<SEC-DOCUMENT>0001656472-21-000091.txt : 20210806
<SEC-HEADER>0001656472-21-000091.hdr.sgml : 20210806
<ACCEPTANCE-DATETIME>20210806073717
ACCESSION NUMBER:		0001656472-21-000091
CONFORMED SUBMISSION TYPE:	10-Q
PUBLIC DOCUMENT COUNT:		81
CONFORMED PERIOD OF REPORT:	20210630
FILED AS OF DATE:		20210806
DATE AS OF CHANGE:		20210806

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			Cronos Group Inc.
		CENTRAL INDEX KEY:			0001656472
		STANDARD INDUSTRIAL CLASSIFICATION:	MEDICINAL CHEMICALS & BOTANICAL PRODUCTS [2833]
		IRS NUMBER:				000000000
		STATE OF INCORPORATION:			A6
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		10-Q
		SEC ACT:		1934 Act
		SEC FILE NUMBER:	001-38403
		FILM NUMBER:		211150575

	BUSINESS ADDRESS:	
		STREET 1:		111 PETER STREET
		STREET 2:		SUITE 300
		CITY:			TORONTO
		STATE:			A6
		ZIP:			M5V 2H1
		BUSINESS PHONE:		(416) 504-0004

	MAIL ADDRESS:	
		STREET 1:		111 PETER STREET
		STREET 2:		SUITE 300
		CITY:			TORONTO
		STATE:			A6
		ZIP:			M5V 2H1

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	PharmaCan Capital Corp.
		DATE OF NAME CHANGE:	20151021
</SEC-HEADER>
<DOCUMENT>
<TYPE>10-Q
<SEQUENCE>1
<FILENAME>cron-20210630.htm
<DESCRIPTION>10-Q
<TEXT>
<XBRL>
<?xml version="1.0" ?><!--XBRL Document Created with Wdesk from Workiva--><!--Copyright 2021 Workiva--><!--r:198d4367-d088-421d-9dd0-dd878c4919c5,g:e5d1c22f-365f-46d5-96bc-44505885d3ea,d:93ca9bb01792476fbb225e5d9dec869f--><html xmlns:us-gaap="http://fasb.org/us-gaap/2021-01-31" xmlns:xbrli="http://www.xbrl.org/2003/instance" xmlns:srt="http://fasb.org/srt/2021-01-31" xmlns:ix="http://www.xbrl.org/2013/inlineXBRL" xmlns:iso4217="http://www.xbrl.org/2003/iso4217" xmlns="http://www.w3.org/1999/xhtml" xmlns:cron="http://thecronosgroup.com/20210630" xmlns:ixt="http://www.xbrl.org/inlineXBRL/transformation/2015-02-26" xmlns:xbrldi="http://xbrl.org/2006/xbrldi" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:ixt-sec="http://www.sec.gov/inlineXBRL/transformation/2015-08-31" xmlns:country="http://xbrl.sec.gov/country/2021" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:utr="http://www.xbrl.org/2009/utr" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:dei="http://xbrl.sec.gov/dei/2021" xml:lang="en-US"><head><meta http-equiv="Content-Type" content="text/html"/>


<title>cron-20210630</title></head><body><div style="display:none"><ix:header><ix:hidden><ix:nonNumeric contextRef="i69782326f71a44e3805518280ee22b6b_D20210101-20210630" name="dei:AmendmentFlag" id="id3VybDovL2RvY3MudjEvZG9jOjkzY2E5YmIwMTc5MjQ3NmZiYjIyNWU1ZDlkZWM4NjlmL3NlYzo5M2NhOWJiMDE3OTI0NzZmYmIyMjVlNWQ5ZGVjODY5Zl80L2ZyYWc6MDA4NmExNGYyYWEzNDc5ODk3ZjYwZWZkYzFkNDNkMTIvdGFibGU6ZDlhNjRjNGJkMzNmNGNmNmI3M2RkMTJiOWYxMWRlMWEvdGFibGVyYW5nZTpkOWE2NGM0YmQzM2Y0Y2Y2YjczZGQxMmI5ZjExZGUxYV8wLTEtMS0xLTA_44c0178a-e7f9-4193-950b-162c1a068bd0">false</ix:nonNumeric><ix:nonNumeric contextRef="i69782326f71a44e3805518280ee22b6b_D20210101-20210630" name="dei:DocumentFiscalYearFocus" id="id3VybDovL2RvY3MudjEvZG9jOjkzY2E5YmIwMTc5MjQ3NmZiYjIyNWU1ZDlkZWM4NjlmL3NlYzo5M2NhOWJiMDE3OTI0NzZmYmIyMjVlNWQ5ZGVjODY5Zl80L2ZyYWc6MDA4NmExNGYyYWEzNDc5ODk3ZjYwZWZkYzFkNDNkMTIvdGFibGU6ZDlhNjRjNGJkMzNmNGNmNmI3M2RkMTJiOWYxMWRlMWEvdGFibGVyYW5nZTpkOWE2NGM0YmQzM2Y0Y2Y2YjczZGQxMmI5ZjExZGUxYV8xLTEtMS0xLTA_f17daa57-ebc7-4f67-b988-2a14a1019a93">2021</ix:nonNumeric><ix:nonNumeric contextRef="i69782326f71a44e3805518280ee22b6b_D20210101-20210630" name="dei:DocumentFiscalPeriodFocus" id="id3VybDovL2RvY3MudjEvZG9jOjkzY2E5YmIwMTc5MjQ3NmZiYjIyNWU1ZDlkZWM4NjlmL3NlYzo5M2NhOWJiMDE3OTI0NzZmYmIyMjVlNWQ5ZGVjODY5Zl80L2ZyYWc6MDA4NmExNGYyYWEzNDc5ODk3ZjYwZWZkYzFkNDNkMTIvdGFibGU6ZDlhNjRjNGJkMzNmNGNmNmI3M2RkMTJiOWYxMWRlMWEvdGFibGVyYW5nZTpkOWE2NGM0YmQzM2Y0Y2Y2YjczZGQxMmI5ZjExZGUxYV8yLTEtMS0xLTA_51b21a39-29f8-43bf-a80b-6fcab57805e2">Q2</ix:nonNumeric><ix:nonNumeric contextRef="i69782326f71a44e3805518280ee22b6b_D20210101-20210630" name="dei:EntityCentralIndexKey" id="id3VybDovL2RvY3MudjEvZG9jOjkzY2E5YmIwMTc5MjQ3NmZiYjIyNWU1ZDlkZWM4NjlmL3NlYzo5M2NhOWJiMDE3OTI0NzZmYmIyMjVlNWQ5ZGVjODY5Zl80L2ZyYWc6MDA4NmExNGYyYWEzNDc5ODk3ZjYwZWZkYzFkNDNkMTIvdGFibGU6ZDlhNjRjNGJkMzNmNGNmNmI3M2RkMTJiOWYxMWRlMWEvdGFibGVyYW5nZTpkOWE2NGM0YmQzM2Y0Y2Y2YjczZGQxMmI5ZjExZGUxYV80LTEtMS0xLTA_08d9fc38-a836-461e-8bc9-aa830148e48f">0001656472</ix:nonNumeric><ix:nonNumeric contextRef="i69782326f71a44e3805518280ee22b6b_D20210101-20210630" name="dei:CurrentFiscalYearEndDate" id="id3VybDovL2RvY3MudjEvZG9jOjkzY2E5YmIwMTc5MjQ3NmZiYjIyNWU1ZDlkZWM4NjlmL3NlYzo5M2NhOWJiMDE3OTI0NzZmYmIyMjVlNWQ5ZGVjODY5Zl80L2ZyYWc6MDA4NmExNGYyYWEzNDc5ODk3ZjYwZWZkYzFkNDNkMTIvdGFibGU6ZDlhNjRjNGJkMzNmNGNmNmI3M2RkMTJiOWYxMWRlMWEvdGFibGVyYW5nZTpkOWE2NGM0YmQzM2Y0Y2Y2YjczZGQxMmI5ZjExZGUxYV81LTEtMS0xLTA_059ee644-fe4b-4115-b867-e2439e6724c0">--12-31</ix:nonNumeric><ix:nonNumeric contextRef="i3d31fbca3c6044d5bd0e62b05769e769_D20200329-20200329" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1" id="id3VybDovL2RvY3MudjEvZG9jOjkzY2E5YmIwMTc5MjQ3NmZiYjIyNWU1ZDlkZWM4NjlmL3NlYzo5M2NhOWJiMDE3OTI0NzZmYmIyMjVlNWQ5ZGVjODY5Zl80OS9mcmFnOjdkOTcyM2RkMjdkODRhNWFiYjJiMzcyOTJmYjZhMmUzL3RleHRyZWdpb246N2Q5NzIzZGQyN2Q4NGE1YWJiMmIzNzI5MmZiNmEyZTNfMTAxNA_bcd0b46d-5e0a-4add-a684-db7137029aee">P3Y</ix:nonNumeric><ix:nonNumeric contextRef="iafb1144677d145049a09cbdbb0457c7b_D20200329-20200329" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1" id="id3VybDovL2RvY3MudjEvZG9jOjkzY2E5YmIwMTc5MjQ3NmZiYjIyNWU1ZDlkZWM4NjlmL3NlYzo5M2NhOWJiMDE3OTI0NzZmYmIyMjVlNWQ5ZGVjODY5Zl80OS9mcmFnOjdkOTcyM2RkMjdkODRhNWFiYjJiMzcyOTJmYjZhMmUzL3RleHRyZWdpb246N2Q5NzIzZGQyN2Q4NGE1YWJiMmIzNzI5MmZiNmEyZTNfMTE1NA_462d9472-3856-448b-97f2-4ab4e5aeb10e">P3Y</ix:nonNumeric></ix:hidden><ix:references xml:lang="en-US"><link:schemaRef xlink:type="simple" xlink:href="cron-20210630.xsd"></link:schemaRef></ix:references><ix:resources><xbrli:context id="i69782326f71a44e3805518280ee22b6b_D20210101-20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001656472</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:unit id="shares"><xbrli:measure>xbrli:shares</xbrli:measure></xbrli:unit><xbrli:context id="ia52c55475f2e488fac07e8b8f24caaa3_I20210805"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001656472</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:instant>2021-08-05</xbrli:instant></xbrli:period></xbrli:context><xbrli:unit id="usd"><xbrli:measure>iso4217:USD</xbrli:measure></xbrli:unit><xbrli:context id="i225f85e38faa4bbdb4de1d8b9cf369bb_I20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001656472</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:instant>2021-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ifbe16ec51ea244519b77d6036b4ef038_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001656472</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i27f4e53b91ad4367b7f8d273eff27769_D20210401-20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001656472</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:startDate>2021-04-01</xbrli:startDate><xbrli:endDate>2021-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i39065c5daf934af885335c12f3cfa83f_D20200401-20200630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001656472</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:startDate>2020-04-01</xbrli:startDate><xbrli:endDate>2020-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i4a110e4972ef4113880ce582e3cda5c5_D20200101-20200630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001656472</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:unit id="usdPerShare"><xbrli:divide><xbrli:unitNumerator><xbrli:measure>iso4217:USD</xbrli:measure></xbrli:unitNumerator><xbrli:unitDenominator><xbrli:measure>xbrli:shares</xbrli:measure></xbrli:unitDenominator></xbrli:divide></xbrli:unit><xbrli:context id="i22dfc818a91c4bc99bcf6f1109597b56_I20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001656472</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="iaba74aed20054433bd6c1d99389ea937_I20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001656472</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="if6552787aa974a6b8ba4aa50cadb2110_I20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001656472</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i3243ae496b5b4b50976442544343adcf_I20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001656472</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i578f5574593f4ae99f69ac675bbba2b7_I20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001656472</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:NoncontrollingInterestMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i672ae438d5904d3aa27f245b59e5ba4c_I20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001656472</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:instant>2021-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i932ec7c01594418eb95662a351e601a2_D20210401-20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001656472</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-04-01</xbrli:startDate><xbrli:endDate>2021-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ia4656c8d89cf4a84bdd02d8823c897bb_D20210401-20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001656472</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-04-01</xbrli:startDate><xbrli:endDate>2021-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i9a1c715fbcf44b979e7e0fcb5928d719_D20210401-20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001656472</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-04-01</xbrli:startDate><xbrli:endDate>2021-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i8e7f3ff52d71479293ec038396352775_D20210401-20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001656472</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:NoncontrollingInterestMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-04-01</xbrli:startDate><xbrli:endDate>2021-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i4e1c8fe7ad9241eaa0d77b74d41be015_D20210401-20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001656472</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-04-01</xbrli:startDate><xbrli:endDate>2021-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i1d565c32dabc40c08d36232dec1a7779_I20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001656472</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ibbfd3d5a9feb460a8f0fe21cf2539d79_I20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001656472</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i5b5acb4a63db4a419bb0b3e0c4a24492_I20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001656472</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i7d990708cda34586a3e37a53dd59fb03_I20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001656472</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i64458da0ec424fd8a6faf87d69636ecd_I20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001656472</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:NoncontrollingInterestMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="id078e2f741bd40b185fe15fe9cf71aa0_I20200331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001656472</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i3168099a593240dc9af0efd91a744144_I20200331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001656472</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i6c7b98afcbdf46659d197205a453981e_I20200331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001656472</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i7f15d7e0c5e448758e421628b06b233f_I20200331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001656472</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i03a4fd9ba8c844bea0cc0519e18e1383_I20200331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001656472</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:NoncontrollingInterestMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i3c0f68bcd0b6498c90c48a6506a0b9e3_I20200331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001656472</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:instant>2020-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i6d595f441a124fe6a1a07ecf8f23ee48_D20200401-20200630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001656472</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-04-01</xbrli:startDate><xbrli:endDate>2020-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ic52bfb3ca2d34600a199a8873b1c09c0_D20200401-20200630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001656472</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-04-01</xbrli:startDate><xbrli:endDate>2020-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ie91f1ea24b414f65af58207f3d177f44_D20200401-20200630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001656472</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-04-01</xbrli:startDate><xbrli:endDate>2020-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i3bd28b951b5141a3ac4946bb9c8d4486_D20200401-20200630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001656472</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:NoncontrollingInterestMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-04-01</xbrli:startDate><xbrli:endDate>2020-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i7d089148856645de804437e1aae7cf7a_D20200401-20200630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001656472</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-04-01</xbrli:startDate><xbrli:endDate>2020-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i7b64ecf012bd43b397dcea9317f0673b_I20200630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001656472</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="if06bdc9d2d5b40ca88594d8c716a000d_I20200630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001656472</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ibd5f91f865b44c90b9aab2e68420d292_I20200630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001656472</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ib7db517c67504b3baeead491589a7ed6_I20200630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001656472</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i87ce495c26b34c268c848a2934ad3f39_I20200630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001656472</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:NoncontrollingInterestMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="id670dc9b33e6430f9d7510009f7495a7_I20200630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001656472</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:instant>2020-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i89f360b9f95a44cea98ec721cc461ecf_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001656472</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="idaa77962d21a4f8ca12568eede000e4f_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001656472</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i6710ab378a79438f94aa90687467e6f3_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001656472</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ib7805645a77f444aa3190c257d456437_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001656472</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ie669a3c1e1ca4bd8acd069f0187ca14a_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001656472</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:NoncontrollingInterestMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i52c9b3fb67014eb083670c6a1d51b149_D20210101-20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001656472</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i32ce7a4cf9fe4b5fb2ba774cbeb3025e_D20210101-20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001656472</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i24b7b1f487f24a12927c251dc2cc0562_D20210101-20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001656472</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="if8ae25ba0a1c4efd878426d129e53e7b_D20210101-20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001656472</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:NoncontrollingInterestMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="if19cdb6b9f6f463e8cdd761179f9db89_D20210101-20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001656472</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ibec8035afed7413580a92eb6c685b162_I20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001656472</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i22d6ccbfd09c4945825d9d9eccef7a82_I20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001656472</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i5e450cfb71c44415b401ef2a8c9b958a_I20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001656472</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i4dec53ede4f44421a40be0b4d3eb49a6_I20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001656472</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ic0274d7a972e4964b3d0fca8bddf9b4c_I20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001656472</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:NoncontrollingInterestMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ie4fc90ad6d7f4d39aea9cb65c8026e09_I20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001656472</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ief0b929c9a76458b843a186c4b2a71f2_D20200101-20200630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001656472</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ie28d03ed3f6c447e8db8badbe540043f_D20200101-20200630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001656472</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i26b7daea50264418b7767fc75a7923c2_D20200101-20200630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001656472</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i7c11393ac61249f3805d21818892a170_D20200101-20200630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001656472</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:NoncontrollingInterestMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ifa1d8c60d03c4b2d83a1d0b04dad4282_D20200101-20200630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001656472</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:unit id="continent"><xbrli:measure>cron:continent</xbrli:measure></xbrli:unit><xbrli:unit id="brand"><xbrli:measure>cron:brand</xbrli:measure></xbrli:unit><xbrli:unit id="number"><xbrli:measure>xbrli:pure</xbrli:measure></xbrli:unit><xbrli:context id="i52d0636c66ed4ea58c20dfcc9a4132e8_I20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001656472</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis">cron:CronosAustraliaLimitedMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i6506a062286b47c0b48f06151d87d9e6_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001656472</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:RestatementAxis">srt:RevisionOfPriorPeriodErrorCorrectionAdjustmentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ErrorCorrectionsAndPriorPeriodAdjustmentsRestatementByRestatementPeriodAndAmountAxis">cron:ErrorRelatedToWithholdingTaxesOnTheNetExerciseOfStockOptionsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ic583ba915ef943c8be4157a2a9ead807_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001656472</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:RestatementAxis">srt:RevisionOfPriorPeriodErrorCorrectionAdjustmentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ErrorCorrectionsAndPriorPeriodAdjustmentsRestatementByRestatementPeriodAndAmountAxis">cron:ErrorRelatedToExerciseOfTopUpRightsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ice66d39b8cf24a6b82c9c3c91f87fece_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001656472</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:RestatementAxis">srt:RevisionOfPriorPeriodErrorCorrectionAdjustmentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ErrorCorrectionsAndPriorPeriodAdjustmentsRestatementByRestatementPeriodAndAmountAxis">cron:ErrorRelatedToExerciseOfTopUpRightsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i71f353c527264f29bc7b447983a0f96b_I20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001656472</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:RestatementAxis">srt:RevisionOfPriorPeriodErrorCorrectionAdjustmentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ErrorCorrectionsAndPriorPeriodAdjustmentsRestatementByRestatementPeriodAndAmountAxis">cron:ErrorRelatedToExerciseOfTopUpRightsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ib02278c2b0d7400b81a88f77d9b1d053_D20210101-20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001656472</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:RestatementAxis">srt:RevisionOfPriorPeriodErrorCorrectionAdjustmentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ErrorCorrectionsAndPriorPeriodAdjustmentsRestatementByRestatementPeriodAndAmountAxis">cron:ErrorRelatedToExerciseOfTopUpRightsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i2c5e7037ffad4b3fb6a481d2db070fa0_D20180614-20180614"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001656472</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ConsolidatedEntitiesAxis">us-gaap:VariableInterestEntityNotPrimaryBeneficiaryMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis">cron:CronosGrowingCompanyInc.Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2018-06-14</xbrli:startDate><xbrli:endDate>2018-06-14</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i5fb990fe11674db5b7f9322fbc74ed16_D20180313-20180313"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001656472</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ConsolidatedEntitiesAxis">us-gaap:VariableInterestEntityNotPrimaryBeneficiaryMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis">cron:MedMenCanadaInc.Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2018-03-13</xbrli:startDate><xbrli:endDate>2018-03-13</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="iee8bd06f99704a93846316c2ce890297_D20180313-20180313"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001656472</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ConsolidatedEntitiesAxis">us-gaap:VariableInterestEntityNotPrimaryBeneficiaryMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis">cron:MedMenCanadaInc.Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2018-03-13</xbrli:startDate><xbrli:endDate>2018-03-13</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i2dd929bbe65b485fba3ba327ce7e73d7_D20210101-20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001656472</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ConsolidatedEntitiesAxis">us-gaap:VariableInterestEntityNotPrimaryBeneficiaryMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis">cron:NatueraMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:unit id="ils"><xbrli:measure>iso4217:ILS</xbrli:measure></xbrli:unit><xbrli:context id="i00bf33a48aaa4cf2930896225af28659_I20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001656472</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis">cron:CannasoulAnalyticsLtdMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">us-gaap:CollaborativeArrangementTransactionWithPartyToCollaborativeArrangementMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ConsolidatedEntitiesAxis">us-gaap:VariableInterestEntityNotPrimaryBeneficiaryMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="cron:LoanReceivableNameAxis">cron:CannasoulCollaborationLoanMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis">us-gaap:LoansReceivableMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ic24b8af14f4a4a25a1f88b1707e38fa7_D20210101-20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001656472</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis">cron:CannasoulAnalyticsLtdMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">us-gaap:CollaborativeArrangementTransactionWithPartyToCollaborativeArrangementMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ConsolidatedEntitiesAxis">us-gaap:VariableInterestEntityNotPrimaryBeneficiaryMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="cron:LoanReceivableNameAxis">cron:CannasoulCollaborationLoanMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis">us-gaap:LoansReceivableMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i5822a176b17c44938c5acb5edec46594_I20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001656472</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis">cron:CannasoulAnalyticsLtdMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">us-gaap:CollaborativeArrangementTransactionWithPartyToCollaborativeArrangementMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ConsolidatedEntitiesAxis">us-gaap:VariableInterestEntityNotPrimaryBeneficiaryMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i78252faeeac94cf1b00fbbab110c7bb8_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001656472</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis">cron:CronosAustraliaLimitedMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i994476164a994f30beee53e661ac1a3f_I20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001656472</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis">cron:CronosGrowingCompanyInc.Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i1b2c600c66ab4356a1aaf56482c504bd_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001656472</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis">cron:CronosGrowingCompanyInc.Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i21b51b5045c34ad2a57cb43054dca216_I20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001656472</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis">cron:NatueraMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i223bb2102d6d47b4988c830f7fa1a159_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001656472</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis">cron:NatueraMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i3851bec177234bbb9f9d96a1e3eab1d3_D20210401-20210401"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001656472</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="cron:LoanReceivableNameAxis">cron:NatuEraSeriesALoanMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis">us-gaap:LoansReceivableMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-04-01</xbrli:startDate><xbrli:endDate>2021-04-01</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i8b8f1fc37db0427b9d081e7b40a48cc0_I20210401"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001656472</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="cron:LoanReceivableNameAxis">cron:NatuEraSeriesALoanMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="dei:LegalEntityAxis">cron:CronosGroupInc.Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis">us-gaap:LoansReceivableMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-04-01</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ia926bcff688b4febb81d8fa1a08955dc_I20210401"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001656472</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="dei:LegalEntityAxis">cron:AgroideaMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="cron:LoanReceivableNameAxis">cron:NatuEraSeriesALoanMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis">us-gaap:LoansReceivableMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-04-01</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i3734fffa32be45c299b65b62d227d165_D20210401-20210401"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001656472</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="cron:LoanReceivableNameAxis">cron:NatuEraSeriesALoanMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="dei:LegalEntityAxis">cron:CronosGroupInc.Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis">us-gaap:LoansReceivableMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-04-01</xbrli:startDate><xbrli:endDate>2021-04-01</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ibb17976a662245c78f9ece050fbca040_D20210401-20210401"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001656472</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="dei:LegalEntityAxis">cron:AgroideaMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="cron:LoanReceivableNameAxis">cron:NatuEraSeriesALoanMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis">us-gaap:LoansReceivableMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-04-01</xbrli:startDate><xbrli:endDate>2021-04-01</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i74feb9a5e3ba4f03b6af6468c854d7d3_I20210401"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001656472</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="cron:LoanReceivableNameAxis">cron:NatuEraSeriesALoanMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis">us-gaap:LoansReceivableMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-04-01</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i30bada16350b499487452cc45133a766_D20210401-20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001656472</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis">cron:CronosAustraliaLimitedMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-04-01</xbrli:startDate><xbrli:endDate>2021-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="if1b554f135154a859f4b34c7f4f919c1_D20200401-20200630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001656472</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis">cron:CronosAustraliaLimitedMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-04-01</xbrli:startDate><xbrli:endDate>2020-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="id0c3e6d83e194fea9819a119d3744bb2_D20210101-20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001656472</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis">cron:CronosAustraliaLimitedMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ia01f832913b34cc9857827304dc28007_D20200101-20200630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001656472</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis">cron:CronosAustraliaLimitedMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ia802a14b03cd4f04a97ecbdec57e7b1f_D20210401-20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001656472</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis">cron:CronosGrowingCompanyInc.Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-04-01</xbrli:startDate><xbrli:endDate>2021-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="iddbb1b3540664f4db9ee13a36913a70f_D20200401-20200630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001656472</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis">cron:CronosGrowingCompanyInc.Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-04-01</xbrli:startDate><xbrli:endDate>2020-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i9f733a1140c84f8286365160805bda02_D20210101-20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001656472</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis">cron:CronosGrowingCompanyInc.Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i747cf8446c5d4312bef9db8f92ed86e7_D20200101-20200630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001656472</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis">cron:CronosGrowingCompanyInc.Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i09025c29bd8b4bf4aa6255cec7a052f9_D20210401-20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001656472</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis">cron:NatueraMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-04-01</xbrli:startDate><xbrli:endDate>2021-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i9c2dea6ae084465eb492033eb5079812_D20200401-20200630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001656472</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis">cron:NatueraMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-04-01</xbrli:startDate><xbrli:endDate>2020-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i1d33f1b94b814dde969a15e41c194555_D20210101-20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001656472</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis">cron:NatueraMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ia3632b75442e4ecab5344b972f4835a5_D20200101-20200630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001656472</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis">cron:NatueraMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i0a6f7aeaf7984695bd038544768f44ce_D20210101-20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001656472</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis">cron:CronosAustraliaLimitedMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ConsolidatedEntitiesAxis">us-gaap:VariableInterestEntityNotPrimaryBeneficiaryMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i9b8aec0ea4404ec8b5d82299348089bf_I20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001656472</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis">cron:CronosAustraliaLimitedMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ConsolidatedEntitiesAxis">us-gaap:VariableInterestEntityNotPrimaryBeneficiaryMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i66749f2799dd4940bef71ca978540e57_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001656472</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis">cron:CronosAustraliaLimitedMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ConsolidatedEntitiesAxis">us-gaap:VariableInterestEntityNotPrimaryBeneficiaryMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="if3db2c911124490fab5cdb3084df56db_D20210101-20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001656472</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ConsolidatedEntitiesAxis">us-gaap:VariableInterestEntityNotPrimaryBeneficiaryMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis">cron:CronosGrowingCompanyInc.Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i353124414ba44af49353f31dc922db70_I20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001656472</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ConsolidatedEntitiesAxis">us-gaap:VariableInterestEntityNotPrimaryBeneficiaryMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis">cron:CronosGrowingCompanyInc.Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i3afecd33173246f185a69d63285abf8c_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001656472</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ConsolidatedEntitiesAxis">us-gaap:VariableInterestEntityNotPrimaryBeneficiaryMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis">cron:CronosGrowingCompanyInc.Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ie2fdd9071c2c4923bce9ab671e6af04d_D20210101-20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001656472</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ConsolidatedEntitiesAxis">us-gaap:VariableInterestEntityNotPrimaryBeneficiaryMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis">cron:MedMenCanadaInc.Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ib9811da8a9704222a0df27a3f63f596b_I20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001656472</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ConsolidatedEntitiesAxis">us-gaap:VariableInterestEntityNotPrimaryBeneficiaryMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis">cron:MedMenCanadaInc.Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="iaaa05d4ed8b34a308235a68b7882864c_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001656472</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ConsolidatedEntitiesAxis">us-gaap:VariableInterestEntityNotPrimaryBeneficiaryMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis">cron:MedMenCanadaInc.Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i3b3152f5409c4a70870bd6f4cb775dd4_D20210101-20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001656472</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ConsolidatedEntitiesAxis">us-gaap:VariableInterestEntityNotPrimaryBeneficiaryMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis">cron:NatuEraMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ibda190acea7645e2a6859c2bdb2fc787_I20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001656472</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ConsolidatedEntitiesAxis">us-gaap:VariableInterestEntityNotPrimaryBeneficiaryMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis">cron:NatuEraMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i390d021c539343388dd3edb041b0e9aa_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001656472</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ConsolidatedEntitiesAxis">us-gaap:VariableInterestEntityNotPrimaryBeneficiaryMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis">cron:NatuEraMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ic4e23b56bd44457695de2dfbd9a6ce67_D20210614-20210614"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001656472</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="dei:LegalEntityAxis">cron:PharmacannMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-06-14</xbrli:startDate><xbrli:endDate>2021-06-14</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="iaa37e41bb48a45ae9333902e59ee2719_I20210614"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001656472</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:instant>2021-06-14</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ibd87bb26d08f46e4bfa11a80236a610a_D20210614-20210614"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001656472</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:startDate>2021-06-14</xbrli:startDate><xbrli:endDate>2021-06-14</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i7e8821bb92b54aa5a40ec87007ddd06a_I20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001656472</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="cron:LoanReceivableNameAxis">cron:NatuEraSeriesALoanMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis">us-gaap:LoansReceivableMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ic0f4e3758c364fee99c468147d904bdc_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001656472</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="cron:LoanReceivableNameAxis">cron:NatuEraSeriesALoanMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis">us-gaap:LoansReceivableMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i4d5e5ad8b8c04f0e81c4f56d20dd2667_I20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001656472</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="cron:LoanReceivableNameAxis">cron:CronosGrowCoCreditFacilityMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis">us-gaap:LoansReceivableMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i389408e323054f34bb2d44166886cfa0_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001656472</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="cron:LoanReceivableNameAxis">cron:CronosGrowCoCreditFacilityMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis">us-gaap:LoansReceivableMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i0709927d1c004766b70bf1b85ffbd9b2_I20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001656472</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis">us-gaap:LoansReceivableMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i830d314bf026450e8e38d200944077bf_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001656472</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis">us-gaap:LoansReceivableMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i6c507204183f49389291963dff6d55c3_I20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001656472</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="cron:LoanReceivableNameAxis">cron:A2645485OntarioInc.MucciPromissoryNoteMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis">us-gaap:LoansReceivableMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i09921e492ba24195a2e19b52c026c6f7_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001656472</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="cron:LoanReceivableNameAxis">cron:A2645485OntarioInc.MucciPromissoryNoteMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis">us-gaap:LoansReceivableMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i49f2e1595c1b41f4bcbef6f1031a9d69_I20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001656472</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="cron:LoanReceivableNameAxis">cron:CannasoulCollaborationLoanMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis">us-gaap:LoansReceivableMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i7c3fa2a3ef8f464583be7da8ce8425ee_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001656472</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="cron:LoanReceivableNameAxis">cron:CannasoulCollaborationLoanMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis">us-gaap:LoansReceivableMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:unit id="cad"><xbrli:measure>iso4217:CAD</xbrli:measure></xbrli:unit><xbrli:context id="i41fdc77f9612409ab114fbdf3c20b8a8_D20210101-20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001656472</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="cron:LoanReceivableNameAxis">cron:CronosGrowCoCreditFacilityMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis">us-gaap:LoansReceivableMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i2873575c69e24565bb61cd0985446112_D20190101-20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001656472</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="cron:LoanReceivableNameAxis">cron:CronosGrowCoCreditFacilityMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis">us-gaap:LoansReceivableMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-01-01</xbrli:startDate><xbrli:endDate>2019-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ifdf5fbc8e97845b297aa6f44576063c3_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001656472</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis">cron:CannasoulAnalyticsLtdMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">us-gaap:CollaborativeArrangementTransactionWithPartyToCollaborativeArrangementMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ConsolidatedEntitiesAxis">us-gaap:VariableInterestEntityNotPrimaryBeneficiaryMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="cron:LoanReceivableNameAxis">cron:CannasoulCollaborationLoanMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis">us-gaap:LoansReceivableMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i74b9dd5702d7406d891cf47a54534f5d_D20190308-20190308"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001656472</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">cron:AltriaInvestmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-03-08</xbrli:startDate><xbrli:endDate>2019-03-08</xbrli:endDate></xbrli:period></xbrli:context><xbrli:unit id="warrant"><xbrli:measure>cron:warrant</xbrli:measure></xbrli:unit><xbrli:context id="i0e42c55484f24f8ca353ad7f388b4066_D20190308-20190308"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001656472</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">cron:AltriaWarrantMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-03-08</xbrli:startDate><xbrli:endDate>2019-03-08</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="idadea534a9454dde961a3571663d9316_I20190308"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001656472</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis">cron:CronosGroupInc.Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="dei:LegalEntityAxis">cron:AltriaGroupInc.Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-03-08</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i12a4ebb046d84e5b9eb27c82479f837b_I20190308"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001656472</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ConsolidatedEntitiesAxis">srt:SubsidiariesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="dei:LegalEntityAxis">cron:AltriaGroupInc.Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-03-08</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i0a23fd4d2173473387281b095562f1e0_I20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001656472</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis">cron:CronosGroupInc.Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="dei:LegalEntityAxis">cron:AltriaGroupInc.Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="iff243ffb3690436c962f2508a95b9bf9_I20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001656472</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ConsolidatedEntitiesAxis">srt:SubsidiariesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="dei:LegalEntityAxis">cron:AltriaGroupInc.Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="iab341b8979a347a9b96abc3a20faff60_I20190308"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001656472</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">cron:AltriaInvestmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-03-08</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i5b5f21f6057c4e8e893d9e27815ea92a_I20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001656472</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">cron:AltriaInvestmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:unit id="cadPerShare"><xbrli:divide><xbrli:unitNumerator><xbrli:measure>iso4217:CAD</xbrli:measure></xbrli:unitNumerator><xbrli:unitDenominator><xbrli:measure>xbrli:shares</xbrli:measure></xbrli:unitDenominator></xbrli:divide></xbrli:unit><xbrli:context id="i1d456d0e4fcf43c6ad21f99b40cbf279_I20190308"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001656472</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">cron:AltriaWarrantMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-03-08</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i379e3f598bfc45909cc782ee94752221_I20190308"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001656472</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">cron:PreemptiveRightsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-03-08</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i92e07d954a1e4dc78f61eca5784be099_D20190308-20190308"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001656472</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">cron:TopupRightsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-03-08</xbrli:startDate><xbrli:endDate>2019-03-08</xbrli:endDate></xbrli:period></xbrli:context><xbrli:unit id="day"><xbrli:measure>cron:day</xbrli:measure></xbrli:unit><xbrli:context id="i5c3db268f31b4ec899f7f0121d0b1bf8_I20190308"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001656472</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">cron:TopupRightsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-03-08</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i7456fc9f9bac466e8f36318a7f2e0986_I20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001656472</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">cron:AltriaWarrantMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="iecf64aa815654085bee554811ab6f80e_D20210401-20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001656472</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">cron:AltriaWarrantMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-04-01</xbrli:startDate><xbrli:endDate>2021-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i34995f47e8ba418fbd529b2ed52790dc_I20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001656472</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">cron:AltriaWarrantMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i626147251ce249d59dd6e68a90196f38_I20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001656472</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">cron:PreemptiveRightsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i8c832bd4137248cb9777e42d7526fc6e_D20210401-20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001656472</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">cron:PreemptiveRightsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-04-01</xbrli:startDate><xbrli:endDate>2021-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ie4ec3b642b3b4457b78cb85e8d1838f0_I20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001656472</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">cron:PreemptiveRightsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i38d49776600045c1b8110dc70e805025_I20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001656472</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">cron:TopupRightsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i03741f2ae4674980813a9701e43f6a2b_D20210401-20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001656472</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">cron:TopupRightsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-04-01</xbrli:startDate><xbrli:endDate>2021-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ia2cd5cb93e97428dabd7e841eee51895_I20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001656472</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">cron:TopupRightsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="if715f02149d34306825baa5114765cba_I20200331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001656472</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">cron:AltriaWarrantMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i1b9a300b5b514425a64d7bc17abb0931_D20200401-20200630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001656472</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">cron:AltriaWarrantMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-04-01</xbrli:startDate><xbrli:endDate>2020-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i69563d705edd465aabff3c895c85c313_I20200630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001656472</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">cron:AltriaWarrantMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="id9dedf3ba4bb445d8d76440d2f0ce670_I20200331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001656472</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">cron:PreemptiveRightsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ifc3c6e8680594375afc563066129c544_D20200401-20200630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001656472</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">cron:PreemptiveRightsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-04-01</xbrli:startDate><xbrli:endDate>2020-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i08475478dc1e46759179fb5a161607ba_I20200630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001656472</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">cron:PreemptiveRightsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i6e6227af7d3b47f5a13d2cf8fabe34f8_I20200331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001656472</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">cron:TopupRightsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="iab54aa6542634043937616e303d80df7_D20200401-20200630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001656472</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">cron:TopupRightsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-04-01</xbrli:startDate><xbrli:endDate>2020-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i1cd84431f8574b82a2e542790c822e83_I20200630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001656472</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">cron:TopupRightsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i386ef852060640f8a03a30f10d03a1cd_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001656472</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">cron:AltriaWarrantMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i45890500f835452a848efa1f84799c48_D20210101-20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001656472</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">cron:AltriaWarrantMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i72ce1ade65834a50bf4468cde26bf617_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001656472</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">cron:PreemptiveRightsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i94f8ae36db664c2bbb298d6c3f5792c3_D20210101-20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001656472</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">cron:PreemptiveRightsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="if0aa3f5449da461c85f0c0831bf3c984_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001656472</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">cron:TopupRightsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i10b0581e8a9b40e0a1e14e14bcc22d54_D20210101-20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001656472</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">cron:TopupRightsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i006bb3bd444d41edb5d292ff7ec0668f_I20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001656472</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">cron:AltriaWarrantMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i19c47df0e3634358808ebcc68facfcde_D20200101-20200630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001656472</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">cron:AltriaWarrantMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="id3abf03099174cf38da9a24a053a4f90_I20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001656472</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">cron:PreemptiveRightsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="idc180b21ce4e4eefa7a1a4ccdb9ba7a9_D20200101-20200630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001656472</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">cron:PreemptiveRightsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i4edcd0f0354740008d30a06bac0ea0bb_I20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001656472</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">cron:TopupRightsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ia9cf8032e9f7433cb50aee032c5b988b_D20200101-20200630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001656472</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">cron:TopupRightsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i1257ed1c2bd045fbb8c920b7a673a2bc_I20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001656472</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:MeasurementInputTypeAxis">us-gaap:MeasurementInputSharePriceMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">cron:AltriaWarrantMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="id354e82bb28e4e4f86ca8adb1f07698c_I20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001656472</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">cron:PreemptiveRightsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:MeasurementInputTypeAxis">us-gaap:MeasurementInputSharePriceMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i63dea78d92f24ac5a2eef5b4454a6dd3_I20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001656472</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">cron:TopupRightsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:MeasurementInputTypeAxis">us-gaap:MeasurementInputSharePriceMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i3353e98ec8c146078a9728dd2c05959d_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001656472</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:MeasurementInputTypeAxis">us-gaap:MeasurementInputSharePriceMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">cron:AltriaWarrantMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i5b7f2fd4ed2c48b588a6b20efe0642c9_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001656472</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">cron:PreemptiveRightsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:MeasurementInputTypeAxis">us-gaap:MeasurementInputSharePriceMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i4a625e9a51bd4f19acfab304939f7b6d_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001656472</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">cron:TopupRightsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:MeasurementInputTypeAxis">us-gaap:MeasurementInputSharePriceMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i339cf0904cfb4c7199ff22f9b0f89460_I20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001656472</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:MeasurementInputTypeAxis">cron:MeasurementInputSubscriptionPriceMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">cron:AltriaWarrantMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ic23329598e00476e92f1af90f155a47c_I20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001656472</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:MeasurementInputTypeAxis">cron:MeasurementInputSubscriptionPriceMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">cron:PreemptiveRightsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i579c24557a25415ab76670fb8c125152_I20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001656472</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:MeasurementInputTypeAxis">cron:MeasurementInputSubscriptionPriceMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">cron:TopupRightsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ib2597206a68d439e9d9fb442a0edbf09_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001656472</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:MeasurementInputTypeAxis">cron:MeasurementInputSubscriptionPriceMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">cron:AltriaWarrantMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="if7010204491b4497933eebbdfcad9d26_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001656472</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:MeasurementInputTypeAxis">cron:MeasurementInputSubscriptionPriceMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">cron:PreemptiveRightsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i26b4cc1b2d2c4abcb74127a35c819ef3_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001656472</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:MeasurementInputTypeAxis">cron:MeasurementInputSubscriptionPriceMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">cron:TopupRightsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i88181468f4494137aa775f1e418165d7_I20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001656472</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:RangeAxis">srt:WeightedAverageMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:MeasurementInputTypeAxis">us-gaap:MeasurementInputRiskFreeInterestRateMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">cron:AltriaWarrantMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ic12d47490ce74a188ddc34240b7f1bea_I20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001656472</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:RangeAxis">srt:WeightedAverageMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">cron:PreemptiveRightsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:MeasurementInputTypeAxis">us-gaap:MeasurementInputRiskFreeInterestRateMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i6100f128578c4248a96b36db6968b813_I20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001656472</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:RangeAxis">srt:WeightedAverageMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">cron:TopupRightsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:MeasurementInputTypeAxis">us-gaap:MeasurementInputRiskFreeInterestRateMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i23edb2809b3b4515a9b05b50daa96971_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001656472</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:RangeAxis">srt:WeightedAverageMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:MeasurementInputTypeAxis">us-gaap:MeasurementInputRiskFreeInterestRateMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">cron:AltriaWarrantMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ida0e51f36f7241508ea9f1cb51fab77b_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001656472</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:RangeAxis">srt:WeightedAverageMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">cron:PreemptiveRightsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:MeasurementInputTypeAxis">us-gaap:MeasurementInputRiskFreeInterestRateMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i1779eecf81de47219b6cdc404ab734e6_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001656472</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:RangeAxis">srt:WeightedAverageMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">cron:TopupRightsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:MeasurementInputTypeAxis">us-gaap:MeasurementInputRiskFreeInterestRateMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ic02211497b5b474a8462f60dfc14b91f_D20210101-20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001656472</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:RangeAxis">srt:WeightedAverageMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:MeasurementInputTypeAxis">us-gaap:MeasurementInputExpectedTermMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">cron:AltriaWarrantMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ie494d1760a574e71a32cae2bcd0bc6f2_D20210101-20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001656472</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:RangeAxis">srt:WeightedAverageMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">cron:PreemptiveRightsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:MeasurementInputTypeAxis">us-gaap:MeasurementInputExpectedTermMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="id2d2173a25434cd79374e4a7cf5568c2_D20210101-20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001656472</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:RangeAxis">srt:WeightedAverageMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">cron:TopupRightsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:MeasurementInputTypeAxis">us-gaap:MeasurementInputExpectedTermMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i1da031054a504cf79b3d31bfcd7a323a_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001656472</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:RangeAxis">srt:WeightedAverageMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:MeasurementInputTypeAxis">us-gaap:MeasurementInputExpectedTermMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">cron:AltriaWarrantMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i1701f6b7d62b4512bfe98026f74288b7_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001656472</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:RangeAxis">srt:WeightedAverageMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">cron:PreemptiveRightsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:MeasurementInputTypeAxis">us-gaap:MeasurementInputExpectedTermMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i10d7bf0cfd8342e5b54a9ede98d85efa_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001656472</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:RangeAxis">srt:WeightedAverageMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">cron:TopupRightsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:MeasurementInputTypeAxis">us-gaap:MeasurementInputExpectedTermMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="if15b10fbb370412cb143458bfa546283_I20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001656472</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:MeasurementInputTypeAxis">us-gaap:MeasurementInputPriceVolatilityMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">cron:AltriaWarrantMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i8c3dd53b7ced472bbe056909c36fa671_I20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001656472</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:MeasurementInputTypeAxis">us-gaap:MeasurementInputPriceVolatilityMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">cron:PreemptiveRightsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ib976b88274494333b0625717658b451c_I20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001656472</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:MeasurementInputTypeAxis">us-gaap:MeasurementInputPriceVolatilityMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">cron:TopupRightsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i3b4e489f4801442fbe965a24c9af5f86_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001656472</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:MeasurementInputTypeAxis">us-gaap:MeasurementInputPriceVolatilityMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">cron:AltriaWarrantMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i57c58eedfb404984b87b46cbe12d3426_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001656472</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:MeasurementInputTypeAxis">us-gaap:MeasurementInputPriceVolatilityMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">cron:PreemptiveRightsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i9859907a6972416e881289ad4a8c7462_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001656472</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:MeasurementInputTypeAxis">us-gaap:MeasurementInputPriceVolatilityMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">cron:TopupRightsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="id612af184d0d4ee8bae904a6cdcdba6f_I20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001656472</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:MeasurementInputTypeAxis">us-gaap:MeasurementInputExpectedDividendRateMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">cron:AltriaWarrantMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="id5167c2418bc49d79a29b1d99ae027e1_I20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001656472</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">cron:PreemptiveRightsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:MeasurementInputTypeAxis">us-gaap:MeasurementInputExpectedDividendRateMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i79aea684554446b8864ca220d82ab826_I20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001656472</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">cron:TopupRightsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:MeasurementInputTypeAxis">us-gaap:MeasurementInputExpectedDividendRateMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i50dc22d6133f49688c294c0961ff3e97_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001656472</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:MeasurementInputTypeAxis">us-gaap:MeasurementInputExpectedDividendRateMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">cron:AltriaWarrantMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i6cc1c73280a94f4ab8a8e4826245a4a9_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001656472</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">cron:PreemptiveRightsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:MeasurementInputTypeAxis">us-gaap:MeasurementInputExpectedDividendRateMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ia1213fa5613b4ccc8ae504fe77e72358_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001656472</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">cron:TopupRightsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:MeasurementInputTypeAxis">us-gaap:MeasurementInputExpectedDividendRateMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i9ca6679fb2564fde8f5c255991b2b07b_I20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001656472</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">cron:PreEmptiveRightsAndTopUpRightsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:MeasurementInputTypeAxis">us-gaap:MeasurementInputRiskFreeInterestRateMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="idce1c11532374f46a0debb9127ec0281_I20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001656472</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">cron:PreEmptiveRightsAndTopUpRightsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:MeasurementInputTypeAxis">us-gaap:MeasurementInputRiskFreeInterestRateMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i91e2aab33be84cc8a26bac33aca37a7b_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001656472</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">cron:PreEmptiveRightsAndTopUpRightsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:MeasurementInputTypeAxis">us-gaap:MeasurementInputRiskFreeInterestRateMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ic5fe8049d90f4163b34bb2524a897f2d_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001656472</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">cron:PreEmptiveRightsAndTopUpRightsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:MeasurementInputTypeAxis">us-gaap:MeasurementInputRiskFreeInterestRateMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i5f97c3a427254d74b99f26c83a33f800_D20210101-20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001656472</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">cron:PreEmptiveRightsAndTopUpRightsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:MeasurementInputTypeAxis">us-gaap:MeasurementInputExpectedTermMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i404e95ab180846458cdfa503e1b9d618_D20210101-20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001656472</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">cron:PreEmptiveRightsAndTopUpRightsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:MeasurementInputTypeAxis">us-gaap:MeasurementInputExpectedTermMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i1a39a101965648319dfe223e050e1870_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001656472</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">cron:PreEmptiveRightsAndTopUpRightsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:MeasurementInputTypeAxis">us-gaap:MeasurementInputExpectedTermMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="id736a2abed614a71a7524cefc38e23df_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001656472</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">cron:PreEmptiveRightsAndTopUpRightsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:MeasurementInputTypeAxis">us-gaap:MeasurementInputExpectedTermMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i1e4726863b724a379f5bd7d27ab5b3cc_D20210401-20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001656472</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-04-01</xbrli:startDate><xbrli:endDate>2021-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ie0f42dd5b3d34fe38a076491f8d4a0a5_D20200401-20200630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001656472</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-04-01</xbrli:startDate><xbrli:endDate>2020-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="idaf424f34df645f9a313b3cbd11846bb_D20210101-20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001656472</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ib8a293d71fca4827bbf9cac05f24fe68_D20200101-20200630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001656472</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ia9e804ad8293416391f6038663c9425b_D20210401-20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001656472</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockUnitsRSUMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-04-01</xbrli:startDate><xbrli:endDate>2021-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="if0a238351a57425a8c0ba03f482ef4b9_D20200401-20200630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001656472</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockUnitsRSUMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-04-01</xbrli:startDate><xbrli:endDate>2020-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ie5eb2f0b8440403abdac2db9e01adbb9_D20210101-20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001656472</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockUnitsRSUMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i10cd1c126464402b99bfac52e7ebdbb2_D20200101-20200630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001656472</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockUnitsRSUMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i3d31fbca3c6044d5bd0e62b05769e769_D20200329-20200329"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001656472</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">cron:A2020OmnibusPlanMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-03-29</xbrli:startDate><xbrli:endDate>2020-03-29</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ic0313757b4a149aca72f641901924190_D20200329-20200329"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001656472</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">cron:A2020OmnibusPlanMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-03-29</xbrli:startDate><xbrli:endDate>2020-03-29</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i568a7b89865a4c0783608a8f7c7a5fbc_D20200329-20200329"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001656472</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">cron:A2020OmnibusPlanMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-03-29</xbrli:startDate><xbrli:endDate>2020-03-29</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="iafb1144677d145049a09cbdbb0457c7b_D20200329-20200329"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001656472</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">cron:PriorOptionPlansMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-03-29</xbrli:startDate><xbrli:endDate>2020-03-29</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i689be39a953e4627b86c363090d56882_D20200329-20200329"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001656472</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">cron:PriorOptionPlansMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-03-29</xbrli:startDate><xbrli:endDate>2020-03-29</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i4146f88cdb16474694c2187038fecec2_D20200329-20200329"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001656472</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">cron:PriorOptionPlansMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-03-29</xbrli:startDate><xbrli:endDate>2020-03-29</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i539631cd7950486e81b39a054a00c7d0_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001656472</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ic1ac4ebbf39f4d85959a2de4a782f891_D20190101-20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001656472</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:startDate>2019-01-01</xbrli:startDate><xbrli:endDate>2019-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ib49e288fbb504210b764575656013515_I20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001656472</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">cron:A2020OmnibusPlanMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i940a5cbdd4164d3996cb15eddebf6022_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001656472</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">cron:A2020OmnibusPlanMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i71217ccb65f54a46844f4ef961eef8ed_I20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001656472</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">cron:A2018StockOptionPlanMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i9901793e0a0c46f483b159aad44d157c_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001656472</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">cron:A2018StockOptionPlanMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i67847aa2abfa472593c968c856dcd228_I20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001656472</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">cron:A2015StockOptionPlanMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ia6fe44bf977249a2919be8435dfaa9a2_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001656472</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">cron:A2015StockOptionPlanMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="iff2854605c9948a0bd946fb90a42d547_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001656472</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockUnitsRSUMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i38f48aaa7a5e481ebe8ebcada37e35a1_I20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001656472</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockUnitsRSUMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i9cd1e43e5a21454dbe1b88627687a079_I20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001656472</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockUnitsRSUMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i80341dfa258d45e4926f94222e4d5cbc_I20200630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001656472</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockUnitsRSUMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="iba2763eff8e446348674f7fa0f12395e_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001656472</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">cron:DeferredShareUnitsDSUsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i4d35a9dc2bff4f0fb74fef37bddc6703_D20210101-20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001656472</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">cron:DeferredShareUnitsDSUsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i8360952c01a040cc9bbd0c14cc59244b_I20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001656472</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">cron:DeferredShareUnitsDSUsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ia6edd5e8ba094c259649f87d1ff2aa61_I20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001656472</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">cron:DeferredShareUnitsDSUsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i64c0d8b09be647f1aa0d0ab87e24a14c_D20200101-20200630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001656472</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">cron:DeferredShareUnitsDSUsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i80be6cf122864924818f07224f0ce952_I20200630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001656472</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">cron:DeferredShareUnitsDSUsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ica96f8af8bfb4c02b4ff8f577beed8a9_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001656472</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:WarrantMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ic97055dc0db04af88f485b12b96f84c2_D20210101-20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001656472</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:WarrantMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="iaa2e66f5a2c14062bebba1811782ccd6_I20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001656472</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:WarrantMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i5b77d92575e64e2d8a23bebd827ac114_I20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001656472</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:WarrantMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ie7aae3f01257471596ea0269c60c3885_I20200630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001656472</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:WarrantMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ibfe5b711341a4fa5b15c489835848fe5_D20210401-20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001656472</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:WarrantMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-04-01</xbrli:startDate><xbrli:endDate>2021-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ife69fdb8512f485a8a3f1f66e868a24d_D20200401-20200630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001656472</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:WarrantMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-04-01</xbrli:startDate><xbrli:endDate>2020-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i4558c25f511848f29e1d0d9bd1c7f160_D20200101-20200630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001656472</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:WarrantMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i07a12b37b7f449bd8480c060ef9d4f22_D20210401-20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001656472</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">cron:GinkgoEquityMilestonesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-04-01</xbrli:startDate><xbrli:endDate>2021-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="idb2773cdb0104962851c16f7f574a50e_D20200401-20200630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001656472</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">cron:GinkgoEquityMilestonesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-04-01</xbrli:startDate><xbrli:endDate>2020-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ibdb85022a38140dab47df2ef46523aed_D20210101-20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001656472</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">cron:GinkgoEquityMilestonesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i50bf03adb5b742b8bc014c0dff5918e9_D20200101-20200630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001656472</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">cron:GinkgoEquityMilestonesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i8e9c7b0c611e46879a52eaa6a261c7ee_D20210401-20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001656472</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">cron:PreemptiveRightsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-04-01</xbrli:startDate><xbrli:endDate>2021-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i0c3ad44a3c0c42b5b2a0e88c68e8f3be_D20200401-20200630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001656472</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">cron:PreemptiveRightsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-04-01</xbrli:startDate><xbrli:endDate>2020-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i02aad9012d39412c8efa06499f3fe95b_D20210101-20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001656472</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">cron:PreemptiveRightsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="id0d09d3774e94fa7b4f1f095f53f1374_D20200101-20200630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001656472</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">cron:PreemptiveRightsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ia14076dba9894856b2d1229c872fe727_D20210401-20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001656472</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">cron:TopUpRightsFixedPriceMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-04-01</xbrli:startDate><xbrli:endDate>2021-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i17878ee04a8b40efa8de800698c7563e_D20200401-20200630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001656472</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">cron:TopUpRightsFixedPriceMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-04-01</xbrli:startDate><xbrli:endDate>2020-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i0edfc387d99e417686a470edbdd373bd_D20210101-20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001656472</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">cron:TopUpRightsFixedPriceMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i58fcf006ddda4fa090550e2cab1cbf48_D20200101-20200630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001656472</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">cron:TopUpRightsFixedPriceMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="if80975f641164c358482aa567573519b_D20210401-20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001656472</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">cron:TopUpRightsMarketPriceMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-04-01</xbrli:startDate><xbrli:endDate>2021-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ie093f63ac9fb4d8581f1cefb3a20923d_D20200401-20200630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001656472</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">cron:TopUpRightsMarketPriceMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-04-01</xbrli:startDate><xbrli:endDate>2020-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i346164b35069484faf6df727aae40e92_D20210101-20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001656472</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">cron:TopUpRightsMarketPriceMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="if20736234eba41eeb39c9dfe0fe61633_D20200101-20200630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001656472</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">cron:TopUpRightsMarketPriceMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i1c433475eb1a48afaf0b953876eeacf2_D20210401-20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001656472</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">cron:AltriaWarrantMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-04-01</xbrli:startDate><xbrli:endDate>2021-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i0f06094e63234299ba9729e0c2d1605e_D20200401-20200630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001656472</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">cron:AltriaWarrantMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-04-01</xbrli:startDate><xbrli:endDate>2020-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i1f706c52ea2f44629f37471cc5d6d92a_D20210101-20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001656472</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">cron:AltriaWarrantMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i36bbfa161e6e4ec991260925b4204c65_D20200101-20200630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001656472</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">cron:AltriaWarrantMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="iaa7604cc407b458bade3731989eb0708_D20210401-20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001656472</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-04-01</xbrli:startDate><xbrli:endDate>2021-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="iea37729d5d364d418285846dc945175f_D20200401-20200630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001656472</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-04-01</xbrli:startDate><xbrli:endDate>2020-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i679dc97e17ab4806a7b6131c4dd48e32_D20210101-20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001656472</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i967a490799294ef8965b69b6ef9525d8_D20200101-20200630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001656472</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ic12652ed09474f2eb1b373fa6ef881fd_D20210401-20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001656472</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">us-gaap:WarrantMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-04-01</xbrli:startDate><xbrli:endDate>2021-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i8c63409f39764b86a65ebcee0efb5293_D20200401-20200630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001656472</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">us-gaap:WarrantMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-04-01</xbrli:startDate><xbrli:endDate>2020-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="iad823a91375044b38784f8b852ef2e86_D20210101-20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001656472</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">us-gaap:WarrantMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i1cb9167df2d047b58be65b1aada6284d_D20200101-20200630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001656472</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">us-gaap:WarrantMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i8b031f75a18e4c55ad561843012164a3_D20210401-20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001656472</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">us-gaap:RestrictedStockUnitsRSUMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-04-01</xbrli:startDate><xbrli:endDate>2021-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i4ae2733b6de04d388d8a96981e02f327_D20200401-20200630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001656472</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">us-gaap:RestrictedStockUnitsRSUMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-04-01</xbrli:startDate><xbrli:endDate>2020-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="if4d517deea8b4c85b4949e8ed9c437c2_D20210101-20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001656472</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">us-gaap:RestrictedStockUnitsRSUMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i120c7bf7be8a425aa4d5a03318d68bf0_D20200101-20200630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001656472</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">us-gaap:RestrictedStockUnitsRSUMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:unit id="segment"><xbrli:measure>cron:segment</xbrli:measure></xbrli:unit><xbrli:context id="ibc692233c14c49be87add169c0e2de75_D20210401-20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001656472</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">cron:UnitedStatesSegmentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">cron:CannabisFlowerMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-04-01</xbrli:startDate><xbrli:endDate>2021-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i8f2910ecf1ae40e091d358fb8405c9bd_D20210401-20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001656472</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">cron:RestOfWorldSegmentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">cron:CannabisFlowerMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-04-01</xbrli:startDate><xbrli:endDate>2021-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ia66d704cc8af4a879583109863080207_D20210401-20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001656472</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:CorporateNonSegmentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">cron:CannabisFlowerMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-04-01</xbrli:startDate><xbrli:endDate>2021-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i79727dab4c1240ceaa1f07e61bb81188_D20210401-20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001656472</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">cron:CannabisFlowerMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-04-01</xbrli:startDate><xbrli:endDate>2021-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ibd153928ae104df6b058cc08f14f6f09_D20210401-20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001656472</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">cron:CannabisExtractsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">cron:UnitedStatesSegmentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-04-01</xbrli:startDate><xbrli:endDate>2021-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i032a3ff320db4a7383246d7d6de2326f_D20210401-20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001656472</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">cron:CannabisExtractsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">cron:RestOfWorldSegmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-04-01</xbrli:startDate><xbrli:endDate>2021-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ia76908c59acf4c64acd394bfc6223beb_D20210401-20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001656472</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">cron:CannabisExtractsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:CorporateNonSegmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-04-01</xbrli:startDate><xbrli:endDate>2021-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="id339c655bfd341ce947f632c28a7cb54_D20210401-20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001656472</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">cron:CannabisExtractsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-04-01</xbrli:startDate><xbrli:endDate>2021-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i32838a57ba6c4493badd924366696106_D20210401-20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001656472</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:ProductAndServiceOtherMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">cron:UnitedStatesSegmentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-04-01</xbrli:startDate><xbrli:endDate>2021-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i6f297f0a314745488d2a9a9e296b5375_D20210401-20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001656472</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:ProductAndServiceOtherMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">cron:RestOfWorldSegmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-04-01</xbrli:startDate><xbrli:endDate>2021-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i07bd26499a384059b217b3a61ccfa0a7_D20210401-20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001656472</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:ProductAndServiceOtherMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:CorporateNonSegmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-04-01</xbrli:startDate><xbrli:endDate>2021-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ib7b191b315bf4d3d9c5a469788ccac38_D20210401-20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001656472</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:ProductAndServiceOtherMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-04-01</xbrli:startDate><xbrli:endDate>2021-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i2a563d1bc1a1451296d5f40e6cdf2912_D20210401-20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001656472</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">cron:UnitedStatesSegmentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-04-01</xbrli:startDate><xbrli:endDate>2021-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i7b627a38d4bb4b2693a9598ca41f647d_D20210401-20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001656472</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">cron:RestOfWorldSegmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-04-01</xbrli:startDate><xbrli:endDate>2021-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ie916e4a685544ae3998d4e82e089944f_D20210401-20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001656472</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:CorporateNonSegmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-04-01</xbrli:startDate><xbrli:endDate>2021-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i1afe4ab017a94c08b0390d1c04588202_I20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001656472</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">cron:UnitedStatesSegmentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i14c7d79dc30c40b9a6db30b130c667da_I20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001656472</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">cron:RestOfWorldSegmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i64489be55285421f8e92af4479a619e6_I20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001656472</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:CorporateNonSegmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="if56e63da868340a8ab5d3b79c974e6b3_D20200401-20200630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001656472</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">cron:UnitedStatesSegmentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">cron:CannabisFlowerMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-04-01</xbrli:startDate><xbrli:endDate>2020-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i15fc6f263af84b999d8cc92973692fbd_D20200401-20200630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001656472</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">cron:RestOfWorldSegmentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">cron:CannabisFlowerMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-04-01</xbrli:startDate><xbrli:endDate>2020-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ie5a13f5798a041098fb7986c993831fa_D20200401-20200630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001656472</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:CorporateNonSegmentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">cron:CannabisFlowerMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-04-01</xbrli:startDate><xbrli:endDate>2020-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ib1f0e90ff5d24c28ad9bc0faf46f5377_D20200401-20200630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001656472</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">cron:CannabisFlowerMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-04-01</xbrli:startDate><xbrli:endDate>2020-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ia93117ffad484ba8bac40f47a8a9f804_D20200401-20200630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001656472</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">cron:CannabisExtractsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">cron:UnitedStatesSegmentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-04-01</xbrli:startDate><xbrli:endDate>2020-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ifab67f8b4459455295c2fdc641d9dc00_D20200401-20200630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001656472</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">cron:CannabisExtractsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">cron:RestOfWorldSegmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-04-01</xbrli:startDate><xbrli:endDate>2020-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i59d84c3c73bb412f8ab90480b3f1cacb_D20200401-20200630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001656472</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">cron:CannabisExtractsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:CorporateNonSegmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-04-01</xbrli:startDate><xbrli:endDate>2020-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i2ca82879f2e54a14819f3d3b95640a8e_D20200401-20200630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001656472</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">cron:CannabisExtractsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-04-01</xbrli:startDate><xbrli:endDate>2020-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i91b1c7740b954489b1fe2f441dc90430_D20200401-20200630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001656472</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:ProductAndServiceOtherMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">cron:UnitedStatesSegmentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-04-01</xbrli:startDate><xbrli:endDate>2020-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i37138226ae7b45ad97bc4468a768b4b1_D20200401-20200630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001656472</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:ProductAndServiceOtherMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">cron:RestOfWorldSegmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-04-01</xbrli:startDate><xbrli:endDate>2020-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="id023d0b7d14c4eb9aba0197ea873d120_D20200401-20200630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001656472</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:ProductAndServiceOtherMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:CorporateNonSegmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-04-01</xbrli:startDate><xbrli:endDate>2020-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i8457d33e4cab43daac2e2e1046176545_D20200401-20200630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001656472</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:ProductAndServiceOtherMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-04-01</xbrli:startDate><xbrli:endDate>2020-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="icb85df07ebfc4bfa99c08f8c9f0cb89c_D20200401-20200630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001656472</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">cron:UnitedStatesSegmentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-04-01</xbrli:startDate><xbrli:endDate>2020-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="if83af42553ab4081bf67a6ecab2097fc_D20200401-20200630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001656472</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">cron:RestOfWorldSegmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-04-01</xbrli:startDate><xbrli:endDate>2020-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i46e2093507a34f2fa6bcbc19a9aaaa63_D20200401-20200630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001656472</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:CorporateNonSegmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-04-01</xbrli:startDate><xbrli:endDate>2020-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i702a586f0ecb4fc1b7bfe544770fb520_I20200630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001656472</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">cron:UnitedStatesSegmentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="if4396fb40fd54b7faa91c1e910136a74_I20200630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001656472</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">cron:RestOfWorldSegmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="iad52c8a5170c4f5bbeca5c035dd90f4e_I20200630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001656472</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:CorporateNonSegmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ia1fd0c77f444432fbb955ee120f3e358_D20210101-20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001656472</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">cron:UnitedStatesSegmentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">cron:CannabisFlowerMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i1c1529d67f66409e980a87cdbacae6d9_D20210101-20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001656472</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">cron:RestOfWorldSegmentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">cron:CannabisFlowerMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ifb7f0980f81c42e9b5667c26408eec94_D20210101-20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001656472</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:CorporateNonSegmentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">cron:CannabisFlowerMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i3f039d262efd4662b7daf3bd025bd767_D20210101-20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001656472</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">cron:CannabisFlowerMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i4f7819da7513417abd35056f14170574_D20210101-20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001656472</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">cron:CannabisExtractsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">cron:UnitedStatesSegmentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i2a692272db324fad8fd9591624ebee99_D20210101-20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001656472</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">cron:CannabisExtractsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">cron:RestOfWorldSegmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ic645ffe32db24fe886c9079930540947_D20210101-20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001656472</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">cron:CannabisExtractsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:CorporateNonSegmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i28cc601c4515423c9fb7c740926652a1_D20210101-20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001656472</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">cron:CannabisExtractsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="iaa3896f04f0b4ffa95465aa6125063d6_D20210101-20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001656472</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:ProductAndServiceOtherMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">cron:UnitedStatesSegmentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="if969ee02513f48cdb95de50cc1bb0d51_D20210101-20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001656472</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:ProductAndServiceOtherMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">cron:RestOfWorldSegmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i2fd2e11500cb4edfaa54ab9e521c7c86_D20210101-20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001656472</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:ProductAndServiceOtherMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:CorporateNonSegmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i1c31a39a4c79400497380f76939db7df_D20210101-20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001656472</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:ProductAndServiceOtherMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i73f2057fe97d4f3a8524f987e78d1493_D20210101-20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001656472</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">cron:UnitedStatesSegmentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i9eea321560784f81a590aa8e3df3b187_D20210101-20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001656472</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">cron:RestOfWorldSegmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i5e244469383d46ddb452d43394f637d1_D20210101-20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001656472</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:CorporateNonSegmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ib6c371f673124f889fe33d8feafa376a_D20200101-20200630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001656472</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">cron:UnitedStatesSegmentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">cron:CannabisFlowerMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i058566bd4b4941cfb44bfaea27053d23_D20200101-20200630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001656472</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">cron:RestOfWorldSegmentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">cron:CannabisFlowerMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ib8262672cddb43529f39e6554b306595_D20200101-20200630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001656472</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:CorporateNonSegmentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">cron:CannabisFlowerMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i4e842f8ace2f420eabc848a65486b991_D20200101-20200630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001656472</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">cron:CannabisFlowerMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i1508a4a4053d4dd08a6db69f6c1e840b_D20200101-20200630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001656472</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">cron:CannabisExtractsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">cron:UnitedStatesSegmentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i08837b8da47246b3a38247a1afce6246_D20200101-20200630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001656472</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">cron:CannabisExtractsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">cron:RestOfWorldSegmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i514785787edd460fb909104cd7dc4a04_D20200101-20200630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001656472</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">cron:CannabisExtractsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:CorporateNonSegmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="if253a5adac88412093cd3c8f27aa185f_D20200101-20200630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001656472</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">cron:CannabisExtractsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i9f4c7e46c3d34f5aa34d2e09db3380cf_D20200101-20200630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001656472</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:ProductAndServiceOtherMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">cron:UnitedStatesSegmentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i943cc5b8191b493f8aa9ee910e58ea43_D20200101-20200630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001656472</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:ProductAndServiceOtherMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">cron:RestOfWorldSegmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i42b8c121915c4f34996c473e36cccd8d_D20200101-20200630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001656472</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:ProductAndServiceOtherMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:CorporateNonSegmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i24f9699a302b4e86895a7c9098da3221_D20200101-20200630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001656472</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:ProductAndServiceOtherMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="iab9b56b2a03f4c6199d282bd8676a924_D20200101-20200630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001656472</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">cron:UnitedStatesSegmentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i13788f202c86441fa347b97f3162a453_D20200101-20200630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001656472</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">cron:RestOfWorldSegmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="iaf98f9473a3d428f9aab9f72e135866f_D20200101-20200630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001656472</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:CorporateNonSegmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i70c4790ac8ca40dd81fcf1ef3cef91b6_D20210401-20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001656472</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:CA</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-04-01</xbrli:startDate><xbrli:endDate>2021-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="iad976d29836c4f2f84c635abe13f093d_D20200401-20200630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001656472</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:CA</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-04-01</xbrli:startDate><xbrli:endDate>2020-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ic93ed3f2e9634d2485631fcd4f0c2325_D20210101-20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001656472</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:CA</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i9028e5a0bc1c44d493f8aa0ff5b63660_D20200101-20200630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001656472</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:CA</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i8506d6aab4b24205822b2a1157fa9c1d_D20210401-20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001656472</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:IL</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-04-01</xbrli:startDate><xbrli:endDate>2021-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i0919d1ea594c4d4dabfdd26b1f697c1a_D20200401-20200630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001656472</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:IL</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-04-01</xbrli:startDate><xbrli:endDate>2020-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i741c56d990404b79b0cac9e98bf9ab73_D20210101-20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001656472</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:IL</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i5bc3d3cb5c994e7b8a8e525b6b1e17e4_D20200101-20200630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001656472</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:IL</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i44de340a6a1041189ce50fede1a5bebb_D20210401-20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001656472</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-04-01</xbrli:startDate><xbrli:endDate>2021-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i64046da960714c4f90fcef13ebc59cac_D20200401-20200630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001656472</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-04-01</xbrli:startDate><xbrli:endDate>2020-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i689f775c23d14a45b6271c2611e144cd_D20210101-20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001656472</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ia3f841640fcf416dbce4a93086b21e5a_D20200101-20200630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001656472</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i12073826a3a04377a7cd14dedf89a23b_D20210401-20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001656472</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">cron:OtherCountriesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-04-01</xbrli:startDate><xbrli:endDate>2021-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="if4be60de0dc04fcaab3cbb8c7454e2b3_D20200401-20200630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001656472</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">cron:OtherCountriesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-04-01</xbrli:startDate><xbrli:endDate>2020-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="id1c815493ddc46f2a6fa5ee4c4885b69_D20210101-20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001656472</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">cron:OtherCountriesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i1dd5859753fc4494bc617d9e788b9a09_D20200101-20200630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001656472</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">cron:OtherCountriesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ib400bcdb825949cb9d87ed7e77387db0_I20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001656472</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:CA</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i6d98056e96104c42af330a91259abb2c_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001656472</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:CA</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ic9b10d1ca8aa427693166bca2adb764d_I20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001656472</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:IL</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i046692f7d6014223b3cb3cd2d79b04f9_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001656472</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:IL</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i18e4d04b45ca4c42a5f461314b4cf1a6_I20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001656472</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i57ed1954cbd8415788c6fb0209f0f8f2_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001656472</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i8c36c75ac6bc43f1a84b689b7e30c990_I20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001656472</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">cron:UnitedStatesSegmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ideeca118de83445d869657437d768780_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001656472</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">cron:UnitedStatesSegmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i094dc56c362c416aac0dd88497f3bd55_D20200401-20200630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001656472</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">cron:UnitedStatesSegmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-04-01</xbrli:startDate><xbrli:endDate>2020-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i812abaaed027463984b850a5e2b42d2c_D20200101-20200630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001656472</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">cron:UnitedStatesSegmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i3a27e92fff0846b5bad95097b919232f_D20210101-20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001656472</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">cron:UnitedStatesSegmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i34f72ee8566f4486917d56bc3b40f37f_D20210401-20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001656472</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">cron:UnitedStatesSegmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-04-01</xbrli:startDate><xbrli:endDate>2021-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i5c2d78ee6853443687a96daa15276fab_D20210401-20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001656472</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:MajorCustomersAxis">cron:FourMajorCustomersMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">cron:RestOfWorldSegmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-04-01</xbrli:startDate><xbrli:endDate>2021-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i93bcd6f71ecb484fbb4d514bb054afb1_D20210401-20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001656472</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:CustomerConcentrationRiskMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:RevenueFromContractWithCustomerMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:MajorCustomersAxis">cron:OntarioCannabisRetailCorporationMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">cron:RestOfWorldSegmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-04-01</xbrli:startDate><xbrli:endDate>2021-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i211d75fcd6a546f899374d2d7176c1e2_D20210401-20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001656472</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:CustomerConcentrationRiskMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:RevenueFromContractWithCustomerMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:MajorCustomersAxis">cron:AlbertGamingLiquorAndCannabisCommissionMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">cron:RestOfWorldSegmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-04-01</xbrli:startDate><xbrli:endDate>2021-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="idd2a2576b3144d36986722b62b737a2d_D20210401-20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001656472</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:CustomerConcentrationRiskMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:RevenueFromContractWithCustomerMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:MajorCustomersAxis">cron:SocieteQuebecoiseDuCannabisMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">cron:RestOfWorldSegmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-04-01</xbrli:startDate><xbrli:endDate>2021-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i74697f2f39824e5d8fa61532bd9225b4_D20200401-20200630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001656472</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:MajorCustomersAxis">cron:FourMajorCustomersMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:CustomerConcentrationRiskMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:RevenueFromContractWithCustomerMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">cron:RestOfWorldSegmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-04-01</xbrli:startDate><xbrli:endDate>2020-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ic588d92572e146368a7065a944f8c099_D20200101-20200630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001656472</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:MajorCustomersAxis">cron:FourMajorCustomersMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">cron:RestOfWorldSegmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="id59e6b6959b841bebcf3af4df3b502e6_D20200101-20200630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001656472</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:CustomerConcentrationRiskMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:RevenueFromContractWithCustomerMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:MajorCustomersAxis">cron:OntarioCannabisRetailCorporationMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">cron:RestOfWorldSegmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="id58ad288eb10460ebcce6bf331a5886c_D20200101-20200630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001656472</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:MajorCustomersAxis">cron:NovologGroupMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:CustomerConcentrationRiskMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:RevenueFromContractWithCustomerMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">cron:RestOfWorldSegmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i3d5f8123b8fe46de8a82ced9ca5ee737_D20200101-20200630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001656472</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:CustomerConcentrationRiskMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:RevenueFromContractWithCustomerMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:MajorCustomersAxis">cron:SocieteQuebecoiseDuCannabisMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">cron:RestOfWorldSegmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ie35646e7e6b447dc960fee8714bca44b_D20200101-20200630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001656472</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:CustomerConcentrationRiskMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:RevenueFromContractWithCustomerMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:MajorCustomersAxis">cron:AlbertGamingLiquorAndCannabisCommissionMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">cron:RestOfWorldSegmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ifefa84f4058a4db3af98ff73cf89d8f4_D20200101-20200630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001656472</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:MajorCustomersAxis">cron:FourMajorCustomersMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:CustomerConcentrationRiskMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:RevenueFromContractWithCustomerMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">cron:RestOfWorldSegmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i72aea01958fa442a951467d9e067fb46_I20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001656472</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">cron:RestOfWorldSegmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ib9d10d92b8c54f02a41178e1141532dd_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001656472</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">cron:RestOfWorldSegmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:unit id="shareholder"><xbrli:measure>cron:shareholder</xbrli:measure></xbrli:unit><xbrli:context id="ia489f6e55d8f4b56a4c35ea7b7898ed6_D20200311-20200312"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001656472</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:LitigationCaseAxis">cron:USDistrictCourtOfEasternDistrictOfNewYorkVsCronosMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LitigationStatusAxis">us-gaap:PendingLitigationMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-03-11</xbrli:startDate><xbrli:endDate>2020-03-12</xbrli:endDate></xbrli:period></xbrli:context><xbrli:unit id="complaint"><xbrli:measure>cron:complaint</xbrli:measure></xbrli:unit><xbrli:context id="i71fed0c557ee4fb3a307e51526e90c95_D20200616-20200616"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001656472</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LitigationStatusAxis">us-gaap:PendingLitigationMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LossContingenciesByNatureOfContingencyAxis">us-gaap:UnfavorableRegulatoryActionMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-06-16</xbrli:startDate><xbrli:endDate>2020-06-16</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="icadc14e3a8f749f28ff691fa21d421ea_I20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001656472</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i7b21c81f18bd4f52a9977bc7f8edb2bc_I20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001656472</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i11247526dfde4bb5bd7e7f7730ae47e9_I20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001656472</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i5fd10eeb00c74a3fa9afaced11fe7a7d_I20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001656472</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i03fa5c3c8b194478a5f52168419d56f6_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001656472</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i79b10885dfdb4c659175e617a6ad2106_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001656472</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="if1d924d84462412da9f6d321275d484c_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001656472</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i3a832b2da99a447594f2d6d56bcc8aa8_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001656472</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i174d8021b6e348aeb60958d0fc273001_D20210101-20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001656472</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:MajorCustomersAxis">cron:FourCustomersMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:AccountsReceivableMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:CreditConcentrationRiskMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i22724e38ce2a43488a65f8a806950144_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001656472</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:MajorCustomersAxis">cron:FourCustomersMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:AccountsReceivableMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:CreditConcentrationRiskMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ic32bc3c69d7c4dd0a165d3622a127739_D20210101-20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001656472</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:AccountsPayableMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ShareBasedGoodsAndNonemployeeServicesTransactionBySupplierAxis">cron:OneVendorMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:SupplierConcentrationRiskMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ib0cf8aff30b04aaebfad1c5a5bfc4c6c_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001656472</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:AccountsPayableMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ShareBasedGoodsAndNonemployeeServicesTransactionBySupplierAxis">cron:FourVendorsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:SupplierConcentrationRiskMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i904d87a0584944d792e0d8b1355a0053_D20210401-20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001656472</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DisposalGroupClassificationAxis">us-gaap:DiscontinuedOperationsHeldforsaleMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis">cron:OriginalBCMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-04-01</xbrli:startDate><xbrli:endDate>2021-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="iecddccc2866d472bbb7974d5d612f613_D20210401-20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001656472</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DisposalGroupClassificationAxis">us-gaap:DisposalGroupHeldforsaleNotDiscontinuedOperationsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis">cron:OriginalBCMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-04-01</xbrli:startDate><xbrli:endDate>2021-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i64c6418b6b224c7487942cebd8660eef_D20200401-20200630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001656472</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DisposalGroupClassificationAxis">us-gaap:DiscontinuedOperationsHeldforsaleMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis">cron:OriginalBCMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-04-01</xbrli:startDate><xbrli:endDate>2020-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i3a272e0b276a4cb1891236e443ba6b9f_D20210101-20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001656472</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DisposalGroupClassificationAxis">us-gaap:DiscontinuedOperationsHeldforsaleMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis">cron:OriginalBCMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i199e66625a3f4900991433f926302578_D20200101-20200630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001656472</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DisposalGroupClassificationAxis">us-gaap:DiscontinuedOperationsHeldforsaleMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis">cron:OriginalBCMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i3460e1558aee458a9a76219571d94bad_I20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001656472</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DisposalGroupClassificationAxis">us-gaap:DiscontinuedOperationsHeldforsaleMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis">cron:OriginalBCMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ibab7e231213f4709bd6c6600c444e9d5_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001656472</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DisposalGroupClassificationAxis">us-gaap:DiscontinuedOperationsHeldforsaleMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis">cron:OriginalBCMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:unit id="sqft"><xbrli:measure>utr:sqft</xbrli:measure></xbrli:unit><xbrli:context id="i037d0ab368aa4200bacafabacd180946_D20200401-20200630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001656472</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ReportingUnitAxis">cron:UnitedStatesSegmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-04-01</xbrli:startDate><xbrli:endDate>2020-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="iee9123f7b84a423aa2034824b667283b_D20200101-20200630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001656472</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ReportingUnitAxis">cron:UnitedStatesSegmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="icaac8e35e79f4bc7b83a47868c7fbccf_D20200401-20200630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001656472</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IndefiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:TradeNamesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-04-01</xbrli:startDate><xbrli:endDate>2020-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i9d77515187ea4c40b907a43fd842a0f9_D20200101-20200630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001656472</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IndefiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:TradeNamesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-06-30</xbrli:endDate></xbrli:period></xbrli:context><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="id3VybDovL2RvY3MudjEvZG9jOjkzY2E5YmIwMTc5MjQ3NmZiYjIyNWU1ZDlkZWM4NjlmL3NlYzo5M2NhOWJiMDE3OTI0NzZmYmIyMjVlNWQ5ZGVjODY5Zl8xNi9mcmFnOmNhM2Q5OWRkMjk1ODQxYzQ4Yzk2ZDg0NGIzMGFkMjA5L3RhYmxlOmQ1Nzc2MTlkODM1ODRhZWNiNTE1YzZiODUwYjcwM2FmL3RhYmxlcmFuZ2U6ZDU3NzYxOWQ4MzU4NGFlY2I1MTVjNmI4NTBiNzAzYWZfMzQtMy0xLTEtMA_45fdf40b-dbc8-4445-906e-9521e4f1d45e" linkRole="http://www.xbrl.org/2003/role/link" toRefs="id3VybDovL2RvY3MudjEvZG9jOjkzY2E5YmIwMTc5MjQ3NmZiYjIyNWU1ZDlkZWM4NjlmL3NlYzo5M2NhOWJiMDE3OTI0NzZmYmIyMjVlNWQ5ZGVjODY5Zl8xNi9mcmFnOmNhM2Q5OWRkMjk1ODQxYzQ4Yzk2ZDg0NGIzMGFkMjA5L3RleHRyZWdpb246Y2EzZDk5ZGQyOTU4NDFjNDhjOTZkODQ0YjMwYWQyMDlfOTg5NTYwNDY1MTE0NQ_eb1add2a-1ec9-4add-ba58-e13e0f90c7fe" order="2"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="id3VybDovL2RvY3MudjEvZG9jOjkzY2E5YmIwMTc5MjQ3NmZiYjIyNWU1ZDlkZWM4NjlmL3NlYzo5M2NhOWJiMDE3OTI0NzZmYmIyMjVlNWQ5ZGVjODY5Zl8xNi9mcmFnOmNhM2Q5OWRkMjk1ODQxYzQ4Yzk2ZDg0NGIzMGFkMjA5L3RhYmxlOmQ1Nzc2MTlkODM1ODRhZWNiNTE1YzZiODUwYjcwM2FmL3RhYmxlcmFuZ2U6ZDU3NzYxOWQ4MzU4NGFlY2I1MTVjNmI4NTBiNzAzYWZfMzQtMy0xLTEtMA_45fdf40b-dbc8-4445-906e-9521e4f1d45e" linkRole="http://www.xbrl.org/2003/role/link" toRefs="id3VybDovL2RvY3MudjEvZG9jOjkzY2E5YmIwMTc5MjQ3NmZiYjIyNWU1ZDlkZWM4NjlmL3NlYzo5M2NhOWJiMDE3OTI0NzZmYmIyMjVlNWQ5ZGVjODY5Zl8xNi9mcmFnOmNhM2Q5OWRkMjk1ODQxYzQ4Yzk2ZDg0NGIzMGFkMjA5L3RleHRyZWdpb246Y2EzZDk5ZGQyOTU4NDFjNDhjOTZkODQ0YjMwYWQyMDlfOTg5NTYwNDY1MTE0NA_8348ab85-1f4e-4ef0-a58d-e175adf1fc29" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="id3VybDovL2RvY3MudjEvZG9jOjkzY2E5YmIwMTc5MjQ3NmZiYjIyNWU1ZDlkZWM4NjlmL3NlYzo5M2NhOWJiMDE3OTI0NzZmYmIyMjVlNWQ5ZGVjODY5Zl8xNi9mcmFnOmNhM2Q5OWRkMjk1ODQxYzQ4Yzk2ZDg0NGIzMGFkMjA5L3RhYmxlOmQ1Nzc2MTlkODM1ODRhZWNiNTE1YzZiODUwYjcwM2FmL3RhYmxlcmFuZ2U6ZDU3NzYxOWQ4MzU4NGFlY2I1MTVjNmI4NTBiNzAzYWZfMzQtMS0xLTEtMA_5e098358-4e52-4202-99a3-6577d5e81128" linkRole="http://www.xbrl.org/2003/role/link" toRefs="id3VybDovL2RvY3MudjEvZG9jOjkzY2E5YmIwMTc5MjQ3NmZiYjIyNWU1ZDlkZWM4NjlmL3NlYzo5M2NhOWJiMDE3OTI0NzZmYmIyMjVlNWQ5ZGVjODY5Zl8xNi9mcmFnOmNhM2Q5OWRkMjk1ODQxYzQ4Yzk2ZDg0NGIzMGFkMjA5L3RleHRyZWdpb246Y2EzZDk5ZGQyOTU4NDFjNDhjOTZkODQ0YjMwYWQyMDlfOTg5NTYwNDY1MTE0NA_8348ab85-1f4e-4ef0-a58d-e175adf1fc29" order="1"></ix:relationship><ix:relationship arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote" fromRefs="id3VybDovL2RvY3MudjEvZG9jOjkzY2E5YmIwMTc5MjQ3NmZiYjIyNWU1ZDlkZWM4NjlmL3NlYzo5M2NhOWJiMDE3OTI0NzZmYmIyMjVlNWQ5ZGVjODY5Zl8xNi9mcmFnOmNhM2Q5OWRkMjk1ODQxYzQ4Yzk2ZDg0NGIzMGFkMjA5L3RhYmxlOmQ1Nzc2MTlkODM1ODRhZWNiNTE1YzZiODUwYjcwM2FmL3RhYmxlcmFuZ2U6ZDU3NzYxOWQ4MzU4NGFlY2I1MTVjNmI4NTBiNzAzYWZfMzQtMS0xLTEtMA_5e098358-4e52-4202-99a3-6577d5e81128" linkRole="http://www.xbrl.org/2003/role/link" toRefs="id3VybDovL2RvY3MudjEvZG9jOjkzY2E5YmIwMTc5MjQ3NmZiYjIyNWU1ZDlkZWM4NjlmL3NlYzo5M2NhOWJiMDE3OTI0NzZmYmIyMjVlNWQ5ZGVjODY5Zl8xNi9mcmFnOmNhM2Q5OWRkMjk1ODQxYzQ4Yzk2ZDg0NGIzMGFkMjA5L3RleHRyZWdpb246Y2EzZDk5ZGQyOTU4NDFjNDhjOTZkODQ0YjMwYWQyMDlfOTg5NTYwNDY1MTE0NQ_eb1add2a-1ec9-4add-ba58-e13e0f90c7fe" order="2"></ix:relationship></ix:resources></ix:header></div><div id="i93ca9bb01792476fbb225e5d9dec869f_1"></div><div style="min-height:36pt;width:100%"><div><span><br/></span></div></div><div style="text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:98.900%"></td><td style="width:0.1%"></td></tr><tr style="height:5pt"><td colspan="3" style="border-bottom:2pt solid #000000;padding:0 1pt"></td></tr></table></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:14pt;font-weight:700;line-height:120%">UNITED STATES</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:14pt;font-weight:700;line-height:120%">SECURITIES AND EXCHANGE COMMISSION</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">Washington, D.C. 20549</span></div><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:18pt;font-weight:700;line-height:120%">Form <ix:nonNumeric contextRef="i69782326f71a44e3805518280ee22b6b_D20210101-20210630" name="dei:DocumentType" id="id3VybDovL2RvY3MudjEvZG9jOjkzY2E5YmIwMTc5MjQ3NmZiYjIyNWU1ZDlkZWM4NjlmL3NlYzo5M2NhOWJiMDE3OTI0NzZmYmIyMjVlNWQ5ZGVjODY5Zl8xL2ZyYWc6Mzc0YjhjZWZhZmU2NDFhYzg4YmIzMmJlZjNkOGZjNTAvdGV4dHJlZ2lvbjozNzRiOGNlZmFmZTY0MWFjODhiYjMyYmVmM2Q4ZmM1MF8yMjQ1_b39b827d-28a1-4485-bd46-d69dc03bf539">10-Q</ix:nonNumeric></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(Mark One)</span></div><div><span style="color:#000000;font-family:'Arial Unicode MS',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonNumeric contextRef="i69782326f71a44e3805518280ee22b6b_D20210101-20210630" format="ixt-sec:boolballotbox" name="dei:DocumentQuarterlyReport" id="id3VybDovL2RvY3MudjEvZG9jOjkzY2E5YmIwMTc5MjQ3NmZiYjIyNWU1ZDlkZWM4NjlmL3NlYzo5M2NhOWJiMDE3OTI0NzZmYmIyMjVlNWQ5ZGVjODY5Zl8xL2ZyYWc6Mzc0YjhjZWZhZmU2NDFhYzg4YmIzMmJlZjNkOGZjNTAvdGV4dHJlZ2lvbjozNzRiOGNlZmFmZTY0MWFjODhiYjMyYmVmM2Q4ZmM1MF8yMjQ2_51165010-4c63-4061-a336-ba40666ee3b0">&#9746;</ix:nonNumeric></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">        QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES </span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">           EXCHANGE ACT OF 1934</span></div><div><span><br/></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">For the quarterly period ended <ix:nonNumeric contextRef="i69782326f71a44e3805518280ee22b6b_D20210101-20210630" format="ixt:datemonthdayyearen" name="dei:DocumentPeriodEndDate" id="id3VybDovL2RvY3MudjEvZG9jOjkzY2E5YmIwMTc5MjQ3NmZiYjIyNWU1ZDlkZWM4NjlmL3NlYzo5M2NhOWJiMDE3OTI0NzZmYmIyMjVlNWQ5ZGVjODY5Zl8xL2ZyYWc6Mzc0YjhjZWZhZmU2NDFhYzg4YmIzMmJlZjNkOGZjNTAvdGV4dHJlZ2lvbjozNzRiOGNlZmFmZTY0MWFjODhiYjMyYmVmM2Q4ZmM1MF8yNzY_d88165bb-014d-4d4b-889f-d9947ae624b1">June&#160;30, 2021</ix:nonNumeric></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">or</span></div><div style="padding-left:36pt;text-indent:-36pt"><span style="color:#000000;font-family:'Arial Unicode MS',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonNumeric contextRef="i69782326f71a44e3805518280ee22b6b_D20210101-20210630" format="ixt-sec:boolballotbox" name="dei:DocumentTransitionReport" id="id3VybDovL2RvY3MudjEvZG9jOjkzY2E5YmIwMTc5MjQ3NmZiYjIyNWU1ZDlkZWM4NjlmL3NlYzo5M2NhOWJiMDE3OTI0NzZmYmIyMjVlNWQ5ZGVjODY5Zl8xL2ZyYWc6Mzc0YjhjZWZhZmU2NDFhYzg4YmIzMmJlZjNkOGZjNTAvdGV4dHJlZ2lvbjozNzRiOGNlZmFmZTY0MWFjODhiYjMyYmVmM2Q4ZmM1MF8yMjQw_49755c8c-826e-43dc-b009-2211122dbbb1">&#9744;</ix:nonNumeric></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934</span></div><div style="padding-left:36pt;text-indent:-36pt"><span><br/></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">For the transition period from to .</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Commission File No. <ix:nonNumeric contextRef="i69782326f71a44e3805518280ee22b6b_D20210101-20210630" name="dei:EntityFileNumber" id="id3VybDovL2RvY3MudjEvZG9jOjkzY2E5YmIwMTc5MjQ3NmZiYjIyNWU1ZDlkZWM4NjlmL3NlYzo5M2NhOWJiMDE3OTI0NzZmYmIyMjVlNWQ5ZGVjODY5Zl8xL2ZyYWc6Mzc0YjhjZWZhZmU2NDFhYzg4YmIzMmJlZjNkOGZjNTAvdGV4dHJlZ2lvbjozNzRiOGNlZmFmZTY0MWFjODhiYjMyYmVmM2Q4ZmM1MF8yMjQ4_cb805ef5-91c0-4178-bc4b-ed0366e93075">001-38403</ix:nonNumeric></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">__________________________</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:20pt;font-weight:700;line-height:120%"><ix:nonNumeric contextRef="i69782326f71a44e3805518280ee22b6b_D20210101-20210630" name="dei:EntityRegistrantName" id="id3VybDovL2RvY3MudjEvZG9jOjkzY2E5YmIwMTc5MjQ3NmZiYjIyNWU1ZDlkZWM4NjlmL3NlYzo5M2NhOWJiMDE3OTI0NzZmYmIyMjVlNWQ5ZGVjODY5Zl8xL2ZyYWc6Mzc0YjhjZWZhZmU2NDFhYzg4YmIzMmJlZjNkOGZjNTAvdGV4dHJlZ2lvbjozNzRiOGNlZmFmZTY0MWFjODhiYjMyYmVmM2Q4ZmM1MF8yMjQ5_559544df-99ef-4e0c-bc22-01fcc7d94335">CRONOS GROUP INC.</ix:nonNumeric></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">(Exact name of registrant as specified in its charter)</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">__________________________</span><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:93.194%"><tr><td style="width:1.0%"></td><td style="width:48.378%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.992%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:48.230%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">British Columbia, <ix:nonNumeric contextRef="i69782326f71a44e3805518280ee22b6b_D20210101-20210630" format="ixt-sec:edgarprovcountryen" name="dei:EntityIncorporationStateCountryCode" id="id3VybDovL2RvY3MudjEvZG9jOjkzY2E5YmIwMTc5MjQ3NmZiYjIyNWU1ZDlkZWM4NjlmL3NlYzo5M2NhOWJiMDE3OTI0NzZmYmIyMjVlNWQ5ZGVjODY5Zl8xL2ZyYWc6Mzc0YjhjZWZhZmU2NDFhYzg4YmIzMmJlZjNkOGZjNTAvdGFibGU6NmI5Yzk1OGY4MDJlNGMzMWE4MWE2ZTNkMjQxOGI3NzgvdGFibGVyYW5nZTo2YjljOTU4ZjgwMmU0YzMxYTgxYTZlM2QyNDE4Yjc3OF8wLTAtMS0xLTAvdGV4dHJlZ2lvbjphNTY5MzJjN2YxMzg0NjJhOWUxNmIwMzg0ZDQ5MjY1YV84_83d9e5e2-eb72-4ea2-85d4-573b1f2e390a">Canada</ix:nonNumeric></span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">N/A</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">(State or other jurisdiction of</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">(I.R.S.  Employer</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">incorporation or organization)</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Identification No.)</span></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonNumeric contextRef="i69782326f71a44e3805518280ee22b6b_D20210101-20210630" name="dei:EntityAddressAddressLine1" id="id3VybDovL2RvY3MudjEvZG9jOjkzY2E5YmIwMTc5MjQ3NmZiYjIyNWU1ZDlkZWM4NjlmL3NlYzo5M2NhOWJiMDE3OTI0NzZmYmIyMjVlNWQ5ZGVjODY5Zl8xL2ZyYWc6Mzc0YjhjZWZhZmU2NDFhYzg4YmIzMmJlZjNkOGZjNTAvdGFibGU6NmI5Yzk1OGY4MDJlNGMzMWE4MWE2ZTNkMjQxOGI3NzgvdGFibGVyYW5nZTo2YjljOTU4ZjgwMmU0YzMxYTgxYTZlM2QyNDE4Yjc3OF80LTAtMS0xLTA_62acaa68-e4eb-4d76-a5f7-3d1a3989975e">111 Peter St. Suite 300</ix:nonNumeric></span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonNumeric contextRef="i69782326f71a44e3805518280ee22b6b_D20210101-20210630" name="dei:EntityAddressCityOrTown" id="id3VybDovL2RvY3MudjEvZG9jOjkzY2E5YmIwMTc5MjQ3NmZiYjIyNWU1ZDlkZWM4NjlmL3NlYzo5M2NhOWJiMDE3OTI0NzZmYmIyMjVlNWQ5ZGVjODY5Zl8xL2ZyYWc6Mzc0YjhjZWZhZmU2NDFhYzg4YmIzMmJlZjNkOGZjNTAvdGFibGU6NmI5Yzk1OGY4MDJlNGMzMWE4MWE2ZTNkMjQxOGI3NzgvdGFibGVyYW5nZTo2YjljOTU4ZjgwMmU0YzMxYTgxYTZlM2QyNDE4Yjc3OF81LTAtMS0xLTAvdGV4dHJlZ2lvbjpmYzdiY2U5YTg1MzE0ZWI0YjU4ZmZiYjg5ZGVlODlkNF80_e045ba5e-323b-4f1c-8684-3292d9e7c2a0">Toronto</ix:nonNumeric>, <ix:nonNumeric contextRef="i69782326f71a44e3805518280ee22b6b_D20210101-20210630" format="ixt-sec:stateprovnameen" name="dei:EntityAddressStateOrProvince" id="id3VybDovL2RvY3MudjEvZG9jOjkzY2E5YmIwMTc5MjQ3NmZiYjIyNWU1ZDlkZWM4NjlmL3NlYzo5M2NhOWJiMDE3OTI0NzZmYmIyMjVlNWQ5ZGVjODY5Zl8xL2ZyYWc6Mzc0YjhjZWZhZmU2NDFhYzg4YmIzMmJlZjNkOGZjNTAvdGFibGU6NmI5Yzk1OGY4MDJlNGMzMWE4MWE2ZTNkMjQxOGI3NzgvdGFibGVyYW5nZTo2YjljOTU4ZjgwMmU0YzMxYTgxYTZlM2QyNDE4Yjc3OF81LTAtMS0xLTAvdGV4dHJlZ2lvbjpmYzdiY2U5YTg1MzE0ZWI0YjU4ZmZiYjg5ZGVlODlkNF84_9fb70a90-69aa-4afb-9f1b-98af9a48e60c">Ontario</ix:nonNumeric></span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonNumeric contextRef="i69782326f71a44e3805518280ee22b6b_D20210101-20210630" name="dei:EntityAddressPostalZipCode" id="id3VybDovL2RvY3MudjEvZG9jOjkzY2E5YmIwMTc5MjQ3NmZiYjIyNWU1ZDlkZWM4NjlmL3NlYzo5M2NhOWJiMDE3OTI0NzZmYmIyMjVlNWQ5ZGVjODY5Zl8xL2ZyYWc6Mzc0YjhjZWZhZmU2NDFhYzg4YmIzMmJlZjNkOGZjNTAvdGFibGU6NmI5Yzk1OGY4MDJlNGMzMWE4MWE2ZTNkMjQxOGI3NzgvdGFibGVyYW5nZTo2YjljOTU4ZjgwMmU0YzMxYTgxYTZlM2QyNDE4Yjc3OF81LTItMS0xLTA_a388e8da-b873-4e17-9643-44dfa02affa0">M5V 2H1</ix:nonNumeric></span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">(Address of principal executive offices)</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">(Zip Code)</span></td></tr></table></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"><ix:nonNumeric contextRef="i69782326f71a44e3805518280ee22b6b_D20210101-20210630" name="dei:CityAreaCode" id="id3VybDovL2RvY3MudjEvZG9jOjkzY2E5YmIwMTc5MjQ3NmZiYjIyNWU1ZDlkZWM4NjlmL3NlYzo5M2NhOWJiMDE3OTI0NzZmYmIyMjVlNWQ5ZGVjODY5Zl8xL2ZyYWc6Mzc0YjhjZWZhZmU2NDFhYzg4YmIzMmJlZjNkOGZjNTAvdGV4dHJlZ2lvbjozNzRiOGNlZmFmZTY0MWFjODhiYjMyYmVmM2Q4ZmM1MF81Njg_6bc77758-6474-4ba6-a00a-a70eee664584">416</ix:nonNumeric>-<ix:nonNumeric contextRef="i69782326f71a44e3805518280ee22b6b_D20210101-20210630" name="dei:LocalPhoneNumber" id="id3VybDovL2RvY3MudjEvZG9jOjkzY2E5YmIwMTc5MjQ3NmZiYjIyNWU1ZDlkZWM4NjlmL3NlYzo5M2NhOWJiMDE3OTI0NzZmYmIyMjVlNWQ5ZGVjODY5Zl8xL2ZyYWc6Mzc0YjhjZWZhZmU2NDFhYzg4YmIzMmJlZjNkOGZjNTAvdGV4dHJlZ2lvbjozNzRiOGNlZmFmZTY0MWFjODhiYjMyYmVmM2Q4ZmM1MF8yMjQy_795e70d4-d436-48d7-91d1-7dbaf72e9328">504-0004</ix:nonNumeric></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(Registrant&#8217;s telephone number, including area code)</span></div><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:18.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.900%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">N/A</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr></table></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(Former name, former address and former fiscal year, if changed since last report)</span></div><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Securities registered pursuant to Section&#160;12(b) of the Act:</span><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:87.500%"><tr><td style="width:1.0%"></td><td style="width:31.280%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:1.228%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:31.280%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:1.228%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:31.284%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Title of each class</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Trading Symbol(s)</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Name of each exchange on which registered</span></td></tr><tr><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="i69782326f71a44e3805518280ee22b6b_D20210101-20210630" name="dei:Security12bTitle" id="id3VybDovL2RvY3MudjEvZG9jOjkzY2E5YmIwMTc5MjQ3NmZiYjIyNWU1ZDlkZWM4NjlmL3NlYzo5M2NhOWJiMDE3OTI0NzZmYmIyMjVlNWQ5ZGVjODY5Zl8xL2ZyYWc6Mzc0YjhjZWZhZmU2NDFhYzg4YmIzMmJlZjNkOGZjNTAvdGFibGU6ZWIzMWUyYjYzOTMzNDRiZTg3YWUzOGU2YTI1ZDg1NDMvdGFibGVyYW5nZTplYjMxZTJiNjM5MzM0NGJlODdhZTM4ZTZhMjVkODU0M18xLTAtMS0xLTA_1eaf822f-661e-4840-9b8c-02b5197e756a">Common Shares, no par value</ix:nonNumeric></span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="i69782326f71a44e3805518280ee22b6b_D20210101-20210630" name="dei:TradingSymbol" id="id3VybDovL2RvY3MudjEvZG9jOjkzY2E5YmIwMTc5MjQ3NmZiYjIyNWU1ZDlkZWM4NjlmL3NlYzo5M2NhOWJiMDE3OTI0NzZmYmIyMjVlNWQ5ZGVjODY5Zl8xL2ZyYWc6Mzc0YjhjZWZhZmU2NDFhYzg4YmIzMmJlZjNkOGZjNTAvdGFibGU6ZWIzMWUyYjYzOTMzNDRiZTg3YWUzOGU2YTI1ZDg1NDMvdGFibGVyYW5nZTplYjMxZTJiNjM5MzM0NGJlODdhZTM4ZTZhMjVkODU0M18xLTItMS0xLTA_46141ba9-876b-4114-b9d8-346f7ed3a0ab">CRON</ix:nonNumeric></span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="i69782326f71a44e3805518280ee22b6b_D20210101-20210630" format="ixt-sec:exchnameen" name="dei:SecurityExchangeName" id="id3VybDovL2RvY3MudjEvZG9jOjkzY2E5YmIwMTc5MjQ3NmZiYjIyNWU1ZDlkZWM4NjlmL3NlYzo5M2NhOWJiMDE3OTI0NzZmYmIyMjVlNWQ5ZGVjODY5Zl8xL2ZyYWc6Mzc0YjhjZWZhZmU2NDFhYzg4YmIzMmJlZjNkOGZjNTAvdGFibGU6ZWIzMWUyYjYzOTMzNDRiZTg3YWUzOGU2YTI1ZDg1NDMvdGFibGVyYW5nZTplYjMxZTJiNjM5MzM0NGJlODdhZTM4ZTZhMjVkODU0M18xLTQtMS0xLTA_3a8e7307-bfb6-4666-8b16-a745022f6a70">The Nasdaq Stock Market LLC</ix:nonNumeric></span></td></tr></table></div><div style="text-align:center"><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:120%">Indicate by check mark whether the registrant: (1)&#160;has filed all reports required to be filed by Section&#160;13 or Section&#160;15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2)&#160;has been subject to such filing requirements for the past 90 days.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:120%"><ix:nonNumeric contextRef="i69782326f71a44e3805518280ee22b6b_D20210101-20210630" name="dei:EntityCurrentReportingStatus" id="id3VybDovL2RvY3MudjEvZG9jOjkzY2E5YmIwMTc5MjQ3NmZiYjIyNWU1ZDlkZWM4NjlmL3NlYzo5M2NhOWJiMDE3OTI0NzZmYmIyMjVlNWQ5ZGVjODY5Zl8xL2ZyYWc6Mzc0YjhjZWZhZmU2NDFhYzg4YmIzMmJlZjNkOGZjNTAvdGV4dHJlZ2lvbjozNzRiOGNlZmFmZTY0MWFjODhiYjMyYmVmM2Q4ZmM1MF8yMjQz_ca05d335-c465-45bb-9d50-0c9a8bd80f78">Yes</ix:nonNumeric> </span><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:8pt;font-weight:400;line-height:120%">x</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:120%">  No </span><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:8pt;font-weight:400;line-height:120%">o</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:120%">Indicate by check mark whether the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T (&#167;232.405 of this chapter) during the preceding 12 months (or for such shorter period that the registrant was required to submit such files).</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:120%"><ix:nonNumeric contextRef="i69782326f71a44e3805518280ee22b6b_D20210101-20210630" name="dei:EntityInteractiveDataCurrent" id="id3VybDovL2RvY3MudjEvZG9jOjkzY2E5YmIwMTc5MjQ3NmZiYjIyNWU1ZDlkZWM4NjlmL3NlYzo5M2NhOWJiMDE3OTI0NzZmYmIyMjVlNWQ5ZGVjODY5Zl8xL2ZyYWc6Mzc0YjhjZWZhZmU2NDFhYzg4YmIzMmJlZjNkOGZjNTAvdGV4dHJlZ2lvbjozNzRiOGNlZmFmZTY0MWFjODhiYjMyYmVmM2Q4ZmM1MF8yMjUw_200937bb-d96f-4c04-8fcb-2f1e44554874">Yes</ix:nonNumeric> </span><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:8pt;font-weight:400;line-height:120%">x</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:120%">  No </span><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:8pt;font-weight:400;line-height:120%">o</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:120%">Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, smaller reporting company, or an emerging growth company.  See the definitions of &#8220;large accelerated filer,&#8221; &#8220;accelerated filer,&#8221; &#8220;smaller reporting company,&#8221; and &#8220;emerging growth company&#8221; in Rule 12b-2 of the Exchange Act.</span><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:20.983%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:2.022%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:50.150%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:20.983%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:2.162%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="i69782326f71a44e3805518280ee22b6b_D20210101-20210630" format="ixt-sec:entityfilercategoryen" name="dei:EntityFilerCategory" id="id3VybDovL2RvY3MudjEvZG9jOjkzY2E5YmIwMTc5MjQ3NmZiYjIyNWU1ZDlkZWM4NjlmL3NlYzo5M2NhOWJiMDE3OTI0NzZmYmIyMjVlNWQ5ZGVjODY5Zl8xL2ZyYWc6Mzc0YjhjZWZhZmU2NDFhYzg4YmIzMmJlZjNkOGZjNTAvdGFibGU6NGUyZWY2MDQ4NjE5NDI1ODlkYWE0NWI3OTA4YmM5MzcvdGFibGVyYW5nZTo0ZTJlZjYwNDg2MTk0MjU4OWRhYTQ1Yjc5MDhiYzkzN18wLTAtMS0xLTA_60d2dfb4-924e-4bd8-8820-61fec54eedd0">Large accelerated filer</ix:nonNumeric></span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:8pt;font-weight:400;line-height:100%">x</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Accelerated filer</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#9744;</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Non-accelerated filer</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:8pt;font-weight:400;line-height:100%">o</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Smaller reporting company</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="i69782326f71a44e3805518280ee22b6b_D20210101-20210630" format="ixt-sec:boolballotbox" name="dei:EntitySmallBusiness" id="id3VybDovL2RvY3MudjEvZG9jOjkzY2E5YmIwMTc5MjQ3NmZiYjIyNWU1ZDlkZWM4NjlmL3NlYzo5M2NhOWJiMDE3OTI0NzZmYmIyMjVlNWQ5ZGVjODY5Zl8xL2ZyYWc6Mzc0YjhjZWZhZmU2NDFhYzg4YmIzMmJlZjNkOGZjNTAvdGFibGU6NGUyZWY2MDQ4NjE5NDI1ODlkYWE0NWI3OTA4YmM5MzcvdGFibGVyYW5nZTo0ZTJlZjYwNDg2MTk0MjU4OWRhYTQ1Yjc5MDhiYzkzN18xLTQtMS0xLTA_12f33673-4b07-4940-8f5f-dc71f290180e">&#9744;</ix:nonNumeric></span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Emerging growth company</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="i69782326f71a44e3805518280ee22b6b_D20210101-20210630" format="ixt-sec:boolballotbox" name="dei:EntityEmergingGrowthCompany" id="id3VybDovL2RvY3MudjEvZG9jOjkzY2E5YmIwMTc5MjQ3NmZiYjIyNWU1ZDlkZWM4NjlmL3NlYzo5M2NhOWJiMDE3OTI0NzZmYmIyMjVlNWQ5ZGVjODY5Zl8xL2ZyYWc6Mzc0YjhjZWZhZmU2NDFhYzg4YmIzMmJlZjNkOGZjNTAvdGFibGU6NGUyZWY2MDQ4NjE5NDI1ODlkYWE0NWI3OTA4YmM5MzcvdGFibGVyYW5nZTo0ZTJlZjYwNDg2MTk0MjU4OWRhYTQ1Yjc5MDhiYzkzN18yLTQtMS0xLTA_d19e1e6d-c4f7-4322-ba85-ee0996269b3a">&#9744;</ix:nonNumeric></span></td></tr></table></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:120%">If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section&#160;13(a) of the Exchange Act. </span><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:8pt;font-weight:400;line-height:120%">o</span></div><div><span><br/></span></div><div style="padding-left:36pt;text-indent:-36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:120%">Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act).</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:120%">Yes </span><span style="color:#000000;font-family:'Arial Unicode MS',sans-serif;font-size:8pt;font-weight:400;line-height:120%"><ix:nonNumeric contextRef="i69782326f71a44e3805518280ee22b6b_D20210101-20210630" format="ixt-sec:boolballotbox" name="dei:EntityShellCompany" id="id3VybDovL2RvY3MudjEvZG9jOjkzY2E5YmIwMTc5MjQ3NmZiYjIyNWU1ZDlkZWM4NjlmL3NlYzo5M2NhOWJiMDE3OTI0NzZmYmIyMjVlNWQ5ZGVjODY5Zl8xL2ZyYWc6Mzc0YjhjZWZhZmU2NDFhYzg4YmIzMmJlZjNkOGZjNTAvdGV4dHJlZ2lvbjozNzRiOGNlZmFmZTY0MWFjODhiYjMyYmVmM2Q4ZmM1MF8yMjQ0_aa1b1ed2-b7a0-40c4-8de2-8c744114b676">&#9744;</ix:nonNumeric></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:120%">  No </span><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:8pt;font-weight:400;line-height:120%">x</span></div><div style="padding-left:36pt;text-indent:-36pt"><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:120%">As of August 5, 2021, there were <ix:nonFraction unitRef="shares" contextRef="ia52c55475f2e488fac07e8b8f24caaa3_I20210805" decimals="INF" format="ixt:numdotdecimal" name="dei:EntityCommonStockSharesOutstanding" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjkzY2E5YmIwMTc5MjQ3NmZiYjIyNWU1ZDlkZWM4NjlmL3NlYzo5M2NhOWJiMDE3OTI0NzZmYmIyMjVlNWQ5ZGVjODY5Zl8xL2ZyYWc6Mzc0YjhjZWZhZmU2NDFhYzg4YmIzMmJlZjNkOGZjNTAvdGV4dHJlZ2lvbjozNzRiOGNlZmFmZTY0MWFjODhiYjMyYmVmM2Q4ZmM1MF8yMTcz_eaa35828-aea2-4422-965b-a7300bbb12c7">371,805,547</ix:nonFraction> common shares of the registrant issued and outstanding. </span></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:98.900%"></td><td style="width:0.1%"></td></tr><tr style="height:5pt"><td colspan="3" style="border-bottom:2pt solid #000000;padding:0 1pt"></td></tr></table></div><div><span><br/></span></div><div style="height:36pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">1</span></div></div></div><div id="i93ca9bb01792476fbb225e5d9dec869f_7"></div><hr style="page-break-after:always"/><div style="min-height:36pt;width:100%"><div><span><br/></span></div></div><div style="text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:9.316%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:26.677%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:26.677%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:26.677%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:5.153%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Table of Contents</span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">PART I</span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">FINANCIAL INFORMATION</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Item&#160;1.</span></td><td colspan="9" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i93ca9bb01792476fbb225e5d9dec869f_13">Financial Statements.</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#0e32e1;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Item&#160;2.</span></td><td colspan="9" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i93ca9bb01792476fbb225e5d9dec869f_136">Management&#8217;s Discussion and Analysis of Financial Condition and Results of Operations.</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#0e32e1;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">29</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Item&#160;3.</span></td><td colspan="9" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i93ca9bb01792476fbb225e5d9dec869f_163">Quantitative and Qualitative Disclosures About Market Risk.</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#0e32e1;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">43</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Item&#160;4.</span></td><td colspan="9" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i93ca9bb01792476fbb225e5d9dec869f_166">Controls and Procedures.</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#0e32e1;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">44</span></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">PART II</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">OTHER INFORMATION</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Item 1.</span></td><td colspan="9" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i93ca9bb01792476fbb225e5d9dec869f_175">Legal Proceedings.</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#0e32e1;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">45</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Item 2.</span></td><td colspan="9" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-top:12pt"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i93ca9bb01792476fbb225e5d9dec869f_181">Unregistered Sales of Equity Securities and Use of Proceeds.</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#0e32e1;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">45</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Item 3.</span></td><td colspan="9" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i93ca9bb01792476fbb225e5d9dec869f_184">Defaults upon Senior Securities.</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#0e32e1;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">45</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Item 4.</span></td><td colspan="9" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i93ca9bb01792476fbb225e5d9dec869f_187">Mine Safety Disclosures.</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#0e32e1;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">45</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Item 5.</span></td><td colspan="9" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i93ca9bb01792476fbb225e5d9dec869f_190">Other Information.</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#0e32e1;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">45</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Item 6.</span></td><td colspan="9" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i93ca9bb01792476fbb225e5d9dec869f_193">Exhibits.</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#0e32e1;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">46</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Signatures.</span></td><td colspan="9" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i93ca9bb01792476fbb225e5d9dec869f_196">Signatures</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#0e32e1;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">47</span></td></tr></table></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span><br/></span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Unless otherwise noted or the context indicates otherwise, references in this Quarterly Report on Form 10-Q (this &#8220;Quarterly Report&#8221;) to the &#8220;Company&#8221;, &#8220;Cronos Group&#8221;, &#8220;we&#8221;, &#8220;us&#8221; and &#8220;our&#8221; refer to Cronos Group Inc., its direct and indirect wholly owned subsidiaries and, if applicable, its joint ventures and investments accounted for by the equity method; the term &#8220;cannabis&#8221; means the plant of any species or subspecies of genus </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Cannabis</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> and any part of that plant, including all derivatives, extracts, cannabinoids, isomers, acids, salts, and salts of isomers; the term &#8220;U.S. hemp&#8221; has the meaning given to term &#8220;hemp&#8221; in the U.S. Agricultural Improvement Act of 2018 (the &#8220;2018 Farm Bill&#8221;), including hemp-derived cannabidiol (&#8220;CBD&#8221;); and the term &#8220;U.S. Schedule I cannabis&#8221; means cannabis excluding U.S. hemp.</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">This Quarterly Report contains references to our trademarks and trade names and to trademarks and trade names belonging to other entities. Solely for convenience, trademarks and trade names referred to in this Quarterly Report may appear without the &#174; or &#8482; symbols, but such references are not intended to indicate, in any way, that their respective owners will not assert, to the fullest extent under applicable law, their rights thereto. We do not intend our use or display of other companies&#8217; trademarks or trade names to imply a relationship with, or endorsement or sponsorship of us or our business by, any other companies. In addition, this Quarterly Report includes website addresses. These website addresses are intended to provide inactive, textual references only. The information on or referred to on these websites is not part of or incorporated into this Quarterly Report.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">All currency amounts in this Quarterly Report are stated in U.S. dollars, which is our reporting currency, unless otherwise noted. All references to &#8220;dollars&#8221; or &#8220;$&#8221; are to U.S. dollars; all references to &#8220;C$&#8221; are to Canadian dollars; all references to &#8220;A$&#8221; are to Australian dollars; and all references to &#8220;ILS&#8221; are to New Israeli Shekels. </span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:52.233%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.344%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:1.466%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.344%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:1.466%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.347%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%">(Exchange rates are shown as C$ per $)</span></td><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">As of</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">June 30, 2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">June 30, 2020</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 31, 2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Average rate</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.2293</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.3856</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.3036</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Spot rate</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.2395</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.3576</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.2751</span></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Year-to-date average rate</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.2481</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.3646</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.3411</span></td></tr></table></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">All summaries of agreements described herein are qualified by the full text of such agreements (certain of which have been filed as exhibits with the U.S. Securities and Exchange Commission).</span></div><div style="margin-bottom:6pt;text-align:justify"><span><br/></span></div><div id="i93ca9bb01792476fbb225e5d9dec869f_10"></div><div style="text-align:center"><span><br/></span></div><div style="height:36pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">2</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:36pt;width:100%"><div><span><br/></span></div></div><div style="margin-bottom:6pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">PART I<br/>FINANCIAL INFORMATION</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:right"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i93ca9bb01792476fbb225e5d9dec869f_7">Table of Contents</a></span></div><div id="i93ca9bb01792476fbb225e5d9dec869f_13"></div><div style="margin-bottom:6pt;margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Item 1. Financial Statements</span><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:92.650%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:5.150%"></td><td style="width:0.1%"></td></tr><tr><td colspan="6" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Table of Contents</span></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0e32e1;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0e32e1;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i93ca9bb01792476fbb225e5d9dec869f_16">Condensed Consolidated Balance Sheets as of </a>June 30, 2021 (Unaudited) and December 31, 2020</span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:right"><span style="color:#0e32e1;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><a style="color:#0e32e1;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:none" href="#i93ca9bb01792476fbb225e5d9dec869f_16">4</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0e32e1;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0e32e1;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i93ca9bb01792476fbb225e5d9dec869f_19">Condensed Consolidated Statements of Net Income (Loss) and Comprehensive Income (Loss) for the three</a><a style="color:#0e32e1;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i93ca9bb01792476fbb225e5d9dec869f_19"> and six</a><a style="color:#0e32e1;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i93ca9bb01792476fbb225e5d9dec869f_19"> months ended </a>June<a style="color:#0e32e1;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i93ca9bb01792476fbb225e5d9dec869f_19">&#160;3</a><a style="color:#0e32e1;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i93ca9bb01792476fbb225e5d9dec869f_19">0</a><a style="color:#0e32e1;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i93ca9bb01792476fbb225e5d9dec869f_19">, 2021 and 2020</a> (Unaudited)</span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:right"><span style="color:#0e32e1;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><a style="color:#0e32e1;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:none" href="#i93ca9bb01792476fbb225e5d9dec869f_19">5</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0e32e1;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0e32e1;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i93ca9bb01792476fbb225e5d9dec869f_25">Condensed Consolidated Statements of Changes in Equity for the three </a><a style="color:#0e32e1;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i93ca9bb01792476fbb225e5d9dec869f_25">and six </a><a style="color:#0e32e1;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i93ca9bb01792476fbb225e5d9dec869f_25">months ended </a><a style="color:#0e32e1;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i93ca9bb01792476fbb225e5d9dec869f_25">June</a><a style="color:#0e32e1;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i93ca9bb01792476fbb225e5d9dec869f_25">&#160;3</a><a style="color:#0e32e1;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i93ca9bb01792476fbb225e5d9dec869f_25">0</a><a style="color:#0e32e1;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i93ca9bb01792476fbb225e5d9dec869f_25">, 2021 and 20</a>20 (Unaudited)</span></div></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:top"><span style="color:#0e32e1;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0e32e1;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0e32e1;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i93ca9bb01792476fbb225e5d9dec869f_28">Condensed Consolidated Statements of Cash Flows for the</a><a style="color:#0e32e1;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i93ca9bb01792476fbb225e5d9dec869f_28"> six </a><a style="color:#0e32e1;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i93ca9bb01792476fbb225e5d9dec869f_28">months ended </a>June 30, 2021 and 2020 (Unaudited)</span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:right"><span style="color:#0e32e1;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><a style="color:#0e32e1;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:none" href="#i93ca9bb01792476fbb225e5d9dec869f_28">8</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-top:0.55pt"><span style="color:#0e32e1;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0e32e1;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i93ca9bb01792476fbb225e5d9dec869f_34">Notes to</a></span><span style="background-color:#ffffff;color:#0e32e1;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="background-color:#ffffff;color:#0e32e1;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i93ca9bb01792476fbb225e5d9dec869f_34"> Condensed </a></span><span style="color:#0e32e1;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0e32e1;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i93ca9bb01792476fbb225e5d9dec869f_34">Consolidated Financial Statements</a> (Unaudited)</span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:right"><span style="color:#0e32e1;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><a style="color:#0e32e1;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:none" href="#i93ca9bb01792476fbb225e5d9dec869f_34">9</a></span></div></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr></table></div><div><span><br/></span></div><div style="height:36pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">3</span></div></div></div><div id="i93ca9bb01792476fbb225e5d9dec869f_16"></div><hr style="page-break-after:always"/><div style="min-height:72pt;width:100%"><div style="margin-top:0.55pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:73.607%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:24.193%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="border-top:1pt solid #FFFFFF;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Cronos Group Inc.</span></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Condensed Consolidated Balance Sheets</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">(In thousands of U.S. dollars, except share amounts)</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i93ca9bb01792476fbb225e5d9dec869f_7">Table of Contents</a></span></div></td></tr></table></div><div><span><br/></span></div></div><div style="text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:64.594%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:15.566%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.772%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:15.568%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">As of June&#160;30, 2021</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">As of December 31, 2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Assets</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%">(Unaudited)</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%">(Audited)</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Current assets</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cash and cash equivalents</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i225f85e38faa4bbdb4de1d8b9cf369bb_I20210630" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:CashAndCashEquivalentsAtCarryingValue" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzY2E5YmIwMTc5MjQ3NmZiYjIyNWU1ZDlkZWM4NjlmL3NlYzo5M2NhOWJiMDE3OTI0NzZmYmIyMjVlNWQ5ZGVjODY5Zl8xNi9mcmFnOmNhM2Q5OWRkMjk1ODQxYzQ4Yzk2ZDg0NGIzMGFkMjA5L3RhYmxlOmQ1Nzc2MTlkODM1ODRhZWNiNTE1YzZiODUwYjcwM2FmL3RhYmxlcmFuZ2U6ZDU3NzYxOWQ4MzU4NGFlY2I1MTVjNmI4NTBiNzAzYWZfMy0xLTEtMS0w_0420cd73-92fc-4ac8-813c-be744163d572">895,181</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ifbe16ec51ea244519b77d6036b4ef038_I20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:CashAndCashEquivalentsAtCarryingValue" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzY2E5YmIwMTc5MjQ3NmZiYjIyNWU1ZDlkZWM4NjlmL3NlYzo5M2NhOWJiMDE3OTI0NzZmYmIyMjVlNWQ5ZGVjODY5Zl8xNi9mcmFnOmNhM2Q5OWRkMjk1ODQxYzQ4Yzk2ZDg0NGIzMGFkMjA5L3RhYmxlOmQ1Nzc2MTlkODM1ODRhZWNiNTE1YzZiODUwYjcwM2FmL3RhYmxlcmFuZ2U6ZDU3NzYxOWQ4MzU4NGFlY2I1MTVjNmI4NTBiNzAzYWZfMy0zLTEtMS0w_9ff5ba0a-1383-4e93-a9b0-2d436e525a15">1,078,023</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Short-term investments</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i225f85e38faa4bbdb4de1d8b9cf369bb_I20210630" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:ShortTermInvestments" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzY2E5YmIwMTc5MjQ3NmZiYjIyNWU1ZDlkZWM4NjlmL3NlYzo5M2NhOWJiMDE3OTI0NzZmYmIyMjVlNWQ5ZGVjODY5Zl8xNi9mcmFnOmNhM2Q5OWRkMjk1ODQxYzQ4Yzk2ZDg0NGIzMGFkMjA5L3RhYmxlOmQ1Nzc2MTlkODM1ODRhZWNiNTE1YzZiODUwYjcwM2FmL3RhYmxlcmFuZ2U6ZDU3NzYxOWQ4MzU4NGFlY2I1MTVjNmI4NTBiNzAzYWZfNC0xLTEtMS0w_d28816aa-2f84-4061-87a4-07f91bd16ca7">201,699</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ifbe16ec51ea244519b77d6036b4ef038_I20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:ShortTermInvestments" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzY2E5YmIwMTc5MjQ3NmZiYjIyNWU1ZDlkZWM4NjlmL3NlYzo5M2NhOWJiMDE3OTI0NzZmYmIyMjVlNWQ5ZGVjODY5Zl8xNi9mcmFnOmNhM2Q5OWRkMjk1ODQxYzQ4Yzk2ZDg0NGIzMGFkMjA5L3RhYmxlOmQ1Nzc2MTlkODM1ODRhZWNiNTE1YzZiODUwYjcwM2FmL3RhYmxlcmFuZ2U6ZDU3NzYxOWQ4MzU4NGFlY2I1MTVjNmI4NTBiNzAzYWZfNC0zLTEtMS0w_4c3509cc-145a-443e-b42d-0da38eeed0bb">211,766</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accounts receivable, net</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i225f85e38faa4bbdb4de1d8b9cf369bb_I20210630" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:AccountsReceivableNetCurrent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzY2E5YmIwMTc5MjQ3NmZiYjIyNWU1ZDlkZWM4NjlmL3NlYzo5M2NhOWJiMDE3OTI0NzZmYmIyMjVlNWQ5ZGVjODY5Zl8xNi9mcmFnOmNhM2Q5OWRkMjk1ODQxYzQ4Yzk2ZDg0NGIzMGFkMjA5L3RhYmxlOmQ1Nzc2MTlkODM1ODRhZWNiNTE1YzZiODUwYjcwM2FmL3RhYmxlcmFuZ2U6ZDU3NzYxOWQ4MzU4NGFlY2I1MTVjNmI4NTBiNzAzYWZfNS0xLTEtMS0w_65fce372-1f11-4b14-9951-f3fbe227277b">11,299</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ifbe16ec51ea244519b77d6036b4ef038_I20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:AccountsReceivableNetCurrent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzY2E5YmIwMTc5MjQ3NmZiYjIyNWU1ZDlkZWM4NjlmL3NlYzo5M2NhOWJiMDE3OTI0NzZmYmIyMjVlNWQ5ZGVjODY5Zl8xNi9mcmFnOmNhM2Q5OWRkMjk1ODQxYzQ4Yzk2ZDg0NGIzMGFkMjA5L3RhYmxlOmQ1Nzc2MTlkODM1ODRhZWNiNTE1YzZiODUwYjcwM2FmL3RhYmxlcmFuZ2U6ZDU3NzYxOWQ4MzU4NGFlY2I1MTVjNmI4NTBiNzAzYWZfNS0zLTEtMS0w_0c1f9c9b-cd80-4a87-a627-32a082ee2bfe">8,928</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other receivables</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i225f85e38faa4bbdb4de1d8b9cf369bb_I20210630" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:OtherReceivablesNetCurrent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzY2E5YmIwMTc5MjQ3NmZiYjIyNWU1ZDlkZWM4NjlmL3NlYzo5M2NhOWJiMDE3OTI0NzZmYmIyMjVlNWQ5ZGVjODY5Zl8xNi9mcmFnOmNhM2Q5OWRkMjk1ODQxYzQ4Yzk2ZDg0NGIzMGFkMjA5L3RhYmxlOmQ1Nzc2MTlkODM1ODRhZWNiNTE1YzZiODUwYjcwM2FmL3RhYmxlcmFuZ2U6ZDU3NzYxOWQ4MzU4NGFlY2I1MTVjNmI4NTBiNzAzYWZfNi0xLTEtMS0w_d8711a30-80ac-4d5a-bc66-e75ffdef203b">2,468</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ifbe16ec51ea244519b77d6036b4ef038_I20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:OtherReceivablesNetCurrent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzY2E5YmIwMTc5MjQ3NmZiYjIyNWU1ZDlkZWM4NjlmL3NlYzo5M2NhOWJiMDE3OTI0NzZmYmIyMjVlNWQ5ZGVjODY5Zl8xNi9mcmFnOmNhM2Q5OWRkMjk1ODQxYzQ4Yzk2ZDg0NGIzMGFkMjA5L3RhYmxlOmQ1Nzc2MTlkODM1ODRhZWNiNTE1YzZiODUwYjcwM2FmL3RhYmxlcmFuZ2U6ZDU3NzYxOWQ4MzU4NGFlY2I1MTVjNmI4NTBiNzAzYWZfNi0zLTEtMS0w_2c84ec50-f6ed-4261-81b2-4ddc346a3206">10,033</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Current portion of loans receivable, net</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i225f85e38faa4bbdb4de1d8b9cf369bb_I20210630" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:NotesAndLoansReceivableNetCurrent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzY2E5YmIwMTc5MjQ3NmZiYjIyNWU1ZDlkZWM4NjlmL3NlYzo5M2NhOWJiMDE3OTI0NzZmYmIyMjVlNWQ5ZGVjODY5Zl8xNi9mcmFnOmNhM2Q5OWRkMjk1ODQxYzQ4Yzk2ZDg0NGIzMGFkMjA5L3RhYmxlOmQ1Nzc2MTlkODM1ODRhZWNiNTE1YzZiODUwYjcwM2FmL3RhYmxlcmFuZ2U6ZDU3NzYxOWQ4MzU4NGFlY2I1MTVjNmI4NTBiNzAzYWZfNy0xLTEtMS0w_accc60a2-966d-4c6c-beab-5606a3f99a90">5,028</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ifbe16ec51ea244519b77d6036b4ef038_I20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:NotesAndLoansReceivableNetCurrent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzY2E5YmIwMTc5MjQ3NmZiYjIyNWU1ZDlkZWM4NjlmL3NlYzo5M2NhOWJiMDE3OTI0NzZmYmIyMjVlNWQ5ZGVjODY5Zl8xNi9mcmFnOmNhM2Q5OWRkMjk1ODQxYzQ4Yzk2ZDg0NGIzMGFkMjA5L3RhYmxlOmQ1Nzc2MTlkODM1ODRhZWNiNTE1YzZiODUwYjcwM2FmL3RhYmxlcmFuZ2U6ZDU3NzYxOWQ4MzU4NGFlY2I1MTVjNmI4NTBiNzAzYWZfNy0zLTEtMS0w_b1a48fd8-f579-43a7-8fa7-1014f9955f2b">7,083</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Prepaids and other current assets</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i225f85e38faa4bbdb4de1d8b9cf369bb_I20210630" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:PrepaidExpenseAndOtherAssetsCurrent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzY2E5YmIwMTc5MjQ3NmZiYjIyNWU1ZDlkZWM4NjlmL3NlYzo5M2NhOWJiMDE3OTI0NzZmYmIyMjVlNWQ5ZGVjODY5Zl8xNi9mcmFnOmNhM2Q5OWRkMjk1ODQxYzQ4Yzk2ZDg0NGIzMGFkMjA5L3RhYmxlOmQ1Nzc2MTlkODM1ODRhZWNiNTE1YzZiODUwYjcwM2FmL3RhYmxlcmFuZ2U6ZDU3NzYxOWQ4MzU4NGFlY2I1MTVjNmI4NTBiNzAzYWZfOC0xLTEtMS0w_118d0c76-b6fc-405b-b8a4-50a0e69e468d">10,153</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ifbe16ec51ea244519b77d6036b4ef038_I20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:PrepaidExpenseAndOtherAssetsCurrent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzY2E5YmIwMTc5MjQ3NmZiYjIyNWU1ZDlkZWM4NjlmL3NlYzo5M2NhOWJiMDE3OTI0NzZmYmIyMjVlNWQ5ZGVjODY5Zl8xNi9mcmFnOmNhM2Q5OWRkMjk1ODQxYzQ4Yzk2ZDg0NGIzMGFkMjA5L3RhYmxlOmQ1Nzc2MTlkODM1ODRhZWNiNTE1YzZiODUwYjcwM2FmL3RhYmxlcmFuZ2U6ZDU3NzYxOWQ4MzU4NGFlY2I1MTVjNmI4NTBiNzAzYWZfOC0zLTEtMS0w_fdbbe8c0-8afa-4709-85cc-f1fbf8af4970">11,161</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Inventory, net</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i225f85e38faa4bbdb4de1d8b9cf369bb_I20210630" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:InventoryNet" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzY2E5YmIwMTc5MjQ3NmZiYjIyNWU1ZDlkZWM4NjlmL3NlYzo5M2NhOWJiMDE3OTI0NzZmYmIyMjVlNWQ5ZGVjODY5Zl8xNi9mcmFnOmNhM2Q5OWRkMjk1ODQxYzQ4Yzk2ZDg0NGIzMGFkMjA5L3RhYmxlOmQ1Nzc2MTlkODM1ODRhZWNiNTE1YzZiODUwYjcwM2FmL3RhYmxlcmFuZ2U6ZDU3NzYxOWQ4MzU4NGFlY2I1MTVjNmI4NTBiNzAzYWZfOS0xLTEtMS0w_eaf8284c-10ec-4b0f-a3f6-1976c42bc1a8">35,605</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ifbe16ec51ea244519b77d6036b4ef038_I20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:InventoryNet" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzY2E5YmIwMTc5MjQ3NmZiYjIyNWU1ZDlkZWM4NjlmL3NlYzo5M2NhOWJiMDE3OTI0NzZmYmIyMjVlNWQ5ZGVjODY5Zl8xNi9mcmFnOmNhM2Q5OWRkMjk1ODQxYzQ4Yzk2ZDg0NGIzMGFkMjA5L3RhYmxlOmQ1Nzc2MTlkODM1ODRhZWNiNTE1YzZiODUwYjcwM2FmL3RhYmxlcmFuZ2U6ZDU3NzYxOWQ4MzU4NGFlY2I1MTVjNmI4NTBiNzAzYWZfOS0zLTEtMS0w_6c80cd8e-21bc-42b2-9b68-19d05a39c70c">44,002</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 8.5pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Held-for-sale assets</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i225f85e38faa4bbdb4de1d8b9cf369bb_I20210630" decimals="-3" name="us-gaap:AssetsHeldForSaleNotPartOfDisposalGroupCurrent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzY2E5YmIwMTc5MjQ3NmZiYjIyNWU1ZDlkZWM4NjlmL3NlYzo5M2NhOWJiMDE3OTI0NzZmYmIyMjVlNWQ5ZGVjODY5Zl8xNi9mcmFnOmNhM2Q5OWRkMjk1ODQxYzQ4Yzk2ZDg0NGIzMGFkMjA5L3RhYmxlOmQ1Nzc2MTlkODM1ODRhZWNiNTE1YzZiODUwYjcwM2FmL3RhYmxlcmFuZ2U6ZDU3NzYxOWQ4MzU4NGFlY2I1MTVjNmI4NTBiNzAzYWZfMTAtMS0xLTEtMA_865dfb73-09b0-4b53-9ec5-b0056b26d88a">645</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ifbe16ec51ea244519b77d6036b4ef038_I20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:AssetsHeldForSaleNotPartOfDisposalGroupCurrent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzY2E5YmIwMTc5MjQ3NmZiYjIyNWU1ZDlkZWM4NjlmL3NlYzo5M2NhOWJiMDE3OTI0NzZmYmIyMjVlNWQ5ZGVjODY5Zl8xNi9mcmFnOmNhM2Q5OWRkMjk1ODQxYzQ4Yzk2ZDg0NGIzMGFkMjA5L3RhYmxlOmQ1Nzc2MTlkODM1ODRhZWNiNTE1YzZiODUwYjcwM2FmL3RhYmxlcmFuZ2U6ZDU3NzYxOWQ4MzU4NGFlY2I1MTVjNmI4NTBiNzAzYWZfMTAtMy0xLTEtMA_f270367b-fe3e-415f-bf66-4b8acf7602c3">1,176</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 14.5pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total current assets</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i225f85e38faa4bbdb4de1d8b9cf369bb_I20210630" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:AssetsCurrent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzY2E5YmIwMTc5MjQ3NmZiYjIyNWU1ZDlkZWM4NjlmL3NlYzo5M2NhOWJiMDE3OTI0NzZmYmIyMjVlNWQ5ZGVjODY5Zl8xNi9mcmFnOmNhM2Q5OWRkMjk1ODQxYzQ4Yzk2ZDg0NGIzMGFkMjA5L3RhYmxlOmQ1Nzc2MTlkODM1ODRhZWNiNTE1YzZiODUwYjcwM2FmL3RhYmxlcmFuZ2U6ZDU3NzYxOWQ4MzU4NGFlY2I1MTVjNmI4NTBiNzAzYWZfMTEtMS0xLTEtMA_b2bc98c5-0c69-426c-9ec1-25041a5eff01">1,162,078</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ifbe16ec51ea244519b77d6036b4ef038_I20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:AssetsCurrent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzY2E5YmIwMTc5MjQ3NmZiYjIyNWU1ZDlkZWM4NjlmL3NlYzo5M2NhOWJiMDE3OTI0NzZmYmIyMjVlNWQ5ZGVjODY5Zl8xNi9mcmFnOmNhM2Q5OWRkMjk1ODQxYzQ4Yzk2ZDg0NGIzMGFkMjA5L3RhYmxlOmQ1Nzc2MTlkODM1ODRhZWNiNTE1YzZiODUwYjcwM2FmL3RhYmxlcmFuZ2U6ZDU3NzYxOWQ4MzU4NGFlY2I1MTVjNmI4NTBiNzAzYWZfMTEtMy0xLTEtMA_93d2f7e6-2096-443d-9947-ab39f248c558">1,372,172</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Advances to joint ventures</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i225f85e38faa4bbdb4de1d8b9cf369bb_I20210630" decimals="-3" name="us-gaap:AdvancesToAffiliate" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzY2E5YmIwMTc5MjQ3NmZiYjIyNWU1ZDlkZWM4NjlmL3NlYzo5M2NhOWJiMDE3OTI0NzZmYmIyMjVlNWQ5ZGVjODY5Zl8xNi9mcmFnOmNhM2Q5OWRkMjk1ODQxYzQ4Yzk2ZDg0NGIzMGFkMjA5L3RhYmxlOmQ1Nzc2MTlkODM1ODRhZWNiNTE1YzZiODUwYjcwM2FmL3RhYmxlcmFuZ2U6ZDU3NzYxOWQ4MzU4NGFlY2I1MTVjNmI4NTBiNzAzYWZfMTItMS0xLTEtMA_9daf52ec-6118-4f3b-b584-2b33b36e9ca8">499</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ifbe16ec51ea244519b77d6036b4ef038_I20201231" decimals="-3" name="us-gaap:AdvancesToAffiliate" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzY2E5YmIwMTc5MjQ3NmZiYjIyNWU1ZDlkZWM4NjlmL3NlYzo5M2NhOWJiMDE3OTI0NzZmYmIyMjVlNWQ5ZGVjODY5Zl8xNi9mcmFnOmNhM2Q5OWRkMjk1ODQxYzQ4Yzk2ZDg0NGIzMGFkMjA5L3RhYmxlOmQ1Nzc2MTlkODM1ODRhZWNiNTE1YzZiODUwYjcwM2FmL3RhYmxlcmFuZ2U6ZDU3NzYxOWQ4MzU4NGFlY2I1MTVjNmI4NTBiNzAzYWZfMTItMy0xLTEtMA_a001d878-c9dd-4aa4-9f16-d5fa9be5e847">467</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Investments in equity accounted investees, net</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i225f85e38faa4bbdb4de1d8b9cf369bb_I20210630" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:EquityMethodInvestments" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzY2E5YmIwMTc5MjQ3NmZiYjIyNWU1ZDlkZWM4NjlmL3NlYzo5M2NhOWJiMDE3OTI0NzZmYmIyMjVlNWQ5ZGVjODY5Zl8xNi9mcmFnOmNhM2Q5OWRkMjk1ODQxYzQ4Yzk2ZDg0NGIzMGFkMjA5L3RhYmxlOmQ1Nzc2MTlkODM1ODRhZWNiNTE1YzZiODUwYjcwM2FmL3RhYmxlcmFuZ2U6ZDU3NzYxOWQ4MzU4NGFlY2I1MTVjNmI4NTBiNzAzYWZfMTMtMS0xLTEtMA_fa2d9f5f-b15d-400f-a145-ac714ad31d43">20,970</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ifbe16ec51ea244519b77d6036b4ef038_I20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:EquityMethodInvestments" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzY2E5YmIwMTc5MjQ3NmZiYjIyNWU1ZDlkZWM4NjlmL3NlYzo5M2NhOWJiMDE3OTI0NzZmYmIyMjVlNWQ5ZGVjODY5Zl8xNi9mcmFnOmNhM2Q5OWRkMjk1ODQxYzQ4Yzk2ZDg0NGIzMGFkMjA5L3RhYmxlOmQ1Nzc2MTlkODM1ODRhZWNiNTE1YzZiODUwYjcwM2FmL3RhYmxlcmFuZ2U6ZDU3NzYxOWQ4MzU4NGFlY2I1MTVjNmI4NTBiNzAzYWZfMTMtMy0xLTEtMA_d3feb182-060e-437f-afe6-0662e0004912">19,235</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other investments</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i225f85e38faa4bbdb4de1d8b9cf369bb_I20210630" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:OtherLongTermInvestments" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzY2E5YmIwMTc5MjQ3NmZiYjIyNWU1ZDlkZWM4NjlmL3NlYzo5M2NhOWJiMDE3OTI0NzZmYmIyMjVlNWQ5ZGVjODY5Zl8xNi9mcmFnOmNhM2Q5OWRkMjk1ODQxYzQ4Yzk2ZDg0NGIzMGFkMjA5L3RhYmxlOmQ1Nzc2MTlkODM1ODRhZWNiNTE1YzZiODUwYjcwM2FmL3RhYmxlcmFuZ2U6ZDU3NzYxOWQ4MzU4NGFlY2I1MTVjNmI4NTBiNzAzYWZfMTQtMS0xLTEtODQzNg_6349d8e2-f007-450d-87e1-95f6b5c5c5a0">110,392</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ifbe16ec51ea244519b77d6036b4ef038_I20201231" decimals="-3" format="ixt:zerodash" name="us-gaap:OtherLongTermInvestments" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzY2E5YmIwMTc5MjQ3NmZiYjIyNWU1ZDlkZWM4NjlmL3NlYzo5M2NhOWJiMDE3OTI0NzZmYmIyMjVlNWQ5ZGVjODY5Zl8xNi9mcmFnOmNhM2Q5OWRkMjk1ODQxYzQ4Yzk2ZDg0NGIzMGFkMjA5L3RhYmxlOmQ1Nzc2MTlkODM1ODRhZWNiNTE1YzZiODUwYjcwM2FmL3RhYmxlcmFuZ2U6ZDU3NzYxOWQ4MzU4NGFlY2I1MTVjNmI4NTBiNzAzYWZfMTQtMy0xLTEtODQzNg_78f83ecf-2e6b-4547-a950-feda249da21c">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Loan receivable, net</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i225f85e38faa4bbdb4de1d8b9cf369bb_I20210630" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:NotesAndLoansReceivableNetNoncurrent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzY2E5YmIwMTc5MjQ3NmZiYjIyNWU1ZDlkZWM4NjlmL3NlYzo5M2NhOWJiMDE3OTI0NzZmYmIyMjVlNWQ5ZGVjODY5Zl8xNi9mcmFnOmNhM2Q5OWRkMjk1ODQxYzQ4Yzk2ZDg0NGIzMGFkMjA5L3RhYmxlOmQ1Nzc2MTlkODM1ODRhZWNiNTE1YzZiODUwYjcwM2FmL3RhYmxlcmFuZ2U6ZDU3NzYxOWQ4MzU4NGFlY2I1MTVjNmI4NTBiNzAzYWZfMTQtMS0xLTEtMA_cd2af544-c7b8-4639-9c5f-3a75dc3e6023">94,113</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ifbe16ec51ea244519b77d6036b4ef038_I20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:NotesAndLoansReceivableNetNoncurrent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzY2E5YmIwMTc5MjQ3NmZiYjIyNWU1ZDlkZWM4NjlmL3NlYzo5M2NhOWJiMDE3OTI0NzZmYmIyMjVlNWQ5ZGVjODY5Zl8xNi9mcmFnOmNhM2Q5OWRkMjk1ODQxYzQ4Yzk2ZDg0NGIzMGFkMjA5L3RhYmxlOmQ1Nzc2MTlkODM1ODRhZWNiNTE1YzZiODUwYjcwM2FmL3RhYmxlcmFuZ2U6ZDU3NzYxOWQ4MzU4NGFlY2I1MTVjNmI4NTBiNzAzYWZfMTQtMy0xLTEtMA_ac828b6e-1391-4a7f-b0df-2e672c33b869">87,191</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Property, plant and equipment, net</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i225f85e38faa4bbdb4de1d8b9cf369bb_I20210630" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:PropertyPlantAndEquipmentNet" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzY2E5YmIwMTc5MjQ3NmZiYjIyNWU1ZDlkZWM4NjlmL3NlYzo5M2NhOWJiMDE3OTI0NzZmYmIyMjVlNWQ5ZGVjODY5Zl8xNi9mcmFnOmNhM2Q5OWRkMjk1ODQxYzQ4Yzk2ZDg0NGIzMGFkMjA5L3RhYmxlOmQ1Nzc2MTlkODM1ODRhZWNiNTE1YzZiODUwYjcwM2FmL3RhYmxlcmFuZ2U6ZDU3NzYxOWQ4MzU4NGFlY2I1MTVjNmI4NTBiNzAzYWZfMTUtMS0xLTEtMA_3916666d-d659-47f3-8eec-a2f69918769a">193,920</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ifbe16ec51ea244519b77d6036b4ef038_I20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:PropertyPlantAndEquipmentNet" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzY2E5YmIwMTc5MjQ3NmZiYjIyNWU1ZDlkZWM4NjlmL3NlYzo5M2NhOWJiMDE3OTI0NzZmYmIyMjVlNWQ5ZGVjODY5Zl8xNi9mcmFnOmNhM2Q5OWRkMjk1ODQxYzQ4Yzk2ZDg0NGIzMGFkMjA5L3RhYmxlOmQ1Nzc2MTlkODM1ODRhZWNiNTE1YzZiODUwYjcwM2FmL3RhYmxlcmFuZ2U6ZDU3NzYxOWQ4MzU4NGFlY2I1MTVjNmI4NTBiNzAzYWZfMTUtMy0xLTEtMA_91755e3c-4f34-4f80-92a9-3a9c10cf4002">187,599</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Right-of-use assets</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i225f85e38faa4bbdb4de1d8b9cf369bb_I20210630" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:OperatingLeaseRightOfUseAsset" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzY2E5YmIwMTc5MjQ3NmZiYjIyNWU1ZDlkZWM4NjlmL3NlYzo5M2NhOWJiMDE3OTI0NzZmYmIyMjVlNWQ5ZGVjODY5Zl8xNi9mcmFnOmNhM2Q5OWRkMjk1ODQxYzQ4Yzk2ZDg0NGIzMGFkMjA5L3RhYmxlOmQ1Nzc2MTlkODM1ODRhZWNiNTE1YzZiODUwYjcwM2FmL3RhYmxlcmFuZ2U6ZDU3NzYxOWQ4MzU4NGFlY2I1MTVjNmI4NTBiNzAzYWZfMTYtMS0xLTEtMA_8ec75659-e40a-49e7-bb34-803f3a312721">6,687</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ifbe16ec51ea244519b77d6036b4ef038_I20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:OperatingLeaseRightOfUseAsset" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzY2E5YmIwMTc5MjQ3NmZiYjIyNWU1ZDlkZWM4NjlmL3NlYzo5M2NhOWJiMDE3OTI0NzZmYmIyMjVlNWQ5ZGVjODY5Zl8xNi9mcmFnOmNhM2Q5OWRkMjk1ODQxYzQ4Yzk2ZDg0NGIzMGFkMjA5L3RhYmxlOmQ1Nzc2MTlkODM1ODRhZWNiNTE1YzZiODUwYjcwM2FmL3RhYmxlcmFuZ2U6ZDU3NzYxOWQ4MzU4NGFlY2I1MTVjNmI4NTBiNzAzYWZfMTYtMy0xLTEtMA_95144322-cc96-4eae-9971-913340b1ee47">9,776</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Intangible assets, net</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i225f85e38faa4bbdb4de1d8b9cf369bb_I20210630" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:IntangibleAssetsNetExcludingGoodwill" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzY2E5YmIwMTc5MjQ3NmZiYjIyNWU1ZDlkZWM4NjlmL3NlYzo5M2NhOWJiMDE3OTI0NzZmYmIyMjVlNWQ5ZGVjODY5Zl8xNi9mcmFnOmNhM2Q5OWRkMjk1ODQxYzQ4Yzk2ZDg0NGIzMGFkMjA5L3RhYmxlOmQ1Nzc2MTlkODM1ODRhZWNiNTE1YzZiODUwYjcwM2FmL3RhYmxlcmFuZ2U6ZDU3NzYxOWQ4MzU4NGFlY2I1MTVjNmI4NTBiNzAzYWZfMTctMS0xLTEtMA_f80f2e8b-640f-45ea-8cd1-5947e2d5ee62">70,409</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ifbe16ec51ea244519b77d6036b4ef038_I20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:IntangibleAssetsNetExcludingGoodwill" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzY2E5YmIwMTc5MjQ3NmZiYjIyNWU1ZDlkZWM4NjlmL3NlYzo5M2NhOWJiMDE3OTI0NzZmYmIyMjVlNWQ5ZGVjODY5Zl8xNi9mcmFnOmNhM2Q5OWRkMjk1ODQxYzQ4Yzk2ZDg0NGIzMGFkMjA5L3RhYmxlOmQ1Nzc2MTlkODM1ODRhZWNiNTE1YzZiODUwYjcwM2FmL3RhYmxlcmFuZ2U6ZDU3NzYxOWQ4MzU4NGFlY2I1MTVjNmI4NTBiNzAzYWZfMTctMy0xLTEtMA_f0698614-3a54-49f3-b41a-d0ae143a8450">69,720</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Goodwill</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i225f85e38faa4bbdb4de1d8b9cf369bb_I20210630" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:Goodwill" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzY2E5YmIwMTc5MjQ3NmZiYjIyNWU1ZDlkZWM4NjlmL3NlYzo5M2NhOWJiMDE3OTI0NzZmYmIyMjVlNWQ5ZGVjODY5Zl8xNi9mcmFnOmNhM2Q5OWRkMjk1ODQxYzQ4Yzk2ZDg0NGIzMGFkMjA5L3RhYmxlOmQ1Nzc2MTlkODM1ODRhZWNiNTE1YzZiODUwYjcwM2FmL3RhYmxlcmFuZ2U6ZDU3NzYxOWQ4MzU4NGFlY2I1MTVjNmI4NTBiNzAzYWZfMTgtMS0xLTEtMA_48965b81-7ff8-4ffd-817c-3aa8cf53c38d">179,543</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ifbe16ec51ea244519b77d6036b4ef038_I20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:Goodwill" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzY2E5YmIwMTc5MjQ3NmZiYjIyNWU1ZDlkZWM4NjlmL3NlYzo5M2NhOWJiMDE3OTI0NzZmYmIyMjVlNWQ5ZGVjODY5Zl8xNi9mcmFnOmNhM2Q5OWRkMjk1ODQxYzQ4Yzk2ZDg0NGIzMGFkMjA5L3RhYmxlOmQ1Nzc2MTlkODM1ODRhZWNiNTE1YzZiODUwYjcwM2FmL3RhYmxlcmFuZ2U6ZDU3NzYxOWQ4MzU4NGFlY2I1MTVjNmI4NTBiNzAzYWZfMTgtMy0xLTEtMA_94d76e50-8e6a-4b2a-864e-58164c97fa32">179,522</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total assets</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i225f85e38faa4bbdb4de1d8b9cf369bb_I20210630" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:Assets" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzY2E5YmIwMTc5MjQ3NmZiYjIyNWU1ZDlkZWM4NjlmL3NlYzo5M2NhOWJiMDE3OTI0NzZmYmIyMjVlNWQ5ZGVjODY5Zl8xNi9mcmFnOmNhM2Q5OWRkMjk1ODQxYzQ4Yzk2ZDg0NGIzMGFkMjA5L3RhYmxlOmQ1Nzc2MTlkODM1ODRhZWNiNTE1YzZiODUwYjcwM2FmL3RhYmxlcmFuZ2U6ZDU3NzYxOWQ4MzU4NGFlY2I1MTVjNmI4NTBiNzAzYWZfMTktMS0xLTEtMA_9132d3ae-43df-4d9f-9744-1eddf966f2e3">1,838,611</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ifbe16ec51ea244519b77d6036b4ef038_I20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:Assets" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzY2E5YmIwMTc5MjQ3NmZiYjIyNWU1ZDlkZWM4NjlmL3NlYzo5M2NhOWJiMDE3OTI0NzZmYmIyMjVlNWQ5ZGVjODY5Zl8xNi9mcmFnOmNhM2Q5OWRkMjk1ODQxYzQ4Yzk2ZDg0NGIzMGFkMjA5L3RhYmxlOmQ1Nzc2MTlkODM1ODRhZWNiNTE1YzZiODUwYjcwM2FmL3RhYmxlcmFuZ2U6ZDU3NzYxOWQ4MzU4NGFlY2I1MTVjNmI4NTBiNzAzYWZfMTktMy0xLTEtMA_c68d410b-3ae2-4e83-a05b-6c650f9a524c">1,925,682</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td></tr><tr style="height:14pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Liabilities</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Current liabilities</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accounts payable and other liabilities</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i225f85e38faa4bbdb4de1d8b9cf369bb_I20210630" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:AccountsPayableAndOtherAccruedLiabilitiesCurrent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzY2E5YmIwMTc5MjQ3NmZiYjIyNWU1ZDlkZWM4NjlmL3NlYzo5M2NhOWJiMDE3OTI0NzZmYmIyMjVlNWQ5ZGVjODY5Zl8xNi9mcmFnOmNhM2Q5OWRkMjk1ODQxYzQ4Yzk2ZDg0NGIzMGFkMjA5L3RhYmxlOmQ1Nzc2MTlkODM1ODRhZWNiNTE1YzZiODUwYjcwM2FmL3RhYmxlcmFuZ2U6ZDU3NzYxOWQ4MzU4NGFlY2I1MTVjNmI4NTBiNzAzYWZfMjMtMS0xLTEtMA_96cb2af7-6e34-4581-9703-d984670a00e3">29,829</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ifbe16ec51ea244519b77d6036b4ef038_I20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:AccountsPayableAndOtherAccruedLiabilitiesCurrent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzY2E5YmIwMTc5MjQ3NmZiYjIyNWU1ZDlkZWM4NjlmL3NlYzo5M2NhOWJiMDE3OTI0NzZmYmIyMjVlNWQ5ZGVjODY5Zl8xNi9mcmFnOmNhM2Q5OWRkMjk1ODQxYzQ4Yzk2ZDg0NGIzMGFkMjA5L3RhYmxlOmQ1Nzc2MTlkODM1ODRhZWNiNTE1YzZiODUwYjcwM2FmL3RhYmxlcmFuZ2U6ZDU3NzYxOWQ4MzU4NGFlY2I1MTVjNmI4NTBiNzAzYWZfMjMtMy0xLTEtMA_d675fa7f-9871-459a-8b98-0277fdb69d93">42,102</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Current portion of lease obligation</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i225f85e38faa4bbdb4de1d8b9cf369bb_I20210630" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:OperatingLeaseLiabilityCurrent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzY2E5YmIwMTc5MjQ3NmZiYjIyNWU1ZDlkZWM4NjlmL3NlYzo5M2NhOWJiMDE3OTI0NzZmYmIyMjVlNWQ5ZGVjODY5Zl8xNi9mcmFnOmNhM2Q5OWRkMjk1ODQxYzQ4Yzk2ZDg0NGIzMGFkMjA5L3RhYmxlOmQ1Nzc2MTlkODM1ODRhZWNiNTE1YzZiODUwYjcwM2FmL3RhYmxlcmFuZ2U6ZDU3NzYxOWQ4MzU4NGFlY2I1MTVjNmI4NTBiNzAzYWZfMjQtMS0xLTEtMA_84cc63ce-ee13-4e31-9718-c8ff48c85b50">1,206</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ifbe16ec51ea244519b77d6036b4ef038_I20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:OperatingLeaseLiabilityCurrent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzY2E5YmIwMTc5MjQ3NmZiYjIyNWU1ZDlkZWM4NjlmL3NlYzo5M2NhOWJiMDE3OTI0NzZmYmIyMjVlNWQ5ZGVjODY5Zl8xNi9mcmFnOmNhM2Q5OWRkMjk1ODQxYzQ4Yzk2ZDg0NGIzMGFkMjA5L3RhYmxlOmQ1Nzc2MTlkODM1ODRhZWNiNTE1YzZiODUwYjcwM2FmL3RhYmxlcmFuZ2U6ZDU3NzYxOWQ4MzU4NGFlY2I1MTVjNmI4NTBiNzAzYWZfMjQtMy0xLTEtMA_42c2263e-4b34-45b2-8adf-7878667f1609">1,322</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Derivative liabilities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i225f85e38faa4bbdb4de1d8b9cf369bb_I20210630" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:DerivativeLiabilitiesCurrent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzY2E5YmIwMTc5MjQ3NmZiYjIyNWU1ZDlkZWM4NjlmL3NlYzo5M2NhOWJiMDE3OTI0NzZmYmIyMjVlNWQ5ZGVjODY5Zl8xNi9mcmFnOmNhM2Q5OWRkMjk1ODQxYzQ4Yzk2ZDg0NGIzMGFkMjA5L3RhYmxlOmQ1Nzc2MTlkODM1ODRhZWNiNTE1YzZiODUwYjcwM2FmL3RhYmxlcmFuZ2U6ZDU3NzYxOWQ4MzU4NGFlY2I1MTVjNmI4NTBiNzAzYWZfMjUtMS0xLTEtMA_3f14bba8-55ab-46a1-a17b-a170fb010546">169,563</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ifbe16ec51ea244519b77d6036b4ef038_I20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:DerivativeLiabilitiesCurrent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzY2E5YmIwMTc5MjQ3NmZiYjIyNWU1ZDlkZWM4NjlmL3NlYzo5M2NhOWJiMDE3OTI0NzZmYmIyMjVlNWQ5ZGVjODY5Zl8xNi9mcmFnOmNhM2Q5OWRkMjk1ODQxYzQ4Yzk2ZDg0NGIzMGFkMjA5L3RhYmxlOmQ1Nzc2MTlkODM1ODRhZWNiNTE1YzZiODUwYjcwM2FmL3RhYmxlcmFuZ2U6ZDU3NzYxOWQ4MzU4NGFlY2I1MTVjNmI4NTBiNzAzYWZfMjUtMy0xLTEtMA_8d437cf4-fef6-4532-a764-bc1b0249381d">163,410</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 14.5pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total current liabilities</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i225f85e38faa4bbdb4de1d8b9cf369bb_I20210630" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:LiabilitiesCurrent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzY2E5YmIwMTc5MjQ3NmZiYjIyNWU1ZDlkZWM4NjlmL3NlYzo5M2NhOWJiMDE3OTI0NzZmYmIyMjVlNWQ5ZGVjODY5Zl8xNi9mcmFnOmNhM2Q5OWRkMjk1ODQxYzQ4Yzk2ZDg0NGIzMGFkMjA5L3RhYmxlOmQ1Nzc2MTlkODM1ODRhZWNiNTE1YzZiODUwYjcwM2FmL3RhYmxlcmFuZ2U6ZDU3NzYxOWQ4MzU4NGFlY2I1MTVjNmI4NTBiNzAzYWZfMjYtMS0xLTEtMA_8a4f97a1-9774-4a6e-86a8-98807fad9a55">200,598</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ifbe16ec51ea244519b77d6036b4ef038_I20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:LiabilitiesCurrent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzY2E5YmIwMTc5MjQ3NmZiYjIyNWU1ZDlkZWM4NjlmL3NlYzo5M2NhOWJiMDE3OTI0NzZmYmIyMjVlNWQ5ZGVjODY5Zl8xNi9mcmFnOmNhM2Q5OWRkMjk1ODQxYzQ4Yzk2ZDg0NGIzMGFkMjA5L3RhYmxlOmQ1Nzc2MTlkODM1ODRhZWNiNTE1YzZiODUwYjcwM2FmL3RhYmxlcmFuZ2U6ZDU3NzYxOWQ4MzU4NGFlY2I1MTVjNmI4NTBiNzAzYWZfMjYtMy0xLTEtMA_703af9e7-ae80-4f05-9cc3-e28ad1336056">206,834</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Due to non-controlling interests</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i225f85e38faa4bbdb4de1d8b9cf369bb_I20210630" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:DueToRelatedPartiesNoncurrent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzY2E5YmIwMTc5MjQ3NmZiYjIyNWU1ZDlkZWM4NjlmL3NlYzo5M2NhOWJiMDE3OTI0NzZmYmIyMjVlNWQ5ZGVjODY5Zl8xNi9mcmFnOmNhM2Q5OWRkMjk1ODQxYzQ4Yzk2ZDg0NGIzMGFkMjA5L3RhYmxlOmQ1Nzc2MTlkODM1ODRhZWNiNTE1YzZiODUwYjcwM2FmL3RhYmxlcmFuZ2U6ZDU3NzYxOWQ4MzU4NGFlY2I1MTVjNmI4NTBiNzAzYWZfMjctMS0xLTEtMA_ed022f65-1de8-4ddd-8048-ced230f122e5">1,768</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ifbe16ec51ea244519b77d6036b4ef038_I20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:DueToRelatedPartiesNoncurrent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzY2E5YmIwMTc5MjQ3NmZiYjIyNWU1ZDlkZWM4NjlmL3NlYzo5M2NhOWJiMDE3OTI0NzZmYmIyMjVlNWQ5ZGVjODY5Zl8xNi9mcmFnOmNhM2Q5OWRkMjk1ODQxYzQ4Yzk2ZDg0NGIzMGFkMjA5L3RhYmxlOmQ1Nzc2MTlkODM1ODRhZWNiNTE1YzZiODUwYjcwM2FmL3RhYmxlcmFuZ2U6ZDU3NzYxOWQ4MzU4NGFlY2I1MTVjNmI4NTBiNzAzYWZfMjctMy0xLTEtMA_e3435fd0-83f9-4d0a-8c33-72bb6c56e3a1">2,188</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Lease obligation</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i225f85e38faa4bbdb4de1d8b9cf369bb_I20210630" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:OperatingLeaseLiabilityNoncurrent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzY2E5YmIwMTc5MjQ3NmZiYjIyNWU1ZDlkZWM4NjlmL3NlYzo5M2NhOWJiMDE3OTI0NzZmYmIyMjVlNWQ5ZGVjODY5Zl8xNi9mcmFnOmNhM2Q5OWRkMjk1ODQxYzQ4Yzk2ZDg0NGIzMGFkMjA5L3RhYmxlOmQ1Nzc2MTlkODM1ODRhZWNiNTE1YzZiODUwYjcwM2FmL3RhYmxlcmFuZ2U6ZDU3NzYxOWQ4MzU4NGFlY2I1MTVjNmI4NTBiNzAzYWZfMjgtMS0xLTEtMA_d05b65e0-13af-49ea-82a0-b6490032f5ca">6,333</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ifbe16ec51ea244519b77d6036b4ef038_I20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:OperatingLeaseLiabilityNoncurrent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzY2E5YmIwMTc5MjQ3NmZiYjIyNWU1ZDlkZWM4NjlmL3NlYzo5M2NhOWJiMDE3OTI0NzZmYmIyMjVlNWQ5ZGVjODY5Zl8xNi9mcmFnOmNhM2Q5OWRkMjk1ODQxYzQ4Yzk2ZDg0NGIzMGFkMjA5L3RhYmxlOmQ1Nzc2MTlkODM1ODRhZWNiNTE1YzZiODUwYjcwM2FmL3RhYmxlcmFuZ2U6ZDU3NzYxOWQ4MzU4NGFlY2I1MTVjNmI4NTBiNzAzYWZfMjgtMy0xLTEtMA_6dba7b1d-42ae-42d4-a471-4bf6ae3289c9">8,492</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 1.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total liabilities</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i225f85e38faa4bbdb4de1d8b9cf369bb_I20210630" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:Liabilities" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzY2E5YmIwMTc5MjQ3NmZiYjIyNWU1ZDlkZWM4NjlmL3NlYzo5M2NhOWJiMDE3OTI0NzZmYmIyMjVlNWQ5ZGVjODY5Zl8xNi9mcmFnOmNhM2Q5OWRkMjk1ODQxYzQ4Yzk2ZDg0NGIzMGFkMjA5L3RhYmxlOmQ1Nzc2MTlkODM1ODRhZWNiNTE1YzZiODUwYjcwM2FmL3RhYmxlcmFuZ2U6ZDU3NzYxOWQ4MzU4NGFlY2I1MTVjNmI4NTBiNzAzYWZfMzAtMS0xLTEtMA_e60262d7-1d26-4bcc-9d20-a239e8b1b834">208,699</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ifbe16ec51ea244519b77d6036b4ef038_I20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:Liabilities" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzY2E5YmIwMTc5MjQ3NmZiYjIyNWU1ZDlkZWM4NjlmL3NlYzo5M2NhOWJiMDE3OTI0NzZmYmIyMjVlNWQ5ZGVjODY5Zl8xNi9mcmFnOmNhM2Q5OWRkMjk1ODQxYzQ4Yzk2ZDg0NGIzMGFkMjA5L3RhYmxlOmQ1Nzc2MTlkODM1ODRhZWNiNTE1YzZiODUwYjcwM2FmL3RhYmxlcmFuZ2U6ZDU3NzYxOWQ4MzU4NGFlY2I1MTVjNmI4NTBiNzAzYWZfMzAtMy0xLTEtMA_6bc5e1c6-db82-41bc-8542-e660237959dd">217,514</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Commitments and contingencies (see Note 9)</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"><ix:nonFraction unitRef="usd" contextRef="i225f85e38faa4bbdb4de1d8b9cf369bb_I20210630" xsi:nil="true" name="us-gaap:CommitmentsAndContingencies" id="id3VybDovL2RvY3MudjEvZG9jOjkzY2E5YmIwMTc5MjQ3NmZiYjIyNWU1ZDlkZWM4NjlmL3NlYzo5M2NhOWJiMDE3OTI0NzZmYmIyMjVlNWQ5ZGVjODY5Zl8xNi9mcmFnOmNhM2Q5OWRkMjk1ODQxYzQ4Yzk2ZDg0NGIzMGFkMjA5L3RhYmxlOmQ1Nzc2MTlkODM1ODRhZWNiNTE1YzZiODUwYjcwM2FmL3RhYmxlcmFuZ2U6ZDU3NzYxOWQ4MzU4NGFlY2I1MTVjNmI4NTBiNzAzYWZfMzEtMS0xLTEtMA_b201c5b5-5d7b-46f4-b52f-f4db029c9312"></ix:nonFraction></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"><ix:nonFraction unitRef="usd" contextRef="ifbe16ec51ea244519b77d6036b4ef038_I20201231" xsi:nil="true" name="us-gaap:CommitmentsAndContingencies" id="id3VybDovL2RvY3MudjEvZG9jOjkzY2E5YmIwMTc5MjQ3NmZiYjIyNWU1ZDlkZWM4NjlmL3NlYzo5M2NhOWJiMDE3OTI0NzZmYmIyMjVlNWQ5ZGVjODY5Zl8xNi9mcmFnOmNhM2Q5OWRkMjk1ODQxYzQ4Yzk2ZDg0NGIzMGFkMjA5L3RhYmxlOmQ1Nzc2MTlkODM1ODRhZWNiNTE1YzZiODUwYjcwM2FmL3RhYmxlcmFuZ2U6ZDU3NzYxOWQ4MzU4NGFlY2I1MTVjNmI4NTBiNzAzYWZfMzEtMy0xLTEtMA_bdaf9669-017d-429f-aa36-335aefc9fd2e"></ix:nonFraction></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Shareholders&#8217; equity</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Share capital </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(i, ii)</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i225f85e38faa4bbdb4de1d8b9cf369bb_I20210630" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:CommonStockValue" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzY2E5YmIwMTc5MjQ3NmZiYjIyNWU1ZDlkZWM4NjlmL3NlYzo5M2NhOWJiMDE3OTI0NzZmYmIyMjVlNWQ5ZGVjODY5Zl8xNi9mcmFnOmNhM2Q5OWRkMjk1ODQxYzQ4Yzk2ZDg0NGIzMGFkMjA5L3RhYmxlOmQ1Nzc2MTlkODM1ODRhZWNiNTE1YzZiODUwYjcwM2FmL3RhYmxlcmFuZ2U6ZDU3NzYxOWQ4MzU4NGFlY2I1MTVjNmI4NTBiNzAzYWZfMzQtMS0xLTEtMA_5e098358-4e52-4202-99a3-6577d5e81128">572,858</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ifbe16ec51ea244519b77d6036b4ef038_I20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:CommonStockValue" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzY2E5YmIwMTc5MjQ3NmZiYjIyNWU1ZDlkZWM4NjlmL3NlYzo5M2NhOWJiMDE3OTI0NzZmYmIyMjVlNWQ5ZGVjODY5Zl8xNi9mcmFnOmNhM2Q5OWRkMjk1ODQxYzQ4Yzk2ZDg0NGIzMGFkMjA5L3RhYmxlOmQ1Nzc2MTlkODM1ODRhZWNiNTE1YzZiODUwYjcwM2FmL3RhYmxlcmFuZ2U6ZDU3NzYxOWQ4MzU4NGFlY2I1MTVjNmI4NTBiNzAzYWZfMzQtMy0xLTEtMA_45fdf40b-dbc8-4445-906e-9521e4f1d45e">569,260</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Additional paid-in capital</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i225f85e38faa4bbdb4de1d8b9cf369bb_I20210630" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:AdditionalPaidInCapital" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzY2E5YmIwMTc5MjQ3NmZiYjIyNWU1ZDlkZWM4NjlmL3NlYzo5M2NhOWJiMDE3OTI0NzZmYmIyMjVlNWQ5ZGVjODY5Zl8xNi9mcmFnOmNhM2Q5OWRkMjk1ODQxYzQ4Yzk2ZDg0NGIzMGFkMjA5L3RhYmxlOmQ1Nzc2MTlkODM1ODRhZWNiNTE1YzZiODUwYjcwM2FmL3RhYmxlcmFuZ2U6ZDU3NzYxOWQ4MzU4NGFlY2I1MTVjNmI4NTBiNzAzYWZfMzUtMS0xLTEtMA_e46d937b-1e49-4eac-b6f5-560e8466ac09">32,368</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ifbe16ec51ea244519b77d6036b4ef038_I20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:AdditionalPaidInCapital" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzY2E5YmIwMTc5MjQ3NmZiYjIyNWU1ZDlkZWM4NjlmL3NlYzo5M2NhOWJiMDE3OTI0NzZmYmIyMjVlNWQ5ZGVjODY5Zl8xNi9mcmFnOmNhM2Q5OWRkMjk1ODQxYzQ4Yzk2ZDg0NGIzMGFkMjA5L3RhYmxlOmQ1Nzc2MTlkODM1ODRhZWNiNTE1YzZiODUwYjcwM2FmL3RhYmxlcmFuZ2U6ZDU3NzYxOWQ4MzU4NGFlY2I1MTVjNmI4NTBiNzAzYWZfMzUtMy0xLTEtMA_78de5e64-ec48-4a8f-aaf0-36e09bc37fe4">34,596</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Retained earnings</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i225f85e38faa4bbdb4de1d8b9cf369bb_I20210630" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:RetainedEarningsAccumulatedDeficit" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzY2E5YmIwMTc5MjQ3NmZiYjIyNWU1ZDlkZWM4NjlmL3NlYzo5M2NhOWJiMDE3OTI0NzZmYmIyMjVlNWQ5ZGVjODY5Zl8xNi9mcmFnOmNhM2Q5OWRkMjk1ODQxYzQ4Yzk2ZDg0NGIzMGFkMjA5L3RhYmxlOmQ1Nzc2MTlkODM1ODRhZWNiNTE1YzZiODUwYjcwM2FmL3RhYmxlcmFuZ2U6ZDU3NzYxOWQ4MzU4NGFlY2I1MTVjNmI4NTBiNzAzYWZfMzYtMS0xLTEtMA_b270e9ba-9492-4254-b390-e0855cb57543">955,721</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ifbe16ec51ea244519b77d6036b4ef038_I20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:RetainedEarningsAccumulatedDeficit" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzY2E5YmIwMTc5MjQ3NmZiYjIyNWU1ZDlkZWM4NjlmL3NlYzo5M2NhOWJiMDE3OTI0NzZmYmIyMjVlNWQ5ZGVjODY5Zl8xNi9mcmFnOmNhM2Q5OWRkMjk1ODQxYzQ4Yzk2ZDg0NGIzMGFkMjA5L3RhYmxlOmQ1Nzc2MTlkODM1ODRhZWNiNTE1YzZiODUwYjcwM2FmL3RhYmxlcmFuZ2U6ZDU3NzYxOWQ4MzU4NGFlY2I1MTVjNmI4NTBiNzAzYWZfMzYtMy0xLTEtMA_b6299a1d-3295-44d3-a7e3-baba37ef358e">1,064,509</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accumulated other comprehensive income</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i225f85e38faa4bbdb4de1d8b9cf369bb_I20210630" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzY2E5YmIwMTc5MjQ3NmZiYjIyNWU1ZDlkZWM4NjlmL3NlYzo5M2NhOWJiMDE3OTI0NzZmYmIyMjVlNWQ5ZGVjODY5Zl8xNi9mcmFnOmNhM2Q5OWRkMjk1ODQxYzQ4Yzk2ZDg0NGIzMGFkMjA5L3RhYmxlOmQ1Nzc2MTlkODM1ODRhZWNiNTE1YzZiODUwYjcwM2FmL3RhYmxlcmFuZ2U6ZDU3NzYxOWQ4MzU4NGFlY2I1MTVjNmI4NTBiNzAzYWZfMzctMS0xLTEtMA_71fa1acb-2160-4dce-bdfb-c3e92ee53b7b">71,729</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ifbe16ec51ea244519b77d6036b4ef038_I20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzY2E5YmIwMTc5MjQ3NmZiYjIyNWU1ZDlkZWM4NjlmL3NlYzo5M2NhOWJiMDE3OTI0NzZmYmIyMjVlNWQ5ZGVjODY5Zl8xNi9mcmFnOmNhM2Q5OWRkMjk1ODQxYzQ4Yzk2ZDg0NGIzMGFkMjA5L3RhYmxlOmQ1Nzc2MTlkODM1ODRhZWNiNTE1YzZiODUwYjcwM2FmL3RhYmxlcmFuZ2U6ZDU3NzYxOWQ4MzU4NGFlY2I1MTVjNmI4NTBiNzAzYWZfMzctMy0xLTEtMA_823baac8-4124-49bc-9b49-93956bcaaf40">42,999</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 14.5pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total equity attributable to shareholders of Cronos Group</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i225f85e38faa4bbdb4de1d8b9cf369bb_I20210630" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:StockholdersEquity" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzY2E5YmIwMTc5MjQ3NmZiYjIyNWU1ZDlkZWM4NjlmL3NlYzo5M2NhOWJiMDE3OTI0NzZmYmIyMjVlNWQ5ZGVjODY5Zl8xNi9mcmFnOmNhM2Q5OWRkMjk1ODQxYzQ4Yzk2ZDg0NGIzMGFkMjA5L3RhYmxlOmQ1Nzc2MTlkODM1ODRhZWNiNTE1YzZiODUwYjcwM2FmL3RhYmxlcmFuZ2U6ZDU3NzYxOWQ4MzU4NGFlY2I1MTVjNmI4NTBiNzAzYWZfMzgtMS0xLTEtMA_ffc64459-bdf4-4976-8c22-76c54e759a01">1,632,676</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ifbe16ec51ea244519b77d6036b4ef038_I20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:StockholdersEquity" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzY2E5YmIwMTc5MjQ3NmZiYjIyNWU1ZDlkZWM4NjlmL3NlYzo5M2NhOWJiMDE3OTI0NzZmYmIyMjVlNWQ5ZGVjODY5Zl8xNi9mcmFnOmNhM2Q5OWRkMjk1ODQxYzQ4Yzk2ZDg0NGIzMGFkMjA5L3RhYmxlOmQ1Nzc2MTlkODM1ODRhZWNiNTE1YzZiODUwYjcwM2FmL3RhYmxlcmFuZ2U6ZDU3NzYxOWQ4MzU4NGFlY2I1MTVjNmI4NTBiNzAzYWZfMzgtMy0xLTEtMA_0b9484df-492a-4086-8c80-d8cc572b0639">1,711,364</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 8.5pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Non-controlling interests</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i225f85e38faa4bbdb4de1d8b9cf369bb_I20210630" decimals="-3" sign="-" format="ixt:numdotdecimal" name="us-gaap:MinorityInterest" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzY2E5YmIwMTc5MjQ3NmZiYjIyNWU1ZDlkZWM4NjlmL3NlYzo5M2NhOWJiMDE3OTI0NzZmYmIyMjVlNWQ5ZGVjODY5Zl8xNi9mcmFnOmNhM2Q5OWRkMjk1ODQxYzQ4Yzk2ZDg0NGIzMGFkMjA5L3RhYmxlOmQ1Nzc2MTlkODM1ODRhZWNiNTE1YzZiODUwYjcwM2FmL3RhYmxlcmFuZ2U6ZDU3NzYxOWQ4MzU4NGFlY2I1MTVjNmI4NTBiNzAzYWZfMzktMS0xLTEtMA_befe71e4-9541-4e7d-a407-9cbdf4ef6d9c">2,764</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ifbe16ec51ea244519b77d6036b4ef038_I20201231" decimals="-3" sign="-" format="ixt:numdotdecimal" name="us-gaap:MinorityInterest" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzY2E5YmIwMTc5MjQ3NmZiYjIyNWU1ZDlkZWM4NjlmL3NlYzo5M2NhOWJiMDE3OTI0NzZmYmIyMjVlNWQ5ZGVjODY5Zl8xNi9mcmFnOmNhM2Q5OWRkMjk1ODQxYzQ4Yzk2ZDg0NGIzMGFkMjA5L3RhYmxlOmQ1Nzc2MTlkODM1ODRhZWNiNTE1YzZiODUwYjcwM2FmL3RhYmxlcmFuZ2U6ZDU3NzYxOWQ4MzU4NGFlY2I1MTVjNmI4NTBiNzAzYWZfMzktMy0xLTEtMA_f7a01bb6-7013-4eab-919b-7f0d18fb8a7a">3,196</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 1.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total shareholders&#8217; equity</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i225f85e38faa4bbdb4de1d8b9cf369bb_I20210630" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzY2E5YmIwMTc5MjQ3NmZiYjIyNWU1ZDlkZWM4NjlmL3NlYzo5M2NhOWJiMDE3OTI0NzZmYmIyMjVlNWQ5ZGVjODY5Zl8xNi9mcmFnOmNhM2Q5OWRkMjk1ODQxYzQ4Yzk2ZDg0NGIzMGFkMjA5L3RhYmxlOmQ1Nzc2MTlkODM1ODRhZWNiNTE1YzZiODUwYjcwM2FmL3RhYmxlcmFuZ2U6ZDU3NzYxOWQ4MzU4NGFlY2I1MTVjNmI4NTBiNzAzYWZfNDAtMS0xLTEtMA_3d292113-2267-40aa-a1f6-3e563d499256">1,629,912</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ifbe16ec51ea244519b77d6036b4ef038_I20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzY2E5YmIwMTc5MjQ3NmZiYjIyNWU1ZDlkZWM4NjlmL3NlYzo5M2NhOWJiMDE3OTI0NzZmYmIyMjVlNWQ5ZGVjODY5Zl8xNi9mcmFnOmNhM2Q5OWRkMjk1ODQxYzQ4Yzk2ZDg0NGIzMGFkMjA5L3RhYmxlOmQ1Nzc2MTlkODM1ODRhZWNiNTE1YzZiODUwYjcwM2FmL3RhYmxlcmFuZ2U6ZDU3NzYxOWQ4MzU4NGFlY2I1MTVjNmI4NTBiNzAzYWZfNDAtMy0xLTEtMA_0e113c35-98c3-4bf3-a85c-8565a4abfbfd">1,708,168</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 1.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total liabilities and shareholders&#8217; equity</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i225f85e38faa4bbdb4de1d8b9cf369bb_I20210630" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:LiabilitiesAndStockholdersEquity" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzY2E5YmIwMTc5MjQ3NmZiYjIyNWU1ZDlkZWM4NjlmL3NlYzo5M2NhOWJiMDE3OTI0NzZmYmIyMjVlNWQ5ZGVjODY5Zl8xNi9mcmFnOmNhM2Q5OWRkMjk1ODQxYzQ4Yzk2ZDg0NGIzMGFkMjA5L3RhYmxlOmQ1Nzc2MTlkODM1ODRhZWNiNTE1YzZiODUwYjcwM2FmL3RhYmxlcmFuZ2U6ZDU3NzYxOWQ4MzU4NGFlY2I1MTVjNmI4NTBiNzAzYWZfNDEtMS0xLTEtMA_65b8af39-e193-423b-84b5-49cf66daf11b">1,838,611</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ifbe16ec51ea244519b77d6036b4ef038_I20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:LiabilitiesAndStockholdersEquity" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzY2E5YmIwMTc5MjQ3NmZiYjIyNWU1ZDlkZWM4NjlmL3NlYzo5M2NhOWJiMDE3OTI0NzZmYmIyMjVlNWQ5ZGVjODY5Zl8xNi9mcmFnOmNhM2Q5OWRkMjk1ODQxYzQ4Yzk2ZDg0NGIzMGFkMjA5L3RhYmxlOmQ1Nzc2MTlkODM1ODRhZWNiNTE1YzZiODUwYjcwM2FmL3RhYmxlcmFuZ2U6ZDU3NzYxOWQ4MzU4NGFlY2I1MTVjNmI4NTBiNzAzYWZfNDEtMy0xLTEtMA_3d9bc560-3aee-4c7d-95d3-894d04ab6615">1,925,682</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td></tr></table></div><div style="margin-top:6pt;padding-left:27pt;text-align:justify;text-indent:-27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:400;line-height:120%;position:relative;top:-2.8pt;vertical-align:baseline">(i)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:22.1pt"><ix:footnote id="id3VybDovL2RvY3MudjEvZG9jOjkzY2E5YmIwMTc5MjQ3NmZiYjIyNWU1ZDlkZWM4NjlmL3NlYzo5M2NhOWJiMDE3OTI0NzZmYmIyMjVlNWQ5ZGVjODY5Zl8xNi9mcmFnOmNhM2Q5OWRkMjk1ODQxYzQ4Yzk2ZDg0NGIzMGFkMjA5L3RleHRyZWdpb246Y2EzZDk5ZGQyOTU4NDFjNDhjOTZkODQ0YjMwYWQyMDlfOTg5NTYwNDY1MTE0NA_8348ab85-1f4e-4ef0-a58d-e175adf1fc29" footnoteRole="http://www.xbrl.org/2003/role/footnote">Authorized for issuance as of June&#160;30, 2021: unlimited and December 31, 2020: unlimited. </ix:footnote></span></div><div style="padding-left:27pt;text-align:justify;text-indent:-27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:400;line-height:120%;position:relative;top:-2.8pt;vertical-align:baseline">(ii)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:20.66pt"><ix:footnote id="id3VybDovL2RvY3MudjEvZG9jOjkzY2E5YmIwMTc5MjQ3NmZiYjIyNWU1ZDlkZWM4NjlmL3NlYzo5M2NhOWJiMDE3OTI0NzZmYmIyMjVlNWQ5ZGVjODY5Zl8xNi9mcmFnOmNhM2Q5OWRkMjk1ODQxYzQ4Yzk2ZDg0NGIzMGFkMjA5L3RleHRyZWdpb246Y2EzZDk5ZGQyOTU4NDFjNDhjOTZkODQ0YjMwYWQyMDlfOTg5NTYwNDY1MTE0NQ_eb1add2a-1ec9-4add-ba58-e13e0f90c7fe" footnoteRole="http://www.xbrl.org/2003/role/footnote">Shares issued as of June&#160;30, 2021: <ix:nonFraction unitRef="shares" contextRef="i225f85e38faa4bbdb4de1d8b9cf369bb_I20210630" decimals="INF" format="ixt:numdotdecimal" name="us-gaap:CommonStockSharesIssued" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjkzY2E5YmIwMTc5MjQ3NmZiYjIyNWU1ZDlkZWM4NjlmL3NlYzo5M2NhOWJiMDE3OTI0NzZmYmIyMjVlNWQ5ZGVjODY5Zl8xNi9mcmFnOmNhM2Q5OWRkMjk1ODQxYzQ4Yzk2ZDg0NGIzMGFkMjA5L3RleHRyZWdpb246Y2EzZDk5ZGQyOTU4NDFjNDhjOTZkODQ0YjMwYWQyMDlfMjc0ODc3OTA2OTk0NQ_0bca332b-e36e-44a0-b4e6-4af2da12ccb6">371,805,547</ix:nonFraction> and December 31, 2020: <ix:nonFraction unitRef="shares" contextRef="ifbe16ec51ea244519b77d6036b4ef038_I20201231" decimals="INF" format="ixt:numdotdecimal" name="us-gaap:CommonStockSharesIssued" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjkzY2E5YmIwMTc5MjQ3NmZiYjIyNWU1ZDlkZWM4NjlmL3NlYzo5M2NhOWJiMDE3OTI0NzZmYmIyMjVlNWQ5ZGVjODY5Zl8xNi9mcmFnOmNhM2Q5OWRkMjk1ODQxYzQ4Yzk2ZDg0NGIzMGFkMjA5L3RleHRyZWdpb246Y2EzZDk5ZGQyOTU4NDFjNDhjOTZkODQ0YjMwYWQyMDlfNDA5_b8b6bb3b-21de-42fe-ab53-6da931387517">360,253,332</ix:nonFraction>.</ix:footnote></span></div><div style="padding-left:27pt;text-align:justify;text-indent:-27pt"><span><br/></span></div><div style="padding-left:27pt;text-align:justify;text-indent:-27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">See notes to condensed consolidated financial statements.</span></div><div style="height:21.6pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">4</span></div></div></div><div id="i93ca9bb01792476fbb225e5d9dec869f_19"></div><hr style="page-break-after:always"/><div style="min-height:72pt;width:100%"><div style="margin-top:0.55pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:70.427%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:27.373%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="border-top:1pt solid #FFFFFF;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Cronos Group Inc.</span></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Condensed Consolidated Statements of Net Income (Loss) and Comprehensive Income (Loss)</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><div style="margin-top:0.55pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">(In thousands of U.S dollars, except share and per share amounts, unaudited)</span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i93ca9bb01792476fbb225e5d9dec869f_7">Table of Contents</a></span></div></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr></table><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:85.416%"><tr><td style="width:1.0%"></td><td style="width:50.769%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:2.239%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:20.526%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:2.239%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:20.527%"></td><td style="width:0.1%"></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr></table></div><div style="margin-top:0.55pt"><span><br/></span></div></div><div style="text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:42.372%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.816%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:1.327%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.816%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:1.605%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.816%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:1.327%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.821%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Three months ended June 30,</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Six months ended June 30,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Net revenue, before excise taxes</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i27f4e53b91ad4367b7f8d273eff27769_D20210401-20210630" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzY2E5YmIwMTc5MjQ3NmZiYjIyNWU1ZDlkZWM4NjlmL3NlYzo5M2NhOWJiMDE3OTI0NzZmYmIyMjVlNWQ5ZGVjODY5Zl8xOS9mcmFnOmNhNDBhNzBkOTFkZDRiMGE4YTQxZjI0NmM2NDMxNTliL3RhYmxlOmZhYjNmZGNhNDc0YTQ1NDg5MWQ5MDg5NjU4NjM0M2RlL3RhYmxlcmFuZ2U6ZmFiM2ZkY2E0NzRhNDU0ODkxZDkwODk2NTg2MzQzZGVfMi0xLTEtMS0w_50888fbe-e363-413a-9c4d-6fa07d22528c">18,848</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i39065c5daf934af885335c12f3cfa83f_D20200401-20200630" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzY2E5YmIwMTc5MjQ3NmZiYjIyNWU1ZDlkZWM4NjlmL3NlYzo5M2NhOWJiMDE3OTI0NzZmYmIyMjVlNWQ5ZGVjODY5Zl8xOS9mcmFnOmNhNDBhNzBkOTFkZDRiMGE4YTQxZjI0NmM2NDMxNTliL3RhYmxlOmZhYjNmZGNhNDc0YTQ1NDg5MWQ5MDg5NjU4NjM0M2RlL3RhYmxlcmFuZ2U6ZmFiM2ZkY2E0NzRhNDU0ODkxZDkwODk2NTg2MzQzZGVfMi0zLTEtMS0w_e5a0d1c6-de8a-42fe-9f9c-9f1dd74eac8c">11,432</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i69782326f71a44e3805518280ee22b6b_D20210101-20210630" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzY2E5YmIwMTc5MjQ3NmZiYjIyNWU1ZDlkZWM4NjlmL3NlYzo5M2NhOWJiMDE3OTI0NzZmYmIyMjVlNWQ5ZGVjODY5Zl8xOS9mcmFnOmNhNDBhNzBkOTFkZDRiMGE4YTQxZjI0NmM2NDMxNTliL3RhYmxlOmZhYjNmZGNhNDc0YTQ1NDg5MWQ5MDg5NjU4NjM0M2RlL3RhYmxlcmFuZ2U6ZmFiM2ZkY2E0NzRhNDU0ODkxZDkwODk2NTg2MzQzZGVfMi01LTEtMS0w_51732b79-af08-43d1-8b57-f241034ec09e">33,502</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4a110e4972ef4113880ce582e3cda5c5_D20200101-20200630" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzY2E5YmIwMTc5MjQ3NmZiYjIyNWU1ZDlkZWM4NjlmL3NlYzo5M2NhOWJiMDE3OTI0NzZmYmIyMjVlNWQ5ZGVjODY5Zl8xOS9mcmFnOmNhNDBhNzBkOTFkZDRiMGE4YTQxZjI0NmM2NDMxNTliL3RhYmxlOmZhYjNmZGNhNDc0YTQ1NDg5MWQ5MDg5NjU4NjM0M2RlL3RhYmxlcmFuZ2U6ZmFiM2ZkY2E0NzRhNDU0ODkxZDkwODk2NTg2MzQzZGVfMi03LTEtMS0w_6525ef23-b7df-4419-9995-4627eee1f413">20,776</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Excise taxes</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i27f4e53b91ad4367b7f8d273eff27769_D20210401-20210630" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:ExciseAndSalesTaxes" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzY2E5YmIwMTc5MjQ3NmZiYjIyNWU1ZDlkZWM4NjlmL3NlYzo5M2NhOWJiMDE3OTI0NzZmYmIyMjVlNWQ5ZGVjODY5Zl8xOS9mcmFnOmNhNDBhNzBkOTFkZDRiMGE4YTQxZjI0NmM2NDMxNTliL3RhYmxlOmZhYjNmZGNhNDc0YTQ1NDg5MWQ5MDg5NjU4NjM0M2RlL3RhYmxlcmFuZ2U6ZmFiM2ZkY2E0NzRhNDU0ODkxZDkwODk2NTg2MzQzZGVfMy0xLTEtMS0w_2b7b4ead-bdf8-49e5-bd0a-ec7ed1202ecc">3,226</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i39065c5daf934af885335c12f3cfa83f_D20200401-20200630" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:ExciseAndSalesTaxes" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzY2E5YmIwMTc5MjQ3NmZiYjIyNWU1ZDlkZWM4NjlmL3NlYzo5M2NhOWJiMDE3OTI0NzZmYmIyMjVlNWQ5ZGVjODY5Zl8xOS9mcmFnOmNhNDBhNzBkOTFkZDRiMGE4YTQxZjI0NmM2NDMxNTliL3RhYmxlOmZhYjNmZGNhNDc0YTQ1NDg5MWQ5MDg5NjU4NjM0M2RlL3RhYmxlcmFuZ2U6ZmFiM2ZkY2E0NzRhNDU0ODkxZDkwODk2NTg2MzQzZGVfMy0zLTEtMS0w_cb49ba58-f5e4-4ae0-aacf-cd515376dbe1">1,549</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i69782326f71a44e3805518280ee22b6b_D20210101-20210630" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:ExciseAndSalesTaxes" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzY2E5YmIwMTc5MjQ3NmZiYjIyNWU1ZDlkZWM4NjlmL3NlYzo5M2NhOWJiMDE3OTI0NzZmYmIyMjVlNWQ5ZGVjODY5Zl8xOS9mcmFnOmNhNDBhNzBkOTFkZDRiMGE4YTQxZjI0NmM2NDMxNTliL3RhYmxlOmZhYjNmZGNhNDc0YTQ1NDg5MWQ5MDg5NjU4NjM0M2RlL3RhYmxlcmFuZ2U6ZmFiM2ZkY2E0NzRhNDU0ODkxZDkwODk2NTg2MzQzZGVfMy01LTEtMS0w_6317ecaa-247d-4a20-ba56-40fc72dfb46d">5,269</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i4a110e4972ef4113880ce582e3cda5c5_D20200101-20200630" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:ExciseAndSalesTaxes" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzY2E5YmIwMTc5MjQ3NmZiYjIyNWU1ZDlkZWM4NjlmL3NlYzo5M2NhOWJiMDE3OTI0NzZmYmIyMjVlNWQ5ZGVjODY5Zl8xOS9mcmFnOmNhNDBhNzBkOTFkZDRiMGE4YTQxZjI0NmM2NDMxNTliL3RhYmxlOmZhYjNmZGNhNDc0YTQ1NDg5MWQ5MDg5NjU4NjM0M2RlL3RhYmxlcmFuZ2U6ZmFiM2ZkY2E0NzRhNDU0ODkxZDkwODk2NTg2MzQzZGVfMy03LTEtMS0w_59e4caee-aac5-4c15-88cc-9e1bda0dde33">2,461</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Net revenue</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i27f4e53b91ad4367b7f8d273eff27769_D20210401-20210630" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzY2E5YmIwMTc5MjQ3NmZiYjIyNWU1ZDlkZWM4NjlmL3NlYzo5M2NhOWJiMDE3OTI0NzZmYmIyMjVlNWQ5ZGVjODY5Zl8xOS9mcmFnOmNhNDBhNzBkOTFkZDRiMGE4YTQxZjI0NmM2NDMxNTliL3RhYmxlOmZhYjNmZGNhNDc0YTQ1NDg5MWQ5MDg5NjU4NjM0M2RlL3RhYmxlcmFuZ2U6ZmFiM2ZkY2E0NzRhNDU0ODkxZDkwODk2NTg2MzQzZGVfNC0xLTEtMS0w_3007c979-7e62-4502-a4ec-0e139822d1a5">15,622</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i39065c5daf934af885335c12f3cfa83f_D20200401-20200630" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzY2E5YmIwMTc5MjQ3NmZiYjIyNWU1ZDlkZWM4NjlmL3NlYzo5M2NhOWJiMDE3OTI0NzZmYmIyMjVlNWQ5ZGVjODY5Zl8xOS9mcmFnOmNhNDBhNzBkOTFkZDRiMGE4YTQxZjI0NmM2NDMxNTliL3RhYmxlOmZhYjNmZGNhNDc0YTQ1NDg5MWQ5MDg5NjU4NjM0M2RlL3RhYmxlcmFuZ2U6ZmFiM2ZkY2E0NzRhNDU0ODkxZDkwODk2NTg2MzQzZGVfNC0zLTEtMS0w_51ad3389-41e9-484c-894e-0921afdc9aef">9,883</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i69782326f71a44e3805518280ee22b6b_D20210101-20210630" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzY2E5YmIwMTc5MjQ3NmZiYjIyNWU1ZDlkZWM4NjlmL3NlYzo5M2NhOWJiMDE3OTI0NzZmYmIyMjVlNWQ5ZGVjODY5Zl8xOS9mcmFnOmNhNDBhNzBkOTFkZDRiMGE4YTQxZjI0NmM2NDMxNTliL3RhYmxlOmZhYjNmZGNhNDc0YTQ1NDg5MWQ5MDg5NjU4NjM0M2RlL3RhYmxlcmFuZ2U6ZmFiM2ZkY2E0NzRhNDU0ODkxZDkwODk2NTg2MzQzZGVfNC01LTEtMS0w_e899cd90-5ab4-439f-b21e-b458d3f71993">28,233</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4a110e4972ef4113880ce582e3cda5c5_D20200101-20200630" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzY2E5YmIwMTc5MjQ3NmZiYjIyNWU1ZDlkZWM4NjlmL3NlYzo5M2NhOWJiMDE3OTI0NzZmYmIyMjVlNWQ5ZGVjODY5Zl8xOS9mcmFnOmNhNDBhNzBkOTFkZDRiMGE4YTQxZjI0NmM2NDMxNTliL3RhYmxlOmZhYjNmZGNhNDc0YTQ1NDg5MWQ5MDg5NjU4NjM0M2RlL3RhYmxlcmFuZ2U6ZmFiM2ZkY2E0NzRhNDU0ODkxZDkwODk2NTg2MzQzZGVfNC03LTEtMS0w_1d2f9ddc-a243-4bf8-8473-7670e85d1ac9">18,315</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cost of sales</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i27f4e53b91ad4367b7f8d273eff27769_D20210401-20210630" decimals="-3" format="ixt:numdotdecimal" name="cron:OtherCostOfGoodsAndServicesSold" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzY2E5YmIwMTc5MjQ3NmZiYjIyNWU1ZDlkZWM4NjlmL3NlYzo5M2NhOWJiMDE3OTI0NzZmYmIyMjVlNWQ5ZGVjODY5Zl8xOS9mcmFnOmNhNDBhNzBkOTFkZDRiMGE4YTQxZjI0NmM2NDMxNTliL3RhYmxlOmZhYjNmZGNhNDc0YTQ1NDg5MWQ5MDg5NjU4NjM0M2RlL3RhYmxlcmFuZ2U6ZmFiM2ZkY2E0NzRhNDU0ODkxZDkwODk2NTg2MzQzZGVfNS0xLTEtMS0w_3ccba461-87a7-4bd0-8d4b-d7c35cb6cde5">19,445</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i39065c5daf934af885335c12f3cfa83f_D20200401-20200630" decimals="-3" format="ixt:numdotdecimal" name="cron:OtherCostOfGoodsAndServicesSold" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzY2E5YmIwMTc5MjQ3NmZiYjIyNWU1ZDlkZWM4NjlmL3NlYzo5M2NhOWJiMDE3OTI0NzZmYmIyMjVlNWQ5ZGVjODY5Zl8xOS9mcmFnOmNhNDBhNzBkOTFkZDRiMGE4YTQxZjI0NmM2NDMxNTliL3RhYmxlOmZhYjNmZGNhNDc0YTQ1NDg5MWQ5MDg5NjU4NjM0M2RlL3RhYmxlcmFuZ2U6ZmFiM2ZkY2E0NzRhNDU0ODkxZDkwODk2NTg2MzQzZGVfNS0zLTEtMS0w_fdce626a-7e83-4776-9eb5-0501c55324d9">9,743</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i69782326f71a44e3805518280ee22b6b_D20210101-20210630" decimals="-3" format="ixt:numdotdecimal" name="cron:OtherCostOfGoodsAndServicesSold" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzY2E5YmIwMTc5MjQ3NmZiYjIyNWU1ZDlkZWM4NjlmL3NlYzo5M2NhOWJiMDE3OTI0NzZmYmIyMjVlNWQ5ZGVjODY5Zl8xOS9mcmFnOmNhNDBhNzBkOTFkZDRiMGE4YTQxZjI0NmM2NDMxNTliL3RhYmxlOmZhYjNmZGNhNDc0YTQ1NDg5MWQ5MDg5NjU4NjM0M2RlL3RhYmxlcmFuZ2U6ZmFiM2ZkY2E0NzRhNDU0ODkxZDkwODk2NTg2MzQzZGVfNS01LTEtMS0w_84f3ea0f-3f7d-4add-b852-0fe82ff1c03d">35,019</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4a110e4972ef4113880ce582e3cda5c5_D20200101-20200630" decimals="-3" format="ixt:numdotdecimal" name="cron:OtherCostOfGoodsAndServicesSold" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzY2E5YmIwMTc5MjQ3NmZiYjIyNWU1ZDlkZWM4NjlmL3NlYzo5M2NhOWJiMDE3OTI0NzZmYmIyMjVlNWQ5ZGVjODY5Zl8xOS9mcmFnOmNhNDBhNzBkOTFkZDRiMGE4YTQxZjI0NmM2NDMxNTliL3RhYmxlOmZhYjNmZGNhNDc0YTQ1NDg5MWQ5MDg5NjU4NjM0M2RlL3RhYmxlcmFuZ2U6ZmFiM2ZkY2E0NzRhNDU0ODkxZDkwODk2NTg2MzQzZGVfNS03LTEtMS0w_ec0b294f-7162-4f9e-832e-d7a721a286f6">16,689</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Inventory write-down</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i27f4e53b91ad4367b7f8d273eff27769_D20210401-20210630" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:InventoryWriteDown" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzY2E5YmIwMTc5MjQ3NmZiYjIyNWU1ZDlkZWM4NjlmL3NlYzo5M2NhOWJiMDE3OTI0NzZmYmIyMjVlNWQ5ZGVjODY5Zl8xOS9mcmFnOmNhNDBhNzBkOTFkZDRiMGE4YTQxZjI0NmM2NDMxNTliL3RhYmxlOmZhYjNmZGNhNDc0YTQ1NDg5MWQ5MDg5NjU4NjM0M2RlL3RhYmxlcmFuZ2U6ZmFiM2ZkY2E0NzRhNDU0ODkxZDkwODk2NTg2MzQzZGVfNi0xLTEtMS0w_2cc0e551-1484-49be-9e25-be9d29f1e286">11,961</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i39065c5daf934af885335c12f3cfa83f_D20200401-20200630" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:InventoryWriteDown" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzY2E5YmIwMTc5MjQ3NmZiYjIyNWU1ZDlkZWM4NjlmL3NlYzo5M2NhOWJiMDE3OTI0NzZmYmIyMjVlNWQ5ZGVjODY5Zl8xOS9mcmFnOmNhNDBhNzBkOTFkZDRiMGE4YTQxZjI0NmM2NDMxNTliL3RhYmxlOmZhYjNmZGNhNDc0YTQ1NDg5MWQ5MDg5NjU4NjM0M2RlL3RhYmxlcmFuZ2U6ZmFiM2ZkY2E0NzRhNDU0ODkxZDkwODk2NTg2MzQzZGVfNi0zLTEtMS0w_1665176c-ff5f-4468-b9af-4a55504bf7cc">3,062</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i69782326f71a44e3805518280ee22b6b_D20210101-20210630" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:InventoryWriteDown" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzY2E5YmIwMTc5MjQ3NmZiYjIyNWU1ZDlkZWM4NjlmL3NlYzo5M2NhOWJiMDE3OTI0NzZmYmIyMjVlNWQ5ZGVjODY5Zl8xOS9mcmFnOmNhNDBhNzBkOTFkZDRiMGE4YTQxZjI0NmM2NDMxNTliL3RhYmxlOmZhYjNmZGNhNDc0YTQ1NDg5MWQ5MDg5NjU4NjM0M2RlL3RhYmxlcmFuZ2U6ZmFiM2ZkY2E0NzRhNDU0ODkxZDkwODk2NTg2MzQzZGVfNi01LTEtMS0w_2a9dafe0-8a61-4eae-a96d-3660507151e9">11,961</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4a110e4972ef4113880ce582e3cda5c5_D20200101-20200630" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:InventoryWriteDown" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzY2E5YmIwMTc5MjQ3NmZiYjIyNWU1ZDlkZWM4NjlmL3NlYzo5M2NhOWJiMDE3OTI0NzZmYmIyMjVlNWQ5ZGVjODY5Zl8xOS9mcmFnOmNhNDBhNzBkOTFkZDRiMGE4YTQxZjI0NmM2NDMxNTliL3RhYmxlOmZhYjNmZGNhNDc0YTQ1NDg5MWQ5MDg5NjU4NjM0M2RlL3RhYmxlcmFuZ2U6ZmFiM2ZkY2E0NzRhNDU0ODkxZDkwODk2NTg2MzQzZGVfNi03LTEtMS0w_c3db7689-9d82-4eed-888e-71ee09f22527">11,024</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Gross loss</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i27f4e53b91ad4367b7f8d273eff27769_D20210401-20210630" decimals="-3" sign="-" format="ixt:numdotdecimal" name="us-gaap:GrossProfit" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzY2E5YmIwMTc5MjQ3NmZiYjIyNWU1ZDlkZWM4NjlmL3NlYzo5M2NhOWJiMDE3OTI0NzZmYmIyMjVlNWQ5ZGVjODY5Zl8xOS9mcmFnOmNhNDBhNzBkOTFkZDRiMGE4YTQxZjI0NmM2NDMxNTliL3RhYmxlOmZhYjNmZGNhNDc0YTQ1NDg5MWQ5MDg5NjU4NjM0M2RlL3RhYmxlcmFuZ2U6ZmFiM2ZkY2E0NzRhNDU0ODkxZDkwODk2NTg2MzQzZGVfNy0xLTEtMS0w_6a972024-7dd6-4b29-8e40-5d0b43be17ac">15,784</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i39065c5daf934af885335c12f3cfa83f_D20200401-20200630" decimals="-3" sign="-" format="ixt:numdotdecimal" name="us-gaap:GrossProfit" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzY2E5YmIwMTc5MjQ3NmZiYjIyNWU1ZDlkZWM4NjlmL3NlYzo5M2NhOWJiMDE3OTI0NzZmYmIyMjVlNWQ5ZGVjODY5Zl8xOS9mcmFnOmNhNDBhNzBkOTFkZDRiMGE4YTQxZjI0NmM2NDMxNTliL3RhYmxlOmZhYjNmZGNhNDc0YTQ1NDg5MWQ5MDg5NjU4NjM0M2RlL3RhYmxlcmFuZ2U6ZmFiM2ZkY2E0NzRhNDU0ODkxZDkwODk2NTg2MzQzZGVfNy0zLTEtMS0w_0869b8a0-3b34-415b-86bf-8142d0f6609a">2,922</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i69782326f71a44e3805518280ee22b6b_D20210101-20210630" decimals="-3" sign="-" format="ixt:numdotdecimal" name="us-gaap:GrossProfit" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzY2E5YmIwMTc5MjQ3NmZiYjIyNWU1ZDlkZWM4NjlmL3NlYzo5M2NhOWJiMDE3OTI0NzZmYmIyMjVlNWQ5ZGVjODY5Zl8xOS9mcmFnOmNhNDBhNzBkOTFkZDRiMGE4YTQxZjI0NmM2NDMxNTliL3RhYmxlOmZhYjNmZGNhNDc0YTQ1NDg5MWQ5MDg5NjU4NjM0M2RlL3RhYmxlcmFuZ2U6ZmFiM2ZkY2E0NzRhNDU0ODkxZDkwODk2NTg2MzQzZGVfNy01LTEtMS0w_9b6716ee-9243-4a31-b94d-e882f90a5140">18,747</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i4a110e4972ef4113880ce582e3cda5c5_D20200101-20200630" decimals="-3" sign="-" format="ixt:numdotdecimal" name="us-gaap:GrossProfit" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzY2E5YmIwMTc5MjQ3NmZiYjIyNWU1ZDlkZWM4NjlmL3NlYzo5M2NhOWJiMDE3OTI0NzZmYmIyMjVlNWQ5ZGVjODY5Zl8xOS9mcmFnOmNhNDBhNzBkOTFkZDRiMGE4YTQxZjI0NmM2NDMxNTliL3RhYmxlOmZhYjNmZGNhNDc0YTQ1NDg5MWQ5MDg5NjU4NjM0M2RlL3RhYmxlcmFuZ2U6ZmFiM2ZkY2E0NzRhNDU0ODkxZDkwODk2NTg2MzQzZGVfNy03LTEtMS0w_c0138458-1c03-4078-a131-5aa07f9eeb8b">9,398</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Operating expenses</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Sales and marketing</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i27f4e53b91ad4367b7f8d273eff27769_D20210401-20210630" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:SellingAndMarketingExpense" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzY2E5YmIwMTc5MjQ3NmZiYjIyNWU1ZDlkZWM4NjlmL3NlYzo5M2NhOWJiMDE3OTI0NzZmYmIyMjVlNWQ5ZGVjODY5Zl8xOS9mcmFnOmNhNDBhNzBkOTFkZDRiMGE4YTQxZjI0NmM2NDMxNTliL3RhYmxlOmZhYjNmZGNhNDc0YTQ1NDg5MWQ5MDg5NjU4NjM0M2RlL3RhYmxlcmFuZ2U6ZmFiM2ZkY2E0NzRhNDU0ODkxZDkwODk2NTg2MzQzZGVfOS0xLTEtMS0w_025080e4-ad38-4b13-b966-204e56eff66b">13,209</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i39065c5daf934af885335c12f3cfa83f_D20200401-20200630" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:SellingAndMarketingExpense" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzY2E5YmIwMTc5MjQ3NmZiYjIyNWU1ZDlkZWM4NjlmL3NlYzo5M2NhOWJiMDE3OTI0NzZmYmIyMjVlNWQ5ZGVjODY5Zl8xOS9mcmFnOmNhNDBhNzBkOTFkZDRiMGE4YTQxZjI0NmM2NDMxNTliL3RhYmxlOmZhYjNmZGNhNDc0YTQ1NDg5MWQ5MDg5NjU4NjM0M2RlL3RhYmxlcmFuZ2U6ZmFiM2ZkY2E0NzRhNDU0ODkxZDkwODk2NTg2MzQzZGVfOS0zLTEtMS0w_077688b7-61ea-42ab-a6f2-c8e6a5769472">6,501</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i69782326f71a44e3805518280ee22b6b_D20210101-20210630" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:SellingAndMarketingExpense" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzY2E5YmIwMTc5MjQ3NmZiYjIyNWU1ZDlkZWM4NjlmL3NlYzo5M2NhOWJiMDE3OTI0NzZmYmIyMjVlNWQ5ZGVjODY5Zl8xOS9mcmFnOmNhNDBhNzBkOTFkZDRiMGE4YTQxZjI0NmM2NDMxNTliL3RhYmxlOmZhYjNmZGNhNDc0YTQ1NDg5MWQ5MDg5NjU4NjM0M2RlL3RhYmxlcmFuZ2U6ZmFiM2ZkY2E0NzRhNDU0ODkxZDkwODk2NTg2MzQzZGVfOS01LTEtMS0w_cbee0a11-7dc9-4f4f-9eba-8346c81d4288">23,463</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4a110e4972ef4113880ce582e3cda5c5_D20200101-20200630" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:SellingAndMarketingExpense" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzY2E5YmIwMTc5MjQ3NmZiYjIyNWU1ZDlkZWM4NjlmL3NlYzo5M2NhOWJiMDE3OTI0NzZmYmIyMjVlNWQ5ZGVjODY5Zl8xOS9mcmFnOmNhNDBhNzBkOTFkZDRiMGE4YTQxZjI0NmM2NDMxNTliL3RhYmxlOmZhYjNmZGNhNDc0YTQ1NDg5MWQ5MDg5NjU4NjM0M2RlL3RhYmxlcmFuZ2U6ZmFiM2ZkY2E0NzRhNDU0ODkxZDkwODk2NTg2MzQzZGVfOS03LTEtMS0w_95da2167-c856-4226-b95f-bfdfd587ea93">13,613</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Research and development (&#8220;R&amp;D&#8221;)</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i27f4e53b91ad4367b7f8d273eff27769_D20210401-20210630" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:ResearchAndDevelopmentExpense" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzY2E5YmIwMTc5MjQ3NmZiYjIyNWU1ZDlkZWM4NjlmL3NlYzo5M2NhOWJiMDE3OTI0NzZmYmIyMjVlNWQ5ZGVjODY5Zl8xOS9mcmFnOmNhNDBhNzBkOTFkZDRiMGE4YTQxZjI0NmM2NDMxNTliL3RhYmxlOmZhYjNmZGNhNDc0YTQ1NDg5MWQ5MDg5NjU4NjM0M2RlL3RhYmxlcmFuZ2U6ZmFiM2ZkY2E0NzRhNDU0ODkxZDkwODk2NTg2MzQzZGVfMTAtMS0xLTEtMA_0d529f5f-2c8c-4e5b-a557-c68a0dd2f62a">5,199</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i39065c5daf934af885335c12f3cfa83f_D20200401-20200630" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:ResearchAndDevelopmentExpense" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzY2E5YmIwMTc5MjQ3NmZiYjIyNWU1ZDlkZWM4NjlmL3NlYzo5M2NhOWJiMDE3OTI0NzZmYmIyMjVlNWQ5ZGVjODY5Zl8xOS9mcmFnOmNhNDBhNzBkOTFkZDRiMGE4YTQxZjI0NmM2NDMxNTliL3RhYmxlOmZhYjNmZGNhNDc0YTQ1NDg5MWQ5MDg5NjU4NjM0M2RlL3RhYmxlcmFuZ2U6ZmFiM2ZkY2E0NzRhNDU0ODkxZDkwODk2NTg2MzQzZGVfMTAtMy0xLTEtMA_02907507-af78-45bc-9e43-64e3f6467d67">3,631</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i69782326f71a44e3805518280ee22b6b_D20210101-20210630" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:ResearchAndDevelopmentExpense" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzY2E5YmIwMTc5MjQ3NmZiYjIyNWU1ZDlkZWM4NjlmL3NlYzo5M2NhOWJiMDE3OTI0NzZmYmIyMjVlNWQ5ZGVjODY5Zl8xOS9mcmFnOmNhNDBhNzBkOTFkZDRiMGE4YTQxZjI0NmM2NDMxNTliL3RhYmxlOmZhYjNmZGNhNDc0YTQ1NDg5MWQ5MDg5NjU4NjM0M2RlL3RhYmxlcmFuZ2U6ZmFiM2ZkY2E0NzRhNDU0ODkxZDkwODk2NTg2MzQzZGVfMTAtNS0xLTEtMA_cac03843-55cc-4442-8d80-9a042c78f2dd">10,301</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4a110e4972ef4113880ce582e3cda5c5_D20200101-20200630" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:ResearchAndDevelopmentExpense" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzY2E5YmIwMTc5MjQ3NmZiYjIyNWU1ZDlkZWM4NjlmL3NlYzo5M2NhOWJiMDE3OTI0NzZmYmIyMjVlNWQ5ZGVjODY5Zl8xOS9mcmFnOmNhNDBhNzBkOTFkZDRiMGE4YTQxZjI0NmM2NDMxNTliL3RhYmxlOmZhYjNmZGNhNDc0YTQ1NDg5MWQ5MDg5NjU4NjM0M2RlL3RhYmxlcmFuZ2U6ZmFiM2ZkY2E0NzRhNDU0ODkxZDkwODk2NTg2MzQzZGVfMTAtNy0xLTEtMA_d7f9bea2-31cd-4966-922b-52864f25933d">8,221</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">General and administrative</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i27f4e53b91ad4367b7f8d273eff27769_D20210401-20210630" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:GeneralAndAdministrativeExpense" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzY2E5YmIwMTc5MjQ3NmZiYjIyNWU1ZDlkZWM4NjlmL3NlYzo5M2NhOWJiMDE3OTI0NzZmYmIyMjVlNWQ5ZGVjODY5Zl8xOS9mcmFnOmNhNDBhNzBkOTFkZDRiMGE4YTQxZjI0NmM2NDMxNTliL3RhYmxlOmZhYjNmZGNhNDc0YTQ1NDg5MWQ5MDg5NjU4NjM0M2RlL3RhYmxlcmFuZ2U6ZmFiM2ZkY2E0NzRhNDU0ODkxZDkwODk2NTg2MzQzZGVfMTEtMS0xLTEtMA_505f630a-5fd9-4ef8-91df-d40ce0c5c8c1">22,417</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i39065c5daf934af885335c12f3cfa83f_D20200401-20200630" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:GeneralAndAdministrativeExpense" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzY2E5YmIwMTc5MjQ3NmZiYjIyNWU1ZDlkZWM4NjlmL3NlYzo5M2NhOWJiMDE3OTI0NzZmYmIyMjVlNWQ5ZGVjODY5Zl8xOS9mcmFnOmNhNDBhNzBkOTFkZDRiMGE4YTQxZjI0NmM2NDMxNTliL3RhYmxlOmZhYjNmZGNhNDc0YTQ1NDg5MWQ5MDg5NjU4NjM0M2RlL3RhYmxlcmFuZ2U6ZmFiM2ZkY2E0NzRhNDU0ODkxZDkwODk2NTg2MzQzZGVfMTEtMy0xLTEtMA_ab7fb95f-6f86-4165-89ca-6b61c0b10ff9">18,429</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i69782326f71a44e3805518280ee22b6b_D20210101-20210630" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:GeneralAndAdministrativeExpense" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzY2E5YmIwMTc5MjQ3NmZiYjIyNWU1ZDlkZWM4NjlmL3NlYzo5M2NhOWJiMDE3OTI0NzZmYmIyMjVlNWQ5ZGVjODY5Zl8xOS9mcmFnOmNhNDBhNzBkOTFkZDRiMGE4YTQxZjI0NmM2NDMxNTliL3RhYmxlOmZhYjNmZGNhNDc0YTQ1NDg5MWQ5MDg5NjU4NjM0M2RlL3RhYmxlcmFuZ2U6ZmFiM2ZkY2E0NzRhNDU0ODkxZDkwODk2NTg2MzQzZGVfMTEtNS0xLTEtMA_0546a3ab-11a0-4698-b117-835e3af02130">44,323</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4a110e4972ef4113880ce582e3cda5c5_D20200101-20200630" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:GeneralAndAdministrativeExpense" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzY2E5YmIwMTc5MjQ3NmZiYjIyNWU1ZDlkZWM4NjlmL3NlYzo5M2NhOWJiMDE3OTI0NzZmYmIyMjVlNWQ5ZGVjODY5Zl8xOS9mcmFnOmNhNDBhNzBkOTFkZDRiMGE4YTQxZjI0NmM2NDMxNTliL3RhYmxlOmZhYjNmZGNhNDc0YTQ1NDg5MWQ5MDg5NjU4NjM0M2RlL3RhYmxlcmFuZ2U6ZmFiM2ZkY2E0NzRhNDU0ODkxZDkwODk2NTg2MzQzZGVfMTEtNy0xLTEtMA_bfcb94ad-ce70-42d1-bc53-f4c0b612fb09">42,188</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Share-based payments</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i27f4e53b91ad4367b7f8d273eff27769_D20210401-20210630" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:AllocatedShareBasedCompensationExpense" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzY2E5YmIwMTc5MjQ3NmZiYjIyNWU1ZDlkZWM4NjlmL3NlYzo5M2NhOWJiMDE3OTI0NzZmYmIyMjVlNWQ5ZGVjODY5Zl8xOS9mcmFnOmNhNDBhNzBkOTFkZDRiMGE4YTQxZjI0NmM2NDMxNTliL3RhYmxlOmZhYjNmZGNhNDc0YTQ1NDg5MWQ5MDg5NjU4NjM0M2RlL3RhYmxlcmFuZ2U6ZmFiM2ZkY2E0NzRhNDU0ODkxZDkwODk2NTg2MzQzZGVfMTItMS0xLTEtMA_06a34de7-b143-4c1d-bed5-3098ad47e395">2,565</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i39065c5daf934af885335c12f3cfa83f_D20200401-20200630" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:AllocatedShareBasedCompensationExpense" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzY2E5YmIwMTc5MjQ3NmZiYjIyNWU1ZDlkZWM4NjlmL3NlYzo5M2NhOWJiMDE3OTI0NzZmYmIyMjVlNWQ5ZGVjODY5Zl8xOS9mcmFnOmNhNDBhNzBkOTFkZDRiMGE4YTQxZjI0NmM2NDMxNTliL3RhYmxlOmZhYjNmZGNhNDc0YTQ1NDg5MWQ5MDg5NjU4NjM0M2RlL3RhYmxlcmFuZ2U6ZmFiM2ZkY2E0NzRhNDU0ODkxZDkwODk2NTg2MzQzZGVfMTItMy0xLTEtMA_39d388f1-71a2-4cdf-a5c4-e8b3aeb4169e">2,546</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i69782326f71a44e3805518280ee22b6b_D20210101-20210630" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:AllocatedShareBasedCompensationExpense" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzY2E5YmIwMTc5MjQ3NmZiYjIyNWU1ZDlkZWM4NjlmL3NlYzo5M2NhOWJiMDE3OTI0NzZmYmIyMjVlNWQ5ZGVjODY5Zl8xOS9mcmFnOmNhNDBhNzBkOTFkZDRiMGE4YTQxZjI0NmM2NDMxNTliL3RhYmxlOmZhYjNmZGNhNDc0YTQ1NDg5MWQ5MDg5NjU4NjM0M2RlL3RhYmxlcmFuZ2U6ZmFiM2ZkY2E0NzRhNDU0ODkxZDkwODk2NTg2MzQzZGVfMTItNS0xLTEtMA_98784325-1ce6-4b35-9d1f-4c7e418f2886">5,064</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4a110e4972ef4113880ce582e3cda5c5_D20200101-20200630" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:AllocatedShareBasedCompensationExpense" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzY2E5YmIwMTc5MjQ3NmZiYjIyNWU1ZDlkZWM4NjlmL3NlYzo5M2NhOWJiMDE3OTI0NzZmYmIyMjVlNWQ5ZGVjODY5Zl8xOS9mcmFnOmNhNDBhNzBkOTFkZDRiMGE4YTQxZjI0NmM2NDMxNTliL3RhYmxlOmZhYjNmZGNhNDc0YTQ1NDg5MWQ5MDg5NjU4NjM0M2RlL3RhYmxlcmFuZ2U6ZmFiM2ZkY2E0NzRhNDU0ODkxZDkwODk2NTg2MzQzZGVfMTItNy0xLTEtMA_486e8ae4-7906-4b21-81e9-fbaa762f344c">4,982</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Depreciation and amortization</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i27f4e53b91ad4367b7f8d273eff27769_D20210401-20210630" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:DepreciationAndAmortization" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzY2E5YmIwMTc5MjQ3NmZiYjIyNWU1ZDlkZWM4NjlmL3NlYzo5M2NhOWJiMDE3OTI0NzZmYmIyMjVlNWQ5ZGVjODY5Zl8xOS9mcmFnOmNhNDBhNzBkOTFkZDRiMGE4YTQxZjI0NmM2NDMxNTliL3RhYmxlOmZhYjNmZGNhNDc0YTQ1NDg5MWQ5MDg5NjU4NjM0M2RlL3RhYmxlcmFuZ2U6ZmFiM2ZkY2E0NzRhNDU0ODkxZDkwODk2NTg2MzQzZGVfMTMtMS0xLTEtMA_c947354a-813b-49ab-8d99-1cfe38dbd840">1,043</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i39065c5daf934af885335c12f3cfa83f_D20200401-20200630" decimals="-3" name="us-gaap:DepreciationAndAmortization" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzY2E5YmIwMTc5MjQ3NmZiYjIyNWU1ZDlkZWM4NjlmL3NlYzo5M2NhOWJiMDE3OTI0NzZmYmIyMjVlNWQ5ZGVjODY5Zl8xOS9mcmFnOmNhNDBhNzBkOTFkZDRiMGE4YTQxZjI0NmM2NDMxNTliL3RhYmxlOmZhYjNmZGNhNDc0YTQ1NDg5MWQ5MDg5NjU4NjM0M2RlL3RhYmxlcmFuZ2U6ZmFiM2ZkY2E0NzRhNDU0ODkxZDkwODk2NTg2MzQzZGVfMTMtMy0xLTEtMA_31e8adc7-f6e1-4047-861e-0d136aa1ac54">679</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i69782326f71a44e3805518280ee22b6b_D20210101-20210630" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:DepreciationAndAmortization" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzY2E5YmIwMTc5MjQ3NmZiYjIyNWU1ZDlkZWM4NjlmL3NlYzo5M2NhOWJiMDE3OTI0NzZmYmIyMjVlNWQ5ZGVjODY5Zl8xOS9mcmFnOmNhNDBhNzBkOTFkZDRiMGE4YTQxZjI0NmM2NDMxNTliL3RhYmxlOmZhYjNmZGNhNDc0YTQ1NDg5MWQ5MDg5NjU4NjM0M2RlL3RhYmxlcmFuZ2U6ZmFiM2ZkY2E0NzRhNDU0ODkxZDkwODk2NTg2MzQzZGVfMTMtNS0xLTEtMA_af54ccab-a75b-4531-84f2-f1c3bb02d345">1,778</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4a110e4972ef4113880ce582e3cda5c5_D20200101-20200630" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:DepreciationAndAmortization" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzY2E5YmIwMTc5MjQ3NmZiYjIyNWU1ZDlkZWM4NjlmL3NlYzo5M2NhOWJiMDE3OTI0NzZmYmIyMjVlNWQ5ZGVjODY5Zl8xOS9mcmFnOmNhNDBhNzBkOTFkZDRiMGE4YTQxZjI0NmM2NDMxNTliL3RhYmxlOmZhYjNmZGNhNDc0YTQ1NDg5MWQ5MDg5NjU4NjM0M2RlL3RhYmxlcmFuZ2U6ZmFiM2ZkY2E0NzRhNDU0ODkxZDkwODk2NTg2MzQzZGVfMTMtNy0xLTEtMA_e55401cc-9fdc-44aa-95c5-1a5ea6db22ab">1,366</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 14.5pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total operating expenses</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i27f4e53b91ad4367b7f8d273eff27769_D20210401-20210630" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:OperatingExpenses" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzY2E5YmIwMTc5MjQ3NmZiYjIyNWU1ZDlkZWM4NjlmL3NlYzo5M2NhOWJiMDE3OTI0NzZmYmIyMjVlNWQ5ZGVjODY5Zl8xOS9mcmFnOmNhNDBhNzBkOTFkZDRiMGE4YTQxZjI0NmM2NDMxNTliL3RhYmxlOmZhYjNmZGNhNDc0YTQ1NDg5MWQ5MDg5NjU4NjM0M2RlL3RhYmxlcmFuZ2U6ZmFiM2ZkY2E0NzRhNDU0ODkxZDkwODk2NTg2MzQzZGVfMTQtMS0xLTEtMA_76ff862d-f1cd-461e-a41d-65bbe27d490e">44,433</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i39065c5daf934af885335c12f3cfa83f_D20200401-20200630" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:OperatingExpenses" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzY2E5YmIwMTc5MjQ3NmZiYjIyNWU1ZDlkZWM4NjlmL3NlYzo5M2NhOWJiMDE3OTI0NzZmYmIyMjVlNWQ5ZGVjODY5Zl8xOS9mcmFnOmNhNDBhNzBkOTFkZDRiMGE4YTQxZjI0NmM2NDMxNTliL3RhYmxlOmZhYjNmZGNhNDc0YTQ1NDg5MWQ5MDg5NjU4NjM0M2RlL3RhYmxlcmFuZ2U6ZmFiM2ZkY2E0NzRhNDU0ODkxZDkwODk2NTg2MzQzZGVfMTQtMy0xLTEtMA_d662f6d2-dcec-4573-9448-2afbdc6b6d7f">31,786</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i69782326f71a44e3805518280ee22b6b_D20210101-20210630" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:OperatingExpenses" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzY2E5YmIwMTc5MjQ3NmZiYjIyNWU1ZDlkZWM4NjlmL3NlYzo5M2NhOWJiMDE3OTI0NzZmYmIyMjVlNWQ5ZGVjODY5Zl8xOS9mcmFnOmNhNDBhNzBkOTFkZDRiMGE4YTQxZjI0NmM2NDMxNTliL3RhYmxlOmZhYjNmZGNhNDc0YTQ1NDg5MWQ5MDg5NjU4NjM0M2RlL3RhYmxlcmFuZ2U6ZmFiM2ZkY2E0NzRhNDU0ODkxZDkwODk2NTg2MzQzZGVfMTQtNS0xLTEtMA_25cb53b8-fb68-4c6f-bf6a-fc066d4b6870">84,929</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4a110e4972ef4113880ce582e3cda5c5_D20200101-20200630" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:OperatingExpenses" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzY2E5YmIwMTc5MjQ3NmZiYjIyNWU1ZDlkZWM4NjlmL3NlYzo5M2NhOWJiMDE3OTI0NzZmYmIyMjVlNWQ5ZGVjODY5Zl8xOS9mcmFnOmNhNDBhNzBkOTFkZDRiMGE4YTQxZjI0NmM2NDMxNTliL3RhYmxlOmZhYjNmZGNhNDc0YTQ1NDg5MWQ5MDg5NjU4NjM0M2RlL3RhYmxlcmFuZ2U6ZmFiM2ZkY2E0NzRhNDU0ODkxZDkwODk2NTg2MzQzZGVfMTQtNy0xLTEtMA_49144751-1082-44fe-b914-c3a27dd73c72">70,370</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Operating loss</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i27f4e53b91ad4367b7f8d273eff27769_D20210401-20210630" decimals="-3" sign="-" format="ixt:numdotdecimal" name="us-gaap:OperatingIncomeLoss" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzY2E5YmIwMTc5MjQ3NmZiYjIyNWU1ZDlkZWM4NjlmL3NlYzo5M2NhOWJiMDE3OTI0NzZmYmIyMjVlNWQ5ZGVjODY5Zl8xOS9mcmFnOmNhNDBhNzBkOTFkZDRiMGE4YTQxZjI0NmM2NDMxNTliL3RhYmxlOmZhYjNmZGNhNDc0YTQ1NDg5MWQ5MDg5NjU4NjM0M2RlL3RhYmxlcmFuZ2U6ZmFiM2ZkY2E0NzRhNDU0ODkxZDkwODk2NTg2MzQzZGVfMTUtMS0xLTEtMA_00dd98e1-7d95-4809-873f-5b36379f6e1a">60,217</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i39065c5daf934af885335c12f3cfa83f_D20200401-20200630" decimals="-3" sign="-" format="ixt:numdotdecimal" name="us-gaap:OperatingIncomeLoss" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzY2E5YmIwMTc5MjQ3NmZiYjIyNWU1ZDlkZWM4NjlmL3NlYzo5M2NhOWJiMDE3OTI0NzZmYmIyMjVlNWQ5ZGVjODY5Zl8xOS9mcmFnOmNhNDBhNzBkOTFkZDRiMGE4YTQxZjI0NmM2NDMxNTliL3RhYmxlOmZhYjNmZGNhNDc0YTQ1NDg5MWQ5MDg5NjU4NjM0M2RlL3RhYmxlcmFuZ2U6ZmFiM2ZkY2E0NzRhNDU0ODkxZDkwODk2NTg2MzQzZGVfMTUtMy0xLTEtMA_ad089d39-f8d7-45b1-aeb4-ab3ae455eb21">34,708</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i69782326f71a44e3805518280ee22b6b_D20210101-20210630" decimals="-3" sign="-" format="ixt:numdotdecimal" name="us-gaap:OperatingIncomeLoss" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzY2E5YmIwMTc5MjQ3NmZiYjIyNWU1ZDlkZWM4NjlmL3NlYzo5M2NhOWJiMDE3OTI0NzZmYmIyMjVlNWQ5ZGVjODY5Zl8xOS9mcmFnOmNhNDBhNzBkOTFkZDRiMGE4YTQxZjI0NmM2NDMxNTliL3RhYmxlOmZhYjNmZGNhNDc0YTQ1NDg5MWQ5MDg5NjU4NjM0M2RlL3RhYmxlcmFuZ2U6ZmFiM2ZkY2E0NzRhNDU0ODkxZDkwODk2NTg2MzQzZGVfMTUtNS0xLTEtMA_0323735d-2f02-4ad0-93ae-120252ff7dc9">103,676</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i4a110e4972ef4113880ce582e3cda5c5_D20200101-20200630" decimals="-3" sign="-" format="ixt:numdotdecimal" name="us-gaap:OperatingIncomeLoss" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzY2E5YmIwMTc5MjQ3NmZiYjIyNWU1ZDlkZWM4NjlmL3NlYzo5M2NhOWJiMDE3OTI0NzZmYmIyMjVlNWQ5ZGVjODY5Zl8xOS9mcmFnOmNhNDBhNzBkOTFkZDRiMGE4YTQxZjI0NmM2NDMxNTliL3RhYmxlOmZhYjNmZGNhNDc0YTQ1NDg5MWQ5MDg5NjU4NjM0M2RlL3RhYmxlcmFuZ2U6ZmFiM2ZkY2E0NzRhNDU0ODkxZDkwODk2NTg2MzQzZGVfMTUtNy0xLTEtMA_a95ae1c2-9d88-449d-ba33-14fad2f31d62">79,768</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Other income (loss)</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Interest income, net</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i27f4e53b91ad4367b7f8d273eff27769_D20210401-20210630" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:InterestIncomeExpenseNonoperatingNet" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzY2E5YmIwMTc5MjQ3NmZiYjIyNWU1ZDlkZWM4NjlmL3NlYzo5M2NhOWJiMDE3OTI0NzZmYmIyMjVlNWQ5ZGVjODY5Zl8xOS9mcmFnOmNhNDBhNzBkOTFkZDRiMGE4YTQxZjI0NmM2NDMxNTliL3RhYmxlOmZhYjNmZGNhNDc0YTQ1NDg5MWQ5MDg5NjU4NjM0M2RlL3RhYmxlcmFuZ2U6ZmFiM2ZkY2E0NzRhNDU0ODkxZDkwODk2NTg2MzQzZGVfMTctMS0xLTEtMA_64e0fa86-15f4-4ccc-a153-6c6277a01829">2,293</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i39065c5daf934af885335c12f3cfa83f_D20200401-20200630" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:InterestIncomeExpenseNonoperatingNet" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzY2E5YmIwMTc5MjQ3NmZiYjIyNWU1ZDlkZWM4NjlmL3NlYzo5M2NhOWJiMDE3OTI0NzZmYmIyMjVlNWQ5ZGVjODY5Zl8xOS9mcmFnOmNhNDBhNzBkOTFkZDRiMGE4YTQxZjI0NmM2NDMxNTliL3RhYmxlOmZhYjNmZGNhNDc0YTQ1NDg5MWQ5MDg5NjU4NjM0M2RlL3RhYmxlcmFuZ2U6ZmFiM2ZkY2E0NzRhNDU0ODkxZDkwODk2NTg2MzQzZGVfMTctMy0xLTEtMA_e3fe6635-8f81-41fd-ac77-ad3f918c36ec">3,734</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i69782326f71a44e3805518280ee22b6b_D20210101-20210630" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:InterestIncomeExpenseNonoperatingNet" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzY2E5YmIwMTc5MjQ3NmZiYjIyNWU1ZDlkZWM4NjlmL3NlYzo5M2NhOWJiMDE3OTI0NzZmYmIyMjVlNWQ5ZGVjODY5Zl8xOS9mcmFnOmNhNDBhNzBkOTFkZDRiMGE4YTQxZjI0NmM2NDMxNTliL3RhYmxlOmZhYjNmZGNhNDc0YTQ1NDg5MWQ5MDg5NjU4NjM0M2RlL3RhYmxlcmFuZ2U6ZmFiM2ZkY2E0NzRhNDU0ODkxZDkwODk2NTg2MzQzZGVfMTctNS0xLTEtMA_740dc3f1-ce94-403b-a17d-2bf316a4ac3e">4,622</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4a110e4972ef4113880ce582e3cda5c5_D20200101-20200630" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:InterestIncomeExpenseNonoperatingNet" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzY2E5YmIwMTc5MjQ3NmZiYjIyNWU1ZDlkZWM4NjlmL3NlYzo5M2NhOWJiMDE3OTI0NzZmYmIyMjVlNWQ5ZGVjODY5Zl8xOS9mcmFnOmNhNDBhNzBkOTFkZDRiMGE4YTQxZjI0NmM2NDMxNTliL3RhYmxlOmZhYjNmZGNhNDc0YTQ1NDg5MWQ5MDg5NjU4NjM0M2RlL3RhYmxlcmFuZ2U6ZmFiM2ZkY2E0NzRhNDU0ODkxZDkwODk2NTg2MzQzZGVfMTctNy0xLTEtMA_6a1e1973-b886-4749-a9db-d7ea7af34f4f">11,485</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Gain (loss) on revaluation of derivative liabilities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i27f4e53b91ad4367b7f8d273eff27769_D20210401-20210630" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:GainLossOnDerivativeInstrumentsNetPretax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzY2E5YmIwMTc5MjQ3NmZiYjIyNWU1ZDlkZWM4NjlmL3NlYzo5M2NhOWJiMDE3OTI0NzZmYmIyMjVlNWQ5ZGVjODY5Zl8xOS9mcmFnOmNhNDBhNzBkOTFkZDRiMGE4YTQxZjI0NmM2NDMxNTliL3RhYmxlOmZhYjNmZGNhNDc0YTQ1NDg5MWQ5MDg5NjU4NjM0M2RlL3RhYmxlcmFuZ2U6ZmFiM2ZkY2E0NzRhNDU0ODkxZDkwODk2NTg2MzQzZGVfMTktMS0xLTEtNjM3_d1d90884-b62b-4af4-b89b-aea8a28387b6">115,248</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i39065c5daf934af885335c12f3cfa83f_D20200401-20200630" decimals="-3" sign="-" format="ixt:numdotdecimal" name="us-gaap:GainLossOnDerivativeInstrumentsNetPretax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzY2E5YmIwMTc5MjQ3NmZiYjIyNWU1ZDlkZWM4NjlmL3NlYzo5M2NhOWJiMDE3OTI0NzZmYmIyMjVlNWQ5ZGVjODY5Zl8xOS9mcmFnOmNhNDBhNzBkOTFkZDRiMGE4YTQxZjI0NmM2NDMxNTliL3RhYmxlOmZhYjNmZGNhNDc0YTQ1NDg5MWQ5MDg5NjU4NjM0M2RlL3RhYmxlcmFuZ2U6ZmFiM2ZkY2E0NzRhNDU0ODkxZDkwODk2NTg2MzQzZGVfMTktMy0xLTEtNjMz_1c96d2e2-ed01-445d-97a6-7fb5e94758bd">35,880</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i69782326f71a44e3805518280ee22b6b_D20210101-20210630" decimals="-3" sign="-" format="ixt:numdotdecimal" name="us-gaap:GainLossOnDerivativeInstrumentsNetPretax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzY2E5YmIwMTc5MjQ3NmZiYjIyNWU1ZDlkZWM4NjlmL3NlYzo5M2NhOWJiMDE3OTI0NzZmYmIyMjVlNWQ5ZGVjODY5Zl8xOS9mcmFnOmNhNDBhNzBkOTFkZDRiMGE4YTQxZjI0NmM2NDMxNTliL3RhYmxlOmZhYjNmZGNhNDc0YTQ1NDg5MWQ5MDg5NjU4NjM0M2RlL3RhYmxlcmFuZ2U6ZmFiM2ZkY2E0NzRhNDU0ODkxZDkwODk2NTg2MzQzZGVfMTgtNS0xLTEtMA_a2d8c34f-2e24-4a70-a1f6-50b7004af31a">1,626</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4a110e4972ef4113880ce582e3cda5c5_D20200101-20200630" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:GainLossOnDerivativeInstrumentsNetPretax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzY2E5YmIwMTc5MjQ3NmZiYjIyNWU1ZDlkZWM4NjlmL3NlYzo5M2NhOWJiMDE3OTI0NzZmYmIyMjVlNWQ5ZGVjODY5Zl8xOS9mcmFnOmNhNDBhNzBkOTFkZDRiMGE4YTQxZjI0NmM2NDMxNTliL3RhYmxlOmZhYjNmZGNhNDc0YTQ1NDg5MWQ5MDg5NjU4NjM0M2RlL3RhYmxlcmFuZ2U6ZmFiM2ZkY2E0NzRhNDU0ODkxZDkwODk2NTg2MzQzZGVfMTgtNy0xLTEtMA_70c96aa2-acaa-4dc6-973e-c0298d288abb">77,488</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Impairment loss on long-lived assets</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i27f4e53b91ad4367b7f8d273eff27769_D20210401-20210630" decimals="-3" format="ixt:zerodash" name="us-gaap:AssetImpairmentCharges" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzY2E5YmIwMTc5MjQ3NmZiYjIyNWU1ZDlkZWM4NjlmL3NlYzo5M2NhOWJiMDE3OTI0NzZmYmIyMjVlNWQ5ZGVjODY5Zl8xOS9mcmFnOmNhNDBhNzBkOTFkZDRiMGE4YTQxZjI0NmM2NDMxNTliL3RhYmxlOmZhYjNmZGNhNDc0YTQ1NDg5MWQ5MDg5NjU4NjM0M2RlL3RhYmxlcmFuZ2U6ZmFiM2ZkY2E0NzRhNDU0ODkxZDkwODk2NTg2MzQzZGVfMTktMS0xLTEtMTEz_82369ee7-aa1e-4dbe-b511-11b7d64e93cc">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i39065c5daf934af885335c12f3cfa83f_D20200401-20200630" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:AssetImpairmentCharges" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzY2E5YmIwMTc5MjQ3NmZiYjIyNWU1ZDlkZWM4NjlmL3NlYzo5M2NhOWJiMDE3OTI0NzZmYmIyMjVlNWQ5ZGVjODY5Zl8xOS9mcmFnOmNhNDBhNzBkOTFkZDRiMGE4YTQxZjI0NmM2NDMxNTliL3RhYmxlOmZhYjNmZGNhNDc0YTQ1NDg5MWQ5MDg5NjU4NjM0M2RlL3RhYmxlcmFuZ2U6ZmFiM2ZkY2E0NzRhNDU0ODkxZDkwODk2NTg2MzQzZGVfMTktMy0xLTEtMTEz_ca1b8020-52de-44fc-ae8e-fa76071aaf2a">40,000</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i69782326f71a44e3805518280ee22b6b_D20210101-20210630" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:AssetImpairmentCharges" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzY2E5YmIwMTc5MjQ3NmZiYjIyNWU1ZDlkZWM4NjlmL3NlYzo5M2NhOWJiMDE3OTI0NzZmYmIyMjVlNWQ5ZGVjODY5Zl8xOS9mcmFnOmNhNDBhNzBkOTFkZDRiMGE4YTQxZjI0NmM2NDMxNTliL3RhYmxlOmZhYjNmZGNhNDc0YTQ1NDg5MWQ5MDg5NjU4NjM0M2RlL3RhYmxlcmFuZ2U6ZmFiM2ZkY2E0NzRhNDU0ODkxZDkwODk2NTg2MzQzZGVfMTktNS0xLTEtMA_d1cda6f3-0d49-401d-a60b-a906330c4342">1,741</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i4a110e4972ef4113880ce582e3cda5c5_D20200101-20200630" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:AssetImpairmentCharges" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzY2E5YmIwMTc5MjQ3NmZiYjIyNWU1ZDlkZWM4NjlmL3NlYzo5M2NhOWJiMDE3OTI0NzZmYmIyMjVlNWQ5ZGVjODY5Zl8xOS9mcmFnOmNhNDBhNzBkOTFkZDRiMGE4YTQxZjI0NmM2NDMxNTliL3RhYmxlOmZhYjNmZGNhNDc0YTQ1NDg5MWQ5MDg5NjU4NjM0M2RlL3RhYmxlcmFuZ2U6ZmFiM2ZkY2E0NzRhNDU0ODkxZDkwODk2NTg2MzQzZGVfMTktNy0xLTEtMA_95197b80-f5ea-4e46-98e5-28e1d1969869">40,000</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Share of loss from equity accounted investments</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i27f4e53b91ad4367b7f8d273eff27769_D20210401-20210630" decimals="-3" sign="-" format="ixt:numdotdecimal" name="us-gaap:IncomeLossFromEquityMethodInvestments" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzY2E5YmIwMTc5MjQ3NmZiYjIyNWU1ZDlkZWM4NjlmL3NlYzo5M2NhOWJiMDE3OTI0NzZmYmIyMjVlNWQ5ZGVjODY5Zl8xOS9mcmFnOmNhNDBhNzBkOTFkZDRiMGE4YTQxZjI0NmM2NDMxNTliL3RhYmxlOmZhYjNmZGNhNDc0YTQ1NDg5MWQ5MDg5NjU4NjM0M2RlL3RhYmxlcmFuZ2U6ZmFiM2ZkY2E0NzRhNDU0ODkxZDkwODk2NTg2MzQzZGVfMjEtMS0xLTEtMzkxNQ_bd4fc427-2453-4440-8064-33c9cbf6a6ad">1,115</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i39065c5daf934af885335c12f3cfa83f_D20200401-20200630" decimals="-3" sign="-" name="us-gaap:IncomeLossFromEquityMethodInvestments" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzY2E5YmIwMTc5MjQ3NmZiYjIyNWU1ZDlkZWM4NjlmL3NlYzo5M2NhOWJiMDE3OTI0NzZmYmIyMjVlNWQ5ZGVjODY5Zl8xOS9mcmFnOmNhNDBhNzBkOTFkZDRiMGE4YTQxZjI0NmM2NDMxNTliL3RhYmxlOmZhYjNmZGNhNDc0YTQ1NDg5MWQ5MDg5NjU4NjM0M2RlL3RhYmxlcmFuZ2U6ZmFiM2ZkY2E0NzRhNDU0ODkxZDkwODk2NTg2MzQzZGVfMjEtMy0xLTEtMzkxNQ_1a89e11e-1298-4e16-ada5-359150eca857">794</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i69782326f71a44e3805518280ee22b6b_D20210101-20210630" decimals="-3" sign="-" format="ixt:numdotdecimal" name="us-gaap:IncomeLossFromEquityMethodInvestments" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzY2E5YmIwMTc5MjQ3NmZiYjIyNWU1ZDlkZWM4NjlmL3NlYzo5M2NhOWJiMDE3OTI0NzZmYmIyMjVlNWQ5ZGVjODY5Zl8xOS9mcmFnOmNhNDBhNzBkOTFkZDRiMGE4YTQxZjI0NmM2NDMxNTliL3RhYmxlOmZhYjNmZGNhNDc0YTQ1NDg5MWQ5MDg5NjU4NjM0M2RlL3RhYmxlcmFuZ2U6ZmFiM2ZkY2E0NzRhNDU0ODkxZDkwODk2NTg2MzQzZGVfMjEtNS0xLTEtMzkxNQ_67662331-2499-4ab6-9ea7-445b2be46cdf">2,758</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i4a110e4972ef4113880ce582e3cda5c5_D20200101-20200630" decimals="-3" sign="-" format="ixt:numdotdecimal" name="us-gaap:IncomeLossFromEquityMethodInvestments" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzY2E5YmIwMTc5MjQ3NmZiYjIyNWU1ZDlkZWM4NjlmL3NlYzo5M2NhOWJiMDE3OTI0NzZmYmIyMjVlNWQ5ZGVjODY5Zl8xOS9mcmFnOmNhNDBhNzBkOTFkZDRiMGE4YTQxZjI0NmM2NDMxNTliL3RhYmxlOmZhYjNmZGNhNDc0YTQ1NDg5MWQ5MDg5NjU4NjM0M2RlL3RhYmxlcmFuZ2U6ZmFiM2ZkY2E0NzRhNDU0ODkxZDkwODk2NTg2MzQzZGVfMjEtNy0xLTEtMzkxNQ_5fce0e49-50d2-445c-80d3-cbdd33ed8f3d">1,966</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other, net</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i27f4e53b91ad4367b7f8d273eff27769_D20210401-20210630" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:OtherNonoperatingIncomeExpense" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzY2E5YmIwMTc5MjQ3NmZiYjIyNWU1ZDlkZWM4NjlmL3NlYzo5M2NhOWJiMDE3OTI0NzZmYmIyMjVlNWQ5ZGVjODY5Zl8xOS9mcmFnOmNhNDBhNzBkOTFkZDRiMGE4YTQxZjI0NmM2NDMxNTliL3RhYmxlOmZhYjNmZGNhNDc0YTQ1NDg5MWQ5MDg5NjU4NjM0M2RlL3RhYmxlcmFuZ2U6ZmFiM2ZkY2E0NzRhNDU0ODkxZDkwODk2NTg2MzQzZGVfMjAtMS0xLTEtMA_9b7348cc-e690-4778-b3b9-75cfd05e96b5">1,127</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i39065c5daf934af885335c12f3cfa83f_D20200401-20200630" decimals="-3" sign="-" name="us-gaap:OtherNonoperatingIncomeExpense" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzY2E5YmIwMTc5MjQ3NmZiYjIyNWU1ZDlkZWM4NjlmL3NlYzo5M2NhOWJiMDE3OTI0NzZmYmIyMjVlNWQ5ZGVjODY5Zl8xOS9mcmFnOmNhNDBhNzBkOTFkZDRiMGE4YTQxZjI0NmM2NDMxNTliL3RhYmxlOmZhYjNmZGNhNDc0YTQ1NDg5MWQ5MDg5NjU4NjM0M2RlL3RhYmxlcmFuZ2U6ZmFiM2ZkY2E0NzRhNDU0ODkxZDkwODk2NTg2MzQzZGVfMjAtMy0xLTEtMA_ef6b5b4d-ed26-4c04-9011-df28853f9fa2">9</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i69782326f71a44e3805518280ee22b6b_D20210101-20210630" decimals="-3" name="us-gaap:OtherNonoperatingIncomeExpense" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzY2E5YmIwMTc5MjQ3NmZiYjIyNWU1ZDlkZWM4NjlmL3NlYzo5M2NhOWJiMDE3OTI0NzZmYmIyMjVlNWQ5ZGVjODY5Zl8xOS9mcmFnOmNhNDBhNzBkOTFkZDRiMGE4YTQxZjI0NmM2NDMxNTliL3RhYmxlOmZhYjNmZGNhNDc0YTQ1NDg5MWQ5MDg5NjU4NjM0M2RlL3RhYmxlcmFuZ2U6ZmFiM2ZkY2E0NzRhNDU0ODkxZDkwODk2NTg2MzQzZGVfMjAtNS0xLTEtMA_f2058b56-451c-4cf2-9ad6-3d356b687d28">911</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4a110e4972ef4113880ce582e3cda5c5_D20200101-20200630" decimals="-3" name="us-gaap:OtherNonoperatingIncomeExpense" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzY2E5YmIwMTc5MjQ3NmZiYjIyNWU1ZDlkZWM4NjlmL3NlYzo5M2NhOWJiMDE3OTI0NzZmYmIyMjVlNWQ5ZGVjODY5Zl8xOS9mcmFnOmNhNDBhNzBkOTFkZDRiMGE4YTQxZjI0NmM2NDMxNTliL3RhYmxlOmZhYjNmZGNhNDc0YTQ1NDg5MWQ5MDg5NjU4NjM0M2RlL3RhYmxlcmFuZ2U6ZmFiM2ZkY2E0NzRhNDU0ODkxZDkwODk2NTg2MzQzZGVfMjAtNy0xLTEtMA_dca83f1f-2004-419d-9000-59fecd0dec29">785</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total other income (loss)</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i27f4e53b91ad4367b7f8d273eff27769_D20210401-20210630" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:NonoperatingIncomeExpense" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzY2E5YmIwMTc5MjQ3NmZiYjIyNWU1ZDlkZWM4NjlmL3NlYzo5M2NhOWJiMDE3OTI0NzZmYmIyMjVlNWQ5ZGVjODY5Zl8xOS9mcmFnOmNhNDBhNzBkOTFkZDRiMGE4YTQxZjI0NmM2NDMxNTliL3RhYmxlOmZhYjNmZGNhNDc0YTQ1NDg5MWQ5MDg5NjU4NjM0M2RlL3RhYmxlcmFuZ2U6ZmFiM2ZkY2E0NzRhNDU0ODkxZDkwODk2NTg2MzQzZGVfMjEtMS0xLTEtMA_507409b5-1de9-4f96-bb3a-06d7bbadc892">117,553</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i39065c5daf934af885335c12f3cfa83f_D20200401-20200630" decimals="-3" sign="-" format="ixt:numdotdecimal" name="us-gaap:NonoperatingIncomeExpense" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzY2E5YmIwMTc5MjQ3NmZiYjIyNWU1ZDlkZWM4NjlmL3NlYzo5M2NhOWJiMDE3OTI0NzZmYmIyMjVlNWQ5ZGVjODY5Zl8xOS9mcmFnOmNhNDBhNzBkOTFkZDRiMGE4YTQxZjI0NmM2NDMxNTliL3RhYmxlOmZhYjNmZGNhNDc0YTQ1NDg5MWQ5MDg5NjU4NjM0M2RlL3RhYmxlcmFuZ2U6ZmFiM2ZkY2E0NzRhNDU0ODkxZDkwODk2NTg2MzQzZGVfMjEtMy0xLTEtMA_20f5d787-7300-42f9-8923-d842f10c0700">72,949</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i69782326f71a44e3805518280ee22b6b_D20210101-20210630" decimals="-3" sign="-" name="us-gaap:NonoperatingIncomeExpense" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzY2E5YmIwMTc5MjQ3NmZiYjIyNWU1ZDlkZWM4NjlmL3NlYzo5M2NhOWJiMDE3OTI0NzZmYmIyMjVlNWQ5ZGVjODY5Zl8xOS9mcmFnOmNhNDBhNzBkOTFkZDRiMGE4YTQxZjI0NmM2NDMxNTliL3RhYmxlOmZhYjNmZGNhNDc0YTQ1NDg5MWQ5MDg5NjU4NjM0M2RlL3RhYmxlcmFuZ2U6ZmFiM2ZkY2E0NzRhNDU0ODkxZDkwODk2NTg2MzQzZGVfMjEtNS0xLTEtMA_355e363d-c0fd-4896-82ab-2bce10c7fbd3">592</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4a110e4972ef4113880ce582e3cda5c5_D20200101-20200630" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:NonoperatingIncomeExpense" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzY2E5YmIwMTc5MjQ3NmZiYjIyNWU1ZDlkZWM4NjlmL3NlYzo5M2NhOWJiMDE3OTI0NzZmYmIyMjVlNWQ5ZGVjODY5Zl8xOS9mcmFnOmNhNDBhNzBkOTFkZDRiMGE4YTQxZjI0NmM2NDMxNTliL3RhYmxlOmZhYjNmZGNhNDc0YTQ1NDg5MWQ5MDg5NjU4NjM0M2RlL3RhYmxlcmFuZ2U6ZmFiM2ZkY2E0NzRhNDU0ODkxZDkwODk2NTg2MzQzZGVfMjEtNy0xLTEtMA_02e8aba5-2441-4aa6-9674-a8eea659a787">47,792</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Income (loss) from continuing operations</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i27f4e53b91ad4367b7f8d273eff27769_D20210401-20210630" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzY2E5YmIwMTc5MjQ3NmZiYjIyNWU1ZDlkZWM4NjlmL3NlYzo5M2NhOWJiMDE3OTI0NzZmYmIyMjVlNWQ5ZGVjODY5Zl8xOS9mcmFnOmNhNDBhNzBkOTFkZDRiMGE4YTQxZjI0NmM2NDMxNTliL3RhYmxlOmZhYjNmZGNhNDc0YTQ1NDg5MWQ5MDg5NjU4NjM0M2RlL3RhYmxlcmFuZ2U6ZmFiM2ZkY2E0NzRhNDU0ODkxZDkwODk2NTg2MzQzZGVfMjQtMS0xLTEtMA_5fef9f9d-278d-44d1-a8d9-83e5348e8cad">57,336</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i39065c5daf934af885335c12f3cfa83f_D20200401-20200630" decimals="-3" sign="-" format="ixt:numdotdecimal" name="us-gaap:IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzY2E5YmIwMTc5MjQ3NmZiYjIyNWU1ZDlkZWM4NjlmL3NlYzo5M2NhOWJiMDE3OTI0NzZmYmIyMjVlNWQ5ZGVjODY5Zl8xOS9mcmFnOmNhNDBhNzBkOTFkZDRiMGE4YTQxZjI0NmM2NDMxNTliL3RhYmxlOmZhYjNmZGNhNDc0YTQ1NDg5MWQ5MDg5NjU4NjM0M2RlL3RhYmxlcmFuZ2U6ZmFiM2ZkY2E0NzRhNDU0ODkxZDkwODk2NTg2MzQzZGVfMjQtMy0xLTEtMA_d8d64f51-9e89-4be4-836b-11f3a14d2d3d">107,657</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i69782326f71a44e3805518280ee22b6b_D20210101-20210630" decimals="-3" sign="-" format="ixt:numdotdecimal" name="us-gaap:IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzY2E5YmIwMTc5MjQ3NmZiYjIyNWU1ZDlkZWM4NjlmL3NlYzo5M2NhOWJiMDE3OTI0NzZmYmIyMjVlNWQ5ZGVjODY5Zl8xOS9mcmFnOmNhNDBhNzBkOTFkZDRiMGE4YTQxZjI0NmM2NDMxNTliL3RhYmxlOmZhYjNmZGNhNDc0YTQ1NDg5MWQ5MDg5NjU4NjM0M2RlL3RhYmxlcmFuZ2U6ZmFiM2ZkY2E0NzRhNDU0ODkxZDkwODk2NTg2MzQzZGVfMjQtNS0xLTEtMA_564ee7b6-8875-4c7d-88f8-d7cc5a295660">104,268</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i4a110e4972ef4113880ce582e3cda5c5_D20200101-20200630" decimals="-3" sign="-" format="ixt:numdotdecimal" name="us-gaap:IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzY2E5YmIwMTc5MjQ3NmZiYjIyNWU1ZDlkZWM4NjlmL3NlYzo5M2NhOWJiMDE3OTI0NzZmYmIyMjVlNWQ5ZGVjODY5Zl8xOS9mcmFnOmNhNDBhNzBkOTFkZDRiMGE4YTQxZjI0NmM2NDMxNTliL3RhYmxlOmZhYjNmZGNhNDc0YTQ1NDg5MWQ5MDg5NjU4NjM0M2RlL3RhYmxlcmFuZ2U6ZmFiM2ZkY2E0NzRhNDU0ODkxZDkwODk2NTg2MzQzZGVfMjQtNy0xLTEtMA_e4d1d80c-4773-4c1a-bf3f-6b8a34278d3a">31,976</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Loss from discontinued operations</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i27f4e53b91ad4367b7f8d273eff27769_D20210401-20210630" decimals="-3" sign="-" name="us-gaap:IncomeLossFromDiscontinuedOperationsNetOfTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzY2E5YmIwMTc5MjQ3NmZiYjIyNWU1ZDlkZWM4NjlmL3NlYzo5M2NhOWJiMDE3OTI0NzZmYmIyMjVlNWQ5ZGVjODY5Zl8xOS9mcmFnOmNhNDBhNzBkOTFkZDRiMGE4YTQxZjI0NmM2NDMxNTliL3RhYmxlOmZhYjNmZGNhNDc0YTQ1NDg5MWQ5MDg5NjU4NjM0M2RlL3RhYmxlcmFuZ2U6ZmFiM2ZkY2E0NzRhNDU0ODkxZDkwODk2NTg2MzQzZGVfMjUtMS0xLTEtMA_fda7a8cd-7e15-4d3d-8983-374f7ca0c393">561</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i39065c5daf934af885335c12f3cfa83f_D20200401-20200630" decimals="-3" sign="-" name="us-gaap:IncomeLossFromDiscontinuedOperationsNetOfTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzY2E5YmIwMTc5MjQ3NmZiYjIyNWU1ZDlkZWM4NjlmL3NlYzo5M2NhOWJiMDE3OTI0NzZmYmIyMjVlNWQ5ZGVjODY5Zl8xOS9mcmFnOmNhNDBhNzBkOTFkZDRiMGE4YTQxZjI0NmM2NDMxNTliL3RhYmxlOmZhYjNmZGNhNDc0YTQ1NDg5MWQ5MDg5NjU4NjM0M2RlL3RhYmxlcmFuZ2U6ZmFiM2ZkY2E0NzRhNDU0ODkxZDkwODk2NTg2MzQzZGVfMjUtMy0xLTEtMA_19315a80-0a6b-45be-ab8b-47caea15a613">46</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i69782326f71a44e3805518280ee22b6b_D20210101-20210630" decimals="-3" sign="-" name="us-gaap:IncomeLossFromDiscontinuedOperationsNetOfTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzY2E5YmIwMTc5MjQ3NmZiYjIyNWU1ZDlkZWM4NjlmL3NlYzo5M2NhOWJiMDE3OTI0NzZmYmIyMjVlNWQ5ZGVjODY5Zl8xOS9mcmFnOmNhNDBhNzBkOTFkZDRiMGE4YTQxZjI0NmM2NDMxNTliL3RhYmxlOmZhYjNmZGNhNDc0YTQ1NDg5MWQ5MDg5NjU4NjM0M2RlL3RhYmxlcmFuZ2U6ZmFiM2ZkY2E0NzRhNDU0ODkxZDkwODk2NTg2MzQzZGVfMjUtNS0xLTEtMA_f5238273-bbab-4751-807f-5217a5fd5eea">582</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i4a110e4972ef4113880ce582e3cda5c5_D20200101-20200630" decimals="-3" sign="-" name="us-gaap:IncomeLossFromDiscontinuedOperationsNetOfTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzY2E5YmIwMTc5MjQ3NmZiYjIyNWU1ZDlkZWM4NjlmL3NlYzo5M2NhOWJiMDE3OTI0NzZmYmIyMjVlNWQ5ZGVjODY5Zl8xOS9mcmFnOmNhNDBhNzBkOTFkZDRiMGE4YTQxZjI0NmM2NDMxNTliL3RhYmxlOmZhYjNmZGNhNDc0YTQ1NDg5MWQ5MDg5NjU4NjM0M2RlL3RhYmxlcmFuZ2U6ZmFiM2ZkY2E0NzRhNDU0ODkxZDkwODk2NTg2MzQzZGVfMjUtNy0xLTEtMA_a9b4ab20-0e12-4791-ab2e-fbb012adbdbd">46</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net income (loss)</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i27f4e53b91ad4367b7f8d273eff27769_D20210401-20210630" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:ProfitLoss" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzY2E5YmIwMTc5MjQ3NmZiYjIyNWU1ZDlkZWM4NjlmL3NlYzo5M2NhOWJiMDE3OTI0NzZmYmIyMjVlNWQ5ZGVjODY5Zl8xOS9mcmFnOmNhNDBhNzBkOTFkZDRiMGE4YTQxZjI0NmM2NDMxNTliL3RhYmxlOmZhYjNmZGNhNDc0YTQ1NDg5MWQ5MDg5NjU4NjM0M2RlL3RhYmxlcmFuZ2U6ZmFiM2ZkY2E0NzRhNDU0ODkxZDkwODk2NTg2MzQzZGVfMjYtMS0xLTEtMA_4d1447d8-1bb1-4b58-92f4-87c32408841e">56,775</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i39065c5daf934af885335c12f3cfa83f_D20200401-20200630" decimals="-3" sign="-" format="ixt:numdotdecimal" name="us-gaap:ProfitLoss" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzY2E5YmIwMTc5MjQ3NmZiYjIyNWU1ZDlkZWM4NjlmL3NlYzo5M2NhOWJiMDE3OTI0NzZmYmIyMjVlNWQ5ZGVjODY5Zl8xOS9mcmFnOmNhNDBhNzBkOTFkZDRiMGE4YTQxZjI0NmM2NDMxNTliL3RhYmxlOmZhYjNmZGNhNDc0YTQ1NDg5MWQ5MDg5NjU4NjM0M2RlL3RhYmxlcmFuZ2U6ZmFiM2ZkY2E0NzRhNDU0ODkxZDkwODk2NTg2MzQzZGVfMjYtMy0xLTEtMA_6ae1f792-179e-4280-9347-1e7ebc6d588a">107,703</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i69782326f71a44e3805518280ee22b6b_D20210101-20210630" decimals="-3" sign="-" format="ixt:numdotdecimal" name="us-gaap:ProfitLoss" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzY2E5YmIwMTc5MjQ3NmZiYjIyNWU1ZDlkZWM4NjlmL3NlYzo5M2NhOWJiMDE3OTI0NzZmYmIyMjVlNWQ5ZGVjODY5Zl8xOS9mcmFnOmNhNDBhNzBkOTFkZDRiMGE4YTQxZjI0NmM2NDMxNTliL3RhYmxlOmZhYjNmZGNhNDc0YTQ1NDg5MWQ5MDg5NjU4NjM0M2RlL3RhYmxlcmFuZ2U6ZmFiM2ZkY2E0NzRhNDU0ODkxZDkwODk2NTg2MzQzZGVfMjYtNS0xLTEtMA_55bc3d61-01c1-4d88-b695-214eacc6cf9f">104,850</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i4a110e4972ef4113880ce582e3cda5c5_D20200101-20200630" decimals="-3" sign="-" format="ixt:numdotdecimal" name="us-gaap:ProfitLoss" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzY2E5YmIwMTc5MjQ3NmZiYjIyNWU1ZDlkZWM4NjlmL3NlYzo5M2NhOWJiMDE3OTI0NzZmYmIyMjVlNWQ5ZGVjODY5Zl8xOS9mcmFnOmNhNDBhNzBkOTFkZDRiMGE4YTQxZjI0NmM2NDMxNTliL3RhYmxlOmZhYjNmZGNhNDc0YTQ1NDg5MWQ5MDg5NjU4NjM0M2RlL3RhYmxlcmFuZ2U6ZmFiM2ZkY2E0NzRhNDU0ODkxZDkwODk2NTg2MzQzZGVfMjYtNy0xLTEtMA_d72007cb-595f-47f0-92e7-5e16e2262170">32,022</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net loss attributable to non-controlling interest</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i27f4e53b91ad4367b7f8d273eff27769_D20210401-20210630" decimals="-3" sign="-" name="us-gaap:NetIncomeLossAttributableToNoncontrollingInterest" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzY2E5YmIwMTc5MjQ3NmZiYjIyNWU1ZDlkZWM4NjlmL3NlYzo5M2NhOWJiMDE3OTI0NzZmYmIyMjVlNWQ5ZGVjODY5Zl8xOS9mcmFnOmNhNDBhNzBkOTFkZDRiMGE4YTQxZjI0NmM2NDMxNTliL3RhYmxlOmZhYjNmZGNhNDc0YTQ1NDg5MWQ5MDg5NjU4NjM0M2RlL3RhYmxlcmFuZ2U6ZmFiM2ZkY2E0NzRhNDU0ODkxZDkwODk2NTg2MzQzZGVfMjgtMS0xLTEtMTI5NDk_7eef6401-b823-4ff2-be3e-4cb830bfefaa">279</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i39065c5daf934af885335c12f3cfa83f_D20200401-20200630" decimals="-3" sign="-" name="us-gaap:NetIncomeLossAttributableToNoncontrollingInterest" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzY2E5YmIwMTc5MjQ3NmZiYjIyNWU1ZDlkZWM4NjlmL3NlYzo5M2NhOWJiMDE3OTI0NzZmYmIyMjVlNWQ5ZGVjODY5Zl8xOS9mcmFnOmNhNDBhNzBkOTFkZDRiMGE4YTQxZjI0NmM2NDMxNTliL3RhYmxlOmZhYjNmZGNhNDc0YTQ1NDg5MWQ5MDg5NjU4NjM0M2RlL3RhYmxlcmFuZ2U6ZmFiM2ZkY2E0NzRhNDU0ODkxZDkwODk2NTg2MzQzZGVfMjgtMy0xLTEtMTI5NDk_4d8a426b-553a-467d-8790-6cc66dcb2a1b">726</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i69782326f71a44e3805518280ee22b6b_D20210101-20210630" decimals="-3" sign="-" name="us-gaap:NetIncomeLossAttributableToNoncontrollingInterest" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzY2E5YmIwMTc5MjQ3NmZiYjIyNWU1ZDlkZWM4NjlmL3NlYzo5M2NhOWJiMDE3OTI0NzZmYmIyMjVlNWQ5ZGVjODY5Zl8xOS9mcmFnOmNhNDBhNzBkOTFkZDRiMGE4YTQxZjI0NmM2NDMxNTliL3RhYmxlOmZhYjNmZGNhNDc0YTQ1NDg5MWQ5MDg5NjU4NjM0M2RlL3RhYmxlcmFuZ2U6ZmFiM2ZkY2E0NzRhNDU0ODkxZDkwODk2NTg2MzQzZGVfMjgtNS0xLTEtMTI5NDk_1273a48c-b23a-42f8-a2a5-aef621ad5f95">592</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i4a110e4972ef4113880ce582e3cda5c5_D20200101-20200630" decimals="-3" sign="-" format="ixt:numdotdecimal" name="us-gaap:NetIncomeLossAttributableToNoncontrollingInterest" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzY2E5YmIwMTc5MjQ3NmZiYjIyNWU1ZDlkZWM4NjlmL3NlYzo5M2NhOWJiMDE3OTI0NzZmYmIyMjVlNWQ5ZGVjODY5Zl8xOS9mcmFnOmNhNDBhNzBkOTFkZDRiMGE4YTQxZjI0NmM2NDMxNTliL3RhYmxlOmZhYjNmZGNhNDc0YTQ1NDg5MWQ5MDg5NjU4NjM0M2RlL3RhYmxlcmFuZ2U6ZmFiM2ZkY2E0NzRhNDU0ODkxZDkwODk2NTg2MzQzZGVfMjgtNy0xLTEtMTI5NDk_3c7f9c88-74af-4cbf-b062-54012a503268">1,085</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net income (loss) attributable to Cronos Group</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i27f4e53b91ad4367b7f8d273eff27769_D20210401-20210630" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:NetIncomeLoss" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzY2E5YmIwMTc5MjQ3NmZiYjIyNWU1ZDlkZWM4NjlmL3NlYzo5M2NhOWJiMDE3OTI0NzZmYmIyMjVlNWQ5ZGVjODY5Zl8xOS9mcmFnOmNhNDBhNzBkOTFkZDRiMGE4YTQxZjI0NmM2NDMxNTliL3RhYmxlOmZhYjNmZGNhNDc0YTQ1NDg5MWQ5MDg5NjU4NjM0M2RlL3RhYmxlcmFuZ2U6ZmFiM2ZkY2E0NzRhNDU0ODkxZDkwODk2NTg2MzQzZGVfMjktMS0xLTEtMTYwODc_fa67c358-ec48-4b00-bdf4-e7d09e1b72f1">57,054</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i39065c5daf934af885335c12f3cfa83f_D20200401-20200630" decimals="-3" sign="-" format="ixt:numdotdecimal" name="us-gaap:NetIncomeLoss" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzY2E5YmIwMTc5MjQ3NmZiYjIyNWU1ZDlkZWM4NjlmL3NlYzo5M2NhOWJiMDE3OTI0NzZmYmIyMjVlNWQ5ZGVjODY5Zl8xOS9mcmFnOmNhNDBhNzBkOTFkZDRiMGE4YTQxZjI0NmM2NDMxNTliL3RhYmxlOmZhYjNmZGNhNDc0YTQ1NDg5MWQ5MDg5NjU4NjM0M2RlL3RhYmxlcmFuZ2U6ZmFiM2ZkY2E0NzRhNDU0ODkxZDkwODk2NTg2MzQzZGVfMjktMy0xLTEtMTYwODc_a2976b37-2b87-4a19-afa9-c434f6a97d48">106,977</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i69782326f71a44e3805518280ee22b6b_D20210101-20210630" decimals="-3" sign="-" format="ixt:numdotdecimal" name="us-gaap:NetIncomeLoss" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzY2E5YmIwMTc5MjQ3NmZiYjIyNWU1ZDlkZWM4NjlmL3NlYzo5M2NhOWJiMDE3OTI0NzZmYmIyMjVlNWQ5ZGVjODY5Zl8xOS9mcmFnOmNhNDBhNzBkOTFkZDRiMGE4YTQxZjI0NmM2NDMxNTliL3RhYmxlOmZhYjNmZGNhNDc0YTQ1NDg5MWQ5MDg5NjU4NjM0M2RlL3RhYmxlcmFuZ2U6ZmFiM2ZkY2E0NzRhNDU0ODkxZDkwODk2NTg2MzQzZGVfMjktNS0xLTEtMTYwODc_d1f7dcc8-1882-4ca7-835a-b576e0001c67">104,258</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i4a110e4972ef4113880ce582e3cda5c5_D20200101-20200630" decimals="-3" sign="-" format="ixt:numdotdecimal" name="us-gaap:NetIncomeLoss" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzY2E5YmIwMTc5MjQ3NmZiYjIyNWU1ZDlkZWM4NjlmL3NlYzo5M2NhOWJiMDE3OTI0NzZmYmIyMjVlNWQ5ZGVjODY5Zl8xOS9mcmFnOmNhNDBhNzBkOTFkZDRiMGE4YTQxZjI0NmM2NDMxNTliL3RhYmxlOmZhYjNmZGNhNDc0YTQ1NDg5MWQ5MDg5NjU4NjM0M2RlL3RhYmxlcmFuZ2U6ZmFiM2ZkY2E0NzRhNDU0ODkxZDkwODk2NTg2MzQzZGVfMjktNy0xLTEtMTYwODc_d12dd780-f9a6-4210-adff-27113f9f841b">30,937</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Other comprehensive income (loss)</span></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net income (loss)</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i27f4e53b91ad4367b7f8d273eff27769_D20210401-20210630" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:ProfitLoss" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzY2E5YmIwMTc5MjQ3NmZiYjIyNWU1ZDlkZWM4NjlmL3NlYzo5M2NhOWJiMDE3OTI0NzZmYmIyMjVlNWQ5ZGVjODY5Zl8xOS9mcmFnOmNhNDBhNzBkOTFkZDRiMGE4YTQxZjI0NmM2NDMxNTliL3RhYmxlOmZhYjNmZGNhNDc0YTQ1NDg5MWQ5MDg5NjU4NjM0M2RlL3RhYmxlcmFuZ2U6ZmFiM2ZkY2E0NzRhNDU0ODkxZDkwODk2NTg2MzQzZGVfMzUtMS0xLTEtMTYwODk_4afaf6da-0f87-4956-9d0e-5d0c6f05cd31">56,775</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i39065c5daf934af885335c12f3cfa83f_D20200401-20200630" decimals="-3" sign="-" format="ixt:numdotdecimal" name="us-gaap:ProfitLoss" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzY2E5YmIwMTc5MjQ3NmZiYjIyNWU1ZDlkZWM4NjlmL3NlYzo5M2NhOWJiMDE3OTI0NzZmYmIyMjVlNWQ5ZGVjODY5Zl8xOS9mcmFnOmNhNDBhNzBkOTFkZDRiMGE4YTQxZjI0NmM2NDMxNTliL3RhYmxlOmZhYjNmZGNhNDc0YTQ1NDg5MWQ5MDg5NjU4NjM0M2RlL3RhYmxlcmFuZ2U6ZmFiM2ZkY2E0NzRhNDU0ODkxZDkwODk2NTg2MzQzZGVfMzUtMy0xLTEtMTYwODk_37150dc4-1f69-4874-83a2-48253f664c04">107,703</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i69782326f71a44e3805518280ee22b6b_D20210101-20210630" decimals="-3" sign="-" format="ixt:numdotdecimal" name="us-gaap:ProfitLoss" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzY2E5YmIwMTc5MjQ3NmZiYjIyNWU1ZDlkZWM4NjlmL3NlYzo5M2NhOWJiMDE3OTI0NzZmYmIyMjVlNWQ5ZGVjODY5Zl8xOS9mcmFnOmNhNDBhNzBkOTFkZDRiMGE4YTQxZjI0NmM2NDMxNTliL3RhYmxlOmZhYjNmZGNhNDc0YTQ1NDg5MWQ5MDg5NjU4NjM0M2RlL3RhYmxlcmFuZ2U6ZmFiM2ZkY2E0NzRhNDU0ODkxZDkwODk2NTg2MzQzZGVfMzUtNS0xLTEtMTYwODk_8b3c14f9-e6f7-41da-9d9e-cc7d41e2c4ba">104,850</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i4a110e4972ef4113880ce582e3cda5c5_D20200101-20200630" decimals="-3" sign="-" format="ixt:numdotdecimal" name="us-gaap:ProfitLoss" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzY2E5YmIwMTc5MjQ3NmZiYjIyNWU1ZDlkZWM4NjlmL3NlYzo5M2NhOWJiMDE3OTI0NzZmYmIyMjVlNWQ5ZGVjODY5Zl8xOS9mcmFnOmNhNDBhNzBkOTFkZDRiMGE4YTQxZjI0NmM2NDMxNTliL3RhYmxlOmZhYjNmZGNhNDc0YTQ1NDg5MWQ5MDg5NjU4NjM0M2RlL3RhYmxlcmFuZ2U6ZmFiM2ZkY2E0NzRhNDU0ODkxZDkwODk2NTg2MzQzZGVfMzUtNy0xLTEtMTYwODk_7fc50773-03cb-4f12-8943-d57c782f46c7">32,022</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other comprehensive income (loss):</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Foreign exchange gain (loss) on translation</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i27f4e53b91ad4367b7f8d273eff27769_D20210401-20210630" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzY2E5YmIwMTc5MjQ3NmZiYjIyNWU1ZDlkZWM4NjlmL3NlYzo5M2NhOWJiMDE3OTI0NzZmYmIyMjVlNWQ5ZGVjODY5Zl8xOS9mcmFnOmNhNDBhNzBkOTFkZDRiMGE4YTQxZjI0NmM2NDMxNTliL3RhYmxlOmZhYjNmZGNhNDc0YTQ1NDg5MWQ5MDg5NjU4NjM0M2RlL3RhYmxlcmFuZ2U6ZmFiM2ZkY2E0NzRhNDU0ODkxZDkwODk2NTg2MzQzZGVfMzItMS0xLTEtMA_90ff8133-880e-4e5b-900e-6ae263acb252">13,470</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i39065c5daf934af885335c12f3cfa83f_D20200401-20200630" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzY2E5YmIwMTc5MjQ3NmZiYjIyNWU1ZDlkZWM4NjlmL3NlYzo5M2NhOWJiMDE3OTI0NzZmYmIyMjVlNWQ5ZGVjODY5Zl8xOS9mcmFnOmNhNDBhNzBkOTFkZDRiMGE4YTQxZjI0NmM2NDMxNTliL3RhYmxlOmZhYjNmZGNhNDc0YTQ1NDg5MWQ5MDg5NjU4NjM0M2RlL3RhYmxlcmFuZ2U6ZmFiM2ZkY2E0NzRhNDU0ODkxZDkwODk2NTg2MzQzZGVfMzItMy0xLTEtMA_32358be9-d812-4334-af9a-d534c93cbdba">51,871</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i69782326f71a44e3805518280ee22b6b_D20210101-20210630" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzY2E5YmIwMTc5MjQ3NmZiYjIyNWU1ZDlkZWM4NjlmL3NlYzo5M2NhOWJiMDE3OTI0NzZmYmIyMjVlNWQ5ZGVjODY5Zl8xOS9mcmFnOmNhNDBhNzBkOTFkZDRiMGE4YTQxZjI0NmM2NDMxNTliL3RhYmxlOmZhYjNmZGNhNDc0YTQ1NDg5MWQ5MDg5NjU4NjM0M2RlL3RhYmxlcmFuZ2U6ZmFiM2ZkY2E0NzRhNDU0ODkxZDkwODk2NTg2MzQzZGVfMzItNS0xLTEtMA_85085618-f3ec-4b74-9704-06e206d07c24">29,754</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i4a110e4972ef4113880ce582e3cda5c5_D20200101-20200630" decimals="-3" sign="-" format="ixt:numdotdecimal" name="us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzY2E5YmIwMTc5MjQ3NmZiYjIyNWU1ZDlkZWM4NjlmL3NlYzo5M2NhOWJiMDE3OTI0NzZmYmIyMjVlNWQ5ZGVjODY5Zl8xOS9mcmFnOmNhNDBhNzBkOTFkZDRiMGE4YTQxZjI0NmM2NDMxNTliL3RhYmxlOmZhYjNmZGNhNDc0YTQ1NDg5MWQ5MDg5NjU4NjM0M2RlL3RhYmxlcmFuZ2U6ZmFiM2ZkY2E0NzRhNDU0ODkxZDkwODk2NTg2MzQzZGVfMzItNy0xLTEtMA_2e6ba7c8-3a43-48b7-bc33-1a6f1aa91458">61,821</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 20.5pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total other comprehensive income (loss)</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i27f4e53b91ad4367b7f8d273eff27769_D20210401-20210630" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:OtherComprehensiveIncomeLossNetOfTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzY2E5YmIwMTc5MjQ3NmZiYjIyNWU1ZDlkZWM4NjlmL3NlYzo5M2NhOWJiMDE3OTI0NzZmYmIyMjVlNWQ5ZGVjODY5Zl8xOS9mcmFnOmNhNDBhNzBkOTFkZDRiMGE4YTQxZjI0NmM2NDMxNTliL3RhYmxlOmZhYjNmZGNhNDc0YTQ1NDg5MWQ5MDg5NjU4NjM0M2RlL3RhYmxlcmFuZ2U6ZmFiM2ZkY2E0NzRhNDU0ODkxZDkwODk2NTg2MzQzZGVfMzQtMS0xLTEtMA_c4d49091-ddfb-4358-a836-ae05ea71afe4">13,470</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i39065c5daf934af885335c12f3cfa83f_D20200401-20200630" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:OtherComprehensiveIncomeLossNetOfTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzY2E5YmIwMTc5MjQ3NmZiYjIyNWU1ZDlkZWM4NjlmL3NlYzo5M2NhOWJiMDE3OTI0NzZmYmIyMjVlNWQ5ZGVjODY5Zl8xOS9mcmFnOmNhNDBhNzBkOTFkZDRiMGE4YTQxZjI0NmM2NDMxNTliL3RhYmxlOmZhYjNmZGNhNDc0YTQ1NDg5MWQ5MDg5NjU4NjM0M2RlL3RhYmxlcmFuZ2U6ZmFiM2ZkY2E0NzRhNDU0ODkxZDkwODk2NTg2MzQzZGVfMzQtMy0xLTEtMA_819160fd-603d-48f1-9d31-43741a55ce78">51,871</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i69782326f71a44e3805518280ee22b6b_D20210101-20210630" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:OtherComprehensiveIncomeLossNetOfTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzY2E5YmIwMTc5MjQ3NmZiYjIyNWU1ZDlkZWM4NjlmL3NlYzo5M2NhOWJiMDE3OTI0NzZmYmIyMjVlNWQ5ZGVjODY5Zl8xOS9mcmFnOmNhNDBhNzBkOTFkZDRiMGE4YTQxZjI0NmM2NDMxNTliL3RhYmxlOmZhYjNmZGNhNDc0YTQ1NDg5MWQ5MDg5NjU4NjM0M2RlL3RhYmxlcmFuZ2U6ZmFiM2ZkY2E0NzRhNDU0ODkxZDkwODk2NTg2MzQzZGVfMzQtNS0xLTEtMA_a5b4984d-593d-474b-b641-1877a0d6c1bd">29,754</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i4a110e4972ef4113880ce582e3cda5c5_D20200101-20200630" decimals="-3" sign="-" format="ixt:numdotdecimal" name="us-gaap:OtherComprehensiveIncomeLossNetOfTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzY2E5YmIwMTc5MjQ3NmZiYjIyNWU1ZDlkZWM4NjlmL3NlYzo5M2NhOWJiMDE3OTI0NzZmYmIyMjVlNWQ5ZGVjODY5Zl8xOS9mcmFnOmNhNDBhNzBkOTFkZDRiMGE4YTQxZjI0NmM2NDMxNTliL3RhYmxlOmZhYjNmZGNhNDc0YTQ1NDg5MWQ5MDg5NjU4NjM0M2RlL3RhYmxlcmFuZ2U6ZmFiM2ZkY2E0NzRhNDU0ODkxZDkwODk2NTg2MzQzZGVfMzQtNy0xLTEtMA_5db6db19-3d6b-4e27-b9b1-fb0945df9e8f">61,821</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Comprehensive income (loss)</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i27f4e53b91ad4367b7f8d273eff27769_D20210401-20210630" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzY2E5YmIwMTc5MjQ3NmZiYjIyNWU1ZDlkZWM4NjlmL3NlYzo5M2NhOWJiMDE3OTI0NzZmYmIyMjVlNWQ5ZGVjODY5Zl8xOS9mcmFnOmNhNDBhNzBkOTFkZDRiMGE4YTQxZjI0NmM2NDMxNTliL3RhYmxlOmZhYjNmZGNhNDc0YTQ1NDg5MWQ5MDg5NjU4NjM0M2RlL3RhYmxlcmFuZ2U6ZmFiM2ZkY2E0NzRhNDU0ODkxZDkwODk2NTg2MzQzZGVfMzUtMS0xLTEtMA_fed700d6-543f-4635-8855-2ba4f42a7372">70,245</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i39065c5daf934af885335c12f3cfa83f_D20200401-20200630" decimals="-3" sign="-" format="ixt:numdotdecimal" name="us-gaap:ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzY2E5YmIwMTc5MjQ3NmZiYjIyNWU1ZDlkZWM4NjlmL3NlYzo5M2NhOWJiMDE3OTI0NzZmYmIyMjVlNWQ5ZGVjODY5Zl8xOS9mcmFnOmNhNDBhNzBkOTFkZDRiMGE4YTQxZjI0NmM2NDMxNTliL3RhYmxlOmZhYjNmZGNhNDc0YTQ1NDg5MWQ5MDg5NjU4NjM0M2RlL3RhYmxlcmFuZ2U6ZmFiM2ZkY2E0NzRhNDU0ODkxZDkwODk2NTg2MzQzZGVfMzUtMy0xLTEtMA_5f1fc832-f63e-4ce5-acfb-88cdba4c7169">55,832</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i69782326f71a44e3805518280ee22b6b_D20210101-20210630" decimals="-3" sign="-" format="ixt:numdotdecimal" name="us-gaap:ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzY2E5YmIwMTc5MjQ3NmZiYjIyNWU1ZDlkZWM4NjlmL3NlYzo5M2NhOWJiMDE3OTI0NzZmYmIyMjVlNWQ5ZGVjODY5Zl8xOS9mcmFnOmNhNDBhNzBkOTFkZDRiMGE4YTQxZjI0NmM2NDMxNTliL3RhYmxlOmZhYjNmZGNhNDc0YTQ1NDg5MWQ5MDg5NjU4NjM0M2RlL3RhYmxlcmFuZ2U6ZmFiM2ZkY2E0NzRhNDU0ODkxZDkwODk2NTg2MzQzZGVfMzUtNS0xLTEtMA_a730a327-053d-4a2f-8693-9c8c5c6013ef">75,096</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i4a110e4972ef4113880ce582e3cda5c5_D20200101-20200630" decimals="-3" sign="-" format="ixt:numdotdecimal" name="us-gaap:ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzY2E5YmIwMTc5MjQ3NmZiYjIyNWU1ZDlkZWM4NjlmL3NlYzo5M2NhOWJiMDE3OTI0NzZmYmIyMjVlNWQ5ZGVjODY5Zl8xOS9mcmFnOmNhNDBhNzBkOTFkZDRiMGE4YTQxZjI0NmM2NDMxNTliL3RhYmxlOmZhYjNmZGNhNDc0YTQ1NDg5MWQ5MDg5NjU4NjM0M2RlL3RhYmxlcmFuZ2U6ZmFiM2ZkY2E0NzRhNDU0ODkxZDkwODk2NTg2MzQzZGVfMzUtNy0xLTEtMA_74f5c2f3-bf79-489f-a64b-1ba5ad24cf6f">93,843</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Less: comprehensive income (loss) attributable to non-controlling interests</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i27f4e53b91ad4367b7f8d273eff27769_D20210401-20210630" decimals="-3" sign="-" name="us-gaap:ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzY2E5YmIwMTc5MjQ3NmZiYjIyNWU1ZDlkZWM4NjlmL3NlYzo5M2NhOWJiMDE3OTI0NzZmYmIyMjVlNWQ5ZGVjODY5Zl8xOS9mcmFnOmNhNDBhNzBkOTFkZDRiMGE4YTQxZjI0NmM2NDMxNTliL3RhYmxlOmZhYjNmZGNhNDc0YTQ1NDg5MWQ5MDg5NjU4NjM0M2RlL3RhYmxlcmFuZ2U6ZmFiM2ZkY2E0NzRhNDU0ODkxZDkwODk2NTg2MzQzZGVfNDItMS0xLTEtMTI5ODE_35e46e90-ce73-44fa-9bed-a607c5dfacda">394</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i39065c5daf934af885335c12f3cfa83f_D20200401-20200630" decimals="-3" sign="-" name="us-gaap:ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzY2E5YmIwMTc5MjQ3NmZiYjIyNWU1ZDlkZWM4NjlmL3NlYzo5M2NhOWJiMDE3OTI0NzZmYmIyMjVlNWQ5ZGVjODY5Zl8xOS9mcmFnOmNhNDBhNzBkOTFkZDRiMGE4YTQxZjI0NmM2NDMxNTliL3RhYmxlOmZhYjNmZGNhNDc0YTQ1NDg5MWQ5MDg5NjU4NjM0M2RlL3RhYmxlcmFuZ2U6ZmFiM2ZkY2E0NzRhNDU0ODkxZDkwODk2NTg2MzQzZGVfNDItMy0xLTEtMTI5ODE_942ed9af-a3cb-40f9-b67a-a975cde18b20">762</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i69782326f71a44e3805518280ee22b6b_D20210101-20210630" decimals="-3" name="us-gaap:ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzY2E5YmIwMTc5MjQ3NmZiYjIyNWU1ZDlkZWM4NjlmL3NlYzo5M2NhOWJiMDE3OTI0NzZmYmIyMjVlNWQ5ZGVjODY5Zl8xOS9mcmFnOmNhNDBhNzBkOTFkZDRiMGE4YTQxZjI0NmM2NDMxNTliL3RhYmxlOmZhYjNmZGNhNDc0YTQ1NDg5MWQ5MDg5NjU4NjM0M2RlL3RhYmxlcmFuZ2U6ZmFiM2ZkY2E0NzRhNDU0ODkxZDkwODk2NTg2MzQzZGVfNDItNS0xLTEtMTI5ODE_32aea538-1db1-44c8-99ea-4686010014c8">432</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i4a110e4972ef4113880ce582e3cda5c5_D20200101-20200630" decimals="-3" sign="-" format="ixt:numdotdecimal" name="us-gaap:ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzY2E5YmIwMTc5MjQ3NmZiYjIyNWU1ZDlkZWM4NjlmL3NlYzo5M2NhOWJiMDE3OTI0NzZmYmIyMjVlNWQ5ZGVjODY5Zl8xOS9mcmFnOmNhNDBhNzBkOTFkZDRiMGE4YTQxZjI0NmM2NDMxNTliL3RhYmxlOmZhYjNmZGNhNDc0YTQ1NDg5MWQ5MDg5NjU4NjM0M2RlL3RhYmxlcmFuZ2U6ZmFiM2ZkY2E0NzRhNDU0ODkxZDkwODk2NTg2MzQzZGVfNDItNy0xLTEtMTI5ODE_770a0068-703a-423e-9c14-d9a4bce4ca5c">1,098</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Comprehensive income (loss) attributable to Cronos Group</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i27f4e53b91ad4367b7f8d273eff27769_D20210401-20210630" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:ComprehensiveIncomeNetOfTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzY2E5YmIwMTc5MjQ3NmZiYjIyNWU1ZDlkZWM4NjlmL3NlYzo5M2NhOWJiMDE3OTI0NzZmYmIyMjVlNWQ5ZGVjODY5Zl8xOS9mcmFnOmNhNDBhNzBkOTFkZDRiMGE4YTQxZjI0NmM2NDMxNTliL3RhYmxlOmZhYjNmZGNhNDc0YTQ1NDg5MWQ5MDg5NjU4NjM0M2RlL3RhYmxlcmFuZ2U6ZmFiM2ZkY2E0NzRhNDU0ODkxZDkwODk2NTg2MzQzZGVfNDItMS0xLTEtMTYwOTY_5f1f75ce-8f04-4d2a-905e-ba6a51cddd16">70,639</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i39065c5daf934af885335c12f3cfa83f_D20200401-20200630" decimals="-3" sign="-" format="ixt:numdotdecimal" name="us-gaap:ComprehensiveIncomeNetOfTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzY2E5YmIwMTc5MjQ3NmZiYjIyNWU1ZDlkZWM4NjlmL3NlYzo5M2NhOWJiMDE3OTI0NzZmYmIyMjVlNWQ5ZGVjODY5Zl8xOS9mcmFnOmNhNDBhNzBkOTFkZDRiMGE4YTQxZjI0NmM2NDMxNTliL3RhYmxlOmZhYjNmZGNhNDc0YTQ1NDg5MWQ5MDg5NjU4NjM0M2RlL3RhYmxlcmFuZ2U6ZmFiM2ZkY2E0NzRhNDU0ODkxZDkwODk2NTg2MzQzZGVfNDItMy0xLTEtMTYwOTY_5ca2a18c-5812-49c0-9d39-fbe731c740e7">55,070</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i69782326f71a44e3805518280ee22b6b_D20210101-20210630" decimals="-3" sign="-" format="ixt:numdotdecimal" name="us-gaap:ComprehensiveIncomeNetOfTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzY2E5YmIwMTc5MjQ3NmZiYjIyNWU1ZDlkZWM4NjlmL3NlYzo5M2NhOWJiMDE3OTI0NzZmYmIyMjVlNWQ5ZGVjODY5Zl8xOS9mcmFnOmNhNDBhNzBkOTFkZDRiMGE4YTQxZjI0NmM2NDMxNTliL3RhYmxlOmZhYjNmZGNhNDc0YTQ1NDg5MWQ5MDg5NjU4NjM0M2RlL3RhYmxlcmFuZ2U6ZmFiM2ZkY2E0NzRhNDU0ODkxZDkwODk2NTg2MzQzZGVfNDItNS0xLTEtMTYwOTY_13c44241-de54-4939-9024-7edf58c64108">75,528</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i4a110e4972ef4113880ce582e3cda5c5_D20200101-20200630" decimals="-3" sign="-" format="ixt:numdotdecimal" name="us-gaap:ComprehensiveIncomeNetOfTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzY2E5YmIwMTc5MjQ3NmZiYjIyNWU1ZDlkZWM4NjlmL3NlYzo5M2NhOWJiMDE3OTI0NzZmYmIyMjVlNWQ5ZGVjODY5Zl8xOS9mcmFnOmNhNDBhNzBkOTFkZDRiMGE4YTQxZjI0NmM2NDMxNTliL3RhYmxlOmZhYjNmZGNhNDc0YTQ1NDg5MWQ5MDg5NjU4NjM0M2RlL3RhYmxlcmFuZ2U6ZmFiM2ZkY2E0NzRhNDU0ODkxZDkwODk2NTg2MzQzZGVfNDItNy0xLTEtMTYwOTY_c15627d1-c45d-42eb-b3d1-4d24efd8de4b">92,745</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Net income (loss) per share</span></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Basic and diluted - continuing operations</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="i27f4e53b91ad4367b7f8d273eff27769_D20210401-20210630" decimals="2" name="us-gaap:IncomeLossFromContinuingOperationsPerDilutedShare" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjkzY2E5YmIwMTc5MjQ3NmZiYjIyNWU1ZDlkZWM4NjlmL3NlYzo5M2NhOWJiMDE3OTI0NzZmYmIyMjVlNWQ5ZGVjODY5Zl8xOS9mcmFnOmNhNDBhNzBkOTFkZDRiMGE4YTQxZjI0NmM2NDMxNTliL3RhYmxlOmZhYjNmZGNhNDc0YTQ1NDg5MWQ5MDg5NjU4NjM0M2RlL3RhYmxlcmFuZ2U6ZmFiM2ZkY2E0NzRhNDU0ODkxZDkwODk2NTg2MzQzZGVfNDEtMS0xLTEtMA_675bf772-1c5c-4a5a-bf15-07244d1c9908"><ix:nonFraction unitRef="usdPerShare" contextRef="i27f4e53b91ad4367b7f8d273eff27769_D20210401-20210630" decimals="2" name="us-gaap:IncomeLossFromContinuingOperationsPerBasicShare" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjkzY2E5YmIwMTc5MjQ3NmZiYjIyNWU1ZDlkZWM4NjlmL3NlYzo5M2NhOWJiMDE3OTI0NzZmYmIyMjVlNWQ5ZGVjODY5Zl8xOS9mcmFnOmNhNDBhNzBkOTFkZDRiMGE4YTQxZjI0NmM2NDMxNTliL3RhYmxlOmZhYjNmZGNhNDc0YTQ1NDg5MWQ5MDg5NjU4NjM0M2RlL3RhYmxlcmFuZ2U6ZmFiM2ZkY2E0NzRhNDU0ODkxZDkwODk2NTg2MzQzZGVfNDEtMS0xLTEtMA_d6281356-db5e-429e-982f-5e42c1d7107f">0.15</ix:nonFraction></ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usdPerShare" contextRef="i39065c5daf934af885335c12f3cfa83f_D20200401-20200630" decimals="2" sign="-" name="us-gaap:IncomeLossFromContinuingOperationsPerDilutedShare" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjkzY2E5YmIwMTc5MjQ3NmZiYjIyNWU1ZDlkZWM4NjlmL3NlYzo5M2NhOWJiMDE3OTI0NzZmYmIyMjVlNWQ5ZGVjODY5Zl8xOS9mcmFnOmNhNDBhNzBkOTFkZDRiMGE4YTQxZjI0NmM2NDMxNTliL3RhYmxlOmZhYjNmZGNhNDc0YTQ1NDg5MWQ5MDg5NjU4NjM0M2RlL3RhYmxlcmFuZ2U6ZmFiM2ZkY2E0NzRhNDU0ODkxZDkwODk2NTg2MzQzZGVfNDEtMy0xLTEtMA_a5ebc63c-dc59-45c0-b4c2-fa5da5562a07"><ix:nonFraction unitRef="usdPerShare" contextRef="i39065c5daf934af885335c12f3cfa83f_D20200401-20200630" decimals="2" sign="-" name="us-gaap:IncomeLossFromContinuingOperationsPerBasicShare" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjkzY2E5YmIwMTc5MjQ3NmZiYjIyNWU1ZDlkZWM4NjlmL3NlYzo5M2NhOWJiMDE3OTI0NzZmYmIyMjVlNWQ5ZGVjODY5Zl8xOS9mcmFnOmNhNDBhNzBkOTFkZDRiMGE4YTQxZjI0NmM2NDMxNTliL3RhYmxlOmZhYjNmZGNhNDc0YTQ1NDg5MWQ5MDg5NjU4NjM0M2RlL3RhYmxlcmFuZ2U6ZmFiM2ZkY2E0NzRhNDU0ODkxZDkwODk2NTg2MzQzZGVfNDEtMy0xLTEtMA_d29c8b5a-9a81-41a0-8b71-7e9336e48fff">0.31</ix:nonFraction></ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usdPerShare" contextRef="i69782326f71a44e3805518280ee22b6b_D20210101-20210630" decimals="2" sign="-" name="us-gaap:IncomeLossFromContinuingOperationsPerBasicShare" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjkzY2E5YmIwMTc5MjQ3NmZiYjIyNWU1ZDlkZWM4NjlmL3NlYzo5M2NhOWJiMDE3OTI0NzZmYmIyMjVlNWQ5ZGVjODY5Zl8xOS9mcmFnOmNhNDBhNzBkOTFkZDRiMGE4YTQxZjI0NmM2NDMxNTliL3RhYmxlOmZhYjNmZGNhNDc0YTQ1NDg5MWQ5MDg5NjU4NjM0M2RlL3RhYmxlcmFuZ2U6ZmFiM2ZkY2E0NzRhNDU0ODkxZDkwODk2NTg2MzQzZGVfNDEtNS0xLTEtMA_4ab65d68-eeb4-44e6-b74a-b4e686f8182d"><ix:nonFraction unitRef="usdPerShare" contextRef="i69782326f71a44e3805518280ee22b6b_D20210101-20210630" decimals="2" sign="-" name="us-gaap:IncomeLossFromContinuingOperationsPerDilutedShare" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjkzY2E5YmIwMTc5MjQ3NmZiYjIyNWU1ZDlkZWM4NjlmL3NlYzo5M2NhOWJiMDE3OTI0NzZmYmIyMjVlNWQ5ZGVjODY5Zl8xOS9mcmFnOmNhNDBhNzBkOTFkZDRiMGE4YTQxZjI0NmM2NDMxNTliL3RhYmxlOmZhYjNmZGNhNDc0YTQ1NDg5MWQ5MDg5NjU4NjM0M2RlL3RhYmxlcmFuZ2U6ZmFiM2ZkY2E0NzRhNDU0ODkxZDkwODk2NTg2MzQzZGVfNDEtNS0xLTEtMA_d2727dbe-cf96-4a0e-a46d-7025f6130db7">0.28</ix:nonFraction></ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usdPerShare" contextRef="i4a110e4972ef4113880ce582e3cda5c5_D20200101-20200630" decimals="2" sign="-" name="us-gaap:IncomeLossFromContinuingOperationsPerDilutedShare" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjkzY2E5YmIwMTc5MjQ3NmZiYjIyNWU1ZDlkZWM4NjlmL3NlYzo5M2NhOWJiMDE3OTI0NzZmYmIyMjVlNWQ5ZGVjODY5Zl8xOS9mcmFnOmNhNDBhNzBkOTFkZDRiMGE4YTQxZjI0NmM2NDMxNTliL3RhYmxlOmZhYjNmZGNhNDc0YTQ1NDg5MWQ5MDg5NjU4NjM0M2RlL3RhYmxlcmFuZ2U6ZmFiM2ZkY2E0NzRhNDU0ODkxZDkwODk2NTg2MzQzZGVfNDEtNy0xLTEtMA_49a34991-6eba-40b5-ae1b-41913455d5f8"><ix:nonFraction unitRef="usdPerShare" contextRef="i4a110e4972ef4113880ce582e3cda5c5_D20200101-20200630" decimals="2" sign="-" name="us-gaap:IncomeLossFromContinuingOperationsPerBasicShare" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjkzY2E5YmIwMTc5MjQ3NmZiYjIyNWU1ZDlkZWM4NjlmL3NlYzo5M2NhOWJiMDE3OTI0NzZmYmIyMjVlNWQ5ZGVjODY5Zl8xOS9mcmFnOmNhNDBhNzBkOTFkZDRiMGE4YTQxZjI0NmM2NDMxNTliL3RhYmxlOmZhYjNmZGNhNDc0YTQ1NDg5MWQ5MDg5NjU4NjM0M2RlL3RhYmxlcmFuZ2U6ZmFiM2ZkY2E0NzRhNDU0ODkxZDkwODk2NTg2MzQzZGVfNDEtNy0xLTEtMA_a34079aa-af6e-499d-a1fc-da2d454db482">0.09</ix:nonFraction></ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Weighted average number of outstanding shares</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Basic</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i27f4e53b91ad4367b7f8d273eff27769_D20210401-20210630" decimals="0" format="ixt:numdotdecimal" name="us-gaap:WeightedAverageNumberOfSharesOutstandingBasic" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjkzY2E5YmIwMTc5MjQ3NmZiYjIyNWU1ZDlkZWM4NjlmL3NlYzo5M2NhOWJiMDE3OTI0NzZmYmIyMjVlNWQ5ZGVjODY5Zl8xOS9mcmFnOmNhNDBhNzBkOTFkZDRiMGE4YTQxZjI0NmM2NDMxNTliL3RhYmxlOmZhYjNmZGNhNDc0YTQ1NDg5MWQ5MDg5NjU4NjM0M2RlL3RhYmxlcmFuZ2U6ZmFiM2ZkY2E0NzRhNDU0ODkxZDkwODk2NTg2MzQzZGVfNDQtMS0xLTEtMA_c1790266-cc19-4baa-9998-4690422a13fd">371,721,382</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i39065c5daf934af885335c12f3cfa83f_D20200401-20200630" decimals="0" format="ixt:numdotdecimal" name="us-gaap:WeightedAverageNumberOfSharesOutstandingBasic" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjkzY2E5YmIwMTc5MjQ3NmZiYjIyNWU1ZDlkZWM4NjlmL3NlYzo5M2NhOWJiMDE3OTI0NzZmYmIyMjVlNWQ5ZGVjODY5Zl8xOS9mcmFnOmNhNDBhNzBkOTFkZDRiMGE4YTQxZjI0NmM2NDMxNTliL3RhYmxlOmZhYjNmZGNhNDc0YTQ1NDg5MWQ5MDg5NjU4NjM0M2RlL3RhYmxlcmFuZ2U6ZmFiM2ZkY2E0NzRhNDU0ODkxZDkwODk2NTg2MzQzZGVfNDQtMy0xLTEtMA_efa4762c-cb7f-4d69-ad3a-ce6da858a38f">349,075,408</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i69782326f71a44e3805518280ee22b6b_D20210101-20210630" decimals="0" format="ixt:numdotdecimal" name="us-gaap:WeightedAverageNumberOfSharesOutstandingBasic" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjkzY2E5YmIwMTc5MjQ3NmZiYjIyNWU1ZDlkZWM4NjlmL3NlYzo5M2NhOWJiMDE3OTI0NzZmYmIyMjVlNWQ5ZGVjODY5Zl8xOS9mcmFnOmNhNDBhNzBkOTFkZDRiMGE4YTQxZjI0NmM2NDMxNTliL3RhYmxlOmZhYjNmZGNhNDc0YTQ1NDg5MWQ5MDg5NjU4NjM0M2RlL3RhYmxlcmFuZ2U6ZmFiM2ZkY2E0NzRhNDU0ODkxZDkwODk2NTg2MzQzZGVfNDQtNS0xLTEtMA_4ee3d5e2-9a1c-4fea-881a-89cd54bd624b">367,391,118</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i4a110e4972ef4113880ce582e3cda5c5_D20200101-20200630" decimals="0" format="ixt:numdotdecimal" name="us-gaap:WeightedAverageNumberOfSharesOutstandingBasic" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjkzY2E5YmIwMTc5MjQ3NmZiYjIyNWU1ZDlkZWM4NjlmL3NlYzo5M2NhOWJiMDE3OTI0NzZmYmIyMjVlNWQ5ZGVjODY5Zl8xOS9mcmFnOmNhNDBhNzBkOTFkZDRiMGE4YTQxZjI0NmM2NDMxNTliL3RhYmxlOmZhYjNmZGNhNDc0YTQ1NDg5MWQ5MDg5NjU4NjM0M2RlL3RhYmxlcmFuZ2U6ZmFiM2ZkY2E0NzRhNDU0ODkxZDkwODk2NTg2MzQzZGVfNDQtNy0xLTEtMA_807fb4c6-c25a-44d7-8ea1-16897ae0dba3">348,946,439</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Diluted</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i27f4e53b91ad4367b7f8d273eff27769_D20210401-20210630" decimals="0" format="ixt:numdotdecimal" name="us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjkzY2E5YmIwMTc5MjQ3NmZiYjIyNWU1ZDlkZWM4NjlmL3NlYzo5M2NhOWJiMDE3OTI0NzZmYmIyMjVlNWQ5ZGVjODY5Zl8xOS9mcmFnOmNhNDBhNzBkOTFkZDRiMGE4YTQxZjI0NmM2NDMxNTliL3RhYmxlOmZhYjNmZGNhNDc0YTQ1NDg5MWQ5MDg5NjU4NjM0M2RlL3RhYmxlcmFuZ2U6ZmFiM2ZkY2E0NzRhNDU0ODkxZDkwODk2NTg2MzQzZGVfNDUtMS0xLTEtMA_5107fc9b-d889-4cc0-84d5-79d228a43b09">375,349,856</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i39065c5daf934af885335c12f3cfa83f_D20200401-20200630" decimals="0" format="ixt:numdotdecimal" name="us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjkzY2E5YmIwMTc5MjQ3NmZiYjIyNWU1ZDlkZWM4NjlmL3NlYzo5M2NhOWJiMDE3OTI0NzZmYmIyMjVlNWQ5ZGVjODY5Zl8xOS9mcmFnOmNhNDBhNzBkOTFkZDRiMGE4YTQxZjI0NmM2NDMxNTliL3RhYmxlOmZhYjNmZGNhNDc0YTQ1NDg5MWQ5MDg5NjU4NjM0M2RlL3RhYmxlcmFuZ2U6ZmFiM2ZkY2E0NzRhNDU0ODkxZDkwODk2NTg2MzQzZGVfNDUtMy0xLTEtMA_9bc7d4f7-fbad-4a4e-b43b-851b78817057">349,075,408</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i69782326f71a44e3805518280ee22b6b_D20210101-20210630" decimals="0" format="ixt:numdotdecimal" name="us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjkzY2E5YmIwMTc5MjQ3NmZiYjIyNWU1ZDlkZWM4NjlmL3NlYzo5M2NhOWJiMDE3OTI0NzZmYmIyMjVlNWQ5ZGVjODY5Zl8xOS9mcmFnOmNhNDBhNzBkOTFkZDRiMGE4YTQxZjI0NmM2NDMxNTliL3RhYmxlOmZhYjNmZGNhNDc0YTQ1NDg5MWQ5MDg5NjU4NjM0M2RlL3RhYmxlcmFuZ2U6ZmFiM2ZkY2E0NzRhNDU0ODkxZDkwODk2NTg2MzQzZGVfNDUtNS0xLTEtMA_6a918055-9de8-4285-a4f4-3356d0079bec">367,391,118</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i4a110e4972ef4113880ce582e3cda5c5_D20200101-20200630" decimals="0" format="ixt:numdotdecimal" name="us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjkzY2E5YmIwMTc5MjQ3NmZiYjIyNWU1ZDlkZWM4NjlmL3NlYzo5M2NhOWJiMDE3OTI0NzZmYmIyMjVlNWQ5ZGVjODY5Zl8xOS9mcmFnOmNhNDBhNzBkOTFkZDRiMGE4YTQxZjI0NmM2NDMxNTliL3RhYmxlOmZhYjNmZGNhNDc0YTQ1NDg5MWQ5MDg5NjU4NjM0M2RlL3RhYmxlcmFuZ2U6ZmFiM2ZkY2E0NzRhNDU0ODkxZDkwODk2NTg2MzQzZGVfNDUtNy0xLTEtMA_046c472e-653d-4981-8c85-075f2e96b826">348,946,439</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr></table></div><div style="text-align:justify"><span><br/></span></div><div style="margin-top:6pt;padding-left:27pt;text-align:justify;text-indent:-27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">See notes to condensed consolidated financial statements.</span></div><div style="height:21.6pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">5</span></div></div></div><div id="i93ca9bb01792476fbb225e5d9dec869f_25"></div><hr style="page-break-after:always"/><div style="min-height:86.4pt;width:100%"><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:69.166%"><tr><td style="width:1.0%"></td><td style="width:98.900%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="border-top:1pt solid #FFFFFF;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Cronos Group Inc.</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Condensed Consolidated Statements of Changes in Equity</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">For the three months ended June&#160;30, 2021 and 2020</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">(In thousands of U.S. dollars, except share amounts, unaudited)</span></td></tr></table></div><div><span><br/></span></div></div><div style="margin-bottom:12pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:31.295%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:6.920%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.945%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:6.295%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.945%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td style="width:1.0%"></td><td style="width:7.545%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.945%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:6.504%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.216%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.566%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.737%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.233%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.945%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.909%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Number of shares</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Share capital</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Additional paid-in capital</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Retained earnings </span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Accumulated other comprehensive income</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Non-controlling interests</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Total shareholders&#8217; equity</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance at April 1, 2021</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i22dfc818a91c4bc99bcf6f1109597b56_I20210331" decimals="INF" format="ixt:numdotdecimal" name="us-gaap:CommonStockSharesOutstanding" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjkzY2E5YmIwMTc5MjQ3NmZiYjIyNWU1ZDlkZWM4NjlmL3NlYzo5M2NhOWJiMDE3OTI0NzZmYmIyMjVlNWQ5ZGVjODY5Zl8yNS9mcmFnOjFhMTNiMjI5MDE5MTQ3NGNhMjc0YzQ2NGY4YWJmOTIwL3RhYmxlOjMwOTcxNjlmZGQ5MDQ3ZDg4ODBjZmRlNjVkYzdiYTZkL3RhYmxlcmFuZ2U6MzA5NzE2OWZkZDkwNDdkODg4MGNmZGU2NWRjN2JhNmRfMS0xLTEtMS0w_331620c2-bcee-42d8-8ac8-bf205420af2a">371,656,590</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i22dfc818a91c4bc99bcf6f1109597b56_I20210331" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzY2E5YmIwMTc5MjQ3NmZiYjIyNWU1ZDlkZWM4NjlmL3NlYzo5M2NhOWJiMDE3OTI0NzZmYmIyMjVlNWQ5ZGVjODY5Zl8yNS9mcmFnOjFhMTNiMjI5MDE5MTQ3NGNhMjc0YzQ2NGY4YWJmOTIwL3RhYmxlOjMwOTcxNjlmZGQ5MDQ3ZDg4ODBjZmRlNjVkYzdiYTZkL3RhYmxlcmFuZ2U6MzA5NzE2OWZkZDkwNDdkODg4MGNmZGU2NWRjN2JhNmRfMS0zLTEtMS0w_efdb7a37-2ab9-46c7-82f8-f3eace2b9385">584,912</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iaba74aed20054433bd6c1d99389ea937_I20210331" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzY2E5YmIwMTc5MjQ3NmZiYjIyNWU1ZDlkZWM4NjlmL3NlYzo5M2NhOWJiMDE3OTI0NzZmYmIyMjVlNWQ5ZGVjODY5Zl8yNS9mcmFnOjFhMTNiMjI5MDE5MTQ3NGNhMjc0YzQ2NGY4YWJmOTIwL3RhYmxlOjMwOTcxNjlmZGQ5MDQ3ZDg4ODBjZmRlNjVkYzdiYTZkL3RhYmxlcmFuZ2U6MzA5NzE2OWZkZDkwNDdkODg4MGNmZGU2NWRjN2JhNmRfMS03LTEtMS0w_ae6c7ab4-d3b1-4619-a783-d1c433fdf74f">32,090</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if6552787aa974a6b8ba4aa50cadb2110_I20210331" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzY2E5YmIwMTc5MjQ3NmZiYjIyNWU1ZDlkZWM4NjlmL3NlYzo5M2NhOWJiMDE3OTI0NzZmYmIyMjVlNWQ5ZGVjODY5Zl8yNS9mcmFnOjFhMTNiMjI5MDE5MTQ3NGNhMjc0YzQ2NGY4YWJmOTIwL3RhYmxlOjMwOTcxNjlmZGQ5MDQ3ZDg4ODBjZmRlNjVkYzdiYTZkL3RhYmxlcmFuZ2U6MzA5NzE2OWZkZDkwNDdkODg4MGNmZGU2NWRjN2JhNmRfMS05LTEtMS0w_9f8acd7d-ae24-4ed9-aa42-1dddc541400d">895,503</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3243ae496b5b4b50976442544343adcf_I20210331" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzY2E5YmIwMTc5MjQ3NmZiYjIyNWU1ZDlkZWM4NjlmL3NlYzo5M2NhOWJiMDE3OTI0NzZmYmIyMjVlNWQ5ZGVjODY5Zl8yNS9mcmFnOjFhMTNiMjI5MDE5MTQ3NGNhMjc0YzQ2NGY4YWJmOTIwL3RhYmxlOjMwOTcxNjlmZGQ5MDQ3ZDg4ODBjZmRlNjVkYzdiYTZkL3RhYmxlcmFuZ2U6MzA5NzE2OWZkZDkwNDdkODg4MGNmZGU2NWRjN2JhNmRfMS0xMS0xLTEtMA_b907a5aa-b0b5-46e7-be2a-962af4bdd19f">58,144</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i578f5574593f4ae99f69ac675bbba2b7_I20210331" decimals="-3" sign="-" format="ixt:numdotdecimal" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzY2E5YmIwMTc5MjQ3NmZiYjIyNWU1ZDlkZWM4NjlmL3NlYzo5M2NhOWJiMDE3OTI0NzZmYmIyMjVlNWQ5ZGVjODY5Zl8yNS9mcmFnOjFhMTNiMjI5MDE5MTQ3NGNhMjc0YzQ2NGY4YWJmOTIwL3RhYmxlOjMwOTcxNjlmZGQ5MDQ3ZDg4ODBjZmRlNjVkYzdiYTZkL3RhYmxlcmFuZ2U6MzA5NzE2OWZkZDkwNDdkODg4MGNmZGU2NWRjN2JhNmRfMS0xMy0xLTEtMA_98ea7ebc-adf6-4668-94a2-4ce7dd262eda">2,370</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i672ae438d5904d3aa27f245b59e5ba4c_I20210331" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzY2E5YmIwMTc5MjQ3NmZiYjIyNWU1ZDlkZWM4NjlmL3NlYzo5M2NhOWJiMDE3OTI0NzZmYmIyMjVlNWQ5ZGVjODY5Zl8yNS9mcmFnOjFhMTNiMjI5MDE5MTQ3NGNhMjc0YzQ2NGY4YWJmOTIwL3RhYmxlOjMwOTcxNjlmZGQ5MDQ3ZDg4ODBjZmRlNjVkYzdiYTZkL3RhYmxlcmFuZ2U6MzA5NzE2OWZkZDkwNDdkODg4MGNmZGU2NWRjN2JhNmRfMS0xNS0xLTEtMA_a6dc8b79-675e-42dd-bf5e-fbe206650b66">1,568,279</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Warrants exercised</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i932ec7c01594418eb95662a351e601a2_D20210401-20210630" decimals="INF" format="ixt:numdotdecimal" name="cron:SharebasedCompensationArrangementBySharebasedPaymentAwardWarrantsExercisesInPeriod" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjkzY2E5YmIwMTc5MjQ3NmZiYjIyNWU1ZDlkZWM4NjlmL3NlYzo5M2NhOWJiMDE3OTI0NzZmYmIyMjVlNWQ5ZGVjODY5Zl8yNS9mcmFnOjFhMTNiMjI5MDE5MTQ3NGNhMjc0YzQ2NGY4YWJmOTIwL3RhYmxlOjMwOTcxNjlmZGQ5MDQ3ZDg4ODBjZmRlNjVkYzdiYTZkL3RhYmxlcmFuZ2U6MzA5NzE2OWZkZDkwNDdkODg4MGNmZGU2NWRjN2JhNmRfNC0xLTEtMS0w_a4b3cf7f-92fa-4626-b488-a1bc4aad801d">10,000</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i932ec7c01594418eb95662a351e601a2_D20210401-20210630" decimals="-3" name="cron:StockIssuedDuringPeriodValueWarrantsExercised" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzY2E5YmIwMTc5MjQ3NmZiYjIyNWU1ZDlkZWM4NjlmL3NlYzo5M2NhOWJiMDE3OTI0NzZmYmIyMjVlNWQ5ZGVjODY5Zl8yNS9mcmFnOjFhMTNiMjI5MDE5MTQ3NGNhMjc0YzQ2NGY4YWJmOTIwL3RhYmxlOjMwOTcxNjlmZGQ5MDQ3ZDg4ODBjZmRlNjVkYzdiYTZkL3RhYmxlcmFuZ2U6MzA5NzE2OWZkZDkwNDdkODg4MGNmZGU2NWRjN2JhNmRfNC0zLTEtMS0w_f5fc3b36-332d-47ca-b476-7f05d665c51d">4</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ia4656c8d89cf4a84bdd02d8823c897bb_D20210401-20210630" decimals="-3" sign="-" name="cron:StockIssuedDuringPeriodValueWarrantsExercised" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzY2E5YmIwMTc5MjQ3NmZiYjIyNWU1ZDlkZWM4NjlmL3NlYzo5M2NhOWJiMDE3OTI0NzZmYmIyMjVlNWQ5ZGVjODY5Zl8yNS9mcmFnOjFhMTNiMjI5MDE5MTQ3NGNhMjc0YzQ2NGY4YWJmOTIwL3RhYmxlOjMwOTcxNjlmZGQ5MDQ3ZDg4ODBjZmRlNjVkYzdiYTZkL3RhYmxlcmFuZ2U6MzA5NzE2OWZkZDkwNDdkODg4MGNmZGU2NWRjN2JhNmRfNC03LTEtMS0w_e8b3c447-3cf8-4e7c-91a9-3e831ee8e78a">2</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i27f4e53b91ad4367b7f8d273eff27769_D20210401-20210630" decimals="-3" name="cron:StockIssuedDuringPeriodValueWarrantsExercised" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzY2E5YmIwMTc5MjQ3NmZiYjIyNWU1ZDlkZWM4NjlmL3NlYzo5M2NhOWJiMDE3OTI0NzZmYmIyMjVlNWQ5ZGVjODY5Zl8yNS9mcmFnOjFhMTNiMjI5MDE5MTQ3NGNhMjc0YzQ2NGY4YWJmOTIwL3RhYmxlOjMwOTcxNjlmZGQ5MDQ3ZDg4ODBjZmRlNjVkYzdiYTZkL3RhYmxlcmFuZ2U6MzA5NzE2OWZkZDkwNDdkODg4MGNmZGU2NWRjN2JhNmRfNC0xNS0xLTEtMA_824391a5-fe5d-4c4b-97e4-e5e6fb276b09">2</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Vesting of options</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia4656c8d89cf4a84bdd02d8823c897bb_D20210401-20210630" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsRequisiteServicePeriodRecognition" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzY2E5YmIwMTc5MjQ3NmZiYjIyNWU1ZDlkZWM4NjlmL3NlYzo5M2NhOWJiMDE3OTI0NzZmYmIyMjVlNWQ5ZGVjODY5Zl8yNS9mcmFnOjFhMTNiMjI5MDE5MTQ3NGNhMjc0YzQ2NGY4YWJmOTIwL3RhYmxlOjMwOTcxNjlmZGQ5MDQ3ZDg4ODBjZmRlNjVkYzdiYTZkL3RhYmxlcmFuZ2U6MzA5NzE2OWZkZDkwNDdkODg4MGNmZGU2NWRjN2JhNmRfNS03LTEtMS0w_5541c564-1550-4ea2-8560-080fa8dd255b">1,864</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i27f4e53b91ad4367b7f8d273eff27769_D20210401-20210630" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsRequisiteServicePeriodRecognition" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzY2E5YmIwMTc5MjQ3NmZiYjIyNWU1ZDlkZWM4NjlmL3NlYzo5M2NhOWJiMDE3OTI0NzZmYmIyMjVlNWQ5ZGVjODY5Zl8yNS9mcmFnOjFhMTNiMjI5MDE5MTQ3NGNhMjc0YzQ2NGY4YWJmOTIwL3RhYmxlOjMwOTcxNjlmZGQ5MDQ3ZDg4ODBjZmRlNjVkYzdiYTZkL3RhYmxlcmFuZ2U6MzA5NzE2OWZkZDkwNDdkODg4MGNmZGU2NWRjN2JhNmRfNS0xNS0xLTEtMA_1c22b66d-30d5-4d73-a4bf-974c45c23b17">1,864</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Options exercised</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i932ec7c01594418eb95662a351e601a2_D20210401-20210630" decimals="INF" format="ixt:numdotdecimal" name="us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjkzY2E5YmIwMTc5MjQ3NmZiYjIyNWU1ZDlkZWM4NjlmL3NlYzo5M2NhOWJiMDE3OTI0NzZmYmIyMjVlNWQ5ZGVjODY5Zl8yNS9mcmFnOjFhMTNiMjI5MDE5MTQ3NGNhMjc0YzQ2NGY4YWJmOTIwL3RhYmxlOjMwOTcxNjlmZGQ5MDQ3ZDg4ODBjZmRlNjVkYzdiYTZkL3RhYmxlcmFuZ2U6MzA5NzE2OWZkZDkwNDdkODg4MGNmZGU2NWRjN2JhNmRfNi0xLTEtMS0w_6cb2bda6-38ad-4110-9331-1a8ab6746fad">80,603</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i932ec7c01594418eb95662a351e601a2_D20210401-20210630" decimals="-3" name="us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzY2E5YmIwMTc5MjQ3NmZiYjIyNWU1ZDlkZWM4NjlmL3NlYzo5M2NhOWJiMDE3OTI0NzZmYmIyMjVlNWQ5ZGVjODY5Zl8yNS9mcmFnOjFhMTNiMjI5MDE5MTQ3NGNhMjc0YzQ2NGY4YWJmOTIwL3RhYmxlOjMwOTcxNjlmZGQ5MDQ3ZDg4ODBjZmRlNjVkYzdiYTZkL3RhYmxlcmFuZ2U6MzA5NzE2OWZkZDkwNDdkODg4MGNmZGU2NWRjN2JhNmRfNi0zLTEtMS0w_acf75c72-2690-4763-ad8d-d5f593261362">102</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ia4656c8d89cf4a84bdd02d8823c897bb_D20210401-20210630" decimals="-3" sign="-" name="us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzY2E5YmIwMTc5MjQ3NmZiYjIyNWU1ZDlkZWM4NjlmL3NlYzo5M2NhOWJiMDE3OTI0NzZmYmIyMjVlNWQ5ZGVjODY5Zl8yNS9mcmFnOjFhMTNiMjI5MDE5MTQ3NGNhMjc0YzQ2NGY4YWJmOTIwL3RhYmxlOjMwOTcxNjlmZGQ5MDQ3ZDg4ODBjZmRlNjVkYzdiYTZkL3RhYmxlcmFuZ2U6MzA5NzE2OWZkZDkwNDdkODg4MGNmZGU2NWRjN2JhNmRfNi03LTEtMS0w_21ee930e-297c-4b97-9b6d-ea80a16d7933">102</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i27f4e53b91ad4367b7f8d273eff27769_D20210401-20210630" decimals="-3" format="ixt:zerodash" name="us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzY2E5YmIwMTc5MjQ3NmZiYjIyNWU1ZDlkZWM4NjlmL3NlYzo5M2NhOWJiMDE3OTI0NzZmYmIyMjVlNWQ5ZGVjODY5Zl8yNS9mcmFnOjFhMTNiMjI5MDE5MTQ3NGNhMjc0YzQ2NGY4YWJmOTIwL3RhYmxlOjMwOTcxNjlmZGQ5MDQ3ZDg4ODBjZmRlNjVkYzdiYTZkL3RhYmxlcmFuZ2U6MzA5NzE2OWZkZDkwNDdkODg4MGNmZGU2NWRjN2JhNmRfNi0xNS0xLTEtMA_a9cd3230-57df-4b2d-8312-0a8d9ef505c7">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Restricted share units settled</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i932ec7c01594418eb95662a351e601a2_D20210401-20210630" decimals="INF" format="ixt:numdotdecimal" name="us-gaap:StockIssuedDuringPeriodSharesRestrictedStockAwardNetOfForfeitures" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjkzY2E5YmIwMTc5MjQ3NmZiYjIyNWU1ZDlkZWM4NjlmL3NlYzo5M2NhOWJiMDE3OTI0NzZmYmIyMjVlNWQ5ZGVjODY5Zl8yNS9mcmFnOjFhMTNiMjI5MDE5MTQ3NGNhMjc0YzQ2NGY4YWJmOTIwL3RhYmxlOjMwOTcxNjlmZGQ5MDQ3ZDg4ODBjZmRlNjVkYzdiYTZkL3RhYmxlcmFuZ2U6MzA5NzE2OWZkZDkwNDdkODg4MGNmZGU2NWRjN2JhNmRfNy0xLTEtMS0w_b8427ac6-14a5-44ab-95a3-32756b43feb2">58,354</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i932ec7c01594418eb95662a351e601a2_D20210401-20210630" decimals="-3" name="us-gaap:StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzY2E5YmIwMTc5MjQ3NmZiYjIyNWU1ZDlkZWM4NjlmL3NlYzo5M2NhOWJiMDE3OTI0NzZmYmIyMjVlNWQ5ZGVjODY5Zl8yNS9mcmFnOjFhMTNiMjI5MDE5MTQ3NGNhMjc0YzQ2NGY4YWJmOTIwL3RhYmxlOjMwOTcxNjlmZGQ5MDQ3ZDg4ODBjZmRlNjVkYzdiYTZkL3RhYmxlcmFuZ2U6MzA5NzE2OWZkZDkwNDdkODg4MGNmZGU2NWRjN2JhNmRfNy0zLTEtMS0w_b72e8b67-b335-472e-b6fb-4ccf6117adf8">345</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ia4656c8d89cf4a84bdd02d8823c897bb_D20210401-20210630" decimals="-3" sign="-" name="us-gaap:StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzY2E5YmIwMTc5MjQ3NmZiYjIyNWU1ZDlkZWM4NjlmL3NlYzo5M2NhOWJiMDE3OTI0NzZmYmIyMjVlNWQ5ZGVjODY5Zl8yNS9mcmFnOjFhMTNiMjI5MDE5MTQ3NGNhMjc0YzQ2NGY4YWJmOTIwL3RhYmxlOjMwOTcxNjlmZGQ5MDQ3ZDg4ODBjZmRlNjVkYzdiYTZkL3RhYmxlcmFuZ2U6MzA5NzE2OWZkZDkwNDdkODg4MGNmZGU2NWRjN2JhNmRfNy03LTEtMS0w_289ae77a-5963-4cf7-8709-329ddf6dd061">345</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i27f4e53b91ad4367b7f8d273eff27769_D20210401-20210630" decimals="-3" format="ixt:zerodash" name="us-gaap:StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzY2E5YmIwMTc5MjQ3NmZiYjIyNWU1ZDlkZWM4NjlmL3NlYzo5M2NhOWJiMDE3OTI0NzZmYmIyMjVlNWQ5ZGVjODY5Zl8yNS9mcmFnOjFhMTNiMjI5MDE5MTQ3NGNhMjc0YzQ2NGY4YWJmOTIwL3RhYmxlOjMwOTcxNjlmZGQ5MDQ3ZDg4ODBjZmRlNjVkYzdiYTZkL3RhYmxlcmFuZ2U6MzA5NzE2OWZkZDkwNDdkODg4MGNmZGU2NWRjN2JhNmRfNy0xNS0xLTEtMA_86e26c03-5c81-4609-814d-651728dc7be4">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Withholding taxes paid on share-based awards</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ia4656c8d89cf4a84bdd02d8823c897bb_D20210401-20210630" decimals="-3" name="us-gaap:AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzY2E5YmIwMTc5MjQ3NmZiYjIyNWU1ZDlkZWM4NjlmL3NlYzo5M2NhOWJiMDE3OTI0NzZmYmIyMjVlNWQ5ZGVjODY5Zl8yNS9mcmFnOjFhMTNiMjI5MDE5MTQ3NGNhMjc0YzQ2NGY4YWJmOTIwL3RhYmxlOjMwOTcxNjlmZGQ5MDQ3ZDg4ODBjZmRlNjVkYzdiYTZkL3RhYmxlcmFuZ2U6MzA5NzE2OWZkZDkwNDdkODg4MGNmZGU2NWRjN2JhNmRfOC03LTEtMS0xMjc3Ng_cfaf04da-0783-48ec-bfe8-2a3131fba781">183</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i9a1c715fbcf44b979e7e0fcb5928d719_D20210401-20210630" decimals="-3" name="us-gaap:AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzY2E5YmIwMTc5MjQ3NmZiYjIyNWU1ZDlkZWM4NjlmL3NlYzo5M2NhOWJiMDE3OTI0NzZmYmIyMjVlNWQ5ZGVjODY5Zl8yNS9mcmFnOjFhMTNiMjI5MDE5MTQ3NGNhMjc0YzQ2NGY4YWJmOTIwL3RhYmxlOjMwOTcxNjlmZGQ5MDQ3ZDg4ODBjZmRlNjVkYzdiYTZkL3RhYmxlcmFuZ2U6MzA5NzE2OWZkZDkwNDdkODg4MGNmZGU2NWRjN2JhNmRfOC05LTEtMS0xMjc3Ng_7d7174e7-a2ad-410b-a0d6-9b451b99f0d4">63</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i27f4e53b91ad4367b7f8d273eff27769_D20210401-20210630" decimals="-3" name="us-gaap:AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzY2E5YmIwMTc5MjQ3NmZiYjIyNWU1ZDlkZWM4NjlmL3NlYzo5M2NhOWJiMDE3OTI0NzZmYmIyMjVlNWQ5ZGVjODY5Zl8yNS9mcmFnOjFhMTNiMjI5MDE5MTQ3NGNhMjc0YzQ2NGY4YWJmOTIwL3RhYmxlOjMwOTcxNjlmZGQ5MDQ3ZDg4ODBjZmRlNjVkYzdiYTZkL3RhYmxlcmFuZ2U6MzA5NzE2OWZkZDkwNDdkODg4MGNmZGU2NWRjN2JhNmRfOC0xNS0xLTEtMTI3NzY_eef71bea-e54b-453f-8c42-9f8fb69676b6">246</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Vesting of restricted share units</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia4656c8d89cf4a84bdd02d8823c897bb_D20210401-20210630" decimals="-3" name="us-gaap:AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationRestrictedStockUnitsRequisiteServicePeriodRecognition" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzY2E5YmIwMTc5MjQ3NmZiYjIyNWU1ZDlkZWM4NjlmL3NlYzo5M2NhOWJiMDE3OTI0NzZmYmIyMjVlNWQ5ZGVjODY5Zl8yNS9mcmFnOjFhMTNiMjI5MDE5MTQ3NGNhMjc0YzQ2NGY4YWJmOTIwL3RhYmxlOjMwOTcxNjlmZGQ5MDQ3ZDg4ODBjZmRlNjVkYzdiYTZkL3RhYmxlcmFuZ2U6MzA5NzE2OWZkZDkwNDdkODg4MGNmZGU2NWRjN2JhNmRfOC03LTEtMS0w_3a2a96c6-733d-4270-8ab6-868843f8245b">701</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i27f4e53b91ad4367b7f8d273eff27769_D20210401-20210630" decimals="-3" name="us-gaap:AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationRestrictedStockUnitsRequisiteServicePeriodRecognition" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzY2E5YmIwMTc5MjQ3NmZiYjIyNWU1ZDlkZWM4NjlmL3NlYzo5M2NhOWJiMDE3OTI0NzZmYmIyMjVlNWQ5ZGVjODY5Zl8yNS9mcmFnOjFhMTNiMjI5MDE5MTQ3NGNhMjc0YzQ2NGY4YWJmOTIwL3RhYmxlOjMwOTcxNjlmZGQ5MDQ3ZDg4ODBjZmRlNjVkYzdiYTZkL3RhYmxlcmFuZ2U6MzA5NzE2OWZkZDkwNDdkODg4MGNmZGU2NWRjN2JhNmRfOC0xNS0xLTEtMA_3b6ed334-404e-432b-ba60-4d41085a1458">701</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Vesting of common shares issued in connection with the use of certain publicity rights in brand development</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i932ec7c01594418eb95662a351e601a2_D20210401-20210630" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationOtherLongtermIncentivePlansRequisiteServicePeriodRecognition" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzY2E5YmIwMTc5MjQ3NmZiYjIyNWU1ZDlkZWM4NjlmL3NlYzo5M2NhOWJiMDE3OTI0NzZmYmIyMjVlNWQ5ZGVjODY5Zl8yNS9mcmFnOjFhMTNiMjI5MDE5MTQ3NGNhMjc0YzQ2NGY4YWJmOTIwL3RhYmxlOjMwOTcxNjlmZGQ5MDQ3ZDg4ODBjZmRlNjVkYzdiYTZkL3RhYmxlcmFuZ2U6MzA5NzE2OWZkZDkwNDdkODg4MGNmZGU2NWRjN2JhNmRfOS0zLTEtMS0w_9c064a72-6019-485e-91ca-5d4e4f683b56">2,000</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ia4656c8d89cf4a84bdd02d8823c897bb_D20210401-20210630" decimals="-3" sign="-" format="ixt:numdotdecimal" name="us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationOtherLongtermIncentivePlansRequisiteServicePeriodRecognition" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzY2E5YmIwMTc5MjQ3NmZiYjIyNWU1ZDlkZWM4NjlmL3NlYzo5M2NhOWJiMDE3OTI0NzZmYmIyMjVlNWQ5ZGVjODY5Zl8yNS9mcmFnOjFhMTNiMjI5MDE5MTQ3NGNhMjc0YzQ2NGY4YWJmOTIwL3RhYmxlOjMwOTcxNjlmZGQ5MDQ3ZDg4ODBjZmRlNjVkYzdiYTZkL3RhYmxlcmFuZ2U6MzA5NzE2OWZkZDkwNDdkODg4MGNmZGU2NWRjN2JhNmRfOS03LTEtMS0w_a7b6cca8-e0a5-44cf-8962-13a5132f7396">1,655</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i27f4e53b91ad4367b7f8d273eff27769_D20210401-20210630" decimals="-3" name="us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationOtherLongtermIncentivePlansRequisiteServicePeriodRecognition" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzY2E5YmIwMTc5MjQ3NmZiYjIyNWU1ZDlkZWM4NjlmL3NlYzo5M2NhOWJiMDE3OTI0NzZmYmIyMjVlNWQ5ZGVjODY5Zl8yNS9mcmFnOjFhMTNiMjI5MDE5MTQ3NGNhMjc0YzQ2NGY4YWJmOTIwL3RhYmxlOjMwOTcxNjlmZGQ5MDQ3ZDg4ODBjZmRlNjVkYzdiYTZkL3RhYmxlcmFuZ2U6MzA5NzE2OWZkZDkwNDdkODg4MGNmZGU2NWRjN2JhNmRfOS0xNS0xLTEtMA_fcc2aa2c-9574-422d-89cf-00daa4441111">345</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Top-up rights out-of-period adjustment</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i932ec7c01594418eb95662a351e601a2_D20210401-20210630" decimals="-3" sign="-" format="ixt:numdotdecimal" name="cron:StockholdersEquityOutOfPeriodAdjustment" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzY2E5YmIwMTc5MjQ3NmZiYjIyNWU1ZDlkZWM4NjlmL3NlYzo5M2NhOWJiMDE3OTI0NzZmYmIyMjVlNWQ5ZGVjODY5Zl8yNS9mcmFnOjFhMTNiMjI5MDE5MTQ3NGNhMjc0YzQ2NGY4YWJmOTIwL3RhYmxlOjMwOTcxNjlmZGQ5MDQ3ZDg4ODBjZmRlNjVkYzdiYTZkL3RhYmxlcmFuZ2U6MzA5NzE2OWZkZDkwNDdkODg4MGNmZGU2NWRjN2JhNmRfMTAtMy0xLTEtMA_51cbd9c5-c50e-4d28-ac8f-ccaa07c0cc5b">14,505</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9a1c715fbcf44b979e7e0fcb5928d719_D20210401-20210630" decimals="-3" format="ixt:numdotdecimal" name="cron:StockholdersEquityOutOfPeriodAdjustment" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzY2E5YmIwMTc5MjQ3NmZiYjIyNWU1ZDlkZWM4NjlmL3NlYzo5M2NhOWJiMDE3OTI0NzZmYmIyMjVlNWQ5ZGVjODY5Zl8yNS9mcmFnOjFhMTNiMjI5MDE5MTQ3NGNhMjc0YzQ2NGY4YWJmOTIwL3RhYmxlOjMwOTcxNjlmZGQ5MDQ3ZDg4ODBjZmRlNjVkYzdiYTZkL3RhYmxlcmFuZ2U6MzA5NzE2OWZkZDkwNDdkODg4MGNmZGU2NWRjN2JhNmRfMTAtOS0xLTEtMA_459fd270-15a9-4318-a7ba-526ea33401ef">3,227</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i27f4e53b91ad4367b7f8d273eff27769_D20210401-20210630" decimals="-3" sign="-" format="ixt:numdotdecimal" name="cron:StockholdersEquityOutOfPeriodAdjustment" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzY2E5YmIwMTc5MjQ3NmZiYjIyNWU1ZDlkZWM4NjlmL3NlYzo5M2NhOWJiMDE3OTI0NzZmYmIyMjVlNWQ5ZGVjODY5Zl8yNS9mcmFnOjFhMTNiMjI5MDE5MTQ3NGNhMjc0YzQ2NGY4YWJmOTIwL3RhYmxlOjMwOTcxNjlmZGQ5MDQ3ZDg4ODBjZmRlNjVkYzdiYTZkL3RhYmxlcmFuZ2U6MzA5NzE2OWZkZDkwNDdkODg4MGNmZGU2NWRjN2JhNmRfMTAtMTUtMS0xLTA_0d5839c6-d741-4ed8-9936-7babad2644af">11,278</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net income (loss)</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9a1c715fbcf44b979e7e0fcb5928d719_D20210401-20210630" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:ProfitLoss" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzY2E5YmIwMTc5MjQ3NmZiYjIyNWU1ZDlkZWM4NjlmL3NlYzo5M2NhOWJiMDE3OTI0NzZmYmIyMjVlNWQ5ZGVjODY5Zl8yNS9mcmFnOjFhMTNiMjI5MDE5MTQ3NGNhMjc0YzQ2NGY4YWJmOTIwL3RhYmxlOjMwOTcxNjlmZGQ5MDQ3ZDg4ODBjZmRlNjVkYzdiYTZkL3RhYmxlcmFuZ2U6MzA5NzE2OWZkZDkwNDdkODg4MGNmZGU2NWRjN2JhNmRfMTEtOS0xLTEtMA_f46b1646-4be2-4dbe-8810-5f5c56ee6286">57,054</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i8e7f3ff52d71479293ec038396352775_D20210401-20210630" decimals="-3" sign="-" name="us-gaap:ProfitLoss" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzY2E5YmIwMTc5MjQ3NmZiYjIyNWU1ZDlkZWM4NjlmL3NlYzo5M2NhOWJiMDE3OTI0NzZmYmIyMjVlNWQ5ZGVjODY5Zl8yNS9mcmFnOjFhMTNiMjI5MDE5MTQ3NGNhMjc0YzQ2NGY4YWJmOTIwL3RhYmxlOjMwOTcxNjlmZGQ5MDQ3ZDg4ODBjZmRlNjVkYzdiYTZkL3RhYmxlcmFuZ2U6MzA5NzE2OWZkZDkwNDdkODg4MGNmZGU2NWRjN2JhNmRfMTEtMTMtMS0xLTA_e32d488c-2541-4b4a-9503-0eaa7b8abf88">279</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i27f4e53b91ad4367b7f8d273eff27769_D20210401-20210630" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:ProfitLoss" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzY2E5YmIwMTc5MjQ3NmZiYjIyNWU1ZDlkZWM4NjlmL3NlYzo5M2NhOWJiMDE3OTI0NzZmYmIyMjVlNWQ5ZGVjODY5Zl8yNS9mcmFnOjFhMTNiMjI5MDE5MTQ3NGNhMjc0YzQ2NGY4YWJmOTIwL3RhYmxlOjMwOTcxNjlmZGQ5MDQ3ZDg4ODBjZmRlNjVkYzdiYTZkL3RhYmxlcmFuZ2U6MzA5NzE2OWZkZDkwNDdkODg4MGNmZGU2NWRjN2JhNmRfMTEtMTUtMS0xLTA_d87e50d2-3984-4f9a-b78e-3fb6a3cee14e">56,775</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Foreign exchange gain (loss) on translation</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4e1c8fe7ad9241eaa0d77b74d41be015_D20210401-20210630" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzY2E5YmIwMTc5MjQ3NmZiYjIyNWU1ZDlkZWM4NjlmL3NlYzo5M2NhOWJiMDE3OTI0NzZmYmIyMjVlNWQ5ZGVjODY5Zl8yNS9mcmFnOjFhMTNiMjI5MDE5MTQ3NGNhMjc0YzQ2NGY4YWJmOTIwL3RhYmxlOjMwOTcxNjlmZGQ5MDQ3ZDg4ODBjZmRlNjVkYzdiYTZkL3RhYmxlcmFuZ2U6MzA5NzE2OWZkZDkwNDdkODg4MGNmZGU2NWRjN2JhNmRfMTItMTEtMS0xLTA_76a2af55-f911-40f7-a175-a310f9cef71f">13,585</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i8e7f3ff52d71479293ec038396352775_D20210401-20210630" decimals="-3" sign="-" name="us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzY2E5YmIwMTc5MjQ3NmZiYjIyNWU1ZDlkZWM4NjlmL3NlYzo5M2NhOWJiMDE3OTI0NzZmYmIyMjVlNWQ5ZGVjODY5Zl8yNS9mcmFnOjFhMTNiMjI5MDE5MTQ3NGNhMjc0YzQ2NGY4YWJmOTIwL3RhYmxlOjMwOTcxNjlmZGQ5MDQ3ZDg4ODBjZmRlNjVkYzdiYTZkL3RhYmxlcmFuZ2U6MzA5NzE2OWZkZDkwNDdkODg4MGNmZGU2NWRjN2JhNmRfMTItMTMtMS0xLTA_7b2dafde-753f-40c4-ae03-a3e1b039e6fc">115</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i27f4e53b91ad4367b7f8d273eff27769_D20210401-20210630" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzY2E5YmIwMTc5MjQ3NmZiYjIyNWU1ZDlkZWM4NjlmL3NlYzo5M2NhOWJiMDE3OTI0NzZmYmIyMjVlNWQ5ZGVjODY5Zl8yNS9mcmFnOjFhMTNiMjI5MDE5MTQ3NGNhMjc0YzQ2NGY4YWJmOTIwL3RhYmxlOjMwOTcxNjlmZGQ5MDQ3ZDg4ODBjZmRlNjVkYzdiYTZkL3RhYmxlcmFuZ2U6MzA5NzE2OWZkZDkwNDdkODg4MGNmZGU2NWRjN2JhNmRfMTItMTUtMS0xLTA_98e4f5be-1c6b-43b0-9581-7b0f8ce6c83b">13,470</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance at June 30, 2021</span></td><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i1d565c32dabc40c08d36232dec1a7779_I20210630" decimals="INF" format="ixt:numdotdecimal" name="us-gaap:CommonStockSharesOutstanding" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjkzY2E5YmIwMTc5MjQ3NmZiYjIyNWU1ZDlkZWM4NjlmL3NlYzo5M2NhOWJiMDE3OTI0NzZmYmIyMjVlNWQ5ZGVjODY5Zl8yNS9mcmFnOjFhMTNiMjI5MDE5MTQ3NGNhMjc0YzQ2NGY4YWJmOTIwL3RhYmxlOjMwOTcxNjlmZGQ5MDQ3ZDg4ODBjZmRlNjVkYzdiYTZkL3RhYmxlcmFuZ2U6MzA5NzE2OWZkZDkwNDdkODg4MGNmZGU2NWRjN2JhNmRfMTMtMS0xLTEtMA_2b83f408-c323-4a96-8c24-2b5333845643">371,805,547</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1d565c32dabc40c08d36232dec1a7779_I20210630" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzY2E5YmIwMTc5MjQ3NmZiYjIyNWU1ZDlkZWM4NjlmL3NlYzo5M2NhOWJiMDE3OTI0NzZmYmIyMjVlNWQ5ZGVjODY5Zl8yNS9mcmFnOjFhMTNiMjI5MDE5MTQ3NGNhMjc0YzQ2NGY4YWJmOTIwL3RhYmxlOjMwOTcxNjlmZGQ5MDQ3ZDg4ODBjZmRlNjVkYzdiYTZkL3RhYmxlcmFuZ2U6MzA5NzE2OWZkZDkwNDdkODg4MGNmZGU2NWRjN2JhNmRfMTMtMy0xLTEtMA_cd0a10ea-b8e9-47f6-82a3-54d89cf345cf">572,858</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ibbfd3d5a9feb460a8f0fe21cf2539d79_I20210630" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzY2E5YmIwMTc5MjQ3NmZiYjIyNWU1ZDlkZWM4NjlmL3NlYzo5M2NhOWJiMDE3OTI0NzZmYmIyMjVlNWQ5ZGVjODY5Zl8yNS9mcmFnOjFhMTNiMjI5MDE5MTQ3NGNhMjc0YzQ2NGY4YWJmOTIwL3RhYmxlOjMwOTcxNjlmZGQ5MDQ3ZDg4ODBjZmRlNjVkYzdiYTZkL3RhYmxlcmFuZ2U6MzA5NzE2OWZkZDkwNDdkODg4MGNmZGU2NWRjN2JhNmRfMTMtNy0xLTEtMA_6b9c2460-760a-4d65-8fca-51f40a0592c0">32,368</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5b5acb4a63db4a419bb0b3e0c4a24492_I20210630" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzY2E5YmIwMTc5MjQ3NmZiYjIyNWU1ZDlkZWM4NjlmL3NlYzo5M2NhOWJiMDE3OTI0NzZmYmIyMjVlNWQ5ZGVjODY5Zl8yNS9mcmFnOjFhMTNiMjI5MDE5MTQ3NGNhMjc0YzQ2NGY4YWJmOTIwL3RhYmxlOjMwOTcxNjlmZGQ5MDQ3ZDg4ODBjZmRlNjVkYzdiYTZkL3RhYmxlcmFuZ2U6MzA5NzE2OWZkZDkwNDdkODg4MGNmZGU2NWRjN2JhNmRfMTMtOS0xLTEtMA_445449a8-f745-41a2-9514-ea9141abb25f">955,721</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7d990708cda34586a3e37a53dd59fb03_I20210630" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzY2E5YmIwMTc5MjQ3NmZiYjIyNWU1ZDlkZWM4NjlmL3NlYzo5M2NhOWJiMDE3OTI0NzZmYmIyMjVlNWQ5ZGVjODY5Zl8yNS9mcmFnOjFhMTNiMjI5MDE5MTQ3NGNhMjc0YzQ2NGY4YWJmOTIwL3RhYmxlOjMwOTcxNjlmZGQ5MDQ3ZDg4ODBjZmRlNjVkYzdiYTZkL3RhYmxlcmFuZ2U6MzA5NzE2OWZkZDkwNDdkODg4MGNmZGU2NWRjN2JhNmRfMTMtMTEtMS0xLTA_3f7236e0-fda0-4dc3-b81a-999b6b17db2e">71,729</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i64458da0ec424fd8a6faf87d69636ecd_I20210630" decimals="-3" sign="-" format="ixt:numdotdecimal" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzY2E5YmIwMTc5MjQ3NmZiYjIyNWU1ZDlkZWM4NjlmL3NlYzo5M2NhOWJiMDE3OTI0NzZmYmIyMjVlNWQ5ZGVjODY5Zl8yNS9mcmFnOjFhMTNiMjI5MDE5MTQ3NGNhMjc0YzQ2NGY4YWJmOTIwL3RhYmxlOjMwOTcxNjlmZGQ5MDQ3ZDg4ODBjZmRlNjVkYzdiYTZkL3RhYmxlcmFuZ2U6MzA5NzE2OWZkZDkwNDdkODg4MGNmZGU2NWRjN2JhNmRfMTMtMTMtMS0xLTA_251a93f1-b505-4980-8b3b-8cfe7cdb6a6c">2,764</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i225f85e38faa4bbdb4de1d8b9cf369bb_I20210630" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzY2E5YmIwMTc5MjQ3NmZiYjIyNWU1ZDlkZWM4NjlmL3NlYzo5M2NhOWJiMDE3OTI0NzZmYmIyMjVlNWQ5ZGVjODY5Zl8yNS9mcmFnOjFhMTNiMjI5MDE5MTQ3NGNhMjc0YzQ2NGY4YWJmOTIwL3RhYmxlOjMwOTcxNjlmZGQ5MDQ3ZDg4ODBjZmRlNjVkYzdiYTZkL3RhYmxlcmFuZ2U6MzA5NzE2OWZkZDkwNDdkODg4MGNmZGU2NWRjN2JhNmRfMTMtMTUtMS0xLTA_692ae098-91c0-41d2-9bd5-d2c5628f596d">1,629,912</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:31.295%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:6.920%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.945%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:6.295%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.945%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td style="width:1.0%"></td><td style="width:7.545%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.945%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:6.504%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.945%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.629%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.945%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.233%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.945%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.909%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Number of shares</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Share capital</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Additional paid-in capital</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Retained earnings </span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Accumulated other comprehensive income (loss)</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Non-controlling interests</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Total shareholders&#8217; equity</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance at April 1, 2020</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="id078e2f741bd40b185fe15fe9cf71aa0_I20200331" decimals="INF" format="ixt:numdotdecimal" name="us-gaap:CommonStockSharesOutstanding" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjkzY2E5YmIwMTc5MjQ3NmZiYjIyNWU1ZDlkZWM4NjlmL3NlYzo5M2NhOWJiMDE3OTI0NzZmYmIyMjVlNWQ5ZGVjODY5Zl8yNS9mcmFnOjFhMTNiMjI5MDE5MTQ3NGNhMjc0YzQ2NGY4YWJmOTIwL3RhYmxlOjI0YWJkMTlmMDhiYTRlM2E4NzJmMjVlOGU0MmQ1ODQyL3RhYmxlcmFuZ2U6MjRhYmQxOWYwOGJhNGUzYTg3MmYyNWU4ZTQyZDU4NDJfMTYtMS0xLTEtNzgzOA_f7268de6-9a82-4f30-8eb6-391bfa036f7f">348,817,472</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id078e2f741bd40b185fe15fe9cf71aa0_I20200331" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzY2E5YmIwMTc5MjQ3NmZiYjIyNWU1ZDlkZWM4NjlmL3NlYzo5M2NhOWJiMDE3OTI0NzZmYmIyMjVlNWQ5ZGVjODY5Zl8yNS9mcmFnOjFhMTNiMjI5MDE5MTQ3NGNhMjc0YzQ2NGY4YWJmOTIwL3RhYmxlOjI0YWJkMTlmMDhiYTRlM2E4NzJmMjVlOGU0MmQ1ODQyL3RhYmxlcmFuZ2U6MjRhYmQxOWYwOGJhNGUzYTg3MmYyNWU4ZTQyZDU4NDJfMTYtMy0xLTEtNzgzOA_22d73b20-3c3e-47f4-8e14-8885d24ba97b">563,165</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3168099a593240dc9af0efd91a744144_I20200331" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzY2E5YmIwMTc5MjQ3NmZiYjIyNWU1ZDlkZWM4NjlmL3NlYzo5M2NhOWJiMDE3OTI0NzZmYmIyMjVlNWQ5ZGVjODY5Zl8yNS9mcmFnOjFhMTNiMjI5MDE5MTQ3NGNhMjc0YzQ2NGY4YWJmOTIwL3RhYmxlOjI0YWJkMTlmMDhiYTRlM2E4NzJmMjVlOGU0MmQ1ODQyL3RhYmxlcmFuZ2U6MjRhYmQxOWYwOGJhNGUzYTg3MmYyNWU4ZTQyZDU4NDJfMTYtNy0xLTEtNzgzOA_af4103c9-b34a-43ae-b1ed-20154798050f">25,483</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6c7b98afcbdf46659d197205a453981e_I20200331" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzY2E5YmIwMTc5MjQ3NmZiYjIyNWU1ZDlkZWM4NjlmL3NlYzo5M2NhOWJiMDE3OTI0NzZmYmIyMjVlNWQ5ZGVjODY5Zl8yNS9mcmFnOjFhMTNiMjI5MDE5MTQ3NGNhMjc0YzQ2NGY4YWJmOTIwL3RhYmxlOjI0YWJkMTlmMDhiYTRlM2E4NzJmMjVlOGU0MmQ1ODQyL3RhYmxlcmFuZ2U6MjRhYmQxOWYwOGJhNGUzYTg3MmYyNWU4ZTQyZDU4NDJfMTYtOS0xLTEtNzgzOA_d8069d2d-1438-4db6-b2ed-8312224622a2">1,213,686</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i7f15d7e0c5e448758e421628b06b233f_I20200331" decimals="-3" sign="-" format="ixt:numdotdecimal" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzY2E5YmIwMTc5MjQ3NmZiYjIyNWU1ZDlkZWM4NjlmL3NlYzo5M2NhOWJiMDE3OTI0NzZmYmIyMjVlNWQ5ZGVjODY5Zl8yNS9mcmFnOjFhMTNiMjI5MDE5MTQ3NGNhMjc0YzQ2NGY4YWJmOTIwL3RhYmxlOjI0YWJkMTlmMDhiYTRlM2E4NzJmMjVlOGU0MmQ1ODQyL3RhYmxlcmFuZ2U6MjRhYmQxOWYwOGJhNGUzYTg3MmYyNWU4ZTQyZDU4NDJfMTYtMTEtMS0xLTc4Mzg_b4a3cba2-6801-47f5-9d9c-663f50d6b634">85,877</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i03a4fd9ba8c844bea0cc0519e18e1383_I20200331" decimals="-3" sign="-" format="ixt:numdotdecimal" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzY2E5YmIwMTc5MjQ3NmZiYjIyNWU1ZDlkZWM4NjlmL3NlYzo5M2NhOWJiMDE3OTI0NzZmYmIyMjVlNWQ5ZGVjODY5Zl8yNS9mcmFnOjFhMTNiMjI5MDE5MTQ3NGNhMjc0YzQ2NGY4YWJmOTIwL3RhYmxlOjI0YWJkMTlmMDhiYTRlM2E4NzJmMjVlOGU0MmQ1ODQyL3RhYmxlcmFuZ2U6MjRhYmQxOWYwOGJhNGUzYTg3MmYyNWU4ZTQyZDU4NDJfMTYtMTMtMS0xLTc4Mzg_bd66113e-3569-4676-a6b0-3497513b3721">1,189</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3c0f68bcd0b6498c90c48a6506a0b9e3_I20200331" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzY2E5YmIwMTc5MjQ3NmZiYjIyNWU1ZDlkZWM4NjlmL3NlYzo5M2NhOWJiMDE3OTI0NzZmYmIyMjVlNWQ5ZGVjODY5Zl8yNS9mcmFnOjFhMTNiMjI5MDE5MTQ3NGNhMjc0YzQ2NGY4YWJmOTIwL3RhYmxlOjI0YWJkMTlmMDhiYTRlM2E4NzJmMjVlOGU0MmQ1ODQyL3RhYmxlcmFuZ2U6MjRhYmQxOWYwOGJhNGUzYTg3MmYyNWU4ZTQyZDU4NDJfMTYtMTUtMS0xLTc4Mzg_f2fccfca-43fa-4b7e-88a7-f33f4922280c">1,715,268</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Vesting of options</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6d595f441a124fe6a1a07ecf8f23ee48_D20200401-20200630" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsRequisiteServicePeriodRecognition" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzY2E5YmIwMTc5MjQ3NmZiYjIyNWU1ZDlkZWM4NjlmL3NlYzo5M2NhOWJiMDE3OTI0NzZmYmIyMjVlNWQ5ZGVjODY5Zl8yNS9mcmFnOjFhMTNiMjI5MDE5MTQ3NGNhMjc0YzQ2NGY4YWJmOTIwL3RhYmxlOjI0YWJkMTlmMDhiYTRlM2E4NzJmMjVlOGU0MmQ1ODQyL3RhYmxlcmFuZ2U6MjRhYmQxOWYwOGJhNGUzYTg3MmYyNWU4ZTQyZDU4NDJfMjAtNy0xLTEtNzgzOA_40289d5d-8168-4fec-a3c7-1331031bfaee">1,770</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i39065c5daf934af885335c12f3cfa83f_D20200401-20200630" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsRequisiteServicePeriodRecognition" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzY2E5YmIwMTc5MjQ3NmZiYjIyNWU1ZDlkZWM4NjlmL3NlYzo5M2NhOWJiMDE3OTI0NzZmYmIyMjVlNWQ5ZGVjODY5Zl8yNS9mcmFnOjFhMTNiMjI5MDE5MTQ3NGNhMjc0YzQ2NGY4YWJmOTIwL3RhYmxlOjI0YWJkMTlmMDhiYTRlM2E4NzJmMjVlOGU0MmQ1ODQyL3RhYmxlcmFuZ2U6MjRhYmQxOWYwOGJhNGUzYTg3MmYyNWU4ZTQyZDU4NDJfMjAtMTUtMS0xLTc4Mzg_1b76f800-5269-4f6a-9ee2-3373bbb8ccf2">1,770</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Options exercised</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="ic52bfb3ca2d34600a199a8873b1c09c0_D20200401-20200630" decimals="INF" format="ixt:numdotdecimal" name="us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjkzY2E5YmIwMTc5MjQ3NmZiYjIyNWU1ZDlkZWM4NjlmL3NlYzo5M2NhOWJiMDE3OTI0NzZmYmIyMjVlNWQ5ZGVjODY5Zl8yNS9mcmFnOjFhMTNiMjI5MDE5MTQ3NGNhMjc0YzQ2NGY4YWJmOTIwL3RhYmxlOjI0YWJkMTlmMDhiYTRlM2E4NzJmMjVlOGU0MmQ1ODQyL3RhYmxlcmFuZ2U6MjRhYmQxOWYwOGJhNGUzYTg3MmYyNWU4ZTQyZDU4NDJfMjEtMS0xLTEtNzgzOA_6b4c76dd-db4a-430b-8141-1abc58e4a101">1,068,930</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic52bfb3ca2d34600a199a8873b1c09c0_D20200401-20200630" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzY2E5YmIwMTc5MjQ3NmZiYjIyNWU1ZDlkZWM4NjlmL3NlYzo5M2NhOWJiMDE3OTI0NzZmYmIyMjVlNWQ5ZGVjODY5Zl8yNS9mcmFnOjFhMTNiMjI5MDE5MTQ3NGNhMjc0YzQ2NGY4YWJmOTIwL3RhYmxlOjI0YWJkMTlmMDhiYTRlM2E4NzJmMjVlOGU0MmQ1ODQyL3RhYmxlcmFuZ2U6MjRhYmQxOWYwOGJhNGUzYTg3MmYyNWU4ZTQyZDU4NDJfMjEtMy0xLTEtNzgzOA_3ee9aa89-59ff-493c-85df-59a044c1de79">1,329</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i6d595f441a124fe6a1a07ecf8f23ee48_D20200401-20200630" decimals="-3" sign="-" format="ixt:numdotdecimal" name="us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzY2E5YmIwMTc5MjQ3NmZiYjIyNWU1ZDlkZWM4NjlmL3NlYzo5M2NhOWJiMDE3OTI0NzZmYmIyMjVlNWQ5ZGVjODY5Zl8yNS9mcmFnOjFhMTNiMjI5MDE5MTQ3NGNhMjc0YzQ2NGY4YWJmOTIwL3RhYmxlOjI0YWJkMTlmMDhiYTRlM2E4NzJmMjVlOGU0MmQ1ODQyL3RhYmxlcmFuZ2U6MjRhYmQxOWYwOGJhNGUzYTg3MmYyNWU4ZTQyZDU4NDJfMjEtNy0xLTEtNzgzOA_152716bc-f713-4e91-bbf8-0462b5c63b1d">1,328</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i39065c5daf934af885335c12f3cfa83f_D20200401-20200630" decimals="-3" name="us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzY2E5YmIwMTc5MjQ3NmZiYjIyNWU1ZDlkZWM4NjlmL3NlYzo5M2NhOWJiMDE3OTI0NzZmYmIyMjVlNWQ5ZGVjODY5Zl8yNS9mcmFnOjFhMTNiMjI5MDE5MTQ3NGNhMjc0YzQ2NGY4YWJmOTIwL3RhYmxlOjI0YWJkMTlmMDhiYTRlM2E4NzJmMjVlOGU0MmQ1ODQyL3RhYmxlcmFuZ2U6MjRhYmQxOWYwOGJhNGUzYTg3MmYyNWU4ZTQyZDU4NDJfMjEtMTUtMS0xLTc4Mzg_4302da0c-7986-42d6-a82e-5e9f4062ef39">1</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Vesting of restricted share units</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6d595f441a124fe6a1a07ecf8f23ee48_D20200401-20200630" decimals="-3" name="us-gaap:AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationRestrictedStockUnitsRequisiteServicePeriodRecognition" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzY2E5YmIwMTc5MjQ3NmZiYjIyNWU1ZDlkZWM4NjlmL3NlYzo5M2NhOWJiMDE3OTI0NzZmYmIyMjVlNWQ5ZGVjODY5Zl8yNS9mcmFnOjFhMTNiMjI5MDE5MTQ3NGNhMjc0YzQ2NGY4YWJmOTIwL3RhYmxlOjI0YWJkMTlmMDhiYTRlM2E4NzJmMjVlOGU0MmQ1ODQyL3RhYmxlcmFuZ2U6MjRhYmQxOWYwOGJhNGUzYTg3MmYyNWU4ZTQyZDU4NDJfMjItNy0xLTEtNzgzOA_4c963c6f-be8e-45f2-8333-1927b3865939">776</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i39065c5daf934af885335c12f3cfa83f_D20200401-20200630" decimals="-3" name="us-gaap:AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationRestrictedStockUnitsRequisiteServicePeriodRecognition" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzY2E5YmIwMTc5MjQ3NmZiYjIyNWU1ZDlkZWM4NjlmL3NlYzo5M2NhOWJiMDE3OTI0NzZmYmIyMjVlNWQ5ZGVjODY5Zl8yNS9mcmFnOjFhMTNiMjI5MDE5MTQ3NGNhMjc0YzQ2NGY4YWJmOTIwL3RhYmxlOjI0YWJkMTlmMDhiYTRlM2E4NzJmMjVlOGU0MmQ1ODQyL3RhYmxlcmFuZ2U6MjRhYmQxOWYwOGJhNGUzYTg3MmYyNWU4ZTQyZDU4NDJfMjItMTUtMS0xLTc4Mzg_c54c8524-a65f-4af6-a9ef-c33b96b07fca">776</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Vesting of common shares issued in connection with the use of certain publicity rights in brand development</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6d595f441a124fe6a1a07ecf8f23ee48_D20200401-20200630" decimals="-3" name="us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationOtherLongtermIncentivePlansRequisiteServicePeriodRecognition" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzY2E5YmIwMTc5MjQ3NmZiYjIyNWU1ZDlkZWM4NjlmL3NlYzo5M2NhOWJiMDE3OTI0NzZmYmIyMjVlNWQ5ZGVjODY5Zl8yNS9mcmFnOjFhMTNiMjI5MDE5MTQ3NGNhMjc0YzQ2NGY4YWJmOTIwL3RhYmxlOjI0YWJkMTlmMDhiYTRlM2E4NzJmMjVlOGU0MmQ1ODQyL3RhYmxlcmFuZ2U6MjRhYmQxOWYwOGJhNGUzYTg3MmYyNWU4ZTQyZDU4NDJfMjMtNy0xLTEtNzgzOA_80543d5b-86cc-4223-b4b3-936be68054bb">345</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i39065c5daf934af885335c12f3cfa83f_D20200401-20200630" decimals="-3" name="us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationOtherLongtermIncentivePlansRequisiteServicePeriodRecognition" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzY2E5YmIwMTc5MjQ3NmZiYjIyNWU1ZDlkZWM4NjlmL3NlYzo5M2NhOWJiMDE3OTI0NzZmYmIyMjVlNWQ5ZGVjODY5Zl8yNS9mcmFnOjFhMTNiMjI5MDE5MTQ3NGNhMjc0YzQ2NGY4YWJmOTIwL3RhYmxlOjI0YWJkMTlmMDhiYTRlM2E4NzJmMjVlOGU0MmQ1ODQyL3RhYmxlcmFuZ2U6MjRhYmQxOWYwOGJhNGUzYTg3MmYyNWU4ZTQyZDU4NDJfMjMtMTUtMS0xLTc4Mzg_4a0cbbe8-3050-4869-8d73-d4e3193b2442">345</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Top-up rights exercised</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic52bfb3ca2d34600a199a8873b1c09c0_D20200401-20200630" decimals="-3" name="cron:StockIssuedDuringPeriodValueTopupRightsExercised" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzY2E5YmIwMTc5MjQ3NmZiYjIyNWU1ZDlkZWM4NjlmL3NlYzo5M2NhOWJiMDE3OTI0NzZmYmIyMjVlNWQ5ZGVjODY5Zl8yNS9mcmFnOjFhMTNiMjI5MDE5MTQ3NGNhMjc0YzQ2NGY4YWJmOTIwL3RhYmxlOjI0YWJkMTlmMDhiYTRlM2E4NzJmMjVlOGU0MmQ1ODQyL3RhYmxlcmFuZ2U6MjRhYmQxOWYwOGJhNGUzYTg3MmYyNWU4ZTQyZDU4NDJfMjQtMy0xLTEtNzgzOA_fa1b0b52-716a-49d4-9986-922e42a12021">717</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i39065c5daf934af885335c12f3cfa83f_D20200401-20200630" decimals="-3" name="cron:StockIssuedDuringPeriodValueTopupRightsExercised" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzY2E5YmIwMTc5MjQ3NmZiYjIyNWU1ZDlkZWM4NjlmL3NlYzo5M2NhOWJiMDE3OTI0NzZmYmIyMjVlNWQ5ZGVjODY5Zl8yNS9mcmFnOjFhMTNiMjI5MDE5MTQ3NGNhMjc0YzQ2NGY4YWJmOTIwL3RhYmxlOjI0YWJkMTlmMDhiYTRlM2E4NzJmMjVlOGU0MmQ1ODQyL3RhYmxlcmFuZ2U6MjRhYmQxOWYwOGJhNGUzYTg3MmYyNWU4ZTQyZDU4NDJfMjQtMTUtMS0xLTc4Mzg_a6c8af97-7b3d-4525-aaeb-63977e0dd28a">717</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net loss</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ie91f1ea24b414f65af58207f3d177f44_D20200401-20200630" decimals="-3" sign="-" format="ixt:numdotdecimal" name="us-gaap:ProfitLoss" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzY2E5YmIwMTc5MjQ3NmZiYjIyNWU1ZDlkZWM4NjlmL3NlYzo5M2NhOWJiMDE3OTI0NzZmYmIyMjVlNWQ5ZGVjODY5Zl8yNS9mcmFnOjFhMTNiMjI5MDE5MTQ3NGNhMjc0YzQ2NGY4YWJmOTIwL3RhYmxlOjI0YWJkMTlmMDhiYTRlM2E4NzJmMjVlOGU0MmQ1ODQyL3RhYmxlcmFuZ2U6MjRhYmQxOWYwOGJhNGUzYTg3MmYyNWU4ZTQyZDU4NDJfMjUtOS0xLTEtNzgzOA_5d2f20b6-fd1c-418c-8dc2-64906dc2a9a5">106,977</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i3bd28b951b5141a3ac4946bb9c8d4486_D20200401-20200630" decimals="-3" sign="-" name="us-gaap:ProfitLoss" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzY2E5YmIwMTc5MjQ3NmZiYjIyNWU1ZDlkZWM4NjlmL3NlYzo5M2NhOWJiMDE3OTI0NzZmYmIyMjVlNWQ5ZGVjODY5Zl8yNS9mcmFnOjFhMTNiMjI5MDE5MTQ3NGNhMjc0YzQ2NGY4YWJmOTIwL3RhYmxlOjI0YWJkMTlmMDhiYTRlM2E4NzJmMjVlOGU0MmQ1ODQyL3RhYmxlcmFuZ2U6MjRhYmQxOWYwOGJhNGUzYTg3MmYyNWU4ZTQyZDU4NDJfMjUtMTMtMS0xLTc4Mzg_179ae8d5-a1ae-4427-b56c-fd9caa9dc8b5">726</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i39065c5daf934af885335c12f3cfa83f_D20200401-20200630" decimals="-3" sign="-" format="ixt:numdotdecimal" name="us-gaap:ProfitLoss" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzY2E5YmIwMTc5MjQ3NmZiYjIyNWU1ZDlkZWM4NjlmL3NlYzo5M2NhOWJiMDE3OTI0NzZmYmIyMjVlNWQ5ZGVjODY5Zl8yNS9mcmFnOjFhMTNiMjI5MDE5MTQ3NGNhMjc0YzQ2NGY4YWJmOTIwL3RhYmxlOjI0YWJkMTlmMDhiYTRlM2E4NzJmMjVlOGU0MmQ1ODQyL3RhYmxlcmFuZ2U6MjRhYmQxOWYwOGJhNGUzYTg3MmYyNWU4ZTQyZDU4NDJfMjUtMTUtMS0xLTc4Mzg_bd618def-5172-4a1c-a633-70ccc626dac0">107,703</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Foreign exchange gain (loss) on translation</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7d089148856645de804437e1aae7cf7a_D20200401-20200630" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzY2E5YmIwMTc5MjQ3NmZiYjIyNWU1ZDlkZWM4NjlmL3NlYzo5M2NhOWJiMDE3OTI0NzZmYmIyMjVlNWQ5ZGVjODY5Zl8yNS9mcmFnOjFhMTNiMjI5MDE5MTQ3NGNhMjc0YzQ2NGY4YWJmOTIwL3RhYmxlOjI0YWJkMTlmMDhiYTRlM2E4NzJmMjVlOGU0MmQ1ODQyL3RhYmxlcmFuZ2U6MjRhYmQxOWYwOGJhNGUzYTg3MmYyNWU4ZTQyZDU4NDJfMjYtMTEtMS0xLTc4Mzg_a98fa4a4-57dd-4afa-aebd-9c55bd47eca1">51,907</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i3bd28b951b5141a3ac4946bb9c8d4486_D20200401-20200630" decimals="-3" sign="-" name="us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzY2E5YmIwMTc5MjQ3NmZiYjIyNWU1ZDlkZWM4NjlmL3NlYzo5M2NhOWJiMDE3OTI0NzZmYmIyMjVlNWQ5ZGVjODY5Zl8yNS9mcmFnOjFhMTNiMjI5MDE5MTQ3NGNhMjc0YzQ2NGY4YWJmOTIwL3RhYmxlOjI0YWJkMTlmMDhiYTRlM2E4NzJmMjVlOGU0MmQ1ODQyL3RhYmxlcmFuZ2U6MjRhYmQxOWYwOGJhNGUzYTg3MmYyNWU4ZTQyZDU4NDJfMjYtMTMtMS0xLTc4Mzg_bfa31179-5e59-4ece-8f5a-69082b689eb4">36</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i39065c5daf934af885335c12f3cfa83f_D20200401-20200630" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzY2E5YmIwMTc5MjQ3NmZiYjIyNWU1ZDlkZWM4NjlmL3NlYzo5M2NhOWJiMDE3OTI0NzZmYmIyMjVlNWQ5ZGVjODY5Zl8yNS9mcmFnOjFhMTNiMjI5MDE5MTQ3NGNhMjc0YzQ2NGY4YWJmOTIwL3RhYmxlOjI0YWJkMTlmMDhiYTRlM2E4NzJmMjVlOGU0MmQ1ODQyL3RhYmxlcmFuZ2U6MjRhYmQxOWYwOGJhNGUzYTg3MmYyNWU4ZTQyZDU4NDJfMjYtMTUtMS0xLTc4Mzg_7649df0c-ddc6-4733-877e-b173ee3bc2a6">51,871</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance at June 30, 2020</span></td><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i7b64ecf012bd43b397dcea9317f0673b_I20200630" decimals="INF" format="ixt:numdotdecimal" name="us-gaap:CommonStockSharesOutstanding" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjkzY2E5YmIwMTc5MjQ3NmZiYjIyNWU1ZDlkZWM4NjlmL3NlYzo5M2NhOWJiMDE3OTI0NzZmYmIyMjVlNWQ5ZGVjODY5Zl8yNS9mcmFnOjFhMTNiMjI5MDE5MTQ3NGNhMjc0YzQ2NGY4YWJmOTIwL3RhYmxlOjI0YWJkMTlmMDhiYTRlM2E4NzJmMjVlOGU0MmQ1ODQyL3RhYmxlcmFuZ2U6MjRhYmQxOWYwOGJhNGUzYTg3MmYyNWU4ZTQyZDU4NDJfMjctMS0xLTEtNzgzOA_03422c76-4712-4433-a281-c8185a8c7d32">349,886,402</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7b64ecf012bd43b397dcea9317f0673b_I20200630" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzY2E5YmIwMTc5MjQ3NmZiYjIyNWU1ZDlkZWM4NjlmL3NlYzo5M2NhOWJiMDE3OTI0NzZmYmIyMjVlNWQ5ZGVjODY5Zl8yNS9mcmFnOjFhMTNiMjI5MDE5MTQ3NGNhMjc0YzQ2NGY4YWJmOTIwL3RhYmxlOjI0YWJkMTlmMDhiYTRlM2E4NzJmMjVlOGU0MmQ1ODQyL3RhYmxlcmFuZ2U6MjRhYmQxOWYwOGJhNGUzYTg3MmYyNWU4ZTQyZDU4NDJfMjctMy0xLTEtNzgzOA_4fa52753-f06b-409f-bc9e-07b12ebc6782">565,211</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if06bdc9d2d5b40ca88594d8c716a000d_I20200630" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzY2E5YmIwMTc5MjQ3NmZiYjIyNWU1ZDlkZWM4NjlmL3NlYzo5M2NhOWJiMDE3OTI0NzZmYmIyMjVlNWQ5ZGVjODY5Zl8yNS9mcmFnOjFhMTNiMjI5MDE5MTQ3NGNhMjc0YzQ2NGY4YWJmOTIwL3RhYmxlOjI0YWJkMTlmMDhiYTRlM2E4NzJmMjVlOGU0MmQ1ODQyL3RhYmxlcmFuZ2U6MjRhYmQxOWYwOGJhNGUzYTg3MmYyNWU4ZTQyZDU4NDJfMjctNy0xLTEtNzgzOA_1f8377cb-c4e7-4696-b8e2-602190dfb4cf">27,046</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ibd5f91f865b44c90b9aab2e68420d292_I20200630" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzY2E5YmIwMTc5MjQ3NmZiYjIyNWU1ZDlkZWM4NjlmL3NlYzo5M2NhOWJiMDE3OTI0NzZmYmIyMjVlNWQ5ZGVjODY5Zl8yNS9mcmFnOjFhMTNiMjI5MDE5MTQ3NGNhMjc0YzQ2NGY4YWJmOTIwL3RhYmxlOjI0YWJkMTlmMDhiYTRlM2E4NzJmMjVlOGU0MmQ1ODQyL3RhYmxlcmFuZ2U6MjRhYmQxOWYwOGJhNGUzYTg3MmYyNWU4ZTQyZDU4NDJfMjctOS0xLTEtNzgzOA_8e7b57f2-6485-41e3-8ef0-4cb55b242d07">1,106,709</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ib7db517c67504b3baeead491589a7ed6_I20200630" decimals="-3" sign="-" format="ixt:numdotdecimal" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzY2E5YmIwMTc5MjQ3NmZiYjIyNWU1ZDlkZWM4NjlmL3NlYzo5M2NhOWJiMDE3OTI0NzZmYmIyMjVlNWQ5ZGVjODY5Zl8yNS9mcmFnOjFhMTNiMjI5MDE5MTQ3NGNhMjc0YzQ2NGY4YWJmOTIwL3RhYmxlOjI0YWJkMTlmMDhiYTRlM2E4NzJmMjVlOGU0MmQ1ODQyL3RhYmxlcmFuZ2U6MjRhYmQxOWYwOGJhNGUzYTg3MmYyNWU4ZTQyZDU4NDJfMjctMTEtMS0xLTc4Mzg_c5042bdb-6d85-4f16-82c0-744982a15378">33,970</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i87ce495c26b34c268c848a2934ad3f39_I20200630" decimals="-3" sign="-" format="ixt:numdotdecimal" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzY2E5YmIwMTc5MjQ3NmZiYjIyNWU1ZDlkZWM4NjlmL3NlYzo5M2NhOWJiMDE3OTI0NzZmYmIyMjVlNWQ5ZGVjODY5Zl8yNS9mcmFnOjFhMTNiMjI5MDE5MTQ3NGNhMjc0YzQ2NGY4YWJmOTIwL3RhYmxlOjI0YWJkMTlmMDhiYTRlM2E4NzJmMjVlOGU0MmQ1ODQyL3RhYmxlcmFuZ2U6MjRhYmQxOWYwOGJhNGUzYTg3MmYyNWU4ZTQyZDU4NDJfMjctMTMtMS0xLTc4Mzg_d4eb1748-a51e-4d55-aa0c-be1e2e374f78">1,951</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id670dc9b33e6430f9d7510009f7495a7_I20200630" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzY2E5YmIwMTc5MjQ3NmZiYjIyNWU1ZDlkZWM4NjlmL3NlYzo5M2NhOWJiMDE3OTI0NzZmYmIyMjVlNWQ5ZGVjODY5Zl8yNS9mcmFnOjFhMTNiMjI5MDE5MTQ3NGNhMjc0YzQ2NGY4YWJmOTIwL3RhYmxlOjI0YWJkMTlmMDhiYTRlM2E4NzJmMjVlOGU0MmQ1ODQyL3RhYmxlcmFuZ2U6MjRhYmQxOWYwOGJhNGUzYTg3MmYyNWU4ZTQyZDU4NDJfMjctMTUtMS0xLTc4Mzg_755d23b8-001c-48f2-944a-e88f45636134">1,663,045</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">See notes to condensed consolidated financial statements.</span></div><div style="height:31.5pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">6</span></div></div></div><div id="i93ca9bb01792476fbb225e5d9dec869f_22"></div><hr style="page-break-after:always"/><div style="min-height:72pt;width:100%"><div style="margin-top:0.55pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:69.629%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:28.171%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="border-top:1pt solid #FFFFFF;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Cronos Group Inc.</span></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Condensed Consolidated Statements of Changes in Equity</span></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">For the six months ended June&#160;30, 2021 and 2020</span></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">(In thousands of U.S. dollars, except share amounts, unaudited)</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i93ca9bb01792476fbb225e5d9dec869f_7">Table of Contents</a></span></div></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr></table></div><div style="text-align:center"><span><br/></span></div></div><div style="text-align:justify"><span><br/></span></div><div style="margin-bottom:12pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:31.295%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:6.920%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.945%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:6.504%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.945%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td style="width:1.0%"></td><td style="width:6.712%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.945%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.233%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.945%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.004%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.945%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.233%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.945%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.429%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Number of shares</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Share capital</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Additional paid-in capital</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Retained earnings</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Accumulated other comprehensive income</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Non-controlling interests</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Total shareholders&#8217; equity</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance as of January 1, 2021</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i89f360b9f95a44cea98ec721cc461ecf_I20201231" decimals="INF" format="ixt:numdotdecimal" name="us-gaap:CommonStockSharesOutstanding" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjkzY2E5YmIwMTc5MjQ3NmZiYjIyNWU1ZDlkZWM4NjlmL3NlYzo5M2NhOWJiMDE3OTI0NzZmYmIyMjVlNWQ5ZGVjODY5Zl8yMi9mcmFnOjQ0ZDZlZTY3ZmE5MDQwOWQ5NzA3MjkyYzUxNjlmNDExL3RhYmxlOmQzODY0MmU2YzkxYjQ0N2JhOWM0YTQ5NWNjZDlkYTVhL3RhYmxlcmFuZ2U6ZDM4NjQyZTZjOTFiNDQ3YmE5YzRhNDk1Y2NkOWRhNWFfMS0xLTEtMS0w_b716cde9-6cd8-4515-820a-20b6d8884a0b">360,253,332</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i89f360b9f95a44cea98ec721cc461ecf_I20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzY2E5YmIwMTc5MjQ3NmZiYjIyNWU1ZDlkZWM4NjlmL3NlYzo5M2NhOWJiMDE3OTI0NzZmYmIyMjVlNWQ5ZGVjODY5Zl8yMi9mcmFnOjQ0ZDZlZTY3ZmE5MDQwOWQ5NzA3MjkyYzUxNjlmNDExL3RhYmxlOmQzODY0MmU2YzkxYjQ0N2JhOWM0YTQ5NWNjZDlkYTVhL3RhYmxlcmFuZ2U6ZDM4NjQyZTZjOTFiNDQ3YmE5YzRhNDk1Y2NkOWRhNWFfMS0zLTEtMS0w_b7ccd0f4-c827-4a39-96bf-7346bf03e5bc">569,260</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="idaa77962d21a4f8ca12568eede000e4f_I20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzY2E5YmIwMTc5MjQ3NmZiYjIyNWU1ZDlkZWM4NjlmL3NlYzo5M2NhOWJiMDE3OTI0NzZmYmIyMjVlNWQ5ZGVjODY5Zl8yMi9mcmFnOjQ0ZDZlZTY3ZmE5MDQwOWQ5NzA3MjkyYzUxNjlmNDExL3RhYmxlOmQzODY0MmU2YzkxYjQ0N2JhOWM0YTQ5NWNjZDlkYTVhL3RhYmxlcmFuZ2U6ZDM4NjQyZTZjOTFiNDQ3YmE5YzRhNDk1Y2NkOWRhNWFfMS03LTEtMS0w_9a3d2063-b698-4813-a1da-edd0bf7fd5fc">34,596</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6710ab378a79438f94aa90687467e6f3_I20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzY2E5YmIwMTc5MjQ3NmZiYjIyNWU1ZDlkZWM4NjlmL3NlYzo5M2NhOWJiMDE3OTI0NzZmYmIyMjVlNWQ5ZGVjODY5Zl8yMi9mcmFnOjQ0ZDZlZTY3ZmE5MDQwOWQ5NzA3MjkyYzUxNjlmNDExL3RhYmxlOmQzODY0MmU2YzkxYjQ0N2JhOWM0YTQ5NWNjZDlkYTVhL3RhYmxlcmFuZ2U6ZDM4NjQyZTZjOTFiNDQ3YmE5YzRhNDk1Y2NkOWRhNWFfMS05LTEtMS0w_c736e2fe-1cef-4123-a11e-d5082ce284a4">1,064,509</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib7805645a77f444aa3190c257d456437_I20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzY2E5YmIwMTc5MjQ3NmZiYjIyNWU1ZDlkZWM4NjlmL3NlYzo5M2NhOWJiMDE3OTI0NzZmYmIyMjVlNWQ5ZGVjODY5Zl8yMi9mcmFnOjQ0ZDZlZTY3ZmE5MDQwOWQ5NzA3MjkyYzUxNjlmNDExL3RhYmxlOmQzODY0MmU2YzkxYjQ0N2JhOWM0YTQ5NWNjZDlkYTVhL3RhYmxlcmFuZ2U6ZDM4NjQyZTZjOTFiNDQ3YmE5YzRhNDk1Y2NkOWRhNWFfMS0xMS0xLTEtMA_860fc2bf-ce4e-4b1d-807e-fce5caa326fb">42,999</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ie669a3c1e1ca4bd8acd069f0187ca14a_I20201231" decimals="-3" sign="-" format="ixt:numdotdecimal" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzY2E5YmIwMTc5MjQ3NmZiYjIyNWU1ZDlkZWM4NjlmL3NlYzo5M2NhOWJiMDE3OTI0NzZmYmIyMjVlNWQ5ZGVjODY5Zl8yMi9mcmFnOjQ0ZDZlZTY3ZmE5MDQwOWQ5NzA3MjkyYzUxNjlmNDExL3RhYmxlOmQzODY0MmU2YzkxYjQ0N2JhOWM0YTQ5NWNjZDlkYTVhL3RhYmxlcmFuZ2U6ZDM4NjQyZTZjOTFiNDQ3YmE5YzRhNDk1Y2NkOWRhNWFfMS0xMy0xLTEtMA_1f331ada-84a1-4c97-af25-7934cf2c3e90">3,196</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ifbe16ec51ea244519b77d6036b4ef038_I20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzY2E5YmIwMTc5MjQ3NmZiYjIyNWU1ZDlkZWM4NjlmL3NlYzo5M2NhOWJiMDE3OTI0NzZmYmIyMjVlNWQ5ZGVjODY5Zl8yMi9mcmFnOjQ0ZDZlZTY3ZmE5MDQwOWQ5NzA3MjkyYzUxNjlmNDExL3RhYmxlOmQzODY0MmU2YzkxYjQ0N2JhOWM0YTQ5NWNjZDlkYTVhL3RhYmxlcmFuZ2U6ZDM4NjQyZTZjOTFiNDQ3YmE5YzRhNDk1Y2NkOWRhNWFfMS0xNS0xLTEtMA_8dba1e05-3655-472b-a1d4-00b648761945">1,708,168</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Warrants exercised</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i52c9b3fb67014eb083670c6a1d51b149_D20210101-20210630" decimals="INF" format="ixt:numdotdecimal" name="cron:SharebasedCompensationArrangementBySharebasedPaymentAwardWarrantsExercisesInPeriod" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjkzY2E5YmIwMTc5MjQ3NmZiYjIyNWU1ZDlkZWM4NjlmL3NlYzo5M2NhOWJiMDE3OTI0NzZmYmIyMjVlNWQ5ZGVjODY5Zl8yMi9mcmFnOjQ0ZDZlZTY3ZmE5MDQwOWQ5NzA3MjkyYzUxNjlmNDExL3RhYmxlOmQzODY0MmU2YzkxYjQ0N2JhOWM0YTQ5NWNjZDlkYTVhL3RhYmxlcmFuZ2U6ZDM4NjQyZTZjOTFiNDQ3YmE5YzRhNDk1Y2NkOWRhNWFfNC0xLTEtMS0w_ad18dadb-8673-4b55-bcf8-147a579c459d">7,842,859</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i52c9b3fb67014eb083670c6a1d51b149_D20210101-20210630" decimals="-3" format="ixt:numdotdecimal" name="cron:StockIssuedDuringPeriodValueWarrantsExercised" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzY2E5YmIwMTc5MjQ3NmZiYjIyNWU1ZDlkZWM4NjlmL3NlYzo5M2NhOWJiMDE3OTI0NzZmYmIyMjVlNWQ5ZGVjODY5Zl8yMi9mcmFnOjQ0ZDZlZTY3ZmE5MDQwOWQ5NzA3MjkyYzUxNjlmNDExL3RhYmxlOmQzODY0MmU2YzkxYjQ0N2JhOWM0YTQ5NWNjZDlkYTVhL3RhYmxlcmFuZ2U6ZDM4NjQyZTZjOTFiNDQ3YmE5YzRhNDk1Y2NkOWRhNWFfNC0zLTEtMS0w_958a3dbc-ee3c-4620-9196-43e42c1626c3">1,165</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i32ce7a4cf9fe4b5fb2ba774cbeb3025e_D20210101-20210630" decimals="-3" sign="-" format="ixt:numdotdecimal" name="cron:StockIssuedDuringPeriodValueWarrantsExercised" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzY2E5YmIwMTc5MjQ3NmZiYjIyNWU1ZDlkZWM4NjlmL3NlYzo5M2NhOWJiMDE3OTI0NzZmYmIyMjVlNWQ5ZGVjODY5Zl8yMi9mcmFnOjQ0ZDZlZTY3ZmE5MDQwOWQ5NzA3MjkyYzUxNjlmNDExL3RhYmxlOmQzODY0MmU2YzkxYjQ0N2JhOWM0YTQ5NWNjZDlkYTVhL3RhYmxlcmFuZ2U6ZDM4NjQyZTZjOTFiNDQ3YmE5YzRhNDk1Y2NkOWRhNWFfNC03LTEtMS0w_4d6375b7-be32-4ee2-8434-d7a7dfe79c6c">1,163</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i69782326f71a44e3805518280ee22b6b_D20210101-20210630" decimals="-3" name="cron:StockIssuedDuringPeriodValueWarrantsExercised" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzY2E5YmIwMTc5MjQ3NmZiYjIyNWU1ZDlkZWM4NjlmL3NlYzo5M2NhOWJiMDE3OTI0NzZmYmIyMjVlNWQ5ZGVjODY5Zl8yMi9mcmFnOjQ0ZDZlZTY3ZmE5MDQwOWQ5NzA3MjkyYzUxNjlmNDExL3RhYmxlOmQzODY0MmU2YzkxYjQ0N2JhOWM0YTQ5NWNjZDlkYTVhL3RhYmxlcmFuZ2U6ZDM4NjQyZTZjOTFiNDQ3YmE5YzRhNDk1Y2NkOWRhNWFfNC0xNS0xLTEtMA_78b1bd78-f57e-4cbe-aea4-358ea478c171">2</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Vesting of options</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i32ce7a4cf9fe4b5fb2ba774cbeb3025e_D20210101-20210630" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsRequisiteServicePeriodRecognition" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzY2E5YmIwMTc5MjQ3NmZiYjIyNWU1ZDlkZWM4NjlmL3NlYzo5M2NhOWJiMDE3OTI0NzZmYmIyMjVlNWQ5ZGVjODY5Zl8yMi9mcmFnOjQ0ZDZlZTY3ZmE5MDQwOWQ5NzA3MjkyYzUxNjlmNDExL3RhYmxlOmQzODY0MmU2YzkxYjQ0N2JhOWM0YTQ5NWNjZDlkYTVhL3RhYmxlcmFuZ2U6ZDM4NjQyZTZjOTFiNDQ3YmE5YzRhNDk1Y2NkOWRhNWFfNS03LTEtMS0w_a890d507-30a7-4b70-bb26-8066a8a7cd4d">3,928</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i69782326f71a44e3805518280ee22b6b_D20210101-20210630" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsRequisiteServicePeriodRecognition" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzY2E5YmIwMTc5MjQ3NmZiYjIyNWU1ZDlkZWM4NjlmL3NlYzo5M2NhOWJiMDE3OTI0NzZmYmIyMjVlNWQ5ZGVjODY5Zl8yMi9mcmFnOjQ0ZDZlZTY3ZmE5MDQwOWQ5NzA3MjkyYzUxNjlmNDExL3RhYmxlOmQzODY0MmU2YzkxYjQ0N2JhOWM0YTQ5NWNjZDlkYTVhL3RhYmxlcmFuZ2U6ZDM4NjQyZTZjOTFiNDQ3YmE5YzRhNDk1Y2NkOWRhNWFfNS0xNS0xLTEtMA_1c43e519-dc28-416e-b4c0-5c318d2544e0">3,928</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Options exercised</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i52c9b3fb67014eb083670c6a1d51b149_D20210101-20210630" decimals="INF" format="ixt:numdotdecimal" name="us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjkzY2E5YmIwMTc5MjQ3NmZiYjIyNWU1ZDlkZWM4NjlmL3NlYzo5M2NhOWJiMDE3OTI0NzZmYmIyMjVlNWQ5ZGVjODY5Zl8yMi9mcmFnOjQ0ZDZlZTY3ZmE5MDQwOWQ5NzA3MjkyYzUxNjlmNDExL3RhYmxlOmQzODY0MmU2YzkxYjQ0N2JhOWM0YTQ5NWNjZDlkYTVhL3RhYmxlcmFuZ2U6ZDM4NjQyZTZjOTFiNDQ3YmE5YzRhNDk1Y2NkOWRhNWFfNi0xLTEtMS0w_cfa07c14-661d-4a2f-851d-e125b6ec66eb">3,651,002</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i52c9b3fb67014eb083670c6a1d51b149_D20210101-20210630" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzY2E5YmIwMTc5MjQ3NmZiYjIyNWU1ZDlkZWM4NjlmL3NlYzo5M2NhOWJiMDE3OTI0NzZmYmIyMjVlNWQ5ZGVjODY5Zl8yMi9mcmFnOjQ0ZDZlZTY3ZmE5MDQwOWQ5NzA3MjkyYzUxNjlmNDExL3RhYmxlOmQzODY0MmU2YzkxYjQ0N2JhOWM0YTQ5NWNjZDlkYTVhL3RhYmxlcmFuZ2U6ZDM4NjQyZTZjOTFiNDQ3YmE5YzRhNDk1Y2NkOWRhNWFfNi0zLTEtMS0w_ab148d6f-3883-468b-b6a7-e2af6ac6efd1">3,315</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i32ce7a4cf9fe4b5fb2ba774cbeb3025e_D20210101-20210630" decimals="-3" sign="-" format="ixt:numdotdecimal" name="us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzY2E5YmIwMTc5MjQ3NmZiYjIyNWU1ZDlkZWM4NjlmL3NlYzo5M2NhOWJiMDE3OTI0NzZmYmIyMjVlNWQ5ZGVjODY5Zl8yMi9mcmFnOjQ0ZDZlZTY3ZmE5MDQwOWQ5NzA3MjkyYzUxNjlmNDExL3RhYmxlOmQzODY0MmU2YzkxYjQ0N2JhOWM0YTQ5NWNjZDlkYTVhL3RhYmxlcmFuZ2U6ZDM4NjQyZTZjOTFiNDQ3YmE5YzRhNDk1Y2NkOWRhNWFfNi03LTEtMS0w_6e8bc71b-8d2a-477e-a8c7-732c4d230e57">3,305</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i69782326f71a44e3805518280ee22b6b_D20210101-20210630" decimals="-3" name="us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzY2E5YmIwMTc5MjQ3NmZiYjIyNWU1ZDlkZWM4NjlmL3NlYzo5M2NhOWJiMDE3OTI0NzZmYmIyMjVlNWQ5ZGVjODY5Zl8yMi9mcmFnOjQ0ZDZlZTY3ZmE5MDQwOWQ5NzA3MjkyYzUxNjlmNDExL3RhYmxlOmQzODY0MmU2YzkxYjQ0N2JhOWM0YTQ5NWNjZDlkYTVhL3RhYmxlcmFuZ2U6ZDM4NjQyZTZjOTFiNDQ3YmE5YzRhNDk1Y2NkOWRhNWFfNi0xNS0xLTEtMA_713e068d-7b63-45ff-b690-9d89211ec947">10</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Restricted share units settled</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i52c9b3fb67014eb083670c6a1d51b149_D20210101-20210630" decimals="INF" format="ixt:numdotdecimal" name="us-gaap:StockIssuedDuringPeriodSharesRestrictedStockAwardNetOfForfeitures" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjkzY2E5YmIwMTc5MjQ3NmZiYjIyNWU1ZDlkZWM4NjlmL3NlYzo5M2NhOWJiMDE3OTI0NzZmYmIyMjVlNWQ5ZGVjODY5Zl8yMi9mcmFnOjQ0ZDZlZTY3ZmE5MDQwOWQ5NzA3MjkyYzUxNjlmNDExL3RhYmxlOmQzODY0MmU2YzkxYjQ0N2JhOWM0YTQ5NWNjZDlkYTVhL3RhYmxlcmFuZ2U6ZDM4NjQyZTZjOTFiNDQ3YmE5YzRhNDk1Y2NkOWRhNWFfNy0xLTEtMS0xMjgxNg_de65bca0-7468-47fd-a7d3-7c1ad42af0a2">58,354</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i52c9b3fb67014eb083670c6a1d51b149_D20210101-20210630" decimals="-3" name="us-gaap:StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzY2E5YmIwMTc5MjQ3NmZiYjIyNWU1ZDlkZWM4NjlmL3NlYzo5M2NhOWJiMDE3OTI0NzZmYmIyMjVlNWQ5ZGVjODY5Zl8yMi9mcmFnOjQ0ZDZlZTY3ZmE5MDQwOWQ5NzA3MjkyYzUxNjlmNDExL3RhYmxlOmQzODY0MmU2YzkxYjQ0N2JhOWM0YTQ5NWNjZDlkYTVhL3RhYmxlcmFuZ2U6ZDM4NjQyZTZjOTFiNDQ3YmE5YzRhNDk1Y2NkOWRhNWFfNy0zLTEtMS0xMjgxNg_e20c0910-4438-45cd-9c90-884f0c56af5a">345</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i32ce7a4cf9fe4b5fb2ba774cbeb3025e_D20210101-20210630" decimals="-3" sign="-" name="us-gaap:StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzY2E5YmIwMTc5MjQ3NmZiYjIyNWU1ZDlkZWM4NjlmL3NlYzo5M2NhOWJiMDE3OTI0NzZmYmIyMjVlNWQ5ZGVjODY5Zl8yMi9mcmFnOjQ0ZDZlZTY3ZmE5MDQwOWQ5NzA3MjkyYzUxNjlmNDExL3RhYmxlOmQzODY0MmU2YzkxYjQ0N2JhOWM0YTQ5NWNjZDlkYTVhL3RhYmxlcmFuZ2U6ZDM4NjQyZTZjOTFiNDQ3YmE5YzRhNDk1Y2NkOWRhNWFfNy03LTEtMS0xMjgyMQ_f32e4f69-45fc-494a-a28b-16d1b38f9849">345</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i69782326f71a44e3805518280ee22b6b_D20210101-20210630" decimals="-3" format="ixt:zerodash" name="us-gaap:StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzY2E5YmIwMTc5MjQ3NmZiYjIyNWU1ZDlkZWM4NjlmL3NlYzo5M2NhOWJiMDE3OTI0NzZmYmIyMjVlNWQ5ZGVjODY5Zl8yMi9mcmFnOjQ0ZDZlZTY3ZmE5MDQwOWQ5NzA3MjkyYzUxNjlmNDExL3RhYmxlOmQzODY0MmU2YzkxYjQ0N2JhOWM0YTQ5NWNjZDlkYTVhL3RhYmxlcmFuZ2U6ZDM4NjQyZTZjOTFiNDQ3YmE5YzRhNDk1Y2NkOWRhNWFfNy0xNS0xLTEtMTI4MjE_2817271c-1d6b-4466-b3d1-7207e7f511af">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Withholding taxes paid on share-based awards</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i32ce7a4cf9fe4b5fb2ba774cbeb3025e_D20210101-20210630" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzY2E5YmIwMTc5MjQ3NmZiYjIyNWU1ZDlkZWM4NjlmL3NlYzo5M2NhOWJiMDE3OTI0NzZmYmIyMjVlNWQ5ZGVjODY5Zl8yMi9mcmFnOjQ0ZDZlZTY3ZmE5MDQwOWQ5NzA3MjkyYzUxNjlmNDExL3RhYmxlOmQzODY0MmU2YzkxYjQ0N2JhOWM0YTQ5NWNjZDlkYTVhL3RhYmxlcmFuZ2U6ZDM4NjQyZTZjOTFiNDQ3YmE5YzRhNDk1Y2NkOWRhNWFfNy03LTEtMS0w_44a339ab-5cad-41d5-9e81-6ccc27df282b">1,162</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i24b7b1f487f24a12927c251dc2cc0562_D20210101-20210630" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzY2E5YmIwMTc5MjQ3NmZiYjIyNWU1ZDlkZWM4NjlmL3NlYzo5M2NhOWJiMDE3OTI0NzZmYmIyMjVlNWQ5ZGVjODY5Zl8yMi9mcmFnOjQ0ZDZlZTY3ZmE5MDQwOWQ5NzA3MjkyYzUxNjlmNDExL3RhYmxlOmQzODY0MmU2YzkxYjQ0N2JhOWM0YTQ5NWNjZDlkYTVhL3RhYmxlcmFuZ2U6ZDM4NjQyZTZjOTFiNDQ3YmE5YzRhNDk1Y2NkOWRhNWFfNy05LTEtMS0w_d4e5d6bc-5ebc-469d-bf24-358c17a25f36">7,757</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i69782326f71a44e3805518280ee22b6b_D20210101-20210630" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzY2E5YmIwMTc5MjQ3NmZiYjIyNWU1ZDlkZWM4NjlmL3NlYzo5M2NhOWJiMDE3OTI0NzZmYmIyMjVlNWQ5ZGVjODY5Zl8yMi9mcmFnOjQ0ZDZlZTY3ZmE5MDQwOWQ5NzA3MjkyYzUxNjlmNDExL3RhYmxlOmQzODY0MmU2YzkxYjQ0N2JhOWM0YTQ5NWNjZDlkYTVhL3RhYmxlcmFuZ2U6ZDM4NjQyZTZjOTFiNDQ3YmE5YzRhNDk1Y2NkOWRhNWFfNy0xNS0xLTEtMA_c3962e72-2656-4abf-8b79-915cbf0d4473">8,919</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Vesting of restricted share units</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i32ce7a4cf9fe4b5fb2ba774cbeb3025e_D20210101-20210630" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationRestrictedStockUnitsRequisiteServicePeriodRecognition" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzY2E5YmIwMTc5MjQ3NmZiYjIyNWU1ZDlkZWM4NjlmL3NlYzo5M2NhOWJiMDE3OTI0NzZmYmIyMjVlNWQ5ZGVjODY5Zl8yMi9mcmFnOjQ0ZDZlZTY3ZmE5MDQwOWQ5NzA3MjkyYzUxNjlmNDExL3RhYmxlOmQzODY0MmU2YzkxYjQ0N2JhOWM0YTQ5NWNjZDlkYTVhL3RhYmxlcmFuZ2U6ZDM4NjQyZTZjOTFiNDQ3YmE5YzRhNDk1Y2NkOWRhNWFfOC03LTEtMS0w_980f3868-7147-4e9d-bf9b-d45c1e42684a">1,136</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i69782326f71a44e3805518280ee22b6b_D20210101-20210630" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationRestrictedStockUnitsRequisiteServicePeriodRecognition" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzY2E5YmIwMTc5MjQ3NmZiYjIyNWU1ZDlkZWM4NjlmL3NlYzo5M2NhOWJiMDE3OTI0NzZmYmIyMjVlNWQ5ZGVjODY5Zl8yMi9mcmFnOjQ0ZDZlZTY3ZmE5MDQwOWQ5NzA3MjkyYzUxNjlmNDExL3RhYmxlOmQzODY0MmU2YzkxYjQ0N2JhOWM0YTQ5NWNjZDlkYTVhL3RhYmxlcmFuZ2U6ZDM4NjQyZTZjOTFiNDQ3YmE5YzRhNDk1Y2NkOWRhNWFfOC0xNS0xLTEtMA_9adbecde-9d0f-4d83-81da-8825c8ddf726">1,136</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Vesting of common shares issued in connection with the use of certain publicity rights in brand development</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i52c9b3fb67014eb083670c6a1d51b149_D20210101-20210630" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationOtherLongtermIncentivePlansRequisiteServicePeriodRecognition" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzY2E5YmIwMTc5MjQ3NmZiYjIyNWU1ZDlkZWM4NjlmL3NlYzo5M2NhOWJiMDE3OTI0NzZmYmIyMjVlNWQ5ZGVjODY5Zl8yMi9mcmFnOjQ0ZDZlZTY3ZmE5MDQwOWQ5NzA3MjkyYzUxNjlmNDExL3RhYmxlOmQzODY0MmU2YzkxYjQ0N2JhOWM0YTQ5NWNjZDlkYTVhL3RhYmxlcmFuZ2U6ZDM4NjQyZTZjOTFiNDQ3YmE5YzRhNDk1Y2NkOWRhNWFfOS0zLTEtMS0w_0c0bb96b-e919-41b9-9598-41110a29fa9c">2,000</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i32ce7a4cf9fe4b5fb2ba774cbeb3025e_D20210101-20210630" decimals="-3" sign="-" format="ixt:numdotdecimal" name="us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationOtherLongtermIncentivePlansRequisiteServicePeriodRecognition" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzY2E5YmIwMTc5MjQ3NmZiYjIyNWU1ZDlkZWM4NjlmL3NlYzo5M2NhOWJiMDE3OTI0NzZmYmIyMjVlNWQ5ZGVjODY5Zl8yMi9mcmFnOjQ0ZDZlZTY3ZmE5MDQwOWQ5NzA3MjkyYzUxNjlmNDExL3RhYmxlOmQzODY0MmU2YzkxYjQ0N2JhOWM0YTQ5NWNjZDlkYTVhL3RhYmxlcmFuZ2U6ZDM4NjQyZTZjOTFiNDQ3YmE5YzRhNDk1Y2NkOWRhNWFfOS03LTEtMS0w_4f030400-8151-4d4b-985a-f10bb6ef0e56">1,317</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i69782326f71a44e3805518280ee22b6b_D20210101-20210630" decimals="-3" name="us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationOtherLongtermIncentivePlansRequisiteServicePeriodRecognition" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzY2E5YmIwMTc5MjQ3NmZiYjIyNWU1ZDlkZWM4NjlmL3NlYzo5M2NhOWJiMDE3OTI0NzZmYmIyMjVlNWQ5ZGVjODY5Zl8yMi9mcmFnOjQ0ZDZlZTY3ZmE5MDQwOWQ5NzA3MjkyYzUxNjlmNDExL3RhYmxlOmQzODY0MmU2YzkxYjQ0N2JhOWM0YTQ5NWNjZDlkYTVhL3RhYmxlcmFuZ2U6ZDM4NjQyZTZjOTFiNDQ3YmE5YzRhNDk1Y2NkOWRhNWFfOS0xNS0xLTEtMA_3c44276a-7fdc-4b49-80a0-e02776941256">683</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Top-up rights out-of-period adjustment</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i52c9b3fb67014eb083670c6a1d51b149_D20210101-20210630" decimals="-3" sign="-" format="ixt:numdotdecimal" name="cron:StockholdersEquityOutOfPeriodAdjustment" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzY2E5YmIwMTc5MjQ3NmZiYjIyNWU1ZDlkZWM4NjlmL3NlYzo5M2NhOWJiMDE3OTI0NzZmYmIyMjVlNWQ5ZGVjODY5Zl8yMi9mcmFnOjQ0ZDZlZTY3ZmE5MDQwOWQ5NzA3MjkyYzUxNjlmNDExL3RhYmxlOmQzODY0MmU2YzkxYjQ0N2JhOWM0YTQ5NWNjZDlkYTVhL3RhYmxlcmFuZ2U6ZDM4NjQyZTZjOTFiNDQ3YmE5YzRhNDk1Y2NkOWRhNWFfMTAtMy0xLTEtMA_ecddda58-4cc1-47da-8239-e98f5a9ffc5c">3,227</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i24b7b1f487f24a12927c251dc2cc0562_D20210101-20210630" decimals="-3" format="ixt:numdotdecimal" name="cron:StockholdersEquityOutOfPeriodAdjustment" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzY2E5YmIwMTc5MjQ3NmZiYjIyNWU1ZDlkZWM4NjlmL3NlYzo5M2NhOWJiMDE3OTI0NzZmYmIyMjVlNWQ5ZGVjODY5Zl8yMi9mcmFnOjQ0ZDZlZTY3ZmE5MDQwOWQ5NzA3MjkyYzUxNjlmNDExL3RhYmxlOmQzODY0MmU2YzkxYjQ0N2JhOWM0YTQ5NWNjZDlkYTVhL3RhYmxlcmFuZ2U6ZDM4NjQyZTZjOTFiNDQ3YmE5YzRhNDk1Y2NkOWRhNWFfMTAtOS0xLTEtMA_658f3b8d-8b17-4f1e-b43d-611e4cf80965">3,227</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i69782326f71a44e3805518280ee22b6b_D20210101-20210630" decimals="-3" format="ixt:zerodash" name="cron:StockholdersEquityOutOfPeriodAdjustment" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzY2E5YmIwMTc5MjQ3NmZiYjIyNWU1ZDlkZWM4NjlmL3NlYzo5M2NhOWJiMDE3OTI0NzZmYmIyMjVlNWQ5ZGVjODY5Zl8yMi9mcmFnOjQ0ZDZlZTY3ZmE5MDQwOWQ5NzA3MjkyYzUxNjlmNDExL3RhYmxlOmQzODY0MmU2YzkxYjQ0N2JhOWM0YTQ5NWNjZDlkYTVhL3RhYmxlcmFuZ2U6ZDM4NjQyZTZjOTFiNDQ3YmE5YzRhNDk1Y2NkOWRhNWFfMTAtMTUtMS0xLTA_9edfd0f7-97cd-4b4d-a82e-47c0fed3a5ff">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net loss</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i24b7b1f487f24a12927c251dc2cc0562_D20210101-20210630" decimals="-3" sign="-" format="ixt:numdotdecimal" name="us-gaap:ProfitLoss" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzY2E5YmIwMTc5MjQ3NmZiYjIyNWU1ZDlkZWM4NjlmL3NlYzo5M2NhOWJiMDE3OTI0NzZmYmIyMjVlNWQ5ZGVjODY5Zl8yMi9mcmFnOjQ0ZDZlZTY3ZmE5MDQwOWQ5NzA3MjkyYzUxNjlmNDExL3RhYmxlOmQzODY0MmU2YzkxYjQ0N2JhOWM0YTQ5NWNjZDlkYTVhL3RhYmxlcmFuZ2U6ZDM4NjQyZTZjOTFiNDQ3YmE5YzRhNDk1Y2NkOWRhNWFfMTEtOS0xLTEtMA_4e1cf775-e12c-41ed-b9dc-e4e95cf384ff">104,258</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="if8ae25ba0a1c4efd878426d129e53e7b_D20210101-20210630" decimals="-3" sign="-" name="us-gaap:ProfitLoss" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzY2E5YmIwMTc5MjQ3NmZiYjIyNWU1ZDlkZWM4NjlmL3NlYzo5M2NhOWJiMDE3OTI0NzZmYmIyMjVlNWQ5ZGVjODY5Zl8yMi9mcmFnOjQ0ZDZlZTY3ZmE5MDQwOWQ5NzA3MjkyYzUxNjlmNDExL3RhYmxlOmQzODY0MmU2YzkxYjQ0N2JhOWM0YTQ5NWNjZDlkYTVhL3RhYmxlcmFuZ2U6ZDM4NjQyZTZjOTFiNDQ3YmE5YzRhNDk1Y2NkOWRhNWFfMTEtMTMtMS0xLTA_17bf8e53-5fa2-4f9b-a767-a0159d3d37f3">592</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i69782326f71a44e3805518280ee22b6b_D20210101-20210630" decimals="-3" sign="-" format="ixt:numdotdecimal" name="us-gaap:ProfitLoss" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzY2E5YmIwMTc5MjQ3NmZiYjIyNWU1ZDlkZWM4NjlmL3NlYzo5M2NhOWJiMDE3OTI0NzZmYmIyMjVlNWQ5ZGVjODY5Zl8yMi9mcmFnOjQ0ZDZlZTY3ZmE5MDQwOWQ5NzA3MjkyYzUxNjlmNDExL3RhYmxlOmQzODY0MmU2YzkxYjQ0N2JhOWM0YTQ5NWNjZDlkYTVhL3RhYmxlcmFuZ2U6ZDM4NjQyZTZjOTFiNDQ3YmE5YzRhNDk1Y2NkOWRhNWFfMTEtMTUtMS0xLTA_7547982c-e3c7-404e-9cba-766af34cb1c3">104,850</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Foreign exchange gain on translation</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if19cdb6b9f6f463e8cdd761179f9db89_D20210101-20210630" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzY2E5YmIwMTc5MjQ3NmZiYjIyNWU1ZDlkZWM4NjlmL3NlYzo5M2NhOWJiMDE3OTI0NzZmYmIyMjVlNWQ5ZGVjODY5Zl8yMi9mcmFnOjQ0ZDZlZTY3ZmE5MDQwOWQ5NzA3MjkyYzUxNjlmNDExL3RhYmxlOmQzODY0MmU2YzkxYjQ0N2JhOWM0YTQ5NWNjZDlkYTVhL3RhYmxlcmFuZ2U6ZDM4NjQyZTZjOTFiNDQ3YmE5YzRhNDk1Y2NkOWRhNWFfMTItMTEtMS0xLTA_659b3ff6-b471-487b-aac4-9f5ad5aac1b5">28,730</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if8ae25ba0a1c4efd878426d129e53e7b_D20210101-20210630" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzY2E5YmIwMTc5MjQ3NmZiYjIyNWU1ZDlkZWM4NjlmL3NlYzo5M2NhOWJiMDE3OTI0NzZmYmIyMjVlNWQ5ZGVjODY5Zl8yMi9mcmFnOjQ0ZDZlZTY3ZmE5MDQwOWQ5NzA3MjkyYzUxNjlmNDExL3RhYmxlOmQzODY0MmU2YzkxYjQ0N2JhOWM0YTQ5NWNjZDlkYTVhL3RhYmxlcmFuZ2U6ZDM4NjQyZTZjOTFiNDQ3YmE5YzRhNDk1Y2NkOWRhNWFfMTItMTMtMS0xLTA_3c61aa62-a104-4eec-9a88-349949e0bea3">1,024</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i69782326f71a44e3805518280ee22b6b_D20210101-20210630" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzY2E5YmIwMTc5MjQ3NmZiYjIyNWU1ZDlkZWM4NjlmL3NlYzo5M2NhOWJiMDE3OTI0NzZmYmIyMjVlNWQ5ZGVjODY5Zl8yMi9mcmFnOjQ0ZDZlZTY3ZmE5MDQwOWQ5NzA3MjkyYzUxNjlmNDExL3RhYmxlOmQzODY0MmU2YzkxYjQ0N2JhOWM0YTQ5NWNjZDlkYTVhL3RhYmxlcmFuZ2U6ZDM4NjQyZTZjOTFiNDQ3YmE5YzRhNDk1Y2NkOWRhNWFfMTItMTUtMS0xLTA_23ce77d2-afcd-42de-bf1f-da6d07b7dc32">29,754</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance at June 30, 2021</span></td><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i1d565c32dabc40c08d36232dec1a7779_I20210630" decimals="INF" format="ixt:numdotdecimal" name="us-gaap:CommonStockSharesOutstanding" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjkzY2E5YmIwMTc5MjQ3NmZiYjIyNWU1ZDlkZWM4NjlmL3NlYzo5M2NhOWJiMDE3OTI0NzZmYmIyMjVlNWQ5ZGVjODY5Zl8yMi9mcmFnOjQ0ZDZlZTY3ZmE5MDQwOWQ5NzA3MjkyYzUxNjlmNDExL3RhYmxlOmQzODY0MmU2YzkxYjQ0N2JhOWM0YTQ5NWNjZDlkYTVhL3RhYmxlcmFuZ2U6ZDM4NjQyZTZjOTFiNDQ3YmE5YzRhNDk1Y2NkOWRhNWFfMTMtMS0xLTEtMA_070308de-8209-4612-af62-a4ff4b468e95">371,805,547</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1d565c32dabc40c08d36232dec1a7779_I20210630" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzY2E5YmIwMTc5MjQ3NmZiYjIyNWU1ZDlkZWM4NjlmL3NlYzo5M2NhOWJiMDE3OTI0NzZmYmIyMjVlNWQ5ZGVjODY5Zl8yMi9mcmFnOjQ0ZDZlZTY3ZmE5MDQwOWQ5NzA3MjkyYzUxNjlmNDExL3RhYmxlOmQzODY0MmU2YzkxYjQ0N2JhOWM0YTQ5NWNjZDlkYTVhL3RhYmxlcmFuZ2U6ZDM4NjQyZTZjOTFiNDQ3YmE5YzRhNDk1Y2NkOWRhNWFfMTMtMy0xLTEtMA_78c1f098-c287-4046-bdf0-acb11c3347b7">572,858</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ibbfd3d5a9feb460a8f0fe21cf2539d79_I20210630" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzY2E5YmIwMTc5MjQ3NmZiYjIyNWU1ZDlkZWM4NjlmL3NlYzo5M2NhOWJiMDE3OTI0NzZmYmIyMjVlNWQ5ZGVjODY5Zl8yMi9mcmFnOjQ0ZDZlZTY3ZmE5MDQwOWQ5NzA3MjkyYzUxNjlmNDExL3RhYmxlOmQzODY0MmU2YzkxYjQ0N2JhOWM0YTQ5NWNjZDlkYTVhL3RhYmxlcmFuZ2U6ZDM4NjQyZTZjOTFiNDQ3YmE5YzRhNDk1Y2NkOWRhNWFfMTMtNy0xLTEtMA_e2ce53ae-1a96-488f-9650-9b2f4c509069">32,368</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5b5acb4a63db4a419bb0b3e0c4a24492_I20210630" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzY2E5YmIwMTc5MjQ3NmZiYjIyNWU1ZDlkZWM4NjlmL3NlYzo5M2NhOWJiMDE3OTI0NzZmYmIyMjVlNWQ5ZGVjODY5Zl8yMi9mcmFnOjQ0ZDZlZTY3ZmE5MDQwOWQ5NzA3MjkyYzUxNjlmNDExL3RhYmxlOmQzODY0MmU2YzkxYjQ0N2JhOWM0YTQ5NWNjZDlkYTVhL3RhYmxlcmFuZ2U6ZDM4NjQyZTZjOTFiNDQ3YmE5YzRhNDk1Y2NkOWRhNWFfMTMtOS0xLTEtMA_55c23544-32c2-4917-9332-19df7e95b76c">955,721</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7d990708cda34586a3e37a53dd59fb03_I20210630" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzY2E5YmIwMTc5MjQ3NmZiYjIyNWU1ZDlkZWM4NjlmL3NlYzo5M2NhOWJiMDE3OTI0NzZmYmIyMjVlNWQ5ZGVjODY5Zl8yMi9mcmFnOjQ0ZDZlZTY3ZmE5MDQwOWQ5NzA3MjkyYzUxNjlmNDExL3RhYmxlOmQzODY0MmU2YzkxYjQ0N2JhOWM0YTQ5NWNjZDlkYTVhL3RhYmxlcmFuZ2U6ZDM4NjQyZTZjOTFiNDQ3YmE5YzRhNDk1Y2NkOWRhNWFfMTMtMTEtMS0xLTA_e56e7295-4892-46f7-ae6a-d230b1b2bee9">71,729</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i64458da0ec424fd8a6faf87d69636ecd_I20210630" decimals="-3" sign="-" format="ixt:numdotdecimal" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzY2E5YmIwMTc5MjQ3NmZiYjIyNWU1ZDlkZWM4NjlmL3NlYzo5M2NhOWJiMDE3OTI0NzZmYmIyMjVlNWQ5ZGVjODY5Zl8yMi9mcmFnOjQ0ZDZlZTY3ZmE5MDQwOWQ5NzA3MjkyYzUxNjlmNDExL3RhYmxlOmQzODY0MmU2YzkxYjQ0N2JhOWM0YTQ5NWNjZDlkYTVhL3RhYmxlcmFuZ2U6ZDM4NjQyZTZjOTFiNDQ3YmE5YzRhNDk1Y2NkOWRhNWFfMTMtMTMtMS0xLTA_f7ddb2a5-5fa5-4d2a-be63-a927ed845a62">2,764</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i225f85e38faa4bbdb4de1d8b9cf369bb_I20210630" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzY2E5YmIwMTc5MjQ3NmZiYjIyNWU1ZDlkZWM4NjlmL3NlYzo5M2NhOWJiMDE3OTI0NzZmYmIyMjVlNWQ5ZGVjODY5Zl8yMi9mcmFnOjQ0ZDZlZTY3ZmE5MDQwOWQ5NzA3MjkyYzUxNjlmNDExL3RhYmxlOmQzODY0MmU2YzkxYjQ0N2JhOWM0YTQ5NWNjZDlkYTVhL3RhYmxlcmFuZ2U6ZDM4NjQyZTZjOTFiNDQ3YmE5YzRhNDk1Y2NkOWRhNWFfMTMtMTUtMS0xLTA_738a6310-ba9d-400d-bfc4-af741e905715">1,629,912</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:31.295%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:6.920%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.945%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:6.504%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.945%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td style="width:1.0%"></td><td style="width:6.712%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.945%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.233%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.945%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.004%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.945%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.233%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.945%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.429%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Number of shares</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Share capital</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Additional paid-in capital</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Retained earnings</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Accumulated other comprehensive income (loss)</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Non-controlling interests</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Total shareholders&#8217; equity</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance as of January 1, 2020</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="ibec8035afed7413580a92eb6c685b162_I20191231" decimals="INF" format="ixt:numdotdecimal" name="us-gaap:CommonStockSharesOutstanding" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjkzY2E5YmIwMTc5MjQ3NmZiYjIyNWU1ZDlkZWM4NjlmL3NlYzo5M2NhOWJiMDE3OTI0NzZmYmIyMjVlNWQ5ZGVjODY5Zl8yMi9mcmFnOjQ0ZDZlZTY3ZmE5MDQwOWQ5NzA3MjkyYzUxNjlmNDExL3RhYmxlOjdmNTJmY2Y3NzgwODQ3NWFiMTRkMWFhMTJlY2Y4OTVhL3RhYmxlcmFuZ2U6N2Y1MmZjZjc3ODA4NDc1YWIxNGQxYWExMmVjZjg5NWFfMS0xLTEtMS0w_20a3c7e0-6b52-444e-b60a-ebfbe7d5b171">348,817,472</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ibec8035afed7413580a92eb6c685b162_I20191231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzY2E5YmIwMTc5MjQ3NmZiYjIyNWU1ZDlkZWM4NjlmL3NlYzo5M2NhOWJiMDE3OTI0NzZmYmIyMjVlNWQ5ZGVjODY5Zl8yMi9mcmFnOjQ0ZDZlZTY3ZmE5MDQwOWQ5NzA3MjkyYzUxNjlmNDExL3RhYmxlOjdmNTJmY2Y3NzgwODQ3NWFiMTRkMWFhMTJlY2Y4OTVhL3RhYmxlcmFuZ2U6N2Y1MmZjZjc3ODA4NDc1YWIxNGQxYWExMmVjZjg5NWFfMS0zLTEtMS0w_7130c729-ec5d-4a9e-836e-dd78232befd6">561,165</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i22d6ccbfd09c4945825d9d9eccef7a82_I20191231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzY2E5YmIwMTc5MjQ3NmZiYjIyNWU1ZDlkZWM4NjlmL3NlYzo5M2NhOWJiMDE3OTI0NzZmYmIyMjVlNWQ5ZGVjODY5Zl8yMi9mcmFnOjQ0ZDZlZTY3ZmE5MDQwOWQ5NzA3MjkyYzUxNjlmNDExL3RhYmxlOjdmNTJmY2Y3NzgwODQ3NWFiMTRkMWFhMTJlY2Y4OTVhL3RhYmxlcmFuZ2U6N2Y1MmZjZjc3ODA4NDc1YWIxNGQxYWExMmVjZjg5NWFfMS03LTEtMS0w_f534d418-a70c-426a-bba3-f95571dc89cc">23,234</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5e450cfb71c44415b401ef2a8c9b958a_I20191231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzY2E5YmIwMTc5MjQ3NmZiYjIyNWU1ZDlkZWM4NjlmL3NlYzo5M2NhOWJiMDE3OTI0NzZmYmIyMjVlNWQ5ZGVjODY5Zl8yMi9mcmFnOjQ0ZDZlZTY3ZmE5MDQwOWQ5NzA3MjkyYzUxNjlmNDExL3RhYmxlOjdmNTJmY2Y3NzgwODQ3NWFiMTRkMWFhMTJlY2Y4OTVhL3RhYmxlcmFuZ2U6N2Y1MmZjZjc3ODA4NDc1YWIxNGQxYWExMmVjZjg5NWFfMS05LTEtMS0w_db358cfa-8e2a-4f16-afbb-49c157c4e74c">1,137,646</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4dec53ede4f44421a40be0b4d3eb49a6_I20191231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzY2E5YmIwMTc5MjQ3NmZiYjIyNWU1ZDlkZWM4NjlmL3NlYzo5M2NhOWJiMDE3OTI0NzZmYmIyMjVlNWQ5ZGVjODY5Zl8yMi9mcmFnOjQ0ZDZlZTY3ZmE5MDQwOWQ5NzA3MjkyYzUxNjlmNDExL3RhYmxlOjdmNTJmY2Y3NzgwODQ3NWFiMTRkMWFhMTJlY2Y4OTVhL3RhYmxlcmFuZ2U6N2Y1MmZjZjc3ODA4NDc1YWIxNGQxYWExMmVjZjg5NWFfMS0xMS0xLTEtMA_32f08f3e-42da-4ad1-beba-2eccf1168eb5">27,838</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ic0274d7a972e4964b3d0fca8bddf9b4c_I20191231" decimals="-3" sign="-" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzY2E5YmIwMTc5MjQ3NmZiYjIyNWU1ZDlkZWM4NjlmL3NlYzo5M2NhOWJiMDE3OTI0NzZmYmIyMjVlNWQ5ZGVjODY5Zl8yMi9mcmFnOjQ0ZDZlZTY3ZmE5MDQwOWQ5NzA3MjkyYzUxNjlmNDExL3RhYmxlOjdmNTJmY2Y3NzgwODQ3NWFiMTRkMWFhMTJlY2Y4OTVhL3RhYmxlcmFuZ2U6N2Y1MmZjZjc3ODA4NDc1YWIxNGQxYWExMmVjZjg5NWFfMS0xMy0xLTEtMA_7fdb1ce6-2849-448e-98c8-53841a71e84d">853</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie4fc90ad6d7f4d39aea9cb65c8026e09_I20191231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzY2E5YmIwMTc5MjQ3NmZiYjIyNWU1ZDlkZWM4NjlmL3NlYzo5M2NhOWJiMDE3OTI0NzZmYmIyMjVlNWQ5ZGVjODY5Zl8yMi9mcmFnOjQ0ZDZlZTY3ZmE5MDQwOWQ5NzA3MjkyYzUxNjlmNDExL3RhYmxlOjdmNTJmY2Y3NzgwODQ3NWFiMTRkMWFhMTJlY2Y4OTVhL3RhYmxlcmFuZ2U6N2Y1MmZjZjc3ODA4NDc1YWIxNGQxYWExMmVjZjg5NWFfMS0xNS0xLTEtMA_4e513851-2d94-4195-b0c3-a78f04b3f3ef">1,749,030</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Vesting of options</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ief0b929c9a76458b843a186c4b2a71f2_D20200101-20200630" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsRequisiteServicePeriodRecognition" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzY2E5YmIwMTc5MjQ3NmZiYjIyNWU1ZDlkZWM4NjlmL3NlYzo5M2NhOWJiMDE3OTI0NzZmYmIyMjVlNWQ5ZGVjODY5Zl8yMi9mcmFnOjQ0ZDZlZTY3ZmE5MDQwOWQ5NzA3MjkyYzUxNjlmNDExL3RhYmxlOjdmNTJmY2Y3NzgwODQ3NWFiMTRkMWFhMTJlY2Y4OTVhL3RhYmxlcmFuZ2U6N2Y1MmZjZjc3ODA4NDc1YWIxNGQxYWExMmVjZjg5NWFfNS03LTEtMS0w_b90ca123-a230-407c-a5ab-354215024eef">3,500</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4a110e4972ef4113880ce582e3cda5c5_D20200101-20200630" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsRequisiteServicePeriodRecognition" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzY2E5YmIwMTc5MjQ3NmZiYjIyNWU1ZDlkZWM4NjlmL3NlYzo5M2NhOWJiMDE3OTI0NzZmYmIyMjVlNWQ5ZGVjODY5Zl8yMi9mcmFnOjQ0ZDZlZTY3ZmE5MDQwOWQ5NzA3MjkyYzUxNjlmNDExL3RhYmxlOjdmNTJmY2Y3NzgwODQ3NWFiMTRkMWFhMTJlY2Y4OTVhL3RhYmxlcmFuZ2U6N2Y1MmZjZjc3ODA4NDc1YWIxNGQxYWExMmVjZjg5NWFfNS0xNS0xLTEtMA_664e3dde-c161-4391-9d5e-53ab9a1ac888">3,500</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Options exercised</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="ie28d03ed3f6c447e8db8badbe540043f_D20200101-20200630" decimals="INF" format="ixt:numdotdecimal" name="us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjkzY2E5YmIwMTc5MjQ3NmZiYjIyNWU1ZDlkZWM4NjlmL3NlYzo5M2NhOWJiMDE3OTI0NzZmYmIyMjVlNWQ5ZGVjODY5Zl8yMi9mcmFnOjQ0ZDZlZTY3ZmE5MDQwOWQ5NzA3MjkyYzUxNjlmNDExL3RhYmxlOjdmNTJmY2Y3NzgwODQ3NWFiMTRkMWFhMTJlY2Y4OTVhL3RhYmxlcmFuZ2U6N2Y1MmZjZjc3ODA4NDc1YWIxNGQxYWExMmVjZjg5NWFfNi0xLTEtMS0w_35b98818-ebb9-42b0-9a45-20b407bcca95">1,068,930</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie28d03ed3f6c447e8db8badbe540043f_D20200101-20200630" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzY2E5YmIwMTc5MjQ3NmZiYjIyNWU1ZDlkZWM4NjlmL3NlYzo5M2NhOWJiMDE3OTI0NzZmYmIyMjVlNWQ5ZGVjODY5Zl8yMi9mcmFnOjQ0ZDZlZTY3ZmE5MDQwOWQ5NzA3MjkyYzUxNjlmNDExL3RhYmxlOjdmNTJmY2Y3NzgwODQ3NWFiMTRkMWFhMTJlY2Y4OTVhL3RhYmxlcmFuZ2U6N2Y1MmZjZjc3ODA4NDc1YWIxNGQxYWExMmVjZjg5NWFfNi0zLTEtMS0w_96b6bb38-9226-4616-aa59-2781f3c7c194">1,329</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ief0b929c9a76458b843a186c4b2a71f2_D20200101-20200630" decimals="-3" sign="-" format="ixt:numdotdecimal" name="us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzY2E5YmIwMTc5MjQ3NmZiYjIyNWU1ZDlkZWM4NjlmL3NlYzo5M2NhOWJiMDE3OTI0NzZmYmIyMjVlNWQ5ZGVjODY5Zl8yMi9mcmFnOjQ0ZDZlZTY3ZmE5MDQwOWQ5NzA3MjkyYzUxNjlmNDExL3RhYmxlOjdmNTJmY2Y3NzgwODQ3NWFiMTRkMWFhMTJlY2Y4OTVhL3RhYmxlcmFuZ2U6N2Y1MmZjZjc3ODA4NDc1YWIxNGQxYWExMmVjZjg5NWFfNi03LTEtMS0w_b831fa31-a0ff-4532-abb4-6b57c2019ed6">1,328</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4a110e4972ef4113880ce582e3cda5c5_D20200101-20200630" decimals="-3" name="us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzY2E5YmIwMTc5MjQ3NmZiYjIyNWU1ZDlkZWM4NjlmL3NlYzo5M2NhOWJiMDE3OTI0NzZmYmIyMjVlNWQ5ZGVjODY5Zl8yMi9mcmFnOjQ0ZDZlZTY3ZmE5MDQwOWQ5NzA3MjkyYzUxNjlmNDExL3RhYmxlOjdmNTJmY2Y3NzgwODQ3NWFiMTRkMWFhMTJlY2Y4OTVhL3RhYmxlcmFuZ2U6N2Y1MmZjZjc3ODA4NDc1YWIxNGQxYWExMmVjZjg5NWFfNi0xNS0xLTEtMA_a7002f7e-71bd-455d-9626-b917155b29a2">1</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Vesting of restricted share units</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ief0b929c9a76458b843a186c4b2a71f2_D20200101-20200630" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationRestrictedStockUnitsRequisiteServicePeriodRecognition" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzY2E5YmIwMTc5MjQ3NmZiYjIyNWU1ZDlkZWM4NjlmL3NlYzo5M2NhOWJiMDE3OTI0NzZmYmIyMjVlNWQ5ZGVjODY5Zl8yMi9mcmFnOjQ0ZDZlZTY3ZmE5MDQwOWQ5NzA3MjkyYzUxNjlmNDExL3RhYmxlOjdmNTJmY2Y3NzgwODQ3NWFiMTRkMWFhMTJlY2Y4OTVhL3RhYmxlcmFuZ2U6N2Y1MmZjZjc3ODA4NDc1YWIxNGQxYWExMmVjZjg5NWFfOS03LTEtMS0w_8bd71b11-ff2c-4389-b71f-36befd6a0c93">1,482</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4a110e4972ef4113880ce582e3cda5c5_D20200101-20200630" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationRestrictedStockUnitsRequisiteServicePeriodRecognition" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzY2E5YmIwMTc5MjQ3NmZiYjIyNWU1ZDlkZWM4NjlmL3NlYzo5M2NhOWJiMDE3OTI0NzZmYmIyMjVlNWQ5ZGVjODY5Zl8yMi9mcmFnOjQ0ZDZlZTY3ZmE5MDQwOWQ5NzA3MjkyYzUxNjlmNDExL3RhYmxlOjdmNTJmY2Y3NzgwODQ3NWFiMTRkMWFhMTJlY2Y4OTVhL3RhYmxlcmFuZ2U6N2Y1MmZjZjc3ODA4NDc1YWIxNGQxYWExMmVjZjg5NWFfOS0xNS0xLTEtMA_2e9af5e6-db83-4c18-8e5b-493f20f173fa">1,482</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Vesting of common shares issued in connection with the use of certain publicity rights in brand development</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie28d03ed3f6c447e8db8badbe540043f_D20200101-20200630" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationOtherLongtermIncentivePlansRequisiteServicePeriodRecognition" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzY2E5YmIwMTc5MjQ3NmZiYjIyNWU1ZDlkZWM4NjlmL3NlYzo5M2NhOWJiMDE3OTI0NzZmYmIyMjVlNWQ5ZGVjODY5Zl8yMi9mcmFnOjQ0ZDZlZTY3ZmE5MDQwOWQ5NzA3MjkyYzUxNjlmNDExL3RhYmxlOjdmNTJmY2Y3NzgwODQ3NWFiMTRkMWFhMTJlY2Y4OTVhL3RhYmxlcmFuZ2U6N2Y1MmZjZjc3ODA4NDc1YWIxNGQxYWExMmVjZjg5NWFfMTAtMy0xLTEtMA_3a94635d-b11e-4f44-bd67-6af609f649ad">2,000</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ief0b929c9a76458b843a186c4b2a71f2_D20200101-20200630" decimals="-3" name="us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationOtherLongtermIncentivePlansRequisiteServicePeriodRecognition" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzY2E5YmIwMTc5MjQ3NmZiYjIyNWU1ZDlkZWM4NjlmL3NlYzo5M2NhOWJiMDE3OTI0NzZmYmIyMjVlNWQ5ZGVjODY5Zl8yMi9mcmFnOjQ0ZDZlZTY3ZmE5MDQwOWQ5NzA3MjkyYzUxNjlmNDExL3RhYmxlOjdmNTJmY2Y3NzgwODQ3NWFiMTRkMWFhMTJlY2Y4OTVhL3RhYmxlcmFuZ2U6N2Y1MmZjZjc3ODA4NDc1YWIxNGQxYWExMmVjZjg5NWFfMTAtNy0xLTEtMA_8736d65c-4b23-4e13-ab9d-2141159cba10">158</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4a110e4972ef4113880ce582e3cda5c5_D20200101-20200630" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationOtherLongtermIncentivePlansRequisiteServicePeriodRecognition" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzY2E5YmIwMTc5MjQ3NmZiYjIyNWU1ZDlkZWM4NjlmL3NlYzo5M2NhOWJiMDE3OTI0NzZmYmIyMjVlNWQ5ZGVjODY5Zl8yMi9mcmFnOjQ0ZDZlZTY3ZmE5MDQwOWQ5NzA3MjkyYzUxNjlmNDExL3RhYmxlOjdmNTJmY2Y3NzgwODQ3NWFiMTRkMWFhMTJlY2Y4OTVhL3RhYmxlcmFuZ2U6N2Y1MmZjZjc3ODA4NDc1YWIxNGQxYWExMmVjZjg5NWFfMTAtMTUtMS0xLTA_f52503dc-25eb-476c-a8ea-2a76489e095e">2,158</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Top-up rights exercised</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie28d03ed3f6c447e8db8badbe540043f_D20200101-20200630" decimals="-3" name="cron:StockIssuedDuringPeriodValueTopupRightsExercised" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzY2E5YmIwMTc5MjQ3NmZiYjIyNWU1ZDlkZWM4NjlmL3NlYzo5M2NhOWJiMDE3OTI0NzZmYmIyMjVlNWQ5ZGVjODY5Zl8yMi9mcmFnOjQ0ZDZlZTY3ZmE5MDQwOWQ5NzA3MjkyYzUxNjlmNDExL3RhYmxlOjdmNTJmY2Y3NzgwODQ3NWFiMTRkMWFhMTJlY2Y4OTVhL3RhYmxlcmFuZ2U6N2Y1MmZjZjc3ODA4NDc1YWIxNGQxYWExMmVjZjg5NWFfMTEtMy0xLTEtMA_51f17b13-9408-41d5-b42c-5a26d8e024f0">717</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4a110e4972ef4113880ce582e3cda5c5_D20200101-20200630" decimals="-3" name="cron:StockIssuedDuringPeriodValueTopupRightsExercised" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzY2E5YmIwMTc5MjQ3NmZiYjIyNWU1ZDlkZWM4NjlmL3NlYzo5M2NhOWJiMDE3OTI0NzZmYmIyMjVlNWQ5ZGVjODY5Zl8yMi9mcmFnOjQ0ZDZlZTY3ZmE5MDQwOWQ5NzA3MjkyYzUxNjlmNDExL3RhYmxlOjdmNTJmY2Y3NzgwODQ3NWFiMTRkMWFhMTJlY2Y4OTVhL3RhYmxlcmFuZ2U6N2Y1MmZjZjc3ODA4NDc1YWIxNGQxYWExMmVjZjg5NWFfMTEtMTUtMS0xLTA_8d81d756-3ab1-4c5e-9c89-ec73d6578778">717</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net loss</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i26b7daea50264418b7767fc75a7923c2_D20200101-20200630" decimals="-3" sign="-" format="ixt:numdotdecimal" name="us-gaap:ProfitLoss" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzY2E5YmIwMTc5MjQ3NmZiYjIyNWU1ZDlkZWM4NjlmL3NlYzo5M2NhOWJiMDE3OTI0NzZmYmIyMjVlNWQ5ZGVjODY5Zl8yMi9mcmFnOjQ0ZDZlZTY3ZmE5MDQwOWQ5NzA3MjkyYzUxNjlmNDExL3RhYmxlOjdmNTJmY2Y3NzgwODQ3NWFiMTRkMWFhMTJlY2Y4OTVhL3RhYmxlcmFuZ2U6N2Y1MmZjZjc3ODA4NDc1YWIxNGQxYWExMmVjZjg5NWFfMTItOS0xLTEtMA_dd266eac-f551-478c-8937-fe896bf1c5b0">30,937</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i7c11393ac61249f3805d21818892a170_D20200101-20200630" decimals="-3" sign="-" format="ixt:numdotdecimal" name="us-gaap:ProfitLoss" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzY2E5YmIwMTc5MjQ3NmZiYjIyNWU1ZDlkZWM4NjlmL3NlYzo5M2NhOWJiMDE3OTI0NzZmYmIyMjVlNWQ5ZGVjODY5Zl8yMi9mcmFnOjQ0ZDZlZTY3ZmE5MDQwOWQ5NzA3MjkyYzUxNjlmNDExL3RhYmxlOjdmNTJmY2Y3NzgwODQ3NWFiMTRkMWFhMTJlY2Y4OTVhL3RhYmxlcmFuZ2U6N2Y1MmZjZjc3ODA4NDc1YWIxNGQxYWExMmVjZjg5NWFfMTItMTMtMS0xLTA_c96e9bcb-d2e0-40d7-9503-5b98fd918f3a">1,085</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i4a110e4972ef4113880ce582e3cda5c5_D20200101-20200630" decimals="-3" sign="-" format="ixt:numdotdecimal" name="us-gaap:ProfitLoss" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzY2E5YmIwMTc5MjQ3NmZiYjIyNWU1ZDlkZWM4NjlmL3NlYzo5M2NhOWJiMDE3OTI0NzZmYmIyMjVlNWQ5ZGVjODY5Zl8yMi9mcmFnOjQ0ZDZlZTY3ZmE5MDQwOWQ5NzA3MjkyYzUxNjlmNDExL3RhYmxlOjdmNTJmY2Y3NzgwODQ3NWFiMTRkMWFhMTJlY2Y4OTVhL3RhYmxlcmFuZ2U6N2Y1MmZjZjc3ODA4NDc1YWIxNGQxYWExMmVjZjg5NWFfMTItMTUtMS0xLTA_5cb5b7b2-73de-4b79-8669-0e8c407ec5b0">32,022</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Foreign exchange loss on translation</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ifa1d8c60d03c4b2d83a1d0b04dad4282_D20200101-20200630" decimals="-3" sign="-" format="ixt:numdotdecimal" name="us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzY2E5YmIwMTc5MjQ3NmZiYjIyNWU1ZDlkZWM4NjlmL3NlYzo5M2NhOWJiMDE3OTI0NzZmYmIyMjVlNWQ5ZGVjODY5Zl8yMi9mcmFnOjQ0ZDZlZTY3ZmE5MDQwOWQ5NzA3MjkyYzUxNjlmNDExL3RhYmxlOjdmNTJmY2Y3NzgwODQ3NWFiMTRkMWFhMTJlY2Y4OTVhL3RhYmxlcmFuZ2U6N2Y1MmZjZjc3ODA4NDc1YWIxNGQxYWExMmVjZjg5NWFfMTMtMTEtMS0xLTA_424673a9-809c-4ac2-a308-11384e8b0b9b">61,808</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i7c11393ac61249f3805d21818892a170_D20200101-20200630" decimals="-3" sign="-" name="us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzY2E5YmIwMTc5MjQ3NmZiYjIyNWU1ZDlkZWM4NjlmL3NlYzo5M2NhOWJiMDE3OTI0NzZmYmIyMjVlNWQ5ZGVjODY5Zl8yMi9mcmFnOjQ0ZDZlZTY3ZmE5MDQwOWQ5NzA3MjkyYzUxNjlmNDExL3RhYmxlOjdmNTJmY2Y3NzgwODQ3NWFiMTRkMWFhMTJlY2Y4OTVhL3RhYmxlcmFuZ2U6N2Y1MmZjZjc3ODA4NDc1YWIxNGQxYWExMmVjZjg5NWFfMTMtMTMtMS0xLTA_b1d09f32-7057-4de8-b2fb-81324e31e287">13</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i4a110e4972ef4113880ce582e3cda5c5_D20200101-20200630" decimals="-3" sign="-" format="ixt:numdotdecimal" name="us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzY2E5YmIwMTc5MjQ3NmZiYjIyNWU1ZDlkZWM4NjlmL3NlYzo5M2NhOWJiMDE3OTI0NzZmYmIyMjVlNWQ5ZGVjODY5Zl8yMi9mcmFnOjQ0ZDZlZTY3ZmE5MDQwOWQ5NzA3MjkyYzUxNjlmNDExL3RhYmxlOjdmNTJmY2Y3NzgwODQ3NWFiMTRkMWFhMTJlY2Y4OTVhL3RhYmxlcmFuZ2U6N2Y1MmZjZjc3ODA4NDc1YWIxNGQxYWExMmVjZjg5NWFfMTMtMTUtMS0xLTA_57c82b48-e4f1-42f6-892a-db3d501db9ca">61,821</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance at June 30, 2020</span></td><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i7b64ecf012bd43b397dcea9317f0673b_I20200630" decimals="INF" format="ixt:numdotdecimal" name="us-gaap:CommonStockSharesOutstanding" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjkzY2E5YmIwMTc5MjQ3NmZiYjIyNWU1ZDlkZWM4NjlmL3NlYzo5M2NhOWJiMDE3OTI0NzZmYmIyMjVlNWQ5ZGVjODY5Zl8yMi9mcmFnOjQ0ZDZlZTY3ZmE5MDQwOWQ5NzA3MjkyYzUxNjlmNDExL3RhYmxlOjdmNTJmY2Y3NzgwODQ3NWFiMTRkMWFhMTJlY2Y4OTVhL3RhYmxlcmFuZ2U6N2Y1MmZjZjc3ODA4NDc1YWIxNGQxYWExMmVjZjg5NWFfMTQtMS0xLTEtMA_6f6c073f-3b64-403f-a64c-1e249c6ade38">349,886,402</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7b64ecf012bd43b397dcea9317f0673b_I20200630" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzY2E5YmIwMTc5MjQ3NmZiYjIyNWU1ZDlkZWM4NjlmL3NlYzo5M2NhOWJiMDE3OTI0NzZmYmIyMjVlNWQ5ZGVjODY5Zl8yMi9mcmFnOjQ0ZDZlZTY3ZmE5MDQwOWQ5NzA3MjkyYzUxNjlmNDExL3RhYmxlOjdmNTJmY2Y3NzgwODQ3NWFiMTRkMWFhMTJlY2Y4OTVhL3RhYmxlcmFuZ2U6N2Y1MmZjZjc3ODA4NDc1YWIxNGQxYWExMmVjZjg5NWFfMTQtMy0xLTEtMA_3ab2ee4c-5879-497e-95d7-292d1dcc2dd6">565,211</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if06bdc9d2d5b40ca88594d8c716a000d_I20200630" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzY2E5YmIwMTc5MjQ3NmZiYjIyNWU1ZDlkZWM4NjlmL3NlYzo5M2NhOWJiMDE3OTI0NzZmYmIyMjVlNWQ5ZGVjODY5Zl8yMi9mcmFnOjQ0ZDZlZTY3ZmE5MDQwOWQ5NzA3MjkyYzUxNjlmNDExL3RhYmxlOjdmNTJmY2Y3NzgwODQ3NWFiMTRkMWFhMTJlY2Y4OTVhL3RhYmxlcmFuZ2U6N2Y1MmZjZjc3ODA4NDc1YWIxNGQxYWExMmVjZjg5NWFfMTQtNy0xLTEtMA_3c037a84-7d73-4593-8408-6ad0e78dccab">27,046</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ibd5f91f865b44c90b9aab2e68420d292_I20200630" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzY2E5YmIwMTc5MjQ3NmZiYjIyNWU1ZDlkZWM4NjlmL3NlYzo5M2NhOWJiMDE3OTI0NzZmYmIyMjVlNWQ5ZGVjODY5Zl8yMi9mcmFnOjQ0ZDZlZTY3ZmE5MDQwOWQ5NzA3MjkyYzUxNjlmNDExL3RhYmxlOjdmNTJmY2Y3NzgwODQ3NWFiMTRkMWFhMTJlY2Y4OTVhL3RhYmxlcmFuZ2U6N2Y1MmZjZjc3ODA4NDc1YWIxNGQxYWExMmVjZjg5NWFfMTQtOS0xLTEtMA_57fdcf06-62d1-48a0-b6ae-3f39596df2e6">1,106,709</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ib7db517c67504b3baeead491589a7ed6_I20200630" decimals="-3" sign="-" format="ixt:numdotdecimal" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzY2E5YmIwMTc5MjQ3NmZiYjIyNWU1ZDlkZWM4NjlmL3NlYzo5M2NhOWJiMDE3OTI0NzZmYmIyMjVlNWQ5ZGVjODY5Zl8yMi9mcmFnOjQ0ZDZlZTY3ZmE5MDQwOWQ5NzA3MjkyYzUxNjlmNDExL3RhYmxlOjdmNTJmY2Y3NzgwODQ3NWFiMTRkMWFhMTJlY2Y4OTVhL3RhYmxlcmFuZ2U6N2Y1MmZjZjc3ODA4NDc1YWIxNGQxYWExMmVjZjg5NWFfMTQtMTEtMS0xLTA_f5f53ba1-064a-4e27-adba-f3fe731ff7ea">33,970</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i87ce495c26b34c268c848a2934ad3f39_I20200630" decimals="-3" sign="-" format="ixt:numdotdecimal" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzY2E5YmIwMTc5MjQ3NmZiYjIyNWU1ZDlkZWM4NjlmL3NlYzo5M2NhOWJiMDE3OTI0NzZmYmIyMjVlNWQ5ZGVjODY5Zl8yMi9mcmFnOjQ0ZDZlZTY3ZmE5MDQwOWQ5NzA3MjkyYzUxNjlmNDExL3RhYmxlOjdmNTJmY2Y3NzgwODQ3NWFiMTRkMWFhMTJlY2Y4OTVhL3RhYmxlcmFuZ2U6N2Y1MmZjZjc3ODA4NDc1YWIxNGQxYWExMmVjZjg5NWFfMTQtMTMtMS0xLTA_f4f65394-2bbf-4931-8922-0ad73fbe9ea6">1,951</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id670dc9b33e6430f9d7510009f7495a7_I20200630" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzY2E5YmIwMTc5MjQ3NmZiYjIyNWU1ZDlkZWM4NjlmL3NlYzo5M2NhOWJiMDE3OTI0NzZmYmIyMjVlNWQ5ZGVjODY5Zl8yMi9mcmFnOjQ0ZDZlZTY3ZmE5MDQwOWQ5NzA3MjkyYzUxNjlmNDExL3RhYmxlOjdmNTJmY2Y3NzgwODQ3NWFiMTRkMWFhMTJlY2Y4OTVhL3RhYmxlcmFuZ2U6N2Y1MmZjZjc3ODA4NDc1YWIxNGQxYWExMmVjZjg5NWFfMTQtMTUtMS0xLTA_6afc9cc0-c3c8-4d59-9aab-09ed61a07df1">1,663,045</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">See notes to condensed consolidated financial statements.</span></div><div style="height:31.5pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">7</span></div></div></div><div id="i93ca9bb01792476fbb225e5d9dec869f_28"></div><hr style="page-break-after:always"/><div style="min-height:72pt;width:100%"><div style="margin-top:0.55pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:65.712%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:32.088%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="border-top:1pt solid #FFFFFF;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Cronos Group Inc.</span></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Condensed Consolidated Statements of Cash Flows</span></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">(In thousands of U.S. dollars, except share amounts, unaudited)</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i93ca9bb01792476fbb225e5d9dec869f_7">Table of Contents</a></span></div></td></tr></table></div><div style="margin-top:0.55pt"><span><br/></span></div></div><div style="padding-left:29.25pt;text-align:justify;text-indent:-27pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.861%"><tr><td style="width:1.0%"></td><td style="width:64.685%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:15.450%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.912%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:15.453%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Six months ended June 30,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Operating activities</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net loss</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i69782326f71a44e3805518280ee22b6b_D20210101-20210630" decimals="-3" sign="-" format="ixt:numdotdecimal" name="us-gaap:ProfitLoss" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzY2E5YmIwMTc5MjQ3NmZiYjIyNWU1ZDlkZWM4NjlmL3NlYzo5M2NhOWJiMDE3OTI0NzZmYmIyMjVlNWQ5ZGVjODY5Zl8yOC9mcmFnOjBmMzU2YWJkNmM5MzQyY2JhM2ZlYzVkNWUzMzA4NzZkL3RhYmxlOmMwM2NjYzgzMmYwMDQxNTlhYjIzZDc4NDg5NThhMzI5L3RhYmxlcmFuZ2U6YzAzY2NjODMyZjAwNDE1OWFiMjNkNzg0ODk1OGEzMjlfMy0xLTEtMS0w_d51ad10f-10e1-4beb-b701-b4325712b6ed">104,850</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i4a110e4972ef4113880ce582e3cda5c5_D20200101-20200630" decimals="-3" sign="-" format="ixt:numdotdecimal" name="us-gaap:ProfitLoss" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzY2E5YmIwMTc5MjQ3NmZiYjIyNWU1ZDlkZWM4NjlmL3NlYzo5M2NhOWJiMDE3OTI0NzZmYmIyMjVlNWQ5ZGVjODY5Zl8yOC9mcmFnOjBmMzU2YWJkNmM5MzQyY2JhM2ZlYzVkNWUzMzA4NzZkL3RhYmxlOmMwM2NjYzgzMmYwMDQxNTlhYjIzZDc4NDg5NThhMzI5L3RhYmxlcmFuZ2U6YzAzY2NjODMyZjAwNDE1OWFiMjNkNzg0ODk1OGEzMjlfMy0zLTEtMS0w_3c0743eb-254f-42b5-a6c3-58082850153e">32,022</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;Adjustments to reconcile net loss to cash provided by operating activities:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Share-based payments</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i69782326f71a44e3805518280ee22b6b_D20210101-20210630" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:ShareBasedCompensation" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzY2E5YmIwMTc5MjQ3NmZiYjIyNWU1ZDlkZWM4NjlmL3NlYzo5M2NhOWJiMDE3OTI0NzZmYmIyMjVlNWQ5ZGVjODY5Zl8yOC9mcmFnOjBmMzU2YWJkNmM5MzQyY2JhM2ZlYzVkNWUzMzA4NzZkL3RhYmxlOmMwM2NjYzgzMmYwMDQxNTlhYjIzZDc4NDg5NThhMzI5L3RhYmxlcmFuZ2U6YzAzY2NjODMyZjAwNDE1OWFiMjNkNzg0ODk1OGEzMjlfNi0xLTEtMS0w_be0b1830-7b5f-4d18-a9f4-83d45608f2ec">5,064</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4a110e4972ef4113880ce582e3cda5c5_D20200101-20200630" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:ShareBasedCompensation" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzY2E5YmIwMTc5MjQ3NmZiYjIyNWU1ZDlkZWM4NjlmL3NlYzo5M2NhOWJiMDE3OTI0NzZmYmIyMjVlNWQ5ZGVjODY5Zl8yOC9mcmFnOjBmMzU2YWJkNmM5MzQyY2JhM2ZlYzVkNWUzMzA4NzZkL3RhYmxlOmMwM2NjYzgzMmYwMDQxNTlhYjIzZDc4NDg5NThhMzI5L3RhYmxlcmFuZ2U6YzAzY2NjODMyZjAwNDE1OWFiMjNkNzg0ODk1OGEzMjlfNi0zLTEtMS0w_2001feb1-7696-4b1a-9b51-55d3c38ce467">4,982</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Depreciation and amortization</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i69782326f71a44e3805518280ee22b6b_D20210101-20210630" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:DepreciationDepletionAndAmortization" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzY2E5YmIwMTc5MjQ3NmZiYjIyNWU1ZDlkZWM4NjlmL3NlYzo5M2NhOWJiMDE3OTI0NzZmYmIyMjVlNWQ5ZGVjODY5Zl8yOC9mcmFnOjBmMzU2YWJkNmM5MzQyY2JhM2ZlYzVkNWUzMzA4NzZkL3RhYmxlOmMwM2NjYzgzMmYwMDQxNTlhYjIzZDc4NDg5NThhMzI5L3RhYmxlcmFuZ2U6YzAzY2NjODMyZjAwNDE1OWFiMjNkNzg0ODk1OGEzMjlfNy0xLTEtMS0w_01546127-9ae4-4194-8158-e986a74a049e">5,083</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4a110e4972ef4113880ce582e3cda5c5_D20200101-20200630" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:DepreciationDepletionAndAmortization" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzY2E5YmIwMTc5MjQ3NmZiYjIyNWU1ZDlkZWM4NjlmL3NlYzo5M2NhOWJiMDE3OTI0NzZmYmIyMjVlNWQ5ZGVjODY5Zl8yOC9mcmFnOjBmMzU2YWJkNmM5MzQyY2JhM2ZlYzVkNWUzMzA4NzZkL3RhYmxlOmMwM2NjYzgzMmYwMDQxNTlhYjIzZDc4NDg5NThhMzI5L3RhYmxlcmFuZ2U6YzAzY2NjODMyZjAwNDE1OWFiMjNkNzg0ODk1OGEzMjlfNy0zLTEtMS0w_65889e10-7331-459a-9b81-25c304b127ff">2,879</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Share of loss from investments in equity accounted investees</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i69782326f71a44e3805518280ee22b6b_D20210101-20210630" decimals="-3" sign="-" format="ixt:numdotdecimal" name="us-gaap:IncomeLossFromEquityMethodInvestments" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzY2E5YmIwMTc5MjQ3NmZiYjIyNWU1ZDlkZWM4NjlmL3NlYzo5M2NhOWJiMDE3OTI0NzZmYmIyMjVlNWQ5ZGVjODY5Zl8yOC9mcmFnOjBmMzU2YWJkNmM5MzQyY2JhM2ZlYzVkNWUzMzA4NzZkL3RhYmxlOmMwM2NjYzgzMmYwMDQxNTlhYjIzZDc4NDg5NThhMzI5L3RhYmxlcmFuZ2U6YzAzY2NjODMyZjAwNDE1OWFiMjNkNzg0ODk1OGEzMjlfOC0xLTEtMS00NDEw_67411db9-bad7-42cc-ba3d-8d5b1fd52132">2,758</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4a110e4972ef4113880ce582e3cda5c5_D20200101-20200630" decimals="-3" sign="-" format="ixt:numdotdecimal" name="us-gaap:IncomeLossFromEquityMethodInvestments" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzY2E5YmIwMTc5MjQ3NmZiYjIyNWU1ZDlkZWM4NjlmL3NlYzo5M2NhOWJiMDE3OTI0NzZmYmIyMjVlNWQ5ZGVjODY5Zl8yOC9mcmFnOjBmMzU2YWJkNmM5MzQyY2JhM2ZlYzVkNWUzMzA4NzZkL3RhYmxlOmMwM2NjYzgzMmYwMDQxNTlhYjIzZDc4NDg5NThhMzI5L3RhYmxlcmFuZ2U6YzAzY2NjODMyZjAwNDE1OWFiMjNkNzg0ODk1OGEzMjlfOC0zLTEtMS00NDEw_a00235f1-96d8-496d-a82b-14ee832a2e94">1,966</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Gain (loss) on revaluation of derivative liabilities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i69782326f71a44e3805518280ee22b6b_D20210101-20210630" decimals="-3" sign="-" format="ixt:numdotdecimal" name="us-gaap:GainLossOnDerivativeInstrumentsNetPretax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzY2E5YmIwMTc5MjQ3NmZiYjIyNWU1ZDlkZWM4NjlmL3NlYzo5M2NhOWJiMDE3OTI0NzZmYmIyMjVlNWQ5ZGVjODY5Zl8yOC9mcmFnOjBmMzU2YWJkNmM5MzQyY2JhM2ZlYzVkNWUzMzA4NzZkL3RhYmxlOmMwM2NjYzgzMmYwMDQxNTlhYjIzZDc4NDg5NThhMzI5L3RhYmxlcmFuZ2U6YzAzY2NjODMyZjAwNDE1OWFiMjNkNzg0ODk1OGEzMjlfOC0xLTEtMS0w_d5ff912b-2fdb-40fc-84a9-8aa091b100de">1,626</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i4a110e4972ef4113880ce582e3cda5c5_D20200101-20200630" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:GainLossOnDerivativeInstrumentsNetPretax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzY2E5YmIwMTc5MjQ3NmZiYjIyNWU1ZDlkZWM4NjlmL3NlYzo5M2NhOWJiMDE3OTI0NzZmYmIyMjVlNWQ5ZGVjODY5Zl8yOC9mcmFnOjBmMzU2YWJkNmM5MzQyY2JhM2ZlYzVkNWUzMzA4NzZkL3RhYmxlOmMwM2NjYzgzMmYwMDQxNTlhYjIzZDc4NDg5NThhMzI5L3RhYmxlcmFuZ2U6YzAzY2NjODMyZjAwNDE1OWFiMjNkNzg0ODk1OGEzMjlfOC0zLTEtMS0w_87d8870d-5673-42c1-a560-02e81bc1743d">77,488</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Impairment loss on long-lived assets</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i69782326f71a44e3805518280ee22b6b_D20210101-20210630" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:AssetImpairmentCharges" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzY2E5YmIwMTc5MjQ3NmZiYjIyNWU1ZDlkZWM4NjlmL3NlYzo5M2NhOWJiMDE3OTI0NzZmYmIyMjVlNWQ5ZGVjODY5Zl8yOC9mcmFnOjBmMzU2YWJkNmM5MzQyY2JhM2ZlYzVkNWUzMzA4NzZkL3RhYmxlOmMwM2NjYzgzMmYwMDQxNTlhYjIzZDc4NDg5NThhMzI5L3RhYmxlcmFuZ2U6YzAzY2NjODMyZjAwNDE1OWFiMjNkNzg0ODk1OGEzMjlfMTEtMS0xLTEtNzQ1_7279763f-ffe8-4c83-94e0-105df3345037">1,741</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4a110e4972ef4113880ce582e3cda5c5_D20200101-20200630" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:AssetImpairmentCharges" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzY2E5YmIwMTc5MjQ3NmZiYjIyNWU1ZDlkZWM4NjlmL3NlYzo5M2NhOWJiMDE3OTI0NzZmYmIyMjVlNWQ5ZGVjODY5Zl8yOC9mcmFnOjBmMzU2YWJkNmM5MzQyY2JhM2ZlYzVkNWUzMzA4NzZkL3RhYmxlOmMwM2NjYzgzMmYwMDQxNTlhYjIzZDc4NDg5NThhMzI5L3RhYmxlcmFuZ2U6YzAzY2NjODMyZjAwNDE1OWFiMjNkNzg0ODk1OGEzMjlfMTEtMy0xLTEtNzQ5_9fc3b0a9-7764-4bde-8a1f-10a1070bca39">40,000</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Expected credit losses on long-term financial assets</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i69782326f71a44e3805518280ee22b6b_D20210101-20210630" decimals="-3" format="ixt:zerodash" name="us-gaap:ProvisionForDoubtfulAccounts" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzY2E5YmIwMTc5MjQ3NmZiYjIyNWU1ZDlkZWM4NjlmL3NlYzo5M2NhOWJiMDE3OTI0NzZmYmIyMjVlNWQ5ZGVjODY5Zl8yOC9mcmFnOjBmMzU2YWJkNmM5MzQyY2JhM2ZlYzVkNWUzMzA4NzZkL3RhYmxlOmMwM2NjYzgzMmYwMDQxNTlhYjIzZDc4NDg5NThhMzI5L3RhYmxlcmFuZ2U6YzAzY2NjODMyZjAwNDE1OWFiMjNkNzg0ODk1OGEzMjlfMTAtMS0xLTEtMA_ee258a8f-f8a7-4776-8b81-d31a6dfa8def">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4a110e4972ef4113880ce582e3cda5c5_D20200101-20200630" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:ProvisionForDoubtfulAccounts" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzY2E5YmIwMTc5MjQ3NmZiYjIyNWU1ZDlkZWM4NjlmL3NlYzo5M2NhOWJiMDE3OTI0NzZmYmIyMjVlNWQ5ZGVjODY5Zl8yOC9mcmFnOjBmMzU2YWJkNmM5MzQyY2JhM2ZlYzVkNWUzMzA4NzZkL3RhYmxlOmMwM2NjYzgzMmYwMDQxNTlhYjIzZDc4NDg5NThhMzI5L3RhYmxlcmFuZ2U6YzAzY2NjODMyZjAwNDE1OWFiMjNkNzg0ODk1OGEzMjlfMTAtMy0xLTEtMA_6757f255-6d80-4358-ae21-a9d5f9a0f89b">1,357</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other non-cash operating activities, net</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i69782326f71a44e3805518280ee22b6b_D20210101-20210630" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:OtherNoncashIncomeExpense" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzY2E5YmIwMTc5MjQ3NmZiYjIyNWU1ZDlkZWM4NjlmL3NlYzo5M2NhOWJiMDE3OTI0NzZmYmIyMjVlNWQ5ZGVjODY5Zl8yOC9mcmFnOjBmMzU2YWJkNmM5MzQyY2JhM2ZlYzVkNWUzMzA4NzZkL3RhYmxlOmMwM2NjYzgzMmYwMDQxNTlhYjIzZDc4NDg5NThhMzI5L3RhYmxlcmFuZ2U6YzAzY2NjODMyZjAwNDE1OWFiMjNkNzg0ODk1OGEzMjlfMTEtMS0xLTEtMA_45a22630-4b05-45ec-a7e8-52745ef7666d">1,192</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4a110e4972ef4113880ce582e3cda5c5_D20200101-20200630" decimals="-3" sign="-" name="us-gaap:OtherNoncashIncomeExpense" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzY2E5YmIwMTc5MjQ3NmZiYjIyNWU1ZDlkZWM4NjlmL3NlYzo5M2NhOWJiMDE3OTI0NzZmYmIyMjVlNWQ5ZGVjODY5Zl8yOC9mcmFnOjBmMzU2YWJkNmM5MzQyY2JhM2ZlYzVkNWUzMzA4NzZkL3RhYmxlOmMwM2NjYzgzMmYwMDQxNTlhYjIzZDc4NDg5NThhMzI5L3RhYmxlcmFuZ2U6YzAzY2NjODMyZjAwNDE1OWFiMjNkNzg0ODk1OGEzMjlfMTEtMy0xLTEtMA_365c3c27-15c9-482c-974d-2c4677ab7c1e">599</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Changes in operating assets and liabilities:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accounts receivable, net</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i69782326f71a44e3805518280ee22b6b_D20210101-20210630" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:IncreaseDecreaseInAccountsReceivable" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzY2E5YmIwMTc5MjQ3NmZiYjIyNWU1ZDlkZWM4NjlmL3NlYzo5M2NhOWJiMDE3OTI0NzZmYmIyMjVlNWQ5ZGVjODY5Zl8yOC9mcmFnOjBmMzU2YWJkNmM5MzQyY2JhM2ZlYzVkNWUzMzA4NzZkL3RhYmxlOmMwM2NjYzgzMmYwMDQxNTlhYjIzZDc4NDg5NThhMzI5L3RhYmxlcmFuZ2U6YzAzY2NjODMyZjAwNDE1OWFiMjNkNzg0ODk1OGEzMjlfMTMtMS0xLTEtMA_0b21eec6-5aaa-410d-8c51-f044ce953e40">2,194</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4a110e4972ef4113880ce582e3cda5c5_D20200101-20200630" decimals="-3" sign="-" format="ixt:numdotdecimal" name="us-gaap:IncreaseDecreaseInAccountsReceivable" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzY2E5YmIwMTc5MjQ3NmZiYjIyNWU1ZDlkZWM4NjlmL3NlYzo5M2NhOWJiMDE3OTI0NzZmYmIyMjVlNWQ5ZGVjODY5Zl8yOC9mcmFnOjBmMzU2YWJkNmM5MzQyY2JhM2ZlYzVkNWUzMzA4NzZkL3RhYmxlOmMwM2NjYzgzMmYwMDQxNTlhYjIzZDc4NDg5NThhMzI5L3RhYmxlcmFuZ2U6YzAzY2NjODMyZjAwNDE1OWFiMjNkNzg0ODk1OGEzMjlfMTMtMy0xLTEtMA_f9bfa8f5-556d-453e-bf65-e26efc774e3d">2,895</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other receivables</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i69782326f71a44e3805518280ee22b6b_D20210101-20210630" decimals="-3" sign="-" format="ixt:numdotdecimal" name="us-gaap:IncreaseDecreaseInOtherReceivables" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzY2E5YmIwMTc5MjQ3NmZiYjIyNWU1ZDlkZWM4NjlmL3NlYzo5M2NhOWJiMDE3OTI0NzZmYmIyMjVlNWQ5ZGVjODY5Zl8yOC9mcmFnOjBmMzU2YWJkNmM5MzQyY2JhM2ZlYzVkNWUzMzA4NzZkL3RhYmxlOmMwM2NjYzgzMmYwMDQxNTlhYjIzZDc4NDg5NThhMzI5L3RhYmxlcmFuZ2U6YzAzY2NjODMyZjAwNDE1OWFiMjNkNzg0ODk1OGEzMjlfMTQtMS0xLTEtMA_c79e36bd-f0b2-43a6-a14c-31b5424aa9df">6,960</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i4a110e4972ef4113880ce582e3cda5c5_D20200101-20200630" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:IncreaseDecreaseInOtherReceivables" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzY2E5YmIwMTc5MjQ3NmZiYjIyNWU1ZDlkZWM4NjlmL3NlYzo5M2NhOWJiMDE3OTI0NzZmYmIyMjVlNWQ5ZGVjODY5Zl8yOC9mcmFnOjBmMzU2YWJkNmM5MzQyY2JhM2ZlYzVkNWUzMzA4NzZkL3RhYmxlOmMwM2NjYzgzMmYwMDQxNTlhYjIzZDc4NDg5NThhMzI5L3RhYmxlcmFuZ2U6YzAzY2NjODMyZjAwNDE1OWFiMjNkNzg0ODk1OGEzMjlfMTQtMy0xLTEtMA_aaa720c7-7d6d-4c94-a0bc-81ef49d6446d">3,047</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Prepaids and other current assets</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i69782326f71a44e3805518280ee22b6b_D20210101-20210630" decimals="-3" sign="-" format="ixt:numdotdecimal" name="us-gaap:IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzY2E5YmIwMTc5MjQ3NmZiYjIyNWU1ZDlkZWM4NjlmL3NlYzo5M2NhOWJiMDE3OTI0NzZmYmIyMjVlNWQ5ZGVjODY5Zl8yOC9mcmFnOjBmMzU2YWJkNmM5MzQyY2JhM2ZlYzVkNWUzMzA4NzZkL3RhYmxlOmMwM2NjYzgzMmYwMDQxNTlhYjIzZDc4NDg5NThhMzI5L3RhYmxlcmFuZ2U6YzAzY2NjODMyZjAwNDE1OWFiMjNkNzg0ODk1OGEzMjlfMTUtMS0xLTEtMA_1ef39fd3-2e42-4b88-86c9-c9859812f401">1,268</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4a110e4972ef4113880ce582e3cda5c5_D20200101-20200630" decimals="-3" sign="-" format="ixt:numdotdecimal" name="us-gaap:IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzY2E5YmIwMTc5MjQ3NmZiYjIyNWU1ZDlkZWM4NjlmL3NlYzo5M2NhOWJiMDE3OTI0NzZmYmIyMjVlNWQ5ZGVjODY5Zl8yOC9mcmFnOjBmMzU2YWJkNmM5MzQyY2JhM2ZlYzVkNWUzMzA4NzZkL3RhYmxlOmMwM2NjYzgzMmYwMDQxNTlhYjIzZDc4NDg5NThhMzI5L3RhYmxlcmFuZ2U6YzAzY2NjODMyZjAwNDE1OWFiMjNkNzg0ODk1OGEzMjlfMTUtMy0xLTEtMA_f2260a37-8a3c-4535-afbd-7cd1177afd33">1,187</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Inventory, net</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i69782326f71a44e3805518280ee22b6b_D20210101-20210630" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:IncreaseDecreaseInInventories" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzY2E5YmIwMTc5MjQ3NmZiYjIyNWU1ZDlkZWM4NjlmL3NlYzo5M2NhOWJiMDE3OTI0NzZmYmIyMjVlNWQ5ZGVjODY5Zl8yOC9mcmFnOjBmMzU2YWJkNmM5MzQyY2JhM2ZlYzVkNWUzMzA4NzZkL3RhYmxlOmMwM2NjYzgzMmYwMDQxNTlhYjIzZDc4NDg5NThhMzI5L3RhYmxlcmFuZ2U6YzAzY2NjODMyZjAwNDE1OWFiMjNkNzg0ODk1OGEzMjlfMTctMS0xLTEtMTkyOTg_75c7bbcb-1eb6-4e8d-8768-f8dde5e80ca3">1,010</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i4a110e4972ef4113880ce582e3cda5c5_D20200101-20200630" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:IncreaseDecreaseInInventories" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzY2E5YmIwMTc5MjQ3NmZiYjIyNWU1ZDlkZWM4NjlmL3NlYzo5M2NhOWJiMDE3OTI0NzZmYmIyMjVlNWQ5ZGVjODY5Zl8yOC9mcmFnOjBmMzU2YWJkNmM5MzQyY2JhM2ZlYzVkNWUzMzA4NzZkL3RhYmxlOmMwM2NjYzgzMmYwMDQxNTlhYjIzZDc4NDg5NThhMzI5L3RhYmxlcmFuZ2U6YzAzY2NjODMyZjAwNDE1OWFiMjNkNzg0ODk1OGEzMjlfMTctMy0xLTEtMTkyOTg_e925392c-2060-4b8c-a15b-5a847cc31d89">24,292</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Inventory write-down</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i69782326f71a44e3805518280ee22b6b_D20210101-20210630" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:InventoryWriteDown" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzY2E5YmIwMTc5MjQ3NmZiYjIyNWU1ZDlkZWM4NjlmL3NlYzo5M2NhOWJiMDE3OTI0NzZmYmIyMjVlNWQ5ZGVjODY5Zl8yOC9mcmFnOjBmMzU2YWJkNmM5MzQyY2JhM2ZlYzVkNWUzMzA4NzZkL3RhYmxlOmMwM2NjYzgzMmYwMDQxNTlhYjIzZDc4NDg5NThhMzI5L3RhYmxlcmFuZ2U6YzAzY2NjODMyZjAwNDE1OWFiMjNkNzg0ODk1OGEzMjlfMTYtMS0xLTEtMA_4f7db48a-7e4d-460d-9094-fe8b741d1e2a">11,961</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4a110e4972ef4113880ce582e3cda5c5_D20200101-20200630" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:InventoryWriteDown" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzY2E5YmIwMTc5MjQ3NmZiYjIyNWU1ZDlkZWM4NjlmL3NlYzo5M2NhOWJiMDE3OTI0NzZmYmIyMjVlNWQ5ZGVjODY5Zl8yOC9mcmFnOjBmMzU2YWJkNmM5MzQyY2JhM2ZlYzVkNWUzMzA4NzZkL3RhYmxlOmMwM2NjYzgzMmYwMDQxNTlhYjIzZDc4NDg5NThhMzI5L3RhYmxlcmFuZ2U6YzAzY2NjODMyZjAwNDE1OWFiMjNkNzg0ODk1OGEzMjlfMTYtMy0xLTEtMA_06a8c857-dce8-4dd1-aad1-81a9486757a6">11,024</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accounts payable and other liabilities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i69782326f71a44e3805518280ee22b6b_D20210101-20210630" decimals="-3" sign="-" format="ixt:numdotdecimal" name="us-gaap:IncreaseDecreaseInAccountsPayableAndOtherOperatingLiabilities" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzY2E5YmIwMTc5MjQ3NmZiYjIyNWU1ZDlkZWM4NjlmL3NlYzo5M2NhOWJiMDE3OTI0NzZmYmIyMjVlNWQ5ZGVjODY5Zl8yOC9mcmFnOjBmMzU2YWJkNmM5MzQyY2JhM2ZlYzVkNWUzMzA4NzZkL3RhYmxlOmMwM2NjYzgzMmYwMDQxNTlhYjIzZDc4NDg5NThhMzI5L3RhYmxlcmFuZ2U6YzAzY2NjODMyZjAwNDE1OWFiMjNkNzg0ODk1OGEzMjlfMTctMS0xLTEtMA_7fa2a5e3-57b0-4b18-845c-a8ddd339a10b">13,412</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i4a110e4972ef4113880ce582e3cda5c5_D20200101-20200630" decimals="-3" sign="-" format="ixt:numdotdecimal" name="us-gaap:IncreaseDecreaseInAccountsPayableAndOtherOperatingLiabilities" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzY2E5YmIwMTc5MjQ3NmZiYjIyNWU1ZDlkZWM4NjlmL3NlYzo5M2NhOWJiMDE3OTI0NzZmYmIyMjVlNWQ5ZGVjODY5Zl8yOC9mcmFnOjBmMzU2YWJkNmM5MzQyY2JhM2ZlYzVkNWUzMzA4NzZkL3RhYmxlOmMwM2NjYzgzMmYwMDQxNTlhYjIzZDc4NDg5NThhMzI5L3RhYmxlcmFuZ2U6YzAzY2NjODMyZjAwNDE1OWFiMjNkNzg0ODk1OGEzMjlfMTctMy0xLTEtMA_f40ef65c-109d-4fc7-bc9f-e4fc39fe6122">8,417</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cash flows used in operating activities</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i69782326f71a44e3805518280ee22b6b_D20210101-20210630" decimals="-3" sign="-" format="ixt:numdotdecimal" name="us-gaap:NetCashProvidedByUsedInOperatingActivities" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzY2E5YmIwMTc5MjQ3NmZiYjIyNWU1ZDlkZWM4NjlmL3NlYzo5M2NhOWJiMDE3OTI0NzZmYmIyMjVlNWQ5ZGVjODY5Zl8yOC9mcmFnOjBmMzU2YWJkNmM5MzQyY2JhM2ZlYzVkNWUzMzA4NzZkL3RhYmxlOmMwM2NjYzgzMmYwMDQxNTlhYjIzZDc4NDg5NThhMzI5L3RhYmxlcmFuZ2U6YzAzY2NjODMyZjAwNDE1OWFiMjNkNzg0ODk1OGEzMjlfMTgtMS0xLTEtMA_799348f1-6bbc-4051-b8a0-94c93e99c899">86,197</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i4a110e4972ef4113880ce582e3cda5c5_D20200101-20200630" decimals="-3" sign="-" format="ixt:numdotdecimal" name="us-gaap:NetCashProvidedByUsedInOperatingActivities" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzY2E5YmIwMTc5MjQ3NmZiYjIyNWU1ZDlkZWM4NjlmL3NlYzo5M2NhOWJiMDE3OTI0NzZmYmIyMjVlNWQ5ZGVjODY5Zl8yOC9mcmFnOjBmMzU2YWJkNmM5MzQyY2JhM2ZlYzVkNWUzMzA4NzZkL3RhYmxlOmMwM2NjYzgzMmYwMDQxNTlhYjIzZDc4NDg5NThhMzI5L3RhYmxlcmFuZ2U6YzAzY2NjODMyZjAwNDE1OWFiMjNkNzg0ODk1OGEzMjlfMTgtMy0xLTEtMA_9a9770ad-6eb4-4337-959e-bf1d24bce191">78,377</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Investing activities</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Purchase of short-term investments</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i69782326f71a44e3805518280ee22b6b_D20210101-20210630" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:PaymentsToAcquireMarketableSecurities" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzY2E5YmIwMTc5MjQ3NmZiYjIyNWU1ZDlkZWM4NjlmL3NlYzo5M2NhOWJiMDE3OTI0NzZmYmIyMjVlNWQ5ZGVjODY5Zl8yOC9mcmFnOjBmMzU2YWJkNmM5MzQyY2JhM2ZlYzVkNWUzMzA4NzZkL3RhYmxlOmMwM2NjYzgzMmYwMDQxNTlhYjIzZDc4NDg5NThhMzI5L3RhYmxlcmFuZ2U6YzAzY2NjODMyZjAwNDE1OWFiMjNkNzg0ODk1OGEzMjlfMjAtMS0xLTEtMA_529156e6-ad27-46b9-be0e-77a2c8ec615f">120,180</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i4a110e4972ef4113880ce582e3cda5c5_D20200101-20200630" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:PaymentsToAcquireMarketableSecurities" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzY2E5YmIwMTc5MjQ3NmZiYjIyNWU1ZDlkZWM4NjlmL3NlYzo5M2NhOWJiMDE3OTI0NzZmYmIyMjVlNWQ5ZGVjODY5Zl8yOC9mcmFnOjBmMzU2YWJkNmM5MzQyY2JhM2ZlYzVkNWUzMzA4NzZkL3RhYmxlOmMwM2NjYzgzMmYwMDQxNTlhYjIzZDc4NDg5NThhMzI5L3RhYmxlcmFuZ2U6YzAzY2NjODMyZjAwNDE1OWFiMjNkNzg0ODk1OGEzMjlfMjAtMy0xLTEtMA_64554e89-ffe9-4867-8099-bb60ceb3e6c1">200,173</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Proceeds from short-term investments</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i69782326f71a44e3805518280ee22b6b_D20210101-20210630" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:ProceedsFromSaleAndMaturityOfMarketableSecurities" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzY2E5YmIwMTc5MjQ3NmZiYjIyNWU1ZDlkZWM4NjlmL3NlYzo5M2NhOWJiMDE3OTI0NzZmYmIyMjVlNWQ5ZGVjODY5Zl8yOC9mcmFnOjBmMzU2YWJkNmM5MzQyY2JhM2ZlYzVkNWUzMzA4NzZkL3RhYmxlOmMwM2NjYzgzMmYwMDQxNTlhYjIzZDc4NDg5NThhMzI5L3RhYmxlcmFuZ2U6YzAzY2NjODMyZjAwNDE1OWFiMjNkNzg0ODk1OGEzMjlfMjItMS0xLTEtMTU4MDE_02074cca-13f6-4322-9bb6-e66ee25753d8">136,204</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4a110e4972ef4113880ce582e3cda5c5_D20200101-20200630" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:ProceedsFromSaleAndMaturityOfMarketableSecurities" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzY2E5YmIwMTc5MjQ3NmZiYjIyNWU1ZDlkZWM4NjlmL3NlYzo5M2NhOWJiMDE3OTI0NzZmYmIyMjVlNWQ5ZGVjODY5Zl8yOC9mcmFnOjBmMzU2YWJkNmM5MzQyY2JhM2ZlYzVkNWUzMzA4NzZkL3RhYmxlOmMwM2NjYzgzMmYwMDQxNTlhYjIzZDc4NDg5NThhMzI5L3RhYmxlcmFuZ2U6YzAzY2NjODMyZjAwNDE1OWFiMjNkNzg0ODk1OGEzMjlfMjItMy0xLTEtMTU4MDE_903c357f-a0ad-4c4d-bd59-465033f29fc4">279,275</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Purchase of other investments</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i69782326f71a44e3805518280ee22b6b_D20210101-20210630" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:PaymentsToAcquireOtherInvestments" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzY2E5YmIwMTc5MjQ3NmZiYjIyNWU1ZDlkZWM4NjlmL3NlYzo5M2NhOWJiMDE3OTI0NzZmYmIyMjVlNWQ5ZGVjODY5Zl8yOC9mcmFnOjBmMzU2YWJkNmM5MzQyY2JhM2ZlYzVkNWUzMzA4NzZkL3RhYmxlOmMwM2NjYzgzMmYwMDQxNTlhYjIzZDc4NDg5NThhMzI5L3RhYmxlcmFuZ2U6YzAzY2NjODMyZjAwNDE1OWFiMjNkNzg0ODk1OGEzMjlfMjMtMS0xLTEtMTU4MDE_32b03a11-c09d-431a-8395-a4bca0ab0e85">110,392</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4a110e4972ef4113880ce582e3cda5c5_D20200101-20200630" decimals="-3" format="ixt:zerodash" name="us-gaap:PaymentsToAcquireOtherInvestments" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzY2E5YmIwMTc5MjQ3NmZiYjIyNWU1ZDlkZWM4NjlmL3NlYzo5M2NhOWJiMDE3OTI0NzZmYmIyMjVlNWQ5ZGVjODY5Zl8yOC9mcmFnOjBmMzU2YWJkNmM5MzQyY2JhM2ZlYzVkNWUzMzA4NzZkL3RhYmxlOmMwM2NjYzgzMmYwMDQxNTlhYjIzZDc4NDg5NThhMzI5L3RhYmxlcmFuZ2U6YzAzY2NjODMyZjAwNDE1OWFiMjNkNzg0ODk1OGEzMjlfMjMtMy0xLTEtMTU4MDE_73eabb7b-3aaf-477a-b948-be7edc66bc6e">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Purchase of property, plant and equipment</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i69782326f71a44e3805518280ee22b6b_D20210101-20210630" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:PaymentsToAcquirePropertyPlantAndEquipment" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzY2E5YmIwMTc5MjQ3NmZiYjIyNWU1ZDlkZWM4NjlmL3NlYzo5M2NhOWJiMDE3OTI0NzZmYmIyMjVlNWQ5ZGVjODY5Zl8yOC9mcmFnOjBmMzU2YWJkNmM5MzQyY2JhM2ZlYzVkNWUzMzA4NzZkL3RhYmxlOmMwM2NjYzgzMmYwMDQxNTlhYjIzZDc4NDg5NThhMzI5L3RhYmxlcmFuZ2U6YzAzY2NjODMyZjAwNDE1OWFiMjNkNzg0ODk1OGEzMjlfMjEtMS0xLTEtMA_8752a128-10a0-4b4a-b146-1f196f0e4dc5">8,347</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i4a110e4972ef4113880ce582e3cda5c5_D20200101-20200630" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:PaymentsToAcquirePropertyPlantAndEquipment" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzY2E5YmIwMTc5MjQ3NmZiYjIyNWU1ZDlkZWM4NjlmL3NlYzo5M2NhOWJiMDE3OTI0NzZmYmIyMjVlNWQ5ZGVjODY5Zl8yOC9mcmFnOjBmMzU2YWJkNmM5MzQyY2JhM2ZlYzVkNWUzMzA4NzZkL3RhYmxlOmMwM2NjYzgzMmYwMDQxNTlhYjIzZDc4NDg5NThhMzI5L3RhYmxlcmFuZ2U6YzAzY2NjODMyZjAwNDE1OWFiMjNkNzg0ODk1OGEzMjlfMjEtMy0xLTEtMA_3fb45069-0d58-4f2d-b821-954139aa3d35">13,344</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Purchase of intangible assets</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i69782326f71a44e3805518280ee22b6b_D20210101-20210630" decimals="-3" name="us-gaap:PaymentsToAcquireIntangibleAssets" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzY2E5YmIwMTc5MjQ3NmZiYjIyNWU1ZDlkZWM4NjlmL3NlYzo5M2NhOWJiMDE3OTI0NzZmYmIyMjVlNWQ5ZGVjODY5Zl8yOC9mcmFnOjBmMzU2YWJkNmM5MzQyY2JhM2ZlYzVkNWUzMzA4NzZkL3RhYmxlOmMwM2NjYzgzMmYwMDQxNTlhYjIzZDc4NDg5NThhMzI5L3RhYmxlcmFuZ2U6YzAzY2NjODMyZjAwNDE1OWFiMjNkNzg0ODk1OGEzMjlfMjItMS0xLTEtMA_13717ba2-2abe-450f-9074-7fad46519f35">843</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i4a110e4972ef4113880ce582e3cda5c5_D20200101-20200630" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:PaymentsToAcquireIntangibleAssets" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzY2E5YmIwMTc5MjQ3NmZiYjIyNWU1ZDlkZWM4NjlmL3NlYzo5M2NhOWJiMDE3OTI0NzZmYmIyMjVlNWQ5ZGVjODY5Zl8yOC9mcmFnOjBmMzU2YWJkNmM5MzQyY2JhM2ZlYzVkNWUzMzA4NzZkL3RhYmxlOmMwM2NjYzgzMmYwMDQxNTlhYjIzZDc4NDg5NThhMzI5L3RhYmxlcmFuZ2U6YzAzY2NjODMyZjAwNDE1OWFiMjNkNzg0ODk1OGEzMjlfMjItMy0xLTEtMA_a0256912-bb07-487a-98ab-740f90ad742f">2,754</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Proceeds from sale of held-for-sale assets</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i69782326f71a44e3805518280ee22b6b_D20210101-20210630" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:ProceedsFromSaleOfPropertyHeldForSale" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzY2E5YmIwMTc5MjQ3NmZiYjIyNWU1ZDlkZWM4NjlmL3NlYzo5M2NhOWJiMDE3OTI0NzZmYmIyMjVlNWQ5ZGVjODY5Zl8yOC9mcmFnOjBmMzU2YWJkNmM5MzQyY2JhM2ZlYzVkNWUzMzA4NzZkL3RhYmxlOmMwM2NjYzgzMmYwMDQxNTlhYjIzZDc4NDg5NThhMzI5L3RhYmxlcmFuZ2U6YzAzY2NjODMyZjAwNDE1OWFiMjNkNzg0ODk1OGEzMjlfMjYtMS0xLTEtMTc2OTU_d0082df5-6a51-40e1-aac5-6fc6b1168543">2,059</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4a110e4972ef4113880ce582e3cda5c5_D20200101-20200630" decimals="-3" format="ixt:zerodash" name="us-gaap:ProceedsFromSaleOfPropertyHeldForSale" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzY2E5YmIwMTc5MjQ3NmZiYjIyNWU1ZDlkZWM4NjlmL3NlYzo5M2NhOWJiMDE3OTI0NzZmYmIyMjVlNWQ5ZGVjODY5Zl8yOC9mcmFnOjBmMzU2YWJkNmM5MzQyY2JhM2ZlYzVkNWUzMzA4NzZkL3RhYmxlOmMwM2NjYzgzMmYwMDQxNTlhYjIzZDc4NDg5NThhMzI5L3RhYmxlcmFuZ2U6YzAzY2NjODMyZjAwNDE1OWFiMjNkNzg0ODk1OGEzMjlfMjYtMy0xLTEtMTc2OTU_d0cb9e6e-7230-4759-9b25-e3826b7fc609">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Advances on loans receivable</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i69782326f71a44e3805518280ee22b6b_D20210101-20210630" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:PaymentsToAcquireLoansReceivable" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzY2E5YmIwMTc5MjQ3NmZiYjIyNWU1ZDlkZWM4NjlmL3NlYzo5M2NhOWJiMDE3OTI0NzZmYmIyMjVlNWQ5ZGVjODY5Zl8yOC9mcmFnOjBmMzU2YWJkNmM5MzQyY2JhM2ZlYzVkNWUzMzA4NzZkL3RhYmxlOmMwM2NjYzgzMmYwMDQxNTlhYjIzZDc4NDg5NThhMzI5L3RhYmxlcmFuZ2U6YzAzY2NjODMyZjAwNDE1OWFiMjNkNzg0ODk1OGEzMjlfMjMtMS0xLTEtMA_6bfad57f-c2db-407f-9a9c-516382361502">5,064</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i4a110e4972ef4113880ce582e3cda5c5_D20200101-20200630" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:PaymentsToAcquireLoansReceivable" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzY2E5YmIwMTc5MjQ3NmZiYjIyNWU1ZDlkZWM4NjlmL3NlYzo5M2NhOWJiMDE3OTI0NzZmYmIyMjVlNWQ5ZGVjODY5Zl8yOC9mcmFnOjBmMzU2YWJkNmM5MzQyY2JhM2ZlYzVkNWUzMzA4NzZkL3RhYmxlOmMwM2NjYzgzMmYwMDQxNTlhYjIzZDc4NDg5NThhMzI5L3RhYmxlcmFuZ2U6YzAzY2NjODMyZjAwNDE1OWFiMjNkNzg0ODk1OGEzMjlfMjMtMy0xLTEtMA_fda055b1-0cd7-460d-9a67-663d9b2fa192">23,974</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Proceeds from sale of other investments</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i69782326f71a44e3805518280ee22b6b_D20210101-20210630" decimals="-3" format="ixt:zerodash" name="us-gaap:ProceedsFromSaleAndMaturityOfOtherInvestments" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzY2E5YmIwMTc5MjQ3NmZiYjIyNWU1ZDlkZWM4NjlmL3NlYzo5M2NhOWJiMDE3OTI0NzZmYmIyMjVlNWQ5ZGVjODY5Zl8yOC9mcmFnOjBmMzU2YWJkNmM5MzQyY2JhM2ZlYzVkNWUzMzA4NzZkL3RhYmxlOmMwM2NjYzgzMmYwMDQxNTlhYjIzZDc4NDg5NThhMzI5L3RhYmxlcmFuZ2U6YzAzY2NjODMyZjAwNDE1OWFiMjNkNzg0ODk1OGEzMjlfMjQtMS0xLTEtMA_62a8d150-0802-4942-89de-79374345dc2f">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4a110e4972ef4113880ce582e3cda5c5_D20200101-20200630" decimals="-3" name="us-gaap:ProceedsFromSaleAndMaturityOfOtherInvestments" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzY2E5YmIwMTc5MjQ3NmZiYjIyNWU1ZDlkZWM4NjlmL3NlYzo5M2NhOWJiMDE3OTI0NzZmYmIyMjVlNWQ5ZGVjODY5Zl8yOC9mcmFnOjBmMzU2YWJkNmM5MzQyY2JhM2ZlYzVkNWUzMzA4NzZkL3RhYmxlOmMwM2NjYzgzMmYwMDQxNTlhYjIzZDc4NDg5NThhMzI5L3RhYmxlcmFuZ2U6YzAzY2NjODMyZjAwNDE1OWFiMjNkNzg0ODk1OGEzMjlfMjQtMy0xLTEtMA_9403f672-8b1e-44fb-8ce5-d97af9a4af4c">769</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cash flows provided by (used in) investing activities</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i69782326f71a44e3805518280ee22b6b_D20210101-20210630" decimals="-3" sign="-" format="ixt:numdotdecimal" name="us-gaap:NetCashProvidedByUsedInInvestingActivities" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzY2E5YmIwMTc5MjQ3NmZiYjIyNWU1ZDlkZWM4NjlmL3NlYzo5M2NhOWJiMDE3OTI0NzZmYmIyMjVlNWQ5ZGVjODY5Zl8yOC9mcmFnOjBmMzU2YWJkNmM5MzQyY2JhM2ZlYzVkNWUzMzA4NzZkL3RhYmxlOmMwM2NjYzgzMmYwMDQxNTlhYjIzZDc4NDg5NThhMzI5L3RhYmxlcmFuZ2U6YzAzY2NjODMyZjAwNDE1OWFiMjNkNzg0ODk1OGEzMjlfMjUtMS0xLTEtMA_25c9f289-8f14-4782-909e-e68c0222511e">106,563</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4a110e4972ef4113880ce582e3cda5c5_D20200101-20200630" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:NetCashProvidedByUsedInInvestingActivities" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzY2E5YmIwMTc5MjQ3NmZiYjIyNWU1ZDlkZWM4NjlmL3NlYzo5M2NhOWJiMDE3OTI0NzZmYmIyMjVlNWQ5ZGVjODY5Zl8yOC9mcmFnOjBmMzU2YWJkNmM5MzQyY2JhM2ZlYzVkNWUzMzA4NzZkL3RhYmxlOmMwM2NjYzgzMmYwMDQxNTlhYjIzZDc4NDg5NThhMzI5L3RhYmxlcmFuZ2U6YzAzY2NjODMyZjAwNDE1OWFiMjNkNzg0ODk1OGEzMjlfMjUtMy0xLTEtMA_c3988d7c-9b8e-4da1-a4a1-40cb8aff6053">39,799</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Financing activities</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Withholding taxes paid on share-based awards</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i69782326f71a44e3805518280ee22b6b_D20210101-20210630" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:PaymentsRelatedToTaxWithholdingForShareBasedCompensation" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzY2E5YmIwMTc5MjQ3NmZiYjIyNWU1ZDlkZWM4NjlmL3NlYzo5M2NhOWJiMDE3OTI0NzZmYmIyMjVlNWQ5ZGVjODY5Zl8yOC9mcmFnOjBmMzU2YWJkNmM5MzQyY2JhM2ZlYzVkNWUzMzA4NzZkL3RhYmxlOmMwM2NjYzgzMmYwMDQxNTlhYjIzZDc4NDg5NThhMzI5L3RhYmxlcmFuZ2U6YzAzY2NjODMyZjAwNDE1OWFiMjNkNzg0ODk1OGEzMjlfMjgtMS0xLTEtMA_e598a358-f866-4084-b4b1-d6f9d9c93119">8,919</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4a110e4972ef4113880ce582e3cda5c5_D20200101-20200630" decimals="-3" format="ixt:zerodash" name="us-gaap:PaymentsRelatedToTaxWithholdingForShareBasedCompensation" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzY2E5YmIwMTc5MjQ3NmZiYjIyNWU1ZDlkZWM4NjlmL3NlYzo5M2NhOWJiMDE3OTI0NzZmYmIyMjVlNWQ5ZGVjODY5Zl8yOC9mcmFnOjBmMzU2YWJkNmM5MzQyY2JhM2ZlYzVkNWUzMzA4NzZkL3RhYmxlOmMwM2NjYzgzMmYwMDQxNTlhYjIzZDc4NDg5NThhMzI5L3RhYmxlcmFuZ2U6YzAzY2NjODMyZjAwNDE1OWFiMjNkNzg0ODk1OGEzMjlfMjgtMy0xLTEtMA_e237d637-99e9-46c2-a4bc-7c03c46196e8">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Proceeds from exercise of warrants and options</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i69782326f71a44e3805518280ee22b6b_D20210101-20210630" decimals="-3" name="us-gaap:ProceedsFromPaymentsForOtherFinancingActivities" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzY2E5YmIwMTc5MjQ3NmZiYjIyNWU1ZDlkZWM4NjlmL3NlYzo5M2NhOWJiMDE3OTI0NzZmYmIyMjVlNWQ5ZGVjODY5Zl8yOC9mcmFnOjBmMzU2YWJkNmM5MzQyY2JhM2ZlYzVkNWUzMzA4NzZkL3RhYmxlOmMwM2NjYzgzMmYwMDQxNTlhYjIzZDc4NDg5NThhMzI5L3RhYmxlcmFuZ2U6YzAzY2NjODMyZjAwNDE1OWFiMjNkNzg0ODk1OGEzMjlfMjktMS0xLTEtMA_ea493b0d-3a87-4c9d-8d69-345f70a0ca8b">12</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4a110e4972ef4113880ce582e3cda5c5_D20200101-20200630" decimals="-3" name="us-gaap:ProceedsFromPaymentsForOtherFinancingActivities" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzY2E5YmIwMTc5MjQ3NmZiYjIyNWU1ZDlkZWM4NjlmL3NlYzo5M2NhOWJiMDE3OTI0NzZmYmIyMjVlNWQ5ZGVjODY5Zl8yOC9mcmFnOjBmMzU2YWJkNmM5MzQyY2JhM2ZlYzVkNWUzMzA4NzZkL3RhYmxlOmMwM2NjYzgzMmYwMDQxNTlhYjIzZDc4NDg5NThhMzI5L3RhYmxlcmFuZ2U6YzAzY2NjODMyZjAwNDE1OWFiMjNkNzg0ODk1OGEzMjlfMjktMy0xLTEtMA_8c1d0a48-d6a4-458b-a7be-962ad6dc00a5">1</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cash flows provided by (used in) financing activities</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i69782326f71a44e3805518280ee22b6b_D20210101-20210630" decimals="-3" sign="-" format="ixt:numdotdecimal" name="us-gaap:NetCashProvidedByUsedInFinancingActivities" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzY2E5YmIwMTc5MjQ3NmZiYjIyNWU1ZDlkZWM4NjlmL3NlYzo5M2NhOWJiMDE3OTI0NzZmYmIyMjVlNWQ5ZGVjODY5Zl8yOC9mcmFnOjBmMzU2YWJkNmM5MzQyY2JhM2ZlYzVkNWUzMzA4NzZkL3RhYmxlOmMwM2NjYzgzMmYwMDQxNTlhYjIzZDc4NDg5NThhMzI5L3RhYmxlcmFuZ2U6YzAzY2NjODMyZjAwNDE1OWFiMjNkNzg0ODk1OGEzMjlfMzAtMS0xLTEtMA_27a88025-6bb4-4caf-9aea-5520e1a8171d">8,907</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4a110e4972ef4113880ce582e3cda5c5_D20200101-20200630" decimals="-3" name="us-gaap:NetCashProvidedByUsedInFinancingActivities" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzY2E5YmIwMTc5MjQ3NmZiYjIyNWU1ZDlkZWM4NjlmL3NlYzo5M2NhOWJiMDE3OTI0NzZmYmIyMjVlNWQ5ZGVjODY5Zl8yOC9mcmFnOjBmMzU2YWJkNmM5MzQyY2JhM2ZlYzVkNWUzMzA4NzZkL3RhYmxlOmMwM2NjYzgzMmYwMDQxNTlhYjIzZDc4NDg5NThhMzI5L3RhYmxlcmFuZ2U6YzAzY2NjODMyZjAwNDE1OWFiMjNkNzg0ODk1OGEzMjlfMzAtMy0xLTEtMA_262c3866-ad53-4316-8a3c-b7bd10bc8779">1</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Effect of foreign currency translation on cash and cash equivalents</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i69782326f71a44e3805518280ee22b6b_D20210101-20210630" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzY2E5YmIwMTc5MjQ3NmZiYjIyNWU1ZDlkZWM4NjlmL3NlYzo5M2NhOWJiMDE3OTI0NzZmYmIyMjVlNWQ5ZGVjODY5Zl8yOC9mcmFnOjBmMzU2YWJkNmM5MzQyY2JhM2ZlYzVkNWUzMzA4NzZkL3RhYmxlOmMwM2NjYzgzMmYwMDQxNTlhYjIzZDc4NDg5NThhMzI5L3RhYmxlcmFuZ2U6YzAzY2NjODMyZjAwNDE1OWFiMjNkNzg0ODk1OGEzMjlfMzEtMS0xLTEtMA_3b97f07e-601f-4aed-9670-aeb1310a86fb">18,825</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i4a110e4972ef4113880ce582e3cda5c5_D20200101-20200630" decimals="-3" sign="-" format="ixt:numdotdecimal" name="us-gaap:EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzY2E5YmIwMTc5MjQ3NmZiYjIyNWU1ZDlkZWM4NjlmL3NlYzo5M2NhOWJiMDE3OTI0NzZmYmIyMjVlNWQ5ZGVjODY5Zl8yOC9mcmFnOjBmMzU2YWJkNmM5MzQyY2JhM2ZlYzVkNWUzMzA4NzZkL3RhYmxlOmMwM2NjYzgzMmYwMDQxNTlhYjIzZDc4NDg5NThhMzI5L3RhYmxlcmFuZ2U6YzAzY2NjODMyZjAwNDE1OWFiMjNkNzg0ODk1OGEzMjlfMzEtMy0xLTEtMA_4184319d-fff3-4fc7-bcde-349ccb020813">51,416</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net change in cash and cash equivalents</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i69782326f71a44e3805518280ee22b6b_D20210101-20210630" decimals="-3" sign="-" format="ixt:numdotdecimal" name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzY2E5YmIwMTc5MjQ3NmZiYjIyNWU1ZDlkZWM4NjlmL3NlYzo5M2NhOWJiMDE3OTI0NzZmYmIyMjVlNWQ5ZGVjODY5Zl8yOC9mcmFnOjBmMzU2YWJkNmM5MzQyY2JhM2ZlYzVkNWUzMzA4NzZkL3RhYmxlOmMwM2NjYzgzMmYwMDQxNTlhYjIzZDc4NDg5NThhMzI5L3RhYmxlcmFuZ2U6YzAzY2NjODMyZjAwNDE1OWFiMjNkNzg0ODk1OGEzMjlfMzItMS0xLTEtMA_8c67a7f9-3d5c-428d-a949-83a21cbcdfb8">182,842</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i4a110e4972ef4113880ce582e3cda5c5_D20200101-20200630" decimals="-3" sign="-" format="ixt:numdotdecimal" name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzY2E5YmIwMTc5MjQ3NmZiYjIyNWU1ZDlkZWM4NjlmL3NlYzo5M2NhOWJiMDE3OTI0NzZmYmIyMjVlNWQ5ZGVjODY5Zl8yOC9mcmFnOjBmMzU2YWJkNmM5MzQyY2JhM2ZlYzVkNWUzMzA4NzZkL3RhYmxlOmMwM2NjYzgzMmYwMDQxNTlhYjIzZDc4NDg5NThhMzI5L3RhYmxlcmFuZ2U6YzAzY2NjODMyZjAwNDE1OWFiMjNkNzg0ODk1OGEzMjlfMzItMy0xLTEtMA_c023987b-42a7-40f1-bc3c-6b5439a2e1c6">89,993</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cash and cash equivalents, beginning of period</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ifbe16ec51ea244519b77d6036b4ef038_I20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzY2E5YmIwMTc5MjQ3NmZiYjIyNWU1ZDlkZWM4NjlmL3NlYzo5M2NhOWJiMDE3OTI0NzZmYmIyMjVlNWQ5ZGVjODY5Zl8yOC9mcmFnOjBmMzU2YWJkNmM5MzQyY2JhM2ZlYzVkNWUzMzA4NzZkL3RhYmxlOmMwM2NjYzgzMmYwMDQxNTlhYjIzZDc4NDg5NThhMzI5L3RhYmxlcmFuZ2U6YzAzY2NjODMyZjAwNDE1OWFiMjNkNzg0ODk1OGEzMjlfMzMtMS0xLTEtMA_0e987f16-671c-4fef-848d-ed08929553c8">1,078,023</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie4fc90ad6d7f4d39aea9cb65c8026e09_I20191231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzY2E5YmIwMTc5MjQ3NmZiYjIyNWU1ZDlkZWM4NjlmL3NlYzo5M2NhOWJiMDE3OTI0NzZmYmIyMjVlNWQ5ZGVjODY5Zl8yOC9mcmFnOjBmMzU2YWJkNmM5MzQyY2JhM2ZlYzVkNWUzMzA4NzZkL3RhYmxlOmMwM2NjYzgzMmYwMDQxNTlhYjIzZDc4NDg5NThhMzI5L3RhYmxlcmFuZ2U6YzAzY2NjODMyZjAwNDE1OWFiMjNkNzg0ODk1OGEzMjlfMzMtMy0xLTEtMA_eb687195-0646-4e8f-b75a-fdbada7b1cb0">1,199,693</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cash and cash equivalents, end of period</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i225f85e38faa4bbdb4de1d8b9cf369bb_I20210630" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzY2E5YmIwMTc5MjQ3NmZiYjIyNWU1ZDlkZWM4NjlmL3NlYzo5M2NhOWJiMDE3OTI0NzZmYmIyMjVlNWQ5ZGVjODY5Zl8yOC9mcmFnOjBmMzU2YWJkNmM5MzQyY2JhM2ZlYzVkNWUzMzA4NzZkL3RhYmxlOmMwM2NjYzgzMmYwMDQxNTlhYjIzZDc4NDg5NThhMzI5L3RhYmxlcmFuZ2U6YzAzY2NjODMyZjAwNDE1OWFiMjNkNzg0ODk1OGEzMjlfMzQtMS0xLTEtMA_01e14023-2df9-418e-bd81-cb55601c6c9c">895,181</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id670dc9b33e6430f9d7510009f7495a7_I20200630" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzY2E5YmIwMTc5MjQ3NmZiYjIyNWU1ZDlkZWM4NjlmL3NlYzo5M2NhOWJiMDE3OTI0NzZmYmIyMjVlNWQ5ZGVjODY5Zl8yOC9mcmFnOjBmMzU2YWJkNmM5MzQyY2JhM2ZlYzVkNWUzMzA4NzZkL3RhYmxlOmMwM2NjYzgzMmYwMDQxNTlhYjIzZDc4NDg5NThhMzI5L3RhYmxlcmFuZ2U6YzAzY2NjODMyZjAwNDE1OWFiMjNkNzg0ODk1OGEzMjlfMzQtMy0xLTEtMA_1d89c288-ab4f-42c6-8b96-9159884b1c79">1,109,700</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Supplemental cash flow information</span></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Interest paid</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i69782326f71a44e3805518280ee22b6b_D20210101-20210630" decimals="-3" format="ixt:zerodash" name="us-gaap:InterestPaidNet" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzY2E5YmIwMTc5MjQ3NmZiYjIyNWU1ZDlkZWM4NjlmL3NlYzo5M2NhOWJiMDE3OTI0NzZmYmIyMjVlNWQ5ZGVjODY5Zl8yOC9mcmFnOjBmMzU2YWJkNmM5MzQyY2JhM2ZlYzVkNWUzMzA4NzZkL3RhYmxlOmMwM2NjYzgzMmYwMDQxNTlhYjIzZDc4NDg5NThhMzI5L3RhYmxlcmFuZ2U6YzAzY2NjODMyZjAwNDE1OWFiMjNkNzg0ODk1OGEzMjlfMzYtMS0xLTEtMA_edcab813-f8ff-4f9f-9203-88e3a158256d">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4a110e4972ef4113880ce582e3cda5c5_D20200101-20200630" decimals="-3" name="us-gaap:InterestPaidNet" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzY2E5YmIwMTc5MjQ3NmZiYjIyNWU1ZDlkZWM4NjlmL3NlYzo5M2NhOWJiMDE3OTI0NzZmYmIyMjVlNWQ5ZGVjODY5Zl8yOC9mcmFnOjBmMzU2YWJkNmM5MzQyY2JhM2ZlYzVkNWUzMzA4NzZkL3RhYmxlOmMwM2NjYzgzMmYwMDQxNTlhYjIzZDc4NDg5NThhMzI5L3RhYmxlcmFuZ2U6YzAzY2NjODMyZjAwNDE1OWFiMjNkNzg0ODk1OGEzMjlfMzYtMy0xLTEtMA_322a8395-c06c-4ce1-96d6-c73ed31d89f7">90</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Interest received</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i69782326f71a44e3805518280ee22b6b_D20210101-20210630" decimals="-3" format="ixt:numdotdecimal" name="cron:InterestReceivedNet" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzY2E5YmIwMTc5MjQ3NmZiYjIyNWU1ZDlkZWM4NjlmL3NlYzo5M2NhOWJiMDE3OTI0NzZmYmIyMjVlNWQ5ZGVjODY5Zl8yOC9mcmFnOjBmMzU2YWJkNmM5MzQyY2JhM2ZlYzVkNWUzMzA4NzZkL3RhYmxlOmMwM2NjYzgzMmYwMDQxNTlhYjIzZDc4NDg5NThhMzI5L3RhYmxlcmFuZ2U6YzAzY2NjODMyZjAwNDE1OWFiMjNkNzg0ODk1OGEzMjlfMzctMS0xLTEtMA_8a473d7a-8346-42f5-ae13-f5f4051fa229">2,961</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4a110e4972ef4113880ce582e3cda5c5_D20200101-20200630" decimals="-3" format="ixt:numdotdecimal" name="cron:InterestReceivedNet" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzY2E5YmIwMTc5MjQ3NmZiYjIyNWU1ZDlkZWM4NjlmL3NlYzo5M2NhOWJiMDE3OTI0NzZmYmIyMjVlNWQ5ZGVjODY5Zl8yOC9mcmFnOjBmMzU2YWJkNmM5MzQyY2JhM2ZlYzVkNWUzMzA4NzZkL3RhYmxlOmMwM2NjYzgzMmYwMDQxNTlhYjIzZDc4NDg5NThhMzI5L3RhYmxlcmFuZ2U6YzAzY2NjODMyZjAwNDE1OWFiMjNkNzg0ODk1OGEzMjlfMzctMy0xLTEtMA_21445440-fc42-4471-8ea7-4a17af1a766e">11,575</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Income taxes paid</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i69782326f71a44e3805518280ee22b6b_D20210101-20210630" decimals="-3" name="us-gaap:IncomeTaxesPaidNet" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzY2E5YmIwMTc5MjQ3NmZiYjIyNWU1ZDlkZWM4NjlmL3NlYzo5M2NhOWJiMDE3OTI0NzZmYmIyMjVlNWQ5ZGVjODY5Zl8yOC9mcmFnOjBmMzU2YWJkNmM5MzQyY2JhM2ZlYzVkNWUzMzA4NzZkL3RhYmxlOmMwM2NjYzgzMmYwMDQxNTlhYjIzZDc4NDg5NThhMzI5L3RhYmxlcmFuZ2U6YzAzY2NjODMyZjAwNDE1OWFiMjNkNzg0ODk1OGEzMjlfMzgtMS0xLTEtMA_c8716145-c744-47f9-b71b-febf97aa6d08">858</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4a110e4972ef4113880ce582e3cda5c5_D20200101-20200630" decimals="-3" format="ixt:zerodash" name="us-gaap:IncomeTaxesPaidNet" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzY2E5YmIwMTc5MjQ3NmZiYjIyNWU1ZDlkZWM4NjlmL3NlYzo5M2NhOWJiMDE3OTI0NzZmYmIyMjVlNWQ5ZGVjODY5Zl8yOC9mcmFnOjBmMzU2YWJkNmM5MzQyY2JhM2ZlYzVkNWUzMzA4NzZkL3RhYmxlOmMwM2NjYzgzMmYwMDQxNTlhYjIzZDc4NDg5NThhMzI5L3RhYmxlcmFuZ2U6YzAzY2NjODMyZjAwNDE1OWFiMjNkNzg0ODk1OGEzMjlfMzgtMy0xLTEtMA_df43c7d1-ca8e-4771-bbc5-735a785e36eb">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="margin-bottom:6pt;margin-top:9pt;text-align:justify;text-indent:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">See notes to condensed consolidated financial statements.</span></div><div style="margin-bottom:6pt;margin-top:9pt;text-align:justify;text-indent:9pt"><span><br/></span></div><div style="margin-bottom:6pt;margin-top:9pt;text-align:justify;text-indent:9pt"><span><br/></span></div><div id="i93ca9bb01792476fbb225e5d9dec869f_31"></div><div><span><br/></span></div><div style="height:21.6pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">8</span></div></div></div><div id="i93ca9bb01792476fbb225e5d9dec869f_34"></div><hr style="page-break-after:always"/><div style="min-height:72pt;width:100%"><div style="margin-top:0.55pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:95.000%"><tr><td style="width:1.0%"></td><td style="width:65.712%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:32.088%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="border-top:1pt solid #FFFFFF;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Cronos Group Inc.</span></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Notes to Condensed Consolidated Financial Statements (Unaudited)</span></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">(In thousands of $, except share amounts)</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i93ca9bb01792476fbb225e5d9dec869f_7">Table of Contents</a></span></div></td></tr></table></div></div><div style="margin-bottom:12pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">1. <ix:nonNumeric contextRef="i69782326f71a44e3805518280ee22b6b_D20210101-20210630" name="us-gaap:BasisOfPresentationAndSignificantAccountingPoliciesTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjkzY2E5YmIwMTc5MjQ3NmZiYjIyNWU1ZDlkZWM4NjlmL3NlYzo5M2NhOWJiMDE3OTI0NzZmYmIyMjVlNWQ5ZGVjODY5Zl8zNC9mcmFnOjYwNzFjM2U1NDE4NTRjN2M5MDhmOWM2ZmI5ZGFhNGQ1L3RleHRyZWdpb246NjA3MWMzZTU0MTg1NGM3YzkwOGY5YzZmYjlkYWE0ZDVfNTU4MA_eaa9fe5c-010f-4703-aa4a-f3ae4e644955" continuedAt="i8fa7c51cad5d41559cf0580030a38376" escape="true">Background, Basis of Presentation and Accounting Policies</ix:nonNumeric></span></div><ix:continuation id="i8fa7c51cad5d41559cf0580030a38376" continuedAt="i353b08aa430e40d7bb6561f9151fc5c7"><div style="margin-bottom:6pt;margin-top:6pt;padding-left:36pt;text-align:justify;text-indent:-36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(a)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;padding-left:24.34pt">Background</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Cronos Group Inc. (&#8220;Cronos Group&#8221; or the &#8220;Company&#8221;) is incorporated in the Province of British Columbia and under the </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Business Corporations Act</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> (British Columbia) with principal executive offices at 111 Peter Street, Suite 300, Toronto, Ontario, M5V 2H1. The Company&#8217;s common shares are currently listed on the Toronto Stock Exchange (&#8220;TSX&#8221;) and Nasdaq Global Market (&#8220;Nasdaq&#8221;) under the ticker symbol &#8220;CRON.&#8221;</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Cronos Group is an innovative global cannabinoid company, with international production and distribution across <ix:nonFraction unitRef="continent" contextRef="i225f85e38faa4bbdb4de1d8b9cf369bb_I20210630" decimals="INF" format="ixt-sec:numwordsen" name="cron:NumberOfContinentsWithInternationalProductionAndDistribution" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjkzY2E5YmIwMTc5MjQ3NmZiYjIyNWU1ZDlkZWM4NjlmL3NlYzo5M2NhOWJiMDE3OTI0NzZmYmIyMjVlNWQ5ZGVjODY5Zl8zNC9mcmFnOjYwNzFjM2U1NDE4NTRjN2M5MDhmOWM2ZmI5ZGFhNGQ1L3RleHRyZWdpb246NjA3MWMzZTU0MTg1NGM3YzkwOGY5YzZmYjlkYWE0ZDVfOTg5NTYwNDY2NDAxMg_0fdef51f-5445-468c-ac7d-67de81765b2c">five</ix:nonFraction> continents. The Company is committed to building disruptive intellectual property by advancing cannabis research, technology and product development and is seeking to build an iconic brand portfolio. Cronos Group&#8217;s brand portfolio includes PEACE NATURALS</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">&#8482;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, a global wellness platform; <ix:nonFraction unitRef="brand" contextRef="i225f85e38faa4bbdb4de1d8b9cf369bb_I20210630" decimals="INF" format="ixt-sec:numwordsen" name="cron:NumberOfAdultuseBrands" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjkzY2E5YmIwMTc5MjQ3NmZiYjIyNWU1ZDlkZWM4NjlmL3NlYzo5M2NhOWJiMDE3OTI0NzZmYmIyMjVlNWQ5ZGVjODY5Zl8zNC9mcmFnOjYwNzFjM2U1NDE4NTRjN2M5MDhmOWM2ZmI5ZGFhNGQ1L3RleHRyZWdpb246NjA3MWMzZTU0MTg1NGM3YzkwOGY5YzZmYjlkYWE0ZDVfOTg5NTYwNDY2NDAyMQ_15ba5786-2607-4d8c-ad12-35b009f880b0">two</ix:nonFraction> adult-use brands, COVE</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">&#8482;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> and Spinach</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">&#8482;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">; and <ix:nonFraction unitRef="brand" contextRef="i225f85e38faa4bbdb4de1d8b9cf369bb_I20210630" decimals="INF" format="ixt-sec:numwordsen" name="cron:NumberOfHempDerivedPersonalCareBrands" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjkzY2E5YmIwMTc5MjQ3NmZiYjIyNWU1ZDlkZWM4NjlmL3NlYzo5M2NhOWJiMDE3OTI0NzZmYmIyMjVlNWQ5ZGVjODY5Zl8zNC9mcmFnOjYwNzFjM2U1NDE4NTRjN2M5MDhmOWM2ZmI5ZGFhNGQ1L3RleHRyZWdpb246NjA3MWMzZTU0MTg1NGM3YzkwOGY5YzZmYjlkYWE0ZDVfOTg5NTYwNDY2NDAyOQ_018f7c97-786b-4b28-a774-65f0486ed419">three</ix:nonFraction> U.S. hemp-derived consumer products brands, Lord Jones</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">&#8482;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, Happy Dance</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">&#8482; </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">and PEACE+</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">&#8482;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Cronos Group has established strategic joint ventures in Canada, Israel, and Colombia. &#8220;Cronos Israel&#8221; consists of a cultivation company (Cronos Israel G.S. Cultivation Ltd.), a manufacturing company (Cronos Israel G.S. Manufacturing Ltd.), a distribution company (Cronos Israel G.S. Store Ltd.) and a pharmacy company (Cronos Israel G.S. Pharmacy Ltd.) and is consolidated for financial reporting purposes. The Company also holds approximately <ix:nonFraction unitRef="number" contextRef="i52d0636c66ed4ea58c20dfcc9a4132e8_I20210630" decimals="2" name="us-gaap:EquityMethodInvestmentOwnershipPercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjkzY2E5YmIwMTc5MjQ3NmZiYjIyNWU1ZDlkZWM4NjlmL3NlYzo5M2NhOWJiMDE3OTI0NzZmYmIyMjVlNWQ5ZGVjODY5Zl8zNC9mcmFnOjYwNzFjM2U1NDE4NTRjN2M5MDhmOWM2ZmI5ZGFhNGQ1L3RleHRyZWdpb246NjA3MWMzZTU0MTg1NGM3YzkwOGY5YzZmYjlkYWE0ZDVfMTE3OQ_4eae84ef-3203-4138-965a-5803a548d246">31</ix:nonFraction>% of the issued capital of Cronos Australia Limited (&#8220;Cronos Australia&#8221;) and accounts for its investment in Cronos Australia under the equity method of accounting. For additional discussion regarding the joint ventures and strategic investment, see Note 3. Investments.</span></div><div style="margin-bottom:6pt;margin-top:6pt;padding-left:36pt;text-align:justify;text-indent:-36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(b)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;padding-left:23.78pt">Out-of-period adjustments</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">During the three months ended March 31, 2021, the Company identified an error in the accounting related to the withholding taxes on the net exercise of stock options, which resulted in an understatement of accounts payable and other liabilities of $<ix:nonFraction unitRef="usd" contextRef="i6506a062286b47c0b48f06151d87d9e6_I20201231" decimals="-3" name="us-gaap:AccountsPayableAndOtherAccruedLiabilitiesCurrent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzY2E5YmIwMTc5MjQ3NmZiYjIyNWU1ZDlkZWM4NjlmL3NlYzo5M2NhOWJiMDE3OTI0NzZmYmIyMjVlNWQ5ZGVjODY5Zl8zNC9mcmFnOjYwNzFjM2U1NDE4NTRjN2M5MDhmOWM2ZmI5ZGFhNGQ1L3RleHRyZWdpb246NjA3MWMzZTU0MTg1NGM3YzkwOGY5YzZmYjlkYWE0ZDVfMTY2Ng_786086c7-f111-4b28-99ac-172beee1cf1a">966</ix:nonFraction> and overstatements of other receivables, retained earnings and share capital of $<ix:nonFraction unitRef="usd" contextRef="i6506a062286b47c0b48f06151d87d9e6_I20201231" decimals="-3" sign="-" format="ixt:numdotdecimal" name="us-gaap:OtherReceivablesNetCurrent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzY2E5YmIwMTc5MjQ3NmZiYjIyNWU1ZDlkZWM4NjlmL3NlYzo5M2NhOWJiMDE3OTI0NzZmYmIyMjVlNWQ5ZGVjODY5Zl8zNC9mcmFnOjYwNzFjM2U1NDE4NTRjN2M5MDhmOWM2ZmI5ZGFhNGQ1L3RleHRyZWdpb246NjA3MWMzZTU0MTg1NGM3YzkwOGY5YzZmYjlkYWE0ZDVfMTc0OA_4469e0db-d9b7-456b-ad9b-70f76e9556f8">3,202</ix:nonFraction>, $<ix:nonFraction unitRef="usd" contextRef="i6506a062286b47c0b48f06151d87d9e6_I20201231" decimals="-3" sign="-" format="ixt:numdotdecimal" name="us-gaap:RetainedEarningsAccumulatedDeficit" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzY2E5YmIwMTc5MjQ3NmZiYjIyNWU1ZDlkZWM4NjlmL3NlYzo5M2NhOWJiMDE3OTI0NzZmYmIyMjVlNWQ5ZGVjODY5Zl8zNC9mcmFnOjYwNzFjM2U1NDE4NTRjN2M5MDhmOWM2ZmI5ZGFhNGQ1L3RleHRyZWdpb246NjA3MWMzZTU0MTg1NGM3YzkwOGY5YzZmYjlkYWE0ZDVfMTc1Mg_d604dd8f-9c5b-418d-bc1f-82f2cb2f7b42">3,838</ix:nonFraction> and $<ix:nonFraction unitRef="usd" contextRef="i6506a062286b47c0b48f06151d87d9e6_I20201231" decimals="-3" sign="-" name="us-gaap:CommonStockValue" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzY2E5YmIwMTc5MjQ3NmZiYjIyNWU1ZDlkZWM4NjlmL3NlYzo5M2NhOWJiMDE3OTI0NzZmYmIyMjVlNWQ5ZGVjODY5Zl8zNC9mcmFnOjYwNzFjM2U1NDE4NTRjN2M5MDhmOWM2ZmI5ZGFhNGQ1L3RleHRyZWdpb246NjA3MWMzZTU0MTg1NGM3YzkwOGY5YzZmYjlkYWE0ZDVfMTc1OQ_2471585c-f69e-4d63-a881-1e297c669aa6">330</ix:nonFraction>, respectively, as of December 31, 2020. The error was deemed immaterial, and thus the Company has recorded an out-of-period adjustment to the condensed consolidated balance sheet and the condensed consolidated statement of changes in equity during the first quarter of 2021 to correct the error. This error had no impact to the condensed consolidated statement of net income (loss) and comprehensive income (loss). The impact of the out-of-period adjustments are included within the changes in operating assets and liabilities and withholding taxes paid on share-based awards lines in the Company&#8217;s condensed consolidated statements of cash flows.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">During the three months ended June 30, 2021, the Company identified an error in the accounting related to the exercise of Top-up Rights (as defined herein), which resulted in an overstatement of share capital and an understatement of gain on revaluation of derivative liabilities of $<ix:nonFraction unitRef="usd" contextRef="ic583ba915ef943c8be4157a2a9ead807_D20200101-20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:GainLossOnDerivativeInstrumentsNetPretax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzY2E5YmIwMTc5MjQ3NmZiYjIyNWU1ZDlkZWM4NjlmL3NlYzo5M2NhOWJiMDE3OTI0NzZmYmIyMjVlNWQ5ZGVjODY5Zl8zNC9mcmFnOjYwNzFjM2U1NDE4NTRjN2M5MDhmOWM2ZmI5ZGFhNGQ1L3RleHRyZWdpb246NjA3MWMzZTU0MTg1NGM3YzkwOGY5YzZmYjlkYWE0ZDVfOTg5NTYwNDY3MjkzNQ_317c4b17-21ba-458b-8a8a-ecf11dcd8add"><ix:nonFraction unitRef="usd" contextRef="ice66d39b8cf24a6b82c9c3c91f87fece_I20201231" decimals="-3" sign="-" format="ixt:numdotdecimal" name="us-gaap:CommonStockValue" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzY2E5YmIwMTc5MjQ3NmZiYjIyNWU1ZDlkZWM4NjlmL3NlYzo5M2NhOWJiMDE3OTI0NzZmYmIyMjVlNWQ5ZGVjODY5Zl8zNC9mcmFnOjYwNzFjM2U1NDE4NTRjN2M5MDhmOWM2ZmI5ZGFhNGQ1L3RleHRyZWdpb246NjA3MWMzZTU0MTg1NGM3YzkwOGY5YzZmYjlkYWE0ZDVfOTg5NTYwNDY3MjkzNQ_fc572c91-68c5-4f4d-8a5d-fd073f2de92b">3,227</ix:nonFraction></ix:nonFraction> as of December 31, 2020, and overstatements of share capital and loss on revaluation of derivative liabilities and an understatement of retained earnings of $<ix:nonFraction unitRef="usd" contextRef="i71f353c527264f29bc7b447983a0f96b_I20210331" decimals="-3" sign="-" format="ixt:numdotdecimal" name="us-gaap:CommonStockValue" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzY2E5YmIwMTc5MjQ3NmZiYjIyNWU1ZDlkZWM4NjlmL3NlYzo5M2NhOWJiMDE3OTI0NzZmYmIyMjVlNWQ5ZGVjODY5Zl8zNC9mcmFnOjYwNzFjM2U1NDE4NTRjN2M5MDhmOWM2ZmI5ZGFhNGQ1L3RleHRyZWdpb246NjA3MWMzZTU0MTg1NGM3YzkwOGY5YzZmYjlkYWE0ZDVfNDk0NzgwMjM0NzU3Mg_f57dc7e5-6e61-4e6a-9333-723b66b6aa93">14,505</ix:nonFraction>, $<ix:nonFraction unitRef="usd" contextRef="ib02278c2b0d7400b81a88f77d9b1d053_D20210101-20210331" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:GainLossOnDerivativeInstrumentsNetPretax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzY2E5YmIwMTc5MjQ3NmZiYjIyNWU1ZDlkZWM4NjlmL3NlYzo5M2NhOWJiMDE3OTI0NzZmYmIyMjVlNWQ5ZGVjODY5Zl8zNC9mcmFnOjYwNzFjM2U1NDE4NTRjN2M5MDhmOWM2ZmI5ZGFhNGQ1L3RleHRyZWdpb246NjA3MWMzZTU0MTg1NGM3YzkwOGY5YzZmYjlkYWE0ZDVfNDk0NzgwMjM0NzU4MQ_138193b6-4b11-4313-be93-df56b0ff22c8">11,278</ix:nonFraction> and $<ix:nonFraction unitRef="usd" contextRef="i71f353c527264f29bc7b447983a0f96b_I20210331" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:RetainedEarningsAccumulatedDeficit" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzY2E5YmIwMTc5MjQ3NmZiYjIyNWU1ZDlkZWM4NjlmL3NlYzo5M2NhOWJiMDE3OTI0NzZmYmIyMjVlNWQ5ZGVjODY5Zl8zNC9mcmFnOjYwNzFjM2U1NDE4NTRjN2M5MDhmOWM2ZmI5ZGFhNGQ1L3RleHRyZWdpb246NjA3MWMzZTU0MTg1NGM3YzkwOGY5YzZmYjlkYWE0ZDVfNDk0NzgwMjM0NzU5MA_bdfbe9e8-7744-454c-941e-97ef7c7e957a">3,227</ix:nonFraction>, respectively, as of March 31, 2021. The error was deemed immaterial, and thus the Company has recorded an out-of-period adjustment to the condensed consolidated balance sheet, the condensed consolidated statement of net income (loss) and comprehensive income (loss) and the condensed consolidated statement of changes in equity during the second quarter of 2021 to correct the error. The impact of the out-of-period adjustments are included within the adjustments to net loss in the Company&#8217;s condensed consolidated statements of cash flows.</span></div><div style="margin-bottom:6pt;margin-top:6pt;padding-left:36pt;text-align:justify;text-indent:-36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(c)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;padding-left:24.91pt"><ix:nonNumeric contextRef="i69782326f71a44e3805518280ee22b6b_D20210101-20210630" name="us-gaap:BasisOfAccountingPolicyPolicyTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjkzY2E5YmIwMTc5MjQ3NmZiYjIyNWU1ZDlkZWM4NjlmL3NlYzo5M2NhOWJiMDE3OTI0NzZmYmIyMjVlNWQ5ZGVjODY5Zl8zNC9mcmFnOjYwNzFjM2U1NDE4NTRjN2M5MDhmOWM2ZmI5ZGFhNGQ1L3RleHRyZWdpb246NjA3MWMzZTU0MTg1NGM3YzkwOGY5YzZmYjlkYWE0ZDVfNTU3OA_77d8fafc-14fa-477b-be06-0f10c598a92c" continuedAt="i2730de04665944d69541aea5de4bb8fe" escape="true">Basis of presentation</ix:nonNumeric></span></div><ix:continuation id="i2730de04665944d69541aea5de4bb8fe"><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The interim condensed consolidated financial statements of Cronos Group are unaudited. They have been prepared in accordance with Generally Accepted Accounting Principles in the United States (&#8220;U.S. GAAP&#8221;) for interim financial information and with applicable rules and regulations of the U.S. Securities and Exchange Commission relating to interim financial statements. Accordingly, they do not include all of the information and footnotes required by U.S. GAAP for complete financial statements. In the opinion of management, all adjustments (consisting of normal recurring accruals) considered necessary for a fair presentation have been included. Operating results for the three and six months ended June&#160;30, 2021 are not necessarily indicative of the results that may be expected for any other reporting period.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">These condensed consolidated financial statements should be read in conjunction with the Company&#8217;s audited consolidated financial statements and related notes included in its Annual Report on Form 10-K for the year ended December 31, 2020 (the &#8220;Annual Financial Statements&#8221;).</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Certain prior year amounts have been reclassified to conform to the current year presentation of our condensed consolidated financial statements. These reclassifications had no effect on the reported results of operations and ending shareholders&#8217; equity.</span></div></ix:continuation></ix:continuation><div style="height:36pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">9</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:72pt;width:100%"><div style="margin-top:0.55pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:95.000%"><tr><td style="width:1.0%"></td><td style="width:65.712%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:32.088%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="border-top:1pt solid #FFFFFF;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Cronos Group Inc.</span></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Notes to Condensed Consolidated Financial Statements (Unaudited)</span></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">(In thousands of $, except share amounts)</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i93ca9bb01792476fbb225e5d9dec869f_7">Table of Contents</a></span></div></td></tr></table></div></div><ix:continuation id="i353b08aa430e40d7bb6561f9151fc5c7"><div style="margin-bottom:6pt;margin-top:6pt;padding-left:36pt;text-align:justify;text-indent:-36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(d)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;padding-left:23.78pt"><ix:nonNumeric contextRef="i69782326f71a44e3805518280ee22b6b_D20210101-20210630" name="us-gaap:NewAccountingPronouncementsPolicyPolicyTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjkzY2E5YmIwMTc5MjQ3NmZiYjIyNWU1ZDlkZWM4NjlmL3NlYzo5M2NhOWJiMDE3OTI0NzZmYmIyMjVlNWQ5ZGVjODY5Zl8zNC9mcmFnOjYwNzFjM2U1NDE4NTRjN2M5MDhmOWM2ZmI5ZGFhNGQ1L3RleHRyZWdpb246NjA3MWMzZTU0MTg1NGM3YzkwOGY5YzZmYjlkYWE0ZDVfNTU3OQ_22755404-4080-40d3-848a-72c114e8f346" continuedAt="ic57c0d6e0a204d18b4c17b1f0e69e913" escape="true">Adoption of new accounting pronouncements</ix:nonNumeric></span></div><ix:continuation id="ic57c0d6e0a204d18b4c17b1f0e69e913"><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On January 1, 2021, the Company adopted ASU No. 2020-01, Investments-Equity Securities (Topic 321), Investments-Equity Method and Joint Ventures (Topic 323), and Derivatives and Hedging (Topic 815) (&#8220;ASU No. 2020-01&#8221;). ASU No. 2020-01 clarifies the interaction of accounting for the transition into and out of the equity method as well as measuring certain purchased options and forward contracts to acquire investments. The adoption of ASU No. 2020-01 did not have an impact on the Company&#8217;s interim condensed consolidated financial statements.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On January 1, 2021, the Company adopted ASU 2019-12, Income Taxes (Topic 740): Simplifying the Accounting for Income Taxes (&#8220;ASU No. 2019-12&#8221;). ASU No. 2019-12 eliminates certain exceptions and simplifies the application of U.S. GAAP-related changes in enacted tax laws or rates and employee stock option plans. The adoption of ASU No. 2019-12 did not have an impact on the Company&#8217;s interim condensed consolidated financial statements.</span></div><div style="margin-bottom:6pt;margin-top:6pt;padding-left:36pt;text-align:justify;text-indent:-36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(e)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;padding-left:24.91pt">New accounting pronouncements not yet adopted</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In August 2020, the FASB issued ASU 2020-06, Debt &#8211;Debt with Conversion and Other Options (Subtopic 470-20) and Derivatives and Hedging&#8212;Contracts in Entity&#8217;s Own Equity (Subtopic 815&#8211;40) (&#8220;ASU No. 2020-06&#8221;). ASU No. 2020-06 simplifies the accounting for certain financial instruments with characteristics of liabilities and equity, including convertible instruments and contracts on an entity&#8217;s own equity. ASU No. 2020-06 is part of the FASB&#8217;s simplification initiative, which aims to reduce unnecessary complexity in U.S. GAAP. ASU No. 2020-06 is effective for fiscal years beginning after December 15, 2021, and interim periods within those fiscal years. The Company is currently evaluating the impact ASU No. 2020-06 will have on its condensed consolidated financial statements.</span></div></ix:continuation></ix:continuation><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span><br/></span></div><div id="i93ca9bb01792476fbb225e5d9dec869f_37"></div><div style="margin-bottom:12pt;margin-top:6pt;padding-left:29.25pt;text-align:justify;text-indent:-27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">2. <ix:nonNumeric contextRef="i69782326f71a44e3805518280ee22b6b_D20210101-20210630" name="us-gaap:InventoryDisclosureTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjkzY2E5YmIwMTc5MjQ3NmZiYjIyNWU1ZDlkZWM4NjlmL3NlYzo5M2NhOWJiMDE3OTI0NzZmYmIyMjVlNWQ5ZGVjODY5Zl8zNy9mcmFnOjdhYTdjOTAyNzgxNDRiNTI5Njg1NmQ3OGRiNGFjMTc5L3RleHRyZWdpb246N2FhN2M5MDI3ODE0NGI1Mjk2ODU2ZDc4ZGI0YWMxNzlfMzMz_a1855cac-6d36-473c-bef2-e6da9691c29a" continuedAt="ib13a077416af45edb07ce3d3b513d8f7" escape="true">Inventory, net</ix:nonNumeric></span></div><ix:continuation id="ib13a077416af45edb07ce3d3b513d8f7"><ix:nonNumeric contextRef="i69782326f71a44e3805518280ee22b6b_D20210101-20210630" name="us-gaap:ScheduleOfInventoryCurrentTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjkzY2E5YmIwMTc5MjQ3NmZiYjIyNWU1ZDlkZWM4NjlmL3NlYzo5M2NhOWJiMDE3OTI0NzZmYmIyMjVlNWQ5ZGVjODY5Zl8zNy9mcmFnOjdhYTdjOTAyNzgxNDRiNTI5Njg1NmQ3OGRiNGFjMTc5L3RleHRyZWdpb246N2FhN2M5MDI3ODE0NGI1Mjk2ODU2ZDc4ZGI0YWMxNzlfMzM0_250c8786-f063-49a9-b06d-60aa2a2e7b93" escape="true"><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Inventory, net is comprised of the following items:</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:59.733%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:1.605%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:16.816%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:1.327%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:16.819%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">As of June&#160;30, 2021</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">As of December 31, 2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Raw materials</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i225f85e38faa4bbdb4de1d8b9cf369bb_I20210630" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:InventoryRawMaterialsNetOfReserves" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzY2E5YmIwMTc5MjQ3NmZiYjIyNWU1ZDlkZWM4NjlmL3NlYzo5M2NhOWJiMDE3OTI0NzZmYmIyMjVlNWQ5ZGVjODY5Zl8zNy9mcmFnOjdhYTdjOTAyNzgxNDRiNTI5Njg1NmQ3OGRiNGFjMTc5L3RhYmxlOmNjY2U3ODc4ZWNiMjQ1NjhhNmRiZDczMWQ5MGYzODRjL3RhYmxlcmFuZ2U6Y2NjZTc4NzhlY2IyNDU2OGE2ZGJkNzMxZDkwZjM4NGNfMS0yLTEtMS0w_e1e96ccd-e9c9-481e-a2ea-f5f19f7972b9">7,471</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ifbe16ec51ea244519b77d6036b4ef038_I20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:InventoryRawMaterialsNetOfReserves" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzY2E5YmIwMTc5MjQ3NmZiYjIyNWU1ZDlkZWM4NjlmL3NlYzo5M2NhOWJiMDE3OTI0NzZmYmIyMjVlNWQ5ZGVjODY5Zl8zNy9mcmFnOjdhYTdjOTAyNzgxNDRiNTI5Njg1NmQ3OGRiNGFjMTc5L3RhYmxlOmNjY2U3ODc4ZWNiMjQ1NjhhNmRiZDczMWQ5MGYzODRjL3RhYmxlcmFuZ2U6Y2NjZTc4NzhlY2IyNDU2OGE2ZGJkNzMxZDkwZjM4NGNfMS00LTEtMS0w_c43bf9c8-c275-4842-bcb1-c172a76f7e42">11,489</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Work-in-progress</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i225f85e38faa4bbdb4de1d8b9cf369bb_I20210630" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:InventoryWorkInProcessNetOfReserves" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzY2E5YmIwMTc5MjQ3NmZiYjIyNWU1ZDlkZWM4NjlmL3NlYzo5M2NhOWJiMDE3OTI0NzZmYmIyMjVlNWQ5ZGVjODY5Zl8zNy9mcmFnOjdhYTdjOTAyNzgxNDRiNTI5Njg1NmQ3OGRiNGFjMTc5L3RhYmxlOmNjY2U3ODc4ZWNiMjQ1NjhhNmRiZDczMWQ5MGYzODRjL3RhYmxlcmFuZ2U6Y2NjZTc4NzhlY2IyNDU2OGE2ZGJkNzMxZDkwZjM4NGNfMi0yLTEtMS0w_f20d1a79-4cf1-4a5c-9a6c-ae982f5e72ce">17,291</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ifbe16ec51ea244519b77d6036b4ef038_I20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:InventoryWorkInProcessNetOfReserves" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzY2E5YmIwMTc5MjQ3NmZiYjIyNWU1ZDlkZWM4NjlmL3NlYzo5M2NhOWJiMDE3OTI0NzZmYmIyMjVlNWQ5ZGVjODY5Zl8zNy9mcmFnOjdhYTdjOTAyNzgxNDRiNTI5Njg1NmQ3OGRiNGFjMTc5L3RhYmxlOmNjY2U3ODc4ZWNiMjQ1NjhhNmRiZDczMWQ5MGYzODRjL3RhYmxlcmFuZ2U6Y2NjZTc4NzhlY2IyNDU2OGE2ZGJkNzMxZDkwZjM4NGNfMi00LTEtMS0w_37de6886-f70a-4cbd-8f42-529b2ce9b409">26,278</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Finished goods</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i225f85e38faa4bbdb4de1d8b9cf369bb_I20210630" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:InventoryFinishedGoodsNetOfReserves" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzY2E5YmIwMTc5MjQ3NmZiYjIyNWU1ZDlkZWM4NjlmL3NlYzo5M2NhOWJiMDE3OTI0NzZmYmIyMjVlNWQ5ZGVjODY5Zl8zNy9mcmFnOjdhYTdjOTAyNzgxNDRiNTI5Njg1NmQ3OGRiNGFjMTc5L3RhYmxlOmNjY2U3ODc4ZWNiMjQ1NjhhNmRiZDczMWQ5MGYzODRjL3RhYmxlcmFuZ2U6Y2NjZTc4NzhlY2IyNDU2OGE2ZGJkNzMxZDkwZjM4NGNfMy0yLTEtMS0w_9611d78a-9159-4cd5-83ed-7449d972779f">10,247</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ifbe16ec51ea244519b77d6036b4ef038_I20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:InventoryFinishedGoodsNetOfReserves" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzY2E5YmIwMTc5MjQ3NmZiYjIyNWU1ZDlkZWM4NjlmL3NlYzo5M2NhOWJiMDE3OTI0NzZmYmIyMjVlNWQ5ZGVjODY5Zl8zNy9mcmFnOjdhYTdjOTAyNzgxNDRiNTI5Njg1NmQ3OGRiNGFjMTc5L3RhYmxlOmNjY2U3ODc4ZWNiMjQ1NjhhNmRiZDczMWQ5MGYzODRjL3RhYmxlcmFuZ2U6Y2NjZTc4NzhlY2IyNDU2OGE2ZGJkNzMxZDkwZjM4NGNfMy00LTEtMS0w_0dfec015-e3ab-40e6-a71c-a49b249c4de5">5,905</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Supplies and consumables</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i225f85e38faa4bbdb4de1d8b9cf369bb_I20210630" decimals="-3" name="us-gaap:InventorySuppliesNetOfReserves" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzY2E5YmIwMTc5MjQ3NmZiYjIyNWU1ZDlkZWM4NjlmL3NlYzo5M2NhOWJiMDE3OTI0NzZmYmIyMjVlNWQ5ZGVjODY5Zl8zNy9mcmFnOjdhYTdjOTAyNzgxNDRiNTI5Njg1NmQ3OGRiNGFjMTc5L3RhYmxlOmNjY2U3ODc4ZWNiMjQ1NjhhNmRiZDczMWQ5MGYzODRjL3RhYmxlcmFuZ2U6Y2NjZTc4NzhlY2IyNDU2OGE2ZGJkNzMxZDkwZjM4NGNfNi0yLTEtMS0w_d7caeb90-4819-4600-a177-5fd3e62f17af">596</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ifbe16ec51ea244519b77d6036b4ef038_I20201231" decimals="-3" name="us-gaap:InventorySuppliesNetOfReserves" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzY2E5YmIwMTc5MjQ3NmZiYjIyNWU1ZDlkZWM4NjlmL3NlYzo5M2NhOWJiMDE3OTI0NzZmYmIyMjVlNWQ5ZGVjODY5Zl8zNy9mcmFnOjdhYTdjOTAyNzgxNDRiNTI5Njg1NmQ3OGRiNGFjMTc5L3RhYmxlOmNjY2U3ODc4ZWNiMjQ1NjhhNmRiZDczMWQ5MGYzODRjL3RhYmxlcmFuZ2U6Y2NjZTc4NzhlY2IyNDU2OGE2ZGJkNzMxZDkwZjM4NGNfNi00LTEtMS0w_87a55435-c86d-43bc-82ac-b1c3160fb3aa">330</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i225f85e38faa4bbdb4de1d8b9cf369bb_I20210630" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:InventoryNet" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzY2E5YmIwMTc5MjQ3NmZiYjIyNWU1ZDlkZWM4NjlmL3NlYzo5M2NhOWJiMDE3OTI0NzZmYmIyMjVlNWQ5ZGVjODY5Zl8zNy9mcmFnOjdhYTdjOTAyNzgxNDRiNTI5Njg1NmQ3OGRiNGFjMTc5L3RhYmxlOmNjY2U3ODc4ZWNiMjQ1NjhhNmRiZDczMWQ5MGYzODRjL3RhYmxlcmFuZ2U6Y2NjZTc4NzhlY2IyNDU2OGE2ZGJkNzMxZDkwZjM4NGNfNy0yLTEtMS0w_b3594964-c55d-4c82-a39d-907f682455b2">35,605</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ifbe16ec51ea244519b77d6036b4ef038_I20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:InventoryNet" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzY2E5YmIwMTc5MjQ3NmZiYjIyNWU1ZDlkZWM4NjlmL3NlYzo5M2NhOWJiMDE3OTI0NzZmYmIyMjVlNWQ5ZGVjODY5Zl8zNy9mcmFnOjdhYTdjOTAyNzgxNDRiNTI5Njg1NmQ3OGRiNGFjMTc5L3RhYmxlOmNjY2U3ODc4ZWNiMjQ1NjhhNmRiZDczMWQ5MGYzODRjL3RhYmxlcmFuZ2U6Y2NjZTc4NzhlY2IyNDU2OGE2ZGJkNzMxZDkwZjM4NGNfNy00LTEtMS0w_a9573f21-d9da-4578-bf4e-f59a45cc6f6b">44,002</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div></ix:nonNumeric><div style="margin-bottom:6pt;margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Inventory is written down for any obsolescence such as slow-moving or non-marketable products, or when the net realizable value of inventory is less than the carrying value. During the three months ended June&#160;30, 2021 and 2020, the Company recorded write-downs related to inventory of $<ix:nonFraction unitRef="usd" contextRef="i27f4e53b91ad4367b7f8d273eff27769_D20210401-20210630" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:InventoryWriteDown" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzY2E5YmIwMTc5MjQ3NmZiYjIyNWU1ZDlkZWM4NjlmL3NlYzo5M2NhOWJiMDE3OTI0NzZmYmIyMjVlNWQ5ZGVjODY5Zl8zNy9mcmFnOjdhYTdjOTAyNzgxNDRiNTI5Njg1NmQ3OGRiNGFjMTc5L3RleHRyZWdpb246N2FhN2M5MDI3ODE0NGI1Mjk2ODU2ZDc4ZGI0YWMxNzlfNDk0NzgwMjMyNTcyNg_07458092-2095-4159-b4a6-34fbda5e72d5">11,961</ix:nonFraction> and $<ix:nonFraction unitRef="usd" contextRef="i39065c5daf934af885335c12f3cfa83f_D20200401-20200630" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:InventoryWriteDown" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzY2E5YmIwMTc5MjQ3NmZiYjIyNWU1ZDlkZWM4NjlmL3NlYzo5M2NhOWJiMDE3OTI0NzZmYmIyMjVlNWQ5ZGVjODY5Zl8zNy9mcmFnOjdhYTdjOTAyNzgxNDRiNTI5Njg1NmQ3OGRiNGFjMTc5L3RleHRyZWdpb246N2FhN2M5MDI3ODE0NGI1Mjk2ODU2ZDc4ZGI0YWMxNzlfNDk0NzgwMjMyNTc1Mg_10cd58b4-15f4-4d29-aaa3-c5a277c7bac5">3,062</ix:nonFraction>, respectively. During the six months ended June&#160;30, 2021 and 2020, the Company recorded write-downs related to inventory of $<ix:nonFraction unitRef="usd" contextRef="i69782326f71a44e3805518280ee22b6b_D20210101-20210630" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:InventoryWriteDown" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzY2E5YmIwMTc5MjQ3NmZiYjIyNWU1ZDlkZWM4NjlmL3NlYzo5M2NhOWJiMDE3OTI0NzZmYmIyMjVlNWQ5ZGVjODY5Zl8zNy9mcmFnOjdhYTdjOTAyNzgxNDRiNTI5Njg1NmQ3OGRiNGFjMTc5L3RleHRyZWdpb246N2FhN2M5MDI3ODE0NGI1Mjk2ODU2ZDc4ZGI0YWMxNzlfNDk0NzgwMjMyNTg1MQ_1728fb08-fd08-4b6e-9305-7ef94115d19d">11,961</ix:nonFraction> and $<ix:nonFraction unitRef="usd" contextRef="i4a110e4972ef4113880ce582e3cda5c5_D20200101-20200630" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:InventoryWriteDown" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzY2E5YmIwMTc5MjQ3NmZiYjIyNWU1ZDlkZWM4NjlmL3NlYzo5M2NhOWJiMDE3OTI0NzZmYmIyMjVlNWQ5ZGVjODY5Zl8zNy9mcmFnOjdhYTdjOTAyNzgxNDRiNTI5Njg1NmQ3OGRiNGFjMTc5L3RleHRyZWdpb246N2FhN2M5MDI3ODE0NGI1Mjk2ODU2ZDc4ZGI0YWMxNzlfNDk0NzgwMjMyNTg1OQ_ef2a2995-09c4-4e1e-8fe6-a90472624070">11,024</ix:nonFraction>, respectively.</span></div></ix:continuation><div style="text-align:justify"><span><br/></span></div><div id="i93ca9bb01792476fbb225e5d9dec869f_40"></div><div style="margin-bottom:12pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">3. <ix:nonNumeric contextRef="i69782326f71a44e3805518280ee22b6b_D20210101-20210630" name="us-gaap:EquityMethodInvestmentsDisclosureTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjkzY2E5YmIwMTc5MjQ3NmZiYjIyNWU1ZDlkZWM4NjlmL3NlYzo5M2NhOWJiMDE3OTI0NzZmYmIyMjVlNWQ5ZGVjODY5Zl80MC9mcmFnOjQwNDNmMGZmZDk0ZjRjOWNiYzg4MjA0YTc0ODU5YjA1L3RleHRyZWdpb246NDA0M2YwZmZkOTRmNGM5Y2JjODgyMDRhNzQ4NTliMDVfNDMyMg_d5789681-d467-4101-9c43-b2ff66eb1057" continuedAt="i616cad2e59e54a0dbc5aa33c57b7edd1" escape="true">Investments</ix:nonNumeric></span></div><ix:continuation id="i616cad2e59e54a0dbc5aa33c57b7edd1" continuedAt="i931548f5eccd47379ff2543770339c9b"><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(a)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;padding-left:24.34pt">Variable interest entities and investments in equity accounted investees, net</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company holds variable interests in Cronos Growing Company Inc. (&#8220;Cronos GrowCo&#8221;), Natuera S.&#224;.r.l (&#8220;Natuera&#8221;), MedMen Canada Inc. (&#8220;MedMen Canada&#8221;) and Cannasoul Lab Services Ltd. (&#8220;CLS&#8221;). The Company&#8217;s investments in Cronos GrowCo, Natuera and MedMen Canada are exposed to economic variability from each entity&#8217;s performance; however, the Company does not consolidate the entities as it does not have the power to direct the activities that most significantly impact each entity&#8217;s economic performance. Thus, Cronos Group is not considered the primary beneficiary of each entity. These investments are accounted for as equity method investments classified as &#8220;Investments in equity accounted investees, net&#8221; in the consolidated balance sheets.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Cronos GrowCo is a joint venture incorporated under the Canada Business Corporations Act (&#8220;CBCA&#8221;) on June 14, 2018 with the objective of cultivating and commercializing cannabis and cannabis products. Cronos Group holds variable interests in Cronos GrowCo through its ownership of <ix:nonFraction unitRef="number" contextRef="i2c5e7037ffad4b3fb6a481d2db070fa0_D20180614-20180614" decimals="INF" name="us-gaap:VariableInterestEntityOwnershipPercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjkzY2E5YmIwMTc5MjQ3NmZiYjIyNWU1ZDlkZWM4NjlmL3NlYzo5M2NhOWJiMDE3OTI0NzZmYmIyMjVlNWQ5ZGVjODY5Zl80MC9mcmFnOjQwNDNmMGZmZDk0ZjRjOWNiYzg4MjA0YTc0ODU5YjA1L3RleHRyZWdpb246NDA0M2YwZmZkOTRmNGM5Y2JjODgyMDRhNzQ4NTliMDVfMTA0NDUzNjA0NzcwNDA_9f53f937-691f-4be1-b490-6352142f2773">50</ix:nonFraction>% of Cronos GrowCo&#8217;s common shares and senior secured debt. Cronos GrowCo&#8217;s economic performance is driven by the quantity and strains of cannabis grown. The joint venture partners mutually determine the quantity and strains of cannabis grown.</span></div></ix:continuation><div style="height:36pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">10</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:72pt;width:100%"><div style="margin-top:0.55pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:95.000%"><tr><td style="width:1.0%"></td><td style="width:65.712%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:32.088%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="border-top:1pt solid #FFFFFF;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Cronos Group Inc.</span></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Notes to Condensed Consolidated Financial Statements (Unaudited)</span></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">(In thousands of $, except share amounts)</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i93ca9bb01792476fbb225e5d9dec869f_7">Table of Contents</a></span></div></td></tr></table></div></div><ix:continuation id="i931548f5eccd47379ff2543770339c9b" continuedAt="i2a57d40aeaa74c4e946631f65f880df3"><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">MedMen Canada is a joint venture incorporated under the CBCA on March 13, 2018, with the objective of the retail sale and marketing of cannabis products in Canada. MedMen Canada holds the exclusive license to the MedMen brand in Canada for a minimum term of <ix:nonNumeric contextRef="i5fb990fe11674db5b7f9322fbc74ed16_D20180313-20180313" format="ixt-sec:duryear" name="cron:VariableInterestEntityQualitativeOrQuantitativeInformationLicenseTerm" id="id3VybDovL2RvY3MudjEvZG9jOjkzY2E5YmIwMTc5MjQ3NmZiYjIyNWU1ZDlkZWM4NjlmL3NlYzo5M2NhOWJiMDE3OTI0NzZmYmIyMjVlNWQ5ZGVjODY5Zl80MC9mcmFnOjQwNDNmMGZmZDk0ZjRjOWNiYzg4MjA0YTc0ODU5YjA1L3RleHRyZWdpb246NDA0M2YwZmZkOTRmNGM5Y2JjODgyMDRhNzQ4NTliMDVfOTky_4fb7ddbe-984b-4767-b2f4-507c4fe08821">20</ix:nonNumeric> years. The Company holds variable interests in MedMen Canada through its ownership of <ix:nonFraction unitRef="number" contextRef="iee8bd06f99704a93846316c2ce890297_D20180313-20180313" decimals="INF" name="us-gaap:VariableInterestEntityOwnershipPercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjkzY2E5YmIwMTc5MjQ3NmZiYjIyNWU1ZDlkZWM4NjlmL3NlYzo5M2NhOWJiMDE3OTI0NzZmYmIyMjVlNWQ5ZGVjODY5Zl80MC9mcmFnOjQwNDNmMGZmZDk0ZjRjOWNiYzg4MjA0YTc0ODU5YjA1L3RleHRyZWdpb246NDA0M2YwZmZkOTRmNGM5Y2JjODgyMDRhNzQ4NTliMDVfMTA3Ng_d9956711-0a82-4932-85a5-220740ddc022">50</ix:nonFraction>% of MedMen Canada&#8217;s common shares and other subordinated debt. MedMen Canada&#8217;s economic performance is driven by the quantity and strains of cannabis sold. Subject to applicable law, the joint venture partners mutually determine the quantity and strains of cannabis to be sold in MedMen Canada&#8217;s retail stores, if and when stores are opened. </span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Natuera is a joint venture registered in Luxembourg with the objective of cultivating and commercializing hemp and cannabis products. The Company holds variable interests in Natuera through its ownership of <ix:nonFraction unitRef="number" contextRef="i2dd929bbe65b485fba3ba327ce7e73d7_D20210101-20210630" decimals="INF" name="us-gaap:VariableInterestEntityOwnershipPercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjkzY2E5YmIwMTc5MjQ3NmZiYjIyNWU1ZDlkZWM4NjlmL3NlYzo5M2NhOWJiMDE3OTI0NzZmYmIyMjVlNWQ5ZGVjODY5Zl80MC9mcmFnOjQwNDNmMGZmZDk0ZjRjOWNiYzg4MjA0YTc0ODU5YjA1L3RleHRyZWdpb246NDA0M2YwZmZkOTRmNGM5Y2JjODgyMDRhNzQ4NTliMDVfMTYyMw_99b12980-172a-4ad9-8fac-2189190ec59c">50</ix:nonFraction>% of Natuera&#8217;s common shares. Natuera&#8217;s economic performance is driven by the quantity and strains of cannabis grown, which is mutually determined by the joint venture partners.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">CLS is a wholly owned subsidiary of Cannasoul Analytics Ltd., incorporated with the purpose of establishing a commercial cannabis analytical testing laboratory located on the premises of Cronos Israel (the &#8220;Cannasoul Collaboration&#8221;). Cronos Israel agreed to advance up to ILS <ix:nonFraction unitRef="ils" contextRef="i00bf33a48aaa4cf2930896225af28659_I20210630" decimals="-3" format="ixt:numdotdecimal" name="cron:CollaborativeArrangementAmountOfAdvances" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzY2E5YmIwMTc5MjQ3NmZiYjIyNWU1ZDlkZWM4NjlmL3NlYzo5M2NhOWJiMDE3OTI0NzZmYmIyMjVlNWQ5ZGVjODY5Zl80MC9mcmFnOjQwNDNmMGZmZDk0ZjRjOWNiYzg4MjA0YTc0ODU5YjA1L3RleHRyZWdpb246NDA0M2YwZmZkOTRmNGM5Y2JjODgyMDRhNzQ4NTliMDVfMjY0OQ_bd73200f-b5d6-4f2d-84d1-b97df58413df">8,297</ix:nonFraction> ($<ix:nonFraction unitRef="usd" contextRef="i00bf33a48aaa4cf2930896225af28659_I20210630" decimals="-3" format="ixt:numdotdecimal" name="cron:CollaborativeArrangementAmountOfAdvances" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzY2E5YmIwMTc5MjQ3NmZiYjIyNWU1ZDlkZWM4NjlmL3NlYzo5M2NhOWJiMDE3OTI0NzZmYmIyMjVlNWQ5ZGVjODY5Zl80MC9mcmFnOjQwNDNmMGZmZDk0ZjRjOWNiYzg4MjA0YTc0ODU5YjA1L3RleHRyZWdpb246NDA0M2YwZmZkOTRmNGM5Y2JjODgyMDRhNzQ4NTliMDVfMjY1Mw_ec3aa220-4513-46c8-bd28-ea6567c30df6">2,511</ix:nonFraction>) by a non-recourse loan (the &#8220;Cannasoul Collaboration Loan&#8221;) to CLS over a period of <ix:nonNumeric contextRef="ic24b8af14f4a4a25a1f88b1707e38fa7_D20210101-20210630" format="ixt-sec:durwordsen" name="cron:CollaborativeArrangementTermOfAgreement" id="id3VybDovL2RvY3MudjEvZG9jOjkzY2E5YmIwMTc5MjQ3NmZiYjIyNWU1ZDlkZWM4NjlmL3NlYzo5M2NhOWJiMDE3OTI0NzZmYmIyMjVlNWQ5ZGVjODY5Zl80MC9mcmFnOjQwNDNmMGZmZDk0ZjRjOWNiYzg4MjA0YTc0ODU5YjA1L3RleHRyZWdpb246NDA0M2YwZmZkOTRmNGM5Y2JjODgyMDRhNzQ4NTliMDVfMjcwNA_e283aa17-a8bc-4567-bc76-ad6e2021cef3">two years</ix:nonNumeric> from April 1, 2020 for the capital and operating expenditures of the laboratory. The loan bears interest at <ix:nonFraction unitRef="number" contextRef="i00bf33a48aaa4cf2930896225af28659_I20210630" decimals="INF" name="us-gaap:DebtInstrumentInterestRateStatedPercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjkzY2E5YmIwMTc5MjQ3NmZiYjIyNWU1ZDlkZWM4NjlmL3NlYzo5M2NhOWJiMDE3OTI0NzZmYmIyMjVlNWQ5ZGVjODY5Zl80MC9mcmFnOjQwNDNmMGZmZDk0ZjRjOWNiYzg4MjA0YTc0ODU5YjA1L3RleHRyZWdpb246NDA0M2YwZmZkOTRmNGM5Y2JjODgyMDRhNzQ4NTliMDVfMjgxNQ_a5bf95ee-9d34-414e-816d-0c823ee31e8c">3.5</ix:nonFraction>% annually. Cronos Israel will receive <ix:nonFraction unitRef="number" contextRef="i5822a176b17c44938c5acb5edec46594_I20210630" decimals="INF" name="cron:CollaborativeArrangementPercentageOfProfitsToBeReceived" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjkzY2E5YmIwMTc5MjQ3NmZiYjIyNWU1ZDlkZWM4NjlmL3NlYzo5M2NhOWJiMDE3OTI0NzZmYmIyMjVlNWQ5ZGVjODY5Zl80MC9mcmFnOjQwNDNmMGZmZDk0ZjRjOWNiYzg4MjA0YTc0ODU5YjA1L3RleHRyZWdpb246NDA0M2YwZmZkOTRmNGM5Y2JjODgyMDRhNzQ4NTliMDVfMjg1NQ_35f177b0-8c0c-44cd-8d72-403ed2879147">70</ix:nonFraction>% of the profits of the laboratory until such time as it has recovered <ix:nonFraction unitRef="number" contextRef="i5822a176b17c44938c5acb5edec46594_I20210630" decimals="INF" name="cron:CollaborativeArrangementProfitsToBeReceivedMaximumPercentageOfAmountsAdvanced" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjkzY2E5YmIwMTc5MjQ3NmZiYjIyNWU1ZDlkZWM4NjlmL3NlYzo5M2NhOWJiMDE3OTI0NzZmYmIyMjVlNWQ5ZGVjODY5Zl80MC9mcmFnOjQwNDNmMGZmZDk0ZjRjOWNiYzg4MjA0YTc0ODU5YjA1L3RleHRyZWdpb246NDA0M2YwZmZkOTRmNGM5Y2JjODgyMDRhNzQ4NTliMDVfMjkyNw_0d2dd3f1-7720-421a-a35e-f475a6716728">150</ix:nonFraction>% of the amounts advanced to CLS, after which time it will receive <ix:nonFraction unitRef="number" contextRef="i5822a176b17c44938c5acb5edec46594_I20210630" decimals="INF" name="cron:CollaborativeArrangementPercentageOfProfitsToBeReceivedTriggeringEventSubsequentToMaximumPercentageOfAmountsAdvancedBeingMet" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjkzY2E5YmIwMTc5MjQ3NmZiYjIyNWU1ZDlkZWM4NjlmL3NlYzo5M2NhOWJiMDE3OTI0NzZmYmIyMjVlNWQ5ZGVjODY5Zl80MC9mcmFnOjQwNDNmMGZmZDk0ZjRjOWNiYzg4MjA0YTc0ODU5YjA1L3RleHRyZWdpb246NDA0M2YwZmZkOTRmNGM5Y2JjODgyMDRhNzQ4NTliMDVfMjk5NQ_ec880521-01a0-4d82-8542-3592ae693595">50</ix:nonFraction>% of the laboratory profits. As a result, the Company is exposed to economic variability from CLS&#8217;s performance. The Company does not consolidate CLS as it does not have the power to direct the activities that most significantly impact the entity&#8217;s economic performance; thus, the Company is not considered the primary beneficiary of the entity. The carrying amount of the non-recourse loan is recorded under loans receivable and the full loan amount, ILS <ix:nonFraction unitRef="ils" contextRef="i00bf33a48aaa4cf2930896225af28659_I20210630" decimals="-3" format="ixt:numdotdecimal" name="cron:CollaborativeArrangementAmountOfAdvances" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzY2E5YmIwMTc5MjQ3NmZiYjIyNWU1ZDlkZWM4NjlmL3NlYzo5M2NhOWJiMDE3OTI0NzZmYmIyMjVlNWQ5ZGVjODY5Zl80MC9mcmFnOjQwNDNmMGZmZDk0ZjRjOWNiYzg4MjA0YTc0ODU5YjA1L3RleHRyZWdpb246NDA0M2YwZmZkOTRmNGM5Y2JjODgyMDRhNzQ4NTliMDVfMzQ1Mg_259e1f5c-a09b-459c-96e6-9c3d0eb711c1">8,297</ix:nonFraction>, represents the Company&#8217;s maximum potential exposure to losses through the Cannasoul Collaboration. See Note 4. Loans Receivable, net for further information regarding loans receivable.</span></div><ix:nonNumeric contextRef="i69782326f71a44e3805518280ee22b6b_D20210101-20210630" name="us-gaap:EquityMethodInvestmentsTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjkzY2E5YmIwMTc5MjQ3NmZiYjIyNWU1ZDlkZWM4NjlmL3NlYzo5M2NhOWJiMDE3OTI0NzZmYmIyMjVlNWQ5ZGVjODY5Zl80MC9mcmFnOjQwNDNmMGZmZDk0ZjRjOWNiYzg4MjA0YTc0ODU5YjA1L3RleHRyZWdpb246NDA0M2YwZmZkOTRmNGM5Y2JjODgyMDRhNzQ4NTliMDVfNDMyNQ_81b0fa31-7410-44d0-a307-c5275483cd9d" escape="true"><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">A reconciliation of the carrying amount of the investments in associates and joint ventures is as follows:</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:45.844%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:15.566%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:1.327%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:15.566%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:1.327%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:15.570%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Ownership interest</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">As of June&#160;30, 2021</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">As of December 31, 2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cronos Australia</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i52d0636c66ed4ea58c20dfcc9a4132e8_I20210630" decimals="2" name="us-gaap:EquityMethodInvestmentOwnershipPercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjkzY2E5YmIwMTc5MjQ3NmZiYjIyNWU1ZDlkZWM4NjlmL3NlYzo5M2NhOWJiMDE3OTI0NzZmYmIyMjVlNWQ5ZGVjODY5Zl80MC9mcmFnOjQwNDNmMGZmZDk0ZjRjOWNiYzg4MjA0YTc0ODU5YjA1L3RhYmxlOjk4NDBhYjI5YWQyMjQ2ZjdiYjYyOTY1NjRlMjFlZjdlL3RhYmxlcmFuZ2U6OTg0MGFiMjlhZDIyNDZmN2JiNjI5NjU2NGUyMWVmN2VfMS0xLTEtMS0w_ed4abdd2-03be-4511-afb3-af6dc2ba925f">31</ix:nonFraction>%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i52d0636c66ed4ea58c20dfcc9a4132e8_I20210630" decimals="-3" format="ixt:zerodash" name="us-gaap:EquityMethodInvestments" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzY2E5YmIwMTc5MjQ3NmZiYjIyNWU1ZDlkZWM4NjlmL3NlYzo5M2NhOWJiMDE3OTI0NzZmYmIyMjVlNWQ5ZGVjODY5Zl80MC9mcmFnOjQwNDNmMGZmZDk0ZjRjOWNiYzg4MjA0YTc0ODU5YjA1L3RhYmxlOjk4NDBhYjI5YWQyMjQ2ZjdiYjYyOTY1NjRlMjFlZjdlL3RhYmxlcmFuZ2U6OTg0MGFiMjlhZDIyNDZmN2JiNjI5NjU2NGUyMWVmN2VfMS0zLTEtMS0w_6b3a564d-2112-448f-994f-5d69079379dc">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i78252faeeac94cf1b00fbbab110c7bb8_I20201231" decimals="-3" format="ixt:zerodash" name="us-gaap:EquityMethodInvestments" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzY2E5YmIwMTc5MjQ3NmZiYjIyNWU1ZDlkZWM4NjlmL3NlYzo5M2NhOWJiMDE3OTI0NzZmYmIyMjVlNWQ5ZGVjODY5Zl80MC9mcmFnOjQwNDNmMGZmZDk0ZjRjOWNiYzg4MjA0YTc0ODU5YjA1L3RhYmxlOjk4NDBhYjI5YWQyMjQ2ZjdiYjYyOTY1NjRlMjFlZjdlL3RhYmxlcmFuZ2U6OTg0MGFiMjlhZDIyNDZmN2JiNjI5NjU2NGUyMWVmN2VfMS01LTEtMS0w_6fd5324a-6d8f-4a73-9617-4a6872be3413">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cronos GrowCo</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i994476164a994f30beee53e661ac1a3f_I20210630" decimals="2" name="us-gaap:EquityMethodInvestmentOwnershipPercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjkzY2E5YmIwMTc5MjQ3NmZiYjIyNWU1ZDlkZWM4NjlmL3NlYzo5M2NhOWJiMDE3OTI0NzZmYmIyMjVlNWQ5ZGVjODY5Zl80MC9mcmFnOjQwNDNmMGZmZDk0ZjRjOWNiYzg4MjA0YTc0ODU5YjA1L3RhYmxlOjk4NDBhYjI5YWQyMjQ2ZjdiYjYyOTY1NjRlMjFlZjdlL3RhYmxlcmFuZ2U6OTg0MGFiMjlhZDIyNDZmN2JiNjI5NjU2NGUyMWVmN2VfMi0xLTEtMS0w_3620b6bd-565b-4363-99b5-9a1242144c2a">50</ix:nonFraction>%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i994476164a994f30beee53e661ac1a3f_I20210630" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:EquityMethodInvestments" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzY2E5YmIwMTc5MjQ3NmZiYjIyNWU1ZDlkZWM4NjlmL3NlYzo5M2NhOWJiMDE3OTI0NzZmYmIyMjVlNWQ5ZGVjODY5Zl80MC9mcmFnOjQwNDNmMGZmZDk0ZjRjOWNiYzg4MjA0YTc0ODU5YjA1L3RhYmxlOjk4NDBhYjI5YWQyMjQ2ZjdiYjYyOTY1NjRlMjFlZjdlL3RhYmxlcmFuZ2U6OTg0MGFiMjlhZDIyNDZmN2JiNjI5NjU2NGUyMWVmN2VfMi0zLTEtMS0w_7a3d21a5-7d1a-4746-a0e7-f024a6078dd2">19,022</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1b2c600c66ab4356a1aaf56482c504bd_I20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:EquityMethodInvestments" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzY2E5YmIwMTc5MjQ3NmZiYjIyNWU1ZDlkZWM4NjlmL3NlYzo5M2NhOWJiMDE3OTI0NzZmYmIyMjVlNWQ5ZGVjODY5Zl80MC9mcmFnOjQwNDNmMGZmZDk0ZjRjOWNiYzg4MjA0YTc0ODU5YjA1L3RhYmxlOjk4NDBhYjI5YWQyMjQ2ZjdiYjYyOTY1NjRlMjFlZjdlL3RhYmxlcmFuZ2U6OTg0MGFiMjlhZDIyNDZmN2JiNjI5NjU2NGUyMWVmN2VfMi01LTEtMS0w_cd64375b-906d-4557-9837-9db4189a0ea6">19,235</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Natuera</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(i)</span></div></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i21b51b5045c34ad2a57cb43054dca216_I20210630" decimals="2" name="us-gaap:EquityMethodInvestmentOwnershipPercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjkzY2E5YmIwMTc5MjQ3NmZiYjIyNWU1ZDlkZWM4NjlmL3NlYzo5M2NhOWJiMDE3OTI0NzZmYmIyMjVlNWQ5ZGVjODY5Zl80MC9mcmFnOjQwNDNmMGZmZDk0ZjRjOWNiYzg4MjA0YTc0ODU5YjA1L3RhYmxlOjk4NDBhYjI5YWQyMjQ2ZjdiYjYyOTY1NjRlMjFlZjdlL3RhYmxlcmFuZ2U6OTg0MGFiMjlhZDIyNDZmN2JiNjI5NjU2NGUyMWVmN2VfMy0xLTEtMS0w_d0287586-f1ae-4a8c-8b9f-0a05aca00eac">50</ix:nonFraction>%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i21b51b5045c34ad2a57cb43054dca216_I20210630" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:EquityMethodInvestments" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzY2E5YmIwMTc5MjQ3NmZiYjIyNWU1ZDlkZWM4NjlmL3NlYzo5M2NhOWJiMDE3OTI0NzZmYmIyMjVlNWQ5ZGVjODY5Zl80MC9mcmFnOjQwNDNmMGZmZDk0ZjRjOWNiYzg4MjA0YTc0ODU5YjA1L3RhYmxlOjk4NDBhYjI5YWQyMjQ2ZjdiYjYyOTY1NjRlMjFlZjdlL3RhYmxlcmFuZ2U6OTg0MGFiMjlhZDIyNDZmN2JiNjI5NjU2NGUyMWVmN2VfMy0zLTEtMS0w_abcdeeae-855d-4c74-8d2a-b4999d09c0fb">1,948</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i223bb2102d6d47b4988c830f7fa1a159_I20201231" decimals="-3" format="ixt:zerodash" name="us-gaap:EquityMethodInvestments" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzY2E5YmIwMTc5MjQ3NmZiYjIyNWU1ZDlkZWM4NjlmL3NlYzo5M2NhOWJiMDE3OTI0NzZmYmIyMjVlNWQ5ZGVjODY5Zl80MC9mcmFnOjQwNDNmMGZmZDk0ZjRjOWNiYzg4MjA0YTc0ODU5YjA1L3RhYmxlOjk4NDBhYjI5YWQyMjQ2ZjdiYjYyOTY1NjRlMjFlZjdlL3RhYmxlcmFuZ2U6OTg0MGFiMjlhZDIyNDZmN2JiNjI5NjU2NGUyMWVmN2VfMy01LTEtMS0w_9e0f7ae7-0501-4c8c-a8f7-a47e8da51881">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i225f85e38faa4bbdb4de1d8b9cf369bb_I20210630" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:EquityMethodInvestments" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzY2E5YmIwMTc5MjQ3NmZiYjIyNWU1ZDlkZWM4NjlmL3NlYzo5M2NhOWJiMDE3OTI0NzZmYmIyMjVlNWQ5ZGVjODY5Zl80MC9mcmFnOjQwNDNmMGZmZDk0ZjRjOWNiYzg4MjA0YTc0ODU5YjA1L3RhYmxlOjk4NDBhYjI5YWQyMjQ2ZjdiYjYyOTY1NjRlMjFlZjdlL3RhYmxlcmFuZ2U6OTg0MGFiMjlhZDIyNDZmN2JiNjI5NjU2NGUyMWVmN2VfNC0zLTEtMS0w_6ac9805e-acfc-4db3-b0ce-19a84ba36c0b">20,970</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ifbe16ec51ea244519b77d6036b4ef038_I20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:EquityMethodInvestments" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzY2E5YmIwMTc5MjQ3NmZiYjIyNWU1ZDlkZWM4NjlmL3NlYzo5M2NhOWJiMDE3OTI0NzZmYmIyMjVlNWQ5ZGVjODY5Zl80MC9mcmFnOjQwNDNmMGZmZDk0ZjRjOWNiYzg4MjA0YTc0ODU5YjA1L3RhYmxlOjk4NDBhYjI5YWQyMjQ2ZjdiYjYyOTY1NjRlMjFlZjdlL3RhYmxlcmFuZ2U6OTg0MGFiMjlhZDIyNDZmN2JiNjI5NjU2NGUyMWVmN2VfNC01LTEtMS0w_85694d07-4d8f-494a-aaca-3438ee16d333">19,235</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="margin-bottom:6pt;margin-top:3pt;padding-left:27pt;text-align:justify;text-indent:-27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:700;line-height:120%;position:relative;top:-2.8pt;vertical-align:baseline">(i)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:22.1pt">On April 1, 2021, the Company and an affiliate of Agroidea (&#8220;AGI&#8221;), the other joint venture partner of Natuera, converted all advances made to Natuera under the master loan agreement entered into with Natuera on September 27, 2019 (the &#8220;Natuera Series A Loan&#8221;), plus accrued interest, into equity of Natuera. Total aggregate gross advances to Natuera under the Natuera Series A Loan were $<ix:nonFraction unitRef="usd" contextRef="i3851bec177234bbb9f9d96a1e3eab1d3_D20210401-20210401" decimals="-3" format="ixt:numdotdecimal" name="cron:InvestmentsInAndAdvancesToAffiliatesAtFairValueAdvancesRepayments" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzY2E5YmIwMTc5MjQ3NmZiYjIyNWU1ZDlkZWM4NjlmL3NlYzo5M2NhOWJiMDE3OTI0NzZmYmIyMjVlNWQ5ZGVjODY5Zl80MC9mcmFnOjQwNDNmMGZmZDk0ZjRjOWNiYzg4MjA0YTc0ODU5YjA1L3RleHRyZWdpb246NDA0M2YwZmZkOTRmNGM5Y2JjODgyMDRhNzQ4NTliMDVfMTY0OTI2NzQ1MTQ2OA_e66e1c5d-6fc5-475f-8235-dc148c2066f0">15,500</ix:nonFraction>, of which the Company advanced <ix:nonFraction unitRef="number" contextRef="i8b8f1fc37db0427b9d081e7b40a48cc0_I20210401" decimals="INF" name="cron:InvestmentsInAndAdvancesToAffiliatesFundingCommitmentPercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjkzY2E5YmIwMTc5MjQ3NmZiYjIyNWU1ZDlkZWM4NjlmL3NlYzo5M2NhOWJiMDE3OTI0NzZmYmIyMjVlNWQ5ZGVjODY5Zl80MC9mcmFnOjQwNDNmMGZmZDk0ZjRjOWNiYzg4MjA0YTc0ODU5YjA1L3RleHRyZWdpb246NDA0M2YwZmZkOTRmNGM5Y2JjODgyMDRhNzQ4NTliMDVfMTY0OTI2NzQ1MTUwMw_e8b30708-26dd-44d4-b3de-61ded34a7e33">50</ix:nonFraction>% and AGI advanced the remaining <ix:nonFraction unitRef="number" contextRef="ia926bcff688b4febb81d8fa1a08955dc_I20210401" decimals="INF" name="cron:InvestmentsInAndAdvancesToAffiliatesFundingCommitmentPercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjkzY2E5YmIwMTc5MjQ3NmZiYjIyNWU1ZDlkZWM4NjlmL3NlYzo5M2NhOWJiMDE3OTI0NzZmYmIyMjVlNWQ5ZGVjODY5Zl80MC9mcmFnOjQwNDNmMGZmZDk0ZjRjOWNiYzg4MjA0YTc0ODU5YjA1L3RleHRyZWdpb246NDA0M2YwZmZkOTRmNGM5Y2JjODgyMDRhNzQ4NTliMDVfMTY0OTI2NzQ1MTUzOA_b38b007b-0b80-448f-97a8-266907209040">50</ix:nonFraction>%, or $<ix:nonFraction unitRef="usd" contextRef="i3734fffa32be45c299b65b62d227d165_D20210401-20210401" decimals="-3" format="ixt:numdotdecimal" name="cron:InvestmentsInAndAdvancesToAffiliatesAtFairValueAdvancesRepayments" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzY2E5YmIwMTc5MjQ3NmZiYjIyNWU1ZDlkZWM4NjlmL3NlYzo5M2NhOWJiMDE3OTI0NzZmYmIyMjVlNWQ5ZGVjODY5Zl80MC9mcmFnOjQwNDNmMGZmZDk0ZjRjOWNiYzg4MjA0YTc0ODU5YjA1L3RleHRyZWdpb246NDA0M2YwZmZkOTRmNGM5Y2JjODgyMDRhNzQ4NTliMDVfMTY0OTI2NzQ1MTU0Ng_570f0ddb-ed8f-417f-9aa7-b9588fa601bd"><ix:nonFraction unitRef="usd" contextRef="ibb17976a662245c78f9ece050fbca040_D20210401-20210401" decimals="-3" format="ixt:numdotdecimal" name="cron:InvestmentsInAndAdvancesToAffiliatesAtFairValueAdvancesRepayments" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzY2E5YmIwMTc5MjQ3NmZiYjIyNWU1ZDlkZWM4NjlmL3NlYzo5M2NhOWJiMDE3OTI0NzZmYmIyMjVlNWQ5ZGVjODY5Zl80MC9mcmFnOjQwNDNmMGZmZDk0ZjRjOWNiYzg4MjA0YTc0ODU5YjA1L3RleHRyZWdpb246NDA0M2YwZmZkOTRmNGM5Y2JjODgyMDRhNzQ4NTliMDVfMTY0OTI2NzQ1MTU0Ng_5e8e6ec9-499b-4911-950e-d1bcd4129b38">7,750</ix:nonFraction></ix:nonFraction> each. As a result, the Company transferred the carrying value of the Natuera Series A Loan of approximately $<ix:nonFraction unitRef="usd" contextRef="i74feb9a5e3ba4f03b6af6468c854d7d3_I20210401" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:NotesReceivableNet" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzY2E5YmIwMTc5MjQ3NmZiYjIyNWU1ZDlkZWM4NjlmL3NlYzo5M2NhOWJiMDE3OTI0NzZmYmIyMjVlNWQ5ZGVjODY5Zl80MC9mcmFnOjQwNDNmMGZmZDk0ZjRjOWNiYzg4MjA0YTc0ODU5YjA1L3RleHRyZWdpb246NDA0M2YwZmZkOTRmNGM5Y2JjODgyMDRhNzQ4NTliMDVfMTY0OTI2NzQ1MTY0MQ_679c199f-fd55-482a-97f3-313aceb94b1e">2,013</ix:nonFraction> plus accrued interest of $<ix:nonFraction unitRef="usd" contextRef="i74feb9a5e3ba4f03b6af6468c854d7d3_I20210401" decimals="-3" name="us-gaap:FinancingReceivableAccruedInterestBeforeAllowanceForCreditLoss" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzY2E5YmIwMTc5MjQ3NmZiYjIyNWU1ZDlkZWM4NjlmL3NlYzo5M2NhOWJiMDE3OTI0NzZmYmIyMjVlNWQ5ZGVjODY5Zl80MC9mcmFnOjQwNDNmMGZmZDk0ZjRjOWNiYzg4MjA0YTc0ODU5YjA1L3RleHRyZWdpb246NDA0M2YwZmZkOTRmNGM5Y2JjODgyMDRhNzQ4NTliMDVfMTY0OTI2NzQ1MTY3MQ_aa069b47-12cd-4847-b730-e43a0ae6dccf">540</ix:nonFraction>, for a total investment value of $<ix:nonFraction unitRef="usd" contextRef="i3851bec177234bbb9f9d96a1e3eab1d3_D20210401-20210401" decimals="-3" format="ixt:numdotdecimal" name="cron:InvestmentsInAndAdvancesToAffiliatesAtFairValueTransferToInvestmentsInEquityAccountedInvestees" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzY2E5YmIwMTc5MjQ3NmZiYjIyNWU1ZDlkZWM4NjlmL3NlYzo5M2NhOWJiMDE3OTI0NzZmYmIyMjVlNWQ5ZGVjODY5Zl80MC9mcmFnOjQwNDNmMGZmZDk0ZjRjOWNiYzg4MjA0YTc0ODU5YjA1L3RleHRyZWdpb246NDA0M2YwZmZkOTRmNGM5Y2JjODgyMDRhNzQ4NTliMDVfMjE5OTAyMzI3Njc2OA_445bb183-6dab-453b-bcac-16d2b68e28aa">2,553</ix:nonFraction>, which approximates fair value, to investments in equity accounted investees in respect of Natuera. See Note 4. Loans Receivable, net.</span></div><div style="margin-bottom:6pt;margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company&#8217;s share of net losses from equity investments accounted for under the equity method of accounting:</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:41.677%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.788%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.355%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.788%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.355%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.788%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.355%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.794%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">For the three months ended June&#160;30,</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">For the six months ended June&#160;30,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020</span></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cronos Australia</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i30bada16350b499487452cc45133a766_D20210401-20210630" decimals="-3" format="ixt:zerodash" name="us-gaap:IncomeLossFromEquityMethodInvestments" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzY2E5YmIwMTc5MjQ3NmZiYjIyNWU1ZDlkZWM4NjlmL3NlYzo5M2NhOWJiMDE3OTI0NzZmYmIyMjVlNWQ5ZGVjODY5Zl80MC9mcmFnOjQwNDNmMGZmZDk0ZjRjOWNiYzg4MjA0YTc0ODU5YjA1L3RhYmxlOjg5ZDk2ZDhkYmNiYTQxYjRiY2JmOTE5NzI5ZjNmODI4L3RhYmxlcmFuZ2U6ODlkOTZkOGRiY2JhNDFiNGJjYmY5MTk3MjlmM2Y4MjhfNC0xLTEtMS0w_a4497b5c-9740-4f8e-a8a8-e28a6eb5cb83">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="if1b554f135154a859f4b34c7f4f919c1_D20200401-20200630" decimals="-3" sign="-" name="us-gaap:IncomeLossFromEquityMethodInvestments" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzY2E5YmIwMTc5MjQ3NmZiYjIyNWU1ZDlkZWM4NjlmL3NlYzo5M2NhOWJiMDE3OTI0NzZmYmIyMjVlNWQ5ZGVjODY5Zl80MC9mcmFnOjQwNDNmMGZmZDk0ZjRjOWNiYzg4MjA0YTc0ODU5YjA1L3RhYmxlOjg5ZDk2ZDhkYmNiYTQxYjRiY2JmOTE5NzI5ZjNmODI4L3RhYmxlcmFuZ2U6ODlkOTZkOGRiY2JhNDFiNGJjYmY5MTk3MjlmM2Y4MjhfNC0zLTEtMS0w_e866611c-215e-4852-8a21-ff33870143a6">235</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id0c3e6d83e194fea9819a119d3744bb2_D20210101-20210630" decimals="-3" format="ixt:zerodash" name="us-gaap:IncomeLossFromEquityMethodInvestments" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzY2E5YmIwMTc5MjQ3NmZiYjIyNWU1ZDlkZWM4NjlmL3NlYzo5M2NhOWJiMDE3OTI0NzZmYmIyMjVlNWQ5ZGVjODY5Zl80MC9mcmFnOjQwNDNmMGZmZDk0ZjRjOWNiYzg4MjA0YTc0ODU5YjA1L3RhYmxlOjg5ZDk2ZDhkYmNiYTQxYjRiY2JmOTE5NzI5ZjNmODI4L3RhYmxlcmFuZ2U6ODlkOTZkOGRiY2JhNDFiNGJjYmY5MTk3MjlmM2Y4MjhfNC01LTEtMS0w_6dd6d2d1-20a5-44e6-8eb0-c598ea0f41fc">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ia01f832913b34cc9857827304dc28007_D20200101-20200630" decimals="-3" sign="-" name="us-gaap:IncomeLossFromEquityMethodInvestments" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzY2E5YmIwMTc5MjQ3NmZiYjIyNWU1ZDlkZWM4NjlmL3NlYzo5M2NhOWJiMDE3OTI0NzZmYmIyMjVlNWQ5ZGVjODY5Zl80MC9mcmFnOjQwNDNmMGZmZDk0ZjRjOWNiYzg4MjA0YTc0ODU5YjA1L3RhYmxlOjg5ZDk2ZDhkYmNiYTQxYjRiY2JmOTE5NzI5ZjNmODI4L3RhYmxlcmFuZ2U6ODlkOTZkOGRiY2JhNDFiNGJjYmY5MTk3MjlmM2Y4MjhfNC03LTEtMS0w_977f6cef-617b-44ac-85c1-0c113d1de8a3">235</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cronos GrowCo</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ia802a14b03cd4f04a97ecbdec57e7b1f_D20210401-20210630" decimals="-3" sign="-" name="us-gaap:IncomeLossFromEquityMethodInvestments" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzY2E5YmIwMTc5MjQ3NmZiYjIyNWU1ZDlkZWM4NjlmL3NlYzo5M2NhOWJiMDE3OTI0NzZmYmIyMjVlNWQ5ZGVjODY5Zl80MC9mcmFnOjQwNDNmMGZmZDk0ZjRjOWNiYzg4MjA0YTc0ODU5YjA1L3RhYmxlOjg5ZDk2ZDhkYmNiYTQxYjRiY2JmOTE5NzI5ZjNmODI4L3RhYmxlcmFuZ2U6ODlkOTZkOGRiY2JhNDFiNGJjYmY5MTk3MjlmM2Y4MjhfNS0xLTEtMS0w_848dff2c-febf-4ce5-b668-46cde27ae477">459</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="iddbb1b3540664f4db9ee13a36913a70f_D20200401-20200630" decimals="-3" sign="-" name="us-gaap:IncomeLossFromEquityMethodInvestments" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzY2E5YmIwMTc5MjQ3NmZiYjIyNWU1ZDlkZWM4NjlmL3NlYzo5M2NhOWJiMDE3OTI0NzZmYmIyMjVlNWQ5ZGVjODY5Zl80MC9mcmFnOjQwNDNmMGZmZDk0ZjRjOWNiYzg4MjA0YTc0ODU5YjA1L3RhYmxlOjg5ZDk2ZDhkYmNiYTQxYjRiY2JmOTE5NzI5ZjNmODI4L3RhYmxlcmFuZ2U6ODlkOTZkOGRiY2JhNDFiNGJjYmY5MTk3MjlmM2Y4MjhfNS0zLTEtMS0w_6d299b13-68b1-4214-aacc-9ba4ff9a35b8">190</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i9f733a1140c84f8286365160805bda02_D20210101-20210630" decimals="-3" sign="-" name="us-gaap:IncomeLossFromEquityMethodInvestments" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzY2E5YmIwMTc5MjQ3NmZiYjIyNWU1ZDlkZWM4NjlmL3NlYzo5M2NhOWJiMDE3OTI0NzZmYmIyMjVlNWQ5ZGVjODY5Zl80MC9mcmFnOjQwNDNmMGZmZDk0ZjRjOWNiYzg4MjA0YTc0ODU5YjA1L3RhYmxlOjg5ZDk2ZDhkYmNiYTQxYjRiY2JmOTE5NzI5ZjNmODI4L3RhYmxlcmFuZ2U6ODlkOTZkOGRiY2JhNDFiNGJjYmY5MTk3MjlmM2Y4MjhfNS01LTEtMS0w_f6884a6c-b5d1-4bc2-af74-bd2687668b3d">758</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i747cf8446c5d4312bef9db8f92ed86e7_D20200101-20200630" decimals="-3" sign="-" name="us-gaap:IncomeLossFromEquityMethodInvestments" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzY2E5YmIwMTc5MjQ3NmZiYjIyNWU1ZDlkZWM4NjlmL3NlYzo5M2NhOWJiMDE3OTI0NzZmYmIyMjVlNWQ5ZGVjODY5Zl80MC9mcmFnOjQwNDNmMGZmZDk0ZjRjOWNiYzg4MjA0YTc0ODU5YjA1L3RhYmxlOjg5ZDk2ZDhkYmNiYTQxYjRiY2JmOTE5NzI5ZjNmODI4L3RhYmxlcmFuZ2U6ODlkOTZkOGRiY2JhNDFiNGJjYmY5MTk3MjlmM2Y4MjhfNS03LTEtMS0w_c5bab81f-61d5-4861-b1f8-d40f2d724639">501</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Natuera</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i09025c29bd8b4bf4aa6255cec7a052f9_D20210401-20210630" decimals="-3" sign="-" name="us-gaap:IncomeLossFromEquityMethodInvestments" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzY2E5YmIwMTc5MjQ3NmZiYjIyNWU1ZDlkZWM4NjlmL3NlYzo5M2NhOWJiMDE3OTI0NzZmYmIyMjVlNWQ5ZGVjODY5Zl80MC9mcmFnOjQwNDNmMGZmZDk0ZjRjOWNiYzg4MjA0YTc0ODU5YjA1L3RhYmxlOjg5ZDk2ZDhkYmNiYTQxYjRiY2JmOTE5NzI5ZjNmODI4L3RhYmxlcmFuZ2U6ODlkOTZkOGRiY2JhNDFiNGJjYmY5MTk3MjlmM2Y4MjhfNy0xLTEtMS0w_63199935-849c-4264-9644-03db850aeef4">656</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i9c2dea6ae084465eb492033eb5079812_D20200401-20200630" decimals="-3" sign="-" name="us-gaap:IncomeLossFromEquityMethodInvestments" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzY2E5YmIwMTc5MjQ3NmZiYjIyNWU1ZDlkZWM4NjlmL3NlYzo5M2NhOWJiMDE3OTI0NzZmYmIyMjVlNWQ5ZGVjODY5Zl80MC9mcmFnOjQwNDNmMGZmZDk0ZjRjOWNiYzg4MjA0YTc0ODU5YjA1L3RhYmxlOjg5ZDk2ZDhkYmNiYTQxYjRiY2JmOTE5NzI5ZjNmODI4L3RhYmxlcmFuZ2U6ODlkOTZkOGRiY2JhNDFiNGJjYmY5MTk3MjlmM2Y4MjhfNy0zLTEtMS0w_77cc1419-6652-496b-9b4b-3c3f162990b4">369</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i1d33f1b94b814dde969a15e41c194555_D20210101-20210630" decimals="-3" sign="-" format="ixt:numdotdecimal" name="us-gaap:IncomeLossFromEquityMethodInvestments" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzY2E5YmIwMTc5MjQ3NmZiYjIyNWU1ZDlkZWM4NjlmL3NlYzo5M2NhOWJiMDE3OTI0NzZmYmIyMjVlNWQ5ZGVjODY5Zl80MC9mcmFnOjQwNDNmMGZmZDk0ZjRjOWNiYzg4MjA0YTc0ODU5YjA1L3RhYmxlOjg5ZDk2ZDhkYmNiYTQxYjRiY2JmOTE5NzI5ZjNmODI4L3RhYmxlcmFuZ2U6ODlkOTZkOGRiY2JhNDFiNGJjYmY5MTk3MjlmM2Y4MjhfNy01LTEtMS0w_c3e91119-1bdc-4d68-8d65-f79e0d8954cd">2,000</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ia3632b75442e4ecab5344b972f4835a5_D20200101-20200630" decimals="-3" sign="-" format="ixt:numdotdecimal" name="us-gaap:IncomeLossFromEquityMethodInvestments" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzY2E5YmIwMTc5MjQ3NmZiYjIyNWU1ZDlkZWM4NjlmL3NlYzo5M2NhOWJiMDE3OTI0NzZmYmIyMjVlNWQ5ZGVjODY5Zl80MC9mcmFnOjQwNDNmMGZmZDk0ZjRjOWNiYzg4MjA0YTc0ODU5YjA1L3RhYmxlOjg5ZDk2ZDhkYmNiYTQxYjRiY2JmOTE5NzI5ZjNmODI4L3RhYmxlcmFuZ2U6ODlkOTZkOGRiY2JhNDFiNGJjYmY5MTk3MjlmM2Y4MjhfNy03LTEtMS0w_9ed907d5-9b5c-43bd-aa32-aeef3fa789e3">1,230</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i27f4e53b91ad4367b7f8d273eff27769_D20210401-20210630" decimals="-3" sign="-" format="ixt:numdotdecimal" name="us-gaap:IncomeLossFromEquityMethodInvestments" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzY2E5YmIwMTc5MjQ3NmZiYjIyNWU1ZDlkZWM4NjlmL3NlYzo5M2NhOWJiMDE3OTI0NzZmYmIyMjVlNWQ5ZGVjODY5Zl80MC9mcmFnOjQwNDNmMGZmZDk0ZjRjOWNiYzg4MjA0YTc0ODU5YjA1L3RhYmxlOjg5ZDk2ZDhkYmNiYTQxYjRiY2JmOTE5NzI5ZjNmODI4L3RhYmxlcmFuZ2U6ODlkOTZkOGRiY2JhNDFiNGJjYmY5MTk3MjlmM2Y4MjhfOS0xLTEtMS0w_d442f1e5-e5f2-4388-a208-2bb6e52a374b">1,115</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i39065c5daf934af885335c12f3cfa83f_D20200401-20200630" decimals="-3" sign="-" name="us-gaap:IncomeLossFromEquityMethodInvestments" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzY2E5YmIwMTc5MjQ3NmZiYjIyNWU1ZDlkZWM4NjlmL3NlYzo5M2NhOWJiMDE3OTI0NzZmYmIyMjVlNWQ5ZGVjODY5Zl80MC9mcmFnOjQwNDNmMGZmZDk0ZjRjOWNiYzg4MjA0YTc0ODU5YjA1L3RhYmxlOjg5ZDk2ZDhkYmNiYTQxYjRiY2JmOTE5NzI5ZjNmODI4L3RhYmxlcmFuZ2U6ODlkOTZkOGRiY2JhNDFiNGJjYmY5MTk3MjlmM2Y4MjhfOS0zLTEtMS0w_692a3ad9-fad4-4ea8-a3c9-fe7e3dc67691">794</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i69782326f71a44e3805518280ee22b6b_D20210101-20210630" decimals="-3" sign="-" format="ixt:numdotdecimal" name="us-gaap:IncomeLossFromEquityMethodInvestments" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzY2E5YmIwMTc5MjQ3NmZiYjIyNWU1ZDlkZWM4NjlmL3NlYzo5M2NhOWJiMDE3OTI0NzZmYmIyMjVlNWQ5ZGVjODY5Zl80MC9mcmFnOjQwNDNmMGZmZDk0ZjRjOWNiYzg4MjA0YTc0ODU5YjA1L3RhYmxlOjg5ZDk2ZDhkYmNiYTQxYjRiY2JmOTE5NzI5ZjNmODI4L3RhYmxlcmFuZ2U6ODlkOTZkOGRiY2JhNDFiNGJjYmY5MTk3MjlmM2Y4MjhfOS01LTEtMS0w_282d8603-39b3-4192-a002-51df0db2f2ec">2,758</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i4a110e4972ef4113880ce582e3cda5c5_D20200101-20200630" decimals="-3" sign="-" format="ixt:numdotdecimal" name="us-gaap:IncomeLossFromEquityMethodInvestments" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzY2E5YmIwMTc5MjQ3NmZiYjIyNWU1ZDlkZWM4NjlmL3NlYzo5M2NhOWJiMDE3OTI0NzZmYmIyMjVlNWQ5ZGVjODY5Zl80MC9mcmFnOjQwNDNmMGZmZDk0ZjRjOWNiYzg4MjA0YTc0ODU5YjA1L3RhYmxlOjg5ZDk2ZDhkYmNiYTQxYjRiY2JmOTE5NzI5ZjNmODI4L3RhYmxlcmFuZ2U6ODlkOTZkOGRiY2JhNDFiNGJjYmY5MTk3MjlmM2Y4MjhfOS03LTEtMS0w_15c7b66c-629d-4657-a7dd-4b4cc3422879">1,966</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div></ix:nonNumeric></ix:continuation><div style="height:36pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">11</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:72pt;width:100%"><div style="margin-top:0.55pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:95.000%"><tr><td style="width:1.0%"></td><td style="width:65.712%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:32.088%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="border-top:1pt solid #FFFFFF;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Cronos Group Inc.</span></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Notes to Condensed Consolidated Financial Statements (Unaudited)</span></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">(In thousands of $, except share amounts)</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i93ca9bb01792476fbb225e5d9dec869f_7">Table of Contents</a></span></div></td></tr></table></div></div><ix:continuation id="i2a57d40aeaa74c4e946631f65f880df3"><div style="margin-bottom:6pt;margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company determined that the maximum exposure of loss on investments in non-consolidated investments is limited to the Company&#8217;s initial investment, advances and/or loans for each variable interest entity. <ix:nonNumeric contextRef="i69782326f71a44e3805518280ee22b6b_D20210101-20210630" name="us-gaap:ScheduleOfVariableInterestEntitiesTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjkzY2E5YmIwMTc5MjQ3NmZiYjIyNWU1ZDlkZWM4NjlmL3NlYzo5M2NhOWJiMDE3OTI0NzZmYmIyMjVlNWQ5ZGVjODY5Zl80MC9mcmFnOjQwNDNmMGZmZDk0ZjRjOWNiYzg4MjA0YTc0ODU5YjA1L3RleHRyZWdpb246NDA0M2YwZmZkOTRmNGM5Y2JjODgyMDRhNzQ4NTliMDVfNDMyNw_0b6300bd-6ea8-40a1-b999-0957fdba3bd2" continuedAt="i014a4ebf03ae428aab79b61d5f55be28" escape="true">The following is a summary of the maximum exposure to loss as of June&#160;30, 2021 and December&#160;31, 2020:</ix:nonNumeric></span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><ix:continuation id="i014a4ebf03ae428aab79b61d5f55be28"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:47.788%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:15.566%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.355%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:15.566%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.355%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:15.570%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Ownership interest</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">As of June&#160;30, 2021</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">As of December 31, 2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cronos Australia</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i0a6f7aeaf7984695bd038544768f44ce_D20210101-20210630" decimals="2" name="us-gaap:VariableInterestEntityOwnershipPercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjkzY2E5YmIwMTc5MjQ3NmZiYjIyNWU1ZDlkZWM4NjlmL3NlYzo5M2NhOWJiMDE3OTI0NzZmYmIyMjVlNWQ5ZGVjODY5Zl80MC9mcmFnOjQwNDNmMGZmZDk0ZjRjOWNiYzg4MjA0YTc0ODU5YjA1L3RhYmxlOjY4M2YyY2JlZTczMDQzOGU5OTM3MTc2NzAzNzM4ZTVmL3RhYmxlcmFuZ2U6NjgzZjJjYmVlNzMwNDM4ZTk5MzcxNzY3MDM3MzhlNWZfMS0xLTEtMS0w_7e757b6a-7383-4768-a70a-9078c64a3fe0">31</ix:nonFraction>%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9b8aec0ea4404ec8b5d82299348089bf_I20210630" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:VariableInterestEntityEntityMaximumLossExposureAmount" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzY2E5YmIwMTc5MjQ3NmZiYjIyNWU1ZDlkZWM4NjlmL3NlYzo5M2NhOWJiMDE3OTI0NzZmYmIyMjVlNWQ5ZGVjODY5Zl80MC9mcmFnOjQwNDNmMGZmZDk0ZjRjOWNiYzg4MjA0YTc0ODU5YjA1L3RhYmxlOjY4M2YyY2JlZTczMDQzOGU5OTM3MTc2NzAzNzM4ZTVmL3RhYmxlcmFuZ2U6NjgzZjJjYmVlNzMwNDM4ZTk5MzcxNzY3MDM3MzhlNWZfMS01LTEtMS0w_02f2529c-88cd-4601-ba85-6ff8f0ddb267">1,573</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i66749f2799dd4940bef71ca978540e57_I20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:VariableInterestEntityEntityMaximumLossExposureAmount" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzY2E5YmIwMTc5MjQ3NmZiYjIyNWU1ZDlkZWM4NjlmL3NlYzo5M2NhOWJiMDE3OTI0NzZmYmIyMjVlNWQ5ZGVjODY5Zl80MC9mcmFnOjQwNDNmMGZmZDk0ZjRjOWNiYzg4MjA0YTc0ODU5YjA1L3RhYmxlOjY4M2YyY2JlZTczMDQzOGU5OTM3MTc2NzAzNzM4ZTVmL3RhYmxlcmFuZ2U6NjgzZjJjYmVlNzMwNDM4ZTk5MzcxNzY3MDM3MzhlNWZfMS05LTEtMS0w_727847f4-f3ad-4664-bd83-f69ea1933085">1,530</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cronos GrowCo</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="if3db2c911124490fab5cdb3084df56db_D20210101-20210630" decimals="2" name="us-gaap:VariableInterestEntityOwnershipPercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjkzY2E5YmIwMTc5MjQ3NmZiYjIyNWU1ZDlkZWM4NjlmL3NlYzo5M2NhOWJiMDE3OTI0NzZmYmIyMjVlNWQ5ZGVjODY5Zl80MC9mcmFnOjQwNDNmMGZmZDk0ZjRjOWNiYzg4MjA0YTc0ODU5YjA1L3RhYmxlOjY4M2YyY2JlZTczMDQzOGU5OTM3MTc2NzAzNzM4ZTVmL3RhYmxlcmFuZ2U6NjgzZjJjYmVlNzMwNDM4ZTk5MzcxNzY3MDM3MzhlNWZfMi0xLTEtMS0w_7361fa43-97bc-438c-9ee1-a0cb0f681613">50</ix:nonFraction>%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i353124414ba44af49353f31dc922db70_I20210630" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:VariableInterestEntityEntityMaximumLossExposureAmount" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzY2E5YmIwMTc5MjQ3NmZiYjIyNWU1ZDlkZWM4NjlmL3NlYzo5M2NhOWJiMDE3OTI0NzZmYmIyMjVlNWQ5ZGVjODY5Zl80MC9mcmFnOjQwNDNmMGZmZDk0ZjRjOWNiYzg4MjA0YTc0ODU5YjA1L3RhYmxlOjY4M2YyY2JlZTczMDQzOGU5OTM3MTc2NzAzNzM4ZTVmL3RhYmxlcmFuZ2U6NjgzZjJjYmVlNzMwNDM4ZTk5MzcxNzY3MDM3MzhlNWZfMi01LTEtMS0w_82573f99-7d51-41c0-a242-6d7453821a1c">21,723</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3afecd33173246f185a69d63285abf8c_I20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:VariableInterestEntityEntityMaximumLossExposureAmount" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzY2E5YmIwMTc5MjQ3NmZiYjIyNWU1ZDlkZWM4NjlmL3NlYzo5M2NhOWJiMDE3OTI0NzZmYmIyMjVlNWQ5ZGVjODY5Zl80MC9mcmFnOjQwNDNmMGZmZDk0ZjRjOWNiYzg4MjA0YTc0ODU5YjA1L3RhYmxlOjY4M2YyY2JlZTczMDQzOGU5OTM3MTc2NzAzNzM4ZTVmL3RhYmxlcmFuZ2U6NjgzZjJjYmVlNzMwNDM4ZTk5MzcxNzY3MDM3MzhlNWZfMi05LTEtMS0w_f8c63ec1-046a-4ea2-bec0-b22c018d00f0">21,125</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">MedMen Canada</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="ie2fdd9071c2c4923bce9ab671e6af04d_D20210101-20210630" decimals="2" name="us-gaap:VariableInterestEntityOwnershipPercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjkzY2E5YmIwMTc5MjQ3NmZiYjIyNWU1ZDlkZWM4NjlmL3NlYzo5M2NhOWJiMDE3OTI0NzZmYmIyMjVlNWQ5ZGVjODY5Zl80MC9mcmFnOjQwNDNmMGZmZDk0ZjRjOWNiYzg4MjA0YTc0ODU5YjA1L3RhYmxlOjY4M2YyY2JlZTczMDQzOGU5OTM3MTc2NzAzNzM4ZTVmL3RhYmxlcmFuZ2U6NjgzZjJjYmVlNzMwNDM4ZTk5MzcxNzY3MDM3MzhlNWZfMy0xLTEtMS0w_16441aa3-3bf6-49bf-8c06-663d046c6cc4">50</ix:nonFraction>%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib9811da8a9704222a0df27a3f63f596b_I20210630" decimals="-3" name="us-gaap:VariableInterestEntityEntityMaximumLossExposureAmount" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzY2E5YmIwMTc5MjQ3NmZiYjIyNWU1ZDlkZWM4NjlmL3NlYzo5M2NhOWJiMDE3OTI0NzZmYmIyMjVlNWQ5ZGVjODY5Zl80MC9mcmFnOjQwNDNmMGZmZDk0ZjRjOWNiYzg4MjA0YTc0ODU5YjA1L3RhYmxlOjY4M2YyY2JlZTczMDQzOGU5OTM3MTc2NzAzNzM4ZTVmL3RhYmxlcmFuZ2U6NjgzZjJjYmVlNzMwNDM4ZTk5MzcxNzY3MDM3MzhlNWZfMy01LTEtMS0w_5fc34070-878a-40fc-81fa-c812f0f094df">494</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iaaa05d4ed8b34a308235a68b7882864c_I20201231" decimals="-3" name="us-gaap:VariableInterestEntityEntityMaximumLossExposureAmount" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzY2E5YmIwMTc5MjQ3NmZiYjIyNWU1ZDlkZWM4NjlmL3NlYzo5M2NhOWJiMDE3OTI0NzZmYmIyMjVlNWQ5ZGVjODY5Zl80MC9mcmFnOjQwNDNmMGZmZDk0ZjRjOWNiYzg4MjA0YTc0ODU5YjA1L3RhYmxlOjY4M2YyY2JlZTczMDQzOGU5OTM3MTc2NzAzNzM4ZTVmL3RhYmxlcmFuZ2U6NjgzZjJjYmVlNzMwNDM4ZTk5MzcxNzY3MDM3MzhlNWZfMy05LTEtMS0w_c475be6a-a3a4-4123-880a-87521cd3b4f6">467</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Natuera</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i3b3152f5409c4a70870bd6f4cb775dd4_D20210101-20210630" decimals="2" name="us-gaap:VariableInterestEntityOwnershipPercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjkzY2E5YmIwMTc5MjQ3NmZiYjIyNWU1ZDlkZWM4NjlmL3NlYzo5M2NhOWJiMDE3OTI0NzZmYmIyMjVlNWQ5ZGVjODY5Zl80MC9mcmFnOjQwNDNmMGZmZDk0ZjRjOWNiYzg4MjA0YTc0ODU5YjA1L3RhYmxlOjY4M2YyY2JlZTczMDQzOGU5OTM3MTc2NzAzNzM4ZTVmL3RhYmxlcmFuZ2U6NjgzZjJjYmVlNzMwNDM4ZTk5MzcxNzY3MDM3MzhlNWZfNC0xLTEtMS0w_425b3805-7355-44b2-913d-58102569ca2f">50</ix:nonFraction>%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ibda190acea7645e2a6859c2bdb2fc787_I20210630" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:VariableInterestEntityEntityMaximumLossExposureAmount" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzY2E5YmIwMTc5MjQ3NmZiYjIyNWU1ZDlkZWM4NjlmL3NlYzo5M2NhOWJiMDE3OTI0NzZmYmIyMjVlNWQ5ZGVjODY5Zl80MC9mcmFnOjQwNDNmMGZmZDk0ZjRjOWNiYzg4MjA0YTc0ODU5YjA1L3RhYmxlOjY4M2YyY2JlZTczMDQzOGU5OTM3MTc2NzAzNzM4ZTVmL3RhYmxlcmFuZ2U6NjgzZjJjYmVlNzMwNDM4ZTk5MzcxNzY3MDM3MzhlNWZfNC01LTEtMS0w_89a9c742-2995-4eb1-ab59-c9f356de370c">8,047</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i390d021c539343388dd3edb041b0e9aa_I20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:VariableInterestEntityEntityMaximumLossExposureAmount" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzY2E5YmIwMTc5MjQ3NmZiYjIyNWU1ZDlkZWM4NjlmL3NlYzo5M2NhOWJiMDE3OTI0NzZmYmIyMjVlNWQ5ZGVjODY5Zl80MC9mcmFnOjQwNDNmMGZmZDk0ZjRjOWNiYzg4MjA0YTc0ODU5YjA1L3RhYmxlOjY4M2YyY2JlZTczMDQzOGU5OTM3MTc2NzAzNzM4ZTVmL3RhYmxlcmFuZ2U6NjgzZjJjYmVlNzMwNDM4ZTk5MzcxNzY3MDM3MzhlNWZfNC05LTEtMS0w_a3160e22-7f45-4781-944a-3c62069f008c">8,154</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i225f85e38faa4bbdb4de1d8b9cf369bb_I20210630" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:VariableInterestEntityEntityMaximumLossExposureAmount" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzY2E5YmIwMTc5MjQ3NmZiYjIyNWU1ZDlkZWM4NjlmL3NlYzo5M2NhOWJiMDE3OTI0NzZmYmIyMjVlNWQ5ZGVjODY5Zl80MC9mcmFnOjQwNDNmMGZmZDk0ZjRjOWNiYzg4MjA0YTc0ODU5YjA1L3RhYmxlOjY4M2YyY2JlZTczMDQzOGU5OTM3MTc2NzAzNzM4ZTVmL3RhYmxlcmFuZ2U6NjgzZjJjYmVlNzMwNDM4ZTk5MzcxNzY3MDM3MzhlNWZfNS01LTEtMS0w_3650ada3-d5fb-401d-a787-ba53dfba64d6">31,837</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ifbe16ec51ea244519b77d6036b4ef038_I20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:VariableInterestEntityEntityMaximumLossExposureAmount" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzY2E5YmIwMTc5MjQ3NmZiYjIyNWU1ZDlkZWM4NjlmL3NlYzo5M2NhOWJiMDE3OTI0NzZmYmIyMjVlNWQ5ZGVjODY5Zl80MC9mcmFnOjQwNDNmMGZmZDk0ZjRjOWNiYzg4MjA0YTc0ODU5YjA1L3RhYmxlOjY4M2YyY2JlZTczMDQzOGU5OTM3MTc2NzAzNzM4ZTVmL3RhYmxlcmFuZ2U6NjgzZjJjYmVlNzMwNDM4ZTk5MzcxNzY3MDM3MzhlNWZfNS05LTEtMS0w_272174e1-b446-45be-83e8-f938df7bf6d5">31,276</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr></table></ix:continuation></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(b)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;padding-left:23.78pt">Other investments</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Other investments consist of investments in options of companies in the cannabis industry.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On June 14, 2021, the Company purchased an option to acquire <ix:nonFraction unitRef="shares" contextRef="ic4e23b56bd44457695de2dfbd9a6ce67_D20210614-20210614" decimals="INF" format="ixt:numdotdecimal" name="us-gaap:SaleOfStockNumberOfSharesIssuedInTransaction" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjkzY2E5YmIwMTc5MjQ3NmZiYjIyNWU1ZDlkZWM4NjlmL3NlYzo5M2NhOWJiMDE3OTI0NzZmYmIyMjVlNWQ5ZGVjODY5Zl80MC9mcmFnOjQwNDNmMGZmZDk0ZjRjOWNiYzg4MjA0YTc0ODU5YjA1L3RleHRyZWdpb246NDA0M2YwZmZkOTRmNGM5Y2JjODgyMDRhNzQ4NTliMDVfMTA5OTUxMTY0Njg5Ng_65aef3bf-1a09-468b-87c3-8c3ce7fcf476">473,787</ix:nonFraction> shares of Class A Common Stock of PharmaCann, Inc. (&#8220;PharmaCann&#8221;), a vertically integrated cannabis company in the United States, at an exercise price of $<ix:nonFraction unitRef="usdPerShare" contextRef="iaa37e41bb48a45ae9333902e59ee2719_I20210614" decimals="INF" name="us-gaap:SaleOfStockPricePerShare" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjkzY2E5YmIwMTc5MjQ3NmZiYjIyNWU1ZDlkZWM4NjlmL3NlYzo5M2NhOWJiMDE3OTI0NzZmYmIyMjVlNWQ5ZGVjODY5Zl80MC9mcmFnOjQwNDNmMGZmZDk0ZjRjOWNiYzg4MjA0YTc0ODU5YjA1L3RleHRyZWdpb246NDA0M2YwZmZkOTRmNGM5Y2JjODgyMDRhNzQ4NTliMDVfMTA5OTUxMTY0NzEyNA_347a5dd4-09a1-437b-a9b5-d1d657602606">0.0001</ix:nonFraction> per share, representing approximately <ix:nonFraction unitRef="number" contextRef="ibd87bb26d08f46e4bfa11a80236a610a_D20210614-20210614" decimals="3" name="us-gaap:SaleOfStockPercentageOfOwnershipAfterTransaction" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjkzY2E5YmIwMTc5MjQ3NmZiYjIyNWU1ZDlkZWM4NjlmL3NlYzo5M2NhOWJiMDE3OTI0NzZmYmIyMjVlNWQ5ZGVjODY5Zl80MC9mcmFnOjQwNDNmMGZmZDk0ZjRjOWNiYzg4MjA0YTc0ODU5YjA1L3RleHRyZWdpb246NDA0M2YwZmZkOTRmNGM5Y2JjODgyMDRhNzQ4NTliMDVfMTA5OTUxMTY0Njg4OQ_d99b3213-88ef-46f7-a6e8-e64dac1f9db6">10.5</ix:nonFraction>% of PharmaCann&#8217;s issued and outstanding capital stock on a fully diluted basis, for an aggregate purchase price of approximately $<ix:nonFraction unitRef="usd" contextRef="ibd87bb26d08f46e4bfa11a80236a610a_D20210614-20210614" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:PaymentsToAcquireOtherInvestments" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzY2E5YmIwMTc5MjQ3NmZiYjIyNWU1ZDlkZWM4NjlmL3NlYzo5M2NhOWJiMDE3OTI0NzZmYmIyMjVlNWQ5ZGVjODY5Zl80MC9mcmFnOjQwNDNmMGZmZDk0ZjRjOWNiYzg4MjA0YTc0ODU5YjA1L3RleHRyZWdpb246NDA0M2YwZmZkOTRmNGM5Y2JjODgyMDRhNzQ4NTliMDVfOTg5NTYwNDY3Mjc4Mw_cb536095-f5fe-4aaf-885f-7456c53a6187">110,392</ix:nonFraction>. The option exercise will be based upon various factors, including the status of U.S. federal cannabis legalization, as well as regulatory approvals, including in the states where PharmaCann operates that may be required upon exercise. This option is classified as an equity security without a readily determinable fair value. The Company has elected to measure the fair value of the option at cost less impairment, if any, and subsequently adjusted for observable price changes in orderly transactions for the identical or a similar investment of the same issuer. The option is reported as other investments on the condensed consolidated balance sheet for the period ended June 30, 2021. As of June 30, 2021 and December 31, 2020, the Company did not hold any additional other investments.</span></div></ix:continuation><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span><br/></span></div><div id="i93ca9bb01792476fbb225e5d9dec869f_43"></div><div style="margin-bottom:12pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">4. <ix:nonNumeric contextRef="i69782326f71a44e3805518280ee22b6b_D20210101-20210630" name="us-gaap:LoansNotesTradeAndOtherReceivablesExcludingAllowanceForCreditLossesTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjkzY2E5YmIwMTc5MjQ3NmZiYjIyNWU1ZDlkZWM4NjlmL3NlYzo5M2NhOWJiMDE3OTI0NzZmYmIyMjVlNWQ5ZGVjODY5Zl80My9mcmFnOjZlZDUwYmJmZmU2ZDRjMDJhOWRiZDFkNzYzNTUzOWFlL3RleHRyZWdpb246NmVkNTBiYmZmZTZkNGMwMmE5ZGJkMWQ3NjM1NTM5YWVfMTIzMw_bab253e1-6ec1-49b0-8f0a-1680d580afe4" continuedAt="i5df1f2b1cf2c493aa4005f0429366828" escape="true">Loans Receivable, net </ix:nonNumeric></span></div><ix:continuation id="i5df1f2b1cf2c493aa4005f0429366828"><ix:nonNumeric contextRef="i69782326f71a44e3805518280ee22b6b_D20210101-20210630" name="us-gaap:ScheduleOfAccountsNotesLoansAndFinancingReceivableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjkzY2E5YmIwMTc5MjQ3NmZiYjIyNWU1ZDlkZWM4NjlmL3NlYzo5M2NhOWJiMDE3OTI0NzZmYmIyMjVlNWQ5ZGVjODY5Zl80My9mcmFnOjZlZDUwYmJmZmU2ZDRjMDJhOWRiZDFkNzYzNTUzOWFlL3RleHRyZWdpb246NmVkNTBiYmZmZTZkNGMwMmE5ZGJkMWQ3NjM1NTM5YWVfMTIzNA_beb8f160-010c-45b0-b789-395cd7083708" escape="true"><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:21.955%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:39.177%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:1.466%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:15.566%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:1.466%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:15.570%"></td><td style="width:0.1%"></td></tr><tr><td colspan="6" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">As of June&#160;30, 2021</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">As of December 31, 2020</span></td></tr><tr><td colspan="6" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><div style="padding-left:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Natuera Series A Loan</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(i)</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7e8821bb92b54aa5a40ec87007ddd06a_I20210630" decimals="-3" format="ixt:zerodash" name="cron:FinancingReceivableBeforeAccruedInterestCurrent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzY2E5YmIwMTc5MjQ3NmZiYjIyNWU1ZDlkZWM4NjlmL3NlYzo5M2NhOWJiMDE3OTI0NzZmYmIyMjVlNWQ5ZGVjODY5Zl80My9mcmFnOjZlZDUwYmJmZmU2ZDRjMDJhOWRiZDFkNzYzNTUzOWFlL3RhYmxlOjc0N2M1NDc3NmU3NDRlZDc4ZjVmNDk5ODMxYTU5YTBkL3RhYmxlcmFuZ2U6NzQ3YzU0Nzc2ZTc0NGVkNzhmNWY0OTk4MzFhNTlhMGRfMS0zLTEtMS0w_11863580-29e9-4727-a1f4-df520bf866ef">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic0f4e3758c364fee99c468147d904bdc_I20201231" decimals="-3" format="ixt:numdotdecimal" name="cron:FinancingReceivableBeforeAccruedInterestCurrent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzY2E5YmIwMTc5MjQ3NmZiYjIyNWU1ZDlkZWM4NjlmL3NlYzo5M2NhOWJiMDE3OTI0NzZmYmIyMjVlNWQ5ZGVjODY5Zl80My9mcmFnOjZlZDUwYmJmZmU2ZDRjMDJhOWRiZDFkNzYzNTUzOWFlL3RhYmxlOjc0N2M1NDc3NmU3NDRlZDc4ZjVmNDk5ODMxYTU5YTBkL3RhYmxlcmFuZ2U6NzQ3YzU0Nzc2ZTc0NGVkNzhmNWY0OTk4MzFhNTlhMGRfMS01LTEtMS0w_b44f87e1-015d-4735-8255-cec7656f377a">3,518</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="6" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><div style="padding-left:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">GrowCo Facility</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(ii)</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4d5e5ad8b8c04f0e81c4f56d20dd2667_I20210630" decimals="-3" format="ixt:numdotdecimal" name="cron:FinancingReceivableBeforeAccruedInterestCurrent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzY2E5YmIwMTc5MjQ3NmZiYjIyNWU1ZDlkZWM4NjlmL3NlYzo5M2NhOWJiMDE3OTI0NzZmYmIyMjVlNWQ5ZGVjODY5Zl80My9mcmFnOjZlZDUwYmJmZmU2ZDRjMDJhOWRiZDFkNzYzNTUzOWFlL3RhYmxlOjc0N2M1NDc3NmU3NDRlZDc4ZjVmNDk5ODMxYTU5YTBkL3RhYmxlcmFuZ2U6NzQ3YzU0Nzc2ZTc0NGVkNzhmNWY0OTk4MzFhNTlhMGRfMi0zLTEtMS0w_5c0b3bdc-cf09-469e-8b98-deebf142e516">1,614</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i389408e323054f34bb2d44166886cfa0_I20201231" decimals="-3" format="ixt:numdotdecimal" name="cron:FinancingReceivableBeforeAccruedInterestCurrent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzY2E5YmIwMTc5MjQ3NmZiYjIyNWU1ZDlkZWM4NjlmL3NlYzo5M2NhOWJiMDE3OTI0NzZmYmIyMjVlNWQ5ZGVjODY5Zl80My9mcmFnOjZlZDUwYmJmZmU2ZDRjMDJhOWRiZDFkNzYzNTUzOWFlL3RhYmxlOjc0N2M1NDc3NmU3NDRlZDc4ZjVmNDk5ODMxYTU5YTBkL3RhYmxlcmFuZ2U6NzQ3YzU0Nzc2ZTc0NGVkNzhmNWY0OTk4MzFhNTlhMGRfMi01LTEtMS0w_40ce824f-fa2d-46a5-9103-eb6595d61db8">3,137</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="6" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Add: Accrued interest</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0709927d1c004766b70bf1b85ffbd9b2_I20210630" decimals="-3" format="ixt:numdotdecimal" name="cron:FinancingReceivableAccruedInterestCurrent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzY2E5YmIwMTc5MjQ3NmZiYjIyNWU1ZDlkZWM4NjlmL3NlYzo5M2NhOWJiMDE3OTI0NzZmYmIyMjVlNWQ5ZGVjODY5Zl80My9mcmFnOjZlZDUwYmJmZmU2ZDRjMDJhOWRiZDFkNzYzNTUzOWFlL3RhYmxlOjc0N2M1NDc3NmU3NDRlZDc4ZjVmNDk5ODMxYTU5YTBkL3RhYmxlcmFuZ2U6NzQ3YzU0Nzc2ZTc0NGVkNzhmNWY0OTk4MzFhNTlhMGRfMy0zLTEtMS0w_967e97be-f0b1-4736-b027-a19d3342eca3">3,414</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i830d314bf026450e8e38d200944077bf_I20201231" decimals="-3" name="cron:FinancingReceivableAccruedInterestCurrent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzY2E5YmIwMTc5MjQ3NmZiYjIyNWU1ZDlkZWM4NjlmL3NlYzo5M2NhOWJiMDE3OTI0NzZmYmIyMjVlNWQ5ZGVjODY5Zl80My9mcmFnOjZlZDUwYmJmZmU2ZDRjMDJhOWRiZDFkNzYzNTUzOWFlL3RhYmxlOjc0N2M1NDc3NmU3NDRlZDc4ZjVmNDk5ODMxYTU5YTBkL3RhYmxlcmFuZ2U6NzQ3YzU0Nzc2ZTc0NGVkNzhmNWY0OTk4MzFhNTlhMGRfMy01LTEtMS0w_ff4b7fc0-cb91-4288-8706-5f364b99a030">428</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="6" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total current portion of loans receivable</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i225f85e38faa4bbdb4de1d8b9cf369bb_I20210630" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:NotesAndLoansReceivableNetCurrent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzY2E5YmIwMTc5MjQ3NmZiYjIyNWU1ZDlkZWM4NjlmL3NlYzo5M2NhOWJiMDE3OTI0NzZmYmIyMjVlNWQ5ZGVjODY5Zl80My9mcmFnOjZlZDUwYmJmZmU2ZDRjMDJhOWRiZDFkNzYzNTUzOWFlL3RhYmxlOjc0N2M1NDc3NmU3NDRlZDc4ZjVmNDk5ODMxYTU5YTBkL3RhYmxlcmFuZ2U6NzQ3YzU0Nzc2ZTc0NGVkNzhmNWY0OTk4MzFhNTlhMGRfNC0zLTEtMS0w_712ed0ae-8357-4c02-936b-d6c65d00c46b">5,028</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ifbe16ec51ea244519b77d6036b4ef038_I20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:NotesAndLoansReceivableNetCurrent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzY2E5YmIwMTc5MjQ3NmZiYjIyNWU1ZDlkZWM4NjlmL3NlYzo5M2NhOWJiMDE3OTI0NzZmYmIyMjVlNWQ5ZGVjODY5Zl80My9mcmFnOjZlZDUwYmJmZmU2ZDRjMDJhOWRiZDFkNzYzNTUzOWFlL3RhYmxlOjc0N2M1NDc3NmU3NDRlZDc4ZjVmNDk5ODMxYTU5YTBkL3RhYmxlcmFuZ2U6NzQ3YzU0Nzc2ZTc0NGVkNzhmNWY0OTk4MzFhNTlhMGRfNC01LTEtMS0w_bf59f9e7-7ab8-4d07-9ca4-4649d985408c">7,083</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="6" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><div style="padding-left:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">GrowCo Facility</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(ii)</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4d5e5ad8b8c04f0e81c4f56d20dd2667_I20210630" decimals="-3" format="ixt:numdotdecimal" name="cron:FinancingReceivableBeforeAccruedInterestNoncurrent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzY2E5YmIwMTc5MjQ3NmZiYjIyNWU1ZDlkZWM4NjlmL3NlYzo5M2NhOWJiMDE3OTI0NzZmYmIyMjVlNWQ5ZGVjODY5Zl80My9mcmFnOjZlZDUwYmJmZmU2ZDRjMDJhOWRiZDFkNzYzNTUzOWFlL3RhYmxlOjc0N2M1NDc3NmU3NDRlZDc4ZjVmNDk5ODMxYTU5YTBkL3RhYmxlcmFuZ2U6NzQ3YzU0Nzc2ZTc0NGVkNzhmNWY0OTk4MzFhNTlhMGRfNS0zLTEtMS0w_0e4ae4cb-3fec-427b-9848-4287c398eba5">77,474</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i389408e323054f34bb2d44166886cfa0_I20201231" decimals="-3" format="ixt:numdotdecimal" name="cron:FinancingReceivableBeforeAccruedInterestNoncurrent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzY2E5YmIwMTc5MjQ3NmZiYjIyNWU1ZDlkZWM4NjlmL3NlYzo5M2NhOWJiMDE3OTI0NzZmYmIyMjVlNWQ5ZGVjODY5Zl80My9mcmFnOjZlZDUwYmJmZmU2ZDRjMDJhOWRiZDFkNzYzNTUzOWFlL3RhYmxlOjc0N2M1NDc3NmU3NDRlZDc4ZjVmNDk5ODMxYTU5YTBkL3RhYmxlcmFuZ2U6NzQ3YzU0Nzc2ZTc0NGVkNzhmNWY0OTk4MzFhNTlhMGRfNS01LTEtMS0w_3fde5649-8a23-4da3-94ee-6e616a61e785">69,939</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="6" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><div style="padding-left:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Mucci Promissory Note</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(iii)</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6c507204183f49389291963dff6d55c3_I20210630" decimals="-3" format="ixt:numdotdecimal" name="cron:FinancingReceivableBeforeAccruedInterestNoncurrent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzY2E5YmIwMTc5MjQ3NmZiYjIyNWU1ZDlkZWM4NjlmL3NlYzo5M2NhOWJiMDE3OTI0NzZmYmIyMjVlNWQ5ZGVjODY5Zl80My9mcmFnOjZlZDUwYmJmZmU2ZDRjMDJhOWRiZDFkNzYzNTUzOWFlL3RhYmxlOjc0N2M1NDc3NmU3NDRlZDc4ZjVmNDk5ODMxYTU5YTBkL3RhYmxlcmFuZ2U6NzQ3YzU0Nzc2ZTc0NGVkNzhmNWY0OTk4MzFhNTlhMGRfNi0zLTEtMS0w_5b2052be-8027-4f6d-8196-75ce197eb52b">13,969</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i09921e492ba24195a2e19b52c026c6f7_I20201231" decimals="-3" format="ixt:numdotdecimal" name="cron:FinancingReceivableBeforeAccruedInterestNoncurrent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzY2E5YmIwMTc5MjQ3NmZiYjIyNWU1ZDlkZWM4NjlmL3NlYzo5M2NhOWJiMDE3OTI0NzZmYmIyMjVlNWQ5ZGVjODY5Zl80My9mcmFnOjZlZDUwYmJmZmU2ZDRjMDJhOWRiZDFkNzYzNTUzOWFlL3RhYmxlOjc0N2M1NDc3NmU3NDRlZDc4ZjVmNDk5ODMxYTU5YTBkL3RhYmxlcmFuZ2U6NzQ3YzU0Nzc2ZTc0NGVkNzhmNWY0OTk4MzFhNTlhMGRfNi01LTEtMS0w_3672a39d-aaa0-4635-8d87-4911b995bb33">13,324</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="6" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><div style="padding-left:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cannasoul Collaboration Loan</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(iv)</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i49f2e1595c1b41f4bcbef6f1031a9d69_I20210630" decimals="-3" format="ixt:numdotdecimal" name="cron:FinancingReceivableBeforeAccruedInterestNoncurrent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzY2E5YmIwMTc5MjQ3NmZiYjIyNWU1ZDlkZWM4NjlmL3NlYzo5M2NhOWJiMDE3OTI0NzZmYmIyMjVlNWQ5ZGVjODY5Zl80My9mcmFnOjZlZDUwYmJmZmU2ZDRjMDJhOWRiZDFkNzYzNTUzOWFlL3RhYmxlOjc0N2M1NDc3NmU3NDRlZDc4ZjVmNDk5ODMxYTU5YTBkL3RhYmxlcmFuZ2U6NzQ3YzU0Nzc2ZTc0NGVkNzhmNWY0OTk4MzFhNTlhMGRfNy0zLTEtMS0w_a8015395-2aeb-4820-9dae-6ef7421017fe">1,870</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7c3fa2a3ef8f464583be7da8ce8425ee_I20201231" decimals="-3" format="ixt:numdotdecimal" name="cron:FinancingReceivableBeforeAccruedInterestNoncurrent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzY2E5YmIwMTc5MjQ3NmZiYjIyNWU1ZDlkZWM4NjlmL3NlYzo5M2NhOWJiMDE3OTI0NzZmYmIyMjVlNWQ5ZGVjODY5Zl80My9mcmFnOjZlZDUwYmJmZmU2ZDRjMDJhOWRiZDFkNzYzNTUzOWFlL3RhYmxlOjc0N2M1NDc3NmU3NDRlZDc4ZjVmNDk5ODMxYTU5YTBkL3RhYmxlcmFuZ2U6NzQ3YzU0Nzc2ZTc0NGVkNzhmNWY0OTk4MzFhNTlhMGRfNy01LTEtMS0w_b0d43e87-255a-4e63-8d2e-60256b24c858">1,261</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="6" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Add: Accrued interest</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0709927d1c004766b70bf1b85ffbd9b2_I20210630" decimals="-3" name="cron:FinancingReceivableAccruedInterestNoncurrent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzY2E5YmIwMTc5MjQ3NmZiYjIyNWU1ZDlkZWM4NjlmL3NlYzo5M2NhOWJiMDE3OTI0NzZmYmIyMjVlNWQ5ZGVjODY5Zl80My9mcmFnOjZlZDUwYmJmZmU2ZDRjMDJhOWRiZDFkNzYzNTUzOWFlL3RhYmxlOjc0N2M1NDc3NmU3NDRlZDc4ZjVmNDk5ODMxYTU5YTBkL3RhYmxlcmFuZ2U6NzQ3YzU0Nzc2ZTc0NGVkNzhmNWY0OTk4MzFhNTlhMGRfOC0zLTEtMS0w_b13bbbe8-5401-49aa-9ac1-01fe6f83039e">800</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i830d314bf026450e8e38d200944077bf_I20201231" decimals="-3" format="ixt:numdotdecimal" name="cron:FinancingReceivableAccruedInterestNoncurrent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzY2E5YmIwMTc5MjQ3NmZiYjIyNWU1ZDlkZWM4NjlmL3NlYzo5M2NhOWJiMDE3OTI0NzZmYmIyMjVlNWQ5ZGVjODY5Zl80My9mcmFnOjZlZDUwYmJmZmU2ZDRjMDJhOWRiZDFkNzYzNTUzOWFlL3RhYmxlOjc0N2M1NDc3NmU3NDRlZDc4ZjVmNDk5ODMxYTU5YTBkL3RhYmxlcmFuZ2U6NzQ3YzU0Nzc2ZTc0NGVkNzhmNWY0OTk4MzFhNTlhMGRfOC01LTEtMS0w_9db8800d-1096-4dc3-80e2-bfaf0304a1c2">2,667</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="6" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total long-term portion of loans receivable</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i225f85e38faa4bbdb4de1d8b9cf369bb_I20210630" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:NotesAndLoansReceivableNetNoncurrent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzY2E5YmIwMTc5MjQ3NmZiYjIyNWU1ZDlkZWM4NjlmL3NlYzo5M2NhOWJiMDE3OTI0NzZmYmIyMjVlNWQ5ZGVjODY5Zl80My9mcmFnOjZlZDUwYmJmZmU2ZDRjMDJhOWRiZDFkNzYzNTUzOWFlL3RhYmxlOjc0N2M1NDc3NmU3NDRlZDc4ZjVmNDk5ODMxYTU5YTBkL3RhYmxlcmFuZ2U6NzQ3YzU0Nzc2ZTc0NGVkNzhmNWY0OTk4MzFhNTlhMGRfOS0zLTEtMS0w_42b0af1c-0781-4b6f-a9dd-e22dcb174691">94,113</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ifbe16ec51ea244519b77d6036b4ef038_I20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:NotesAndLoansReceivableNetNoncurrent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzY2E5YmIwMTc5MjQ3NmZiYjIyNWU1ZDlkZWM4NjlmL3NlYzo5M2NhOWJiMDE3OTI0NzZmYmIyMjVlNWQ5ZGVjODY5Zl80My9mcmFnOjZlZDUwYmJmZmU2ZDRjMDJhOWRiZDFkNzYzNTUzOWFlL3RhYmxlOjc0N2M1NDc3NmU3NDRlZDc4ZjVmNDk5ODMxYTU5YTBkL3RhYmxlcmFuZ2U6NzQ3YzU0Nzc2ZTc0NGVkNzhmNWY0OTk4MzFhNTlhMGRfOS01LTEtMS0w_b287c20e-8d57-4943-b285-b43e8411e1d1">87,191</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="6" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total loans receivable, net</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i225f85e38faa4bbdb4de1d8b9cf369bb_I20210630" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:NotesReceivableNet" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzY2E5YmIwMTc5MjQ3NmZiYjIyNWU1ZDlkZWM4NjlmL3NlYzo5M2NhOWJiMDE3OTI0NzZmYmIyMjVlNWQ5ZGVjODY5Zl80My9mcmFnOjZlZDUwYmJmZmU2ZDRjMDJhOWRiZDFkNzYzNTUzOWFlL3RhYmxlOjc0N2M1NDc3NmU3NDRlZDc4ZjVmNDk5ODMxYTU5YTBkL3RhYmxlcmFuZ2U6NzQ3YzU0Nzc2ZTc0NGVkNzhmNWY0OTk4MzFhNTlhMGRfMTAtMy0xLTEtMA_d5d628af-b72d-4b23-8e95-da091c6c25fc">99,141</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ifbe16ec51ea244519b77d6036b4ef038_I20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:NotesReceivableNet" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzY2E5YmIwMTc5MjQ3NmZiYjIyNWU1ZDlkZWM4NjlmL3NlYzo5M2NhOWJiMDE3OTI0NzZmYmIyMjVlNWQ5ZGVjODY5Zl80My9mcmFnOjZlZDUwYmJmZmU2ZDRjMDJhOWRiZDFkNzYzNTUzOWFlL3RhYmxlOjc0N2M1NDc3NmU3NDRlZDc4ZjVmNDk5ODMxYTU5YTBkL3RhYmxlcmFuZ2U6NzQ3YzU0Nzc2ZTc0NGVkNzhmNWY0OTk4MzFhNTlhMGRfMTAtNS0xLTEtMA_da35c047-bc79-40c3-8bc9-496bf87ca80a">94,274</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr></table></div><div style="margin-bottom:3pt;margin-top:3pt;padding-left:27pt;text-align:justify;text-indent:-27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(i)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:19.46pt">On April 1, 2021, the Company and AGI converted all advances made to Natuera under the Series A Loan, plus accrued interest, into equity of Natuera. Total aggregate gross advances to Natuera under the Natuera Series A Loan were $<ix:nonFraction unitRef="usd" contextRef="i3851bec177234bbb9f9d96a1e3eab1d3_D20210401-20210401" decimals="-3" format="ixt:numdotdecimal" name="cron:InvestmentsInAndAdvancesToAffiliatesAtFairValueAdvancesRepayments" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzY2E5YmIwMTc5MjQ3NmZiYjIyNWU1ZDlkZWM4NjlmL3NlYzo5M2NhOWJiMDE3OTI0NzZmYmIyMjVlNWQ5ZGVjODY5Zl80My9mcmFnOjZlZDUwYmJmZmU2ZDRjMDJhOWRiZDFkNzYzNTUzOWFlL3RleHRyZWdpb246NmVkNTBiYmZmZTZkNGMwMmE5ZGJkMWQ3NjM1NTM5YWVfMTA5OTUxMTYzMTg5MA_e66e1c5d-6fc5-475f-8235-dc148c2066f0">15,500</ix:nonFraction>, of which the Company advanced <ix:nonFraction unitRef="number" contextRef="i8b8f1fc37db0427b9d081e7b40a48cc0_I20210401" decimals="INF" name="cron:InvestmentsInAndAdvancesToAffiliatesFundingCommitmentPercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjkzY2E5YmIwMTc5MjQ3NmZiYjIyNWU1ZDlkZWM4NjlmL3NlYzo5M2NhOWJiMDE3OTI0NzZmYmIyMjVlNWQ5ZGVjODY5Zl80My9mcmFnOjZlZDUwYmJmZmU2ZDRjMDJhOWRiZDFkNzYzNTUzOWFlL3RleHRyZWdpb246NmVkNTBiYmZmZTZkNGMwMmE5ZGJkMWQ3NjM1NTM5YWVfMTY0OTI2NzQ0OTc4Ng_e8b30708-26dd-44d4-b3de-61ded34a7e33">50</ix:nonFraction>% and AGI advanced the remaining <ix:nonFraction unitRef="number" contextRef="ia926bcff688b4febb81d8fa1a08955dc_I20210401" decimals="INF" name="cron:InvestmentsInAndAdvancesToAffiliatesFundingCommitmentPercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjkzY2E5YmIwMTc5MjQ3NmZiYjIyNWU1ZDlkZWM4NjlmL3NlYzo5M2NhOWJiMDE3OTI0NzZmYmIyMjVlNWQ5ZGVjODY5Zl80My9mcmFnOjZlZDUwYmJmZmU2ZDRjMDJhOWRiZDFkNzYzNTUzOWFlL3RleHRyZWdpb246NmVkNTBiYmZmZTZkNGMwMmE5ZGJkMWQ3NjM1NTM5YWVfMTY0OTI2NzQ0OTc5MA_b38b007b-0b80-448f-97a8-266907209040">50</ix:nonFraction>%, or $<ix:nonFraction unitRef="usd" contextRef="i3734fffa32be45c299b65b62d227d165_D20210401-20210401" decimals="-3" format="ixt:numdotdecimal" name="cron:InvestmentsInAndAdvancesToAffiliatesAtFairValueAdvancesRepayments" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzY2E5YmIwMTc5MjQ3NmZiYjIyNWU1ZDlkZWM4NjlmL3NlYzo5M2NhOWJiMDE3OTI0NzZmYmIyMjVlNWQ5ZGVjODY5Zl80My9mcmFnOjZlZDUwYmJmZmU2ZDRjMDJhOWRiZDFkNzYzNTUzOWFlL3RleHRyZWdpb246NmVkNTBiYmZmZTZkNGMwMmE5ZGJkMWQ3NjM1NTM5YWVfMTA5OTUxMTYzMTk4Mg_570f0ddb-ed8f-417f-9aa7-b9588fa601bd"><ix:nonFraction unitRef="usd" contextRef="ibb17976a662245c78f9ece050fbca040_D20210401-20210401" decimals="-3" format="ixt:numdotdecimal" name="cron:InvestmentsInAndAdvancesToAffiliatesAtFairValueAdvancesRepayments" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzY2E5YmIwMTc5MjQ3NmZiYjIyNWU1ZDlkZWM4NjlmL3NlYzo5M2NhOWJiMDE3OTI0NzZmYmIyMjVlNWQ5ZGVjODY5Zl80My9mcmFnOjZlZDUwYmJmZmU2ZDRjMDJhOWRiZDFkNzYzNTUzOWFlL3RleHRyZWdpb246NmVkNTBiYmZmZTZkNGMwMmE5ZGJkMWQ3NjM1NTM5YWVfMTA5OTUxMTYzMTk4Mg_5e8e6ec9-499b-4911-950e-d1bcd4129b38">7,750</ix:nonFraction></ix:nonFraction> each. As a result, the Company transferred the carrying value of the Natuera Series A Loan of approximately $<ix:nonFraction unitRef="usd" contextRef="i74feb9a5e3ba4f03b6af6468c854d7d3_I20210401" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:NotesReceivableNet" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzY2E5YmIwMTc5MjQ3NmZiYjIyNWU1ZDlkZWM4NjlmL3NlYzo5M2NhOWJiMDE3OTI0NzZmYmIyMjVlNWQ5ZGVjODY5Zl80My9mcmFnOjZlZDUwYmJmZmU2ZDRjMDJhOWRiZDFkNzYzNTUzOWFlL3RleHRyZWdpb246NmVkNTBiYmZmZTZkNGMwMmE5ZGJkMWQ3NjM1NTM5YWVfMTA5OTUxMTYzMjA2NA_679c199f-fd55-482a-97f3-313aceb94b1e">2,013</ix:nonFraction> plus accrued interest of $<ix:nonFraction unitRef="usd" contextRef="i74feb9a5e3ba4f03b6af6468c854d7d3_I20210401" decimals="-3" name="us-gaap:FinancingReceivableAccruedInterestBeforeAllowanceForCreditLoss" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzY2E5YmIwMTc5MjQ3NmZiYjIyNWU1ZDlkZWM4NjlmL3NlYzo5M2NhOWJiMDE3OTI0NzZmYmIyMjVlNWQ5ZGVjODY5Zl80My9mcmFnOjZlZDUwYmJmZmU2ZDRjMDJhOWRiZDFkNzYzNTUzOWFlL3RleHRyZWdpb246NmVkNTBiYmZmZTZkNGMwMmE5ZGJkMWQ3NjM1NTM5YWVfMzg0ODI5MDcwMzg5Ng_aa069b47-12cd-4847-b730-e43a0ae6dccf">540</ix:nonFraction>, for a total investment value of $<ix:nonFraction unitRef="usd" contextRef="i3851bec177234bbb9f9d96a1e3eab1d3_D20210401-20210401" decimals="-3" format="ixt:numdotdecimal" name="cron:InvestmentsInAndAdvancesToAffiliatesAtFairValueTransferToInvestmentsInEquityAccountedInvestees" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzY2E5YmIwMTc5MjQ3NmZiYjIyNWU1ZDlkZWM4NjlmL3NlYzo5M2NhOWJiMDE3OTI0NzZmYmIyMjVlNWQ5ZGVjODY5Zl80My9mcmFnOjZlZDUwYmJmZmU2ZDRjMDJhOWRiZDFkNzYzNTUzOWFlL3RleHRyZWdpb246NmVkNTBiYmZmZTZkNGMwMmE5ZGJkMWQ3NjM1NTM5YWVfMjE5OTAyMzI2NTcwMQ_445bb183-6dab-453b-bcac-16d2b68e28aa">2,553</ix:nonFraction>, which approximates fair value, to investments in equity accounted investees in respect of Natuera. See Note 3. Investments.</span></div><div style="margin-bottom:3pt;margin-top:3pt;padding-left:27pt;text-align:justify;text-indent:-27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:400;line-height:120%;position:relative;top:-2.8pt;vertical-align:baseline">(ii)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:20.66pt">As of June&#160;30, 2021 and December&#160;31, 2020, Cronos GrowCo had drawn C$<ix:nonFraction unitRef="cad" contextRef="i41fdc77f9612409ab114fbdf3c20b8a8_D20210101-20210630" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:PaymentsToAcquireLoansReceivable" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzY2E5YmIwMTc5MjQ3NmZiYjIyNWU1ZDlkZWM4NjlmL3NlYzo5M2NhOWJiMDE3OTI0NzZmYmIyMjVlNWQ5ZGVjODY5Zl80My9mcmFnOjZlZDUwYmJmZmU2ZDRjMDJhOWRiZDFkNzYzNTUzOWFlL3RleHRyZWdpb246NmVkNTBiYmZmZTZkNGMwMmE5ZGJkMWQ3NjM1NTM5YWVfNTQ5_707e9ef3-46b3-4d0c-b671-734fb32a8069">100,000</ix:nonFraction> ($<ix:nonFraction unitRef="usd" contextRef="i41fdc77f9612409ab114fbdf3c20b8a8_D20210101-20210630" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:PaymentsToAcquireLoansReceivable" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzY2E5YmIwMTc5MjQ3NmZiYjIyNWU1ZDlkZWM4NjlmL3NlYzo5M2NhOWJiMDE3OTI0NzZmYmIyMjVlNWQ5ZGVjODY5Zl80My9mcmFnOjZlZDUwYmJmZmU2ZDRjMDJhOWRiZDFkNzYzNTUzOWFlL3RleHRyZWdpb246NmVkNTBiYmZmZTZkNGMwMmE5ZGJkMWQ3NjM1NTM5YWVfNTUz_c8193541-7313-427f-8513-eb231f924146">80,678</ix:nonFraction>) and C$<ix:nonFraction unitRef="cad" contextRef="i2873575c69e24565bb61cd0985446112_D20190101-20191231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:PaymentsToAcquireLoansReceivable" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzY2E5YmIwMTc5MjQ3NmZiYjIyNWU1ZDlkZWM4NjlmL3NlYzo5M2NhOWJiMDE3OTI0NzZmYmIyMjVlNWQ5ZGVjODY5Zl80My9mcmFnOjZlZDUwYmJmZmU2ZDRjMDJhOWRiZDFkNzYzNTUzOWFlL3RleHRyZWdpb246NmVkNTBiYmZmZTZkNGMwMmE5ZGJkMWQ3NjM1NTM5YWVfNTYy_0c6fb0df-5076-41f5-8c09-ddf02c0a3a16">95,150</ix:nonFraction> ($<ix:nonFraction unitRef="usd" contextRef="i2873575c69e24565bb61cd0985446112_D20190101-20191231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:PaymentsToAcquireLoansReceivable" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzY2E5YmIwMTc5MjQ3NmZiYjIyNWU1ZDlkZWM4NjlmL3NlYzo5M2NhOWJiMDE3OTI0NzZmYmIyMjVlNWQ5ZGVjODY5Zl80My9mcmFnOjZlZDUwYmJmZmU2ZDRjMDJhOWRiZDFkNzYzNTUzOWFlL3RleHRyZWdpb246NmVkNTBiYmZmZTZkNGMwMmE5ZGJkMWQ3NjM1NTM5YWVfNTY2_e58a442f-65d2-4871-b75a-7a81068718e8">74,626</ix:nonFraction>), respectively, from a credit agreement it entered into with the Company in August 2019 (the &#8220;GrowCo Facility&#8221;). As of June&#160;30, 2021 and December&#160;31, 2020, the Company had an allowance for credit losses of $<ix:nonFraction unitRef="usd" contextRef="i4d5e5ad8b8c04f0e81c4f56d20dd2667_I20210630" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:FinancingReceivableAllowanceForCreditLosses" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzY2E5YmIwMTc5MjQ3NmZiYjIyNWU1ZDlkZWM4NjlmL3NlYzo5M2NhOWJiMDE3OTI0NzZmYmIyMjVlNWQ5ZGVjODY5Zl80My9mcmFnOjZlZDUwYmJmZmU2ZDRjMDJhOWRiZDFkNzYzNTUzOWFlL3RleHRyZWdpb246NmVkNTBiYmZmZTZkNGMwMmE5ZGJkMWQ3NjM1NTM5YWVfNDk0NzgwMjMzNDMyMw_f023dde9-978b-4a19-80f9-963460f84d83">1,590</ix:nonFraction> and $<ix:nonFraction unitRef="usd" contextRef="i389408e323054f34bb2d44166886cfa0_I20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:FinancingReceivableAllowanceForCreditLosses" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzY2E5YmIwMTc5MjQ3NmZiYjIyNWU1ZDlkZWM4NjlmL3NlYzo5M2NhOWJiMDE3OTI0NzZmYmIyMjVlNWQ5ZGVjODY5Zl80My9mcmFnOjZlZDUwYmJmZmU2ZDRjMDJhOWRiZDFkNzYzNTUzOWFlL3RleHRyZWdpb246NmVkNTBiYmZmZTZkNGMwMmE5ZGJkMWQ3NjM1NTM5YWVfNzY1_b91c0f31-76e7-4842-ba5a-6c80a0c1a980">1,470</ix:nonFraction>, respectively, recorded against the GrowCo Facility.</span></div><div style="margin-bottom:3pt;margin-top:3pt;padding-left:27pt;text-align:justify;text-indent:-27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:400;line-height:120%;position:relative;top:-2.8pt;vertical-align:baseline">(iii)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:19.22pt">As of June&#160;30, 2021 and December&#160;31, 2020, the Company had an allowance for credit losses of $<ix:nonFraction unitRef="usd" contextRef="i6c507204183f49389291963dff6d55c3_I20210630" decimals="-3" name="us-gaap:FinancingReceivableAllowanceForCreditLosses" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzY2E5YmIwMTc5MjQ3NmZiYjIyNWU1ZDlkZWM4NjlmL3NlYzo5M2NhOWJiMDE3OTI0NzZmYmIyMjVlNWQ5ZGVjODY5Zl80My9mcmFnOjZlZDUwYmJmZmU2ZDRjMDJhOWRiZDFkNzYzNTUzOWFlL3RleHRyZWdpb246NmVkNTBiYmZmZTZkNGMwMmE5ZGJkMWQ3NjM1NTM5YWVfNDk0NzgwMjMzNDMzMg_2470e089-428f-4a22-aff0-109e62fd86fa">278</ix:nonFraction> and</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">$<ix:nonFraction unitRef="usd" contextRef="i09921e492ba24195a2e19b52c026c6f7_I20201231" decimals="-3" name="us-gaap:FinancingReceivableAllowanceForCreditLosses" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzY2E5YmIwMTc5MjQ3NmZiYjIyNWU1ZDlkZWM4NjlmL3NlYzo5M2NhOWJiMDE3OTI0NzZmYmIyMjVlNWQ5ZGVjODY5Zl80My9mcmFnOjZlZDUwYmJmZmU2ZDRjMDJhOWRiZDFkNzYzNTUzOWFlL3RleHRyZWdpb246NmVkNTBiYmZmZTZkNGMwMmE5ZGJkMWQ3NjM1NTM5YWVfOTA4_690464a4-d137-45ef-a5c6-2ffa1d3838a5">259</ix:nonFraction>, respectively, recorded against the promissory note receivable agreement entered into with Mucci on June 28, 2019 (the &#8220;Mucci Promissory Note&#8221;).</span></div><div style="margin-bottom:6pt;margin-top:3pt;padding-left:27pt;text-align:justify;text-indent:-27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:400;line-height:120%;position:relative;top:-2.8pt;vertical-align:baseline">(iv)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:19.5pt">As of June&#160;30, 2021 and December&#160;31, 2020 CLS has received ILS <ix:nonFraction unitRef="ils" contextRef="i00bf33a48aaa4cf2930896225af28659_I20210630" decimals="-3" format="ixt:numdotdecimal" name="cron:CollaborativeArrangementInstallmentsReceived" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzY2E5YmIwMTc5MjQ3NmZiYjIyNWU1ZDlkZWM4NjlmL3NlYzo5M2NhOWJiMDE3OTI0NzZmYmIyMjVlNWQ5ZGVjODY5Zl80My9mcmFnOjZlZDUwYmJmZmU2ZDRjMDJhOWRiZDFkNzYzNTUzOWFlL3RleHRyZWdpb246NmVkNTBiYmZmZTZkNGMwMmE5ZGJkMWQ3NjM1NTM5YWVfMTAyNg_ce71c4a8-c236-4bf8-90e9-ea8f1a28de6f">6,223</ix:nonFraction> and ILS <ix:nonFraction unitRef="ils" contextRef="ifdf5fbc8e97845b297aa6f44576063c3_I20201231" decimals="-3" format="ixt:numdotdecimal" name="cron:CollaborativeArrangementInstallmentsReceived" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzY2E5YmIwMTc5MjQ3NmZiYjIyNWU1ZDlkZWM4NjlmL3NlYzo5M2NhOWJiMDE3OTI0NzZmYmIyMjVlNWQ5ZGVjODY5Zl80My9mcmFnOjZlZDUwYmJmZmU2ZDRjMDJhOWRiZDFkNzYzNTUzOWFlL3RleHRyZWdpb246NmVkNTBiYmZmZTZkNGMwMmE5ZGJkMWQ3NjM1NTM5YWVfNDk0NzgwMjMzMzM5OA_e5c3256e-6ff9-4e14-b7dc-584129f868a0">4,149</ix:nonFraction> (approximately $<ix:nonFraction unitRef="usd" contextRef="i00bf33a48aaa4cf2930896225af28659_I20210630" decimals="-3" format="ixt:numdotdecimal" name="cron:CollaborativeArrangementInstallmentsReceived" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzY2E5YmIwMTc5MjQ3NmZiYjIyNWU1ZDlkZWM4NjlmL3NlYzo5M2NhOWJiMDE3OTI0NzZmYmIyMjVlNWQ5ZGVjODY5Zl80My9mcmFnOjZlZDUwYmJmZmU2ZDRjMDJhOWRiZDFkNzYzNTUzOWFlL3RleHRyZWdpb246NmVkNTBiYmZmZTZkNGMwMmE5ZGJkMWQ3NjM1NTM5YWVfMTA0NA_ede7b69e-4904-4403-9a29-cb17f7e3dffd">1,909</ix:nonFraction> and $<ix:nonFraction unitRef="usd" contextRef="ifdf5fbc8e97845b297aa6f44576063c3_I20201231" decimals="-3" format="ixt:numdotdecimal" name="cron:CollaborativeArrangementInstallmentsReceived" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzY2E5YmIwMTc5MjQ3NmZiYjIyNWU1ZDlkZWM4NjlmL3NlYzo5M2NhOWJiMDE3OTI0NzZmYmIyMjVlNWQ5ZGVjODY5Zl80My9mcmFnOjZlZDUwYmJmZmU2ZDRjMDJhOWRiZDFkNzYzNTUzOWFlL3RleHRyZWdpb246NmVkNTBiYmZmZTZkNGMwMmE5ZGJkMWQ3NjM1NTM5YWVfNDk0NzgwMjMzMzQyOQ_bb849e87-ea11-4cfa-a8f4-319ec230a954">1,287</ix:nonFraction> respectively) from the Cannasoul Collaboration Loan. As of June&#160;30, 2021 and December&#160;31, 2020, the Company had an allowance for credit losses of $<ix:nonFraction unitRef="usd" contextRef="i00bf33a48aaa4cf2930896225af28659_I20210630" decimals="-3" name="us-gaap:AllowanceForDoubtfulAccountsReceivableCurrent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzY2E5YmIwMTc5MjQ3NmZiYjIyNWU1ZDlkZWM4NjlmL3NlYzo5M2NhOWJiMDE3OTI0NzZmYmIyMjVlNWQ5ZGVjODY5Zl80My9mcmFnOjZlZDUwYmJmZmU2ZDRjMDJhOWRiZDFkNzYzNTUzOWFlL3RleHRyZWdpb246NmVkNTBiYmZmZTZkNGMwMmE5ZGJkMWQ3NjM1NTM5YWVfNDk0NzgwMjMzNDMzNg_af46af08-6270-415f-8b48-ca34c104d9b6">39</ix:nonFraction> and $<ix:nonFraction unitRef="usd" contextRef="ifdf5fbc8e97845b297aa6f44576063c3_I20201231" decimals="-3" name="us-gaap:AllowanceForDoubtfulAccountsReceivableCurrent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzY2E5YmIwMTc5MjQ3NmZiYjIyNWU1ZDlkZWM4NjlmL3NlYzo5M2NhOWJiMDE3OTI0NzZmYmIyMjVlNWQ5ZGVjODY5Zl80My9mcmFnOjZlZDUwYmJmZmU2ZDRjMDJhOWRiZDFkNzYzNTUzOWFlL3RleHRyZWdpb246NmVkNTBiYmZmZTZkNGMwMmE5ZGJkMWQ3NjM1NTM5YWVfMTE1Ng_e6339b68-ae9e-4709-9e6d-fb3f413f3312">25</ix:nonFraction>, respectively, recorded against the Cannasoul Collaboration Loan.</span></div></ix:nonNumeric></ix:continuation><div style="text-align:justify"><span><br/></span></div><div style="height:36pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">12</span></div></div></div><div id="i93ca9bb01792476fbb225e5d9dec869f_46"></div><hr style="page-break-after:always"/><div style="min-height:72pt;width:100%"><div style="margin-top:0.55pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:95.000%"><tr><td style="width:1.0%"></td><td style="width:65.712%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:32.088%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="border-top:1pt solid #FFFFFF;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Cronos Group Inc.</span></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Notes to Condensed Consolidated Financial Statements (Unaudited)</span></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">(In thousands of $, except share amounts)</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i93ca9bb01792476fbb225e5d9dec869f_7">Table of Contents</a></span></div></td></tr></table></div></div><div style="margin-bottom:12pt;margin-top:6pt;padding-left:29.25pt;text-align:justify;text-indent:-27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">5. <ix:nonNumeric contextRef="i69782326f71a44e3805518280ee22b6b_D20210101-20210630" name="us-gaap:DerivativeInstrumentsAndHedgingActivitiesDisclosureTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjkzY2E5YmIwMTc5MjQ3NmZiYjIyNWU1ZDlkZWM4NjlmL3NlYzo5M2NhOWJiMDE3OTI0NzZmYmIyMjVlNWQ5ZGVjODY5Zl80Ni9mcmFnOjE0YjkzMDBhMzZkNDQ1OTdhZGI5NzM0MDBlZTk5ZjYwL3RleHRyZWdpb246MTRiOTMwMGEzNmQ0NDU5N2FkYjk3MzQwMGVlOTlmNjBfNzQ2OA_cef53bc0-3a50-45ae-bd6c-26131cc3be3e" continuedAt="i9d39f65b1b9b43fa82b242ef8d90d4b4" escape="true">Derivative Liabilities </ix:nonNumeric></span></div><ix:continuation id="i9d39f65b1b9b43fa82b242ef8d90d4b4" continuedAt="iab599a4e6f3a41b68cafab7aeca9c4bc"><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On March 8, 2019, the Company closed the previously announced investment in the Company (the &#8220;Altria Investment&#8221;) by Altria Group, Inc. (&#8220;Altria&#8221;), pursuant to a subscription agreement dated December 7, 2018. As of the closing date of the Altria Investment, the Altria Investment consisted of <ix:nonFraction unitRef="shares" contextRef="i74b9dd5702d7406d891cf47a54534f5d_D20190308-20190308" decimals="INF" format="ixt:numdotdecimal" name="us-gaap:StockIssuedDuringPeriodSharesNewIssues" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjkzY2E5YmIwMTc5MjQ3NmZiYjIyNWU1ZDlkZWM4NjlmL3NlYzo5M2NhOWJiMDE3OTI0NzZmYmIyMjVlNWQ5ZGVjODY5Zl80Ni9mcmFnOjE0YjkzMDBhMzZkNDQ1OTdhZGI5NzM0MDBlZTk5ZjYwL3RleHRyZWdpb246MTRiOTMwMGEzNmQ0NDU5N2FkYjk3MzQwMGVlOTlmNjBfMzA2_d27b0752-950f-46ef-95f9-4f88214a341f">149,831,154</ix:nonFraction> common shares of the Company and <ix:nonFraction unitRef="warrant" contextRef="i0e42c55484f24f8ca353ad7f388b4066_D20190308-20190308" decimals="INF" format="ixt-sec:numwordsen" name="cron:ClassOfWarrantOrRightNumberOfWarrantsIssued" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjkzY2E5YmIwMTc5MjQ3NmZiYjIyNWU1ZDlkZWM4NjlmL3NlYzo5M2NhOWJiMDE3OTI0NzZmYmIyMjVlNWQ5ZGVjODY5Zl80Ni9mcmFnOjE0YjkzMDBhMzZkNDQ1OTdhZGI5NzM0MDBlZTk5ZjYwL3RleHRyZWdpb246MTRiOTMwMGEzNmQ0NDU5N2FkYjk3MzQwMGVlOTlmNjBfMzQy_46bdb129-abfa-413d-bde0-1f8fb8e15568">one</ix:nonFraction> warrant of the Company (the &#8220;Altria Warrant&#8221;), all of which were issued to a wholly owned subsidiary of Altria. As of the closing date of the Altria Investment, Altria beneficially held an approximately <ix:nonFraction unitRef="number" contextRef="idadea534a9454dde961a3571663d9316_I20190308" decimals="2" name="us-gaap:EquityMethodInvestmentOwnershipPercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjkzY2E5YmIwMTc5MjQ3NmZiYjIyNWU1ZDlkZWM4NjlmL3NlYzo5M2NhOWJiMDE3OTI0NzZmYmIyMjVlNWQ5ZGVjODY5Zl80Ni9mcmFnOjE0YjkzMDBhMzZkNDQ1OTdhZGI5NzM0MDBlZTk5ZjYwL3RleHRyZWdpb246MTRiOTMwMGEzNmQ0NDU5N2FkYjk3MzQwMGVlOTlmNjBfNTQ4_37250c61-39e1-46d6-85ed-3a8b513b4893">45</ix:nonFraction>% ownership interest in the Company (calculated on a non-diluted basis). As summarized in this note, if exercised in full on such date, the exercise of the Altria Warrant would have resulted in Altria holding a total ownership interest in the Company of approximately <ix:nonFraction unitRef="number" contextRef="i12a4ebb046d84e5b9eb27c82479f837b_I20190308" decimals="2" name="cron:SubsidiaryOrEquityMethodInvesteeCumulativePercentageOwnershipAfterAllTransactionsIfWarrantsExercised" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjkzY2E5YmIwMTc5MjQ3NmZiYjIyNWU1ZDlkZWM4NjlmL3NlYzo5M2NhOWJiMDE3OTI0NzZmYmIyMjVlNWQ5ZGVjODY5Zl80Ni9mcmFnOjE0YjkzMDBhMzZkNDQ1OTdhZGI5NzM0MDBlZTk5ZjYwL3RleHRyZWdpb246MTRiOTMwMGEzNmQ0NDU5N2FkYjk3MzQwMGVlOTlmNjBfODE3_298cb24c-9eda-4807-9de6-b1bff4c27b1d">55</ix:nonFraction>% (calculated on a non-diluted basis). As of June 30, 2021, Altria beneficially held an approximately <ix:nonFraction unitRef="number" contextRef="i0a23fd4d2173473387281b095562f1e0_I20210630" decimals="2" name="us-gaap:EquityMethodInvestmentOwnershipPercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjkzY2E5YmIwMTc5MjQ3NmZiYjIyNWU1ZDlkZWM4NjlmL3NlYzo5M2NhOWJiMDE3OTI0NzZmYmIyMjVlNWQ5ZGVjODY5Zl80Ni9mcmFnOjE0YjkzMDBhMzZkNDQ1OTdhZGI5NzM0MDBlZTk5ZjYwL3RleHRyZWdpb246MTRiOTMwMGEzNmQ0NDU5N2FkYjk3MzQwMGVlOTlmNjBfMjE5OTAyMzI2ODk1OA_9e2c78ed-2702-4c6b-957b-e432cf94a181">42</ix:nonFraction>% ownership interest in the Company (calculated on a non-diluted basis). As summarized in this note, if exercised in full on such date, the exercise of the Altria Warrant would have resulted in Altria holding a total ownership interest in the Company of approximately <ix:nonFraction unitRef="number" contextRef="iff243ffb3690436c962f2508a95b9bf9_I20210630" decimals="2" name="cron:SubsidiaryOrEquityMethodInvesteeCumulativePercentageOwnershipAfterAllTransactionsIfWarrantsExercised" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjkzY2E5YmIwMTc5MjQ3NmZiYjIyNWU1ZDlkZWM4NjlmL3NlYzo5M2NhOWJiMDE3OTI0NzZmYmIyMjVlNWQ5ZGVjODY5Zl80Ni9mcmFnOjE0YjkzMDBhMzZkNDQ1OTdhZGI5NzM0MDBlZTk5ZjYwL3RleHRyZWdpb246MTRiOTMwMGEzNmQ0NDU5N2FkYjk3MzQwMGVlOTlmNjBfMjE5OTAyMzI2ODk2Mw_aacf34c7-4169-4a46-82f6-c7d7db82ee20">53</ix:nonFraction>% (calculated on a non-diluted basis). Pursuant to the investor rights agreement between the Company and Altria, entered into in connection with the closing of the Altria Investment (the &#8220;Investor Rights Agreement&#8221;), the Company granted Altria certain rights, among others, summarized in this note.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The summaries below are qualified entirely by the terms and conditions fully set out in the Investor Rights Agreement and the Altria Warrant, as applicable.</span></div><div style="margin-bottom:6pt;margin-top:6pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">a.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:11.07pt">The Altria Warrant entitles the holder, subject to certain qualifications and limitations, to subscribe for and purchase up to an additional approximate <ix:nonFraction unitRef="number" contextRef="iab341b8979a347a9b96abc3a20faff60_I20190308" decimals="INF" name="cron:ClassOfWarrantOrRightMaximumAdditionalSubscriptionPercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjkzY2E5YmIwMTc5MjQ3NmZiYjIyNWU1ZDlkZWM4NjlmL3NlYzo5M2NhOWJiMDE3OTI0NzZmYmIyMjVlNWQ5ZGVjODY5Zl80Ni9mcmFnOjE0YjkzMDBhMzZkNDQ1OTdhZGI5NzM0MDBlZTk5ZjYwL3RleHRyZWdpb246MTRiOTMwMGEzNmQ0NDU5N2FkYjk3MzQwMGVlOTlmNjBfMTQxNg_d08b9a1a-259a-40da-9305-99a0c3434a73">10</ix:nonFraction>% of the common shares of Cronos (approximately <ix:nonFraction unitRef="shares" contextRef="i5b5f21f6057c4e8e893d9e27815ea92a_I20210630" decimals="-6" format="ixt:numdotdecimal" name="cron:ClassOfWarrantOrRightAdditionalSubscriptionNumberOfSecuritiesCalledByWarrantsOrRights" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjkzY2E5YmIwMTc5MjQ3NmZiYjIyNWU1ZDlkZWM4NjlmL3NlYzo5M2NhOWJiMDE3OTI0NzZmYmIyMjVlNWQ5ZGVjODY5Zl80Ni9mcmFnOjE0YjkzMDBhMzZkNDQ1OTdhZGI5NzM0MDBlZTk5ZjYwL3RleHRyZWdpb246MTRiOTMwMGEzNmQ0NDU5N2FkYjk3MzQwMGVlOTlmNjBfMTQ2NQ_947cc10e-8d56-4a5a-a4cb-e543470fdbe4">83</ix:nonFraction> million common shares at June&#160;30, 2021) at a per share exercise price of C$<ix:nonFraction unitRef="cadPerShare" contextRef="i1d456d0e4fcf43c6ad21f99b40cbf279_I20190308" decimals="INF" name="us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjkzY2E5YmIwMTc5MjQ3NmZiYjIyNWU1ZDlkZWM4NjlmL3NlYzo5M2NhOWJiMDE3OTI0NzZmYmIyMjVlNWQ5ZGVjODY5Zl80Ni9mcmFnOjE0YjkzMDBhMzZkNDQ1OTdhZGI5NzM0MDBlZTk5ZjYwL3RleHRyZWdpb246MTRiOTMwMGEzNmQ0NDU5N2FkYjk3MzQwMGVlOTlmNjBfMTUyMw_daa8aa02-7caa-4bcd-acb5-d2de65bd1899">19.00</ix:nonFraction>, which expires on March 8, 2023.</span></div><div style="margin-bottom:6pt;margin-top:6pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">b.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:10.5pt">The Company granted to Altria, subject to certain qualifications and limitations, upon the occurrence of certain issuances of common shares of the Company executed by the Company (including issuances pursuant to the R&amp;D partnership with Ginkgo Bioworks Inc. (&#8220;Ginkgo&#8221;) (the &#8220;Ginkgo Strategic Partnership&#8221;)), the right to purchase up to such number of common shares of the Company in order to maintain their ownership percentage of issued and outstanding common shares of the Company immediately preceding any issuance of shares by the Company (&#8220;Pre-emptive Rights&#8221;), at the same price per common share of the Company at which the common shares are sold in the relevant issuance. The price per common share of the Company to be paid by Altria pursuant to its exercise of its Pre-emptive Rights related to the Ginkgo Strategic Partnership will be C$<ix:nonFraction unitRef="cadPerShare" contextRef="i379e3f598bfc45909cc782ee94752221_I20190308" decimals="INF" name="us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjkzY2E5YmIwMTc5MjQ3NmZiYjIyNWU1ZDlkZWM4NjlmL3NlYzo5M2NhOWJiMDE3OTI0NzZmYmIyMjVlNWQ5ZGVjODY5Zl80Ni9mcmFnOjE0YjkzMDBhMzZkNDQ1OTdhZGI5NzM0MDBlZTk5ZjYwL3RleHRyZWdpb246MTRiOTMwMGEzNmQ0NDU5N2FkYjk3MzQwMGVlOTlmNjBfMjQwNg_6d10f726-40df-4b18-a003-51253c0fcfc0">16.25</ix:nonFraction> per common share. These rights may not be exercised if Altria&#8217;s ownership percentage of the issued and outstanding shares of the Company falls below <ix:nonFraction unitRef="number" contextRef="i379e3f598bfc45909cc782ee94752221_I20190308" decimals="INF" name="cron:ClassOfWarrantOrRightMinimumOwnershipPercentageRequired" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjkzY2E5YmIwMTc5MjQ3NmZiYjIyNWU1ZDlkZWM4NjlmL3NlYzo5M2NhOWJiMDE3OTI0NzZmYmIyMjVlNWQ5ZGVjODY5Zl80Ni9mcmFnOjE0YjkzMDBhMzZkNDQ1OTdhZGI5NzM0MDBlZTk5ZjYwL3RleHRyZWdpb246MTRiOTMwMGEzNmQ0NDU5N2FkYjk3MzQwMGVlOTlmNjBfMjU1OA_ee923d28-daa0-4183-a1f6-cf5793ad326a">20</ix:nonFraction>%.</span></div><div style="margin-bottom:6pt;margin-top:6pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">c.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:11.07pt">In addition to (and without duplication of) the Pre-emptive Rights, the Company granted to Altria, subject to certain qualifications and limitations, the right to subscribe for common shares of the Company issuable in connection with the exercise, conversion or exchange of convertible securities of the Company issued prior to March 8, 2019 or thereafter (excluding any convertible securities of the Company owned by Altria or any of its subsidiaries), a share incentive plan of the Company, the exercise of any right granted by the Company pro rata to all shareholders of the Company to purchase additional common shares and/or securities of the Company, bona fide bank debt, equipment financing or non-equity interim financing transactions that contemplate an equity component or bona fide acquisitions (including acquisitions of assets or rights under a license or otherwise), mergers or similar business combination transactions or joint ventures involving the Company in order to maintain their ownership percentage of issued and outstanding common shares of the Company immediately preceding any such transactions (&#8220;Top-up Rights&#8221;).</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The price per common share to be paid by Altria pursuant to the exercise of its Top-up Rights will be, subject to certain limited exceptions, the <ix:nonNumeric contextRef="i92e07d954a1e4dc78f61eca5784be099_D20190308-20190308" format="ixt-sec:durday" name="cron:ClassOfWarrantOrRightExercisePriceVolumeWeightedAveragePriceMeasurementPeriod" id="id3VybDovL2RvY3MudjEvZG9jOjkzY2E5YmIwMTc5MjQ3NmZiYjIyNWU1ZDlkZWM4NjlmL3NlYzo5M2NhOWJiMDE3OTI0NzZmYmIyMjVlNWQ5ZGVjODY5Zl80Ni9mcmFnOjE0YjkzMDBhMzZkNDQ1OTdhZGI5NzM0MDBlZTk5ZjYwL3RleHRyZWdpb246MTRiOTMwMGEzNmQ0NDU5N2FkYjk3MzQwMGVlOTlmNjBfMzg0OA_a6772cdc-6587-4eec-a5a3-aa1f8e7fc4d9">10</ix:nonNumeric>-day volume-weighted average price of the common shares of the Company on the TSX for the <ix:nonFraction unitRef="day" contextRef="i92e07d954a1e4dc78f61eca5784be099_D20190308-20190308" decimals="INF" format="ixt-sec:numwordsen" name="cron:ClassOfWarrantOrRightExercisePriceVolumeWeightedAveragePriceMeasurementPeriodDaysPrecedingExercise" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjkzY2E5YmIwMTc5MjQ3NmZiYjIyNWU1ZDlkZWM4NjlmL3NlYzo5M2NhOWJiMDE3OTI0NzZmYmIyMjVlNWQ5ZGVjODY5Zl80Ni9mcmFnOjE0YjkzMDBhMzZkNDQ1OTdhZGI5NzM0MDBlZTk5ZjYwL3RleHRyZWdpb246MTRiOTMwMGEzNmQ0NDU5N2FkYjk3MzQwMGVlOTlmNjBfMzk0MA_90b12341-c29f-4d69-a590-ea1b5c64260a">ten</ix:nonFraction> full days preceding such exercise by Altria, provided that the price per common share of the Company to be paid by Altria pursuant to the exercise of its Top-up Rights in connection with the issuance of common shares of the Company pursuant to the exercise of options or warrants that were outstanding as of March 8, 2019 will be C$<ix:nonFraction unitRef="cadPerShare" contextRef="i5c3db268f31b4ec899f7f0121d0b1bf8_I20190308" decimals="INF" name="us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjkzY2E5YmIwMTc5MjQ3NmZiYjIyNWU1ZDlkZWM4NjlmL3NlYzo5M2NhOWJiMDE3OTI0NzZmYmIyMjVlNWQ5ZGVjODY5Zl80Ni9mcmFnOjE0YjkzMDBhMzZkNDQ1OTdhZGI5NzM0MDBlZTk5ZjYwL3RleHRyZWdpb246MTRiOTMwMGEzNmQ0NDU5N2FkYjk3MzQwMGVlOTlmNjBfNDI3NA_4602a0c8-bc5c-4f87-b268-a5852dc167da">16.25</ix:nonFraction> per common share without any set off, counterclaim, deduction, or withholding. These rights may not be exercised if Altria&#8217;s ownership percentage of the issued and outstanding shares of the Company falls below <ix:nonFraction unitRef="number" contextRef="i5c3db268f31b4ec899f7f0121d0b1bf8_I20190308" decimals="INF" name="cron:ClassOfWarrantOrRightMinimumOwnershipPercentageRequired" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjkzY2E5YmIwMTc5MjQ3NmZiYjIyNWU1ZDlkZWM4NjlmL3NlYzo5M2NhOWJiMDE3OTI0NzZmYmIyMjVlNWQ5ZGVjODY5Zl80Ni9mcmFnOjE0YjkzMDBhMzZkNDQ1OTdhZGI5NzM0MDBlZTk5ZjYwL3RleHRyZWdpb246MTRiOTMwMGEzNmQ0NDU5N2FkYjk3MzQwMGVlOTlmNjBfNDQ4Nw_793dd295-6df3-4652-88cf-739a3ba2cb96">20</ix:nonFraction>%. The Altria Warrant, Pre-emptive Rights, and fixed price Top-up Rights have been classified as derivative liabilities.</span></div></ix:continuation><div style="height:36pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">13</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:72pt;width:100%"><div style="margin-top:0.55pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:95.000%"><tr><td style="width:1.0%"></td><td style="width:65.712%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:32.088%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="border-top:1pt solid #FFFFFF;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Cronos Group Inc.</span></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Notes to Condensed Consolidated Financial Statements (Unaudited)</span></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">(In thousands of $, except share amounts)</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i93ca9bb01792476fbb225e5d9dec869f_7">Table of Contents</a></span></div></td></tr></table></div></div><ix:continuation id="iab599a4e6f3a41b68cafab7aeca9c4bc" continuedAt="ie5066fae4684439797dda82bc6c4744a"><ix:nonNumeric contextRef="i69782326f71a44e3805518280ee22b6b_D20210101-20210630" name="us-gaap:FairValueNetDerivativeAssetLiabilityMeasuredOnRecurringBasisUnobservableInputReconciliationTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjkzY2E5YmIwMTc5MjQ3NmZiYjIyNWU1ZDlkZWM4NjlmL3NlYzo5M2NhOWJiMDE3OTI0NzZmYmIyMjVlNWQ5ZGVjODY5Zl80Ni9mcmFnOjE0YjkzMDBhMzZkNDQ1OTdhZGI5NzM0MDBlZTk5ZjYwL3RleHRyZWdpb246MTRiOTMwMGEzNmQ0NDU5N2FkYjk3MzQwMGVlOTlmNjBfNzQ2OQ_b87c5e18-6915-4bb5-98b1-0a0ffb925563" escape="true"><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">A reconciliation of the carrying amounts of the derivative liability for the three months ended June&#160;30, 2021 and 2020:</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:18.483%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.761%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.911%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:14.316%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.911%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.761%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.911%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:14.872%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.911%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.763%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">As of April 1, 2021</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Revaluation gain</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Out-of-period adjustment</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Foreign exchange effect</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">As of June 30, 2021</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(a) Altria Warrant</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7456fc9f9bac466e8f36318a7f2e0986_I20210331" decimals="-3" sign="-" format="ixt:numdotdecimal" name="us-gaap:FairValueNetDerivativeAssetLiabilityMeasuredOnRecurringBasisWithUnobservableInputs" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzY2E5YmIwMTc5MjQ3NmZiYjIyNWU1ZDlkZWM4NjlmL3NlYzo5M2NhOWJiMDE3OTI0NzZmYmIyMjVlNWQ5ZGVjODY5Zl80Ni9mcmFnOjE0YjkzMDBhMzZkNDQ1OTdhZGI5NzM0MDBlZTk5ZjYwL3RhYmxlOjM4OGFhOWUwZjEyYjQ4NTlhMzQ1MjQ1NjU3M2VmOTAwL3RhYmxlcmFuZ2U6Mzg4YWE5ZTBmMTJiNDg1OWEzNDUyNDU2NTczZWY5MDBfMS0xLTEtMS0w_461fd02a-9913-482d-b1a2-9def5e3d73c1">234,656</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="iecf64aa815654085bee554811ab6f80e_D20210401-20210630" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:FairValueNetDerivativeAssetLiabilityMeasuredOnRecurringBasisUnobservableInputsReconciliationGainLossIncludedInEarnings" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzY2E5YmIwMTc5MjQ3NmZiYjIyNWU1ZDlkZWM4NjlmL3NlYzo5M2NhOWJiMDE3OTI0NzZmYmIyMjVlNWQ5ZGVjODY5Zl80Ni9mcmFnOjE0YjkzMDBhMzZkNDQ1OTdhZGI5NzM0MDBlZTk5ZjYwL3RhYmxlOjM4OGFhOWUwZjEyYjQ4NTlhMzQ1MjQ1NjU3M2VmOTAwL3RhYmxlcmFuZ2U6Mzg4YWE5ZTBmMTJiNDg1OWEzNDUyNDU2NTczZWY5MDBfMS0zLTEtMS0w_c9437e57-40f8-466a-a8eb-264e63b19511">85,778</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iecf64aa815654085bee554811ab6f80e_D20210401-20210630" decimals="-3" format="ixt:zerodash" name="cron:FairValueNetDerivativeAssetLiabilityMeasuredOnRecurringBasisUnobservableInputsReconciliationOutOfPeriodAdjustment" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzY2E5YmIwMTc5MjQ3NmZiYjIyNWU1ZDlkZWM4NjlmL3NlYzo5M2NhOWJiMDE3OTI0NzZmYmIyMjVlNWQ5ZGVjODY5Zl80Ni9mcmFnOjE0YjkzMDBhMzZkNDQ1OTdhZGI5NzM0MDBlZTk5ZjYwL3RhYmxlOjM4OGFhOWUwZjEyYjQ4NTlhMzQ1MjQ1NjU3M2VmOTAwL3RhYmxlcmFuZ2U6Mzg4YWE5ZTBmMTJiNDg1OWEzNDUyNDU2NTczZWY5MDBfMS01LTEtMS0w_477440f5-db1f-4b2e-aaba-772b9baf5164">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iecf64aa815654085bee554811ab6f80e_D20210401-20210630" decimals="-3" sign="-" format="ixt:numdotdecimal" name="us-gaap:FairValueNetDerivativeAssetLiabilityMeasuredOnRecurringBasisUnobservableInputsReconciliationGainLossIncludedInOtherComprehensiveIncomeLoss" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzY2E5YmIwMTc5MjQ3NmZiYjIyNWU1ZDlkZWM4NjlmL3NlYzo5M2NhOWJiMDE3OTI0NzZmYmIyMjVlNWQ5ZGVjODY5Zl80Ni9mcmFnOjE0YjkzMDBhMzZkNDQ1OTdhZGI5NzM0MDBlZTk5ZjYwL3RhYmxlOjM4OGFhOWUwZjEyYjQ4NTlhMzQ1MjQ1NjU3M2VmOTAwL3RhYmxlcmFuZ2U6Mzg4YWE5ZTBmMTJiNDg1OWEzNDUyNDU2NTczZWY5MDBfMS03LTEtMS0w_e552a374-7069-4b2f-80c9-0ca86c9dd9f0">1,205</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i34995f47e8ba418fbd529b2ed52790dc_I20210630" decimals="-3" sign="-" format="ixt:numdotdecimal" name="us-gaap:FairValueNetDerivativeAssetLiabilityMeasuredOnRecurringBasisWithUnobservableInputs" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzY2E5YmIwMTc5MjQ3NmZiYjIyNWU1ZDlkZWM4NjlmL3NlYzo5M2NhOWJiMDE3OTI0NzZmYmIyMjVlNWQ5ZGVjODY5Zl80Ni9mcmFnOjE0YjkzMDBhMzZkNDQ1OTdhZGI5NzM0MDBlZTk5ZjYwL3RhYmxlOjM4OGFhOWUwZjEyYjQ4NTlhMzQ1MjQ1NjU3M2VmOTAwL3RhYmxlcmFuZ2U6Mzg4YWE5ZTBmMTJiNDg1OWEzNDUyNDU2NTczZWY5MDBfMS05LTEtMS0w_edfa0266-b71f-414a-adc2-c55541aff7b1">150,083</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(b) Pre-emptive Rights</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i626147251ce249d59dd6e68a90196f38_I20210331" decimals="-3" sign="-" format="ixt:numdotdecimal" name="us-gaap:FairValueNetDerivativeAssetLiabilityMeasuredOnRecurringBasisWithUnobservableInputs" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzY2E5YmIwMTc5MjQ3NmZiYjIyNWU1ZDlkZWM4NjlmL3NlYzo5M2NhOWJiMDE3OTI0NzZmYmIyMjVlNWQ5ZGVjODY5Zl80Ni9mcmFnOjE0YjkzMDBhMzZkNDQ1OTdhZGI5NzM0MDBlZTk5ZjYwL3RhYmxlOjM4OGFhOWUwZjEyYjQ4NTlhMzQ1MjQ1NjU3M2VmOTAwL3RhYmxlcmFuZ2U6Mzg4YWE5ZTBmMTJiNDg1OWEzNDUyNDU2NTczZWY5MDBfMi0xLTEtMS0w_16ff4cd1-25b7-4add-8cd5-d736672b5276">20,173</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i8c832bd4137248cb9777e42d7526fc6e_D20210401-20210630" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:FairValueNetDerivativeAssetLiabilityMeasuredOnRecurringBasisUnobservableInputsReconciliationGainLossIncludedInEarnings" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzY2E5YmIwMTc5MjQ3NmZiYjIyNWU1ZDlkZWM4NjlmL3NlYzo5M2NhOWJiMDE3OTI0NzZmYmIyMjVlNWQ5ZGVjODY5Zl80Ni9mcmFnOjE0YjkzMDBhMzZkNDQ1OTdhZGI5NzM0MDBlZTk5ZjYwL3RhYmxlOjM4OGFhOWUwZjEyYjQ4NTlhMzQ1MjQ1NjU3M2VmOTAwL3RhYmxlcmFuZ2U6Mzg4YWE5ZTBmMTJiNDg1OWEzNDUyNDU2NTczZWY5MDBfMi0zLTEtMS0w_6d70dda5-824e-4e4f-8401-c172147bbb53">6,360</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8c832bd4137248cb9777e42d7526fc6e_D20210401-20210630" decimals="-3" format="ixt:zerodash" name="cron:FairValueNetDerivativeAssetLiabilityMeasuredOnRecurringBasisUnobservableInputsReconciliationOutOfPeriodAdjustment" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzY2E5YmIwMTc5MjQ3NmZiYjIyNWU1ZDlkZWM4NjlmL3NlYzo5M2NhOWJiMDE3OTI0NzZmYmIyMjVlNWQ5ZGVjODY5Zl80Ni9mcmFnOjE0YjkzMDBhMzZkNDQ1OTdhZGI5NzM0MDBlZTk5ZjYwL3RhYmxlOjM4OGFhOWUwZjEyYjQ4NTlhMzQ1MjQ1NjU3M2VmOTAwL3RhYmxlcmFuZ2U6Mzg4YWE5ZTBmMTJiNDg1OWEzNDUyNDU2NTczZWY5MDBfMi01LTEtMS0w_02ccb2ca-4d60-455e-b8f9-4c3e9954bfde">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8c832bd4137248cb9777e42d7526fc6e_D20210401-20210630" decimals="-3" sign="-" name="us-gaap:FairValueNetDerivativeAssetLiabilityMeasuredOnRecurringBasisUnobservableInputsReconciliationGainLossIncludedInOtherComprehensiveIncomeLoss" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzY2E5YmIwMTc5MjQ3NmZiYjIyNWU1ZDlkZWM4NjlmL3NlYzo5M2NhOWJiMDE3OTI0NzZmYmIyMjVlNWQ5ZGVjODY5Zl80Ni9mcmFnOjE0YjkzMDBhMzZkNDQ1OTdhZGI5NzM0MDBlZTk5ZjYwL3RhYmxlOjM4OGFhOWUwZjEyYjQ4NTlhMzQ1MjQ1NjU3M2VmOTAwL3RhYmxlcmFuZ2U6Mzg4YWE5ZTBmMTJiNDg1OWEzNDUyNDU2NTczZWY5MDBfMi03LTEtMS0w_47b61bee-54e2-42d5-a164-5eda8ff45d32">113</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie4ec3b642b3b4457b78cb85e8d1838f0_I20210630" decimals="-3" sign="-" format="ixt:numdotdecimal" name="us-gaap:FairValueNetDerivativeAssetLiabilityMeasuredOnRecurringBasisWithUnobservableInputs" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzY2E5YmIwMTc5MjQ3NmZiYjIyNWU1ZDlkZWM4NjlmL3NlYzo5M2NhOWJiMDE3OTI0NzZmYmIyMjVlNWQ5ZGVjODY5Zl80Ni9mcmFnOjE0YjkzMDBhMzZkNDQ1OTdhZGI5NzM0MDBlZTk5ZjYwL3RhYmxlOjM4OGFhOWUwZjEyYjQ4NTlhMzQ1MjQ1NjU3M2VmOTAwL3RhYmxlcmFuZ2U6Mzg4YWE5ZTBmMTJiNDg1OWEzNDUyNDU2NTczZWY5MDBfMi05LTEtMS0w_3a2b5ed5-9fd2-47c5-9bf0-74960021d956">13,926</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(c) Top-up Rights</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i38d49776600045c1b8110dc70e805025_I20210331" decimals="-3" sign="-" format="ixt:numdotdecimal" name="us-gaap:FairValueNetDerivativeAssetLiabilityMeasuredOnRecurringBasisWithUnobservableInputs" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzY2E5YmIwMTc5MjQ3NmZiYjIyNWU1ZDlkZWM4NjlmL3NlYzo5M2NhOWJiMDE3OTI0NzZmYmIyMjVlNWQ5ZGVjODY5Zl80Ni9mcmFnOjE0YjkzMDBhMzZkNDQ1OTdhZGI5NzM0MDBlZTk5ZjYwL3RhYmxlOjM4OGFhOWUwZjEyYjQ4NTlhMzQ1MjQ1NjU3M2VmOTAwL3RhYmxlcmFuZ2U6Mzg4YWE5ZTBmMTJiNDg1OWEzNDUyNDU2NTczZWY5MDBfMy0xLTEtMS0w_d80eb727-ecf1-4548-9e4a-e99107cff58d">17,471</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i03741f2ae4674980813a9701e43f6a2b_D20210401-20210630" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:FairValueNetDerivativeAssetLiabilityMeasuredOnRecurringBasisUnobservableInputsReconciliationGainLossIncludedInEarnings" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzY2E5YmIwMTc5MjQ3NmZiYjIyNWU1ZDlkZWM4NjlmL3NlYzo5M2NhOWJiMDE3OTI0NzZmYmIyMjVlNWQ5ZGVjODY5Zl80Ni9mcmFnOjE0YjkzMDBhMzZkNDQ1OTdhZGI5NzM0MDBlZTk5ZjYwL3RhYmxlOjM4OGFhOWUwZjEyYjQ4NTlhMzQ1MjQ1NjU3M2VmOTAwL3RhYmxlcmFuZ2U6Mzg4YWE5ZTBmMTJiNDg1OWEzNDUyNDU2NTczZWY5MDBfMy0zLTEtMS0w_008f0c4a-4acd-4382-9541-47a9b3718dc9">23,110</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i03741f2ae4674980813a9701e43f6a2b_D20210401-20210630" decimals="-3" sign="-" format="ixt:numdotdecimal" name="cron:FairValueNetDerivativeAssetLiabilityMeasuredOnRecurringBasisUnobservableInputsReconciliationOutOfPeriodAdjustment" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzY2E5YmIwMTc5MjQ3NmZiYjIyNWU1ZDlkZWM4NjlmL3NlYzo5M2NhOWJiMDE3OTI0NzZmYmIyMjVlNWQ5ZGVjODY5Zl80Ni9mcmFnOjE0YjkzMDBhMzZkNDQ1OTdhZGI5NzM0MDBlZTk5ZjYwL3RhYmxlOjM4OGFhOWUwZjEyYjQ4NTlhMzQ1MjQ1NjU3M2VmOTAwL3RhYmxlcmFuZ2U6Mzg4YWE5ZTBmMTJiNDg1OWEzNDUyNDU2NTczZWY5MDBfMy01LTEtMS0w_91c86d35-7047-45a4-90eb-91c7d7f69132">11,278</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i03741f2ae4674980813a9701e43f6a2b_D20210401-20210630" decimals="-3" name="us-gaap:FairValueNetDerivativeAssetLiabilityMeasuredOnRecurringBasisUnobservableInputsReconciliationGainLossIncludedInOtherComprehensiveIncomeLoss" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzY2E5YmIwMTc5MjQ3NmZiYjIyNWU1ZDlkZWM4NjlmL3NlYzo5M2NhOWJiMDE3OTI0NzZmYmIyMjVlNWQ5ZGVjODY5Zl80Ni9mcmFnOjE0YjkzMDBhMzZkNDQ1OTdhZGI5NzM0MDBlZTk5ZjYwL3RhYmxlOjM4OGFhOWUwZjEyYjQ4NTlhMzQ1MjQ1NjU3M2VmOTAwL3RhYmxlcmFuZ2U6Mzg4YWE5ZTBmMTJiNDg1OWEzNDUyNDU2NTczZWY5MDBfMy03LTEtMS0w_d70bad0d-c4bd-4b33-be65-d4946b418743">85</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia2cd5cb93e97428dabd7e841eee51895_I20210630" decimals="-3" sign="-" format="ixt:numdotdecimal" name="us-gaap:FairValueNetDerivativeAssetLiabilityMeasuredOnRecurringBasisWithUnobservableInputs" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzY2E5YmIwMTc5MjQ3NmZiYjIyNWU1ZDlkZWM4NjlmL3NlYzo5M2NhOWJiMDE3OTI0NzZmYmIyMjVlNWQ5ZGVjODY5Zl80Ni9mcmFnOjE0YjkzMDBhMzZkNDQ1OTdhZGI5NzM0MDBlZTk5ZjYwL3RhYmxlOjM4OGFhOWUwZjEyYjQ4NTlhMzQ1MjQ1NjU3M2VmOTAwL3RhYmxlcmFuZ2U6Mzg4YWE5ZTBmMTJiNDg1OWEzNDUyNDU2NTczZWY5MDBfMy05LTEtMS0w_fe4872dc-8e83-4eec-a2ce-b7bf421dd3d8">5,554</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i672ae438d5904d3aa27f245b59e5ba4c_I20210331" decimals="-3" sign="-" format="ixt:numdotdecimal" name="us-gaap:FairValueNetDerivativeAssetLiabilityMeasuredOnRecurringBasisWithUnobservableInputs" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzY2E5YmIwMTc5MjQ3NmZiYjIyNWU1ZDlkZWM4NjlmL3NlYzo5M2NhOWJiMDE3OTI0NzZmYmIyMjVlNWQ5ZGVjODY5Zl80Ni9mcmFnOjE0YjkzMDBhMzZkNDQ1OTdhZGI5NzM0MDBlZTk5ZjYwL3RhYmxlOjM4OGFhOWUwZjEyYjQ4NTlhMzQ1MjQ1NjU3M2VmOTAwL3RhYmxlcmFuZ2U6Mzg4YWE5ZTBmMTJiNDg1OWEzNDUyNDU2NTczZWY5MDBfNC0xLTEtMS0w_36ecf572-c3ba-4181-9f63-30802d986c02">272,300</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i27f4e53b91ad4367b7f8d273eff27769_D20210401-20210630" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:FairValueNetDerivativeAssetLiabilityMeasuredOnRecurringBasisUnobservableInputsReconciliationGainLossIncludedInEarnings" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzY2E5YmIwMTc5MjQ3NmZiYjIyNWU1ZDlkZWM4NjlmL3NlYzo5M2NhOWJiMDE3OTI0NzZmYmIyMjVlNWQ5ZGVjODY5Zl80Ni9mcmFnOjE0YjkzMDBhMzZkNDQ1OTdhZGI5NzM0MDBlZTk5ZjYwL3RhYmxlOjM4OGFhOWUwZjEyYjQ4NTlhMzQ1MjQ1NjU3M2VmOTAwL3RhYmxlcmFuZ2U6Mzg4YWE5ZTBmMTJiNDg1OWEzNDUyNDU2NTczZWY5MDBfNC0zLTEtMS0w_7184c9f0-f62d-4176-8c47-17749d1650f2">115,248</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i27f4e53b91ad4367b7f8d273eff27769_D20210401-20210630" decimals="-3" sign="-" format="ixt:numdotdecimal" name="cron:FairValueNetDerivativeAssetLiabilityMeasuredOnRecurringBasisUnobservableInputsReconciliationOutOfPeriodAdjustment" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzY2E5YmIwMTc5MjQ3NmZiYjIyNWU1ZDlkZWM4NjlmL3NlYzo5M2NhOWJiMDE3OTI0NzZmYmIyMjVlNWQ5ZGVjODY5Zl80Ni9mcmFnOjE0YjkzMDBhMzZkNDQ1OTdhZGI5NzM0MDBlZTk5ZjYwL3RhYmxlOjM4OGFhOWUwZjEyYjQ4NTlhMzQ1MjQ1NjU3M2VmOTAwL3RhYmxlcmFuZ2U6Mzg4YWE5ZTBmMTJiNDg1OWEzNDUyNDU2NTczZWY5MDBfNC01LTEtMS0w_971ff4e9-6b97-4d20-a105-159e4de8f00d">11,278</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i27f4e53b91ad4367b7f8d273eff27769_D20210401-20210630" decimals="-3" sign="-" format="ixt:numdotdecimal" name="us-gaap:FairValueNetDerivativeAssetLiabilityMeasuredOnRecurringBasisUnobservableInputsReconciliationGainLossIncludedInOtherComprehensiveIncomeLoss" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzY2E5YmIwMTc5MjQ3NmZiYjIyNWU1ZDlkZWM4NjlmL3NlYzo5M2NhOWJiMDE3OTI0NzZmYmIyMjVlNWQ5ZGVjODY5Zl80Ni9mcmFnOjE0YjkzMDBhMzZkNDQ1OTdhZGI5NzM0MDBlZTk5ZjYwL3RhYmxlOjM4OGFhOWUwZjEyYjQ4NTlhMzQ1MjQ1NjU3M2VmOTAwL3RhYmxlcmFuZ2U6Mzg4YWE5ZTBmMTJiNDg1OWEzNDUyNDU2NTczZWY5MDBfNC03LTEtMS0w_51adc08c-cda6-4de7-bbf0-aa1100e3226f">1,233</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i225f85e38faa4bbdb4de1d8b9cf369bb_I20210630" decimals="-3" sign="-" format="ixt:numdotdecimal" name="us-gaap:FairValueNetDerivativeAssetLiabilityMeasuredOnRecurringBasisWithUnobservableInputs" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzY2E5YmIwMTc5MjQ3NmZiYjIyNWU1ZDlkZWM4NjlmL3NlYzo5M2NhOWJiMDE3OTI0NzZmYmIyMjVlNWQ5ZGVjODY5Zl80Ni9mcmFnOjE0YjkzMDBhMzZkNDQ1OTdhZGI5NzM0MDBlZTk5ZjYwL3RhYmxlOjM4OGFhOWUwZjEyYjQ4NTlhMzQ1MjQ1NjU3M2VmOTAwL3RhYmxlcmFuZ2U6Mzg4YWE5ZTBmMTJiNDg1OWEzNDUyNDU2NTczZWY5MDBfNC05LTEtMS0w_4509e7bb-3ae8-4ae2-bf2e-eab993072adf">169,563</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td></tr></table></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:18.483%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.761%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.911%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:14.316%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.911%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.761%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.911%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:14.872%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.911%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.763%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">As of April 1, 2020</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Revaluation loss</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Exercise of rights</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Foreign exchange effect</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">As of June&#160;30, 2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(a) Altria Warrant</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if715f02149d34306825baa5114765cba_I20200331" decimals="-3" sign="-" format="ixt:numdotdecimal" name="us-gaap:FairValueNetDerivativeAssetLiabilityMeasuredOnRecurringBasisWithUnobservableInputs" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzY2E5YmIwMTc5MjQ3NmZiYjIyNWU1ZDlkZWM4NjlmL3NlYzo5M2NhOWJiMDE3OTI0NzZmYmIyMjVlNWQ5ZGVjODY5Zl80Ni9mcmFnOjE0YjkzMDBhMzZkNDQ1OTdhZGI5NzM0MDBlZTk5ZjYwL3RhYmxlOmVlZTEyYWNiZmVjNjQwYmI4MGRlN2ZjYzBiN2Y5NWRkL3RhYmxlcmFuZ2U6ZWVlMTJhY2JmZWM2NDBiYjgwZGU3ZmNjMGI3Zjk1ZGRfMS0xLTEtMS04NTQ_c4f84a9b-15e2-4912-bb5c-5d208d161bba">132,366</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1b9a300b5b514425a64d7bc17abb0931_D20200401-20200630" decimals="-3" sign="-" format="ixt:numdotdecimal" name="us-gaap:FairValueNetDerivativeAssetLiabilityMeasuredOnRecurringBasisUnobservableInputsReconciliationGainLossIncludedInEarnings" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzY2E5YmIwMTc5MjQ3NmZiYjIyNWU1ZDlkZWM4NjlmL3NlYzo5M2NhOWJiMDE3OTI0NzZmYmIyMjVlNWQ5ZGVjODY5Zl80Ni9mcmFnOjE0YjkzMDBhMzZkNDQ1OTdhZGI5NzM0MDBlZTk5ZjYwL3RhYmxlOmVlZTEyYWNiZmVjNjQwYmI4MGRlN2ZjYzBiN2Y5NWRkL3RhYmxlcmFuZ2U6ZWVlMTJhY2JmZWM2NDBiYjgwZGU3ZmNjMGI3Zjk1ZGRfMS0zLTEtMS04NTg_da72d22d-b07a-4aee-b177-8ee5f6a2dc2b">30,052</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1b9a300b5b514425a64d7bc17abb0931_D20200401-20200630" decimals="-3" format="ixt:zerodash" name="us-gaap:FairValueNetDerivativeAssetLiabilityMeasuredOnRecurringBasisUnobservableInputsReconciliationSettlements" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzY2E5YmIwMTc5MjQ3NmZiYjIyNWU1ZDlkZWM4NjlmL3NlYzo5M2NhOWJiMDE3OTI0NzZmYmIyMjVlNWQ5ZGVjODY5Zl80Ni9mcmFnOjE0YjkzMDBhMzZkNDQ1OTdhZGI5NzM0MDBlZTk5ZjYwL3RhYmxlOmVlZTEyYWNiZmVjNjQwYmI4MGRlN2ZjYzBiN2Y5NWRkL3RhYmxlcmFuZ2U6ZWVlMTJhY2JmZWM2NDBiYjgwZGU3ZmNjMGI3Zjk1ZGRfMS01LTEtMS04NjE_bc9d8b9f-3865-4dec-ad51-22a604eaa340">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1b9a300b5b514425a64d7bc17abb0931_D20200401-20200630" decimals="-3" sign="-" format="ixt:numdotdecimal" name="us-gaap:FairValueNetDerivativeAssetLiabilityMeasuredOnRecurringBasisUnobservableInputsReconciliationGainLossIncludedInOtherComprehensiveIncomeLoss" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzY2E5YmIwMTc5MjQ3NmZiYjIyNWU1ZDlkZWM4NjlmL3NlYzo5M2NhOWJiMDE3OTI0NzZmYmIyMjVlNWQ5ZGVjODY5Zl80Ni9mcmFnOjE0YjkzMDBhMzZkNDQ1OTdhZGI5NzM0MDBlZTk5ZjYwL3RhYmxlOmVlZTEyYWNiZmVjNjQwYmI4MGRlN2ZjYzBiN2Y5NWRkL3RhYmxlcmFuZ2U6ZWVlMTJhY2JmZWM2NDBiYjgwZGU3ZmNjMGI3Zjk1ZGRfMS03LTEtMS04NjQ_f7c912ae-0a50-4a1c-b789-f7eba3d131ca">3,540</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i69563d705edd465aabff3c895c85c313_I20200630" decimals="-3" sign="-" format="ixt:numdotdecimal" name="us-gaap:FairValueNetDerivativeAssetLiabilityMeasuredOnRecurringBasisWithUnobservableInputs" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzY2E5YmIwMTc5MjQ3NmZiYjIyNWU1ZDlkZWM4NjlmL3NlYzo5M2NhOWJiMDE3OTI0NzZmYmIyMjVlNWQ5ZGVjODY5Zl80Ni9mcmFnOjE0YjkzMDBhMzZkNDQ1OTdhZGI5NzM0MDBlZTk5ZjYwL3RhYmxlOmVlZTEyYWNiZmVjNjQwYmI4MGRlN2ZjYzBiN2Y5NWRkL3RhYmxlcmFuZ2U6ZWVlMTJhY2JmZWM2NDBiYjgwZGU3ZmNjMGI3Zjk1ZGRfMS05LTEtMS04Njc_b70b154f-d467-4557-a47a-22a2aecfea93">165,958</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(b) Pre-emptive Rights</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id9dedf3ba4bb445d8d76440d2f0ce670_I20200331" decimals="-3" sign="-" format="ixt:numdotdecimal" name="us-gaap:FairValueNetDerivativeAssetLiabilityMeasuredOnRecurringBasisWithUnobservableInputs" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzY2E5YmIwMTc5MjQ3NmZiYjIyNWU1ZDlkZWM4NjlmL3NlYzo5M2NhOWJiMDE3OTI0NzZmYmIyMjVlNWQ5ZGVjODY5Zl80Ni9mcmFnOjE0YjkzMDBhMzZkNDQ1OTdhZGI5NzM0MDBlZTk5ZjYwL3RhYmxlOmVlZTEyYWNiZmVjNjQwYmI4MGRlN2ZjYzBiN2Y5NWRkL3RhYmxlcmFuZ2U6ZWVlMTJhY2JmZWM2NDBiYjgwZGU3ZmNjMGI3Zjk1ZGRfMi0xLTEtMS04NTQ_c4dd45b8-c68c-4db4-a523-2e2bf941503e">13,070</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ifc3c6e8680594375afc563066129c544_D20200401-20200630" decimals="-3" sign="-" format="ixt:numdotdecimal" name="us-gaap:FairValueNetDerivativeAssetLiabilityMeasuredOnRecurringBasisUnobservableInputsReconciliationGainLossIncludedInEarnings" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzY2E5YmIwMTc5MjQ3NmZiYjIyNWU1ZDlkZWM4NjlmL3NlYzo5M2NhOWJiMDE3OTI0NzZmYmIyMjVlNWQ5ZGVjODY5Zl80Ni9mcmFnOjE0YjkzMDBhMzZkNDQ1OTdhZGI5NzM0MDBlZTk5ZjYwL3RhYmxlOmVlZTEyYWNiZmVjNjQwYmI4MGRlN2ZjYzBiN2Y5NWRkL3RhYmxlcmFuZ2U6ZWVlMTJhY2JmZWM2NDBiYjgwZGU3ZmNjMGI3Zjk1ZGRfMi0zLTEtMS04NTg_67062593-834a-4538-98c7-67e160c07c96">2,610</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ifc3c6e8680594375afc563066129c544_D20200401-20200630" decimals="-3" format="ixt:zerodash" name="us-gaap:FairValueNetDerivativeAssetLiabilityMeasuredOnRecurringBasisUnobservableInputsReconciliationSettlements" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzY2E5YmIwMTc5MjQ3NmZiYjIyNWU1ZDlkZWM4NjlmL3NlYzo5M2NhOWJiMDE3OTI0NzZmYmIyMjVlNWQ5ZGVjODY5Zl80Ni9mcmFnOjE0YjkzMDBhMzZkNDQ1OTdhZGI5NzM0MDBlZTk5ZjYwL3RhYmxlOmVlZTEyYWNiZmVjNjQwYmI4MGRlN2ZjYzBiN2Y5NWRkL3RhYmxlcmFuZ2U6ZWVlMTJhY2JmZWM2NDBiYjgwZGU3ZmNjMGI3Zjk1ZGRfMi01LTEtMS04NjE_22c5b8c9-b94b-4f38-9512-d9db681fe514">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ifc3c6e8680594375afc563066129c544_D20200401-20200630" decimals="-3" sign="-" name="us-gaap:FairValueNetDerivativeAssetLiabilityMeasuredOnRecurringBasisUnobservableInputsReconciliationGainLossIncludedInOtherComprehensiveIncomeLoss" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzY2E5YmIwMTc5MjQ3NmZiYjIyNWU1ZDlkZWM4NjlmL3NlYzo5M2NhOWJiMDE3OTI0NzZmYmIyMjVlNWQ5ZGVjODY5Zl80Ni9mcmFnOjE0YjkzMDBhMzZkNDQ1OTdhZGI5NzM0MDBlZTk5ZjYwL3RhYmxlOmVlZTEyYWNiZmVjNjQwYmI4MGRlN2ZjYzBiN2Y5NWRkL3RhYmxlcmFuZ2U6ZWVlMTJhY2JmZWM2NDBiYjgwZGU3ZmNjMGI3Zjk1ZGRfMi03LTEtMS04NjQ_8694efed-d80e-4177-81e9-3dba2aed326a">500</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i08475478dc1e46759179fb5a161607ba_I20200630" decimals="-3" sign="-" format="ixt:numdotdecimal" name="us-gaap:FairValueNetDerivativeAssetLiabilityMeasuredOnRecurringBasisWithUnobservableInputs" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzY2E5YmIwMTc5MjQ3NmZiYjIyNWU1ZDlkZWM4NjlmL3NlYzo5M2NhOWJiMDE3OTI0NzZmYmIyMjVlNWQ5ZGVjODY5Zl80Ni9mcmFnOjE0YjkzMDBhMzZkNDQ1OTdhZGI5NzM0MDBlZTk5ZjYwL3RhYmxlOmVlZTEyYWNiZmVjNjQwYmI4MGRlN2ZjYzBiN2Y5NWRkL3RhYmxlcmFuZ2U6ZWVlMTJhY2JmZWM2NDBiYjgwZGU3ZmNjMGI3Zjk1ZGRfMi05LTEtMS04Njc_b81ca247-02e4-40f8-a1be-761eb4c7453a">16,180</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(c) Top-up Rights</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6e6227af7d3b47f5a13d2cf8fabe34f8_I20200331" decimals="-3" sign="-" format="ixt:numdotdecimal" name="us-gaap:FairValueNetDerivativeAssetLiabilityMeasuredOnRecurringBasisWithUnobservableInputs" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzY2E5YmIwMTc5MjQ3NmZiYjIyNWU1ZDlkZWM4NjlmL3NlYzo5M2NhOWJiMDE3OTI0NzZmYmIyMjVlNWQ5ZGVjODY5Zl80Ni9mcmFnOjE0YjkzMDBhMzZkNDQ1OTdhZGI5NzM0MDBlZTk5ZjYwL3RhYmxlOmVlZTEyYWNiZmVjNjQwYmI4MGRlN2ZjYzBiN2Y5NWRkL3RhYmxlcmFuZ2U6ZWVlMTJhY2JmZWM2NDBiYjgwZGU3ZmNjMGI3Zjk1ZGRfMy0xLTEtMS04NTQ_f2be34d8-edfc-4083-a304-6b80d5a43b8f">20,013</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iab54aa6542634043937616e303d80df7_D20200401-20200630" decimals="-3" sign="-" format="ixt:numdotdecimal" name="us-gaap:FairValueNetDerivativeAssetLiabilityMeasuredOnRecurringBasisUnobservableInputsReconciliationGainLossIncludedInEarnings" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzY2E5YmIwMTc5MjQ3NmZiYjIyNWU1ZDlkZWM4NjlmL3NlYzo5M2NhOWJiMDE3OTI0NzZmYmIyMjVlNWQ5ZGVjODY5Zl80Ni9mcmFnOjE0YjkzMDBhMzZkNDQ1OTdhZGI5NzM0MDBlZTk5ZjYwL3RhYmxlOmVlZTEyYWNiZmVjNjQwYmI4MGRlN2ZjYzBiN2Y5NWRkL3RhYmxlcmFuZ2U6ZWVlMTJhY2JmZWM2NDBiYjgwZGU3ZmNjMGI3Zjk1ZGRfMy0zLTEtMS04NTg_bdd08cdb-f119-4a34-8581-343447465a7f">3,218</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="iab54aa6542634043937616e303d80df7_D20200401-20200630" decimals="-3" name="us-gaap:FairValueNetDerivativeAssetLiabilityMeasuredOnRecurringBasisUnobservableInputsReconciliationSettlements" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzY2E5YmIwMTc5MjQ3NmZiYjIyNWU1ZDlkZWM4NjlmL3NlYzo5M2NhOWJiMDE3OTI0NzZmYmIyMjVlNWQ5ZGVjODY5Zl80Ni9mcmFnOjE0YjkzMDBhMzZkNDQ1OTdhZGI5NzM0MDBlZTk5ZjYwL3RhYmxlOmVlZTEyYWNiZmVjNjQwYmI4MGRlN2ZjYzBiN2Y5NWRkL3RhYmxlcmFuZ2U6ZWVlMTJhY2JmZWM2NDBiYjgwZGU3ZmNjMGI3Zjk1ZGRfMy01LTEtMS04NjE_8529e58a-d636-4840-aa56-4675871d6eb1">727</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iab54aa6542634043937616e303d80df7_D20200401-20200630" decimals="-3" sign="-" format="ixt:numdotdecimal" name="us-gaap:FairValueNetDerivativeAssetLiabilityMeasuredOnRecurringBasisUnobservableInputsReconciliationGainLossIncludedInOtherComprehensiveIncomeLoss" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzY2E5YmIwMTc5MjQ3NmZiYjIyNWU1ZDlkZWM4NjlmL3NlYzo5M2NhOWJiMDE3OTI0NzZmYmIyMjVlNWQ5ZGVjODY5Zl80Ni9mcmFnOjE0YjkzMDBhMzZkNDQ1OTdhZGI5NzM0MDBlZTk5ZjYwL3RhYmxlOmVlZTEyYWNiZmVjNjQwYmI4MGRlN2ZjYzBiN2Y5NWRkL3RhYmxlcmFuZ2U6ZWVlMTJhY2JmZWM2NDBiYjgwZGU3ZmNjMGI3Zjk1ZGRfMy03LTEtMS04NjQ_38070c6b-9f57-43dc-b7d7-a6c4925cf809">1,072</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1cd84431f8574b82a2e542790c822e83_I20200630" decimals="-3" sign="-" format="ixt:numdotdecimal" name="us-gaap:FairValueNetDerivativeAssetLiabilityMeasuredOnRecurringBasisWithUnobservableInputs" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzY2E5YmIwMTc5MjQ3NmZiYjIyNWU1ZDlkZWM4NjlmL3NlYzo5M2NhOWJiMDE3OTI0NzZmYmIyMjVlNWQ5ZGVjODY5Zl80Ni9mcmFnOjE0YjkzMDBhMzZkNDQ1OTdhZGI5NzM0MDBlZTk5ZjYwL3RhYmxlOmVlZTEyYWNiZmVjNjQwYmI4MGRlN2ZjYzBiN2Y5NWRkL3RhYmxlcmFuZ2U6ZWVlMTJhY2JmZWM2NDBiYjgwZGU3ZmNjMGI3Zjk1ZGRfMy05LTEtMS04Njc_b639a704-2833-4e7e-8944-e7e34ca4ef3f">23,576</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3c0f68bcd0b6498c90c48a6506a0b9e3_I20200331" decimals="-3" sign="-" format="ixt:numdotdecimal" name="us-gaap:FairValueNetDerivativeAssetLiabilityMeasuredOnRecurringBasisWithUnobservableInputs" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzY2E5YmIwMTc5MjQ3NmZiYjIyNWU1ZDlkZWM4NjlmL3NlYzo5M2NhOWJiMDE3OTI0NzZmYmIyMjVlNWQ5ZGVjODY5Zl80Ni9mcmFnOjE0YjkzMDBhMzZkNDQ1OTdhZGI5NzM0MDBlZTk5ZjYwL3RhYmxlOmVlZTEyYWNiZmVjNjQwYmI4MGRlN2ZjYzBiN2Y5NWRkL3RhYmxlcmFuZ2U6ZWVlMTJhY2JmZWM2NDBiYjgwZGU3ZmNjMGI3Zjk1ZGRfNC0xLTEtMS04NTQ_df56adb0-3518-42a0-9d7c-4bc2712db324">165,449</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i39065c5daf934af885335c12f3cfa83f_D20200401-20200630" decimals="-3" sign="-" format="ixt:numdotdecimal" name="us-gaap:FairValueNetDerivativeAssetLiabilityMeasuredOnRecurringBasisUnobservableInputsReconciliationGainLossIncludedInEarnings" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzY2E5YmIwMTc5MjQ3NmZiYjIyNWU1ZDlkZWM4NjlmL3NlYzo5M2NhOWJiMDE3OTI0NzZmYmIyMjVlNWQ5ZGVjODY5Zl80Ni9mcmFnOjE0YjkzMDBhMzZkNDQ1OTdhZGI5NzM0MDBlZTk5ZjYwL3RhYmxlOmVlZTEyYWNiZmVjNjQwYmI4MGRlN2ZjYzBiN2Y5NWRkL3RhYmxlcmFuZ2U6ZWVlMTJhY2JmZWM2NDBiYjgwZGU3ZmNjMGI3Zjk1ZGRfNC0zLTEtMS04NTg_f2dddc31-5e3b-43ce-b424-544f44576562">35,880</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i39065c5daf934af885335c12f3cfa83f_D20200401-20200630" decimals="-3" name="us-gaap:FairValueNetDerivativeAssetLiabilityMeasuredOnRecurringBasisUnobservableInputsReconciliationSettlements" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzY2E5YmIwMTc5MjQ3NmZiYjIyNWU1ZDlkZWM4NjlmL3NlYzo5M2NhOWJiMDE3OTI0NzZmYmIyMjVlNWQ5ZGVjODY5Zl80Ni9mcmFnOjE0YjkzMDBhMzZkNDQ1OTdhZGI5NzM0MDBlZTk5ZjYwL3RhYmxlOmVlZTEyYWNiZmVjNjQwYmI4MGRlN2ZjYzBiN2Y5NWRkL3RhYmxlcmFuZ2U6ZWVlMTJhY2JmZWM2NDBiYjgwZGU3ZmNjMGI3Zjk1ZGRfNC01LTEtMS04NjE_eee83a8a-1c18-45c9-8a95-e7d7482aed77">727</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i39065c5daf934af885335c12f3cfa83f_D20200401-20200630" decimals="-3" sign="-" format="ixt:numdotdecimal" name="us-gaap:FairValueNetDerivativeAssetLiabilityMeasuredOnRecurringBasisUnobservableInputsReconciliationGainLossIncludedInOtherComprehensiveIncomeLoss" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzY2E5YmIwMTc5MjQ3NmZiYjIyNWU1ZDlkZWM4NjlmL3NlYzo5M2NhOWJiMDE3OTI0NzZmYmIyMjVlNWQ5ZGVjODY5Zl80Ni9mcmFnOjE0YjkzMDBhMzZkNDQ1OTdhZGI5NzM0MDBlZTk5ZjYwL3RhYmxlOmVlZTEyYWNiZmVjNjQwYmI4MGRlN2ZjYzBiN2Y5NWRkL3RhYmxlcmFuZ2U6ZWVlMTJhY2JmZWM2NDBiYjgwZGU3ZmNjMGI3Zjk1ZGRfNC03LTEtMS04NjQ_d4b2bf50-5ee8-43e5-b1ab-78e11ace99dd">5,112</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id670dc9b33e6430f9d7510009f7495a7_I20200630" decimals="-3" sign="-" format="ixt:numdotdecimal" name="us-gaap:FairValueNetDerivativeAssetLiabilityMeasuredOnRecurringBasisWithUnobservableInputs" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzY2E5YmIwMTc5MjQ3NmZiYjIyNWU1ZDlkZWM4NjlmL3NlYzo5M2NhOWJiMDE3OTI0NzZmYmIyMjVlNWQ5ZGVjODY5Zl80Ni9mcmFnOjE0YjkzMDBhMzZkNDQ1OTdhZGI5NzM0MDBlZTk5ZjYwL3RhYmxlOmVlZTEyYWNiZmVjNjQwYmI4MGRlN2ZjYzBiN2Y5NWRkL3RhYmxlcmFuZ2U6ZWVlMTJhY2JmZWM2NDBiYjgwZGU3ZmNjMGI3Zjk1ZGRfNC05LTEtMS04Njc_245d6b9f-eb46-451d-9e9f-5ab6597d5abb">205,714</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td></tr></table></div><div style="margin-bottom:6pt;margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">A reconciliation of the carrying amounts of the derivative liability for the six months ended June&#160;30, 2021 and 2020:</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:18.483%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.761%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.911%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:14.316%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.911%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.761%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.911%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:14.872%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.911%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.763%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">As of January 1, 2021</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Revaluation loss/(gain)</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Exercise of rights</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Foreign exchange effect</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">As of June 30, 2021</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(a) Altria Warrant</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i386ef852060640f8a03a30f10d03a1cd_I20201231" decimals="-3" sign="-" format="ixt:numdotdecimal" name="us-gaap:FairValueNetDerivativeAssetLiabilityMeasuredOnRecurringBasisWithUnobservableInputs" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzY2E5YmIwMTc5MjQ3NmZiYjIyNWU1ZDlkZWM4NjlmL3NlYzo5M2NhOWJiMDE3OTI0NzZmYmIyMjVlNWQ5ZGVjODY5Zl80Ni9mcmFnOjE0YjkzMDBhMzZkNDQ1OTdhZGI5NzM0MDBlZTk5ZjYwL3RhYmxlOjkyOGJiNDdkZjAzYzQyNjI4YWFkMjk1NDAwNTFhNjExL3RhYmxlcmFuZ2U6OTI4YmI0N2RmMDNjNDI2MjhhYWQyOTU0MDA1MWE2MTFfMS0xLTEtMS05MDc_638aec61-af97-483b-8f63-f22ed09094be">138,858</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i45890500f835452a848efa1f84799c48_D20210101-20210630" decimals="-3" sign="-" format="ixt:numdotdecimal" name="us-gaap:FairValueNetDerivativeAssetLiabilityMeasuredOnRecurringBasisUnobservableInputsReconciliationGainLossIncludedInEarnings" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzY2E5YmIwMTc5MjQ3NmZiYjIyNWU1ZDlkZWM4NjlmL3NlYzo5M2NhOWJiMDE3OTI0NzZmYmIyMjVlNWQ5ZGVjODY5Zl80Ni9mcmFnOjE0YjkzMDBhMzZkNDQ1OTdhZGI5NzM0MDBlZTk5ZjYwL3RhYmxlOjkyOGJiNDdkZjAzYzQyNjI4YWFkMjk1NDAwNTFhNjExL3RhYmxlcmFuZ2U6OTI4YmI0N2RmMDNjNDI2MjhhYWQyOTU0MDA1MWE2MTFfMS0zLTEtMS05MjM_11eca65c-e03d-47c6-a1e4-51e5fa1dd34c">7,186</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i45890500f835452a848efa1f84799c48_D20210101-20210630" decimals="-3" format="ixt:zerodash" name="us-gaap:FairValueNetDerivativeAssetLiabilityMeasuredOnRecurringBasisUnobservableInputsReconciliationSettlements" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzY2E5YmIwMTc5MjQ3NmZiYjIyNWU1ZDlkZWM4NjlmL3NlYzo5M2NhOWJiMDE3OTI0NzZmYmIyMjVlNWQ5ZGVjODY5Zl80Ni9mcmFnOjE0YjkzMDBhMzZkNDQ1OTdhZGI5NzM0MDBlZTk5ZjYwL3RhYmxlOjkyOGJiNDdkZjAzYzQyNjI4YWFkMjk1NDAwNTFhNjExL3RhYmxlcmFuZ2U6OTI4YmI0N2RmMDNjNDI2MjhhYWQyOTU0MDA1MWE2MTFfMS01LTEtMS05Mzg_72dd1203-71f1-44e0-9404-fdcc4385c479">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i45890500f835452a848efa1f84799c48_D20210101-20210630" decimals="-3" sign="-" format="ixt:numdotdecimal" name="us-gaap:FairValueNetDerivativeAssetLiabilityMeasuredOnRecurringBasisUnobservableInputsReconciliationGainLossIncludedInOtherComprehensiveIncomeLoss" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzY2E5YmIwMTc5MjQ3NmZiYjIyNWU1ZDlkZWM4NjlmL3NlYzo5M2NhOWJiMDE3OTI0NzZmYmIyMjVlNWQ5ZGVjODY5Zl80Ni9mcmFnOjE0YjkzMDBhMzZkNDQ1OTdhZGI5NzM0MDBlZTk5ZjYwL3RhYmxlOjkyOGJiNDdkZjAzYzQyNjI4YWFkMjk1NDAwNTFhNjExL3RhYmxlcmFuZ2U6OTI4YmI0N2RmMDNjNDI2MjhhYWQyOTU0MDA1MWE2MTFfMS03LTEtMS05NDI_8cb8271f-c15a-4a9a-b66b-865dcf78ba8b">4,039</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i34995f47e8ba418fbd529b2ed52790dc_I20210630" decimals="-3" sign="-" format="ixt:numdotdecimal" name="us-gaap:FairValueNetDerivativeAssetLiabilityMeasuredOnRecurringBasisWithUnobservableInputs" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzY2E5YmIwMTc5MjQ3NmZiYjIyNWU1ZDlkZWM4NjlmL3NlYzo5M2NhOWJiMDE3OTI0NzZmYmIyMjVlNWQ5ZGVjODY5Zl80Ni9mcmFnOjE0YjkzMDBhMzZkNDQ1OTdhZGI5NzM0MDBlZTk5ZjYwL3RhYmxlOjkyOGJiNDdkZjAzYzQyNjI4YWFkMjk1NDAwNTFhNjExL3RhYmxlcmFuZ2U6OTI4YmI0N2RmMDNjNDI2MjhhYWQyOTU0MDA1MWE2MTFfMS05LTEtMS05NDY_30381700-78a3-4f4e-9128-eb698829d686">150,083</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(b) Pre-emptive Rights</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i72ce1ade65834a50bf4468cde26bf617_I20201231" decimals="-3" sign="-" format="ixt:numdotdecimal" name="us-gaap:FairValueNetDerivativeAssetLiabilityMeasuredOnRecurringBasisWithUnobservableInputs" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzY2E5YmIwMTc5MjQ3NmZiYjIyNWU1ZDlkZWM4NjlmL3NlYzo5M2NhOWJiMDE3OTI0NzZmYmIyMjVlNWQ5ZGVjODY5Zl80Ni9mcmFnOjE0YjkzMDBhMzZkNDQ1OTdhZGI5NzM0MDBlZTk5ZjYwL3RhYmxlOjkyOGJiNDdkZjAzYzQyNjI4YWFkMjk1NDAwNTFhNjExL3RhYmxlcmFuZ2U6OTI4YmI0N2RmMDNjNDI2MjhhYWQyOTU0MDA1MWE2MTFfMi0xLTEtMS05MDc_a3de5b4e-78e5-41c5-b7ef-ccd3151a0676">12,095</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i94f8ae36db664c2bbb298d6c3f5792c3_D20210101-20210630" decimals="-3" sign="-" format="ixt:numdotdecimal" name="us-gaap:FairValueNetDerivativeAssetLiabilityMeasuredOnRecurringBasisUnobservableInputsReconciliationGainLossIncludedInEarnings" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzY2E5YmIwMTc5MjQ3NmZiYjIyNWU1ZDlkZWM4NjlmL3NlYzo5M2NhOWJiMDE3OTI0NzZmYmIyMjVlNWQ5ZGVjODY5Zl80Ni9mcmFnOjE0YjkzMDBhMzZkNDQ1OTdhZGI5NzM0MDBlZTk5ZjYwL3RhYmxlOjkyOGJiNDdkZjAzYzQyNjI4YWFkMjk1NDAwNTFhNjExL3RhYmxlcmFuZ2U6OTI4YmI0N2RmMDNjNDI2MjhhYWQyOTU0MDA1MWE2MTFfMi0zLTEtMS05MjM_06eba498-3388-42ba-98ad-028a4e4bb64f">1,473</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i94f8ae36db664c2bbb298d6c3f5792c3_D20210101-20210630" decimals="-3" format="ixt:zerodash" name="us-gaap:FairValueNetDerivativeAssetLiabilityMeasuredOnRecurringBasisUnobservableInputsReconciliationSettlements" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzY2E5YmIwMTc5MjQ3NmZiYjIyNWU1ZDlkZWM4NjlmL3NlYzo5M2NhOWJiMDE3OTI0NzZmYmIyMjVlNWQ5ZGVjODY5Zl80Ni9mcmFnOjE0YjkzMDBhMzZkNDQ1OTdhZGI5NzM0MDBlZTk5ZjYwL3RhYmxlOjkyOGJiNDdkZjAzYzQyNjI4YWFkMjk1NDAwNTFhNjExL3RhYmxlcmFuZ2U6OTI4YmI0N2RmMDNjNDI2MjhhYWQyOTU0MDA1MWE2MTFfMi01LTEtMS05Mzg_12d4d415-9df0-465e-979b-f17201dee517">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i94f8ae36db664c2bbb298d6c3f5792c3_D20210101-20210630" decimals="-3" sign="-" name="us-gaap:FairValueNetDerivativeAssetLiabilityMeasuredOnRecurringBasisUnobservableInputsReconciliationGainLossIncludedInOtherComprehensiveIncomeLoss" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzY2E5YmIwMTc5MjQ3NmZiYjIyNWU1ZDlkZWM4NjlmL3NlYzo5M2NhOWJiMDE3OTI0NzZmYmIyMjVlNWQ5ZGVjODY5Zl80Ni9mcmFnOjE0YjkzMDBhMzZkNDQ1OTdhZGI5NzM0MDBlZTk5ZjYwL3RhYmxlOjkyOGJiNDdkZjAzYzQyNjI4YWFkMjk1NDAwNTFhNjExL3RhYmxlcmFuZ2U6OTI4YmI0N2RmMDNjNDI2MjhhYWQyOTU0MDA1MWE2MTFfMi03LTEtMS05NDI_7bea7996-7cc3-4206-b120-dfe029c4c555">358</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie4ec3b642b3b4457b78cb85e8d1838f0_I20210630" decimals="-3" sign="-" format="ixt:numdotdecimal" name="us-gaap:FairValueNetDerivativeAssetLiabilityMeasuredOnRecurringBasisWithUnobservableInputs" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzY2E5YmIwMTc5MjQ3NmZiYjIyNWU1ZDlkZWM4NjlmL3NlYzo5M2NhOWJiMDE3OTI0NzZmYmIyMjVlNWQ5ZGVjODY5Zl80Ni9mcmFnOjE0YjkzMDBhMzZkNDQ1OTdhZGI5NzM0MDBlZTk5ZjYwL3RhYmxlOjkyOGJiNDdkZjAzYzQyNjI4YWFkMjk1NDAwNTFhNjExL3RhYmxlcmFuZ2U6OTI4YmI0N2RmMDNjNDI2MjhhYWQyOTU0MDA1MWE2MTFfMi05LTEtMS05NDY_220643c5-a51f-46ad-84a5-a2d8463f5786">13,926</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(c) Top-up Rights</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if0aa3f5449da461c85f0c0831bf3c984_I20201231" decimals="-3" sign="-" format="ixt:numdotdecimal" name="us-gaap:FairValueNetDerivativeAssetLiabilityMeasuredOnRecurringBasisWithUnobservableInputs" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzY2E5YmIwMTc5MjQ3NmZiYjIyNWU1ZDlkZWM4NjlmL3NlYzo5M2NhOWJiMDE3OTI0NzZmYmIyMjVlNWQ5ZGVjODY5Zl80Ni9mcmFnOjE0YjkzMDBhMzZkNDQ1OTdhZGI5NzM0MDBlZTk5ZjYwL3RhYmxlOjkyOGJiNDdkZjAzYzQyNjI4YWFkMjk1NDAwNTFhNjExL3RhYmxlcmFuZ2U6OTI4YmI0N2RmMDNjNDI2MjhhYWQyOTU0MDA1MWE2MTFfMy0xLTEtMS05MDc_cdfc7d19-bb69-446b-9bf2-38265adf66cd">12,457</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i10b0581e8a9b40e0a1e14e14bcc22d54_D20210101-20210630" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:FairValueNetDerivativeAssetLiabilityMeasuredOnRecurringBasisUnobservableInputsReconciliationGainLossIncludedInEarnings" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzY2E5YmIwMTc5MjQ3NmZiYjIyNWU1ZDlkZWM4NjlmL3NlYzo5M2NhOWJiMDE3OTI0NzZmYmIyMjVlNWQ5ZGVjODY5Zl80Ni9mcmFnOjE0YjkzMDBhMzZkNDQ1OTdhZGI5NzM0MDBlZTk5ZjYwL3RhYmxlOjkyOGJiNDdkZjAzYzQyNjI4YWFkMjk1NDAwNTFhNjExL3RhYmxlcmFuZ2U6OTI4YmI0N2RmMDNjNDI2MjhhYWQyOTU0MDA1MWE2MTFfMy0zLTEtMS05MjM_29485a9b-c06c-4c4a-b666-626e5eba4767">7,033</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i10b0581e8a9b40e0a1e14e14bcc22d54_D20210101-20210630" decimals="-3" format="ixt:zerodash" name="us-gaap:FairValueNetDerivativeAssetLiabilityMeasuredOnRecurringBasisUnobservableInputsReconciliationSettlements" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzY2E5YmIwMTc5MjQ3NmZiYjIyNWU1ZDlkZWM4NjlmL3NlYzo5M2NhOWJiMDE3OTI0NzZmYmIyMjVlNWQ5ZGVjODY5Zl80Ni9mcmFnOjE0YjkzMDBhMzZkNDQ1OTdhZGI5NzM0MDBlZTk5ZjYwL3RhYmxlOjkyOGJiNDdkZjAzYzQyNjI4YWFkMjk1NDAwNTFhNjExL3RhYmxlcmFuZ2U6OTI4YmI0N2RmMDNjNDI2MjhhYWQyOTU0MDA1MWE2MTFfMy01LTEtMS05Mzg_2e8f2730-8b39-4208-ae80-262fa76819a6">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i10b0581e8a9b40e0a1e14e14bcc22d54_D20210101-20210630" decimals="-3" sign="-" name="us-gaap:FairValueNetDerivativeAssetLiabilityMeasuredOnRecurringBasisUnobservableInputsReconciliationGainLossIncludedInOtherComprehensiveIncomeLoss" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzY2E5YmIwMTc5MjQ3NmZiYjIyNWU1ZDlkZWM4NjlmL3NlYzo5M2NhOWJiMDE3OTI0NzZmYmIyMjVlNWQ5ZGVjODY5Zl80Ni9mcmFnOjE0YjkzMDBhMzZkNDQ1OTdhZGI5NzM0MDBlZTk5ZjYwL3RhYmxlOjkyOGJiNDdkZjAzYzQyNjI4YWFkMjk1NDAwNTFhNjExL3RhYmxlcmFuZ2U6OTI4YmI0N2RmMDNjNDI2MjhhYWQyOTU0MDA1MWE2MTFfMy03LTEtMS05NDI_a09acc68-320a-4d4d-8db0-d54488a6329d">130</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia2cd5cb93e97428dabd7e841eee51895_I20210630" decimals="-3" sign="-" format="ixt:numdotdecimal" name="us-gaap:FairValueNetDerivativeAssetLiabilityMeasuredOnRecurringBasisWithUnobservableInputs" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzY2E5YmIwMTc5MjQ3NmZiYjIyNWU1ZDlkZWM4NjlmL3NlYzo5M2NhOWJiMDE3OTI0NzZmYmIyMjVlNWQ5ZGVjODY5Zl80Ni9mcmFnOjE0YjkzMDBhMzZkNDQ1OTdhZGI5NzM0MDBlZTk5ZjYwL3RhYmxlOjkyOGJiNDdkZjAzYzQyNjI4YWFkMjk1NDAwNTFhNjExL3RhYmxlcmFuZ2U6OTI4YmI0N2RmMDNjNDI2MjhhYWQyOTU0MDA1MWE2MTFfMy05LTEtMS05NDY_34f9d373-a301-49f9-a8ce-97624a701828">5,554</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ifbe16ec51ea244519b77d6036b4ef038_I20201231" decimals="-3" sign="-" format="ixt:numdotdecimal" name="us-gaap:FairValueNetDerivativeAssetLiabilityMeasuredOnRecurringBasisWithUnobservableInputs" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzY2E5YmIwMTc5MjQ3NmZiYjIyNWU1ZDlkZWM4NjlmL3NlYzo5M2NhOWJiMDE3OTI0NzZmYmIyMjVlNWQ5ZGVjODY5Zl80Ni9mcmFnOjE0YjkzMDBhMzZkNDQ1OTdhZGI5NzM0MDBlZTk5ZjYwL3RhYmxlOjkyOGJiNDdkZjAzYzQyNjI4YWFkMjk1NDAwNTFhNjExL3RhYmxlcmFuZ2U6OTI4YmI0N2RmMDNjNDI2MjhhYWQyOTU0MDA1MWE2MTFfNC0xLTEtMS05MDc_131fa8e0-7a7c-4141-ae59-e790e31c3b48">163,410</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i69782326f71a44e3805518280ee22b6b_D20210101-20210630" decimals="-3" sign="-" format="ixt:numdotdecimal" name="us-gaap:FairValueNetDerivativeAssetLiabilityMeasuredOnRecurringBasisUnobservableInputsReconciliationGainLossIncludedInEarnings" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzY2E5YmIwMTc5MjQ3NmZiYjIyNWU1ZDlkZWM4NjlmL3NlYzo5M2NhOWJiMDE3OTI0NzZmYmIyMjVlNWQ5ZGVjODY5Zl80Ni9mcmFnOjE0YjkzMDBhMzZkNDQ1OTdhZGI5NzM0MDBlZTk5ZjYwL3RhYmxlOjkyOGJiNDdkZjAzYzQyNjI4YWFkMjk1NDAwNTFhNjExL3RhYmxlcmFuZ2U6OTI4YmI0N2RmMDNjNDI2MjhhYWQyOTU0MDA1MWE2MTFfNC0zLTEtMS05MjM_3433f0dd-60c3-4a71-a90b-7aa4946a6bc8">1,626</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i69782326f71a44e3805518280ee22b6b_D20210101-20210630" decimals="-3" format="ixt:zerodash" name="us-gaap:FairValueNetDerivativeAssetLiabilityMeasuredOnRecurringBasisUnobservableInputsReconciliationSettlements" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzY2E5YmIwMTc5MjQ3NmZiYjIyNWU1ZDlkZWM4NjlmL3NlYzo5M2NhOWJiMDE3OTI0NzZmYmIyMjVlNWQ5ZGVjODY5Zl80Ni9mcmFnOjE0YjkzMDBhMzZkNDQ1OTdhZGI5NzM0MDBlZTk5ZjYwL3RhYmxlOjkyOGJiNDdkZjAzYzQyNjI4YWFkMjk1NDAwNTFhNjExL3RhYmxlcmFuZ2U6OTI4YmI0N2RmMDNjNDI2MjhhYWQyOTU0MDA1MWE2MTFfNC01LTEtMS05Mzg_cd3ba1fe-97cf-4e20-944c-8e6ef63a087e">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i69782326f71a44e3805518280ee22b6b_D20210101-20210630" decimals="-3" sign="-" format="ixt:numdotdecimal" name="us-gaap:FairValueNetDerivativeAssetLiabilityMeasuredOnRecurringBasisUnobservableInputsReconciliationGainLossIncludedInOtherComprehensiveIncomeLoss" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzY2E5YmIwMTc5MjQ3NmZiYjIyNWU1ZDlkZWM4NjlmL3NlYzo5M2NhOWJiMDE3OTI0NzZmYmIyMjVlNWQ5ZGVjODY5Zl80Ni9mcmFnOjE0YjkzMDBhMzZkNDQ1OTdhZGI5NzM0MDBlZTk5ZjYwL3RhYmxlOjkyOGJiNDdkZjAzYzQyNjI4YWFkMjk1NDAwNTFhNjExL3RhYmxlcmFuZ2U6OTI4YmI0N2RmMDNjNDI2MjhhYWQyOTU0MDA1MWE2MTFfNC03LTEtMS05NDI_7b60a4e3-6dbe-4f45-b67a-4112d9bd9d2e">4,527</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i225f85e38faa4bbdb4de1d8b9cf369bb_I20210630" decimals="-3" sign="-" format="ixt:numdotdecimal" name="us-gaap:FairValueNetDerivativeAssetLiabilityMeasuredOnRecurringBasisWithUnobservableInputs" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzY2E5YmIwMTc5MjQ3NmZiYjIyNWU1ZDlkZWM4NjlmL3NlYzo5M2NhOWJiMDE3OTI0NzZmYmIyMjVlNWQ5ZGVjODY5Zl80Ni9mcmFnOjE0YjkzMDBhMzZkNDQ1OTdhZGI5NzM0MDBlZTk5ZjYwL3RhYmxlOjkyOGJiNDdkZjAzYzQyNjI4YWFkMjk1NDAwNTFhNjExL3RhYmxlcmFuZ2U6OTI4YmI0N2RmMDNjNDI2MjhhYWQyOTU0MDA1MWE2MTFfNC05LTEtMS05NDY_6bb99e07-4903-45a4-8eba-d2c601c794c7">169,563</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td></tr></table></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:18.483%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.761%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.911%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:14.316%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.911%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.761%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.911%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:14.872%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.911%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.763%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">As of January 1, 2020</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Revaluation loss/(gain)</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Exercise of rights</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Foreign exchange effect</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">As of June&#160;30, 2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(a) Altria Warrant</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i006bb3bd444d41edb5d292ff7ec0668f_I20191231" decimals="-3" sign="-" format="ixt:numdotdecimal" name="us-gaap:FairValueNetDerivativeAssetLiabilityMeasuredOnRecurringBasisWithUnobservableInputs" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzY2E5YmIwMTc5MjQ3NmZiYjIyNWU1ZDlkZWM4NjlmL3NlYzo5M2NhOWJiMDE3OTI0NzZmYmIyMjVlNWQ5ZGVjODY5Zl80Ni9mcmFnOjE0YjkzMDBhMzZkNDQ1OTdhZGI5NzM0MDBlZTk5ZjYwL3RhYmxlOjhkZTMyYzc2NmZiNTRiOTJiNzE2NzE0NGY0YTI4NTcwL3RhYmxlcmFuZ2U6OGRlMzJjNzY2ZmI1NGI5MmI3MTY3MTQ0ZjRhMjg1NzBfMS0xLTEtMS0w_8a496581-7473-4151-8227-c38334bf146c">234,428</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i19c47df0e3634358808ebcc68facfcde_D20200101-20200630" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:FairValueNetDerivativeAssetLiabilityMeasuredOnRecurringBasisUnobservableInputsReconciliationGainLossIncludedInEarnings" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzY2E5YmIwMTc5MjQ3NmZiYjIyNWU1ZDlkZWM4NjlmL3NlYzo5M2NhOWJiMDE3OTI0NzZmYmIyMjVlNWQ5ZGVjODY5Zl80Ni9mcmFnOjE0YjkzMDBhMzZkNDQ1OTdhZGI5NzM0MDBlZTk5ZjYwL3RhYmxlOjhkZTMyYzc2NmZiNTRiOTJiNzE2NzE0NGY0YTI4NTcwL3RhYmxlcmFuZ2U6OGRlMzJjNzY2ZmI1NGI5MmI3MTY3MTQ0ZjRhMjg1NzBfMS0zLTEtMS0w_cefbb5d7-c3ec-4310-9598-6b36a81f1552">58,052</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i19c47df0e3634358808ebcc68facfcde_D20200101-20200630" decimals="-3" format="ixt:zerodash" name="us-gaap:FairValueNetDerivativeAssetLiabilityMeasuredOnRecurringBasisUnobservableInputsReconciliationSettlements" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzY2E5YmIwMTc5MjQ3NmZiYjIyNWU1ZDlkZWM4NjlmL3NlYzo5M2NhOWJiMDE3OTI0NzZmYmIyMjVlNWQ5ZGVjODY5Zl80Ni9mcmFnOjE0YjkzMDBhMzZkNDQ1OTdhZGI5NzM0MDBlZTk5ZjYwL3RhYmxlOjhkZTMyYzc2NmZiNTRiOTJiNzE2NzE0NGY0YTI4NTcwL3RhYmxlcmFuZ2U6OGRlMzJjNzY2ZmI1NGI5MmI3MTY3MTQ0ZjRhMjg1NzBfMS01LTEtMS0w_5b71d7d6-9305-4c07-9070-4ecd4007ad08">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i19c47df0e3634358808ebcc68facfcde_D20200101-20200630" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:FairValueNetDerivativeAssetLiabilityMeasuredOnRecurringBasisUnobservableInputsReconciliationGainLossIncludedInOtherComprehensiveIncomeLoss" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzY2E5YmIwMTc5MjQ3NmZiYjIyNWU1ZDlkZWM4NjlmL3NlYzo5M2NhOWJiMDE3OTI0NzZmYmIyMjVlNWQ5ZGVjODY5Zl80Ni9mcmFnOjE0YjkzMDBhMzZkNDQ1OTdhZGI5NzM0MDBlZTk5ZjYwL3RhYmxlOjhkZTMyYzc2NmZiNTRiOTJiNzE2NzE0NGY0YTI4NTcwL3RhYmxlcmFuZ2U6OGRlMzJjNzY2ZmI1NGI5MmI3MTY3MTQ0ZjRhMjg1NzBfMS03LTEtMS0w_5fb50549-34aa-4fcb-89aa-fa615c24f47a">10,418</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i69563d705edd465aabff3c895c85c313_I20200630" decimals="-3" sign="-" format="ixt:numdotdecimal" name="us-gaap:FairValueNetDerivativeAssetLiabilityMeasuredOnRecurringBasisWithUnobservableInputs" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzY2E5YmIwMTc5MjQ3NmZiYjIyNWU1ZDlkZWM4NjlmL3NlYzo5M2NhOWJiMDE3OTI0NzZmYmIyMjVlNWQ5ZGVjODY5Zl80Ni9mcmFnOjE0YjkzMDBhMzZkNDQ1OTdhZGI5NzM0MDBlZTk5ZjYwL3RhYmxlOjhkZTMyYzc2NmZiNTRiOTJiNzE2NzE0NGY0YTI4NTcwL3RhYmxlcmFuZ2U6OGRlMzJjNzY2ZmI1NGI5MmI3MTY3MTQ0ZjRhMjg1NzBfMS05LTEtMS0w_9fd7247b-aa02-493e-9e81-d66134dd90e3">165,958</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(b) Pre-emptive Rights</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id3abf03099174cf38da9a24a053a4f90_I20191231" decimals="-3" sign="-" format="ixt:numdotdecimal" name="us-gaap:FairValueNetDerivativeAssetLiabilityMeasuredOnRecurringBasisWithUnobservableInputs" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzY2E5YmIwMTc5MjQ3NmZiYjIyNWU1ZDlkZWM4NjlmL3NlYzo5M2NhOWJiMDE3OTI0NzZmYmIyMjVlNWQ5ZGVjODY5Zl80Ni9mcmFnOjE0YjkzMDBhMzZkNDQ1OTdhZGI5NzM0MDBlZTk5ZjYwL3RhYmxlOjhkZTMyYzc2NmZiNTRiOTJiNzE2NzE0NGY0YTI4NTcwL3RhYmxlcmFuZ2U6OGRlMzJjNzY2ZmI1NGI5MmI3MTY3MTQ0ZjRhMjg1NzBfMi0xLTEtMS0w_fd4af16f-f3be-4c8c-9d29-bf31d6d5d0d7">12,787</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="idc180b21ce4e4eefa7a1a4ccdb9ba7a9_D20200101-20200630" decimals="-3" sign="-" format="ixt:numdotdecimal" name="us-gaap:FairValueNetDerivativeAssetLiabilityMeasuredOnRecurringBasisUnobservableInputsReconciliationGainLossIncludedInEarnings" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzY2E5YmIwMTc5MjQ3NmZiYjIyNWU1ZDlkZWM4NjlmL3NlYzo5M2NhOWJiMDE3OTI0NzZmYmIyMjVlNWQ5ZGVjODY5Zl80Ni9mcmFnOjE0YjkzMDBhMzZkNDQ1OTdhZGI5NzM0MDBlZTk5ZjYwL3RhYmxlOjhkZTMyYzc2NmZiNTRiOTJiNzE2NzE0NGY0YTI4NTcwL3RhYmxlcmFuZ2U6OGRlMzJjNzY2ZmI1NGI5MmI3MTY3MTQ0ZjRhMjg1NzBfMi0zLTEtMS0w_9b40bba1-a001-482d-ae4b-47b2d51a7df5">3,925</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="idc180b21ce4e4eefa7a1a4ccdb9ba7a9_D20200101-20200630" decimals="-3" format="ixt:zerodash" name="us-gaap:FairValueNetDerivativeAssetLiabilityMeasuredOnRecurringBasisUnobservableInputsReconciliationSettlements" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzY2E5YmIwMTc5MjQ3NmZiYjIyNWU1ZDlkZWM4NjlmL3NlYzo5M2NhOWJiMDE3OTI0NzZmYmIyMjVlNWQ5ZGVjODY5Zl80Ni9mcmFnOjE0YjkzMDBhMzZkNDQ1OTdhZGI5NzM0MDBlZTk5ZjYwL3RhYmxlOjhkZTMyYzc2NmZiNTRiOTJiNzE2NzE0NGY0YTI4NTcwL3RhYmxlcmFuZ2U6OGRlMzJjNzY2ZmI1NGI5MmI3MTY3MTQ0ZjRhMjg1NzBfMi01LTEtMS0w_47aae470-94bc-488a-9926-7006ff130dd3">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="idc180b21ce4e4eefa7a1a4ccdb9ba7a9_D20200101-20200630" decimals="-3" name="us-gaap:FairValueNetDerivativeAssetLiabilityMeasuredOnRecurringBasisUnobservableInputsReconciliationGainLossIncludedInOtherComprehensiveIncomeLoss" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzY2E5YmIwMTc5MjQ3NmZiYjIyNWU1ZDlkZWM4NjlmL3NlYzo5M2NhOWJiMDE3OTI0NzZmYmIyMjVlNWQ5ZGVjODY5Zl80Ni9mcmFnOjE0YjkzMDBhMzZkNDQ1OTdhZGI5NzM0MDBlZTk5ZjYwL3RhYmxlOjhkZTMyYzc2NmZiNTRiOTJiNzE2NzE0NGY0YTI4NTcwL3RhYmxlcmFuZ2U6OGRlMzJjNzY2ZmI1NGI5MmI3MTY3MTQ0ZjRhMjg1NzBfMi03LTEtMS0w_95007e1e-030e-48f0-90b2-4ff8d383c01c">532</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i08475478dc1e46759179fb5a161607ba_I20200630" decimals="-3" sign="-" format="ixt:numdotdecimal" name="us-gaap:FairValueNetDerivativeAssetLiabilityMeasuredOnRecurringBasisWithUnobservableInputs" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzY2E5YmIwMTc5MjQ3NmZiYjIyNWU1ZDlkZWM4NjlmL3NlYzo5M2NhOWJiMDE3OTI0NzZmYmIyMjVlNWQ5ZGVjODY5Zl80Ni9mcmFnOjE0YjkzMDBhMzZkNDQ1OTdhZGI5NzM0MDBlZTk5ZjYwL3RhYmxlOjhkZTMyYzc2NmZiNTRiOTJiNzE2NzE0NGY0YTI4NTcwL3RhYmxlcmFuZ2U6OGRlMzJjNzY2ZmI1NGI5MmI3MTY3MTQ0ZjRhMjg1NzBfMi05LTEtMS0w_104e3f72-dc17-4feb-85a7-c5075bea9212">16,180</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(c) Top-up Rights</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4edcd0f0354740008d30a06bac0ea0bb_I20191231" decimals="-3" sign="-" format="ixt:numdotdecimal" name="us-gaap:FairValueNetDerivativeAssetLiabilityMeasuredOnRecurringBasisWithUnobservableInputs" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzY2E5YmIwMTc5MjQ3NmZiYjIyNWU1ZDlkZWM4NjlmL3NlYzo5M2NhOWJiMDE3OTI0NzZmYmIyMjVlNWQ5ZGVjODY5Zl80Ni9mcmFnOjE0YjkzMDBhMzZkNDQ1OTdhZGI5NzM0MDBlZTk5ZjYwL3RhYmxlOjhkZTMyYzc2NmZiNTRiOTJiNzE2NzE0NGY0YTI4NTcwL3RhYmxlcmFuZ2U6OGRlMzJjNzY2ZmI1NGI5MmI3MTY3MTQ0ZjRhMjg1NzBfMy0xLTEtMS0w_03ef05c0-a14b-4299-b554-1e037adf2b8a">49,945</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ia9cf8032e9f7433cb50aee032c5b988b_D20200101-20200630" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:FairValueNetDerivativeAssetLiabilityMeasuredOnRecurringBasisUnobservableInputsReconciliationGainLossIncludedInEarnings" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzY2E5YmIwMTc5MjQ3NmZiYjIyNWU1ZDlkZWM4NjlmL3NlYzo5M2NhOWJiMDE3OTI0NzZmYmIyMjVlNWQ5ZGVjODY5Zl80Ni9mcmFnOjE0YjkzMDBhMzZkNDQ1OTdhZGI5NzM0MDBlZTk5ZjYwL3RhYmxlOjhkZTMyYzc2NmZiNTRiOTJiNzE2NzE0NGY0YTI4NTcwL3RhYmxlcmFuZ2U6OGRlMzJjNzY2ZmI1NGI5MmI3MTY3MTQ0ZjRhMjg1NzBfMy0zLTEtMS0w_8c79d1fb-2252-417b-a84b-c71345b4c816">23,361</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ia9cf8032e9f7433cb50aee032c5b988b_D20200101-20200630" decimals="-3" name="us-gaap:FairValueNetDerivativeAssetLiabilityMeasuredOnRecurringBasisUnobservableInputsReconciliationSettlements" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzY2E5YmIwMTc5MjQ3NmZiYjIyNWU1ZDlkZWM4NjlmL3NlYzo5M2NhOWJiMDE3OTI0NzZmYmIyMjVlNWQ5ZGVjODY5Zl80Ni9mcmFnOjE0YjkzMDBhMzZkNDQ1OTdhZGI5NzM0MDBlZTk5ZjYwL3RhYmxlOjhkZTMyYzc2NmZiNTRiOTJiNzE2NzE0NGY0YTI4NTcwL3RhYmxlcmFuZ2U6OGRlMzJjNzY2ZmI1NGI5MmI3MTY3MTQ0ZjRhMjg1NzBfMy01LTEtMS0w_a16af34e-f553-4129-87af-a7d95565c245">727</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ia9cf8032e9f7433cb50aee032c5b988b_D20200101-20200630" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:FairValueNetDerivativeAssetLiabilityMeasuredOnRecurringBasisUnobservableInputsReconciliationGainLossIncludedInOtherComprehensiveIncomeLoss" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzY2E5YmIwMTc5MjQ3NmZiYjIyNWU1ZDlkZWM4NjlmL3NlYzo5M2NhOWJiMDE3OTI0NzZmYmIyMjVlNWQ5ZGVjODY5Zl80Ni9mcmFnOjE0YjkzMDBhMzZkNDQ1OTdhZGI5NzM0MDBlZTk5ZjYwL3RhYmxlOjhkZTMyYzc2NmZiNTRiOTJiNzE2NzE0NGY0YTI4NTcwL3RhYmxlcmFuZ2U6OGRlMzJjNzY2ZmI1NGI5MmI3MTY3MTQ0ZjRhMjg1NzBfMy03LTEtMS0w_c2ffae57-d160-4ae0-b19a-7eb7d7317f57">2,281</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1cd84431f8574b82a2e542790c822e83_I20200630" decimals="-3" sign="-" format="ixt:numdotdecimal" name="us-gaap:FairValueNetDerivativeAssetLiabilityMeasuredOnRecurringBasisWithUnobservableInputs" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzY2E5YmIwMTc5MjQ3NmZiYjIyNWU1ZDlkZWM4NjlmL3NlYzo5M2NhOWJiMDE3OTI0NzZmYmIyMjVlNWQ5ZGVjODY5Zl80Ni9mcmFnOjE0YjkzMDBhMzZkNDQ1OTdhZGI5NzM0MDBlZTk5ZjYwL3RhYmxlOjhkZTMyYzc2NmZiNTRiOTJiNzE2NzE0NGY0YTI4NTcwL3RhYmxlcmFuZ2U6OGRlMzJjNzY2ZmI1NGI5MmI3MTY3MTQ0ZjRhMjg1NzBfMy05LTEtMS0w_a2705e9f-a2eb-4502-b2be-2d5c3479bb69">23,576</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie4fc90ad6d7f4d39aea9cb65c8026e09_I20191231" decimals="-3" sign="-" format="ixt:numdotdecimal" name="us-gaap:FairValueNetDerivativeAssetLiabilityMeasuredOnRecurringBasisWithUnobservableInputs" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzY2E5YmIwMTc5MjQ3NmZiYjIyNWU1ZDlkZWM4NjlmL3NlYzo5M2NhOWJiMDE3OTI0NzZmYmIyMjVlNWQ5ZGVjODY5Zl80Ni9mcmFnOjE0YjkzMDBhMzZkNDQ1OTdhZGI5NzM0MDBlZTk5ZjYwL3RhYmxlOjhkZTMyYzc2NmZiNTRiOTJiNzE2NzE0NGY0YTI4NTcwL3RhYmxlcmFuZ2U6OGRlMzJjNzY2ZmI1NGI5MmI3MTY3MTQ0ZjRhMjg1NzBfNC0xLTEtMS0w_5eb20162-5ace-47a6-9653-d9b03d99af66">297,160</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i4a110e4972ef4113880ce582e3cda5c5_D20200101-20200630" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:FairValueNetDerivativeAssetLiabilityMeasuredOnRecurringBasisUnobservableInputsReconciliationGainLossIncludedInEarnings" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzY2E5YmIwMTc5MjQ3NmZiYjIyNWU1ZDlkZWM4NjlmL3NlYzo5M2NhOWJiMDE3OTI0NzZmYmIyMjVlNWQ5ZGVjODY5Zl80Ni9mcmFnOjE0YjkzMDBhMzZkNDQ1OTdhZGI5NzM0MDBlZTk5ZjYwL3RhYmxlOjhkZTMyYzc2NmZiNTRiOTJiNzE2NzE0NGY0YTI4NTcwL3RhYmxlcmFuZ2U6OGRlMzJjNzY2ZmI1NGI5MmI3MTY3MTQ0ZjRhMjg1NzBfNC0zLTEtMS0w_9430cb60-c922-4e02-8d21-e4167a4c442a">77,488</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i4a110e4972ef4113880ce582e3cda5c5_D20200101-20200630" decimals="-3" name="us-gaap:FairValueNetDerivativeAssetLiabilityMeasuredOnRecurringBasisUnobservableInputsReconciliationSettlements" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzY2E5YmIwMTc5MjQ3NmZiYjIyNWU1ZDlkZWM4NjlmL3NlYzo5M2NhOWJiMDE3OTI0NzZmYmIyMjVlNWQ5ZGVjODY5Zl80Ni9mcmFnOjE0YjkzMDBhMzZkNDQ1OTdhZGI5NzM0MDBlZTk5ZjYwL3RhYmxlOjhkZTMyYzc2NmZiNTRiOTJiNzE2NzE0NGY0YTI4NTcwL3RhYmxlcmFuZ2U6OGRlMzJjNzY2ZmI1NGI5MmI3MTY3MTQ0ZjRhMjg1NzBfNC01LTEtMS0w_73a3fb63-6c6f-4baf-a945-3d82fc8b5add">727</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i4a110e4972ef4113880ce582e3cda5c5_D20200101-20200630" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:FairValueNetDerivativeAssetLiabilityMeasuredOnRecurringBasisUnobservableInputsReconciliationGainLossIncludedInOtherComprehensiveIncomeLoss" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzY2E5YmIwMTc5MjQ3NmZiYjIyNWU1ZDlkZWM4NjlmL3NlYzo5M2NhOWJiMDE3OTI0NzZmYmIyMjVlNWQ5ZGVjODY5Zl80Ni9mcmFnOjE0YjkzMDBhMzZkNDQ1OTdhZGI5NzM0MDBlZTk5ZjYwL3RhYmxlOjhkZTMyYzc2NmZiNTRiOTJiNzE2NzE0NGY0YTI4NTcwL3RhYmxlcmFuZ2U6OGRlMzJjNzY2ZmI1NGI5MmI3MTY3MTQ0ZjRhMjg1NzBfNC03LTEtMS0w_660264a5-4817-460c-b5d8-59cc28a7004d">13,231</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id670dc9b33e6430f9d7510009f7495a7_I20200630" decimals="-3" sign="-" format="ixt:numdotdecimal" name="us-gaap:FairValueNetDerivativeAssetLiabilityMeasuredOnRecurringBasisWithUnobservableInputs" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzY2E5YmIwMTc5MjQ3NmZiYjIyNWU1ZDlkZWM4NjlmL3NlYzo5M2NhOWJiMDE3OTI0NzZmYmIyMjVlNWQ5ZGVjODY5Zl80Ni9mcmFnOjE0YjkzMDBhMzZkNDQ1OTdhZGI5NzM0MDBlZTk5ZjYwL3RhYmxlOjhkZTMyYzc2NmZiNTRiOTJiNzE2NzE0NGY0YTI4NTcwL3RhYmxlcmFuZ2U6OGRlMzJjNzY2ZmI1NGI5MmI3MTY3MTQ0ZjRhMjg1NzBfNC05LTEtMS0w_f3eea383-10b5-4f64-8d44-07c64831f806">205,714</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td></tr></table></div></ix:nonNumeric><div style="margin-bottom:12pt;margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Fluctuations in the Company&#8217;s share price are a primary driver for the changes in the derivative valuations during each reporting period. As the share price decreases for each of the related derivative instruments, the liability of the instrument generally decreases. Share price is one of the significant observable inputs used in the fair value measurement of each of the Company&#8217;s derivative instruments. During the three months ended June&#160;30, 2021, the Company&#8217;s share price decreased from April 1, 2021 and we recorded an out-of-period adjustment of $<ix:nonFraction unitRef="usd" contextRef="i27f4e53b91ad4367b7f8d273eff27769_D20210401-20210630" decimals="-3" sign="-" format="ixt:numdotdecimal" name="cron:FairValueNetDerivativeAssetLiabilityMeasuredOnRecurringBasisUnobservableInputsReconciliationOutOfPeriodAdjustment" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzY2E5YmIwMTc5MjQ3NmZiYjIyNWU1ZDlkZWM4NjlmL3NlYzo5M2NhOWJiMDE3OTI0NzZmYmIyMjVlNWQ5ZGVjODY5Zl80Ni9mcmFnOjE0YjkzMDBhMzZkNDQ1OTdhZGI5NzM0MDBlZTk5ZjYwL3RleHRyZWdpb246MTRiOTMwMGEzNmQ0NDU5N2FkYjk3MzQwMGVlOTlmNjBfOTg5NTYwNDY2ODk2NA_8f941f88-90e8-4c77-84e3-90e44fcbb743">11,278</ix:nonFraction>. See Note 1. Background, Basis of Presentation and Accounting Policies for more information on the out-of-period adjustment.</span></div></ix:continuation><div style="height:36pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">14</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:72pt;width:100%"><div style="margin-top:0.55pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:95.000%"><tr><td style="width:1.0%"></td><td style="width:65.712%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:32.088%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="border-top:1pt solid #FFFFFF;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Cronos Group Inc.</span></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Notes to Condensed Consolidated Financial Statements (Unaudited)</span></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">(In thousands of $, except share amounts)</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i93ca9bb01792476fbb225e5d9dec869f_7">Table of Contents</a></span></div></td></tr></table></div></div><ix:continuation id="ie5066fae4684439797dda82bc6c4744a"><ix:nonNumeric contextRef="i69782326f71a44e3805518280ee22b6b_D20210101-20210630" name="us-gaap:FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjkzY2E5YmIwMTc5MjQ3NmZiYjIyNWU1ZDlkZWM4NjlmL3NlYzo5M2NhOWJiMDE3OTI0NzZmYmIyMjVlNWQ5ZGVjODY5Zl80Ni9mcmFnOjE0YjkzMDBhMzZkNDQ1OTdhZGI5NzM0MDBlZTk5ZjYwL3RleHRyZWdpb246MTRiOTMwMGEzNmQ0NDU5N2FkYjk3MzQwMGVlOTlmNjBfNzQ2NA_52065bd4-f3b9-47f6-8e6f-42cf9c4676cd" escape="true"><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The fair values of the derivative liabilities were determined using the Black-Scholes pricing model as of June&#160;30, 2021 and December 31, 2020 applying the following inputs:</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.583%"><tr><td style="width:1.0%"></td><td style="width:31.257%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.639%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.357%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.639%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.357%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.639%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.776%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.639%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.357%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.639%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.357%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.644%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">As of June&#160;30, 2021</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">As of December 31, 2020</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Altria Warrant</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Pre-emptive Rights</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Top-up Rights</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Altria Warrant</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Pre-emptive Rights</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Top-up Rights</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Share price at valuation date </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(i)</span></div></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$<ix:nonFraction unitRef="cadPerShare" contextRef="i1257ed1c2bd045fbb8c920b7a673a2bc_I20210630" decimals="2" name="us-gaap:DerivativeLiabilityMeasurementInput" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjkzY2E5YmIwMTc5MjQ3NmZiYjIyNWU1ZDlkZWM4NjlmL3NlYzo5M2NhOWJiMDE3OTI0NzZmYmIyMjVlNWQ5ZGVjODY5Zl80Ni9mcmFnOjE0YjkzMDBhMzZkNDQ1OTdhZGI5NzM0MDBlZTk5ZjYwL3RhYmxlOjUwYzczMTgxNmExNTQxNDA4MzhhNmZlN2M0MzQxMjNlL3RhYmxlcmFuZ2U6NTBjNzMxODE2YTE1NDE0MDgzOGE2ZmU3YzQzNDEyM2VfMi0xLTEtMS0w_cb6ffe98-492a-422a-849b-29b9632576ba">10.68</ix:nonFraction></span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$<ix:nonFraction unitRef="cadPerShare" contextRef="id354e82bb28e4e4f86ca8adb1f07698c_I20210630" decimals="2" name="us-gaap:DerivativeLiabilityMeasurementInput" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjkzY2E5YmIwMTc5MjQ3NmZiYjIyNWU1ZDlkZWM4NjlmL3NlYzo5M2NhOWJiMDE3OTI0NzZmYmIyMjVlNWQ5ZGVjODY5Zl80Ni9mcmFnOjE0YjkzMDBhMzZkNDQ1OTdhZGI5NzM0MDBlZTk5ZjYwL3RhYmxlOjUwYzczMTgxNmExNTQxNDA4MzhhNmZlN2M0MzQxMjNlL3RhYmxlcmFuZ2U6NTBjNzMxODE2YTE1NDE0MDgzOGE2ZmU3YzQzNDEyM2VfMi0zLTEtMS0w_1cc96a5b-0c62-4234-abe5-32c9f4ac5910">10.68</ix:nonFraction></span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$<ix:nonFraction unitRef="cadPerShare" contextRef="i63dea78d92f24ac5a2eef5b4454a6dd3_I20210630" decimals="2" name="us-gaap:DerivativeLiabilityMeasurementInput" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjkzY2E5YmIwMTc5MjQ3NmZiYjIyNWU1ZDlkZWM4NjlmL3NlYzo5M2NhOWJiMDE3OTI0NzZmYmIyMjVlNWQ5ZGVjODY5Zl80Ni9mcmFnOjE0YjkzMDBhMzZkNDQ1OTdhZGI5NzM0MDBlZTk5ZjYwL3RhYmxlOjUwYzczMTgxNmExNTQxNDA4MzhhNmZlN2M0MzQxMjNlL3RhYmxlcmFuZ2U6NTBjNzMxODE2YTE1NDE0MDgzOGE2ZmU3YzQzNDEyM2VfMi01LTEtMS0w_cd04f056-9624-4a29-ae51-ae5d6d48f124">10.68</ix:nonFraction></span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$<ix:nonFraction unitRef="cadPerShare" contextRef="i3353e98ec8c146078a9728dd2c05959d_I20201231" decimals="2" name="us-gaap:DerivativeLiabilityMeasurementInput" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjkzY2E5YmIwMTc5MjQ3NmZiYjIyNWU1ZDlkZWM4NjlmL3NlYzo5M2NhOWJiMDE3OTI0NzZmYmIyMjVlNWQ5ZGVjODY5Zl80Ni9mcmFnOjE0YjkzMDBhMzZkNDQ1OTdhZGI5NzM0MDBlZTk5ZjYwL3RhYmxlOjUwYzczMTgxNmExNTQxNDA4MzhhNmZlN2M0MzQxMjNlL3RhYmxlcmFuZ2U6NTBjNzMxODE2YTE1NDE0MDgzOGE2ZmU3YzQzNDEyM2VfMi03LTEtMS0w_e2772dda-a78c-456f-8b05-6d20b9153eab">8.84</ix:nonFraction></span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$<ix:nonFraction unitRef="cadPerShare" contextRef="i5b7f2fd4ed2c48b588a6b20efe0642c9_I20201231" decimals="2" name="us-gaap:DerivativeLiabilityMeasurementInput" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjkzY2E5YmIwMTc5MjQ3NmZiYjIyNWU1ZDlkZWM4NjlmL3NlYzo5M2NhOWJiMDE3OTI0NzZmYmIyMjVlNWQ5ZGVjODY5Zl80Ni9mcmFnOjE0YjkzMDBhMzZkNDQ1OTdhZGI5NzM0MDBlZTk5ZjYwL3RhYmxlOjUwYzczMTgxNmExNTQxNDA4MzhhNmZlN2M0MzQxMjNlL3RhYmxlcmFuZ2U6NTBjNzMxODE2YTE1NDE0MDgzOGE2ZmU3YzQzNDEyM2VfMi05LTEtMS0w_38e57ad7-88be-4be6-bca9-8ff3de5a2522">8.84</ix:nonFraction></span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$<ix:nonFraction unitRef="cadPerShare" contextRef="i4a625e9a51bd4f19acfab304939f7b6d_I20201231" decimals="2" name="us-gaap:DerivativeLiabilityMeasurementInput" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjkzY2E5YmIwMTc5MjQ3NmZiYjIyNWU1ZDlkZWM4NjlmL3NlYzo5M2NhOWJiMDE3OTI0NzZmYmIyMjVlNWQ5ZGVjODY5Zl80Ni9mcmFnOjE0YjkzMDBhMzZkNDQ1OTdhZGI5NzM0MDBlZTk5ZjYwL3RhYmxlOjUwYzczMTgxNmExNTQxNDA4MzhhNmZlN2M0MzQxMjNlL3RhYmxlcmFuZ2U6NTBjNzMxODE2YTE1NDE0MDgzOGE2ZmU3YzQzNDEyM2VfMi0xMS0xLTEtMA_2d1ff392-685f-42cd-9601-4121a2695b0a">8.84</ix:nonFraction></span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Subscription price </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(i)</span></div></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$<ix:nonFraction unitRef="cadPerShare" contextRef="i339cf0904cfb4c7199ff22f9b0f89460_I20210630" decimals="2" name="us-gaap:DerivativeLiabilityMeasurementInput" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjkzY2E5YmIwMTc5MjQ3NmZiYjIyNWU1ZDlkZWM4NjlmL3NlYzo5M2NhOWJiMDE3OTI0NzZmYmIyMjVlNWQ5ZGVjODY5Zl80Ni9mcmFnOjE0YjkzMDBhMzZkNDQ1OTdhZGI5NzM0MDBlZTk5ZjYwL3RhYmxlOjUwYzczMTgxNmExNTQxNDA4MzhhNmZlN2M0MzQxMjNlL3RhYmxlcmFuZ2U6NTBjNzMxODE2YTE1NDE0MDgzOGE2ZmU3YzQzNDEyM2VfMy0xLTEtMS0w_6ebc5005-9a99-4328-9143-b43881361924">19.00</ix:nonFraction></span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$<ix:nonFraction unitRef="cadPerShare" contextRef="ic23329598e00476e92f1af90f155a47c_I20210630" decimals="2" name="us-gaap:DerivativeLiabilityMeasurementInput" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjkzY2E5YmIwMTc5MjQ3NmZiYjIyNWU1ZDlkZWM4NjlmL3NlYzo5M2NhOWJiMDE3OTI0NzZmYmIyMjVlNWQ5ZGVjODY5Zl80Ni9mcmFnOjE0YjkzMDBhMzZkNDQ1OTdhZGI5NzM0MDBlZTk5ZjYwL3RhYmxlOjUwYzczMTgxNmExNTQxNDA4MzhhNmZlN2M0MzQxMjNlL3RhYmxlcmFuZ2U6NTBjNzMxODE2YTE1NDE0MDgzOGE2ZmU3YzQzNDEyM2VfMy0zLTEtMS0w_a335cbea-e943-4eb4-93ac-f524c9241fa7">16.25</ix:nonFraction></span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$<ix:nonFraction unitRef="cadPerShare" contextRef="i579c24557a25415ab76670fb8c125152_I20210630" decimals="2" name="us-gaap:DerivativeLiabilityMeasurementInput" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjkzY2E5YmIwMTc5MjQ3NmZiYjIyNWU1ZDlkZWM4NjlmL3NlYzo5M2NhOWJiMDE3OTI0NzZmYmIyMjVlNWQ5ZGVjODY5Zl80Ni9mcmFnOjE0YjkzMDBhMzZkNDQ1OTdhZGI5NzM0MDBlZTk5ZjYwL3RhYmxlOjUwYzczMTgxNmExNTQxNDA4MzhhNmZlN2M0MzQxMjNlL3RhYmxlcmFuZ2U6NTBjNzMxODE2YTE1NDE0MDgzOGE2ZmU3YzQzNDEyM2VfMy01LTEtMS0w_6b12a8c8-f390-4888-bf12-03b2e93c0466">16.25</ix:nonFraction></span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$<ix:nonFraction unitRef="cadPerShare" contextRef="ib2597206a68d439e9d9fb442a0edbf09_I20201231" decimals="2" name="us-gaap:DerivativeLiabilityMeasurementInput" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjkzY2E5YmIwMTc5MjQ3NmZiYjIyNWU1ZDlkZWM4NjlmL3NlYzo5M2NhOWJiMDE3OTI0NzZmYmIyMjVlNWQ5ZGVjODY5Zl80Ni9mcmFnOjE0YjkzMDBhMzZkNDQ1OTdhZGI5NzM0MDBlZTk5ZjYwL3RhYmxlOjUwYzczMTgxNmExNTQxNDA4MzhhNmZlN2M0MzQxMjNlL3RhYmxlcmFuZ2U6NTBjNzMxODE2YTE1NDE0MDgzOGE2ZmU3YzQzNDEyM2VfMy03LTEtMS0w_52216157-346c-47aa-9d8e-ae8ea7c772a2">19.00</ix:nonFraction></span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$<ix:nonFraction unitRef="cadPerShare" contextRef="if7010204491b4497933eebbdfcad9d26_I20201231" decimals="2" name="us-gaap:DerivativeLiabilityMeasurementInput" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjkzY2E5YmIwMTc5MjQ3NmZiYjIyNWU1ZDlkZWM4NjlmL3NlYzo5M2NhOWJiMDE3OTI0NzZmYmIyMjVlNWQ5ZGVjODY5Zl80Ni9mcmFnOjE0YjkzMDBhMzZkNDQ1OTdhZGI5NzM0MDBlZTk5ZjYwL3RhYmxlOjUwYzczMTgxNmExNTQxNDA4MzhhNmZlN2M0MzQxMjNlL3RhYmxlcmFuZ2U6NTBjNzMxODE2YTE1NDE0MDgzOGE2ZmU3YzQzNDEyM2VfMy05LTEtMS0w_d692a59d-1cbf-4db4-b646-d8064ea70133">16.25</ix:nonFraction></span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$<ix:nonFraction unitRef="cadPerShare" contextRef="i26b4cc1b2d2c4abcb74127a35c819ef3_I20201231" decimals="2" name="us-gaap:DerivativeLiabilityMeasurementInput" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjkzY2E5YmIwMTc5MjQ3NmZiYjIyNWU1ZDlkZWM4NjlmL3NlYzo5M2NhOWJiMDE3OTI0NzZmYmIyMjVlNWQ5ZGVjODY5Zl80Ni9mcmFnOjE0YjkzMDBhMzZkNDQ1OTdhZGI5NzM0MDBlZTk5ZjYwL3RhYmxlOjUwYzczMTgxNmExNTQxNDA4MzhhNmZlN2M0MzQxMjNlL3RhYmxlcmFuZ2U6NTBjNzMxODE2YTE1NDE0MDgzOGE2ZmU3YzQzNDEyM2VfMy0xMS0xLTEtMA_5ad425ee-ba11-4c12-b434-99f290536ab8">16.25</ix:nonFraction></span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><div style="margin-top:1pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Weighted average risk-free interest rate </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">(ii)</span></div></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i88181468f4494137aa775f1e418165d7_I20210630" decimals="4" name="us-gaap:DerivativeLiabilityMeasurementInput" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjkzY2E5YmIwMTc5MjQ3NmZiYjIyNWU1ZDlkZWM4NjlmL3NlYzo5M2NhOWJiMDE3OTI0NzZmYmIyMjVlNWQ5ZGVjODY5Zl80Ni9mcmFnOjE0YjkzMDBhMzZkNDQ1OTdhZGI5NzM0MDBlZTk5ZjYwL3RhYmxlOjUwYzczMTgxNmExNTQxNDA4MzhhNmZlN2M0MzQxMjNlL3RhYmxlcmFuZ2U6NTBjNzMxODE2YTE1NDE0MDgzOGE2ZmU3YzQzNDEyM2VfNC0xLTEtMS0w_d28d87a5-fcf3-4a23-beb0-d28a9a7976b2">0.38</ix:nonFraction>%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="ic12d47490ce74a188ddc34240b7f1bea_I20210630" decimals="4" name="us-gaap:DerivativeLiabilityMeasurementInput" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjkzY2E5YmIwMTc5MjQ3NmZiYjIyNWU1ZDlkZWM4NjlmL3NlYzo5M2NhOWJiMDE3OTI0NzZmYmIyMjVlNWQ5ZGVjODY5Zl80Ni9mcmFnOjE0YjkzMDBhMzZkNDQ1OTdhZGI5NzM0MDBlZTk5ZjYwL3RhYmxlOjUwYzczMTgxNmExNTQxNDA4MzhhNmZlN2M0MzQxMjNlL3RhYmxlcmFuZ2U6NTBjNzMxODE2YTE1NDE0MDgzOGE2ZmU3YzQzNDEyM2VfNC0zLTEtMS0w_7cf1a343-a10a-4907-906c-6d34cec34347">0.28</ix:nonFraction>%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i6100f128578c4248a96b36db6968b813_I20210630" decimals="4" name="us-gaap:DerivativeLiabilityMeasurementInput" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjkzY2E5YmIwMTc5MjQ3NmZiYjIyNWU1ZDlkZWM4NjlmL3NlYzo5M2NhOWJiMDE3OTI0NzZmYmIyMjVlNWQ5ZGVjODY5Zl80Ni9mcmFnOjE0YjkzMDBhMzZkNDQ1OTdhZGI5NzM0MDBlZTk5ZjYwL3RhYmxlOjUwYzczMTgxNmExNTQxNDA4MzhhNmZlN2M0MzQxMjNlL3RhYmxlcmFuZ2U6NTBjNzMxODE2YTE1NDE0MDgzOGE2ZmU3YzQzNDEyM2VfNC01LTEtMS0w_87dcd147-383d-4840-ab69-ccafc13f3b6f">0.31</ix:nonFraction>%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i23edb2809b3b4515a9b05b50daa96971_I20201231" decimals="4" name="us-gaap:DerivativeLiabilityMeasurementInput" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjkzY2E5YmIwMTc5MjQ3NmZiYjIyNWU1ZDlkZWM4NjlmL3NlYzo5M2NhOWJiMDE3OTI0NzZmYmIyMjVlNWQ5ZGVjODY5Zl80Ni9mcmFnOjE0YjkzMDBhMzZkNDQ1OTdhZGI5NzM0MDBlZTk5ZjYwL3RhYmxlOjUwYzczMTgxNmExNTQxNDA4MzhhNmZlN2M0MzQxMjNlL3RhYmxlcmFuZ2U6NTBjNzMxODE2YTE1NDE0MDgzOGE2ZmU3YzQzNDEyM2VfNC03LTEtMS0w_cf800445-65ee-4252-ad05-5751b2b0890f">0.21</ix:nonFraction>%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="ida0e51f36f7241508ea9f1cb51fab77b_I20201231" decimals="4" name="us-gaap:DerivativeLiabilityMeasurementInput" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjkzY2E5YmIwMTc5MjQ3NmZiYjIyNWU1ZDlkZWM4NjlmL3NlYzo5M2NhOWJiMDE3OTI0NzZmYmIyMjVlNWQ5ZGVjODY5Zl80Ni9mcmFnOjE0YjkzMDBhMzZkNDQ1OTdhZGI5NzM0MDBlZTk5ZjYwL3RhYmxlOjUwYzczMTgxNmExNTQxNDA4MzhhNmZlN2M0MzQxMjNlL3RhYmxlcmFuZ2U6NTBjNzMxODE2YTE1NDE0MDgzOGE2ZmU3YzQzNDEyM2VfNC05LTEtMS0w_59fdc892-1cc3-4d4d-8e9a-0d6979d9054d">0.17</ix:nonFraction>%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i1779eecf81de47219b6cdc404ab734e6_I20201231" decimals="4" name="us-gaap:DerivativeLiabilityMeasurementInput" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjkzY2E5YmIwMTc5MjQ3NmZiYjIyNWU1ZDlkZWM4NjlmL3NlYzo5M2NhOWJiMDE3OTI0NzZmYmIyMjVlNWQ5ZGVjODY5Zl80Ni9mcmFnOjE0YjkzMDBhMzZkNDQ1OTdhZGI5NzM0MDBlZTk5ZjYwL3RhYmxlOjUwYzczMTgxNmExNTQxNDA4MzhhNmZlN2M0MzQxMjNlL3RhYmxlcmFuZ2U6NTBjNzMxODE2YTE1NDE0MDgzOGE2ZmU3YzQzNDEyM2VfNC0xMS0xLTEtMA_47c317ac-f7ac-4c06-a7d8-16b14ff6b859">0.13</ix:nonFraction>%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><div style="margin-top:1pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Weighted average expected life </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">(iii)</span></div></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="ic02211497b5b474a8462f60dfc14b91f_D20210101-20210630" format="ixt-sec:duryear" name="cron:DerivativeLiabilityUsefulLifeTerm" id="id3VybDovL2RvY3MudjEvZG9jOjkzY2E5YmIwMTc5MjQ3NmZiYjIyNWU1ZDlkZWM4NjlmL3NlYzo5M2NhOWJiMDE3OTI0NzZmYmIyMjVlNWQ5ZGVjODY5Zl80Ni9mcmFnOjE0YjkzMDBhMzZkNDQ1OTdhZGI5NzM0MDBlZTk5ZjYwL3RhYmxlOjUwYzczMTgxNmExNTQxNDA4MzhhNmZlN2M0MzQxMjNlL3RhYmxlcmFuZ2U6NTBjNzMxODE2YTE1NDE0MDgzOGE2ZmU3YzQzNDEyM2VfNS0xLTEtMS0w_81a29758-18a3-487f-ad0d-b4bbce273433">1.68</ix:nonNumeric></span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="ie494d1760a574e71a32cae2bcd0bc6f2_D20210101-20210630" format="ixt-sec:duryear" name="cron:DerivativeLiabilityUsefulLifeTerm" id="id3VybDovL2RvY3MudjEvZG9jOjkzY2E5YmIwMTc5MjQ3NmZiYjIyNWU1ZDlkZWM4NjlmL3NlYzo5M2NhOWJiMDE3OTI0NzZmYmIyMjVlNWQ5ZGVjODY5Zl80Ni9mcmFnOjE0YjkzMDBhMzZkNDQ1OTdhZGI5NzM0MDBlZTk5ZjYwL3RhYmxlOjUwYzczMTgxNmExNTQxNDA4MzhhNmZlN2M0MzQxMjNlL3RhYmxlcmFuZ2U6NTBjNzMxODE2YTE1NDE0MDgzOGE2ZmU3YzQzNDEyM2VfNS0zLTEtMS0w_27b38e0a-9589-4846-a0af-496e9b6cd2ba">1.25</ix:nonNumeric></span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="id2d2173a25434cd79374e4a7cf5568c2_D20210101-20210630" format="ixt-sec:duryear" name="cron:DerivativeLiabilityUsefulLifeTerm" id="id3VybDovL2RvY3MudjEvZG9jOjkzY2E5YmIwMTc5MjQ3NmZiYjIyNWU1ZDlkZWM4NjlmL3NlYzo5M2NhOWJiMDE3OTI0NzZmYmIyMjVlNWQ5ZGVjODY5Zl80Ni9mcmFnOjE0YjkzMDBhMzZkNDQ1OTdhZGI5NzM0MDBlZTk5ZjYwL3RhYmxlOjUwYzczMTgxNmExNTQxNDA4MzhhNmZlN2M0MzQxMjNlL3RhYmxlcmFuZ2U6NTBjNzMxODE2YTE1NDE0MDgzOGE2ZmU3YzQzNDEyM2VfNS01LTEtMS0w_ca55db2d-fee9-4efa-ad66-34c08ec08069">1.31</ix:nonNumeric></span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="i1da031054a504cf79b3d31bfcd7a323a_D20200101-20201231" format="ixt-sec:duryear" name="cron:DerivativeLiabilityUsefulLifeTerm" id="id3VybDovL2RvY3MudjEvZG9jOjkzY2E5YmIwMTc5MjQ3NmZiYjIyNWU1ZDlkZWM4NjlmL3NlYzo5M2NhOWJiMDE3OTI0NzZmYmIyMjVlNWQ5ZGVjODY5Zl80Ni9mcmFnOjE0YjkzMDBhMzZkNDQ1OTdhZGI5NzM0MDBlZTk5ZjYwL3RhYmxlOjUwYzczMTgxNmExNTQxNDA4MzhhNmZlN2M0MzQxMjNlL3RhYmxlcmFuZ2U6NTBjNzMxODE2YTE1NDE0MDgzOGE2ZmU3YzQzNDEyM2VfNS03LTEtMS0w_fff172ef-dc29-4edb-882c-2d9912e3c813">2.18</ix:nonNumeric></span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="i1701f6b7d62b4512bfe98026f74288b7_D20200101-20201231" format="ixt-sec:duryear" name="cron:DerivativeLiabilityUsefulLifeTerm" id="id3VybDovL2RvY3MudjEvZG9jOjkzY2E5YmIwMTc5MjQ3NmZiYjIyNWU1ZDlkZWM4NjlmL3NlYzo5M2NhOWJiMDE3OTI0NzZmYmIyMjVlNWQ5ZGVjODY5Zl80Ni9mcmFnOjE0YjkzMDBhMzZkNDQ1OTdhZGI5NzM0MDBlZTk5ZjYwL3RhYmxlOjUwYzczMTgxNmExNTQxNDA4MzhhNmZlN2M0MzQxMjNlL3RhYmxlcmFuZ2U6NTBjNzMxODE2YTE1NDE0MDgzOGE2ZmU3YzQzNDEyM2VfNS05LTEtMS0w_2d8b6842-36d5-4c40-b9a9-3c3c810a89f0">1.50</ix:nonNumeric></span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="i10d7bf0cfd8342e5b54a9ede98d85efa_D20200101-20201231" format="ixt-sec:duryear" name="cron:DerivativeLiabilityUsefulLifeTerm" id="id3VybDovL2RvY3MudjEvZG9jOjkzY2E5YmIwMTc5MjQ3NmZiYjIyNWU1ZDlkZWM4NjlmL3NlYzo5M2NhOWJiMDE3OTI0NzZmYmIyMjVlNWQ5ZGVjODY5Zl80Ni9mcmFnOjE0YjkzMDBhMzZkNDQ1OTdhZGI5NzM0MDBlZTk5ZjYwL3RhYmxlOjUwYzczMTgxNmExNTQxNDA4MzhhNmZlN2M0MzQxMjNlL3RhYmxlcmFuZ2U6NTBjNzMxODE2YTE1NDE0MDgzOGE2ZmU3YzQzNDEyM2VfNS0xMS0xLTEtMA_a9f2f136-2344-4318-954f-689e9d2ae8e0">0.98</ix:nonNumeric></span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><div style="margin-top:1pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Expected annualized volatility</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline"> (iv)</span></div></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="if15b10fbb370412cb143458bfa546283_I20210630" decimals="2" name="us-gaap:DerivativeLiabilityMeasurementInput" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjkzY2E5YmIwMTc5MjQ3NmZiYjIyNWU1ZDlkZWM4NjlmL3NlYzo5M2NhOWJiMDE3OTI0NzZmYmIyMjVlNWQ5ZGVjODY5Zl80Ni9mcmFnOjE0YjkzMDBhMzZkNDQ1OTdhZGI5NzM0MDBlZTk5ZjYwL3RhYmxlOjUwYzczMTgxNmExNTQxNDA4MzhhNmZlN2M0MzQxMjNlL3RhYmxlcmFuZ2U6NTBjNzMxODE2YTE1NDE0MDgzOGE2ZmU3YzQzNDEyM2VfNi0xLTEtMS0w_cd445620-9cbb-4777-84e8-2dabede20742">75</ix:nonFraction>%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i8c3dd53b7ced472bbe056909c36fa671_I20210630" decimals="2" name="us-gaap:DerivativeLiabilityMeasurementInput" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjkzY2E5YmIwMTc5MjQ3NmZiYjIyNWU1ZDlkZWM4NjlmL3NlYzo5M2NhOWJiMDE3OTI0NzZmYmIyMjVlNWQ5ZGVjODY5Zl80Ni9mcmFnOjE0YjkzMDBhMzZkNDQ1OTdhZGI5NzM0MDBlZTk5ZjYwL3RhYmxlOjUwYzczMTgxNmExNTQxNDA4MzhhNmZlN2M0MzQxMjNlL3RhYmxlcmFuZ2U6NTBjNzMxODE2YTE1NDE0MDgzOGE2ZmU3YzQzNDEyM2VfNi0zLTEtMS0w_b41fcbc2-220a-4309-8fe5-6d3628692131">75</ix:nonFraction>%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="ib976b88274494333b0625717658b451c_I20210630" decimals="2" name="us-gaap:DerivativeLiabilityMeasurementInput" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjkzY2E5YmIwMTc5MjQ3NmZiYjIyNWU1ZDlkZWM4NjlmL3NlYzo5M2NhOWJiMDE3OTI0NzZmYmIyMjVlNWQ5ZGVjODY5Zl80Ni9mcmFnOjE0YjkzMDBhMzZkNDQ1OTdhZGI5NzM0MDBlZTk5ZjYwL3RhYmxlOjUwYzczMTgxNmExNTQxNDA4MzhhNmZlN2M0MzQxMjNlL3RhYmxlcmFuZ2U6NTBjNzMxODE2YTE1NDE0MDgzOGE2ZmU3YzQzNDEyM2VfNi01LTEtMS0w_ac5c457e-8721-4603-9b9e-4251abf1388d">75</ix:nonFraction>%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i3b4e489f4801442fbe965a24c9af5f86_I20201231" decimals="2" name="us-gaap:DerivativeLiabilityMeasurementInput" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjkzY2E5YmIwMTc5MjQ3NmZiYjIyNWU1ZDlkZWM4NjlmL3NlYzo5M2NhOWJiMDE3OTI0NzZmYmIyMjVlNWQ5ZGVjODY5Zl80Ni9mcmFnOjE0YjkzMDBhMzZkNDQ1OTdhZGI5NzM0MDBlZTk5ZjYwL3RhYmxlOjUwYzczMTgxNmExNTQxNDA4MzhhNmZlN2M0MzQxMjNlL3RhYmxlcmFuZ2U6NTBjNzMxODE2YTE1NDE0MDgzOGE2ZmU3YzQzNDEyM2VfNi03LTEtMS0w_225f6a76-1a3b-4c7f-b5b1-b29face513a4">81</ix:nonFraction>%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i57c58eedfb404984b87b46cbe12d3426_I20201231" decimals="2" name="us-gaap:DerivativeLiabilityMeasurementInput" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjkzY2E5YmIwMTc5MjQ3NmZiYjIyNWU1ZDlkZWM4NjlmL3NlYzo5M2NhOWJiMDE3OTI0NzZmYmIyMjVlNWQ5ZGVjODY5Zl80Ni9mcmFnOjE0YjkzMDBhMzZkNDQ1OTdhZGI5NzM0MDBlZTk5ZjYwL3RhYmxlOjUwYzczMTgxNmExNTQxNDA4MzhhNmZlN2M0MzQxMjNlL3RhYmxlcmFuZ2U6NTBjNzMxODE2YTE1NDE0MDgzOGE2ZmU3YzQzNDEyM2VfNi05LTEtMS0w_e3228824-d44f-4546-9000-150df3094048">81</ix:nonFraction>%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i9859907a6972416e881289ad4a8c7462_I20201231" decimals="2" name="us-gaap:DerivativeLiabilityMeasurementInput" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjkzY2E5YmIwMTc5MjQ3NmZiYjIyNWU1ZDlkZWM4NjlmL3NlYzo5M2NhOWJiMDE3OTI0NzZmYmIyMjVlNWQ5ZGVjODY5Zl80Ni9mcmFnOjE0YjkzMDBhMzZkNDQ1OTdhZGI5NzM0MDBlZTk5ZjYwL3RhYmxlOjUwYzczMTgxNmExNTQxNDA4MzhhNmZlN2M0MzQxMjNlL3RhYmxlcmFuZ2U6NTBjNzMxODE2YTE1NDE0MDgzOGE2ZmU3YzQzNDEyM2VfNi0xMS0xLTEtMA_b67b4095-c420-4ff6-94d5-eb70d5365f69">81</ix:nonFraction>%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Expected dividend yield</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="id612af184d0d4ee8bae904a6cdcdba6f_I20210630" decimals="INF" format="ixt:zerodash" name="us-gaap:DerivativeLiabilityMeasurementInput" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjkzY2E5YmIwMTc5MjQ3NmZiYjIyNWU1ZDlkZWM4NjlmL3NlYzo5M2NhOWJiMDE3OTI0NzZmYmIyMjVlNWQ5ZGVjODY5Zl80Ni9mcmFnOjE0YjkzMDBhMzZkNDQ1OTdhZGI5NzM0MDBlZTk5ZjYwL3RhYmxlOjUwYzczMTgxNmExNTQxNDA4MzhhNmZlN2M0MzQxMjNlL3RhYmxlcmFuZ2U6NTBjNzMxODE2YTE1NDE0MDgzOGE2ZmU3YzQzNDEyM2VfNy0xLTEtMS0w_6828738a-2d21-4c99-9409-7eb631ee12b3">&#8212;</ix:nonFraction>%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="id5167c2418bc49d79a29b1d99ae027e1_I20210630" decimals="INF" format="ixt:zerodash" name="us-gaap:DerivativeLiabilityMeasurementInput" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjkzY2E5YmIwMTc5MjQ3NmZiYjIyNWU1ZDlkZWM4NjlmL3NlYzo5M2NhOWJiMDE3OTI0NzZmYmIyMjVlNWQ5ZGVjODY5Zl80Ni9mcmFnOjE0YjkzMDBhMzZkNDQ1OTdhZGI5NzM0MDBlZTk5ZjYwL3RhYmxlOjUwYzczMTgxNmExNTQxNDA4MzhhNmZlN2M0MzQxMjNlL3RhYmxlcmFuZ2U6NTBjNzMxODE2YTE1NDE0MDgzOGE2ZmU3YzQzNDEyM2VfNy0zLTEtMS0w_f19d9208-466b-4ff8-8fa2-f3adec706632">&#8212;</ix:nonFraction>%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i79aea684554446b8864ca220d82ab826_I20210630" decimals="INF" format="ixt:zerodash" name="us-gaap:DerivativeLiabilityMeasurementInput" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjkzY2E5YmIwMTc5MjQ3NmZiYjIyNWU1ZDlkZWM4NjlmL3NlYzo5M2NhOWJiMDE3OTI0NzZmYmIyMjVlNWQ5ZGVjODY5Zl80Ni9mcmFnOjE0YjkzMDBhMzZkNDQ1OTdhZGI5NzM0MDBlZTk5ZjYwL3RhYmxlOjUwYzczMTgxNmExNTQxNDA4MzhhNmZlN2M0MzQxMjNlL3RhYmxlcmFuZ2U6NTBjNzMxODE2YTE1NDE0MDgzOGE2ZmU3YzQzNDEyM2VfNy01LTEtMS0w_a151e755-4300-4a02-bc2a-c1a7306f4db4">&#8212;</ix:nonFraction>%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i50dc22d6133f49688c294c0961ff3e97_I20201231" decimals="INF" format="ixt:zerodash" name="us-gaap:DerivativeLiabilityMeasurementInput" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjkzY2E5YmIwMTc5MjQ3NmZiYjIyNWU1ZDlkZWM4NjlmL3NlYzo5M2NhOWJiMDE3OTI0NzZmYmIyMjVlNWQ5ZGVjODY5Zl80Ni9mcmFnOjE0YjkzMDBhMzZkNDQ1OTdhZGI5NzM0MDBlZTk5ZjYwL3RhYmxlOjUwYzczMTgxNmExNTQxNDA4MzhhNmZlN2M0MzQxMjNlL3RhYmxlcmFuZ2U6NTBjNzMxODE2YTE1NDE0MDgzOGE2ZmU3YzQzNDEyM2VfNy03LTEtMS0w_d366995e-cbf9-4ccb-8199-ee858041b6ea">&#8212;</ix:nonFraction>%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i6cc1c73280a94f4ab8a8e4826245a4a9_I20201231" decimals="INF" format="ixt:zerodash" name="us-gaap:DerivativeLiabilityMeasurementInput" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjkzY2E5YmIwMTc5MjQ3NmZiYjIyNWU1ZDlkZWM4NjlmL3NlYzo5M2NhOWJiMDE3OTI0NzZmYmIyMjVlNWQ5ZGVjODY5Zl80Ni9mcmFnOjE0YjkzMDBhMzZkNDQ1OTdhZGI5NzM0MDBlZTk5ZjYwL3RhYmxlOjUwYzczMTgxNmExNTQxNDA4MzhhNmZlN2M0MzQxMjNlL3RhYmxlcmFuZ2U6NTBjNzMxODE2YTE1NDE0MDgzOGE2ZmU3YzQzNDEyM2VfNy05LTEtMS0w_78e0d713-d0ef-450a-a0d4-4e3872094307">&#8212;</ix:nonFraction>%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="ia1213fa5613b4ccc8ae504fe77e72358_I20201231" decimals="INF" format="ixt:zerodash" name="us-gaap:DerivativeLiabilityMeasurementInput" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjkzY2E5YmIwMTc5MjQ3NmZiYjIyNWU1ZDlkZWM4NjlmL3NlYzo5M2NhOWJiMDE3OTI0NzZmYmIyMjVlNWQ5ZGVjODY5Zl80Ni9mcmFnOjE0YjkzMDBhMzZkNDQ1OTdhZGI5NzM0MDBlZTk5ZjYwL3RhYmxlOjUwYzczMTgxNmExNTQxNDA4MzhhNmZlN2M0MzQxMjNlL3RhYmxlcmFuZ2U6NTBjNzMxODE2YTE1NDE0MDgzOGE2ZmU3YzQzNDEyM2VfNy0xMS0xLTEtMA_1ab941c0-8200-4339-828e-43e1c52cb94b">&#8212;</ix:nonFraction>%</span></td></tr></table></div><div style="margin-top:6pt;padding-left:27pt;text-align:justify;text-indent:-27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:400;line-height:120%;position:relative;top:-2.8pt;vertical-align:baseline">(i)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:22.1pt">Per share in C$.</span></div><div style="margin-bottom:3pt;margin-top:3pt;padding-left:27pt;text-align:justify;text-indent:-27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:400;line-height:120%;position:relative;top:-2.8pt;vertical-align:baseline">(ii)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:20.66pt">The risk-free interest rate was based on Bank of Canada government treasury bills and bonds with a remaining term equal to the expected life of the derivative liabilities. As of June&#160;30, 2021 and December 31, 2020, the risk-free interest rate uses a range of approximately <ix:nonFraction unitRef="number" contextRef="i9ca6679fb2564fde8f5c255991b2b07b_I20210630" decimals="4" name="us-gaap:DerivativeLiabilityMeasurementInput" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjkzY2E5YmIwMTc5MjQ3NmZiYjIyNWU1ZDlkZWM4NjlmL3NlYzo5M2NhOWJiMDE3OTI0NzZmYmIyMjVlNWQ5ZGVjODY5Zl80Ni9mcmFnOjE0YjkzMDBhMzZkNDQ1OTdhZGI5NzM0MDBlZTk5ZjYwL3RleHRyZWdpb246MTRiOTMwMGEzNmQ0NDU5N2FkYjk3MzQwMGVlOTlmNjBfNTc4OQ_796bbadc-bece-44be-8ab3-35728628e152">0.15</ix:nonFraction>% to <ix:nonFraction unitRef="number" contextRef="idce1c11532374f46a0debb9127ec0281_I20210630" decimals="4" name="us-gaap:DerivativeLiabilityMeasurementInput" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjkzY2E5YmIwMTc5MjQ3NmZiYjIyNWU1ZDlkZWM4NjlmL3NlYzo5M2NhOWJiMDE3OTI0NzZmYmIyMjVlNWQ5ZGVjODY5Zl80Ni9mcmFnOjE0YjkzMDBhMzZkNDQ1OTdhZGI5NzM0MDBlZTk5ZjYwL3RleHRyZWdpb246MTRiOTMwMGEzNmQ0NDU5N2FkYjk3MzQwMGVlOTlmNjBfNTc5NQ_16be9763-f195-4f0a-abd8-e3c5d5b09c07">0.85</ix:nonFraction>% and <ix:nonFraction unitRef="number" contextRef="i91e2aab33be84cc8a26bac33aca37a7b_I20201231" decimals="4" name="us-gaap:DerivativeLiabilityMeasurementInput" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjkzY2E5YmIwMTc5MjQ3NmZiYjIyNWU1ZDlkZWM4NjlmL3NlYzo5M2NhOWJiMDE3OTI0NzZmYmIyMjVlNWQ5ZGVjODY5Zl80Ni9mcmFnOjE0YjkzMDBhMzZkNDQ1OTdhZGI5NzM0MDBlZTk5ZjYwL3RleHRyZWdpb246MTRiOTMwMGEzNmQ0NDU5N2FkYjk3MzQwMGVlOTlmNjBfNTgwMg_19e1e73d-23ac-4319-bdc1-6d4823d8c3a1">0.10</ix:nonFraction>% to <ix:nonFraction unitRef="number" contextRef="ic5fe8049d90f4163b34bb2524a897f2d_I20201231" decimals="4" name="us-gaap:DerivativeLiabilityMeasurementInput" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjkzY2E5YmIwMTc5MjQ3NmZiYjIyNWU1ZDlkZWM4NjlmL3NlYzo5M2NhOWJiMDE3OTI0NzZmYmIyMjVlNWQ5ZGVjODY5Zl80Ni9mcmFnOjE0YjkzMDBhMzZkNDQ1OTdhZGI5NzM0MDBlZTk5ZjYwL3RleHRyZWdpb246MTRiOTMwMGEzNmQ0NDU5N2FkYjk3MzQwMGVlOTlmNjBfNTgwOA_f2e82eef-0fc6-4ba4-b9b6-4c7ab96fef45">0.39</ix:nonFraction>%, respectively, for the Pre-emptive Rights and Top-up Rights.</span></div><div style="margin-bottom:3pt;margin-top:3pt;padding-left:27pt;text-align:justify;text-indent:-27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:400;line-height:120%;position:relative;top:-2.8pt;vertical-align:baseline">(iii)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:19.22pt">The expected life represents the period of time, in years, that the derivative liabilities are expected to be outstanding. The expected life of the Pre-emptive Rights and Top-up Rights is determined based on the expected term of the underlying options, warrants, and shares, to which the Pre-emptive Rights and Top-up Rights are linked. As of June&#160;30, 2021 and December 31, 2020, the expected life uses a range of approximately <ix:nonNumeric contextRef="i5f97c3a427254d74b99f26c83a33f800_D20210101-20210630" format="ixt-sec:duryear" name="cron:DerivativeLiabilityUsefulLifeTerm" id="id3VybDovL2RvY3MudjEvZG9jOjkzY2E5YmIwMTc5MjQ3NmZiYjIyNWU1ZDlkZWM4NjlmL3NlYzo5M2NhOWJiMDE3OTI0NzZmYmIyMjVlNWQ5ZGVjODY5Zl80Ni9mcmFnOjE0YjkzMDBhMzZkNDQ1OTdhZGI5NzM0MDBlZTk5ZjYwL3RleHRyZWdpb246MTRiOTMwMGEzNmQ0NDU5N2FkYjk3MzQwMGVlOTlmNjBfNjI3NA_7b48e660-1f3e-4fe1-9a3d-50cda25fb354">0.25</ix:nonNumeric> year to <ix:nonNumeric contextRef="i404e95ab180846458cdfa503e1b9d618_D20210101-20210630" format="ixt-sec:duryear" name="cron:DerivativeLiabilityUsefulLifeTerm" id="id3VybDovL2RvY3MudjEvZG9jOjkzY2E5YmIwMTc5MjQ3NmZiYjIyNWU1ZDlkZWM4NjlmL3NlYzo5M2NhOWJiMDE3OTI0NzZmYmIyMjVlNWQ5ZGVjODY5Zl80Ni9mcmFnOjE0YjkzMDBhMzZkNDQ1OTdhZGI5NzM0MDBlZTk5ZjYwL3RleHRyZWdpb246MTRiOTMwMGEzNmQ0NDU5N2FkYjk3MzQwMGVlOTlmNjBfNjI4NQ_63d25a5d-8672-4194-9889-e9e737b551d4">4.25</ix:nonNumeric> years and <ix:nonNumeric contextRef="i1a39a101965648319dfe223e050e1870_D20200101-20201231" format="ixt-sec:duryear" name="cron:DerivativeLiabilityUsefulLifeTerm" id="id3VybDovL2RvY3MudjEvZG9jOjkzY2E5YmIwMTc5MjQ3NmZiYjIyNWU1ZDlkZWM4NjlmL3NlYzo5M2NhOWJiMDE3OTI0NzZmYmIyMjVlNWQ5ZGVjODY5Zl80Ni9mcmFnOjE0YjkzMDBhMzZkNDQ1OTdhZGI5NzM0MDBlZTk5ZjYwL3RleHRyZWdpb246MTRiOTMwMGEzNmQ0NDU5N2FkYjk3MzQwMGVlOTlmNjBfNjI5OA_5c0493d3-8a4e-4820-b470-e4118d65aecf">0.50</ix:nonNumeric> year to <ix:nonNumeric contextRef="id736a2abed614a71a7524cefc38e23df_D20200101-20201231" format="ixt-sec:duryear" name="cron:DerivativeLiabilityUsefulLifeTerm" id="id3VybDovL2RvY3MudjEvZG9jOjkzY2E5YmIwMTc5MjQ3NmZiYjIyNWU1ZDlkZWM4NjlmL3NlYzo5M2NhOWJiMDE3OTI0NzZmYmIyMjVlNWQ5ZGVjODY5Zl80Ni9mcmFnOjE0YjkzMDBhMzZkNDQ1OTdhZGI5NzM0MDBlZTk5ZjYwL3RleHRyZWdpb246MTRiOTMwMGEzNmQ0NDU5N2FkYjk3MzQwMGVlOTlmNjBfNjMwOQ_fe112d48-c93c-4451-b389-f89a34cce0c8">5.00</ix:nonNumeric> years, respectively.</span></div><div style="margin-bottom:6pt;margin-top:3pt;padding-left:27pt;text-align:justify;text-indent:-27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:400;line-height:120%;position:relative;top:-2.8pt;vertical-align:baseline">(iv)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:19.5pt">Volatility was based on an equally weighted blended historical and implied volatility level of the underlying equity securities of the Company as of June&#160;30, 2021. As of December 31, 2020, volatility was based on the blended historical volatility levels of the Company and peer companies.</span></div></ix:nonNumeric><ix:nonNumeric contextRef="i69782326f71a44e3805518280ee22b6b_D20210101-20210630" name="cron:SensitivityAnalysisImpactOnNetIncomeLossTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjkzY2E5YmIwMTc5MjQ3NmZiYjIyNWU1ZDlkZWM4NjlmL3NlYzo5M2NhOWJiMDE3OTI0NzZmYmIyMjVlNWQ5ZGVjODY5Zl80Ni9mcmFnOjE0YjkzMDBhMzZkNDQ1OTdhZGI5NzM0MDBlZTk5ZjYwL3RleHRyZWdpb246MTRiOTMwMGEzNmQ0NDU5N2FkYjk3MzQwMGVlOTlmNjBfNzQ2Ng_c46ce939-fadb-4ffb-a63e-a0b42748c039" escape="true"><div style="margin-bottom:6pt;margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table quantifies each of the significant inputs described above and provides a sensitivity analysis of the impact on the reported values of the derivative liabilities. The sensitivity analysis for each significant input is performed by assuming a 10% decrease in the input while other significant inputs remain constant at management&#8217;s best estimate as of the respective dates. While a decrease in the inputs noted below would cause a decrease in the carrying value of the derivative liability, there would also be an equal but opposite impact on net income (loss).</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:28.761%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:1.466%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.038%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:1.327%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.038%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:1.327%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.038%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:1.327%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.038%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:1.327%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.038%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:1.327%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.048%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Decrease as of June&#160;30, 2021</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Decrease as of December 31, 2020</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Altria Warrant</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Pre-emptive Rights</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Top-up Rights</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Altria Warrant</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Pre-emptive Rights</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Top-up Rights</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Share price</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i34995f47e8ba418fbd529b2ed52790dc_I20210630" decimals="-3" format="ixt:numdotdecimal" name="cron:SensitivityAnalysisImpactOf10PercentDecreaseIncreaseInSharePriceOnNetIncomeLoss" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzY2E5YmIwMTc5MjQ3NmZiYjIyNWU1ZDlkZWM4NjlmL3NlYzo5M2NhOWJiMDE3OTI0NzZmYmIyMjVlNWQ5ZGVjODY5Zl80Ni9mcmFnOjE0YjkzMDBhMzZkNDQ1OTdhZGI5NzM0MDBlZTk5ZjYwL3RhYmxlOjU4YjhkMGUzODQyMzRjMzVhNWZjN2EyODMxMWFiZGMwL3RhYmxlcmFuZ2U6NThiOGQwZTM4NDIzNGMzNWE1ZmM3YTI4MzExYWJkYzBfMi0yLTEtMS0w_5123154e-7f95-46f5-ab57-11f538fe8200">31,375</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie4ec3b642b3b4457b78cb85e8d1838f0_I20210630" decimals="-3" format="ixt:numdotdecimal" name="cron:SensitivityAnalysisImpactOf10PercentDecreaseIncreaseInSharePriceOnNetIncomeLoss" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzY2E5YmIwMTc5MjQ3NmZiYjIyNWU1ZDlkZWM4NjlmL3NlYzo5M2NhOWJiMDE3OTI0NzZmYmIyMjVlNWQ5ZGVjODY5Zl80Ni9mcmFnOjE0YjkzMDBhMzZkNDQ1OTdhZGI5NzM0MDBlZTk5ZjYwL3RhYmxlOjU4YjhkMGUzODQyMzRjMzVhNWZjN2EyODMxMWFiZGMwL3RhYmxlcmFuZ2U6NThiOGQwZTM4NDIzNGMzNWE1ZmM3YTI4MzExYWJkYzBfMi00LTEtMS0w_4a7485a2-7d1c-4b2a-a77d-e29f858fb9a4">3,146</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia2cd5cb93e97428dabd7e841eee51895_I20210630" decimals="-3" format="ixt:numdotdecimal" name="cron:SensitivityAnalysisImpactOf10PercentDecreaseIncreaseInSharePriceOnNetIncomeLoss" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzY2E5YmIwMTc5MjQ3NmZiYjIyNWU1ZDlkZWM4NjlmL3NlYzo5M2NhOWJiMDE3OTI0NzZmYmIyMjVlNWQ5ZGVjODY5Zl80Ni9mcmFnOjE0YjkzMDBhMzZkNDQ1OTdhZGI5NzM0MDBlZTk5ZjYwL3RhYmxlOjU4YjhkMGUzODQyMzRjMzVhNWZjN2EyODMxMWFiZGMwL3RhYmxlcmFuZ2U6NThiOGQwZTM4NDIzNGMzNWE1ZmM3YTI4MzExYWJkYzBfMi02LTEtMS0w_d4ad0e4c-b2d0-4568-86f7-51d2025ce760">1,302</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i386ef852060640f8a03a30f10d03a1cd_I20201231" decimals="-3" format="ixt:numdotdecimal" name="cron:SensitivityAnalysisImpactOf10PercentDecreaseIncreaseInSharePriceOnNetIncomeLoss" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzY2E5YmIwMTc5MjQ3NmZiYjIyNWU1ZDlkZWM4NjlmL3NlYzo5M2NhOWJiMDE3OTI0NzZmYmIyMjVlNWQ5ZGVjODY5Zl80Ni9mcmFnOjE0YjkzMDBhMzZkNDQ1OTdhZGI5NzM0MDBlZTk5ZjYwL3RhYmxlOjU4YjhkMGUzODQyMzRjMzVhNWZjN2EyODMxMWFiZGMwL3RhYmxlcmFuZ2U6NThiOGQwZTM4NDIzNGMzNWE1ZmM3YTI4MzExYWJkYzBfMi04LTEtMS0xMDIx_c4c03914-7c81-4852-8c60-f6fe9a4f2391">25,819</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i72ce1ade65834a50bf4468cde26bf617_I20201231" decimals="-3" format="ixt:numdotdecimal" name="cron:SensitivityAnalysisImpactOf10PercentDecreaseIncreaseInSharePriceOnNetIncomeLoss" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzY2E5YmIwMTc5MjQ3NmZiYjIyNWU1ZDlkZWM4NjlmL3NlYzo5M2NhOWJiMDE3OTI0NzZmYmIyMjVlNWQ5ZGVjODY5Zl80Ni9mcmFnOjE0YjkzMDBhMzZkNDQ1OTdhZGI5NzM0MDBlZTk5ZjYwL3RhYmxlOjU4YjhkMGUzODQyMzRjMzVhNWZjN2EyODMxMWFiZGMwL3RhYmxlcmFuZ2U6NThiOGQwZTM4NDIzNGMzNWE1ZmM3YTI4MzExYWJkYzBfMi0xMC0xLTEtMTAyNQ_24e0c336-1145-4fa7-bad5-af15b3ddc2c5">2,527</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if0aa3f5449da461c85f0c0831bf3c984_I20201231" decimals="-3" format="ixt:numdotdecimal" name="cron:SensitivityAnalysisImpactOf10PercentDecreaseIncreaseInSharePriceOnNetIncomeLoss" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzY2E5YmIwMTc5MjQ3NmZiYjIyNWU1ZDlkZWM4NjlmL3NlYzo5M2NhOWJiMDE3OTI0NzZmYmIyMjVlNWQ5ZGVjODY5Zl80Ni9mcmFnOjE0YjkzMDBhMzZkNDQ1OTdhZGI5NzM0MDBlZTk5ZjYwL3RhYmxlOjU4YjhkMGUzODQyMzRjMzVhNWZjN2EyODMxMWFiZGMwL3RhYmxlcmFuZ2U6NThiOGQwZTM4NDIzNGMzNWE1ZmM3YTI4MzExYWJkYzBfMi0xMi0xLTEtMTAyOQ_1a135dcf-b1e9-441e-a7b0-4cb653137c5a">2,989</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Weighted average expected life</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i34995f47e8ba418fbd529b2ed52790dc_I20210630" decimals="-3" format="ixt:numdotdecimal" name="cron:SensitivityAnalysisImpactOf10PercentDecreaseIncreaseInWeightedAverageExpectedLifeOnNetIncomeLoss" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzY2E5YmIwMTc5MjQ3NmZiYjIyNWU1ZDlkZWM4NjlmL3NlYzo5M2NhOWJiMDE3OTI0NzZmYmIyMjVlNWQ5ZGVjODY5Zl80Ni9mcmFnOjE0YjkzMDBhMzZkNDQ1OTdhZGI5NzM0MDBlZTk5ZjYwL3RhYmxlOjU4YjhkMGUzODQyMzRjMzVhNWZjN2EyODMxMWFiZGMwL3RhYmxlcmFuZ2U6NThiOGQwZTM4NDIzNGMzNWE1ZmM3YTI4MzExYWJkYzBfMy0yLTEtMS0w_2ae1d6db-391d-4cbe-bd8d-b3ef432a52ab">14,220</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie4ec3b642b3b4457b78cb85e8d1838f0_I20210630" decimals="-3" format="ixt:numdotdecimal" name="cron:SensitivityAnalysisImpactOf10PercentDecreaseIncreaseInWeightedAverageExpectedLifeOnNetIncomeLoss" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzY2E5YmIwMTc5MjQ3NmZiYjIyNWU1ZDlkZWM4NjlmL3NlYzo5M2NhOWJiMDE3OTI0NzZmYmIyMjVlNWQ5ZGVjODY5Zl80Ni9mcmFnOjE0YjkzMDBhMzZkNDQ1OTdhZGI5NzM0MDBlZTk5ZjYwL3RhYmxlOjU4YjhkMGUzODQyMzRjMzVhNWZjN2EyODMxMWFiZGMwL3RhYmxlcmFuZ2U6NThiOGQwZTM4NDIzNGMzNWE1ZmM3YTI4MzExYWJkYzBfMy00LTEtMS0w_5a4bef55-3cbb-43b8-9682-4e3776f9a4ec">5,266</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia2cd5cb93e97428dabd7e841eee51895_I20210630" decimals="-3" name="cron:SensitivityAnalysisImpactOf10PercentDecreaseIncreaseInWeightedAverageExpectedLifeOnNetIncomeLoss" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzY2E5YmIwMTc5MjQ3NmZiYjIyNWU1ZDlkZWM4NjlmL3NlYzo5M2NhOWJiMDE3OTI0NzZmYmIyMjVlNWQ5ZGVjODY5Zl80Ni9mcmFnOjE0YjkzMDBhMzZkNDQ1OTdhZGI5NzM0MDBlZTk5ZjYwL3RhYmxlOjU4YjhkMGUzODQyMzRjMzVhNWZjN2EyODMxMWFiZGMwL3RhYmxlcmFuZ2U6NThiOGQwZTM4NDIzNGMzNWE1ZmM3YTI4MzExYWJkYzBfMy02LTEtMS0w_5dbe3b2b-dd33-4210-9d99-6333e793fc89">502</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i386ef852060640f8a03a30f10d03a1cd_I20201231" decimals="-3" format="ixt:numdotdecimal" name="cron:SensitivityAnalysisImpactOf10PercentDecreaseIncreaseInWeightedAverageExpectedLifeOnNetIncomeLoss" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzY2E5YmIwMTc5MjQ3NmZiYjIyNWU1ZDlkZWM4NjlmL3NlYzo5M2NhOWJiMDE3OTI0NzZmYmIyMjVlNWQ5ZGVjODY5Zl80Ni9mcmFnOjE0YjkzMDBhMzZkNDQ1OTdhZGI5NzM0MDBlZTk5ZjYwL3RhYmxlOjU4YjhkMGUzODQyMzRjMzVhNWZjN2EyODMxMWFiZGMwL3RhYmxlcmFuZ2U6NThiOGQwZTM4NDIzNGMzNWE1ZmM3YTI4MzExYWJkYzBfMy04LTEtMS0xMDIx_b977409d-fff1-443b-ad1a-3fa079b699c2">13,541</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i72ce1ade65834a50bf4468cde26bf617_I20201231" decimals="-3" format="ixt:numdotdecimal" name="cron:SensitivityAnalysisImpactOf10PercentDecreaseIncreaseInWeightedAverageExpectedLifeOnNetIncomeLoss" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzY2E5YmIwMTc5MjQ3NmZiYjIyNWU1ZDlkZWM4NjlmL3NlYzo5M2NhOWJiMDE3OTI0NzZmYmIyMjVlNWQ5ZGVjODY5Zl80Ni9mcmFnOjE0YjkzMDBhMzZkNDQ1OTdhZGI5NzM0MDBlZTk5ZjYwL3RhYmxlOjU4YjhkMGUzODQyMzRjMzVhNWZjN2EyODMxMWFiZGMwL3RhYmxlcmFuZ2U6NThiOGQwZTM4NDIzNGMzNWE1ZmM3YTI4MzExYWJkYzBfMy0xMC0xLTEtMTAyNQ_9756bf2e-97ad-4137-a7d8-ca0f0b57cf21">1,988</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if0aa3f5449da461c85f0c0831bf3c984_I20201231" decimals="-3" format="ixt:numdotdecimal" name="cron:SensitivityAnalysisImpactOf10PercentDecreaseIncreaseInWeightedAverageExpectedLifeOnNetIncomeLoss" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzY2E5YmIwMTc5MjQ3NmZiYjIyNWU1ZDlkZWM4NjlmL3NlYzo5M2NhOWJiMDE3OTI0NzZmYmIyMjVlNWQ5ZGVjODY5Zl80Ni9mcmFnOjE0YjkzMDBhMzZkNDQ1OTdhZGI5NzM0MDBlZTk5ZjYwL3RhYmxlOjU4YjhkMGUzODQyMzRjMzVhNWZjN2EyODMxMWFiZGMwL3RhYmxlcmFuZ2U6NThiOGQwZTM4NDIzNGMzNWE1ZmM3YTI4MzExYWJkYzBfMy0xMi0xLTEtMTAyOQ_5a4a6583-b2b0-42a9-998e-b27ac2569131">2,121</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Expected annualized volatility</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i34995f47e8ba418fbd529b2ed52790dc_I20210630" decimals="-3" format="ixt:numdotdecimal" name="cron:SensitivityAnalysisImpactOf10PercentDecreaseIncreaseInExpectedAnnualizedVolatilityOnNetIncomeLoss" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzY2E5YmIwMTc5MjQ3NmZiYjIyNWU1ZDlkZWM4NjlmL3NlYzo5M2NhOWJiMDE3OTI0NzZmYmIyMjVlNWQ5ZGVjODY5Zl80Ni9mcmFnOjE0YjkzMDBhMzZkNDQ1OTdhZGI5NzM0MDBlZTk5ZjYwL3RhYmxlOjU4YjhkMGUzODQyMzRjMzVhNWZjN2EyODMxMWFiZGMwL3RhYmxlcmFuZ2U6NThiOGQwZTM4NDIzNGMzNWE1ZmM3YTI4MzExYWJkYzBfNC0yLTEtMS0w_e5c7c4c9-c0ec-48f6-86d2-f0db4fdc2696">27,375</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie4ec3b642b3b4457b78cb85e8d1838f0_I20210630" decimals="-3" format="ixt:numdotdecimal" name="cron:SensitivityAnalysisImpactOf10PercentDecreaseIncreaseInExpectedAnnualizedVolatilityOnNetIncomeLoss" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzY2E5YmIwMTc5MjQ3NmZiYjIyNWU1ZDlkZWM4NjlmL3NlYzo5M2NhOWJiMDE3OTI0NzZmYmIyMjVlNWQ5ZGVjODY5Zl80Ni9mcmFnOjE0YjkzMDBhMzZkNDQ1OTdhZGI5NzM0MDBlZTk5ZjYwL3RhYmxlOjU4YjhkMGUzODQyMzRjMzVhNWZjN2EyODMxMWFiZGMwL3RhYmxlcmFuZ2U6NThiOGQwZTM4NDIzNGMzNWE1ZmM3YTI4MzExYWJkYzBfNC00LTEtMS0w_a2ac04f8-7b20-4281-8455-3a8eadb647d8">2,348</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia2cd5cb93e97428dabd7e841eee51895_I20210630" decimals="-3" name="cron:SensitivityAnalysisImpactOf10PercentDecreaseIncreaseInExpectedAnnualizedVolatilityOnNetIncomeLoss" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzY2E5YmIwMTc5MjQ3NmZiYjIyNWU1ZDlkZWM4NjlmL3NlYzo5M2NhOWJiMDE3OTI0NzZmYmIyMjVlNWQ5ZGVjODY5Zl80Ni9mcmFnOjE0YjkzMDBhMzZkNDQ1OTdhZGI5NzM0MDBlZTk5ZjYwL3RhYmxlOjU4YjhkMGUzODQyMzRjMzVhNWZjN2EyODMxMWFiZGMwL3RhYmxlcmFuZ2U6NThiOGQwZTM4NDIzNGMzNWE1ZmM3YTI4MzExYWJkYzBfNC02LTEtMS0w_bd186cbf-8049-4564-8906-36f18d560681">968</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i386ef852060640f8a03a30f10d03a1cd_I20201231" decimals="-3" format="ixt:numdotdecimal" name="cron:SensitivityAnalysisImpactOf10PercentDecreaseIncreaseInExpectedAnnualizedVolatilityOnNetIncomeLoss" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzY2E5YmIwMTc5MjQ3NmZiYjIyNWU1ZDlkZWM4NjlmL3NlYzo5M2NhOWJiMDE3OTI0NzZmYmIyMjVlNWQ5ZGVjODY5Zl80Ni9mcmFnOjE0YjkzMDBhMzZkNDQ1OTdhZGI5NzM0MDBlZTk5ZjYwL3RhYmxlOjU4YjhkMGUzODQyMzRjMzVhNWZjN2EyODMxMWFiZGMwL3RhYmxlcmFuZ2U6NThiOGQwZTM4NDIzNGMzNWE1ZmM3YTI4MzExYWJkYzBfNC04LTEtMS0xMDIx_73104c36-a6bd-490f-aba3-9ee2fba17d27">26,183</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i72ce1ade65834a50bf4468cde26bf617_I20201231" decimals="-3" format="ixt:numdotdecimal" name="cron:SensitivityAnalysisImpactOf10PercentDecreaseIncreaseInExpectedAnnualizedVolatilityOnNetIncomeLoss" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzY2E5YmIwMTc5MjQ3NmZiYjIyNWU1ZDlkZWM4NjlmL3NlYzo5M2NhOWJiMDE3OTI0NzZmYmIyMjVlNWQ5ZGVjODY5Zl80Ni9mcmFnOjE0YjkzMDBhMzZkNDQ1OTdhZGI5NzM0MDBlZTk5ZjYwL3RhYmxlOjU4YjhkMGUzODQyMzRjMzVhNWZjN2EyODMxMWFiZGMwL3RhYmxlcmFuZ2U6NThiOGQwZTM4NDIzNGMzNWE1ZmM3YTI4MzExYWJkYzBfNC0xMC0xLTEtMTAyNQ_06685eef-53d7-40c3-9a06-74a9f452b3ff">2,269</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if0aa3f5449da461c85f0c0831bf3c984_I20201231" decimals="-3" format="ixt:numdotdecimal" name="cron:SensitivityAnalysisImpactOf10PercentDecreaseIncreaseInExpectedAnnualizedVolatilityOnNetIncomeLoss" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzY2E5YmIwMTc5MjQ3NmZiYjIyNWU1ZDlkZWM4NjlmL3NlYzo5M2NhOWJiMDE3OTI0NzZmYmIyMjVlNWQ5ZGVjODY5Zl80Ni9mcmFnOjE0YjkzMDBhMzZkNDQ1OTdhZGI5NzM0MDBlZTk5ZjYwL3RhYmxlOjU4YjhkMGUzODQyMzRjMzVhNWZjN2EyODMxMWFiZGMwL3RhYmxlcmFuZ2U6NThiOGQwZTM4NDIzNGMzNWE1ZmM3YTI4MzExYWJkYzBfNC0xMi0xLTEtMTAyOQ_030ea8b6-ef15-44c4-b33d-75a5e7cac3f3">2,602</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr></table></div></ix:nonNumeric><div style="margin-bottom:6pt;margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">These inputs are classified in Level 3 on the fair value hierarchy and are subject to volatility and several factors outside of the Company&#8217;s control, which could significantly affect the fair value of these derivative liabilities in future periods.</span></div></ix:continuation><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span><br/></span></div><div style="height:36pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">15</span></div></div></div><div id="i93ca9bb01792476fbb225e5d9dec869f_49"></div><hr style="page-break-after:always"/><div style="min-height:72pt;width:100%"><div style="margin-top:0.55pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:95.000%"><tr><td style="width:1.0%"></td><td style="width:65.712%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:32.088%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="border-top:1pt solid #FFFFFF;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Cronos Group Inc.</span></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Notes to Condensed Consolidated Financial Statements (Unaudited)</span></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">(In thousands of $, except share amounts)</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i93ca9bb01792476fbb225e5d9dec869f_7">Table of Contents</a></span></div></td></tr></table></div></div><div style="margin-bottom:12pt;margin-top:6pt;text-align:justify"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">6. </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%"><ix:nonNumeric contextRef="i69782326f71a44e3805518280ee22b6b_D20210101-20210630" name="us-gaap:DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjkzY2E5YmIwMTc5MjQ3NmZiYjIyNWU1ZDlkZWM4NjlmL3NlYzo5M2NhOWJiMDE3OTI0NzZmYmIyMjVlNWQ5ZGVjODY5Zl80OS9mcmFnOjdkOTcyM2RkMjdkODRhNWFiYjJiMzcyOTJmYjZhMmUzL3RleHRyZWdpb246N2Q5NzIzZGQyN2Q4NGE1YWJiMmIzNzI5MmZiNmEyZTNfMjg0Ng_e91c1337-5cd8-448d-baba-6ee45cbbc70c" continuedAt="iae4711065ae7476591e18c710fa89cb7" escape="true">Share-based Payments</ix:nonNumeric></span></div><ix:continuation id="iae4711065ae7476591e18c710fa89cb7" continuedAt="if15489640cbd4fa6a03ae357adf8e8fd"><div style="margin-bottom:6pt;margin-top:6pt;padding-left:36pt;text-align:justify;text-indent:-36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(a)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;padding-left:24.34pt">Share-based award plans</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company has granted stock options, restricted share units (&#8220;RSUs&#8221;) and deferred share units (&#8220;DSUs&#8221;) to employees and non-employee directors under the Stock Option Plan dated May 26, 2015 (the &#8220;2015 Stock Option Plan&#8221;), the 2018 Stock Option Plan dated June 28, 2018 (the &#8220;2018 Stock Option Plan&#8221; and, together with the 2015 Stock Option Plan, the &#8220;Prior Option Plans&#8221;), the 2020 Omnibus Equity Incentive Plan dated March 29, 2020 (the &#8220;2020 Omnibus Plan&#8221;) and the DSU plan dated August 10, 2019 (the &#8220;DSU Plan&#8221;). The Company can no longer make grants under the Prior Option Plans.</span></div><ix:nonNumeric contextRef="i69782326f71a44e3805518280ee22b6b_D20210101-20210630" name="us-gaap:ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjkzY2E5YmIwMTc5MjQ3NmZiYjIyNWU1ZDlkZWM4NjlmL3NlYzo5M2NhOWJiMDE3OTI0NzZmYmIyMjVlNWQ5ZGVjODY5Zl80OS9mcmFnOjdkOTcyM2RkMjdkODRhNWFiYjJiMzcyOTJmYjZhMmUzL3RleHRyZWdpb246N2Q5NzIzZGQyN2Q4NGE1YWJiMmIzNzI5MmZiNmEyZTNfMjg0Nw_ef2174e4-e275-407d-93c0-6a5cea9949f5" escape="true"><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table summarizes the total share-based payments associated with the Company&#8217;s stock options and RSUs for the three and six months ended June 30, 2021 and 2020:</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:40.427%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.788%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.772%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.788%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.772%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.788%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.772%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.793%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">For the three months ended June&#160;30,</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">For the six months ended June&#160;30,</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Stock options</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1e4726863b724a379f5bd7d27ab5b3cc_D20210401-20210630" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:AllocatedShareBasedCompensationExpense" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzY2E5YmIwMTc5MjQ3NmZiYjIyNWU1ZDlkZWM4NjlmL3NlYzo5M2NhOWJiMDE3OTI0NzZmYmIyMjVlNWQ5ZGVjODY5Zl80OS9mcmFnOjdkOTcyM2RkMjdkODRhNWFiYjJiMzcyOTJmYjZhMmUzL3RhYmxlOjNhYjFkOTRlOWViOTRiMDJhNjYyYjJlZDA0NTY0MDBkL3RhYmxlcmFuZ2U6M2FiMWQ5NGU5ZWI5NGIwMmE2NjJiMmVkMDQ1NjQwMGRfMi0xLTEtMS0xNDM2Mg_f5e036b7-8e71-4583-8b6a-e18fbaf2e444">1,864</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie0f42dd5b3d34fe38a076491f8d4a0a5_D20200401-20200630" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:AllocatedShareBasedCompensationExpense" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzY2E5YmIwMTc5MjQ3NmZiYjIyNWU1ZDlkZWM4NjlmL3NlYzo5M2NhOWJiMDE3OTI0NzZmYmIyMjVlNWQ5ZGVjODY5Zl80OS9mcmFnOjdkOTcyM2RkMjdkODRhNWFiYjJiMzcyOTJmYjZhMmUzL3RhYmxlOjNhYjFkOTRlOWViOTRiMDJhNjYyYjJlZDA0NTY0MDBkL3RhYmxlcmFuZ2U6M2FiMWQ5NGU5ZWI5NGIwMmE2NjJiMmVkMDQ1NjQwMGRfMi0zLTEtMS0xNDM2Mg_ab36b14b-9e78-4e88-a4d6-3d86f6c5d447">1,770</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="idaf424f34df645f9a313b3cbd11846bb_D20210101-20210630" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:AllocatedShareBasedCompensationExpense" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzY2E5YmIwMTc5MjQ3NmZiYjIyNWU1ZDlkZWM4NjlmL3NlYzo5M2NhOWJiMDE3OTI0NzZmYmIyMjVlNWQ5ZGVjODY5Zl80OS9mcmFnOjdkOTcyM2RkMjdkODRhNWFiYjJiMzcyOTJmYjZhMmUzL3RhYmxlOjNhYjFkOTRlOWViOTRiMDJhNjYyYjJlZDA0NTY0MDBkL3RhYmxlcmFuZ2U6M2FiMWQ5NGU5ZWI5NGIwMmE2NjJiMmVkMDQ1NjQwMGRfMi0yLTEtMS0w_0b61be96-45ec-4a04-8481-9ab2bd97e1d5">3,928</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib8a293d71fca4827bbf9cac05f24fe68_D20200101-20200630" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:AllocatedShareBasedCompensationExpense" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzY2E5YmIwMTc5MjQ3NmZiYjIyNWU1ZDlkZWM4NjlmL3NlYzo5M2NhOWJiMDE3OTI0NzZmYmIyMjVlNWQ5ZGVjODY5Zl80OS9mcmFnOjdkOTcyM2RkMjdkODRhNWFiYjJiMzcyOTJmYjZhMmUzL3RhYmxlOjNhYjFkOTRlOWViOTRiMDJhNjYyYjJlZDA0NTY0MDBkL3RhYmxlcmFuZ2U6M2FiMWQ5NGU5ZWI5NGIwMmE2NjJiMmVkMDQ1NjQwMGRfMi00LTEtMS0w_29a73df4-c130-49cd-bacb-04f802e42011">3,500</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">RSUs</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia9e804ad8293416391f6038663c9425b_D20210401-20210630" decimals="-3" name="us-gaap:AllocatedShareBasedCompensationExpense" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzY2E5YmIwMTc5MjQ3NmZiYjIyNWU1ZDlkZWM4NjlmL3NlYzo5M2NhOWJiMDE3OTI0NzZmYmIyMjVlNWQ5ZGVjODY5Zl80OS9mcmFnOjdkOTcyM2RkMjdkODRhNWFiYjJiMzcyOTJmYjZhMmUzL3RhYmxlOjNhYjFkOTRlOWViOTRiMDJhNjYyYjJlZDA0NTY0MDBkL3RhYmxlcmFuZ2U6M2FiMWQ5NGU5ZWI5NGIwMmE2NjJiMmVkMDQ1NjQwMGRfMy0xLTEtMS0xNDM2Mg_05a54901-0906-45e6-812c-782056c62ead">701</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if0a238351a57425a8c0ba03f482ef4b9_D20200401-20200630" decimals="-3" name="us-gaap:AllocatedShareBasedCompensationExpense" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzY2E5YmIwMTc5MjQ3NmZiYjIyNWU1ZDlkZWM4NjlmL3NlYzo5M2NhOWJiMDE3OTI0NzZmYmIyMjVlNWQ5ZGVjODY5Zl80OS9mcmFnOjdkOTcyM2RkMjdkODRhNWFiYjJiMzcyOTJmYjZhMmUzL3RhYmxlOjNhYjFkOTRlOWViOTRiMDJhNjYyYjJlZDA0NTY0MDBkL3RhYmxlcmFuZ2U6M2FiMWQ5NGU5ZWI5NGIwMmE2NjJiMmVkMDQ1NjQwMGRfMy0zLTEtMS0xNDM2Mg_0b56367b-4e96-47d5-bb38-9fd8c653a521">776</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie5eb2f0b8440403abdac2db9e01adbb9_D20210101-20210630" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:AllocatedShareBasedCompensationExpense" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzY2E5YmIwMTc5MjQ3NmZiYjIyNWU1ZDlkZWM4NjlmL3NlYzo5M2NhOWJiMDE3OTI0NzZmYmIyMjVlNWQ5ZGVjODY5Zl80OS9mcmFnOjdkOTcyM2RkMjdkODRhNWFiYjJiMzcyOTJmYjZhMmUzL3RhYmxlOjNhYjFkOTRlOWViOTRiMDJhNjYyYjJlZDA0NTY0MDBkL3RhYmxlcmFuZ2U6M2FiMWQ5NGU5ZWI5NGIwMmE2NjJiMmVkMDQ1NjQwMGRfMy0yLTEtMS0w_50766b7f-58e9-4bec-a4ca-0a27bbb8f1ae">1,136</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i10cd1c126464402b99bfac52e7ebdbb2_D20200101-20200630" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:AllocatedShareBasedCompensationExpense" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzY2E5YmIwMTc5MjQ3NmZiYjIyNWU1ZDlkZWM4NjlmL3NlYzo5M2NhOWJiMDE3OTI0NzZmYmIyMjVlNWQ5ZGVjODY5Zl80OS9mcmFnOjdkOTcyM2RkMjdkODRhNWFiYjJiMzcyOTJmYjZhMmUzL3RhYmxlOjNhYjFkOTRlOWViOTRiMDJhNjYyYjJlZDA0NTY0MDBkL3RhYmxlcmFuZ2U6M2FiMWQ5NGU5ZWI5NGIwMmE2NjJiMmVkMDQ1NjQwMGRfMy00LTEtMS0w_d01f762b-15c6-44f8-ad1d-09147c5b40a2">1,482</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total share-based payments</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i27f4e53b91ad4367b7f8d273eff27769_D20210401-20210630" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:AllocatedShareBasedCompensationExpense" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzY2E5YmIwMTc5MjQ3NmZiYjIyNWU1ZDlkZWM4NjlmL3NlYzo5M2NhOWJiMDE3OTI0NzZmYmIyMjVlNWQ5ZGVjODY5Zl80OS9mcmFnOjdkOTcyM2RkMjdkODRhNWFiYjJiMzcyOTJmYjZhMmUzL3RhYmxlOjNhYjFkOTRlOWViOTRiMDJhNjYyYjJlZDA0NTY0MDBkL3RhYmxlcmFuZ2U6M2FiMWQ5NGU5ZWI5NGIwMmE2NjJiMmVkMDQ1NjQwMGRfNC0xLTEtMS0xNDM2Mg_8ada6da0-0a22-4444-a222-17de39fc48a8">2,565</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i39065c5daf934af885335c12f3cfa83f_D20200401-20200630" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:AllocatedShareBasedCompensationExpense" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzY2E5YmIwMTc5MjQ3NmZiYjIyNWU1ZDlkZWM4NjlmL3NlYzo5M2NhOWJiMDE3OTI0NzZmYmIyMjVlNWQ5ZGVjODY5Zl80OS9mcmFnOjdkOTcyM2RkMjdkODRhNWFiYjJiMzcyOTJmYjZhMmUzL3RhYmxlOjNhYjFkOTRlOWViOTRiMDJhNjYyYjJlZDA0NTY0MDBkL3RhYmxlcmFuZ2U6M2FiMWQ5NGU5ZWI5NGIwMmE2NjJiMmVkMDQ1NjQwMGRfNC0zLTEtMS0xNDM2Mg_5da5659d-dc2b-435d-bce1-10dfbf8942fb">2,546</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i69782326f71a44e3805518280ee22b6b_D20210101-20210630" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:AllocatedShareBasedCompensationExpense" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzY2E5YmIwMTc5MjQ3NmZiYjIyNWU1ZDlkZWM4NjlmL3NlYzo5M2NhOWJiMDE3OTI0NzZmYmIyMjVlNWQ5ZGVjODY5Zl80OS9mcmFnOjdkOTcyM2RkMjdkODRhNWFiYjJiMzcyOTJmYjZhMmUzL3RhYmxlOjNhYjFkOTRlOWViOTRiMDJhNjYyYjJlZDA0NTY0MDBkL3RhYmxlcmFuZ2U6M2FiMWQ5NGU5ZWI5NGIwMmE2NjJiMmVkMDQ1NjQwMGRfNC0yLTEtMS0w_a4234147-60c5-4f1c-8cdf-2d0b6e51a319">5,064</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4a110e4972ef4113880ce582e3cda5c5_D20200101-20200630" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:AllocatedShareBasedCompensationExpense" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzY2E5YmIwMTc5MjQ3NmZiYjIyNWU1ZDlkZWM4NjlmL3NlYzo5M2NhOWJiMDE3OTI0NzZmYmIyMjVlNWQ5ZGVjODY5Zl80OS9mcmFnOjdkOTcyM2RkMjdkODRhNWFiYjJiMzcyOTJmYjZhMmUzL3RhYmxlOjNhYjFkOTRlOWViOTRiMDJhNjYyYjJlZDA0NTY0MDBkL3RhYmxlcmFuZ2U6M2FiMWQ5NGU5ZWI5NGIwMmE2NjJiMmVkMDQ1NjQwMGRfNC00LTEtMS0w_9ab62728-59d0-4f51-ba53-317fccd61468">4,982</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div></ix:nonNumeric><div style="margin-bottom:6pt;margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(b)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;padding-left:23.78pt">Stock options</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Vesting conditions for grants of options are determined by the Compensation Committee of the Company&#8217;s Board of Directors. The typical vesting for stock option grants made under the 2020 Omnibus Plan is annual vesting over <span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOjkzY2E5YmIwMTc5MjQ3NmZiYjIyNWU1ZDlkZWM4NjlmL3NlYzo5M2NhOWJiMDE3OTI0NzZmYmIyMjVlNWQ5ZGVjODY5Zl80OS9mcmFnOjdkOTcyM2RkMjdkODRhNWFiYjJiMzcyOTJmYjZhMmUzL3RleHRyZWdpb246N2Q5NzIzZGQyN2Q4NGE1YWJiMmIzNzI5MmZiNmEyZTNfMTAxNA_bcd0b46d-5e0a-4add-a684-db7137029aee">three</span> to <ix:nonNumeric contextRef="ic0313757b4a149aca72f641901924190_D20200329-20200329" format="ixt-sec:durwordsen" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1" id="id3VybDovL2RvY3MudjEvZG9jOjkzY2E5YmIwMTc5MjQ3NmZiYjIyNWU1ZDlkZWM4NjlmL3NlYzo5M2NhOWJiMDE3OTI0NzZmYmIyMjVlNWQ5ZGVjODY5Zl80OS9mcmFnOjdkOTcyM2RkMjdkODRhNWFiYjJiMzcyOTJmYjZhMmUzL3RleHRyZWdpb246N2Q5NzIzZGQyN2Q4NGE1YWJiMmIzNzI5MmZiNmEyZTNfMTAyMA_9fd472b2-0b73-43fd-b64a-3040747336d6">five years</ix:nonNumeric> with a maximum term of <ix:nonNumeric contextRef="i568a7b89865a4c0783608a8f7c7a5fbc_D20200329-20200329" format="ixt-sec:durwordsen" name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod" id="id3VybDovL2RvY3MudjEvZG9jOjkzY2E5YmIwMTc5MjQ3NmZiYjIyNWU1ZDlkZWM4NjlmL3NlYzo5M2NhOWJiMDE3OTI0NzZmYmIyMjVlNWQ5ZGVjODY5Zl80OS9mcmFnOjdkOTcyM2RkMjdkODRhNWFiYjJiMzcyOTJmYjZhMmUzL3RleHRyZWdpb246N2Q5NzIzZGQyN2Q4NGE1YWJiMmIzNzI5MmZiNmEyZTNfMTA0Ng_1e6d2e01-f0e4-44e8-839d-6889a52e44e7">ten years</ix:nonNumeric>. The typical vesting for stock option grants made under the Prior Option Plans is quarterly vesting over <span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOjkzY2E5YmIwMTc5MjQ3NmZiYjIyNWU1ZDlkZWM4NjlmL3NlYzo5M2NhOWJiMDE3OTI0NzZmYmIyMjVlNWQ5ZGVjODY5Zl80OS9mcmFnOjdkOTcyM2RkMjdkODRhNWFiYjJiMzcyOTJmYjZhMmUzL3RleHRyZWdpb246N2Q5NzIzZGQyN2Q4NGE1YWJiMmIzNzI5MmZiNmEyZTNfMTE1NA_462d9472-3856-448b-97f2-4ab4e5aeb10e">three</span> to <ix:nonNumeric contextRef="i689be39a953e4627b86c363090d56882_D20200329-20200329" format="ixt-sec:durwordsen" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1" id="id3VybDovL2RvY3MudjEvZG9jOjkzY2E5YmIwMTc5MjQ3NmZiYjIyNWU1ZDlkZWM4NjlmL3NlYzo5M2NhOWJiMDE3OTI0NzZmYmIyMjVlNWQ5ZGVjODY5Zl80OS9mcmFnOjdkOTcyM2RkMjdkODRhNWFiYjJiMzcyOTJmYjZhMmUzL3RleHRyZWdpb246N2Q5NzIzZGQyN2Q4NGE1YWJiMmIzNzI5MmZiNmEyZTNfMTE2MA_52bb3a29-d2c9-4c32-89ee-157091af1a23">five years</ix:nonNumeric> with a maximum term of <ix:nonNumeric contextRef="i4146f88cdb16474694c2187038fecec2_D20200329-20200329" format="ixt-sec:durwordsen" name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod" id="id3VybDovL2RvY3MudjEvZG9jOjkzY2E5YmIwMTc5MjQ3NmZiYjIyNWU1ZDlkZWM4NjlmL3NlYzo5M2NhOWJiMDE3OTI0NzZmYmIyMjVlNWQ5ZGVjODY5Zl80OS9mcmFnOjdkOTcyM2RkMjdkODRhNWFiYjJiMzcyOTJmYjZhMmUzL3RleHRyZWdpb246N2Q5NzIzZGQyN2Q4NGE1YWJiMmIzNzI5MmZiNmEyZTNfMTE4Ng_84526134-c85d-42c1-9304-57a0b82583bb">seven years</ix:nonNumeric>. The Prior Option Plans did not, and the 2020 Omnibus Plan does not, authorize grants of options with an exercise price below fair market value.</span></div><ix:nonNumeric contextRef="i69782326f71a44e3805518280ee22b6b_D20210101-20210630" name="us-gaap:ScheduleOfStockOptionsRollForwardTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjkzY2E5YmIwMTc5MjQ3NmZiYjIyNWU1ZDlkZWM4NjlmL3NlYzo5M2NhOWJiMDE3OTI0NzZmYmIyMjVlNWQ5ZGVjODY5Zl80OS9mcmFnOjdkOTcyM2RkMjdkODRhNWFiYjJiMzcyOTJmYjZhMmUzL3RleHRyZWdpb246N2Q5NzIzZGQyN2Q4NGE1YWJiMmIzNzI5MmZiNmEyZTNfMjg0MA_1356cb73-8cd8-4e5d-8a1b-f81044080ffb" continuedAt="i90cc4673c54049d6b2bd4d086a61ec09" escape="true"><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following is a summary of the changes in stock options during the six months ended June&#160;30, 2021 and 2020:</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:51.261%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.761%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:1.327%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.761%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:1.327%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.763%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Weighted average exercise price (C$)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:700;line-height:100%;position:relative;top:-2.8pt;vertical-align:baseline"> (i)</span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Number of options</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Weighted average remaining contractual term (years)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance as of January 1, 2021</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="cadPerShare" contextRef="ifbe16ec51ea244519b77d6036b4ef038_I20201231" decimals="2" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjkzY2E5YmIwMTc5MjQ3NmZiYjIyNWU1ZDlkZWM4NjlmL3NlYzo5M2NhOWJiMDE3OTI0NzZmYmIyMjVlNWQ5ZGVjODY5Zl80OS9mcmFnOjdkOTcyM2RkMjdkODRhNWFiYjJiMzcyOTJmYjZhMmUzL3RhYmxlOmQ5YzFjYTA3OWJlYzQxMWE4MjBhMjdjODg1MGI0NDUzL3RhYmxlcmFuZ2U6ZDljMWNhMDc5YmVjNDExYTgyMGEyN2M4ODUwYjQ0NTNfMS0xLTEtMS0w_07aff689-1599-4233-89f2-1eb206816744">5.40</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="ifbe16ec51ea244519b77d6036b4ef038_I20201231" decimals="INF" format="ixt:numdotdecimal" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjkzY2E5YmIwMTc5MjQ3NmZiYjIyNWU1ZDlkZWM4NjlmL3NlYzo5M2NhOWJiMDE3OTI0NzZmYmIyMjVlNWQ5ZGVjODY5Zl80OS9mcmFnOjdkOTcyM2RkMjdkODRhNWFiYjJiMzcyOTJmYjZhMmUzL3RhYmxlOmQ5YzFjYTA3OWJlYzQxMWE4MjBhMjdjODg1MGI0NDUzL3RhYmxlcmFuZ2U6ZDljMWNhMDc5YmVjNDExYTgyMGEyN2M4ODUwYjQ0NTNfMS0zLTEtMS0w_6bab0956-0eb1-449c-b4c2-4e508f90c77b">13,755,148</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="i539631cd7950486e81b39a054a00c7d0_D20200101-20201231" format="ixt-sec:duryear" name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2" id="id3VybDovL2RvY3MudjEvZG9jOjkzY2E5YmIwMTc5MjQ3NmZiYjIyNWU1ZDlkZWM4NjlmL3NlYzo5M2NhOWJiMDE3OTI0NzZmYmIyMjVlNWQ5ZGVjODY5Zl80OS9mcmFnOjdkOTcyM2RkMjdkODRhNWFiYjJiMzcyOTJmYjZhMmUzL3RhYmxlOmQ5YzFjYTA3OWJlYzQxMWE4MjBhMjdjODg1MGI0NDUzL3RhYmxlcmFuZ2U6ZDljMWNhMDc5YmVjNDExYTgyMGEyN2M4ODUwYjQ0NTNfMS01LTEtMS0w_45e59289-00f6-4194-9fcc-ad14d44dbcb8">2.30</ix:nonNumeric></span></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Exercise of options</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="cadPerShare" contextRef="i69782326f71a44e3805518280ee22b6b_D20210101-20210630" decimals="2" name="us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjkzY2E5YmIwMTc5MjQ3NmZiYjIyNWU1ZDlkZWM4NjlmL3NlYzo5M2NhOWJiMDE3OTI0NzZmYmIyMjVlNWQ5ZGVjODY5Zl80OS9mcmFnOjdkOTcyM2RkMjdkODRhNWFiYjJiMzcyOTJmYjZhMmUzL3RhYmxlOmQ5YzFjYTA3OWJlYzQxMWE4MjBhMjdjODg1MGI0NDUzL3RhYmxlcmFuZ2U6ZDljMWNhMDc5YmVjNDExYTgyMGEyN2M4ODUwYjQ0NTNfMy0xLTEtMS0w_5a561712-e136-454e-814e-e6ea8b1962eb">2.14</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="shares" contextRef="i69782326f71a44e3805518280ee22b6b_D20210101-20210630" decimals="INF" format="ixt:numdotdecimal" name="us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjkzY2E5YmIwMTc5MjQ3NmZiYjIyNWU1ZDlkZWM4NjlmL3NlYzo5M2NhOWJiMDE3OTI0NzZmYmIyMjVlNWQ5ZGVjODY5Zl80OS9mcmFnOjdkOTcyM2RkMjdkODRhNWFiYjJiMzcyOTJmYjZhMmUzL3RhYmxlOmQ5YzFjYTA3OWJlYzQxMWE4MjBhMjdjODg1MGI0NDUzL3RhYmxlcmFuZ2U6ZDljMWNhMDc5YmVjNDExYTgyMGEyN2M4ODUwYjQ0NTNfMy0zLTEtMS0w_ebb9e5bf-46a6-4312-8952-81230dc8c36f">5,349,818</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cancellation, forfeiture and expiry of options</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="cadPerShare" contextRef="i69782326f71a44e3805518280ee22b6b_D20210101-20210630" decimals="2" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjkzY2E5YmIwMTc5MjQ3NmZiYjIyNWU1ZDlkZWM4NjlmL3NlYzo5M2NhOWJiMDE3OTI0NzZmYmIyMjVlNWQ5ZGVjODY5Zl80OS9mcmFnOjdkOTcyM2RkMjdkODRhNWFiYjJiMzcyOTJmYjZhMmUzL3RhYmxlOmQ5YzFjYTA3OWJlYzQxMWE4MjBhMjdjODg1MGI0NDUzL3RhYmxlcmFuZ2U6ZDljMWNhMDc5YmVjNDExYTgyMGEyN2M4ODUwYjQ0NTNfNC0xLTEtMS0w_b8f39da8-5774-486c-bc6c-24e5453c936f">14.86</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="shares" contextRef="i69782326f71a44e3805518280ee22b6b_D20210101-20210630" decimals="INF" format="ixt:numdotdecimal" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjkzY2E5YmIwMTc5MjQ3NmZiYjIyNWU1ZDlkZWM4NjlmL3NlYzo5M2NhOWJiMDE3OTI0NzZmYmIyMjVlNWQ5ZGVjODY5Zl80OS9mcmFnOjdkOTcyM2RkMjdkODRhNWFiYjJiMzcyOTJmYjZhMmUzL3RhYmxlOmQ5YzFjYTA3OWJlYzQxMWE4MjBhMjdjODg1MGI0NDUzL3RhYmxlcmFuZ2U6ZDljMWNhMDc5YmVjNDExYTgyMGEyN2M4ODUwYjQ0NTNfNC0zLTEtMS0w_0c0d2b75-1331-429e-b705-d652f274473e">33,699</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance as of June&#160;30, 2021</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="cadPerShare" contextRef="i225f85e38faa4bbdb4de1d8b9cf369bb_I20210630" decimals="2" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjkzY2E5YmIwMTc5MjQ3NmZiYjIyNWU1ZDlkZWM4NjlmL3NlYzo5M2NhOWJiMDE3OTI0NzZmYmIyMjVlNWQ5ZGVjODY5Zl80OS9mcmFnOjdkOTcyM2RkMjdkODRhNWFiYjJiMzcyOTJmYjZhMmUzL3RhYmxlOmQ5YzFjYTA3OWJlYzQxMWE4MjBhMjdjODg1MGI0NDUzL3RhYmxlcmFuZ2U6ZDljMWNhMDc5YmVjNDExYTgyMGEyN2M4ODUwYjQ0NTNfNS0xLTEtMS0w_dc0bca1a-88e9-480e-9c50-e31912492255">7.45</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i225f85e38faa4bbdb4de1d8b9cf369bb_I20210630" decimals="INF" format="ixt:numdotdecimal" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjkzY2E5YmIwMTc5MjQ3NmZiYjIyNWU1ZDlkZWM4NjlmL3NlYzo5M2NhOWJiMDE3OTI0NzZmYmIyMjVlNWQ5ZGVjODY5Zl80OS9mcmFnOjdkOTcyM2RkMjdkODRhNWFiYjJiMzcyOTJmYjZhMmUzL3RhYmxlOmQ5YzFjYTA3OWJlYzQxMWE4MjBhMjdjODg1MGI0NDUzL3RhYmxlcmFuZ2U6ZDljMWNhMDc5YmVjNDExYTgyMGEyN2M4ODUwYjQ0NTNfNS0zLTEtMS0w_b0c3501d-805d-4e8c-80ce-2f020a97c01e">8,371,631</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="i69782326f71a44e3805518280ee22b6b_D20210101-20210630" format="ixt-sec:duryear" name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2" id="id3VybDovL2RvY3MudjEvZG9jOjkzY2E5YmIwMTc5MjQ3NmZiYjIyNWU1ZDlkZWM4NjlmL3NlYzo5M2NhOWJiMDE3OTI0NzZmYmIyMjVlNWQ5ZGVjODY5Zl80OS9mcmFnOjdkOTcyM2RkMjdkODRhNWFiYjJiMzcyOTJmYjZhMmUzL3RhYmxlOmQ5YzFjYTA3OWJlYzQxMWE4MjBhMjdjODg1MGI0NDUzL3RhYmxlcmFuZ2U6ZDljMWNhMDc5YmVjNDExYTgyMGEyN2M4ODUwYjQ0NTNfNS01LTEtMS0w_5d120e9c-8493-49f4-851b-747ad49ddb65">2.66</ix:nonNumeric></span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Exercisable as of June&#160;30, 2021</span></td><td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="i225f85e38faa4bbdb4de1d8b9cf369bb_I20210630" decimals="2" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjkzY2E5YmIwMTc5MjQ3NmZiYjIyNWU1ZDlkZWM4NjlmL3NlYzo5M2NhOWJiMDE3OTI0NzZmYmIyMjVlNWQ5ZGVjODY5Zl80OS9mcmFnOjdkOTcyM2RkMjdkODRhNWFiYjJiMzcyOTJmYjZhMmUzL3RhYmxlOmQ5YzFjYTA3OWJlYzQxMWE4MjBhMjdjODg1MGI0NDUzL3RhYmxlcmFuZ2U6ZDljMWNhMDc5YmVjNDExYTgyMGEyN2M4ODUwYjQ0NTNfNi0xLTEtMS0w_ce965b30-36d8-4127-a2e7-c3df228577dc">6.49</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i225f85e38faa4bbdb4de1d8b9cf369bb_I20210630" decimals="INF" format="ixt:numdotdecimal" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjkzY2E5YmIwMTc5MjQ3NmZiYjIyNWU1ZDlkZWM4NjlmL3NlYzo5M2NhOWJiMDE3OTI0NzZmYmIyMjVlNWQ5ZGVjODY5Zl80OS9mcmFnOjdkOTcyM2RkMjdkODRhNWFiYjJiMzcyOTJmYjZhMmUzL3RhYmxlOmQ5YzFjYTA3OWJlYzQxMWE4MjBhMjdjODg1MGI0NDUzL3RhYmxlcmFuZ2U6ZDljMWNhMDc5YmVjNDExYTgyMGEyN2M4ODUwYjQ0NTNfNi0zLTEtMS0w_25589765-0714-4b37-894a-6fcc3ed2f8e8">4,679,240</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="i69782326f71a44e3805518280ee22b6b_D20210101-20210630" format="ixt-sec:duryear" name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageRemainingContractualTerm1" id="id3VybDovL2RvY3MudjEvZG9jOjkzY2E5YmIwMTc5MjQ3NmZiYjIyNWU1ZDlkZWM4NjlmL3NlYzo5M2NhOWJiMDE3OTI0NzZmYmIyMjVlNWQ5ZGVjODY5Zl80OS9mcmFnOjdkOTcyM2RkMjdkODRhNWFiYjJiMzcyOTJmYjZhMmUzL3RhYmxlOmQ5YzFjYTA3OWJlYzQxMWE4MjBhMjdjODg1MGI0NDUzL3RhYmxlcmFuZ2U6ZDljMWNhMDc5YmVjNDExYTgyMGEyN2M4ODUwYjQ0NTNfNi01LTEtMS0w_4e5cda04-bc6d-4ab4-a81c-209b25e5ada7">1.43</ix:nonNumeric></span></td></tr></table></div><div style="margin-top:6pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:400;line-height:120%;position:relative;top:-2.8pt;vertical-align:baseline">(i)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:13.1pt">The weighted average exercise price reflects the conversion of foreign currency-denominated stock options translated into C$ using the average foreign exchange rate as of the date of issuance. </span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:51.538%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.483%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:1.327%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.483%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:1.327%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:14.042%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Weighted average exercise price (C$)</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Number of options</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Weighted average remaining contractual term (years)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance as of January 1, 2020</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="cadPerShare" contextRef="ie4fc90ad6d7f4d39aea9cb65c8026e09_I20191231" decimals="2" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjkzY2E5YmIwMTc5MjQ3NmZiYjIyNWU1ZDlkZWM4NjlmL3NlYzo5M2NhOWJiMDE3OTI0NzZmYmIyMjVlNWQ5ZGVjODY5Zl80OS9mcmFnOjdkOTcyM2RkMjdkODRhNWFiYjJiMzcyOTJmYjZhMmUzL3RhYmxlOjIwZTFlMjU5ZDFlOTQwMGI5ZjY5MTE2NTY1OWMzZDFmL3RhYmxlcmFuZ2U6MjBlMWUyNTlkMWU5NDAwYjlmNjkxMTY1NjU5YzNkMWZfMS0xLTEtMS0w_499e0fea-a085-4d4c-90b1-6213b6198b0f">4.84</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="ie4fc90ad6d7f4d39aea9cb65c8026e09_I20191231" decimals="INF" format="ixt:numdotdecimal" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjkzY2E5YmIwMTc5MjQ3NmZiYjIyNWU1ZDlkZWM4NjlmL3NlYzo5M2NhOWJiMDE3OTI0NzZmYmIyMjVlNWQ5ZGVjODY5Zl80OS9mcmFnOjdkOTcyM2RkMjdkODRhNWFiYjJiMzcyOTJmYjZhMmUzL3RhYmxlOjIwZTFlMjU5ZDFlOTQwMGI5ZjY5MTE2NTY1OWMzZDFmL3RhYmxlcmFuZ2U6MjBlMWUyNTlkMWU5NDAwYjlmNjkxMTY1NjU5YzNkMWZfMS0zLTEtMS0w_57e17fbe-b0cf-4003-81ca-8c32d8728305">14,149,502</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="ic1ac4ebbf39f4d85959a2de4a782f891_D20190101-20191231" format="ixt-sec:duryear" name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2" id="id3VybDovL2RvY3MudjEvZG9jOjkzY2E5YmIwMTc5MjQ3NmZiYjIyNWU1ZDlkZWM4NjlmL3NlYzo5M2NhOWJiMDE3OTI0NzZmYmIyMjVlNWQ5ZGVjODY5Zl80OS9mcmFnOjdkOTcyM2RkMjdkODRhNWFiYjJiMzcyOTJmYjZhMmUzL3RhYmxlOjIwZTFlMjU5ZDFlOTQwMGI5ZjY5MTE2NTY1OWMzZDFmL3RhYmxlcmFuZ2U6MjBlMWUyNTlkMWU5NDAwYjlmNjkxMTY1NjU5YzNkMWZfMS01LTEtMS0w_e6da048f-5fc0-41a0-93be-182b6d605404">2.56</ix:nonNumeric></span></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Exercise of options</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="cadPerShare" contextRef="i4a110e4972ef4113880ce582e3cda5c5_D20200101-20200630" decimals="2" name="us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjkzY2E5YmIwMTc5MjQ3NmZiYjIyNWU1ZDlkZWM4NjlmL3NlYzo5M2NhOWJiMDE3OTI0NzZmYmIyMjVlNWQ5ZGVjODY5Zl80OS9mcmFnOjdkOTcyM2RkMjdkODRhNWFiYjJiMzcyOTJmYjZhMmUzL3RhYmxlOjIwZTFlMjU5ZDFlOTQwMGI5ZjY5MTE2NTY1OWMzZDFmL3RhYmxlcmFuZ2U6MjBlMWUyNTlkMWU5NDAwYjlmNjkxMTY1NjU5YzNkMWZfMy0xLTEtMS0w_9cedfc66-2a18-4b1d-b424-a47ed32a8fd8">2.05</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="shares" contextRef="i4a110e4972ef4113880ce582e3cda5c5_D20200101-20200630" decimals="INF" format="ixt:numdotdecimal" name="us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjkzY2E5YmIwMTc5MjQ3NmZiYjIyNWU1ZDlkZWM4NjlmL3NlYzo5M2NhOWJiMDE3OTI0NzZmYmIyMjVlNWQ5ZGVjODY5Zl80OS9mcmFnOjdkOTcyM2RkMjdkODRhNWFiYjJiMzcyOTJmYjZhMmUzL3RhYmxlOjIwZTFlMjU5ZDFlOTQwMGI5ZjY5MTE2NTY1OWMzZDFmL3RhYmxlcmFuZ2U6MjBlMWUyNTlkMWU5NDAwYjlmNjkxMTY1NjU5YzNkMWZfMy0zLTEtMS0w_a07e8d92-d503-4d19-a462-0fa318ee23a5">1,807,909</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cancellation, forfeiture and expiry of options</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="cadPerShare" contextRef="i4a110e4972ef4113880ce582e3cda5c5_D20200101-20200630" decimals="2" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjkzY2E5YmIwMTc5MjQ3NmZiYjIyNWU1ZDlkZWM4NjlmL3NlYzo5M2NhOWJiMDE3OTI0NzZmYmIyMjVlNWQ5ZGVjODY5Zl80OS9mcmFnOjdkOTcyM2RkMjdkODRhNWFiYjJiMzcyOTJmYjZhMmUzL3RhYmxlOjIwZTFlMjU5ZDFlOTQwMGI5ZjY5MTE2NTY1OWMzZDFmL3RhYmxlcmFuZ2U6MjBlMWUyNTlkMWU5NDAwYjlmNjkxMTY1NjU5YzNkMWZfNC0xLTEtMS0w_416989f9-3f0e-4833-b9ab-948f8c85caf0">15.78</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="shares" contextRef="i4a110e4972ef4113880ce582e3cda5c5_D20200101-20200630" decimals="INF" format="ixt:numdotdecimal" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjkzY2E5YmIwMTc5MjQ3NmZiYjIyNWU1ZDlkZWM4NjlmL3NlYzo5M2NhOWJiMDE3OTI0NzZmYmIyMjVlNWQ5ZGVjODY5Zl80OS9mcmFnOjdkOTcyM2RkMjdkODRhNWFiYjJiMzcyOTJmYjZhMmUzL3RhYmxlOjIwZTFlMjU5ZDFlOTQwMGI5ZjY5MTE2NTY1OWMzZDFmL3RhYmxlcmFuZ2U6MjBlMWUyNTlkMWU5NDAwYjlmNjkxMTY1NjU5YzNkMWZfNC0zLTEtMS0w_ffd369f3-970e-458d-ace1-54a517c160f3">127,045</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance as of June&#160;30, 2020</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="cadPerShare" contextRef="id670dc9b33e6430f9d7510009f7495a7_I20200630" decimals="2" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjkzY2E5YmIwMTc5MjQ3NmZiYjIyNWU1ZDlkZWM4NjlmL3NlYzo5M2NhOWJiMDE3OTI0NzZmYmIyMjVlNWQ5ZGVjODY5Zl80OS9mcmFnOjdkOTcyM2RkMjdkODRhNWFiYjJiMzcyOTJmYjZhMmUzL3RhYmxlOjIwZTFlMjU5ZDFlOTQwMGI5ZjY5MTE2NTY1OWMzZDFmL3RhYmxlcmFuZ2U6MjBlMWUyNTlkMWU5NDAwYjlmNjkxMTY1NjU5YzNkMWZfNS0xLTEtMS0w_ce4ca463-450c-4b88-be99-a665c9cfa89a">5.13</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="id670dc9b33e6430f9d7510009f7495a7_I20200630" decimals="INF" format="ixt:numdotdecimal" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjkzY2E5YmIwMTc5MjQ3NmZiYjIyNWU1ZDlkZWM4NjlmL3NlYzo5M2NhOWJiMDE3OTI0NzZmYmIyMjVlNWQ5ZGVjODY5Zl80OS9mcmFnOjdkOTcyM2RkMjdkODRhNWFiYjJiMzcyOTJmYjZhMmUzL3RhYmxlOjIwZTFlMjU5ZDFlOTQwMGI5ZjY5MTE2NTY1OWMzZDFmL3RhYmxlcmFuZ2U6MjBlMWUyNTlkMWU5NDAwYjlmNjkxMTY1NjU5YzNkMWZfNS0zLTEtMS0w_b61a8e30-d30e-433d-9b71-a5a6cd6ed1d1">12,214,548</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="i4a110e4972ef4113880ce582e3cda5c5_D20200101-20200630" format="ixt-sec:duryear" name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2" id="id3VybDovL2RvY3MudjEvZG9jOjkzY2E5YmIwMTc5MjQ3NmZiYjIyNWU1ZDlkZWM4NjlmL3NlYzo5M2NhOWJiMDE3OTI0NzZmYmIyMjVlNWQ5ZGVjODY5Zl80OS9mcmFnOjdkOTcyM2RkMjdkODRhNWFiYjJiMzcyOTJmYjZhMmUzL3RhYmxlOjIwZTFlMjU5ZDFlOTQwMGI5ZjY5MTE2NTY1OWMzZDFmL3RhYmxlcmFuZ2U6MjBlMWUyNTlkMWU5NDAwYjlmNjkxMTY1NjU5YzNkMWZfNS01LTEtMS0w_ca3e882f-239f-416d-bac3-a5210a85f694">2.05</ix:nonNumeric></span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Exercisable as of June&#160;30, 2020</span></td><td style="background-color:#cceeff;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:3pt double #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="id670dc9b33e6430f9d7510009f7495a7_I20200630" decimals="2" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjkzY2E5YmIwMTc5MjQ3NmZiYjIyNWU1ZDlkZWM4NjlmL3NlYzo5M2NhOWJiMDE3OTI0NzZmYmIyMjVlNWQ5ZGVjODY5Zl80OS9mcmFnOjdkOTcyM2RkMjdkODRhNWFiYjJiMzcyOTJmYjZhMmUzL3RhYmxlOjIwZTFlMjU5ZDFlOTQwMGI5ZjY5MTE2NTY1OWMzZDFmL3RhYmxlcmFuZ2U6MjBlMWUyNTlkMWU5NDAwYjlmNjkxMTY1NjU5YzNkMWZfNi0xLTEtMS0w_0c31cf01-9a77-4769-a0ef-acb4d2d340eb">3.42</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="id670dc9b33e6430f9d7510009f7495a7_I20200630" decimals="INF" format="ixt:numdotdecimal" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjkzY2E5YmIwMTc5MjQ3NmZiYjIyNWU1ZDlkZWM4NjlmL3NlYzo5M2NhOWJiMDE3OTI0NzZmYmIyMjVlNWQ5ZGVjODY5Zl80OS9mcmFnOjdkOTcyM2RkMjdkODRhNWFiYjJiMzcyOTJmYjZhMmUzL3RhYmxlOjIwZTFlMjU5ZDFlOTQwMGI5ZjY5MTE2NTY1OWMzZDFmL3RhYmxlcmFuZ2U6MjBlMWUyNTlkMWU5NDAwYjlmNjkxMTY1NjU5YzNkMWZfNi0zLTEtMS0w_a5b54eca-0238-4de1-a19c-e689f7c1ccf7">8,688,645</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="i4a110e4972ef4113880ce582e3cda5c5_D20200101-20200630" format="ixt-sec:duryear" name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageRemainingContractualTerm1" id="id3VybDovL2RvY3MudjEvZG9jOjkzY2E5YmIwMTc5MjQ3NmZiYjIyNWU1ZDlkZWM4NjlmL3NlYzo5M2NhOWJiMDE3OTI0NzZmYmIyMjVlNWQ5ZGVjODY5Zl80OS9mcmFnOjdkOTcyM2RkMjdkODRhNWFiYjJiMzcyOTJmYjZhMmUzL3RhYmxlOjIwZTFlMjU5ZDFlOTQwMGI5ZjY5MTE2NTY1OWMzZDFmL3RhYmxlcmFuZ2U6MjBlMWUyNTlkMWU5NDAwYjlmNjkxMTY1NjU5YzNkMWZfNi01LTEtMS0w_fec723da-3dc7-4f67-bbeb-318f70f07cc4">1.78</ix:nonNumeric></span></td></tr></table></div></ix:nonNumeric><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="shares" contextRef="i4a110e4972ef4113880ce582e3cda5c5_D20200101-20200630" decimals="INF" format="ixt-sec:numwordsen" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjkzY2E5YmIwMTc5MjQ3NmZiYjIyNWU1ZDlkZWM4NjlmL3NlYzo5M2NhOWJiMDE3OTI0NzZmYmIyMjVlNWQ5ZGVjODY5Zl80OS9mcmFnOjdkOTcyM2RkMjdkODRhNWFiYjJiMzcyOTJmYjZhMmUzL3RleHRyZWdpb246N2Q5NzIzZGQyN2Q4NGE1YWJiMmIzNzI5MmZiNmEyZTNfOTg5NTYwNDY1NTAyMw_1c9f2158-f8c5-4387-870a-bb6978ced946"><ix:nonFraction unitRef="shares" contextRef="i69782326f71a44e3805518280ee22b6b_D20210101-20210630" decimals="INF" format="ixt-sec:numwordsen" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjkzY2E5YmIwMTc5MjQ3NmZiYjIyNWU1ZDlkZWM4NjlmL3NlYzo5M2NhOWJiMDE3OTI0NzZmYmIyMjVlNWQ5ZGVjODY5Zl80OS9mcmFnOjdkOTcyM2RkMjdkODRhNWFiYjJiMzcyOTJmYjZhMmUzL3RleHRyZWdpb246N2Q5NzIzZGQyN2Q4NGE1YWJiMmIzNzI5MmZiNmEyZTNfOTg5NTYwNDY1NTAyMw_44f9f77c-5915-459e-bbdb-987a4cdcdae2">No</ix:nonFraction></ix:nonFraction> stock options were granted during the six months ended June&#160;30, 2021 and 2020.</span></div></ix:continuation><div style="height:36pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">16</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:72pt;width:100%"><div style="margin-top:0.55pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:95.000%"><tr><td style="width:1.0%"></td><td style="width:65.712%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:32.088%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="border-top:1pt solid #FFFFFF;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Cronos Group Inc.</span></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Notes to Condensed Consolidated Financial Statements (Unaudited)</span></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">(In thousands of $, except share amounts)</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i93ca9bb01792476fbb225e5d9dec869f_7">Table of Contents</a></span></div></td></tr></table></div></div><ix:continuation id="if15489640cbd4fa6a03ae357adf8e8fd" continuedAt="idb0bc2e58b7b47408cc53bc7c33aebdc"><ix:continuation id="i90cc4673c54049d6b2bd4d086a61ec09"><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table summarizes stock options outstanding for the 2020 Omnibus Plan, the 2018 Stock Option Plan, and the 2015 Stock Option Plan:</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.861%"><tr><td style="width:1.0%"></td><td style="width:52.168%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:21.431%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:1.468%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:21.433%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Stock options outstanding as of</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">June 30, 2021</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 31, 2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2020 Omnibus Plan</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="ib49e288fbb504210b764575656013515_I20210630" decimals="INF" format="ixt:numdotdecimal" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjkzY2E5YmIwMTc5MjQ3NmZiYjIyNWU1ZDlkZWM4NjlmL3NlYzo5M2NhOWJiMDE3OTI0NzZmYmIyMjVlNWQ5ZGVjODY5Zl80OS9mcmFnOjdkOTcyM2RkMjdkODRhNWFiYjJiMzcyOTJmYjZhMmUzL3RhYmxlOjc0ZjZkOWViM2ZhNDQ5NDBhNmJiMTA3YjVmZjFhNzIwL3RhYmxlcmFuZ2U6NzRmNmQ5ZWIzZmE0NDk0MGE2YmIxMDdiNWZmMWE3MjBfMi0xLTEtMS0w_d4b5518f-942b-4451-91ad-544e2110b40d">2,000,000</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i940a5cbdd4164d3996cb15eddebf6022_I20201231" decimals="INF" format="ixt:numdotdecimal" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjkzY2E5YmIwMTc5MjQ3NmZiYjIyNWU1ZDlkZWM4NjlmL3NlYzo5M2NhOWJiMDE3OTI0NzZmYmIyMjVlNWQ5ZGVjODY5Zl80OS9mcmFnOjdkOTcyM2RkMjdkODRhNWFiYjJiMzcyOTJmYjZhMmUzL3RhYmxlOjc0ZjZkOWViM2ZhNDQ5NDBhNmJiMTA3YjVmZjFhNzIwL3RhYmxlcmFuZ2U6NzRmNmQ5ZWIzZmE0NDk0MGE2YmIxMDdiNWZmMWE3MjBfMi0zLTEtMS0w_d80c9ac7-4e5a-41a2-8d40-55d32cfb9467">2,000,000</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2018 Stock Option Plan </span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i71217ccb65f54a46844f4ef961eef8ed_I20210630" decimals="INF" format="ixt:numdotdecimal" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjkzY2E5YmIwMTc5MjQ3NmZiYjIyNWU1ZDlkZWM4NjlmL3NlYzo5M2NhOWJiMDE3OTI0NzZmYmIyMjVlNWQ5ZGVjODY5Zl80OS9mcmFnOjdkOTcyM2RkMjdkODRhNWFiYjJiMzcyOTJmYjZhMmUzL3RhYmxlOjc0ZjZkOWViM2ZhNDQ5NDBhNmJiMTA3YjVmZjFhNzIwL3RhYmxlcmFuZ2U6NzRmNmQ5ZWIzZmE0NDk0MGE2YmIxMDdiNWZmMWE3MjBfMy0xLTEtMS0w_3c55cfa7-a411-4f48-93c9-7b2cbc73c17b">1,586,725</ix:nonFraction></span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i9901793e0a0c46f483b159aad44d157c_I20201231" decimals="INF" format="ixt:numdotdecimal" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjkzY2E5YmIwMTc5MjQ3NmZiYjIyNWU1ZDlkZWM4NjlmL3NlYzo5M2NhOWJiMDE3OTI0NzZmYmIyMjVlNWQ5ZGVjODY5Zl80OS9mcmFnOjdkOTcyM2RkMjdkODRhNWFiYjJiMzcyOTJmYjZhMmUzL3RhYmxlOjc0ZjZkOWViM2ZhNDQ5NDBhNmJiMTA3YjVmZjFhNzIwL3RhYmxlcmFuZ2U6NzRmNmQ5ZWIzZmE0NDk0MGE2YmIxMDdiNWZmMWE3MjBfMy0zLTEtMS0w_2af36e37-09ea-4f9e-a481-fc7f859e8756">1,627,715</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2015 Stock Option Plan </span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i67847aa2abfa472593c968c856dcd228_I20210630" decimals="INF" format="ixt:numdotdecimal" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjkzY2E5YmIwMTc5MjQ3NmZiYjIyNWU1ZDlkZWM4NjlmL3NlYzo5M2NhOWJiMDE3OTI0NzZmYmIyMjVlNWQ5ZGVjODY5Zl80OS9mcmFnOjdkOTcyM2RkMjdkODRhNWFiYjJiMzcyOTJmYjZhMmUzL3RhYmxlOjc0ZjZkOWViM2ZhNDQ5NDBhNmJiMTA3YjVmZjFhNzIwL3RhYmxlcmFuZ2U6NzRmNmQ5ZWIzZmE0NDk0MGE2YmIxMDdiNWZmMWE3MjBfNC0xLTEtMS0w_3aa8f9c3-6732-45b4-99a9-3420f0924b92">4,784,906</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="ia6fe44bf977249a2919be8435dfaa9a2_I20201231" decimals="INF" format="ixt:numdotdecimal" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjkzY2E5YmIwMTc5MjQ3NmZiYjIyNWU1ZDlkZWM4NjlmL3NlYzo5M2NhOWJiMDE3OTI0NzZmYmIyMjVlNWQ5ZGVjODY5Zl80OS9mcmFnOjdkOTcyM2RkMjdkODRhNWFiYjJiMzcyOTJmYjZhMmUzL3RhYmxlOjc0ZjZkOWViM2ZhNDQ5NDBhNmJiMTA3YjVmZjFhNzIwL3RhYmxlcmFuZ2U6NzRmNmQ5ZWIzZmE0NDk0MGE2YmIxMDdiNWZmMWE3MjBfNC0zLTEtMS0w_6765a4f1-3637-4cb3-8aa4-ae7bb5770e38">10,127,433</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total stock options outstanding</span></td><td colspan="3" style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i225f85e38faa4bbdb4de1d8b9cf369bb_I20210630" decimals="INF" format="ixt:numdotdecimal" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjkzY2E5YmIwMTc5MjQ3NmZiYjIyNWU1ZDlkZWM4NjlmL3NlYzo5M2NhOWJiMDE3OTI0NzZmYmIyMjVlNWQ5ZGVjODY5Zl80OS9mcmFnOjdkOTcyM2RkMjdkODRhNWFiYjJiMzcyOTJmYjZhMmUzL3RhYmxlOjc0ZjZkOWViM2ZhNDQ5NDBhNmJiMTA3YjVmZjFhNzIwL3RhYmxlcmFuZ2U6NzRmNmQ5ZWIzZmE0NDk0MGE2YmIxMDdiNWZmMWE3MjBfNS0xLTEtMS0w_15a5f4ba-9758-4d4d-a9b5-a0371bf50205">8,371,631</ix:nonFraction></span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="ifbe16ec51ea244519b77d6036b4ef038_I20201231" decimals="INF" format="ixt:numdotdecimal" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjkzY2E5YmIwMTc5MjQ3NmZiYjIyNWU1ZDlkZWM4NjlmL3NlYzo5M2NhOWJiMDE3OTI0NzZmYmIyMjVlNWQ5ZGVjODY5Zl80OS9mcmFnOjdkOTcyM2RkMjdkODRhNWFiYjJiMzcyOTJmYjZhMmUzL3RhYmxlOjc0ZjZkOWViM2ZhNDQ5NDBhNmJiMTA3YjVmZjFhNzIwL3RhYmxlcmFuZ2U6NzRmNmQ5ZWIzZmE0NDk0MGE2YmIxMDdiNWZmMWE3MjBfNS0zLTEtMS0w_b282df74-adc3-430b-ad55-50a2a05a7483">13,755,148</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr></table></div></ix:continuation><div style="margin-bottom:6pt;margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">(c)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;padding-left:27.13pt">Restricted share units</span></div><ix:nonNumeric contextRef="i69782326f71a44e3805518280ee22b6b_D20210101-20210630" name="us-gaap:ScheduleOfShareBasedCompensationRestrictedStockUnitsAwardActivityTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjkzY2E5YmIwMTc5MjQ3NmZiYjIyNWU1ZDlkZWM4NjlmL3NlYzo5M2NhOWJiMDE3OTI0NzZmYmIyMjVlNWQ5ZGVjODY5Zl80OS9mcmFnOjdkOTcyM2RkMjdkODRhNWFiYjJiMzcyOTJmYjZhMmUzL3RleHRyZWdpb246N2Q5NzIzZGQyN2Q4NGE1YWJiMmIzNzI5MmZiNmEyZTNfMjg0MQ_add9c867-0e51-4f73-9683-0ff59b835251" continuedAt="i043213e0a3474d74b59734701af1f084" escape="true"><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following is a summary of the changes in RSUs for the six months ended June&#160;30, 2021 and 2020: </span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:61.538%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:16.816%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:1.327%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:16.819%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Number of RSUs</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:700;line-height:100%;position:relative;top:-2.8pt;vertical-align:baseline"> (i)</span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Weighted average grant date fair value (C$)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:700;line-height:100%;position:relative;top:-2.8pt;vertical-align:baseline">(ii)</span></div></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance as of January 1, 2021</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="iff2854605c9948a0bd946fb90a42d547_I20201231" decimals="INF" format="ixt:numdotdecimal" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjkzY2E5YmIwMTc5MjQ3NmZiYjIyNWU1ZDlkZWM4NjlmL3NlYzo5M2NhOWJiMDE3OTI0NzZmYmIyMjVlNWQ5ZGVjODY5Zl80OS9mcmFnOjdkOTcyM2RkMjdkODRhNWFiYjJiMzcyOTJmYjZhMmUzL3RhYmxlOjFlNGUzYmI3ZWJmODRkYmQ5MmRiMzY5NjY5Y2RhYTg5L3RhYmxlcmFuZ2U6MWU0ZTNiYjdlYmY4NGRiZDkyZGIzNjk2NjljZGFhODlfMS0xLTEtMS0w_6bd9abb8-0329-47b7-83c5-6ec076acd590">948,357</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="iff2854605c9948a0bd946fb90a42d547_I20201231" decimals="2" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjkzY2E5YmIwMTc5MjQ3NmZiYjIyNWU1ZDlkZWM4NjlmL3NlYzo5M2NhOWJiMDE3OTI0NzZmYmIyMjVlNWQ5ZGVjODY5Zl80OS9mcmFnOjdkOTcyM2RkMjdkODRhNWFiYjJiMzcyOTJmYjZhMmUzL3RhYmxlOjFlNGUzYmI3ZWJmODRkYmQ5MmRiMzY5NjY5Y2RhYTg5L3RhYmxlcmFuZ2U6MWU0ZTNiYjdlYmY4NGRiZDkyZGIzNjk2NjljZGFhODlfMS0zLTEtMS0w_45af9d43-61db-48df-867b-adb161eedbed">7.66</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Granted</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(i)</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="ie5eb2f0b8440403abdac2db9e01adbb9_D20210101-20210630" decimals="INF" format="ixt:numdotdecimal" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjkzY2E5YmIwMTc5MjQ3NmZiYjIyNWU1ZDlkZWM4NjlmL3NlYzo5M2NhOWJiMDE3OTI0NzZmYmIyMjVlNWQ5ZGVjODY5Zl80OS9mcmFnOjdkOTcyM2RkMjdkODRhNWFiYjJiMzcyOTJmYjZhMmUzL3RhYmxlOjFlNGUzYmI3ZWJmODRkYmQ5MmRiMzY5NjY5Y2RhYTg5L3RhYmxlcmFuZ2U6MWU0ZTNiYjdlYmY4NGRiZDkyZGIzNjk2NjljZGFhODlfMi0xLTEtMS0w_1e813088-e498-42f8-bb3d-833eca936248">515,433</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="ie5eb2f0b8440403abdac2db9e01adbb9_D20210101-20210630" decimals="2" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjkzY2E5YmIwMTc5MjQ3NmZiYjIyNWU1ZDlkZWM4NjlmL3NlYzo5M2NhOWJiMDE3OTI0NzZmYmIyMjVlNWQ5ZGVjODY5Zl80OS9mcmFnOjdkOTcyM2RkMjdkODRhNWFiYjJiMzcyOTJmYjZhMmUzL3RhYmxlOjFlNGUzYmI3ZWJmODRkYmQ5MmRiMzY5NjY5Y2RhYTg5L3RhYmxlcmFuZ2U6MWU0ZTNiYjdlYmY4NGRiZDkyZGIzNjk2NjljZGFhODlfMi0zLTEtMS0w_fa014f5d-1178-44c8-bd5e-b6aba2e326c0">11.29</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Vested and issued</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="shares" contextRef="ie5eb2f0b8440403abdac2db9e01adbb9_D20210101-20210630" decimals="INF" format="ixt:numdotdecimal" name="cron:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedAndIssuedInPeriod" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjkzY2E5YmIwMTc5MjQ3NmZiYjIyNWU1ZDlkZWM4NjlmL3NlYzo5M2NhOWJiMDE3OTI0NzZmYmIyMjVlNWQ5ZGVjODY5Zl80OS9mcmFnOjdkOTcyM2RkMjdkODRhNWFiYjJiMzcyOTJmYjZhMmUzL3RhYmxlOjFlNGUzYmI3ZWJmODRkYmQ5MmRiMzY5NjY5Y2RhYTg5L3RhYmxlcmFuZ2U6MWU0ZTNiYjdlYmY4NGRiZDkyZGIzNjk2NjljZGFhODlfMy0xLTEtMS0w_445ab38e-dcb8-433e-a2ae-76776543141a">89,912</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="ie5eb2f0b8440403abdac2db9e01adbb9_D20210101-20210630" decimals="2" name="cron:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedAndIssuedInPeriodWeightedAverageGrantDateFairValue" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjkzY2E5YmIwMTc5MjQ3NmZiYjIyNWU1ZDlkZWM4NjlmL3NlYzo5M2NhOWJiMDE3OTI0NzZmYmIyMjVlNWQ5ZGVjODY5Zl80OS9mcmFnOjdkOTcyM2RkMjdkODRhNWFiYjJiMzcyOTJmYjZhMmUzL3RhYmxlOjFlNGUzYmI3ZWJmODRkYmQ5MmRiMzY5NjY5Y2RhYTg5L3RhYmxlcmFuZ2U6MWU0ZTNiYjdlYmY4NGRiZDkyZGIzNjk2NjljZGFhODlfMy0zLTEtMS0w_29f4da68-d180-402e-9078-734d5cd3daa2">7.52</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance as of June&#160;30, 2021</span></td><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i38f48aaa7a5e481ebe8ebcada37e35a1_I20210630" decimals="INF" format="ixt:numdotdecimal" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjkzY2E5YmIwMTc5MjQ3NmZiYjIyNWU1ZDlkZWM4NjlmL3NlYzo5M2NhOWJiMDE3OTI0NzZmYmIyMjVlNWQ5ZGVjODY5Zl80OS9mcmFnOjdkOTcyM2RkMjdkODRhNWFiYjJiMzcyOTJmYjZhMmUzL3RhYmxlOjFlNGUzYmI3ZWJmODRkYmQ5MmRiMzY5NjY5Y2RhYTg5L3RhYmxlcmFuZ2U6MWU0ZTNiYjdlYmY4NGRiZDkyZGIzNjk2NjljZGFhODlfNS0xLTEtMS0w_c621807d-96cf-46f8-bdb6-65b069e3eac3">1,373,878</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="i38f48aaa7a5e481ebe8ebcada37e35a1_I20210630" decimals="2" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjkzY2E5YmIwMTc5MjQ3NmZiYjIyNWU1ZDlkZWM4NjlmL3NlYzo5M2NhOWJiMDE3OTI0NzZmYmIyMjVlNWQ5ZGVjODY5Zl80OS9mcmFnOjdkOTcyM2RkMjdkODRhNWFiYjJiMzcyOTJmYjZhMmUzL3RhYmxlOjFlNGUzYmI3ZWJmODRkYmQ5MmRiMzY5NjY5Y2RhYTg5L3RhYmxlcmFuZ2U6MWU0ZTNiYjdlYmY4NGRiZDkyZGIzNjk2NjljZGFhODlfNS0zLTEtMS0w_45bac9d2-df68-4979-956d-f95f936b42cc">9.03</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:61.538%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:16.816%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:1.327%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:16.819%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Number of RSUs</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:700;line-height:100%;position:relative;top:-2.8pt;vertical-align:baseline"> (i)</span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Weighted average grant date fair value (C$)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:700;line-height:100%;position:relative;top:-2.8pt;vertical-align:baseline">(ii)</span></div></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance as of January 1, 2020</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i9cd1e43e5a21454dbe1b88627687a079_I20191231" decimals="INF" format="ixt:numdotdecimal" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjkzY2E5YmIwMTc5MjQ3NmZiYjIyNWU1ZDlkZWM4NjlmL3NlYzo5M2NhOWJiMDE3OTI0NzZmYmIyMjVlNWQ5ZGVjODY5Zl80OS9mcmFnOjdkOTcyM2RkMjdkODRhNWFiYjJiMzcyOTJmYjZhMmUzL3RhYmxlOmJiMDVkOTg3NzdmODRmMDlhNDk3OWUyZDEwN2Y0ZTNkL3RhYmxlcmFuZ2U6YmIwNWQ5ODc3N2Y4NGYwOWE0OTc5ZTJkMTA3ZjRlM2RfMS0xLTEtMS01MjI1_273643ef-475f-4af2-ad97-b1dad6b1657a">732,972</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="i9cd1e43e5a21454dbe1b88627687a079_I20191231" decimals="2" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjkzY2E5YmIwMTc5MjQ3NmZiYjIyNWU1ZDlkZWM4NjlmL3NlYzo5M2NhOWJiMDE3OTI0NzZmYmIyMjVlNWQ5ZGVjODY5Zl80OS9mcmFnOjdkOTcyM2RkMjdkODRhNWFiYjJiMzcyOTJmYjZhMmUzL3RhYmxlOmJiMDVkOTg3NzdmODRmMDlhNDk3OWUyZDEwN2Y0ZTNkL3RhYmxlcmFuZ2U6YmIwNWQ5ODc3N2Y4NGYwOWE0OTc5ZTJkMTA3ZjRlM2RfMS0zLTEtMS01MjI1_35ac3b4e-ab9b-4d3e-bf86-df430bf21bf7">15.34</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Granted</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(i)</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i10cd1c126464402b99bfac52e7ebdbb2_D20200101-20200630" decimals="INF" format="ixt:numdotdecimal" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjkzY2E5YmIwMTc5MjQ3NmZiYjIyNWU1ZDlkZWM4NjlmL3NlYzo5M2NhOWJiMDE3OTI0NzZmYmIyMjVlNWQ5ZGVjODY5Zl80OS9mcmFnOjdkOTcyM2RkMjdkODRhNWFiYjJiMzcyOTJmYjZhMmUzL3RhYmxlOmJiMDVkOTg3NzdmODRmMDlhNDk3OWUyZDEwN2Y0ZTNkL3RhYmxlcmFuZ2U6YmIwNWQ5ODc3N2Y4NGYwOWE0OTc5ZTJkMTA3ZjRlM2RfMi0xLTEtMS01NTg0_8f105689-011a-48d6-b653-cf7186cf09b3">279,277</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="i10cd1c126464402b99bfac52e7ebdbb2_D20200101-20200630" decimals="2" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjkzY2E5YmIwMTc5MjQ3NmZiYjIyNWU1ZDlkZWM4NjlmL3NlYzo5M2NhOWJiMDE3OTI0NzZmYmIyMjVlNWQ5ZGVjODY5Zl80OS9mcmFnOjdkOTcyM2RkMjdkODRhNWFiYjJiMzcyOTJmYjZhMmUzL3RhYmxlOmJiMDVkOTg3NzdmODRmMDlhNDk3OWUyZDEwN2Y0ZTNkL3RhYmxlcmFuZ2U6YmIwNWQ5ODc3N2Y4NGYwOWE0OTc5ZTJkMTA3ZjRlM2RfMi0zLTEtMS01NTg3_21ccc7b0-0788-4237-a050-8e0693c37f64">7.52</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance as of June&#160;30, 2020</span></td><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i80341dfa258d45e4926f94222e4d5cbc_I20200630" decimals="INF" format="ixt:numdotdecimal" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjkzY2E5YmIwMTc5MjQ3NmZiYjIyNWU1ZDlkZWM4NjlmL3NlYzo5M2NhOWJiMDE3OTI0NzZmYmIyMjVlNWQ5ZGVjODY5Zl80OS9mcmFnOjdkOTcyM2RkMjdkODRhNWFiYjJiMzcyOTJmYjZhMmUzL3RhYmxlOmJiMDVkOTg3NzdmODRmMDlhNDk3OWUyZDEwN2Y0ZTNkL3RhYmxlcmFuZ2U6YmIwNWQ5ODc3N2Y4NGYwOWE0OTc5ZTJkMTA3ZjRlM2RfMy0xLTEtMS01MjI1_8aa5d1dc-5f2f-48b4-877c-e333262cdabf">1,012,249</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="i80341dfa258d45e4926f94222e4d5cbc_I20200630" decimals="2" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjkzY2E5YmIwMTc5MjQ3NmZiYjIyNWU1ZDlkZWM4NjlmL3NlYzo5M2NhOWJiMDE3OTI0NzZmYmIyMjVlNWQ5ZGVjODY5Zl80OS9mcmFnOjdkOTcyM2RkMjdkODRhNWFiYjJiMzcyOTJmYjZhMmUzL3RhYmxlOmJiMDVkOTg3NzdmODRmMDlhNDk3OWUyZDEwN2Y0ZTNkL3RhYmxlcmFuZ2U6YmIwNWQ5ODc3N2Y4NGYwOWE0OTc5ZTJkMTA3ZjRlM2RfNS0zLTEtMS01NjEy_2d262693-5a28-4335-80a5-eb7fd4cda577">13.18</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="margin-bottom:6pt;margin-top:6pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:400;line-height:120%;position:relative;top:-2.8pt;vertical-align:baseline">(i)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:13.1pt">RSUs granted in the period vest annually in equal installments over a <ix:nonNumeric contextRef="ie5eb2f0b8440403abdac2db9e01adbb9_D20210101-20210630" format="ixt-sec:durwordsen" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1" id="id3VybDovL2RvY3MudjEvZG9jOjkzY2E5YmIwMTc5MjQ3NmZiYjIyNWU1ZDlkZWM4NjlmL3NlYzo5M2NhOWJiMDE3OTI0NzZmYmIyMjVlNWQ5ZGVjODY5Zl80OS9mcmFnOjdkOTcyM2RkMjdkODRhNWFiYjJiMzcyOTJmYjZhMmUzL3RleHRyZWdpb246N2Q5NzIzZGQyN2Q4NGE1YWJiMmIzNzI5MmZiNmEyZTNfMjg0OA_72b50007-32a0-4807-86f2-3661661e4530"><ix:nonNumeric contextRef="i10cd1c126464402b99bfac52e7ebdbb2_D20200101-20200630" format="ixt-sec:durwordsen" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1" id="id3VybDovL2RvY3MudjEvZG9jOjkzY2E5YmIwMTc5MjQ3NmZiYjIyNWU1ZDlkZWM4NjlmL3NlYzo5M2NhOWJiMDE3OTI0NzZmYmIyMjVlNWQ5ZGVjODY5Zl80OS9mcmFnOjdkOTcyM2RkMjdkODRhNWFiYjJiMzcyOTJmYjZhMmUzL3RleHRyZWdpb246N2Q5NzIzZGQyN2Q4NGE1YWJiMmIzNzI5MmZiNmEyZTNfMjg0OA_9c0b6df3-6542-4281-a61b-250263daa164">three-year</ix:nonNumeric></ix:nonNumeric> period following the grant date, subject to such holder&#8217;s continued employment through each vesting date. The vesting of such RSUs is not subject to the achievement of any performance criteria.</span></div></ix:nonNumeric><div style="margin-bottom:6pt;margin-top:6pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:400;line-height:120%;position:relative;top:-2.8pt;vertical-align:baseline"><ix:continuation id="i043213e0a3474d74b59734701af1f084" continuedAt="idc8878d6ce144c98a6787fbc4f2c61eb">(ii)</ix:continuation></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:11.66pt"><ix:continuation id="idc8878d6ce144c98a6787fbc4f2c61eb">The weighted average grant date fair value reflects the conversion of foreign currency-denominated RSUs translated into C$ using the foreign exchange rate as of the date of issuance.</ix:continuation> </span></div><div style="margin-bottom:6pt;margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">(d)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;padding-left:26.24pt">Deferred share units</span></div><ix:nonNumeric contextRef="i69782326f71a44e3805518280ee22b6b_D20210101-20210630" name="us-gaap:ScheduleOfOtherShareBasedCompensationActivityTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjkzY2E5YmIwMTc5MjQ3NmZiYjIyNWU1ZDlkZWM4NjlmL3NlYzo5M2NhOWJiMDE3OTI0NzZmYmIyMjVlNWQ5ZGVjODY5Zl80OS9mcmFnOjdkOTcyM2RkMjdkODRhNWFiYjJiMzcyOTJmYjZhMmUzL3RleHRyZWdpb246N2Q5NzIzZGQyN2Q4NGE1YWJiMmIzNzI5MmZiNmEyZTNfMjg1MA_968920cb-a02b-4e00-8d38-789dc681899d" continuedAt="i19732d969baa44c4834ed032a80ce85b" escape="true"><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following is a summary of the changes in DSUs during the six months ended June&#160;30, 2021 and 2020:</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:61.538%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:16.816%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:1.327%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:16.819%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Number of DSUs</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Financial liability </span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance as of January 1, 2021</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="iba2763eff8e446348674f7fa0f12395e_I20201231" decimals="INF" format="ixt:numdotdecimal" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjkzY2E5YmIwMTc5MjQ3NmZiYjIyNWU1ZDlkZWM4NjlmL3NlYzo5M2NhOWJiMDE3OTI0NzZmYmIyMjVlNWQ5ZGVjODY5Zl80OS9mcmFnOjdkOTcyM2RkMjdkODRhNWFiYjJiMzcyOTJmYjZhMmUzL3RhYmxlOjg2NDc3YzNmNzVjZTRmOWY4MWMwNTQ2NjIwMDM4MDI4L3RhYmxlcmFuZ2U6ODY0NzdjM2Y3NWNlNGY5ZjgxYzA1NDY2MjAwMzgwMjhfMS0xLTEtMS0w_e6b075cd-1041-449d-89ea-23397581044a">83,293</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iba2763eff8e446348674f7fa0f12395e_I20201231" decimals="-3" name="us-gaap:DeferredCompensationSharebasedArrangementsLiabilityCurrentAndNoncurrent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzY2E5YmIwMTc5MjQ3NmZiYjIyNWU1ZDlkZWM4NjlmL3NlYzo5M2NhOWJiMDE3OTI0NzZmYmIyMjVlNWQ5ZGVjODY5Zl80OS9mcmFnOjdkOTcyM2RkMjdkODRhNWFiYjJiMzcyOTJmYjZhMmUzL3RhYmxlOjg2NDc3YzNmNzVjZTRmOWY4MWMwNTQ2NjIwMDM4MDI4L3RhYmxlcmFuZ2U6ODY0NzdjM2Y3NWNlNGY5ZjgxYzA1NDY2MjAwMzgwMjhfMS0zLTEtMS0w_4e61fd67-905d-4659-ba4f-9728d79a32f2">577</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Loss on revaluation</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4d35a9dc2bff4f0fb74fef37bddc6703_D20210101-20210630" decimals="-3" sign="-" name="cron:ShareBasedPaymentArrangementGainLossOnRevaluation" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzY2E5YmIwMTc5MjQ3NmZiYjIyNWU1ZDlkZWM4NjlmL3NlYzo5M2NhOWJiMDE3OTI0NzZmYmIyMjVlNWQ5ZGVjODY5Zl80OS9mcmFnOjdkOTcyM2RkMjdkODRhNWFiYjJiMzcyOTJmYjZhMmUzL3RhYmxlOjg2NDc3YzNmNzVjZTRmOWY4MWMwNTQ2NjIwMDM4MDI4L3RhYmxlcmFuZ2U6ODY0NzdjM2Y3NWNlNGY5ZjgxYzA1NDY2MjAwMzgwMjhfNC0zLTEtMS0w_d7a177d4-f6b9-460a-b631-34ecc9d71c74">141</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance as of June&#160;30, 2021</span></td><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i8360952c01a040cc9bbd0c14cc59244b_I20210630" decimals="INF" format="ixt:numdotdecimal" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjkzY2E5YmIwMTc5MjQ3NmZiYjIyNWU1ZDlkZWM4NjlmL3NlYzo5M2NhOWJiMDE3OTI0NzZmYmIyMjVlNWQ5ZGVjODY5Zl80OS9mcmFnOjdkOTcyM2RkMjdkODRhNWFiYjJiMzcyOTJmYjZhMmUzL3RhYmxlOjg2NDc3YzNmNzVjZTRmOWY4MWMwNTQ2NjIwMDM4MDI4L3RhYmxlcmFuZ2U6ODY0NzdjM2Y3NWNlNGY5ZjgxYzA1NDY2MjAwMzgwMjhfNS0xLTEtMS0w_7979c684-a1e5-4c6b-972b-e64082fe1d78">83,293</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8360952c01a040cc9bbd0c14cc59244b_I20210630" decimals="-3" name="us-gaap:DeferredCompensationSharebasedArrangementsLiabilityCurrentAndNoncurrent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzY2E5YmIwMTc5MjQ3NmZiYjIyNWU1ZDlkZWM4NjlmL3NlYzo5M2NhOWJiMDE3OTI0NzZmYmIyMjVlNWQ5ZGVjODY5Zl80OS9mcmFnOjdkOTcyM2RkMjdkODRhNWFiYjJiMzcyOTJmYjZhMmUzL3RhYmxlOjg2NDc3YzNmNzVjZTRmOWY4MWMwNTQ2NjIwMDM4MDI4L3RhYmxlcmFuZ2U6ODY0NzdjM2Y3NWNlNGY5ZjgxYzA1NDY2MjAwMzgwMjhfNS0zLTEtMS0w_7e50a1b4-43ce-44f7-a8c3-885562da3a91">718</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:61.538%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:16.816%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:1.327%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:16.819%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Number of DSUs</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Financial liability </span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance as of January 1, 2020</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="ia6edd5e8ba094c259649f87d1ff2aa61_I20191231" decimals="INF" format="ixt:numdotdecimal" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjkzY2E5YmIwMTc5MjQ3NmZiYjIyNWU1ZDlkZWM4NjlmL3NlYzo5M2NhOWJiMDE3OTI0NzZmYmIyMjVlNWQ5ZGVjODY5Zl80OS9mcmFnOjdkOTcyM2RkMjdkODRhNWFiYjJiMzcyOTJmYjZhMmUzL3RhYmxlOjgzYWNiMzA0OTBlZDRjNmY4NjVjNDcyZjQ0NGRlN2RkL3RhYmxlcmFuZ2U6ODNhY2IzMDQ5MGVkNGM2Zjg2NWM0NzJmNDQ0ZGU3ZGRfMS0xLTEtMS0w_51e381f1-e0df-4f35-a242-fe0c4e04caa0">33,397</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia6edd5e8ba094c259649f87d1ff2aa61_I20191231" decimals="-3" name="us-gaap:DeferredCompensationSharebasedArrangementsLiabilityCurrentAndNoncurrent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzY2E5YmIwMTc5MjQ3NmZiYjIyNWU1ZDlkZWM4NjlmL3NlYzo5M2NhOWJiMDE3OTI0NzZmYmIyMjVlNWQ5ZGVjODY5Zl80OS9mcmFnOjdkOTcyM2RkMjdkODRhNWFiYjJiMzcyOTJmYjZhMmUzL3RhYmxlOjgzYWNiMzA0OTBlZDRjNmY4NjVjNDcyZjQ0NGRlN2RkL3RhYmxlcmFuZ2U6ODNhY2IzMDQ5MGVkNGM2Zjg2NWM0NzJmNDQ0ZGU3ZGRfMS0zLTEtMS0w_08bca8b1-c703-46f3-9456-441c8bd3882d">255</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">DSU liabilities settled</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="shares" contextRef="i64c0d8b09be647f1aa0d0ab87e24a14c_D20200101-20200630" decimals="INF" format="ixt:numdotdecimal" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjkzY2E5YmIwMTc5MjQ3NmZiYjIyNWU1ZDlkZWM4NjlmL3NlYzo5M2NhOWJiMDE3OTI0NzZmYmIyMjVlNWQ5ZGVjODY5Zl80OS9mcmFnOjdkOTcyM2RkMjdkODRhNWFiYjJiMzcyOTJmYjZhMmUzL3RhYmxlOjgzYWNiMzA0OTBlZDRjNmY4NjVjNDcyZjQ0NGRlN2RkL3RhYmxlcmFuZ2U6ODNhY2IzMDQ5MGVkNGM2Zjg2NWM0NzJmNDQ0ZGU3ZGRfMy0xLTEtMS0w_ee35ddd4-8f9c-4183-8d5e-0877ce8420f4">8,484</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i64c0d8b09be647f1aa0d0ab87e24a14c_D20200101-20200630" decimals="-3" name="cron:ShareBasedPaymentArrangementLiabilitiesSettled" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzY2E5YmIwMTc5MjQ3NmZiYjIyNWU1ZDlkZWM4NjlmL3NlYzo5M2NhOWJiMDE3OTI0NzZmYmIyMjVlNWQ5ZGVjODY5Zl80OS9mcmFnOjdkOTcyM2RkMjdkODRhNWFiYjJiMzcyOTJmYjZhMmUzL3RhYmxlOjgzYWNiMzA0OTBlZDRjNmY4NjVjNDcyZjQ0NGRlN2RkL3RhYmxlcmFuZ2U6ODNhY2IzMDQ5MGVkNGM2Zjg2NWM0NzJmNDQ0ZGU3ZGRfMy0zLTEtMS0xMTE5_5aa710d3-71cd-4d7e-a1b2-3ab770c80d48">46</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Gain on revaluation</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i64c0d8b09be647f1aa0d0ab87e24a14c_D20200101-20200630" decimals="-3" name="cron:ShareBasedPaymentArrangementGainLossOnRevaluation" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzY2E5YmIwMTc5MjQ3NmZiYjIyNWU1ZDlkZWM4NjlmL3NlYzo5M2NhOWJiMDE3OTI0NzZmYmIyMjVlNWQ5ZGVjODY5Zl80OS9mcmFnOjdkOTcyM2RkMjdkODRhNWFiYjJiMzcyOTJmYjZhMmUzL3RhYmxlOjgzYWNiMzA0OTBlZDRjNmY4NjVjNDcyZjQ0NGRlN2RkL3RhYmxlcmFuZ2U6ODNhY2IzMDQ5MGVkNGM2Zjg2NWM0NzJmNDQ0ZGU3ZGRfNC0zLTEtMS0w_5c8f875f-2198-4962-95f3-2e35f10ec6b8">56</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance as of June&#160;30, 2020</span></td><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i80be6cf122864924818f07224f0ce952_I20200630" decimals="INF" format="ixt:numdotdecimal" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjkzY2E5YmIwMTc5MjQ3NmZiYjIyNWU1ZDlkZWM4NjlmL3NlYzo5M2NhOWJiMDE3OTI0NzZmYmIyMjVlNWQ5ZGVjODY5Zl80OS9mcmFnOjdkOTcyM2RkMjdkODRhNWFiYjJiMzcyOTJmYjZhMmUzL3RhYmxlOjgzYWNiMzA0OTBlZDRjNmY4NjVjNDcyZjQ0NGRlN2RkL3RhYmxlcmFuZ2U6ODNhY2IzMDQ5MGVkNGM2Zjg2NWM0NzJmNDQ0ZGU3ZGRfNS0xLTEtMS0w_e0c101d7-9e94-4177-97f7-154b5ccf3dd8">24,913</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i80be6cf122864924818f07224f0ce952_I20200630" decimals="-3" name="us-gaap:DeferredCompensationSharebasedArrangementsLiabilityCurrentAndNoncurrent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzY2E5YmIwMTc5MjQ3NmZiYjIyNWU1ZDlkZWM4NjlmL3NlYzo5M2NhOWJiMDE3OTI0NzZmYmIyMjVlNWQ5ZGVjODY5Zl80OS9mcmFnOjdkOTcyM2RkMjdkODRhNWFiYjJiMzcyOTJmYjZhMmUzL3RhYmxlOjgzYWNiMzA0OTBlZDRjNmY4NjVjNDcyZjQ0NGRlN2RkL3RhYmxlcmFuZ2U6ODNhY2IzMDQ5MGVkNGM2Zjg2NWM0NzJmNDQ0ZGU3ZGRfNS0zLTEtMS0w_e4cbf62d-2c10-4f60-b8b7-aad9c3b27397">153</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div></ix:nonNumeric></ix:continuation><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span><br/></span></div><div style="height:36pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">17</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:72pt;width:100%"><div style="margin-top:0.55pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:95.000%"><tr><td style="width:1.0%"></td><td style="width:65.712%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:32.088%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="border-top:1pt solid #FFFFFF;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Cronos Group Inc.</span></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Notes to Condensed Consolidated Financial Statements (Unaudited)</span></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">(In thousands of $, except share amounts)</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i93ca9bb01792476fbb225e5d9dec869f_7">Table of Contents</a></span></div></td></tr></table></div></div><ix:continuation id="idb0bc2e58b7b47408cc53bc7c33aebdc"><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(e)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;padding-left:24.91pt">Warrants</span></div><ix:continuation id="i19732d969baa44c4834ed032a80ce85b"><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following is a summary of the changes in warrants during the six months ended June&#160;30, 2021 and 2020:</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:49.316%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:23.205%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.772%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:23.207%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Weighted average exercise price (C$)</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Number of warrants</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance as of January 1, 2021</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="cadPerShare" contextRef="ica96f8af8bfb4c02b4ff8f577beed8a9_I20201231" decimals="2" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjkzY2E5YmIwMTc5MjQ3NmZiYjIyNWU1ZDlkZWM4NjlmL3NlYzo5M2NhOWJiMDE3OTI0NzZmYmIyMjVlNWQ5ZGVjODY5Zl80OS9mcmFnOjdkOTcyM2RkMjdkODRhNWFiYjJiMzcyOTJmYjZhMmUzL3RhYmxlOjA0OTgyOGY1YTAwYTQ3NGRiMTRmZGE5MzYxNTFmMjlhL3RhYmxlcmFuZ2U6MDQ5ODI4ZjVhMDBhNDc0ZGIxNGZkYTkzNjE1MWYyOWFfMS0xLTEtMS0w_8984b337-e609-4143-bdcb-681e6f26473c">0.25</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="ica96f8af8bfb4c02b4ff8f577beed8a9_I20201231" decimals="INF" format="ixt:numdotdecimal" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjkzY2E5YmIwMTc5MjQ3NmZiYjIyNWU1ZDlkZWM4NjlmL3NlYzo5M2NhOWJiMDE3OTI0NzZmYmIyMjVlNWQ5ZGVjODY5Zl80OS9mcmFnOjdkOTcyM2RkMjdkODRhNWFiYjJiMzcyOTJmYjZhMmUzL3RhYmxlOjA0OTgyOGY1YTAwYTQ3NGRiMTRmZGE5MzYxNTFmMjlhL3RhYmxlcmFuZ2U6MDQ5ODI4ZjVhMDBhNDc0ZGIxNGZkYTkzNjE1MWYyOWFfMS0zLTEtMS0w_46bc9d2d-3965-4b33-9448-05f6c28f0dae">7,987,349</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Exercise of warrants</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="cadPerShare" contextRef="ic97055dc0db04af88f485b12b96f84c2_D20210101-20210630" decimals="2" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjkzY2E5YmIwMTc5MjQ3NmZiYjIyNWU1ZDlkZWM4NjlmL3NlYzo5M2NhOWJiMDE3OTI0NzZmYmIyMjVlNWQ5ZGVjODY5Zl80OS9mcmFnOjdkOTcyM2RkMjdkODRhNWFiYjJiMzcyOTJmYjZhMmUzL3RhYmxlOjA0OTgyOGY1YTAwYTQ3NGRiMTRmZGE5MzYxNTFmMjlhL3RhYmxlcmFuZ2U6MDQ5ODI4ZjVhMDBhNDc0ZGIxNGZkYTkzNjE1MWYyOWFfMi0xLTEtMS0w_9336ed94-e294-4fae-bd51-275da6743183">0.25</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="shares" contextRef="ic97055dc0db04af88f485b12b96f84c2_D20210101-20210630" decimals="INF" format="ixt:numdotdecimal" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjkzY2E5YmIwMTc5MjQ3NmZiYjIyNWU1ZDlkZWM4NjlmL3NlYzo5M2NhOWJiMDE3OTI0NzZmYmIyMjVlNWQ5ZGVjODY5Zl80OS9mcmFnOjdkOTcyM2RkMjdkODRhNWFiYjJiMzcyOTJmYjZhMmUzL3RhYmxlOjA0OTgyOGY1YTAwYTQ3NGRiMTRmZGE5MzYxNTFmMjlhL3RhYmxlcmFuZ2U6MDQ5ODI4ZjVhMDBhNDc0ZGIxNGZkYTkzNjE1MWYyOWFfMi0zLTEtMS0w_9be40a79-306d-4b70-bf13-1d62d4720749">7,987,349</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance as of June&#160;30, 2021</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="cadPerShare" contextRef="iaa2e66f5a2c14062bebba1811782ccd6_I20210630" decimals="2" format="ixt:zerodash" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjkzY2E5YmIwMTc5MjQ3NmZiYjIyNWU1ZDlkZWM4NjlmL3NlYzo5M2NhOWJiMDE3OTI0NzZmYmIyMjVlNWQ5ZGVjODY5Zl80OS9mcmFnOjdkOTcyM2RkMjdkODRhNWFiYjJiMzcyOTJmYjZhMmUzL3RhYmxlOjA0OTgyOGY1YTAwYTQ3NGRiMTRmZGE5MzYxNTFmMjlhL3RhYmxlcmFuZ2U6MDQ5ODI4ZjVhMDBhNDc0ZGIxNGZkYTkzNjE1MWYyOWFfNC0xLTEtMS0w_ab517be4-c18d-4675-8b30-cfc2b44a977f">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="iaa2e66f5a2c14062bebba1811782ccd6_I20210630" decimals="INF" format="ixt:zerodash" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjkzY2E5YmIwMTc5MjQ3NmZiYjIyNWU1ZDlkZWM4NjlmL3NlYzo5M2NhOWJiMDE3OTI0NzZmYmIyMjVlNWQ5ZGVjODY5Zl80OS9mcmFnOjdkOTcyM2RkMjdkODRhNWFiYjJiMzcyOTJmYjZhMmUzL3RhYmxlOjA0OTgyOGY1YTAwYTQ3NGRiMTRmZGE5MzYxNTFmMjlhL3RhYmxlcmFuZ2U6MDQ5ODI4ZjVhMDBhNDc0ZGIxNGZkYTkzNjE1MWYyOWFfNC0zLTEtMS0w_9a725745-125f-416c-a57e-5f928020a4b8">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:49.316%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:23.205%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.772%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:23.207%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Weighted average exercise price (C$)</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Number of warrants</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance as of January 1, 2020 and June 30, 2020</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="cadPerShare" contextRef="i5b77d92575e64e2d8a23bebd827ac114_I20191231" decimals="2" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjkzY2E5YmIwMTc5MjQ3NmZiYjIyNWU1ZDlkZWM4NjlmL3NlYzo5M2NhOWJiMDE3OTI0NzZmYmIyMjVlNWQ5ZGVjODY5Zl80OS9mcmFnOjdkOTcyM2RkMjdkODRhNWFiYjJiMzcyOTJmYjZhMmUzL3RhYmxlOjg4ODQ3NzBiMDg1ODQ4MTE4MzgzYTZjODIzZDhjODMwL3RhYmxlcmFuZ2U6ODg4NDc3MGIwODU4NDgxMTgzODNhNmM4MjNkOGM4MzBfMS0xLTEtMS0w_819de121-1faf-454f-8b7e-284a4901021c"><ix:nonFraction unitRef="cadPerShare" contextRef="ie7aae3f01257471596ea0269c60c3885_I20200630" decimals="2" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjkzY2E5YmIwMTc5MjQ3NmZiYjIyNWU1ZDlkZWM4NjlmL3NlYzo5M2NhOWJiMDE3OTI0NzZmYmIyMjVlNWQ5ZGVjODY5Zl80OS9mcmFnOjdkOTcyM2RkMjdkODRhNWFiYjJiMzcyOTJmYjZhMmUzL3RhYmxlOjg4ODQ3NzBiMDg1ODQ4MTE4MzgzYTZjODIzZDhjODMwL3RhYmxlcmFuZ2U6ODg4NDc3MGIwODU4NDgxMTgzODNhNmM4MjNkOGM4MzBfMS0xLTEtMS0w_c930209e-a000-4491-abc1-391e885025e7">0.26</ix:nonFraction></ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i5b77d92575e64e2d8a23bebd827ac114_I20191231" decimals="INF" format="ixt:numdotdecimal" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjkzY2E5YmIwMTc5MjQ3NmZiYjIyNWU1ZDlkZWM4NjlmL3NlYzo5M2NhOWJiMDE3OTI0NzZmYmIyMjVlNWQ5ZGVjODY5Zl80OS9mcmFnOjdkOTcyM2RkMjdkODRhNWFiYjJiMzcyOTJmYjZhMmUzL3RhYmxlOjg4ODQ3NzBiMDg1ODQ4MTE4MzgzYTZjODIzZDhjODMwL3RhYmxlcmFuZ2U6ODg4NDc3MGIwODU4NDgxMTgzODNhNmM4MjNkOGM4MzBfMS0zLTEtMS0w_46cdb59f-846d-46dd-a74e-0d9ea7b37e96"><ix:nonFraction unitRef="shares" contextRef="ie7aae3f01257471596ea0269c60c3885_I20200630" decimals="INF" format="ixt:numdotdecimal" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjkzY2E5YmIwMTc5MjQ3NmZiYjIyNWU1ZDlkZWM4NjlmL3NlYzo5M2NhOWJiMDE3OTI0NzZmYmIyMjVlNWQ5ZGVjODY5Zl80OS9mcmFnOjdkOTcyM2RkMjdkODRhNWFiYjJiMzcyOTJmYjZhMmUzL3RhYmxlOjg4ODQ3NzBiMDg1ODQ4MTE4MzgzYTZjODIzZDhjODMwL3RhYmxlcmFuZ2U6ODg4NDc3MGIwODU4NDgxMTgzODNhNmM4MjNkOGM4MzBfMS0zLTEtMS0w_a3825c8f-b647-4773-b6b8-d4c348c2724f">18,066,662</ix:nonFraction></ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr></table></div></ix:continuation><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span><br/></span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As of June 30, 2021, there are <ix:nonFraction unitRef="shares" contextRef="iaa2e66f5a2c14062bebba1811782ccd6_I20210630" decimals="INF" format="ixt-sec:numwordsen" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjkzY2E5YmIwMTc5MjQ3NmZiYjIyNWU1ZDlkZWM4NjlmL3NlYzo5M2NhOWJiMDE3OTI0NzZmYmIyMjVlNWQ5ZGVjODY5Zl80OS9mcmFnOjdkOTcyM2RkMjdkODRhNWFiYjJiMzcyOTJmYjZhMmUzL3RleHRyZWdpb246N2Q5NzIzZGQyN2Q4NGE1YWJiMmIzNzI5MmZiNmEyZTNfOTg5NTYwNDY1NDIzMw_a01fecb0-ad10-423e-8841-199ed5424c71">no</ix:nonFraction> warrants outstanding other than the Altria Warrant. See Note 5. Derivative Liabilities for further description on the Altria Warrant.</span></div></ix:continuation><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span><br/></span></div><div style="height:36pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">18</span></div></div></div><div id="i93ca9bb01792476fbb225e5d9dec869f_52"></div><hr style="page-break-after:always"/><div style="min-height:72pt;width:100%"><div style="margin-top:0.55pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:95.000%"><tr><td style="width:1.0%"></td><td style="width:65.712%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:32.088%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="border-top:1pt solid #FFFFFF;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Cronos Group Inc.</span></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Notes to Condensed Consolidated Financial Statements (Unaudited)</span></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">(In thousands of $, except share amounts)</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i93ca9bb01792476fbb225e5d9dec869f_7">Table of Contents</a></span></div></td></tr></table></div></div><div style="margin-bottom:12pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">7. <ix:nonNumeric contextRef="i69782326f71a44e3805518280ee22b6b_D20210101-20210630" name="us-gaap:EarningsPerShareTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjkzY2E5YmIwMTc5MjQ3NmZiYjIyNWU1ZDlkZWM4NjlmL3NlYzo5M2NhOWJiMDE3OTI0NzZmYmIyMjVlNWQ5ZGVjODY5Zl81Mi9mcmFnOjlkZDkxMTIyZjQxYzQzNzk5OGZlMGIyOGMwYjRhYjgwL3RleHRyZWdpb246OWRkOTExMjJmNDFjNDM3OTk4ZmUwYjI4YzBiNGFiODBfNzE3_83c919e8-4ffa-4ac5-b013-f119b79926a7" continuedAt="id9fae4f01306433884130f07cb9082e2" escape="true">Earnings (Loss) per Share</ix:nonNumeric></span></div><ix:continuation id="id9fae4f01306433884130f07cb9082e2" continuedAt="iabd83da8c9564a99a5a6e785fc7e01bc"><ix:nonNumeric contextRef="i69782326f71a44e3805518280ee22b6b_D20210101-20210630" name="us-gaap:ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjkzY2E5YmIwMTc5MjQ3NmZiYjIyNWU1ZDlkZWM4NjlmL3NlYzo5M2NhOWJiMDE3OTI0NzZmYmIyMjVlNWQ5ZGVjODY5Zl81Mi9mcmFnOjlkZDkxMTIyZjQxYzQzNzk5OGZlMGIyOGMwYjRhYjgwL3RleHRyZWdpb246OWRkOTExMjJmNDFjNDM3OTk4ZmUwYjI4YzBiNGFiODBfNzE4_c7ece831-eee2-4664-8209-68b4c085ddec" escape="true"><div style="margin-bottom:3pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Basic and diluted earnings (loss) per share from continuing operations are calculated using the following numerators and denominators:</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:50.705%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.566%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.772%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.566%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.772%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.872%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.772%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.875%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">For the three months ended June 30,</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">For the six months ended June 30,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 2.12pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 2.12pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Basic earnings (loss) per share computation</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net income (loss) from continuing operations attributable to the shareholders of Cronos&#160;Group</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i27f4e53b91ad4367b7f8d273eff27769_D20210401-20210630" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:NetIncomeLossFromContinuingOperationsAvailableToCommonShareholdersBasic" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzY2E5YmIwMTc5MjQ3NmZiYjIyNWU1ZDlkZWM4NjlmL3NlYzo5M2NhOWJiMDE3OTI0NzZmYmIyMjVlNWQ5ZGVjODY5Zl81Mi9mcmFnOjlkZDkxMTIyZjQxYzQzNzk5OGZlMGIyOGMwYjRhYjgwL3RhYmxlOmQ2NGI3MDhhZjNkNzQ1NWVhNmU0MGM2NTYyMjk5ZDZkL3RhYmxlcmFuZ2U6ZDY0YjcwOGFmM2Q3NDU1ZWE2ZTQwYzY1NjIyOTlkNmRfMy0xLTEtMS0w_29424dbb-e08f-456d-8419-eb4be6fdd600">57,615</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i39065c5daf934af885335c12f3cfa83f_D20200401-20200630" decimals="-3" sign="-" format="ixt:numdotdecimal" name="us-gaap:NetIncomeLossFromContinuingOperationsAvailableToCommonShareholdersBasic" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzY2E5YmIwMTc5MjQ3NmZiYjIyNWU1ZDlkZWM4NjlmL3NlYzo5M2NhOWJiMDE3OTI0NzZmYmIyMjVlNWQ5ZGVjODY5Zl81Mi9mcmFnOjlkZDkxMTIyZjQxYzQzNzk5OGZlMGIyOGMwYjRhYjgwL3RhYmxlOmQ2NGI3MDhhZjNkNzQ1NWVhNmU0MGM2NTYyMjk5ZDZkL3RhYmxlcmFuZ2U6ZDY0YjcwOGFmM2Q3NDU1ZWE2ZTQwYzY1NjIyOTlkNmRfMy0zLTEtMS0w_3c162154-5e6f-4ff5-a8e6-f5ed5403108d">106,931</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i69782326f71a44e3805518280ee22b6b_D20210101-20210630" decimals="-3" sign="-" format="ixt:numdotdecimal" name="us-gaap:NetIncomeLossFromContinuingOperationsAvailableToCommonShareholdersBasic" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzY2E5YmIwMTc5MjQ3NmZiYjIyNWU1ZDlkZWM4NjlmL3NlYzo5M2NhOWJiMDE3OTI0NzZmYmIyMjVlNWQ5ZGVjODY5Zl81Mi9mcmFnOjlkZDkxMTIyZjQxYzQzNzk5OGZlMGIyOGMwYjRhYjgwL3RhYmxlOmQ2NGI3MDhhZjNkNzQ1NWVhNmU0MGM2NTYyMjk5ZDZkL3RhYmxlcmFuZ2U6ZDY0YjcwOGFmM2Q3NDU1ZWE2ZTQwYzY1NjIyOTlkNmRfMy01LTEtMS0w_f65919a5-108c-4adf-80f1-08bd06f98795">103,676</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i4a110e4972ef4113880ce582e3cda5c5_D20200101-20200630" decimals="-3" sign="-" format="ixt:numdotdecimal" name="us-gaap:NetIncomeLossFromContinuingOperationsAvailableToCommonShareholdersBasic" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzY2E5YmIwMTc5MjQ3NmZiYjIyNWU1ZDlkZWM4NjlmL3NlYzo5M2NhOWJiMDE3OTI0NzZmYmIyMjVlNWQ5ZGVjODY5Zl81Mi9mcmFnOjlkZDkxMTIyZjQxYzQzNzk5OGZlMGIyOGMwYjRhYjgwL3RhYmxlOmQ2NGI3MDhhZjNkNzQ1NWVhNmU0MGM2NTYyMjk5ZDZkL3RhYmxlcmFuZ2U6ZDY0YjcwOGFmM2Q3NDU1ZWE2ZTQwYzY1NjIyOTlkNmRfMy03LTEtMS0w_eb805059-c0f8-4dec-befd-ff84869d9a9e">30,891</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Weighted average number of common shares outstanding</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i27f4e53b91ad4367b7f8d273eff27769_D20210401-20210630" decimals="0" format="ixt:numdotdecimal" name="us-gaap:WeightedAverageNumberOfSharesOutstandingBasic" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjkzY2E5YmIwMTc5MjQ3NmZiYjIyNWU1ZDlkZWM4NjlmL3NlYzo5M2NhOWJiMDE3OTI0NzZmYmIyMjVlNWQ5ZGVjODY5Zl81Mi9mcmFnOjlkZDkxMTIyZjQxYzQzNzk5OGZlMGIyOGMwYjRhYjgwL3RhYmxlOmQ2NGI3MDhhZjNkNzQ1NWVhNmU0MGM2NTYyMjk5ZDZkL3RhYmxlcmFuZ2U6ZDY0YjcwOGFmM2Q3NDU1ZWE2ZTQwYzY1NjIyOTlkNmRfNC0xLTEtMS0w_0508c3ce-7e69-44da-a446-a48c778029ef">371,721,382</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i39065c5daf934af885335c12f3cfa83f_D20200401-20200630" decimals="0" format="ixt:numdotdecimal" name="us-gaap:WeightedAverageNumberOfSharesOutstandingBasic" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjkzY2E5YmIwMTc5MjQ3NmZiYjIyNWU1ZDlkZWM4NjlmL3NlYzo5M2NhOWJiMDE3OTI0NzZmYmIyMjVlNWQ5ZGVjODY5Zl81Mi9mcmFnOjlkZDkxMTIyZjQxYzQzNzk5OGZlMGIyOGMwYjRhYjgwL3RhYmxlOmQ2NGI3MDhhZjNkNzQ1NWVhNmU0MGM2NTYyMjk5ZDZkL3RhYmxlcmFuZ2U6ZDY0YjcwOGFmM2Q3NDU1ZWE2ZTQwYzY1NjIyOTlkNmRfNC0zLTEtMS0w_3debb25a-6c20-4a88-b1f9-c9cddd22d655">349,075,408</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i69782326f71a44e3805518280ee22b6b_D20210101-20210630" decimals="0" format="ixt:numdotdecimal" name="us-gaap:WeightedAverageNumberOfSharesOutstandingBasic" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjkzY2E5YmIwMTc5MjQ3NmZiYjIyNWU1ZDlkZWM4NjlmL3NlYzo5M2NhOWJiMDE3OTI0NzZmYmIyMjVlNWQ5ZGVjODY5Zl81Mi9mcmFnOjlkZDkxMTIyZjQxYzQzNzk5OGZlMGIyOGMwYjRhYjgwL3RhYmxlOmQ2NGI3MDhhZjNkNzQ1NWVhNmU0MGM2NTYyMjk5ZDZkL3RhYmxlcmFuZ2U6ZDY0YjcwOGFmM2Q3NDU1ZWE2ZTQwYzY1NjIyOTlkNmRfNC01LTEtMS0w_2aeb164a-6f3c-4b8c-be2f-23c6655835ed">367,391,118</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i4a110e4972ef4113880ce582e3cda5c5_D20200101-20200630" decimals="0" format="ixt:numdotdecimal" name="us-gaap:WeightedAverageNumberOfSharesOutstandingBasic" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjkzY2E5YmIwMTc5MjQ3NmZiYjIyNWU1ZDlkZWM4NjlmL3NlYzo5M2NhOWJiMDE3OTI0NzZmYmIyMjVlNWQ5ZGVjODY5Zl81Mi9mcmFnOjlkZDkxMTIyZjQxYzQzNzk5OGZlMGIyOGMwYjRhYjgwL3RhYmxlOmQ2NGI3MDhhZjNkNzQ1NWVhNmU0MGM2NTYyMjk5ZDZkL3RhYmxlcmFuZ2U6ZDY0YjcwOGFmM2Q3NDU1ZWE2ZTQwYzY1NjIyOTlkNmRfNC03LTEtMS0w_898b5cab-217b-47cc-a8da-27cd1abb0e54">348,946,439</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:11.25pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;Basic earnings (loss) from continuing operations per share</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(i)</span></div></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="i27f4e53b91ad4367b7f8d273eff27769_D20210401-20210630" decimals="2" name="us-gaap:IncomeLossFromContinuingOperationsPerBasicShare" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjkzY2E5YmIwMTc5MjQ3NmZiYjIyNWU1ZDlkZWM4NjlmL3NlYzo5M2NhOWJiMDE3OTI0NzZmYmIyMjVlNWQ5ZGVjODY5Zl81Mi9mcmFnOjlkZDkxMTIyZjQxYzQzNzk5OGZlMGIyOGMwYjRhYjgwL3RhYmxlOmQ2NGI3MDhhZjNkNzQ1NWVhNmU0MGM2NTYyMjk5ZDZkL3RhYmxlcmFuZ2U6ZDY0YjcwOGFmM2Q3NDU1ZWE2ZTQwYzY1NjIyOTlkNmRfNS0xLTEtMS0w_0da241c4-8f05-45dd-be8f-03513ed252c6">0.15</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usdPerShare" contextRef="i39065c5daf934af885335c12f3cfa83f_D20200401-20200630" decimals="2" sign="-" name="us-gaap:IncomeLossFromContinuingOperationsPerBasicShare" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjkzY2E5YmIwMTc5MjQ3NmZiYjIyNWU1ZDlkZWM4NjlmL3NlYzo5M2NhOWJiMDE3OTI0NzZmYmIyMjVlNWQ5ZGVjODY5Zl81Mi9mcmFnOjlkZDkxMTIyZjQxYzQzNzk5OGZlMGIyOGMwYjRhYjgwL3RhYmxlOmQ2NGI3MDhhZjNkNzQ1NWVhNmU0MGM2NTYyMjk5ZDZkL3RhYmxlcmFuZ2U6ZDY0YjcwOGFmM2Q3NDU1ZWE2ZTQwYzY1NjIyOTlkNmRfNS0zLTEtMS0w_199befcd-4ecf-4326-a09a-b0797f7c45e2">0.31</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usdPerShare" contextRef="i69782326f71a44e3805518280ee22b6b_D20210101-20210630" decimals="2" sign="-" name="us-gaap:IncomeLossFromContinuingOperationsPerBasicShare" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjkzY2E5YmIwMTc5MjQ3NmZiYjIyNWU1ZDlkZWM4NjlmL3NlYzo5M2NhOWJiMDE3OTI0NzZmYmIyMjVlNWQ5ZGVjODY5Zl81Mi9mcmFnOjlkZDkxMTIyZjQxYzQzNzk5OGZlMGIyOGMwYjRhYjgwL3RhYmxlOmQ2NGI3MDhhZjNkNzQ1NWVhNmU0MGM2NTYyMjk5ZDZkL3RhYmxlcmFuZ2U6ZDY0YjcwOGFmM2Q3NDU1ZWE2ZTQwYzY1NjIyOTlkNmRfNS01LTEtMS0w_4ceb4e89-57e7-457a-aff8-e4284e9ce2b1">0.28</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usdPerShare" contextRef="i4a110e4972ef4113880ce582e3cda5c5_D20200101-20200630" decimals="2" sign="-" name="us-gaap:IncomeLossFromContinuingOperationsPerBasicShare" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjkzY2E5YmIwMTc5MjQ3NmZiYjIyNWU1ZDlkZWM4NjlmL3NlYzo5M2NhOWJiMDE3OTI0NzZmYmIyMjVlNWQ5ZGVjODY5Zl81Mi9mcmFnOjlkZDkxMTIyZjQxYzQzNzk5OGZlMGIyOGMwYjRhYjgwL3RhYmxlOmQ2NGI3MDhhZjNkNzQ1NWVhNmU0MGM2NTYyMjk5ZDZkL3RhYmxlcmFuZ2U6ZDY0YjcwOGFmM2Q3NDU1ZWE2ZTQwYzY1NjIyOTlkNmRfNS03LTEtMS0w_81c4ff3c-90a7-414b-84ba-a215015c6042">0.09</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:9pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Loss from discontinued operations attributable to the shareholders of Cronos Group</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i27f4e53b91ad4367b7f8d273eff27769_D20210401-20210630" decimals="-3" sign="-" name="us-gaap:NetIncomeLossFromDiscontinuedOperationsAvailableToCommonShareholdersBasic" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzY2E5YmIwMTc5MjQ3NmZiYjIyNWU1ZDlkZWM4NjlmL3NlYzo5M2NhOWJiMDE3OTI0NzZmYmIyMjVlNWQ5ZGVjODY5Zl81Mi9mcmFnOjlkZDkxMTIyZjQxYzQzNzk5OGZlMGIyOGMwYjRhYjgwL3RhYmxlOmQ2NGI3MDhhZjNkNzQ1NWVhNmU0MGM2NTYyMjk5ZDZkL3RhYmxlcmFuZ2U6ZDY0YjcwOGFmM2Q3NDU1ZWE2ZTQwYzY1NjIyOTlkNmRfNy0xLTEtMS0xOTE2OQ_8dda8444-4003-422e-891a-aa72f0f3617e">561</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i39065c5daf934af885335c12f3cfa83f_D20200401-20200630" decimals="-3" sign="-" name="us-gaap:NetIncomeLossFromDiscontinuedOperationsAvailableToCommonShareholdersBasic" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzY2E5YmIwMTc5MjQ3NmZiYjIyNWU1ZDlkZWM4NjlmL3NlYzo5M2NhOWJiMDE3OTI0NzZmYmIyMjVlNWQ5ZGVjODY5Zl81Mi9mcmFnOjlkZDkxMTIyZjQxYzQzNzk5OGZlMGIyOGMwYjRhYjgwL3RhYmxlOmQ2NGI3MDhhZjNkNzQ1NWVhNmU0MGM2NTYyMjk5ZDZkL3RhYmxlcmFuZ2U6ZDY0YjcwOGFmM2Q3NDU1ZWE2ZTQwYzY1NjIyOTlkNmRfNy0zLTEtMS0xOTE2OQ_40610ab6-4c0d-4fc9-b72c-28372035648e">46</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i69782326f71a44e3805518280ee22b6b_D20210101-20210630" decimals="-3" sign="-" name="us-gaap:NetIncomeLossFromDiscontinuedOperationsAvailableToCommonShareholdersBasic" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzY2E5YmIwMTc5MjQ3NmZiYjIyNWU1ZDlkZWM4NjlmL3NlYzo5M2NhOWJiMDE3OTI0NzZmYmIyMjVlNWQ5ZGVjODY5Zl81Mi9mcmFnOjlkZDkxMTIyZjQxYzQzNzk5OGZlMGIyOGMwYjRhYjgwL3RhYmxlOmQ2NGI3MDhhZjNkNzQ1NWVhNmU0MGM2NTYyMjk5ZDZkL3RhYmxlcmFuZ2U6ZDY0YjcwOGFmM2Q3NDU1ZWE2ZTQwYzY1NjIyOTlkNmRfNy01LTEtMS0xOTE2OQ_1fa02a03-d5b5-496f-a11e-504a64a6e10b">582</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i4a110e4972ef4113880ce582e3cda5c5_D20200101-20200630" decimals="-3" sign="-" name="us-gaap:NetIncomeLossFromDiscontinuedOperationsAvailableToCommonShareholdersBasic" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzY2E5YmIwMTc5MjQ3NmZiYjIyNWU1ZDlkZWM4NjlmL3NlYzo5M2NhOWJiMDE3OTI0NzZmYmIyMjVlNWQ5ZGVjODY5Zl81Mi9mcmFnOjlkZDkxMTIyZjQxYzQzNzk5OGZlMGIyOGMwYjRhYjgwL3RhYmxlOmQ2NGI3MDhhZjNkNzQ1NWVhNmU0MGM2NTYyMjk5ZDZkL3RhYmxlcmFuZ2U6ZDY0YjcwOGFmM2Q3NDU1ZWE2ZTQwYzY1NjIyOTlkNmRfNy03LTEtMS0xOTE2OQ_26121a25-aeef-4f13-94ea-2f3c84d5690d">46</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Weighted average number of common shares outstanding</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i27f4e53b91ad4367b7f8d273eff27769_D20210401-20210630" decimals="0" format="ixt:numdotdecimal" name="us-gaap:WeightedAverageNumberOfSharesOutstandingBasic" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjkzY2E5YmIwMTc5MjQ3NmZiYjIyNWU1ZDlkZWM4NjlmL3NlYzo5M2NhOWJiMDE3OTI0NzZmYmIyMjVlNWQ5ZGVjODY5Zl81Mi9mcmFnOjlkZDkxMTIyZjQxYzQzNzk5OGZlMGIyOGMwYjRhYjgwL3RhYmxlOmQ2NGI3MDhhZjNkNzQ1NWVhNmU0MGM2NTYyMjk5ZDZkL3RhYmxlcmFuZ2U6ZDY0YjcwOGFmM2Q3NDU1ZWE2ZTQwYzY1NjIyOTlkNmRfOC0xLTEtMS0xOTE2OQ_8e62d8ca-0a68-42d8-8b92-23014c9f1189">371,721,382</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i39065c5daf934af885335c12f3cfa83f_D20200401-20200630" decimals="0" format="ixt:numdotdecimal" name="us-gaap:WeightedAverageNumberOfSharesOutstandingBasic" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjkzY2E5YmIwMTc5MjQ3NmZiYjIyNWU1ZDlkZWM4NjlmL3NlYzo5M2NhOWJiMDE3OTI0NzZmYmIyMjVlNWQ5ZGVjODY5Zl81Mi9mcmFnOjlkZDkxMTIyZjQxYzQzNzk5OGZlMGIyOGMwYjRhYjgwL3RhYmxlOmQ2NGI3MDhhZjNkNzQ1NWVhNmU0MGM2NTYyMjk5ZDZkL3RhYmxlcmFuZ2U6ZDY0YjcwOGFmM2Q3NDU1ZWE2ZTQwYzY1NjIyOTlkNmRfOC0zLTEtMS0xOTE2OQ_77b1d58d-2a4a-414f-ac33-f546e44ce51e">349,075,408</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i69782326f71a44e3805518280ee22b6b_D20210101-20210630" decimals="0" format="ixt:numdotdecimal" name="us-gaap:WeightedAverageNumberOfSharesOutstandingBasic" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjkzY2E5YmIwMTc5MjQ3NmZiYjIyNWU1ZDlkZWM4NjlmL3NlYzo5M2NhOWJiMDE3OTI0NzZmYmIyMjVlNWQ5ZGVjODY5Zl81Mi9mcmFnOjlkZDkxMTIyZjQxYzQzNzk5OGZlMGIyOGMwYjRhYjgwL3RhYmxlOmQ2NGI3MDhhZjNkNzQ1NWVhNmU0MGM2NTYyMjk5ZDZkL3RhYmxlcmFuZ2U6ZDY0YjcwOGFmM2Q3NDU1ZWE2ZTQwYzY1NjIyOTlkNmRfOC01LTEtMS0xOTE2OQ_66131be3-91c5-46c0-b6f1-b5bc54f2e3a7">367,391,118</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i4a110e4972ef4113880ce582e3cda5c5_D20200101-20200630" decimals="0" format="ixt:numdotdecimal" name="us-gaap:WeightedAverageNumberOfSharesOutstandingBasic" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjkzY2E5YmIwMTc5MjQ3NmZiYjIyNWU1ZDlkZWM4NjlmL3NlYzo5M2NhOWJiMDE3OTI0NzZmYmIyMjVlNWQ5ZGVjODY5Zl81Mi9mcmFnOjlkZDkxMTIyZjQxYzQzNzk5OGZlMGIyOGMwYjRhYjgwL3RhYmxlOmQ2NGI3MDhhZjNkNzQ1NWVhNmU0MGM2NTYyMjk5ZDZkL3RhYmxlcmFuZ2U6ZDY0YjcwOGFmM2Q3NDU1ZWE2ZTQwYzY1NjIyOTlkNmRfOC03LTEtMS0xOTE2OQ_1515293c-ff96-47d4-89ff-2631066cdd21">348,946,439</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Basic earnings from discontinued operations per share</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="i27f4e53b91ad4367b7f8d273eff27769_D20210401-20210630" decimals="2" name="us-gaap:IncomeLossFromDiscontinuedOperationsNetOfTaxPerBasicShare" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjkzY2E5YmIwMTc5MjQ3NmZiYjIyNWU1ZDlkZWM4NjlmL3NlYzo5M2NhOWJiMDE3OTI0NzZmYmIyMjVlNWQ5ZGVjODY5Zl81Mi9mcmFnOjlkZDkxMTIyZjQxYzQzNzk5OGZlMGIyOGMwYjRhYjgwL3RhYmxlOmQ2NGI3MDhhZjNkNzQ1NWVhNmU0MGM2NTYyMjk5ZDZkL3RhYmxlcmFuZ2U6ZDY0YjcwOGFmM2Q3NDU1ZWE2ZTQwYzY1NjIyOTlkNmRfOS0xLTEtMS0xOTE2OQ_0d22c099-3b80-4a92-a0b0-3927c80a8bdf">0.00</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="i39065c5daf934af885335c12f3cfa83f_D20200401-20200630" decimals="2" name="us-gaap:IncomeLossFromDiscontinuedOperationsNetOfTaxPerBasicShare" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjkzY2E5YmIwMTc5MjQ3NmZiYjIyNWU1ZDlkZWM4NjlmL3NlYzo5M2NhOWJiMDE3OTI0NzZmYmIyMjVlNWQ5ZGVjODY5Zl81Mi9mcmFnOjlkZDkxMTIyZjQxYzQzNzk5OGZlMGIyOGMwYjRhYjgwL3RhYmxlOmQ2NGI3MDhhZjNkNzQ1NWVhNmU0MGM2NTYyMjk5ZDZkL3RhYmxlcmFuZ2U6ZDY0YjcwOGFmM2Q3NDU1ZWE2ZTQwYzY1NjIyOTlkNmRfOS0zLTEtMS0xOTE2OQ_637aaf9b-cf74-4b94-a559-a3544c6707eb">0.00</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="i69782326f71a44e3805518280ee22b6b_D20210101-20210630" decimals="2" name="us-gaap:IncomeLossFromDiscontinuedOperationsNetOfTaxPerBasicShare" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjkzY2E5YmIwMTc5MjQ3NmZiYjIyNWU1ZDlkZWM4NjlmL3NlYzo5M2NhOWJiMDE3OTI0NzZmYmIyMjVlNWQ5ZGVjODY5Zl81Mi9mcmFnOjlkZDkxMTIyZjQxYzQzNzk5OGZlMGIyOGMwYjRhYjgwL3RhYmxlOmQ2NGI3MDhhZjNkNzQ1NWVhNmU0MGM2NTYyMjk5ZDZkL3RhYmxlcmFuZ2U6ZDY0YjcwOGFmM2Q3NDU1ZWE2ZTQwYzY1NjIyOTlkNmRfOS01LTEtMS0xOTE2OQ_216e8235-d95b-4aa5-a6dc-aeb473a1d6cf">0.00</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="i4a110e4972ef4113880ce582e3cda5c5_D20200101-20200630" decimals="2" name="us-gaap:IncomeLossFromDiscontinuedOperationsNetOfTaxPerBasicShare" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjkzY2E5YmIwMTc5MjQ3NmZiYjIyNWU1ZDlkZWM4NjlmL3NlYzo5M2NhOWJiMDE3OTI0NzZmYmIyMjVlNWQ5ZGVjODY5Zl81Mi9mcmFnOjlkZDkxMTIyZjQxYzQzNzk5OGZlMGIyOGMwYjRhYjgwL3RhYmxlOmQ2NGI3MDhhZjNkNzQ1NWVhNmU0MGM2NTYyMjk5ZDZkL3RhYmxlcmFuZ2U6ZDY0YjcwOGFmM2Q3NDU1ZWE2ZTQwYzY1NjIyOTlkNmRfOS03LTEtMS0xOTE2OQ_5ab8315c-4db3-40b6-960b-1d6104d848f4">0.00</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:9pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Diluted earnings (loss) per share computation</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net income (loss) used in the computation of basic earnings (loss) from continuing operations per share</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i27f4e53b91ad4367b7f8d273eff27769_D20210401-20210630" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:NetIncomeLossFromContinuingOperationsAvailableToCommonShareholdersBasic" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzY2E5YmIwMTc5MjQ3NmZiYjIyNWU1ZDlkZWM4NjlmL3NlYzo5M2NhOWJiMDE3OTI0NzZmYmIyMjVlNWQ5ZGVjODY5Zl81Mi9mcmFnOjlkZDkxMTIyZjQxYzQzNzk5OGZlMGIyOGMwYjRhYjgwL3RhYmxlOmQ2NGI3MDhhZjNkNzQ1NWVhNmU0MGM2NTYyMjk5ZDZkL3RhYmxlcmFuZ2U6ZDY0YjcwOGFmM2Q3NDU1ZWE2ZTQwYzY1NjIyOTlkNmRfNy0xLTEtMS0w_4c439f2a-99b9-4d63-8bf1-9773839b87c7">57,615</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i39065c5daf934af885335c12f3cfa83f_D20200401-20200630" decimals="-3" sign="-" format="ixt:numdotdecimal" name="us-gaap:NetIncomeLossFromContinuingOperationsAvailableToCommonShareholdersBasic" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzY2E5YmIwMTc5MjQ3NmZiYjIyNWU1ZDlkZWM4NjlmL3NlYzo5M2NhOWJiMDE3OTI0NzZmYmIyMjVlNWQ5ZGVjODY5Zl81Mi9mcmFnOjlkZDkxMTIyZjQxYzQzNzk5OGZlMGIyOGMwYjRhYjgwL3RhYmxlOmQ2NGI3MDhhZjNkNzQ1NWVhNmU0MGM2NTYyMjk5ZDZkL3RhYmxlcmFuZ2U6ZDY0YjcwOGFmM2Q3NDU1ZWE2ZTQwYzY1NjIyOTlkNmRfNy0zLTEtMS0w_adddecbf-195f-4609-8ee7-585f46546e43">106,931</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i69782326f71a44e3805518280ee22b6b_D20210101-20210630" decimals="-3" sign="-" format="ixt:numdotdecimal" name="us-gaap:NetIncomeLossFromContinuingOperationsAvailableToCommonShareholdersBasic" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzY2E5YmIwMTc5MjQ3NmZiYjIyNWU1ZDlkZWM4NjlmL3NlYzo5M2NhOWJiMDE3OTI0NzZmYmIyMjVlNWQ5ZGVjODY5Zl81Mi9mcmFnOjlkZDkxMTIyZjQxYzQzNzk5OGZlMGIyOGMwYjRhYjgwL3RhYmxlOmQ2NGI3MDhhZjNkNzQ1NWVhNmU0MGM2NTYyMjk5ZDZkL3RhYmxlcmFuZ2U6ZDY0YjcwOGFmM2Q3NDU1ZWE2ZTQwYzY1NjIyOTlkNmRfNy01LTEtMS0w_13771483-fbce-43f7-84f0-b485717346de">103,676</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i4a110e4972ef4113880ce582e3cda5c5_D20200101-20200630" decimals="-3" sign="-" format="ixt:numdotdecimal" name="us-gaap:NetIncomeLossFromContinuingOperationsAvailableToCommonShareholdersBasic" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzY2E5YmIwMTc5MjQ3NmZiYjIyNWU1ZDlkZWM4NjlmL3NlYzo5M2NhOWJiMDE3OTI0NzZmYmIyMjVlNWQ5ZGVjODY5Zl81Mi9mcmFnOjlkZDkxMTIyZjQxYzQzNzk5OGZlMGIyOGMwYjRhYjgwL3RhYmxlOmQ2NGI3MDhhZjNkNzQ1NWVhNmU0MGM2NTYyMjk5ZDZkL3RhYmxlcmFuZ2U6ZDY0YjcwOGFmM2Q3NDU1ZWE2ZTQwYzY1NjIyOTlkNmRfNy03LTEtMS0w_581f3439-c903-435e-9c9f-51b229141306">30,891</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Adjustment for gain (loss) on revaluation of derivative liabilities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i27f4e53b91ad4367b7f8d273eff27769_D20210401-20210630" decimals="-3" format="ixt:zerodash" name="us-gaap:DilutiveSecurities" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzY2E5YmIwMTc5MjQ3NmZiYjIyNWU1ZDlkZWM4NjlmL3NlYzo5M2NhOWJiMDE3OTI0NzZmYmIyMjVlNWQ5ZGVjODY5Zl81Mi9mcmFnOjlkZDkxMTIyZjQxYzQzNzk5OGZlMGIyOGMwYjRhYjgwL3RhYmxlOmQ2NGI3MDhhZjNkNzQ1NWVhNmU0MGM2NTYyMjk5ZDZkL3RhYmxlcmFuZ2U6ZDY0YjcwOGFmM2Q3NDU1ZWE2ZTQwYzY1NjIyOTlkNmRfOC0xLTEtMS0w_68d52c15-c56b-428f-8aa3-546bf5150ab3">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i39065c5daf934af885335c12f3cfa83f_D20200401-20200630" decimals="-3" sign="-" name="us-gaap:DilutiveSecurities" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzY2E5YmIwMTc5MjQ3NmZiYjIyNWU1ZDlkZWM4NjlmL3NlYzo5M2NhOWJiMDE3OTI0NzZmYmIyMjVlNWQ5ZGVjODY5Zl81Mi9mcmFnOjlkZDkxMTIyZjQxYzQzNzk5OGZlMGIyOGMwYjRhYjgwL3RhYmxlOmQ2NGI3MDhhZjNkNzQ1NWVhNmU0MGM2NTYyMjk5ZDZkL3RhYmxlcmFuZ2U6ZDY0YjcwOGFmM2Q3NDU1ZWE2ZTQwYzY1NjIyOTlkNmRfOC0zLTEtMS0w_3f186e2d-9318-43e1-a697-af5fd34a4a64">729</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i69782326f71a44e3805518280ee22b6b_D20210101-20210630" decimals="-3" format="ixt:zerodash" name="us-gaap:DilutiveSecurities" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzY2E5YmIwMTc5MjQ3NmZiYjIyNWU1ZDlkZWM4NjlmL3NlYzo5M2NhOWJiMDE3OTI0NzZmYmIyMjVlNWQ5ZGVjODY5Zl81Mi9mcmFnOjlkZDkxMTIyZjQxYzQzNzk5OGZlMGIyOGMwYjRhYjgwL3RhYmxlOmQ2NGI3MDhhZjNkNzQ1NWVhNmU0MGM2NTYyMjk5ZDZkL3RhYmxlcmFuZ2U6ZDY0YjcwOGFmM2Q3NDU1ZWE2ZTQwYzY1NjIyOTlkNmRfOC01LTEtMS0w_5a71d3b7-1e72-4733-a054-3f817922de9c">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i4a110e4972ef4113880ce582e3cda5c5_D20200101-20200630" decimals="-3" sign="-" name="us-gaap:DilutiveSecurities" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzY2E5YmIwMTc5MjQ3NmZiYjIyNWU1ZDlkZWM4NjlmL3NlYzo5M2NhOWJiMDE3OTI0NzZmYmIyMjVlNWQ5ZGVjODY5Zl81Mi9mcmFnOjlkZDkxMTIyZjQxYzQzNzk5OGZlMGIyOGMwYjRhYjgwL3RhYmxlOmQ2NGI3MDhhZjNkNzQ1NWVhNmU0MGM2NTYyMjk5ZDZkL3RhYmxlcmFuZ2U6ZDY0YjcwOGFmM2Q3NDU1ZWE2ZTQwYzY1NjIyOTlkNmRfOC03LTEtMS0w_ce14450a-6dd1-4b40-b430-1814abe5ca34">729</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net income (loss) used in the computation of diluted earnings (loss) from continuing operations per share</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i27f4e53b91ad4367b7f8d273eff27769_D20210401-20210630" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:NetIncomeLossFromContinuingOperationsAvailableToCommonShareholdersDiluted" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzY2E5YmIwMTc5MjQ3NmZiYjIyNWU1ZDlkZWM4NjlmL3NlYzo5M2NhOWJiMDE3OTI0NzZmYmIyMjVlNWQ5ZGVjODY5Zl81Mi9mcmFnOjlkZDkxMTIyZjQxYzQzNzk5OGZlMGIyOGMwYjRhYjgwL3RhYmxlOmQ2NGI3MDhhZjNkNzQ1NWVhNmU0MGM2NTYyMjk5ZDZkL3RhYmxlcmFuZ2U6ZDY0YjcwOGFmM2Q3NDU1ZWE2ZTQwYzY1NjIyOTlkNmRfOS0xLTEtMS0w_9fe034cf-6265-4970-bcc7-db6fc6bdf720">57,615</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i39065c5daf934af885335c12f3cfa83f_D20200401-20200630" decimals="-3" sign="-" format="ixt:numdotdecimal" name="us-gaap:NetIncomeLossFromContinuingOperationsAvailableToCommonShareholdersDiluted" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzY2E5YmIwMTc5MjQ3NmZiYjIyNWU1ZDlkZWM4NjlmL3NlYzo5M2NhOWJiMDE3OTI0NzZmYmIyMjVlNWQ5ZGVjODY5Zl81Mi9mcmFnOjlkZDkxMTIyZjQxYzQzNzk5OGZlMGIyOGMwYjRhYjgwL3RhYmxlOmQ2NGI3MDhhZjNkNzQ1NWVhNmU0MGM2NTYyMjk5ZDZkL3RhYmxlcmFuZ2U6ZDY0YjcwOGFmM2Q3NDU1ZWE2ZTQwYzY1NjIyOTlkNmRfOS0zLTEtMS0w_278b8152-b23f-46c5-b65a-4a94397fa4b4">107,660</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i69782326f71a44e3805518280ee22b6b_D20210101-20210630" decimals="-3" sign="-" format="ixt:numdotdecimal" name="us-gaap:NetIncomeLossFromContinuingOperationsAvailableToCommonShareholdersDiluted" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzY2E5YmIwMTc5MjQ3NmZiYjIyNWU1ZDlkZWM4NjlmL3NlYzo5M2NhOWJiMDE3OTI0NzZmYmIyMjVlNWQ5ZGVjODY5Zl81Mi9mcmFnOjlkZDkxMTIyZjQxYzQzNzk5OGZlMGIyOGMwYjRhYjgwL3RhYmxlOmQ2NGI3MDhhZjNkNzQ1NWVhNmU0MGM2NTYyMjk5ZDZkL3RhYmxlcmFuZ2U6ZDY0YjcwOGFmM2Q3NDU1ZWE2ZTQwYzY1NjIyOTlkNmRfOS01LTEtMS0w_ecad5897-c6be-49d5-9466-0971df4129bb">103,676</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i4a110e4972ef4113880ce582e3cda5c5_D20200101-20200630" decimals="-3" sign="-" format="ixt:numdotdecimal" name="us-gaap:NetIncomeLossFromContinuingOperationsAvailableToCommonShareholdersDiluted" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzY2E5YmIwMTc5MjQ3NmZiYjIyNWU1ZDlkZWM4NjlmL3NlYzo5M2NhOWJiMDE3OTI0NzZmYmIyMjVlNWQ5ZGVjODY5Zl81Mi9mcmFnOjlkZDkxMTIyZjQxYzQzNzk5OGZlMGIyOGMwYjRhYjgwL3RhYmxlOmQ2NGI3MDhhZjNkNzQ1NWVhNmU0MGM2NTYyMjk5ZDZkL3RhYmxlcmFuZ2U6ZDY0YjcwOGFmM2Q3NDU1ZWE2ZTQwYzY1NjIyOTlkNmRfOS03LTEtMS0w_207de005-1408-4e1f-951a-847510918bf2">31,620</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:9pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Weighted average number of common shares outstanding used in the computation of basic earnings (loss) per share</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i27f4e53b91ad4367b7f8d273eff27769_D20210401-20210630" decimals="0" format="ixt:numdotdecimal" name="us-gaap:WeightedAverageNumberOfSharesOutstandingBasic" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjkzY2E5YmIwMTc5MjQ3NmZiYjIyNWU1ZDlkZWM4NjlmL3NlYzo5M2NhOWJiMDE3OTI0NzZmYmIyMjVlNWQ5ZGVjODY5Zl81Mi9mcmFnOjlkZDkxMTIyZjQxYzQzNzk5OGZlMGIyOGMwYjRhYjgwL3RhYmxlOmQ2NGI3MDhhZjNkNzQ1NWVhNmU0MGM2NTYyMjk5ZDZkL3RhYmxlcmFuZ2U6ZDY0YjcwOGFmM2Q3NDU1ZWE2ZTQwYzY1NjIyOTlkNmRfMTEtMS0xLTEtMA_c5250765-7544-4221-9fb4-dcb6899dfe61">371,721,382</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i39065c5daf934af885335c12f3cfa83f_D20200401-20200630" decimals="0" format="ixt:numdotdecimal" name="us-gaap:WeightedAverageNumberOfSharesOutstandingBasic" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjkzY2E5YmIwMTc5MjQ3NmZiYjIyNWU1ZDlkZWM4NjlmL3NlYzo5M2NhOWJiMDE3OTI0NzZmYmIyMjVlNWQ5ZGVjODY5Zl81Mi9mcmFnOjlkZDkxMTIyZjQxYzQzNzk5OGZlMGIyOGMwYjRhYjgwL3RhYmxlOmQ2NGI3MDhhZjNkNzQ1NWVhNmU0MGM2NTYyMjk5ZDZkL3RhYmxlcmFuZ2U6ZDY0YjcwOGFmM2Q3NDU1ZWE2ZTQwYzY1NjIyOTlkNmRfMTEtMy0xLTEtMA_891ab39f-b0a8-402a-9552-714c361cce01">349,075,408</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i69782326f71a44e3805518280ee22b6b_D20210101-20210630" decimals="0" format="ixt:numdotdecimal" name="us-gaap:WeightedAverageNumberOfSharesOutstandingBasic" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjkzY2E5YmIwMTc5MjQ3NmZiYjIyNWU1ZDlkZWM4NjlmL3NlYzo5M2NhOWJiMDE3OTI0NzZmYmIyMjVlNWQ5ZGVjODY5Zl81Mi9mcmFnOjlkZDkxMTIyZjQxYzQzNzk5OGZlMGIyOGMwYjRhYjgwL3RhYmxlOmQ2NGI3MDhhZjNkNzQ1NWVhNmU0MGM2NTYyMjk5ZDZkL3RhYmxlcmFuZ2U6ZDY0YjcwOGFmM2Q3NDU1ZWE2ZTQwYzY1NjIyOTlkNmRfMTEtNS0xLTEtMA_f17f8b3d-b0bf-4cf2-b5a8-8001d7f1c188">367,391,118</ix:nonFraction></span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i4a110e4972ef4113880ce582e3cda5c5_D20200101-20200630" decimals="0" format="ixt:numdotdecimal" name="us-gaap:WeightedAverageNumberOfSharesOutstandingBasic" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjkzY2E5YmIwMTc5MjQ3NmZiYjIyNWU1ZDlkZWM4NjlmL3NlYzo5M2NhOWJiMDE3OTI0NzZmYmIyMjVlNWQ5ZGVjODY5Zl81Mi9mcmFnOjlkZDkxMTIyZjQxYzQzNzk5OGZlMGIyOGMwYjRhYjgwL3RhYmxlOmQ2NGI3MDhhZjNkNzQ1NWVhNmU0MGM2NTYyMjk5ZDZkL3RhYmxlcmFuZ2U6ZDY0YjcwOGFmM2Q3NDU1ZWE2ZTQwYzY1NjIyOTlkNmRfMTEtNy0xLTEtMA_754a2b28-b91c-46bb-83cd-cc4fd4a79c20">348,946,439</ix:nonFraction></span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Dilutive effect of warrants</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="ibfe5b711341a4fa5b15c489835848fe5_D20210401-20210630" decimals="0" format="ixt:numdotdecimal" name="us-gaap:IncrementalCommonSharesAttributableToShareBasedPaymentArrangements" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjkzY2E5YmIwMTc5MjQ3NmZiYjIyNWU1ZDlkZWM4NjlmL3NlYzo5M2NhOWJiMDE3OTI0NzZmYmIyMjVlNWQ5ZGVjODY5Zl81Mi9mcmFnOjlkZDkxMTIyZjQxYzQzNzk5OGZlMGIyOGMwYjRhYjgwL3RhYmxlOmQ2NGI3MDhhZjNkNzQ1NWVhNmU0MGM2NTYyMjk5ZDZkL3RhYmxlcmFuZ2U6ZDY0YjcwOGFmM2Q3NDU1ZWE2ZTQwYzY1NjIyOTlkNmRfMTItMS0xLTEtMA_3196ded5-16ad-4b47-b5ff-7f4f260f33b1">5,577</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="ife69fdb8512f485a8a3f1f66e868a24d_D20200401-20200630" decimals="0" format="ixt:zerodash" name="us-gaap:IncrementalCommonSharesAttributableToShareBasedPaymentArrangements" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjkzY2E5YmIwMTc5MjQ3NmZiYjIyNWU1ZDlkZWM4NjlmL3NlYzo5M2NhOWJiMDE3OTI0NzZmYmIyMjVlNWQ5ZGVjODY5Zl81Mi9mcmFnOjlkZDkxMTIyZjQxYzQzNzk5OGZlMGIyOGMwYjRhYjgwL3RhYmxlOmQ2NGI3MDhhZjNkNzQ1NWVhNmU0MGM2NTYyMjk5ZDZkL3RhYmxlcmFuZ2U6ZDY0YjcwOGFmM2Q3NDU1ZWE2ZTQwYzY1NjIyOTlkNmRfMTItMy0xLTEtMA_e7d19ebe-bb12-4fd2-8193-b4302f60808c">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="ic97055dc0db04af88f485b12b96f84c2_D20210101-20210630" decimals="0" format="ixt:zerodash" name="us-gaap:IncrementalCommonSharesAttributableToShareBasedPaymentArrangements" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjkzY2E5YmIwMTc5MjQ3NmZiYjIyNWU1ZDlkZWM4NjlmL3NlYzo5M2NhOWJiMDE3OTI0NzZmYmIyMjVlNWQ5ZGVjODY5Zl81Mi9mcmFnOjlkZDkxMTIyZjQxYzQzNzk5OGZlMGIyOGMwYjRhYjgwL3RhYmxlOmQ2NGI3MDhhZjNkNzQ1NWVhNmU0MGM2NTYyMjk5ZDZkL3RhYmxlcmFuZ2U6ZDY0YjcwOGFmM2Q3NDU1ZWE2ZTQwYzY1NjIyOTlkNmRfMTItNS0xLTEtMA_20d63197-dfa3-431e-968a-12d8711ec4a4">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i4558c25f511848f29e1d0d9bd1c7f160_D20200101-20200630" decimals="0" format="ixt:zerodash" name="us-gaap:IncrementalCommonSharesAttributableToShareBasedPaymentArrangements" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjkzY2E5YmIwMTc5MjQ3NmZiYjIyNWU1ZDlkZWM4NjlmL3NlYzo5M2NhOWJiMDE3OTI0NzZmYmIyMjVlNWQ5ZGVjODY5Zl81Mi9mcmFnOjlkZDkxMTIyZjQxYzQzNzk5OGZlMGIyOGMwYjRhYjgwL3RhYmxlOmQ2NGI3MDhhZjNkNzQ1NWVhNmU0MGM2NTYyMjk5ZDZkL3RhYmxlcmFuZ2U6ZDY0YjcwOGFmM2Q3NDU1ZWE2ZTQwYzY1NjIyOTlkNmRfMTItNy0xLTEtMA_6522e4d8-617c-49d3-b9e0-2e04a780e6d5">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Dilutive effect of stock options</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i1e4726863b724a379f5bd7d27ab5b3cc_D20210401-20210630" decimals="0" format="ixt:numdotdecimal" name="us-gaap:IncrementalCommonSharesAttributableToShareBasedPaymentArrangements" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjkzY2E5YmIwMTc5MjQ3NmZiYjIyNWU1ZDlkZWM4NjlmL3NlYzo5M2NhOWJiMDE3OTI0NzZmYmIyMjVlNWQ5ZGVjODY5Zl81Mi9mcmFnOjlkZDkxMTIyZjQxYzQzNzk5OGZlMGIyOGMwYjRhYjgwL3RhYmxlOmQ2NGI3MDhhZjNkNzQ1NWVhNmU0MGM2NTYyMjk5ZDZkL3RhYmxlcmFuZ2U6ZDY0YjcwOGFmM2Q3NDU1ZWE2ZTQwYzY1NjIyOTlkNmRfMTMtMS0xLTEtMA_4318fba8-0c34-4d82-89b6-4d77ae85c464">3,027,518</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="ie0f42dd5b3d34fe38a076491f8d4a0a5_D20200401-20200630" decimals="0" format="ixt:zerodash" name="us-gaap:IncrementalCommonSharesAttributableToShareBasedPaymentArrangements" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjkzY2E5YmIwMTc5MjQ3NmZiYjIyNWU1ZDlkZWM4NjlmL3NlYzo5M2NhOWJiMDE3OTI0NzZmYmIyMjVlNWQ5ZGVjODY5Zl81Mi9mcmFnOjlkZDkxMTIyZjQxYzQzNzk5OGZlMGIyOGMwYjRhYjgwL3RhYmxlOmQ2NGI3MDhhZjNkNzQ1NWVhNmU0MGM2NTYyMjk5ZDZkL3RhYmxlcmFuZ2U6ZDY0YjcwOGFmM2Q3NDU1ZWE2ZTQwYzY1NjIyOTlkNmRfMTMtMy0xLTEtMA_f066c33b-4cf7-4dbd-abb6-8c9e69ae9f44">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="idaf424f34df645f9a313b3cbd11846bb_D20210101-20210630" decimals="0" format="ixt:zerodash" name="us-gaap:IncrementalCommonSharesAttributableToShareBasedPaymentArrangements" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjkzY2E5YmIwMTc5MjQ3NmZiYjIyNWU1ZDlkZWM4NjlmL3NlYzo5M2NhOWJiMDE3OTI0NzZmYmIyMjVlNWQ5ZGVjODY5Zl81Mi9mcmFnOjlkZDkxMTIyZjQxYzQzNzk5OGZlMGIyOGMwYjRhYjgwL3RhYmxlOmQ2NGI3MDhhZjNkNzQ1NWVhNmU0MGM2NTYyMjk5ZDZkL3RhYmxlcmFuZ2U6ZDY0YjcwOGFmM2Q3NDU1ZWE2ZTQwYzY1NjIyOTlkNmRfMTMtNS0xLTEtMA_cb22d87b-9c48-4770-afbb-fa8fd91dd0ff">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="ib8a293d71fca4827bbf9cac05f24fe68_D20200101-20200630" decimals="0" format="ixt:zerodash" name="us-gaap:IncrementalCommonSharesAttributableToShareBasedPaymentArrangements" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjkzY2E5YmIwMTc5MjQ3NmZiYjIyNWU1ZDlkZWM4NjlmL3NlYzo5M2NhOWJiMDE3OTI0NzZmYmIyMjVlNWQ5ZGVjODY5Zl81Mi9mcmFnOjlkZDkxMTIyZjQxYzQzNzk5OGZlMGIyOGMwYjRhYjgwL3RhYmxlOmQ2NGI3MDhhZjNkNzQ1NWVhNmU0MGM2NTYyMjk5ZDZkL3RhYmxlcmFuZ2U6ZDY0YjcwOGFmM2Q3NDU1ZWE2ZTQwYzY1NjIyOTlkNmRfMTMtNy0xLTEtMA_73a98ecb-6fd2-45fa-884d-cbd8bc3645a0">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Dilutive effect of RSUs</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="ia9e804ad8293416391f6038663c9425b_D20210401-20210630" decimals="0" format="ixt:numdotdecimal" name="us-gaap:IncrementalCommonSharesAttributableToShareBasedPaymentArrangements" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjkzY2E5YmIwMTc5MjQ3NmZiYjIyNWU1ZDlkZWM4NjlmL3NlYzo5M2NhOWJiMDE3OTI0NzZmYmIyMjVlNWQ5ZGVjODY5Zl81Mi9mcmFnOjlkZDkxMTIyZjQxYzQzNzk5OGZlMGIyOGMwYjRhYjgwL3RhYmxlOmQ2NGI3MDhhZjNkNzQ1NWVhNmU0MGM2NTYyMjk5ZDZkL3RhYmxlcmFuZ2U6ZDY0YjcwOGFmM2Q3NDU1ZWE2ZTQwYzY1NjIyOTlkNmRfMTQtMS0xLTEtMA_1c9a87c5-0227-4976-8584-239734114cc3">595,379</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="if0a238351a57425a8c0ba03f482ef4b9_D20200401-20200630" decimals="0" format="ixt:zerodash" name="us-gaap:IncrementalCommonSharesAttributableToShareBasedPaymentArrangements" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjkzY2E5YmIwMTc5MjQ3NmZiYjIyNWU1ZDlkZWM4NjlmL3NlYzo5M2NhOWJiMDE3OTI0NzZmYmIyMjVlNWQ5ZGVjODY5Zl81Mi9mcmFnOjlkZDkxMTIyZjQxYzQzNzk5OGZlMGIyOGMwYjRhYjgwL3RhYmxlOmQ2NGI3MDhhZjNkNzQ1NWVhNmU0MGM2NTYyMjk5ZDZkL3RhYmxlcmFuZ2U6ZDY0YjcwOGFmM2Q3NDU1ZWE2ZTQwYzY1NjIyOTlkNmRfMTQtMy0xLTEtMA_da134421-02b3-4a91-83e8-ba3100ed8766">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="ie5eb2f0b8440403abdac2db9e01adbb9_D20210101-20210630" decimals="0" format="ixt:zerodash" name="us-gaap:IncrementalCommonSharesAttributableToShareBasedPaymentArrangements" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjkzY2E5YmIwMTc5MjQ3NmZiYjIyNWU1ZDlkZWM4NjlmL3NlYzo5M2NhOWJiMDE3OTI0NzZmYmIyMjVlNWQ5ZGVjODY5Zl81Mi9mcmFnOjlkZDkxMTIyZjQxYzQzNzk5OGZlMGIyOGMwYjRhYjgwL3RhYmxlOmQ2NGI3MDhhZjNkNzQ1NWVhNmU0MGM2NTYyMjk5ZDZkL3RhYmxlcmFuZ2U6ZDY0YjcwOGFmM2Q3NDU1ZWE2ZTQwYzY1NjIyOTlkNmRfMTQtNS0xLTEtMA_69cdac88-daf5-4580-8f0b-8927ae4e24b4">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i10cd1c126464402b99bfac52e7ebdbb2_D20200101-20200630" decimals="0" format="ixt:zerodash" name="us-gaap:IncrementalCommonSharesAttributableToShareBasedPaymentArrangements" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjkzY2E5YmIwMTc5MjQ3NmZiYjIyNWU1ZDlkZWM4NjlmL3NlYzo5M2NhOWJiMDE3OTI0NzZmYmIyMjVlNWQ5ZGVjODY5Zl81Mi9mcmFnOjlkZDkxMTIyZjQxYzQzNzk5OGZlMGIyOGMwYjRhYjgwL3RhYmxlOmQ2NGI3MDhhZjNkNzQ1NWVhNmU0MGM2NTYyMjk5ZDZkL3RhYmxlcmFuZ2U6ZDY0YjcwOGFmM2Q3NDU1ZWE2ZTQwYzY1NjIyOTlkNmRfMTQtNy0xLTEtMA_199b738c-9a17-42c1-a843-75da81d418a2">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><div style="padding-left:11.25pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Weighted average number of common shares for computation of diluted earnings (loss) from continuing operations per share</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(i)</span></div></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i27f4e53b91ad4367b7f8d273eff27769_D20210401-20210630" decimals="0" format="ixt:numdotdecimal" name="us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjkzY2E5YmIwMTc5MjQ3NmZiYjIyNWU1ZDlkZWM4NjlmL3NlYzo5M2NhOWJiMDE3OTI0NzZmYmIyMjVlNWQ5ZGVjODY5Zl81Mi9mcmFnOjlkZDkxMTIyZjQxYzQzNzk5OGZlMGIyOGMwYjRhYjgwL3RhYmxlOmQ2NGI3MDhhZjNkNzQ1NWVhNmU0MGM2NTYyMjk5ZDZkL3RhYmxlcmFuZ2U6ZDY0YjcwOGFmM2Q3NDU1ZWE2ZTQwYzY1NjIyOTlkNmRfMTctMS0xLTEtMA_286055b8-99e5-4121-8ee8-a2a7a07a2446">375,349,856</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i39065c5daf934af885335c12f3cfa83f_D20200401-20200630" decimals="0" format="ixt:numdotdecimal" name="us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjkzY2E5YmIwMTc5MjQ3NmZiYjIyNWU1ZDlkZWM4NjlmL3NlYzo5M2NhOWJiMDE3OTI0NzZmYmIyMjVlNWQ5ZGVjODY5Zl81Mi9mcmFnOjlkZDkxMTIyZjQxYzQzNzk5OGZlMGIyOGMwYjRhYjgwL3RhYmxlOmQ2NGI3MDhhZjNkNzQ1NWVhNmU0MGM2NTYyMjk5ZDZkL3RhYmxlcmFuZ2U6ZDY0YjcwOGFmM2Q3NDU1ZWE2ZTQwYzY1NjIyOTlkNmRfMTctMy0xLTEtMA_52c4e66b-3922-4913-8ef0-99d403be3436">349,075,408</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i69782326f71a44e3805518280ee22b6b_D20210101-20210630" decimals="0" format="ixt:numdotdecimal" name="us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjkzY2E5YmIwMTc5MjQ3NmZiYjIyNWU1ZDlkZWM4NjlmL3NlYzo5M2NhOWJiMDE3OTI0NzZmYmIyMjVlNWQ5ZGVjODY5Zl81Mi9mcmFnOjlkZDkxMTIyZjQxYzQzNzk5OGZlMGIyOGMwYjRhYjgwL3RhYmxlOmQ2NGI3MDhhZjNkNzQ1NWVhNmU0MGM2NTYyMjk5ZDZkL3RhYmxlcmFuZ2U6ZDY0YjcwOGFmM2Q3NDU1ZWE2ZTQwYzY1NjIyOTlkNmRfMTctNS0xLTEtMA_573aa8b7-bf4a-41e3-9d84-1d7057dffd3b">367,391,118</ix:nonFraction></span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i4a110e4972ef4113880ce582e3cda5c5_D20200101-20200630" decimals="0" format="ixt:numdotdecimal" name="us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjkzY2E5YmIwMTc5MjQ3NmZiYjIyNWU1ZDlkZWM4NjlmL3NlYzo5M2NhOWJiMDE3OTI0NzZmYmIyMjVlNWQ5ZGVjODY5Zl81Mi9mcmFnOjlkZDkxMTIyZjQxYzQzNzk5OGZlMGIyOGMwYjRhYjgwL3RhYmxlOmQ2NGI3MDhhZjNkNzQ1NWVhNmU0MGM2NTYyMjk5ZDZkL3RhYmxlcmFuZ2U6ZDY0YjcwOGFmM2Q3NDU1ZWE2ZTQwYzY1NjIyOTlkNmRfMTctNy0xLTEtMA_eecd38c8-76db-42c3-a5f6-fc8fa86a360c">348,946,439</ix:nonFraction></span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Diluted earnings (loss) from continuing operations per share</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="i27f4e53b91ad4367b7f8d273eff27769_D20210401-20210630" decimals="2" name="us-gaap:IncomeLossFromContinuingOperationsPerDilutedShare" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjkzY2E5YmIwMTc5MjQ3NmZiYjIyNWU1ZDlkZWM4NjlmL3NlYzo5M2NhOWJiMDE3OTI0NzZmYmIyMjVlNWQ5ZGVjODY5Zl81Mi9mcmFnOjlkZDkxMTIyZjQxYzQzNzk5OGZlMGIyOGMwYjRhYjgwL3RhYmxlOmQ2NGI3MDhhZjNkNzQ1NWVhNmU0MGM2NTYyMjk5ZDZkL3RhYmxlcmFuZ2U6ZDY0YjcwOGFmM2Q3NDU1ZWE2ZTQwYzY1NjIyOTlkNmRfMTgtMS0xLTEtMA_14e82c38-bc6e-45dd-9c06-b706ac2489dc">0.15</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usdPerShare" contextRef="i39065c5daf934af885335c12f3cfa83f_D20200401-20200630" decimals="2" sign="-" name="us-gaap:IncomeLossFromContinuingOperationsPerDilutedShare" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjkzY2E5YmIwMTc5MjQ3NmZiYjIyNWU1ZDlkZWM4NjlmL3NlYzo5M2NhOWJiMDE3OTI0NzZmYmIyMjVlNWQ5ZGVjODY5Zl81Mi9mcmFnOjlkZDkxMTIyZjQxYzQzNzk5OGZlMGIyOGMwYjRhYjgwL3RhYmxlOmQ2NGI3MDhhZjNkNzQ1NWVhNmU0MGM2NTYyMjk5ZDZkL3RhYmxlcmFuZ2U6ZDY0YjcwOGFmM2Q3NDU1ZWE2ZTQwYzY1NjIyOTlkNmRfMTgtMy0xLTEtMA_c728f08e-2a53-46e7-a8b5-ec5c5d4e70d1">0.31</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usdPerShare" contextRef="i69782326f71a44e3805518280ee22b6b_D20210101-20210630" decimals="2" sign="-" name="us-gaap:IncomeLossFromContinuingOperationsPerDilutedShare" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjkzY2E5YmIwMTc5MjQ3NmZiYjIyNWU1ZDlkZWM4NjlmL3NlYzo5M2NhOWJiMDE3OTI0NzZmYmIyMjVlNWQ5ZGVjODY5Zl81Mi9mcmFnOjlkZDkxMTIyZjQxYzQzNzk5OGZlMGIyOGMwYjRhYjgwL3RhYmxlOmQ2NGI3MDhhZjNkNzQ1NWVhNmU0MGM2NTYyMjk5ZDZkL3RhYmxlcmFuZ2U6ZDY0YjcwOGFmM2Q3NDU1ZWE2ZTQwYzY1NjIyOTlkNmRfMTgtNS0xLTEtMA_e0966c2a-9958-4223-a75e-8c2f6284c6f0">0.28</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usdPerShare" contextRef="i4a110e4972ef4113880ce582e3cda5c5_D20200101-20200630" decimals="2" sign="-" name="us-gaap:IncomeLossFromContinuingOperationsPerDilutedShare" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjkzY2E5YmIwMTc5MjQ3NmZiYjIyNWU1ZDlkZWM4NjlmL3NlYzo5M2NhOWJiMDE3OTI0NzZmYmIyMjVlNWQ5ZGVjODY5Zl81Mi9mcmFnOjlkZDkxMTIyZjQxYzQzNzk5OGZlMGIyOGMwYjRhYjgwL3RhYmxlOmQ2NGI3MDhhZjNkNzQ1NWVhNmU0MGM2NTYyMjk5ZDZkL3RhYmxlcmFuZ2U6ZDY0YjcwOGFmM2Q3NDU1ZWE2ZTQwYzY1NjIyOTlkNmRfMTgtNy0xLTEtMA_dfd83635-60cc-43c1-96e6-297c7ae2f200">0.09</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:9pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Loss from discontinued operations attributable to the shareholders of Cronos Group</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i27f4e53b91ad4367b7f8d273eff27769_D20210401-20210630" decimals="-3" sign="-" name="us-gaap:NetIncomeLossFromDiscontinuedOperationsAvailableToCommonShareholdersDiluted" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzY2E5YmIwMTc5MjQ3NmZiYjIyNWU1ZDlkZWM4NjlmL3NlYzo5M2NhOWJiMDE3OTI0NzZmYmIyMjVlNWQ5ZGVjODY5Zl81Mi9mcmFnOjlkZDkxMTIyZjQxYzQzNzk5OGZlMGIyOGMwYjRhYjgwL3RhYmxlOmQ2NGI3MDhhZjNkNzQ1NWVhNmU0MGM2NTYyMjk5ZDZkL3RhYmxlcmFuZ2U6ZDY0YjcwOGFmM2Q3NDU1ZWE2ZTQwYzY1NjIyOTlkNmRfMjUtMS0xLTEtMTkxODY_f7ca1a4b-b8df-4b76-b4b3-efceb4da1beb">561</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i39065c5daf934af885335c12f3cfa83f_D20200401-20200630" decimals="-3" sign="-" name="us-gaap:NetIncomeLossFromDiscontinuedOperationsAvailableToCommonShareholdersDiluted" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzY2E5YmIwMTc5MjQ3NmZiYjIyNWU1ZDlkZWM4NjlmL3NlYzo5M2NhOWJiMDE3OTI0NzZmYmIyMjVlNWQ5ZGVjODY5Zl81Mi9mcmFnOjlkZDkxMTIyZjQxYzQzNzk5OGZlMGIyOGMwYjRhYjgwL3RhYmxlOmQ2NGI3MDhhZjNkNzQ1NWVhNmU0MGM2NTYyMjk5ZDZkL3RhYmxlcmFuZ2U6ZDY0YjcwOGFmM2Q3NDU1ZWE2ZTQwYzY1NjIyOTlkNmRfMjUtMy0xLTEtMTkxODY_0e7a68ca-0814-439f-87d2-99fefdb73fc5">46</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i69782326f71a44e3805518280ee22b6b_D20210101-20210630" decimals="-3" sign="-" name="us-gaap:NetIncomeLossFromDiscontinuedOperationsAvailableToCommonShareholdersDiluted" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzY2E5YmIwMTc5MjQ3NmZiYjIyNWU1ZDlkZWM4NjlmL3NlYzo5M2NhOWJiMDE3OTI0NzZmYmIyMjVlNWQ5ZGVjODY5Zl81Mi9mcmFnOjlkZDkxMTIyZjQxYzQzNzk5OGZlMGIyOGMwYjRhYjgwL3RhYmxlOmQ2NGI3MDhhZjNkNzQ1NWVhNmU0MGM2NTYyMjk5ZDZkL3RhYmxlcmFuZ2U6ZDY0YjcwOGFmM2Q3NDU1ZWE2ZTQwYzY1NjIyOTlkNmRfMjUtNS0xLTEtMTkxODY_51901021-9fb1-424b-a029-6757f2293dd4">582</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i4a110e4972ef4113880ce582e3cda5c5_D20200101-20200630" decimals="-3" sign="-" name="us-gaap:NetIncomeLossFromDiscontinuedOperationsAvailableToCommonShareholdersDiluted" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzY2E5YmIwMTc5MjQ3NmZiYjIyNWU1ZDlkZWM4NjlmL3NlYzo5M2NhOWJiMDE3OTI0NzZmYmIyMjVlNWQ5ZGVjODY5Zl81Mi9mcmFnOjlkZDkxMTIyZjQxYzQzNzk5OGZlMGIyOGMwYjRhYjgwL3RhYmxlOmQ2NGI3MDhhZjNkNzQ1NWVhNmU0MGM2NTYyMjk5ZDZkL3RhYmxlcmFuZ2U6ZDY0YjcwOGFmM2Q3NDU1ZWE2ZTQwYzY1NjIyOTlkNmRfMjUtNy0xLTEtMTkxODY_37f8c43d-b730-494a-ae63-dac03dde4b57">46</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Weighted average number of common shares for computation of diluted loss from discontinued operations per share</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i27f4e53b91ad4367b7f8d273eff27769_D20210401-20210630" decimals="0" format="ixt:numdotdecimal" name="us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjkzY2E5YmIwMTc5MjQ3NmZiYjIyNWU1ZDlkZWM4NjlmL3NlYzo5M2NhOWJiMDE3OTI0NzZmYmIyMjVlNWQ5ZGVjODY5Zl81Mi9mcmFnOjlkZDkxMTIyZjQxYzQzNzk5OGZlMGIyOGMwYjRhYjgwL3RhYmxlOmQ2NGI3MDhhZjNkNzQ1NWVhNmU0MGM2NTYyMjk5ZDZkL3RhYmxlcmFuZ2U6ZDY0YjcwOGFmM2Q3NDU1ZWE2ZTQwYzY1NjIyOTlkNmRfMjYtMS0xLTEtMTkxODY_be568b3e-6ef5-4d9c-a0a1-41c52fe052e9">375,349,856</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i39065c5daf934af885335c12f3cfa83f_D20200401-20200630" decimals="0" format="ixt:numdotdecimal" name="us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjkzY2E5YmIwMTc5MjQ3NmZiYjIyNWU1ZDlkZWM4NjlmL3NlYzo5M2NhOWJiMDE3OTI0NzZmYmIyMjVlNWQ5ZGVjODY5Zl81Mi9mcmFnOjlkZDkxMTIyZjQxYzQzNzk5OGZlMGIyOGMwYjRhYjgwL3RhYmxlOmQ2NGI3MDhhZjNkNzQ1NWVhNmU0MGM2NTYyMjk5ZDZkL3RhYmxlcmFuZ2U6ZDY0YjcwOGFmM2Q3NDU1ZWE2ZTQwYzY1NjIyOTlkNmRfMjYtMy0xLTEtMTkxODY_7f362494-05bc-40a8-8f69-83344762fca1">349,075,408</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i69782326f71a44e3805518280ee22b6b_D20210101-20210630" decimals="0" format="ixt:numdotdecimal" name="us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjkzY2E5YmIwMTc5MjQ3NmZiYjIyNWU1ZDlkZWM4NjlmL3NlYzo5M2NhOWJiMDE3OTI0NzZmYmIyMjVlNWQ5ZGVjODY5Zl81Mi9mcmFnOjlkZDkxMTIyZjQxYzQzNzk5OGZlMGIyOGMwYjRhYjgwL3RhYmxlOmQ2NGI3MDhhZjNkNzQ1NWVhNmU0MGM2NTYyMjk5ZDZkL3RhYmxlcmFuZ2U6ZDY0YjcwOGFmM2Q3NDU1ZWE2ZTQwYzY1NjIyOTlkNmRfMjYtNS0xLTEtMTkxODY_4f27cf26-3e5f-4ae4-be38-a0cb7fcf294c">367,391,118</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i4a110e4972ef4113880ce582e3cda5c5_D20200101-20200630" decimals="0" format="ixt:numdotdecimal" name="us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjkzY2E5YmIwMTc5MjQ3NmZiYjIyNWU1ZDlkZWM4NjlmL3NlYzo5M2NhOWJiMDE3OTI0NzZmYmIyMjVlNWQ5ZGVjODY5Zl81Mi9mcmFnOjlkZDkxMTIyZjQxYzQzNzk5OGZlMGIyOGMwYjRhYjgwL3RhYmxlOmQ2NGI3MDhhZjNkNzQ1NWVhNmU0MGM2NTYyMjk5ZDZkL3RhYmxlcmFuZ2U6ZDY0YjcwOGFmM2Q3NDU1ZWE2ZTQwYzY1NjIyOTlkNmRfMjYtNy0xLTEtMTkxODY_12fc0eb3-36ad-4aff-b6e5-4724dd2c63d4">348,946,439</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Diluted earnings from discontinued operations per share</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="i27f4e53b91ad4367b7f8d273eff27769_D20210401-20210630" decimals="2" name="us-gaap:IncomeLossFromDiscontinuedOperationsNetOfTaxPerDilutedShare" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjkzY2E5YmIwMTc5MjQ3NmZiYjIyNWU1ZDlkZWM4NjlmL3NlYzo5M2NhOWJiMDE3OTI0NzZmYmIyMjVlNWQ5ZGVjODY5Zl81Mi9mcmFnOjlkZDkxMTIyZjQxYzQzNzk5OGZlMGIyOGMwYjRhYjgwL3RhYmxlOmQ2NGI3MDhhZjNkNzQ1NWVhNmU0MGM2NTYyMjk5ZDZkL3RhYmxlcmFuZ2U6ZDY0YjcwOGFmM2Q3NDU1ZWE2ZTQwYzY1NjIyOTlkNmRfMjctMS0xLTEtMTkxODY_474e3bee-1a30-4e86-b041-12ecd93f56b3">0.00</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="i39065c5daf934af885335c12f3cfa83f_D20200401-20200630" decimals="2" name="us-gaap:IncomeLossFromDiscontinuedOperationsNetOfTaxPerDilutedShare" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjkzY2E5YmIwMTc5MjQ3NmZiYjIyNWU1ZDlkZWM4NjlmL3NlYzo5M2NhOWJiMDE3OTI0NzZmYmIyMjVlNWQ5ZGVjODY5Zl81Mi9mcmFnOjlkZDkxMTIyZjQxYzQzNzk5OGZlMGIyOGMwYjRhYjgwL3RhYmxlOmQ2NGI3MDhhZjNkNzQ1NWVhNmU0MGM2NTYyMjk5ZDZkL3RhYmxlcmFuZ2U6ZDY0YjcwOGFmM2Q3NDU1ZWE2ZTQwYzY1NjIyOTlkNmRfMjctMy0xLTEtMTkxODY_8f9f871d-4828-4667-865c-0e51c0da9360">0.00</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="i69782326f71a44e3805518280ee22b6b_D20210101-20210630" decimals="2" name="us-gaap:IncomeLossFromDiscontinuedOperationsNetOfTaxPerDilutedShare" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjkzY2E5YmIwMTc5MjQ3NmZiYjIyNWU1ZDlkZWM4NjlmL3NlYzo5M2NhOWJiMDE3OTI0NzZmYmIyMjVlNWQ5ZGVjODY5Zl81Mi9mcmFnOjlkZDkxMTIyZjQxYzQzNzk5OGZlMGIyOGMwYjRhYjgwL3RhYmxlOmQ2NGI3MDhhZjNkNzQ1NWVhNmU0MGM2NTYyMjk5ZDZkL3RhYmxlcmFuZ2U6ZDY0YjcwOGFmM2Q3NDU1ZWE2ZTQwYzY1NjIyOTlkNmRfMjctNS0xLTEtMTkxODY_1d1177e2-fb6a-44d0-9567-c715c929c9c7">0.00</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="i4a110e4972ef4113880ce582e3cda5c5_D20200101-20200630" decimals="2" name="us-gaap:IncomeLossFromDiscontinuedOperationsNetOfTaxPerDilutedShare" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjkzY2E5YmIwMTc5MjQ3NmZiYjIyNWU1ZDlkZWM4NjlmL3NlYzo5M2NhOWJiMDE3OTI0NzZmYmIyMjVlNWQ5ZGVjODY5Zl81Mi9mcmFnOjlkZDkxMTIyZjQxYzQzNzk5OGZlMGIyOGMwYjRhYjgwL3RhYmxlOmQ2NGI3MDhhZjNkNzQ1NWVhNmU0MGM2NTYyMjk5ZDZkL3RhYmxlcmFuZ2U6ZDY0YjcwOGFmM2Q3NDU1ZWE2ZTQwYzY1NjIyOTlkNmRfMjctNy0xLTEtMTkxODY_8150edc2-08fe-48bd-93b4-7e6a66d47bbf">0.00</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="margin-bottom:3pt;margin-top:3pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:400;line-height:120%;position:relative;top:-2.8pt;vertical-align:baseline">(i)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:13.1pt">In computing diluted earnings per share, incremental common shares are not considered in periods in which a net loss is reported as the inclusion of the common share equivalents would be anti-dilutive.</span></div></ix:nonNumeric></ix:continuation><div style="height:36pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">19</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:72pt;width:100%"><div style="margin-top:0.55pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:95.000%"><tr><td style="width:1.0%"></td><td style="width:65.712%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:32.088%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="border-top:1pt solid #FFFFFF;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Cronos Group Inc.</span></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Notes to Condensed Consolidated Financial Statements (Unaudited)</span></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">(In thousands of $, except share amounts)</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i93ca9bb01792476fbb225e5d9dec869f_7">Table of Contents</a></span></div></td></tr></table></div></div><ix:continuation id="iabd83da8c9564a99a5a6e785fc7e01bc"><ix:nonNumeric contextRef="i69782326f71a44e3805518280ee22b6b_D20210101-20210630" name="us-gaap:ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjkzY2E5YmIwMTc5MjQ3NmZiYjIyNWU1ZDlkZWM4NjlmL3NlYzo5M2NhOWJiMDE3OTI0NzZmYmIyMjVlNWQ5ZGVjODY5Zl81Mi9mcmFnOjlkZDkxMTIyZjQxYzQzNzk5OGZlMGIyOGMwYjRhYjgwL3RleHRyZWdpb246OWRkOTExMjJmNDFjNDM3OTk4ZmUwYjI4YzBiNGFiODBfNzIx_f2d80644-b529-4765-8294-a0d0a1ebbf3c" escape="true"><div style="margin-bottom:6pt;margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following securities were not included in the computation of diluted shares outstanding because the effect would be anti-dilutive or because conditions for contingently issuable shares were not satisfied at the end of the reporting periods.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:45.705%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.983%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:1.327%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.983%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:1.605%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.983%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:1.327%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.987%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Three months ended June&#160;30,</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Six months ended June&#160;30,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Ginkgo equity milestones</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i07a12b37b7f449bd8480c060ef9d4f22_D20210401-20210630" decimals="0" format="ixt:numdotdecimal" name="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjkzY2E5YmIwMTc5MjQ3NmZiYjIyNWU1ZDlkZWM4NjlmL3NlYzo5M2NhOWJiMDE3OTI0NzZmYmIyMjVlNWQ5ZGVjODY5Zl81Mi9mcmFnOjlkZDkxMTIyZjQxYzQzNzk5OGZlMGIyOGMwYjRhYjgwL3RhYmxlOjdjZGYyNzg5Njc4MDQ5MWQ4NWM1MDI2ZmNmNzU5YTg2L3RhYmxlcmFuZ2U6N2NkZjI3ODk2NzgwNDkxZDg1YzUwMjZmY2Y3NTlhODZfMi0xLTEtMS0w_a4d42dd8-37fd-4970-9199-2b619162f682">14,674,904</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="idb2773cdb0104962851c16f7f574a50e_D20200401-20200630" decimals="0" format="ixt:numdotdecimal" name="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjkzY2E5YmIwMTc5MjQ3NmZiYjIyNWU1ZDlkZWM4NjlmL3NlYzo5M2NhOWJiMDE3OTI0NzZmYmIyMjVlNWQ5ZGVjODY5Zl81Mi9mcmFnOjlkZDkxMTIyZjQxYzQzNzk5OGZlMGIyOGMwYjRhYjgwL3RhYmxlOjdjZGYyNzg5Njc4MDQ5MWQ4NWM1MDI2ZmNmNzU5YTg2L3RhYmxlcmFuZ2U6N2NkZjI3ODk2NzgwNDkxZDg1YzUwMjZmY2Y3NTlhODZfMi0zLTEtMS0w_6db87154-0841-4108-9fbc-a328abd94c0f">14,674,904</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="ibdb85022a38140dab47df2ef46523aed_D20210101-20210630" decimals="0" format="ixt:numdotdecimal" name="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjkzY2E5YmIwMTc5MjQ3NmZiYjIyNWU1ZDlkZWM4NjlmL3NlYzo5M2NhOWJiMDE3OTI0NzZmYmIyMjVlNWQ5ZGVjODY5Zl81Mi9mcmFnOjlkZDkxMTIyZjQxYzQzNzk5OGZlMGIyOGMwYjRhYjgwL3RhYmxlOjdjZGYyNzg5Njc4MDQ5MWQ4NWM1MDI2ZmNmNzU5YTg2L3RhYmxlcmFuZ2U6N2NkZjI3ODk2NzgwNDkxZDg1YzUwMjZmY2Y3NTlhODZfMi01LTEtMS0w_1d8985cb-65e4-4271-96cf-e6ab9ffe0455">14,674,904</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i50bf03adb5b742b8bc014c0dff5918e9_D20200101-20200630" decimals="0" format="ixt:numdotdecimal" name="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjkzY2E5YmIwMTc5MjQ3NmZiYjIyNWU1ZDlkZWM4NjlmL3NlYzo5M2NhOWJiMDE3OTI0NzZmYmIyMjVlNWQ5ZGVjODY5Zl81Mi9mcmFnOjlkZDkxMTIyZjQxYzQzNzk5OGZlMGIyOGMwYjRhYjgwL3RhYmxlOjdjZGYyNzg5Njc4MDQ5MWQ4NWM1MDI2ZmNmNzU5YTg2L3RhYmxlcmFuZ2U6N2NkZjI3ODk2NzgwNDkxZDg1YzUwMjZmY2Y3NTlhODZfMi03LTEtMS0w_01cd8907-82bb-4216-8eb8-583f90cbc3c6">14,674,904</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Pre-emptive Rights</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i8e9c7b0c611e46879a52eaa6a261c7ee_D20210401-20210630" decimals="0" format="ixt:numdotdecimal" name="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjkzY2E5YmIwMTc5MjQ3NmZiYjIyNWU1ZDlkZWM4NjlmL3NlYzo5M2NhOWJiMDE3OTI0NzZmYmIyMjVlNWQ5ZGVjODY5Zl81Mi9mcmFnOjlkZDkxMTIyZjQxYzQzNzk5OGZlMGIyOGMwYjRhYjgwL3RhYmxlOjdjZGYyNzg5Njc4MDQ5MWQ4NWM1MDI2ZmNmNzU5YTg2L3RhYmxlcmFuZ2U6N2NkZjI3ODk2NzgwNDkxZDg1YzUwMjZmY2Y3NTlhODZfMy0xLTEtMS0w_20ef9135-94b9-41e0-bc3d-e83f78320a92">10,683,330</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i0c3ad44a3c0c42b5b2a0e88c68e8f3be_D20200401-20200630" decimals="0" format="ixt:numdotdecimal" name="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjkzY2E5YmIwMTc5MjQ3NmZiYjIyNWU1ZDlkZWM4NjlmL3NlYzo5M2NhOWJiMDE3OTI0NzZmYmIyMjVlNWQ5ZGVjODY5Zl81Mi9mcmFnOjlkZDkxMTIyZjQxYzQzNzk5OGZlMGIyOGMwYjRhYjgwL3RhYmxlOjdjZGYyNzg5Njc4MDQ5MWQ4NWM1MDI2ZmNmNzU5YTg2L3RhYmxlcmFuZ2U6N2NkZjI3ODk2NzgwNDkxZDg1YzUwMjZmY2Y3NTlhODZfMy0zLTEtMS0w_b543c295-051d-4135-a5a2-ce3cb44f4c6c">12,006,740</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i02aad9012d39412c8efa06499f3fe95b_D20210101-20210630" decimals="0" format="ixt:numdotdecimal" name="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjkzY2E5YmIwMTc5MjQ3NmZiYjIyNWU1ZDlkZWM4NjlmL3NlYzo5M2NhOWJiMDE3OTI0NzZmYmIyMjVlNWQ5ZGVjODY5Zl81Mi9mcmFnOjlkZDkxMTIyZjQxYzQzNzk5OGZlMGIyOGMwYjRhYjgwL3RhYmxlOjdjZGYyNzg5Njc4MDQ5MWQ4NWM1MDI2ZmNmNzU5YTg2L3RhYmxlcmFuZ2U6N2NkZjI3ODk2NzgwNDkxZDg1YzUwMjZmY2Y3NTlhODZfMy01LTEtMS0w_d0d59383-da3d-44d1-88a0-8e23c6b3cbb2">10,984,166</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="id0d09d3774e94fa7b4f1f095f53f1374_D20200101-20200630" decimals="0" format="ixt:numdotdecimal" name="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjkzY2E5YmIwMTc5MjQ3NmZiYjIyNWU1ZDlkZWM4NjlmL3NlYzo5M2NhOWJiMDE3OTI0NzZmYmIyMjVlNWQ5ZGVjODY5Zl81Mi9mcmFnOjlkZDkxMTIyZjQxYzQzNzk5OGZlMGIyOGMwYjRhYjgwL3RhYmxlOjdjZGYyNzg5Njc4MDQ5MWQ4NWM1MDI2ZmNmNzU5YTg2L3RhYmxlcmFuZ2U6N2NkZjI3ODk2NzgwNDkxZDg1YzUwMjZmY2Y3NTlhODZfMy03LTEtMS0w_6da4a7ae-fb93-419d-9aa7-44868aa40de0">12,006,740</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Top-up Rights &#8211; fixed price</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="ia14076dba9894856b2d1229c872fe727_D20210401-20210630" decimals="0" format="ixt:numdotdecimal" name="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjkzY2E5YmIwMTc5MjQ3NmZiYjIyNWU1ZDlkZWM4NjlmL3NlYzo5M2NhOWJiMDE3OTI0NzZmYmIyMjVlNWQ5ZGVjODY5Zl81Mi9mcmFnOjlkZDkxMTIyZjQxYzQzNzk5OGZlMGIyOGMwYjRhYjgwL3RhYmxlOjdjZGYyNzg5Njc4MDQ5MWQ4NWM1MDI2ZmNmNzU5YTg2L3RhYmxlcmFuZ2U6N2NkZjI3ODk2NzgwNDkxZDg1YzUwMjZmY2Y3NTlhODZfNC0xLTEtMS0w_61ac0a39-1028-4a30-bdd5-601c484aeb13">3,698,611</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i17878ee04a8b40efa8de800698c7563e_D20200401-20200630" decimals="0" format="ixt:numdotdecimal" name="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjkzY2E5YmIwMTc5MjQ3NmZiYjIyNWU1ZDlkZWM4NjlmL3NlYzo5M2NhOWJiMDE3OTI0NzZmYmIyMjVlNWQ5ZGVjODY5Zl81Mi9mcmFnOjlkZDkxMTIyZjQxYzQzNzk5OGZlMGIyOGMwYjRhYjgwL3RhYmxlOjdjZGYyNzg5Njc4MDQ5MWQ4NWM1MDI2ZmNmNzU5YTg2L3RhYmxlcmFuZ2U6N2NkZjI3ODk2NzgwNDkxZDg1YzUwMjZmY2Y3NTlhODZfNC0zLTEtMS0w_ac01b393-8f86-4ee0-9dbe-22d69444123d">26,686,413</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i0edfc387d99e417686a470edbdd373bd_D20210101-20210630" decimals="0" format="ixt:numdotdecimal" name="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjkzY2E5YmIwMTc5MjQ3NmZiYjIyNWU1ZDlkZWM4NjlmL3NlYzo5M2NhOWJiMDE3OTI0NzZmYmIyMjVlNWQ5ZGVjODY5Zl81Mi9mcmFnOjlkZDkxMTIyZjQxYzQzNzk5OGZlMGIyOGMwYjRhYjgwL3RhYmxlOjdjZGYyNzg5Njc4MDQ5MWQ4NWM1MDI2ZmNmNzU5YTg2L3RhYmxlcmFuZ2U6N2NkZjI3ODk2NzgwNDkxZDg1YzUwMjZmY2Y3NTlhODZfNC01LTEtMS0w_c3dfd653-ad3e-49a2-8b9a-194533f325f9">7,406,031</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i58fcf006ddda4fa090550e2cab1cbf48_D20200101-20200630" decimals="0" format="ixt:numdotdecimal" name="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjkzY2E5YmIwMTc5MjQ3NmZiYjIyNWU1ZDlkZWM4NjlmL3NlYzo5M2NhOWJiMDE3OTI0NzZmYmIyMjVlNWQ5ZGVjODY5Zl81Mi9mcmFnOjlkZDkxMTIyZjQxYzQzNzk5OGZlMGIyOGMwYjRhYjgwL3RhYmxlOjdjZGYyNzg5Njc4MDQ5MWQ4NWM1MDI2ZmNmNzU5YTg2L3RhYmxlcmFuZ2U6N2NkZjI3ODk2NzgwNDkxZDg1YzUwMjZmY2Y3NTlhODZfNC03LTEtMS0w_250458fc-f232-4021-b6a0-9fe049fb366e">26,686,413</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Top-up Rights &#8211; market price</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="if80975f641164c358482aa567573519b_D20210401-20210630" decimals="0" format="ixt:numdotdecimal" name="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjkzY2E5YmIwMTc5MjQ3NmZiYjIyNWU1ZDlkZWM4NjlmL3NlYzo5M2NhOWJiMDE3OTI0NzZmYmIyMjVlNWQ5ZGVjODY5Zl81Mi9mcmFnOjlkZDkxMTIyZjQxYzQzNzk5OGZlMGIyOGMwYjRhYjgwL3RhYmxlOjdjZGYyNzg5Njc4MDQ5MWQ4NWM1MDI2ZmNmNzU5YTg2L3RhYmxlcmFuZ2U6N2NkZjI3ODk2NzgwNDkxZDg1YzUwMjZmY2Y3NTlhODZfNS0xLTEtMS0w_352cff5f-fdb6-422d-b994-09933cbb7478">3,504,561</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="ie093f63ac9fb4d8581f1cefb3a20923d_D20200401-20200630" decimals="0" format="ixt:numdotdecimal" name="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjkzY2E5YmIwMTc5MjQ3NmZiYjIyNWU1ZDlkZWM4NjlmL3NlYzo5M2NhOWJiMDE3OTI0NzZmYmIyMjVlNWQ5ZGVjODY5Zl81Mi9mcmFnOjlkZDkxMTIyZjQxYzQzNzk5OGZlMGIyOGMwYjRhYjgwL3RhYmxlOjdjZGYyNzg5Njc4MDQ5MWQ4NWM1MDI2ZmNmNzU5YTg2L3RhYmxlcmFuZ2U6N2NkZjI3ODk2NzgwNDkxZDg1YzUwMjZmY2Y3NTlhODZfNS0zLTEtMS0w_97501ffd-0934-4a14-9b61-a218dce6a4cb">1,941,349</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i346164b35069484faf6df727aae40e92_D20210101-20210630" decimals="0" format="ixt:numdotdecimal" name="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjkzY2E5YmIwMTc5MjQ3NmZiYjIyNWU1ZDlkZWM4NjlmL3NlYzo5M2NhOWJiMDE3OTI0NzZmYmIyMjVlNWQ5ZGVjODY5Zl81Mi9mcmFnOjlkZDkxMTIyZjQxYzQzNzk5OGZlMGIyOGMwYjRhYjgwL3RhYmxlOjdjZGYyNzg5Njc4MDQ5MWQ4NWM1MDI2ZmNmNzU5YTg2L3RhYmxlcmFuZ2U6N2NkZjI3ODk2NzgwNDkxZDg1YzUwMjZmY2Y3NTlhODZfNS01LTEtMS0w_14d5576e-794e-4bf2-b5bb-4ead3aba6737">3,063,822</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="if20736234eba41eeb39c9dfe0fe61633_D20200101-20200630" decimals="0" format="ixt:numdotdecimal" name="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjkzY2E5YmIwMTc5MjQ3NmZiYjIyNWU1ZDlkZWM4NjlmL3NlYzo5M2NhOWJiMDE3OTI0NzZmYmIyMjVlNWQ5ZGVjODY5Zl81Mi9mcmFnOjlkZDkxMTIyZjQxYzQzNzk5OGZlMGIyOGMwYjRhYjgwL3RhYmxlOjdjZGYyNzg5Njc4MDQ5MWQ4NWM1MDI2ZmNmNzU5YTg2L3RhYmxlcmFuZ2U6N2NkZjI3ODk2NzgwNDkxZDg1YzUwMjZmY2Y3NTlhODZfNS03LTEtMS0w_ecb94320-7cb7-47ca-b25d-4e005878e025">1,941,349</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Altria Warrant</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i1c433475eb1a48afaf0b953876eeacf2_D20210401-20210630" decimals="0" format="ixt:numdotdecimal" name="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjkzY2E5YmIwMTc5MjQ3NmZiYjIyNWU1ZDlkZWM4NjlmL3NlYzo5M2NhOWJiMDE3OTI0NzZmYmIyMjVlNWQ5ZGVjODY5Zl81Mi9mcmFnOjlkZDkxMTIyZjQxYzQzNzk5OGZlMGIyOGMwYjRhYjgwL3RhYmxlOjdjZGYyNzg5Njc4MDQ5MWQ4NWM1MDI2ZmNmNzU5YTg2L3RhYmxlcmFuZ2U6N2NkZjI3ODk2NzgwNDkxZDg1YzUwMjZmY2Y3NTlhODZfNi0xLTEtMS0w_fa318b8e-466d-4ee2-a0a0-55a2c92fd739">82,623,455</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i0f06094e63234299ba9729e0c2d1605e_D20200401-20200630" decimals="0" format="ixt:numdotdecimal" name="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjkzY2E5YmIwMTc5MjQ3NmZiYjIyNWU1ZDlkZWM4NjlmL3NlYzo5M2NhOWJiMDE3OTI0NzZmYmIyMjVlNWQ5ZGVjODY5Zl81Mi9mcmFnOjlkZDkxMTIyZjQxYzQzNzk5OGZlMGIyOGMwYjRhYjgwL3RhYmxlOjdjZGYyNzg5Njc4MDQ5MWQ4NWM1MDI2ZmNmNzU5YTg2L3RhYmxlcmFuZ2U6N2NkZjI3ODk2NzgwNDkxZDg1YzUwMjZmY2Y3NTlhODZfNi0zLTEtMS0w_cdc807af-b7f5-40c1-ad45-683ef208d551">77,752,533</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i1f706c52ea2f44629f37471cc5d6d92a_D20210101-20210630" decimals="0" format="ixt:numdotdecimal" name="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjkzY2E5YmIwMTc5MjQ3NmZiYjIyNWU1ZDlkZWM4NjlmL3NlYzo5M2NhOWJiMDE3OTI0NzZmYmIyMjVlNWQ5ZGVjODY5Zl81Mi9mcmFnOjlkZDkxMTIyZjQxYzQzNzk5OGZlMGIyOGMwYjRhYjgwL3RhYmxlOjdjZGYyNzg5Njc4MDQ5MWQ4NWM1MDI2ZmNmNzU5YTg2L3RhYmxlcmFuZ2U6N2NkZjI3ODk2NzgwNDkxZDg1YzUwMjZmY2Y3NTlhODZfNi01LTEtMS0w_b5ee4f27-e63f-41a4-b09b-fff0c127167b">82,606,904</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i36bbfa161e6e4ec991260925b4204c65_D20200101-20200630" decimals="0" format="ixt:numdotdecimal" name="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjkzY2E5YmIwMTc5MjQ3NmZiYjIyNWU1ZDlkZWM4NjlmL3NlYzo5M2NhOWJiMDE3OTI0NzZmYmIyMjVlNWQ5ZGVjODY5Zl81Mi9mcmFnOjlkZDkxMTIyZjQxYzQzNzk5OGZlMGIyOGMwYjRhYjgwL3RhYmxlOjdjZGYyNzg5Njc4MDQ5MWQ4NWM1MDI2ZmNmNzU5YTg2L3RhYmxlcmFuZ2U6N2NkZjI3ODk2NzgwNDkxZDg1YzUwMjZmY2Y3NTlhODZfNi03LTEtMS0w_1b4f6de5-eae1-4f18-9f3d-cf89327b2be3">77,752,533</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Stock options</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="iaa7604cc407b458bade3731989eb0708_D20210401-20210630" decimals="0" format="ixt:numdotdecimal" name="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjkzY2E5YmIwMTc5MjQ3NmZiYjIyNWU1ZDlkZWM4NjlmL3NlYzo5M2NhOWJiMDE3OTI0NzZmYmIyMjVlNWQ5ZGVjODY5Zl81Mi9mcmFnOjlkZDkxMTIyZjQxYzQzNzk5OGZlMGIyOGMwYjRhYjgwL3RhYmxlOjdjZGYyNzg5Njc4MDQ5MWQ4NWM1MDI2ZmNmNzU5YTg2L3RhYmxlcmFuZ2U6N2NkZjI3ODk2NzgwNDkxZDg1YzUwMjZmY2Y3NTlhODZfNy0xLTEtMS0w_fd2b5a12-6c01-4417-8211-fec2567f182f">1,411,944</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="iea37729d5d364d418285846dc945175f_D20200401-20200630" decimals="0" format="ixt:numdotdecimal" name="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjkzY2E5YmIwMTc5MjQ3NmZiYjIyNWU1ZDlkZWM4NjlmL3NlYzo5M2NhOWJiMDE3OTI0NzZmYmIyMjVlNWQ5ZGVjODY5Zl81Mi9mcmFnOjlkZDkxMTIyZjQxYzQzNzk5OGZlMGIyOGMwYjRhYjgwL3RhYmxlOjdjZGYyNzg5Njc4MDQ5MWQ4NWM1MDI2ZmNmNzU5YTg2L3RhYmxlcmFuZ2U6N2NkZjI3ODk2NzgwNDkxZDg1YzUwMjZmY2Y3NTlhODZfNy0zLTEtMS0w_c9c027a5-2422-42af-b874-d68202e55959">10,495,235</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i679dc97e17ab4806a7b6131c4dd48e32_D20210101-20210630" decimals="0" format="ixt:numdotdecimal" name="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjkzY2E5YmIwMTc5MjQ3NmZiYjIyNWU1ZDlkZWM4NjlmL3NlYzo5M2NhOWJiMDE3OTI0NzZmYmIyMjVlNWQ5ZGVjODY5Zl81Mi9mcmFnOjlkZDkxMTIyZjQxYzQzNzk5OGZlMGIyOGMwYjRhYjgwL3RhYmxlOjdjZGYyNzg5Njc4MDQ5MWQ4NWM1MDI2ZmNmNzU5YTg2L3RhYmxlcmFuZ2U6N2NkZjI3ODk2NzgwNDkxZDg1YzUwMjZmY2Y3NTlhODZfNy01LTEtMS0w_126b4b5f-e44a-411a-8d62-6bc1bc6baf32">6,136,113</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i967a490799294ef8965b69b6ef9525d8_D20200101-20200630" decimals="0" format="ixt:numdotdecimal" name="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjkzY2E5YmIwMTc5MjQ3NmZiYjIyNWU1ZDlkZWM4NjlmL3NlYzo5M2NhOWJiMDE3OTI0NzZmYmIyMjVlNWQ5ZGVjODY5Zl81Mi9mcmFnOjlkZDkxMTIyZjQxYzQzNzk5OGZlMGIyOGMwYjRhYjgwL3RhYmxlOjdjZGYyNzg5Njc4MDQ5MWQ4NWM1MDI2ZmNmNzU5YTg2L3RhYmxlcmFuZ2U6N2NkZjI3ODk2NzgwNDkxZDg1YzUwMjZmY2Y3NTlhODZfNy03LTEtMS0w_65f6f8c6-a7af-4dd6-8fc0-4120f84638dd">10,547,256</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Warrants</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="ic12652ed09474f2eb1b373fa6ef881fd_D20210401-20210630" decimals="0" format="ixt:zerodash" name="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjkzY2E5YmIwMTc5MjQ3NmZiYjIyNWU1ZDlkZWM4NjlmL3NlYzo5M2NhOWJiMDE3OTI0NzZmYmIyMjVlNWQ5ZGVjODY5Zl81Mi9mcmFnOjlkZDkxMTIyZjQxYzQzNzk5OGZlMGIyOGMwYjRhYjgwL3RhYmxlOjdjZGYyNzg5Njc4MDQ5MWQ4NWM1MDI2ZmNmNzU5YTg2L3RhYmxlcmFuZ2U6N2NkZjI3ODk2NzgwNDkxZDg1YzUwMjZmY2Y3NTlhODZfOC0xLTEtMS0w_869b30e1-dfeb-4151-9d57-a686d9ba350a">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i8c63409f39764b86a65ebcee0efb5293_D20200401-20200630" decimals="0" format="ixt:numdotdecimal" name="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjkzY2E5YmIwMTc5MjQ3NmZiYjIyNWU1ZDlkZWM4NjlmL3NlYzo5M2NhOWJiMDE3OTI0NzZmYmIyMjVlNWQ5ZGVjODY5Zl81Mi9mcmFnOjlkZDkxMTIyZjQxYzQzNzk5OGZlMGIyOGMwYjRhYjgwL3RhYmxlOjdjZGYyNzg5Njc4MDQ5MWQ4NWM1MDI2ZmNmNzU5YTg2L3RhYmxlcmFuZ2U6N2NkZjI3ODk2NzgwNDkxZDg1YzUwMjZmY2Y3NTlhODZfOC0zLTEtMS0w_a537da30-bd94-4fd0-a3f3-5a7de2add4a2">17,521,903</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="iad823a91375044b38784f8b852ef2e86_D20210101-20210630" decimals="0" format="ixt:numdotdecimal" name="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjkzY2E5YmIwMTc5MjQ3NmZiYjIyNWU1ZDlkZWM4NjlmL3NlYzo5M2NhOWJiMDE3OTI0NzZmYmIyMjVlNWQ5ZGVjODY5Zl81Mi9mcmFnOjlkZDkxMTIyZjQxYzQzNzk5OGZlMGIyOGMwYjRhYjgwL3RhYmxlOjdjZGYyNzg5Njc4MDQ5MWQ4NWM1MDI2ZmNmNzU5YTg2L3RhYmxlcmFuZ2U6N2NkZjI3ODk2NzgwNDkxZDg1YzUwMjZmY2Y3NTlhODZfOC01LTEtMS0w_cf482d7a-ea6b-4bec-96cb-8654119d4ffc">2,784,377</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i1cb9167df2d047b58be65b1aada6284d_D20200101-20200630" decimals="0" format="ixt:numdotdecimal" name="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjkzY2E5YmIwMTc5MjQ3NmZiYjIyNWU1ZDlkZWM4NjlmL3NlYzo5M2NhOWJiMDE3OTI0NzZmYmIyMjVlNWQ5ZGVjODY5Zl81Mi9mcmFnOjlkZDkxMTIyZjQxYzQzNzk5OGZlMGIyOGMwYjRhYjgwL3RhYmxlOjdjZGYyNzg5Njc4MDQ5MWQ4NWM1MDI2ZmNmNzU5YTg2L3RhYmxlcmFuZ2U6N2NkZjI3ODk2NzgwNDkxZDg1YzUwMjZmY2Y3NTlhODZfOC03LTEtMS0w_3b562304-3940-4838-bf4e-3376183bdf1c">17,536,558</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Restricted share units</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i8b031f75a18e4c55ad561843012164a3_D20210401-20210630" decimals="0" format="ixt:numdotdecimal" name="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjkzY2E5YmIwMTc5MjQ3NmZiYjIyNWU1ZDlkZWM4NjlmL3NlYzo5M2NhOWJiMDE3OTI0NzZmYmIyMjVlNWQ5ZGVjODY5Zl81Mi9mcmFnOjlkZDkxMTIyZjQxYzQzNzk5OGZlMGIyOGMwYjRhYjgwL3RhYmxlOjdjZGYyNzg5Njc4MDQ5MWQ4NWM1MDI2ZmNmNzU5YTg2L3RhYmxlcmFuZ2U6N2NkZjI3ODk2NzgwNDkxZDg1YzUwMjZmY2Y3NTlhODZfOS0xLTEtMS0w_fc6d8ca3-dfbe-4ea4-95cd-2e09875cadab">265,904</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i4ae2733b6de04d388d8a96981e02f327_D20200401-20200630" decimals="0" format="ixt:numdotdecimal" name="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjkzY2E5YmIwMTc5MjQ3NmZiYjIyNWU1ZDlkZWM4NjlmL3NlYzo5M2NhOWJiMDE3OTI0NzZmYmIyMjVlNWQ5ZGVjODY5Zl81Mi9mcmFnOjlkZDkxMTIyZjQxYzQzNzk5OGZlMGIyOGMwYjRhYjgwL3RhYmxlOjdjZGYyNzg5Njc4MDQ5MWQ4NWM1MDI2ZmNmNzU5YTg2L3RhYmxlcmFuZ2U6N2NkZjI3ODk2NzgwNDkxZDg1YzUwMjZmY2Y3NTlhODZfOS0zLTEtMS0w_f73016ec-af2c-4ee0-ac4a-41e80481a47d">1,012,249</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="if4d517deea8b4c85b4949e8ed9c437c2_D20210101-20210630" decimals="0" format="ixt:numdotdecimal" name="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjkzY2E5YmIwMTc5MjQ3NmZiYjIyNWU1ZDlkZWM4NjlmL3NlYzo5M2NhOWJiMDE3OTI0NzZmYmIyMjVlNWQ5ZGVjODY5Zl81Mi9mcmFnOjlkZDkxMTIyZjQxYzQzNzk5OGZlMGIyOGMwYjRhYjgwL3RhYmxlOjdjZGYyNzg5Njc4MDQ5MWQ4NWM1MDI2ZmNmNzU5YTg2L3RhYmxlcmFuZ2U6N2NkZjI3ODk2NzgwNDkxZDg1YzUwMjZmY2Y3NTlhODZfOS01LTEtMS0w_c9847566-e2b3-4ecb-a095-692c8e6cabb0">717,127</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i120c7bf7be8a425aa4d5a03318d68bf0_D20200101-20200630" decimals="0" format="ixt:numdotdecimal" name="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjkzY2E5YmIwMTc5MjQ3NmZiYjIyNWU1ZDlkZWM4NjlmL3NlYzo5M2NhOWJiMDE3OTI0NzZmYmIyMjVlNWQ5ZGVjODY5Zl81Mi9mcmFnOjlkZDkxMTIyZjQxYzQzNzk5OGZlMGIyOGMwYjRhYjgwL3RhYmxlOjdjZGYyNzg5Njc4MDQ5MWQ4NWM1MDI2ZmNmNzU5YTg2L3RhYmxlcmFuZ2U6N2NkZjI3ODk2NzgwNDkxZDg1YzUwMjZmY2Y3NTlhODZfOS03LTEtMS0w_c5a7ef67-b223-445e-bbb4-560e86170c6c">1,012,249</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total anti-dilutive securities</span></td><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i27f4e53b91ad4367b7f8d273eff27769_D20210401-20210630" decimals="0" format="ixt:numdotdecimal" name="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjkzY2E5YmIwMTc5MjQ3NmZiYjIyNWU1ZDlkZWM4NjlmL3NlYzo5M2NhOWJiMDE3OTI0NzZmYmIyMjVlNWQ5ZGVjODY5Zl81Mi9mcmFnOjlkZDkxMTIyZjQxYzQzNzk5OGZlMGIyOGMwYjRhYjgwL3RhYmxlOjdjZGYyNzg5Njc4MDQ5MWQ4NWM1MDI2ZmNmNzU5YTg2L3RhYmxlcmFuZ2U6N2NkZjI3ODk2NzgwNDkxZDg1YzUwMjZmY2Y3NTlhODZfMTAtMS0xLTEtMA_a3dbf2ac-e849-415f-beca-c7b7b937aaef">116,862,709</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i39065c5daf934af885335c12f3cfa83f_D20200401-20200630" decimals="0" format="ixt:numdotdecimal" name="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjkzY2E5YmIwMTc5MjQ3NmZiYjIyNWU1ZDlkZWM4NjlmL3NlYzo5M2NhOWJiMDE3OTI0NzZmYmIyMjVlNWQ5ZGVjODY5Zl81Mi9mcmFnOjlkZDkxMTIyZjQxYzQzNzk5OGZlMGIyOGMwYjRhYjgwL3RhYmxlOjdjZGYyNzg5Njc4MDQ5MWQ4NWM1MDI2ZmNmNzU5YTg2L3RhYmxlcmFuZ2U6N2NkZjI3ODk2NzgwNDkxZDg1YzUwMjZmY2Y3NTlhODZfMTAtMy0xLTEtMA_bbac9698-5fb9-4e71-83a6-15492780e884">162,091,326</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i69782326f71a44e3805518280ee22b6b_D20210101-20210630" decimals="0" format="ixt:numdotdecimal" name="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjkzY2E5YmIwMTc5MjQ3NmZiYjIyNWU1ZDlkZWM4NjlmL3NlYzo5M2NhOWJiMDE3OTI0NzZmYmIyMjVlNWQ5ZGVjODY5Zl81Mi9mcmFnOjlkZDkxMTIyZjQxYzQzNzk5OGZlMGIyOGMwYjRhYjgwL3RhYmxlOjdjZGYyNzg5Njc4MDQ5MWQ4NWM1MDI2ZmNmNzU5YTg2L3RhYmxlcmFuZ2U6N2NkZjI3ODk2NzgwNDkxZDg1YzUwMjZmY2Y3NTlhODZfMTAtNS0xLTEtMA_376096a0-b5ec-474e-9697-c83ca431b7a6">128,373,444</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i4a110e4972ef4113880ce582e3cda5c5_D20200101-20200630" decimals="0" format="ixt:numdotdecimal" name="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjkzY2E5YmIwMTc5MjQ3NmZiYjIyNWU1ZDlkZWM4NjlmL3NlYzo5M2NhOWJiMDE3OTI0NzZmYmIyMjVlNWQ5ZGVjODY5Zl81Mi9mcmFnOjlkZDkxMTIyZjQxYzQzNzk5OGZlMGIyOGMwYjRhYjgwL3RhYmxlOjdjZGYyNzg5Njc4MDQ5MWQ4NWM1MDI2ZmNmNzU5YTg2L3RhYmxlcmFuZ2U6N2NkZjI3ODk2NzgwNDkxZDg1YzUwMjZmY2Y3NTlhODZfMTAtNy0xLTEtMA_f8fd5504-797a-401a-bbf4-5d50bf06f1cf">162,158,002</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div></ix:nonNumeric></ix:continuation><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span><br/></span></div><div id="i93ca9bb01792476fbb225e5d9dec869f_55"></div><div style="margin-bottom:12pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">8. <ix:nonNumeric contextRef="i69782326f71a44e3805518280ee22b6b_D20210101-20210630" name="us-gaap:SegmentReportingDisclosureTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjkzY2E5YmIwMTc5MjQ3NmZiYjIyNWU1ZDlkZWM4NjlmL3NlYzo5M2NhOWJiMDE3OTI0NzZmYmIyMjVlNWQ5ZGVjODY5Zl81NS9mcmFnOjk0NGQ2N2RjOTNmMjQ1MjliZTc4ZmNlMzRiOGMyZTBiL3RleHRyZWdpb246OTQ0ZDY3ZGM5M2YyNDUyOWJlNzhmY2UzNGI4YzJlMGJfMjk5Mg_05bfe000-43f3-4c58-882c-b87a25bd2a57" continuedAt="i37468f368333497d9dddfb42931ba3ed" escape="true">Segment Information</ix:nonNumeric></span></div><ix:continuation id="i37468f368333497d9dddfb42931ba3ed" continuedAt="i94c85bec855643cdb12619efdd2d0a0b"><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Segment reporting is prepared on the same basis that the Company&#8217;s chief operating decision makers (the &#8220;CODMs&#8221;) manage the business, make operating decisions and assess the Company&#8217;s performance. The Company determined that it has the following <ix:nonFraction unitRef="segment" contextRef="i69782326f71a44e3805518280ee22b6b_D20210101-20210630" decimals="INF" format="ixt-sec:numwordsen" name="us-gaap:NumberOfReportableSegments" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjkzY2E5YmIwMTc5MjQ3NmZiYjIyNWU1ZDlkZWM4NjlmL3NlYzo5M2NhOWJiMDE3OTI0NzZmYmIyMjVlNWQ5ZGVjODY5Zl81NS9mcmFnOjk0NGQ2N2RjOTNmMjQ1MjliZTc4ZmNlMzRiOGMyZTBiL3RleHRyZWdpb246OTQ0ZDY3ZGM5M2YyNDUyOWJlNzhmY2UzNGI4YzJlMGJfNDk0NzgwMjM1OTE1Ng_e8829cae-abeb-4c97-a237-0d9bc6cd122f">two</ix:nonFraction> reportable segments: United States and Rest of World. </span><span style="color:#212529;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The United States operating segment consists of the </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">manufacture and distribution of hemp-derived CBD infused products. </span><span style="color:#212529;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Rest of World operating segment is involved in </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">the cultivation, manufacture, and marketing of cannabis and cannabis-derived products for the medical and adult-use markets</span><span style="color:#212529;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">These <ix:nonFraction unitRef="segment" contextRef="i69782326f71a44e3805518280ee22b6b_D20210101-20210630" decimals="INF" format="ixt-sec:numwordsen" name="us-gaap:NumberOfReportableSegments" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjkzY2E5YmIwMTc5MjQ3NmZiYjIyNWU1ZDlkZWM4NjlmL3NlYzo5M2NhOWJiMDE3OTI0NzZmYmIyMjVlNWQ5ZGVjODY5Zl81NS9mcmFnOjk0NGQ2N2RjOTNmMjQ1MjliZTc4ZmNlMzRiOGMyZTBiL3RleHRyZWdpb246OTQ0ZDY3ZGM5M2YyNDUyOWJlNzhmY2UzNGI4YzJlMGJfNDk0NzgwMjM1OTE1MQ_b49c94c5-86fe-4869-b661-8acfbf3c093f">two</ix:nonFraction> segments represent the geographic regions in which the Company operates and the different product offerings within each geographic region. The results of each segment are regularly reviewed by the CODMs to assess the performance of the segment and make decisions regarding the allocation of resources. The CODMs review adjusted earnings (loss) before interest, tax, depreciation and amortization (&#8220;Adjusted EBITDA&#8221;) as the measure of segment profit or loss to evaluate performance of and allocate resources for its reportable segments. Adjusted EBITDA is defined as earnings before interest, tax, depreciation, non-cash items and items that do not reflect management&#8217;s assessment of on-going business performance.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The tables below set forth our condensed consolidated results of operations, expressed in thousands of U.S. dollars for the periods presented. Our condensed consolidated financial results for these periods are not necessarily indicative of the consolidated financial results that we will achieve in future periods</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">.</span></div></ix:continuation><div style="height:36pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">20</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:72pt;width:100%"><div style="margin-top:0.55pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:95.000%"><tr><td style="width:1.0%"></td><td style="width:65.712%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:32.088%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="border-top:1pt solid #FFFFFF;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Cronos Group Inc.</span></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Notes to Condensed Consolidated Financial Statements (Unaudited)</span></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">(In thousands of $, except share amounts)</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i93ca9bb01792476fbb225e5d9dec869f_7">Table of Contents</a></span></div></td></tr></table></div></div><ix:continuation id="i94c85bec855643cdb12619efdd2d0a0b" continuedAt="i10d1eef574204b548ac3ab5a07c24842"><ix:nonNumeric contextRef="i69782326f71a44e3805518280ee22b6b_D20210101-20210630" name="us-gaap:ScheduleOfSegmentReportingInformationBySegmentTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjkzY2E5YmIwMTc5MjQ3NmZiYjIyNWU1ZDlkZWM4NjlmL3NlYzo5M2NhOWJiMDE3OTI0NzZmYmIyMjVlNWQ5ZGVjODY5Zl81NS9mcmFnOjk0NGQ2N2RjOTNmMjQ1MjliZTc4ZmNlMzRiOGMyZTBiL3RleHRyZWdpb246OTQ0ZDY3ZGM5M2YyNDUyOWJlNzhmY2UzNGI4YzJlMGJfMjk5Mw_517f7b72-239e-4893-aaa2-9809afbc3936" continuedAt="ib015cfd120634e7b8bb13c1ff6157ed5" escape="true"><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Segment data was as follows for the three and six months ended June&#160;30, 2021 and 2020: </span></div><div style="margin-bottom:12pt;margin-top:6pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:49.316%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.566%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.772%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.566%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.772%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.566%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.772%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.570%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="21" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Three months ended June&#160;30, 2021</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">United States</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Rest of World</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Corporate Expenses</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Total</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cannabis flower</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ibc692233c14c49be87add169c0e2de75_D20210401-20210630" decimals="-3" format="ixt:zerodash" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzY2E5YmIwMTc5MjQ3NmZiYjIyNWU1ZDlkZWM4NjlmL3NlYzo5M2NhOWJiMDE3OTI0NzZmYmIyMjVlNWQ5ZGVjODY5Zl81NS9mcmFnOjk0NGQ2N2RjOTNmMjQ1MjliZTc4ZmNlMzRiOGMyZTBiL3RhYmxlOjhlMGRhYjE1OGMzYTQyNTdhOWJkMTAzNzRmMDNiYzkxL3RhYmxlcmFuZ2U6OGUwZGFiMTU4YzNhNDI1N2E5YmQxMDM3NGYwM2JjOTFfMy0xLTEtMS0w_4c403b20-7b6c-4bd7-84f5-72b8b8552dfa">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8f2910ecf1ae40e091d358fb8405c9bd_D20210401-20210630" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzY2E5YmIwMTc5MjQ3NmZiYjIyNWU1ZDlkZWM4NjlmL3NlYzo5M2NhOWJiMDE3OTI0NzZmYmIyMjVlNWQ5ZGVjODY5Zl81NS9mcmFnOjk0NGQ2N2RjOTNmMjQ1MjliZTc4ZmNlMzRiOGMyZTBiL3RhYmxlOjhlMGRhYjE1OGMzYTQyNTdhOWJkMTAzNzRmMDNiYzkxL3RhYmxlcmFuZ2U6OGUwZGFiMTU4YzNhNDI1N2E5YmQxMDM3NGYwM2JjOTFfMy0zLTEtMS0w_830bdc55-1781-4c1b-81ed-e0a56f374274">11,597</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia66d704cc8af4a879583109863080207_D20210401-20210630" decimals="-3" format="ixt:zerodash" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzY2E5YmIwMTc5MjQ3NmZiYjIyNWU1ZDlkZWM4NjlmL3NlYzo5M2NhOWJiMDE3OTI0NzZmYmIyMjVlNWQ5ZGVjODY5Zl81NS9mcmFnOjk0NGQ2N2RjOTNmMjQ1MjliZTc4ZmNlMzRiOGMyZTBiL3RhYmxlOjhlMGRhYjE1OGMzYTQyNTdhOWJkMTAzNzRmMDNiYzkxL3RhYmxlcmFuZ2U6OGUwZGFiMTU4YzNhNDI1N2E5YmQxMDM3NGYwM2JjOTFfMy01LTEtMS0w_802fa7b8-86e9-4edc-86f1-0e738108b314">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i79727dab4c1240ceaa1f07e61bb81188_D20210401-20210630" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzY2E5YmIwMTc5MjQ3NmZiYjIyNWU1ZDlkZWM4NjlmL3NlYzo5M2NhOWJiMDE3OTI0NzZmYmIyMjVlNWQ5ZGVjODY5Zl81NS9mcmFnOjk0NGQ2N2RjOTNmMjQ1MjliZTc4ZmNlMzRiOGMyZTBiL3RhYmxlOjhlMGRhYjE1OGMzYTQyNTdhOWJkMTAzNzRmMDNiYzkxL3RhYmxlcmFuZ2U6OGUwZGFiMTU4YzNhNDI1N2E5YmQxMDM3NGYwM2JjOTFfMy03LTEtMS0w_bbc57635-f6d3-4c0f-9f0a-5db6696bf9bc">11,597</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cannabis extracts</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ibd153928ae104df6b058cc08f14f6f09_D20210401-20210630" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzY2E5YmIwMTc5MjQ3NmZiYjIyNWU1ZDlkZWM4NjlmL3NlYzo5M2NhOWJiMDE3OTI0NzZmYmIyMjVlNWQ5ZGVjODY5Zl81NS9mcmFnOjk0NGQ2N2RjOTNmMjQ1MjliZTc4ZmNlMzRiOGMyZTBiL3RhYmxlOjhlMGRhYjE1OGMzYTQyNTdhOWJkMTAzNzRmMDNiYzkxL3RhYmxlcmFuZ2U6OGUwZGFiMTU4YzNhNDI1N2E5YmQxMDM3NGYwM2JjOTFfNC0xLTEtMS0w_9c17c1f3-64b1-4477-8ba6-988b0530d9fa">2,227</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i032a3ff320db4a7383246d7d6de2326f_D20210401-20210630" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzY2E5YmIwMTc5MjQ3NmZiYjIyNWU1ZDlkZWM4NjlmL3NlYzo5M2NhOWJiMDE3OTI0NzZmYmIyMjVlNWQ5ZGVjODY5Zl81NS9mcmFnOjk0NGQ2N2RjOTNmMjQ1MjliZTc4ZmNlMzRiOGMyZTBiL3RhYmxlOjhlMGRhYjE1OGMzYTQyNTdhOWJkMTAzNzRmMDNiYzkxL3RhYmxlcmFuZ2U6OGUwZGFiMTU4YzNhNDI1N2E5YmQxMDM3NGYwM2JjOTFfNC0zLTEtMS0w_ec78163b-4092-4f23-8199-d0c994690527">1,531</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia76908c59acf4c64acd394bfc6223beb_D20210401-20210630" decimals="-3" format="ixt:zerodash" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzY2E5YmIwMTc5MjQ3NmZiYjIyNWU1ZDlkZWM4NjlmL3NlYzo5M2NhOWJiMDE3OTI0NzZmYmIyMjVlNWQ5ZGVjODY5Zl81NS9mcmFnOjk0NGQ2N2RjOTNmMjQ1MjliZTc4ZmNlMzRiOGMyZTBiL3RhYmxlOjhlMGRhYjE1OGMzYTQyNTdhOWJkMTAzNzRmMDNiYzkxL3RhYmxlcmFuZ2U6OGUwZGFiMTU4YzNhNDI1N2E5YmQxMDM3NGYwM2JjOTFfNC01LTEtMS0w_a342db14-6fbb-43d4-a306-9b4a76e06d61">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id339c655bfd341ce947f632c28a7cb54_D20210401-20210630" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzY2E5YmIwMTc5MjQ3NmZiYjIyNWU1ZDlkZWM4NjlmL3NlYzo5M2NhOWJiMDE3OTI0NzZmYmIyMjVlNWQ5ZGVjODY5Zl81NS9mcmFnOjk0NGQ2N2RjOTNmMjQ1MjliZTc4ZmNlMzRiOGMyZTBiL3RhYmxlOjhlMGRhYjE1OGMzYTQyNTdhOWJkMTAzNzRmMDNiYzkxL3RhYmxlcmFuZ2U6OGUwZGFiMTU4YzNhNDI1N2E5YmQxMDM3NGYwM2JjOTFfNC03LTEtMS0w_5f801e1f-c534-4388-a96d-84324f9b7734">3,758</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i32838a57ba6c4493badd924366696106_D20210401-20210630" decimals="-3" format="ixt:zerodash" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzY2E5YmIwMTc5MjQ3NmZiYjIyNWU1ZDlkZWM4NjlmL3NlYzo5M2NhOWJiMDE3OTI0NzZmYmIyMjVlNWQ5ZGVjODY5Zl81NS9mcmFnOjk0NGQ2N2RjOTNmMjQ1MjliZTc4ZmNlMzRiOGMyZTBiL3RhYmxlOjhlMGRhYjE1OGMzYTQyNTdhOWJkMTAzNzRmMDNiYzkxL3RhYmxlcmFuZ2U6OGUwZGFiMTU4YzNhNDI1N2E5YmQxMDM3NGYwM2JjOTFfNS0xLTEtMS0w_cd420d1a-1bb7-44f7-9052-b7aa1d91a389">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6f297f0a314745488d2a9a9e296b5375_D20210401-20210630" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzY2E5YmIwMTc5MjQ3NmZiYjIyNWU1ZDlkZWM4NjlmL3NlYzo5M2NhOWJiMDE3OTI0NzZmYmIyMjVlNWQ5ZGVjODY5Zl81NS9mcmFnOjk0NGQ2N2RjOTNmMjQ1MjliZTc4ZmNlMzRiOGMyZTBiL3RhYmxlOjhlMGRhYjE1OGMzYTQyNTdhOWJkMTAzNzRmMDNiYzkxL3RhYmxlcmFuZ2U6OGUwZGFiMTU4YzNhNDI1N2E5YmQxMDM3NGYwM2JjOTFfNS0zLTEtMS0w_9c03d995-4751-4510-affb-23d833dfc1f3">267</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i07bd26499a384059b217b3a61ccfa0a7_D20210401-20210630" decimals="-3" format="ixt:zerodash" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzY2E5YmIwMTc5MjQ3NmZiYjIyNWU1ZDlkZWM4NjlmL3NlYzo5M2NhOWJiMDE3OTI0NzZmYmIyMjVlNWQ5ZGVjODY5Zl81NS9mcmFnOjk0NGQ2N2RjOTNmMjQ1MjliZTc4ZmNlMzRiOGMyZTBiL3RhYmxlOjhlMGRhYjE1OGMzYTQyNTdhOWJkMTAzNzRmMDNiYzkxL3RhYmxlcmFuZ2U6OGUwZGFiMTU4YzNhNDI1N2E5YmQxMDM3NGYwM2JjOTFfNS01LTEtMS0w_f0762c96-b55c-4e12-80af-21984a261780">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib7b191b315bf4d3d9c5a469788ccac38_D20210401-20210630" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzY2E5YmIwMTc5MjQ3NmZiYjIyNWU1ZDlkZWM4NjlmL3NlYzo5M2NhOWJiMDE3OTI0NzZmYmIyMjVlNWQ5ZGVjODY5Zl81NS9mcmFnOjk0NGQ2N2RjOTNmMjQ1MjliZTc4ZmNlMzRiOGMyZTBiL3RhYmxlOjhlMGRhYjE1OGMzYTQyNTdhOWJkMTAzNzRmMDNiYzkxL3RhYmxlcmFuZ2U6OGUwZGFiMTU4YzNhNDI1N2E5YmQxMDM3NGYwM2JjOTFfNS03LTEtMS0w_15bc19a9-73ec-4e1f-8c40-84cef371a9fb">267</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net revenue</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2a563d1bc1a1451296d5f40e6cdf2912_D20210401-20210630" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzY2E5YmIwMTc5MjQ3NmZiYjIyNWU1ZDlkZWM4NjlmL3NlYzo5M2NhOWJiMDE3OTI0NzZmYmIyMjVlNWQ5ZGVjODY5Zl81NS9mcmFnOjk0NGQ2N2RjOTNmMjQ1MjliZTc4ZmNlMzRiOGMyZTBiL3RhYmxlOjhlMGRhYjE1OGMzYTQyNTdhOWJkMTAzNzRmMDNiYzkxL3RhYmxlcmFuZ2U6OGUwZGFiMTU4YzNhNDI1N2E5YmQxMDM3NGYwM2JjOTFfNi0xLTEtMS0w_53fd6949-c66c-4cbe-a727-91ee75511ac6">2,227</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7b627a38d4bb4b2693a9598ca41f647d_D20210401-20210630" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzY2E5YmIwMTc5MjQ3NmZiYjIyNWU1ZDlkZWM4NjlmL3NlYzo5M2NhOWJiMDE3OTI0NzZmYmIyMjVlNWQ5ZGVjODY5Zl81NS9mcmFnOjk0NGQ2N2RjOTNmMjQ1MjliZTc4ZmNlMzRiOGMyZTBiL3RhYmxlOjhlMGRhYjE1OGMzYTQyNTdhOWJkMTAzNzRmMDNiYzkxL3RhYmxlcmFuZ2U6OGUwZGFiMTU4YzNhNDI1N2E5YmQxMDM3NGYwM2JjOTFfNi0zLTEtMS0w_fa008124-4d81-4ebd-8498-5b396ad9fa9c">13,395</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie916e4a685544ae3998d4e82e089944f_D20210401-20210630" decimals="-3" format="ixt:zerodash" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzY2E5YmIwMTc5MjQ3NmZiYjIyNWU1ZDlkZWM4NjlmL3NlYzo5M2NhOWJiMDE3OTI0NzZmYmIyMjVlNWQ5ZGVjODY5Zl81NS9mcmFnOjk0NGQ2N2RjOTNmMjQ1MjliZTc4ZmNlMzRiOGMyZTBiL3RhYmxlOjhlMGRhYjE1OGMzYTQyNTdhOWJkMTAzNzRmMDNiYzkxL3RhYmxlcmFuZ2U6OGUwZGFiMTU4YzNhNDI1N2E5YmQxMDM3NGYwM2JjOTFfNi01LTEtMS0w_e37d6565-d73c-46f0-917d-fba75c7306aa">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i27f4e53b91ad4367b7f8d273eff27769_D20210401-20210630" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzY2E5YmIwMTc5MjQ3NmZiYjIyNWU1ZDlkZWM4NjlmL3NlYzo5M2NhOWJiMDE3OTI0NzZmYmIyMjVlNWQ5ZGVjODY5Zl81NS9mcmFnOjk0NGQ2N2RjOTNmMjQ1MjliZTc4ZmNlMzRiOGMyZTBiL3RhYmxlOjhlMGRhYjE1OGMzYTQyNTdhOWJkMTAzNzRmMDNiYzkxL3RhYmxlcmFuZ2U6OGUwZGFiMTU4YzNhNDI1N2E5YmQxMDM3NGYwM2JjOTFfNi03LTEtMS0w_00ed97cd-fbb9-4cc8-943c-6e34548ed27c">15,622</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Share of loss from equity accounted investments</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2a563d1bc1a1451296d5f40e6cdf2912_D20210401-20210630" decimals="-3" format="ixt:zerodash" name="us-gaap:IncomeLossFromEquityMethodInvestments" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzY2E5YmIwMTc5MjQ3NmZiYjIyNWU1ZDlkZWM4NjlmL3NlYzo5M2NhOWJiMDE3OTI0NzZmYmIyMjVlNWQ5ZGVjODY5Zl81NS9mcmFnOjk0NGQ2N2RjOTNmMjQ1MjliZTc4ZmNlMzRiOGMyZTBiL3RhYmxlOjhlMGRhYjE1OGMzYTQyNTdhOWJkMTAzNzRmMDNiYzkxL3RhYmxlcmFuZ2U6OGUwZGFiMTU4YzNhNDI1N2E5YmQxMDM3NGYwM2JjOTFfOC0xLTEtMS0w_5158990c-552e-4b9f-a0e7-27d06f93b558">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7b627a38d4bb4b2693a9598ca41f647d_D20210401-20210630" decimals="-3" sign="-" format="ixt:numdotdecimal" name="us-gaap:IncomeLossFromEquityMethodInvestments" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzY2E5YmIwMTc5MjQ3NmZiYjIyNWU1ZDlkZWM4NjlmL3NlYzo5M2NhOWJiMDE3OTI0NzZmYmIyMjVlNWQ5ZGVjODY5Zl81NS9mcmFnOjk0NGQ2N2RjOTNmMjQ1MjliZTc4ZmNlMzRiOGMyZTBiL3RhYmxlOjhlMGRhYjE1OGMzYTQyNTdhOWJkMTAzNzRmMDNiYzkxL3RhYmxlcmFuZ2U6OGUwZGFiMTU4YzNhNDI1N2E5YmQxMDM3NGYwM2JjOTFfOC0zLTEtMS0w_5d926584-255c-43ec-bda4-7f74a9d8cf78">1,115</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie916e4a685544ae3998d4e82e089944f_D20210401-20210630" decimals="-3" format="ixt:zerodash" name="us-gaap:IncomeLossFromEquityMethodInvestments" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzY2E5YmIwMTc5MjQ3NmZiYjIyNWU1ZDlkZWM4NjlmL3NlYzo5M2NhOWJiMDE3OTI0NzZmYmIyMjVlNWQ5ZGVjODY5Zl81NS9mcmFnOjk0NGQ2N2RjOTNmMjQ1MjliZTc4ZmNlMzRiOGMyZTBiL3RhYmxlOjhlMGRhYjE1OGMzYTQyNTdhOWJkMTAzNzRmMDNiYzkxL3RhYmxlcmFuZ2U6OGUwZGFiMTU4YzNhNDI1N2E5YmQxMDM3NGYwM2JjOTFfOC01LTEtMS0w_4c09fe26-9d42-4b9b-8b53-6cd739545048">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i27f4e53b91ad4367b7f8d273eff27769_D20210401-20210630" decimals="-3" sign="-" format="ixt:numdotdecimal" name="us-gaap:IncomeLossFromEquityMethodInvestments" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzY2E5YmIwMTc5MjQ3NmZiYjIyNWU1ZDlkZWM4NjlmL3NlYzo5M2NhOWJiMDE3OTI0NzZmYmIyMjVlNWQ5ZGVjODY5Zl81NS9mcmFnOjk0NGQ2N2RjOTNmMjQ1MjliZTc4ZmNlMzRiOGMyZTBiL3RhYmxlOjhlMGRhYjE1OGMzYTQyNTdhOWJkMTAzNzRmMDNiYzkxL3RhYmxlcmFuZ2U6OGUwZGFiMTU4YzNhNDI1N2E5YmQxMDM3NGYwM2JjOTFfOC03LTEtMS0w_00457667-79e9-4660-a4ac-0a8f9a314736">1,115</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Interest income</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2a563d1bc1a1451296d5f40e6cdf2912_D20210401-20210630" decimals="-3" name="us-gaap:InvestmentIncomeInterest" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzY2E5YmIwMTc5MjQ3NmZiYjIyNWU1ZDlkZWM4NjlmL3NlYzo5M2NhOWJiMDE3OTI0NzZmYmIyMjVlNWQ5ZGVjODY5Zl81NS9mcmFnOjk0NGQ2N2RjOTNmMjQ1MjliZTc4ZmNlMzRiOGMyZTBiL3RhYmxlOjhlMGRhYjE1OGMzYTQyNTdhOWJkMTAzNzRmMDNiYzkxL3RhYmxlcmFuZ2U6OGUwZGFiMTU4YzNhNDI1N2E5YmQxMDM3NGYwM2JjOTFfMTAtMS0xLTEtMA_7fa5688d-327b-4846-ba0c-af944cb9d6da">20</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7b627a38d4bb4b2693a9598ca41f647d_D20210401-20210630" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:InvestmentIncomeInterest" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzY2E5YmIwMTc5MjQ3NmZiYjIyNWU1ZDlkZWM4NjlmL3NlYzo5M2NhOWJiMDE3OTI0NzZmYmIyMjVlNWQ5ZGVjODY5Zl81NS9mcmFnOjk0NGQ2N2RjOTNmMjQ1MjliZTc4ZmNlMzRiOGMyZTBiL3RhYmxlOjhlMGRhYjE1OGMzYTQyNTdhOWJkMTAzNzRmMDNiYzkxL3RhYmxlcmFuZ2U6OGUwZGFiMTU4YzNhNDI1N2E5YmQxMDM3NGYwM2JjOTFfMTAtMy0xLTEtMA_a04a18d1-b2f1-4c85-8c55-56475e7cf6a1">2,280</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie916e4a685544ae3998d4e82e089944f_D20210401-20210630" decimals="-3" format="ixt:zerodash" name="us-gaap:InvestmentIncomeInterest" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzY2E5YmIwMTc5MjQ3NmZiYjIyNWU1ZDlkZWM4NjlmL3NlYzo5M2NhOWJiMDE3OTI0NzZmYmIyMjVlNWQ5ZGVjODY5Zl81NS9mcmFnOjk0NGQ2N2RjOTNmMjQ1MjliZTc4ZmNlMzRiOGMyZTBiL3RhYmxlOjhlMGRhYjE1OGMzYTQyNTdhOWJkMTAzNzRmMDNiYzkxL3RhYmxlcmFuZ2U6OGUwZGFiMTU4YzNhNDI1N2E5YmQxMDM3NGYwM2JjOTFfMTAtNS0xLTEtMA_26bb86e4-f4bd-4ef9-9ee7-521ca62d9628">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i27f4e53b91ad4367b7f8d273eff27769_D20210401-20210630" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:InvestmentIncomeInterest" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzY2E5YmIwMTc5MjQ3NmZiYjIyNWU1ZDlkZWM4NjlmL3NlYzo5M2NhOWJiMDE3OTI0NzZmYmIyMjVlNWQ5ZGVjODY5Zl81NS9mcmFnOjk0NGQ2N2RjOTNmMjQ1MjliZTc4ZmNlMzRiOGMyZTBiL3RhYmxlOjhlMGRhYjE1OGMzYTQyNTdhOWJkMTAzNzRmMDNiYzkxL3RhYmxlcmFuZ2U6OGUwZGFiMTU4YzNhNDI1N2E5YmQxMDM3NGYwM2JjOTFfMTAtNy0xLTEtMA_ed221811-0036-4060-a3a2-48166c964fe8">2,300</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Interest expense</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2a563d1bc1a1451296d5f40e6cdf2912_D20210401-20210630" decimals="-3" format="ixt:zerodash" name="us-gaap:InterestExpense" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzY2E5YmIwMTc5MjQ3NmZiYjIyNWU1ZDlkZWM4NjlmL3NlYzo5M2NhOWJiMDE3OTI0NzZmYmIyMjVlNWQ5ZGVjODY5Zl81NS9mcmFnOjk0NGQ2N2RjOTNmMjQ1MjliZTc4ZmNlMzRiOGMyZTBiL3RhYmxlOjhlMGRhYjE1OGMzYTQyNTdhOWJkMTAzNzRmMDNiYzkxL3RhYmxlcmFuZ2U6OGUwZGFiMTU4YzNhNDI1N2E5YmQxMDM3NGYwM2JjOTFfMTEtMS0xLTEtMA_a65379d7-f92a-4061-bfc5-f0ad4cb7ea50">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i7b627a38d4bb4b2693a9598ca41f647d_D20210401-20210630" decimals="-3" name="us-gaap:InterestExpense" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzY2E5YmIwMTc5MjQ3NmZiYjIyNWU1ZDlkZWM4NjlmL3NlYzo5M2NhOWJiMDE3OTI0NzZmYmIyMjVlNWQ5ZGVjODY5Zl81NS9mcmFnOjk0NGQ2N2RjOTNmMjQ1MjliZTc4ZmNlMzRiOGMyZTBiL3RhYmxlOjhlMGRhYjE1OGMzYTQyNTdhOWJkMTAzNzRmMDNiYzkxL3RhYmxlcmFuZ2U6OGUwZGFiMTU4YzNhNDI1N2E5YmQxMDM3NGYwM2JjOTFfMTEtMy0xLTEtMA_df7b010c-79f0-4d15-8b75-2129fea9b465">7</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie916e4a685544ae3998d4e82e089944f_D20210401-20210630" decimals="-3" format="ixt:zerodash" name="us-gaap:InterestExpense" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzY2E5YmIwMTc5MjQ3NmZiYjIyNWU1ZDlkZWM4NjlmL3NlYzo5M2NhOWJiMDE3OTI0NzZmYmIyMjVlNWQ5ZGVjODY5Zl81NS9mcmFnOjk0NGQ2N2RjOTNmMjQ1MjliZTc4ZmNlMzRiOGMyZTBiL3RhYmxlOjhlMGRhYjE1OGMzYTQyNTdhOWJkMTAzNzRmMDNiYzkxL3RhYmxlcmFuZ2U6OGUwZGFiMTU4YzNhNDI1N2E5YmQxMDM3NGYwM2JjOTFfMTEtNS0xLTEtMA_ed404494-4d7e-4d5a-b88e-049b4d74fcab">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i27f4e53b91ad4367b7f8d273eff27769_D20210401-20210630" decimals="-3" name="us-gaap:InterestExpense" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzY2E5YmIwMTc5MjQ3NmZiYjIyNWU1ZDlkZWM4NjlmL3NlYzo5M2NhOWJiMDE3OTI0NzZmYmIyMjVlNWQ5ZGVjODY5Zl81NS9mcmFnOjk0NGQ2N2RjOTNmMjQ1MjliZTc4ZmNlMzRiOGMyZTBiL3RhYmxlOjhlMGRhYjE1OGMzYTQyNTdhOWJkMTAzNzRmMDNiYzkxL3RhYmxlcmFuZ2U6OGUwZGFiMTU4YzNhNDI1N2E5YmQxMDM3NGYwM2JjOTFfMTEtNy0xLTEtMA_9876d077-74c9-4d02-ace7-4edd2174d9cd">7</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Interest income, net</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2a563d1bc1a1451296d5f40e6cdf2912_D20210401-20210630" decimals="-3" name="us-gaap:InterestIncomeExpenseNonoperatingNet" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzY2E5YmIwMTc5MjQ3NmZiYjIyNWU1ZDlkZWM4NjlmL3NlYzo5M2NhOWJiMDE3OTI0NzZmYmIyMjVlNWQ5ZGVjODY5Zl81NS9mcmFnOjk0NGQ2N2RjOTNmMjQ1MjliZTc4ZmNlMzRiOGMyZTBiL3RhYmxlOjhlMGRhYjE1OGMzYTQyNTdhOWJkMTAzNzRmMDNiYzkxL3RhYmxlcmFuZ2U6OGUwZGFiMTU4YzNhNDI1N2E5YmQxMDM3NGYwM2JjOTFfMTItMS0xLTEtMA_9a41ebc5-5aad-4c9b-9613-389d76b2102c">20</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7b627a38d4bb4b2693a9598ca41f647d_D20210401-20210630" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:InterestIncomeExpenseNonoperatingNet" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzY2E5YmIwMTc5MjQ3NmZiYjIyNWU1ZDlkZWM4NjlmL3NlYzo5M2NhOWJiMDE3OTI0NzZmYmIyMjVlNWQ5ZGVjODY5Zl81NS9mcmFnOjk0NGQ2N2RjOTNmMjQ1MjliZTc4ZmNlMzRiOGMyZTBiL3RhYmxlOjhlMGRhYjE1OGMzYTQyNTdhOWJkMTAzNzRmMDNiYzkxL3RhYmxlcmFuZ2U6OGUwZGFiMTU4YzNhNDI1N2E5YmQxMDM3NGYwM2JjOTFfMTItMy0xLTEtMA_4f3599e8-71af-4ea0-8378-c8086ddb427c">2,273</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie916e4a685544ae3998d4e82e089944f_D20210401-20210630" decimals="-3" format="ixt:zerodash" name="us-gaap:InterestIncomeExpenseNonoperatingNet" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzY2E5YmIwMTc5MjQ3NmZiYjIyNWU1ZDlkZWM4NjlmL3NlYzo5M2NhOWJiMDE3OTI0NzZmYmIyMjVlNWQ5ZGVjODY5Zl81NS9mcmFnOjk0NGQ2N2RjOTNmMjQ1MjliZTc4ZmNlMzRiOGMyZTBiL3RhYmxlOjhlMGRhYjE1OGMzYTQyNTdhOWJkMTAzNzRmMDNiYzkxL3RhYmxlcmFuZ2U6OGUwZGFiMTU4YzNhNDI1N2E5YmQxMDM3NGYwM2JjOTFfMTItNS0xLTEtMA_e43a4fd3-a9c7-4beb-99e5-c3d531446ab1">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i27f4e53b91ad4367b7f8d273eff27769_D20210401-20210630" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:InterestIncomeExpenseNonoperatingNet" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzY2E5YmIwMTc5MjQ3NmZiYjIyNWU1ZDlkZWM4NjlmL3NlYzo5M2NhOWJiMDE3OTI0NzZmYmIyMjVlNWQ5ZGVjODY5Zl81NS9mcmFnOjk0NGQ2N2RjOTNmMjQ1MjliZTc4ZmNlMzRiOGMyZTBiL3RhYmxlOjhlMGRhYjE1OGMzYTQyNTdhOWJkMTAzNzRmMDNiYzkxL3RhYmxlcmFuZ2U6OGUwZGFiMTU4YzNhNDI1N2E5YmQxMDM3NGYwM2JjOTFfMTItNy0xLTEtMA_552911d2-957e-4849-99e6-9d65e5fa0041">2,293</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total assets</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1afe4ab017a94c08b0390d1c04588202_I20210630" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:Assets" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzY2E5YmIwMTc5MjQ3NmZiYjIyNWU1ZDlkZWM4NjlmL3NlYzo5M2NhOWJiMDE3OTI0NzZmYmIyMjVlNWQ5ZGVjODY5Zl81NS9mcmFnOjk0NGQ2N2RjOTNmMjQ1MjliZTc4ZmNlMzRiOGMyZTBiL3RhYmxlOjhlMGRhYjE1OGMzYTQyNTdhOWJkMTAzNzRmMDNiYzkxL3RhYmxlcmFuZ2U6OGUwZGFiMTU4YzNhNDI1N2E5YmQxMDM3NGYwM2JjOTFfMTMtMS0xLTEtMTg0MzM_ffce79d1-5da8-4f0f-b770-cc5a1cac2e8b">709,956</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i14c7d79dc30c40b9a6db30b130c667da_I20210630" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:Assets" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzY2E5YmIwMTc5MjQ3NmZiYjIyNWU1ZDlkZWM4NjlmL3NlYzo5M2NhOWJiMDE3OTI0NzZmYmIyMjVlNWQ5ZGVjODY5Zl81NS9mcmFnOjk0NGQ2N2RjOTNmMjQ1MjliZTc4ZmNlMzRiOGMyZTBiL3RhYmxlOjhlMGRhYjE1OGMzYTQyNTdhOWJkMTAzNzRmMDNiYzkxL3RhYmxlcmFuZ2U6OGUwZGFiMTU4YzNhNDI1N2E5YmQxMDM3NGYwM2JjOTFfMTMtMy0xLTEtMTg0MzM_25a89660-c625-46d7-aa85-98303a629f26">386,805</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i64489be55285421f8e92af4479a619e6_I20210630" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:Assets" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzY2E5YmIwMTc5MjQ3NmZiYjIyNWU1ZDlkZWM4NjlmL3NlYzo5M2NhOWJiMDE3OTI0NzZmYmIyMjVlNWQ5ZGVjODY5Zl81NS9mcmFnOjk0NGQ2N2RjOTNmMjQ1MjliZTc4ZmNlMzRiOGMyZTBiL3RhYmxlOjhlMGRhYjE1OGMzYTQyNTdhOWJkMTAzNzRmMDNiYzkxL3RhYmxlcmFuZ2U6OGUwZGFiMTU4YzNhNDI1N2E5YmQxMDM3NGYwM2JjOTFfMTMtNS0xLTEtMTg0MzM_3ec9931f-3f5f-4081-8806-84dddfb88904">741,850</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i225f85e38faa4bbdb4de1d8b9cf369bb_I20210630" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:Assets" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzY2E5YmIwMTc5MjQ3NmZiYjIyNWU1ZDlkZWM4NjlmL3NlYzo5M2NhOWJiMDE3OTI0NzZmYmIyMjVlNWQ5ZGVjODY5Zl81NS9mcmFnOjk0NGQ2N2RjOTNmMjQ1MjliZTc4ZmNlMzRiOGMyZTBiL3RhYmxlOjhlMGRhYjE1OGMzYTQyNTdhOWJkMTAzNzRmMDNiYzkxL3RhYmxlcmFuZ2U6OGUwZGFiMTU4YzNhNDI1N2E5YmQxMDM3NGYwM2JjOTFfMTMtNy0xLTEtMTg0NTQ_e160f066-5076-4dea-ab85-57238fb63efc">1,838,611</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Depreciation and amortization</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2a563d1bc1a1451296d5f40e6cdf2912_D20210401-20210630" decimals="-3" name="us-gaap:DepreciationAndAmortization" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzY2E5YmIwMTc5MjQ3NmZiYjIyNWU1ZDlkZWM4NjlmL3NlYzo5M2NhOWJiMDE3OTI0NzZmYmIyMjVlNWQ5ZGVjODY5Zl81NS9mcmFnOjk0NGQ2N2RjOTNmMjQ1MjliZTc4ZmNlMzRiOGMyZTBiL3RhYmxlOjhlMGRhYjE1OGMzYTQyNTdhOWJkMTAzNzRmMDNiYzkxL3RhYmxlcmFuZ2U6OGUwZGFiMTU4YzNhNDI1N2E5YmQxMDM3NGYwM2JjOTFfMTQtMS0xLTEtMA_3bd1dbb2-dafc-49e8-96cb-4bf826ce84d4">68</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7b627a38d4bb4b2693a9598ca41f647d_D20210401-20210630" decimals="-3" name="us-gaap:DepreciationAndAmortization" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzY2E5YmIwMTc5MjQ3NmZiYjIyNWU1ZDlkZWM4NjlmL3NlYzo5M2NhOWJiMDE3OTI0NzZmYmIyMjVlNWQ5ZGVjODY5Zl81NS9mcmFnOjk0NGQ2N2RjOTNmMjQ1MjliZTc4ZmNlMzRiOGMyZTBiL3RhYmxlOjhlMGRhYjE1OGMzYTQyNTdhOWJkMTAzNzRmMDNiYzkxL3RhYmxlcmFuZ2U6OGUwZGFiMTU4YzNhNDI1N2E5YmQxMDM3NGYwM2JjOTFfMTQtMy0xLTEtMA_1365003d-9946-4bd6-9db6-40fa846d6b2b">975</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie916e4a685544ae3998d4e82e089944f_D20210401-20210630" decimals="-3" format="ixt:zerodash" name="us-gaap:DepreciationAndAmortization" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzY2E5YmIwMTc5MjQ3NmZiYjIyNWU1ZDlkZWM4NjlmL3NlYzo5M2NhOWJiMDE3OTI0NzZmYmIyMjVlNWQ5ZGVjODY5Zl81NS9mcmFnOjk0NGQ2N2RjOTNmMjQ1MjliZTc4ZmNlMzRiOGMyZTBiL3RhYmxlOjhlMGRhYjE1OGMzYTQyNTdhOWJkMTAzNzRmMDNiYzkxL3RhYmxlcmFuZ2U6OGUwZGFiMTU4YzNhNDI1N2E5YmQxMDM3NGYwM2JjOTFfMTQtNS0xLTEtMA_8fc11468-c8b7-454f-b9e9-478a24891283">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i27f4e53b91ad4367b7f8d273eff27769_D20210401-20210630" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:DepreciationAndAmortization" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzY2E5YmIwMTc5MjQ3NmZiYjIyNWU1ZDlkZWM4NjlmL3NlYzo5M2NhOWJiMDE3OTI0NzZmYmIyMjVlNWQ5ZGVjODY5Zl81NS9mcmFnOjk0NGQ2N2RjOTNmMjQ1MjliZTc4ZmNlMzRiOGMyZTBiL3RhYmxlOjhlMGRhYjE1OGMzYTQyNTdhOWJkMTAzNzRmMDNiYzkxL3RhYmxlcmFuZ2U6OGUwZGFiMTU4YzNhNDI1N2E5YmQxMDM3NGYwM2JjOTFfMTQtNy0xLTEtMA_fc5947a4-61ff-450e-924a-a08565265f8e">1,043</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Adjusted EBITDA</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i2a563d1bc1a1451296d5f40e6cdf2912_D20210401-20210630" decimals="-3" sign="-" format="ixt:numdotdecimal" name="cron:AdjustedEarningsBeforeInterestTaxesDepreciationAndAmortization" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzY2E5YmIwMTc5MjQ3NmZiYjIyNWU1ZDlkZWM4NjlmL3NlYzo5M2NhOWJiMDE3OTI0NzZmYmIyMjVlNWQ5ZGVjODY5Zl81NS9mcmFnOjk0NGQ2N2RjOTNmMjQ1MjliZTc4ZmNlMzRiOGMyZTBiL3RhYmxlOjhlMGRhYjE1OGMzYTQyNTdhOWJkMTAzNzRmMDNiYzkxL3RhYmxlcmFuZ2U6OGUwZGFiMTU4YzNhNDI1N2E5YmQxMDM3NGYwM2JjOTFfMTctMS0xLTEtMA_57e4b109-8def-4e42-8ff8-0e8e4bb172a8">10,711</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i7b627a38d4bb4b2693a9598ca41f647d_D20210401-20210630" decimals="-3" sign="-" format="ixt:numdotdecimal" name="cron:AdjustedEarningsBeforeInterestTaxesDepreciationAndAmortization" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzY2E5YmIwMTc5MjQ3NmZiYjIyNWU1ZDlkZWM4NjlmL3NlYzo5M2NhOWJiMDE3OTI0NzZmYmIyMjVlNWQ5ZGVjODY5Zl81NS9mcmFnOjk0NGQ2N2RjOTNmMjQ1MjliZTc4ZmNlMzRiOGMyZTBiL3RhYmxlOjhlMGRhYjE1OGMzYTQyNTdhOWJkMTAzNzRmMDNiYzkxL3RhYmxlcmFuZ2U6OGUwZGFiMTU4YzNhNDI1N2E5YmQxMDM3NGYwM2JjOTFfMTctMy0xLTEtMA_569de834-eee9-40f4-9f61-31d686a54c8d">32,605</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ie916e4a685544ae3998d4e82e089944f_D20210401-20210630" decimals="-3" sign="-" format="ixt:numdotdecimal" name="cron:AdjustedEarningsBeforeInterestTaxesDepreciationAndAmortization" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzY2E5YmIwMTc5MjQ3NmZiYjIyNWU1ZDlkZWM4NjlmL3NlYzo5M2NhOWJiMDE3OTI0NzZmYmIyMjVlNWQ5ZGVjODY5Zl81NS9mcmFnOjk0NGQ2N2RjOTNmMjQ1MjliZTc4ZmNlMzRiOGMyZTBiL3RhYmxlOjhlMGRhYjE1OGMzYTQyNTdhOWJkMTAzNzRmMDNiYzkxL3RhYmxlcmFuZ2U6OGUwZGFiMTU4YzNhNDI1N2E5YmQxMDM3NGYwM2JjOTFfMTctNS0xLTEtMA_6c1504cd-f4c3-4ba3-bc08-8f443b4ec895">6,443</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i27f4e53b91ad4367b7f8d273eff27769_D20210401-20210630" decimals="-3" sign="-" format="ixt:numdotdecimal" name="cron:AdjustedEarningsBeforeInterestTaxesDepreciationAndAmortization" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzY2E5YmIwMTc5MjQ3NmZiYjIyNWU1ZDlkZWM4NjlmL3NlYzo5M2NhOWJiMDE3OTI0NzZmYmIyMjVlNWQ5ZGVjODY5Zl81NS9mcmFnOjk0NGQ2N2RjOTNmMjQ1MjliZTc4ZmNlMzRiOGMyZTBiL3RhYmxlOjhlMGRhYjE1OGMzYTQyNTdhOWJkMTAzNzRmMDNiYzkxL3RhYmxlcmFuZ2U6OGUwZGFiMTU4YzNhNDI1N2E5YmQxMDM3NGYwM2JjOTFfMTctNy0xLTEtMA_d69df234-602f-48dc-8603-b607556daba7">49,759</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Purchase of property, plant and equipment, net</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2a563d1bc1a1451296d5f40e6cdf2912_D20210401-20210630" decimals="-3" name="us-gaap:PropertyPlantAndEquipmentAdditions" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzY2E5YmIwMTc5MjQ3NmZiYjIyNWU1ZDlkZWM4NjlmL3NlYzo5M2NhOWJiMDE3OTI0NzZmYmIyMjVlNWQ5ZGVjODY5Zl81NS9mcmFnOjk0NGQ2N2RjOTNmMjQ1MjliZTc4ZmNlMzRiOGMyZTBiL3RhYmxlOjhlMGRhYjE1OGMzYTQyNTdhOWJkMTAzNzRmMDNiYzkxL3RhYmxlcmFuZ2U6OGUwZGFiMTU4YzNhNDI1N2E5YmQxMDM3NGYwM2JjOTFfMTctMS0xLTEtMTcyMzc_730c3d32-bb68-49bd-a85d-60a2126170ed">239</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7b627a38d4bb4b2693a9598ca41f647d_D20210401-20210630" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:PropertyPlantAndEquipmentAdditions" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzY2E5YmIwMTc5MjQ3NmZiYjIyNWU1ZDlkZWM4NjlmL3NlYzo5M2NhOWJiMDE3OTI0NzZmYmIyMjVlNWQ5ZGVjODY5Zl81NS9mcmFnOjk0NGQ2N2RjOTNmMjQ1MjliZTc4ZmNlMzRiOGMyZTBiL3RhYmxlOjhlMGRhYjE1OGMzYTQyNTdhOWJkMTAzNzRmMDNiYzkxL3RhYmxlcmFuZ2U6OGUwZGFiMTU4YzNhNDI1N2E5YmQxMDM3NGYwM2JjOTFfMTctMy0xLTEtMTcyNDY_8cf62ce6-0392-410e-915f-e56cc01355d9">1,428</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie916e4a685544ae3998d4e82e089944f_D20210401-20210630" decimals="-3" format="ixt:zerodash" name="us-gaap:PropertyPlantAndEquipmentAdditions" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzY2E5YmIwMTc5MjQ3NmZiYjIyNWU1ZDlkZWM4NjlmL3NlYzo5M2NhOWJiMDE3OTI0NzZmYmIyMjVlNWQ5ZGVjODY5Zl81NS9mcmFnOjk0NGQ2N2RjOTNmMjQ1MjliZTc4ZmNlMzRiOGMyZTBiL3RhYmxlOjhlMGRhYjE1OGMzYTQyNTdhOWJkMTAzNzRmMDNiYzkxL3RhYmxlcmFuZ2U6OGUwZGFiMTU4YzNhNDI1N2E5YmQxMDM3NGYwM2JjOTFfMTctNS0xLTEtMTcyNDk_f526aa93-3c34-4f7b-a3da-4d4e5130f49c">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i27f4e53b91ad4367b7f8d273eff27769_D20210401-20210630" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:PropertyPlantAndEquipmentAdditions" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzY2E5YmIwMTc5MjQ3NmZiYjIyNWU1ZDlkZWM4NjlmL3NlYzo5M2NhOWJiMDE3OTI0NzZmYmIyMjVlNWQ5ZGVjODY5Zl81NS9mcmFnOjk0NGQ2N2RjOTNmMjQ1MjliZTc4ZmNlMzRiOGMyZTBiL3RhYmxlOjhlMGRhYjE1OGMzYTQyNTdhOWJkMTAzNzRmMDNiYzkxL3RhYmxlcmFuZ2U6OGUwZGFiMTU4YzNhNDI1N2E5YmQxMDM3NGYwM2JjOTFfMTctNy0xLTEtMTczNjk_1c7169c8-99b0-4309-9d0d-db244943d138">1,667</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr></table></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:49.316%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.566%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.772%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.566%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.772%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.566%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.772%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.570%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="21" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Three months ended June 30, 2020</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">United States</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Rest of World</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Corporate Expenses</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Total</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cannabis flower</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if56e63da868340a8ab5d3b79c974e6b3_D20200401-20200630" decimals="-3" format="ixt:zerodash" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzY2E5YmIwMTc5MjQ3NmZiYjIyNWU1ZDlkZWM4NjlmL3NlYzo5M2NhOWJiMDE3OTI0NzZmYmIyMjVlNWQ5ZGVjODY5Zl81NS9mcmFnOjk0NGQ2N2RjOTNmMjQ1MjliZTc4ZmNlMzRiOGMyZTBiL3RhYmxlOmVkMDExMzdmNzA1MjRmMGE5MzVlYzlhOTNmOGViMDc2L3RhYmxlcmFuZ2U6ZWQwMTEzN2Y3MDUyNGYwYTkzNWVjOWE5M2Y4ZWIwNzZfMy0xLTEtMS0xMzMz_2a5f3de2-f87c-43db-bfe6-7b14ac8a9b0f">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i15fc6f263af84b999d8cc92973692fbd_D20200401-20200630" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzY2E5YmIwMTc5MjQ3NmZiYjIyNWU1ZDlkZWM4NjlmL3NlYzo5M2NhOWJiMDE3OTI0NzZmYmIyMjVlNWQ5ZGVjODY5Zl81NS9mcmFnOjk0NGQ2N2RjOTNmMjQ1MjliZTc4ZmNlMzRiOGMyZTBiL3RhYmxlOmVkMDExMzdmNzA1MjRmMGE5MzVlYzlhOTNmOGViMDc2L3RhYmxlcmFuZ2U6ZWQwMTEzN2Y3MDUyNGYwYTkzNWVjOWE5M2Y4ZWIwNzZfMy0zLTEtMS0xMzMz_e5e9d8b7-969b-47b4-9774-c22317d011c2">5,674</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie5a13f5798a041098fb7986c993831fa_D20200401-20200630" decimals="-3" format="ixt:zerodash" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzY2E5YmIwMTc5MjQ3NmZiYjIyNWU1ZDlkZWM4NjlmL3NlYzo5M2NhOWJiMDE3OTI0NzZmYmIyMjVlNWQ5ZGVjODY5Zl81NS9mcmFnOjk0NGQ2N2RjOTNmMjQ1MjliZTc4ZmNlMzRiOGMyZTBiL3RhYmxlOmVkMDExMzdmNzA1MjRmMGE5MzVlYzlhOTNmOGViMDc2L3RhYmxlcmFuZ2U6ZWQwMTEzN2Y3MDUyNGYwYTkzNWVjOWE5M2Y4ZWIwNzZfMy01LTEtMS0xMzMz_fc787ad6-f668-4ee5-914b-8031bc262907">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib1f0e90ff5d24c28ad9bc0faf46f5377_D20200401-20200630" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzY2E5YmIwMTc5MjQ3NmZiYjIyNWU1ZDlkZWM4NjlmL3NlYzo5M2NhOWJiMDE3OTI0NzZmYmIyMjVlNWQ5ZGVjODY5Zl81NS9mcmFnOjk0NGQ2N2RjOTNmMjQ1MjliZTc4ZmNlMzRiOGMyZTBiL3RhYmxlOmVkMDExMzdmNzA1MjRmMGE5MzVlYzlhOTNmOGViMDc2L3RhYmxlcmFuZ2U6ZWQwMTEzN2Y3MDUyNGYwYTkzNWVjOWE5M2Y4ZWIwNzZfMi03LTEtMS0xNjIwMg_7a1531a4-6320-4d27-90ee-61b467466ca2">5,674</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cannabis extracts</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia93117ffad484ba8bac40f47a8a9f804_D20200401-20200630" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzY2E5YmIwMTc5MjQ3NmZiYjIyNWU1ZDlkZWM4NjlmL3NlYzo5M2NhOWJiMDE3OTI0NzZmYmIyMjVlNWQ5ZGVjODY5Zl81NS9mcmFnOjk0NGQ2N2RjOTNmMjQ1MjliZTc4ZmNlMzRiOGMyZTBiL3RhYmxlOmVkMDExMzdmNzA1MjRmMGE5MzVlYzlhOTNmOGViMDc2L3RhYmxlcmFuZ2U6ZWQwMTEzN2Y3MDUyNGYwYTkzNWVjOWE5M2Y4ZWIwNzZfNC0xLTEtMS0xMzMz_97bea40d-5049-40ce-ba21-c46661cfb4ab">2,174</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ifab67f8b4459455295c2fdc641d9dc00_D20200401-20200630" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzY2E5YmIwMTc5MjQ3NmZiYjIyNWU1ZDlkZWM4NjlmL3NlYzo5M2NhOWJiMDE3OTI0NzZmYmIyMjVlNWQ5ZGVjODY5Zl81NS9mcmFnOjk0NGQ2N2RjOTNmMjQ1MjliZTc4ZmNlMzRiOGMyZTBiL3RhYmxlOmVkMDExMzdmNzA1MjRmMGE5MzVlYzlhOTNmOGViMDc2L3RhYmxlcmFuZ2U6ZWQwMTEzN2Y3MDUyNGYwYTkzNWVjOWE5M2Y4ZWIwNzZfNC0zLTEtMS0xMzMz_27c26ff4-bfeb-4a6a-965e-e100e87dbfb4">1,917</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i59d84c3c73bb412f8ab90480b3f1cacb_D20200401-20200630" decimals="-3" format="ixt:zerodash" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzY2E5YmIwMTc5MjQ3NmZiYjIyNWU1ZDlkZWM4NjlmL3NlYzo5M2NhOWJiMDE3OTI0NzZmYmIyMjVlNWQ5ZGVjODY5Zl81NS9mcmFnOjk0NGQ2N2RjOTNmMjQ1MjliZTc4ZmNlMzRiOGMyZTBiL3RhYmxlOmVkMDExMzdmNzA1MjRmMGE5MzVlYzlhOTNmOGViMDc2L3RhYmxlcmFuZ2U6ZWQwMTEzN2Y3MDUyNGYwYTkzNWVjOWE5M2Y4ZWIwNzZfNC01LTEtMS0xMzMz_0d31fb89-1989-46fe-be2f-5c019f7ea009">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2ca82879f2e54a14819f3d3b95640a8e_D20200401-20200630" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzY2E5YmIwMTc5MjQ3NmZiYjIyNWU1ZDlkZWM4NjlmL3NlYzo5M2NhOWJiMDE3OTI0NzZmYmIyMjVlNWQ5ZGVjODY5Zl81NS9mcmFnOjk0NGQ2N2RjOTNmMjQ1MjliZTc4ZmNlMzRiOGMyZTBiL3RhYmxlOmVkMDExMzdmNzA1MjRmMGE5MzVlYzlhOTNmOGViMDc2L3RhYmxlcmFuZ2U6ZWQwMTEzN2Y3MDUyNGYwYTkzNWVjOWE5M2Y4ZWIwNzZfMy03LTEtMS0xNjIwMg_c7b193d3-e7ea-4fb1-9e5b-c67c8814e768">4,091</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i91b1c7740b954489b1fe2f441dc90430_D20200401-20200630" decimals="-3" format="ixt:zerodash" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzY2E5YmIwMTc5MjQ3NmZiYjIyNWU1ZDlkZWM4NjlmL3NlYzo5M2NhOWJiMDE3OTI0NzZmYmIyMjVlNWQ5ZGVjODY5Zl81NS9mcmFnOjk0NGQ2N2RjOTNmMjQ1MjliZTc4ZmNlMzRiOGMyZTBiL3RhYmxlOmVkMDExMzdmNzA1MjRmMGE5MzVlYzlhOTNmOGViMDc2L3RhYmxlcmFuZ2U6ZWQwMTEzN2Y3MDUyNGYwYTkzNWVjOWE5M2Y4ZWIwNzZfNS0xLTEtMS0xMzMz_5db23390-bf4a-4a8d-9c3e-76c4c8b6e679">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i37138226ae7b45ad97bc4468a768b4b1_D20200401-20200630" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzY2E5YmIwMTc5MjQ3NmZiYjIyNWU1ZDlkZWM4NjlmL3NlYzo5M2NhOWJiMDE3OTI0NzZmYmIyMjVlNWQ5ZGVjODY5Zl81NS9mcmFnOjk0NGQ2N2RjOTNmMjQ1MjliZTc4ZmNlMzRiOGMyZTBiL3RhYmxlOmVkMDExMzdmNzA1MjRmMGE5MzVlYzlhOTNmOGViMDc2L3RhYmxlcmFuZ2U6ZWQwMTEzN2Y3MDUyNGYwYTkzNWVjOWE5M2Y4ZWIwNzZfNS0zLTEtMS0xMzMz_2e3e4394-376b-4fb6-af6f-ce2b3ab7ab73">118</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id023d0b7d14c4eb9aba0197ea873d120_D20200401-20200630" decimals="-3" format="ixt:zerodash" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzY2E5YmIwMTc5MjQ3NmZiYjIyNWU1ZDlkZWM4NjlmL3NlYzo5M2NhOWJiMDE3OTI0NzZmYmIyMjVlNWQ5ZGVjODY5Zl81NS9mcmFnOjk0NGQ2N2RjOTNmMjQ1MjliZTc4ZmNlMzRiOGMyZTBiL3RhYmxlOmVkMDExMzdmNzA1MjRmMGE5MzVlYzlhOTNmOGViMDc2L3RhYmxlcmFuZ2U6ZWQwMTEzN2Y3MDUyNGYwYTkzNWVjOWE5M2Y4ZWIwNzZfNS01LTEtMS0xMzMz_07945778-aabe-4ba5-9509-645b868622e0">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8457d33e4cab43daac2e2e1046176545_D20200401-20200630" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzY2E5YmIwMTc5MjQ3NmZiYjIyNWU1ZDlkZWM4NjlmL3NlYzo5M2NhOWJiMDE3OTI0NzZmYmIyMjVlNWQ5ZGVjODY5Zl81NS9mcmFnOjk0NGQ2N2RjOTNmMjQ1MjliZTc4ZmNlMzRiOGMyZTBiL3RhYmxlOmVkMDExMzdmNzA1MjRmMGE5MzVlYzlhOTNmOGViMDc2L3RhYmxlcmFuZ2U6ZWQwMTEzN2Y3MDUyNGYwYTkzNWVjOWE5M2Y4ZWIwNzZfNC03LTEtMS0xNjIwMg_105f7454-4d5c-450c-9f1f-49cb87c6e3b6">118</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net revenue</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="icb85df07ebfc4bfa99c08f8c9f0cb89c_D20200401-20200630" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzY2E5YmIwMTc5MjQ3NmZiYjIyNWU1ZDlkZWM4NjlmL3NlYzo5M2NhOWJiMDE3OTI0NzZmYmIyMjVlNWQ5ZGVjODY5Zl81NS9mcmFnOjk0NGQ2N2RjOTNmMjQ1MjliZTc4ZmNlMzRiOGMyZTBiL3RhYmxlOmVkMDExMzdmNzA1MjRmMGE5MzVlYzlhOTNmOGViMDc2L3RhYmxlcmFuZ2U6ZWQwMTEzN2Y3MDUyNGYwYTkzNWVjOWE5M2Y4ZWIwNzZfNS0xLTEtMS0xNjIwMg_8f112d6b-2112-48c7-9166-c726a40c6290">2,174</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if83af42553ab4081bf67a6ecab2097fc_D20200401-20200630" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzY2E5YmIwMTc5MjQ3NmZiYjIyNWU1ZDlkZWM4NjlmL3NlYzo5M2NhOWJiMDE3OTI0NzZmYmIyMjVlNWQ5ZGVjODY5Zl81NS9mcmFnOjk0NGQ2N2RjOTNmMjQ1MjliZTc4ZmNlMzRiOGMyZTBiL3RhYmxlOmVkMDExMzdmNzA1MjRmMGE5MzVlYzlhOTNmOGViMDc2L3RhYmxlcmFuZ2U6ZWQwMTEzN2Y3MDUyNGYwYTkzNWVjOWE5M2Y4ZWIwNzZfNS0zLTEtMS0xNjIwMg_420f596f-a4d3-4b9f-94c0-5fed8968adf6">7,709</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i46e2093507a34f2fa6bcbc19a9aaaa63_D20200401-20200630" decimals="-3" format="ixt:zerodash" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzY2E5YmIwMTc5MjQ3NmZiYjIyNWU1ZDlkZWM4NjlmL3NlYzo5M2NhOWJiMDE3OTI0NzZmYmIyMjVlNWQ5ZGVjODY5Zl81NS9mcmFnOjk0NGQ2N2RjOTNmMjQ1MjliZTc4ZmNlMzRiOGMyZTBiL3RhYmxlOmVkMDExMzdmNzA1MjRmMGE5MzVlYzlhOTNmOGViMDc2L3RhYmxlcmFuZ2U6ZWQwMTEzN2Y3MDUyNGYwYTkzNWVjOWE5M2Y4ZWIwNzZfNS01LTEtMS0xNjIwMg_d1a4f77c-a65b-4139-a549-6205e62a5066">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i39065c5daf934af885335c12f3cfa83f_D20200401-20200630" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzY2E5YmIwMTc5MjQ3NmZiYjIyNWU1ZDlkZWM4NjlmL3NlYzo5M2NhOWJiMDE3OTI0NzZmYmIyMjVlNWQ5ZGVjODY5Zl81NS9mcmFnOjk0NGQ2N2RjOTNmMjQ1MjliZTc4ZmNlMzRiOGMyZTBiL3RhYmxlOmVkMDExMzdmNzA1MjRmMGE5MzVlYzlhOTNmOGViMDc2L3RhYmxlcmFuZ2U6ZWQwMTEzN2Y3MDUyNGYwYTkzNWVjOWE5M2Y4ZWIwNzZfNS03LTEtMS0xNjIwMg_08b5d34a-3c9d-410d-ac66-ce602d3d5bce">9,883</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Share of loss from equity accounted investments</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="icb85df07ebfc4bfa99c08f8c9f0cb89c_D20200401-20200630" decimals="-3" format="ixt:zerodash" name="us-gaap:IncomeLossFromEquityMethodInvestments" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzY2E5YmIwMTc5MjQ3NmZiYjIyNWU1ZDlkZWM4NjlmL3NlYzo5M2NhOWJiMDE3OTI0NzZmYmIyMjVlNWQ5ZGVjODY5Zl81NS9mcmFnOjk0NGQ2N2RjOTNmMjQ1MjliZTc4ZmNlMzRiOGMyZTBiL3RhYmxlOmVkMDExMzdmNzA1MjRmMGE5MzVlYzlhOTNmOGViMDc2L3RhYmxlcmFuZ2U6ZWQwMTEzN2Y3MDUyNGYwYTkzNWVjOWE5M2Y4ZWIwNzZfOC0xLTEtMS0xMzQz_a3fe5f04-b34a-4d6d-8368-97458a31214d">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if83af42553ab4081bf67a6ecab2097fc_D20200401-20200630" decimals="-3" sign="-" name="us-gaap:IncomeLossFromEquityMethodInvestments" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzY2E5YmIwMTc5MjQ3NmZiYjIyNWU1ZDlkZWM4NjlmL3NlYzo5M2NhOWJiMDE3OTI0NzZmYmIyMjVlNWQ5ZGVjODY5Zl81NS9mcmFnOjk0NGQ2N2RjOTNmMjQ1MjliZTc4ZmNlMzRiOGMyZTBiL3RhYmxlOmVkMDExMzdmNzA1MjRmMGE5MzVlYzlhOTNmOGViMDc2L3RhYmxlcmFuZ2U6ZWQwMTEzN2Y3MDUyNGYwYTkzNWVjOWE5M2Y4ZWIwNzZfOC0zLTEtMS0xMzQz_d81ffa5b-68eb-40f0-9ef3-96f2ceb46532">794</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i46e2093507a34f2fa6bcbc19a9aaaa63_D20200401-20200630" decimals="-3" format="ixt:zerodash" name="us-gaap:IncomeLossFromEquityMethodInvestments" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzY2E5YmIwMTc5MjQ3NmZiYjIyNWU1ZDlkZWM4NjlmL3NlYzo5M2NhOWJiMDE3OTI0NzZmYmIyMjVlNWQ5ZGVjODY5Zl81NS9mcmFnOjk0NGQ2N2RjOTNmMjQ1MjliZTc4ZmNlMzRiOGMyZTBiL3RhYmxlOmVkMDExMzdmNzA1MjRmMGE5MzVlYzlhOTNmOGViMDc2L3RhYmxlcmFuZ2U6ZWQwMTEzN2Y3MDUyNGYwYTkzNWVjOWE5M2Y4ZWIwNzZfOC01LTEtMS0xMzQz_28ef78bf-eccd-4c96-af7a-85820fcf7e3d">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i39065c5daf934af885335c12f3cfa83f_D20200401-20200630" decimals="-3" sign="-" name="us-gaap:IncomeLossFromEquityMethodInvestments" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzY2E5YmIwMTc5MjQ3NmZiYjIyNWU1ZDlkZWM4NjlmL3NlYzo5M2NhOWJiMDE3OTI0NzZmYmIyMjVlNWQ5ZGVjODY5Zl81NS9mcmFnOjk0NGQ2N2RjOTNmMjQ1MjliZTc4ZmNlMzRiOGMyZTBiL3RhYmxlOmVkMDExMzdmNzA1MjRmMGE5MzVlYzlhOTNmOGViMDc2L3RhYmxlcmFuZ2U6ZWQwMTEzN2Y3MDUyNGYwYTkzNWVjOWE5M2Y4ZWIwNzZfNy03LTEtMS0xNjIwNA_17e728e3-f8e8-4c8d-9666-b88de6033d92">794</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Interest income</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="icb85df07ebfc4bfa99c08f8c9f0cb89c_D20200401-20200630" decimals="-3" name="us-gaap:InvestmentIncomeInterest" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzY2E5YmIwMTc5MjQ3NmZiYjIyNWU1ZDlkZWM4NjlmL3NlYzo5M2NhOWJiMDE3OTI0NzZmYmIyMjVlNWQ5ZGVjODY5Zl81NS9mcmFnOjk0NGQ2N2RjOTNmMjQ1MjliZTc4ZmNlMzRiOGMyZTBiL3RhYmxlOmVkMDExMzdmNzA1MjRmMGE5MzVlYzlhOTNmOGViMDc2L3RhYmxlcmFuZ2U6ZWQwMTEzN2Y3MDUyNGYwYTkzNWVjOWE5M2Y4ZWIwNzZfMTAtMS0xLTEtMTM0Nw_0f846088-2edf-4055-b068-89fe73c4d3e2">9</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if83af42553ab4081bf67a6ecab2097fc_D20200401-20200630" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:InvestmentIncomeInterest" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzY2E5YmIwMTc5MjQ3NmZiYjIyNWU1ZDlkZWM4NjlmL3NlYzo5M2NhOWJiMDE3OTI0NzZmYmIyMjVlNWQ5ZGVjODY5Zl81NS9mcmFnOjk0NGQ2N2RjOTNmMjQ1MjliZTc4ZmNlMzRiOGMyZTBiL3RhYmxlOmVkMDExMzdmNzA1MjRmMGE5MzVlYzlhOTNmOGViMDc2L3RhYmxlcmFuZ2U6ZWQwMTEzN2Y3MDUyNGYwYTkzNWVjOWE5M2Y4ZWIwNzZfMTAtMy0xLTEtMTM0Nw_cd39280f-c889-4590-b8e6-a934d16839ca">3,808</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i46e2093507a34f2fa6bcbc19a9aaaa63_D20200401-20200630" decimals="-3" format="ixt:zerodash" name="us-gaap:InvestmentIncomeInterest" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzY2E5YmIwMTc5MjQ3NmZiYjIyNWU1ZDlkZWM4NjlmL3NlYzo5M2NhOWJiMDE3OTI0NzZmYmIyMjVlNWQ5ZGVjODY5Zl81NS9mcmFnOjk0NGQ2N2RjOTNmMjQ1MjliZTc4ZmNlMzRiOGMyZTBiL3RhYmxlOmVkMDExMzdmNzA1MjRmMGE5MzVlYzlhOTNmOGViMDc2L3RhYmxlcmFuZ2U6ZWQwMTEzN2Y3MDUyNGYwYTkzNWVjOWE5M2Y4ZWIwNzZfMTAtNS0xLTEtMTM0Nw_ab8afa46-6ae8-4280-ae20-1ddad99516bb">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i39065c5daf934af885335c12f3cfa83f_D20200401-20200630" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:InvestmentIncomeInterest" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzY2E5YmIwMTc5MjQ3NmZiYjIyNWU1ZDlkZWM4NjlmL3NlYzo5M2NhOWJiMDE3OTI0NzZmYmIyMjVlNWQ5ZGVjODY5Zl81NS9mcmFnOjk0NGQ2N2RjOTNmMjQ1MjliZTc4ZmNlMzRiOGMyZTBiL3RhYmxlOmVkMDExMzdmNzA1MjRmMGE5MzVlYzlhOTNmOGViMDc2L3RhYmxlcmFuZ2U6ZWQwMTEzN2Y3MDUyNGYwYTkzNWVjOWE5M2Y4ZWIwNzZfOS03LTEtMS0xNjIwNg_2abe7529-dc1e-4afc-b961-aeb6cf141aa1">3,817</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Interest expense</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="icb85df07ebfc4bfa99c08f8c9f0cb89c_D20200401-20200630" decimals="-3" format="ixt:zerodash" name="us-gaap:InterestExpense" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzY2E5YmIwMTc5MjQ3NmZiYjIyNWU1ZDlkZWM4NjlmL3NlYzo5M2NhOWJiMDE3OTI0NzZmYmIyMjVlNWQ5ZGVjODY5Zl81NS9mcmFnOjk0NGQ2N2RjOTNmMjQ1MjliZTc4ZmNlMzRiOGMyZTBiL3RhYmxlOmVkMDExMzdmNzA1MjRmMGE5MzVlYzlhOTNmOGViMDc2L3RhYmxlcmFuZ2U6ZWQwMTEzN2Y3MDUyNGYwYTkzNWVjOWE5M2Y4ZWIwNzZfMTEtMS0xLTEtMTM0Nw_84d42842-557b-484d-ac24-66672ae9a2d6">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="if83af42553ab4081bf67a6ecab2097fc_D20200401-20200630" decimals="-3" name="us-gaap:InterestExpense" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzY2E5YmIwMTc5MjQ3NmZiYjIyNWU1ZDlkZWM4NjlmL3NlYzo5M2NhOWJiMDE3OTI0NzZmYmIyMjVlNWQ5ZGVjODY5Zl81NS9mcmFnOjk0NGQ2N2RjOTNmMjQ1MjliZTc4ZmNlMzRiOGMyZTBiL3RhYmxlOmVkMDExMzdmNzA1MjRmMGE5MzVlYzlhOTNmOGViMDc2L3RhYmxlcmFuZ2U6ZWQwMTEzN2Y3MDUyNGYwYTkzNWVjOWE5M2Y4ZWIwNzZfMTEtMy0xLTEtMTM0Nw_3a5920c1-650d-407d-873d-f5ab17875aeb">83</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i46e2093507a34f2fa6bcbc19a9aaaa63_D20200401-20200630" decimals="-3" format="ixt:zerodash" name="us-gaap:InterestExpense" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzY2E5YmIwMTc5MjQ3NmZiYjIyNWU1ZDlkZWM4NjlmL3NlYzo5M2NhOWJiMDE3OTI0NzZmYmIyMjVlNWQ5ZGVjODY5Zl81NS9mcmFnOjk0NGQ2N2RjOTNmMjQ1MjliZTc4ZmNlMzRiOGMyZTBiL3RhYmxlOmVkMDExMzdmNzA1MjRmMGE5MzVlYzlhOTNmOGViMDc2L3RhYmxlcmFuZ2U6ZWQwMTEzN2Y3MDUyNGYwYTkzNWVjOWE5M2Y4ZWIwNzZfMTEtNS0xLTEtMTM0Nw_f291d225-4d3b-47d9-8cf6-a4e4e8bcfe3a">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i39065c5daf934af885335c12f3cfa83f_D20200401-20200630" decimals="-3" name="us-gaap:InterestExpense" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzY2E5YmIwMTc5MjQ3NmZiYjIyNWU1ZDlkZWM4NjlmL3NlYzo5M2NhOWJiMDE3OTI0NzZmYmIyMjVlNWQ5ZGVjODY5Zl81NS9mcmFnOjk0NGQ2N2RjOTNmMjQ1MjliZTc4ZmNlMzRiOGMyZTBiL3RhYmxlOmVkMDExMzdmNzA1MjRmMGE5MzVlYzlhOTNmOGViMDc2L3RhYmxlcmFuZ2U6ZWQwMTEzN2Y3MDUyNGYwYTkzNWVjOWE5M2Y4ZWIwNzZfMTAtNy0xLTEtMTYyMDY_2c70ed67-41c5-48e7-a095-881c123a677f">83</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Interest income, net</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="icb85df07ebfc4bfa99c08f8c9f0cb89c_D20200401-20200630" decimals="-3" name="us-gaap:InterestIncomeExpenseNonoperatingNet" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzY2E5YmIwMTc5MjQ3NmZiYjIyNWU1ZDlkZWM4NjlmL3NlYzo5M2NhOWJiMDE3OTI0NzZmYmIyMjVlNWQ5ZGVjODY5Zl81NS9mcmFnOjk0NGQ2N2RjOTNmMjQ1MjliZTc4ZmNlMzRiOGMyZTBiL3RhYmxlOmVkMDExMzdmNzA1MjRmMGE5MzVlYzlhOTNmOGViMDc2L3RhYmxlcmFuZ2U6ZWQwMTEzN2Y3MDUyNGYwYTkzNWVjOWE5M2Y4ZWIwNzZfMTEtMS0xLTEtMTYyMDY_bd32567a-e24b-4e02-b4c8-247598d5c801">9</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if83af42553ab4081bf67a6ecab2097fc_D20200401-20200630" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:InterestIncomeExpenseNonoperatingNet" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzY2E5YmIwMTc5MjQ3NmZiYjIyNWU1ZDlkZWM4NjlmL3NlYzo5M2NhOWJiMDE3OTI0NzZmYmIyMjVlNWQ5ZGVjODY5Zl81NS9mcmFnOjk0NGQ2N2RjOTNmMjQ1MjliZTc4ZmNlMzRiOGMyZTBiL3RhYmxlOmVkMDExMzdmNzA1MjRmMGE5MzVlYzlhOTNmOGViMDc2L3RhYmxlcmFuZ2U6ZWQwMTEzN2Y3MDUyNGYwYTkzNWVjOWE5M2Y4ZWIwNzZfMTEtMy0xLTEtMTYyMDY_b77efbd3-980e-463e-85ae-57795c573252">3,725</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i46e2093507a34f2fa6bcbc19a9aaaa63_D20200401-20200630" decimals="-3" format="ixt:zerodash" name="us-gaap:InterestIncomeExpenseNonoperatingNet" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzY2E5YmIwMTc5MjQ3NmZiYjIyNWU1ZDlkZWM4NjlmL3NlYzo5M2NhOWJiMDE3OTI0NzZmYmIyMjVlNWQ5ZGVjODY5Zl81NS9mcmFnOjk0NGQ2N2RjOTNmMjQ1MjliZTc4ZmNlMzRiOGMyZTBiL3RhYmxlOmVkMDExMzdmNzA1MjRmMGE5MzVlYzlhOTNmOGViMDc2L3RhYmxlcmFuZ2U6ZWQwMTEzN2Y3MDUyNGYwYTkzNWVjOWE5M2Y4ZWIwNzZfMTEtNS0xLTEtMTYyMDY_609cad11-bf31-45b7-9f36-c6e9a50f66ad">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i39065c5daf934af885335c12f3cfa83f_D20200401-20200630" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:InterestIncomeExpenseNonoperatingNet" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzY2E5YmIwMTc5MjQ3NmZiYjIyNWU1ZDlkZWM4NjlmL3NlYzo5M2NhOWJiMDE3OTI0NzZmYmIyMjVlNWQ5ZGVjODY5Zl81NS9mcmFnOjk0NGQ2N2RjOTNmMjQ1MjliZTc4ZmNlMzRiOGMyZTBiL3RhYmxlOmVkMDExMzdmNzA1MjRmMGE5MzVlYzlhOTNmOGViMDc2L3RhYmxlcmFuZ2U6ZWQwMTEzN2Y3MDUyNGYwYTkzNWVjOWE5M2Y4ZWIwNzZfMTEtNy0xLTEtMTYyMDY_efc35f66-ba04-4838-83e4-fe162b200f78">3,734</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total assets</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i702a586f0ecb4fc1b7bfe544770fb520_I20200630" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:Assets" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzY2E5YmIwMTc5MjQ3NmZiYjIyNWU1ZDlkZWM4NjlmL3NlYzo5M2NhOWJiMDE3OTI0NzZmYmIyMjVlNWQ5ZGVjODY5Zl81NS9mcmFnOjk0NGQ2N2RjOTNmMjQ1MjliZTc4ZmNlMzRiOGMyZTBiL3RhYmxlOmVkMDExMzdmNzA1MjRmMGE5MzVlYzlhOTNmOGViMDc2L3RhYmxlcmFuZ2U6ZWQwMTEzN2Y3MDUyNGYwYTkzNWVjOWE5M2Y4ZWIwNzZfMTMtMS0xLTEtMTg0NDg_8e663f09-901c-40ed-baa1-8ffe06db5c1e">250,470</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if4396fb40fd54b7faa91c1e910136a74_I20200630" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:Assets" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzY2E5YmIwMTc5MjQ3NmZiYjIyNWU1ZDlkZWM4NjlmL3NlYzo5M2NhOWJiMDE3OTI0NzZmYmIyMjVlNWQ5ZGVjODY5Zl81NS9mcmFnOjk0NGQ2N2RjOTNmMjQ1MjliZTc4ZmNlMzRiOGMyZTBiL3RhYmxlOmVkMDExMzdmNzA1MjRmMGE5MzVlYzlhOTNmOGViMDc2L3RhYmxlcmFuZ2U6ZWQwMTEzN2Y3MDUyNGYwYTkzNWVjOWE5M2Y4ZWIwNzZfMTMtMy0xLTEtMTg0NDg_8f416a52-504d-4659-b177-51a13822d4a2">348,569</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iad52c8a5170c4f5bbeca5c035dd90f4e_I20200630" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:Assets" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzY2E5YmIwMTc5MjQ3NmZiYjIyNWU1ZDlkZWM4NjlmL3NlYzo5M2NhOWJiMDE3OTI0NzZmYmIyMjVlNWQ5ZGVjODY5Zl81NS9mcmFnOjk0NGQ2N2RjOTNmMjQ1MjliZTc4ZmNlMzRiOGMyZTBiL3RhYmxlOmVkMDExMzdmNzA1MjRmMGE5MzVlYzlhOTNmOGViMDc2L3RhYmxlcmFuZ2U6ZWQwMTEzN2Y3MDUyNGYwYTkzNWVjOWE5M2Y4ZWIwNzZfMTMtNS0xLTEtMTg0NDg_91101b96-2db3-48f2-8b70-41f23ed8c047">1,311,248</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id670dc9b33e6430f9d7510009f7495a7_I20200630" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:Assets" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzY2E5YmIwMTc5MjQ3NmZiYjIyNWU1ZDlkZWM4NjlmL3NlYzo5M2NhOWJiMDE3OTI0NzZmYmIyMjVlNWQ5ZGVjODY5Zl81NS9mcmFnOjk0NGQ2N2RjOTNmMjQ1MjliZTc4ZmNlMzRiOGMyZTBiL3RhYmxlOmVkMDExMzdmNzA1MjRmMGE5MzVlYzlhOTNmOGViMDc2L3RhYmxlcmFuZ2U6ZWQwMTEzN2Y3MDUyNGYwYTkzNWVjOWE5M2Y4ZWIwNzZfMTMtNy0xLTEtMjA3NzA_8b17fee5-34b1-419e-8c5f-a13cb137fce3">1,910,287</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Depreciation and amortization</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="icb85df07ebfc4bfa99c08f8c9f0cb89c_D20200401-20200630" decimals="-3" name="us-gaap:DepreciationAndAmortization" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzY2E5YmIwMTc5MjQ3NmZiYjIyNWU1ZDlkZWM4NjlmL3NlYzo5M2NhOWJiMDE3OTI0NzZmYmIyMjVlNWQ5ZGVjODY5Zl81NS9mcmFnOjk0NGQ2N2RjOTNmMjQ1MjliZTc4ZmNlMzRiOGMyZTBiL3RhYmxlOmVkMDExMzdmNzA1MjRmMGE5MzVlYzlhOTNmOGViMDc2L3RhYmxlcmFuZ2U6ZWQwMTEzN2Y3MDUyNGYwYTkzNWVjOWE5M2Y4ZWIwNzZfMTUtMS0xLTEtMTM1Ng_682e495b-b8be-48aa-bfd4-0b28e5baa246">36</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if83af42553ab4081bf67a6ecab2097fc_D20200401-20200630" decimals="-3" name="us-gaap:DepreciationAndAmortization" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzY2E5YmIwMTc5MjQ3NmZiYjIyNWU1ZDlkZWM4NjlmL3NlYzo5M2NhOWJiMDE3OTI0NzZmYmIyMjVlNWQ5ZGVjODY5Zl81NS9mcmFnOjk0NGQ2N2RjOTNmMjQ1MjliZTc4ZmNlMzRiOGMyZTBiL3RhYmxlOmVkMDExMzdmNzA1MjRmMGE5MzVlYzlhOTNmOGViMDc2L3RhYmxlcmFuZ2U6ZWQwMTEzN2Y3MDUyNGYwYTkzNWVjOWE5M2Y4ZWIwNzZfMTUtMy0xLTEtMTM1Ng_5ac469e1-4e74-4c7a-b126-bf01bfec0299">643</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i46e2093507a34f2fa6bcbc19a9aaaa63_D20200401-20200630" decimals="-3" format="ixt:zerodash" name="us-gaap:DepreciationAndAmortization" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzY2E5YmIwMTc5MjQ3NmZiYjIyNWU1ZDlkZWM4NjlmL3NlYzo5M2NhOWJiMDE3OTI0NzZmYmIyMjVlNWQ5ZGVjODY5Zl81NS9mcmFnOjk0NGQ2N2RjOTNmMjQ1MjliZTc4ZmNlMzRiOGMyZTBiL3RhYmxlOmVkMDExMzdmNzA1MjRmMGE5MzVlYzlhOTNmOGViMDc2L3RhYmxlcmFuZ2U6ZWQwMTEzN2Y3MDUyNGYwYTkzNWVjOWE5M2Y4ZWIwNzZfMTUtNS0xLTEtMTM1Ng_1a542e9b-7a6e-4567-b2cd-f04686ea33da">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i39065c5daf934af885335c12f3cfa83f_D20200401-20200630" decimals="-3" name="us-gaap:DepreciationAndAmortization" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzY2E5YmIwMTc5MjQ3NmZiYjIyNWU1ZDlkZWM4NjlmL3NlYzo5M2NhOWJiMDE3OTI0NzZmYmIyMjVlNWQ5ZGVjODY5Zl81NS9mcmFnOjk0NGQ2N2RjOTNmMjQ1MjliZTc4ZmNlMzRiOGMyZTBiL3RhYmxlOmVkMDExMzdmNzA1MjRmMGE5MzVlYzlhOTNmOGViMDc2L3RhYmxlcmFuZ2U6ZWQwMTEzN2Y3MDUyNGYwYTkzNWVjOWE5M2Y4ZWIwNzZfMTMtNy0xLTEtMTYyMDg_10624d13-4308-448d-83e8-3baf618fd51e">679</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Impairment loss on long-lived assets</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="icb85df07ebfc4bfa99c08f8c9f0cb89c_D20200401-20200630" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:OperatingLeaseRightOfUseAssetAmortizationExpense" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzY2E5YmIwMTc5MjQ3NmZiYjIyNWU1ZDlkZWM4NjlmL3NlYzo5M2NhOWJiMDE3OTI0NzZmYmIyMjVlNWQ5ZGVjODY5Zl81NS9mcmFnOjk0NGQ2N2RjOTNmMjQ1MjliZTc4ZmNlMzRiOGMyZTBiL3RhYmxlOmVkMDExMzdmNzA1MjRmMGE5MzVlYzlhOTNmOGViMDc2L3RhYmxlcmFuZ2U6ZWQwMTEzN2Y3MDUyNGYwYTkzNWVjOWE5M2Y4ZWIwNzZfMTUtMS0xLTEtNDg2Nw_7fde9b16-52b6-4127-a601-fa3e4d64a58e">40,000</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if83af42553ab4081bf67a6ecab2097fc_D20200401-20200630" decimals="-3" format="ixt:zerodash" name="us-gaap:OperatingLeaseRightOfUseAssetAmortizationExpense" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzY2E5YmIwMTc5MjQ3NmZiYjIyNWU1ZDlkZWM4NjlmL3NlYzo5M2NhOWJiMDE3OTI0NzZmYmIyMjVlNWQ5ZGVjODY5Zl81NS9mcmFnOjk0NGQ2N2RjOTNmMjQ1MjliZTc4ZmNlMzRiOGMyZTBiL3RhYmxlOmVkMDExMzdmNzA1MjRmMGE5MzVlYzlhOTNmOGViMDc2L3RhYmxlcmFuZ2U6ZWQwMTEzN2Y3MDUyNGYwYTkzNWVjOWE5M2Y4ZWIwNzZfMTUtMy0xLTEtNDg2Nw_a526966b-225b-4a58-a897-c1e184576be9">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i46e2093507a34f2fa6bcbc19a9aaaa63_D20200401-20200630" decimals="-3" format="ixt:zerodash" name="us-gaap:OperatingLeaseRightOfUseAssetAmortizationExpense" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzY2E5YmIwMTc5MjQ3NmZiYjIyNWU1ZDlkZWM4NjlmL3NlYzo5M2NhOWJiMDE3OTI0NzZmYmIyMjVlNWQ5ZGVjODY5Zl81NS9mcmFnOjk0NGQ2N2RjOTNmMjQ1MjliZTc4ZmNlMzRiOGMyZTBiL3RhYmxlOmVkMDExMzdmNzA1MjRmMGE5MzVlYzlhOTNmOGViMDc2L3RhYmxlcmFuZ2U6ZWQwMTEzN2Y3MDUyNGYwYTkzNWVjOWE5M2Y4ZWIwNzZfMTUtNS0xLTEtNDg2Nw_d744cfce-d143-4b03-be3f-3a21bcc1d416">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i39065c5daf934af885335c12f3cfa83f_D20200401-20200630" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:OperatingLeaseRightOfUseAssetAmortizationExpense" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzY2E5YmIwMTc5MjQ3NmZiYjIyNWU1ZDlkZWM4NjlmL3NlYzo5M2NhOWJiMDE3OTI0NzZmYmIyMjVlNWQ5ZGVjODY5Zl81NS9mcmFnOjk0NGQ2N2RjOTNmMjQ1MjliZTc4ZmNlMzRiOGMyZTBiL3RhYmxlOmVkMDExMzdmNzA1MjRmMGE5MzVlYzlhOTNmOGViMDc2L3RhYmxlcmFuZ2U6ZWQwMTEzN2Y3MDUyNGYwYTkzNWVjOWE5M2Y4ZWIwNzZfMTUtNy0xLTEtNDg2Nw_be4bacd7-728e-4b3b-8252-586c18849d14">40,000</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Adjusted EBITDA</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="icb85df07ebfc4bfa99c08f8c9f0cb89c_D20200401-20200630" decimals="-3" sign="-" format="ixt:numdotdecimal" name="cron:AdjustedEarningsBeforeInterestTaxesDepreciationAndAmortization" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzY2E5YmIwMTc5MjQ3NmZiYjIyNWU1ZDlkZWM4NjlmL3NlYzo5M2NhOWJiMDE3OTI0NzZmYmIyMjVlNWQ5ZGVjODY5Zl81NS9mcmFnOjk0NGQ2N2RjOTNmMjQ1MjliZTc4ZmNlMzRiOGMyZTBiL3RhYmxlOmVkMDExMzdmNzA1MjRmMGE5MzVlYzlhOTNmOGViMDc2L3RhYmxlcmFuZ2U6ZWQwMTEzN2Y3MDUyNGYwYTkzNWVjOWE5M2Y4ZWIwNzZfMTctMS0xLTEtMTM2Mg_f39c239b-6e9f-4165-91de-66906c4f739b">4,785</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="if83af42553ab4081bf67a6ecab2097fc_D20200401-20200630" decimals="-3" sign="-" format="ixt:numdotdecimal" name="cron:AdjustedEarningsBeforeInterestTaxesDepreciationAndAmortization" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzY2E5YmIwMTc5MjQ3NmZiYjIyNWU1ZDlkZWM4NjlmL3NlYzo5M2NhOWJiMDE3OTI0NzZmYmIyMjVlNWQ5ZGVjODY5Zl81NS9mcmFnOjk0NGQ2N2RjOTNmMjQ1MjliZTc4ZmNlMzRiOGMyZTBiL3RhYmxlOmVkMDExMzdmNzA1MjRmMGE5MzVlYzlhOTNmOGViMDc2L3RhYmxlcmFuZ2U6ZWQwMTEzN2Y3MDUyNGYwYTkzNWVjOWE5M2Y4ZWIwNzZfMTctMy0xLTEtMTM2Mg_023c4e51-5cfc-42d9-95c0-0f1493e1c17b">18,618</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i46e2093507a34f2fa6bcbc19a9aaaa63_D20200401-20200630" decimals="-3" sign="-" format="ixt:numdotdecimal" name="cron:AdjustedEarningsBeforeInterestTaxesDepreciationAndAmortization" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzY2E5YmIwMTc5MjQ3NmZiYjIyNWU1ZDlkZWM4NjlmL3NlYzo5M2NhOWJiMDE3OTI0NzZmYmIyMjVlNWQ5ZGVjODY5Zl81NS9mcmFnOjk0NGQ2N2RjOTNmMjQ1MjliZTc4ZmNlMzRiOGMyZTBiL3RhYmxlOmVkMDExMzdmNzA1MjRmMGE5MzVlYzlhOTNmOGViMDc2L3RhYmxlcmFuZ2U6ZWQwMTEzN2Y3MDUyNGYwYTkzNWVjOWE5M2Y4ZWIwNzZfMTctNS0xLTEtMTM2Mg_482e1c1e-9085-4940-9fb9-a0b304384c10">3,583</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i39065c5daf934af885335c12f3cfa83f_D20200401-20200630" decimals="-3" sign="-" format="ixt:numdotdecimal" name="cron:AdjustedEarningsBeforeInterestTaxesDepreciationAndAmortization" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzY2E5YmIwMTc5MjQ3NmZiYjIyNWU1ZDlkZWM4NjlmL3NlYzo5M2NhOWJiMDE3OTI0NzZmYmIyMjVlNWQ5ZGVjODY5Zl81NS9mcmFnOjk0NGQ2N2RjOTNmMjQ1MjliZTc4ZmNlMzRiOGMyZTBiL3RhYmxlOmVkMDExMzdmNzA1MjRmMGE5MzVlYzlhOTNmOGViMDc2L3RhYmxlcmFuZ2U6ZWQwMTEzN2Y3MDUyNGYwYTkzNWVjOWE5M2Y4ZWIwNzZfMTYtNy0xLTEtMTYyMDg_857c2eef-6ea3-4079-8be6-c1a73409a36c">26,986</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Purchase of property, plant and equipment, net</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="icb85df07ebfc4bfa99c08f8c9f0cb89c_D20200401-20200630" decimals="-3" name="us-gaap:PropertyPlantAndEquipmentAdditions" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzY2E5YmIwMTc5MjQ3NmZiYjIyNWU1ZDlkZWM4NjlmL3NlYzo5M2NhOWJiMDE3OTI0NzZmYmIyMjVlNWQ5ZGVjODY5Zl81NS9mcmFnOjk0NGQ2N2RjOTNmMjQ1MjliZTc4ZmNlMzRiOGMyZTBiL3RhYmxlOmVkMDExMzdmNzA1MjRmMGE5MzVlYzlhOTNmOGViMDc2L3RhYmxlcmFuZ2U6ZWQwMTEzN2Y3MDUyNGYwYTkzNWVjOWE5M2Y4ZWIwNzZfMTctMS0xLTEtMTczMDY_fa82f900-fafa-436b-be8f-77efe39ffbd3">39</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if83af42553ab4081bf67a6ecab2097fc_D20200401-20200630" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:PropertyPlantAndEquipmentAdditions" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzY2E5YmIwMTc5MjQ3NmZiYjIyNWU1ZDlkZWM4NjlmL3NlYzo5M2NhOWJiMDE3OTI0NzZmYmIyMjVlNWQ5ZGVjODY5Zl81NS9mcmFnOjk0NGQ2N2RjOTNmMjQ1MjliZTc4ZmNlMzRiOGMyZTBiL3RhYmxlOmVkMDExMzdmNzA1MjRmMGE5MzVlYzlhOTNmOGViMDc2L3RhYmxlcmFuZ2U6ZWQwMTEzN2Y3MDUyNGYwYTkzNWVjOWE5M2Y4ZWIwNzZfMTctMy0xLTEtMTczMDk_e3dcfd0d-a8b1-43de-a11f-81faab3eb0ca">6,894</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i46e2093507a34f2fa6bcbc19a9aaaa63_D20200401-20200630" decimals="-3" format="ixt:zerodash" name="us-gaap:PropertyPlantAndEquipmentAdditions" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzY2E5YmIwMTc5MjQ3NmZiYjIyNWU1ZDlkZWM4NjlmL3NlYzo5M2NhOWJiMDE3OTI0NzZmYmIyMjVlNWQ5ZGVjODY5Zl81NS9mcmFnOjk0NGQ2N2RjOTNmMjQ1MjliZTc4ZmNlMzRiOGMyZTBiL3RhYmxlOmVkMDExMzdmNzA1MjRmMGE5MzVlYzlhOTNmOGViMDc2L3RhYmxlcmFuZ2U6ZWQwMTEzN2Y3MDUyNGYwYTkzNWVjOWE5M2Y4ZWIwNzZfMTctNS0xLTEtMTczMTI_10cbea11-8c2e-4c49-81c4-97acedde1b90">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i39065c5daf934af885335c12f3cfa83f_D20200401-20200630" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:PropertyPlantAndEquipmentAdditions" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzY2E5YmIwMTc5MjQ3NmZiYjIyNWU1ZDlkZWM4NjlmL3NlYzo5M2NhOWJiMDE3OTI0NzZmYmIyMjVlNWQ5ZGVjODY5Zl81NS9mcmFnOjk0NGQ2N2RjOTNmMjQ1MjliZTc4ZmNlMzRiOGMyZTBiL3RhYmxlOmVkMDExMzdmNzA1MjRmMGE5MzVlYzlhOTNmOGViMDc2L3RhYmxlcmFuZ2U6ZWQwMTEzN2Y3MDUyNGYwYTkzNWVjOWE5M2Y4ZWIwNzZfMTctNy0xLTEtMTczNzI_ab991bab-95b0-474a-9f23-8796bca75c9e">6,933</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div></ix:nonNumeric></ix:continuation><div style="margin-bottom:6pt;margin-top:3pt;text-align:justify"><span><br/></span></div><div style="height:36pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">21</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:72pt;width:100%"><div style="margin-top:0.55pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:95.000%"><tr><td style="width:1.0%"></td><td style="width:65.712%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:32.088%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="border-top:1pt solid #FFFFFF;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Cronos Group Inc.</span></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Notes to Condensed Consolidated Financial Statements (Unaudited)</span></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">(In thousands of $, except share amounts)</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i93ca9bb01792476fbb225e5d9dec869f_7">Table of Contents</a></span></div></td></tr></table></div></div><ix:continuation id="i10d1eef574204b548ac3ab5a07c24842" continuedAt="i5166505034c14d3db46b76423c5b74d3"><ix:continuation id="ib015cfd120634e7b8bb13c1ff6157ed5" continuedAt="i94e8d24753c34f368f84aa4553a44685"><div style="margin-bottom:12pt;margin-top:6pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:49.316%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.566%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.772%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.566%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.772%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.566%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.772%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.570%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="21" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Six months ended June&#160;30, 2021</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">United States</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Rest of World</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Corporate Expenses</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Total</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cannabis flower</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia1fd0c77f444432fbb955ee120f3e358_D20210101-20210630" decimals="-3" format="ixt:zerodash" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzY2E5YmIwMTc5MjQ3NmZiYjIyNWU1ZDlkZWM4NjlmL3NlYzo5M2NhOWJiMDE3OTI0NzZmYmIyMjVlNWQ5ZGVjODY5Zl81NS9mcmFnOjk0NGQ2N2RjOTNmMjQ1MjliZTc4ZmNlMzRiOGMyZTBiL3RhYmxlOjA0NzkyNmRhYWViMzQxYWY4MzY2OWVhN2M4NjhiY2I0L3RhYmxlcmFuZ2U6MDQ3OTI2ZGFhZWIzNDFhZjgzNjY5ZWE3Yzg2OGJjYjRfMy0xLTEtMS0xMjU5_3e78ff5f-a89b-43f6-b0d0-0b9e498ced63">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1c1529d67f66409e980a87cdbacae6d9_D20210101-20210630" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzY2E5YmIwMTc5MjQ3NmZiYjIyNWU1ZDlkZWM4NjlmL3NlYzo5M2NhOWJiMDE3OTI0NzZmYmIyMjVlNWQ5ZGVjODY5Zl81NS9mcmFnOjk0NGQ2N2RjOTNmMjQ1MjliZTc4ZmNlMzRiOGMyZTBiL3RhYmxlOjA0NzkyNmRhYWViMzQxYWY4MzY2OWVhN2M4NjhiY2I0L3RhYmxlcmFuZ2U6MDQ3OTI2ZGFhZWIzNDFhZjgzNjY5ZWE3Yzg2OGJjYjRfMy0zLTEtMS0xMjc1_e182321c-c052-4a74-8144-4492c7d74c88">21,031</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ifb7f0980f81c42e9b5667c26408eec94_D20210101-20210630" decimals="-3" format="ixt:zerodash" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzY2E5YmIwMTc5MjQ3NmZiYjIyNWU1ZDlkZWM4NjlmL3NlYzo5M2NhOWJiMDE3OTI0NzZmYmIyMjVlNWQ5ZGVjODY5Zl81NS9mcmFnOjk0NGQ2N2RjOTNmMjQ1MjliZTc4ZmNlMzRiOGMyZTBiL3RhYmxlOjA0NzkyNmRhYWViMzQxYWY4MzY2OWVhN2M4NjhiY2I0L3RhYmxlcmFuZ2U6MDQ3OTI2ZGFhZWIzNDFhZjgzNjY5ZWE3Yzg2OGJjYjRfMy01LTEtMS0xMjc5_48d7172b-efb9-44d7-8345-7846ed1511d8">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3f039d262efd4662b7daf3bd025bd767_D20210101-20210630" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzY2E5YmIwMTc5MjQ3NmZiYjIyNWU1ZDlkZWM4NjlmL3NlYzo5M2NhOWJiMDE3OTI0NzZmYmIyMjVlNWQ5ZGVjODY5Zl81NS9mcmFnOjk0NGQ2N2RjOTNmMjQ1MjliZTc4ZmNlMzRiOGMyZTBiL3RhYmxlOjA0NzkyNmRhYWViMzQxYWY4MzY2OWVhN2M4NjhiY2I0L3RhYmxlcmFuZ2U6MDQ3OTI2ZGFhZWIzNDFhZjgzNjY5ZWE3Yzg2OGJjYjRfMi03LTEtMS0xNjIxMA_70212a95-03e0-499d-9fa9-e592e53a86f8">21,031</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cannabis extracts</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4f7819da7513417abd35056f14170574_D20210101-20210630" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzY2E5YmIwMTc5MjQ3NmZiYjIyNWU1ZDlkZWM4NjlmL3NlYzo5M2NhOWJiMDE3OTI0NzZmYmIyMjVlNWQ5ZGVjODY5Zl81NS9mcmFnOjk0NGQ2N2RjOTNmMjQ1MjliZTc4ZmNlMzRiOGMyZTBiL3RhYmxlOjA0NzkyNmRhYWViMzQxYWY4MzY2OWVhN2M4NjhiY2I0L3RhYmxlcmFuZ2U6MDQ3OTI2ZGFhZWIzNDFhZjgzNjY5ZWE3Yzg2OGJjYjRfNC0xLTEtMS0xMjU5_ef88475b-782b-45fc-9f47-8c57644eb927">4,668</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2a692272db324fad8fd9591624ebee99_D20210101-20210630" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzY2E5YmIwMTc5MjQ3NmZiYjIyNWU1ZDlkZWM4NjlmL3NlYzo5M2NhOWJiMDE3OTI0NzZmYmIyMjVlNWQ5ZGVjODY5Zl81NS9mcmFnOjk0NGQ2N2RjOTNmMjQ1MjliZTc4ZmNlMzRiOGMyZTBiL3RhYmxlOjA0NzkyNmRhYWViMzQxYWY4MzY2OWVhN2M4NjhiY2I0L3RhYmxlcmFuZ2U6MDQ3OTI2ZGFhZWIzNDFhZjgzNjY5ZWE3Yzg2OGJjYjRfNC0zLTEtMS0xMjc1_a6bfb8ec-7103-4e5f-b767-5c570b2d6ff6">2,234</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic645ffe32db24fe886c9079930540947_D20210101-20210630" decimals="-3" format="ixt:zerodash" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzY2E5YmIwMTc5MjQ3NmZiYjIyNWU1ZDlkZWM4NjlmL3NlYzo5M2NhOWJiMDE3OTI0NzZmYmIyMjVlNWQ5ZGVjODY5Zl81NS9mcmFnOjk0NGQ2N2RjOTNmMjQ1MjliZTc4ZmNlMzRiOGMyZTBiL3RhYmxlOjA0NzkyNmRhYWViMzQxYWY4MzY2OWVhN2M4NjhiY2I0L3RhYmxlcmFuZ2U6MDQ3OTI2ZGFhZWIzNDFhZjgzNjY5ZWE3Yzg2OGJjYjRfNC01LTEtMS0xMjc5_145ba5fb-eaa0-4a22-b73e-714f72503d8e">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i28cc601c4515423c9fb7c740926652a1_D20210101-20210630" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzY2E5YmIwMTc5MjQ3NmZiYjIyNWU1ZDlkZWM4NjlmL3NlYzo5M2NhOWJiMDE3OTI0NzZmYmIyMjVlNWQ5ZGVjODY5Zl81NS9mcmFnOjk0NGQ2N2RjOTNmMjQ1MjliZTc4ZmNlMzRiOGMyZTBiL3RhYmxlOjA0NzkyNmRhYWViMzQxYWY4MzY2OWVhN2M4NjhiY2I0L3RhYmxlcmFuZ2U6MDQ3OTI2ZGFhZWIzNDFhZjgzNjY5ZWE3Yzg2OGJjYjRfMy03LTEtMS0xNjIxMA_714e0cdb-4dc7-4a9b-9f89-19bfc04f59d9">6,902</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iaa3896f04f0b4ffa95465aa6125063d6_D20210101-20210630" decimals="-3" format="ixt:zerodash" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzY2E5YmIwMTc5MjQ3NmZiYjIyNWU1ZDlkZWM4NjlmL3NlYzo5M2NhOWJiMDE3OTI0NzZmYmIyMjVlNWQ5ZGVjODY5Zl81NS9mcmFnOjk0NGQ2N2RjOTNmMjQ1MjliZTc4ZmNlMzRiOGMyZTBiL3RhYmxlOjA0NzkyNmRhYWViMzQxYWY4MzY2OWVhN2M4NjhiY2I0L3RhYmxlcmFuZ2U6MDQ3OTI2ZGFhZWIzNDFhZjgzNjY5ZWE3Yzg2OGJjYjRfNS0xLTEtMS0xMjU5_f87f1f3b-0405-470a-8f87-a8392c6f86fd">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if969ee02513f48cdb95de50cc1bb0d51_D20210101-20210630" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzY2E5YmIwMTc5MjQ3NmZiYjIyNWU1ZDlkZWM4NjlmL3NlYzo5M2NhOWJiMDE3OTI0NzZmYmIyMjVlNWQ5ZGVjODY5Zl81NS9mcmFnOjk0NGQ2N2RjOTNmMjQ1MjliZTc4ZmNlMzRiOGMyZTBiL3RhYmxlOjA0NzkyNmRhYWViMzQxYWY4MzY2OWVhN2M4NjhiY2I0L3RhYmxlcmFuZ2U6MDQ3OTI2ZGFhZWIzNDFhZjgzNjY5ZWE3Yzg2OGJjYjRfNS0zLTEtMS0xMjc1_42ebefcf-43eb-4fd6-8a08-6a645cb8b97a">300</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2fd2e11500cb4edfaa54ab9e521c7c86_D20210101-20210630" decimals="-3" format="ixt:zerodash" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzY2E5YmIwMTc5MjQ3NmZiYjIyNWU1ZDlkZWM4NjlmL3NlYzo5M2NhOWJiMDE3OTI0NzZmYmIyMjVlNWQ5ZGVjODY5Zl81NS9mcmFnOjk0NGQ2N2RjOTNmMjQ1MjliZTc4ZmNlMzRiOGMyZTBiL3RhYmxlOjA0NzkyNmRhYWViMzQxYWY4MzY2OWVhN2M4NjhiY2I0L3RhYmxlcmFuZ2U6MDQ3OTI2ZGFhZWIzNDFhZjgzNjY5ZWE3Yzg2OGJjYjRfNS01LTEtMS0xMjc5_ec85d8ce-e5a8-47a4-8377-b3ba76463761">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1c31a39a4c79400497380f76939db7df_D20210101-20210630" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzY2E5YmIwMTc5MjQ3NmZiYjIyNWU1ZDlkZWM4NjlmL3NlYzo5M2NhOWJiMDE3OTI0NzZmYmIyMjVlNWQ5ZGVjODY5Zl81NS9mcmFnOjk0NGQ2N2RjOTNmMjQ1MjliZTc4ZmNlMzRiOGMyZTBiL3RhYmxlOjA0NzkyNmRhYWViMzQxYWY4MzY2OWVhN2M4NjhiY2I0L3RhYmxlcmFuZ2U6MDQ3OTI2ZGFhZWIzNDFhZjgzNjY5ZWE3Yzg2OGJjYjRfNC03LTEtMS0xNjIxMA_dcc86184-c55f-451b-bf19-8fdb91e90e79">300</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net revenue</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i73f2057fe97d4f3a8524f987e78d1493_D20210101-20210630" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzY2E5YmIwMTc5MjQ3NmZiYjIyNWU1ZDlkZWM4NjlmL3NlYzo5M2NhOWJiMDE3OTI0NzZmYmIyMjVlNWQ5ZGVjODY5Zl81NS9mcmFnOjk0NGQ2N2RjOTNmMjQ1MjliZTc4ZmNlMzRiOGMyZTBiL3RhYmxlOjA0NzkyNmRhYWViMzQxYWY4MzY2OWVhN2M4NjhiY2I0L3RhYmxlcmFuZ2U6MDQ3OTI2ZGFhZWIzNDFhZjgzNjY5ZWE3Yzg2OGJjYjRfNS0xLTEtMS0xNjIxMA_9aa172ba-838a-4ab2-8afe-8235b9ad6868">4,668</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9eea321560784f81a590aa8e3df3b187_D20210101-20210630" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzY2E5YmIwMTc5MjQ3NmZiYjIyNWU1ZDlkZWM4NjlmL3NlYzo5M2NhOWJiMDE3OTI0NzZmYmIyMjVlNWQ5ZGVjODY5Zl81NS9mcmFnOjk0NGQ2N2RjOTNmMjQ1MjliZTc4ZmNlMzRiOGMyZTBiL3RhYmxlOjA0NzkyNmRhYWViMzQxYWY4MzY2OWVhN2M4NjhiY2I0L3RhYmxlcmFuZ2U6MDQ3OTI2ZGFhZWIzNDFhZjgzNjY5ZWE3Yzg2OGJjYjRfNS0zLTEtMS0xNjIxMA_8d58adde-509c-4d89-9e1d-385682764558">23,565</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5e244469383d46ddb452d43394f637d1_D20210101-20210630" decimals="-3" format="ixt:zerodash" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzY2E5YmIwMTc5MjQ3NmZiYjIyNWU1ZDlkZWM4NjlmL3NlYzo5M2NhOWJiMDE3OTI0NzZmYmIyMjVlNWQ5ZGVjODY5Zl81NS9mcmFnOjk0NGQ2N2RjOTNmMjQ1MjliZTc4ZmNlMzRiOGMyZTBiL3RhYmxlOjA0NzkyNmRhYWViMzQxYWY4MzY2OWVhN2M4NjhiY2I0L3RhYmxlcmFuZ2U6MDQ3OTI2ZGFhZWIzNDFhZjgzNjY5ZWE3Yzg2OGJjYjRfNS01LTEtMS0xNjIxMA_21848447-a165-472b-b918-f410f669bcaf">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i69782326f71a44e3805518280ee22b6b_D20210101-20210630" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzY2E5YmIwMTc5MjQ3NmZiYjIyNWU1ZDlkZWM4NjlmL3NlYzo5M2NhOWJiMDE3OTI0NzZmYmIyMjVlNWQ5ZGVjODY5Zl81NS9mcmFnOjk0NGQ2N2RjOTNmMjQ1MjliZTc4ZmNlMzRiOGMyZTBiL3RhYmxlOjA0NzkyNmRhYWViMzQxYWY4MzY2OWVhN2M4NjhiY2I0L3RhYmxlcmFuZ2U6MDQ3OTI2ZGFhZWIzNDFhZjgzNjY5ZWE3Yzg2OGJjYjRfNS03LTEtMS0xNTQzOA_b9582a15-802b-4586-88d5-26c1da2c9f42">28,233</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr style="height:14pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Share of loss from equity accounted investments</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i73f2057fe97d4f3a8524f987e78d1493_D20210101-20210630" decimals="-3" format="ixt:zerodash" name="us-gaap:IncomeLossFromEquityMethodInvestments" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzY2E5YmIwMTc5MjQ3NmZiYjIyNWU1ZDlkZWM4NjlmL3NlYzo5M2NhOWJiMDE3OTI0NzZmYmIyMjVlNWQ5ZGVjODY5Zl81NS9mcmFnOjk0NGQ2N2RjOTNmMjQ1MjliZTc4ZmNlMzRiOGMyZTBiL3RhYmxlOjA0NzkyNmRhYWViMzQxYWY4MzY2OWVhN2M4NjhiY2I0L3RhYmxlcmFuZ2U6MDQ3OTI2ZGFhZWIzNDFhZjgzNjY5ZWE3Yzg2OGJjYjRfOC0xLTEtMS0xMjgz_1b5c7490-33a3-476c-a840-982419084d81">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9eea321560784f81a590aa8e3df3b187_D20210101-20210630" decimals="-3" sign="-" format="ixt:numdotdecimal" name="us-gaap:IncomeLossFromEquityMethodInvestments" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzY2E5YmIwMTc5MjQ3NmZiYjIyNWU1ZDlkZWM4NjlmL3NlYzo5M2NhOWJiMDE3OTI0NzZmYmIyMjVlNWQ5ZGVjODY5Zl81NS9mcmFnOjk0NGQ2N2RjOTNmMjQ1MjliZTc4ZmNlMzRiOGMyZTBiL3RhYmxlOjA0NzkyNmRhYWViMzQxYWY4MzY2OWVhN2M4NjhiY2I0L3RhYmxlcmFuZ2U6MDQ3OTI2ZGFhZWIzNDFhZjgzNjY5ZWE3Yzg2OGJjYjRfOC0zLTEtMS0xMjgz_b61ce4c5-3839-4c7f-9034-376cb7d9b7f6">2,758</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5e244469383d46ddb452d43394f637d1_D20210101-20210630" decimals="-3" format="ixt:zerodash" name="us-gaap:IncomeLossFromEquityMethodInvestments" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzY2E5YmIwMTc5MjQ3NmZiYjIyNWU1ZDlkZWM4NjlmL3NlYzo5M2NhOWJiMDE3OTI0NzZmYmIyMjVlNWQ5ZGVjODY5Zl81NS9mcmFnOjk0NGQ2N2RjOTNmMjQ1MjliZTc4ZmNlMzRiOGMyZTBiL3RhYmxlOjA0NzkyNmRhYWViMzQxYWY4MzY2OWVhN2M4NjhiY2I0L3RhYmxlcmFuZ2U6MDQ3OTI2ZGFhZWIzNDFhZjgzNjY5ZWE3Yzg2OGJjYjRfOC01LTEtMS0xMjgz_3a23b406-8593-46d6-9c28-3972379ec837">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i69782326f71a44e3805518280ee22b6b_D20210101-20210630" decimals="-3" sign="-" format="ixt:numdotdecimal" name="us-gaap:IncomeLossFromEquityMethodInvestments" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzY2E5YmIwMTc5MjQ3NmZiYjIyNWU1ZDlkZWM4NjlmL3NlYzo5M2NhOWJiMDE3OTI0NzZmYmIyMjVlNWQ5ZGVjODY5Zl81NS9mcmFnOjk0NGQ2N2RjOTNmMjQ1MjliZTc4ZmNlMzRiOGMyZTBiL3RhYmxlOjA0NzkyNmRhYWViMzQxYWY4MzY2OWVhN2M4NjhiY2I0L3RhYmxlcmFuZ2U6MDQ3OTI2ZGFhZWIzNDFhZjgzNjY5ZWE3Yzg2OGJjYjRfNy03LTEtMS0xNjIxMA_51077a31-2ec7-42cb-8069-b1322ca9923f">2,758</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr style="height:14pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Interest income</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i73f2057fe97d4f3a8524f987e78d1493_D20210101-20210630" decimals="-3" name="us-gaap:InvestmentIncomeInterest" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzY2E5YmIwMTc5MjQ3NmZiYjIyNWU1ZDlkZWM4NjlmL3NlYzo5M2NhOWJiMDE3OTI0NzZmYmIyMjVlNWQ5ZGVjODY5Zl81NS9mcmFnOjk0NGQ2N2RjOTNmMjQ1MjliZTc4ZmNlMzRiOGMyZTBiL3RhYmxlOjA0NzkyNmRhYWViMzQxYWY4MzY2OWVhN2M4NjhiY2I0L3RhYmxlcmFuZ2U6MDQ3OTI2ZGFhZWIzNDFhZjgzNjY5ZWE3Yzg2OGJjYjRfMTAtMS0xLTEtMTI4Nw_740918f2-4c47-4bc1-991b-6bb334711773">23</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9eea321560784f81a590aa8e3df3b187_D20210101-20210630" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:InvestmentIncomeInterest" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzY2E5YmIwMTc5MjQ3NmZiYjIyNWU1ZDlkZWM4NjlmL3NlYzo5M2NhOWJiMDE3OTI0NzZmYmIyMjVlNWQ5ZGVjODY5Zl81NS9mcmFnOjk0NGQ2N2RjOTNmMjQ1MjliZTc4ZmNlMzRiOGMyZTBiL3RhYmxlOjA0NzkyNmRhYWViMzQxYWY4MzY2OWVhN2M4NjhiY2I0L3RhYmxlcmFuZ2U6MDQ3OTI2ZGFhZWIzNDFhZjgzNjY5ZWE3Yzg2OGJjYjRfMTAtMy0xLTEtMTI4Nw_44abf7c3-2a58-486c-b0fa-7a2dbecb53cc">4,612</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5e244469383d46ddb452d43394f637d1_D20210101-20210630" decimals="-3" format="ixt:zerodash" name="us-gaap:InvestmentIncomeInterest" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzY2E5YmIwMTc5MjQ3NmZiYjIyNWU1ZDlkZWM4NjlmL3NlYzo5M2NhOWJiMDE3OTI0NzZmYmIyMjVlNWQ5ZGVjODY5Zl81NS9mcmFnOjk0NGQ2N2RjOTNmMjQ1MjliZTc4ZmNlMzRiOGMyZTBiL3RhYmxlOjA0NzkyNmRhYWViMzQxYWY4MzY2OWVhN2M4NjhiY2I0L3RhYmxlcmFuZ2U6MDQ3OTI2ZGFhZWIzNDFhZjgzNjY5ZWE3Yzg2OGJjYjRfMTAtNS0xLTEtMTI4Nw_56164f1a-f704-4d3f-8c41-5b09804abcd5">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i69782326f71a44e3805518280ee22b6b_D20210101-20210630" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:InvestmentIncomeInterest" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzY2E5YmIwMTc5MjQ3NmZiYjIyNWU1ZDlkZWM4NjlmL3NlYzo5M2NhOWJiMDE3OTI0NzZmYmIyMjVlNWQ5ZGVjODY5Zl81NS9mcmFnOjk0NGQ2N2RjOTNmMjQ1MjliZTc4ZmNlMzRiOGMyZTBiL3RhYmxlOjA0NzkyNmRhYWViMzQxYWY4MzY2OWVhN2M4NjhiY2I0L3RhYmxlcmFuZ2U6MDQ3OTI2ZGFhZWIzNDFhZjgzNjY5ZWE3Yzg2OGJjYjRfOS03LTEtMS0xNjIxMA_825784b9-8b8a-4bc2-8d73-bfbb50704fe5">4,635</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Interest expense</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i73f2057fe97d4f3a8524f987e78d1493_D20210101-20210630" decimals="-3" format="ixt:zerodash" name="us-gaap:InterestExpense" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzY2E5YmIwMTc5MjQ3NmZiYjIyNWU1ZDlkZWM4NjlmL3NlYzo5M2NhOWJiMDE3OTI0NzZmYmIyMjVlNWQ5ZGVjODY5Zl81NS9mcmFnOjk0NGQ2N2RjOTNmMjQ1MjliZTc4ZmNlMzRiOGMyZTBiL3RhYmxlOjA0NzkyNmRhYWViMzQxYWY4MzY2OWVhN2M4NjhiY2I0L3RhYmxlcmFuZ2U6MDQ3OTI2ZGFhZWIzNDFhZjgzNjY5ZWE3Yzg2OGJjYjRfMTEtMS0xLTEtMTI4Nw_bf4b388e-ce72-4ede-b56c-f1899270fe5a">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i9eea321560784f81a590aa8e3df3b187_D20210101-20210630" decimals="-3" name="us-gaap:InterestExpense" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzY2E5YmIwMTc5MjQ3NmZiYjIyNWU1ZDlkZWM4NjlmL3NlYzo5M2NhOWJiMDE3OTI0NzZmYmIyMjVlNWQ5ZGVjODY5Zl81NS9mcmFnOjk0NGQ2N2RjOTNmMjQ1MjliZTc4ZmNlMzRiOGMyZTBiL3RhYmxlOjA0NzkyNmRhYWViMzQxYWY4MzY2OWVhN2M4NjhiY2I0L3RhYmxlcmFuZ2U6MDQ3OTI2ZGFhZWIzNDFhZjgzNjY5ZWE3Yzg2OGJjYjRfMTEtMy0xLTEtMTI4Nw_778ee972-20c8-42d1-86e9-a954e3b67f58">13</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5e244469383d46ddb452d43394f637d1_D20210101-20210630" decimals="-3" format="ixt:zerodash" name="us-gaap:InterestExpense" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzY2E5YmIwMTc5MjQ3NmZiYjIyNWU1ZDlkZWM4NjlmL3NlYzo5M2NhOWJiMDE3OTI0NzZmYmIyMjVlNWQ5ZGVjODY5Zl81NS9mcmFnOjk0NGQ2N2RjOTNmMjQ1MjliZTc4ZmNlMzRiOGMyZTBiL3RhYmxlOjA0NzkyNmRhYWViMzQxYWY4MzY2OWVhN2M4NjhiY2I0L3RhYmxlcmFuZ2U6MDQ3OTI2ZGFhZWIzNDFhZjgzNjY5ZWE3Yzg2OGJjYjRfMTEtNS0xLTEtMTI4Nw_116db466-5524-4849-b91c-e61dd2d887de">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i69782326f71a44e3805518280ee22b6b_D20210101-20210630" decimals="-3" name="us-gaap:InterestExpense" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzY2E5YmIwMTc5MjQ3NmZiYjIyNWU1ZDlkZWM4NjlmL3NlYzo5M2NhOWJiMDE3OTI0NzZmYmIyMjVlNWQ5ZGVjODY5Zl81NS9mcmFnOjk0NGQ2N2RjOTNmMjQ1MjliZTc4ZmNlMzRiOGMyZTBiL3RhYmxlOjA0NzkyNmRhYWViMzQxYWY4MzY2OWVhN2M4NjhiY2I0L3RhYmxlcmFuZ2U6MDQ3OTI2ZGFhZWIzNDFhZjgzNjY5ZWE3Yzg2OGJjYjRfMTAtNy0xLTEtMTYyMTA_8c6bcb28-6911-4d53-bded-992140ffc65b">13</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Interest income, net</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i73f2057fe97d4f3a8524f987e78d1493_D20210101-20210630" decimals="-3" name="us-gaap:InterestIncomeExpenseNonoperatingNet" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzY2E5YmIwMTc5MjQ3NmZiYjIyNWU1ZDlkZWM4NjlmL3NlYzo5M2NhOWJiMDE3OTI0NzZmYmIyMjVlNWQ5ZGVjODY5Zl81NS9mcmFnOjk0NGQ2N2RjOTNmMjQ1MjliZTc4ZmNlMzRiOGMyZTBiL3RhYmxlOjA0NzkyNmRhYWViMzQxYWY4MzY2OWVhN2M4NjhiY2I0L3RhYmxlcmFuZ2U6MDQ3OTI2ZGFhZWIzNDFhZjgzNjY5ZWE3Yzg2OGJjYjRfMTEtMS0xLTEtMTYyMTA_25e7bd76-9379-47b0-b7c1-d66f217b4762">23</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9eea321560784f81a590aa8e3df3b187_D20210101-20210630" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:InterestIncomeExpenseNonoperatingNet" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzY2E5YmIwMTc5MjQ3NmZiYjIyNWU1ZDlkZWM4NjlmL3NlYzo5M2NhOWJiMDE3OTI0NzZmYmIyMjVlNWQ5ZGVjODY5Zl81NS9mcmFnOjk0NGQ2N2RjOTNmMjQ1MjliZTc4ZmNlMzRiOGMyZTBiL3RhYmxlOjA0NzkyNmRhYWViMzQxYWY4MzY2OWVhN2M4NjhiY2I0L3RhYmxlcmFuZ2U6MDQ3OTI2ZGFhZWIzNDFhZjgzNjY5ZWE3Yzg2OGJjYjRfMTEtMy0xLTEtMTYyMTA_5261988c-fa8c-4bb6-a00a-13916f101ae6">4,599</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5e244469383d46ddb452d43394f637d1_D20210101-20210630" decimals="-3" format="ixt:zerodash" name="us-gaap:InterestIncomeExpenseNonoperatingNet" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzY2E5YmIwMTc5MjQ3NmZiYjIyNWU1ZDlkZWM4NjlmL3NlYzo5M2NhOWJiMDE3OTI0NzZmYmIyMjVlNWQ5ZGVjODY5Zl81NS9mcmFnOjk0NGQ2N2RjOTNmMjQ1MjliZTc4ZmNlMzRiOGMyZTBiL3RhYmxlOjA0NzkyNmRhYWViMzQxYWY4MzY2OWVhN2M4NjhiY2I0L3RhYmxlcmFuZ2U6MDQ3OTI2ZGFhZWIzNDFhZjgzNjY5ZWE3Yzg2OGJjYjRfMTEtNS0xLTEtMTYyMTA_4487f02f-99bc-435d-80e6-16a09ca2e01f">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i69782326f71a44e3805518280ee22b6b_D20210101-20210630" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:InterestIncomeExpenseNonoperatingNet" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzY2E5YmIwMTc5MjQ3NmZiYjIyNWU1ZDlkZWM4NjlmL3NlYzo5M2NhOWJiMDE3OTI0NzZmYmIyMjVlNWQ5ZGVjODY5Zl81NS9mcmFnOjk0NGQ2N2RjOTNmMjQ1MjliZTc4ZmNlMzRiOGMyZTBiL3RhYmxlOjA0NzkyNmRhYWViMzQxYWY4MzY2OWVhN2M4NjhiY2I0L3RhYmxlcmFuZ2U6MDQ3OTI2ZGFhZWIzNDFhZjgzNjY5ZWE3Yzg2OGJjYjRfMTEtNy0xLTEtMTYyMTA_442372f7-f599-437d-b4e1-cc59a21344f5">4,622</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr style="height:14pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total assets</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1afe4ab017a94c08b0390d1c04588202_I20210630" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:Assets" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzY2E5YmIwMTc5MjQ3NmZiYjIyNWU1ZDlkZWM4NjlmL3NlYzo5M2NhOWJiMDE3OTI0NzZmYmIyMjVlNWQ5ZGVjODY5Zl81NS9mcmFnOjk0NGQ2N2RjOTNmMjQ1MjliZTc4ZmNlMzRiOGMyZTBiL3RhYmxlOjA0NzkyNmRhYWViMzQxYWY4MzY2OWVhN2M4NjhiY2I0L3RhYmxlcmFuZ2U6MDQ3OTI2ZGFhZWIzNDFhZjgzNjY5ZWE3Yzg2OGJjYjRfMTMtMS0xLTEtMTg0NTY_ffce79d1-5da8-4f0f-b770-cc5a1cac2e8b">709,956</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i14c7d79dc30c40b9a6db30b130c667da_I20210630" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:Assets" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzY2E5YmIwMTc5MjQ3NmZiYjIyNWU1ZDlkZWM4NjlmL3NlYzo5M2NhOWJiMDE3OTI0NzZmYmIyMjVlNWQ5ZGVjODY5Zl81NS9mcmFnOjk0NGQ2N2RjOTNmMjQ1MjliZTc4ZmNlMzRiOGMyZTBiL3RhYmxlOjA0NzkyNmRhYWViMzQxYWY4MzY2OWVhN2M4NjhiY2I0L3RhYmxlcmFuZ2U6MDQ3OTI2ZGFhZWIzNDFhZjgzNjY5ZWE3Yzg2OGJjYjRfMTMtMy0xLTEtMTg0NTY_25a89660-c625-46d7-aa85-98303a629f26">386,805</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i64489be55285421f8e92af4479a619e6_I20210630" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:Assets" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzY2E5YmIwMTc5MjQ3NmZiYjIyNWU1ZDlkZWM4NjlmL3NlYzo5M2NhOWJiMDE3OTI0NzZmYmIyMjVlNWQ5ZGVjODY5Zl81NS9mcmFnOjk0NGQ2N2RjOTNmMjQ1MjliZTc4ZmNlMzRiOGMyZTBiL3RhYmxlOjA0NzkyNmRhYWViMzQxYWY4MzY2OWVhN2M4NjhiY2I0L3RhYmxlcmFuZ2U6MDQ3OTI2ZGFhZWIzNDFhZjgzNjY5ZWE3Yzg2OGJjYjRfMTMtNS0xLTEtMTg0NTY_3ec9931f-3f5f-4081-8806-84dddfb88904">741,850</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i225f85e38faa4bbdb4de1d8b9cf369bb_I20210630" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:Assets" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzY2E5YmIwMTc5MjQ3NmZiYjIyNWU1ZDlkZWM4NjlmL3NlYzo5M2NhOWJiMDE3OTI0NzZmYmIyMjVlNWQ5ZGVjODY5Zl81NS9mcmFnOjk0NGQ2N2RjOTNmMjQ1MjliZTc4ZmNlMzRiOGMyZTBiL3RhYmxlOjA0NzkyNmRhYWViMzQxYWY4MzY2OWVhN2M4NjhiY2I0L3RhYmxlcmFuZ2U6MDQ3OTI2ZGFhZWIzNDFhZjgzNjY5ZWE3Yzg2OGJjYjRfMTMtNy0xLTEtMTg0NTY_dc23281b-91d7-4c8d-9741-2a5050f00e64">1,838,611</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Depreciation and amortization</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i73f2057fe97d4f3a8524f987e78d1493_D20210101-20210630" decimals="-3" name="us-gaap:DepreciationAndAmortization" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzY2E5YmIwMTc5MjQ3NmZiYjIyNWU1ZDlkZWM4NjlmL3NlYzo5M2NhOWJiMDE3OTI0NzZmYmIyMjVlNWQ5ZGVjODY5Zl81NS9mcmFnOjk0NGQ2N2RjOTNmMjQ1MjliZTc4ZmNlMzRiOGMyZTBiL3RhYmxlOjA0NzkyNmRhYWViMzQxYWY4MzY2OWVhN2M4NjhiY2I0L3RhYmxlcmFuZ2U6MDQ3OTI2ZGFhZWIzNDFhZjgzNjY5ZWE3Yzg2OGJjYjRfMTQtMS0xLTEtMTI5MQ_8d26312a-0efe-498f-8752-1f76b1c91ef2">139</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9eea321560784f81a590aa8e3df3b187_D20210101-20210630" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:DepreciationAndAmortization" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzY2E5YmIwMTc5MjQ3NmZiYjIyNWU1ZDlkZWM4NjlmL3NlYzo5M2NhOWJiMDE3OTI0NzZmYmIyMjVlNWQ5ZGVjODY5Zl81NS9mcmFnOjk0NGQ2N2RjOTNmMjQ1MjliZTc4ZmNlMzRiOGMyZTBiL3RhYmxlOjA0NzkyNmRhYWViMzQxYWY4MzY2OWVhN2M4NjhiY2I0L3RhYmxlcmFuZ2U6MDQ3OTI2ZGFhZWIzNDFhZjgzNjY5ZWE3Yzg2OGJjYjRfMTQtMy0xLTEtMTI5MQ_b545d71c-55ca-4cb9-ac01-09f2325a9976">1,639</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5e244469383d46ddb452d43394f637d1_D20210101-20210630" decimals="-3" format="ixt:zerodash" name="us-gaap:DepreciationAndAmortization" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzY2E5YmIwMTc5MjQ3NmZiYjIyNWU1ZDlkZWM4NjlmL3NlYzo5M2NhOWJiMDE3OTI0NzZmYmIyMjVlNWQ5ZGVjODY5Zl81NS9mcmFnOjk0NGQ2N2RjOTNmMjQ1MjliZTc4ZmNlMzRiOGMyZTBiL3RhYmxlOjA0NzkyNmRhYWViMzQxYWY4MzY2OWVhN2M4NjhiY2I0L3RhYmxlcmFuZ2U6MDQ3OTI2ZGFhZWIzNDFhZjgzNjY5ZWE3Yzg2OGJjYjRfMTQtNS0xLTEtMTI5MQ_88d9511e-d31c-4508-bafb-a7701af8445a">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i69782326f71a44e3805518280ee22b6b_D20210101-20210630" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:DepreciationAndAmortization" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzY2E5YmIwMTc5MjQ3NmZiYjIyNWU1ZDlkZWM4NjlmL3NlYzo5M2NhOWJiMDE3OTI0NzZmYmIyMjVlNWQ5ZGVjODY5Zl81NS9mcmFnOjk0NGQ2N2RjOTNmMjQ1MjliZTc4ZmNlMzRiOGMyZTBiL3RhYmxlOjA0NzkyNmRhYWViMzQxYWY4MzY2OWVhN2M4NjhiY2I0L3RhYmxlcmFuZ2U6MDQ3OTI2ZGFhZWIzNDFhZjgzNjY5ZWE3Yzg2OGJjYjRfMTMtNy0xLTEtMTU0NDA_438a74e0-7919-4016-a276-7dd3fc741e02">1,778</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Impairment loss on long-lived assets</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i73f2057fe97d4f3a8524f987e78d1493_D20210101-20210630" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:OperatingLeaseRightOfUseAssetAmortizationExpense" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzY2E5YmIwMTc5MjQ3NmZiYjIyNWU1ZDlkZWM4NjlmL3NlYzo5M2NhOWJiMDE3OTI0NzZmYmIyMjVlNWQ5ZGVjODY5Zl81NS9mcmFnOjk0NGQ2N2RjOTNmMjQ1MjliZTc4ZmNlMzRiOGMyZTBiL3RhYmxlOjA0NzkyNmRhYWViMzQxYWY4MzY2OWVhN2M4NjhiY2I0L3RhYmxlcmFuZ2U6MDQ3OTI2ZGFhZWIzNDFhZjgzNjY5ZWE3Yzg2OGJjYjRfMTUtMS0xLTEtMTI5NQ_a107479f-6e19-4929-a67c-2f047c4a6e5a">1,741</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9eea321560784f81a590aa8e3df3b187_D20210101-20210630" decimals="-3" format="ixt:zerodash" name="us-gaap:OperatingLeaseRightOfUseAssetAmortizationExpense" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzY2E5YmIwMTc5MjQ3NmZiYjIyNWU1ZDlkZWM4NjlmL3NlYzo5M2NhOWJiMDE3OTI0NzZmYmIyMjVlNWQ5ZGVjODY5Zl81NS9mcmFnOjk0NGQ2N2RjOTNmMjQ1MjliZTc4ZmNlMzRiOGMyZTBiL3RhYmxlOjA0NzkyNmRhYWViMzQxYWY4MzY2OWVhN2M4NjhiY2I0L3RhYmxlcmFuZ2U6MDQ3OTI2ZGFhZWIzNDFhZjgzNjY5ZWE3Yzg2OGJjYjRfMTUtMy0xLTEtMTI5NQ_88d753e4-60dc-4974-8e39-77f13b6009e0">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5e244469383d46ddb452d43394f637d1_D20210101-20210630" decimals="-3" format="ixt:zerodash" name="us-gaap:OperatingLeaseRightOfUseAssetAmortizationExpense" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzY2E5YmIwMTc5MjQ3NmZiYjIyNWU1ZDlkZWM4NjlmL3NlYzo5M2NhOWJiMDE3OTI0NzZmYmIyMjVlNWQ5ZGVjODY5Zl81NS9mcmFnOjk0NGQ2N2RjOTNmMjQ1MjliZTc4ZmNlMzRiOGMyZTBiL3RhYmxlOjA0NzkyNmRhYWViMzQxYWY4MzY2OWVhN2M4NjhiY2I0L3RhYmxlcmFuZ2U6MDQ3OTI2ZGFhZWIzNDFhZjgzNjY5ZWE3Yzg2OGJjYjRfMTUtNS0xLTEtMTI5NQ_11e4b365-9bcf-4f37-a943-43ae60518ad8">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i69782326f71a44e3805518280ee22b6b_D20210101-20210630" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:OperatingLeaseRightOfUseAssetAmortizationExpense" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzY2E5YmIwMTc5MjQ3NmZiYjIyNWU1ZDlkZWM4NjlmL3NlYzo5M2NhOWJiMDE3OTI0NzZmYmIyMjVlNWQ5ZGVjODY5Zl81NS9mcmFnOjk0NGQ2N2RjOTNmMjQ1MjliZTc4ZmNlMzRiOGMyZTBiL3RhYmxlOjA0NzkyNmRhYWViMzQxYWY4MzY2OWVhN2M4NjhiY2I0L3RhYmxlcmFuZ2U6MDQ3OTI2ZGFhZWIzNDFhZjgzNjY5ZWE3Yzg2OGJjYjRfMTQtNy0xLTEtMTYyMTk_bd1f6e9c-393c-4a21-95ab-5dc6ab9b9fc1">1,741</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Adjusted EBITDA</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i73f2057fe97d4f3a8524f987e78d1493_D20210101-20210630" decimals="-3" sign="-" format="ixt:numdotdecimal" name="cron:AdjustedEarningsBeforeInterestTaxesDepreciationAndAmortization" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzY2E5YmIwMTc5MjQ3NmZiYjIyNWU1ZDlkZWM4NjlmL3NlYzo5M2NhOWJiMDE3OTI0NzZmYmIyMjVlNWQ5ZGVjODY5Zl81NS9mcmFnOjk0NGQ2N2RjOTNmMjQ1MjliZTc4ZmNlMzRiOGMyZTBiL3RhYmxlOjA0NzkyNmRhYWViMzQxYWY4MzY2OWVhN2M4NjhiY2I0L3RhYmxlcmFuZ2U6MDQ3OTI2ZGFhZWIzNDFhZjgzNjY5ZWE3Yzg2OGJjYjRfMTctMS0xLTEtMTI5OQ_6a9b45d4-cc00-440d-9bbb-a20cff8cc73f">20,221</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i9eea321560784f81a590aa8e3df3b187_D20210101-20210630" decimals="-3" sign="-" format="ixt:numdotdecimal" name="cron:AdjustedEarningsBeforeInterestTaxesDepreciationAndAmortization" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzY2E5YmIwMTc5MjQ3NmZiYjIyNWU1ZDlkZWM4NjlmL3NlYzo5M2NhOWJiMDE3OTI0NzZmYmIyMjVlNWQ5ZGVjODY5Zl81NS9mcmFnOjk0NGQ2N2RjOTNmMjQ1MjliZTc4ZmNlMzRiOGMyZTBiL3RhYmxlOjA0NzkyNmRhYWViMzQxYWY4MzY2OWVhN2M4NjhiY2I0L3RhYmxlcmFuZ2U6MDQ3OTI2ZGFhZWIzNDFhZjgzNjY5ZWE3Yzg2OGJjYjRfMTctMy0xLTEtMTI5OQ_746ee244-5d26-4b27-8a37-d5fcbeceb8b2">54,789</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i5e244469383d46ddb452d43394f637d1_D20210101-20210630" decimals="-3" sign="-" format="ixt:numdotdecimal" name="cron:AdjustedEarningsBeforeInterestTaxesDepreciationAndAmortization" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzY2E5YmIwMTc5MjQ3NmZiYjIyNWU1ZDlkZWM4NjlmL3NlYzo5M2NhOWJiMDE3OTI0NzZmYmIyMjVlNWQ5ZGVjODY5Zl81NS9mcmFnOjk0NGQ2N2RjOTNmMjQ1MjliZTc4ZmNlMzRiOGMyZTBiL3RhYmxlOjA0NzkyNmRhYWViMzQxYWY4MzY2OWVhN2M4NjhiY2I0L3RhYmxlcmFuZ2U6MDQ3OTI2ZGFhZWIzNDFhZjgzNjY5ZWE3Yzg2OGJjYjRfMTctNS0xLTEtMTI5OQ_f4c4c635-51e0-45df-8ee6-eea33178ad48">11,323</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i69782326f71a44e3805518280ee22b6b_D20210101-20210630" decimals="-3" sign="-" format="ixt:numdotdecimal" name="cron:AdjustedEarningsBeforeInterestTaxesDepreciationAndAmortization" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzY2E5YmIwMTc5MjQ3NmZiYjIyNWU1ZDlkZWM4NjlmL3NlYzo5M2NhOWJiMDE3OTI0NzZmYmIyMjVlNWQ5ZGVjODY5Zl81NS9mcmFnOjk0NGQ2N2RjOTNmMjQ1MjliZTc4ZmNlMzRiOGMyZTBiL3RhYmxlOjA0NzkyNmRhYWViMzQxYWY4MzY2OWVhN2M4NjhiY2I0L3RhYmxlcmFuZ2U6MDQ3OTI2ZGFhZWIzNDFhZjgzNjY5ZWE3Yzg2OGJjYjRfMTYtNy0xLTEtMTYyMjE_38592921-8220-4539-8f04-672997a4687b">86,333</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Purchase of property, plant and equipment, net</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i73f2057fe97d4f3a8524f987e78d1493_D20210101-20210630" decimals="-3" name="us-gaap:PropertyPlantAndEquipmentAdditions" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzY2E5YmIwMTc5MjQ3NmZiYjIyNWU1ZDlkZWM4NjlmL3NlYzo5M2NhOWJiMDE3OTI0NzZmYmIyMjVlNWQ5ZGVjODY5Zl81NS9mcmFnOjk0NGQ2N2RjOTNmMjQ1MjliZTc4ZmNlMzRiOGMyZTBiL3RhYmxlOjA0NzkyNmRhYWViMzQxYWY4MzY2OWVhN2M4NjhiY2I0L3RhYmxlcmFuZ2U6MDQ3OTI2ZGFhZWIzNDFhZjgzNjY5ZWE3Yzg2OGJjYjRfMjItMS0xLTEtMTMxMQ_96db76de-a4b7-44e6-888e-07de528185f5">319</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9eea321560784f81a590aa8e3df3b187_D20210101-20210630" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:PropertyPlantAndEquipmentAdditions" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzY2E5YmIwMTc5MjQ3NmZiYjIyNWU1ZDlkZWM4NjlmL3NlYzo5M2NhOWJiMDE3OTI0NzZmYmIyMjVlNWQ5ZGVjODY5Zl81NS9mcmFnOjk0NGQ2N2RjOTNmMjQ1MjliZTc4ZmNlMzRiOGMyZTBiL3RhYmxlOjA0NzkyNmRhYWViMzQxYWY4MzY2OWVhN2M4NjhiY2I0L3RhYmxlcmFuZ2U6MDQ3OTI2ZGFhZWIzNDFhZjgzNjY5ZWE3Yzg2OGJjYjRfMjItMy0xLTEtMTMxMQ_d352ed4b-e578-49e9-86f3-98d3d660f07e">8,028</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5e244469383d46ddb452d43394f637d1_D20210101-20210630" decimals="-3" format="ixt:zerodash" name="us-gaap:PropertyPlantAndEquipmentAdditions" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzY2E5YmIwMTc5MjQ3NmZiYjIyNWU1ZDlkZWM4NjlmL3NlYzo5M2NhOWJiMDE3OTI0NzZmYmIyMjVlNWQ5ZGVjODY5Zl81NS9mcmFnOjk0NGQ2N2RjOTNmMjQ1MjliZTc4ZmNlMzRiOGMyZTBiL3RhYmxlOjA0NzkyNmRhYWViMzQxYWY4MzY2OWVhN2M4NjhiY2I0L3RhYmxlcmFuZ2U6MDQ3OTI2ZGFhZWIzNDFhZjgzNjY5ZWE3Yzg2OGJjYjRfMjItNS0xLTEtMTMxMQ_e09f5751-c288-46a8-9b76-d0054cf090ff">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i69782326f71a44e3805518280ee22b6b_D20210101-20210630" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:PropertyPlantAndEquipmentAdditions" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzY2E5YmIwMTc5MjQ3NmZiYjIyNWU1ZDlkZWM4NjlmL3NlYzo5M2NhOWJiMDE3OTI0NzZmYmIyMjVlNWQ5ZGVjODY5Zl81NS9mcmFnOjk0NGQ2N2RjOTNmMjQ1MjliZTc4ZmNlMzRiOGMyZTBiL3RhYmxlOjA0NzkyNmRhYWViMzQxYWY4MzY2OWVhN2M4NjhiY2I0L3RhYmxlcmFuZ2U6MDQ3OTI2ZGFhZWIzNDFhZjgzNjY5ZWE3Yzg2OGJjYjRfMTctNy0xLTEtMTczNzU_2de3bd09-8d84-4b08-a1d9-95116abca677">8,347</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr></table></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:49.316%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.566%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.772%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.566%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.772%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.566%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.772%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.570%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="21" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Six months ended June 30, 2020</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">United States</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Rest of World</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Corporate Expenses</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Total</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cannabis flower</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib6c371f673124f889fe33d8feafa376a_D20200101-20200630" decimals="-3" format="ixt:zerodash" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzY2E5YmIwMTc5MjQ3NmZiYjIyNWU1ZDlkZWM4NjlmL3NlYzo5M2NhOWJiMDE3OTI0NzZmYmIyMjVlNWQ5ZGVjODY5Zl81NS9mcmFnOjk0NGQ2N2RjOTNmMjQ1MjliZTc4ZmNlMzRiOGMyZTBiL3RhYmxlOjhjMmVjZjQ0MTM3MTQ4MzI4MDE3YTEwMzNhZjE3MjY4L3RhYmxlcmFuZ2U6OGMyZWNmNDQxMzcxNDgzMjgwMTdhMTAzM2FmMTcyNjhfMy0xLTEtMS0w_4aae2141-ae9e-40a4-91d5-2fdfa4cefe11">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i058566bd4b4941cfb44bfaea27053d23_D20200101-20200630" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzY2E5YmIwMTc5MjQ3NmZiYjIyNWU1ZDlkZWM4NjlmL3NlYzo5M2NhOWJiMDE3OTI0NzZmYmIyMjVlNWQ5ZGVjODY5Zl81NS9mcmFnOjk0NGQ2N2RjOTNmMjQ1MjliZTc4ZmNlMzRiOGMyZTBiL3RhYmxlOjhjMmVjZjQ0MTM3MTQ4MzI4MDE3YTEwMzNhZjE3MjY4L3RhYmxlcmFuZ2U6OGMyZWNmNDQxMzcxNDgzMjgwMTdhMTAzM2FmMTcyNjhfMy0zLTEtMS0w_e4ac74cc-2f54-4c6b-b6ff-124c957bd8c6">8,415</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib8262672cddb43529f39e6554b306595_D20200101-20200630" decimals="-3" format="ixt:zerodash" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzY2E5YmIwMTc5MjQ3NmZiYjIyNWU1ZDlkZWM4NjlmL3NlYzo5M2NhOWJiMDE3OTI0NzZmYmIyMjVlNWQ5ZGVjODY5Zl81NS9mcmFnOjk0NGQ2N2RjOTNmMjQ1MjliZTc4ZmNlMzRiOGMyZTBiL3RhYmxlOjhjMmVjZjQ0MTM3MTQ4MzI4MDE3YTEwMzNhZjE3MjY4L3RhYmxlcmFuZ2U6OGMyZWNmNDQxMzcxNDgzMjgwMTdhMTAzM2FmMTcyNjhfMy01LTEtMS0w_d290110c-4571-479f-bdd3-d577a7359c13">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4e842f8ace2f420eabc848a65486b991_D20200101-20200630" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzY2E5YmIwMTc5MjQ3NmZiYjIyNWU1ZDlkZWM4NjlmL3NlYzo5M2NhOWJiMDE3OTI0NzZmYmIyMjVlNWQ5ZGVjODY5Zl81NS9mcmFnOjk0NGQ2N2RjOTNmMjQ1MjliZTc4ZmNlMzRiOGMyZTBiL3RhYmxlOjhjMmVjZjQ0MTM3MTQ4MzI4MDE3YTEwMzNhZjE3MjY4L3RhYmxlcmFuZ2U6OGMyZWNmNDQxMzcxNDgzMjgwMTdhMTAzM2FmMTcyNjhfMy03LTEtMS0w_5f5b7991-fa0f-46b8-8cbc-c071554fc4c4">8,415</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cannabis extracts</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1508a4a4053d4dd08a6db69f6c1e840b_D20200101-20200630" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzY2E5YmIwMTc5MjQ3NmZiYjIyNWU1ZDlkZWM4NjlmL3NlYzo5M2NhOWJiMDE3OTI0NzZmYmIyMjVlNWQ5ZGVjODY5Zl81NS9mcmFnOjk0NGQ2N2RjOTNmMjQ1MjliZTc4ZmNlMzRiOGMyZTBiL3RhYmxlOjhjMmVjZjQ0MTM3MTQ4MzI4MDE3YTEwMzNhZjE3MjY4L3RhYmxlcmFuZ2U6OGMyZWNmNDQxMzcxNDgzMjgwMTdhMTAzM2FmMTcyNjhfNC0xLTEtMS0w_92c485a7-0997-4286-b4e4-1877d02883c3">4,350</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i08837b8da47246b3a38247a1afce6246_D20200101-20200630" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzY2E5YmIwMTc5MjQ3NmZiYjIyNWU1ZDlkZWM4NjlmL3NlYzo5M2NhOWJiMDE3OTI0NzZmYmIyMjVlNWQ5ZGVjODY5Zl81NS9mcmFnOjk0NGQ2N2RjOTNmMjQ1MjliZTc4ZmNlMzRiOGMyZTBiL3RhYmxlOjhjMmVjZjQ0MTM3MTQ4MzI4MDE3YTEwMzNhZjE3MjY4L3RhYmxlcmFuZ2U6OGMyZWNmNDQxMzcxNDgzMjgwMTdhMTAzM2FmMTcyNjhfNC0zLTEtMS0w_3c6aafd8-3125-497a-b5e6-ee14b46e0c7e">5,317</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i514785787edd460fb909104cd7dc4a04_D20200101-20200630" decimals="-3" format="ixt:zerodash" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzY2E5YmIwMTc5MjQ3NmZiYjIyNWU1ZDlkZWM4NjlmL3NlYzo5M2NhOWJiMDE3OTI0NzZmYmIyMjVlNWQ5ZGVjODY5Zl81NS9mcmFnOjk0NGQ2N2RjOTNmMjQ1MjliZTc4ZmNlMzRiOGMyZTBiL3RhYmxlOjhjMmVjZjQ0MTM3MTQ4MzI4MDE3YTEwMzNhZjE3MjY4L3RhYmxlcmFuZ2U6OGMyZWNmNDQxMzcxNDgzMjgwMTdhMTAzM2FmMTcyNjhfNC01LTEtMS0w_cd704c4c-5eeb-4a50-9570-4d5ac9b26078">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if253a5adac88412093cd3c8f27aa185f_D20200101-20200630" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzY2E5YmIwMTc5MjQ3NmZiYjIyNWU1ZDlkZWM4NjlmL3NlYzo5M2NhOWJiMDE3OTI0NzZmYmIyMjVlNWQ5ZGVjODY5Zl81NS9mcmFnOjk0NGQ2N2RjOTNmMjQ1MjliZTc4ZmNlMzRiOGMyZTBiL3RhYmxlOjhjMmVjZjQ0MTM3MTQ4MzI4MDE3YTEwMzNhZjE3MjY4L3RhYmxlcmFuZ2U6OGMyZWNmNDQxMzcxNDgzMjgwMTdhMTAzM2FmMTcyNjhfNC03LTEtMS0w_3c4f2481-2e7c-40d6-a14e-aac182750ee7">9,667</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9f4c7e46c3d34f5aa34d2e09db3380cf_D20200101-20200630" decimals="-3" format="ixt:zerodash" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzY2E5YmIwMTc5MjQ3NmZiYjIyNWU1ZDlkZWM4NjlmL3NlYzo5M2NhOWJiMDE3OTI0NzZmYmIyMjVlNWQ5ZGVjODY5Zl81NS9mcmFnOjk0NGQ2N2RjOTNmMjQ1MjliZTc4ZmNlMzRiOGMyZTBiL3RhYmxlOjhjMmVjZjQ0MTM3MTQ4MzI4MDE3YTEwMzNhZjE3MjY4L3RhYmxlcmFuZ2U6OGMyZWNmNDQxMzcxNDgzMjgwMTdhMTAzM2FmMTcyNjhfNS0xLTEtMS0w_4c9f5f61-87ed-49cd-aee4-956a6261a4ba">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i943cc5b8191b493f8aa9ee910e58ea43_D20200101-20200630" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzY2E5YmIwMTc5MjQ3NmZiYjIyNWU1ZDlkZWM4NjlmL3NlYzo5M2NhOWJiMDE3OTI0NzZmYmIyMjVlNWQ5ZGVjODY5Zl81NS9mcmFnOjk0NGQ2N2RjOTNmMjQ1MjliZTc4ZmNlMzRiOGMyZTBiL3RhYmxlOjhjMmVjZjQ0MTM3MTQ4MzI4MDE3YTEwMzNhZjE3MjY4L3RhYmxlcmFuZ2U6OGMyZWNmNDQxMzcxNDgzMjgwMTdhMTAzM2FmMTcyNjhfNS0zLTEtMS0w_1ce7e4b1-f14b-421f-b697-4628d704b35c">233</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i42b8c121915c4f34996c473e36cccd8d_D20200101-20200630" decimals="-3" format="ixt:zerodash" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzY2E5YmIwMTc5MjQ3NmZiYjIyNWU1ZDlkZWM4NjlmL3NlYzo5M2NhOWJiMDE3OTI0NzZmYmIyMjVlNWQ5ZGVjODY5Zl81NS9mcmFnOjk0NGQ2N2RjOTNmMjQ1MjliZTc4ZmNlMzRiOGMyZTBiL3RhYmxlOjhjMmVjZjQ0MTM3MTQ4MzI4MDE3YTEwMzNhZjE3MjY4L3RhYmxlcmFuZ2U6OGMyZWNmNDQxMzcxNDgzMjgwMTdhMTAzM2FmMTcyNjhfNS01LTEtMS0w_a1b9b441-5a87-42a7-94dc-fb417a3295f3">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i24f9699a302b4e86895a7c9098da3221_D20200101-20200630" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzY2E5YmIwMTc5MjQ3NmZiYjIyNWU1ZDlkZWM4NjlmL3NlYzo5M2NhOWJiMDE3OTI0NzZmYmIyMjVlNWQ5ZGVjODY5Zl81NS9mcmFnOjk0NGQ2N2RjOTNmMjQ1MjliZTc4ZmNlMzRiOGMyZTBiL3RhYmxlOjhjMmVjZjQ0MTM3MTQ4MzI4MDE3YTEwMzNhZjE3MjY4L3RhYmxlcmFuZ2U6OGMyZWNmNDQxMzcxNDgzMjgwMTdhMTAzM2FmMTcyNjhfNS03LTEtMS0w_485c6f64-29f6-4090-b949-8909282b120a">233</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net revenue</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iab9b56b2a03f4c6199d282bd8676a924_D20200101-20200630" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzY2E5YmIwMTc5MjQ3NmZiYjIyNWU1ZDlkZWM4NjlmL3NlYzo5M2NhOWJiMDE3OTI0NzZmYmIyMjVlNWQ5ZGVjODY5Zl81NS9mcmFnOjk0NGQ2N2RjOTNmMjQ1MjliZTc4ZmNlMzRiOGMyZTBiL3RhYmxlOjhjMmVjZjQ0MTM3MTQ4MzI4MDE3YTEwMzNhZjE3MjY4L3RhYmxlcmFuZ2U6OGMyZWNmNDQxMzcxNDgzMjgwMTdhMTAzM2FmMTcyNjhfNi0xLTEtMS0w_0c854099-25cf-453a-9d34-29a8a65a8892">4,350</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i13788f202c86441fa347b97f3162a453_D20200101-20200630" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzY2E5YmIwMTc5MjQ3NmZiYjIyNWU1ZDlkZWM4NjlmL3NlYzo5M2NhOWJiMDE3OTI0NzZmYmIyMjVlNWQ5ZGVjODY5Zl81NS9mcmFnOjk0NGQ2N2RjOTNmMjQ1MjliZTc4ZmNlMzRiOGMyZTBiL3RhYmxlOjhjMmVjZjQ0MTM3MTQ4MzI4MDE3YTEwMzNhZjE3MjY4L3RhYmxlcmFuZ2U6OGMyZWNmNDQxMzcxNDgzMjgwMTdhMTAzM2FmMTcyNjhfNi0zLTEtMS0w_372e6528-17d4-4d9b-9baf-b9bb91b853f6">13,965</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iaf98f9473a3d428f9aab9f72e135866f_D20200101-20200630" decimals="-3" format="ixt:zerodash" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzY2E5YmIwMTc5MjQ3NmZiYjIyNWU1ZDlkZWM4NjlmL3NlYzo5M2NhOWJiMDE3OTI0NzZmYmIyMjVlNWQ5ZGVjODY5Zl81NS9mcmFnOjk0NGQ2N2RjOTNmMjQ1MjliZTc4ZmNlMzRiOGMyZTBiL3RhYmxlOjhjMmVjZjQ0MTM3MTQ4MzI4MDE3YTEwMzNhZjE3MjY4L3RhYmxlcmFuZ2U6OGMyZWNmNDQxMzcxNDgzMjgwMTdhMTAzM2FmMTcyNjhfNi01LTEtMS0w_75afa57b-7b82-486f-8272-610d60c40a21">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4a110e4972ef4113880ce582e3cda5c5_D20200101-20200630" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzY2E5YmIwMTc5MjQ3NmZiYjIyNWU1ZDlkZWM4NjlmL3NlYzo5M2NhOWJiMDE3OTI0NzZmYmIyMjVlNWQ5ZGVjODY5Zl81NS9mcmFnOjk0NGQ2N2RjOTNmMjQ1MjliZTc4ZmNlMzRiOGMyZTBiL3RhYmxlOjhjMmVjZjQ0MTM3MTQ4MzI4MDE3YTEwMzNhZjE3MjY4L3RhYmxlcmFuZ2U6OGMyZWNmNDQxMzcxNDgzMjgwMTdhMTAzM2FmMTcyNjhfNi03LTEtMS0w_173187a3-4df6-40ff-8fd3-a07deb6a8904">18,315</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr style="height:14pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Share of loss from equity accounted investments</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iab9b56b2a03f4c6199d282bd8676a924_D20200101-20200630" decimals="-3" format="ixt:zerodash" name="us-gaap:IncomeLossFromEquityMethodInvestments" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzY2E5YmIwMTc5MjQ3NmZiYjIyNWU1ZDlkZWM4NjlmL3NlYzo5M2NhOWJiMDE3OTI0NzZmYmIyMjVlNWQ5ZGVjODY5Zl81NS9mcmFnOjk0NGQ2N2RjOTNmMjQ1MjliZTc4ZmNlMzRiOGMyZTBiL3RhYmxlOjhjMmVjZjQ0MTM3MTQ4MzI4MDE3YTEwMzNhZjE3MjY4L3RhYmxlcmFuZ2U6OGMyZWNmNDQxMzcxNDgzMjgwMTdhMTAzM2FmMTcyNjhfOC0xLTEtMS0w_1c99ea07-612c-42c8-9db8-d9725189b552">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i13788f202c86441fa347b97f3162a453_D20200101-20200630" decimals="-3" sign="-" format="ixt:numdotdecimal" name="us-gaap:IncomeLossFromEquityMethodInvestments" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzY2E5YmIwMTc5MjQ3NmZiYjIyNWU1ZDlkZWM4NjlmL3NlYzo5M2NhOWJiMDE3OTI0NzZmYmIyMjVlNWQ5ZGVjODY5Zl81NS9mcmFnOjk0NGQ2N2RjOTNmMjQ1MjliZTc4ZmNlMzRiOGMyZTBiL3RhYmxlOjhjMmVjZjQ0MTM3MTQ4MzI4MDE3YTEwMzNhZjE3MjY4L3RhYmxlcmFuZ2U6OGMyZWNmNDQxMzcxNDgzMjgwMTdhMTAzM2FmMTcyNjhfOC0zLTEtMS0w_18b82a3b-04c0-4156-a9d1-2043fb8d628b">1,966</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iaf98f9473a3d428f9aab9f72e135866f_D20200101-20200630" decimals="-3" format="ixt:zerodash" name="us-gaap:IncomeLossFromEquityMethodInvestments" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzY2E5YmIwMTc5MjQ3NmZiYjIyNWU1ZDlkZWM4NjlmL3NlYzo5M2NhOWJiMDE3OTI0NzZmYmIyMjVlNWQ5ZGVjODY5Zl81NS9mcmFnOjk0NGQ2N2RjOTNmMjQ1MjliZTc4ZmNlMzRiOGMyZTBiL3RhYmxlOjhjMmVjZjQ0MTM3MTQ4MzI4MDE3YTEwMzNhZjE3MjY4L3RhYmxlcmFuZ2U6OGMyZWNmNDQxMzcxNDgzMjgwMTdhMTAzM2FmMTcyNjhfOC01LTEtMS0w_3326b8f4-8bc8-42f7-842e-9d24e3d9067a">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4a110e4972ef4113880ce582e3cda5c5_D20200101-20200630" decimals="-3" sign="-" format="ixt:numdotdecimal" name="us-gaap:IncomeLossFromEquityMethodInvestments" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzY2E5YmIwMTc5MjQ3NmZiYjIyNWU1ZDlkZWM4NjlmL3NlYzo5M2NhOWJiMDE3OTI0NzZmYmIyMjVlNWQ5ZGVjODY5Zl81NS9mcmFnOjk0NGQ2N2RjOTNmMjQ1MjliZTc4ZmNlMzRiOGMyZTBiL3RhYmxlOjhjMmVjZjQ0MTM3MTQ4MzI4MDE3YTEwMzNhZjE3MjY4L3RhYmxlcmFuZ2U6OGMyZWNmNDQxMzcxNDgzMjgwMTdhMTAzM2FmMTcyNjhfOC03LTEtMS0w_f0a43b54-f378-4519-902a-d5cf4fea6e24">1,966</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr style="height:14pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Interest income</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iab9b56b2a03f4c6199d282bd8676a924_D20200101-20200630" decimals="-3" name="us-gaap:InvestmentIncomeInterest" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzY2E5YmIwMTc5MjQ3NmZiYjIyNWU1ZDlkZWM4NjlmL3NlYzo5M2NhOWJiMDE3OTI0NzZmYmIyMjVlNWQ5ZGVjODY5Zl81NS9mcmFnOjk0NGQ2N2RjOTNmMjQ1MjliZTc4ZmNlMzRiOGMyZTBiL3RhYmxlOjhjMmVjZjQ0MTM3MTQ4MzI4MDE3YTEwMzNhZjE3MjY4L3RhYmxlcmFuZ2U6OGMyZWNmNDQxMzcxNDgzMjgwMTdhMTAzM2FmMTcyNjhfMTAtMS0xLTEtMA_d002bc93-e4e9-445f-b77c-04d9e60821d8">16</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i13788f202c86441fa347b97f3162a453_D20200101-20200630" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:InvestmentIncomeInterest" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzY2E5YmIwMTc5MjQ3NmZiYjIyNWU1ZDlkZWM4NjlmL3NlYzo5M2NhOWJiMDE3OTI0NzZmYmIyMjVlNWQ5ZGVjODY5Zl81NS9mcmFnOjk0NGQ2N2RjOTNmMjQ1MjliZTc4ZmNlMzRiOGMyZTBiL3RhYmxlOjhjMmVjZjQ0MTM3MTQ4MzI4MDE3YTEwMzNhZjE3MjY4L3RhYmxlcmFuZ2U6OGMyZWNmNDQxMzcxNDgzMjgwMTdhMTAzM2FmMTcyNjhfMTAtMy0xLTEtMA_96356487-dd06-490a-9f5e-1c979da06c2c">11,559</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iaf98f9473a3d428f9aab9f72e135866f_D20200101-20200630" decimals="-3" format="ixt:zerodash" name="us-gaap:InvestmentIncomeInterest" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzY2E5YmIwMTc5MjQ3NmZiYjIyNWU1ZDlkZWM4NjlmL3NlYzo5M2NhOWJiMDE3OTI0NzZmYmIyMjVlNWQ5ZGVjODY5Zl81NS9mcmFnOjk0NGQ2N2RjOTNmMjQ1MjliZTc4ZmNlMzRiOGMyZTBiL3RhYmxlOjhjMmVjZjQ0MTM3MTQ4MzI4MDE3YTEwMzNhZjE3MjY4L3RhYmxlcmFuZ2U6OGMyZWNmNDQxMzcxNDgzMjgwMTdhMTAzM2FmMTcyNjhfMTAtNS0xLTEtMA_bb114d4e-28cf-4668-8a4a-2a7747fd3321">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4a110e4972ef4113880ce582e3cda5c5_D20200101-20200630" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:InvestmentIncomeInterest" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzY2E5YmIwMTc5MjQ3NmZiYjIyNWU1ZDlkZWM4NjlmL3NlYzo5M2NhOWJiMDE3OTI0NzZmYmIyMjVlNWQ5ZGVjODY5Zl81NS9mcmFnOjk0NGQ2N2RjOTNmMjQ1MjliZTc4ZmNlMzRiOGMyZTBiL3RhYmxlOjhjMmVjZjQ0MTM3MTQ4MzI4MDE3YTEwMzNhZjE3MjY4L3RhYmxlcmFuZ2U6OGMyZWNmNDQxMzcxNDgzMjgwMTdhMTAzM2FmMTcyNjhfMTAtNy0xLTEtMA_c4f40852-4587-4247-aaaa-cf5f0c2f4c7c">11,575</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Interest expense</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iab9b56b2a03f4c6199d282bd8676a924_D20200101-20200630" decimals="-3" format="ixt:zerodash" name="us-gaap:InterestExpense" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzY2E5YmIwMTc5MjQ3NmZiYjIyNWU1ZDlkZWM4NjlmL3NlYzo5M2NhOWJiMDE3OTI0NzZmYmIyMjVlNWQ5ZGVjODY5Zl81NS9mcmFnOjk0NGQ2N2RjOTNmMjQ1MjliZTc4ZmNlMzRiOGMyZTBiL3RhYmxlOjhjMmVjZjQ0MTM3MTQ4MzI4MDE3YTEwMzNhZjE3MjY4L3RhYmxlcmFuZ2U6OGMyZWNmNDQxMzcxNDgzMjgwMTdhMTAzM2FmMTcyNjhfMTEtMS0xLTEtMA_6ec94f43-6bd4-442f-b06c-58b5a05fe3b7">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i13788f202c86441fa347b97f3162a453_D20200101-20200630" decimals="-3" name="us-gaap:InterestExpense" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzY2E5YmIwMTc5MjQ3NmZiYjIyNWU1ZDlkZWM4NjlmL3NlYzo5M2NhOWJiMDE3OTI0NzZmYmIyMjVlNWQ5ZGVjODY5Zl81NS9mcmFnOjk0NGQ2N2RjOTNmMjQ1MjliZTc4ZmNlMzRiOGMyZTBiL3RhYmxlOjhjMmVjZjQ0MTM3MTQ4MzI4MDE3YTEwMzNhZjE3MjY4L3RhYmxlcmFuZ2U6OGMyZWNmNDQxMzcxNDgzMjgwMTdhMTAzM2FmMTcyNjhfMTEtMy0xLTEtMA_6074cf46-fd17-4344-891c-1b6cc31a3b5e">90</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iaf98f9473a3d428f9aab9f72e135866f_D20200101-20200630" decimals="-3" format="ixt:zerodash" name="us-gaap:InterestExpense" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzY2E5YmIwMTc5MjQ3NmZiYjIyNWU1ZDlkZWM4NjlmL3NlYzo5M2NhOWJiMDE3OTI0NzZmYmIyMjVlNWQ5ZGVjODY5Zl81NS9mcmFnOjk0NGQ2N2RjOTNmMjQ1MjliZTc4ZmNlMzRiOGMyZTBiL3RhYmxlOjhjMmVjZjQ0MTM3MTQ4MzI4MDE3YTEwMzNhZjE3MjY4L3RhYmxlcmFuZ2U6OGMyZWNmNDQxMzcxNDgzMjgwMTdhMTAzM2FmMTcyNjhfMTEtNS0xLTEtMA_32b06b76-65e3-4d6d-8b03-5601f187f8e6">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i4a110e4972ef4113880ce582e3cda5c5_D20200101-20200630" decimals="-3" name="us-gaap:InterestExpense" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzY2E5YmIwMTc5MjQ3NmZiYjIyNWU1ZDlkZWM4NjlmL3NlYzo5M2NhOWJiMDE3OTI0NzZmYmIyMjVlNWQ5ZGVjODY5Zl81NS9mcmFnOjk0NGQ2N2RjOTNmMjQ1MjliZTc4ZmNlMzRiOGMyZTBiL3RhYmxlOjhjMmVjZjQ0MTM3MTQ4MzI4MDE3YTEwMzNhZjE3MjY4L3RhYmxlcmFuZ2U6OGMyZWNmNDQxMzcxNDgzMjgwMTdhMTAzM2FmMTcyNjhfMTEtNy0xLTEtMA_757b439f-423a-419e-a167-e7b48dff7cbe">90</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Interest income, net</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iab9b56b2a03f4c6199d282bd8676a924_D20200101-20200630" decimals="-3" name="us-gaap:InterestIncomeExpenseNonoperatingNet" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzY2E5YmIwMTc5MjQ3NmZiYjIyNWU1ZDlkZWM4NjlmL3NlYzo5M2NhOWJiMDE3OTI0NzZmYmIyMjVlNWQ5ZGVjODY5Zl81NS9mcmFnOjk0NGQ2N2RjOTNmMjQ1MjliZTc4ZmNlMzRiOGMyZTBiL3RhYmxlOjhjMmVjZjQ0MTM3MTQ4MzI4MDE3YTEwMzNhZjE3MjY4L3RhYmxlcmFuZ2U6OGMyZWNmNDQxMzcxNDgzMjgwMTdhMTAzM2FmMTcyNjhfMTItMS0xLTEtMA_2f1bcff9-e2a9-415a-8d3f-b0d0f5a569a4">16</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i13788f202c86441fa347b97f3162a453_D20200101-20200630" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:InterestIncomeExpenseNonoperatingNet" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzY2E5YmIwMTc5MjQ3NmZiYjIyNWU1ZDlkZWM4NjlmL3NlYzo5M2NhOWJiMDE3OTI0NzZmYmIyMjVlNWQ5ZGVjODY5Zl81NS9mcmFnOjk0NGQ2N2RjOTNmMjQ1MjliZTc4ZmNlMzRiOGMyZTBiL3RhYmxlOjhjMmVjZjQ0MTM3MTQ4MzI4MDE3YTEwMzNhZjE3MjY4L3RhYmxlcmFuZ2U6OGMyZWNmNDQxMzcxNDgzMjgwMTdhMTAzM2FmMTcyNjhfMTItMy0xLTEtMA_b890db61-7acf-4368-9d1c-423378aea53b">11,469</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iaf98f9473a3d428f9aab9f72e135866f_D20200101-20200630" decimals="-3" format="ixt:zerodash" name="us-gaap:InterestIncomeExpenseNonoperatingNet" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzY2E5YmIwMTc5MjQ3NmZiYjIyNWU1ZDlkZWM4NjlmL3NlYzo5M2NhOWJiMDE3OTI0NzZmYmIyMjVlNWQ5ZGVjODY5Zl81NS9mcmFnOjk0NGQ2N2RjOTNmMjQ1MjliZTc4ZmNlMzRiOGMyZTBiL3RhYmxlOjhjMmVjZjQ0MTM3MTQ4MzI4MDE3YTEwMzNhZjE3MjY4L3RhYmxlcmFuZ2U6OGMyZWNmNDQxMzcxNDgzMjgwMTdhMTAzM2FmMTcyNjhfMTItNS0xLTEtMA_c8019994-dccc-48ce-9d9a-fca7943a8846">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4a110e4972ef4113880ce582e3cda5c5_D20200101-20200630" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:InterestIncomeExpenseNonoperatingNet" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzY2E5YmIwMTc5MjQ3NmZiYjIyNWU1ZDlkZWM4NjlmL3NlYzo5M2NhOWJiMDE3OTI0NzZmYmIyMjVlNWQ5ZGVjODY5Zl81NS9mcmFnOjk0NGQ2N2RjOTNmMjQ1MjliZTc4ZmNlMzRiOGMyZTBiL3RhYmxlOjhjMmVjZjQ0MTM3MTQ4MzI4MDE3YTEwMzNhZjE3MjY4L3RhYmxlcmFuZ2U6OGMyZWNmNDQxMzcxNDgzMjgwMTdhMTAzM2FmMTcyNjhfMTItNy0xLTEtMA_018256d4-4d38-4750-b890-e54c8b7e1794">11,485</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr style="height:14pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total assets</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i702a586f0ecb4fc1b7bfe544770fb520_I20200630" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:Assets" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzY2E5YmIwMTc5MjQ3NmZiYjIyNWU1ZDlkZWM4NjlmL3NlYzo5M2NhOWJiMDE3OTI0NzZmYmIyMjVlNWQ5ZGVjODY5Zl81NS9mcmFnOjk0NGQ2N2RjOTNmMjQ1MjliZTc4ZmNlMzRiOGMyZTBiL3RhYmxlOjhjMmVjZjQ0MTM3MTQ4MzI4MDE3YTEwMzNhZjE3MjY4L3RhYmxlcmFuZ2U6OGMyZWNmNDQxMzcxNDgzMjgwMTdhMTAzM2FmMTcyNjhfMTMtMS0xLTEtMTg0Njk_8e663f09-901c-40ed-baa1-8ffe06db5c1e">250,470</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if4396fb40fd54b7faa91c1e910136a74_I20200630" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:Assets" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzY2E5YmIwMTc5MjQ3NmZiYjIyNWU1ZDlkZWM4NjlmL3NlYzo5M2NhOWJiMDE3OTI0NzZmYmIyMjVlNWQ5ZGVjODY5Zl81NS9mcmFnOjk0NGQ2N2RjOTNmMjQ1MjliZTc4ZmNlMzRiOGMyZTBiL3RhYmxlOjhjMmVjZjQ0MTM3MTQ4MzI4MDE3YTEwMzNhZjE3MjY4L3RhYmxlcmFuZ2U6OGMyZWNmNDQxMzcxNDgzMjgwMTdhMTAzM2FmMTcyNjhfMTMtMy0xLTEtMTg0Njk_8f416a52-504d-4659-b177-51a13822d4a2">348,569</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iad52c8a5170c4f5bbeca5c035dd90f4e_I20200630" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:Assets" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzY2E5YmIwMTc5MjQ3NmZiYjIyNWU1ZDlkZWM4NjlmL3NlYzo5M2NhOWJiMDE3OTI0NzZmYmIyMjVlNWQ5ZGVjODY5Zl81NS9mcmFnOjk0NGQ2N2RjOTNmMjQ1MjliZTc4ZmNlMzRiOGMyZTBiL3RhYmxlOjhjMmVjZjQ0MTM3MTQ4MzI4MDE3YTEwMzNhZjE3MjY4L3RhYmxlcmFuZ2U6OGMyZWNmNDQxMzcxNDgzMjgwMTdhMTAzM2FmMTcyNjhfMTMtNS0xLTEtMTg0Njk_91101b96-2db3-48f2-8b70-41f23ed8c047">1,311,248</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id670dc9b33e6430f9d7510009f7495a7_I20200630" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:Assets" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzY2E5YmIwMTc5MjQ3NmZiYjIyNWU1ZDlkZWM4NjlmL3NlYzo5M2NhOWJiMDE3OTI0NzZmYmIyMjVlNWQ5ZGVjODY5Zl81NS9mcmFnOjk0NGQ2N2RjOTNmMjQ1MjliZTc4ZmNlMzRiOGMyZTBiL3RhYmxlOjhjMmVjZjQ0MTM3MTQ4MzI4MDE3YTEwMzNhZjE3MjY4L3RhYmxlcmFuZ2U6OGMyZWNmNDQxMzcxNDgzMjgwMTdhMTAzM2FmMTcyNjhfMTMtNy0xLTEtMjA3NzQ_a1389a8d-ecd6-4889-9285-cd64dc330ed9">1,910,287</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Depreciation and amortization</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iab9b56b2a03f4c6199d282bd8676a924_D20200101-20200630" decimals="-3" name="us-gaap:DepreciationAndAmortization" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzY2E5YmIwMTc5MjQ3NmZiYjIyNWU1ZDlkZWM4NjlmL3NlYzo5M2NhOWJiMDE3OTI0NzZmYmIyMjVlNWQ5ZGVjODY5Zl81NS9mcmFnOjk0NGQ2N2RjOTNmMjQ1MjliZTc4ZmNlMzRiOGMyZTBiL3RhYmxlOjhjMmVjZjQ0MTM3MTQ4MzI4MDE3YTEwMzNhZjE3MjY4L3RhYmxlcmFuZ2U6OGMyZWNmNDQxMzcxNDgzMjgwMTdhMTAzM2FmMTcyNjhfMTQtMS0xLTEtMA_e23f4612-34eb-4114-8ae3-806ac80533fb">69</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i13788f202c86441fa347b97f3162a453_D20200101-20200630" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:DepreciationAndAmortization" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzY2E5YmIwMTc5MjQ3NmZiYjIyNWU1ZDlkZWM4NjlmL3NlYzo5M2NhOWJiMDE3OTI0NzZmYmIyMjVlNWQ5ZGVjODY5Zl81NS9mcmFnOjk0NGQ2N2RjOTNmMjQ1MjliZTc4ZmNlMzRiOGMyZTBiL3RhYmxlOjhjMmVjZjQ0MTM3MTQ4MzI4MDE3YTEwMzNhZjE3MjY4L3RhYmxlcmFuZ2U6OGMyZWNmNDQxMzcxNDgzMjgwMTdhMTAzM2FmMTcyNjhfMTQtMy0xLTEtMA_298878db-e2b2-4671-8c33-e223a71299a5">1,297</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iaf98f9473a3d428f9aab9f72e135866f_D20200101-20200630" decimals="-3" format="ixt:zerodash" name="us-gaap:DepreciationAndAmortization" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzY2E5YmIwMTc5MjQ3NmZiYjIyNWU1ZDlkZWM4NjlmL3NlYzo5M2NhOWJiMDE3OTI0NzZmYmIyMjVlNWQ5ZGVjODY5Zl81NS9mcmFnOjk0NGQ2N2RjOTNmMjQ1MjliZTc4ZmNlMzRiOGMyZTBiL3RhYmxlOjhjMmVjZjQ0MTM3MTQ4MzI4MDE3YTEwMzNhZjE3MjY4L3RhYmxlcmFuZ2U6OGMyZWNmNDQxMzcxNDgzMjgwMTdhMTAzM2FmMTcyNjhfMTQtNS0xLTEtMA_9833871b-af05-440f-9b44-0143a1fca9de">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4a110e4972ef4113880ce582e3cda5c5_D20200101-20200630" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:DepreciationAndAmortization" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzY2E5YmIwMTc5MjQ3NmZiYjIyNWU1ZDlkZWM4NjlmL3NlYzo5M2NhOWJiMDE3OTI0NzZmYmIyMjVlNWQ5ZGVjODY5Zl81NS9mcmFnOjk0NGQ2N2RjOTNmMjQ1MjliZTc4ZmNlMzRiOGMyZTBiL3RhYmxlOjhjMmVjZjQ0MTM3MTQ4MzI4MDE3YTEwMzNhZjE3MjY4L3RhYmxlcmFuZ2U6OGMyZWNmNDQxMzcxNDgzMjgwMTdhMTAzM2FmMTcyNjhfMTQtNy0xLTEtMA_91fd1444-829a-497d-b20a-fbbf01c1078f">1,366</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Impairment loss on long-lived assets</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iab9b56b2a03f4c6199d282bd8676a924_D20200101-20200630" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:OperatingLeaseRightOfUseAssetAmortizationExpense" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzY2E5YmIwMTc5MjQ3NmZiYjIyNWU1ZDlkZWM4NjlmL3NlYzo5M2NhOWJiMDE3OTI0NzZmYmIyMjVlNWQ5ZGVjODY5Zl81NS9mcmFnOjk0NGQ2N2RjOTNmMjQ1MjliZTc4ZmNlMzRiOGMyZTBiL3RhYmxlOjhjMmVjZjQ0MTM3MTQ4MzI4MDE3YTEwMzNhZjE3MjY4L3RhYmxlcmFuZ2U6OGMyZWNmNDQxMzcxNDgzMjgwMTdhMTAzM2FmMTcyNjhfMTUtMS0xLTEtNDg3OQ_ad4589c1-f724-418a-89df-1f9f81bb8166">40,000</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i13788f202c86441fa347b97f3162a453_D20200101-20200630" decimals="-3" format="ixt:zerodash" name="us-gaap:OperatingLeaseRightOfUseAssetAmortizationExpense" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzY2E5YmIwMTc5MjQ3NmZiYjIyNWU1ZDlkZWM4NjlmL3NlYzo5M2NhOWJiMDE3OTI0NzZmYmIyMjVlNWQ5ZGVjODY5Zl81NS9mcmFnOjk0NGQ2N2RjOTNmMjQ1MjliZTc4ZmNlMzRiOGMyZTBiL3RhYmxlOjhjMmVjZjQ0MTM3MTQ4MzI4MDE3YTEwMzNhZjE3MjY4L3RhYmxlcmFuZ2U6OGMyZWNmNDQxMzcxNDgzMjgwMTdhMTAzM2FmMTcyNjhfMTUtMy0xLTEtNDg3OQ_30a7b9a7-1095-46af-b7ae-edba715f082b">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iaf98f9473a3d428f9aab9f72e135866f_D20200101-20200630" decimals="-3" format="ixt:zerodash" name="us-gaap:OperatingLeaseRightOfUseAssetAmortizationExpense" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzY2E5YmIwMTc5MjQ3NmZiYjIyNWU1ZDlkZWM4NjlmL3NlYzo5M2NhOWJiMDE3OTI0NzZmYmIyMjVlNWQ5ZGVjODY5Zl81NS9mcmFnOjk0NGQ2N2RjOTNmMjQ1MjliZTc4ZmNlMzRiOGMyZTBiL3RhYmxlOjhjMmVjZjQ0MTM3MTQ4MzI4MDE3YTEwMzNhZjE3MjY4L3RhYmxlcmFuZ2U6OGMyZWNmNDQxMzcxNDgzMjgwMTdhMTAzM2FmMTcyNjhfMTUtNS0xLTEtNDg3OQ_ec9e0662-c15a-46c3-85f8-7532d5b65751">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4a110e4972ef4113880ce582e3cda5c5_D20200101-20200630" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:OperatingLeaseRightOfUseAssetAmortizationExpense" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzY2E5YmIwMTc5MjQ3NmZiYjIyNWU1ZDlkZWM4NjlmL3NlYzo5M2NhOWJiMDE3OTI0NzZmYmIyMjVlNWQ5ZGVjODY5Zl81NS9mcmFnOjk0NGQ2N2RjOTNmMjQ1MjliZTc4ZmNlMzRiOGMyZTBiL3RhYmxlOjhjMmVjZjQ0MTM3MTQ4MzI4MDE3YTEwMzNhZjE3MjY4L3RhYmxlcmFuZ2U6OGMyZWNmNDQxMzcxNDgzMjgwMTdhMTAzM2FmMTcyNjhfMTUtNy0xLTEtNDg3OQ_26ed7780-8329-44d8-b476-2d95c83b835b">40,000</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Adjusted EBITDA</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="iab9b56b2a03f4c6199d282bd8676a924_D20200101-20200630" decimals="-3" sign="-" format="ixt:numdotdecimal" name="cron:AdjustedEarningsBeforeInterestTaxesDepreciationAndAmortization" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzY2E5YmIwMTc5MjQ3NmZiYjIyNWU1ZDlkZWM4NjlmL3NlYzo5M2NhOWJiMDE3OTI0NzZmYmIyMjVlNWQ5ZGVjODY5Zl81NS9mcmFnOjk0NGQ2N2RjOTNmMjQ1MjliZTc4ZmNlMzRiOGMyZTBiL3RhYmxlOjhjMmVjZjQ0MTM3MTQ4MzI4MDE3YTEwMzNhZjE3MjY4L3RhYmxlcmFuZ2U6OGMyZWNmNDQxMzcxNDgzMjgwMTdhMTAzM2FmMTcyNjhfMTYtMS0xLTEtMA_39a26a65-5881-4ce7-adec-148286212de3">10,567</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i13788f202c86441fa347b97f3162a453_D20200101-20200630" decimals="-3" sign="-" format="ixt:numdotdecimal" name="cron:AdjustedEarningsBeforeInterestTaxesDepreciationAndAmortization" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzY2E5YmIwMTc5MjQ3NmZiYjIyNWU1ZDlkZWM4NjlmL3NlYzo5M2NhOWJiMDE3OTI0NzZmYmIyMjVlNWQ5ZGVjODY5Zl81NS9mcmFnOjk0NGQ2N2RjOTNmMjQ1MjliZTc4ZmNlMzRiOGMyZTBiL3RhYmxlOjhjMmVjZjQ0MTM3MTQ4MzI4MDE3YTEwMzNhZjE3MjY4L3RhYmxlcmFuZ2U6OGMyZWNmNDQxMzcxNDgzMjgwMTdhMTAzM2FmMTcyNjhfMTYtMy0xLTEtMA_d5093e20-883b-4b0c-a035-5f8a34231e73">47,628</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="iaf98f9473a3d428f9aab9f72e135866f_D20200101-20200630" decimals="-3" sign="-" format="ixt:numdotdecimal" name="cron:AdjustedEarningsBeforeInterestTaxesDepreciationAndAmortization" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzY2E5YmIwMTc5MjQ3NmZiYjIyNWU1ZDlkZWM4NjlmL3NlYzo5M2NhOWJiMDE3OTI0NzZmYmIyMjVlNWQ5ZGVjODY5Zl81NS9mcmFnOjk0NGQ2N2RjOTNmMjQ1MjliZTc4ZmNlMzRiOGMyZTBiL3RhYmxlOjhjMmVjZjQ0MTM3MTQ4MzI4MDE3YTEwMzNhZjE3MjY4L3RhYmxlcmFuZ2U6OGMyZWNmNDQxMzcxNDgzMjgwMTdhMTAzM2FmMTcyNjhfMTYtNS0xLTEtMA_9dd97150-fc31-427e-ba71-ce067dd92775">5,846</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i4a110e4972ef4113880ce582e3cda5c5_D20200101-20200630" decimals="-3" sign="-" format="ixt:numdotdecimal" name="cron:AdjustedEarningsBeforeInterestTaxesDepreciationAndAmortization" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzY2E5YmIwMTc5MjQ3NmZiYjIyNWU1ZDlkZWM4NjlmL3NlYzo5M2NhOWJiMDE3OTI0NzZmYmIyMjVlNWQ5ZGVjODY5Zl81NS9mcmFnOjk0NGQ2N2RjOTNmMjQ1MjliZTc4ZmNlMzRiOGMyZTBiL3RhYmxlOjhjMmVjZjQ0MTM3MTQ4MzI4MDE3YTEwMzNhZjE3MjY4L3RhYmxlcmFuZ2U6OGMyZWNmNDQxMzcxNDgzMjgwMTdhMTAzM2FmMTcyNjhfMTYtNy0xLTEtMA_ec9e2bda-0c9a-4fa1-9250-9d4259532f6b">64,041</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Purchase of property, plant and equipment, net</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iab9b56b2a03f4c6199d282bd8676a924_D20200101-20200630" decimals="-3" name="us-gaap:PropertyPlantAndEquipmentAdditions" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzY2E5YmIwMTc5MjQ3NmZiYjIyNWU1ZDlkZWM4NjlmL3NlYzo5M2NhOWJiMDE3OTI0NzZmYmIyMjVlNWQ5ZGVjODY5Zl81NS9mcmFnOjk0NGQ2N2RjOTNmMjQ1MjliZTc4ZmNlMzRiOGMyZTBiL3RhYmxlOjhjMmVjZjQ0MTM3MTQ4MzI4MDE3YTEwMzNhZjE3MjY4L3RhYmxlcmFuZ2U6OGMyZWNmNDQxMzcxNDgzMjgwMTdhMTAzM2FmMTcyNjhfMTctMS0xLTEtMTczMTc_5ba36614-38b3-481b-b4ee-15e92aaf74bc">219</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i13788f202c86441fa347b97f3162a453_D20200101-20200630" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:PropertyPlantAndEquipmentAdditions" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzY2E5YmIwMTc5MjQ3NmZiYjIyNWU1ZDlkZWM4NjlmL3NlYzo5M2NhOWJiMDE3OTI0NzZmYmIyMjVlNWQ5ZGVjODY5Zl81NS9mcmFnOjk0NGQ2N2RjOTNmMjQ1MjliZTc4ZmNlMzRiOGMyZTBiL3RhYmxlOjhjMmVjZjQ0MTM3MTQ4MzI4MDE3YTEwMzNhZjE3MjY4L3RhYmxlcmFuZ2U6OGMyZWNmNDQxMzcxNDgzMjgwMTdhMTAzM2FmMTcyNjhfMTctMy0xLTEtMTczMjA_8f97333a-21dc-4a84-a267-35fd9ff4c7c5">13,125</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iaf98f9473a3d428f9aab9f72e135866f_D20200101-20200630" decimals="-3" format="ixt:zerodash" name="us-gaap:PropertyPlantAndEquipmentAdditions" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzY2E5YmIwMTc5MjQ3NmZiYjIyNWU1ZDlkZWM4NjlmL3NlYzo5M2NhOWJiMDE3OTI0NzZmYmIyMjVlNWQ5ZGVjODY5Zl81NS9mcmFnOjk0NGQ2N2RjOTNmMjQ1MjliZTc4ZmNlMzRiOGMyZTBiL3RhYmxlOjhjMmVjZjQ0MTM3MTQ4MzI4MDE3YTEwMzNhZjE3MjY4L3RhYmxlcmFuZ2U6OGMyZWNmNDQxMzcxNDgzMjgwMTdhMTAzM2FmMTcyNjhfMTctNS0xLTEtMTczMjM_a4424b99-a8fe-4451-ad11-1a57c3c94d55">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4a110e4972ef4113880ce582e3cda5c5_D20200101-20200630" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:PropertyPlantAndEquipmentAdditions" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzY2E5YmIwMTc5MjQ3NmZiYjIyNWU1ZDlkZWM4NjlmL3NlYzo5M2NhOWJiMDE3OTI0NzZmYmIyMjVlNWQ5ZGVjODY5Zl81NS9mcmFnOjk0NGQ2N2RjOTNmMjQ1MjliZTc4ZmNlMzRiOGMyZTBiL3RhYmxlOjhjMmVjZjQ0MTM3MTQ4MzI4MDE3YTEwMzNhZjE3MjY4L3RhYmxlcmFuZ2U6OGMyZWNmNDQxMzcxNDgzMjgwMTdhMTAzM2FmMTcyNjhfMTctNy0xLTEtMTczNzc_b2992648-f21d-43d0-af40-012e35200cc9">13,344</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr></table></div></ix:continuation></ix:continuation><div style="margin-bottom:6pt;margin-top:3pt;text-align:justify;text-indent:-9pt"><span><br/></span></div><div style="height:36pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">22</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:72pt;width:100%"><div style="margin-top:0.55pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:95.000%"><tr><td style="width:1.0%"></td><td style="width:65.712%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:32.088%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="border-top:1pt solid #FFFFFF;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Cronos Group Inc.</span></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Notes to Condensed Consolidated Financial Statements (Unaudited)</span></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">(In thousands of $, except share amounts)</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i93ca9bb01792476fbb225e5d9dec869f_7">Table of Contents</a></span></div></td></tr></table></div></div><ix:continuation id="i5166505034c14d3db46b76423c5b74d3" continuedAt="id60c1be92bfc41ccab11e03515c8d381"><ix:continuation id="i94e8d24753c34f368f84aa4553a44685" continuedAt="i1ee9823bd4c04d489e453e3073b868ca"><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following tables set forth a reconciliation of net income (loss) as determined in accordance with U.S. GAAP to Adjusted EBITDA for the periods indicated:</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:42.650%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.233%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.772%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.233%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.772%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.233%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.772%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.235%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="21" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Three months ended June&#160;30, 2021</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">United States</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Rest of World</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Corporate Expenses</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Total</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 6.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net income (loss)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i2a563d1bc1a1451296d5f40e6cdf2912_D20210401-20210630" decimals="-3" sign="-" format="ixt:numdotdecimal" name="us-gaap:ProfitLoss" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzY2E5YmIwMTc5MjQ3NmZiYjIyNWU1ZDlkZWM4NjlmL3NlYzo5M2NhOWJiMDE3OTI0NzZmYmIyMjVlNWQ5ZGVjODY5Zl81NS9mcmFnOjk0NGQ2N2RjOTNmMjQ1MjliZTc4ZmNlMzRiOGMyZTBiL3RhYmxlOjM0OTY4NTgyMjZmNzQzZWE4Y2M4ZWM1ZTVkMmQzODY5L3RhYmxlcmFuZ2U6MzQ5Njg1ODIyNmY3NDNlYThjYzhlYzVlNWQyZDM4NjlfMi0xLTEtMS0w_f657e865-a751-48a0-a8de-b818378b5fba">11,719</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7b627a38d4bb4b2693a9598ca41f647d_D20210401-20210630" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:ProfitLoss" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzY2E5YmIwMTc5MjQ3NmZiYjIyNWU1ZDlkZWM4NjlmL3NlYzo5M2NhOWJiMDE3OTI0NzZmYmIyMjVlNWQ5ZGVjODY5Zl81NS9mcmFnOjk0NGQ2N2RjOTNmMjQ1MjliZTc4ZmNlMzRiOGMyZTBiL3RhYmxlOjM0OTY4NTgyMjZmNzQzZWE4Y2M4ZWM1ZTVkMmQzODY5L3RhYmxlcmFuZ2U6MzQ5Njg1ODIyNmY3NDNlYThjYzhlYzVlNWQyZDM4NjlfMi0zLTEtMS0w_7a1e6278-aaa3-44a3-bf2f-cdc21e411303">79,627</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ie916e4a685544ae3998d4e82e089944f_D20210401-20210630" decimals="-3" sign="-" format="ixt:numdotdecimal" name="us-gaap:ProfitLoss" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzY2E5YmIwMTc5MjQ3NmZiYjIyNWU1ZDlkZWM4NjlmL3NlYzo5M2NhOWJiMDE3OTI0NzZmYmIyMjVlNWQ5ZGVjODY5Zl81NS9mcmFnOjk0NGQ2N2RjOTNmMjQ1MjliZTc4ZmNlMzRiOGMyZTBiL3RhYmxlOjM0OTY4NTgyMjZmNzQzZWE4Y2M4ZWM1ZTVkMmQzODY5L3RhYmxlcmFuZ2U6MzQ5Njg1ODIyNmY3NDNlYThjYzhlYzVlNWQyZDM4NjlfMi01LTEtMS0w_a5538eb3-86cc-4829-9311-b85a56e98e16">11,133</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 7pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i27f4e53b91ad4367b7f8d273eff27769_D20210401-20210630" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:ProfitLoss" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzY2E5YmIwMTc5MjQ3NmZiYjIyNWU1ZDlkZWM4NjlmL3NlYzo5M2NhOWJiMDE3OTI0NzZmYmIyMjVlNWQ5ZGVjODY5Zl81NS9mcmFnOjk0NGQ2N2RjOTNmMjQ1MjliZTc4ZmNlMzRiOGMyZTBiL3RhYmxlOjM0OTY4NTgyMjZmNzQzZWE4Y2M4ZWM1ZTVkMmQzODY5L3RhYmxlcmFuZ2U6MzQ5Njg1ODIyNmY3NDNlYThjYzhlYzVlNWQyZDM4NjlfMi03LTEtMS0w_da32e140-d521-44b5-91bc-a7db57f6cd34">56,775</ix:nonFraction></span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 18.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Interest income, net</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i2a563d1bc1a1451296d5f40e6cdf2912_D20210401-20210630" decimals="-3" name="us-gaap:InterestIncomeExpenseNonoperatingNet" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzY2E5YmIwMTc5MjQ3NmZiYjIyNWU1ZDlkZWM4NjlmL3NlYzo5M2NhOWJiMDE3OTI0NzZmYmIyMjVlNWQ5ZGVjODY5Zl81NS9mcmFnOjk0NGQ2N2RjOTNmMjQ1MjliZTc4ZmNlMzRiOGMyZTBiL3RhYmxlOjM0OTY4NTgyMjZmNzQzZWE4Y2M4ZWM1ZTVkMmQzODY5L3RhYmxlcmFuZ2U6MzQ5Njg1ODIyNmY3NDNlYThjYzhlYzVlNWQyZDM4NjlfNC0xLTEtMS0w_586d6ce2-6f6c-4ff8-8c22-f8eca29da557">20</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i7b627a38d4bb4b2693a9598ca41f647d_D20210401-20210630" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:InterestIncomeExpenseNonoperatingNet" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzY2E5YmIwMTc5MjQ3NmZiYjIyNWU1ZDlkZWM4NjlmL3NlYzo5M2NhOWJiMDE3OTI0NzZmYmIyMjVlNWQ5ZGVjODY5Zl81NS9mcmFnOjk0NGQ2N2RjOTNmMjQ1MjliZTc4ZmNlMzRiOGMyZTBiL3RhYmxlOjM0OTY4NTgyMjZmNzQzZWE4Y2M4ZWM1ZTVkMmQzODY5L3RhYmxlcmFuZ2U6MzQ5Njg1ODIyNmY3NDNlYThjYzhlYzVlNWQyZDM4NjlfNC0zLTEtMS0w_5adee23b-78e8-432d-9c47-ed77d08c7ffd">2,273</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie916e4a685544ae3998d4e82e089944f_D20210401-20210630" decimals="-3" format="ixt:zerodash" name="us-gaap:InterestIncomeExpenseNonoperatingNet" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzY2E5YmIwMTc5MjQ3NmZiYjIyNWU1ZDlkZWM4NjlmL3NlYzo5M2NhOWJiMDE3OTI0NzZmYmIyMjVlNWQ5ZGVjODY5Zl81NS9mcmFnOjk0NGQ2N2RjOTNmMjQ1MjliZTc4ZmNlMzRiOGMyZTBiL3RhYmxlOjM0OTY4NTgyMjZmNzQzZWE4Y2M4ZWM1ZTVkMmQzODY5L3RhYmxlcmFuZ2U6MzQ5Njg1ODIyNmY3NDNlYThjYzhlYzVlNWQyZDM4NjlfNC01LTEtMS0w_0c0df99a-1374-423b-ac43-80d787abe862">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i27f4e53b91ad4367b7f8d273eff27769_D20210401-20210630" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:InterestIncomeExpenseNonoperatingNet" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzY2E5YmIwMTc5MjQ3NmZiYjIyNWU1ZDlkZWM4NjlmL3NlYzo5M2NhOWJiMDE3OTI0NzZmYmIyMjVlNWQ5ZGVjODY5Zl81NS9mcmFnOjk0NGQ2N2RjOTNmMjQ1MjliZTc4ZmNlMzRiOGMyZTBiL3RhYmxlOjM0OTY4NTgyMjZmNzQzZWE4Y2M4ZWM1ZTVkMmQzODY5L3RhYmxlcmFuZ2U6MzQ5Njg1ODIyNmY3NDNlYThjYzhlYzVlNWQyZDM4NjlfNC03LTEtMS0w_20e1efe0-adea-41bd-bf6a-1ac2a887761f">2,293</ix:nonFraction>)</span></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 18.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Share of loss from equity accounted investments</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2a563d1bc1a1451296d5f40e6cdf2912_D20210401-20210630" decimals="-3" format="ixt:zerodash" name="us-gaap:IncomeLossFromEquityMethodInvestments" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzY2E5YmIwMTc5MjQ3NmZiYjIyNWU1ZDlkZWM4NjlmL3NlYzo5M2NhOWJiMDE3OTI0NzZmYmIyMjVlNWQ5ZGVjODY5Zl81NS9mcmFnOjk0NGQ2N2RjOTNmMjQ1MjliZTc4ZmNlMzRiOGMyZTBiL3RhYmxlOjM0OTY4NTgyMjZmNzQzZWE4Y2M4ZWM1ZTVkMmQzODY5L3RhYmxlcmFuZ2U6MzQ5Njg1ODIyNmY3NDNlYThjYzhlYzVlNWQyZDM4NjlfNi0xLTEtMS0w_b290ea8b-26fe-49f4-af18-73d9b3b52e8e">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7b627a38d4bb4b2693a9598ca41f647d_D20210401-20210630" decimals="-3" sign="-" format="ixt:numdotdecimal" name="us-gaap:IncomeLossFromEquityMethodInvestments" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzY2E5YmIwMTc5MjQ3NmZiYjIyNWU1ZDlkZWM4NjlmL3NlYzo5M2NhOWJiMDE3OTI0NzZmYmIyMjVlNWQ5ZGVjODY5Zl81NS9mcmFnOjk0NGQ2N2RjOTNmMjQ1MjliZTc4ZmNlMzRiOGMyZTBiL3RhYmxlOjM0OTY4NTgyMjZmNzQzZWE4Y2M4ZWM1ZTVkMmQzODY5L3RhYmxlcmFuZ2U6MzQ5Njg1ODIyNmY3NDNlYThjYzhlYzVlNWQyZDM4NjlfNi0zLTEtMS0w_7a75b06b-775e-4640-a66a-52ee433b2d28">1,115</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie916e4a685544ae3998d4e82e089944f_D20210401-20210630" decimals="-3" format="ixt:zerodash" name="us-gaap:IncomeLossFromEquityMethodInvestments" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzY2E5YmIwMTc5MjQ3NmZiYjIyNWU1ZDlkZWM4NjlmL3NlYzo5M2NhOWJiMDE3OTI0NzZmYmIyMjVlNWQ5ZGVjODY5Zl81NS9mcmFnOjk0NGQ2N2RjOTNmMjQ1MjliZTc4ZmNlMzRiOGMyZTBiL3RhYmxlOjM0OTY4NTgyMjZmNzQzZWE4Y2M4ZWM1ZTVkMmQzODY5L3RhYmxlcmFuZ2U6MzQ5Njg1ODIyNmY3NDNlYThjYzhlYzVlNWQyZDM4NjlfNi01LTEtMS0w_b969682d-8085-406e-a32a-b5c90704cef6">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i27f4e53b91ad4367b7f8d273eff27769_D20210401-20210630" decimals="-3" sign="-" format="ixt:numdotdecimal" name="us-gaap:IncomeLossFromEquityMethodInvestments" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzY2E5YmIwMTc5MjQ3NmZiYjIyNWU1ZDlkZWM4NjlmL3NlYzo5M2NhOWJiMDE3OTI0NzZmYmIyMjVlNWQ5ZGVjODY5Zl81NS9mcmFnOjk0NGQ2N2RjOTNmMjQ1MjliZTc4ZmNlMzRiOGMyZTBiL3RhYmxlOjM0OTY4NTgyMjZmNzQzZWE4Y2M4ZWM1ZTVkMmQzODY5L3RhYmxlcmFuZ2U6MzQ5Njg1ODIyNmY3NDNlYThjYzhlYzVlNWQyZDM4NjlfNi03LTEtMS0w_d45cd22c-2f1d-4a40-b8e8-6cc65906a998">1,115</ix:nonFraction></span></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:17.25pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Gain on revaluation of derivative liabilities</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(ii)</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2a563d1bc1a1451296d5f40e6cdf2912_D20210401-20210630" decimals="-3" format="ixt:zerodash" name="us-gaap:GainLossOnDerivativeInstrumentsNetPretax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzY2E5YmIwMTc5MjQ3NmZiYjIyNWU1ZDlkZWM4NjlmL3NlYzo5M2NhOWJiMDE3OTI0NzZmYmIyMjVlNWQ5ZGVjODY5Zl81NS9mcmFnOjk0NGQ2N2RjOTNmMjQ1MjliZTc4ZmNlMzRiOGMyZTBiL3RhYmxlOjM0OTY4NTgyMjZmNzQzZWE4Y2M4ZWM1ZTVkMmQzODY5L3RhYmxlcmFuZ2U6MzQ5Njg1ODIyNmY3NDNlYThjYzhlYzVlNWQyZDM4NjlfOC0xLTEtMS0w_730051d0-88c6-4eda-814d-27458d0710fc">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i7b627a38d4bb4b2693a9598ca41f647d_D20210401-20210630" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:GainLossOnDerivativeInstrumentsNetPretax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzY2E5YmIwMTc5MjQ3NmZiYjIyNWU1ZDlkZWM4NjlmL3NlYzo5M2NhOWJiMDE3OTI0NzZmYmIyMjVlNWQ5ZGVjODY5Zl81NS9mcmFnOjk0NGQ2N2RjOTNmMjQ1MjliZTc4ZmNlMzRiOGMyZTBiL3RhYmxlOjM0OTY4NTgyMjZmNzQzZWE4Y2M4ZWM1ZTVkMmQzODY5L3RhYmxlcmFuZ2U6MzQ5Njg1ODIyNmY3NDNlYThjYzhlYzVlNWQyZDM4NjlfOC0zLTEtMS0w_1f3fcfa9-ef68-415b-8dee-fc7e2edf8005">115,248</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie916e4a685544ae3998d4e82e089944f_D20210401-20210630" decimals="-3" format="ixt:zerodash" name="us-gaap:GainLossOnDerivativeInstrumentsNetPretax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzY2E5YmIwMTc5MjQ3NmZiYjIyNWU1ZDlkZWM4NjlmL3NlYzo5M2NhOWJiMDE3OTI0NzZmYmIyMjVlNWQ5ZGVjODY5Zl81NS9mcmFnOjk0NGQ2N2RjOTNmMjQ1MjliZTc4ZmNlMzRiOGMyZTBiL3RhYmxlOjM0OTY4NTgyMjZmNzQzZWE4Y2M4ZWM1ZTVkMmQzODY5L3RhYmxlcmFuZ2U6MzQ5Njg1ODIyNmY3NDNlYThjYzhlYzVlNWQyZDM4NjlfOC01LTEtMS0w_c828bc56-e22c-4c1d-a59b-d5812f8e49b7">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i27f4e53b91ad4367b7f8d273eff27769_D20210401-20210630" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:GainLossOnDerivativeInstrumentsNetPretax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzY2E5YmIwMTc5MjQ3NmZiYjIyNWU1ZDlkZWM4NjlmL3NlYzo5M2NhOWJiMDE3OTI0NzZmYmIyMjVlNWQ5ZGVjODY5Zl81NS9mcmFnOjk0NGQ2N2RjOTNmMjQ1MjliZTc4ZmNlMzRiOGMyZTBiL3RhYmxlOjM0OTY4NTgyMjZmNzQzZWE4Y2M4ZWM1ZTVkMmQzODY5L3RhYmxlcmFuZ2U6MzQ5Njg1ODIyNmY3NDNlYThjYzhlYzVlNWQyZDM4NjlfOC03LTEtMS0w_cd28e2de-0da3-4a3d-af3a-56ff0353e822">115,248</ix:nonFraction>)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:17.25pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Transaction costs</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(iii)</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2a563d1bc1a1451296d5f40e6cdf2912_D20210401-20210630" decimals="-3" format="ixt:zerodash" name="us-gaap:RestructuringCharges" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzY2E5YmIwMTc5MjQ3NmZiYjIyNWU1ZDlkZWM4NjlmL3NlYzo5M2NhOWJiMDE3OTI0NzZmYmIyMjVlNWQ5ZGVjODY5Zl81NS9mcmFnOjk0NGQ2N2RjOTNmMjQ1MjliZTc4ZmNlMzRiOGMyZTBiL3RhYmxlOjM0OTY4NTgyMjZmNzQzZWE4Y2M4ZWM1ZTVkMmQzODY5L3RhYmxlcmFuZ2U6MzQ5Njg1ODIyNmY3NDNlYThjYzhlYzVlNWQyZDM4NjlfOS0xLTEtMS0w_6192ed8c-2094-41de-807e-d23bf1f141fb">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7b627a38d4bb4b2693a9598ca41f647d_D20210401-20210630" decimals="-3" format="ixt:zerodash" name="us-gaap:RestructuringCharges" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzY2E5YmIwMTc5MjQ3NmZiYjIyNWU1ZDlkZWM4NjlmL3NlYzo5M2NhOWJiMDE3OTI0NzZmYmIyMjVlNWQ5ZGVjODY5Zl81NS9mcmFnOjk0NGQ2N2RjOTNmMjQ1MjliZTc4ZmNlMzRiOGMyZTBiL3RhYmxlOjM0OTY4NTgyMjZmNzQzZWE4Y2M4ZWM1ZTVkMmQzODY5L3RhYmxlcmFuZ2U6MzQ5Njg1ODIyNmY3NDNlYThjYzhlYzVlNWQyZDM4NjlfOS0zLTEtMS0w_0697837e-b508-4d40-9dd1-24b0e7e26c82">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie916e4a685544ae3998d4e82e089944f_D20210401-20210630" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:RestructuringCharges" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzY2E5YmIwMTc5MjQ3NmZiYjIyNWU1ZDlkZWM4NjlmL3NlYzo5M2NhOWJiMDE3OTI0NzZmYmIyMjVlNWQ5ZGVjODY5Zl81NS9mcmFnOjk0NGQ2N2RjOTNmMjQ1MjliZTc4ZmNlMzRiOGMyZTBiL3RhYmxlOjM0OTY4NTgyMjZmNzQzZWE4Y2M4ZWM1ZTVkMmQzODY5L3RhYmxlcmFuZ2U6MzQ5Njg1ODIyNmY3NDNlYThjYzhlYzVlNWQyZDM4NjlfOS01LTEtMS0w_ad54e217-211c-4b00-8500-8c0d75c7072b">2,758</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i27f4e53b91ad4367b7f8d273eff27769_D20210401-20210630" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:RestructuringCharges" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzY2E5YmIwMTc5MjQ3NmZiYjIyNWU1ZDlkZWM4NjlmL3NlYzo5M2NhOWJiMDE3OTI0NzZmYmIyMjVlNWQ5ZGVjODY5Zl81NS9mcmFnOjk0NGQ2N2RjOTNmMjQ1MjliZTc4ZmNlMzRiOGMyZTBiL3RhYmxlOjM0OTY4NTgyMjZmNzQzZWE4Y2M4ZWM1ZTVkMmQzODY5L3RhYmxlcmFuZ2U6MzQ5Njg1ODIyNmY3NDNlYThjYzhlYzVlNWQyZDM4NjlfOS03LTEtMS0w_0ad89a7f-172c-451d-a76e-9c73cc204946">2,758</ix:nonFraction></span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:17.25pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other, net</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(iv)</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2a563d1bc1a1451296d5f40e6cdf2912_D20210401-20210630" decimals="-3" format="ixt:zerodash" name="us-gaap:OtherNonoperatingIncomeExpense" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzY2E5YmIwMTc5MjQ3NmZiYjIyNWU1ZDlkZWM4NjlmL3NlYzo5M2NhOWJiMDE3OTI0NzZmYmIyMjVlNWQ5ZGVjODY5Zl81NS9mcmFnOjk0NGQ2N2RjOTNmMjQ1MjliZTc4ZmNlMzRiOGMyZTBiL3RhYmxlOjM0OTY4NTgyMjZmNzQzZWE4Y2M4ZWM1ZTVkMmQzODY5L3RhYmxlcmFuZ2U6MzQ5Njg1ODIyNmY3NDNlYThjYzhlYzVlNWQyZDM4NjlfMTAtMS0xLTEtMA_d2f48d18-2d19-4ffd-aa5c-fca673df4a46">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i7b627a38d4bb4b2693a9598ca41f647d_D20210401-20210630" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:OtherNonoperatingIncomeExpense" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzY2E5YmIwMTc5MjQ3NmZiYjIyNWU1ZDlkZWM4NjlmL3NlYzo5M2NhOWJiMDE3OTI0NzZmYmIyMjVlNWQ5ZGVjODY5Zl81NS9mcmFnOjk0NGQ2N2RjOTNmMjQ1MjliZTc4ZmNlMzRiOGMyZTBiL3RhYmxlOjM0OTY4NTgyMjZmNzQzZWE4Y2M4ZWM1ZTVkMmQzODY5L3RhYmxlcmFuZ2U6MzQ5Njg1ODIyNmY3NDNlYThjYzhlYzVlNWQyZDM4NjlfMTAtMy0xLTEtMA_1e3e52dd-ac8a-41b8-951c-72045a477c8f">1,127</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie916e4a685544ae3998d4e82e089944f_D20210401-20210630" decimals="-3" format="ixt:zerodash" name="us-gaap:OtherNonoperatingIncomeExpense" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzY2E5YmIwMTc5MjQ3NmZiYjIyNWU1ZDlkZWM4NjlmL3NlYzo5M2NhOWJiMDE3OTI0NzZmYmIyMjVlNWQ5ZGVjODY5Zl81NS9mcmFnOjk0NGQ2N2RjOTNmMjQ1MjliZTc4ZmNlMzRiOGMyZTBiL3RhYmxlOjM0OTY4NTgyMjZmNzQzZWE4Y2M4ZWM1ZTVkMmQzODY5L3RhYmxlcmFuZ2U6MzQ5Njg1ODIyNmY3NDNlYThjYzhlYzVlNWQyZDM4NjlfMTAtNS0xLTEtMA_0ffe8f41-f3b8-4022-891e-336d94c198d9">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i27f4e53b91ad4367b7f8d273eff27769_D20210401-20210630" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:OtherNonoperatingIncomeExpense" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzY2E5YmIwMTc5MjQ3NmZiYjIyNWU1ZDlkZWM4NjlmL3NlYzo5M2NhOWJiMDE3OTI0NzZmYmIyMjVlNWQ5ZGVjODY5Zl81NS9mcmFnOjk0NGQ2N2RjOTNmMjQ1MjliZTc4ZmNlMzRiOGMyZTBiL3RhYmxlOjM0OTY4NTgyMjZmNzQzZWE4Y2M4ZWM1ZTVkMmQzODY5L3RhYmxlcmFuZ2U6MzQ5Njg1ODIyNmY3NDNlYThjYzhlYzVlNWQyZDM4NjlfMTAtNy0xLTEtMA_445d6dc7-897f-496d-aa3f-1cfe282b2181">1,127</ix:nonFraction>)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:17.25pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Loss from discontinued operations</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(v)</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2a563d1bc1a1451296d5f40e6cdf2912_D20210401-20210630" decimals="-3" format="ixt:zerodash" name="us-gaap:IncomeLossFromDiscontinuedOperationsNetOfTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzY2E5YmIwMTc5MjQ3NmZiYjIyNWU1ZDlkZWM4NjlmL3NlYzo5M2NhOWJiMDE3OTI0NzZmYmIyMjVlNWQ5ZGVjODY5Zl81NS9mcmFnOjk0NGQ2N2RjOTNmMjQ1MjliZTc4ZmNlMzRiOGMyZTBiL3RhYmxlOjM0OTY4NTgyMjZmNzQzZWE4Y2M4ZWM1ZTVkMmQzODY5L3RhYmxlcmFuZ2U6MzQ5Njg1ODIyNmY3NDNlYThjYzhlYzVlNWQyZDM4NjlfMTEtMS0xLTEtMA_1871a03f-72fb-4263-bccf-1f042356cee1">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7b627a38d4bb4b2693a9598ca41f647d_D20210401-20210630" decimals="-3" sign="-" name="us-gaap:IncomeLossFromDiscontinuedOperationsNetOfTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzY2E5YmIwMTc5MjQ3NmZiYjIyNWU1ZDlkZWM4NjlmL3NlYzo5M2NhOWJiMDE3OTI0NzZmYmIyMjVlNWQ5ZGVjODY5Zl81NS9mcmFnOjk0NGQ2N2RjOTNmMjQ1MjliZTc4ZmNlMzRiOGMyZTBiL3RhYmxlOjM0OTY4NTgyMjZmNzQzZWE4Y2M4ZWM1ZTVkMmQzODY5L3RhYmxlcmFuZ2U6MzQ5Njg1ODIyNmY3NDNlYThjYzhlYzVlNWQyZDM4NjlfMTEtMy0xLTEtMA_970ae643-c0c5-4063-8b0f-6105b74b7330">561</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie916e4a685544ae3998d4e82e089944f_D20210401-20210630" decimals="-3" format="ixt:zerodash" name="us-gaap:IncomeLossFromDiscontinuedOperationsNetOfTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzY2E5YmIwMTc5MjQ3NmZiYjIyNWU1ZDlkZWM4NjlmL3NlYzo5M2NhOWJiMDE3OTI0NzZmYmIyMjVlNWQ5ZGVjODY5Zl81NS9mcmFnOjk0NGQ2N2RjOTNmMjQ1MjliZTc4ZmNlMzRiOGMyZTBiL3RhYmxlOjM0OTY4NTgyMjZmNzQzZWE4Y2M4ZWM1ZTVkMmQzODY5L3RhYmxlcmFuZ2U6MzQ5Njg1ODIyNmY3NDNlYThjYzhlYzVlNWQyZDM4NjlfMTEtNS0xLTEtMA_c42646e2-50d4-4efe-96a2-bab50fc2313e">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i27f4e53b91ad4367b7f8d273eff27769_D20210401-20210630" decimals="-3" sign="-" name="us-gaap:IncomeLossFromDiscontinuedOperationsNetOfTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzY2E5YmIwMTc5MjQ3NmZiYjIyNWU1ZDlkZWM4NjlmL3NlYzo5M2NhOWJiMDE3OTI0NzZmYmIyMjVlNWQ5ZGVjODY5Zl81NS9mcmFnOjk0NGQ2N2RjOTNmMjQ1MjliZTc4ZmNlMzRiOGMyZTBiL3RhYmxlOjM0OTY4NTgyMjZmNzQzZWE4Y2M4ZWM1ZTVkMmQzODY5L3RhYmxlcmFuZ2U6MzQ5Njg1ODIyNmY3NDNlYThjYzhlYzVlNWQyZDM4NjlfMTEtNy0xLTEtMA_33d6817a-73c0-4e22-8f92-7cb2465d467a">561</ix:nonFraction></span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:17.25pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Share-based payments</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(vi)</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2a563d1bc1a1451296d5f40e6cdf2912_D20210401-20210630" decimals="-3" name="us-gaap:AllocatedShareBasedCompensationExpense" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzY2E5YmIwMTc5MjQ3NmZiYjIyNWU1ZDlkZWM4NjlmL3NlYzo5M2NhOWJiMDE3OTI0NzZmYmIyMjVlNWQ5ZGVjODY5Zl81NS9mcmFnOjk0NGQ2N2RjOTNmMjQ1MjliZTc4ZmNlMzRiOGMyZTBiL3RhYmxlOjM0OTY4NTgyMjZmNzQzZWE4Y2M4ZWM1ZTVkMmQzODY5L3RhYmxlcmFuZ2U6MzQ5Njg1ODIyNmY3NDNlYThjYzhlYzVlNWQyZDM4NjlfMTItMS0xLTEtMA_b171d295-ad2f-4149-89af-b07de08f1bec">822</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7b627a38d4bb4b2693a9598ca41f647d_D20210401-20210630" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:AllocatedShareBasedCompensationExpense" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzY2E5YmIwMTc5MjQ3NmZiYjIyNWU1ZDlkZWM4NjlmL3NlYzo5M2NhOWJiMDE3OTI0NzZmYmIyMjVlNWQ5ZGVjODY5Zl81NS9mcmFnOjk0NGQ2N2RjOTNmMjQ1MjliZTc4ZmNlMzRiOGMyZTBiL3RhYmxlOjM0OTY4NTgyMjZmNzQzZWE4Y2M4ZWM1ZTVkMmQzODY5L3RhYmxlcmFuZ2U6MzQ5Njg1ODIyNmY3NDNlYThjYzhlYzVlNWQyZDM4NjlfMTItMy0xLTEtMA_ae289c09-f263-405d-8be6-73456b019fc9">1,743</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie916e4a685544ae3998d4e82e089944f_D20210401-20210630" decimals="-3" format="ixt:zerodash" name="us-gaap:AllocatedShareBasedCompensationExpense" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzY2E5YmIwMTc5MjQ3NmZiYjIyNWU1ZDlkZWM4NjlmL3NlYzo5M2NhOWJiMDE3OTI0NzZmYmIyMjVlNWQ5ZGVjODY5Zl81NS9mcmFnOjk0NGQ2N2RjOTNmMjQ1MjliZTc4ZmNlMzRiOGMyZTBiL3RhYmxlOjM0OTY4NTgyMjZmNzQzZWE4Y2M4ZWM1ZTVkMmQzODY5L3RhYmxlcmFuZ2U6MzQ5Njg1ODIyNmY3NDNlYThjYzhlYzVlNWQyZDM4NjlfMTItNS0xLTEtMA_6984f92d-c004-49df-b95d-ccd8ebde8377">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i27f4e53b91ad4367b7f8d273eff27769_D20210401-20210630" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:AllocatedShareBasedCompensationExpense" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzY2E5YmIwMTc5MjQ3NmZiYjIyNWU1ZDlkZWM4NjlmL3NlYzo5M2NhOWJiMDE3OTI0NzZmYmIyMjVlNWQ5ZGVjODY5Zl81NS9mcmFnOjk0NGQ2N2RjOTNmMjQ1MjliZTc4ZmNlMzRiOGMyZTBiL3RhYmxlOjM0OTY4NTgyMjZmNzQzZWE4Y2M4ZWM1ZTVkMmQzODY5L3RhYmxlcmFuZ2U6MzQ5Njg1ODIyNmY3NDNlYThjYzhlYzVlNWQyZDM4NjlfMTItNy0xLTEtMA_a8a1c35a-ac56-46d9-9101-26f70318d23b">2,565</ix:nonFraction></span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:17.25pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Review costs related to restatement of 2019 interim financial statements</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(vii)</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2a563d1bc1a1451296d5f40e6cdf2912_D20210401-20210630" decimals="-3" format="ixt:zerodash" name="cron:RestatementReviewExpense" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzY2E5YmIwMTc5MjQ3NmZiYjIyNWU1ZDlkZWM4NjlmL3NlYzo5M2NhOWJiMDE3OTI0NzZmYmIyMjVlNWQ5ZGVjODY5Zl81NS9mcmFnOjk0NGQ2N2RjOTNmMjQ1MjliZTc4ZmNlMzRiOGMyZTBiL3RhYmxlOjM0OTY4NTgyMjZmNzQzZWE4Y2M4ZWM1ZTVkMmQzODY5L3RhYmxlcmFuZ2U6MzQ5Njg1ODIyNmY3NDNlYThjYzhlYzVlNWQyZDM4NjlfMTMtMS0xLTEtMA_77019d1f-bb2f-4112-8b2c-14eedd9ef86b">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7b627a38d4bb4b2693a9598ca41f647d_D20210401-20210630" decimals="-3" format="ixt:zerodash" name="cron:RestatementReviewExpense" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzY2E5YmIwMTc5MjQ3NmZiYjIyNWU1ZDlkZWM4NjlmL3NlYzo5M2NhOWJiMDE3OTI0NzZmYmIyMjVlNWQ5ZGVjODY5Zl81NS9mcmFnOjk0NGQ2N2RjOTNmMjQ1MjliZTc4ZmNlMzRiOGMyZTBiL3RhYmxlOjM0OTY4NTgyMjZmNzQzZWE4Y2M4ZWM1ZTVkMmQzODY5L3RhYmxlcmFuZ2U6MzQ5Njg1ODIyNmY3NDNlYThjYzhlYzVlNWQyZDM4NjlfMTMtMy0xLTEtMA_282c233e-9dea-47eb-b3fa-4521d72adb2f">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie916e4a685544ae3998d4e82e089944f_D20210401-20210630" decimals="-3" format="ixt:numdotdecimal" name="cron:RestatementReviewExpense" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzY2E5YmIwMTc5MjQ3NmZiYjIyNWU1ZDlkZWM4NjlmL3NlYzo5M2NhOWJiMDE3OTI0NzZmYmIyMjVlNWQ5ZGVjODY5Zl81NS9mcmFnOjk0NGQ2N2RjOTNmMjQ1MjliZTc4ZmNlMzRiOGMyZTBiL3RhYmxlOjM0OTY4NTgyMjZmNzQzZWE4Y2M4ZWM1ZTVkMmQzODY5L3RhYmxlcmFuZ2U6MzQ5Njg1ODIyNmY3NDNlYThjYzhlYzVlNWQyZDM4NjlfMTMtNS0xLTEtMA_98276b24-2b36-4ff2-b09e-bf041e10b7b7">1,932</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i27f4e53b91ad4367b7f8d273eff27769_D20210401-20210630" decimals="-3" format="ixt:numdotdecimal" name="cron:RestatementReviewExpense" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzY2E5YmIwMTc5MjQ3NmZiYjIyNWU1ZDlkZWM4NjlmL3NlYzo5M2NhOWJiMDE3OTI0NzZmYmIyMjVlNWQ5ZGVjODY5Zl81NS9mcmFnOjk0NGQ2N2RjOTNmMjQ1MjliZTc4ZmNlMzRiOGMyZTBiL3RhYmxlOjM0OTY4NTgyMjZmNzQzZWE4Y2M4ZWM1ZTVkMmQzODY5L3RhYmxlcmFuZ2U6MzQ5Njg1ODIyNmY3NDNlYThjYzhlYzVlNWQyZDM4NjlfMTMtNy0xLTEtMA_3bdfe2d8-21ef-4d1a-8d10-bbb6cd8f242e">1,932</ix:nonFraction></span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Depreciation and amortization</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2a563d1bc1a1451296d5f40e6cdf2912_D20210401-20210630" decimals="-3" name="us-gaap:DepreciationDepletionAndAmortization" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzY2E5YmIwMTc5MjQ3NmZiYjIyNWU1ZDlkZWM4NjlmL3NlYzo5M2NhOWJiMDE3OTI0NzZmYmIyMjVlNWQ5ZGVjODY5Zl81NS9mcmFnOjk0NGQ2N2RjOTNmMjQ1MjliZTc4ZmNlMzRiOGMyZTBiL3RhYmxlOjM0OTY4NTgyMjZmNzQzZWE4Y2M4ZWM1ZTVkMmQzODY5L3RhYmxlcmFuZ2U6MzQ5Njg1ODIyNmY3NDNlYThjYzhlYzVlNWQyZDM4NjlfMTYtMS0xLTEtMA_219d519d-c1fd-4fbb-a776-c4bab35c2c16">206</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7b627a38d4bb4b2693a9598ca41f647d_D20210401-20210630" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:DepreciationDepletionAndAmortization" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzY2E5YmIwMTc5MjQ3NmZiYjIyNWU1ZDlkZWM4NjlmL3NlYzo5M2NhOWJiMDE3OTI0NzZmYmIyMjVlNWQ5ZGVjODY5Zl81NS9mcmFnOjk0NGQ2N2RjOTNmMjQ1MjliZTc4ZmNlMzRiOGMyZTBiL3RhYmxlOjM0OTY4NTgyMjZmNzQzZWE4Y2M4ZWM1ZTVkMmQzODY5L3RhYmxlcmFuZ2U6MzQ5Njg1ODIyNmY3NDNlYThjYzhlYzVlNWQyZDM4NjlfMTYtMy0xLTEtMA_8114dcad-f6c0-412b-9f56-f07ce2e60167">2,997</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie916e4a685544ae3998d4e82e089944f_D20210401-20210630" decimals="-3" format="ixt:zerodash" name="us-gaap:DepreciationDepletionAndAmortization" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzY2E5YmIwMTc5MjQ3NmZiYjIyNWU1ZDlkZWM4NjlmL3NlYzo5M2NhOWJiMDE3OTI0NzZmYmIyMjVlNWQ5ZGVjODY5Zl81NS9mcmFnOjk0NGQ2N2RjOTNmMjQ1MjliZTc4ZmNlMzRiOGMyZTBiL3RhYmxlOjM0OTY4NTgyMjZmNzQzZWE4Y2M4ZWM1ZTVkMmQzODY5L3RhYmxlcmFuZ2U6MzQ5Njg1ODIyNmY3NDNlYThjYzhlYzVlNWQyZDM4NjlfMTYtNS0xLTEtMA_b92caf0a-9d8e-455e-a663-5a00890fb73a">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i27f4e53b91ad4367b7f8d273eff27769_D20210401-20210630" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:DepreciationDepletionAndAmortization" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzY2E5YmIwMTc5MjQ3NmZiYjIyNWU1ZDlkZWM4NjlmL3NlYzo5M2NhOWJiMDE3OTI0NzZmYmIyMjVlNWQ5ZGVjODY5Zl81NS9mcmFnOjk0NGQ2N2RjOTNmMjQ1MjliZTc4ZmNlMzRiOGMyZTBiL3RhYmxlOjM0OTY4NTgyMjZmNzQzZWE4Y2M4ZWM1ZTVkMmQzODY5L3RhYmxlcmFuZ2U6MzQ5Njg1ODIyNmY3NDNlYThjYzhlYzVlNWQyZDM4NjlfMTYtNy0xLTEtMA_569720c7-696e-405d-aee5-e36505a34739">3,203</ix:nonFraction></span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Adjusted EBITDA</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i2a563d1bc1a1451296d5f40e6cdf2912_D20210401-20210630" decimals="-3" sign="-" format="ixt:numdotdecimal" name="cron:AdjustedEarningsBeforeInterestTaxesDepreciationAndAmortization" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzY2E5YmIwMTc5MjQ3NmZiYjIyNWU1ZDlkZWM4NjlmL3NlYzo5M2NhOWJiMDE3OTI0NzZmYmIyMjVlNWQ5ZGVjODY5Zl81NS9mcmFnOjk0NGQ2N2RjOTNmMjQ1MjliZTc4ZmNlMzRiOGMyZTBiL3RhYmxlOjM0OTY4NTgyMjZmNzQzZWE4Y2M4ZWM1ZTVkMmQzODY5L3RhYmxlcmFuZ2U6MzQ5Njg1ODIyNmY3NDNlYThjYzhlYzVlNWQyZDM4NjlfMTctMS0xLTEtMA_7624d3cb-0115-427b-acb6-f7e93a008f82">10,711</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i7b627a38d4bb4b2693a9598ca41f647d_D20210401-20210630" decimals="-3" sign="-" format="ixt:numdotdecimal" name="cron:AdjustedEarningsBeforeInterestTaxesDepreciationAndAmortization" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzY2E5YmIwMTc5MjQ3NmZiYjIyNWU1ZDlkZWM4NjlmL3NlYzo5M2NhOWJiMDE3OTI0NzZmYmIyMjVlNWQ5ZGVjODY5Zl81NS9mcmFnOjk0NGQ2N2RjOTNmMjQ1MjliZTc4ZmNlMzRiOGMyZTBiL3RhYmxlOjM0OTY4NTgyMjZmNzQzZWE4Y2M4ZWM1ZTVkMmQzODY5L3RhYmxlcmFuZ2U6MzQ5Njg1ODIyNmY3NDNlYThjYzhlYzVlNWQyZDM4NjlfMTctMy0xLTEtMA_0885fa9e-ffce-420e-bf80-0ab5f8eb01f2">32,605</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ie916e4a685544ae3998d4e82e089944f_D20210401-20210630" decimals="-3" sign="-" format="ixt:numdotdecimal" name="cron:AdjustedEarningsBeforeInterestTaxesDepreciationAndAmortization" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzY2E5YmIwMTc5MjQ3NmZiYjIyNWU1ZDlkZWM4NjlmL3NlYzo5M2NhOWJiMDE3OTI0NzZmYmIyMjVlNWQ5ZGVjODY5Zl81NS9mcmFnOjk0NGQ2N2RjOTNmMjQ1MjliZTc4ZmNlMzRiOGMyZTBiL3RhYmxlOjM0OTY4NTgyMjZmNzQzZWE4Y2M4ZWM1ZTVkMmQzODY5L3RhYmxlcmFuZ2U6MzQ5Njg1ODIyNmY3NDNlYThjYzhlYzVlNWQyZDM4NjlfMTctNS0xLTEtMA_53cecb8c-6b6e-4329-9e17-abfe339ed31d">6,443</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i27f4e53b91ad4367b7f8d273eff27769_D20210401-20210630" decimals="-3" sign="-" format="ixt:numdotdecimal" name="cron:AdjustedEarningsBeforeInterestTaxesDepreciationAndAmortization" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzY2E5YmIwMTc5MjQ3NmZiYjIyNWU1ZDlkZWM4NjlmL3NlYzo5M2NhOWJiMDE3OTI0NzZmYmIyMjVlNWQ5ZGVjODY5Zl81NS9mcmFnOjk0NGQ2N2RjOTNmMjQ1MjliZTc4ZmNlMzRiOGMyZTBiL3RhYmxlOjM0OTY4NTgyMjZmNzQzZWE4Y2M4ZWM1ZTVkMmQzODY5L3RhYmxlcmFuZ2U6MzQ5Njg1ODIyNmY3NDNlYThjYzhlYzVlNWQyZDM4NjlfMTctNy0xLTEtMA_d2cc0332-6b58-4812-a395-a09eb7997787">49,759</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:42.650%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.233%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.772%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.233%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.772%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.233%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.772%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.235%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="21" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Three months ended June&#160;30, 2020</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">United States</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Rest of World</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Corporate<br/>Expenses</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Total</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net loss</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="icb85df07ebfc4bfa99c08f8c9f0cb89c_D20200401-20200630" decimals="-3" sign="-" format="ixt:numdotdecimal" name="us-gaap:ProfitLoss" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzY2E5YmIwMTc5MjQ3NmZiYjIyNWU1ZDlkZWM4NjlmL3NlYzo5M2NhOWJiMDE3OTI0NzZmYmIyMjVlNWQ5ZGVjODY5Zl81NS9mcmFnOjk0NGQ2N2RjOTNmMjQ1MjliZTc4ZmNlMzRiOGMyZTBiL3RhYmxlOmMyMDc5OGU3NTU0NTRhYTc5N2Y1NGI2M2U3Njc3ZDY4L3RhYmxlcmFuZ2U6YzIwNzk4ZTc1NTQ1NGFhNzk3ZjU0YjYzZTc2NzdkNjhfMi0xLTEtMS0w_be69e42d-503d-4756-bb15-8bd79180e690">45,566</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="if83af42553ab4081bf67a6ecab2097fc_D20200401-20200630" decimals="-3" sign="-" format="ixt:numdotdecimal" name="us-gaap:ProfitLoss" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzY2E5YmIwMTc5MjQ3NmZiYjIyNWU1ZDlkZWM4NjlmL3NlYzo5M2NhOWJiMDE3OTI0NzZmYmIyMjVlNWQ5ZGVjODY5Zl81NS9mcmFnOjk0NGQ2N2RjOTNmMjQ1MjliZTc4ZmNlMzRiOGMyZTBiL3RhYmxlOmMyMDc5OGU3NTU0NTRhYTc5N2Y1NGI2M2U3Njc3ZDY4L3RhYmxlcmFuZ2U6YzIwNzk4ZTc1NTQ1NGFhNzk3ZjU0YjYzZTc2NzdkNjhfMi0zLTEtMS0w_a6bd6b69-ba9c-4ba5-b1f2-687f6d216cda">55,095</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i46e2093507a34f2fa6bcbc19a9aaaa63_D20200401-20200630" decimals="-3" sign="-" format="ixt:numdotdecimal" name="us-gaap:ProfitLoss" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzY2E5YmIwMTc5MjQ3NmZiYjIyNWU1ZDlkZWM4NjlmL3NlYzo5M2NhOWJiMDE3OTI0NzZmYmIyMjVlNWQ5ZGVjODY5Zl81NS9mcmFnOjk0NGQ2N2RjOTNmMjQ1MjliZTc4ZmNlMzRiOGMyZTBiL3RhYmxlOmMyMDc5OGU3NTU0NTRhYTc5N2Y1NGI2M2U3Njc3ZDY4L3RhYmxlcmFuZ2U6YzIwNzk4ZTc1NTQ1NGFhNzk3ZjU0YjYzZTc2NzdkNjhfMi01LTEtMS0w_368acd1c-a5e5-4f9b-b41e-aad443a33581">7,042</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 7pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i39065c5daf934af885335c12f3cfa83f_D20200401-20200630" decimals="-3" sign="-" format="ixt:numdotdecimal" name="us-gaap:ProfitLoss" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzY2E5YmIwMTc5MjQ3NmZiYjIyNWU1ZDlkZWM4NjlmL3NlYzo5M2NhOWJiMDE3OTI0NzZmYmIyMjVlNWQ5ZGVjODY5Zl81NS9mcmFnOjk0NGQ2N2RjOTNmMjQ1MjliZTc4ZmNlMzRiOGMyZTBiL3RhYmxlOmMyMDc5OGU3NTU0NTRhYTc5N2Y1NGI2M2U3Njc3ZDY4L3RhYmxlcmFuZ2U6YzIwNzk4ZTc1NTQ1NGFhNzk3ZjU0YjYzZTc2NzdkNjhfMi03LTEtMS0w_b0d7cb03-83f9-4d7a-91bc-465ceae20d98">107,703</ix:nonFraction>)</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 25pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Interest income, net</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="icb85df07ebfc4bfa99c08f8c9f0cb89c_D20200401-20200630" decimals="-3" name="us-gaap:InterestIncomeExpenseNonoperatingNet" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzY2E5YmIwMTc5MjQ3NmZiYjIyNWU1ZDlkZWM4NjlmL3NlYzo5M2NhOWJiMDE3OTI0NzZmYmIyMjVlNWQ5ZGVjODY5Zl81NS9mcmFnOjk0NGQ2N2RjOTNmMjQ1MjliZTc4ZmNlMzRiOGMyZTBiL3RhYmxlOmMyMDc5OGU3NTU0NTRhYTc5N2Y1NGI2M2U3Njc3ZDY4L3RhYmxlcmFuZ2U6YzIwNzk4ZTc1NTQ1NGFhNzk3ZjU0YjYzZTc2NzdkNjhfNC0xLTEtMS0w_d8e32372-de74-4046-b6f4-b2717854386f">9</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="if83af42553ab4081bf67a6ecab2097fc_D20200401-20200630" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:InterestIncomeExpenseNonoperatingNet" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzY2E5YmIwMTc5MjQ3NmZiYjIyNWU1ZDlkZWM4NjlmL3NlYzo5M2NhOWJiMDE3OTI0NzZmYmIyMjVlNWQ5ZGVjODY5Zl81NS9mcmFnOjk0NGQ2N2RjOTNmMjQ1MjliZTc4ZmNlMzRiOGMyZTBiL3RhYmxlOmMyMDc5OGU3NTU0NTRhYTc5N2Y1NGI2M2U3Njc3ZDY4L3RhYmxlcmFuZ2U6YzIwNzk4ZTc1NTQ1NGFhNzk3ZjU0YjYzZTc2NzdkNjhfNC0zLTEtMS0w_d9316d33-79b8-4046-9a55-701eb344226c">3,725</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i46e2093507a34f2fa6bcbc19a9aaaa63_D20200401-20200630" decimals="-3" format="ixt:zerodash" name="us-gaap:InterestIncomeExpenseNonoperatingNet" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzY2E5YmIwMTc5MjQ3NmZiYjIyNWU1ZDlkZWM4NjlmL3NlYzo5M2NhOWJiMDE3OTI0NzZmYmIyMjVlNWQ5ZGVjODY5Zl81NS9mcmFnOjk0NGQ2N2RjOTNmMjQ1MjliZTc4ZmNlMzRiOGMyZTBiL3RhYmxlOmMyMDc5OGU3NTU0NTRhYTc5N2Y1NGI2M2U3Njc3ZDY4L3RhYmxlcmFuZ2U6YzIwNzk4ZTc1NTQ1NGFhNzk3ZjU0YjYzZTc2NzdkNjhfNC01LTEtMS0w_c74897cf-f503-4a39-a846-2549dc82646f">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i39065c5daf934af885335c12f3cfa83f_D20200401-20200630" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:InterestIncomeExpenseNonoperatingNet" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzY2E5YmIwMTc5MjQ3NmZiYjIyNWU1ZDlkZWM4NjlmL3NlYzo5M2NhOWJiMDE3OTI0NzZmYmIyMjVlNWQ5ZGVjODY5Zl81NS9mcmFnOjk0NGQ2N2RjOTNmMjQ1MjliZTc4ZmNlMzRiOGMyZTBiL3RhYmxlOmMyMDc5OGU3NTU0NTRhYTc5N2Y1NGI2M2U3Njc3ZDY4L3RhYmxlcmFuZ2U6YzIwNzk4ZTc1NTQ1NGFhNzk3ZjU0YjYzZTc2NzdkNjhfNC03LTEtMS0w_d1b61393-0635-4c7b-8a7e-729d81f12326">3,734</ix:nonFraction>)</span></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 25pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Share of loss from equity accounted investments</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="icb85df07ebfc4bfa99c08f8c9f0cb89c_D20200401-20200630" decimals="-3" format="ixt:zerodash" name="us-gaap:IncomeLossFromEquityMethodInvestments" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzY2E5YmIwMTc5MjQ3NmZiYjIyNWU1ZDlkZWM4NjlmL3NlYzo5M2NhOWJiMDE3OTI0NzZmYmIyMjVlNWQ5ZGVjODY5Zl81NS9mcmFnOjk0NGQ2N2RjOTNmMjQ1MjliZTc4ZmNlMzRiOGMyZTBiL3RhYmxlOmMyMDc5OGU3NTU0NTRhYTc5N2Y1NGI2M2U3Njc3ZDY4L3RhYmxlcmFuZ2U6YzIwNzk4ZTc1NTQ1NGFhNzk3ZjU0YjYzZTc2NzdkNjhfNi0xLTEtMS00NjQx_60e06f9b-c3b1-47fd-929f-c67e48327fa5">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if83af42553ab4081bf67a6ecab2097fc_D20200401-20200630" decimals="-3" sign="-" name="us-gaap:IncomeLossFromEquityMethodInvestments" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzY2E5YmIwMTc5MjQ3NmZiYjIyNWU1ZDlkZWM4NjlmL3NlYzo5M2NhOWJiMDE3OTI0NzZmYmIyMjVlNWQ5ZGVjODY5Zl81NS9mcmFnOjk0NGQ2N2RjOTNmMjQ1MjliZTc4ZmNlMzRiOGMyZTBiL3RhYmxlOmMyMDc5OGU3NTU0NTRhYTc5N2Y1NGI2M2U3Njc3ZDY4L3RhYmxlcmFuZ2U6YzIwNzk4ZTc1NTQ1NGFhNzk3ZjU0YjYzZTc2NzdkNjhfNi0zLTEtMS00NjQx_16c4a77a-5b18-4cd6-b271-6f5ebffd23d2">794</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i46e2093507a34f2fa6bcbc19a9aaaa63_D20200401-20200630" decimals="-3" format="ixt:zerodash" name="us-gaap:IncomeLossFromEquityMethodInvestments" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzY2E5YmIwMTc5MjQ3NmZiYjIyNWU1ZDlkZWM4NjlmL3NlYzo5M2NhOWJiMDE3OTI0NzZmYmIyMjVlNWQ5ZGVjODY5Zl81NS9mcmFnOjk0NGQ2N2RjOTNmMjQ1MjliZTc4ZmNlMzRiOGMyZTBiL3RhYmxlOmMyMDc5OGU3NTU0NTRhYTc5N2Y1NGI2M2U3Njc3ZDY4L3RhYmxlcmFuZ2U6YzIwNzk4ZTc1NTQ1NGFhNzk3ZjU0YjYzZTc2NzdkNjhfNi01LTEtMS00NjQx_adda06ea-fbd7-4351-92d4-aedb710ab592">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i39065c5daf934af885335c12f3cfa83f_D20200401-20200630" decimals="-3" sign="-" name="us-gaap:IncomeLossFromEquityMethodInvestments" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzY2E5YmIwMTc5MjQ3NmZiYjIyNWU1ZDlkZWM4NjlmL3NlYzo5M2NhOWJiMDE3OTI0NzZmYmIyMjVlNWQ5ZGVjODY5Zl81NS9mcmFnOjk0NGQ2N2RjOTNmMjQ1MjliZTc4ZmNlMzRiOGMyZTBiL3RhYmxlOmMyMDc5OGU3NTU0NTRhYTc5N2Y1NGI2M2U3Njc3ZDY4L3RhYmxlcmFuZ2U6YzIwNzk4ZTc1NTQ1NGFhNzk3ZjU0YjYzZTc2NzdkNjhfNi03LTEtMS00NjQx_c15f8c62-aef4-4ccb-82c4-0c3ca0404dc7">794</ix:nonFraction></span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:24pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Impairment loss on long-lived assets</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(i)</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="icb85df07ebfc4bfa99c08f8c9f0cb89c_D20200401-20200630" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:AssetImpairmentCharges" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzY2E5YmIwMTc5MjQ3NmZiYjIyNWU1ZDlkZWM4NjlmL3NlYzo5M2NhOWJiMDE3OTI0NzZmYmIyMjVlNWQ5ZGVjODY5Zl81NS9mcmFnOjk0NGQ2N2RjOTNmMjQ1MjliZTc4ZmNlMzRiOGMyZTBiL3RhYmxlOmMyMDc5OGU3NTU0NTRhYTc5N2Y1NGI2M2U3Njc3ZDY4L3RhYmxlcmFuZ2U6YzIwNzk4ZTc1NTQ1NGFhNzk3ZjU0YjYzZTc2NzdkNjhfNi0xLTEtMS0w_3071a3e3-3926-4021-aeee-831a50dffbd2">40,000</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if83af42553ab4081bf67a6ecab2097fc_D20200401-20200630" decimals="-3" format="ixt:zerodash" name="us-gaap:AssetImpairmentCharges" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzY2E5YmIwMTc5MjQ3NmZiYjIyNWU1ZDlkZWM4NjlmL3NlYzo5M2NhOWJiMDE3OTI0NzZmYmIyMjVlNWQ5ZGVjODY5Zl81NS9mcmFnOjk0NGQ2N2RjOTNmMjQ1MjliZTc4ZmNlMzRiOGMyZTBiL3RhYmxlOmMyMDc5OGU3NTU0NTRhYTc5N2Y1NGI2M2U3Njc3ZDY4L3RhYmxlcmFuZ2U6YzIwNzk4ZTc1NTQ1NGFhNzk3ZjU0YjYzZTc2NzdkNjhfNi0zLTEtMS0w_262e6dd4-72d6-419d-a63a-d18acb975993">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i46e2093507a34f2fa6bcbc19a9aaaa63_D20200401-20200630" decimals="-3" format="ixt:zerodash" name="us-gaap:AssetImpairmentCharges" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzY2E5YmIwMTc5MjQ3NmZiYjIyNWU1ZDlkZWM4NjlmL3NlYzo5M2NhOWJiMDE3OTI0NzZmYmIyMjVlNWQ5ZGVjODY5Zl81NS9mcmFnOjk0NGQ2N2RjOTNmMjQ1MjliZTc4ZmNlMzRiOGMyZTBiL3RhYmxlOmMyMDc5OGU3NTU0NTRhYTc5N2Y1NGI2M2U3Njc3ZDY4L3RhYmxlcmFuZ2U6YzIwNzk4ZTc1NTQ1NGFhNzk3ZjU0YjYzZTc2NzdkNjhfNi01LTEtMS0w_4bfcdebb-884d-4960-93b9-ed713c868c73">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i39065c5daf934af885335c12f3cfa83f_D20200401-20200630" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:AssetImpairmentCharges" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzY2E5YmIwMTc5MjQ3NmZiYjIyNWU1ZDlkZWM4NjlmL3NlYzo5M2NhOWJiMDE3OTI0NzZmYmIyMjVlNWQ5ZGVjODY5Zl81NS9mcmFnOjk0NGQ2N2RjOTNmMjQ1MjliZTc4ZmNlMzRiOGMyZTBiL3RhYmxlOmMyMDc5OGU3NTU0NTRhYTc5N2Y1NGI2M2U3Njc3ZDY4L3RhYmxlcmFuZ2U6YzIwNzk4ZTc1NTQ1NGFhNzk3ZjU0YjYzZTc2NzdkNjhfNi03LTEtMS0w_daa4e268-efa1-45d5-8df8-b92d04c65b49">40,000</ix:nonFraction></span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:24pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Loss on revaluation of derivative liabilities</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(ii)</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="icb85df07ebfc4bfa99c08f8c9f0cb89c_D20200401-20200630" decimals="-3" format="ixt:zerodash" name="us-gaap:GainLossOnDerivativeInstrumentsNetPretax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzY2E5YmIwMTc5MjQ3NmZiYjIyNWU1ZDlkZWM4NjlmL3NlYzo5M2NhOWJiMDE3OTI0NzZmYmIyMjVlNWQ5ZGVjODY5Zl81NS9mcmFnOjk0NGQ2N2RjOTNmMjQ1MjliZTc4ZmNlMzRiOGMyZTBiL3RhYmxlOmMyMDc5OGU3NTU0NTRhYTc5N2Y1NGI2M2U3Njc3ZDY4L3RhYmxlcmFuZ2U6YzIwNzk4ZTc1NTQ1NGFhNzk3ZjU0YjYzZTc2NzdkNjhfNy0xLTEtMS0w_5ea2882c-3f61-48f1-8599-a9ee9d41eaa6">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if83af42553ab4081bf67a6ecab2097fc_D20200401-20200630" decimals="-3" sign="-" format="ixt:numdotdecimal" name="us-gaap:GainLossOnDerivativeInstrumentsNetPretax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzY2E5YmIwMTc5MjQ3NmZiYjIyNWU1ZDlkZWM4NjlmL3NlYzo5M2NhOWJiMDE3OTI0NzZmYmIyMjVlNWQ5ZGVjODY5Zl81NS9mcmFnOjk0NGQ2N2RjOTNmMjQ1MjliZTc4ZmNlMzRiOGMyZTBiL3RhYmxlOmMyMDc5OGU3NTU0NTRhYTc5N2Y1NGI2M2U3Njc3ZDY4L3RhYmxlcmFuZ2U6YzIwNzk4ZTc1NTQ1NGFhNzk3ZjU0YjYzZTc2NzdkNjhfNy0zLTEtMS0w_18fdf2a2-4b47-43b2-999b-d69b02117056">35,880</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i46e2093507a34f2fa6bcbc19a9aaaa63_D20200401-20200630" decimals="-3" format="ixt:zerodash" name="us-gaap:GainLossOnDerivativeInstrumentsNetPretax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzY2E5YmIwMTc5MjQ3NmZiYjIyNWU1ZDlkZWM4NjlmL3NlYzo5M2NhOWJiMDE3OTI0NzZmYmIyMjVlNWQ5ZGVjODY5Zl81NS9mcmFnOjk0NGQ2N2RjOTNmMjQ1MjliZTc4ZmNlMzRiOGMyZTBiL3RhYmxlOmMyMDc5OGU3NTU0NTRhYTc5N2Y1NGI2M2U3Njc3ZDY4L3RhYmxlcmFuZ2U6YzIwNzk4ZTc1NTQ1NGFhNzk3ZjU0YjYzZTc2NzdkNjhfNy01LTEtMS0w_d0707f33-5fe4-460f-92b8-3d7850075f4a">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i39065c5daf934af885335c12f3cfa83f_D20200401-20200630" decimals="-3" sign="-" format="ixt:numdotdecimal" name="us-gaap:GainLossOnDerivativeInstrumentsNetPretax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzY2E5YmIwMTc5MjQ3NmZiYjIyNWU1ZDlkZWM4NjlmL3NlYzo5M2NhOWJiMDE3OTI0NzZmYmIyMjVlNWQ5ZGVjODY5Zl81NS9mcmFnOjk0NGQ2N2RjOTNmMjQ1MjliZTc4ZmNlMzRiOGMyZTBiL3RhYmxlOmMyMDc5OGU3NTU0NTRhYTc5N2Y1NGI2M2U3Njc3ZDY4L3RhYmxlcmFuZ2U6YzIwNzk4ZTc1NTQ1NGFhNzk3ZjU0YjYzZTc2NzdkNjhfNy03LTEtMS0w_839287ff-625e-418e-a056-0e1e5fe5eba8">35,880</ix:nonFraction></span></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:24pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other, net</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(iv)</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="icb85df07ebfc4bfa99c08f8c9f0cb89c_D20200401-20200630" decimals="-3" format="ixt:zerodash" name="us-gaap:OtherNonoperatingIncomeExpense" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzY2E5YmIwMTc5MjQ3NmZiYjIyNWU1ZDlkZWM4NjlmL3NlYzo5M2NhOWJiMDE3OTI0NzZmYmIyMjVlNWQ5ZGVjODY5Zl81NS9mcmFnOjk0NGQ2N2RjOTNmMjQ1MjliZTc4ZmNlMzRiOGMyZTBiL3RhYmxlOmMyMDc5OGU3NTU0NTRhYTc5N2Y1NGI2M2U3Njc3ZDY4L3RhYmxlcmFuZ2U6YzIwNzk4ZTc1NTQ1NGFhNzk3ZjU0YjYzZTc2NzdkNjhfOC0xLTEtMS0w_0f46155e-9d49-4820-ab24-8d64141992e0">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if83af42553ab4081bf67a6ecab2097fc_D20200401-20200630" decimals="-3" sign="-" name="us-gaap:OtherNonoperatingIncomeExpense" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzY2E5YmIwMTc5MjQ3NmZiYjIyNWU1ZDlkZWM4NjlmL3NlYzo5M2NhOWJiMDE3OTI0NzZmYmIyMjVlNWQ5ZGVjODY5Zl81NS9mcmFnOjk0NGQ2N2RjOTNmMjQ1MjliZTc4ZmNlMzRiOGMyZTBiL3RhYmxlOmMyMDc5OGU3NTU0NTRhYTc5N2Y1NGI2M2U3Njc3ZDY4L3RhYmxlcmFuZ2U6YzIwNzk4ZTc1NTQ1NGFhNzk3ZjU0YjYzZTc2NzdkNjhfOC0zLTEtMS0w_599d5269-9c6a-4c6a-a182-a1e32113134b">9</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i46e2093507a34f2fa6bcbc19a9aaaa63_D20200401-20200630" decimals="-3" format="ixt:zerodash" name="us-gaap:OtherNonoperatingIncomeExpense" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzY2E5YmIwMTc5MjQ3NmZiYjIyNWU1ZDlkZWM4NjlmL3NlYzo5M2NhOWJiMDE3OTI0NzZmYmIyMjVlNWQ5ZGVjODY5Zl81NS9mcmFnOjk0NGQ2N2RjOTNmMjQ1MjliZTc4ZmNlMzRiOGMyZTBiL3RhYmxlOmMyMDc5OGU3NTU0NTRhYTc5N2Y1NGI2M2U3Njc3ZDY4L3RhYmxlcmFuZ2U6YzIwNzk4ZTc1NTQ1NGFhNzk3ZjU0YjYzZTc2NzdkNjhfOC01LTEtMS0w_a2b624f4-3733-4e9d-b48d-37b6f1572f52">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i39065c5daf934af885335c12f3cfa83f_D20200401-20200630" decimals="-3" sign="-" name="us-gaap:OtherNonoperatingIncomeExpense" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzY2E5YmIwMTc5MjQ3NmZiYjIyNWU1ZDlkZWM4NjlmL3NlYzo5M2NhOWJiMDE3OTI0NzZmYmIyMjVlNWQ5ZGVjODY5Zl81NS9mcmFnOjk0NGQ2N2RjOTNmMjQ1MjliZTc4ZmNlMzRiOGMyZTBiL3RhYmxlOmMyMDc5OGU3NTU0NTRhYTc5N2Y1NGI2M2U3Njc3ZDY4L3RhYmxlcmFuZ2U6YzIwNzk4ZTc1NTQ1NGFhNzk3ZjU0YjYzZTc2NzdkNjhfOC03LTEtMS0w_85c2d9c9-4244-4464-b3a6-6a00ce81f36c">9</ix:nonFraction></span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:24pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Loss from discontinued operations</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(v)</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="icb85df07ebfc4bfa99c08f8c9f0cb89c_D20200401-20200630" decimals="-3" format="ixt:zerodash" name="us-gaap:IncomeLossFromDiscontinuedOperationsNetOfTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzY2E5YmIwMTc5MjQ3NmZiYjIyNWU1ZDlkZWM4NjlmL3NlYzo5M2NhOWJiMDE3OTI0NzZmYmIyMjVlNWQ5ZGVjODY5Zl81NS9mcmFnOjk0NGQ2N2RjOTNmMjQ1MjliZTc4ZmNlMzRiOGMyZTBiL3RhYmxlOmMyMDc5OGU3NTU0NTRhYTc5N2Y1NGI2M2U3Njc3ZDY4L3RhYmxlcmFuZ2U6YzIwNzk4ZTc1NTQ1NGFhNzk3ZjU0YjYzZTc2NzdkNjhfOS0xLTEtMS0w_3f9e48a5-84fa-4875-af45-5916b89bf8fd">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if83af42553ab4081bf67a6ecab2097fc_D20200401-20200630" decimals="-3" sign="-" name="us-gaap:IncomeLossFromDiscontinuedOperationsNetOfTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzY2E5YmIwMTc5MjQ3NmZiYjIyNWU1ZDlkZWM4NjlmL3NlYzo5M2NhOWJiMDE3OTI0NzZmYmIyMjVlNWQ5ZGVjODY5Zl81NS9mcmFnOjk0NGQ2N2RjOTNmMjQ1MjliZTc4ZmNlMzRiOGMyZTBiL3RhYmxlOmMyMDc5OGU3NTU0NTRhYTc5N2Y1NGI2M2U3Njc3ZDY4L3RhYmxlcmFuZ2U6YzIwNzk4ZTc1NTQ1NGFhNzk3ZjU0YjYzZTc2NzdkNjhfOS0zLTEtMS0w_454ef881-316f-40ea-8bb5-e4c0d46746dc">46</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i46e2093507a34f2fa6bcbc19a9aaaa63_D20200401-20200630" decimals="-3" format="ixt:zerodash" name="us-gaap:IncomeLossFromDiscontinuedOperationsNetOfTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzY2E5YmIwMTc5MjQ3NmZiYjIyNWU1ZDlkZWM4NjlmL3NlYzo5M2NhOWJiMDE3OTI0NzZmYmIyMjVlNWQ5ZGVjODY5Zl81NS9mcmFnOjk0NGQ2N2RjOTNmMjQ1MjliZTc4ZmNlMzRiOGMyZTBiL3RhYmxlOmMyMDc5OGU3NTU0NTRhYTc5N2Y1NGI2M2U3Njc3ZDY4L3RhYmxlcmFuZ2U6YzIwNzk4ZTc1NTQ1NGFhNzk3ZjU0YjYzZTc2NzdkNjhfOS01LTEtMS0w_eb7dff5f-d0a9-4206-8fea-3f3d2c344391">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i39065c5daf934af885335c12f3cfa83f_D20200401-20200630" decimals="-3" sign="-" name="us-gaap:IncomeLossFromDiscontinuedOperationsNetOfTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzY2E5YmIwMTc5MjQ3NmZiYjIyNWU1ZDlkZWM4NjlmL3NlYzo5M2NhOWJiMDE3OTI0NzZmYmIyMjVlNWQ5ZGVjODY5Zl81NS9mcmFnOjk0NGQ2N2RjOTNmMjQ1MjliZTc4ZmNlMzRiOGMyZTBiL3RhYmxlOmMyMDc5OGU3NTU0NTRhYTc5N2Y1NGI2M2U3Njc3ZDY4L3RhYmxlcmFuZ2U6YzIwNzk4ZTc1NTQ1NGFhNzk3ZjU0YjYzZTc2NzdkNjhfOS03LTEtMS0w_df3666d5-6b0a-4df9-8264-450d1dee8e7b">46</ix:nonFraction></span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:24pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Share-based payments</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(vi)</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="icb85df07ebfc4bfa99c08f8c9f0cb89c_D20200401-20200630" decimals="-3" name="us-gaap:AllocatedShareBasedCompensationExpense" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzY2E5YmIwMTc5MjQ3NmZiYjIyNWU1ZDlkZWM4NjlmL3NlYzo5M2NhOWJiMDE3OTI0NzZmYmIyMjVlNWQ5ZGVjODY5Zl81NS9mcmFnOjk0NGQ2N2RjOTNmMjQ1MjliZTc4ZmNlMzRiOGMyZTBiL3RhYmxlOmMyMDc5OGU3NTU0NTRhYTc5N2Y1NGI2M2U3Njc3ZDY4L3RhYmxlcmFuZ2U6YzIwNzk4ZTc1NTQ1NGFhNzk3ZjU0YjYzZTc2NzdkNjhfMTAtMS0xLTEtMA_aab7c79e-9f0f-4ed2-8312-208f56540ff5">756</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if83af42553ab4081bf67a6ecab2097fc_D20200401-20200630" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:AllocatedShareBasedCompensationExpense" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzY2E5YmIwMTc5MjQ3NmZiYjIyNWU1ZDlkZWM4NjlmL3NlYzo5M2NhOWJiMDE3OTI0NzZmYmIyMjVlNWQ5ZGVjODY5Zl81NS9mcmFnOjk0NGQ2N2RjOTNmMjQ1MjliZTc4ZmNlMzRiOGMyZTBiL3RhYmxlOmMyMDc5OGU3NTU0NTRhYTc5N2Y1NGI2M2U3Njc3ZDY4L3RhYmxlcmFuZ2U6YzIwNzk4ZTc1NTQ1NGFhNzk3ZjU0YjYzZTc2NzdkNjhfMTAtMy0xLTEtMA_dfafe621-a75c-4725-8453-c1b6a12773f9">1,790</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i46e2093507a34f2fa6bcbc19a9aaaa63_D20200401-20200630" decimals="-3" format="ixt:zerodash" name="us-gaap:AllocatedShareBasedCompensationExpense" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzY2E5YmIwMTc5MjQ3NmZiYjIyNWU1ZDlkZWM4NjlmL3NlYzo5M2NhOWJiMDE3OTI0NzZmYmIyMjVlNWQ5ZGVjODY5Zl81NS9mcmFnOjk0NGQ2N2RjOTNmMjQ1MjliZTc4ZmNlMzRiOGMyZTBiL3RhYmxlOmMyMDc5OGU3NTU0NTRhYTc5N2Y1NGI2M2U3Njc3ZDY4L3RhYmxlcmFuZ2U6YzIwNzk4ZTc1NTQ1NGFhNzk3ZjU0YjYzZTc2NzdkNjhfMTAtNS0xLTEtMA_311539ec-5480-4f70-8894-17db321cf96c">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i39065c5daf934af885335c12f3cfa83f_D20200401-20200630" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:AllocatedShareBasedCompensationExpense" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzY2E5YmIwMTc5MjQ3NmZiYjIyNWU1ZDlkZWM4NjlmL3NlYzo5M2NhOWJiMDE3OTI0NzZmYmIyMjVlNWQ5ZGVjODY5Zl81NS9mcmFnOjk0NGQ2N2RjOTNmMjQ1MjliZTc4ZmNlMzRiOGMyZTBiL3RhYmxlOmMyMDc5OGU3NTU0NTRhYTc5N2Y1NGI2M2U3Njc3ZDY4L3RhYmxlcmFuZ2U6YzIwNzk4ZTc1NTQ1NGFhNzk3ZjU0YjYzZTc2NzdkNjhfMTAtNy0xLTEtMA_622fbd51-95cc-40df-9919-c63864527864">2,546</ix:nonFraction></span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:24pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Review costs related to restatement of 2019 interim financial statements</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(vii)</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="icb85df07ebfc4bfa99c08f8c9f0cb89c_D20200401-20200630" decimals="-3" format="ixt:zerodash" name="cron:RestatementReviewExpense" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzY2E5YmIwMTc5MjQ3NmZiYjIyNWU1ZDlkZWM4NjlmL3NlYzo5M2NhOWJiMDE3OTI0NzZmYmIyMjVlNWQ5ZGVjODY5Zl81NS9mcmFnOjk0NGQ2N2RjOTNmMjQ1MjliZTc4ZmNlMzRiOGMyZTBiL3RhYmxlOmMyMDc5OGU3NTU0NTRhYTc5N2Y1NGI2M2U3Njc3ZDY4L3RhYmxlcmFuZ2U6YzIwNzk4ZTc1NTQ1NGFhNzk3ZjU0YjYzZTc2NzdkNjhfMTEtMS0xLTEtMA_7d95c61c-2707-4a32-8c77-a4b7fbc1da1b">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if83af42553ab4081bf67a6ecab2097fc_D20200401-20200630" decimals="-3" format="ixt:zerodash" name="cron:RestatementReviewExpense" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzY2E5YmIwMTc5MjQ3NmZiYjIyNWU1ZDlkZWM4NjlmL3NlYzo5M2NhOWJiMDE3OTI0NzZmYmIyMjVlNWQ5ZGVjODY5Zl81NS9mcmFnOjk0NGQ2N2RjOTNmMjQ1MjliZTc4ZmNlMzRiOGMyZTBiL3RhYmxlOmMyMDc5OGU3NTU0NTRhYTc5N2Y1NGI2M2U3Njc3ZDY4L3RhYmxlcmFuZ2U6YzIwNzk4ZTc1NTQ1NGFhNzk3ZjU0YjYzZTc2NzdkNjhfMTEtMy0xLTEtMA_1e3f15ff-4299-43cc-99d8-c7292d57c513">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i46e2093507a34f2fa6bcbc19a9aaaa63_D20200401-20200630" decimals="-3" format="ixt:numdotdecimal" name="cron:RestatementReviewExpense" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzY2E5YmIwMTc5MjQ3NmZiYjIyNWU1ZDlkZWM4NjlmL3NlYzo5M2NhOWJiMDE3OTI0NzZmYmIyMjVlNWQ5ZGVjODY5Zl81NS9mcmFnOjk0NGQ2N2RjOTNmMjQ1MjliZTc4ZmNlMzRiOGMyZTBiL3RhYmxlOmMyMDc5OGU3NTU0NTRhYTc5N2Y1NGI2M2U3Njc3ZDY4L3RhYmxlcmFuZ2U6YzIwNzk4ZTc1NTQ1NGFhNzk3ZjU0YjYzZTc2NzdkNjhfMTEtNS0xLTEtMA_255728d8-140e-4815-a661-4d0f6aa9b008">3,459</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i39065c5daf934af885335c12f3cfa83f_D20200401-20200630" decimals="-3" format="ixt:numdotdecimal" name="cron:RestatementReviewExpense" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzY2E5YmIwMTc5MjQ3NmZiYjIyNWU1ZDlkZWM4NjlmL3NlYzo5M2NhOWJiMDE3OTI0NzZmYmIyMjVlNWQ5ZGVjODY5Zl81NS9mcmFnOjk0NGQ2N2RjOTNmMjQ1MjliZTc4ZmNlMzRiOGMyZTBiL3RhYmxlOmMyMDc5OGU3NTU0NTRhYTc5N2Y1NGI2M2U3Njc3ZDY4L3RhYmxlcmFuZ2U6YzIwNzk4ZTc1NTQ1NGFhNzk3ZjU0YjYzZTc2NzdkNjhfMTEtNy0xLTEtMA_037620c4-dc13-46e7-af34-55779c34cd5d">3,459</ix:nonFraction></span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Depreciation and amortization</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="icb85df07ebfc4bfa99c08f8c9f0cb89c_D20200401-20200630" decimals="-3" name="us-gaap:DepreciationDepletionAndAmortization" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzY2E5YmIwMTc5MjQ3NmZiYjIyNWU1ZDlkZWM4NjlmL3NlYzo5M2NhOWJiMDE3OTI0NzZmYmIyMjVlNWQ5ZGVjODY5Zl81NS9mcmFnOjk0NGQ2N2RjOTNmMjQ1MjliZTc4ZmNlMzRiOGMyZTBiL3RhYmxlOmMyMDc5OGU3NTU0NTRhYTc5N2Y1NGI2M2U3Njc3ZDY4L3RhYmxlcmFuZ2U6YzIwNzk4ZTc1NTQ1NGFhNzk3ZjU0YjYzZTc2NzdkNjhfMTQtMS0xLTEtMA_0cf4efd0-aa3e-47a0-b6d3-067d92dba9d3">34</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if83af42553ab4081bf67a6ecab2097fc_D20200401-20200630" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:DepreciationDepletionAndAmortization" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzY2E5YmIwMTc5MjQ3NmZiYjIyNWU1ZDlkZWM4NjlmL3NlYzo5M2NhOWJiMDE3OTI0NzZmYmIyMjVlNWQ5ZGVjODY5Zl81NS9mcmFnOjk0NGQ2N2RjOTNmMjQ1MjliZTc4ZmNlMzRiOGMyZTBiL3RhYmxlOmMyMDc5OGU3NTU0NTRhYTc5N2Y1NGI2M2U3Njc3ZDY4L3RhYmxlcmFuZ2U6YzIwNzk4ZTc1NTQ1NGFhNzk3ZjU0YjYzZTc2NzdkNjhfMTQtMy0xLTEtMA_0af69bc0-a05b-4268-9898-f7793b77e37c">1,683</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i46e2093507a34f2fa6bcbc19a9aaaa63_D20200401-20200630" decimals="-3" format="ixt:zerodash" name="us-gaap:DepreciationDepletionAndAmortization" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzY2E5YmIwMTc5MjQ3NmZiYjIyNWU1ZDlkZWM4NjlmL3NlYzo5M2NhOWJiMDE3OTI0NzZmYmIyMjVlNWQ5ZGVjODY5Zl81NS9mcmFnOjk0NGQ2N2RjOTNmMjQ1MjliZTc4ZmNlMzRiOGMyZTBiL3RhYmxlOmMyMDc5OGU3NTU0NTRhYTc5N2Y1NGI2M2U3Njc3ZDY4L3RhYmxlcmFuZ2U6YzIwNzk4ZTc1NTQ1NGFhNzk3ZjU0YjYzZTc2NzdkNjhfMTQtNS0xLTEtMA_ccc8a804-1486-499a-bf4f-5410e5179d59">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i39065c5daf934af885335c12f3cfa83f_D20200401-20200630" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:DepreciationDepletionAndAmortization" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzY2E5YmIwMTc5MjQ3NmZiYjIyNWU1ZDlkZWM4NjlmL3NlYzo5M2NhOWJiMDE3OTI0NzZmYmIyMjVlNWQ5ZGVjODY5Zl81NS9mcmFnOjk0NGQ2N2RjOTNmMjQ1MjliZTc4ZmNlMzRiOGMyZTBiL3RhYmxlOmMyMDc5OGU3NTU0NTRhYTc5N2Y1NGI2M2U3Njc3ZDY4L3RhYmxlcmFuZ2U6YzIwNzk4ZTc1NTQ1NGFhNzk3ZjU0YjYzZTc2NzdkNjhfMTQtNy0xLTEtMA_6cc79ca8-46e1-40a0-aaa9-a218d6630b84">1,717</ix:nonFraction></span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Adjusted EBITDA</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="icb85df07ebfc4bfa99c08f8c9f0cb89c_D20200401-20200630" decimals="-3" sign="-" format="ixt:numdotdecimal" name="cron:AdjustedEarningsBeforeInterestTaxesDepreciationAndAmortization" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzY2E5YmIwMTc5MjQ3NmZiYjIyNWU1ZDlkZWM4NjlmL3NlYzo5M2NhOWJiMDE3OTI0NzZmYmIyMjVlNWQ5ZGVjODY5Zl81NS9mcmFnOjk0NGQ2N2RjOTNmMjQ1MjliZTc4ZmNlMzRiOGMyZTBiL3RhYmxlOmMyMDc5OGU3NTU0NTRhYTc5N2Y1NGI2M2U3Njc3ZDY4L3RhYmxlcmFuZ2U6YzIwNzk4ZTc1NTQ1NGFhNzk3ZjU0YjYzZTc2NzdkNjhfMTUtMS0xLTEtMA_3479ff87-385e-4e68-81b9-00ecaa15e0be">4,785</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="if83af42553ab4081bf67a6ecab2097fc_D20200401-20200630" decimals="-3" sign="-" format="ixt:numdotdecimal" name="cron:AdjustedEarningsBeforeInterestTaxesDepreciationAndAmortization" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzY2E5YmIwMTc5MjQ3NmZiYjIyNWU1ZDlkZWM4NjlmL3NlYzo5M2NhOWJiMDE3OTI0NzZmYmIyMjVlNWQ5ZGVjODY5Zl81NS9mcmFnOjk0NGQ2N2RjOTNmMjQ1MjliZTc4ZmNlMzRiOGMyZTBiL3RhYmxlOmMyMDc5OGU3NTU0NTRhYTc5N2Y1NGI2M2U3Njc3ZDY4L3RhYmxlcmFuZ2U6YzIwNzk4ZTc1NTQ1NGFhNzk3ZjU0YjYzZTc2NzdkNjhfMTUtMy0xLTEtMA_ec2ad022-4c16-43c0-b620-03d67c1d84c4">18,618</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i46e2093507a34f2fa6bcbc19a9aaaa63_D20200401-20200630" decimals="-3" sign="-" format="ixt:numdotdecimal" name="cron:AdjustedEarningsBeforeInterestTaxesDepreciationAndAmortization" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzY2E5YmIwMTc5MjQ3NmZiYjIyNWU1ZDlkZWM4NjlmL3NlYzo5M2NhOWJiMDE3OTI0NzZmYmIyMjVlNWQ5ZGVjODY5Zl81NS9mcmFnOjk0NGQ2N2RjOTNmMjQ1MjliZTc4ZmNlMzRiOGMyZTBiL3RhYmxlOmMyMDc5OGU3NTU0NTRhYTc5N2Y1NGI2M2U3Njc3ZDY4L3RhYmxlcmFuZ2U6YzIwNzk4ZTc1NTQ1NGFhNzk3ZjU0YjYzZTc2NzdkNjhfMTUtNS0xLTEtMA_507fbc64-73e7-4a3c-aaaa-89f5a4e827b1">3,583</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i39065c5daf934af885335c12f3cfa83f_D20200401-20200630" decimals="-3" sign="-" format="ixt:numdotdecimal" name="cron:AdjustedEarningsBeforeInterestTaxesDepreciationAndAmortization" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzY2E5YmIwMTc5MjQ3NmZiYjIyNWU1ZDlkZWM4NjlmL3NlYzo5M2NhOWJiMDE3OTI0NzZmYmIyMjVlNWQ5ZGVjODY5Zl81NS9mcmFnOjk0NGQ2N2RjOTNmMjQ1MjliZTc4ZmNlMzRiOGMyZTBiL3RhYmxlOmMyMDc5OGU3NTU0NTRhYTc5N2Y1NGI2M2U3Njc3ZDY4L3RhYmxlcmFuZ2U6YzIwNzk4ZTc1NTQ1NGFhNzk3ZjU0YjYzZTc2NzdkNjhfMTUtNy0xLTEtMA_a9b8f8f4-a370-490e-a4d8-9621694599ba">26,986</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:42.650%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.233%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.772%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.233%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.772%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.233%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.772%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.235%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="21" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Six months ended June&#160;30, 2021</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">United States</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Rest of World</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Corporate Expenses</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Total</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 6.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net loss</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i73f2057fe97d4f3a8524f987e78d1493_D20210101-20210630" decimals="-3" sign="-" format="ixt:numdotdecimal" name="us-gaap:ProfitLoss" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzY2E5YmIwMTc5MjQ3NmZiYjIyNWU1ZDlkZWM4NjlmL3NlYzo5M2NhOWJiMDE3OTI0NzZmYmIyMjVlNWQ5ZGVjODY5Zl81NS9mcmFnOjk0NGQ2N2RjOTNmMjQ1MjliZTc4ZmNlMzRiOGMyZTBiL3RhYmxlOjEzZmNjYmI1NjhiMDRhNzk4OWQ0NDZkNWNkYjk4MWVjL3RhYmxlcmFuZ2U6MTNmY2NiYjU2OGIwNGE3OTg5ZDQ0NmQ1Y2RiOTgxZWNfMi0xLTEtMS0xNzAx_cf528f5d-8dab-4364-8090-48bbf2b8f18b">23,811</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i9eea321560784f81a590aa8e3df3b187_D20210101-20210630" decimals="-3" sign="-" format="ixt:numdotdecimal" name="us-gaap:ProfitLoss" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzY2E5YmIwMTc5MjQ3NmZiYjIyNWU1ZDlkZWM4NjlmL3NlYzo5M2NhOWJiMDE3OTI0NzZmYmIyMjVlNWQ5ZGVjODY5Zl81NS9mcmFnOjk0NGQ2N2RjOTNmMjQ1MjliZTc4ZmNlMzRiOGMyZTBiL3RhYmxlOjEzZmNjYmI1NjhiMDRhNzk4OWQ0NDZkNWNkYjk4MWVjL3RhYmxlcmFuZ2U6MTNmY2NiYjU2OGIwNGE3OTg5ZDQ0NmQ1Y2RiOTgxZWNfMi0zLTEtMS0xNzEy_c28a6a7a-4eba-485b-9ee0-049b50c00913">62,520</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i5e244469383d46ddb452d43394f637d1_D20210101-20210630" decimals="-3" sign="-" format="ixt:numdotdecimal" name="us-gaap:ProfitLoss" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzY2E5YmIwMTc5MjQ3NmZiYjIyNWU1ZDlkZWM4NjlmL3NlYzo5M2NhOWJiMDE3OTI0NzZmYmIyMjVlNWQ5ZGVjODY5Zl81NS9mcmFnOjk0NGQ2N2RjOTNmMjQ1MjliZTc4ZmNlMzRiOGMyZTBiL3RhYmxlOjEzZmNjYmI1NjhiMDRhNzk4OWQ0NDZkNWNkYjk4MWVjL3RhYmxlcmFuZ2U6MTNmY2NiYjU2OGIwNGE3OTg5ZDQ0NmQ1Y2RiOTgxZWNfMi01LTEtMS0xNzE4_71ce97af-69b0-4b37-876c-c4b0c8b1d91d">18,519</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 7pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i69782326f71a44e3805518280ee22b6b_D20210101-20210630" decimals="-3" sign="-" format="ixt:numdotdecimal" name="us-gaap:ProfitLoss" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzY2E5YmIwMTc5MjQ3NmZiYjIyNWU1ZDlkZWM4NjlmL3NlYzo5M2NhOWJiMDE3OTI0NzZmYmIyMjVlNWQ5ZGVjODY5Zl81NS9mcmFnOjk0NGQ2N2RjOTNmMjQ1MjliZTc4ZmNlMzRiOGMyZTBiL3RhYmxlOjEzZmNjYmI1NjhiMDRhNzk4OWQ0NDZkNWNkYjk4MWVjL3RhYmxlcmFuZ2U6MTNmY2NiYjU2OGIwNGE3OTg5ZDQ0NmQ1Y2RiOTgxZWNfMi03LTEtMS0xNjc1Mg_ae638d7d-512d-438d-b880-58219c2eafa2">104,850</ix:nonFraction>)</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 18.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Interest income, net</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i73f2057fe97d4f3a8524f987e78d1493_D20210101-20210630" decimals="-3" name="us-gaap:InterestIncomeExpenseNonoperatingNet" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzY2E5YmIwMTc5MjQ3NmZiYjIyNWU1ZDlkZWM4NjlmL3NlYzo5M2NhOWJiMDE3OTI0NzZmYmIyMjVlNWQ5ZGVjODY5Zl81NS9mcmFnOjk0NGQ2N2RjOTNmMjQ1MjliZTc4ZmNlMzRiOGMyZTBiL3RhYmxlOjEzZmNjYmI1NjhiMDRhNzk4OWQ0NDZkNWNkYjk4MWVjL3RhYmxlcmFuZ2U6MTNmY2NiYjU2OGIwNGE3OTg5ZDQ0NmQ1Y2RiOTgxZWNfNC0xLTEtMS0xNzAx_3ece2715-f39b-4a6d-8980-5de2f0025bbe">23</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i9eea321560784f81a590aa8e3df3b187_D20210101-20210630" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:InterestIncomeExpenseNonoperatingNet" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzY2E5YmIwMTc5MjQ3NmZiYjIyNWU1ZDlkZWM4NjlmL3NlYzo5M2NhOWJiMDE3OTI0NzZmYmIyMjVlNWQ5ZGVjODY5Zl81NS9mcmFnOjk0NGQ2N2RjOTNmMjQ1MjliZTc4ZmNlMzRiOGMyZTBiL3RhYmxlOjEzZmNjYmI1NjhiMDRhNzk4OWQ0NDZkNWNkYjk4MWVjL3RhYmxlcmFuZ2U6MTNmY2NiYjU2OGIwNGE3OTg5ZDQ0NmQ1Y2RiOTgxZWNfNC0zLTEtMS0xNzEy_e059f80e-578c-40aa-be1b-963eac434b19">4,599</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5e244469383d46ddb452d43394f637d1_D20210101-20210630" decimals="-3" format="ixt:zerodash" name="us-gaap:InterestIncomeExpenseNonoperatingNet" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzY2E5YmIwMTc5MjQ3NmZiYjIyNWU1ZDlkZWM4NjlmL3NlYzo5M2NhOWJiMDE3OTI0NzZmYmIyMjVlNWQ5ZGVjODY5Zl81NS9mcmFnOjk0NGQ2N2RjOTNmMjQ1MjliZTc4ZmNlMzRiOGMyZTBiL3RhYmxlOjEzZmNjYmI1NjhiMDRhNzk4OWQ0NDZkNWNkYjk4MWVjL3RhYmxlcmFuZ2U6MTNmY2NiYjU2OGIwNGE3OTg5ZDQ0NmQ1Y2RiOTgxZWNfNC01LTEtMS0xNzE4_83495ea8-d717-4b36-8fc4-e2d5c78ca1e2">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i69782326f71a44e3805518280ee22b6b_D20210101-20210630" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:InterestIncomeExpenseNonoperatingNet" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzY2E5YmIwMTc5MjQ3NmZiYjIyNWU1ZDlkZWM4NjlmL3NlYzo5M2NhOWJiMDE3OTI0NzZmYmIyMjVlNWQ5ZGVjODY5Zl81NS9mcmFnOjk0NGQ2N2RjOTNmMjQ1MjliZTc4ZmNlMzRiOGMyZTBiL3RhYmxlOjEzZmNjYmI1NjhiMDRhNzk4OWQ0NDZkNWNkYjk4MWVjL3RhYmxlcmFuZ2U6MTNmY2NiYjU2OGIwNGE3OTg5ZDQ0NmQ1Y2RiOTgxZWNfMy03LTEtMS0xNjc1Mg_fa6ba203-7694-4fd7-8e0a-e4163e28d018">4,622</ix:nonFraction>)</span></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 18.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Share of loss from equity accounted investments</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i73f2057fe97d4f3a8524f987e78d1493_D20210101-20210630" decimals="-3" format="ixt:zerodash" name="us-gaap:IncomeLossFromEquityMethodInvestments" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzY2E5YmIwMTc5MjQ3NmZiYjIyNWU1ZDlkZWM4NjlmL3NlYzo5M2NhOWJiMDE3OTI0NzZmYmIyMjVlNWQ5ZGVjODY5Zl81NS9mcmFnOjk0NGQ2N2RjOTNmMjQ1MjliZTc4ZmNlMzRiOGMyZTBiL3RhYmxlOjEzZmNjYmI1NjhiMDRhNzk4OWQ0NDZkNWNkYjk4MWVjL3RhYmxlcmFuZ2U6MTNmY2NiYjU2OGIwNGE3OTg5ZDQ0NmQ1Y2RiOTgxZWNfNi0xLTEtMS0xNzAx_7832ce39-0e22-48e0-b48f-6aaa37b10b84">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9eea321560784f81a590aa8e3df3b187_D20210101-20210630" decimals="-3" sign="-" format="ixt:numdotdecimal" name="us-gaap:IncomeLossFromEquityMethodInvestments" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzY2E5YmIwMTc5MjQ3NmZiYjIyNWU1ZDlkZWM4NjlmL3NlYzo5M2NhOWJiMDE3OTI0NzZmYmIyMjVlNWQ5ZGVjODY5Zl81NS9mcmFnOjk0NGQ2N2RjOTNmMjQ1MjliZTc4ZmNlMzRiOGMyZTBiL3RhYmxlOjEzZmNjYmI1NjhiMDRhNzk4OWQ0NDZkNWNkYjk4MWVjL3RhYmxlcmFuZ2U6MTNmY2NiYjU2OGIwNGE3OTg5ZDQ0NmQ1Y2RiOTgxZWNfNi0zLTEtMS0xNzEy_76ac5fce-0a74-4882-aebb-2079ed2364e9">2,758</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5e244469383d46ddb452d43394f637d1_D20210101-20210630" decimals="-3" format="ixt:zerodash" name="us-gaap:IncomeLossFromEquityMethodInvestments" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzY2E5YmIwMTc5MjQ3NmZiYjIyNWU1ZDlkZWM4NjlmL3NlYzo5M2NhOWJiMDE3OTI0NzZmYmIyMjVlNWQ5ZGVjODY5Zl81NS9mcmFnOjk0NGQ2N2RjOTNmMjQ1MjliZTc4ZmNlMzRiOGMyZTBiL3RhYmxlOjEzZmNjYmI1NjhiMDRhNzk4OWQ0NDZkNWNkYjk4MWVjL3RhYmxlcmFuZ2U6MTNmY2NiYjU2OGIwNGE3OTg5ZDQ0NmQ1Y2RiOTgxZWNfNi01LTEtMS0xNzE4_f94e189a-364d-4741-afcf-801f7d8fbef9">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i69782326f71a44e3805518280ee22b6b_D20210101-20210630" decimals="-3" sign="-" format="ixt:numdotdecimal" name="us-gaap:IncomeLossFromEquityMethodInvestments" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzY2E5YmIwMTc5MjQ3NmZiYjIyNWU1ZDlkZWM4NjlmL3NlYzo5M2NhOWJiMDE3OTI0NzZmYmIyMjVlNWQ5ZGVjODY5Zl81NS9mcmFnOjk0NGQ2N2RjOTNmMjQ1MjliZTc4ZmNlMzRiOGMyZTBiL3RhYmxlOjEzZmNjYmI1NjhiMDRhNzk4OWQ0NDZkNWNkYjk4MWVjL3RhYmxlcmFuZ2U6MTNmY2NiYjU2OGIwNGE3OTg5ZDQ0NmQ1Y2RiOTgxZWNfNS03LTEtMS0xNjc1Mg_bd7f2044-8c92-4f4e-b69e-4cdc09035217">2,758</ix:nonFraction></span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><div style="padding-left:17.25pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Impairment loss on long-lived assets</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(i)</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i73f2057fe97d4f3a8524f987e78d1493_D20210101-20210630" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:AssetImpairmentCharges" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzY2E5YmIwMTc5MjQ3NmZiYjIyNWU1ZDlkZWM4NjlmL3NlYzo5M2NhOWJiMDE3OTI0NzZmYmIyMjVlNWQ5ZGVjODY5Zl81NS9mcmFnOjk0NGQ2N2RjOTNmMjQ1MjliZTc4ZmNlMzRiOGMyZTBiL3RhYmxlOjEzZmNjYmI1NjhiMDRhNzk4OWQ0NDZkNWNkYjk4MWVjL3RhYmxlcmFuZ2U6MTNmY2NiYjU2OGIwNGE3OTg5ZDQ0NmQ1Y2RiOTgxZWNfNy0xLTEtMS0xNzAx_39dc4d7e-ef08-4760-ab5a-0f1ff2c09f95">1,741</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9eea321560784f81a590aa8e3df3b187_D20210101-20210630" decimals="-3" format="ixt:zerodash" name="us-gaap:AssetImpairmentCharges" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzY2E5YmIwMTc5MjQ3NmZiYjIyNWU1ZDlkZWM4NjlmL3NlYzo5M2NhOWJiMDE3OTI0NzZmYmIyMjVlNWQ5ZGVjODY5Zl81NS9mcmFnOjk0NGQ2N2RjOTNmMjQ1MjliZTc4ZmNlMzRiOGMyZTBiL3RhYmxlOjEzZmNjYmI1NjhiMDRhNzk4OWQ0NDZkNWNkYjk4MWVjL3RhYmxlcmFuZ2U6MTNmY2NiYjU2OGIwNGE3OTg5ZDQ0NmQ1Y2RiOTgxZWNfNy0zLTEtMS0xNzEy_31d50ebb-8d0d-4f2f-82d5-beb1d6bc4e03">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5e244469383d46ddb452d43394f637d1_D20210101-20210630" decimals="-3" format="ixt:zerodash" name="us-gaap:AssetImpairmentCharges" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzY2E5YmIwMTc5MjQ3NmZiYjIyNWU1ZDlkZWM4NjlmL3NlYzo5M2NhOWJiMDE3OTI0NzZmYmIyMjVlNWQ5ZGVjODY5Zl81NS9mcmFnOjk0NGQ2N2RjOTNmMjQ1MjliZTc4ZmNlMzRiOGMyZTBiL3RhYmxlOjEzZmNjYmI1NjhiMDRhNzk4OWQ0NDZkNWNkYjk4MWVjL3RhYmxlcmFuZ2U6MTNmY2NiYjU2OGIwNGE3OTg5ZDQ0NmQ1Y2RiOTgxZWNfNy01LTEtMS0xNzE4_ac238863-8216-4c38-9b68-675828676c43">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i69782326f71a44e3805518280ee22b6b_D20210101-20210630" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:AssetImpairmentCharges" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzY2E5YmIwMTc5MjQ3NmZiYjIyNWU1ZDlkZWM4NjlmL3NlYzo5M2NhOWJiMDE3OTI0NzZmYmIyMjVlNWQ5ZGVjODY5Zl81NS9mcmFnOjk0NGQ2N2RjOTNmMjQ1MjliZTc4ZmNlMzRiOGMyZTBiL3RhYmxlOjEzZmNjYmI1NjhiMDRhNzk4OWQ0NDZkNWNkYjk4MWVjL3RhYmxlcmFuZ2U6MTNmY2NiYjU2OGIwNGE3OTg5ZDQ0NmQ1Y2RiOTgxZWNfNi03LTEtMS0xNjc1Mg_e8299219-36c4-45e6-8588-716d69077d55">1,741</ix:nonFraction></span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:17.25pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Loss on revaluation of derivative liabilities</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(ii)</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i73f2057fe97d4f3a8524f987e78d1493_D20210101-20210630" decimals="-3" format="ixt:zerodash" name="us-gaap:GainLossOnDerivativeInstrumentsNetPretax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzY2E5YmIwMTc5MjQ3NmZiYjIyNWU1ZDlkZWM4NjlmL3NlYzo5M2NhOWJiMDE3OTI0NzZmYmIyMjVlNWQ5ZGVjODY5Zl81NS9mcmFnOjk0NGQ2N2RjOTNmMjQ1MjliZTc4ZmNlMzRiOGMyZTBiL3RhYmxlOjEzZmNjYmI1NjhiMDRhNzk4OWQ0NDZkNWNkYjk4MWVjL3RhYmxlcmFuZ2U6MTNmY2NiYjU2OGIwNGE3OTg5ZDQ0NmQ1Y2RiOTgxZWNfOC0xLTEtMS0xNzAx_b1c484f4-bbd6-4232-8acf-105dca149120">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9eea321560784f81a590aa8e3df3b187_D20210101-20210630" decimals="-3" sign="-" format="ixt:numdotdecimal" name="us-gaap:GainLossOnDerivativeInstrumentsNetPretax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzY2E5YmIwMTc5MjQ3NmZiYjIyNWU1ZDlkZWM4NjlmL3NlYzo5M2NhOWJiMDE3OTI0NzZmYmIyMjVlNWQ5ZGVjODY5Zl81NS9mcmFnOjk0NGQ2N2RjOTNmMjQ1MjliZTc4ZmNlMzRiOGMyZTBiL3RhYmxlOjEzZmNjYmI1NjhiMDRhNzk4OWQ0NDZkNWNkYjk4MWVjL3RhYmxlcmFuZ2U6MTNmY2NiYjU2OGIwNGE3OTg5ZDQ0NmQ1Y2RiOTgxZWNfOC0zLTEtMS0xNzEy_bb1ca37e-6dad-4b35-8b37-869c38ceecae">1,626</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5e244469383d46ddb452d43394f637d1_D20210101-20210630" decimals="-3" format="ixt:zerodash" name="us-gaap:GainLossOnDerivativeInstrumentsNetPretax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzY2E5YmIwMTc5MjQ3NmZiYjIyNWU1ZDlkZWM4NjlmL3NlYzo5M2NhOWJiMDE3OTI0NzZmYmIyMjVlNWQ5ZGVjODY5Zl81NS9mcmFnOjk0NGQ2N2RjOTNmMjQ1MjliZTc4ZmNlMzRiOGMyZTBiL3RhYmxlOjEzZmNjYmI1NjhiMDRhNzk4OWQ0NDZkNWNkYjk4MWVjL3RhYmxlcmFuZ2U6MTNmY2NiYjU2OGIwNGE3OTg5ZDQ0NmQ1Y2RiOTgxZWNfOC01LTEtMS0xNzE4_f7e612bd-b93f-4abd-9cdb-dca56cd5d68d">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i69782326f71a44e3805518280ee22b6b_D20210101-20210630" decimals="-3" sign="-" format="ixt:numdotdecimal" name="us-gaap:GainLossOnDerivativeInstrumentsNetPretax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzY2E5YmIwMTc5MjQ3NmZiYjIyNWU1ZDlkZWM4NjlmL3NlYzo5M2NhOWJiMDE3OTI0NzZmYmIyMjVlNWQ5ZGVjODY5Zl81NS9mcmFnOjk0NGQ2N2RjOTNmMjQ1MjliZTc4ZmNlMzRiOGMyZTBiL3RhYmxlOjEzZmNjYmI1NjhiMDRhNzk4OWQ0NDZkNWNkYjk4MWVjL3RhYmxlcmFuZ2U6MTNmY2NiYjU2OGIwNGE3OTg5ZDQ0NmQ1Y2RiOTgxZWNfNy03LTEtMS0xNjc1Mg_2a6366a1-618b-48e5-ba8e-2783dfdd54b4">1,626</ix:nonFraction></span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:17.25pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Transaction costs</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(iii)</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i73f2057fe97d4f3a8524f987e78d1493_D20210101-20210630" decimals="-3" format="ixt:zerodash" name="us-gaap:RestructuringCharges" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzY2E5YmIwMTc5MjQ3NmZiYjIyNWU1ZDlkZWM4NjlmL3NlYzo5M2NhOWJiMDE3OTI0NzZmYmIyMjVlNWQ5ZGVjODY5Zl81NS9mcmFnOjk0NGQ2N2RjOTNmMjQ1MjliZTc4ZmNlMzRiOGMyZTBiL3RhYmxlOjEzZmNjYmI1NjhiMDRhNzk4OWQ0NDZkNWNkYjk4MWVjL3RhYmxlcmFuZ2U6MTNmY2NiYjU2OGIwNGE3OTg5ZDQ0NmQ1Y2RiOTgxZWNfOS0xLTEtMS0xNzAx_2206768a-927b-4e70-9d41-6768ef50cbf2">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9eea321560784f81a590aa8e3df3b187_D20210101-20210630" decimals="-3" format="ixt:zerodash" name="us-gaap:RestructuringCharges" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzY2E5YmIwMTc5MjQ3NmZiYjIyNWU1ZDlkZWM4NjlmL3NlYzo5M2NhOWJiMDE3OTI0NzZmYmIyMjVlNWQ5ZGVjODY5Zl81NS9mcmFnOjk0NGQ2N2RjOTNmMjQ1MjliZTc4ZmNlMzRiOGMyZTBiL3RhYmxlOjEzZmNjYmI1NjhiMDRhNzk4OWQ0NDZkNWNkYjk4MWVjL3RhYmxlcmFuZ2U6MTNmY2NiYjU2OGIwNGE3OTg5ZDQ0NmQ1Y2RiOTgxZWNfOS0zLTEtMS0xNzEy_e840017e-2b42-4da2-86e8-a6ab67e4192c">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5e244469383d46ddb452d43394f637d1_D20210101-20210630" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:RestructuringCharges" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzY2E5YmIwMTc5MjQ3NmZiYjIyNWU1ZDlkZWM4NjlmL3NlYzo5M2NhOWJiMDE3OTI0NzZmYmIyMjVlNWQ5ZGVjODY5Zl81NS9mcmFnOjk0NGQ2N2RjOTNmMjQ1MjliZTc4ZmNlMzRiOGMyZTBiL3RhYmxlOjEzZmNjYmI1NjhiMDRhNzk4OWQ0NDZkNWNkYjk4MWVjL3RhYmxlcmFuZ2U6MTNmY2NiYjU2OGIwNGE3OTg5ZDQ0NmQ1Y2RiOTgxZWNfOS01LTEtMS0xNzE4_09d6ca30-e2a2-4bf7-9fc2-17fe87c1e163">3,259</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i69782326f71a44e3805518280ee22b6b_D20210101-20210630" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:RestructuringCharges" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzY2E5YmIwMTc5MjQ3NmZiYjIyNWU1ZDlkZWM4NjlmL3NlYzo5M2NhOWJiMDE3OTI0NzZmYmIyMjVlNWQ5ZGVjODY5Zl81NS9mcmFnOjk0NGQ2N2RjOTNmMjQ1MjliZTc4ZmNlMzRiOGMyZTBiL3RhYmxlOjEzZmNjYmI1NjhiMDRhNzk4OWQ0NDZkNWNkYjk4MWVjL3RhYmxlcmFuZ2U6MTNmY2NiYjU2OGIwNGE3OTg5ZDQ0NmQ1Y2RiOTgxZWNfOC03LTEtMS0xNjc1Mg_027f4f07-ee14-4bc5-8dbf-54b64fd838e9">3,259</ix:nonFraction></span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:17.25pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other, net</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(iv)</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i73f2057fe97d4f3a8524f987e78d1493_D20210101-20210630" decimals="-3" format="ixt:zerodash" name="us-gaap:OtherNonoperatingIncomeExpense" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzY2E5YmIwMTc5MjQ3NmZiYjIyNWU1ZDlkZWM4NjlmL3NlYzo5M2NhOWJiMDE3OTI0NzZmYmIyMjVlNWQ5ZGVjODY5Zl81NS9mcmFnOjk0NGQ2N2RjOTNmMjQ1MjliZTc4ZmNlMzRiOGMyZTBiL3RhYmxlOjEzZmNjYmI1NjhiMDRhNzk4OWQ0NDZkNWNkYjk4MWVjL3RhYmxlcmFuZ2U6MTNmY2NiYjU2OGIwNGE3OTg5ZDQ0NmQ1Y2RiOTgxZWNfMTAtMS0xLTEtMTcwMQ_ce6c1bac-cdac-494d-bf5b-fea24eff7e26">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i9eea321560784f81a590aa8e3df3b187_D20210101-20210630" decimals="-3" name="us-gaap:OtherNonoperatingIncomeExpense" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzY2E5YmIwMTc5MjQ3NmZiYjIyNWU1ZDlkZWM4NjlmL3NlYzo5M2NhOWJiMDE3OTI0NzZmYmIyMjVlNWQ5ZGVjODY5Zl81NS9mcmFnOjk0NGQ2N2RjOTNmMjQ1MjliZTc4ZmNlMzRiOGMyZTBiL3RhYmxlOjEzZmNjYmI1NjhiMDRhNzk4OWQ0NDZkNWNkYjk4MWVjL3RhYmxlcmFuZ2U6MTNmY2NiYjU2OGIwNGE3OTg5ZDQ0NmQ1Y2RiOTgxZWNfMTAtMy0xLTEtMTcxMg_01f6892f-f1d3-48b8-ad99-dc7f7447d861">911</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5e244469383d46ddb452d43394f637d1_D20210101-20210630" decimals="-3" format="ixt:zerodash" name="us-gaap:OtherNonoperatingIncomeExpense" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzY2E5YmIwMTc5MjQ3NmZiYjIyNWU1ZDlkZWM4NjlmL3NlYzo5M2NhOWJiMDE3OTI0NzZmYmIyMjVlNWQ5ZGVjODY5Zl81NS9mcmFnOjk0NGQ2N2RjOTNmMjQ1MjliZTc4ZmNlMzRiOGMyZTBiL3RhYmxlOjEzZmNjYmI1NjhiMDRhNzk4OWQ0NDZkNWNkYjk4MWVjL3RhYmxlcmFuZ2U6MTNmY2NiYjU2OGIwNGE3OTg5ZDQ0NmQ1Y2RiOTgxZWNfMTAtNS0xLTEtMTcxOA_f531328c-8e89-4ea4-9d96-a770a6257f3f">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i69782326f71a44e3805518280ee22b6b_D20210101-20210630" decimals="-3" name="us-gaap:OtherNonoperatingIncomeExpense" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzY2E5YmIwMTc5MjQ3NmZiYjIyNWU1ZDlkZWM4NjlmL3NlYzo5M2NhOWJiMDE3OTI0NzZmYmIyMjVlNWQ5ZGVjODY5Zl81NS9mcmFnOjk0NGQ2N2RjOTNmMjQ1MjliZTc4ZmNlMzRiOGMyZTBiL3RhYmxlOjEzZmNjYmI1NjhiMDRhNzk4OWQ0NDZkNWNkYjk4MWVjL3RhYmxlcmFuZ2U6MTNmY2NiYjU2OGIwNGE3OTg5ZDQ0NmQ1Y2RiOTgxZWNfOS03LTEtMS0xNjc1Mg_18d1101c-8233-476f-954e-bd5e28e3ca54">911</ix:nonFraction>)</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:17.25pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Loss from discontinued operations</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(v)</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i73f2057fe97d4f3a8524f987e78d1493_D20210101-20210630" decimals="-3" format="ixt:zerodash" name="us-gaap:IncomeLossFromDiscontinuedOperationsNetOfTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzY2E5YmIwMTc5MjQ3NmZiYjIyNWU1ZDlkZWM4NjlmL3NlYzo5M2NhOWJiMDE3OTI0NzZmYmIyMjVlNWQ5ZGVjODY5Zl81NS9mcmFnOjk0NGQ2N2RjOTNmMjQ1MjliZTc4ZmNlMzRiOGMyZTBiL3RhYmxlOjEzZmNjYmI1NjhiMDRhNzk4OWQ0NDZkNWNkYjk4MWVjL3RhYmxlcmFuZ2U6MTNmY2NiYjU2OGIwNGE3OTg5ZDQ0NmQ1Y2RiOTgxZWNfMTEtMS0xLTEtMTcwMQ_e6df5383-772c-4a33-9afc-27a6bb3e9605">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9eea321560784f81a590aa8e3df3b187_D20210101-20210630" decimals="-3" sign="-" name="us-gaap:IncomeLossFromDiscontinuedOperationsNetOfTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzY2E5YmIwMTc5MjQ3NmZiYjIyNWU1ZDlkZWM4NjlmL3NlYzo5M2NhOWJiMDE3OTI0NzZmYmIyMjVlNWQ5ZGVjODY5Zl81NS9mcmFnOjk0NGQ2N2RjOTNmMjQ1MjliZTc4ZmNlMzRiOGMyZTBiL3RhYmxlOjEzZmNjYmI1NjhiMDRhNzk4OWQ0NDZkNWNkYjk4MWVjL3RhYmxlcmFuZ2U6MTNmY2NiYjU2OGIwNGE3OTg5ZDQ0NmQ1Y2RiOTgxZWNfMTEtMy0xLTEtMTcxMg_b9fabc92-7aed-4388-8805-8d7275ff23d7">582</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5e244469383d46ddb452d43394f637d1_D20210101-20210630" decimals="-3" format="ixt:zerodash" name="us-gaap:IncomeLossFromDiscontinuedOperationsNetOfTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzY2E5YmIwMTc5MjQ3NmZiYjIyNWU1ZDlkZWM4NjlmL3NlYzo5M2NhOWJiMDE3OTI0NzZmYmIyMjVlNWQ5ZGVjODY5Zl81NS9mcmFnOjk0NGQ2N2RjOTNmMjQ1MjliZTc4ZmNlMzRiOGMyZTBiL3RhYmxlOjEzZmNjYmI1NjhiMDRhNzk4OWQ0NDZkNWNkYjk4MWVjL3RhYmxlcmFuZ2U6MTNmY2NiYjU2OGIwNGE3OTg5ZDQ0NmQ1Y2RiOTgxZWNfMTEtNS0xLTEtMTcxOA_3d668e13-5e7e-4692-ab30-af1a14e743e6">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i69782326f71a44e3805518280ee22b6b_D20210101-20210630" decimals="-3" sign="-" name="us-gaap:IncomeLossFromDiscontinuedOperationsNetOfTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzY2E5YmIwMTc5MjQ3NmZiYjIyNWU1ZDlkZWM4NjlmL3NlYzo5M2NhOWJiMDE3OTI0NzZmYmIyMjVlNWQ5ZGVjODY5Zl81NS9mcmFnOjk0NGQ2N2RjOTNmMjQ1MjliZTc4ZmNlMzRiOGMyZTBiL3RhYmxlOjEzZmNjYmI1NjhiMDRhNzk4OWQ0NDZkNWNkYjk4MWVjL3RhYmxlcmFuZ2U6MTNmY2NiYjU2OGIwNGE3OTg5ZDQ0NmQ1Y2RiOTgxZWNfMTAtNy0xLTEtMTY3NTI_b8aa1b20-fd2e-48c5-a4b4-73a118d43241">582</ix:nonFraction></span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:17.25pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Share-based payments</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(vi)</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i73f2057fe97d4f3a8524f987e78d1493_D20210101-20210630" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:AllocatedShareBasedCompensationExpense" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzY2E5YmIwMTc5MjQ3NmZiYjIyNWU1ZDlkZWM4NjlmL3NlYzo5M2NhOWJiMDE3OTI0NzZmYmIyMjVlNWQ5ZGVjODY5Zl81NS9mcmFnOjk0NGQ2N2RjOTNmMjQ1MjliZTc4ZmNlMzRiOGMyZTBiL3RhYmxlOjEzZmNjYmI1NjhiMDRhNzk4OWQ0NDZkNWNkYjk4MWVjL3RhYmxlcmFuZ2U6MTNmY2NiYjU2OGIwNGE3OTg5ZDQ0NmQ1Y2RiOTgxZWNfMTItMS0xLTEtMTcwMQ_9de835dc-3bce-49e4-bd4e-bd68f92294d4">1,567</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9eea321560784f81a590aa8e3df3b187_D20210101-20210630" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:AllocatedShareBasedCompensationExpense" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzY2E5YmIwMTc5MjQ3NmZiYjIyNWU1ZDlkZWM4NjlmL3NlYzo5M2NhOWJiMDE3OTI0NzZmYmIyMjVlNWQ5ZGVjODY5Zl81NS9mcmFnOjk0NGQ2N2RjOTNmMjQ1MjliZTc4ZmNlMzRiOGMyZTBiL3RhYmxlOjEzZmNjYmI1NjhiMDRhNzk4OWQ0NDZkNWNkYjk4MWVjL3RhYmxlcmFuZ2U6MTNmY2NiYjU2OGIwNGE3OTg5ZDQ0NmQ1Y2RiOTgxZWNfMTItMy0xLTEtMTcxMg_81250ff9-07a2-4bfd-9702-c4a76ecb0af3">3,497</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5e244469383d46ddb452d43394f637d1_D20210101-20210630" decimals="-3" format="ixt:zerodash" name="us-gaap:AllocatedShareBasedCompensationExpense" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzY2E5YmIwMTc5MjQ3NmZiYjIyNWU1ZDlkZWM4NjlmL3NlYzo5M2NhOWJiMDE3OTI0NzZmYmIyMjVlNWQ5ZGVjODY5Zl81NS9mcmFnOjk0NGQ2N2RjOTNmMjQ1MjliZTc4ZmNlMzRiOGMyZTBiL3RhYmxlOjEzZmNjYmI1NjhiMDRhNzk4OWQ0NDZkNWNkYjk4MWVjL3RhYmxlcmFuZ2U6MTNmY2NiYjU2OGIwNGE3OTg5ZDQ0NmQ1Y2RiOTgxZWNfMTItNS0xLTEtMTcxOA_67749959-1271-4389-b25b-b2eee3d17340">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i69782326f71a44e3805518280ee22b6b_D20210101-20210630" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:AllocatedShareBasedCompensationExpense" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzY2E5YmIwMTc5MjQ3NmZiYjIyNWU1ZDlkZWM4NjlmL3NlYzo5M2NhOWJiMDE3OTI0NzZmYmIyMjVlNWQ5ZGVjODY5Zl81NS9mcmFnOjk0NGQ2N2RjOTNmMjQ1MjliZTc4ZmNlMzRiOGMyZTBiL3RhYmxlOjEzZmNjYmI1NjhiMDRhNzk4OWQ0NDZkNWNkYjk4MWVjL3RhYmxlcmFuZ2U6MTNmY2NiYjU2OGIwNGE3OTg5ZDQ0NmQ1Y2RiOTgxZWNfMTEtNy0xLTEtMTY3NTI_228de170-de64-4f9a-8d6f-448f027839b0">5,064</ix:nonFraction></span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:17.25pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Review costs related to restatement of 2019 interim financial statements</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(vii)</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i73f2057fe97d4f3a8524f987e78d1493_D20210101-20210630" decimals="-3" format="ixt:zerodash" name="cron:RestatementReviewExpense" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzY2E5YmIwMTc5MjQ3NmZiYjIyNWU1ZDlkZWM4NjlmL3NlYzo5M2NhOWJiMDE3OTI0NzZmYmIyMjVlNWQ5ZGVjODY5Zl81NS9mcmFnOjk0NGQ2N2RjOTNmMjQ1MjliZTc4ZmNlMzRiOGMyZTBiL3RhYmxlOjEzZmNjYmI1NjhiMDRhNzk4OWQ0NDZkNWNkYjk4MWVjL3RhYmxlcmFuZ2U6MTNmY2NiYjU2OGIwNGE3OTg5ZDQ0NmQ1Y2RiOTgxZWNfMTMtMS0xLTEtMTcwMQ_19c6ae73-5a11-4d52-980f-ec48c0f11bda">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9eea321560784f81a590aa8e3df3b187_D20210101-20210630" decimals="-3" format="ixt:zerodash" name="cron:RestatementReviewExpense" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzY2E5YmIwMTc5MjQ3NmZiYjIyNWU1ZDlkZWM4NjlmL3NlYzo5M2NhOWJiMDE3OTI0NzZmYmIyMjVlNWQ5ZGVjODY5Zl81NS9mcmFnOjk0NGQ2N2RjOTNmMjQ1MjliZTc4ZmNlMzRiOGMyZTBiL3RhYmxlOjEzZmNjYmI1NjhiMDRhNzk4OWQ0NDZkNWNkYjk4MWVjL3RhYmxlcmFuZ2U6MTNmY2NiYjU2OGIwNGE3OTg5ZDQ0NmQ1Y2RiOTgxZWNfMTMtMy0xLTEtMTcxMg_87726422-c0dc-4c12-9f66-f43f9cd8d63a">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5e244469383d46ddb452d43394f637d1_D20210101-20210630" decimals="-3" format="ixt:numdotdecimal" name="cron:RestatementReviewExpense" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzY2E5YmIwMTc5MjQ3NmZiYjIyNWU1ZDlkZWM4NjlmL3NlYzo5M2NhOWJiMDE3OTI0NzZmYmIyMjVlNWQ5ZGVjODY5Zl81NS9mcmFnOjk0NGQ2N2RjOTNmMjQ1MjliZTc4ZmNlMzRiOGMyZTBiL3RhYmxlOjEzZmNjYmI1NjhiMDRhNzk4OWQ0NDZkNWNkYjk4MWVjL3RhYmxlcmFuZ2U6MTNmY2NiYjU2OGIwNGE3OTg5ZDQ0NmQ1Y2RiOTgxZWNfMTMtNS0xLTEtMTcxOA_e0f9912a-2d42-4f13-861e-2eb57b1530be">3,937</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i69782326f71a44e3805518280ee22b6b_D20210101-20210630" decimals="-3" format="ixt:numdotdecimal" name="cron:RestatementReviewExpense" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzY2E5YmIwMTc5MjQ3NmZiYjIyNWU1ZDlkZWM4NjlmL3NlYzo5M2NhOWJiMDE3OTI0NzZmYmIyMjVlNWQ5ZGVjODY5Zl81NS9mcmFnOjk0NGQ2N2RjOTNmMjQ1MjliZTc4ZmNlMzRiOGMyZTBiL3RhYmxlOjEzZmNjYmI1NjhiMDRhNzk4OWQ0NDZkNWNkYjk4MWVjL3RhYmxlcmFuZ2U6MTNmY2NiYjU2OGIwNGE3OTg5ZDQ0NmQ1Y2RiOTgxZWNfMTItNy0xLTEtMTY3NTI_3e2cf275-9772-4284-815b-22cb8c6c0413">3,937</ix:nonFraction></span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Depreciation and amortization</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i73f2057fe97d4f3a8524f987e78d1493_D20210101-20210630" decimals="-3" name="us-gaap:DepreciationDepletionAndAmortization" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzY2E5YmIwMTc5MjQ3NmZiYjIyNWU1ZDlkZWM4NjlmL3NlYzo5M2NhOWJiMDE3OTI0NzZmYmIyMjVlNWQ5ZGVjODY5Zl81NS9mcmFnOjk0NGQ2N2RjOTNmMjQ1MjliZTc4ZmNlMzRiOGMyZTBiL3RhYmxlOjEzZmNjYmI1NjhiMDRhNzk4OWQ0NDZkNWNkYjk4MWVjL3RhYmxlcmFuZ2U6MTNmY2NiYjU2OGIwNGE3OTg5ZDQ0NmQ1Y2RiOTgxZWNfMTYtMS0xLTEtMTcwOQ_07d215ad-8944-43e2-8677-68fc2653ab0f">305</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9eea321560784f81a590aa8e3df3b187_D20210101-20210630" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:DepreciationDepletionAndAmortization" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzY2E5YmIwMTc5MjQ3NmZiYjIyNWU1ZDlkZWM4NjlmL3NlYzo5M2NhOWJiMDE3OTI0NzZmYmIyMjVlNWQ5ZGVjODY5Zl81NS9mcmFnOjk0NGQ2N2RjOTNmMjQ1MjliZTc4ZmNlMzRiOGMyZTBiL3RhYmxlOjEzZmNjYmI1NjhiMDRhNzk4OWQ0NDZkNWNkYjk4MWVjL3RhYmxlcmFuZ2U6MTNmY2NiYjU2OGIwNGE3OTg5ZDQ0NmQ1Y2RiOTgxZWNfMTYtMy0xLTEtMTcxNQ_95eaedf0-b6a9-4704-bc3d-c0d153952da0">4,778</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5e244469383d46ddb452d43394f637d1_D20210101-20210630" decimals="-3" format="ixt:zerodash" name="us-gaap:DepreciationDepletionAndAmortization" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzY2E5YmIwMTc5MjQ3NmZiYjIyNWU1ZDlkZWM4NjlmL3NlYzo5M2NhOWJiMDE3OTI0NzZmYmIyMjVlNWQ5ZGVjODY5Zl81NS9mcmFnOjk0NGQ2N2RjOTNmMjQ1MjliZTc4ZmNlMzRiOGMyZTBiL3RhYmxlOjEzZmNjYmI1NjhiMDRhNzk4OWQ0NDZkNWNkYjk4MWVjL3RhYmxlcmFuZ2U6MTNmY2NiYjU2OGIwNGE3OTg5ZDQ0NmQ1Y2RiOTgxZWNfMTYtNS0xLTEtMTcyMQ_402feeb8-1666-4436-b7ef-ff1f519b0cd8">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i69782326f71a44e3805518280ee22b6b_D20210101-20210630" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:DepreciationDepletionAndAmortization" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzY2E5YmIwMTc5MjQ3NmZiYjIyNWU1ZDlkZWM4NjlmL3NlYzo5M2NhOWJiMDE3OTI0NzZmYmIyMjVlNWQ5ZGVjODY5Zl81NS9mcmFnOjk0NGQ2N2RjOTNmMjQ1MjliZTc4ZmNlMzRiOGMyZTBiL3RhYmxlOjEzZmNjYmI1NjhiMDRhNzk4OWQ0NDZkNWNkYjk4MWVjL3RhYmxlcmFuZ2U6MTNmY2NiYjU2OGIwNGE3OTg5ZDQ0NmQ1Y2RiOTgxZWNfMTMtNy0xLTEtMTY3NTI_816aa317-b47d-4779-b7ea-99c3e4941922">5,083</ix:nonFraction></span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Adjusted EBITDA</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i73f2057fe97d4f3a8524f987e78d1493_D20210101-20210630" decimals="-3" sign="-" format="ixt:numdotdecimal" name="cron:AdjustedEarningsBeforeInterestTaxesDepreciationAndAmortization" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzY2E5YmIwMTc5MjQ3NmZiYjIyNWU1ZDlkZWM4NjlmL3NlYzo5M2NhOWJiMDE3OTI0NzZmYmIyMjVlNWQ5ZGVjODY5Zl81NS9mcmFnOjk0NGQ2N2RjOTNmMjQ1MjliZTc4ZmNlMzRiOGMyZTBiL3RhYmxlOjEzZmNjYmI1NjhiMDRhNzk4OWQ0NDZkNWNkYjk4MWVjL3RhYmxlcmFuZ2U6MTNmY2NiYjU2OGIwNGE3OTg5ZDQ0NmQ1Y2RiOTgxZWNfMTQtMS0xLTEtMTY3NTI_c17dd40a-29f7-4e35-8de1-797c870f5003">20,221</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i9eea321560784f81a590aa8e3df3b187_D20210101-20210630" decimals="-3" sign="-" format="ixt:numdotdecimal" name="cron:AdjustedEarningsBeforeInterestTaxesDepreciationAndAmortization" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzY2E5YmIwMTc5MjQ3NmZiYjIyNWU1ZDlkZWM4NjlmL3NlYzo5M2NhOWJiMDE3OTI0NzZmYmIyMjVlNWQ5ZGVjODY5Zl81NS9mcmFnOjk0NGQ2N2RjOTNmMjQ1MjliZTc4ZmNlMzRiOGMyZTBiL3RhYmxlOjEzZmNjYmI1NjhiMDRhNzk4OWQ0NDZkNWNkYjk4MWVjL3RhYmxlcmFuZ2U6MTNmY2NiYjU2OGIwNGE3OTg5ZDQ0NmQ1Y2RiOTgxZWNfMTQtMy0xLTEtMTY3NTI_c05a2836-09db-47c3-acd9-19a14300e23f">54,789</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i5e244469383d46ddb452d43394f637d1_D20210101-20210630" decimals="-3" sign="-" format="ixt:numdotdecimal" name="cron:AdjustedEarningsBeforeInterestTaxesDepreciationAndAmortization" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzY2E5YmIwMTc5MjQ3NmZiYjIyNWU1ZDlkZWM4NjlmL3NlYzo5M2NhOWJiMDE3OTI0NzZmYmIyMjVlNWQ5ZGVjODY5Zl81NS9mcmFnOjk0NGQ2N2RjOTNmMjQ1MjliZTc4ZmNlMzRiOGMyZTBiL3RhYmxlOjEzZmNjYmI1NjhiMDRhNzk4OWQ0NDZkNWNkYjk4MWVjL3RhYmxlcmFuZ2U6MTNmY2NiYjU2OGIwNGE3OTg5ZDQ0NmQ1Y2RiOTgxZWNfMTQtNS0xLTEtMTY3NTI_1ccbab0d-49cb-47f6-87f3-ccabe6394974">11,323</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i69782326f71a44e3805518280ee22b6b_D20210101-20210630" decimals="-3" sign="-" format="ixt:numdotdecimal" name="cron:AdjustedEarningsBeforeInterestTaxesDepreciationAndAmortization" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzY2E5YmIwMTc5MjQ3NmZiYjIyNWU1ZDlkZWM4NjlmL3NlYzo5M2NhOWJiMDE3OTI0NzZmYmIyMjVlNWQ5ZGVjODY5Zl81NS9mcmFnOjk0NGQ2N2RjOTNmMjQ1MjliZTc4ZmNlMzRiOGMyZTBiL3RhYmxlOjEzZmNjYmI1NjhiMDRhNzk4OWQ0NDZkNWNkYjk4MWVjL3RhYmxlcmFuZ2U6MTNmY2NiYjU2OGIwNGE3OTg5ZDQ0NmQ1Y2RiOTgxZWNfMTQtNy0xLTEtMTY3NTI_be715c07-f65b-4fc2-a221-23cc456acc7b">86,333</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div></ix:continuation></ix:continuation><div style="height:36pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">23</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:72pt;width:100%"><div style="margin-top:0.55pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:95.000%"><tr><td style="width:1.0%"></td><td style="width:65.712%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:32.088%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="border-top:1pt solid #FFFFFF;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Cronos Group Inc.</span></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Notes to Condensed Consolidated Financial Statements (Unaudited)</span></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">(In thousands of $, except share amounts)</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i93ca9bb01792476fbb225e5d9dec869f_7">Table of Contents</a></span></div></td></tr></table></div></div><ix:continuation id="id60c1be92bfc41ccab11e03515c8d381" continuedAt="iaca7063ce197461f85c325e68d28fcb6"><ix:continuation id="i1ee9823bd4c04d489e453e3073b868ca" continuedAt="i26257594cd534cd8930b4d97cbeb09cd"><div style="margin-bottom:6pt;margin-top:6pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:42.650%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.233%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.772%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.233%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.772%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.233%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.772%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.235%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="21" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Six months ended June&#160;30, 2020</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">United States</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Rest of World</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Corporate Expenses</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Total</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net income (loss)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="iab9b56b2a03f4c6199d282bd8676a924_D20200101-20200630" decimals="-3" sign="-" format="ixt:numdotdecimal" name="us-gaap:ProfitLoss" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzY2E5YmIwMTc5MjQ3NmZiYjIyNWU1ZDlkZWM4NjlmL3NlYzo5M2NhOWJiMDE3OTI0NzZmYmIyMjVlNWQ5ZGVjODY5Zl81NS9mcmFnOjk0NGQ2N2RjOTNmMjQ1MjliZTc4ZmNlMzRiOGMyZTBiL3RhYmxlOmRjZTc4NDZiYzM0MjRlNzc4YTQxZjY1OTBkNjY4NTg5L3RhYmxlcmFuZ2U6ZGNlNzg0NmJjMzQyNGU3NzhhNDFmNjU5MGQ2Njg1ODlfMi0xLTEtMS0xNzMy_99e196a5-ae87-4d69-bba7-f76a4d2df75f">52,082</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i13788f202c86441fa347b97f3162a453_D20200101-20200630" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:ProfitLoss" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzY2E5YmIwMTc5MjQ3NmZiYjIyNWU1ZDlkZWM4NjlmL3NlYzo5M2NhOWJiMDE3OTI0NzZmYmIyMjVlNWQ5ZGVjODY5Zl81NS9mcmFnOjk0NGQ2N2RjOTNmMjQ1MjliZTc4ZmNlMzRiOGMyZTBiL3RhYmxlOmRjZTc4NDZiYzM0MjRlNzc4YTQxZjY1OTBkNjY4NTg5L3RhYmxlcmFuZ2U6ZGNlNzg0NmJjMzQyNGU3NzhhNDFmNjU5MGQ2Njg1ODlfMi0zLTEtMS0xNzM1_3ad3b8e6-2ebe-42c8-8f8b-af247d5e1580">33,772</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="iaf98f9473a3d428f9aab9f72e135866f_D20200101-20200630" decimals="-3" sign="-" format="ixt:numdotdecimal" name="us-gaap:ProfitLoss" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzY2E5YmIwMTc5MjQ3NmZiYjIyNWU1ZDlkZWM4NjlmL3NlYzo5M2NhOWJiMDE3OTI0NzZmYmIyMjVlNWQ5ZGVjODY5Zl81NS9mcmFnOjk0NGQ2N2RjOTNmMjQ1MjliZTc4ZmNlMzRiOGMyZTBiL3RhYmxlOmRjZTc4NDZiYzM0MjRlNzc4YTQxZjY1OTBkNjY4NTg5L3RhYmxlcmFuZ2U6ZGNlNzg0NmJjMzQyNGU3NzhhNDFmNjU5MGQ2Njg1ODlfMi01LTEtMS0xNzM4_1ad97707-aafe-4854-8247-47ccaaf8d1c2">13,712</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 7pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i4a110e4972ef4113880ce582e3cda5c5_D20200101-20200630" decimals="-3" sign="-" format="ixt:numdotdecimal" name="us-gaap:ProfitLoss" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzY2E5YmIwMTc5MjQ3NmZiYjIyNWU1ZDlkZWM4NjlmL3NlYzo5M2NhOWJiMDE3OTI0NzZmYmIyMjVlNWQ5ZGVjODY5Zl81NS9mcmFnOjk0NGQ2N2RjOTNmMjQ1MjliZTc4ZmNlMzRiOGMyZTBiL3RhYmxlOmRjZTc4NDZiYzM0MjRlNzc4YTQxZjY1OTBkNjY4NTg5L3RhYmxlcmFuZ2U6ZGNlNzg0NmJjMzQyNGU3NzhhNDFmNjU5MGQ2Njg1ODlfMi03LTEtMS0xNjc4MQ_e687316b-52fa-4d28-83bd-0305e8c81912">32,022</ix:nonFraction>)</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Interest income, net</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="iab9b56b2a03f4c6199d282bd8676a924_D20200101-20200630" decimals="-3" name="us-gaap:InterestIncomeExpenseNonoperatingNet" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzY2E5YmIwMTc5MjQ3NmZiYjIyNWU1ZDlkZWM4NjlmL3NlYzo5M2NhOWJiMDE3OTI0NzZmYmIyMjVlNWQ5ZGVjODY5Zl81NS9mcmFnOjk0NGQ2N2RjOTNmMjQ1MjliZTc4ZmNlMzRiOGMyZTBiL3RhYmxlOmRjZTc4NDZiYzM0MjRlNzc4YTQxZjY1OTBkNjY4NTg5L3RhYmxlcmFuZ2U6ZGNlNzg0NmJjMzQyNGU3NzhhNDFmNjU5MGQ2Njg1ODlfNC0xLTEtMS0xNzMy_54969d62-f270-471e-a37c-e8dc40c4b007">16</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i13788f202c86441fa347b97f3162a453_D20200101-20200630" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:InterestIncomeExpenseNonoperatingNet" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzY2E5YmIwMTc5MjQ3NmZiYjIyNWU1ZDlkZWM4NjlmL3NlYzo5M2NhOWJiMDE3OTI0NzZmYmIyMjVlNWQ5ZGVjODY5Zl81NS9mcmFnOjk0NGQ2N2RjOTNmMjQ1MjliZTc4ZmNlMzRiOGMyZTBiL3RhYmxlOmRjZTc4NDZiYzM0MjRlNzc4YTQxZjY1OTBkNjY4NTg5L3RhYmxlcmFuZ2U6ZGNlNzg0NmJjMzQyNGU3NzhhNDFmNjU5MGQ2Njg1ODlfNC0zLTEtMS0xNzM1_3c4e55b9-a522-4cda-9281-8d138a0f525a">11,469</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iaf98f9473a3d428f9aab9f72e135866f_D20200101-20200630" decimals="-3" format="ixt:zerodash" name="us-gaap:InterestIncomeExpenseNonoperatingNet" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzY2E5YmIwMTc5MjQ3NmZiYjIyNWU1ZDlkZWM4NjlmL3NlYzo5M2NhOWJiMDE3OTI0NzZmYmIyMjVlNWQ5ZGVjODY5Zl81NS9mcmFnOjk0NGQ2N2RjOTNmMjQ1MjliZTc4ZmNlMzRiOGMyZTBiL3RhYmxlOmRjZTc4NDZiYzM0MjRlNzc4YTQxZjY1OTBkNjY4NTg5L3RhYmxlcmFuZ2U6ZGNlNzg0NmJjMzQyNGU3NzhhNDFmNjU5MGQ2Njg1ODlfNC01LTEtMS0xNzM4_296a8671-f14f-4784-a412-b2a7af871959">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i4a110e4972ef4113880ce582e3cda5c5_D20200101-20200630" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:InterestIncomeExpenseNonoperatingNet" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzY2E5YmIwMTc5MjQ3NmZiYjIyNWU1ZDlkZWM4NjlmL3NlYzo5M2NhOWJiMDE3OTI0NzZmYmIyMjVlNWQ5ZGVjODY5Zl81NS9mcmFnOjk0NGQ2N2RjOTNmMjQ1MjliZTc4ZmNlMzRiOGMyZTBiL3RhYmxlOmRjZTc4NDZiYzM0MjRlNzc4YTQxZjY1OTBkNjY4NTg5L3RhYmxlcmFuZ2U6ZGNlNzg0NmJjMzQyNGU3NzhhNDFmNjU5MGQ2Njg1ODlfMy03LTEtMS0xNjc4MQ_5a66ea62-0565-4b43-8c3a-6f30b994b477">11,485</ix:nonFraction>)</span></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Share of loss from equity accounted investments</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iab9b56b2a03f4c6199d282bd8676a924_D20200101-20200630" decimals="-3" format="ixt:zerodash" name="us-gaap:IncomeLossFromEquityMethodInvestments" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzY2E5YmIwMTc5MjQ3NmZiYjIyNWU1ZDlkZWM4NjlmL3NlYzo5M2NhOWJiMDE3OTI0NzZmYmIyMjVlNWQ5ZGVjODY5Zl81NS9mcmFnOjk0NGQ2N2RjOTNmMjQ1MjliZTc4ZmNlMzRiOGMyZTBiL3RhYmxlOmRjZTc4NDZiYzM0MjRlNzc4YTQxZjY1OTBkNjY4NTg5L3RhYmxlcmFuZ2U6ZGNlNzg0NmJjMzQyNGU3NzhhNDFmNjU5MGQ2Njg1ODlfNi0xLTEtMS00NjYy_12927d66-3155-476d-8cb9-0e5719a61078">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i13788f202c86441fa347b97f3162a453_D20200101-20200630" decimals="-3" sign="-" format="ixt:numdotdecimal" name="us-gaap:IncomeLossFromEquityMethodInvestments" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzY2E5YmIwMTc5MjQ3NmZiYjIyNWU1ZDlkZWM4NjlmL3NlYzo5M2NhOWJiMDE3OTI0NzZmYmIyMjVlNWQ5ZGVjODY5Zl81NS9mcmFnOjk0NGQ2N2RjOTNmMjQ1MjliZTc4ZmNlMzRiOGMyZTBiL3RhYmxlOmRjZTc4NDZiYzM0MjRlNzc4YTQxZjY1OTBkNjY4NTg5L3RhYmxlcmFuZ2U6ZGNlNzg0NmJjMzQyNGU3NzhhNDFmNjU5MGQ2Njg1ODlfNi0zLTEtMS00NjYy_46459b55-b935-4958-9f41-1b00aaa3eac8">1,966</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iaf98f9473a3d428f9aab9f72e135866f_D20200101-20200630" decimals="-3" format="ixt:zerodash" name="us-gaap:IncomeLossFromEquityMethodInvestments" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzY2E5YmIwMTc5MjQ3NmZiYjIyNWU1ZDlkZWM4NjlmL3NlYzo5M2NhOWJiMDE3OTI0NzZmYmIyMjVlNWQ5ZGVjODY5Zl81NS9mcmFnOjk0NGQ2N2RjOTNmMjQ1MjliZTc4ZmNlMzRiOGMyZTBiL3RhYmxlOmRjZTc4NDZiYzM0MjRlNzc4YTQxZjY1OTBkNjY4NTg5L3RhYmxlcmFuZ2U6ZGNlNzg0NmJjMzQyNGU3NzhhNDFmNjU5MGQ2Njg1ODlfNi01LTEtMS00NjYy_2b4fba51-2c6b-468e-b98e-8b85e6c267d3">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4a110e4972ef4113880ce582e3cda5c5_D20200101-20200630" decimals="-3" sign="-" format="ixt:numdotdecimal" name="us-gaap:IncomeLossFromEquityMethodInvestments" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzY2E5YmIwMTc5MjQ3NmZiYjIyNWU1ZDlkZWM4NjlmL3NlYzo5M2NhOWJiMDE3OTI0NzZmYmIyMjVlNWQ5ZGVjODY5Zl81NS9mcmFnOjk0NGQ2N2RjOTNmMjQ1MjliZTc4ZmNlMzRiOGMyZTBiL3RhYmxlOmRjZTc4NDZiYzM0MjRlNzc4YTQxZjY1OTBkNjY4NTg5L3RhYmxlcmFuZ2U6ZGNlNzg0NmJjMzQyNGU3NzhhNDFmNjU5MGQ2Njg1ODlfNS03LTEtMS0xNjc4MQ_89ba48cc-7e0e-4213-a031-982223fd6daa">1,966</ix:nonFraction></span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><div style="padding-left:17.25pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Impairment loss on long-lived assets</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(i)</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iab9b56b2a03f4c6199d282bd8676a924_D20200101-20200630" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:AssetImpairmentCharges" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzY2E5YmIwMTc5MjQ3NmZiYjIyNWU1ZDlkZWM4NjlmL3NlYzo5M2NhOWJiMDE3OTI0NzZmYmIyMjVlNWQ5ZGVjODY5Zl81NS9mcmFnOjk0NGQ2N2RjOTNmMjQ1MjliZTc4ZmNlMzRiOGMyZTBiL3RhYmxlOmRjZTc4NDZiYzM0MjRlNzc4YTQxZjY1OTBkNjY4NTg5L3RhYmxlcmFuZ2U6ZGNlNzg0NmJjMzQyNGU3NzhhNDFmNjU5MGQ2Njg1ODlfNi0xLTEtMS0xNzMy_e157e46c-db79-4e23-902b-4047f64ef882">40,000</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i13788f202c86441fa347b97f3162a453_D20200101-20200630" decimals="-3" format="ixt:zerodash" name="us-gaap:AssetImpairmentCharges" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzY2E5YmIwMTc5MjQ3NmZiYjIyNWU1ZDlkZWM4NjlmL3NlYzo5M2NhOWJiMDE3OTI0NzZmYmIyMjVlNWQ5ZGVjODY5Zl81NS9mcmFnOjk0NGQ2N2RjOTNmMjQ1MjliZTc4ZmNlMzRiOGMyZTBiL3RhYmxlOmRjZTc4NDZiYzM0MjRlNzc4YTQxZjY1OTBkNjY4NTg5L3RhYmxlcmFuZ2U6ZGNlNzg0NmJjMzQyNGU3NzhhNDFmNjU5MGQ2Njg1ODlfNi0zLTEtMS0xNzM1_cd4ab666-b99f-4a60-9638-55989e1c4ecf">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iaf98f9473a3d428f9aab9f72e135866f_D20200101-20200630" decimals="-3" format="ixt:zerodash" name="us-gaap:AssetImpairmentCharges" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzY2E5YmIwMTc5MjQ3NmZiYjIyNWU1ZDlkZWM4NjlmL3NlYzo5M2NhOWJiMDE3OTI0NzZmYmIyMjVlNWQ5ZGVjODY5Zl81NS9mcmFnOjk0NGQ2N2RjOTNmMjQ1MjliZTc4ZmNlMzRiOGMyZTBiL3RhYmxlOmRjZTc4NDZiYzM0MjRlNzc4YTQxZjY1OTBkNjY4NTg5L3RhYmxlcmFuZ2U6ZGNlNzg0NmJjMzQyNGU3NzhhNDFmNjU5MGQ2Njg1ODlfNi01LTEtMS0xNzM4_b15ddd88-19ec-4edd-a6a9-e18b9cdb6a64">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4a110e4972ef4113880ce582e3cda5c5_D20200101-20200630" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:AssetImpairmentCharges" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzY2E5YmIwMTc5MjQ3NmZiYjIyNWU1ZDlkZWM4NjlmL3NlYzo5M2NhOWJiMDE3OTI0NzZmYmIyMjVlNWQ5ZGVjODY5Zl81NS9mcmFnOjk0NGQ2N2RjOTNmMjQ1MjliZTc4ZmNlMzRiOGMyZTBiL3RhYmxlOmRjZTc4NDZiYzM0MjRlNzc4YTQxZjY1OTBkNjY4NTg5L3RhYmxlcmFuZ2U6ZGNlNzg0NmJjMzQyNGU3NzhhNDFmNjU5MGQ2Njg1ODlfNi03LTEtMS0xNjc4MQ_5cfd4a07-fcdc-4f22-9f37-8870d5c74d51">40,000</ix:nonFraction></span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:17.25pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Loss on revaluation of derivative liabilities</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(ii)</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iab9b56b2a03f4c6199d282bd8676a924_D20200101-20200630" decimals="-3" format="ixt:zerodash" name="us-gaap:GainLossOnDerivativeInstrumentsNetPretax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzY2E5YmIwMTc5MjQ3NmZiYjIyNWU1ZDlkZWM4NjlmL3NlYzo5M2NhOWJiMDE3OTI0NzZmYmIyMjVlNWQ5ZGVjODY5Zl81NS9mcmFnOjk0NGQ2N2RjOTNmMjQ1MjliZTc4ZmNlMzRiOGMyZTBiL3RhYmxlOmRjZTc4NDZiYzM0MjRlNzc4YTQxZjY1OTBkNjY4NTg5L3RhYmxlcmFuZ2U6ZGNlNzg0NmJjMzQyNGU3NzhhNDFmNjU5MGQ2Njg1ODlfNy0xLTEtMS0xNzMy_c7de39d2-7b44-4eed-83cc-5b718d96fbe9">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i13788f202c86441fa347b97f3162a453_D20200101-20200630" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:GainLossOnDerivativeInstrumentsNetPretax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzY2E5YmIwMTc5MjQ3NmZiYjIyNWU1ZDlkZWM4NjlmL3NlYzo5M2NhOWJiMDE3OTI0NzZmYmIyMjVlNWQ5ZGVjODY5Zl81NS9mcmFnOjk0NGQ2N2RjOTNmMjQ1MjliZTc4ZmNlMzRiOGMyZTBiL3RhYmxlOmRjZTc4NDZiYzM0MjRlNzc4YTQxZjY1OTBkNjY4NTg5L3RhYmxlcmFuZ2U6ZGNlNzg0NmJjMzQyNGU3NzhhNDFmNjU5MGQ2Njg1ODlfNy0zLTEtMS0xNzM1_8303b1fe-b218-4361-ab04-bfac2c330e79">77,488</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iaf98f9473a3d428f9aab9f72e135866f_D20200101-20200630" decimals="-3" format="ixt:zerodash" name="us-gaap:GainLossOnDerivativeInstrumentsNetPretax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzY2E5YmIwMTc5MjQ3NmZiYjIyNWU1ZDlkZWM4NjlmL3NlYzo5M2NhOWJiMDE3OTI0NzZmYmIyMjVlNWQ5ZGVjODY5Zl81NS9mcmFnOjk0NGQ2N2RjOTNmMjQ1MjliZTc4ZmNlMzRiOGMyZTBiL3RhYmxlOmRjZTc4NDZiYzM0MjRlNzc4YTQxZjY1OTBkNjY4NTg5L3RhYmxlcmFuZ2U6ZGNlNzg0NmJjMzQyNGU3NzhhNDFmNjU5MGQ2Njg1ODlfNy01LTEtMS0xNzM4_9575e333-1842-46a3-959e-098d6e8d0e11">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i4a110e4972ef4113880ce582e3cda5c5_D20200101-20200630" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:GainLossOnDerivativeInstrumentsNetPretax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzY2E5YmIwMTc5MjQ3NmZiYjIyNWU1ZDlkZWM4NjlmL3NlYzo5M2NhOWJiMDE3OTI0NzZmYmIyMjVlNWQ5ZGVjODY5Zl81NS9mcmFnOjk0NGQ2N2RjOTNmMjQ1MjliZTc4ZmNlMzRiOGMyZTBiL3RhYmxlOmRjZTc4NDZiYzM0MjRlNzc4YTQxZjY1OTBkNjY4NTg5L3RhYmxlcmFuZ2U6ZGNlNzg0NmJjMzQyNGU3NzhhNDFmNjU5MGQ2Njg1ODlfNy03LTEtMS0xNjc4MQ_64f71760-ca12-4364-955d-236b7d868869">77,488</ix:nonFraction>)</span></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:17.25pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other, net</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(iv)</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iab9b56b2a03f4c6199d282bd8676a924_D20200101-20200630" decimals="-3" format="ixt:zerodash" name="us-gaap:OtherNonoperatingIncomeExpense" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzY2E5YmIwMTc5MjQ3NmZiYjIyNWU1ZDlkZWM4NjlmL3NlYzo5M2NhOWJiMDE3OTI0NzZmYmIyMjVlNWQ5ZGVjODY5Zl81NS9mcmFnOjk0NGQ2N2RjOTNmMjQ1MjliZTc4ZmNlMzRiOGMyZTBiL3RhYmxlOmRjZTc4NDZiYzM0MjRlNzc4YTQxZjY1OTBkNjY4NTg5L3RhYmxlcmFuZ2U6ZGNlNzg0NmJjMzQyNGU3NzhhNDFmNjU5MGQ2Njg1ODlfOC0xLTEtMS0xNzMy_39a9ff1d-951b-4146-a660-0bd8724ff39b">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i13788f202c86441fa347b97f3162a453_D20200101-20200630" decimals="-3" name="us-gaap:OtherNonoperatingIncomeExpense" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzY2E5YmIwMTc5MjQ3NmZiYjIyNWU1ZDlkZWM4NjlmL3NlYzo5M2NhOWJiMDE3OTI0NzZmYmIyMjVlNWQ5ZGVjODY5Zl81NS9mcmFnOjk0NGQ2N2RjOTNmMjQ1MjliZTc4ZmNlMzRiOGMyZTBiL3RhYmxlOmRjZTc4NDZiYzM0MjRlNzc4YTQxZjY1OTBkNjY4NTg5L3RhYmxlcmFuZ2U6ZGNlNzg0NmJjMzQyNGU3NzhhNDFmNjU5MGQ2Njg1ODlfOC0zLTEtMS0xNzM1_5508d13d-945a-4822-9b50-d3c7c38b7d0b">785</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iaf98f9473a3d428f9aab9f72e135866f_D20200101-20200630" decimals="-3" format="ixt:zerodash" name="us-gaap:OtherNonoperatingIncomeExpense" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzY2E5YmIwMTc5MjQ3NmZiYjIyNWU1ZDlkZWM4NjlmL3NlYzo5M2NhOWJiMDE3OTI0NzZmYmIyMjVlNWQ5ZGVjODY5Zl81NS9mcmFnOjk0NGQ2N2RjOTNmMjQ1MjliZTc4ZmNlMzRiOGMyZTBiL3RhYmxlOmRjZTc4NDZiYzM0MjRlNzc4YTQxZjY1OTBkNjY4NTg5L3RhYmxlcmFuZ2U6ZGNlNzg0NmJjMzQyNGU3NzhhNDFmNjU5MGQ2Njg1ODlfOC01LTEtMS0xNzM4_05f23833-594a-4c94-abde-14e1870ae9d8">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i4a110e4972ef4113880ce582e3cda5c5_D20200101-20200630" decimals="-3" name="us-gaap:OtherNonoperatingIncomeExpense" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzY2E5YmIwMTc5MjQ3NmZiYjIyNWU1ZDlkZWM4NjlmL3NlYzo5M2NhOWJiMDE3OTI0NzZmYmIyMjVlNWQ5ZGVjODY5Zl81NS9mcmFnOjk0NGQ2N2RjOTNmMjQ1MjliZTc4ZmNlMzRiOGMyZTBiL3RhYmxlOmRjZTc4NDZiYzM0MjRlNzc4YTQxZjY1OTBkNjY4NTg5L3RhYmxlcmFuZ2U6ZGNlNzg0NmJjMzQyNGU3NzhhNDFmNjU5MGQ2Njg1ODlfOS03LTEtMS0xNjc4MQ_43f9f884-4d3f-40bf-8755-93258b87edcd">785</ix:nonFraction>)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:17.25pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Loss from discontinued operations</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(v)</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iab9b56b2a03f4c6199d282bd8676a924_D20200101-20200630" decimals="-3" format="ixt:zerodash" name="us-gaap:IncomeLossFromDiscontinuedOperationsNetOfTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzY2E5YmIwMTc5MjQ3NmZiYjIyNWU1ZDlkZWM4NjlmL3NlYzo5M2NhOWJiMDE3OTI0NzZmYmIyMjVlNWQ5ZGVjODY5Zl81NS9mcmFnOjk0NGQ2N2RjOTNmMjQ1MjliZTc4ZmNlMzRiOGMyZTBiL3RhYmxlOmRjZTc4NDZiYzM0MjRlNzc4YTQxZjY1OTBkNjY4NTg5L3RhYmxlcmFuZ2U6ZGNlNzg0NmJjMzQyNGU3NzhhNDFmNjU5MGQ2Njg1ODlfOS0xLTEtMS0xNzMy_bc701271-77e6-4e87-a381-6f48667003e4">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i13788f202c86441fa347b97f3162a453_D20200101-20200630" decimals="-3" sign="-" name="us-gaap:IncomeLossFromDiscontinuedOperationsNetOfTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzY2E5YmIwMTc5MjQ3NmZiYjIyNWU1ZDlkZWM4NjlmL3NlYzo5M2NhOWJiMDE3OTI0NzZmYmIyMjVlNWQ5ZGVjODY5Zl81NS9mcmFnOjk0NGQ2N2RjOTNmMjQ1MjliZTc4ZmNlMzRiOGMyZTBiL3RhYmxlOmRjZTc4NDZiYzM0MjRlNzc4YTQxZjY1OTBkNjY4NTg5L3RhYmxlcmFuZ2U6ZGNlNzg0NmJjMzQyNGU3NzhhNDFmNjU5MGQ2Njg1ODlfOS0zLTEtMS0xNzM1_f9613262-888b-478c-b44b-ea2d06978ea5">46</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iaf98f9473a3d428f9aab9f72e135866f_D20200101-20200630" decimals="-3" format="ixt:zerodash" name="us-gaap:IncomeLossFromDiscontinuedOperationsNetOfTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzY2E5YmIwMTc5MjQ3NmZiYjIyNWU1ZDlkZWM4NjlmL3NlYzo5M2NhOWJiMDE3OTI0NzZmYmIyMjVlNWQ5ZGVjODY5Zl81NS9mcmFnOjk0NGQ2N2RjOTNmMjQ1MjliZTc4ZmNlMzRiOGMyZTBiL3RhYmxlOmRjZTc4NDZiYzM0MjRlNzc4YTQxZjY1OTBkNjY4NTg5L3RhYmxlcmFuZ2U6ZGNlNzg0NmJjMzQyNGU3NzhhNDFmNjU5MGQ2Njg1ODlfOS01LTEtMS0xNzM4_a850fc10-9372-42db-b13b-0b96574010e6">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4a110e4972ef4113880ce582e3cda5c5_D20200101-20200630" decimals="-3" sign="-" name="us-gaap:IncomeLossFromDiscontinuedOperationsNetOfTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzY2E5YmIwMTc5MjQ3NmZiYjIyNWU1ZDlkZWM4NjlmL3NlYzo5M2NhOWJiMDE3OTI0NzZmYmIyMjVlNWQ5ZGVjODY5Zl81NS9mcmFnOjk0NGQ2N2RjOTNmMjQ1MjliZTc4ZmNlMzRiOGMyZTBiL3RhYmxlOmRjZTc4NDZiYzM0MjRlNzc4YTQxZjY1OTBkNjY4NTg5L3RhYmxlcmFuZ2U6ZGNlNzg0NmJjMzQyNGU3NzhhNDFmNjU5MGQ2Njg1ODlfMTAtNy0xLTEtMTY3ODE_414c05b9-82f9-4b8f-92c5-e5bb98a55111">46</ix:nonFraction></span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:17.25pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Share-based payments</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(vi)</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iab9b56b2a03f4c6199d282bd8676a924_D20200101-20200630" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:AllocatedShareBasedCompensationExpense" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzY2E5YmIwMTc5MjQ3NmZiYjIyNWU1ZDlkZWM4NjlmL3NlYzo5M2NhOWJiMDE3OTI0NzZmYmIyMjVlNWQ5ZGVjODY5Zl81NS9mcmFnOjk0NGQ2N2RjOTNmMjQ1MjliZTc4ZmNlMzRiOGMyZTBiL3RhYmxlOmRjZTc4NDZiYzM0MjRlNzc4YTQxZjY1OTBkNjY4NTg5L3RhYmxlcmFuZ2U6ZGNlNzg0NmJjMzQyNGU3NzhhNDFmNjU5MGQ2Njg1ODlfMTAtMS0xLTEtMTczMg_5d0c8fbe-14f1-4787-82c8-f2d46600203a">1,462</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i13788f202c86441fa347b97f3162a453_D20200101-20200630" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:AllocatedShareBasedCompensationExpense" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzY2E5YmIwMTc5MjQ3NmZiYjIyNWU1ZDlkZWM4NjlmL3NlYzo5M2NhOWJiMDE3OTI0NzZmYmIyMjVlNWQ5ZGVjODY5Zl81NS9mcmFnOjk0NGQ2N2RjOTNmMjQ1MjliZTc4ZmNlMzRiOGMyZTBiL3RhYmxlOmRjZTc4NDZiYzM0MjRlNzc4YTQxZjY1OTBkNjY4NTg5L3RhYmxlcmFuZ2U6ZGNlNzg0NmJjMzQyNGU3NzhhNDFmNjU5MGQ2Njg1ODlfMTAtMy0xLTEtMTczNQ_e2c1a4ae-35d7-4313-9ac6-2c87c87e7e20">3,520</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iaf98f9473a3d428f9aab9f72e135866f_D20200101-20200630" decimals="-3" format="ixt:zerodash" name="us-gaap:AllocatedShareBasedCompensationExpense" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzY2E5YmIwMTc5MjQ3NmZiYjIyNWU1ZDlkZWM4NjlmL3NlYzo5M2NhOWJiMDE3OTI0NzZmYmIyMjVlNWQ5ZGVjODY5Zl81NS9mcmFnOjk0NGQ2N2RjOTNmMjQ1MjliZTc4ZmNlMzRiOGMyZTBiL3RhYmxlOmRjZTc4NDZiYzM0MjRlNzc4YTQxZjY1OTBkNjY4NTg5L3RhYmxlcmFuZ2U6ZGNlNzg0NmJjMzQyNGU3NzhhNDFmNjU5MGQ2Njg1ODlfMTAtNS0xLTEtMTczOA_885f781d-6b92-459a-a1cf-959f9f2167c2">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4a110e4972ef4113880ce582e3cda5c5_D20200101-20200630" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:AllocatedShareBasedCompensationExpense" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzY2E5YmIwMTc5MjQ3NmZiYjIyNWU1ZDlkZWM4NjlmL3NlYzo5M2NhOWJiMDE3OTI0NzZmYmIyMjVlNWQ5ZGVjODY5Zl81NS9mcmFnOjk0NGQ2N2RjOTNmMjQ1MjliZTc4ZmNlMzRiOGMyZTBiL3RhYmxlOmRjZTc4NDZiYzM0MjRlNzc4YTQxZjY1OTBkNjY4NTg5L3RhYmxlcmFuZ2U6ZGNlNzg0NmJjMzQyNGU3NzhhNDFmNjU5MGQ2Njg1ODlfMTEtNy0xLTEtMTY3ODE_8dd0c8a8-0a89-4642-9fac-8692ad406fd6">4,982</ix:nonFraction></span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:17.25pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Review costs related to restatement of 2019 interim financial statements</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(vii)</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iab9b56b2a03f4c6199d282bd8676a924_D20200101-20200630" decimals="-3" format="ixt:zerodash" name="cron:RestatementReviewExpense" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzY2E5YmIwMTc5MjQ3NmZiYjIyNWU1ZDlkZWM4NjlmL3NlYzo5M2NhOWJiMDE3OTI0NzZmYmIyMjVlNWQ5ZGVjODY5Zl81NS9mcmFnOjk0NGQ2N2RjOTNmMjQ1MjliZTc4ZmNlMzRiOGMyZTBiL3RhYmxlOmRjZTc4NDZiYzM0MjRlNzc4YTQxZjY1OTBkNjY4NTg5L3RhYmxlcmFuZ2U6ZGNlNzg0NmJjMzQyNGU3NzhhNDFmNjU5MGQ2Njg1ODlfMTEtMS0xLTEtMTczMg_f7fbebf7-3470-4c68-97f9-f3748c7b58ca">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i13788f202c86441fa347b97f3162a453_D20200101-20200630" decimals="-3" format="ixt:zerodash" name="cron:RestatementReviewExpense" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzY2E5YmIwMTc5MjQ3NmZiYjIyNWU1ZDlkZWM4NjlmL3NlYzo5M2NhOWJiMDE3OTI0NzZmYmIyMjVlNWQ5ZGVjODY5Zl81NS9mcmFnOjk0NGQ2N2RjOTNmMjQ1MjliZTc4ZmNlMzRiOGMyZTBiL3RhYmxlOmRjZTc4NDZiYzM0MjRlNzc4YTQxZjY1OTBkNjY4NTg5L3RhYmxlcmFuZ2U6ZGNlNzg0NmJjMzQyNGU3NzhhNDFmNjU5MGQ2Njg1ODlfMTEtMy0xLTEtMTczNQ_dfe62f94-b180-4e49-9c59-bca71b50f49c">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iaf98f9473a3d428f9aab9f72e135866f_D20200101-20200630" decimals="-3" format="ixt:numdotdecimal" name="cron:RestatementReviewExpense" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzY2E5YmIwMTc5MjQ3NmZiYjIyNWU1ZDlkZWM4NjlmL3NlYzo5M2NhOWJiMDE3OTI0NzZmYmIyMjVlNWQ5ZGVjODY5Zl81NS9mcmFnOjk0NGQ2N2RjOTNmMjQ1MjliZTc4ZmNlMzRiOGMyZTBiL3RhYmxlOmRjZTc4NDZiYzM0MjRlNzc4YTQxZjY1OTBkNjY4NTg5L3RhYmxlcmFuZ2U6ZGNlNzg0NmJjMzQyNGU3NzhhNDFmNjU5MGQ2Njg1ODlfMTEtNS0xLTEtMTczOA_0561ddec-5381-4d17-9e3f-9b2182d1797c">7,866</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4a110e4972ef4113880ce582e3cda5c5_D20200101-20200630" decimals="-3" format="ixt:numdotdecimal" name="cron:RestatementReviewExpense" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzY2E5YmIwMTc5MjQ3NmZiYjIyNWU1ZDlkZWM4NjlmL3NlYzo5M2NhOWJiMDE3OTI0NzZmYmIyMjVlNWQ5ZGVjODY5Zl81NS9mcmFnOjk0NGQ2N2RjOTNmMjQ1MjliZTc4ZmNlMzRiOGMyZTBiL3RhYmxlOmRjZTc4NDZiYzM0MjRlNzc4YTQxZjY1OTBkNjY4NTg5L3RhYmxlcmFuZ2U6ZGNlNzg0NmJjMzQyNGU3NzhhNDFmNjU5MGQ2Njg1ODlfMTItNy0xLTEtMTY3ODE_c111221e-3431-4505-a3fc-baad5f6c2ad6">7,866</ix:nonFraction></span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Depreciation and amortization</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iab9b56b2a03f4c6199d282bd8676a924_D20200101-20200630" decimals="-3" name="us-gaap:DepreciationDepletionAndAmortization" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzY2E5YmIwMTc5MjQ3NmZiYjIyNWU1ZDlkZWM4NjlmL3NlYzo5M2NhOWJiMDE3OTI0NzZmYmIyMjVlNWQ5ZGVjODY5Zl81NS9mcmFnOjk0NGQ2N2RjOTNmMjQ1MjliZTc4ZmNlMzRiOGMyZTBiL3RhYmxlOmRjZTc4NDZiYzM0MjRlNzc4YTQxZjY1OTBkNjY4NTg5L3RhYmxlcmFuZ2U6ZGNlNzg0NmJjMzQyNGU3NzhhNDFmNjU5MGQ2Njg1ODlfMTQtMS0xLTEtMTc0MQ_70d9815e-f761-44af-98db-75e724d46fba">69</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i13788f202c86441fa347b97f3162a453_D20200101-20200630" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:DepreciationDepletionAndAmortization" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzY2E5YmIwMTc5MjQ3NmZiYjIyNWU1ZDlkZWM4NjlmL3NlYzo5M2NhOWJiMDE3OTI0NzZmYmIyMjVlNWQ5ZGVjODY5Zl81NS9mcmFnOjk0NGQ2N2RjOTNmMjQ1MjliZTc4ZmNlMzRiOGMyZTBiL3RhYmxlOmRjZTc4NDZiYzM0MjRlNzc4YTQxZjY1OTBkNjY4NTg5L3RhYmxlcmFuZ2U6ZGNlNzg0NmJjMzQyNGU3NzhhNDFmNjU5MGQ2Njg1ODlfMTQtMy0xLTEtMTc0NA_d9ac38d9-5e6d-440e-aba5-b348abbab165">2,810</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iaf98f9473a3d428f9aab9f72e135866f_D20200101-20200630" decimals="-3" format="ixt:zerodash" name="us-gaap:DepreciationDepletionAndAmortization" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzY2E5YmIwMTc5MjQ3NmZiYjIyNWU1ZDlkZWM4NjlmL3NlYzo5M2NhOWJiMDE3OTI0NzZmYmIyMjVlNWQ5ZGVjODY5Zl81NS9mcmFnOjk0NGQ2N2RjOTNmMjQ1MjliZTc4ZmNlMzRiOGMyZTBiL3RhYmxlOmRjZTc4NDZiYzM0MjRlNzc4YTQxZjY1OTBkNjY4NTg5L3RhYmxlcmFuZ2U6ZGNlNzg0NmJjMzQyNGU3NzhhNDFmNjU5MGQ2Njg1ODlfMTQtNS0xLTEtMTc0Nw_66fdc31b-3446-4d27-86cc-345e12b8136c">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4a110e4972ef4113880ce582e3cda5c5_D20200101-20200630" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:DepreciationDepletionAndAmortization" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzY2E5YmIwMTc5MjQ3NmZiYjIyNWU1ZDlkZWM4NjlmL3NlYzo5M2NhOWJiMDE3OTI0NzZmYmIyMjVlNWQ5ZGVjODY5Zl81NS9mcmFnOjk0NGQ2N2RjOTNmMjQ1MjliZTc4ZmNlMzRiOGMyZTBiL3RhYmxlOmRjZTc4NDZiYzM0MjRlNzc4YTQxZjY1OTBkNjY4NTg5L3RhYmxlcmFuZ2U6ZGNlNzg0NmJjMzQyNGU3NzhhNDFmNjU5MGQ2Njg1ODlfMTMtNy0xLTEtMTY3ODE_3a4432ef-7db3-4bae-9956-2ac224b2a8be">2,879</ix:nonFraction></span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Adjusted EBITDA</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="iab9b56b2a03f4c6199d282bd8676a924_D20200101-20200630" decimals="-3" sign="-" format="ixt:numdotdecimal" name="cron:AdjustedEarningsBeforeInterestTaxesDepreciationAndAmortization" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzY2E5YmIwMTc5MjQ3NmZiYjIyNWU1ZDlkZWM4NjlmL3NlYzo5M2NhOWJiMDE3OTI0NzZmYmIyMjVlNWQ5ZGVjODY5Zl81NS9mcmFnOjk0NGQ2N2RjOTNmMjQ1MjliZTc4ZmNlMzRiOGMyZTBiL3RhYmxlOmRjZTc4NDZiYzM0MjRlNzc4YTQxZjY1OTBkNjY4NTg5L3RhYmxlcmFuZ2U6ZGNlNzg0NmJjMzQyNGU3NzhhNDFmNjU5MGQ2Njg1ODlfMTQtMS0xLTEtMTY3ODE_ea5a00be-82a7-42ce-a800-0ae2ed7a6c8d">10,567</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i13788f202c86441fa347b97f3162a453_D20200101-20200630" decimals="-3" sign="-" format="ixt:numdotdecimal" name="cron:AdjustedEarningsBeforeInterestTaxesDepreciationAndAmortization" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzY2E5YmIwMTc5MjQ3NmZiYjIyNWU1ZDlkZWM4NjlmL3NlYzo5M2NhOWJiMDE3OTI0NzZmYmIyMjVlNWQ5ZGVjODY5Zl81NS9mcmFnOjk0NGQ2N2RjOTNmMjQ1MjliZTc4ZmNlMzRiOGMyZTBiL3RhYmxlOmRjZTc4NDZiYzM0MjRlNzc4YTQxZjY1OTBkNjY4NTg5L3RhYmxlcmFuZ2U6ZGNlNzg0NmJjMzQyNGU3NzhhNDFmNjU5MGQ2Njg1ODlfMTQtMy0xLTEtMTY3ODE_891e1fe2-103a-47ab-845a-0f599bc03b75">47,628</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="iaf98f9473a3d428f9aab9f72e135866f_D20200101-20200630" decimals="-3" sign="-" format="ixt:numdotdecimal" name="cron:AdjustedEarningsBeforeInterestTaxesDepreciationAndAmortization" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzY2E5YmIwMTc5MjQ3NmZiYjIyNWU1ZDlkZWM4NjlmL3NlYzo5M2NhOWJiMDE3OTI0NzZmYmIyMjVlNWQ5ZGVjODY5Zl81NS9mcmFnOjk0NGQ2N2RjOTNmMjQ1MjliZTc4ZmNlMzRiOGMyZTBiL3RhYmxlOmRjZTc4NDZiYzM0MjRlNzc4YTQxZjY1OTBkNjY4NTg5L3RhYmxlcmFuZ2U6ZGNlNzg0NmJjMzQyNGU3NzhhNDFmNjU5MGQ2Njg1ODlfMTQtNS0xLTEtMTY3ODE_ad7c8e69-469c-429a-ae4f-97045dcc7f80">5,846</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i4a110e4972ef4113880ce582e3cda5c5_D20200101-20200630" decimals="-3" sign="-" format="ixt:numdotdecimal" name="cron:AdjustedEarningsBeforeInterestTaxesDepreciationAndAmortization" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzY2E5YmIwMTc5MjQ3NmZiYjIyNWU1ZDlkZWM4NjlmL3NlYzo5M2NhOWJiMDE3OTI0NzZmYmIyMjVlNWQ5ZGVjODY5Zl81NS9mcmFnOjk0NGQ2N2RjOTNmMjQ1MjliZTc4ZmNlMzRiOGMyZTBiL3RhYmxlOmRjZTc4NDZiYzM0MjRlNzc4YTQxZjY1OTBkNjY4NTg5L3RhYmxlcmFuZ2U6ZGNlNzg0NmJjMzQyNGU3NzhhNDFmNjU5MGQ2Njg1ODlfMTQtNy0xLTEtMTY3ODE_211fd703-cd36-4f57-8291-82e739611b7d">64,041</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="margin-bottom:6pt;margin-top:3pt;padding-left:27pt;text-align:justify;text-indent:-27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:400;line-height:120%;position:relative;top:-2.8pt;vertical-align:baseline">(i)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:22.1pt">For the six months ended June 30, 2021, impairment loss on long-lived assets relates to impairment on a leased premise in the U.S. segment, and for the three and six months ended June 30, 2020, impairment loss on long-lived assets relates to impairment on goodwill and intangibles related to our U.S. segment in 2020. See Note 12. Impairment Loss on Long-Lived Assets.</span></div><div style="margin-bottom:3pt;margin-top:3pt;padding-left:27pt;text-align:justify;text-indent:-27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:400;line-height:120%;position:relative;top:-2.8pt;vertical-align:baseline">(ii)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:20.66pt">For the three and six months ended June 30, 2021 and 2020, gain/loss on revaluation of derivative liabilities represents the fair value changes on the derivative liabilities. See Note 5. Derivative Liabilities.</span></div><div style="margin-bottom:3pt;margin-top:3pt;padding-left:27pt;text-align:justify;text-indent:-27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:400;line-height:120%;position:relative;top:-2.8pt;vertical-align:baseline">(iii)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:19.22pt">For the three and six months ended June 30, 2021, transaction costs represents legal, financial and other advisory fees and expenses incurred in connection with various strategic investments. These costs are included in general and administrative expenses on the condensed consolidated statements of net income (loss) and comprehensive income (loss).</span></div><div style="margin-bottom:3pt;margin-top:3pt;padding-left:27pt;text-align:justify;text-indent:-27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:400;line-height:120%;position:relative;top:-2.8pt;vertical-align:baseline">(iv)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:19.5pt">For the three and six months ended June 30, 2021, other, net is related to gain recorded on sale of the Company&#8217;s Winnipeg facility previously designated as held-for-sale in the first quarter of 2021, For the three and six months ended June 30, 2020, other, net is primarily comprised of the gain recorded related to the sale of common shares of Aurora Cannabis, Inc. (&#8220;Aurora&#8221;), which were received in connection with the achievement of a milestone related to Aurora&#8217;s acquisition of Whistler Medical Marijuana Corporation.</span></div><div style="margin-bottom:3pt;margin-top:3pt;padding-left:27pt;text-align:justify;text-indent:-27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:400;line-height:120%;position:relative;top:-2.8pt;vertical-align:baseline">(v)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:20.94pt">For the three and six months ended June 30, 2020, loss from discontinued operations relates to the discontinuance of Original B.C. Ltd. (&#8220;OGBC&#8221;). See Note 11. Held-For-Sale Assets and Discontinued Operations.</span></div><div style="margin-bottom:3pt;margin-top:3pt;padding-left:27pt;text-align:justify;text-indent:-27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:400;line-height:120%;position:relative;top:-2.8pt;vertical-align:baseline">(vi)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:19.5pt">For the three and six months ended June 30, 2021 and 2020, share-based payments relates to the vesting expenses of share-based compensation awarded to employees under the Company&#8217;s share-based award plans as described in Note 6. Share-based Payments.</span></div></ix:continuation><div style="margin-bottom:3pt;margin-top:3pt;padding-left:27pt;text-align:justify;text-indent:-27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:400;line-height:120%;position:relative;top:-2.8pt;vertical-align:baseline"><ix:continuation id="i26257594cd534cd8930b4d97cbeb09cd" continuedAt="i0fe1abcae70d408fbe48cf153b966941">(vii)</ix:continuation></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:18.06pt"><ix:continuation id="i0fe1abcae70d408fbe48cf153b966941">For the three and six months ended June 30, 2021 and 2020, the financial statement review costs include costs related to the restatement of the Company&#8217;s 2019 interim financial statements, costs related to the Company&#8217;s responses to requests for information from various regulatory authorities relating to such restatement and legal costs defending shareholder class action complaints brought against the Company as a result of the restatement.</ix:continuation> </span></div><ix:nonNumeric contextRef="i69782326f71a44e3805518280ee22b6b_D20210101-20210630" name="us-gaap:RevenueFromExternalCustomersByGeographicAreasTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjkzY2E5YmIwMTc5MjQ3NmZiYjIyNWU1ZDlkZWM4NjlmL3NlYzo5M2NhOWJiMDE3OTI0NzZmYmIyMjVlNWQ5ZGVjODY5Zl81NS9mcmFnOjk0NGQ2N2RjOTNmMjQ1MjliZTc4ZmNlMzRiOGMyZTBiL3RleHRyZWdpb246OTQ0ZDY3ZGM5M2YyNDUyOWJlNzhmY2UzNGI4YzJlMGJfMjk4Ng_2aed6107-15c2-46ce-a5e6-c370d5bf51e6" escape="true"><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Net revenue attributed to a geographic region based on the location of the customer were as follows:</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:42.372%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.816%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:1.327%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.816%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:1.605%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.816%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:1.327%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.821%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Three months ended June 30,</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Six months ended June 30,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Canada</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i70c4790ac8ca40dd81fcf1ef3cef91b6_D20210401-20210630" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzY2E5YmIwMTc5MjQ3NmZiYjIyNWU1ZDlkZWM4NjlmL3NlYzo5M2NhOWJiMDE3OTI0NzZmYmIyMjVlNWQ5ZGVjODY5Zl81NS9mcmFnOjk0NGQ2N2RjOTNmMjQ1MjliZTc4ZmNlMzRiOGMyZTBiL3RhYmxlOjRjZWFlMWI0OTIwOTQwOGY5NDZmNTU5MmUwNGU0MjFhL3RhYmxlcmFuZ2U6NGNlYWUxYjQ5MjA5NDA4Zjk0NmY1NTkyZTA0ZTQyMWFfMi0xLTEtMS0w_bfdf6f59-cda5-49b1-91d2-6e2f9d45a1da">10,664</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iad976d29836c4f2f84c635abe13f093d_D20200401-20200630" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzY2E5YmIwMTc5MjQ3NmZiYjIyNWU1ZDlkZWM4NjlmL3NlYzo5M2NhOWJiMDE3OTI0NzZmYmIyMjVlNWQ5ZGVjODY5Zl81NS9mcmFnOjk0NGQ2N2RjOTNmMjQ1MjliZTc4ZmNlMzRiOGMyZTBiL3RhYmxlOjRjZWFlMWI0OTIwOTQwOGY5NDZmNTU5MmUwNGU0MjFhL3RhYmxlcmFuZ2U6NGNlYWUxYjQ5MjA5NDA4Zjk0NmY1NTkyZTA0ZTQyMWFfMi0zLTEtMS0w_3404d339-7f58-4850-a471-b2bd82f4156a">7,416</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic93ed3f2e9634d2485631fcd4f0c2325_D20210101-20210630" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzY2E5YmIwMTc5MjQ3NmZiYjIyNWU1ZDlkZWM4NjlmL3NlYzo5M2NhOWJiMDE3OTI0NzZmYmIyMjVlNWQ5ZGVjODY5Zl81NS9mcmFnOjk0NGQ2N2RjOTNmMjQ1MjliZTc4ZmNlMzRiOGMyZTBiL3RhYmxlOjRjZWFlMWI0OTIwOTQwOGY5NDZmNTU5MmUwNGU0MjFhL3RhYmxlcmFuZ2U6NGNlYWUxYjQ5MjA5NDA4Zjk0NmY1NTkyZTA0ZTQyMWFfMi01LTEtMS0w_6c71dee7-377a-4ac9-8f2c-be75d449c905">18,246</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9028e5a0bc1c44d493f8aa0ff5b63660_D20200101-20200630" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzY2E5YmIwMTc5MjQ3NmZiYjIyNWU1ZDlkZWM4NjlmL3NlYzo5M2NhOWJiMDE3OTI0NzZmYmIyMjVlNWQ5ZGVjODY5Zl81NS9mcmFnOjk0NGQ2N2RjOTNmMjQ1MjliZTc4ZmNlMzRiOGMyZTBiL3RhYmxlOjRjZWFlMWI0OTIwOTQwOGY5NDZmNTU5MmUwNGU0MjFhL3RhYmxlcmFuZ2U6NGNlYWUxYjQ5MjA5NDA4Zjk0NmY1NTkyZTA0ZTQyMWFfMi03LTEtMS0w_8fc6277a-ef0c-44dc-a4dc-3dfcb14002d1">13,507</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Israel</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8506d6aab4b24205822b2a1157fa9c1d_D20210401-20210630" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzY2E5YmIwMTc5MjQ3NmZiYjIyNWU1ZDlkZWM4NjlmL3NlYzo5M2NhOWJiMDE3OTI0NzZmYmIyMjVlNWQ5ZGVjODY5Zl81NS9mcmFnOjk0NGQ2N2RjOTNmMjQ1MjliZTc4ZmNlMzRiOGMyZTBiL3RhYmxlOjRjZWFlMWI0OTIwOTQwOGY5NDZmNTU5MmUwNGU0MjFhL3RhYmxlcmFuZ2U6NGNlYWUxYjQ5MjA5NDA4Zjk0NmY1NTkyZTA0ZTQyMWFfMy0xLTEtMS0xNzc5_724c342b-39a7-4624-a093-95b124afe0a9">2,310</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0919d1ea594c4d4dabfdd26b1f697c1a_D20200401-20200630" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzY2E5YmIwMTc5MjQ3NmZiYjIyNWU1ZDlkZWM4NjlmL3NlYzo5M2NhOWJiMDE3OTI0NzZmYmIyMjVlNWQ5ZGVjODY5Zl81NS9mcmFnOjk0NGQ2N2RjOTNmMjQ1MjliZTc4ZmNlMzRiOGMyZTBiL3RhYmxlOjRjZWFlMWI0OTIwOTQwOGY5NDZmNTU5MmUwNGU0MjFhL3RhYmxlcmFuZ2U6NGNlYWUxYjQ5MjA5NDA4Zjk0NmY1NTkyZTA0ZTQyMWFfMy0zLTEtMS0xNzgz_24df3290-2dfb-46c2-af26-ae44d5430624">293</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i741c56d990404b79b0cac9e98bf9ab73_D20210101-20210630" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzY2E5YmIwMTc5MjQ3NmZiYjIyNWU1ZDlkZWM4NjlmL3NlYzo5M2NhOWJiMDE3OTI0NzZmYmIyMjVlNWQ5ZGVjODY5Zl81NS9mcmFnOjk0NGQ2N2RjOTNmMjQ1MjliZTc4ZmNlMzRiOGMyZTBiL3RhYmxlOjRjZWFlMWI0OTIwOTQwOGY5NDZmNTU5MmUwNGU0MjFhL3RhYmxlcmFuZ2U6NGNlYWUxYjQ5MjA5NDA4Zjk0NmY1NTkyZTA0ZTQyMWFfMy01LTEtMS0w_7170b08a-1d91-4943-89fa-e950edc27f7b">4,828</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5bc3d3cb5c994e7b8a8e525b6b1e17e4_D20200101-20200630" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzY2E5YmIwMTc5MjQ3NmZiYjIyNWU1ZDlkZWM4NjlmL3NlYzo5M2NhOWJiMDE3OTI0NzZmYmIyMjVlNWQ5ZGVjODY5Zl81NS9mcmFnOjk0NGQ2N2RjOTNmMjQ1MjliZTc4ZmNlMzRiOGMyZTBiL3RhYmxlOjRjZWFlMWI0OTIwOTQwOGY5NDZmNTU5MmUwNGU0MjFhL3RhYmxlcmFuZ2U6NGNlYWUxYjQ5MjA5NDA4Zjk0NmY1NTkyZTA0ZTQyMWFfMy03LTEtMS0w_102d9b80-b0f2-40e3-80fe-c4c38a46c01b">293</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">United States</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i44de340a6a1041189ce50fede1a5bebb_D20210401-20210630" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzY2E5YmIwMTc5MjQ3NmZiYjIyNWU1ZDlkZWM4NjlmL3NlYzo5M2NhOWJiMDE3OTI0NzZmYmIyMjVlNWQ5ZGVjODY5Zl81NS9mcmFnOjk0NGQ2N2RjOTNmMjQ1MjliZTc4ZmNlMzRiOGMyZTBiL3RhYmxlOjRjZWFlMWI0OTIwOTQwOGY5NDZmNTU5MmUwNGU0MjFhL3RhYmxlcmFuZ2U6NGNlYWUxYjQ5MjA5NDA4Zjk0NmY1NTkyZTA0ZTQyMWFfNC0xLTEtMS0w_02e8ceb3-c157-45f7-9ea1-1630ee5abaa9">2,227</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i64046da960714c4f90fcef13ebc59cac_D20200401-20200630" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzY2E5YmIwMTc5MjQ3NmZiYjIyNWU1ZDlkZWM4NjlmL3NlYzo5M2NhOWJiMDE3OTI0NzZmYmIyMjVlNWQ5ZGVjODY5Zl81NS9mcmFnOjk0NGQ2N2RjOTNmMjQ1MjliZTc4ZmNlMzRiOGMyZTBiL3RhYmxlOjRjZWFlMWI0OTIwOTQwOGY5NDZmNTU5MmUwNGU0MjFhL3RhYmxlcmFuZ2U6NGNlYWUxYjQ5MjA5NDA4Zjk0NmY1NTkyZTA0ZTQyMWFfNC0zLTEtMS0w_3cc96490-cf20-4633-b2a3-90bebf4a15b2">2,174</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i689f775c23d14a45b6271c2611e144cd_D20210101-20210630" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzY2E5YmIwMTc5MjQ3NmZiYjIyNWU1ZDlkZWM4NjlmL3NlYzo5M2NhOWJiMDE3OTI0NzZmYmIyMjVlNWQ5ZGVjODY5Zl81NS9mcmFnOjk0NGQ2N2RjOTNmMjQ1MjliZTc4ZmNlMzRiOGMyZTBiL3RhYmxlOjRjZWFlMWI0OTIwOTQwOGY5NDZmNTU5MmUwNGU0MjFhL3RhYmxlcmFuZ2U6NGNlYWUxYjQ5MjA5NDA4Zjk0NmY1NTkyZTA0ZTQyMWFfNC01LTEtMS0w_f6131d53-496f-43b1-9734-48f3473cf1ce">4,668</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia3f841640fcf416dbce4a93086b21e5a_D20200101-20200630" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzY2E5YmIwMTc5MjQ3NmZiYjIyNWU1ZDlkZWM4NjlmL3NlYzo5M2NhOWJiMDE3OTI0NzZmYmIyMjVlNWQ5ZGVjODY5Zl81NS9mcmFnOjk0NGQ2N2RjOTNmMjQ1MjliZTc4ZmNlMzRiOGMyZTBiL3RhYmxlOjRjZWFlMWI0OTIwOTQwOGY5NDZmNTU5MmUwNGU0MjFhL3RhYmxlcmFuZ2U6NGNlYWUxYjQ5MjA5NDA4Zjk0NmY1NTkyZTA0ZTQyMWFfNC03LTEtMS0w_e369a9cd-e1dd-44cc-bc05-df05fb88d3fd">4,350</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other countries</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i12073826a3a04377a7cd14dedf89a23b_D20210401-20210630" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzY2E5YmIwMTc5MjQ3NmZiYjIyNWU1ZDlkZWM4NjlmL3NlYzo5M2NhOWJiMDE3OTI0NzZmYmIyMjVlNWQ5ZGVjODY5Zl81NS9mcmFnOjk0NGQ2N2RjOTNmMjQ1MjliZTc4ZmNlMzRiOGMyZTBiL3RhYmxlOjRjZWFlMWI0OTIwOTQwOGY5NDZmNTU5MmUwNGU0MjFhL3RhYmxlcmFuZ2U6NGNlYWUxYjQ5MjA5NDA4Zjk0NmY1NTkyZTA0ZTQyMWFfNS0xLTEtMS0w_9a4e4085-b24f-478e-b191-c3a675bbeec8">421</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if4be60de0dc04fcaab3cbb8c7454e2b3_D20200401-20200630" decimals="-3" format="ixt:zerodash" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzY2E5YmIwMTc5MjQ3NmZiYjIyNWU1ZDlkZWM4NjlmL3NlYzo5M2NhOWJiMDE3OTI0NzZmYmIyMjVlNWQ5ZGVjODY5Zl81NS9mcmFnOjk0NGQ2N2RjOTNmMjQ1MjliZTc4ZmNlMzRiOGMyZTBiL3RhYmxlOjRjZWFlMWI0OTIwOTQwOGY5NDZmNTU5MmUwNGU0MjFhL3RhYmxlcmFuZ2U6NGNlYWUxYjQ5MjA5NDA4Zjk0NmY1NTkyZTA0ZTQyMWFfNS0zLTEtMS0w_a581b375-5917-4674-b4b2-73eb0ac0c843">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id1c815493ddc46f2a6fa5ee4c4885b69_D20210101-20210630" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzY2E5YmIwMTc5MjQ3NmZiYjIyNWU1ZDlkZWM4NjlmL3NlYzo5M2NhOWJiMDE3OTI0NzZmYmIyMjVlNWQ5ZGVjODY5Zl81NS9mcmFnOjk0NGQ2N2RjOTNmMjQ1MjliZTc4ZmNlMzRiOGMyZTBiL3RhYmxlOjRjZWFlMWI0OTIwOTQwOGY5NDZmNTU5MmUwNGU0MjFhL3RhYmxlcmFuZ2U6NGNlYWUxYjQ5MjA5NDA4Zjk0NmY1NTkyZTA0ZTQyMWFfNS01LTEtMS0w_b06b0a8c-ec85-4f02-979d-455bde1efa12">491</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1dd5859753fc4494bc617d9e788b9a09_D20200101-20200630" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzY2E5YmIwMTc5MjQ3NmZiYjIyNWU1ZDlkZWM4NjlmL3NlYzo5M2NhOWJiMDE3OTI0NzZmYmIyMjVlNWQ5ZGVjODY5Zl81NS9mcmFnOjk0NGQ2N2RjOTNmMjQ1MjliZTc4ZmNlMzRiOGMyZTBiL3RhYmxlOjRjZWFlMWI0OTIwOTQwOGY5NDZmNTU5MmUwNGU0MjFhL3RhYmxlcmFuZ2U6NGNlYWUxYjQ5MjA5NDA4Zjk0NmY1NTkyZTA0ZTQyMWFfNS03LTEtMS0w_f8f86a2b-f4d5-4425-aac0-ef4d9a032d82">165</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net revenue</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i27f4e53b91ad4367b7f8d273eff27769_D20210401-20210630" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzY2E5YmIwMTc5MjQ3NmZiYjIyNWU1ZDlkZWM4NjlmL3NlYzo5M2NhOWJiMDE3OTI0NzZmYmIyMjVlNWQ5ZGVjODY5Zl81NS9mcmFnOjk0NGQ2N2RjOTNmMjQ1MjliZTc4ZmNlMzRiOGMyZTBiL3RhYmxlOjRjZWFlMWI0OTIwOTQwOGY5NDZmNTU5MmUwNGU0MjFhL3RhYmxlcmFuZ2U6NGNlYWUxYjQ5MjA5NDA4Zjk0NmY1NTkyZTA0ZTQyMWFfNi0xLTEtMS0w_0de542a5-c80d-4cfe-aae8-23ee4addbd07">15,622</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i39065c5daf934af885335c12f3cfa83f_D20200401-20200630" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzY2E5YmIwMTc5MjQ3NmZiYjIyNWU1ZDlkZWM4NjlmL3NlYzo5M2NhOWJiMDE3OTI0NzZmYmIyMjVlNWQ5ZGVjODY5Zl81NS9mcmFnOjk0NGQ2N2RjOTNmMjQ1MjliZTc4ZmNlMzRiOGMyZTBiL3RhYmxlOjRjZWFlMWI0OTIwOTQwOGY5NDZmNTU5MmUwNGU0MjFhL3RhYmxlcmFuZ2U6NGNlYWUxYjQ5MjA5NDA4Zjk0NmY1NTkyZTA0ZTQyMWFfNi0zLTEtMS0w_7c356f1f-9228-4026-b0e8-8b47866c07ba">9,883</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i69782326f71a44e3805518280ee22b6b_D20210101-20210630" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzY2E5YmIwMTc5MjQ3NmZiYjIyNWU1ZDlkZWM4NjlmL3NlYzo5M2NhOWJiMDE3OTI0NzZmYmIyMjVlNWQ5ZGVjODY5Zl81NS9mcmFnOjk0NGQ2N2RjOTNmMjQ1MjliZTc4ZmNlMzRiOGMyZTBiL3RhYmxlOjRjZWFlMWI0OTIwOTQwOGY5NDZmNTU5MmUwNGU0MjFhL3RhYmxlcmFuZ2U6NGNlYWUxYjQ5MjA5NDA4Zjk0NmY1NTkyZTA0ZTQyMWFfNi01LTEtMS0w_79c3b612-99ee-4210-b125-7a396f390868">28,233</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4a110e4972ef4113880ce582e3cda5c5_D20200101-20200630" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzY2E5YmIwMTc5MjQ3NmZiYjIyNWU1ZDlkZWM4NjlmL3NlYzo5M2NhOWJiMDE3OTI0NzZmYmIyMjVlNWQ5ZGVjODY5Zl81NS9mcmFnOjk0NGQ2N2RjOTNmMjQ1MjliZTc4ZmNlMzRiOGMyZTBiL3RhYmxlOjRjZWFlMWI0OTIwOTQwOGY5NDZmNTU5MmUwNGU0MjFhL3RhYmxlcmFuZ2U6NGNlYWUxYjQ5MjA5NDA4Zjk0NmY1NTkyZTA0ZTQyMWFfNi03LTEtMS0w_39441bca-9e6e-44bc-8b83-38a21ff8b5c4">18,315</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div></ix:nonNumeric><ix:nonNumeric contextRef="i69782326f71a44e3805518280ee22b6b_D20210101-20210630" name="us-gaap:LongLivedAssetsByGeographicAreasTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjkzY2E5YmIwMTc5MjQ3NmZiYjIyNWU1ZDlkZWM4NjlmL3NlYzo5M2NhOWJiMDE3OTI0NzZmYmIyMjVlNWQ5ZGVjODY5Zl81NS9mcmFnOjk0NGQ2N2RjOTNmMjQ1MjliZTc4ZmNlMzRiOGMyZTBiL3RleHRyZWdpb246OTQ0ZDY3ZGM5M2YyNDUyOWJlNzhmY2UzNGI4YzJlMGJfMjk5MA_6a0b13ee-d91c-4afd-a22b-0c87292316b7" escape="true"><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Property, plant and equipment assets were physically located in the following geographic regions:</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:60.150%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:17.372%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:1.605%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:17.373%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">As of June&#160;30, 2021</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">As of December 31, 2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Canada</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib400bcdb825949cb9d87ed7e77387db0_I20210630" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:NoncurrentAssets" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzY2E5YmIwMTc5MjQ3NmZiYjIyNWU1ZDlkZWM4NjlmL3NlYzo5M2NhOWJiMDE3OTI0NzZmYmIyMjVlNWQ5ZGVjODY5Zl81NS9mcmFnOjk0NGQ2N2RjOTNmMjQ1MjliZTc4ZmNlMzRiOGMyZTBiL3RhYmxlOjM0OGU0MTA2ZTVkYTQwMTliNzBjYTIyOTlmOTZiYjUxL3RhYmxlcmFuZ2U6MzQ4ZTQxMDZlNWRhNDAxOWI3MGNhMjI5OWY5NmJiNTFfMS0xLTEtMS0w_a2a75155-9fad-4929-adf3-5eb782ffb94f">168,462</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6d98056e96104c42af330a91259abb2c_I20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:NoncurrentAssets" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzY2E5YmIwMTc5MjQ3NmZiYjIyNWU1ZDlkZWM4NjlmL3NlYzo5M2NhOWJiMDE3OTI0NzZmYmIyMjVlNWQ5ZGVjODY5Zl81NS9mcmFnOjk0NGQ2N2RjOTNmMjQ1MjliZTc4ZmNlMzRiOGMyZTBiL3RhYmxlOjM0OGU0MTA2ZTVkYTQwMTliNzBjYTIyOTlmOTZiYjUxL3RhYmxlcmFuZ2U6MzQ4ZTQxMDZlNWRhNDAxOWI3MGNhMjI5OWY5NmJiNTFfMS0zLTEtMS0w_5e35ad5d-d43a-4985-897a-0b5b7d3ff1d0">162,163</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Israel</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic9b10d1ca8aa427693166bca2adb764d_I20210630" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:NoncurrentAssets" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzY2E5YmIwMTc5MjQ3NmZiYjIyNWU1ZDlkZWM4NjlmL3NlYzo5M2NhOWJiMDE3OTI0NzZmYmIyMjVlNWQ5ZGVjODY5Zl81NS9mcmFnOjk0NGQ2N2RjOTNmMjQ1MjliZTc4ZmNlMzRiOGMyZTBiL3RhYmxlOjM0OGU0MTA2ZTVkYTQwMTliNzBjYTIyOTlmOTZiYjUxL3RhYmxlcmFuZ2U6MzQ4ZTQxMDZlNWRhNDAxOWI3MGNhMjI5OWY5NmJiNTFfMi0xLTEtMS0w_7aed5896-64a5-4497-bc1e-7e26152e1fe2">23,936</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i046692f7d6014223b3cb3cd2d79b04f9_I20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:NoncurrentAssets" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzY2E5YmIwMTc5MjQ3NmZiYjIyNWU1ZDlkZWM4NjlmL3NlYzo5M2NhOWJiMDE3OTI0NzZmYmIyMjVlNWQ5ZGVjODY5Zl81NS9mcmFnOjk0NGQ2N2RjOTNmMjQ1MjliZTc4ZmNlMzRiOGMyZTBiL3RhYmxlOjM0OGU0MTA2ZTVkYTQwMTliNzBjYTIyOTlmOTZiYjUxL3RhYmxlcmFuZ2U6MzQ4ZTQxMDZlNWRhNDAxOWI3MGNhMjI5OWY5NmJiNTFfMi0zLTEtMS0w_57177905-caeb-4dd1-8c2b-bd2b1e0912eb">23,143</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">United States</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i18e4d04b45ca4c42a5f461314b4cf1a6_I20210630" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:NoncurrentAssets" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzY2E5YmIwMTc5MjQ3NmZiYjIyNWU1ZDlkZWM4NjlmL3NlYzo5M2NhOWJiMDE3OTI0NzZmYmIyMjVlNWQ5ZGVjODY5Zl81NS9mcmFnOjk0NGQ2N2RjOTNmMjQ1MjliZTc4ZmNlMzRiOGMyZTBiL3RhYmxlOjM0OGU0MTA2ZTVkYTQwMTliNzBjYTIyOTlmOTZiYjUxL3RhYmxlcmFuZ2U6MzQ4ZTQxMDZlNWRhNDAxOWI3MGNhMjI5OWY5NmJiNTFfMy0xLTEtMS0w_0e1dbe63-43f4-431b-b9ce-9bd99fe08487">1,522</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i57ed1954cbd8415788c6fb0209f0f8f2_I20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:NoncurrentAssets" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzY2E5YmIwMTc5MjQ3NmZiYjIyNWU1ZDlkZWM4NjlmL3NlYzo5M2NhOWJiMDE3OTI0NzZmYmIyMjVlNWQ5ZGVjODY5Zl81NS9mcmFnOjk0NGQ2N2RjOTNmMjQ1MjliZTc4ZmNlMzRiOGMyZTBiL3RhYmxlOjM0OGU0MTA2ZTVkYTQwMTliNzBjYTIyOTlmOTZiYjUxL3RhYmxlcmFuZ2U6MzQ4ZTQxMDZlNWRhNDAxOWI3MGNhMjI5OWY5NmJiNTFfMy0zLTEtMS0w_bb8be446-6181-4870-a2dd-5ff1d2d1d2a4">2,293</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total </span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i225f85e38faa4bbdb4de1d8b9cf369bb_I20210630" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:NoncurrentAssets" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzY2E5YmIwMTc5MjQ3NmZiYjIyNWU1ZDlkZWM4NjlmL3NlYzo5M2NhOWJiMDE3OTI0NzZmYmIyMjVlNWQ5ZGVjODY5Zl81NS9mcmFnOjk0NGQ2N2RjOTNmMjQ1MjliZTc4ZmNlMzRiOGMyZTBiL3RhYmxlOjM0OGU0MTA2ZTVkYTQwMTliNzBjYTIyOTlmOTZiYjUxL3RhYmxlcmFuZ2U6MzQ4ZTQxMDZlNWRhNDAxOWI3MGNhMjI5OWY5NmJiNTFfNS0xLTEtMS0w_0ddf8f6f-4c22-4eed-837f-7a802349be0d">193,920</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ifbe16ec51ea244519b77d6036b4ef038_I20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:NoncurrentAssets" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzY2E5YmIwMTc5MjQ3NmZiYjIyNWU1ZDlkZWM4NjlmL3NlYzo5M2NhOWJiMDE3OTI0NzZmYmIyMjVlNWQ5ZGVjODY5Zl81NS9mcmFnOjk0NGQ2N2RjOTNmMjQ1MjliZTc4ZmNlMzRiOGMyZTBiL3RhYmxlOjM0OGU0MTA2ZTVkYTQwMTliNzBjYTIyOTlmOTZiYjUxL3RhYmxlcmFuZ2U6MzQ4ZTQxMDZlNWRhNDAxOWI3MGNhMjI5OWY5NmJiNTFfNS0zLTEtMS0w_2dab9b11-2630-4d18-80cc-d720c426d5e4">187,599</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div></ix:nonNumeric><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company sells products through a limited number of major customers. Major customers are defined as customers that each individually accounted for greater than 10% of the Company&#8217;s revenues.</span></div></ix:continuation><div style="height:36pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">24</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:72pt;width:100%"><div style="margin-top:0.55pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:95.000%"><tr><td style="width:1.0%"></td><td style="width:65.712%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:32.088%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="border-top:1pt solid #FFFFFF;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Cronos Group Inc.</span></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Notes to Condensed Consolidated Financial Statements (Unaudited)</span></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">(In thousands of $, except share amounts)</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i93ca9bb01792476fbb225e5d9dec869f_7">Table of Contents</a></span></div></td></tr></table></div></div><ix:continuation id="iaca7063ce197461f85c325e68d28fcb6"><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">United States</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">During the three and six months ended June&#160;30, 2021 and 2020, the U.S. segment had no major customers.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As of June&#160;30, 2021 and December 31, 2020, the Company had $<ix:nonFraction unitRef="usd" contextRef="i8c36c75ac6bc43f1a84b689b7e30c990_I20210630" decimals="-3" name="us-gaap:AllowanceForDoubtfulAccountsReceivableCurrent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzY2E5YmIwMTc5MjQ3NmZiYjIyNWU1ZDlkZWM4NjlmL3NlYzo5M2NhOWJiMDE3OTI0NzZmYmIyMjVlNWQ5ZGVjODY5Zl81NS9mcmFnOjk0NGQ2N2RjOTNmMjQ1MjliZTc4ZmNlMzRiOGMyZTBiL3RleHRyZWdpb246OTQ0ZDY3ZGM5M2YyNDUyOWJlNzhmY2UzNGI4YzJlMGJfMjEwOA_ad32467d-27c9-4541-9aa0-96fca14655d7">106</ix:nonFraction> and $<ix:nonFraction unitRef="usd" contextRef="ideeca118de83445d869657437d768780_I20201231" decimals="-3" name="us-gaap:AllowanceForDoubtfulAccountsReceivableCurrent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzY2E5YmIwMTc5MjQ3NmZiYjIyNWU1ZDlkZWM4NjlmL3NlYzo5M2NhOWJiMDE3OTI0NzZmYmIyMjVlNWQ5ZGVjODY5Zl81NS9mcmFnOjk0NGQ2N2RjOTNmMjQ1MjliZTc4ZmNlMzRiOGMyZTBiL3RleHRyZWdpb246OTQ0ZDY3ZGM5M2YyNDUyOWJlNzhmY2UzNGI4YzJlMGJfMjExNQ_8fb0bb26-ac80-4e0d-b685-a77fc14e7f8f">65</ix:nonFraction>, respectively, in expected credit losses that have been recognized on receivables from contracts with customers.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">There was <ix:nonFraction unitRef="usd" contextRef="i094dc56c362c416aac0dd88497f3bd55_D20200401-20200630" decimals="INF" format="ixt-sec:numwordsen" name="us-gaap:IncomeLossFromDiscontinuedOperationsNetOfTax" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjkzY2E5YmIwMTc5MjQ3NmZiYjIyNWU1ZDlkZWM4NjlmL3NlYzo5M2NhOWJiMDE3OTI0NzZmYmIyMjVlNWQ5ZGVjODY5Zl81NS9mcmFnOjk0NGQ2N2RjOTNmMjQ1MjliZTc4ZmNlMzRiOGMyZTBiL3RleHRyZWdpb246OTQ0ZDY3ZGM5M2YyNDUyOWJlNzhmY2UzNGI4YzJlMGJfOTg5NTYwNDY5NzE2Mg_37534e0f-076a-462e-ab8e-bb643cb224ed"><ix:nonFraction unitRef="usd" contextRef="i812abaaed027463984b850a5e2b42d2c_D20200101-20200630" decimals="INF" format="ixt-sec:numwordsen" name="us-gaap:IncomeLossFromDiscontinuedOperationsNetOfTax" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjkzY2E5YmIwMTc5MjQ3NmZiYjIyNWU1ZDlkZWM4NjlmL3NlYzo5M2NhOWJiMDE3OTI0NzZmYmIyMjVlNWQ5ZGVjODY5Zl81NS9mcmFnOjk0NGQ2N2RjOTNmMjQ1MjliZTc4ZmNlMzRiOGMyZTBiL3RleHRyZWdpb246OTQ0ZDY3ZGM5M2YyNDUyOWJlNzhmY2UzNGI4YzJlMGJfOTg5NTYwNDY5NzE2Mg_959e8722-2302-4fc8-ad39-fcee292819e8"><ix:nonFraction unitRef="usd" contextRef="i3a27e92fff0846b5bad95097b919232f_D20210101-20210630" decimals="INF" format="ixt-sec:numwordsen" name="us-gaap:IncomeLossFromDiscontinuedOperationsNetOfTax" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjkzY2E5YmIwMTc5MjQ3NmZiYjIyNWU1ZDlkZWM4NjlmL3NlYzo5M2NhOWJiMDE3OTI0NzZmYmIyMjVlNWQ5ZGVjODY5Zl81NS9mcmFnOjk0NGQ2N2RjOTNmMjQ1MjliZTc4ZmNlMzRiOGMyZTBiL3RleHRyZWdpb246OTQ0ZDY3ZGM5M2YyNDUyOWJlNzhmY2UzNGI4YzJlMGJfOTg5NTYwNDY5NzE2Mg_e6adc93e-e496-4a67-b7a1-6b277e5b915e"><ix:nonFraction unitRef="usd" contextRef="i34f72ee8566f4486917d56bc3b40f37f_D20210401-20210630" decimals="INF" format="ixt-sec:numwordsen" name="us-gaap:IncomeLossFromDiscontinuedOperationsNetOfTax" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjkzY2E5YmIwMTc5MjQ3NmZiYjIyNWU1ZDlkZWM4NjlmL3NlYzo5M2NhOWJiMDE3OTI0NzZmYmIyMjVlNWQ5ZGVjODY5Zl81NS9mcmFnOjk0NGQ2N2RjOTNmMjQ1MjliZTc4ZmNlMzRiOGMyZTBiL3RleHRyZWdpb246OTQ0ZDY3ZGM5M2YyNDUyOWJlNzhmY2UzNGI4YzJlMGJfOTg5NTYwNDY5NzE2Mg_f7140db0-4d63-4458-a295-abf41a559758">no</ix:nonFraction></ix:nonFraction></ix:nonFraction></ix:nonFraction> loss from discontinued operations from the U.S. Segment for the three and six months ended June 30, 2021 and 2020.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Rest of World</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">During the three months ended June&#160;30, 2021, the Rest of World segment earned a total net revenue before excise taxes of $<ix:nonFraction unitRef="usd" contextRef="i5c2d78ee6853443687a96daa15276fab_D20210401-20210630" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzY2E5YmIwMTc5MjQ3NmZiYjIyNWU1ZDlkZWM4NjlmL3NlYzo5M2NhOWJiMDE3OTI0NzZmYmIyMjVlNWQ5ZGVjODY5Zl81NS9mcmFnOjk0NGQ2N2RjOTNmMjQ1MjliZTc4ZmNlMzRiOGMyZTBiL3RleHRyZWdpb246OTQ0ZDY3ZGM5M2YyNDUyOWJlNzhmY2UzNGI4YzJlMGJfMjM0Mg_4b45b5e7-318f-415d-aa42-6562b6139f24">8,497</ix:nonFraction> from three major customers, Ontario Cannabis Retail Corporation, Alberta Gaming, Liquor and Cannabis Commission and Soci&#233;t&#233; Qu&#233;b&#233;coise du Cannabis, accounting for <ix:nonFraction unitRef="number" contextRef="i93bcd6f71ecb484fbb4d514bb054afb1_D20210401-20210630" decimals="2" name="us-gaap:ConcentrationRiskPercentage1" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjkzY2E5YmIwMTc5MjQ3NmZiYjIyNWU1ZDlkZWM4NjlmL3NlYzo5M2NhOWJiMDE3OTI0NzZmYmIyMjVlNWQ5ZGVjODY5Zl81NS9mcmFnOjk0NGQ2N2RjOTNmMjQ1MjliZTc4ZmNlMzRiOGMyZTBiL3RleHRyZWdpb246OTQ0ZDY3ZGM5M2YyNDUyOWJlNzhmY2UzNGI4YzJlMGJfMjE5OTAyMzI2NTk2NA_ed53a79d-49d0-4f54-8f10-42c4d7e690ed">19</ix:nonFraction>%, <ix:nonFraction unitRef="number" contextRef="i211d75fcd6a546f899374d2d7176c1e2_D20210401-20210630" decimals="2" name="us-gaap:ConcentrationRiskPercentage1" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjkzY2E5YmIwMTc5MjQ3NmZiYjIyNWU1ZDlkZWM4NjlmL3NlYzo5M2NhOWJiMDE3OTI0NzZmYmIyMjVlNWQ5ZGVjODY5Zl81NS9mcmFnOjk0NGQ2N2RjOTNmMjQ1MjliZTc4ZmNlMzRiOGMyZTBiL3RleHRyZWdpb246OTQ0ZDY3ZGM5M2YyNDUyOWJlNzhmY2UzNGI4YzJlMGJfMjE5OTAyMzI2NTk3MA_fccb9fea-caf9-4666-949c-bbaa204795ea">14</ix:nonFraction>% and <ix:nonFraction unitRef="number" contextRef="idd2a2576b3144d36986722b62b737a2d_D20210401-20210630" decimals="2" name="us-gaap:ConcentrationRiskPercentage1" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjkzY2E5YmIwMTc5MjQ3NmZiYjIyNWU1ZDlkZWM4NjlmL3NlYzo5M2NhOWJiMDE3OTI0NzZmYmIyMjVlNWQ5ZGVjODY5Zl81NS9mcmFnOjk0NGQ2N2RjOTNmMjQ1MjliZTc4ZmNlMzRiOGMyZTBiL3RleHRyZWdpb246OTQ0ZDY3ZGM5M2YyNDUyOWJlNzhmY2UzNGI4YzJlMGJfMjQwNA_610cc8bf-ff01-4b6d-a989-2e0ffbc8045b">12</ix:nonFraction>%, respectively, of the Company&#8217;s total net revenue before excise taxes. During the three months ended June&#160;30, 2020, the Rest of World segment earned a total net revenue before excise taxes of $<ix:nonFraction unitRef="usd" contextRef="i74697f2f39824e5d8fa61532bd9225b4_D20200401-20200630" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzY2E5YmIwMTc5MjQ3NmZiYjIyNWU1ZDlkZWM4NjlmL3NlYzo5M2NhOWJiMDE3OTI0NzZmYmIyMjVlNWQ5ZGVjODY5Zl81NS9mcmFnOjk0NGQ2N2RjOTNmMjQ1MjliZTc4ZmNlMzRiOGMyZTBiL3RleHRyZWdpb246OTQ0ZDY3ZGM5M2YyNDUyOWJlNzhmY2UzNGI4YzJlMGJfMzI5ODUzNDg4NjgyOA_ff7f542c-a957-4352-98ca-add863ab70bf">7,040</ix:nonFraction> from four major customers, together accounting for <ix:nonFraction unitRef="number" contextRef="i74697f2f39824e5d8fa61532bd9225b4_D20200401-20200630" decimals="2" name="us-gaap:ConcentrationRiskPercentage1" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjkzY2E5YmIwMTc5MjQ3NmZiYjIyNWU1ZDlkZWM4NjlmL3NlYzo5M2NhOWJiMDE3OTI0NzZmYmIyMjVlNWQ5ZGVjODY5Zl81NS9mcmFnOjk0NGQ2N2RjOTNmMjQ1MjliZTc4ZmNlMzRiOGMyZTBiL3RleHRyZWdpb246OTQ0ZDY3ZGM5M2YyNDUyOWJlNzhmY2UzNGI4YzJlMGJfMzI5ODUzNDg4NzA2Ng_994dd834-924c-420e-87ee-f6a01628cae4">71</ix:nonFraction>% of the Company&#8217;s total net revenues before excise taxes.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">During the six months ended June 30, 2021, the Rest of World segment earned a total net revenue before excise taxes of $<ix:nonFraction unitRef="usd" contextRef="ic588d92572e146368a7065a944f8c099_D20200101-20200630" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzY2E5YmIwMTc5MjQ3NmZiYjIyNWU1ZDlkZWM4NjlmL3NlYzo5M2NhOWJiMDE3OTI0NzZmYmIyMjVlNWQ5ZGVjODY5Zl81NS9mcmFnOjk0NGQ2N2RjOTNmMjQ1MjliZTc4ZmNlMzRiOGMyZTBiL3RleHRyZWdpb246OTQ0ZDY3ZGM5M2YyNDUyOWJlNzhmY2UzNGI4YzJlMGJfMzI5ODUzNDg4NzA5NA_4543c1e3-a6af-42bc-98d2-6ab00da320c5">18,250</ix:nonFraction> from four major customers, Ontario Cannabis Retail Corporation, Novolog Group, Soci&#233;t&#233; Qu&#233;b&#233;coise du Cannabis and Alberta Gaming, Liquor and Cannabis Commission, accounting for <ix:nonFraction unitRef="number" contextRef="id59e6b6959b841bebcf3af4df3b502e6_D20200101-20200630" decimals="2" name="us-gaap:ConcentrationRiskPercentage1" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjkzY2E5YmIwMTc5MjQ3NmZiYjIyNWU1ZDlkZWM4NjlmL3NlYzo5M2NhOWJiMDE3OTI0NzZmYmIyMjVlNWQ5ZGVjODY5Zl81NS9mcmFnOjk0NGQ2N2RjOTNmMjQ1MjliZTc4ZmNlMzRiOGMyZTBiL3RleHRyZWdpb246OTQ0ZDY3ZGM5M2YyNDUyOWJlNzhmY2UzNGI4YzJlMGJfMjE5OTAyMzI2NjAyNg_ad58b772-20ab-490b-a7b0-7a6a22996232">15</ix:nonFraction>%, <ix:nonFraction unitRef="number" contextRef="id58ad288eb10460ebcce6bf331a5886c_D20200101-20200630" decimals="2" name="us-gaap:ConcentrationRiskPercentage1" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjkzY2E5YmIwMTc5MjQ3NmZiYjIyNWU1ZDlkZWM4NjlmL3NlYzo5M2NhOWJiMDE3OTI0NzZmYmIyMjVlNWQ5ZGVjODY5Zl81NS9mcmFnOjk0NGQ2N2RjOTNmMjQ1MjliZTc4ZmNlMzRiOGMyZTBiL3RleHRyZWdpb246OTQ0ZDY3ZGM5M2YyNDUyOWJlNzhmY2UzNGI4YzJlMGJfMjE5OTAyMzI2NjAzMg_c1e6154b-faa1-46bb-82b5-08760f0e75b5">14</ix:nonFraction>%, <ix:nonFraction unitRef="number" contextRef="i3d5f8123b8fe46de8a82ced9ca5ee737_D20200101-20200630" decimals="2" name="us-gaap:ConcentrationRiskPercentage1" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjkzY2E5YmIwMTc5MjQ3NmZiYjIyNWU1ZDlkZWM4NjlmL3NlYzo5M2NhOWJiMDE3OTI0NzZmYmIyMjVlNWQ5ZGVjODY5Zl81NS9mcmFnOjk0NGQ2N2RjOTNmMjQ1MjliZTc4ZmNlMzRiOGMyZTBiL3RleHRyZWdpb246OTQ0ZDY3ZGM5M2YyNDUyOWJlNzhmY2UzNGI4YzJlMGJfMzI5ODUzNDg4NzExMA_5f817b96-3233-461c-ab99-6403cd9b906c">13</ix:nonFraction>%, and <ix:nonFraction unitRef="number" contextRef="ie35646e7e6b447dc960fee8714bca44b_D20200101-20200630" decimals="2" name="us-gaap:ConcentrationRiskPercentage1" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjkzY2E5YmIwMTc5MjQ3NmZiYjIyNWU1ZDlkZWM4NjlmL3NlYzo5M2NhOWJiMDE3OTI0NzZmYmIyMjVlNWQ5ZGVjODY5Zl81NS9mcmFnOjk0NGQ2N2RjOTNmMjQ1MjliZTc4ZmNlMzRiOGMyZTBiL3RleHRyZWdpb246OTQ0ZDY3ZGM5M2YyNDUyOWJlNzhmY2UzNGI4YzJlMGJfMzI5ODUzNDg4NzEyNQ_1b43fc50-a122-4d7d-903a-604c31790516">12</ix:nonFraction>% respectively, of the Company&#8217;s total net revenue before excise taxes. During the six months ended June&#160;30, 2020, the Rest of World segment earned a total net revenue before excise taxes of $<ix:nonFraction unitRef="usd" contextRef="ifefa84f4058a4db3af98ff73cf89d8f4_D20200101-20200630" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzY2E5YmIwMTc5MjQ3NmZiYjIyNWU1ZDlkZWM4NjlmL3NlYzo5M2NhOWJiMDE3OTI0NzZmYmIyMjVlNWQ5ZGVjODY5Zl81NS9mcmFnOjk0NGQ2N2RjOTNmMjQ1MjliZTc4ZmNlMzRiOGMyZTBiL3RleHRyZWdpb246OTQ0ZDY3ZGM5M2YyNDUyOWJlNzhmY2UzNGI4YzJlMGJfMzI5ODUzNDg4NzA1Nw_a80c5e07-48d3-4847-8da8-2b82c495d1df">11,819</ix:nonFraction> from four major customers, together accounting for <ix:nonFraction unitRef="number" contextRef="ifefa84f4058a4db3af98ff73cf89d8f4_D20200101-20200630" decimals="2" name="us-gaap:ConcentrationRiskPercentage1" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjkzY2E5YmIwMTc5MjQ3NmZiYjIyNWU1ZDlkZWM4NjlmL3NlYzo5M2NhOWJiMDE3OTI0NzZmYmIyMjVlNWQ5ZGVjODY5Zl81NS9mcmFnOjk0NGQ2N2RjOTNmMjQ1MjliZTc4ZmNlMzRiOGMyZTBiL3RleHRyZWdpb246OTQ0ZDY3ZGM5M2YyNDUyOWJlNzhmY2UzNGI4YzJlMGJfMzI5ODUzNDg4Njk5Mg_f6ef6b33-ed02-4e7c-bd29-8d739a73795e">65</ix:nonFraction>% of the Company&#8217;s total net revenues before excise taxes.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As of June&#160;30, 2021 and December 31, 2020, the Company had $<ix:nonFraction unitRef="usd" contextRef="i72aea01958fa442a951467d9e067fb46_I20210630" decimals="-3" name="us-gaap:AllowanceForDoubtfulAccountsReceivableCurrent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzY2E5YmIwMTc5MjQ3NmZiYjIyNWU1ZDlkZWM4NjlmL3NlYzo5M2NhOWJiMDE3OTI0NzZmYmIyMjVlNWQ5ZGVjODY5Zl81NS9mcmFnOjk0NGQ2N2RjOTNmMjQ1MjliZTc4ZmNlMzRiOGMyZTBiL3RleHRyZWdpb246OTQ0ZDY3ZGM5M2YyNDUyOWJlNzhmY2UzNGI4YzJlMGJfMjc0MA_c269875d-d068-4819-95ac-6d4159058501">158</ix:nonFraction> and $<ix:nonFraction unitRef="usd" contextRef="ib9d10d92b8c54f02a41178e1141532dd_I20201231" decimals="-3" name="us-gaap:AllowanceForDoubtfulAccountsReceivableCurrent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzY2E5YmIwMTc5MjQ3NmZiYjIyNWU1ZDlkZWM4NjlmL3NlYzo5M2NhOWJiMDE3OTI0NzZmYmIyMjVlNWQ5ZGVjODY5Zl81NS9mcmFnOjk0NGQ2N2RjOTNmMjQ1MjliZTc4ZmNlMzRiOGMyZTBiL3RleHRyZWdpb246OTQ0ZDY3ZGM5M2YyNDUyOWJlNzhmY2UzNGI4YzJlMGJfMjc0Nw_5428aaad-6b6a-4257-b063-39a8d7c12d31">9</ix:nonFraction>, respectively, in expected credit losses that have been recognized on receivables from contracts with customers.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The loss from discontinued operations from the Rest of World segment for the three months ended June&#160;30, 2021 and 2020 was $<ix:nonFraction unitRef="usd" contextRef="i27f4e53b91ad4367b7f8d273eff27769_D20210401-20210630" decimals="INF" sign="-" name="us-gaap:IncomeLossFromDiscontinuedOperationsNetOfTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzY2E5YmIwMTc5MjQ3NmZiYjIyNWU1ZDlkZWM4NjlmL3NlYzo5M2NhOWJiMDE3OTI0NzZmYmIyMjVlNWQ5ZGVjODY5Zl81NS9mcmFnOjk0NGQ2N2RjOTNmMjQ1MjliZTc4ZmNlMzRiOGMyZTBiL3RleHRyZWdpb246OTQ0ZDY3ZGM5M2YyNDUyOWJlNzhmY2UzNGI4YzJlMGJfNTQ5NzU1ODE0MzA2Ng_975b6be6-740c-4075-a747-c05a860e9e18">561</ix:nonFraction> and $<ix:nonFraction unitRef="usd" contextRef="i39065c5daf934af885335c12f3cfa83f_D20200401-20200630" decimals="-3" sign="-" name="us-gaap:IncomeLossFromDiscontinuedOperationsNetOfTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzY2E5YmIwMTc5MjQ3NmZiYjIyNWU1ZDlkZWM4NjlmL3NlYzo5M2NhOWJiMDE3OTI0NzZmYmIyMjVlNWQ5ZGVjODY5Zl81NS9mcmFnOjk0NGQ2N2RjOTNmMjQ1MjliZTc4ZmNlMzRiOGMyZTBiL3RleHRyZWdpb246OTQ0ZDY3ZGM5M2YyNDUyOWJlNzhmY2UzNGI4YzJlMGJfNTQ5NzU1ODE0MzA4Mg_8c25c2e7-3f05-441c-9d24-5126991f4b23">46</ix:nonFraction>, respectively. The loss from discontinued operations from the Rest of World segment for the six months ended June&#160;30, 2021 and 2020 was $<ix:nonFraction unitRef="usd" contextRef="i69782326f71a44e3805518280ee22b6b_D20210101-20210630" decimals="-3" sign="-" name="us-gaap:IncomeLossFromDiscontinuedOperationsNetOfTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzY2E5YmIwMTc5MjQ3NmZiYjIyNWU1ZDlkZWM4NjlmL3NlYzo5M2NhOWJiMDE3OTI0NzZmYmIyMjVlNWQ5ZGVjODY5Zl81NS9mcmFnOjk0NGQ2N2RjOTNmMjQ1MjliZTc4ZmNlMzRiOGMyZTBiL3RleHRyZWdpb246OTQ0ZDY3ZGM5M2YyNDUyOWJlNzhmY2UzNGI4YzJlMGJfNDk0NzgwMjMyOTM0Mw_baa9badb-5ffa-4186-a150-7b68d9089f70">582</ix:nonFraction> and $<ix:nonFraction unitRef="usd" contextRef="i4a110e4972ef4113880ce582e3cda5c5_D20200101-20200630" decimals="-3" sign="-" name="us-gaap:IncomeLossFromDiscontinuedOperationsNetOfTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzY2E5YmIwMTc5MjQ3NmZiYjIyNWU1ZDlkZWM4NjlmL3NlYzo5M2NhOWJiMDE3OTI0NzZmYmIyMjVlNWQ5ZGVjODY5Zl81NS9mcmFnOjk0NGQ2N2RjOTNmMjQ1MjliZTc4ZmNlMzRiOGMyZTBiL3RleHRyZWdpb246OTQ0ZDY3ZGM5M2YyNDUyOWJlNzhmY2UzNGI4YzJlMGJfNDk0NzgwMjMyOTM1Mg_b72b2f6d-e92d-4c8b-91df-8b0cab54e583">46</ix:nonFraction>, respectively.</span></div></ix:continuation><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span><br/></span></div><div id="i93ca9bb01792476fbb225e5d9dec869f_58"></div><div style="margin-bottom:12pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">9. <ix:nonNumeric contextRef="i69782326f71a44e3805518280ee22b6b_D20210101-20210630" name="us-gaap:LossContingencyDisclosures" id="id3VybDovL2RvY3MudjEvZG9jOjkzY2E5YmIwMTc5MjQ3NmZiYjIyNWU1ZDlkZWM4NjlmL3NlYzo5M2NhOWJiMDE3OTI0NzZmYmIyMjVlNWQ5ZGVjODY5Zl81OC9mcmFnOjg2ZmM2YjFiZjYyMDRmNzViNjAyMjE0MWU1MWMyYjU2L3RleHRyZWdpb246ODZmYzZiMWJmNjIwNGY3NWI2MDIyMTQxZTUxYzJiNTZfNjM3Ng_be8aeebc-2359-4fbd-9a9c-e893fafe8a8b" continuedAt="i30d74c673cb645e98983a8b12727cb4b" escape="true">Commitments and Contingencies</ix:nonNumeric></span></div><ix:continuation id="i30d74c673cb645e98983a8b12727cb4b" continuedAt="i097dd96c76d74eb0914be3f67f2f399d"><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(a)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;padding-left:24.34pt">Commitments</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">There have been no material changes in the information regarding commitments as disclosed in the Company&#8217;s Annual Financial Statements.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(b)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;padding-left:23.78pt">Contingencies</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company is subject to various legal proceedings in the ordinary course of its business and in connection with its marketing, distribution and sale of its products. Many of these legal proceedings are in the early stages of litigation and seek damages that are unspecified or not quantified. Although the outcome of these matters cannot be predicted with certainty, the Company does not believe these legal proceedings, individually or in the aggregate, will have a material adverse effect on its financial condition but could be material to its results of operations for a quarterly period depending, in part, on its results for that quarter.</span></div><div style="margin-bottom:6pt;margin-top:6pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">(i)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%;padding-left:8.57pt">Class action complaints relating to restatement</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On March 11 and 12, 2020, <ix:nonFraction unitRef="shareholder" contextRef="ia489f6e55d8f4b56a4c35ea7b7898ed6_D20200311-20200312" decimals="INF" format="ixt-sec:numwordsen" name="us-gaap:LossContingencyNumberOfPlaintiffs" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjkzY2E5YmIwMTc5MjQ3NmZiYjIyNWU1ZDlkZWM4NjlmL3NlYzo5M2NhOWJiMDE3OTI0NzZmYmIyMjVlNWQ5ZGVjODY5Zl81OC9mcmFnOjg2ZmM2YjFiZjYyMDRmNzViNjAyMjE0MWU1MWMyYjU2L3RleHRyZWdpb246ODZmYzZiMWJmNjIwNGY3NWI2MDIyMTQxZTUxYzJiNTZfODk1_82770464-5c4b-4be2-b20a-14db15e04572">two</ix:nonFraction> alleged shareholders of the Company separately filed <ix:nonFraction unitRef="complaint" contextRef="ia489f6e55d8f4b56a4c35ea7b7898ed6_D20200311-20200312" decimals="INF" format="ixt-sec:numwordsen" name="us-gaap:LossContingencyNewClaimsFiledNumber" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjkzY2E5YmIwMTc5MjQ3NmZiYjIyNWU1ZDlkZWM4NjlmL3NlYzo5M2NhOWJiMDE3OTI0NzZmYmIyMjVlNWQ5ZGVjODY5Zl81OC9mcmFnOjg2ZmM2YjFiZjYyMDRmNzViNjAyMjE0MWU1MWMyYjU2L3RleHRyZWdpb246ODZmYzZiMWJmNjIwNGY3NWI2MDIyMTQxZTUxYzJiNTZfOTUx_74044aaa-26bf-49d7-a853-95b680b37c67">two</ix:nonFraction> putative class action complaints in the U.S. District Court for the Eastern District of New York against the Company and its former Chief Executive Officer (now Executive Chairman) and Chief Financial Officer. The court has consolidated the cases, and the consolidated amended complaint alleges violations of Section 10(b) of the Securities Exchange Act of 1934 (the &#8220;Exchange Act&#8221;) and Rule 10b-5 promulgated thereunder against all defendants, and Section 20(a) of the Exchange Act against the individual defendants. The consolidated amended complaint generally alleges that certain of the Company&#8217;s prior public statements about revenues and internal controls were incorrect based on the Company&#8217;s disclosures relating to the Audit Committee of the Board of Directors&#8217; review of the appropriateness of revenue recognized in connection with certain bulk resin purchases and sales of products through the wholesale channel. The consolidated amended complaint does not quantify a damage request. Defendants moved to dismiss on February 8, 2021. </span></div></ix:continuation><div style="height:36pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">25</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:72pt;width:100%"><div style="margin-top:0.55pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:95.000%"><tr><td style="width:1.0%"></td><td style="width:65.712%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:32.088%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="border-top:1pt solid #FFFFFF;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Cronos Group Inc.</span></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Notes to Condensed Consolidated Financial Statements (Unaudited)</span></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">(In thousands of $, except share amounts)</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i93ca9bb01792476fbb225e5d9dec869f_7">Table of Contents</a></span></div></td></tr></table></div></div><ix:continuation id="i097dd96c76d74eb0914be3f67f2f399d" continuedAt="ib1ac27d748544b4c8f63cc7572d4744b"><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On June 3, 2020, an alleged shareholder filed a Statement of Claim, as amended on August 12, 2020, in the Ontario Superior Court of Justice in Toronto, Ontario, Canada, seeking, among other things, an order certifying the action as a class action on behalf of a putative class of shareholders and damages of an unspecified amount. The Amended Statement of Claim names the Company, its former Chief Executive Officer (now Executive Chairman), Chief Financial Officer, former Chief Financial Officer and Chief Commercial Officer, and current and former members of the Board of Directors as defendants and alleges breaches of the Ontario Securities Act, oppression under the Ontario Business Corporations Act and common law misrepresentation. The Amended Statement of Claim generally alleges that certain of the Company&#8217;s prior public statements about revenues and internal controls were misrepresentations based on the Company&#8217;s March 2, 2020 disclosure that the Audit Committee of the Board of Directors was conducting a review of the appropriateness of revenue recognized in connection with certain bulk resin purchases and sales of products through the wholesale channel, and the Company&#8217;s subsequent restatement. The Amended Statement of Claim does not quantify a damage request. On June 28, 2021, the Ontario Court dismissed motions brought by the plaintiff for leave to commence a claim for misrepresentation under the Ontario Securities Act and for certification of the action as a class action. The plaintiff appealed the Court&#8217;s dismissal of the motions, except with respect to the former Chief Financial Officer and Chief Commercial Officer, who agreed not to seek costs from plaintiff in connection with the dismissal of the motions</span></div><div style="margin-bottom:6pt;margin-top:6pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">(ii)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%;padding-left:5.8pt">Regulatory reviews relating to restatement</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company has been responding to requests for information from various regulatory authorities relating to its previously disclosed restatement of its financial statements for the first three quarters of 2019. The Company is responding to all such requests for information and cooperating with all regulatory authorities. The Company cannot predict the outcome of any such regulatory review or investigation and it is possible that additional investigations or one or more formal proceedings may be commenced against the Company and its current and former officers and directors in connection with these regulatory reviews and investigations. </span></div><div style="margin-bottom:6pt;margin-top:6pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">(iii)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%;padding-left:3.03pt">Litigation relating to marketing, distribution and sale of products</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On June 16, 2020, an alleged consumer filed a Statement of Claim on behalf of a class in the Court of Queen&#8217;s Bench of Alberta in Alberta, Canada, against the Company and other Canadian cannabis manufacturers and/or distributors. On December 4, 2020, a Third Amended Statement of Claim was filed, which added a second alleged consumer. The Third Amended Statement of Claim alleges claims related to the defendants&#8217; advertised content of cannabinoids in cannabis products for medicinal use on or after June 16, 2010 and cannabis products for adult use on or after October 17, 2018. The Third Amended Statement of Claim seeks a total of C$<ix:nonFraction unitRef="cad" contextRef="i71fed0c557ee4fb3a307e51526e90c95_D20200616-20200616" decimals="-6" format="ixt:numdotdecimal" name="us-gaap:LossContingencyDamagesSoughtValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjkzY2E5YmIwMTc5MjQ3NmZiYjIyNWU1ZDlkZWM4NjlmL3NlYzo5M2NhOWJiMDE3OTI0NzZmYmIyMjVlNWQ5ZGVjODY5Zl81OC9mcmFnOjg2ZmM2YjFiZjYyMDRmNzViNjAyMjE0MWU1MWMyYjU2L3RleHRyZWdpb246ODZmYzZiMWJmNjIwNGY3NWI2MDIyMTQxZTUxYzJiNTZfNDY3NA_88401b7c-75c6-4e7a-af74-8ad9ef9c632b">500</ix:nonFraction> million for breach of contract, compensatory damages, and unjust enrichment or such other amount as may be proven in trial and C$<ix:nonFraction unitRef="cad" contextRef="i71fed0c557ee4fb3a307e51526e90c95_D20200616-20200616" decimals="-6" format="ixt:numdotdecimal" name="cron:LossContingencyPunitiveDamagesSoughtValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjkzY2E5YmIwMTc5MjQ3NmZiYjIyNWU1ZDlkZWM4NjlmL3NlYzo5M2NhOWJiMDE3OTI0NzZmYmIyMjVlNWQ5ZGVjODY5Zl81OC9mcmFnOjg2ZmM2YjFiZjYyMDRmNzViNjAyMjE0MWU1MWMyYjU2L3RleHRyZWdpb246ODZmYzZiMWJmNjIwNGY3NWI2MDIyMTQxZTUxYzJiNTZfNDc5Nw_ef32fc2d-bc61-45c6-8dd8-e1112c7d4098">5</ix:nonFraction> million in punitive damages against each defendant, including the Company. The Third Amended Statement of Claim also seeks interest and costs associated with the action. The Company has not responded to the Third Amended Statement of Claim. </span></div></ix:continuation><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:continuation id="ib1ac27d748544b4c8f63cc7572d4744b">A number of claims, including purported class actions, have been brought in the U.S. against companies engaged in the U.S. hemp business alleging, among other things, violations of state consumer protection, health and advertising laws. On April 8, 2020, a putative class action complaint was filed in the U.S. District Court for the Central District of California against Redwood Holding Group, LLC (&#8220;Redwood&#8221;), alleging violations of California&#8217;s Unfair Competition Law, False Advertising Law, Consumers Legal Remedies Act, and breaches of the California Commercial Code for breach of express warranties and implied warranty of merchantability with respect to Redwood&#8217;s marketing and sale of U.S. hemp products. The complaint did not quantify a damage request. On April 10, 2020, the class action complaint was dismissed for certain pleading deficiencies and the plaintiff was granted leave until April 24, 2020 to amend the complaint to establish federal subject matter jurisdiction. On April 28, 2020, the action was dismissed without prejudice for failure to prosecute and for failure to comply with a court order. As of the date of this Quarterly Report, the plaintiff has not refiled the complaint. The Company expects litigation and regulatory proceedings relating to the marketing, distribution and sale of its products to increase.</ix:continuation> </span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span><br/></span></div><div id="i93ca9bb01792476fbb225e5d9dec869f_61"></div><div style="margin-bottom:12pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">10. <ix:nonNumeric contextRef="i69782326f71a44e3805518280ee22b6b_D20210101-20210630" name="us-gaap:ConcentrationRiskDisclosureTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjkzY2E5YmIwMTc5MjQ3NmZiYjIyNWU1ZDlkZWM4NjlmL3NlYzo5M2NhOWJiMDE3OTI0NzZmYmIyMjVlNWQ5ZGVjODY5Zl82MS9mcmFnOjE3NDk5MWNiMmM0ZjRmM2I4NDJjMzkxZWM3ZGRiZGY1L3RleHRyZWdpb246MTc0OTkxY2IyYzRmNGYzYjg0MmMzOTFlYzdkZGJkZjVfNzczNA_e7401738-a008-4ed0-ae24-f7109fd2a4d2" continuedAt="ie38dd10dfd9e4a6d97f9d9d3daae9703" escape="true">Financial Instruments </ix:nonNumeric></span></div><ix:continuation id="ie38dd10dfd9e4a6d97f9d9d3daae9703" continuedAt="ic011e530329141ec9753c58b01c70c28"><div style="margin-bottom:6pt;margin-top:6pt;padding-left:36pt;text-align:justify;text-indent:-36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(a)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;padding-left:24.34pt">Fair value measurement </span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company complies with ASC 820, Fair Value Measurements, for its financial assets and liabilities that are re-measured and reported at fair value at each reporting period, and non-financial assets and liabilities that are re-measured and reported at fair value at least annually. In general, fair values are determined by:</span></div><div style="margin-bottom:6pt;margin-top:6pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Level 1 inputs utilize quoted prices (unadjusted) in active markets for identical assets or liabilities. </span></div><div style="margin-bottom:6pt;margin-top:6pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Level 2 inputs utilize data points that are observable such as quoted prices, interest rates and yield curves. </span></div><div style="margin-bottom:6pt;margin-top:6pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Level 3 inputs are unobservable data points for the asset or liability, and includes situations where there is little, if any, market activity for the asset or liability.</span></div></ix:continuation><div style="height:36pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">26</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:72pt;width:100%"><div style="margin-top:0.55pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:95.000%"><tr><td style="width:1.0%"></td><td style="width:65.712%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:32.088%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="border-top:1pt solid #FFFFFF;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Cronos Group Inc.</span></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Notes to Condensed Consolidated Financial Statements (Unaudited)</span></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">(In thousands of $, except share amounts)</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i93ca9bb01792476fbb225e5d9dec869f_7">Table of Contents</a></span></div></td></tr></table></div></div><ix:continuation id="ic011e530329141ec9753c58b01c70c28" continuedAt="i03c2b09b9b5740b38a69510e4a99a336"><ix:nonNumeric contextRef="i69782326f71a44e3805518280ee22b6b_D20210101-20210630" name="us-gaap:ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjkzY2E5YmIwMTc5MjQ3NmZiYjIyNWU1ZDlkZWM4NjlmL3NlYzo5M2NhOWJiMDE3OTI0NzZmYmIyMjVlNWQ5ZGVjODY5Zl82MS9mcmFnOjE3NDk5MWNiMmM0ZjRmM2I4NDJjMzkxZWM3ZGRiZGY1L3RleHRyZWdpb246MTc0OTkxY2IyYzRmNGYzYjg0MmMzOTFlYzdkZGJkZjVfNzczNg_c97bc85a-5a92-4862-b2d0-7ae04f40228e" escape="true"><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following tables present information about the Company&#8217;s assets that are measured at fair value on a recurring basis as of June&#160;30, 2021 and December 31, 2020 and indicate the fair value hierarchy of the valuation techniques the Company utilized to determine such fair value.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:45.983%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.983%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:1.327%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.983%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:1.327%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.983%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:1.327%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.987%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="21" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">June&#160;30, 2021</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Level 1</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Level 2</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Level 3</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Total</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cash and cash equivalents</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="icadc14e3a8f749f28ff691fa21d421ea_I20210630" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:CashAndCashEquivalentsFairValueDisclosure" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzY2E5YmIwMTc5MjQ3NmZiYjIyNWU1ZDlkZWM4NjlmL3NlYzo5M2NhOWJiMDE3OTI0NzZmYmIyMjVlNWQ5ZGVjODY5Zl82MS9mcmFnOjE3NDk5MWNiMmM0ZjRmM2I4NDJjMzkxZWM3ZGRiZGY1L3RhYmxlOjc1NmQ2ODFiMGVkNzRlZWU5NzNjNzFhOGQyZGUxODZkL3RhYmxlcmFuZ2U6NzU2ZDY4MWIwZWQ3NGVlZTk3M2M3MWE4ZDJkZTE4NmRfMi0xLTEtMS0w_8b54b5dd-93c1-47c2-9676-7d6a21fe54e2">895,181</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7b21c81f18bd4f52a9977bc7f8edb2bc_I20210630" decimals="-3" format="ixt:zerodash" name="us-gaap:CashAndCashEquivalentsFairValueDisclosure" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzY2E5YmIwMTc5MjQ3NmZiYjIyNWU1ZDlkZWM4NjlmL3NlYzo5M2NhOWJiMDE3OTI0NzZmYmIyMjVlNWQ5ZGVjODY5Zl82MS9mcmFnOjE3NDk5MWNiMmM0ZjRmM2I4NDJjMzkxZWM3ZGRiZGY1L3RhYmxlOjc1NmQ2ODFiMGVkNzRlZWU5NzNjNzFhOGQyZGUxODZkL3RhYmxlcmFuZ2U6NzU2ZDY4MWIwZWQ3NGVlZTk3M2M3MWE4ZDJkZTE4NmRfMi0zLTEtMS0w_81b25ab3-caf2-4640-9275-c2674ef23a5c">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i11247526dfde4bb5bd7e7f7730ae47e9_I20210630" decimals="-3" format="ixt:zerodash" name="us-gaap:CashAndCashEquivalentsFairValueDisclosure" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzY2E5YmIwMTc5MjQ3NmZiYjIyNWU1ZDlkZWM4NjlmL3NlYzo5M2NhOWJiMDE3OTI0NzZmYmIyMjVlNWQ5ZGVjODY5Zl82MS9mcmFnOjE3NDk5MWNiMmM0ZjRmM2I4NDJjMzkxZWM3ZGRiZGY1L3RhYmxlOjc1NmQ2ODFiMGVkNzRlZWU5NzNjNzFhOGQyZGUxODZkL3RhYmxlcmFuZ2U6NzU2ZDY4MWIwZWQ3NGVlZTk3M2M3MWE4ZDJkZTE4NmRfMi01LTEtMS0w_a5b02b63-6dee-41a9-a497-c8e98c10fd47">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5fd10eeb00c74a3fa9afaced11fe7a7d_I20210630" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:CashAndCashEquivalentsFairValueDisclosure" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzY2E5YmIwMTc5MjQ3NmZiYjIyNWU1ZDlkZWM4NjlmL3NlYzo5M2NhOWJiMDE3OTI0NzZmYmIyMjVlNWQ5ZGVjODY5Zl82MS9mcmFnOjE3NDk5MWNiMmM0ZjRmM2I4NDJjMzkxZWM3ZGRiZGY1L3RhYmxlOjc1NmQ2ODFiMGVkNzRlZWU5NzNjNzFhOGQyZGUxODZkL3RhYmxlcmFuZ2U6NzU2ZDY4MWIwZWQ3NGVlZTk3M2M3MWE4ZDJkZTE4NmRfMi03LTEtMS0w_89a572c6-5e4f-46ff-9d3e-4e302a7dd383">895,181</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Short-term investments</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="icadc14e3a8f749f28ff691fa21d421ea_I20210630" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzY2E5YmIwMTc5MjQ3NmZiYjIyNWU1ZDlkZWM4NjlmL3NlYzo5M2NhOWJiMDE3OTI0NzZmYmIyMjVlNWQ5ZGVjODY5Zl82MS9mcmFnOjE3NDk5MWNiMmM0ZjRmM2I4NDJjMzkxZWM3ZGRiZGY1L3RhYmxlOjc1NmQ2ODFiMGVkNzRlZWU5NzNjNzFhOGQyZGUxODZkL3RhYmxlcmFuZ2U6NzU2ZDY4MWIwZWQ3NGVlZTk3M2M3MWE4ZDJkZTE4NmRfMy0xLTEtMS0w_7b114ea7-304c-4764-bc9a-52aed8be7a2a">201,699</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7b21c81f18bd4f52a9977bc7f8edb2bc_I20210630" decimals="-3" format="ixt:zerodash" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzY2E5YmIwMTc5MjQ3NmZiYjIyNWU1ZDlkZWM4NjlmL3NlYzo5M2NhOWJiMDE3OTI0NzZmYmIyMjVlNWQ5ZGVjODY5Zl82MS9mcmFnOjE3NDk5MWNiMmM0ZjRmM2I4NDJjMzkxZWM3ZGRiZGY1L3RhYmxlOjc1NmQ2ODFiMGVkNzRlZWU5NzNjNzFhOGQyZGUxODZkL3RhYmxlcmFuZ2U6NzU2ZDY4MWIwZWQ3NGVlZTk3M2M3MWE4ZDJkZTE4NmRfMy0zLTEtMS0w_ea4f8f75-cb69-490a-8146-99b5e286fcd4">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i11247526dfde4bb5bd7e7f7730ae47e9_I20210630" decimals="-3" format="ixt:zerodash" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzY2E5YmIwMTc5MjQ3NmZiYjIyNWU1ZDlkZWM4NjlmL3NlYzo5M2NhOWJiMDE3OTI0NzZmYmIyMjVlNWQ5ZGVjODY5Zl82MS9mcmFnOjE3NDk5MWNiMmM0ZjRmM2I4NDJjMzkxZWM3ZGRiZGY1L3RhYmxlOjc1NmQ2ODFiMGVkNzRlZWU5NzNjNzFhOGQyZGUxODZkL3RhYmxlcmFuZ2U6NzU2ZDY4MWIwZWQ3NGVlZTk3M2M3MWE4ZDJkZTE4NmRfMy01LTEtMS0w_26cdb429-d320-4e6c-a35b-a94b169027a3">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5fd10eeb00c74a3fa9afaced11fe7a7d_I20210630" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzY2E5YmIwMTc5MjQ3NmZiYjIyNWU1ZDlkZWM4NjlmL3NlYzo5M2NhOWJiMDE3OTI0NzZmYmIyMjVlNWQ5ZGVjODY5Zl82MS9mcmFnOjE3NDk5MWNiMmM0ZjRmM2I4NDJjMzkxZWM3ZGRiZGY1L3RhYmxlOjc1NmQ2ODFiMGVkNzRlZWU5NzNjNzFhOGQyZGUxODZkL3RhYmxlcmFuZ2U6NzU2ZDY4MWIwZWQ3NGVlZTk3M2M3MWE4ZDJkZTE4NmRfMy03LTEtMS0w_07cab8e2-2ce6-4d5a-810f-a7fd5e756705">201,699</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Derivative liabilities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="icadc14e3a8f749f28ff691fa21d421ea_I20210630" decimals="-3" format="ixt:zerodash" name="us-gaap:DerivativeLiabilities" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzY2E5YmIwMTc5MjQ3NmZiYjIyNWU1ZDlkZWM4NjlmL3NlYzo5M2NhOWJiMDE3OTI0NzZmYmIyMjVlNWQ5ZGVjODY5Zl82MS9mcmFnOjE3NDk5MWNiMmM0ZjRmM2I4NDJjMzkxZWM3ZGRiZGY1L3RhYmxlOjc1NmQ2ODFiMGVkNzRlZWU5NzNjNzFhOGQyZGUxODZkL3RhYmxlcmFuZ2U6NzU2ZDY4MWIwZWQ3NGVlZTk3M2M3MWE4ZDJkZTE4NmRfNC0xLTEtMS0w_0c398e06-daae-41f4-a8e2-6d7e254f6bba">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7b21c81f18bd4f52a9977bc7f8edb2bc_I20210630" decimals="-3" format="ixt:zerodash" name="us-gaap:DerivativeLiabilities" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzY2E5YmIwMTc5MjQ3NmZiYjIyNWU1ZDlkZWM4NjlmL3NlYzo5M2NhOWJiMDE3OTI0NzZmYmIyMjVlNWQ5ZGVjODY5Zl82MS9mcmFnOjE3NDk5MWNiMmM0ZjRmM2I4NDJjMzkxZWM3ZGRiZGY1L3RhYmxlOjc1NmQ2ODFiMGVkNzRlZWU5NzNjNzFhOGQyZGUxODZkL3RhYmxlcmFuZ2U6NzU2ZDY4MWIwZWQ3NGVlZTk3M2M3MWE4ZDJkZTE4NmRfNC0zLTEtMS0w_b0d275b7-f6ed-4070-a74f-1402bc0bfa5f">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i11247526dfde4bb5bd7e7f7730ae47e9_I20210630" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:DerivativeLiabilities" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzY2E5YmIwMTc5MjQ3NmZiYjIyNWU1ZDlkZWM4NjlmL3NlYzo5M2NhOWJiMDE3OTI0NzZmYmIyMjVlNWQ5ZGVjODY5Zl82MS9mcmFnOjE3NDk5MWNiMmM0ZjRmM2I4NDJjMzkxZWM3ZGRiZGY1L3RhYmxlOjc1NmQ2ODFiMGVkNzRlZWU5NzNjNzFhOGQyZGUxODZkL3RhYmxlcmFuZ2U6NzU2ZDY4MWIwZWQ3NGVlZTk3M2M3MWE4ZDJkZTE4NmRfNC01LTEtMS0w_1503c0de-807a-45cb-8475-f0d70a5017dd">169,563</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5fd10eeb00c74a3fa9afaced11fe7a7d_I20210630" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:DerivativeLiabilities" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzY2E5YmIwMTc5MjQ3NmZiYjIyNWU1ZDlkZWM4NjlmL3NlYzo5M2NhOWJiMDE3OTI0NzZmYmIyMjVlNWQ5ZGVjODY5Zl82MS9mcmFnOjE3NDk5MWNiMmM0ZjRmM2I4NDJjMzkxZWM3ZGRiZGY1L3RhYmxlOjc1NmQ2ODFiMGVkNzRlZWU5NzNjNzFhOGQyZGUxODZkL3RhYmxlcmFuZ2U6NzU2ZDY4MWIwZWQ3NGVlZTk3M2M3MWE4ZDJkZTE4NmRfNC03LTEtMS0w_4ebb0b29-c3bc-4460-97a2-e424545397cd">169,563</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:45.983%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.983%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:1.327%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.983%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:1.327%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.983%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:1.327%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.987%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="21" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 31, 2020</span></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Level 1</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Level 2</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Level 3</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Total</span></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cash and cash equivalents</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i03fa5c3c8b194478a5f52168419d56f6_I20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:CashAndCashEquivalentsFairValueDisclosure" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzY2E5YmIwMTc5MjQ3NmZiYjIyNWU1ZDlkZWM4NjlmL3NlYzo5M2NhOWJiMDE3OTI0NzZmYmIyMjVlNWQ5ZGVjODY5Zl82MS9mcmFnOjE3NDk5MWNiMmM0ZjRmM2I4NDJjMzkxZWM3ZGRiZGY1L3RhYmxlOjZmNjlhNGYxMDIwZTRlYmNiNmNmMzQyNTQ5M2UzNmQ0L3RhYmxlcmFuZ2U6NmY2OWE0ZjEwMjBlNGViY2I2Y2YzNDI1NDkzZTM2ZDRfMi0xLTEtMS0w_3b936414-e7dd-4805-b33f-c792b725e5b4">1,078,023</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i79b10885dfdb4c659175e617a6ad2106_I20201231" decimals="-3" format="ixt:zerodash" name="us-gaap:CashAndCashEquivalentsFairValueDisclosure" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzY2E5YmIwMTc5MjQ3NmZiYjIyNWU1ZDlkZWM4NjlmL3NlYzo5M2NhOWJiMDE3OTI0NzZmYmIyMjVlNWQ5ZGVjODY5Zl82MS9mcmFnOjE3NDk5MWNiMmM0ZjRmM2I4NDJjMzkxZWM3ZGRiZGY1L3RhYmxlOjZmNjlhNGYxMDIwZTRlYmNiNmNmMzQyNTQ5M2UzNmQ0L3RhYmxlcmFuZ2U6NmY2OWE0ZjEwMjBlNGViY2I2Y2YzNDI1NDkzZTM2ZDRfMi0zLTEtMS0w_7e3de884-ff67-4c47-bd69-daafbde56966">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if1d924d84462412da9f6d321275d484c_I20201231" decimals="-3" format="ixt:zerodash" name="us-gaap:CashAndCashEquivalentsFairValueDisclosure" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzY2E5YmIwMTc5MjQ3NmZiYjIyNWU1ZDlkZWM4NjlmL3NlYzo5M2NhOWJiMDE3OTI0NzZmYmIyMjVlNWQ5ZGVjODY5Zl82MS9mcmFnOjE3NDk5MWNiMmM0ZjRmM2I4NDJjMzkxZWM3ZGRiZGY1L3RhYmxlOjZmNjlhNGYxMDIwZTRlYmNiNmNmMzQyNTQ5M2UzNmQ0L3RhYmxlcmFuZ2U6NmY2OWE0ZjEwMjBlNGViY2I2Y2YzNDI1NDkzZTM2ZDRfMi01LTEtMS0w_e51bb8be-4de4-479b-b781-c30f2f67b320">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3a832b2da99a447594f2d6d56bcc8aa8_I20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:CashAndCashEquivalentsFairValueDisclosure" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzY2E5YmIwMTc5MjQ3NmZiYjIyNWU1ZDlkZWM4NjlmL3NlYzo5M2NhOWJiMDE3OTI0NzZmYmIyMjVlNWQ5ZGVjODY5Zl82MS9mcmFnOjE3NDk5MWNiMmM0ZjRmM2I4NDJjMzkxZWM3ZGRiZGY1L3RhYmxlOjZmNjlhNGYxMDIwZTRlYmNiNmNmMzQyNTQ5M2UzNmQ0L3RhYmxlcmFuZ2U6NmY2OWE0ZjEwMjBlNGViY2I2Y2YzNDI1NDkzZTM2ZDRfMi03LTEtMS0w_c4f3d644-de11-42d6-be4d-c3bcc310b2ab">1,078,023</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Short-term investments</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i03fa5c3c8b194478a5f52168419d56f6_I20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzY2E5YmIwMTc5MjQ3NmZiYjIyNWU1ZDlkZWM4NjlmL3NlYzo5M2NhOWJiMDE3OTI0NzZmYmIyMjVlNWQ5ZGVjODY5Zl82MS9mcmFnOjE3NDk5MWNiMmM0ZjRmM2I4NDJjMzkxZWM3ZGRiZGY1L3RhYmxlOjZmNjlhNGYxMDIwZTRlYmNiNmNmMzQyNTQ5M2UzNmQ0L3RhYmxlcmFuZ2U6NmY2OWE0ZjEwMjBlNGViY2I2Y2YzNDI1NDkzZTM2ZDRfMy0xLTEtMS0w_4978c422-259a-4cfe-97dd-2b074143c52d">211,766</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i79b10885dfdb4c659175e617a6ad2106_I20201231" decimals="-3" format="ixt:zerodash" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzY2E5YmIwMTc5MjQ3NmZiYjIyNWU1ZDlkZWM4NjlmL3NlYzo5M2NhOWJiMDE3OTI0NzZmYmIyMjVlNWQ5ZGVjODY5Zl82MS9mcmFnOjE3NDk5MWNiMmM0ZjRmM2I4NDJjMzkxZWM3ZGRiZGY1L3RhYmxlOjZmNjlhNGYxMDIwZTRlYmNiNmNmMzQyNTQ5M2UzNmQ0L3RhYmxlcmFuZ2U6NmY2OWE0ZjEwMjBlNGViY2I2Y2YzNDI1NDkzZTM2ZDRfMy0zLTEtMS0w_f40994d1-0da6-4ec2-911e-45123aab516e">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if1d924d84462412da9f6d321275d484c_I20201231" decimals="-3" format="ixt:zerodash" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzY2E5YmIwMTc5MjQ3NmZiYjIyNWU1ZDlkZWM4NjlmL3NlYzo5M2NhOWJiMDE3OTI0NzZmYmIyMjVlNWQ5ZGVjODY5Zl82MS9mcmFnOjE3NDk5MWNiMmM0ZjRmM2I4NDJjMzkxZWM3ZGRiZGY1L3RhYmxlOjZmNjlhNGYxMDIwZTRlYmNiNmNmMzQyNTQ5M2UzNmQ0L3RhYmxlcmFuZ2U6NmY2OWE0ZjEwMjBlNGViY2I2Y2YzNDI1NDkzZTM2ZDRfMy01LTEtMS0w_14083911-c046-498e-a93e-8622a70400c7">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3a832b2da99a447594f2d6d56bcc8aa8_I20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzY2E5YmIwMTc5MjQ3NmZiYjIyNWU1ZDlkZWM4NjlmL3NlYzo5M2NhOWJiMDE3OTI0NzZmYmIyMjVlNWQ5ZGVjODY5Zl82MS9mcmFnOjE3NDk5MWNiMmM0ZjRmM2I4NDJjMzkxZWM3ZGRiZGY1L3RhYmxlOjZmNjlhNGYxMDIwZTRlYmNiNmNmMzQyNTQ5M2UzNmQ0L3RhYmxlcmFuZ2U6NmY2OWE0ZjEwMjBlNGViY2I2Y2YzNDI1NDkzZTM2ZDRfMy03LTEtMS0w_6afd8bf7-dc6c-4765-b00d-b9321e42586f">211,766</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Derivative liabilities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i03fa5c3c8b194478a5f52168419d56f6_I20201231" decimals="-3" format="ixt:zerodash" name="us-gaap:DerivativeLiabilities" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzY2E5YmIwMTc5MjQ3NmZiYjIyNWU1ZDlkZWM4NjlmL3NlYzo5M2NhOWJiMDE3OTI0NzZmYmIyMjVlNWQ5ZGVjODY5Zl82MS9mcmFnOjE3NDk5MWNiMmM0ZjRmM2I4NDJjMzkxZWM3ZGRiZGY1L3RhYmxlOjZmNjlhNGYxMDIwZTRlYmNiNmNmMzQyNTQ5M2UzNmQ0L3RhYmxlcmFuZ2U6NmY2OWE0ZjEwMjBlNGViY2I2Y2YzNDI1NDkzZTM2ZDRfNC0xLTEtMS0w_f4d95628-9a67-45aa-acb7-9b24b7a8d705">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i79b10885dfdb4c659175e617a6ad2106_I20201231" decimals="-3" format="ixt:zerodash" name="us-gaap:DerivativeLiabilities" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzY2E5YmIwMTc5MjQ3NmZiYjIyNWU1ZDlkZWM4NjlmL3NlYzo5M2NhOWJiMDE3OTI0NzZmYmIyMjVlNWQ5ZGVjODY5Zl82MS9mcmFnOjE3NDk5MWNiMmM0ZjRmM2I4NDJjMzkxZWM3ZGRiZGY1L3RhYmxlOjZmNjlhNGYxMDIwZTRlYmNiNmNmMzQyNTQ5M2UzNmQ0L3RhYmxlcmFuZ2U6NmY2OWE0ZjEwMjBlNGViY2I2Y2YzNDI1NDkzZTM2ZDRfNC0zLTEtMS0w_b44634ca-9432-45ec-85b5-02b50650812f">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if1d924d84462412da9f6d321275d484c_I20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:DerivativeLiabilities" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzY2E5YmIwMTc5MjQ3NmZiYjIyNWU1ZDlkZWM4NjlmL3NlYzo5M2NhOWJiMDE3OTI0NzZmYmIyMjVlNWQ5ZGVjODY5Zl82MS9mcmFnOjE3NDk5MWNiMmM0ZjRmM2I4NDJjMzkxZWM3ZGRiZGY1L3RhYmxlOjZmNjlhNGYxMDIwZTRlYmNiNmNmMzQyNTQ5M2UzNmQ0L3RhYmxlcmFuZ2U6NmY2OWE0ZjEwMjBlNGViY2I2Y2YzNDI1NDkzZTM2ZDRfNC01LTEtMS0w_c113bb6e-3945-4e4a-9819-83234f9676ed">163,410</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3a832b2da99a447594f2d6d56bcc8aa8_I20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:DerivativeLiabilities" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzY2E5YmIwMTc5MjQ3NmZiYjIyNWU1ZDlkZWM4NjlmL3NlYzo5M2NhOWJiMDE3OTI0NzZmYmIyMjVlNWQ5ZGVjODY5Zl82MS9mcmFnOjE3NDk5MWNiMmM0ZjRmM2I4NDJjMzkxZWM3ZGRiZGY1L3RhYmxlOjZmNjlhNGYxMDIwZTRlYmNiNmNmMzQyNTQ5M2UzNmQ0L3RhYmxlcmFuZ2U6NmY2OWE0ZjEwMjBlNGViY2I2Y2YzNDI1NDkzZTM2ZDRfNC03LTEtMS0w_7950ef78-5082-48ca-9334-01d11f33cd40">163,410</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td></tr></table></div></ix:nonNumeric><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">There were no transfers between categories during the periods presented.</span></div><div style="margin-bottom:6pt;margin-top:6pt;padding-left:36pt;text-align:justify;text-indent:-36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(b)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;padding-left:23.78pt">Financial risks</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company&#8217;s activities expose it to a variety of financial risks, including credit risk, market risk, interest rate risk, liquidity risk, and foreign currency rate risk.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">(i)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%;padding-left:26.57pt">Credit risk</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Credit risk is the risk of financial loss to the Company if a customer or counterparty to a financial instrument fails to meet its contractual obligations. The Company is exposed to credit risk from its operating activities, primarily accounts receivable and other receivables, and its investing activities, including cash held with banks and financial institutions, short-term investments, loans receivable, and advances to joint ventures. The Company&#8217;s maximum exposure to this risk is equal to the carrying amount of these financial assets, which amounted to $<ix:nonFraction unitRef="usd" contextRef="i69782326f71a44e3805518280ee22b6b_D20210101-20210630" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:ConcentrationRiskCreditRiskFinancialInstrumentMaximumExposure" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzY2E5YmIwMTc5MjQ3NmZiYjIyNWU1ZDlkZWM4NjlmL3NlYzo5M2NhOWJiMDE3OTI0NzZmYmIyMjVlNWQ5ZGVjODY5Zl82MS9mcmFnOjE3NDk5MWNiMmM0ZjRmM2I4NDJjMzkxZWM3ZGRiZGY1L3RleHRyZWdpb246MTc0OTkxY2IyYzRmNGYzYjg0MmMzOTFlYzdkZGJkZjVfMTg2NQ_9598ec73-6e98-41df-9836-2f5a9e83d14d">1,210,287</ix:nonFraction> and $<ix:nonFraction unitRef="usd" contextRef="i539631cd7950486e81b39a054a00c7d0_D20200101-20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:ConcentrationRiskCreditRiskFinancialInstrumentMaximumExposure" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzY2E5YmIwMTc5MjQ3NmZiYjIyNWU1ZDlkZWM4NjlmL3NlYzo5M2NhOWJiMDE3OTI0NzZmYmIyMjVlNWQ5ZGVjODY5Zl82MS9mcmFnOjE3NDk5MWNiMmM0ZjRmM2I4NDJjMzkxZWM3ZGRiZGY1L3RleHRyZWdpb246MTc0OTkxY2IyYzRmNGYzYjg0MmMzOTFlYzdkZGJkZjVfMTg3Mg_2574ae69-d093-47cf-9895-8c62aa48e634">1,403,491</ix:nonFraction> as of June&#160;30, 2021 and December 31, 2020, respectively.</span></div><div style="margin-bottom:6pt;margin-top:6pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">(a)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:120%;padding-left:6.34pt">C</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">ash and cash equivalents, short-term investments, and other receivables</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company held cash and cash equivalents and short-term investments and related interest receivable. Short-term investments and related interest receivable represents short-term investments with a maturity of less than a year and accrued interest as of period end. The cash and cash equivalents and short-term investments, including guaranteed investment certificates and bankers&#8217; acceptances, are held with central banks and financial institutions that are highly rated. In addition to interest receivable, other receivables include sales taxes receivable from the government. As such, the Company has assessed an insignificant loss allowance on these financial instruments. </span></div><div style="margin-bottom:6pt;margin-top:6pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">(b)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;padding-left:6.34pt">Accounts receivable</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">An impairment analysis is performed at each reporting date using a provision matrix to measure expected credit losses. The provision rates are based on the days past due for groupings of various customer segments with similar loss patterns. The calculation reflects the probability-weighted outcome, the time value of money and reasonable and supportable information that is available at the reporting date about past events, current conditions and forecasts of future economic conditions. Accounts receivable are written off when there is no reasonable expectation of recovery. Indicators that there is no reasonable expectation of recovery include, among others, the failure of a debtor to engage in a repayment plan and a failure to make contractual payments for a period of greater than <ix:nonNumeric contextRef="i225f85e38faa4bbdb4de1d8b9cf369bb_I20210630" format="ixt-sec:durday" name="us-gaap:AccountsReceivableNoncurrentThresholdPeriodPastDueWriteoff" id="id3VybDovL2RvY3MudjEvZG9jOjkzY2E5YmIwMTc5MjQ3NmZiYjIyNWU1ZDlkZWM4NjlmL3NlYzo5M2NhOWJiMDE3OTI0NzZmYmIyMjVlNWQ5ZGVjODY5Zl82MS9mcmFnOjE3NDk5MWNiMmM0ZjRmM2I4NDJjMzkxZWM3ZGRiZGY1L3RleHRyZWdpb246MTc0OTkxY2IyYzRmNGYzYjg0MmMzOTFlYzdkZGJkZjVfMzUyMA_8b83ec1d-c82e-45b4-8a74-ad210fc2eaf8">120</ix:nonNumeric> days past due. As of June&#160;30, 2021 and December 31, 2020, the Company had an allowance for credit losses of $<ix:nonFraction unitRef="usd" contextRef="i225f85e38faa4bbdb4de1d8b9cf369bb_I20210630" decimals="-3" name="us-gaap:AllowanceForDoubtfulAccountsReceivableCurrent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzY2E5YmIwMTc5MjQ3NmZiYjIyNWU1ZDlkZWM4NjlmL3NlYzo5M2NhOWJiMDE3OTI0NzZmYmIyMjVlNWQ5ZGVjODY5Zl82MS9mcmFnOjE3NDk5MWNiMmM0ZjRmM2I4NDJjMzkxZWM3ZGRiZGY1L3RleHRyZWdpb246MTc0OTkxY2IyYzRmNGYzYjg0MmMzOTFlYzdkZGJkZjVfNDk0NzgwMjMzNTc0Mg_8724b485-884d-4535-a0c8-c9f74a1c662a">264</ix:nonFraction> and $<ix:nonFraction unitRef="usd" contextRef="ifbe16ec51ea244519b77d6036b4ef038_I20201231" decimals="-3" name="us-gaap:AllowanceForDoubtfulAccountsReceivableCurrent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzY2E5YmIwMTc5MjQ3NmZiYjIyNWU1ZDlkZWM4NjlmL3NlYzo5M2NhOWJiMDE3OTI0NzZmYmIyMjVlNWQ5ZGVjODY5Zl82MS9mcmFnOjE3NDk5MWNiMmM0ZjRmM2I4NDJjMzkxZWM3ZGRiZGY1L3RleHRyZWdpb246MTc0OTkxY2IyYzRmNGYzYjg0MmMzOTFlYzdkZGJkZjVfNDk0NzgwMjMzNTc0Ng_bcda2e9d-6d9b-4d5e-8167-0abab21f5ff3">74</ix:nonFraction>, respectively.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As of June&#160;30, 2021, the Company has assessed that there is a concentration of credit risk, as <ix:nonFraction unitRef="number" contextRef="i174d8021b6e348aeb60958d0fc273001_D20210101-20210630" decimals="2" name="us-gaap:ConcentrationRiskPercentage1" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjkzY2E5YmIwMTc5MjQ3NmZiYjIyNWU1ZDlkZWM4NjlmL3NlYzo5M2NhOWJiMDE3OTI0NzZmYmIyMjVlNWQ5ZGVjODY5Zl82MS9mcmFnOjE3NDk5MWNiMmM0ZjRmM2I4NDJjMzkxZWM3ZGRiZGY1L3RleHRyZWdpb246MTc0OTkxY2IyYzRmNGYzYjg0MmMzOTFlYzdkZGJkZjVfMzczOA_f2a38f29-dc0e-4c59-b35d-d366dab79ee9">74</ix:nonFraction>% of the Company&#8217;s accounts receivable were due from four customers with an established credit history with the Company. As of December 31, 2020, <ix:nonFraction unitRef="number" contextRef="i22724e38ce2a43488a65f8a806950144_D20200101-20201231" decimals="2" name="us-gaap:ConcentrationRiskPercentage1" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjkzY2E5YmIwMTc5MjQ3NmZiYjIyNWU1ZDlkZWM4NjlmL3NlYzo5M2NhOWJiMDE3OTI0NzZmYmIyMjVlNWQ5ZGVjODY5Zl82MS9mcmFnOjE3NDk5MWNiMmM0ZjRmM2I4NDJjMzkxZWM3ZGRiZGY1L3RleHRyZWdpb246MTc0OTkxY2IyYzRmNGYzYjg0MmMzOTFlYzdkZGJkZjVfMzg3MQ_fb83ad79-ef2e-42f6-98fc-e2b50b66785a">78</ix:nonFraction>% of the Company&#8217;s accounts receivable were due from four customers with an established credit history with the Company.</span></div></ix:continuation><div style="height:36pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">27</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:72pt;width:100%"><div style="margin-top:0.55pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:95.000%"><tr><td style="width:1.0%"></td><td style="width:65.712%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:32.088%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="border-top:1pt solid #FFFFFF;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Cronos Group Inc.</span></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Notes to Condensed Consolidated Financial Statements (Unaudited)</span></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">(In thousands of $, except share amounts)</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i93ca9bb01792476fbb225e5d9dec869f_7">Table of Contents</a></span></div></td></tr></table></div></div><ix:continuation id="i03c2b09b9b5740b38a69510e4a99a336"><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">(ii)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%;padding-left:23.8pt">Market risk</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Market risk is the risk that the fair value of, or future cash flows from, the Company&#8217;s financial instruments will significantly fluctuate due to changes in market prices. The value of financial instruments can be affected by changes in interest rates, market and economic conditions, and equity and commodity prices. The Company is exposed to market risk in divesting its investments, such that unfavorable market conditions could result in dispositions of investments at less than their carrying values. Further, the revaluation of securities classified as fair value through net income could result in significant write-downs of the Company&#8217;s investments, which would have an adverse impact on the Company&#8217;s financial position, unless these would flow through other comprehensive income.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company manages market risk by having a portfolio of securities from multiple issuers so that the Company is not materially exposed to any one issuer.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">(iii)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%;padding-left:21.03pt">Interest rate risk</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Interest rate risk is the risk that the value or yield of fixed-income investments may decline if interest rates change. Fluctuations in interest rates may impact the level of income and expense recorded on the cash equivalents and short-term investments, and the market value of all interest-earning assets, other than those which possess a short-term to maturity. A 10% change in the interest rate in effect on June&#160;30, 2021 and December 31, 2020 would not have a material effect on (i) fair value of the cash equivalents and short-term investments as the majority of the portfolio has a maturity date of three months or less or (ii) interest income. Management continues to monitor external interest rates and revise the Company&#8217;s investment strategy as a result. </span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">During the three months ended June&#160;30, 2021 and 2020, the Company recorded net interest income of $<ix:nonFraction unitRef="usd" contextRef="i27f4e53b91ad4367b7f8d273eff27769_D20210401-20210630" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:InterestIncomeExpenseNonoperatingNet" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzY2E5YmIwMTc5MjQ3NmZiYjIyNWU1ZDlkZWM4NjlmL3NlYzo5M2NhOWJiMDE3OTI0NzZmYmIyMjVlNWQ5ZGVjODY5Zl82MS9mcmFnOjE3NDk5MWNiMmM0ZjRmM2I4NDJjMzkxZWM3ZGRiZGY1L3RleHRyZWdpb246MTc0OTkxY2IyYzRmNGYzYjg0MmMzOTFlYzdkZGJkZjVfNDk0NzgwMjMzMzI1MA_64e0fa86-15f4-4ccc-a153-6c6277a01829">2,293</ix:nonFraction> and $<ix:nonFraction unitRef="usd" contextRef="i39065c5daf934af885335c12f3cfa83f_D20200401-20200630" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:InterestIncomeExpenseNonoperatingNet" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzY2E5YmIwMTc5MjQ3NmZiYjIyNWU1ZDlkZWM4NjlmL3NlYzo5M2NhOWJiMDE3OTI0NzZmYmIyMjVlNWQ5ZGVjODY5Zl82MS9mcmFnOjE3NDk5MWNiMmM0ZjRmM2I4NDJjMzkxZWM3ZGRiZGY1L3RleHRyZWdpb246MTc0OTkxY2IyYzRmNGYzYjg0MmMzOTFlYzdkZGJkZjVfNDk0NzgwMjMzMzI4OQ_e3fe6635-8f81-41fd-ac77-ad3f918c36ec">3,734</ix:nonFraction>, respectively. During the six months ended June&#160;30, 2021 and 2020, the Company recorded net interest income of $<ix:nonFraction unitRef="usd" contextRef="i69782326f71a44e3805518280ee22b6b_D20210101-20210630" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:InterestIncomeExpenseNonoperatingNet" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzY2E5YmIwMTc5MjQ3NmZiYjIyNWU1ZDlkZWM4NjlmL3NlYzo5M2NhOWJiMDE3OTI0NzZmYmIyMjVlNWQ5ZGVjODY5Zl82MS9mcmFnOjE3NDk5MWNiMmM0ZjRmM2I4NDJjMzkxZWM3ZGRiZGY1L3RleHRyZWdpb246MTc0OTkxY2IyYzRmNGYzYjg0MmMzOTFlYzdkZGJkZjVfNTc2NA_740dc3f1-ce94-403b-a17d-2bf316a4ac3e">4,622</ix:nonFraction> and $<ix:nonFraction unitRef="usd" contextRef="i4a110e4972ef4113880ce582e3cda5c5_D20200101-20200630" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:InterestIncomeExpenseNonoperatingNet" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzY2E5YmIwMTc5MjQ3NmZiYjIyNWU1ZDlkZWM4NjlmL3NlYzo5M2NhOWJiMDE3OTI0NzZmYmIyMjVlNWQ5ZGVjODY5Zl82MS9mcmFnOjE3NDk5MWNiMmM0ZjRmM2I4NDJjMzkxZWM3ZGRiZGY1L3RleHRyZWdpb246MTc0OTkxY2IyYzRmNGYzYjg0MmMzOTFlYzdkZGJkZjVfNTc3MQ_6a1e1973-b886-4749-a9db-d7ea7af34f4f">11,485</ix:nonFraction>, respectively.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">(iv)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%;padding-left:22.14pt">Liquidity risk</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Liquidity risk is the risk that the Company will not be able to meet its financial obligations as they become due and arises principally from the Company&#8217;s accounts payable and other liabilities. The Company&#8217;s policy is to review liquidity resources and ensure that sufficient funds are available to meet financial obligations as they become due. Further, the Company&#8217;s management is responsible for ensuring funds exist and are readily accessible to support business opportunities as they arise. The Company&#8217;s funding was primarily provided in the form of capital raised through the issuance of common shares and warrants. As of June&#160;30, 2021, the Company had assessed a concentration risk of vendors as <ix:nonFraction unitRef="number" contextRef="ic32bc3c69d7c4dd0a165d3622a127739_D20210101-20210630" decimals="2" name="us-gaap:ConcentrationRiskPercentage1" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjkzY2E5YmIwMTc5MjQ3NmZiYjIyNWU1ZDlkZWM4NjlmL3NlYzo5M2NhOWJiMDE3OTI0NzZmYmIyMjVlNWQ5ZGVjODY5Zl82MS9mcmFnOjE3NDk5MWNiMmM0ZjRmM2I4NDJjMzkxZWM3ZGRiZGY1L3RleHRyZWdpb246MTc0OTkxY2IyYzRmNGYzYjg0MmMzOTFlYzdkZGJkZjVfNjUwMg_160cdbf3-a318-47dc-a62f-d5727a5a8cef">32</ix:nonFraction>% of accounts payables were due to one vendor. As of December 31, 2020, the Company had assessed a concentration risk of vendors as <ix:nonFraction unitRef="number" contextRef="ib0cf8aff30b04aaebfad1c5a5bfc4c6c_D20200101-20201231" decimals="2" name="us-gaap:ConcentrationRiskPercentage1" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjkzY2E5YmIwMTc5MjQ3NmZiYjIyNWU1ZDlkZWM4NjlmL3NlYzo5M2NhOWJiMDE3OTI0NzZmYmIyMjVlNWQ5ZGVjODY5Zl82MS9mcmFnOjE3NDk5MWNiMmM0ZjRmM2I4NDJjMzkxZWM3ZGRiZGY1L3RleHRyZWdpb246MTc0OTkxY2IyYzRmNGYzYjg0MmMzOTFlYzdkZGJkZjVfNjYyMw_3cc3293a-cd2d-4a7b-b3bf-fa927d57c705">64</ix:nonFraction>% due to four vendors.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">(v)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%;padding-left:24.91pt">Foreign currency risk</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Currency rate risk is the risk that the fair value of, or future cash flows from, the Company&#8217;s financial instruments will significantly fluctuate due to changes in foreign exchange rates. The Company is exposed to this risk on investments in equity investees denominated in dollars, A$ and C$, and other assets and liabilities denominated in A$ and C$. The Company is further exposed to this risk through subsidiaries operating in Israel and the U.S. as the Company&#8217;s functional currency is in Canadian dollars. The Company does not currently use foreign exchange contracts to hedge its exposure to currency rate risk. As such, the Company&#8217;s financial position and financial results may be adversely affected by the unfavorable fluctuations in currency exchange rates. </span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">During the three months ended June&#160;30, 2021 and 2020, the Company had foreign currency gain on translation of $<ix:nonFraction unitRef="usd" contextRef="i27f4e53b91ad4367b7f8d273eff27769_D20210401-20210630" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzY2E5YmIwMTc5MjQ3NmZiYjIyNWU1ZDlkZWM4NjlmL3NlYzo5M2NhOWJiMDE3OTI0NzZmYmIyMjVlNWQ5ZGVjODY5Zl82MS9mcmFnOjE3NDk5MWNiMmM0ZjRmM2I4NDJjMzkxZWM3ZGRiZGY1L3RleHRyZWdpb246MTc0OTkxY2IyYzRmNGYzYjg0MmMzOTFlYzdkZGJkZjVfNDk0NzgwMjMzMjk0NQ_90ff8133-880e-4e5b-900e-6ae263acb252">13,470</ix:nonFraction> and $<ix:nonFraction unitRef="usd" contextRef="i39065c5daf934af885335c12f3cfa83f_D20200401-20200630" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzY2E5YmIwMTc5MjQ3NmZiYjIyNWU1ZDlkZWM4NjlmL3NlYzo5M2NhOWJiMDE3OTI0NzZmYmIyMjVlNWQ5ZGVjODY5Zl82MS9mcmFnOjE3NDk5MWNiMmM0ZjRmM2I4NDJjMzkxZWM3ZGRiZGY1L3RleHRyZWdpb246MTc0OTkxY2IyYzRmNGYzYjg0MmMzOTFlYzdkZGJkZjVfNDk0NzgwMjMzMzEzNQ_32358be9-d812-4334-af9a-d534c93cbdba">51,871</ix:nonFraction>, respectively. During the six months ended June&#160;30, 2021 and 2020, the Company had foreign currency gain (loss) on translation of $<ix:nonFraction unitRef="usd" contextRef="i69782326f71a44e3805518280ee22b6b_D20210101-20210630" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzY2E5YmIwMTc5MjQ3NmZiYjIyNWU1ZDlkZWM4NjlmL3NlYzo5M2NhOWJiMDE3OTI0NzZmYmIyMjVlNWQ5ZGVjODY5Zl82MS9mcmFnOjE3NDk5MWNiMmM0ZjRmM2I4NDJjMzkxZWM3ZGRiZGY1L3RleHRyZWdpb246MTc0OTkxY2IyYzRmNGYzYjg0MmMzOTFlYzdkZGJkZjVfNDk0NzgwMjMzMzA5Nw_85085618-f3ec-4b74-9704-06e206d07c24">29,754</ix:nonFraction> and $(<ix:nonFraction unitRef="usd" contextRef="i4a110e4972ef4113880ce582e3cda5c5_D20200101-20200630" decimals="-3" sign="-" format="ixt:numdotdecimal" name="us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzY2E5YmIwMTc5MjQ3NmZiYjIyNWU1ZDlkZWM4NjlmL3NlYzo5M2NhOWJiMDE3OTI0NzZmYmIyMjVlNWQ5ZGVjODY5Zl82MS9mcmFnOjE3NDk5MWNiMmM0ZjRmM2I4NDJjMzkxZWM3ZGRiZGY1L3RleHRyZWdpb246MTc0OTkxY2IyYzRmNGYzYjg0MmMzOTFlYzdkZGJkZjVfNDk0NzgwMjMzMzEyMw_2e6ba7c8-3a43-48b7-bc33-1a6f1aa91458">61,821</ix:nonFraction>), respectively. A 10% change in the exchange rates for the U.S. dollar would affect the carrying value of net assets by approximately $<ix:nonFraction unitRef="usd" contextRef="i225f85e38faa4bbdb4de1d8b9cf369bb_I20210630" decimals="-3" format="ixt:numdotdecimal" name="cron:SensitivityAnalysisOfCarryingValueNetAssetsImpactOf10PercentChangeInExchangeRate" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzY2E5YmIwMTc5MjQ3NmZiYjIyNWU1ZDlkZWM4NjlmL3NlYzo5M2NhOWJiMDE3OTI0NzZmYmIyMjVlNWQ5ZGVjODY5Zl82MS9mcmFnOjE3NDk5MWNiMmM0ZjRmM2I4NDJjMzkxZWM3ZGRiZGY1L3RleHRyZWdpb246MTc0OTkxY2IyYzRmNGYzYjg0MmMzOTFlYzdkZGJkZjVfNzY4OA_d56eb1bd-bd86-431e-bdee-6675515e2031">162,991</ix:nonFraction> and $<ix:nonFraction unitRef="usd" contextRef="ifbe16ec51ea244519b77d6036b4ef038_I20201231" decimals="-3" format="ixt:numdotdecimal" name="cron:SensitivityAnalysisOfCarryingValueNetAssetsImpactOf10PercentChangeInExchangeRate" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzY2E5YmIwMTc5MjQ3NmZiYjIyNWU1ZDlkZWM4NjlmL3NlYzo5M2NhOWJiMDE3OTI0NzZmYmIyMjVlNWQ5ZGVjODY5Zl82MS9mcmFnOjE3NDk5MWNiMmM0ZjRmM2I4NDJjMzkxZWM3ZGRiZGY1L3RleHRyZWdpb246MTc0OTkxY2IyYzRmNGYzYjg0MmMzOTFlYzdkZGJkZjVfNzY5NQ_b4f58b00-43e2-4a77-99d3-23cff531f6c1">170,817</ix:nonFraction> as of June&#160;30, 2021 and December 31, 2020, respectively.</span></div></ix:continuation><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span><br/></span></div><div id="i93ca9bb01792476fbb225e5d9dec869f_64"></div><div style="margin-bottom:12pt;margin-top:6pt;padding-left:29.25pt;text-align:justify;text-indent:-27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">11. <ix:nonNumeric contextRef="i69782326f71a44e3805518280ee22b6b_D20210101-20210630" name="us-gaap:DisposalGroupsIncludingDiscontinuedOperationsDisclosureTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjkzY2E5YmIwMTc5MjQ3NmZiYjIyNWU1ZDlkZWM4NjlmL3NlYzo5M2NhOWJiMDE3OTI0NzZmYmIyMjVlNWQ5ZGVjODY5Zl82NC9mcmFnOjhlNjI5OTI1ODgxNTQ1M2E4NWZjOGM0NTY4Nzc5ZWFlL3RleHRyZWdpb246OGU2Mjk5MjU4ODE1NDUzYTg1ZmM4YzQ1Njg3NzllYWVfMTI5MQ_0af8d67e-a4d1-42cc-ba93-aae1742a3530" continuedAt="id3b0b5e6cbb64956ae6a885dfb8a7969" escape="true">Held-For-Sale Assets and Discontinued Operations</ix:nonNumeric></span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:continuation id="id3b0b5e6cbb64956ae6a885dfb8a7969" continuedAt="i6d1a28b1a3014b3cad26dce48062002a">During the year ended December 31, 2020, the Company advanced its plans for the sale and disposal of substantially all of the assets of OGBC and as a result, OGBC&#8217;s results of operations were reclassified as discontinued operations in the accompanying condensed consolidated financial statements for all periods presented. During the quarter ended June 30, 2021, the Company determined that the fair value of OGBC was lower than the carrying value of the assets. As such, a write-down to these held-for-sale assets of $<ix:nonFraction unitRef="usd" contextRef="i904d87a0584944d792e0d8b1355a0053_D20210401-20210630" decimals="-3" name="us-gaap:ImpairmentOfLongLivedAssetsToBeDisposedOf" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzY2E5YmIwMTc5MjQ3NmZiYjIyNWU1ZDlkZWM4NjlmL3NlYzo5M2NhOWJiMDE3OTI0NzZmYmIyMjVlNWQ5ZGVjODY5Zl82NC9mcmFnOjhlNjI5OTI1ODgxNTQ1M2E4NWZjOGM0NTY4Nzc5ZWFlL3RleHRyZWdpb246OGU2Mjk5MjU4ODE1NDUzYTg1ZmM4YzQ1Njg3NzllYWVfMzI5ODUzNDg4OTQyOA_0ee52be7-f21c-4728-94cc-7be788ed5a5c">561</ix:nonFraction> was recorded in the second quarter of 2021. As of June&#160;30, 2021, the assets and liabilities of OGBC continue to meet the definition of discontinued operations and are included as &#8220;held-for-sale&#8221; assets on the condensed consolidated balance sheet as of June&#160;30, 2021 and December 31, 2020, and loss from discontinued operations on the condensed consolidated statements of net income and comprehensive income for the three and six months ended June&#160;30, 2021 and 2020. </ix:continuation></span></div><div style="height:36pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">28</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:72pt;width:100%"><div style="margin-top:0.55pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:95.000%"><tr><td style="width:1.0%"></td><td style="width:65.712%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:32.088%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="border-top:1pt solid #FFFFFF;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Cronos Group Inc.</span></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Notes to Condensed Consolidated Financial Statements (Unaudited)</span></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">(In thousands of $, except share amounts)</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i93ca9bb01792476fbb225e5d9dec869f_7">Table of Contents</a></span></div></td></tr></table></div></div><ix:continuation id="i6d1a28b1a3014b3cad26dce48062002a"><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On June 10, 2021, the land and office building located in Winnipeg, Manitoba Canada, previously designated as held-for-sale in the first quarter of 2021, was sold for $<ix:nonFraction unitRef="usd" contextRef="iecddccc2866d472bbb7974d5d612f613_D20210401-20210630" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:ProceedsFromSaleOfPropertyHeldForSale" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzY2E5YmIwMTc5MjQ3NmZiYjIyNWU1ZDlkZWM4NjlmL3NlYzo5M2NhOWJiMDE3OTI0NzZmYmIyMjVlNWQ5ZGVjODY5Zl82NC9mcmFnOjhlNjI5OTI1ODgxNTQ1M2E4NWZjOGM0NTY4Nzc5ZWFlL3RleHRyZWdpb246OGU2Mjk5MjU4ODE1NDUzYTg1ZmM4YzQ1Njg3NzllYWVfMjE5OTAyMzI1OTIzOA_25900e3a-737f-4d51-99f0-2d429805141e">2,059</ix:nonFraction>, net of costs to sell. As a result, the Company recorded a gain on the sale of $<ix:nonFraction unitRef="usd" contextRef="iecddccc2866d472bbb7974d5d612f613_D20210401-20210630" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:DisposalGroupNotDiscontinuedOperationGainLossOnDisposal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzY2E5YmIwMTc5MjQ3NmZiYjIyNWU1ZDlkZWM4NjlmL3NlYzo5M2NhOWJiMDE3OTI0NzZmYmIyMjVlNWQ5ZGVjODY5Zl82NC9mcmFnOjhlNjI5OTI1ODgxNTQ1M2E4NWZjOGM0NTY4Nzc5ZWFlL3RleHRyZWdpb246OGU2Mjk5MjU4ODE1NDUzYTg1ZmM4YzQ1Njg3NzllYWVfMjE5OTAyMzI1OTI2Nw_63e8d548-5d39-4512-a9ea-9185524eb317">1,279</ix:nonFraction> in other, net in its condensed consolidated income statement for the three and six months ended June 30, 2021.</span></div><ix:nonNumeric contextRef="i69782326f71a44e3805518280ee22b6b_D20210101-20210630" name="us-gaap:ScheduleOfDisposalGroupsIncludingDiscontinuedOperationsIncomeStatementBalanceSheetAndAdditionalDisclosuresTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjkzY2E5YmIwMTc5MjQ3NmZiYjIyNWU1ZDlkZWM4NjlmL3NlYzo5M2NhOWJiMDE3OTI0NzZmYmIyMjVlNWQ5ZGVjODY5Zl82NC9mcmFnOjhlNjI5OTI1ODgxNTQ1M2E4NWZjOGM0NTY4Nzc5ZWFlL3RleHRyZWdpb246OGU2Mjk5MjU4ODE1NDUzYTg1ZmM4YzQ1Njg3NzllYWVfMTI5MA_6efd5daa-210a-41cb-b95d-734c9fd2340d" escape="true"><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table summarizes the financial information for discontinued operations:</span><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:41.261%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.911%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td style="width:1.0%"></td><td style="width:11.816%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:1.327%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.816%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:1.605%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.816%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:1.327%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.821%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="9" style="border-bottom:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Three months ended June 30,</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="border-bottom:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Six months ended June 30,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Loss from discontinued operations, net of income taxes</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i904d87a0584944d792e0d8b1355a0053_D20210401-20210630" decimals="-3" sign="-" name="us-gaap:DiscontinuedOperationIncomeLossFromDiscontinuedOperationDuringPhaseOutPeriodNetOfTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzY2E5YmIwMTc5MjQ3NmZiYjIyNWU1ZDlkZWM4NjlmL3NlYzo5M2NhOWJiMDE3OTI0NzZmYmIyMjVlNWQ5ZGVjODY5Zl82NC9mcmFnOjhlNjI5OTI1ODgxNTQ1M2E4NWZjOGM0NTY4Nzc5ZWFlL3RhYmxlOjBhODRmMDc3MDYzYjQwZTFiZjI5YjljOTM3NzkxZjA4L3RhYmxlcmFuZ2U6MGE4NGYwNzcwNjNiNDBlMWJmMjliOWM5Mzc3OTFmMDhfMi0xMC0xLTEtMA_056aaafb-0916-4abd-8351-11e1fa5b64fe">561</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i64c6418b6b224c7487942cebd8660eef_D20200401-20200630" decimals="-3" sign="-" name="us-gaap:DiscontinuedOperationIncomeLossFromDiscontinuedOperationDuringPhaseOutPeriodNetOfTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzY2E5YmIwMTc5MjQ3NmZiYjIyNWU1ZDlkZWM4NjlmL3NlYzo5M2NhOWJiMDE3OTI0NzZmYmIyMjVlNWQ5ZGVjODY5Zl82NC9mcmFnOjhlNjI5OTI1ODgxNTQ1M2E4NWZjOGM0NTY4Nzc5ZWFlL3RhYmxlOjBhODRmMDc3MDYzYjQwZTFiZjI5YjljOTM3NzkxZjA4L3RhYmxlcmFuZ2U6MGE4NGYwNzcwNjNiNDBlMWJmMjliOWM5Mzc3OTFmMDhfMi0xMi0xLTEtMA_dd4ba73c-96b3-4f79-8bf4-7ec8bb7d1559">46</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i3a272e0b276a4cb1891236e443ba6b9f_D20210101-20210630" decimals="-3" sign="-" name="us-gaap:DiscontinuedOperationIncomeLossFromDiscontinuedOperationDuringPhaseOutPeriodNetOfTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzY2E5YmIwMTc5MjQ3NmZiYjIyNWU1ZDlkZWM4NjlmL3NlYzo5M2NhOWJiMDE3OTI0NzZmYmIyMjVlNWQ5ZGVjODY5Zl82NC9mcmFnOjhlNjI5OTI1ODgxNTQ1M2E4NWZjOGM0NTY4Nzc5ZWFlL3RhYmxlOjBhODRmMDc3MDYzYjQwZTFiZjI5YjljOTM3NzkxZjA4L3RhYmxlcmFuZ2U6MGE4NGYwNzcwNjNiNDBlMWJmMjliOWM5Mzc3OTFmMDhfMi0xNC0xLTEtMA_ee5c582d-8328-41b6-8770-c603a6ee2770">582</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i199e66625a3f4900991433f926302578_D20200101-20200630" decimals="-3" sign="-" name="us-gaap:DiscontinuedOperationIncomeLossFromDiscontinuedOperationDuringPhaseOutPeriodNetOfTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzY2E5YmIwMTc5MjQ3NmZiYjIyNWU1ZDlkZWM4NjlmL3NlYzo5M2NhOWJiMDE3OTI0NzZmYmIyMjVlNWQ5ZGVjODY5Zl82NC9mcmFnOjhlNjI5OTI1ODgxNTQ1M2E4NWZjOGM0NTY4Nzc5ZWFlL3RhYmxlOjBhODRmMDc3MDYzYjQwZTFiZjI5YjljOTM3NzkxZjA4L3RhYmxlcmFuZ2U6MGE4NGYwNzcwNjNiNDBlMWJmMjliOWM5Mzc3OTFmMDhfMi0xNi0xLTEtMA_f45113cd-24bc-4b95-86a5-c3932ba16981">46</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr></table></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:62.094%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.772%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td style="width:0.1%"></td><td style="width:0.772%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:15.983%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.494%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:15.985%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">As of June&#160;30, 2021</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">As of December 31, 2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">OGBC assets classified as held-for-sale</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3460e1558aee458a9a76219571d94bad_I20210630" decimals="-3" name="us-gaap:DisposalGroupIncludingDiscontinuedOperationAssetsNoncurrent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzY2E5YmIwMTc5MjQ3NmZiYjIyNWU1ZDlkZWM4NjlmL3NlYzo5M2NhOWJiMDE3OTI0NzZmYmIyMjVlNWQ5ZGVjODY5Zl82NC9mcmFnOjhlNjI5OTI1ODgxNTQ1M2E4NWZjOGM0NTY4Nzc5ZWFlL3RhYmxlOjcyNjAxYzQxYWQ0ZTQ5YWZhNTgyMTBkYzFkNDI0ZWUxL3RhYmxlcmFuZ2U6NzI2MDFjNDFhZDRlNDlhZmE1ODIxMGRjMWQ0MjRlZTFfMS0xMS0xLTEtMA_c162f2f8-1827-41e9-9474-a07ee3751386">645</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ibab7e231213f4709bd6c6600c444e9d5_I20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:DisposalGroupIncludingDiscontinuedOperationAssetsNoncurrent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzY2E5YmIwMTc5MjQ3NmZiYjIyNWU1ZDlkZWM4NjlmL3NlYzo5M2NhOWJiMDE3OTI0NzZmYmIyMjVlNWQ5ZGVjODY5Zl82NC9mcmFnOjhlNjI5OTI1ODgxNTQ1M2E4NWZjOGM0NTY4Nzc5ZWFlL3RhYmxlOjcyNjAxYzQxYWQ0ZTQ5YWZhNTgyMTBkYzFkNDI0ZWUxL3RhYmxlcmFuZ2U6NzI2MDFjNDFhZDRlNDlhZmE1ODIxMGRjMWQ0MjRlZTFfMS0xMy0xLTEtMA_e4d2469d-6234-442b-b0c2-0789fa76b903">1,176</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr></table></div></ix:nonNumeric></ix:continuation><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span><br/></span></div><div id="i93ca9bb01792476fbb225e5d9dec869f_70"></div><div style="margin-bottom:12pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">12. <ix:nonNumeric contextRef="i69782326f71a44e3805518280ee22b6b_D20210101-20210630" name="us-gaap:AssetImpairmentChargesTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjkzY2E5YmIwMTc5MjQ3NmZiYjIyNWU1ZDlkZWM4NjlmL3NlYzo5M2NhOWJiMDE3OTI0NzZmYmIyMjVlNWQ5ZGVjODY5Zl83MC9mcmFnOjMxN2NmYTJiYTEwYzQ5NjdhNTM1YzEwZjJiYWUzZjVkL3RleHRyZWdpb246MzE3Y2ZhMmJhMTBjNDk2N2E1MzVjMTBmMmJhZTNmNWRfOTY4_1bde1912-55b8-485a-9654-578fee4a6e49" continuedAt="i31a17c7be3714bb1b94d4854a46a55d1" escape="true">Impairment Loss on Long-Lived Assets</ix:nonNumeric></span></div><ix:continuation id="i31a17c7be3714bb1b94d4854a46a55d1"><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(a)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;padding-left:24.34pt">Property, plant, and equipment, net and right-of-use assets</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">During the six months ended June&#160;30, 2021, the Company recognized an impairment charge of $<ix:nonFraction unitRef="usd" contextRef="i69782326f71a44e3805518280ee22b6b_D20210101-20210630" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:ImpairmentOfLongLivedAssetsToBeDisposedOf" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzY2E5YmIwMTc5MjQ3NmZiYjIyNWU1ZDlkZWM4NjlmL3NlYzo5M2NhOWJiMDE3OTI0NzZmYmIyMjVlNWQ5ZGVjODY5Zl83MC9mcmFnOjMxN2NmYTJiYTEwYzQ5NjdhNTM1YzEwZjJiYWUzZjVkL3RleHRyZWdpb246MzE3Y2ZhMmJhMTBjNDk2N2E1MzVjMTBmMmJhZTNmNWRfNzc_255452c6-a0f3-4a03-81d6-a4a9d0c741e0">1,039</ix:nonFraction> related to leasehold improvements located within leased premises, encompassing approximately <ix:nonFraction unitRef="sqft" contextRef="i69782326f71a44e3805518280ee22b6b_D20210101-20210630" decimals="-3" format="ixt:numdotdecimal" name="cron:LesseeOperatingLeaseAreaOfLandToBeDisposedOf" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjkzY2E5YmIwMTc5MjQ3NmZiYjIyNWU1ZDlkZWM4NjlmL3NlYzo5M2NhOWJiMDE3OTI0NzZmYmIyMjVlNWQ5ZGVjODY5Zl83MC9mcmFnOjMxN2NmYTJiYTEwYzQ5NjdhNTM1YzEwZjJiYWUzZjVkL3RleHRyZWdpb246MzE3Y2ZhMmJhMTBjNDk2N2E1MzVjMTBmMmJhZTNmNWRfMTcz_e139630c-8938-4ceb-abdd-0b74c253ea8d">6,000</ix:nonFraction> square feet, in Los Angeles, California, which the Company determined it no longer had plans to use. The significant change in the extent and manner in which the leasehold improvements are being used and the expectation that, more likely than not, the leasehold improvements will be disposed of before the end of their useful life triggered an impairment. The right-of-use lease asset associated with the leasehold improvements was also written down as a result of our decision to no longer use the leased premises. The Company recognized an impairment charge on the de-recognition of the right-of-use asset of $<ix:nonFraction unitRef="usd" contextRef="i69782326f71a44e3805518280ee22b6b_D20210101-20210630" decimals="-3" name="us-gaap:OperatingLeaseImpairmentLoss" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzY2E5YmIwMTc5MjQ3NmZiYjIyNWU1ZDlkZWM4NjlmL3NlYzo5M2NhOWJiMDE3OTI0NzZmYmIyMjVlNWQ5ZGVjODY5Zl83MC9mcmFnOjMxN2NmYTJiYTEwYzQ5NjdhNTM1YzEwZjJiYWUzZjVkL3RleHRyZWdpb246MzE3Y2ZhMmJhMTBjNDk2N2E1MzVjMTBmMmJhZTNmNWRfNzg3_42fbc03b-1c57-4168-90bc-e62d1f443ac4">702</ix:nonFraction> during the six months ended June&#160;30, 2021. Both of the impairment charges are recognized in the statement of net income (loss) as impairment loss on property, plant and equipment and right-of-use assets. No impairment charges were recorded during the three months ended June 30, 2021 and the three and six months ended June 30, 2020 on property, plant and equipment and right-of-use assets.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(b)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;padding-left:23.78pt">Intangible assets, net and goodwill</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Goodwill and indefinite life intangible assets are reviewed for impairment annually or more frequently when events or changes in circumstances indicate that fair value of the reporting unit has been reduced to less than its carrying value. During the three months ended June&#160;30, 2020, the Company concluded that the projected impact of the COVID-19 pandemic on its sales and revenues in the near term, together with the volatility in the market conditions during the quarter, represented potential indicators of impairment for the Company&#8217;s U.S. reporting unit as well as its Lord Jones brand acquired in September 2019. Accordingly, the Company performed an interim impairment analysis during the second quarter of 2020. As a result of this analysis, the Company recorded impairment charges of $<ix:nonFraction unitRef="usd" contextRef="i037d0ab368aa4200bacafabacd180946_D20200401-20200630" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:GoodwillImpairmentLoss" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzY2E5YmIwMTc5MjQ3NmZiYjIyNWU1ZDlkZWM4NjlmL3NlYzo5M2NhOWJiMDE3OTI0NzZmYmIyMjVlNWQ5ZGVjODY5Zl83MC9mcmFnOjMxN2NmYTJiYTEwYzQ5NjdhNTM1YzEwZjJiYWUzZjVkL3RleHRyZWdpb246MzE3Y2ZhMmJhMTBjNDk2N2E1MzVjMTBmMmJhZTNmNWRfNDk0NzgwMjMyODI0Nw_93d8588d-124e-44df-ad35-3087cdfc138b"><ix:nonFraction unitRef="usd" contextRef="iee9123f7b84a423aa2034824b667283b_D20200101-20200630" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:GoodwillImpairmentLoss" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzY2E5YmIwMTc5MjQ3NmZiYjIyNWU1ZDlkZWM4NjlmL3NlYzo5M2NhOWJiMDE3OTI0NzZmYmIyMjVlNWQ5ZGVjODY5Zl83MC9mcmFnOjMxN2NmYTJiYTEwYzQ5NjdhNTM1YzEwZjJiYWUzZjVkL3RleHRyZWdpb246MzE3Y2ZhMmJhMTBjNDk2N2E1MzVjMTBmMmJhZTNmNWRfNDk0NzgwMjMyODI0Nw_f4a9e6ae-25d2-4254-b78c-06fc5cd6e2b0">35,000</ix:nonFraction></ix:nonFraction> on its U.S. reporting unit and $<ix:nonFraction unitRef="usd" contextRef="icaac8e35e79f4bc7b83a47868c7fbccf_D20200401-20200630" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:ImpairmentOfIntangibleAssetsIndefinitelivedExcludingGoodwill" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzY2E5YmIwMTc5MjQ3NmZiYjIyNWU1ZDlkZWM4NjlmL3NlYzo5M2NhOWJiMDE3OTI0NzZmYmIyMjVlNWQ5ZGVjODY5Zl83MC9mcmFnOjMxN2NmYTJiYTEwYzQ5NjdhNTM1YzEwZjJiYWUzZjVkL3RleHRyZWdpb246MzE3Y2ZhMmJhMTBjNDk2N2E1MzVjMTBmMmJhZTNmNWRfNDk0NzgwMjMyODI2Mg_1519610b-6b3f-48ad-9e75-c70746d1af98"><ix:nonFraction unitRef="usd" contextRef="i9d77515187ea4c40b907a43fd842a0f9_D20200101-20200630" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:ImpairmentOfIntangibleAssetsIndefinitelivedExcludingGoodwill" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjkzY2E5YmIwMTc5MjQ3NmZiYjIyNWU1ZDlkZWM4NjlmL3NlYzo5M2NhOWJiMDE3OTI0NzZmYmIyMjVlNWQ5ZGVjODY5Zl83MC9mcmFnOjMxN2NmYTJiYTEwYzQ5NjdhNTM1YzEwZjJiYWUzZjVkL3RleHRyZWdpb246MzE3Y2ZhMmJhMTBjNDk2N2E1MzVjMTBmMmJhZTNmNWRfNDk0NzgwMjMyODI2Mg_2293c6d8-df17-4ba1-9ab2-7684f409caee">5,000</ix:nonFraction></ix:nonFraction> on its Lord Jones&#8482; brand for the three and six months ended June 30, 2020, when the carrying value of these assets exceeded their fair value. No triggering events were identified or impairment charges recorded during the three and six months ended June 30, 2021 on intangible assets and goodwill.</span></div></ix:continuation><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span><br/></span></div><div style="height:36pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">29</span></div></div></div><div id="i93ca9bb01792476fbb225e5d9dec869f_136"></div><hr style="page-break-after:always"/><div style="min-height:36pt;width:100%"><div style="text-align:right"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i93ca9bb01792476fbb225e5d9dec869f_7">Tab</a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i93ca9bb01792476fbb225e5d9dec869f_7">l</a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i93ca9bb01792476fbb225e5d9dec869f_7">e of Contents</a></span></div></div><div style="margin-bottom:12pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Item 2. Management&#8217;s Discussion and Analysis of Financial Condition and Results of Operations.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following discussion and analysis should be read together with other information, including Cronos Group&#8217;s condensed consolidated financial statements and the related notes to those statements, included in Part I, Item 1. of this Quarterly Report on Form 10-Q for the quarterly period ended June&#160;30, 2021 (this &#8220;Quarterly Report&#8221;), consolidated financial statements appearing in the Company&#8217;s Annual Report on Form 10-K for the year ended December 31, 2020 (the &#8220;Annual Report&#8221;) and Part I, Item 1A, Risk Factors, of the Annual Report. </span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Forward-Looking Statements</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">This Quarterly Report, the documents incorporated into this Quarterly Report by reference, other reports we file with, or furnish to, the U.S. Securities and Exchange Commission (&#8220;SEC&#8221;) and other regulatory agencies, and statements by our directors, officers, other employees and other persons authorized to speak on our behalf contain information that may constitute forward-looking information and forward-looking statements within the meaning of applicable securities laws (collectively, &#8220;Forward-Looking Statements&#8221;), which are based upon our current internal expectations, estimates, projections, assumptions and beliefs. All information that is not clearly historical in nature may constitute Forward-Looking Statements. In some cases, Forward-Looking Statements can be identified by the use of forward-looking terminology, such as &#8220;expect&#8221;, &#8220;likely&#8221;, &#8220;may&#8221;, &#8220;will&#8221;, &#8220;should&#8221;, &#8220;intend&#8221;, &#8220;anticipate&#8221;, &#8220;potential&#8221;, &#8220;proposed&#8221;, &#8220;estimate&#8221; and other similar words, expressions and phrases, including negative and grammatical variations thereof, or statements that certain events or conditions &#8220;may&#8221; or &#8220;will&#8221; happen, or by discussion of strategy. Forward-Looking Statements include estimates, plans, expectations, opinions, forecasts, projections, targets, guidance or other statements that are not statements of historical fact.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Forward-Looking Statements include, but are not limited to, statements with respect to: </span></div><div style="margin-bottom:3pt;margin-top:3pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">the uncertainties associated with the COVID-19 pandemic, including our ability, and the abilities of our joint ventures and our suppliers and distributors, to effectively deal with the restrictions, limitations and health issues presented by the COVID-19 pandemic, the ability to continue our production, distribution and sale of our products, and demand for and the use of our products by consumers;</span></div><div style="margin-bottom:3pt;margin-top:3pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">laws and regulations and any amendments thereto applicable to our business and the impact thereof, including uncertainty regarding the application of United States (&#8220;U.S.&#8221;) state and federal law to U.S. hemp (including CBD) products and the scope of any regulations by the U.S. Food and Drug Administration (the &#8220;FDA&#8221;), the U.S. Drug Enforcement Administration (the &#8220;DEA&#8221;), the U.S. Federal Trade Commission (the &#8220;FTC&#8221;), the U.S. Patent and Trademark Office (the &#8220;PTO&#8221;) and any state equivalent regulatory agencies over U.S. hemp (including CBD) products;</span></div><div style="margin-bottom:3pt;margin-top:3pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">the laws and regulations and any amendments thereto relating to the U.S. hemp industry in the U.S., including the promulgation of regulations for the U.S. hemp industry by the U.S. Department of Agriculture (the &#8220;USDA&#8221;) and relevant state regulatory authorities;</span></div><div style="margin-bottom:3pt;margin-top:3pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">the grant, renewal and impact of any license or supplemental license to conduct activities with cannabis or any amendments thereof;</span></div><div style="margin-bottom:3pt;margin-top:3pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">our international activities and joint venture interests, including required regulatory approvals and licensing, anticipated costs and timing, and expected impact;</span></div><div style="margin-bottom:3pt;margin-top:3pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">our ability to successfully create and launch brands and further create, launch and scale U.S. hemp-derived consumer products and cannabis products;</span></div><div style="margin-bottom:3pt;margin-top:3pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">the benefits, viability, safety, efficacy, dosing and social acceptance of cannabis, including CBD and other cannabinoids;</span></div><div style="margin-bottom:3pt;margin-top:3pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">expectations regarding the implementation and effectiveness of key personnel changes;</span></div><div style="margin-bottom:3pt;margin-top:3pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">the anticipated benefits and impact of Altria Group, Inc.&#8217;s investment in the Company (the &#8220;Altria Investment&#8221;), pursuant to a subscription agreement dated December 7, 2018;</span></div><div style="margin-bottom:3pt;margin-top:3pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">the potential exercise of one warrant of the Company included as part of the Altria Investment, pre-emptive rights and/or top-up rights in connection with the Altria Investment, including proceeds to us that may result therefrom;</span></div><div style="margin-bottom:3pt;margin-top:3pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">expectations regarding the use of proceeds of equity financings, including the proceeds from the Altria Investment;</span></div><div style="margin-bottom:3pt;margin-top:3pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">the legalization of the use of cannabis for medical or adult-use in jurisdictions outside of Canada, the related timing and impact thereof and our intentions to participate in such markets, if and when such use is legalized;</span></div><div style="margin-bottom:3pt;margin-top:3pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">expectations regarding the potential success of, and the costs and benefits associated with, our joint ventures, strategic alliances and equity investments, including the strategic partnership (the &#8220;Ginkgo Strategic Partnership&#8221;) with Ginkgo Bioworks, Inc. (&#8220;Ginkgo&#8221;);</span></div><div style="margin-bottom:3pt;margin-top:3pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">our ability to execute on our strategy and the anticipated benefits of such strategy;</span></div><div style="margin-bottom:3pt;margin-top:3pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">expectations of the amount or frequency of impairment losses, including as a result of the write-down of intangible assets, including goodwill;</span></div><div style="height:36pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">30</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:36pt;width:100%"><div style="text-align:right"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i93ca9bb01792476fbb225e5d9dec869f_7">Tab</a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i93ca9bb01792476fbb225e5d9dec869f_7">l</a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i93ca9bb01792476fbb225e5d9dec869f_7">e of Contents</a></span></div></div><div style="margin-bottom:3pt;margin-top:3pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">the ongoing impact of the legalization of additional cannabis product types and forms for adult-use in Canada, including federal, provincial, territorial and municipal regulations pertaining thereto, the related timing and impact thereof and our intentions to participate in such markets;</span></div><div style="margin-bottom:3pt;margin-top:3pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">the future performance of our business and operations;</span></div><div style="margin-bottom:3pt;margin-top:3pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">our competitive advantages and business strategies;</span></div><div style="margin-bottom:3pt;margin-top:3pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">the competitive conditions of the industry;</span></div><div style="margin-bottom:3pt;margin-top:3pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">the expected growth in the number of customers using our products;</span></div><div style="margin-bottom:3pt;margin-top:3pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">our ability or plans to identify, develop, commercialize or expand our technology and research and development (&#8220;R&amp;D&#8221;) initiatives in cannabinoids, or the success thereof;</span></div><div style="margin-bottom:3pt;margin-top:3pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">expectations regarding acquisitions and dispositions and the anticipated benefits therefrom, including the proposed sale of our Original B.C. Ltd. (&#8220;OGBC&#8221;) production facility;</span></div><div style="margin-bottom:3pt;margin-top:3pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">uncertainties as to our ability to exercise the PharmaCann Option (as defined herein) in the near term or the future or in full or in part, including the uncertainties as to the status and future development of federal legalization of cannabis in the U.S. and our ability to realize the anticipated benefits of the transaction with PharmaCann (as defined herein);</span></div><div style="margin-bottom:3pt;margin-top:3pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">expectations regarding revenues, expenses and anticipated cash needs;</span></div><div style="margin-bottom:3pt;margin-top:3pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">expectations regarding cash flow, liquidity and sources of funding;</span></div><div style="margin-bottom:3pt;margin-top:3pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">expectations regarding capital expenditures;</span></div><div style="margin-bottom:3pt;margin-top:3pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">the expansion of our production and manufacturing, the costs and timing associated therewith and the receipt of applicable production and sale licenses;</span></div><div style="margin-bottom:3pt;margin-top:3pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">the expected growth in our growing, production and supply chain capacities;</span></div><div style="margin-bottom:3pt;margin-top:3pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">expectations regarding the resolution of litigation and other legal and regulatory proceedings, reviews and investigations;</span></div><div style="margin-bottom:3pt;margin-top:3pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">expectations with respect to future production costs;</span></div><div style="margin-bottom:3pt;margin-top:3pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">expectations with respect to future sales and distribution channels and networks;</span></div><div style="margin-bottom:3pt;margin-top:3pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">the expected methods to be used to distribute and sell our products; </span></div><div style="margin-bottom:3pt;margin-top:3pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">the anticipated future gross margins of our operations;</span></div><div style="margin-bottom:3pt;margin-top:3pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">accounting standards and estimates;</span></div><div style="margin-bottom:3pt;margin-top:3pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">our ability to timely and effectively remediate any material weaknesses in our internal control over financial reporting; and </span></div><div style="margin-bottom:3pt;margin-top:3pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">expectations regarding the costs and benefits associated with our contracts and agreements with third parties, including under our third-party supply and manufacturing agreements. </span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Certain of the Forward-Looking Statements contained herein concerning the industries in which we conduct our business are based on estimates prepared by us using data from publicly available governmental sources, market research, industry analysis and on assumptions based on data and knowledge of these industries, which we believe to be reasonable. However, although generally indicative of relative market positions, market shares and performance characteristics, such data is inherently imprecise. The industries in which we conduct our business involve risks and uncertainties that are subject to change based on various factors, which are described further below.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Forward-Looking Statements contained herein are based upon certain material assumptions that were applied in drawing a conclusion or making a forecast or projection, including: (i) our ability, and the abilities of our joint ventures and our suppliers and distributors, to effectively deal with the restrictions, limitations and health issues presented by the COVID-19 pandemic and the ability to continue our production, distribution and sale of our products and customer demand for and use of our products; (ii) management&#8217;s perceptions of historical trends, current conditions and expected future developments; (iii) our ability to generate cash flow from operations; (iv) general economic, financial market, regulatory and political conditions in which we operate; (v) the production and manufacturing capabilities and output from our facilities and our joint ventures, strategic alliances and equity investments; (vi) consumer interest in our products; (vii) competition; (viii) anticipated and unanticipated costs; (ix) government regulation of our activities and products including, but not limited to, the areas of taxation and environmental protection; (x) the timely receipt of any required regulatory authorizations, approvals, consents, permits and/or licenses; (xi) our ability to obtain qualified staff, equipment and services in a timely and cost-efficient manner; (xii) our ability to conduct operations in a safe, efficient and effective manner; (xiii) our ability to realize anticipated benefits, synergies or generate revenue, profits or value from our recent acquisitions into our existing operations; (xiv) our ability to complete planned dispositions, including the sale of OGBC, and, if completed, obtain our anticipated sales price; (xv) our ability to exercise the PharmaCann Option and realize the anticipated benefits of the transaction with PharmaCann; and (xvi) other considerations that management believes to be appropriate in the circumstances. While our management considers these assumptions to be reasonable based on information currently available to management, there is no assurance that such expectations will prove to be correct.</span></div><div style="height:36pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">31</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:36pt;width:100%"><div style="text-align:right"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i93ca9bb01792476fbb225e5d9dec869f_7">Tab</a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i93ca9bb01792476fbb225e5d9dec869f_7">l</a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i93ca9bb01792476fbb225e5d9dec869f_7">e of Contents</a></span></div></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">By their nature, Forward-Looking Statements are subject to inherent risks and uncertainties that may be general or specific and which give rise to the possibility that expectations, forecasts, predictions, projections or conclusions will not prove to be accurate, that assumptions may not be correct and that objectives, strategic goals and priorities will not be achieved. A variety of factors, including known and unknown risks, many of which are beyond our control, could cause actual results to differ materially from the Forward-Looking Statements in this Quarterly Report and other reports we file with, or furnish to, the SEC and other regulatory agencies and made by our directors, officers, other employees and other persons authorized to speak on our behalf. Such factors include, without limitation, the risk that the COVID-19 pandemic may disrupt our operations and those of our suppliers and distribution channels and negatively impact the demand for and use of our products; the risk that cost savings and any other synergies from the Altria Investment may not be fully realized or may take longer to realize than expected; the risk that we will not complete planned dispositions, including the sale of OGBC, or, if completed, obtain our anticipated sales price; the implementation and effectiveness of key personnel changes; future levels of revenues; consumer demand for cannabis and U.S. hemp products; our ability to manage disruptions in credit markets or changes to our credit ratings; future levels of capital, environmental or maintenance expenditures, general and administrative and other expenses; the success or timing of completion of ongoing or anticipated capital or maintenance projects; business strategies, growth opportunities and expected investment; the adequacy of our capital resources and liquidity, including but not limited to, availability of sufficient cash flow to execute our business plan (either within the expected timeframe or at all); the potential effects of judicial, regulatory or other proceedings, or threatened litigation or proceedings, on our business, financial condition, results of operations and cash flows; volatility in and/or degradation of general economic, market, industry or business conditions; compliance with applicable environmental, economic, health and safety, energy and other policies and regulations and in particular health concerns with respect to vaping and the use of cannabis and U.S. hemp products in vaping devices; the anticipated effects of actions of third parties such as competitors, activist investors or federal (including U.S. federal), state, provincial, territorial or local regulatory authorities or self-regulatory organizations; changes in regulatory requirements in relation to our business and products; legal or regulatory obstacles that could prevent us from being able to exercise the PharmaCann Option and thereby realizing the anticipated benefits of the transaction with PharmaCann; and the factors discussed under Part I, Item 1A, &#8220;Risk Factors&#8221; of the Annual Report. Readers are cautioned to consider these and other factors, uncertainties and potential events carefully and not to put undue reliance on Forward-Looking Statements.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Forward-Looking Statements are provided for the purposes of assisting the reader in understanding our financial performance, financial position and cash flows as of and for periods ended on certain dates and to present information about management&#8217;s current expectations and plans relating to the future, and the reader is cautioned that the Forward-Looking Statements may not be appropriate for any other purpose. While we believe that the assumptions and expectations reflected in the Forward-Looking Statements are reasonable based on information currently available to management, there is no assurance that such assumptions and expectations will prove to have been correct. Forward-Looking Statements are made as of the date they are made and are based on the beliefs, estimates, expectations and opinions of management on that date. We undertake no obligation to update or revise any Forward-Looking Statements, whether as a result of new information, estimates or opinions, future events or results or otherwise or to explain any material difference between subsequent actual events and such Forward-Looking Statements. The Forward-Looking Statements contained in this Quarterly Report and other reports we file with, or furnish to, the SEC and other regulatory agencies and made by our directors, officers, other employees and other persons authorized to speak on our behalf are expressly qualified in their entirety by these cautionary statements.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Foreign currency exchange rates</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">All currency amounts in this Quarterly Report are stated in U.S. dollars, which is our reporting currency, unless otherwise noted. All references to &#8220;dollars&#8221; or &#8220;$&#8221; are to U.S. dollars. The assets and liabilities of the Company&#8217;s foreign operations are translated into dollars at the exchange rate in effect as of June&#160;30, 2021, June&#160;30, 2020 and December 31, 2020. Transactions affecting the shareholders&#8217; equity are translated at historical foreign exchange rates. The condensed consolidated statements of net income (loss) and comprehensive income (loss) and condensed consolidated statements of cash flows of the Company&#8217;s foreign operations are translated into dollars by applying the average foreign exchange rate in effect for the reporting period using Bloomberg.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The exchange rates used to translate from Canadian dollars (&#8220;C$&#8221;) to dollars is shown below:</span><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:52.233%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.344%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:1.466%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.344%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:1.466%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.347%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%">(Exchange rates are shown as C$ per $)</span></td><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">As of</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">June 30, 2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">June 30, 2020</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 31, 2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Average rate</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.2293</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.3856</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.3036</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Spot rate</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.2395</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.3576</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.2751</span></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Year-to-date average rate</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.2481</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.3646</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.3411</span></td></tr></table></div><div style="margin-bottom:6pt;text-align:justify"><span><br/></span></div><div style="height:36pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">32</span></div></div></div><div id="i93ca9bb01792476fbb225e5d9dec869f_139"></div><hr style="page-break-after:always"/><div style="min-height:36pt;width:100%"><div style="text-align:right"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i93ca9bb01792476fbb225e5d9dec869f_7">Tab</a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i93ca9bb01792476fbb225e5d9dec869f_7">l</a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i93ca9bb01792476fbb225e5d9dec869f_7">e of Contents</a></span></div></div><div style="margin-bottom:12pt;margin-top:6pt;padding-right:36pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Business Overview</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Cronos Group is an innovative global cannabinoid company with international production and distribution across five continents. Cronos Group is committed to building disruptive intellectual property by advancing cannabis research, technology and product development and is building an iconic brand portfolio. Cronos Group&#8217;s brand portfolio includes PEACE NATURALS</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">&#8482;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, a global wellness platform; two adult-use brands, COVE</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">&#8482;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> and Spinach</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">&#8482;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">; and three U.S. hemp-derived consumer products brands, Lord Jones</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">&#8482;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, Happy Dance</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">&#8482;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> and PEACE+</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">&#8482;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. </span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Strategy</span></div><div style="margin-top:3pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Cronos Group seeks to create value for shareholders by focusing on four core strategic priorities:</span></div><div style="margin-top:3pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:13.8pt">growing a portfolio of iconic brands that responsibly elevate the consumer experience;</span></div><div style="margin-top:6pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:13.8pt">developing a diversified global sales and distribution network;</span></div><div style="margin-top:6pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:13.8pt">establishing an efficient global supply chain; and</span></div><div style="margin-top:6pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:13.8pt">creating and monetizing disruptive intellectual property.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Business segments</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Cronos Group reports through two segments: &#8220;United States&#8221; (&#8220;U.S.&#8221;) and &#8220;Rest of World&#8221; (&#8220;ROW&#8221;). These two segments represent the geographic regions in which the Company operates and the different product offerings within each geographic region. </span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The United States segment manufactures, markets and distributes U.S. hemp-derived supplements and cosmetic products through e-commerce, retail and hospitality partner channels in the United States under the brands Lord Jones</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">&#8482;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, Happy Dance</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">&#8482; </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">and PEACE+</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">&#8482;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The ROW segment is involved in the cultivation, manufacture, and marketing of cannabis and cannabis-derived products for the medical and adult-use markets. In Canada, Cronos Group operates two wholly owned license holders under the Cannabis Act (Canada), Peace Naturals Project Inc. (&#8220;Peace Naturals&#8221;), which has production facilities near Stayner, Ontario (the &#8220;Peace Naturals Campus&#8221;), and Cronos Fermentation, which has fermentation and manufacturing facilities in Winnipeg, Manitoba. In Israel, the Company operates under the IMC-GAP, IMC-GMP and IMC-GDP certifications required for the cultivation, production and marketing of dried flower, pre-rolls and cannabis oils in the Israeli medical market. Cronos Group has established strategic joint ventures in Canada, Israel and Colombia. Cronos Group additionally holds approximately 31% of the issued capital of Cronos Australia Limited, which is listed on the Australian Securities Exchange under the trading symbol &#8220;CAU.&#8221; Cronos Group currently exports cannabis products to countries that permit the import of such products, such as Australia, Germany and Israel.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span><br/></span></div><div id="i93ca9bb01792476fbb225e5d9dec869f_142"></div><div style="margin-bottom:12pt;margin-top:6pt;padding-right:36pt;text-align:justify"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Recent </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Developments</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">COVID-19 update</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The COVID-19 pandemic continues to impact the global economy and, specifically, the U.S., Canada, Israel, and the other countries in which the Company or its affiliates operate (including Australia and Colombia). Cronos Group continues to closely monitor and respond, where possible, to the ongoing COVID-19 pandemic. As the global situation continues to change rapidly, ensuring the health and safety of our employees remains one of our top priorities. </span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In the U.S., numerous states have continued to remove their COVID-19 related restrictions as the rollout of vaccines continues. This has resulted in the re-opening of, and increased occupancy capacities in, retail outlets, including those that sell the Company&#8217;s products. Any reinstatement of restrictions on the operations of retail outlets could negatively impact the Company&#8217;s short-term results of operations in the U.S. Recently in the U.S., there have been a number of supply chain challenges, such as container ships facing delays due to congestion in ports, impacting many industries, including the industries in which the Company operates. Although we have not yet seen a significant impact, we continue to monitor our supply chain closely.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In Canada, COVID-19 restrictions began gradually easing at the end of June 2021 as the vaccination rate increases. Each province is responsible for implementing re-opening plans and certain provinces, including Ontario, are progressing through phases of re-opening which may permit continued increases to the allowance of in-person shopping, typically in the form of percentage of store capacity. All provinces have some form of cannabis retail open to consumers, whether it be restricted in-person shopping, curb-side pickup or delivery. The lockdown measures taken in the first six months of 2021 to slow infection rates negatively impacted the Company&#8217;s short-term revenue growth in Canada. However, if provincial reopening plans are effective across some provinces in the third quarter of 2021, we expect to partially mitigate this negative impact.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In Israel, most COVID-19 restrictions have been removed as vaccination rates have increased. Occupancy limitations in retail outlets have been removed, including those that sell the Company&#8217;s products. The Company does not expect the remaining COVID-19 restrictions to have a material impact on the Company&#8217;s short-term revenue growth in Israel.</span></div><div style="height:36pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">33</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:36pt;width:100%"><div style="text-align:right"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i93ca9bb01792476fbb225e5d9dec869f_7">Tab</a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i93ca9bb01792476fbb225e5d9dec869f_7">l</a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i93ca9bb01792476fbb225e5d9dec869f_7">e of Contents</a></span></div></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In both the U.S. and ROW segments, there were no material increases in the current expected credit loss in connection with COVID-19. The Company continues to closely monitor the effects of COVID-19 on its operating results.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Collectively, the effects of the COVID-19 pandemic have adversely affected the Company&#8217;s results of operations and, if the effects continue unabated, could continue to do so as long as measures to combat the COVID-19 pandemic remain in effect. At this time, neither the duration nor scope of the disruption can be predicted; therefore, the ultimate impact to the Company&#8217;s business cannot be reasonably estimated but such impact could materially adversely affect the Company&#8217;s business and financial results. </span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Despite the impacts of the COVID-19 pandemic, the Company believes that its significant cash on hand and short-term investments will be adequate to meet liquidity and capital requirements for at least the next twelve months. The impact of reduced interest rates has inhibited the Company&#8217;s ability to generate interest income, but this has not had, and is not expected to have, a material impact on the liquidity or capital resources of the Company.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Transaction</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In June 2021, Cronos Group announced a strategic investment (the &#8220;PharmaCann Investment&#8221;) in PharmaCann Inc. (&#8220;PharmaCann&#8221;), a leading vertically integrated U.S. cannabis company. A wholly owned subsidiary of Cronos Group purchased an option (the &#8220;PharmaCann Option&#8221;) to acquire an approximately 10.5% ownership stake in PharmaCann on a fully-diluted basis for a total consideration of approximately $110.4 million. PharmaCann has a broad geographic footprint in the U.S. and has built an efficient, effective and scalable operating model, including six production facilities and 24 dispensaries operating under the Verilife&#8482; brand across the following six limited license states: New York, Illinois, Ohio, Maryland, Pennsylvania and Massachusetts. PharmaCann continues to invest in its manufacturing infrastructure and brand development to capitalize on the significant consumer retail and business-to-business wholesale opportunities. Following the exercise of the PharmaCann Option (which will be based upon various factors, including the status of U.S. federal cannabis legalization), Cronos Group and PharmaCann will enter into commercial agreements that would permit each party to offer its products through either party&#8217;s distribution channels.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Brand and product portfolio</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In June 2021, Cronos Group launched SOURZ by Spinach&#8482;, an exciting new line of cannabis gummies with bold and unique dual flavor combinations, into the Canadian adult-use market. SOURZ by Spinach&#8482; delivers bold fruit flavors in a distinctive &#8220;S&#8221; shape with a proprietary coating designed to provide a sour and sweet flavor profile, differentiating the product and elevating the consumer experience. SOURZ by Spinach&#8482; has quickly risen to being one of the top performing brands in the edibles category.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In June 2021, Cronos Group launched Spinach&#8482; DABZ, a new line of cannabis concentrates, into the Canadian adult-use market. Spinach&#8482; DABZ are 100% cannabis-derived with no color remediation or additives to preserve terpenes and full spectrum cannabinoids. Broadening the reach of Cronos Group&#8217;s Spinach&#8482; brand into new and emerging categories with differentiated products will continue to be the key driver of innovation initiatives.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">During the second quarter of 2021, the Spinach&#8482; brand also launched a 28-gram format for Spinach&#8482; flower, Spinach&#8482; Nuggetz, and a new flower SKU, Spinach&#8482; GMO Cookies, in select markets in Canada.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In June 2021, the Company officially re-launched PEACE+&#8482;, Cronos Group&#8217;s U.S. hemp-derived CBD offering that is positioned in the mainstream market through its direct-to-consumer website, peaceplus.com. PEACE+&#8482;&#8217;s initial product portfolio consists of four tinctures. The Company intends to expand the product portfolio over time with innovative U.S. hemp-derived CBD products.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Subsequent to the end of the second quarter of 2021, in July 2021, Happy Dance&#8482; launched a new facial skin care product, Look Alive CBD Face Moisturizer. This moisturizer has a whipped, light texture and is packed with hydrating ingredients such as avocado oil, hyaluronic acid and high-quality U.S. hemp-derived CBD. The product is now available online to U.S. consumers through the brand&#8217;s direct-to-consumer website, doahappydance.com, and online at ULTA.com and is expected to become available in ULTA Beauty&#8482; stores throughout the U.S. in the coming weeks.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Intellectual property initiatives</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In June 2021, Cronos Group and Ginkgo Bioworks, Inc. (&#8220;Ginkgo&#8221;) announced an amended collaboration and license agreement that will enable the companies to accelerate the commercialization of cultured cannabinoids at scale. The amended agreement follows the receipt of Cronos Fermentation&#8217;s processing license in April 2021, and most recently the receipt of its license issued by the Canada Revenue Agency. With the amended agreement and both licenses in hand, Cronos Fermentation commenced commercial-scale production of cannabigerol (&#8220;CBG&#8221;) in June 2021. Cronos Group is prioritizing rare cannabinoids, such as CBG, and plans to sequence commercial production and subsequent product launches based on this approach. Cronos Group expects that the final productivity target for CBG will be achieved prior to September 2021, as previously announced.</span></div><div style="height:36pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">34</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:36pt;width:100%"><div style="text-align:right"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i93ca9bb01792476fbb225e5d9dec869f_7">Tab</a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i93ca9bb01792476fbb225e5d9dec869f_7">l</a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i93ca9bb01792476fbb225e5d9dec869f_7">e of Contents</a></span></div></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Appointments</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Kendrick Ashton Jr. was elected to Cronos Group&#8217;s Board of Directors at the Annual Meeting of Shareholders held on June 25, 2021. Mr. Ashton is the Co-Founder and Co-Chief Executive Officer of The St. James, a leading developer and operator of performance, wellness and lifestyle brands, experiences and destinations. Prior to founding The St. James in 2014, Mr. Ashton was a founding member and Managing Director of Perella Weinberg Partners, a boutique financial services firm founded in 2006. Prior to joining Perella Weinberg Partners, Mr. Ashton was an investment banker at Goldman, Sachs &amp; Co. and gained legal experience at Cravath, Swaine &amp; Moore LLP and Wachtell, Lipton, Rosen &amp; Katz. Mr. Ashton is a member of the Board of Trustees of the Colonial Williamsburg Foundation, the Board of Trustees of the National Urban League, the Board of Directors of Archbishop John Carroll High School and the Board of Directors of Bellwether Education Partners and is an emeritus member of the Board of Visitors and Foundation Board of the College of William &amp; Mary.</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">In April 2021, Thomas Cohn joined Cronos Group as Head of Regulatory and Product. Mr. Cohn joined Cronos Group from The Avon Company, where he served as General Counsel and Corporate Secretary. Mr. Cohn also served as Deputy General Counsel, Regulatory at NBTY, Inc., a leading vertically integrated manufacturer, marketer and distributor of nutritional supplements with global operations. Prior to his time at NBTY, Inc., Mr. Cohn served in various roles at the Federal Trade Commission (&#8220;FTC&#8221;) from 1991 to 2008, including as Director and Assistant Director of its Northeast Region, where he was responsible for managing antitrust and consumer protection investigations and law enforcement actions, as well as local and regional outreach efforts to educate consumers, businesses, and law enforcement agencies on fraud identification and avoidance, and how to comply with antitrust and consumer protection laws enforced by the FTC.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In July 2021, Anthony Parisi joined Cronos Group as Global Head of Audit, a newly formed role for the Company. Mr. Parisi joins Cronos Group with over 20 years of audit experience, most recently serving as Vice President of Global Audit and Risk Management for Reliance Worldwide Corporation, an ASX listed company.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In June 2021, Carlos Cortez joined Cronos Group as Vice President &amp; Controller, a role which includes serving as the Company&#8217;s principal accounting officer. Mr. Cortez joins Cronos Group with over 18 years of experience, most recently serving as Corporate Controller of SharpSpring, Inc., a publicly traded cloud-based marketing technology company. Prior to his time at SharpSpring, Inc., Mr. Cortez was the Senior Finance Director &#8211; Record to Report for Discovery, Inc., a publicly traded global media company, from August 2019 until December 2020. Prior to his time at Discovery, Inc., Mr. Cortez spent five years as Corporate Controller for Malibu Boats, Inc., a publicly traded manufacturer of recreational powerboats. </span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span><br/></span></div><div id="i93ca9bb01792476fbb225e5d9dec869f_1747"></div><div style="margin-bottom:12pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Consolidated Results of Operations</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The tables below sets forth our condensed consolidated results of operations, expressed in thousands of U.S. dollars for the periods presented. Our condensed consolidated financial results for these periods are not necessarily indicative of the consolidated financial results that we will achieve in future periods</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">.</span></div><div style="margin-top:6pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:51.261%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.288%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.355%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td style="width:1.0%"></td><td style="width:10.288%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.772%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td style="width:1.0%"></td><td style="width:10.288%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.355%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td style="width:1.0%"></td><td style="width:10.293%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="12" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">For the three months ended June&#160;30,</span></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">For the six months ended June&#160;30,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Net revenue before excise taxes</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 7pt 2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">18,848</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 7pt 2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">11,432</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 7pt 2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">33,502</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 7pt 2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">20,776</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Excise taxes</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(3,226)</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#ffffff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(1,549)</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#ffffff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(5,269)</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#ffffff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(2,461)</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Net revenue</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">15,622</span></td><td colspan="3" style="background-color:#cceeff;padding:0 7pt 0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">9,883</span></td><td colspan="3" style="background-color:#cceeff;padding:0 7pt 0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">28,233</span></td><td colspan="3" style="background-color:#cceeff;padding:0 7pt 0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">18,315</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Cost of sales</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">19,445</span></td><td colspan="3" style="background-color:#ffffff;padding:0 7pt 0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#ffffff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">9,743</span></td><td colspan="3" style="background-color:#ffffff;padding:0 7pt 0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#ffffff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">35,019</span></td><td colspan="3" style="background-color:#ffffff;padding:0 7pt 0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#ffffff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">16,689</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Inventory write-down</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">11,961</span></td><td colspan="3" style="background-color:#cceeff;padding:0 7pt 0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#cceeff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">3,062</span></td><td colspan="3" style="background-color:#cceeff;padding:0 7pt 0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#cceeff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">11,961</span></td><td colspan="3" style="background-color:#cceeff;padding:0 7pt 0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#cceeff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">11,024</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Gross loss</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(15,784)</span></td><td colspan="3" style="background-color:#ffffff;padding:0 7pt 0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(2,922)</span></td><td colspan="3" style="background-color:#ffffff;padding:0 7pt 0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(18,747)</span></td><td colspan="3" style="background-color:#ffffff;padding:0 7pt 0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(9,398)</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Operating expenses:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 7pt 0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 7pt 0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#cceeff;padding:0 7pt 0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 7pt 0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 7pt 0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#cceeff;padding:0 7pt 0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Sales and marketing</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">13,209</span></td><td colspan="3" style="background-color:#ffffff;padding:0 7pt 0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#ffffff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">6,501</span></td><td colspan="3" style="background-color:#ffffff;padding:0 7pt 0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#ffffff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">23,463</span></td><td colspan="3" style="background-color:#ffffff;padding:0 7pt 0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#ffffff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">13,613</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Research and development</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">5,199</span></td><td colspan="3" style="background-color:#cceeff;padding:0 7pt 0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#cceeff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">3,631</span></td><td colspan="3" style="background-color:#cceeff;padding:0 7pt 0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#cceeff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">10,301</span></td><td colspan="3" style="background-color:#cceeff;padding:0 7pt 0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#cceeff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">8,221</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">General and administrative</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">22,417</span></td><td colspan="3" style="background-color:#ffffff;padding:0 7pt 0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#ffffff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">18,429</span></td><td colspan="3" style="background-color:#ffffff;padding:0 7pt 0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#ffffff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">44,323</span></td><td colspan="3" style="background-color:#ffffff;padding:0 7pt 0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#ffffff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">42,188</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Share-based payments</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2,565</span></td><td colspan="3" style="background-color:#cceeff;padding:0 7pt 0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#cceeff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2,546</span></td><td colspan="3" style="background-color:#cceeff;padding:0 7pt 0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#cceeff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">5,064</span></td><td colspan="3" style="background-color:#cceeff;padding:0 7pt 0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#cceeff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">4,982</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Depreciation and amortization</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,043</span></td><td colspan="3" style="background-color:#ffffff;padding:0 7pt 0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#ffffff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">679</span></td><td colspan="3" style="background-color:#ffffff;padding:0 7pt 0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#ffffff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,778</span></td><td colspan="3" style="background-color:#ffffff;padding:0 7pt 0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#ffffff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,366</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Total operating expenses</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">44,433</span></td><td colspan="3" style="background-color:#cceeff;padding:0 7pt 0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">31,786</span></td><td colspan="3" style="background-color:#cceeff;padding:0 7pt 0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">84,929</span></td><td colspan="3" style="background-color:#cceeff;padding:0 7pt 0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">70,370</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Operating loss</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(60,217)</span></td><td colspan="3" style="background-color:#ffffff;padding:0 7pt 0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(34,708)</span></td><td colspan="3" style="background-color:#ffffff;padding:0 7pt 0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(103,676)</span></td><td colspan="3" style="background-color:#ffffff;padding:0 7pt 0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(79,768)</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Other income (loss)</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">117,553</span></td><td colspan="3" style="background-color:#cceeff;padding:0 7pt 0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#cceeff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(72,949)</span></td><td colspan="3" style="background-color:#cceeff;padding:0 7pt 0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#cceeff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(592)</span></td><td colspan="3" style="background-color:#cceeff;padding:0 7pt 0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#cceeff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">47,792</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Loss from discontinued operations</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(561)</span></td><td colspan="3" style="background-color:#ffffff;padding:0 7pt 0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#ffffff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(46)</span></td><td colspan="3" style="background-color:#ffffff;padding:0 7pt 0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#ffffff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(582)</span></td><td colspan="3" style="background-color:#ffffff;padding:0 7pt 0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#ffffff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(46)</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Net income (loss)</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">56,775</span></td><td colspan="3" style="background-color:#cceeff;padding:0 7pt 0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(107,703)</span></td><td colspan="3" style="background-color:#cceeff;padding:0 7pt 0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(104,850)</span></td><td colspan="3" style="background-color:#cceeff;padding:0 7pt 0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(32,022)</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Net loss attributable to non-controlling interests</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(279)</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#ffffff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(726)</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#ffffff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(592)</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#ffffff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(1,085)</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Net income (loss) attributable to Cronos Group</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 7pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">57,054</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 7pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(106,977)</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 7pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(104,258)</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 7pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(30,937)</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr></table></div><div style="height:36pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">35</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:36pt;width:100%"><div style="text-align:right"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i93ca9bb01792476fbb225e5d9dec869f_7">Tab</a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i93ca9bb01792476fbb225e5d9dec869f_7">l</a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i93ca9bb01792476fbb225e5d9dec869f_7">e of Contents</a></span></div></div><div style="margin-bottom:3pt;margin-top:6pt;text-align:justify"><span><br/></span></div><div style="margin-bottom:3pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Summary of select financial results</span></div><div style="text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.583%"><tr><td style="width:1.0%"></td><td style="width:25.538%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.407%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.497%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.407%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.636%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.407%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.357%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.407%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.915%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.407%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.357%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.407%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.776%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.407%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.357%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.418%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">For the three months ended June&#160;30,</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Change</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">For the six months ended June&#160;30,</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Change</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">$</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">%</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">$</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Net revenue</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">15,622&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">9,883&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">5,739&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">58&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">28,233&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">18,315&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">9,918&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">54&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Cost of sales</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">19,445&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">9,743&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">9,702&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">100&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">35,019&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">16,689&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">18,330&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">110&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Inventory write-down</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">11,961&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">3,062&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">8,899&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">291&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">11,961&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">11,024&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">937&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">8&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Gross loss</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(15,784)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(2,922)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(12,862)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">440&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(18,747)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(9,398)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(9,349)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">99&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Gross margin</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(101)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(30)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">N/A</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(71)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">pp</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(66)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(51)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">N/A</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(15)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">pp</span></td></tr></table></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Net revenue</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">For the three months ended June&#160;30, 2021, we reported consolidated net revenue of $15.6 million, representing an increase of $5.7 million from the three months ended June 30, 2020. For the six months ended June&#160;30, 2021 we reported consolidated net revenue of $28.2 million, representing an increase of $9.9 million from the six months ended June&#160;30, 2020.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">For both the three and six month comparative periods, the increase was primarily due to the continued growth of the adult-use market in Canada and increased sales in the Israeli medical market. </span></div><div style="margin-bottom:6pt;margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Cost of sales</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">For the three months ended June&#160;30, 2021, we reported consolidated cost of sales of</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$19.4 million, representing an increase of approximately $9.7 million from the three months ended June 30, 2020. For the six months ended June&#160;30, 2021, we reported consolidated cost of sales of $35.0 million, representing an increase of approximately $18.3 million from the six months ended June 30, 2020.</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:107%">For both the three and six month comparative periods, the increase was primarily due to the increase in sales volume noted above as well as start-up costs associated with new product development in the ROW segment.</span></div><div style="margin-bottom:6pt;margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Inventory write-downs</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">For the three months ended June&#160;30, 2021, we reported consolidated inventory write-downs of $12.0 million, representing an increase of approximately $8.9 million from the three months ended June 30, 2020. For the six months ended June&#160;30, 2021, we reported consolidated inventory write-downs of $12.0 million, representing an increase of approximately $0.9 million from the six months ended June 30, 2020. </span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">For both the three and six month comparative periods, the increases in inventory-write downs were primarily related to cannabis strains and potency levels that are no longer in-line with consumer preferences in the Canadian market and adjustments for obsolete inventory in Canada.</span></div><div style="margin-bottom:6pt;margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Gross loss</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">For the three months ended June&#160;30, 2021, we reported consolidated gross loss of $15.8 million, representing an increase in losses of $12.9 million from the three months ended June&#160;30, 2020. For the six months ended June&#160;30, 2021, we reported gross loss of $18.7 million, representing an increase in losses of $9.3 million from the six months ended June&#160;30, 2020.</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">For the three month comparative periods, the changes in gross loss and gross margin percentage were primarily due to inventory write-downs in the ROW segment, the impact of strategic price reductions on various adult-use cannabis products in Canada in the second half of 2020 as well as start up costs associated with new product development in the ROW segment. For the six month comparative periods, the changes in gross loss and gross margin percentage were primarily due to the impact of strategic price reductions on various adult-use cannabis products in Canada in the second half of 2020 as well as start up costs associated with new product development in the ROW segment.</span></div><div style="height:36pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">36</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:36pt;width:100%"><div style="text-align:right"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i93ca9bb01792476fbb225e5d9dec869f_7">Tab</a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i93ca9bb01792476fbb225e5d9dec869f_7">l</a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i93ca9bb01792476fbb225e5d9dec869f_7">e of Contents</a></span></div></div><div style="margin-bottom:6pt;margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Operating expenses</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.583%"><tr><td style="width:1.0%"></td><td style="width:25.538%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.407%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.497%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.407%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.636%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.407%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.357%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.407%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.915%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.407%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.357%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.407%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.776%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.407%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.357%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.418%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">For the three months ended June&#160;30,</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Change</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">For the six months ended June&#160;30,</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Change</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">$</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">%</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">$</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Sales and marketing</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 7pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">13,209</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 7pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">6,501</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">6,708&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">103&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 7pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">23,463</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 7pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">13,613</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">9,850&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">72&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Research and development</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">5,199</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">3,631</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,568&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">43&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">10,301</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">8,221</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2,080&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">25&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">General and administrative</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">22,417</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">18,429</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">3,988&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">22&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">44,323</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">42,188</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2,135&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">5&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Share-based payments</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2,565</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2,546</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">19&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">5,064</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">4,982</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">82&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Depreciation and amortization</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,043</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">679</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">364&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">54&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,778</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,366</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">412&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">30&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Total operating expenses</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 7pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">44,433</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 7pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">31,786</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 7pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">12,647</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">40&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 7pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">84,929</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 7pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">70,370</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 7pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">14,559</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">21&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td></tr></table></div><div style="margin-bottom:6pt;margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Sales and marketing</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">For the three months ended June&#160;30, 2021, sales and marketing expenses were $13.2 million, representing an increase of $6.7 million from the three months ended June&#160;30, 2020. For the six months ended June&#160;30, 2021, sales and marketing expenses were $23.5 million, representing an increase of $9.9 million from the six months ended June&#160;30, 2020. </span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">For both the three and six month comparative periods, the increase was primarily due to an increase in ongoing advertising and marketing campaigns related to our brands in the U.S. segment, which began in the second half of 2020 as well as increased headcount and related costs tied to these marketing efforts. During the first half of 2020, new hiring and spending on sales and marketing were delayed in the U.S. segment due to the impact of COVID-19.</span></div><div style="margin-bottom:6pt;margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Research and development</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">For the three months ended June&#160;30, 2021, research and development expenses were $5.2 million, representing an increase of $1.6 million from the three months ended June&#160;30, 2020. For the six months ended June&#160;30, 2021, research and development expenses were $10.3 million, representing an increase of $2.1 million from the six months ended June&#160;30, 2020. </span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:107%">For both the three and six month comparative periods, this increase was primarily driven by increased spending on product development and developing cannabinoid intellectual property in the ROW segment. </span></div><div style="margin-bottom:6pt;margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">General and administrative</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">For the three months ended June&#160;30, 2021, general and administrative expenses were $22.4 million, representing an increase of $4.0 million from the three months ended June&#160;30, 2020. For the six months ended June&#160;30, 2021, general and administrative expenses were $44.3 million, representing an increase of $2.1 million from the six months ended June&#160;30, 2020. </span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">For both the three and six month comparative periods, this change was primarily due to increased advisory fees associated with strategic initiatives including the PharmaCann investment, which did not take place during the comparable periods in 2020.</span></div><div style="margin-bottom:6pt;margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Depreciation and amortization</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">For the three months ended June&#160;30, 2021, depreciation and amortization expenses were $1.0 million, representing an increase of $0.4 million from the three months ended June&#160;30, 2020. For the six months ended June&#160;30, 2021, depreciation and amortization expenses were $1.8 million, representing an increase of $0.4 million from the six months ended June&#160;30, 2020. </span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">For both the three and six month comparative periods, the change was primarily due to the increased capital expenditures in the ROW segment in the second half of 2020.</span></div><div style="height:36pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">37</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:36pt;width:100%"><div style="text-align:right"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i93ca9bb01792476fbb225e5d9dec869f_7">Tab</a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i93ca9bb01792476fbb225e5d9dec869f_7">l</a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i93ca9bb01792476fbb225e5d9dec869f_7">e of Contents</a></span></div></div><div style="margin-bottom:6pt;margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Other income (loss) &amp; discontinued operations</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.583%"><tr><td style="width:1.0%"></td><td style="width:25.538%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.407%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.497%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.407%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.636%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.407%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.357%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.407%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.915%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.407%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.357%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.407%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.776%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.407%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.357%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.418%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">For the three months ended June&#160;30,</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Change</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">For the six months ended June&#160;30,</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Change</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">$</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">%</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">$</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Interest income, net</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2,293&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">3,734&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(1,441)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(39)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 7pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">4,622</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 7pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">11,485</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(6,863)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(60)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Gain (loss) on revaluation of derivative liabilities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">115,248&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(35,880)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">151,128&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">421&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(1,626)</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">77,488</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(79,114)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(102)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Impairment on long-lived assets</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(40,000)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">40,000&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">100&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(1,741)</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(40,000)</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">38,259&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">96&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Share of loss from equity accounted investments</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(1,115)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(794)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(321)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(40)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(2,758)</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(1,966)</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(792)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(40)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Other, net</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,127&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(9)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,136&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">12622&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">911</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">785</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">126&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">16&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Total other income (loss)</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">117,553&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(72,949)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">190,502&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">261&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(592)</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">47,792</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(48,384)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(101)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Loss from discontinued operations</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(561)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(46)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(515)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(1120)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(582)</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(46)</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(536)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(1165)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Net income (loss)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">56,775&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(107,703)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">164,478&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">153&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 7pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(104,850)</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 7pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(32,022)</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(72,828)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(227)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td></tr></table></div><div style="margin-bottom:6pt;margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Interest income</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">For the three months ended June&#160;30, 2021, net interest income was $2.3 million, representing a decrease of $1.4 million from the three months ended June&#160;30, 2020. For the six months ended June&#160;30, 2021, net interest income was $4.6 million, representing a decrease of $6.9 million from the six months ended June&#160;30, 2020. </span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">For both the three and six month comparative periods, the decrease in net interest income was primarily due to reduced interest rates on interest earning accounts as well as a decrease in interest earning assets during the three and six months ended June 30, 2021 compared to the same periods in 2020.</span></div><div style="margin-bottom:6pt;margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Gain/loss on revaluation of derivative liabilities</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">For the three months ended June&#160;30, 2021, gain on revaluation on derivatives was $115.2 million, including an out-of-period adjustment of $11.3 million, representing an increase of $151.1 million from the three months ended June&#160;30, 2020. For the six months ended June&#160;30, 2021, loss on revaluation on derivatives was $1.6 million, representing a decrease of $79.1 million from the six months ended June&#160;30, 2020. </span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The valuation of derivative liabilities is based on inputs such as the Company&#8217;s share price and volatility, expected term and expected risk-free interest rate which have in the past, and may in the future, fluctuate significantly period-to-period. The Company expects continued fluctuations in derivative valuations. For further information, see Note 5. Derivative Liabilities to the Company&#8217;s condensed consolidated financial statements under Item 1. &#8220;Financial Statements&#8221; of this Quarterly Report.</span></div><div style="margin-bottom:6pt;margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Impairment loss on long-lived assets</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">For the three months ended June&#160;30, 2021, there were no impairments on long lived assets. For the six months ended June&#160;30, 2021, impairment on long lived assets was $1.7 million, representing a decrease of $38.3 million from the six months ended June&#160;30, 2020. </span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">For both the three and six month comparative periods, the decrease in impairment loss on long-lived assets was due to $40.0 million in impairment charges recorded on the U.S. reporting unit and the Lord Jones&#8482; brand recorded in the first half of 2020.</span></div><div style="margin-bottom:6pt;margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Share of loss from equity accounted investments</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">For the three months ended June&#160;30, 2021, share of loss from equity accounted investments was $1.1 million, representing an increase of $0.3 million from the three months ended June&#160;30, 2020. For the six months ended June&#160;30, 2021, share of loss from equity accounted investments was $2.8 million, representing an increase of $0.8 million from the six months ended June&#160;30, 2020. </span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">For both the three and six month comparative periods, the change was due to recurring losses from the Company&#8217;s equity accounted investments. For further information, see Note 3. Investments to the Company&#8217;s condensed consolidated financial statements under Item 1. &#8220;Financial Statements&#8221; of this Quarterly Report.</span></div><div style="margin-bottom:6pt;margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Other, net</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">For the three months ended June&#160;30, 2021, other income was $1.1 million, representing an increase of $1.1 million from the three months ended June&#160;30, 2020. This change was primarily due to a gain on held-for-sale assets in the three months ended June 30, 2021 compared with a small gain on disposal of other assets in the three months ended June&#160;30, 2020. For the six months ended June&#160;30, 2021, other income was $0.9 million, essentially unchanged from the six months ended June&#160;30, 2020. </span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span><br/></span></div><div style="height:36pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">38</span></div></div></div><div id="i93ca9bb01792476fbb225e5d9dec869f_3848290698975"></div><hr style="page-break-after:always"/><div style="min-height:36pt;width:100%"><div style="text-align:right"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i93ca9bb01792476fbb225e5d9dec869f_7">Tab</a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i93ca9bb01792476fbb225e5d9dec869f_7">l</a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i93ca9bb01792476fbb225e5d9dec869f_7">e of Contents</a></span></div></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Results of Operations by Business Segment:</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The tables below sets forth our condensed consolidated results of operations by our two business segments: ROW and U.S., expressed in U.S. dollars and in thousands for the periods presented. Our condensed consolidated financial results for these periods are not necessarily indicative of the consolidated financial results that we will achieve in future periods. Certain totals in the tables below will not sum to exactly 100% due to rounding</span><span style="background-color:#ffffff;color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%">.</span></div><div style="margin-bottom:6pt;margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Summary of select financial results </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">&#8211;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"> ROW</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:25.011%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.233%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.355%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.233%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.911%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.372%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.911%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.372%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.911%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.233%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.772%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.372%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.772%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.233%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.772%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.237%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">For the three months ended June&#160;30,</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Change</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">For the six months ended June&#160;30,</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Change</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">$</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">%</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">$</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Net revenue</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">13,395&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">7,709&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">5,686&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">74&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">23,565&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">13,965&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">9,600&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">69&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Cost of sales</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">17,862&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#ffffff;padding:0 7pt 0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">8,156&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#ffffff;padding:0 7pt 0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">9,706&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">119&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">32,171&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#ffffff;padding:0 7pt 0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">14,008&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#ffffff;padding:0 7pt 0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">18,163&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">130&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Inventory write-down</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">11,961&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#cceeff;padding:0 7pt 0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">3,062&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#cceeff;padding:0 7pt 0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">8,899&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">291&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">11,961&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#cceeff;padding:0 7pt 0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">11,024&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#cceeff;padding:0 7pt 0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">937&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">8&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Gross loss</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(16,428)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(3,509)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(12,919)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">368&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(20,567)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(11,067)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(9,500)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">86&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Gross margin</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(123)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(46)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">N/A</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(77)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">pp</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(87)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(79)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">N/A</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(8)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">pp</span></td></tr></table></div><div style="margin-bottom:6pt;margin-top:12pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Net revenue </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">&#8211;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"> ROW</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:24.872%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.233%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.355%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.233%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.911%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.372%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.911%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.233%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.911%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.233%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.911%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.233%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.911%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.233%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.911%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.237%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">For the three months ended June&#160;30,</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Change</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">For the six months ended June&#160;30,</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Change</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">$</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">%</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">$</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Cannabis flower</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">11,597&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">5,674&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">5,923&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">104&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">21,031&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">8,415&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">12,616&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">150&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Cannabis extracts</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,531&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,917&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(386)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(20)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2,234&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">5,317&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(3,083)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(58)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Other</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">267&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">118&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">149&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">126&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">300&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">233&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">67&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">29&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Net revenue</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">13,395&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">7,709&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">5,686&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">74&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">23,565&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">13,965&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">9,600&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">69&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td></tr></table></div><div style="margin-bottom:6pt;margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">For the three months ended June&#160;30, 2021, the ROW segment reported net revenue of $13.4 million, representing an increase of $5.7 million from the three months ended June&#160;30, 2020. For the six months ended June&#160;30, 2021, the ROW segment reported net revenue of $23.6 million, representing an increase of $9.6 million from the six months ended June&#160;30, 2020. </span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">For both the three and six month comparative periods, the change was primarily due to continued growth of the adult-use cannabis flower market in Canada and sales in the Israeli medical cannabis market.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Cost of sales </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">&#8211;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"> ROW</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">For the three months ended June&#160;30, 2021, the ROW segment reported cost of sales of $17.9 million, representing an increase of $9.7 million from the three months ended June&#160;30, 2020. For the six months ended June&#160;30, 2021, the ROW segment reported cost of sales of $32.2 million, representing an increase of $18.2 million from the six months ended June&#160;30, 2020. </span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">For both the three and six month comparative periods, the increase was primarily due to an increase in sales volume as well as start-up costs associated with new product development in Canada.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Inventory write-downs </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">&#8211;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"> ROW</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">For the three months ended June 30, 2021, the ROW segment reported inventory write-downs of $12.0 million, representing an increase of approximately $8.9 million from the three months ended June 30, 2020. For the six months ended June 30, 2021, the ROW segment reported inventory write-downs of $12.0 million, representing an increase of approximately $0.9 million from the six months ended June 30, 2020.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">For both the three and six month comparative periods, the increase in inventory-write downs primarily relates to cannabis strains and potency levels that are no longer in-line with consumer preferences in the Canadian market and adjustments for obsolete inventory in Canada.</span></div><div style="height:36pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">39</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:36pt;width:100%"><div style="text-align:right"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i93ca9bb01792476fbb225e5d9dec869f_7">Tab</a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i93ca9bb01792476fbb225e5d9dec869f_7">l</a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i93ca9bb01792476fbb225e5d9dec869f_7">e of Contents</a></span></div></div><div style="margin-bottom:6pt;margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Gross loss </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">&#8211;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"> ROW</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">For the three months ended June&#160;30, 2021, the ROW segment reported a gross loss of $16.4 million, representing an increase in losses of $12.9 million from the three months ended June&#160;30, 2020. For the six months ended June&#160;30, 2021, the ROW segment reported a gross loss of $20.6 million, representing an increase in losses of $9.5 million from the six months ended June&#160;30, 2020.</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">For the three month comparative periods, the changes in gross loss and gross margin percentage were primarily due to inventory write-downs, the impact of strategic price reductions on various adult-use cannabis products in Canada in the second half of 2020, as well as start-up costs associated with new product development. For the six month comparative periods, the changes in gross loss and gross margin percentage were primarily due to the impact of strategic price reductions on various adult-use cannabis products in Canada in the second half of 2020, as well as start-up costs associated with new product development.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span><br/></span></div><div id="i93ca9bb01792476fbb225e5d9dec869f_3848290698986"></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Summary of select financial results </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">&#8211;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"> U.S.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:27.094%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.233%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.355%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.233%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.355%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.233%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.355%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.233%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.355%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.233%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.772%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.233%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.772%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.233%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.772%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.239%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">For the three months ended June&#160;30,</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Change</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">For the six months ended June&#160;30,</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Change</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">$</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">%</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">$</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Net revenue</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 7pt 2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2,227</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 7pt 2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2,174</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">53&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 7pt 2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">4,668</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 7pt 2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">4,350</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">318&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">7&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Cost of sales</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,583</span></td><td colspan="3" style="background-color:#ffffff;padding:0 7pt 0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,587</span></td><td colspan="3" style="background-color:#ffffff;padding:0 7pt 0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(4)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2,848</span></td><td colspan="3" style="background-color:#ffffff;padding:0 7pt 0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2,681</span></td><td colspan="3" style="background-color:#ffffff;padding:0 7pt 0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">167&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">6&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Gross profit</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">644</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">587</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">57&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">10&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,820</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,669</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">151&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">9&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Gross margin</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">29&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">27&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">N/A</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">pp</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">39&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">38&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">N/A</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">pp</span></td></tr></table></div><div style="margin-bottom:6pt;margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Net revenue </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">&#8211;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"> U.S.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">For the three months ended June&#160;30, 2021, the U.S. segment reported net revenue of $2.2 million, essentially unchanged from the three months ended June&#160;30, 2020. For the six months ended June&#160;30, 2021, the U.S. segment reported net revenue of $4.7 million, representing an increase of $0.3 million from the six months ended June&#160;30, 2020. </span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">For the six month comparative period, the increase was primarily driven by sales of U.S. hemp-derived CBD products introduced in the second half of 2020.</span></div><div style="margin-bottom:6pt;margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Cost of sales </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">&#8211;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"> U.S.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">For the three months ended June&#160;30, 2021, the U.S. segment reported cost of sales of $1.6 million, essentially unchanged from the three months ended June&#160;30, 2020. For the six months ended June&#160;30, 2021, the U.S. segment reported cost of sales of $2.8 million, representing an increase of $0.2 million from the six months ended June&#160;30, 2020. </span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">For the six months ended June 30, 2021, the increase was primarily due to an increase in sales volumes.</span></div><div style="margin-bottom:6pt;margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Gross profit </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">&#8211;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"> U.S.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">For the three months ended June&#160;30, 2021, the U.S. segment reported gross profit of $0.6&#160;million, essentially unchanged from the three months ended June&#160;30, 2020. For the six months ended June&#160;30, 2021, the U.S. segment reported gross profits of $1.8&#160;million, representing a $0.2&#160;million increase from the six months ended June&#160;30, 2020. </span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">For the six month comparative period, the increase was primarily due to the increase in net revenue, partially offset by higher cost of sales as stated above.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span><br/></span></div><div id="i93ca9bb01792476fbb225e5d9dec869f_154"></div><div style="margin-bottom:12pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Non-GAAP Measures</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Cronos Group reports its financial results in accordance with Generally Accepted Accounting Principles in the United States (&#8220;U.S. GAAP&#8221;). This Quarterly Report refers to measures not recognized under U.S. GAAP (&#8220;non-GAAP measures&#8221;). These non-GAAP measures do not have a standardized meaning prescribed by U.S. GAAP and are therefore unlikely to be comparable to similar measures presented by other companies. Rather, these non-GAAP measures are provided as a supplement to corresponding U.S. GAAP measures to provide additional information regarding the results of operations from management&#8217;s perspective. Accordingly, non-GAAP measures should not be considered a substitute for, or superior to, the financial information prepared and presented in accordance with U.S. GAAP. All non-GAAP measures presented in this Quarterly Report are reconciled to their closest reported U.S. GAAP measure. Reconciliations of historical adjusted financial measures to corresponding U.S. GAAP measures are provided below.</span></div><div style="height:36pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">40</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:36pt;width:100%"><div style="text-align:right"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i93ca9bb01792476fbb225e5d9dec869f_7">Tab</a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i93ca9bb01792476fbb225e5d9dec869f_7">l</a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i93ca9bb01792476fbb225e5d9dec869f_7">e of Contents</a></span></div></div><div style="margin-bottom:3pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Adjusted EBITDA</span></div><div style="margin-bottom:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Management reviews Adjusted EBITDA, a non-GAAP measure which excludes non-cash items and items that do not reflect management&#8217;s assessment of on-going business performance of our operating segments. Management defines Adjusted EBITDA as net income (loss) before interest, tax expense, depreciation and amortization adjusted for: share of loss from equity accounted investments, impairment loss on long-lived assets, loss (gain) on revaluation of derivative liabilities, transaction costs related to strategic projects, other, net, loss from discontinued operations, share-based payments and review costs related to the restatement of the Company&#8217;s 2019 interim financial statements, the Company&#8217;s responses to the reviews of such interim financial statements by various regulatory authorities and legal costs defending shareholder class action complaints brought against the Company as a result of the restatement (see Part II, Item 1. &#8220;Legal Proceedings&#8221; of this Quarterly Report for a discussion of the regulatory reviews and shareholder class action complaints relating to the restatement of the 2019 interim financial statements).</span></div><div style="margin-bottom:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Management believes that Adjusted EBITDA provides the most useful insight into underlying business trends and results and provides a more meaningful comparison of period-over-period results. Management uses Adjusted EBITDA for planning, forecasting and evaluating business and financial performance, including allocating resources and evaluating results relative to employee compensation targets.</span></div><div style="margin-bottom:3pt;text-align:justify"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table sets forth a reconciliation of net loss as determined in accordance with GAAP to Adjusted EBITDA for the periods indicated (dollars in thousands):</span></div><div style="margin-bottom:9pt;margin-top:9pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:42.650%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.233%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.772%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.233%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.772%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.233%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.772%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.235%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="21" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Three months ended June&#160;30, 2021</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">United States</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Rest of World</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Corporate<br/>Expenses</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Total</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Net income (loss)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(11,719)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">79,627&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(11,133)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 7pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">56,775</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Interest income, net</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(20)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(2,273)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(2,293)</span></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Share of loss from equity accounted investments</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,115&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,115</span></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:11.25pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Gain on revaluation of derivative liabilities</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:100%;position:relative;top:-3.15pt;vertical-align:baseline">(ii)</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(115,248)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(115,248)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Transaction costs</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:100%;position:relative;top:-3.15pt;vertical-align:baseline">(iii)</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2,758&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2,758</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:11.25pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Other, net</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:100%;position:relative;top:-3.15pt;vertical-align:baseline">(iv)</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(1,127)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(1,127)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:11.25pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Loss from discontinued operations</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:100%;position:relative;top:-3.15pt;vertical-align:baseline">(v)</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">561&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">561</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:11.25pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Share-based payments</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:100%;position:relative;top:-3.15pt;vertical-align:baseline">(vi)</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">822&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,743&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2,565</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:11.25pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Review costs related to restatement of 2019 interim financial statements</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:100%;position:relative;top:-3.15pt;vertical-align:baseline">(vii)</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,932&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,932</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Depreciation and amortization</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">206&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2,997&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">3,203</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Adjusted EBITDA</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(10,711)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(32,605)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(6,443)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(49,759)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="margin-bottom:9pt;margin-top:9pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:42.650%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.233%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.772%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.233%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.772%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.233%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.772%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.235%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="21" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Three months ended June&#160;30, 2020</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">United States</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Rest of World</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Corporate<br/>Expenses</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Total</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Net loss</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(45,566)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(55,095)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(7,042)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(107,703)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Interest income, net</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(9)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(3,725)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(3,734)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Share of loss from equity accounted investments</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">794&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">794&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Impairment loss on long-lived assets</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:100%;position:relative;top:-3.15pt;vertical-align:baseline">(i)</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">40,000&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">40,000&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Loss on revaluation of derivative liabilities</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:100%;position:relative;top:-3.15pt;vertical-align:baseline">(ii)</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">35,880&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">35,880&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Other, net</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:100%;position:relative;top:-3.15pt;vertical-align:baseline">(iv)</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">9&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">9&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Loss from discontinued operations</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:100%;position:relative;top:-3.15pt;vertical-align:baseline">(v)</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">46&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">46&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Share-based payments</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:100%;position:relative;top:-3.15pt;vertical-align:baseline">(vi)</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">756&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,790&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2,546&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Review costs related to restatement of 2019 interim financial statements</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:100%;position:relative;top:-3.15pt;vertical-align:baseline">(vii)</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">3,459&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">3,459&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Depreciation and amortization</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">34&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,683&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,717&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Adjusted EBITDA</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(4,785)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(18,618)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(3,583)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(26,986)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="height:36pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">41</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:36pt;width:100%"><div style="text-align:right"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i93ca9bb01792476fbb225e5d9dec869f_7">Tab</a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i93ca9bb01792476fbb225e5d9dec869f_7">l</a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i93ca9bb01792476fbb225e5d9dec869f_7">e of Contents</a></span></div></div><div style="margin-bottom:9pt;margin-top:9pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:42.650%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.233%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.772%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.233%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.772%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.233%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.772%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.235%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="21" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Six months ended June&#160;30, 2021</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">United States</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Rest of World</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Corporate<br/>Expenses</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Total</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Net loss</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(23,811)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(62,520)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(18,519)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(104,850)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Interest income, net</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(23)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(4,599)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(4,622)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Share of loss from equity accounted investments</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2,758&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2,758&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Impairment loss on long-lived assets</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:100%;position:relative;top:-3.15pt;vertical-align:baseline">(i)</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,741&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,741&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Loss on revaluation of derivative liabilities</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:100%;position:relative;top:-3.15pt;vertical-align:baseline">(ii)</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,626&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,626&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Transaction costs</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:100%;position:relative;top:-3.15pt;vertical-align:baseline">(iii)</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">3,259&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">3,259&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Other, net</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:100%;position:relative;top:-3.15pt;vertical-align:baseline">(iv)</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(911)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(911)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Loss from discontinued operations</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:100%;position:relative;top:-3.15pt;vertical-align:baseline">(v)</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">582&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">582&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Share-based payments</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:100%;position:relative;top:-3.15pt;vertical-align:baseline">(vi)</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,567&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">3,497&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">5,064&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Review costs related to restatement of 2019 interim financial statements</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:100%;position:relative;top:-3.15pt;vertical-align:baseline">(vii)</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">3,937&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">3,937&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Depreciation and amortization</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">305&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">4,778&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">5,083&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Adjusted EBITDA</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(20,221)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(54,789)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(11,323)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(86,333)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="margin-bottom:9pt;margin-top:9pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:42.650%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.233%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.772%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.233%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.772%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.233%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.772%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.235%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="21" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Six months ended June&#160;30, 2020</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">United States</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Rest of World</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Corporate<br/>Expenses</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Total</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Net income (loss)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(52,082)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">33,772&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(13,712)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 7pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(32,022)</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Interest income, net</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(16)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(11,469)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(11,485)</span></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Share of loss from equity accounted investments</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,966&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,966</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Impairment loss on long-lived assets</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:100%;position:relative;top:-3.15pt;vertical-align:baseline">(i)</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">40,000&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">40,000</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Gain on revaluation of derivative liabilities</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:100%;position:relative;top:-3.15pt;vertical-align:baseline">(ii)</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(77,488)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(77,488)</span></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Other, net</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:100%;position:relative;top:-3.15pt;vertical-align:baseline">(iv)</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(785)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(785)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Loss from discontinued operations</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:100%;position:relative;top:-3.15pt;vertical-align:baseline">(v)</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">46&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">46</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Share-based payments</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:100%;position:relative;top:-3.15pt;vertical-align:baseline">(vi)</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,462&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">3,520&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">4,982</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Review costs related to restatement of 2019 interim financial statements</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.85pt;font-weight:400;line-height:100%;position:relative;top:-3.15pt;vertical-align:baseline">(vii)</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">7,866&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">7,866</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Depreciation and amortization</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">69&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2,810&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2,879</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Adjusted EBITDA</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(10,567)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(47,628)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(5,846)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 7pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(64,041)</span></td></tr></table></div><div style="margin-bottom:3pt;margin-top:3pt;padding-left:27pt;text-align:justify;text-indent:-27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:400;line-height:120%;position:relative;top:-2.8pt;vertical-align:baseline">(i)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:22.1pt">For the six months ended June 30, 2021, impairment loss on long-lived assets relates to impairment on a leased premise in the U.S. segment, and for the three and six months ended June 30, 2020, impairment loss on long-lived assets relates to impairment on goodwill and intangibles related to our U.S. segment in 2020. See Note 12. Impairment Loss on Long-Lived Assets to the Company&#8217;s condensed consolidated financial statements under Item 1. &#8220;Financial Statements&#8221; of this Quarterly Report.</span></div><div style="margin-bottom:3pt;margin-top:3pt;padding-left:27pt;text-align:justify;text-indent:-27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:400;line-height:120%;position:relative;top:-2.8pt;vertical-align:baseline">(ii)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:20.66pt">For the three and six months ended June 30, 2021 and 2020, gain/loss on revaluation of derivative liabilities represents the fair value changes on the derivative liabilities. See Note 5. Derivative Liabilities to the Company&#8217;s condensed consolidated financial statements under Item 1. &#8220;Financial Statements&#8221; of this Quarterly Report.</span></div><div style="margin-bottom:3pt;margin-top:3pt;padding-left:27pt;text-align:justify;text-indent:-27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:400;line-height:120%;position:relative;top:-2.8pt;vertical-align:baseline">(iii)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:19.22pt">For the three and six months ended June 30, 2021, transaction costs represents legal, financial and other advisory fees and expenses incurred in connection with various strategic investments. These costs are included in general and administrative expenses on the condensed consolidated statements of net income (loss) and comprehensive income (loss) under Item 1. &#8220;Financial Statements&#8221; of this Quarterly Report.</span></div><div style="margin-bottom:3pt;margin-top:3pt;padding-left:27pt;text-align:justify;text-indent:-27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:400;line-height:120%;position:relative;top:-2.8pt;vertical-align:baseline">(iv)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:19.5pt">For the three and six months ended June 30, 2021, other, net, primarily related to gain recorded on sale of the Company&#8217;s Winnipeg facility previously designated as held-for-sale in the first quarter of 2021, For the three and six months ended June 30, 2020, other, net is primarily comprised of the gain recorded related to the sale of common shares of Aurora Cannabis Inc. (&#8220;Aurora&#8221;), which were received in connection with the achievement of a milestone related to Aurora&#8217;s acquisition of Whistler Medical Marijuana Corporation.</span></div><div style="margin-bottom:3pt;margin-top:3pt;padding-left:27pt;text-align:justify;text-indent:-27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:400;line-height:120%;position:relative;top:-2.8pt;vertical-align:baseline">(v)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:20.94pt">For the three and six months ended June 30, 2020, loss from discontinued operations relates to the discontinuance of OGBC. See Note 11. Held-For-Sale Assets and Discontinued Operations to the Company&#8217;s condensed consolidated financial statements under Item 1. &#8220;Financial Statements&#8221; of this Quarterly Report.</span></div><div style="margin-bottom:3pt;margin-top:3pt;padding-left:27pt;text-align:justify;text-indent:-27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:400;line-height:120%;position:relative;top:-2.8pt;vertical-align:baseline">(vi)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:19.5pt">For the three and six months ended June 30, 2021 and 2020, share-based payments relates to the vesting expenses of share-based compensation awarded to employees under the Company&#8217;s share-based award plans as described in Note 6. Share-based Payments to the Company&#8217;s condensed consolidated financial statements under Item 1. &#8220;Financial Statements&#8221; of this Quarterly Report.</span></div><div style="margin-bottom:3pt;margin-top:3pt;padding-left:27pt;text-align:justify;text-indent:-27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:400;line-height:120%;position:relative;top:-2.8pt;vertical-align:baseline">(vii)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:18.06pt">For the three and six months ended June 30, 2021 and 2020, the financial statement review costs include costs related to the restatement of the Company&#8217;s 2019 interim financial statements, costs related to the Company&#8217;s responses to requests for information from various regulatory authorities relating to such restatement and legal costs defending shareholder class action complaints brought against the Company as a result of the restatement. </span></div><div><span><br/></span></div><div style="height:36pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">42</span></div></div></div><div id="i93ca9bb01792476fbb225e5d9dec869f_157"></div><hr style="page-break-after:always"/><div style="min-height:36pt;width:100%"><div style="text-align:right"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i93ca9bb01792476fbb225e5d9dec869f_7">Tab</a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i93ca9bb01792476fbb225e5d9dec869f_7">l</a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i93ca9bb01792476fbb225e5d9dec869f_7">e of Contents</a></span></div></div><div style="margin-bottom:12pt;margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Liquidity and Capital Resources</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">As of June&#160;30, 2021, we had $895.2 million in cash and cash equivalents and $201.7 million in short-term investments, which comprise the majority of the Company&#8217;s cash position. Cronos Group believes that the existing cash and cash equivalents and the short-term investments will be sufficient to fund the business operations and capital expenditures over the next twelve months. </span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">The following table summarizes the cash flows from operating, investing and financing activities (dollars in thousands):</span></div><div style="margin-bottom:6pt;text-align:justify"><span><br/></span></div><div style="margin-bottom:6pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:59.872%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:17.372%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:1.883%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:17.373%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">For the six months ended June&#160;30,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cash used in operating activities</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(86,197)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(78,377)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cash provided/(used) in investing activities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(106,563)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">39,799&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cash provided/(used) in financing activities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(8,907)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Effect of foreign currency translation on cash and cash equivalents</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">18,825&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(51,416)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net change in cash</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(182,842)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(89,993)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="margin-bottom:6pt;margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Comparison of the six months ended June&#160;30, 2021 to the six months ended June&#160;30, 2020</span></div><div style="margin-bottom:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Operating&#160;activities</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">During the six months ended June 30, 2021,&#160;we&#160;used $86.2 million of cash in operating activities as compared to cash used of $78.4 million in the six months ended June 30, 2020, representing an increase in cash used of $7.8 million. This&#160;change is primarily driven by a $32.0 million decrease in net income after adjusting for non-cash items, partially offset by an increase of $24.2 million in operating assets and liabilities during the six months ended June 30, 2021 compared to the six months ended June 30, 2020.</span></div><div style="margin-bottom:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Investing&#160;activities</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">During the six months ended June 30, 2021,&#160;we used $106.6 million of cash in investing activities, compared to $39.8 million&#160;of cash provided by investing activities during the six months ended June 30,&#160;2020, representing an increase of $146.4 million in cash used by investing activities.&#160;This change is primarily driven by the Company&#8217;s investment in PharmaCann of approximately $110.4 million, a $63.1 million, net, decrease in proceeds from short-term investments and a $1.3 million increase in proceeds from the sale of other assets, partially offset by a $18.9 million decrease in loans receivables from joint ventures and a $6.9 million decrease in capital expenditures compared to the six months ended June 30, 2020. The decrease in capital expenditures is primarily due to a reduction in construction costs in the ROW segment and a decrease in costs related to the implementation of the Company&#8217;s enterprise resource planning system compared to the six months ended June 30, 2020.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Financing&#160;activities</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">During the six months ended June 30, 2021,&#160;cash used in financing activities was $8.9 million higher than six months ended June 30, 2020. This change is primarily driven by&#160;an increase of $8.9 million in withholding taxes paid on share-based awards during the six months ended June 30, 2021 compared to the six months ended June 30, 2020.</span></div><div style="margin-bottom:6pt;text-align:justify"><span><br/></span></div><div id="i93ca9bb01792476fbb225e5d9dec869f_160"></div><div style="margin-bottom:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Critical Accounting Policies and Estimates</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company&#8217;s critical accounting policies and estimates are discussed in the 2020 Annual Report. There have been no material changes to these critical accounting policies and estimates.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span><br/></span></div><div style="height:36pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">43</span></div></div></div><div id="i93ca9bb01792476fbb225e5d9dec869f_163"></div><hr style="page-break-after:always"/><div style="min-height:36pt;width:100%"><div style="text-align:right"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i93ca9bb01792476fbb225e5d9dec869f_7">Tab</a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i93ca9bb01792476fbb225e5d9dec869f_7">l</a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i93ca9bb01792476fbb225e5d9dec869f_7">e of Contents</a></span></div></div><div style="margin-bottom:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Item 3. Quantitative and Qualitative Disclosures About Market Risk.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Interest rate risk</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Interest rate risk is the risk that the value or yield of fixed-income investments may decline if interest rates change. Fluctuations in interest rates may impact the level of income and expense recorded on the cash equivalents and short-term investments, and the market value of all interest-earning assets, other than those which possess a short-term to maturity. A 10% change in the interest rate in effect on June&#160;30, 2021 and December 31, 2020, would not have a material effect on (i) fair value of the cash equivalents and short-term investments as the majority of the portfolio has a maturity date of three months or less or (ii) interest income. Management continues to monitor external interest rates and revise the Company&#8217;s investment strategy as a result. </span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">During the three months ended June&#160;30, 2021 and 2020, the Company recorded net interest income of $2.3 million and $3.7 million, respectively. During the six months ended June&#160;30, 2021 and 2020, the Company recorded net interest income of $4.6 million and $11.5 million, respectively. Net interest income in the first half of 2021 decreased compared to the first half of 2020 primarily due to lower interest earning assets during the six months ended June&#160;30, 2021 compared to the interest earning assets during the six months ended June 30, 2020.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Foreign currency risk</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company&#8217;s consolidated financial statements included in Part I, Item 1. of this Quarterly Report are expressed in U.S. dollars. In addition. the Company has net assets, liabilities and revenues denominated in foreign currencies, including Canadian dollars and Israeli new shekels. As a result, we are exposed to foreign currency translation gains and losses. Revenue and expenses of all foreign operations are translated into U.S. dollars at the foreign currency exchange rates that approximate the rates in effect during the period when such items are recognized. Appreciating foreign currencies relative to the U.S. dollar will adversely impact operating income and net earnings, while depreciating foreign currencies relative to the U.S. dollar will have a positive impact.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">A 10% change in the exchange rates for the Canadian dollar would affect the carrying value of net assets by approximately $163.0 million and $170.8 million as of June&#160;30, 2021 and December 31, 2020, respectively. The corresponding impact would be recorded in accumulated other comprehensive income. We have not historically engaged in hedging transactions and do not currently contemplate engaging in hedging transactions to mitigate foreign exchange risks. As we continue to recognize gains and losses in foreign currency transactions, depending upon changes in future currency rates, such gains or losses could have a significant, and potentially adverse, effect on the Company&#8217;s results of operations.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span><br/></span></div><div style="height:36pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">44</span></div></div></div><div id="i93ca9bb01792476fbb225e5d9dec869f_166"></div><hr style="page-break-after:always"/><div style="min-height:36pt;width:100%"><div style="text-align:right"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i93ca9bb01792476fbb225e5d9dec869f_7">Tab</a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i93ca9bb01792476fbb225e5d9dec869f_7">l</a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i93ca9bb01792476fbb225e5d9dec869f_7">e of Contents</a></span></div></div><div style="margin-bottom:12pt;margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Item 4. Controls and Procedures.</span></div><div style="margin-bottom:6pt;margin-top:6pt;padding-left:36pt;text-align:justify;text-indent:-36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">(a)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;padding-left:24.34pt">Evaluation of Disclosure Controls and Procedures. </span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company&#8217;s management, with the participation of the Chief Executive Officer and the Chief Financial Officer, performed an evaluation of the disclosure controls and procedures, as defined in Rules 13a-15(e) and 15d-15(e) of the Securities Exchange Act of 1934 (the &#8220;Exchange Act&#8221;), as of June&#160;30, 2021. Based on that evaluation, management has concluded that, as of June&#160;30, 2021, due to the existence of a material weakness in the Company&#8217;s internal control over financial reporting described below, the disclosure controls and procedures were not effective to provide reasonable assurance that the information required to be disclosed by us in reports we file or submit under the Exchange Act were recorded, processed, summarized and reported within the time periods specified in the rules and forms of the SEC, and to ensure that the information required to be disclosed by us in reports that we file or submit under the Exchange Act, is accumulated and communicated to management, including the principal executive officer and principal financial officer, as appropriate, to allow timely decisions regarding required disclosure.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Material Weakness in Internal Controls Over Financial Reporting</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">A material weakness is a deficiency, or combination of deficiencies in internal controls over financial reporting, such that there is a reasonable possibility that a material misstatement of the annual or interim financial statements will not be prevented or detected on a timely basis. As previously disclosed in the Company&#8217;s Annual Report on Form 10-K for the year ended December 31, 2020 (the &#8220;Annual Report&#8221;), we have identified the following material weakness:</span></div><div style="margin-bottom:6pt;margin-top:6pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;padding-left:14.5pt">Inventory Verification:</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> The Company failed to properly design and execute sufficient procedures to verify inventory quantities. Specifically, while inventory counts were performed in the fourth quarter, (i) the aggregate value of items excluded from the count exceeded the Company&#8217;s materiality threshold, and (ii) human error in count execution, data transposition and reconciliation analysis resulted in inaccurate adjustments.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">This deficiency did not result in errors that were quantitatively material. Nevertheless, the deficiency creates a reasonable possibility that a material misstatement to the consolidated financial statements will not be prevented or detected on a timely basis.</span></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Remediation Plan and Status</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company&#8217;s management, with oversight from the Audit Committee of the Board of Directors, has initiated a plan to remediate the material weakness, previously disclosed in the Annual Report. During the six months ended June&#160;30, 2021, the Company started the implementation process on all remediation controls identified in its remediation plan as disclosed in the table below. The Company does not expect full remediation until year end 2021.</span></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The plan and progress to date is described below:</span><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:9.872%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:1.327%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:48.483%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:1.327%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.011%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:1.327%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.011%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:1.327%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.015%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Material Weakness</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Control, Control Enhancement or Mitigant</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Implementation Status</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Management Testing Status</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Remediation Status</span></td><td colspan="3" style="display:none"></td></tr><tr style="height:35pt"><td colspan="3" rowspan="3" style="border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Inventory Verification</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:middle"><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;padding-left:14.5pt">Enhance count procedures to ensure appropriate consideration and coverage of their total inventory balance</span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">In Progress</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Not Tested</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Not Remediated</span></td><td colspan="3" style="display:none"></td></tr><tr style="height:35pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:middle"><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;padding-left:14.5pt">Implement cycle counts as a redundant control to supplement the annual physical count</span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Completed</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Not Tested</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Not Remediated</span></td><td colspan="3" style="display:none"></td></tr><tr style="height:35pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:middle"><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;padding-left:14.5pt">Provide training to inventory teams on count procedures and inventory management control expectations</span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">In Progress</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Not Tested</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Not Remediated</span></td><td colspan="3" style="display:none"></td></tr></table></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span><br/></span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Cronos Group will continue to review, optimize, and enhance its financial reporting controls and procedures. As the Company continues to evaluate and work to improve its internal control over financial reporting, the Company may implement additional measures to address the material weakness or certain of the remediation measures described above may be enhanced or modified. The material weakness will not be considered remediated until the applicable remediated controls operate for a sufficient period of time and management has concluded, through further testing, that these controls are operating effectively.</span></div><div style="margin-bottom:6pt;margin-top:6pt;padding-left:36pt;text-align:justify;text-indent:-36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">(b)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;padding-left:24.34pt">Changes in Internal Control over Financial Reporting</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Other than those measures described above to remediate the material weaknesses, there were no changes in the Company&#8217;s internal control over financial reporting (as defined in Rules 13a-15(f) and 15d-15(f) under the Exchange Act), that occurred during the quarter ended June&#160;30, 2021, that have materially affected, or are reasonably likely to materially affect, the Company&#8217;s internal control over financial reporting. </span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span><br/></span></div><div style="height:36pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">45</span></div></div></div><div id="i93ca9bb01792476fbb225e5d9dec869f_172"></div><hr style="page-break-after:always"/><div style="min-height:36pt;width:100%"><div style="text-align:right"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i93ca9bb01792476fbb225e5d9dec869f_7">Table of Contents</a></span></div></div><div style="margin-bottom:6pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">PART II<br/>OTHER INFORMATION</span></div><div style="margin-bottom:6pt;text-align:center"><span><br/></span></div><div id="i93ca9bb01792476fbb225e5d9dec869f_175"></div><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Item 1: Legal Proceedings. </span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The information set forth under Note 9(b), Contingencies, to the Company&#8217;s condensed consolidated financial statements included in Part I, Item 1. &#8220;Financial Statements&#8221; of this Quarterly Report is incorporated herein by reference.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span><br/></span></div><div id="i93ca9bb01792476fbb225e5d9dec869f_178"></div><div style="margin-bottom:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Item 1 A: Risk Factors.</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">An investment in us involves a number of risks. A detailed discussion of our risk factors appears in Part I, Item 1A. Risk Factors of the Annual Report. Any of the matters highlighted in the risk factors described in the Annual Report and the risk factor below could adversely affect our business, results of operations and financial condition, causing an investor to lose all, or part of, its, his or her investment. The risks and uncertainties described in the Annual Report and below are those we currently believe to be material, but they are not the only ones we face. If any of the risks described in the Annual Report, the following risk factor, or any other risks and uncertainties that we have not yet identified or that we currently consider not to be material, actually occur or become material risks, our business, prospects, financial condition, results of operations and cash flows and consequently the price of our securities could be materially and adversely affected.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Our U.S. strategy in part depends on the success of the PharmaCann Investment and there is no guarantee that we will exercise the PharmaCann Option in the near term, or at all, and, even if exercised, that the PharmaCann Investment will achieve the expected benefits of the transaction.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our ability to exercise the PharmaCann Option will depend on the satisfaction of several conditions, including U.S. federal cannabis legalization. In addition, our ability to exercise the PharmaCann Option is subject to the receipt of any required regulatory approvals, including in the states where PharmaCann operates that may be required upon exercise, as well as Altria&#8217;s approval under the Investor Rights Agreement. These conditions are outside of our control and therefore there can be no certainty that the PharmaCann Option will be exercised in the near term, or at all. If the PharmaCann Option is not exercised, we will not receive the benefits of the contemplated commercial arrangements between us and PharmaCann. </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In addition, the regulatory approval processes in connection with the exercise of any PharmaCann Option may take a prolonged period of time to complete, which could significantly delay our ability to exercise the PharmaCann Option and realize the benefits of the PharmaCann Investment, or result in our not being able to exercise all or part of the PharmaCann Option. Furthermore, in connection with obtaining approvals from or otherwise satisfying the requests of the state regulators or applicable laws, we may be required to divest all or a portion of the PharmaCann Option, or if after the exercise of the PharmaCann Option, our shares of PharmaCann. </span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Even if we are able to and do exercise the PharmaCann Option, the intended benefits of the PharmaCann Investment may not be realized. We cannot assure you that the PharmaCann Investment will be accretive to us in the near term or at all. For example, if entered into, the commercial arrangements between us and PharmaCann may not be successful or beneficial to us. Furthermore, if we fail to realize the intended benefits of the PharmaCann Investment, our stock price could decline to the extent that the market price anticipates those benefits.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We are entitled to certain limited governance rights with respect to PharmaCann, including limited information rights and board observer rights. Therefore, we will have little to no ability to influence the strategy and material decisions of PharmaCann&#8217;s business. Furthermore, until such time as we exercise the PharmaCann Option, we will not have the ability to vote on matters requiring the vote of PharmaCann&#8217;s shareholders and, until the exercise of the PharmaCann Option, will not have the right to appoint directors to the PharmaCann board of directors. Even after exercising the PharmaCann Option, we are entitled to appoint a director of PharmaCann&#8217;s board only if we continue to own at least 10% of the outstanding capital stock of PharmaCann, and in any event may appoint no more than two directors. In addition, we are subject to certain standstill restrictions, both prior to and after the exercise of the PharmaCann Option, which restrictions further limit our ability to influence decisions of PharmaCann.</span></div><div style="text-align:justify"><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Although we are entitled to certain anti-dilution protections with respect to our investment in PharmaCann, such protections are subject to various conditions, and our potential ownership in PharmaCann may be significantly diluted by, among other things, future issuances of PharmaCann securities or </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">bona fide</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> acquisition activity in which PharmaCann uses its equity as consideration. Any such activity could be significantly dilutive to our ownership in PharmaCann and may adversely impact the potential benefits we may realize from the PharmaCann Investment.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span><br/></span></div><div style="height:36pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">46</span></div></div></div><div id="i93ca9bb01792476fbb225e5d9dec869f_181"></div><hr style="page-break-after:always"/><div style="min-height:36pt;width:100%"><div style="text-align:right"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i93ca9bb01792476fbb225e5d9dec869f_7">Table of Contents</a></span></div></div><div style="margin-bottom:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Item 2. Unregistered Sales of Equity Securities and Use of Proceeds.</span></div><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">None.</span></div><div style="margin-bottom:6pt"><span><br/></span></div><div id="i93ca9bb01792476fbb225e5d9dec869f_184"></div><div style="margin-bottom:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Item 3. Defaults Upon Senior Securities. </span></div><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">None.</span></div><div style="margin-bottom:6pt"><span><br/></span></div><div id="i93ca9bb01792476fbb225e5d9dec869f_187"></div><div style="margin-bottom:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Item 4. Mine Safety Disclosures.</span></div><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Not applicable.</span></div><div style="margin-bottom:6pt"><span><br/></span></div><div id="i93ca9bb01792476fbb225e5d9dec869f_190"></div><div style="margin-bottom:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Item 5. Other Information.</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On August 5, 2021, the Board of Directors (the &#8220;Board&#8221;) of Cronos Group Inc. (&#8220;Cronos Group&#8221;) appointed Robert Madore (age 56) as Chief Financial Officer of Cronos Group, effective as of August 9, 2021 (the &#8220;Effective Date&#8221;).  As of August 9, 2021, Jerry Barbato will transition from the position of Chief Financial Officer of Cronos Group.        </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;text-decoration:underline">Madore Agreement</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In connection with Mr. Madore&#8217;s appointment, Cronos USA Client Services LLC (&#8220;Cronos USA&#8221;), Cronos Group and Mr. Madore entered into an executive employment agreement (the &#8220;Madore Agreement&#8221;) setting forth the terms and conditions of Mr. Madore&#8217;s employment.  The Madore Agreement provides for annual base salary of $450,000, annual target bonus opportunity of 125% of base salary starting in the 2022 fiscal year, an initial annual long-term target incentive opportunity of $787,500 starting in the 2022 fiscal year, and participation in the employee benefit programs of Cronos USA or Cronos Group, as applicable.  In addition, Mr. Madore will receive a sign-on bonus in the form of a one-time lump sum cash payment of $372,000, which will be earned, subject to the terms of the Madore Agreement, on the first anniversary of the Effective Date, and a one-time sign-on grant of equity-based awards, comprised of (a) 900,000 non-qualified stock options that vest ratably on a quarterly basis over a four-year period following the date of grant and have an exercise price equal to the fair market value of the common shares of Cronos Group (the &#8220;Common Shares&#8221;) on the trading day prior to the grant date and (b) 50,000 restricted share units that vest on the third anniversary of the grant date and settle in Common Shares on a one for one basis.  </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In the event Mr. Madore&#8217;s employment is terminated by Cronos USA without Just Cause or he resigns for Good Reason (each, as defined in the Madore Agreement), he would be entitled to a severance payment in the amount equal to one year of his annual base salary, employee benefit continuation for up to one year following termination and a pro-rated annual bonus for the year of termination, in each case subject to Mr. Madore entering into a customary release of claims in favor of Cronos Group and its affiliates and related entities.  Upon termination of Mr. Madore&#8217;s employment, treatment of any outstanding equity-based awards will be governed by the terms and conditions of any applicable plan and award agreement.  </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Mr. Madore is subject to ongoing confidentiality and mutual non-disparagement provisions, non-competition and customer non-solicitation covenants during his employment and upon termination of his employment for any reason for the one-year period following termination and an employee non-solicitation covenant for the two-year period following termination, subject to customary exceptions.                 </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Mr. Madore most recently served as Chief Financial Officer of MacAndrews &amp; Forbes Incorporated, an operator of a diverse range of businesses, from January 2021 until March 2021. Prior to MacAndrews &amp; Forbes Incorporated, Mr. Madore served as Executive Vice President and Chief Financial Officer of American Eagle Outfitters Inc. from 2016 through 2020. Prior to joining American Eagle Outfitters Inc., Mr. Madore served in a number of key financial and operational roles at Ralph Lauren Corporation beginning in 2004 through 2016, most recently as Senior Vice President and Chief Financial Officer from April 2015 to September 2016. Before joining Ralph Lauren Corporation, Mr. Madore was Executive Vice President and Chief Financial Officer for New York &amp; Company from 2003 to 2004, and served as Chief Operating Officer and Chief Financial Officer of FutureBrand, a division of McCann Erickson, from 2001 to 2003. Before that, he held various executive management positions at Nine West Group, Inc. from 1995 through 2000. Mr. Madore began his career in 1987 at Deloitte &amp; Touche LLP in audit services and worked in the firm&#8217;s mergers and acquisitions practice from 1993 until 1995. Mr. Madore received a Bachelor of Science from the Southern Connecticut State University, New Haven. Mr. Madore does not have any family relationships with any of Cronos Group&#8217;s directors or executive officers, and is not a party to any transactions listed in Item 404(a) of Regulation S-K.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span><br/></span></div><div style="height:36pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">47</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:36pt;width:100%"><div style="text-align:right"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i93ca9bb01792476fbb225e5d9dec869f_7">Table of Contents</a></span></div></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;text-decoration:underline">Barbato Agreement</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In connection with Mr. Barbato&#8217;s transition from his role as Chief Financial Officer of Cronos Group, Hortican Inc. (&#8220;Hortican&#8221;) and Cronos Group entered into a letter agreement with Mr. Barbato (the &#8220;Barbato Agreement&#8221;). Under the Barbato Agreement, Mr. Barbato will cease serving as Chief Financial Officer of Cronos Group on August 9, 2021 and will continue to be employed by the Company and assist with the transition of his duties and responsibilities to Mr. Madore as successor Chief Financial Officer of Cronos Group until September 9, 2021 (the &#8220;Separation Date&#8221;, and the period from the August 9, 2021 to the Separation Date, the &#8220;Transition Period&#8221;).  During the Transition Period, Mr. Barbato will be entitled to receive the same base salary as applicable under Mr. Barbato&#8217;s prior employment agreement with Cronos Group and Hortican. Mr. Barbato will generally remain eligible to receive (a) annual bonuses of $155,762 for Cronos Group&#8217;s 2019 fiscal year, $201,411 for Cronos Group&#8217;s 2020 fiscal year and $130,585 for Cronos Group&#8217;s 2021 fiscal year (based on target performance and prorated based on the number of complete months of such fiscal year of employment prior to the Separation Date) and (b) annual grants of restricted share units equal to $298,480 for Cronos Group&#8217;s 2020 fiscal year and $298,480 for Cronos Group&#8217;s 2021 fiscal year (each, an &#8220;LTI Grant&#8221;).  Any annual bonus and LTI Grant awards Mr. Barbato is eligible to receive under the Barbato Agreement are contingent on the conclusion of the currently pending investigations (the &#8220;Investigations&#8221;) by the U.S. Securities and Exchange Commission (&#8220;SEC&#8221;) and Ontario Securities Commission (&#8220;OSC&#8221;) into Cronos Group, and the Investigations not resulting in a penalty being levied by the SEC and/or the OSC against Mr. Barbato personally or against Cronos on account of any misconduct, mismanagement or failure to supervise by Mr. Barbato (the &#8220;Payment Condition&#8221;).  The LTI Grants will vest on what would have been their original vesting schedules, based on the vesting dates applicable to grants in respect of the 2020 and 2021 fiscal years made to other Cronos Group named executive officers; provided that any portion of the awards that would have vested prior to the date of grant will be deemed to vest on the date of grant.  Any outstanding equity-based awards that are held by Mr. Barbato as of the Separation Date will remain outstanding and will vest and be settled on the times set forth in the applicable award agreements, subject to the Payment Condition and Mr. Barbato&#8217;s compliance with his post-employment obligations. Subject to the Payment Condition, any unvested or unpaid amounts of the LTI Grants will vest and be settled immediately upon a Change of Control of Cronos Group (as defined in the Cronos Group Inc. Amended and Restated 2018 Stock Option Plan).</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Following the Separation Date, Mr. Barbato will be entitled to severance equal to 6 months&#8217; base salary and benefit continuation for 6 months, subject to Mr. Barbato&#8217;s entering into a release of claims in favor of Cronos Group and its affiliates and related entities.  Mr. Barbato will also be reimbursed for expenses incurred for annual tax return services for the 2019, 2020 and 2021 tax years in an amount not to exceed $15,000 per tax year and relocation expenses in an amount not to exceed $20,000. Pursuant to the Barbato Agreement, Mr. Barbato is subject to the ongoing non-disparagement provision. In connection with the Barbato Agreement, Mr. Barbato reaffirmed the ongoing confidentiality and intellectual property provisions, and non-competition, which will not apply to Mr. Barbato obtaining employment with Altria Group, and non-solicitation requirements contained in the Executive Employment Agreement, effective as of April 15, 2019, by and among Hortican, Mr. Barbato and Cronos Group.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The foregoing descriptions of the Madore Agreement and Barbato Agreement do not purport to be complete and are qualified in its entirety by reference to the full text of the Madore Agreement and Barbato Agreement, which are attached hereto as Exhibits 10.3 and 10.4, respectively, and incorporated herein by reference.</span></div><div style="height:36pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">48</span></div></div></div><div id="i93ca9bb01792476fbb225e5d9dec869f_193"></div><hr style="page-break-after:always"/><div style="min-height:36pt;width:100%"><div style="-sec-extract:summary;text-align:right"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i93ca9bb01792476fbb225e5d9dec869f_7">Table of Contents</a></span></div></div><div style="-sec-extract:summary;margin-bottom:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Item 6. Exhibits</span></div><div style="margin-bottom:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The exhibits listed in the Exhibit Index immediately below are filed as part of this Quarterly Report, which Exhibit Index is corporate by reference herein. </span><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:8.761%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:2.577%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:86.262%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Exhibit Number</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Exhibit Index</span></td></tr><tr><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.1+</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/1656472/000165647221000075/ex21to8k.htm">Option Purchase Agreement, dated June 14, 2021, by and between Cronos USA Holdings Inc. and PharmaCann Inc. (incorporated by reference to Exhibit 2.1 to the Current Report on Form 8-K of Cronos Group Inc., filed June 15, 2021).</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.2</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/1656472/000165647221000075/ex22to8k.htm">Option, dated June 14, 2021, issued by PharmaCann Inc. to Cronos USA Holdings Inc. (incorporated by reference to Exhibit 2.2 to the Current Report on Form 8-K of Cronos Group Inc., filed June 15, 2021).</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.1</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/1656472/000165647220000073/exhibit31q2.htm">Certificate of Continuance, Notice of Articles and Articles of Cronos Group Inc. (incorporated by reference to Exhibit 3.1 to the Quarterly Report on Form 10-Q of Cronos Group Inc., filed August 6, 2020).</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.1++</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/1656472/000165647221000063/ex101finalagr.htm">Amended and Restated Collaboration and License Agreement, dated as of June 3, 2021, by and between Gingko Bioworks, Inc. and Cronos Group Inc. (incorporated by reference to Exhibit 10.1 to the Current Report on Form 8-K of Cronos Group Inc., filed June 4, 2021).</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.2&#8224;*</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="a10-qq22021102.htm">Amended and Restated </a><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="a10-qq22021102.htm">Executive Employment Agreement, dated as of </a><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="a10-qq22021102.htm">June</a><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="a10-qq22021102.htm"> </a><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="a10-qq22021102.htm">3</a><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="a10-qq22021102.htm">, 202</a><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="a10-qq22021102.htm">1</a><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="a10-qq22021102.htm">, by and among Cronos USA Client Services LLC, Cronos Group Inc. and </a><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="a10-qq22021102.htm">Todd Abraham</a><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="a10-qq22021102.htm">.</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.3&#8224;*</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="ex103robertmadoreemploymen.htm">Executive Employment Agreement, dated as of August 6, 2021, between Cronos USA, Cronos Group and</a><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="ex103robertmadoreemploymen.htm"> </a><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="ex103robertmadoreemploymen.htm">Robert Madore</a><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="ex103robertmadoreemploymen.htm">.</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.4&#8224;*</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="ex104jerrybarbato.htm">Letter Agreement, dated as of August 6, 2021, between Hortican, Cronos Group and Jerry Barbato.</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">31.1*</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="a10-qq22021311.htm">Certification of the Principal Executive Officer pursuant to Rules 13a-14(a) and 15d-14(a) of the Securities Exchange Act of 1934, as amended, as adopted pursuant to Section 302 of the Sarbanes-Oxley Act of 2002.</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">31.2*</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="a10-qq22021312.htm">Certification of the Principal Financial Officer pursuant to Rules 13a-14(a) and 15d-14(a) of the Securities Exchange Act of 1934, as amended, as adopted pursuant to Section 302 of the Sarbanes-Oxley Act of 2002.</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">32.1**</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="a10-qq22021321.htm">Certification of the Principal Executive Officer pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002.</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">32.2**</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="a10-qq22021322.htm">Certification of the Principal Financial Officer pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002.</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">101.INS*</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">XBRL Instance Document</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">101.SCH*</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">XBRL Taxonomy Extension Schema Document.</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">101.CAL*</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">XBRL Taxonomy Extension Calculation Linkbase Document.</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">101.DEF*</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">XBRL Taxonomy Extension Definition Linkbase Document.</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">101.LAB*</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">XBRL Taxonomy Extension Label Linkbase Document.</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">101.PRE*</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">XBRL Taxonomy Extension Presentation Linkbase Document.</span></td></tr></table></div><div style="margin-bottom:18pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.861%"><tr><td style="width:1.0%"></td><td style="width:43.406%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:17.397%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:17.397%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:17.400%"></td><td style="width:0.1%"></td></tr><tr style="height:5pt"><td colspan="3" style="border-bottom:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr></table></div><div style="margin-bottom:3pt;padding-left:36pt;text-indent:-36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">+&#160;&#160;&#160;&#160;Certain schedules (or similar attachments) have been omitted pursuant to Item 601(b)(2) of Regulation S-K. The registrant agrees to furnish supplementally a copy of any such omitted schedule or other attachment to the SEC upon its request.</span></div><div style="margin-bottom:3pt;padding-left:36pt;text-indent:-36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">++&#160;&#160;&#160;&#160;Certain portions of this exhibit have been redacted pursuant to Item 601(b)(10)(iv) of Regulation S-K. The registrant agrees to furnish supplementally an unredacted copy of the exhibit to the SEC upon its request.</span></div><div style="margin-bottom:3pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8224;&#160;&#160;&#160;&#160;Management contract or compensatory plan or arrangement.</span></div><div style="margin-bottom:3pt;padding-left:36pt;text-indent:-36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">*&#160;&#160;&#160;&#160;Filed herewith.</span></div><div style="margin-bottom:3pt;padding-left:36pt;text-indent:-36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">**&#160;&#160;&#160;&#160;Furnished herewith and not &#8220;filed&#8221; for purposes of Section 18 of the Securities Exchange Act of 1934, as amended.</span></div><div style="height:36pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="-sec-extract:summary;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">49</span></div></div></div><div id="i93ca9bb01792476fbb225e5d9dec869f_196"></div><hr style="page-break-after:always"/><div style="min-height:36pt;width:100%"><div style="text-align:right"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i93ca9bb01792476fbb225e5d9dec869f_7">Table of Contents</a></span></div></div><div style="padding-left:6.75pt;padding-right:6.75pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:174%">SIGNATURES</span></div><div style="margin-bottom:3pt;text-align:justify;text-indent:-36pt"><span><br/></span></div><div style="margin-bottom:3pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized.</span><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:46.960%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:2.778%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:46.962%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="6" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">CRONOS GROUP INC.</span></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">By:</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">/s/ Jerry Barbato</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-bottom:2pt;margin-top:2pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Jerry Barbato</span></div><div style="margin-bottom:2pt;margin-top:2pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Chief Financial Officer</span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Date: August 6, 2021</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr></table></div><div style="text-align:center"><span><br/></span></div><div style="margin-bottom:6pt;text-align:center"><span><br/></span></div><div style="height:36pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">50</span></div></div></div></body></html>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-10.2
<SEQUENCE>2
<FILENAME>a10-qq22021102.htm
<DESCRIPTION>EX-10.2
<TEXT>
<!DOCTYPE html PUBLIC "-//W3C//DTD HTML 4.01 Transitional//EN" "http://www.w3.org/TR/html4/loose.dtd"><html><head>
<!-- Document created using Wdesk -->
<!-- Copyright 2021 Workiva -->
<title>Document</title></head><body><div id="ib8b7be172b5f4b788f78aa489bca1437_33"></div><div style="min-height:72pt;width:100%"><div style="text-align:right"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:174%">Exhibit 10.2</font></div></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:174%">AMENDED AND RESTATED </font></div><div style="margin-bottom:12pt;margin-top:12pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%">EXECUTIVE EMPLOYMENT AGREEMENT</font></div><div style="margin-bottom:12pt;margin-top:12pt;text-align:center;text-indent:195.35pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">(this &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%">Agreement</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#8221;)</font></div><div style="margin-bottom:12pt;margin-top:12pt;text-indent:5.95pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">BETWEEN&#58;</font></div><div style="margin-bottom:12pt;margin-top:12pt;text-indent:113.95pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%">CRONOS USA CLIENT SERVICES LLC</font></div><div style="margin-bottom:12pt;margin-top:12pt;text-indent:113.95pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">(the &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%">Company</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#8221;)</font></div><div style="margin-bottom:12pt;margin-top:12pt;text-indent:113.95pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%">- </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">and -</font></div><div style="margin-bottom:12pt;margin-top:12pt;text-indent:113.95pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%">TODD ABRAHAM</font></div><div style="margin-bottom:12pt;margin-top:12pt;text-indent:113.95pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">(the &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%">Executive</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#8221;)</font></div><div style="margin-bottom:12pt;margin-top:12pt;text-indent:113.95pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">- and &#8211;</font></div><div style="margin-bottom:12pt;margin-top:12pt;text-indent:113.95pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">solely for the purposes specified herein,</font></div><div style="margin-bottom:12pt;margin-top:12pt;text-indent:113.95pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%">CRONOS GROUP INC.</font></div><div style="margin-bottom:12pt;margin-top:12pt;text-indent:113.95pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">(&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%">Cronos Group</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#8221;) and</font></div><div style="margin-bottom:12pt;margin-top:12pt;text-indent:113.95pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">solely for the purposes specified herein,</font></div><div style="margin-bottom:12pt;margin-top:12pt;text-indent:113.95pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%">HORTICAN INC.</font></div><div style="margin-bottom:12pt;margin-top:12pt;text-indent:113.95pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">(&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%">Hortican</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#8221;)</font></div><div style="margin-bottom:12pt;margin-top:12pt;text-indent:59.95pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%">WHEREAS </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">the Company is a wholly-owned subsidiary of Cronos Group&#59;</font></div><div style="margin-bottom:12pt;margin-top:12pt;text-indent:59.95pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%">WHEREAS </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">the Executive previously entered into an employment agreement with Hortican, another wholly owned subsidiary of Cronos Group, in July 2019, which the parties considered to be operational (the &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%">Original Agreement</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#8221;)&#59;</font></div><div style="margin-bottom:12pt;margin-top:12pt;text-indent:59.95pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%">WHEREAS</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">, in January 2020, Hortican assigned the Executive&#8217;s employment to the Company pursuant to Section 8.9 of the Original Agreement&#59;</font></div><div style="margin-bottom:12pt;margin-top:12pt;text-indent:59.95pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%">WHEREAS </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">the Executive is currently employed by the Company in the position of Chief Innovation Officer&#59;</font></div><div style="margin-bottom:12pt;margin-top:12pt;text-indent:59.95pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%">WHEREAS</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">, effective June 1, 2021 (the &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%">Effective Date</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#8221;), the Company and the Executive wish to amend and restate the Original Agreement as set forth herein&#59;</font></div><div style="margin-bottom:12pt;margin-top:12pt;text-indent:59.95pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%">WHEREAS </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">the Executive will continue to have extensive access to the customers, vendors, suppliers, distribution processes and other unique and valuable confidential information and trade secrets</font></div><div style="height:63pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="text-align:right"><font><br></font></div></div><div style="margin-bottom:12pt;margin-top:12pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">of the Company, Cronos Group, and their respective affiliates (excluding Altria Group, Inc. and its subsidiaries) and related entities (together, the &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%">Group</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#8221;)&#59;</font></div><div style="margin-bottom:12pt;margin-top:12pt;text-indent:59.95pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%">AND WHEREAS </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">the Executive acknowledges that this Agreement, including, without limitation, the proprietary rights, confidentiality, non-solicitation and non-competition provisions that form part of this Agreement are essential to protect the legitimate business interests of the Group&#59;</font></div><div style="margin-bottom:12pt;margin-top:12pt;text-indent:59.95pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%">NOW THEREFORE </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">in consideration of the above, the mutual covenants and agreements set forth in this Agreement, and other good and valuable consideration, including without limitation the increased Base Salary (as defined at Section 5.1 below), target bonus opportunity (as set out at Section 5.2 below), and target incentive opportunity (as set out at Section 5.3 below), the receipt and sufficiency of which are hereby acknowledged, the Company and the Executive (together, the &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%">Parties</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#8221;), and solely for the purposes of Section 5.3 herein, Cronos Group, and solely for the purposes of Section 8.14 herein, Hortican, agree as follows.</font></div><div style="margin-bottom:12pt;margin-top:12pt;padding-left:36pt;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%">1.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%;padding-left:27.75pt;text-decoration:underline">Position</font></div><div style="margin-bottom:12pt;margin-top:12pt;padding-left:36pt;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">1.1</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;padding-left:22.25pt">The Executive will continue be employed in the position of Chief Innovation Officer.</font></div><div style="margin-bottom:12pt;margin-top:12pt;padding-left:36pt;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%">2.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%;padding-left:27.75pt;text-decoration:underline">Location</font></div><div style="margin-bottom:12pt;margin-top:12pt;padding-left:36pt;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">2.1</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;padding-left:22.25pt">The Executive shall be based primarily from the Executive&#8217;s home office. During the term of the Executive&#8217;s employment with the Company, the Executive&#8217;s principal place of residence shall remain in the United States. The Executive will be available for business travel as reasonably required to perform the Executive&#8217;s duties hereunder.</font></div><div style="margin-bottom:12pt;margin-top:12pt;padding-left:36pt;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%">3.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%;padding-left:27.75pt;text-decoration:underline">Work Authorizations</font></div><div style="margin-bottom:12pt;margin-top:12pt;padding-left:36pt;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">3.1</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;padding-left:22.25pt">It is a condition of this Agreement and the Executive&#8217;s employment that the Executive shall be able to work lawfully in Canada and the United States. However, it is understood and agreed that the Executive&#8217;s position may require that the Executive work abroad, as needed by the Company. The Executive&#8217;s employment with the Company is therefore also conditional upon the securing of all necessary visas, work permits and other authorizations that may be required to enter and&#47;or to work in any of the countries in which the Executive may be assigned to work or visit during the term of employment. The Company shall provide reasonable assistance in respect of immigration matters. Despite such assistance, the Company cannot guarantee when or whether the Executive&#8217;s application for a work permit, visa, permanent residence status or other immigration status or documents will be approved. Should the necessary authorizations that permit the Executive to legally work in Canada, the United States, or in any other jurisdiction in which the Executive will be required to work not be obtained, this Agreement shall be null and void and of no force or effect. At any time, should necessary authorizations that permit the Executive to legally work in Canada, the United States, or any other jurisdiction in which the Executive will be required to work or visit expire without the possibility of renewal, the Executive&#8217;s employment shall come to an end and shall be treated by the Company as a termination without Just Cause (as defined below).</font></div><div style="margin-bottom:12pt;margin-top:12pt;padding-left:36pt;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%">4.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%;padding-left:27.75pt;text-decoration:underline">Employment Duties</font></div><div style="margin-bottom:12pt;margin-top:12pt;padding-left:36pt;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">4.1</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;padding-left:22.25pt">The Executive shall perform such duties and exercise such powers as are normally associated with or incidental and ancillary to the Executive&#8217;s position and as may be assigned to the</font></div><div style="height:63pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">2</font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="text-align:right"><font><br></font></div></div><div style="margin-bottom:12pt;margin-top:12pt;padding-left:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">Executive from time to time. In fulfilling the Executive&#8217;s duties to the Company, the Executive shall be instructed by and shall regularly report to the Chief Executive Officer of Cronos Group (the &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%">CEO</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#8221;). The Executive&#8217;s duties, hours of work, location of employment and reporting relationships may be adjusted from time to time by the Company to meet changing business and operational needs. Without limiting the foregoing, the Executive shall</font></div><div style="margin-bottom:12pt;margin-top:12pt;padding-left:72pt;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">(a)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;padding-left:23.8pt">devote the Executive&#8217;s full working time and attention during normal business hours and such other times as may be reasonably required to the business and affairs of the Company and shall not, without the prior written consent of the CEO, undertake any other business or occupation or public office&#59;</font></div><div style="margin-bottom:12pt;margin-top:12pt;padding-left:72pt;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">(b)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;padding-left:23.18pt">perform those duties that may be assigned to the Executive diligently, honestly, and faithfully to the best of the Executive&#8217;s ability and in the best interest of the Company&#59;</font></div><div style="margin-bottom:12pt;margin-top:12pt;padding-left:72pt;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">(c)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;padding-left:23.8pt">abide by all Company policies, as instituted and amended from time to time including but not limited to, the applicable Cronos Group Employee Handbook&#59;</font></div><div style="margin-bottom:12pt;margin-top:12pt;padding-left:72pt;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">(d)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;padding-left:23.18pt">use best efforts to promote the interests and goodwill of the Company and not knowingly do, or permit to be done, anything which may be prejudicial to the Company&#8217;s interests, it being understood and agreed that the Executive is a fiduciary of the Company and owes fiduciary obligations to the Company that are not extinguished by this Agreement&#59; and</font></div><div style="margin-bottom:12pt;margin-top:12pt;padding-left:72pt;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">(e)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;padding-left:23.8pt">identify and immediately report to the CEO any gross misrepresentations or violations of any Group policy or applicable law by the Company or its management.</font></div><div style="margin-bottom:12pt;margin-top:12pt;padding-left:36pt;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%">5.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%;padding-left:27.75pt;text-decoration:underline">Compensation and Benefits</font></div><div style="margin-bottom:12pt;margin-top:12pt;padding-left:36pt;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">5.1</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%;padding-left:22.25pt">Base Salary. </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">As of the Effective Date, the Company shall pay the Executive an annual base salary of US$240,000, less applicable deductions and withholdings (the &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%">Base Salary</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#8221;). The Base Salary shall be paid by direct deposit on a bi-weekly basis (as may be amended from time to time), in accordance with the Company&#8217;s payroll practices. Any changes to Base Salary shall be at the sole discretion of the Company.</font></div><div style="margin-bottom:12pt;margin-top:12pt;padding-left:36pt;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">5.2</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%;padding-left:22.25pt">Annual Performance Bonus. </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">In addition to the Base Salary, the Executive shall be eligible to participate in the Company&#8217;s annual cash bonus plan as may be in effect from time to time, and to receive an annual bonus, subject to the terms and conditions of that plan as determined by the Company at its sole discretion. The Executive&#8217;s annual target bonus opportunity shall initially be 100% of Base Salary, provided that the actual bonus amount, if any, will be determined pursuant to the terms of the applicable annual bonus plan. Nothing in this Agreement guarantees that the Company will maintain an annual bonus plan, and the Company reserves the right to amend or terminate any annual bonus plan established or adopted at any time, without notice or further obligation (subject only to the minimum requirements of applicable legislation, if any). The Executive must be actively employed by the Company on the applicable payment date in order to be eligible for any annual bonus for that year, subject only to the minimum requirements of applicable legislation, unless provided otherwise pursuant to the applicable annual cash bonus plan. For certainty, if the Executive&#8217;s employment is terminated by the Company with or without Just Cause, or the Executive resigns or otherwise terminates employment for any reason, the Executive will cease to be &#8220;actively employed&#8221; on the last day of employment as specified in the Company&#8217;s or the Executive&#8217;s written notice of termination, as applicable, will not be considered &#8220;actively employed&#8221; during any period of notice, pay in lieu of notice, or severance pay, and will not be entitled to an annual bonus (or any part thereof) or damages in lieu of the Executive&#8217;s</font></div><div style="height:63pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">3</font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="text-align:right"><font><br></font></div></div><div style="margin-bottom:12pt;margin-top:12pt;padding-left:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">eligibility for a bonus, subject only to the minimum requirements of applicable legislation or unless provided otherwise pursuant to the applicable annual cash bonus plan. There shall be no guarantee of a bonus in any given year.</font></div><div style="margin-bottom:12pt;margin-top:12pt;padding-left:36pt;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">5.3</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%;padding-left:22.25pt">Long-Term Incentive Opportunity</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">. The Executive shall be eligible to receive annual grants of equity-based awards over shares of Cronos Group with an initial target incentive opportunity of US$300,000 (based on the grant date fair value of such awards), provided that the actual amount, if any, of the grants shall be determined by the board of directors of Cronos Group (the &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%">Board</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#8221;) at its sole discretion. Any such equity-based grants shall be governed by the terms and conditions of the equity award plan or any other applicable plan of Cronos Group and&#47;or the applicable award agreement. Such plan or plans may be amended from time to time at Cronos Group&#8217;s sole discretion. In the event of the cessation of the Executive&#8217;s employment for any reason, the Executive&#8217;s entitlements in respect of any equity-based awards shall be governed by the terms and conditions of the applicable equity award plan, any other applicable plan and the applicable award agreement. Subject to the express minimum requirements of applicable legislation, if any, the Executive shall not be eligible for any further grants of equity-based awards following the effective date of termination or damages in lieu thereof, regardless of any applicable notice period, pay in lieu of notice, severance payment or similar amount.</font></div><div style="margin-bottom:12pt;margin-top:12pt;padding-left:36pt;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">5.4</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%;padding-left:22.25pt">Group Insured Benefits</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">. The Executive shall be eligible to participate in the benefits programs of the Company, as applicable, for health and dental, life insurance, disability and other benefits as may be available to the employees of the Company from time to time, subject to the terms and conditions of the applicable plan document. The Company reserves the right to alter, amend or discontinue all benefits, coverages, plans and programs referred to in this paragraph, without advance notice or other obligation, subject only to the minimum requirements of applicable legislation.</font></div><div style="margin-bottom:12pt;margin-top:12pt;padding-left:36pt;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">5.5</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%;padding-left:22.25pt">Vacation</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">. The Executive shall be eligible for four weeks&#8217; paid vacation per year. The Executive shall take vacation time at such times as are approved in advance by the Company in accordance with the policies of the Company, as applicable. Vacation shall be accrued in accordance with the vacation policy of the Company.</font></div><div style="margin-bottom:12pt;margin-top:12pt;padding-left:36pt;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">5.6</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%;padding-left:22.25pt">Business Expenses</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">. The Executive shall be reimbursed for all reasonable travel and other out-of- pocket expenses properly incurred by the Executive from time to time in connection with performance of the Executive&#8217;s duties. The Executive shall furnish to the Company on a monthly basis and in accordance with any of the Company&#8217;s policies or procedures for expense reimbursement all invoices or statements in respect of expenses for which the Executive seeks reimbursement.</font></div><div style="margin-bottom:12pt;margin-top:12pt;padding-left:36pt;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">5.7</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%;padding-left:22.25pt">Clawback Policy&#59; Share Ownership Guidelines. </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">The Executive agrees and acknowledges that any annual, long-term or other cash, equity or equity-based incentive or bonus compensation paid, provided or awarded to the Executive is subject to the terms and conditions of any clawback or recapture policy that Cronos Group may adopt from time to time, and may be subject to the requirement that such compensation be repaid to the Company after it has been distributed to Executive. In addition, by virtue of the Executive&#8217;s position with the Company, the Executive will be subject to Cronos Group&#8217;s executive share ownership guidelines, as it may be amended from time to time. The current executive share ownership guidelines require that the Executive own Cronos Group equity equal to at least two times the Executive&#8217;s annual base salary by the fifth anniversary of the effective date of the Original Agreement and thereafter during the term of the Executive&#8217;s employment with the Company.</font></div><div style="margin-bottom:12pt;margin-top:12pt"><font><br></font></div><div style="height:63pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">4</font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="text-align:right"><font><br></font></div></div><div style="margin-bottom:12pt;margin-top:12pt;padding-left:36pt;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">5.8</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%;padding-left:22.25pt">Deductions and Withholdings</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">. The Company shall make such deductions and withholdings from the Executive&#8217;s remuneration and any other payments or benefits provided to the Executive pursuant to this Agreement as may be required by law.</font></div><div style="margin-bottom:12pt;margin-top:12pt;padding-left:36pt;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%">6.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%;padding-left:27.75pt;text-decoration:underline">Termination of Employment</font></div><div style="margin-bottom:12pt;margin-top:12pt;padding-left:36pt;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">6.1</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%;padding-left:22.25pt">Termination by the Executive. </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">The Executive may terminate his employment with the Company at any time by providing the Company with at least three months of notice in writing. If, upon receipt of the Executive&#8217;s resignation (or any later date during such notice period), the Company terminates the Executive&#8217;s employment before the date the resignation was to be effective, the Company shall, in full satisfaction of its obligations to the Executive&#58; (a) pay the Executive&#8217;s Base Salary and vacation pay accrued until the date the resignation was to be effective up to a maximum of three months&#59; (b) reimburse the outstanding expenses properly incurred by the Executive until the date the Executive&#8217;s employment ceases&#59; and (c) provide the Executive with such other compensation and benefits that are expressly required pursuant to applicable legislation, if any. In such circumstances the Executive shall be ineligible for any pro- rated bonus for the year of termination, and any entitlements in respect of any equity-based awards shall be governed by the terms and conditions of the applicable equity award plan, any other applicable plan and the applicable award agreement.</font></div><div style="margin-bottom:12pt;margin-top:12pt;padding-left:36pt;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">6.2</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%;padding-left:22.25pt">Termination by the Company for Just Cause or on Death or Disability</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">. The Company may terminate the Executive&#8217;s employment at any time for Just Cause without prior notice or in the event of the Executive&#8217;s death or Disability (as defined below). On the termination of the Executive&#8217;s employment for Just Cause or on the Executive&#8217;s death or Disability, this Agreement and the Executive&#8217;s employment shall terminate and the Company shall, in full satisfaction of its obligations to the Executive&#58; (a) pay the Executive&#8217;s Base Salary and vacation pay accrued until the date the Executive&#8217;s employment ceases&#59; (b) reimburse the outstanding expenses properly incurred by the Executive until the date the Executive&#8217;s employment ceases&#59; and (c) provide the Executive with such other compensation and benefits that are expressly required pursuant to applicable legislation, if any. In such circumstances the Executive shall be ineligible for any pro- rated bonus for the year of termination, and any entitlements in respect of equity-based awards shall be governed by the terms and conditions of the applicable equity award plan, any other applicable plan and the applicable award agreement. For the purposes of this Agreement, (A) &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%">Just Cause</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#8221; means&#58; (i) any act or omission constituting &#8220;just cause&#8221; for dismissal without notice under applicable law&#59; (ii) the Executive&#8217;s repeated failure or refusal to perform the Executive&#8217;s principal duties and responsibilities after notice from the CEO or other officer of the Company&#59; (iii) misappropriation of the funds or property of the Company&#59; (iv) use of alcohol or drugs in violation of the Company&#8217;s policies on such use or that interferes with the Executive&#8217;s obligations under this Agreement, continuing after a single warning (subject to the Company&#8217;s obligations under applicable human rights legislation)&#59; (v) the indictment, arrest or conviction in a court of law for, or the entering of a plea of guilty to, a summary or indictable offence or any crime involving moral turpitude, fraud, dishonesty or theft (subject to the Company&#8217;s obligations under applicable human rights legislation)&#59; (vi) the misuse of Company computers or computer network systems for non-Company business&#59; (vii) engaging in any act (including, without limitation, an act of sexual harassment as determined by the Company) which is a violation of any law, regulation or Company policy&#59; or (viii) any wilful or intentional act which injures or could reasonably be expected to injure the reputation, business or business relationships of the Company, and (B) &#8220;Disability&#8221; means a physical or mental incapacity of the Executive that has prevented the Executive from performing the duties customarily assigned to the Executive for 180 calendar days, whether or not consecutive, out of </font></div><div style="margin-bottom:12pt;margin-top:12pt;padding-left:36pt"><font><br></font></div><div style="height:63pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">5</font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="text-align:right"><font><br></font></div></div><div style="margin-bottom:12pt;margin-top:12pt;padding-left:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">any twelve consecutive months and that in the opinion of the Company, acting on the basis of advice from a duly qualified medical practitioner, is likely to continue to a similar degree.</font></div><div style="margin-bottom:12pt;margin-top:12pt;padding-left:36pt;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">6.3</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%;padding-left:22.25pt">Termination by the Company without Just Cause or Resignation for Good Reason on Change of Control</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">. The Company may terminate the Executive&#8217;s employment at any time without Just Cause, on providing thirty days&#8217; written notice to the Executive. The Executive may resign the Executive&#8217;s employment for Good Reason (as defined below) within twenty-four months of the occurrence of a Change in Control (as defined below), on providing thirty days&#8217; written notice to the Company. If&#58; (i) the Company terminates the Executive&#8217;s employment without Just Cause, or (ii) if the Executive resigns his employment for Good Reason within twenty-four months of the occurrence of a Change of Control, and in each case if the Executive signs and delivers and does not revoke a release in favour of the Group pursuant to the form customarily used by the Group and on the timing set forth therein in consideration of amounts (including, for the avoidance of doubt, under clause (e) below) in excess of the Executive&#8217;s minimum entitlements under applicable legislation, the Company, shall, in full satisfaction of its obligations to the Executive&#58;</font></div><div style="margin-bottom:12pt;margin-top:12pt;padding-left:72pt;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">(a)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;padding-left:23.8pt">pay the Executive&#8217;s Base Salary and accrued but unpaid vacation pay in accordance with applicable legislation&#59;</font></div><div style="margin-bottom:12pt;margin-top:12pt;padding-left:72pt;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">(b)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;padding-left:23.18pt">reimburse the Executive&#8217;s expenses properly incurred until the date the Executive&#8217;s employment ceases&#59;</font></div><div style="margin-bottom:12pt;margin-top:12pt;padding-left:72pt;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">(c)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;padding-left:23.8pt">in lieu of notice, pay the Executive the greater of (i) one month of the Executive&#8217;s annual base salary in effect at the time of termination for each completed year of service with the Group, to a maximum of twelve months of base salary, payable by way of lump sum payment within sixty days following such termination, and (ii) the minimum termination pay and severance pay entitlements of the Executive pursuant to applicable legislation, if any&#59;</font></div><div style="margin-bottom:12pt;margin-top:12pt;padding-left:72pt;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">(d)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;padding-left:23.18pt">continue the Executive&#8217;s group insured benefits, if any, until the end of the notice period calculated under (c) above or the date on which the Executive obtains alternate benefit coverage, whichever occurs first, subject to the terms and conditions of the benefit plans, as amended from time to time, and the minimum requirements of applicable legislation, if any. If the Company is unable for any reason to continue its contributions to the benefit plans as set out in this Agreement, it shall pay the Executive an amount equal to the Company&#8217;s required contributions to such benefit plans on behalf of the Executive for such period. The Executive agrees that he is required to notify the Company when he obtains alternate life, medical and dental benefit coverage&#59; and</font></div><div style="margin-bottom:12pt;margin-top:12pt;padding-left:72pt;text-align:justify;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">(e)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;padding-left:23.8pt">determine the Executive&#8217;s entitlements in respect of equity-based awards in accordance with the terms and conditions of the applicable equity award plan, any other applicable plan and the applicable award agreement.</font></div><div style="margin-bottom:12pt;margin-top:12pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">If the Executive does not sign and deliver to the Company the release in favour of the Group described above, or if the Executive revokes the foregoing release, the Company shall only provide the Executive with such compensation (including any Base Salary and accrued but unpaid vacation pay, termination pay and severance pay) and benefits that are expressly required pursuant to applicable legislation, if any.</font></div><div style="margin-bottom:12pt;margin-top:12pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">In this Agreement, &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%">Change of Control</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#8221; means&#58;</font></div><div style="margin-bottom:12pt;margin-top:12pt"><font><br></font></div><div style="height:63pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">6</font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="text-align:right"><font><br></font></div></div><div style="margin-bottom:12pt;margin-top:12pt;padding-left:36pt;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">(a)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;padding-left:23.8pt">the consummation of any transaction or series of transactions including any reorganization, recapitalization, statutory share exchange, consolidation, amalgamation, arrangement, merger or issue of voting shares in the capital of Cronos Group, the result of which is that any individual, corporation (including not-for-profit), general or limited partnership, limited liability company, joint venture, association, joint-stock company, estate, trust, organization, governmental authority or other entity of any kind or nature (&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%">Person</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#8221;) or group of Persons acting jointly or in concert for purposes of such transaction or series of transactions becomes the beneficial owner, directly or indirectly, of more than 50% of the voting securities in the capital of the entity resulting from such transaction or series of transactions or the entity that acquired all or substantially all of the business or assets of Cronos Group in a transaction or series of transactions described in paragraph (ii) below (in each case, the &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%">Surviving Company</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#8221;) or the ultimate parent entity that has beneficial ownership of sufficient voting power to elect a majority of the board of directors (or analogous governing body) of the Surviving Company (the &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%">Parent Company</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#8221;), measured by voting power of the outstanding voting securities eligible to elect members of the board of directors (or the analogous governing body) of the Parent Company (or, if there is no Parent Company, the Surviving Company) rather than number of securities (but shall not include the creation of a holding company or other transaction that does not involve any substantial change in the proportion of direct or indirect beneficial ownership of the voting securities of Cronos Group prior to the consummation of the transaction or series of transactions), provided that the exercise by Altria Summit LLC (or any of its affiliates) of the Purchased Warrant (as defined in the Subscription Agreement by and among Cronos Group Inc., Altria Summit LLC and Altria Group, Inc. dated as of December 7, 2018 as may be amended or otherwise modified from time to time in accordance with its terms) shall not constitute a Change of Control pursuant to this clause (a)&#59;</font></div><div style="margin-bottom:12pt;margin-top:12pt;padding-left:36pt;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">(b)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;padding-left:23.18pt">the direct or indirect sale, transfer or other disposition, in one or a series of transactions, of all or substantially all of the business or assets of Cronos Group, taken as a whole, to any person or group of persons acting jointly or in concert for purposes of such transaction or series of transactions (other than to any affiliates of Cronos Group)&#59; or</font></div><div style="margin-bottom:12pt;margin-top:12pt;padding-left:36pt;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">(c)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;padding-left:23.8pt">Incumbent Directors during any consecutive twelve month period ceasing to constitute a majority of the Board of Cronos Group (for the purposes of this paragraph, an &#8220;Incumbent Director&#8221; shall mean any member of the Board who is a member of the Board immediately prior to the occurrence of a contested election of directors of Cronos Group).</font></div><div style="margin-bottom:12pt;margin-top:12pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">In this Agreement, &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%">Good Reason</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#8221; means the occurrence of any of the following events without the Executive&#8217;s consent, except in each case for any isolated, immaterial or inadvertent action not taken in bad faith and which is remedied by the Company within thirty days after a written notice thereof by the Executive (provided that such notice must be given to the Company within sixty days of Executive becoming aware of such condition)&#58;</font></div><div style="margin-bottom:12pt;margin-top:12pt;padding-left:36pt;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">(a)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;padding-left:23.8pt">the assignment to the Executive of duties materially different than the duties assigned to the Executive hereunder&#59;</font></div><div style="margin-bottom:12pt;margin-top:12pt;padding-left:36pt;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">(b)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;padding-left:23.18pt">a material diminution in the Executive&#8217;s title, status, seniority, reporting relationship, responsibilities or authority&#59; or</font></div><div style="margin-bottom:12pt;margin-top:12pt;padding-left:36pt;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">(c)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;padding-left:23.8pt">a material reduction in the Executive&#8217;s Base Salary.</font></div><div style="height:63pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">7</font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="text-align:right"><font><br></font></div></div><div style="margin-bottom:12pt;margin-top:12pt;padding-left:36pt;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">6.4</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%;padding-left:22.25pt">Resignation on Termination</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">. The Executive agrees that upon any termination of employment with the Company for any reason the Executive shall immediately tender resignation from any position the Executive may hold as an officer or director of the Company and take all steps necessary to remove Executive from any and all designated positions under any applicable laws, including without limitation, the </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:400;line-height:120%">Cannabis Act </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">(Canada) and the regulations thereunder, as the same may be amended from time to time, or any subsidiary or affiliate of the Company. In the event that the Executive fails to comply with this obligation within three days of the Executive's termination or resignation, the Executive hereby irrevocably authorizes the Company to appoint a Person in the Executive's name and on the Executive's behalf to sign or execute any documents and&#47;or do all things necessary or requisite to give effect to such resignation.</font></div><div style="margin-bottom:12pt;margin-top:12pt;padding-left:36pt;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">6.5</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%;padding-left:22.25pt">Compliance with Laws. </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">The Executive understands and agrees that the entitlements under this Section 6</font><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%"> </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">are provided in full satisfaction of the Executive&#8217;s entitlements to notice of termination, pay in lieu of notice, and severance pay, if any, under applicable legislation, this Agreement, any employee benefit plan sponsored or maintained by the Group, applicable law (including the common law) or otherwise.</font></div><div style="margin-bottom:12pt;margin-top:12pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%">7.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%;padding-left:27.75pt;text-decoration:underline">Restrictive Covenants</font></div><div style="margin-bottom:12pt;margin-top:12pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">7.1</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%;padding-left:22.25pt">Non-Disclosure</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">. The Executive acknowledges and agrees that&#58;</font></div><div style="margin-bottom:12pt;margin-top:12pt;padding-left:72pt;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">(a)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;padding-left:23.8pt">during the term of the Executive&#8217;s employment, the Executive may be given access to or may become acquainted with confidential and proprietary information of the Company and its affiliates and related entities and third parties to which the Group may have any obligations of non-disclosure or confidentiality, including but not limited to&#58; trade secrets&#59; know-how&#59; Intellectual Property (as defined below)&#59; Employee Inventions (as defined below), Invention Records (as defined below), existing and contemplated work product resulting from or related to projects performed or to be performed by or for the Group&#59; programs and program modules&#59; processes&#59; algorithms&#59; design concepts&#59; system designs&#59; production data&#59; test data&#59; research and development information&#59; information regarding the acquisition, protection, enforcement and licensing of proprietary rights&#59; technology&#59; joint ventures&#59; business, accounting, engineering and financial information and data&#59; marketing and development plans and methods of obtaining business&#59; forecasts&#59; future plans and strategies of the Group&#59; pricing, cost, billing and fee arrangements and policies&#59; quoting procedures&#59; special methods and processes&#59; lists and&#47;or identities of customers, suppliers, vendors and contractors&#59; the type, quantity and specifications of products and services purchased, leased, licensed or received by the Group and&#47;or any of its customers, suppliers, or vendors&#59; internal personnel and financial information&#59; business and&#47;or personal information about any senior staff members of the Group or any Person with which the Company enters a strategic alliance or any other partnering arrangements&#59; vendor and supplier information&#59; the manner and method of conducting the Group&#8217;s business&#59; the identity or nature of relationship of any persons or entities associated with or engaged as consultants, advisers, agents, distributors or sales representatives (the &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%">Confidential Information</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#8221;) the disclosure of any of which to competitors of the Group or to the general public, or the use of same by the Executive or any competitor of the Group, would be highly detrimental to the interests of the Company&#59;</font></div><div style="margin-bottom:12pt;margin-top:12pt;padding-left:72pt;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">(b)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;padding-left:23.18pt">disclosure or use of Confidential Information, other than in connection with the Group&#8217;s business or as specifically authorized by the Group, will be highly detrimental to the business and interests of the Group and could result in serious loss of business and damage to it. </font></div><div style="height:63pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">8</font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="text-align:right"><font><br></font></div></div><div style="margin-bottom:12pt;margin-top:12pt;padding-left:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">Accordingly, the Executive specifically agrees to hold all Confidential Information in strictest confidence, and the Executive agrees that the Executive shall not, without the Company&#8217;s prior written consent, disclose, divulge or reveal to any person, or use for any purpose other than for the exclusive benefit of the Company, any Confidential Information, in whatever form contained&#59; provided that the foregoing shall not apply to information (except for personal information about identifiable individuals) that&#58; (i) was known to the public prior to its disclosure to the Executive&#59; (ii) becomes generally known to the public subsequent to disclosure to the Executive other than by reason of the Executive&#8217;s breach of this Section&#59; (iii) becomes available to the Executive from a source independent of the Group&#59; or (iv) the Executive is specifically required to disclose by applicable law or legal process (provided that the Executive provides the Company with prompt advance written notice of the contemplated disclosure and cooperates with the Company in seeking a protective order or other appropriate protection of such information)&#59;</font></div><div style="margin-bottom:12pt;margin-top:12pt;padding-left:72pt;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">(c)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;padding-left:23.8pt">the Executive shall deliver to the Company, immediately upon termination of employment (for any reason and regardless of whether the Executive or the Company terminate the employment) or at any time the Company so requests&#58; (i) any and all documents, files, notes, memoranda, models, databases, computer files and&#47;or other computer programs reflecting any Confidential Information whatsoever or otherwise relating to the Group&#8217;s business&#59; (ii) lists or other documents regarding customers, suppliers, or vendors of the Group or leads or referrals to prospective business deals&#59; and (iii) any computer equipment, home office equipment, automobile or other business equipment belonging to the Group that the Executive may then possess or have under the Executive&#8217;s control&#59; and</font></div><div style="margin-bottom:12pt;margin-top:12pt;padding-left:72pt;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">(d)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;padding-left:23.18pt">for the avoidance of doubt, nothing in this Agreement limits, restricts or in any other way affects the Executive communicating with any governmental authority or entity concerning matters relevant to the governmental authority or entity. The Executive and the Company agree that no confidentiality or other obligation the Executive owes to the Group prohibits the Executive from reporting possible violations of law or regulation to any governmental authority or entity under any applicable whistleblower protection provision of applicable Canadian, U.S. Federal or U.S. State law or regulation (including Section 21F of the Securities Exchange Act of 1934 or Section 806 of the Sarbanes- Oxley Act of 2002) or requires the Executive to notify the Company of any such report. The Executive is hereby notified that the immunity provisions in Section 1833 of title 18 of the United States Code provide that an individual cannot be held criminally or civilly liable under any federal or state trade secret law for any disclosure of a trade secret that is made (i) in confidence to federal, state or local government officials, either directly or indirectly, or to an attorney, and is solely for the purpose of reporting or investigating a suspected violation of the law, (ii) under seal in a complaint or other document filed in a lawsuit or other proceeding, or (iii) to the Executive&#8217;s attorney in connection with a lawsuit for retaliation for reporting a suspected violation of law (and the trade secret may be used in the court proceedings for such lawsuit) as long as any document containing the trade secret is filed under seal and the trade secret is not disclosed except pursuant to court order.</font></div><div style="margin-bottom:12pt;margin-top:12pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">7.2</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%;padding-left:22.25pt">Intellectual Property</font></div><div style="margin-bottom:12pt;margin-top:12pt;padding-left:72pt;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">(a)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;padding-left:23.8pt">In this Section 7.2, the term &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%">Germplasm</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#8221; means any living or preserved biological tissue or material which may be used for the purpose of plant breeding and&#47;or propagation, including,</font></div><div style="height:63pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">9</font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="text-align:right"><font><br></font></div></div><div style="margin-bottom:12pt;margin-top:12pt;padding-left:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">without limitation, plants, cuttings, seeds, clones, cells, tissues, plant materials and genetic materials (including, without limitation, nucleic acids, genes, promoters, reading frames, regulatory sequences, terminators, chromosomes whether artificial or natural and vectors).</font></div><div style="margin-bottom:12pt;margin-top:12pt;padding-left:72pt;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">(b)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;padding-left:23.18pt">For the purposes of this Agreement, &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%">Intellectual Property</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#8221; means any and all intellectual property rights and proprietary rights existing in any jurisdiction throughout the world, including any rights in or to&#58; (i) patents, patent applications, patent rights, inventions, industrial designs, industrial design applications, industrial design rights, ideas, discoveries and invention disclosures (whether or not patentable), and any divisionals, continuations, continuations-in-part, reissues, renewals, reexaminations and extensions of any of the foregoing&#59; (ii) trademarks, service marks, trade names, trade dress, logos, packaging designs, slogans, other indicia of source, Internet domain names and URLs, and registrations and applications for registration of any of the foregoing and any renewals thereof, together with any goodwill symbolized thereby&#59; (iii) copyrightable works (including with respect to software and compilations of data), whether published or unpublished, including all copyrights, copyright registrations and applications&#59; (iv) trade secrets, and confidential or proprietary information, data or database rights, know- how, techniques, designs, processes, recipes and formulas&#59; (v) Germplasm, plant varieties, and applications and registrations for plant varieties issued by or pending before any Governmental Authority, including under the Plant Variety Protection Act (United States) or the Plant Breeders&#8217; Rights Act (Canada)&#59; and (vi) circuit topographies, database rights and software.</font></div><div style="margin-bottom:12pt;margin-top:12pt;padding-left:72pt;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">(c)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;padding-left:23.8pt">The Executive agrees to promptly disclose to the Company (including, without limitation, to the Executive&#8217;s manager) all Intellectual Property, including with respect to, but without limitation, Germplasm, and whether or not any of the foregoing are registrable, which the Executive may author, make, conceive, develop, discover or reduce to practice, solely, jointly or in common with other employees, during the Executive&#8217;s employment with the Company, and which relate to the business activities of the Company or any of its affiliates (&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%">Employee Inventions</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#8221;). The Executive agrees to maintain as confidential any Employee Inventions unless and until made generally public by the Company, and not to make application for registration of rights in respect of any Employee Inventions unless it is at the request and direction of the Company. Intellectual Property coming within the scope of the business of the Company made and&#47;or developed by the Executive while in the employ of the Company, whether or not conceived or made during regular working hours and whether or not the Executive is specifically instructed to make or develop the same, shall be for the benefit of the Company and shall be considered to have been made pursuant to this Agreement and shall be deemed Employee Inventions and shall immediately become exclusive property of the Company. The Executive must keep, maintain and make available to the Company complete and up-to-date records relating to any such Intellectual Property, and agree that all such records are the sole and absolute property of the Company.</font></div><div style="margin-bottom:12pt;margin-top:12pt;padding-left:72pt;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">(d)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;padding-left:23.18pt">The Executive further acknowledges that all Employee Inventions are &#8220;work made for hire&#8221; (to the greatest extent permitted by applicable Law) owned exclusively by the Company and that the Executive has been compensated for such Employee Inventions by the Executive&#8217;s salary, commissions and other benefits, unless regulated otherwise by Law. To the extent such Employee Inventions are not &#8220;work made for hire&#8221; or otherwise not owned automatically and exclusively by the Company as a matter of Law, then to the greatest extent permitted under by applicable Law, the Executive hereby irrevocably assigns and transfers, and shall assign and </font></div><div style="height:63pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">10</font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="text-align:right"><font><br></font></div></div><div style="margin-bottom:12pt;margin-top:12pt;padding-left:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">transfer, to the Company, the Executive&#8217;s entire right, title and interest in and to any and all Employee Inventions, and the Executive agrees to execute and deliver to the Company any and all instruments necessary or desirable to accomplish the foregoing and, in addition, to do all lawful acts which may be necessary or desirable to assist the Company to obtain and enforce protection of Employee Inventions. If and to the extent the foregoing assignment cannot be effected as a matter of law with respect to any Employee Inventions, the Executive hereby grants to the Company an exclusive, perpetual, fully-paid, royalty-free, irrevocable, worldwide, fully-transferable, fully sublicensable (on multiple levels) license to use, modify, display, perform, make, have made, copy, make derivative works, import, export, distribute and otherwise exploit such Employee Inventions for any purpose. The Executive shall, at the request and cost of the Company, and for no additional compensation or consideration from the Company, sign, execute, make and do all such deeds, documents, acts and things as the Company and its duly authorized agents may reasonably require&#58; (i) to apply for, obtain and vest in the name of the Company alone (unless the Company otherwise directs) registered rights in any Employee Inventions, including any patents, industrial designs, letters patent, copyrights, plant breeders&#8217; rights, trademarks, service marks or other analogous protection in any country throughout the world and when so obtained or vested to renew and restore the same&#59; (ii) to perfect or evidence ownership by the Company or its designees of any and all Employee Inventions, in form suitable for recordation in the United States, Canada and any other intellectual property office anywhere in the world&#59; (iii) to defend any opposition proceedings of any type whatsoever in respect of such applications, and any opposition proceedings or petitions or applications of any type whatsoever for revocation of such Employee Inventions, whether such proceedings are brought before a court or any administrative body&#59; (iv) to defend and&#47;or assert the Company&#8217;s rights in any Intellectual Property against any third party&#59; and (v) to assert the Executive&#8217;s moral rights in any Intellectual Property against any third party. For greater certainty, all materials related to Employee Inventions (including, without limitation, notes, records and correspondence, whether written or electronic) (collectively, &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%">Invention Records</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#8221;) are the property of the Company, which the Executive shall provide to the Company upon request. Invention Records shall not be removed from Company premises without the prior written consent of the Company. The Executive further waives all moral rights in and to any Employee Inventions and all work the Executive produced during the course of the Executive&#8217;s employment in favor of the Company, its licensees, successors and assigns, and transferees of the Employee Inventions and such work</font></div><div style="margin-bottom:12pt;margin-top:12pt;padding-left:72pt;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">(e)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;padding-left:23.8pt">In the course of performing duties pursuant to this Agreement, the Executive shall only use Germplasm provided by the Company, and the Executive agrees that any such Germplasm provided by the Company remains the sole property of the Company and that such Germplasm shall not be removed from Company premises without the prior written consent of the Company.</font></div><div style="margin-bottom:12pt;margin-top:12pt;padding-left:72pt;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">(f)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;padding-left:25.02pt">The Executive represents and warrants that the Executive does not possess any Intellectual Property or Germplasm of any third party, including, without limitation, any prior employer or competitor of the Company, and the Executive shall not acquire and&#47;or use Intellectual Property or Germplasm of any third party in the course of performing duties pursuant to this Agreement and shall not bring any Germplasm of any third party onto Company premises.</font></div><div style="height:63pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">11</font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="text-align:right"><font><br></font></div></div><div style="margin-bottom:12pt;margin-top:12pt;padding-left:36pt;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">7.3</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%;padding-left:22.25pt">Non-Competition</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">. The Executive shall not at any time during the Executive&#8217;s employment with the Company and for a period of one year following the date of the termination of the Executive&#8217;s employment with the Company for any reason, as specified in written notice by the Company or the Executive, as applicable (the &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%">Termination Date</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#8221;), either individually or in partnership or jointly or in conjunction with any Person as principal, agent, consultant, employee, partner, director, shareholder (other than an investment of less than five per cent of the shares of a company traded on a registered stock exchange or traded in the over the counter market in Canada), or in any other capacity whatsoever&#58;</font></div><div style="margin-bottom:12pt;margin-top:12pt;padding-left:72pt;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">(a)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;padding-left:23.8pt">engage in employment or enter into a contract to do work related to the research into, development, cultivation, production, supply, sales or marketing of cannabis or cannabis derived products&#59; or the development or provision of any services (including, but not limited to, technical and product support, or consultancy or customer services) which relate to cannabis or cannabis derived products (the &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%">Business</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#8221;)&#59; or</font></div><div style="margin-bottom:12pt;margin-top:12pt;padding-left:72pt;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">(b)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;padding-left:23.18pt">have any financial or other interest (including by way of royalty or other compensation arrangements) in or in respect of the business of any Person which carries on the Business&#59; or</font></div><div style="margin-bottom:12pt;margin-top:12pt;padding-left:72pt;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">(c)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;padding-left:23.8pt">advise, lend money to or guarantee the debts or obligations of any Person which carries on the Business&#59;</font></div><div style="margin-bottom:12pt;margin-top:12pt;padding-left:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">anywhere within Canada and&#47;or the United States of America.</font></div><div style="margin-bottom:12pt;margin-top:12pt;padding-left:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">For purposes of this section, &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%">cannabis</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#8221; means (a) any plant or seed, whether live or dead, from any species or subspecies of genus </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:400;line-height:120%">Cannabis</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">, including </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:400;line-height:120%">Cannabis sativa</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">, </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:400;line-height:120%">Cannabis indica </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">and </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:400;line-height:120%">Cannabis ruderalis</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">, Marijuana and Industrial Hemp and any part, whether live or dead, of the plant or seed thereof, including any stalk, branch, root, leaf, flower, or trichome&#59; (b) any material obtained, extracted, isolated, or purified from the plant or seed or the parts contemplated by clause (a) of this definition, including any oil, cannabinoid, terpene, genetic material or any combination thereof&#59; (c) any organism engineered to biosynthetically produce the material contemplated by clause (b) of this definition, including any micro-organism engineered for such purpose&#59; (d) any biologically or chemically synthesized version of the material contemplated by clause (b) of this definition or any analog thereof, including any product made by any organism contemplated by clause (c) of this definition&#59; and (e) any other meaning ascribed to the term &#8220;cannabis&#8221; under applicable Law, including the CDSA and the </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:400;line-height:120%">Cannabis Act</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">.</font></div><div style="margin-bottom:12pt;margin-top:12pt;padding-left:36pt;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">7.4</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%;padding-left:22.25pt">Non-Solicitation of Customers</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">. The Executive shall not, during the Executive&#8217;s employment and for the one year period immediately following the Termination Date, whether alone or for or in conjunction with any Person or entity, whether as an employee, partner, director, principal, agent, consultant or in any other capacity whatsoever, directly or indirectly solicit or attempt to solicit any Customer or Prospective Customer for the purpose of obtaining the business of any Customer or Prospective Customer or persuading any such Customer or Prospective Customer to cease to do business with or reduce the amount of business it would otherwise provide to the Group. For the purpose of this Agreement, &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%">Customer</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#8221; means any Person which is a current customer or has been a customer of the Group during the term of the Executive&#8217;s employment with the Company but in the event of the cessation of the Executive&#8217;s employment &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%">Customer</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#8221; shall include only those current customers of the Group with whom the Executive had direct contact or access to Confidential Information by virtue of the Executive&#8217;s role as an employee of the Company at any time during the twelve month period preceding the Termination Date&#59; &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%">direct contact</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#8221; means direct communications with or by the </font></div><div style="height:63pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">12</font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="text-align:right"><font><br></font></div></div><div style="margin-bottom:12pt;margin-top:12pt;padding-left:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">Executive, whether in Person or otherwise, for purposes of servicing, selling, or marketing on behalf of the Company, but only if such communications are more than trivial in nature, and in any case excluding bulk or mass marketing communications directed to multiple customers&#59; and, &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%">Prospective Customer</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#8221; means any organization, individual or entity which has been actively contacted and solicited for its business by representatives of the Group, but in the event of the cessation of the Executive&#8217;s employment within the twelve month period immediately preceding the Termination Date, with the involvement and knowledge of the Executive.</font></div><div style="margin-bottom:12pt;margin-top:12pt;padding-left:36pt;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">7.5</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%;padding-left:22.25pt">Non-Solicitation of Employees</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">. The Executive shall not, during the Executive&#8217;s employment and for two years following the Termination Date, whether alone or for or in conjunction with any Person or entity, whether as an employee, partner, director, principal, agent, consultant or in any other capacity whatsoever, directly or indirectly solicit or assist in the solicitation of any employee of the Group to leave such employment.</font></div><div style="margin-bottom:12pt;margin-top:12pt;padding-left:36pt;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">7.6</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%;padding-left:22.25pt">Disclosure</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">. During the Executive&#8217;s employment with the Company, the Executive shall promptly disclose to the Board full information concerning any interest, direct or indirect, of the Executive (whether as owner, shareholder, partner, lender or other investor, director, officer, employee, consultant or otherwise) or any member of the Executive&#8217;s immediate family, in any business which is reasonably known to the Executive to purchase or otherwise obtain services or products from, or to sell or otherwise provide services or products to the Company or to any of their respective suppliers or Customers.</font></div><div style="margin-bottom:12pt;margin-top:12pt;padding-left:36pt;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">7.7</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%;padding-left:22.25pt">Other Employment. </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">During the Executive&#8217;s employment with the Company, the Executive shall not, except as a representative of the Company or with the prior written approval of the Executive&#8217;s manager, whether paid or unpaid, be directly or indirectly engaged, concerned or have any financial interest in any capacity in any other business, trade, professional or occupation (or the setting up of any business, trade, profession or occupation).</font></div><div style="margin-bottom:12pt;margin-top:12pt;padding-left:36pt;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">7.8</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%;padding-left:22.25pt">Return of Materials</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">. All files, forms, brochures, books, materials, written correspondence (including email and instant messages), memoranda, documents, manuals, computer disks, software products and lists (including financial and other information and lists of customers, suppliers, products and prices) pertaining to the Group which may come into the Executive&#8217;s possession or control shall at all times remain the property of the Group. Upon termination of the Executive&#8217;s employment for any reason, the Executive agrees to immediately deliver to the Company all such property in the Executive&#8217;s possession or directly or indirectly under the Executive&#8217;s control. The Executive agrees not to make, for the Executive&#8217;s personal or business use or that of any other person, reproductions or copies of any such property or other property of the Group.</font></div><div style="margin-bottom:12pt;margin-top:12pt;padding-left:36pt;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">7.9</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%;padding-left:22.25pt">Non-Disparagement</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">. Subject to Section 7.1(d) of this Agreement, the Executive shall refrain, both during and after the cessation of the Executive&#8217;s employment with the Company, from making, publicly or privately, any statement or announcement that constitutes an </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:400;line-height:120%">ad hominem </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">attack on, or that otherwise disparages, defames, slanders, impugns or is reasonably likely to damage the reputation of the Group, or its or any of their respective directors, members, limited or general partners, equity holders, officers, employees, agents, consultants, advisors or other representatives.</font></div><div style="margin-bottom:12pt;margin-top:12pt;padding-left:36pt;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%">8.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%;padding-left:27.75pt;text-decoration:underline">General</font></div><div style="margin-bottom:12pt;margin-top:12pt;padding-left:36pt;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">8.1</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%;padding-left:22.25pt">Reasonableness of Restrictions and Covenants</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">. The Executive hereby confirms and agrees that the covenants and restrictions contained in this Agreement, including, without limitation, those contained </font></div><div style="height:63pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">13</font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="text-align:right"><font><br></font></div></div><div style="margin-bottom:12pt;margin-top:12pt;padding-left:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">in Article 7</font><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">, </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">are reasonable and valid the Executive further acknowledges and agrees that the Company may suffer irreparable injury in the event of any breach by the Executive of the obligations under any such covenant or restriction. Accordingly, the Executive hereby acknowledges and agrees that damages would be an inadequate remedy at law in connection with any such breach and that the Company shall therefore be entitled, in addition to any other right or remedy which it may have at law, in equity or otherwise, to temporary and permanent injunctive relief enjoining and restraining the Executive from any such breach.</font></div><div style="margin-bottom:12pt;margin-top:12pt;padding-left:36pt;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">8.2</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%;padding-left:22.25pt">Survival. </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">Article 7</font><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%"> </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">and this Section 8.2 survive the termination of this Agreement and the Executive&#8217;s employment for any reason whatsoever.</font></div><div style="margin-bottom:12pt;margin-top:12pt;padding-left:36pt;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">8.3</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%;padding-left:22.25pt">Entire Agreement</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">. This is the entire agreement between the Parties on the subject matters addressed herein. There are no representations, warranties or collateral agreements, whether written or oral, outside of this written Agreement. This Agreement and the terms and conditions of employment contained herein supersede and replace any prior understandings or discussions between the Parties, including the Original Agreement, regarding the Executive&#8217;s employment.</font></div><div style="margin-bottom:12pt;margin-top:12pt;padding-left:36pt;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">8.4</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%;padding-left:22.25pt">Withholding Taxes</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">. The Company may withhold from any amounts or benefits payable under this Agreement income taxes and payroll taxes that are required to be withheld pursuant to any applicable law or regulation.</font></div><div style="margin-bottom:12pt;margin-top:12pt;padding-left:36pt;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">8.5</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%;padding-left:22.25pt">Section 409A Compliance</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">. To the extent applicable, this Agreement is intended to comply with the requirements of Section 409A of the United States Internal Revenue Code of 1986, as amended (together with the applicable regulations thereunder, &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%">Section 409A</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#8221;). To the extent that any provision in this Agreement is ambiguous as to its compliance with Section 409A or to the extent any provision in this Agreement must be modified to comply with Section 409A (including, without limitation, Treasury Regulation 1.409A-3(c)), such provision shall be read, or shall be modified (with the mutual consent of the parties, which consent shall not be unreasonably withheld), as the case may be, in such a manner so that all payments due under this Agreement shall comply with Section 409A. For purposes of Section 409A, each payment made under this Agreement shall be treated as a separate payment. In no event may Executive, directly or indirectly, designate the calendar year of payment. Notwithstanding any provision of this Agreement to the contrary, if necessary to comply with the restriction in Section 409A(a)(2)(B) concerning payments to &#8220;specified employees&#8221; (as defined in Section 409A) any payment on account of the Executive&#8217;s separation from service that would otherwise be due hereunder within six months after such separation shall nonetheless be delayed until the first business day of the seventh month following the Executive&#8217;s date of termination and the first such payment shall include the cumulative amount of any payments that would have been paid prior to such date if not for such restriction. Notwithstanding anything contained herein to the contrary, the Executive shall not be considered to have terminated employment with the Company for purposes of this Agreement unless he would be considered to have incurred a &#8220;separation from service&#8221; from the Company within the meaning of Section 409A.</font></div><div style="margin-bottom:12pt;margin-top:12pt;padding-left:36pt;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">8.6</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%;padding-left:22.25pt">Amendments. </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">This Agreement may only be amended by written agreement executed by the Parties. However, changes to the Executive&#8217;s position, duties, vacation, benefits and compensation, over time in the normal course, do not affect the validity or enforceability of the Agreement.</font></div><div style="margin-bottom:12pt;margin-top:12pt;padding-left:36pt;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">8.7</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%;padding-left:22.25pt">Governing Law</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">. This Agreement shall be governed by and construed in accordance with the laws of the State of Delaware and the laws of the United States applicable in the State of Delaware. The Company and the Executive each irrevocably consent to the exclusive jurisdiction of the courts of </font></div><div style="height:63pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">14</font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="text-align:right"><font><br></font></div></div><div style="margin-bottom:12pt;margin-top:12pt;padding-left:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">Delaware and the courts of Delaware shall have the sole and exclusive jurisdiction to entertain any action arising under this Agreement.</font></div><div style="margin-bottom:12pt;margin-top:12pt;padding-left:36pt;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">8.8</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%;padding-left:22.25pt">Severability</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">. If any provision in this Agreement is determined to be invalid or unenforceable, such provision shall be severed from this Agreement, and the remaining provisions shall continue in full force and effect. If for any reason any court of competent jurisdiction will find any provisions of this Agreement unreasonable in duration or geographic scope or otherwise, the Parties agree that the restrictions and prohibitions contained herein will be effective to the fullest extent allowed under applicable law in such jurisdiction.</font></div><div style="margin-bottom:12pt;margin-top:12pt;padding-left:36pt;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">8.9</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%;padding-left:22.25pt">Assignment</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">. The Company may assign this Agreement to an affiliate or subsidiary, and it enures to the benefit of the Company, its successors or assigns.</font></div><div style="margin-bottom:12pt;margin-top:12pt;padding-left:36pt;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">8.10</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%;padding-left:16.75pt">Independent Legal Advice</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">. The Executive acknowledges that the Executive has been encouraged to obtain independent legal advice regarding the execution of this Agreement, and that the Executive has either obtained such advice or voluntarily chosen not to do so, and hereby waives any objections or claims the Executive may make resulting from any failure on the Executive&#8217;s part to obtain such advice.</font></div><div style="margin-bottom:12pt;margin-top:12pt;padding-left:36pt;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">8.11</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%;padding-left:16.75pt">Waiver. </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">No waiver of any of the provisions of this Agreement shall be effective or binding, unless made in writing and signed by the party purporting to give the same. No waiver of any of the provisions of this Agreement shall be deemed or shall constitute a waiver of any other provisions, whether or not similar, nor shall such waiver constitute a continuing waiver, unless expressly stated otherwise.</font></div><div style="margin-bottom:12pt;margin-top:12pt;padding-left:36pt;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">8.12</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%;padding-left:16.75pt">Conditions</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">. This Agreement and the Executive&#8217;s continued employment hereunder is conditional on the Company&#8217;s satisfaction (determined in the Company&#8217;s sole discretion) that the Executive has met the legal requirements to perform the Executive&#8217;s role, including but not limited to satisfactory results of Health Canada or any other applicable security clearance checks and criminal record checks and other reference checks that the Company performs. The Executive acknowledges and agrees that in signing this Agreement, and providing the Company with the necessary documentation to perform the checks required for the Executive&#8217;s role and with references, the Executive is providing consent to the Company or its agent, to performs such checks and contact the references the Executive provided to the Company.</font></div><div style="margin-bottom:12pt;margin-top:12pt;padding-left:36pt;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">8.13</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%;padding-left:16.75pt">Prior Restrictions</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">. By signing below, the Executive represents that the Executive is not bound by the terms of any agreement with any Person which restricts in any way the Executive&#8217;s hiring by the Company and the performance of the Executive&#8217;s expected job duties&#59; the Executive also represents that, during the Executive&#8217;s employment with the Company, the Executive shall not disclose or make use of any confidential information of any other persons or entities in violation of any of their applicable policies or agreements and&#47;or applicable law.</font></div><div style="margin-bottom:12pt;margin-top:12pt;padding-left:36pt;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">8.14</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%;padding-left:16.75pt">Resignation from Hortican</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">. Without limiting the generality of Section 8.3 above, by signing below, the Executive confirms that&#58; (i) the Executive voluntarily and irrevocably resigned from his employment with Hortican, and Hortican accepted the Executive resignation, effective as of the date of the assignment of the Original Agreement to, and the start of the Executive&#8217;s employment with, Cronos USA&#59; and (ii) the Executive has no rights or entitlements in respect of the cessation of such employment with Hortican, whether pursuant to contract, statute or the common law. For the avoidance of doubt, the Executive&#8217;s resignation from his employment with Horitcan does not impact any Cronos Group equity-based awards granted to the Executive before the Effective Date, which remain in full force and effect.</font></div><div style="height:63pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">15</font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="text-align:right"><font><br></font></div></div><div style="margin-bottom:6pt;margin-top:6pt;padding-left:36pt;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">8.15</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%;padding-left:16.75pt">Counterparts. </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">This Agreement may be executed in one or more counterparts, each of which when executed shall be deemed to be an original but all of which taken together shall constitute one and the same agreement. Delivery of an executed counterpart of a signature page to this Agreement by electronic transmission, including in portable document format (.pdf), shall be deemed as effective as delivery of an original executed counterpart of this Agreement.</font></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:400;line-height:120%">&#91;Signature Page Follows&#93;</font></div><div style="margin-bottom:12pt;margin-top:12pt"><font><br></font></div><div style="margin-bottom:12pt;margin-top:12pt"><font><br></font></div><div style="margin-bottom:12pt;margin-top:12pt"><font><br></font></div><div style="margin-bottom:12pt;margin-top:12pt"><font><br></font></div><div style="margin-bottom:12pt;margin-top:12pt"><font><br></font></div><div style="margin-bottom:12pt;margin-top:12pt"><font><br></font></div><div style="margin-bottom:12pt;margin-top:12pt"><font><br></font></div><div style="margin-bottom:12pt;margin-top:12pt"><font><br></font></div><div style="margin-bottom:12pt;margin-top:12pt"><font><br></font></div><div style="margin-bottom:12pt;margin-top:12pt"><font><br></font></div><div style="margin-bottom:12pt;margin-top:12pt"><font><br></font></div><div style="margin-bottom:12pt;margin-top:12pt"><font><br></font></div><div style="margin-bottom:12pt;margin-top:12pt"><font><br></font></div><div style="margin-bottom:12pt;margin-top:12pt"><font><br></font></div><div style="margin-bottom:12pt;margin-top:12pt"><font><br></font></div><div style="margin-bottom:12pt;margin-top:12pt"><font><br></font></div><div style="margin-bottom:12pt;margin-top:12pt"><font><br></font></div><div style="margin-bottom:12pt;margin-top:12pt"><font><br></font></div><div style="margin-bottom:12pt;margin-top:12pt"><font><br></font></div><div style="margin-bottom:12pt;margin-top:12pt"><font><br></font></div><div style="margin-bottom:12pt;margin-top:12pt"><font><br></font></div><div style="margin-bottom:12pt;margin-top:12pt"><font><br></font></div><div style="height:63pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">16</font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="text-align:right"><font><br></font></div></div><div style="margin-bottom:12pt;margin-top:12pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%">IN WITNESS WHEREOF </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">this Agreement has been executed by the Parties as of this 3rd day of June, 2021.</font></div><div style="margin-bottom:12pt;margin-top:12pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:43.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:16.475%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:36.325%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:100%">CRONOS USA CLIENT SERVICES LLC</font></td></tr><tr style="height:20pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt;text-indent:298.95pt"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">By&#58;    </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">&#47;s&#47; Michael Gorenstein           </font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;Name&#58; Michael Gorenstein</font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;Title&#58; Executive Chairman</font></div></td></tr><tr style="height:14pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr style="height:14pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:100%">CRONOS GROUP INC.</font></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:100%">solely with respect to Section 5.3</font></td></tr><tr style="height:21pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">By&#58;    </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">&#47;s&#47; Kurt Schmidt                     </font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;Name&#58; Kurt Schmidt</font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;Title&#58; President &#38; CEO</font></div></td></tr><tr style="height:14pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr style="height:14pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:100%">HORTICAN INC.</font></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:100%">solely with respect to Section 8.14</font></td></tr><tr style="height:23pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">By&#58;    </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">&#47;s&#47; Michael Gorenstein            </font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;Name&#58; Michael Gorenstein</font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;Title&#58; Executive Chairman</font></div></td></tr><tr style="height:14pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr style="height:14pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:100%">EXECUTIVE</font></td></tr><tr style="height:20pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">&#47;s&#47; Todd Abraham                    </font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;Name&#58; Todd Abraham</font></div></td></tr><tr style="height:14pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr style="height:14pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr style="height:14pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr style="height:14pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:100%">Signed and Returned to Shannon Buggy using electronic signature</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:100%">SIGNED AND DELIVERED</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"> in the presence of</font></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr style="height:14pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Witness Signature</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr style="height:14pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Witness Print Name</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr></table></div><div><font><br></font></div><div style="height:63pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">17</font></div></div></div></body></html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-10.3
<SEQUENCE>3
<FILENAME>ex103robertmadoreemploymen.htm
<DESCRIPTION>EX-10.3
<TEXT>
<!DOCTYPE html PUBLIC "-//W3C//DTD HTML 4.01 Transitional//EN" "http://www.w3.org/TR/html4/loose.dtd"><html><head>
<!-- Document created using Wdesk -->
<!-- Copyright 2021 Workiva -->
<title>Document</title></head><body><div id="id49e3c955fe1438c8f96d18cf1c2c6e3_1"></div><div style="min-height:72pt;width:100%"><div style="margin-bottom:3pt;text-align:right"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Exhibit 10.3</font></div><div style="margin-bottom:0.12pt;text-align:right"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">EXECUTION VERSION</font></div></div><div style="margin-bottom:12pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">EXECUTIVE EMPLOYMENT AGREEMENT</font></div><div style="margin-bottom:12pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">(this &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%">Agreement</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#8221;)</font></div><div style="margin-bottom:12pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">BETWEEN&#58;</font></div><div style="padding-left:108pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%">CRONOS USA CLIENT SERVICES LLC</font></div><div style="padding-left:108pt"><font><br></font></div><div style="padding-left:108pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">(the &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%">Company</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#8221;)</font></div><div style="padding-left:108pt"><font><br></font></div><div style="padding-left:108pt;text-indent:-108pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;- and -</font></div><div style="padding-left:108pt"><font><br></font></div><div style="padding-left:108pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%">ROBERT MADORE</font></div><div style="padding-left:108pt"><font><br></font></div><div style="padding-left:108pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">(the &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%">Executive</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#8221;) </font></div><div><font><br></font></div><div style="padding-left:108pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">- and &#8211;</font></div><div style="padding-left:108pt"><font><br></font></div><div style="padding-left:108pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">solely for the purposes specified herein, </font></div><div style="padding-left:108pt"><font><br></font></div><div style="padding-left:108pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%">CRONOS GROUP INC.</font></div><div style="padding-left:108pt"><font><br></font></div><div style="padding-left:108pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">(&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%">Cronos Group</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#8221;)</font></div><div style="margin-top:12pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%">&#160;&#160;&#160;&#160;WHEREAS</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%"> the Company is a wholly-owned subsidiary of Cronos Group&#59; </font></div><div style="margin-top:12pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%">&#160;&#160;&#160;&#160;WHEREAS</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%"> the Company wishes to engage the services of the Executive in the position of Chief Financial Officer of Cronos Group&#59;</font></div><div style="margin-top:12pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%">WHEREAS</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%"> the Executive will have extensive access to the customers, vendors, suppliers, distribution processes and other unique and valuable confidential information and trade secrets of the Company, Cronos Group and their respective affiliates (excluding Altria Group, Inc. and its subsidiaries) and related entities (together, the &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%">Group</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#8221;)&#59;</font></div><div style="margin-top:12pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%">&#160;&#160;&#160;&#160;WHEREAS</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%"> the Company and the Executive desire to enter into a written employment agreement&#59; </font></div><div style="margin-top:12pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%">AND WHEREAS</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%"> the Executive acknowledges that this Agreement, including, without limitation, the proprietary rights, confidentiality, non-solicitation and non-competition provisions that form part of this Agreement are essential to protect the legitimate business interests of the Group&#59; </font></div><div style="margin-top:12pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%">&#160;&#160;&#160;&#160;NOW THEREFORE</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%"> in consideration of the foregoing, the mutual covenants and agreements contained in this Agreement, and other good and valuable consideration, the receipt and sufficiency of which are hereby acknowledged, the Company and the Executive, and solely for the purposes specified herein, Cronos Group (together, the &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%">Parties</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#8221;), agree as follows&#58;<br></font></div><div style="margin-bottom:12pt;padding-left:36pt;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%">1.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%;padding-left:27.75pt;text-decoration:underline">Position</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">1.1</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;padding-left:22.25pt">The Executive shall be employed in the position of Chief Financial Officer, commencing on August 9, 2021, or such other date as agreed between the Executive and the Company in writing, </font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:12pt"><font><br></font></div><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="margin-bottom:12pt;text-align:right"><font><br></font></div></div><div style="margin-bottom:12pt;padding-left:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">email being sufficient (the actual date on which the Executive commences employment with the Company, the &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%">Effective Date</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#8221;).</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%">2.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%;padding-left:27.75pt;text-decoration:underline">Location</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">2.1</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;padding-left:22.25pt">The Executive shall be based primarily from the Executive&#8217;s home office. During the term of the Executive&#8217;s employment with the Company, the Executive&#8217;s principal place of residence shall remain in the United States. The Executive shall be available for business travel as reasonably required to perform the Executive&#8217;s duties hereunder.</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%">3.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%;padding-left:27.75pt;text-decoration:underline">Work Authorizations</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">3.1</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;padding-left:22.25pt">It is a condition of this Agreement and the Executive&#8217;s employment that the Executive shall be based in the United States. However, it is understood and agreed that the Executive&#8217;s position may require that the Executive work abroad from time to time, as needed by the Group. The Executive&#8217;s employment with the Company is therefore also conditional upon the securing of all necessary visas, work permits and other authorizations that may be reasonably required to enter and&#47;or to work in any of the countries in which the Executive may be assigned to work or visit during the term of employment. The Company shall provide reasonable assistance in respect of immigration matters. Despite such assistance, the Company cannot guarantee when or whether the Executive&#8217;s application for a work permit, visa, permanent residence status or other immigration status or documents will be approved. At any time, should necessary authorizations that permit the Executive to legally work outside the United States or in any other jurisdiction in which the Executive will be required to work or visit not be obtained or expire without the possibility of renewal, the Executive&#8217;s employment shall come to an end and shall be treated by the Company as a termination without Just Cause (as defined below)&#59; provided, that if such authorization expires without the possibility of renewal due to any action or inaction by the Executive that is not otherwise approved by the Company, the Executive&#8217;s employment shall come to an end and shall be treated by the Company as a termination with Just Cause.</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%">4.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%;padding-left:27.75pt;text-decoration:underline">Employment Duties</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">4.1</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;padding-left:22.25pt">The Executive shall perform such duties and exercise such powers as are normally associated with or incidental and ancillary to the Executive&#8217;s position and as may be assigned to the Executive from time to time. In fulfilling the Executive&#8217;s duties to the Company, the Executive shall be instructed by and shall regularly report to the Chief Executive Officer of Cronos Group, (the &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%">CEO</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#8221;). The Executive&#8217;s duties, hours of work, location of employment and reporting relationships may be reasonably adjusted from time to time by the Company to meet changing business and operational needs. Without limiting the foregoing, the Executive shall&#58;</font></div><div style="margin-bottom:12pt;padding-left:72pt;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">(a)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;padding-left:23.8pt">devote the Executive&#8217;s full working time and attention during normal business hours and such other times as may be reasonably required to the business and affairs of the Group and shall not, without the prior written consent of the CEO, undertake any other business (including any position on a board of any for profit, public benefit or nonprofit entity) or occupation or public office&#59;</font></div><div style="margin-bottom:12pt;padding-left:72pt;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">(b)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;padding-left:23.18pt">perform those duties that may be assigned to the Executive diligently, honestly, and faithfully to the best of the Executive&#8217;s ability and in the best interest of the Group&#59;</font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:12pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">2</font></div><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="margin-bottom:12pt;text-align:right"><font><br></font></div></div><div style="margin-bottom:12pt;padding-left:72pt;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">(c)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;padding-left:23.8pt">abide by all Cronos Group policies, as instituted and amended from time to time, including, without limitation, the Cronos Group - Employee Handbook (United States)&#59; </font></div><div style="margin-bottom:12pt;padding-left:72pt;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">(d)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;padding-left:23.18pt">use best efforts to promote the interests and goodwill of the Group and not knowingly do, or permit to be done, anything that may be prejudicial to the Group&#8217;s interests, it being understood and agreed that the Executive is a fiduciary of Cronos Group and owes fiduciary obligations to Cronos Group that are not extinguished or limited by this Agreement&#59; and</font></div><div style="margin-bottom:12pt;padding-left:72pt;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">(e)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;padding-left:23.8pt">identify and immediately report to the CEO</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%"> </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">any gross misrepresentations or violations of any Cronos Group policy, including, without limitation, the Cronos Group &#8211; Employee Handbook (United States) or applicable law by Cronos Group or its management. </font></div><div style="margin-bottom:12pt;padding-left:36pt;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%">5.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%;padding-left:27.75pt;text-decoration:underline">Compensation and Benefits</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">5.1</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%;padding-left:22.25pt">Base Salary.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%"> The Company shall pay the Executive an annual base salary of US$450,000, less applicable deductions and withholdings (&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%">Base Salary</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#8221;). The Base Salary shall be paid by direct deposit on a bi-weekly basis, in accordance with the Company&#8217;s payroll practices (as may be amended from time to time by the Company in its sole discretion). Any changes to Base Salary shall be at the sole discretion of the Company. The Base Salary shall be subject to increases, but not decreases.</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">5.2</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%;padding-left:22.25pt">Annual Performance Bonus.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%"> Starting in the 2022 fiscal year, the Executive shall be eligible to participate in the Group&#8217;s annual cash bonus plan as may be in effect from time to time, and to receive an annual bonus, subject to the terms and conditions of that plan as determined by Cronos Group at its sole discretion. The Executive&#8217;s annual target bonus opportunity shall initially be 125% of Base Salary, provided that the actual bonus amount, if any, shall be determined pursuant to the terms of the applicable Group annual bonus plan. For the avoidance of doubt, the Executive will not be eligible for an annual cash bonus in respect of the 2021 fiscal year. The Company reserves the right to amend or terminate any annual bonus plan established or adopted at any time, without notice or further obligation. Subject to the foregoing and to Section 6.3 of this Agreement, the Executive must be actively employed by the Company on the applicable payment date to be eligible for any annual bonus, unless provided otherwise pursuant to the applicable annual cash bonus plan. For certainty, if the Executive&#8217;s employment is terminated by the Company with or without Just Cause, or the Executive resigns or otherwise terminates employment for any reason, the Executive shall cease to be &#8220;actively employed&#8221; on the last day of employment as specified in the Company&#8217;s or the Executive&#8217;s written notice of termination, as applicable, shall not be considered &#8220;actively employed&#8221; during any period of notice, pay in lieu of notice, severance payment or similar amount, and shall not be entitled to an annual bonus (or any part thereof) or damages in lieu of the Executive&#8217;s eligibility for a bonus, unless provided otherwise pursuant to Section 6.3 of this Agreement and&#47;or the applicable annual cash bonus plan. There shall be no guarantee of a bonus in any given year.</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">5.3</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%;padding-left:22.25pt">Long-Term Incentive Opportunity</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">. </font></div><div style="margin-bottom:12pt;padding-left:72pt;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">(a)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;padding-left:23.8pt">Starting in the 2022 fiscal year, the Executive shall be eligible to receive annual grants of equity-based awards over shares of Cronos Group with an initial target incentive opportunity of US$787,500 (based on the grant date fair value of such awards), provided that the actual amount, if any, of the grants shall be determined by the board of directors </font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:12pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">3</font></div><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="margin-bottom:12pt;text-align:right"><font><br></font></div></div><div style="margin-bottom:12pt;padding-left:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">of Cronos Group (the &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%">Board</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#8221;) or the Compensation Committee of the Board, as applicable, at its sole discretion. Any equity-based grants shall be governed by the terms and conditions of the equity award plan or any other applicable plan of Cronos Group and the applicable award agreement, except as expressly set forth herein. Such plan or plans may be amended from time to time at Cronos Group&#8217;s sole discretion. In the event of the cessation of the Executive&#8217;s employment for any reason, the Executive&#8217;s entitlements in respect of any equity-based awards shall be governed by the terms and conditions of the applicable equity award plan, any other applicable plan and the applicable award agreement. The Executive shall not be eligible for any further grants of equity-based awards following the effective date of termination or damages in lieu thereof, regardless of any applicable notice period, pay in lieu of notice, severance payment or similar amount. </font></div><div style="margin-bottom:12pt;padding-left:72pt;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">(b)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;padding-left:23.18pt">In addition, as soon as reasonably practicable after the Effective Date, the Board shall grant the Executive a one-time grant of equity-based awards, comprised of (a) 900,000 non-qualified stock options, vesting ratably on a quarterly basis over a four (4) year period following the date of grant, and (b) 50,000 restricted share units, vesting on the third (3</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.15pt;font-weight:400;line-height:120%;position:relative;top:-3.85pt;vertical-align:baseline">rd</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">) anniversary of the grant date (together, the &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%">Sign-On Awards</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#8221;). The Sign-On Awards shall be subject to the terms and conditions set forth in Cronos Group&#8217;s 2020 Omnibus Equity Incentive Plan and the applicable award agreements, in substantially the forms attached hereto as&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">Exhibit A</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#160;and&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">Exhibit B</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">. </font></div><div style="margin-bottom:12pt;padding-left:36pt;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">5.4</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%;padding-left:22.25pt">Group Insured Benefits</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">. The Executive shall be eligible to participate in the benefits programs of the Company or Cronos Group, as applicable, for health and dental, life insurance, disability and other benefits as may be available to its senior executive employees from time to time, subject to the terms and conditions of the applicable plan document. The Company or the Group, as applicable, reserves the right to alter, amend or discontinue all benefits, coverages, plans and programs referred to in this Section 5.4, without advance notice or other obligation. </font></div><div style="margin-bottom:12pt;padding-left:36pt;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">5.5</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%;padding-left:22.25pt">Signing Bonus</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">. The Company shall provide the Executive with a one-time lump sum cash payment of US$372,000, less applicable deductions and withholdings, to be earned on the first anniversary of the Effective Date and paid by the Company&#8217;s within sixty (60) days of such anniversary date (the &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%">Signing Bonus</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#8221;). If the Executive provides notice of resignation for any reason other than Good Reason (as defined herein), or the Company terminates the Executive&#8217;s employment for Just Cause, in either case before the first anniversary of the Effective Date, the Executive shall forfeit the Signing Bonus in its entirety. If the Company terminates the Executive&#8217;s employment without Just Cause, or the Executive provides notice of resignation for Good Reason, in either case before the first anniversary of the Effective Date, the Signing Bonus shall be prorated by multiplying the annualized award by a fraction where the numerator is the number of completed months that the Executive was employed by the Company, and the denominator is twelve (12).</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">5.6</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%;padding-left:22.25pt">Vacation</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">. The Executive shall be eligible for four (4) weeks of paid vacation per calendar year, or for such greater length of time as may be consistent with the vacation policy of the Company for its senior executives. The Executive shall take vacation time at such times as are approved in advance by the Company in accordance with the policies of the Company. Vacation shall be accrued in accordance with the Company&#8217;s vacation policy, as may be amended from time to time. </font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:12pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">4</font></div><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="margin-bottom:12pt;text-align:right"><font><br></font></div></div><div style="margin-bottom:12pt;padding-left:36pt;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">5.7</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%;padding-left:22.25pt">Business Expenses</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">. The Executive shall be reimbursed for all reasonable travel and other out-of-pocket expenses properly incurred by the Executive from time to time in connection with performance of the Executive&#8217;s duties and submitted for reimbursement in accordance with the following sentence of this Section&#160;5.7. The Executive shall furnish to the Company all invoices or statements in respect of expenses for which the Executive seeks reimbursement in accordance with the Company&#8217;s policies or procedures for expense reimbursement, as may be amended from time to time. </font></div><div style="margin-bottom:12pt;padding-left:36pt;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">5.8</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%;padding-left:22.25pt">Clawback Policy&#59; Share Ownership Guidelines. </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">The Executive agrees and acknowledges that any annual, long-term or other cash, equity or equity-based incentive or bonus compensation paid, provided or awarded to the Executive, including, notwithstanding anything to the contrary in such policy, the non-qualified stock options and restricted share units awarded in connection with the Sign-On Awards, is subject to the terms and conditions of any clawback or recapture policy that Cronos Group may adopt from time to time, and may be subject to the requirement that such compensation be repaid to the Company after it has been distributed to the Executive.&#160; The Executive agrees and acknowledges that Executive shall be subject to Cronos Group&#8217;s share ownership guidelines for the Executive&#8217;s position, as the same may be in effect or amended from time to time. As of the Effective Date, such guidelines require the Executive to achieve, within five (5) years of the Effective Date and thereafter during the term of the Executive&#8217;s employment with the Company, a level of ownership equal to two (2) times Base Salary.</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%">6.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%;padding-left:27.75pt;text-decoration:underline">Termination of Employment</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">6.1</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%;padding-left:22.25pt">Termination by the Executive</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%"> </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">The Executive may terminate the Executive&#8217;s employment with the Company at any time by providing the Company with at least three (3) months of notice in writing. If, upon receipt of the Executive&#8217;s resignation (or any later date during such notice period), the Company terminates the Executive&#8217;s employment before the date the resignation was to be effective, the Company shall, in full satisfaction of its obligations to the Executive&#58; (a) pay the Executive&#8217;s Base Salary until the date the resignation was to be effective up to a maximum of three (3) months, plus all vacation pay accrued or to be accrued as of the effective date of resignation&#59; and (b) reimburse the outstanding expenses properly incurred by the Executive until the date the Executive&#8217;s employment ceases and submitted for reimbursement pursuant to Section 5.7. In such circumstances the Executive shall be ineligible for any pro-rated bonus for the year of termination, and any entitlements in respect of any equity-based awards shall be governed by the terms and conditions of the applicable equity award plan, any other applicable plan and the applicable award agreement. </font></div><div style="margin-bottom:12pt;padding-left:36pt;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">6.2</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%;padding-left:22.25pt">Termination by the Company for Just Cause or on Death or Disability</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">. The Company may terminate the Executive&#8217;s employment at any time for Just Cause without prior notice or in the event of the Executive&#8217;s death or Disability (as defined below). On the termination of the Executive&#8217;s employment for Just Cause or on the Executive&#8217;s death or Disability, this Agreement and the Executive&#8217;s employment shall terminate and the Company shall, in full satisfaction of its obligations to the Executive&#58; (a) pay the Executive&#8217;s Base Salary and vacation pay accrued until the date the Executive&#8217;s employment ceases&#59; and (b) reimburse the outstanding expenses properly incurred by the Executive until the date the Executive&#8217;s employment ceases and submitted for reimbursement pursuant to Section 5.7. In such circumstances the Executive shall be ineligible for any pro-rated bonus for the year of termination, and any entitlements in respect of equity-based awards shall be governed by the terms and conditions of the applicable equity award plan, any other applicable plan and the applicable award agreement. For the purposes of this </font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:12pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">5</font></div><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="margin-bottom:12pt;text-align:right"><font><br></font></div></div><div style="margin-bottom:12pt;padding-left:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">Agreement, (A) &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%">Just Cause</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#8221; means&#58; (i) any act or omission constituting &#8220;just cause&#8221; for dismissal without notice under applicable law&#59; (ii) the Executive&#8217;s repeated failure or refusal to perform the Executive&#8217;s principal duties and responsibilities after advance notice from the CEO or other officer of the Company and providing fifteen (15) days for the Executive to cure such non-performance&#59; (iii) misappropriation of the funds or property of the Company&#59; (iv) use of alcohol or drugs in violation of the Company&#8217;s policies on such use or that interferes with the Executive&#8217;s obligations under this Agreement, continuing after a single warning (subject to the Company&#8217;s obligations under applicable law)&#59; (v) the indictment, arrest or conviction in a court of law for, or the entering of a plea of guilty or nolo contendere to, a summary or indictable offence or any crime involving moral turpitude, fraud, dishonesty or theft (subject to the Company&#8217;s obligations under applicable human rights legislation)&#59; (vi) engaging in any act which is a violation of any law, regulation or Cronos Group policy, that, if violated, injures or could reasonably be expected to injure the reputation, business or business relationships of the Group&#59; (vii) engaging in any act which is a violation of any Cronos Group policy with respect to sexual harassment, discrimination or similar or related policies&#59; or (viii) any willful or intentional act which injures or could reasonably be expected to injure the reputation, business or business relationships of the Group, and (B) &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%">Disability</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#8221; means a physical or mental incapacity of the Executive that has prevented the Executive from performing, with or without a reasonable accommodation, the duties customarily assigned to the Executive for 180 calendar days, whether or not consecutive, out of any twelve consecutive months and that in the opinion of the Company, acting on the basis of advice from a duly qualified medical practitioner, is likely to continue to a similar degree.</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">6.3</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%;padding-left:22.25pt">Termination by the Company without Just Cause or Resignation for Good Reason</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">. The Company may terminate the Executive&#8217;s employment at any time without Just Cause, on providing thirty (30) days of written notice to the Executive. The Executive may resign from the Executive&#8217;s employment for Good Reason (as defined below) on providing thirty (30) days of written notice to the Company. If&#58; (a) the Company terminates the Executive&#8217;s employment without Just Cause, or (b) the Executive resigns from the Executive&#8217;s employment for Good Reason, and, in each case, if the Executive signs and delivers and does not revoke a release in favor of the Group to the Company in the form attached as&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">Exhibit C</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#160;to this Agreement, the Company, shall, in full satisfaction of its obligations to the Executive&#58; </font></div><div style="margin-bottom:12pt;padding-left:72pt;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">(i)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;padding-left:25.63pt">pay the Executive&#8217;s Base Salary in accordance with applicable legislation, and accrued but unpaid vacation pay&#59;</font></div><div style="margin-bottom:12pt;padding-left:72pt;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">(ii)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;padding-left:22.58pt">reimburse the Executive&#8217;s expenses properly incurred until the date the Executive&#8217;s employment ceases&#59;</font></div><div style="margin-bottom:12pt;padding-left:72pt;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">(iii)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;padding-left:19.53pt">pay the Executive a lump sum payment equal to the Executive&#8217;s Base Salary, payable within sixty (60) days (or the next following business day if the sixtieth (60</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.15pt;font-weight:400;line-height:120%;position:relative;top:-3.85pt;vertical-align:baseline">th</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">) day is not a business day) following the Executive&#8217;s date of termination&#59;</font></div><div style="margin-bottom:12pt;padding-left:72pt;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">(iv)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;padding-left:20.13pt">continue the Executive&#8217;s group insured benefits at active employee rates under the Consolidated Omnibus Reconciliation Act of 1985, as amended, for one (1) year following the Executive&#8217;s date of termination or until the date on which the Executive obtains alternate benefit coverage, whichever occurs first, subject to the terms and conditions of the benefit plans, as amended from time to time. If the Company is unable for any reason to continue its contributions to the benefit plans as set out in this </font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:12pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">6</font></div><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="margin-bottom:12pt;text-align:right"><font><br></font></div></div><div style="margin-bottom:12pt;padding-left:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">Agreement, it shall pay the Executive an amount equal to the Company&#8217;s required contributions to such benefit plans on behalf of the Executive for such period, in addition to any mandatory subsidy provided by law. The Executive agrees that the Executive is required to notify the Company when the Executive obtains alternate life, medical and dental benefit coverage&#59; </font></div><div style="margin-bottom:12pt;padding-left:72pt;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">(v)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;padding-left:23.18pt">subject to the terms and conditions of the Group&#8217;s annual cash bonus plan in effect at such time, provide the Executive with an annual performance bonus in respect of the fiscal year in which the Executive&#8217;s employment terminates. The annual bonus, if any, shall be (i) prorated based on the number of complete months of such fiscal year during which the Executive was actively employed up to the date of the Executive&#8217;s termination of employment, and (ii) payable as a lump sum when annual bonuses in respect of the fiscal year are paid to other senior executives of the Company. Any assessment of the Company&#8217;s and the Executive&#8217;s year-to-date performances for purposes of determining the amount of the annual cash bonus, if any, shall be at the Company&#8217;s sole discretion. For the avoidance of doubt and notwithstanding anything to the contrary in the foregoing, if the Executive&#8217;s employment terminates after the end of a fiscal year, but before the payment of any annual performance bonus in respect of such year, the Executive shall only be eligible for a performance bonus in respect of such completed fiscal year, and shall not be eligible for a prorated bonus in respect of any subsequent fiscal year(s)&#59; and</font></div><div style="margin-bottom:12pt;padding-left:72pt;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">(vi)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;padding-left:20.13pt">determine the Executive&#8217;s entitlements in respect of equity-based awards in accordance with the terms and conditions of the applicable equity award plan, any other applicable plan and the applicable award agreement. </font></div><div style="margin-bottom:12pt;padding-left:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">If the Executive does not sign and deliver to the Company the release in favor of the Group described above, or if the Executive revokes the foregoing release, the Company shall only provide the Executive with such compensation (including any Base Salary and accrued but unpaid vacation pay, termination pay, severance pay and expense reimbursements submitted in accordance with Section 5.7) and benefits that are expressly required pursuant to applicable law, if any.</font></div><div style="margin-bottom:12pt;padding-left:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">In this Agreement, &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%">Good Reason</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#8221; means the occurrence of any of the following events without the Executive&#8217;s consent, except in each case for any action not taken in bad faith and which is remedied by the Company within thirty (30) days after a written notice thereof by the Executive (provided that such written notice must be received by the Company within sixty (60) days of the Executive becoming aware of such condition)&#58;</font></div><div style="margin-bottom:12pt;padding-left:72pt;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">(aa)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;padding-left:18.92pt">the assignment to the Executive of duties materially different than the duties assigned to the Executive hereunder&#59;</font></div><div style="margin-bottom:12pt;padding-left:72pt;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">(bb)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;padding-left:17.68pt"> a material diminution in the Executive&#8217;s title, status, seniority, responsibilities or authority and&#47;or a requirement to report to any person other than the Company&#8217;s CEO&#59;</font></div><div style="margin-bottom:12pt;padding-left:72pt;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">(cc)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;padding-left:18.92pt">the relocation of the Executive&#8217;s principal place of employment more than thirty-five (35) miles from its current location&#59;</font></div><div style="margin-bottom:12pt;padding-left:72pt;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">(dd)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;padding-left:17.68pt">a material reduction in the Executive&#8217;s Base Salary, target bonus opportunity or target long-term incentive opportunity&#59; or </font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:12pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">7</font></div><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="margin-bottom:12pt;text-align:right"><font><br></font></div></div><div style="margin-bottom:12pt;padding-left:72pt;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">(ee)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;padding-left:18.92pt">a material breach by the Company of the terms of this Agreement.</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">6.4</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%;padding-left:22.25pt">Resignation on Termination</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">. The Executive agrees that upon any termination of employment with the Company for any reason the Executive shall immediately tender resignation from any position the Executive may hold as an officer or director of the Company and take all steps necessary to remove the Executive from any and all designated positions under any applicable laws, including without limitation, the </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:400;line-height:120%">Cannabis Act</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%"> (Canada) and the regulations thereunder, as the same may be amended from time to time, or any subsidiary or affiliate of Cronos Group. In the event that the Executive fails to comply with this obligation within three (3) days of the Executive's termination or resignation, the Executive hereby irrevocably authorizes Cronos Group to appoint a person in the Executive's name and on the Executive's behalf to sign or execute any documents and&#47;or do all things necessary or requisite to give effect to such resignation.</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">6.5</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%;padding-left:22.25pt">Compliance with Laws</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%"> </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">The Executive understands and agrees that the entitlements under this Article 6 are provided in full satisfaction of the Executive&#8217;s entitlements to notice of termination, pay in lieu of notice, and severance pay, if any, under this Agreement, any employee benefit plan sponsored or maintained by the Group, applicable law (including the common law) or otherwise.</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%">7.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%;padding-left:27.75pt;text-decoration:underline">Restrictive Covenants</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">7.1</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%;padding-left:22.25pt">Non-Disclosure</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">. The Executive acknowledges and agrees that&#58;</font></div><div style="margin-bottom:12pt;padding-left:72pt;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">(a)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;padding-left:23.8pt">during the term of the Executive&#8217;s employment, the Executive may be given access to or may become acquainted with confidential and proprietary information of the Group and third parties to which the Group may have any obligations of non-disclosure or confidentiality, including without limitation&#58; trade secrets&#59; know-how&#59; Intellectual Property (as defined below)&#59; Executive-Developed IP (as defined below), Development Records (as defined below), existing and contemplated work product resulting from or related to projects performed or to be performed by or for the Group&#59; programs and program modules&#59; processes&#59; algorithms&#59; design concepts&#59; system designs&#59; production data&#59; test data&#59; research and development information&#59; information regarding the acquisition, protection, enforcement and licensing of proprietary rights&#59; technology&#59; joint ventures&#59; business, accounting, engineering and financial information and data&#59; marketing and development plans and methods of obtaining business&#59; forecasts&#59; future plans and strategies of the Group&#59; pricing, cost, billing and fee arrangements and policies&#59; quoting procedures&#59; special methods and processes&#59; lists and&#47;or identities of customers, suppliers, vendors and contractors&#59; the type, quantity and specifications of products and services purchased, leased, licensed or received by the Group and&#47;or any of its customers, suppliers, or vendors&#59; internal personnel and financial information&#59; business and&#47;or personal information about any senior staff members of the Group or any individual, corporation (including not-for-profit), general or limited partnership, limited liability company, joint venture, association, joint-stock company, estate, trust, organization, governmental authority or other entity of any kind or nature (&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%">Person</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#8221;) with which the Group enters a strategic alliance or any other partnering arrangements&#59; vendor and supplier information&#59; the manner and method of conducting the Group&#8217;s business&#59; the identity or nature of relationship of any Persons associated with or engaged as consultants, advisers, agents, distributors or sales representatives (the &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%">Confidential Information</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#8221;) the disclosure of any of which to competitors of the Group or to the </font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:12pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">8</font></div><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="margin-bottom:12pt;text-align:right"><font><br></font></div></div><div style="margin-bottom:12pt;padding-left:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">general public, or the use of same by the Executive or any competitor of the Group, would be highly detrimental to the interests of the Group&#59;</font></div><div style="margin-bottom:12pt;padding-left:72pt;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">(b)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;padding-left:23.18pt">disclosure or use of Confidential Information, other than in connection with the Group&#8217;s business or as specifically authorized by the Group, will be highly detrimental to the business and interests of the Group and could result in serious loss of business and damage to it. Accordingly, the Executive specifically agrees to hold all Confidential Information in strictest confidence, and the Executive agrees that the Executive shall not, without the Company&#8217;s prior written consent, disclose, divulge or reveal to any Person, or use for any purpose other than for the exclusive benefit of the Company, any Confidential Information, in whatever form contained&#59; provided that the foregoing shall not apply to information (except for personal information about identifiable individuals) that&#58; (i)&#160;was known to the public prior to its disclosure to the Executive&#59; (ii)&#160;becomes generally known to the public subsequent to disclosure to the Executive other than by reason of the Executive&#8217;s breach of this Section&#59; (iii)&#160;becomes available to the Executive from a source independent of the Group&#59; or (iv)&#160;the Executive is specifically required to disclose by applicable law or legal process (provided that, to the extent legally permissible, the Executive provides the Company with prompt advance written notice of the contemplated disclosure and cooperates with the Company in seeking a protective order or other appropriate protection of such information)&#59; and</font></div><div style="margin-bottom:12pt;padding-left:72pt;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">(c)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;padding-left:23.8pt">the Executive shall deliver to the Company, immediately upon termination of employment (for any reason and regardless of whether the Executive or the Company terminate the employment) or at any time the Company so requests&#58; (i)&#160;any and all documents, files, notes, memoranda, models, databases, computer files and&#47;or other computer programs reflecting any Confidential Information whatsoever or otherwise relating to the Group&#8217;s business&#59; (ii)&#160;lists or other documents regarding customers, suppliers, or vendors of the Group or leads or referrals to prospective business deals&#59; and (iii)&#160;any computer equipment, home office equipment, automobile or other business equipment belonging to the Company that the Executive may then possess or have under the Executive&#8217;s control.</font></div><div style="margin-bottom:12pt;padding-left:72pt;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">(d)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;padding-left:23.18pt">For the avoidance of doubt, nothing in this Agreement limits, restricts or in any other way affects the Executive communicating with any governmental authority or entity concerning matters relevant to the governmental authority or entity. The Executive and the Company agree that no confidentiality or other obligation the Executive owes to the Group prohibits the Executive from reporting possible violations of law or regulation to any governmental authority or entity under any applicable whistleblower protection provision of applicable Canadian, U.S. Federal or U.S. State law or regulation (including Section 21F of the Securities Exchange Act of 1934 or Section 806 of the Sarbanes-Oxley Act of 2002) or requires the Executive to notify the Company of any such report. The Executive is hereby notified that the immunity provisions in Section 1833 of title 18 of the United States Code provide that an individual cannot be held criminally or civilly liable under any federal or state trade secret law for any disclosure of a trade secret that is made (i) in confidence to federal, state or local government officials, either directly or indirectly, or to an attorney, and is solely for the purpose of reporting or investigating a suspected violation of the law, (ii) under seal in a complaint or other document filed in a lawsuit or other proceeding, or (iii) to the Executive&#8217;s attorney in connection with a lawsuit for retaliation for reporting a suspected violation of law (and the trade secret may </font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:12pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">9</font></div><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="margin-bottom:12pt;text-align:right"><font><br></font></div></div><div style="margin-bottom:12pt;padding-left:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">be used in the court proceedings for such lawsuit) as long as any document containing the trade secret is filed under seal and the trade secret is not disclosed except pursuant to court order.</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">7.2</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%;padding-left:22.25pt">Intellectual Property</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">.</font></div><div style="margin-bottom:12pt;padding-left:72pt;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">(a) &#160;&#160;&#160;&#160;In this Section 7.2, the term &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%">Germplasm</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#8221; means any living or preserved biological tissue or material which may be used for the purpose of plant breeding and&#47;or propagation, including, without limitation, plants, cuttings, seeds, clones, cells, tissues, plant materials and genetic materials (including, without limitation, nucleic acids, genes, promoters, reading frames, regulatory sequences, terminators, chromosomes whether artificial or natural and vectors).</font></div><div style="margin-bottom:12pt;padding-left:72pt;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">(b)&#160;&#160;&#160;&#160;For the purposes of this Agreement, &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%">Intellectual Property</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#8221; means any and all intellectual property rights and proprietary rights existing in any jurisdiction throughout the world, including any rights in or to&#58;  (i) patents, patent applications, patent rights, inventions, industrial designs, industrial design applications, industrial design rights, ideas, discoveries and invention disclosures (whether or not patentable), and any divisionals, continuations, continuations-in-part, reissues, renewals, reexaminations and extensions of any of the foregoing&#59; (ii) trademarks, service marks, trade names, trade dress, logos, packaging designs, slogans, other indicia of source, Internet domain names and URLs, and registrations and applications for registration of any of the foregoing and any renewals thereof, together with any goodwill symbolized thereby&#59; (iii) copyrightable works (including with respect to software and compilations of data), whether published or unpublished, including all copyrights, copyright registrations and applications&#59; (iv)&#160;trade secrets, and confidential or proprietary information, data or database rights, know-how, techniques, designs, processes, recipes and formulas&#59; (v) Germplasm, plant varieties, and applications and registrations for plant varieties issued by or pending before any Governmental Authority, including under the Plant Variety Protection Act (United States) or the Plant Breeders&#8217; Rights Act (Canada)&#59; and (vi) circuit topographies, database rights and software.</font></div><div style="margin-bottom:12pt;padding-left:72pt;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">(c)&#160;&#160;&#160;&#160;The Executive agrees to promptly disclose to the Company (including, without limitation, to the CEO) all Intellectual Property, including with respect to, but without limitation, Germplasm, and whether or not any of the foregoing are registrable, which the Executive may author, make, conceive, develop, discover or reduce to practice, solely, jointly or in common with other employees, during the Executive&#8217;s employment with the Company, and which relate to the business activities of the Group (&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%">Executive-Developed IP</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#8221;). Intellectual Property coming within the scope of the business of the Company made and&#47;or developed by the Executive while in the employ of the Company, whether or not conceived or made during regular working hours and whether or not the Executive is specifically instructed to make or develop the same, shall be for the benefit of the Company and shall be considered to have been made pursuant to this Agreement and shall be deemed Executive-Developed IP and shall immediately become exclusive property of the Company. </font></div><div style="margin-bottom:12pt;padding-left:72pt;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">(d)&#160;&#160;&#160;&#160;The Executive further acknowledges that all Executive-Developed IP is &#8220;work made for hire&#8221; (to the greatest extent permitted by applicable law), &#8220;made in the course of employment&#8221; and owned exclusively by the Company and that the Executive has been </font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:12pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">10</font></div><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="margin-bottom:12pt;text-align:right"><font><br></font></div></div><div style="margin-bottom:12pt;padding-left:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">compensated for such Executive-Developed IP by the Executive&#8217;s salary, commissions and other benefits, unless regulated otherwise by law. To the extent such Executive-Developed IP is not &#8220;work made for hire&#8221;, &#8220;made in the course of employment&#8221; or otherwise not owned automatically and exclusively by the Company as a matter of law, then to the greatest extent permitted under by applicable law, the Executive hereby irrevocably assigns and transfers, and shall assign and transfer, to the Company, the Executive&#8217;s entire right, title and interest in and to any and all Executive-Developed IP, and the Executive agrees to execute and deliver to the Company any and all instruments necessary or desirable to accomplish the foregoing and, in addition, to do all lawful acts which may be necessary or desirable to assist the Company to obtain and enforce protection of Executive-Developed IP. If and to the extent the foregoing assignment cannot be effected as a matter of law with respect to any Executive-Developed IP, the Executive hereby grants to the Company an exclusive, perpetual, fully-paid, royalty-free, irrevocable, worldwide, fully-transferable, fully sublicensable (on multiple levels) license to use, modify, display, perform, make, have made, copy, make derivative works, import, export, distribute and otherwise exploit such Executive-Developed IP for any purpose. </font></div><div style="margin-bottom:12pt;padding-left:72pt;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">(e)&#160;&#160;&#160;&#160;The Executive must keep, maintain and make available to the Company complete and up-to-date records relating to any Executive-Developed IP, and agree that all such records are the sole and absolute property of the Company. For greater certainty, all materials related to Executive-Developed IP (including, without limitation, notes, records and correspondence, whether written or electronic) (collectively, &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%">Development Records</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#8221;) are the property of the Company, which the Executive shall provide to the Company upon request. Development Records shall not be removed from Company premises without the prior written consent of the Company. The Executive agrees to maintain as confidential any Executive-Developed IP and Development Records unless and until made generally public by the Company, and not to make application for registration of rights in respect of any Executive-Developed IP unless it is at the request and direction of the Company.</font></div><div style="margin-bottom:12pt;padding-left:72pt;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">(f)&#160;&#160;&#160;&#160;The Executive shall, at the request and cost of the Company, and for no additional compensation or consideration from the Company, sign, execute, make and do all such deeds, documents, acts and things as the Company and its duly authorized agents may reasonably require&#58;  (i) to apply for, obtain and vest in the name of the Company alone (unless the Company otherwise directs) registered rights in any Executive-Developed IP, including any patents, industrial designs, letters patent, copyrights, plant breeders&#8217; rights, trademarks, service marks or other analogous protection in any country throughout the world and when so obtained or vested to renew and restore the same&#59; (ii)&#160;to perfect or evidence ownership by the Company or its designees of any and all Executive-Developed IP, in form suitable for recordation in the United States, Canada and any other intellectual property office anywhere in the world&#59; (iii) to defend any opposition proceedings of any type whatsoever in respect of such applications, and any opposition proceedings or petitions or applications of any type whatsoever for revocation of such Executive-Developed IP, whether such proceedings are brought before a court or any administrative body&#59; (iv) to defend and&#47;or assert the Group&#8217;s rights in any Intellectual Property against any third party&#59; and (v) to assert the Executive&#8217;s moral rights in any Intellectual Property against any third party. The Executive further waives all moral rights in and to any Executive-Developed IP and all work the Executive produced during the course of the </font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:12pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">11</font></div><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="margin-bottom:12pt;text-align:right"><font><br></font></div></div><div style="margin-bottom:12pt;padding-left:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">Executive&#8217;s employment in favor of the Company, its licensees, successors and assigns, and transferees of the Executive-Developed IP and such work</font></div><div style="margin-bottom:12pt;padding-left:72pt;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">(g)&#160;&#160;&#160;&#160;If, in the course of performing duties pursuant to this Agreement, the Executive uses any Germplasm, the Executive shall only use Germplasm provided by the Company, and the Executive agrees that any such Germplasm provided by the Company remains the sole property of the Company and that such Germplasm shall not be removed from Company premises without the prior written consent of the Company. </font></div><div style="margin-bottom:12pt;padding-left:72pt;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">(h)&#160;&#160;&#160;&#160;The Executive represents and warrants that the Executive does not possess any Intellectual Property or Germplasm of any third party, including, without limitation, any prior employer or competitor of the Group, and the Executive shall not acquire and&#47;or use Intellectual Property or Germplasm of any third party in the course of performing duties pursuant to this Agreement and shall not bring any Germplasm of any third party onto Company premises.</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">7.3</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%;padding-left:22.25pt">Non-Competition</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">. The Executive shall not at any time during the Executive&#8217;s employment with the Company and for a period of one (1) year following the termination of the Executive&#8217;s employment with the Company for any reason, either individually or in partnership or jointly or in conjunction with any Person as principal, agent, consultant, employee, partner, director,  shareholder (other than an investment of less than five percent of the shares of a company traded on a registered stock exchange or traded in the over the counter market in the United States or Canada), or in any other capacity whatsoever&#58; </font></div><div style="margin-bottom:12pt;padding-left:72pt;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">(a)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;padding-left:23.8pt">engage in employment or enter into a contract to do work related to the research into, development, cultivation, production, supply, sales or marketing of cannabis or cannabis derived products&#59; or the development or provision of any services (including, without limitation, technical and product support, or consultancy or customer services) which relate to cannabis or cannabis derived products (the &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%">Business</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#8221;)&#59; or</font></div><div style="margin-bottom:12pt;padding-left:72pt;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">(b)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;padding-left:23.18pt">have any financial or other interest (including by way of royalty or other compensation arrangements) in or in respect of the business of any Person which carries on the Business in any respect&#59; or </font></div><div style="margin-bottom:12pt;padding-left:72pt;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">(c)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;padding-left:23.8pt">advise, lend money to or guarantee the debts or obligations of any Person which carries on the Business in any respect&#59;  </font></div><div style="margin-bottom:12pt;padding-left:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">anywhere within Canada and&#47;or the United States of America. </font></div><div style="margin-bottom:12pt;padding-left:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">For purposes of this section, &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%">cannabis</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#8221; means (a) any plant or seed, whether live or dead, from any species or subspecies of genus </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:400;line-height:120%">Cannabis</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">, including </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:400;line-height:120%">Cannabis sativa</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">, </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:400;line-height:120%">Cannabis indica</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%"> and </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:400;line-height:120%">Cannabis ruderalis</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">, marijuana (which has the meaning ascribed to such term under applicable law, including the Controlled Substances Act) and industrial hemp (which has the meaning ascribed to such term and the term &#8220;hemp&#8221; under applicable law, including the </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:400;line-height:120%">Industrial Hemp Regulations</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%"> (Canada) issued under the Cannabis Act and under the Agricultural Marketing Act of 1946) and any part, whether live or dead, of the plant or seed thereof, including any stalk, branch, root, leaf, flower, or trichome&#59; (b) any material obtained, extracted, isolated, or purified from the plant or seed or the parts contemplated by clause (a) of this definition, including any oil, cannabinoid, terpene, genetic material or any combination thereof&#59; (c) any organism engineered to biosynthetically produce the material contemplated by clause (b) of this definition, including </font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:12pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">12</font></div><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="margin-bottom:12pt;text-align:right"><font><br></font></div></div><div style="margin-bottom:12pt;padding-left:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">any micro-organism engineered for such purpose&#59; (d) any biologically or chemically synthesized version of the material contemplated by clause (b) of this definition or any analog thereof, including any product made by any organism contemplated by clause (c) of this definition&#59; and (e) any other meaning ascribed to the term &#8220;cannabis&#8221; under applicable law, including the </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:400;line-height:120%">Controlled Drugs and Substances Act</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%"> and the </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:400;line-height:120%">Cannabis Act</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">.</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">7.4</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%;padding-left:22.25pt">Non-Solicitation of Customers</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">. The Executive shall not, during the Executive&#8217;s employment and for the one (1) year period immediately following the termination of the Executive&#8217;s employment for any reason, whether alone or for or in conjunction with any Person, whether as an employee, partner, director, principal, agent, consultant or in any other capacity whatsoever, directly or indirectly solicit or attempt to solicit any Customer or Prospective Customer for the purpose of obtaining the business of any Customer or Prospective Customer or persuading any such Customer or Prospective Customer to cease to do business with or reduce the amount of business it would otherwise provide to the Group. For the purpose of this Agreement, &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%">Customer</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#8221; means any Person which is a current customer or has been a customer of the Group during the term of the Executive&#8217;s employment with the Company but in the event of the cessation of the Executive&#8217;s employment &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%">Customer</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#8221; shall include only those current customers of the Group with whom the Executive had direct contact or access to Confidential Information by virtue of the Executive&#8217;s role as an employee of the Company at any time during the twelve (12) month period preceding the date of the cessation of the Executive&#8217;s employment&#59; &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%">direct contact</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#8221; means direct communications with or by the Executive, whether in person or otherwise, for purposes of servicing, selling, or marketing on behalf of the Company, but only if such communications are more than trivial in nature, and in any case excluding bulk or mass marketing communications directed to multiple customers&#59; and, &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%">Prospective Customer</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#8221; means any Person has been actively contacted and solicited for its business by representatives of the Group, but in the event of the cessation of the Executive&#8217;s employment, shall include only those Persons contacted with the involvement and knowledge of the Executive within the twelve (12) month period immediately preceding the date of the cessation of the Executive&#8217;s employment. </font></div><div style="margin-bottom:12pt;padding-left:36pt;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">7.5</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%;padding-left:22.25pt">Non-Solicitation of Employees</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">. The Executive shall not, during the Executive&#8217;s employment and for two&#160;(2) years following the termination of the Executive&#8217;s employment for any reason, whether alone or for or in conjunction with any Person, whether as an employee, partner, director, principal, agent, consultant or in any other capacity whatsoever, directly or indirectly solicit or assist in the solicitation of any employee of the Group to leave such employment. </font></div><div style="margin-bottom:12pt;padding-left:36pt;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">7.6</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%;padding-left:22.25pt">Disclosure</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">. During the Executive&#8217;s employment with the Company, the Executive shall promptly disclose to the Board full information concerning any interest, direct or indirect, of the Executive (whether as owner, shareholder, partner, lender or other investor, director, officer, employee, consultant or otherwise) or any member of the Executive&#8217;s immediate family, in any business which is reasonably known to the Executive to purchase or otherwise obtain services or products from, or to sell or otherwise provide services or products to the Group or to any of their respective suppliers or Customers.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%"> </font></div><div style="margin-bottom:12pt;padding-left:36pt;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">7.7</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%;padding-left:22.25pt">Other Employment</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">. During the Executive&#8217;s employment with the Company, the Executive shall not, except as a representative of the Company or with the prior written approval of the CEO, whether paid or unpaid, be directly or indirectly engaged, concerned or have any financial interest in any capacity in any other business, trade, professional or occupation (or the setting up of any business, trade, profession or occupation).</font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:12pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">13</font></div><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="margin-bottom:12pt;text-align:right"><font><br></font></div></div><div style="margin-bottom:12pt;padding-left:36pt;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">7.8</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%;padding-left:22.25pt">Return of Materials</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">. All files, forms, brochures, books, materials, written correspondence (including email and instant messages), memoranda, documents, manuals, computer disks, software products and lists (including financial and other information and lists of customers, suppliers, products and prices) pertaining to the Group which may come into the Executive&#8217;s possession or control as a result of his employment with the Company shall at all times remain the property of the Group as applicable. Upon termination of the Executive&#8217;s employment for any reason, the Executive agrees to immediately deliver to the Company all such property in the Executive&#8217;s possession or directly or indirectly under the Executive&#8217;s control. The Executive agrees not to make, for the Executive&#8217;s personal or business use or that of any other person, reproductions or copies of any such property or other property of the Group.</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">7.9</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%;padding-left:22.25pt">Non-Disparagement</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">. Subject to Section 7.1(d) of this Agreement, the Executive shall refrain, both during and after the cessation of the Executive&#8217;s employment with the Company, from making, publicly or privately, any statement or announcement that constitutes an </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:400;line-height:120%">ad hominem</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%"> attack on, or that otherwise disparages, defames, slanders, impugns or is reasonably likely to damage the reputation of Company or the Group, or any of their respective directors, members, limited or general partners, equity holders, officers, employees, agents, consultants, advisors or other representatives. Similarly, both during and after the cessation of the Executive&#8217;s employment with the Company, the Company shall direct its CEO and Board to refrain from making any public or private statement or announcement that constitutes an </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:400;line-height:120%">ad hominem</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%"> attack on, or that otherwise disparages, defames, slanders, impugns or is reasonably likely to damage Executive&#8217;s reputation. For the avoidance of doubt, nothing contained herein shall adversely affect or impair any Party&#8217;s right to enforce any of the restrictive covenants or other post-employment obligations contained in this Agreement, or any other agreement to which such Party is a party or otherwise bound.</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%">8.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%;padding-left:27.75pt;text-decoration:underline">General</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">8.1</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%;padding-left:22.25pt">Reasonableness of Restrictions and Covenants</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">. The Executive hereby confirms and agrees that the covenants and restrictions contained in this Agreement, including, without limitation, those contained in Article&#160;7, are reasonable and valid the Executive further acknowledges and agrees that the Company may suffer irreparable injury in the event of any breach by the Executive of the obligations under any such covenant or restriction. Accordingly, the Executive hereby acknowledges and agrees that damages would be an inadequate remedy at law in connection with any such breach and that the Company shall therefore be entitled, in addition to any other right or remedy which it may have at law, in equity or otherwise, to temporary and permanent injunctive relief enjoining and restraining the Executive from any such breach.</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">8.2</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%;padding-left:22.25pt">Survival</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%"> </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">Article 7 and this Section 8.2 survive the termination of this Agreement and the Executive&#8217;s employment for any reason whatsoever. </font></div><div style="margin-bottom:12pt;padding-left:36pt;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">8.3</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%;padding-left:22.25pt">Entire Agreement</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">. This Agreement (including the exhibits hereto) sets forth the entire agreement between the Parties on the subject matters addressed herein. There are no representations, warranties or collateral agreements, whether written or oral, outside of this written Agreement. This Agreement and the terms and conditions of employment contained herein supersede and replace any prior and contemporaneous understandings or discussions between the Parties regarding the Executive&#8217;s employment. </font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:12pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">14</font></div><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="margin-bottom:12pt;text-align:right"><font><br></font></div></div><div style="margin-bottom:12pt;padding-left:36pt;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">8.4</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%;padding-left:22.25pt">Withholding Taxes</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">. The Company may deduct or withhold from any amounts or benefits payable under this Agreement income taxes and payroll taxes that are required to be withheld pursuant to any applicable law or regulation.</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">8.5</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%;padding-left:22.25pt">Section 409A Compliance</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">. To the extent applicable, this Agreement is intended to comply with the requirements of Section 409A of the United States Internal Revenue Code of 1986, as amended (together with the applicable regulations thereunder, &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%">Section 409A</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#8221;). To the extent that any provision in this Agreement is ambiguous as to its compliance with Section 409A or to the extent any provision in this Agreement must be modified to comply with Section 409A (including, without limitation, Treasury Regulation 1.409A-3(c)), such provision shall be read, or shall be modified (with the mutual consent of the Parties, which consent shall not be unreasonably withheld), as the case may be, in such a manner so that all payments due under this Agreement shall comply with Section 409A. For purposes of Section 409A, each payment made under this Agreement shall be treated as a separate payment. In no event may the Executive, directly or indirectly, designate the calendar year of payment. Notwithstanding any provision of this Agreement to the contrary, if necessary to comply with the restriction in Section 409A(a)(2)(B) concerning payments to &#8220;specified employees&#8221; (as defined in Section 409A) any payment on account of the Executive&#8217;s separation from service that would otherwise be due hereunder within six (6) months after such separation shall nonetheless be delayed until the first business day of the seventh (7</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.15pt;font-weight:400;line-height:120%;position:relative;top:-3.85pt;vertical-align:baseline">th</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">) month following the Executive&#8217;s date of termination and the first such payment shall include the cumulative amount of any payments that would have been paid prior to such date if not for such restriction. Notwithstanding anything contained herein to the contrary, the Executive shall not be considered to have terminated employment with the Company for purposes of this Agreement unless he would be considered to have incurred a &#8220;separation from service&#8221; from the Company within the meaning of Section 409A. </font></div><div style="margin-bottom:12pt;padding-left:36pt;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">8.6</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%;padding-left:22.25pt">Amendments</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%"> </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">This Agreement may only be amended by written agreement executed by the Parties. However, changes to the Executive&#8217;s position, duties, vacation, benefits and compensation, over time in the normal course as otherwise in compliance with the terms of this Agreement, do not affect the validity or enforceability of the Agreement.</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">8.7</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%;padding-left:22.25pt">Governing Law</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">. This Agreement shall be governed by and construed in accordance with the laws of the State of Delaware and the laws of the United States applicable in the State of Delaware. </font></div><div style="margin-bottom:12pt;padding-left:36pt;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">8.8</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%;padding-left:22.25pt">Severability</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">. If any provision in this Agreement is determined to be invalid or unenforceable, such provision shall be severed from this Agreement, and the remaining provisions shall continue in full force and effect. If for any reason any court of competent jurisdiction shall find any provisions of this Agreement unreasonable in duration or geographic scope or otherwise, the Parties agree that the restrictions and prohibitions contained herein shall be effective to the fullest extent allowed under applicable law in such jurisdiction.</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">8.9</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%;padding-left:22.25pt">Assignment</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">. The Company may assign this Agreement to an affiliate or subsidiary, and it inures to the benefit of the Company, its successors or assigns.</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">8.10</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%;padding-left:16.75pt">Independent Legal Advice</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">. The Executive acknowledges that the Executive has been encouraged to obtain independent legal advice regarding the execution of this Agreement&#160;at the Company&#8217;s expense in an amount not to exceed US $8,000, and that the Executive has either obtained such advice or voluntarily chosen not to do so, and hereby waives any objections or </font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:12pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">15</font></div><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="margin-bottom:12pt;text-align:right"><font><br></font></div></div><div style="margin-bottom:12pt;padding-left:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">claims the Executive may make resulting from any failure on the Executive&#8217;s part to obtain such advice.</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">8.11</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%;padding-left:16.75pt">Waiver</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%"> </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">No waiver of any of the provisions of this Agreement shall be effective or binding, unless made in writing and signed by the party purporting to give the same. No waiver of any of the provisions of this Agreement shall be deemed or shall constitute a waiver of any other provisions, whether or not similar, nor shall such waiver constitute a continuing waiver, unless expressly stated otherwise. </font></div><div style="margin-bottom:12pt;padding-left:36pt;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">8.12</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%;padding-left:16.75pt">Conditions</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">. This Agreement and the Executive&#8217;s continued employment hereunder is conditional on the Company&#8217;s satisfaction (determined in the Company&#8217;s sole discretion) that the Executive has met the legal requirements to perform the Executive&#8217;s role, including, without limitation, satisfactory results of Health Canada or any other applicable security clearance checks and criminal record checks and other reference checks that the Company performs. The Executive acknowledges and agrees that in signing this Agreement, and providing the Company with the necessary documentation to perform the checks required for the Executive&#8217;s role and with references, the Executive is providing consent to the Company or its agent, to performs such checks and contact the references the Executive provided to the Company.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%"> </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">  </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%"> </font></div><div style="margin-bottom:12pt;padding-left:36pt;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">8.13</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%;padding-left:16.75pt">Prior Restrictions</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">. By signing below, the Executive represents that the Executive is not bound by the terms of any agreement with any Person which restricts in any way the Executive&#8217;s hiring by the Company and the performance of the Executive&#8217;s expected job duties&#59; the Executive also represents that, during the Executive&#8217;s employment with the Company, the Executive shall not disclose or make use of any confidential information of any other persons or entities in violation of any of their applicable policies or agreements and&#47;or applicable law.</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">8.14</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%;padding-left:16.75pt">Counterparts. </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">This Agreement may be executed in one or more counterparts, each of which when executed shall be deemed to be an original but all of which taken together shall constitute one and the same agreement. Delivery of an executed counterpart of a signature page to this Agreement by electronic transmission, including in portable document format (.pdf), shall be deemed as effective as delivery of an original executed counterpart of this Agreement.</font></div><div style="margin-bottom:12pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:400;line-height:120%">&#91;Signature Page Follows&#93;</font></div><div style="margin-bottom:12pt"><font><br></font></div><div style="margin-bottom:12pt;text-align:center;text-indent:36pt"><font><br></font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:12pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">16</font></div><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="margin-bottom:12pt;text-align:right"><font><br></font></div></div><div style="margin-bottom:12pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%">IN WITNESS WHEREOF</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%"> this Agreement has been executed by the Parties as of this 6</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.15pt;font-weight:400;line-height:120%;position:relative;top:-3.85pt;vertical-align:baseline">th</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%"> day of August, 2021.</font></div><div style="margin-bottom:6pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:6.556%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:37.493%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:6.400%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:6.400%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:37.651%"></td><td style="width:0.1%"></td></tr><tr><td colspan="6" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="6" style="padding:2px 1pt 2px 4.12pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:125%">CRONOS USA CLIENT SERVICES LLC</font></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt 2px 4.12pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:125%">By&#58;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:125%">&#47;s&#47; Kurt Schmidt</font></td></tr><tr><td colspan="3" style="padding:0 1pt"><div style="padding-left:39.1pt;padding-right:3.1pt;text-indent:-36pt"><font><br></font></div></td><td colspan="3" style="padding:0 1pt"><div style="padding-left:39.1pt;padding-right:3.1pt;text-indent:-36pt"><font><br></font></div></td><td colspan="3" style="padding:0 1pt"><div style="padding-left:39.1pt;padding-right:3.1pt;text-indent:-36pt"><font><br></font></div></td><td colspan="3" style="padding:0 1pt"><div style="padding-left:39.1pt;padding-right:3.1pt;text-indent:-36pt"><font><br></font></div></td><td colspan="3" style="border-top:0.25pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:39.1pt;padding-right:3.1pt;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">Kurt Schmidt&#160;&#160;&#160;&#160; </font></div><div style="padding-left:39.1pt;padding-right:3.1pt;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">President&#160;&#160;&#160;&#160;</font></div></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="6" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="6" style="padding:2px 1pt 2px 4.12pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:125%">CRONOS GROUP INC.</font></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt 2px 4.12pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:125%">By&#58;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:125%">&#47;s&#47; Kurt Schmidt</font></td></tr><tr><td colspan="3" style="padding:0 1pt"><div style="padding-left:39.1pt;padding-right:3.1pt;text-indent:-36pt"><font><br></font></div></td><td colspan="3" style="padding:0 1pt"><div style="padding-left:39.1pt;padding-right:3.1pt;text-indent:-36pt"><font><br></font></div></td><td colspan="3" style="padding:0 1pt"><div style="padding-left:39.1pt;padding-right:3.1pt;text-indent:-36pt"><font><br></font></div></td><td colspan="3" style="padding:0 1pt"><div style="padding-left:39.1pt;padding-right:3.1pt;text-indent:-36pt"><font><br></font></div></td><td colspan="3" style="border-top:0.25pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:39.1pt;padding-right:3.1pt;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">Kurt Schmidt</font></div><div style="padding-left:3.1pt;padding-right:3.1pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">President and Chief Executive Officer&#160;&#160;&#160;&#160;</font></div></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"><div style="padding-left:39.1pt;padding-right:3.1pt;text-indent:-36pt"><font><br></font></div></td><td colspan="3" style="padding:0 1pt"><div style="padding-left:39.1pt;padding-right:3.1pt;text-indent:-36pt"><font><br></font></div></td><td colspan="3" style="padding:0 1pt"><div style="padding-left:39.1pt;padding-right:3.1pt;text-indent:-36pt"><font><br></font></div></td><td colspan="3" style="padding:0 1pt"><div style="padding-left:39.1pt;padding-right:3.1pt;text-indent:-36pt"><font><br></font></div></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"><div style="padding-left:39.1pt;padding-right:3.1pt;text-indent:-36pt"><font><br></font></div></td><td colspan="3" style="padding:0 1pt"><div style="padding-left:39.1pt;padding-right:3.1pt;text-indent:-36pt"><font><br></font></div></td><td colspan="3" style="padding:0 1pt"><div style="padding-left:39.1pt;padding-right:3.1pt;text-indent:-36pt"><font><br></font></div></td><td colspan="3" style="padding:0 1pt"><div style="padding-left:39.1pt;padding-right:3.1pt;text-indent:-36pt"><font><br></font></div></td></tr><tr><td colspan="6" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="6" style="padding:2px 1pt 2px 4.12pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:125%">ROBERT MADORE</font></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:125%">&#47;s&#47; Robert Madore</font></td></tr><tr><td colspan="3" style="padding:0 1pt"><div style="padding-left:39.1pt;padding-right:3.1pt;text-indent:-36pt"><font><br></font></div></td><td colspan="3" style="padding:0 1pt"><div style="padding-left:39.1pt;padding-right:3.1pt;text-indent:-36pt"><font><br></font></div></td><td colspan="3" style="padding:0 1pt"><div style="padding-left:39.1pt;padding-right:3.1pt;text-indent:-36pt"><font><br></font></div></td><td colspan="3" style="padding:0 1pt"><div style="padding-left:39.1pt;padding-right:3.1pt;text-indent:-36pt"><font><br></font></div></td><td colspan="3" style="border-top:0.25pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:0.36pt;padding-right:3.1pt;text-indent:-0.36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">Date&#58;&#160;&#160;&#160;&#160;August 6, 2021</font></div></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"><div style="padding-left:39.1pt;padding-right:3.1pt;text-indent:-36pt"><font><br></font></div></td><td colspan="3" style="padding:0 1pt"><div style="padding-left:39.1pt;padding-right:3.1pt;text-indent:-36pt"><font><br></font></div></td><td colspan="3" style="padding:0 1pt"><div style="padding-left:39.1pt;padding-right:3.1pt;text-indent:-36pt"><font><br></font></div></td><td colspan="3" style="padding:0 1pt"><div style="padding-left:39.1pt;padding-right:3.1pt;text-indent:-36pt"><font><br></font></div></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr></table></div><div style="margin-bottom:12pt"><font><br></font></div><div style="margin-bottom:8pt"><font><br></font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:12pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">17</font></div><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="margin-bottom:12pt;text-align:right"><font><br></font></div></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%">EXHIBIT A</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%">CRONOS GROUP INC.</font></div><div style="margin-bottom:12pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%">OPTION AWARD AGREEMENT </font></div><div style="margin-bottom:12pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;This Option Award Agreement (hereinafter referred to as the &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%">Agreement</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#8221;) is made and entered into this ______ day of ______, 2021 (the &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%">Grant Date</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#8221;) by and between Cronos Group Inc. (hereinafter referred to as &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%">Cronos</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#8221; and, together with any subsidiary, and any successor entity thereto, the &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%">Company</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#8221;) and Robert Madore (hereinafter referred to as the &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%">Grantee</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#8221;), pursuant to the </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%">Cronos Group Inc. 2020 Omnibus Equity Incentive Plan </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%"> (hereinafter referred to as the &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%">Plan</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#8221;).  All terms and provisions of the Plan are hereby incorporated into and shall govern the Agreement except where general provisions of the Plan are superseded by particular provisions of the Agreement.  To the extent that the terms of Grantee&#8217;s Executive Employment Agreement with the Company effective August 9, 2021 (the &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%">Employment Agreement</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#8221;) and any terms set forth herein conflict or are otherwise inconsistent with any terms or conditions set forth in the Employment Agreement, the terms and conditions set forth in the Employment Agreement shall govern.  All capitalized terms used in the Agreement shall have the same meaning given the terms in the Plan.</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">1.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;padding-left:27.75pt;text-decoration:underline">Grant of Options</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">.  Cronos hereby grants the Grantee 900,000 non-qualified stock options (the &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%">Options</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#8221;) (hereinafter referred to as the &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%">Award</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#8221;), which are subject to terms and conditions set forth below.  Each Option represents the right to purchase one Common Share at the Exercise Price set forth below.</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">2.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;padding-left:27.75pt;text-decoration:underline">Exercise Price</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">.  The Exercise Price will be $</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%">&#91;____&#93;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.15pt;font-weight:400;line-height:120%;position:relative;top:-3.85pt;vertical-align:baseline">1</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%"> per Option (the &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%">Exercise Price</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#8221;).</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">3.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;padding-left:27.75pt;text-decoration:underline">Vesting Dates</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">.  The Award shall vest quarterly over four (4) years, with one-sixteenth (1&#47;16</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.15pt;font-weight:400;line-height:120%;position:relative;top:-3.85pt;vertical-align:baseline">th</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">) of the Award vesting on such date that is three (3) months after the Grant Date and every three (3) months thereafter until the fourth (4</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.15pt;font-weight:400;line-height:120%;position:relative;top:-3.85pt;vertical-align:baseline">th</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">) anniversary of the Grant Date (each, a &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%">Vesting Date</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#8221;), provided, that the Grantee remains employed at the Company through such applicable Vesting Date.</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">4.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;padding-left:27.75pt;text-decoration:underline">Expiration Date</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#58;  Subject to the terms and conditions of this Agreement and the Plan, the latest date the Options will expire is on the seventh anniversary of the Grant Date (the &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%">Expiration Date</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#8221;). </font></div><div style="margin-bottom:12pt;padding-left:36pt;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">5.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;padding-left:27.75pt;text-decoration:underline">Termination of Employment&#59; Change of Control</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">.  </font></div><div style="margin-bottom:12pt;padding-left:72pt;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">(a)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;padding-left:23.8pt">In the event that prior to the final Vesting Date, the Grantee&#8217;s Employment terminates because of death or Disability, the Award shall remain outstanding and continue to vest and be exercisable in the same manner as provided for in Sections 3 and 6 and all vested Options may be exercised by the Grantee or the Grantee&#8217;s estate, as applicable, at any time within six (6) months from the date of such termination of Employment. </font></div><div style="margin-bottom:12pt;padding-left:72pt;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">(b)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;padding-left:23.18pt">In the event that prior to the final Vesting Date, the Grantee&#8217;s Employment terminates without Just Cause or for Good Reason (as defined in the Employment Agreement), the Award will become vested immediately, in part or in full as follows, and exercisable in accordance with Section 6 of the Agreement and all vested Options may be exercised by </font></div><div style="border-bottom:1pt solid black;margin-bottom:5pt;margin-top:10pt;width:150pt"></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">1</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Note to Draft</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#58; To be the closing price reported on Nasdaq on the trading date immediately preceding the date of grant.</font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:12pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">18</font></div><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="margin-bottom:12pt;text-align:right"><font><br></font></div></div><div style="margin-bottom:12pt;padding-left:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">the Grantee at any time within six (6) months from the date of such termination of Employment (subject to the Expiration Date)&#58;</font></div><div style="margin-bottom:12pt;padding-left:126pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">i.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;padding-left:12.2pt">if the date of such termination of Employment occurs on or before the first anniversary of the Grant Date, 50% of the Award shall vest&#59;</font></div><div style="margin-bottom:12pt;padding-left:126pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">ii.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;padding-left:9.15pt">if the date of such termination of Employment occurs after the first anniversary of the Grant Date and on or before the second anniversary of the Grant Date, an additional 50% of the Award shall vest (such that 75% of the total Award shall be vested)&#59; and</font></div><div style="margin-bottom:12pt;padding-left:126pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">iii.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;padding-left:6.1pt">if the date of such termination of Employment occurs after the second anniversary of the Grant Date, the Award shall become fully vested.</font></div><div style="margin-bottom:12pt;padding-left:72pt;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">(c)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;padding-left:23.8pt">In the event that prior to the final Vesting Date&#58; (i) a Change of Control involving the purchase of Company securities described in Rule 13e-3 to the Exchange Act (including without limitation one in which Altria Group, Inc. or any of its subsidiaries is the acquirer and, as a result of such Change of Control, there is a reasonable likelihood or a purpose of causing the common stock of Cronos to be either eligible for termination from registration or reporting obligations under the Exchange Act or removed from listing on a national securities exchange), and (ii) the Grantee&#8217;s Employment terminates without Just Cause or for Good Reason within twenty four (24) months of such Change of Control, the Award will become fully vested immediately and exercisable in accordance with Section 6 of the Agreement and all vested Options may be exercised by the Grantee at any time within six (6) months from the date of such termination of Employment (subject to the Expiration Date).</font></div><div style="margin-bottom:12pt;padding-left:72pt;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">(d)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;padding-left:23.18pt">Except as set forth in Sections 5(b) and 5(c), in the event that prior to the final Vesting Date, the Grantee&#8217;s Employment terminates for any reason other than death or Disability, then the unvested portion of the Award shall be forfeited for no consideration.  </font></div><div style="margin-bottom:12pt;padding-left:72pt;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">(e)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;padding-left:23.8pt">Notwithstanding anything to the contrary, to the extent any payments or benefits in connection with an applicable termination of Employment are contingent on the delivery of an effective release and waiver of claims as set out in the Employment Agreement, any accelerated vesting of the Award upon such termination of Employment shall also be contingent on such release and waiver of claims.</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">6.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;padding-left:27.75pt;text-decoration:underline">Exercise of Options</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">.  Vested Options may be exercised by submitting to Cronos a written notice specifying the number of Options to be exercised accompanied by payment of the full purchase price, in an amount equal to the aggregate Exercise Price of the Options that are being exercised, in cash or in another form, which may include&#58; (a) bank transfer&#59; (b) Common Shares, based on the Fair Market Value as of the exercise date&#59; (c) cashless exercise&#59; (d) any other form of consideration approved by the Company and permitted by applicable law&#59; and (e) any combination of the foregoing.  As soon as reasonably practicable following Cronos&#8217; determination that the Options have been validly exercised, Cronos will issue the relevant number of Shares to be allocated to the Grantee, subject to applicable tax withholding as provided in Section 3.2 of the Plan.</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">7.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;padding-left:27.75pt;text-decoration:underline">Employment</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">.  Nothing in the Agreement shall interfere with or limit in any way the right of the Company to terminate the Grantee&#8217;s Employment nor confer upon any Grantee any right to </font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:12pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">19</font></div><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="margin-bottom:12pt;text-align:right"><font><br></font></div></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">continue in the employ of the Company.  For greater certainty, a Grantee&#8217;s termination of Employment will include both voluntary and involuntary terminations, and the involuntary termination of a Grantee&#8217;s Employment shall occur on the date that the Grantee ceases performing services for the Company on a permanent basis, whether such termination is lawful or otherwise, without regard to any required period of notice, pay in lieu of notice, severance pay or similar compensation or benefits (and without regard for any claim for damages in respect thereof), except as expressly required by applicable employment or labor standards legislation.</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">8.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;padding-left:27.75pt;text-decoration:underline">Non-Transferable</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">.  The rights or interests of the Grantee under this Agreement, including, without limitation, the Options, shall not be assignable or transferable, otherwise than in the case of death of the Grantee as set out in the Plan, and such rights or interests shall not be encumbered by any means.</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">9.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;padding-left:27.75pt;text-decoration:underline">Not Shares</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">.  The Options are not Common Shares, and the Options shall not entitle the Grantee to exercise voting rights or any other rights attaching to the ownership of Common Shares, including, without limitation, rights on liquidation.</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">10.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;padding-left:22.25pt;text-decoration:underline">Withholding Taxes</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">.  The Grantee acknowledges and agrees that the Company has the right to deduct from any payments due to the Grantee any federal, state, provincial or local taxes required by law to be withheld with respect to the Award.</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">11.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;padding-left:22.25pt;text-decoration:underline">Section 409A</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">.  Payments under this Agreement are intended to be exempt from or comply with Section 409A of the Internal Revenue Code (&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%">Section 409A</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#8221;) to the extent applicable, and this Agreement shall be administered accordingly. Notwithstanding anything to the contrary contained in this Agreement or the Employment Agreement, to the extent that any payment under this Agreement is determined by the Company to constitute &#8220;non-qualified deferred compensation&#8221; subject to Section 409A and is payable to the Grantee by reason of termination of the Grantee&#8217;s Employment, then (a) such payment shall be made to the Grantee only upon a &#8220;separation from service&#8221; as defined for purposes of Section 409A under applicable regulations and (b) if the Grantee is a &#8220;specified employee&#8221; (within the meaning of Section 409A and as determined by the Company), such payment shall not be made before the date that is six (6) months after the date of the Grantee&#8217;s separation from service (or the Grantee&#8217;s earlier death). Each payment under this Agreement shall be treated as a separate payment for purposes of Section 409A.</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">12.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;padding-left:22.25pt;text-decoration:underline">Governing Law</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">.  The Plan and this Agreement shall be construed in accordance with and governed by the laws of the State of Delaware.</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">13.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;padding-left:22.25pt;text-decoration:underline">Binding Effect</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">.  This Agreement shall be binding upon and inure to the benefit of any successors to the Company and all persons lawfully claiming under Grantee. By accepting the Award on the terms set forth herein,</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%"> </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">the Grantee acknowledges and agrees to the matters and conditions set forth herein and in the Plan. The Grantee hereby further confirms and acknowledges receipt of a copy of the Plan. </font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:12pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">20</font></div><div><font><br></font></div></div></div><div id="id49e3c955fe1438c8f96d18cf1c2c6e3_4"></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="margin-bottom:12pt;text-align:right"><font><br></font></div></div><div style="margin-bottom:12pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">IN WITNESS WHEREOF, this Agreement is executed by Cronos and by Grantee as of this _____ day of ___________, 2021.</font></div><div style="margin-bottom:12pt"><font><br></font></div><div style="padding-left:252pt;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%">CRONOS GROUP INC.</font></div><div style="padding-left:252pt;text-indent:-36pt"><font><br></font></div><div style="padding-left:252pt;text-indent:-36pt"><font><br></font></div><div style="padding-left:216pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">&#160;&#160;&#160;&#160;</font></div><div style="padding-left:252pt;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">By&#58;&#160;&#160;&#160;&#160;Kurt Schmidt</font></div><div style="padding-left:252pt;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">Title&#58;  &#160;&#160;&#160;&#160;President and Chief Executive Officer</font></div><div style="padding-left:252pt;text-indent:-36pt"><font><br></font></div><div style="padding-left:252pt;text-indent:-36pt"><font><br></font></div><div style="margin-bottom:12pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">The Grantee (a) accepts the Award, (b) agrees to be bound by, and comply with, the terms of the Plan and this Agreement, and (c)&#160;agrees that all good faith decisions and determinations of the Administrator with respect to the Award shall be final and binding on the Grantee and any other person having or claiming an interest under the Award.</font></div><div style="padding-left:252pt;text-indent:-36pt"><font><br></font></div><div style="padding-left:252pt;text-indent:-36pt"><font><br></font></div><div style="padding-left:252pt;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%">GRANTEE</font></div><div style="padding-left:252pt;text-indent:-36pt"><font><br></font></div><div style="padding-left:252pt;text-indent:-36pt"><font><br></font></div><div style="padding-left:252pt;text-indent:-36pt"><font><br></font></div><div style="padding-left:252pt;text-indent:-36pt"><font><br></font></div><div style="padding-left:216pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">&#160;&#160;&#160;&#160;</font></div><div style="padding-left:252pt;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">Robert Madore</font></div><div style="margin-bottom:24pt;text-align:center"><font><br></font></div><div style="margin-bottom:8pt"><font><br></font></div><div style="margin-bottom:8pt"><font><br></font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:12pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">21</font></div><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="margin-bottom:12pt;text-align:right"><font><br></font></div></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%">EXHIBIT B</font></div><div style="margin-bottom:8pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:125%">CRONOS GROUP INC.<br>RESTRICTED SHARE UNIT AWARD AGREEMENT </font></div><div style="text-align:center"><font><br></font></div><div style="margin-bottom:12pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;This Restricted Share Unit Award Agreement (hereinafter referred to as the &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%">Agreement</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#8221;) is made and entered into this </font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:120%">______</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%"> day of </font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:120%">______</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">, 2021 (the &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%">Grant Date</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#8221;) by and between Cronos Group Inc. (hereinafter referred to as &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%">Cronos</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#8221; and, together with any subsidiary, and any successor entity thereto, the &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%">Company</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#8221;) and Robert Madore (hereinafter referred to as the &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%">Grantee</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#8221;), pursuant to the </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%">Cronos Group Inc. 2020 Omnibus Equity Incentive Plan</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%"> (hereinafter referred to as the &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%">Plan</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#8221;).  All terms and provisions of the Plan are hereby incorporated into and shall govern the Agreement except where general provisions of the Plan are superseded by particular provisions of the Agreement.  To the extent that the terms of Grantee&#8217;s Executive Employment Agreement with the Company effective August 9, 2019 (the &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%">Employment Agreement</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#8221;) and any terms set forth herein conflict or are otherwise inconsistent with any terms or conditions set forth in the Employment Agreement, the terms and conditions set forth in the Employment Agreement shall govern.  All capitalized terms used in the Agreement shall have the same meaning given the terms in the Plan.</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">1.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;padding-left:27.75pt;text-decoration:underline">Grant of Restricted Share Units</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">.  Cronos hereby grants the Grantee 50,000 Restricted Share Units (hereinafter referred to as the &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%">Award</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#8221;), which are subject to terms and conditions set forth below.</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">2.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;padding-left:27.75pt;text-decoration:underline">Vesting and Settlement of Restricted Share Units</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">.  Subject to the terms and conditions of this Agreement and the Plan&#58; </font></div><div style="margin-bottom:12pt;padding-left:72pt;text-align:justify;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">(a)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;padding-left:23.8pt">the Award shall vest on the third (3</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.15pt;font-weight:400;line-height:120%;position:relative;top:-3.85pt;vertical-align:baseline">rd</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">) anniversary of the Grant Date (the &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%">Vesting Date</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#8221;), provided, that the Grantee remains employed at the Company through such Vesting Date&#59;</font></div><div style="margin-bottom:12pt;padding-left:72pt;text-align:justify;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">(b)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;padding-left:23.18pt">upon the Vesting Date, the Award shall promptly (but not later than sixty (60) calendar days thereafter) be paid out in Common Shares, cash or a combination of Common Shares or cash, as determined by the Committee&#59; and</font></div><div style="margin-bottom:12pt;padding-left:72pt;text-align:justify;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">(c)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;padding-left:23.8pt">where the Committee decides to settle all or a portion of the Grantee&#8217;s vested Awards in Common Shares, settlement shall be made by the issuance and delivery of one Common Share for each Restricted Share Unit which the Committee decides to settle in Common Shares. Where the Committee decides to settle all or a portion of the Grantee&#8217;s vested Awards in cash, a cash payment shall be made to the Grantee equal to the Fair Market Value determined as of the applicable Vesting Date of the Award multiplied by the number of vested Restricted Share Units that the Committee wishes to settle in cash. </font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">3.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;padding-left:27.75pt;text-decoration:underline">Termination of Employment</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">.  </font></div><div style="margin-bottom:12pt;padding-left:72pt;text-align:justify;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">(a)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;padding-left:23.8pt">In the event that prior to the Vesting Date, the Grantee&#8217;s Employment terminates because of death or Disability, the Award shall remain outstanding and continue to vest and be settled in the same manner as provided for in Section 2. </font></div><div style="margin-bottom:12pt;padding-left:72pt;text-align:justify;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">(b)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;padding-left:23.18pt">In the event that prior to the Vesting Date, the Grantee&#8217;s Employment terminates without Just Cause or for Good Reason (as defined in the Employment Agreement), the Award will vest as follows and be settled in accordance with Sections 2(b) and (c) above&#58;</font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:12pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">22</font></div><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="margin-bottom:12pt;text-align:right"><font><br></font></div></div><div style="margin-bottom:12pt;padding-left:135pt;text-indent:-27pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">i.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;padding-left:21.2pt">if the date of such termination of Employment occurs on or before the first anniversary of the Grant Date, 50% of the Award shall vest&#59;</font></div><div style="margin-bottom:12pt;padding-left:135pt;text-indent:-27pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">ii.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;padding-left:18.15pt">if the date of such termination of Employment occurs after the first anniversary of the Grant Date and on or before the second anniversary of the Grant Date, 75% of the Award shall vest&#59; and</font></div><div style="margin-bottom:12pt;padding-left:135pt;text-indent:-27pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">iii.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;padding-left:15.1pt">if the date of such termination of Employment occurs after the second anniversary of the Grant Date, the Award shall become fully vested.</font></div><div style="margin-bottom:12pt;padding-left:72pt;text-align:justify;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">(c)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;padding-left:23.8pt">In the event that prior to the Vesting Date&#58; (i) a Change of Control involving the purchase of Company securities described in Rule 13e-3 to the Exchange Act (including without limitation one in which Altria Group, Inc. or any of its subsidiaries is the acquirer and, as a result of such Change of Control, there is a reasonable likelihood or a purpose of causing the common stock of Cronos to be either eligible for termination from registration or reporting obligations under the Exchange Act or removed from listing on a national securities exchange), (ii) the Grantee&#8217;s Employment terminates without Just Cause or for Good Reason within twenty four (24) months of such Change of Control, the Award will become fully vested and settled in accordance with Section 2 on the date of such termination of Employment.  </font></div><div style="margin-bottom:12pt;padding-left:72pt;text-align:justify;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">(d)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;padding-left:23.18pt">Except as set forth in Sections 3(b) and 3(c), in the event that prior to the Vesting Date, the Grantee&#8217;s Employment terminates for any reason other than death or Disability, then the Award shall be forfeited for no consideration.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%">  </font></div><div style="margin-bottom:12pt;padding-left:72pt;text-align:justify;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">(e)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;padding-left:23.8pt">Notwithstanding anything to the contrary, to the extent any payments or benefits in connection with an applicable termination of Employment are contingent on the delivery of an effective release and waiver of claims as set out in the Employment Agreement, any accelerated vesting of the Award upon such termination of Employment shall also be contingent on such release and waiver of claims.  </font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">4.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;padding-left:27.75pt;text-decoration:underline">Employment</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">.  Nothing in the Agreement shall interfere with or limit in any way the right of the Company to terminate the Grantee&#8217;s Employment nor confer upon any Grantee any right to continue in the employ of the Company.  For greater certainty, a Grantee&#8217;s termination of Employment will include both voluntary and involuntary terminations, and the involuntary termination of a Grantee&#8217;s Employment shall occur on the date that the Grantee ceases performing services for the Company on a permanent basis, whether such termination is lawful or otherwise, without regard to any required period of notice, pay in lieu of notice, severance pay or similar compensation or benefits (and without regard for any claim for damages in respect thereof), except as expressly required by applicable employment or labor standards legislation.</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">5.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;padding-left:27.75pt;text-decoration:underline">Non-Transferable</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">.  The rights or interests of the Grantee under this Agreement, including, without limitation, the Restricted Share Units, shall not be assignable or transferable, otherwise than in the case of death of the Grantee as set out in the Plan, and such rights or interests shall not be encumbered by any means.</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">6.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;padding-left:27.75pt;text-decoration:underline">Not Shares</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">.  The Restricted Share Units are not Common Shares, and the Restricted Share Units shall not entitle the Grantee to exercise voting rights or any other rights attaching to the ownership of Common Shares, including, without limitation, rights on liquidation.</font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:12pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">23</font></div><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="margin-bottom:12pt;text-align:right"><font><br></font></div></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">7.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;padding-left:27.75pt;text-decoration:underline">Withholding Taxes</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">.  The Grantee acknowledges and agrees that the Company has the right to deduct from any payments due to the Grantee any federal, state, provincial or local taxes required by law to be withheld with respect to the Award.</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">8.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;padding-left:27.75pt;text-decoration:underline">Section 409A</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">.  Payments under this Agreement are intended to be exempt from or comply with Section 409A of the Internal Revenue Code (&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%">Section 409A</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#8221;) to the extent applicable, and this Agreement shall be administered accordingly. Notwithstanding anything to the contrary contained in this Agreement or the Employment Agreement, to the extent that any payment under this Agreement is determined by the Company to constitute &#8220;non-qualified deferred compensation&#8221; subject to Section 409A and is payable to the Grantee by reason of termination of the Grantee&#8217;s Employment, then (a) such payment shall be made to the Grantee only upon a &#8220;separation from service&#8221; as defined for purposes of Section 409A under applicable regulations and (b) if the Grantee is a &#8220;specified employee&#8221; (within the meaning of Section 409A and as determined by the Company), such payment shall not be made before the date that is six (6) months after the date of the Grantee&#8217;s separation from service (or the Grantee&#8217;s earlier death). Each payment under this Agreement shall be treated as a separate payment for purposes of Section 409A.</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">9.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;padding-left:27.75pt;text-decoration:underline">Governing Law</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">.  The Plan and this Agreement shall be construed in accordance with and governed by the laws of the State of Delaware.</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">10.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;padding-left:22.25pt;text-decoration:underline">Binding Effect</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">.  This Agreement shall be binding upon and inure to the benefit of any successors to the Company and all persons lawfully claiming under Grantee. By accepting the Award on the terms set forth herein,</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%"> </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">the Grantee acknowledges and agrees to the matters and conditions set forth herein and in the Plan. The Grantee hereby further confirms and acknowledges receipt of a copy of the Plan.</font></div><div style="margin-bottom:12pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:400;line-height:120%">&#91;Signature Page Follows&#93;</font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:12pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">24</font></div><div><font><br></font></div></div></div><div id="id49e3c955fe1438c8f96d18cf1c2c6e3_7"></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="margin-bottom:12pt;text-align:right"><font><br></font></div></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify"><font><br></font></div><div style="margin-bottom:12pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">IN WITNESS WHEREOF, this Agreement is executed by Cronos and by Grantee as of this ______ day of ______, 2021.</font></div><div style="margin-bottom:12pt"><font><br></font></div><div style="padding-left:252pt;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%">CRONOS GROUP INC.</font></div><div style="padding-left:252pt;text-indent:-36pt"><font><br></font></div><div style="padding-left:252pt;text-indent:-36pt"><font><br></font></div><div style="padding-left:216pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">&#160;&#160;&#160;&#160;</font></div><div style="padding-left:252pt;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">By&#58;&#160;&#160;&#160;&#160;Kurt Schmidt </font></div><div style="padding-left:252pt;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">Title&#58;  &#160;&#160;&#160;&#160;President and Chief Executive Officer </font></div><div style="padding-left:252pt;text-indent:-36pt"><font><br></font></div><div style="padding-left:252pt;text-indent:-36pt"><font><br></font></div><div style="margin-bottom:12pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">The Grantee (a) accepts the Award, (b) agrees to be bound by, and comply with, the terms of the Plan and this Agreement, and (c)&#160;agrees that all decisions and determinations of the Administrator with respect to the Award shall be final and binding on the Grantee and any other person having or claiming an interest under the Award.</font></div><div style="padding-left:252pt;text-indent:-36pt"><font><br></font></div><div style="padding-left:252pt;text-indent:-36pt"><font><br></font></div><div style="padding-left:252pt;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%">GRANTEE</font></div><div style="padding-left:252pt;text-indent:-36pt"><font><br></font></div><div style="padding-left:252pt;text-indent:-36pt"><font><br></font></div><div style="padding-left:252pt;text-indent:-36pt"><font><br></font></div><div style="padding-left:252pt;text-indent:-36pt"><font><br></font></div><div style="padding-left:216pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">&#160;&#160;&#160;&#160;</font></div><div style="margin-bottom:24pt;text-align:center;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">Robert Madore</font></div><div style="margin-bottom:8pt"><font><br></font></div><div style="margin-bottom:8pt"><font><br></font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:12pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">25</font></div><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="margin-bottom:12pt"><font><br></font></div></div><div style="margin-bottom:8pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:125%">EXHIBIT C<br>FORM OF FULL AND FINAL RELEASE</font></div><div><font><br></font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%">GENERAL RELEASE AND WAIVER OF CLAIMS </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">(this &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%">Release</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#8221;), by the undersigned</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%"> </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">(hereinafter called the &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%">Releasor</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#8221;) in favor of </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%">Cronos Group, Inc. </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">and its subsidiaries (hereinafter referred to as the &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%">Employer</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#8221;), affiliates, stockholders, beneficial owners of its stock, its current or former officers, directors, employees, members, attorneys and agents, and their predecessors, successors and assigns, individually and in their official capacities (hereinafter called the &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%">Releasees</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#8221;).</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%">WHEREAS</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">, Releasor has been employed as Chief Financial Officer of Cronos Group, Inc.&#59; </font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%">WHEREAS</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">, Releasor&#8217;s employment with Cronos USA Client Services LLC was terminated, effective as of </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%">&#9679; </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">(the &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%">Effective Date</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#8221;)&#59; and </font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%">WHEREAS</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">, Releasor shall receive certain payments under Section 6.3 of the employment agreement entered into by Cronos USA Client Services LLC, the Releasor and, solely for the purposes specified therein, Cronos Group, Inc., effective August 9, 2021 (hereinafter called the &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%">Employment Agreement</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#8221;), that are conditioned on the effectiveness of this Release.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%">NOW, THEREFORE</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">, in consideration of such payments and benefits and the covenants and agreements hereinafter set forth, the parties agree as follows&#58;</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">1.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%;padding-left:27.75pt">GENERAL RELEASE</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">. Releasor knowingly and voluntarily waives, terminates, cancels, releases and discharges forever the Releasees from any and all suits, actions, causes of action, claims, allegations, rights, obligations, liabilities, demands, entitlements or charges (collectively, &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%">Claims</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#8221;) that Releasor (or Releasor&#8217;s heirs, executors, administrators, successors and assigns) has or may have, whether known, unknown or unforeseen, vested or contingent, by reason of any matter, cause or thing occurring at any time before and including the date of this Release, including all claims arising under or in connection with Releasor&#8217;s employment, or termination or resignation of employment with the Employer, including, without limitation&#58;  Claims under United States federal, state or local law and the national or local law of any foreign country (statutory or decisional), for wrongful, abusive, constructive or unlawful discharge or dismissal, for breach of any contract, or for discrimination based upon race, color, ethnicity, sex, age, national origin, religion, disability, sexual orientation, or any other unlawful criterion or circumstance, including rights or Claims under the Age Discrimination in Employment Act of 1967 (&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%">ADEA</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#8221;), the Older Workers Benefit Protection Act of 1990 (&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%">OWBPA</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#8221;), violations of the Equal Pay Act, Title VII of the Civil Rights Act of 1964, the Civil Rights Act of 1991, the Americans with Disabilities Act of 1991, the Employee Retirement Income Security Act of 1974 (&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%">ERISA</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#8221;), the Fair Labor Standards Act, the Worker Adjustment Retraining and Notification Act, the Family Medical Leave Act, including all amendments to any of the aforementioned acts&#59; and violations of any other federal, state, or municipal fair employment statutes or laws, including, without limitation, violations of any other law, rule, regulation, or ordinance pertaining to employment, wages, compensation, hours worked, or any other Claims for compensation or bonuses, whether or not paid under any compensation plan or arrangement&#59; breach of contract&#59; tort and other common law Claims&#59; defamation&#59; libel&#59; slander&#59; impairment of economic opportunity defamation&#59; sexual harassment&#59; retaliation&#59; attorneys&#8217; fees&#59; emotional distress&#59; intentional infliction of emotional distress&#59; assault&#59; battery, pain and suffering&#59; and punitive or exemplary damages (the &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%">Released Matters</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#8221;).  In addition, in consideration of the provisions of this Release, Releasor further agrees to waive any and all rights under the laws of any jurisdiction in the United States, or any other country, that limit a general release to those </font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:12pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">26</font></div><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="margin-bottom:12pt"><font><br></font></div></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">Claims that are known or suspected to exist in Releasor&#8217;s favor as of the Release Effective Date (as defined below).</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">Thus, notwithstanding the purpose of implementing a full and complete release and discharge of the claims released by this Release, Releasor expressly acknowledges that this Release is intended to include in its effect, without limitation, all claims which Releasor does not know or suspect to exist in his favor at the time of execution hereof arising out of or relating in any way to the subject matter of the actions referred to herein above and that this Release contemplates the extinguishment of any such claims.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">2.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%;padding-left:27.75pt">SURVIVING CLAIMS</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">.  Notwithstanding anything herein to the contrary, this Release shall not&#58;</font></div><div style="margin-bottom:12pt;padding-left:117pt;text-align:justify;text-indent:-27pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">(i)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;padding-left:16.63pt">release any Claims for payment of amounts payable under</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%"> </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">the Employment Agreement (including, without limitation, under Section 6.3 thereof)&#59;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.15pt;font-weight:400;line-height:120%;position:relative;top:-3.85pt;vertical-align:baseline"> </font></div><div style="margin-bottom:12pt;padding-left:117pt;text-align:justify;text-indent:-27pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">(ii)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;padding-left:13.58pt">release any Claim for employee benefits under plans covered by ERISA to the extent any such Claim may not lawfully be waived or for any payments or benefits under any Employer plans that have vested (including any 401(k) plan) according to the terms of those plans&#59;</font></div><div style="margin-bottom:12pt;padding-left:117pt;text-align:justify;text-indent:-27pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">(iii)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;padding-left:10.53pt">release any Claim or right Releasor may have pursuant to indemnification, advancement, defense, or reimbursement pursuant to any applicable D&#38;O policies, any similar insurance policies, applicable law or otherwise&#59;</font></div><div style="margin-bottom:12pt;padding-left:117pt;text-align:justify;text-indent:-27pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">(iv)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;padding-left:11.13pt">release any Claim that may not lawfully be waived in a private agreement between the parties&#59; or</font></div><div style="margin-bottom:12pt;padding-left:117pt;text-align:justify;text-indent:-27pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">(v)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;padding-left:14.18pt">limit Releasor&#8217;s rights under applicable law to provide truthful information to any governmental entity or to file a charge with or participate in an investigation conducted by any governmental entity.  Notwithstanding the foregoing, Releasor agrees to waive Releasor&#8217;s right to recover monetary damages in connection with any charge, complaint or lawsuit filed by Releasor or anyone else on Releasor&#8217;s behalf (whether involving a governmental entity or not)&#59; provided that Releasor is not agreeing to waive, and this Release shall not be read as requiring Releasor to waive, any right Releasor may have to receive an award for information provided to any governmental entity.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">3.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%;padding-left:27.75pt">ADDITIONAL REPRESENTATIONS</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">.  Releasor further represents and warrants that Releasor has not filed any civil action, suit, arbitration, administrative charge, or legal proceeding against any Releasees nor, has Releasor assigned, pledged, or hypothecated as of the Release Effective Date any Claim to any person and no other person has an interest in the Claims that he is releasing.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">4.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%;padding-left:27.75pt">ACKNOWLEDGMENT BY RELEASOR</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">.  Releasor acknowledges and agrees that Releasor</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%"> </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">has read this Release in its entirety and that this Release is a general release of all known and unknown Claims.  Releasor further acknowledges and agrees that&#58;</font></div><div style="margin-bottom:12pt;padding-left:117pt;text-align:justify;text-indent:-27pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">(i)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;padding-left:16.63pt">this Release does not release, waive or discharge any rights or Claims that may arise for actions or omissions after the Release Effective Date and Releasor </font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:12pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">27</font></div><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="margin-bottom:12pt"><font><br></font></div></div><div style="margin-bottom:12pt;padding-left:117pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">acknowledges that he is not releasing, waiving or discharging any ADEA Claims that may arise after the Release Effective Date&#59;</font></div><div style="margin-bottom:12pt;padding-left:117pt;text-align:justify;text-indent:-27pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">(ii)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;padding-left:13.58pt">Releasor is entering into this Release and releasing, waiving and discharging rights or Claims only in exchange for consideration which he is not already entitled to receive&#59;</font></div><div style="margin-bottom:12pt;padding-left:117pt;text-align:justify;text-indent:-27pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">(iii)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;padding-left:10.53pt">Releasor has been advised, and is being advised by the Release, to consult with an attorney before executing this Release&#59; </font></div><div style="margin-bottom:12pt;padding-left:117pt;text-align:justify;text-indent:-27pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">(iv)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;padding-left:11.13pt">Releasor has been advised, and is being advised by this Release, that he has been given at least </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%">&#91;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">twenty-one (21)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%">&#93; &#91;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">forty-five (45)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%">&#93;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%"> days within which to consider the Release, but Releasor can execute this Release at any time prior to the expiration of such review period&#59; </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%">&#91;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">and</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%">&#93;</font></div><div style="margin-bottom:12pt;padding-left:117pt;text-align:justify;text-indent:-27pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">(v)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%;padding-left:14.18pt">&#91;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">Because this Release includes a release of claims under ADEA, Releasor is being provided with the information contained in </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">Schedule 1</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%"> hereto in accordance with the OWBPA&#59; and</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%">&#93;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.15pt;font-weight:400;line-height:120%;position:relative;top:-3.85pt;vertical-align:baseline">2</font></div><div style="margin-bottom:12pt;padding-left:117pt;text-align:justify;text-indent:-27pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">(vi)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;padding-left:11.13pt">Releasor is aware that this Release shall become null and void if he or she revokes his or her agreement to this Release within seven (7) days following the date of execution of this Release.  Releasor may revoke this Release at any time during such seven-day period by delivering (or causing to be delivered) to the Employer written notice of his or her revocation of this Release no later than 5&#58;00 p.m. Eastern time on the seventh (7</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.15pt;font-weight:400;line-height:120%;position:relative;top:-3.85pt;vertical-align:baseline">th</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">) full day following the date of execution of this Release (the &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%">Release Effective Date</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#8221;).  Releasor agrees and acknowledges that a letter of revocation that is not received by such date and time shall be invalid and shall not revoke this Release.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">5.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%;padding-left:27.75pt">COOPERATION WITH INVESTIGATIONS AND LITIGATION</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">. Releasor agrees, upon the Employer&#8217;s reasonable request and consistent with Releasor&#8217;s reasonable business and personal obligations, to reasonably cooperate with the Employer in any investigation, litigation, arbitration or regulatory proceeding regarding events that occurred during Releasor&#8217;s tenure with the Employer or its affiliate, including making himself or herself reasonably available to consult with Employer&#8217;s counsel, to provide information and to give testimony.  Employer shall reimburse Releasor for reasonable out-of-pocket expenses Releasor incurs in extending such cooperation, so long as Releasor provides satisfactory documentation of the expenses.  Nothing in this Section is intended to, and shall not, restrict or limit Releasor from exercising his or her protected rights described in Sections 2, 4, 5 or 6 hereof or restrict or limit Releasor from providing truthful information in response to a subpoena, other legal process or valid governmental inquiry.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">6.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%;padding-left:27.75pt">RESTRICTIVE COVENANTS</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%"> </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">Releasor hereby affirms the restrictive covenants set forth in Section 7 of the Employment Agreement shall continue to apply following the Release Effective Date in accordance with their terms.</font></div><div style="border-bottom:1pt solid black;margin-bottom:5pt;margin-top:10pt;width:150pt"></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.82pt;font-weight:400;line-height:120%;position:relative;top:-3.67pt;vertical-align:baseline">2</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10.5pt;font-weight:400;line-height:120%"> </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10.5pt;font-weight:400;line-height:120%;text-decoration:underline">Note to Draft</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10.5pt;font-weight:400;line-height:120%">&#58;  To be included (along with 45 day consideration period and Schedule 1 attached hereto) in consideration for ADEA&#47;OWBPA claims in terminations involving multiple employees.</font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:12pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">28</font></div><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="margin-bottom:12pt"><font><br></font></div></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">7.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%;padding-left:27.75pt">GOVERNING LAW</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">.  To the extent not subject to federal law, this Release shall be governed by and construed in accordance with the law of the State of Delaware applicable to contracts made and to be performed entirely within that state.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">8.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%;padding-left:27.75pt">SEVERABILITY</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">.  If any provision of this Release should be declared to be unenforceable by any administrative agency or court of law, then remainder of the Release shall remain in full force and effect.  </font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">9.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%;padding-left:27.75pt">CAPTIONS&#59; SECTION HEADINGS</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">.  Captions and section headings used herein are for convenience only and are not a part of this Release and shall not be used in construing it.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">10.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%;padding-left:22.25pt">COUNTERPARTS&#59; FACSIMILE SIGNATURES</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">.  This Release may be executed in any number of counterparts, each of which when so executed and delivered shall be deemed an original instrument without the production of any other counterpart.  Any signature on this Release, delivered by either party by photographic, facsimile or PDF shall be deemed to be an original signature thereto.</font></div><div style="text-align:justify"><font><br></font></div><div style="margin-bottom:12pt;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%">IN WITNESS WHEREOF</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%"> I have hereunder set my hand this _______ day of ___________, 20____.</font></div><div style="margin-bottom:12pt;text-indent:72pt"><font><br></font></div><div style="margin-bottom:6pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:46.661%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:51.139%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:2.75pt;padding-right:2.75pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%">SIGNED AND DELIVERED</font></div><div style="padding-left:2.75pt;padding-right:2.75pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">in the presence of&#58;</font></div><div style="margin-top:36pt;padding-left:2.75pt;padding-right:2.75pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</font></div><div style="padding-left:2.75pt;padding-right:2.75pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">Witness&#8217; Signature</font></div><div style="margin-top:36pt;padding-left:2.75pt;padding-right:2.75pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</font></div><div style="padding-left:2.75pt;padding-right:2.75pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">Print Name of Witness</font></div><div style="margin-top:36pt;padding-left:2.75pt;padding-right:2.75pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</font></div><div style="padding-left:2.75pt;padding-right:2.75pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">Address of Witness</font></div></td><td colspan="3" style="border-left:0.25pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-bottom:6pt;padding-left:2.75pt;padding-right:2.75pt"><font><br></font></div><div style="margin-bottom:6pt;margin-top:30pt;padding-left:2.75pt;padding-right:2.75pt"><font><br></font></div><div style="padding-left:2.75pt;padding-right:2.75pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</font></div><div style="padding-left:6.35pt;padding-right:2.75pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%">&#91;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">Name of Executive</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%">&#93;</font></div></td></tr></table></div><div><font><br></font></div><div style="margin-bottom:8pt"><font><br></font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:12pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">29</font></div><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="margin-bottom:12pt"><font><br></font></div></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%;text-decoration:underline">Schedule 1</font></div><div style="text-align:center"><font><br></font></div><div style="margin-bottom:12pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%">&#91;TO BE COMPLETED AND PROVIDED IF APPLICABLE&#93;</font></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;As required by the Older Workers Benefit Protection Act, the Employer is providing the following information.  </font></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%">&#160;&#160;&#160;&#160;To respect the privacy of your colleagues, we ask that you use the information on this Schedule only for its intended purpose &#8211; to help you decide whether to enter into the Release &#8211; and that you otherwise treat this information as confidential.</font></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%">&#91;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">All employees of the Employer</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%">&#93;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%"> </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%">&#91;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:400;line-height:120%">describe subset of employees considered for separation</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%">&#93;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%"> (known as the &#8220;decisional unit&#8221;) were considered for the separation program.  The chart below shows the job titles and ages, as of </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%">&#9679;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">, of each employee in the decisional unit and whether or not such employee has been selected for termination and offered separation pay in exchange for signing a release under the separation program.  Employees have 45 days to consider whether to sign and 7 days to revoke any such release.</font></div><div style="margin-bottom:12pt"><font><br></font></div><div style="margin-bottom:6pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:32.233%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:32.233%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:32.234%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="border-left:0.25pt solid #000000;border-top:0.25pt solid #000000;padding:2px 1pt 2px 4.12pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:125%">Job Title</font></td><td colspan="3" style="border-left:0.25pt solid #000000;border-top:0.25pt solid #000000;padding:2px 1pt 2px 4.12pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:125%">Age<br>(as of &#9679;)</font></td><td colspan="3" style="border-left:0.25pt solid #000000;border-right:0.25pt solid #000000;border-top:0.25pt solid #000000;padding:2px 1pt 2px 4.12pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:125%">Selected for the separation program&#63;</font></td></tr><tr style="height:18pt"><td colspan="3" style="border-left:0.25pt solid #000000;border-top:0.25pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-left:0.25pt solid #000000;border-top:0.25pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-left:0.25pt solid #000000;border-right:0.25pt solid #000000;border-top:0.25pt solid #000000;padding:0 1pt"></td></tr><tr style="height:18pt"><td colspan="3" style="border-left:0.25pt solid #000000;border-top:0.25pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-left:0.25pt solid #000000;border-top:0.25pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-left:0.25pt solid #000000;border-right:0.25pt solid #000000;border-top:0.25pt solid #000000;padding:0 1pt"></td></tr><tr style="height:18pt"><td colspan="3" style="border-left:0.25pt solid #000000;border-top:0.25pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-left:0.25pt solid #000000;border-top:0.25pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-left:0.25pt solid #000000;border-right:0.25pt solid #000000;border-top:0.25pt solid #000000;padding:0 1pt"></td></tr><tr style="height:18pt"><td colspan="3" style="border-left:0.25pt solid #000000;border-top:0.25pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-left:0.25pt solid #000000;border-top:0.25pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-left:0.25pt solid #000000;border-right:0.25pt solid #000000;border-top:0.25pt solid #000000;padding:0 1pt"></td></tr><tr style="height:18pt"><td colspan="3" style="border-left:0.25pt solid #000000;border-top:0.25pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-left:0.25pt solid #000000;border-top:0.25pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-left:0.25pt solid #000000;border-right:0.25pt solid #000000;border-top:0.25pt solid #000000;padding:0 1pt"></td></tr><tr style="height:18pt"><td colspan="3" style="border-left:0.25pt solid #000000;border-top:0.25pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-left:0.25pt solid #000000;border-top:0.25pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-left:0.25pt solid #000000;border-right:0.25pt solid #000000;border-top:0.25pt solid #000000;padding:0 1pt"></td></tr><tr style="height:19pt"><td colspan="3" style="border-bottom:0.25pt solid #000000;border-left:0.25pt solid #000000;border-top:0.25pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-bottom:0.25pt solid #000000;border-left:0.25pt solid #000000;border-top:0.25pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-bottom:0.25pt solid #000000;border-left:0.25pt solid #000000;border-right:0.25pt solid #000000;border-top:0.25pt solid #000000;padding:0 1pt"></td></tr></table></div><div style="margin-bottom:12pt"><font><br></font></div><div style="margin-bottom:8pt"><font><br></font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:12pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">30</font></div><div><font><br></font></div></div></div></body></html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-10.4
<SEQUENCE>4
<FILENAME>ex104jerrybarbato.htm
<DESCRIPTION>EX-10.4
<TEXT>
<!DOCTYPE html PUBLIC "-//W3C//DTD HTML 4.01 Transitional//EN" "http://www.w3.org/TR/html4/loose.dtd"><html><head>
<!-- Document created using Wdesk -->
<!-- Copyright 2021 Workiva -->
<title>Document</title></head><body><div id="i9da4c605d8c64ee9bd79eed9df418a99_1"></div><div style="min-height:91.17pt;width:100%"><div style="text-align:right"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Exhibit 10.4</font></div><div style="margin-top:6pt;text-align:right"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">EXECUTION VERSION</font></div></div><div style="margin-bottom:12pt;margin-top:60pt;text-align:right"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">August 6, 2021</font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">Jerry Barbato</font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">At the Address on file with the Company</font></div><div style="margin-bottom:12pt"><font><br></font></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">Dear Jerry,</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">This letter agreement (this &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">Letter Agreement</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#8221;), effective as of August 9, 2021 (the &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">Effective Date</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#8221;), sets forth the terms and conditions of our agreement regarding the separation of your employment with Hortican Inc., a corporation organized under the federal laws of Canada (the &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">Company</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#8221;).  Capitalized terms used in this Letter Agreement that are not defined herein have the meanings set forth in your employment agreement with the Company, dated as of April 2, 2019 (the &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">Employment Agreement</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#8221;).  </font></div><div style="margin-bottom:12pt;padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">1.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%;padding-left:9.75pt;text-decoration:underline">Employment Separation</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">Effective as of September 9, 2021 (the &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">Separation Date</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#8221;)&#58; (a) your employment with the Company shall terminate&#59; and (b) the Company and Cronos Group Inc., a corporation organized under the laws of the Province of British Columbia (&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">Cronos Group</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#8221;), hereby accept, acknowledge, and agree to your resignation from all other positions you may hold as an officer or director (or similar or equivalent position) of the Company, Cronos Group or any subsidiary thereof, effective as of the Separation Date (collectively, the &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">Resignations</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#8221;).  If any other documentation is necessary to properly effectuate the Resignations, you agree to cooperate reasonably and promptly in executing and delivering it at the request of the Company or Cronos Group. </font></div><div style="margin-bottom:12pt;padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">2.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%;padding-left:9.75pt;text-decoration:underline">Transition Period</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">From the Effective Date to the Separation Date&#58; (a) you shall continue to be employed by the Company but shall cease to serve as Chief Financial Officer of Cronos Group, (b) you shall perform such work that is necessary to assist with the transition of your duties and responsibilities to the successor Chief Financial Officer of Cronos Group&#59; and (c) the Company may in good faith reassign or reduce your duties and responsibilities.  </font></div><div style="margin-bottom:12pt;padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">3.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%;padding-left:9.75pt;text-decoration:underline">Severance Benefits, Deferred Compensation, and Long-Term Incentives</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">.  </font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">Contingent on your execution and non-revocation of the Release and Waiver of Claims attached hereto as </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">Exhibit A</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%"> (the &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">Release</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#8221;) during the applicable revocation period and subject to </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">Section 4</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%"> of this Letter Agreement, in consideration of amounts in excess of the minimum entitlements under applicable law&#58;  </font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">(a)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;padding-left:23.8pt">the Company, shall, in full satisfaction of its obligations to you&#58; </font></div><div style="margin-bottom:12pt;padding-left:108pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">i.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;padding-left:12.2pt">continue to pay your Base Salary for period up to the Separation Date in accordance with applicable law&#59;</font></div><div style="margin-bottom:12pt;padding-left:108pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">ii.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;padding-left:9.15pt">following the Separation Date, pay any accrued but unpaid vacation pay owing to you in accordance with applicable law&#59;</font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:91.17pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:12pt;padding-left:108pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">iii.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;padding-left:6.1pt">reimburse your documented expenses properly incurred prior to the Separation Date in accordance with the Company&#8217;s expense reimbursement policy&#59; </font></div><div style="margin-bottom:12pt;padding-left:108pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">iv.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;padding-left:6.7pt">pay you US $111,756.82, which represents six (6) months of your annual base salary, payable by way of lump sum payment within sixty (60) days after the Separation Date&#59; </font></div><div style="margin-bottom:12pt;padding-left:108pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">v.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;padding-left:9.75pt">continue to make contributions towards your life insurance and medical and dental benefits until the earlier of March 6, 2022 and the date on which you obtain alternate benefit coverage, whichever occurs first, subject to the terms and conditions of the benefit plans. You agree to notify the Human Resources Department of the Company in writing when you obtain alternate life, medical and dental benefit coverage&#59; and </font></div><div style="margin-bottom:12pt;padding-left:108pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">vi.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;padding-left:6.7pt">contingent on the conclusion of the U.S. Securities and Exchange Commission (&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%">SEC</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#8221;) and Ontario Securities Commission (&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%">OSC</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#8221;) investigations (the &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%">Investigations</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#8221;) into Cronos Group that are pending as of the Effective Date, and provided that the Investigations do not result in a penalty being levied or an order by the SEC and&#47;or the OSC against you personally or against Cronos Group on account of any misconduct, mismanagement or failure to supervise by you (the &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%">Payment Condition</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#8221;), provide you with&#58; (1) an annual bonus in respect of Cronos Group&#8217;s 2019 fiscal year in the amount of US $155,762&#59; (2) an annual bonus in respect of Cronos Group&#8217;s 2020 fiscal year in the amount of US $201,411&#59; and (3) an annual bonus in respect of Cronos Group&#8217;s 2021 fiscal year in the amount of US $130,585 (which is based on target performance and prorated based on the number of complete months of such fiscal year during which you shall be employed prior to the Separation Date). Such annual bonuses in the foregoing sentence shall be released and paid within thirty (30) days following the conclusion of the Investigations, as determined by the Board of Directors of Cronos Group (the &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%">Board</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#8221;)&#160;in its sole discretion, subject to the Payment Condition, provided that the annual bonus in respect of the 2021 fiscal year shall be paid on the same date on which awards under Cronos Group&#8217;s Discretionary Short-Term Incentive Compensation Program in respect of the 2021 fiscal year are provided to other Cronos Group named executive officers&#59; provided, further, that subject to the Payment Condition any unpaid amounts of the foregoing bonuses shall be paid immediately upon a Change of Control of Cronos Group (as defined in the Cronos Group Inc. Amended and Restated 2018 Stock Option Plan)&#59; and </font></div><div style="margin-bottom:12pt;padding-left:72pt;text-align:justify;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">(b)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;padding-left:23.18pt">Cronos Group shall, in full satisfaction of its obligations to you, and contingent on the Payment Condition, provide you with&#58; (1) a 2020 long-term incentive award grant in the form of restricted stock units in the amount of US $298,480&#59; and (2) a 2021 long-term incentive award grant in the form of restricted stock units in the amount of US $298,480 (together, the &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%">LTI Grants</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#8221;). The LTI Grants shall&#58; (1) be calculated using the closing price of Cronos Group&#8217;s common shares on the NASDAQ Global Market on the trading day immediately preceding the date on which the Investigations are concluded, as determined by the Board&#160;in its sole discretion, subject to the Payment Condition&#59; (2) be granted as soon as practicable following the conclusion of the Investigations, as </font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">2</font></div><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:91.17pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:12pt;padding-left:72pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">determined by the Board in its sole discretion, subject to the Payment Condition&#59; (3) be subject to your compliance with the terms and conditions of this Letter Agreement and the post-employment obligations set forth in Article 7 of the Employment Agreement, including without limitation, as relates to non-competition, non-solicitation, confidentiality, intellectual property, and return of property&#59; and (4) vest and be settled on what would have been their original vesting and settlement schedules (as though you had provided services to the Company or Cronos Group on each applicable vesting date), based on the vesting dates applicable to grants in respect of the 2020 and 2021 fiscal years made to other Cronos Group named executive officers&#59; provided that any portion of the awards that would have vested prior to the date of grant will be deemed to vest on the date of grant.  Any other outstanding and unvested equity awards held by you as of the Effective Date shall continue to vest in accordance with the terms and conditions of the applicable award agreements (without your need to provide services to the Company or Cronos Group on each applicable vesting date), subject to the Payment Condition and your compliance with the terms and conditions of this Letter Agreement and the post-employment obligations set forth in Article 7 of the Employment Agreement, including without limitation, as relates to non-competition, non-solicitation, confidentiality, intellectual property, and return of property, subject to Section 5 below. Subject to the Payment Condition, any unvested or unpaid amounts of the LTI Grants shall be vested and settled immediately upon a Change of Control of Cronos Group (as defined in the Cronos Group Inc. Amended and Restated 2018 Stock Option Plan). If Cronos Group is unable to grant equity to you (e.g., as a result of your not being a service provider of the Cronos Group on the applicable date of grant), then in lieu of your right to receive such equity, Cronos Group shall pay you the cash equivalent value of any unpaid LTI Grants.  </font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">You understand and agree that the entitlements under this </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">Section 3</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%"> are provided in satisfaction of your entitlements to notice of termination, pay in lieu of notice, termination pay, and severance pay under the Employment Agreement, any employee benefit plan sponsored by the Company or any of its affiliates, applicable law or otherwise.  You shall not be entitled to any other payments or benefits under the Employment Agreement, except as specifically provided herein.</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">4.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%;padding-left:9.75pt;text-decoration:underline">Clawback Policy</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">You understand and agree that any cash, equity or equity-based compensation paid, provided or awarded pursuant to paragraphs 3(a)(vi) and 3(b) of this Letter Agreement are subject to the terms and conditions of Cronos Group&#8217;s Clawback Policy, and may be subject to a requirement that such compensation be repaid to the Company after it has been distributed to you.</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">5.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%;padding-left:9.75pt;text-decoration:underline">Restrictive Covenants&#59; Return of Materials</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%"> </font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">You hereby affirm that the restrictive covenants and other post-employment obligations contained in the Employment Agreement are and shall remain in effect and enforceable in accordance with the terms of the Employment Agreement, and you hereby reaffirm the existence and reasonableness of those obligations (including, without limitation, any non-disclosure obligations, and any non-competition, and non-solicitation restrictions). The Company and Cronos Group acknowledge hereunder that employment by or services provided to Altria Group, Inc. or any of its direct or indirect subsidiaries shall not in and of itself constitute a violation of your post-employment obligations set forth in Article 7 of the Employment Agreement&#59; provided, however, Article 7 of the Employment Agreement shall survive pursuant to the </font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">3</font></div><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:91.17pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">terms thereof and the specific actions taken by you while employed or while providing services to Altria Group, Inc., or any of its direct or indirect subsidiaries may be taken into account in determining whether you have complied with such obligations.</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">6.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%;padding-left:9.75pt;text-decoration:underline">Cooperation with Litigation, Investigations and Regulatory Proceedings</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">You agree, upon the Company&#8217;s request, to cooperate with the Company in any investigation, litigation, arbitration or regulatory proceeding regarding events that occurred during your tenure with the Company and&#47;or its affiliates, including by making yourself reasonably available to consult with the Company&#8217;s counsel. The Company shall reimburse you for reasonable out-of-pocket expenses that you incur in extending such cooperation, so long as you provide satisfactory documentation of the expenses.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">Cronos Group hereby affirms that the Indemnity Agreement between you and Cronos Group shall remain in effect in accordance with its terms following the Effective Date.</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">7.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%;padding-left:9.75pt;text-decoration:underline">Deductions and Withholdings</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">. </font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">You understand and agree that the Company shall make such deductions and withholdings from your remuneration and any other payments or benefits provided to you pursuant to this Letter Agreement as may be required by law.</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">8.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%;padding-left:9.75pt;text-decoration:underline">Amendments</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">.  </font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">This Letter Agreement may only be amended by written agreement executed by the Company, Cronos Group and you.</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">9.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%;padding-left:9.75pt;text-decoration:underline">Independent Legal Advice</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">.  </font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">You acknowledge that you have been encouraged to obtain independent legal advice regarding the execution of this Letter Agreement, and that you have either obtained such advice or voluntarily chosen not to do so, and hereby waive any objections or claims you may make resulting from any failure on your part to obtain such advice.</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">10.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%;padding-left:4.25pt;text-decoration:underline">Expenses</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">.  </font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">All costs, fees and expenses incurred in connection with this Letter Agreement and the transactions contemplated this Letter Agreement including all costs, fees and expenses of representatives the parties hereto, shall be paid by the party incurring such cost, fee or expense.  Notwithstanding the foregoing, you shall be reimbursed for reasonable expenses actually incurred (1) for annual tax return services in Canada and the United States for the 2021 tax year, and any additional support for tax and accounting services in the 2019 and 2020 tax years arising out of your employment with the Company and Cronos Group, provided such expenses are incurred and receipts are submitted on or prior to December 31, 2022 (and in any event within such period following the date the expenses are incurred to allow the Company to make the reimbursement payments in accordance with Section 409A of the Code as described in the last sentence of this Section 10, in an amount not to exceed US $15,000 per tax year, and (2) in respect of your relocation to the Richmond, Virginia area, provided such expenses are incurred by October 31, 2021, in an amount not to exceed US $20,000. You shall provide appropriate receipts or other vouchers to the Company in support of such professional services and relocation expense claims </font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">4</font></div><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:91.17pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">before receiving reimbursement, and such reimbursements shall be paid within thirty (30) days after providing appropriate receipts. To avoid accelerated taxation and&#47;or tax penalties to you under Section 409A of the U.S. Internal Revenue Code of 1986, as amended, amounts reimbursable to you under this Letter Agreement shall be paid to you on or before the last day of the year following the year in which the expense was incurred and the amount of expenses eligible for reimbursement (and in-kind benefits provided to Employee) during one year may not affect amounts reimbursable or provided in any subsequent year, and the right to reimbursement (or in-kind-benefits) is not subject to liquidation or exchange for another benefit.</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">11.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%;padding-left:4.25pt;text-decoration:underline">Counterparts</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%">  </font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">This Letter Agreement may be executed in one or more counterparts, each of which when executed shall be deemed to be an original but all of which taken together shall constitute one and the same agreement.  Delivery of an executed counterpart of a signature page to this Letter Agreement by electronic transmission, including in portable document format (.pdf), shall be deemed as effective as delivery of an original executed counterpart of this Letter Agreement.</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#91;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:400;line-height:120%">Signature Page Follows</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#93;</font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">5</font></div><div><font><br></font></div></div></div><div id="i9da4c605d8c64ee9bd79eed9df418a99_4"></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">If you agree that this Agreement correctly memorializes our understandings, please sign and return this Agreement, which shall become a binding agreement as the Effective Date.</font></div><div style="margin-bottom:12pt;padding-left:252pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">Sincerely,</font></div><div style="margin-bottom:48pt;padding-left:288pt;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%">HORTICAN INC.</font></div><div style="margin-bottom:24pt;margin-top:24pt;padding-left:288pt;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">By&#58;&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">&#47;s&#47; Michael Gorenstein&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%"><br>Name&#58;&#160;&#160;&#160;&#160;Michael Gorenstein<br>Title&#58;&#160;&#160;&#160;&#160;President </font></div><div style="margin-bottom:48pt;padding-left:288pt;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%">CRONOS GROUP INC.</font></div><div style="margin-bottom:24pt;margin-top:24pt;padding-left:288pt;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">By&#58;&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">&#47;s&#47; Kurt Schmidt&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%"><br>Name&#58;&#160;&#160;&#160;&#160;Kurt Schmidt<br>Title&#58;&#160;&#160;&#160;&#160;President and Chief Executive Officer</font></div><div style="margin-bottom:24pt;margin-top:24pt;padding-left:288pt;text-indent:-36pt"><font><br></font></div><div style="margin-bottom:48pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">Accepted and Agreed&#58;</font></div><div style="margin-bottom:12pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;text-decoration:underline">&#47;s&#47; Jerry Barbato&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%"><br></font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%">Jerry Barbato</font></div><div style="margin-bottom:12pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">Date&#58; August 6, 2021</font></div><div><font><br></font></div><div style="height:73.25pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#91;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:400;line-height:120%">Signature Page to Resignation Letter Agreement</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#93;</font></div><div><font style="font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%"></font></div><div><font style="font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%"></font></div></div></div><div id="i9da4c605d8c64ee9bd79eed9df418a99_7"></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%;text-decoration:underline">Exhibit A</font></div><div><font><br></font></div><div style="padding-left:288pt;padding-right:288pt;text-align:center;text-indent:-576pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%">FULL AND FINAL RELEASE AND WAIVER OF CLAIMS</font></div><div><font><br></font></div><div style="text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%">GENERAL RELEASE AND WAIVER OF CLAIMS </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">(this &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%">Release</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#8221;), by the undersigned</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%"> </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">(the &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%">Releasor</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#8221;) in favor of </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%">Hortican Inc.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">, </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%">Cronos Group Inc., </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">and their respective subsidiaries (collectively, the &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%">Employer</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#8221;), affiliates, stockholders, beneficial owners of its stock, its current or former officers, directors, employees, members, attorneys and agents, and their predecessors, successors and assigns, individually and in their official capacities (the &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%">Releasees</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#8221;).</font></div><div style="text-align:justify;text-indent:72pt"><font><br></font></div><div style="text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%">WHEREAS</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">, Releasor has been employed as Chief Financial Officer of Cronos Group Inc.&#59; </font></div><div style="text-align:justify;text-indent:72pt"><font><br></font></div><div style="text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%">WHEREAS</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">, Releasor&#8217;s employment with Employer was terminated, effective as of&#160;September 9, 2021</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%">&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">(the &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%">Effective Date</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#8221;)&#59; and </font></div><div style="text-align:justify;text-indent:72pt"><font><br></font></div><div style="text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%">WHEREAS</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">, Employer has offered to provide Releasor with certain payments, compensation and benefits pursuant to a letter agreement dated August 9, 2021 (hereinafter called the &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%">Letter Agreement</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#8221;), that are conditioned on the effectiveness of this Release.</font></div><div style="text-align:justify;text-indent:72pt"><font><br></font></div><div style="text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%">NOW, THEREFORE</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">, in consideration of such payments, compensation and benefits and the covenants and agreements set forth in the Letter Agreement, the parties hereto, intending to be legally bound, agree as follows&#58;</font></div><div style="text-align:justify;text-indent:72pt"><font><br></font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">1.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%;padding-left:27.75pt">GENERAL RELEASE</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">. Releasor knowingly and voluntarily waives, terminates, cancels, releases and discharges forever the Releasees from any and all suits, actions, causes of action, claims, allegations, rights, obligations, liabilities, demands, entitlements or charges (collectively, &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%">Claims</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#8221;) that Releasor (or Releasor&#8217;s heirs, executors, administrators, successors and assigns) has or may have, whether known, unknown or unforeseen, vested or contingent, by reason of any matter, cause or thing occurring at any time before and including the date of this Release, including all claims arising under or in connection with Releasor&#8217;s employment, or termination or resignation of employment with the Employer, including, without limitation&#58;  Claims under United States federal, state or local law and the national, provincial or local law of any foreign country (statutory or decisional), including without limitation Canada, for wrongful, abusive, constructive or unlawful discharge or dismissal, for breach of any contract, or for discrimination based upon race, color, ethnicity, sex, age, national origin, religion, disability, sexual orientation, or any other unlawful criterion or circumstance, including rights or Claims under the Age Discrimination in Employment Act of 1967 (&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%">ADEA</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#8221;), the Older Workers Benefit Protection Act of 1990 (&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%">OWBPA</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#8221;), violations of the Equal Pay Act, Title VII of the Civil Rights Act of 1964, the Civil Rights Act of 1991, the Americans with Disabilities Act of 1991, the Employee Retirement Income Security Act of 1974 (&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%">ERISA</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#8221;), the Fair Labor Standards Act, the Worker Adjustment Retraining and Notification Act, the Family Medical Leave Act, the Ontario </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:400;line-height:120%">Employment Standards Act, 2000, </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">the Ontario </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:400;line-height:120%">Human Rights Code</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">, the Ontario </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:400;line-height:120%">Pay Equity Act</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">, the Ontario </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:400;line-height:120%">Occupational Health and Safety Act</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">, and the Ontario </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:400;line-height:120%">Workplace Safety and Insurance Act, 1997</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">, including all amendments to any of the aforementioned acts&#59; and violations of any other federal, provincial, state, or municipal fair employment statutes or laws, including, without limitation, violations of any other law, rule, regulation, or ordinance pertaining to employment, wages, compensation, hours worked, or any other Claims for compensation or bonuses, whether or not paid under any compensation plan or arrangement&#59; breach of contract&#59; tort and other common law Claims (including, without limitation, any common law Claims to notice of termination, pay in lieu of notice of termination, termination pay or </font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">severance pay)&#59; defamation&#59; libel&#59; slander&#59; impairment of economic opportunity defamation&#59; sexual harassment&#59; retaliation&#59; attorneys&#8217; fees&#59; emotional distress&#59; intentional infliction of emotional distress&#59; assault&#59; battery, pain and suffering&#59; and punitive or exemplary damages (the &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%">Released Matters</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#8221;).  In addition, in consideration of the provisions of this Release, Releasor further agrees to waive any and all rights under the laws of any jurisdiction in the United States, Canada, or any other country that limit a general release to those Claims that are known or suspected to exist in Releasor&#8217;s favor as of the Release Effective Date (as defined below). Releasor further represents and acknowledges that the Releasees have complied with the </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:400;line-height:120%">Human Rights Code</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%"> (Ontario) in respect of the Releasor&#8217;s employment and the termination of such employment.</font></div><div style="text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">Thus, notwithstanding the purpose of implementing a full and complete release and discharge of the claims released by this Release, Releasor expressly acknowledges that this Release is intended to include in its effect, without limitation, all claims which Releasor does not know or suspect to exist in his favor at the time of execution hereof arising out of or relating in any way to the subject matter of the actions referred to herein above and that this Release contemplates the extinguishment of any such claims.</font></div><div style="text-align:justify;text-indent:72pt"><font><br></font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">2.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%;padding-left:27.75pt">SURVIVING CLAIMS</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">.  Notwithstanding anything herein to the contrary, this Release shall not&#58;</font></div><div style="margin-bottom:12pt;padding-left:108pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">(i)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;padding-left:7.63pt">release any Claims for payment of cash or equity amounts payable under</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%"> </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">the Letter Agreement&#59;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.15pt;font-weight:400;line-height:120%;position:relative;top:-3.85pt;vertical-align:baseline"> </font></div><div style="margin-bottom:12pt;padding-left:108pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">(ii)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;padding-left:4.58pt">release any Claim for employee benefits under plans covered by ERISA to the extent any such Claim may not lawfully be waived or for any payments or benefits under any Employer plans that have vested (including any 401(k) plan) according to the terms of those plans&#59;</font></div><div style="margin-bottom:12pt;padding-left:108pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">(iii)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;padding-left:1.53pt">release any Claim or right Releasor may have pursuant to indemnification, advancement, defense, or reimbursement pursuant to any applicable D&#38;O policies, any similar insurance policies, applicable law or otherwise&#59;</font></div><div style="margin-bottom:12pt;padding-left:108pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">(iv)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;padding-left:2.13pt">release any Claim that may not lawfully be waived in a private agreement between the parties&#59; or</font></div><div style="margin-bottom:12pt;padding-left:108pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">(v)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;padding-left:5.18pt">limit Releasor&#8217;s rights under applicable law to provide truthful information to any governmental entity or to file a charge with or participate in an investigation conducted by any governmental entity.  Notwithstanding the foregoing, Releasor agrees to waive Releasor&#8217;s right to recover monetary damages in connection with any charge, complaint or lawsuit filed by Releasor or anyone else on Releasor&#8217;s behalf (whether involving a governmental entity or not)&#59; provided that Releasor is not agreeing to waive, and this Release shall not be read as requiring Releasor to waive, any right Releasor may have to receive an award for information provided to any governmental entity.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">3.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%;padding-left:27.75pt">ADDITIONAL REPRESENTATIONS</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">.  Releasor further represents and warrants that Releasor has not filed any civil action, suit, arbitration, administrative charge, or legal proceeding against any Releasees nor, has Releasor assigned, pledged, or hypothecated as of the Release </font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">2</font></div><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">Effective Date any Claim to any person and no other person has an interest in the Claims that he is releasing.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">4.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%;padding-left:27.75pt">ACKNOWLEDGMENT BY RELEASOR</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">.  Releasor acknowledges and agrees that Releasor</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%"> </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">has read this Release in its entirety and that this Release is a general release of all known and unknown Claims.  Releasor further acknowledges and agrees that&#58;</font></div><div style="margin-bottom:12pt;padding-left:108pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">(i)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;padding-left:7.63pt">this Release does not release, waive or discharge any rights or Claims that may arise for actions or omissions after the Release Effective Date and Releasor acknowledges that he is not releasing, waiving or discharging any ADEA Claims that may arise after the Release Effective Date&#59;</font></div><div style="margin-bottom:12pt;padding-left:108pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">(ii)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;padding-left:4.58pt">Releasor is entering into this Release and releasing, waiving and discharging rights or Claims only in exchange for consideration which he is not already entitled to receive&#59;</font></div><div style="margin-bottom:12pt;padding-left:108pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">(iii)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;padding-left:1.53pt">Releasor has been advised, and is being advised by the Release, to consult with an attorney before executing this Release&#59; </font></div><div style="margin-bottom:12pt;padding-left:108pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">(iv)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;padding-left:2.13pt">Releasor has been advised, and is being advised by this Release, that he has been given at least twenty-one (21)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%"> </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">days within which to consider the Release, but Releasor can execute this Release at any time prior to the expiration of such review period&#59; and</font></div><div style="margin-bottom:12pt;padding-left:108pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">(v)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%;padding-left:5.18pt">Releasor is aware that this Release shall become null and void if he revokes his agreement to this Release within seven (7) days following the date of execution of this Release.  Releasor may revoke this Release at any time during such seven-day period by delivering (or causing to be delivered) to the Employer written notice of his or her revocation of this Release no later than 5&#58;00 p.m. Eastern time on the seventh (7</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.15pt;font-weight:400;line-height:120%;position:relative;top:-3.85pt;vertical-align:baseline">th</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">) full day following the date of execution of this Release (the &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%">Release Effective Date</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#8221;).  Releasor agrees and acknowledges that a letter of revocation that is not received by such date and time shall be invalid and shall not revoke this Release.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">5.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%;padding-left:27.75pt">NON-DISPARAGEMENT</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">.  Releasor agrees not to speak or act in a manner that would reasonably be expected to disparage or defame or damage the goodwill of Employer or its Affiliates, or the business or personal reputations of any of its officers, directors, partners, agents employees, clients or suppliers, and further agrees not to engage in any other depreciating conduct or communications with respect to Employer or its Affiliates including, without limitation, on social media.  Notwithstanding the foregoing, nothing hereunder shall prevent Releasor from (i) responding publicly to any incorrect, disparaging or derogatory public statement to the extent reasonably necessary to correct or refute such public statement, (ii) making any truthful statement to the extent (x) necessary with respect to any litigation, arbitration, mediation or proceeding involving the Releasees, or (y) required by law or by any court, arbitrator, mediator or administrative or legislative body (including any committee thereof) with actual or apparent jurisdiction to order the Releasor to disclose or make accessible such information, or (iii) responding truthfully to any request by the U.S. Securities and Exchange Commission or the Ontario Securities Commission in connection with either of their investigations into Cronos Group that are pending as of August 9, 2021. </font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">3</font></div><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">6.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%;padding-left:27.75pt">GOVERNING LAW</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">.  To the extent not subject to federal law, this Release shall be governed by and construed in accordance with the law of the State of Delaware applicable to contracts made and to be performed entirely within that state.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">7.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%;padding-left:27.75pt">SEVERABILITY</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">.  If any provision of this Release should be declared to be unenforceable by any administrative agency or court of law, then the remainder of the Release shall remain in full force and effect.  </font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">8.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%;padding-left:27.75pt">CAPTIONS&#59; SECTION HEADINGS</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">.  Captions and section headings used herein are for convenience only and are not a part of this Release and shall not be used in construing it.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">9.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%;padding-left:27.75pt">COUNTERPARTS&#59; FACSIMILE SIGNATURES</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">.  This Release may be executed in any number of counterparts, each of which when so executed and delivered shall be deemed an original instrument without the production of any other counterpart.  Any signature on this Release, delivered by either party by photographic, facsimile or PDF shall be deemed to be an original signature thereto.</font></div><div style="text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%">IN WITNESS WHEREOF</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%"> I have hereunder set my hand this 6th day of August, 2021.</font></div><div style="text-indent:72pt"><font><br></font></div><div style="text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:40.085%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.714%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:1.944%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:45.857%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%">SIGNED AND DELIVERED</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-left:0.25pt solid #000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">in the presence of&#58;</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-left:0.25pt solid #000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-left:0.25pt solid #000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-left:0.25pt solid #000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#47;s&#47; Shayne Laidlaw</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-left:0.25pt solid #000;padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#47;s&#47; Jerry Barbato</font></td></tr><tr><td colspan="3" style="border-top:0.25pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">Witness&#8217; Signature</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-left:0.25pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:0.25pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%">JERRY BARBATO</font></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-left:0.25pt solid #000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">Shayne Laidlaw</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-left:0.25pt solid #000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="border-top:0.25pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">Print Name of Witness</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-left:0.25pt solid #000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-left:0.25pt solid #000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">22 Putnam Green, Greenwich, CT 06830</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-left:0.25pt solid #000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="border-top:0.25pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">Address of Witness</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-left:0.25pt solid #000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr></table></div><div style="text-indent:72pt"><font><br></font></div><div><font><br></font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">4</font></div><div><font><br></font></div></div></div></body></html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-31.1
<SEQUENCE>5
<FILENAME>a10-qq22021311.htm
<DESCRIPTION>EX-31.1
<TEXT>
<!DOCTYPE html PUBLIC "-//W3C//DTD HTML 4.01 Transitional//EN" "http://www.w3.org/TR/html4/loose.dtd"><html><head>
<!-- Document created using Wdesk -->
<!-- Copyright 2021 Workiva -->
<title>Document</title></head><body><div id="ic558977f0e184f54bc397a117d71d11a_1"></div><div style="min-height:36pt;width:100%"><div><font><br></font></div></div><div style="text-align:center"><font><br></font></div><div style="text-align:right"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:174%">Exhibit&#160;31.1</font></div><div><font><br></font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:115%">CERTIFICATION OF PRINCIPAL EXECUTIVE OFFICER</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:115%">PURSUANT TO SECTION 302 OF</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:115%">THE SARBANES-OXLEY ACT OF 2002</font></div><div><font><br></font></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:174%">I, Kurt Schmidt, certify that&#58;</font></div><div style="margin-top:6pt;padding-left:18pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">1.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:10.5pt">I have reviewed this Quarterly Report on Form&#160;10-Q of Cronos Group Inc.&#59; </font></div><div style="margin-top:6pt;padding-left:18pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">2.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:10.5pt">Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report&#59;</font></div><div style="margin-top:6pt;padding-left:18pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">3.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:10.5pt">Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report&#59;</font></div><div style="margin-top:6pt;padding-left:18pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">4.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:10.5pt">The registrant&#8217;s other certifying officer(s) and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have&#58;</font></div><div style="margin-top:6pt;padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(a) </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:4.41pt">Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared&#59;</font></div><div style="margin-top:6pt;padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(b) </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:3.84pt">Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles&#59;</font></div><div style="margin-top:6pt;padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(c) </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:4.41pt">Evaluated the effectiveness of the registrant&#8217;s disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation&#59; and</font></div><div style="margin-top:6pt;padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(d) </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:3.84pt">Disclosed in this report any change in the registrant&#8217;s internal control over financial reporting that occurred during the registrant&#8217;s most recent fiscal quarter (the registrant&#8217;s fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant&#8217;s internal control over financial reporting&#59; and</font></div><div style="margin-top:6pt;padding-left:18pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">5.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:10.5pt">The registrant&#8217;s other certifying officer(s) and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant&#8217;s auditors and the audit committee of the registrant&#8217;s board of directors (or persons performing the equivalent functions)&#58;</font></div><div style="margin-top:6pt;padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(a) </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:4.41pt">All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant&#8217;s ability to record, process, summarize and report financial information&#59; and</font></div><div style="margin-top:6pt;padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(b) </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:3.84pt">Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant&#8217;s internal control over financial reporting.</font></div><div style="padding-right:-9pt;text-align:center;text-indent:18pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:42.094%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:55.706%"></td><td style="width:0.1%"></td></tr><tr style="height:0pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#47;s&#47; Kurt Schmidt</font></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Kurt Schmidt</font></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">President and Chief Executive Officer</font></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-bottom:2pt;margin-top:2pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(Principal Executive Officer)</font></div></td><td colspan="3" style="padding:0 1pt"></td></tr></table></div><div style="margin-top:3pt"><font><br></font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:174%">Date&#58; August 6, 2021</font></div><div><font><br></font></div><div style="height:36pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:10pt;margin-top:10pt;text-align:center"><font><br></font></div></div></div></body></html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-31.2
<SEQUENCE>6
<FILENAME>a10-qq22021312.htm
<DESCRIPTION>EX-31.2
<TEXT>
<!DOCTYPE html PUBLIC "-//W3C//DTD HTML 4.01 Transitional//EN" "http://www.w3.org/TR/html4/loose.dtd"><html><head>
<!-- Document created using Wdesk -->
<!-- Copyright 2021 Workiva -->
<title>Document</title></head><body><div id="if2ff00b8523044038a5b5b1b78bc643d_1"></div><div style="min-height:36pt;width:100%"><div><font><br></font></div></div><div><font><br></font></div><div style="text-align:right"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:174%">Exhibit&#160;31.2</font></div><div><font><br></font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:115%">CERTIFICATION OF PRINCIPAL FINANCIAL OFFICER</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:115%">PURSUANT TO SECTION 302 OF</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:115%">THE SARBANES-OXLEY ACT OF 2002</font></div><div><font><br></font></div><div style="margin-bottom:12pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">I, Jerry Barbato, certify that&#58;</font></div><div style="margin-top:6pt;padding-left:18pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">1.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:10.5pt">I have reviewed this Quarterly Report on Form&#160;10-Q of Cronos Group Inc.&#59; </font></div><div style="margin-top:6pt;padding-left:18pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">2.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:10.5pt">Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report&#59;</font></div><div style="margin-top:6pt;padding-left:18pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">3.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:10.5pt">Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report&#59;</font></div><div style="margin-top:6pt;padding-left:18pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">4.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:10.5pt">The registrant&#8217;s other certifying officer(s) and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have&#58;</font></div><div style="margin-top:6pt;padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(a) </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:4.41pt">Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under &#160;&#160;&#160;&#160;our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared&#59;</font></div><div style="margin-top:6pt;padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(b) </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:3.84pt">Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles&#59;</font></div><div style="margin-top:6pt;padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(c) </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:4.41pt">Evaluated the effectiveness of the registrant&#8217;s disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation&#59; and</font></div><div style="margin-top:6pt;padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(d) </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:3.84pt">Disclosed in this report any change in the registrant&#8217;s internal control over financial reporting that occurred during the registrant&#8217;s most recent fiscal quarter (the registrant&#8217;s fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant&#8217;s internal control over financial reporting&#59; and</font></div><div style="margin-top:6pt;padding-left:18pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">5.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:10.5pt">The registrant&#8217;s other certifying officer(s) and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant&#8217;s auditors and the audit committee of the registrant&#8217;s board of directors (or persons performing the equivalent functions)&#58;</font></div><div style="margin-top:6pt;padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(a) </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:4.41pt">All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant&#8217;s ability to record, process, summarize and report financial information&#59; and</font></div><div style="margin-top:6pt;padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(b) </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:3.84pt">Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant&#8217;s internal control over financial reporting.</font></div><div style="padding-right:-9pt;text-align:center;text-indent:18pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:42.094%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:55.706%"></td><td style="width:0.1%"></td></tr><tr style="height:0pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">&#47;s&#47; Jerry Barbato</font></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">Jerry Barbato</font></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Chief Financial Officer</font></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-bottom:2pt;margin-top:2pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">Principal Financial Officer</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">)</font></div></td><td colspan="3" style="padding:0 1pt"></td></tr></table></div><div style="margin-top:3pt"><font><br></font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:174%">Date&#58; August 6, 2021</font></div><div><font><br></font></div><div style="height:36pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:10pt;margin-top:10pt;text-align:center"><font><br></font></div></div></div></body></html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-32.1
<SEQUENCE>7
<FILENAME>a10-qq22021321.htm
<DESCRIPTION>EX-32.1
<TEXT>
<!DOCTYPE html PUBLIC "-//W3C//DTD HTML 4.01 Transitional//EN" "http://www.w3.org/TR/html4/loose.dtd"><html><head>
<!-- Document created using Wdesk -->
<!-- Copyright 2021 Workiva -->
<title>Document</title></head><body><div id="ie18ddd24cb4245c59c2f145e1e5279cd_1"></div><div style="min-height:36pt;width:100%"><div style="margin-bottom:10pt;margin-top:10pt"><font><br></font></div></div><div style="margin-bottom:3pt;text-align:right"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Exhibit&#160;32.1</font></div><div style="margin-bottom:3pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:115%">CERTIFICATION OF PRINCIPAL EXECUTIVE OFFICER</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:115%">PURSUANT TO 18 U.S.C. SECTION 1350,</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:115%">AS ADOPTED PURSUANT TO SECTION 906</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:115%">OF THE SARBANES-OXLEY ACT OF 2002</font></div><div style="margin-bottom:3pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</font></div><div style="text-indent:13.5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">In connection with the Quarterly Report on Form 10-Q for the period ended June&#160;30, 2021 of Cronos Group Inc. (the &#8220;Company&#8221;) as filed with the U.S. Securities and Exchange Commission (the &#8220;SEC&#8221;) on the date hereof (the &#8220;Report&#8221;), I, Kurt Schmidt, President and Chief Executive Officer of the Company, certify, pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, that, to my knowledge&#58;</font></div><div style="margin-bottom:3pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</font></div><div style="margin-bottom:3pt;padding-left:18pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">1.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:10.5pt">The Report fully complies with the requirements of Section 13(a) or Section 15(d), as applicable, of the Securities Exchange Act of 1934, as amended&#59; and</font></div><div style="margin-bottom:3pt;text-indent:2.25pt"><font><br></font></div><div style="margin-bottom:3pt;padding-left:18pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">2.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:10.5pt">The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company.</font></div><div style="margin-bottom:3pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</font></div><div style="margin-bottom:3pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</font><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:76.527%"><tr><td style="width:1.0%"></td><td style="width:47.538%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:50.262%"></td><td style="width:0.1%"></td></tr><tr style="height:0pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#47;s&#47; Kurt Schmidt</font></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-bottom:1pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Kurt Schmidt</font></div></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-bottom:1pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">President and Chief Executive Officer</font></div></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-bottom:1pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">Principal Executive Officer</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">)</font></div></td><td colspan="3" style="padding:0 1pt"></td></tr></table></div><div style="margin-bottom:3pt"><font><br></font></div><div style="margin-bottom:3pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Date&#58; August 6, 2021</font></div><div style="margin-bottom:3pt;text-align:justify"><font><br></font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">A signed original of this written statement required by Section 906 has been provided to the Company and will be retained by the Company and furnished to the SEC or its staff upon request.</font></div><div><font><br></font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">This certification accompanies the Form 10-Q to which it relates, is not deemed filed with the SEC and is not to be incorporated by reference into any filing of the Company under the Securities Act of 1933, as amended, or the Securities Exchange Act of 1934, as amended (whether made before or after the date of the Form 10-Q), irrespective of any general incorporation language contained in such filing.</font></div><div style="margin-bottom:3pt"><font><br></font></div><div style="height:36pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:10pt;margin-top:10pt;text-align:center"><font><br></font></div></div></div></body></html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-32.2
<SEQUENCE>8
<FILENAME>a10-qq22021322.htm
<DESCRIPTION>EX-32.2
<TEXT>
<!DOCTYPE html PUBLIC "-//W3C//DTD HTML 4.01 Transitional//EN" "http://www.w3.org/TR/html4/loose.dtd"><html><head>
<!-- Document created using Wdesk -->
<!-- Copyright 2021 Workiva -->
<title>Document</title></head><body><div id="id10ccbc8bac6422c8fa3750b72b43ab5_1"></div><div style="min-height:36pt;width:100%"><div style="margin-bottom:10pt;margin-top:10pt"><font><br></font></div></div><div style="text-align:right"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Exhibit&#160;32.2</font></div><div style="margin-bottom:3pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:115%">CERTIFICATION OF PRINCIPAL FINANCIAL OFFICER</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:115%">PURSUANT TO 18 U.S.C. SECTION 1350,</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:115%">AS ADOPTED PURSUANT TO SECTION 906</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:115%">OF THE SARBANES-OXLEY ACT OF 2002</font></div><div style="margin-bottom:3pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</font></div><div style="text-indent:13.5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">In connection with the Quarterly Report on Form 10-Q for the period ended June&#160;30, 2021 of Cronos Group Inc. (the &#8220;Company&#8221;) as filed with the U.S. Securities and Exchange Commission (the &#8220;SEC&#8221;) on the date hereof (the &#8220;Report&#8221;), I, Jerry Barbato, Chief Financial Officer of the Company, certify, pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, that, to my knowledge&#58;</font></div><div style="margin-bottom:3pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</font></div><div style="margin-bottom:3pt;padding-left:18pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">1.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:10.5pt">The Report fully complies with the requirements of Section 13(a) or Section 15(d), as applicable, of the Securities Exchange Act of 1934, as amended&#59; and</font></div><div style="margin-bottom:3pt;text-indent:2.25pt"><font><br></font></div><div style="margin-bottom:3pt;padding-left:18pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">2.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:10.5pt">The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company.</font></div><div style="margin-bottom:3pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</font></div><div style="margin-bottom:3pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</font><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:76.527%"><tr><td style="width:1.0%"></td><td style="width:47.538%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:50.262%"></td><td style="width:0.1%"></td></tr><tr style="height:0pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#47;s&#47; Jerry Barbato</font></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-bottom:1pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Jerry Barbato</font></div></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-bottom:1pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Chief Financial Officer</font></div></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-bottom:1pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">Principal Financial Officer</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">)</font></div></td><td colspan="3" style="padding:0 1pt"></td></tr></table></div><div><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Date&#58; August 6, 2021</font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">A signed original of this written statement required by Section 906 has been provided to the Company and will be retained by the Company and furnished to the SEC or its staff upon request.</font></div><div><font><br></font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">This certification accompanies the Form 10-Q to which it relates, is not deemed filed with the SEC and is not to be incorporated by reference into any filing of the Company under the Securities Act of 1933, as amended, or the Securities Exchange Act of 1934, as amended (whether made before or after the date of the Form 10-Q), irrespective of any general incorporation language contained in such filing.</font></div><div style="height:36pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:10pt;margin-top:10pt;text-align:center"><font><br></font></div></div></div></body></html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.SCH
<SEQUENCE>9
<FILENAME>cron-20210630.xsd
<DESCRIPTION>XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT
<TEXT>
<XBRL>
<?xml version="1.0" encoding="UTF-8"?>

<!--XBRL Document Created with Wdesk from Workiva-->
<!--Copyright 2021 Workiva-->
<!--r:198d4367-d088-421d-9dd0-dd878c4919c5,g:e5d1c22f-365f-46d5-96bc-44505885d3ea-->
<xs:schema xmlns:xs="http://www.w3.org/2001/XMLSchema" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:cron="http://thecronosgroup.com/20210630" xmlns:xbrli="http://www.xbrl.org/2003/instance" xmlns:dtr-types="http://www.xbrl.org/dtr/type/2020-01-21" xmlns:xbrldt="http://xbrl.org/2005/xbrldt" attributeFormDefault="unqualified" elementFormDefault="qualified" targetNamespace="http://thecronosgroup.com/20210630">
  <xs:import namespace="http://fasb.org/srt/2021-01-31" schemaLocation="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd"/>
  <xs:import namespace="http://fasb.org/us-gaap/2021-01-31" schemaLocation="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd"/>
  <xs:import namespace="http://www.w3.org/1999/xlink" schemaLocation="http://www.xbrl.org/2003/xlink-2003-12-31.xsd"/>
  <xs:import namespace="http://www.xbrl.org/2003/instance" schemaLocation="http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd"/>
  <xs:import namespace="http://www.xbrl.org/2003/linkbase" schemaLocation="http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd"/>
  <xs:import namespace="http://www.xbrl.org/dtr/type/2020-01-21" schemaLocation="https://www.xbrl.org/dtr/type/2020-01-21/types.xsd"/>
  <xs:import namespace="http://xbrl.org/2005/xbrldt" schemaLocation="http://www.xbrl.org/2005/xbrldt-2005.xsd"/>
  <xs:import namespace="http://xbrl.sec.gov/country/2021" schemaLocation="https://xbrl.sec.gov/country/2021/country-2021.xsd"/>
  <xs:import namespace="http://xbrl.sec.gov/dei/2021" schemaLocation="https://xbrl.sec.gov/dei/2021/dei-2021.xsd"/>
  <xs:annotation>
    <xs:appinfo>
      <link:linkbaseRef xmlns:xlink="http://www.w3.org/1999/xlink" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:href="cron-20210630_lab.xml" xlink:role="http://www.xbrl.org/2003/role/labelLinkbaseRef" xlink:type="simple"/>
      <link:linkbaseRef xmlns:xlink="http://www.w3.org/1999/xlink" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:href="cron-20210630_pre.xml" xlink:role="http://www.xbrl.org/2003/role/presentationLinkbaseRef" xlink:type="simple"/>
      <link:linkbaseRef xmlns:xlink="http://www.w3.org/1999/xlink" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:href="cron-20210630_cal.xml" xlink:role="http://www.xbrl.org/2003/role/calculationLinkbaseRef" xlink:type="simple"/>
      <link:linkbaseRef xmlns:xlink="http://www.w3.org/1999/xlink" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:href="cron-20210630_def.xml" xlink:role="http://www.xbrl.org/2003/role/definitionLinkbaseRef" xlink:type="simple"/>
      <link:roleType id="CoverPage" roleURI="http://thecronosgroup.com/role/CoverPage">
        <link:definition>0001001 - Document - Cover Page</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="CondensedConsolidatedBalanceSheets" roleURI="http://thecronosgroup.com/role/CondensedConsolidatedBalanceSheets">
        <link:definition>1001002 - Statement - Condensed Consolidated Balance Sheets</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="CondensedConsolidatedBalanceSheetParenthetical" roleURI="http://thecronosgroup.com/role/CondensedConsolidatedBalanceSheetParenthetical">
        <link:definition>1002003 - Statement - Condensed Consolidated Balance Sheet (Parenthetical)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="CondensedConsolidatedStatementsofNetIncomeLossandComprehensiveIncomeLoss" roleURI="http://thecronosgroup.com/role/CondensedConsolidatedStatementsofNetIncomeLossandComprehensiveIncomeLoss">
        <link:definition>1003004 - Statement - Condensed Consolidated Statements of Net Income (Loss) and Comprehensive Income (Loss)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="CondensedConsolidatedStatementsofChangesinEquity" roleURI="http://thecronosgroup.com/role/CondensedConsolidatedStatementsofChangesinEquity">
        <link:definition>1004005 - Statement - Condensed Consolidated Statements of Changes in Equity</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="CondensedConsolidatedStatementsofCashFlows" roleURI="http://thecronosgroup.com/role/CondensedConsolidatedStatementsofCashFlows">
        <link:definition>1005006 - Statement - Condensed Consolidated Statements of Cash Flows</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="BackgroundBasisofPresentationandAccountingPolicies" roleURI="http://thecronosgroup.com/role/BackgroundBasisofPresentationandAccountingPolicies">
        <link:definition>2101101 - Disclosure - Background, Basis of Presentation and Accounting Policies</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="BackgroundBasisofPresentationandAccountingPoliciesPolicies" roleURI="http://thecronosgroup.com/role/BackgroundBasisofPresentationandAccountingPoliciesPolicies">
        <link:definition>2202201 - Disclosure - Background, Basis of Presentation and Accounting Policies (Policies)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="BackgroundBasisofPresentationandAccountingPoliciesDetails" roleURI="http://thecronosgroup.com/role/BackgroundBasisofPresentationandAccountingPoliciesDetails">
        <link:definition>2403401 - Disclosure - Background, Basis of Presentation and Accounting Policies (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="Inventorynet" roleURI="http://thecronosgroup.com/role/Inventorynet">
        <link:definition>2104102 - Disclosure - Inventory, net</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="InventorynetTables" roleURI="http://thecronosgroup.com/role/InventorynetTables">
        <link:definition>2305301 - Disclosure - Inventory, net (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="InventorynetDetails" roleURI="http://thecronosgroup.com/role/InventorynetDetails">
        <link:definition>2406402 - Disclosure - Inventory, net (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="Investments" roleURI="http://thecronosgroup.com/role/Investments">
        <link:definition>2107103 - Disclosure - Investments</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="InvestmentsTables" roleURI="http://thecronosgroup.com/role/InvestmentsTables">
        <link:definition>2308302 - Disclosure - Investments (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="InvestmentsNarrativeDetails" roleURI="http://thecronosgroup.com/role/InvestmentsNarrativeDetails">
        <link:definition>2409403 - Disclosure - Investments - Narrative (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="InvestmentsScheduleofInvestmentsinAssociatesandJointVenturesDetails" roleURI="http://thecronosgroup.com/role/InvestmentsScheduleofInvestmentsinAssociatesandJointVenturesDetails">
        <link:definition>2410404 - Disclosure - Investments - Schedule of Investments in Associates and Joint Ventures (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="InvestmentsScheduleofVariableInterestEntitiesDetails" roleURI="http://thecronosgroup.com/role/InvestmentsScheduleofVariableInterestEntitiesDetails">
        <link:definition>2411405 - Disclosure - Investments - Schedule of Variable Interest Entities (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="LoansReceivablenet" roleURI="http://thecronosgroup.com/role/LoansReceivablenet">
        <link:definition>2112104 - Disclosure - Loans Receivable, net</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="LoansReceivablenetTables" roleURI="http://thecronosgroup.com/role/LoansReceivablenetTables">
        <link:definition>2313303 - Disclosure - Loans Receivable, net (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="LoansReceivablenetDetails" roleURI="http://thecronosgroup.com/role/LoansReceivablenetDetails">
        <link:definition>2414406 - Disclosure - Loans Receivable, net (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="DerivativeLiabilities" roleURI="http://thecronosgroup.com/role/DerivativeLiabilities">
        <link:definition>2115105 - Disclosure - Derivative Liabilities</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="DerivativeLiabilitiesTables" roleURI="http://thecronosgroup.com/role/DerivativeLiabilitiesTables">
        <link:definition>2316304 - Disclosure - Derivative Liabilities (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="DerivativeLiabilitiesNarrativeDetails" roleURI="http://thecronosgroup.com/role/DerivativeLiabilitiesNarrativeDetails">
        <link:definition>2417407 - Disclosure - Derivative Liabilities - Narrative (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="DerivativeLiabilitiesScheduleofReconciliationofCarryingAmountsDetails" roleURI="http://thecronosgroup.com/role/DerivativeLiabilitiesScheduleofReconciliationofCarryingAmountsDetails">
        <link:definition>2418408 - Disclosure - Derivative Liabilities - Schedule of Reconciliation of Carrying Amounts (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="DerivativeLiabilitiesScheduleofFairValuesofDerivativeLiabilitiesDetails" roleURI="http://thecronosgroup.com/role/DerivativeLiabilitiesScheduleofFairValuesofDerivativeLiabilitiesDetails">
        <link:definition>2419409 - Disclosure - Derivative Liabilities - Schedule of Fair Values of Derivative Liabilities (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="DerivativeLiabilitiesScheduleofSensitivityAnalysisDetails" roleURI="http://thecronosgroup.com/role/DerivativeLiabilitiesScheduleofSensitivityAnalysisDetails">
        <link:definition>2420410 - Disclosure - Derivative Liabilities - Schedule of Sensitivity Analysis (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="SharebasedPayments" roleURI="http://thecronosgroup.com/role/SharebasedPayments">
        <link:definition>2121106 - Disclosure - Share-based Payments</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="SharebasedPaymentsTables" roleURI="http://thecronosgroup.com/role/SharebasedPaymentsTables">
        <link:definition>2322305 - Disclosure - Share-based Payments (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="SharebasedPaymentsSummaryofStockbasedCompensationExpenseDetails" roleURI="http://thecronosgroup.com/role/SharebasedPaymentsSummaryofStockbasedCompensationExpenseDetails">
        <link:definition>2423411 - Disclosure - Share-based Payments - Summary of Stock-based Compensation Expense (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="SharebasedPaymentsStockOptionsNarrativeDetails" roleURI="http://thecronosgroup.com/role/SharebasedPaymentsStockOptionsNarrativeDetails">
        <link:definition>2424412 - Disclosure - Share-based Payments - Stock Options Narrative (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="SharebasedPaymentsSummaryoftheChangesinOptionsDetails" roleURI="http://thecronosgroup.com/role/SharebasedPaymentsSummaryoftheChangesinOptionsDetails">
        <link:definition>2425413 - Disclosure - Share-based Payments - Summary of the Changes in Options (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="SharebasedPaymentsScheduleofStockOptionsOutstandingDetails" roleURI="http://thecronosgroup.com/role/SharebasedPaymentsScheduleofStockOptionsOutstandingDetails">
        <link:definition>2426414 - Disclosure - Share-based Payments - Schedule of Stock Options Outstanding (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="SharebasedPaymentsSummaryofChangesinRSUsDetails" roleURI="http://thecronosgroup.com/role/SharebasedPaymentsSummaryofChangesinRSUsDetails">
        <link:definition>2427415 - Disclosure - Share-based Payments - Summary of Changes in RSUs (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="SharebasedPaymentsSummaryofDSUActivityDetails" roleURI="http://thecronosgroup.com/role/SharebasedPaymentsSummaryofDSUActivityDetails">
        <link:definition>2428416 - Disclosure - Share-based Payments - Summary of DSU Activity (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="SharebasedPaymentsSummaryofChangesinWarrantsDetails" roleURI="http://thecronosgroup.com/role/SharebasedPaymentsSummaryofChangesinWarrantsDetails">
        <link:definition>2429417 - Disclosure - Share-based Payments - Summary of Changes in Warrants (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="SharebasedPaymentsSummaryofOutstandingWarrantsDetails" roleURI="http://thecronosgroup.com/role/SharebasedPaymentsSummaryofOutstandingWarrantsDetails">
        <link:definition>2430418 - Disclosure - Share-based Payments - Summary of Outstanding Warrants (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="EarningsLossPerShare" roleURI="http://thecronosgroup.com/role/EarningsLossPerShare">
        <link:definition>2131107 - Disclosure - Earnings (Loss) Per Share</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="EarningsLossPerShareTables" roleURI="http://thecronosgroup.com/role/EarningsLossPerShareTables">
        <link:definition>2332306 - Disclosure - Earnings (Loss) Per Share (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="EarningsLossPerShareScheduleofEarningsLossPerShareDetails" roleURI="http://thecronosgroup.com/role/EarningsLossPerShareScheduleofEarningsLossPerShareDetails">
        <link:definition>2433419 - Disclosure - Earnings (Loss) Per Share - Schedule of Earnings (Loss) Per Share (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="EarningsLossPerShareScheduleofAntidilutiveSecuritiesExcludedfromComputationofDilutedSharesOutstandingDetails" roleURI="http://thecronosgroup.com/role/EarningsLossPerShareScheduleofAntidilutiveSecuritiesExcludedfromComputationofDilutedSharesOutstandingDetails">
        <link:definition>2434420 - Disclosure - Earnings (Loss) Per Share - Schedule of Antidilutive Securities Excluded from Computation of Diluted Shares Outstanding (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="SegmentInformation" roleURI="http://thecronosgroup.com/role/SegmentInformation">
        <link:definition>2135108 - Disclosure - Segment Information</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="SegmentInformationTables" roleURI="http://thecronosgroup.com/role/SegmentInformationTables">
        <link:definition>2336307 - Disclosure - Segment Information (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="SegmentInformationNarrativeDetails" roleURI="http://thecronosgroup.com/role/SegmentInformationNarrativeDetails">
        <link:definition>2437421 - Disclosure - Segment Information - Narrative (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="SegmentInformationScheduleofSegmentDataDetails" roleURI="http://thecronosgroup.com/role/SegmentInformationScheduleofSegmentDataDetails">
        <link:definition>2438422 - Disclosure - Segment Information - Schedule of Segment Data (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="SegmentInformationScheduleofAdjustedEBITDADetails" roleURI="http://thecronosgroup.com/role/SegmentInformationScheduleofAdjustedEBITDADetails">
        <link:definition>2439423 - Disclosure - Segment Information - Schedule of Adjusted EBITDA (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="SegmentInformationScheduleofRevenuefromExternalCustomersbyGeographicAreasDetails" roleURI="http://thecronosgroup.com/role/SegmentInformationScheduleofRevenuefromExternalCustomersbyGeographicAreasDetails">
        <link:definition>2440424 - Disclosure - Segment Information - Schedule of Revenue from External Customers by Geographic Areas (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="SegmentInformationScheduleofLonglivedAssetsbyGeographicAreasDetails" roleURI="http://thecronosgroup.com/role/SegmentInformationScheduleofLonglivedAssetsbyGeographicAreasDetails">
        <link:definition>2441425 - Disclosure - Segment Information - Schedule of Long-lived Assets by Geographic Areas (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="CommitmentsandContingencies" roleURI="http://thecronosgroup.com/role/CommitmentsandContingencies">
        <link:definition>2142109 - Disclosure - Commitments and Contingencies</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="CommitmentsandContingenciesDetails" roleURI="http://thecronosgroup.com/role/CommitmentsandContingenciesDetails">
        <link:definition>2443426 - Disclosure - Commitments and Contingencies (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="FinancialInstruments" roleURI="http://thecronosgroup.com/role/FinancialInstruments">
        <link:definition>2144110 - Disclosure - Financial Instruments</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="FinancialInstrumentsTables" roleURI="http://thecronosgroup.com/role/FinancialInstrumentsTables">
        <link:definition>2345308 - Disclosure - Financial Instruments (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="FinancialInstrumentsScheduleofFairValueofAssetsMeasuredonRecurringBasisDetails" roleURI="http://thecronosgroup.com/role/FinancialInstrumentsScheduleofFairValueofAssetsMeasuredonRecurringBasisDetails">
        <link:definition>2446427 - Disclosure - Financial Instruments - Schedule of Fair Value of Assets Measured on Recurring Basis (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="FinancialInstrumentsCreditRiskNarrativeDetails" roleURI="http://thecronosgroup.com/role/FinancialInstrumentsCreditRiskNarrativeDetails">
        <link:definition>2447428 - Disclosure - Financial Instruments - Credit Risk Narrative (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="FinancialInstrumentsInterestRateRiskNarrativeDetails" roleURI="http://thecronosgroup.com/role/FinancialInstrumentsInterestRateRiskNarrativeDetails">
        <link:definition>2448429 - Disclosure - Financial Instruments - Interest Rate Risk Narrative (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="FinancialInstrumentsLiquidityRiskNarrativeDetails" roleURI="http://thecronosgroup.com/role/FinancialInstrumentsLiquidityRiskNarrativeDetails">
        <link:definition>2449430 - Disclosure - Financial Instruments - Liquidity Risk Narrative (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="FinancialInstrumentsCurrencyRateRiskNarrativeDetails" roleURI="http://thecronosgroup.com/role/FinancialInstrumentsCurrencyRateRiskNarrativeDetails">
        <link:definition>2450431 - Disclosure - Financial Instruments - Currency Rate Risk Narrative (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="HeldForSaleAssetsandDiscontinuedOperations" roleURI="http://thecronosgroup.com/role/HeldForSaleAssetsandDiscontinuedOperations">
        <link:definition>2151111 - Disclosure - Held-For-Sale Assets and Discontinued Operations</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="HeldForSaleAssetsandDiscontinuedOperationsTables" roleURI="http://thecronosgroup.com/role/HeldForSaleAssetsandDiscontinuedOperationsTables">
        <link:definition>2352309 - Disclosure - Held-For-Sale Assets and Discontinued Operations (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="HeldForSaleAssetsandDiscontinuedOperationsDetails" roleURI="http://thecronosgroup.com/role/HeldForSaleAssetsandDiscontinuedOperationsDetails">
        <link:definition>2453432 - Disclosure - Held-For-Sale Assets and Discontinued Operations (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="ImpairmentLossonLongLivedAssets" roleURI="http://thecronosgroup.com/role/ImpairmentLossonLongLivedAssets">
        <link:definition>2154112 - Disclosure - Impairment Loss on Long-Lived Assets</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="ImpairmentLossonLongLivedAssetsDetails" roleURI="http://thecronosgroup.com/role/ImpairmentLossonLongLivedAssetsDetails">
        <link:definition>2455433 - Disclosure - Impairment Loss on Long-Lived Assets (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
    </xs:appinfo>
  </xs:annotation>
  <xs:element id="cron_NumberOfHempDerivedPersonalCareBrands" abstract="false" name="NumberOfHempDerivedPersonalCareBrands" nillable="true" xbrli:periodType="instant" substitutionGroup="xbrli:item" type="xbrli:integerItemType"/>
  <xs:element id="cron_SensitivityAnalysisOfCarryingValueNetAssetsImpactOf10PercentChangeInExchangeRate" abstract="false" name="SensitivityAnalysisOfCarryingValueNetAssetsImpactOf10PercentChangeInExchangeRate" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="cron_VariableInterestEntityQualitativeOrQuantitativeInformationLicenseTerm" abstract="false" name="VariableInterestEntityQualitativeOrQuantitativeInformationLicenseTerm" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:durationItemType"/>
  <xs:element id="cron_LesseeOperatingLeaseAreaOfLandToBeDisposedOf" abstract="false" name="LesseeOperatingLeaseAreaOfLandToBeDisposedOf" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:areaItemType"/>
  <xs:element id="cron_InvestmentsInAndAdvancesToAffiliatesFundingCommitmentPercentage" abstract="false" name="InvestmentsInAndAdvancesToAffiliatesFundingCommitmentPercentage" nillable="true" xbrli:periodType="instant" substitutionGroup="xbrli:item" type="xbrli:pureItemType"/>
  <xs:element id="cron_AlbertGamingLiquorAndCannabisCommissionMember" abstract="true" name="AlbertGamingLiquorAndCannabisCommissionMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="cron_RestOfWorldSegmentMember" abstract="true" name="RestOfWorldSegmentMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="cron_AgroideaMember" abstract="true" name="AgroideaMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="cron_DeferredCompensationSharebasedArrangementsLiabilityRollForward" abstract="true" name="DeferredCompensationSharebasedArrangementsLiabilityRollForward" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:stringItemType"/>
  <xs:element id="cron_ClassOfWarrantOrRightNumberOfWarrantsIssued" abstract="false" name="ClassOfWarrantOrRightNumberOfWarrantsIssued" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:integerItemType"/>
  <xs:element id="cron_CollaborativeArrangementProfitsToBeReceivedMaximumPercentageOfAmountsAdvanced" abstract="false" name="CollaborativeArrangementProfitsToBeReceivedMaximumPercentageOfAmountsAdvanced" nillable="true" xbrli:periodType="instant" substitutionGroup="xbrli:item" type="dtr-types:percentItemType"/>
  <xs:element id="cron_USDistrictCourtOfEasternDistrictOfNewYorkVsCronosMember" abstract="true" name="USDistrictCourtOfEasternDistrictOfNewYorkVsCronosMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="cron_CollaborativeArrangementTermOfAgreement" abstract="false" name="CollaborativeArrangementTermOfAgreement" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:durationItemType"/>
  <xs:element id="cron_AltriaGroupInc.Member" abstract="true" name="AltriaGroupInc.Member" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="cron_CannasoulCollaborationLoanMember" abstract="true" name="CannasoulCollaborationLoanMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="cron_LossContingencyPunitiveDamagesSoughtValue" abstract="false" name="LossContingencyPunitiveDamagesSoughtValue" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="cron_FinancingReceivableAccruedInterestNoncurrent" abstract="false" name="FinancingReceivableAccruedInterestNoncurrent" nillable="true" xbrli:periodType="instant" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="cron_FinancingReceivableAccruedInterestCurrent" abstract="false" name="FinancingReceivableAccruedInterestCurrent" nillable="true" xbrli:periodType="instant" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="cron_FinancingReceivableBeforeAccruedInterestCurrent" abstract="false" name="FinancingReceivableBeforeAccruedInterestCurrent" nillable="true" xbrli:periodType="instant" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="cron_SensitivityAnalysisImpactOf10PercentDecreaseIncreaseOnNetIncomeLossAbstract" abstract="true" name="SensitivityAnalysisImpactOf10PercentDecreaseIncreaseOnNetIncomeLossAbstract" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:stringItemType"/>
  <xs:element id="cron_AltriaWarrantMember" abstract="true" name="AltriaWarrantMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="cron_FourCustomersMember" abstract="true" name="FourCustomersMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="cron_NumberOfAdultuseBrands" abstract="false" name="NumberOfAdultuseBrands" nillable="true" xbrli:periodType="instant" substitutionGroup="xbrli:item" type="xbrli:integerItemType"/>
  <xs:element id="cron_UnitedStatesSegmentMember" abstract="true" name="UnitedStatesSegmentMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="cron_CollaborativeArrangementPercentageOfProfitsToBeReceived" abstract="false" name="CollaborativeArrangementPercentageOfProfitsToBeReceived" nillable="true" xbrli:periodType="instant" substitutionGroup="xbrli:item" type="dtr-types:percentItemType"/>
  <xs:element id="cron_TopUpRightsMarketPriceMember" abstract="true" name="TopUpRightsMarketPriceMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="cron_A2020OmnibusPlanMember" abstract="true" name="A2020OmnibusPlanMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="cron_StockholdersEquityOutOfPeriodAdjustment" abstract="false" name="StockholdersEquityOutOfPeriodAdjustment" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="cron_CannabisExtractsMember" abstract="true" name="CannabisExtractsMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="cron_TopUpRightsFixedPriceMember" abstract="true" name="TopUpRightsFixedPriceMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="cron_OntarioCannabisRetailCorporationMember" abstract="true" name="OntarioCannabisRetailCorporationMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="cron_DerivativeLiabilityUsefulLifeTerm" abstract="false" name="DerivativeLiabilityUsefulLifeTerm" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:durationItemType"/>
  <xs:element id="cron_InvestmentsInAndAdvancesToAffiliatesAtFairValueTransferToInvestmentsInEquityAccountedInvestees" abstract="false" name="InvestmentsInAndAdvancesToAffiliatesAtFairValueTransferToInvestmentsInEquityAccountedInvestees" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="cron_PharmacannMember" abstract="true" name="PharmacannMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="cron_CronosGrowCoCreditFacilityMember" abstract="true" name="CronosGrowCoCreditFacilityMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="cron_SensitivityAnalysisImpactOf10PercentDecreaseIncreaseInExpectedAnnualizedVolatilityOnNetIncomeLoss" abstract="false" name="SensitivityAnalysisImpactOf10PercentDecreaseIncreaseInExpectedAnnualizedVolatilityOnNetIncomeLoss" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="cron_StockIssuedDuringPeriodValueTopupRightsExercised" abstract="false" name="StockIssuedDuringPeriodValueTopupRightsExercised" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="cron_NatuEraMember" abstract="true" name="NatuEraMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="cron_ClassOfWarrantOrRightExercisePriceVolumeWeightedAveragePriceMeasurementPeriod" abstract="false" name="ClassOfWarrantOrRightExercisePriceVolumeWeightedAveragePriceMeasurementPeriod" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:durationItemType"/>
  <xs:element id="cron_TopupRightsMember" abstract="true" name="TopupRightsMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="cron_SubsidiaryOrEquityMethodInvesteeCumulativePercentageOwnershipAfterAllTransactionsIfWarrantsExercised" abstract="false" name="SubsidiaryOrEquityMethodInvesteeCumulativePercentageOwnershipAfterAllTransactionsIfWarrantsExercised" nillable="true" xbrli:periodType="instant" substitutionGroup="xbrli:item" type="dtr-types:percentItemType"/>
  <xs:element id="cron_CollaborativeArrangementPercentageOfProfitsToBeReceivedTriggeringEventSubsequentToMaximumPercentageOfAmountsAdvancedBeingMet" abstract="false" name="CollaborativeArrangementPercentageOfProfitsToBeReceivedTriggeringEventSubsequentToMaximumPercentageOfAmountsAdvancedBeingMet" nillable="true" xbrli:periodType="instant" substitutionGroup="xbrli:item" type="dtr-types:percentItemType"/>
  <xs:element id="cron_InvestmentsInAndAdvancesToAffiliatesAtFairValueAdvancesRepayments" abstract="false" name="InvestmentsInAndAdvancesToAffiliatesAtFairValueAdvancesRepayments" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="cron_CronosAustraliaLimitedMember" abstract="true" name="CronosAustraliaLimitedMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="cron_CannabisFlowerMember" abstract="true" name="CannabisFlowerMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="cron_SocieteQuebecoiseDuCannabisMember" abstract="true" name="SocieteQuebecoiseDuCannabisMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="cron_SensitivityAnalysisImpactOnNetIncomeLossTableTextBlock" abstract="false" name="SensitivityAnalysisImpactOnNetIncomeLossTableTextBlock" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:textBlockItemType"/>
  <xs:element id="cron_FourMajorCustomersMember" abstract="true" name="FourMajorCustomersMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="cron_NumberOfContinentsWithInternationalProductionAndDistribution" abstract="false" name="NumberOfContinentsWithInternationalProductionAndDistribution" nillable="true" xbrli:periodType="instant" substitutionGroup="xbrli:item" type="xbrli:integerItemType"/>
  <xs:element id="cron_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedAndIssuedInPeriod" abstract="false" name="ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedAndIssuedInPeriod" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:sharesItemType"/>
  <xs:element id="cron_A2645485OntarioInc.MucciPromissoryNoteMember" abstract="true" name="A2645485OntarioInc.MucciPromissoryNoteMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="cron_A2018StockOptionPlanMember" abstract="true" name="A2018StockOptionPlanMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="cron_CronosGroupInc.Member" abstract="true" name="CronosGroupInc.Member" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="cron_ShareBasedPaymentArrangementLiabilitiesSettled" abstract="false" name="ShareBasedPaymentArrangementLiabilitiesSettled" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="cron_RestatementReviewExpense" abstract="false" name="RestatementReviewExpense" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="cron_DerivativeInstrumentsRollForward" abstract="true" name="DerivativeInstrumentsRollForward" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:stringItemType"/>
  <xs:element id="cron_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedAndIssuedInPeriodWeightedAverageGrantDateFairValue" abstract="false" name="ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedAndIssuedInPeriodWeightedAverageGrantDateFairValue" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:perShareItemType"/>
  <xs:element id="cron_GinkgoEquityMilestonesMember" abstract="true" name="GinkgoEquityMilestonesMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="cron_ClassOfWarrantOrRightMaximumAdditionalSubscriptionPercentage" abstract="false" name="ClassOfWarrantOrRightMaximumAdditionalSubscriptionPercentage" nillable="true" xbrli:periodType="instant" substitutionGroup="xbrli:item" type="dtr-types:percentItemType"/>
  <xs:element id="cron_SensitivityAnalysisImpactOf10PercentDecreaseIncreaseInWeightedAverageExpectedLifeOnNetIncomeLoss" abstract="false" name="SensitivityAnalysisImpactOf10PercentDecreaseIncreaseInWeightedAverageExpectedLifeOnNetIncomeLoss" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="cron_DeferredShareUnitsDSUsMember" abstract="true" name="DeferredShareUnitsDSUsMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="cron_ErrorRelatedToExerciseOfTopUpRightsMember" abstract="true" name="ErrorRelatedToExerciseOfTopUpRightsMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="cron_FairValueNetDerivativeAssetLiabilityMeasuredOnRecurringBasisUnobservableInputsReconciliationOutOfPeriodAdjustment" abstract="false" name="FairValueNetDerivativeAssetLiabilityMeasuredOnRecurringBasisUnobservableInputsReconciliationOutOfPeriodAdjustment" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="cron_OneVendorMember" abstract="true" name="OneVendorMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="cron_InterestReceivedNet" abstract="false" name="InterestReceivedNet" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="cron_ErrorRelatedToWithholdingTaxesOnTheNetExerciseOfStockOptionsMember" abstract="true" name="ErrorRelatedToWithholdingTaxesOnTheNetExerciseOfStockOptionsMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="cron_MeasurementInputSubscriptionPriceMember" abstract="true" name="MeasurementInputSubscriptionPriceMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="cron_AdjustedEarningsBeforeInterestTaxesDepreciationAndAmortization" abstract="false" name="AdjustedEarningsBeforeInterestTaxesDepreciationAndAmortization" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="cron_CronosGrowingCompanyInc.Member" abstract="true" name="CronosGrowingCompanyInc.Member" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="cron_NatueraMember" abstract="true" name="NatueraMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="cron_SensitivityAnalysisImpactOf10PercentDecreaseIncreaseInSharePriceOnNetIncomeLoss" abstract="false" name="SensitivityAnalysisImpactOf10PercentDecreaseIncreaseInSharePriceOnNetIncomeLoss" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="cron_SharebasedCompensationArrangementBySharebasedPaymentAwardWarrantsExercisesInPeriod" abstract="false" name="SharebasedCompensationArrangementBySharebasedPaymentAwardWarrantsExercisesInPeriod" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:sharesItemType"/>
  <xs:element id="cron_A2015StockOptionPlanMember" abstract="true" name="A2015StockOptionPlanMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="cron_ClassOfWarrantOrRightAdditionalSubscriptionNumberOfSecuritiesCalledByWarrantsOrRights" abstract="false" name="ClassOfWarrantOrRightAdditionalSubscriptionNumberOfSecuritiesCalledByWarrantsOrRights" nillable="true" xbrli:periodType="instant" substitutionGroup="xbrli:item" type="xbrli:sharesItemType"/>
  <xs:element id="cron_CollaborativeArrangementInstallmentsReceived" abstract="false" name="CollaborativeArrangementInstallmentsReceived" nillable="true" xbrli:periodType="instant" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="cron_FourVendorsMember" abstract="true" name="FourVendorsMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="cron_NovologGroupMember" abstract="true" name="NovologGroupMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="cron_FinancingReceivableBeforeAccruedInterestNoncurrent" abstract="false" name="FinancingReceivableBeforeAccruedInterestNoncurrent" nillable="true" xbrli:periodType="instant" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="cron_NatuEraSeriesALoanMember" abstract="true" name="NatuEraSeriesALoanMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="cron_OtherCountriesMember" abstract="true" name="OtherCountriesMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="cron_OriginalBCMember" abstract="true" name="OriginalBCMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="cron_ClassOfWarrantOrRightMinimumOwnershipPercentageRequired" abstract="false" name="ClassOfWarrantOrRightMinimumOwnershipPercentageRequired" nillable="true" xbrli:periodType="instant" substitutionGroup="xbrli:item" type="dtr-types:percentItemType"/>
  <xs:element id="cron_LoanReceivableNameDomain" abstract="true" name="LoanReceivableNameDomain" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="cron_ShareBasedPaymentArrangementGainLossOnRevaluation" abstract="false" name="ShareBasedPaymentArrangementGainLossOnRevaluation" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="cron_AltriaInvestmentMember" abstract="true" name="AltriaInvestmentMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="cron_MedMenCanadaInc.Member" abstract="true" name="MedMenCanadaInc.Member" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="cron_PriorOptionPlansMember" abstract="true" name="PriorOptionPlansMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="cron_StockIssuedDuringPeriodValueWarrantsExercised" abstract="false" name="StockIssuedDuringPeriodValueWarrantsExercised" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="cron_CollaborativeArrangementAmountOfAdvances" abstract="false" name="CollaborativeArrangementAmountOfAdvances" nillable="true" xbrli:periodType="instant" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="cron_OtherCostOfGoodsAndServicesSold" abstract="false" name="OtherCostOfGoodsAndServicesSold" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="cron_CannasoulAnalyticsLtdMember" abstract="true" name="CannasoulAnalyticsLtdMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="cron_ClassOfWarrantOrRightExercisePriceVolumeWeightedAveragePriceMeasurementPeriodDaysPrecedingExercise" abstract="false" name="ClassOfWarrantOrRightExercisePriceVolumeWeightedAveragePriceMeasurementPeriodDaysPrecedingExercise" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:integerItemType"/>
  <xs:element id="cron_PreemptiveRightsMember" abstract="true" name="PreemptiveRightsMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="cron_PreEmptiveRightsAndTopUpRightsMember" abstract="true" name="PreEmptiveRightsAndTopUpRightsMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="cron_LoanReceivableNameAxis" abstract="true" name="LoanReceivableNameAxis" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrldt:dimensionItem" type="xbrli:stringItemType"/>
</xs:schema>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.CAL
<SEQUENCE>10
<FILENAME>cron-20210630_cal.xml
<DESCRIPTION>XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT
<TEXT>
<XBRL>
<?xml version="1.0" encoding="UTF-8"?>

<!--XBRL Document Created with Wdesk from Workiva-->
<!--Copyright 2021 Workiva-->
<!--r:198d4367-d088-421d-9dd0-dd878c4919c5,g:e5d1c22f-365f-46d5-96bc-44505885d3ea-->
<link:linkbase xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
  <link:roleRef roleURI="http://thecronosgroup.com/role/CondensedConsolidatedBalanceSheets" xlink:type="simple" xlink:href="cron-20210630.xsd#CondensedConsolidatedBalanceSheets"/>
  <link:calculationLink xlink:role="http://thecronosgroup.com/role/CondensedConsolidatedBalanceSheets" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Liabilities_47c417d2-4fea-4cce-b68d-eab8beb94035" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_Liabilities"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesCurrent_f09b6bd6-92d5-4559-acac-8dd1efc17010" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LiabilitiesCurrent"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Liabilities_47c417d2-4fea-4cce-b68d-eab8beb94035" xlink:to="loc_us-gaap_LiabilitiesCurrent_f09b6bd6-92d5-4559-acac-8dd1efc17010" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DueToRelatedPartiesNoncurrent_4be4d1df-ca4f-4af5-9bec-bd9c63b5d1d7" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DueToRelatedPartiesNoncurrent"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Liabilities_47c417d2-4fea-4cce-b68d-eab8beb94035" xlink:to="loc_us-gaap_DueToRelatedPartiesNoncurrent_4be4d1df-ca4f-4af5-9bec-bd9c63b5d1d7" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseLiabilityNoncurrent_bdc1f2a4-ccdd-4561-a232-8ebd863fc9b5" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingLeaseLiabilityNoncurrent"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Liabilities_47c417d2-4fea-4cce-b68d-eab8beb94035" xlink:to="loc_us-gaap_OperatingLeaseLiabilityNoncurrent_bdc1f2a4-ccdd-4561-a232-8ebd863fc9b5" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquity_ac2a8691-993c-4160-b794-39c384d5ce4a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockholdersEquity"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockValue_5373fa57-c79b-4ee9-9368-062b75d0a8f8" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommonStockValue"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_StockholdersEquity_ac2a8691-993c-4160-b794-39c384d5ce4a" xlink:to="loc_us-gaap_CommonStockValue_5373fa57-c79b-4ee9-9368-062b75d0a8f8" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdditionalPaidInCapital_336a6d31-5fee-4f0f-aaf4-370d7ad6af52" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AdditionalPaidInCapital"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_StockholdersEquity_ac2a8691-993c-4160-b794-39c384d5ce4a" xlink:to="loc_us-gaap_AdditionalPaidInCapital_336a6d31-5fee-4f0f-aaf4-370d7ad6af52" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetainedEarningsAccumulatedDeficit_07221019-8643-47a3-8bc8-443a2274d3a1" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RetainedEarningsAccumulatedDeficit"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_StockholdersEquity_ac2a8691-993c-4160-b794-39c384d5ce4a" xlink:to="loc_us-gaap_RetainedEarningsAccumulatedDeficit_07221019-8643-47a3-8bc8-443a2274d3a1" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax_68c0fc64-6fb9-4106-95ca-57b9424af925" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_StockholdersEquity_ac2a8691-993c-4160-b794-39c384d5ce4a" xlink:to="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax_68c0fc64-6fb9-4106-95ca-57b9424af925" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Assets_67cb6c4b-9e23-453b-82aa-3f43ace540e2" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_Assets"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseRightOfUseAsset_bfa5be8d-9e76-498c-8c1d-eda70f1f7797" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingLeaseRightOfUseAsset"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Assets_67cb6c4b-9e23-453b-82aa-3f43ace540e2" xlink:to="loc_us-gaap_OperatingLeaseRightOfUseAsset_bfa5be8d-9e76-498c-8c1d-eda70f1f7797" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdvancesToAffiliate_c7f56ac0-4a3f-4197-a8fa-a04f75a2fb2a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AdvancesToAffiliate"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Assets_67cb6c4b-9e23-453b-82aa-3f43ace540e2" xlink:to="loc_us-gaap_AdvancesToAffiliate_c7f56ac0-4a3f-4197-a8fa-a04f75a2fb2a" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherLongTermInvestments_3cefd87c-8d05-48cb-a8b3-aca5dde6de93" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherLongTermInvestments"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Assets_67cb6c4b-9e23-453b-82aa-3f43ace540e2" xlink:to="loc_us-gaap_OtherLongTermInvestments_3cefd87c-8d05-48cb-a8b3-aca5dde6de93" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentNet_3857bdac-114c-42b5-bacd-11030955228a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PropertyPlantAndEquipmentNet"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Assets_67cb6c4b-9e23-453b-82aa-3f43ace540e2" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentNet_3857bdac-114c-42b5-bacd-11030955228a" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsCurrent_748a4541-e403-4487-a744-082ed9871ce9" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AssetsCurrent"/>
    <link:calculationArc order="5" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Assets_67cb6c4b-9e23-453b-82aa-3f43ace540e2" xlink:to="loc_us-gaap_AssetsCurrent_748a4541-e403-4487-a744-082ed9871ce9" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Goodwill_ae59a612-8c4a-4ef0-827b-ba5ec8e52abb" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_Goodwill"/>
    <link:calculationArc order="6" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Assets_67cb6c4b-9e23-453b-82aa-3f43ace540e2" xlink:to="loc_us-gaap_Goodwill_ae59a612-8c4a-4ef0-827b-ba5ec8e52abb" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IntangibleAssetsNetExcludingGoodwill_9640060f-d93e-44b9-942e-ea27779b15a4" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IntangibleAssetsNetExcludingGoodwill"/>
    <link:calculationArc order="7" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Assets_67cb6c4b-9e23-453b-82aa-3f43ace540e2" xlink:to="loc_us-gaap_IntangibleAssetsNetExcludingGoodwill_9640060f-d93e-44b9-942e-ea27779b15a4" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityMethodInvestments_976ddb9e-bda1-4d10-b5a8-e905248c8970" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EquityMethodInvestments"/>
    <link:calculationArc order="8" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Assets_67cb6c4b-9e23-453b-82aa-3f43ace540e2" xlink:to="loc_us-gaap_EquityMethodInvestments_976ddb9e-bda1-4d10-b5a8-e905248c8970" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NotesAndLoansReceivableNetNoncurrent_0b33b199-c69c-4206-bdf3-cf3b06d3af7e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NotesAndLoansReceivableNetNoncurrent"/>
    <link:calculationArc order="9" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Assets_67cb6c4b-9e23-453b-82aa-3f43ace540e2" xlink:to="loc_us-gaap_NotesAndLoansReceivableNetNoncurrent_0b33b199-c69c-4206-bdf3-cf3b06d3af7e" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesAndStockholdersEquity_94febccc-a31c-443c-bcbf-63000bfaa587" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LiabilitiesAndStockholdersEquity"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_000e7917-2828-4bc5-b643-48df84a84c74" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquity_94febccc-a31c-443c-bcbf-63000bfaa587" xlink:to="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_000e7917-2828-4bc5-b643-48df84a84c74" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Liabilities_02bb8982-6149-4d19-b6be-f3180994867d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_Liabilities"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquity_94febccc-a31c-443c-bcbf-63000bfaa587" xlink:to="loc_us-gaap_Liabilities_02bb8982-6149-4d19-b6be-f3180994867d" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommitmentsAndContingencies_e70211b0-7595-41a6-a59c-8705f7a04428" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommitmentsAndContingencies"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquity_94febccc-a31c-443c-bcbf-63000bfaa587" xlink:to="loc_us-gaap_CommitmentsAndContingencies_e70211b0-7595-41a6-a59c-8705f7a04428" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_64c75605-3511-4d83-8238-c81267b9a96e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquity_2d9ee74b-d601-4bc5-b990-a3b222c2a4b0" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockholdersEquity"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_64c75605-3511-4d83-8238-c81267b9a96e" xlink:to="loc_us-gaap_StockholdersEquity_2d9ee74b-d601-4bc5-b990-a3b222c2a4b0" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MinorityInterest_b6dd86c9-dd6b-4c76-aaf7-811cbb80a9c0" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_MinorityInterest"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_64c75605-3511-4d83-8238-c81267b9a96e" xlink:to="loc_us-gaap_MinorityInterest_b6dd86c9-dd6b-4c76-aaf7-811cbb80a9c0" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsCurrent_6fa1f426-d245-4b5f-80ad-c022c939d6be" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AssetsCurrent"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue_c1e35650-04ab-4094-87d0-3fcd84c6f5b0" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CashAndCashEquivalentsAtCarryingValue"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AssetsCurrent_6fa1f426-d245-4b5f-80ad-c022c939d6be" xlink:to="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue_c1e35650-04ab-4094-87d0-3fcd84c6f5b0" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShortTermInvestments_1c44f9ed-f0a2-425d-bd31-cdcc1a0eca7e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShortTermInvestments"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AssetsCurrent_6fa1f426-d245-4b5f-80ad-c022c939d6be" xlink:to="loc_us-gaap_ShortTermInvestments_1c44f9ed-f0a2-425d-bd31-cdcc1a0eca7e" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountsReceivableNetCurrent_00f857ab-218c-4510-949b-a4fc147c417b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccountsReceivableNetCurrent"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AssetsCurrent_6fa1f426-d245-4b5f-80ad-c022c939d6be" xlink:to="loc_us-gaap_AccountsReceivableNetCurrent_00f857ab-218c-4510-949b-a4fc147c417b" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherReceivablesNetCurrent_0fba2c0a-23f4-4349-94c5-af3c9f90e377" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherReceivablesNetCurrent"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AssetsCurrent_6fa1f426-d245-4b5f-80ad-c022c939d6be" xlink:to="loc_us-gaap_OtherReceivablesNetCurrent_0fba2c0a-23f4-4349-94c5-af3c9f90e377" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NotesAndLoansReceivableNetCurrent_aac6b0b2-a67f-441d-991f-cb84f02e17d0" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NotesAndLoansReceivableNetCurrent"/>
    <link:calculationArc order="5" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AssetsCurrent_6fa1f426-d245-4b5f-80ad-c022c939d6be" xlink:to="loc_us-gaap_NotesAndLoansReceivableNetCurrent_aac6b0b2-a67f-441d-991f-cb84f02e17d0" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PrepaidExpenseAndOtherAssetsCurrent_4ca7fd35-150a-4a65-a54e-8f37ec337799" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PrepaidExpenseAndOtherAssetsCurrent"/>
    <link:calculationArc order="6" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AssetsCurrent_6fa1f426-d245-4b5f-80ad-c022c939d6be" xlink:to="loc_us-gaap_PrepaidExpenseAndOtherAssetsCurrent_4ca7fd35-150a-4a65-a54e-8f37ec337799" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryNet_4debbf6f-29c7-4813-aeba-da6e2e29f967" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InventoryNet"/>
    <link:calculationArc order="7" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AssetsCurrent_6fa1f426-d245-4b5f-80ad-c022c939d6be" xlink:to="loc_us-gaap_InventoryNet_4debbf6f-29c7-4813-aeba-da6e2e29f967" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsHeldForSaleNotPartOfDisposalGroupCurrent_6f5a2a8b-1be9-4a40-aceb-c69354bd6a35" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AssetsHeldForSaleNotPartOfDisposalGroupCurrent"/>
    <link:calculationArc order="8" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AssetsCurrent_6fa1f426-d245-4b5f-80ad-c022c939d6be" xlink:to="loc_us-gaap_AssetsHeldForSaleNotPartOfDisposalGroupCurrent_6f5a2a8b-1be9-4a40-aceb-c69354bd6a35" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesCurrent_1a340b35-444b-4946-83fa-b6cd2cc2903d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LiabilitiesCurrent"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountsPayableAndOtherAccruedLiabilitiesCurrent_1c52e9ac-b8e3-43a6-8d81-690c97792c17" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccountsPayableAndOtherAccruedLiabilitiesCurrent"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesCurrent_1a340b35-444b-4946-83fa-b6cd2cc2903d" xlink:to="loc_us-gaap_AccountsPayableAndOtherAccruedLiabilitiesCurrent_1c52e9ac-b8e3-43a6-8d81-690c97792c17" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeLiabilitiesCurrent_200f0e77-1d01-4f72-a520-bdff285aa7ea" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DerivativeLiabilitiesCurrent"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesCurrent_1a340b35-444b-4946-83fa-b6cd2cc2903d" xlink:to="loc_us-gaap_DerivativeLiabilitiesCurrent_200f0e77-1d01-4f72-a520-bdff285aa7ea" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseLiabilityCurrent_f0c33372-eb32-4a5a-9008-ff16ede0565e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingLeaseLiabilityCurrent"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesCurrent_1a340b35-444b-4946-83fa-b6cd2cc2903d" xlink:to="loc_us-gaap_OperatingLeaseLiabilityCurrent_f0c33372-eb32-4a5a-9008-ff16ede0565e" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://thecronosgroup.com/role/CondensedConsolidatedStatementsofNetIncomeLossandComprehensiveIncomeLoss" xlink:type="simple" xlink:href="cron-20210630.xsd#CondensedConsolidatedStatementsofNetIncomeLossandComprehensiveIncomeLoss"/>
  <link:calculationLink xlink:role="http://thecronosgroup.com/role/CondensedConsolidatedStatementsofNetIncomeLossandComprehensiveIncomeLoss" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLoss_d75779eb-d275-432e-8d98-ec2efae67476" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetIncomeLoss"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLossAttributableToNoncontrollingInterest_db49936e-8b52-4939-99f6-a532357390e8" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetIncomeLossAttributableToNoncontrollingInterest"/>
    <link:calculationArc order="1" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetIncomeLoss_d75779eb-d275-432e-8d98-ec2efae67476" xlink:to="loc_us-gaap_NetIncomeLossAttributableToNoncontrollingInterest_db49936e-8b52-4939-99f6-a532357390e8" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProfitLoss_87924504-aadc-49de-9a47-50778043b6e7" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ProfitLoss"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetIncomeLoss_d75779eb-d275-432e-8d98-ec2efae67476" xlink:to="loc_us-gaap_ProfitLoss_87924504-aadc-49de-9a47-50778043b6e7" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest_0c90fcd9-16e5-403d-a6f9-57f9f98b3333" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NonoperatingIncomeExpense_0d713116-2c4d-4d89-8a52-c49d7140dd85" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NonoperatingIncomeExpense"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest_0c90fcd9-16e5-403d-a6f9-57f9f98b3333" xlink:to="loc_us-gaap_NonoperatingIncomeExpense_0d713116-2c4d-4d89-8a52-c49d7140dd85" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingIncomeLoss_e9c55cf8-724d-492a-8780-d16ddf78924a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingIncomeLoss"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest_0c90fcd9-16e5-403d-a6f9-57f9f98b3333" xlink:to="loc_us-gaap_OperatingIncomeLoss_e9c55cf8-724d-492a-8780-d16ddf78924a" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_f085197b-5212-43d9-9e08-9a8abf449c4a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerIncludingAssessedTax_2cdb5eb3-f232-4535-ae08-46e7457c5ecd" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RevenueFromContractWithCustomerIncludingAssessedTax"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_f085197b-5212-43d9-9e08-9a8abf449c4a" xlink:to="loc_us-gaap_RevenueFromContractWithCustomerIncludingAssessedTax_2cdb5eb3-f232-4535-ae08-46e7457c5ecd" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ExciseAndSalesTaxes_f711e4cb-0ef5-45ab-b511-df0f3da7151a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ExciseAndSalesTaxes"/>
    <link:calculationArc order="2" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_f085197b-5212-43d9-9e08-9a8abf449c4a" xlink:to="loc_us-gaap_ExciseAndSalesTaxes_f711e4cb-0ef5-45ab-b511-df0f3da7151a" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingIncomeLoss_fc85a37b-fa36-46a0-bf6e-415c418d0fcd" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingIncomeLoss"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingExpenses_09f75773-2761-4a48-be10-4b035c20d483" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingExpenses"/>
    <link:calculationArc order="1" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OperatingIncomeLoss_fc85a37b-fa36-46a0-bf6e-415c418d0fcd" xlink:to="loc_us-gaap_OperatingExpenses_09f75773-2761-4a48-be10-4b035c20d483" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GrossProfit_7881f650-6cab-4740-b767-5384b8671bf4" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_GrossProfit"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OperatingIncomeLoss_fc85a37b-fa36-46a0-bf6e-415c418d0fcd" xlink:to="loc_us-gaap_GrossProfit_7881f650-6cab-4740-b767-5384b8671bf4" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest_69d76f3e-c180-44aa-a77e-cc088b4c5d2b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTax_aae98b3c-3841-4d3d-b1d5-0474247bfc93" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossNetOfTax"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest_69d76f3e-c180-44aa-a77e-cc088b4c5d2b" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTax_aae98b3c-3841-4d3d-b1d5-0474247bfc93" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProfitLoss_166d8627-ac09-41aa-a169-d307520543f1" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ProfitLoss"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest_69d76f3e-c180-44aa-a77e-cc088b4c5d2b" xlink:to="loc_us-gaap_ProfitLoss_166d8627-ac09-41aa-a169-d307520543f1" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GrossProfit_518f7241-019c-4fd9-ab15-9ee127de27b5" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_GrossProfit"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_a2e06513-63e4-4713-8e71-c3b1ba56398b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_GrossProfit_518f7241-019c-4fd9-ab15-9ee127de27b5" xlink:to="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_a2e06513-63e4-4713-8e71-c3b1ba56398b" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_cron_OtherCostOfGoodsAndServicesSold_224d5a42-90d4-457d-892d-04a5854ab52e" xlink:href="cron-20210630.xsd#cron_OtherCostOfGoodsAndServicesSold"/>
    <link:calculationArc order="2" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_GrossProfit_518f7241-019c-4fd9-ab15-9ee127de27b5" xlink:to="loc_cron_OtherCostOfGoodsAndServicesSold_224d5a42-90d4-457d-892d-04a5854ab52e" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryWriteDown_ae147b32-b5c2-49ab-9d7b-a06e362834bd" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InventoryWriteDown"/>
    <link:calculationArc order="3" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_GrossProfit_518f7241-019c-4fd9-ab15-9ee127de27b5" xlink:to="loc_us-gaap_InventoryWriteDown_ae147b32-b5c2-49ab-9d7b-a06e362834bd" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NonoperatingIncomeExpense_b6853d0c-5569-4ac1-9a32-6fbad4ea7f13" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NonoperatingIncomeExpense"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetImpairmentCharges_7ab5701c-ab4a-4063-b63a-969ca080fe6e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AssetImpairmentCharges"/>
    <link:calculationArc order="1" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NonoperatingIncomeExpense_b6853d0c-5569-4ac1-9a32-6fbad4ea7f13" xlink:to="loc_us-gaap_AssetImpairmentCharges_7ab5701c-ab4a-4063-b63a-969ca080fe6e" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromEquityMethodInvestments_ea10cc7e-5690-42c9-b3cf-b93258da41e1" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeLossFromEquityMethodInvestments"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NonoperatingIncomeExpense_b6853d0c-5569-4ac1-9a32-6fbad4ea7f13" xlink:to="loc_us-gaap_IncomeLossFromEquityMethodInvestments_ea10cc7e-5690-42c9-b3cf-b93258da41e1" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GainLossOnDerivativeInstrumentsNetPretax_bf940d88-83d9-4600-a1ab-e0de88e8e235" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_GainLossOnDerivativeInstrumentsNetPretax"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NonoperatingIncomeExpense_b6853d0c-5569-4ac1-9a32-6fbad4ea7f13" xlink:to="loc_us-gaap_GainLossOnDerivativeInstrumentsNetPretax_bf940d88-83d9-4600-a1ab-e0de88e8e235" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestIncomeExpenseNonoperatingNet_0147d2d8-eb7f-481c-8476-1e8047b96ce8" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InterestIncomeExpenseNonoperatingNet"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NonoperatingIncomeExpense_b6853d0c-5569-4ac1-9a32-6fbad4ea7f13" xlink:to="loc_us-gaap_InterestIncomeExpenseNonoperatingNet_0147d2d8-eb7f-481c-8476-1e8047b96ce8" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherNonoperatingIncomeExpense_569c19b5-001b-4b19-877d-5c29da6ec4a6" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherNonoperatingIncomeExpense"/>
    <link:calculationArc order="5" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NonoperatingIncomeExpense_b6853d0c-5569-4ac1-9a32-6fbad4ea7f13" xlink:to="loc_us-gaap_OtherNonoperatingIncomeExpense_569c19b5-001b-4b19-877d-5c29da6ec4a6" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingExpenses_c129fb75-d47d-4a17-88e0-5447d84fc756" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingExpenses"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SellingAndMarketingExpense_620d62dc-5303-4719-b16b-f0fae3e9b068" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SellingAndMarketingExpense"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OperatingExpenses_c129fb75-d47d-4a17-88e0-5447d84fc756" xlink:to="loc_us-gaap_SellingAndMarketingExpense_620d62dc-5303-4719-b16b-f0fae3e9b068" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ResearchAndDevelopmentExpense_2fcb9c4d-dd3d-4eef-8211-8cab410cda13" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ResearchAndDevelopmentExpense"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OperatingExpenses_c129fb75-d47d-4a17-88e0-5447d84fc756" xlink:to="loc_us-gaap_ResearchAndDevelopmentExpense_2fcb9c4d-dd3d-4eef-8211-8cab410cda13" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GeneralAndAdministrativeExpense_9c8fb8bd-1e78-4468-b9cd-0e1f0cde7d5a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_GeneralAndAdministrativeExpense"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OperatingExpenses_c129fb75-d47d-4a17-88e0-5447d84fc756" xlink:to="loc_us-gaap_GeneralAndAdministrativeExpense_9c8fb8bd-1e78-4468-b9cd-0e1f0cde7d5a" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AllocatedShareBasedCompensationExpense_5a35c3c9-5ced-4c96-85c8-0ac7a4732a47" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AllocatedShareBasedCompensationExpense"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OperatingExpenses_c129fb75-d47d-4a17-88e0-5447d84fc756" xlink:to="loc_us-gaap_AllocatedShareBasedCompensationExpense_5a35c3c9-5ced-4c96-85c8-0ac7a4732a47" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DepreciationAndAmortization_e6bfb090-0d64-4e66-9d59-61ca12b7caa6" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DepreciationAndAmortization"/>
    <link:calculationArc order="5" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OperatingExpenses_c129fb75-d47d-4a17-88e0-5447d84fc756" xlink:to="loc_us-gaap_DepreciationAndAmortization_e6bfb090-0d64-4e66-9d59-61ca12b7caa6" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProfitLoss_8e5a4fc3-0b52-47a6-a804-591813560547" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ProfitLoss"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTax_f04617ab-2739-4189-9405-953c4b64b45e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTax"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_ProfitLoss_8e5a4fc3-0b52-47a6-a804-591813560547" xlink:to="loc_us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTax_f04617ab-2739-4189-9405-953c4b64b45e" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest_73581e99-baec-4a59-a74f-21bb60718337" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_ProfitLoss_8e5a4fc3-0b52-47a6-a804-591813560547" xlink:to="loc_us-gaap_IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest_73581e99-baec-4a59-a74f-21bb60718337" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ComprehensiveIncomeNetOfTax_ec9afbd1-c081-4d37-a476-6ac029fbcce9" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ComprehensiveIncomeNetOfTax"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest_6524c008-e4aa-486b-9f07-9398a7ddb04d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest"/>
    <link:calculationArc order="1" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_ComprehensiveIncomeNetOfTax_ec9afbd1-c081-4d37-a476-6ac029fbcce9" xlink:to="loc_us-gaap_ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest_6524c008-e4aa-486b-9f07-9398a7ddb04d" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest_97afac95-cbe2-48e9-9a03-617f5349f7ca" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_ComprehensiveIncomeNetOfTax_ec9afbd1-c081-4d37-a476-6ac029fbcce9" xlink:to="loc_us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest_97afac95-cbe2-48e9-9a03-617f5349f7ca" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTax_0fc11318-6945-4d75-bbb4-d09a1db648e1" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossNetOfTax"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax_719dabf5-6af4-40d1-85db-9eb95731cf54" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTax_0fc11318-6945-4d75-bbb4-d09a1db648e1" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax_719dabf5-6af4-40d1-85db-9eb95731cf54" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://thecronosgroup.com/role/CondensedConsolidatedStatementsofCashFlows" xlink:type="simple" xlink:href="cron-20210630.xsd#CondensedConsolidatedStatementsofCashFlows"/>
  <link:calculationLink xlink:role="http://thecronosgroup.com/role/CondensedConsolidatedStatementsofCashFlows" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_fb2f639f-3994-4f36-9290-2ef5ef07e908" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_e5615dfd-51b1-416c-877f-2a45fb52a206" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_fb2f639f-3994-4f36-9290-2ef5ef07e908" xlink:to="loc_us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_e5615dfd-51b1-416c-877f-2a45fb52a206" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_8d29afc8-ef84-4958-8f74-5071ed07e97e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivities"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_fb2f639f-3994-4f36-9290-2ef5ef07e908" xlink:to="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_8d29afc8-ef84-4958-8f74-5071ed07e97e" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_084ec591-9d99-42c8-87c3-71243d4011da" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivities"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_fb2f639f-3994-4f36-9290-2ef5ef07e908" xlink:to="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_084ec591-9d99-42c8-87c3-71243d4011da" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_649e118d-b14a-4b54-be6c-a631e00a321c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivities"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_fb2f639f-3994-4f36-9290-2ef5ef07e908" xlink:to="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_649e118d-b14a-4b54-be6c-a631e00a321c" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_93cf1385-05c7-47aa-a09d-278ac1b272e1" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivities"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromSaleAndMaturityOfOtherInvestments_46573123-7f7b-422e-9b74-8ba9be4be5fe" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ProceedsFromSaleAndMaturityOfOtherInvestments"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_93cf1385-05c7-47aa-a09d-278ac1b272e1" xlink:to="loc_us-gaap_ProceedsFromSaleAndMaturityOfOtherInvestments_46573123-7f7b-422e-9b74-8ba9be4be5fe" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquireMarketableSecurities_a485b77b-c509-46ec-a832-9d6a6f32b4a1" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PaymentsToAcquireMarketableSecurities"/>
    <link:calculationArc order="2" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_93cf1385-05c7-47aa-a09d-278ac1b272e1" xlink:to="loc_us-gaap_PaymentsToAcquireMarketableSecurities_a485b77b-c509-46ec-a832-9d6a6f32b4a1" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquireIntangibleAssets_f90dc9c0-0fe6-4ebd-9d65-ca57d0d344b7" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PaymentsToAcquireIntangibleAssets"/>
    <link:calculationArc order="3" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_93cf1385-05c7-47aa-a09d-278ac1b272e1" xlink:to="loc_us-gaap_PaymentsToAcquireIntangibleAssets_f90dc9c0-0fe6-4ebd-9d65-ca57d0d344b7" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment_29286b74-519a-477d-85fe-775a3b769c35" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PaymentsToAcquirePropertyPlantAndEquipment"/>
    <link:calculationArc order="4" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_93cf1385-05c7-47aa-a09d-278ac1b272e1" xlink:to="loc_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment_29286b74-519a-477d-85fe-775a3b769c35" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquireLoansReceivable_89475ee9-7787-48fe-810c-75effc4e2230" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PaymentsToAcquireLoansReceivable"/>
    <link:calculationArc order="5" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_93cf1385-05c7-47aa-a09d-278ac1b272e1" xlink:to="loc_us-gaap_PaymentsToAcquireLoansReceivable_89475ee9-7787-48fe-810c-75effc4e2230" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromSaleAndMaturityOfMarketableSecurities_e4068a7a-4181-4092-9acb-191ae4a50782" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ProceedsFromSaleAndMaturityOfMarketableSecurities"/>
    <link:calculationArc order="6" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_93cf1385-05c7-47aa-a09d-278ac1b272e1" xlink:to="loc_us-gaap_ProceedsFromSaleAndMaturityOfMarketableSecurities_e4068a7a-4181-4092-9acb-191ae4a50782" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquireOtherInvestments_4f930300-6f7a-4eb4-96da-899d76e79685" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PaymentsToAcquireOtherInvestments"/>
    <link:calculationArc order="7" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_93cf1385-05c7-47aa-a09d-278ac1b272e1" xlink:to="loc_us-gaap_PaymentsToAcquireOtherInvestments_4f930300-6f7a-4eb4-96da-899d76e79685" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromSaleOfPropertyHeldForSale_6ed44713-b410-4397-bf82-723cbffb3f8d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ProceedsFromSaleOfPropertyHeldForSale"/>
    <link:calculationArc order="8" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_93cf1385-05c7-47aa-a09d-278ac1b272e1" xlink:to="loc_us-gaap_ProceedsFromSaleOfPropertyHeldForSale_6ed44713-b410-4397-bf82-723cbffb3f8d" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_a6847bcd-4872-4cf6-91e0-dc6a594fe450" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivities"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherNoncashIncomeExpense_1b34c876-060c-463f-957c-70e9a60204b6" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherNoncashIncomeExpense"/>
    <link:calculationArc order="1" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_a6847bcd-4872-4cf6-91e0-dc6a594fe450" xlink:to="loc_us-gaap_OtherNoncashIncomeExpense_1b34c876-060c-463f-957c-70e9a60204b6" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryWriteDown_0360b45b-aaad-4dd6-b6fa-bfe5e597aa45" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InventoryWriteDown"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_a6847bcd-4872-4cf6-91e0-dc6a594fe450" xlink:to="loc_us-gaap_InventoryWriteDown_0360b45b-aaad-4dd6-b6fa-bfe5e597aa45" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInOtherReceivables_74734771-5fbc-4d72-ad71-f9bc96aeef64" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncreaseDecreaseInOtherReceivables"/>
    <link:calculationArc order="3" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_a6847bcd-4872-4cf6-91e0-dc6a594fe450" xlink:to="loc_us-gaap_IncreaseDecreaseInOtherReceivables_74734771-5fbc-4d72-ad71-f9bc96aeef64" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProvisionForDoubtfulAccounts_ba47c748-5303-44e9-b87c-e846af045c64" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ProvisionForDoubtfulAccounts"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_a6847bcd-4872-4cf6-91e0-dc6a594fe450" xlink:to="loc_us-gaap_ProvisionForDoubtfulAccounts_ba47c748-5303-44e9-b87c-e846af045c64" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets_07f621d9-1f80-4326-b5d6-b7832c56b1a6" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets"/>
    <link:calculationArc order="5" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_a6847bcd-4872-4cf6-91e0-dc6a594fe450" xlink:to="loc_us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets_07f621d9-1f80-4326-b5d6-b7832c56b1a6" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInAccountsReceivable_067c788c-1e08-456e-873a-4cc9fdf95bd5" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncreaseDecreaseInAccountsReceivable"/>
    <link:calculationArc order="6" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_a6847bcd-4872-4cf6-91e0-dc6a594fe450" xlink:to="loc_us-gaap_IncreaseDecreaseInAccountsReceivable_067c788c-1e08-456e-873a-4cc9fdf95bd5" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProfitLoss_f7067614-6520-4f70-8f95-02ab8a7f9fcc" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ProfitLoss"/>
    <link:calculationArc order="7" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_a6847bcd-4872-4cf6-91e0-dc6a594fe450" xlink:to="loc_us-gaap_ProfitLoss_f7067614-6520-4f70-8f95-02ab8a7f9fcc" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensation_23f34345-da9b-4cfe-b897-7c60145a169c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensation"/>
    <link:calculationArc order="8" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_a6847bcd-4872-4cf6-91e0-dc6a594fe450" xlink:to="loc_us-gaap_ShareBasedCompensation_23f34345-da9b-4cfe-b897-7c60145a169c" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInInventories_80ed36da-a144-4a7b-8e7c-7e4bf8421148" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncreaseDecreaseInInventories"/>
    <link:calculationArc order="9" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_a6847bcd-4872-4cf6-91e0-dc6a594fe450" xlink:to="loc_us-gaap_IncreaseDecreaseInInventories_80ed36da-a144-4a7b-8e7c-7e4bf8421148" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInAccountsPayableAndOtherOperatingLiabilities_7329f0ec-c4e1-47f4-be0a-927bdac3005a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncreaseDecreaseInAccountsPayableAndOtherOperatingLiabilities"/>
    <link:calculationArc order="10" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_a6847bcd-4872-4cf6-91e0-dc6a594fe450" xlink:to="loc_us-gaap_IncreaseDecreaseInAccountsPayableAndOtherOperatingLiabilities_7329f0ec-c4e1-47f4-be0a-927bdac3005a" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GainLossOnDerivativeInstrumentsNetPretax_26c74754-8385-4be6-bb4c-0a57a1654a8e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_GainLossOnDerivativeInstrumentsNetPretax"/>
    <link:calculationArc order="11" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_a6847bcd-4872-4cf6-91e0-dc6a594fe450" xlink:to="loc_us-gaap_GainLossOnDerivativeInstrumentsNetPretax_26c74754-8385-4be6-bb4c-0a57a1654a8e" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromEquityMethodInvestments_ba0efa22-0e3a-4a04-8d52-5234a65985c6" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeLossFromEquityMethodInvestments"/>
    <link:calculationArc order="12" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_a6847bcd-4872-4cf6-91e0-dc6a594fe450" xlink:to="loc_us-gaap_IncomeLossFromEquityMethodInvestments_ba0efa22-0e3a-4a04-8d52-5234a65985c6" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DepreciationDepletionAndAmortization_9908c818-b77d-493f-ac3b-2f155257e891" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DepreciationDepletionAndAmortization"/>
    <link:calculationArc order="13" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_a6847bcd-4872-4cf6-91e0-dc6a594fe450" xlink:to="loc_us-gaap_DepreciationDepletionAndAmortization_9908c818-b77d-493f-ac3b-2f155257e891" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetImpairmentCharges_c643a621-bc8f-4f98-b800-b8f52e7cc8e1" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AssetImpairmentCharges"/>
    <link:calculationArc order="14" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_a6847bcd-4872-4cf6-91e0-dc6a594fe450" xlink:to="loc_us-gaap_AssetImpairmentCharges_c643a621-bc8f-4f98-b800-b8f52e7cc8e1" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_89c8feb3-7a98-4183-9c05-ee527a5d2dc1" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivities"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromPaymentsForOtherFinancingActivities_5a1ab39f-dd45-42f5-9eed-cc10e0eccdc1" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ProceedsFromPaymentsForOtherFinancingActivities"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_89c8feb3-7a98-4183-9c05-ee527a5d2dc1" xlink:to="loc_us-gaap_ProceedsFromPaymentsForOtherFinancingActivities_5a1ab39f-dd45-42f5-9eed-cc10e0eccdc1" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsRelatedToTaxWithholdingForShareBasedCompensation_b5fedd10-0cab-4f15-9c3c-675d304be114" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PaymentsRelatedToTaxWithholdingForShareBasedCompensation"/>
    <link:calculationArc order="2" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_89c8feb3-7a98-4183-9c05-ee527a5d2dc1" xlink:to="loc_us-gaap_PaymentsRelatedToTaxWithholdingForShareBasedCompensation_b5fedd10-0cab-4f15-9c3c-675d304be114" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://thecronosgroup.com/role/InventorynetDetails" xlink:type="simple" xlink:href="cron-20210630.xsd#InventorynetDetails"/>
  <link:calculationLink xlink:role="http://thecronosgroup.com/role/InventorynetDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryNet_d6dab7ee-4a61-4ca6-a4c8-4b53065837b6" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InventoryNet"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryFinishedGoodsNetOfReserves_9930a9f0-15cd-4458-aa85-dc8313468bc5" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InventoryFinishedGoodsNetOfReserves"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_InventoryNet_d6dab7ee-4a61-4ca6-a4c8-4b53065837b6" xlink:to="loc_us-gaap_InventoryFinishedGoodsNetOfReserves_9930a9f0-15cd-4458-aa85-dc8313468bc5" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryWorkInProcessNetOfReserves_061472a2-514f-4d5c-817b-1979ad9c5818" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InventoryWorkInProcessNetOfReserves"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_InventoryNet_d6dab7ee-4a61-4ca6-a4c8-4b53065837b6" xlink:to="loc_us-gaap_InventoryWorkInProcessNetOfReserves_061472a2-514f-4d5c-817b-1979ad9c5818" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventorySuppliesNetOfReserves_b28ce20c-eb8d-4b5e-a96b-b301f726d95a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InventorySuppliesNetOfReserves"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_InventoryNet_d6dab7ee-4a61-4ca6-a4c8-4b53065837b6" xlink:to="loc_us-gaap_InventorySuppliesNetOfReserves_b28ce20c-eb8d-4b5e-a96b-b301f726d95a" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryRawMaterialsNetOfReserves_8dcf6313-00e7-4ecd-b105-776d6afa1a96" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InventoryRawMaterialsNetOfReserves"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_InventoryNet_d6dab7ee-4a61-4ca6-a4c8-4b53065837b6" xlink:to="loc_us-gaap_InventoryRawMaterialsNetOfReserves_8dcf6313-00e7-4ecd-b105-776d6afa1a96" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://thecronosgroup.com/role/LoansReceivablenetDetails" xlink:type="simple" xlink:href="cron-20210630.xsd#LoansReceivablenetDetails"/>
  <link:calculationLink xlink:role="http://thecronosgroup.com/role/LoansReceivablenetDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NotesAndLoansReceivableNetNoncurrent_f7dd056e-2672-4643-9e3c-5cb386de8dd9" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NotesAndLoansReceivableNetNoncurrent"/>
    <link:loc xlink:type="locator" xlink:label="loc_cron_FinancingReceivableBeforeAccruedInterestNoncurrent_325b1689-09f4-4961-8b72-437f3c6bcc7c" xlink:href="cron-20210630.xsd#cron_FinancingReceivableBeforeAccruedInterestNoncurrent"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NotesAndLoansReceivableNetNoncurrent_f7dd056e-2672-4643-9e3c-5cb386de8dd9" xlink:to="loc_cron_FinancingReceivableBeforeAccruedInterestNoncurrent_325b1689-09f4-4961-8b72-437f3c6bcc7c" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_cron_FinancingReceivableAccruedInterestNoncurrent_458ec68b-2607-4e4a-9ec2-3fc2881ae612" xlink:href="cron-20210630.xsd#cron_FinancingReceivableAccruedInterestNoncurrent"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NotesAndLoansReceivableNetNoncurrent_f7dd056e-2672-4643-9e3c-5cb386de8dd9" xlink:to="loc_cron_FinancingReceivableAccruedInterestNoncurrent_458ec68b-2607-4e4a-9ec2-3fc2881ae612" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NotesReceivableNet_1999a1a9-b36e-4ce7-9d1c-36fda08b74ac" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NotesReceivableNet"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NotesAndLoansReceivableNetCurrent_bb23f562-b46d-4216-b808-61cd7722e766" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NotesAndLoansReceivableNetCurrent"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NotesReceivableNet_1999a1a9-b36e-4ce7-9d1c-36fda08b74ac" xlink:to="loc_us-gaap_NotesAndLoansReceivableNetCurrent_bb23f562-b46d-4216-b808-61cd7722e766" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NotesAndLoansReceivableNetNoncurrent_259539cb-bde4-441e-b355-3117062c2d50" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NotesAndLoansReceivableNetNoncurrent"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NotesReceivableNet_1999a1a9-b36e-4ce7-9d1c-36fda08b74ac" xlink:to="loc_us-gaap_NotesAndLoansReceivableNetNoncurrent_259539cb-bde4-441e-b355-3117062c2d50" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NotesAndLoansReceivableNetCurrent_c64d8c1b-8535-4d26-8730-5f46db5fbe78" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NotesAndLoansReceivableNetCurrent"/>
    <link:loc xlink:type="locator" xlink:label="loc_cron_FinancingReceivableBeforeAccruedInterestCurrent_df2612c1-96ad-420b-b614-3afecd0c7c51" xlink:href="cron-20210630.xsd#cron_FinancingReceivableBeforeAccruedInterestCurrent"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NotesAndLoansReceivableNetCurrent_c64d8c1b-8535-4d26-8730-5f46db5fbe78" xlink:to="loc_cron_FinancingReceivableBeforeAccruedInterestCurrent_df2612c1-96ad-420b-b614-3afecd0c7c51" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_cron_FinancingReceivableAccruedInterestCurrent_8278b815-eb91-49f2-9d14-2fc964840e9a" xlink:href="cron-20210630.xsd#cron_FinancingReceivableAccruedInterestCurrent"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NotesAndLoansReceivableNetCurrent_c64d8c1b-8535-4d26-8730-5f46db5fbe78" xlink:to="loc_cron_FinancingReceivableAccruedInterestCurrent_8278b815-eb91-49f2-9d14-2fc964840e9a" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://thecronosgroup.com/role/EarningsLossPerShareScheduleofEarningsLossPerShareDetails" xlink:type="simple" xlink:href="cron-20210630.xsd#EarningsLossPerShareScheduleofEarningsLossPerShareDetails"/>
  <link:calculationLink xlink:role="http://thecronosgroup.com/role/EarningsLossPerShareScheduleofEarningsLossPerShareDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_e5387e4f-d003-42af-8144-34a7b92a9628" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_ca2de289-7124-47ad-9052-4c8e89a3d984" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_WeightedAverageNumberOfSharesOutstandingBasic"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_e5387e4f-d003-42af-8144-34a7b92a9628" xlink:to="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_ca2de289-7124-47ad-9052-4c8e89a3d984" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncrementalCommonSharesAttributableToShareBasedPaymentArrangements_145311ac-25a4-450a-b335-79d77a52a5b0" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncrementalCommonSharesAttributableToShareBasedPaymentArrangements"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_e5387e4f-d003-42af-8144-34a7b92a9628" xlink:to="loc_us-gaap_IncrementalCommonSharesAttributableToShareBasedPaymentArrangements_145311ac-25a4-450a-b335-79d77a52a5b0" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLossFromContinuingOperationsAvailableToCommonShareholdersDiluted_18514f93-5c83-434c-b852-90385444b34c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetIncomeLossFromContinuingOperationsAvailableToCommonShareholdersDiluted"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLossFromContinuingOperationsAvailableToCommonShareholdersBasic_0d17d536-ae29-43e9-a3bc-22a3face41f0" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetIncomeLossFromContinuingOperationsAvailableToCommonShareholdersBasic"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetIncomeLossFromContinuingOperationsAvailableToCommonShareholdersDiluted_18514f93-5c83-434c-b852-90385444b34c" xlink:to="loc_us-gaap_NetIncomeLossFromContinuingOperationsAvailableToCommonShareholdersBasic_0d17d536-ae29-43e9-a3bc-22a3face41f0" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DilutiveSecurities_d0532e7d-e371-4233-b587-a6bdf986bcfe" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DilutiveSecurities"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetIncomeLossFromContinuingOperationsAvailableToCommonShareholdersDiluted_18514f93-5c83-434c-b852-90385444b34c" xlink:to="loc_us-gaap_DilutiveSecurities_d0532e7d-e371-4233-b587-a6bdf986bcfe" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://thecronosgroup.com/role/SegmentInformationScheduleofSegmentDataDetails" xlink:type="simple" xlink:href="cron-20210630.xsd#SegmentInformationScheduleofSegmentDataDetails"/>
  <link:calculationLink xlink:role="http://thecronosgroup.com/role/SegmentInformationScheduleofSegmentDataDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestIncomeExpenseNonoperatingNet_09a2e538-fe99-474c-99cb-3006b5fa8cc2" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InterestIncomeExpenseNonoperatingNet"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentIncomeInterest_c6047da3-2ac2-497a-a25b-7c7d8867d653" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InvestmentIncomeInterest"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_InterestIncomeExpenseNonoperatingNet_09a2e538-fe99-474c-99cb-3006b5fa8cc2" xlink:to="loc_us-gaap_InvestmentIncomeInterest_c6047da3-2ac2-497a-a25b-7c7d8867d653" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestExpense_9a18f67b-6686-4494-9d03-26ff55f548c6" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InterestExpense"/>
    <link:calculationArc order="2" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_InterestIncomeExpenseNonoperatingNet_09a2e538-fe99-474c-99cb-3006b5fa8cc2" xlink:to="loc_us-gaap_InterestExpense_9a18f67b-6686-4494-9d03-26ff55f548c6" xlink:type="arc"/>
  </link:calculationLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.DEF
<SEQUENCE>11
<FILENAME>cron-20210630_def.xml
<DESCRIPTION>XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT
<TEXT>
<XBRL>
<?xml version="1.0" encoding="UTF-8"?>

<!--XBRL Document Created with Wdesk from Workiva-->
<!--Copyright 2021 Workiva-->
<!--r:198d4367-d088-421d-9dd0-dd878c4919c5,g:e5d1c22f-365f-46d5-96bc-44505885d3ea-->
<link:linkbase xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:xbrldt="http://xbrl.org/2005/xbrldt" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
  <link:arcroleRef arcroleURI="http://xbrl.org/int/dim/arcrole/all" xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#all"/>
  <link:arcroleRef arcroleURI="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#hypercube-dimension"/>
  <link:arcroleRef arcroleURI="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#dimension-default"/>
  <link:arcroleRef arcroleURI="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#dimension-domain"/>
  <link:arcroleRef arcroleURI="http://xbrl.org/int/dim/arcrole/domain-member" xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#domain-member"/>
  <link:roleRef roleURI="http://thecronosgroup.com/role/CondensedConsolidatedStatementsofChangesinEquity" xlink:type="simple" xlink:href="cron-20210630.xsd#CondensedConsolidatedStatementsofChangesinEquity"/>
  <link:definitionLink xlink:role="http://thecronosgroup.com/role/CondensedConsolidatedStatementsofChangesinEquity" xlink:type="extended" id="i440a4b063ded4134b8b5093dfb244a6b_CondensedConsolidatedStatementsofChangesinEquity">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementLineItems_3706e504-c212-49a4-9024-0e681b04a72b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_d16da9b3-b34e-48f6-833c-9d409644adbc" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncreaseDecreaseInStockholdersEquityRollForward"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_3706e504-c212-49a4-9024-0e681b04a72b" xlink:to="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_d16da9b3-b34e-48f6-833c-9d409644adbc" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockSharesOutstanding_0c774d55-4092-486e-ab63-79240680e0d1" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommonStockSharesOutstanding"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_d16da9b3-b34e-48f6-833c-9d409644adbc" xlink:to="loc_us-gaap_CommonStockSharesOutstanding_0c774d55-4092-486e-ab63-79240680e0d1" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_2ba56bb8-c72d-4a91-889c-f6dccdad2af6" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_d16da9b3-b34e-48f6-833c-9d409644adbc" xlink:to="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_2ba56bb8-c72d-4a91-889c-f6dccdad2af6" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_cron_SharebasedCompensationArrangementBySharebasedPaymentAwardWarrantsExercisesInPeriod_56229802-512e-4b32-a289-a7d91e6a5370" xlink:href="cron-20210630.xsd#cron_SharebasedCompensationArrangementBySharebasedPaymentAwardWarrantsExercisesInPeriod"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_d16da9b3-b34e-48f6-833c-9d409644adbc" xlink:to="loc_cron_SharebasedCompensationArrangementBySharebasedPaymentAwardWarrantsExercisesInPeriod_56229802-512e-4b32-a289-a7d91e6a5370" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_cron_StockIssuedDuringPeriodValueWarrantsExercised_dfecd52f-d7f2-4a5e-b614-e931fb882d6d" xlink:href="cron-20210630.xsd#cron_StockIssuedDuringPeriodValueWarrantsExercised"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_d16da9b3-b34e-48f6-833c-9d409644adbc" xlink:to="loc_cron_StockIssuedDuringPeriodValueWarrantsExercised_dfecd52f-d7f2-4a5e-b614-e931fb882d6d" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsRequisiteServicePeriodRecognition_ab6aaaa3-91dd-4cd5-8a8e-b2f70a7dc513" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsRequisiteServicePeriodRecognition"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_d16da9b3-b34e-48f6-833c-9d409644adbc" xlink:to="loc_us-gaap_AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsRequisiteServicePeriodRecognition_ab6aaaa3-91dd-4cd5-8a8e-b2f70a7dc513" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised_19b0ba91-c2c4-488b-a248-bddd7fdb6ab4" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_d16da9b3-b34e-48f6-833c-9d409644adbc" xlink:to="loc_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised_19b0ba91-c2c4-488b-a248-bddd7fdb6ab4" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised_7a41ff20-79b3-4401-9148-159e859c70a8" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_d16da9b3-b34e-48f6-833c-9d409644adbc" xlink:to="loc_us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised_7a41ff20-79b3-4401-9148-159e859c70a8" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodSharesRestrictedStockAwardNetOfForfeitures_3d5f46ff-6305-4666-a762-caeed6b8c8b9" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockIssuedDuringPeriodSharesRestrictedStockAwardNetOfForfeitures"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_d16da9b3-b34e-48f6-833c-9d409644adbc" xlink:to="loc_us-gaap_StockIssuedDuringPeriodSharesRestrictedStockAwardNetOfForfeitures_3d5f46ff-6305-4666-a762-caeed6b8c8b9" xlink:type="arc" order="8"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures_a4edf586-cfef-44f4-8238-88818a222e2a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_d16da9b3-b34e-48f6-833c-9d409644adbc" xlink:to="loc_us-gaap_StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures_a4edf586-cfef-44f4-8238-88818a222e2a" xlink:type="arc" order="9"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation_680ffe6c-46c3-4719-bbb6-c023e4add2ff" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_d16da9b3-b34e-48f6-833c-9d409644adbc" xlink:to="loc_us-gaap_AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation_680ffe6c-46c3-4719-bbb6-c023e4add2ff" xlink:type="arc" order="10"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationRestrictedStockUnitsRequisiteServicePeriodRecognition_02500f28-6ec1-4e71-ba35-519d10a58de8" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationRestrictedStockUnitsRequisiteServicePeriodRecognition"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_d16da9b3-b34e-48f6-833c-9d409644adbc" xlink:to="loc_us-gaap_AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationRestrictedStockUnitsRequisiteServicePeriodRecognition_02500f28-6ec1-4e71-ba35-519d10a58de8" xlink:type="arc" order="11"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationOtherLongtermIncentivePlansRequisiteServicePeriodRecognition_5456614b-405f-4714-bbe9-d133cccaff0c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationOtherLongtermIncentivePlansRequisiteServicePeriodRecognition"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_d16da9b3-b34e-48f6-833c-9d409644adbc" xlink:to="loc_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationOtherLongtermIncentivePlansRequisiteServicePeriodRecognition_5456614b-405f-4714-bbe9-d133cccaff0c" xlink:type="arc" order="12"/>
    <link:loc xlink:type="locator" xlink:label="loc_cron_StockholdersEquityOutOfPeriodAdjustment_81349103-5491-4473-9073-0d813cb68bfe" xlink:href="cron-20210630.xsd#cron_StockholdersEquityOutOfPeriodAdjustment"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_d16da9b3-b34e-48f6-833c-9d409644adbc" xlink:to="loc_cron_StockholdersEquityOutOfPeriodAdjustment_81349103-5491-4473-9073-0d813cb68bfe" xlink:type="arc" order="13"/>
    <link:loc xlink:type="locator" xlink:label="loc_cron_StockIssuedDuringPeriodValueTopupRightsExercised_fb1c14bf-2639-440b-8b81-27aee0310ff0" xlink:href="cron-20210630.xsd#cron_StockIssuedDuringPeriodValueTopupRightsExercised"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_d16da9b3-b34e-48f6-833c-9d409644adbc" xlink:to="loc_cron_StockIssuedDuringPeriodValueTopupRightsExercised_fb1c14bf-2639-440b-8b81-27aee0310ff0" xlink:type="arc" order="14"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProfitLoss_ad4906de-b06e-4633-a8c5-e23798f525bb" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ProfitLoss"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_d16da9b3-b34e-48f6-833c-9d409644adbc" xlink:to="loc_us-gaap_ProfitLoss_ad4906de-b06e-4633-a8c5-e23798f525bb" xlink:type="arc" order="15"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax_05cb7245-e504-41a4-8bfb-a08051003f8e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_d16da9b3-b34e-48f6-833c-9d409644adbc" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax_05cb7245-e504-41a4-8bfb-a08051003f8e" xlink:type="arc" order="16"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockSharesOutstanding_e7be8a50-14bb-4da7-8a5e-6f3e8e38ef7a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommonStockSharesOutstanding"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_0bb91785-07f7-4c7e-8b04-2e2a81bf112c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementTable_114de933-5614-41cb-b416-c17b7834527c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_StatementLineItems_3706e504-c212-49a4-9024-0e681b04a72b" xlink:to="loc_us-gaap_StatementTable_114de933-5614-41cb-b416-c17b7834527c" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementEquityComponentsAxis_31849148-53af-4337-a095-9e9fc7661194" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementEquityComponentsAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_StatementTable_114de933-5614-41cb-b416-c17b7834527c" xlink:to="loc_us-gaap_StatementEquityComponentsAxis_31849148-53af-4337-a095-9e9fc7661194" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityComponentDomain_31849148-53af-4337-a095-9e9fc7661194_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EquityComponentDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_StatementEquityComponentsAxis_31849148-53af-4337-a095-9e9fc7661194" xlink:to="loc_us-gaap_EquityComponentDomain_31849148-53af-4337-a095-9e9fc7661194_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityComponentDomain_0dd49764-f589-4543-b63e-fa3ce0d801fa" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EquityComponentDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_StatementEquityComponentsAxis_31849148-53af-4337-a095-9e9fc7661194" xlink:to="loc_us-gaap_EquityComponentDomain_0dd49764-f589-4543-b63e-fa3ce0d801fa" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockMember_dc69e18e-d1fa-4cca-b995-78a5be4fde18" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommonStockMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EquityComponentDomain_0dd49764-f589-4543-b63e-fa3ce0d801fa" xlink:to="loc_us-gaap_CommonStockMember_dc69e18e-d1fa-4cca-b995-78a5be4fde18" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdditionalPaidInCapitalMember_39967651-bdad-4fbb-8769-68aae773ab38" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AdditionalPaidInCapitalMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EquityComponentDomain_0dd49764-f589-4543-b63e-fa3ce0d801fa" xlink:to="loc_us-gaap_AdditionalPaidInCapitalMember_39967651-bdad-4fbb-8769-68aae773ab38" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetainedEarningsMember_7b71b587-86f1-4b7c-b294-57468b97da5e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RetainedEarningsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EquityComponentDomain_0dd49764-f589-4543-b63e-fa3ce0d801fa" xlink:to="loc_us-gaap_RetainedEarningsMember_7b71b587-86f1-4b7c-b294-57468b97da5e" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeMember_c863dd48-0c2c-4707-bd79-85476bf79adc" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EquityComponentDomain_0dd49764-f589-4543-b63e-fa3ce0d801fa" xlink:to="loc_us-gaap_AccumulatedOtherComprehensiveIncomeMember_c863dd48-0c2c-4707-bd79-85476bf79adc" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NoncontrollingInterestMember_4218f357-54ba-43e0-ad4c-7d7e61e9a2ba" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NoncontrollingInterestMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EquityComponentDomain_0dd49764-f589-4543-b63e-fa3ce0d801fa" xlink:to="loc_us-gaap_NoncontrollingInterestMember_4218f357-54ba-43e0-ad4c-7d7e61e9a2ba" xlink:type="arc" order="4"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://thecronosgroup.com/role/BackgroundBasisofPresentationandAccountingPoliciesDetails" xlink:type="simple" xlink:href="cron-20210630.xsd#BackgroundBasisofPresentationandAccountingPoliciesDetails"/>
  <link:definitionLink xlink:role="http://thecronosgroup.com/role/BackgroundBasisofPresentationandAccountingPoliciesDetails" xlink:type="extended" id="i94b680e78e6e4ed0a69575b9ef25ae5c_BackgroundBasisofPresentationandAccountingPoliciesDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfEquityMethodInvestmentsLineItems_6cf254d1-6535-481c-8e33-e55ab529b7d3" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfEquityMethodInvestmentsLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_cron_NumberOfContinentsWithInternationalProductionAndDistribution_31f9e479-d3c8-45ec-83bb-aec6a6bb61cc" xlink:href="cron-20210630.xsd#cron_NumberOfContinentsWithInternationalProductionAndDistribution"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ScheduleOfEquityMethodInvestmentsLineItems_6cf254d1-6535-481c-8e33-e55ab529b7d3" xlink:to="loc_cron_NumberOfContinentsWithInternationalProductionAndDistribution_31f9e479-d3c8-45ec-83bb-aec6a6bb61cc" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_cron_NumberOfAdultuseBrands_310e3e54-de60-4014-888c-c5e58b8f3c43" xlink:href="cron-20210630.xsd#cron_NumberOfAdultuseBrands"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ScheduleOfEquityMethodInvestmentsLineItems_6cf254d1-6535-481c-8e33-e55ab529b7d3" xlink:to="loc_cron_NumberOfAdultuseBrands_310e3e54-de60-4014-888c-c5e58b8f3c43" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_cron_NumberOfHempDerivedPersonalCareBrands_3c5c6706-beae-405c-9aa5-9e2946a1aa40" xlink:href="cron-20210630.xsd#cron_NumberOfHempDerivedPersonalCareBrands"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ScheduleOfEquityMethodInvestmentsLineItems_6cf254d1-6535-481c-8e33-e55ab529b7d3" xlink:to="loc_cron_NumberOfHempDerivedPersonalCareBrands_3c5c6706-beae-405c-9aa5-9e2946a1aa40" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityMethodInvestmentOwnershipPercentage_50fde880-071c-42c5-9a2e-6b1e3970db0a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EquityMethodInvestmentOwnershipPercentage"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ScheduleOfEquityMethodInvestmentsLineItems_6cf254d1-6535-481c-8e33-e55ab529b7d3" xlink:to="loc_us-gaap_EquityMethodInvestmentOwnershipPercentage_50fde880-071c-42c5-9a2e-6b1e3970db0a" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountsPayableAndOtherAccruedLiabilitiesCurrent_2918bbd7-33f5-40af-8a37-0133cbd3e191" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccountsPayableAndOtherAccruedLiabilitiesCurrent"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ScheduleOfEquityMethodInvestmentsLineItems_6cf254d1-6535-481c-8e33-e55ab529b7d3" xlink:to="loc_us-gaap_AccountsPayableAndOtherAccruedLiabilitiesCurrent_2918bbd7-33f5-40af-8a37-0133cbd3e191" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherReceivablesNetCurrent_86315373-adbf-4be4-9dad-54a86e9133ce" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherReceivablesNetCurrent"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ScheduleOfEquityMethodInvestmentsLineItems_6cf254d1-6535-481c-8e33-e55ab529b7d3" xlink:to="loc_us-gaap_OtherReceivablesNetCurrent_86315373-adbf-4be4-9dad-54a86e9133ce" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetainedEarningsAccumulatedDeficit_ac8fe76d-1f62-4453-8aec-ab9cc7f137d1" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RetainedEarningsAccumulatedDeficit"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ScheduleOfEquityMethodInvestmentsLineItems_6cf254d1-6535-481c-8e33-e55ab529b7d3" xlink:to="loc_us-gaap_RetainedEarningsAccumulatedDeficit_ac8fe76d-1f62-4453-8aec-ab9cc7f137d1" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockValue_56a019c6-fdb9-49bc-85ff-ae60cc7ba271" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommonStockValue"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ScheduleOfEquityMethodInvestmentsLineItems_6cf254d1-6535-481c-8e33-e55ab529b7d3" xlink:to="loc_us-gaap_CommonStockValue_56a019c6-fdb9-49bc-85ff-ae60cc7ba271" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GainLossOnDerivativeInstrumentsNetPretax_d456fa06-019f-41b3-920b-7f52d5266c29" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_GainLossOnDerivativeInstrumentsNetPretax"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ScheduleOfEquityMethodInvestmentsLineItems_6cf254d1-6535-481c-8e33-e55ab529b7d3" xlink:to="loc_us-gaap_GainLossOnDerivativeInstrumentsNetPretax_d456fa06-019f-41b3-920b-7f52d5266c29" xlink:type="arc" order="8"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfEquityMethodInvestmentsTable_047db9f7-670b-4a6f-bc35-fd990d37b9cb" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfEquityMethodInvestmentsTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_ScheduleOfEquityMethodInvestmentsLineItems_6cf254d1-6535-481c-8e33-e55ab529b7d3" xlink:to="loc_us-gaap_ScheduleOfEquityMethodInvestmentsTable_047db9f7-670b-4a6f-bc35-fd990d37b9cb" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis_cd0836a8-f8b7-4b16-a82f-f46c9bbfa45a" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfEquityMethodInvestmentsTable_047db9f7-670b-4a6f-bc35-fd990d37b9cb" xlink:to="loc_srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis_cd0836a8-f8b7-4b16-a82f-f46c9bbfa45a" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_EquityMethodInvesteeNameDomain_cd0836a8-f8b7-4b16-a82f-f46c9bbfa45a_default" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_EquityMethodInvesteeNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis_cd0836a8-f8b7-4b16-a82f-f46c9bbfa45a" xlink:to="loc_srt_EquityMethodInvesteeNameDomain_cd0836a8-f8b7-4b16-a82f-f46c9bbfa45a_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_EquityMethodInvesteeNameDomain_213364c0-1d8e-4427-8772-d083eae888c1" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_EquityMethodInvesteeNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis_cd0836a8-f8b7-4b16-a82f-f46c9bbfa45a" xlink:to="loc_srt_EquityMethodInvesteeNameDomain_213364c0-1d8e-4427-8772-d083eae888c1" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_cron_CronosAustraliaLimitedMember_a12e958c-4c57-4a0f-9176-b084f8d8ee7d" xlink:href="cron-20210630.xsd#cron_CronosAustraliaLimitedMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_EquityMethodInvesteeNameDomain_213364c0-1d8e-4427-8772-d083eae888c1" xlink:to="loc_cron_CronosAustraliaLimitedMember_a12e958c-4c57-4a0f-9176-b084f8d8ee7d" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RestatementAxis_8b62f686-1713-4bb0-ba25-71cd7067cfce" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_RestatementAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfEquityMethodInvestmentsTable_047db9f7-670b-4a6f-bc35-fd990d37b9cb" xlink:to="loc_srt_RestatementAxis_8b62f686-1713-4bb0-ba25-71cd7067cfce" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RestatementDomain_8b62f686-1713-4bb0-ba25-71cd7067cfce_default" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_RestatementDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_RestatementAxis_8b62f686-1713-4bb0-ba25-71cd7067cfce" xlink:to="loc_srt_RestatementDomain_8b62f686-1713-4bb0-ba25-71cd7067cfce_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RestatementDomain_3b26e92c-941d-4b97-adcd-e01642f4bc39" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_RestatementDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_RestatementAxis_8b62f686-1713-4bb0-ba25-71cd7067cfce" xlink:to="loc_srt_RestatementDomain_3b26e92c-941d-4b97-adcd-e01642f4bc39" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RevisionOfPriorPeriodErrorCorrectionAdjustmentMember_efef96f4-559f-4373-8abf-c37e1b88d302" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_RevisionOfPriorPeriodErrorCorrectionAdjustmentMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_RestatementDomain_3b26e92c-941d-4b97-adcd-e01642f4bc39" xlink:to="loc_srt_RevisionOfPriorPeriodErrorCorrectionAdjustmentMember_efef96f4-559f-4373-8abf-c37e1b88d302" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ErrorCorrectionsAndPriorPeriodAdjustmentsRestatementByRestatementPeriodAndAmountAxis_58095d2f-fe88-4d7a-aa0d-53f5a0af6dd8" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ErrorCorrectionsAndPriorPeriodAdjustmentsRestatementByRestatementPeriodAndAmountAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfEquityMethodInvestmentsTable_047db9f7-670b-4a6f-bc35-fd990d37b9cb" xlink:to="loc_us-gaap_ErrorCorrectionsAndPriorPeriodAdjustmentsRestatementByRestatementPeriodAndAmountAxis_58095d2f-fe88-4d7a-aa0d-53f5a0af6dd8" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdjustmentsForErrorCorrectionDomain_58095d2f-fe88-4d7a-aa0d-53f5a0af6dd8_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AdjustmentsForErrorCorrectionDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_ErrorCorrectionsAndPriorPeriodAdjustmentsRestatementByRestatementPeriodAndAmountAxis_58095d2f-fe88-4d7a-aa0d-53f5a0af6dd8" xlink:to="loc_us-gaap_AdjustmentsForErrorCorrectionDomain_58095d2f-fe88-4d7a-aa0d-53f5a0af6dd8_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdjustmentsForErrorCorrectionDomain_71369c4f-9384-4240-ae03-62c8ba0d9a60" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AdjustmentsForErrorCorrectionDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_ErrorCorrectionsAndPriorPeriodAdjustmentsRestatementByRestatementPeriodAndAmountAxis_58095d2f-fe88-4d7a-aa0d-53f5a0af6dd8" xlink:to="loc_us-gaap_AdjustmentsForErrorCorrectionDomain_71369c4f-9384-4240-ae03-62c8ba0d9a60" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_cron_ErrorRelatedToWithholdingTaxesOnTheNetExerciseOfStockOptionsMember_2b4957f6-b1e8-4899-afb5-ff746b5dfdda" xlink:href="cron-20210630.xsd#cron_ErrorRelatedToWithholdingTaxesOnTheNetExerciseOfStockOptionsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AdjustmentsForErrorCorrectionDomain_71369c4f-9384-4240-ae03-62c8ba0d9a60" xlink:to="loc_cron_ErrorRelatedToWithholdingTaxesOnTheNetExerciseOfStockOptionsMember_2b4957f6-b1e8-4899-afb5-ff746b5dfdda" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_cron_ErrorRelatedToExerciseOfTopUpRightsMember_b971f0f9-959c-4c0b-b369-8557c9771006" xlink:href="cron-20210630.xsd#cron_ErrorRelatedToExerciseOfTopUpRightsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AdjustmentsForErrorCorrectionDomain_71369c4f-9384-4240-ae03-62c8ba0d9a60" xlink:to="loc_cron_ErrorRelatedToExerciseOfTopUpRightsMember_b971f0f9-959c-4c0b-b369-8557c9771006" xlink:type="arc" order="1"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://thecronosgroup.com/role/InvestmentsNarrativeDetails" xlink:type="simple" xlink:href="cron-20210630.xsd#InvestmentsNarrativeDetails"/>
  <link:definitionLink xlink:role="http://thecronosgroup.com/role/InvestmentsNarrativeDetails" xlink:type="extended" id="i78a8b4a795674aa3b1e9c56a4e7aee90_InvestmentsNarrativeDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_VariableInterestEntityLineItems_99fbc284-05e1-441c-82c0-e1a90f6cf59c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_VariableInterestEntityLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_VariableInterestEntityOwnershipPercentage_fde984ce-f25b-4160-9e2e-d73baa4a96af" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_VariableInterestEntityOwnershipPercentage"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_VariableInterestEntityLineItems_99fbc284-05e1-441c-82c0-e1a90f6cf59c" xlink:to="loc_us-gaap_VariableInterestEntityOwnershipPercentage_fde984ce-f25b-4160-9e2e-d73baa4a96af" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_cron_VariableInterestEntityQualitativeOrQuantitativeInformationLicenseTerm_91783141-ed93-4cd6-bdc0-6278e26f05bb" xlink:href="cron-20210630.xsd#cron_VariableInterestEntityQualitativeOrQuantitativeInformationLicenseTerm"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_VariableInterestEntityLineItems_99fbc284-05e1-441c-82c0-e1a90f6cf59c" xlink:to="loc_cron_VariableInterestEntityQualitativeOrQuantitativeInformationLicenseTerm_91783141-ed93-4cd6-bdc0-6278e26f05bb" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_cron_CollaborativeArrangementAmountOfAdvances_611dc02d-3041-4814-8b5f-ded31b6c7511" xlink:href="cron-20210630.xsd#cron_CollaborativeArrangementAmountOfAdvances"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_VariableInterestEntityLineItems_99fbc284-05e1-441c-82c0-e1a90f6cf59c" xlink:to="loc_cron_CollaborativeArrangementAmountOfAdvances_611dc02d-3041-4814-8b5f-ded31b6c7511" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_cron_CollaborativeArrangementTermOfAgreement_d7233e45-824f-4056-8a1d-4f5eda7d087b" xlink:href="cron-20210630.xsd#cron_CollaborativeArrangementTermOfAgreement"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_VariableInterestEntityLineItems_99fbc284-05e1-441c-82c0-e1a90f6cf59c" xlink:to="loc_cron_CollaborativeArrangementTermOfAgreement_d7233e45-824f-4056-8a1d-4f5eda7d087b" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentInterestRateStatedPercentage_4960ef81-0347-41d2-9143-6b39d1d8202b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentInterestRateStatedPercentage"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_VariableInterestEntityLineItems_99fbc284-05e1-441c-82c0-e1a90f6cf59c" xlink:to="loc_us-gaap_DebtInstrumentInterestRateStatedPercentage_4960ef81-0347-41d2-9143-6b39d1d8202b" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_cron_CollaborativeArrangementPercentageOfProfitsToBeReceived_6a49b1f2-4318-42c6-a459-dff2eb50fb46" xlink:href="cron-20210630.xsd#cron_CollaborativeArrangementPercentageOfProfitsToBeReceived"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_VariableInterestEntityLineItems_99fbc284-05e1-441c-82c0-e1a90f6cf59c" xlink:to="loc_cron_CollaborativeArrangementPercentageOfProfitsToBeReceived_6a49b1f2-4318-42c6-a459-dff2eb50fb46" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_cron_CollaborativeArrangementProfitsToBeReceivedMaximumPercentageOfAmountsAdvanced_a2945776-41f8-44ad-be17-9738ab90a7c5" xlink:href="cron-20210630.xsd#cron_CollaborativeArrangementProfitsToBeReceivedMaximumPercentageOfAmountsAdvanced"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_VariableInterestEntityLineItems_99fbc284-05e1-441c-82c0-e1a90f6cf59c" xlink:to="loc_cron_CollaborativeArrangementProfitsToBeReceivedMaximumPercentageOfAmountsAdvanced_a2945776-41f8-44ad-be17-9738ab90a7c5" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_cron_CollaborativeArrangementPercentageOfProfitsToBeReceivedTriggeringEventSubsequentToMaximumPercentageOfAmountsAdvancedBeingMet_1d5066d1-ea19-43ca-b7bb-93ce1f1e949b" xlink:href="cron-20210630.xsd#cron_CollaborativeArrangementPercentageOfProfitsToBeReceivedTriggeringEventSubsequentToMaximumPercentageOfAmountsAdvancedBeingMet"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_VariableInterestEntityLineItems_99fbc284-05e1-441c-82c0-e1a90f6cf59c" xlink:to="loc_cron_CollaborativeArrangementPercentageOfProfitsToBeReceivedTriggeringEventSubsequentToMaximumPercentageOfAmountsAdvancedBeingMet_1d5066d1-ea19-43ca-b7bb-93ce1f1e949b" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SaleOfStockNumberOfSharesIssuedInTransaction_645823cc-d079-4fe3-97ef-17c6d4976958" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SaleOfStockNumberOfSharesIssuedInTransaction"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_VariableInterestEntityLineItems_99fbc284-05e1-441c-82c0-e1a90f6cf59c" xlink:to="loc_us-gaap_SaleOfStockNumberOfSharesIssuedInTransaction_645823cc-d079-4fe3-97ef-17c6d4976958" xlink:type="arc" order="8"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SaleOfStockPricePerShare_a4f050cc-11d9-467f-b207-52d4c6a44a00" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SaleOfStockPricePerShare"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_VariableInterestEntityLineItems_99fbc284-05e1-441c-82c0-e1a90f6cf59c" xlink:to="loc_us-gaap_SaleOfStockPricePerShare_a4f050cc-11d9-467f-b207-52d4c6a44a00" xlink:type="arc" order="9"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SaleOfStockPercentageOfOwnershipAfterTransaction_1831f56a-5102-4728-aa09-c01ad151c603" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SaleOfStockPercentageOfOwnershipAfterTransaction"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_VariableInterestEntityLineItems_99fbc284-05e1-441c-82c0-e1a90f6cf59c" xlink:to="loc_us-gaap_SaleOfStockPercentageOfOwnershipAfterTransaction_1831f56a-5102-4728-aa09-c01ad151c603" xlink:type="arc" order="10"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquireOtherInvestments_02a77302-c1ea-4ec3-b61b-00139c4497da" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PaymentsToAcquireOtherInvestments"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_VariableInterestEntityLineItems_99fbc284-05e1-441c-82c0-e1a90f6cf59c" xlink:to="loc_us-gaap_PaymentsToAcquireOtherInvestments_02a77302-c1ea-4ec3-b61b-00139c4497da" xlink:type="arc" order="11"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfVariableInterestEntitiesTable_7cb95632-3c01-444c-aae5-0b2087122780" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfVariableInterestEntitiesTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_VariableInterestEntityLineItems_99fbc284-05e1-441c-82c0-e1a90f6cf59c" xlink:to="loc_us-gaap_ScheduleOfVariableInterestEntitiesTable_7cb95632-3c01-444c-aae5-0b2087122780" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeAxis_33b2be55-9f8e-4205-b298-c518434fa0ac" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_RangeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfVariableInterestEntitiesTable_7cb95632-3c01-444c-aae5-0b2087122780" xlink:to="loc_srt_RangeAxis_33b2be55-9f8e-4205-b298-c518434fa0ac" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_33b2be55-9f8e-4205-b298-c518434fa0ac_default" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_RangeMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_RangeAxis_33b2be55-9f8e-4205-b298-c518434fa0ac" xlink:to="loc_srt_RangeMember_33b2be55-9f8e-4205-b298-c518434fa0ac_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_11790656-ebf8-4170-b650-cacb85eebf1e" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_RangeMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_RangeAxis_33b2be55-9f8e-4205-b298-c518434fa0ac" xlink:to="loc_srt_RangeMember_11790656-ebf8-4170-b650-cacb85eebf1e" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MinimumMember_d841083c-09fc-4d28-88a8-36fa8c11cb01" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_MinimumMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_RangeMember_11790656-ebf8-4170-b650-cacb85eebf1e" xlink:to="loc_srt_MinimumMember_d841083c-09fc-4d28-88a8-36fa8c11cb01" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis_f653f9db-2818-4279-8375-c943ee64cddd" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfVariableInterestEntitiesTable_7cb95632-3c01-444c-aae5-0b2087122780" xlink:to="loc_srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis_f653f9db-2818-4279-8375-c943ee64cddd" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_EquityMethodInvesteeNameDomain_f653f9db-2818-4279-8375-c943ee64cddd_default" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_EquityMethodInvesteeNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis_f653f9db-2818-4279-8375-c943ee64cddd" xlink:to="loc_srt_EquityMethodInvesteeNameDomain_f653f9db-2818-4279-8375-c943ee64cddd_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_EquityMethodInvesteeNameDomain_9dcf1b15-d616-4f0e-b9ca-64bea1c221b1" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_EquityMethodInvesteeNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis_f653f9db-2818-4279-8375-c943ee64cddd" xlink:to="loc_srt_EquityMethodInvesteeNameDomain_9dcf1b15-d616-4f0e-b9ca-64bea1c221b1" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_cron_CronosGrowingCompanyInc.Member_a73f9d9c-0c7d-42a8-8715-d41f16093d4d" xlink:href="cron-20210630.xsd#cron_CronosGrowingCompanyInc.Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_EquityMethodInvesteeNameDomain_9dcf1b15-d616-4f0e-b9ca-64bea1c221b1" xlink:to="loc_cron_CronosGrowingCompanyInc.Member_a73f9d9c-0c7d-42a8-8715-d41f16093d4d" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_cron_MedMenCanadaInc.Member_de793418-10f4-466e-a1c3-e09a1e771c13" xlink:href="cron-20210630.xsd#cron_MedMenCanadaInc.Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_EquityMethodInvesteeNameDomain_9dcf1b15-d616-4f0e-b9ca-64bea1c221b1" xlink:to="loc_cron_MedMenCanadaInc.Member_de793418-10f4-466e-a1c3-e09a1e771c13" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_cron_NatueraMember_9238d758-467d-4268-b03a-202e8551c149" xlink:href="cron-20210630.xsd#cron_NatueraMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_EquityMethodInvesteeNameDomain_9dcf1b15-d616-4f0e-b9ca-64bea1c221b1" xlink:to="loc_cron_NatueraMember_9238d758-467d-4268-b03a-202e8551c149" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_cron_CannasoulAnalyticsLtdMember_a5056ec4-09b3-4d3c-bf6b-02fda9b88910" xlink:href="cron-20210630.xsd#cron_CannasoulAnalyticsLtdMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_EquityMethodInvesteeNameDomain_9dcf1b15-d616-4f0e-b9ca-64bea1c221b1" xlink:to="loc_cron_CannasoulAnalyticsLtdMember_a5056ec4-09b3-4d3c-bf6b-02fda9b88910" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TypeOfArrangementAxis_cf5d7411-cdc2-4284-a4ba-3f83616b3371" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TypeOfArrangementAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfVariableInterestEntitiesTable_7cb95632-3c01-444c-aae5-0b2087122780" xlink:to="loc_us-gaap_TypeOfArrangementAxis_cf5d7411-cdc2-4284-a4ba-3f83616b3371" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ArrangementsAndNonarrangementTransactionsMember_cf5d7411-cdc2-4284-a4ba-3f83616b3371_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ArrangementsAndNonarrangementTransactionsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_TypeOfArrangementAxis_cf5d7411-cdc2-4284-a4ba-3f83616b3371" xlink:to="loc_us-gaap_ArrangementsAndNonarrangementTransactionsMember_cf5d7411-cdc2-4284-a4ba-3f83616b3371_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ArrangementsAndNonarrangementTransactionsMember_43611e63-783a-4d67-adea-d164273dca4d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ArrangementsAndNonarrangementTransactionsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_TypeOfArrangementAxis_cf5d7411-cdc2-4284-a4ba-3f83616b3371" xlink:to="loc_us-gaap_ArrangementsAndNonarrangementTransactionsMember_43611e63-783a-4d67-adea-d164273dca4d" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CollaborativeArrangementTransactionWithPartyToCollaborativeArrangementMember_c62c051c-95c5-4663-95cd-79e60e20836e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CollaborativeArrangementTransactionWithPartyToCollaborativeArrangementMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ArrangementsAndNonarrangementTransactionsMember_43611e63-783a-4d67-adea-d164273dca4d" xlink:to="loc_us-gaap_CollaborativeArrangementTransactionWithPartyToCollaborativeArrangementMember_c62c051c-95c5-4663-95cd-79e60e20836e" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ConsolidatedEntitiesAxis_2efaa60e-8f31-45b3-aeef-226d3c9be4aa" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_ConsolidatedEntitiesAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfVariableInterestEntitiesTable_7cb95632-3c01-444c-aae5-0b2087122780" xlink:to="loc_srt_ConsolidatedEntitiesAxis_2efaa60e-8f31-45b3-aeef-226d3c9be4aa" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ConsolidatedEntitiesDomain_2efaa60e-8f31-45b3-aeef-226d3c9be4aa_default" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_ConsolidatedEntitiesDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_ConsolidatedEntitiesAxis_2efaa60e-8f31-45b3-aeef-226d3c9be4aa" xlink:to="loc_srt_ConsolidatedEntitiesDomain_2efaa60e-8f31-45b3-aeef-226d3c9be4aa_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ConsolidatedEntitiesDomain_9c2b6637-27db-461a-8d0e-a0081c86962e" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_ConsolidatedEntitiesDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_ConsolidatedEntitiesAxis_2efaa60e-8f31-45b3-aeef-226d3c9be4aa" xlink:to="loc_srt_ConsolidatedEntitiesDomain_9c2b6637-27db-461a-8d0e-a0081c86962e" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_VariableInterestEntityNotPrimaryBeneficiaryMember_c800a6ae-e118-4768-8171-99190f8fbe1a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_VariableInterestEntityNotPrimaryBeneficiaryMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_ConsolidatedEntitiesDomain_9c2b6637-27db-461a-8d0e-a0081c86962e" xlink:to="loc_us-gaap_VariableInterestEntityNotPrimaryBeneficiaryMember_c800a6ae-e118-4768-8171-99190f8fbe1a" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_cron_LoanReceivableNameAxis_0f9e5857-20f1-477b-bbfc-b895f3b0ebcc" xlink:href="cron-20210630.xsd#cron_LoanReceivableNameAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfVariableInterestEntitiesTable_7cb95632-3c01-444c-aae5-0b2087122780" xlink:to="loc_cron_LoanReceivableNameAxis_0f9e5857-20f1-477b-bbfc-b895f3b0ebcc" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_cron_LoanReceivableNameDomain_0f9e5857-20f1-477b-bbfc-b895f3b0ebcc_default" xlink:href="cron-20210630.xsd#cron_LoanReceivableNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_cron_LoanReceivableNameAxis_0f9e5857-20f1-477b-bbfc-b895f3b0ebcc" xlink:to="loc_cron_LoanReceivableNameDomain_0f9e5857-20f1-477b-bbfc-b895f3b0ebcc_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_cron_LoanReceivableNameDomain_03d20ba5-737c-4dc5-b841-5eaa4acb6290" xlink:href="cron-20210630.xsd#cron_LoanReceivableNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_cron_LoanReceivableNameAxis_0f9e5857-20f1-477b-bbfc-b895f3b0ebcc" xlink:to="loc_cron_LoanReceivableNameDomain_03d20ba5-737c-4dc5-b841-5eaa4acb6290" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_cron_CannasoulCollaborationLoanMember_d2853938-0e2b-4b2d-9bcb-678db4bab221" xlink:href="cron-20210630.xsd#cron_CannasoulCollaborationLoanMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_cron_LoanReceivableNameDomain_03d20ba5-737c-4dc5-b841-5eaa4acb6290" xlink:to="loc_cron_CannasoulCollaborationLoanMember_d2853938-0e2b-4b2d-9bcb-678db4bab221" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis_9b1bd28f-07e9-4373-81eb-133eb62ecc6a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfVariableInterestEntitiesTable_7cb95632-3c01-444c-aae5-0b2087122780" xlink:to="loc_us-gaap_AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis_9b1bd28f-07e9-4373-81eb-133eb62ecc6a" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ReceivableTypeDomain_9b1bd28f-07e9-4373-81eb-133eb62ecc6a_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ReceivableTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis_9b1bd28f-07e9-4373-81eb-133eb62ecc6a" xlink:to="loc_us-gaap_ReceivableTypeDomain_9b1bd28f-07e9-4373-81eb-133eb62ecc6a_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ReceivableTypeDomain_f3fb962a-2a03-4686-8d59-44b448861d9b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ReceivableTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis_9b1bd28f-07e9-4373-81eb-133eb62ecc6a" xlink:to="loc_us-gaap_ReceivableTypeDomain_f3fb962a-2a03-4686-8d59-44b448861d9b" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LoansReceivableMember_aaeb4a98-888d-4d02-8e2f-98e959eed915" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LoansReceivableMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ReceivableTypeDomain_f3fb962a-2a03-4686-8d59-44b448861d9b" xlink:to="loc_us-gaap_LoansReceivableMember_aaeb4a98-888d-4d02-8e2f-98e959eed915" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_LegalEntityAxis_e4fa086e-32c1-40e3-b688-f07611476e50" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_LegalEntityAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfVariableInterestEntitiesTable_7cb95632-3c01-444c-aae5-0b2087122780" xlink:to="loc_dei_LegalEntityAxis_e4fa086e-32c1-40e3-b688-f07611476e50" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityDomain_e4fa086e-32c1-40e3-b688-f07611476e50_default" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_dei_LegalEntityAxis_e4fa086e-32c1-40e3-b688-f07611476e50" xlink:to="loc_dei_EntityDomain_e4fa086e-32c1-40e3-b688-f07611476e50_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityDomain_9584dba5-c7f9-4661-a4a8-b2ca0ba42fa6" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_dei_LegalEntityAxis_e4fa086e-32c1-40e3-b688-f07611476e50" xlink:to="loc_dei_EntityDomain_9584dba5-c7f9-4661-a4a8-b2ca0ba42fa6" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_cron_PharmacannMember_071ae71f-7bea-47eb-bf1b-d27d810f8ba7" xlink:href="cron-20210630.xsd#cron_PharmacannMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_EntityDomain_9584dba5-c7f9-4661-a4a8-b2ca0ba42fa6" xlink:to="loc_cron_PharmacannMember_071ae71f-7bea-47eb-bf1b-d27d810f8ba7" xlink:type="arc" order="0"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://thecronosgroup.com/role/InvestmentsScheduleofInvestmentsinAssociatesandJointVenturesDetails" xlink:type="simple" xlink:href="cron-20210630.xsd#InvestmentsScheduleofInvestmentsinAssociatesandJointVenturesDetails"/>
  <link:definitionLink xlink:role="http://thecronosgroup.com/role/InvestmentsScheduleofInvestmentsinAssociatesandJointVenturesDetails" xlink:type="extended" id="i143671191f8845bbb0f1e3bdce585156_InvestmentsScheduleofInvestmentsinAssociatesandJointVenturesDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfEquityMethodInvestmentsLineItems_e731813f-d294-41d9-9b06-4dd179da296a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfEquityMethodInvestmentsLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityMethodInvestmentOwnershipPercentage_425f0ae1-115c-4912-b688-5fe3bf05b9f2" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EquityMethodInvestmentOwnershipPercentage"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ScheduleOfEquityMethodInvestmentsLineItems_e731813f-d294-41d9-9b06-4dd179da296a" xlink:to="loc_us-gaap_EquityMethodInvestmentOwnershipPercentage_425f0ae1-115c-4912-b688-5fe3bf05b9f2" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityMethodInvestments_fa70e822-397c-48b7-91dd-1813c9426286" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EquityMethodInvestments"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ScheduleOfEquityMethodInvestmentsLineItems_e731813f-d294-41d9-9b06-4dd179da296a" xlink:to="loc_us-gaap_EquityMethodInvestments_fa70e822-397c-48b7-91dd-1813c9426286" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_cron_InvestmentsInAndAdvancesToAffiliatesAtFairValueAdvancesRepayments_75f456b8-d75d-4fc2-8413-644bb570ba37" xlink:href="cron-20210630.xsd#cron_InvestmentsInAndAdvancesToAffiliatesAtFairValueAdvancesRepayments"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ScheduleOfEquityMethodInvestmentsLineItems_e731813f-d294-41d9-9b06-4dd179da296a" xlink:to="loc_cron_InvestmentsInAndAdvancesToAffiliatesAtFairValueAdvancesRepayments_75f456b8-d75d-4fc2-8413-644bb570ba37" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_cron_InvestmentsInAndAdvancesToAffiliatesFundingCommitmentPercentage_81f5e8c8-9634-4394-a05f-f9d79b2ff115" xlink:href="cron-20210630.xsd#cron_InvestmentsInAndAdvancesToAffiliatesFundingCommitmentPercentage"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ScheduleOfEquityMethodInvestmentsLineItems_e731813f-d294-41d9-9b06-4dd179da296a" xlink:to="loc_cron_InvestmentsInAndAdvancesToAffiliatesFundingCommitmentPercentage_81f5e8c8-9634-4394-a05f-f9d79b2ff115" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NotesReceivableNet_3ded0467-ac0a-4cf5-aa1a-37204856e6c2" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NotesReceivableNet"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ScheduleOfEquityMethodInvestmentsLineItems_e731813f-d294-41d9-9b06-4dd179da296a" xlink:to="loc_us-gaap_NotesReceivableNet_3ded0467-ac0a-4cf5-aa1a-37204856e6c2" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinancingReceivableAccruedInterestBeforeAllowanceForCreditLoss_f88bfee0-7389-4680-ae18-951bc88dc221" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FinancingReceivableAccruedInterestBeforeAllowanceForCreditLoss"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ScheduleOfEquityMethodInvestmentsLineItems_e731813f-d294-41d9-9b06-4dd179da296a" xlink:to="loc_us-gaap_FinancingReceivableAccruedInterestBeforeAllowanceForCreditLoss_f88bfee0-7389-4680-ae18-951bc88dc221" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_cron_InvestmentsInAndAdvancesToAffiliatesAtFairValueTransferToInvestmentsInEquityAccountedInvestees_ef3eef3a-4fcc-4b28-ae7e-1a2047e0feec" xlink:href="cron-20210630.xsd#cron_InvestmentsInAndAdvancesToAffiliatesAtFairValueTransferToInvestmentsInEquityAccountedInvestees"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ScheduleOfEquityMethodInvestmentsLineItems_e731813f-d294-41d9-9b06-4dd179da296a" xlink:to="loc_cron_InvestmentsInAndAdvancesToAffiliatesAtFairValueTransferToInvestmentsInEquityAccountedInvestees_ef3eef3a-4fcc-4b28-ae7e-1a2047e0feec" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromEquityMethodInvestments_2e5f3610-f3a3-42ff-bbde-a4193ae88960" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeLossFromEquityMethodInvestments"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ScheduleOfEquityMethodInvestmentsLineItems_e731813f-d294-41d9-9b06-4dd179da296a" xlink:to="loc_us-gaap_IncomeLossFromEquityMethodInvestments_2e5f3610-f3a3-42ff-bbde-a4193ae88960" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfEquityMethodInvestmentsTable_06c734fd-9c65-4aee-bde7-3665d4965832" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfEquityMethodInvestmentsTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_ScheduleOfEquityMethodInvestmentsLineItems_e731813f-d294-41d9-9b06-4dd179da296a" xlink:to="loc_us-gaap_ScheduleOfEquityMethodInvestmentsTable_06c734fd-9c65-4aee-bde7-3665d4965832" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis_64eb75f4-712e-4560-b20b-4d93e9847030" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfEquityMethodInvestmentsTable_06c734fd-9c65-4aee-bde7-3665d4965832" xlink:to="loc_srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis_64eb75f4-712e-4560-b20b-4d93e9847030" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_EquityMethodInvesteeNameDomain_64eb75f4-712e-4560-b20b-4d93e9847030_default" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_EquityMethodInvesteeNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis_64eb75f4-712e-4560-b20b-4d93e9847030" xlink:to="loc_srt_EquityMethodInvesteeNameDomain_64eb75f4-712e-4560-b20b-4d93e9847030_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_EquityMethodInvesteeNameDomain_4f5d2549-8427-4d53-b877-fc3046f32ccf" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_EquityMethodInvesteeNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis_64eb75f4-712e-4560-b20b-4d93e9847030" xlink:to="loc_srt_EquityMethodInvesteeNameDomain_4f5d2549-8427-4d53-b877-fc3046f32ccf" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_cron_CronosAustraliaLimitedMember_5df32534-7c57-4089-87e6-3f7ac214f7ac" xlink:href="cron-20210630.xsd#cron_CronosAustraliaLimitedMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_EquityMethodInvesteeNameDomain_4f5d2549-8427-4d53-b877-fc3046f32ccf" xlink:to="loc_cron_CronosAustraliaLimitedMember_5df32534-7c57-4089-87e6-3f7ac214f7ac" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_cron_CronosGrowingCompanyInc.Member_0196aa90-c0f0-495f-8efa-6b5b6b630960" xlink:href="cron-20210630.xsd#cron_CronosGrowingCompanyInc.Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_EquityMethodInvesteeNameDomain_4f5d2549-8427-4d53-b877-fc3046f32ccf" xlink:to="loc_cron_CronosGrowingCompanyInc.Member_0196aa90-c0f0-495f-8efa-6b5b6b630960" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_cron_NatueraMember_271bf106-6b9e-49de-9761-aab859a1bcd6" xlink:href="cron-20210630.xsd#cron_NatueraMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_EquityMethodInvesteeNameDomain_4f5d2549-8427-4d53-b877-fc3046f32ccf" xlink:to="loc_cron_NatueraMember_271bf106-6b9e-49de-9761-aab859a1bcd6" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_cron_LoanReceivableNameAxis_7a0f9053-6732-4486-afd6-a915cabee27b" xlink:href="cron-20210630.xsd#cron_LoanReceivableNameAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfEquityMethodInvestmentsTable_06c734fd-9c65-4aee-bde7-3665d4965832" xlink:to="loc_cron_LoanReceivableNameAxis_7a0f9053-6732-4486-afd6-a915cabee27b" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_cron_LoanReceivableNameDomain_7a0f9053-6732-4486-afd6-a915cabee27b_default" xlink:href="cron-20210630.xsd#cron_LoanReceivableNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_cron_LoanReceivableNameAxis_7a0f9053-6732-4486-afd6-a915cabee27b" xlink:to="loc_cron_LoanReceivableNameDomain_7a0f9053-6732-4486-afd6-a915cabee27b_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_cron_LoanReceivableNameDomain_6844b1c5-28b8-4cd2-93d0-5f0769496e39" xlink:href="cron-20210630.xsd#cron_LoanReceivableNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_cron_LoanReceivableNameAxis_7a0f9053-6732-4486-afd6-a915cabee27b" xlink:to="loc_cron_LoanReceivableNameDomain_6844b1c5-28b8-4cd2-93d0-5f0769496e39" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_cron_NatuEraSeriesALoanMember_0a888e3f-3259-4ec5-b86d-8f1dd30a4f46" xlink:href="cron-20210630.xsd#cron_NatuEraSeriesALoanMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_cron_LoanReceivableNameDomain_6844b1c5-28b8-4cd2-93d0-5f0769496e39" xlink:to="loc_cron_NatuEraSeriesALoanMember_0a888e3f-3259-4ec5-b86d-8f1dd30a4f46" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis_35dbe5ac-680a-41ef-8cac-f9e8faa7e5be" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfEquityMethodInvestmentsTable_06c734fd-9c65-4aee-bde7-3665d4965832" xlink:to="loc_us-gaap_AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis_35dbe5ac-680a-41ef-8cac-f9e8faa7e5be" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ReceivableTypeDomain_35dbe5ac-680a-41ef-8cac-f9e8faa7e5be_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ReceivableTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis_35dbe5ac-680a-41ef-8cac-f9e8faa7e5be" xlink:to="loc_us-gaap_ReceivableTypeDomain_35dbe5ac-680a-41ef-8cac-f9e8faa7e5be_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ReceivableTypeDomain_715d5e51-d033-418a-a3c4-072c5a4b9385" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ReceivableTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis_35dbe5ac-680a-41ef-8cac-f9e8faa7e5be" xlink:to="loc_us-gaap_ReceivableTypeDomain_715d5e51-d033-418a-a3c4-072c5a4b9385" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LoansReceivableMember_18646125-50ca-4abd-b260-56a4aff16ec4" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LoansReceivableMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ReceivableTypeDomain_715d5e51-d033-418a-a3c4-072c5a4b9385" xlink:to="loc_us-gaap_LoansReceivableMember_18646125-50ca-4abd-b260-56a4aff16ec4" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_LegalEntityAxis_997f485b-b42e-4280-aff3-d75f82056bb5" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_LegalEntityAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfEquityMethodInvestmentsTable_06c734fd-9c65-4aee-bde7-3665d4965832" xlink:to="loc_dei_LegalEntityAxis_997f485b-b42e-4280-aff3-d75f82056bb5" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityDomain_997f485b-b42e-4280-aff3-d75f82056bb5_default" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_dei_LegalEntityAxis_997f485b-b42e-4280-aff3-d75f82056bb5" xlink:to="loc_dei_EntityDomain_997f485b-b42e-4280-aff3-d75f82056bb5_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityDomain_ddc2c3b8-dd3b-4aa9-a4db-7c74dc0bc53b" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_dei_LegalEntityAxis_997f485b-b42e-4280-aff3-d75f82056bb5" xlink:to="loc_dei_EntityDomain_ddc2c3b8-dd3b-4aa9-a4db-7c74dc0bc53b" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_cron_CronosGroupInc.Member_418af3a7-9258-4a1f-aa5c-16240842bcc6" xlink:href="cron-20210630.xsd#cron_CronosGroupInc.Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_EntityDomain_ddc2c3b8-dd3b-4aa9-a4db-7c74dc0bc53b" xlink:to="loc_cron_CronosGroupInc.Member_418af3a7-9258-4a1f-aa5c-16240842bcc6" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_cron_AgroideaMember_222394e3-25cf-4711-906d-127db197cd69" xlink:href="cron-20210630.xsd#cron_AgroideaMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_EntityDomain_ddc2c3b8-dd3b-4aa9-a4db-7c74dc0bc53b" xlink:to="loc_cron_AgroideaMember_222394e3-25cf-4711-906d-127db197cd69" xlink:type="arc" order="1"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://thecronosgroup.com/role/InvestmentsScheduleofVariableInterestEntitiesDetails" xlink:type="simple" xlink:href="cron-20210630.xsd#InvestmentsScheduleofVariableInterestEntitiesDetails"/>
  <link:definitionLink xlink:role="http://thecronosgroup.com/role/InvestmentsScheduleofVariableInterestEntitiesDetails" xlink:type="extended" id="i753a42cda2e94e439ac4da095471361c_InvestmentsScheduleofVariableInterestEntitiesDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_VariableInterestEntityLineItems_12dcfc9a-2772-4559-b0b4-78b2084acea3" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_VariableInterestEntityLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_VariableInterestEntityOwnershipPercentage_a2906a13-4603-4681-849b-538818bfae04" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_VariableInterestEntityOwnershipPercentage"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_VariableInterestEntityLineItems_12dcfc9a-2772-4559-b0b4-78b2084acea3" xlink:to="loc_us-gaap_VariableInterestEntityOwnershipPercentage_a2906a13-4603-4681-849b-538818bfae04" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_VariableInterestEntityEntityMaximumLossExposureAmount_bfb58136-8e9f-4a3c-81f3-d7885927cac4" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_VariableInterestEntityEntityMaximumLossExposureAmount"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_VariableInterestEntityLineItems_12dcfc9a-2772-4559-b0b4-78b2084acea3" xlink:to="loc_us-gaap_VariableInterestEntityEntityMaximumLossExposureAmount_bfb58136-8e9f-4a3c-81f3-d7885927cac4" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfVariableInterestEntitiesTable_db3332e1-f435-4d0f-93c1-846a6e1862ef" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfVariableInterestEntitiesTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_VariableInterestEntityLineItems_12dcfc9a-2772-4559-b0b4-78b2084acea3" xlink:to="loc_us-gaap_ScheduleOfVariableInterestEntitiesTable_db3332e1-f435-4d0f-93c1-846a6e1862ef" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis_9d78d58b-aced-446f-b958-955e03e04c8f" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfVariableInterestEntitiesTable_db3332e1-f435-4d0f-93c1-846a6e1862ef" xlink:to="loc_srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis_9d78d58b-aced-446f-b958-955e03e04c8f" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_EquityMethodInvesteeNameDomain_9d78d58b-aced-446f-b958-955e03e04c8f_default" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_EquityMethodInvesteeNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis_9d78d58b-aced-446f-b958-955e03e04c8f" xlink:to="loc_srt_EquityMethodInvesteeNameDomain_9d78d58b-aced-446f-b958-955e03e04c8f_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_EquityMethodInvesteeNameDomain_ebb8e7e2-5565-4512-9f2f-88d9e904d7b2" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_EquityMethodInvesteeNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis_9d78d58b-aced-446f-b958-955e03e04c8f" xlink:to="loc_srt_EquityMethodInvesteeNameDomain_ebb8e7e2-5565-4512-9f2f-88d9e904d7b2" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_cron_CronosAustraliaLimitedMember_4fd64d43-b257-420a-8b02-a67aee6e3886" xlink:href="cron-20210630.xsd#cron_CronosAustraliaLimitedMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_EquityMethodInvesteeNameDomain_ebb8e7e2-5565-4512-9f2f-88d9e904d7b2" xlink:to="loc_cron_CronosAustraliaLimitedMember_4fd64d43-b257-420a-8b02-a67aee6e3886" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_cron_CronosGrowingCompanyInc.Member_a1710145-21a2-4d96-a15f-ca796a21712b" xlink:href="cron-20210630.xsd#cron_CronosGrowingCompanyInc.Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_EquityMethodInvesteeNameDomain_ebb8e7e2-5565-4512-9f2f-88d9e904d7b2" xlink:to="loc_cron_CronosGrowingCompanyInc.Member_a1710145-21a2-4d96-a15f-ca796a21712b" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_cron_MedMenCanadaInc.Member_9f6aac73-55a2-4227-aac1-579dd52167ca" xlink:href="cron-20210630.xsd#cron_MedMenCanadaInc.Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_EquityMethodInvesteeNameDomain_ebb8e7e2-5565-4512-9f2f-88d9e904d7b2" xlink:to="loc_cron_MedMenCanadaInc.Member_9f6aac73-55a2-4227-aac1-579dd52167ca" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_cron_NatuEraMember_6c26379e-314c-4e93-a186-6c72dfca6b76" xlink:href="cron-20210630.xsd#cron_NatuEraMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_EquityMethodInvesteeNameDomain_ebb8e7e2-5565-4512-9f2f-88d9e904d7b2" xlink:to="loc_cron_NatuEraMember_6c26379e-314c-4e93-a186-6c72dfca6b76" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ConsolidatedEntitiesAxis_5a9524ec-fd53-4ff9-abb5-0cac1cf3cf9a" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_ConsolidatedEntitiesAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfVariableInterestEntitiesTable_db3332e1-f435-4d0f-93c1-846a6e1862ef" xlink:to="loc_srt_ConsolidatedEntitiesAxis_5a9524ec-fd53-4ff9-abb5-0cac1cf3cf9a" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ConsolidatedEntitiesDomain_5a9524ec-fd53-4ff9-abb5-0cac1cf3cf9a_default" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_ConsolidatedEntitiesDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_ConsolidatedEntitiesAxis_5a9524ec-fd53-4ff9-abb5-0cac1cf3cf9a" xlink:to="loc_srt_ConsolidatedEntitiesDomain_5a9524ec-fd53-4ff9-abb5-0cac1cf3cf9a_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ConsolidatedEntitiesDomain_563f68b1-ee6b-482b-9adc-f51d0c9f65bb" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_ConsolidatedEntitiesDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_ConsolidatedEntitiesAxis_5a9524ec-fd53-4ff9-abb5-0cac1cf3cf9a" xlink:to="loc_srt_ConsolidatedEntitiesDomain_563f68b1-ee6b-482b-9adc-f51d0c9f65bb" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_VariableInterestEntityNotPrimaryBeneficiaryMember_0874f90a-5734-41c3-9446-5de564e95ddf" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_VariableInterestEntityNotPrimaryBeneficiaryMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_ConsolidatedEntitiesDomain_563f68b1-ee6b-482b-9adc-f51d0c9f65bb" xlink:to="loc_us-gaap_VariableInterestEntityNotPrimaryBeneficiaryMember_0874f90a-5734-41c3-9446-5de564e95ddf" xlink:type="arc" order="0"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://thecronosgroup.com/role/LoansReceivablenetDetails" xlink:type="simple" xlink:href="cron-20210630.xsd#LoansReceivablenetDetails"/>
  <link:definitionLink xlink:role="http://thecronosgroup.com/role/LoansReceivablenetDetails" xlink:type="extended" id="i9e4770ea3caa4182aea43c36a73fa8ca_LoansReceivablenetDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountsNotesAndLoansReceivableLineItems_2bf600d8-b0b7-4326-a480-2bb2d7f2f32a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccountsNotesAndLoansReceivableLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_cron_FinancingReceivableBeforeAccruedInterestCurrent_c6172048-3407-448b-9782-e986a4fd2e3b" xlink:href="cron-20210630.xsd#cron_FinancingReceivableBeforeAccruedInterestCurrent"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AccountsNotesAndLoansReceivableLineItems_2bf600d8-b0b7-4326-a480-2bb2d7f2f32a" xlink:to="loc_cron_FinancingReceivableBeforeAccruedInterestCurrent_c6172048-3407-448b-9782-e986a4fd2e3b" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_cron_FinancingReceivableAccruedInterestCurrent_c255a6cc-cd08-46cf-b7e5-576c52306357" xlink:href="cron-20210630.xsd#cron_FinancingReceivableAccruedInterestCurrent"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AccountsNotesAndLoansReceivableLineItems_2bf600d8-b0b7-4326-a480-2bb2d7f2f32a" xlink:to="loc_cron_FinancingReceivableAccruedInterestCurrent_c255a6cc-cd08-46cf-b7e5-576c52306357" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NotesAndLoansReceivableNetCurrent_a8829e9a-0fda-4026-800a-0f1ac8ede608" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NotesAndLoansReceivableNetCurrent"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AccountsNotesAndLoansReceivableLineItems_2bf600d8-b0b7-4326-a480-2bb2d7f2f32a" xlink:to="loc_us-gaap_NotesAndLoansReceivableNetCurrent_a8829e9a-0fda-4026-800a-0f1ac8ede608" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_cron_FinancingReceivableBeforeAccruedInterestNoncurrent_6fcd3674-a83a-49e9-a939-194beab419e1" xlink:href="cron-20210630.xsd#cron_FinancingReceivableBeforeAccruedInterestNoncurrent"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AccountsNotesAndLoansReceivableLineItems_2bf600d8-b0b7-4326-a480-2bb2d7f2f32a" xlink:to="loc_cron_FinancingReceivableBeforeAccruedInterestNoncurrent_6fcd3674-a83a-49e9-a939-194beab419e1" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_cron_FinancingReceivableAccruedInterestNoncurrent_71481045-760a-41b7-ad34-a2c983697b4d" xlink:href="cron-20210630.xsd#cron_FinancingReceivableAccruedInterestNoncurrent"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AccountsNotesAndLoansReceivableLineItems_2bf600d8-b0b7-4326-a480-2bb2d7f2f32a" xlink:to="loc_cron_FinancingReceivableAccruedInterestNoncurrent_71481045-760a-41b7-ad34-a2c983697b4d" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NotesAndLoansReceivableNetNoncurrent_4b3bf462-bb4f-4f81-86cb-cdccd1ca44cb" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NotesAndLoansReceivableNetNoncurrent"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AccountsNotesAndLoansReceivableLineItems_2bf600d8-b0b7-4326-a480-2bb2d7f2f32a" xlink:to="loc_us-gaap_NotesAndLoansReceivableNetNoncurrent_4b3bf462-bb4f-4f81-86cb-cdccd1ca44cb" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NotesReceivableNet_366bed9f-e66a-4124-acbb-8b2208869dca" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NotesReceivableNet"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AccountsNotesAndLoansReceivableLineItems_2bf600d8-b0b7-4326-a480-2bb2d7f2f32a" xlink:to="loc_us-gaap_NotesReceivableNet_366bed9f-e66a-4124-acbb-8b2208869dca" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_cron_InvestmentsInAndAdvancesToAffiliatesAtFairValueAdvancesRepayments_0246280e-ea20-4f6f-85af-ea1df9e0326b" xlink:href="cron-20210630.xsd#cron_InvestmentsInAndAdvancesToAffiliatesAtFairValueAdvancesRepayments"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AccountsNotesAndLoansReceivableLineItems_2bf600d8-b0b7-4326-a480-2bb2d7f2f32a" xlink:to="loc_cron_InvestmentsInAndAdvancesToAffiliatesAtFairValueAdvancesRepayments_0246280e-ea20-4f6f-85af-ea1df9e0326b" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_cron_InvestmentsInAndAdvancesToAffiliatesFundingCommitmentPercentage_4a2462ba-e290-42b0-b6a4-8ab0d5655d2a" xlink:href="cron-20210630.xsd#cron_InvestmentsInAndAdvancesToAffiliatesFundingCommitmentPercentage"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AccountsNotesAndLoansReceivableLineItems_2bf600d8-b0b7-4326-a480-2bb2d7f2f32a" xlink:to="loc_cron_InvestmentsInAndAdvancesToAffiliatesFundingCommitmentPercentage_4a2462ba-e290-42b0-b6a4-8ab0d5655d2a" xlink:type="arc" order="8"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinancingReceivableAccruedInterestBeforeAllowanceForCreditLoss_570a16c3-174f-49b1-a634-1b0093137a6f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FinancingReceivableAccruedInterestBeforeAllowanceForCreditLoss"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AccountsNotesAndLoansReceivableLineItems_2bf600d8-b0b7-4326-a480-2bb2d7f2f32a" xlink:to="loc_us-gaap_FinancingReceivableAccruedInterestBeforeAllowanceForCreditLoss_570a16c3-174f-49b1-a634-1b0093137a6f" xlink:type="arc" order="9"/>
    <link:loc xlink:type="locator" xlink:label="loc_cron_InvestmentsInAndAdvancesToAffiliatesAtFairValueTransferToInvestmentsInEquityAccountedInvestees_b3aa4046-250f-4a73-9a4e-015238c56577" xlink:href="cron-20210630.xsd#cron_InvestmentsInAndAdvancesToAffiliatesAtFairValueTransferToInvestmentsInEquityAccountedInvestees"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AccountsNotesAndLoansReceivableLineItems_2bf600d8-b0b7-4326-a480-2bb2d7f2f32a" xlink:to="loc_cron_InvestmentsInAndAdvancesToAffiliatesAtFairValueTransferToInvestmentsInEquityAccountedInvestees_b3aa4046-250f-4a73-9a4e-015238c56577" xlink:type="arc" order="10"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquireLoansReceivable_ef5dda8a-8763-4b74-a55a-bf1c92bbf842" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PaymentsToAcquireLoansReceivable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AccountsNotesAndLoansReceivableLineItems_2bf600d8-b0b7-4326-a480-2bb2d7f2f32a" xlink:to="loc_us-gaap_PaymentsToAcquireLoansReceivable_ef5dda8a-8763-4b74-a55a-bf1c92bbf842" xlink:type="arc" order="11"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinancingReceivableAllowanceForCreditLosses_e1254e85-bfc7-4df3-a747-b9617fef9615" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FinancingReceivableAllowanceForCreditLosses"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AccountsNotesAndLoansReceivableLineItems_2bf600d8-b0b7-4326-a480-2bb2d7f2f32a" xlink:to="loc_us-gaap_FinancingReceivableAllowanceForCreditLosses_e1254e85-bfc7-4df3-a747-b9617fef9615" xlink:type="arc" order="12"/>
    <link:loc xlink:type="locator" xlink:label="loc_cron_CollaborativeArrangementInstallmentsReceived_f47d50f6-7735-4e70-b745-f734e4a73894" xlink:href="cron-20210630.xsd#cron_CollaborativeArrangementInstallmentsReceived"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AccountsNotesAndLoansReceivableLineItems_2bf600d8-b0b7-4326-a480-2bb2d7f2f32a" xlink:to="loc_cron_CollaborativeArrangementInstallmentsReceived_f47d50f6-7735-4e70-b745-f734e4a73894" xlink:type="arc" order="13"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AllowanceForDoubtfulAccountsReceivableCurrent_180c9d50-dac5-4201-94b0-857d9c74c7a3" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AllowanceForDoubtfulAccountsReceivableCurrent"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AccountsNotesAndLoansReceivableLineItems_2bf600d8-b0b7-4326-a480-2bb2d7f2f32a" xlink:to="loc_us-gaap_AllowanceForDoubtfulAccountsReceivableCurrent_180c9d50-dac5-4201-94b0-857d9c74c7a3" xlink:type="arc" order="14"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfAccountsNotesLoansAndFinancingReceivableTable_de9bfa5f-d96e-4580-a430-ae1fa04bd001" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfAccountsNotesLoansAndFinancingReceivableTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_AccountsNotesAndLoansReceivableLineItems_2bf600d8-b0b7-4326-a480-2bb2d7f2f32a" xlink:to="loc_us-gaap_ScheduleOfAccountsNotesLoansAndFinancingReceivableTable_de9bfa5f-d96e-4580-a430-ae1fa04bd001" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_cron_LoanReceivableNameAxis_590aaa42-a6f4-46fe-b478-f919b3c2e814" xlink:href="cron-20210630.xsd#cron_LoanReceivableNameAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfAccountsNotesLoansAndFinancingReceivableTable_de9bfa5f-d96e-4580-a430-ae1fa04bd001" xlink:to="loc_cron_LoanReceivableNameAxis_590aaa42-a6f4-46fe-b478-f919b3c2e814" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_cron_LoanReceivableNameDomain_590aaa42-a6f4-46fe-b478-f919b3c2e814_default" xlink:href="cron-20210630.xsd#cron_LoanReceivableNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_cron_LoanReceivableNameAxis_590aaa42-a6f4-46fe-b478-f919b3c2e814" xlink:to="loc_cron_LoanReceivableNameDomain_590aaa42-a6f4-46fe-b478-f919b3c2e814_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_cron_LoanReceivableNameDomain_91dc20ed-572e-4ceb-b17c-e8525b08b6ba" xlink:href="cron-20210630.xsd#cron_LoanReceivableNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_cron_LoanReceivableNameAxis_590aaa42-a6f4-46fe-b478-f919b3c2e814" xlink:to="loc_cron_LoanReceivableNameDomain_91dc20ed-572e-4ceb-b17c-e8525b08b6ba" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_cron_NatuEraSeriesALoanMember_47eb661c-a412-4232-880b-002e2665d367" xlink:href="cron-20210630.xsd#cron_NatuEraSeriesALoanMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_cron_LoanReceivableNameDomain_91dc20ed-572e-4ceb-b17c-e8525b08b6ba" xlink:to="loc_cron_NatuEraSeriesALoanMember_47eb661c-a412-4232-880b-002e2665d367" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_cron_CronosGrowCoCreditFacilityMember_2301dfe6-6efc-4b0b-a5ff-18408d8a746f" xlink:href="cron-20210630.xsd#cron_CronosGrowCoCreditFacilityMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_cron_LoanReceivableNameDomain_91dc20ed-572e-4ceb-b17c-e8525b08b6ba" xlink:to="loc_cron_CronosGrowCoCreditFacilityMember_2301dfe6-6efc-4b0b-a5ff-18408d8a746f" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_cron_A2645485OntarioInc.MucciPromissoryNoteMember_05eae362-f2e1-433c-b19f-6118c56ba02f" xlink:href="cron-20210630.xsd#cron_A2645485OntarioInc.MucciPromissoryNoteMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_cron_LoanReceivableNameDomain_91dc20ed-572e-4ceb-b17c-e8525b08b6ba" xlink:to="loc_cron_A2645485OntarioInc.MucciPromissoryNoteMember_05eae362-f2e1-433c-b19f-6118c56ba02f" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_cron_CannasoulCollaborationLoanMember_70e267a0-c3b9-40da-b69f-76450e3437dc" xlink:href="cron-20210630.xsd#cron_CannasoulCollaborationLoanMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_cron_LoanReceivableNameDomain_91dc20ed-572e-4ceb-b17c-e8525b08b6ba" xlink:to="loc_cron_CannasoulCollaborationLoanMember_70e267a0-c3b9-40da-b69f-76450e3437dc" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis_cd025f1d-f43d-44fe-94c1-2412fa98eb7d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfAccountsNotesLoansAndFinancingReceivableTable_de9bfa5f-d96e-4580-a430-ae1fa04bd001" xlink:to="loc_us-gaap_AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis_cd025f1d-f43d-44fe-94c1-2412fa98eb7d" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ReceivableTypeDomain_cd025f1d-f43d-44fe-94c1-2412fa98eb7d_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ReceivableTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis_cd025f1d-f43d-44fe-94c1-2412fa98eb7d" xlink:to="loc_us-gaap_ReceivableTypeDomain_cd025f1d-f43d-44fe-94c1-2412fa98eb7d_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ReceivableTypeDomain_c6a8c082-1ce2-4d2a-ac62-2933ec5189ca" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ReceivableTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis_cd025f1d-f43d-44fe-94c1-2412fa98eb7d" xlink:to="loc_us-gaap_ReceivableTypeDomain_c6a8c082-1ce2-4d2a-ac62-2933ec5189ca" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LoansReceivableMember_907e0f53-ce25-452d-9f89-1f226693cb04" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LoansReceivableMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ReceivableTypeDomain_c6a8c082-1ce2-4d2a-ac62-2933ec5189ca" xlink:to="loc_us-gaap_LoansReceivableMember_907e0f53-ce25-452d-9f89-1f226693cb04" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TypeOfArrangementAxis_ff053703-7ea4-4529-89db-74844d70f15d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TypeOfArrangementAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfAccountsNotesLoansAndFinancingReceivableTable_de9bfa5f-d96e-4580-a430-ae1fa04bd001" xlink:to="loc_us-gaap_TypeOfArrangementAxis_ff053703-7ea4-4529-89db-74844d70f15d" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ArrangementsAndNonarrangementTransactionsMember_ff053703-7ea4-4529-89db-74844d70f15d_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ArrangementsAndNonarrangementTransactionsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_TypeOfArrangementAxis_ff053703-7ea4-4529-89db-74844d70f15d" xlink:to="loc_us-gaap_ArrangementsAndNonarrangementTransactionsMember_ff053703-7ea4-4529-89db-74844d70f15d_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ArrangementsAndNonarrangementTransactionsMember_f090fb07-cf46-49a9-a582-831cf19e5300" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ArrangementsAndNonarrangementTransactionsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_TypeOfArrangementAxis_ff053703-7ea4-4529-89db-74844d70f15d" xlink:to="loc_us-gaap_ArrangementsAndNonarrangementTransactionsMember_f090fb07-cf46-49a9-a582-831cf19e5300" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CollaborativeArrangementTransactionWithPartyToCollaborativeArrangementMember_fcc7115b-4d7f-4173-8740-cfa415d99b01" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CollaborativeArrangementTransactionWithPartyToCollaborativeArrangementMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ArrangementsAndNonarrangementTransactionsMember_f090fb07-cf46-49a9-a582-831cf19e5300" xlink:to="loc_us-gaap_CollaborativeArrangementTransactionWithPartyToCollaborativeArrangementMember_fcc7115b-4d7f-4173-8740-cfa415d99b01" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis_8855685c-3766-4634-ac61-f4606f378f42" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfAccountsNotesLoansAndFinancingReceivableTable_de9bfa5f-d96e-4580-a430-ae1fa04bd001" xlink:to="loc_srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis_8855685c-3766-4634-ac61-f4606f378f42" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_EquityMethodInvesteeNameDomain_8855685c-3766-4634-ac61-f4606f378f42_default" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_EquityMethodInvesteeNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis_8855685c-3766-4634-ac61-f4606f378f42" xlink:to="loc_srt_EquityMethodInvesteeNameDomain_8855685c-3766-4634-ac61-f4606f378f42_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_EquityMethodInvesteeNameDomain_da9f8349-9416-4f22-94b9-1988a541ab79" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_EquityMethodInvesteeNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis_8855685c-3766-4634-ac61-f4606f378f42" xlink:to="loc_srt_EquityMethodInvesteeNameDomain_da9f8349-9416-4f22-94b9-1988a541ab79" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_cron_CannasoulAnalyticsLtdMember_2ba1ad3f-814f-4b9d-88d1-5fa0830b9ed7" xlink:href="cron-20210630.xsd#cron_CannasoulAnalyticsLtdMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_EquityMethodInvesteeNameDomain_da9f8349-9416-4f22-94b9-1988a541ab79" xlink:to="loc_cron_CannasoulAnalyticsLtdMember_2ba1ad3f-814f-4b9d-88d1-5fa0830b9ed7" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ConsolidatedEntitiesAxis_2024eca4-dc43-47c6-97bb-8defb0ed6d3a" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_ConsolidatedEntitiesAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfAccountsNotesLoansAndFinancingReceivableTable_de9bfa5f-d96e-4580-a430-ae1fa04bd001" xlink:to="loc_srt_ConsolidatedEntitiesAxis_2024eca4-dc43-47c6-97bb-8defb0ed6d3a" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ConsolidatedEntitiesDomain_2024eca4-dc43-47c6-97bb-8defb0ed6d3a_default" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_ConsolidatedEntitiesDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_ConsolidatedEntitiesAxis_2024eca4-dc43-47c6-97bb-8defb0ed6d3a" xlink:to="loc_srt_ConsolidatedEntitiesDomain_2024eca4-dc43-47c6-97bb-8defb0ed6d3a_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ConsolidatedEntitiesDomain_129e59cf-37f1-4ca8-b13e-676370d57af8" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_ConsolidatedEntitiesDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_ConsolidatedEntitiesAxis_2024eca4-dc43-47c6-97bb-8defb0ed6d3a" xlink:to="loc_srt_ConsolidatedEntitiesDomain_129e59cf-37f1-4ca8-b13e-676370d57af8" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_VariableInterestEntityNotPrimaryBeneficiaryMember_fca26e75-1d50-41c1-a259-8564868fa3ff" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_VariableInterestEntityNotPrimaryBeneficiaryMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_ConsolidatedEntitiesDomain_129e59cf-37f1-4ca8-b13e-676370d57af8" xlink:to="loc_us-gaap_VariableInterestEntityNotPrimaryBeneficiaryMember_fca26e75-1d50-41c1-a259-8564868fa3ff" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_LegalEntityAxis_3de5c64d-a264-40fb-b86f-a4f36cf80bca" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_LegalEntityAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfAccountsNotesLoansAndFinancingReceivableTable_de9bfa5f-d96e-4580-a430-ae1fa04bd001" xlink:to="loc_dei_LegalEntityAxis_3de5c64d-a264-40fb-b86f-a4f36cf80bca" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityDomain_3de5c64d-a264-40fb-b86f-a4f36cf80bca_default" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_dei_LegalEntityAxis_3de5c64d-a264-40fb-b86f-a4f36cf80bca" xlink:to="loc_dei_EntityDomain_3de5c64d-a264-40fb-b86f-a4f36cf80bca_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityDomain_528429da-5d79-4c90-9fd8-49d836ada7b2" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_dei_LegalEntityAxis_3de5c64d-a264-40fb-b86f-a4f36cf80bca" xlink:to="loc_dei_EntityDomain_528429da-5d79-4c90-9fd8-49d836ada7b2" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_cron_CronosGroupInc.Member_4564928e-6449-4aea-a373-46700f987acc" xlink:href="cron-20210630.xsd#cron_CronosGroupInc.Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_EntityDomain_528429da-5d79-4c90-9fd8-49d836ada7b2" xlink:to="loc_cron_CronosGroupInc.Member_4564928e-6449-4aea-a373-46700f987acc" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_cron_AgroideaMember_3eb64f9b-2e93-48ae-971e-2485aab03c0c" xlink:href="cron-20210630.xsd#cron_AgroideaMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_EntityDomain_528429da-5d79-4c90-9fd8-49d836ada7b2" xlink:to="loc_cron_AgroideaMember_3eb64f9b-2e93-48ae-971e-2485aab03c0c" xlink:type="arc" order="1"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://thecronosgroup.com/role/DerivativeLiabilitiesNarrativeDetails" xlink:type="simple" xlink:href="cron-20210630.xsd#DerivativeLiabilitiesNarrativeDetails"/>
  <link:definitionLink xlink:role="http://thecronosgroup.com/role/DerivativeLiabilitiesNarrativeDetails" xlink:type="extended" id="ib17cfe9a8e294bb3b7d9b0e9bef47b66_DerivativeLiabilitiesNarrativeDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeLineItems_26768879-7456-48cf-88f4-a847197023c9" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DerivativeLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodSharesNewIssues_c0be0412-ca4c-40de-b39a-468fa58ce048" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockIssuedDuringPeriodSharesNewIssues"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativeLineItems_26768879-7456-48cf-88f4-a847197023c9" xlink:to="loc_us-gaap_StockIssuedDuringPeriodSharesNewIssues_c0be0412-ca4c-40de-b39a-468fa58ce048" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_cron_ClassOfWarrantOrRightNumberOfWarrantsIssued_9f91fb3a-218f-494f-94ad-c24e46f2de06" xlink:href="cron-20210630.xsd#cron_ClassOfWarrantOrRightNumberOfWarrantsIssued"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativeLineItems_26768879-7456-48cf-88f4-a847197023c9" xlink:to="loc_cron_ClassOfWarrantOrRightNumberOfWarrantsIssued_9f91fb3a-218f-494f-94ad-c24e46f2de06" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityMethodInvestmentOwnershipPercentage_b4697707-e61e-43b6-af07-1aa4ffb41412" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EquityMethodInvestmentOwnershipPercentage"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativeLineItems_26768879-7456-48cf-88f4-a847197023c9" xlink:to="loc_us-gaap_EquityMethodInvestmentOwnershipPercentage_b4697707-e61e-43b6-af07-1aa4ffb41412" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_cron_SubsidiaryOrEquityMethodInvesteeCumulativePercentageOwnershipAfterAllTransactionsIfWarrantsExercised_eb976670-77d7-4ca1-827b-89f98eadbbf1" xlink:href="cron-20210630.xsd#cron_SubsidiaryOrEquityMethodInvesteeCumulativePercentageOwnershipAfterAllTransactionsIfWarrantsExercised"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativeLineItems_26768879-7456-48cf-88f4-a847197023c9" xlink:to="loc_cron_SubsidiaryOrEquityMethodInvesteeCumulativePercentageOwnershipAfterAllTransactionsIfWarrantsExercised_eb976670-77d7-4ca1-827b-89f98eadbbf1" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_cron_ClassOfWarrantOrRightMaximumAdditionalSubscriptionPercentage_b6bb788b-c8bd-47ef-8706-f351e43fb8d2" xlink:href="cron-20210630.xsd#cron_ClassOfWarrantOrRightMaximumAdditionalSubscriptionPercentage"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativeLineItems_26768879-7456-48cf-88f4-a847197023c9" xlink:to="loc_cron_ClassOfWarrantOrRightMaximumAdditionalSubscriptionPercentage_b6bb788b-c8bd-47ef-8706-f351e43fb8d2" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_cron_ClassOfWarrantOrRightAdditionalSubscriptionNumberOfSecuritiesCalledByWarrantsOrRights_17043709-d88f-4717-9cda-5a7d7314d42b" xlink:href="cron-20210630.xsd#cron_ClassOfWarrantOrRightAdditionalSubscriptionNumberOfSecuritiesCalledByWarrantsOrRights"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativeLineItems_26768879-7456-48cf-88f4-a847197023c9" xlink:to="loc_cron_ClassOfWarrantOrRightAdditionalSubscriptionNumberOfSecuritiesCalledByWarrantsOrRights_17043709-d88f-4717-9cda-5a7d7314d42b" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_3bfd3c45-4bbd-4673-964d-17f9be5ca6f9" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativeLineItems_26768879-7456-48cf-88f4-a847197023c9" xlink:to="loc_us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_3bfd3c45-4bbd-4673-964d-17f9be5ca6f9" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_cron_ClassOfWarrantOrRightMinimumOwnershipPercentageRequired_11ed9d95-0716-4880-be4b-488ccf6e09a6" xlink:href="cron-20210630.xsd#cron_ClassOfWarrantOrRightMinimumOwnershipPercentageRequired"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativeLineItems_26768879-7456-48cf-88f4-a847197023c9" xlink:to="loc_cron_ClassOfWarrantOrRightMinimumOwnershipPercentageRequired_11ed9d95-0716-4880-be4b-488ccf6e09a6" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_cron_ClassOfWarrantOrRightExercisePriceVolumeWeightedAveragePriceMeasurementPeriod_e6069092-0a75-4d52-9109-9421427acb08" xlink:href="cron-20210630.xsd#cron_ClassOfWarrantOrRightExercisePriceVolumeWeightedAveragePriceMeasurementPeriod"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativeLineItems_26768879-7456-48cf-88f4-a847197023c9" xlink:to="loc_cron_ClassOfWarrantOrRightExercisePriceVolumeWeightedAveragePriceMeasurementPeriod_e6069092-0a75-4d52-9109-9421427acb08" xlink:type="arc" order="8"/>
    <link:loc xlink:type="locator" xlink:label="loc_cron_ClassOfWarrantOrRightExercisePriceVolumeWeightedAveragePriceMeasurementPeriodDaysPrecedingExercise_c7f74c97-5822-4e02-bee3-dd4f94683868" xlink:href="cron-20210630.xsd#cron_ClassOfWarrantOrRightExercisePriceVolumeWeightedAveragePriceMeasurementPeriodDaysPrecedingExercise"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativeLineItems_26768879-7456-48cf-88f4-a847197023c9" xlink:to="loc_cron_ClassOfWarrantOrRightExercisePriceVolumeWeightedAveragePriceMeasurementPeriodDaysPrecedingExercise_c7f74c97-5822-4e02-bee3-dd4f94683868" xlink:type="arc" order="9"/>
    <link:loc xlink:type="locator" xlink:label="loc_cron_FairValueNetDerivativeAssetLiabilityMeasuredOnRecurringBasisUnobservableInputsReconciliationOutOfPeriodAdjustment_564b6ca6-8dbb-4723-a50e-910f4f91b92e" xlink:href="cron-20210630.xsd#cron_FairValueNetDerivativeAssetLiabilityMeasuredOnRecurringBasisUnobservableInputsReconciliationOutOfPeriodAdjustment"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativeLineItems_26768879-7456-48cf-88f4-a847197023c9" xlink:to="loc_cron_FairValueNetDerivativeAssetLiabilityMeasuredOnRecurringBasisUnobservableInputsReconciliationOutOfPeriodAdjustment_564b6ca6-8dbb-4723-a50e-910f4f91b92e" xlink:type="arc" order="10"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeTable_356bd26e-0408-4638-bb6f-7ae2e96cb0de" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DerivativeTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_DerivativeLineItems_26768879-7456-48cf-88f4-a847197023c9" xlink:to="loc_us-gaap_DerivativeTable_356bd26e-0408-4638-bb6f-7ae2e96cb0de" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfWarrantOrRightAxis_a88423dc-e7ca-4de8-858c-696076631168" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ClassOfWarrantOrRightAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DerivativeTable_356bd26e-0408-4638-bb6f-7ae2e96cb0de" xlink:to="loc_us-gaap_ClassOfWarrantOrRightAxis_a88423dc-e7ca-4de8-858c-696076631168" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfWarrantOrRightDomain_a88423dc-e7ca-4de8-858c-696076631168_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ClassOfWarrantOrRightDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_ClassOfWarrantOrRightAxis_a88423dc-e7ca-4de8-858c-696076631168" xlink:to="loc_us-gaap_ClassOfWarrantOrRightDomain_a88423dc-e7ca-4de8-858c-696076631168_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfWarrantOrRightDomain_998620b5-c488-4b60-991a-4feda4fc87ee" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ClassOfWarrantOrRightDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_ClassOfWarrantOrRightAxis_a88423dc-e7ca-4de8-858c-696076631168" xlink:to="loc_us-gaap_ClassOfWarrantOrRightDomain_998620b5-c488-4b60-991a-4feda4fc87ee" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_cron_AltriaInvestmentMember_65c4528a-6031-448d-812e-3b70d69af20e" xlink:href="cron-20210630.xsd#cron_AltriaInvestmentMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ClassOfWarrantOrRightDomain_998620b5-c488-4b60-991a-4feda4fc87ee" xlink:to="loc_cron_AltriaInvestmentMember_65c4528a-6031-448d-812e-3b70d69af20e" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_cron_AltriaWarrantMember_a5abd400-f963-4703-9c5d-00290c89afbb" xlink:href="cron-20210630.xsd#cron_AltriaWarrantMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ClassOfWarrantOrRightDomain_998620b5-c488-4b60-991a-4feda4fc87ee" xlink:to="loc_cron_AltriaWarrantMember_a5abd400-f963-4703-9c5d-00290c89afbb" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_cron_PreemptiveRightsMember_3ec26e4a-7f61-4af1-add2-b8f0c7ce0a62" xlink:href="cron-20210630.xsd#cron_PreemptiveRightsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ClassOfWarrantOrRightDomain_998620b5-c488-4b60-991a-4feda4fc87ee" xlink:to="loc_cron_PreemptiveRightsMember_3ec26e4a-7f61-4af1-add2-b8f0c7ce0a62" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_cron_TopupRightsMember_f70d0424-4e9f-432b-b9f0-2607aadd8534" xlink:href="cron-20210630.xsd#cron_TopupRightsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ClassOfWarrantOrRightDomain_998620b5-c488-4b60-991a-4feda4fc87ee" xlink:to="loc_cron_TopupRightsMember_f70d0424-4e9f-432b-b9f0-2607aadd8534" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ConsolidatedEntitiesAxis_4323acdf-5922-407e-bccc-ae74074b6d94" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_ConsolidatedEntitiesAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DerivativeTable_356bd26e-0408-4638-bb6f-7ae2e96cb0de" xlink:to="loc_srt_ConsolidatedEntitiesAxis_4323acdf-5922-407e-bccc-ae74074b6d94" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ConsolidatedEntitiesDomain_4323acdf-5922-407e-bccc-ae74074b6d94_default" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_ConsolidatedEntitiesDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_ConsolidatedEntitiesAxis_4323acdf-5922-407e-bccc-ae74074b6d94" xlink:to="loc_srt_ConsolidatedEntitiesDomain_4323acdf-5922-407e-bccc-ae74074b6d94_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ConsolidatedEntitiesDomain_451681ab-d685-4e57-b635-8e13754814fc" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_ConsolidatedEntitiesDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_ConsolidatedEntitiesAxis_4323acdf-5922-407e-bccc-ae74074b6d94" xlink:to="loc_srt_ConsolidatedEntitiesDomain_451681ab-d685-4e57-b635-8e13754814fc" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_SubsidiariesMember_41df86af-b25a-4f57-87fe-4dafa2b31cf6" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_SubsidiariesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_ConsolidatedEntitiesDomain_451681ab-d685-4e57-b635-8e13754814fc" xlink:to="loc_srt_SubsidiariesMember_41df86af-b25a-4f57-87fe-4dafa2b31cf6" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsidiarySaleOfStockAxis_f107d0f0-c313-4e4b-bd38-862b74fd3fdf" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SubsidiarySaleOfStockAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DerivativeTable_356bd26e-0408-4638-bb6f-7ae2e96cb0de" xlink:to="loc_us-gaap_SubsidiarySaleOfStockAxis_f107d0f0-c313-4e4b-bd38-862b74fd3fdf" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SaleOfStockNameOfTransactionDomain_f107d0f0-c313-4e4b-bd38-862b74fd3fdf_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SaleOfStockNameOfTransactionDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_SubsidiarySaleOfStockAxis_f107d0f0-c313-4e4b-bd38-862b74fd3fdf" xlink:to="loc_us-gaap_SaleOfStockNameOfTransactionDomain_f107d0f0-c313-4e4b-bd38-862b74fd3fdf_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SaleOfStockNameOfTransactionDomain_a79e3fb4-2770-4790-9e8b-967f98672bfb" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SaleOfStockNameOfTransactionDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_SubsidiarySaleOfStockAxis_f107d0f0-c313-4e4b-bd38-862b74fd3fdf" xlink:to="loc_us-gaap_SaleOfStockNameOfTransactionDomain_a79e3fb4-2770-4790-9e8b-967f98672bfb" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_cron_AltriaInvestmentMember_64daa54b-d520-4e1a-a466-3aeb99c82d69" xlink:href="cron-20210630.xsd#cron_AltriaInvestmentMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SaleOfStockNameOfTransactionDomain_a79e3fb4-2770-4790-9e8b-967f98672bfb" xlink:to="loc_cron_AltriaInvestmentMember_64daa54b-d520-4e1a-a466-3aeb99c82d69" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_LegalEntityAxis_54511b50-3539-4366-aba3-e51ebd75c007" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_LegalEntityAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DerivativeTable_356bd26e-0408-4638-bb6f-7ae2e96cb0de" xlink:to="loc_dei_LegalEntityAxis_54511b50-3539-4366-aba3-e51ebd75c007" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityDomain_54511b50-3539-4366-aba3-e51ebd75c007_default" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_dei_LegalEntityAxis_54511b50-3539-4366-aba3-e51ebd75c007" xlink:to="loc_dei_EntityDomain_54511b50-3539-4366-aba3-e51ebd75c007_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityDomain_eabc4c15-fb3c-4ea2-86f2-6c1f139d0535" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_dei_LegalEntityAxis_54511b50-3539-4366-aba3-e51ebd75c007" xlink:to="loc_dei_EntityDomain_eabc4c15-fb3c-4ea2-86f2-6c1f139d0535" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_cron_AltriaGroupInc.Member_07d3c09b-1301-4957-888e-7774b48e24c1" xlink:href="cron-20210630.xsd#cron_AltriaGroupInc.Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_EntityDomain_eabc4c15-fb3c-4ea2-86f2-6c1f139d0535" xlink:to="loc_cron_AltriaGroupInc.Member_07d3c09b-1301-4957-888e-7774b48e24c1" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis_4be13726-b9f2-4f9e-825f-512fcfc81d2c" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DerivativeTable_356bd26e-0408-4638-bb6f-7ae2e96cb0de" xlink:to="loc_srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis_4be13726-b9f2-4f9e-825f-512fcfc81d2c" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_EquityMethodInvesteeNameDomain_4be13726-b9f2-4f9e-825f-512fcfc81d2c_default" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_EquityMethodInvesteeNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis_4be13726-b9f2-4f9e-825f-512fcfc81d2c" xlink:to="loc_srt_EquityMethodInvesteeNameDomain_4be13726-b9f2-4f9e-825f-512fcfc81d2c_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_EquityMethodInvesteeNameDomain_beaa4c84-3a45-467c-a63d-3b10ec8e43cc" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_EquityMethodInvesteeNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis_4be13726-b9f2-4f9e-825f-512fcfc81d2c" xlink:to="loc_srt_EquityMethodInvesteeNameDomain_beaa4c84-3a45-467c-a63d-3b10ec8e43cc" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_cron_CronosGroupInc.Member_da82400a-fbbf-4839-8ad9-b6492a9f1e2a" xlink:href="cron-20210630.xsd#cron_CronosGroupInc.Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_EquityMethodInvesteeNameDomain_beaa4c84-3a45-467c-a63d-3b10ec8e43cc" xlink:to="loc_cron_CronosGroupInc.Member_da82400a-fbbf-4839-8ad9-b6492a9f1e2a" xlink:type="arc" order="0"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://thecronosgroup.com/role/DerivativeLiabilitiesScheduleofReconciliationofCarryingAmountsDetails" xlink:type="simple" xlink:href="cron-20210630.xsd#DerivativeLiabilitiesScheduleofReconciliationofCarryingAmountsDetails"/>
  <link:definitionLink xlink:role="http://thecronosgroup.com/role/DerivativeLiabilitiesScheduleofReconciliationofCarryingAmountsDetails" xlink:type="extended" id="ic845e5db51f84e27850c89c56d5b6bc8_DerivativeLiabilitiesScheduleofReconciliationofCarryingAmountsDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentsGainLossLineItems_1aacac1b-30bb-4b4e-a05b-8d6b41b26ca6" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DerivativeInstrumentsGainLossLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_cron_DerivativeInstrumentsRollForward_95fa3ae6-873d-4dbd-94bd-b9606c0f0d88" xlink:href="cron-20210630.xsd#cron_DerivativeInstrumentsRollForward"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossLineItems_1aacac1b-30bb-4b4e-a05b-8d6b41b26ca6" xlink:to="loc_cron_DerivativeInstrumentsRollForward_95fa3ae6-873d-4dbd-94bd-b9606c0f0d88" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueNetDerivativeAssetLiabilityMeasuredOnRecurringBasisWithUnobservableInputs_60903f59-8208-4e5a-8f3e-0fd1342ebeb4" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueNetDerivativeAssetLiabilityMeasuredOnRecurringBasisWithUnobservableInputs"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_cron_DerivativeInstrumentsRollForward_95fa3ae6-873d-4dbd-94bd-b9606c0f0d88" xlink:to="loc_us-gaap_FairValueNetDerivativeAssetLiabilityMeasuredOnRecurringBasisWithUnobservableInputs_60903f59-8208-4e5a-8f3e-0fd1342ebeb4" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueNetDerivativeAssetLiabilityMeasuredOnRecurringBasisUnobservableInputsReconciliationGainLossIncludedInEarnings_b034a739-86e7-4ff9-a7d6-25d08ce621e0" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueNetDerivativeAssetLiabilityMeasuredOnRecurringBasisUnobservableInputsReconciliationGainLossIncludedInEarnings"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_cron_DerivativeInstrumentsRollForward_95fa3ae6-873d-4dbd-94bd-b9606c0f0d88" xlink:to="loc_us-gaap_FairValueNetDerivativeAssetLiabilityMeasuredOnRecurringBasisUnobservableInputsReconciliationGainLossIncludedInEarnings_b034a739-86e7-4ff9-a7d6-25d08ce621e0" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueNetDerivativeAssetLiabilityMeasuredOnRecurringBasisUnobservableInputsReconciliationSettlements_e45adc29-e061-44e4-8d01-64b09ba5260c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueNetDerivativeAssetLiabilityMeasuredOnRecurringBasisUnobservableInputsReconciliationSettlements"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_cron_DerivativeInstrumentsRollForward_95fa3ae6-873d-4dbd-94bd-b9606c0f0d88" xlink:to="loc_us-gaap_FairValueNetDerivativeAssetLiabilityMeasuredOnRecurringBasisUnobservableInputsReconciliationSettlements_e45adc29-e061-44e4-8d01-64b09ba5260c" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_cron_FairValueNetDerivativeAssetLiabilityMeasuredOnRecurringBasisUnobservableInputsReconciliationOutOfPeriodAdjustment_7794f598-17c1-4925-b36d-1a389ffa36c2" xlink:href="cron-20210630.xsd#cron_FairValueNetDerivativeAssetLiabilityMeasuredOnRecurringBasisUnobservableInputsReconciliationOutOfPeriodAdjustment"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_cron_DerivativeInstrumentsRollForward_95fa3ae6-873d-4dbd-94bd-b9606c0f0d88" xlink:to="loc_cron_FairValueNetDerivativeAssetLiabilityMeasuredOnRecurringBasisUnobservableInputsReconciliationOutOfPeriodAdjustment_7794f598-17c1-4925-b36d-1a389ffa36c2" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueNetDerivativeAssetLiabilityMeasuredOnRecurringBasisUnobservableInputsReconciliationGainLossIncludedInOtherComprehensiveIncomeLoss_7545f2a0-dac2-4d5d-91d1-f25e2ff67269" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueNetDerivativeAssetLiabilityMeasuredOnRecurringBasisUnobservableInputsReconciliationGainLossIncludedInOtherComprehensiveIncomeLoss"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_cron_DerivativeInstrumentsRollForward_95fa3ae6-873d-4dbd-94bd-b9606c0f0d88" xlink:to="loc_us-gaap_FairValueNetDerivativeAssetLiabilityMeasuredOnRecurringBasisUnobservableInputsReconciliationGainLossIncludedInOtherComprehensiveIncomeLoss_7545f2a0-dac2-4d5d-91d1-f25e2ff67269" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueNetDerivativeAssetLiabilityMeasuredOnRecurringBasisWithUnobservableInputs_3118af40-f45c-47d4-a6d8-3cfef07e1c20" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueNetDerivativeAssetLiabilityMeasuredOnRecurringBasisWithUnobservableInputs"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipByIncomeStatementLocationByDerivativeInstrumentRiskTable_89d73e1b-e29f-4e43-886f-8205d62199c7" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipByIncomeStatementLocationByDerivativeInstrumentRiskTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossLineItems_1aacac1b-30bb-4b4e-a05b-8d6b41b26ca6" xlink:to="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipByIncomeStatementLocationByDerivativeInstrumentRiskTable_89d73e1b-e29f-4e43-886f-8205d62199c7" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfWarrantOrRightAxis_caec1b77-aa99-4414-9c33-1e2f3505b8d9" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ClassOfWarrantOrRightAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipByIncomeStatementLocationByDerivativeInstrumentRiskTable_89d73e1b-e29f-4e43-886f-8205d62199c7" xlink:to="loc_us-gaap_ClassOfWarrantOrRightAxis_caec1b77-aa99-4414-9c33-1e2f3505b8d9" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfWarrantOrRightDomain_caec1b77-aa99-4414-9c33-1e2f3505b8d9_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ClassOfWarrantOrRightDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_ClassOfWarrantOrRightAxis_caec1b77-aa99-4414-9c33-1e2f3505b8d9" xlink:to="loc_us-gaap_ClassOfWarrantOrRightDomain_caec1b77-aa99-4414-9c33-1e2f3505b8d9_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfWarrantOrRightDomain_3cef6310-1260-49a5-bfc0-8eb9907223be" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ClassOfWarrantOrRightDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_ClassOfWarrantOrRightAxis_caec1b77-aa99-4414-9c33-1e2f3505b8d9" xlink:to="loc_us-gaap_ClassOfWarrantOrRightDomain_3cef6310-1260-49a5-bfc0-8eb9907223be" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_cron_AltriaWarrantMember_58b8e79b-e77b-4255-8fa4-8000b8a4dd33" xlink:href="cron-20210630.xsd#cron_AltriaWarrantMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ClassOfWarrantOrRightDomain_3cef6310-1260-49a5-bfc0-8eb9907223be" xlink:to="loc_cron_AltriaWarrantMember_58b8e79b-e77b-4255-8fa4-8000b8a4dd33" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_cron_PreemptiveRightsMember_0add1cd4-9d40-4efc-911c-5305c6f68646" xlink:href="cron-20210630.xsd#cron_PreemptiveRightsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ClassOfWarrantOrRightDomain_3cef6310-1260-49a5-bfc0-8eb9907223be" xlink:to="loc_cron_PreemptiveRightsMember_0add1cd4-9d40-4efc-911c-5305c6f68646" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_cron_TopupRightsMember_39d461b0-ce18-4602-8e16-f88ed2999ba5" xlink:href="cron-20210630.xsd#cron_TopupRightsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ClassOfWarrantOrRightDomain_3cef6310-1260-49a5-bfc0-8eb9907223be" xlink:to="loc_cron_TopupRightsMember_39d461b0-ce18-4602-8e16-f88ed2999ba5" xlink:type="arc" order="2"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://thecronosgroup.com/role/DerivativeLiabilitiesScheduleofFairValuesofDerivativeLiabilitiesDetails" xlink:type="simple" xlink:href="cron-20210630.xsd#DerivativeLiabilitiesScheduleofFairValuesofDerivativeLiabilitiesDetails"/>
  <link:definitionLink xlink:role="http://thecronosgroup.com/role/DerivativeLiabilitiesScheduleofFairValuesofDerivativeLiabilitiesDetails" xlink:type="extended" id="i720a15d03ddc42e391d07e7c677c78ec_DerivativeLiabilitiesScheduleofFairValuesofDerivativeLiabilitiesDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesLineItems_6a9eb2e7-a93c-40e1-8ee2-212dba6b0304" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeLiabilityMeasurementInput_0a6ea427-9fed-40c5-8f3f-12a76e234891" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DerivativeLiabilityMeasurementInput"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesLineItems_6a9eb2e7-a93c-40e1-8ee2-212dba6b0304" xlink:to="loc_us-gaap_DerivativeLiabilityMeasurementInput_0a6ea427-9fed-40c5-8f3f-12a76e234891" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_cron_DerivativeLiabilityUsefulLifeTerm_73bd4fbf-619b-4e2a-ba09-6685d1cdd479" xlink:href="cron-20210630.xsd#cron_DerivativeLiabilityUsefulLifeTerm"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesLineItems_6a9eb2e7-a93c-40e1-8ee2-212dba6b0304" xlink:to="loc_cron_DerivativeLiabilityUsefulLifeTerm_73bd4fbf-619b-4e2a-ba09-6685d1cdd479" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTable_1b52c7cb-5ab8-4a0d-ad66-b00c96e643e0" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesLineItems_6a9eb2e7-a93c-40e1-8ee2-212dba6b0304" xlink:to="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTable_1b52c7cb-5ab8-4a0d-ad66-b00c96e643e0" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfWarrantOrRightAxis_cf96efae-59fb-4ee9-bb63-21774beb1ab3" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ClassOfWarrantOrRightAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTable_1b52c7cb-5ab8-4a0d-ad66-b00c96e643e0" xlink:to="loc_us-gaap_ClassOfWarrantOrRightAxis_cf96efae-59fb-4ee9-bb63-21774beb1ab3" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfWarrantOrRightDomain_cf96efae-59fb-4ee9-bb63-21774beb1ab3_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ClassOfWarrantOrRightDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_ClassOfWarrantOrRightAxis_cf96efae-59fb-4ee9-bb63-21774beb1ab3" xlink:to="loc_us-gaap_ClassOfWarrantOrRightDomain_cf96efae-59fb-4ee9-bb63-21774beb1ab3_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfWarrantOrRightDomain_aca3f77c-9dbf-4989-a0d7-0bf6ad547264" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ClassOfWarrantOrRightDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_ClassOfWarrantOrRightAxis_cf96efae-59fb-4ee9-bb63-21774beb1ab3" xlink:to="loc_us-gaap_ClassOfWarrantOrRightDomain_aca3f77c-9dbf-4989-a0d7-0bf6ad547264" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_cron_AltriaWarrantMember_50db2b3a-842c-4c53-baa1-8b3b3ed78bb5" xlink:href="cron-20210630.xsd#cron_AltriaWarrantMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ClassOfWarrantOrRightDomain_aca3f77c-9dbf-4989-a0d7-0bf6ad547264" xlink:to="loc_cron_AltriaWarrantMember_50db2b3a-842c-4c53-baa1-8b3b3ed78bb5" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_cron_PreemptiveRightsMember_6c6b9309-b7f7-4a69-b05a-e55f01d1e2c4" xlink:href="cron-20210630.xsd#cron_PreemptiveRightsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ClassOfWarrantOrRightDomain_aca3f77c-9dbf-4989-a0d7-0bf6ad547264" xlink:to="loc_cron_PreemptiveRightsMember_6c6b9309-b7f7-4a69-b05a-e55f01d1e2c4" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_cron_TopupRightsMember_27202630-26de-4ebb-8285-8a6366e8d799" xlink:href="cron-20210630.xsd#cron_TopupRightsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ClassOfWarrantOrRightDomain_aca3f77c-9dbf-4989-a0d7-0bf6ad547264" xlink:to="loc_cron_TopupRightsMember_27202630-26de-4ebb-8285-8a6366e8d799" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_cron_PreEmptiveRightsAndTopUpRightsMember_5b765119-864e-45ad-a3f8-cee7c902f61f" xlink:href="cron-20210630.xsd#cron_PreEmptiveRightsAndTopUpRightsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ClassOfWarrantOrRightDomain_aca3f77c-9dbf-4989-a0d7-0bf6ad547264" xlink:to="loc_cron_PreEmptiveRightsAndTopUpRightsMember_5b765119-864e-45ad-a3f8-cee7c902f61f" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeAxis_0f3d725c-bb78-441a-8ec5-e7c09a861f68" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_RangeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTable_1b52c7cb-5ab8-4a0d-ad66-b00c96e643e0" xlink:to="loc_srt_RangeAxis_0f3d725c-bb78-441a-8ec5-e7c09a861f68" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_0f3d725c-bb78-441a-8ec5-e7c09a861f68_default" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_RangeMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_RangeAxis_0f3d725c-bb78-441a-8ec5-e7c09a861f68" xlink:to="loc_srt_RangeMember_0f3d725c-bb78-441a-8ec5-e7c09a861f68_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_7b0646f3-687e-40b9-a2bd-c4bcdcd96600" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_RangeMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_RangeAxis_0f3d725c-bb78-441a-8ec5-e7c09a861f68" xlink:to="loc_srt_RangeMember_7b0646f3-687e-40b9-a2bd-c4bcdcd96600" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_WeightedAverageMember_5be0cbbb-1434-4cb4-a57f-aab2b7e40a09" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_WeightedAverageMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_RangeMember_7b0646f3-687e-40b9-a2bd-c4bcdcd96600" xlink:to="loc_srt_WeightedAverageMember_5be0cbbb-1434-4cb4-a57f-aab2b7e40a09" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MinimumMember_db68e8f3-4e75-4249-9258-0d714edf2b33" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_MinimumMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_RangeMember_7b0646f3-687e-40b9-a2bd-c4bcdcd96600" xlink:to="loc_srt_MinimumMember_db68e8f3-4e75-4249-9258-0d714edf2b33" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MaximumMember_7fdc5f2b-cbd7-4bce-844e-1c2bf3d33f9a" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_MaximumMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_RangeMember_7b0646f3-687e-40b9-a2bd-c4bcdcd96600" xlink:to="loc_srt_MaximumMember_7fdc5f2b-cbd7-4bce-844e-1c2bf3d33f9a" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MeasurementInputTypeAxis_45be7957-41ae-438b-b30e-339bdc293e03" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_MeasurementInputTypeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTable_1b52c7cb-5ab8-4a0d-ad66-b00c96e643e0" xlink:to="loc_us-gaap_MeasurementInputTypeAxis_45be7957-41ae-438b-b30e-339bdc293e03" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MeasurementInputTypeDomain_45be7957-41ae-438b-b30e-339bdc293e03_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_MeasurementInputTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_MeasurementInputTypeAxis_45be7957-41ae-438b-b30e-339bdc293e03" xlink:to="loc_us-gaap_MeasurementInputTypeDomain_45be7957-41ae-438b-b30e-339bdc293e03_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MeasurementInputTypeDomain_33f6f170-eb54-4f3f-8814-79547d1251b6" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_MeasurementInputTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_MeasurementInputTypeAxis_45be7957-41ae-438b-b30e-339bdc293e03" xlink:to="loc_us-gaap_MeasurementInputTypeDomain_33f6f170-eb54-4f3f-8814-79547d1251b6" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MeasurementInputSharePriceMember_320322fc-39dc-4af9-b9ab-1c53902bd2b2" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_MeasurementInputSharePriceMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_MeasurementInputTypeDomain_33f6f170-eb54-4f3f-8814-79547d1251b6" xlink:to="loc_us-gaap_MeasurementInputSharePriceMember_320322fc-39dc-4af9-b9ab-1c53902bd2b2" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_cron_MeasurementInputSubscriptionPriceMember_cc2cdc52-8a12-463a-a89c-b8e952f62bd1" xlink:href="cron-20210630.xsd#cron_MeasurementInputSubscriptionPriceMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_MeasurementInputTypeDomain_33f6f170-eb54-4f3f-8814-79547d1251b6" xlink:to="loc_cron_MeasurementInputSubscriptionPriceMember_cc2cdc52-8a12-463a-a89c-b8e952f62bd1" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MeasurementInputRiskFreeInterestRateMember_bd481f2c-46ad-430b-8ec2-11bef837c520" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_MeasurementInputRiskFreeInterestRateMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_MeasurementInputTypeDomain_33f6f170-eb54-4f3f-8814-79547d1251b6" xlink:to="loc_us-gaap_MeasurementInputRiskFreeInterestRateMember_bd481f2c-46ad-430b-8ec2-11bef837c520" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MeasurementInputExpectedTermMember_edb6bb25-ab2b-4d65-a457-239c72b87c93" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_MeasurementInputExpectedTermMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_MeasurementInputTypeDomain_33f6f170-eb54-4f3f-8814-79547d1251b6" xlink:to="loc_us-gaap_MeasurementInputExpectedTermMember_edb6bb25-ab2b-4d65-a457-239c72b87c93" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MeasurementInputPriceVolatilityMember_3702eb03-6522-4f07-bdcc-182350b94e31" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_MeasurementInputPriceVolatilityMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_MeasurementInputTypeDomain_33f6f170-eb54-4f3f-8814-79547d1251b6" xlink:to="loc_us-gaap_MeasurementInputPriceVolatilityMember_3702eb03-6522-4f07-bdcc-182350b94e31" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MeasurementInputExpectedDividendRateMember_cf8ed1c9-5273-454f-979d-c5135e22e0b6" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_MeasurementInputExpectedDividendRateMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_MeasurementInputTypeDomain_33f6f170-eb54-4f3f-8814-79547d1251b6" xlink:to="loc_us-gaap_MeasurementInputExpectedDividendRateMember_cf8ed1c9-5273-454f-979d-c5135e22e0b6" xlink:type="arc" order="5"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://thecronosgroup.com/role/DerivativeLiabilitiesScheduleofSensitivityAnalysisDetails" xlink:type="simple" xlink:href="cron-20210630.xsd#DerivativeLiabilitiesScheduleofSensitivityAnalysisDetails"/>
  <link:definitionLink xlink:role="http://thecronosgroup.com/role/DerivativeLiabilitiesScheduleofSensitivityAnalysisDetails" xlink:type="extended" id="i998bb75d8e42492a98c1ff0e3bdcdfc8_DerivativeLiabilitiesScheduleofSensitivityAnalysisDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeLineItems_b997f3ae-3137-40c3-89f5-ede0200d2549" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DerivativeLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_cron_SensitivityAnalysisImpactOf10PercentDecreaseIncreaseOnNetIncomeLossAbstract_370cff4d-8987-486c-9196-75e7ca7bacbf" xlink:href="cron-20210630.xsd#cron_SensitivityAnalysisImpactOf10PercentDecreaseIncreaseOnNetIncomeLossAbstract"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativeLineItems_b997f3ae-3137-40c3-89f5-ede0200d2549" xlink:to="loc_cron_SensitivityAnalysisImpactOf10PercentDecreaseIncreaseOnNetIncomeLossAbstract_370cff4d-8987-486c-9196-75e7ca7bacbf" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_cron_SensitivityAnalysisImpactOf10PercentDecreaseIncreaseInSharePriceOnNetIncomeLoss_8b17820f-0600-4ce2-a1c5-94478ca0bfec" xlink:href="cron-20210630.xsd#cron_SensitivityAnalysisImpactOf10PercentDecreaseIncreaseInSharePriceOnNetIncomeLoss"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_cron_SensitivityAnalysisImpactOf10PercentDecreaseIncreaseOnNetIncomeLossAbstract_370cff4d-8987-486c-9196-75e7ca7bacbf" xlink:to="loc_cron_SensitivityAnalysisImpactOf10PercentDecreaseIncreaseInSharePriceOnNetIncomeLoss_8b17820f-0600-4ce2-a1c5-94478ca0bfec" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_cron_SensitivityAnalysisImpactOf10PercentDecreaseIncreaseInWeightedAverageExpectedLifeOnNetIncomeLoss_cea805b1-3533-47d9-9b36-e16eb9adee47" xlink:href="cron-20210630.xsd#cron_SensitivityAnalysisImpactOf10PercentDecreaseIncreaseInWeightedAverageExpectedLifeOnNetIncomeLoss"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_cron_SensitivityAnalysisImpactOf10PercentDecreaseIncreaseOnNetIncomeLossAbstract_370cff4d-8987-486c-9196-75e7ca7bacbf" xlink:to="loc_cron_SensitivityAnalysisImpactOf10PercentDecreaseIncreaseInWeightedAverageExpectedLifeOnNetIncomeLoss_cea805b1-3533-47d9-9b36-e16eb9adee47" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_cron_SensitivityAnalysisImpactOf10PercentDecreaseIncreaseInExpectedAnnualizedVolatilityOnNetIncomeLoss_d435142b-f22b-47a5-b7a9-449dbc1ea5e3" xlink:href="cron-20210630.xsd#cron_SensitivityAnalysisImpactOf10PercentDecreaseIncreaseInExpectedAnnualizedVolatilityOnNetIncomeLoss"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_cron_SensitivityAnalysisImpactOf10PercentDecreaseIncreaseOnNetIncomeLossAbstract_370cff4d-8987-486c-9196-75e7ca7bacbf" xlink:to="loc_cron_SensitivityAnalysisImpactOf10PercentDecreaseIncreaseInExpectedAnnualizedVolatilityOnNetIncomeLoss_d435142b-f22b-47a5-b7a9-449dbc1ea5e3" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeTable_978279d9-b8a4-408d-8804-b26d3ce8c04a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DerivativeTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_DerivativeLineItems_b997f3ae-3137-40c3-89f5-ede0200d2549" xlink:to="loc_us-gaap_DerivativeTable_978279d9-b8a4-408d-8804-b26d3ce8c04a" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfWarrantOrRightAxis_07666398-81af-4932-9ddd-99f8b4595f49" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ClassOfWarrantOrRightAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DerivativeTable_978279d9-b8a4-408d-8804-b26d3ce8c04a" xlink:to="loc_us-gaap_ClassOfWarrantOrRightAxis_07666398-81af-4932-9ddd-99f8b4595f49" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfWarrantOrRightDomain_07666398-81af-4932-9ddd-99f8b4595f49_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ClassOfWarrantOrRightDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_ClassOfWarrantOrRightAxis_07666398-81af-4932-9ddd-99f8b4595f49" xlink:to="loc_us-gaap_ClassOfWarrantOrRightDomain_07666398-81af-4932-9ddd-99f8b4595f49_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfWarrantOrRightDomain_fde39d62-4d4b-48a5-a162-705825975626" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ClassOfWarrantOrRightDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_ClassOfWarrantOrRightAxis_07666398-81af-4932-9ddd-99f8b4595f49" xlink:to="loc_us-gaap_ClassOfWarrantOrRightDomain_fde39d62-4d4b-48a5-a162-705825975626" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_cron_AltriaWarrantMember_d3f4aeb3-a57c-4b0f-906c-fd2a0ac1f041" xlink:href="cron-20210630.xsd#cron_AltriaWarrantMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ClassOfWarrantOrRightDomain_fde39d62-4d4b-48a5-a162-705825975626" xlink:to="loc_cron_AltriaWarrantMember_d3f4aeb3-a57c-4b0f-906c-fd2a0ac1f041" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_cron_PreemptiveRightsMember_b5d0e6c0-4c27-4bd4-bb13-9ac2ec92be47" xlink:href="cron-20210630.xsd#cron_PreemptiveRightsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ClassOfWarrantOrRightDomain_fde39d62-4d4b-48a5-a162-705825975626" xlink:to="loc_cron_PreemptiveRightsMember_b5d0e6c0-4c27-4bd4-bb13-9ac2ec92be47" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_cron_TopupRightsMember_5b1aafe7-647a-4513-a930-a76ccd9ef2ed" xlink:href="cron-20210630.xsd#cron_TopupRightsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ClassOfWarrantOrRightDomain_fde39d62-4d4b-48a5-a162-705825975626" xlink:to="loc_cron_TopupRightsMember_5b1aafe7-647a-4513-a930-a76ccd9ef2ed" xlink:type="arc" order="2"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://thecronosgroup.com/role/SharebasedPaymentsSummaryofStockbasedCompensationExpenseDetails" xlink:type="simple" xlink:href="cron-20210630.xsd#SharebasedPaymentsSummaryofStockbasedCompensationExpenseDetails"/>
  <link:definitionLink xlink:role="http://thecronosgroup.com/role/SharebasedPaymentsSummaryofStockbasedCompensationExpenseDetails" xlink:type="extended" id="id76d44c95f714dc0bb2ab81683e3ddb4_SharebasedPaymentsSummaryofStockbasedCompensationExpenseDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems_83a508db-bdec-4b64-b86d-f7a90d638559" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AllocatedShareBasedCompensationExpense_05ae9739-1516-4331-99ee-39a0d2e675d8" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AllocatedShareBasedCompensationExpense"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems_83a508db-bdec-4b64-b86d-f7a90d638559" xlink:to="loc_us-gaap_AllocatedShareBasedCompensationExpense_05ae9739-1516-4331-99ee-39a0d2e675d8" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTable_1591be10-c3ed-4dc8-b488-8b5adba47251" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems_83a508db-bdec-4b64-b86d-f7a90d638559" xlink:to="loc_us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTable_1591be10-c3ed-4dc8-b488-8b5adba47251" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AwardTypeAxis_d388da90-f14a-45c5-9d03-9ef8cfdb9dc6" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AwardTypeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTable_1591be10-c3ed-4dc8-b488-8b5adba47251" xlink:to="loc_us-gaap_AwardTypeAxis_d388da90-f14a-45c5-9d03-9ef8cfdb9dc6" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_d388da90-f14a-45c5-9d03-9ef8cfdb9dc6_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_AwardTypeAxis_d388da90-f14a-45c5-9d03-9ef8cfdb9dc6" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_d388da90-f14a-45c5-9d03-9ef8cfdb9dc6_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_5590d504-ff8a-4dcd-8f9f-f261a3163578" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_AwardTypeAxis_d388da90-f14a-45c5-9d03-9ef8cfdb9dc6" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_5590d504-ff8a-4dcd-8f9f-f261a3163578" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeStockOptionMember_8f1e1d0d-016c-4d18-b4c9-fe823590172b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EmployeeStockOptionMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_5590d504-ff8a-4dcd-8f9f-f261a3163578" xlink:to="loc_us-gaap_EmployeeStockOptionMember_8f1e1d0d-016c-4d18-b4c9-fe823590172b" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestrictedStockUnitsRSUMember_188de5a4-6792-4d53-a3bc-05165bfa5ef8" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RestrictedStockUnitsRSUMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_5590d504-ff8a-4dcd-8f9f-f261a3163578" xlink:to="loc_us-gaap_RestrictedStockUnitsRSUMember_188de5a4-6792-4d53-a3bc-05165bfa5ef8" xlink:type="arc" order="1"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://thecronosgroup.com/role/SharebasedPaymentsStockOptionsNarrativeDetails" xlink:type="simple" xlink:href="cron-20210630.xsd#SharebasedPaymentsStockOptionsNarrativeDetails"/>
  <link:definitionLink xlink:role="http://thecronosgroup.com/role/SharebasedPaymentsStockOptionsNarrativeDetails" xlink:type="extended" id="id915361655d5428ea94fdf86f9e5f495_SharebasedPaymentsStockOptionsNarrativeDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_9a476ee5-dc7a-4be8-8b0b-85c749ebf5da" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1_9f6d712b-07ce-496c-9f3d-46e096c2730d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_9a476ee5-dc7a-4be8-8b0b-85c749ebf5da" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1_9f6d712b-07ce-496c-9f3d-46e096c2730d" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod_39a2e3ea-d82b-4c7a-a1d5-cb7cce28e9ea" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_9a476ee5-dc7a-4be8-8b0b-85c749ebf5da" xlink:to="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod_39a2e3ea-d82b-4c7a-a1d5-cb7cce28e9ea" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross_ffa498c8-1c8c-4dcd-ab07-8abf40900218" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_9a476ee5-dc7a-4be8-8b0b-85c749ebf5da" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross_ffa498c8-1c8c-4dcd-ab07-8abf40900218" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_443c716c-e42c-4351-a50a-3ffbd4476f09" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_9a476ee5-dc7a-4be8-8b0b-85c749ebf5da" xlink:to="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_443c716c-e42c-4351-a50a-3ffbd4476f09" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeAxis_18d9e237-4c4d-44e0-b4a3-c1fbd22d67c4" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_RangeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_443c716c-e42c-4351-a50a-3ffbd4476f09" xlink:to="loc_srt_RangeAxis_18d9e237-4c4d-44e0-b4a3-c1fbd22d67c4" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_18d9e237-4c4d-44e0-b4a3-c1fbd22d67c4_default" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_RangeMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_RangeAxis_18d9e237-4c4d-44e0-b4a3-c1fbd22d67c4" xlink:to="loc_srt_RangeMember_18d9e237-4c4d-44e0-b4a3-c1fbd22d67c4_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_71b69e6c-92bb-4720-ad9c-777f2212e0a5" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_RangeMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_RangeAxis_18d9e237-4c4d-44e0-b4a3-c1fbd22d67c4" xlink:to="loc_srt_RangeMember_71b69e6c-92bb-4720-ad9c-777f2212e0a5" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MinimumMember_904d169b-72ea-4a92-babc-8d88e5a53017" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_MinimumMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_RangeMember_71b69e6c-92bb-4720-ad9c-777f2212e0a5" xlink:to="loc_srt_MinimumMember_904d169b-72ea-4a92-babc-8d88e5a53017" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MaximumMember_8e2f7b58-abfd-47f3-9021-3be7e9cbd7c9" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_MaximumMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_RangeMember_71b69e6c-92bb-4720-ad9c-777f2212e0a5" xlink:to="loc_srt_MaximumMember_8e2f7b58-abfd-47f3-9021-3be7e9cbd7c9" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AwardTypeAxis_e0b4de31-34e5-4c04-84d6-06b8b5ff3979" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AwardTypeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_443c716c-e42c-4351-a50a-3ffbd4476f09" xlink:to="loc_us-gaap_AwardTypeAxis_e0b4de31-34e5-4c04-84d6-06b8b5ff3979" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_e0b4de31-34e5-4c04-84d6-06b8b5ff3979_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_AwardTypeAxis_e0b4de31-34e5-4c04-84d6-06b8b5ff3979" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_e0b4de31-34e5-4c04-84d6-06b8b5ff3979_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_a98d3c0a-f5c8-43c4-8073-b265bc0b473a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_AwardTypeAxis_e0b4de31-34e5-4c04-84d6-06b8b5ff3979" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_a98d3c0a-f5c8-43c4-8073-b265bc0b473a" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeStockOptionMember_d097849d-7b96-4adb-acfa-3d40c691eb7b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EmployeeStockOptionMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_a98d3c0a-f5c8-43c4-8073-b265bc0b473a" xlink:to="loc_us-gaap_EmployeeStockOptionMember_d097849d-7b96-4adb-acfa-3d40c691eb7b" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PlanNameAxis_fa9396a4-57d4-4c45-bb7d-e7ca14bacb9b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PlanNameAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_443c716c-e42c-4351-a50a-3ffbd4476f09" xlink:to="loc_us-gaap_PlanNameAxis_fa9396a4-57d4-4c45-bb7d-e7ca14bacb9b" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PlanNameDomain_fa9396a4-57d4-4c45-bb7d-e7ca14bacb9b_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PlanNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_PlanNameAxis_fa9396a4-57d4-4c45-bb7d-e7ca14bacb9b" xlink:to="loc_us-gaap_PlanNameDomain_fa9396a4-57d4-4c45-bb7d-e7ca14bacb9b_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PlanNameDomain_e31c84f0-13c0-457c-b153-a064f7461114" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PlanNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_PlanNameAxis_fa9396a4-57d4-4c45-bb7d-e7ca14bacb9b" xlink:to="loc_us-gaap_PlanNameDomain_e31c84f0-13c0-457c-b153-a064f7461114" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_cron_A2020OmnibusPlanMember_01b28fed-0687-4eb2-b495-b6117ea45b42" xlink:href="cron-20210630.xsd#cron_A2020OmnibusPlanMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PlanNameDomain_e31c84f0-13c0-457c-b153-a064f7461114" xlink:to="loc_cron_A2020OmnibusPlanMember_01b28fed-0687-4eb2-b495-b6117ea45b42" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_cron_PriorOptionPlansMember_e8732173-6218-42d0-9749-bf1d37dcb62d" xlink:href="cron-20210630.xsd#cron_PriorOptionPlansMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PlanNameDomain_e31c84f0-13c0-457c-b153-a064f7461114" xlink:to="loc_cron_PriorOptionPlansMember_e8732173-6218-42d0-9749-bf1d37dcb62d" xlink:type="arc" order="1"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://thecronosgroup.com/role/SharebasedPaymentsScheduleofStockOptionsOutstandingDetails" xlink:type="simple" xlink:href="cron-20210630.xsd#SharebasedPaymentsScheduleofStockOptionsOutstandingDetails"/>
  <link:definitionLink xlink:role="http://thecronosgroup.com/role/SharebasedPaymentsScheduleofStockOptionsOutstandingDetails" xlink:type="extended" id="ib5079de963174ef6a18bb8b1263cb616_SharebasedPaymentsScheduleofStockOptionsOutstandingDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_0dda1dc6-acdf-45af-8629-101f3087f3c2" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_73932616-e21f-45b2-b2c6-64631c030f4a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_0dda1dc6-acdf-45af-8629-101f3087f3c2" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_73932616-e21f-45b2-b2c6-64631c030f4a" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_8b2eb389-330e-4558-90b2-6e2fad014875" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_0dda1dc6-acdf-45af-8629-101f3087f3c2" xlink:to="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_8b2eb389-330e-4558-90b2-6e2fad014875" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PlanNameAxis_c43b6f74-5b5b-4358-aaf2-bdad906f2cb8" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PlanNameAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_8b2eb389-330e-4558-90b2-6e2fad014875" xlink:to="loc_us-gaap_PlanNameAxis_c43b6f74-5b5b-4358-aaf2-bdad906f2cb8" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PlanNameDomain_c43b6f74-5b5b-4358-aaf2-bdad906f2cb8_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PlanNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_PlanNameAxis_c43b6f74-5b5b-4358-aaf2-bdad906f2cb8" xlink:to="loc_us-gaap_PlanNameDomain_c43b6f74-5b5b-4358-aaf2-bdad906f2cb8_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PlanNameDomain_361cf29a-6015-4ee4-8f80-5de41d51f357" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PlanNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_PlanNameAxis_c43b6f74-5b5b-4358-aaf2-bdad906f2cb8" xlink:to="loc_us-gaap_PlanNameDomain_361cf29a-6015-4ee4-8f80-5de41d51f357" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_cron_A2020OmnibusPlanMember_ee035859-3f98-4e24-8ec4-37a7d65f0126" xlink:href="cron-20210630.xsd#cron_A2020OmnibusPlanMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PlanNameDomain_361cf29a-6015-4ee4-8f80-5de41d51f357" xlink:to="loc_cron_A2020OmnibusPlanMember_ee035859-3f98-4e24-8ec4-37a7d65f0126" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_cron_A2018StockOptionPlanMember_0f40b6d4-9c46-41d9-a951-6221802eb56b" xlink:href="cron-20210630.xsd#cron_A2018StockOptionPlanMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PlanNameDomain_361cf29a-6015-4ee4-8f80-5de41d51f357" xlink:to="loc_cron_A2018StockOptionPlanMember_0f40b6d4-9c46-41d9-a951-6221802eb56b" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_cron_A2015StockOptionPlanMember_74ae4064-ac45-465f-b041-bd5f3b993c87" xlink:href="cron-20210630.xsd#cron_A2015StockOptionPlanMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PlanNameDomain_361cf29a-6015-4ee4-8f80-5de41d51f357" xlink:to="loc_cron_A2015StockOptionPlanMember_74ae4064-ac45-465f-b041-bd5f3b993c87" xlink:type="arc" order="2"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://thecronosgroup.com/role/SharebasedPaymentsSummaryofChangesinRSUsDetails" xlink:type="simple" xlink:href="cron-20210630.xsd#SharebasedPaymentsSummaryofChangesinRSUsDetails"/>
  <link:definitionLink xlink:role="http://thecronosgroup.com/role/SharebasedPaymentsSummaryofChangesinRSUsDetails" xlink:type="extended" id="if23d5d616dd248f3934f579d32117e20_SharebasedPaymentsSummaryofChangesinRSUsDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_ad1c3f2c-187c-447e-8b62-f14de578d4cb" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward_a8a0b908-0dc9-4fce-a570-6a025e13bf02" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_ad1c3f2c-187c-447e-8b62-f14de578d4cb" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward_a8a0b908-0dc9-4fce-a570-6a025e13bf02" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber_3c231a87-9989-4756-9d4e-1158d9559d19" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward_a8a0b908-0dc9-4fce-a570-6a025e13bf02" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber_3c231a87-9989-4756-9d4e-1158d9559d19" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod_c260a0b8-b9d0-4fa5-bb0f-63e15f629c2f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward_a8a0b908-0dc9-4fce-a570-6a025e13bf02" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod_c260a0b8-b9d0-4fa5-bb0f-63e15f629c2f" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_cron_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedAndIssuedInPeriod_930c4e1b-bd72-4ad7-b3c3-4cb9ac1904f9" xlink:href="cron-20210630.xsd#cron_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedAndIssuedInPeriod"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward_a8a0b908-0dc9-4fce-a570-6a025e13bf02" xlink:to="loc_cron_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedAndIssuedInPeriod_930c4e1b-bd72-4ad7-b3c3-4cb9ac1904f9" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber_4b5fc176-f01a-4c9f-963f-b8bcb5d3d01b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber"/>
    <link:loc xlink:type="locator" xlink:label="loc_cron_DeferredCompensationSharebasedArrangementsLiabilityRollForward_d3ee9d08-a607-477f-889b-45549c1d1427" xlink:href="cron-20210630.xsd#cron_DeferredCompensationSharebasedArrangementsLiabilityRollForward"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_ad1c3f2c-187c-447e-8b62-f14de578d4cb" xlink:to="loc_cron_DeferredCompensationSharebasedArrangementsLiabilityRollForward_d3ee9d08-a607-477f-889b-45549c1d1427" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue_71827cec-4ed0-4595-a588-69a1a2c9b3af" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_cron_DeferredCompensationSharebasedArrangementsLiabilityRollForward_d3ee9d08-a607-477f-889b-45549c1d1427" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue_71827cec-4ed0-4595-a588-69a1a2c9b3af" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_32325a7b-61a1-490a-a2fe-4c625c317e50" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_cron_DeferredCompensationSharebasedArrangementsLiabilityRollForward_d3ee9d08-a607-477f-889b-45549c1d1427" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_32325a7b-61a1-490a-a2fe-4c625c317e50" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_cron_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedAndIssuedInPeriodWeightedAverageGrantDateFairValue_1da41825-5fe1-43e8-87f4-5599baaa8a89" xlink:href="cron-20210630.xsd#cron_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedAndIssuedInPeriodWeightedAverageGrantDateFairValue"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_cron_DeferredCompensationSharebasedArrangementsLiabilityRollForward_d3ee9d08-a607-477f-889b-45549c1d1427" xlink:to="loc_cron_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedAndIssuedInPeriodWeightedAverageGrantDateFairValue_1da41825-5fe1-43e8-87f4-5599baaa8a89" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue_737b4276-26d0-443d-bd83-b12e26c52b59" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1_1a6e169a-0806-43ec-aeed-8103d706a3ea" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_ad1c3f2c-187c-447e-8b62-f14de578d4cb" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1_1a6e169a-0806-43ec-aeed-8103d706a3ea" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_7ac7f192-6bf4-45af-ac31-d3738580f0c2" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_ad1c3f2c-187c-447e-8b62-f14de578d4cb" xlink:to="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_7ac7f192-6bf4-45af-ac31-d3738580f0c2" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AwardTypeAxis_e349b557-596c-4a3c-84cb-b85ead783962" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AwardTypeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_7ac7f192-6bf4-45af-ac31-d3738580f0c2" xlink:to="loc_us-gaap_AwardTypeAxis_e349b557-596c-4a3c-84cb-b85ead783962" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_e349b557-596c-4a3c-84cb-b85ead783962_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_AwardTypeAxis_e349b557-596c-4a3c-84cb-b85ead783962" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_e349b557-596c-4a3c-84cb-b85ead783962_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_32410656-4ebd-4708-916e-09f7372f17f5" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_AwardTypeAxis_e349b557-596c-4a3c-84cb-b85ead783962" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_32410656-4ebd-4708-916e-09f7372f17f5" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestrictedStockUnitsRSUMember_a8d5fa9e-e6f0-4b29-886e-1bc2bcc31432" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RestrictedStockUnitsRSUMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_32410656-4ebd-4708-916e-09f7372f17f5" xlink:to="loc_us-gaap_RestrictedStockUnitsRSUMember_a8d5fa9e-e6f0-4b29-886e-1bc2bcc31432" xlink:type="arc" order="0"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://thecronosgroup.com/role/SharebasedPaymentsSummaryofDSUActivityDetails" xlink:type="simple" xlink:href="cron-20210630.xsd#SharebasedPaymentsSummaryofDSUActivityDetails"/>
  <link:definitionLink xlink:role="http://thecronosgroup.com/role/SharebasedPaymentsSummaryofDSUActivityDetails" xlink:type="extended" id="iab03c97b19e942d0a6adce5730e2cdcf_SharebasedPaymentsSummaryofDSUActivityDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_bcce287c-5ee7-4bde-ba89-227a910f98e4" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward_dec71013-f62f-4f33-ba9a-176912d077f9" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_bcce287c-5ee7-4bde-ba89-227a910f98e4" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward_dec71013-f62f-4f33-ba9a-176912d077f9" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber_1b8d06d6-e597-4fe9-9369-5e2b6e7ee7d3" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward_dec71013-f62f-4f33-ba9a-176912d077f9" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber_1b8d06d6-e597-4fe9-9369-5e2b6e7ee7d3" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod_c3bf83ce-f08d-4f7b-8b92-589a6d6559f4" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward_dec71013-f62f-4f33-ba9a-176912d077f9" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod_c3bf83ce-f08d-4f7b-8b92-589a6d6559f4" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber_f007ba33-4a3f-4f7a-afbd-4e46719667ab" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber"/>
    <link:loc xlink:type="locator" xlink:label="loc_cron_DeferredCompensationSharebasedArrangementsLiabilityRollForward_7123e253-7d97-4f4e-a0a1-e4dc5b63885f" xlink:href="cron-20210630.xsd#cron_DeferredCompensationSharebasedArrangementsLiabilityRollForward"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_bcce287c-5ee7-4bde-ba89-227a910f98e4" xlink:to="loc_cron_DeferredCompensationSharebasedArrangementsLiabilityRollForward_7123e253-7d97-4f4e-a0a1-e4dc5b63885f" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredCompensationSharebasedArrangementsLiabilityCurrentAndNoncurrent_c5a2e285-961b-48b6-8f73-e7560fb1b99f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredCompensationSharebasedArrangementsLiabilityCurrentAndNoncurrent"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_cron_DeferredCompensationSharebasedArrangementsLiabilityRollForward_7123e253-7d97-4f4e-a0a1-e4dc5b63885f" xlink:to="loc_us-gaap_DeferredCompensationSharebasedArrangementsLiabilityCurrentAndNoncurrent_c5a2e285-961b-48b6-8f73-e7560fb1b99f" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_cron_ShareBasedPaymentArrangementLiabilitiesSettled_c7b942c9-d297-46e9-ad68-bb229478891c" xlink:href="cron-20210630.xsd#cron_ShareBasedPaymentArrangementLiabilitiesSettled"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_cron_DeferredCompensationSharebasedArrangementsLiabilityRollForward_7123e253-7d97-4f4e-a0a1-e4dc5b63885f" xlink:to="loc_cron_ShareBasedPaymentArrangementLiabilitiesSettled_c7b942c9-d297-46e9-ad68-bb229478891c" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_cron_ShareBasedPaymentArrangementGainLossOnRevaluation_c6b16cb2-deca-41b3-8765-1e3997c3a537" xlink:href="cron-20210630.xsd#cron_ShareBasedPaymentArrangementGainLossOnRevaluation"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_cron_DeferredCompensationSharebasedArrangementsLiabilityRollForward_7123e253-7d97-4f4e-a0a1-e4dc5b63885f" xlink:to="loc_cron_ShareBasedPaymentArrangementGainLossOnRevaluation_c6b16cb2-deca-41b3-8765-1e3997c3a537" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredCompensationSharebasedArrangementsLiabilityCurrentAndNoncurrent_55b7b1e5-4200-4e76-bec2-526667d93ab2" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredCompensationSharebasedArrangementsLiabilityCurrentAndNoncurrent"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_1af2e86b-185a-4dc2-93e3-75b1976c415c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_bcce287c-5ee7-4bde-ba89-227a910f98e4" xlink:to="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_1af2e86b-185a-4dc2-93e3-75b1976c415c" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AwardTypeAxis_f5d099d2-05ec-4e06-8f92-ac0245b69025" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AwardTypeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_1af2e86b-185a-4dc2-93e3-75b1976c415c" xlink:to="loc_us-gaap_AwardTypeAxis_f5d099d2-05ec-4e06-8f92-ac0245b69025" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_f5d099d2-05ec-4e06-8f92-ac0245b69025_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_AwardTypeAxis_f5d099d2-05ec-4e06-8f92-ac0245b69025" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_f5d099d2-05ec-4e06-8f92-ac0245b69025_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_b4d92fba-e9e9-4290-a9b6-c30c20f629d9" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_AwardTypeAxis_f5d099d2-05ec-4e06-8f92-ac0245b69025" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_b4d92fba-e9e9-4290-a9b6-c30c20f629d9" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_cron_DeferredShareUnitsDSUsMember_32a5f50f-41ca-404a-ad61-6a16ce07e9ab" xlink:href="cron-20210630.xsd#cron_DeferredShareUnitsDSUsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_b4d92fba-e9e9-4290-a9b6-c30c20f629d9" xlink:to="loc_cron_DeferredShareUnitsDSUsMember_32a5f50f-41ca-404a-ad61-6a16ce07e9ab" xlink:type="arc" order="0"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://thecronosgroup.com/role/SharebasedPaymentsSummaryofChangesinWarrantsDetails" xlink:type="simple" xlink:href="cron-20210630.xsd#SharebasedPaymentsSummaryofChangesinWarrantsDetails"/>
  <link:definitionLink xlink:role="http://thecronosgroup.com/role/SharebasedPaymentsSummaryofChangesinWarrantsDetails" xlink:type="extended" id="iabccc8a7162543aba529aca217a50dd1_SharebasedPaymentsSummaryofChangesinWarrantsDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_ad8d3672-1ba0-4000-89ca-ebe5a4bd9806" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward_d04f2422-7f38-4297-9f51-e3bc178e3a56" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_ad8d3672-1ba0-4000-89ca-ebe5a4bd9806" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward_d04f2422-7f38-4297-9f51-e3bc178e3a56" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue_d2760205-67f6-4a2a-b30a-c723513f0973" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward_d04f2422-7f38-4297-9f51-e3bc178e3a56" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue_d2760205-67f6-4a2a-b30a-c723513f0973" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue_8d371427-b089-4310-96b8-12797cbcbe82" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward_d04f2422-7f38-4297-9f51-e3bc178e3a56" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue_8d371427-b089-4310-96b8-12797cbcbe82" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue_92b5ae2a-d2ac-44d8-b305-2d40943e3ed7" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward_68b0be4c-86ab-45db-bfce-c1599a803707" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_ad8d3672-1ba0-4000-89ca-ebe5a4bd9806" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward_68b0be4c-86ab-45db-bfce-c1599a803707" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber_db61fe21-9e37-4849-9017-791d7146829d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward_68b0be4c-86ab-45db-bfce-c1599a803707" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber_db61fe21-9e37-4849-9017-791d7146829d" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod_a4f2be23-61e5-49dd-bf54-5521e86f382c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward_68b0be4c-86ab-45db-bfce-c1599a803707" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod_a4f2be23-61e5-49dd-bf54-5521e86f382c" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber_63166d35-3595-4d8f-8db0-4bb4cddcae9a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_0a5ca946-3977-49f7-8b6c-33777e90688d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_ad8d3672-1ba0-4000-89ca-ebe5a4bd9806" xlink:to="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_0a5ca946-3977-49f7-8b6c-33777e90688d" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AwardTypeAxis_22f7a2f1-e518-4b70-9e78-c6f029d3036b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AwardTypeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_0a5ca946-3977-49f7-8b6c-33777e90688d" xlink:to="loc_us-gaap_AwardTypeAxis_22f7a2f1-e518-4b70-9e78-c6f029d3036b" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_22f7a2f1-e518-4b70-9e78-c6f029d3036b_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_AwardTypeAxis_22f7a2f1-e518-4b70-9e78-c6f029d3036b" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_22f7a2f1-e518-4b70-9e78-c6f029d3036b_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_a426375c-cc6c-46b1-9f65-697a89a63743" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_AwardTypeAxis_22f7a2f1-e518-4b70-9e78-c6f029d3036b" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_a426375c-cc6c-46b1-9f65-697a89a63743" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WarrantMember_6d064e74-ba6d-43e2-af5c-66ed49e6a5a6" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_WarrantMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_a426375c-cc6c-46b1-9f65-697a89a63743" xlink:to="loc_us-gaap_WarrantMember_6d064e74-ba6d-43e2-af5c-66ed49e6a5a6" xlink:type="arc" order="0"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://thecronosgroup.com/role/SharebasedPaymentsSummaryofOutstandingWarrantsDetails" xlink:type="simple" xlink:href="cron-20210630.xsd#SharebasedPaymentsSummaryofOutstandingWarrantsDetails"/>
  <link:definitionLink xlink:role="http://thecronosgroup.com/role/SharebasedPaymentsSummaryofOutstandingWarrantsDetails" xlink:type="extended" id="ie2aade4906f34bcdbeb12abdf72b0156_SharebasedPaymentsSummaryofOutstandingWarrantsDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_73dfcedb-36fc-4d1d-9fa9-419f97c70fe8" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber_437e7e8c-4e47-481a-a2f0-c7869f326237" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_73dfcedb-36fc-4d1d-9fa9-419f97c70fe8" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber_437e7e8c-4e47-481a-a2f0-c7869f326237" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_a05870e2-0b03-420b-8837-915269868b5d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_73dfcedb-36fc-4d1d-9fa9-419f97c70fe8" xlink:to="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_a05870e2-0b03-420b-8837-915269868b5d" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AwardTypeAxis_b3362f5a-f8cf-4c5b-953f-bdf1972247a3" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AwardTypeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_a05870e2-0b03-420b-8837-915269868b5d" xlink:to="loc_us-gaap_AwardTypeAxis_b3362f5a-f8cf-4c5b-953f-bdf1972247a3" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_b3362f5a-f8cf-4c5b-953f-bdf1972247a3_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_AwardTypeAxis_b3362f5a-f8cf-4c5b-953f-bdf1972247a3" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_b3362f5a-f8cf-4c5b-953f-bdf1972247a3_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_0583aa8e-b6a3-4699-b276-22c40401c3d4" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_AwardTypeAxis_b3362f5a-f8cf-4c5b-953f-bdf1972247a3" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_0583aa8e-b6a3-4699-b276-22c40401c3d4" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WarrantMember_74acaadc-6abe-40b8-af3d-e54209e389e7" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_WarrantMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_0583aa8e-b6a3-4699-b276-22c40401c3d4" xlink:to="loc_us-gaap_WarrantMember_74acaadc-6abe-40b8-af3d-e54209e389e7" xlink:type="arc" order="0"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://thecronosgroup.com/role/EarningsLossPerShareScheduleofEarningsLossPerShareDetails" xlink:type="simple" xlink:href="cron-20210630.xsd#EarningsLossPerShareScheduleofEarningsLossPerShareDetails"/>
  <link:definitionLink xlink:role="http://thecronosgroup.com/role/EarningsLossPerShareScheduleofEarningsLossPerShareDetails" xlink:type="extended" id="if6dec4ccf7ff434da25a0443255a13d4_EarningsLossPerShareScheduleofEarningsLossPerShareDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareDilutedLineItems_49ffc5a0-f79b-44b6-9668-df95322c5837" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EarningsPerShareDilutedLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLossAvailableToCommonStockholdersDilutedAbstract_3c4b9c81-16ff-47c9-b47b-ceaee3cc9cbc" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetIncomeLossAvailableToCommonStockholdersDilutedAbstract"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EarningsPerShareDilutedLineItems_49ffc5a0-f79b-44b6-9668-df95322c5837" xlink:to="loc_us-gaap_NetIncomeLossAvailableToCommonStockholdersDilutedAbstract_3c4b9c81-16ff-47c9-b47b-ceaee3cc9cbc" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLossFromContinuingOperationsAvailableToCommonShareholdersBasic_ad03fa58-7eb1-457e-a39b-7d33186638e0" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetIncomeLossFromContinuingOperationsAvailableToCommonShareholdersBasic"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_NetIncomeLossAvailableToCommonStockholdersDilutedAbstract_3c4b9c81-16ff-47c9-b47b-ceaee3cc9cbc" xlink:to="loc_us-gaap_NetIncomeLossFromContinuingOperationsAvailableToCommonShareholdersBasic_ad03fa58-7eb1-457e-a39b-7d33186638e0" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_ca8da938-2c5f-41a2-bd74-eef7acddd5fc" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_WeightedAverageNumberOfSharesOutstandingBasic"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_NetIncomeLossAvailableToCommonStockholdersDilutedAbstract_3c4b9c81-16ff-47c9-b47b-ceaee3cc9cbc" xlink:to="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_ca8da938-2c5f-41a2-bd74-eef7acddd5fc" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromContinuingOperationsPerBasicShare_d4f38fd3-068b-4bae-8501-94d1bb7867d5" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeLossFromContinuingOperationsPerBasicShare"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_NetIncomeLossAvailableToCommonStockholdersDilutedAbstract_3c4b9c81-16ff-47c9-b47b-ceaee3cc9cbc" xlink:to="loc_us-gaap_IncomeLossFromContinuingOperationsPerBasicShare_d4f38fd3-068b-4bae-8501-94d1bb7867d5" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLossFromDiscontinuedOperationsAvailableToCommonShareholdersBasic_6958b7aa-f3e8-4417-aec3-9041fc708bf6" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetIncomeLossFromDiscontinuedOperationsAvailableToCommonShareholdersBasic"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_NetIncomeLossAvailableToCommonStockholdersDilutedAbstract_3c4b9c81-16ff-47c9-b47b-ceaee3cc9cbc" xlink:to="loc_us-gaap_NetIncomeLossFromDiscontinuedOperationsAvailableToCommonShareholdersBasic_6958b7aa-f3e8-4417-aec3-9041fc708bf6" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_886b61d7-3c2a-4e3d-9634-25c615d3d2e1" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_WeightedAverageNumberOfSharesOutstandingBasic"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTaxPerBasicShare_609c1a46-5caa-4b12-a36f-f338e5924914" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTaxPerBasicShare"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_NetIncomeLossAvailableToCommonStockholdersDilutedAbstract_3c4b9c81-16ff-47c9-b47b-ceaee3cc9cbc" xlink:to="loc_us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTaxPerBasicShare_609c1a46-5caa-4b12-a36f-f338e5924914" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingDilutedDisclosureItemsAbstract_959022f2-028c-45f3-918f-ccf5f13bcc93" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_WeightedAverageNumberOfSharesOutstandingDilutedDisclosureItemsAbstract"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EarningsPerShareDilutedLineItems_49ffc5a0-f79b-44b6-9668-df95322c5837" xlink:to="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingDilutedDisclosureItemsAbstract_959022f2-028c-45f3-918f-ccf5f13bcc93" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLossFromContinuingOperationsAvailableToCommonShareholdersBasic_2c1b9c94-e05e-443b-9473-7cc72c4f991e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetIncomeLossFromContinuingOperationsAvailableToCommonShareholdersBasic"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DilutiveSecurities_ceefcfba-6d6c-49fe-bd5e-290a7093485c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DilutiveSecurities"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingDilutedDisclosureItemsAbstract_959022f2-028c-45f3-918f-ccf5f13bcc93" xlink:to="loc_us-gaap_DilutiveSecurities_ceefcfba-6d6c-49fe-bd5e-290a7093485c" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLossFromContinuingOperationsAvailableToCommonShareholdersDiluted_5de672cf-2f2b-43a6-bac7-721556bd8622" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetIncomeLossFromContinuingOperationsAvailableToCommonShareholdersDiluted"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingDilutedDisclosureItemsAbstract_959022f2-028c-45f3-918f-ccf5f13bcc93" xlink:to="loc_us-gaap_NetIncomeLossFromContinuingOperationsAvailableToCommonShareholdersDiluted_5de672cf-2f2b-43a6-bac7-721556bd8622" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_74c861a2-c456-487c-a582-903ff2872100" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_WeightedAverageNumberOfSharesOutstandingBasic"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncrementalCommonSharesAttributableToShareBasedPaymentArrangements_99735043-765a-405d-9795-2c89e68e4c34" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncrementalCommonSharesAttributableToShareBasedPaymentArrangements"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingDilutedDisclosureItemsAbstract_959022f2-028c-45f3-918f-ccf5f13bcc93" xlink:to="loc_us-gaap_IncrementalCommonSharesAttributableToShareBasedPaymentArrangements_99735043-765a-405d-9795-2c89e68e4c34" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_bd401d00-ac45-4694-a34e-0ea2da4cd5cf" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingDilutedDisclosureItemsAbstract_959022f2-028c-45f3-918f-ccf5f13bcc93" xlink:to="loc_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_bd401d00-ac45-4694-a34e-0ea2da4cd5cf" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromContinuingOperationsPerDilutedShare_2328ef15-5170-468a-af60-662286469fb1" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeLossFromContinuingOperationsPerDilutedShare"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingDilutedDisclosureItemsAbstract_959022f2-028c-45f3-918f-ccf5f13bcc93" xlink:to="loc_us-gaap_IncomeLossFromContinuingOperationsPerDilutedShare_2328ef15-5170-468a-af60-662286469fb1" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLossFromDiscontinuedOperationsAvailableToCommonShareholdersDiluted_3b6114d1-2cef-4665-9c44-4409167604a5" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetIncomeLossFromDiscontinuedOperationsAvailableToCommonShareholdersDiluted"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingDilutedDisclosureItemsAbstract_959022f2-028c-45f3-918f-ccf5f13bcc93" xlink:to="loc_us-gaap_NetIncomeLossFromDiscontinuedOperationsAvailableToCommonShareholdersDiluted_3b6114d1-2cef-4665-9c44-4409167604a5" xlink:type="arc" order="8"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_f8afcbe6-3f3f-43a2-b4c2-9ea2a08f7169" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTaxPerDilutedShare_a8f83bf7-f21d-424c-9954-33a0bd304db3" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTaxPerDilutedShare"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingDilutedDisclosureItemsAbstract_959022f2-028c-45f3-918f-ccf5f13bcc93" xlink:to="loc_us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTaxPerDilutedShare_a8f83bf7-f21d-424c-9954-33a0bd304db3" xlink:type="arc" order="10"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfEarningsPerShareDilutedByCommonClassTable_07163f89-25ab-4cd2-a2d8-e03e6ce17819" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfEarningsPerShareDilutedByCommonClassTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_EarningsPerShareDilutedLineItems_49ffc5a0-f79b-44b6-9668-df95322c5837" xlink:to="loc_us-gaap_ScheduleOfEarningsPerShareDilutedByCommonClassTable_07163f89-25ab-4cd2-a2d8-e03e6ce17819" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AwardTypeAxis_e809a511-ddf4-4d68-af8a-9437efbb26ef" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AwardTypeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfEarningsPerShareDilutedByCommonClassTable_07163f89-25ab-4cd2-a2d8-e03e6ce17819" xlink:to="loc_us-gaap_AwardTypeAxis_e809a511-ddf4-4d68-af8a-9437efbb26ef" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_e809a511-ddf4-4d68-af8a-9437efbb26ef_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_AwardTypeAxis_e809a511-ddf4-4d68-af8a-9437efbb26ef" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_e809a511-ddf4-4d68-af8a-9437efbb26ef_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_5e0aaec0-00fa-4274-9660-af975f5935a5" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_AwardTypeAxis_e809a511-ddf4-4d68-af8a-9437efbb26ef" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_5e0aaec0-00fa-4274-9660-af975f5935a5" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WarrantMember_c6771aa7-9489-4a68-8473-716966b243fa" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_WarrantMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_5e0aaec0-00fa-4274-9660-af975f5935a5" xlink:to="loc_us-gaap_WarrantMember_c6771aa7-9489-4a68-8473-716966b243fa" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeStockOptionMember_04df6197-a6dc-496b-a798-c5250106f6c5" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EmployeeStockOptionMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_5e0aaec0-00fa-4274-9660-af975f5935a5" xlink:to="loc_us-gaap_EmployeeStockOptionMember_04df6197-a6dc-496b-a798-c5250106f6c5" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestrictedStockUnitsRSUMember_ab4f954d-0de2-4bc6-bf7d-f49a8bd7c4a8" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RestrictedStockUnitsRSUMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_5e0aaec0-00fa-4274-9660-af975f5935a5" xlink:to="loc_us-gaap_RestrictedStockUnitsRSUMember_ab4f954d-0de2-4bc6-bf7d-f49a8bd7c4a8" xlink:type="arc" order="2"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://thecronosgroup.com/role/EarningsLossPerShareScheduleofAntidilutiveSecuritiesExcludedfromComputationofDilutedSharesOutstandingDetails" xlink:type="simple" xlink:href="cron-20210630.xsd#EarningsLossPerShareScheduleofAntidilutiveSecuritiesExcludedfromComputationofDilutedSharesOutstandingDetails"/>
  <link:definitionLink xlink:role="http://thecronosgroup.com/role/EarningsLossPerShareScheduleofAntidilutiveSecuritiesExcludedfromComputationofDilutedSharesOutstandingDetails" xlink:type="extended" id="iaee6155d75764a86909f51c9354b9606_EarningsLossPerShareScheduleofAntidilutiveSecuritiesExcludedfromComputationofDilutedSharesOutstandingDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems_626306f7-ad1e-4a7e-a741-247b37dbb227" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_621c2929-5162-47d8-8162-1b545989a0ed" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems_626306f7-ad1e-4a7e-a741-247b37dbb227" xlink:to="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_621c2929-5162-47d8-8162-1b545989a0ed" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable_516cebef-0bfa-40a8-86d8-10b504b34e23" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems_626306f7-ad1e-4a7e-a741-247b37dbb227" xlink:to="loc_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable_516cebef-0bfa-40a8-86d8-10b504b34e23" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis_fb0fc414-97cc-4ff9-96c6-20f192e0085d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable_516cebef-0bfa-40a8-86d8-10b504b34e23" xlink:to="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis_fb0fc414-97cc-4ff9-96c6-20f192e0085d" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AntidilutiveSecuritiesNameDomain_fb0fc414-97cc-4ff9-96c6-20f192e0085d_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AntidilutiveSecuritiesNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis_fb0fc414-97cc-4ff9-96c6-20f192e0085d" xlink:to="loc_us-gaap_AntidilutiveSecuritiesNameDomain_fb0fc414-97cc-4ff9-96c6-20f192e0085d_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AntidilutiveSecuritiesNameDomain_0a6eb2d7-e08b-424a-92f5-28fd5560e5a2" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AntidilutiveSecuritiesNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis_fb0fc414-97cc-4ff9-96c6-20f192e0085d" xlink:to="loc_us-gaap_AntidilutiveSecuritiesNameDomain_0a6eb2d7-e08b-424a-92f5-28fd5560e5a2" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_cron_GinkgoEquityMilestonesMember_4ab5b8ad-7d5e-4e4b-af52-9094c0e6accd" xlink:href="cron-20210630.xsd#cron_GinkgoEquityMilestonesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AntidilutiveSecuritiesNameDomain_0a6eb2d7-e08b-424a-92f5-28fd5560e5a2" xlink:to="loc_cron_GinkgoEquityMilestonesMember_4ab5b8ad-7d5e-4e4b-af52-9094c0e6accd" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_cron_PreemptiveRightsMember_3a813b9a-6771-4374-a59c-cbb1ebaa9aa6" xlink:href="cron-20210630.xsd#cron_PreemptiveRightsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AntidilutiveSecuritiesNameDomain_0a6eb2d7-e08b-424a-92f5-28fd5560e5a2" xlink:to="loc_cron_PreemptiveRightsMember_3a813b9a-6771-4374-a59c-cbb1ebaa9aa6" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_cron_TopUpRightsFixedPriceMember_b1e32a16-5770-4c38-925f-c78a3dfca08e" xlink:href="cron-20210630.xsd#cron_TopUpRightsFixedPriceMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AntidilutiveSecuritiesNameDomain_0a6eb2d7-e08b-424a-92f5-28fd5560e5a2" xlink:to="loc_cron_TopUpRightsFixedPriceMember_b1e32a16-5770-4c38-925f-c78a3dfca08e" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_cron_TopUpRightsMarketPriceMember_df3a93a2-4cbe-427f-8eb9-a2fe09a4e2db" xlink:href="cron-20210630.xsd#cron_TopUpRightsMarketPriceMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AntidilutiveSecuritiesNameDomain_0a6eb2d7-e08b-424a-92f5-28fd5560e5a2" xlink:to="loc_cron_TopUpRightsMarketPriceMember_df3a93a2-4cbe-427f-8eb9-a2fe09a4e2db" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_cron_AltriaWarrantMember_ae82f08d-7f48-43bd-99db-eea9e3055efb" xlink:href="cron-20210630.xsd#cron_AltriaWarrantMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AntidilutiveSecuritiesNameDomain_0a6eb2d7-e08b-424a-92f5-28fd5560e5a2" xlink:to="loc_cron_AltriaWarrantMember_ae82f08d-7f48-43bd-99db-eea9e3055efb" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeStockOptionMember_065335be-a192-4e56-a073-a55a6bd402e1" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EmployeeStockOptionMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AntidilutiveSecuritiesNameDomain_0a6eb2d7-e08b-424a-92f5-28fd5560e5a2" xlink:to="loc_us-gaap_EmployeeStockOptionMember_065335be-a192-4e56-a073-a55a6bd402e1" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WarrantMember_6468afc2-d330-40ae-a82f-78ed6540edc6" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_WarrantMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AntidilutiveSecuritiesNameDomain_0a6eb2d7-e08b-424a-92f5-28fd5560e5a2" xlink:to="loc_us-gaap_WarrantMember_6468afc2-d330-40ae-a82f-78ed6540edc6" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestrictedStockUnitsRSUMember_b5c2dd9d-c538-4d0e-a20c-fe812550b7c8" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RestrictedStockUnitsRSUMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AntidilutiveSecuritiesNameDomain_0a6eb2d7-e08b-424a-92f5-28fd5560e5a2" xlink:to="loc_us-gaap_RestrictedStockUnitsRSUMember_b5c2dd9d-c538-4d0e-a20c-fe812550b7c8" xlink:type="arc" order="7"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://thecronosgroup.com/role/SegmentInformationNarrativeDetails" xlink:type="simple" xlink:href="cron-20210630.xsd#SegmentInformationNarrativeDetails"/>
  <link:definitionLink xlink:role="http://thecronosgroup.com/role/SegmentInformationNarrativeDetails" xlink:type="extended" id="i38199ccd94064902a2a2f4810cbd2634_SegmentInformationNarrativeDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentReportingInformationLineItems_77b73a61-46c7-4bb4-a221-33d14fd3a394" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SegmentReportingInformationLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NumberOfReportableSegments_5cefa5d5-6be3-403b-bb34-d77f31ebe82b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NumberOfReportableSegments"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_77b73a61-46c7-4bb4-a221-33d14fd3a394" xlink:to="loc_us-gaap_NumberOfReportableSegments_5cefa5d5-6be3-403b-bb34-d77f31ebe82b" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AllowanceForDoubtfulAccountsReceivableCurrent_da92af86-834a-499d-8586-c025206c6c50" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AllowanceForDoubtfulAccountsReceivableCurrent"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_77b73a61-46c7-4bb4-a221-33d14fd3a394" xlink:to="loc_us-gaap_AllowanceForDoubtfulAccountsReceivableCurrent_da92af86-834a-499d-8586-c025206c6c50" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTax_0692114c-af11-40ab-8bf3-2eec8a86fa53" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTax"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_77b73a61-46c7-4bb4-a221-33d14fd3a394" xlink:to="loc_us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTax_0692114c-af11-40ab-8bf3-2eec8a86fa53" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerIncludingAssessedTax_8d77797e-daca-4a98-a6b4-6216a673951c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RevenueFromContractWithCustomerIncludingAssessedTax"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_77b73a61-46c7-4bb4-a221-33d14fd3a394" xlink:to="loc_us-gaap_RevenueFromContractWithCustomerIncludingAssessedTax_8d77797e-daca-4a98-a6b4-6216a673951c" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskPercentage1_2fc8bc25-b346-4bff-b86e-b381fa2dfee9" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ConcentrationRiskPercentage1"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_77b73a61-46c7-4bb4-a221-33d14fd3a394" xlink:to="loc_us-gaap_ConcentrationRiskPercentage1_2fc8bc25-b346-4bff-b86e-b381fa2dfee9" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_79b3e653-5119-4abe-b1c9-e3ec1159d34e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_77b73a61-46c7-4bb4-a221-33d14fd3a394" xlink:to="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_79b3e653-5119-4abe-b1c9-e3ec1159d34e" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskByTypeAxis_621a931b-6255-45bd-b126-7949f23d24ca" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ConcentrationRiskByTypeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_79b3e653-5119-4abe-b1c9-e3ec1159d34e" xlink:to="loc_us-gaap_ConcentrationRiskByTypeAxis_621a931b-6255-45bd-b126-7949f23d24ca" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskTypeDomain_621a931b-6255-45bd-b126-7949f23d24ca_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ConcentrationRiskTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_ConcentrationRiskByTypeAxis_621a931b-6255-45bd-b126-7949f23d24ca" xlink:to="loc_us-gaap_ConcentrationRiskTypeDomain_621a931b-6255-45bd-b126-7949f23d24ca_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskTypeDomain_97070a58-3377-4170-a88d-87d78364ec5c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ConcentrationRiskTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_ConcentrationRiskByTypeAxis_621a931b-6255-45bd-b126-7949f23d24ca" xlink:to="loc_us-gaap_ConcentrationRiskTypeDomain_97070a58-3377-4170-a88d-87d78364ec5c" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CustomerConcentrationRiskMember_8318de89-758a-4ab7-814e-99ab1e38d76c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CustomerConcentrationRiskMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ConcentrationRiskTypeDomain_97070a58-3377-4170-a88d-87d78364ec5c" xlink:to="loc_us-gaap_CustomerConcentrationRiskMember_8318de89-758a-4ab7-814e-99ab1e38d76c" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskByBenchmarkAxis_f4226b0e-4428-4879-a535-34e48abc5dae" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ConcentrationRiskByBenchmarkAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_79b3e653-5119-4abe-b1c9-e3ec1159d34e" xlink:to="loc_us-gaap_ConcentrationRiskByBenchmarkAxis_f4226b0e-4428-4879-a535-34e48abc5dae" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskBenchmarkDomain_f4226b0e-4428-4879-a535-34e48abc5dae_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ConcentrationRiskBenchmarkDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_ConcentrationRiskByBenchmarkAxis_f4226b0e-4428-4879-a535-34e48abc5dae" xlink:to="loc_us-gaap_ConcentrationRiskBenchmarkDomain_f4226b0e-4428-4879-a535-34e48abc5dae_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskBenchmarkDomain_397ad820-bea1-4be6-9402-20efe8b41672" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ConcentrationRiskBenchmarkDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_ConcentrationRiskByBenchmarkAxis_f4226b0e-4428-4879-a535-34e48abc5dae" xlink:to="loc_us-gaap_ConcentrationRiskBenchmarkDomain_397ad820-bea1-4be6-9402-20efe8b41672" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerMember_ec30495b-7e95-4d12-944d-bda2b11e1670" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RevenueFromContractWithCustomerMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ConcentrationRiskBenchmarkDomain_397ad820-bea1-4be6-9402-20efe8b41672" xlink:to="loc_us-gaap_RevenueFromContractWithCustomerMember_ec30495b-7e95-4d12-944d-bda2b11e1670" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MajorCustomersAxis_e6ad3b73-c221-433a-878c-4591b7454426" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_MajorCustomersAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_79b3e653-5119-4abe-b1c9-e3ec1159d34e" xlink:to="loc_srt_MajorCustomersAxis_e6ad3b73-c221-433a-878c-4591b7454426" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_NameOfMajorCustomerDomain_e6ad3b73-c221-433a-878c-4591b7454426_default" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_NameOfMajorCustomerDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_MajorCustomersAxis_e6ad3b73-c221-433a-878c-4591b7454426" xlink:to="loc_srt_NameOfMajorCustomerDomain_e6ad3b73-c221-433a-878c-4591b7454426_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_NameOfMajorCustomerDomain_f047054b-9965-48c3-ae7c-434db8f26385" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_NameOfMajorCustomerDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_MajorCustomersAxis_e6ad3b73-c221-433a-878c-4591b7454426" xlink:to="loc_srt_NameOfMajorCustomerDomain_f047054b-9965-48c3-ae7c-434db8f26385" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_cron_FourMajorCustomersMember_43d04ab3-6339-45f5-a25b-1d13620a164e" xlink:href="cron-20210630.xsd#cron_FourMajorCustomersMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_NameOfMajorCustomerDomain_f047054b-9965-48c3-ae7c-434db8f26385" xlink:to="loc_cron_FourMajorCustomersMember_43d04ab3-6339-45f5-a25b-1d13620a164e" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_cron_OntarioCannabisRetailCorporationMember_4feec6a8-0c4b-401a-8230-1b6a2f649dce" xlink:href="cron-20210630.xsd#cron_OntarioCannabisRetailCorporationMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_cron_FourMajorCustomersMember_43d04ab3-6339-45f5-a25b-1d13620a164e" xlink:to="loc_cron_OntarioCannabisRetailCorporationMember_4feec6a8-0c4b-401a-8230-1b6a2f649dce" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_cron_NovologGroupMember_fde131b3-1c85-467d-a3ad-08ebc56ef99c" xlink:href="cron-20210630.xsd#cron_NovologGroupMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_cron_FourMajorCustomersMember_43d04ab3-6339-45f5-a25b-1d13620a164e" xlink:to="loc_cron_NovologGroupMember_fde131b3-1c85-467d-a3ad-08ebc56ef99c" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_cron_AlbertGamingLiquorAndCannabisCommissionMember_c31fb23e-267a-4d4f-95df-3a0ff6c38376" xlink:href="cron-20210630.xsd#cron_AlbertGamingLiquorAndCannabisCommissionMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_cron_FourMajorCustomersMember_43d04ab3-6339-45f5-a25b-1d13620a164e" xlink:to="loc_cron_AlbertGamingLiquorAndCannabisCommissionMember_c31fb23e-267a-4d4f-95df-3a0ff6c38376" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_cron_SocieteQuebecoiseDuCannabisMember_20f60722-116a-4abe-b5fd-a4cd940f8a36" xlink:href="cron-20210630.xsd#cron_SocieteQuebecoiseDuCannabisMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_cron_FourMajorCustomersMember_43d04ab3-6339-45f5-a25b-1d13620a164e" xlink:to="loc_cron_SocieteQuebecoiseDuCannabisMember_20f60722-116a-4abe-b5fd-a4cd940f8a36" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementBusinessSegmentsAxis_b0c0bac0-599d-47b1-b026-0b0352a2c893" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementBusinessSegmentsAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_79b3e653-5119-4abe-b1c9-e3ec1159d34e" xlink:to="loc_us-gaap_StatementBusinessSegmentsAxis_b0c0bac0-599d-47b1-b026-0b0352a2c893" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentDomain_b0c0bac0-599d-47b1-b026-0b0352a2c893_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SegmentDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_StatementBusinessSegmentsAxis_b0c0bac0-599d-47b1-b026-0b0352a2c893" xlink:to="loc_us-gaap_SegmentDomain_b0c0bac0-599d-47b1-b026-0b0352a2c893_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentDomain_e4513422-d148-4478-a957-ccaf4416b947" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SegmentDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_StatementBusinessSegmentsAxis_b0c0bac0-599d-47b1-b026-0b0352a2c893" xlink:to="loc_us-gaap_SegmentDomain_e4513422-d148-4478-a957-ccaf4416b947" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_cron_UnitedStatesSegmentMember_f138c5f4-6cfa-4475-ab81-5f3dc65a5421" xlink:href="cron-20210630.xsd#cron_UnitedStatesSegmentMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentDomain_e4513422-d148-4478-a957-ccaf4416b947" xlink:to="loc_cron_UnitedStatesSegmentMember_f138c5f4-6cfa-4475-ab81-5f3dc65a5421" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_cron_RestOfWorldSegmentMember_ee304c3c-4035-413e-be1d-7fc99a7719c5" xlink:href="cron-20210630.xsd#cron_RestOfWorldSegmentMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentDomain_e4513422-d148-4478-a957-ccaf4416b947" xlink:to="loc_cron_RestOfWorldSegmentMember_ee304c3c-4035-413e-be1d-7fc99a7719c5" xlink:type="arc" order="1"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://thecronosgroup.com/role/SegmentInformationScheduleofSegmentDataDetails" xlink:type="simple" xlink:href="cron-20210630.xsd#SegmentInformationScheduleofSegmentDataDetails"/>
  <link:definitionLink xlink:role="http://thecronosgroup.com/role/SegmentInformationScheduleofSegmentDataDetails" xlink:type="extended" id="i95f6ef2009094c96b2e8511f95dc94e0_SegmentInformationScheduleofSegmentDataDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentReportingInformationLineItems_4ad1a0ab-b18d-480e-9e35-129ee32e3cc4" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SegmentReportingInformationLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_d0965b7a-0ba7-4219-af6e-92a68e100ac4" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_4ad1a0ab-b18d-480e-9e35-129ee32e3cc4" xlink:to="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_d0965b7a-0ba7-4219-af6e-92a68e100ac4" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromEquityMethodInvestments_81fa712b-1f1d-44e2-8c16-9a7186644b07" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeLossFromEquityMethodInvestments"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_4ad1a0ab-b18d-480e-9e35-129ee32e3cc4" xlink:to="loc_us-gaap_IncomeLossFromEquityMethodInvestments_81fa712b-1f1d-44e2-8c16-9a7186644b07" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentIncomeInterest_dd6ddf27-bc7b-41e0-879c-70bb9ca4ae40" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InvestmentIncomeInterest"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_4ad1a0ab-b18d-480e-9e35-129ee32e3cc4" xlink:to="loc_us-gaap_InvestmentIncomeInterest_dd6ddf27-bc7b-41e0-879c-70bb9ca4ae40" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestExpense_c6492cd9-52c8-4189-8b74-afe2d49a3704" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InterestExpense"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_4ad1a0ab-b18d-480e-9e35-129ee32e3cc4" xlink:to="loc_us-gaap_InterestExpense_c6492cd9-52c8-4189-8b74-afe2d49a3704" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestIncomeExpenseNonoperatingNet_ad526b5b-8562-4e4b-b6fd-01e2004843a2" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InterestIncomeExpenseNonoperatingNet"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_4ad1a0ab-b18d-480e-9e35-129ee32e3cc4" xlink:to="loc_us-gaap_InterestIncomeExpenseNonoperatingNet_ad526b5b-8562-4e4b-b6fd-01e2004843a2" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Assets_2667bdde-5151-4325-8ed1-1114a0448789" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_Assets"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_4ad1a0ab-b18d-480e-9e35-129ee32e3cc4" xlink:to="loc_us-gaap_Assets_2667bdde-5151-4325-8ed1-1114a0448789" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DepreciationAndAmortization_3fe485e1-a284-406f-82b9-3d22ab5ecf50" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DepreciationAndAmortization"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_4ad1a0ab-b18d-480e-9e35-129ee32e3cc4" xlink:to="loc_us-gaap_DepreciationAndAmortization_3fe485e1-a284-406f-82b9-3d22ab5ecf50" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseRightOfUseAssetAmortizationExpense_4d416a02-2e46-4ca1-bf06-8ddd747e0feb" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingLeaseRightOfUseAssetAmortizationExpense"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_4ad1a0ab-b18d-480e-9e35-129ee32e3cc4" xlink:to="loc_us-gaap_OperatingLeaseRightOfUseAssetAmortizationExpense_4d416a02-2e46-4ca1-bf06-8ddd747e0feb" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_cron_AdjustedEarningsBeforeInterestTaxesDepreciationAndAmortization_8a1d60e1-39cc-4146-ac33-cc77d75bfc11" xlink:href="cron-20210630.xsd#cron_AdjustedEarningsBeforeInterestTaxesDepreciationAndAmortization"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_4ad1a0ab-b18d-480e-9e35-129ee32e3cc4" xlink:to="loc_cron_AdjustedEarningsBeforeInterestTaxesDepreciationAndAmortization_8a1d60e1-39cc-4146-ac33-cc77d75bfc11" xlink:type="arc" order="8"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentAdditions_2fbc2b8f-5263-41fe-b45f-1afd1d0e1f22" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PropertyPlantAndEquipmentAdditions"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_4ad1a0ab-b18d-480e-9e35-129ee32e3cc4" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentAdditions_2fbc2b8f-5263-41fe-b45f-1afd1d0e1f22" xlink:type="arc" order="9"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_a5e2ed95-9321-4848-a20e-7b68fb1b6b69" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_4ad1a0ab-b18d-480e-9e35-129ee32e3cc4" xlink:to="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_a5e2ed95-9321-4848-a20e-7b68fb1b6b69" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductOrServiceAxis_53aa6a85-380e-4a5a-b0b1-1b8365c59ef2" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_ProductOrServiceAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_a5e2ed95-9321-4848-a20e-7b68fb1b6b69" xlink:to="loc_srt_ProductOrServiceAxis_53aa6a85-380e-4a5a-b0b1-1b8365c59ef2" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductsAndServicesDomain_53aa6a85-380e-4a5a-b0b1-1b8365c59ef2_default" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_ProductsAndServicesDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_ProductOrServiceAxis_53aa6a85-380e-4a5a-b0b1-1b8365c59ef2" xlink:to="loc_srt_ProductsAndServicesDomain_53aa6a85-380e-4a5a-b0b1-1b8365c59ef2_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductsAndServicesDomain_174b2751-edd0-4002-8a89-37242eccbf12" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_ProductsAndServicesDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_ProductOrServiceAxis_53aa6a85-380e-4a5a-b0b1-1b8365c59ef2" xlink:to="loc_srt_ProductsAndServicesDomain_174b2751-edd0-4002-8a89-37242eccbf12" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_cron_CannabisFlowerMember_71846c7c-05f0-4324-aec1-0b0981f3ddda" xlink:href="cron-20210630.xsd#cron_CannabisFlowerMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_ProductsAndServicesDomain_174b2751-edd0-4002-8a89-37242eccbf12" xlink:to="loc_cron_CannabisFlowerMember_71846c7c-05f0-4324-aec1-0b0981f3ddda" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_cron_CannabisExtractsMember_dad839eb-87f7-4419-89e7-b53897f3b2a7" xlink:href="cron-20210630.xsd#cron_CannabisExtractsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_ProductsAndServicesDomain_174b2751-edd0-4002-8a89-37242eccbf12" xlink:to="loc_cron_CannabisExtractsMember_dad839eb-87f7-4419-89e7-b53897f3b2a7" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProductAndServiceOtherMember_4479b2fd-33ed-4771-985a-bb041c121fca" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ProductAndServiceOtherMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_ProductsAndServicesDomain_174b2751-edd0-4002-8a89-37242eccbf12" xlink:to="loc_us-gaap_ProductAndServiceOtherMember_4479b2fd-33ed-4771-985a-bb041c121fca" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ConsolidationItemsAxis_c2f4646f-4779-438c-b731-48005ec5ca1b" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_ConsolidationItemsAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_a5e2ed95-9321-4848-a20e-7b68fb1b6b69" xlink:to="loc_srt_ConsolidationItemsAxis_c2f4646f-4779-438c-b731-48005ec5ca1b" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ConsolidationItemsDomain_c2f4646f-4779-438c-b731-48005ec5ca1b_default" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_ConsolidationItemsDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_ConsolidationItemsAxis_c2f4646f-4779-438c-b731-48005ec5ca1b" xlink:to="loc_srt_ConsolidationItemsDomain_c2f4646f-4779-438c-b731-48005ec5ca1b_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ConsolidationItemsDomain_68d92b8b-2329-43bf-a49c-71734716ba26" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_ConsolidationItemsDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_ConsolidationItemsAxis_c2f4646f-4779-438c-b731-48005ec5ca1b" xlink:to="loc_srt_ConsolidationItemsDomain_68d92b8b-2329-43bf-a49c-71734716ba26" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingSegmentsMember_f3b73c80-1a5c-4601-a4ef-2beb4b2c04ef" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingSegmentsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_ConsolidationItemsDomain_68d92b8b-2329-43bf-a49c-71734716ba26" xlink:to="loc_us-gaap_OperatingSegmentsMember_f3b73c80-1a5c-4601-a4ef-2beb4b2c04ef" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CorporateNonSegmentMember_d1377300-72d5-4c57-82a9-066abac4b8e6" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CorporateNonSegmentMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_ConsolidationItemsDomain_68d92b8b-2329-43bf-a49c-71734716ba26" xlink:to="loc_us-gaap_CorporateNonSegmentMember_d1377300-72d5-4c57-82a9-066abac4b8e6" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementBusinessSegmentsAxis_d984e0e9-6d8b-4517-b01e-23feb26c4971" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementBusinessSegmentsAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_a5e2ed95-9321-4848-a20e-7b68fb1b6b69" xlink:to="loc_us-gaap_StatementBusinessSegmentsAxis_d984e0e9-6d8b-4517-b01e-23feb26c4971" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentDomain_d984e0e9-6d8b-4517-b01e-23feb26c4971_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SegmentDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_StatementBusinessSegmentsAxis_d984e0e9-6d8b-4517-b01e-23feb26c4971" xlink:to="loc_us-gaap_SegmentDomain_d984e0e9-6d8b-4517-b01e-23feb26c4971_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentDomain_8014214e-0e8d-4524-b230-9aa1b7db17c3" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SegmentDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_StatementBusinessSegmentsAxis_d984e0e9-6d8b-4517-b01e-23feb26c4971" xlink:to="loc_us-gaap_SegmentDomain_8014214e-0e8d-4524-b230-9aa1b7db17c3" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_cron_UnitedStatesSegmentMember_d123d51e-9cf6-4da7-89a6-b3346ae904b8" xlink:href="cron-20210630.xsd#cron_UnitedStatesSegmentMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentDomain_8014214e-0e8d-4524-b230-9aa1b7db17c3" xlink:to="loc_cron_UnitedStatesSegmentMember_d123d51e-9cf6-4da7-89a6-b3346ae904b8" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_cron_RestOfWorldSegmentMember_91cecc9e-4c79-4a97-95cb-b2f482e8e371" xlink:href="cron-20210630.xsd#cron_RestOfWorldSegmentMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentDomain_8014214e-0e8d-4524-b230-9aa1b7db17c3" xlink:to="loc_cron_RestOfWorldSegmentMember_91cecc9e-4c79-4a97-95cb-b2f482e8e371" xlink:type="arc" order="1"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://thecronosgroup.com/role/SegmentInformationScheduleofAdjustedEBITDADetails" xlink:type="simple" xlink:href="cron-20210630.xsd#SegmentInformationScheduleofAdjustedEBITDADetails"/>
  <link:definitionLink xlink:role="http://thecronosgroup.com/role/SegmentInformationScheduleofAdjustedEBITDADetails" xlink:type="extended" id="ie36227bfd82a4de3847bcecf9a92a9d3_SegmentInformationScheduleofAdjustedEBITDADetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentReportingInformationLineItems_d1307834-6e82-4b5f-a542-76204c3b4836" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SegmentReportingInformationLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProfitLoss_742a782d-32dd-4a64-b18c-14206dae37bd" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ProfitLoss"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_d1307834-6e82-4b5f-a542-76204c3b4836" xlink:to="loc_us-gaap_ProfitLoss_742a782d-32dd-4a64-b18c-14206dae37bd" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestIncomeExpenseNonoperatingNet_12202bdc-5976-4f94-9d1f-e583e3f6ea0b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InterestIncomeExpenseNonoperatingNet"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_d1307834-6e82-4b5f-a542-76204c3b4836" xlink:to="loc_us-gaap_InterestIncomeExpenseNonoperatingNet_12202bdc-5976-4f94-9d1f-e583e3f6ea0b" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromEquityMethodInvestments_e3f94681-b7b0-4b4a-9535-41092e42e310" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeLossFromEquityMethodInvestments"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_d1307834-6e82-4b5f-a542-76204c3b4836" xlink:to="loc_us-gaap_IncomeLossFromEquityMethodInvestments_e3f94681-b7b0-4b4a-9535-41092e42e310" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetImpairmentCharges_7aed31a3-ac88-42a4-a7e6-bc575dbb9a16" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AssetImpairmentCharges"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_d1307834-6e82-4b5f-a542-76204c3b4836" xlink:to="loc_us-gaap_AssetImpairmentCharges_7aed31a3-ac88-42a4-a7e6-bc575dbb9a16" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GainLossOnDerivativeInstrumentsNetPretax_1ee18f08-e412-46b7-88c6-1fac6e505ef6" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_GainLossOnDerivativeInstrumentsNetPretax"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_d1307834-6e82-4b5f-a542-76204c3b4836" xlink:to="loc_us-gaap_GainLossOnDerivativeInstrumentsNetPretax_1ee18f08-e412-46b7-88c6-1fac6e505ef6" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringCharges_8b7e0137-1f71-479d-839f-543dd2c1e93c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RestructuringCharges"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_d1307834-6e82-4b5f-a542-76204c3b4836" xlink:to="loc_us-gaap_RestructuringCharges_8b7e0137-1f71-479d-839f-543dd2c1e93c" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherNonoperatingIncomeExpense_fcd1c198-aa44-423c-9d3b-7e2568e3748f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherNonoperatingIncomeExpense"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_d1307834-6e82-4b5f-a542-76204c3b4836" xlink:to="loc_us-gaap_OtherNonoperatingIncomeExpense_fcd1c198-aa44-423c-9d3b-7e2568e3748f" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTax_2c6b1982-776c-401a-8014-cf5b67ccdda4" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTax"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_d1307834-6e82-4b5f-a542-76204c3b4836" xlink:to="loc_us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTax_2c6b1982-776c-401a-8014-cf5b67ccdda4" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AllocatedShareBasedCompensationExpense_03df6c56-5717-47d7-ab2f-540e40d16dc6" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AllocatedShareBasedCompensationExpense"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_d1307834-6e82-4b5f-a542-76204c3b4836" xlink:to="loc_us-gaap_AllocatedShareBasedCompensationExpense_03df6c56-5717-47d7-ab2f-540e40d16dc6" xlink:type="arc" order="8"/>
    <link:loc xlink:type="locator" xlink:label="loc_cron_RestatementReviewExpense_68678676-e131-44b1-9dab-8f6958d109b9" xlink:href="cron-20210630.xsd#cron_RestatementReviewExpense"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_d1307834-6e82-4b5f-a542-76204c3b4836" xlink:to="loc_cron_RestatementReviewExpense_68678676-e131-44b1-9dab-8f6958d109b9" xlink:type="arc" order="9"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DepreciationDepletionAndAmortization_0c2f5afb-b9bd-4823-8a0b-5fbc6c6fd160" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DepreciationDepletionAndAmortization"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_d1307834-6e82-4b5f-a542-76204c3b4836" xlink:to="loc_us-gaap_DepreciationDepletionAndAmortization_0c2f5afb-b9bd-4823-8a0b-5fbc6c6fd160" xlink:type="arc" order="10"/>
    <link:loc xlink:type="locator" xlink:label="loc_cron_AdjustedEarningsBeforeInterestTaxesDepreciationAndAmortization_5fc3f49c-86ec-43d8-9c2d-12cc8915bd65" xlink:href="cron-20210630.xsd#cron_AdjustedEarningsBeforeInterestTaxesDepreciationAndAmortization"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_d1307834-6e82-4b5f-a542-76204c3b4836" xlink:to="loc_cron_AdjustedEarningsBeforeInterestTaxesDepreciationAndAmortization_5fc3f49c-86ec-43d8-9c2d-12cc8915bd65" xlink:type="arc" order="11"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_f016d413-94b1-4707-b16d-2b91b8b429ed" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_d1307834-6e82-4b5f-a542-76204c3b4836" xlink:to="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_f016d413-94b1-4707-b16d-2b91b8b429ed" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ConsolidationItemsAxis_3b53b6c8-d81b-426c-b85a-72b29031ed56" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_ConsolidationItemsAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_f016d413-94b1-4707-b16d-2b91b8b429ed" xlink:to="loc_srt_ConsolidationItemsAxis_3b53b6c8-d81b-426c-b85a-72b29031ed56" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ConsolidationItemsDomain_3b53b6c8-d81b-426c-b85a-72b29031ed56_default" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_ConsolidationItemsDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_ConsolidationItemsAxis_3b53b6c8-d81b-426c-b85a-72b29031ed56" xlink:to="loc_srt_ConsolidationItemsDomain_3b53b6c8-d81b-426c-b85a-72b29031ed56_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ConsolidationItemsDomain_24d0c395-706f-4e92-867e-01891c9c5689" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_ConsolidationItemsDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_ConsolidationItemsAxis_3b53b6c8-d81b-426c-b85a-72b29031ed56" xlink:to="loc_srt_ConsolidationItemsDomain_24d0c395-706f-4e92-867e-01891c9c5689" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingSegmentsMember_559371fd-a151-4fe2-a4a8-723eafbe59b9" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingSegmentsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_ConsolidationItemsDomain_24d0c395-706f-4e92-867e-01891c9c5689" xlink:to="loc_us-gaap_OperatingSegmentsMember_559371fd-a151-4fe2-a4a8-723eafbe59b9" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CorporateNonSegmentMember_5ca5b8a2-12c7-4da5-8b98-672d2cf34890" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CorporateNonSegmentMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_ConsolidationItemsDomain_24d0c395-706f-4e92-867e-01891c9c5689" xlink:to="loc_us-gaap_CorporateNonSegmentMember_5ca5b8a2-12c7-4da5-8b98-672d2cf34890" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementBusinessSegmentsAxis_e4cec899-bf0f-49cd-90dd-4464fe072589" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementBusinessSegmentsAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_f016d413-94b1-4707-b16d-2b91b8b429ed" xlink:to="loc_us-gaap_StatementBusinessSegmentsAxis_e4cec899-bf0f-49cd-90dd-4464fe072589" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentDomain_e4cec899-bf0f-49cd-90dd-4464fe072589_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SegmentDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_StatementBusinessSegmentsAxis_e4cec899-bf0f-49cd-90dd-4464fe072589" xlink:to="loc_us-gaap_SegmentDomain_e4cec899-bf0f-49cd-90dd-4464fe072589_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentDomain_0c5c34de-74b9-44fb-8055-5ddf33de213e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SegmentDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_StatementBusinessSegmentsAxis_e4cec899-bf0f-49cd-90dd-4464fe072589" xlink:to="loc_us-gaap_SegmentDomain_0c5c34de-74b9-44fb-8055-5ddf33de213e" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_cron_UnitedStatesSegmentMember_5ca5a307-2581-4668-b7c1-10a9a04a1447" xlink:href="cron-20210630.xsd#cron_UnitedStatesSegmentMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentDomain_0c5c34de-74b9-44fb-8055-5ddf33de213e" xlink:to="loc_cron_UnitedStatesSegmentMember_5ca5a307-2581-4668-b7c1-10a9a04a1447" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_cron_RestOfWorldSegmentMember_25dc3c9f-5038-46e5-acd9-74395f2fb15e" xlink:href="cron-20210630.xsd#cron_RestOfWorldSegmentMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentDomain_0c5c34de-74b9-44fb-8055-5ddf33de213e" xlink:to="loc_cron_RestOfWorldSegmentMember_25dc3c9f-5038-46e5-acd9-74395f2fb15e" xlink:type="arc" order="1"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://thecronosgroup.com/role/SegmentInformationScheduleofRevenuefromExternalCustomersbyGeographicAreasDetails" xlink:type="simple" xlink:href="cron-20210630.xsd#SegmentInformationScheduleofRevenuefromExternalCustomersbyGeographicAreasDetails"/>
  <link:definitionLink xlink:role="http://thecronosgroup.com/role/SegmentInformationScheduleofRevenuefromExternalCustomersbyGeographicAreasDetails" xlink:type="extended" id="i655a87e92d1e42a0a0afbadff2528847_SegmentInformationScheduleofRevenuefromExternalCustomersbyGeographicAreasDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenuesFromExternalCustomersAndLongLivedAssetsLineItems_238058b8-470b-4be9-8074-ff22b3377205" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RevenuesFromExternalCustomersAndLongLivedAssetsLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_f2d6244a-c3b2-454f-9b4e-18918b97443d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RevenuesFromExternalCustomersAndLongLivedAssetsLineItems_238058b8-470b-4be9-8074-ff22b3377205" xlink:to="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_f2d6244a-c3b2-454f-9b4e-18918b97443d" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfRevenuesFromExternalCustomersAndLongLivedAssetsTable_4422931b-14b3-4167-9b8d-68c3ea75a16c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfRevenuesFromExternalCustomersAndLongLivedAssetsTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_RevenuesFromExternalCustomersAndLongLivedAssetsLineItems_238058b8-470b-4be9-8074-ff22b3377205" xlink:to="loc_us-gaap_ScheduleOfRevenuesFromExternalCustomersAndLongLivedAssetsTable_4422931b-14b3-4167-9b8d-68c3ea75a16c" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_StatementGeographicalAxis_0129a438-d310-4165-aa33-70b086093cd0" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_StatementGeographicalAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfRevenuesFromExternalCustomersAndLongLivedAssetsTable_4422931b-14b3-4167-9b8d-68c3ea75a16c" xlink:to="loc_srt_StatementGeographicalAxis_0129a438-d310-4165-aa33-70b086093cd0" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_SegmentGeographicalDomain_0129a438-d310-4165-aa33-70b086093cd0_default" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_SegmentGeographicalDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_StatementGeographicalAxis_0129a438-d310-4165-aa33-70b086093cd0" xlink:to="loc_srt_SegmentGeographicalDomain_0129a438-d310-4165-aa33-70b086093cd0_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_SegmentGeographicalDomain_6a32f9e3-9eb9-4930-a97c-00cda1347ea9" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_SegmentGeographicalDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_StatementGeographicalAxis_0129a438-d310-4165-aa33-70b086093cd0" xlink:to="loc_srt_SegmentGeographicalDomain_6a32f9e3-9eb9-4930-a97c-00cda1347ea9" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_country_CA_55e3d676-2c63-4587-ae78-1d8b65d8b00f" xlink:href="https://xbrl.sec.gov/country/2021/country-2021.xsd#country_CA"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_SegmentGeographicalDomain_6a32f9e3-9eb9-4930-a97c-00cda1347ea9" xlink:to="loc_country_CA_55e3d676-2c63-4587-ae78-1d8b65d8b00f" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_country_US_9c7b5ac0-19f9-4d12-964b-9a42f51f4109" xlink:href="https://xbrl.sec.gov/country/2021/country-2021.xsd#country_US"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_SegmentGeographicalDomain_6a32f9e3-9eb9-4930-a97c-00cda1347ea9" xlink:to="loc_country_US_9c7b5ac0-19f9-4d12-964b-9a42f51f4109" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_country_IL_5979ff37-93e7-4a34-b401-38a6d748a084" xlink:href="https://xbrl.sec.gov/country/2021/country-2021.xsd#country_IL"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_SegmentGeographicalDomain_6a32f9e3-9eb9-4930-a97c-00cda1347ea9" xlink:to="loc_country_IL_5979ff37-93e7-4a34-b401-38a6d748a084" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_cron_OtherCountriesMember_8dbbdf2f-4ca6-4a0f-9878-59e215b302c6" xlink:href="cron-20210630.xsd#cron_OtherCountriesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_SegmentGeographicalDomain_6a32f9e3-9eb9-4930-a97c-00cda1347ea9" xlink:to="loc_cron_OtherCountriesMember_8dbbdf2f-4ca6-4a0f-9878-59e215b302c6" xlink:type="arc" order="3"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://thecronosgroup.com/role/SegmentInformationScheduleofLonglivedAssetsbyGeographicAreasDetails" xlink:type="simple" xlink:href="cron-20210630.xsd#SegmentInformationScheduleofLonglivedAssetsbyGeographicAreasDetails"/>
  <link:definitionLink xlink:role="http://thecronosgroup.com/role/SegmentInformationScheduleofLonglivedAssetsbyGeographicAreasDetails" xlink:type="extended" id="i256c0e5cb53a43b0a92ca79141e50a50_SegmentInformationScheduleofLonglivedAssetsbyGeographicAreasDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenuesFromExternalCustomersAndLongLivedAssetsLineItems_624e6d94-f43a-4e90-ae9c-627bc7859ebc" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RevenuesFromExternalCustomersAndLongLivedAssetsLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NoncurrentAssets_82fd1116-dd50-4a52-b202-12742628c4c5" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NoncurrentAssets"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RevenuesFromExternalCustomersAndLongLivedAssetsLineItems_624e6d94-f43a-4e90-ae9c-627bc7859ebc" xlink:to="loc_us-gaap_NoncurrentAssets_82fd1116-dd50-4a52-b202-12742628c4c5" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfRevenuesFromExternalCustomersAndLongLivedAssetsTable_efddf121-6a92-4eeb-ad4a-7b4d3dae4a09" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfRevenuesFromExternalCustomersAndLongLivedAssetsTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_RevenuesFromExternalCustomersAndLongLivedAssetsLineItems_624e6d94-f43a-4e90-ae9c-627bc7859ebc" xlink:to="loc_us-gaap_ScheduleOfRevenuesFromExternalCustomersAndLongLivedAssetsTable_efddf121-6a92-4eeb-ad4a-7b4d3dae4a09" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_StatementGeographicalAxis_08b324e5-7d02-4483-a03e-a08241813475" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_StatementGeographicalAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfRevenuesFromExternalCustomersAndLongLivedAssetsTable_efddf121-6a92-4eeb-ad4a-7b4d3dae4a09" xlink:to="loc_srt_StatementGeographicalAxis_08b324e5-7d02-4483-a03e-a08241813475" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_SegmentGeographicalDomain_08b324e5-7d02-4483-a03e-a08241813475_default" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_SegmentGeographicalDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_StatementGeographicalAxis_08b324e5-7d02-4483-a03e-a08241813475" xlink:to="loc_srt_SegmentGeographicalDomain_08b324e5-7d02-4483-a03e-a08241813475_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_SegmentGeographicalDomain_12d17952-615b-4a4c-8d6c-2ce2b428458d" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_SegmentGeographicalDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_StatementGeographicalAxis_08b324e5-7d02-4483-a03e-a08241813475" xlink:to="loc_srt_SegmentGeographicalDomain_12d17952-615b-4a4c-8d6c-2ce2b428458d" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_country_CA_ad2a15c5-ee12-4dd8-8e71-e479c1af6b60" xlink:href="https://xbrl.sec.gov/country/2021/country-2021.xsd#country_CA"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_SegmentGeographicalDomain_12d17952-615b-4a4c-8d6c-2ce2b428458d" xlink:to="loc_country_CA_ad2a15c5-ee12-4dd8-8e71-e479c1af6b60" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_country_IL_936f478e-34e3-49b8-b5a8-b810a32e0e7a" xlink:href="https://xbrl.sec.gov/country/2021/country-2021.xsd#country_IL"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_SegmentGeographicalDomain_12d17952-615b-4a4c-8d6c-2ce2b428458d" xlink:to="loc_country_IL_936f478e-34e3-49b8-b5a8-b810a32e0e7a" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_country_US_4612fca5-f3fc-4fff-866d-001b7095f2a0" xlink:href="https://xbrl.sec.gov/country/2021/country-2021.xsd#country_US"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_SegmentGeographicalDomain_12d17952-615b-4a4c-8d6c-2ce2b428458d" xlink:to="loc_country_US_4612fca5-f3fc-4fff-866d-001b7095f2a0" xlink:type="arc" order="2"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://thecronosgroup.com/role/CommitmentsandContingenciesDetails" xlink:type="simple" xlink:href="cron-20210630.xsd#CommitmentsandContingenciesDetails"/>
  <link:definitionLink xlink:role="http://thecronosgroup.com/role/CommitmentsandContingenciesDetails" xlink:type="extended" id="ib85e1c1504ed4d629bdd7bde57a64f3b_CommitmentsandContingenciesDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LossContingenciesLineItems_ae654244-64cd-441f-9ed3-ef33f5a41086" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LossContingenciesLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LossContingencyNumberOfPlaintiffs_ddaf5e8a-e67b-4091-9f66-a727527f91e7" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LossContingencyNumberOfPlaintiffs"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LossContingenciesLineItems_ae654244-64cd-441f-9ed3-ef33f5a41086" xlink:to="loc_us-gaap_LossContingencyNumberOfPlaintiffs_ddaf5e8a-e67b-4091-9f66-a727527f91e7" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LossContingencyNewClaimsFiledNumber_490a423a-f1d7-4d8c-95af-783a1216ac56" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LossContingencyNewClaimsFiledNumber"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LossContingenciesLineItems_ae654244-64cd-441f-9ed3-ef33f5a41086" xlink:to="loc_us-gaap_LossContingencyNewClaimsFiledNumber_490a423a-f1d7-4d8c-95af-783a1216ac56" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LossContingencyDamagesSoughtValue_f6186454-2f79-4c96-9a85-ca2a36f958ae" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LossContingencyDamagesSoughtValue"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LossContingenciesLineItems_ae654244-64cd-441f-9ed3-ef33f5a41086" xlink:to="loc_us-gaap_LossContingencyDamagesSoughtValue_f6186454-2f79-4c96-9a85-ca2a36f958ae" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_cron_LossContingencyPunitiveDamagesSoughtValue_00f57145-d319-4f62-941b-2ba87c7c4984" xlink:href="cron-20210630.xsd#cron_LossContingencyPunitiveDamagesSoughtValue"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LossContingenciesLineItems_ae654244-64cd-441f-9ed3-ef33f5a41086" xlink:to="loc_cron_LossContingencyPunitiveDamagesSoughtValue_00f57145-d319-4f62-941b-2ba87c7c4984" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LossContingenciesTable_804a346d-558f-427c-a154-de5aebe549b6" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LossContingenciesTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_LossContingenciesLineItems_ae654244-64cd-441f-9ed3-ef33f5a41086" xlink:to="loc_us-gaap_LossContingenciesTable_804a346d-558f-427c-a154-de5aebe549b6" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_LitigationCaseAxis_f8cbd56b-af22-4394-9df3-ec2c01fd5cc9" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_LitigationCaseAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_LossContingenciesTable_804a346d-558f-427c-a154-de5aebe549b6" xlink:to="loc_srt_LitigationCaseAxis_f8cbd56b-af22-4394-9df3-ec2c01fd5cc9" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_LitigationCaseTypeDomain_f8cbd56b-af22-4394-9df3-ec2c01fd5cc9_default" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_LitigationCaseTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_LitigationCaseAxis_f8cbd56b-af22-4394-9df3-ec2c01fd5cc9" xlink:to="loc_srt_LitigationCaseTypeDomain_f8cbd56b-af22-4394-9df3-ec2c01fd5cc9_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_LitigationCaseTypeDomain_9c611218-22ac-453e-b8fc-5a2b5c8dfcb1" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_LitigationCaseTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_LitigationCaseAxis_f8cbd56b-af22-4394-9df3-ec2c01fd5cc9" xlink:to="loc_srt_LitigationCaseTypeDomain_9c611218-22ac-453e-b8fc-5a2b5c8dfcb1" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_cron_USDistrictCourtOfEasternDistrictOfNewYorkVsCronosMember_5fddf62e-fc56-4a26-b1c1-2df547dfd545" xlink:href="cron-20210630.xsd#cron_USDistrictCourtOfEasternDistrictOfNewYorkVsCronosMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_LitigationCaseTypeDomain_9c611218-22ac-453e-b8fc-5a2b5c8dfcb1" xlink:to="loc_cron_USDistrictCourtOfEasternDistrictOfNewYorkVsCronosMember_5fddf62e-fc56-4a26-b1c1-2df547dfd545" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LitigationStatusAxis_2fafe1f2-6845-41ed-8e00-e129965bc2d3" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LitigationStatusAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_LossContingenciesTable_804a346d-558f-427c-a154-de5aebe549b6" xlink:to="loc_us-gaap_LitigationStatusAxis_2fafe1f2-6845-41ed-8e00-e129965bc2d3" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LitigationStatusDomain_2fafe1f2-6845-41ed-8e00-e129965bc2d3_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LitigationStatusDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_LitigationStatusAxis_2fafe1f2-6845-41ed-8e00-e129965bc2d3" xlink:to="loc_us-gaap_LitigationStatusDomain_2fafe1f2-6845-41ed-8e00-e129965bc2d3_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LitigationStatusDomain_3b8f11f4-8d02-4b89-959f-1b85c70fb8c2" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LitigationStatusDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_LitigationStatusAxis_2fafe1f2-6845-41ed-8e00-e129965bc2d3" xlink:to="loc_us-gaap_LitigationStatusDomain_3b8f11f4-8d02-4b89-959f-1b85c70fb8c2" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PendingLitigationMember_e42d7673-caf5-447e-8fd6-3c60776f88e8" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PendingLitigationMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LitigationStatusDomain_3b8f11f4-8d02-4b89-959f-1b85c70fb8c2" xlink:to="loc_us-gaap_PendingLitigationMember_e42d7673-caf5-447e-8fd6-3c60776f88e8" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LossContingenciesByNatureOfContingencyAxis_bf39c466-c792-4253-b1f8-06afc988a522" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LossContingenciesByNatureOfContingencyAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_LossContingenciesTable_804a346d-558f-427c-a154-de5aebe549b6" xlink:to="loc_us-gaap_LossContingenciesByNatureOfContingencyAxis_bf39c466-c792-4253-b1f8-06afc988a522" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LossContingencyNatureDomain_bf39c466-c792-4253-b1f8-06afc988a522_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LossContingencyNatureDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_LossContingenciesByNatureOfContingencyAxis_bf39c466-c792-4253-b1f8-06afc988a522" xlink:to="loc_us-gaap_LossContingencyNatureDomain_bf39c466-c792-4253-b1f8-06afc988a522_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LossContingencyNatureDomain_e5644be3-7f6e-411e-b589-a56e733a2be6" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LossContingencyNatureDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_LossContingenciesByNatureOfContingencyAxis_bf39c466-c792-4253-b1f8-06afc988a522" xlink:to="loc_us-gaap_LossContingencyNatureDomain_e5644be3-7f6e-411e-b589-a56e733a2be6" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UnfavorableRegulatoryActionMember_db29d6e0-521e-4db1-b503-625465fa5862" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_UnfavorableRegulatoryActionMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LossContingencyNatureDomain_e5644be3-7f6e-411e-b589-a56e733a2be6" xlink:to="loc_us-gaap_UnfavorableRegulatoryActionMember_db29d6e0-521e-4db1-b503-625465fa5862" xlink:type="arc" order="0"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://thecronosgroup.com/role/FinancialInstrumentsScheduleofFairValueofAssetsMeasuredonRecurringBasisDetails" xlink:type="simple" xlink:href="cron-20210630.xsd#FinancialInstrumentsScheduleofFairValueofAssetsMeasuredonRecurringBasisDetails"/>
  <link:definitionLink xlink:role="http://thecronosgroup.com/role/FinancialInstrumentsScheduleofFairValueofAssetsMeasuredonRecurringBasisDetails" xlink:type="extended" id="ie938a0a322974c398345ab6bcc37544d_FinancialInstrumentsScheduleofFairValueofAssetsMeasuredonRecurringBasisDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_cccb5528-98c9-48de-8fc8-aacca428d9e4" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashAndCashEquivalentsFairValueDisclosure_35e07873-f479-4c06-9918-54337b0d782d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CashAndCashEquivalentsFairValueDisclosure"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_cccb5528-98c9-48de-8fc8-aacca428d9e4" xlink:to="loc_us-gaap_CashAndCashEquivalentsFairValueDisclosure_35e07873-f479-4c06-9918-54337b0d782d" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleSecuritiesDebtSecurities_d9e7e71a-4c17-4966-99b1-03d88968d36f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AvailableForSaleSecuritiesDebtSecurities"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_cccb5528-98c9-48de-8fc8-aacca428d9e4" xlink:to="loc_us-gaap_AvailableForSaleSecuritiesDebtSecurities_d9e7e71a-4c17-4966-99b1-03d88968d36f" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeLiabilities_1015af7c-bec9-46c0-a41f-67ec84d2fc0d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DerivativeLiabilities"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_cccb5528-98c9-48de-8fc8-aacca428d9e4" xlink:to="loc_us-gaap_DerivativeLiabilities_1015af7c-bec9-46c0-a41f-67ec84d2fc0d" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_a7565cbe-fc1f-4f33-9f8e-5938834ea1b2" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_cccb5528-98c9-48de-8fc8-aacca428d9e4" xlink:to="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_a7565cbe-fc1f-4f33-9f8e-5938834ea1b2" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueByMeasurementFrequencyAxis_0d012536-f460-48a5-af29-ef5deb1373cc" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueByMeasurementFrequencyAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_a7565cbe-fc1f-4f33-9f8e-5938834ea1b2" xlink:to="loc_us-gaap_FairValueByMeasurementFrequencyAxis_0d012536-f460-48a5-af29-ef5deb1373cc" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementFrequencyDomain_0d012536-f460-48a5-af29-ef5deb1373cc_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueMeasurementFrequencyDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_FairValueByMeasurementFrequencyAxis_0d012536-f460-48a5-af29-ef5deb1373cc" xlink:to="loc_us-gaap_FairValueMeasurementFrequencyDomain_0d012536-f460-48a5-af29-ef5deb1373cc_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementFrequencyDomain_855ccf78-08a2-48fa-9615-09748c57b07b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueMeasurementFrequencyDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_FairValueByMeasurementFrequencyAxis_0d012536-f460-48a5-af29-ef5deb1373cc" xlink:to="loc_us-gaap_FairValueMeasurementFrequencyDomain_855ccf78-08a2-48fa-9615-09748c57b07b" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementsRecurringMember_197f58d2-d9dd-4782-971d-066cc4a231a8" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueMeasurementsRecurringMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueMeasurementFrequencyDomain_855ccf78-08a2-48fa-9615-09748c57b07b" xlink:to="loc_us-gaap_FairValueMeasurementsRecurringMember_197f58d2-d9dd-4782-971d-066cc4a231a8" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_485f9a27-b6d6-4d60-bc49-b62b1d61dc83" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueByFairValueHierarchyLevelAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_a7565cbe-fc1f-4f33-9f8e-5938834ea1b2" xlink:to="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_485f9a27-b6d6-4d60-bc49-b62b1d61dc83" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_485f9a27-b6d6-4d60-bc49-b62b1d61dc83_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueMeasurementsFairValueHierarchyDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_485f9a27-b6d6-4d60-bc49-b62b1d61dc83" xlink:to="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_485f9a27-b6d6-4d60-bc49-b62b1d61dc83_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_96a2fb9a-bf28-4c36-be41-c95b850926a9" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueMeasurementsFairValueHierarchyDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_485f9a27-b6d6-4d60-bc49-b62b1d61dc83" xlink:to="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_96a2fb9a-bf28-4c36-be41-c95b850926a9" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueInputsLevel1Member_d96b2292-4792-4f24-a953-5bc25c4354f9" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueInputsLevel1Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_96a2fb9a-bf28-4c36-be41-c95b850926a9" xlink:to="loc_us-gaap_FairValueInputsLevel1Member_d96b2292-4792-4f24-a953-5bc25c4354f9" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueInputsLevel2Member_f8b0ef85-8f0b-4d2c-b0d7-89e1a29b0766" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueInputsLevel2Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_96a2fb9a-bf28-4c36-be41-c95b850926a9" xlink:to="loc_us-gaap_FairValueInputsLevel2Member_f8b0ef85-8f0b-4d2c-b0d7-89e1a29b0766" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueInputsLevel3Member_74d2f5fd-70e6-4676-b46f-1c990bf9dd99" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueInputsLevel3Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_96a2fb9a-bf28-4c36-be41-c95b850926a9" xlink:to="loc_us-gaap_FairValueInputsLevel3Member_74d2f5fd-70e6-4676-b46f-1c990bf9dd99" xlink:type="arc" order="2"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://thecronosgroup.com/role/FinancialInstrumentsCreditRiskNarrativeDetails" xlink:type="simple" xlink:href="cron-20210630.xsd#FinancialInstrumentsCreditRiskNarrativeDetails"/>
  <link:definitionLink xlink:role="http://thecronosgroup.com/role/FinancialInstrumentsCreditRiskNarrativeDetails" xlink:type="extended" id="iae1b407f12154aa88af84380f9d4d309_FinancialInstrumentsCreditRiskNarrativeDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskLineItems_110b5da5-c470-4f66-b717-08e097f5ca93" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ConcentrationRiskLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskCreditRiskFinancialInstrumentMaximumExposure_23e0b7ed-6426-474b-b590-1f4efc4c4631" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ConcentrationRiskCreditRiskFinancialInstrumentMaximumExposure"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ConcentrationRiskLineItems_110b5da5-c470-4f66-b717-08e097f5ca93" xlink:to="loc_us-gaap_ConcentrationRiskCreditRiskFinancialInstrumentMaximumExposure_23e0b7ed-6426-474b-b590-1f4efc4c4631" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountsReceivableNoncurrentThresholdPeriodPastDueWriteoff_ce546eaa-4832-4eec-8490-21ff1ea59e18" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccountsReceivableNoncurrentThresholdPeriodPastDueWriteoff"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ConcentrationRiskLineItems_110b5da5-c470-4f66-b717-08e097f5ca93" xlink:to="loc_us-gaap_AccountsReceivableNoncurrentThresholdPeriodPastDueWriteoff_ce546eaa-4832-4eec-8490-21ff1ea59e18" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AllowanceForDoubtfulAccountsReceivableCurrent_1d25c227-a39e-4b0c-b1db-2c4adb183dd0" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AllowanceForDoubtfulAccountsReceivableCurrent"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ConcentrationRiskLineItems_110b5da5-c470-4f66-b717-08e097f5ca93" xlink:to="loc_us-gaap_AllowanceForDoubtfulAccountsReceivableCurrent_1d25c227-a39e-4b0c-b1db-2c4adb183dd0" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskPercentage1_9f9fcc85-94db-4ea6-8f46-1f7bcb2b6f87" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ConcentrationRiskPercentage1"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ConcentrationRiskLineItems_110b5da5-c470-4f66-b717-08e097f5ca93" xlink:to="loc_us-gaap_ConcentrationRiskPercentage1_9f9fcc85-94db-4ea6-8f46-1f7bcb2b6f87" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskTable_dd7e93dd-c983-4419-b12c-8c2eb197a259" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ConcentrationRiskTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_ConcentrationRiskLineItems_110b5da5-c470-4f66-b717-08e097f5ca93" xlink:to="loc_us-gaap_ConcentrationRiskTable_dd7e93dd-c983-4419-b12c-8c2eb197a259" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskByBenchmarkAxis_8c6fcb9c-f5c7-4d4d-a59d-df0a337ed0db" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ConcentrationRiskByBenchmarkAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ConcentrationRiskTable_dd7e93dd-c983-4419-b12c-8c2eb197a259" xlink:to="loc_us-gaap_ConcentrationRiskByBenchmarkAxis_8c6fcb9c-f5c7-4d4d-a59d-df0a337ed0db" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskBenchmarkDomain_8c6fcb9c-f5c7-4d4d-a59d-df0a337ed0db_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ConcentrationRiskBenchmarkDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_ConcentrationRiskByBenchmarkAxis_8c6fcb9c-f5c7-4d4d-a59d-df0a337ed0db" xlink:to="loc_us-gaap_ConcentrationRiskBenchmarkDomain_8c6fcb9c-f5c7-4d4d-a59d-df0a337ed0db_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskBenchmarkDomain_51be1f2e-611f-4dce-b97f-0980676e000d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ConcentrationRiskBenchmarkDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_ConcentrationRiskByBenchmarkAxis_8c6fcb9c-f5c7-4d4d-a59d-df0a337ed0db" xlink:to="loc_us-gaap_ConcentrationRiskBenchmarkDomain_51be1f2e-611f-4dce-b97f-0980676e000d" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountsReceivableMember_df5074c0-0699-48ee-946d-ff4f8fa7f639" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccountsReceivableMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ConcentrationRiskBenchmarkDomain_51be1f2e-611f-4dce-b97f-0980676e000d" xlink:to="loc_us-gaap_AccountsReceivableMember_df5074c0-0699-48ee-946d-ff4f8fa7f639" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskByTypeAxis_762f595a-b182-4fb6-8d28-758e08b23516" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ConcentrationRiskByTypeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ConcentrationRiskTable_dd7e93dd-c983-4419-b12c-8c2eb197a259" xlink:to="loc_us-gaap_ConcentrationRiskByTypeAxis_762f595a-b182-4fb6-8d28-758e08b23516" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskTypeDomain_762f595a-b182-4fb6-8d28-758e08b23516_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ConcentrationRiskTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_ConcentrationRiskByTypeAxis_762f595a-b182-4fb6-8d28-758e08b23516" xlink:to="loc_us-gaap_ConcentrationRiskTypeDomain_762f595a-b182-4fb6-8d28-758e08b23516_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskTypeDomain_f8d2db8b-f8e6-4dde-8ba8-353eb932d826" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ConcentrationRiskTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_ConcentrationRiskByTypeAxis_762f595a-b182-4fb6-8d28-758e08b23516" xlink:to="loc_us-gaap_ConcentrationRiskTypeDomain_f8d2db8b-f8e6-4dde-8ba8-353eb932d826" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CreditConcentrationRiskMember_26068578-31bf-45f1-9514-d31105193b29" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CreditConcentrationRiskMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ConcentrationRiskTypeDomain_f8d2db8b-f8e6-4dde-8ba8-353eb932d826" xlink:to="loc_us-gaap_CreditConcentrationRiskMember_26068578-31bf-45f1-9514-d31105193b29" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MajorCustomersAxis_a3497dda-9ea7-4422-bf61-a9527e8093c6" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_MajorCustomersAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ConcentrationRiskTable_dd7e93dd-c983-4419-b12c-8c2eb197a259" xlink:to="loc_srt_MajorCustomersAxis_a3497dda-9ea7-4422-bf61-a9527e8093c6" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_NameOfMajorCustomerDomain_a3497dda-9ea7-4422-bf61-a9527e8093c6_default" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_NameOfMajorCustomerDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_MajorCustomersAxis_a3497dda-9ea7-4422-bf61-a9527e8093c6" xlink:to="loc_srt_NameOfMajorCustomerDomain_a3497dda-9ea7-4422-bf61-a9527e8093c6_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_NameOfMajorCustomerDomain_279216bc-aa0c-4425-a93b-34ccbc8464bf" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_NameOfMajorCustomerDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_MajorCustomersAxis_a3497dda-9ea7-4422-bf61-a9527e8093c6" xlink:to="loc_srt_NameOfMajorCustomerDomain_279216bc-aa0c-4425-a93b-34ccbc8464bf" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_cron_FourCustomersMember_868b5e98-b9cf-4155-ac0d-d708ac8cfbf5" xlink:href="cron-20210630.xsd#cron_FourCustomersMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_NameOfMajorCustomerDomain_279216bc-aa0c-4425-a93b-34ccbc8464bf" xlink:to="loc_cron_FourCustomersMember_868b5e98-b9cf-4155-ac0d-d708ac8cfbf5" xlink:type="arc" order="0"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://thecronosgroup.com/role/FinancialInstrumentsLiquidityRiskNarrativeDetails" xlink:type="simple" xlink:href="cron-20210630.xsd#FinancialInstrumentsLiquidityRiskNarrativeDetails"/>
  <link:definitionLink xlink:role="http://thecronosgroup.com/role/FinancialInstrumentsLiquidityRiskNarrativeDetails" xlink:type="extended" id="i4e15c09f23f642dfb3bd2bc1dfb27683_FinancialInstrumentsLiquidityRiskNarrativeDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskLineItems_5c009d6f-214b-43b3-9d98-6d1d1e6718ec" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ConcentrationRiskLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskPercentage1_c6d726b4-fbf7-44a4-85f2-2224639e12a5" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ConcentrationRiskPercentage1"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ConcentrationRiskLineItems_5c009d6f-214b-43b3-9d98-6d1d1e6718ec" xlink:to="loc_us-gaap_ConcentrationRiskPercentage1_c6d726b4-fbf7-44a4-85f2-2224639e12a5" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskTable_49fba6d9-b81d-44cb-9c89-8700b62a75db" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ConcentrationRiskTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_ConcentrationRiskLineItems_5c009d6f-214b-43b3-9d98-6d1d1e6718ec" xlink:to="loc_us-gaap_ConcentrationRiskTable_49fba6d9-b81d-44cb-9c89-8700b62a75db" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskByBenchmarkAxis_c23d184d-6bb8-4bdf-9fe0-bba4f06b04a8" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ConcentrationRiskByBenchmarkAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ConcentrationRiskTable_49fba6d9-b81d-44cb-9c89-8700b62a75db" xlink:to="loc_us-gaap_ConcentrationRiskByBenchmarkAxis_c23d184d-6bb8-4bdf-9fe0-bba4f06b04a8" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskBenchmarkDomain_c23d184d-6bb8-4bdf-9fe0-bba4f06b04a8_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ConcentrationRiskBenchmarkDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_ConcentrationRiskByBenchmarkAxis_c23d184d-6bb8-4bdf-9fe0-bba4f06b04a8" xlink:to="loc_us-gaap_ConcentrationRiskBenchmarkDomain_c23d184d-6bb8-4bdf-9fe0-bba4f06b04a8_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskBenchmarkDomain_6fbd3f77-7164-42de-80dd-a94d34806056" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ConcentrationRiskBenchmarkDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_ConcentrationRiskByBenchmarkAxis_c23d184d-6bb8-4bdf-9fe0-bba4f06b04a8" xlink:to="loc_us-gaap_ConcentrationRiskBenchmarkDomain_6fbd3f77-7164-42de-80dd-a94d34806056" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountsPayableMember_45f27b83-1996-48d9-ac44-3f854d15519b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccountsPayableMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ConcentrationRiskBenchmarkDomain_6fbd3f77-7164-42de-80dd-a94d34806056" xlink:to="loc_us-gaap_AccountsPayableMember_45f27b83-1996-48d9-ac44-3f854d15519b" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskByTypeAxis_4c03edf9-d21b-4a42-abf5-4c801e26f206" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ConcentrationRiskByTypeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ConcentrationRiskTable_49fba6d9-b81d-44cb-9c89-8700b62a75db" xlink:to="loc_us-gaap_ConcentrationRiskByTypeAxis_4c03edf9-d21b-4a42-abf5-4c801e26f206" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskTypeDomain_4c03edf9-d21b-4a42-abf5-4c801e26f206_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ConcentrationRiskTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_ConcentrationRiskByTypeAxis_4c03edf9-d21b-4a42-abf5-4c801e26f206" xlink:to="loc_us-gaap_ConcentrationRiskTypeDomain_4c03edf9-d21b-4a42-abf5-4c801e26f206_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskTypeDomain_ee7c83b4-97e4-470f-8c84-2ba3d40552b9" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ConcentrationRiskTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_ConcentrationRiskByTypeAxis_4c03edf9-d21b-4a42-abf5-4c801e26f206" xlink:to="loc_us-gaap_ConcentrationRiskTypeDomain_ee7c83b4-97e4-470f-8c84-2ba3d40552b9" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SupplierConcentrationRiskMember_30b9a2ab-d509-4cff-a91a-b74823c40101" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SupplierConcentrationRiskMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ConcentrationRiskTypeDomain_ee7c83b4-97e4-470f-8c84-2ba3d40552b9" xlink:to="loc_us-gaap_SupplierConcentrationRiskMember_30b9a2ab-d509-4cff-a91a-b74823c40101" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedGoodsAndNonemployeeServicesTransactionBySupplierAxis_120e6086-0785-44ea-9799-42e5052d4bc7" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedGoodsAndNonemployeeServicesTransactionBySupplierAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ConcentrationRiskTable_49fba6d9-b81d-44cb-9c89-8700b62a75db" xlink:to="loc_us-gaap_ShareBasedGoodsAndNonemployeeServicesTransactionBySupplierAxis_120e6086-0785-44ea-9799-42e5052d4bc7" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedGoodsAndNonemployeeServicesTransactionSupplierDomain_120e6086-0785-44ea-9799-42e5052d4bc7_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedGoodsAndNonemployeeServicesTransactionSupplierDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_ShareBasedGoodsAndNonemployeeServicesTransactionBySupplierAxis_120e6086-0785-44ea-9799-42e5052d4bc7" xlink:to="loc_us-gaap_ShareBasedGoodsAndNonemployeeServicesTransactionSupplierDomain_120e6086-0785-44ea-9799-42e5052d4bc7_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedGoodsAndNonemployeeServicesTransactionSupplierDomain_1ad0e983-4885-4b03-beac-a635dd1a86ba" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedGoodsAndNonemployeeServicesTransactionSupplierDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_ShareBasedGoodsAndNonemployeeServicesTransactionBySupplierAxis_120e6086-0785-44ea-9799-42e5052d4bc7" xlink:to="loc_us-gaap_ShareBasedGoodsAndNonemployeeServicesTransactionSupplierDomain_1ad0e983-4885-4b03-beac-a635dd1a86ba" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_cron_OneVendorMember_da273a05-c97a-486d-9d04-39ace861f218" xlink:href="cron-20210630.xsd#cron_OneVendorMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedGoodsAndNonemployeeServicesTransactionSupplierDomain_1ad0e983-4885-4b03-beac-a635dd1a86ba" xlink:to="loc_cron_OneVendorMember_da273a05-c97a-486d-9d04-39ace861f218" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_cron_FourVendorsMember_6cbaa566-9f25-4820-9d49-6d7f98275da6" xlink:href="cron-20210630.xsd#cron_FourVendorsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedGoodsAndNonemployeeServicesTransactionSupplierDomain_1ad0e983-4885-4b03-beac-a635dd1a86ba" xlink:to="loc_cron_FourVendorsMember_6cbaa566-9f25-4820-9d49-6d7f98275da6" xlink:type="arc" order="1"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://thecronosgroup.com/role/HeldForSaleAssetsandDiscontinuedOperationsDetails" xlink:type="simple" xlink:href="cron-20210630.xsd#HeldForSaleAssetsandDiscontinuedOperationsDetails"/>
  <link:definitionLink xlink:role="http://thecronosgroup.com/role/HeldForSaleAssetsandDiscontinuedOperationsDetails" xlink:type="extended" id="ib4f6f6fd96b54e46bcad26ac4379b33c_HeldForSaleAssetsandDiscontinuedOperationsDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems_ceca3993-4a59-4c2e-a4a1-c5612e051281" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ImpairmentOfLongLivedAssetsToBeDisposedOf_cfecbf20-e2be-46d2-87b8-3c8445dbc382" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ImpairmentOfLongLivedAssetsToBeDisposedOf"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems_ceca3993-4a59-4c2e-a4a1-c5612e051281" xlink:to="loc_us-gaap_ImpairmentOfLongLivedAssetsToBeDisposedOf_cfecbf20-e2be-46d2-87b8-3c8445dbc382" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromSaleOfPropertyHeldForSale_e57772b0-3ef7-4d5e-8704-3879098c7a5d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ProceedsFromSaleOfPropertyHeldForSale"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems_ceca3993-4a59-4c2e-a4a1-c5612e051281" xlink:to="loc_us-gaap_ProceedsFromSaleOfPropertyHeldForSale_e57772b0-3ef7-4d5e-8704-3879098c7a5d" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupNotDiscontinuedOperationGainLossOnDisposal_7ce346e8-5754-47ac-bd59-14617ebb5c8d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DisposalGroupNotDiscontinuedOperationGainLossOnDisposal"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems_ceca3993-4a59-4c2e-a4a1-c5612e051281" xlink:to="loc_us-gaap_DisposalGroupNotDiscontinuedOperationGainLossOnDisposal_7ce346e8-5754-47ac-bd59-14617ebb5c8d" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DiscontinuedOperationIncomeLossFromDiscontinuedOperationDuringPhaseOutPeriodNetOfTax_67753ad4-cfd0-45cb-aa63-b50432d7cc01" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DiscontinuedOperationIncomeLossFromDiscontinuedOperationDuringPhaseOutPeriodNetOfTax"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems_ceca3993-4a59-4c2e-a4a1-c5612e051281" xlink:to="loc_us-gaap_DiscontinuedOperationIncomeLossFromDiscontinuedOperationDuringPhaseOutPeriodNetOfTax_67753ad4-cfd0-45cb-aa63-b50432d7cc01" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationAssetsNoncurrent_694418bd-0e9c-4571-bf49-09b857274ab3" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DisposalGroupIncludingDiscontinuedOperationAssetsNoncurrent"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems_ceca3993-4a59-4c2e-a4a1-c5612e051281" xlink:to="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationAssetsNoncurrent_694418bd-0e9c-4571-bf49-09b857274ab3" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsTable_a4ddcbae-61af-4cff-8b20-8d6633423d04" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems_ceca3993-4a59-4c2e-a4a1-c5612e051281" xlink:to="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsTable_a4ddcbae-61af-4cff-8b20-8d6633423d04" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupClassificationAxis_7c31e07e-795c-4df6-af04-d893dc0202b2" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DisposalGroupClassificationAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsTable_a4ddcbae-61af-4cff-8b20-8d6633423d04" xlink:to="loc_us-gaap_DisposalGroupClassificationAxis_7c31e07e-795c-4df6-af04-d893dc0202b2" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupClassificationDomain_7c31e07e-795c-4df6-af04-d893dc0202b2_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DisposalGroupClassificationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_DisposalGroupClassificationAxis_7c31e07e-795c-4df6-af04-d893dc0202b2" xlink:to="loc_us-gaap_DisposalGroupClassificationDomain_7c31e07e-795c-4df6-af04-d893dc0202b2_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupClassificationDomain_73873b8e-9227-49b9-af73-a255ee10b62d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DisposalGroupClassificationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_DisposalGroupClassificationAxis_7c31e07e-795c-4df6-af04-d893dc0202b2" xlink:to="loc_us-gaap_DisposalGroupClassificationDomain_73873b8e-9227-49b9-af73-a255ee10b62d" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DiscontinuedOperationsHeldforsaleMember_8d1356f4-a0ce-4942-89cd-6ff48e3cfc89" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DiscontinuedOperationsHeldforsaleMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DisposalGroupClassificationDomain_73873b8e-9227-49b9-af73-a255ee10b62d" xlink:to="loc_us-gaap_DiscontinuedOperationsHeldforsaleMember_8d1356f4-a0ce-4942-89cd-6ff48e3cfc89" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupHeldforsaleNotDiscontinuedOperationsMember_4d7a793e-cef9-416d-bddd-c190605b0a7a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DisposalGroupHeldforsaleNotDiscontinuedOperationsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DisposalGroupClassificationDomain_73873b8e-9227-49b9-af73-a255ee10b62d" xlink:to="loc_us-gaap_DisposalGroupHeldforsaleNotDiscontinuedOperationsMember_4d7a793e-cef9-416d-bddd-c190605b0a7a" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis_a5c2bb37-14b8-478c-b5e6-c144ee1eb147" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsTable_a4ddcbae-61af-4cff-8b20-8d6633423d04" xlink:to="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis_a5c2bb37-14b8-478c-b5e6-c144ee1eb147" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain_a5c2bb37-14b8-478c-b5e6-c144ee1eb147_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis_a5c2bb37-14b8-478c-b5e6-c144ee1eb147" xlink:to="loc_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain_a5c2bb37-14b8-478c-b5e6-c144ee1eb147_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain_f25f78db-af9d-4264-bc42-1b8d396e55d2" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis_a5c2bb37-14b8-478c-b5e6-c144ee1eb147" xlink:to="loc_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain_f25f78db-af9d-4264-bc42-1b8d396e55d2" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_cron_OriginalBCMember_368c51a4-ed9a-4262-92a5-f87b31ca0907" xlink:href="cron-20210630.xsd#cron_OriginalBCMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain_f25f78db-af9d-4264-bc42-1b8d396e55d2" xlink:to="loc_cron_OriginalBCMember_368c51a4-ed9a-4262-92a5-f87b31ca0907" xlink:type="arc" order="0"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://thecronosgroup.com/role/ImpairmentLossonLongLivedAssetsDetails" xlink:type="simple" xlink:href="cron-20210630.xsd#ImpairmentLossonLongLivedAssetsDetails"/>
  <link:definitionLink xlink:role="http://thecronosgroup.com/role/ImpairmentLossonLongLivedAssetsDetails" xlink:type="extended" id="i38b534578630473b937c0587e91bca6e_ImpairmentLossonLongLivedAssetsDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassLineItems_2233be60-ece2-47e8-b960-b193386738dc" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ImpairmentOfLongLivedAssetsToBeDisposedOf_82efa43d-97ed-4950-a766-5b6db42a34ae" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ImpairmentOfLongLivedAssetsToBeDisposedOf"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassLineItems_2233be60-ece2-47e8-b960-b193386738dc" xlink:to="loc_us-gaap_ImpairmentOfLongLivedAssetsToBeDisposedOf_82efa43d-97ed-4950-a766-5b6db42a34ae" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_cron_LesseeOperatingLeaseAreaOfLandToBeDisposedOf_c6503946-65fc-42ea-a798-26156f052666" xlink:href="cron-20210630.xsd#cron_LesseeOperatingLeaseAreaOfLandToBeDisposedOf"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassLineItems_2233be60-ece2-47e8-b960-b193386738dc" xlink:to="loc_cron_LesseeOperatingLeaseAreaOfLandToBeDisposedOf_c6503946-65fc-42ea-a798-26156f052666" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseImpairmentLoss_30175e6d-5720-4881-950d-e81c92851dba" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingLeaseImpairmentLoss"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassLineItems_2233be60-ece2-47e8-b960-b193386738dc" xlink:to="loc_us-gaap_OperatingLeaseImpairmentLoss_30175e6d-5720-4881-950d-e81c92851dba" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillImpairmentLoss_71fb231a-0c7b-4770-a2f4-91a451ebdd25" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_GoodwillImpairmentLoss"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassLineItems_2233be60-ece2-47e8-b960-b193386738dc" xlink:to="loc_us-gaap_GoodwillImpairmentLoss_71fb231a-0c7b-4770-a2f4-91a451ebdd25" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ImpairmentOfIntangibleAssetsIndefinitelivedExcludingGoodwill_d7d7df83-44a7-4d4f-86bd-430a3fb13e74" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ImpairmentOfIntangibleAssetsIndefinitelivedExcludingGoodwill"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassLineItems_2233be60-ece2-47e8-b960-b193386738dc" xlink:to="loc_us-gaap_ImpairmentOfIntangibleAssetsIndefinitelivedExcludingGoodwill_d7d7df83-44a7-4d4f-86bd-430a3fb13e74" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfIndefiniteLivedIntangibleAssetsTable_096fb33e-10f7-419e-9807-6898d5d89628" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfIndefiniteLivedIntangibleAssetsTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassLineItems_2233be60-ece2-47e8-b960-b193386738dc" xlink:to="loc_us-gaap_ScheduleOfIndefiniteLivedIntangibleAssetsTable_096fb33e-10f7-419e-9807-6898d5d89628" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis_11f6f56a-acf0-47d5-aede-e8887d59120c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfIndefiniteLivedIntangibleAssetsTable_096fb33e-10f7-419e-9807-6898d5d89628" xlink:to="loc_us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis_11f6f56a-acf0-47d5-aede-e8887d59120c" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IndefiniteLivedIntangibleAssetsMajorClassNameDomain_11f6f56a-acf0-47d5-aede-e8887d59120c_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IndefiniteLivedIntangibleAssetsMajorClassNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis_11f6f56a-acf0-47d5-aede-e8887d59120c" xlink:to="loc_us-gaap_IndefiniteLivedIntangibleAssetsMajorClassNameDomain_11f6f56a-acf0-47d5-aede-e8887d59120c_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IndefiniteLivedIntangibleAssetsMajorClassNameDomain_8977f020-fb2e-4fe4-aec5-83f8a07b7e02" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IndefiniteLivedIntangibleAssetsMajorClassNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis_11f6f56a-acf0-47d5-aede-e8887d59120c" xlink:to="loc_us-gaap_IndefiniteLivedIntangibleAssetsMajorClassNameDomain_8977f020-fb2e-4fe4-aec5-83f8a07b7e02" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TradeNamesMember_6565e906-96af-4c72-adf1-faa86abb8df2" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TradeNamesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IndefiniteLivedIntangibleAssetsMajorClassNameDomain_8977f020-fb2e-4fe4-aec5-83f8a07b7e02" xlink:to="loc_us-gaap_TradeNamesMember_6565e906-96af-4c72-adf1-faa86abb8df2" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ReportingUnitAxis_bde3f975-59e3-4a73-89c0-857332ffc1c3" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ReportingUnitAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfIndefiniteLivedIntangibleAssetsTable_096fb33e-10f7-419e-9807-6898d5d89628" xlink:to="loc_us-gaap_ReportingUnitAxis_bde3f975-59e3-4a73-89c0-857332ffc1c3" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ReportingUnitDomain_bde3f975-59e3-4a73-89c0-857332ffc1c3_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ReportingUnitDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_ReportingUnitAxis_bde3f975-59e3-4a73-89c0-857332ffc1c3" xlink:to="loc_us-gaap_ReportingUnitDomain_bde3f975-59e3-4a73-89c0-857332ffc1c3_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ReportingUnitDomain_fb5f2081-8415-4bbe-91be-1aa4d106aeca" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ReportingUnitDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_ReportingUnitAxis_bde3f975-59e3-4a73-89c0-857332ffc1c3" xlink:to="loc_us-gaap_ReportingUnitDomain_fb5f2081-8415-4bbe-91be-1aa4d106aeca" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_cron_UnitedStatesSegmentMember_f59772c6-af77-425e-8746-53eb38931234" xlink:href="cron-20210630.xsd#cron_UnitedStatesSegmentMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ReportingUnitDomain_fb5f2081-8415-4bbe-91be-1aa4d106aeca" xlink:to="loc_cron_UnitedStatesSegmentMember_f59772c6-af77-425e-8746-53eb38931234" xlink:type="arc" order="0"/>
  </link:definitionLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.LAB
<SEQUENCE>12
<FILENAME>cron-20210630_lab.xml
<DESCRIPTION>XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT
<TEXT>
<XBRL>
<?xml version="1.0" encoding="UTF-8"?>

<!--XBRL Document Created with Wdesk from Workiva-->
<!--Copyright 2021 Workiva-->
<!--r:198d4367-d088-421d-9dd0-dd878c4919c5,g:e5d1c22f-365f-46d5-96bc-44505885d3ea-->
<link:linkbase xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedPeriodStartLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedPeriodStartLabel"/>
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/netLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/net-2009-12-16.xsd#netLabel"/>
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedNetLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedNetLabel"/>
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedTerseLabel"/>
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedPeriodEndLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedPeriodEndLabel"/>
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedLabel"/>
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedTotalLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedTotalLabel"/>
  <link:labelLink xlink:role="http://www.xbrl.org/2003/role/link" xlink:type="extended">
    <link:label id="lab_us-gaap_SupplementalCashFlowInformationAbstract_49d7a9d6-fd89-40f0-95a3-7e12a6bd1d59_terseLabel_en-US" xlink:label="lab_us-gaap_SupplementalCashFlowInformationAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Supplemental cash flow information</link:label>
    <link:label id="lab_us-gaap_SupplementalCashFlowInformationAbstract_label_en-US" xlink:label="lab_us-gaap_SupplementalCashFlowInformationAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Supplemental Cash Flow Information [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SupplementalCashFlowInformationAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SupplementalCashFlowInformationAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SupplementalCashFlowInformationAbstract" xlink:to="lab_us-gaap_SupplementalCashFlowInformationAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NotesAndLoansReceivableNetNoncurrent_043f9824-3c57-495c-8af5-0846f711ab32_terseLabel_en-US" xlink:label="lab_us-gaap_NotesAndLoansReceivableNetNoncurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Loan receivable, net</link:label>
    <link:label id="lab_us-gaap_NotesAndLoansReceivableNetNoncurrent_5b738b67-0007-41b6-aa1d-79b78407b4fe_totalLabel_en-US" xlink:label="lab_us-gaap_NotesAndLoansReceivableNetNoncurrent" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total long-term portion of loans receivable</link:label>
    <link:label id="lab_us-gaap_NotesAndLoansReceivableNetNoncurrent_label_en-US" xlink:label="lab_us-gaap_NotesAndLoansReceivableNetNoncurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Financing Receivable, after Allowance for Credit Loss, Noncurrent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NotesAndLoansReceivableNetNoncurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NotesAndLoansReceivableNetNoncurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NotesAndLoansReceivableNetNoncurrent" xlink:to="lab_us-gaap_NotesAndLoansReceivableNetNoncurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_NameOfMajorCustomerDomain_2c5ca448-de36-4a78-9151-c67a326bb74e_terseLabel_en-US" xlink:label="lab_srt_NameOfMajorCustomerDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Customer [Domain]</link:label>
    <link:label id="lab_srt_NameOfMajorCustomerDomain_label_en-US" xlink:label="lab_srt_NameOfMajorCustomerDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Customer [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_NameOfMajorCustomerDomain" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_NameOfMajorCustomerDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_NameOfMajorCustomerDomain" xlink:to="lab_srt_NameOfMajorCustomerDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod_f3d41e5a-d9ec-424c-a480-1a089721a5bc_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Vested and issued/liabilities settled (in shares)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod_341cec67-b775-4d7a-8eb9-e43b32c970cc_negatedLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Exercise of warrants (in shares)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Vested in Period</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_ff848c62-85f1-45e6-88bd-cc3533549270_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueMeasurementsFairValueHierarchyDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value Hierarchy and NAV [Domain]</link:label>
    <link:label id="lab_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_label_en-US" xlink:label="lab_us-gaap_FairValueMeasurementsFairValueHierarchyDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value Hierarchy and NAV [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueMeasurementsFairValueHierarchyDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain" xlink:to="lab_us-gaap_FairValueMeasurementsFairValueHierarchyDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NetIncomeLoss_f2dfa5ac-1785-42ca-b9e5-0c7f77881651_totalLabel_en-US" xlink:label="lab_us-gaap_NetIncomeLoss" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net income (loss) attributable to Cronos Group</link:label>
    <link:label id="lab_us-gaap_NetIncomeLoss_label_en-US" xlink:label="lab_us-gaap_NetIncomeLoss" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net Income (Loss) Attributable to Parent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLoss" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetIncomeLoss"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NetIncomeLoss" xlink:to="lab_us-gaap_NetIncomeLoss" xlink:type="arc" order="1"/>
    <link:label id="lab_cron_RestOfWorldSegmentMember_45096bb0-a9d3-4167-a483-91ff9dccd200_terseLabel_en-US" xlink:label="lab_cron_RestOfWorldSegmentMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Rest of World</link:label>
    <link:label id="lab_cron_RestOfWorldSegmentMember_label_en-US" xlink:label="lab_cron_RestOfWorldSegmentMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Rest Of World Segment [Member]</link:label>
    <link:label id="lab_cron_RestOfWorldSegmentMember_documentation_en-US" xlink:label="lab_cron_RestOfWorldSegmentMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Rest Of World Segment [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_cron_RestOfWorldSegmentMember" xlink:href="cron-20210630.xsd#cron_RestOfWorldSegmentMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cron_RestOfWorldSegmentMember" xlink:to="lab_cron_RestOfWorldSegmentMember" xlink:type="arc" order="1"/>
    <link:label id="lab_cron_CronosGroupInc.Member_ed9fd9ae-5e07-4f71-b944-2689fcc8aa54_terseLabel_en-US" xlink:label="lab_cron_CronosGroupInc.Member" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cronos Group, Inc.</link:label>
    <link:label id="lab_cron_CronosGroupInc.Member_label_en-US" xlink:label="lab_cron_CronosGroupInc.Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cronos Group, Inc. [Member]</link:label>
    <link:label id="lab_cron_CronosGroupInc.Member_documentation_en-US" xlink:label="lab_cron_CronosGroupInc.Member" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cronos Group, Inc. [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_cron_CronosGroupInc.Member" xlink:href="cron-20210630.xsd#cron_CronosGroupInc.Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cron_CronosGroupInc.Member" xlink:to="lab_cron_CronosGroupInc.Member" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_ConsolidatedEntitiesAxis_85e0f488-1b39-4d45-8d4d-33df8a7ec642_terseLabel_en-US" xlink:label="lab_srt_ConsolidatedEntitiesAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Consolidated Entities [Axis]</link:label>
    <link:label id="lab_srt_ConsolidatedEntitiesAxis_label_en-US" xlink:label="lab_srt_ConsolidatedEntitiesAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Consolidated Entities [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ConsolidatedEntitiesAxis" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_ConsolidatedEntitiesAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_ConsolidatedEntitiesAxis" xlink:to="lab_srt_ConsolidatedEntitiesAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityEmergingGrowthCompany_ecb587f5-5ee5-49ab-b1e4-1c22c81c1976_terseLabel_en-US" xlink:label="lab_dei_EntityEmergingGrowthCompany" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Emerging Growth Company</link:label>
    <link:label id="lab_dei_EntityEmergingGrowthCompany_label_en-US" xlink:label="lab_dei_EntityEmergingGrowthCompany" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Emerging Growth Company</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityEmergingGrowthCompany" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityEmergingGrowthCompany"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityEmergingGrowthCompany" xlink:to="lab_dei_EntityEmergingGrowthCompany" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OperatingLeaseRightOfUseAsset_b263bc54-c888-4de2-9c36-e345b52eabf6_verboseLabel_en-US" xlink:label="lab_us-gaap_OperatingLeaseRightOfUseAsset" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Right-of-use assets</link:label>
    <link:label id="lab_us-gaap_OperatingLeaseRightOfUseAsset_label_en-US" xlink:label="lab_us-gaap_OperatingLeaseRightOfUseAsset" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Lease, Right-of-Use Asset</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseRightOfUseAsset" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingLeaseRightOfUseAsset"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OperatingLeaseRightOfUseAsset" xlink:to="lab_us-gaap_OperatingLeaseRightOfUseAsset" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RisksAndUncertaintiesAbstract_c4ff977e-9a83-493e-bb93-1e2cd0ff8085_terseLabel_en-US" xlink:label="lab_us-gaap_RisksAndUncertaintiesAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Risks and Uncertainties [Abstract]</link:label>
    <link:label id="lab_us-gaap_RisksAndUncertaintiesAbstract_label_en-US" xlink:label="lab_us-gaap_RisksAndUncertaintiesAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Risks and Uncertainties [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RisksAndUncertaintiesAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RisksAndUncertaintiesAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RisksAndUncertaintiesAbstract" xlink:to="lab_us-gaap_RisksAndUncertaintiesAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis_2a307355-747d-4ed9-9c48-9e6788b45e17_terseLabel_en-US" xlink:label="lab_us-gaap_AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Receivable Type [Axis]</link:label>
    <link:label id="lab_us-gaap_AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis_label_en-US" xlink:label="lab_us-gaap_AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Receivable Type [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis" xlink:to="lab_us-gaap_AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_RangeMember_cf3db2a0-4236-4906-a4c8-63947a7c4a7c_terseLabel_en-US" xlink:label="lab_srt_RangeMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statistical Measurement [Domain]</link:label>
    <link:label id="lab_srt_RangeMember_label_en-US" xlink:label="lab_srt_RangeMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statistical Measurement [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_RangeMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_RangeMember" xlink:to="lab_srt_RangeMember" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityAddressAddressLine1_0134565e-34c3-4581-a4a7-d768964c4b95_terseLabel_en-US" xlink:label="lab_dei_EntityAddressAddressLine1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Address, Address Line One</link:label>
    <link:label id="lab_dei_EntityAddressAddressLine1_label_en-US" xlink:label="lab_dei_EntityAddressAddressLine1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Address, Address Line One</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressAddressLine1" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityAddressAddressLine1"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityAddressAddressLine1" xlink:to="lab_dei_EntityAddressAddressLine1" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DerivativeLiabilities_d987abe1-3b54-4088-9bed-2da5025ad63e_terseLabel_en-US" xlink:label="lab_us-gaap_DerivativeLiabilities" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative liabilities</link:label>
    <link:label id="lab_us-gaap_DerivativeLiabilities_label_en-US" xlink:label="lab_us-gaap_DerivativeLiabilities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative Liability</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeLiabilities" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DerivativeLiabilities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DerivativeLiabilities" xlink:to="lab_us-gaap_DerivativeLiabilities" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ExciseAndSalesTaxes_07e1ad5f-7fab-42b2-93d2-4c3e44ab6fd1_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_ExciseAndSalesTaxes" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Excise taxes</link:label>
    <link:label id="lab_us-gaap_ExciseAndSalesTaxes_label_en-US" xlink:label="lab_us-gaap_ExciseAndSalesTaxes" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Excise and Sales Taxes</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ExciseAndSalesTaxes" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ExciseAndSalesTaxes"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ExciseAndSalesTaxes" xlink:to="lab_us-gaap_ExciseAndSalesTaxes" xlink:type="arc" order="1"/>
    <link:label id="lab_cron_ClassOfWarrantOrRightMaximumAdditionalSubscriptionPercentage_ee1faa56-6b19-4d1f-b36b-f51f304c5a22_terseLabel_en-US" xlink:label="lab_cron_ClassOfWarrantOrRightMaximumAdditionalSubscriptionPercentage" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Maximum additional subscription percentage</link:label>
    <link:label id="lab_cron_ClassOfWarrantOrRightMaximumAdditionalSubscriptionPercentage_label_en-US" xlink:label="lab_cron_ClassOfWarrantOrRightMaximumAdditionalSubscriptionPercentage" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Class Of Warrant Or Right, Maximum Additional Subscription Percentage</link:label>
    <link:label id="lab_cron_ClassOfWarrantOrRightMaximumAdditionalSubscriptionPercentage_documentation_en-US" xlink:label="lab_cron_ClassOfWarrantOrRightMaximumAdditionalSubscriptionPercentage" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Class Of Warrant Or Right, Maximum Additional Subscription Percentage</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_cron_ClassOfWarrantOrRightMaximumAdditionalSubscriptionPercentage" xlink:href="cron-20210630.xsd#cron_ClassOfWarrantOrRightMaximumAdditionalSubscriptionPercentage"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cron_ClassOfWarrantOrRightMaximumAdditionalSubscriptionPercentage" xlink:to="lab_cron_ClassOfWarrantOrRightMaximumAdditionalSubscriptionPercentage" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityFilerCategory_e85ded67-0a18-407c-9b10-850495b56d68_terseLabel_en-US" xlink:label="lab_dei_EntityFilerCategory" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Filer Category</link:label>
    <link:label id="lab_dei_EntityFilerCategory_label_en-US" xlink:label="lab_dei_EntityFilerCategory" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Filer Category</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityFilerCategory" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityFilerCategory"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityFilerCategory" xlink:to="lab_dei_EntityFilerCategory" xlink:type="arc" order="1"/>
    <link:label id="lab_cron_NatuEraMember_eed72617-798b-4f4c-a682-68eb0c0802b8_terseLabel_en-US" xlink:label="lab_cron_NatuEraMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Natuera</link:label>
    <link:label id="lab_cron_NatuEraMember_label_en-US" xlink:label="lab_cron_NatuEraMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">NatuEra [Member]</link:label>
    <link:label id="lab_cron_NatuEraMember_documentation_en-US" xlink:label="lab_cron_NatuEraMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">NatuEra [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_cron_NatuEraMember" xlink:href="cron-20210630.xsd#cron_NatuEraMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cron_NatuEraMember" xlink:to="lab_cron_NatuEraMember" xlink:type="arc" order="1"/>
    <link:label id="lab_cron_UnitedStatesSegmentMember_175bac53-59a5-4a75-8f36-89243db69d21_terseLabel_en-US" xlink:label="lab_cron_UnitedStatesSegmentMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">United States</link:label>
    <link:label id="lab_cron_UnitedStatesSegmentMember_label_en-US" xlink:label="lab_cron_UnitedStatesSegmentMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">United States Segment [Member]</link:label>
    <link:label id="lab_cron_UnitedStatesSegmentMember_documentation_en-US" xlink:label="lab_cron_UnitedStatesSegmentMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">United States Segment [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_cron_UnitedStatesSegmentMember" xlink:href="cron-20210630.xsd#cron_UnitedStatesSegmentMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cron_UnitedStatesSegmentMember" xlink:to="lab_cron_UnitedStatesSegmentMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NotesAndLoansReceivableNetCurrent_a67fbd88-bbff-4cfb-8e2e-97a3ed2fc033_terseLabel_en-US" xlink:label="lab_us-gaap_NotesAndLoansReceivableNetCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Current portion of loans receivable, net</link:label>
    <link:label id="lab_us-gaap_NotesAndLoansReceivableNetCurrent_986f7bd3-dcb2-412b-a3ac-e2fafac02318_totalLabel_en-US" xlink:label="lab_us-gaap_NotesAndLoansReceivableNetCurrent" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total current portion of loans receivable</link:label>
    <link:label id="lab_us-gaap_NotesAndLoansReceivableNetCurrent_label_en-US" xlink:label="lab_us-gaap_NotesAndLoansReceivableNetCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Financing Receivable, after Allowance for Credit Loss, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NotesAndLoansReceivableNetCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NotesAndLoansReceivableNetCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NotesAndLoansReceivableNetCurrent" xlink:to="lab_us-gaap_NotesAndLoansReceivableNetCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_b942fb45-529c-459c-8895-39d1e962d079_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Share-based Compensation Arrangements by Share-based Payment Award [Table]</link:label>
    <link:label id="lab_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_label_en-US" xlink:label="lab_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Share-based Compensation Arrangements by Share-based Payment Award [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:to="lab_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis_abf85701-2ae2-43b8-bb46-bdd7616d134b_terseLabel_en-US" xlink:label="lab_srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Investment, Name [Axis]</link:label>
    <link:label id="lab_srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis_label_en-US" xlink:label="lab_srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Investment, Name [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis" xlink:to="lab_srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StatementBusinessSegmentsAxis_c7e4a190-0138-4ecf-9d46-c5495caa8ec0_terseLabel_en-US" xlink:label="lab_us-gaap_StatementBusinessSegmentsAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Segments [Axis]</link:label>
    <link:label id="lab_us-gaap_StatementBusinessSegmentsAxis_label_en-US" xlink:label="lab_us-gaap_StatementBusinessSegmentsAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Segments [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementBusinessSegmentsAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementBusinessSegmentsAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StatementBusinessSegmentsAxis" xlink:to="lab_us-gaap_StatementBusinessSegmentsAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_cron_SensitivityAnalysisImpactOf10PercentDecreaseIncreaseInSharePriceOnNetIncomeLoss_ad23b4c0-cba4-44f7-b158-bad130a1de4a_terseLabel_en-US" xlink:label="lab_cron_SensitivityAnalysisImpactOf10PercentDecreaseIncreaseInSharePriceOnNetIncomeLoss" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share price</link:label>
    <link:label id="lab_cron_SensitivityAnalysisImpactOf10PercentDecreaseIncreaseInSharePriceOnNetIncomeLoss_label_en-US" xlink:label="lab_cron_SensitivityAnalysisImpactOf10PercentDecreaseIncreaseInSharePriceOnNetIncomeLoss" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Sensitivity Analysis, Impact Of 10 Percent Decrease (Increase) In Share Price On Net Income (Loss)</link:label>
    <link:label id="lab_cron_SensitivityAnalysisImpactOf10PercentDecreaseIncreaseInSharePriceOnNetIncomeLoss_documentation_en-US" xlink:label="lab_cron_SensitivityAnalysisImpactOf10PercentDecreaseIncreaseInSharePriceOnNetIncomeLoss" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Sensitivity Analysis, Impact Of 10 Percent Decrease (Increase) In Share Price On Net Income (Loss)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_cron_SensitivityAnalysisImpactOf10PercentDecreaseIncreaseInSharePriceOnNetIncomeLoss" xlink:href="cron-20210630.xsd#cron_SensitivityAnalysisImpactOf10PercentDecreaseIncreaseInSharePriceOnNetIncomeLoss"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cron_SensitivityAnalysisImpactOf10PercentDecreaseIncreaseInSharePriceOnNetIncomeLoss" xlink:to="lab_cron_SensitivityAnalysisImpactOf10PercentDecreaseIncreaseInSharePriceOnNetIncomeLoss" xlink:type="arc" order="1"/>
    <link:label id="lab_cron_CronosGrowingCompanyInc.Member_4a59ea13-60db-4090-93f2-48ecb8b16229_terseLabel_en-US" xlink:label="lab_cron_CronosGrowingCompanyInc.Member" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cronos GrowCo</link:label>
    <link:label id="lab_cron_CronosGrowingCompanyInc.Member_label_en-US" xlink:label="lab_cron_CronosGrowingCompanyInc.Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cronos Growing Company Inc. [Member]</link:label>
    <link:label id="lab_cron_CronosGrowingCompanyInc.Member_documentation_en-US" xlink:label="lab_cron_CronosGrowingCompanyInc.Member" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cronos Growing Company Inc. [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_cron_CronosGrowingCompanyInc.Member" xlink:href="cron-20210630.xsd#cron_CronosGrowingCompanyInc.Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cron_CronosGrowingCompanyInc.Member" xlink:to="lab_cron_CronosGrowingCompanyInc.Member" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueNetDerivativeAssetLiabilityMeasuredOnRecurringBasisUnobservableInputReconciliationTableTextBlock_bc0443d9-b333-4f1b-8acf-b4a82b034ca1_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueNetDerivativeAssetLiabilityMeasuredOnRecurringBasisUnobservableInputReconciliationTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Reconciliation of Carrying Amounts</link:label>
    <link:label id="lab_us-gaap_FairValueNetDerivativeAssetLiabilityMeasuredOnRecurringBasisUnobservableInputReconciliationTableTextBlock_label_en-US" xlink:label="lab_us-gaap_FairValueNetDerivativeAssetLiabilityMeasuredOnRecurringBasisUnobservableInputReconciliationTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value, Net Derivative Asset (Liability) Measured on Recurring Basis, Unobservable Input Reconciliation [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueNetDerivativeAssetLiabilityMeasuredOnRecurringBasisUnobservableInputReconciliationTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueNetDerivativeAssetLiabilityMeasuredOnRecurringBasisUnobservableInputReconciliationTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueNetDerivativeAssetLiabilityMeasuredOnRecurringBasisUnobservableInputReconciliationTableTextBlock" xlink:to="lab_us-gaap_FairValueNetDerivativeAssetLiabilityMeasuredOnRecurringBasisUnobservableInputReconciliationTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_e28f27d7-caf5-4ac9-96a8-ba52e823b422_totalLabel_en-US" xlink:label="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net change in cash and cash equivalents</link:label>
    <link:label id="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_label_en-US" xlink:label="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" xlink:to="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" xlink:type="arc" order="1"/>
    <link:label id="lab_cron_SensitivityAnalysisImpactOf10PercentDecreaseIncreaseOnNetIncomeLossAbstract_e3e62118-af43-42d7-903c-54fde3bb437d_terseLabel_en-US" xlink:label="lab_cron_SensitivityAnalysisImpactOf10PercentDecreaseIncreaseOnNetIncomeLossAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Sensitivity Analysis, Impact of 10 Percent Decrease (Increase) on Net Income (Loss) [Abstract]</link:label>
    <link:label id="lab_cron_SensitivityAnalysisImpactOf10PercentDecreaseIncreaseOnNetIncomeLossAbstract_label_en-US" xlink:label="lab_cron_SensitivityAnalysisImpactOf10PercentDecreaseIncreaseOnNetIncomeLossAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Sensitivity Analysis, Impact Of 10 Percent Decrease (Increase) On Net Income (Loss) [Abstract]</link:label>
    <link:label id="lab_cron_SensitivityAnalysisImpactOf10PercentDecreaseIncreaseOnNetIncomeLossAbstract_documentation_en-US" xlink:label="lab_cron_SensitivityAnalysisImpactOf10PercentDecreaseIncreaseOnNetIncomeLossAbstract" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Sensitivity Analysis, Impact Of 10 Percent Decrease (Increase) On Net Income (Loss) [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_cron_SensitivityAnalysisImpactOf10PercentDecreaseIncreaseOnNetIncomeLossAbstract" xlink:href="cron-20210630.xsd#cron_SensitivityAnalysisImpactOf10PercentDecreaseIncreaseOnNetIncomeLossAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cron_SensitivityAnalysisImpactOf10PercentDecreaseIncreaseOnNetIncomeLossAbstract" xlink:to="lab_cron_SensitivityAnalysisImpactOf10PercentDecreaseIncreaseOnNetIncomeLossAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_cron_NumberOfAdultuseBrands_984880bc-e5ab-46fb-9ad9-2294be145598_terseLabel_en-US" xlink:label="lab_cron_NumberOfAdultuseBrands" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Number of adult-use brands</link:label>
    <link:label id="lab_cron_NumberOfAdultuseBrands_label_en-US" xlink:label="lab_cron_NumberOfAdultuseBrands" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Number Of Adult-use Brands</link:label>
    <link:label id="lab_cron_NumberOfAdultuseBrands_documentation_en-US" xlink:label="lab_cron_NumberOfAdultuseBrands" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Number Of Adult-use Brands</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_cron_NumberOfAdultuseBrands" xlink:href="cron-20210630.xsd#cron_NumberOfAdultuseBrands"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cron_NumberOfAdultuseBrands" xlink:to="lab_cron_NumberOfAdultuseBrands" xlink:type="arc" order="1"/>
    <link:label id="lab_cron_ClassOfWarrantOrRightAdditionalSubscriptionNumberOfSecuritiesCalledByWarrantsOrRights_e87aabd9-9ba6-4c30-8784-e5fdff4291fc_terseLabel_en-US" xlink:label="lab_cron_ClassOfWarrantOrRightAdditionalSubscriptionNumberOfSecuritiesCalledByWarrantsOrRights" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative liability, additional subscription (in shares)</link:label>
    <link:label id="lab_cron_ClassOfWarrantOrRightAdditionalSubscriptionNumberOfSecuritiesCalledByWarrantsOrRights_label_en-US" xlink:label="lab_cron_ClassOfWarrantOrRightAdditionalSubscriptionNumberOfSecuritiesCalledByWarrantsOrRights" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Class Of Warrant Or Right, Additional Subscription, Number Of Securities Called By Warrants Or Rights</link:label>
    <link:label id="lab_cron_ClassOfWarrantOrRightAdditionalSubscriptionNumberOfSecuritiesCalledByWarrantsOrRights_documentation_en-US" xlink:label="lab_cron_ClassOfWarrantOrRightAdditionalSubscriptionNumberOfSecuritiesCalledByWarrantsOrRights" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Class Of Warrant Or Right, Additional Subscription, Number Of Securities Called By Warrants Or Rights</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_cron_ClassOfWarrantOrRightAdditionalSubscriptionNumberOfSecuritiesCalledByWarrantsOrRights" xlink:href="cron-20210630.xsd#cron_ClassOfWarrantOrRightAdditionalSubscriptionNumberOfSecuritiesCalledByWarrantsOrRights"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cron_ClassOfWarrantOrRightAdditionalSubscriptionNumberOfSecuritiesCalledByWarrantsOrRights" xlink:to="lab_cron_ClassOfWarrantOrRightAdditionalSubscriptionNumberOfSecuritiesCalledByWarrantsOrRights" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ProceedsFromSaleAndMaturityOfOtherInvestments_c0ade16a-319d-48f1-a210-cc9b97c16f3b_terseLabel_en-US" xlink:label="lab_us-gaap_ProceedsFromSaleAndMaturityOfOtherInvestments" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Proceeds from sale of other investments</link:label>
    <link:label id="lab_us-gaap_ProceedsFromSaleAndMaturityOfOtherInvestments_label_en-US" xlink:label="lab_us-gaap_ProceedsFromSaleAndMaturityOfOtherInvestments" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Proceeds from Sale and Maturity of Other Investments</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromSaleAndMaturityOfOtherInvestments" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ProceedsFromSaleAndMaturityOfOtherInvestments"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ProceedsFromSaleAndMaturityOfOtherInvestments" xlink:to="lab_us-gaap_ProceedsFromSaleAndMaturityOfOtherInvestments" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod_fda32150-e569-4586-a8aa-fc7f8fed2703_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cancellation, forfeiture and expiry of options (in shares)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Options, Forfeitures and Expirations in Period</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueNetDerivativeAssetLiabilityMeasuredOnRecurringBasisUnobservableInputsReconciliationSettlements_d236f0a5-0d6f-4b3b-83f0-21a321750944_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_FairValueNetDerivativeAssetLiabilityMeasuredOnRecurringBasisUnobservableInputsReconciliationSettlements" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Exercise of rights</link:label>
    <link:label id="lab_us-gaap_FairValueNetDerivativeAssetLiabilityMeasuredOnRecurringBasisUnobservableInputsReconciliationSettlements_label_en-US" xlink:label="lab_us-gaap_FairValueNetDerivativeAssetLiabilityMeasuredOnRecurringBasisUnobservableInputsReconciliationSettlements" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value, Net Derivative Asset (Liability) Measured on Recurring Basis, Unobservable Inputs Reconciliation, Settlements</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueNetDerivativeAssetLiabilityMeasuredOnRecurringBasisUnobservableInputsReconciliationSettlements" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueNetDerivativeAssetLiabilityMeasuredOnRecurringBasisUnobservableInputsReconciliationSettlements"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueNetDerivativeAssetLiabilityMeasuredOnRecurringBasisUnobservableInputsReconciliationSettlements" xlink:to="lab_us-gaap_FairValueNetDerivativeAssetLiabilityMeasuredOnRecurringBasisUnobservableInputsReconciliationSettlements" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsDisclosureTextBlock_4eda868f-436c-48f6-afab-62ce6ad6edc6_terseLabel_en-US" xlink:label="lab_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Held-For-Sale Assets and Discontinued Operations</link:label>
    <link:label id="lab_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsDisclosureTextBlock_label_en-US" xlink:label="lab_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disposal Groups, Including Discontinued Operations, Disclosure [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsDisclosureTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DisposalGroupsIncludingDiscontinuedOperationsDisclosureTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsDisclosureTextBlock" xlink:to="lab_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsDisclosureTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_DocumentFiscalYearFocus_3459d4a3-5602-4ed7-9f94-c40621c68647_terseLabel_en-US" xlink:label="lab_dei_DocumentFiscalYearFocus" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Fiscal Year Focus</link:label>
    <link:label id="lab_dei_DocumentFiscalYearFocus_label_en-US" xlink:label="lab_dei_DocumentFiscalYearFocus" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Fiscal Year Focus</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentFiscalYearFocus" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_DocumentFiscalYearFocus"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_DocumentFiscalYearFocus" xlink:to="lab_dei_DocumentFiscalYearFocus" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CreditConcentrationRiskMember_48732c4a-11cb-4e63-b3e4-ba00d1f5bc94_terseLabel_en-US" xlink:label="lab_us-gaap_CreditConcentrationRiskMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Credit Concentration Risk</link:label>
    <link:label id="lab_us-gaap_CreditConcentrationRiskMember_label_en-US" xlink:label="lab_us-gaap_CreditConcentrationRiskMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Credit Concentration Risk [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CreditConcentrationRiskMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CreditConcentrationRiskMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CreditConcentrationRiskMember" xlink:to="lab_us-gaap_CreditConcentrationRiskMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_5130afac-23d7-4126-a716-50fbc3832e66_terseLabel_en-US" xlink:label="lab_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Organization, Consolidation and Presentation of Financial Statements [Abstract]</link:label>
    <link:label id="lab_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_label_en-US" xlink:label="lab_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Organization, Consolidation and Presentation of Financial Statements [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract" xlink:to="lab_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ImpairmentOfLongLivedAssetsToBeDisposedOf_1652b366-ac19-4482-922f-81544ab57387_verboseLabel_en-US" xlink:label="lab_us-gaap_ImpairmentOfLongLivedAssetsToBeDisposedOf" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Write-down to held-for-sale assets</link:label>
    <link:label id="lab_us-gaap_ImpairmentOfLongLivedAssetsToBeDisposedOf_eb97acc3-1f01-472c-a354-cc5be1043a21_terseLabel_en-US" xlink:label="lab_us-gaap_ImpairmentOfLongLivedAssetsToBeDisposedOf" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Impairment of leasehold improvements to be disposed of</link:label>
    <link:label id="lab_us-gaap_ImpairmentOfLongLivedAssetsToBeDisposedOf_label_en-US" xlink:label="lab_us-gaap_ImpairmentOfLongLivedAssetsToBeDisposedOf" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Impairment of Long-Lived Assets to be Disposed of</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ImpairmentOfLongLivedAssetsToBeDisposedOf" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ImpairmentOfLongLivedAssetsToBeDisposedOf"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ImpairmentOfLongLivedAssetsToBeDisposedOf" xlink:to="lab_us-gaap_ImpairmentOfLongLivedAssetsToBeDisposedOf" xlink:type="arc" order="1"/>
    <link:label id="lab_cron_DerivativeInstrumentsRollForward_7116d090-4f4e-4363-a7e2-78c859467fc3_terseLabel_en-US" xlink:label="lab_cron_DerivativeInstrumentsRollForward" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative Instruments [Roll Forward]</link:label>
    <link:label id="lab_cron_DerivativeInstrumentsRollForward_label_en-US" xlink:label="lab_cron_DerivativeInstrumentsRollForward" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative Instruments [Roll Forward]</link:label>
    <link:label id="lab_cron_DerivativeInstrumentsRollForward_documentation_en-US" xlink:label="lab_cron_DerivativeInstrumentsRollForward" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative Instruments [Roll Forward]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_cron_DerivativeInstrumentsRollForward" xlink:href="cron-20210630.xsd#cron_DerivativeInstrumentsRollForward"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cron_DerivativeInstrumentsRollForward" xlink:to="lab_cron_DerivativeInstrumentsRollForward" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_9d8972c2-d9d2-409e-b261-bd6af3a3f723_terseLabel_en-US" xlink:label="lab_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total anti-dilutive securities (in shares)</link:label>
    <link:label id="lab_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_label_en-US" xlink:label="lab_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" xlink:to="lab_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfInventoryCurrentTableTextBlock_b9ee7609-02fe-4220-ac0f-5580ce468e12_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfInventoryCurrentTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Inventory</link:label>
    <link:label id="lab_us-gaap_ScheduleOfInventoryCurrentTableTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfInventoryCurrentTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Inventory, Current [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfInventoryCurrentTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfInventoryCurrentTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfInventoryCurrentTableTextBlock" xlink:to="lab_us-gaap_ScheduleOfInventoryCurrentTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SubsidiarySaleOfStockAxis_2139e0be-4cc3-4567-88ff-a93007deec8a_terseLabel_en-US" xlink:label="lab_us-gaap_SubsidiarySaleOfStockAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Sale of Stock [Axis]</link:label>
    <link:label id="lab_us-gaap_SubsidiarySaleOfStockAxis_label_en-US" xlink:label="lab_us-gaap_SubsidiarySaleOfStockAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Sale of Stock [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsidiarySaleOfStockAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SubsidiarySaleOfStockAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SubsidiarySaleOfStockAxis" xlink:to="lab_us-gaap_SubsidiarySaleOfStockAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_cron_NatuEraSeriesALoanMember_a4d34928-ff91-4369-8f22-f80402854e27_terseLabel_en-US" xlink:label="lab_cron_NatuEraSeriesALoanMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">NatuEra Series A Loan</link:label>
    <link:label id="lab_cron_NatuEraSeriesALoanMember_label_en-US" xlink:label="lab_cron_NatuEraSeriesALoanMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">NatuEra Series A Loan [Member]</link:label>
    <link:label id="lab_cron_NatuEraSeriesALoanMember_documentation_en-US" xlink:label="lab_cron_NatuEraSeriesALoanMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">NatuEra Series A Loan [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_cron_NatuEraSeriesALoanMember" xlink:href="cron-20210630.xsd#cron_NatuEraSeriesALoanMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cron_NatuEraSeriesALoanMember" xlink:to="lab_cron_NatuEraSeriesALoanMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FinancingReceivableAccruedInterestBeforeAllowanceForCreditLoss_38e685f5-2528-4c7c-8526-a549186c1904_terseLabel_en-US" xlink:label="lab_us-gaap_FinancingReceivableAccruedInterestBeforeAllowanceForCreditLoss" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accrued interest</link:label>
    <link:label id="lab_us-gaap_FinancingReceivableAccruedInterestBeforeAllowanceForCreditLoss_label_en-US" xlink:label="lab_us-gaap_FinancingReceivableAccruedInterestBeforeAllowanceForCreditLoss" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Financing Receivable, Accrued Interest, before Allowance for Credit Loss</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinancingReceivableAccruedInterestBeforeAllowanceForCreditLoss" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FinancingReceivableAccruedInterestBeforeAllowanceForCreditLoss"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FinancingReceivableAccruedInterestBeforeAllowanceForCreditLoss" xlink:to="lab_us-gaap_FinancingReceivableAccruedInterestBeforeAllowanceForCreditLoss" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_1f8ecf47-9eed-40f9-b2ce-98161d67d85c_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Granted (in dollars per share)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Grants in Period, Weighted Average Grant Date Fair Value</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" xlink:type="arc" order="1"/>
    <link:label id="lab_cron_MeasurementInputSubscriptionPriceMember_21a35cfe-1a0b-41fd-b494-a684bfaf04a2_terseLabel_en-US" xlink:label="lab_cron_MeasurementInputSubscriptionPriceMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Subscription price</link:label>
    <link:label id="lab_cron_MeasurementInputSubscriptionPriceMember_label_en-US" xlink:label="lab_cron_MeasurementInputSubscriptionPriceMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Measurement Input, Subscription Price [Member]</link:label>
    <link:label id="lab_cron_MeasurementInputSubscriptionPriceMember_documentation_en-US" xlink:label="lab_cron_MeasurementInputSubscriptionPriceMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Measurement Input, Subscription Price [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_cron_MeasurementInputSubscriptionPriceMember" xlink:href="cron-20210630.xsd#cron_MeasurementInputSubscriptionPriceMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cron_MeasurementInputSubscriptionPriceMember" xlink:to="lab_cron_MeasurementInputSubscriptionPriceMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis_b195a1aa-b02d-498c-862b-d067e2c4e78e_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disposal Group Name [Axis]</link:label>
    <link:label id="lab_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis_label_en-US" xlink:label="lab_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disposal Group Name [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis" xlink:to="lab_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_91a2da63-f232-49df-805b-f6fbb1688d00_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Award Type [Domain]</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Award Type [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AssetsAbstract_25303da2-8fbf-4a7b-ab79-c3e1768d2017_terseLabel_en-US" xlink:label="lab_us-gaap_AssetsAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Assets</link:label>
    <link:label id="lab_us-gaap_AssetsAbstract_label_en-US" xlink:label="lab_us-gaap_AssetsAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Assets [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AssetsAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AssetsAbstract" xlink:to="lab_us-gaap_AssetsAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_cron_CollaborativeArrangementPercentageOfProfitsToBeReceivedTriggeringEventSubsequentToMaximumPercentageOfAmountsAdvancedBeingMet_39d62d95-0bf4-47bb-beaa-dd26aa609547_terseLabel_en-US" xlink:label="lab_cron_CollaborativeArrangementPercentageOfProfitsToBeReceivedTriggeringEventSubsequentToMaximumPercentageOfAmountsAdvancedBeingMet" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Collaboration agreement, percentage of profits to be received, triggering event, subsequent to maximum percentage of amounts advanced being met</link:label>
    <link:label id="lab_cron_CollaborativeArrangementPercentageOfProfitsToBeReceivedTriggeringEventSubsequentToMaximumPercentageOfAmountsAdvancedBeingMet_label_en-US" xlink:label="lab_cron_CollaborativeArrangementPercentageOfProfitsToBeReceivedTriggeringEventSubsequentToMaximumPercentageOfAmountsAdvancedBeingMet" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Collaborative Arrangement, Percentage Of Profits To Be Received, Triggering Event, Subsequent To Maximum Percentage Of Amounts Advanced Being Met</link:label>
    <link:label id="lab_cron_CollaborativeArrangementPercentageOfProfitsToBeReceivedTriggeringEventSubsequentToMaximumPercentageOfAmountsAdvancedBeingMet_documentation_en-US" xlink:label="lab_cron_CollaborativeArrangementPercentageOfProfitsToBeReceivedTriggeringEventSubsequentToMaximumPercentageOfAmountsAdvancedBeingMet" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Collaborative Arrangement, Percentage Of Profits To Be Received, Triggering Event, Subsequent To Maximum Percentage Of Amounts Advanced Being Met</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_cron_CollaborativeArrangementPercentageOfProfitsToBeReceivedTriggeringEventSubsequentToMaximumPercentageOfAmountsAdvancedBeingMet" xlink:href="cron-20210630.xsd#cron_CollaborativeArrangementPercentageOfProfitsToBeReceivedTriggeringEventSubsequentToMaximumPercentageOfAmountsAdvancedBeingMet"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cron_CollaborativeArrangementPercentageOfProfitsToBeReceivedTriggeringEventSubsequentToMaximumPercentageOfAmountsAdvancedBeingMet" xlink:to="lab_cron_CollaborativeArrangementPercentageOfProfitsToBeReceivedTriggeringEventSubsequentToMaximumPercentageOfAmountsAdvancedBeingMet" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber_6b390157-9d29-4aba-b530-3c86b2b7e9d2_verboseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Exercisable (in shares)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Number</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureTextBlock_7019bab9-cc67-4f50-b8c5-9b5ded35d941_terseLabel_en-US" xlink:label="lab_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative Liabilities</link:label>
    <link:label id="lab_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureTextBlock_label_en-US" xlink:label="lab_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative Instruments and Hedging Activities Disclosure [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureTextBlock" xlink:to="lab_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfStockOptionsRollForwardTableTextBlock_b4a4ec08-09ac-41f0-8c5a-b795a85abfca_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfStockOptionsRollForwardTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Summary of the Changes in Options and Options Outstanding</link:label>
    <link:label id="lab_us-gaap_ScheduleOfStockOptionsRollForwardTableTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfStockOptionsRollForwardTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Stock Options Roll Forward [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfStockOptionsRollForwardTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfStockOptionsRollForwardTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfStockOptionsRollForwardTableTextBlock" xlink:to="lab_us-gaap_ScheduleOfStockOptionsRollForwardTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_cron_TopUpRightsMarketPriceMember_a4c737f6-c190-4e3c-970d-d2b6c5fd6355_terseLabel_en-US" xlink:label="lab_cron_TopUpRightsMarketPriceMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Top-up Rights &#8211; market price</link:label>
    <link:label id="lab_cron_TopUpRightsMarketPriceMember_label_en-US" xlink:label="lab_cron_TopUpRightsMarketPriceMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Top-Up Rights - Market Price [Member]</link:label>
    <link:label id="lab_cron_TopUpRightsMarketPriceMember_documentation_en-US" xlink:label="lab_cron_TopUpRightsMarketPriceMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Top-Up Rights - Market Price [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_cron_TopUpRightsMarketPriceMember" xlink:href="cron-20210630.xsd#cron_TopUpRightsMarketPriceMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cron_TopUpRightsMarketPriceMember" xlink:to="lab_cron_TopUpRightsMarketPriceMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod_84af665f-c240-4910-ae37-7f8fa8363943_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Granted (in shares)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Grants in Period</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ConcentrationRiskPercentage1_d2383f7a-3dfd-4b2d-907d-e9a5183ff6f6_terseLabel_en-US" xlink:label="lab_us-gaap_ConcentrationRiskPercentage1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Concentration risk, percentage</link:label>
    <link:label id="lab_us-gaap_ConcentrationRiskPercentage1_label_en-US" xlink:label="lab_us-gaap_ConcentrationRiskPercentage1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Concentration Risk, Percentage</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskPercentage1" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ConcentrationRiskPercentage1"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ConcentrationRiskPercentage1" xlink:to="lab_us-gaap_ConcentrationRiskPercentage1" xlink:type="arc" order="1"/>
    <link:label id="lab_cron_SensitivityAnalysisImpactOf10PercentDecreaseIncreaseInExpectedAnnualizedVolatilityOnNetIncomeLoss_1073da6c-b053-4637-9259-d1a41fff79af_terseLabel_en-US" xlink:label="lab_cron_SensitivityAnalysisImpactOf10PercentDecreaseIncreaseInExpectedAnnualizedVolatilityOnNetIncomeLoss" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Expected annualized volatility</link:label>
    <link:label id="lab_cron_SensitivityAnalysisImpactOf10PercentDecreaseIncreaseInExpectedAnnualizedVolatilityOnNetIncomeLoss_label_en-US" xlink:label="lab_cron_SensitivityAnalysisImpactOf10PercentDecreaseIncreaseInExpectedAnnualizedVolatilityOnNetIncomeLoss" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Sensitivity Analysis, Impact Of 10 Percent Decrease (Increase) In Expected Annualized Volatility On Net Income (Loss)</link:label>
    <link:label id="lab_cron_SensitivityAnalysisImpactOf10PercentDecreaseIncreaseInExpectedAnnualizedVolatilityOnNetIncomeLoss_documentation_en-US" xlink:label="lab_cron_SensitivityAnalysisImpactOf10PercentDecreaseIncreaseInExpectedAnnualizedVolatilityOnNetIncomeLoss" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Sensitivity Analysis, Impact Of 10 Percent Decrease (Increase) In Expected Annualized Volatility On Net Income (Loss)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_cron_SensitivityAnalysisImpactOf10PercentDecreaseIncreaseInExpectedAnnualizedVolatilityOnNetIncomeLoss" xlink:href="cron-20210630.xsd#cron_SensitivityAnalysisImpactOf10PercentDecreaseIncreaseInExpectedAnnualizedVolatilityOnNetIncomeLoss"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cron_SensitivityAnalysisImpactOf10PercentDecreaseIncreaseInExpectedAnnualizedVolatilityOnNetIncomeLoss" xlink:to="lab_cron_SensitivityAnalysisImpactOf10PercentDecreaseIncreaseInExpectedAnnualizedVolatilityOnNetIncomeLoss" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_661a9195-b9b2-4792-ab5a-0899f3387f1d_periodStartLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Balance at beginning of period (in shares)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_46973679-242c-4697-a72d-74b0727a5c2e_periodEndLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Balance at end of period (in shares)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_62f58fc3-1804-4b4a-81d0-7bac12db0ca2_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Number of options outstanding (in shares)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Number</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityAddressCityOrTown_42bc03d3-3950-4cff-9b13-3e46dfda97c0_terseLabel_en-US" xlink:label="lab_dei_EntityAddressCityOrTown" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Address, City or Town</link:label>
    <link:label id="lab_dei_EntityAddressCityOrTown_label_en-US" xlink:label="lab_dei_EntityAddressCityOrTown" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Address, City or Town</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressCityOrTown" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityAddressCityOrTown"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityAddressCityOrTown" xlink:to="lab_dei_EntityAddressCityOrTown" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_VariableInterestEntityNotPrimaryBeneficiaryMember_ada532c3-877f-4893-af3b-c858872e5915_terseLabel_en-US" xlink:label="lab_us-gaap_VariableInterestEntityNotPrimaryBeneficiaryMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Variable Interest Entity, Not Primary Beneficiary</link:label>
    <link:label id="lab_us-gaap_VariableInterestEntityNotPrimaryBeneficiaryMember_label_en-US" xlink:label="lab_us-gaap_VariableInterestEntityNotPrimaryBeneficiaryMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Variable Interest Entity, Not Primary Beneficiary [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_VariableInterestEntityNotPrimaryBeneficiaryMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_VariableInterestEntityNotPrimaryBeneficiaryMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_VariableInterestEntityNotPrimaryBeneficiaryMember" xlink:to="lab_us-gaap_VariableInterestEntityNotPrimaryBeneficiaryMember" xlink:type="arc" order="1"/>
    <link:label id="lab_cron_NumberOfHempDerivedPersonalCareBrands_734be619-3f12-43da-8ae2-00467e3787ae_terseLabel_en-US" xlink:label="lab_cron_NumberOfHempDerivedPersonalCareBrands" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Number of hemp-derived cannabidiol personal care brands</link:label>
    <link:label id="lab_cron_NumberOfHempDerivedPersonalCareBrands_label_en-US" xlink:label="lab_cron_NumberOfHempDerivedPersonalCareBrands" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Number Of Hemp-derived Personal Care Brands</link:label>
    <link:label id="lab_cron_NumberOfHempDerivedPersonalCareBrands_documentation_en-US" xlink:label="lab_cron_NumberOfHempDerivedPersonalCareBrands" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Number Of Hemp-derived Personal Care Brands</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_cron_NumberOfHempDerivedPersonalCareBrands" xlink:href="cron-20210630.xsd#cron_NumberOfHempDerivedPersonalCareBrands"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cron_NumberOfHempDerivedPersonalCareBrands" xlink:to="lab_cron_NumberOfHempDerivedPersonalCareBrands" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_TradeNamesMember_45f49a15-9b6d-4b35-8de8-1d6d9f6fd034_terseLabel_en-US" xlink:label="lab_us-gaap_TradeNamesMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lord Jones brand</link:label>
    <link:label id="lab_us-gaap_TradeNamesMember_label_en-US" xlink:label="lab_us-gaap_TradeNamesMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Trade Names [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TradeNamesMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TradeNamesMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_TradeNamesMember" xlink:to="lab_us-gaap_TradeNamesMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RetainedEarningsMember_c6f7127c-a4bd-46dd-8b74-a617e247a732_terseLabel_en-US" xlink:label="lab_us-gaap_RetainedEarningsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Retained earnings</link:label>
    <link:label id="lab_us-gaap_RetainedEarningsMember_label_en-US" xlink:label="lab_us-gaap_RetainedEarningsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Retained Earnings [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetainedEarningsMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RetainedEarningsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RetainedEarningsMember" xlink:to="lab_us-gaap_RetainedEarningsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets_733d7884-6d42-42d7-b5e6-5817445ca4b1_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Prepaids and other current assets</link:label>
    <link:label id="lab_us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets_label_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Increase (Decrease) in Prepaid Expense and Other Assets</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets" xlink:to="lab_us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets" xlink:type="arc" order="1"/>
    <link:label id="lab_cron_FairValueNetDerivativeAssetLiabilityMeasuredOnRecurringBasisUnobservableInputsReconciliationOutOfPeriodAdjustment_f2587c03-8e05-469b-b395-366ac3ca66e8_negatedLabel_en-US" xlink:label="lab_cron_FairValueNetDerivativeAssetLiabilityMeasuredOnRecurringBasisUnobservableInputsReconciliationOutOfPeriodAdjustment" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative liability, out-of-period adjustment</link:label>
    <link:label id="lab_cron_FairValueNetDerivativeAssetLiabilityMeasuredOnRecurringBasisUnobservableInputsReconciliationOutOfPeriodAdjustment_2294a5a2-604c-48ae-8226-1c7d34e8d7de_negatedTerseLabel_en-US" xlink:label="lab_cron_FairValueNetDerivativeAssetLiabilityMeasuredOnRecurringBasisUnobservableInputsReconciliationOutOfPeriodAdjustment" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Out-of-period adjustment</link:label>
    <link:label id="lab_cron_FairValueNetDerivativeAssetLiabilityMeasuredOnRecurringBasisUnobservableInputsReconciliationOutOfPeriodAdjustment_label_en-US" xlink:label="lab_cron_FairValueNetDerivativeAssetLiabilityMeasuredOnRecurringBasisUnobservableInputsReconciliationOutOfPeriodAdjustment" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value, Net Derivative Asset (Liability) Measured On Recurring Basis, Unobservable Inputs Reconciliation, Out-Of-Period Adjustment</link:label>
    <link:label id="lab_cron_FairValueNetDerivativeAssetLiabilityMeasuredOnRecurringBasisUnobservableInputsReconciliationOutOfPeriodAdjustment_documentation_en-US" xlink:label="lab_cron_FairValueNetDerivativeAssetLiabilityMeasuredOnRecurringBasisUnobservableInputsReconciliationOutOfPeriodAdjustment" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value, Net Derivative Asset (Liability) Measured On Recurring Basis, Unobservable Inputs Reconciliation, Out-Of-Period Adjustment</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_cron_FairValueNetDerivativeAssetLiabilityMeasuredOnRecurringBasisUnobservableInputsReconciliationOutOfPeriodAdjustment" xlink:href="cron-20210630.xsd#cron_FairValueNetDerivativeAssetLiabilityMeasuredOnRecurringBasisUnobservableInputsReconciliationOutOfPeriodAdjustment"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cron_FairValueNetDerivativeAssetLiabilityMeasuredOnRecurringBasisUnobservableInputsReconciliationOutOfPeriodAdjustment" xlink:to="lab_cron_FairValueNetDerivativeAssetLiabilityMeasuredOnRecurringBasisUnobservableInputsReconciliationOutOfPeriodAdjustment" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable_951c9d32-ee09-4a6a-90b7-4a466499e383_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Antidilutive Securities Excluded from Computation of Earnings Per Share [Table]</link:label>
    <link:label id="lab_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable_label_en-US" xlink:label="lab_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Antidilutive Securities Excluded from Computation of Earnings Per Share [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable" xlink:to="lab_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable" xlink:type="arc" order="1"/>
    <link:label id="lab_cron_FinancingReceivableBeforeAccruedInterestNoncurrent_1af07856-66c3-4aed-bcea-84983465fb89_terseLabel_en-US" xlink:label="lab_cron_FinancingReceivableBeforeAccruedInterestNoncurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long term portion of loans receivable, before accrued interest</link:label>
    <link:label id="lab_cron_FinancingReceivableBeforeAccruedInterestNoncurrent_label_en-US" xlink:label="lab_cron_FinancingReceivableBeforeAccruedInterestNoncurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Financing Receivable, Before Accrued Interest, Noncurrent</link:label>
    <link:label id="lab_cron_FinancingReceivableBeforeAccruedInterestNoncurrent_documentation_en-US" xlink:label="lab_cron_FinancingReceivableBeforeAccruedInterestNoncurrent" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Financing Receivable, Before Accrued Interest, Noncurrent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_cron_FinancingReceivableBeforeAccruedInterestNoncurrent" xlink:href="cron-20210630.xsd#cron_FinancingReceivableBeforeAccruedInterestNoncurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cron_FinancingReceivableBeforeAccruedInterestNoncurrent" xlink:to="lab_cron_FinancingReceivableBeforeAccruedInterestNoncurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_VariableInterestEntityOwnershipPercentage_b198051f-cb9f-4b69-8b75-6a8bf6f3014e_terseLabel_en-US" xlink:label="lab_us-gaap_VariableInterestEntityOwnershipPercentage" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Ownership percentage</link:label>
    <link:label id="lab_us-gaap_VariableInterestEntityOwnershipPercentage_7b53becb-3374-4787-a481-26cf6d78ef9a_verboseLabel_en-US" xlink:label="lab_us-gaap_VariableInterestEntityOwnershipPercentage" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Ownership interest</link:label>
    <link:label id="lab_us-gaap_VariableInterestEntityOwnershipPercentage_label_en-US" xlink:label="lab_us-gaap_VariableInterestEntityOwnershipPercentage" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Variable Interest Entity, Qualitative or Quantitative Information, Ownership Percentage</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_VariableInterestEntityOwnershipPercentage" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_VariableInterestEntityOwnershipPercentage"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_VariableInterestEntityOwnershipPercentage" xlink:to="lab_us-gaap_VariableInterestEntityOwnershipPercentage" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_InvestmentsAllOtherInvestmentsAbstract_label_en-US" xlink:label="lab_us-gaap_InvestmentsAllOtherInvestmentsAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Investments, All Other Investments [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentsAllOtherInvestmentsAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InvestmentsAllOtherInvestmentsAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InvestmentsAllOtherInvestmentsAbstract" xlink:to="lab_us-gaap_InvestmentsAllOtherInvestmentsAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LongLivedAssetsByGeographicAreasTableTextBlock_9f78f718-1923-4c67-8d4b-ca9a8f5464de_terseLabel_en-US" xlink:label="lab_us-gaap_LongLivedAssetsByGeographicAreasTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Long-lived Assets by Geographic Areas</link:label>
    <link:label id="lab_us-gaap_LongLivedAssetsByGeographicAreasTableTextBlock_label_en-US" xlink:label="lab_us-gaap_LongLivedAssetsByGeographicAreasTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-lived Assets by Geographic Areas [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongLivedAssetsByGeographicAreasTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LongLivedAssetsByGeographicAreasTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LongLivedAssetsByGeographicAreasTableTextBlock" xlink:to="lab_us-gaap_LongLivedAssetsByGeographicAreasTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncreaseDecreaseInAccountsReceivable_abde66f8-a6fc-4e71-8a4e-006407a17862_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInAccountsReceivable" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounts receivable, net</link:label>
    <link:label id="lab_us-gaap_IncreaseDecreaseInAccountsReceivable_label_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInAccountsReceivable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Increase (Decrease) in Accounts Receivable</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInAccountsReceivable" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncreaseDecreaseInAccountsReceivable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncreaseDecreaseInAccountsReceivable" xlink:to="lab_us-gaap_IncreaseDecreaseInAccountsReceivable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract_e5d5ce8a-0caa-402e-b552-37105c1730cc_terseLabel_en-US" xlink:label="lab_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative Instruments and Hedging Activities Disclosure [Abstract]</link:label>
    <link:label id="lab_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract_label_en-US" xlink:label="lab_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative Instruments and Hedging Activities Disclosure [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract" xlink:to="lab_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LossContingencyDisclosures_780c4048-26eb-42b7-9862-14c49ffabef2_terseLabel_en-US" xlink:label="lab_us-gaap_LossContingencyDisclosures" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Commitments and Contingencies</link:label>
    <link:label id="lab_us-gaap_LossContingencyDisclosures_label_en-US" xlink:label="lab_us-gaap_LossContingencyDisclosures" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Contingencies Disclosure [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LossContingencyDisclosures" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LossContingencyDisclosures"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LossContingencyDisclosures" xlink:to="lab_us-gaap_LossContingencyDisclosures" xlink:type="arc" order="1"/>
    <link:label id="lab_cron_CollaborativeArrangementProfitsToBeReceivedMaximumPercentageOfAmountsAdvanced_e364beff-e266-4195-962c-548941f88bab_terseLabel_en-US" xlink:label="lab_cron_CollaborativeArrangementProfitsToBeReceivedMaximumPercentageOfAmountsAdvanced" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Collaboration agreement, profits to be received, maximum percentage of amounts advanced</link:label>
    <link:label id="lab_cron_CollaborativeArrangementProfitsToBeReceivedMaximumPercentageOfAmountsAdvanced_label_en-US" xlink:label="lab_cron_CollaborativeArrangementProfitsToBeReceivedMaximumPercentageOfAmountsAdvanced" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Collaborative Arrangement, Profits To Be Received, Maximum Percentage Of Amounts Advanced</link:label>
    <link:label id="lab_cron_CollaborativeArrangementProfitsToBeReceivedMaximumPercentageOfAmountsAdvanced_documentation_en-US" xlink:label="lab_cron_CollaborativeArrangementProfitsToBeReceivedMaximumPercentageOfAmountsAdvanced" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Collaborative Arrangement, Profits To Be Received, Maximum Percentage Of Amounts Advanced</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_cron_CollaborativeArrangementProfitsToBeReceivedMaximumPercentageOfAmountsAdvanced" xlink:href="cron-20210630.xsd#cron_CollaborativeArrangementProfitsToBeReceivedMaximumPercentageOfAmountsAdvanced"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cron_CollaborativeArrangementProfitsToBeReceivedMaximumPercentageOfAmountsAdvanced" xlink:to="lab_cron_CollaborativeArrangementProfitsToBeReceivedMaximumPercentageOfAmountsAdvanced" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest_1cb75631-ae16-464e-a6af-ee4b1ed471b2_totalLabel_en-US" xlink:label="lab_us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Comprehensive income (loss)</link:label>
    <link:label id="lab_us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest_label_en-US" xlink:label="lab_us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Comprehensive Income (Loss), Net of Tax, Including Portion Attributable to Noncontrolling Interest</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest" xlink:to="lab_us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedGoodsAndNonemployeeServicesTransactionBySupplierAxis_e0dbc25b-096a-4660-8bc9-c2054693322b_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedGoodsAndNonemployeeServicesTransactionBySupplierAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Supplier [Axis]</link:label>
    <link:label id="lab_us-gaap_ShareBasedGoodsAndNonemployeeServicesTransactionBySupplierAxis_label_en-US" xlink:label="lab_us-gaap_ShareBasedGoodsAndNonemployeeServicesTransactionBySupplierAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Supplier [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedGoodsAndNonemployeeServicesTransactionBySupplierAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedGoodsAndNonemployeeServicesTransactionBySupplierAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedGoodsAndNonemployeeServicesTransactionBySupplierAxis" xlink:to="lab_us-gaap_ShareBasedGoodsAndNonemployeeServicesTransactionBySupplierAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LoansReceivableMember_5970c65a-afb9-4164-9c0d-a470137a3914_terseLabel_en-US" xlink:label="lab_us-gaap_LoansReceivableMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Loans Receivable</link:label>
    <link:label id="lab_us-gaap_LoansReceivableMember_label_en-US" xlink:label="lab_us-gaap_LoansReceivableMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Loans Receivable [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LoansReceivableMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LoansReceivableMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LoansReceivableMember" xlink:to="lab_us-gaap_LoansReceivableMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_801fe153-1418-4195-b7d4-d325749a9c3c_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Segment Reporting Information, by Segment [Table]</link:label>
    <link:label id="lab_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_label_en-US" xlink:label="lab_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Segment Reporting Information, by Segment [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable" xlink:to="lab_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_RevisionOfPriorPeriodErrorCorrectionAdjustmentMember_783d5274-0b76-43db-8f5c-8e0de6b60a96_terseLabel_en-US" xlink:label="lab_srt_RevisionOfPriorPeriodErrorCorrectionAdjustmentMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Error Correction, Adjustment</link:label>
    <link:label id="lab_srt_RevisionOfPriorPeriodErrorCorrectionAdjustmentMember_label_en-US" xlink:label="lab_srt_RevisionOfPriorPeriodErrorCorrectionAdjustmentMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revision of Prior Period, Error Correction, Adjustment [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RevisionOfPriorPeriodErrorCorrectionAdjustmentMember" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_RevisionOfPriorPeriodErrorCorrectionAdjustmentMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_RevisionOfPriorPeriodErrorCorrectionAdjustmentMember" xlink:to="lab_srt_RevisionOfPriorPeriodErrorCorrectionAdjustmentMember" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityInteractiveDataCurrent_1c79a8d9-8f07-427a-8134-027247febf71_terseLabel_en-US" xlink:label="lab_dei_EntityInteractiveDataCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Interactive Data Current</link:label>
    <link:label id="lab_dei_EntityInteractiveDataCurrent_label_en-US" xlink:label="lab_dei_EntityInteractiveDataCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Interactive Data Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityInteractiveDataCurrent" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityInteractiveDataCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityInteractiveDataCurrent" xlink:to="lab_dei_EntityInteractiveDataCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_cron_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedAndIssuedInPeriod_4c2f4414-a56c-47d4-a492-34bd1bc9935b_negatedTerseLabel_en-US" xlink:label="lab_cron_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedAndIssuedInPeriod" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Vested and issued/liabilities settled (in shares)</link:label>
    <link:label id="lab_cron_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedAndIssuedInPeriod_label_en-US" xlink:label="lab_cron_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedAndIssuedInPeriod" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Compensation Arrangement By Share-Based Payment Award, Equity Instruments Other Than Options, Vested And Issued In Period</link:label>
    <link:label id="lab_cron_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedAndIssuedInPeriod_documentation_en-US" xlink:label="lab_cron_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedAndIssuedInPeriod" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Compensation Arrangement By Share-Based Payment Award, Equity Instruments Other Than Options, Vested And Issued In Period</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_cron_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedAndIssuedInPeriod" xlink:href="cron-20210630.xsd#cron_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedAndIssuedInPeriod"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cron_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedAndIssuedInPeriod" xlink:to="lab_cron_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedAndIssuedInPeriod" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PaymentsToAcquireLoansReceivable_87f42baf-b6ec-46f8-bc82-246e1f8f1d4f_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_PaymentsToAcquireLoansReceivable" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Advances on loans receivable</link:label>
    <link:label id="lab_us-gaap_PaymentsToAcquireLoansReceivable_4c4616b3-5478-4a3a-8c4c-2ebd48077381_terseLabel_en-US" xlink:label="lab_us-gaap_PaymentsToAcquireLoansReceivable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Draw downs</link:label>
    <link:label id="lab_us-gaap_PaymentsToAcquireLoansReceivable_label_en-US" xlink:label="lab_us-gaap_PaymentsToAcquireLoansReceivable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payments to Acquire Loans Receivable</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquireLoansReceivable" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PaymentsToAcquireLoansReceivable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PaymentsToAcquireLoansReceivable" xlink:to="lab_us-gaap_PaymentsToAcquireLoansReceivable" xlink:type="arc" order="1"/>
    <link:label id="lab_cron_LossContingencyPunitiveDamagesSoughtValue_29c444c9-8b11-4f87-8d51-b1fc68ac68d3_terseLabel_en-US" xlink:label="lab_cron_LossContingencyPunitiveDamagesSoughtValue" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Punitive damages sought</link:label>
    <link:label id="lab_cron_LossContingencyPunitiveDamagesSoughtValue_label_en-US" xlink:label="lab_cron_LossContingencyPunitiveDamagesSoughtValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Loss Contingency, Punitive Damages Sought, Value</link:label>
    <link:label id="lab_cron_LossContingencyPunitiveDamagesSoughtValue_documentation_en-US" xlink:label="lab_cron_LossContingencyPunitiveDamagesSoughtValue" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Loss Contingency, Punitive Damages Sought, Value</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_cron_LossContingencyPunitiveDamagesSoughtValue" xlink:href="cron-20210630.xsd#cron_LossContingencyPunitiveDamagesSoughtValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cron_LossContingencyPunitiveDamagesSoughtValue" xlink:to="lab_cron_LossContingencyPunitiveDamagesSoughtValue" xlink:type="arc" order="1"/>
    <link:label id="lab_cron_SubsidiaryOrEquityMethodInvesteeCumulativePercentageOwnershipAfterAllTransactionsIfWarrantsExercised_5db81332-015b-4e0c-80a1-8bcac0d6a519_terseLabel_en-US" xlink:label="lab_cron_SubsidiaryOrEquityMethodInvesteeCumulativePercentageOwnershipAfterAllTransactionsIfWarrantsExercised" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Ownership percentage, if warrant exercised</link:label>
    <link:label id="lab_cron_SubsidiaryOrEquityMethodInvesteeCumulativePercentageOwnershipAfterAllTransactionsIfWarrantsExercised_label_en-US" xlink:label="lab_cron_SubsidiaryOrEquityMethodInvesteeCumulativePercentageOwnershipAfterAllTransactionsIfWarrantsExercised" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Subsidiary Or Equity Method Investee, Cumulative Percentage Ownership After All Transactions, If Warrants Exercised</link:label>
    <link:label id="lab_cron_SubsidiaryOrEquityMethodInvesteeCumulativePercentageOwnershipAfterAllTransactionsIfWarrantsExercised_documentation_en-US" xlink:label="lab_cron_SubsidiaryOrEquityMethodInvesteeCumulativePercentageOwnershipAfterAllTransactionsIfWarrantsExercised" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Subsidiary Or Equity Method Investee, Cumulative Percentage Ownership After All Transactions, If Warrants Exercised</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_cron_SubsidiaryOrEquityMethodInvesteeCumulativePercentageOwnershipAfterAllTransactionsIfWarrantsExercised" xlink:href="cron-20210630.xsd#cron_SubsidiaryOrEquityMethodInvesteeCumulativePercentageOwnershipAfterAllTransactionsIfWarrantsExercised"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cron_SubsidiaryOrEquityMethodInvesteeCumulativePercentageOwnershipAfterAllTransactionsIfWarrantsExercised" xlink:to="lab_cron_SubsidiaryOrEquityMethodInvesteeCumulativePercentageOwnershipAfterAllTransactionsIfWarrantsExercised" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems_dc2b6679-cf24-4388-9475-d04a4ca6636b_terseLabel_en-US" xlink:label="lab_us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Payment Arrangement, Expensed and Capitalized, Amount [Line Items]</link:label>
    <link:label id="lab_us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems_label_en-US" xlink:label="lab_us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Payment Arrangement, Expensed and Capitalized, Amount [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems" xlink:to="lab_us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_cron_ClassOfWarrantOrRightExercisePriceVolumeWeightedAveragePriceMeasurementPeriod_f4e9e202-e2f3-4475-8cd5-e943e5fdb8db_terseLabel_en-US" xlink:label="lab_cron_ClassOfWarrantOrRightExercisePriceVolumeWeightedAveragePriceMeasurementPeriod" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Exercise price, volume-weighted average price, measurement period</link:label>
    <link:label id="lab_cron_ClassOfWarrantOrRightExercisePriceVolumeWeightedAveragePriceMeasurementPeriod_label_en-US" xlink:label="lab_cron_ClassOfWarrantOrRightExercisePriceVolumeWeightedAveragePriceMeasurementPeriod" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Class Of Warrant Or Right, Exercise Price, Volume-Weighted Average Price, Measurement Period</link:label>
    <link:label id="lab_cron_ClassOfWarrantOrRightExercisePriceVolumeWeightedAveragePriceMeasurementPeriod_documentation_en-US" xlink:label="lab_cron_ClassOfWarrantOrRightExercisePriceVolumeWeightedAveragePriceMeasurementPeriod" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Class Of Warrant Or Right, Exercise Price, Volume-Weighted Average Price, Measurement Period</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_cron_ClassOfWarrantOrRightExercisePriceVolumeWeightedAveragePriceMeasurementPeriod" xlink:href="cron-20210630.xsd#cron_ClassOfWarrantOrRightExercisePriceVolumeWeightedAveragePriceMeasurementPeriod"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cron_ClassOfWarrantOrRightExercisePriceVolumeWeightedAveragePriceMeasurementPeriod" xlink:to="lab_cron_ClassOfWarrantOrRightExercisePriceVolumeWeightedAveragePriceMeasurementPeriod" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IndefiniteLivedIntangibleAssetsMajorClassNameDomain_4eb9e43a-9beb-4618-8bc8-2f0c312649cd_terseLabel_en-US" xlink:label="lab_us-gaap_IndefiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Indefinite-lived Intangible Assets, Major Class Name [Domain]</link:label>
    <link:label id="lab_us-gaap_IndefiniteLivedIntangibleAssetsMajorClassNameDomain_label_en-US" xlink:label="lab_us-gaap_IndefiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Indefinite-lived Intangible Assets, Major Class Name [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IndefiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IndefiniteLivedIntangibleAssetsMajorClassNameDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IndefiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:to="lab_us-gaap_IndefiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DeferredCompensationSharebasedArrangementsLiabilityCurrentAndNoncurrent_3d226f9f-265b-43d5-8850-1548cf0691aa_periodStartLabel_en-US" xlink:label="lab_us-gaap_DeferredCompensationSharebasedArrangementsLiabilityCurrentAndNoncurrent" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Balance at beginning of period</link:label>
    <link:label id="lab_us-gaap_DeferredCompensationSharebasedArrangementsLiabilityCurrentAndNoncurrent_60f4f9cd-a398-40ea-a0bd-8d7c6a2f54eb_periodEndLabel_en-US" xlink:label="lab_us-gaap_DeferredCompensationSharebasedArrangementsLiabilityCurrentAndNoncurrent" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Balance at end of period</link:label>
    <link:label id="lab_us-gaap_DeferredCompensationSharebasedArrangementsLiabilityCurrentAndNoncurrent_label_en-US" xlink:label="lab_us-gaap_DeferredCompensationSharebasedArrangementsLiabilityCurrentAndNoncurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred Compensation Share-based Arrangements, Liability, Current and Noncurrent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredCompensationSharebasedArrangementsLiabilityCurrentAndNoncurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredCompensationSharebasedArrangementsLiabilityCurrentAndNoncurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DeferredCompensationSharebasedArrangementsLiabilityCurrentAndNoncurrent" xlink:to="lab_us-gaap_DeferredCompensationSharebasedArrangementsLiabilityCurrentAndNoncurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber_5193a89b-5312-44ae-b72f-ca8a44fdf593_periodStartLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Balance at beginning of period (in shares)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber_99ad0b3a-4d49-4f0c-b2bb-dd2ec089fd50_periodEndLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Balance at end of period (in shares)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber_ab4211bc-dfe9-4a69-9d1f-c8194e626e08_verboseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Number of warrants (in shares)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Number</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_DocumentType_b0fab4bb-593f-485b-8488-7079b7cb9b03_terseLabel_en-US" xlink:label="lab_dei_DocumentType" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Type</link:label>
    <link:label id="lab_dei_DocumentType_label_en-US" xlink:label="lab_dei_DocumentType" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Type</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentType" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_DocumentType"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_DocumentType" xlink:to="lab_dei_DocumentType" xlink:type="arc" order="1"/>
    <link:label id="lab_country_CA_980b9af4-2fdf-44ce-8e9b-584eac914de6_terseLabel_en-US" xlink:label="lab_country_CA" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Canada</link:label>
    <link:label id="lab_country_CA_label_en-US" xlink:label="lab_country_CA" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">CANADA</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_country_CA" xlink:href="https://xbrl.sec.gov/country/2021/country-2021.xsd#country_CA"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_country_CA" xlink:to="lab_country_CA" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ReportingUnitDomain_b5f6884c-3df7-4256-a062-b80c13125a8d_terseLabel_en-US" xlink:label="lab_us-gaap_ReportingUnitDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Reporting Unit [Domain]</link:label>
    <link:label id="lab_us-gaap_ReportingUnitDomain_label_en-US" xlink:label="lab_us-gaap_ReportingUnitDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Reporting Unit [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ReportingUnitDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ReportingUnitDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ReportingUnitDomain" xlink:to="lab_us-gaap_ReportingUnitDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward_2c732b86-71a6-42ee-81b1-d4de671c5c2b_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Number of awards</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Number of Shares [Roll Forward]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityCurrentReportingStatus_909ea082-5785-4e6e-9f97-7c3072aa71a5_terseLabel_en-US" xlink:label="lab_dei_EntityCurrentReportingStatus" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Current Reporting Status</link:label>
    <link:label id="lab_dei_EntityCurrentReportingStatus_label_en-US" xlink:label="lab_dei_EntityCurrentReportingStatus" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Current Reporting Status</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityCurrentReportingStatus" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityCurrentReportingStatus"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityCurrentReportingStatus" xlink:to="lab_dei_EntityCurrentReportingStatus" xlink:type="arc" order="1"/>
    <link:label id="lab_cron_SocieteQuebecoiseDuCannabisMember_2122131d-9c3b-466f-a1f8-a4c69abb60cf_terseLabel_en-US" xlink:label="lab_cron_SocieteQuebecoiseDuCannabisMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Societe Quebecoise Du Cannabis</link:label>
    <link:label id="lab_cron_SocieteQuebecoiseDuCannabisMember_label_en-US" xlink:label="lab_cron_SocieteQuebecoiseDuCannabisMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Societe Quebecoise du Cannabis [Member]</link:label>
    <link:label id="lab_cron_SocieteQuebecoiseDuCannabisMember_documentation_en-US" xlink:label="lab_cron_SocieteQuebecoiseDuCannabisMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Societe Quebecoise du Cannabis</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_cron_SocieteQuebecoiseDuCannabisMember" xlink:href="cron-20210630.xsd#cron_SocieteQuebecoiseDuCannabisMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cron_SocieteQuebecoiseDuCannabisMember" xlink:to="lab_cron_SocieteQuebecoiseDuCannabisMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedWeightedAverageGrantDateFairValueAbstract_0e70c0bb-2520-43f5-aa8b-7ebce5a0b179_terseLabel_en-US" xlink:label="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedWeightedAverageGrantDateFairValueAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Weighted average remaining contractual term (years)</link:label>
    <link:label id="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedWeightedAverageGrantDateFairValueAbstract_label_en-US" xlink:label="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedWeightedAverageGrantDateFairValueAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Options, Nonvested, Weighted Average Grant Date Fair Value [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedWeightedAverageGrantDateFairValueAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedWeightedAverageGrantDateFairValueAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedWeightedAverageGrantDateFairValueAbstract" xlink:to="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedWeightedAverageGrantDateFairValueAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation_da13423f-c9a0-4aa2-bcc3-5afc48fef51c_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Withholding taxes paid on share-based awards</link:label>
    <link:label id="lab_us-gaap_AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation_label_en-US" xlink:label="lab_us-gaap_AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Payment Arrangement, Decrease for Tax Withholding Obligation</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation" xlink:to="lab_us-gaap_AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherNoncashIncomeExpense_151cffa2-c1d4-4fab-9cce-581bf470d212_negatedLabel_en-US" xlink:label="lab_us-gaap_OtherNoncashIncomeExpense" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other non-cash operating activities, net</link:label>
    <link:label id="lab_us-gaap_OtherNoncashIncomeExpense_label_en-US" xlink:label="lab_us-gaap_OtherNoncashIncomeExpense" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Noncash Income (Expense)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherNoncashIncomeExpense" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherNoncashIncomeExpense"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherNoncashIncomeExpense" xlink:to="lab_us-gaap_OtherNoncashIncomeExpense" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LossContingencyNumberOfPlaintiffs_03685e8e-b2a9-47ef-a15a-b1e03f009f43_terseLabel_en-US" xlink:label="lab_us-gaap_LossContingencyNumberOfPlaintiffs" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Number of alleged shareholders</link:label>
    <link:label id="lab_us-gaap_LossContingencyNumberOfPlaintiffs_label_en-US" xlink:label="lab_us-gaap_LossContingencyNumberOfPlaintiffs" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Loss Contingency, Number of Plaintiffs</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LossContingencyNumberOfPlaintiffs" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LossContingencyNumberOfPlaintiffs"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LossContingencyNumberOfPlaintiffs" xlink:to="lab_us-gaap_LossContingencyNumberOfPlaintiffs" xlink:type="arc" order="1"/>
    <link:label id="lab_cron_InvestmentsInAndAdvancesToAffiliatesAtFairValueTransferToInvestmentsInEquityAccountedInvestees_2e6d7f57-9fc6-45b5-9688-4a006a3abd81_terseLabel_en-US" xlink:label="lab_cron_InvestmentsInAndAdvancesToAffiliatesAtFairValueTransferToInvestmentsInEquityAccountedInvestees" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Transfer to investments in equity accounted investees</link:label>
    <link:label id="lab_cron_InvestmentsInAndAdvancesToAffiliatesAtFairValueTransferToInvestmentsInEquityAccountedInvestees_label_en-US" xlink:label="lab_cron_InvestmentsInAndAdvancesToAffiliatesAtFairValueTransferToInvestmentsInEquityAccountedInvestees" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Investments In And Advances To Affiliates, At Fair Value, Transfer To Investments In Equity Accounted Investees</link:label>
    <link:label id="lab_cron_InvestmentsInAndAdvancesToAffiliatesAtFairValueTransferToInvestmentsInEquityAccountedInvestees_documentation_en-US" xlink:label="lab_cron_InvestmentsInAndAdvancesToAffiliatesAtFairValueTransferToInvestmentsInEquityAccountedInvestees" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Investments In And Advances To Affiliates, At Fair Value, Transfer To Investments In Equity Accounted Investees</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_cron_InvestmentsInAndAdvancesToAffiliatesAtFairValueTransferToInvestmentsInEquityAccountedInvestees" xlink:href="cron-20210630.xsd#cron_InvestmentsInAndAdvancesToAffiliatesAtFairValueTransferToInvestmentsInEquityAccountedInvestees"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cron_InvestmentsInAndAdvancesToAffiliatesAtFairValueTransferToInvestmentsInEquityAccountedInvestees" xlink:to="lab_cron_InvestmentsInAndAdvancesToAffiliatesAtFairValueTransferToInvestmentsInEquityAccountedInvestees" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ProvisionForDoubtfulAccounts_51b209c3-d4cf-4f03-9850-62eb9f06bc6b_terseLabel_en-US" xlink:label="lab_us-gaap_ProvisionForDoubtfulAccounts" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Expected credit losses on long-term financial assets</link:label>
    <link:label id="lab_us-gaap_ProvisionForDoubtfulAccounts_label_en-US" xlink:label="lab_us-gaap_ProvisionForDoubtfulAccounts" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounts Receivable, Credit Loss Expense (Reversal)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProvisionForDoubtfulAccounts" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ProvisionForDoubtfulAccounts"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ProvisionForDoubtfulAccounts" xlink:to="lab_us-gaap_ProvisionForDoubtfulAccounts" xlink:type="arc" order="1"/>
    <link:label id="lab_cron_CronosAustraliaLimitedMember_03f56b6b-62e3-4dc2-adcb-244720717cbf_terseLabel_en-US" xlink:label="lab_cron_CronosAustraliaLimitedMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cronos Australia</link:label>
    <link:label id="lab_cron_CronosAustraliaLimitedMember_label_en-US" xlink:label="lab_cron_CronosAustraliaLimitedMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cronos Australia Limited [Member]</link:label>
    <link:label id="lab_cron_CronosAustraliaLimitedMember_documentation_en-US" xlink:label="lab_cron_CronosAustraliaLimitedMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cronos Australia Limited [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_cron_CronosAustraliaLimitedMember" xlink:href="cron-20210630.xsd#cron_CronosAustraliaLimitedMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cron_CronosAustraliaLimitedMember" xlink:to="lab_cron_CronosAustraliaLimitedMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsTable_30933175-4918-4ea0-9223-e167573daf75_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disposal Groups, Including Discontinued Operations [Table]</link:label>
    <link:label id="lab_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsTable_label_en-US" xlink:label="lab_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disposal Groups, Including Discontinued Operations [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsTable" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsTable" xlink:to="lab_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ReportingUnitAxis_aa22af6e-28d9-4491-9603-decf58acc14a_terseLabel_en-US" xlink:label="lab_us-gaap_ReportingUnitAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Reporting Unit [Axis]</link:label>
    <link:label id="lab_us-gaap_ReportingUnitAxis_label_en-US" xlink:label="lab_us-gaap_ReportingUnitAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Reporting Unit [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ReportingUnitAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ReportingUnitAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ReportingUnitAxis" xlink:to="lab_us-gaap_ReportingUnitAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeLossFromContinuingOperationsPerDilutedShare_4d58fe0a-c19d-4f8d-a1fc-412996c6368d_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeLossFromContinuingOperationsPerDilutedShare" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Diluted - continuing operations (in dollars per share)</link:label>
    <link:label id="lab_us-gaap_IncomeLossFromContinuingOperationsPerDilutedShare_117d8f0f-3c3f-4531-a217-52f8a9003b6b_verboseLabel_en-US" xlink:label="lab_us-gaap_IncomeLossFromContinuingOperationsPerDilutedShare" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Diluted earnings (loss) from continuing operations per share (in dollars per share)</link:label>
    <link:label id="lab_us-gaap_IncomeLossFromContinuingOperationsPerDilutedShare_label_en-US" xlink:label="lab_us-gaap_IncomeLossFromContinuingOperationsPerDilutedShare" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income (Loss) from Continuing Operations, Per Diluted Share</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromContinuingOperationsPerDilutedShare" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeLossFromContinuingOperationsPerDilutedShare"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeLossFromContinuingOperationsPerDilutedShare" xlink:to="lab_us-gaap_IncomeLossFromContinuingOperationsPerDilutedShare" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PlanNameAxis_4dd32c27-2204-4cb0-a46b-3488a30c5213_terseLabel_en-US" xlink:label="lab_us-gaap_PlanNameAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Plan Name [Axis]</link:label>
    <link:label id="lab_us-gaap_PlanNameAxis_label_en-US" xlink:label="lab_us-gaap_PlanNameAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Plan Name [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PlanNameAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PlanNameAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PlanNameAxis" xlink:to="lab_us-gaap_PlanNameAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueInputsLevel1Member_f0e8b686-e8fb-4221-bf48-41b05da04e32_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueInputsLevel1Member" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Level 1</link:label>
    <link:label id="lab_us-gaap_FairValueInputsLevel1Member_label_en-US" xlink:label="lab_us-gaap_FairValueInputsLevel1Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value, Inputs, Level 1 [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueInputsLevel1Member" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueInputsLevel1Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueInputsLevel1Member" xlink:to="lab_us-gaap_FairValueInputsLevel1Member" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_307a91ca-e593-4b5d-8c1d-826a026a4ce7_terseLabel_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Investing activities</link:label>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_label_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net Cash Provided by (Used in) Investing Activities [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract" xlink:to="lab_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_GoodwillImpairmentLoss_da085acb-0aae-4aa5-be4e-c65da74c1764_verboseLabel_en-US" xlink:label="lab_us-gaap_GoodwillImpairmentLoss" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Goodwill, impairment loss</link:label>
    <link:label id="lab_us-gaap_GoodwillImpairmentLoss_label_en-US" xlink:label="lab_us-gaap_GoodwillImpairmentLoss" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Goodwill, Impairment Loss</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillImpairmentLoss" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_GoodwillImpairmentLoss"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_GoodwillImpairmentLoss" xlink:to="lab_us-gaap_GoodwillImpairmentLoss" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_DocumentTransitionReport_2abc12d6-f531-4e89-a1a1-791998688093_terseLabel_en-US" xlink:label="lab_dei_DocumentTransitionReport" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Transition Report</link:label>
    <link:label id="lab_dei_DocumentTransitionReport_label_en-US" xlink:label="lab_dei_DocumentTransitionReport" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Transition Report</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentTransitionReport" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_DocumentTransitionReport"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_DocumentTransitionReport" xlink:to="lab_dei_DocumentTransitionReport" xlink:type="arc" order="1"/>
    <link:label id="lab_cron_StockholdersEquityOutOfPeriodAdjustment_ea600bf0-ad20-409a-a499-f2d22eb85d2c_terseLabel_en-US" xlink:label="lab_cron_StockholdersEquityOutOfPeriodAdjustment" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Top-up rights out-of-period adjustment</link:label>
    <link:label id="lab_cron_StockholdersEquityOutOfPeriodAdjustment_label_en-US" xlink:label="lab_cron_StockholdersEquityOutOfPeriodAdjustment" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stockholders' Equity, Out-Of-Period Adjustment</link:label>
    <link:label id="lab_cron_StockholdersEquityOutOfPeriodAdjustment_documentation_en-US" xlink:label="lab_cron_StockholdersEquityOutOfPeriodAdjustment" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stockholders' Equity, Out-Of-Period Adjustment</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_cron_StockholdersEquityOutOfPeriodAdjustment" xlink:href="cron-20210630.xsd#cron_StockholdersEquityOutOfPeriodAdjustment"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cron_StockholdersEquityOutOfPeriodAdjustment" xlink:to="lab_cron_StockholdersEquityOutOfPeriodAdjustment" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EarningsPerShareBasicAndDilutedOtherDisclosuresAbstract_10441d9c-77cb-4f63-a695-0c586311cbf3_terseLabel_en-US" xlink:label="lab_us-gaap_EarningsPerShareBasicAndDilutedOtherDisclosuresAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Weighted average number of outstanding shares</link:label>
    <link:label id="lab_us-gaap_EarningsPerShareBasicAndDilutedOtherDisclosuresAbstract_label_en-US" xlink:label="lab_us-gaap_EarningsPerShareBasicAndDilutedOtherDisclosuresAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Earnings Per Share, Basic and Diluted, Other Disclosures [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareBasicAndDilutedOtherDisclosuresAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EarningsPerShareBasicAndDilutedOtherDisclosuresAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EarningsPerShareBasicAndDilutedOtherDisclosuresAbstract" xlink:to="lab_us-gaap_EarningsPerShareBasicAndDilutedOtherDisclosuresAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LiabilitiesAndStockholdersEquity_aab24a9b-469a-4a86-a561-3b4a79594e8c_totalLabel_en-US" xlink:label="lab_us-gaap_LiabilitiesAndStockholdersEquity" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total liabilities and shareholders&#8217; equity</link:label>
    <link:label id="lab_us-gaap_LiabilitiesAndStockholdersEquity_label_en-US" xlink:label="lab_us-gaap_LiabilitiesAndStockholdersEquity" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Liabilities and Equity</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesAndStockholdersEquity" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LiabilitiesAndStockholdersEquity"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquity" xlink:to="lab_us-gaap_LiabilitiesAndStockholdersEquity" xlink:type="arc" order="1"/>
    <link:label id="lab_cron_AgroideaMember_82305d1b-91e7-4ed7-a3a8-49be29ec14e3_terseLabel_en-US" xlink:label="lab_cron_AgroideaMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">AGI</link:label>
    <link:label id="lab_cron_AgroideaMember_label_en-US" xlink:label="lab_cron_AgroideaMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Agroidea [Member]</link:label>
    <link:label id="lab_cron_AgroideaMember_documentation_en-US" xlink:label="lab_cron_AgroideaMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Agroidea</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_cron_AgroideaMember" xlink:href="cron-20210630.xsd#cron_AgroideaMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cron_AgroideaMember" xlink:to="lab_cron_AgroideaMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PendingLitigationMember_326ba2a8-6a66-4be6-b3d1-7420f7a166c6_terseLabel_en-US" xlink:label="lab_us-gaap_PendingLitigationMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Pending Litigation</link:label>
    <link:label id="lab_us-gaap_PendingLitigationMember_label_en-US" xlink:label="lab_us-gaap_PendingLitigationMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Pending Litigation [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PendingLitigationMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PendingLitigationMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PendingLitigationMember" xlink:to="lab_us-gaap_PendingLitigationMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DueToRelatedPartiesNoncurrent_1e0e6596-0fe0-4dc4-abac-c80a67db6abe_terseLabel_en-US" xlink:label="lab_us-gaap_DueToRelatedPartiesNoncurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Due to non-controlling interests</link:label>
    <link:label id="lab_us-gaap_DueToRelatedPartiesNoncurrent_label_en-US" xlink:label="lab_us-gaap_DueToRelatedPartiesNoncurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Due to Related Parties, Noncurrent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DueToRelatedPartiesNoncurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DueToRelatedPartiesNoncurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DueToRelatedPartiesNoncurrent" xlink:to="lab_us-gaap_DueToRelatedPartiesNoncurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTaxPerDilutedShare_94f8866c-13e0-4fe5-a641-e87850646a26_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTaxPerDilutedShare" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Diluted earnings from discontinued operations per share (in dollars per share)</link:label>
    <link:label id="lab_us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTaxPerDilutedShare_label_en-US" xlink:label="lab_us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTaxPerDilutedShare" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income (Loss) from Discontinued Operations and Disposal of Discontinued Operations, Net of Tax, Per Diluted Share</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTaxPerDilutedShare" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTaxPerDilutedShare"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTaxPerDilutedShare" xlink:to="lab_us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTaxPerDilutedShare" xlink:type="arc" order="1"/>
    <link:label id="lab_cron_PriorOptionPlansMember_b038bce9-0f96-4e3c-a5ba-5fede6b673d0_terseLabel_en-US" xlink:label="lab_cron_PriorOptionPlansMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Prior Option Plans</link:label>
    <link:label id="lab_cron_PriorOptionPlansMember_label_en-US" xlink:label="lab_cron_PriorOptionPlansMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Prior Option Plans [Member]</link:label>
    <link:label id="lab_cron_PriorOptionPlansMember_documentation_en-US" xlink:label="lab_cron_PriorOptionPlansMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Prior Option Plans</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_cron_PriorOptionPlansMember" xlink:href="cron-20210630.xsd#cron_PriorOptionPlansMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cron_PriorOptionPlansMember" xlink:to="lab_cron_PriorOptionPlansMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice_ffb585b6-150f-4751-a000-d765da4a2db8_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Exercise of options (in dollars per share)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangements by Share-based Payment Award, Options, Exercises in Period, Weighted Average Exercise Price</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AdditionalPaidInCapital_a24fa32f-497d-4ec9-ae47-2c6e147fd738_terseLabel_en-US" xlink:label="lab_us-gaap_AdditionalPaidInCapital" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Additional paid-in capital</link:label>
    <link:label id="lab_us-gaap_AdditionalPaidInCapital_label_en-US" xlink:label="lab_us-gaap_AdditionalPaidInCapital" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Additional Paid in Capital</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdditionalPaidInCapital" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AdditionalPaidInCapital"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AdditionalPaidInCapital" xlink:to="lab_us-gaap_AdditionalPaidInCapital" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ImpairmentOfIntangibleAssetsIndefinitelivedExcludingGoodwill_be9c63a7-b5e1-4b9d-bd06-76569ca3577a_terseLabel_en-US" xlink:label="lab_us-gaap_ImpairmentOfIntangibleAssetsIndefinitelivedExcludingGoodwill" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Impairment of intangible assets, indefinite-lived (excluding goodwill)</link:label>
    <link:label id="lab_us-gaap_ImpairmentOfIntangibleAssetsIndefinitelivedExcludingGoodwill_label_en-US" xlink:label="lab_us-gaap_ImpairmentOfIntangibleAssetsIndefinitelivedExcludingGoodwill" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Impairment of Intangible Assets, Indefinite-lived (Excluding Goodwill)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ImpairmentOfIntangibleAssetsIndefinitelivedExcludingGoodwill" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ImpairmentOfIntangibleAssetsIndefinitelivedExcludingGoodwill"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ImpairmentOfIntangibleAssetsIndefinitelivedExcludingGoodwill" xlink:to="lab_us-gaap_ImpairmentOfIntangibleAssetsIndefinitelivedExcludingGoodwill" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ConcentrationRiskLineItems_d7f412fd-fe94-4357-9f88-7a86258b7dd7_terseLabel_en-US" xlink:label="lab_us-gaap_ConcentrationRiskLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Concentration Risk [Line Items]</link:label>
    <link:label id="lab_us-gaap_ConcentrationRiskLineItems_label_en-US" xlink:label="lab_us-gaap_ConcentrationRiskLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Concentration Risk [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ConcentrationRiskLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ConcentrationRiskLineItems" xlink:to="lab_us-gaap_ConcentrationRiskLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DerivativeLineItems_1d56e1bc-5acc-4c49-b009-72749d15ea63_terseLabel_en-US" xlink:label="lab_us-gaap_DerivativeLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative [Line Items]</link:label>
    <link:label id="lab_us-gaap_DerivativeLineItems_label_en-US" xlink:label="lab_us-gaap_DerivativeLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DerivativeLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DerivativeLineItems" xlink:to="lab_us-gaap_DerivativeLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OperatingLeaseImpairmentLoss_5e6a70f8-4c34-400e-ae16-0efbe4b84025_terseLabel_en-US" xlink:label="lab_us-gaap_OperatingLeaseImpairmentLoss" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Impairment charge on the de-recognition of the right-of-use asset</link:label>
    <link:label id="lab_us-gaap_OperatingLeaseImpairmentLoss_label_en-US" xlink:label="lab_us-gaap_OperatingLeaseImpairmentLoss" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Lease, Impairment Loss</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseImpairmentLoss" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingLeaseImpairmentLoss"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OperatingLeaseImpairmentLoss" xlink:to="lab_us-gaap_OperatingLeaseImpairmentLoss" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EarningsPerShareTextBlock_97f1b6fc-aa44-4223-bc61-5867e9ece026_terseLabel_en-US" xlink:label="lab_us-gaap_EarningsPerShareTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Earnings (Loss) Per Share</link:label>
    <link:label id="lab_us-gaap_EarningsPerShareTextBlock_label_en-US" xlink:label="lab_us-gaap_EarningsPerShareTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Earnings Per Share [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EarningsPerShareTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EarningsPerShareTextBlock" xlink:to="lab_us-gaap_EarningsPerShareTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DerivativeLiabilitiesCurrent_7d340e6c-ee79-4bcb-9d76-20061eb54fd1_terseLabel_en-US" xlink:label="lab_us-gaap_DerivativeLiabilitiesCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative liabilities</link:label>
    <link:label id="lab_us-gaap_DerivativeLiabilitiesCurrent_label_en-US" xlink:label="lab_us-gaap_DerivativeLiabilitiesCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative Liability, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeLiabilitiesCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DerivativeLiabilitiesCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DerivativeLiabilitiesCurrent" xlink:to="lab_us-gaap_DerivativeLiabilitiesCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OperatingExpensesAbstract_a98eede4-9d50-49f6-95e7-1c6e11e88b97_terseLabel_en-US" xlink:label="lab_us-gaap_OperatingExpensesAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating expenses</link:label>
    <link:label id="lab_us-gaap_OperatingExpensesAbstract_label_en-US" xlink:label="lab_us-gaap_OperatingExpensesAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Expenses [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingExpensesAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingExpensesAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OperatingExpensesAbstract" xlink:to="lab_us-gaap_OperatingExpensesAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EquityMethodInvestmentOwnershipPercentage_6b6fe804-775a-4b72-b493-723a99828f40_verboseLabel_en-US" xlink:label="lab_us-gaap_EquityMethodInvestmentOwnershipPercentage" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Ownership interest</link:label>
    <link:label id="lab_us-gaap_EquityMethodInvestmentOwnershipPercentage_label_en-US" xlink:label="lab_us-gaap_EquityMethodInvestmentOwnershipPercentage" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity Method Investment, Ownership Percentage</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityMethodInvestmentOwnershipPercentage" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EquityMethodInvestmentOwnershipPercentage"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EquityMethodInvestmentOwnershipPercentage" xlink:to="lab_us-gaap_EquityMethodInvestmentOwnershipPercentage" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised_45a9e1a0-b5e5-4781-ac33-8ef753399534_terseLabel_en-US" xlink:label="lab_us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Options exercised</link:label>
    <link:label id="lab_us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised_label_en-US" xlink:label="lab_us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stock Issued During Period, Value, Stock Options Exercised</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised" xlink:to="lab_us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised" xlink:type="arc" order="1"/>
    <link:label id="lab_cron_CannasoulAnalyticsLtdMember_d23be5af-c95b-44f9-9e96-b9652b9a4f55_terseLabel_en-US" xlink:label="lab_cron_CannasoulAnalyticsLtdMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cannasoul</link:label>
    <link:label id="lab_cron_CannasoulAnalyticsLtdMember_label_en-US" xlink:label="lab_cron_CannasoulAnalyticsLtdMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cannasoul Analytics Ltd. [Member]</link:label>
    <link:label id="lab_cron_CannasoulAnalyticsLtdMember_documentation_en-US" xlink:label="lab_cron_CannasoulAnalyticsLtdMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cannasoul Analytics Ltd.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_cron_CannasoulAnalyticsLtdMember" xlink:href="cron-20210630.xsd#cron_CannasoulAnalyticsLtdMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cron_CannasoulAnalyticsLtdMember" xlink:to="lab_cron_CannasoulAnalyticsLtdMember" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_MinimumMember_83c1b360-6ca9-4c02-8c0d-c5c49b614760_terseLabel_en-US" xlink:label="lab_srt_MinimumMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Minimum</link:label>
    <link:label id="lab_srt_MinimumMember_label_en-US" xlink:label="lab_srt_MinimumMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Minimum [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MinimumMember" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_MinimumMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_MinimumMember" xlink:to="lab_srt_MinimumMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LossContingencyAbstract_c624ecdd-c3a3-412c-884e-3153b5b762e8_terseLabel_en-US" xlink:label="lab_us-gaap_LossContingencyAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Loss Contingency [Abstract]</link:label>
    <link:label id="lab_us-gaap_LossContingencyAbstract_label_en-US" xlink:label="lab_us-gaap_LossContingencyAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Loss Contingency [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LossContingencyAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LossContingencyAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LossContingencyAbstract" xlink:to="lab_us-gaap_LossContingencyAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ErrorCorrectionsAndPriorPeriodAdjustmentsRestatementByRestatementPeriodAndAmountAxis_bd8655b6-4062-48b2-b641-8e364fc6a2cf_terseLabel_en-US" xlink:label="lab_us-gaap_ErrorCorrectionsAndPriorPeriodAdjustmentsRestatementByRestatementPeriodAndAmountAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Error Correction, Type [Axis]</link:label>
    <link:label id="lab_us-gaap_ErrorCorrectionsAndPriorPeriodAdjustmentsRestatementByRestatementPeriodAndAmountAxis_label_en-US" xlink:label="lab_us-gaap_ErrorCorrectionsAndPriorPeriodAdjustmentsRestatementByRestatementPeriodAndAmountAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Error Correction, Type [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ErrorCorrectionsAndPriorPeriodAdjustmentsRestatementByRestatementPeriodAndAmountAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ErrorCorrectionsAndPriorPeriodAdjustmentsRestatementByRestatementPeriodAndAmountAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ErrorCorrectionsAndPriorPeriodAdjustmentsRestatementByRestatementPeriodAndAmountAxis" xlink:to="lab_us-gaap_ErrorCorrectionsAndPriorPeriodAdjustmentsRestatementByRestatementPeriodAndAmountAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_cron_AltriaWarrantMember_df9e61f7-0433-430d-8910-ca010924dddc_verboseLabel_en-US" xlink:label="lab_cron_AltriaWarrantMember" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Altria Warrant</link:label>
    <link:label id="lab_cron_AltriaWarrantMember_544d7cef-e7e2-40e3-9c50-8553ff8bc789_terseLabel_en-US" xlink:label="lab_cron_AltriaWarrantMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Altria Warrant</link:label>
    <link:label id="lab_cron_AltriaWarrantMember_label_en-US" xlink:label="lab_cron_AltriaWarrantMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Altria Warrant [Member]</link:label>
    <link:label id="lab_cron_AltriaWarrantMember_documentation_en-US" xlink:label="lab_cron_AltriaWarrantMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Altria Warrant [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_cron_AltriaWarrantMember" xlink:href="cron-20210630.xsd#cron_AltriaWarrantMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cron_AltriaWarrantMember" xlink:to="lab_cron_AltriaWarrantMember" xlink:type="arc" order="1"/>
    <link:label id="lab_cron_ErrorRelatedToWithholdingTaxesOnTheNetExerciseOfStockOptionsMember_3ad6dd2b-56bd-416b-bcb8-aff2a302e719_terseLabel_en-US" xlink:label="lab_cron_ErrorRelatedToWithholdingTaxesOnTheNetExerciseOfStockOptionsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Error Related to Withholding Taxes on the Net Exercise of Stock Options</link:label>
    <link:label id="lab_cron_ErrorRelatedToWithholdingTaxesOnTheNetExerciseOfStockOptionsMember_label_en-US" xlink:label="lab_cron_ErrorRelatedToWithholdingTaxesOnTheNetExerciseOfStockOptionsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Error Related To Withholding Taxes On The Net Exercise Of Stock Options [Member]</link:label>
    <link:label id="lab_cron_ErrorRelatedToWithholdingTaxesOnTheNetExerciseOfStockOptionsMember_documentation_en-US" xlink:label="lab_cron_ErrorRelatedToWithholdingTaxesOnTheNetExerciseOfStockOptionsMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Error Related To Withholding Taxes On The Net Exercise Of Stock Options</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_cron_ErrorRelatedToWithholdingTaxesOnTheNetExerciseOfStockOptionsMember" xlink:href="cron-20210630.xsd#cron_ErrorRelatedToWithholdingTaxesOnTheNetExerciseOfStockOptionsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cron_ErrorRelatedToWithholdingTaxesOnTheNetExerciseOfStockOptionsMember" xlink:to="lab_cron_ErrorRelatedToWithholdingTaxesOnTheNetExerciseOfStockOptionsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_cron_PreemptiveRightsMember_7d4f0b5d-89a1-4047-a639-6f155855f18c_verboseLabel_en-US" xlink:label="lab_cron_PreemptiveRightsMember" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Pre-emptive Rights</link:label>
    <link:label id="lab_cron_PreemptiveRightsMember_8e6df41b-e7ef-4745-983a-42201a2e5f0f_terseLabel_en-US" xlink:label="lab_cron_PreemptiveRightsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Pre-emptive Rights</link:label>
    <link:label id="lab_cron_PreemptiveRightsMember_label_en-US" xlink:label="lab_cron_PreemptiveRightsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Pre-emptive Rights [Member]</link:label>
    <link:label id="lab_cron_PreemptiveRightsMember_documentation_en-US" xlink:label="lab_cron_PreemptiveRightsMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Pre-emptive Rights [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_cron_PreemptiveRightsMember" xlink:href="cron-20210630.xsd#cron_PreemptiveRightsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cron_PreemptiveRightsMember" xlink:to="lab_cron_PreemptiveRightsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_GrossProfit_9436e4ec-af5c-40da-ba32-45673d136fb7_totalLabel_en-US" xlink:label="lab_us-gaap_GrossProfit" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Gross loss</link:label>
    <link:label id="lab_us-gaap_GrossProfit_label_en-US" xlink:label="lab_us-gaap_GrossProfit" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Gross Profit</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GrossProfit" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_GrossProfit"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_GrossProfit" xlink:to="lab_us-gaap_GrossProfit" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_a2faaa5a-f5a4-4120-af9c-5a15d91a8053_terseLabel_en-US" xlink:label="lab_us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Effect of foreign currency translation on cash and cash equivalents</link:label>
    <link:label id="lab_us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_label_en-US" xlink:label="lab_us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Effect of Exchange Rate on Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:to="lab_us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfRevenuesFromExternalCustomersAndLongLivedAssetsTable_5948c3e2-5a19-4609-8f41-adf4de940dd6_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfRevenuesFromExternalCustomersAndLongLivedAssetsTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Revenues from External Customers and Long-Lived Assets [Table]</link:label>
    <link:label id="lab_us-gaap_ScheduleOfRevenuesFromExternalCustomersAndLongLivedAssetsTable_label_en-US" xlink:label="lab_us-gaap_ScheduleOfRevenuesFromExternalCustomersAndLongLivedAssetsTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Revenues from External Customers and Long-Lived Assets [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfRevenuesFromExternalCustomersAndLongLivedAssetsTable" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfRevenuesFromExternalCustomersAndLongLivedAssetsTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfRevenuesFromExternalCustomersAndLongLivedAssetsTable" xlink:to="lab_us-gaap_ScheduleOfRevenuesFromExternalCustomersAndLongLivedAssetsTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest_a57ae627-b3f0-40cc-81e0-587433c64274_terseLabel_en-US" xlink:label="lab_us-gaap_ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Less: comprehensive income (loss) attributable to non-controlling interests</link:label>
    <link:label id="lab_us-gaap_ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest_label_en-US" xlink:label="lab_us-gaap_ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Comprehensive Income (Loss), Net of Tax, Attributable to Noncontrolling Interest</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest" xlink:to="lab_us-gaap_ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice_0273a316-fa8f-4e4d-a1c8-ac165f473fb5_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cancellation, forfeiture and expiry of options (in dollars per share)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Options, Forfeitures and Expirations in Period, Weighted Average Exercise Price</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis_e57c4ee8-e50c-47a7-8942-d477b23d08a6_terseLabel_en-US" xlink:label="lab_us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Indefinite-lived Intangible Assets [Axis]</link:label>
    <link:label id="lab_us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis_label_en-US" xlink:label="lab_us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Indefinite-lived Intangible Assets [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis" xlink:to="lab_us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_SubsidiariesMember_89eeec47-c08c-4957-a84c-cee43501892d_terseLabel_en-US" xlink:label="lab_srt_SubsidiariesMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cronos Group, Inc.</link:label>
    <link:label id="lab_srt_SubsidiariesMember_label_en-US" xlink:label="lab_srt_SubsidiariesMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Subsidiaries [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_SubsidiariesMember" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_SubsidiariesMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_SubsidiariesMember" xlink:to="lab_srt_SubsidiariesMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ClassOfWarrantOrRightDomain_2e5de1c0-393f-4693-a675-4065cd20eca7_terseLabel_en-US" xlink:label="lab_us-gaap_ClassOfWarrantOrRightDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Class of Warrant or Right [Domain]</link:label>
    <link:label id="lab_us-gaap_ClassOfWarrantOrRightDomain_label_en-US" xlink:label="lab_us-gaap_ClassOfWarrantOrRightDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Class of Warrant or Right [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfWarrantOrRightDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ClassOfWarrantOrRightDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ClassOfWarrantOrRightDomain" xlink:to="lab_us-gaap_ClassOfWarrantOrRightDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_TradingSymbol_2109e43d-5849-40d9-8368-d8c5f18d5e38_terseLabel_en-US" xlink:label="lab_dei_TradingSymbol" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Trading Symbol</link:label>
    <link:label id="lab_dei_TradingSymbol_label_en-US" xlink:label="lab_dei_TradingSymbol" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Trading Symbol</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_TradingSymbol" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_TradingSymbol"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_TradingSymbol" xlink:to="lab_dei_TradingSymbol" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LossContingencyDamagesSoughtValue_ed877c64-8504-4222-a9ea-839a522d0554_terseLabel_en-US" xlink:label="lab_us-gaap_LossContingencyDamagesSoughtValue" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Damages sought</link:label>
    <link:label id="lab_us-gaap_LossContingencyDamagesSoughtValue_label_en-US" xlink:label="lab_us-gaap_LossContingencyDamagesSoughtValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Loss Contingency, Damages Sought, Value</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LossContingencyDamagesSoughtValue" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LossContingencyDamagesSoughtValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LossContingencyDamagesSoughtValue" xlink:to="lab_us-gaap_LossContingencyDamagesSoughtValue" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LiabilitiesCurrentAbstract_3174e782-b1c2-43a3-863c-5e515389d04f_terseLabel_en-US" xlink:label="lab_us-gaap_LiabilitiesCurrentAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Current liabilities</link:label>
    <link:label id="lab_us-gaap_LiabilitiesCurrentAbstract_label_en-US" xlink:label="lab_us-gaap_LiabilitiesCurrentAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Liabilities, Current [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesCurrentAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LiabilitiesCurrentAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LiabilitiesCurrentAbstract" xlink:to="lab_us-gaap_LiabilitiesCurrentAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ReceivableTypeDomain_7954f790-31d0-4817-ba45-dce3a3c0448d_terseLabel_en-US" xlink:label="lab_us-gaap_ReceivableTypeDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Receivable [Domain]</link:label>
    <link:label id="lab_us-gaap_ReceivableTypeDomain_label_en-US" xlink:label="lab_us-gaap_ReceivableTypeDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Receivable [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ReceivableTypeDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ReceivableTypeDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ReceivableTypeDomain" xlink:to="lab_us-gaap_ReceivableTypeDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_cron_TopUpRightsFixedPriceMember_c4e70e68-35cb-4945-a4d8-683554ea8c37_terseLabel_en-US" xlink:label="lab_cron_TopUpRightsFixedPriceMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Top-up Rights &#8211; fixed price</link:label>
    <link:label id="lab_cron_TopUpRightsFixedPriceMember_label_en-US" xlink:label="lab_cron_TopUpRightsFixedPriceMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Top-Up Rights - Fixed Price [Member]</link:label>
    <link:label id="lab_cron_TopUpRightsFixedPriceMember_documentation_en-US" xlink:label="lab_cron_TopUpRightsFixedPriceMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Top-Up Rights - Fixed Price [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_cron_TopUpRightsFixedPriceMember" xlink:href="cron-20210630.xsd#cron_TopUpRightsFixedPriceMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cron_TopUpRightsFixedPriceMember" xlink:to="lab_cron_TopUpRightsFixedPriceMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_GeneralAndAdministrativeExpense_20518f59-6064-4b8b-8134-9f1ddc1e1960_terseLabel_en-US" xlink:label="lab_us-gaap_GeneralAndAdministrativeExpense" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">General and administrative</link:label>
    <link:label id="lab_us-gaap_GeneralAndAdministrativeExpense_label_en-US" xlink:label="lab_us-gaap_GeneralAndAdministrativeExpense" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">General and Administrative Expense</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GeneralAndAdministrativeExpense" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_GeneralAndAdministrativeExpense"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_GeneralAndAdministrativeExpense" xlink:to="lab_us-gaap_GeneralAndAdministrativeExpense" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_RestatementAxis_84f15863-5f10-47c3-b497-bd0a37405810_terseLabel_en-US" xlink:label="lab_srt_RestatementAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restatement [Axis]</link:label>
    <link:label id="lab_srt_RestatementAxis_label_en-US" xlink:label="lab_srt_RestatementAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revision of Prior Period [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RestatementAxis" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_RestatementAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_RestatementAxis" xlink:to="lab_srt_RestatementAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice_fefd644b-46b9-44a2-ad3d-c7cd27b10f4a_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Weighted average exercise price of options exercisable (in dollars per share)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Weighted Average Exercise Price</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock_3f1da7a3-2c32-4775-aaca-8dc106538288_terseLabel_en-US" xlink:label="lab_us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Payments</link:label>
    <link:label id="lab_us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock_label_en-US" xlink:label="lab_us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Payment Arrangement [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock" xlink:to="lab_us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueInputsLevel3Member_d94fc2fb-253a-444e-b619-a8f052338f23_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueInputsLevel3Member" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Level 3</link:label>
    <link:label id="lab_us-gaap_FairValueInputsLevel3Member_label_en-US" xlink:label="lab_us-gaap_FairValueInputsLevel3Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value, Inputs, Level 3 [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueInputsLevel3Member" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueInputsLevel3Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueInputsLevel3Member" xlink:to="lab_us-gaap_FairValueInputsLevel3Member" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_InventoryDisclosureTextBlock_7148b537-26f0-43b0-b8d0-bf1eadcd53cc_terseLabel_en-US" xlink:label="lab_us-gaap_InventoryDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Inventory, net</link:label>
    <link:label id="lab_us-gaap_InventoryDisclosureTextBlock_label_en-US" xlink:label="lab_us-gaap_InventoryDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Inventory Disclosure [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryDisclosureTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InventoryDisclosureTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InventoryDisclosureTextBlock" xlink:to="lab_us-gaap_InventoryDisclosureTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesLineItems_149f990e-a753-4e24-963f-fbaa8b3b0e89_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value Measurement Inputs and Valuation Techniques [Line Items]</link:label>
    <link:label id="lab_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesLineItems_label_en-US" xlink:label="lab_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value Measurement Inputs and Valuation Techniques [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesLineItems" xlink:to="lab_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LoansNotesTradeAndOtherReceivablesExcludingAllowanceForCreditLossesTextBlock_df8c855c-444d-4770-b073-dde90d7b6340_terseLabel_en-US" xlink:label="lab_us-gaap_LoansNotesTradeAndOtherReceivablesExcludingAllowanceForCreditLossesTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Loans Receivable, net</link:label>
    <link:label id="lab_us-gaap_LoansNotesTradeAndOtherReceivablesExcludingAllowanceForCreditLossesTextBlock_label_en-US" xlink:label="lab_us-gaap_LoansNotesTradeAndOtherReceivablesExcludingAllowanceForCreditLossesTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Loans, Notes, Trade and Other Receivables, Excluding Allowance for Credit Losses [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LoansNotesTradeAndOtherReceivablesExcludingAllowanceForCreditLossesTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LoansNotesTradeAndOtherReceivablesExcludingAllowanceForCreditLossesTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LoansNotesTradeAndOtherReceivablesExcludingAllowanceForCreditLossesTextBlock" xlink:to="lab_us-gaap_LoansNotesTradeAndOtherReceivablesExcludingAllowanceForCreditLossesTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2_67790a2e-d179-4c2a-8bae-cc54ce436c34_verboseLabel_en-US" xlink:label="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Outstanding</link:label>
    <link:label id="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2_label_en-US" xlink:label="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Weighted Average Remaining Contractual Term</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2" xlink:to="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StockIssuedDuringPeriodSharesNewIssues_8bb759c1-6af6-4eb3-9e9f-432bd4b92038_terseLabel_en-US" xlink:label="lab_us-gaap_StockIssuedDuringPeriodSharesNewIssues" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Shares issued (in shares)</link:label>
    <link:label id="lab_us-gaap_StockIssuedDuringPeriodSharesNewIssues_label_en-US" xlink:label="lab_us-gaap_StockIssuedDuringPeriodSharesNewIssues" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stock Issued During Period, Shares, New Issues</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodSharesNewIssues" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockIssuedDuringPeriodSharesNewIssues"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockIssuedDuringPeriodSharesNewIssues" xlink:to="lab_us-gaap_StockIssuedDuringPeriodSharesNewIssues" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NumberOfReportableSegments_437034d6-6596-4f66-b1e7-76e686d15d81_terseLabel_en-US" xlink:label="lab_us-gaap_NumberOfReportableSegments" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Number of reportable segments</link:label>
    <link:label id="lab_us-gaap_NumberOfReportableSegments_label_en-US" xlink:label="lab_us-gaap_NumberOfReportableSegments" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Number of Reportable Segments</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NumberOfReportableSegments" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NumberOfReportableSegments"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NumberOfReportableSegments" xlink:to="lab_us-gaap_NumberOfReportableSegments" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CommonStockValue_b8885b24-b1e1-458e-8d70-84a5e08c5639_terseLabel_en-US" xlink:label="lab_us-gaap_CommonStockValue" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share capital</link:label>
    <link:label id="lab_us-gaap_CommonStockValue_label_en-US" xlink:label="lab_us-gaap_CommonStockValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common Stock, Value, Issued</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockValue" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommonStockValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CommonStockValue" xlink:to="lab_us-gaap_CommonStockValue" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NonoperatingIncomeExpense_cb3c1113-6990-4caa-bc72-f2c662f8040d_totalLabel_en-US" xlink:label="lab_us-gaap_NonoperatingIncomeExpense" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total other income (loss)</link:label>
    <link:label id="lab_us-gaap_NonoperatingIncomeExpense_label_en-US" xlink:label="lab_us-gaap_NonoperatingIncomeExpense" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Nonoperating Income (Expense)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NonoperatingIncomeExpense" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NonoperatingIncomeExpense"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NonoperatingIncomeExpense" xlink:to="lab_us-gaap_NonoperatingIncomeExpense" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CustomerConcentrationRiskMember_c0899e23-2793-44bc-8116-88dbcce106f3_terseLabel_en-US" xlink:label="lab_us-gaap_CustomerConcentrationRiskMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Customer Concentration Risk</link:label>
    <link:label id="lab_us-gaap_CustomerConcentrationRiskMember_label_en-US" xlink:label="lab_us-gaap_CustomerConcentrationRiskMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Customer Concentration Risk [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CustomerConcentrationRiskMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CustomerConcentrationRiskMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CustomerConcentrationRiskMember" xlink:to="lab_us-gaap_CustomerConcentrationRiskMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue_6d25de20-48ad-4cd2-b634-28a285596862_periodStartLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Balance at beginning of period (in dollars per share)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue_160e575c-6b12-4bad-8aff-5a0c76f4b9ca_periodEndLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Balance at end of period (in dollars per share)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Weighted Average Grant Date Fair Value</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BasisOfAccountingPolicyPolicyTextBlock_9388ddae-5b00-4c51-a8d1-c6ebf6208227_terseLabel_en-US" xlink:label="lab_us-gaap_BasisOfAccountingPolicyPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Basis of presentation</link:label>
    <link:label id="lab_us-gaap_BasisOfAccountingPolicyPolicyTextBlock_label_en-US" xlink:label="lab_us-gaap_BasisOfAccountingPolicyPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Basis of Accounting, Policy [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BasisOfAccountingPolicyPolicyTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BasisOfAccountingPolicyPolicyTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BasisOfAccountingPolicyPolicyTextBlock" xlink:to="lab_us-gaap_BasisOfAccountingPolicyPolicyTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CommitmentsAndContingencies_949347ca-eab9-403e-8c50-a93c0a638fd3_terseLabel_en-US" xlink:label="lab_us-gaap_CommitmentsAndContingencies" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Commitments and contingencies</link:label>
    <link:label id="lab_us-gaap_CommitmentsAndContingencies_label_en-US" xlink:label="lab_us-gaap_CommitmentsAndContingencies" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Commitments and Contingencies</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommitmentsAndContingencies" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommitmentsAndContingencies"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CommitmentsAndContingencies" xlink:to="lab_us-gaap_CommitmentsAndContingencies" xlink:type="arc" order="1"/>
    <link:label id="lab_cron_ShareBasedPaymentArrangementGainLossOnRevaluation_64d8720d-39bd-43fc-bc47-2937b648199a_negatedTerseLabel_en-US" xlink:label="lab_cron_ShareBasedPaymentArrangementGainLossOnRevaluation" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Loss on revaluation</link:label>
    <link:label id="lab_cron_ShareBasedPaymentArrangementGainLossOnRevaluation_label_en-US" xlink:label="lab_cron_ShareBasedPaymentArrangementGainLossOnRevaluation" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Payment Arrangement, Gain (Loss) On Revaluation</link:label>
    <link:label id="lab_cron_ShareBasedPaymentArrangementGainLossOnRevaluation_documentation_en-US" xlink:label="lab_cron_ShareBasedPaymentArrangementGainLossOnRevaluation" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Payment Arrangement, Gain (Loss) On Revaluation</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_cron_ShareBasedPaymentArrangementGainLossOnRevaluation" xlink:href="cron-20210630.xsd#cron_ShareBasedPaymentArrangementGainLossOnRevaluation"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cron_ShareBasedPaymentArrangementGainLossOnRevaluation" xlink:to="lab_cron_ShareBasedPaymentArrangementGainLossOnRevaluation" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax_52d0c5f1-2c69-4957-a042-fd944f798712_terseLabel_en-US" xlink:label="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accumulated other comprehensive income</link:label>
    <link:label id="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax_label_en-US" xlink:label="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accumulated Other Comprehensive Income (Loss), Net of Tax</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax" xlink:to="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AllowanceForDoubtfulAccountsReceivableCurrent_1d00e500-21e6-4a1a-83bd-8faa646fb2c7_verboseLabel_en-US" xlink:label="lab_us-gaap_AllowanceForDoubtfulAccountsReceivableCurrent" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Current expected credit loss allowance on accounts receivable</link:label>
    <link:label id="lab_us-gaap_AllowanceForDoubtfulAccountsReceivableCurrent_label_en-US" xlink:label="lab_us-gaap_AllowanceForDoubtfulAccountsReceivableCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounts Receivable, Allowance for Credit Loss, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AllowanceForDoubtfulAccountsReceivableCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AllowanceForDoubtfulAccountsReceivableCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AllowanceForDoubtfulAccountsReceivableCurrent" xlink:to="lab_us-gaap_AllowanceForDoubtfulAccountsReceivableCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ConcentrationRiskCreditRiskFinancialInstrumentMaximumExposure_d6cc4f55-7839-482d-901c-9242dd1ca879_terseLabel_en-US" xlink:label="lab_us-gaap_ConcentrationRiskCreditRiskFinancialInstrumentMaximumExposure" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Maximum exposure to credit risk</link:label>
    <link:label id="lab_us-gaap_ConcentrationRiskCreditRiskFinancialInstrumentMaximumExposure_label_en-US" xlink:label="lab_us-gaap_ConcentrationRiskCreditRiskFinancialInstrumentMaximumExposure" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Concentration Risk, Credit Risk, Financial Instrument, Maximum Exposure</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskCreditRiskFinancialInstrumentMaximumExposure" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ConcentrationRiskCreditRiskFinancialInstrumentMaximumExposure"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ConcentrationRiskCreditRiskFinancialInstrumentMaximumExposure" xlink:to="lab_us-gaap_ConcentrationRiskCreditRiskFinancialInstrumentMaximumExposure" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueNetDerivativeAssetLiabilityMeasuredOnRecurringBasisWithUnobservableInputs_59433521-63f1-43c2-a066-69c97fa9ed8a_negatedPeriodStartLabel_en-US" xlink:label="lab_us-gaap_FairValueNetDerivativeAssetLiabilityMeasuredOnRecurringBasisWithUnobservableInputs" xlink:role="http://www.xbrl.org/2009/role/negatedPeriodStartLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Beginning balance</link:label>
    <link:label id="lab_us-gaap_FairValueNetDerivativeAssetLiabilityMeasuredOnRecurringBasisWithUnobservableInputs_fbc25de4-7808-4ad1-871d-f491cb8e384f_negatedPeriodEndLabel_en-US" xlink:label="lab_us-gaap_FairValueNetDerivativeAssetLiabilityMeasuredOnRecurringBasisWithUnobservableInputs" xlink:role="http://www.xbrl.org/2009/role/negatedPeriodEndLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Ending balance</link:label>
    <link:label id="lab_us-gaap_FairValueNetDerivativeAssetLiabilityMeasuredOnRecurringBasisWithUnobservableInputs_label_en-US" xlink:label="lab_us-gaap_FairValueNetDerivativeAssetLiabilityMeasuredOnRecurringBasisWithUnobservableInputs" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value, Net Derivative Asset (Liability) Measured on Recurring Basis with Unobservable Inputs</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueNetDerivativeAssetLiabilityMeasuredOnRecurringBasisWithUnobservableInputs" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueNetDerivativeAssetLiabilityMeasuredOnRecurringBasisWithUnobservableInputs"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueNetDerivativeAssetLiabilityMeasuredOnRecurringBasisWithUnobservableInputs" xlink:to="lab_us-gaap_FairValueNetDerivativeAssetLiabilityMeasuredOnRecurringBasisWithUnobservableInputs" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_InventoryWriteDown_05b08c0b-2f59-4921-b3b5-37dee4d76902_terseLabel_en-US" xlink:label="lab_us-gaap_InventoryWriteDown" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Inventory write-down</link:label>
    <link:label id="lab_us-gaap_InventoryWriteDown_label_en-US" xlink:label="lab_us-gaap_InventoryWriteDown" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Inventory Write-down</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryWriteDown" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InventoryWriteDown"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InventoryWriteDown" xlink:to="lab_us-gaap_InventoryWriteDown" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DilutiveSecurities_276a4797-2a7b-40b4-be95-1074000fface_terseLabel_en-US" xlink:label="lab_us-gaap_DilutiveSecurities" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Adjustment for gain (loss) on revaluation of derivative liabilities</link:label>
    <link:label id="lab_us-gaap_DilutiveSecurities_label_en-US" xlink:label="lab_us-gaap_DilutiveSecurities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Dilutive Securities, Effect on Basic Earnings Per Share</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DilutiveSecurities" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DilutiveSecurities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DilutiveSecurities" xlink:to="lab_us-gaap_DilutiveSecurities" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ReceivablesAbstract_d40f2289-1437-429a-91aa-d1ef3173284f_terseLabel_en-US" xlink:label="lab_us-gaap_ReceivablesAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Receivables [Abstract]</link:label>
    <link:label id="lab_us-gaap_ReceivablesAbstract_label_en-US" xlink:label="lab_us-gaap_ReceivablesAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Receivables [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ReceivablesAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ReceivablesAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ReceivablesAbstract" xlink:to="lab_us-gaap_ReceivablesAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DisposalGroupClassificationAxis_f90da7a9-e554-403e-9b37-f0a676a1c6a7_terseLabel_en-US" xlink:label="lab_us-gaap_DisposalGroupClassificationAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disposal Group Classification [Axis]</link:label>
    <link:label id="lab_us-gaap_DisposalGroupClassificationAxis_label_en-US" xlink:label="lab_us-gaap_DisposalGroupClassificationAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disposal Group Classification [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupClassificationAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DisposalGroupClassificationAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DisposalGroupClassificationAxis" xlink:to="lab_us-gaap_DisposalGroupClassificationAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AntidilutiveSecuritiesNameDomain_fff124d3-a2d8-409d-8865-63a1083936ab_terseLabel_en-US" xlink:label="lab_us-gaap_AntidilutiveSecuritiesNameDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Antidilutive Securities, Name [Domain]</link:label>
    <link:label id="lab_us-gaap_AntidilutiveSecuritiesNameDomain_label_en-US" xlink:label="lab_us-gaap_AntidilutiveSecuritiesNameDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Antidilutive Securities, Name [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AntidilutiveSecuritiesNameDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AntidilutiveSecuritiesNameDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AntidilutiveSecuritiesNameDomain" xlink:to="lab_us-gaap_AntidilutiveSecuritiesNameDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_DocumentPeriodEndDate_64bfdef1-b23e-41cf-98b0-a0f968f6d803_terseLabel_en-US" xlink:label="lab_dei_DocumentPeriodEndDate" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Period End Date</link:label>
    <link:label id="lab_dei_DocumentPeriodEndDate_label_en-US" xlink:label="lab_dei_DocumentPeriodEndDate" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Period End Date</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentPeriodEndDate" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_DocumentPeriodEndDate"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_DocumentPeriodEndDate" xlink:to="lab_dei_DocumentPeriodEndDate" xlink:type="arc" order="1"/>
    <link:label id="lab_cron_LesseeOperatingLeaseAreaOfLandToBeDisposedOf_bf70b356-5def-40f4-82b2-44168b9f566d_terseLabel_en-US" xlink:label="lab_cron_LesseeOperatingLeaseAreaOfLandToBeDisposedOf" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lessee, operating lease, area of land to be disposed of (in sqft)</link:label>
    <link:label id="lab_cron_LesseeOperatingLeaseAreaOfLandToBeDisposedOf_label_en-US" xlink:label="lab_cron_LesseeOperatingLeaseAreaOfLandToBeDisposedOf" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lessee, Operating Lease, Area Of Land To Be Disposed Of</link:label>
    <link:label id="lab_cron_LesseeOperatingLeaseAreaOfLandToBeDisposedOf_documentation_en-US" xlink:label="lab_cron_LesseeOperatingLeaseAreaOfLandToBeDisposedOf" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lessee, Operating Lease, Area Of Land To Be Disposed Of</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_cron_LesseeOperatingLeaseAreaOfLandToBeDisposedOf" xlink:href="cron-20210630.xsd#cron_LesseeOperatingLeaseAreaOfLandToBeDisposedOf"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cron_LesseeOperatingLeaseAreaOfLandToBeDisposedOf" xlink:to="lab_cron_LesseeOperatingLeaseAreaOfLandToBeDisposedOf" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncrementalCommonSharesAttributableToShareBasedPaymentArrangements_3b934539-289c-45e3-bf5b-bfceedf653f5_terseLabel_en-US" xlink:label="lab_us-gaap_IncrementalCommonSharesAttributableToShareBasedPaymentArrangements" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Dilutive effect of awards (in shares)</link:label>
    <link:label id="lab_us-gaap_IncrementalCommonSharesAttributableToShareBasedPaymentArrangements_label_en-US" xlink:label="lab_us-gaap_IncrementalCommonSharesAttributableToShareBasedPaymentArrangements" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Incremental Common Shares Attributable to Dilutive Effect of Share-based Payment Arrangements</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncrementalCommonSharesAttributableToShareBasedPaymentArrangements" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncrementalCommonSharesAttributableToShareBasedPaymentArrangements"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncrementalCommonSharesAttributableToShareBasedPaymentArrangements" xlink:to="lab_us-gaap_IncrementalCommonSharesAttributableToShareBasedPaymentArrangements" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RevenuesFromExternalCustomersAndLongLivedAssetsLineItems_feb87428-520a-48a8-9821-5462ded3e0de_terseLabel_en-US" xlink:label="lab_us-gaap_RevenuesFromExternalCustomersAndLongLivedAssetsLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revenues from External Customers and Long-Lived Assets [Line Items]</link:label>
    <link:label id="lab_us-gaap_RevenuesFromExternalCustomersAndLongLivedAssetsLineItems_label_en-US" xlink:label="lab_us-gaap_RevenuesFromExternalCustomersAndLongLivedAssetsLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revenues from External Customers and Long-Lived Assets [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenuesFromExternalCustomersAndLongLivedAssetsLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RevenuesFromExternalCustomersAndLongLivedAssetsLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RevenuesFromExternalCustomersAndLongLivedAssetsLineItems" xlink:to="lab_us-gaap_RevenuesFromExternalCustomersAndLongLivedAssetsLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RevenueFromExternalCustomersByGeographicAreasTableTextBlock_3c8e0668-bcb5-4335-aaa2-6b2994b859d9_terseLabel_en-US" xlink:label="lab_us-gaap_RevenueFromExternalCustomersByGeographicAreasTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Revenue from External Customers by Geographic Areas</link:label>
    <link:label id="lab_us-gaap_RevenueFromExternalCustomersByGeographicAreasTableTextBlock_label_en-US" xlink:label="lab_us-gaap_RevenueFromExternalCustomersByGeographicAreasTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revenue from External Customers by Geographic Areas [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromExternalCustomersByGeographicAreasTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RevenueFromExternalCustomersByGeographicAreasTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RevenueFromExternalCustomersByGeographicAreasTableTextBlock" xlink:to="lab_us-gaap_RevenueFromExternalCustomersByGeographicAreasTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityRegistrantName_83882401-5d4e-4285-8a65-9c3d34350054_terseLabel_en-US" xlink:label="lab_dei_EntityRegistrantName" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Registrant Name</link:label>
    <link:label id="lab_dei_EntityRegistrantName_label_en-US" xlink:label="lab_dei_EntityRegistrantName" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Registrant Name</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityRegistrantName" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityRegistrantName"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityRegistrantName" xlink:to="lab_dei_EntityRegistrantName" xlink:type="arc" order="1"/>
    <link:label id="lab_cron_AlbertGamingLiquorAndCannabisCommissionMember_8335ee15-7c3f-462e-86b0-5050f8253f9c_terseLabel_en-US" xlink:label="lab_cron_AlbertGamingLiquorAndCannabisCommissionMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Albert Gaming, Liquor and Cannabis Commission</link:label>
    <link:label id="lab_cron_AlbertGamingLiquorAndCannabisCommissionMember_label_en-US" xlink:label="lab_cron_AlbertGamingLiquorAndCannabisCommissionMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Albert Gaming, Liquor And Cannabis Commission [Member]</link:label>
    <link:label id="lab_cron_AlbertGamingLiquorAndCannabisCommissionMember_documentation_en-US" xlink:label="lab_cron_AlbertGamingLiquorAndCannabisCommissionMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Albert Gaming, Liquor And Cannabis Commission</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_cron_AlbertGamingLiquorAndCannabisCommissionMember" xlink:href="cron-20210630.xsd#cron_AlbertGamingLiquorAndCannabisCommissionMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cron_AlbertGamingLiquorAndCannabisCommissionMember" xlink:to="lab_cron_AlbertGamingLiquorAndCannabisCommissionMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NetIncomeLossAvailableToCommonStockholdersDilutedAbstract_990d495d-75bd-4302-910e-440478a215ea_terseLabel_en-US" xlink:label="lab_us-gaap_NetIncomeLossAvailableToCommonStockholdersDilutedAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Basic earnings (loss) per share computation</link:label>
    <link:label id="lab_us-gaap_NetIncomeLossAvailableToCommonStockholdersDilutedAbstract_label_en-US" xlink:label="lab_us-gaap_NetIncomeLossAvailableToCommonStockholdersDilutedAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net Income (Loss) Available to Common Stockholders, Diluted [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLossAvailableToCommonStockholdersDilutedAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetIncomeLossAvailableToCommonStockholdersDilutedAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NetIncomeLossAvailableToCommonStockholdersDilutedAbstract" xlink:to="lab_us-gaap_NetIncomeLossAvailableToCommonStockholdersDilutedAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_TypeOfArrangementAxis_4f77c600-b66a-4ac3-bca0-e8746b6eb973_terseLabel_en-US" xlink:label="lab_us-gaap_TypeOfArrangementAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Collaborative Arrangement and Arrangement Other than Collaborative [Axis]</link:label>
    <link:label id="lab_us-gaap_TypeOfArrangementAxis_label_en-US" xlink:label="lab_us-gaap_TypeOfArrangementAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Collaborative Arrangement and Arrangement Other than Collaborative [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TypeOfArrangementAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TypeOfArrangementAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_TypeOfArrangementAxis" xlink:to="lab_us-gaap_TypeOfArrangementAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_InventoryWorkInProcessNetOfReserves_3d54d81c-4311-4f54-968f-0f62b28ce04f_terseLabel_en-US" xlink:label="lab_us-gaap_InventoryWorkInProcessNetOfReserves" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Work-in-progress</link:label>
    <link:label id="lab_us-gaap_InventoryWorkInProcessNetOfReserves_label_en-US" xlink:label="lab_us-gaap_InventoryWorkInProcessNetOfReserves" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Inventory, Work in Process, Net of Reserves</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryWorkInProcessNetOfReserves" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InventoryWorkInProcessNetOfReserves"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InventoryWorkInProcessNetOfReserves" xlink:to="lab_us-gaap_InventoryWorkInProcessNetOfReserves" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PrepaidExpenseAndOtherAssetsCurrent_e1a07953-ed9b-4b1b-b935-52b9dbe206ca_terseLabel_en-US" xlink:label="lab_us-gaap_PrepaidExpenseAndOtherAssetsCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Prepaids and other current assets</link:label>
    <link:label id="lab_us-gaap_PrepaidExpenseAndOtherAssetsCurrent_label_en-US" xlink:label="lab_us-gaap_PrepaidExpenseAndOtherAssetsCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Prepaid Expense and Other Assets, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PrepaidExpenseAndOtherAssetsCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PrepaidExpenseAndOtherAssetsCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PrepaidExpenseAndOtherAssetsCurrent" xlink:to="lab_us-gaap_PrepaidExpenseAndOtherAssetsCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueNetDerivativeAssetLiabilityMeasuredOnRecurringBasisUnobservableInputsReconciliationGainLossIncludedInEarnings_c623ddbd-1437-4d7a-802c-113c5e0197d8_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_FairValueNetDerivativeAssetLiabilityMeasuredOnRecurringBasisUnobservableInputsReconciliationGainLossIncludedInEarnings" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revaluation loss/(gain)</link:label>
    <link:label id="lab_us-gaap_FairValueNetDerivativeAssetLiabilityMeasuredOnRecurringBasisUnobservableInputsReconciliationGainLossIncludedInEarnings_label_en-US" xlink:label="lab_us-gaap_FairValueNetDerivativeAssetLiabilityMeasuredOnRecurringBasisUnobservableInputsReconciliationGainLossIncludedInEarnings" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value, Net Derivative Asset (Liability) Measured on Recurring Basis, Unobservable Inputs Reconciliation, Gain (Loss) Included in Earnings</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueNetDerivativeAssetLiabilityMeasuredOnRecurringBasisUnobservableInputsReconciliationGainLossIncludedInEarnings" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueNetDerivativeAssetLiabilityMeasuredOnRecurringBasisUnobservableInputsReconciliationGainLossIncludedInEarnings"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueNetDerivativeAssetLiabilityMeasuredOnRecurringBasisUnobservableInputsReconciliationGainLossIncludedInEarnings" xlink:to="lab_us-gaap_FairValueNetDerivativeAssetLiabilityMeasuredOnRecurringBasisUnobservableInputsReconciliationGainLossIncludedInEarnings" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_6be337f9-15a2-4fb8-b656-60c102d95f7e_totalLabel_en-US" xlink:label="lab_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net revenue</link:label>
    <link:label id="lab_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_b3dfd265-cbd8-4999-8ed9-bc710b38cd2f_verboseLabel_en-US" xlink:label="lab_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net revenue</link:label>
    <link:label id="lab_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_label_en-US" xlink:label="lab_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revenue from Contract with Customer, Excluding Assessed Tax</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax" xlink:to="lab_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax" xlink:type="arc" order="1"/>
    <link:label id="lab_cron_CollaborativeArrangementAmountOfAdvances_9c7ab194-3780-49a8-92d4-d123cd385f3e_terseLabel_en-US" xlink:label="lab_cron_CollaborativeArrangementAmountOfAdvances" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Collaboration agreement, amount of advances</link:label>
    <link:label id="lab_cron_CollaborativeArrangementAmountOfAdvances_label_en-US" xlink:label="lab_cron_CollaborativeArrangementAmountOfAdvances" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Collaborative Arrangement, Amount Of Advances</link:label>
    <link:label id="lab_cron_CollaborativeArrangementAmountOfAdvances_documentation_en-US" xlink:label="lab_cron_CollaborativeArrangementAmountOfAdvances" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Collaborative Arrangement, Amount Of Advances</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_cron_CollaborativeArrangementAmountOfAdvances" xlink:href="cron-20210630.xsd#cron_CollaborativeArrangementAmountOfAdvances"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cron_CollaborativeArrangementAmountOfAdvances" xlink:to="lab_cron_CollaborativeArrangementAmountOfAdvances" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_InventoryFinishedGoodsNetOfReserves_fad07994-a3f0-45ef-aa04-65ff835cf251_terseLabel_en-US" xlink:label="lab_us-gaap_InventoryFinishedGoodsNetOfReserves" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finished goods</link:label>
    <link:label id="lab_us-gaap_InventoryFinishedGoodsNetOfReserves_label_en-US" xlink:label="lab_us-gaap_InventoryFinishedGoodsNetOfReserves" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Inventory, Finished Goods, Net of Reserves</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryFinishedGoodsNetOfReserves" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InventoryFinishedGoodsNetOfReserves"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InventoryFinishedGoodsNetOfReserves" xlink:to="lab_us-gaap_InventoryFinishedGoodsNetOfReserves" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EmployeeStockOptionMember_287de456-6b91-4713-aa81-9be1745c8299_terseLabel_en-US" xlink:label="lab_us-gaap_EmployeeStockOptionMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stock options</link:label>
    <link:label id="lab_us-gaap_EmployeeStockOptionMember_label_en-US" xlink:label="lab_us-gaap_EmployeeStockOptionMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Payment Arrangement, Option [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeStockOptionMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EmployeeStockOptionMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EmployeeStockOptionMember" xlink:to="lab_us-gaap_EmployeeStockOptionMember" xlink:type="arc" order="1"/>
    <link:label id="lab_cron_InvestmentsInAndAdvancesToAffiliatesFundingCommitmentPercentage_4901fc1f-4888-4c86-9603-5a06952a2835_terseLabel_en-US" xlink:label="lab_cron_InvestmentsInAndAdvancesToAffiliatesFundingCommitmentPercentage" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Funding commitment percentage</link:label>
    <link:label id="lab_cron_InvestmentsInAndAdvancesToAffiliatesFundingCommitmentPercentage_label_en-US" xlink:label="lab_cron_InvestmentsInAndAdvancesToAffiliatesFundingCommitmentPercentage" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Investments In And Advances To Affiliates, Funding Commitment Percentage</link:label>
    <link:label id="lab_cron_InvestmentsInAndAdvancesToAffiliatesFundingCommitmentPercentage_documentation_en-US" xlink:label="lab_cron_InvestmentsInAndAdvancesToAffiliatesFundingCommitmentPercentage" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Investments In And Advances To Affiliates, Funding Commitment Percentage</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_cron_InvestmentsInAndAdvancesToAffiliatesFundingCommitmentPercentage" xlink:href="cron-20210630.xsd#cron_InvestmentsInAndAdvancesToAffiliatesFundingCommitmentPercentage"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cron_InvestmentsInAndAdvancesToAffiliatesFundingCommitmentPercentage" xlink:to="lab_cron_InvestmentsInAndAdvancesToAffiliatesFundingCommitmentPercentage" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueByFairValueHierarchyLevelAxis_1965bede-a4ce-421d-86dc-bd98fcb2917e_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueByFairValueHierarchyLevelAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value Hierarchy and NAV [Axis]</link:label>
    <link:label id="lab_us-gaap_FairValueByFairValueHierarchyLevelAxis_label_en-US" xlink:label="lab_us-gaap_FairValueByFairValueHierarchyLevelAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value Hierarchy and NAV [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueByFairValueHierarchyLevelAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis" xlink:to="lab_us-gaap_FairValueByFairValueHierarchyLevelAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_ConsolidationItemsDomain_0accef18-fbb9-4df5-b68d-c75bc5923f5c_terseLabel_en-US" xlink:label="lab_srt_ConsolidationItemsDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Consolidation Items [Domain]</link:label>
    <link:label id="lab_srt_ConsolidationItemsDomain_label_en-US" xlink:label="lab_srt_ConsolidationItemsDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Consolidation Items [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ConsolidationItemsDomain" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_ConsolidationItemsDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_ConsolidationItemsDomain" xlink:to="lab_srt_ConsolidationItemsDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_cron_CronosGrowCoCreditFacilityMember_83f3754b-e499-4f4d-a4e9-de7162d714e5_terseLabel_en-US" xlink:label="lab_cron_CronosGrowCoCreditFacilityMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">GrowCo Facility</link:label>
    <link:label id="lab_cron_CronosGrowCoCreditFacilityMember_label_en-US" xlink:label="lab_cron_CronosGrowCoCreditFacilityMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cronos GrowCo Credit Facility [Member]</link:label>
    <link:label id="lab_cron_CronosGrowCoCreditFacilityMember_documentation_en-US" xlink:label="lab_cron_CronosGrowCoCreditFacilityMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cronos GrowCo Credit Facility [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_cron_CronosGrowCoCreditFacilityMember" xlink:href="cron-20210630.xsd#cron_CronosGrowCoCreditFacilityMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cron_CronosGrowCoCreditFacilityMember" xlink:to="lab_cron_CronosGrowCoCreditFacilityMember" xlink:type="arc" order="1"/>
    <link:label id="lab_cron_InterestReceivedNet_fa6e5fe8-b94f-481f-a675-83b53b3ca057_terseLabel_en-US" xlink:label="lab_cron_InterestReceivedNet" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Interest received</link:label>
    <link:label id="lab_cron_InterestReceivedNet_label_en-US" xlink:label="lab_cron_InterestReceivedNet" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Interest Received, Net</link:label>
    <link:label id="lab_cron_InterestReceivedNet_documentation_en-US" xlink:label="lab_cron_InterestReceivedNet" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Interest Received, Net</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_cron_InterestReceivedNet" xlink:href="cron-20210630.xsd#cron_InterestReceivedNet"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cron_InterestReceivedNet" xlink:to="lab_cron_InterestReceivedNet" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_MeasurementInputTypeDomain_544437ed-e4c1-455c-bef2-ceefe90c8db4_terseLabel_en-US" xlink:label="lab_us-gaap_MeasurementInputTypeDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Measurement Input Type [Domain]</link:label>
    <link:label id="lab_us-gaap_MeasurementInputTypeDomain_label_en-US" xlink:label="lab_us-gaap_MeasurementInputTypeDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Measurement Input Type [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MeasurementInputTypeDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_MeasurementInputTypeDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_MeasurementInputTypeDomain" xlink:to="lab_us-gaap_MeasurementInputTypeDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_InventorySuppliesNetOfReserves_0a040557-314b-4d25-bf2b-5d04a7bbc35d_terseLabel_en-US" xlink:label="lab_us-gaap_InventorySuppliesNetOfReserves" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Supplies and consumables</link:label>
    <link:label id="lab_us-gaap_InventorySuppliesNetOfReserves_label_en-US" xlink:label="lab_us-gaap_InventorySuppliesNetOfReserves" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Inventory, Supplies, Net of Reserves</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventorySuppliesNetOfReserves" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InventorySuppliesNetOfReserves"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InventorySuppliesNetOfReserves" xlink:to="lab_us-gaap_InventorySuppliesNetOfReserves" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_InvestmentIncomeInterest_aa8805ea-908b-4dde-95e9-2def65ddcf4c_terseLabel_en-US" xlink:label="lab_us-gaap_InvestmentIncomeInterest" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Interest income</link:label>
    <link:label id="lab_us-gaap_InvestmentIncomeInterest_label_en-US" xlink:label="lab_us-gaap_InvestmentIncomeInterest" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Investment Income, Interest</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentIncomeInterest" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InvestmentIncomeInterest"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InvestmentIncomeInterest" xlink:to="lab_us-gaap_InvestmentIncomeInterest" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CommonStockMember_22046542-15b5-4b9a-b16a-9c19cc128770_verboseLabel_en-US" xlink:label="lab_us-gaap_CommonStockMember" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share capital</link:label>
    <link:label id="lab_us-gaap_CommonStockMember_label_en-US" xlink:label="lab_us-gaap_CommonStockMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common Stock [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommonStockMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CommonStockMember" xlink:to="lab_us-gaap_CommonStockMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SegmentReportingDisclosureTextBlock_1315e926-70fd-453f-843f-009cdc60fe0f_terseLabel_en-US" xlink:label="lab_us-gaap_SegmentReportingDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Segment Information</link:label>
    <link:label id="lab_us-gaap_SegmentReportingDisclosureTextBlock_label_en-US" xlink:label="lab_us-gaap_SegmentReportingDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Segment Reporting Disclosure [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentReportingDisclosureTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SegmentReportingDisclosureTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SegmentReportingDisclosureTextBlock" xlink:to="lab_us-gaap_SegmentReportingDisclosureTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OperatingIncomeLoss_25cda4e4-6154-4b26-bae3-79b1975ae1f1_totalLabel_en-US" xlink:label="lab_us-gaap_OperatingIncomeLoss" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating loss</link:label>
    <link:label id="lab_us-gaap_OperatingIncomeLoss_label_en-US" xlink:label="lab_us-gaap_OperatingIncomeLoss" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Income (Loss)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingIncomeLoss" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingIncomeLoss"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OperatingIncomeLoss" xlink:to="lab_us-gaap_OperatingIncomeLoss" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OperatingLeaseLiabilityCurrent_86b2ba99-9640-4fef-b888-4eacf91d1b23_verboseLabel_en-US" xlink:label="lab_us-gaap_OperatingLeaseLiabilityCurrent" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Current portion of lease obligation</link:label>
    <link:label id="lab_us-gaap_OperatingLeaseLiabilityCurrent_label_en-US" xlink:label="lab_us-gaap_OperatingLeaseLiabilityCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Lease, Liability, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseLiabilityCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingLeaseLiabilityCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OperatingLeaseLiabilityCurrent" xlink:to="lab_us-gaap_OperatingLeaseLiabilityCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_cron_A2645485OntarioInc.MucciPromissoryNoteMember_4fb6aabd-0037-4899-888a-5e17e7eeb26d_terseLabel_en-US" xlink:label="lab_cron_A2645485OntarioInc.MucciPromissoryNoteMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Mucci promissory note</link:label>
    <link:label id="lab_cron_A2645485OntarioInc.MucciPromissoryNoteMember_label_en-US" xlink:label="lab_cron_A2645485OntarioInc.MucciPromissoryNoteMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2645485 Ontario Inc. Mucci Promissory Note [Member]</link:label>
    <link:label id="lab_cron_A2645485OntarioInc.MucciPromissoryNoteMember_documentation_en-US" xlink:label="lab_cron_A2645485OntarioInc.MucciPromissoryNoteMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2645485 Ontario Inc. Mucci Promissory Note [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_cron_A2645485OntarioInc.MucciPromissoryNoteMember" xlink:href="cron-20210630.xsd#cron_A2645485OntarioInc.MucciPromissoryNoteMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cron_A2645485OntarioInc.MucciPromissoryNoteMember" xlink:to="lab_cron_A2645485OntarioInc.MucciPromissoryNoteMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_5122a606-406b-4496-a9cb-02f8a34f4bfd_terseLabel_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Increase (Decrease) in Stockholders' Equity [Roll Forward]</link:label>
    <link:label id="lab_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_label_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Increase (Decrease) in Stockholders' Equity [Roll Forward]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncreaseDecreaseInStockholdersEquityRollForward"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward" xlink:to="lab_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensation_6d35cf05-eaf9-4a29-ba45-962d54de67aa_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensation" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based payments</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensation_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensation" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Payment Arrangement, Noncash Expense</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensation" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensation"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensation" xlink:to="lab_us-gaap_ShareBasedCompensation" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PaymentsToAcquireOtherInvestments_addb06aa-cba3-4bcc-9aea-c9ec6309a98c_negatedLabel_en-US" xlink:label="lab_us-gaap_PaymentsToAcquireOtherInvestments" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Purchase of other investments</link:label>
    <link:label id="lab_us-gaap_PaymentsToAcquireOtherInvestments_6b61e6fb-f59a-47ee-9b12-7f6205a3353f_terseLabel_en-US" xlink:label="lab_us-gaap_PaymentsToAcquireOtherInvestments" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Purchase of other investments</link:label>
    <link:label id="lab_us-gaap_PaymentsToAcquireOtherInvestments_label_en-US" xlink:label="lab_us-gaap_PaymentsToAcquireOtherInvestments" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payments to Acquire Other Investments</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquireOtherInvestments" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PaymentsToAcquireOtherInvestments"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PaymentsToAcquireOtherInvestments" xlink:to="lab_us-gaap_PaymentsToAcquireOtherInvestments" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AdditionalPaidInCapitalMember_c34699f1-c609-4245-bc8f-3da06a19c8e6_terseLabel_en-US" xlink:label="lab_us-gaap_AdditionalPaidInCapitalMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Additional paid-in capital</link:label>
    <link:label id="lab_us-gaap_AdditionalPaidInCapitalMember_label_en-US" xlink:label="lab_us-gaap_AdditionalPaidInCapitalMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Additional Paid-in Capital [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdditionalPaidInCapitalMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AdditionalPaidInCapitalMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AdditionalPaidInCapitalMember" xlink:to="lab_us-gaap_AdditionalPaidInCapitalMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CashAndCashEquivalentsAtCarryingValue_9c12ea4b-156e-46fb-953b-9e74b26040ad_terseLabel_en-US" xlink:label="lab_us-gaap_CashAndCashEquivalentsAtCarryingValue" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash and cash equivalents</link:label>
    <link:label id="lab_us-gaap_CashAndCashEquivalentsAtCarryingValue_label_en-US" xlink:label="lab_us-gaap_CashAndCashEquivalentsAtCarryingValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash and Cash Equivalents, at Carrying Value</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CashAndCashEquivalentsAtCarryingValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue" xlink:to="lab_us-gaap_CashAndCashEquivalentsAtCarryingValue" xlink:type="arc" order="1"/>
    <link:label id="lab_cron_CannasoulCollaborationLoanMember_1acb29c5-6c77-41cc-92c4-58782e7cf19b_terseLabel_en-US" xlink:label="lab_cron_CannasoulCollaborationLoanMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cannasoul collaboration loan</link:label>
    <link:label id="lab_cron_CannasoulCollaborationLoanMember_label_en-US" xlink:label="lab_cron_CannasoulCollaborationLoanMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cannasoul Collaboration Loan [Member]</link:label>
    <link:label id="lab_cron_CannasoulCollaborationLoanMember_documentation_en-US" xlink:label="lab_cron_CannasoulCollaborationLoanMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cannasoul Collaboration Loan</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_cron_CannasoulCollaborationLoanMember" xlink:href="cron-20210630.xsd#cron_CannasoulCollaborationLoanMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cron_CannasoulCollaborationLoanMember" xlink:to="lab_cron_CannasoulCollaborationLoanMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_GainLossOnDerivativeInstrumentsNetPretax_d0dd8d50-92ff-4220-886b-6141cbc97351_terseLabel_en-US" xlink:label="lab_us-gaap_GainLossOnDerivativeInstrumentsNetPretax" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Gain (loss) on revaluation of derivative liabilities</link:label>
    <link:label id="lab_us-gaap_GainLossOnDerivativeInstrumentsNetPretax_9c4f1cd0-f511-43d8-bc8f-9d4f3b1498e3_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_GainLossOnDerivativeInstrumentsNetPretax" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Gain (loss) on revaluation of derivative liabilities</link:label>
    <link:label id="lab_us-gaap_GainLossOnDerivativeInstrumentsNetPretax_label_en-US" xlink:label="lab_us-gaap_GainLossOnDerivativeInstrumentsNetPretax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Gain (Loss) on Derivative Instruments, Net, Pretax</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GainLossOnDerivativeInstrumentsNetPretax" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_GainLossOnDerivativeInstrumentsNetPretax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_GainLossOnDerivativeInstrumentsNetPretax" xlink:to="lab_us-gaap_GainLossOnDerivativeInstrumentsNetPretax" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ArrangementsAndNonarrangementTransactionsMember_7965441c-c73e-43bb-9708-b6dbcd36a113_terseLabel_en-US" xlink:label="lab_us-gaap_ArrangementsAndNonarrangementTransactionsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Collaborative Arrangement and Arrangement Other than Collaborative [Domain]</link:label>
    <link:label id="lab_us-gaap_ArrangementsAndNonarrangementTransactionsMember_label_en-US" xlink:label="lab_us-gaap_ArrangementsAndNonarrangementTransactionsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Collaborative Arrangement and Arrangement Other than Collaborative [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ArrangementsAndNonarrangementTransactionsMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ArrangementsAndNonarrangementTransactionsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ArrangementsAndNonarrangementTransactionsMember" xlink:to="lab_us-gaap_ArrangementsAndNonarrangementTransactionsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfShareBasedCompensationRestrictedStockUnitsAwardActivityTableTextBlock_8a7fca00-4495-4554-b4dd-4dd56536d1bc_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfShareBasedCompensationRestrictedStockUnitsAwardActivityTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Summary of Changes in RSUs</link:label>
    <link:label id="lab_us-gaap_ScheduleOfShareBasedCompensationRestrictedStockUnitsAwardActivityTableTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfShareBasedCompensationRestrictedStockUnitsAwardActivityTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Payment Arrangement, Restricted Stock Unit, Activity [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfShareBasedCompensationRestrictedStockUnitsAwardActivityTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfShareBasedCompensationRestrictedStockUnitsAwardActivityTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationRestrictedStockUnitsAwardActivityTableTextBlock" xlink:to="lab_us-gaap_ScheduleOfShareBasedCompensationRestrictedStockUnitsAwardActivityTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_cron_CannabisFlowerMember_e4b5acb7-ba14-433d-bd3e-02d27ad540b2_terseLabel_en-US" xlink:label="lab_cron_CannabisFlowerMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cannabis flower</link:label>
    <link:label id="lab_cron_CannabisFlowerMember_label_en-US" xlink:label="lab_cron_CannabisFlowerMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cannabis Flower [Member]</link:label>
    <link:label id="lab_cron_CannabisFlowerMember_documentation_en-US" xlink:label="lab_cron_CannabisFlowerMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cannabis Flower [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_cron_CannabisFlowerMember" xlink:href="cron-20210630.xsd#cron_CannabisFlowerMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cron_CannabisFlowerMember" xlink:to="lab_cron_CannabisFlowerMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AssetImpairmentCharges_8ad2c65a-0027-4c64-838a-fda949130528_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_AssetImpairmentCharges" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Impairment loss on long-lived assets</link:label>
    <link:label id="lab_us-gaap_AssetImpairmentCharges_3ae63923-138f-4a6d-935f-7d71b0fd7e72_terseLabel_en-US" xlink:label="lab_us-gaap_AssetImpairmentCharges" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Impairment loss on long-lived assets</link:label>
    <link:label id="lab_us-gaap_AssetImpairmentCharges_label_en-US" xlink:label="lab_us-gaap_AssetImpairmentCharges" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Asset Impairment Charges</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetImpairmentCharges" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AssetImpairmentCharges"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AssetImpairmentCharges" xlink:to="lab_us-gaap_AssetImpairmentCharges" xlink:type="arc" order="1"/>
    <link:label id="lab_cron_FinancingReceivableAccruedInterestNoncurrent_0aa1ce91-43d5-4229-9e22-307538ab98d7_terseLabel_en-US" xlink:label="lab_cron_FinancingReceivableAccruedInterestNoncurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Add: Accrued interest</link:label>
    <link:label id="lab_cron_FinancingReceivableAccruedInterestNoncurrent_label_en-US" xlink:label="lab_cron_FinancingReceivableAccruedInterestNoncurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Financing Receivable, Accrued Interest, Noncurrent</link:label>
    <link:label id="lab_cron_FinancingReceivableAccruedInterestNoncurrent_documentation_en-US" xlink:label="lab_cron_FinancingReceivableAccruedInterestNoncurrent" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Financing Receivable, Accrued Interest, Noncurrent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_cron_FinancingReceivableAccruedInterestNoncurrent" xlink:href="cron-20210630.xsd#cron_FinancingReceivableAccruedInterestNoncurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cron_FinancingReceivableAccruedInterestNoncurrent" xlink:to="lab_cron_FinancingReceivableAccruedInterestNoncurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NotesReceivableNet_53f10531-3640-464e-ae6c-1f03f21a34e3_terseLabel_en-US" xlink:label="lab_us-gaap_NotesReceivableNet" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Transfer to investments in equity accounted investees, excluding accrued interest</link:label>
    <link:label id="lab_us-gaap_NotesReceivableNet_36947c75-1b9d-41c2-9e8c-bee05038cef8_totalLabel_en-US" xlink:label="lab_us-gaap_NotesReceivableNet" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total loans receivable, net</link:label>
    <link:label id="lab_us-gaap_NotesReceivableNet_label_en-US" xlink:label="lab_us-gaap_NotesReceivableNet" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Financing Receivable, after Allowance for Credit Loss</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NotesReceivableNet" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NotesReceivableNet"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NotesReceivableNet" xlink:to="lab_us-gaap_NotesReceivableNet" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationRestrictedStockUnitsRequisiteServicePeriodRecognition_8da6b5e9-fc87-4430-9ddd-4f51eb80bd47_terseLabel_en-US" xlink:label="lab_us-gaap_AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationRestrictedStockUnitsRequisiteServicePeriodRecognition" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Vesting of restricted share units</link:label>
    <link:label id="lab_us-gaap_AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationRestrictedStockUnitsRequisiteServicePeriodRecognition_label_en-US" xlink:label="lab_us-gaap_AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationRestrictedStockUnitsRequisiteServicePeriodRecognition" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">APIC, Share-based Payment Arrangement, Restricted Stock Unit, Increase for Cost Recognition</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationRestrictedStockUnitsRequisiteServicePeriodRecognition" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationRestrictedStockUnitsRequisiteServicePeriodRecognition"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationRestrictedStockUnitsRequisiteServicePeriodRecognition" xlink:to="lab_us-gaap_AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationRestrictedStockUnitsRequisiteServicePeriodRecognition" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherNonoperatingIncomeExpense_cdda5494-c8ea-43a2-9bef-d50da9b755a4_terseLabel_en-US" xlink:label="lab_us-gaap_OtherNonoperatingIncomeExpense" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other, net</link:label>
    <link:label id="lab_us-gaap_OtherNonoperatingIncomeExpense_9e32e102-692b-4760-9281-f2cb2401bf38_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_OtherNonoperatingIncomeExpense" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other, net</link:label>
    <link:label id="lab_us-gaap_OtherNonoperatingIncomeExpense_label_en-US" xlink:label="lab_us-gaap_OtherNonoperatingIncomeExpense" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Nonoperating Income (Expense)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherNonoperatingIncomeExpense" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherNonoperatingIncomeExpense"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherNonoperatingIncomeExpense" xlink:to="lab_us-gaap_OtherNonoperatingIncomeExpense" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment_ec1edfad-f83c-4a2e-b229-fe66b56b1dbb_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Purchase of property, plant and equipment</link:label>
    <link:label id="lab_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment_label_en-US" xlink:label="lab_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payments to Acquire Property, Plant, and Equipment</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PaymentsToAcquirePropertyPlantAndEquipment"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment" xlink:to="lab_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment" xlink:type="arc" order="1"/>
    <link:label id="lab_cron_NovologGroupMember_18d40f5b-7620-4726-87c2-bc2b2e58e6d7_terseLabel_en-US" xlink:label="lab_cron_NovologGroupMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Novolog Group</link:label>
    <link:label id="lab_cron_NovologGroupMember_label_en-US" xlink:label="lab_cron_NovologGroupMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Novolog Group [Member]</link:label>
    <link:label id="lab_cron_NovologGroupMember_documentation_en-US" xlink:label="lab_cron_NovologGroupMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Novolog Group</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_cron_NovologGroupMember" xlink:href="cron-20210630.xsd#cron_NovologGroupMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cron_NovologGroupMember" xlink:to="lab_cron_NovologGroupMember" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_MaximumMember_dda01345-c616-42f2-b384-ffbae804dd65_terseLabel_en-US" xlink:label="lab_srt_MaximumMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Maximum</link:label>
    <link:label id="lab_srt_MaximumMember_label_en-US" xlink:label="lab_srt_MaximumMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Maximum [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MaximumMember" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_MaximumMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_MaximumMember" xlink:to="lab_srt_MaximumMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_b9b7d012-d505-4673-8dde-63cbc3b21f39_terseLabel_en-US" xlink:label="lab_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Payment Arrangement [Abstract]</link:label>
    <link:label id="lab_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_label_en-US" xlink:label="lab_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Payment Arrangement [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" xlink:to="lab_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LossContingencyNatureDomain_3e4bf399-0e52-4a86-a983-7166b2191c97_terseLabel_en-US" xlink:label="lab_us-gaap_LossContingencyNatureDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Loss Contingency, Nature [Domain]</link:label>
    <link:label id="lab_us-gaap_LossContingencyNatureDomain_label_en-US" xlink:label="lab_us-gaap_LossContingencyNatureDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Loss Contingency, Nature [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LossContingencyNatureDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LossContingencyNatureDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LossContingencyNatureDomain" xlink:to="lab_us-gaap_LossContingencyNatureDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_Liabilities_85715f31-03c5-4866-a1ed-8233f8e15caa_totalLabel_en-US" xlink:label="lab_us-gaap_Liabilities" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total liabilities</link:label>
    <link:label id="lab_us-gaap_Liabilities_label_en-US" xlink:label="lab_us-gaap_Liabilities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Liabilities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Liabilities" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_Liabilities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_Liabilities" xlink:to="lab_us-gaap_Liabilities" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_InventoryRawMaterialsNetOfReserves_fefc1d8d-d87f-4948-b2aa-3221f9ad6ba4_terseLabel_en-US" xlink:label="lab_us-gaap_InventoryRawMaterialsNetOfReserves" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Raw materials</link:label>
    <link:label id="lab_us-gaap_InventoryRawMaterialsNetOfReserves_label_en-US" xlink:label="lab_us-gaap_InventoryRawMaterialsNetOfReserves" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Inventory, Raw Materials, Net of Reserves</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryRawMaterialsNetOfReserves" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InventoryRawMaterialsNetOfReserves"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InventoryRawMaterialsNetOfReserves" xlink:to="lab_us-gaap_InventoryRawMaterialsNetOfReserves" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_LegalEntityAxis_2bca39ef-2ba9-46cb-ad25-29b7ba093667_terseLabel_en-US" xlink:label="lab_dei_LegalEntityAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Legal Entity [Axis]</link:label>
    <link:label id="lab_dei_LegalEntityAxis_label_en-US" xlink:label="lab_dei_LegalEntityAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Legal Entity [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_LegalEntityAxis" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_LegalEntityAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_LegalEntityAxis" xlink:to="lab_dei_LegalEntityAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_cron_DeferredShareUnitsDSUsMember_9957d3af-bc44-40c3-bdcc-a896e20c8b05_terseLabel_en-US" xlink:label="lab_cron_DeferredShareUnitsDSUsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred Share Units (DSUs)</link:label>
    <link:label id="lab_cron_DeferredShareUnitsDSUsMember_label_en-US" xlink:label="lab_cron_DeferredShareUnitsDSUsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred Share Units (DSUs) [Member]</link:label>
    <link:label id="lab_cron_DeferredShareUnitsDSUsMember_documentation_en-US" xlink:label="lab_cron_DeferredShareUnitsDSUsMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred Share Units (DSUs) [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_cron_DeferredShareUnitsDSUsMember" xlink:href="cron-20210630.xsd#cron_DeferredShareUnitsDSUsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cron_DeferredShareUnitsDSUsMember" xlink:to="lab_cron_DeferredShareUnitsDSUsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_cron_SharebasedCompensationArrangementBySharebasedPaymentAwardWarrantsExercisesInPeriod_e6ad1edc-acaa-44a5-8d70-e37a3f48c49f_terseLabel_en-US" xlink:label="lab_cron_SharebasedCompensationArrangementBySharebasedPaymentAwardWarrantsExercisesInPeriod" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Warrants exercised (in shares)</link:label>
    <link:label id="lab_cron_SharebasedCompensationArrangementBySharebasedPaymentAwardWarrantsExercisesInPeriod_label_en-US" xlink:label="lab_cron_SharebasedCompensationArrangementBySharebasedPaymentAwardWarrantsExercisesInPeriod" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement By Share-based Payment Award, Warrants, Exercises In Period</link:label>
    <link:label id="lab_cron_SharebasedCompensationArrangementBySharebasedPaymentAwardWarrantsExercisesInPeriod_documentation_en-US" xlink:label="lab_cron_SharebasedCompensationArrangementBySharebasedPaymentAwardWarrantsExercisesInPeriod" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement By Share-based Payment Award, Warrants, Exercises In Period</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_cron_SharebasedCompensationArrangementBySharebasedPaymentAwardWarrantsExercisesInPeriod" xlink:href="cron-20210630.xsd#cron_SharebasedCompensationArrangementBySharebasedPaymentAwardWarrantsExercisesInPeriod"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cron_SharebasedCompensationArrangementBySharebasedPaymentAwardWarrantsExercisesInPeriod" xlink:to="lab_cron_SharebasedCompensationArrangementBySharebasedPaymentAwardWarrantsExercisesInPeriod" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AwardTypeAxis_9eacf4b2-c001-4d7c-a407-ab782a00404e_terseLabel_en-US" xlink:label="lab_us-gaap_AwardTypeAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Award Type [Axis]</link:label>
    <link:label id="lab_us-gaap_AwardTypeAxis_label_en-US" xlink:label="lab_us-gaap_AwardTypeAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Award Type [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AwardTypeAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AwardTypeAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AwardTypeAxis" xlink:to="lab_us-gaap_AwardTypeAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_45cf9fbb-91db-4678-b5fb-476d58a9d9c9_terseLabel_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Financing activities</link:label>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_label_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net Cash Provided by (Used in) Financing Activities [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:to="lab_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_ConsolidationItemsAxis_353056fb-43f9-4c7c-97bb-7d62374e0884_terseLabel_en-US" xlink:label="lab_srt_ConsolidationItemsAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Consolidation Items [Axis]</link:label>
    <link:label id="lab_srt_ConsolidationItemsAxis_label_en-US" xlink:label="lab_srt_ConsolidationItemsAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Consolidation Items [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ConsolidationItemsAxis" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_ConsolidationItemsAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_ConsolidationItemsAxis" xlink:to="lab_srt_ConsolidationItemsAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_MeasurementInputTypeAxis_23ac8d30-ff4e-484d-b58e-45bb3f015f8a_terseLabel_en-US" xlink:label="lab_us-gaap_MeasurementInputTypeAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Measurement Input Type [Axis]</link:label>
    <link:label id="lab_us-gaap_MeasurementInputTypeAxis_label_en-US" xlink:label="lab_us-gaap_MeasurementInputTypeAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Measurement Input Type [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MeasurementInputTypeAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_MeasurementInputTypeAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_MeasurementInputTypeAxis" xlink:to="lab_us-gaap_MeasurementInputTypeAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StockholdersEquity_ecdb2e05-d65c-44e3-bdef-6a460c4b9e6c_totalLabel_en-US" xlink:label="lab_us-gaap_StockholdersEquity" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total equity attributable to shareholders of Cronos Group</link:label>
    <link:label id="lab_us-gaap_StockholdersEquity_label_en-US" xlink:label="lab_us-gaap_StockholdersEquity" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stockholders' Equity Attributable to Parent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquity" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockholdersEquity"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockholdersEquity" xlink:to="lab_us-gaap_StockholdersEquity" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CommonStockSharesIssued_c174b91e-e595-4cad-b98d-e78120547858_terseLabel_en-US" xlink:label="lab_us-gaap_CommonStockSharesIssued" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common stock, shares issued (in shares)</link:label>
    <link:label id="lab_us-gaap_CommonStockSharesIssued_label_en-US" xlink:label="lab_us-gaap_CommonStockSharesIssued" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common Stock, Shares, Issued</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockSharesIssued" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommonStockSharesIssued"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CommonStockSharesIssued" xlink:to="lab_us-gaap_CommonStockSharesIssued" xlink:type="arc" order="1"/>
    <link:label id="lab_cron_RestatementReviewExpense_a531c991-32c7-42bf-b59e-b2ba4f7e12bd_verboseLabel_en-US" xlink:label="lab_cron_RestatementReviewExpense" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Review costs related to restatement of 2019 interim financial statements</link:label>
    <link:label id="lab_cron_RestatementReviewExpense_label_en-US" xlink:label="lab_cron_RestatementReviewExpense" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restatement Review Expense</link:label>
    <link:label id="lab_cron_RestatementReviewExpense_documentation_en-US" xlink:label="lab_cron_RestatementReviewExpense" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restatement Review Expense</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_cron_RestatementReviewExpense" xlink:href="cron-20210630.xsd#cron_RestatementReviewExpense"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cron_RestatementReviewExpense" xlink:to="lab_cron_RestatementReviewExpense" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EquityMethodInvestmentsDisclosureTextBlock_c3a19e03-cea2-4354-8b40-66d4d0038939_terseLabel_en-US" xlink:label="lab_us-gaap_EquityMethodInvestmentsDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Investments</link:label>
    <link:label id="lab_us-gaap_EquityMethodInvestmentsDisclosureTextBlock_label_en-US" xlink:label="lab_us-gaap_EquityMethodInvestmentsDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity Method Investments and Joint Ventures Disclosure [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityMethodInvestmentsDisclosureTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EquityMethodInvestmentsDisclosureTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EquityMethodInvestmentsDisclosureTextBlock" xlink:to="lab_us-gaap_EquityMethodInvestmentsDisclosureTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_cron_A2020OmnibusPlanMember_439ce8cb-e5aa-45f2-9ecf-d8cf32190a8c_terseLabel_en-US" xlink:label="lab_cron_A2020OmnibusPlanMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2020 Omnibus Plan</link:label>
    <link:label id="lab_cron_A2020OmnibusPlanMember_label_en-US" xlink:label="lab_cron_A2020OmnibusPlanMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2020 Omnibus Plan [Member]</link:label>
    <link:label id="lab_cron_A2020OmnibusPlanMember_documentation_en-US" xlink:label="lab_cron_A2020OmnibusPlanMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2020 Omnibus Plan</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_cron_A2020OmnibusPlanMember" xlink:href="cron-20210630.xsd#cron_A2020OmnibusPlanMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cron_A2020OmnibusPlanMember" xlink:to="lab_cron_A2020OmnibusPlanMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_a014c556-cbf1-44fa-9cc5-d87fc5ce6d0e_terseLabel_en-US" xlink:label="lab_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Goodwill and Intangible Assets Disclosure [Abstract]</link:label>
    <link:label id="lab_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_label_en-US" xlink:label="lab_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Goodwill and Intangible Assets Disclosure [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract" xlink:to="lab_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_MeasurementInputExpectedTermMember_f69a1082-63a7-485b-b446-8dc55ba29cac_terseLabel_en-US" xlink:label="lab_us-gaap_MeasurementInputExpectedTermMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Weight average expected life</link:label>
    <link:label id="lab_us-gaap_MeasurementInputExpectedTermMember_label_en-US" xlink:label="lab_us-gaap_MeasurementInputExpectedTermMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Measurement Input, Expected Term [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MeasurementInputExpectedTermMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_MeasurementInputExpectedTermMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_MeasurementInputExpectedTermMember" xlink:to="lab_us-gaap_MeasurementInputExpectedTermMember" xlink:type="arc" order="1"/>
    <link:label id="lab_cron_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedAndIssuedInPeriodWeightedAverageGrantDateFairValue_6a469463-ee4f-4c14-80cd-6dc1bc88c4d1_terseLabel_en-US" xlink:label="lab_cron_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedAndIssuedInPeriodWeightedAverageGrantDateFairValue" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Vested and issued (in dollars per share)</link:label>
    <link:label id="lab_cron_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedAndIssuedInPeriodWeightedAverageGrantDateFairValue_label_en-US" xlink:label="lab_cron_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedAndIssuedInPeriodWeightedAverageGrantDateFairValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Compensation Arrangement By Share-Based Payment Award, Equity Instruments Other Than Options, Vested And Issued In Period, Weighted Average Grant Date Fair Value</link:label>
    <link:label id="lab_cron_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedAndIssuedInPeriodWeightedAverageGrantDateFairValue_documentation_en-US" xlink:label="lab_cron_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedAndIssuedInPeriodWeightedAverageGrantDateFairValue" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Compensation Arrangement By Share-Based Payment Award, Equity Instruments Other Than Options, Vested And Issued In Period, Weighted Average Grant Date Fair Value</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_cron_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedAndIssuedInPeriodWeightedAverageGrantDateFairValue" xlink:href="cron-20210630.xsd#cron_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedAndIssuedInPeriodWeightedAverageGrantDateFairValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cron_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedAndIssuedInPeriodWeightedAverageGrantDateFairValue" xlink:to="lab_cron_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedAndIssuedInPeriodWeightedAverageGrantDateFairValue" xlink:type="arc" order="1"/>
    <link:label id="lab_country_IL_06ae34b2-743d-4d66-95b4-814398864241_terseLabel_en-US" xlink:label="lab_country_IL" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Israel</link:label>
    <link:label id="lab_country_IL_label_en-US" xlink:label="lab_country_IL" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">ISRAEL</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_country_IL" xlink:href="https://xbrl.sec.gov/country/2021/country-2021.xsd#country_IL"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_country_IL" xlink:to="lab_country_IL" xlink:type="arc" order="1"/>
    <link:label id="lab_cron_AltriaGroupInc.Member_3bfe4d1b-c259-4fd8-8d15-6f68f8a433e7_terseLabel_en-US" xlink:label="lab_cron_AltriaGroupInc.Member" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Altria Group, Inc.</link:label>
    <link:label id="lab_cron_AltriaGroupInc.Member_label_en-US" xlink:label="lab_cron_AltriaGroupInc.Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Altria Group, Inc. [Member]</link:label>
    <link:label id="lab_cron_AltriaGroupInc.Member_documentation_en-US" xlink:label="lab_cron_AltriaGroupInc.Member" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Altria Group, Inc. [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_cron_AltriaGroupInc.Member" xlink:href="cron-20210630.xsd#cron_AltriaGroupInc.Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cron_AltriaGroupInc.Member" xlink:to="lab_cron_AltriaGroupInc.Member" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DisposalGroupNotDiscontinuedOperationGainLossOnDisposal_34434df5-42f7-405f-9d6e-0423feb2cd30_terseLabel_en-US" xlink:label="lab_us-gaap_DisposalGroupNotDiscontinuedOperationGainLossOnDisposal" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Gain on sale of property held-for-sale</link:label>
    <link:label id="lab_us-gaap_DisposalGroupNotDiscontinuedOperationGainLossOnDisposal_label_en-US" xlink:label="lab_us-gaap_DisposalGroupNotDiscontinuedOperationGainLossOnDisposal" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disposal Group, Not Discontinued Operation, Gain (Loss) on Disposal</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupNotDiscontinuedOperationGainLossOnDisposal" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DisposalGroupNotDiscontinuedOperationGainLossOnDisposal"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DisposalGroupNotDiscontinuedOperationGainLossOnDisposal" xlink:to="lab_us-gaap_DisposalGroupNotDiscontinuedOperationGainLossOnDisposal" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfIndefiniteLivedIntangibleAssetsTable_d3a4927b-bdcc-4e52-a932-1a38c494956b_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfIndefiniteLivedIntangibleAssetsTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Indefinite-Lived Intangible Assets [Table]</link:label>
    <link:label id="lab_us-gaap_ScheduleOfIndefiniteLivedIntangibleAssetsTable_label_en-US" xlink:label="lab_us-gaap_ScheduleOfIndefiniteLivedIntangibleAssetsTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Indefinite-Lived Intangible Assets [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfIndefiniteLivedIntangibleAssetsTable" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfIndefiniteLivedIntangibleAssetsTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfIndefiniteLivedIntangibleAssetsTable" xlink:to="lab_us-gaap_ScheduleOfIndefiniteLivedIntangibleAssetsTable" xlink:type="arc" order="1"/>
    <link:label id="lab_cron_CannabisExtractsMember_af38db72-cdef-4a75-9244-8db746bd4441_terseLabel_en-US" xlink:label="lab_cron_CannabisExtractsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cannabis extracts</link:label>
    <link:label id="lab_cron_CannabisExtractsMember_label_en-US" xlink:label="lab_cron_CannabisExtractsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cannabis Extracts [Member]</link:label>
    <link:label id="lab_cron_CannabisExtractsMember_documentation_en-US" xlink:label="lab_cron_CannabisExtractsMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cannabis Extracts [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_cron_CannabisExtractsMember" xlink:href="cron-20210630.xsd#cron_CannabisExtractsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cron_CannabisExtractsMember" xlink:to="lab_cron_CannabisExtractsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OperatingLeaseLiabilityNoncurrent_37cc508e-21ca-4070-abc7-dafc1a717d32_verboseLabel_en-US" xlink:label="lab_us-gaap_OperatingLeaseLiabilityNoncurrent" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lease obligation</link:label>
    <link:label id="lab_us-gaap_OperatingLeaseLiabilityNoncurrent_label_en-US" xlink:label="lab_us-gaap_OperatingLeaseLiabilityNoncurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Lease, Liability, Noncurrent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseLiabilityNoncurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingLeaseLiabilityNoncurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OperatingLeaseLiabilityNoncurrent" xlink:to="lab_us-gaap_OperatingLeaseLiabilityNoncurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueMeasurementFrequencyDomain_56c28d66-72fc-4010-870a-b81e3ad6045b_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueMeasurementFrequencyDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Measurement Frequency [Domain]</link:label>
    <link:label id="lab_us-gaap_FairValueMeasurementFrequencyDomain_label_en-US" xlink:label="lab_us-gaap_FairValueMeasurementFrequencyDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Measurement Frequency [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementFrequencyDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueMeasurementFrequencyDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueMeasurementFrequencyDomain" xlink:to="lab_us-gaap_FairValueMeasurementFrequencyDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_InterestExpense_7109f87c-517b-4a60-aa56-2479dd0ef4f2_negatedLabel_en-US" xlink:label="lab_us-gaap_InterestExpense" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Interest expense</link:label>
    <link:label id="lab_us-gaap_InterestExpense_label_en-US" xlink:label="lab_us-gaap_InterestExpense" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Interest Expense</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestExpense" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InterestExpense"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InterestExpense" xlink:to="lab_us-gaap_InterestExpense" xlink:type="arc" order="1"/>
    <link:label id="lab_cron_FourCustomersMember_ead80640-a82b-42c2-af97-55dd9014f376_terseLabel_en-US" xlink:label="lab_cron_FourCustomersMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Four Customers</link:label>
    <link:label id="lab_cron_FourCustomersMember_label_en-US" xlink:label="lab_cron_FourCustomersMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Four Customers [Member]</link:label>
    <link:label id="lab_cron_FourCustomersMember_documentation_en-US" xlink:label="lab_cron_FourCustomersMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Four Customers</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_cron_FourCustomersMember" xlink:href="cron-20210630.xsd#cron_FourCustomersMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cron_FourCustomersMember" xlink:to="lab_cron_FourCustomersMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DiscontinuedOperationsAndDisposalGroupsAbstract_label_en-US" xlink:label="lab_us-gaap_DiscontinuedOperationsAndDisposalGroupsAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Discontinued Operations and Disposal Groups [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DiscontinuedOperationsAndDisposalGroupsAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DiscontinuedOperationsAndDisposalGroupsAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DiscontinuedOperationsAndDisposalGroupsAbstract" xlink:to="lab_us-gaap_DiscontinuedOperationsAndDisposalGroupsAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LossContingenciesByNatureOfContingencyAxis_ba6c31cb-1a3d-4d9d-b139-bdb35c84ee68_terseLabel_en-US" xlink:label="lab_us-gaap_LossContingenciesByNatureOfContingencyAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Loss Contingency Nature [Axis]</link:label>
    <link:label id="lab_us-gaap_LossContingenciesByNatureOfContingencyAxis_label_en-US" xlink:label="lab_us-gaap_LossContingenciesByNatureOfContingencyAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Loss Contingency Nature [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LossContingenciesByNatureOfContingencyAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LossContingenciesByNatureOfContingencyAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LossContingenciesByNatureOfContingencyAxis" xlink:to="lab_us-gaap_LossContingenciesByNatureOfContingencyAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_CityAreaCode_aa10d619-e08e-4e83-9801-20d2dc280df5_terseLabel_en-US" xlink:label="lab_dei_CityAreaCode" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">City Area Code</link:label>
    <link:label id="lab_dei_CityAreaCode_label_en-US" xlink:label="lab_dei_CityAreaCode" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">City Area Code</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_CityAreaCode" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_CityAreaCode"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_CityAreaCode" xlink:to="lab_dei_CityAreaCode" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RetainedEarningsAccumulatedDeficit_4b0e8306-d34d-43e5-8a7f-01abdeb2fd39_terseLabel_en-US" xlink:label="lab_us-gaap_RetainedEarningsAccumulatedDeficit" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Retained earnings</link:label>
    <link:label id="lab_us-gaap_RetainedEarningsAccumulatedDeficit_label_en-US" xlink:label="lab_us-gaap_RetainedEarningsAccumulatedDeficit" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Retained Earnings (Accumulated Deficit)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetainedEarningsAccumulatedDeficit" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RetainedEarningsAccumulatedDeficit"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RetainedEarningsAccumulatedDeficit" xlink:to="lab_us-gaap_RetainedEarningsAccumulatedDeficit" xlink:type="arc" order="1"/>
    <link:label id="lab_cron_FinancingReceivableAccruedInterestCurrent_f6dd37d5-0673-4d4a-8176-ca6bb88fb064_terseLabel_en-US" xlink:label="lab_cron_FinancingReceivableAccruedInterestCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Add: Accrued interest</link:label>
    <link:label id="lab_cron_FinancingReceivableAccruedInterestCurrent_label_en-US" xlink:label="lab_cron_FinancingReceivableAccruedInterestCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Financing Receivable, Accrued Interest, Current</link:label>
    <link:label id="lab_cron_FinancingReceivableAccruedInterestCurrent_documentation_en-US" xlink:label="lab_cron_FinancingReceivableAccruedInterestCurrent" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Financing Receivable, Accrued Interest, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_cron_FinancingReceivableAccruedInterestCurrent" xlink:href="cron-20210630.xsd#cron_FinancingReceivableAccruedInterestCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cron_FinancingReceivableAccruedInterestCurrent" xlink:to="lab_cron_FinancingReceivableAccruedInterestCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OperatingSegmentsMember_1144e169-9ad0-48bf-b5b0-075d7b188c1f_terseLabel_en-US" xlink:label="lab_us-gaap_OperatingSegmentsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Segments</link:label>
    <link:label id="lab_us-gaap_OperatingSegmentsMember_label_en-US" xlink:label="lab_us-gaap_OperatingSegmentsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Segments [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingSegmentsMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingSegmentsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OperatingSegmentsMember" xlink:to="lab_us-gaap_OperatingSegmentsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_LitigationCaseTypeDomain_323978bb-ead1-41c9-9f00-0c87005ddafc_terseLabel_en-US" xlink:label="lab_srt_LitigationCaseTypeDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Litigation Case [Domain]</link:label>
    <link:label id="lab_srt_LitigationCaseTypeDomain_label_en-US" xlink:label="lab_srt_LitigationCaseTypeDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Litigation Case [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_LitigationCaseTypeDomain" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_LitigationCaseTypeDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_LitigationCaseTypeDomain" xlink:to="lab_srt_LitigationCaseTypeDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod_d0c78112-8961-44e9-98f7-7b4df3a5cac7_terseLabel_en-US" xlink:label="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Expiration period</link:label>
    <link:label id="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod_label_en-US" xlink:label="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Expiration Period</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod" xlink:to="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTable_3e10ad6e-f888-421e-bbf1-23571e15825e_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value Measurement Inputs and Valuation Techniques [Table]</link:label>
    <link:label id="lab_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTable_label_en-US" xlink:label="lab_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value Measurement Inputs and Valuation Techniques [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTable" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTable" xlink:to="lab_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RestrictedStockUnitsRSUMember_be83f0eb-8cef-4464-885f-25bb6c68d86f_terseLabel_en-US" xlink:label="lab_us-gaap_RestrictedStockUnitsRSUMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restricted share units</link:label>
    <link:label id="lab_us-gaap_RestrictedStockUnitsRSUMember_label_en-US" xlink:label="lab_us-gaap_RestrictedStockUnitsRSUMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restricted Stock Units (RSUs) [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestrictedStockUnitsRSUMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RestrictedStockUnitsRSUMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RestrictedStockUnitsRSUMember" xlink:to="lab_us-gaap_RestrictedStockUnitsRSUMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StatementOfStockholdersEquityAbstract_a7f9d562-0b50-45b8-a502-d695b4dc8baf_terseLabel_en-US" xlink:label="lab_us-gaap_StatementOfStockholdersEquityAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statement of Stockholders' Equity [Abstract]</link:label>
    <link:label id="lab_us-gaap_StatementOfStockholdersEquityAbstract_label_en-US" xlink:label="lab_us-gaap_StatementOfStockholdersEquityAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statement of Stockholders' Equity [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementOfStockholdersEquityAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementOfStockholdersEquityAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StatementOfStockholdersEquityAbstract" xlink:to="lab_us-gaap_StatementOfStockholdersEquityAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EquityMethodInvestmentsTextBlock_b4efdc0d-2e48-4ae6-9f51-ce46fdf171b5_terseLabel_en-US" xlink:label="lab_us-gaap_EquityMethodInvestmentsTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Investments in Associates and Joint Ventures</link:label>
    <link:label id="lab_us-gaap_EquityMethodInvestmentsTextBlock_label_en-US" xlink:label="lab_us-gaap_EquityMethodInvestmentsTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity Method Investments [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityMethodInvestmentsTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EquityMethodInvestmentsTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EquityMethodInvestmentsTextBlock" xlink:to="lab_us-gaap_EquityMethodInvestmentsTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_RestatementDomain_a187aaed-baa5-4638-b392-971ba2cf4391_terseLabel_en-US" xlink:label="lab_srt_RestatementDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restatement [Domain]</link:label>
    <link:label id="lab_srt_RestatementDomain_label_en-US" xlink:label="lab_srt_RestatementDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revision of Prior Period [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RestatementDomain" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_RestatementDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_RestatementDomain" xlink:to="lab_srt_RestatementDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_cron_A2018StockOptionPlanMember_9d860e8b-f6a4-4a83-81e4-4e77bfbcf2a6_terseLabel_en-US" xlink:label="lab_cron_A2018StockOptionPlanMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2018 Stock Option Plan</link:label>
    <link:label id="lab_cron_A2018StockOptionPlanMember_label_en-US" xlink:label="lab_cron_A2018StockOptionPlanMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2018 Stock Option Plan [Member]</link:label>
    <link:label id="lab_cron_A2018StockOptionPlanMember_documentation_en-US" xlink:label="lab_cron_A2018StockOptionPlanMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2018 Stock Option Plan [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_cron_A2018StockOptionPlanMember" xlink:href="cron-20210630.xsd#cron_A2018StockOptionPlanMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cron_A2018StockOptionPlanMember" xlink:to="lab_cron_A2018StockOptionPlanMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeStatementAbstract_bd03d6ce-b068-444b-970a-02333e5626c0_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeStatementAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Statement [Abstract]</link:label>
    <link:label id="lab_us-gaap_IncomeStatementAbstract_label_en-US" xlink:label="lab_us-gaap_IncomeStatementAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Statement [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeStatementAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeStatementAbstract" xlink:to="lab_us-gaap_IncomeStatementAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EquityMethodInvestments_56396bc9-b246-422e-8be3-469b77ac331b_verboseLabel_en-US" xlink:label="lab_us-gaap_EquityMethodInvestments" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Investments in equity accounted investees, net</link:label>
    <link:label id="lab_us-gaap_EquityMethodInvestments_label_en-US" xlink:label="lab_us-gaap_EquityMethodInvestments" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity Method Investments</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityMethodInvestments" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EquityMethodInvestments"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EquityMethodInvestments" xlink:to="lab_us-gaap_EquityMethodInvestments" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_AmendmentFlag_bfa2de69-514d-450b-973c-58df2701e194_terseLabel_en-US" xlink:label="lab_dei_AmendmentFlag" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Amendment Flag</link:label>
    <link:label id="lab_dei_AmendmentFlag_label_en-US" xlink:label="lab_dei_AmendmentFlag" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Amendment Flag</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_AmendmentFlag" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_AmendmentFlag"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_AmendmentFlag" xlink:to="lab_dei_AmendmentFlag" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ConcentrationRiskTable_a5740ebb-df4c-4461-a189-4652706d68bd_terseLabel_en-US" xlink:label="lab_us-gaap_ConcentrationRiskTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Concentration Risk [Table]</link:label>
    <link:label id="lab_us-gaap_ConcentrationRiskTable_label_en-US" xlink:label="lab_us-gaap_ConcentrationRiskTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Concentration Risk [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskTable" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ConcentrationRiskTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ConcentrationRiskTable" xlink:to="lab_us-gaap_ConcentrationRiskTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfOtherShareBasedCompensationActivityTableTextBlock_4e215523-b600-4891-91d3-255afd244da3_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfOtherShareBasedCompensationActivityTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Summary of Changes in DSUs and Warrants</link:label>
    <link:label id="lab_us-gaap_ScheduleOfOtherShareBasedCompensationActivityTableTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfOtherShareBasedCompensationActivityTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Payment Arrangement, Outstanding Award, Activity, Excluding Option [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfOtherShareBasedCompensationActivityTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfOtherShareBasedCompensationActivityTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfOtherShareBasedCompensationActivityTableTextBlock" xlink:to="lab_us-gaap_ScheduleOfOtherShareBasedCompensationActivityTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_InventoryDisclosureAbstract_ddf72c4b-78da-4636-be59-b7506c4a2ccf_terseLabel_en-US" xlink:label="lab_us-gaap_InventoryDisclosureAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Inventory Disclosure [Abstract]</link:label>
    <link:label id="lab_us-gaap_InventoryDisclosureAbstract_label_en-US" xlink:label="lab_us-gaap_InventoryDisclosureAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Inventory Disclosure [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryDisclosureAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InventoryDisclosureAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InventoryDisclosureAbstract" xlink:to="lab_us-gaap_InventoryDisclosureAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_cron_DerivativeLiabilityUsefulLifeTerm_3247e241-3cc6-45c2-9292-2c524ce49471_terseLabel_en-US" xlink:label="lab_cron_DerivativeLiabilityUsefulLifeTerm" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Expected life</link:label>
    <link:label id="lab_cron_DerivativeLiabilityUsefulLifeTerm_label_en-US" xlink:label="lab_cron_DerivativeLiabilityUsefulLifeTerm" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative Liability, Useful Life, Term</link:label>
    <link:label id="lab_cron_DerivativeLiabilityUsefulLifeTerm_documentation_en-US" xlink:label="lab_cron_DerivativeLiabilityUsefulLifeTerm" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative Liability, Useful Life, Term</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_cron_DerivativeLiabilityUsefulLifeTerm" xlink:href="cron-20210630.xsd#cron_DerivativeLiabilityUsefulLifeTerm"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cron_DerivativeLiabilityUsefulLifeTerm" xlink:to="lab_cron_DerivativeLiabilityUsefulLifeTerm" xlink:type="arc" order="1"/>
    <link:label id="lab_cron_OriginalBCMember_f8d4a077-9e47-4752-b7d2-97fb76889134_terseLabel_en-US" xlink:label="lab_cron_OriginalBCMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">OGBC</link:label>
    <link:label id="lab_cron_OriginalBCMember_label_en-US" xlink:label="lab_cron_OriginalBCMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Original BC [Member]</link:label>
    <link:label id="lab_cron_OriginalBCMember_documentation_en-US" xlink:label="lab_cron_OriginalBCMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Original BC</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_cron_OriginalBCMember" xlink:href="cron-20210630.xsd#cron_OriginalBCMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cron_OriginalBCMember" xlink:to="lab_cron_OriginalBCMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DiscontinuedOperationsHeldforsaleMember_2b53b1d0-ab25-470c-8af5-e04108717252_terseLabel_en-US" xlink:label="lab_us-gaap_DiscontinuedOperationsHeldforsaleMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Discontinued Operations, Held-for-sale</link:label>
    <link:label id="lab_us-gaap_DiscontinuedOperationsHeldforsaleMember_label_en-US" xlink:label="lab_us-gaap_DiscontinuedOperationsHeldforsaleMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Discontinued Operations, Held-for-sale [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DiscontinuedOperationsHeldforsaleMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DiscontinuedOperationsHeldforsaleMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DiscontinuedOperationsHeldforsaleMember" xlink:to="lab_us-gaap_DiscontinuedOperationsHeldforsaleMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShortTermInvestments_b030eb0a-dbae-4db3-9e04-6465a51cf016_terseLabel_en-US" xlink:label="lab_us-gaap_ShortTermInvestments" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Short-term investments</link:label>
    <link:label id="lab_us-gaap_ShortTermInvestments_label_en-US" xlink:label="lab_us-gaap_ShortTermInvestments" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Short-term Investments</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShortTermInvestments" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShortTermInvestments"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShortTermInvestments" xlink:to="lab_us-gaap_ShortTermInvestments" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BasisOfPresentationAndSignificantAccountingPoliciesTextBlock_fc16b36e-37ce-4e81-865e-8fc350ed50b0_terseLabel_en-US" xlink:label="lab_us-gaap_BasisOfPresentationAndSignificantAccountingPoliciesTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Background, Basis of Presentation and Accounting Policies</link:label>
    <link:label id="lab_us-gaap_BasisOfPresentationAndSignificantAccountingPoliciesTextBlock_label_en-US" xlink:label="lab_us-gaap_BasisOfPresentationAndSignificantAccountingPoliciesTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Basis of Presentation and Significant Accounting Policies [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BasisOfPresentationAndSignificantAccountingPoliciesTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BasisOfPresentationAndSignificantAccountingPoliciesTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BasisOfPresentationAndSignificantAccountingPoliciesTextBlock" xlink:to="lab_us-gaap_BasisOfPresentationAndSignificantAccountingPoliciesTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_cron_A2015StockOptionPlanMember_4e88154a-7da6-4e97-8e5f-be53f45fa45c_terseLabel_en-US" xlink:label="lab_cron_A2015StockOptionPlanMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2015 Stock Option Plan</link:label>
    <link:label id="lab_cron_A2015StockOptionPlanMember_label_en-US" xlink:label="lab_cron_A2015StockOptionPlanMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2015 Stock Option Plan [Member]</link:label>
    <link:label id="lab_cron_A2015StockOptionPlanMember_documentation_en-US" xlink:label="lab_cron_A2015StockOptionPlanMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2015 Stock Option Plan [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_cron_A2015StockOptionPlanMember" xlink:href="cron-20210630.xsd#cron_A2015StockOptionPlanMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cron_A2015StockOptionPlanMember" xlink:to="lab_cron_A2015StockOptionPlanMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_638a7a99-726a-46b3-8f27-19195601f3ee_totalLabel_en-US" xlink:label="lab_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total shareholders&#8217; equity</link:label>
    <link:label id="lab_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_d4bb846b-a834-41c9-8624-c4bc55549b0b_periodStartLabel_en-US" xlink:label="lab_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Beginning balance</link:label>
    <link:label id="lab_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_06b26737-f11f-48b6-8b05-9f43fde39e16_periodEndLabel_en-US" xlink:label="lab_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Ending balance</link:label>
    <link:label id="lab_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_label_en-US" xlink:label="lab_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stockholders' Equity, Including Portion Attributable to Noncontrolling Interest</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" xlink:to="lab_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccountsReceivableNetCurrent_6f0cb61c-b9c8-4314-9141-99f86e4d8eed_verboseLabel_en-US" xlink:label="lab_us-gaap_AccountsReceivableNetCurrent" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounts receivable, net</link:label>
    <link:label id="lab_us-gaap_AccountsReceivableNetCurrent_label_en-US" xlink:label="lab_us-gaap_AccountsReceivableNetCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounts Receivable, after Allowance for Credit Loss, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountsReceivableNetCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccountsReceivableNetCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccountsReceivableNetCurrent" xlink:to="lab_us-gaap_AccountsReceivableNetCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StatementEquityComponentsAxis_0a61bece-66a9-4089-9154-924e39c18ba1_terseLabel_en-US" xlink:label="lab_us-gaap_StatementEquityComponentsAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity Components [Axis]</link:label>
    <link:label id="lab_us-gaap_StatementEquityComponentsAxis_label_en-US" xlink:label="lab_us-gaap_StatementEquityComponentsAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity Components [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementEquityComponentsAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementEquityComponentsAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StatementEquityComponentsAxis" xlink:to="lab_us-gaap_StatementEquityComponentsAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueDisclosuresAbstract_1f196f76-1827-42cb-974e-a9b5cb46966e_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueDisclosuresAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value Disclosures [Abstract]</link:label>
    <link:label id="lab_us-gaap_FairValueDisclosuresAbstract_label_en-US" xlink:label="lab_us-gaap_FairValueDisclosuresAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value Disclosures [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueDisclosuresAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueDisclosuresAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueDisclosuresAbstract" xlink:to="lab_us-gaap_FairValueDisclosuresAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis_ac90efa6-8ced-4595-86e3-b624fea9788a_terseLabel_en-US" xlink:label="lab_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Antidilutive Securities [Axis]</link:label>
    <link:label id="lab_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis_label_en-US" xlink:label="lab_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Antidilutive Securities [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis" xlink:to="lab_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NetIncomeLossFromContinuingOperationsAvailableToCommonShareholdersDiluted_38e7876b-942b-4885-9a66-e9edcc12a8b2_totalLabel_en-US" xlink:label="lab_us-gaap_NetIncomeLossFromContinuingOperationsAvailableToCommonShareholdersDiluted" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net income (loss) used in the computation of diluted earnings (loss) from continuing operations per share</link:label>
    <link:label id="lab_us-gaap_NetIncomeLossFromContinuingOperationsAvailableToCommonShareholdersDiluted_label_en-US" xlink:label="lab_us-gaap_NetIncomeLossFromContinuingOperationsAvailableToCommonShareholdersDiluted" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net Income (Loss) from Continuing Operations Available to Common Shareholders, Diluted</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLossFromContinuingOperationsAvailableToCommonShareholdersDiluted" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetIncomeLossFromContinuingOperationsAvailableToCommonShareholdersDiluted"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NetIncomeLossFromContinuingOperationsAvailableToCommonShareholdersDiluted" xlink:to="lab_us-gaap_NetIncomeLossFromContinuingOperationsAvailableToCommonShareholdersDiluted" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AssetsCurrent_34dca45d-f6fe-4938-8d53-65d63da5ec0f_totalLabel_en-US" xlink:label="lab_us-gaap_AssetsCurrent" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total current assets</link:label>
    <link:label id="lab_us-gaap_AssetsCurrent_label_en-US" xlink:label="lab_us-gaap_AssetsCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Assets, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AssetsCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AssetsCurrent" xlink:to="lab_us-gaap_AssetsCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccountsReceivableMember_044ad3ca-7181-482f-a9fb-f487b970b9a6_terseLabel_en-US" xlink:label="lab_us-gaap_AccountsReceivableMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounts Receivable</link:label>
    <link:label id="lab_us-gaap_AccountsReceivableMember_label_en-US" xlink:label="lab_us-gaap_AccountsReceivableMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounts Receivable [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountsReceivableMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccountsReceivableMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccountsReceivableMember" xlink:to="lab_us-gaap_AccountsReceivableMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ConcentrationRiskTypeDomain_05b3614a-1aa8-46a8-be45-acc2950954e3_terseLabel_en-US" xlink:label="lab_us-gaap_ConcentrationRiskTypeDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Concentration Risk Type [Domain]</link:label>
    <link:label id="lab_us-gaap_ConcentrationRiskTypeDomain_label_en-US" xlink:label="lab_us-gaap_ConcentrationRiskTypeDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Concentration Risk Type [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskTypeDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ConcentrationRiskTypeDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ConcentrationRiskTypeDomain" xlink:to="lab_us-gaap_ConcentrationRiskTypeDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SaleOfStockNameOfTransactionDomain_ce73f363-f433-4e17-ad66-d7039c9032b8_terseLabel_en-US" xlink:label="lab_us-gaap_SaleOfStockNameOfTransactionDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Sale of Stock [Domain]</link:label>
    <link:label id="lab_us-gaap_SaleOfStockNameOfTransactionDomain_label_en-US" xlink:label="lab_us-gaap_SaleOfStockNameOfTransactionDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Sale of Stock [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SaleOfStockNameOfTransactionDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SaleOfStockNameOfTransactionDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SaleOfStockNameOfTransactionDomain" xlink:to="lab_us-gaap_SaleOfStockNameOfTransactionDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_WeightedAverageNumberOfSharesOutstandingDilutedDisclosureItemsAbstract_e82f6385-d6ec-4442-8a77-644180bb1760_terseLabel_en-US" xlink:label="lab_us-gaap_WeightedAverageNumberOfSharesOutstandingDilutedDisclosureItemsAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Diluted earnings (loss) per share computation</link:label>
    <link:label id="lab_us-gaap_WeightedAverageNumberOfSharesOutstandingDilutedDisclosureItemsAbstract_label_en-US" xlink:label="lab_us-gaap_WeightedAverageNumberOfSharesOutstandingDilutedDisclosureItemsAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Weighted Average Number of Shares Outstanding Reconciliation [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingDilutedDisclosureItemsAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_WeightedAverageNumberOfSharesOutstandingDilutedDisclosureItemsAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingDilutedDisclosureItemsAbstract" xlink:to="lab_us-gaap_WeightedAverageNumberOfSharesOutstandingDilutedDisclosureItemsAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_InventoryNet_ffd70f31-7703-4c84-bd43-d06669c95fa1_terseLabel_en-US" xlink:label="lab_us-gaap_InventoryNet" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Inventory, net</link:label>
    <link:label id="lab_us-gaap_InventoryNet_d8fdf626-cc4f-441f-a5ac-6584030ba811_totalLabel_en-US" xlink:label="lab_us-gaap_InventoryNet" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Inventory, net</link:label>
    <link:label id="lab_us-gaap_InventoryNet_label_en-US" xlink:label="lab_us-gaap_InventoryNet" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Inventory, Net</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryNet" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InventoryNet"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InventoryNet" xlink:to="lab_us-gaap_InventoryNet" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock_30d0ffd1-4b60-4d15-ad97-c40f7c137eaf_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Segment Data and Adjusted EBITDA</link:label>
    <link:label id="lab_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Segment Reporting Information, by Segment [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock" xlink:to="lab_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityFileNumber_8d343c39-365a-41ac-ab9a-e02a2ba95876_terseLabel_en-US" xlink:label="lab_dei_EntityFileNumber" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity File Number</link:label>
    <link:label id="lab_dei_EntityFileNumber_label_en-US" xlink:label="lab_dei_EntityFileNumber" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity File Number</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityFileNumber" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityFileNumber"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityFileNumber" xlink:to="lab_dei_EntityFileNumber" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_b91e4ce7-1478-4d60-9fe8-b01c6b5375ee_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]</link:label>
    <link:label id="lab_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_label_en-US" xlink:label="lab_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems" xlink:to="lab_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfVariableInterestEntitiesTable_318b7ca4-d5d1-4108-a39f-63d1fd9d4e95_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfVariableInterestEntitiesTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Variable Interest Entities [Table]</link:label>
    <link:label id="lab_us-gaap_ScheduleOfVariableInterestEntitiesTable_label_en-US" xlink:label="lab_us-gaap_ScheduleOfVariableInterestEntitiesTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Variable Interest Entities [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfVariableInterestEntitiesTable" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfVariableInterestEntitiesTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfVariableInterestEntitiesTable" xlink:to="lab_us-gaap_ScheduleOfVariableInterestEntitiesTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EquityMethodInvestmentsAndJointVenturesAbstract_7599db35-e906-4018-b96a-1fe114ea7fe9_terseLabel_en-US" xlink:label="lab_us-gaap_EquityMethodInvestmentsAndJointVenturesAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity Method Investments and Joint Ventures [Abstract]</link:label>
    <link:label id="lab_us-gaap_EquityMethodInvestmentsAndJointVenturesAbstract_label_en-US" xlink:label="lab_us-gaap_EquityMethodInvestmentsAndJointVenturesAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity Method Investments and Joint Ventures [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityMethodInvestmentsAndJointVenturesAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EquityMethodInvestmentsAndJointVenturesAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EquityMethodInvestmentsAndJointVenturesAbstract" xlink:to="lab_us-gaap_EquityMethodInvestmentsAndJointVenturesAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StatementOfFinancialPositionAbstract_bd42f289-f8fd-47fa-914f-555c66ce1342_terseLabel_en-US" xlink:label="lab_us-gaap_StatementOfFinancialPositionAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statement of Financial Position [Abstract]</link:label>
    <link:label id="lab_us-gaap_StatementOfFinancialPositionAbstract_label_en-US" xlink:label="lab_us-gaap_StatementOfFinancialPositionAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statement of Financial Position [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementOfFinancialPositionAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementOfFinancialPositionAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StatementOfFinancialPositionAbstract" xlink:to="lab_us-gaap_StatementOfFinancialPositionAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_cron_NumberOfContinentsWithInternationalProductionAndDistribution_ecbb2b07-662b-483d-9686-266999fadef0_terseLabel_en-US" xlink:label="lab_cron_NumberOfContinentsWithInternationalProductionAndDistribution" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Number of continents with international production and distribution</link:label>
    <link:label id="lab_cron_NumberOfContinentsWithInternationalProductionAndDistribution_label_en-US" xlink:label="lab_cron_NumberOfContinentsWithInternationalProductionAndDistribution" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Number Of Continents With International Production And Distribution</link:label>
    <link:label id="lab_cron_NumberOfContinentsWithInternationalProductionAndDistribution_documentation_en-US" xlink:label="lab_cron_NumberOfContinentsWithInternationalProductionAndDistribution" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Number Of Continents With International Production And Distribution</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_cron_NumberOfContinentsWithInternationalProductionAndDistribution" xlink:href="cron-20210630.xsd#cron_NumberOfContinentsWithInternationalProductionAndDistribution"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cron_NumberOfContinentsWithInternationalProductionAndDistribution" xlink:to="lab_cron_NumberOfContinentsWithInternationalProductionAndDistribution" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DerivativeLiabilityMeasurementInput_4e12a9db-50d3-437a-a517-4c54154d6c74_terseLabel_en-US" xlink:label="lab_us-gaap_DerivativeLiabilityMeasurementInput" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative liability, measurement input</link:label>
    <link:label id="lab_us-gaap_DerivativeLiabilityMeasurementInput_label_en-US" xlink:label="lab_us-gaap_DerivativeLiabilityMeasurementInput" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative Liability, Measurement Input</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeLiabilityMeasurementInput" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DerivativeLiabilityMeasurementInput"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DerivativeLiabilityMeasurementInput" xlink:to="lab_us-gaap_DerivativeLiabilityMeasurementInput" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_ProductOrServiceAxis_165d046b-f77b-4ec4-894e-6c1d439d3023_terseLabel_en-US" xlink:label="lab_srt_ProductOrServiceAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Product and Service [Axis]</link:label>
    <link:label id="lab_srt_ProductOrServiceAxis_label_en-US" xlink:label="lab_srt_ProductOrServiceAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Product and Service [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductOrServiceAxis" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_ProductOrServiceAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_ProductOrServiceAxis" xlink:to="lab_srt_ProductOrServiceAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityIncorporationStateCountryCode_c65f48e9-b248-48fb-b1a9-1817fe167bf7_terseLabel_en-US" xlink:label="lab_dei_EntityIncorporationStateCountryCode" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Incorporation, State or Country Code</link:label>
    <link:label id="lab_dei_EntityIncorporationStateCountryCode_label_en-US" xlink:label="lab_dei_EntityIncorporationStateCountryCode" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Incorporation, State or Country Code</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityIncorporationStateCountryCode" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityIncorporationStateCountryCode"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityIncorporationStateCountryCode" xlink:to="lab_dei_EntityIncorporationStateCountryCode" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DerivativeInstrumentsGainLossLineItems_63845be8-8fa4-43f2-9961-71a9173d243d_terseLabel_en-US" xlink:label="lab_us-gaap_DerivativeInstrumentsGainLossLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative Instruments, Gain (Loss) [Line Items]</link:label>
    <link:label id="lab_us-gaap_DerivativeInstrumentsGainLossLineItems_label_en-US" xlink:label="lab_us-gaap_DerivativeInstrumentsGainLossLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative Instruments, Gain (Loss) [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentsGainLossLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DerivativeInstrumentsGainLossLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossLineItems" xlink:to="lab_us-gaap_DerivativeInstrumentsGainLossLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntitySmallBusiness_f003e976-5426-4126-b979-1036d0bcb277_terseLabel_en-US" xlink:label="lab_dei_EntitySmallBusiness" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Small Business</link:label>
    <link:label id="lab_dei_EntitySmallBusiness_label_en-US" xlink:label="lab_dei_EntitySmallBusiness" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Small Business</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntitySmallBusiness" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntitySmallBusiness"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntitySmallBusiness" xlink:to="lab_dei_EntitySmallBusiness" xlink:type="arc" order="1"/>
    <link:label id="lab_cron_ClassOfWarrantOrRightNumberOfWarrantsIssued_48034cf2-2958-4c42-9e03-8690171b5291_terseLabel_en-US" xlink:label="lab_cron_ClassOfWarrantOrRightNumberOfWarrantsIssued" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Number of warrants issued</link:label>
    <link:label id="lab_cron_ClassOfWarrantOrRightNumberOfWarrantsIssued_label_en-US" xlink:label="lab_cron_ClassOfWarrantOrRightNumberOfWarrantsIssued" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Class Of Warrant Or Right, Number Of Warrants Issued</link:label>
    <link:label id="lab_cron_ClassOfWarrantOrRightNumberOfWarrantsIssued_documentation_en-US" xlink:label="lab_cron_ClassOfWarrantOrRightNumberOfWarrantsIssued" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Class Of Warrant Or Right, Number Of Warrants Issued</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_cron_ClassOfWarrantOrRightNumberOfWarrantsIssued" xlink:href="cron-20210630.xsd#cron_ClassOfWarrantOrRightNumberOfWarrantsIssued"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cron_ClassOfWarrantOrRightNumberOfWarrantsIssued" xlink:to="lab_cron_ClassOfWarrantOrRightNumberOfWarrantsIssued" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AdjustmentsForErrorCorrectionDomain_cdc895de-a7df-46a8-8e28-3847a0f5d240_terseLabel_en-US" xlink:label="lab_us-gaap_AdjustmentsForErrorCorrectionDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Error Correction, Type [Domain]</link:label>
    <link:label id="lab_us-gaap_AdjustmentsForErrorCorrectionDomain_label_en-US" xlink:label="lab_us-gaap_AdjustmentsForErrorCorrectionDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Error Correction, Type [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdjustmentsForErrorCorrectionDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AdjustmentsForErrorCorrectionDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AdjustmentsForErrorCorrectionDomain" xlink:to="lab_us-gaap_AdjustmentsForErrorCorrectionDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EquityComponentDomain_36246f81-87d9-43d9-8bc2-f11d8a10d85a_terseLabel_en-US" xlink:label="lab_us-gaap_EquityComponentDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity Component [Domain]</link:label>
    <link:label id="lab_us-gaap_EquityComponentDomain_label_en-US" xlink:label="lab_us-gaap_EquityComponentDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity Component [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityComponentDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EquityComponentDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EquityComponentDomain" xlink:to="lab_us-gaap_EquityComponentDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SellingAndMarketingExpense_61abf081-53d5-4d76-be6f-f41aaefa135a_terseLabel_en-US" xlink:label="lab_us-gaap_SellingAndMarketingExpense" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Sales and marketing</link:label>
    <link:label id="lab_us-gaap_SellingAndMarketingExpense_label_en-US" xlink:label="lab_us-gaap_SellingAndMarketingExpense" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Selling and Marketing Expense</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SellingAndMarketingExpense" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SellingAndMarketingExpense"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SellingAndMarketingExpense" xlink:to="lab_us-gaap_SellingAndMarketingExpense" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax_8d66c47d-64b0-4493-a306-41e512452e20_terseLabel_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Foreign exchange gain (loss) on translation</link:label>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax_48aec5ec-3da2-4af5-bdc9-b4788e065b73_verboseLabel_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Foreign exchange gain (loss) on translation</link:label>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax_label_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Comprehensive Income (Loss), Foreign Currency Transaction and Translation Adjustment, Net of Tax</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax" xlink:to="lab_us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain_1829e2c8-8ad3-492b-9ab4-e5d96454853d_terseLabel_en-US" xlink:label="lab_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disposal Group Name [Domain]</link:label>
    <link:label id="lab_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain_label_en-US" xlink:label="lab_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disposal Group Name [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain" xlink:to="lab_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfAccountsNotesLoansAndFinancingReceivableTable_f3e06c4b-73cd-459d-8171-926cba1ccaec_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfAccountsNotesLoansAndFinancingReceivableTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Accounts, Notes, Loans and Financing Receivable [Table]</link:label>
    <link:label id="lab_us-gaap_ScheduleOfAccountsNotesLoansAndFinancingReceivableTable_label_en-US" xlink:label="lab_us-gaap_ScheduleOfAccountsNotesLoansAndFinancingReceivableTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Accounts, Notes, Loans and Financing Receivable [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfAccountsNotesLoansAndFinancingReceivableTable" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfAccountsNotesLoansAndFinancingReceivableTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfAccountsNotesLoansAndFinancingReceivableTable" xlink:to="lab_us-gaap_ScheduleOfAccountsNotesLoansAndFinancingReceivableTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_VariableInterestEntityLineItems_447ec141-6e82-431e-b560-74be2cdcdc58_terseLabel_en-US" xlink:label="lab_us-gaap_VariableInterestEntityLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Variable Interest Entity [Line Items]</link:label>
    <link:label id="lab_us-gaap_VariableInterestEntityLineItems_label_en-US" xlink:label="lab_us-gaap_VariableInterestEntityLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Variable Interest Entity [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_VariableInterestEntityLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_VariableInterestEntityLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_VariableInterestEntityLineItems" xlink:to="lab_us-gaap_VariableInterestEntityLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfEquityMethodInvestmentsTable_0fee90f7-b18b-4656-8d2a-703f2334edfb_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfEquityMethodInvestmentsTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Equity Method Investments [Table]</link:label>
    <link:label id="lab_us-gaap_ScheduleOfEquityMethodInvestmentsTable_label_en-US" xlink:label="lab_us-gaap_ScheduleOfEquityMethodInvestmentsTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Equity Method Investments [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfEquityMethodInvestmentsTable" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfEquityMethodInvestmentsTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfEquityMethodInvestmentsTable" xlink:to="lab_us-gaap_ScheduleOfEquityMethodInvestmentsTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StatementLineItems_ce60d56b-9597-44e8-8f19-74819b0bbb8c_terseLabel_en-US" xlink:label="lab_us-gaap_StatementLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statement [Line Items]</link:label>
    <link:label id="lab_us-gaap_StatementLineItems_label_en-US" xlink:label="lab_us-gaap_StatementLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statement [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StatementLineItems" xlink:to="lab_us-gaap_StatementLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_LitigationCaseAxis_aa31828e-651f-4445-98ef-29e0db4bf97e_terseLabel_en-US" xlink:label="lab_srt_LitigationCaseAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Litigation Case [Axis]</link:label>
    <link:label id="lab_srt_LitigationCaseAxis_label_en-US" xlink:label="lab_srt_LitigationCaseAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Litigation Case [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_LitigationCaseAxis" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_LitigationCaseAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_LitigationCaseAxis" xlink:to="lab_srt_LitigationCaseAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward_215f7a87-2756-408b-ae12-a4963c498432_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Weighted average exercise price (C$)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Weighted Average Exercise Price [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueNetDerivativeAssetLiabilityMeasuredOnRecurringBasisUnobservableInputsReconciliationGainLossIncludedInOtherComprehensiveIncomeLoss_30b2ddfa-5f35-4f62-a9e5-f543ab00c0d4_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_FairValueNetDerivativeAssetLiabilityMeasuredOnRecurringBasisUnobservableInputsReconciliationGainLossIncludedInOtherComprehensiveIncomeLoss" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Foreign exchange effect</link:label>
    <link:label id="lab_us-gaap_FairValueNetDerivativeAssetLiabilityMeasuredOnRecurringBasisUnobservableInputsReconciliationGainLossIncludedInOtherComprehensiveIncomeLoss_label_en-US" xlink:label="lab_us-gaap_FairValueNetDerivativeAssetLiabilityMeasuredOnRecurringBasisUnobservableInputsReconciliationGainLossIncludedInOtherComprehensiveIncomeLoss" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value, Net Derivative Asset (Liability) Measured on Recurring Basis, Unobservable Inputs Reconciliation, Gain (Loss) Included in Other Comprehensive Income (Loss)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueNetDerivativeAssetLiabilityMeasuredOnRecurringBasisUnobservableInputsReconciliationGainLossIncludedInOtherComprehensiveIncomeLoss" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueNetDerivativeAssetLiabilityMeasuredOnRecurringBasisUnobservableInputsReconciliationGainLossIncludedInOtherComprehensiveIncomeLoss"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueNetDerivativeAssetLiabilityMeasuredOnRecurringBasisUnobservableInputsReconciliationGainLossIncludedInOtherComprehensiveIncomeLoss" xlink:to="lab_us-gaap_FairValueNetDerivativeAssetLiabilityMeasuredOnRecurringBasisUnobservableInputsReconciliationGainLossIncludedInOtherComprehensiveIncomeLoss" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DiscontinuedOperationIncomeLossFromDiscontinuedOperationDuringPhaseOutPeriodNetOfTax_8a5ecb7d-5493-4655-a69f-2dab7f3b7cfb_terseLabel_en-US" xlink:label="lab_us-gaap_DiscontinuedOperationIncomeLossFromDiscontinuedOperationDuringPhaseOutPeriodNetOfTax" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Loss from discontinued operations, net of income taxes</link:label>
    <link:label id="lab_us-gaap_DiscontinuedOperationIncomeLossFromDiscontinuedOperationDuringPhaseOutPeriodNetOfTax_label_en-US" xlink:label="lab_us-gaap_DiscontinuedOperationIncomeLossFromDiscontinuedOperationDuringPhaseOutPeriodNetOfTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Discontinued Operation, Income (Loss) from Discontinued Operation During Phase-out Period, Net of Tax</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DiscontinuedOperationIncomeLossFromDiscontinuedOperationDuringPhaseOutPeriodNetOfTax" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DiscontinuedOperationIncomeLossFromDiscontinuedOperationDuringPhaseOutPeriodNetOfTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DiscontinuedOperationIncomeLossFromDiscontinuedOperationDuringPhaseOutPeriodNetOfTax" xlink:to="lab_us-gaap_DiscontinuedOperationIncomeLossFromDiscontinuedOperationDuringPhaseOutPeriodNetOfTax" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LiabilitiesAbstract_464e9cae-f7de-4286-8baf-8bdcdfeb5ba5_terseLabel_en-US" xlink:label="lab_us-gaap_LiabilitiesAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Liabilities</link:label>
    <link:label id="lab_us-gaap_LiabilitiesAbstract_label_en-US" xlink:label="lab_us-gaap_LiabilitiesAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Liabilities [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LiabilitiesAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LiabilitiesAbstract" xlink:to="lab_us-gaap_LiabilitiesAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_cron_ClassOfWarrantOrRightMinimumOwnershipPercentageRequired_4be21f25-af8f-4a30-b548-8609db406e49_terseLabel_en-US" xlink:label="lab_cron_ClassOfWarrantOrRightMinimumOwnershipPercentageRequired" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Exercise rights, minimum ownership percentage</link:label>
    <link:label id="lab_cron_ClassOfWarrantOrRightMinimumOwnershipPercentageRequired_label_en-US" xlink:label="lab_cron_ClassOfWarrantOrRightMinimumOwnershipPercentageRequired" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Class Of Warrant Or Right, Minimum Ownership Percentage Required</link:label>
    <link:label id="lab_cron_ClassOfWarrantOrRightMinimumOwnershipPercentageRequired_documentation_en-US" xlink:label="lab_cron_ClassOfWarrantOrRightMinimumOwnershipPercentageRequired" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Class Of Warrant Or Right, Minimum Ownership Percentage Required</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_cron_ClassOfWarrantOrRightMinimumOwnershipPercentageRequired" xlink:href="cron-20210630.xsd#cron_ClassOfWarrantOrRightMinimumOwnershipPercentageRequired"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cron_ClassOfWarrantOrRightMinimumOwnershipPercentageRequired" xlink:to="lab_cron_ClassOfWarrantOrRightMinimumOwnershipPercentageRequired" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures_78ea2df5-8c60-4ddd-9112-202bf87db6b6_terseLabel_en-US" xlink:label="lab_us-gaap_StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restricted share units settled</link:label>
    <link:label id="lab_us-gaap_StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures_label_en-US" xlink:label="lab_us-gaap_StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stock Issued During Period, Value, Restricted Stock Award, Net of Forfeitures</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures" xlink:to="lab_us-gaap_StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AvailableForSaleSecuritiesDebtSecurities_587388eb-3dca-42c4-937b-b16fef2cf46d_terseLabel_en-US" xlink:label="lab_us-gaap_AvailableForSaleSecuritiesDebtSecurities" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Short-term investments</link:label>
    <link:label id="lab_us-gaap_AvailableForSaleSecuritiesDebtSecurities_label_en-US" xlink:label="lab_us-gaap_AvailableForSaleSecuritiesDebtSecurities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Securities, Available-for-sale</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleSecuritiesDebtSecurities" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AvailableForSaleSecuritiesDebtSecurities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AvailableForSaleSecuritiesDebtSecurities" xlink:to="lab_us-gaap_AvailableForSaleSecuritiesDebtSecurities" xlink:type="arc" order="1"/>
    <link:label id="lab_cron_USDistrictCourtOfEasternDistrictOfNewYorkVsCronosMember_4f110e40-433d-4b2f-a77d-ee9da956a921_terseLabel_en-US" xlink:label="lab_cron_USDistrictCourtOfEasternDistrictOfNewYorkVsCronosMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">U.S. District Court of Eastern District of New York Vs. Cronos</link:label>
    <link:label id="lab_cron_USDistrictCourtOfEasternDistrictOfNewYorkVsCronosMember_label_en-US" xlink:label="lab_cron_USDistrictCourtOfEasternDistrictOfNewYorkVsCronosMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">U.S. District Court of Eastern District of New York Vs. Cronos [Member]</link:label>
    <link:label id="lab_cron_USDistrictCourtOfEasternDistrictOfNewYorkVsCronosMember_documentation_en-US" xlink:label="lab_cron_USDistrictCourtOfEasternDistrictOfNewYorkVsCronosMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">U.S. District Court of Eastern District of New York Vs. Cronos</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_cron_USDistrictCourtOfEasternDistrictOfNewYorkVsCronosMember" xlink:href="cron-20210630.xsd#cron_USDistrictCourtOfEasternDistrictOfNewYorkVsCronosMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cron_USDistrictCourtOfEasternDistrictOfNewYorkVsCronosMember" xlink:to="lab_cron_USDistrictCourtOfEasternDistrictOfNewYorkVsCronosMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ProceedsFromSaleOfPropertyHeldForSale_9bd1f74a-8d58-420a-a8e0-986eaedbccb1_terseLabel_en-US" xlink:label="lab_us-gaap_ProceedsFromSaleOfPropertyHeldForSale" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Proceeds from sale of held-for-sale assets</link:label>
    <link:label id="lab_us-gaap_ProceedsFromSaleOfPropertyHeldForSale_label_en-US" xlink:label="lab_us-gaap_ProceedsFromSaleOfPropertyHeldForSale" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Proceeds from Sale of Property Held-for-sale</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromSaleOfPropertyHeldForSale" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ProceedsFromSaleOfPropertyHeldForSale"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ProceedsFromSaleOfPropertyHeldForSale" xlink:to="lab_us-gaap_ProceedsFromSaleOfPropertyHeldForSale" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_WeightedAverageMember_90dc4ade-a180-464f-9041-e17bd89a0d26_terseLabel_en-US" xlink:label="lab_srt_WeightedAverageMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Weighted Average</link:label>
    <link:label id="lab_srt_WeightedAverageMember_label_en-US" xlink:label="lab_srt_WeightedAverageMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Weighted Average [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_WeightedAverageMember" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_WeightedAverageMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_WeightedAverageMember" xlink:to="lab_srt_WeightedAverageMember" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityAddressStateOrProvince_8d44d50d-99a1-4f5d-9549-f6ec891b32af_terseLabel_en-US" xlink:label="lab_dei_EntityAddressStateOrProvince" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Address, State or Province</link:label>
    <link:label id="lab_dei_EntityAddressStateOrProvince_label_en-US" xlink:label="lab_dei_EntityAddressStateOrProvince" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Address, State or Province</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressStateOrProvince" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityAddressStateOrProvince"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityAddressStateOrProvince" xlink:to="lab_dei_EntityAddressStateOrProvince" xlink:type="arc" order="1"/>
    <link:label id="lab_cron_FourVendorsMember_77b3cec6-24b6-4ffe-8aec-1bd9560032d3_terseLabel_en-US" xlink:label="lab_cron_FourVendorsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Four Vendors</link:label>
    <link:label id="lab_cron_FourVendorsMember_label_en-US" xlink:label="lab_cron_FourVendorsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Four Vendors [Member]</link:label>
    <link:label id="lab_cron_FourVendorsMember_documentation_en-US" xlink:label="lab_cron_FourVendorsMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Four Vendors</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_cron_FourVendorsMember" xlink:href="cron-20210630.xsd#cron_FourVendorsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cron_FourVendorsMember" xlink:to="lab_cron_FourVendorsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PaymentsToAcquireMarketableSecurities_adb20542-a533-4ac1-8959-1d6576652e1a_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_PaymentsToAcquireMarketableSecurities" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Purchase of short-term investments</link:label>
    <link:label id="lab_us-gaap_PaymentsToAcquireMarketableSecurities_label_en-US" xlink:label="lab_us-gaap_PaymentsToAcquireMarketableSecurities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payments to Acquire Marketable Securities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquireMarketableSecurities" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PaymentsToAcquireMarketableSecurities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PaymentsToAcquireMarketableSecurities" xlink:to="lab_us-gaap_PaymentsToAcquireMarketableSecurities" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueInputsLevel2Member_425e73ee-24d2-4ee7-89de-b2fcd157966a_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueInputsLevel2Member" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Level 2</link:label>
    <link:label id="lab_us-gaap_FairValueInputsLevel2Member_label_en-US" xlink:label="lab_us-gaap_FairValueInputsLevel2Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value, Inputs, Level 2 [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueInputsLevel2Member" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueInputsLevel2Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueInputsLevel2Member" xlink:to="lab_us-gaap_FairValueInputsLevel2Member" xlink:type="arc" order="1"/>
    <link:label id="lab_cron_TopupRightsMember_2e80859a-3bdd-44dc-aefd-133054bc3343_verboseLabel_en-US" xlink:label="lab_cron_TopupRightsMember" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Top-up Rights</link:label>
    <link:label id="lab_cron_TopupRightsMember_label_en-US" xlink:label="lab_cron_TopupRightsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Top-up Rights [Member]</link:label>
    <link:label id="lab_cron_TopupRightsMember_documentation_en-US" xlink:label="lab_cron_TopupRightsMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Top-up Rights [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_cron_TopupRightsMember" xlink:href="cron-20210630.xsd#cron_TopupRightsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cron_TopupRightsMember" xlink:to="lab_cron_TopupRightsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_MeasurementInputExpectedDividendRateMember_1bef6120-2fb9-4046-a367-65c29adf54f0_terseLabel_en-US" xlink:label="lab_us-gaap_MeasurementInputExpectedDividendRateMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Expected dividend yield</link:label>
    <link:label id="lab_us-gaap_MeasurementInputExpectedDividendRateMember_label_en-US" xlink:label="lab_us-gaap_MeasurementInputExpectedDividendRateMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Measurement Input, Expected Dividend Rate [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MeasurementInputExpectedDividendRateMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_MeasurementInputExpectedDividendRateMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_MeasurementInputExpectedDividendRateMember" xlink:to="lab_us-gaap_MeasurementInputExpectedDividendRateMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CorporateNonSegmentMember_2b15927b-6065-4b45-b2be-dc16b96122fd_terseLabel_en-US" xlink:label="lab_us-gaap_CorporateNonSegmentMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Corporate Expenses</link:label>
    <link:label id="lab_us-gaap_CorporateNonSegmentMember_label_en-US" xlink:label="lab_us-gaap_CorporateNonSegmentMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Corporate, Non-Segment [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CorporateNonSegmentMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CorporateNonSegmentMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CorporateNonSegmentMember" xlink:to="lab_us-gaap_CorporateNonSegmentMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SegmentReportingAbstract_8a62c804-7883-4b91-887b-fb86eba7f7b0_terseLabel_en-US" xlink:label="lab_us-gaap_SegmentReportingAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Segment Reporting [Abstract]</link:label>
    <link:label id="lab_us-gaap_SegmentReportingAbstract_label_en-US" xlink:label="lab_us-gaap_SegmentReportingAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Segment Reporting [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentReportingAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SegmentReportingAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SegmentReportingAbstract" xlink:to="lab_us-gaap_SegmentReportingAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityDomain_d8a2c505-fd18-485e-940f-fc75dd119a68_terseLabel_en-US" xlink:label="lab_dei_EntityDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity [Domain]</link:label>
    <link:label id="lab_dei_EntityDomain_label_en-US" xlink:label="lab_dei_EntityDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityDomain" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityDomain" xlink:to="lab_dei_EntityDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_MajorCustomersAxis_bc33902e-82d6-4030-97a8-58d0f24bcd60_terseLabel_en-US" xlink:label="lab_srt_MajorCustomersAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Customer [Axis]</link:label>
    <link:label id="lab_srt_MajorCustomersAxis_label_en-US" xlink:label="lab_srt_MajorCustomersAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Customer [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MajorCustomersAxis" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_MajorCustomersAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_MajorCustomersAxis" xlink:to="lab_srt_MajorCustomersAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock_653b935e-8ca8-4c3a-893c-e5e668491548_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Earnings (Loss) Per Share</link:label>
    <link:label id="lab_us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Earnings Per Share, Basic and Diluted [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock" xlink:to="lab_us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross_dfbdee21-5bc0-49d8-8d60-e42d314d08fd_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Issuance of options (in shares)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Gross</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityShellCompany_b5dadf1b-bab3-49ef-9224-0e4f73b886e9_terseLabel_en-US" xlink:label="lab_dei_EntityShellCompany" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Shell Company</link:label>
    <link:label id="lab_dei_EntityShellCompany_label_en-US" xlink:label="lab_dei_EntityShellCompany" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Shell Company</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityShellCompany" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityShellCompany"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityShellCompany" xlink:to="lab_dei_EntityShellCompany" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_LocalPhoneNumber_a554c304-e807-4d8f-a578-a8a29fc99e65_terseLabel_en-US" xlink:label="lab_dei_LocalPhoneNumber" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Local Phone Number</link:label>
    <link:label id="lab_dei_LocalPhoneNumber_label_en-US" xlink:label="lab_dei_LocalPhoneNumber" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Local Phone Number</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_LocalPhoneNumber" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_LocalPhoneNumber"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_LocalPhoneNumber" xlink:to="lab_dei_LocalPhoneNumber" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock_ea4c7a7f-6c05-45bb-bf91-a91615829758_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Summary of Stock-based Compensation Expense</link:label>
    <link:label id="lab_us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Payment Arrangement, Expensed and Capitalized, Amount [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock" xlink:to="lab_us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_Assets_82a2e1f3-1855-48a2-8d0a-a36b3ac455c4_totalLabel_en-US" xlink:label="lab_us-gaap_Assets" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total assets</link:label>
    <link:label id="lab_us-gaap_Assets_104ece4b-f011-4295-8948-02b177ff6afe_terseLabel_en-US" xlink:label="lab_us-gaap_Assets" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total assets</link:label>
    <link:label id="lab_us-gaap_Assets_label_en-US" xlink:label="lab_us-gaap_Assets" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Assets</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Assets" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_Assets"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_Assets" xlink:to="lab_us-gaap_Assets" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_EquityMethodInvesteeNameDomain_bb26d90a-d5eb-4788-a600-8b8f103567fa_terseLabel_en-US" xlink:label="lab_srt_EquityMethodInvesteeNameDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Investment, Name [Domain]</link:label>
    <link:label id="lab_srt_EquityMethodInvesteeNameDomain_label_en-US" xlink:label="lab_srt_EquityMethodInvesteeNameDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Investment, Name [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_EquityMethodInvesteeNameDomain" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_EquityMethodInvesteeNameDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_EquityMethodInvesteeNameDomain" xlink:to="lab_srt_EquityMethodInvesteeNameDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PlanNameDomain_a3dba1e0-853b-40e8-9f82-a05b6be69e20_terseLabel_en-US" xlink:label="lab_us-gaap_PlanNameDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Plan Name [Domain]</link:label>
    <link:label id="lab_us-gaap_PlanNameDomain_label_en-US" xlink:label="lab_us-gaap_PlanNameDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Plan Name [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PlanNameDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PlanNameDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PlanNameDomain" xlink:to="lab_us-gaap_PlanNameDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageRemainingContractualTerm1_ed4517b1-033d-439c-97a5-3e04b7d15b3f_terseLabel_en-US" xlink:label="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageRemainingContractualTerm1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Exercisable</link:label>
    <link:label id="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageRemainingContractualTerm1_label_en-US" xlink:label="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageRemainingContractualTerm1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested and Expected to Vest, Exercisable, Weighted Average Remaining Contractual Term</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageRemainingContractualTerm1" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageRemainingContractualTerm1"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageRemainingContractualTerm1" xlink:to="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageRemainingContractualTerm1" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherLongTermInvestments_179e2ba5-8bb8-4c01-a60d-546e285db0a8_terseLabel_en-US" xlink:label="lab_us-gaap_OtherLongTermInvestments" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other investments</link:label>
    <link:label id="lab_us-gaap_OtherLongTermInvestments_label_en-US" xlink:label="lab_us-gaap_OtherLongTermInvestments" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Long-term Investments</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherLongTermInvestments" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherLongTermInvestments"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherLongTermInvestments" xlink:to="lab_us-gaap_OtherLongTermInvestments" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_InterestPaidNet_3cdf5114-fda4-4d2c-919f-6e3a2f1916c4_terseLabel_en-US" xlink:label="lab_us-gaap_InterestPaidNet" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Interest paid</link:label>
    <link:label id="lab_us-gaap_InterestPaidNet_label_en-US" xlink:label="lab_us-gaap_InterestPaidNet" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Interest Paid, Excluding Capitalized Interest, Operating Activities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestPaidNet" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InterestPaidNet"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InterestPaidNet" xlink:to="lab_us-gaap_InterestPaidNet" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_SegmentGeographicalDomain_59aff174-f910-41b7-804a-44f76ffd87e9_terseLabel_en-US" xlink:label="lab_srt_SegmentGeographicalDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Geographical [Domain]</link:label>
    <link:label id="lab_srt_SegmentGeographicalDomain_label_en-US" xlink:label="lab_srt_SegmentGeographicalDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Geographical [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_SegmentGeographicalDomain" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_SegmentGeographicalDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_SegmentGeographicalDomain" xlink:to="lab_srt_SegmentGeographicalDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_MeasurementInputSharePriceMember_82c32e4c-1e2e-4057-a800-90f65eab5888_terseLabel_en-US" xlink:label="lab_us-gaap_MeasurementInputSharePriceMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share price at valuation date</link:label>
    <link:label id="lab_us-gaap_MeasurementInputSharePriceMember_label_en-US" xlink:label="lab_us-gaap_MeasurementInputSharePriceMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Measurement Input, Share Price [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MeasurementInputSharePriceMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_MeasurementInputSharePriceMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_MeasurementInputSharePriceMember" xlink:to="lab_us-gaap_MeasurementInputSharePriceMember" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_ProductsAndServicesDomain_f07d99c5-3164-466f-8a3d-fc5e4f34a3dc_terseLabel_en-US" xlink:label="lab_srt_ProductsAndServicesDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Product and Service [Domain]</link:label>
    <link:label id="lab_srt_ProductsAndServicesDomain_label_en-US" xlink:label="lab_srt_ProductsAndServicesDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Product and Service [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductsAndServicesDomain" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_ProductsAndServicesDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_ProductsAndServicesDomain" xlink:to="lab_srt_ProductsAndServicesDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NoncontrollingInterestMember_823a48d2-38b8-4101-8962-ade48072532e_terseLabel_en-US" xlink:label="lab_us-gaap_NoncontrollingInterestMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Non-controlling interests</link:label>
    <link:label id="lab_us-gaap_NoncontrollingInterestMember_label_en-US" xlink:label="lab_us-gaap_NoncontrollingInterestMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Noncontrolling Interest [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NoncontrollingInterestMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NoncontrollingInterestMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NoncontrollingInterestMember" xlink:to="lab_us-gaap_NoncontrollingInterestMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ResearchAndDevelopmentExpense_aa205beb-6621-4242-a0bb-270c9ed5e7a7_terseLabel_en-US" xlink:label="lab_us-gaap_ResearchAndDevelopmentExpense" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Research and development (&#8220;R&amp;D&#8221;)</link:label>
    <link:label id="lab_us-gaap_ResearchAndDevelopmentExpense_label_en-US" xlink:label="lab_us-gaap_ResearchAndDevelopmentExpense" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Research and Development Expense</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ResearchAndDevelopmentExpense" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ResearchAndDevelopmentExpense"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ResearchAndDevelopmentExpense" xlink:to="lab_us-gaap_ResearchAndDevelopmentExpense" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccountsReceivableNoncurrentThresholdPeriodPastDueWriteoff_1e9e1e9f-e86c-4420-bb9b-5079dc2ef8eb_terseLabel_en-US" xlink:label="lab_us-gaap_AccountsReceivableNoncurrentThresholdPeriodPastDueWriteoff" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounts receivable, threshold period past due, writeoff</link:label>
    <link:label id="lab_us-gaap_AccountsReceivableNoncurrentThresholdPeriodPastDueWriteoff_label_en-US" xlink:label="lab_us-gaap_AccountsReceivableNoncurrentThresholdPeriodPastDueWriteoff" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounts Receivable, Noncurrent, Threshold Period Past Due, Writeoff</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountsReceivableNoncurrentThresholdPeriodPastDueWriteoff" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccountsReceivableNoncurrentThresholdPeriodPastDueWriteoff"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccountsReceivableNoncurrentThresholdPeriodPastDueWriteoff" xlink:to="lab_us-gaap_AccountsReceivableNoncurrentThresholdPeriodPastDueWriteoff" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DepreciationAndAmortization_dc803f83-b86e-4ce8-99db-df0fab754d18_terseLabel_en-US" xlink:label="lab_us-gaap_DepreciationAndAmortization" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Depreciation and amortization</link:label>
    <link:label id="lab_us-gaap_DepreciationAndAmortization_9a41127e-20a5-46ca-95c7-24bcd5534784_verboseLabel_en-US" xlink:label="lab_us-gaap_DepreciationAndAmortization" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Depreciation and amortization</link:label>
    <link:label id="lab_us-gaap_DepreciationAndAmortization_label_en-US" xlink:label="lab_us-gaap_DepreciationAndAmortization" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Depreciation, Depletion and Amortization, Nonproduction</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DepreciationAndAmortization" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DepreciationAndAmortization"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DepreciationAndAmortization" xlink:to="lab_us-gaap_DepreciationAndAmortization" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfAccountsNotesLoansAndFinancingReceivableTextBlock_4bf7ffb9-848b-4f66-aa0d-bc709f8cecca_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfAccountsNotesLoansAndFinancingReceivableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Loan Receivable</link:label>
    <link:label id="lab_us-gaap_ScheduleOfAccountsNotesLoansAndFinancingReceivableTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfAccountsNotesLoansAndFinancingReceivableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Accounts, Notes, Loans and Financing Receivable [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfAccountsNotesLoansAndFinancingReceivableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfAccountsNotesLoansAndFinancingReceivableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfAccountsNotesLoansAndFinancingReceivableTextBlock" xlink:to="lab_us-gaap_ScheduleOfAccountsNotesLoansAndFinancingReceivableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtInstrumentInterestRateStatedPercentage_6ef80b74-5ae7-49bd-a607-d25a29fb4c19_terseLabel_en-US" xlink:label="lab_us-gaap_DebtInstrumentInterestRateStatedPercentage" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Interest rate</link:label>
    <link:label id="lab_us-gaap_DebtInstrumentInterestRateStatedPercentage_label_en-US" xlink:label="lab_us-gaap_DebtInstrumentInterestRateStatedPercentage" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument, Interest Rate, Stated Percentage</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentInterestRateStatedPercentage" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentInterestRateStatedPercentage"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtInstrumentInterestRateStatedPercentage" xlink:to="lab_us-gaap_DebtInstrumentInterestRateStatedPercentage" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NetIncomeLossAttributableToNoncontrollingInterest_a026f1da-bda5-4c29-a106-adf6f0c2a7d1_terseLabel_en-US" xlink:label="lab_us-gaap_NetIncomeLossAttributableToNoncontrollingInterest" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net loss attributable to non-controlling interest</link:label>
    <link:label id="lab_us-gaap_NetIncomeLossAttributableToNoncontrollingInterest_label_en-US" xlink:label="lab_us-gaap_NetIncomeLossAttributableToNoncontrollingInterest" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net Income (Loss) Attributable to Noncontrolling Interest</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLossAttributableToNoncontrollingInterest" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetIncomeLossAttributableToNoncontrollingInterest"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NetIncomeLossAttributableToNoncontrollingInterest" xlink:to="lab_us-gaap_NetIncomeLossAttributableToNoncontrollingInterest" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_d7e1efcc-f4b0-468a-bea4-ac0d8950f419_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_cron_LoanReceivableNameAxis_295b7cd5-09ab-45cc-8497-e8b659872dc3_terseLabel_en-US" xlink:label="lab_cron_LoanReceivableNameAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Loan Receivable, Name [Axis]</link:label>
    <link:label id="lab_cron_LoanReceivableNameAxis_label_en-US" xlink:label="lab_cron_LoanReceivableNameAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Loan Receivable, Name [Axis]</link:label>
    <link:label id="lab_cron_LoanReceivableNameAxis_documentation_en-US" xlink:label="lab_cron_LoanReceivableNameAxis" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Loan Receivable, Name [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_cron_LoanReceivableNameAxis" xlink:href="cron-20210630.xsd#cron_LoanReceivableNameAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cron_LoanReceivableNameAxis" xlink:to="lab_cron_LoanReceivableNameAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueByMeasurementFrequencyAxis_56256141-ea23-4d1d-be3e-7b482d4a494b_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueByMeasurementFrequencyAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Measurement Frequency [Axis]</link:label>
    <link:label id="lab_us-gaap_FairValueByMeasurementFrequencyAxis_label_en-US" xlink:label="lab_us-gaap_FairValueByMeasurementFrequencyAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Measurement Frequency [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueByMeasurementFrequencyAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueByMeasurementFrequencyAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueByMeasurementFrequencyAxis" xlink:to="lab_us-gaap_FairValueByMeasurementFrequencyAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInOperatingActivities_e2dd964a-589c-4305-8b57-fb9ac83216f5_totalLabel_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash flows used in operating activities</link:label>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInOperatingActivities_label_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net Cash Provided by (Used in) Operating Activities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:to="lab_us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EarningsPerShareDilutedLineItems_54fc534e-b080-4051-b214-f503489d9efb_terseLabel_en-US" xlink:label="lab_us-gaap_EarningsPerShareDilutedLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Earnings Per Share, Diluted, by Common Class, Including Two Class Method [Line Items]</link:label>
    <link:label id="lab_us-gaap_EarningsPerShareDilutedLineItems_label_en-US" xlink:label="lab_us-gaap_EarningsPerShareDilutedLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Earnings Per Share, Diluted, by Common Class, Including Two Class Method [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareDilutedLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EarningsPerShareDilutedLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EarningsPerShareDilutedLineItems" xlink:to="lab_us-gaap_EarningsPerShareDilutedLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccountsNotesAndLoansReceivableLineItems_65bf10e0-d184-4eeb-b744-8b74939c38e7_terseLabel_en-US" xlink:label="lab_us-gaap_AccountsNotesAndLoansReceivableLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounts, Notes, Loans and Financing Receivable [Line Items]</link:label>
    <link:label id="lab_us-gaap_AccountsNotesAndLoansReceivableLineItems_label_en-US" xlink:label="lab_us-gaap_AccountsNotesAndLoansReceivableLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounts, Notes, Loans and Financing Receivable [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountsNotesAndLoansReceivableLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccountsNotesAndLoansReceivableLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccountsNotesAndLoansReceivableLineItems" xlink:to="lab_us-gaap_AccountsNotesAndLoansReceivableLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LitigationStatusAxis_87b3d54b-3b67-4b25-b2b4-c468463e3fa1_terseLabel_en-US" xlink:label="lab_us-gaap_LitigationStatusAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Litigation Status [Axis]</link:label>
    <link:label id="lab_us-gaap_LitigationStatusAxis_label_en-US" xlink:label="lab_us-gaap_LitigationStatusAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Litigation Status [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LitigationStatusAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LitigationStatusAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LitigationStatusAxis" xlink:to="lab_us-gaap_LitigationStatusAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_acc7e715-51c4-4677-a30c-e471bfe250f1_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value, Recurring and Nonrecurring [Table]</link:label>
    <link:label id="lab_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_label_en-US" xlink:label="lab_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value, Recurring and Nonrecurring [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable" xlink:to="lab_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NetIncomeLossFromDiscontinuedOperationsAvailableToCommonShareholdersBasic_9cc5a0a4-20a1-4a3a-85b3-1810c77ff841_terseLabel_en-US" xlink:label="lab_us-gaap_NetIncomeLossFromDiscontinuedOperationsAvailableToCommonShareholdersBasic" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Loss from discontinued operations attributable to the shareholders of Cronos Group</link:label>
    <link:label id="lab_us-gaap_NetIncomeLossFromDiscontinuedOperationsAvailableToCommonShareholdersBasic_label_en-US" xlink:label="lab_us-gaap_NetIncomeLossFromDiscontinuedOperationsAvailableToCommonShareholdersBasic" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net Income (Loss) from Discontinued Operations Available to Common Shareholders, Basic</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLossFromDiscontinuedOperationsAvailableToCommonShareholdersBasic" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetIncomeLossFromDiscontinuedOperationsAvailableToCommonShareholdersBasic"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NetIncomeLossFromDiscontinuedOperationsAvailableToCommonShareholdersBasic" xlink:to="lab_us-gaap_NetIncomeLossFromDiscontinuedOperationsAvailableToCommonShareholdersBasic" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherReceivablesNetCurrent_331c8123-4a8c-4dc9-9121-7b27c8facf5b_terseLabel_en-US" xlink:label="lab_us-gaap_OtherReceivablesNetCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other receivables</link:label>
    <link:label id="lab_us-gaap_OtherReceivablesNetCurrent_label_en-US" xlink:label="lab_us-gaap_OtherReceivablesNetCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Receivables, Net, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherReceivablesNetCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherReceivablesNetCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherReceivablesNetCurrent" xlink:to="lab_us-gaap_OtherReceivablesNetCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_StatementGeographicalAxis_bca30ef6-81b6-4e5e-a658-b1c3af898a8b_terseLabel_en-US" xlink:label="lab_srt_StatementGeographicalAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Geographical [Axis]</link:label>
    <link:label id="lab_srt_StatementGeographicalAxis_label_en-US" xlink:label="lab_srt_StatementGeographicalAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Geographical [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_StatementGeographicalAxis" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_StatementGeographicalAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_StatementGeographicalAxis" xlink:to="lab_srt_StatementGeographicalAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_4ae71918-51c2-4c86-9254-a2e09f3ed628_verboseLabel_en-US" xlink:label="lab_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Basic (in shares)</link:label>
    <link:label id="lab_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_0e326318-b717-489e-9d7d-f64ff3f507df_terseLabel_en-US" xlink:label="lab_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Weighted average number of common shares outstanding (in shares)</link:label>
    <link:label id="lab_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_label_en-US" xlink:label="lab_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Weighted Average Number of Shares Outstanding, Basic</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_WeightedAverageNumberOfSharesOutstandingBasic"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic" xlink:to="lab_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SegmentDomain_86eabace-5b49-422b-9ed5-713530916c7d_terseLabel_en-US" xlink:label="lab_us-gaap_SegmentDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Segments [Domain]</link:label>
    <link:label id="lab_us-gaap_SegmentDomain_label_en-US" xlink:label="lab_us-gaap_SegmentDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Segments [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SegmentDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SegmentDomain" xlink:to="lab_us-gaap_SegmentDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OperatingLeaseRightOfUseAssetAmortizationExpense_c5764e65-cea9-49fa-882c-a6aa039dd2b7_terseLabel_en-US" xlink:label="lab_us-gaap_OperatingLeaseRightOfUseAssetAmortizationExpense" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Impairment loss on long-lived assets</link:label>
    <link:label id="lab_us-gaap_OperatingLeaseRightOfUseAssetAmortizationExpense_label_en-US" xlink:label="lab_us-gaap_OperatingLeaseRightOfUseAssetAmortizationExpense" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Lease, Right-of-Use Asset, Amortization Expense</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseRightOfUseAssetAmortizationExpense" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingLeaseRightOfUseAssetAmortizationExpense"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OperatingLeaseRightOfUseAssetAmortizationExpense" xlink:to="lab_us-gaap_OperatingLeaseRightOfUseAssetAmortizationExpense" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SaleOfStockPricePerShare_40d14239-1707-4bef-84db-020d82cd7aea_terseLabel_en-US" xlink:label="lab_us-gaap_SaleOfStockPricePerShare" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Sale of stock, price per share (in dollars per share)</link:label>
    <link:label id="lab_us-gaap_SaleOfStockPricePerShare_label_en-US" xlink:label="lab_us-gaap_SaleOfStockPricePerShare" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Sale of Stock, Price Per Share</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SaleOfStockPricePerShare" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SaleOfStockPricePerShare"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SaleOfStockPricePerShare" xlink:to="lab_us-gaap_SaleOfStockPricePerShare" xlink:type="arc" order="1"/>
    <link:label id="lab_cron_InvestmentsInAndAdvancesToAffiliatesAtFairValueAdvancesRepayments_22beba15-a368-4956-8e7e-87b9b07dee52_verboseLabel_en-US" xlink:label="lab_cron_InvestmentsInAndAdvancesToAffiliatesAtFairValueAdvancesRepayments" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Advances to affiliates</link:label>
    <link:label id="lab_cron_InvestmentsInAndAdvancesToAffiliatesAtFairValueAdvancesRepayments_label_en-US" xlink:label="lab_cron_InvestmentsInAndAdvancesToAffiliatesAtFairValueAdvancesRepayments" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Investments In And Advances To Affiliates, At Fair Value, Advances (Repayments)</link:label>
    <link:label id="lab_cron_InvestmentsInAndAdvancesToAffiliatesAtFairValueAdvancesRepayments_documentation_en-US" xlink:label="lab_cron_InvestmentsInAndAdvancesToAffiliatesAtFairValueAdvancesRepayments" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Investments In And Advances To Affiliates, At Fair Value, Advances (Repayments)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_cron_InvestmentsInAndAdvancesToAffiliatesAtFairValueAdvancesRepayments" xlink:href="cron-20210630.xsd#cron_InvestmentsInAndAdvancesToAffiliatesAtFairValueAdvancesRepayments"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cron_InvestmentsInAndAdvancesToAffiliatesAtFairValueAdvancesRepayments" xlink:to="lab_cron_InvestmentsInAndAdvancesToAffiliatesAtFairValueAdvancesRepayments" xlink:type="arc" order="1"/>
    <link:label id="lab_cron_LoanReceivableNameDomain_5fee1894-03cf-4e1c-a95d-d6a28da18d37_terseLabel_en-US" xlink:label="lab_cron_LoanReceivableNameDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Loan Receivable, Name [Domain]</link:label>
    <link:label id="lab_cron_LoanReceivableNameDomain_label_en-US" xlink:label="lab_cron_LoanReceivableNameDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Loan Receivable, Name [Domain]</link:label>
    <link:label id="lab_cron_LoanReceivableNameDomain_documentation_en-US" xlink:label="lab_cron_LoanReceivableNameDomain" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">[Domain] for Loan Receivable, Name [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_cron_LoanReceivableNameDomain" xlink:href="cron-20210630.xsd#cron_LoanReceivableNameDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cron_LoanReceivableNameDomain" xlink:to="lab_cron_LoanReceivableNameDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeTaxesPaidNet_d7a02640-929b-462a-8e37-334714906997_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeTaxesPaidNet" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income taxes paid</link:label>
    <link:label id="lab_us-gaap_IncomeTaxesPaidNet_label_en-US" xlink:label="lab_us-gaap_IncomeTaxesPaidNet" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Taxes Paid, Net</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxesPaidNet" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeTaxesPaidNet"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeTaxesPaidNet" xlink:to="lab_us-gaap_IncomeTaxesPaidNet" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedGoodsAndNonemployeeServicesTransactionSupplierDomain_3b594443-6d51-45eb-9e65-20a1b0422c21_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedGoodsAndNonemployeeServicesTransactionSupplierDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Supplier [Domain]</link:label>
    <link:label id="lab_us-gaap_ShareBasedGoodsAndNonemployeeServicesTransactionSupplierDomain_label_en-US" xlink:label="lab_us-gaap_ShareBasedGoodsAndNonemployeeServicesTransactionSupplierDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Supplier [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedGoodsAndNonemployeeServicesTransactionSupplierDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedGoodsAndNonemployeeServicesTransactionSupplierDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedGoodsAndNonemployeeServicesTransactionSupplierDomain" xlink:to="lab_us-gaap_ShareBasedGoodsAndNonemployeeServicesTransactionSupplierDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NetIncomeLossFromContinuingOperationsAvailableToCommonShareholdersBasic_7ba58dfd-5cba-4aed-b336-345818dba870_terseLabel_en-US" xlink:label="lab_us-gaap_NetIncomeLossFromContinuingOperationsAvailableToCommonShareholdersBasic" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net income (loss) from continuing operations attributable to the shareholders of Cronos&#160;Group</link:label>
    <link:label id="lab_us-gaap_NetIncomeLossFromContinuingOperationsAvailableToCommonShareholdersBasic_50f06d53-f834-4936-8c25-1d70010e50ae_verboseLabel_en-US" xlink:label="lab_us-gaap_NetIncomeLossFromContinuingOperationsAvailableToCommonShareholdersBasic" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net income (loss) used in the computation of basic earnings (loss) from continuing operations per share</link:label>
    <link:label id="lab_us-gaap_NetIncomeLossFromContinuingOperationsAvailableToCommonShareholdersBasic_label_en-US" xlink:label="lab_us-gaap_NetIncomeLossFromContinuingOperationsAvailableToCommonShareholdersBasic" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net Income (Loss) from Continuing Operations Available to Common Shareholders, Basic</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLossFromContinuingOperationsAvailableToCommonShareholdersBasic" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetIncomeLossFromContinuingOperationsAvailableToCommonShareholdersBasic"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NetIncomeLossFromContinuingOperationsAvailableToCommonShareholdersBasic" xlink:to="lab_us-gaap_NetIncomeLossFromContinuingOperationsAvailableToCommonShareholdersBasic" xlink:type="arc" order="1"/>
    <link:label id="lab_cron_ShareBasedPaymentArrangementLiabilitiesSettled_52cd3fb4-3578-4a25-8a18-e84bb0488c65_negatedTerseLabel_en-US" xlink:label="lab_cron_ShareBasedPaymentArrangementLiabilitiesSettled" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">DSU liabilities settled</link:label>
    <link:label id="lab_cron_ShareBasedPaymentArrangementLiabilitiesSettled_label_en-US" xlink:label="lab_cron_ShareBasedPaymentArrangementLiabilitiesSettled" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Payment Arrangement, Liabilities Settled</link:label>
    <link:label id="lab_cron_ShareBasedPaymentArrangementLiabilitiesSettled_documentation_en-US" xlink:label="lab_cron_ShareBasedPaymentArrangementLiabilitiesSettled" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Payment Arrangement, Liabilities Settled</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_cron_ShareBasedPaymentArrangementLiabilitiesSettled" xlink:href="cron-20210630.xsd#cron_ShareBasedPaymentArrangementLiabilitiesSettled"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cron_ShareBasedPaymentArrangementLiabilitiesSettled" xlink:to="lab_cron_ShareBasedPaymentArrangementLiabilitiesSettled" xlink:type="arc" order="1"/>
    <link:label id="lab_cron_FinancingReceivableBeforeAccruedInterestCurrent_cc58f684-9114-4de5-9f53-8fdc46bb90b3_terseLabel_en-US" xlink:label="lab_cron_FinancingReceivableBeforeAccruedInterestCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Current portion of loans receivable, before accrued interest</link:label>
    <link:label id="lab_cron_FinancingReceivableBeforeAccruedInterestCurrent_label_en-US" xlink:label="lab_cron_FinancingReceivableBeforeAccruedInterestCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Financing Receivable, Before Accrued Interest, Current</link:label>
    <link:label id="lab_cron_FinancingReceivableBeforeAccruedInterestCurrent_documentation_en-US" xlink:label="lab_cron_FinancingReceivableBeforeAccruedInterestCurrent" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Financing Receivable, Before Accrued Interest, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_cron_FinancingReceivableBeforeAccruedInterestCurrent" xlink:href="cron-20210630.xsd#cron_FinancingReceivableBeforeAccruedInterestCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cron_FinancingReceivableBeforeAccruedInterestCurrent" xlink:to="lab_cron_FinancingReceivableBeforeAccruedInterestCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ComprehensiveIncomeNetOfTax_dfdaa0a1-263e-423c-85d5-4cb4d6174b20_totalLabel_en-US" xlink:label="lab_us-gaap_ComprehensiveIncomeNetOfTax" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cronos Group</link:label>
    <link:label id="lab_us-gaap_ComprehensiveIncomeNetOfTax_label_en-US" xlink:label="lab_us-gaap_ComprehensiveIncomeNetOfTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Comprehensive Income (Loss), Net of Tax, Attributable to Parent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ComprehensiveIncomeNetOfTax" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ComprehensiveIncomeNetOfTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ComprehensiveIncomeNetOfTax" xlink:to="lab_us-gaap_ComprehensiveIncomeNetOfTax" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IntangibleAssetsNetExcludingGoodwill_f9ad6626-7833-4b64-ad6e-5391a349ca6e_terseLabel_en-US" xlink:label="lab_us-gaap_IntangibleAssetsNetExcludingGoodwill" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Intangible assets, net</link:label>
    <link:label id="lab_us-gaap_IntangibleAssetsNetExcludingGoodwill_label_en-US" xlink:label="lab_us-gaap_IntangibleAssetsNetExcludingGoodwill" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Intangible Assets, Net (Excluding Goodwill)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IntangibleAssetsNetExcludingGoodwill" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IntangibleAssetsNetExcludingGoodwill"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IntangibleAssetsNetExcludingGoodwill" xlink:to="lab_us-gaap_IntangibleAssetsNetExcludingGoodwill" xlink:type="arc" order="1"/>
    <link:label id="lab_cron_SensitivityAnalysisOfCarryingValueNetAssetsImpactOf10PercentChangeInExchangeRate_63459123-fa1f-4871-83ef-798bd725758c_terseLabel_en-US" xlink:label="lab_cron_SensitivityAnalysisOfCarryingValueNetAssetsImpactOf10PercentChangeInExchangeRate" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Impact of ten percent change in exchange rate</link:label>
    <link:label id="lab_cron_SensitivityAnalysisOfCarryingValueNetAssetsImpactOf10PercentChangeInExchangeRate_label_en-US" xlink:label="lab_cron_SensitivityAnalysisOfCarryingValueNetAssetsImpactOf10PercentChangeInExchangeRate" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Sensitivity Analysis Of Carrying Value, Net Assets, Impact Of 10 Percent Change In Exchange Rate</link:label>
    <link:label id="lab_cron_SensitivityAnalysisOfCarryingValueNetAssetsImpactOf10PercentChangeInExchangeRate_documentation_en-US" xlink:label="lab_cron_SensitivityAnalysisOfCarryingValueNetAssetsImpactOf10PercentChangeInExchangeRate" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Sensitivity Analysis Of Carrying Value, Net Assets, Impact Of 10 Percent Change In Exchange Rate</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_cron_SensitivityAnalysisOfCarryingValueNetAssetsImpactOf10PercentChangeInExchangeRate" xlink:href="cron-20210630.xsd#cron_SensitivityAnalysisOfCarryingValueNetAssetsImpactOf10PercentChangeInExchangeRate"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cron_SensitivityAnalysisOfCarryingValueNetAssetsImpactOf10PercentChangeInExchangeRate" xlink:to="lab_cron_SensitivityAnalysisOfCarryingValueNetAssetsImpactOf10PercentChangeInExchangeRate" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInFinancingActivities_02415e49-10e3-46c7-bb85-d63c419dc838_totalLabel_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInFinancingActivities" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash flows provided by (used in) financing activities</link:label>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInFinancingActivities_label_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInFinancingActivities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net Cash Provided by (Used in) Financing Activities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities" xlink:to="lab_us-gaap_NetCashProvidedByUsedInFinancingActivities" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract_5e387e06-e485-407a-b9e4-4295ae345b81_terseLabel_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other comprehensive income (loss)</link:label>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract_label_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Comprehensive Income (Loss), Net of Tax [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract" xlink:to="lab_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationOtherLongtermIncentivePlansRequisiteServicePeriodRecognition_7c5fdda6-ffce-4b92-bad4-4bbb1a9af3f9_terseLabel_en-US" xlink:label="lab_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationOtherLongtermIncentivePlansRequisiteServicePeriodRecognition" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Vesting of common shares issued in connection with the use of certain publicity rights in brand development</link:label>
    <link:label id="lab_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationOtherLongtermIncentivePlansRequisiteServicePeriodRecognition_label_en-US" xlink:label="lab_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationOtherLongtermIncentivePlansRequisiteServicePeriodRecognition" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">APIC, Share-based Payment Arrangement, Other, Increase for Cost Recognition</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationOtherLongtermIncentivePlansRequisiteServicePeriodRecognition" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationOtherLongtermIncentivePlansRequisiteServicePeriodRecognition"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationOtherLongtermIncentivePlansRequisiteServicePeriodRecognition" xlink:to="lab_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationOtherLongtermIncentivePlansRequisiteServicePeriodRecognition" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1_a303d987-1cce-45e7-bb73-73417ead7277_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Vesting period</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Award Vesting Period</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeLossFromEquityMethodInvestments_fd8a442a-b5b2-441f-bc08-52cd2d83153a_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeLossFromEquityMethodInvestments" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share of loss from equity accounted investments</link:label>
    <link:label id="lab_us-gaap_IncomeLossFromEquityMethodInvestments_3734f018-35ac-4569-bb65-92c643cca7cd_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_IncomeLossFromEquityMethodInvestments" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share of loss from investments in equity accounted investees</link:label>
    <link:label id="lab_us-gaap_IncomeLossFromEquityMethodInvestments_65d170bf-4654-4846-b8ee-753109ce9193_verboseLabel_en-US" xlink:label="lab_us-gaap_IncomeLossFromEquityMethodInvestments" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share of loss from investments in equity accounted investees</link:label>
    <link:label id="lab_us-gaap_IncomeLossFromEquityMethodInvestments_83fe1db4-a624-4641-b20e-b54a8c73563b_negatedLabel_en-US" xlink:label="lab_us-gaap_IncomeLossFromEquityMethodInvestments" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share of loss from equity accounted investments</link:label>
    <link:label id="lab_us-gaap_IncomeLossFromEquityMethodInvestments_label_en-US" xlink:label="lab_us-gaap_IncomeLossFromEquityMethodInvestments" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income (Loss) from Equity Method Investments</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromEquityMethodInvestments" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeLossFromEquityMethodInvestments"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeLossFromEquityMethodInvestments" xlink:to="lab_us-gaap_IncomeLossFromEquityMethodInvestments" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeLossFromContinuingOperationsPerBasicShare_be38ebb6-cdac-4233-93cc-108eebff2649_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeLossFromContinuingOperationsPerBasicShare" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Basic - continuing operations (in dollars per share)</link:label>
    <link:label id="lab_us-gaap_IncomeLossFromContinuingOperationsPerBasicShare_38931543-0da9-4f0c-8cf0-821268b59853_verboseLabel_en-US" xlink:label="lab_us-gaap_IncomeLossFromContinuingOperationsPerBasicShare" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Basic earnings (loss) from continuing operations per share (in dollars per share)</link:label>
    <link:label id="lab_us-gaap_IncomeLossFromContinuingOperationsPerBasicShare_label_en-US" xlink:label="lab_us-gaap_IncomeLossFromContinuingOperationsPerBasicShare" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income (Loss) from Continuing Operations, Per Basic Share</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromContinuingOperationsPerBasicShare" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeLossFromContinuingOperationsPerBasicShare"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeLossFromContinuingOperationsPerBasicShare" xlink:to="lab_us-gaap_IncomeLossFromContinuingOperationsPerBasicShare" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTax_b52e99a1-5dc0-4dc6-a9cb-cd131afe2826_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTax" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Loss from discontinued operations</link:label>
    <link:label id="lab_us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTax_7f2cc2cc-b063-4bee-8d52-49f16ae15577_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTax" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Loss from discontinued operations</link:label>
    <link:label id="lab_us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTax_label_en-US" xlink:label="lab_us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income (Loss) from Discontinued Operations, Net of Tax, Including Portion Attributable to Noncontrolling Interest</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTax" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTax" xlink:to="lab_us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTax" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RestructuringCharges_5c51ea4c-71bf-4a41-83f8-705f8a70219d_terseLabel_en-US" xlink:label="lab_us-gaap_RestructuringCharges" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Transaction costs</link:label>
    <link:label id="lab_us-gaap_RestructuringCharges_label_en-US" xlink:label="lab_us-gaap_RestructuringCharges" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restructuring Charges</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringCharges" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RestructuringCharges"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RestructuringCharges" xlink:to="lab_us-gaap_RestructuringCharges" xlink:type="arc" order="1"/>
    <link:label id="lab_cron_AltriaInvestmentMember_8a77bcbe-a9bf-4fbd-b96a-fb050dd89104_terseLabel_en-US" xlink:label="lab_cron_AltriaInvestmentMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Altria Investment</link:label>
    <link:label id="lab_cron_AltriaInvestmentMember_label_en-US" xlink:label="lab_cron_AltriaInvestmentMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Altria Investment [Member]</link:label>
    <link:label id="lab_cron_AltriaInvestmentMember_documentation_en-US" xlink:label="lab_cron_AltriaInvestmentMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Altria Investment [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_cron_AltriaInvestmentMember" xlink:href="cron-20210630.xsd#cron_AltriaInvestmentMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cron_AltriaInvestmentMember" xlink:to="lab_cron_AltriaInvestmentMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ConcentrationRiskByTypeAxis_37adf35d-62d1-465c-8383-46f91a113cfe_terseLabel_en-US" xlink:label="lab_us-gaap_ConcentrationRiskByTypeAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Concentration Risk Type [Axis]</link:label>
    <link:label id="lab_us-gaap_ConcentrationRiskByTypeAxis_label_en-US" xlink:label="lab_us-gaap_ConcentrationRiskByTypeAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Concentration Risk Type [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskByTypeAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ConcentrationRiskByTypeAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ConcentrationRiskByTypeAxis" xlink:to="lab_us-gaap_ConcentrationRiskByTypeAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DepreciationDepletionAndAmortization_a772ed1d-799a-454c-b263-1f2280b4ba27_verboseLabel_en-US" xlink:label="lab_us-gaap_DepreciationDepletionAndAmortization" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Depreciation and amortization</link:label>
    <link:label id="lab_us-gaap_DepreciationDepletionAndAmortization_bb74f81d-763e-419c-b980-91f13791c339_terseLabel_en-US" xlink:label="lab_us-gaap_DepreciationDepletionAndAmortization" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Depreciation and amortization</link:label>
    <link:label id="lab_us-gaap_DepreciationDepletionAndAmortization_label_en-US" xlink:label="lab_us-gaap_DepreciationDepletionAndAmortization" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Depreciation, Depletion and Amortization</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DepreciationDepletionAndAmortization" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DepreciationDepletionAndAmortization"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DepreciationDepletionAndAmortization" xlink:to="lab_us-gaap_DepreciationDepletionAndAmortization" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock_2af843d7-2ff6-4e88-ad14-793e9987faf0_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Fair Value of Assets Measured on Recurring Basis</link:label>
    <link:label id="lab_us-gaap_ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Fair Value, Assets and Liabilities Measured on Recurring Basis [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock" xlink:to="lab_us-gaap_ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfVariableInterestEntitiesTextBlock_4364ee9f-cc11-48e7-8945-f016ac022262_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfVariableInterestEntitiesTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Variable Interest Entities</link:label>
    <link:label id="lab_us-gaap_ScheduleOfVariableInterestEntitiesTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfVariableInterestEntitiesTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Variable Interest Entities [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfVariableInterestEntitiesTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfVariableInterestEntitiesTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfVariableInterestEntitiesTextBlock" xlink:to="lab_us-gaap_ScheduleOfVariableInterestEntitiesTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccumulatedOtherComprehensiveIncomeMember_2c9684cf-412b-422a-b694-b9693be3ecb0_terseLabel_en-US" xlink:label="lab_us-gaap_AccumulatedOtherComprehensiveIncomeMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accumulated other comprehensive income (loss)</link:label>
    <link:label id="lab_us-gaap_AccumulatedOtherComprehensiveIncomeMember_label_en-US" xlink:label="lab_us-gaap_AccumulatedOtherComprehensiveIncomeMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">AOCI Attributable to Parent [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccumulatedOtherComprehensiveIncomeMember" xlink:to="lab_us-gaap_AccumulatedOtherComprehensiveIncomeMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncreaseDecreaseInInventories_90be9ae8-0a63-44cb-ada2-374c08c47fca_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInInventories" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Inventory, net</link:label>
    <link:label id="lab_us-gaap_IncreaseDecreaseInInventories_label_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInInventories" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Increase (Decrease) in Inventories</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInInventories" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncreaseDecreaseInInventories"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncreaseDecreaseInInventories" xlink:to="lab_us-gaap_IncreaseDecreaseInInventories" xlink:type="arc" order="1"/>
    <link:label id="lab_cron_StockIssuedDuringPeriodValueTopupRightsExercised_5dec7a3f-8573-4b3c-b904-ec2cca6d5828_terseLabel_en-US" xlink:label="lab_cron_StockIssuedDuringPeriodValueTopupRightsExercised" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Top-up rights exercised</link:label>
    <link:label id="lab_cron_StockIssuedDuringPeriodValueTopupRightsExercised_label_en-US" xlink:label="lab_cron_StockIssuedDuringPeriodValueTopupRightsExercised" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stock Issued During Period, Value, Top-up Rights Exercised</link:label>
    <link:label id="lab_cron_StockIssuedDuringPeriodValueTopupRightsExercised_documentation_en-US" xlink:label="lab_cron_StockIssuedDuringPeriodValueTopupRightsExercised" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stock Issued During Period, Value, Top-up Rights Exercised</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_cron_StockIssuedDuringPeriodValueTopupRightsExercised" xlink:href="cron-20210630.xsd#cron_StockIssuedDuringPeriodValueTopupRightsExercised"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cron_StockIssuedDuringPeriodValueTopupRightsExercised" xlink:to="lab_cron_StockIssuedDuringPeriodValueTopupRightsExercised" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CommonStockSharesOutstanding_20a885c8-dc6a-4f39-a20f-da5da1f19acd_periodStartLabel_en-US" xlink:label="lab_us-gaap_CommonStockSharesOutstanding" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Beginning balance (in shares)</link:label>
    <link:label id="lab_us-gaap_CommonStockSharesOutstanding_c08c47f8-a0d6-4466-bc27-646231261577_periodEndLabel_en-US" xlink:label="lab_us-gaap_CommonStockSharesOutstanding" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Ending balance (in shares)</link:label>
    <link:label id="lab_us-gaap_CommonStockSharesOutstanding_label_en-US" xlink:label="lab_us-gaap_CommonStockSharesOutstanding" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common Stock, Shares, Outstanding</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockSharesOutstanding" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommonStockSharesOutstanding"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CommonStockSharesOutstanding" xlink:to="lab_us-gaap_CommonStockSharesOutstanding" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_UnfavorableRegulatoryActionMember_3219fcef-a642-451b-bfb9-742413e4c681_terseLabel_en-US" xlink:label="lab_us-gaap_UnfavorableRegulatoryActionMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Litigation Relating to Marketing, Distribution and Sale of Products</link:label>
    <link:label id="lab_us-gaap_UnfavorableRegulatoryActionMember_label_en-US" xlink:label="lab_us-gaap_UnfavorableRegulatoryActionMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Unfavorable Regulatory Action [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UnfavorableRegulatoryActionMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_UnfavorableRegulatoryActionMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_UnfavorableRegulatoryActionMember" xlink:to="lab_us-gaap_UnfavorableRegulatoryActionMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SupplierConcentrationRiskMember_4bab7a9f-9943-42f9-83a5-5a90ddc17c43_terseLabel_en-US" xlink:label="lab_us-gaap_SupplierConcentrationRiskMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Supplier Concentration Risk</link:label>
    <link:label id="lab_us-gaap_SupplierConcentrationRiskMember_label_en-US" xlink:label="lab_us-gaap_SupplierConcentrationRiskMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Supplier Concentration Risk [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SupplierConcentrationRiskMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SupplierConcentrationRiskMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SupplierConcentrationRiskMember" xlink:to="lab_us-gaap_SupplierConcentrationRiskMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DerivativeTable_a8dcf1bc-7a17-4bf5-a01e-e4dad458838e_terseLabel_en-US" xlink:label="lab_us-gaap_DerivativeTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative [Table]</link:label>
    <link:label id="lab_us-gaap_DerivativeTable_label_en-US" xlink:label="lab_us-gaap_DerivativeTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeTable" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DerivativeTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DerivativeTable" xlink:to="lab_us-gaap_DerivativeTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SaleOfStockPercentageOfOwnershipAfterTransaction_a04edfd8-f27b-4f7f-a0b8-e57812127110_terseLabel_en-US" xlink:label="lab_us-gaap_SaleOfStockPercentageOfOwnershipAfterTransaction" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Sale of stock, percentage of ownership after transaction</link:label>
    <link:label id="lab_us-gaap_SaleOfStockPercentageOfOwnershipAfterTransaction_label_en-US" xlink:label="lab_us-gaap_SaleOfStockPercentageOfOwnershipAfterTransaction" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Sale of Stock, Percentage of Ownership after Transaction</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SaleOfStockPercentageOfOwnershipAfterTransaction" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SaleOfStockPercentageOfOwnershipAfterTransaction"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SaleOfStockPercentageOfOwnershipAfterTransaction" xlink:to="lab_us-gaap_SaleOfStockPercentageOfOwnershipAfterTransaction" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StockIssuedDuringPeriodSharesRestrictedStockAwardNetOfForfeitures_a5a97910-1de6-4473-a785-5823d0745be9_terseLabel_en-US" xlink:label="lab_us-gaap_StockIssuedDuringPeriodSharesRestrictedStockAwardNetOfForfeitures" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restricted share units settled (in shares)</link:label>
    <link:label id="lab_us-gaap_StockIssuedDuringPeriodSharesRestrictedStockAwardNetOfForfeitures_label_en-US" xlink:label="lab_us-gaap_StockIssuedDuringPeriodSharesRestrictedStockAwardNetOfForfeitures" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stock Issued During Period, Shares, Restricted Stock Award, Net of Forfeitures</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodSharesRestrictedStockAwardNetOfForfeitures" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockIssuedDuringPeriodSharesRestrictedStockAwardNetOfForfeitures"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockIssuedDuringPeriodSharesRestrictedStockAwardNetOfForfeitures" xlink:to="lab_us-gaap_StockIssuedDuringPeriodSharesRestrictedStockAwardNetOfForfeitures" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PaymentsToAcquireIntangibleAssets_71b630e0-894b-4ad3-bafa-16185bcc9e10_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_PaymentsToAcquireIntangibleAssets" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Purchase of intangible assets</link:label>
    <link:label id="lab_us-gaap_PaymentsToAcquireIntangibleAssets_label_en-US" xlink:label="lab_us-gaap_PaymentsToAcquireIntangibleAssets" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payments to Acquire Intangible Assets</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquireIntangibleAssets" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PaymentsToAcquireIntangibleAssets"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PaymentsToAcquireIntangibleAssets" xlink:to="lab_us-gaap_PaymentsToAcquireIntangibleAssets" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ConcentrationRiskBenchmarkDomain_aac33399-e8d9-451a-82fd-b098d7fd53f8_terseLabel_en-US" xlink:label="lab_us-gaap_ConcentrationRiskBenchmarkDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Concentration Risk Benchmark [Domain]</link:label>
    <link:label id="lab_us-gaap_ConcentrationRiskBenchmarkDomain_label_en-US" xlink:label="lab_us-gaap_ConcentrationRiskBenchmarkDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Concentration Risk Benchmark [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskBenchmarkDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ConcentrationRiskBenchmarkDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ConcentrationRiskBenchmarkDomain" xlink:to="lab_us-gaap_ConcentrationRiskBenchmarkDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems_4cfbf155-6990-4060-97bf-5ab6a8e6b6d3_terseLabel_en-US" xlink:label="lab_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]</link:label>
    <link:label id="lab_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems_label_en-US" xlink:label="lab_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems" xlink:to="lab_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_cron_SensitivityAnalysisImpactOnNetIncomeLossTableTextBlock_6fcbeedf-b342-4941-8d2f-4ba1c364fa5c_terseLabel_en-US" xlink:label="lab_cron_SensitivityAnalysisImpactOnNetIncomeLossTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Sensitivity Analysis</link:label>
    <link:label id="lab_cron_SensitivityAnalysisImpactOnNetIncomeLossTableTextBlock_label_en-US" xlink:label="lab_cron_SensitivityAnalysisImpactOnNetIncomeLossTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Sensitivity Analysis, Impact On Net Income (Loss) [Table Text Block]</link:label>
    <link:label id="lab_cron_SensitivityAnalysisImpactOnNetIncomeLossTableTextBlock_documentation_en-US" xlink:label="lab_cron_SensitivityAnalysisImpactOnNetIncomeLossTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Sensitivity Analysis, Impact On Net Income (Loss) [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_cron_SensitivityAnalysisImpactOnNetIncomeLossTableTextBlock" xlink:href="cron-20210630.xsd#cron_SensitivityAnalysisImpactOnNetIncomeLossTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cron_SensitivityAnalysisImpactOnNetIncomeLossTableTextBlock" xlink:to="lab_cron_SensitivityAnalysisImpactOnNetIncomeLossTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ProductAndServiceOtherMember_d5d3a5fd-a82a-4722-b1b6-9617ef528a89_terseLabel_en-US" xlink:label="lab_us-gaap_ProductAndServiceOtherMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other</link:label>
    <link:label id="lab_us-gaap_ProductAndServiceOtherMember_label_en-US" xlink:label="lab_us-gaap_ProductAndServiceOtherMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Product and Service, Other [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProductAndServiceOtherMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ProductAndServiceOtherMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ProductAndServiceOtherMember" xlink:to="lab_us-gaap_ProductAndServiceOtherMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward_2dbab288-4b9f-46ed-b03c-804a168f6c55_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Number of options</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding [Roll Forward]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_ConsolidatedEntitiesDomain_039fce11-8388-4eb2-baf9-ad9a1cf3691f_terseLabel_en-US" xlink:label="lab_srt_ConsolidatedEntitiesDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Consolidated Entities [Domain]</link:label>
    <link:label id="lab_srt_ConsolidatedEntitiesDomain_label_en-US" xlink:label="lab_srt_ConsolidatedEntitiesDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Consolidated Entities [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ConsolidatedEntitiesDomain" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_ConsolidatedEntitiesDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_ConsolidatedEntitiesDomain" xlink:to="lab_srt_ConsolidatedEntitiesDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems_4889e2d7-c43c-48cd-b47c-e7989a74b19b_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Statement, Balance Sheet and Additional Disclosures by Disposal Groups, Including Discontinued Operations [Line Items]</link:label>
    <link:label id="lab_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems_label_en-US" xlink:label="lab_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Statement, Balance Sheet and Additional Disclosures by Disposal Groups, Including Discontinued Operations [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems" xlink:to="lab_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfEarningsPerShareDilutedByCommonClassTable_f9be911a-d9d2-4f60-b1db-c7efb53cdf2c_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfEarningsPerShareDilutedByCommonClassTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Earnings Per Share, Diluted, by Common Class, Including Two Class Method [Table]</link:label>
    <link:label id="lab_us-gaap_ScheduleOfEarningsPerShareDilutedByCommonClassTable_label_en-US" xlink:label="lab_us-gaap_ScheduleOfEarningsPerShareDilutedByCommonClassTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Earnings Per Share, Diluted, by Common Class, Including Two Class Method [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfEarningsPerShareDilutedByCommonClassTable" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfEarningsPerShareDilutedByCommonClassTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfEarningsPerShareDilutedByCommonClassTable" xlink:to="lab_us-gaap_ScheduleOfEarningsPerShareDilutedByCommonClassTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterestAbstract_4c7a75c5-b242-4ea3-986e-475310b58f59_terseLabel_en-US" xlink:label="lab_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterestAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stockholders' Equity, Including Portion Attributable to Noncontrolling Interest [Abstract]</link:label>
    <link:label id="lab_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterestAbstract_label_en-US" xlink:label="lab_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterestAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stockholders' Equity, Including Portion Attributable to Noncontrolling Interest [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterestAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterestAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterestAbstract" xlink:to="lab_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterestAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_cron_VariableInterestEntityQualitativeOrQuantitativeInformationLicenseTerm_f1c6999f-f01c-4449-a2bd-75bf851bfb17_terseLabel_en-US" xlink:label="lab_cron_VariableInterestEntityQualitativeOrQuantitativeInformationLicenseTerm" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">License term</link:label>
    <link:label id="lab_cron_VariableInterestEntityQualitativeOrQuantitativeInformationLicenseTerm_label_en-US" xlink:label="lab_cron_VariableInterestEntityQualitativeOrQuantitativeInformationLicenseTerm" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Variable Interest Entity, Qualitative Or Quantitative Information, License Term</link:label>
    <link:label id="lab_cron_VariableInterestEntityQualitativeOrQuantitativeInformationLicenseTerm_documentation_en-US" xlink:label="lab_cron_VariableInterestEntityQualitativeOrQuantitativeInformationLicenseTerm" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Variable Interest Entity, Qualitative Or Quantitative Information, License Term</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_cron_VariableInterestEntityQualitativeOrQuantitativeInformationLicenseTerm" xlink:href="cron-20210630.xsd#cron_VariableInterestEntityQualitativeOrQuantitativeInformationLicenseTerm"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cron_VariableInterestEntityQualitativeOrQuantitativeInformationLicenseTerm" xlink:to="lab_cron_VariableInterestEntityQualitativeOrQuantitativeInformationLicenseTerm" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DisposalGroupHeldforsaleNotDiscontinuedOperationsMember_6e5bd7f3-bee6-4e4a-a0e3-7a2ca7183263_terseLabel_en-US" xlink:label="lab_us-gaap_DisposalGroupHeldforsaleNotDiscontinuedOperationsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disposal Group, Held-for-sale, Not Discontinued Operations</link:label>
    <link:label id="lab_us-gaap_DisposalGroupHeldforsaleNotDiscontinuedOperationsMember_label_en-US" xlink:label="lab_us-gaap_DisposalGroupHeldforsaleNotDiscontinuedOperationsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disposal Group, Held-for-sale, Not Discontinued Operations [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupHeldforsaleNotDiscontinuedOperationsMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DisposalGroupHeldforsaleNotDiscontinuedOperationsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DisposalGroupHeldforsaleNotDiscontinuedOperationsMember" xlink:to="lab_us-gaap_DisposalGroupHeldforsaleNotDiscontinuedOperationsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AssetImpairmentChargesTextBlock_d63f1828-f37c-41fc-8c1f-6dbc87dfe64a_terseLabel_en-US" xlink:label="lab_us-gaap_AssetImpairmentChargesTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Impairment Loss on Long-Lived Assets</link:label>
    <link:label id="lab_us-gaap_AssetImpairmentChargesTextBlock_label_en-US" xlink:label="lab_us-gaap_AssetImpairmentChargesTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Asset Impairment Charges [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetImpairmentChargesTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AssetImpairmentChargesTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AssetImpairmentChargesTextBlock" xlink:to="lab_us-gaap_AssetImpairmentChargesTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ConcentrationRiskDisclosureTextBlock_53dc658c-1e0e-4ff3-b144-4d03b73b7ca1_terseLabel_en-US" xlink:label="lab_us-gaap_ConcentrationRiskDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Financial Instruments</link:label>
    <link:label id="lab_us-gaap_ConcentrationRiskDisclosureTextBlock_label_en-US" xlink:label="lab_us-gaap_ConcentrationRiskDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Concentration Risk Disclosure [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskDisclosureTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ConcentrationRiskDisclosureTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ConcentrationRiskDisclosureTextBlock" xlink:to="lab_us-gaap_ConcentrationRiskDisclosureTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LossContingenciesLineItems_07e656dc-f152-487f-aab9-08ef62c171d2_terseLabel_en-US" xlink:label="lab_us-gaap_LossContingenciesLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Loss Contingencies [Line Items]</link:label>
    <link:label id="lab_us-gaap_LossContingenciesLineItems_label_en-US" xlink:label="lab_us-gaap_LossContingenciesLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Loss Contingencies [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LossContingenciesLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LossContingenciesLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LossContingenciesLineItems" xlink:to="lab_us-gaap_LossContingenciesLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentNet_9de241ea-2d58-4317-b6c9-6fc21e268f73_verboseLabel_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentNet" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Property, plant and equipment, net</link:label>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentNet_label_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentNet" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Property, Plant and Equipment, Net</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentNet" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PropertyPlantAndEquipmentNet"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentNet" xlink:to="lab_us-gaap_PropertyPlantAndEquipmentNet" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OperatingExpenses_9fefcd4b-0e15-42e7-adb2-4f6911a80672_totalLabel_en-US" xlink:label="lab_us-gaap_OperatingExpenses" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total operating expenses</link:label>
    <link:label id="lab_us-gaap_OperatingExpenses_label_en-US" xlink:label="lab_us-gaap_OperatingExpenses" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Expenses</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingExpenses" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingExpenses"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OperatingExpenses" xlink:to="lab_us-gaap_OperatingExpenses" xlink:type="arc" order="1"/>
    <link:label id="lab_cron_OneVendorMember_85e2ae3e-3204-47e2-bdce-e48b4593064d_terseLabel_en-US" xlink:label="lab_cron_OneVendorMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">One Vendor</link:label>
    <link:label id="lab_cron_OneVendorMember_label_en-US" xlink:label="lab_cron_OneVendorMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">One Vendor [Member]</link:label>
    <link:label id="lab_cron_OneVendorMember_documentation_en-US" xlink:label="lab_cron_OneVendorMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">One Vendor</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_cron_OneVendorMember" xlink:href="cron-20210630.xsd#cron_OneVendorMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cron_OneVendorMember" xlink:to="lab_cron_OneVendorMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTable_5e37d2e9-9bc7-4d51-92f1-a3684ddac418_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Payment Arrangement, Expensed and Capitalized, Amount [Table]</link:label>
    <link:label id="lab_us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTable_label_en-US" xlink:label="lab_us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Payment Arrangement, Expensed and Capitalized, Amount [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTable" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTable" xlink:to="lab_us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EarningsPerShareAbstract_b0a1ef7b-0d51-440a-bdf6-a797c8e8ccff_terseLabel_en-US" xlink:label="lab_us-gaap_EarningsPerShareAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Earnings Per Share [Abstract]</link:label>
    <link:label id="lab_us-gaap_EarningsPerShareAbstract_label_en-US" xlink:label="lab_us-gaap_EarningsPerShareAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Earnings Per Share [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EarningsPerShareAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EarningsPerShareAbstract" xlink:to="lab_us-gaap_EarningsPerShareAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccountsPayableMember_c9a6f0c2-fc7c-4704-ab11-305605987e14_terseLabel_en-US" xlink:label="lab_us-gaap_AccountsPayableMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounts Payable</link:label>
    <link:label id="lab_us-gaap_AccountsPayableMember_label_en-US" xlink:label="lab_us-gaap_AccountsPayableMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounts Payable [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountsPayableMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccountsPayableMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccountsPayableMember" xlink:to="lab_us-gaap_AccountsPayableMember" xlink:type="arc" order="1"/>
    <link:label id="lab_cron_SensitivityAnalysisImpactOf10PercentDecreaseIncreaseInWeightedAverageExpectedLifeOnNetIncomeLoss_93c73eb0-5a50-43b8-ac06-e99de95cc422_terseLabel_en-US" xlink:label="lab_cron_SensitivityAnalysisImpactOf10PercentDecreaseIncreaseInWeightedAverageExpectedLifeOnNetIncomeLoss" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Weighted average expected life</link:label>
    <link:label id="lab_cron_SensitivityAnalysisImpactOf10PercentDecreaseIncreaseInWeightedAverageExpectedLifeOnNetIncomeLoss_label_en-US" xlink:label="lab_cron_SensitivityAnalysisImpactOf10PercentDecreaseIncreaseInWeightedAverageExpectedLifeOnNetIncomeLoss" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Sensitivity Analysis, Impact Of 10 Percent Decrease (Increase) In Weighted Average Expected Life On Net Income (Loss)</link:label>
    <link:label id="lab_cron_SensitivityAnalysisImpactOf10PercentDecreaseIncreaseInWeightedAverageExpectedLifeOnNetIncomeLoss_documentation_en-US" xlink:label="lab_cron_SensitivityAnalysisImpactOf10PercentDecreaseIncreaseInWeightedAverageExpectedLifeOnNetIncomeLoss" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Sensitivity Analysis, Impact Of 10 Percent Decrease (Increase) In Weighted Average Expected Life On Net Income (Loss)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_cron_SensitivityAnalysisImpactOf10PercentDecreaseIncreaseInWeightedAverageExpectedLifeOnNetIncomeLoss" xlink:href="cron-20210630.xsd#cron_SensitivityAnalysisImpactOf10PercentDecreaseIncreaseInWeightedAverageExpectedLifeOnNetIncomeLoss"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cron_SensitivityAnalysisImpactOf10PercentDecreaseIncreaseInWeightedAverageExpectedLifeOnNetIncomeLoss" xlink:to="lab_cron_SensitivityAnalysisImpactOf10PercentDecreaseIncreaseInWeightedAverageExpectedLifeOnNetIncomeLoss" xlink:type="arc" order="1"/>
    <link:label id="lab_cron_FourMajorCustomersMember_4d713994-01cc-4e5c-aa5b-06d18fa8a5e0_terseLabel_en-US" xlink:label="lab_cron_FourMajorCustomersMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Four Major Customers</link:label>
    <link:label id="lab_cron_FourMajorCustomersMember_label_en-US" xlink:label="lab_cron_FourMajorCustomersMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Four Major Customers [Member]</link:label>
    <link:label id="lab_cron_FourMajorCustomersMember_documentation_en-US" xlink:label="lab_cron_FourMajorCustomersMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Four Major Customers</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_cron_FourMajorCustomersMember" xlink:href="cron-20210630.xsd#cron_FourMajorCustomersMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cron_FourMajorCustomersMember" xlink:to="lab_cron_FourMajorCustomersMember" xlink:type="arc" order="1"/>
    <link:label id="lab_cron_StockIssuedDuringPeriodValueWarrantsExercised_ac13eac0-575d-4b1d-9686-953f3e786c3f_terseLabel_en-US" xlink:label="lab_cron_StockIssuedDuringPeriodValueWarrantsExercised" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Warrants exercised</link:label>
    <link:label id="lab_cron_StockIssuedDuringPeriodValueWarrantsExercised_label_en-US" xlink:label="lab_cron_StockIssuedDuringPeriodValueWarrantsExercised" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stock Issued During Period, Value, Warrants Exercised</link:label>
    <link:label id="lab_cron_StockIssuedDuringPeriodValueWarrantsExercised_documentation_en-US" xlink:label="lab_cron_StockIssuedDuringPeriodValueWarrantsExercised" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stock Issued During Period, Value, Warrants Exercised</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_cron_StockIssuedDuringPeriodValueWarrantsExercised" xlink:href="cron-20210630.xsd#cron_StockIssuedDuringPeriodValueWarrantsExercised"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cron_StockIssuedDuringPeriodValueWarrantsExercised" xlink:to="lab_cron_StockIssuedDuringPeriodValueWarrantsExercised" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RevenueFromContractWithCustomerMember_fa99527c-6ec0-45a8-b90b-6eaa063c27bb_terseLabel_en-US" xlink:label="lab_us-gaap_RevenueFromContractWithCustomerMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revenue Benchmark</link:label>
    <link:label id="lab_us-gaap_RevenueFromContractWithCustomerMember_label_en-US" xlink:label="lab_us-gaap_RevenueFromContractWithCustomerMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revenue from Contract with Customer Benchmark [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RevenueFromContractWithCustomerMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RevenueFromContractWithCustomerMember" xlink:to="lab_us-gaap_RevenueFromContractWithCustomerMember" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_DocumentQuarterlyReport_6ed39c6e-97de-4a99-9b28-9ba146e2e5a4_terseLabel_en-US" xlink:label="lab_dei_DocumentQuarterlyReport" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Quarterly Report</link:label>
    <link:label id="lab_dei_DocumentQuarterlyReport_label_en-US" xlink:label="lab_dei_DocumentQuarterlyReport" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Quarterly Report</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentQuarterlyReport" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_DocumentQuarterlyReport"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_DocumentQuarterlyReport" xlink:to="lab_dei_DocumentQuarterlyReport" xlink:type="arc" order="1"/>
    <link:label id="lab_cron_OtherCountriesMember_64a67b68-cd13-4eca-93e0-32ade2e89ad5_terseLabel_en-US" xlink:label="lab_cron_OtherCountriesMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other countries</link:label>
    <link:label id="lab_cron_OtherCountriesMember_label_en-US" xlink:label="lab_cron_OtherCountriesMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Countries [Member]</link:label>
    <link:label id="lab_cron_OtherCountriesMember_documentation_en-US" xlink:label="lab_cron_OtherCountriesMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Countries [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_cron_OtherCountriesMember" xlink:href="cron-20210630.xsd#cron_OtherCountriesMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cron_OtherCountriesMember" xlink:to="lab_cron_OtherCountriesMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_74a64a82-c4f6-4dea-a9bc-c95eef5e2dec_terseLabel_en-US" xlink:label="lab_us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Exercise price (in dollars per share)</link:label>
    <link:label id="lab_us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_label_en-US" xlink:label="lab_us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Class of Warrant or Right, Exercise Price of Warrants or Rights</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1" xlink:to="lab_us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTaxPerBasicShare_55d3a2f3-1f51-4b73-aadc-309d6e1ce2db_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTaxPerBasicShare" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Basic earnings from discontinued operations per share (in dollars per share)</link:label>
    <link:label id="lab_us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTaxPerBasicShare_label_en-US" xlink:label="lab_us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTaxPerBasicShare" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income (Loss) from Discontinued Operations and Disposal of Discontinued Operations, Net of Tax, Per Basic Share</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTaxPerBasicShare" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTaxPerBasicShare"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTaxPerBasicShare" xlink:to="lab_us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTaxPerBasicShare" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_WarrantMember_a26711c0-e6fc-4991-a00b-45c8bf5811b8_terseLabel_en-US" xlink:label="lab_us-gaap_WarrantMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Warrants</link:label>
    <link:label id="lab_us-gaap_WarrantMember_label_en-US" xlink:label="lab_us-gaap_WarrantMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Warrant [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WarrantMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_WarrantMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_WarrantMember" xlink:to="lab_us-gaap_WarrantMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_469e5b02-80e0-4650-95e1-45d782a3b67f_periodStartLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Balance at beginning of period (in dollars per share)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_7de8f2e1-c7df-4320-bc13-834a2660423b_periodEndLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Balance at end of period (in dollars per share)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Weighted Average Exercise Price</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityCommonStockSharesOutstanding_6832cb37-9c5b-4b3e-8693-0dc76d6cea27_terseLabel_en-US" xlink:label="lab_dei_EntityCommonStockSharesOutstanding" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Common Stock, Shares Outstanding (in shares)</link:label>
    <link:label id="lab_dei_EntityCommonStockSharesOutstanding_label_en-US" xlink:label="lab_dei_EntityCommonStockSharesOutstanding" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Common Stock, Shares Outstanding</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityCommonStockSharesOutstanding" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityCommonStockSharesOutstanding"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityCommonStockSharesOutstanding" xlink:to="lab_dei_EntityCommonStockSharesOutstanding" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AllocatedShareBasedCompensationExpense_6defab3f-4d2e-4a46-ae48-93cc7fc4761c_terseLabel_en-US" xlink:label="lab_us-gaap_AllocatedShareBasedCompensationExpense" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based payments</link:label>
    <link:label id="lab_us-gaap_AllocatedShareBasedCompensationExpense_label_en-US" xlink:label="lab_us-gaap_AllocatedShareBasedCompensationExpense" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Payment Arrangement, Expense</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AllocatedShareBasedCompensationExpense" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AllocatedShareBasedCompensationExpense"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AllocatedShareBasedCompensationExpense" xlink:to="lab_us-gaap_AllocatedShareBasedCompensationExpense" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfEquityMethodInvestmentsLineItems_b1148eda-ad24-4b13-ba06-c553059e4b4c_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfEquityMethodInvestmentsLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Equity Method Investments [Line Items]</link:label>
    <link:label id="lab_us-gaap_ScheduleOfEquityMethodInvestmentsLineItems_label_en-US" xlink:label="lab_us-gaap_ScheduleOfEquityMethodInvestmentsLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Equity Method Investments [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfEquityMethodInvestmentsLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfEquityMethodInvestmentsLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfEquityMethodInvestmentsLineItems" xlink:to="lab_us-gaap_ScheduleOfEquityMethodInvestmentsLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_cron_ErrorRelatedToExerciseOfTopUpRightsMember_f41d10c2-0cae-43c7-892c-c029ae532010_terseLabel_en-US" xlink:label="lab_cron_ErrorRelatedToExerciseOfTopUpRightsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Error Related to Exercise of Top-up Rights</link:label>
    <link:label id="lab_cron_ErrorRelatedToExerciseOfTopUpRightsMember_label_en-US" xlink:label="lab_cron_ErrorRelatedToExerciseOfTopUpRightsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Error Related To Exercise Of Top-Up Rights [Member]</link:label>
    <link:label id="lab_cron_ErrorRelatedToExerciseOfTopUpRightsMember_documentation_en-US" xlink:label="lab_cron_ErrorRelatedToExerciseOfTopUpRightsMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Error Related To Exercise Of Top-Up Rights</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_cron_ErrorRelatedToExerciseOfTopUpRightsMember" xlink:href="cron-20210630.xsd#cron_ErrorRelatedToExerciseOfTopUpRightsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cron_ErrorRelatedToExerciseOfTopUpRightsMember" xlink:to="lab_cron_ErrorRelatedToExerciseOfTopUpRightsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_MeasurementInputRiskFreeInterestRateMember_f1d5754b-313a-4aec-9839-aa1baf904b55_terseLabel_en-US" xlink:label="lab_us-gaap_MeasurementInputRiskFreeInterestRateMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Weighted average risk-free interest rate</link:label>
    <link:label id="lab_us-gaap_MeasurementInputRiskFreeInterestRateMember_label_en-US" xlink:label="lab_us-gaap_MeasurementInputRiskFreeInterestRateMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Measurement Input, Risk Free Interest Rate [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MeasurementInputRiskFreeInterestRateMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_MeasurementInputRiskFreeInterestRateMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_MeasurementInputRiskFreeInterestRateMember" xlink:to="lab_us-gaap_MeasurementInputRiskFreeInterestRateMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EarningsPerShareBasicAndDilutedAbstract_d3d3a965-1881-466a-bbbd-357b54c90203_terseLabel_en-US" xlink:label="lab_us-gaap_EarningsPerShareBasicAndDilutedAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net income (loss) per share</link:label>
    <link:label id="lab_us-gaap_EarningsPerShareBasicAndDilutedAbstract_label_en-US" xlink:label="lab_us-gaap_EarningsPerShareBasicAndDilutedAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Earnings Per Share, Basic and Diluted [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareBasicAndDilutedAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EarningsPerShareBasicAndDilutedAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EarningsPerShareBasicAndDilutedAbstract" xlink:to="lab_us-gaap_EarningsPerShareBasicAndDilutedAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward_2cd2fee1-2126-4ac2-b5cb-c0a270c3b19b_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Weighted average exercise price (C$)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Weighted Average Grant Date Fair Value [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_DocumentFiscalPeriodFocus_e3efd4c3-4f6b-4e9c-95d9-1cf4180d4341_terseLabel_en-US" xlink:label="lab_dei_DocumentFiscalPeriodFocus" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Fiscal Period Focus</link:label>
    <link:label id="lab_dei_DocumentFiscalPeriodFocus_label_en-US" xlink:label="lab_dei_DocumentFiscalPeriodFocus" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Fiscal Period Focus</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentFiscalPeriodFocus" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_DocumentFiscalPeriodFocus"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_DocumentFiscalPeriodFocus" xlink:to="lab_dei_DocumentFiscalPeriodFocus" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ProfitLoss_50f81e5c-4329-492e-8052-9ab03e5a2ba7_totalLabel_en-US" xlink:label="lab_us-gaap_ProfitLoss" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net income (loss)</link:label>
    <link:label id="lab_us-gaap_ProfitLoss_80a93209-ec48-4ae6-b967-733c193b4fda_verboseLabel_en-US" xlink:label="lab_us-gaap_ProfitLoss" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net income (loss)</link:label>
    <link:label id="lab_us-gaap_ProfitLoss_label_en-US" xlink:label="lab_us-gaap_ProfitLoss" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net Income (Loss), Including Portion Attributable to Noncontrolling Interest</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProfitLoss" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ProfitLoss"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ProfitLoss" xlink:to="lab_us-gaap_ProfitLoss" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ProceedsFromSaleAndMaturityOfMarketableSecurities_6c1c2449-292f-4773-ac48-63372da5cc82_terseLabel_en-US" xlink:label="lab_us-gaap_ProceedsFromSaleAndMaturityOfMarketableSecurities" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Proceeds from short-term investments</link:label>
    <link:label id="lab_us-gaap_ProceedsFromSaleAndMaturityOfMarketableSecurities_label_en-US" xlink:label="lab_us-gaap_ProceedsFromSaleAndMaturityOfMarketableSecurities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Proceeds from Sale and Maturity of Marketable Securities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromSaleAndMaturityOfMarketableSecurities" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ProceedsFromSaleAndMaturityOfMarketableSecurities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ProceedsFromSaleAndMaturityOfMarketableSecurities" xlink:to="lab_us-gaap_ProceedsFromSaleAndMaturityOfMarketableSecurities" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ClassOfWarrantOrRightAxis_7ab5d60a-2528-4273-9932-fb3bb347e2b4_terseLabel_en-US" xlink:label="lab_us-gaap_ClassOfWarrantOrRightAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Class of Warrant or Right [Axis]</link:label>
    <link:label id="lab_us-gaap_ClassOfWarrantOrRightAxis_label_en-US" xlink:label="lab_us-gaap_ClassOfWarrantOrRightAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Class of Warrant or Right [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfWarrantOrRightAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ClassOfWarrantOrRightAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ClassOfWarrantOrRightAxis" xlink:to="lab_us-gaap_ClassOfWarrantOrRightAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_cron_CollaborativeArrangementPercentageOfProfitsToBeReceived_c1875b71-4c06-4f7a-8229-234a7d963811_terseLabel_en-US" xlink:label="lab_cron_CollaborativeArrangementPercentageOfProfitsToBeReceived" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Collaboration agreement, percentage of profits to be received</link:label>
    <link:label id="lab_cron_CollaborativeArrangementPercentageOfProfitsToBeReceived_label_en-US" xlink:label="lab_cron_CollaborativeArrangementPercentageOfProfitsToBeReceived" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Collaborative Arrangement, Percentage Of Profits To Be Received</link:label>
    <link:label id="lab_cron_CollaborativeArrangementPercentageOfProfitsToBeReceived_documentation_en-US" xlink:label="lab_cron_CollaborativeArrangementPercentageOfProfitsToBeReceived" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Collaborative Arrangement, Percentage Of Profits To Be Received</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_cron_CollaborativeArrangementPercentageOfProfitsToBeReceived" xlink:href="cron-20210630.xsd#cron_CollaborativeArrangementPercentageOfProfitsToBeReceived"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cron_CollaborativeArrangementPercentageOfProfitsToBeReceived" xlink:to="lab_cron_CollaborativeArrangementPercentageOfProfitsToBeReceived" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_74f790ec-b06b-4835-a0ca-b7efa3ebdef3_periodStartLabel_en-US" xlink:label="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash and cash equivalents, beginning of period</link:label>
    <link:label id="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_46081456-6f7c-4213-abdd-b6b63f81545d_periodEndLabel_en-US" xlink:label="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash and cash equivalents, end of period</link:label>
    <link:label id="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_label_en-US" xlink:label="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:to="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:type="arc" order="1"/>
    <link:label id="lab_country_US_17389748-d9fd-46c6-b91e-ae4193b86ecc_terseLabel_en-US" xlink:label="lab_country_US" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">United States</link:label>
    <link:label id="lab_country_US_label_en-US" xlink:label="lab_country_US" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">UNITED STATES</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_country_US" xlink:href="https://xbrl.sec.gov/country/2021/country-2021.xsd#country_US"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_country_US" xlink:to="lab_country_US" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SaleOfStockNumberOfSharesIssuedInTransaction_1819211a-962b-4077-80e2-dcf80fe17bf0_terseLabel_en-US" xlink:label="lab_us-gaap_SaleOfStockNumberOfSharesIssuedInTransaction" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Sale of stock, number of shares issued in transaction (in shares)</link:label>
    <link:label id="lab_us-gaap_SaleOfStockNumberOfSharesIssuedInTransaction_label_en-US" xlink:label="lab_us-gaap_SaleOfStockNumberOfSharesIssuedInTransaction" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Sale of Stock, Number of Shares Issued in Transaction</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SaleOfStockNumberOfSharesIssuedInTransaction" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SaleOfStockNumberOfSharesIssuedInTransaction"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SaleOfStockNumberOfSharesIssuedInTransaction" xlink:to="lab_us-gaap_SaleOfStockNumberOfSharesIssuedInTransaction" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract_0f99bb9e-cd5d-4f70-afdd-f89127f5e72e_terseLabel_en-US" xlink:label="lab_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statement of Comprehensive Income [Abstract]</link:label>
    <link:label id="lab_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract_label_en-US" xlink:label="lab_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statement of Comprehensive Income [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract" xlink:to="lab_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AssetsCurrentAbstract_b2e58a65-5a7e-45cf-b666-381dce2fb7e2_terseLabel_en-US" xlink:label="lab_us-gaap_AssetsCurrentAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Current assets</link:label>
    <link:label id="lab_us-gaap_AssetsCurrentAbstract_label_en-US" xlink:label="lab_us-gaap_AssetsCurrentAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Assets, Current [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsCurrentAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AssetsCurrentAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AssetsCurrentAbstract" xlink:to="lab_us-gaap_AssetsCurrentAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ProceedsFromPaymentsForOtherFinancingActivities_70b7352e-636e-4e13-ba6c-545bf92324bb_terseLabel_en-US" xlink:label="lab_us-gaap_ProceedsFromPaymentsForOtherFinancingActivities" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Proceeds from exercise of warrants and options</link:label>
    <link:label id="lab_us-gaap_ProceedsFromPaymentsForOtherFinancingActivities_label_en-US" xlink:label="lab_us-gaap_ProceedsFromPaymentsForOtherFinancingActivities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Proceeds from (Payments for) Other Financing Activities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromPaymentsForOtherFinancingActivities" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ProceedsFromPaymentsForOtherFinancingActivities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ProceedsFromPaymentsForOtherFinancingActivities" xlink:to="lab_us-gaap_ProceedsFromPaymentsForOtherFinancingActivities" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_InterestIncomeExpenseNonoperatingNet_bc90ab57-02d0-4d69-b5bf-e42eab568d08_terseLabel_en-US" xlink:label="lab_us-gaap_InterestIncomeExpenseNonoperatingNet" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Interest income, net</link:label>
    <link:label id="lab_us-gaap_InterestIncomeExpenseNonoperatingNet_8e4258dd-998e-4cad-8a02-b30a98eb08f2_totalLabel_en-US" xlink:label="lab_us-gaap_InterestIncomeExpenseNonoperatingNet" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Interest income, net</link:label>
    <link:label id="lab_us-gaap_InterestIncomeExpenseNonoperatingNet_efec8b48-4216-4892-babc-1a7e9186c7a1_negatedLabel_en-US" xlink:label="lab_us-gaap_InterestIncomeExpenseNonoperatingNet" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Interest income, net</link:label>
    <link:label id="lab_us-gaap_InterestIncomeExpenseNonoperatingNet_label_en-US" xlink:label="lab_us-gaap_InterestIncomeExpenseNonoperatingNet" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Interest Income (Expense), Nonoperating, Net</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestIncomeExpenseNonoperatingNet" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InterestIncomeExpenseNonoperatingNet"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InterestIncomeExpenseNonoperatingNet" xlink:to="lab_us-gaap_InterestIncomeExpenseNonoperatingNet" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityCentralIndexKey_7b4003e7-fa5a-4131-aea3-0c91e248627d_terseLabel_en-US" xlink:label="lab_dei_EntityCentralIndexKey" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Central Index Key</link:label>
    <link:label id="lab_dei_EntityCentralIndexKey_label_en-US" xlink:label="lab_dei_EntityCentralIndexKey" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Central Index Key</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityCentralIndexKey" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityCentralIndexKey"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityCentralIndexKey" xlink:to="lab_dei_EntityCentralIndexKey" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentAdditions_02b1e7d1-db00-4545-8543-ca8624eca067_terseLabel_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentAdditions" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Purchase of property, plant and equipment, net</link:label>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentAdditions_label_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentAdditions" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Property, Plant and Equipment, Additions</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentAdditions" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PropertyPlantAndEquipmentAdditions"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentAdditions" xlink:to="lab_us-gaap_PropertyPlantAndEquipmentAdditions" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_SecurityExchangeName_b6e48f82-f251-46ca-bd95-b416c033788c_terseLabel_en-US" xlink:label="lab_dei_SecurityExchangeName" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Security Exchange Name</link:label>
    <link:label id="lab_dei_SecurityExchangeName_label_en-US" xlink:label="lab_dei_SecurityExchangeName" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Security Exchange Name</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_SecurityExchangeName" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_SecurityExchangeName"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_SecurityExchangeName" xlink:to="lab_dei_SecurityExchangeName" xlink:type="arc" order="1"/>
    <link:label id="lab_cron_DeferredCompensationSharebasedArrangementsLiabilityRollForward_86efa5f0-03de-49da-bd76-35899be5d84c_terseLabel_en-US" xlink:label="lab_cron_DeferredCompensationSharebasedArrangementsLiabilityRollForward" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred Compensation Share-based Arrangements, Liability [Roll Forward]</link:label>
    <link:label id="lab_cron_DeferredCompensationSharebasedArrangementsLiabilityRollForward_82cfc470-8b9e-4764-bffc-b3facdfd1044_verboseLabel_en-US" xlink:label="lab_cron_DeferredCompensationSharebasedArrangementsLiabilityRollForward" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Financial liability</link:label>
    <link:label id="lab_cron_DeferredCompensationSharebasedArrangementsLiabilityRollForward_label_en-US" xlink:label="lab_cron_DeferredCompensationSharebasedArrangementsLiabilityRollForward" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred Compensation Share-based Arrangements, Liability [Roll Forward]</link:label>
    <link:label id="lab_cron_DeferredCompensationSharebasedArrangementsLiabilityRollForward_documentation_en-US" xlink:label="lab_cron_DeferredCompensationSharebasedArrangementsLiabilityRollForward" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred Compensation Share-based Arrangements, Liability [Roll Forward]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_cron_DeferredCompensationSharebasedArrangementsLiabilityRollForward" xlink:href="cron-20210630.xsd#cron_DeferredCompensationSharebasedArrangementsLiabilityRollForward"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cron_DeferredCompensationSharebasedArrangementsLiabilityRollForward" xlink:to="lab_cron_DeferredCompensationSharebasedArrangementsLiabilityRollForward" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DisposalGroupClassificationDomain_cb50a2ac-b6e0-4662-a3f8-7570749eb233_terseLabel_en-US" xlink:label="lab_us-gaap_DisposalGroupClassificationDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disposal Group Classification [Domain]</link:label>
    <link:label id="lab_us-gaap_DisposalGroupClassificationDomain_label_en-US" xlink:label="lab_us-gaap_DisposalGroupClassificationDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disposal Group Classification [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupClassificationDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DisposalGroupClassificationDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DisposalGroupClassificationDomain" xlink:to="lab_us-gaap_DisposalGroupClassificationDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CashAndCashEquivalentsFairValueDisclosure_9debeebc-3077-4b42-8cac-928996b58f6f_terseLabel_en-US" xlink:label="lab_us-gaap_CashAndCashEquivalentsFairValueDisclosure" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash and cash equivalents</link:label>
    <link:label id="lab_us-gaap_CashAndCashEquivalentsFairValueDisclosure_label_en-US" xlink:label="lab_us-gaap_CashAndCashEquivalentsFairValueDisclosure" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash and Cash Equivalents, Fair Value Disclosure</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashAndCashEquivalentsFairValueDisclosure" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CashAndCashEquivalentsFairValueDisclosure"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CashAndCashEquivalentsFairValueDisclosure" xlink:to="lab_us-gaap_CashAndCashEquivalentsFairValueDisclosure" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised_10e8aa22-0794-4d30-bade-ef434fcb67b1_terseLabel_en-US" xlink:label="lab_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Options exercised (in shares)</link:label>
    <link:label id="lab_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised_b9a16c9d-54b6-4018-881c-a80e555dae86_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Exercise of options (in shares)</link:label>
    <link:label id="lab_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised_label_en-US" xlink:label="lab_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercises in Period</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised" xlink:to="lab_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_ec847d5a-d81c-4015-86b9-188fa1e8d060_terseLabel_en-US" xlink:label="lab_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Diluted (in shares)</link:label>
    <link:label id="lab_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_f3dfadb3-2a0f-41d6-a51a-c683922ffac9_totalLabel_en-US" xlink:label="lab_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Weighted average number of common shares for computation of diluted earnings (loss) from continuing operations per share (in shares)</link:label>
    <link:label id="lab_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_4afe39dd-9bea-49ad-adc3-bbaf12a666e0_verboseLabel_en-US" xlink:label="lab_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Weighted average number of common shares for computation of diluted loss from discontinued operations per share (in shares)</link:label>
    <link:label id="lab_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_label_en-US" xlink:label="lab_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Weighted Average Number of Shares Outstanding, Diluted</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding" xlink:to="lab_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossNetOfTax_ee5abb2e-c987-4881-bebe-81c8cfeaa8f9_totalLabel_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossNetOfTax" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total other comprehensive income (loss)</link:label>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossNetOfTax_label_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossNetOfTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Comprehensive Income (Loss), Net of Tax</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTax" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossNetOfTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTax" xlink:to="lab_us-gaap_OtherComprehensiveIncomeLossNetOfTax" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueMeasurementsRecurringMember_a137809a-c180-44be-bdc0-d62e6d1d5018_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueMeasurementsRecurringMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value, Recurring</link:label>
    <link:label id="lab_us-gaap_FairValueMeasurementsRecurringMember_label_en-US" xlink:label="lab_us-gaap_FairValueMeasurementsRecurringMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value, Recurring [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementsRecurringMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueMeasurementsRecurringMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueMeasurementsRecurringMember" xlink:to="lab_us-gaap_FairValueMeasurementsRecurringMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DisposalGroupIncludingDiscontinuedOperationAssetsNoncurrent_0af404f4-b518-4d98-a13e-3bb5e3d5b255_terseLabel_en-US" xlink:label="lab_us-gaap_DisposalGroupIncludingDiscontinuedOperationAssetsNoncurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">OGBC assets classified as held-for-sale</link:label>
    <link:label id="lab_us-gaap_DisposalGroupIncludingDiscontinuedOperationAssetsNoncurrent_label_en-US" xlink:label="lab_us-gaap_DisposalGroupIncludingDiscontinuedOperationAssetsNoncurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disposal Group, Including Discontinued Operation, Assets, Noncurrent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationAssetsNoncurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DisposalGroupIncludingDiscontinuedOperationAssetsNoncurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationAssetsNoncurrent" xlink:to="lab_us-gaap_DisposalGroupIncludingDiscontinuedOperationAssetsNoncurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_CurrentFiscalYearEndDate_c4ea69ba-cbc5-4a77-afb3-3e906443f9e3_terseLabel_en-US" xlink:label="lab_dei_CurrentFiscalYearEndDate" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Current Fiscal Year End Date</link:label>
    <link:label id="lab_dei_CurrentFiscalYearEndDate_label_en-US" xlink:label="lab_dei_CurrentFiscalYearEndDate" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Current Fiscal Year End Date</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_CurrentFiscalYearEndDate" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_CurrentFiscalYearEndDate"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_CurrentFiscalYearEndDate" xlink:to="lab_dei_CurrentFiscalYearEndDate" xlink:type="arc" order="1"/>
    <link:label id="lab_cron_AdjustedEarningsBeforeInterestTaxesDepreciationAndAmortization_5a5e60f9-23d7-4bc5-ae0b-d3792dea3e99_terseLabel_en-US" xlink:label="lab_cron_AdjustedEarningsBeforeInterestTaxesDepreciationAndAmortization" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Adjusted EBITDA</link:label>
    <link:label id="lab_cron_AdjustedEarningsBeforeInterestTaxesDepreciationAndAmortization_label_en-US" xlink:label="lab_cron_AdjustedEarningsBeforeInterestTaxesDepreciationAndAmortization" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Adjusted Earnings Before Interest, Taxes, Depreciation And Amortization</link:label>
    <link:label id="lab_cron_AdjustedEarningsBeforeInterestTaxesDepreciationAndAmortization_documentation_en-US" xlink:label="lab_cron_AdjustedEarningsBeforeInterestTaxesDepreciationAndAmortization" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Adjusted Earnings Before Interest, Taxes, Depreciation And Amortization</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_cron_AdjustedEarningsBeforeInterestTaxesDepreciationAndAmortization" xlink:href="cron-20210630.xsd#cron_AdjustedEarningsBeforeInterestTaxesDepreciationAndAmortization"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cron_AdjustedEarningsBeforeInterestTaxesDepreciationAndAmortization" xlink:to="lab_cron_AdjustedEarningsBeforeInterestTaxesDepreciationAndAmortization" xlink:type="arc" order="1"/>
    <link:label id="lab_cron_NatueraMember_cf680382-0a9a-4cd2-9079-7c5d108a98c8_terseLabel_en-US" xlink:label="lab_cron_NatueraMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Natuera</link:label>
    <link:label id="lab_cron_NatueraMember_label_en-US" xlink:label="lab_cron_NatueraMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Natuera [Member]</link:label>
    <link:label id="lab_cron_NatueraMember_documentation_en-US" xlink:label="lab_cron_NatueraMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Natuera [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_cron_NatueraMember" xlink:href="cron-20210630.xsd#cron_NatueraMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cron_NatueraMember" xlink:to="lab_cron_NatueraMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfDisposalGroupsIncludingDiscontinuedOperationsIncomeStatementBalanceSheetAndAdditionalDisclosuresTextBlock_36a7568e-c3f1-4cd6-b41a-ae19fc57307e_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfDisposalGroupsIncludingDiscontinuedOperationsIncomeStatementBalanceSheetAndAdditionalDisclosuresTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Summary of Financial Information for Discontinued Operations</link:label>
    <link:label id="lab_us-gaap_ScheduleOfDisposalGroupsIncludingDiscontinuedOperationsIncomeStatementBalanceSheetAndAdditionalDisclosuresTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfDisposalGroupsIncludingDiscontinuedOperationsIncomeStatementBalanceSheetAndAdditionalDisclosuresTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disposal Groups, Including Discontinued Operations [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfDisposalGroupsIncludingDiscontinuedOperationsIncomeStatementBalanceSheetAndAdditionalDisclosuresTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfDisposalGroupsIncludingDiscontinuedOperationsIncomeStatementBalanceSheetAndAdditionalDisclosuresTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfDisposalGroupsIncludingDiscontinuedOperationsIncomeStatementBalanceSheetAndAdditionalDisclosuresTextBlock" xlink:to="lab_us-gaap_ScheduleOfDisposalGroupsIncludingDiscontinuedOperationsIncomeStatementBalanceSheetAndAdditionalDisclosuresTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock_3d87e03a-41c2-4553-aaf4-5ad2340580ca_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Antidilutive Securities Excluded from Computation of Diluted Shares Outstanding</link:label>
    <link:label id="lab_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Antidilutive Securities Excluded from Computation of Earnings Per Share [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock" xlink:to="lab_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StatementOfCashFlowsAbstract_c0923643-3961-44a7-b650-df611b67706a_terseLabel_en-US" xlink:label="lab_us-gaap_StatementOfCashFlowsAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statement of Cash Flows [Abstract]</link:label>
    <link:label id="lab_us-gaap_StatementOfCashFlowsAbstract_label_en-US" xlink:label="lab_us-gaap_StatementOfCashFlowsAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statement of Cash Flows [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementOfCashFlowsAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementOfCashFlowsAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StatementOfCashFlowsAbstract" xlink:to="lab_us-gaap_StatementOfCashFlowsAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NonoperatingIncomeExpenseAbstract_3ba76fd5-543b-46ca-811b-be530b6f0f46_terseLabel_en-US" xlink:label="lab_us-gaap_NonoperatingIncomeExpenseAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other income (loss)</link:label>
    <link:label id="lab_us-gaap_NonoperatingIncomeExpenseAbstract_label_en-US" xlink:label="lab_us-gaap_NonoperatingIncomeExpenseAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Nonoperating Income (Expense) [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NonoperatingIncomeExpenseAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NonoperatingIncomeExpenseAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NonoperatingIncomeExpenseAbstract" xlink:to="lab_us-gaap_NonoperatingIncomeExpenseAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_VariableInterestEntityEntityMaximumLossExposureAmount_7c5f34b4-e0c5-4891-ad9b-768a0126833e_terseLabel_en-US" xlink:label="lab_us-gaap_VariableInterestEntityEntityMaximumLossExposureAmount" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Maximum Exposure to Loss</link:label>
    <link:label id="lab_us-gaap_VariableInterestEntityEntityMaximumLossExposureAmount_label_en-US" xlink:label="lab_us-gaap_VariableInterestEntityEntityMaximumLossExposureAmount" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Variable Interest Entity, Reporting Entity Involvement, Maximum Loss Exposure, Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_VariableInterestEntityEntityMaximumLossExposureAmount" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_VariableInterestEntityEntityMaximumLossExposureAmount"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_VariableInterestEntityEntityMaximumLossExposureAmount" xlink:to="lab_us-gaap_VariableInterestEntityEntityMaximumLossExposureAmount" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassLineItems_66f2bafd-0e9c-4077-98c6-7988d0a3ed90_terseLabel_en-US" xlink:label="lab_us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Indefinite-lived Intangible Assets [Line Items]</link:label>
    <link:label id="lab_us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassLineItems_label_en-US" xlink:label="lab_us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Indefinite-lived Intangible Assets [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassLineItems" xlink:to="lab_us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInInvestingActivities_b31b73d7-545b-4e72-8dfc-406314f494cd_totalLabel_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInInvestingActivities" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash flows provided by (used in) investing activities</link:label>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInInvestingActivities_label_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInInvestingActivities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net Cash Provided by (Used in) Investing Activities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities" xlink:to="lab_us-gaap_NetCashProvidedByUsedInInvestingActivities" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AdvancesToAffiliate_614cfeaf-ed08-40b2-999c-f92d77c86f38_terseLabel_en-US" xlink:label="lab_us-gaap_AdvancesToAffiliate" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Advances to joint ventures</link:label>
    <link:label id="lab_us-gaap_AdvancesToAffiliate_label_en-US" xlink:label="lab_us-gaap_AdvancesToAffiliate" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Advances to Affiliate</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdvancesToAffiliate" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AdvancesToAffiliate"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AdvancesToAffiliate" xlink:to="lab_us-gaap_AdvancesToAffiliate" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_176df13b-8b60-4e23-b5b3-fd86bcf292f4_terseLabel_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Changes in operating assets and liabilities:</link:label>
    <link:label id="lab_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_label_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Increase (Decrease) in Operating Capital [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncreaseDecreaseInOperatingCapitalAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract" xlink:to="lab_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CollaborativeArrangementTransactionWithPartyToCollaborativeArrangementMember_8fff40c5-9de3-42c3-8dc3-5e548938fd53_terseLabel_en-US" xlink:label="lab_us-gaap_CollaborativeArrangementTransactionWithPartyToCollaborativeArrangementMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Establishment of a Commercial Cannabis Analytical Testing Laboratory</link:label>
    <link:label id="lab_us-gaap_CollaborativeArrangementTransactionWithPartyToCollaborativeArrangementMember_label_en-US" xlink:label="lab_us-gaap_CollaborativeArrangementTransactionWithPartyToCollaborativeArrangementMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Collaborative Arrangement, Transaction with Party to Collaborative Arrangement [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CollaborativeArrangementTransactionWithPartyToCollaborativeArrangementMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CollaborativeArrangementTransactionWithPartyToCollaborativeArrangementMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CollaborativeArrangementTransactionWithPartyToCollaborativeArrangementMember" xlink:to="lab_us-gaap_CollaborativeArrangementTransactionWithPartyToCollaborativeArrangementMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_06838065-64a4-4e72-bec2-ad362318162e_terseLabel_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating activities</link:label>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_label_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net Cash Provided by (Used in) Operating Activities [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract" xlink:to="lab_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue_8e36e615-0958-4319-ba71-8fc58c417b91_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Exercise of warrants (in dollars per share)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Vested in Period, Weighted Average Grant Date Fair Value</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue" xlink:type="arc" order="1"/>
    <link:label id="lab_cron_ClassOfWarrantOrRightExercisePriceVolumeWeightedAveragePriceMeasurementPeriodDaysPrecedingExercise_da05541b-d6c0-4a4d-badd-1511d3d5abf4_terseLabel_en-US" xlink:label="lab_cron_ClassOfWarrantOrRightExercisePriceVolumeWeightedAveragePriceMeasurementPeriodDaysPrecedingExercise" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Exercise price, volume-weighted average price, measurement period, days preceding exercise</link:label>
    <link:label id="lab_cron_ClassOfWarrantOrRightExercisePriceVolumeWeightedAveragePriceMeasurementPeriodDaysPrecedingExercise_label_en-US" xlink:label="lab_cron_ClassOfWarrantOrRightExercisePriceVolumeWeightedAveragePriceMeasurementPeriodDaysPrecedingExercise" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Class Of Warrant Or Right, Exercise Price, Volume-Weighted Average Price, Measurement Period, Days Preceding Exercise</link:label>
    <link:label id="lab_cron_ClassOfWarrantOrRightExercisePriceVolumeWeightedAveragePriceMeasurementPeriodDaysPrecedingExercise_documentation_en-US" xlink:label="lab_cron_ClassOfWarrantOrRightExercisePriceVolumeWeightedAveragePriceMeasurementPeriodDaysPrecedingExercise" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Class Of Warrant Or Right, Exercise Price, Volume-Weighted Average Price, Measurement Period, Days Preceding Exercise</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_cron_ClassOfWarrantOrRightExercisePriceVolumeWeightedAveragePriceMeasurementPeriodDaysPrecedingExercise" xlink:href="cron-20210630.xsd#cron_ClassOfWarrantOrRightExercisePriceVolumeWeightedAveragePriceMeasurementPeriodDaysPrecedingExercise"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cron_ClassOfWarrantOrRightExercisePriceVolumeWeightedAveragePriceMeasurementPeriodDaysPrecedingExercise" xlink:to="lab_cron_ClassOfWarrantOrRightExercisePriceVolumeWeightedAveragePriceMeasurementPeriodDaysPrecedingExercise" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LiabilitiesCurrent_40df27b2-77e3-4859-a131-994709d8ffd2_totalLabel_en-US" xlink:label="lab_us-gaap_LiabilitiesCurrent" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total current liabilities</link:label>
    <link:label id="lab_us-gaap_LiabilitiesCurrent_label_en-US" xlink:label="lab_us-gaap_LiabilitiesCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Liabilities, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LiabilitiesCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LiabilitiesCurrent" xlink:to="lab_us-gaap_LiabilitiesCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PaymentsRelatedToTaxWithholdingForShareBasedCompensation_7fae9edc-5bbe-4a3b-9273-d4e077bedb15_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_PaymentsRelatedToTaxWithholdingForShareBasedCompensation" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Withholding taxes paid on share-based awards</link:label>
    <link:label id="lab_us-gaap_PaymentsRelatedToTaxWithholdingForShareBasedCompensation_label_en-US" xlink:label="lab_us-gaap_PaymentsRelatedToTaxWithholdingForShareBasedCompensation" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payment, Tax Withholding, Share-based Payment Arrangement</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsRelatedToTaxWithholdingForShareBasedCompensation" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PaymentsRelatedToTaxWithholdingForShareBasedCompensation"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PaymentsRelatedToTaxWithholdingForShareBasedCompensation" xlink:to="lab_us-gaap_PaymentsRelatedToTaxWithholdingForShareBasedCompensation" xlink:type="arc" order="1"/>
    <link:label id="lab_cron_MedMenCanadaInc.Member_c80256af-1443-4100-b990-c4eb5badae51_terseLabel_en-US" xlink:label="lab_cron_MedMenCanadaInc.Member" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">MedMen Canada</link:label>
    <link:label id="lab_cron_MedMenCanadaInc.Member_label_en-US" xlink:label="lab_cron_MedMenCanadaInc.Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">MedMen Canada Inc. [Member]</link:label>
    <link:label id="lab_cron_MedMenCanadaInc.Member_documentation_en-US" xlink:label="lab_cron_MedMenCanadaInc.Member" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">MedMen Canada Inc. [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_cron_MedMenCanadaInc.Member" xlink:href="cron-20210630.xsd#cron_MedMenCanadaInc.Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cron_MedMenCanadaInc.Member" xlink:to="lab_cron_MedMenCanadaInc.Member" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsRequisiteServicePeriodRecognition_8bd5cc7d-77e1-4ac1-b022-d9c9e18c875e_terseLabel_en-US" xlink:label="lab_us-gaap_AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsRequisiteServicePeriodRecognition" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Vesting of options</link:label>
    <link:label id="lab_us-gaap_AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsRequisiteServicePeriodRecognition_label_en-US" xlink:label="lab_us-gaap_AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsRequisiteServicePeriodRecognition" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">APIC, Share-based Payment Arrangement, Option, Increase for Cost Recognition</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsRequisiteServicePeriodRecognition" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsRequisiteServicePeriodRecognition"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsRequisiteServicePeriodRecognition" xlink:to="lab_us-gaap_AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsRequisiteServicePeriodRecognition" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LitigationStatusDomain_2e441769-a770-413f-8ceb-a693228f3efb_terseLabel_en-US" xlink:label="lab_us-gaap_LitigationStatusDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Litigation Status [Domain]</link:label>
    <link:label id="lab_us-gaap_LitigationStatusDomain_label_en-US" xlink:label="lab_us-gaap_LitigationStatusDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Litigation Status [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LitigationStatusDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LitigationStatusDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LitigationStatusDomain" xlink:to="lab_us-gaap_LitigationStatusDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_cron_OtherCostOfGoodsAndServicesSold_02c5b7ca-eb98-4049-b94b-be4a58bacc58_terseLabel_en-US" xlink:label="lab_cron_OtherCostOfGoodsAndServicesSold" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cost of sales</link:label>
    <link:label id="lab_cron_OtherCostOfGoodsAndServicesSold_label_en-US" xlink:label="lab_cron_OtherCostOfGoodsAndServicesSold" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Cost Of Goods And Services Sold</link:label>
    <link:label id="lab_cron_OtherCostOfGoodsAndServicesSold_documentation_en-US" xlink:label="lab_cron_OtherCostOfGoodsAndServicesSold" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Cost Of Goods And Services Sold</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_cron_OtherCostOfGoodsAndServicesSold" xlink:href="cron-20210630.xsd#cron_OtherCostOfGoodsAndServicesSold"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cron_OtherCostOfGoodsAndServicesSold" xlink:to="lab_cron_OtherCostOfGoodsAndServicesSold" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LossContingenciesTable_0c94d2bc-db84-4482-8c29-d48b3779db55_terseLabel_en-US" xlink:label="lab_us-gaap_LossContingenciesTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Loss Contingencies [Table]</link:label>
    <link:label id="lab_us-gaap_LossContingenciesTable_label_en-US" xlink:label="lab_us-gaap_LossContingenciesTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Loss Contingencies [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LossContingenciesTable" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LossContingenciesTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LossContingenciesTable" xlink:to="lab_us-gaap_LossContingenciesTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RevenueFromContractWithCustomerIncludingAssessedTax_454c3828-9c3f-42aa-8db6-9dc2f3299f9c_terseLabel_en-US" xlink:label="lab_us-gaap_RevenueFromContractWithCustomerIncludingAssessedTax" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net revenue, before excise taxes</link:label>
    <link:label id="lab_us-gaap_RevenueFromContractWithCustomerIncludingAssessedTax_label_en-US" xlink:label="lab_us-gaap_RevenueFromContractWithCustomerIncludingAssessedTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revenue from Contract with Customer, Including Assessed Tax</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerIncludingAssessedTax" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RevenueFromContractWithCustomerIncludingAssessedTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RevenueFromContractWithCustomerIncludingAssessedTax" xlink:to="lab_us-gaap_RevenueFromContractWithCustomerIncludingAssessedTax" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SegmentReportingInformationLineItems_ae7305d2-1961-4454-b668-2350037dfa30_terseLabel_en-US" xlink:label="lab_us-gaap_SegmentReportingInformationLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Segment Reporting Information [Line Items]</link:label>
    <link:label id="lab_us-gaap_SegmentReportingInformationLineItems_label_en-US" xlink:label="lab_us-gaap_SegmentReportingInformationLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Segment Reporting Information [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentReportingInformationLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SegmentReportingInformationLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems" xlink:to="lab_us-gaap_SegmentReportingInformationLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityAddressPostalZipCode_8ae94a82-7372-482d-b06b-1ea928ffa8c6_terseLabel_en-US" xlink:label="lab_dei_EntityAddressPostalZipCode" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Address, Postal Zip Code</link:label>
    <link:label id="lab_dei_EntityAddressPostalZipCode_label_en-US" xlink:label="lab_dei_EntityAddressPostalZipCode" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Address, Postal Zip Code</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressPostalZipCode" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityAddressPostalZipCode"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityAddressPostalZipCode" xlink:to="lab_dei_EntityAddressPostalZipCode" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NetIncomeLossFromDiscontinuedOperationsAvailableToCommonShareholdersDiluted_c15b2098-ea54-4809-86cd-4bc0f1687193_terseLabel_en-US" xlink:label="lab_us-gaap_NetIncomeLossFromDiscontinuedOperationsAvailableToCommonShareholdersDiluted" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Loss from discontinued operations attributable to the shareholders of Cronos Group</link:label>
    <link:label id="lab_us-gaap_NetIncomeLossFromDiscontinuedOperationsAvailableToCommonShareholdersDiluted_label_en-US" xlink:label="lab_us-gaap_NetIncomeLossFromDiscontinuedOperationsAvailableToCommonShareholdersDiluted" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net Income (Loss) from Discontinued Operations Available to Common Shareholders, Diluted</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLossFromDiscontinuedOperationsAvailableToCommonShareholdersDiluted" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetIncomeLossFromDiscontinuedOperationsAvailableToCommonShareholdersDiluted"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NetIncomeLossFromDiscontinuedOperationsAvailableToCommonShareholdersDiluted" xlink:to="lab_us-gaap_NetIncomeLossFromDiscontinuedOperationsAvailableToCommonShareholdersDiluted" xlink:type="arc" order="1"/>
    <link:label id="lab_cron_PharmacannMember_e818df12-4747-4f56-bc7c-b0a5cea777c4_terseLabel_en-US" xlink:label="lab_cron_PharmacannMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Pharmacann</link:label>
    <link:label id="lab_cron_PharmacannMember_label_en-US" xlink:label="lab_cron_PharmacannMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Pharmacann [Member]</link:label>
    <link:label id="lab_cron_PharmacannMember_documentation_en-US" xlink:label="lab_cron_PharmacannMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Pharmacann</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_cron_PharmacannMember" xlink:href="cron-20210630.xsd#cron_PharmacannMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cron_PharmacannMember" xlink:to="lab_cron_PharmacannMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipByIncomeStatementLocationByDerivativeInstrumentRiskTable_4ac331b0-cecf-4d3f-bb8e-38d6e418ccf7_terseLabel_en-US" xlink:label="lab_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipByIncomeStatementLocationByDerivativeInstrumentRiskTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative Instruments, Gain (Loss) [Table]</link:label>
    <link:label id="lab_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipByIncomeStatementLocationByDerivativeInstrumentRiskTable_label_en-US" xlink:label="lab_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipByIncomeStatementLocationByDerivativeInstrumentRiskTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative Instruments, Gain (Loss) [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipByIncomeStatementLocationByDerivativeInstrumentRiskTable" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipByIncomeStatementLocationByDerivativeInstrumentRiskTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipByIncomeStatementLocationByDerivativeInstrumentRiskTable" xlink:to="lab_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipByIncomeStatementLocationByDerivativeInstrumentRiskTable" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_Security12bTitle_daae5c7e-29cf-4edf-b0c7-cfe734bf2813_terseLabel_en-US" xlink:label="lab_dei_Security12bTitle" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Title of 12(b) Security</link:label>
    <link:label id="lab_dei_Security12bTitle_label_en-US" xlink:label="lab_dei_Security12bTitle" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Title of 12(b) Security</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_Security12bTitle" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_Security12bTitle"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_Security12bTitle" xlink:to="lab_dei_Security12bTitle" xlink:type="arc" order="1"/>
    <link:label id="lab_cron_GinkgoEquityMilestonesMember_5f9370d5-5fbd-4844-9cef-62fd6a79e0d8_terseLabel_en-US" xlink:label="lab_cron_GinkgoEquityMilestonesMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Ginkgo equity milestones</link:label>
    <link:label id="lab_cron_GinkgoEquityMilestonesMember_label_en-US" xlink:label="lab_cron_GinkgoEquityMilestonesMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Ginkgo Equity Milestones [Member]</link:label>
    <link:label id="lab_cron_GinkgoEquityMilestonesMember_documentation_en-US" xlink:label="lab_cron_GinkgoEquityMilestonesMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Ginkgo Equity Milestones [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_cron_GinkgoEquityMilestonesMember" xlink:href="cron-20210630.xsd#cron_GinkgoEquityMilestonesMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cron_GinkgoEquityMilestonesMember" xlink:to="lab_cron_GinkgoEquityMilestonesMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NoncurrentAssets_e7ad2de5-cc58-489f-a921-99815e97ac17_terseLabel_en-US" xlink:label="lab_us-gaap_NoncurrentAssets" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-lived assets</link:label>
    <link:label id="lab_us-gaap_NoncurrentAssets_label_en-US" xlink:label="lab_us-gaap_NoncurrentAssets" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-Lived Assets</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NoncurrentAssets" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NoncurrentAssets"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NoncurrentAssets" xlink:to="lab_us-gaap_NoncurrentAssets" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StatementTable_a7a96c06-456d-4328-8a60-a13648fb512a_terseLabel_en-US" xlink:label="lab_us-gaap_StatementTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statement [Table]</link:label>
    <link:label id="lab_us-gaap_StatementTable_label_en-US" xlink:label="lab_us-gaap_StatementTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statement [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementTable" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StatementTable" xlink:to="lab_us-gaap_StatementTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock_e4046fb4-3a3b-4f68-b32e-e81eb8ebce46_terseLabel_en-US" xlink:label="lab_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Adoption of new accounting pronouncements and New accounting pronouncements not yet adopted</link:label>
    <link:label id="lab_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock_label_en-US" xlink:label="lab_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">New Accounting Pronouncements, Policy [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock" xlink:to="lab_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AssetsHeldForSaleNotPartOfDisposalGroupCurrent_37a18cae-b29f-4a69-b83b-1b776b2e3274_terseLabel_en-US" xlink:label="lab_us-gaap_AssetsHeldForSaleNotPartOfDisposalGroupCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Held-for-sale assets</link:label>
    <link:label id="lab_us-gaap_AssetsHeldForSaleNotPartOfDisposalGroupCurrent_label_en-US" xlink:label="lab_us-gaap_AssetsHeldForSaleNotPartOfDisposalGroupCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Assets Held-for-sale, Not Part of Disposal Group, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsHeldForSaleNotPartOfDisposalGroupCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AssetsHeldForSaleNotPartOfDisposalGroupCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AssetsHeldForSaleNotPartOfDisposalGroupCurrent" xlink:to="lab_us-gaap_AssetsHeldForSaleNotPartOfDisposalGroupCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_cron_OntarioCannabisRetailCorporationMember_9d2114a8-daac-469d-ab8b-d3b244fb4850_terseLabel_en-US" xlink:label="lab_cron_OntarioCannabisRetailCorporationMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Ontario Cannabis Retail Corporation</link:label>
    <link:label id="lab_cron_OntarioCannabisRetailCorporationMember_label_en-US" xlink:label="lab_cron_OntarioCannabisRetailCorporationMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Ontario Cannabis Retail Corporation [Member]</link:label>
    <link:label id="lab_cron_OntarioCannabisRetailCorporationMember_documentation_en-US" xlink:label="lab_cron_OntarioCannabisRetailCorporationMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Ontario Cannabis Retail Corporation</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_cron_OntarioCannabisRetailCorporationMember" xlink:href="cron-20210630.xsd#cron_OntarioCannabisRetailCorporationMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cron_OntarioCannabisRetailCorporationMember" xlink:to="lab_cron_OntarioCannabisRetailCorporationMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LossContingencyNewClaimsFiledNumber_bc723b3d-ba96-45f3-81d1-5be8af69a2a6_terseLabel_en-US" xlink:label="lab_us-gaap_LossContingencyNewClaimsFiledNumber" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Number of putative class action complaints</link:label>
    <link:label id="lab_us-gaap_LossContingencyNewClaimsFiledNumber_label_en-US" xlink:label="lab_us-gaap_LossContingencyNewClaimsFiledNumber" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Loss Contingency, New Claims Filed, Number</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LossContingencyNewClaimsFiledNumber" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LossContingencyNewClaimsFiledNumber"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LossContingencyNewClaimsFiledNumber" xlink:to="lab_us-gaap_LossContingencyNewClaimsFiledNumber" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_RangeAxis_b33400e2-3073-426e-a7c4-720921ddc0d2_terseLabel_en-US" xlink:label="lab_srt_RangeAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statistical Measurement [Axis]</link:label>
    <link:label id="lab_srt_RangeAxis_label_en-US" xlink:label="lab_srt_RangeAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statistical Measurement [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeAxis" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_RangeAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_RangeAxis" xlink:to="lab_srt_RangeAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncreaseDecreaseInOtherReceivables_db33188e-cdd6-48e6-ac9c-ad8e136de870_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInOtherReceivables" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other receivables</link:label>
    <link:label id="lab_us-gaap_IncreaseDecreaseInOtherReceivables_label_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInOtherReceivables" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Increase (Decrease) in Other Receivables</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInOtherReceivables" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncreaseDecreaseInOtherReceivables"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncreaseDecreaseInOtherReceivables" xlink:to="lab_us-gaap_IncreaseDecreaseInOtherReceivables" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_CoverAbstract_e3de478c-e4fe-4c66-97a7-68af22b03882_terseLabel_en-US" xlink:label="lab_dei_CoverAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cover page.</link:label>
    <link:label id="lab_dei_CoverAbstract_label_en-US" xlink:label="lab_dei_CoverAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cover [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_CoverAbstract" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_CoverAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_CoverAbstract" xlink:to="lab_dei_CoverAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_cron_CollaborativeArrangementTermOfAgreement_745d1d80-bac3-4827-b986-e3ae4acfae1f_terseLabel_en-US" xlink:label="lab_cron_CollaborativeArrangementTermOfAgreement" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Collaboration agreement, term of agreement</link:label>
    <link:label id="lab_cron_CollaborativeArrangementTermOfAgreement_label_en-US" xlink:label="lab_cron_CollaborativeArrangementTermOfAgreement" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Collaborative Arrangement, Term Of Agreement</link:label>
    <link:label id="lab_cron_CollaborativeArrangementTermOfAgreement_documentation_en-US" xlink:label="lab_cron_CollaborativeArrangementTermOfAgreement" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Collaborative Arrangement, Term Of Agreement</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_cron_CollaborativeArrangementTermOfAgreement" xlink:href="cron-20210630.xsd#cron_CollaborativeArrangementTermOfAgreement"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cron_CollaborativeArrangementTermOfAgreement" xlink:to="lab_cron_CollaborativeArrangementTermOfAgreement" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FinancingReceivableAllowanceForCreditLosses_4b6533b4-20b7-4f51-88fe-9d3c3e498890_terseLabel_en-US" xlink:label="lab_us-gaap_FinancingReceivableAllowanceForCreditLosses" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Allowance for credit loss</link:label>
    <link:label id="lab_us-gaap_FinancingReceivableAllowanceForCreditLosses_label_en-US" xlink:label="lab_us-gaap_FinancingReceivableAllowanceForCreditLosses" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Financing Receivable, Allowance for Credit Loss</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinancingReceivableAllowanceForCreditLosses" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FinancingReceivableAllowanceForCreditLosses"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FinancingReceivableAllowanceForCreditLosses" xlink:to="lab_us-gaap_FinancingReceivableAllowanceForCreditLosses" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_Goodwill_b771d333-431b-404e-b83e-f703f0226656_verboseLabel_en-US" xlink:label="lab_us-gaap_Goodwill" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Goodwill</link:label>
    <link:label id="lab_us-gaap_Goodwill_label_en-US" xlink:label="lab_us-gaap_Goodwill" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Goodwill</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Goodwill" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_Goodwill"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_Goodwill" xlink:to="lab_us-gaap_Goodwill" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_MinorityInterest_219bec5a-03da-4945-97ff-14266cf6b8df_terseLabel_en-US" xlink:label="lab_us-gaap_MinorityInterest" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Non-controlling interests</link:label>
    <link:label id="lab_us-gaap_MinorityInterest_label_en-US" xlink:label="lab_us-gaap_MinorityInterest" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stockholders' Equity Attributable to Noncontrolling Interest</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MinorityInterest" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_MinorityInterest"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_MinorityInterest" xlink:to="lab_us-gaap_MinorityInterest" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_MeasurementInputPriceVolatilityMember_13a0765b-9be7-4a2a-bcd2-a9dc1993c204_terseLabel_en-US" xlink:label="lab_us-gaap_MeasurementInputPriceVolatilityMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Expected annualized volatility</link:label>
    <link:label id="lab_us-gaap_MeasurementInputPriceVolatilityMember_label_en-US" xlink:label="lab_us-gaap_MeasurementInputPriceVolatilityMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Measurement Input, Price Volatility [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MeasurementInputPriceVolatilityMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_MeasurementInputPriceVolatilityMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_MeasurementInputPriceVolatilityMember" xlink:to="lab_us-gaap_MeasurementInputPriceVolatilityMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTableTextBlock_1830ca2c-fd86-4d5a-8ede-79d7007e696d_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Fair Values of Derivative Liabilities</link:label>
    <link:label id="lab_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTableTextBlock_label_en-US" xlink:label="lab_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value Measurement Inputs and Valuation Techniques [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTableTextBlock" xlink:to="lab_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_cron_PreEmptiveRightsAndTopUpRightsMember_2960aa54-7c12-4e6c-92bb-01447299dee1_terseLabel_en-US" xlink:label="lab_cron_PreEmptiveRightsAndTopUpRightsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Pre-emptive Rights and Top-up Rights</link:label>
    <link:label id="lab_cron_PreEmptiveRightsAndTopUpRightsMember_label_en-US" xlink:label="lab_cron_PreEmptiveRightsAndTopUpRightsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Pre-Emptive Rights And Top-Up Rights [Member]</link:label>
    <link:label id="lab_cron_PreEmptiveRightsAndTopUpRightsMember_documentation_en-US" xlink:label="lab_cron_PreEmptiveRightsAndTopUpRightsMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Pre-Emptive Rights And Top-Up Rights</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_cron_PreEmptiveRightsAndTopUpRightsMember" xlink:href="cron-20210630.xsd#cron_PreEmptiveRightsAndTopUpRightsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cron_PreEmptiveRightsAndTopUpRightsMember" xlink:to="lab_cron_PreEmptiveRightsAndTopUpRightsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest_24a0cf96-fe2c-40c4-aff9-732919f26aef_totalLabel_en-US" xlink:label="lab_us-gaap_IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income (loss) from continuing operations</link:label>
    <link:label id="lab_us-gaap_IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest_label_en-US" xlink:label="lab_us-gaap_IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income (Loss) from Continuing Operations, Net of Tax, Including Portion Attributable to Noncontrolling Interest</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest" xlink:to="lab_us-gaap_IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest" xlink:type="arc" order="1"/>
    <link:label id="lab_cron_CollaborativeArrangementInstallmentsReceived_fac595f4-c26f-42a4-bb2a-1ee41ddcd3d6_terseLabel_en-US" xlink:label="lab_cron_CollaborativeArrangementInstallmentsReceived" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Collaborative arrangement, installment received</link:label>
    <link:label id="lab_cron_CollaborativeArrangementInstallmentsReceived_label_en-US" xlink:label="lab_cron_CollaborativeArrangementInstallmentsReceived" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Collaborative Arrangement, Installments Received</link:label>
    <link:label id="lab_cron_CollaborativeArrangementInstallmentsReceived_documentation_en-US" xlink:label="lab_cron_CollaborativeArrangementInstallmentsReceived" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Collaborative Arrangement, Installments Received</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_cron_CollaborativeArrangementInstallmentsReceived" xlink:href="cron-20210630.xsd#cron_CollaborativeArrangementInstallmentsReceived"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cron_CollaborativeArrangementInstallmentsReceived" xlink:to="lab_cron_CollaborativeArrangementInstallmentsReceived" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncreaseDecreaseInAccountsPayableAndOtherOperatingLiabilities_a6de139e-7a53-46b4-bee0-d77a23e81544_terseLabel_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInAccountsPayableAndOtherOperatingLiabilities" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounts payable and other liabilities</link:label>
    <link:label id="lab_us-gaap_IncreaseDecreaseInAccountsPayableAndOtherOperatingLiabilities_label_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInAccountsPayableAndOtherOperatingLiabilities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Increase (Decrease) in Accounts Payable and Other Operating Liabilities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInAccountsPayableAndOtherOperatingLiabilities" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncreaseDecreaseInAccountsPayableAndOtherOperatingLiabilities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncreaseDecreaseInAccountsPayableAndOtherOperatingLiabilities" xlink:to="lab_us-gaap_IncreaseDecreaseInAccountsPayableAndOtherOperatingLiabilities" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccountsPayableAndOtherAccruedLiabilitiesCurrent_e431051a-da07-4ec7-9826-0d5e18f55284_terseLabel_en-US" xlink:label="lab_us-gaap_AccountsPayableAndOtherAccruedLiabilitiesCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounts payable and other liabilities</link:label>
    <link:label id="lab_us-gaap_AccountsPayableAndOtherAccruedLiabilitiesCurrent_label_en-US" xlink:label="lab_us-gaap_AccountsPayableAndOtherAccruedLiabilitiesCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounts Payable and Other Accrued Liabilities, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountsPayableAndOtherAccruedLiabilitiesCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccountsPayableAndOtherAccruedLiabilitiesCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccountsPayableAndOtherAccruedLiabilitiesCurrent" xlink:to="lab_us-gaap_AccountsPayableAndOtherAccruedLiabilitiesCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ConcentrationRiskByBenchmarkAxis_178cd82a-024d-4e1d-97ef-883be1d6d86b_terseLabel_en-US" xlink:label="lab_us-gaap_ConcentrationRiskByBenchmarkAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Concentration Risk Benchmark [Axis]</link:label>
    <link:label id="lab_us-gaap_ConcentrationRiskByBenchmarkAxis_label_en-US" xlink:label="lab_us-gaap_ConcentrationRiskByBenchmarkAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Concentration Risk Benchmark [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskByBenchmarkAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ConcentrationRiskByBenchmarkAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ConcentrationRiskByBenchmarkAxis" xlink:to="lab_us-gaap_ConcentrationRiskByBenchmarkAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AdjustmentsNoncashItemsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_464b4c5e-ddea-41f2-a2dc-f631fc20c1de_terseLabel_en-US" xlink:label="lab_us-gaap_AdjustmentsNoncashItemsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Adjustments to reconcile net loss to cash provided by operating activities:</link:label>
    <link:label id="lab_us-gaap_AdjustmentsNoncashItemsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_label_en-US" xlink:label="lab_us-gaap_AdjustmentsNoncashItemsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Adjustments, Noncash Items, to Reconcile Net Income (Loss) to Cash Provided by (Used in) Operating Activities [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdjustmentsNoncashItemsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AdjustmentsNoncashItemsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AdjustmentsNoncashItemsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:to="lab_us-gaap_AdjustmentsNoncashItemsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:type="arc" order="1"/>
  </link:labelLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.PRE
<SEQUENCE>13
<FILENAME>cron-20210630_pre.xml
<DESCRIPTION>XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT
<TEXT>
<XBRL>
<?xml version="1.0" encoding="UTF-8"?>

<!--XBRL Document Created with Wdesk from Workiva-->
<!--Copyright 2021 Workiva-->
<!--r:198d4367-d088-421d-9dd0-dd878c4919c5,g:e5d1c22f-365f-46d5-96bc-44505885d3ea-->
<link:linkbase xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
  <link:roleRef roleURI="http://thecronosgroup.com/role/CoverPage" xlink:type="simple" xlink:href="cron-20210630.xsd#CoverPage"/>
  <link:presentationLink xlink:role="http://thecronosgroup.com/role/CoverPage" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_dei_CoverAbstract_97746e12-28ec-4457-a1af-c1da58648a64" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_CoverAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentType_c719a4d7-2520-4f94-a807-f1bab592e533" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_DocumentType"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_97746e12-28ec-4457-a1af-c1da58648a64" xlink:to="loc_dei_DocumentType_c719a4d7-2520-4f94-a807-f1bab592e533" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentQuarterlyReport_ef1a648d-970d-44c5-99da-e5ca14f29569" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_DocumentQuarterlyReport"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_97746e12-28ec-4457-a1af-c1da58648a64" xlink:to="loc_dei_DocumentQuarterlyReport_ef1a648d-970d-44c5-99da-e5ca14f29569" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentPeriodEndDate_8425c9c1-23c7-4e1e-be3b-c90e84df6fd0" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_DocumentPeriodEndDate"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_97746e12-28ec-4457-a1af-c1da58648a64" xlink:to="loc_dei_DocumentPeriodEndDate_8425c9c1-23c7-4e1e-be3b-c90e84df6fd0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentTransitionReport_429e3db3-aed9-49ae-92c3-c65b35a8ae79" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_DocumentTransitionReport"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_97746e12-28ec-4457-a1af-c1da58648a64" xlink:to="loc_dei_DocumentTransitionReport_429e3db3-aed9-49ae-92c3-c65b35a8ae79" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityFileNumber_978b8287-cd2b-44e6-a6ad-0ee642237d58" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityFileNumber"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_97746e12-28ec-4457-a1af-c1da58648a64" xlink:to="loc_dei_EntityFileNumber_978b8287-cd2b-44e6-a6ad-0ee642237d58" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityRegistrantName_03d1b2ca-97d1-46f1-b985-034cdb640620" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityRegistrantName"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_97746e12-28ec-4457-a1af-c1da58648a64" xlink:to="loc_dei_EntityRegistrantName_03d1b2ca-97d1-46f1-b985-034cdb640620" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityIncorporationStateCountryCode_94e9e441-a769-46d2-8804-a1239c9cbbfd" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityIncorporationStateCountryCode"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_97746e12-28ec-4457-a1af-c1da58648a64" xlink:to="loc_dei_EntityIncorporationStateCountryCode_94e9e441-a769-46d2-8804-a1239c9cbbfd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressAddressLine1_90ef710f-7a44-4648-9273-117e9e3577fd" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityAddressAddressLine1"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_97746e12-28ec-4457-a1af-c1da58648a64" xlink:to="loc_dei_EntityAddressAddressLine1_90ef710f-7a44-4648-9273-117e9e3577fd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressCityOrTown_a4f8c683-5aa2-4f62-b5be-77d7e7e9d839" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityAddressCityOrTown"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_97746e12-28ec-4457-a1af-c1da58648a64" xlink:to="loc_dei_EntityAddressCityOrTown_a4f8c683-5aa2-4f62-b5be-77d7e7e9d839" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressStateOrProvince_975166ea-7341-4202-a385-540b6e6aeedc" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityAddressStateOrProvince"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_97746e12-28ec-4457-a1af-c1da58648a64" xlink:to="loc_dei_EntityAddressStateOrProvince_975166ea-7341-4202-a385-540b6e6aeedc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressPostalZipCode_9f737b81-01e5-4f56-9ab9-3f1f47cf633e" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityAddressPostalZipCode"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_97746e12-28ec-4457-a1af-c1da58648a64" xlink:to="loc_dei_EntityAddressPostalZipCode_9f737b81-01e5-4f56-9ab9-3f1f47cf633e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_CityAreaCode_fa3695f2-7d46-4152-b9d7-97e47d4ccd0a" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_CityAreaCode"/>
    <link:presentationArc order="12" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_97746e12-28ec-4457-a1af-c1da58648a64" xlink:to="loc_dei_CityAreaCode_fa3695f2-7d46-4152-b9d7-97e47d4ccd0a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_LocalPhoneNumber_32b1e180-fc1f-4ab2-b690-d9d50a682be9" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_LocalPhoneNumber"/>
    <link:presentationArc order="13" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_97746e12-28ec-4457-a1af-c1da58648a64" xlink:to="loc_dei_LocalPhoneNumber_32b1e180-fc1f-4ab2-b690-d9d50a682be9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_Security12bTitle_d14bc00b-6692-4df9-a50d-53762517a3fa" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_Security12bTitle"/>
    <link:presentationArc order="14" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_97746e12-28ec-4457-a1af-c1da58648a64" xlink:to="loc_dei_Security12bTitle_d14bc00b-6692-4df9-a50d-53762517a3fa" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_TradingSymbol_f69580f3-a965-41ef-ba56-7df17e8819ee" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_TradingSymbol"/>
    <link:presentationArc order="15" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_97746e12-28ec-4457-a1af-c1da58648a64" xlink:to="loc_dei_TradingSymbol_f69580f3-a965-41ef-ba56-7df17e8819ee" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_SecurityExchangeName_a84346c2-868d-4679-8c61-7895bbf6ee8e" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_SecurityExchangeName"/>
    <link:presentationArc order="16" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_97746e12-28ec-4457-a1af-c1da58648a64" xlink:to="loc_dei_SecurityExchangeName_a84346c2-868d-4679-8c61-7895bbf6ee8e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityCurrentReportingStatus_b9418878-2c7f-411f-8a97-4d611c6a4a1f" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityCurrentReportingStatus"/>
    <link:presentationArc order="17" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_97746e12-28ec-4457-a1af-c1da58648a64" xlink:to="loc_dei_EntityCurrentReportingStatus_b9418878-2c7f-411f-8a97-4d611c6a4a1f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityInteractiveDataCurrent_0d199498-25ee-4691-8f3c-a69ee397226d" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityInteractiveDataCurrent"/>
    <link:presentationArc order="18" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_97746e12-28ec-4457-a1af-c1da58648a64" xlink:to="loc_dei_EntityInteractiveDataCurrent_0d199498-25ee-4691-8f3c-a69ee397226d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityFilerCategory_b52af3b4-4275-4b1d-a64d-79754ed1e233" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityFilerCategory"/>
    <link:presentationArc order="19" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_97746e12-28ec-4457-a1af-c1da58648a64" xlink:to="loc_dei_EntityFilerCategory_b52af3b4-4275-4b1d-a64d-79754ed1e233" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntitySmallBusiness_09e01bfa-acc9-4b63-acec-ccb0dc266dfa" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntitySmallBusiness"/>
    <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_97746e12-28ec-4457-a1af-c1da58648a64" xlink:to="loc_dei_EntitySmallBusiness_09e01bfa-acc9-4b63-acec-ccb0dc266dfa" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityEmergingGrowthCompany_cb253ec6-c436-467a-b94f-ded554e807ef" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityEmergingGrowthCompany"/>
    <link:presentationArc order="21" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_97746e12-28ec-4457-a1af-c1da58648a64" xlink:to="loc_dei_EntityEmergingGrowthCompany_cb253ec6-c436-467a-b94f-ded554e807ef" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityShellCompany_138eb37d-9fed-4dae-9cd8-215d0ae30cc8" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityShellCompany"/>
    <link:presentationArc order="22" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_97746e12-28ec-4457-a1af-c1da58648a64" xlink:to="loc_dei_EntityShellCompany_138eb37d-9fed-4dae-9cd8-215d0ae30cc8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityCommonStockSharesOutstanding_00af3caf-0d72-48c5-a2bb-736819849ea1" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityCommonStockSharesOutstanding"/>
    <link:presentationArc order="23" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_97746e12-28ec-4457-a1af-c1da58648a64" xlink:to="loc_dei_EntityCommonStockSharesOutstanding_00af3caf-0d72-48c5-a2bb-736819849ea1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_AmendmentFlag_9930a938-34ad-4c01-8e2f-c03d2a567ab0" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_AmendmentFlag"/>
    <link:presentationArc order="24" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_97746e12-28ec-4457-a1af-c1da58648a64" xlink:to="loc_dei_AmendmentFlag_9930a938-34ad-4c01-8e2f-c03d2a567ab0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentFiscalYearFocus_53742967-c728-41c4-b866-2f464c66a5a9" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_DocumentFiscalYearFocus"/>
    <link:presentationArc order="25" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_97746e12-28ec-4457-a1af-c1da58648a64" xlink:to="loc_dei_DocumentFiscalYearFocus_53742967-c728-41c4-b866-2f464c66a5a9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentFiscalPeriodFocus_8422c4b4-fd50-4d67-ba66-1c7c9d918b48" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_DocumentFiscalPeriodFocus"/>
    <link:presentationArc order="26" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_97746e12-28ec-4457-a1af-c1da58648a64" xlink:to="loc_dei_DocumentFiscalPeriodFocus_8422c4b4-fd50-4d67-ba66-1c7c9d918b48" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityCentralIndexKey_5d00101a-0b54-468f-98dc-cb6f26b0bf96" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityCentralIndexKey"/>
    <link:presentationArc order="27" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_97746e12-28ec-4457-a1af-c1da58648a64" xlink:to="loc_dei_EntityCentralIndexKey_5d00101a-0b54-468f-98dc-cb6f26b0bf96" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_CurrentFiscalYearEndDate_ccbe9bbf-f8d6-4f27-ac6c-d84215d2943a" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_CurrentFiscalYearEndDate"/>
    <link:presentationArc order="28" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_97746e12-28ec-4457-a1af-c1da58648a64" xlink:to="loc_dei_CurrentFiscalYearEndDate_ccbe9bbf-f8d6-4f27-ac6c-d84215d2943a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://thecronosgroup.com/role/CondensedConsolidatedBalanceSheets" xlink:type="simple" xlink:href="cron-20210630.xsd#CondensedConsolidatedBalanceSheets"/>
  <link:presentationLink xlink:role="http://thecronosgroup.com/role/CondensedConsolidatedBalanceSheets" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementOfFinancialPositionAbstract_0df77d83-82bc-4abe-9a7d-03f3936482b0" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementOfFinancialPositionAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsAbstract_f8727305-ebf6-4307-9223-4d484e3fb4f2" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AssetsAbstract"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfFinancialPositionAbstract_0df77d83-82bc-4abe-9a7d-03f3936482b0" xlink:to="loc_us-gaap_AssetsAbstract_f8727305-ebf6-4307-9223-4d484e3fb4f2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsCurrentAbstract_18595f88-70f7-4183-a3dc-625b702b7582" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AssetsCurrentAbstract"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsAbstract_f8727305-ebf6-4307-9223-4d484e3fb4f2" xlink:to="loc_us-gaap_AssetsCurrentAbstract_18595f88-70f7-4183-a3dc-625b702b7582" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue_2516effd-df58-4adc-9a9b-4b3c09375152" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CashAndCashEquivalentsAtCarryingValue"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsCurrentAbstract_18595f88-70f7-4183-a3dc-625b702b7582" xlink:to="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue_2516effd-df58-4adc-9a9b-4b3c09375152" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShortTermInvestments_7519e7f7-42ea-4538-b9fd-5f4950f83ecf" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShortTermInvestments"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsCurrentAbstract_18595f88-70f7-4183-a3dc-625b702b7582" xlink:to="loc_us-gaap_ShortTermInvestments_7519e7f7-42ea-4538-b9fd-5f4950f83ecf" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountsReceivableNetCurrent_faa98c53-f9f3-4243-b082-152886c638f9" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccountsReceivableNetCurrent"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsCurrentAbstract_18595f88-70f7-4183-a3dc-625b702b7582" xlink:to="loc_us-gaap_AccountsReceivableNetCurrent_faa98c53-f9f3-4243-b082-152886c638f9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherReceivablesNetCurrent_11f8590a-81b6-40db-8310-b1580a811aac" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherReceivablesNetCurrent"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsCurrentAbstract_18595f88-70f7-4183-a3dc-625b702b7582" xlink:to="loc_us-gaap_OtherReceivablesNetCurrent_11f8590a-81b6-40db-8310-b1580a811aac" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NotesAndLoansReceivableNetCurrent_23e62873-bc2b-46aa-9116-54a0db3c0cc0" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NotesAndLoansReceivableNetCurrent"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsCurrentAbstract_18595f88-70f7-4183-a3dc-625b702b7582" xlink:to="loc_us-gaap_NotesAndLoansReceivableNetCurrent_23e62873-bc2b-46aa-9116-54a0db3c0cc0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PrepaidExpenseAndOtherAssetsCurrent_2d7a411d-5019-4942-9c1f-220f48534e61" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PrepaidExpenseAndOtherAssetsCurrent"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsCurrentAbstract_18595f88-70f7-4183-a3dc-625b702b7582" xlink:to="loc_us-gaap_PrepaidExpenseAndOtherAssetsCurrent_2d7a411d-5019-4942-9c1f-220f48534e61" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryNet_c4951c48-b32b-41c9-825a-97cff714cfc7" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InventoryNet"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsCurrentAbstract_18595f88-70f7-4183-a3dc-625b702b7582" xlink:to="loc_us-gaap_InventoryNet_c4951c48-b32b-41c9-825a-97cff714cfc7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsHeldForSaleNotPartOfDisposalGroupCurrent_954d3785-1726-4d01-ba0f-20eea51fec5a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AssetsHeldForSaleNotPartOfDisposalGroupCurrent"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsCurrentAbstract_18595f88-70f7-4183-a3dc-625b702b7582" xlink:to="loc_us-gaap_AssetsHeldForSaleNotPartOfDisposalGroupCurrent_954d3785-1726-4d01-ba0f-20eea51fec5a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsCurrent_32c515a7-3b5d-4034-af2f-362d4bce2458" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AssetsCurrent"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsCurrentAbstract_18595f88-70f7-4183-a3dc-625b702b7582" xlink:to="loc_us-gaap_AssetsCurrent_32c515a7-3b5d-4034-af2f-362d4bce2458" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdvancesToAffiliate_af3c4c63-008e-4c92-879c-241f7b9caf00" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AdvancesToAffiliate"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsAbstract_f8727305-ebf6-4307-9223-4d484e3fb4f2" xlink:to="loc_us-gaap_AdvancesToAffiliate_af3c4c63-008e-4c92-879c-241f7b9caf00" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityMethodInvestments_9f8d1cb1-57e4-403a-8a00-f29b2fb99efb" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EquityMethodInvestments"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsAbstract_f8727305-ebf6-4307-9223-4d484e3fb4f2" xlink:to="loc_us-gaap_EquityMethodInvestments_9f8d1cb1-57e4-403a-8a00-f29b2fb99efb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherLongTermInvestments_29565ad0-31ab-4e31-b744-31738b5d9417" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherLongTermInvestments"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsAbstract_f8727305-ebf6-4307-9223-4d484e3fb4f2" xlink:to="loc_us-gaap_OtherLongTermInvestments_29565ad0-31ab-4e31-b744-31738b5d9417" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NotesAndLoansReceivableNetNoncurrent_5d491f5d-7cbf-42de-bcc5-e42e5cdcefe6" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NotesAndLoansReceivableNetNoncurrent"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsAbstract_f8727305-ebf6-4307-9223-4d484e3fb4f2" xlink:to="loc_us-gaap_NotesAndLoansReceivableNetNoncurrent_5d491f5d-7cbf-42de-bcc5-e42e5cdcefe6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentNet_cd585172-4504-4799-a1cf-def5889058a3" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PropertyPlantAndEquipmentNet"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsAbstract_f8727305-ebf6-4307-9223-4d484e3fb4f2" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentNet_cd585172-4504-4799-a1cf-def5889058a3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseRightOfUseAsset_c2583792-19d7-4e73-b9b1-8e72bc7284ea" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingLeaseRightOfUseAsset"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsAbstract_f8727305-ebf6-4307-9223-4d484e3fb4f2" xlink:to="loc_us-gaap_OperatingLeaseRightOfUseAsset_c2583792-19d7-4e73-b9b1-8e72bc7284ea" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IntangibleAssetsNetExcludingGoodwill_ee65811f-f684-4a81-92aa-5a64cfac39cb" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IntangibleAssetsNetExcludingGoodwill"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsAbstract_f8727305-ebf6-4307-9223-4d484e3fb4f2" xlink:to="loc_us-gaap_IntangibleAssetsNetExcludingGoodwill_ee65811f-f684-4a81-92aa-5a64cfac39cb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Goodwill_528e656d-2055-4d3f-b7d8-e7e1145f2014" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_Goodwill"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsAbstract_f8727305-ebf6-4307-9223-4d484e3fb4f2" xlink:to="loc_us-gaap_Goodwill_528e656d-2055-4d3f-b7d8-e7e1145f2014" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Assets_c85f6385-8875-4986-8164-5d3ad49aa36f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_Assets"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsAbstract_f8727305-ebf6-4307-9223-4d484e3fb4f2" xlink:to="loc_us-gaap_Assets_c85f6385-8875-4986-8164-5d3ad49aa36f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesAbstract_f3c4f1c3-9c4e-481b-84d4-26abd9ff65ab" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LiabilitiesAbstract"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfFinancialPositionAbstract_0df77d83-82bc-4abe-9a7d-03f3936482b0" xlink:to="loc_us-gaap_LiabilitiesAbstract_f3c4f1c3-9c4e-481b-84d4-26abd9ff65ab" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesCurrentAbstract_40baf34d-0220-4da3-b45a-78af23252710" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LiabilitiesCurrentAbstract"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesAbstract_f3c4f1c3-9c4e-481b-84d4-26abd9ff65ab" xlink:to="loc_us-gaap_LiabilitiesCurrentAbstract_40baf34d-0220-4da3-b45a-78af23252710" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountsPayableAndOtherAccruedLiabilitiesCurrent_bd70ee48-7840-4317-9bb7-4b4cecd457b3" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccountsPayableAndOtherAccruedLiabilitiesCurrent"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesCurrentAbstract_40baf34d-0220-4da3-b45a-78af23252710" xlink:to="loc_us-gaap_AccountsPayableAndOtherAccruedLiabilitiesCurrent_bd70ee48-7840-4317-9bb7-4b4cecd457b3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseLiabilityCurrent_447a04cf-c9d4-49ce-8264-9177b9da96d9" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingLeaseLiabilityCurrent"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesCurrentAbstract_40baf34d-0220-4da3-b45a-78af23252710" xlink:to="loc_us-gaap_OperatingLeaseLiabilityCurrent_447a04cf-c9d4-49ce-8264-9177b9da96d9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeLiabilitiesCurrent_681ae7f3-1dec-4824-8ead-220785764108" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DerivativeLiabilitiesCurrent"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesCurrentAbstract_40baf34d-0220-4da3-b45a-78af23252710" xlink:to="loc_us-gaap_DerivativeLiabilitiesCurrent_681ae7f3-1dec-4824-8ead-220785764108" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesCurrent_63103bf5-aeb4-4891-8e4e-0218058adf23" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LiabilitiesCurrent"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesCurrentAbstract_40baf34d-0220-4da3-b45a-78af23252710" xlink:to="loc_us-gaap_LiabilitiesCurrent_63103bf5-aeb4-4891-8e4e-0218058adf23" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DueToRelatedPartiesNoncurrent_cc253fd9-c5df-4060-8ff2-1383e1ebb05e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DueToRelatedPartiesNoncurrent"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesAbstract_f3c4f1c3-9c4e-481b-84d4-26abd9ff65ab" xlink:to="loc_us-gaap_DueToRelatedPartiesNoncurrent_cc253fd9-c5df-4060-8ff2-1383e1ebb05e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseLiabilityNoncurrent_ac2c68ca-abbb-442a-ab6b-587acb1d262b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingLeaseLiabilityNoncurrent"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesAbstract_f3c4f1c3-9c4e-481b-84d4-26abd9ff65ab" xlink:to="loc_us-gaap_OperatingLeaseLiabilityNoncurrent_ac2c68ca-abbb-442a-ab6b-587acb1d262b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Liabilities_791993e4-06c8-40c5-97a5-f355f3d8c0b9" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_Liabilities"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesAbstract_f3c4f1c3-9c4e-481b-84d4-26abd9ff65ab" xlink:to="loc_us-gaap_Liabilities_791993e4-06c8-40c5-97a5-f355f3d8c0b9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommitmentsAndContingencies_16372b15-976f-49c8-a90b-edd5b536671a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommitmentsAndContingencies"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfFinancialPositionAbstract_0df77d83-82bc-4abe-9a7d-03f3936482b0" xlink:to="loc_us-gaap_CommitmentsAndContingencies_16372b15-976f-49c8-a90b-edd5b536671a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterestAbstract_0b75079e-63e0-4240-90e9-89f2e82616e7" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterestAbstract"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfFinancialPositionAbstract_0df77d83-82bc-4abe-9a7d-03f3936482b0" xlink:to="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterestAbstract_0b75079e-63e0-4240-90e9-89f2e82616e7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockValue_dc4e6566-b3cc-4845-a3e1-f90c598e7f19" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommonStockValue"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterestAbstract_0b75079e-63e0-4240-90e9-89f2e82616e7" xlink:to="loc_us-gaap_CommonStockValue_dc4e6566-b3cc-4845-a3e1-f90c598e7f19" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdditionalPaidInCapital_0ff17931-3ec8-40c0-a431-82e51864bf7d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AdditionalPaidInCapital"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterestAbstract_0b75079e-63e0-4240-90e9-89f2e82616e7" xlink:to="loc_us-gaap_AdditionalPaidInCapital_0ff17931-3ec8-40c0-a431-82e51864bf7d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetainedEarningsAccumulatedDeficit_6d870b4f-c08f-4588-b09d-8f76c50da095" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RetainedEarningsAccumulatedDeficit"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterestAbstract_0b75079e-63e0-4240-90e9-89f2e82616e7" xlink:to="loc_us-gaap_RetainedEarningsAccumulatedDeficit_6d870b4f-c08f-4588-b09d-8f76c50da095" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax_d35d0827-fbec-42a0-8111-600b4595ada2" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterestAbstract_0b75079e-63e0-4240-90e9-89f2e82616e7" xlink:to="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax_d35d0827-fbec-42a0-8111-600b4595ada2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquity_16724468-7da6-4d45-8c2c-fa9d1a0e8e07" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockholdersEquity"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterestAbstract_0b75079e-63e0-4240-90e9-89f2e82616e7" xlink:to="loc_us-gaap_StockholdersEquity_16724468-7da6-4d45-8c2c-fa9d1a0e8e07" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MinorityInterest_0c4ace8c-e3ff-4498-89ec-9eae05e03d2a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_MinorityInterest"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterestAbstract_0b75079e-63e0-4240-90e9-89f2e82616e7" xlink:to="loc_us-gaap_MinorityInterest_0c4ace8c-e3ff-4498-89ec-9eae05e03d2a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_f254399a-b41e-44d8-a9c0-e4e811465952" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterestAbstract_0b75079e-63e0-4240-90e9-89f2e82616e7" xlink:to="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_f254399a-b41e-44d8-a9c0-e4e811465952" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesAndStockholdersEquity_1536cdd1-adcf-4288-837b-e0c35cb7f376" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LiabilitiesAndStockholdersEquity"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfFinancialPositionAbstract_0df77d83-82bc-4abe-9a7d-03f3936482b0" xlink:to="loc_us-gaap_LiabilitiesAndStockholdersEquity_1536cdd1-adcf-4288-837b-e0c35cb7f376" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://thecronosgroup.com/role/CondensedConsolidatedBalanceSheetParenthetical" xlink:type="simple" xlink:href="cron-20210630.xsd#CondensedConsolidatedBalanceSheetParenthetical"/>
  <link:presentationLink xlink:role="http://thecronosgroup.com/role/CondensedConsolidatedBalanceSheetParenthetical" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementOfFinancialPositionAbstract_db5a5388-2e2c-41f2-81a1-182e72c60e5a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementOfFinancialPositionAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockSharesIssued_165c0b70-2638-4b50-ba3e-2335b2288f8e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommonStockSharesIssued"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfFinancialPositionAbstract_db5a5388-2e2c-41f2-81a1-182e72c60e5a" xlink:to="loc_us-gaap_CommonStockSharesIssued_165c0b70-2638-4b50-ba3e-2335b2288f8e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://thecronosgroup.com/role/CondensedConsolidatedStatementsofNetIncomeLossandComprehensiveIncomeLoss" xlink:type="simple" xlink:href="cron-20210630.xsd#CondensedConsolidatedStatementsofNetIncomeLossandComprehensiveIncomeLoss"/>
  <link:presentationLink xlink:role="http://thecronosgroup.com/role/CondensedConsolidatedStatementsofNetIncomeLossandComprehensiveIncomeLoss" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementAbstract_e33bb8fc-6e4f-4675-b235-1d977036e67d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeStatementAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerIncludingAssessedTax_21ef6455-75a5-45ed-aa38-f1b87ee8eb05" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RevenueFromContractWithCustomerIncludingAssessedTax"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementAbstract_e33bb8fc-6e4f-4675-b235-1d977036e67d" xlink:to="loc_us-gaap_RevenueFromContractWithCustomerIncludingAssessedTax_21ef6455-75a5-45ed-aa38-f1b87ee8eb05" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ExciseAndSalesTaxes_413ff7f1-9df6-478d-9b4b-53b5e4a3c415" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ExciseAndSalesTaxes"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementAbstract_e33bb8fc-6e4f-4675-b235-1d977036e67d" xlink:to="loc_us-gaap_ExciseAndSalesTaxes_413ff7f1-9df6-478d-9b4b-53b5e4a3c415" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_3f527a87-cfe1-4015-8b72-ed7867b1e261" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementAbstract_e33bb8fc-6e4f-4675-b235-1d977036e67d" xlink:to="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_3f527a87-cfe1-4015-8b72-ed7867b1e261" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cron_OtherCostOfGoodsAndServicesSold_33c324dd-b69c-48f0-814d-ca984f546548" xlink:href="cron-20210630.xsd#cron_OtherCostOfGoodsAndServicesSold"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementAbstract_e33bb8fc-6e4f-4675-b235-1d977036e67d" xlink:to="loc_cron_OtherCostOfGoodsAndServicesSold_33c324dd-b69c-48f0-814d-ca984f546548" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryWriteDown_4427937e-dd7f-4e55-a38b-f81aee0e6716" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InventoryWriteDown"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementAbstract_e33bb8fc-6e4f-4675-b235-1d977036e67d" xlink:to="loc_us-gaap_InventoryWriteDown_4427937e-dd7f-4e55-a38b-f81aee0e6716" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GrossProfit_37cabd50-a914-4a23-8dac-a1f0df30538d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_GrossProfit"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementAbstract_e33bb8fc-6e4f-4675-b235-1d977036e67d" xlink:to="loc_us-gaap_GrossProfit_37cabd50-a914-4a23-8dac-a1f0df30538d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingExpensesAbstract_83f50eb3-b429-4fac-ac8c-aa338d42f7b3" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingExpensesAbstract"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementAbstract_e33bb8fc-6e4f-4675-b235-1d977036e67d" xlink:to="loc_us-gaap_OperatingExpensesAbstract_83f50eb3-b429-4fac-ac8c-aa338d42f7b3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SellingAndMarketingExpense_a401a64d-882f-47a7-87dd-47eb4c107207" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SellingAndMarketingExpense"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OperatingExpensesAbstract_83f50eb3-b429-4fac-ac8c-aa338d42f7b3" xlink:to="loc_us-gaap_SellingAndMarketingExpense_a401a64d-882f-47a7-87dd-47eb4c107207" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ResearchAndDevelopmentExpense_cc441970-5613-424e-8b25-33316f5eff2f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ResearchAndDevelopmentExpense"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OperatingExpensesAbstract_83f50eb3-b429-4fac-ac8c-aa338d42f7b3" xlink:to="loc_us-gaap_ResearchAndDevelopmentExpense_cc441970-5613-424e-8b25-33316f5eff2f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GeneralAndAdministrativeExpense_f5be56db-2428-4394-8fdb-51979fd7d55f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_GeneralAndAdministrativeExpense"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OperatingExpensesAbstract_83f50eb3-b429-4fac-ac8c-aa338d42f7b3" xlink:to="loc_us-gaap_GeneralAndAdministrativeExpense_f5be56db-2428-4394-8fdb-51979fd7d55f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AllocatedShareBasedCompensationExpense_626e3143-2809-46fe-8665-048f2cf008e4" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AllocatedShareBasedCompensationExpense"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OperatingExpensesAbstract_83f50eb3-b429-4fac-ac8c-aa338d42f7b3" xlink:to="loc_us-gaap_AllocatedShareBasedCompensationExpense_626e3143-2809-46fe-8665-048f2cf008e4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DepreciationAndAmortization_f0fe0228-ca73-49fa-9dcd-ed2f5d2a836d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DepreciationAndAmortization"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OperatingExpensesAbstract_83f50eb3-b429-4fac-ac8c-aa338d42f7b3" xlink:to="loc_us-gaap_DepreciationAndAmortization_f0fe0228-ca73-49fa-9dcd-ed2f5d2a836d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingExpenses_8bbca72b-34c7-4fbd-a606-85e695471457" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingExpenses"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OperatingExpensesAbstract_83f50eb3-b429-4fac-ac8c-aa338d42f7b3" xlink:to="loc_us-gaap_OperatingExpenses_8bbca72b-34c7-4fbd-a606-85e695471457" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingIncomeLoss_6fc36df4-bf76-4bf5-9258-495d1314bc6b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingIncomeLoss"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementAbstract_e33bb8fc-6e4f-4675-b235-1d977036e67d" xlink:to="loc_us-gaap_OperatingIncomeLoss_6fc36df4-bf76-4bf5-9258-495d1314bc6b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NonoperatingIncomeExpenseAbstract_4812e1fd-a92e-40db-8373-ab19f46fc135" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NonoperatingIncomeExpenseAbstract"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementAbstract_e33bb8fc-6e4f-4675-b235-1d977036e67d" xlink:to="loc_us-gaap_NonoperatingIncomeExpenseAbstract_4812e1fd-a92e-40db-8373-ab19f46fc135" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestIncomeExpenseNonoperatingNet_ae13b88d-a91d-4ae8-a8f9-9e58ed43e40f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InterestIncomeExpenseNonoperatingNet"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NonoperatingIncomeExpenseAbstract_4812e1fd-a92e-40db-8373-ab19f46fc135" xlink:to="loc_us-gaap_InterestIncomeExpenseNonoperatingNet_ae13b88d-a91d-4ae8-a8f9-9e58ed43e40f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GainLossOnDerivativeInstrumentsNetPretax_b836d15a-04d2-413b-b71c-fd5e892f3d56" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_GainLossOnDerivativeInstrumentsNetPretax"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NonoperatingIncomeExpenseAbstract_4812e1fd-a92e-40db-8373-ab19f46fc135" xlink:to="loc_us-gaap_GainLossOnDerivativeInstrumentsNetPretax_b836d15a-04d2-413b-b71c-fd5e892f3d56" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetImpairmentCharges_92b858e5-82b7-4abc-ac94-adf28252e5a4" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AssetImpairmentCharges"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NonoperatingIncomeExpenseAbstract_4812e1fd-a92e-40db-8373-ab19f46fc135" xlink:to="loc_us-gaap_AssetImpairmentCharges_92b858e5-82b7-4abc-ac94-adf28252e5a4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromEquityMethodInvestments_0aa8c80e-9e83-4cd4-84f2-aeabcefe589f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeLossFromEquityMethodInvestments"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NonoperatingIncomeExpenseAbstract_4812e1fd-a92e-40db-8373-ab19f46fc135" xlink:to="loc_us-gaap_IncomeLossFromEquityMethodInvestments_0aa8c80e-9e83-4cd4-84f2-aeabcefe589f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherNonoperatingIncomeExpense_99164416-393d-443a-8260-4b0610dfe32e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherNonoperatingIncomeExpense"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NonoperatingIncomeExpenseAbstract_4812e1fd-a92e-40db-8373-ab19f46fc135" xlink:to="loc_us-gaap_OtherNonoperatingIncomeExpense_99164416-393d-443a-8260-4b0610dfe32e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NonoperatingIncomeExpense_74dc8977-0d39-4c47-9dda-38b9ff87c836" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NonoperatingIncomeExpense"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NonoperatingIncomeExpenseAbstract_4812e1fd-a92e-40db-8373-ab19f46fc135" xlink:to="loc_us-gaap_NonoperatingIncomeExpense_74dc8977-0d39-4c47-9dda-38b9ff87c836" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest_081e9ef4-b80b-4323-8713-6027a65f87a8" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementAbstract_e33bb8fc-6e4f-4675-b235-1d977036e67d" xlink:to="loc_us-gaap_IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest_081e9ef4-b80b-4323-8713-6027a65f87a8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTax_474013dc-f677-4441-b2d7-a672342de4e0" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTax"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementAbstract_e33bb8fc-6e4f-4675-b235-1d977036e67d" xlink:to="loc_us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTax_474013dc-f677-4441-b2d7-a672342de4e0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProfitLoss_a8f032fd-183d-400d-8749-17aaa0a4b75b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ProfitLoss"/>
    <link:presentationArc order="12" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementAbstract_e33bb8fc-6e4f-4675-b235-1d977036e67d" xlink:to="loc_us-gaap_ProfitLoss_a8f032fd-183d-400d-8749-17aaa0a4b75b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLossAttributableToNoncontrollingInterest_65daae5e-9067-46e3-b586-7b9b152f7f61" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetIncomeLossAttributableToNoncontrollingInterest"/>
    <link:presentationArc order="13" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementAbstract_e33bb8fc-6e4f-4675-b235-1d977036e67d" xlink:to="loc_us-gaap_NetIncomeLossAttributableToNoncontrollingInterest_65daae5e-9067-46e3-b586-7b9b152f7f61" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLoss_55cb4750-d8a0-46f1-bdd9-f7ef6a5df7a6" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetIncomeLoss"/>
    <link:presentationArc order="14" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementAbstract_e33bb8fc-6e4f-4675-b235-1d977036e67d" xlink:to="loc_us-gaap_NetIncomeLoss_55cb4750-d8a0-46f1-bdd9-f7ef6a5df7a6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract_e51ecc05-5566-48c2-88c9-7c3c17fcd4e3" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract"/>
    <link:presentationArc order="15" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementAbstract_e33bb8fc-6e4f-4675-b235-1d977036e67d" xlink:to="loc_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract_e51ecc05-5566-48c2-88c9-7c3c17fcd4e3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProfitLoss_a3e0885e-c3b2-4c12-af5e-fc3ed15f1327" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ProfitLoss"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract_e51ecc05-5566-48c2-88c9-7c3c17fcd4e3" xlink:to="loc_us-gaap_ProfitLoss_a3e0885e-c3b2-4c12-af5e-fc3ed15f1327" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract_23e39d12-4e49-4b0d-9c4a-15559cafdd03" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract_e51ecc05-5566-48c2-88c9-7c3c17fcd4e3" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract_23e39d12-4e49-4b0d-9c4a-15559cafdd03" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax_ad7363f8-8bdc-4b67-8236-c5209cb8f5c3" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract_23e39d12-4e49-4b0d-9c4a-15559cafdd03" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax_ad7363f8-8bdc-4b67-8236-c5209cb8f5c3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTax_9e20ef5f-3522-4d0d-a4d1-d298b25bb4d1" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossNetOfTax"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract_23e39d12-4e49-4b0d-9c4a-15559cafdd03" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTax_9e20ef5f-3522-4d0d-a4d1-d298b25bb4d1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest_c7b98b83-ee5b-4b3b-8457-f65e6884dfe0" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract_e51ecc05-5566-48c2-88c9-7c3c17fcd4e3" xlink:to="loc_us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest_c7b98b83-ee5b-4b3b-8457-f65e6884dfe0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest_f178ba71-0f6e-4a4d-b8ed-30c4d4a8aa2d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract_e51ecc05-5566-48c2-88c9-7c3c17fcd4e3" xlink:to="loc_us-gaap_ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest_f178ba71-0f6e-4a4d-b8ed-30c4d4a8aa2d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ComprehensiveIncomeNetOfTax_7c307666-ce73-4a67-9714-8e0385c694c1" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ComprehensiveIncomeNetOfTax"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract_e51ecc05-5566-48c2-88c9-7c3c17fcd4e3" xlink:to="loc_us-gaap_ComprehensiveIncomeNetOfTax_7c307666-ce73-4a67-9714-8e0385c694c1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareBasicAndDilutedAbstract_f7241237-afd7-4c17-afd4-6df994b8dfba" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EarningsPerShareBasicAndDilutedAbstract"/>
    <link:presentationArc order="16" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementAbstract_e33bb8fc-6e4f-4675-b235-1d977036e67d" xlink:to="loc_us-gaap_EarningsPerShareBasicAndDilutedAbstract_f7241237-afd7-4c17-afd4-6df994b8dfba" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromContinuingOperationsPerBasicShare_a5a4b12d-3ae1-4f92-9ca7-42a46df46d7f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeLossFromContinuingOperationsPerBasicShare"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EarningsPerShareBasicAndDilutedAbstract_f7241237-afd7-4c17-afd4-6df994b8dfba" xlink:to="loc_us-gaap_IncomeLossFromContinuingOperationsPerBasicShare_a5a4b12d-3ae1-4f92-9ca7-42a46df46d7f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromContinuingOperationsPerDilutedShare_1de7a317-a1c1-4156-951d-90ebf9ec7212" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeLossFromContinuingOperationsPerDilutedShare"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EarningsPerShareBasicAndDilutedAbstract_f7241237-afd7-4c17-afd4-6df994b8dfba" xlink:to="loc_us-gaap_IncomeLossFromContinuingOperationsPerDilutedShare_1de7a317-a1c1-4156-951d-90ebf9ec7212" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareBasicAndDilutedOtherDisclosuresAbstract_39f93f70-55d5-4fff-96cb-10c7f4a9c5a4" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EarningsPerShareBasicAndDilutedOtherDisclosuresAbstract"/>
    <link:presentationArc order="17" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementAbstract_e33bb8fc-6e4f-4675-b235-1d977036e67d" xlink:to="loc_us-gaap_EarningsPerShareBasicAndDilutedOtherDisclosuresAbstract_39f93f70-55d5-4fff-96cb-10c7f4a9c5a4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_08387ec9-7389-4dd8-b704-eb207f014148" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_WeightedAverageNumberOfSharesOutstandingBasic"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EarningsPerShareBasicAndDilutedOtherDisclosuresAbstract_39f93f70-55d5-4fff-96cb-10c7f4a9c5a4" xlink:to="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_08387ec9-7389-4dd8-b704-eb207f014148" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_641381af-637d-4bed-8f4e-fe32e7d137aa" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EarningsPerShareBasicAndDilutedOtherDisclosuresAbstract_39f93f70-55d5-4fff-96cb-10c7f4a9c5a4" xlink:to="loc_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_641381af-637d-4bed-8f4e-fe32e7d137aa" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://thecronosgroup.com/role/CondensedConsolidatedStatementsofChangesinEquity" xlink:type="simple" xlink:href="cron-20210630.xsd#CondensedConsolidatedStatementsofChangesinEquity"/>
  <link:presentationLink xlink:role="http://thecronosgroup.com/role/CondensedConsolidatedStatementsofChangesinEquity" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementOfStockholdersEquityAbstract_9d6e7a18-4e49-4324-b7cb-2eb7915def4f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementOfStockholdersEquityAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementTable_114de933-5614-41cb-b416-c17b7834527c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfStockholdersEquityAbstract_9d6e7a18-4e49-4324-b7cb-2eb7915def4f" xlink:to="loc_us-gaap_StatementTable_114de933-5614-41cb-b416-c17b7834527c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementEquityComponentsAxis_31849148-53af-4337-a095-9e9fc7661194" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementEquityComponentsAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementTable_114de933-5614-41cb-b416-c17b7834527c" xlink:to="loc_us-gaap_StatementEquityComponentsAxis_31849148-53af-4337-a095-9e9fc7661194" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityComponentDomain_0dd49764-f589-4543-b63e-fa3ce0d801fa" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EquityComponentDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementEquityComponentsAxis_31849148-53af-4337-a095-9e9fc7661194" xlink:to="loc_us-gaap_EquityComponentDomain_0dd49764-f589-4543-b63e-fa3ce0d801fa" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockMember_dc69e18e-d1fa-4cca-b995-78a5be4fde18" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommonStockMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityComponentDomain_0dd49764-f589-4543-b63e-fa3ce0d801fa" xlink:to="loc_us-gaap_CommonStockMember_dc69e18e-d1fa-4cca-b995-78a5be4fde18" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdditionalPaidInCapitalMember_39967651-bdad-4fbb-8769-68aae773ab38" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AdditionalPaidInCapitalMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityComponentDomain_0dd49764-f589-4543-b63e-fa3ce0d801fa" xlink:to="loc_us-gaap_AdditionalPaidInCapitalMember_39967651-bdad-4fbb-8769-68aae773ab38" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetainedEarningsMember_7b71b587-86f1-4b7c-b294-57468b97da5e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RetainedEarningsMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityComponentDomain_0dd49764-f589-4543-b63e-fa3ce0d801fa" xlink:to="loc_us-gaap_RetainedEarningsMember_7b71b587-86f1-4b7c-b294-57468b97da5e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeMember_c863dd48-0c2c-4707-bd79-85476bf79adc" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeMember"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityComponentDomain_0dd49764-f589-4543-b63e-fa3ce0d801fa" xlink:to="loc_us-gaap_AccumulatedOtherComprehensiveIncomeMember_c863dd48-0c2c-4707-bd79-85476bf79adc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NoncontrollingInterestMember_4218f357-54ba-43e0-ad4c-7d7e61e9a2ba" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NoncontrollingInterestMember"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityComponentDomain_0dd49764-f589-4543-b63e-fa3ce0d801fa" xlink:to="loc_us-gaap_NoncontrollingInterestMember_4218f357-54ba-43e0-ad4c-7d7e61e9a2ba" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementLineItems_3706e504-c212-49a4-9024-0e681b04a72b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementTable_114de933-5614-41cb-b416-c17b7834527c" xlink:to="loc_us-gaap_StatementLineItems_3706e504-c212-49a4-9024-0e681b04a72b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_d16da9b3-b34e-48f6-833c-9d409644adbc" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncreaseDecreaseInStockholdersEquityRollForward"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_3706e504-c212-49a4-9024-0e681b04a72b" xlink:to="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_d16da9b3-b34e-48f6-833c-9d409644adbc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockSharesOutstanding_0c774d55-4092-486e-ab63-79240680e0d1" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommonStockSharesOutstanding"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_d16da9b3-b34e-48f6-833c-9d409644adbc" xlink:to="loc_us-gaap_CommonStockSharesOutstanding_0c774d55-4092-486e-ab63-79240680e0d1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_2ba56bb8-c72d-4a91-889c-f6dccdad2af6" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_d16da9b3-b34e-48f6-833c-9d409644adbc" xlink:to="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_2ba56bb8-c72d-4a91-889c-f6dccdad2af6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cron_SharebasedCompensationArrangementBySharebasedPaymentAwardWarrantsExercisesInPeriod_56229802-512e-4b32-a289-a7d91e6a5370" xlink:href="cron-20210630.xsd#cron_SharebasedCompensationArrangementBySharebasedPaymentAwardWarrantsExercisesInPeriod"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_d16da9b3-b34e-48f6-833c-9d409644adbc" xlink:to="loc_cron_SharebasedCompensationArrangementBySharebasedPaymentAwardWarrantsExercisesInPeriod_56229802-512e-4b32-a289-a7d91e6a5370" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cron_StockIssuedDuringPeriodValueWarrantsExercised_dfecd52f-d7f2-4a5e-b614-e931fb882d6d" xlink:href="cron-20210630.xsd#cron_StockIssuedDuringPeriodValueWarrantsExercised"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_d16da9b3-b34e-48f6-833c-9d409644adbc" xlink:to="loc_cron_StockIssuedDuringPeriodValueWarrantsExercised_dfecd52f-d7f2-4a5e-b614-e931fb882d6d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsRequisiteServicePeriodRecognition_ab6aaaa3-91dd-4cd5-8a8e-b2f70a7dc513" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsRequisiteServicePeriodRecognition"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_d16da9b3-b34e-48f6-833c-9d409644adbc" xlink:to="loc_us-gaap_AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsRequisiteServicePeriodRecognition_ab6aaaa3-91dd-4cd5-8a8e-b2f70a7dc513" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised_19b0ba91-c2c4-488b-a248-bddd7fdb6ab4" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_d16da9b3-b34e-48f6-833c-9d409644adbc" xlink:to="loc_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised_19b0ba91-c2c4-488b-a248-bddd7fdb6ab4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised_7a41ff20-79b3-4401-9148-159e859c70a8" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_d16da9b3-b34e-48f6-833c-9d409644adbc" xlink:to="loc_us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised_7a41ff20-79b3-4401-9148-159e859c70a8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodSharesRestrictedStockAwardNetOfForfeitures_3d5f46ff-6305-4666-a762-caeed6b8c8b9" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockIssuedDuringPeriodSharesRestrictedStockAwardNetOfForfeitures"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_d16da9b3-b34e-48f6-833c-9d409644adbc" xlink:to="loc_us-gaap_StockIssuedDuringPeriodSharesRestrictedStockAwardNetOfForfeitures_3d5f46ff-6305-4666-a762-caeed6b8c8b9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures_a4edf586-cfef-44f4-8238-88818a222e2a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_d16da9b3-b34e-48f6-833c-9d409644adbc" xlink:to="loc_us-gaap_StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures_a4edf586-cfef-44f4-8238-88818a222e2a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation_680ffe6c-46c3-4719-bbb6-c023e4add2ff" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_d16da9b3-b34e-48f6-833c-9d409644adbc" xlink:to="loc_us-gaap_AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation_680ffe6c-46c3-4719-bbb6-c023e4add2ff" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationRestrictedStockUnitsRequisiteServicePeriodRecognition_02500f28-6ec1-4e71-ba35-519d10a58de8" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationRestrictedStockUnitsRequisiteServicePeriodRecognition"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_d16da9b3-b34e-48f6-833c-9d409644adbc" xlink:to="loc_us-gaap_AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationRestrictedStockUnitsRequisiteServicePeriodRecognition_02500f28-6ec1-4e71-ba35-519d10a58de8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationOtherLongtermIncentivePlansRequisiteServicePeriodRecognition_5456614b-405f-4714-bbe9-d133cccaff0c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationOtherLongtermIncentivePlansRequisiteServicePeriodRecognition"/>
    <link:presentationArc order="12" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_d16da9b3-b34e-48f6-833c-9d409644adbc" xlink:to="loc_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationOtherLongtermIncentivePlansRequisiteServicePeriodRecognition_5456614b-405f-4714-bbe9-d133cccaff0c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cron_StockholdersEquityOutOfPeriodAdjustment_81349103-5491-4473-9073-0d813cb68bfe" xlink:href="cron-20210630.xsd#cron_StockholdersEquityOutOfPeriodAdjustment"/>
    <link:presentationArc order="13" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_d16da9b3-b34e-48f6-833c-9d409644adbc" xlink:to="loc_cron_StockholdersEquityOutOfPeriodAdjustment_81349103-5491-4473-9073-0d813cb68bfe" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cron_StockIssuedDuringPeriodValueTopupRightsExercised_fb1c14bf-2639-440b-8b81-27aee0310ff0" xlink:href="cron-20210630.xsd#cron_StockIssuedDuringPeriodValueTopupRightsExercised"/>
    <link:presentationArc order="14" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_d16da9b3-b34e-48f6-833c-9d409644adbc" xlink:to="loc_cron_StockIssuedDuringPeriodValueTopupRightsExercised_fb1c14bf-2639-440b-8b81-27aee0310ff0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProfitLoss_ad4906de-b06e-4633-a8c5-e23798f525bb" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ProfitLoss"/>
    <link:presentationArc order="15" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_d16da9b3-b34e-48f6-833c-9d409644adbc" xlink:to="loc_us-gaap_ProfitLoss_ad4906de-b06e-4633-a8c5-e23798f525bb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax_05cb7245-e504-41a4-8bfb-a08051003f8e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax"/>
    <link:presentationArc order="16" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_d16da9b3-b34e-48f6-833c-9d409644adbc" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax_05cb7245-e504-41a4-8bfb-a08051003f8e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockSharesOutstanding_e7be8a50-14bb-4da7-8a5e-6f3e8e38ef7a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommonStockSharesOutstanding"/>
    <link:presentationArc order="17" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_d16da9b3-b34e-48f6-833c-9d409644adbc" xlink:to="loc_us-gaap_CommonStockSharesOutstanding_e7be8a50-14bb-4da7-8a5e-6f3e8e38ef7a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_0bb91785-07f7-4c7e-8b04-2e2a81bf112c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest"/>
    <link:presentationArc order="18" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_d16da9b3-b34e-48f6-833c-9d409644adbc" xlink:to="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_0bb91785-07f7-4c7e-8b04-2e2a81bf112c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://thecronosgroup.com/role/CondensedConsolidatedStatementsofCashFlows" xlink:type="simple" xlink:href="cron-20210630.xsd#CondensedConsolidatedStatementsofCashFlows"/>
  <link:presentationLink xlink:role="http://thecronosgroup.com/role/CondensedConsolidatedStatementsofCashFlows" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementOfCashFlowsAbstract_85743eec-c966-4fbe-b0b0-8007768b62e6" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementOfCashFlowsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_1e9f70e5-d430-4660-acaa-36f2845f3c57" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfCashFlowsAbstract_85743eec-c966-4fbe-b0b0-8007768b62e6" xlink:to="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_1e9f70e5-d430-4660-acaa-36f2845f3c57" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProfitLoss_cac00bfe-1686-4c28-a320-6fd13678b918" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ProfitLoss"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_1e9f70e5-d430-4660-acaa-36f2845f3c57" xlink:to="loc_us-gaap_ProfitLoss_cac00bfe-1686-4c28-a320-6fd13678b918" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdjustmentsNoncashItemsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_02195c1a-df15-4dfe-8f35-57095e31e8d0" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AdjustmentsNoncashItemsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_1e9f70e5-d430-4660-acaa-36f2845f3c57" xlink:to="loc_us-gaap_AdjustmentsNoncashItemsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_02195c1a-df15-4dfe-8f35-57095e31e8d0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensation_e7a68d60-af3f-467a-a498-91eeecc5fbf3" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensation"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AdjustmentsNoncashItemsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_02195c1a-df15-4dfe-8f35-57095e31e8d0" xlink:to="loc_us-gaap_ShareBasedCompensation_e7a68d60-af3f-467a-a498-91eeecc5fbf3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DepreciationDepletionAndAmortization_f13a53e8-be5a-411b-bfc1-0e71181aee84" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DepreciationDepletionAndAmortization"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AdjustmentsNoncashItemsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_02195c1a-df15-4dfe-8f35-57095e31e8d0" xlink:to="loc_us-gaap_DepreciationDepletionAndAmortization_f13a53e8-be5a-411b-bfc1-0e71181aee84" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromEquityMethodInvestments_412847dc-f3b8-469b-a7f4-4cede52036f6" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeLossFromEquityMethodInvestments"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AdjustmentsNoncashItemsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_02195c1a-df15-4dfe-8f35-57095e31e8d0" xlink:to="loc_us-gaap_IncomeLossFromEquityMethodInvestments_412847dc-f3b8-469b-a7f4-4cede52036f6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GainLossOnDerivativeInstrumentsNetPretax_b83f688d-3573-49dd-b2cc-ae185a6f1285" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_GainLossOnDerivativeInstrumentsNetPretax"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AdjustmentsNoncashItemsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_02195c1a-df15-4dfe-8f35-57095e31e8d0" xlink:to="loc_us-gaap_GainLossOnDerivativeInstrumentsNetPretax_b83f688d-3573-49dd-b2cc-ae185a6f1285" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetImpairmentCharges_6df32829-4c41-42eb-bfa3-71c708cb5db2" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AssetImpairmentCharges"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AdjustmentsNoncashItemsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_02195c1a-df15-4dfe-8f35-57095e31e8d0" xlink:to="loc_us-gaap_AssetImpairmentCharges_6df32829-4c41-42eb-bfa3-71c708cb5db2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProvisionForDoubtfulAccounts_5370da93-a9c3-45d9-ad99-f7e755dbc9c8" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ProvisionForDoubtfulAccounts"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AdjustmentsNoncashItemsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_02195c1a-df15-4dfe-8f35-57095e31e8d0" xlink:to="loc_us-gaap_ProvisionForDoubtfulAccounts_5370da93-a9c3-45d9-ad99-f7e755dbc9c8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherNoncashIncomeExpense_cc8dbb97-06a0-4a80-9d3b-14efe6c13290" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherNoncashIncomeExpense"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AdjustmentsNoncashItemsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_02195c1a-df15-4dfe-8f35-57095e31e8d0" xlink:to="loc_us-gaap_OtherNoncashIncomeExpense_cc8dbb97-06a0-4a80-9d3b-14efe6c13290" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_28e553d9-b93b-46a6-a828-afc563b73c8a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncreaseDecreaseInOperatingCapitalAbstract"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AdjustmentsNoncashItemsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_02195c1a-df15-4dfe-8f35-57095e31e8d0" xlink:to="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_28e553d9-b93b-46a6-a828-afc563b73c8a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInAccountsReceivable_51eff226-b0a7-4744-9d46-219bab79c974" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncreaseDecreaseInAccountsReceivable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_28e553d9-b93b-46a6-a828-afc563b73c8a" xlink:to="loc_us-gaap_IncreaseDecreaseInAccountsReceivable_51eff226-b0a7-4744-9d46-219bab79c974" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInOtherReceivables_0348f24f-95d7-4ac7-ba1d-930b527bb1d1" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncreaseDecreaseInOtherReceivables"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_28e553d9-b93b-46a6-a828-afc563b73c8a" xlink:to="loc_us-gaap_IncreaseDecreaseInOtherReceivables_0348f24f-95d7-4ac7-ba1d-930b527bb1d1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets_e34e3131-a74f-44ec-a38e-3013a5781fe3" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_28e553d9-b93b-46a6-a828-afc563b73c8a" xlink:to="loc_us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets_e34e3131-a74f-44ec-a38e-3013a5781fe3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInInventories_ebd28bba-d561-45af-9800-94fdcdf9c521" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncreaseDecreaseInInventories"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_28e553d9-b93b-46a6-a828-afc563b73c8a" xlink:to="loc_us-gaap_IncreaseDecreaseInInventories_ebd28bba-d561-45af-9800-94fdcdf9c521" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryWriteDown_d628b8e9-52ef-4432-8506-b53264618bce" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InventoryWriteDown"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_28e553d9-b93b-46a6-a828-afc563b73c8a" xlink:to="loc_us-gaap_InventoryWriteDown_d628b8e9-52ef-4432-8506-b53264618bce" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInAccountsPayableAndOtherOperatingLiabilities_dbcc3ac0-0c4a-4c5d-a9db-7a94095f3146" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncreaseDecreaseInAccountsPayableAndOtherOperatingLiabilities"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_28e553d9-b93b-46a6-a828-afc563b73c8a" xlink:to="loc_us-gaap_IncreaseDecreaseInAccountsPayableAndOtherOperatingLiabilities_dbcc3ac0-0c4a-4c5d-a9db-7a94095f3146" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_fa4e593b-e002-4505-9384-86085356e666" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivities"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_1e9f70e5-d430-4660-acaa-36f2845f3c57" xlink:to="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_fa4e593b-e002-4505-9384-86085356e666" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_f3a7ae63-2f6c-4851-8c8d-f43a519249e5" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfCashFlowsAbstract_85743eec-c966-4fbe-b0b0-8007768b62e6" xlink:to="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_f3a7ae63-2f6c-4851-8c8d-f43a519249e5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquireMarketableSecurities_2a46b2b2-9524-4e16-bd92-81870ee7ac48" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PaymentsToAcquireMarketableSecurities"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_f3a7ae63-2f6c-4851-8c8d-f43a519249e5" xlink:to="loc_us-gaap_PaymentsToAcquireMarketableSecurities_2a46b2b2-9524-4e16-bd92-81870ee7ac48" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromSaleAndMaturityOfMarketableSecurities_75316543-fe5a-40fc-91b3-4029931d1f7f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ProceedsFromSaleAndMaturityOfMarketableSecurities"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_f3a7ae63-2f6c-4851-8c8d-f43a519249e5" xlink:to="loc_us-gaap_ProceedsFromSaleAndMaturityOfMarketableSecurities_75316543-fe5a-40fc-91b3-4029931d1f7f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquireOtherInvestments_fbae6858-e810-404e-a331-4ecdfa98c234" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PaymentsToAcquireOtherInvestments"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_f3a7ae63-2f6c-4851-8c8d-f43a519249e5" xlink:to="loc_us-gaap_PaymentsToAcquireOtherInvestments_fbae6858-e810-404e-a331-4ecdfa98c234" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment_069e10d1-64b4-4704-bd66-66bea53a0328" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PaymentsToAcquirePropertyPlantAndEquipment"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_f3a7ae63-2f6c-4851-8c8d-f43a519249e5" xlink:to="loc_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment_069e10d1-64b4-4704-bd66-66bea53a0328" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquireIntangibleAssets_9823d15d-9271-4c1b-bd6d-de7d064a71a5" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PaymentsToAcquireIntangibleAssets"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_f3a7ae63-2f6c-4851-8c8d-f43a519249e5" xlink:to="loc_us-gaap_PaymentsToAcquireIntangibleAssets_9823d15d-9271-4c1b-bd6d-de7d064a71a5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromSaleOfPropertyHeldForSale_ad75f160-c3b1-4b4e-a0c2-86b3a0745d38" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ProceedsFromSaleOfPropertyHeldForSale"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_f3a7ae63-2f6c-4851-8c8d-f43a519249e5" xlink:to="loc_us-gaap_ProceedsFromSaleOfPropertyHeldForSale_ad75f160-c3b1-4b4e-a0c2-86b3a0745d38" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquireLoansReceivable_26f1b301-e5c5-46c2-a4ec-8c739868a48a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PaymentsToAcquireLoansReceivable"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_f3a7ae63-2f6c-4851-8c8d-f43a519249e5" xlink:to="loc_us-gaap_PaymentsToAcquireLoansReceivable_26f1b301-e5c5-46c2-a4ec-8c739868a48a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromSaleAndMaturityOfOtherInvestments_6881989d-5836-4443-af62-7224326144be" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ProceedsFromSaleAndMaturityOfOtherInvestments"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_f3a7ae63-2f6c-4851-8c8d-f43a519249e5" xlink:to="loc_us-gaap_ProceedsFromSaleAndMaturityOfOtherInvestments_6881989d-5836-4443-af62-7224326144be" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_9dac5806-3a0e-4118-9beb-47c8cc84af65" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivities"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_f3a7ae63-2f6c-4851-8c8d-f43a519249e5" xlink:to="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_9dac5806-3a0e-4118-9beb-47c8cc84af65" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_d6dd1b1f-1b80-4756-834c-ddcdc974f83a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfCashFlowsAbstract_85743eec-c966-4fbe-b0b0-8007768b62e6" xlink:to="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_d6dd1b1f-1b80-4756-834c-ddcdc974f83a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsRelatedToTaxWithholdingForShareBasedCompensation_11a2f00c-b2e0-428a-8061-f3cf7d70239d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PaymentsRelatedToTaxWithholdingForShareBasedCompensation"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_d6dd1b1f-1b80-4756-834c-ddcdc974f83a" xlink:to="loc_us-gaap_PaymentsRelatedToTaxWithholdingForShareBasedCompensation_11a2f00c-b2e0-428a-8061-f3cf7d70239d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromPaymentsForOtherFinancingActivities_91d388c5-cfbb-4788-aa58-2e55e44eb27b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ProceedsFromPaymentsForOtherFinancingActivities"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_d6dd1b1f-1b80-4756-834c-ddcdc974f83a" xlink:to="loc_us-gaap_ProceedsFromPaymentsForOtherFinancingActivities_91d388c5-cfbb-4788-aa58-2e55e44eb27b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_d91859c9-fdc2-4b4b-a05e-d04af94b0f96" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivities"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_d6dd1b1f-1b80-4756-834c-ddcdc974f83a" xlink:to="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_d91859c9-fdc2-4b4b-a05e-d04af94b0f96" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_4c12e274-9030-4a5f-8ca3-2d977e1c3f05" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfCashFlowsAbstract_85743eec-c966-4fbe-b0b0-8007768b62e6" xlink:to="loc_us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_4c12e274-9030-4a5f-8ca3-2d977e1c3f05" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_64f7cb27-5ddb-467b-9c75-5b38516d01d8" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfCashFlowsAbstract_85743eec-c966-4fbe-b0b0-8007768b62e6" xlink:to="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_64f7cb27-5ddb-467b-9c75-5b38516d01d8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_ccda82ce-3890-4176-836e-6850234d0c90" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfCashFlowsAbstract_85743eec-c966-4fbe-b0b0-8007768b62e6" xlink:to="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_ccda82ce-3890-4176-836e-6850234d0c90" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_b3805194-8a78-49b6-bec3-ac93de4e05b2" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfCashFlowsAbstract_85743eec-c966-4fbe-b0b0-8007768b62e6" xlink:to="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_b3805194-8a78-49b6-bec3-ac93de4e05b2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SupplementalCashFlowInformationAbstract_6eb55dc3-24c6-49ab-951e-13899872c41e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SupplementalCashFlowInformationAbstract"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfCashFlowsAbstract_85743eec-c966-4fbe-b0b0-8007768b62e6" xlink:to="loc_us-gaap_SupplementalCashFlowInformationAbstract_6eb55dc3-24c6-49ab-951e-13899872c41e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestPaidNet_89342777-a4bf-434f-b4e8-45f744f1c7bb" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InterestPaidNet"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SupplementalCashFlowInformationAbstract_6eb55dc3-24c6-49ab-951e-13899872c41e" xlink:to="loc_us-gaap_InterestPaidNet_89342777-a4bf-434f-b4e8-45f744f1c7bb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cron_InterestReceivedNet_916a1c63-6869-4bdb-924d-990e252c315c" xlink:href="cron-20210630.xsd#cron_InterestReceivedNet"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SupplementalCashFlowInformationAbstract_6eb55dc3-24c6-49ab-951e-13899872c41e" xlink:to="loc_cron_InterestReceivedNet_916a1c63-6869-4bdb-924d-990e252c315c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxesPaidNet_75f5520b-306b-4077-ae75-4149a1843ced" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeTaxesPaidNet"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SupplementalCashFlowInformationAbstract_6eb55dc3-24c6-49ab-951e-13899872c41e" xlink:to="loc_us-gaap_IncomeTaxesPaidNet_75f5520b-306b-4077-ae75-4149a1843ced" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://thecronosgroup.com/role/BackgroundBasisofPresentationandAccountingPolicies" xlink:type="simple" xlink:href="cron-20210630.xsd#BackgroundBasisofPresentationandAccountingPolicies"/>
  <link:presentationLink xlink:role="http://thecronosgroup.com/role/BackgroundBasisofPresentationandAccountingPolicies" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_648a2dac-0ae6-4aae-a28d-5287a565df34" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BasisOfPresentationAndSignificantAccountingPoliciesTextBlock_d9a80771-9206-48d5-80d5-a3db49c0d48b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BasisOfPresentationAndSignificantAccountingPoliciesTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_648a2dac-0ae6-4aae-a28d-5287a565df34" xlink:to="loc_us-gaap_BasisOfPresentationAndSignificantAccountingPoliciesTextBlock_d9a80771-9206-48d5-80d5-a3db49c0d48b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://thecronosgroup.com/role/BackgroundBasisofPresentationandAccountingPoliciesPolicies" xlink:type="simple" xlink:href="cron-20210630.xsd#BackgroundBasisofPresentationandAccountingPoliciesPolicies"/>
  <link:presentationLink xlink:role="http://thecronosgroup.com/role/BackgroundBasisofPresentationandAccountingPoliciesPolicies" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_1f19b523-cc1d-4508-aaf8-a0c5df2354fe" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BasisOfAccountingPolicyPolicyTextBlock_aab874f0-44d8-443a-9da1-20a02a0267c6" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BasisOfAccountingPolicyPolicyTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_1f19b523-cc1d-4508-aaf8-a0c5df2354fe" xlink:to="loc_us-gaap_BasisOfAccountingPolicyPolicyTextBlock_aab874f0-44d8-443a-9da1-20a02a0267c6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock_1ca2f065-3999-4d8c-aa8c-9191a7e8c119" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_1f19b523-cc1d-4508-aaf8-a0c5df2354fe" xlink:to="loc_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock_1ca2f065-3999-4d8c-aa8c-9191a7e8c119" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://thecronosgroup.com/role/BackgroundBasisofPresentationandAccountingPoliciesDetails" xlink:type="simple" xlink:href="cron-20210630.xsd#BackgroundBasisofPresentationandAccountingPoliciesDetails"/>
  <link:presentationLink xlink:role="http://thecronosgroup.com/role/BackgroundBasisofPresentationandAccountingPoliciesDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_28484217-ec1f-4a9a-965e-38dceabba0f1" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfEquityMethodInvestmentsTable_047db9f7-670b-4a6f-bc35-fd990d37b9cb" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfEquityMethodInvestmentsTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_28484217-ec1f-4a9a-965e-38dceabba0f1" xlink:to="loc_us-gaap_ScheduleOfEquityMethodInvestmentsTable_047db9f7-670b-4a6f-bc35-fd990d37b9cb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis_cd0836a8-f8b7-4b16-a82f-f46c9bbfa45a" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfEquityMethodInvestmentsTable_047db9f7-670b-4a6f-bc35-fd990d37b9cb" xlink:to="loc_srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis_cd0836a8-f8b7-4b16-a82f-f46c9bbfa45a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_EquityMethodInvesteeNameDomain_213364c0-1d8e-4427-8772-d083eae888c1" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_EquityMethodInvesteeNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis_cd0836a8-f8b7-4b16-a82f-f46c9bbfa45a" xlink:to="loc_srt_EquityMethodInvesteeNameDomain_213364c0-1d8e-4427-8772-d083eae888c1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cron_CronosAustraliaLimitedMember_a12e958c-4c57-4a0f-9176-b084f8d8ee7d" xlink:href="cron-20210630.xsd#cron_CronosAustraliaLimitedMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_EquityMethodInvesteeNameDomain_213364c0-1d8e-4427-8772-d083eae888c1" xlink:to="loc_cron_CronosAustraliaLimitedMember_a12e958c-4c57-4a0f-9176-b084f8d8ee7d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RestatementAxis_8b62f686-1713-4bb0-ba25-71cd7067cfce" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_RestatementAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfEquityMethodInvestmentsTable_047db9f7-670b-4a6f-bc35-fd990d37b9cb" xlink:to="loc_srt_RestatementAxis_8b62f686-1713-4bb0-ba25-71cd7067cfce" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RestatementDomain_3b26e92c-941d-4b97-adcd-e01642f4bc39" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_RestatementDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RestatementAxis_8b62f686-1713-4bb0-ba25-71cd7067cfce" xlink:to="loc_srt_RestatementDomain_3b26e92c-941d-4b97-adcd-e01642f4bc39" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RevisionOfPriorPeriodErrorCorrectionAdjustmentMember_efef96f4-559f-4373-8abf-c37e1b88d302" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_RevisionOfPriorPeriodErrorCorrectionAdjustmentMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RestatementDomain_3b26e92c-941d-4b97-adcd-e01642f4bc39" xlink:to="loc_srt_RevisionOfPriorPeriodErrorCorrectionAdjustmentMember_efef96f4-559f-4373-8abf-c37e1b88d302" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ErrorCorrectionsAndPriorPeriodAdjustmentsRestatementByRestatementPeriodAndAmountAxis_58095d2f-fe88-4d7a-aa0d-53f5a0af6dd8" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ErrorCorrectionsAndPriorPeriodAdjustmentsRestatementByRestatementPeriodAndAmountAxis"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfEquityMethodInvestmentsTable_047db9f7-670b-4a6f-bc35-fd990d37b9cb" xlink:to="loc_us-gaap_ErrorCorrectionsAndPriorPeriodAdjustmentsRestatementByRestatementPeriodAndAmountAxis_58095d2f-fe88-4d7a-aa0d-53f5a0af6dd8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdjustmentsForErrorCorrectionDomain_71369c4f-9384-4240-ae03-62c8ba0d9a60" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AdjustmentsForErrorCorrectionDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ErrorCorrectionsAndPriorPeriodAdjustmentsRestatementByRestatementPeriodAndAmountAxis_58095d2f-fe88-4d7a-aa0d-53f5a0af6dd8" xlink:to="loc_us-gaap_AdjustmentsForErrorCorrectionDomain_71369c4f-9384-4240-ae03-62c8ba0d9a60" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cron_ErrorRelatedToWithholdingTaxesOnTheNetExerciseOfStockOptionsMember_2b4957f6-b1e8-4899-afb5-ff746b5dfdda" xlink:href="cron-20210630.xsd#cron_ErrorRelatedToWithholdingTaxesOnTheNetExerciseOfStockOptionsMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AdjustmentsForErrorCorrectionDomain_71369c4f-9384-4240-ae03-62c8ba0d9a60" xlink:to="loc_cron_ErrorRelatedToWithholdingTaxesOnTheNetExerciseOfStockOptionsMember_2b4957f6-b1e8-4899-afb5-ff746b5dfdda" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cron_ErrorRelatedToExerciseOfTopUpRightsMember_b971f0f9-959c-4c0b-b369-8557c9771006" xlink:href="cron-20210630.xsd#cron_ErrorRelatedToExerciseOfTopUpRightsMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AdjustmentsForErrorCorrectionDomain_71369c4f-9384-4240-ae03-62c8ba0d9a60" xlink:to="loc_cron_ErrorRelatedToExerciseOfTopUpRightsMember_b971f0f9-959c-4c0b-b369-8557c9771006" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfEquityMethodInvestmentsLineItems_6cf254d1-6535-481c-8e33-e55ab529b7d3" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfEquityMethodInvestmentsLineItems"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfEquityMethodInvestmentsTable_047db9f7-670b-4a6f-bc35-fd990d37b9cb" xlink:to="loc_us-gaap_ScheduleOfEquityMethodInvestmentsLineItems_6cf254d1-6535-481c-8e33-e55ab529b7d3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cron_NumberOfContinentsWithInternationalProductionAndDistribution_31f9e479-d3c8-45ec-83bb-aec6a6bb61cc" xlink:href="cron-20210630.xsd#cron_NumberOfContinentsWithInternationalProductionAndDistribution"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfEquityMethodInvestmentsLineItems_6cf254d1-6535-481c-8e33-e55ab529b7d3" xlink:to="loc_cron_NumberOfContinentsWithInternationalProductionAndDistribution_31f9e479-d3c8-45ec-83bb-aec6a6bb61cc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cron_NumberOfAdultuseBrands_310e3e54-de60-4014-888c-c5e58b8f3c43" xlink:href="cron-20210630.xsd#cron_NumberOfAdultuseBrands"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfEquityMethodInvestmentsLineItems_6cf254d1-6535-481c-8e33-e55ab529b7d3" xlink:to="loc_cron_NumberOfAdultuseBrands_310e3e54-de60-4014-888c-c5e58b8f3c43" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cron_NumberOfHempDerivedPersonalCareBrands_3c5c6706-beae-405c-9aa5-9e2946a1aa40" xlink:href="cron-20210630.xsd#cron_NumberOfHempDerivedPersonalCareBrands"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfEquityMethodInvestmentsLineItems_6cf254d1-6535-481c-8e33-e55ab529b7d3" xlink:to="loc_cron_NumberOfHempDerivedPersonalCareBrands_3c5c6706-beae-405c-9aa5-9e2946a1aa40" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityMethodInvestmentOwnershipPercentage_50fde880-071c-42c5-9a2e-6b1e3970db0a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EquityMethodInvestmentOwnershipPercentage"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfEquityMethodInvestmentsLineItems_6cf254d1-6535-481c-8e33-e55ab529b7d3" xlink:to="loc_us-gaap_EquityMethodInvestmentOwnershipPercentage_50fde880-071c-42c5-9a2e-6b1e3970db0a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountsPayableAndOtherAccruedLiabilitiesCurrent_2918bbd7-33f5-40af-8a37-0133cbd3e191" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccountsPayableAndOtherAccruedLiabilitiesCurrent"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfEquityMethodInvestmentsLineItems_6cf254d1-6535-481c-8e33-e55ab529b7d3" xlink:to="loc_us-gaap_AccountsPayableAndOtherAccruedLiabilitiesCurrent_2918bbd7-33f5-40af-8a37-0133cbd3e191" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherReceivablesNetCurrent_86315373-adbf-4be4-9dad-54a86e9133ce" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherReceivablesNetCurrent"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfEquityMethodInvestmentsLineItems_6cf254d1-6535-481c-8e33-e55ab529b7d3" xlink:to="loc_us-gaap_OtherReceivablesNetCurrent_86315373-adbf-4be4-9dad-54a86e9133ce" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetainedEarningsAccumulatedDeficit_ac8fe76d-1f62-4453-8aec-ab9cc7f137d1" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RetainedEarningsAccumulatedDeficit"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfEquityMethodInvestmentsLineItems_6cf254d1-6535-481c-8e33-e55ab529b7d3" xlink:to="loc_us-gaap_RetainedEarningsAccumulatedDeficit_ac8fe76d-1f62-4453-8aec-ab9cc7f137d1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockValue_56a019c6-fdb9-49bc-85ff-ae60cc7ba271" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommonStockValue"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfEquityMethodInvestmentsLineItems_6cf254d1-6535-481c-8e33-e55ab529b7d3" xlink:to="loc_us-gaap_CommonStockValue_56a019c6-fdb9-49bc-85ff-ae60cc7ba271" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GainLossOnDerivativeInstrumentsNetPretax_d456fa06-019f-41b3-920b-7f52d5266c29" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_GainLossOnDerivativeInstrumentsNetPretax"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfEquityMethodInvestmentsLineItems_6cf254d1-6535-481c-8e33-e55ab529b7d3" xlink:to="loc_us-gaap_GainLossOnDerivativeInstrumentsNetPretax_d456fa06-019f-41b3-920b-7f52d5266c29" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://thecronosgroup.com/role/Inventorynet" xlink:type="simple" xlink:href="cron-20210630.xsd#Inventorynet"/>
  <link:presentationLink xlink:role="http://thecronosgroup.com/role/Inventorynet" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryDisclosureAbstract_288b723f-608e-4155-a334-343d608ac46d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InventoryDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryDisclosureTextBlock_ceb0c927-5a3b-4624-b46a-6778776873d2" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InventoryDisclosureTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_InventoryDisclosureAbstract_288b723f-608e-4155-a334-343d608ac46d" xlink:to="loc_us-gaap_InventoryDisclosureTextBlock_ceb0c927-5a3b-4624-b46a-6778776873d2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://thecronosgroup.com/role/InventorynetTables" xlink:type="simple" xlink:href="cron-20210630.xsd#InventorynetTables"/>
  <link:presentationLink xlink:role="http://thecronosgroup.com/role/InventorynetTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryDisclosureAbstract_661e8e27-63af-4070-8da5-4cd36f46cdd1" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InventoryDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfInventoryCurrentTableTextBlock_a3344928-9659-465e-91a3-7fd9743f3020" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfInventoryCurrentTableTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_InventoryDisclosureAbstract_661e8e27-63af-4070-8da5-4cd36f46cdd1" xlink:to="loc_us-gaap_ScheduleOfInventoryCurrentTableTextBlock_a3344928-9659-465e-91a3-7fd9743f3020" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://thecronosgroup.com/role/InventorynetDetails" xlink:type="simple" xlink:href="cron-20210630.xsd#InventorynetDetails"/>
  <link:presentationLink xlink:role="http://thecronosgroup.com/role/InventorynetDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryDisclosureAbstract_0b0a629d-869e-4cef-a37b-3190a2101cc5" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InventoryDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryRawMaterialsNetOfReserves_faecbce8-cb26-4735-b9f8-031ffb7f0078" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InventoryRawMaterialsNetOfReserves"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_InventoryDisclosureAbstract_0b0a629d-869e-4cef-a37b-3190a2101cc5" xlink:to="loc_us-gaap_InventoryRawMaterialsNetOfReserves_faecbce8-cb26-4735-b9f8-031ffb7f0078" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryWorkInProcessNetOfReserves_fcb90cea-da53-4289-8973-afaeb3e3100e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InventoryWorkInProcessNetOfReserves"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_InventoryDisclosureAbstract_0b0a629d-869e-4cef-a37b-3190a2101cc5" xlink:to="loc_us-gaap_InventoryWorkInProcessNetOfReserves_fcb90cea-da53-4289-8973-afaeb3e3100e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryFinishedGoodsNetOfReserves_4a818324-48c6-4958-9ef3-bb03670c4a70" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InventoryFinishedGoodsNetOfReserves"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_InventoryDisclosureAbstract_0b0a629d-869e-4cef-a37b-3190a2101cc5" xlink:to="loc_us-gaap_InventoryFinishedGoodsNetOfReserves_4a818324-48c6-4958-9ef3-bb03670c4a70" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventorySuppliesNetOfReserves_cbd46f58-40f5-455c-b984-330953304726" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InventorySuppliesNetOfReserves"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_InventoryDisclosureAbstract_0b0a629d-869e-4cef-a37b-3190a2101cc5" xlink:to="loc_us-gaap_InventorySuppliesNetOfReserves_cbd46f58-40f5-455c-b984-330953304726" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryNet_1351e0cf-8d56-4a86-859c-2fa0cc7dfc93" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InventoryNet"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_InventoryDisclosureAbstract_0b0a629d-869e-4cef-a37b-3190a2101cc5" xlink:to="loc_us-gaap_InventoryNet_1351e0cf-8d56-4a86-859c-2fa0cc7dfc93" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryWriteDown_8d9ec4b4-b185-41c7-b5e2-c6b593529302" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InventoryWriteDown"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_InventoryDisclosureAbstract_0b0a629d-869e-4cef-a37b-3190a2101cc5" xlink:to="loc_us-gaap_InventoryWriteDown_8d9ec4b4-b185-41c7-b5e2-c6b593529302" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://thecronosgroup.com/role/Investments" xlink:type="simple" xlink:href="cron-20210630.xsd#Investments"/>
  <link:presentationLink xlink:role="http://thecronosgroup.com/role/Investments" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityMethodInvestmentsAndJointVenturesAbstract_cf712d42-013b-441f-be7c-65980750fd19" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EquityMethodInvestmentsAndJointVenturesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityMethodInvestmentsDisclosureTextBlock_8858e314-6017-4ca0-a7b9-b365e5a3dba1" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EquityMethodInvestmentsDisclosureTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityMethodInvestmentsAndJointVenturesAbstract_cf712d42-013b-441f-be7c-65980750fd19" xlink:to="loc_us-gaap_EquityMethodInvestmentsDisclosureTextBlock_8858e314-6017-4ca0-a7b9-b365e5a3dba1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://thecronosgroup.com/role/InvestmentsTables" xlink:type="simple" xlink:href="cron-20210630.xsd#InvestmentsTables"/>
  <link:presentationLink xlink:role="http://thecronosgroup.com/role/InvestmentsTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityMethodInvestmentsAndJointVenturesAbstract_cac47963-c57e-4466-9e41-ca0d48c24b70" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EquityMethodInvestmentsAndJointVenturesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityMethodInvestmentsTextBlock_cafd9989-8323-41ef-9b6e-19025fa9545b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EquityMethodInvestmentsTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityMethodInvestmentsAndJointVenturesAbstract_cac47963-c57e-4466-9e41-ca0d48c24b70" xlink:to="loc_us-gaap_EquityMethodInvestmentsTextBlock_cafd9989-8323-41ef-9b6e-19025fa9545b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfVariableInterestEntitiesTextBlock_5e3f90c2-5036-4790-999f-2fc258051e99" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfVariableInterestEntitiesTextBlock"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityMethodInvestmentsAndJointVenturesAbstract_cac47963-c57e-4466-9e41-ca0d48c24b70" xlink:to="loc_us-gaap_ScheduleOfVariableInterestEntitiesTextBlock_5e3f90c2-5036-4790-999f-2fc258051e99" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://thecronosgroup.com/role/InvestmentsNarrativeDetails" xlink:type="simple" xlink:href="cron-20210630.xsd#InvestmentsNarrativeDetails"/>
  <link:presentationLink xlink:role="http://thecronosgroup.com/role/InvestmentsNarrativeDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityMethodInvestmentsAndJointVenturesAbstract_cc98d99a-e30c-4a65-b142-b12467d02056" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EquityMethodInvestmentsAndJointVenturesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfVariableInterestEntitiesTable_7cb95632-3c01-444c-aae5-0b2087122780" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfVariableInterestEntitiesTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityMethodInvestmentsAndJointVenturesAbstract_cc98d99a-e30c-4a65-b142-b12467d02056" xlink:to="loc_us-gaap_ScheduleOfVariableInterestEntitiesTable_7cb95632-3c01-444c-aae5-0b2087122780" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeAxis_33b2be55-9f8e-4205-b298-c518434fa0ac" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_RangeAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfVariableInterestEntitiesTable_7cb95632-3c01-444c-aae5-0b2087122780" xlink:to="loc_srt_RangeAxis_33b2be55-9f8e-4205-b298-c518434fa0ac" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_11790656-ebf8-4170-b650-cacb85eebf1e" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_RangeMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeAxis_33b2be55-9f8e-4205-b298-c518434fa0ac" xlink:to="loc_srt_RangeMember_11790656-ebf8-4170-b650-cacb85eebf1e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MinimumMember_d841083c-09fc-4d28-88a8-36fa8c11cb01" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_MinimumMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeMember_11790656-ebf8-4170-b650-cacb85eebf1e" xlink:to="loc_srt_MinimumMember_d841083c-09fc-4d28-88a8-36fa8c11cb01" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis_f653f9db-2818-4279-8375-c943ee64cddd" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfVariableInterestEntitiesTable_7cb95632-3c01-444c-aae5-0b2087122780" xlink:to="loc_srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis_f653f9db-2818-4279-8375-c943ee64cddd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_EquityMethodInvesteeNameDomain_9dcf1b15-d616-4f0e-b9ca-64bea1c221b1" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_EquityMethodInvesteeNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis_f653f9db-2818-4279-8375-c943ee64cddd" xlink:to="loc_srt_EquityMethodInvesteeNameDomain_9dcf1b15-d616-4f0e-b9ca-64bea1c221b1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cron_CronosGrowingCompanyInc.Member_a73f9d9c-0c7d-42a8-8715-d41f16093d4d" xlink:href="cron-20210630.xsd#cron_CronosGrowingCompanyInc.Member"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_EquityMethodInvesteeNameDomain_9dcf1b15-d616-4f0e-b9ca-64bea1c221b1" xlink:to="loc_cron_CronosGrowingCompanyInc.Member_a73f9d9c-0c7d-42a8-8715-d41f16093d4d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cron_MedMenCanadaInc.Member_de793418-10f4-466e-a1c3-e09a1e771c13" xlink:href="cron-20210630.xsd#cron_MedMenCanadaInc.Member"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_EquityMethodInvesteeNameDomain_9dcf1b15-d616-4f0e-b9ca-64bea1c221b1" xlink:to="loc_cron_MedMenCanadaInc.Member_de793418-10f4-466e-a1c3-e09a1e771c13" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cron_NatueraMember_9238d758-467d-4268-b03a-202e8551c149" xlink:href="cron-20210630.xsd#cron_NatueraMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_EquityMethodInvesteeNameDomain_9dcf1b15-d616-4f0e-b9ca-64bea1c221b1" xlink:to="loc_cron_NatueraMember_9238d758-467d-4268-b03a-202e8551c149" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cron_CannasoulAnalyticsLtdMember_a5056ec4-09b3-4d3c-bf6b-02fda9b88910" xlink:href="cron-20210630.xsd#cron_CannasoulAnalyticsLtdMember"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_EquityMethodInvesteeNameDomain_9dcf1b15-d616-4f0e-b9ca-64bea1c221b1" xlink:to="loc_cron_CannasoulAnalyticsLtdMember_a5056ec4-09b3-4d3c-bf6b-02fda9b88910" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TypeOfArrangementAxis_cf5d7411-cdc2-4284-a4ba-3f83616b3371" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TypeOfArrangementAxis"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfVariableInterestEntitiesTable_7cb95632-3c01-444c-aae5-0b2087122780" xlink:to="loc_us-gaap_TypeOfArrangementAxis_cf5d7411-cdc2-4284-a4ba-3f83616b3371" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ArrangementsAndNonarrangementTransactionsMember_43611e63-783a-4d67-adea-d164273dca4d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ArrangementsAndNonarrangementTransactionsMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_TypeOfArrangementAxis_cf5d7411-cdc2-4284-a4ba-3f83616b3371" xlink:to="loc_us-gaap_ArrangementsAndNonarrangementTransactionsMember_43611e63-783a-4d67-adea-d164273dca4d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CollaborativeArrangementTransactionWithPartyToCollaborativeArrangementMember_c62c051c-95c5-4663-95cd-79e60e20836e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CollaborativeArrangementTransactionWithPartyToCollaborativeArrangementMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ArrangementsAndNonarrangementTransactionsMember_43611e63-783a-4d67-adea-d164273dca4d" xlink:to="loc_us-gaap_CollaborativeArrangementTransactionWithPartyToCollaborativeArrangementMember_c62c051c-95c5-4663-95cd-79e60e20836e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ConsolidatedEntitiesAxis_2efaa60e-8f31-45b3-aeef-226d3c9be4aa" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_ConsolidatedEntitiesAxis"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfVariableInterestEntitiesTable_7cb95632-3c01-444c-aae5-0b2087122780" xlink:to="loc_srt_ConsolidatedEntitiesAxis_2efaa60e-8f31-45b3-aeef-226d3c9be4aa" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ConsolidatedEntitiesDomain_9c2b6637-27db-461a-8d0e-a0081c86962e" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_ConsolidatedEntitiesDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ConsolidatedEntitiesAxis_2efaa60e-8f31-45b3-aeef-226d3c9be4aa" xlink:to="loc_srt_ConsolidatedEntitiesDomain_9c2b6637-27db-461a-8d0e-a0081c86962e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_VariableInterestEntityNotPrimaryBeneficiaryMember_c800a6ae-e118-4768-8171-99190f8fbe1a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_VariableInterestEntityNotPrimaryBeneficiaryMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ConsolidatedEntitiesDomain_9c2b6637-27db-461a-8d0e-a0081c86962e" xlink:to="loc_us-gaap_VariableInterestEntityNotPrimaryBeneficiaryMember_c800a6ae-e118-4768-8171-99190f8fbe1a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cron_LoanReceivableNameAxis_0f9e5857-20f1-477b-bbfc-b895f3b0ebcc" xlink:href="cron-20210630.xsd#cron_LoanReceivableNameAxis"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfVariableInterestEntitiesTable_7cb95632-3c01-444c-aae5-0b2087122780" xlink:to="loc_cron_LoanReceivableNameAxis_0f9e5857-20f1-477b-bbfc-b895f3b0ebcc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cron_LoanReceivableNameDomain_03d20ba5-737c-4dc5-b841-5eaa4acb6290" xlink:href="cron-20210630.xsd#cron_LoanReceivableNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_cron_LoanReceivableNameAxis_0f9e5857-20f1-477b-bbfc-b895f3b0ebcc" xlink:to="loc_cron_LoanReceivableNameDomain_03d20ba5-737c-4dc5-b841-5eaa4acb6290" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cron_CannasoulCollaborationLoanMember_d2853938-0e2b-4b2d-9bcb-678db4bab221" xlink:href="cron-20210630.xsd#cron_CannasoulCollaborationLoanMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_cron_LoanReceivableNameDomain_03d20ba5-737c-4dc5-b841-5eaa4acb6290" xlink:to="loc_cron_CannasoulCollaborationLoanMember_d2853938-0e2b-4b2d-9bcb-678db4bab221" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis_9b1bd28f-07e9-4373-81eb-133eb62ecc6a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfVariableInterestEntitiesTable_7cb95632-3c01-444c-aae5-0b2087122780" xlink:to="loc_us-gaap_AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis_9b1bd28f-07e9-4373-81eb-133eb62ecc6a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ReceivableTypeDomain_f3fb962a-2a03-4686-8d59-44b448861d9b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ReceivableTypeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis_9b1bd28f-07e9-4373-81eb-133eb62ecc6a" xlink:to="loc_us-gaap_ReceivableTypeDomain_f3fb962a-2a03-4686-8d59-44b448861d9b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LoansReceivableMember_aaeb4a98-888d-4d02-8e2f-98e959eed915" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LoansReceivableMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ReceivableTypeDomain_f3fb962a-2a03-4686-8d59-44b448861d9b" xlink:to="loc_us-gaap_LoansReceivableMember_aaeb4a98-888d-4d02-8e2f-98e959eed915" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_LegalEntityAxis_e4fa086e-32c1-40e3-b688-f07611476e50" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_LegalEntityAxis"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfVariableInterestEntitiesTable_7cb95632-3c01-444c-aae5-0b2087122780" xlink:to="loc_dei_LegalEntityAxis_e4fa086e-32c1-40e3-b688-f07611476e50" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityDomain_9584dba5-c7f9-4661-a4a8-b2ca0ba42fa6" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_LegalEntityAxis_e4fa086e-32c1-40e3-b688-f07611476e50" xlink:to="loc_dei_EntityDomain_9584dba5-c7f9-4661-a4a8-b2ca0ba42fa6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cron_PharmacannMember_071ae71f-7bea-47eb-bf1b-d27d810f8ba7" xlink:href="cron-20210630.xsd#cron_PharmacannMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_EntityDomain_9584dba5-c7f9-4661-a4a8-b2ca0ba42fa6" xlink:to="loc_cron_PharmacannMember_071ae71f-7bea-47eb-bf1b-d27d810f8ba7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_VariableInterestEntityLineItems_99fbc284-05e1-441c-82c0-e1a90f6cf59c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_VariableInterestEntityLineItems"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfVariableInterestEntitiesTable_7cb95632-3c01-444c-aae5-0b2087122780" xlink:to="loc_us-gaap_VariableInterestEntityLineItems_99fbc284-05e1-441c-82c0-e1a90f6cf59c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_VariableInterestEntityOwnershipPercentage_fde984ce-f25b-4160-9e2e-d73baa4a96af" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_VariableInterestEntityOwnershipPercentage"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_VariableInterestEntityLineItems_99fbc284-05e1-441c-82c0-e1a90f6cf59c" xlink:to="loc_us-gaap_VariableInterestEntityOwnershipPercentage_fde984ce-f25b-4160-9e2e-d73baa4a96af" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cron_VariableInterestEntityQualitativeOrQuantitativeInformationLicenseTerm_91783141-ed93-4cd6-bdc0-6278e26f05bb" xlink:href="cron-20210630.xsd#cron_VariableInterestEntityQualitativeOrQuantitativeInformationLicenseTerm"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_VariableInterestEntityLineItems_99fbc284-05e1-441c-82c0-e1a90f6cf59c" xlink:to="loc_cron_VariableInterestEntityQualitativeOrQuantitativeInformationLicenseTerm_91783141-ed93-4cd6-bdc0-6278e26f05bb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cron_CollaborativeArrangementAmountOfAdvances_611dc02d-3041-4814-8b5f-ded31b6c7511" xlink:href="cron-20210630.xsd#cron_CollaborativeArrangementAmountOfAdvances"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_VariableInterestEntityLineItems_99fbc284-05e1-441c-82c0-e1a90f6cf59c" xlink:to="loc_cron_CollaborativeArrangementAmountOfAdvances_611dc02d-3041-4814-8b5f-ded31b6c7511" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cron_CollaborativeArrangementTermOfAgreement_d7233e45-824f-4056-8a1d-4f5eda7d087b" xlink:href="cron-20210630.xsd#cron_CollaborativeArrangementTermOfAgreement"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_VariableInterestEntityLineItems_99fbc284-05e1-441c-82c0-e1a90f6cf59c" xlink:to="loc_cron_CollaborativeArrangementTermOfAgreement_d7233e45-824f-4056-8a1d-4f5eda7d087b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentInterestRateStatedPercentage_4960ef81-0347-41d2-9143-6b39d1d8202b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentInterestRateStatedPercentage"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_VariableInterestEntityLineItems_99fbc284-05e1-441c-82c0-e1a90f6cf59c" xlink:to="loc_us-gaap_DebtInstrumentInterestRateStatedPercentage_4960ef81-0347-41d2-9143-6b39d1d8202b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cron_CollaborativeArrangementPercentageOfProfitsToBeReceived_6a49b1f2-4318-42c6-a459-dff2eb50fb46" xlink:href="cron-20210630.xsd#cron_CollaborativeArrangementPercentageOfProfitsToBeReceived"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_VariableInterestEntityLineItems_99fbc284-05e1-441c-82c0-e1a90f6cf59c" xlink:to="loc_cron_CollaborativeArrangementPercentageOfProfitsToBeReceived_6a49b1f2-4318-42c6-a459-dff2eb50fb46" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cron_CollaborativeArrangementProfitsToBeReceivedMaximumPercentageOfAmountsAdvanced_a2945776-41f8-44ad-be17-9738ab90a7c5" xlink:href="cron-20210630.xsd#cron_CollaborativeArrangementProfitsToBeReceivedMaximumPercentageOfAmountsAdvanced"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_VariableInterestEntityLineItems_99fbc284-05e1-441c-82c0-e1a90f6cf59c" xlink:to="loc_cron_CollaborativeArrangementProfitsToBeReceivedMaximumPercentageOfAmountsAdvanced_a2945776-41f8-44ad-be17-9738ab90a7c5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cron_CollaborativeArrangementPercentageOfProfitsToBeReceivedTriggeringEventSubsequentToMaximumPercentageOfAmountsAdvancedBeingMet_1d5066d1-ea19-43ca-b7bb-93ce1f1e949b" xlink:href="cron-20210630.xsd#cron_CollaborativeArrangementPercentageOfProfitsToBeReceivedTriggeringEventSubsequentToMaximumPercentageOfAmountsAdvancedBeingMet"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_VariableInterestEntityLineItems_99fbc284-05e1-441c-82c0-e1a90f6cf59c" xlink:to="loc_cron_CollaborativeArrangementPercentageOfProfitsToBeReceivedTriggeringEventSubsequentToMaximumPercentageOfAmountsAdvancedBeingMet_1d5066d1-ea19-43ca-b7bb-93ce1f1e949b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SaleOfStockNumberOfSharesIssuedInTransaction_645823cc-d079-4fe3-97ef-17c6d4976958" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SaleOfStockNumberOfSharesIssuedInTransaction"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_VariableInterestEntityLineItems_99fbc284-05e1-441c-82c0-e1a90f6cf59c" xlink:to="loc_us-gaap_SaleOfStockNumberOfSharesIssuedInTransaction_645823cc-d079-4fe3-97ef-17c6d4976958" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SaleOfStockPricePerShare_a4f050cc-11d9-467f-b207-52d4c6a44a00" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SaleOfStockPricePerShare"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_VariableInterestEntityLineItems_99fbc284-05e1-441c-82c0-e1a90f6cf59c" xlink:to="loc_us-gaap_SaleOfStockPricePerShare_a4f050cc-11d9-467f-b207-52d4c6a44a00" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SaleOfStockPercentageOfOwnershipAfterTransaction_1831f56a-5102-4728-aa09-c01ad151c603" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SaleOfStockPercentageOfOwnershipAfterTransaction"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_VariableInterestEntityLineItems_99fbc284-05e1-441c-82c0-e1a90f6cf59c" xlink:to="loc_us-gaap_SaleOfStockPercentageOfOwnershipAfterTransaction_1831f56a-5102-4728-aa09-c01ad151c603" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquireOtherInvestments_02a77302-c1ea-4ec3-b61b-00139c4497da" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PaymentsToAcquireOtherInvestments"/>
    <link:presentationArc order="12" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_VariableInterestEntityLineItems_99fbc284-05e1-441c-82c0-e1a90f6cf59c" xlink:to="loc_us-gaap_PaymentsToAcquireOtherInvestments_02a77302-c1ea-4ec3-b61b-00139c4497da" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://thecronosgroup.com/role/InvestmentsScheduleofInvestmentsinAssociatesandJointVenturesDetails" xlink:type="simple" xlink:href="cron-20210630.xsd#InvestmentsScheduleofInvestmentsinAssociatesandJointVenturesDetails"/>
  <link:presentationLink xlink:role="http://thecronosgroup.com/role/InvestmentsScheduleofInvestmentsinAssociatesandJointVenturesDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityMethodInvestmentsAndJointVenturesAbstract_f0514874-6228-45ed-a638-04dbd7966772" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EquityMethodInvestmentsAndJointVenturesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfEquityMethodInvestmentsTable_06c734fd-9c65-4aee-bde7-3665d4965832" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfEquityMethodInvestmentsTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityMethodInvestmentsAndJointVenturesAbstract_f0514874-6228-45ed-a638-04dbd7966772" xlink:to="loc_us-gaap_ScheduleOfEquityMethodInvestmentsTable_06c734fd-9c65-4aee-bde7-3665d4965832" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis_64eb75f4-712e-4560-b20b-4d93e9847030" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfEquityMethodInvestmentsTable_06c734fd-9c65-4aee-bde7-3665d4965832" xlink:to="loc_srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis_64eb75f4-712e-4560-b20b-4d93e9847030" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_EquityMethodInvesteeNameDomain_4f5d2549-8427-4d53-b877-fc3046f32ccf" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_EquityMethodInvesteeNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis_64eb75f4-712e-4560-b20b-4d93e9847030" xlink:to="loc_srt_EquityMethodInvesteeNameDomain_4f5d2549-8427-4d53-b877-fc3046f32ccf" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cron_CronosAustraliaLimitedMember_5df32534-7c57-4089-87e6-3f7ac214f7ac" xlink:href="cron-20210630.xsd#cron_CronosAustraliaLimitedMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_EquityMethodInvesteeNameDomain_4f5d2549-8427-4d53-b877-fc3046f32ccf" xlink:to="loc_cron_CronosAustraliaLimitedMember_5df32534-7c57-4089-87e6-3f7ac214f7ac" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cron_CronosGrowingCompanyInc.Member_0196aa90-c0f0-495f-8efa-6b5b6b630960" xlink:href="cron-20210630.xsd#cron_CronosGrowingCompanyInc.Member"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_EquityMethodInvesteeNameDomain_4f5d2549-8427-4d53-b877-fc3046f32ccf" xlink:to="loc_cron_CronosGrowingCompanyInc.Member_0196aa90-c0f0-495f-8efa-6b5b6b630960" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cron_NatueraMember_271bf106-6b9e-49de-9761-aab859a1bcd6" xlink:href="cron-20210630.xsd#cron_NatueraMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_EquityMethodInvesteeNameDomain_4f5d2549-8427-4d53-b877-fc3046f32ccf" xlink:to="loc_cron_NatueraMember_271bf106-6b9e-49de-9761-aab859a1bcd6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cron_LoanReceivableNameAxis_7a0f9053-6732-4486-afd6-a915cabee27b" xlink:href="cron-20210630.xsd#cron_LoanReceivableNameAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfEquityMethodInvestmentsTable_06c734fd-9c65-4aee-bde7-3665d4965832" xlink:to="loc_cron_LoanReceivableNameAxis_7a0f9053-6732-4486-afd6-a915cabee27b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cron_LoanReceivableNameDomain_6844b1c5-28b8-4cd2-93d0-5f0769496e39" xlink:href="cron-20210630.xsd#cron_LoanReceivableNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_cron_LoanReceivableNameAxis_7a0f9053-6732-4486-afd6-a915cabee27b" xlink:to="loc_cron_LoanReceivableNameDomain_6844b1c5-28b8-4cd2-93d0-5f0769496e39" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cron_NatuEraSeriesALoanMember_0a888e3f-3259-4ec5-b86d-8f1dd30a4f46" xlink:href="cron-20210630.xsd#cron_NatuEraSeriesALoanMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_cron_LoanReceivableNameDomain_6844b1c5-28b8-4cd2-93d0-5f0769496e39" xlink:to="loc_cron_NatuEraSeriesALoanMember_0a888e3f-3259-4ec5-b86d-8f1dd30a4f46" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis_35dbe5ac-680a-41ef-8cac-f9e8faa7e5be" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfEquityMethodInvestmentsTable_06c734fd-9c65-4aee-bde7-3665d4965832" xlink:to="loc_us-gaap_AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis_35dbe5ac-680a-41ef-8cac-f9e8faa7e5be" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ReceivableTypeDomain_715d5e51-d033-418a-a3c4-072c5a4b9385" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ReceivableTypeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis_35dbe5ac-680a-41ef-8cac-f9e8faa7e5be" xlink:to="loc_us-gaap_ReceivableTypeDomain_715d5e51-d033-418a-a3c4-072c5a4b9385" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LoansReceivableMember_18646125-50ca-4abd-b260-56a4aff16ec4" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LoansReceivableMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ReceivableTypeDomain_715d5e51-d033-418a-a3c4-072c5a4b9385" xlink:to="loc_us-gaap_LoansReceivableMember_18646125-50ca-4abd-b260-56a4aff16ec4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_LegalEntityAxis_997f485b-b42e-4280-aff3-d75f82056bb5" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_LegalEntityAxis"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfEquityMethodInvestmentsTable_06c734fd-9c65-4aee-bde7-3665d4965832" xlink:to="loc_dei_LegalEntityAxis_997f485b-b42e-4280-aff3-d75f82056bb5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityDomain_ddc2c3b8-dd3b-4aa9-a4db-7c74dc0bc53b" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_LegalEntityAxis_997f485b-b42e-4280-aff3-d75f82056bb5" xlink:to="loc_dei_EntityDomain_ddc2c3b8-dd3b-4aa9-a4db-7c74dc0bc53b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cron_CronosGroupInc.Member_418af3a7-9258-4a1f-aa5c-16240842bcc6" xlink:href="cron-20210630.xsd#cron_CronosGroupInc.Member"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_EntityDomain_ddc2c3b8-dd3b-4aa9-a4db-7c74dc0bc53b" xlink:to="loc_cron_CronosGroupInc.Member_418af3a7-9258-4a1f-aa5c-16240842bcc6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cron_AgroideaMember_222394e3-25cf-4711-906d-127db197cd69" xlink:href="cron-20210630.xsd#cron_AgroideaMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_EntityDomain_ddc2c3b8-dd3b-4aa9-a4db-7c74dc0bc53b" xlink:to="loc_cron_AgroideaMember_222394e3-25cf-4711-906d-127db197cd69" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfEquityMethodInvestmentsLineItems_e731813f-d294-41d9-9b06-4dd179da296a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfEquityMethodInvestmentsLineItems"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfEquityMethodInvestmentsTable_06c734fd-9c65-4aee-bde7-3665d4965832" xlink:to="loc_us-gaap_ScheduleOfEquityMethodInvestmentsLineItems_e731813f-d294-41d9-9b06-4dd179da296a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityMethodInvestmentOwnershipPercentage_425f0ae1-115c-4912-b688-5fe3bf05b9f2" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EquityMethodInvestmentOwnershipPercentage"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfEquityMethodInvestmentsLineItems_e731813f-d294-41d9-9b06-4dd179da296a" xlink:to="loc_us-gaap_EquityMethodInvestmentOwnershipPercentage_425f0ae1-115c-4912-b688-5fe3bf05b9f2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityMethodInvestments_fa70e822-397c-48b7-91dd-1813c9426286" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EquityMethodInvestments"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfEquityMethodInvestmentsLineItems_e731813f-d294-41d9-9b06-4dd179da296a" xlink:to="loc_us-gaap_EquityMethodInvestments_fa70e822-397c-48b7-91dd-1813c9426286" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cron_InvestmentsInAndAdvancesToAffiliatesAtFairValueAdvancesRepayments_75f456b8-d75d-4fc2-8413-644bb570ba37" xlink:href="cron-20210630.xsd#cron_InvestmentsInAndAdvancesToAffiliatesAtFairValueAdvancesRepayments"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfEquityMethodInvestmentsLineItems_e731813f-d294-41d9-9b06-4dd179da296a" xlink:to="loc_cron_InvestmentsInAndAdvancesToAffiliatesAtFairValueAdvancesRepayments_75f456b8-d75d-4fc2-8413-644bb570ba37" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cron_InvestmentsInAndAdvancesToAffiliatesFundingCommitmentPercentage_81f5e8c8-9634-4394-a05f-f9d79b2ff115" xlink:href="cron-20210630.xsd#cron_InvestmentsInAndAdvancesToAffiliatesFundingCommitmentPercentage"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfEquityMethodInvestmentsLineItems_e731813f-d294-41d9-9b06-4dd179da296a" xlink:to="loc_cron_InvestmentsInAndAdvancesToAffiliatesFundingCommitmentPercentage_81f5e8c8-9634-4394-a05f-f9d79b2ff115" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NotesReceivableNet_3ded0467-ac0a-4cf5-aa1a-37204856e6c2" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NotesReceivableNet"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfEquityMethodInvestmentsLineItems_e731813f-d294-41d9-9b06-4dd179da296a" xlink:to="loc_us-gaap_NotesReceivableNet_3ded0467-ac0a-4cf5-aa1a-37204856e6c2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinancingReceivableAccruedInterestBeforeAllowanceForCreditLoss_f88bfee0-7389-4680-ae18-951bc88dc221" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FinancingReceivableAccruedInterestBeforeAllowanceForCreditLoss"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfEquityMethodInvestmentsLineItems_e731813f-d294-41d9-9b06-4dd179da296a" xlink:to="loc_us-gaap_FinancingReceivableAccruedInterestBeforeAllowanceForCreditLoss_f88bfee0-7389-4680-ae18-951bc88dc221" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cron_InvestmentsInAndAdvancesToAffiliatesAtFairValueTransferToInvestmentsInEquityAccountedInvestees_ef3eef3a-4fcc-4b28-ae7e-1a2047e0feec" xlink:href="cron-20210630.xsd#cron_InvestmentsInAndAdvancesToAffiliatesAtFairValueTransferToInvestmentsInEquityAccountedInvestees"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfEquityMethodInvestmentsLineItems_e731813f-d294-41d9-9b06-4dd179da296a" xlink:to="loc_cron_InvestmentsInAndAdvancesToAffiliatesAtFairValueTransferToInvestmentsInEquityAccountedInvestees_ef3eef3a-4fcc-4b28-ae7e-1a2047e0feec" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromEquityMethodInvestments_2e5f3610-f3a3-42ff-bbde-a4193ae88960" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeLossFromEquityMethodInvestments"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfEquityMethodInvestmentsLineItems_e731813f-d294-41d9-9b06-4dd179da296a" xlink:to="loc_us-gaap_IncomeLossFromEquityMethodInvestments_2e5f3610-f3a3-42ff-bbde-a4193ae88960" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://thecronosgroup.com/role/InvestmentsScheduleofVariableInterestEntitiesDetails" xlink:type="simple" xlink:href="cron-20210630.xsd#InvestmentsScheduleofVariableInterestEntitiesDetails"/>
  <link:presentationLink xlink:role="http://thecronosgroup.com/role/InvestmentsScheduleofVariableInterestEntitiesDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityMethodInvestmentsAndJointVenturesAbstract_16ac8ac3-639e-4d4f-ab89-6948126911fa" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EquityMethodInvestmentsAndJointVenturesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfVariableInterestEntitiesTable_db3332e1-f435-4d0f-93c1-846a6e1862ef" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfVariableInterestEntitiesTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityMethodInvestmentsAndJointVenturesAbstract_16ac8ac3-639e-4d4f-ab89-6948126911fa" xlink:to="loc_us-gaap_ScheduleOfVariableInterestEntitiesTable_db3332e1-f435-4d0f-93c1-846a6e1862ef" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis_9d78d58b-aced-446f-b958-955e03e04c8f" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfVariableInterestEntitiesTable_db3332e1-f435-4d0f-93c1-846a6e1862ef" xlink:to="loc_srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis_9d78d58b-aced-446f-b958-955e03e04c8f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_EquityMethodInvesteeNameDomain_ebb8e7e2-5565-4512-9f2f-88d9e904d7b2" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_EquityMethodInvesteeNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis_9d78d58b-aced-446f-b958-955e03e04c8f" xlink:to="loc_srt_EquityMethodInvesteeNameDomain_ebb8e7e2-5565-4512-9f2f-88d9e904d7b2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cron_CronosAustraliaLimitedMember_4fd64d43-b257-420a-8b02-a67aee6e3886" xlink:href="cron-20210630.xsd#cron_CronosAustraliaLimitedMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_EquityMethodInvesteeNameDomain_ebb8e7e2-5565-4512-9f2f-88d9e904d7b2" xlink:to="loc_cron_CronosAustraliaLimitedMember_4fd64d43-b257-420a-8b02-a67aee6e3886" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cron_CronosGrowingCompanyInc.Member_a1710145-21a2-4d96-a15f-ca796a21712b" xlink:href="cron-20210630.xsd#cron_CronosGrowingCompanyInc.Member"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_EquityMethodInvesteeNameDomain_ebb8e7e2-5565-4512-9f2f-88d9e904d7b2" xlink:to="loc_cron_CronosGrowingCompanyInc.Member_a1710145-21a2-4d96-a15f-ca796a21712b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cron_MedMenCanadaInc.Member_9f6aac73-55a2-4227-aac1-579dd52167ca" xlink:href="cron-20210630.xsd#cron_MedMenCanadaInc.Member"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_EquityMethodInvesteeNameDomain_ebb8e7e2-5565-4512-9f2f-88d9e904d7b2" xlink:to="loc_cron_MedMenCanadaInc.Member_9f6aac73-55a2-4227-aac1-579dd52167ca" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cron_NatuEraMember_6c26379e-314c-4e93-a186-6c72dfca6b76" xlink:href="cron-20210630.xsd#cron_NatuEraMember"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_EquityMethodInvesteeNameDomain_ebb8e7e2-5565-4512-9f2f-88d9e904d7b2" xlink:to="loc_cron_NatuEraMember_6c26379e-314c-4e93-a186-6c72dfca6b76" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ConsolidatedEntitiesAxis_5a9524ec-fd53-4ff9-abb5-0cac1cf3cf9a" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_ConsolidatedEntitiesAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfVariableInterestEntitiesTable_db3332e1-f435-4d0f-93c1-846a6e1862ef" xlink:to="loc_srt_ConsolidatedEntitiesAxis_5a9524ec-fd53-4ff9-abb5-0cac1cf3cf9a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ConsolidatedEntitiesDomain_563f68b1-ee6b-482b-9adc-f51d0c9f65bb" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_ConsolidatedEntitiesDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ConsolidatedEntitiesAxis_5a9524ec-fd53-4ff9-abb5-0cac1cf3cf9a" xlink:to="loc_srt_ConsolidatedEntitiesDomain_563f68b1-ee6b-482b-9adc-f51d0c9f65bb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_VariableInterestEntityNotPrimaryBeneficiaryMember_0874f90a-5734-41c3-9446-5de564e95ddf" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_VariableInterestEntityNotPrimaryBeneficiaryMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ConsolidatedEntitiesDomain_563f68b1-ee6b-482b-9adc-f51d0c9f65bb" xlink:to="loc_us-gaap_VariableInterestEntityNotPrimaryBeneficiaryMember_0874f90a-5734-41c3-9446-5de564e95ddf" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_VariableInterestEntityLineItems_12dcfc9a-2772-4559-b0b4-78b2084acea3" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_VariableInterestEntityLineItems"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfVariableInterestEntitiesTable_db3332e1-f435-4d0f-93c1-846a6e1862ef" xlink:to="loc_us-gaap_VariableInterestEntityLineItems_12dcfc9a-2772-4559-b0b4-78b2084acea3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_VariableInterestEntityOwnershipPercentage_a2906a13-4603-4681-849b-538818bfae04" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_VariableInterestEntityOwnershipPercentage"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_VariableInterestEntityLineItems_12dcfc9a-2772-4559-b0b4-78b2084acea3" xlink:to="loc_us-gaap_VariableInterestEntityOwnershipPercentage_a2906a13-4603-4681-849b-538818bfae04" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_VariableInterestEntityEntityMaximumLossExposureAmount_bfb58136-8e9f-4a3c-81f3-d7885927cac4" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_VariableInterestEntityEntityMaximumLossExposureAmount"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_VariableInterestEntityLineItems_12dcfc9a-2772-4559-b0b4-78b2084acea3" xlink:to="loc_us-gaap_VariableInterestEntityEntityMaximumLossExposureAmount_bfb58136-8e9f-4a3c-81f3-d7885927cac4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://thecronosgroup.com/role/LoansReceivablenet" xlink:type="simple" xlink:href="cron-20210630.xsd#LoansReceivablenet"/>
  <link:presentationLink xlink:role="http://thecronosgroup.com/role/LoansReceivablenet" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ReceivablesAbstract_ce36b806-e646-4c1e-bf09-fa16aa3fc6d6" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ReceivablesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LoansNotesTradeAndOtherReceivablesExcludingAllowanceForCreditLossesTextBlock_eab5452f-4416-40b7-98eb-3ccd94dd2e95" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LoansNotesTradeAndOtherReceivablesExcludingAllowanceForCreditLossesTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ReceivablesAbstract_ce36b806-e646-4c1e-bf09-fa16aa3fc6d6" xlink:to="loc_us-gaap_LoansNotesTradeAndOtherReceivablesExcludingAllowanceForCreditLossesTextBlock_eab5452f-4416-40b7-98eb-3ccd94dd2e95" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://thecronosgroup.com/role/LoansReceivablenetTables" xlink:type="simple" xlink:href="cron-20210630.xsd#LoansReceivablenetTables"/>
  <link:presentationLink xlink:role="http://thecronosgroup.com/role/LoansReceivablenetTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ReceivablesAbstract_f646458a-29cf-41f8-ad85-8812ebdd1cae" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ReceivablesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfAccountsNotesLoansAndFinancingReceivableTextBlock_a553539d-a8e3-46dc-8f45-1126aeacc7e8" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfAccountsNotesLoansAndFinancingReceivableTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ReceivablesAbstract_f646458a-29cf-41f8-ad85-8812ebdd1cae" xlink:to="loc_us-gaap_ScheduleOfAccountsNotesLoansAndFinancingReceivableTextBlock_a553539d-a8e3-46dc-8f45-1126aeacc7e8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://thecronosgroup.com/role/LoansReceivablenetDetails" xlink:type="simple" xlink:href="cron-20210630.xsd#LoansReceivablenetDetails"/>
  <link:presentationLink xlink:role="http://thecronosgroup.com/role/LoansReceivablenetDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ReceivablesAbstract_fe0a7a57-724a-4f52-b290-f96de8f45b5e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ReceivablesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfAccountsNotesLoansAndFinancingReceivableTable_de9bfa5f-d96e-4580-a430-ae1fa04bd001" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfAccountsNotesLoansAndFinancingReceivableTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ReceivablesAbstract_fe0a7a57-724a-4f52-b290-f96de8f45b5e" xlink:to="loc_us-gaap_ScheduleOfAccountsNotesLoansAndFinancingReceivableTable_de9bfa5f-d96e-4580-a430-ae1fa04bd001" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cron_LoanReceivableNameAxis_590aaa42-a6f4-46fe-b478-f919b3c2e814" xlink:href="cron-20210630.xsd#cron_LoanReceivableNameAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfAccountsNotesLoansAndFinancingReceivableTable_de9bfa5f-d96e-4580-a430-ae1fa04bd001" xlink:to="loc_cron_LoanReceivableNameAxis_590aaa42-a6f4-46fe-b478-f919b3c2e814" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cron_LoanReceivableNameDomain_91dc20ed-572e-4ceb-b17c-e8525b08b6ba" xlink:href="cron-20210630.xsd#cron_LoanReceivableNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_cron_LoanReceivableNameAxis_590aaa42-a6f4-46fe-b478-f919b3c2e814" xlink:to="loc_cron_LoanReceivableNameDomain_91dc20ed-572e-4ceb-b17c-e8525b08b6ba" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cron_NatuEraSeriesALoanMember_47eb661c-a412-4232-880b-002e2665d367" xlink:href="cron-20210630.xsd#cron_NatuEraSeriesALoanMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_cron_LoanReceivableNameDomain_91dc20ed-572e-4ceb-b17c-e8525b08b6ba" xlink:to="loc_cron_NatuEraSeriesALoanMember_47eb661c-a412-4232-880b-002e2665d367" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cron_CronosGrowCoCreditFacilityMember_2301dfe6-6efc-4b0b-a5ff-18408d8a746f" xlink:href="cron-20210630.xsd#cron_CronosGrowCoCreditFacilityMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_cron_LoanReceivableNameDomain_91dc20ed-572e-4ceb-b17c-e8525b08b6ba" xlink:to="loc_cron_CronosGrowCoCreditFacilityMember_2301dfe6-6efc-4b0b-a5ff-18408d8a746f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cron_A2645485OntarioInc.MucciPromissoryNoteMember_05eae362-f2e1-433c-b19f-6118c56ba02f" xlink:href="cron-20210630.xsd#cron_A2645485OntarioInc.MucciPromissoryNoteMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_cron_LoanReceivableNameDomain_91dc20ed-572e-4ceb-b17c-e8525b08b6ba" xlink:to="loc_cron_A2645485OntarioInc.MucciPromissoryNoteMember_05eae362-f2e1-433c-b19f-6118c56ba02f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cron_CannasoulCollaborationLoanMember_70e267a0-c3b9-40da-b69f-76450e3437dc" xlink:href="cron-20210630.xsd#cron_CannasoulCollaborationLoanMember"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_cron_LoanReceivableNameDomain_91dc20ed-572e-4ceb-b17c-e8525b08b6ba" xlink:to="loc_cron_CannasoulCollaborationLoanMember_70e267a0-c3b9-40da-b69f-76450e3437dc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis_cd025f1d-f43d-44fe-94c1-2412fa98eb7d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfAccountsNotesLoansAndFinancingReceivableTable_de9bfa5f-d96e-4580-a430-ae1fa04bd001" xlink:to="loc_us-gaap_AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis_cd025f1d-f43d-44fe-94c1-2412fa98eb7d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ReceivableTypeDomain_c6a8c082-1ce2-4d2a-ac62-2933ec5189ca" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ReceivableTypeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis_cd025f1d-f43d-44fe-94c1-2412fa98eb7d" xlink:to="loc_us-gaap_ReceivableTypeDomain_c6a8c082-1ce2-4d2a-ac62-2933ec5189ca" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LoansReceivableMember_907e0f53-ce25-452d-9f89-1f226693cb04" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LoansReceivableMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ReceivableTypeDomain_c6a8c082-1ce2-4d2a-ac62-2933ec5189ca" xlink:to="loc_us-gaap_LoansReceivableMember_907e0f53-ce25-452d-9f89-1f226693cb04" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TypeOfArrangementAxis_ff053703-7ea4-4529-89db-74844d70f15d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TypeOfArrangementAxis"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfAccountsNotesLoansAndFinancingReceivableTable_de9bfa5f-d96e-4580-a430-ae1fa04bd001" xlink:to="loc_us-gaap_TypeOfArrangementAxis_ff053703-7ea4-4529-89db-74844d70f15d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ArrangementsAndNonarrangementTransactionsMember_f090fb07-cf46-49a9-a582-831cf19e5300" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ArrangementsAndNonarrangementTransactionsMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_TypeOfArrangementAxis_ff053703-7ea4-4529-89db-74844d70f15d" xlink:to="loc_us-gaap_ArrangementsAndNonarrangementTransactionsMember_f090fb07-cf46-49a9-a582-831cf19e5300" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CollaborativeArrangementTransactionWithPartyToCollaborativeArrangementMember_fcc7115b-4d7f-4173-8740-cfa415d99b01" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CollaborativeArrangementTransactionWithPartyToCollaborativeArrangementMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ArrangementsAndNonarrangementTransactionsMember_f090fb07-cf46-49a9-a582-831cf19e5300" xlink:to="loc_us-gaap_CollaborativeArrangementTransactionWithPartyToCollaborativeArrangementMember_fcc7115b-4d7f-4173-8740-cfa415d99b01" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis_8855685c-3766-4634-ac61-f4606f378f42" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfAccountsNotesLoansAndFinancingReceivableTable_de9bfa5f-d96e-4580-a430-ae1fa04bd001" xlink:to="loc_srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis_8855685c-3766-4634-ac61-f4606f378f42" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_EquityMethodInvesteeNameDomain_da9f8349-9416-4f22-94b9-1988a541ab79" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_EquityMethodInvesteeNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis_8855685c-3766-4634-ac61-f4606f378f42" xlink:to="loc_srt_EquityMethodInvesteeNameDomain_da9f8349-9416-4f22-94b9-1988a541ab79" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cron_CannasoulAnalyticsLtdMember_2ba1ad3f-814f-4b9d-88d1-5fa0830b9ed7" xlink:href="cron-20210630.xsd#cron_CannasoulAnalyticsLtdMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_EquityMethodInvesteeNameDomain_da9f8349-9416-4f22-94b9-1988a541ab79" xlink:to="loc_cron_CannasoulAnalyticsLtdMember_2ba1ad3f-814f-4b9d-88d1-5fa0830b9ed7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ConsolidatedEntitiesAxis_2024eca4-dc43-47c6-97bb-8defb0ed6d3a" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_ConsolidatedEntitiesAxis"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfAccountsNotesLoansAndFinancingReceivableTable_de9bfa5f-d96e-4580-a430-ae1fa04bd001" xlink:to="loc_srt_ConsolidatedEntitiesAxis_2024eca4-dc43-47c6-97bb-8defb0ed6d3a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ConsolidatedEntitiesDomain_129e59cf-37f1-4ca8-b13e-676370d57af8" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_ConsolidatedEntitiesDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ConsolidatedEntitiesAxis_2024eca4-dc43-47c6-97bb-8defb0ed6d3a" xlink:to="loc_srt_ConsolidatedEntitiesDomain_129e59cf-37f1-4ca8-b13e-676370d57af8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_VariableInterestEntityNotPrimaryBeneficiaryMember_fca26e75-1d50-41c1-a259-8564868fa3ff" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_VariableInterestEntityNotPrimaryBeneficiaryMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ConsolidatedEntitiesDomain_129e59cf-37f1-4ca8-b13e-676370d57af8" xlink:to="loc_us-gaap_VariableInterestEntityNotPrimaryBeneficiaryMember_fca26e75-1d50-41c1-a259-8564868fa3ff" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_LegalEntityAxis_3de5c64d-a264-40fb-b86f-a4f36cf80bca" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_LegalEntityAxis"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfAccountsNotesLoansAndFinancingReceivableTable_de9bfa5f-d96e-4580-a430-ae1fa04bd001" xlink:to="loc_dei_LegalEntityAxis_3de5c64d-a264-40fb-b86f-a4f36cf80bca" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityDomain_528429da-5d79-4c90-9fd8-49d836ada7b2" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_LegalEntityAxis_3de5c64d-a264-40fb-b86f-a4f36cf80bca" xlink:to="loc_dei_EntityDomain_528429da-5d79-4c90-9fd8-49d836ada7b2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cron_CronosGroupInc.Member_4564928e-6449-4aea-a373-46700f987acc" xlink:href="cron-20210630.xsd#cron_CronosGroupInc.Member"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_EntityDomain_528429da-5d79-4c90-9fd8-49d836ada7b2" xlink:to="loc_cron_CronosGroupInc.Member_4564928e-6449-4aea-a373-46700f987acc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cron_AgroideaMember_3eb64f9b-2e93-48ae-971e-2485aab03c0c" xlink:href="cron-20210630.xsd#cron_AgroideaMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_EntityDomain_528429da-5d79-4c90-9fd8-49d836ada7b2" xlink:to="loc_cron_AgroideaMember_3eb64f9b-2e93-48ae-971e-2485aab03c0c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountsNotesAndLoansReceivableLineItems_2bf600d8-b0b7-4326-a480-2bb2d7f2f32a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccountsNotesAndLoansReceivableLineItems"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfAccountsNotesLoansAndFinancingReceivableTable_de9bfa5f-d96e-4580-a430-ae1fa04bd001" xlink:to="loc_us-gaap_AccountsNotesAndLoansReceivableLineItems_2bf600d8-b0b7-4326-a480-2bb2d7f2f32a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cron_FinancingReceivableBeforeAccruedInterestCurrent_c6172048-3407-448b-9782-e986a4fd2e3b" xlink:href="cron-20210630.xsd#cron_FinancingReceivableBeforeAccruedInterestCurrent"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountsNotesAndLoansReceivableLineItems_2bf600d8-b0b7-4326-a480-2bb2d7f2f32a" xlink:to="loc_cron_FinancingReceivableBeforeAccruedInterestCurrent_c6172048-3407-448b-9782-e986a4fd2e3b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cron_FinancingReceivableAccruedInterestCurrent_c255a6cc-cd08-46cf-b7e5-576c52306357" xlink:href="cron-20210630.xsd#cron_FinancingReceivableAccruedInterestCurrent"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountsNotesAndLoansReceivableLineItems_2bf600d8-b0b7-4326-a480-2bb2d7f2f32a" xlink:to="loc_cron_FinancingReceivableAccruedInterestCurrent_c255a6cc-cd08-46cf-b7e5-576c52306357" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NotesAndLoansReceivableNetCurrent_a8829e9a-0fda-4026-800a-0f1ac8ede608" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NotesAndLoansReceivableNetCurrent"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountsNotesAndLoansReceivableLineItems_2bf600d8-b0b7-4326-a480-2bb2d7f2f32a" xlink:to="loc_us-gaap_NotesAndLoansReceivableNetCurrent_a8829e9a-0fda-4026-800a-0f1ac8ede608" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cron_FinancingReceivableBeforeAccruedInterestNoncurrent_6fcd3674-a83a-49e9-a939-194beab419e1" xlink:href="cron-20210630.xsd#cron_FinancingReceivableBeforeAccruedInterestNoncurrent"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountsNotesAndLoansReceivableLineItems_2bf600d8-b0b7-4326-a480-2bb2d7f2f32a" xlink:to="loc_cron_FinancingReceivableBeforeAccruedInterestNoncurrent_6fcd3674-a83a-49e9-a939-194beab419e1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cron_FinancingReceivableAccruedInterestNoncurrent_71481045-760a-41b7-ad34-a2c983697b4d" xlink:href="cron-20210630.xsd#cron_FinancingReceivableAccruedInterestNoncurrent"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountsNotesAndLoansReceivableLineItems_2bf600d8-b0b7-4326-a480-2bb2d7f2f32a" xlink:to="loc_cron_FinancingReceivableAccruedInterestNoncurrent_71481045-760a-41b7-ad34-a2c983697b4d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NotesAndLoansReceivableNetNoncurrent_4b3bf462-bb4f-4f81-86cb-cdccd1ca44cb" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NotesAndLoansReceivableNetNoncurrent"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountsNotesAndLoansReceivableLineItems_2bf600d8-b0b7-4326-a480-2bb2d7f2f32a" xlink:to="loc_us-gaap_NotesAndLoansReceivableNetNoncurrent_4b3bf462-bb4f-4f81-86cb-cdccd1ca44cb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NotesReceivableNet_366bed9f-e66a-4124-acbb-8b2208869dca" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NotesReceivableNet"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountsNotesAndLoansReceivableLineItems_2bf600d8-b0b7-4326-a480-2bb2d7f2f32a" xlink:to="loc_us-gaap_NotesReceivableNet_366bed9f-e66a-4124-acbb-8b2208869dca" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cron_InvestmentsInAndAdvancesToAffiliatesAtFairValueAdvancesRepayments_0246280e-ea20-4f6f-85af-ea1df9e0326b" xlink:href="cron-20210630.xsd#cron_InvestmentsInAndAdvancesToAffiliatesAtFairValueAdvancesRepayments"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountsNotesAndLoansReceivableLineItems_2bf600d8-b0b7-4326-a480-2bb2d7f2f32a" xlink:to="loc_cron_InvestmentsInAndAdvancesToAffiliatesAtFairValueAdvancesRepayments_0246280e-ea20-4f6f-85af-ea1df9e0326b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cron_InvestmentsInAndAdvancesToAffiliatesFundingCommitmentPercentage_4a2462ba-e290-42b0-b6a4-8ab0d5655d2a" xlink:href="cron-20210630.xsd#cron_InvestmentsInAndAdvancesToAffiliatesFundingCommitmentPercentage"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountsNotesAndLoansReceivableLineItems_2bf600d8-b0b7-4326-a480-2bb2d7f2f32a" xlink:to="loc_cron_InvestmentsInAndAdvancesToAffiliatesFundingCommitmentPercentage_4a2462ba-e290-42b0-b6a4-8ab0d5655d2a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinancingReceivableAccruedInterestBeforeAllowanceForCreditLoss_570a16c3-174f-49b1-a634-1b0093137a6f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FinancingReceivableAccruedInterestBeforeAllowanceForCreditLoss"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountsNotesAndLoansReceivableLineItems_2bf600d8-b0b7-4326-a480-2bb2d7f2f32a" xlink:to="loc_us-gaap_FinancingReceivableAccruedInterestBeforeAllowanceForCreditLoss_570a16c3-174f-49b1-a634-1b0093137a6f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cron_InvestmentsInAndAdvancesToAffiliatesAtFairValueTransferToInvestmentsInEquityAccountedInvestees_b3aa4046-250f-4a73-9a4e-015238c56577" xlink:href="cron-20210630.xsd#cron_InvestmentsInAndAdvancesToAffiliatesAtFairValueTransferToInvestmentsInEquityAccountedInvestees"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountsNotesAndLoansReceivableLineItems_2bf600d8-b0b7-4326-a480-2bb2d7f2f32a" xlink:to="loc_cron_InvestmentsInAndAdvancesToAffiliatesAtFairValueTransferToInvestmentsInEquityAccountedInvestees_b3aa4046-250f-4a73-9a4e-015238c56577" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquireLoansReceivable_ef5dda8a-8763-4b74-a55a-bf1c92bbf842" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PaymentsToAcquireLoansReceivable"/>
    <link:presentationArc order="12" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountsNotesAndLoansReceivableLineItems_2bf600d8-b0b7-4326-a480-2bb2d7f2f32a" xlink:to="loc_us-gaap_PaymentsToAcquireLoansReceivable_ef5dda8a-8763-4b74-a55a-bf1c92bbf842" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinancingReceivableAllowanceForCreditLosses_e1254e85-bfc7-4df3-a747-b9617fef9615" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FinancingReceivableAllowanceForCreditLosses"/>
    <link:presentationArc order="13" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountsNotesAndLoansReceivableLineItems_2bf600d8-b0b7-4326-a480-2bb2d7f2f32a" xlink:to="loc_us-gaap_FinancingReceivableAllowanceForCreditLosses_e1254e85-bfc7-4df3-a747-b9617fef9615" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cron_CollaborativeArrangementInstallmentsReceived_f47d50f6-7735-4e70-b745-f734e4a73894" xlink:href="cron-20210630.xsd#cron_CollaborativeArrangementInstallmentsReceived"/>
    <link:presentationArc order="14" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountsNotesAndLoansReceivableLineItems_2bf600d8-b0b7-4326-a480-2bb2d7f2f32a" xlink:to="loc_cron_CollaborativeArrangementInstallmentsReceived_f47d50f6-7735-4e70-b745-f734e4a73894" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AllowanceForDoubtfulAccountsReceivableCurrent_180c9d50-dac5-4201-94b0-857d9c74c7a3" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AllowanceForDoubtfulAccountsReceivableCurrent"/>
    <link:presentationArc order="15" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountsNotesAndLoansReceivableLineItems_2bf600d8-b0b7-4326-a480-2bb2d7f2f32a" xlink:to="loc_us-gaap_AllowanceForDoubtfulAccountsReceivableCurrent_180c9d50-dac5-4201-94b0-857d9c74c7a3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://thecronosgroup.com/role/DerivativeLiabilities" xlink:type="simple" xlink:href="cron-20210630.xsd#DerivativeLiabilities"/>
  <link:presentationLink xlink:role="http://thecronosgroup.com/role/DerivativeLiabilities" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract_f5b9663c-39f8-465e-a084-7f1311c69a29" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureTextBlock_fc044e25-d336-4890-b796-ca0055977737" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract_f5b9663c-39f8-465e-a084-7f1311c69a29" xlink:to="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureTextBlock_fc044e25-d336-4890-b796-ca0055977737" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://thecronosgroup.com/role/DerivativeLiabilitiesTables" xlink:type="simple" xlink:href="cron-20210630.xsd#DerivativeLiabilitiesTables"/>
  <link:presentationLink xlink:role="http://thecronosgroup.com/role/DerivativeLiabilitiesTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract_01bdb7ed-4165-47a1-b5a1-789f44af9f5c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueNetDerivativeAssetLiabilityMeasuredOnRecurringBasisUnobservableInputReconciliationTableTextBlock_0f50dde3-bf4e-4d3e-9662-db55d79f4933" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueNetDerivativeAssetLiabilityMeasuredOnRecurringBasisUnobservableInputReconciliationTableTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract_01bdb7ed-4165-47a1-b5a1-789f44af9f5c" xlink:to="loc_us-gaap_FairValueNetDerivativeAssetLiabilityMeasuredOnRecurringBasisUnobservableInputReconciliationTableTextBlock_0f50dde3-bf4e-4d3e-9662-db55d79f4933" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTableTextBlock_ab1fd5b8-1f7d-4db0-9dc0-65ae6b8578af" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTableTextBlock"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract_01bdb7ed-4165-47a1-b5a1-789f44af9f5c" xlink:to="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTableTextBlock_ab1fd5b8-1f7d-4db0-9dc0-65ae6b8578af" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cron_SensitivityAnalysisImpactOnNetIncomeLossTableTextBlock_a5c92371-7a6a-497d-b052-00ed46e941d0" xlink:href="cron-20210630.xsd#cron_SensitivityAnalysisImpactOnNetIncomeLossTableTextBlock"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract_01bdb7ed-4165-47a1-b5a1-789f44af9f5c" xlink:to="loc_cron_SensitivityAnalysisImpactOnNetIncomeLossTableTextBlock_a5c92371-7a6a-497d-b052-00ed46e941d0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://thecronosgroup.com/role/DerivativeLiabilitiesNarrativeDetails" xlink:type="simple" xlink:href="cron-20210630.xsd#DerivativeLiabilitiesNarrativeDetails"/>
  <link:presentationLink xlink:role="http://thecronosgroup.com/role/DerivativeLiabilitiesNarrativeDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract_abd5ccff-38e2-4887-b110-439c37dbc097" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeTable_356bd26e-0408-4638-bb6f-7ae2e96cb0de" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DerivativeTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract_abd5ccff-38e2-4887-b110-439c37dbc097" xlink:to="loc_us-gaap_DerivativeTable_356bd26e-0408-4638-bb6f-7ae2e96cb0de" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfWarrantOrRightAxis_a88423dc-e7ca-4de8-858c-696076631168" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ClassOfWarrantOrRightAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeTable_356bd26e-0408-4638-bb6f-7ae2e96cb0de" xlink:to="loc_us-gaap_ClassOfWarrantOrRightAxis_a88423dc-e7ca-4de8-858c-696076631168" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfWarrantOrRightDomain_998620b5-c488-4b60-991a-4feda4fc87ee" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ClassOfWarrantOrRightDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfWarrantOrRightAxis_a88423dc-e7ca-4de8-858c-696076631168" xlink:to="loc_us-gaap_ClassOfWarrantOrRightDomain_998620b5-c488-4b60-991a-4feda4fc87ee" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cron_AltriaInvestmentMember_65c4528a-6031-448d-812e-3b70d69af20e" xlink:href="cron-20210630.xsd#cron_AltriaInvestmentMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfWarrantOrRightDomain_998620b5-c488-4b60-991a-4feda4fc87ee" xlink:to="loc_cron_AltriaInvestmentMember_65c4528a-6031-448d-812e-3b70d69af20e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cron_AltriaWarrantMember_a5abd400-f963-4703-9c5d-00290c89afbb" xlink:href="cron-20210630.xsd#cron_AltriaWarrantMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfWarrantOrRightDomain_998620b5-c488-4b60-991a-4feda4fc87ee" xlink:to="loc_cron_AltriaWarrantMember_a5abd400-f963-4703-9c5d-00290c89afbb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cron_PreemptiveRightsMember_3ec26e4a-7f61-4af1-add2-b8f0c7ce0a62" xlink:href="cron-20210630.xsd#cron_PreemptiveRightsMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfWarrantOrRightDomain_998620b5-c488-4b60-991a-4feda4fc87ee" xlink:to="loc_cron_PreemptiveRightsMember_3ec26e4a-7f61-4af1-add2-b8f0c7ce0a62" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cron_TopupRightsMember_f70d0424-4e9f-432b-b9f0-2607aadd8534" xlink:href="cron-20210630.xsd#cron_TopupRightsMember"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfWarrantOrRightDomain_998620b5-c488-4b60-991a-4feda4fc87ee" xlink:to="loc_cron_TopupRightsMember_f70d0424-4e9f-432b-b9f0-2607aadd8534" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ConsolidatedEntitiesAxis_4323acdf-5922-407e-bccc-ae74074b6d94" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_ConsolidatedEntitiesAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeTable_356bd26e-0408-4638-bb6f-7ae2e96cb0de" xlink:to="loc_srt_ConsolidatedEntitiesAxis_4323acdf-5922-407e-bccc-ae74074b6d94" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ConsolidatedEntitiesDomain_451681ab-d685-4e57-b635-8e13754814fc" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_ConsolidatedEntitiesDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ConsolidatedEntitiesAxis_4323acdf-5922-407e-bccc-ae74074b6d94" xlink:to="loc_srt_ConsolidatedEntitiesDomain_451681ab-d685-4e57-b635-8e13754814fc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_SubsidiariesMember_41df86af-b25a-4f57-87fe-4dafa2b31cf6" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_SubsidiariesMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ConsolidatedEntitiesDomain_451681ab-d685-4e57-b635-8e13754814fc" xlink:to="loc_srt_SubsidiariesMember_41df86af-b25a-4f57-87fe-4dafa2b31cf6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsidiarySaleOfStockAxis_f107d0f0-c313-4e4b-bd38-862b74fd3fdf" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SubsidiarySaleOfStockAxis"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeTable_356bd26e-0408-4638-bb6f-7ae2e96cb0de" xlink:to="loc_us-gaap_SubsidiarySaleOfStockAxis_f107d0f0-c313-4e4b-bd38-862b74fd3fdf" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SaleOfStockNameOfTransactionDomain_a79e3fb4-2770-4790-9e8b-967f98672bfb" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SaleOfStockNameOfTransactionDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SubsidiarySaleOfStockAxis_f107d0f0-c313-4e4b-bd38-862b74fd3fdf" xlink:to="loc_us-gaap_SaleOfStockNameOfTransactionDomain_a79e3fb4-2770-4790-9e8b-967f98672bfb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cron_AltriaInvestmentMember_64daa54b-d520-4e1a-a466-3aeb99c82d69" xlink:href="cron-20210630.xsd#cron_AltriaInvestmentMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SaleOfStockNameOfTransactionDomain_a79e3fb4-2770-4790-9e8b-967f98672bfb" xlink:to="loc_cron_AltriaInvestmentMember_64daa54b-d520-4e1a-a466-3aeb99c82d69" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_LegalEntityAxis_54511b50-3539-4366-aba3-e51ebd75c007" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_LegalEntityAxis"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeTable_356bd26e-0408-4638-bb6f-7ae2e96cb0de" xlink:to="loc_dei_LegalEntityAxis_54511b50-3539-4366-aba3-e51ebd75c007" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityDomain_eabc4c15-fb3c-4ea2-86f2-6c1f139d0535" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_LegalEntityAxis_54511b50-3539-4366-aba3-e51ebd75c007" xlink:to="loc_dei_EntityDomain_eabc4c15-fb3c-4ea2-86f2-6c1f139d0535" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cron_AltriaGroupInc.Member_07d3c09b-1301-4957-888e-7774b48e24c1" xlink:href="cron-20210630.xsd#cron_AltriaGroupInc.Member"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_EntityDomain_eabc4c15-fb3c-4ea2-86f2-6c1f139d0535" xlink:to="loc_cron_AltriaGroupInc.Member_07d3c09b-1301-4957-888e-7774b48e24c1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis_4be13726-b9f2-4f9e-825f-512fcfc81d2c" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeTable_356bd26e-0408-4638-bb6f-7ae2e96cb0de" xlink:to="loc_srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis_4be13726-b9f2-4f9e-825f-512fcfc81d2c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_EquityMethodInvesteeNameDomain_beaa4c84-3a45-467c-a63d-3b10ec8e43cc" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_EquityMethodInvesteeNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis_4be13726-b9f2-4f9e-825f-512fcfc81d2c" xlink:to="loc_srt_EquityMethodInvesteeNameDomain_beaa4c84-3a45-467c-a63d-3b10ec8e43cc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cron_CronosGroupInc.Member_da82400a-fbbf-4839-8ad9-b6492a9f1e2a" xlink:href="cron-20210630.xsd#cron_CronosGroupInc.Member"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_EquityMethodInvesteeNameDomain_beaa4c84-3a45-467c-a63d-3b10ec8e43cc" xlink:to="loc_cron_CronosGroupInc.Member_da82400a-fbbf-4839-8ad9-b6492a9f1e2a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeLineItems_26768879-7456-48cf-88f4-a847197023c9" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DerivativeLineItems"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeTable_356bd26e-0408-4638-bb6f-7ae2e96cb0de" xlink:to="loc_us-gaap_DerivativeLineItems_26768879-7456-48cf-88f4-a847197023c9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodSharesNewIssues_c0be0412-ca4c-40de-b39a-468fa58ce048" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockIssuedDuringPeriodSharesNewIssues"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeLineItems_26768879-7456-48cf-88f4-a847197023c9" xlink:to="loc_us-gaap_StockIssuedDuringPeriodSharesNewIssues_c0be0412-ca4c-40de-b39a-468fa58ce048" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cron_ClassOfWarrantOrRightNumberOfWarrantsIssued_9f91fb3a-218f-494f-94ad-c24e46f2de06" xlink:href="cron-20210630.xsd#cron_ClassOfWarrantOrRightNumberOfWarrantsIssued"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeLineItems_26768879-7456-48cf-88f4-a847197023c9" xlink:to="loc_cron_ClassOfWarrantOrRightNumberOfWarrantsIssued_9f91fb3a-218f-494f-94ad-c24e46f2de06" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityMethodInvestmentOwnershipPercentage_b4697707-e61e-43b6-af07-1aa4ffb41412" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EquityMethodInvestmentOwnershipPercentage"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeLineItems_26768879-7456-48cf-88f4-a847197023c9" xlink:to="loc_us-gaap_EquityMethodInvestmentOwnershipPercentage_b4697707-e61e-43b6-af07-1aa4ffb41412" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cron_SubsidiaryOrEquityMethodInvesteeCumulativePercentageOwnershipAfterAllTransactionsIfWarrantsExercised_eb976670-77d7-4ca1-827b-89f98eadbbf1" xlink:href="cron-20210630.xsd#cron_SubsidiaryOrEquityMethodInvesteeCumulativePercentageOwnershipAfterAllTransactionsIfWarrantsExercised"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeLineItems_26768879-7456-48cf-88f4-a847197023c9" xlink:to="loc_cron_SubsidiaryOrEquityMethodInvesteeCumulativePercentageOwnershipAfterAllTransactionsIfWarrantsExercised_eb976670-77d7-4ca1-827b-89f98eadbbf1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cron_ClassOfWarrantOrRightMaximumAdditionalSubscriptionPercentage_b6bb788b-c8bd-47ef-8706-f351e43fb8d2" xlink:href="cron-20210630.xsd#cron_ClassOfWarrantOrRightMaximumAdditionalSubscriptionPercentage"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeLineItems_26768879-7456-48cf-88f4-a847197023c9" xlink:to="loc_cron_ClassOfWarrantOrRightMaximumAdditionalSubscriptionPercentage_b6bb788b-c8bd-47ef-8706-f351e43fb8d2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cron_ClassOfWarrantOrRightAdditionalSubscriptionNumberOfSecuritiesCalledByWarrantsOrRights_17043709-d88f-4717-9cda-5a7d7314d42b" xlink:href="cron-20210630.xsd#cron_ClassOfWarrantOrRightAdditionalSubscriptionNumberOfSecuritiesCalledByWarrantsOrRights"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeLineItems_26768879-7456-48cf-88f4-a847197023c9" xlink:to="loc_cron_ClassOfWarrantOrRightAdditionalSubscriptionNumberOfSecuritiesCalledByWarrantsOrRights_17043709-d88f-4717-9cda-5a7d7314d42b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_3bfd3c45-4bbd-4673-964d-17f9be5ca6f9" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeLineItems_26768879-7456-48cf-88f4-a847197023c9" xlink:to="loc_us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_3bfd3c45-4bbd-4673-964d-17f9be5ca6f9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cron_ClassOfWarrantOrRightMinimumOwnershipPercentageRequired_11ed9d95-0716-4880-be4b-488ccf6e09a6" xlink:href="cron-20210630.xsd#cron_ClassOfWarrantOrRightMinimumOwnershipPercentageRequired"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeLineItems_26768879-7456-48cf-88f4-a847197023c9" xlink:to="loc_cron_ClassOfWarrantOrRightMinimumOwnershipPercentageRequired_11ed9d95-0716-4880-be4b-488ccf6e09a6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cron_ClassOfWarrantOrRightExercisePriceVolumeWeightedAveragePriceMeasurementPeriod_e6069092-0a75-4d52-9109-9421427acb08" xlink:href="cron-20210630.xsd#cron_ClassOfWarrantOrRightExercisePriceVolumeWeightedAveragePriceMeasurementPeriod"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeLineItems_26768879-7456-48cf-88f4-a847197023c9" xlink:to="loc_cron_ClassOfWarrantOrRightExercisePriceVolumeWeightedAveragePriceMeasurementPeriod_e6069092-0a75-4d52-9109-9421427acb08" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cron_ClassOfWarrantOrRightExercisePriceVolumeWeightedAveragePriceMeasurementPeriodDaysPrecedingExercise_c7f74c97-5822-4e02-bee3-dd4f94683868" xlink:href="cron-20210630.xsd#cron_ClassOfWarrantOrRightExercisePriceVolumeWeightedAveragePriceMeasurementPeriodDaysPrecedingExercise"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeLineItems_26768879-7456-48cf-88f4-a847197023c9" xlink:to="loc_cron_ClassOfWarrantOrRightExercisePriceVolumeWeightedAveragePriceMeasurementPeriodDaysPrecedingExercise_c7f74c97-5822-4e02-bee3-dd4f94683868" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cron_FairValueNetDerivativeAssetLiabilityMeasuredOnRecurringBasisUnobservableInputsReconciliationOutOfPeriodAdjustment_564b6ca6-8dbb-4723-a50e-910f4f91b92e" xlink:href="cron-20210630.xsd#cron_FairValueNetDerivativeAssetLiabilityMeasuredOnRecurringBasisUnobservableInputsReconciliationOutOfPeriodAdjustment"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeLineItems_26768879-7456-48cf-88f4-a847197023c9" xlink:to="loc_cron_FairValueNetDerivativeAssetLiabilityMeasuredOnRecurringBasisUnobservableInputsReconciliationOutOfPeriodAdjustment_564b6ca6-8dbb-4723-a50e-910f4f91b92e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://thecronosgroup.com/role/DerivativeLiabilitiesScheduleofReconciliationofCarryingAmountsDetails" xlink:type="simple" xlink:href="cron-20210630.xsd#DerivativeLiabilitiesScheduleofReconciliationofCarryingAmountsDetails"/>
  <link:presentationLink xlink:role="http://thecronosgroup.com/role/DerivativeLiabilitiesScheduleofReconciliationofCarryingAmountsDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract_8681e852-3f80-4a60-bc9a-47fa9053a232" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipByIncomeStatementLocationByDerivativeInstrumentRiskTable_89d73e1b-e29f-4e43-886f-8205d62199c7" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipByIncomeStatementLocationByDerivativeInstrumentRiskTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract_8681e852-3f80-4a60-bc9a-47fa9053a232" xlink:to="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipByIncomeStatementLocationByDerivativeInstrumentRiskTable_89d73e1b-e29f-4e43-886f-8205d62199c7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfWarrantOrRightAxis_caec1b77-aa99-4414-9c33-1e2f3505b8d9" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ClassOfWarrantOrRightAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipByIncomeStatementLocationByDerivativeInstrumentRiskTable_89d73e1b-e29f-4e43-886f-8205d62199c7" xlink:to="loc_us-gaap_ClassOfWarrantOrRightAxis_caec1b77-aa99-4414-9c33-1e2f3505b8d9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfWarrantOrRightDomain_3cef6310-1260-49a5-bfc0-8eb9907223be" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ClassOfWarrantOrRightDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfWarrantOrRightAxis_caec1b77-aa99-4414-9c33-1e2f3505b8d9" xlink:to="loc_us-gaap_ClassOfWarrantOrRightDomain_3cef6310-1260-49a5-bfc0-8eb9907223be" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cron_AltriaWarrantMember_58b8e79b-e77b-4255-8fa4-8000b8a4dd33" xlink:href="cron-20210630.xsd#cron_AltriaWarrantMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfWarrantOrRightDomain_3cef6310-1260-49a5-bfc0-8eb9907223be" xlink:to="loc_cron_AltriaWarrantMember_58b8e79b-e77b-4255-8fa4-8000b8a4dd33" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cron_PreemptiveRightsMember_0add1cd4-9d40-4efc-911c-5305c6f68646" xlink:href="cron-20210630.xsd#cron_PreemptiveRightsMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfWarrantOrRightDomain_3cef6310-1260-49a5-bfc0-8eb9907223be" xlink:to="loc_cron_PreemptiveRightsMember_0add1cd4-9d40-4efc-911c-5305c6f68646" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cron_TopupRightsMember_39d461b0-ce18-4602-8e16-f88ed2999ba5" xlink:href="cron-20210630.xsd#cron_TopupRightsMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfWarrantOrRightDomain_3cef6310-1260-49a5-bfc0-8eb9907223be" xlink:to="loc_cron_TopupRightsMember_39d461b0-ce18-4602-8e16-f88ed2999ba5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentsGainLossLineItems_1aacac1b-30bb-4b4e-a05b-8d6b41b26ca6" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DerivativeInstrumentsGainLossLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipByIncomeStatementLocationByDerivativeInstrumentRiskTable_89d73e1b-e29f-4e43-886f-8205d62199c7" xlink:to="loc_us-gaap_DerivativeInstrumentsGainLossLineItems_1aacac1b-30bb-4b4e-a05b-8d6b41b26ca6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cron_DerivativeInstrumentsRollForward_95fa3ae6-873d-4dbd-94bd-b9606c0f0d88" xlink:href="cron-20210630.xsd#cron_DerivativeInstrumentsRollForward"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossLineItems_1aacac1b-30bb-4b4e-a05b-8d6b41b26ca6" xlink:to="loc_cron_DerivativeInstrumentsRollForward_95fa3ae6-873d-4dbd-94bd-b9606c0f0d88" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueNetDerivativeAssetLiabilityMeasuredOnRecurringBasisWithUnobservableInputs_60903f59-8208-4e5a-8f3e-0fd1342ebeb4" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueNetDerivativeAssetLiabilityMeasuredOnRecurringBasisWithUnobservableInputs"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_cron_DerivativeInstrumentsRollForward_95fa3ae6-873d-4dbd-94bd-b9606c0f0d88" xlink:to="loc_us-gaap_FairValueNetDerivativeAssetLiabilityMeasuredOnRecurringBasisWithUnobservableInputs_60903f59-8208-4e5a-8f3e-0fd1342ebeb4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedPeriodStartLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueNetDerivativeAssetLiabilityMeasuredOnRecurringBasisUnobservableInputsReconciliationGainLossIncludedInEarnings_b034a739-86e7-4ff9-a7d6-25d08ce621e0" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueNetDerivativeAssetLiabilityMeasuredOnRecurringBasisUnobservableInputsReconciliationGainLossIncludedInEarnings"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_cron_DerivativeInstrumentsRollForward_95fa3ae6-873d-4dbd-94bd-b9606c0f0d88" xlink:to="loc_us-gaap_FairValueNetDerivativeAssetLiabilityMeasuredOnRecurringBasisUnobservableInputsReconciliationGainLossIncludedInEarnings_b034a739-86e7-4ff9-a7d6-25d08ce621e0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueNetDerivativeAssetLiabilityMeasuredOnRecurringBasisUnobservableInputsReconciliationSettlements_e45adc29-e061-44e4-8d01-64b09ba5260c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueNetDerivativeAssetLiabilityMeasuredOnRecurringBasisUnobservableInputsReconciliationSettlements"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_cron_DerivativeInstrumentsRollForward_95fa3ae6-873d-4dbd-94bd-b9606c0f0d88" xlink:to="loc_us-gaap_FairValueNetDerivativeAssetLiabilityMeasuredOnRecurringBasisUnobservableInputsReconciliationSettlements_e45adc29-e061-44e4-8d01-64b09ba5260c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cron_FairValueNetDerivativeAssetLiabilityMeasuredOnRecurringBasisUnobservableInputsReconciliationOutOfPeriodAdjustment_7794f598-17c1-4925-b36d-1a389ffa36c2" xlink:href="cron-20210630.xsd#cron_FairValueNetDerivativeAssetLiabilityMeasuredOnRecurringBasisUnobservableInputsReconciliationOutOfPeriodAdjustment"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_cron_DerivativeInstrumentsRollForward_95fa3ae6-873d-4dbd-94bd-b9606c0f0d88" xlink:to="loc_cron_FairValueNetDerivativeAssetLiabilityMeasuredOnRecurringBasisUnobservableInputsReconciliationOutOfPeriodAdjustment_7794f598-17c1-4925-b36d-1a389ffa36c2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueNetDerivativeAssetLiabilityMeasuredOnRecurringBasisUnobservableInputsReconciliationGainLossIncludedInOtherComprehensiveIncomeLoss_7545f2a0-dac2-4d5d-91d1-f25e2ff67269" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueNetDerivativeAssetLiabilityMeasuredOnRecurringBasisUnobservableInputsReconciliationGainLossIncludedInOtherComprehensiveIncomeLoss"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_cron_DerivativeInstrumentsRollForward_95fa3ae6-873d-4dbd-94bd-b9606c0f0d88" xlink:to="loc_us-gaap_FairValueNetDerivativeAssetLiabilityMeasuredOnRecurringBasisUnobservableInputsReconciliationGainLossIncludedInOtherComprehensiveIncomeLoss_7545f2a0-dac2-4d5d-91d1-f25e2ff67269" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueNetDerivativeAssetLiabilityMeasuredOnRecurringBasisWithUnobservableInputs_3118af40-f45c-47d4-a6d8-3cfef07e1c20" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueNetDerivativeAssetLiabilityMeasuredOnRecurringBasisWithUnobservableInputs"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_cron_DerivativeInstrumentsRollForward_95fa3ae6-873d-4dbd-94bd-b9606c0f0d88" xlink:to="loc_us-gaap_FairValueNetDerivativeAssetLiabilityMeasuredOnRecurringBasisWithUnobservableInputs_3118af40-f45c-47d4-a6d8-3cfef07e1c20" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedPeriodEndLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://thecronosgroup.com/role/DerivativeLiabilitiesScheduleofFairValuesofDerivativeLiabilitiesDetails" xlink:type="simple" xlink:href="cron-20210630.xsd#DerivativeLiabilitiesScheduleofFairValuesofDerivativeLiabilitiesDetails"/>
  <link:presentationLink xlink:role="http://thecronosgroup.com/role/DerivativeLiabilitiesScheduleofFairValuesofDerivativeLiabilitiesDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract_9f2e6a8b-fe28-4667-8102-1c53be51009f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTable_1b52c7cb-5ab8-4a0d-ad66-b00c96e643e0" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract_9f2e6a8b-fe28-4667-8102-1c53be51009f" xlink:to="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTable_1b52c7cb-5ab8-4a0d-ad66-b00c96e643e0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfWarrantOrRightAxis_cf96efae-59fb-4ee9-bb63-21774beb1ab3" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ClassOfWarrantOrRightAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTable_1b52c7cb-5ab8-4a0d-ad66-b00c96e643e0" xlink:to="loc_us-gaap_ClassOfWarrantOrRightAxis_cf96efae-59fb-4ee9-bb63-21774beb1ab3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfWarrantOrRightDomain_aca3f77c-9dbf-4989-a0d7-0bf6ad547264" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ClassOfWarrantOrRightDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfWarrantOrRightAxis_cf96efae-59fb-4ee9-bb63-21774beb1ab3" xlink:to="loc_us-gaap_ClassOfWarrantOrRightDomain_aca3f77c-9dbf-4989-a0d7-0bf6ad547264" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cron_AltriaWarrantMember_50db2b3a-842c-4c53-baa1-8b3b3ed78bb5" xlink:href="cron-20210630.xsd#cron_AltriaWarrantMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfWarrantOrRightDomain_aca3f77c-9dbf-4989-a0d7-0bf6ad547264" xlink:to="loc_cron_AltriaWarrantMember_50db2b3a-842c-4c53-baa1-8b3b3ed78bb5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cron_PreemptiveRightsMember_6c6b9309-b7f7-4a69-b05a-e55f01d1e2c4" xlink:href="cron-20210630.xsd#cron_PreemptiveRightsMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfWarrantOrRightDomain_aca3f77c-9dbf-4989-a0d7-0bf6ad547264" xlink:to="loc_cron_PreemptiveRightsMember_6c6b9309-b7f7-4a69-b05a-e55f01d1e2c4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cron_TopupRightsMember_27202630-26de-4ebb-8285-8a6366e8d799" xlink:href="cron-20210630.xsd#cron_TopupRightsMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfWarrantOrRightDomain_aca3f77c-9dbf-4989-a0d7-0bf6ad547264" xlink:to="loc_cron_TopupRightsMember_27202630-26de-4ebb-8285-8a6366e8d799" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cron_PreEmptiveRightsAndTopUpRightsMember_5b765119-864e-45ad-a3f8-cee7c902f61f" xlink:href="cron-20210630.xsd#cron_PreEmptiveRightsAndTopUpRightsMember"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfWarrantOrRightDomain_aca3f77c-9dbf-4989-a0d7-0bf6ad547264" xlink:to="loc_cron_PreEmptiveRightsAndTopUpRightsMember_5b765119-864e-45ad-a3f8-cee7c902f61f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeAxis_0f3d725c-bb78-441a-8ec5-e7c09a861f68" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_RangeAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTable_1b52c7cb-5ab8-4a0d-ad66-b00c96e643e0" xlink:to="loc_srt_RangeAxis_0f3d725c-bb78-441a-8ec5-e7c09a861f68" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_7b0646f3-687e-40b9-a2bd-c4bcdcd96600" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_RangeMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeAxis_0f3d725c-bb78-441a-8ec5-e7c09a861f68" xlink:to="loc_srt_RangeMember_7b0646f3-687e-40b9-a2bd-c4bcdcd96600" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_WeightedAverageMember_5be0cbbb-1434-4cb4-a57f-aab2b7e40a09" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_WeightedAverageMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeMember_7b0646f3-687e-40b9-a2bd-c4bcdcd96600" xlink:to="loc_srt_WeightedAverageMember_5be0cbbb-1434-4cb4-a57f-aab2b7e40a09" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MinimumMember_db68e8f3-4e75-4249-9258-0d714edf2b33" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_MinimumMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeMember_7b0646f3-687e-40b9-a2bd-c4bcdcd96600" xlink:to="loc_srt_MinimumMember_db68e8f3-4e75-4249-9258-0d714edf2b33" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MaximumMember_7fdc5f2b-cbd7-4bce-844e-1c2bf3d33f9a" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_MaximumMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeMember_7b0646f3-687e-40b9-a2bd-c4bcdcd96600" xlink:to="loc_srt_MaximumMember_7fdc5f2b-cbd7-4bce-844e-1c2bf3d33f9a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MeasurementInputTypeAxis_45be7957-41ae-438b-b30e-339bdc293e03" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_MeasurementInputTypeAxis"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTable_1b52c7cb-5ab8-4a0d-ad66-b00c96e643e0" xlink:to="loc_us-gaap_MeasurementInputTypeAxis_45be7957-41ae-438b-b30e-339bdc293e03" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MeasurementInputTypeDomain_33f6f170-eb54-4f3f-8814-79547d1251b6" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_MeasurementInputTypeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_MeasurementInputTypeAxis_45be7957-41ae-438b-b30e-339bdc293e03" xlink:to="loc_us-gaap_MeasurementInputTypeDomain_33f6f170-eb54-4f3f-8814-79547d1251b6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MeasurementInputSharePriceMember_320322fc-39dc-4af9-b9ab-1c53902bd2b2" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_MeasurementInputSharePriceMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_MeasurementInputTypeDomain_33f6f170-eb54-4f3f-8814-79547d1251b6" xlink:to="loc_us-gaap_MeasurementInputSharePriceMember_320322fc-39dc-4af9-b9ab-1c53902bd2b2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cron_MeasurementInputSubscriptionPriceMember_cc2cdc52-8a12-463a-a89c-b8e952f62bd1" xlink:href="cron-20210630.xsd#cron_MeasurementInputSubscriptionPriceMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_MeasurementInputTypeDomain_33f6f170-eb54-4f3f-8814-79547d1251b6" xlink:to="loc_cron_MeasurementInputSubscriptionPriceMember_cc2cdc52-8a12-463a-a89c-b8e952f62bd1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MeasurementInputRiskFreeInterestRateMember_bd481f2c-46ad-430b-8ec2-11bef837c520" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_MeasurementInputRiskFreeInterestRateMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_MeasurementInputTypeDomain_33f6f170-eb54-4f3f-8814-79547d1251b6" xlink:to="loc_us-gaap_MeasurementInputRiskFreeInterestRateMember_bd481f2c-46ad-430b-8ec2-11bef837c520" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MeasurementInputExpectedTermMember_edb6bb25-ab2b-4d65-a457-239c72b87c93" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_MeasurementInputExpectedTermMember"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_MeasurementInputTypeDomain_33f6f170-eb54-4f3f-8814-79547d1251b6" xlink:to="loc_us-gaap_MeasurementInputExpectedTermMember_edb6bb25-ab2b-4d65-a457-239c72b87c93" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MeasurementInputPriceVolatilityMember_3702eb03-6522-4f07-bdcc-182350b94e31" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_MeasurementInputPriceVolatilityMember"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_MeasurementInputTypeDomain_33f6f170-eb54-4f3f-8814-79547d1251b6" xlink:to="loc_us-gaap_MeasurementInputPriceVolatilityMember_3702eb03-6522-4f07-bdcc-182350b94e31" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MeasurementInputExpectedDividendRateMember_cf8ed1c9-5273-454f-979d-c5135e22e0b6" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_MeasurementInputExpectedDividendRateMember"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_MeasurementInputTypeDomain_33f6f170-eb54-4f3f-8814-79547d1251b6" xlink:to="loc_us-gaap_MeasurementInputExpectedDividendRateMember_cf8ed1c9-5273-454f-979d-c5135e22e0b6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesLineItems_6a9eb2e7-a93c-40e1-8ee2-212dba6b0304" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesLineItems"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTable_1b52c7cb-5ab8-4a0d-ad66-b00c96e643e0" xlink:to="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesLineItems_6a9eb2e7-a93c-40e1-8ee2-212dba6b0304" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeLiabilityMeasurementInput_0a6ea427-9fed-40c5-8f3f-12a76e234891" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DerivativeLiabilityMeasurementInput"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesLineItems_6a9eb2e7-a93c-40e1-8ee2-212dba6b0304" xlink:to="loc_us-gaap_DerivativeLiabilityMeasurementInput_0a6ea427-9fed-40c5-8f3f-12a76e234891" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cron_DerivativeLiabilityUsefulLifeTerm_73bd4fbf-619b-4e2a-ba09-6685d1cdd479" xlink:href="cron-20210630.xsd#cron_DerivativeLiabilityUsefulLifeTerm"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesLineItems_6a9eb2e7-a93c-40e1-8ee2-212dba6b0304" xlink:to="loc_cron_DerivativeLiabilityUsefulLifeTerm_73bd4fbf-619b-4e2a-ba09-6685d1cdd479" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://thecronosgroup.com/role/DerivativeLiabilitiesScheduleofSensitivityAnalysisDetails" xlink:type="simple" xlink:href="cron-20210630.xsd#DerivativeLiabilitiesScheduleofSensitivityAnalysisDetails"/>
  <link:presentationLink xlink:role="http://thecronosgroup.com/role/DerivativeLiabilitiesScheduleofSensitivityAnalysisDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract_8b99e644-6867-49df-9746-f0d8bd0653f3" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeTable_978279d9-b8a4-408d-8804-b26d3ce8c04a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DerivativeTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract_8b99e644-6867-49df-9746-f0d8bd0653f3" xlink:to="loc_us-gaap_DerivativeTable_978279d9-b8a4-408d-8804-b26d3ce8c04a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfWarrantOrRightAxis_07666398-81af-4932-9ddd-99f8b4595f49" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ClassOfWarrantOrRightAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeTable_978279d9-b8a4-408d-8804-b26d3ce8c04a" xlink:to="loc_us-gaap_ClassOfWarrantOrRightAxis_07666398-81af-4932-9ddd-99f8b4595f49" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfWarrantOrRightDomain_fde39d62-4d4b-48a5-a162-705825975626" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ClassOfWarrantOrRightDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfWarrantOrRightAxis_07666398-81af-4932-9ddd-99f8b4595f49" xlink:to="loc_us-gaap_ClassOfWarrantOrRightDomain_fde39d62-4d4b-48a5-a162-705825975626" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cron_AltriaWarrantMember_d3f4aeb3-a57c-4b0f-906c-fd2a0ac1f041" xlink:href="cron-20210630.xsd#cron_AltriaWarrantMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfWarrantOrRightDomain_fde39d62-4d4b-48a5-a162-705825975626" xlink:to="loc_cron_AltriaWarrantMember_d3f4aeb3-a57c-4b0f-906c-fd2a0ac1f041" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cron_PreemptiveRightsMember_b5d0e6c0-4c27-4bd4-bb13-9ac2ec92be47" xlink:href="cron-20210630.xsd#cron_PreemptiveRightsMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfWarrantOrRightDomain_fde39d62-4d4b-48a5-a162-705825975626" xlink:to="loc_cron_PreemptiveRightsMember_b5d0e6c0-4c27-4bd4-bb13-9ac2ec92be47" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cron_TopupRightsMember_5b1aafe7-647a-4513-a930-a76ccd9ef2ed" xlink:href="cron-20210630.xsd#cron_TopupRightsMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfWarrantOrRightDomain_fde39d62-4d4b-48a5-a162-705825975626" xlink:to="loc_cron_TopupRightsMember_5b1aafe7-647a-4513-a930-a76ccd9ef2ed" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeLineItems_b997f3ae-3137-40c3-89f5-ede0200d2549" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DerivativeLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeTable_978279d9-b8a4-408d-8804-b26d3ce8c04a" xlink:to="loc_us-gaap_DerivativeLineItems_b997f3ae-3137-40c3-89f5-ede0200d2549" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cron_SensitivityAnalysisImpactOf10PercentDecreaseIncreaseOnNetIncomeLossAbstract_370cff4d-8987-486c-9196-75e7ca7bacbf" xlink:href="cron-20210630.xsd#cron_SensitivityAnalysisImpactOf10PercentDecreaseIncreaseOnNetIncomeLossAbstract"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeLineItems_b997f3ae-3137-40c3-89f5-ede0200d2549" xlink:to="loc_cron_SensitivityAnalysisImpactOf10PercentDecreaseIncreaseOnNetIncomeLossAbstract_370cff4d-8987-486c-9196-75e7ca7bacbf" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cron_SensitivityAnalysisImpactOf10PercentDecreaseIncreaseInSharePriceOnNetIncomeLoss_8b17820f-0600-4ce2-a1c5-94478ca0bfec" xlink:href="cron-20210630.xsd#cron_SensitivityAnalysisImpactOf10PercentDecreaseIncreaseInSharePriceOnNetIncomeLoss"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_cron_SensitivityAnalysisImpactOf10PercentDecreaseIncreaseOnNetIncomeLossAbstract_370cff4d-8987-486c-9196-75e7ca7bacbf" xlink:to="loc_cron_SensitivityAnalysisImpactOf10PercentDecreaseIncreaseInSharePriceOnNetIncomeLoss_8b17820f-0600-4ce2-a1c5-94478ca0bfec" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cron_SensitivityAnalysisImpactOf10PercentDecreaseIncreaseInWeightedAverageExpectedLifeOnNetIncomeLoss_cea805b1-3533-47d9-9b36-e16eb9adee47" xlink:href="cron-20210630.xsd#cron_SensitivityAnalysisImpactOf10PercentDecreaseIncreaseInWeightedAverageExpectedLifeOnNetIncomeLoss"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_cron_SensitivityAnalysisImpactOf10PercentDecreaseIncreaseOnNetIncomeLossAbstract_370cff4d-8987-486c-9196-75e7ca7bacbf" xlink:to="loc_cron_SensitivityAnalysisImpactOf10PercentDecreaseIncreaseInWeightedAverageExpectedLifeOnNetIncomeLoss_cea805b1-3533-47d9-9b36-e16eb9adee47" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cron_SensitivityAnalysisImpactOf10PercentDecreaseIncreaseInExpectedAnnualizedVolatilityOnNetIncomeLoss_d435142b-f22b-47a5-b7a9-449dbc1ea5e3" xlink:href="cron-20210630.xsd#cron_SensitivityAnalysisImpactOf10PercentDecreaseIncreaseInExpectedAnnualizedVolatilityOnNetIncomeLoss"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_cron_SensitivityAnalysisImpactOf10PercentDecreaseIncreaseOnNetIncomeLossAbstract_370cff4d-8987-486c-9196-75e7ca7bacbf" xlink:to="loc_cron_SensitivityAnalysisImpactOf10PercentDecreaseIncreaseInExpectedAnnualizedVolatilityOnNetIncomeLoss_d435142b-f22b-47a5-b7a9-449dbc1ea5e3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://thecronosgroup.com/role/SharebasedPayments" xlink:type="simple" xlink:href="cron-20210630.xsd#SharebasedPayments"/>
  <link:presentationLink xlink:role="http://thecronosgroup.com/role/SharebasedPayments" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_5c6762ca-ac61-428f-bf88-70d27ebbe48b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock_bf8a45cb-1c0d-48ca-94b4-cb6c166c0e72" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_5c6762ca-ac61-428f-bf88-70d27ebbe48b" xlink:to="loc_us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock_bf8a45cb-1c0d-48ca-94b4-cb6c166c0e72" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://thecronosgroup.com/role/SharebasedPaymentsTables" xlink:type="simple" xlink:href="cron-20210630.xsd#SharebasedPaymentsTables"/>
  <link:presentationLink xlink:role="http://thecronosgroup.com/role/SharebasedPaymentsTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_ab740a29-c749-4926-a722-281612e5dae0" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock_eeb65180-b015-4882-8a8d-5e8957d2c70e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_ab740a29-c749-4926-a722-281612e5dae0" xlink:to="loc_us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock_eeb65180-b015-4882-8a8d-5e8957d2c70e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfStockOptionsRollForwardTableTextBlock_91a2af02-8336-45be-b0cf-46dff5025ea2" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfStockOptionsRollForwardTableTextBlock"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_ab740a29-c749-4926-a722-281612e5dae0" xlink:to="loc_us-gaap_ScheduleOfStockOptionsRollForwardTableTextBlock_91a2af02-8336-45be-b0cf-46dff5025ea2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfShareBasedCompensationRestrictedStockUnitsAwardActivityTableTextBlock_f36f334d-85b2-463b-b634-757426334682" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfShareBasedCompensationRestrictedStockUnitsAwardActivityTableTextBlock"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_ab740a29-c749-4926-a722-281612e5dae0" xlink:to="loc_us-gaap_ScheduleOfShareBasedCompensationRestrictedStockUnitsAwardActivityTableTextBlock_f36f334d-85b2-463b-b634-757426334682" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfOtherShareBasedCompensationActivityTableTextBlock_4b3c9815-593f-4c2b-aa1c-37590c55b836" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfOtherShareBasedCompensationActivityTableTextBlock"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_ab740a29-c749-4926-a722-281612e5dae0" xlink:to="loc_us-gaap_ScheduleOfOtherShareBasedCompensationActivityTableTextBlock_4b3c9815-593f-4c2b-aa1c-37590c55b836" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://thecronosgroup.com/role/SharebasedPaymentsSummaryofStockbasedCompensationExpenseDetails" xlink:type="simple" xlink:href="cron-20210630.xsd#SharebasedPaymentsSummaryofStockbasedCompensationExpenseDetails"/>
  <link:presentationLink xlink:role="http://thecronosgroup.com/role/SharebasedPaymentsSummaryofStockbasedCompensationExpenseDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_4948ef0f-2ac4-416d-a592-6f4dd6e8f878" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTable_1591be10-c3ed-4dc8-b488-8b5adba47251" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_4948ef0f-2ac4-416d-a592-6f4dd6e8f878" xlink:to="loc_us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTable_1591be10-c3ed-4dc8-b488-8b5adba47251" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AwardTypeAxis_d388da90-f14a-45c5-9d03-9ef8cfdb9dc6" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AwardTypeAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTable_1591be10-c3ed-4dc8-b488-8b5adba47251" xlink:to="loc_us-gaap_AwardTypeAxis_d388da90-f14a-45c5-9d03-9ef8cfdb9dc6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_5590d504-ff8a-4dcd-8f9f-f261a3163578" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AwardTypeAxis_d388da90-f14a-45c5-9d03-9ef8cfdb9dc6" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_5590d504-ff8a-4dcd-8f9f-f261a3163578" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeStockOptionMember_8f1e1d0d-016c-4d18-b4c9-fe823590172b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EmployeeStockOptionMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_5590d504-ff8a-4dcd-8f9f-f261a3163578" xlink:to="loc_us-gaap_EmployeeStockOptionMember_8f1e1d0d-016c-4d18-b4c9-fe823590172b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestrictedStockUnitsRSUMember_188de5a4-6792-4d53-a3bc-05165bfa5ef8" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RestrictedStockUnitsRSUMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_5590d504-ff8a-4dcd-8f9f-f261a3163578" xlink:to="loc_us-gaap_RestrictedStockUnitsRSUMember_188de5a4-6792-4d53-a3bc-05165bfa5ef8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems_83a508db-bdec-4b64-b86d-f7a90d638559" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTable_1591be10-c3ed-4dc8-b488-8b5adba47251" xlink:to="loc_us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems_83a508db-bdec-4b64-b86d-f7a90d638559" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AllocatedShareBasedCompensationExpense_05ae9739-1516-4331-99ee-39a0d2e675d8" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AllocatedShareBasedCompensationExpense"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems_83a508db-bdec-4b64-b86d-f7a90d638559" xlink:to="loc_us-gaap_AllocatedShareBasedCompensationExpense_05ae9739-1516-4331-99ee-39a0d2e675d8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://thecronosgroup.com/role/SharebasedPaymentsStockOptionsNarrativeDetails" xlink:type="simple" xlink:href="cron-20210630.xsd#SharebasedPaymentsStockOptionsNarrativeDetails"/>
  <link:presentationLink xlink:role="http://thecronosgroup.com/role/SharebasedPaymentsStockOptionsNarrativeDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_f97f5b65-e9da-4102-96d7-5f8989ba151d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_443c716c-e42c-4351-a50a-3ffbd4476f09" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_f97f5b65-e9da-4102-96d7-5f8989ba151d" xlink:to="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_443c716c-e42c-4351-a50a-3ffbd4476f09" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeAxis_18d9e237-4c4d-44e0-b4a3-c1fbd22d67c4" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_RangeAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_443c716c-e42c-4351-a50a-3ffbd4476f09" xlink:to="loc_srt_RangeAxis_18d9e237-4c4d-44e0-b4a3-c1fbd22d67c4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_71b69e6c-92bb-4720-ad9c-777f2212e0a5" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_RangeMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeAxis_18d9e237-4c4d-44e0-b4a3-c1fbd22d67c4" xlink:to="loc_srt_RangeMember_71b69e6c-92bb-4720-ad9c-777f2212e0a5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MinimumMember_904d169b-72ea-4a92-babc-8d88e5a53017" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_MinimumMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeMember_71b69e6c-92bb-4720-ad9c-777f2212e0a5" xlink:to="loc_srt_MinimumMember_904d169b-72ea-4a92-babc-8d88e5a53017" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MaximumMember_8e2f7b58-abfd-47f3-9021-3be7e9cbd7c9" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_MaximumMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeMember_71b69e6c-92bb-4720-ad9c-777f2212e0a5" xlink:to="loc_srt_MaximumMember_8e2f7b58-abfd-47f3-9021-3be7e9cbd7c9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AwardTypeAxis_e0b4de31-34e5-4c04-84d6-06b8b5ff3979" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AwardTypeAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_443c716c-e42c-4351-a50a-3ffbd4476f09" xlink:to="loc_us-gaap_AwardTypeAxis_e0b4de31-34e5-4c04-84d6-06b8b5ff3979" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_a98d3c0a-f5c8-43c4-8073-b265bc0b473a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AwardTypeAxis_e0b4de31-34e5-4c04-84d6-06b8b5ff3979" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_a98d3c0a-f5c8-43c4-8073-b265bc0b473a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeStockOptionMember_d097849d-7b96-4adb-acfa-3d40c691eb7b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EmployeeStockOptionMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_a98d3c0a-f5c8-43c4-8073-b265bc0b473a" xlink:to="loc_us-gaap_EmployeeStockOptionMember_d097849d-7b96-4adb-acfa-3d40c691eb7b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PlanNameAxis_fa9396a4-57d4-4c45-bb7d-e7ca14bacb9b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PlanNameAxis"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_443c716c-e42c-4351-a50a-3ffbd4476f09" xlink:to="loc_us-gaap_PlanNameAxis_fa9396a4-57d4-4c45-bb7d-e7ca14bacb9b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PlanNameDomain_e31c84f0-13c0-457c-b153-a064f7461114" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PlanNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PlanNameAxis_fa9396a4-57d4-4c45-bb7d-e7ca14bacb9b" xlink:to="loc_us-gaap_PlanNameDomain_e31c84f0-13c0-457c-b153-a064f7461114" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cron_A2020OmnibusPlanMember_01b28fed-0687-4eb2-b495-b6117ea45b42" xlink:href="cron-20210630.xsd#cron_A2020OmnibusPlanMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PlanNameDomain_e31c84f0-13c0-457c-b153-a064f7461114" xlink:to="loc_cron_A2020OmnibusPlanMember_01b28fed-0687-4eb2-b495-b6117ea45b42" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cron_PriorOptionPlansMember_e8732173-6218-42d0-9749-bf1d37dcb62d" xlink:href="cron-20210630.xsd#cron_PriorOptionPlansMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PlanNameDomain_e31c84f0-13c0-457c-b153-a064f7461114" xlink:to="loc_cron_PriorOptionPlansMember_e8732173-6218-42d0-9749-bf1d37dcb62d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_9a476ee5-dc7a-4be8-8b0b-85c749ebf5da" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_443c716c-e42c-4351-a50a-3ffbd4476f09" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_9a476ee5-dc7a-4be8-8b0b-85c749ebf5da" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1_9f6d712b-07ce-496c-9f3d-46e096c2730d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_9a476ee5-dc7a-4be8-8b0b-85c749ebf5da" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1_9f6d712b-07ce-496c-9f3d-46e096c2730d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod_39a2e3ea-d82b-4c7a-a1d5-cb7cce28e9ea" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_9a476ee5-dc7a-4be8-8b0b-85c749ebf5da" xlink:to="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod_39a2e3ea-d82b-4c7a-a1d5-cb7cce28e9ea" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross_ffa498c8-1c8c-4dcd-ab07-8abf40900218" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_9a476ee5-dc7a-4be8-8b0b-85c749ebf5da" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross_ffa498c8-1c8c-4dcd-ab07-8abf40900218" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://thecronosgroup.com/role/SharebasedPaymentsSummaryoftheChangesinOptionsDetails" xlink:type="simple" xlink:href="cron-20210630.xsd#SharebasedPaymentsSummaryoftheChangesinOptionsDetails"/>
  <link:presentationLink xlink:role="http://thecronosgroup.com/role/SharebasedPaymentsSummaryoftheChangesinOptionsDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_0be17587-d78f-4ed4-a0a5-335a559c8ae1" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward_935796a5-a6a6-4f7e-999f-fe07c3845289" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_0be17587-d78f-4ed4-a0a5-335a559c8ae1" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward_935796a5-a6a6-4f7e-999f-fe07c3845289" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_93ea5601-38bc-42df-9770-067c1f8d8b76" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward_935796a5-a6a6-4f7e-999f-fe07c3845289" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_93ea5601-38bc-42df-9770-067c1f8d8b76" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice_652dd112-3421-430f-b124-4a67b7324f87" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward_935796a5-a6a6-4f7e-999f-fe07c3845289" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice_652dd112-3421-430f-b124-4a67b7324f87" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice_00fe6007-e957-4d7b-a107-fbb65f76c80e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward_935796a5-a6a6-4f7e-999f-fe07c3845289" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice_00fe6007-e957-4d7b-a107-fbb65f76c80e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_ea12e298-138b-4ca9-9d36-076e57de140d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward_935796a5-a6a6-4f7e-999f-fe07c3845289" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_ea12e298-138b-4ca9-9d36-076e57de140d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice_f31e8c07-f446-42ca-93b2-46327e26f690" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_0be17587-d78f-4ed4-a0a5-335a559c8ae1" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice_f31e8c07-f446-42ca-93b2-46327e26f690" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward_36a528e1-36d6-4144-9f76-51b7eacc38a5" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_0be17587-d78f-4ed4-a0a5-335a559c8ae1" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward_36a528e1-36d6-4144-9f76-51b7eacc38a5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_d7d3521b-38d0-4bcc-8842-5f00c1028dbd" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward_36a528e1-36d6-4144-9f76-51b7eacc38a5" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_d7d3521b-38d0-4bcc-8842-5f00c1028dbd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised_57337e93-38a6-41c1-8acf-0668526299c4" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward_36a528e1-36d6-4144-9f76-51b7eacc38a5" xlink:to="loc_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised_57337e93-38a6-41c1-8acf-0668526299c4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod_6a0aee01-5a30-4c0c-b381-209a06fc7968" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward_36a528e1-36d6-4144-9f76-51b7eacc38a5" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod_6a0aee01-5a30-4c0c-b381-209a06fc7968" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_6fb8c60f-0b88-4a11-8936-f94577eb289a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward_36a528e1-36d6-4144-9f76-51b7eacc38a5" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_6fb8c60f-0b88-4a11-8936-f94577eb289a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber_64afb343-e3c7-4661-bfa5-0a2e92321960" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_0be17587-d78f-4ed4-a0a5-335a559c8ae1" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber_64afb343-e3c7-4661-bfa5-0a2e92321960" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedWeightedAverageGrantDateFairValueAbstract_8f7ee2b1-5947-4ff2-b4ca-7b330bec450e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedWeightedAverageGrantDateFairValueAbstract"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_0be17587-d78f-4ed4-a0a5-335a559c8ae1" xlink:to="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedWeightedAverageGrantDateFairValueAbstract_8f7ee2b1-5947-4ff2-b4ca-7b330bec450e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2_346c4326-f102-40fd-9b89-65ef47fb3f9c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedWeightedAverageGrantDateFairValueAbstract_8f7ee2b1-5947-4ff2-b4ca-7b330bec450e" xlink:to="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2_346c4326-f102-40fd-9b89-65ef47fb3f9c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageRemainingContractualTerm1_5e334032-b422-416b-b76e-422d53f35346" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageRemainingContractualTerm1"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedWeightedAverageGrantDateFairValueAbstract_8f7ee2b1-5947-4ff2-b4ca-7b330bec450e" xlink:to="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageRemainingContractualTerm1_5e334032-b422-416b-b76e-422d53f35346" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://thecronosgroup.com/role/SharebasedPaymentsScheduleofStockOptionsOutstandingDetails" xlink:type="simple" xlink:href="cron-20210630.xsd#SharebasedPaymentsScheduleofStockOptionsOutstandingDetails"/>
  <link:presentationLink xlink:role="http://thecronosgroup.com/role/SharebasedPaymentsScheduleofStockOptionsOutstandingDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_9c3a6761-07d5-47e6-a55a-0c052a83dccc" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_8b2eb389-330e-4558-90b2-6e2fad014875" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_9c3a6761-07d5-47e6-a55a-0c052a83dccc" xlink:to="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_8b2eb389-330e-4558-90b2-6e2fad014875" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PlanNameAxis_c43b6f74-5b5b-4358-aaf2-bdad906f2cb8" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PlanNameAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_8b2eb389-330e-4558-90b2-6e2fad014875" xlink:to="loc_us-gaap_PlanNameAxis_c43b6f74-5b5b-4358-aaf2-bdad906f2cb8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PlanNameDomain_361cf29a-6015-4ee4-8f80-5de41d51f357" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PlanNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PlanNameAxis_c43b6f74-5b5b-4358-aaf2-bdad906f2cb8" xlink:to="loc_us-gaap_PlanNameDomain_361cf29a-6015-4ee4-8f80-5de41d51f357" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cron_A2020OmnibusPlanMember_ee035859-3f98-4e24-8ec4-37a7d65f0126" xlink:href="cron-20210630.xsd#cron_A2020OmnibusPlanMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PlanNameDomain_361cf29a-6015-4ee4-8f80-5de41d51f357" xlink:to="loc_cron_A2020OmnibusPlanMember_ee035859-3f98-4e24-8ec4-37a7d65f0126" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cron_A2018StockOptionPlanMember_0f40b6d4-9c46-41d9-a951-6221802eb56b" xlink:href="cron-20210630.xsd#cron_A2018StockOptionPlanMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PlanNameDomain_361cf29a-6015-4ee4-8f80-5de41d51f357" xlink:to="loc_cron_A2018StockOptionPlanMember_0f40b6d4-9c46-41d9-a951-6221802eb56b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cron_A2015StockOptionPlanMember_74ae4064-ac45-465f-b041-bd5f3b993c87" xlink:href="cron-20210630.xsd#cron_A2015StockOptionPlanMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PlanNameDomain_361cf29a-6015-4ee4-8f80-5de41d51f357" xlink:to="loc_cron_A2015StockOptionPlanMember_74ae4064-ac45-465f-b041-bd5f3b993c87" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_0dda1dc6-acdf-45af-8629-101f3087f3c2" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_8b2eb389-330e-4558-90b2-6e2fad014875" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_0dda1dc6-acdf-45af-8629-101f3087f3c2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_73932616-e21f-45b2-b2c6-64631c030f4a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_0dda1dc6-acdf-45af-8629-101f3087f3c2" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_73932616-e21f-45b2-b2c6-64631c030f4a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://thecronosgroup.com/role/SharebasedPaymentsSummaryofChangesinRSUsDetails" xlink:type="simple" xlink:href="cron-20210630.xsd#SharebasedPaymentsSummaryofChangesinRSUsDetails"/>
  <link:presentationLink xlink:role="http://thecronosgroup.com/role/SharebasedPaymentsSummaryofChangesinRSUsDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_b0088d68-8e79-4bdf-a239-0b820c98b7bf" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_7ac7f192-6bf4-45af-ac31-d3738580f0c2" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_b0088d68-8e79-4bdf-a239-0b820c98b7bf" xlink:to="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_7ac7f192-6bf4-45af-ac31-d3738580f0c2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AwardTypeAxis_e349b557-596c-4a3c-84cb-b85ead783962" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AwardTypeAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_7ac7f192-6bf4-45af-ac31-d3738580f0c2" xlink:to="loc_us-gaap_AwardTypeAxis_e349b557-596c-4a3c-84cb-b85ead783962" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_32410656-4ebd-4708-916e-09f7372f17f5" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AwardTypeAxis_e349b557-596c-4a3c-84cb-b85ead783962" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_32410656-4ebd-4708-916e-09f7372f17f5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestrictedStockUnitsRSUMember_a8d5fa9e-e6f0-4b29-886e-1bc2bcc31432" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RestrictedStockUnitsRSUMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_32410656-4ebd-4708-916e-09f7372f17f5" xlink:to="loc_us-gaap_RestrictedStockUnitsRSUMember_a8d5fa9e-e6f0-4b29-886e-1bc2bcc31432" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_ad1c3f2c-187c-447e-8b62-f14de578d4cb" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_7ac7f192-6bf4-45af-ac31-d3738580f0c2" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_ad1c3f2c-187c-447e-8b62-f14de578d4cb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward_a8a0b908-0dc9-4fce-a570-6a025e13bf02" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_ad1c3f2c-187c-447e-8b62-f14de578d4cb" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward_a8a0b908-0dc9-4fce-a570-6a025e13bf02" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber_3c231a87-9989-4756-9d4e-1158d9559d19" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward_a8a0b908-0dc9-4fce-a570-6a025e13bf02" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber_3c231a87-9989-4756-9d4e-1158d9559d19" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod_c260a0b8-b9d0-4fa5-bb0f-63e15f629c2f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward_a8a0b908-0dc9-4fce-a570-6a025e13bf02" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod_c260a0b8-b9d0-4fa5-bb0f-63e15f629c2f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cron_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedAndIssuedInPeriod_930c4e1b-bd72-4ad7-b3c3-4cb9ac1904f9" xlink:href="cron-20210630.xsd#cron_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedAndIssuedInPeriod"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward_a8a0b908-0dc9-4fce-a570-6a025e13bf02" xlink:to="loc_cron_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedAndIssuedInPeriod_930c4e1b-bd72-4ad7-b3c3-4cb9ac1904f9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber_4b5fc176-f01a-4c9f-963f-b8bcb5d3d01b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward_a8a0b908-0dc9-4fce-a570-6a025e13bf02" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber_4b5fc176-f01a-4c9f-963f-b8bcb5d3d01b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cron_DeferredCompensationSharebasedArrangementsLiabilityRollForward_d3ee9d08-a607-477f-889b-45549c1d1427" xlink:href="cron-20210630.xsd#cron_DeferredCompensationSharebasedArrangementsLiabilityRollForward"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_ad1c3f2c-187c-447e-8b62-f14de578d4cb" xlink:to="loc_cron_DeferredCompensationSharebasedArrangementsLiabilityRollForward_d3ee9d08-a607-477f-889b-45549c1d1427" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue_71827cec-4ed0-4595-a588-69a1a2c9b3af" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_cron_DeferredCompensationSharebasedArrangementsLiabilityRollForward_d3ee9d08-a607-477f-889b-45549c1d1427" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue_71827cec-4ed0-4595-a588-69a1a2c9b3af" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_32325a7b-61a1-490a-a2fe-4c625c317e50" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_cron_DeferredCompensationSharebasedArrangementsLiabilityRollForward_d3ee9d08-a607-477f-889b-45549c1d1427" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_32325a7b-61a1-490a-a2fe-4c625c317e50" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cron_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedAndIssuedInPeriodWeightedAverageGrantDateFairValue_1da41825-5fe1-43e8-87f4-5599baaa8a89" xlink:href="cron-20210630.xsd#cron_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedAndIssuedInPeriodWeightedAverageGrantDateFairValue"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_cron_DeferredCompensationSharebasedArrangementsLiabilityRollForward_d3ee9d08-a607-477f-889b-45549c1d1427" xlink:to="loc_cron_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedAndIssuedInPeriodWeightedAverageGrantDateFairValue_1da41825-5fe1-43e8-87f4-5599baaa8a89" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue_737b4276-26d0-443d-bd83-b12e26c52b59" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_cron_DeferredCompensationSharebasedArrangementsLiabilityRollForward_d3ee9d08-a607-477f-889b-45549c1d1427" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue_737b4276-26d0-443d-bd83-b12e26c52b59" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1_1a6e169a-0806-43ec-aeed-8103d706a3ea" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_ad1c3f2c-187c-447e-8b62-f14de578d4cb" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1_1a6e169a-0806-43ec-aeed-8103d706a3ea" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://thecronosgroup.com/role/SharebasedPaymentsSummaryofDSUActivityDetails" xlink:type="simple" xlink:href="cron-20210630.xsd#SharebasedPaymentsSummaryofDSUActivityDetails"/>
  <link:presentationLink xlink:role="http://thecronosgroup.com/role/SharebasedPaymentsSummaryofDSUActivityDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_d415dacf-7738-4f9d-91c4-838aea25be06" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_1af2e86b-185a-4dc2-93e3-75b1976c415c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_d415dacf-7738-4f9d-91c4-838aea25be06" xlink:to="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_1af2e86b-185a-4dc2-93e3-75b1976c415c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AwardTypeAxis_f5d099d2-05ec-4e06-8f92-ac0245b69025" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AwardTypeAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_1af2e86b-185a-4dc2-93e3-75b1976c415c" xlink:to="loc_us-gaap_AwardTypeAxis_f5d099d2-05ec-4e06-8f92-ac0245b69025" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_b4d92fba-e9e9-4290-a9b6-c30c20f629d9" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AwardTypeAxis_f5d099d2-05ec-4e06-8f92-ac0245b69025" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_b4d92fba-e9e9-4290-a9b6-c30c20f629d9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cron_DeferredShareUnitsDSUsMember_32a5f50f-41ca-404a-ad61-6a16ce07e9ab" xlink:href="cron-20210630.xsd#cron_DeferredShareUnitsDSUsMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_b4d92fba-e9e9-4290-a9b6-c30c20f629d9" xlink:to="loc_cron_DeferredShareUnitsDSUsMember_32a5f50f-41ca-404a-ad61-6a16ce07e9ab" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_bcce287c-5ee7-4bde-ba89-227a910f98e4" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_1af2e86b-185a-4dc2-93e3-75b1976c415c" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_bcce287c-5ee7-4bde-ba89-227a910f98e4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward_dec71013-f62f-4f33-ba9a-176912d077f9" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_bcce287c-5ee7-4bde-ba89-227a910f98e4" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward_dec71013-f62f-4f33-ba9a-176912d077f9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber_1b8d06d6-e597-4fe9-9369-5e2b6e7ee7d3" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward_dec71013-f62f-4f33-ba9a-176912d077f9" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber_1b8d06d6-e597-4fe9-9369-5e2b6e7ee7d3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod_c3bf83ce-f08d-4f7b-8b92-589a6d6559f4" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward_dec71013-f62f-4f33-ba9a-176912d077f9" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod_c3bf83ce-f08d-4f7b-8b92-589a6d6559f4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber_f007ba33-4a3f-4f7a-afbd-4e46719667ab" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward_dec71013-f62f-4f33-ba9a-176912d077f9" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber_f007ba33-4a3f-4f7a-afbd-4e46719667ab" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cron_DeferredCompensationSharebasedArrangementsLiabilityRollForward_7123e253-7d97-4f4e-a0a1-e4dc5b63885f" xlink:href="cron-20210630.xsd#cron_DeferredCompensationSharebasedArrangementsLiabilityRollForward"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_bcce287c-5ee7-4bde-ba89-227a910f98e4" xlink:to="loc_cron_DeferredCompensationSharebasedArrangementsLiabilityRollForward_7123e253-7d97-4f4e-a0a1-e4dc5b63885f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredCompensationSharebasedArrangementsLiabilityCurrentAndNoncurrent_c5a2e285-961b-48b6-8f73-e7560fb1b99f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredCompensationSharebasedArrangementsLiabilityCurrentAndNoncurrent"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_cron_DeferredCompensationSharebasedArrangementsLiabilityRollForward_7123e253-7d97-4f4e-a0a1-e4dc5b63885f" xlink:to="loc_us-gaap_DeferredCompensationSharebasedArrangementsLiabilityCurrentAndNoncurrent_c5a2e285-961b-48b6-8f73-e7560fb1b99f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cron_ShareBasedPaymentArrangementLiabilitiesSettled_c7b942c9-d297-46e9-ad68-bb229478891c" xlink:href="cron-20210630.xsd#cron_ShareBasedPaymentArrangementLiabilitiesSettled"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_cron_DeferredCompensationSharebasedArrangementsLiabilityRollForward_7123e253-7d97-4f4e-a0a1-e4dc5b63885f" xlink:to="loc_cron_ShareBasedPaymentArrangementLiabilitiesSettled_c7b942c9-d297-46e9-ad68-bb229478891c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cron_ShareBasedPaymentArrangementGainLossOnRevaluation_c6b16cb2-deca-41b3-8765-1e3997c3a537" xlink:href="cron-20210630.xsd#cron_ShareBasedPaymentArrangementGainLossOnRevaluation"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_cron_DeferredCompensationSharebasedArrangementsLiabilityRollForward_7123e253-7d97-4f4e-a0a1-e4dc5b63885f" xlink:to="loc_cron_ShareBasedPaymentArrangementGainLossOnRevaluation_c6b16cb2-deca-41b3-8765-1e3997c3a537" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredCompensationSharebasedArrangementsLiabilityCurrentAndNoncurrent_55b7b1e5-4200-4e76-bec2-526667d93ab2" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredCompensationSharebasedArrangementsLiabilityCurrentAndNoncurrent"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_cron_DeferredCompensationSharebasedArrangementsLiabilityRollForward_7123e253-7d97-4f4e-a0a1-e4dc5b63885f" xlink:to="loc_us-gaap_DeferredCompensationSharebasedArrangementsLiabilityCurrentAndNoncurrent_55b7b1e5-4200-4e76-bec2-526667d93ab2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://thecronosgroup.com/role/SharebasedPaymentsSummaryofChangesinWarrantsDetails" xlink:type="simple" xlink:href="cron-20210630.xsd#SharebasedPaymentsSummaryofChangesinWarrantsDetails"/>
  <link:presentationLink xlink:role="http://thecronosgroup.com/role/SharebasedPaymentsSummaryofChangesinWarrantsDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_1e26b4b2-4763-4660-b0c9-dc5719fccf33" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_0a5ca946-3977-49f7-8b6c-33777e90688d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_1e26b4b2-4763-4660-b0c9-dc5719fccf33" xlink:to="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_0a5ca946-3977-49f7-8b6c-33777e90688d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AwardTypeAxis_22f7a2f1-e518-4b70-9e78-c6f029d3036b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AwardTypeAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_0a5ca946-3977-49f7-8b6c-33777e90688d" xlink:to="loc_us-gaap_AwardTypeAxis_22f7a2f1-e518-4b70-9e78-c6f029d3036b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_a426375c-cc6c-46b1-9f65-697a89a63743" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AwardTypeAxis_22f7a2f1-e518-4b70-9e78-c6f029d3036b" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_a426375c-cc6c-46b1-9f65-697a89a63743" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WarrantMember_6d064e74-ba6d-43e2-af5c-66ed49e6a5a6" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_WarrantMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_a426375c-cc6c-46b1-9f65-697a89a63743" xlink:to="loc_us-gaap_WarrantMember_6d064e74-ba6d-43e2-af5c-66ed49e6a5a6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_ad8d3672-1ba0-4000-89ca-ebe5a4bd9806" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_0a5ca946-3977-49f7-8b6c-33777e90688d" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_ad8d3672-1ba0-4000-89ca-ebe5a4bd9806" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward_d04f2422-7f38-4297-9f51-e3bc178e3a56" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_ad8d3672-1ba0-4000-89ca-ebe5a4bd9806" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward_d04f2422-7f38-4297-9f51-e3bc178e3a56" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue_d2760205-67f6-4a2a-b30a-c723513f0973" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward_d04f2422-7f38-4297-9f51-e3bc178e3a56" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue_d2760205-67f6-4a2a-b30a-c723513f0973" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue_8d371427-b089-4310-96b8-12797cbcbe82" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward_d04f2422-7f38-4297-9f51-e3bc178e3a56" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue_8d371427-b089-4310-96b8-12797cbcbe82" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue_92b5ae2a-d2ac-44d8-b305-2d40943e3ed7" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward_d04f2422-7f38-4297-9f51-e3bc178e3a56" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue_92b5ae2a-d2ac-44d8-b305-2d40943e3ed7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward_68b0be4c-86ab-45db-bfce-c1599a803707" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_ad8d3672-1ba0-4000-89ca-ebe5a4bd9806" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward_68b0be4c-86ab-45db-bfce-c1599a803707" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber_db61fe21-9e37-4849-9017-791d7146829d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward_68b0be4c-86ab-45db-bfce-c1599a803707" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber_db61fe21-9e37-4849-9017-791d7146829d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod_a4f2be23-61e5-49dd-bf54-5521e86f382c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward_68b0be4c-86ab-45db-bfce-c1599a803707" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod_a4f2be23-61e5-49dd-bf54-5521e86f382c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber_63166d35-3595-4d8f-8db0-4bb4cddcae9a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward_68b0be4c-86ab-45db-bfce-c1599a803707" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber_63166d35-3595-4d8f-8db0-4bb4cddcae9a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://thecronosgroup.com/role/SharebasedPaymentsSummaryofOutstandingWarrantsDetails" xlink:type="simple" xlink:href="cron-20210630.xsd#SharebasedPaymentsSummaryofOutstandingWarrantsDetails"/>
  <link:presentationLink xlink:role="http://thecronosgroup.com/role/SharebasedPaymentsSummaryofOutstandingWarrantsDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_67a55e66-6316-4341-acab-1f89c7524270" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_a05870e2-0b03-420b-8837-915269868b5d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_67a55e66-6316-4341-acab-1f89c7524270" xlink:to="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_a05870e2-0b03-420b-8837-915269868b5d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AwardTypeAxis_b3362f5a-f8cf-4c5b-953f-bdf1972247a3" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AwardTypeAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_a05870e2-0b03-420b-8837-915269868b5d" xlink:to="loc_us-gaap_AwardTypeAxis_b3362f5a-f8cf-4c5b-953f-bdf1972247a3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_0583aa8e-b6a3-4699-b276-22c40401c3d4" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AwardTypeAxis_b3362f5a-f8cf-4c5b-953f-bdf1972247a3" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_0583aa8e-b6a3-4699-b276-22c40401c3d4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WarrantMember_74acaadc-6abe-40b8-af3d-e54209e389e7" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_WarrantMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_0583aa8e-b6a3-4699-b276-22c40401c3d4" xlink:to="loc_us-gaap_WarrantMember_74acaadc-6abe-40b8-af3d-e54209e389e7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_73dfcedb-36fc-4d1d-9fa9-419f97c70fe8" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_a05870e2-0b03-420b-8837-915269868b5d" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_73dfcedb-36fc-4d1d-9fa9-419f97c70fe8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber_437e7e8c-4e47-481a-a2f0-c7869f326237" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_73dfcedb-36fc-4d1d-9fa9-419f97c70fe8" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber_437e7e8c-4e47-481a-a2f0-c7869f326237" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://thecronosgroup.com/role/EarningsLossPerShare" xlink:type="simple" xlink:href="cron-20210630.xsd#EarningsLossPerShare"/>
  <link:presentationLink xlink:role="http://thecronosgroup.com/role/EarningsLossPerShare" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareAbstract_8abdca41-6fea-491c-a51f-86b8d7eaea52" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EarningsPerShareAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareTextBlock_86b947bb-3f68-4c54-9f95-cd081b675b59" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EarningsPerShareTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EarningsPerShareAbstract_8abdca41-6fea-491c-a51f-86b8d7eaea52" xlink:to="loc_us-gaap_EarningsPerShareTextBlock_86b947bb-3f68-4c54-9f95-cd081b675b59" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://thecronosgroup.com/role/EarningsLossPerShareTables" xlink:type="simple" xlink:href="cron-20210630.xsd#EarningsLossPerShareTables"/>
  <link:presentationLink xlink:role="http://thecronosgroup.com/role/EarningsLossPerShareTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareAbstract_361d1627-6f19-419d-85e4-271f4248c4e0" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EarningsPerShareAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock_0589801f-8027-4298-b678-5701488929df" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EarningsPerShareAbstract_361d1627-6f19-419d-85e4-271f4248c4e0" xlink:to="loc_us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock_0589801f-8027-4298-b678-5701488929df" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock_50676d5e-cf96-40d8-96c1-e9487fbf6eea" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EarningsPerShareAbstract_361d1627-6f19-419d-85e4-271f4248c4e0" xlink:to="loc_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock_50676d5e-cf96-40d8-96c1-e9487fbf6eea" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://thecronosgroup.com/role/EarningsLossPerShareScheduleofEarningsLossPerShareDetails" xlink:type="simple" xlink:href="cron-20210630.xsd#EarningsLossPerShareScheduleofEarningsLossPerShareDetails"/>
  <link:presentationLink xlink:role="http://thecronosgroup.com/role/EarningsLossPerShareScheduleofEarningsLossPerShareDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareAbstract_bea1892e-e5be-48d8-b222-a3f1e43a58e2" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EarningsPerShareAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfEarningsPerShareDilutedByCommonClassTable_07163f89-25ab-4cd2-a2d8-e03e6ce17819" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfEarningsPerShareDilutedByCommonClassTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EarningsPerShareAbstract_bea1892e-e5be-48d8-b222-a3f1e43a58e2" xlink:to="loc_us-gaap_ScheduleOfEarningsPerShareDilutedByCommonClassTable_07163f89-25ab-4cd2-a2d8-e03e6ce17819" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AwardTypeAxis_e809a511-ddf4-4d68-af8a-9437efbb26ef" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AwardTypeAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfEarningsPerShareDilutedByCommonClassTable_07163f89-25ab-4cd2-a2d8-e03e6ce17819" xlink:to="loc_us-gaap_AwardTypeAxis_e809a511-ddf4-4d68-af8a-9437efbb26ef" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_5e0aaec0-00fa-4274-9660-af975f5935a5" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AwardTypeAxis_e809a511-ddf4-4d68-af8a-9437efbb26ef" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_5e0aaec0-00fa-4274-9660-af975f5935a5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WarrantMember_c6771aa7-9489-4a68-8473-716966b243fa" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_WarrantMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_5e0aaec0-00fa-4274-9660-af975f5935a5" xlink:to="loc_us-gaap_WarrantMember_c6771aa7-9489-4a68-8473-716966b243fa" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeStockOptionMember_04df6197-a6dc-496b-a798-c5250106f6c5" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EmployeeStockOptionMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_5e0aaec0-00fa-4274-9660-af975f5935a5" xlink:to="loc_us-gaap_EmployeeStockOptionMember_04df6197-a6dc-496b-a798-c5250106f6c5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestrictedStockUnitsRSUMember_ab4f954d-0de2-4bc6-bf7d-f49a8bd7c4a8" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RestrictedStockUnitsRSUMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_5e0aaec0-00fa-4274-9660-af975f5935a5" xlink:to="loc_us-gaap_RestrictedStockUnitsRSUMember_ab4f954d-0de2-4bc6-bf7d-f49a8bd7c4a8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareDilutedLineItems_49ffc5a0-f79b-44b6-9668-df95322c5837" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EarningsPerShareDilutedLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfEarningsPerShareDilutedByCommonClassTable_07163f89-25ab-4cd2-a2d8-e03e6ce17819" xlink:to="loc_us-gaap_EarningsPerShareDilutedLineItems_49ffc5a0-f79b-44b6-9668-df95322c5837" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLossAvailableToCommonStockholdersDilutedAbstract_3c4b9c81-16ff-47c9-b47b-ceaee3cc9cbc" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetIncomeLossAvailableToCommonStockholdersDilutedAbstract"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EarningsPerShareDilutedLineItems_49ffc5a0-f79b-44b6-9668-df95322c5837" xlink:to="loc_us-gaap_NetIncomeLossAvailableToCommonStockholdersDilutedAbstract_3c4b9c81-16ff-47c9-b47b-ceaee3cc9cbc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLossFromContinuingOperationsAvailableToCommonShareholdersBasic_ad03fa58-7eb1-457e-a39b-7d33186638e0" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetIncomeLossFromContinuingOperationsAvailableToCommonShareholdersBasic"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetIncomeLossAvailableToCommonStockholdersDilutedAbstract_3c4b9c81-16ff-47c9-b47b-ceaee3cc9cbc" xlink:to="loc_us-gaap_NetIncomeLossFromContinuingOperationsAvailableToCommonShareholdersBasic_ad03fa58-7eb1-457e-a39b-7d33186638e0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_ca8da938-2c5f-41a2-bd74-eef7acddd5fc" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_WeightedAverageNumberOfSharesOutstandingBasic"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetIncomeLossAvailableToCommonStockholdersDilutedAbstract_3c4b9c81-16ff-47c9-b47b-ceaee3cc9cbc" xlink:to="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_ca8da938-2c5f-41a2-bd74-eef7acddd5fc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromContinuingOperationsPerBasicShare_d4f38fd3-068b-4bae-8501-94d1bb7867d5" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeLossFromContinuingOperationsPerBasicShare"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetIncomeLossAvailableToCommonStockholdersDilutedAbstract_3c4b9c81-16ff-47c9-b47b-ceaee3cc9cbc" xlink:to="loc_us-gaap_IncomeLossFromContinuingOperationsPerBasicShare_d4f38fd3-068b-4bae-8501-94d1bb7867d5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLossFromDiscontinuedOperationsAvailableToCommonShareholdersBasic_6958b7aa-f3e8-4417-aec3-9041fc708bf6" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetIncomeLossFromDiscontinuedOperationsAvailableToCommonShareholdersBasic"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetIncomeLossAvailableToCommonStockholdersDilutedAbstract_3c4b9c81-16ff-47c9-b47b-ceaee3cc9cbc" xlink:to="loc_us-gaap_NetIncomeLossFromDiscontinuedOperationsAvailableToCommonShareholdersBasic_6958b7aa-f3e8-4417-aec3-9041fc708bf6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_886b61d7-3c2a-4e3d-9634-25c615d3d2e1" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_WeightedAverageNumberOfSharesOutstandingBasic"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTaxPerBasicShare_609c1a46-5caa-4b12-a36f-f338e5924914" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTaxPerBasicShare"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetIncomeLossAvailableToCommonStockholdersDilutedAbstract_3c4b9c81-16ff-47c9-b47b-ceaee3cc9cbc" xlink:to="loc_us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTaxPerBasicShare_609c1a46-5caa-4b12-a36f-f338e5924914" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingDilutedDisclosureItemsAbstract_959022f2-028c-45f3-918f-ccf5f13bcc93" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_WeightedAverageNumberOfSharesOutstandingDilutedDisclosureItemsAbstract"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EarningsPerShareDilutedLineItems_49ffc5a0-f79b-44b6-9668-df95322c5837" xlink:to="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingDilutedDisclosureItemsAbstract_959022f2-028c-45f3-918f-ccf5f13bcc93" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLossFromContinuingOperationsAvailableToCommonShareholdersBasic_2c1b9c94-e05e-443b-9473-7cc72c4f991e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetIncomeLossFromContinuingOperationsAvailableToCommonShareholdersBasic"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingDilutedDisclosureItemsAbstract_959022f2-028c-45f3-918f-ccf5f13bcc93" xlink:to="loc_us-gaap_NetIncomeLossFromContinuingOperationsAvailableToCommonShareholdersBasic_2c1b9c94-e05e-443b-9473-7cc72c4f991e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DilutiveSecurities_ceefcfba-6d6c-49fe-bd5e-290a7093485c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DilutiveSecurities"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingDilutedDisclosureItemsAbstract_959022f2-028c-45f3-918f-ccf5f13bcc93" xlink:to="loc_us-gaap_DilutiveSecurities_ceefcfba-6d6c-49fe-bd5e-290a7093485c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLossFromContinuingOperationsAvailableToCommonShareholdersDiluted_5de672cf-2f2b-43a6-bac7-721556bd8622" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetIncomeLossFromContinuingOperationsAvailableToCommonShareholdersDiluted"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingDilutedDisclosureItemsAbstract_959022f2-028c-45f3-918f-ccf5f13bcc93" xlink:to="loc_us-gaap_NetIncomeLossFromContinuingOperationsAvailableToCommonShareholdersDiluted_5de672cf-2f2b-43a6-bac7-721556bd8622" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_74c861a2-c456-487c-a582-903ff2872100" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_WeightedAverageNumberOfSharesOutstandingBasic"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingDilutedDisclosureItemsAbstract_959022f2-028c-45f3-918f-ccf5f13bcc93" xlink:to="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_74c861a2-c456-487c-a582-903ff2872100" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncrementalCommonSharesAttributableToShareBasedPaymentArrangements_99735043-765a-405d-9795-2c89e68e4c34" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncrementalCommonSharesAttributableToShareBasedPaymentArrangements"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingDilutedDisclosureItemsAbstract_959022f2-028c-45f3-918f-ccf5f13bcc93" xlink:to="loc_us-gaap_IncrementalCommonSharesAttributableToShareBasedPaymentArrangements_99735043-765a-405d-9795-2c89e68e4c34" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_bd401d00-ac45-4694-a34e-0ea2da4cd5cf" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingDilutedDisclosureItemsAbstract_959022f2-028c-45f3-918f-ccf5f13bcc93" xlink:to="loc_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_bd401d00-ac45-4694-a34e-0ea2da4cd5cf" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromContinuingOperationsPerDilutedShare_2328ef15-5170-468a-af60-662286469fb1" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeLossFromContinuingOperationsPerDilutedShare"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingDilutedDisclosureItemsAbstract_959022f2-028c-45f3-918f-ccf5f13bcc93" xlink:to="loc_us-gaap_IncomeLossFromContinuingOperationsPerDilutedShare_2328ef15-5170-468a-af60-662286469fb1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLossFromDiscontinuedOperationsAvailableToCommonShareholdersDiluted_3b6114d1-2cef-4665-9c44-4409167604a5" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetIncomeLossFromDiscontinuedOperationsAvailableToCommonShareholdersDiluted"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingDilutedDisclosureItemsAbstract_959022f2-028c-45f3-918f-ccf5f13bcc93" xlink:to="loc_us-gaap_NetIncomeLossFromDiscontinuedOperationsAvailableToCommonShareholdersDiluted_3b6114d1-2cef-4665-9c44-4409167604a5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_f8afcbe6-3f3f-43a2-b4c2-9ea2a08f7169" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingDilutedDisclosureItemsAbstract_959022f2-028c-45f3-918f-ccf5f13bcc93" xlink:to="loc_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_f8afcbe6-3f3f-43a2-b4c2-9ea2a08f7169" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTaxPerDilutedShare_a8f83bf7-f21d-424c-9954-33a0bd304db3" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTaxPerDilutedShare"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingDilutedDisclosureItemsAbstract_959022f2-028c-45f3-918f-ccf5f13bcc93" xlink:to="loc_us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTaxPerDilutedShare_a8f83bf7-f21d-424c-9954-33a0bd304db3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://thecronosgroup.com/role/EarningsLossPerShareScheduleofAntidilutiveSecuritiesExcludedfromComputationofDilutedSharesOutstandingDetails" xlink:type="simple" xlink:href="cron-20210630.xsd#EarningsLossPerShareScheduleofAntidilutiveSecuritiesExcludedfromComputationofDilutedSharesOutstandingDetails"/>
  <link:presentationLink xlink:role="http://thecronosgroup.com/role/EarningsLossPerShareScheduleofAntidilutiveSecuritiesExcludedfromComputationofDilutedSharesOutstandingDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareAbstract_24fc12e3-5a8d-453c-bf85-1758aa2b1f1c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EarningsPerShareAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable_516cebef-0bfa-40a8-86d8-10b504b34e23" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EarningsPerShareAbstract_24fc12e3-5a8d-453c-bf85-1758aa2b1f1c" xlink:to="loc_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable_516cebef-0bfa-40a8-86d8-10b504b34e23" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis_fb0fc414-97cc-4ff9-96c6-20f192e0085d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable_516cebef-0bfa-40a8-86d8-10b504b34e23" xlink:to="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis_fb0fc414-97cc-4ff9-96c6-20f192e0085d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AntidilutiveSecuritiesNameDomain_0a6eb2d7-e08b-424a-92f5-28fd5560e5a2" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AntidilutiveSecuritiesNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis_fb0fc414-97cc-4ff9-96c6-20f192e0085d" xlink:to="loc_us-gaap_AntidilutiveSecuritiesNameDomain_0a6eb2d7-e08b-424a-92f5-28fd5560e5a2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cron_GinkgoEquityMilestonesMember_4ab5b8ad-7d5e-4e4b-af52-9094c0e6accd" xlink:href="cron-20210630.xsd#cron_GinkgoEquityMilestonesMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AntidilutiveSecuritiesNameDomain_0a6eb2d7-e08b-424a-92f5-28fd5560e5a2" xlink:to="loc_cron_GinkgoEquityMilestonesMember_4ab5b8ad-7d5e-4e4b-af52-9094c0e6accd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cron_PreemptiveRightsMember_3a813b9a-6771-4374-a59c-cbb1ebaa9aa6" xlink:href="cron-20210630.xsd#cron_PreemptiveRightsMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AntidilutiveSecuritiesNameDomain_0a6eb2d7-e08b-424a-92f5-28fd5560e5a2" xlink:to="loc_cron_PreemptiveRightsMember_3a813b9a-6771-4374-a59c-cbb1ebaa9aa6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cron_TopUpRightsFixedPriceMember_b1e32a16-5770-4c38-925f-c78a3dfca08e" xlink:href="cron-20210630.xsd#cron_TopUpRightsFixedPriceMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AntidilutiveSecuritiesNameDomain_0a6eb2d7-e08b-424a-92f5-28fd5560e5a2" xlink:to="loc_cron_TopUpRightsFixedPriceMember_b1e32a16-5770-4c38-925f-c78a3dfca08e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cron_TopUpRightsMarketPriceMember_df3a93a2-4cbe-427f-8eb9-a2fe09a4e2db" xlink:href="cron-20210630.xsd#cron_TopUpRightsMarketPriceMember"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AntidilutiveSecuritiesNameDomain_0a6eb2d7-e08b-424a-92f5-28fd5560e5a2" xlink:to="loc_cron_TopUpRightsMarketPriceMember_df3a93a2-4cbe-427f-8eb9-a2fe09a4e2db" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cron_AltriaWarrantMember_ae82f08d-7f48-43bd-99db-eea9e3055efb" xlink:href="cron-20210630.xsd#cron_AltriaWarrantMember"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AntidilutiveSecuritiesNameDomain_0a6eb2d7-e08b-424a-92f5-28fd5560e5a2" xlink:to="loc_cron_AltriaWarrantMember_ae82f08d-7f48-43bd-99db-eea9e3055efb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeStockOptionMember_065335be-a192-4e56-a073-a55a6bd402e1" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EmployeeStockOptionMember"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AntidilutiveSecuritiesNameDomain_0a6eb2d7-e08b-424a-92f5-28fd5560e5a2" xlink:to="loc_us-gaap_EmployeeStockOptionMember_065335be-a192-4e56-a073-a55a6bd402e1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WarrantMember_6468afc2-d330-40ae-a82f-78ed6540edc6" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_WarrantMember"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AntidilutiveSecuritiesNameDomain_0a6eb2d7-e08b-424a-92f5-28fd5560e5a2" xlink:to="loc_us-gaap_WarrantMember_6468afc2-d330-40ae-a82f-78ed6540edc6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestrictedStockUnitsRSUMember_b5c2dd9d-c538-4d0e-a20c-fe812550b7c8" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RestrictedStockUnitsRSUMember"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AntidilutiveSecuritiesNameDomain_0a6eb2d7-e08b-424a-92f5-28fd5560e5a2" xlink:to="loc_us-gaap_RestrictedStockUnitsRSUMember_b5c2dd9d-c538-4d0e-a20c-fe812550b7c8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems_626306f7-ad1e-4a7e-a741-247b37dbb227" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable_516cebef-0bfa-40a8-86d8-10b504b34e23" xlink:to="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems_626306f7-ad1e-4a7e-a741-247b37dbb227" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_621c2929-5162-47d8-8162-1b545989a0ed" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems_626306f7-ad1e-4a7e-a741-247b37dbb227" xlink:to="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_621c2929-5162-47d8-8162-1b545989a0ed" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://thecronosgroup.com/role/SegmentInformation" xlink:type="simple" xlink:href="cron-20210630.xsd#SegmentInformation"/>
  <link:presentationLink xlink:role="http://thecronosgroup.com/role/SegmentInformation" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentReportingAbstract_ddb93037-3a35-4501-8e33-2967b3342ff2" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SegmentReportingAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentReportingDisclosureTextBlock_bbda4085-db3d-4230-8a13-61a8525b0a75" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SegmentReportingDisclosureTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingAbstract_ddb93037-3a35-4501-8e33-2967b3342ff2" xlink:to="loc_us-gaap_SegmentReportingDisclosureTextBlock_bbda4085-db3d-4230-8a13-61a8525b0a75" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://thecronosgroup.com/role/SegmentInformationTables" xlink:type="simple" xlink:href="cron-20210630.xsd#SegmentInformationTables"/>
  <link:presentationLink xlink:role="http://thecronosgroup.com/role/SegmentInformationTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentReportingAbstract_0ece5d1b-e6da-4ae7-913e-00a34651ab47" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SegmentReportingAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock_a6ea382d-8924-4945-8af7-9d599a778401" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingAbstract_0ece5d1b-e6da-4ae7-913e-00a34651ab47" xlink:to="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock_a6ea382d-8924-4945-8af7-9d599a778401" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromExternalCustomersByGeographicAreasTableTextBlock_98eefa15-bf58-4c7e-8d50-a3ac563805c8" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RevenueFromExternalCustomersByGeographicAreasTableTextBlock"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingAbstract_0ece5d1b-e6da-4ae7-913e-00a34651ab47" xlink:to="loc_us-gaap_RevenueFromExternalCustomersByGeographicAreasTableTextBlock_98eefa15-bf58-4c7e-8d50-a3ac563805c8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongLivedAssetsByGeographicAreasTableTextBlock_bb3d7414-1641-4d0f-bba7-630bb15b11d7" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LongLivedAssetsByGeographicAreasTableTextBlock"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingAbstract_0ece5d1b-e6da-4ae7-913e-00a34651ab47" xlink:to="loc_us-gaap_LongLivedAssetsByGeographicAreasTableTextBlock_bb3d7414-1641-4d0f-bba7-630bb15b11d7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://thecronosgroup.com/role/SegmentInformationNarrativeDetails" xlink:type="simple" xlink:href="cron-20210630.xsd#SegmentInformationNarrativeDetails"/>
  <link:presentationLink xlink:role="http://thecronosgroup.com/role/SegmentInformationNarrativeDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentReportingAbstract_8997fd2a-81d9-47f3-bc9a-9c72095894c1" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SegmentReportingAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_79b3e653-5119-4abe-b1c9-e3ec1159d34e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingAbstract_8997fd2a-81d9-47f3-bc9a-9c72095894c1" xlink:to="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_79b3e653-5119-4abe-b1c9-e3ec1159d34e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskByTypeAxis_621a931b-6255-45bd-b126-7949f23d24ca" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ConcentrationRiskByTypeAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_79b3e653-5119-4abe-b1c9-e3ec1159d34e" xlink:to="loc_us-gaap_ConcentrationRiskByTypeAxis_621a931b-6255-45bd-b126-7949f23d24ca" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskTypeDomain_97070a58-3377-4170-a88d-87d78364ec5c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ConcentrationRiskTypeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ConcentrationRiskByTypeAxis_621a931b-6255-45bd-b126-7949f23d24ca" xlink:to="loc_us-gaap_ConcentrationRiskTypeDomain_97070a58-3377-4170-a88d-87d78364ec5c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CustomerConcentrationRiskMember_8318de89-758a-4ab7-814e-99ab1e38d76c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CustomerConcentrationRiskMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ConcentrationRiskTypeDomain_97070a58-3377-4170-a88d-87d78364ec5c" xlink:to="loc_us-gaap_CustomerConcentrationRiskMember_8318de89-758a-4ab7-814e-99ab1e38d76c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskByBenchmarkAxis_f4226b0e-4428-4879-a535-34e48abc5dae" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ConcentrationRiskByBenchmarkAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_79b3e653-5119-4abe-b1c9-e3ec1159d34e" xlink:to="loc_us-gaap_ConcentrationRiskByBenchmarkAxis_f4226b0e-4428-4879-a535-34e48abc5dae" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskBenchmarkDomain_397ad820-bea1-4be6-9402-20efe8b41672" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ConcentrationRiskBenchmarkDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ConcentrationRiskByBenchmarkAxis_f4226b0e-4428-4879-a535-34e48abc5dae" xlink:to="loc_us-gaap_ConcentrationRiskBenchmarkDomain_397ad820-bea1-4be6-9402-20efe8b41672" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerMember_ec30495b-7e95-4d12-944d-bda2b11e1670" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RevenueFromContractWithCustomerMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ConcentrationRiskBenchmarkDomain_397ad820-bea1-4be6-9402-20efe8b41672" xlink:to="loc_us-gaap_RevenueFromContractWithCustomerMember_ec30495b-7e95-4d12-944d-bda2b11e1670" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MajorCustomersAxis_e6ad3b73-c221-433a-878c-4591b7454426" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_MajorCustomersAxis"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_79b3e653-5119-4abe-b1c9-e3ec1159d34e" xlink:to="loc_srt_MajorCustomersAxis_e6ad3b73-c221-433a-878c-4591b7454426" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_NameOfMajorCustomerDomain_f047054b-9965-48c3-ae7c-434db8f26385" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_NameOfMajorCustomerDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_MajorCustomersAxis_e6ad3b73-c221-433a-878c-4591b7454426" xlink:to="loc_srt_NameOfMajorCustomerDomain_f047054b-9965-48c3-ae7c-434db8f26385" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cron_FourMajorCustomersMember_43d04ab3-6339-45f5-a25b-1d13620a164e" xlink:href="cron-20210630.xsd#cron_FourMajorCustomersMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_NameOfMajorCustomerDomain_f047054b-9965-48c3-ae7c-434db8f26385" xlink:to="loc_cron_FourMajorCustomersMember_43d04ab3-6339-45f5-a25b-1d13620a164e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cron_OntarioCannabisRetailCorporationMember_4feec6a8-0c4b-401a-8230-1b6a2f649dce" xlink:href="cron-20210630.xsd#cron_OntarioCannabisRetailCorporationMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_cron_FourMajorCustomersMember_43d04ab3-6339-45f5-a25b-1d13620a164e" xlink:to="loc_cron_OntarioCannabisRetailCorporationMember_4feec6a8-0c4b-401a-8230-1b6a2f649dce" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cron_NovologGroupMember_fde131b3-1c85-467d-a3ad-08ebc56ef99c" xlink:href="cron-20210630.xsd#cron_NovologGroupMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_cron_FourMajorCustomersMember_43d04ab3-6339-45f5-a25b-1d13620a164e" xlink:to="loc_cron_NovologGroupMember_fde131b3-1c85-467d-a3ad-08ebc56ef99c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cron_AlbertGamingLiquorAndCannabisCommissionMember_c31fb23e-267a-4d4f-95df-3a0ff6c38376" xlink:href="cron-20210630.xsd#cron_AlbertGamingLiquorAndCannabisCommissionMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_cron_FourMajorCustomersMember_43d04ab3-6339-45f5-a25b-1d13620a164e" xlink:to="loc_cron_AlbertGamingLiquorAndCannabisCommissionMember_c31fb23e-267a-4d4f-95df-3a0ff6c38376" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cron_SocieteQuebecoiseDuCannabisMember_20f60722-116a-4abe-b5fd-a4cd940f8a36" xlink:href="cron-20210630.xsd#cron_SocieteQuebecoiseDuCannabisMember"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_cron_FourMajorCustomersMember_43d04ab3-6339-45f5-a25b-1d13620a164e" xlink:to="loc_cron_SocieteQuebecoiseDuCannabisMember_20f60722-116a-4abe-b5fd-a4cd940f8a36" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementBusinessSegmentsAxis_b0c0bac0-599d-47b1-b026-0b0352a2c893" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementBusinessSegmentsAxis"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_79b3e653-5119-4abe-b1c9-e3ec1159d34e" xlink:to="loc_us-gaap_StatementBusinessSegmentsAxis_b0c0bac0-599d-47b1-b026-0b0352a2c893" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentDomain_e4513422-d148-4478-a957-ccaf4416b947" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SegmentDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementBusinessSegmentsAxis_b0c0bac0-599d-47b1-b026-0b0352a2c893" xlink:to="loc_us-gaap_SegmentDomain_e4513422-d148-4478-a957-ccaf4416b947" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cron_UnitedStatesSegmentMember_f138c5f4-6cfa-4475-ab81-5f3dc65a5421" xlink:href="cron-20210630.xsd#cron_UnitedStatesSegmentMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentDomain_e4513422-d148-4478-a957-ccaf4416b947" xlink:to="loc_cron_UnitedStatesSegmentMember_f138c5f4-6cfa-4475-ab81-5f3dc65a5421" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cron_RestOfWorldSegmentMember_ee304c3c-4035-413e-be1d-7fc99a7719c5" xlink:href="cron-20210630.xsd#cron_RestOfWorldSegmentMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentDomain_e4513422-d148-4478-a957-ccaf4416b947" xlink:to="loc_cron_RestOfWorldSegmentMember_ee304c3c-4035-413e-be1d-7fc99a7719c5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentReportingInformationLineItems_77b73a61-46c7-4bb4-a221-33d14fd3a394" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SegmentReportingInformationLineItems"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_79b3e653-5119-4abe-b1c9-e3ec1159d34e" xlink:to="loc_us-gaap_SegmentReportingInformationLineItems_77b73a61-46c7-4bb4-a221-33d14fd3a394" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NumberOfReportableSegments_5cefa5d5-6be3-403b-bb34-d77f31ebe82b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NumberOfReportableSegments"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_77b73a61-46c7-4bb4-a221-33d14fd3a394" xlink:to="loc_us-gaap_NumberOfReportableSegments_5cefa5d5-6be3-403b-bb34-d77f31ebe82b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AllowanceForDoubtfulAccountsReceivableCurrent_da92af86-834a-499d-8586-c025206c6c50" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AllowanceForDoubtfulAccountsReceivableCurrent"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_77b73a61-46c7-4bb4-a221-33d14fd3a394" xlink:to="loc_us-gaap_AllowanceForDoubtfulAccountsReceivableCurrent_da92af86-834a-499d-8586-c025206c6c50" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTax_0692114c-af11-40ab-8bf3-2eec8a86fa53" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTax"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_77b73a61-46c7-4bb4-a221-33d14fd3a394" xlink:to="loc_us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTax_0692114c-af11-40ab-8bf3-2eec8a86fa53" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerIncludingAssessedTax_8d77797e-daca-4a98-a6b4-6216a673951c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RevenueFromContractWithCustomerIncludingAssessedTax"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_77b73a61-46c7-4bb4-a221-33d14fd3a394" xlink:to="loc_us-gaap_RevenueFromContractWithCustomerIncludingAssessedTax_8d77797e-daca-4a98-a6b4-6216a673951c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskPercentage1_2fc8bc25-b346-4bff-b86e-b381fa2dfee9" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ConcentrationRiskPercentage1"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_77b73a61-46c7-4bb4-a221-33d14fd3a394" xlink:to="loc_us-gaap_ConcentrationRiskPercentage1_2fc8bc25-b346-4bff-b86e-b381fa2dfee9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://thecronosgroup.com/role/SegmentInformationScheduleofSegmentDataDetails" xlink:type="simple" xlink:href="cron-20210630.xsd#SegmentInformationScheduleofSegmentDataDetails"/>
  <link:presentationLink xlink:role="http://thecronosgroup.com/role/SegmentInformationScheduleofSegmentDataDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentReportingAbstract_152d8cb3-2932-4478-975e-aaba3f65d158" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SegmentReportingAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_a5e2ed95-9321-4848-a20e-7b68fb1b6b69" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingAbstract_152d8cb3-2932-4478-975e-aaba3f65d158" xlink:to="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_a5e2ed95-9321-4848-a20e-7b68fb1b6b69" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductOrServiceAxis_53aa6a85-380e-4a5a-b0b1-1b8365c59ef2" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_ProductOrServiceAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_a5e2ed95-9321-4848-a20e-7b68fb1b6b69" xlink:to="loc_srt_ProductOrServiceAxis_53aa6a85-380e-4a5a-b0b1-1b8365c59ef2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductsAndServicesDomain_174b2751-edd0-4002-8a89-37242eccbf12" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_ProductsAndServicesDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ProductOrServiceAxis_53aa6a85-380e-4a5a-b0b1-1b8365c59ef2" xlink:to="loc_srt_ProductsAndServicesDomain_174b2751-edd0-4002-8a89-37242eccbf12" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cron_CannabisFlowerMember_71846c7c-05f0-4324-aec1-0b0981f3ddda" xlink:href="cron-20210630.xsd#cron_CannabisFlowerMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ProductsAndServicesDomain_174b2751-edd0-4002-8a89-37242eccbf12" xlink:to="loc_cron_CannabisFlowerMember_71846c7c-05f0-4324-aec1-0b0981f3ddda" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cron_CannabisExtractsMember_dad839eb-87f7-4419-89e7-b53897f3b2a7" xlink:href="cron-20210630.xsd#cron_CannabisExtractsMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ProductsAndServicesDomain_174b2751-edd0-4002-8a89-37242eccbf12" xlink:to="loc_cron_CannabisExtractsMember_dad839eb-87f7-4419-89e7-b53897f3b2a7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProductAndServiceOtherMember_4479b2fd-33ed-4771-985a-bb041c121fca" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ProductAndServiceOtherMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ProductsAndServicesDomain_174b2751-edd0-4002-8a89-37242eccbf12" xlink:to="loc_us-gaap_ProductAndServiceOtherMember_4479b2fd-33ed-4771-985a-bb041c121fca" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ConsolidationItemsAxis_c2f4646f-4779-438c-b731-48005ec5ca1b" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_ConsolidationItemsAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_a5e2ed95-9321-4848-a20e-7b68fb1b6b69" xlink:to="loc_srt_ConsolidationItemsAxis_c2f4646f-4779-438c-b731-48005ec5ca1b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ConsolidationItemsDomain_68d92b8b-2329-43bf-a49c-71734716ba26" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_ConsolidationItemsDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ConsolidationItemsAxis_c2f4646f-4779-438c-b731-48005ec5ca1b" xlink:to="loc_srt_ConsolidationItemsDomain_68d92b8b-2329-43bf-a49c-71734716ba26" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingSegmentsMember_f3b73c80-1a5c-4601-a4ef-2beb4b2c04ef" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingSegmentsMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ConsolidationItemsDomain_68d92b8b-2329-43bf-a49c-71734716ba26" xlink:to="loc_us-gaap_OperatingSegmentsMember_f3b73c80-1a5c-4601-a4ef-2beb4b2c04ef" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CorporateNonSegmentMember_d1377300-72d5-4c57-82a9-066abac4b8e6" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CorporateNonSegmentMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ConsolidationItemsDomain_68d92b8b-2329-43bf-a49c-71734716ba26" xlink:to="loc_us-gaap_CorporateNonSegmentMember_d1377300-72d5-4c57-82a9-066abac4b8e6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementBusinessSegmentsAxis_d984e0e9-6d8b-4517-b01e-23feb26c4971" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementBusinessSegmentsAxis"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_a5e2ed95-9321-4848-a20e-7b68fb1b6b69" xlink:to="loc_us-gaap_StatementBusinessSegmentsAxis_d984e0e9-6d8b-4517-b01e-23feb26c4971" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentDomain_8014214e-0e8d-4524-b230-9aa1b7db17c3" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SegmentDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementBusinessSegmentsAxis_d984e0e9-6d8b-4517-b01e-23feb26c4971" xlink:to="loc_us-gaap_SegmentDomain_8014214e-0e8d-4524-b230-9aa1b7db17c3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cron_UnitedStatesSegmentMember_d123d51e-9cf6-4da7-89a6-b3346ae904b8" xlink:href="cron-20210630.xsd#cron_UnitedStatesSegmentMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentDomain_8014214e-0e8d-4524-b230-9aa1b7db17c3" xlink:to="loc_cron_UnitedStatesSegmentMember_d123d51e-9cf6-4da7-89a6-b3346ae904b8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cron_RestOfWorldSegmentMember_91cecc9e-4c79-4a97-95cb-b2f482e8e371" xlink:href="cron-20210630.xsd#cron_RestOfWorldSegmentMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentDomain_8014214e-0e8d-4524-b230-9aa1b7db17c3" xlink:to="loc_cron_RestOfWorldSegmentMember_91cecc9e-4c79-4a97-95cb-b2f482e8e371" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentReportingInformationLineItems_4ad1a0ab-b18d-480e-9e35-129ee32e3cc4" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SegmentReportingInformationLineItems"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_a5e2ed95-9321-4848-a20e-7b68fb1b6b69" xlink:to="loc_us-gaap_SegmentReportingInformationLineItems_4ad1a0ab-b18d-480e-9e35-129ee32e3cc4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_d0965b7a-0ba7-4219-af6e-92a68e100ac4" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_4ad1a0ab-b18d-480e-9e35-129ee32e3cc4" xlink:to="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_d0965b7a-0ba7-4219-af6e-92a68e100ac4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromEquityMethodInvestments_81fa712b-1f1d-44e2-8c16-9a7186644b07" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeLossFromEquityMethodInvestments"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_4ad1a0ab-b18d-480e-9e35-129ee32e3cc4" xlink:to="loc_us-gaap_IncomeLossFromEquityMethodInvestments_81fa712b-1f1d-44e2-8c16-9a7186644b07" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentIncomeInterest_dd6ddf27-bc7b-41e0-879c-70bb9ca4ae40" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InvestmentIncomeInterest"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_4ad1a0ab-b18d-480e-9e35-129ee32e3cc4" xlink:to="loc_us-gaap_InvestmentIncomeInterest_dd6ddf27-bc7b-41e0-879c-70bb9ca4ae40" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestExpense_c6492cd9-52c8-4189-8b74-afe2d49a3704" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InterestExpense"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_4ad1a0ab-b18d-480e-9e35-129ee32e3cc4" xlink:to="loc_us-gaap_InterestExpense_c6492cd9-52c8-4189-8b74-afe2d49a3704" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestIncomeExpenseNonoperatingNet_ad526b5b-8562-4e4b-b6fd-01e2004843a2" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InterestIncomeExpenseNonoperatingNet"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_4ad1a0ab-b18d-480e-9e35-129ee32e3cc4" xlink:to="loc_us-gaap_InterestIncomeExpenseNonoperatingNet_ad526b5b-8562-4e4b-b6fd-01e2004843a2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Assets_2667bdde-5151-4325-8ed1-1114a0448789" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_Assets"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_4ad1a0ab-b18d-480e-9e35-129ee32e3cc4" xlink:to="loc_us-gaap_Assets_2667bdde-5151-4325-8ed1-1114a0448789" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DepreciationAndAmortization_3fe485e1-a284-406f-82b9-3d22ab5ecf50" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DepreciationAndAmortization"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_4ad1a0ab-b18d-480e-9e35-129ee32e3cc4" xlink:to="loc_us-gaap_DepreciationAndAmortization_3fe485e1-a284-406f-82b9-3d22ab5ecf50" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseRightOfUseAssetAmortizationExpense_4d416a02-2e46-4ca1-bf06-8ddd747e0feb" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingLeaseRightOfUseAssetAmortizationExpense"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_4ad1a0ab-b18d-480e-9e35-129ee32e3cc4" xlink:to="loc_us-gaap_OperatingLeaseRightOfUseAssetAmortizationExpense_4d416a02-2e46-4ca1-bf06-8ddd747e0feb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cron_AdjustedEarningsBeforeInterestTaxesDepreciationAndAmortization_8a1d60e1-39cc-4146-ac33-cc77d75bfc11" xlink:href="cron-20210630.xsd#cron_AdjustedEarningsBeforeInterestTaxesDepreciationAndAmortization"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_4ad1a0ab-b18d-480e-9e35-129ee32e3cc4" xlink:to="loc_cron_AdjustedEarningsBeforeInterestTaxesDepreciationAndAmortization_8a1d60e1-39cc-4146-ac33-cc77d75bfc11" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentAdditions_2fbc2b8f-5263-41fe-b45f-1afd1d0e1f22" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PropertyPlantAndEquipmentAdditions"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_4ad1a0ab-b18d-480e-9e35-129ee32e3cc4" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentAdditions_2fbc2b8f-5263-41fe-b45f-1afd1d0e1f22" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://thecronosgroup.com/role/SegmentInformationScheduleofAdjustedEBITDADetails" xlink:type="simple" xlink:href="cron-20210630.xsd#SegmentInformationScheduleofAdjustedEBITDADetails"/>
  <link:presentationLink xlink:role="http://thecronosgroup.com/role/SegmentInformationScheduleofAdjustedEBITDADetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentReportingAbstract_5cab2041-33dc-4017-af7d-6e5360be5264" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SegmentReportingAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_f016d413-94b1-4707-b16d-2b91b8b429ed" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingAbstract_5cab2041-33dc-4017-af7d-6e5360be5264" xlink:to="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_f016d413-94b1-4707-b16d-2b91b8b429ed" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ConsolidationItemsAxis_3b53b6c8-d81b-426c-b85a-72b29031ed56" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_ConsolidationItemsAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_f016d413-94b1-4707-b16d-2b91b8b429ed" xlink:to="loc_srt_ConsolidationItemsAxis_3b53b6c8-d81b-426c-b85a-72b29031ed56" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ConsolidationItemsDomain_24d0c395-706f-4e92-867e-01891c9c5689" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_ConsolidationItemsDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ConsolidationItemsAxis_3b53b6c8-d81b-426c-b85a-72b29031ed56" xlink:to="loc_srt_ConsolidationItemsDomain_24d0c395-706f-4e92-867e-01891c9c5689" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingSegmentsMember_559371fd-a151-4fe2-a4a8-723eafbe59b9" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingSegmentsMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ConsolidationItemsDomain_24d0c395-706f-4e92-867e-01891c9c5689" xlink:to="loc_us-gaap_OperatingSegmentsMember_559371fd-a151-4fe2-a4a8-723eafbe59b9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CorporateNonSegmentMember_5ca5b8a2-12c7-4da5-8b98-672d2cf34890" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CorporateNonSegmentMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ConsolidationItemsDomain_24d0c395-706f-4e92-867e-01891c9c5689" xlink:to="loc_us-gaap_CorporateNonSegmentMember_5ca5b8a2-12c7-4da5-8b98-672d2cf34890" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementBusinessSegmentsAxis_e4cec899-bf0f-49cd-90dd-4464fe072589" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementBusinessSegmentsAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_f016d413-94b1-4707-b16d-2b91b8b429ed" xlink:to="loc_us-gaap_StatementBusinessSegmentsAxis_e4cec899-bf0f-49cd-90dd-4464fe072589" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentDomain_0c5c34de-74b9-44fb-8055-5ddf33de213e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SegmentDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementBusinessSegmentsAxis_e4cec899-bf0f-49cd-90dd-4464fe072589" xlink:to="loc_us-gaap_SegmentDomain_0c5c34de-74b9-44fb-8055-5ddf33de213e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cron_UnitedStatesSegmentMember_5ca5a307-2581-4668-b7c1-10a9a04a1447" xlink:href="cron-20210630.xsd#cron_UnitedStatesSegmentMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentDomain_0c5c34de-74b9-44fb-8055-5ddf33de213e" xlink:to="loc_cron_UnitedStatesSegmentMember_5ca5a307-2581-4668-b7c1-10a9a04a1447" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cron_RestOfWorldSegmentMember_25dc3c9f-5038-46e5-acd9-74395f2fb15e" xlink:href="cron-20210630.xsd#cron_RestOfWorldSegmentMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentDomain_0c5c34de-74b9-44fb-8055-5ddf33de213e" xlink:to="loc_cron_RestOfWorldSegmentMember_25dc3c9f-5038-46e5-acd9-74395f2fb15e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentReportingInformationLineItems_d1307834-6e82-4b5f-a542-76204c3b4836" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SegmentReportingInformationLineItems"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_f016d413-94b1-4707-b16d-2b91b8b429ed" xlink:to="loc_us-gaap_SegmentReportingInformationLineItems_d1307834-6e82-4b5f-a542-76204c3b4836" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProfitLoss_742a782d-32dd-4a64-b18c-14206dae37bd" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ProfitLoss"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_d1307834-6e82-4b5f-a542-76204c3b4836" xlink:to="loc_us-gaap_ProfitLoss_742a782d-32dd-4a64-b18c-14206dae37bd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestIncomeExpenseNonoperatingNet_12202bdc-5976-4f94-9d1f-e583e3f6ea0b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InterestIncomeExpenseNonoperatingNet"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_d1307834-6e82-4b5f-a542-76204c3b4836" xlink:to="loc_us-gaap_InterestIncomeExpenseNonoperatingNet_12202bdc-5976-4f94-9d1f-e583e3f6ea0b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromEquityMethodInvestments_e3f94681-b7b0-4b4a-9535-41092e42e310" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeLossFromEquityMethodInvestments"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_d1307834-6e82-4b5f-a542-76204c3b4836" xlink:to="loc_us-gaap_IncomeLossFromEquityMethodInvestments_e3f94681-b7b0-4b4a-9535-41092e42e310" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetImpairmentCharges_7aed31a3-ac88-42a4-a7e6-bc575dbb9a16" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AssetImpairmentCharges"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_d1307834-6e82-4b5f-a542-76204c3b4836" xlink:to="loc_us-gaap_AssetImpairmentCharges_7aed31a3-ac88-42a4-a7e6-bc575dbb9a16" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GainLossOnDerivativeInstrumentsNetPretax_1ee18f08-e412-46b7-88c6-1fac6e505ef6" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_GainLossOnDerivativeInstrumentsNetPretax"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_d1307834-6e82-4b5f-a542-76204c3b4836" xlink:to="loc_us-gaap_GainLossOnDerivativeInstrumentsNetPretax_1ee18f08-e412-46b7-88c6-1fac6e505ef6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringCharges_8b7e0137-1f71-479d-839f-543dd2c1e93c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RestructuringCharges"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_d1307834-6e82-4b5f-a542-76204c3b4836" xlink:to="loc_us-gaap_RestructuringCharges_8b7e0137-1f71-479d-839f-543dd2c1e93c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherNonoperatingIncomeExpense_fcd1c198-aa44-423c-9d3b-7e2568e3748f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherNonoperatingIncomeExpense"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_d1307834-6e82-4b5f-a542-76204c3b4836" xlink:to="loc_us-gaap_OtherNonoperatingIncomeExpense_fcd1c198-aa44-423c-9d3b-7e2568e3748f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTax_2c6b1982-776c-401a-8014-cf5b67ccdda4" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTax"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_d1307834-6e82-4b5f-a542-76204c3b4836" xlink:to="loc_us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTax_2c6b1982-776c-401a-8014-cf5b67ccdda4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AllocatedShareBasedCompensationExpense_03df6c56-5717-47d7-ab2f-540e40d16dc6" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AllocatedShareBasedCompensationExpense"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_d1307834-6e82-4b5f-a542-76204c3b4836" xlink:to="loc_us-gaap_AllocatedShareBasedCompensationExpense_03df6c56-5717-47d7-ab2f-540e40d16dc6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cron_RestatementReviewExpense_68678676-e131-44b1-9dab-8f6958d109b9" xlink:href="cron-20210630.xsd#cron_RestatementReviewExpense"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_d1307834-6e82-4b5f-a542-76204c3b4836" xlink:to="loc_cron_RestatementReviewExpense_68678676-e131-44b1-9dab-8f6958d109b9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DepreciationDepletionAndAmortization_0c2f5afb-b9bd-4823-8a0b-5fbc6c6fd160" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DepreciationDepletionAndAmortization"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_d1307834-6e82-4b5f-a542-76204c3b4836" xlink:to="loc_us-gaap_DepreciationDepletionAndAmortization_0c2f5afb-b9bd-4823-8a0b-5fbc6c6fd160" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cron_AdjustedEarningsBeforeInterestTaxesDepreciationAndAmortization_5fc3f49c-86ec-43d8-9c2d-12cc8915bd65" xlink:href="cron-20210630.xsd#cron_AdjustedEarningsBeforeInterestTaxesDepreciationAndAmortization"/>
    <link:presentationArc order="12" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_d1307834-6e82-4b5f-a542-76204c3b4836" xlink:to="loc_cron_AdjustedEarningsBeforeInterestTaxesDepreciationAndAmortization_5fc3f49c-86ec-43d8-9c2d-12cc8915bd65" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://thecronosgroup.com/role/SegmentInformationScheduleofRevenuefromExternalCustomersbyGeographicAreasDetails" xlink:type="simple" xlink:href="cron-20210630.xsd#SegmentInformationScheduleofRevenuefromExternalCustomersbyGeographicAreasDetails"/>
  <link:presentationLink xlink:role="http://thecronosgroup.com/role/SegmentInformationScheduleofRevenuefromExternalCustomersbyGeographicAreasDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentReportingAbstract_b3876bcc-a06c-4377-9ae0-536b89d82cce" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SegmentReportingAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfRevenuesFromExternalCustomersAndLongLivedAssetsTable_4422931b-14b3-4167-9b8d-68c3ea75a16c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfRevenuesFromExternalCustomersAndLongLivedAssetsTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingAbstract_b3876bcc-a06c-4377-9ae0-536b89d82cce" xlink:to="loc_us-gaap_ScheduleOfRevenuesFromExternalCustomersAndLongLivedAssetsTable_4422931b-14b3-4167-9b8d-68c3ea75a16c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_StatementGeographicalAxis_0129a438-d310-4165-aa33-70b086093cd0" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_StatementGeographicalAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfRevenuesFromExternalCustomersAndLongLivedAssetsTable_4422931b-14b3-4167-9b8d-68c3ea75a16c" xlink:to="loc_srt_StatementGeographicalAxis_0129a438-d310-4165-aa33-70b086093cd0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_SegmentGeographicalDomain_6a32f9e3-9eb9-4930-a97c-00cda1347ea9" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_SegmentGeographicalDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_StatementGeographicalAxis_0129a438-d310-4165-aa33-70b086093cd0" xlink:to="loc_srt_SegmentGeographicalDomain_6a32f9e3-9eb9-4930-a97c-00cda1347ea9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_country_CA_55e3d676-2c63-4587-ae78-1d8b65d8b00f" xlink:href="https://xbrl.sec.gov/country/2021/country-2021.xsd#country_CA"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_SegmentGeographicalDomain_6a32f9e3-9eb9-4930-a97c-00cda1347ea9" xlink:to="loc_country_CA_55e3d676-2c63-4587-ae78-1d8b65d8b00f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_country_US_9c7b5ac0-19f9-4d12-964b-9a42f51f4109" xlink:href="https://xbrl.sec.gov/country/2021/country-2021.xsd#country_US"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_SegmentGeographicalDomain_6a32f9e3-9eb9-4930-a97c-00cda1347ea9" xlink:to="loc_country_US_9c7b5ac0-19f9-4d12-964b-9a42f51f4109" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_country_IL_5979ff37-93e7-4a34-b401-38a6d748a084" xlink:href="https://xbrl.sec.gov/country/2021/country-2021.xsd#country_IL"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_SegmentGeographicalDomain_6a32f9e3-9eb9-4930-a97c-00cda1347ea9" xlink:to="loc_country_IL_5979ff37-93e7-4a34-b401-38a6d748a084" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cron_OtherCountriesMember_8dbbdf2f-4ca6-4a0f-9878-59e215b302c6" xlink:href="cron-20210630.xsd#cron_OtherCountriesMember"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_SegmentGeographicalDomain_6a32f9e3-9eb9-4930-a97c-00cda1347ea9" xlink:to="loc_cron_OtherCountriesMember_8dbbdf2f-4ca6-4a0f-9878-59e215b302c6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenuesFromExternalCustomersAndLongLivedAssetsLineItems_238058b8-470b-4be9-8074-ff22b3377205" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RevenuesFromExternalCustomersAndLongLivedAssetsLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfRevenuesFromExternalCustomersAndLongLivedAssetsTable_4422931b-14b3-4167-9b8d-68c3ea75a16c" xlink:to="loc_us-gaap_RevenuesFromExternalCustomersAndLongLivedAssetsLineItems_238058b8-470b-4be9-8074-ff22b3377205" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_f2d6244a-c3b2-454f-9b4e-18918b97443d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RevenuesFromExternalCustomersAndLongLivedAssetsLineItems_238058b8-470b-4be9-8074-ff22b3377205" xlink:to="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_f2d6244a-c3b2-454f-9b4e-18918b97443d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://thecronosgroup.com/role/SegmentInformationScheduleofLonglivedAssetsbyGeographicAreasDetails" xlink:type="simple" xlink:href="cron-20210630.xsd#SegmentInformationScheduleofLonglivedAssetsbyGeographicAreasDetails"/>
  <link:presentationLink xlink:role="http://thecronosgroup.com/role/SegmentInformationScheduleofLonglivedAssetsbyGeographicAreasDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentReportingAbstract_1486b450-66a9-42b5-8240-e5a6cde5432a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SegmentReportingAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfRevenuesFromExternalCustomersAndLongLivedAssetsTable_efddf121-6a92-4eeb-ad4a-7b4d3dae4a09" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfRevenuesFromExternalCustomersAndLongLivedAssetsTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingAbstract_1486b450-66a9-42b5-8240-e5a6cde5432a" xlink:to="loc_us-gaap_ScheduleOfRevenuesFromExternalCustomersAndLongLivedAssetsTable_efddf121-6a92-4eeb-ad4a-7b4d3dae4a09" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_StatementGeographicalAxis_08b324e5-7d02-4483-a03e-a08241813475" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_StatementGeographicalAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfRevenuesFromExternalCustomersAndLongLivedAssetsTable_efddf121-6a92-4eeb-ad4a-7b4d3dae4a09" xlink:to="loc_srt_StatementGeographicalAxis_08b324e5-7d02-4483-a03e-a08241813475" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_SegmentGeographicalDomain_12d17952-615b-4a4c-8d6c-2ce2b428458d" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_SegmentGeographicalDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_StatementGeographicalAxis_08b324e5-7d02-4483-a03e-a08241813475" xlink:to="loc_srt_SegmentGeographicalDomain_12d17952-615b-4a4c-8d6c-2ce2b428458d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_country_CA_ad2a15c5-ee12-4dd8-8e71-e479c1af6b60" xlink:href="https://xbrl.sec.gov/country/2021/country-2021.xsd#country_CA"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_SegmentGeographicalDomain_12d17952-615b-4a4c-8d6c-2ce2b428458d" xlink:to="loc_country_CA_ad2a15c5-ee12-4dd8-8e71-e479c1af6b60" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_country_IL_936f478e-34e3-49b8-b5a8-b810a32e0e7a" xlink:href="https://xbrl.sec.gov/country/2021/country-2021.xsd#country_IL"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_SegmentGeographicalDomain_12d17952-615b-4a4c-8d6c-2ce2b428458d" xlink:to="loc_country_IL_936f478e-34e3-49b8-b5a8-b810a32e0e7a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_country_US_4612fca5-f3fc-4fff-866d-001b7095f2a0" xlink:href="https://xbrl.sec.gov/country/2021/country-2021.xsd#country_US"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_SegmentGeographicalDomain_12d17952-615b-4a4c-8d6c-2ce2b428458d" xlink:to="loc_country_US_4612fca5-f3fc-4fff-866d-001b7095f2a0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenuesFromExternalCustomersAndLongLivedAssetsLineItems_624e6d94-f43a-4e90-ae9c-627bc7859ebc" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RevenuesFromExternalCustomersAndLongLivedAssetsLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfRevenuesFromExternalCustomersAndLongLivedAssetsTable_efddf121-6a92-4eeb-ad4a-7b4d3dae4a09" xlink:to="loc_us-gaap_RevenuesFromExternalCustomersAndLongLivedAssetsLineItems_624e6d94-f43a-4e90-ae9c-627bc7859ebc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NoncurrentAssets_82fd1116-dd50-4a52-b202-12742628c4c5" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NoncurrentAssets"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RevenuesFromExternalCustomersAndLongLivedAssetsLineItems_624e6d94-f43a-4e90-ae9c-627bc7859ebc" xlink:to="loc_us-gaap_NoncurrentAssets_82fd1116-dd50-4a52-b202-12742628c4c5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://thecronosgroup.com/role/CommitmentsandContingencies" xlink:type="simple" xlink:href="cron-20210630.xsd#CommitmentsandContingencies"/>
  <link:presentationLink xlink:role="http://thecronosgroup.com/role/CommitmentsandContingencies" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LossContingencyAbstract_a7a4d13a-96c1-4abe-886f-51ccd49086c5" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LossContingencyAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LossContingencyDisclosures_28f32e7e-c4e3-4a82-9a50-7f27aecfccd5" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LossContingencyDisclosures"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LossContingencyAbstract_a7a4d13a-96c1-4abe-886f-51ccd49086c5" xlink:to="loc_us-gaap_LossContingencyDisclosures_28f32e7e-c4e3-4a82-9a50-7f27aecfccd5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://thecronosgroup.com/role/CommitmentsandContingenciesDetails" xlink:type="simple" xlink:href="cron-20210630.xsd#CommitmentsandContingenciesDetails"/>
  <link:presentationLink xlink:role="http://thecronosgroup.com/role/CommitmentsandContingenciesDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LossContingencyAbstract_6253ec50-aa16-463e-a8b4-c1e821f914f1" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LossContingencyAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LossContingenciesTable_804a346d-558f-427c-a154-de5aebe549b6" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LossContingenciesTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LossContingencyAbstract_6253ec50-aa16-463e-a8b4-c1e821f914f1" xlink:to="loc_us-gaap_LossContingenciesTable_804a346d-558f-427c-a154-de5aebe549b6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_LitigationCaseAxis_f8cbd56b-af22-4394-9df3-ec2c01fd5cc9" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_LitigationCaseAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LossContingenciesTable_804a346d-558f-427c-a154-de5aebe549b6" xlink:to="loc_srt_LitigationCaseAxis_f8cbd56b-af22-4394-9df3-ec2c01fd5cc9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_LitigationCaseTypeDomain_9c611218-22ac-453e-b8fc-5a2b5c8dfcb1" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_LitigationCaseTypeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_LitigationCaseAxis_f8cbd56b-af22-4394-9df3-ec2c01fd5cc9" xlink:to="loc_srt_LitigationCaseTypeDomain_9c611218-22ac-453e-b8fc-5a2b5c8dfcb1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cron_USDistrictCourtOfEasternDistrictOfNewYorkVsCronosMember_5fddf62e-fc56-4a26-b1c1-2df547dfd545" xlink:href="cron-20210630.xsd#cron_USDistrictCourtOfEasternDistrictOfNewYorkVsCronosMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_LitigationCaseTypeDomain_9c611218-22ac-453e-b8fc-5a2b5c8dfcb1" xlink:to="loc_cron_USDistrictCourtOfEasternDistrictOfNewYorkVsCronosMember_5fddf62e-fc56-4a26-b1c1-2df547dfd545" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LitigationStatusAxis_2fafe1f2-6845-41ed-8e00-e129965bc2d3" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LitigationStatusAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LossContingenciesTable_804a346d-558f-427c-a154-de5aebe549b6" xlink:to="loc_us-gaap_LitigationStatusAxis_2fafe1f2-6845-41ed-8e00-e129965bc2d3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LitigationStatusDomain_3b8f11f4-8d02-4b89-959f-1b85c70fb8c2" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LitigationStatusDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LitigationStatusAxis_2fafe1f2-6845-41ed-8e00-e129965bc2d3" xlink:to="loc_us-gaap_LitigationStatusDomain_3b8f11f4-8d02-4b89-959f-1b85c70fb8c2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PendingLitigationMember_e42d7673-caf5-447e-8fd6-3c60776f88e8" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PendingLitigationMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LitigationStatusDomain_3b8f11f4-8d02-4b89-959f-1b85c70fb8c2" xlink:to="loc_us-gaap_PendingLitigationMember_e42d7673-caf5-447e-8fd6-3c60776f88e8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LossContingenciesByNatureOfContingencyAxis_bf39c466-c792-4253-b1f8-06afc988a522" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LossContingenciesByNatureOfContingencyAxis"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LossContingenciesTable_804a346d-558f-427c-a154-de5aebe549b6" xlink:to="loc_us-gaap_LossContingenciesByNatureOfContingencyAxis_bf39c466-c792-4253-b1f8-06afc988a522" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LossContingencyNatureDomain_e5644be3-7f6e-411e-b589-a56e733a2be6" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LossContingencyNatureDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LossContingenciesByNatureOfContingencyAxis_bf39c466-c792-4253-b1f8-06afc988a522" xlink:to="loc_us-gaap_LossContingencyNatureDomain_e5644be3-7f6e-411e-b589-a56e733a2be6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UnfavorableRegulatoryActionMember_db29d6e0-521e-4db1-b503-625465fa5862" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_UnfavorableRegulatoryActionMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LossContingencyNatureDomain_e5644be3-7f6e-411e-b589-a56e733a2be6" xlink:to="loc_us-gaap_UnfavorableRegulatoryActionMember_db29d6e0-521e-4db1-b503-625465fa5862" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LossContingenciesLineItems_ae654244-64cd-441f-9ed3-ef33f5a41086" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LossContingenciesLineItems"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LossContingenciesTable_804a346d-558f-427c-a154-de5aebe549b6" xlink:to="loc_us-gaap_LossContingenciesLineItems_ae654244-64cd-441f-9ed3-ef33f5a41086" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LossContingencyNumberOfPlaintiffs_ddaf5e8a-e67b-4091-9f66-a727527f91e7" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LossContingencyNumberOfPlaintiffs"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LossContingenciesLineItems_ae654244-64cd-441f-9ed3-ef33f5a41086" xlink:to="loc_us-gaap_LossContingencyNumberOfPlaintiffs_ddaf5e8a-e67b-4091-9f66-a727527f91e7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LossContingencyNewClaimsFiledNumber_490a423a-f1d7-4d8c-95af-783a1216ac56" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LossContingencyNewClaimsFiledNumber"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LossContingenciesLineItems_ae654244-64cd-441f-9ed3-ef33f5a41086" xlink:to="loc_us-gaap_LossContingencyNewClaimsFiledNumber_490a423a-f1d7-4d8c-95af-783a1216ac56" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LossContingencyDamagesSoughtValue_f6186454-2f79-4c96-9a85-ca2a36f958ae" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LossContingencyDamagesSoughtValue"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LossContingenciesLineItems_ae654244-64cd-441f-9ed3-ef33f5a41086" xlink:to="loc_us-gaap_LossContingencyDamagesSoughtValue_f6186454-2f79-4c96-9a85-ca2a36f958ae" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cron_LossContingencyPunitiveDamagesSoughtValue_00f57145-d319-4f62-941b-2ba87c7c4984" xlink:href="cron-20210630.xsd#cron_LossContingencyPunitiveDamagesSoughtValue"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LossContingenciesLineItems_ae654244-64cd-441f-9ed3-ef33f5a41086" xlink:to="loc_cron_LossContingencyPunitiveDamagesSoughtValue_00f57145-d319-4f62-941b-2ba87c7c4984" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://thecronosgroup.com/role/FinancialInstruments" xlink:type="simple" xlink:href="cron-20210630.xsd#FinancialInstruments"/>
  <link:presentationLink xlink:role="http://thecronosgroup.com/role/FinancialInstruments" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RisksAndUncertaintiesAbstract_84f4a3bc-bf79-4ffb-8bb6-82620650fb70" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RisksAndUncertaintiesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskDisclosureTextBlock_648f3f16-65cf-46ea-a59b-cc658d50ac13" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ConcentrationRiskDisclosureTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RisksAndUncertaintiesAbstract_84f4a3bc-bf79-4ffb-8bb6-82620650fb70" xlink:to="loc_us-gaap_ConcentrationRiskDisclosureTextBlock_648f3f16-65cf-46ea-a59b-cc658d50ac13" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://thecronosgroup.com/role/FinancialInstrumentsTables" xlink:type="simple" xlink:href="cron-20210630.xsd#FinancialInstrumentsTables"/>
  <link:presentationLink xlink:role="http://thecronosgroup.com/role/FinancialInstrumentsTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RisksAndUncertaintiesAbstract_20d597c2-3ff5-493a-a4e1-6fe653792821" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RisksAndUncertaintiesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock_af43ce70-585d-4aeb-8302-19ed7b7c4d53" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RisksAndUncertaintiesAbstract_20d597c2-3ff5-493a-a4e1-6fe653792821" xlink:to="loc_us-gaap_ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock_af43ce70-585d-4aeb-8302-19ed7b7c4d53" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://thecronosgroup.com/role/FinancialInstrumentsScheduleofFairValueofAssetsMeasuredonRecurringBasisDetails" xlink:type="simple" xlink:href="cron-20210630.xsd#FinancialInstrumentsScheduleofFairValueofAssetsMeasuredonRecurringBasisDetails"/>
  <link:presentationLink xlink:role="http://thecronosgroup.com/role/FinancialInstrumentsScheduleofFairValueofAssetsMeasuredonRecurringBasisDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueDisclosuresAbstract_e0fc9689-1388-4fa4-a814-188d0044ca64" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueDisclosuresAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_a7565cbe-fc1f-4f33-9f8e-5938834ea1b2" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueDisclosuresAbstract_e0fc9689-1388-4fa4-a814-188d0044ca64" xlink:to="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_a7565cbe-fc1f-4f33-9f8e-5938834ea1b2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueByMeasurementFrequencyAxis_0d012536-f460-48a5-af29-ef5deb1373cc" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueByMeasurementFrequencyAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_a7565cbe-fc1f-4f33-9f8e-5938834ea1b2" xlink:to="loc_us-gaap_FairValueByMeasurementFrequencyAxis_0d012536-f460-48a5-af29-ef5deb1373cc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementFrequencyDomain_855ccf78-08a2-48fa-9615-09748c57b07b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueMeasurementFrequencyDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueByMeasurementFrequencyAxis_0d012536-f460-48a5-af29-ef5deb1373cc" xlink:to="loc_us-gaap_FairValueMeasurementFrequencyDomain_855ccf78-08a2-48fa-9615-09748c57b07b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementsRecurringMember_197f58d2-d9dd-4782-971d-066cc4a231a8" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueMeasurementsRecurringMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueMeasurementFrequencyDomain_855ccf78-08a2-48fa-9615-09748c57b07b" xlink:to="loc_us-gaap_FairValueMeasurementsRecurringMember_197f58d2-d9dd-4782-971d-066cc4a231a8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_485f9a27-b6d6-4d60-bc49-b62b1d61dc83" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueByFairValueHierarchyLevelAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_a7565cbe-fc1f-4f33-9f8e-5938834ea1b2" xlink:to="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_485f9a27-b6d6-4d60-bc49-b62b1d61dc83" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_96a2fb9a-bf28-4c36-be41-c95b850926a9" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueMeasurementsFairValueHierarchyDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_485f9a27-b6d6-4d60-bc49-b62b1d61dc83" xlink:to="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_96a2fb9a-bf28-4c36-be41-c95b850926a9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueInputsLevel1Member_d96b2292-4792-4f24-a953-5bc25c4354f9" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueInputsLevel1Member"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_96a2fb9a-bf28-4c36-be41-c95b850926a9" xlink:to="loc_us-gaap_FairValueInputsLevel1Member_d96b2292-4792-4f24-a953-5bc25c4354f9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueInputsLevel2Member_f8b0ef85-8f0b-4d2c-b0d7-89e1a29b0766" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueInputsLevel2Member"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_96a2fb9a-bf28-4c36-be41-c95b850926a9" xlink:to="loc_us-gaap_FairValueInputsLevel2Member_f8b0ef85-8f0b-4d2c-b0d7-89e1a29b0766" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueInputsLevel3Member_74d2f5fd-70e6-4676-b46f-1c990bf9dd99" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueInputsLevel3Member"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_96a2fb9a-bf28-4c36-be41-c95b850926a9" xlink:to="loc_us-gaap_FairValueInputsLevel3Member_74d2f5fd-70e6-4676-b46f-1c990bf9dd99" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_cccb5528-98c9-48de-8fc8-aacca428d9e4" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_a7565cbe-fc1f-4f33-9f8e-5938834ea1b2" xlink:to="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_cccb5528-98c9-48de-8fc8-aacca428d9e4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashAndCashEquivalentsFairValueDisclosure_35e07873-f479-4c06-9918-54337b0d782d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CashAndCashEquivalentsFairValueDisclosure"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_cccb5528-98c9-48de-8fc8-aacca428d9e4" xlink:to="loc_us-gaap_CashAndCashEquivalentsFairValueDisclosure_35e07873-f479-4c06-9918-54337b0d782d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleSecuritiesDebtSecurities_d9e7e71a-4c17-4966-99b1-03d88968d36f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AvailableForSaleSecuritiesDebtSecurities"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_cccb5528-98c9-48de-8fc8-aacca428d9e4" xlink:to="loc_us-gaap_AvailableForSaleSecuritiesDebtSecurities_d9e7e71a-4c17-4966-99b1-03d88968d36f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeLiabilities_1015af7c-bec9-46c0-a41f-67ec84d2fc0d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DerivativeLiabilities"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_cccb5528-98c9-48de-8fc8-aacca428d9e4" xlink:to="loc_us-gaap_DerivativeLiabilities_1015af7c-bec9-46c0-a41f-67ec84d2fc0d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://thecronosgroup.com/role/FinancialInstrumentsCreditRiskNarrativeDetails" xlink:type="simple" xlink:href="cron-20210630.xsd#FinancialInstrumentsCreditRiskNarrativeDetails"/>
  <link:presentationLink xlink:role="http://thecronosgroup.com/role/FinancialInstrumentsCreditRiskNarrativeDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RisksAndUncertaintiesAbstract_ff5f7789-52ea-4751-b742-cb6d97058aa2" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RisksAndUncertaintiesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskTable_dd7e93dd-c983-4419-b12c-8c2eb197a259" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ConcentrationRiskTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RisksAndUncertaintiesAbstract_ff5f7789-52ea-4751-b742-cb6d97058aa2" xlink:to="loc_us-gaap_ConcentrationRiskTable_dd7e93dd-c983-4419-b12c-8c2eb197a259" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskByBenchmarkAxis_8c6fcb9c-f5c7-4d4d-a59d-df0a337ed0db" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ConcentrationRiskByBenchmarkAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ConcentrationRiskTable_dd7e93dd-c983-4419-b12c-8c2eb197a259" xlink:to="loc_us-gaap_ConcentrationRiskByBenchmarkAxis_8c6fcb9c-f5c7-4d4d-a59d-df0a337ed0db" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskBenchmarkDomain_51be1f2e-611f-4dce-b97f-0980676e000d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ConcentrationRiskBenchmarkDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ConcentrationRiskByBenchmarkAxis_8c6fcb9c-f5c7-4d4d-a59d-df0a337ed0db" xlink:to="loc_us-gaap_ConcentrationRiskBenchmarkDomain_51be1f2e-611f-4dce-b97f-0980676e000d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountsReceivableMember_df5074c0-0699-48ee-946d-ff4f8fa7f639" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccountsReceivableMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ConcentrationRiskBenchmarkDomain_51be1f2e-611f-4dce-b97f-0980676e000d" xlink:to="loc_us-gaap_AccountsReceivableMember_df5074c0-0699-48ee-946d-ff4f8fa7f639" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskByTypeAxis_762f595a-b182-4fb6-8d28-758e08b23516" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ConcentrationRiskByTypeAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ConcentrationRiskTable_dd7e93dd-c983-4419-b12c-8c2eb197a259" xlink:to="loc_us-gaap_ConcentrationRiskByTypeAxis_762f595a-b182-4fb6-8d28-758e08b23516" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskTypeDomain_f8d2db8b-f8e6-4dde-8ba8-353eb932d826" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ConcentrationRiskTypeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ConcentrationRiskByTypeAxis_762f595a-b182-4fb6-8d28-758e08b23516" xlink:to="loc_us-gaap_ConcentrationRiskTypeDomain_f8d2db8b-f8e6-4dde-8ba8-353eb932d826" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CreditConcentrationRiskMember_26068578-31bf-45f1-9514-d31105193b29" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CreditConcentrationRiskMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ConcentrationRiskTypeDomain_f8d2db8b-f8e6-4dde-8ba8-353eb932d826" xlink:to="loc_us-gaap_CreditConcentrationRiskMember_26068578-31bf-45f1-9514-d31105193b29" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MajorCustomersAxis_a3497dda-9ea7-4422-bf61-a9527e8093c6" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_MajorCustomersAxis"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ConcentrationRiskTable_dd7e93dd-c983-4419-b12c-8c2eb197a259" xlink:to="loc_srt_MajorCustomersAxis_a3497dda-9ea7-4422-bf61-a9527e8093c6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_NameOfMajorCustomerDomain_279216bc-aa0c-4425-a93b-34ccbc8464bf" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_NameOfMajorCustomerDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_MajorCustomersAxis_a3497dda-9ea7-4422-bf61-a9527e8093c6" xlink:to="loc_srt_NameOfMajorCustomerDomain_279216bc-aa0c-4425-a93b-34ccbc8464bf" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cron_FourCustomersMember_868b5e98-b9cf-4155-ac0d-d708ac8cfbf5" xlink:href="cron-20210630.xsd#cron_FourCustomersMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_NameOfMajorCustomerDomain_279216bc-aa0c-4425-a93b-34ccbc8464bf" xlink:to="loc_cron_FourCustomersMember_868b5e98-b9cf-4155-ac0d-d708ac8cfbf5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskLineItems_110b5da5-c470-4f66-b717-08e097f5ca93" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ConcentrationRiskLineItems"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ConcentrationRiskTable_dd7e93dd-c983-4419-b12c-8c2eb197a259" xlink:to="loc_us-gaap_ConcentrationRiskLineItems_110b5da5-c470-4f66-b717-08e097f5ca93" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskCreditRiskFinancialInstrumentMaximumExposure_23e0b7ed-6426-474b-b590-1f4efc4c4631" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ConcentrationRiskCreditRiskFinancialInstrumentMaximumExposure"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ConcentrationRiskLineItems_110b5da5-c470-4f66-b717-08e097f5ca93" xlink:to="loc_us-gaap_ConcentrationRiskCreditRiskFinancialInstrumentMaximumExposure_23e0b7ed-6426-474b-b590-1f4efc4c4631" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountsReceivableNoncurrentThresholdPeriodPastDueWriteoff_ce546eaa-4832-4eec-8490-21ff1ea59e18" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccountsReceivableNoncurrentThresholdPeriodPastDueWriteoff"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ConcentrationRiskLineItems_110b5da5-c470-4f66-b717-08e097f5ca93" xlink:to="loc_us-gaap_AccountsReceivableNoncurrentThresholdPeriodPastDueWriteoff_ce546eaa-4832-4eec-8490-21ff1ea59e18" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AllowanceForDoubtfulAccountsReceivableCurrent_1d25c227-a39e-4b0c-b1db-2c4adb183dd0" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AllowanceForDoubtfulAccountsReceivableCurrent"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ConcentrationRiskLineItems_110b5da5-c470-4f66-b717-08e097f5ca93" xlink:to="loc_us-gaap_AllowanceForDoubtfulAccountsReceivableCurrent_1d25c227-a39e-4b0c-b1db-2c4adb183dd0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskPercentage1_9f9fcc85-94db-4ea6-8f46-1f7bcb2b6f87" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ConcentrationRiskPercentage1"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ConcentrationRiskLineItems_110b5da5-c470-4f66-b717-08e097f5ca93" xlink:to="loc_us-gaap_ConcentrationRiskPercentage1_9f9fcc85-94db-4ea6-8f46-1f7bcb2b6f87" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://thecronosgroup.com/role/FinancialInstrumentsInterestRateRiskNarrativeDetails" xlink:type="simple" xlink:href="cron-20210630.xsd#FinancialInstrumentsInterestRateRiskNarrativeDetails"/>
  <link:presentationLink xlink:role="http://thecronosgroup.com/role/FinancialInstrumentsInterestRateRiskNarrativeDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentsAllOtherInvestmentsAbstract_e2607fb4-30fd-4dc6-a609-30a3a37897b7" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InvestmentsAllOtherInvestmentsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestIncomeExpenseNonoperatingNet_e11195fa-76d9-4580-beee-81afa18fb29b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InterestIncomeExpenseNonoperatingNet"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_InvestmentsAllOtherInvestmentsAbstract_e2607fb4-30fd-4dc6-a609-30a3a37897b7" xlink:to="loc_us-gaap_InterestIncomeExpenseNonoperatingNet_e11195fa-76d9-4580-beee-81afa18fb29b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://thecronosgroup.com/role/FinancialInstrumentsLiquidityRiskNarrativeDetails" xlink:type="simple" xlink:href="cron-20210630.xsd#FinancialInstrumentsLiquidityRiskNarrativeDetails"/>
  <link:presentationLink xlink:role="http://thecronosgroup.com/role/FinancialInstrumentsLiquidityRiskNarrativeDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RisksAndUncertaintiesAbstract_42f47fc1-f95d-4b8f-a5b6-48793714a10b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RisksAndUncertaintiesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskTable_49fba6d9-b81d-44cb-9c89-8700b62a75db" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ConcentrationRiskTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RisksAndUncertaintiesAbstract_42f47fc1-f95d-4b8f-a5b6-48793714a10b" xlink:to="loc_us-gaap_ConcentrationRiskTable_49fba6d9-b81d-44cb-9c89-8700b62a75db" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskByBenchmarkAxis_c23d184d-6bb8-4bdf-9fe0-bba4f06b04a8" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ConcentrationRiskByBenchmarkAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ConcentrationRiskTable_49fba6d9-b81d-44cb-9c89-8700b62a75db" xlink:to="loc_us-gaap_ConcentrationRiskByBenchmarkAxis_c23d184d-6bb8-4bdf-9fe0-bba4f06b04a8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskBenchmarkDomain_6fbd3f77-7164-42de-80dd-a94d34806056" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ConcentrationRiskBenchmarkDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ConcentrationRiskByBenchmarkAxis_c23d184d-6bb8-4bdf-9fe0-bba4f06b04a8" xlink:to="loc_us-gaap_ConcentrationRiskBenchmarkDomain_6fbd3f77-7164-42de-80dd-a94d34806056" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountsPayableMember_45f27b83-1996-48d9-ac44-3f854d15519b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccountsPayableMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ConcentrationRiskBenchmarkDomain_6fbd3f77-7164-42de-80dd-a94d34806056" xlink:to="loc_us-gaap_AccountsPayableMember_45f27b83-1996-48d9-ac44-3f854d15519b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskByTypeAxis_4c03edf9-d21b-4a42-abf5-4c801e26f206" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ConcentrationRiskByTypeAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ConcentrationRiskTable_49fba6d9-b81d-44cb-9c89-8700b62a75db" xlink:to="loc_us-gaap_ConcentrationRiskByTypeAxis_4c03edf9-d21b-4a42-abf5-4c801e26f206" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskTypeDomain_ee7c83b4-97e4-470f-8c84-2ba3d40552b9" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ConcentrationRiskTypeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ConcentrationRiskByTypeAxis_4c03edf9-d21b-4a42-abf5-4c801e26f206" xlink:to="loc_us-gaap_ConcentrationRiskTypeDomain_ee7c83b4-97e4-470f-8c84-2ba3d40552b9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SupplierConcentrationRiskMember_30b9a2ab-d509-4cff-a91a-b74823c40101" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SupplierConcentrationRiskMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ConcentrationRiskTypeDomain_ee7c83b4-97e4-470f-8c84-2ba3d40552b9" xlink:to="loc_us-gaap_SupplierConcentrationRiskMember_30b9a2ab-d509-4cff-a91a-b74823c40101" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedGoodsAndNonemployeeServicesTransactionBySupplierAxis_120e6086-0785-44ea-9799-42e5052d4bc7" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedGoodsAndNonemployeeServicesTransactionBySupplierAxis"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ConcentrationRiskTable_49fba6d9-b81d-44cb-9c89-8700b62a75db" xlink:to="loc_us-gaap_ShareBasedGoodsAndNonemployeeServicesTransactionBySupplierAxis_120e6086-0785-44ea-9799-42e5052d4bc7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedGoodsAndNonemployeeServicesTransactionSupplierDomain_1ad0e983-4885-4b03-beac-a635dd1a86ba" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedGoodsAndNonemployeeServicesTransactionSupplierDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedGoodsAndNonemployeeServicesTransactionBySupplierAxis_120e6086-0785-44ea-9799-42e5052d4bc7" xlink:to="loc_us-gaap_ShareBasedGoodsAndNonemployeeServicesTransactionSupplierDomain_1ad0e983-4885-4b03-beac-a635dd1a86ba" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cron_OneVendorMember_da273a05-c97a-486d-9d04-39ace861f218" xlink:href="cron-20210630.xsd#cron_OneVendorMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedGoodsAndNonemployeeServicesTransactionSupplierDomain_1ad0e983-4885-4b03-beac-a635dd1a86ba" xlink:to="loc_cron_OneVendorMember_da273a05-c97a-486d-9d04-39ace861f218" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cron_FourVendorsMember_6cbaa566-9f25-4820-9d49-6d7f98275da6" xlink:href="cron-20210630.xsd#cron_FourVendorsMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedGoodsAndNonemployeeServicesTransactionSupplierDomain_1ad0e983-4885-4b03-beac-a635dd1a86ba" xlink:to="loc_cron_FourVendorsMember_6cbaa566-9f25-4820-9d49-6d7f98275da6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskLineItems_5c009d6f-214b-43b3-9d98-6d1d1e6718ec" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ConcentrationRiskLineItems"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ConcentrationRiskTable_49fba6d9-b81d-44cb-9c89-8700b62a75db" xlink:to="loc_us-gaap_ConcentrationRiskLineItems_5c009d6f-214b-43b3-9d98-6d1d1e6718ec" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskPercentage1_c6d726b4-fbf7-44a4-85f2-2224639e12a5" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ConcentrationRiskPercentage1"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ConcentrationRiskLineItems_5c009d6f-214b-43b3-9d98-6d1d1e6718ec" xlink:to="loc_us-gaap_ConcentrationRiskPercentage1_c6d726b4-fbf7-44a4-85f2-2224639e12a5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://thecronosgroup.com/role/FinancialInstrumentsCurrencyRateRiskNarrativeDetails" xlink:type="simple" xlink:href="cron-20210630.xsd#FinancialInstrumentsCurrencyRateRiskNarrativeDetails"/>
  <link:presentationLink xlink:role="http://thecronosgroup.com/role/FinancialInstrumentsCurrencyRateRiskNarrativeDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RisksAndUncertaintiesAbstract_53986233-7d02-4d8c-9e86-26adeb1711b7" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RisksAndUncertaintiesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax_fb280472-2550-401f-9c6d-3fa60675b300" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RisksAndUncertaintiesAbstract_53986233-7d02-4d8c-9e86-26adeb1711b7" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax_fb280472-2550-401f-9c6d-3fa60675b300" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cron_SensitivityAnalysisOfCarryingValueNetAssetsImpactOf10PercentChangeInExchangeRate_c610a466-576c-484d-a1fb-eea0bc00205e" xlink:href="cron-20210630.xsd#cron_SensitivityAnalysisOfCarryingValueNetAssetsImpactOf10PercentChangeInExchangeRate"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RisksAndUncertaintiesAbstract_53986233-7d02-4d8c-9e86-26adeb1711b7" xlink:to="loc_cron_SensitivityAnalysisOfCarryingValueNetAssetsImpactOf10PercentChangeInExchangeRate_c610a466-576c-484d-a1fb-eea0bc00205e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://thecronosgroup.com/role/HeldForSaleAssetsandDiscontinuedOperations" xlink:type="simple" xlink:href="cron-20210630.xsd#HeldForSaleAssetsandDiscontinuedOperations"/>
  <link:presentationLink xlink:role="http://thecronosgroup.com/role/HeldForSaleAssetsandDiscontinuedOperations" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DiscontinuedOperationsAndDisposalGroupsAbstract_753c9a72-191b-4181-98a0-b127af594f9e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DiscontinuedOperationsAndDisposalGroupsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsDisclosureTextBlock_bf18040d-f2f3-4e91-98e4-962d997b3add" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DisposalGroupsIncludingDiscontinuedOperationsDisclosureTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DiscontinuedOperationsAndDisposalGroupsAbstract_753c9a72-191b-4181-98a0-b127af594f9e" xlink:to="loc_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsDisclosureTextBlock_bf18040d-f2f3-4e91-98e4-962d997b3add" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://thecronosgroup.com/role/HeldForSaleAssetsandDiscontinuedOperationsTables" xlink:type="simple" xlink:href="cron-20210630.xsd#HeldForSaleAssetsandDiscontinuedOperationsTables"/>
  <link:presentationLink xlink:role="http://thecronosgroup.com/role/HeldForSaleAssetsandDiscontinuedOperationsTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DiscontinuedOperationsAndDisposalGroupsAbstract_8c3f76f4-d014-4f64-b384-b5de43280a0c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DiscontinuedOperationsAndDisposalGroupsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfDisposalGroupsIncludingDiscontinuedOperationsIncomeStatementBalanceSheetAndAdditionalDisclosuresTextBlock_d4e1c702-e62d-4d65-a117-3c929d5c5d78" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfDisposalGroupsIncludingDiscontinuedOperationsIncomeStatementBalanceSheetAndAdditionalDisclosuresTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DiscontinuedOperationsAndDisposalGroupsAbstract_8c3f76f4-d014-4f64-b384-b5de43280a0c" xlink:to="loc_us-gaap_ScheduleOfDisposalGroupsIncludingDiscontinuedOperationsIncomeStatementBalanceSheetAndAdditionalDisclosuresTextBlock_d4e1c702-e62d-4d65-a117-3c929d5c5d78" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://thecronosgroup.com/role/HeldForSaleAssetsandDiscontinuedOperationsDetails" xlink:type="simple" xlink:href="cron-20210630.xsd#HeldForSaleAssetsandDiscontinuedOperationsDetails"/>
  <link:presentationLink xlink:role="http://thecronosgroup.com/role/HeldForSaleAssetsandDiscontinuedOperationsDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DiscontinuedOperationsAndDisposalGroupsAbstract_9cef2a4b-f480-49b3-97ee-6adffadb4626" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DiscontinuedOperationsAndDisposalGroupsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsTable_a4ddcbae-61af-4cff-8b20-8d6633423d04" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DiscontinuedOperationsAndDisposalGroupsAbstract_9cef2a4b-f480-49b3-97ee-6adffadb4626" xlink:to="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsTable_a4ddcbae-61af-4cff-8b20-8d6633423d04" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupClassificationAxis_7c31e07e-795c-4df6-af04-d893dc0202b2" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DisposalGroupClassificationAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsTable_a4ddcbae-61af-4cff-8b20-8d6633423d04" xlink:to="loc_us-gaap_DisposalGroupClassificationAxis_7c31e07e-795c-4df6-af04-d893dc0202b2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupClassificationDomain_73873b8e-9227-49b9-af73-a255ee10b62d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DisposalGroupClassificationDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisposalGroupClassificationAxis_7c31e07e-795c-4df6-af04-d893dc0202b2" xlink:to="loc_us-gaap_DisposalGroupClassificationDomain_73873b8e-9227-49b9-af73-a255ee10b62d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DiscontinuedOperationsHeldforsaleMember_8d1356f4-a0ce-4942-89cd-6ff48e3cfc89" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DiscontinuedOperationsHeldforsaleMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisposalGroupClassificationDomain_73873b8e-9227-49b9-af73-a255ee10b62d" xlink:to="loc_us-gaap_DiscontinuedOperationsHeldforsaleMember_8d1356f4-a0ce-4942-89cd-6ff48e3cfc89" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupHeldforsaleNotDiscontinuedOperationsMember_4d7a793e-cef9-416d-bddd-c190605b0a7a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DisposalGroupHeldforsaleNotDiscontinuedOperationsMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisposalGroupClassificationDomain_73873b8e-9227-49b9-af73-a255ee10b62d" xlink:to="loc_us-gaap_DisposalGroupHeldforsaleNotDiscontinuedOperationsMember_4d7a793e-cef9-416d-bddd-c190605b0a7a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis_a5c2bb37-14b8-478c-b5e6-c144ee1eb147" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsTable_a4ddcbae-61af-4cff-8b20-8d6633423d04" xlink:to="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis_a5c2bb37-14b8-478c-b5e6-c144ee1eb147" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain_f25f78db-af9d-4264-bc42-1b8d396e55d2" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis_a5c2bb37-14b8-478c-b5e6-c144ee1eb147" xlink:to="loc_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain_f25f78db-af9d-4264-bc42-1b8d396e55d2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cron_OriginalBCMember_368c51a4-ed9a-4262-92a5-f87b31ca0907" xlink:href="cron-20210630.xsd#cron_OriginalBCMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain_f25f78db-af9d-4264-bc42-1b8d396e55d2" xlink:to="loc_cron_OriginalBCMember_368c51a4-ed9a-4262-92a5-f87b31ca0907" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems_ceca3993-4a59-4c2e-a4a1-c5612e051281" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsTable_a4ddcbae-61af-4cff-8b20-8d6633423d04" xlink:to="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems_ceca3993-4a59-4c2e-a4a1-c5612e051281" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ImpairmentOfLongLivedAssetsToBeDisposedOf_cfecbf20-e2be-46d2-87b8-3c8445dbc382" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ImpairmentOfLongLivedAssetsToBeDisposedOf"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems_ceca3993-4a59-4c2e-a4a1-c5612e051281" xlink:to="loc_us-gaap_ImpairmentOfLongLivedAssetsToBeDisposedOf_cfecbf20-e2be-46d2-87b8-3c8445dbc382" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromSaleOfPropertyHeldForSale_e57772b0-3ef7-4d5e-8704-3879098c7a5d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ProceedsFromSaleOfPropertyHeldForSale"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems_ceca3993-4a59-4c2e-a4a1-c5612e051281" xlink:to="loc_us-gaap_ProceedsFromSaleOfPropertyHeldForSale_e57772b0-3ef7-4d5e-8704-3879098c7a5d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupNotDiscontinuedOperationGainLossOnDisposal_7ce346e8-5754-47ac-bd59-14617ebb5c8d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DisposalGroupNotDiscontinuedOperationGainLossOnDisposal"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems_ceca3993-4a59-4c2e-a4a1-c5612e051281" xlink:to="loc_us-gaap_DisposalGroupNotDiscontinuedOperationGainLossOnDisposal_7ce346e8-5754-47ac-bd59-14617ebb5c8d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DiscontinuedOperationIncomeLossFromDiscontinuedOperationDuringPhaseOutPeriodNetOfTax_67753ad4-cfd0-45cb-aa63-b50432d7cc01" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DiscontinuedOperationIncomeLossFromDiscontinuedOperationDuringPhaseOutPeriodNetOfTax"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems_ceca3993-4a59-4c2e-a4a1-c5612e051281" xlink:to="loc_us-gaap_DiscontinuedOperationIncomeLossFromDiscontinuedOperationDuringPhaseOutPeriodNetOfTax_67753ad4-cfd0-45cb-aa63-b50432d7cc01" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationAssetsNoncurrent_694418bd-0e9c-4571-bf49-09b857274ab3" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DisposalGroupIncludingDiscontinuedOperationAssetsNoncurrent"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems_ceca3993-4a59-4c2e-a4a1-c5612e051281" xlink:to="loc_us-gaap_DisposalGroupIncludingDiscontinuedOperationAssetsNoncurrent_694418bd-0e9c-4571-bf49-09b857274ab3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://thecronosgroup.com/role/ImpairmentLossonLongLivedAssets" xlink:type="simple" xlink:href="cron-20210630.xsd#ImpairmentLossonLongLivedAssets"/>
  <link:presentationLink xlink:role="http://thecronosgroup.com/role/ImpairmentLossonLongLivedAssets" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_abe39898-63d2-414e-a814-b2e91ea51de0" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetImpairmentChargesTextBlock_43736f95-c355-4b01-ad58-4a294e8f1d73" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AssetImpairmentChargesTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_abe39898-63d2-414e-a814-b2e91ea51de0" xlink:to="loc_us-gaap_AssetImpairmentChargesTextBlock_43736f95-c355-4b01-ad58-4a294e8f1d73" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://thecronosgroup.com/role/ImpairmentLossonLongLivedAssetsDetails" xlink:type="simple" xlink:href="cron-20210630.xsd#ImpairmentLossonLongLivedAssetsDetails"/>
  <link:presentationLink xlink:role="http://thecronosgroup.com/role/ImpairmentLossonLongLivedAssetsDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_169af139-4c31-44a0-a2ea-59386e5ce348" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfIndefiniteLivedIntangibleAssetsTable_096fb33e-10f7-419e-9807-6898d5d89628" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfIndefiniteLivedIntangibleAssetsTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_169af139-4c31-44a0-a2ea-59386e5ce348" xlink:to="loc_us-gaap_ScheduleOfIndefiniteLivedIntangibleAssetsTable_096fb33e-10f7-419e-9807-6898d5d89628" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis_11f6f56a-acf0-47d5-aede-e8887d59120c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfIndefiniteLivedIntangibleAssetsTable_096fb33e-10f7-419e-9807-6898d5d89628" xlink:to="loc_us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis_11f6f56a-acf0-47d5-aede-e8887d59120c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IndefiniteLivedIntangibleAssetsMajorClassNameDomain_8977f020-fb2e-4fe4-aec5-83f8a07b7e02" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IndefiniteLivedIntangibleAssetsMajorClassNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis_11f6f56a-acf0-47d5-aede-e8887d59120c" xlink:to="loc_us-gaap_IndefiniteLivedIntangibleAssetsMajorClassNameDomain_8977f020-fb2e-4fe4-aec5-83f8a07b7e02" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TradeNamesMember_6565e906-96af-4c72-adf1-faa86abb8df2" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TradeNamesMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IndefiniteLivedIntangibleAssetsMajorClassNameDomain_8977f020-fb2e-4fe4-aec5-83f8a07b7e02" xlink:to="loc_us-gaap_TradeNamesMember_6565e906-96af-4c72-adf1-faa86abb8df2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ReportingUnitAxis_bde3f975-59e3-4a73-89c0-857332ffc1c3" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ReportingUnitAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfIndefiniteLivedIntangibleAssetsTable_096fb33e-10f7-419e-9807-6898d5d89628" xlink:to="loc_us-gaap_ReportingUnitAxis_bde3f975-59e3-4a73-89c0-857332ffc1c3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ReportingUnitDomain_fb5f2081-8415-4bbe-91be-1aa4d106aeca" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ReportingUnitDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ReportingUnitAxis_bde3f975-59e3-4a73-89c0-857332ffc1c3" xlink:to="loc_us-gaap_ReportingUnitDomain_fb5f2081-8415-4bbe-91be-1aa4d106aeca" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cron_UnitedStatesSegmentMember_f59772c6-af77-425e-8746-53eb38931234" xlink:href="cron-20210630.xsd#cron_UnitedStatesSegmentMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ReportingUnitDomain_fb5f2081-8415-4bbe-91be-1aa4d106aeca" xlink:to="loc_cron_UnitedStatesSegmentMember_f59772c6-af77-425e-8746-53eb38931234" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassLineItems_2233be60-ece2-47e8-b960-b193386738dc" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassLineItems"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfIndefiniteLivedIntangibleAssetsTable_096fb33e-10f7-419e-9807-6898d5d89628" xlink:to="loc_us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassLineItems_2233be60-ece2-47e8-b960-b193386738dc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ImpairmentOfLongLivedAssetsToBeDisposedOf_82efa43d-97ed-4950-a766-5b6db42a34ae" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ImpairmentOfLongLivedAssetsToBeDisposedOf"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassLineItems_2233be60-ece2-47e8-b960-b193386738dc" xlink:to="loc_us-gaap_ImpairmentOfLongLivedAssetsToBeDisposedOf_82efa43d-97ed-4950-a766-5b6db42a34ae" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cron_LesseeOperatingLeaseAreaOfLandToBeDisposedOf_c6503946-65fc-42ea-a798-26156f052666" xlink:href="cron-20210630.xsd#cron_LesseeOperatingLeaseAreaOfLandToBeDisposedOf"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassLineItems_2233be60-ece2-47e8-b960-b193386738dc" xlink:to="loc_cron_LesseeOperatingLeaseAreaOfLandToBeDisposedOf_c6503946-65fc-42ea-a798-26156f052666" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseImpairmentLoss_30175e6d-5720-4881-950d-e81c92851dba" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingLeaseImpairmentLoss"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassLineItems_2233be60-ece2-47e8-b960-b193386738dc" xlink:to="loc_us-gaap_OperatingLeaseImpairmentLoss_30175e6d-5720-4881-950d-e81c92851dba" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillImpairmentLoss_71fb231a-0c7b-4770-a2f4-91a451ebdd25" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_GoodwillImpairmentLoss"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassLineItems_2233be60-ece2-47e8-b960-b193386738dc" xlink:to="loc_us-gaap_GoodwillImpairmentLoss_71fb231a-0c7b-4770-a2f4-91a451ebdd25" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ImpairmentOfIntangibleAssetsIndefinitelivedExcludingGoodwill_d7d7df83-44a7-4d4f-86bd-430a3fb13e74" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ImpairmentOfIntangibleAssetsIndefinitelivedExcludingGoodwill"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassLineItems_2233be60-ece2-47e8-b960-b193386738dc" xlink:to="loc_us-gaap_ImpairmentOfIntangibleAssetsIndefinitelivedExcludingGoodwill_d7d7df83-44a7-4d4f-86bd-430a3fb13e74" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>14
<FILENAME>cron-20210630_htm.xml
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<XML>
<?xml version="1.0" encoding="utf-8"?>
<xbrl
  xml:lang="en-US"
  xmlns="http://www.xbrl.org/2003/instance"
  xmlns:country="http://xbrl.sec.gov/country/2021"
  xmlns:cron="http://thecronosgroup.com/20210630"
  xmlns:dei="http://xbrl.sec.gov/dei/2021"
  xmlns:iso4217="http://www.xbrl.org/2003/iso4217"
  xmlns:link="http://www.xbrl.org/2003/linkbase"
  xmlns:srt="http://fasb.org/srt/2021-01-31"
  xmlns:us-gaap="http://fasb.org/us-gaap/2021-01-31"
  xmlns:utr="http://www.xbrl.org/2009/utr"
  xmlns:xbrldi="http://xbrl.org/2006/xbrldi"
  xmlns:xlink="http://www.w3.org/1999/xlink"
  xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance">
    <link:schemaRef xlink:href="cron-20210630.xsd" xlink:type="simple"/>
    <context id="i69782326f71a44e3805518280ee22b6b_D20210101-20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001656472</identifier>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-06-30</endDate>
        </period>
    </context>
    <context id="ia52c55475f2e488fac07e8b8f24caaa3_I20210805">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001656472</identifier>
        </entity>
        <period>
            <instant>2021-08-05</instant>
        </period>
    </context>
    <context id="i225f85e38faa4bbdb4de1d8b9cf369bb_I20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001656472</identifier>
        </entity>
        <period>
            <instant>2021-06-30</instant>
        </period>
    </context>
    <context id="ifbe16ec51ea244519b77d6036b4ef038_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001656472</identifier>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i27f4e53b91ad4367b7f8d273eff27769_D20210401-20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001656472</identifier>
        </entity>
        <period>
            <startDate>2021-04-01</startDate>
            <endDate>2021-06-30</endDate>
        </period>
    </context>
    <context id="i39065c5daf934af885335c12f3cfa83f_D20200401-20200630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001656472</identifier>
        </entity>
        <period>
            <startDate>2020-04-01</startDate>
            <endDate>2020-06-30</endDate>
        </period>
    </context>
    <context id="i4a110e4972ef4113880ce582e3cda5c5_D20200101-20200630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001656472</identifier>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-06-30</endDate>
        </period>
    </context>
    <context id="i22dfc818a91c4bc99bcf6f1109597b56_I20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001656472</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-03-31</instant>
        </period>
    </context>
    <context id="iaba74aed20054433bd6c1d99389ea937_I20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001656472</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-03-31</instant>
        </period>
    </context>
    <context id="if6552787aa974a6b8ba4aa50cadb2110_I20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001656472</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-03-31</instant>
        </period>
    </context>
    <context id="i3243ae496b5b4b50976442544343adcf_I20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001656472</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-03-31</instant>
        </period>
    </context>
    <context id="i578f5574593f4ae99f69ac675bbba2b7_I20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001656472</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:NoncontrollingInterestMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-03-31</instant>
        </period>
    </context>
    <context id="i672ae438d5904d3aa27f245b59e5ba4c_I20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001656472</identifier>
        </entity>
        <period>
            <instant>2021-03-31</instant>
        </period>
    </context>
    <context id="i932ec7c01594418eb95662a351e601a2_D20210401-20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001656472</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-04-01</startDate>
            <endDate>2021-06-30</endDate>
        </period>
    </context>
    <context id="ia4656c8d89cf4a84bdd02d8823c897bb_D20210401-20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001656472</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-04-01</startDate>
            <endDate>2021-06-30</endDate>
        </period>
    </context>
    <context id="i9a1c715fbcf44b979e7e0fcb5928d719_D20210401-20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001656472</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-04-01</startDate>
            <endDate>2021-06-30</endDate>
        </period>
    </context>
    <context id="i8e7f3ff52d71479293ec038396352775_D20210401-20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001656472</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:NoncontrollingInterestMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-04-01</startDate>
            <endDate>2021-06-30</endDate>
        </period>
    </context>
    <context id="i4e1c8fe7ad9241eaa0d77b74d41be015_D20210401-20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001656472</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-04-01</startDate>
            <endDate>2021-06-30</endDate>
        </period>
    </context>
    <context id="i1d565c32dabc40c08d36232dec1a7779_I20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001656472</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-06-30</instant>
        </period>
    </context>
    <context id="ibbfd3d5a9feb460a8f0fe21cf2539d79_I20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001656472</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-06-30</instant>
        </period>
    </context>
    <context id="i5b5acb4a63db4a419bb0b3e0c4a24492_I20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001656472</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-06-30</instant>
        </period>
    </context>
    <context id="i7d990708cda34586a3e37a53dd59fb03_I20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001656472</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-06-30</instant>
        </period>
    </context>
    <context id="i64458da0ec424fd8a6faf87d69636ecd_I20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001656472</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:NoncontrollingInterestMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-06-30</instant>
        </period>
    </context>
    <context id="id078e2f741bd40b185fe15fe9cf71aa0_I20200331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001656472</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-03-31</instant>
        </period>
    </context>
    <context id="i3168099a593240dc9af0efd91a744144_I20200331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001656472</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-03-31</instant>
        </period>
    </context>
    <context id="i6c7b98afcbdf46659d197205a453981e_I20200331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001656472</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-03-31</instant>
        </period>
    </context>
    <context id="i7f15d7e0c5e448758e421628b06b233f_I20200331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001656472</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-03-31</instant>
        </period>
    </context>
    <context id="i03a4fd9ba8c844bea0cc0519e18e1383_I20200331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001656472</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:NoncontrollingInterestMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-03-31</instant>
        </period>
    </context>
    <context id="i3c0f68bcd0b6498c90c48a6506a0b9e3_I20200331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001656472</identifier>
        </entity>
        <period>
            <instant>2020-03-31</instant>
        </period>
    </context>
    <context id="i6d595f441a124fe6a1a07ecf8f23ee48_D20200401-20200630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001656472</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-04-01</startDate>
            <endDate>2020-06-30</endDate>
        </period>
    </context>
    <context id="ic52bfb3ca2d34600a199a8873b1c09c0_D20200401-20200630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001656472</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-04-01</startDate>
            <endDate>2020-06-30</endDate>
        </period>
    </context>
    <context id="ie91f1ea24b414f65af58207f3d177f44_D20200401-20200630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001656472</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-04-01</startDate>
            <endDate>2020-06-30</endDate>
        </period>
    </context>
    <context id="i3bd28b951b5141a3ac4946bb9c8d4486_D20200401-20200630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001656472</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:NoncontrollingInterestMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-04-01</startDate>
            <endDate>2020-06-30</endDate>
        </period>
    </context>
    <context id="i7d089148856645de804437e1aae7cf7a_D20200401-20200630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001656472</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-04-01</startDate>
            <endDate>2020-06-30</endDate>
        </period>
    </context>
    <context id="i7b64ecf012bd43b397dcea9317f0673b_I20200630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001656472</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-06-30</instant>
        </period>
    </context>
    <context id="if06bdc9d2d5b40ca88594d8c716a000d_I20200630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001656472</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-06-30</instant>
        </period>
    </context>
    <context id="ibd5f91f865b44c90b9aab2e68420d292_I20200630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001656472</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-06-30</instant>
        </period>
    </context>
    <context id="ib7db517c67504b3baeead491589a7ed6_I20200630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001656472</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-06-30</instant>
        </period>
    </context>
    <context id="i87ce495c26b34c268c848a2934ad3f39_I20200630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001656472</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:NoncontrollingInterestMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-06-30</instant>
        </period>
    </context>
    <context id="id670dc9b33e6430f9d7510009f7495a7_I20200630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001656472</identifier>
        </entity>
        <period>
            <instant>2020-06-30</instant>
        </period>
    </context>
    <context id="i89f360b9f95a44cea98ec721cc461ecf_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001656472</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="idaa77962d21a4f8ca12568eede000e4f_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001656472</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i6710ab378a79438f94aa90687467e6f3_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001656472</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="ib7805645a77f444aa3190c257d456437_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001656472</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="ie669a3c1e1ca4bd8acd069f0187ca14a_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001656472</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:NoncontrollingInterestMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i52c9b3fb67014eb083670c6a1d51b149_D20210101-20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001656472</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-06-30</endDate>
        </period>
    </context>
    <context id="i32ce7a4cf9fe4b5fb2ba774cbeb3025e_D20210101-20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001656472</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-06-30</endDate>
        </period>
    </context>
    <context id="i24b7b1f487f24a12927c251dc2cc0562_D20210101-20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001656472</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-06-30</endDate>
        </period>
    </context>
    <context id="if8ae25ba0a1c4efd878426d129e53e7b_D20210101-20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001656472</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:NoncontrollingInterestMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-06-30</endDate>
        </period>
    </context>
    <context id="if19cdb6b9f6f463e8cdd761179f9db89_D20210101-20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001656472</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-06-30</endDate>
        </period>
    </context>
    <context id="ibec8035afed7413580a92eb6c685b162_I20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001656472</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="i22d6ccbfd09c4945825d9d9eccef7a82_I20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001656472</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="i5e450cfb71c44415b401ef2a8c9b958a_I20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001656472</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="i4dec53ede4f44421a40be0b4d3eb49a6_I20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001656472</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="ic0274d7a972e4964b3d0fca8bddf9b4c_I20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001656472</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:NoncontrollingInterestMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="ie4fc90ad6d7f4d39aea9cb65c8026e09_I20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001656472</identifier>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="ief0b929c9a76458b843a186c4b2a71f2_D20200101-20200630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001656472</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-06-30</endDate>
        </period>
    </context>
    <context id="ie28d03ed3f6c447e8db8badbe540043f_D20200101-20200630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001656472</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-06-30</endDate>
        </period>
    </context>
    <context id="i26b7daea50264418b7767fc75a7923c2_D20200101-20200630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001656472</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-06-30</endDate>
        </period>
    </context>
    <context id="i7c11393ac61249f3805d21818892a170_D20200101-20200630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001656472</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:NoncontrollingInterestMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-06-30</endDate>
        </period>
    </context>
    <context id="ifa1d8c60d03c4b2d83a1d0b04dad4282_D20200101-20200630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001656472</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-06-30</endDate>
        </period>
    </context>
    <context id="i52d0636c66ed4ea58c20dfcc9a4132e8_I20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001656472</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis">cron:CronosAustraliaLimitedMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-06-30</instant>
        </period>
    </context>
    <context id="i6506a062286b47c0b48f06151d87d9e6_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001656472</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RestatementAxis">srt:RevisionOfPriorPeriodErrorCorrectionAdjustmentMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ErrorCorrectionsAndPriorPeriodAdjustmentsRestatementByRestatementPeriodAndAmountAxis">cron:ErrorRelatedToWithholdingTaxesOnTheNetExerciseOfStockOptionsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="ic583ba915ef943c8be4157a2a9ead807_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001656472</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RestatementAxis">srt:RevisionOfPriorPeriodErrorCorrectionAdjustmentMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ErrorCorrectionsAndPriorPeriodAdjustmentsRestatementByRestatementPeriodAndAmountAxis">cron:ErrorRelatedToExerciseOfTopUpRightsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="ice66d39b8cf24a6b82c9c3c91f87fece_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001656472</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RestatementAxis">srt:RevisionOfPriorPeriodErrorCorrectionAdjustmentMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ErrorCorrectionsAndPriorPeriodAdjustmentsRestatementByRestatementPeriodAndAmountAxis">cron:ErrorRelatedToExerciseOfTopUpRightsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i71f353c527264f29bc7b447983a0f96b_I20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001656472</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RestatementAxis">srt:RevisionOfPriorPeriodErrorCorrectionAdjustmentMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ErrorCorrectionsAndPriorPeriodAdjustmentsRestatementByRestatementPeriodAndAmountAxis">cron:ErrorRelatedToExerciseOfTopUpRightsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-03-31</instant>
        </period>
    </context>
    <context id="ib02278c2b0d7400b81a88f77d9b1d053_D20210101-20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001656472</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RestatementAxis">srt:RevisionOfPriorPeriodErrorCorrectionAdjustmentMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ErrorCorrectionsAndPriorPeriodAdjustmentsRestatementByRestatementPeriodAndAmountAxis">cron:ErrorRelatedToExerciseOfTopUpRightsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-03-31</endDate>
        </period>
    </context>
    <context id="i2c5e7037ffad4b3fb6a481d2db070fa0_D20180614-20180614">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001656472</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidatedEntitiesAxis">us-gaap:VariableInterestEntityNotPrimaryBeneficiaryMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis">cron:CronosGrowingCompanyInc.Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2018-06-14</startDate>
            <endDate>2018-06-14</endDate>
        </period>
    </context>
    <context id="i5fb990fe11674db5b7f9322fbc74ed16_D20180313-20180313">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001656472</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidatedEntitiesAxis">us-gaap:VariableInterestEntityNotPrimaryBeneficiaryMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis">cron:MedMenCanadaInc.Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2018-03-13</startDate>
            <endDate>2018-03-13</endDate>
        </period>
    </context>
    <context id="iee8bd06f99704a93846316c2ce890297_D20180313-20180313">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001656472</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidatedEntitiesAxis">us-gaap:VariableInterestEntityNotPrimaryBeneficiaryMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis">cron:MedMenCanadaInc.Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2018-03-13</startDate>
            <endDate>2018-03-13</endDate>
        </period>
    </context>
    <context id="i2dd929bbe65b485fba3ba327ce7e73d7_D20210101-20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001656472</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidatedEntitiesAxis">us-gaap:VariableInterestEntityNotPrimaryBeneficiaryMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis">cron:NatueraMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-06-30</endDate>
        </period>
    </context>
    <context id="i00bf33a48aaa4cf2930896225af28659_I20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001656472</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidatedEntitiesAxis">us-gaap:VariableInterestEntityNotPrimaryBeneficiaryMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis">cron:CannasoulAnalyticsLtdMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis">us-gaap:LoansReceivableMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">us-gaap:CollaborativeArrangementTransactionWithPartyToCollaborativeArrangementMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="cron:LoanReceivableNameAxis">cron:CannasoulCollaborationLoanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-06-30</instant>
        </period>
    </context>
    <context id="ic24b8af14f4a4a25a1f88b1707e38fa7_D20210101-20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001656472</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidatedEntitiesAxis">us-gaap:VariableInterestEntityNotPrimaryBeneficiaryMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis">cron:CannasoulAnalyticsLtdMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis">us-gaap:LoansReceivableMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">us-gaap:CollaborativeArrangementTransactionWithPartyToCollaborativeArrangementMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="cron:LoanReceivableNameAxis">cron:CannasoulCollaborationLoanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-06-30</endDate>
        </period>
    </context>
    <context id="i5822a176b17c44938c5acb5edec46594_I20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001656472</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidatedEntitiesAxis">us-gaap:VariableInterestEntityNotPrimaryBeneficiaryMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis">cron:CannasoulAnalyticsLtdMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">us-gaap:CollaborativeArrangementTransactionWithPartyToCollaborativeArrangementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-06-30</instant>
        </period>
    </context>
    <context id="i78252faeeac94cf1b00fbbab110c7bb8_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001656472</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis">cron:CronosAustraliaLimitedMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i994476164a994f30beee53e661ac1a3f_I20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001656472</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis">cron:CronosGrowingCompanyInc.Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-06-30</instant>
        </period>
    </context>
    <context id="i1b2c600c66ab4356a1aaf56482c504bd_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001656472</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis">cron:CronosGrowingCompanyInc.Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i21b51b5045c34ad2a57cb43054dca216_I20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001656472</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis">cron:NatueraMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-06-30</instant>
        </period>
    </context>
    <context id="i223bb2102d6d47b4988c830f7fa1a159_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001656472</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis">cron:NatueraMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i3851bec177234bbb9f9d96a1e3eab1d3_D20210401-20210401">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001656472</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis">us-gaap:LoansReceivableMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="cron:LoanReceivableNameAxis">cron:NatuEraSeriesALoanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-04-01</startDate>
            <endDate>2021-04-01</endDate>
        </period>
    </context>
    <context id="i8b8f1fc37db0427b9d081e7b40a48cc0_I20210401">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001656472</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis">us-gaap:LoansReceivableMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="cron:LoanReceivableNameAxis">cron:NatuEraSeriesALoanMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">cron:CronosGroupInc.Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-04-01</instant>
        </period>
    </context>
    <context id="ia926bcff688b4febb81d8fa1a08955dc_I20210401">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001656472</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis">us-gaap:LoansReceivableMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="cron:LoanReceivableNameAxis">cron:NatuEraSeriesALoanMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">cron:AgroideaMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-04-01</instant>
        </period>
    </context>
    <context id="i3734fffa32be45c299b65b62d227d165_D20210401-20210401">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001656472</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis">us-gaap:LoansReceivableMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="cron:LoanReceivableNameAxis">cron:NatuEraSeriesALoanMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">cron:CronosGroupInc.Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-04-01</startDate>
            <endDate>2021-04-01</endDate>
        </period>
    </context>
    <context id="ibb17976a662245c78f9ece050fbca040_D20210401-20210401">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001656472</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis">us-gaap:LoansReceivableMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="cron:LoanReceivableNameAxis">cron:NatuEraSeriesALoanMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">cron:AgroideaMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-04-01</startDate>
            <endDate>2021-04-01</endDate>
        </period>
    </context>
    <context id="i74feb9a5e3ba4f03b6af6468c854d7d3_I20210401">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001656472</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis">us-gaap:LoansReceivableMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="cron:LoanReceivableNameAxis">cron:NatuEraSeriesALoanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-04-01</instant>
        </period>
    </context>
    <context id="i30bada16350b499487452cc45133a766_D20210401-20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001656472</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis">cron:CronosAustraliaLimitedMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-04-01</startDate>
            <endDate>2021-06-30</endDate>
        </period>
    </context>
    <context id="if1b554f135154a859f4b34c7f4f919c1_D20200401-20200630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001656472</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis">cron:CronosAustraliaLimitedMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-04-01</startDate>
            <endDate>2020-06-30</endDate>
        </period>
    </context>
    <context id="id0c3e6d83e194fea9819a119d3744bb2_D20210101-20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001656472</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis">cron:CronosAustraliaLimitedMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-06-30</endDate>
        </period>
    </context>
    <context id="ia01f832913b34cc9857827304dc28007_D20200101-20200630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001656472</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis">cron:CronosAustraliaLimitedMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-06-30</endDate>
        </period>
    </context>
    <context id="ia802a14b03cd4f04a97ecbdec57e7b1f_D20210401-20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001656472</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis">cron:CronosGrowingCompanyInc.Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-04-01</startDate>
            <endDate>2021-06-30</endDate>
        </period>
    </context>
    <context id="iddbb1b3540664f4db9ee13a36913a70f_D20200401-20200630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001656472</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis">cron:CronosGrowingCompanyInc.Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-04-01</startDate>
            <endDate>2020-06-30</endDate>
        </period>
    </context>
    <context id="i9f733a1140c84f8286365160805bda02_D20210101-20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001656472</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis">cron:CronosGrowingCompanyInc.Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-06-30</endDate>
        </period>
    </context>
    <context id="i747cf8446c5d4312bef9db8f92ed86e7_D20200101-20200630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001656472</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis">cron:CronosGrowingCompanyInc.Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-06-30</endDate>
        </period>
    </context>
    <context id="i09025c29bd8b4bf4aa6255cec7a052f9_D20210401-20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001656472</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis">cron:NatueraMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-04-01</startDate>
            <endDate>2021-06-30</endDate>
        </period>
    </context>
    <context id="i9c2dea6ae084465eb492033eb5079812_D20200401-20200630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001656472</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis">cron:NatueraMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-04-01</startDate>
            <endDate>2020-06-30</endDate>
        </period>
    </context>
    <context id="i1d33f1b94b814dde969a15e41c194555_D20210101-20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001656472</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis">cron:NatueraMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-06-30</endDate>
        </period>
    </context>
    <context id="ia3632b75442e4ecab5344b972f4835a5_D20200101-20200630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001656472</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis">cron:NatueraMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-06-30</endDate>
        </period>
    </context>
    <context id="i0a6f7aeaf7984695bd038544768f44ce_D20210101-20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001656472</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidatedEntitiesAxis">us-gaap:VariableInterestEntityNotPrimaryBeneficiaryMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis">cron:CronosAustraliaLimitedMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-06-30</endDate>
        </period>
    </context>
    <context id="i9b8aec0ea4404ec8b5d82299348089bf_I20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001656472</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidatedEntitiesAxis">us-gaap:VariableInterestEntityNotPrimaryBeneficiaryMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis">cron:CronosAustraliaLimitedMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-06-30</instant>
        </period>
    </context>
    <context id="i66749f2799dd4940bef71ca978540e57_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001656472</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidatedEntitiesAxis">us-gaap:VariableInterestEntityNotPrimaryBeneficiaryMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis">cron:CronosAustraliaLimitedMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="if3db2c911124490fab5cdb3084df56db_D20210101-20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001656472</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidatedEntitiesAxis">us-gaap:VariableInterestEntityNotPrimaryBeneficiaryMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis">cron:CronosGrowingCompanyInc.Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-06-30</endDate>
        </period>
    </context>
    <context id="i353124414ba44af49353f31dc922db70_I20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001656472</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidatedEntitiesAxis">us-gaap:VariableInterestEntityNotPrimaryBeneficiaryMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis">cron:CronosGrowingCompanyInc.Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-06-30</instant>
        </period>
    </context>
    <context id="i3afecd33173246f185a69d63285abf8c_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001656472</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidatedEntitiesAxis">us-gaap:VariableInterestEntityNotPrimaryBeneficiaryMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis">cron:CronosGrowingCompanyInc.Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="ie2fdd9071c2c4923bce9ab671e6af04d_D20210101-20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001656472</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidatedEntitiesAxis">us-gaap:VariableInterestEntityNotPrimaryBeneficiaryMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis">cron:MedMenCanadaInc.Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-06-30</endDate>
        </period>
    </context>
    <context id="ib9811da8a9704222a0df27a3f63f596b_I20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001656472</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidatedEntitiesAxis">us-gaap:VariableInterestEntityNotPrimaryBeneficiaryMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis">cron:MedMenCanadaInc.Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-06-30</instant>
        </period>
    </context>
    <context id="iaaa05d4ed8b34a308235a68b7882864c_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001656472</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidatedEntitiesAxis">us-gaap:VariableInterestEntityNotPrimaryBeneficiaryMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis">cron:MedMenCanadaInc.Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i3b3152f5409c4a70870bd6f4cb775dd4_D20210101-20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001656472</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidatedEntitiesAxis">us-gaap:VariableInterestEntityNotPrimaryBeneficiaryMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis">cron:NatuEraMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-06-30</endDate>
        </period>
    </context>
    <context id="ibda190acea7645e2a6859c2bdb2fc787_I20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001656472</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidatedEntitiesAxis">us-gaap:VariableInterestEntityNotPrimaryBeneficiaryMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis">cron:NatuEraMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-06-30</instant>
        </period>
    </context>
    <context id="i390d021c539343388dd3edb041b0e9aa_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001656472</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidatedEntitiesAxis">us-gaap:VariableInterestEntityNotPrimaryBeneficiaryMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis">cron:NatuEraMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="ic4e23b56bd44457695de2dfbd9a6ce67_D20210614-20210614">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001656472</identifier>
            <segment>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">cron:PharmacannMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-06-14</startDate>
            <endDate>2021-06-14</endDate>
        </period>
    </context>
    <context id="iaa37e41bb48a45ae9333902e59ee2719_I20210614">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001656472</identifier>
        </entity>
        <period>
            <instant>2021-06-14</instant>
        </period>
    </context>
    <context id="ibd87bb26d08f46e4bfa11a80236a610a_D20210614-20210614">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001656472</identifier>
        </entity>
        <period>
            <startDate>2021-06-14</startDate>
            <endDate>2021-06-14</endDate>
        </period>
    </context>
    <context id="i7e8821bb92b54aa5a40ec87007ddd06a_I20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001656472</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis">us-gaap:LoansReceivableMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="cron:LoanReceivableNameAxis">cron:NatuEraSeriesALoanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-06-30</instant>
        </period>
    </context>
    <context id="ic0f4e3758c364fee99c468147d904bdc_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001656472</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis">us-gaap:LoansReceivableMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="cron:LoanReceivableNameAxis">cron:NatuEraSeriesALoanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i4d5e5ad8b8c04f0e81c4f56d20dd2667_I20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001656472</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis">us-gaap:LoansReceivableMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="cron:LoanReceivableNameAxis">cron:CronosGrowCoCreditFacilityMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-06-30</instant>
        </period>
    </context>
    <context id="i389408e323054f34bb2d44166886cfa0_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001656472</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis">us-gaap:LoansReceivableMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="cron:LoanReceivableNameAxis">cron:CronosGrowCoCreditFacilityMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i0709927d1c004766b70bf1b85ffbd9b2_I20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001656472</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis">us-gaap:LoansReceivableMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-06-30</instant>
        </period>
    </context>
    <context id="i830d314bf026450e8e38d200944077bf_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001656472</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis">us-gaap:LoansReceivableMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i6c507204183f49389291963dff6d55c3_I20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001656472</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis">us-gaap:LoansReceivableMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="cron:LoanReceivableNameAxis">cron:A2645485OntarioInc.MucciPromissoryNoteMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-06-30</instant>
        </period>
    </context>
    <context id="i09921e492ba24195a2e19b52c026c6f7_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001656472</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis">us-gaap:LoansReceivableMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="cron:LoanReceivableNameAxis">cron:A2645485OntarioInc.MucciPromissoryNoteMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i49f2e1595c1b41f4bcbef6f1031a9d69_I20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001656472</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis">us-gaap:LoansReceivableMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="cron:LoanReceivableNameAxis">cron:CannasoulCollaborationLoanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-06-30</instant>
        </period>
    </context>
    <context id="i7c3fa2a3ef8f464583be7da8ce8425ee_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001656472</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis">us-gaap:LoansReceivableMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="cron:LoanReceivableNameAxis">cron:CannasoulCollaborationLoanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i41fdc77f9612409ab114fbdf3c20b8a8_D20210101-20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001656472</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis">us-gaap:LoansReceivableMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="cron:LoanReceivableNameAxis">cron:CronosGrowCoCreditFacilityMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-06-30</endDate>
        </period>
    </context>
    <context id="i2873575c69e24565bb61cd0985446112_D20190101-20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001656472</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis">us-gaap:LoansReceivableMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="cron:LoanReceivableNameAxis">cron:CronosGrowCoCreditFacilityMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-01-01</startDate>
            <endDate>2019-12-31</endDate>
        </period>
    </context>
    <context id="ifdf5fbc8e97845b297aa6f44576063c3_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001656472</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidatedEntitiesAxis">us-gaap:VariableInterestEntityNotPrimaryBeneficiaryMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis">cron:CannasoulAnalyticsLtdMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis">us-gaap:LoansReceivableMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">us-gaap:CollaborativeArrangementTransactionWithPartyToCollaborativeArrangementMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="cron:LoanReceivableNameAxis">cron:CannasoulCollaborationLoanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i74b9dd5702d7406d891cf47a54534f5d_D20190308-20190308">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001656472</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">cron:AltriaInvestmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-03-08</startDate>
            <endDate>2019-03-08</endDate>
        </period>
    </context>
    <context id="i0e42c55484f24f8ca353ad7f388b4066_D20190308-20190308">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001656472</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">cron:AltriaWarrantMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-03-08</startDate>
            <endDate>2019-03-08</endDate>
        </period>
    </context>
    <context id="idadea534a9454dde961a3571663d9316_I20190308">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001656472</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis">cron:CronosGroupInc.Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">cron:AltriaGroupInc.Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-03-08</instant>
        </period>
    </context>
    <context id="i12a4ebb046d84e5b9eb27c82479f837b_I20190308">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001656472</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidatedEntitiesAxis">srt:SubsidiariesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">cron:AltriaGroupInc.Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-03-08</instant>
        </period>
    </context>
    <context id="i0a23fd4d2173473387281b095562f1e0_I20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001656472</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis">cron:CronosGroupInc.Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">cron:AltriaGroupInc.Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-06-30</instant>
        </period>
    </context>
    <context id="iff243ffb3690436c962f2508a95b9bf9_I20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001656472</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidatedEntitiesAxis">srt:SubsidiariesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">cron:AltriaGroupInc.Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-06-30</instant>
        </period>
    </context>
    <context id="iab341b8979a347a9b96abc3a20faff60_I20190308">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001656472</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">cron:AltriaInvestmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-03-08</instant>
        </period>
    </context>
    <context id="i5b5f21f6057c4e8e893d9e27815ea92a_I20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001656472</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">cron:AltriaInvestmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-06-30</instant>
        </period>
    </context>
    <context id="i1d456d0e4fcf43c6ad21f99b40cbf279_I20190308">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001656472</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">cron:AltriaWarrantMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-03-08</instant>
        </period>
    </context>
    <context id="i379e3f598bfc45909cc782ee94752221_I20190308">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001656472</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">cron:PreemptiveRightsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-03-08</instant>
        </period>
    </context>
    <context id="i92e07d954a1e4dc78f61eca5784be099_D20190308-20190308">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001656472</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">cron:TopupRightsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-03-08</startDate>
            <endDate>2019-03-08</endDate>
        </period>
    </context>
    <context id="i5c3db268f31b4ec899f7f0121d0b1bf8_I20190308">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001656472</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">cron:TopupRightsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-03-08</instant>
        </period>
    </context>
    <context id="i7456fc9f9bac466e8f36318a7f2e0986_I20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001656472</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">cron:AltriaWarrantMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-03-31</instant>
        </period>
    </context>
    <context id="iecf64aa815654085bee554811ab6f80e_D20210401-20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001656472</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">cron:AltriaWarrantMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-04-01</startDate>
            <endDate>2021-06-30</endDate>
        </period>
    </context>
    <context id="i34995f47e8ba418fbd529b2ed52790dc_I20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001656472</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">cron:AltriaWarrantMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-06-30</instant>
        </period>
    </context>
    <context id="i626147251ce249d59dd6e68a90196f38_I20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001656472</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">cron:PreemptiveRightsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-03-31</instant>
        </period>
    </context>
    <context id="i8c832bd4137248cb9777e42d7526fc6e_D20210401-20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001656472</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">cron:PreemptiveRightsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-04-01</startDate>
            <endDate>2021-06-30</endDate>
        </period>
    </context>
    <context id="ie4ec3b642b3b4457b78cb85e8d1838f0_I20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001656472</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">cron:PreemptiveRightsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-06-30</instant>
        </period>
    </context>
    <context id="i38d49776600045c1b8110dc70e805025_I20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001656472</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">cron:TopupRightsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-03-31</instant>
        </period>
    </context>
    <context id="i03741f2ae4674980813a9701e43f6a2b_D20210401-20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001656472</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">cron:TopupRightsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-04-01</startDate>
            <endDate>2021-06-30</endDate>
        </period>
    </context>
    <context id="ia2cd5cb93e97428dabd7e841eee51895_I20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001656472</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">cron:TopupRightsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-06-30</instant>
        </period>
    </context>
    <context id="if715f02149d34306825baa5114765cba_I20200331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001656472</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">cron:AltriaWarrantMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-03-31</instant>
        </period>
    </context>
    <context id="i1b9a300b5b514425a64d7bc17abb0931_D20200401-20200630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001656472</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">cron:AltriaWarrantMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-04-01</startDate>
            <endDate>2020-06-30</endDate>
        </period>
    </context>
    <context id="i69563d705edd465aabff3c895c85c313_I20200630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001656472</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">cron:AltriaWarrantMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-06-30</instant>
        </period>
    </context>
    <context id="id9dedf3ba4bb445d8d76440d2f0ce670_I20200331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001656472</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">cron:PreemptiveRightsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-03-31</instant>
        </period>
    </context>
    <context id="ifc3c6e8680594375afc563066129c544_D20200401-20200630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001656472</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">cron:PreemptiveRightsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-04-01</startDate>
            <endDate>2020-06-30</endDate>
        </period>
    </context>
    <context id="i08475478dc1e46759179fb5a161607ba_I20200630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001656472</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">cron:PreemptiveRightsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-06-30</instant>
        </period>
    </context>
    <context id="i6e6227af7d3b47f5a13d2cf8fabe34f8_I20200331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001656472</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">cron:TopupRightsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-03-31</instant>
        </period>
    </context>
    <context id="iab54aa6542634043937616e303d80df7_D20200401-20200630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001656472</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">cron:TopupRightsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-04-01</startDate>
            <endDate>2020-06-30</endDate>
        </period>
    </context>
    <context id="i1cd84431f8574b82a2e542790c822e83_I20200630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001656472</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">cron:TopupRightsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-06-30</instant>
        </period>
    </context>
    <context id="i386ef852060640f8a03a30f10d03a1cd_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001656472</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">cron:AltriaWarrantMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i45890500f835452a848efa1f84799c48_D20210101-20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001656472</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">cron:AltriaWarrantMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-06-30</endDate>
        </period>
    </context>
    <context id="i72ce1ade65834a50bf4468cde26bf617_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001656472</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">cron:PreemptiveRightsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i94f8ae36db664c2bbb298d6c3f5792c3_D20210101-20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001656472</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">cron:PreemptiveRightsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-06-30</endDate>
        </period>
    </context>
    <context id="if0aa3f5449da461c85f0c0831bf3c984_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001656472</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">cron:TopupRightsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i10b0581e8a9b40e0a1e14e14bcc22d54_D20210101-20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001656472</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">cron:TopupRightsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-06-30</endDate>
        </period>
    </context>
    <context id="i006bb3bd444d41edb5d292ff7ec0668f_I20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001656472</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">cron:AltriaWarrantMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="i19c47df0e3634358808ebcc68facfcde_D20200101-20200630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001656472</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">cron:AltriaWarrantMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-06-30</endDate>
        </period>
    </context>
    <context id="id3abf03099174cf38da9a24a053a4f90_I20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001656472</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">cron:PreemptiveRightsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="idc180b21ce4e4eefa7a1a4ccdb9ba7a9_D20200101-20200630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001656472</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">cron:PreemptiveRightsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-06-30</endDate>
        </period>
    </context>
    <context id="i4edcd0f0354740008d30a06bac0ea0bb_I20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001656472</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">cron:TopupRightsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="ia9cf8032e9f7433cb50aee032c5b988b_D20200101-20200630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001656472</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">cron:TopupRightsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-06-30</endDate>
        </period>
    </context>
    <context id="i1257ed1c2bd045fbb8c920b7a673a2bc_I20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001656472</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">cron:AltriaWarrantMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:MeasurementInputTypeAxis">us-gaap:MeasurementInputSharePriceMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-06-30</instant>
        </period>
    </context>
    <context id="id354e82bb28e4e4f86ca8adb1f07698c_I20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001656472</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">cron:PreemptiveRightsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:MeasurementInputTypeAxis">us-gaap:MeasurementInputSharePriceMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-06-30</instant>
        </period>
    </context>
    <context id="i63dea78d92f24ac5a2eef5b4454a6dd3_I20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001656472</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">cron:TopupRightsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:MeasurementInputTypeAxis">us-gaap:MeasurementInputSharePriceMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-06-30</instant>
        </period>
    </context>
    <context id="i3353e98ec8c146078a9728dd2c05959d_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001656472</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">cron:AltriaWarrantMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:MeasurementInputTypeAxis">us-gaap:MeasurementInputSharePriceMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i5b7f2fd4ed2c48b588a6b20efe0642c9_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001656472</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">cron:PreemptiveRightsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:MeasurementInputTypeAxis">us-gaap:MeasurementInputSharePriceMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i4a625e9a51bd4f19acfab304939f7b6d_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001656472</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">cron:TopupRightsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:MeasurementInputTypeAxis">us-gaap:MeasurementInputSharePriceMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i339cf0904cfb4c7199ff22f9b0f89460_I20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001656472</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">cron:AltriaWarrantMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:MeasurementInputTypeAxis">cron:MeasurementInputSubscriptionPriceMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-06-30</instant>
        </period>
    </context>
    <context id="ic23329598e00476e92f1af90f155a47c_I20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001656472</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">cron:PreemptiveRightsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:MeasurementInputTypeAxis">cron:MeasurementInputSubscriptionPriceMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-06-30</instant>
        </period>
    </context>
    <context id="i579c24557a25415ab76670fb8c125152_I20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001656472</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">cron:TopupRightsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:MeasurementInputTypeAxis">cron:MeasurementInputSubscriptionPriceMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-06-30</instant>
        </period>
    </context>
    <context id="ib2597206a68d439e9d9fb442a0edbf09_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001656472</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">cron:AltriaWarrantMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:MeasurementInputTypeAxis">cron:MeasurementInputSubscriptionPriceMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="if7010204491b4497933eebbdfcad9d26_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001656472</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">cron:PreemptiveRightsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:MeasurementInputTypeAxis">cron:MeasurementInputSubscriptionPriceMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i26b4cc1b2d2c4abcb74127a35c819ef3_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001656472</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">cron:TopupRightsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:MeasurementInputTypeAxis">cron:MeasurementInputSubscriptionPriceMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i88181468f4494137aa775f1e418165d7_I20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001656472</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:WeightedAverageMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">cron:AltriaWarrantMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:MeasurementInputTypeAxis">us-gaap:MeasurementInputRiskFreeInterestRateMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-06-30</instant>
        </period>
    </context>
    <context id="ic12d47490ce74a188ddc34240b7f1bea_I20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001656472</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:WeightedAverageMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">cron:PreemptiveRightsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:MeasurementInputTypeAxis">us-gaap:MeasurementInputRiskFreeInterestRateMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-06-30</instant>
        </period>
    </context>
    <context id="i6100f128578c4248a96b36db6968b813_I20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001656472</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:WeightedAverageMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">cron:TopupRightsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:MeasurementInputTypeAxis">us-gaap:MeasurementInputRiskFreeInterestRateMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-06-30</instant>
        </period>
    </context>
    <context id="i23edb2809b3b4515a9b05b50daa96971_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001656472</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:WeightedAverageMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">cron:AltriaWarrantMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:MeasurementInputTypeAxis">us-gaap:MeasurementInputRiskFreeInterestRateMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="ida0e51f36f7241508ea9f1cb51fab77b_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001656472</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:WeightedAverageMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">cron:PreemptiveRightsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:MeasurementInputTypeAxis">us-gaap:MeasurementInputRiskFreeInterestRateMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i1779eecf81de47219b6cdc404ab734e6_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001656472</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:WeightedAverageMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">cron:TopupRightsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:MeasurementInputTypeAxis">us-gaap:MeasurementInputRiskFreeInterestRateMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="ic02211497b5b474a8462f60dfc14b91f_D20210101-20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001656472</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:WeightedAverageMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">cron:AltriaWarrantMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:MeasurementInputTypeAxis">us-gaap:MeasurementInputExpectedTermMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-06-30</endDate>
        </period>
    </context>
    <context id="ie494d1760a574e71a32cae2bcd0bc6f2_D20210101-20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001656472</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:WeightedAverageMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">cron:PreemptiveRightsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:MeasurementInputTypeAxis">us-gaap:MeasurementInputExpectedTermMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-06-30</endDate>
        </period>
    </context>
    <context id="id2d2173a25434cd79374e4a7cf5568c2_D20210101-20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001656472</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:WeightedAverageMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">cron:TopupRightsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:MeasurementInputTypeAxis">us-gaap:MeasurementInputExpectedTermMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-06-30</endDate>
        </period>
    </context>
    <context id="i1da031054a504cf79b3d31bfcd7a323a_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001656472</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:WeightedAverageMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">cron:AltriaWarrantMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:MeasurementInputTypeAxis">us-gaap:MeasurementInputExpectedTermMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="i1701f6b7d62b4512bfe98026f74288b7_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001656472</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:WeightedAverageMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">cron:PreemptiveRightsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:MeasurementInputTypeAxis">us-gaap:MeasurementInputExpectedTermMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="i10d7bf0cfd8342e5b54a9ede98d85efa_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001656472</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:WeightedAverageMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">cron:TopupRightsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:MeasurementInputTypeAxis">us-gaap:MeasurementInputExpectedTermMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="if15b10fbb370412cb143458bfa546283_I20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001656472</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">cron:AltriaWarrantMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:MeasurementInputTypeAxis">us-gaap:MeasurementInputPriceVolatilityMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-06-30</instant>
        </period>
    </context>
    <context id="i8c3dd53b7ced472bbe056909c36fa671_I20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001656472</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">cron:PreemptiveRightsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:MeasurementInputTypeAxis">us-gaap:MeasurementInputPriceVolatilityMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-06-30</instant>
        </period>
    </context>
    <context id="ib976b88274494333b0625717658b451c_I20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001656472</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">cron:TopupRightsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:MeasurementInputTypeAxis">us-gaap:MeasurementInputPriceVolatilityMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-06-30</instant>
        </period>
    </context>
    <context id="i3b4e489f4801442fbe965a24c9af5f86_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001656472</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">cron:AltriaWarrantMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:MeasurementInputTypeAxis">us-gaap:MeasurementInputPriceVolatilityMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i57c58eedfb404984b87b46cbe12d3426_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001656472</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">cron:PreemptiveRightsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:MeasurementInputTypeAxis">us-gaap:MeasurementInputPriceVolatilityMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i9859907a6972416e881289ad4a8c7462_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001656472</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">cron:TopupRightsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:MeasurementInputTypeAxis">us-gaap:MeasurementInputPriceVolatilityMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="id612af184d0d4ee8bae904a6cdcdba6f_I20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001656472</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">cron:AltriaWarrantMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:MeasurementInputTypeAxis">us-gaap:MeasurementInputExpectedDividendRateMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-06-30</instant>
        </period>
    </context>
    <context id="id5167c2418bc49d79a29b1d99ae027e1_I20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001656472</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">cron:PreemptiveRightsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:MeasurementInputTypeAxis">us-gaap:MeasurementInputExpectedDividendRateMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-06-30</instant>
        </period>
    </context>
    <context id="i79aea684554446b8864ca220d82ab826_I20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001656472</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">cron:TopupRightsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:MeasurementInputTypeAxis">us-gaap:MeasurementInputExpectedDividendRateMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-06-30</instant>
        </period>
    </context>
    <context id="i50dc22d6133f49688c294c0961ff3e97_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001656472</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">cron:AltriaWarrantMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:MeasurementInputTypeAxis">us-gaap:MeasurementInputExpectedDividendRateMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i6cc1c73280a94f4ab8a8e4826245a4a9_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001656472</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">cron:PreemptiveRightsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:MeasurementInputTypeAxis">us-gaap:MeasurementInputExpectedDividendRateMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="ia1213fa5613b4ccc8ae504fe77e72358_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001656472</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">cron:TopupRightsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:MeasurementInputTypeAxis">us-gaap:MeasurementInputExpectedDividendRateMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i9ca6679fb2564fde8f5c255991b2b07b_I20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001656472</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">cron:PreEmptiveRightsAndTopUpRightsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:MeasurementInputTypeAxis">us-gaap:MeasurementInputRiskFreeInterestRateMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-06-30</instant>
        </period>
    </context>
    <context id="idce1c11532374f46a0debb9127ec0281_I20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001656472</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">cron:PreEmptiveRightsAndTopUpRightsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:MeasurementInputTypeAxis">us-gaap:MeasurementInputRiskFreeInterestRateMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-06-30</instant>
        </period>
    </context>
    <context id="i91e2aab33be84cc8a26bac33aca37a7b_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001656472</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">cron:PreEmptiveRightsAndTopUpRightsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:MeasurementInputTypeAxis">us-gaap:MeasurementInputRiskFreeInterestRateMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="ic5fe8049d90f4163b34bb2524a897f2d_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001656472</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">cron:PreEmptiveRightsAndTopUpRightsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:MeasurementInputTypeAxis">us-gaap:MeasurementInputRiskFreeInterestRateMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i5f97c3a427254d74b99f26c83a33f800_D20210101-20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001656472</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">cron:PreEmptiveRightsAndTopUpRightsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:MeasurementInputTypeAxis">us-gaap:MeasurementInputExpectedTermMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-06-30</endDate>
        </period>
    </context>
    <context id="i404e95ab180846458cdfa503e1b9d618_D20210101-20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001656472</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">cron:PreEmptiveRightsAndTopUpRightsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:MeasurementInputTypeAxis">us-gaap:MeasurementInputExpectedTermMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-06-30</endDate>
        </period>
    </context>
    <context id="i1a39a101965648319dfe223e050e1870_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001656472</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">cron:PreEmptiveRightsAndTopUpRightsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:MeasurementInputTypeAxis">us-gaap:MeasurementInputExpectedTermMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="id736a2abed614a71a7524cefc38e23df_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001656472</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">cron:PreEmptiveRightsAndTopUpRightsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:MeasurementInputTypeAxis">us-gaap:MeasurementInputExpectedTermMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="i1e4726863b724a379f5bd7d27ab5b3cc_D20210401-20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001656472</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-04-01</startDate>
            <endDate>2021-06-30</endDate>
        </period>
    </context>
    <context id="ie0f42dd5b3d34fe38a076491f8d4a0a5_D20200401-20200630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001656472</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-04-01</startDate>
            <endDate>2020-06-30</endDate>
        </period>
    </context>
    <context id="idaf424f34df645f9a313b3cbd11846bb_D20210101-20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001656472</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-06-30</endDate>
        </period>
    </context>
    <context id="ib8a293d71fca4827bbf9cac05f24fe68_D20200101-20200630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001656472</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-06-30</endDate>
        </period>
    </context>
    <context id="ia9e804ad8293416391f6038663c9425b_D20210401-20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001656472</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockUnitsRSUMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-04-01</startDate>
            <endDate>2021-06-30</endDate>
        </period>
    </context>
    <context id="if0a238351a57425a8c0ba03f482ef4b9_D20200401-20200630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001656472</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockUnitsRSUMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-04-01</startDate>
            <endDate>2020-06-30</endDate>
        </period>
    </context>
    <context id="ie5eb2f0b8440403abdac2db9e01adbb9_D20210101-20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001656472</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockUnitsRSUMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-06-30</endDate>
        </period>
    </context>
    <context id="i10cd1c126464402b99bfac52e7ebdbb2_D20200101-20200630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001656472</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockUnitsRSUMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-06-30</endDate>
        </period>
    </context>
    <context id="i3d31fbca3c6044d5bd0e62b05769e769_D20200329-20200329">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001656472</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">cron:A2020OmnibusPlanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-03-29</startDate>
            <endDate>2020-03-29</endDate>
        </period>
    </context>
    <context id="ic0313757b4a149aca72f641901924190_D20200329-20200329">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001656472</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">cron:A2020OmnibusPlanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-03-29</startDate>
            <endDate>2020-03-29</endDate>
        </period>
    </context>
    <context id="i568a7b89865a4c0783608a8f7c7a5fbc_D20200329-20200329">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001656472</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">cron:A2020OmnibusPlanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-03-29</startDate>
            <endDate>2020-03-29</endDate>
        </period>
    </context>
    <context id="iafb1144677d145049a09cbdbb0457c7b_D20200329-20200329">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001656472</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">cron:PriorOptionPlansMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-03-29</startDate>
            <endDate>2020-03-29</endDate>
        </period>
    </context>
    <context id="i689be39a953e4627b86c363090d56882_D20200329-20200329">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001656472</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">cron:PriorOptionPlansMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-03-29</startDate>
            <endDate>2020-03-29</endDate>
        </period>
    </context>
    <context id="i4146f88cdb16474694c2187038fecec2_D20200329-20200329">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001656472</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">cron:PriorOptionPlansMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-03-29</startDate>
            <endDate>2020-03-29</endDate>
        </period>
    </context>
    <context id="i539631cd7950486e81b39a054a00c7d0_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001656472</identifier>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="ic1ac4ebbf39f4d85959a2de4a782f891_D20190101-20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001656472</identifier>
        </entity>
        <period>
            <startDate>2019-01-01</startDate>
            <endDate>2019-12-31</endDate>
        </period>
    </context>
    <context id="ib49e288fbb504210b764575656013515_I20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001656472</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">cron:A2020OmnibusPlanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-06-30</instant>
        </period>
    </context>
    <context id="i940a5cbdd4164d3996cb15eddebf6022_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001656472</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">cron:A2020OmnibusPlanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i71217ccb65f54a46844f4ef961eef8ed_I20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001656472</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">cron:A2018StockOptionPlanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-06-30</instant>
        </period>
    </context>
    <context id="i9901793e0a0c46f483b159aad44d157c_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001656472</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">cron:A2018StockOptionPlanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i67847aa2abfa472593c968c856dcd228_I20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001656472</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">cron:A2015StockOptionPlanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-06-30</instant>
        </period>
    </context>
    <context id="ia6fe44bf977249a2919be8435dfaa9a2_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001656472</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">cron:A2015StockOptionPlanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="iff2854605c9948a0bd946fb90a42d547_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001656472</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockUnitsRSUMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i38f48aaa7a5e481ebe8ebcada37e35a1_I20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001656472</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockUnitsRSUMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-06-30</instant>
        </period>
    </context>
    <context id="i9cd1e43e5a21454dbe1b88627687a079_I20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001656472</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockUnitsRSUMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="i80341dfa258d45e4926f94222e4d5cbc_I20200630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001656472</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockUnitsRSUMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-06-30</instant>
        </period>
    </context>
    <context id="iba2763eff8e446348674f7fa0f12395e_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001656472</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">cron:DeferredShareUnitsDSUsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i4d35a9dc2bff4f0fb74fef37bddc6703_D20210101-20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001656472</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">cron:DeferredShareUnitsDSUsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-06-30</endDate>
        </period>
    </context>
    <context id="i8360952c01a040cc9bbd0c14cc59244b_I20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001656472</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">cron:DeferredShareUnitsDSUsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-06-30</instant>
        </period>
    </context>
    <context id="ia6edd5e8ba094c259649f87d1ff2aa61_I20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001656472</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">cron:DeferredShareUnitsDSUsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="i64c0d8b09be647f1aa0d0ab87e24a14c_D20200101-20200630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001656472</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">cron:DeferredShareUnitsDSUsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-06-30</endDate>
        </period>
    </context>
    <context id="i80be6cf122864924818f07224f0ce952_I20200630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001656472</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">cron:DeferredShareUnitsDSUsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-06-30</instant>
        </period>
    </context>
    <context id="ica96f8af8bfb4c02b4ff8f577beed8a9_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001656472</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:WarrantMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="ic97055dc0db04af88f485b12b96f84c2_D20210101-20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001656472</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:WarrantMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-06-30</endDate>
        </period>
    </context>
    <context id="iaa2e66f5a2c14062bebba1811782ccd6_I20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001656472</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:WarrantMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-06-30</instant>
        </period>
    </context>
    <context id="i5b77d92575e64e2d8a23bebd827ac114_I20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001656472</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:WarrantMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="ie7aae3f01257471596ea0269c60c3885_I20200630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001656472</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:WarrantMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-06-30</instant>
        </period>
    </context>
    <context id="ibfe5b711341a4fa5b15c489835848fe5_D20210401-20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001656472</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:WarrantMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-04-01</startDate>
            <endDate>2021-06-30</endDate>
        </period>
    </context>
    <context id="ife69fdb8512f485a8a3f1f66e868a24d_D20200401-20200630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001656472</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:WarrantMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-04-01</startDate>
            <endDate>2020-06-30</endDate>
        </period>
    </context>
    <context id="i4558c25f511848f29e1d0d9bd1c7f160_D20200101-20200630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001656472</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:WarrantMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-06-30</endDate>
        </period>
    </context>
    <context id="i07a12b37b7f449bd8480c060ef9d4f22_D20210401-20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001656472</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">cron:GinkgoEquityMilestonesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-04-01</startDate>
            <endDate>2021-06-30</endDate>
        </period>
    </context>
    <context id="idb2773cdb0104962851c16f7f574a50e_D20200401-20200630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001656472</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">cron:GinkgoEquityMilestonesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-04-01</startDate>
            <endDate>2020-06-30</endDate>
        </period>
    </context>
    <context id="ibdb85022a38140dab47df2ef46523aed_D20210101-20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001656472</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">cron:GinkgoEquityMilestonesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-06-30</endDate>
        </period>
    </context>
    <context id="i50bf03adb5b742b8bc014c0dff5918e9_D20200101-20200630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001656472</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">cron:GinkgoEquityMilestonesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-06-30</endDate>
        </period>
    </context>
    <context id="i8e9c7b0c611e46879a52eaa6a261c7ee_D20210401-20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001656472</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">cron:PreemptiveRightsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-04-01</startDate>
            <endDate>2021-06-30</endDate>
        </period>
    </context>
    <context id="i0c3ad44a3c0c42b5b2a0e88c68e8f3be_D20200401-20200630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001656472</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">cron:PreemptiveRightsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-04-01</startDate>
            <endDate>2020-06-30</endDate>
        </period>
    </context>
    <context id="i02aad9012d39412c8efa06499f3fe95b_D20210101-20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001656472</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">cron:PreemptiveRightsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-06-30</endDate>
        </period>
    </context>
    <context id="id0d09d3774e94fa7b4f1f095f53f1374_D20200101-20200630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001656472</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">cron:PreemptiveRightsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-06-30</endDate>
        </period>
    </context>
    <context id="ia14076dba9894856b2d1229c872fe727_D20210401-20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001656472</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">cron:TopUpRightsFixedPriceMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-04-01</startDate>
            <endDate>2021-06-30</endDate>
        </period>
    </context>
    <context id="i17878ee04a8b40efa8de800698c7563e_D20200401-20200630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001656472</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">cron:TopUpRightsFixedPriceMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-04-01</startDate>
            <endDate>2020-06-30</endDate>
        </period>
    </context>
    <context id="i0edfc387d99e417686a470edbdd373bd_D20210101-20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001656472</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">cron:TopUpRightsFixedPriceMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-06-30</endDate>
        </period>
    </context>
    <context id="i58fcf006ddda4fa090550e2cab1cbf48_D20200101-20200630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001656472</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">cron:TopUpRightsFixedPriceMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-06-30</endDate>
        </period>
    </context>
    <context id="if80975f641164c358482aa567573519b_D20210401-20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001656472</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">cron:TopUpRightsMarketPriceMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-04-01</startDate>
            <endDate>2021-06-30</endDate>
        </period>
    </context>
    <context id="ie093f63ac9fb4d8581f1cefb3a20923d_D20200401-20200630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001656472</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">cron:TopUpRightsMarketPriceMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-04-01</startDate>
            <endDate>2020-06-30</endDate>
        </period>
    </context>
    <context id="i346164b35069484faf6df727aae40e92_D20210101-20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001656472</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">cron:TopUpRightsMarketPriceMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-06-30</endDate>
        </period>
    </context>
    <context id="if20736234eba41eeb39c9dfe0fe61633_D20200101-20200630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001656472</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">cron:TopUpRightsMarketPriceMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-06-30</endDate>
        </period>
    </context>
    <context id="i1c433475eb1a48afaf0b953876eeacf2_D20210401-20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001656472</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">cron:AltriaWarrantMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-04-01</startDate>
            <endDate>2021-06-30</endDate>
        </period>
    </context>
    <context id="i0f06094e63234299ba9729e0c2d1605e_D20200401-20200630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001656472</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">cron:AltriaWarrantMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-04-01</startDate>
            <endDate>2020-06-30</endDate>
        </period>
    </context>
    <context id="i1f706c52ea2f44629f37471cc5d6d92a_D20210101-20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001656472</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">cron:AltriaWarrantMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-06-30</endDate>
        </period>
    </context>
    <context id="i36bbfa161e6e4ec991260925b4204c65_D20200101-20200630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001656472</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">cron:AltriaWarrantMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-06-30</endDate>
        </period>
    </context>
    <context id="iaa7604cc407b458bade3731989eb0708_D20210401-20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001656472</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-04-01</startDate>
            <endDate>2021-06-30</endDate>
        </period>
    </context>
    <context id="iea37729d5d364d418285846dc945175f_D20200401-20200630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001656472</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-04-01</startDate>
            <endDate>2020-06-30</endDate>
        </period>
    </context>
    <context id="i679dc97e17ab4806a7b6131c4dd48e32_D20210101-20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001656472</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-06-30</endDate>
        </period>
    </context>
    <context id="i967a490799294ef8965b69b6ef9525d8_D20200101-20200630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001656472</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-06-30</endDate>
        </period>
    </context>
    <context id="ic12652ed09474f2eb1b373fa6ef881fd_D20210401-20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001656472</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">us-gaap:WarrantMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-04-01</startDate>
            <endDate>2021-06-30</endDate>
        </period>
    </context>
    <context id="i8c63409f39764b86a65ebcee0efb5293_D20200401-20200630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001656472</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">us-gaap:WarrantMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-04-01</startDate>
            <endDate>2020-06-30</endDate>
        </period>
    </context>
    <context id="iad823a91375044b38784f8b852ef2e86_D20210101-20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001656472</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">us-gaap:WarrantMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-06-30</endDate>
        </period>
    </context>
    <context id="i1cb9167df2d047b58be65b1aada6284d_D20200101-20200630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001656472</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">us-gaap:WarrantMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-06-30</endDate>
        </period>
    </context>
    <context id="i8b031f75a18e4c55ad561843012164a3_D20210401-20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001656472</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">us-gaap:RestrictedStockUnitsRSUMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-04-01</startDate>
            <endDate>2021-06-30</endDate>
        </period>
    </context>
    <context id="i4ae2733b6de04d388d8a96981e02f327_D20200401-20200630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001656472</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">us-gaap:RestrictedStockUnitsRSUMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-04-01</startDate>
            <endDate>2020-06-30</endDate>
        </period>
    </context>
    <context id="if4d517deea8b4c85b4949e8ed9c437c2_D20210101-20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001656472</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">us-gaap:RestrictedStockUnitsRSUMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-06-30</endDate>
        </period>
    </context>
    <context id="i120c7bf7be8a425aa4d5a03318d68bf0_D20200101-20200630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001656472</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">us-gaap:RestrictedStockUnitsRSUMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-06-30</endDate>
        </period>
    </context>
    <context id="ibc692233c14c49be87add169c0e2de75_D20210401-20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001656472</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">cron:CannabisFlowerMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">cron:UnitedStatesSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-04-01</startDate>
            <endDate>2021-06-30</endDate>
        </period>
    </context>
    <context id="i8f2910ecf1ae40e091d358fb8405c9bd_D20210401-20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001656472</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">cron:CannabisFlowerMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">cron:RestOfWorldSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-04-01</startDate>
            <endDate>2021-06-30</endDate>
        </period>
    </context>
    <context id="ia66d704cc8af4a879583109863080207_D20210401-20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001656472</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:CorporateNonSegmentMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">cron:CannabisFlowerMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-04-01</startDate>
            <endDate>2021-06-30</endDate>
        </period>
    </context>
    <context id="i79727dab4c1240ceaa1f07e61bb81188_D20210401-20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001656472</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">cron:CannabisFlowerMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-04-01</startDate>
            <endDate>2021-06-30</endDate>
        </period>
    </context>
    <context id="ibd153928ae104df6b058cc08f14f6f09_D20210401-20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001656472</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">cron:CannabisExtractsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">cron:UnitedStatesSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-04-01</startDate>
            <endDate>2021-06-30</endDate>
        </period>
    </context>
    <context id="i032a3ff320db4a7383246d7d6de2326f_D20210401-20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001656472</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">cron:CannabisExtractsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">cron:RestOfWorldSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-04-01</startDate>
            <endDate>2021-06-30</endDate>
        </period>
    </context>
    <context id="ia76908c59acf4c64acd394bfc6223beb_D20210401-20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001656472</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:CorporateNonSegmentMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">cron:CannabisExtractsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-04-01</startDate>
            <endDate>2021-06-30</endDate>
        </period>
    </context>
    <context id="id339c655bfd341ce947f632c28a7cb54_D20210401-20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001656472</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">cron:CannabisExtractsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-04-01</startDate>
            <endDate>2021-06-30</endDate>
        </period>
    </context>
    <context id="i32838a57ba6c4493badd924366696106_D20210401-20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001656472</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:ProductAndServiceOtherMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">cron:UnitedStatesSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-04-01</startDate>
            <endDate>2021-06-30</endDate>
        </period>
    </context>
    <context id="i6f297f0a314745488d2a9a9e296b5375_D20210401-20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001656472</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:ProductAndServiceOtherMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">cron:RestOfWorldSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-04-01</startDate>
            <endDate>2021-06-30</endDate>
        </period>
    </context>
    <context id="i07bd26499a384059b217b3a61ccfa0a7_D20210401-20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001656472</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:CorporateNonSegmentMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:ProductAndServiceOtherMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-04-01</startDate>
            <endDate>2021-06-30</endDate>
        </period>
    </context>
    <context id="ib7b191b315bf4d3d9c5a469788ccac38_D20210401-20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001656472</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:ProductAndServiceOtherMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-04-01</startDate>
            <endDate>2021-06-30</endDate>
        </period>
    </context>
    <context id="i2a563d1bc1a1451296d5f40e6cdf2912_D20210401-20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001656472</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">cron:UnitedStatesSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-04-01</startDate>
            <endDate>2021-06-30</endDate>
        </period>
    </context>
    <context id="i7b627a38d4bb4b2693a9598ca41f647d_D20210401-20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001656472</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">cron:RestOfWorldSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-04-01</startDate>
            <endDate>2021-06-30</endDate>
        </period>
    </context>
    <context id="ie916e4a685544ae3998d4e82e089944f_D20210401-20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001656472</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:CorporateNonSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-04-01</startDate>
            <endDate>2021-06-30</endDate>
        </period>
    </context>
    <context id="i1afe4ab017a94c08b0390d1c04588202_I20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001656472</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">cron:UnitedStatesSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-06-30</instant>
        </period>
    </context>
    <context id="i14c7d79dc30c40b9a6db30b130c667da_I20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001656472</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">cron:RestOfWorldSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-06-30</instant>
        </period>
    </context>
    <context id="i64489be55285421f8e92af4479a619e6_I20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001656472</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:CorporateNonSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-06-30</instant>
        </period>
    </context>
    <context id="if56e63da868340a8ab5d3b79c974e6b3_D20200401-20200630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001656472</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">cron:CannabisFlowerMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">cron:UnitedStatesSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-04-01</startDate>
            <endDate>2020-06-30</endDate>
        </period>
    </context>
    <context id="i15fc6f263af84b999d8cc92973692fbd_D20200401-20200630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001656472</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">cron:CannabisFlowerMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">cron:RestOfWorldSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-04-01</startDate>
            <endDate>2020-06-30</endDate>
        </period>
    </context>
    <context id="ie5a13f5798a041098fb7986c993831fa_D20200401-20200630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001656472</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:CorporateNonSegmentMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">cron:CannabisFlowerMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-04-01</startDate>
            <endDate>2020-06-30</endDate>
        </period>
    </context>
    <context id="ib1f0e90ff5d24c28ad9bc0faf46f5377_D20200401-20200630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001656472</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">cron:CannabisFlowerMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-04-01</startDate>
            <endDate>2020-06-30</endDate>
        </period>
    </context>
    <context id="ia93117ffad484ba8bac40f47a8a9f804_D20200401-20200630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001656472</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">cron:CannabisExtractsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">cron:UnitedStatesSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-04-01</startDate>
            <endDate>2020-06-30</endDate>
        </period>
    </context>
    <context id="ifab67f8b4459455295c2fdc641d9dc00_D20200401-20200630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001656472</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">cron:CannabisExtractsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">cron:RestOfWorldSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-04-01</startDate>
            <endDate>2020-06-30</endDate>
        </period>
    </context>
    <context id="i59d84c3c73bb412f8ab90480b3f1cacb_D20200401-20200630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001656472</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:CorporateNonSegmentMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">cron:CannabisExtractsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-04-01</startDate>
            <endDate>2020-06-30</endDate>
        </period>
    </context>
    <context id="i2ca82879f2e54a14819f3d3b95640a8e_D20200401-20200630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001656472</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">cron:CannabisExtractsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-04-01</startDate>
            <endDate>2020-06-30</endDate>
        </period>
    </context>
    <context id="i91b1c7740b954489b1fe2f441dc90430_D20200401-20200630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001656472</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:ProductAndServiceOtherMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">cron:UnitedStatesSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-04-01</startDate>
            <endDate>2020-06-30</endDate>
        </period>
    </context>
    <context id="i37138226ae7b45ad97bc4468a768b4b1_D20200401-20200630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001656472</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:ProductAndServiceOtherMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">cron:RestOfWorldSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-04-01</startDate>
            <endDate>2020-06-30</endDate>
        </period>
    </context>
    <context id="id023d0b7d14c4eb9aba0197ea873d120_D20200401-20200630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001656472</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:CorporateNonSegmentMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:ProductAndServiceOtherMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-04-01</startDate>
            <endDate>2020-06-30</endDate>
        </period>
    </context>
    <context id="i8457d33e4cab43daac2e2e1046176545_D20200401-20200630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001656472</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:ProductAndServiceOtherMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-04-01</startDate>
            <endDate>2020-06-30</endDate>
        </period>
    </context>
    <context id="icb85df07ebfc4bfa99c08f8c9f0cb89c_D20200401-20200630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001656472</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">cron:UnitedStatesSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-04-01</startDate>
            <endDate>2020-06-30</endDate>
        </period>
    </context>
    <context id="if83af42553ab4081bf67a6ecab2097fc_D20200401-20200630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001656472</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">cron:RestOfWorldSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-04-01</startDate>
            <endDate>2020-06-30</endDate>
        </period>
    </context>
    <context id="i46e2093507a34f2fa6bcbc19a9aaaa63_D20200401-20200630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001656472</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:CorporateNonSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-04-01</startDate>
            <endDate>2020-06-30</endDate>
        </period>
    </context>
    <context id="i702a586f0ecb4fc1b7bfe544770fb520_I20200630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001656472</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">cron:UnitedStatesSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-06-30</instant>
        </period>
    </context>
    <context id="if4396fb40fd54b7faa91c1e910136a74_I20200630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001656472</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">cron:RestOfWorldSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-06-30</instant>
        </period>
    </context>
    <context id="iad52c8a5170c4f5bbeca5c035dd90f4e_I20200630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001656472</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:CorporateNonSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-06-30</instant>
        </period>
    </context>
    <context id="ia1fd0c77f444432fbb955ee120f3e358_D20210101-20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001656472</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">cron:CannabisFlowerMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">cron:UnitedStatesSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-06-30</endDate>
        </period>
    </context>
    <context id="i1c1529d67f66409e980a87cdbacae6d9_D20210101-20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001656472</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">cron:CannabisFlowerMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">cron:RestOfWorldSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-06-30</endDate>
        </period>
    </context>
    <context id="ifb7f0980f81c42e9b5667c26408eec94_D20210101-20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001656472</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:CorporateNonSegmentMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">cron:CannabisFlowerMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-06-30</endDate>
        </period>
    </context>
    <context id="i3f039d262efd4662b7daf3bd025bd767_D20210101-20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001656472</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">cron:CannabisFlowerMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-06-30</endDate>
        </period>
    </context>
    <context id="i4f7819da7513417abd35056f14170574_D20210101-20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001656472</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">cron:CannabisExtractsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">cron:UnitedStatesSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-06-30</endDate>
        </period>
    </context>
    <context id="i2a692272db324fad8fd9591624ebee99_D20210101-20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001656472</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">cron:CannabisExtractsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">cron:RestOfWorldSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-06-30</endDate>
        </period>
    </context>
    <context id="ic645ffe32db24fe886c9079930540947_D20210101-20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001656472</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:CorporateNonSegmentMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">cron:CannabisExtractsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-06-30</endDate>
        </period>
    </context>
    <context id="i28cc601c4515423c9fb7c740926652a1_D20210101-20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001656472</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">cron:CannabisExtractsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-06-30</endDate>
        </period>
    </context>
    <context id="iaa3896f04f0b4ffa95465aa6125063d6_D20210101-20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001656472</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:ProductAndServiceOtherMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">cron:UnitedStatesSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-06-30</endDate>
        </period>
    </context>
    <context id="if969ee02513f48cdb95de50cc1bb0d51_D20210101-20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001656472</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:ProductAndServiceOtherMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">cron:RestOfWorldSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-06-30</endDate>
        </period>
    </context>
    <context id="i2fd2e11500cb4edfaa54ab9e521c7c86_D20210101-20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001656472</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:CorporateNonSegmentMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:ProductAndServiceOtherMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-06-30</endDate>
        </period>
    </context>
    <context id="i1c31a39a4c79400497380f76939db7df_D20210101-20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001656472</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:ProductAndServiceOtherMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-06-30</endDate>
        </period>
    </context>
    <context id="i73f2057fe97d4f3a8524f987e78d1493_D20210101-20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001656472</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">cron:UnitedStatesSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-06-30</endDate>
        </period>
    </context>
    <context id="i9eea321560784f81a590aa8e3df3b187_D20210101-20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001656472</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">cron:RestOfWorldSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-06-30</endDate>
        </period>
    </context>
    <context id="i5e244469383d46ddb452d43394f637d1_D20210101-20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001656472</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:CorporateNonSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-06-30</endDate>
        </period>
    </context>
    <context id="ib6c371f673124f889fe33d8feafa376a_D20200101-20200630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001656472</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">cron:CannabisFlowerMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">cron:UnitedStatesSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-06-30</endDate>
        </period>
    </context>
    <context id="i058566bd4b4941cfb44bfaea27053d23_D20200101-20200630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001656472</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">cron:CannabisFlowerMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">cron:RestOfWorldSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-06-30</endDate>
        </period>
    </context>
    <context id="ib8262672cddb43529f39e6554b306595_D20200101-20200630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001656472</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:CorporateNonSegmentMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">cron:CannabisFlowerMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-06-30</endDate>
        </period>
    </context>
    <context id="i4e842f8ace2f420eabc848a65486b991_D20200101-20200630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001656472</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">cron:CannabisFlowerMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-06-30</endDate>
        </period>
    </context>
    <context id="i1508a4a4053d4dd08a6db69f6c1e840b_D20200101-20200630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001656472</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">cron:CannabisExtractsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">cron:UnitedStatesSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-06-30</endDate>
        </period>
    </context>
    <context id="i08837b8da47246b3a38247a1afce6246_D20200101-20200630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001656472</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">cron:CannabisExtractsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">cron:RestOfWorldSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-06-30</endDate>
        </period>
    </context>
    <context id="i514785787edd460fb909104cd7dc4a04_D20200101-20200630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001656472</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:CorporateNonSegmentMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">cron:CannabisExtractsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-06-30</endDate>
        </period>
    </context>
    <context id="if253a5adac88412093cd3c8f27aa185f_D20200101-20200630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001656472</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">cron:CannabisExtractsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-06-30</endDate>
        </period>
    </context>
    <context id="i9f4c7e46c3d34f5aa34d2e09db3380cf_D20200101-20200630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001656472</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:ProductAndServiceOtherMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">cron:UnitedStatesSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-06-30</endDate>
        </period>
    </context>
    <context id="i943cc5b8191b493f8aa9ee910e58ea43_D20200101-20200630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001656472</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:ProductAndServiceOtherMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">cron:RestOfWorldSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-06-30</endDate>
        </period>
    </context>
    <context id="i42b8c121915c4f34996c473e36cccd8d_D20200101-20200630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001656472</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:CorporateNonSegmentMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:ProductAndServiceOtherMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-06-30</endDate>
        </period>
    </context>
    <context id="i24f9699a302b4e86895a7c9098da3221_D20200101-20200630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001656472</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:ProductAndServiceOtherMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-06-30</endDate>
        </period>
    </context>
    <context id="iab9b56b2a03f4c6199d282bd8676a924_D20200101-20200630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001656472</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">cron:UnitedStatesSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-06-30</endDate>
        </period>
    </context>
    <context id="i13788f202c86441fa347b97f3162a453_D20200101-20200630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001656472</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">cron:RestOfWorldSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-06-30</endDate>
        </period>
    </context>
    <context id="iaf98f9473a3d428f9aab9f72e135866f_D20200101-20200630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001656472</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:CorporateNonSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-06-30</endDate>
        </period>
    </context>
    <context id="i70c4790ac8ca40dd81fcf1ef3cef91b6_D20210401-20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001656472</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:CA</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-04-01</startDate>
            <endDate>2021-06-30</endDate>
        </period>
    </context>
    <context id="iad976d29836c4f2f84c635abe13f093d_D20200401-20200630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001656472</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:CA</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-04-01</startDate>
            <endDate>2020-06-30</endDate>
        </period>
    </context>
    <context id="ic93ed3f2e9634d2485631fcd4f0c2325_D20210101-20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001656472</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:CA</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-06-30</endDate>
        </period>
    </context>
    <context id="i9028e5a0bc1c44d493f8aa0ff5b63660_D20200101-20200630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001656472</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:CA</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-06-30</endDate>
        </period>
    </context>
    <context id="i8506d6aab4b24205822b2a1157fa9c1d_D20210401-20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001656472</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:IL</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-04-01</startDate>
            <endDate>2021-06-30</endDate>
        </period>
    </context>
    <context id="i0919d1ea594c4d4dabfdd26b1f697c1a_D20200401-20200630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001656472</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:IL</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-04-01</startDate>
            <endDate>2020-06-30</endDate>
        </period>
    </context>
    <context id="i741c56d990404b79b0cac9e98bf9ab73_D20210101-20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001656472</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:IL</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-06-30</endDate>
        </period>
    </context>
    <context id="i5bc3d3cb5c994e7b8a8e525b6b1e17e4_D20200101-20200630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001656472</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:IL</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-06-30</endDate>
        </period>
    </context>
    <context id="i44de340a6a1041189ce50fede1a5bebb_D20210401-20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001656472</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-04-01</startDate>
            <endDate>2021-06-30</endDate>
        </period>
    </context>
    <context id="i64046da960714c4f90fcef13ebc59cac_D20200401-20200630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001656472</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-04-01</startDate>
            <endDate>2020-06-30</endDate>
        </period>
    </context>
    <context id="i689f775c23d14a45b6271c2611e144cd_D20210101-20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001656472</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-06-30</endDate>
        </period>
    </context>
    <context id="ia3f841640fcf416dbce4a93086b21e5a_D20200101-20200630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001656472</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-06-30</endDate>
        </period>
    </context>
    <context id="i12073826a3a04377a7cd14dedf89a23b_D20210401-20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001656472</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">cron:OtherCountriesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-04-01</startDate>
            <endDate>2021-06-30</endDate>
        </period>
    </context>
    <context id="if4be60de0dc04fcaab3cbb8c7454e2b3_D20200401-20200630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001656472</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">cron:OtherCountriesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-04-01</startDate>
            <endDate>2020-06-30</endDate>
        </period>
    </context>
    <context id="id1c815493ddc46f2a6fa5ee4c4885b69_D20210101-20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001656472</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">cron:OtherCountriesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-06-30</endDate>
        </period>
    </context>
    <context id="i1dd5859753fc4494bc617d9e788b9a09_D20200101-20200630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001656472</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">cron:OtherCountriesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-06-30</endDate>
        </period>
    </context>
    <context id="ib400bcdb825949cb9d87ed7e77387db0_I20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001656472</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:CA</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-06-30</instant>
        </period>
    </context>
    <context id="i6d98056e96104c42af330a91259abb2c_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001656472</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:CA</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="ic9b10d1ca8aa427693166bca2adb764d_I20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001656472</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:IL</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-06-30</instant>
        </period>
    </context>
    <context id="i046692f7d6014223b3cb3cd2d79b04f9_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001656472</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:IL</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i18e4d04b45ca4c42a5f461314b4cf1a6_I20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001656472</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-06-30</instant>
        </period>
    </context>
    <context id="i57ed1954cbd8415788c6fb0209f0f8f2_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001656472</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i8c36c75ac6bc43f1a84b689b7e30c990_I20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001656472</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">cron:UnitedStatesSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-06-30</instant>
        </period>
    </context>
    <context id="ideeca118de83445d869657437d768780_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001656472</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">cron:UnitedStatesSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i094dc56c362c416aac0dd88497f3bd55_D20200401-20200630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001656472</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">cron:UnitedStatesSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-04-01</startDate>
            <endDate>2020-06-30</endDate>
        </period>
    </context>
    <context id="i812abaaed027463984b850a5e2b42d2c_D20200101-20200630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001656472</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">cron:UnitedStatesSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-06-30</endDate>
        </period>
    </context>
    <context id="i3a27e92fff0846b5bad95097b919232f_D20210101-20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001656472</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">cron:UnitedStatesSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-06-30</endDate>
        </period>
    </context>
    <context id="i34f72ee8566f4486917d56bc3b40f37f_D20210401-20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001656472</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">cron:UnitedStatesSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-04-01</startDate>
            <endDate>2021-06-30</endDate>
        </period>
    </context>
    <context id="i5c2d78ee6853443687a96daa15276fab_D20210401-20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001656472</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:MajorCustomersAxis">cron:FourMajorCustomersMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">cron:RestOfWorldSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-04-01</startDate>
            <endDate>2021-06-30</endDate>
        </period>
    </context>
    <context id="i93bcd6f71ecb484fbb4d514bb054afb1_D20210401-20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001656472</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:MajorCustomersAxis">cron:OntarioCannabisRetailCorporationMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:RevenueFromContractWithCustomerMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:CustomerConcentrationRiskMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">cron:RestOfWorldSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-04-01</startDate>
            <endDate>2021-06-30</endDate>
        </period>
    </context>
    <context id="i211d75fcd6a546f899374d2d7176c1e2_D20210401-20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001656472</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:MajorCustomersAxis">cron:AlbertGamingLiquorAndCannabisCommissionMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:RevenueFromContractWithCustomerMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:CustomerConcentrationRiskMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">cron:RestOfWorldSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-04-01</startDate>
            <endDate>2021-06-30</endDate>
        </period>
    </context>
    <context id="idd2a2576b3144d36986722b62b737a2d_D20210401-20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001656472</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:MajorCustomersAxis">cron:SocieteQuebecoiseDuCannabisMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:RevenueFromContractWithCustomerMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:CustomerConcentrationRiskMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">cron:RestOfWorldSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-04-01</startDate>
            <endDate>2021-06-30</endDate>
        </period>
    </context>
    <context id="i74697f2f39824e5d8fa61532bd9225b4_D20200401-20200630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001656472</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:MajorCustomersAxis">cron:FourMajorCustomersMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:RevenueFromContractWithCustomerMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:CustomerConcentrationRiskMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">cron:RestOfWorldSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-04-01</startDate>
            <endDate>2020-06-30</endDate>
        </period>
    </context>
    <context id="ic588d92572e146368a7065a944f8c099_D20200101-20200630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001656472</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:MajorCustomersAxis">cron:FourMajorCustomersMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">cron:RestOfWorldSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-06-30</endDate>
        </period>
    </context>
    <context id="id59e6b6959b841bebcf3af4df3b502e6_D20200101-20200630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001656472</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:MajorCustomersAxis">cron:OntarioCannabisRetailCorporationMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:RevenueFromContractWithCustomerMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:CustomerConcentrationRiskMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">cron:RestOfWorldSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-06-30</endDate>
        </period>
    </context>
    <context id="id58ad288eb10460ebcce6bf331a5886c_D20200101-20200630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001656472</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:MajorCustomersAxis">cron:NovologGroupMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:RevenueFromContractWithCustomerMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:CustomerConcentrationRiskMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">cron:RestOfWorldSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-06-30</endDate>
        </period>
    </context>
    <context id="i3d5f8123b8fe46de8a82ced9ca5ee737_D20200101-20200630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001656472</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:MajorCustomersAxis">cron:SocieteQuebecoiseDuCannabisMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:RevenueFromContractWithCustomerMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:CustomerConcentrationRiskMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">cron:RestOfWorldSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-06-30</endDate>
        </period>
    </context>
    <context id="ie35646e7e6b447dc960fee8714bca44b_D20200101-20200630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001656472</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:MajorCustomersAxis">cron:AlbertGamingLiquorAndCannabisCommissionMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:RevenueFromContractWithCustomerMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:CustomerConcentrationRiskMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">cron:RestOfWorldSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-06-30</endDate>
        </period>
    </context>
    <context id="ifefa84f4058a4db3af98ff73cf89d8f4_D20200101-20200630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001656472</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:MajorCustomersAxis">cron:FourMajorCustomersMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:RevenueFromContractWithCustomerMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:CustomerConcentrationRiskMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">cron:RestOfWorldSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-06-30</endDate>
        </period>
    </context>
    <context id="i72aea01958fa442a951467d9e067fb46_I20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001656472</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">cron:RestOfWorldSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-06-30</instant>
        </period>
    </context>
    <context id="ib9d10d92b8c54f02a41178e1141532dd_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001656472</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">cron:RestOfWorldSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="ia489f6e55d8f4b56a4c35ea7b7898ed6_D20200311-20200312">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001656472</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:LitigationCaseAxis">cron:USDistrictCourtOfEasternDistrictOfNewYorkVsCronosMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LitigationStatusAxis">us-gaap:PendingLitigationMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-03-11</startDate>
            <endDate>2020-03-12</endDate>
        </period>
    </context>
    <context id="i71fed0c557ee4fb3a307e51526e90c95_D20200616-20200616">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001656472</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:LitigationStatusAxis">us-gaap:PendingLitigationMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LossContingenciesByNatureOfContingencyAxis">us-gaap:UnfavorableRegulatoryActionMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-06-16</startDate>
            <endDate>2020-06-16</endDate>
        </period>
    </context>
    <context id="icadc14e3a8f749f28ff691fa21d421ea_I20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001656472</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-06-30</instant>
        </period>
    </context>
    <context id="i7b21c81f18bd4f52a9977bc7f8edb2bc_I20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001656472</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-06-30</instant>
        </period>
    </context>
    <context id="i11247526dfde4bb5bd7e7f7730ae47e9_I20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001656472</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-06-30</instant>
        </period>
    </context>
    <context id="i5fd10eeb00c74a3fa9afaced11fe7a7d_I20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001656472</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-06-30</instant>
        </period>
    </context>
    <context id="i03fa5c3c8b194478a5f52168419d56f6_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001656472</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i79b10885dfdb4c659175e617a6ad2106_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001656472</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="if1d924d84462412da9f6d321275d484c_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001656472</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i3a832b2da99a447594f2d6d56bcc8aa8_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001656472</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i174d8021b6e348aeb60958d0fc273001_D20210101-20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001656472</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:MajorCustomersAxis">cron:FourCustomersMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:AccountsReceivableMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:CreditConcentrationRiskMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-06-30</endDate>
        </period>
    </context>
    <context id="i22724e38ce2a43488a65f8a806950144_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001656472</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:MajorCustomersAxis">cron:FourCustomersMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:AccountsReceivableMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:CreditConcentrationRiskMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="ic32bc3c69d7c4dd0a165d3622a127739_D20210101-20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001656472</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:AccountsPayableMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:SupplierConcentrationRiskMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ShareBasedGoodsAndNonemployeeServicesTransactionBySupplierAxis">cron:OneVendorMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-06-30</endDate>
        </period>
    </context>
    <context id="ib0cf8aff30b04aaebfad1c5a5bfc4c6c_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001656472</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:AccountsPayableMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:SupplierConcentrationRiskMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ShareBasedGoodsAndNonemployeeServicesTransactionBySupplierAxis">cron:FourVendorsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="i904d87a0584944d792e0d8b1355a0053_D20210401-20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001656472</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DisposalGroupClassificationAxis">us-gaap:DiscontinuedOperationsHeldforsaleMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis">cron:OriginalBCMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-04-01</startDate>
            <endDate>2021-06-30</endDate>
        </period>
    </context>
    <context id="iecddccc2866d472bbb7974d5d612f613_D20210401-20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001656472</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DisposalGroupClassificationAxis">us-gaap:DisposalGroupHeldforsaleNotDiscontinuedOperationsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis">cron:OriginalBCMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-04-01</startDate>
            <endDate>2021-06-30</endDate>
        </period>
    </context>
    <context id="i64c6418b6b224c7487942cebd8660eef_D20200401-20200630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001656472</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DisposalGroupClassificationAxis">us-gaap:DiscontinuedOperationsHeldforsaleMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis">cron:OriginalBCMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-04-01</startDate>
            <endDate>2020-06-30</endDate>
        </period>
    </context>
    <context id="i3a272e0b276a4cb1891236e443ba6b9f_D20210101-20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001656472</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DisposalGroupClassificationAxis">us-gaap:DiscontinuedOperationsHeldforsaleMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis">cron:OriginalBCMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-06-30</endDate>
        </period>
    </context>
    <context id="i199e66625a3f4900991433f926302578_D20200101-20200630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001656472</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DisposalGroupClassificationAxis">us-gaap:DiscontinuedOperationsHeldforsaleMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis">cron:OriginalBCMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-06-30</endDate>
        </period>
    </context>
    <context id="i3460e1558aee458a9a76219571d94bad_I20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001656472</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DisposalGroupClassificationAxis">us-gaap:DiscontinuedOperationsHeldforsaleMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis">cron:OriginalBCMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-06-30</instant>
        </period>
    </context>
    <context id="ibab7e231213f4709bd6c6600c444e9d5_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001656472</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DisposalGroupClassificationAxis">us-gaap:DiscontinuedOperationsHeldforsaleMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis">cron:OriginalBCMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i037d0ab368aa4200bacafabacd180946_D20200401-20200630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001656472</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ReportingUnitAxis">cron:UnitedStatesSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-04-01</startDate>
            <endDate>2020-06-30</endDate>
        </period>
    </context>
    <context id="iee9123f7b84a423aa2034824b667283b_D20200101-20200630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001656472</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ReportingUnitAxis">cron:UnitedStatesSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-06-30</endDate>
        </period>
    </context>
    <context id="icaac8e35e79f4bc7b83a47868c7fbccf_D20200401-20200630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001656472</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IndefiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:TradeNamesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-04-01</startDate>
            <endDate>2020-06-30</endDate>
        </period>
    </context>
    <context id="i9d77515187ea4c40b907a43fd842a0f9_D20200101-20200630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001656472</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IndefiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:TradeNamesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-06-30</endDate>
        </period>
    </context>
    <unit id="shares">
        <measure>shares</measure>
    </unit>
    <unit id="usd">
        <measure>iso4217:USD</measure>
    </unit>
    <unit id="usdPerShare">
        <divide>
            <unitNumerator>
                <measure>iso4217:USD</measure>
            </unitNumerator>
            <unitDenominator>
                <measure>shares</measure>
            </unitDenominator>
        </divide>
    </unit>
    <unit id="continent">
        <measure>cron:continent</measure>
    </unit>
    <unit id="brand">
        <measure>cron:brand</measure>
    </unit>
    <unit id="number">
        <measure>pure</measure>
    </unit>
    <unit id="ils">
        <measure>iso4217:ILS</measure>
    </unit>
    <unit id="cad">
        <measure>iso4217:CAD</measure>
    </unit>
    <unit id="warrant">
        <measure>cron:warrant</measure>
    </unit>
    <unit id="cadPerShare">
        <divide>
            <unitNumerator>
                <measure>iso4217:CAD</measure>
            </unitNumerator>
            <unitDenominator>
                <measure>shares</measure>
            </unitDenominator>
        </divide>
    </unit>
    <unit id="day">
        <measure>cron:day</measure>
    </unit>
    <unit id="segment">
        <measure>cron:segment</measure>
    </unit>
    <unit id="shareholder">
        <measure>cron:shareholder</measure>
    </unit>
    <unit id="complaint">
        <measure>cron:complaint</measure>
    </unit>
    <unit id="sqft">
        <measure>utr:sqft</measure>
    </unit>
    <dei:AmendmentFlag
      contextRef="i69782326f71a44e3805518280ee22b6b_D20210101-20210630"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzY2E5YmIwMTc5MjQ3NmZiYjIyNWU1ZDlkZWM4NjlmL3NlYzo5M2NhOWJiMDE3OTI0NzZmYmIyMjVlNWQ5ZGVjODY5Zl80L2ZyYWc6MDA4NmExNGYyYWEzNDc5ODk3ZjYwZWZkYzFkNDNkMTIvdGFibGU6ZDlhNjRjNGJkMzNmNGNmNmI3M2RkMTJiOWYxMWRlMWEvdGFibGVyYW5nZTpkOWE2NGM0YmQzM2Y0Y2Y2YjczZGQxMmI5ZjExZGUxYV8wLTEtMS0xLTA_44c0178a-e7f9-4193-950b-162c1a068bd0">false</dei:AmendmentFlag>
    <dei:DocumentFiscalYearFocus
      contextRef="i69782326f71a44e3805518280ee22b6b_D20210101-20210630"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzY2E5YmIwMTc5MjQ3NmZiYjIyNWU1ZDlkZWM4NjlmL3NlYzo5M2NhOWJiMDE3OTI0NzZmYmIyMjVlNWQ5ZGVjODY5Zl80L2ZyYWc6MDA4NmExNGYyYWEzNDc5ODk3ZjYwZWZkYzFkNDNkMTIvdGFibGU6ZDlhNjRjNGJkMzNmNGNmNmI3M2RkMTJiOWYxMWRlMWEvdGFibGVyYW5nZTpkOWE2NGM0YmQzM2Y0Y2Y2YjczZGQxMmI5ZjExZGUxYV8xLTEtMS0xLTA_f17daa57-ebc7-4f67-b988-2a14a1019a93">2021</dei:DocumentFiscalYearFocus>
    <dei:DocumentFiscalPeriodFocus
      contextRef="i69782326f71a44e3805518280ee22b6b_D20210101-20210630"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzY2E5YmIwMTc5MjQ3NmZiYjIyNWU1ZDlkZWM4NjlmL3NlYzo5M2NhOWJiMDE3OTI0NzZmYmIyMjVlNWQ5ZGVjODY5Zl80L2ZyYWc6MDA4NmExNGYyYWEzNDc5ODk3ZjYwZWZkYzFkNDNkMTIvdGFibGU6ZDlhNjRjNGJkMzNmNGNmNmI3M2RkMTJiOWYxMWRlMWEvdGFibGVyYW5nZTpkOWE2NGM0YmQzM2Y0Y2Y2YjczZGQxMmI5ZjExZGUxYV8yLTEtMS0xLTA_51b21a39-29f8-43bf-a80b-6fcab57805e2">Q2</dei:DocumentFiscalPeriodFocus>
    <dei:EntityCentralIndexKey
      contextRef="i69782326f71a44e3805518280ee22b6b_D20210101-20210630"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzY2E5YmIwMTc5MjQ3NmZiYjIyNWU1ZDlkZWM4NjlmL3NlYzo5M2NhOWJiMDE3OTI0NzZmYmIyMjVlNWQ5ZGVjODY5Zl80L2ZyYWc6MDA4NmExNGYyYWEzNDc5ODk3ZjYwZWZkYzFkNDNkMTIvdGFibGU6ZDlhNjRjNGJkMzNmNGNmNmI3M2RkMTJiOWYxMWRlMWEvdGFibGVyYW5nZTpkOWE2NGM0YmQzM2Y0Y2Y2YjczZGQxMmI5ZjExZGUxYV80LTEtMS0xLTA_08d9fc38-a836-461e-8bc9-aa830148e48f">0001656472</dei:EntityCentralIndexKey>
    <dei:CurrentFiscalYearEndDate
      contextRef="i69782326f71a44e3805518280ee22b6b_D20210101-20210630"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzY2E5YmIwMTc5MjQ3NmZiYjIyNWU1ZDlkZWM4NjlmL3NlYzo5M2NhOWJiMDE3OTI0NzZmYmIyMjVlNWQ5ZGVjODY5Zl80L2ZyYWc6MDA4NmExNGYyYWEzNDc5ODk3ZjYwZWZkYzFkNDNkMTIvdGFibGU6ZDlhNjRjNGJkMzNmNGNmNmI3M2RkMTJiOWYxMWRlMWEvdGFibGVyYW5nZTpkOWE2NGM0YmQzM2Y0Y2Y2YjczZGQxMmI5ZjExZGUxYV81LTEtMS0xLTA_059ee644-fe4b-4115-b867-e2439e6724c0">--12-31</dei:CurrentFiscalYearEndDate>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1
      contextRef="i3d31fbca3c6044d5bd0e62b05769e769_D20200329-20200329"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzY2E5YmIwMTc5MjQ3NmZiYjIyNWU1ZDlkZWM4NjlmL3NlYzo5M2NhOWJiMDE3OTI0NzZmYmIyMjVlNWQ5ZGVjODY5Zl80OS9mcmFnOjdkOTcyM2RkMjdkODRhNWFiYjJiMzcyOTJmYjZhMmUzL3RleHRyZWdpb246N2Q5NzIzZGQyN2Q4NGE1YWJiMmIzNzI5MmZiNmEyZTNfMTAxNA_bcd0b46d-5e0a-4add-a684-db7137029aee">P3Y</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1
      contextRef="iafb1144677d145049a09cbdbb0457c7b_D20200329-20200329"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzY2E5YmIwMTc5MjQ3NmZiYjIyNWU1ZDlkZWM4NjlmL3NlYzo5M2NhOWJiMDE3OTI0NzZmYmIyMjVlNWQ5ZGVjODY5Zl80OS9mcmFnOjdkOTcyM2RkMjdkODRhNWFiYjJiMzcyOTJmYjZhMmUzL3RleHRyZWdpb246N2Q5NzIzZGQyN2Q4NGE1YWJiMmIzNzI5MmZiNmEyZTNfMTE1NA_462d9472-3856-448b-97f2-4ab4e5aeb10e">P3Y</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1>
    <dei:DocumentType
      contextRef="i69782326f71a44e3805518280ee22b6b_D20210101-20210630"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzY2E5YmIwMTc5MjQ3NmZiYjIyNWU1ZDlkZWM4NjlmL3NlYzo5M2NhOWJiMDE3OTI0NzZmYmIyMjVlNWQ5ZGVjODY5Zl8xL2ZyYWc6Mzc0YjhjZWZhZmU2NDFhYzg4YmIzMmJlZjNkOGZjNTAvdGV4dHJlZ2lvbjozNzRiOGNlZmFmZTY0MWFjODhiYjMyYmVmM2Q4ZmM1MF8yMjQ1_b39b827d-28a1-4485-bd46-d69dc03bf539">10-Q</dei:DocumentType>
    <dei:DocumentQuarterlyReport
      contextRef="i69782326f71a44e3805518280ee22b6b_D20210101-20210630"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzY2E5YmIwMTc5MjQ3NmZiYjIyNWU1ZDlkZWM4NjlmL3NlYzo5M2NhOWJiMDE3OTI0NzZmYmIyMjVlNWQ5ZGVjODY5Zl8xL2ZyYWc6Mzc0YjhjZWZhZmU2NDFhYzg4YmIzMmJlZjNkOGZjNTAvdGV4dHJlZ2lvbjozNzRiOGNlZmFmZTY0MWFjODhiYjMyYmVmM2Q4ZmM1MF8yMjQ2_51165010-4c63-4061-a336-ba40666ee3b0">true</dei:DocumentQuarterlyReport>
    <dei:DocumentPeriodEndDate
      contextRef="i69782326f71a44e3805518280ee22b6b_D20210101-20210630"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzY2E5YmIwMTc5MjQ3NmZiYjIyNWU1ZDlkZWM4NjlmL3NlYzo5M2NhOWJiMDE3OTI0NzZmYmIyMjVlNWQ5ZGVjODY5Zl8xL2ZyYWc6Mzc0YjhjZWZhZmU2NDFhYzg4YmIzMmJlZjNkOGZjNTAvdGV4dHJlZ2lvbjozNzRiOGNlZmFmZTY0MWFjODhiYjMyYmVmM2Q4ZmM1MF8yNzY_d88165bb-014d-4d4b-889f-d9947ae624b1">2021-06-30</dei:DocumentPeriodEndDate>
    <dei:DocumentTransitionReport
      contextRef="i69782326f71a44e3805518280ee22b6b_D20210101-20210630"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzY2E5YmIwMTc5MjQ3NmZiYjIyNWU1ZDlkZWM4NjlmL3NlYzo5M2NhOWJiMDE3OTI0NzZmYmIyMjVlNWQ5ZGVjODY5Zl8xL2ZyYWc6Mzc0YjhjZWZhZmU2NDFhYzg4YmIzMmJlZjNkOGZjNTAvdGV4dHJlZ2lvbjozNzRiOGNlZmFmZTY0MWFjODhiYjMyYmVmM2Q4ZmM1MF8yMjQw_49755c8c-826e-43dc-b009-2211122dbbb1">false</dei:DocumentTransitionReport>
    <dei:EntityFileNumber
      contextRef="i69782326f71a44e3805518280ee22b6b_D20210101-20210630"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzY2E5YmIwMTc5MjQ3NmZiYjIyNWU1ZDlkZWM4NjlmL3NlYzo5M2NhOWJiMDE3OTI0NzZmYmIyMjVlNWQ5ZGVjODY5Zl8xL2ZyYWc6Mzc0YjhjZWZhZmU2NDFhYzg4YmIzMmJlZjNkOGZjNTAvdGV4dHJlZ2lvbjozNzRiOGNlZmFmZTY0MWFjODhiYjMyYmVmM2Q4ZmM1MF8yMjQ4_cb805ef5-91c0-4178-bc4b-ed0366e93075">001-38403</dei:EntityFileNumber>
    <dei:EntityRegistrantName
      contextRef="i69782326f71a44e3805518280ee22b6b_D20210101-20210630"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzY2E5YmIwMTc5MjQ3NmZiYjIyNWU1ZDlkZWM4NjlmL3NlYzo5M2NhOWJiMDE3OTI0NzZmYmIyMjVlNWQ5ZGVjODY5Zl8xL2ZyYWc6Mzc0YjhjZWZhZmU2NDFhYzg4YmIzMmJlZjNkOGZjNTAvdGV4dHJlZ2lvbjozNzRiOGNlZmFmZTY0MWFjODhiYjMyYmVmM2Q4ZmM1MF8yMjQ5_559544df-99ef-4e0c-bc22-01fcc7d94335">CRONOS GROUP INC.</dei:EntityRegistrantName>
    <dei:EntityIncorporationStateCountryCode
      contextRef="i69782326f71a44e3805518280ee22b6b_D20210101-20210630"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzY2E5YmIwMTc5MjQ3NmZiYjIyNWU1ZDlkZWM4NjlmL3NlYzo5M2NhOWJiMDE3OTI0NzZmYmIyMjVlNWQ5ZGVjODY5Zl8xL2ZyYWc6Mzc0YjhjZWZhZmU2NDFhYzg4YmIzMmJlZjNkOGZjNTAvdGFibGU6NmI5Yzk1OGY4MDJlNGMzMWE4MWE2ZTNkMjQxOGI3NzgvdGFibGVyYW5nZTo2YjljOTU4ZjgwMmU0YzMxYTgxYTZlM2QyNDE4Yjc3OF8wLTAtMS0xLTAvdGV4dHJlZ2lvbjphNTY5MzJjN2YxMzg0NjJhOWUxNmIwMzg0ZDQ5MjY1YV84_83d9e5e2-eb72-4ea2-85d4-573b1f2e390a">Z4</dei:EntityIncorporationStateCountryCode>
    <dei:EntityAddressAddressLine1
      contextRef="i69782326f71a44e3805518280ee22b6b_D20210101-20210630"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzY2E5YmIwMTc5MjQ3NmZiYjIyNWU1ZDlkZWM4NjlmL3NlYzo5M2NhOWJiMDE3OTI0NzZmYmIyMjVlNWQ5ZGVjODY5Zl8xL2ZyYWc6Mzc0YjhjZWZhZmU2NDFhYzg4YmIzMmJlZjNkOGZjNTAvdGFibGU6NmI5Yzk1OGY4MDJlNGMzMWE4MWE2ZTNkMjQxOGI3NzgvdGFibGVyYW5nZTo2YjljOTU4ZjgwMmU0YzMxYTgxYTZlM2QyNDE4Yjc3OF80LTAtMS0xLTA_62acaa68-e4eb-4d76-a5f7-3d1a3989975e">111 Peter St. Suite 300</dei:EntityAddressAddressLine1>
    <dei:EntityAddressCityOrTown
      contextRef="i69782326f71a44e3805518280ee22b6b_D20210101-20210630"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzY2E5YmIwMTc5MjQ3NmZiYjIyNWU1ZDlkZWM4NjlmL3NlYzo5M2NhOWJiMDE3OTI0NzZmYmIyMjVlNWQ5ZGVjODY5Zl8xL2ZyYWc6Mzc0YjhjZWZhZmU2NDFhYzg4YmIzMmJlZjNkOGZjNTAvdGFibGU6NmI5Yzk1OGY4MDJlNGMzMWE4MWE2ZTNkMjQxOGI3NzgvdGFibGVyYW5nZTo2YjljOTU4ZjgwMmU0YzMxYTgxYTZlM2QyNDE4Yjc3OF81LTAtMS0xLTAvdGV4dHJlZ2lvbjpmYzdiY2U5YTg1MzE0ZWI0YjU4ZmZiYjg5ZGVlODlkNF80_e045ba5e-323b-4f1c-8684-3292d9e7c2a0">Toronto</dei:EntityAddressCityOrTown>
    <dei:EntityAddressStateOrProvince
      contextRef="i69782326f71a44e3805518280ee22b6b_D20210101-20210630"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzY2E5YmIwMTc5MjQ3NmZiYjIyNWU1ZDlkZWM4NjlmL3NlYzo5M2NhOWJiMDE3OTI0NzZmYmIyMjVlNWQ5ZGVjODY5Zl8xL2ZyYWc6Mzc0YjhjZWZhZmU2NDFhYzg4YmIzMmJlZjNkOGZjNTAvdGFibGU6NmI5Yzk1OGY4MDJlNGMzMWE4MWE2ZTNkMjQxOGI3NzgvdGFibGVyYW5nZTo2YjljOTU4ZjgwMmU0YzMxYTgxYTZlM2QyNDE4Yjc3OF81LTAtMS0xLTAvdGV4dHJlZ2lvbjpmYzdiY2U5YTg1MzE0ZWI0YjU4ZmZiYjg5ZGVlODlkNF84_9fb70a90-69aa-4afb-9f1b-98af9a48e60c">ON</dei:EntityAddressStateOrProvince>
    <dei:EntityAddressPostalZipCode
      contextRef="i69782326f71a44e3805518280ee22b6b_D20210101-20210630"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzY2E5YmIwMTc5MjQ3NmZiYjIyNWU1ZDlkZWM4NjlmL3NlYzo5M2NhOWJiMDE3OTI0NzZmYmIyMjVlNWQ5ZGVjODY5Zl8xL2ZyYWc6Mzc0YjhjZWZhZmU2NDFhYzg4YmIzMmJlZjNkOGZjNTAvdGFibGU6NmI5Yzk1OGY4MDJlNGMzMWE4MWE2ZTNkMjQxOGI3NzgvdGFibGVyYW5nZTo2YjljOTU4ZjgwMmU0YzMxYTgxYTZlM2QyNDE4Yjc3OF81LTItMS0xLTA_a388e8da-b873-4e17-9643-44dfa02affa0">M5V 2H1</dei:EntityAddressPostalZipCode>
    <dei:CityAreaCode
      contextRef="i69782326f71a44e3805518280ee22b6b_D20210101-20210630"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzY2E5YmIwMTc5MjQ3NmZiYjIyNWU1ZDlkZWM4NjlmL3NlYzo5M2NhOWJiMDE3OTI0NzZmYmIyMjVlNWQ5ZGVjODY5Zl8xL2ZyYWc6Mzc0YjhjZWZhZmU2NDFhYzg4YmIzMmJlZjNkOGZjNTAvdGV4dHJlZ2lvbjozNzRiOGNlZmFmZTY0MWFjODhiYjMyYmVmM2Q4ZmM1MF81Njg_6bc77758-6474-4ba6-a00a-a70eee664584">416</dei:CityAreaCode>
    <dei:LocalPhoneNumber
      contextRef="i69782326f71a44e3805518280ee22b6b_D20210101-20210630"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzY2E5YmIwMTc5MjQ3NmZiYjIyNWU1ZDlkZWM4NjlmL3NlYzo5M2NhOWJiMDE3OTI0NzZmYmIyMjVlNWQ5ZGVjODY5Zl8xL2ZyYWc6Mzc0YjhjZWZhZmU2NDFhYzg4YmIzMmJlZjNkOGZjNTAvdGV4dHJlZ2lvbjozNzRiOGNlZmFmZTY0MWFjODhiYjMyYmVmM2Q4ZmM1MF8yMjQy_795e70d4-d436-48d7-91d1-7dbaf72e9328">504-0004</dei:LocalPhoneNumber>
    <dei:Security12bTitle
      contextRef="i69782326f71a44e3805518280ee22b6b_D20210101-20210630"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzY2E5YmIwMTc5MjQ3NmZiYjIyNWU1ZDlkZWM4NjlmL3NlYzo5M2NhOWJiMDE3OTI0NzZmYmIyMjVlNWQ5ZGVjODY5Zl8xL2ZyYWc6Mzc0YjhjZWZhZmU2NDFhYzg4YmIzMmJlZjNkOGZjNTAvdGFibGU6ZWIzMWUyYjYzOTMzNDRiZTg3YWUzOGU2YTI1ZDg1NDMvdGFibGVyYW5nZTplYjMxZTJiNjM5MzM0NGJlODdhZTM4ZTZhMjVkODU0M18xLTAtMS0xLTA_1eaf822f-661e-4840-9b8c-02b5197e756a">Common Shares, no par value</dei:Security12bTitle>
    <dei:TradingSymbol
      contextRef="i69782326f71a44e3805518280ee22b6b_D20210101-20210630"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzY2E5YmIwMTc5MjQ3NmZiYjIyNWU1ZDlkZWM4NjlmL3NlYzo5M2NhOWJiMDE3OTI0NzZmYmIyMjVlNWQ5ZGVjODY5Zl8xL2ZyYWc6Mzc0YjhjZWZhZmU2NDFhYzg4YmIzMmJlZjNkOGZjNTAvdGFibGU6ZWIzMWUyYjYzOTMzNDRiZTg3YWUzOGU2YTI1ZDg1NDMvdGFibGVyYW5nZTplYjMxZTJiNjM5MzM0NGJlODdhZTM4ZTZhMjVkODU0M18xLTItMS0xLTA_46141ba9-876b-4114-b9d8-346f7ed3a0ab">CRON</dei:TradingSymbol>
    <dei:SecurityExchangeName
      contextRef="i69782326f71a44e3805518280ee22b6b_D20210101-20210630"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzY2E5YmIwMTc5MjQ3NmZiYjIyNWU1ZDlkZWM4NjlmL3NlYzo5M2NhOWJiMDE3OTI0NzZmYmIyMjVlNWQ5ZGVjODY5Zl8xL2ZyYWc6Mzc0YjhjZWZhZmU2NDFhYzg4YmIzMmJlZjNkOGZjNTAvdGFibGU6ZWIzMWUyYjYzOTMzNDRiZTg3YWUzOGU2YTI1ZDg1NDMvdGFibGVyYW5nZTplYjMxZTJiNjM5MzM0NGJlODdhZTM4ZTZhMjVkODU0M18xLTQtMS0xLTA_3a8e7307-bfb6-4666-8b16-a745022f6a70">NASDAQ</dei:SecurityExchangeName>
    <dei:EntityCurrentReportingStatus
      contextRef="i69782326f71a44e3805518280ee22b6b_D20210101-20210630"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzY2E5YmIwMTc5MjQ3NmZiYjIyNWU1ZDlkZWM4NjlmL3NlYzo5M2NhOWJiMDE3OTI0NzZmYmIyMjVlNWQ5ZGVjODY5Zl8xL2ZyYWc6Mzc0YjhjZWZhZmU2NDFhYzg4YmIzMmJlZjNkOGZjNTAvdGV4dHJlZ2lvbjozNzRiOGNlZmFmZTY0MWFjODhiYjMyYmVmM2Q4ZmM1MF8yMjQz_ca05d335-c465-45bb-9d50-0c9a8bd80f78">Yes</dei:EntityCurrentReportingStatus>
    <dei:EntityInteractiveDataCurrent
      contextRef="i69782326f71a44e3805518280ee22b6b_D20210101-20210630"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzY2E5YmIwMTc5MjQ3NmZiYjIyNWU1ZDlkZWM4NjlmL3NlYzo5M2NhOWJiMDE3OTI0NzZmYmIyMjVlNWQ5ZGVjODY5Zl8xL2ZyYWc6Mzc0YjhjZWZhZmU2NDFhYzg4YmIzMmJlZjNkOGZjNTAvdGV4dHJlZ2lvbjozNzRiOGNlZmFmZTY0MWFjODhiYjMyYmVmM2Q4ZmM1MF8yMjUw_200937bb-d96f-4c04-8fcb-2f1e44554874">Yes</dei:EntityInteractiveDataCurrent>
    <dei:EntityFilerCategory
      contextRef="i69782326f71a44e3805518280ee22b6b_D20210101-20210630"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzY2E5YmIwMTc5MjQ3NmZiYjIyNWU1ZDlkZWM4NjlmL3NlYzo5M2NhOWJiMDE3OTI0NzZmYmIyMjVlNWQ5ZGVjODY5Zl8xL2ZyYWc6Mzc0YjhjZWZhZmU2NDFhYzg4YmIzMmJlZjNkOGZjNTAvdGFibGU6NGUyZWY2MDQ4NjE5NDI1ODlkYWE0NWI3OTA4YmM5MzcvdGFibGVyYW5nZTo0ZTJlZjYwNDg2MTk0MjU4OWRhYTQ1Yjc5MDhiYzkzN18wLTAtMS0xLTA_60d2dfb4-924e-4bd8-8820-61fec54eedd0">Large Accelerated Filer</dei:EntityFilerCategory>
    <dei:EntitySmallBusiness
      contextRef="i69782326f71a44e3805518280ee22b6b_D20210101-20210630"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzY2E5YmIwMTc5MjQ3NmZiYjIyNWU1ZDlkZWM4NjlmL3NlYzo5M2NhOWJiMDE3OTI0NzZmYmIyMjVlNWQ5ZGVjODY5Zl8xL2ZyYWc6Mzc0YjhjZWZhZmU2NDFhYzg4YmIzMmJlZjNkOGZjNTAvdGFibGU6NGUyZWY2MDQ4NjE5NDI1ODlkYWE0NWI3OTA4YmM5MzcvdGFibGVyYW5nZTo0ZTJlZjYwNDg2MTk0MjU4OWRhYTQ1Yjc5MDhiYzkzN18xLTQtMS0xLTA_12f33673-4b07-4940-8f5f-dc71f290180e">false</dei:EntitySmallBusiness>
    <dei:EntityEmergingGrowthCompany
      contextRef="i69782326f71a44e3805518280ee22b6b_D20210101-20210630"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzY2E5YmIwMTc5MjQ3NmZiYjIyNWU1ZDlkZWM4NjlmL3NlYzo5M2NhOWJiMDE3OTI0NzZmYmIyMjVlNWQ5ZGVjODY5Zl8xL2ZyYWc6Mzc0YjhjZWZhZmU2NDFhYzg4YmIzMmJlZjNkOGZjNTAvdGFibGU6NGUyZWY2MDQ4NjE5NDI1ODlkYWE0NWI3OTA4YmM5MzcvdGFibGVyYW5nZTo0ZTJlZjYwNDg2MTk0MjU4OWRhYTQ1Yjc5MDhiYzkzN18yLTQtMS0xLTA_d19e1e6d-c4f7-4322-ba85-ee0996269b3a">false</dei:EntityEmergingGrowthCompany>
    <dei:EntityShellCompany
      contextRef="i69782326f71a44e3805518280ee22b6b_D20210101-20210630"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzY2E5YmIwMTc5MjQ3NmZiYjIyNWU1ZDlkZWM4NjlmL3NlYzo5M2NhOWJiMDE3OTI0NzZmYmIyMjVlNWQ5ZGVjODY5Zl8xL2ZyYWc6Mzc0YjhjZWZhZmU2NDFhYzg4YmIzMmJlZjNkOGZjNTAvdGV4dHJlZ2lvbjozNzRiOGNlZmFmZTY0MWFjODhiYjMyYmVmM2Q4ZmM1MF8yMjQ0_aa1b1ed2-b7a0-40c4-8de2-8c744114b676">false</dei:EntityShellCompany>
    <dei:EntityCommonStockSharesOutstanding
      contextRef="ia52c55475f2e488fac07e8b8f24caaa3_I20210805"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzY2E5YmIwMTc5MjQ3NmZiYjIyNWU1ZDlkZWM4NjlmL3NlYzo5M2NhOWJiMDE3OTI0NzZmYmIyMjVlNWQ5ZGVjODY5Zl8xL2ZyYWc6Mzc0YjhjZWZhZmU2NDFhYzg4YmIzMmJlZjNkOGZjNTAvdGV4dHJlZ2lvbjozNzRiOGNlZmFmZTY0MWFjODhiYjMyYmVmM2Q4ZmM1MF8yMTcz_eaa35828-aea2-4422-965b-a7300bbb12c7"
      unitRef="shares">371805547</dei:EntityCommonStockSharesOutstanding>
    <us-gaap:CashAndCashEquivalentsAtCarryingValue
      contextRef="i225f85e38faa4bbdb4de1d8b9cf369bb_I20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzY2E5YmIwMTc5MjQ3NmZiYjIyNWU1ZDlkZWM4NjlmL3NlYzo5M2NhOWJiMDE3OTI0NzZmYmIyMjVlNWQ5ZGVjODY5Zl8xNi9mcmFnOmNhM2Q5OWRkMjk1ODQxYzQ4Yzk2ZDg0NGIzMGFkMjA5L3RhYmxlOmQ1Nzc2MTlkODM1ODRhZWNiNTE1YzZiODUwYjcwM2FmL3RhYmxlcmFuZ2U6ZDU3NzYxOWQ4MzU4NGFlY2I1MTVjNmI4NTBiNzAzYWZfMy0xLTEtMS0w_0420cd73-92fc-4ac8-813c-be744163d572"
      unitRef="usd">895181000</us-gaap:CashAndCashEquivalentsAtCarryingValue>
    <us-gaap:CashAndCashEquivalentsAtCarryingValue
      contextRef="ifbe16ec51ea244519b77d6036b4ef038_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzY2E5YmIwMTc5MjQ3NmZiYjIyNWU1ZDlkZWM4NjlmL3NlYzo5M2NhOWJiMDE3OTI0NzZmYmIyMjVlNWQ5ZGVjODY5Zl8xNi9mcmFnOmNhM2Q5OWRkMjk1ODQxYzQ4Yzk2ZDg0NGIzMGFkMjA5L3RhYmxlOmQ1Nzc2MTlkODM1ODRhZWNiNTE1YzZiODUwYjcwM2FmL3RhYmxlcmFuZ2U6ZDU3NzYxOWQ4MzU4NGFlY2I1MTVjNmI4NTBiNzAzYWZfMy0zLTEtMS0w_9ff5ba0a-1383-4e93-a9b0-2d436e525a15"
      unitRef="usd">1078023000</us-gaap:CashAndCashEquivalentsAtCarryingValue>
    <us-gaap:ShortTermInvestments
      contextRef="i225f85e38faa4bbdb4de1d8b9cf369bb_I20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzY2E5YmIwMTc5MjQ3NmZiYjIyNWU1ZDlkZWM4NjlmL3NlYzo5M2NhOWJiMDE3OTI0NzZmYmIyMjVlNWQ5ZGVjODY5Zl8xNi9mcmFnOmNhM2Q5OWRkMjk1ODQxYzQ4Yzk2ZDg0NGIzMGFkMjA5L3RhYmxlOmQ1Nzc2MTlkODM1ODRhZWNiNTE1YzZiODUwYjcwM2FmL3RhYmxlcmFuZ2U6ZDU3NzYxOWQ4MzU4NGFlY2I1MTVjNmI4NTBiNzAzYWZfNC0xLTEtMS0w_d28816aa-2f84-4061-87a4-07f91bd16ca7"
      unitRef="usd">201699000</us-gaap:ShortTermInvestments>
    <us-gaap:ShortTermInvestments
      contextRef="ifbe16ec51ea244519b77d6036b4ef038_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzY2E5YmIwMTc5MjQ3NmZiYjIyNWU1ZDlkZWM4NjlmL3NlYzo5M2NhOWJiMDE3OTI0NzZmYmIyMjVlNWQ5ZGVjODY5Zl8xNi9mcmFnOmNhM2Q5OWRkMjk1ODQxYzQ4Yzk2ZDg0NGIzMGFkMjA5L3RhYmxlOmQ1Nzc2MTlkODM1ODRhZWNiNTE1YzZiODUwYjcwM2FmL3RhYmxlcmFuZ2U6ZDU3NzYxOWQ4MzU4NGFlY2I1MTVjNmI4NTBiNzAzYWZfNC0zLTEtMS0w_4c3509cc-145a-443e-b42d-0da38eeed0bb"
      unitRef="usd">211766000</us-gaap:ShortTermInvestments>
    <us-gaap:AccountsReceivableNetCurrent
      contextRef="i225f85e38faa4bbdb4de1d8b9cf369bb_I20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzY2E5YmIwMTc5MjQ3NmZiYjIyNWU1ZDlkZWM4NjlmL3NlYzo5M2NhOWJiMDE3OTI0NzZmYmIyMjVlNWQ5ZGVjODY5Zl8xNi9mcmFnOmNhM2Q5OWRkMjk1ODQxYzQ4Yzk2ZDg0NGIzMGFkMjA5L3RhYmxlOmQ1Nzc2MTlkODM1ODRhZWNiNTE1YzZiODUwYjcwM2FmL3RhYmxlcmFuZ2U6ZDU3NzYxOWQ4MzU4NGFlY2I1MTVjNmI4NTBiNzAzYWZfNS0xLTEtMS0w_65fce372-1f11-4b14-9951-f3fbe227277b"
      unitRef="usd">11299000</us-gaap:AccountsReceivableNetCurrent>
    <us-gaap:AccountsReceivableNetCurrent
      contextRef="ifbe16ec51ea244519b77d6036b4ef038_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzY2E5YmIwMTc5MjQ3NmZiYjIyNWU1ZDlkZWM4NjlmL3NlYzo5M2NhOWJiMDE3OTI0NzZmYmIyMjVlNWQ5ZGVjODY5Zl8xNi9mcmFnOmNhM2Q5OWRkMjk1ODQxYzQ4Yzk2ZDg0NGIzMGFkMjA5L3RhYmxlOmQ1Nzc2MTlkODM1ODRhZWNiNTE1YzZiODUwYjcwM2FmL3RhYmxlcmFuZ2U6ZDU3NzYxOWQ4MzU4NGFlY2I1MTVjNmI4NTBiNzAzYWZfNS0zLTEtMS0w_0c1f9c9b-cd80-4a87-a627-32a082ee2bfe"
      unitRef="usd">8928000</us-gaap:AccountsReceivableNetCurrent>
    <us-gaap:OtherReceivablesNetCurrent
      contextRef="i225f85e38faa4bbdb4de1d8b9cf369bb_I20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzY2E5YmIwMTc5MjQ3NmZiYjIyNWU1ZDlkZWM4NjlmL3NlYzo5M2NhOWJiMDE3OTI0NzZmYmIyMjVlNWQ5ZGVjODY5Zl8xNi9mcmFnOmNhM2Q5OWRkMjk1ODQxYzQ4Yzk2ZDg0NGIzMGFkMjA5L3RhYmxlOmQ1Nzc2MTlkODM1ODRhZWNiNTE1YzZiODUwYjcwM2FmL3RhYmxlcmFuZ2U6ZDU3NzYxOWQ4MzU4NGFlY2I1MTVjNmI4NTBiNzAzYWZfNi0xLTEtMS0w_d8711a30-80ac-4d5a-bc66-e75ffdef203b"
      unitRef="usd">2468000</us-gaap:OtherReceivablesNetCurrent>
    <us-gaap:OtherReceivablesNetCurrent
      contextRef="ifbe16ec51ea244519b77d6036b4ef038_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzY2E5YmIwMTc5MjQ3NmZiYjIyNWU1ZDlkZWM4NjlmL3NlYzo5M2NhOWJiMDE3OTI0NzZmYmIyMjVlNWQ5ZGVjODY5Zl8xNi9mcmFnOmNhM2Q5OWRkMjk1ODQxYzQ4Yzk2ZDg0NGIzMGFkMjA5L3RhYmxlOmQ1Nzc2MTlkODM1ODRhZWNiNTE1YzZiODUwYjcwM2FmL3RhYmxlcmFuZ2U6ZDU3NzYxOWQ4MzU4NGFlY2I1MTVjNmI4NTBiNzAzYWZfNi0zLTEtMS0w_2c84ec50-f6ed-4261-81b2-4ddc346a3206"
      unitRef="usd">10033000</us-gaap:OtherReceivablesNetCurrent>
    <us-gaap:NotesAndLoansReceivableNetCurrent
      contextRef="i225f85e38faa4bbdb4de1d8b9cf369bb_I20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzY2E5YmIwMTc5MjQ3NmZiYjIyNWU1ZDlkZWM4NjlmL3NlYzo5M2NhOWJiMDE3OTI0NzZmYmIyMjVlNWQ5ZGVjODY5Zl8xNi9mcmFnOmNhM2Q5OWRkMjk1ODQxYzQ4Yzk2ZDg0NGIzMGFkMjA5L3RhYmxlOmQ1Nzc2MTlkODM1ODRhZWNiNTE1YzZiODUwYjcwM2FmL3RhYmxlcmFuZ2U6ZDU3NzYxOWQ4MzU4NGFlY2I1MTVjNmI4NTBiNzAzYWZfNy0xLTEtMS0w_accc60a2-966d-4c6c-beab-5606a3f99a90"
      unitRef="usd">5028000</us-gaap:NotesAndLoansReceivableNetCurrent>
    <us-gaap:NotesAndLoansReceivableNetCurrent
      contextRef="ifbe16ec51ea244519b77d6036b4ef038_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzY2E5YmIwMTc5MjQ3NmZiYjIyNWU1ZDlkZWM4NjlmL3NlYzo5M2NhOWJiMDE3OTI0NzZmYmIyMjVlNWQ5ZGVjODY5Zl8xNi9mcmFnOmNhM2Q5OWRkMjk1ODQxYzQ4Yzk2ZDg0NGIzMGFkMjA5L3RhYmxlOmQ1Nzc2MTlkODM1ODRhZWNiNTE1YzZiODUwYjcwM2FmL3RhYmxlcmFuZ2U6ZDU3NzYxOWQ4MzU4NGFlY2I1MTVjNmI4NTBiNzAzYWZfNy0zLTEtMS0w_b1a48fd8-f579-43a7-8fa7-1014f9955f2b"
      unitRef="usd">7083000</us-gaap:NotesAndLoansReceivableNetCurrent>
    <us-gaap:PrepaidExpenseAndOtherAssetsCurrent
      contextRef="i225f85e38faa4bbdb4de1d8b9cf369bb_I20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzY2E5YmIwMTc5MjQ3NmZiYjIyNWU1ZDlkZWM4NjlmL3NlYzo5M2NhOWJiMDE3OTI0NzZmYmIyMjVlNWQ5ZGVjODY5Zl8xNi9mcmFnOmNhM2Q5OWRkMjk1ODQxYzQ4Yzk2ZDg0NGIzMGFkMjA5L3RhYmxlOmQ1Nzc2MTlkODM1ODRhZWNiNTE1YzZiODUwYjcwM2FmL3RhYmxlcmFuZ2U6ZDU3NzYxOWQ4MzU4NGFlY2I1MTVjNmI4NTBiNzAzYWZfOC0xLTEtMS0w_118d0c76-b6fc-405b-b8a4-50a0e69e468d"
      unitRef="usd">10153000</us-gaap:PrepaidExpenseAndOtherAssetsCurrent>
    <us-gaap:PrepaidExpenseAndOtherAssetsCurrent
      contextRef="ifbe16ec51ea244519b77d6036b4ef038_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzY2E5YmIwMTc5MjQ3NmZiYjIyNWU1ZDlkZWM4NjlmL3NlYzo5M2NhOWJiMDE3OTI0NzZmYmIyMjVlNWQ5ZGVjODY5Zl8xNi9mcmFnOmNhM2Q5OWRkMjk1ODQxYzQ4Yzk2ZDg0NGIzMGFkMjA5L3RhYmxlOmQ1Nzc2MTlkODM1ODRhZWNiNTE1YzZiODUwYjcwM2FmL3RhYmxlcmFuZ2U6ZDU3NzYxOWQ4MzU4NGFlY2I1MTVjNmI4NTBiNzAzYWZfOC0zLTEtMS0w_fdbbe8c0-8afa-4709-85cc-f1fbf8af4970"
      unitRef="usd">11161000</us-gaap:PrepaidExpenseAndOtherAssetsCurrent>
    <us-gaap:InventoryNet
      contextRef="i225f85e38faa4bbdb4de1d8b9cf369bb_I20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzY2E5YmIwMTc5MjQ3NmZiYjIyNWU1ZDlkZWM4NjlmL3NlYzo5M2NhOWJiMDE3OTI0NzZmYmIyMjVlNWQ5ZGVjODY5Zl8xNi9mcmFnOmNhM2Q5OWRkMjk1ODQxYzQ4Yzk2ZDg0NGIzMGFkMjA5L3RhYmxlOmQ1Nzc2MTlkODM1ODRhZWNiNTE1YzZiODUwYjcwM2FmL3RhYmxlcmFuZ2U6ZDU3NzYxOWQ4MzU4NGFlY2I1MTVjNmI4NTBiNzAzYWZfOS0xLTEtMS0w_eaf8284c-10ec-4b0f-a3f6-1976c42bc1a8"
      unitRef="usd">35605000</us-gaap:InventoryNet>
    <us-gaap:InventoryNet
      contextRef="ifbe16ec51ea244519b77d6036b4ef038_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzY2E5YmIwMTc5MjQ3NmZiYjIyNWU1ZDlkZWM4NjlmL3NlYzo5M2NhOWJiMDE3OTI0NzZmYmIyMjVlNWQ5ZGVjODY5Zl8xNi9mcmFnOmNhM2Q5OWRkMjk1ODQxYzQ4Yzk2ZDg0NGIzMGFkMjA5L3RhYmxlOmQ1Nzc2MTlkODM1ODRhZWNiNTE1YzZiODUwYjcwM2FmL3RhYmxlcmFuZ2U6ZDU3NzYxOWQ4MzU4NGFlY2I1MTVjNmI4NTBiNzAzYWZfOS0zLTEtMS0w_6c80cd8e-21bc-42b2-9b68-19d05a39c70c"
      unitRef="usd">44002000</us-gaap:InventoryNet>
    <us-gaap:AssetsHeldForSaleNotPartOfDisposalGroupCurrent
      contextRef="i225f85e38faa4bbdb4de1d8b9cf369bb_I20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzY2E5YmIwMTc5MjQ3NmZiYjIyNWU1ZDlkZWM4NjlmL3NlYzo5M2NhOWJiMDE3OTI0NzZmYmIyMjVlNWQ5ZGVjODY5Zl8xNi9mcmFnOmNhM2Q5OWRkMjk1ODQxYzQ4Yzk2ZDg0NGIzMGFkMjA5L3RhYmxlOmQ1Nzc2MTlkODM1ODRhZWNiNTE1YzZiODUwYjcwM2FmL3RhYmxlcmFuZ2U6ZDU3NzYxOWQ4MzU4NGFlY2I1MTVjNmI4NTBiNzAzYWZfMTAtMS0xLTEtMA_865dfb73-09b0-4b53-9ec5-b0056b26d88a"
      unitRef="usd">645000</us-gaap:AssetsHeldForSaleNotPartOfDisposalGroupCurrent>
    <us-gaap:AssetsHeldForSaleNotPartOfDisposalGroupCurrent
      contextRef="ifbe16ec51ea244519b77d6036b4ef038_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzY2E5YmIwMTc5MjQ3NmZiYjIyNWU1ZDlkZWM4NjlmL3NlYzo5M2NhOWJiMDE3OTI0NzZmYmIyMjVlNWQ5ZGVjODY5Zl8xNi9mcmFnOmNhM2Q5OWRkMjk1ODQxYzQ4Yzk2ZDg0NGIzMGFkMjA5L3RhYmxlOmQ1Nzc2MTlkODM1ODRhZWNiNTE1YzZiODUwYjcwM2FmL3RhYmxlcmFuZ2U6ZDU3NzYxOWQ4MzU4NGFlY2I1MTVjNmI4NTBiNzAzYWZfMTAtMy0xLTEtMA_f270367b-fe3e-415f-bf66-4b8acf7602c3"
      unitRef="usd">1176000</us-gaap:AssetsHeldForSaleNotPartOfDisposalGroupCurrent>
    <us-gaap:AssetsCurrent
      contextRef="i225f85e38faa4bbdb4de1d8b9cf369bb_I20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzY2E5YmIwMTc5MjQ3NmZiYjIyNWU1ZDlkZWM4NjlmL3NlYzo5M2NhOWJiMDE3OTI0NzZmYmIyMjVlNWQ5ZGVjODY5Zl8xNi9mcmFnOmNhM2Q5OWRkMjk1ODQxYzQ4Yzk2ZDg0NGIzMGFkMjA5L3RhYmxlOmQ1Nzc2MTlkODM1ODRhZWNiNTE1YzZiODUwYjcwM2FmL3RhYmxlcmFuZ2U6ZDU3NzYxOWQ4MzU4NGFlY2I1MTVjNmI4NTBiNzAzYWZfMTEtMS0xLTEtMA_b2bc98c5-0c69-426c-9ec1-25041a5eff01"
      unitRef="usd">1162078000</us-gaap:AssetsCurrent>
    <us-gaap:AssetsCurrent
      contextRef="ifbe16ec51ea244519b77d6036b4ef038_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzY2E5YmIwMTc5MjQ3NmZiYjIyNWU1ZDlkZWM4NjlmL3NlYzo5M2NhOWJiMDE3OTI0NzZmYmIyMjVlNWQ5ZGVjODY5Zl8xNi9mcmFnOmNhM2Q5OWRkMjk1ODQxYzQ4Yzk2ZDg0NGIzMGFkMjA5L3RhYmxlOmQ1Nzc2MTlkODM1ODRhZWNiNTE1YzZiODUwYjcwM2FmL3RhYmxlcmFuZ2U6ZDU3NzYxOWQ4MzU4NGFlY2I1MTVjNmI4NTBiNzAzYWZfMTEtMy0xLTEtMA_93d2f7e6-2096-443d-9947-ab39f248c558"
      unitRef="usd">1372172000</us-gaap:AssetsCurrent>
    <us-gaap:AdvancesToAffiliate
      contextRef="i225f85e38faa4bbdb4de1d8b9cf369bb_I20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzY2E5YmIwMTc5MjQ3NmZiYjIyNWU1ZDlkZWM4NjlmL3NlYzo5M2NhOWJiMDE3OTI0NzZmYmIyMjVlNWQ5ZGVjODY5Zl8xNi9mcmFnOmNhM2Q5OWRkMjk1ODQxYzQ4Yzk2ZDg0NGIzMGFkMjA5L3RhYmxlOmQ1Nzc2MTlkODM1ODRhZWNiNTE1YzZiODUwYjcwM2FmL3RhYmxlcmFuZ2U6ZDU3NzYxOWQ4MzU4NGFlY2I1MTVjNmI4NTBiNzAzYWZfMTItMS0xLTEtMA_9daf52ec-6118-4f3b-b584-2b33b36e9ca8"
      unitRef="usd">499000</us-gaap:AdvancesToAffiliate>
    <us-gaap:AdvancesToAffiliate
      contextRef="ifbe16ec51ea244519b77d6036b4ef038_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzY2E5YmIwMTc5MjQ3NmZiYjIyNWU1ZDlkZWM4NjlmL3NlYzo5M2NhOWJiMDE3OTI0NzZmYmIyMjVlNWQ5ZGVjODY5Zl8xNi9mcmFnOmNhM2Q5OWRkMjk1ODQxYzQ4Yzk2ZDg0NGIzMGFkMjA5L3RhYmxlOmQ1Nzc2MTlkODM1ODRhZWNiNTE1YzZiODUwYjcwM2FmL3RhYmxlcmFuZ2U6ZDU3NzYxOWQ4MzU4NGFlY2I1MTVjNmI4NTBiNzAzYWZfMTItMy0xLTEtMA_a001d878-c9dd-4aa4-9f16-d5fa9be5e847"
      unitRef="usd">467000</us-gaap:AdvancesToAffiliate>
    <us-gaap:EquityMethodInvestments
      contextRef="i225f85e38faa4bbdb4de1d8b9cf369bb_I20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzY2E5YmIwMTc5MjQ3NmZiYjIyNWU1ZDlkZWM4NjlmL3NlYzo5M2NhOWJiMDE3OTI0NzZmYmIyMjVlNWQ5ZGVjODY5Zl8xNi9mcmFnOmNhM2Q5OWRkMjk1ODQxYzQ4Yzk2ZDg0NGIzMGFkMjA5L3RhYmxlOmQ1Nzc2MTlkODM1ODRhZWNiNTE1YzZiODUwYjcwM2FmL3RhYmxlcmFuZ2U6ZDU3NzYxOWQ4MzU4NGFlY2I1MTVjNmI4NTBiNzAzYWZfMTMtMS0xLTEtMA_fa2d9f5f-b15d-400f-a145-ac714ad31d43"
      unitRef="usd">20970000</us-gaap:EquityMethodInvestments>
    <us-gaap:EquityMethodInvestments
      contextRef="ifbe16ec51ea244519b77d6036b4ef038_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzY2E5YmIwMTc5MjQ3NmZiYjIyNWU1ZDlkZWM4NjlmL3NlYzo5M2NhOWJiMDE3OTI0NzZmYmIyMjVlNWQ5ZGVjODY5Zl8xNi9mcmFnOmNhM2Q5OWRkMjk1ODQxYzQ4Yzk2ZDg0NGIzMGFkMjA5L3RhYmxlOmQ1Nzc2MTlkODM1ODRhZWNiNTE1YzZiODUwYjcwM2FmL3RhYmxlcmFuZ2U6ZDU3NzYxOWQ4MzU4NGFlY2I1MTVjNmI4NTBiNzAzYWZfMTMtMy0xLTEtMA_d3feb182-060e-437f-afe6-0662e0004912"
      unitRef="usd">19235000</us-gaap:EquityMethodInvestments>
    <us-gaap:OtherLongTermInvestments
      contextRef="i225f85e38faa4bbdb4de1d8b9cf369bb_I20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzY2E5YmIwMTc5MjQ3NmZiYjIyNWU1ZDlkZWM4NjlmL3NlYzo5M2NhOWJiMDE3OTI0NzZmYmIyMjVlNWQ5ZGVjODY5Zl8xNi9mcmFnOmNhM2Q5OWRkMjk1ODQxYzQ4Yzk2ZDg0NGIzMGFkMjA5L3RhYmxlOmQ1Nzc2MTlkODM1ODRhZWNiNTE1YzZiODUwYjcwM2FmL3RhYmxlcmFuZ2U6ZDU3NzYxOWQ4MzU4NGFlY2I1MTVjNmI4NTBiNzAzYWZfMTQtMS0xLTEtODQzNg_6349d8e2-f007-450d-87e1-95f6b5c5c5a0"
      unitRef="usd">110392000</us-gaap:OtherLongTermInvestments>
    <us-gaap:OtherLongTermInvestments
      contextRef="ifbe16ec51ea244519b77d6036b4ef038_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzY2E5YmIwMTc5MjQ3NmZiYjIyNWU1ZDlkZWM4NjlmL3NlYzo5M2NhOWJiMDE3OTI0NzZmYmIyMjVlNWQ5ZGVjODY5Zl8xNi9mcmFnOmNhM2Q5OWRkMjk1ODQxYzQ4Yzk2ZDg0NGIzMGFkMjA5L3RhYmxlOmQ1Nzc2MTlkODM1ODRhZWNiNTE1YzZiODUwYjcwM2FmL3RhYmxlcmFuZ2U6ZDU3NzYxOWQ4MzU4NGFlY2I1MTVjNmI4NTBiNzAzYWZfMTQtMy0xLTEtODQzNg_78f83ecf-2e6b-4547-a950-feda249da21c"
      unitRef="usd">0</us-gaap:OtherLongTermInvestments>
    <us-gaap:NotesAndLoansReceivableNetNoncurrent
      contextRef="i225f85e38faa4bbdb4de1d8b9cf369bb_I20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzY2E5YmIwMTc5MjQ3NmZiYjIyNWU1ZDlkZWM4NjlmL3NlYzo5M2NhOWJiMDE3OTI0NzZmYmIyMjVlNWQ5ZGVjODY5Zl8xNi9mcmFnOmNhM2Q5OWRkMjk1ODQxYzQ4Yzk2ZDg0NGIzMGFkMjA5L3RhYmxlOmQ1Nzc2MTlkODM1ODRhZWNiNTE1YzZiODUwYjcwM2FmL3RhYmxlcmFuZ2U6ZDU3NzYxOWQ4MzU4NGFlY2I1MTVjNmI4NTBiNzAzYWZfMTQtMS0xLTEtMA_cd2af544-c7b8-4639-9c5f-3a75dc3e6023"
      unitRef="usd">94113000</us-gaap:NotesAndLoansReceivableNetNoncurrent>
    <us-gaap:NotesAndLoansReceivableNetNoncurrent
      contextRef="ifbe16ec51ea244519b77d6036b4ef038_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzY2E5YmIwMTc5MjQ3NmZiYjIyNWU1ZDlkZWM4NjlmL3NlYzo5M2NhOWJiMDE3OTI0NzZmYmIyMjVlNWQ5ZGVjODY5Zl8xNi9mcmFnOmNhM2Q5OWRkMjk1ODQxYzQ4Yzk2ZDg0NGIzMGFkMjA5L3RhYmxlOmQ1Nzc2MTlkODM1ODRhZWNiNTE1YzZiODUwYjcwM2FmL3RhYmxlcmFuZ2U6ZDU3NzYxOWQ4MzU4NGFlY2I1MTVjNmI4NTBiNzAzYWZfMTQtMy0xLTEtMA_ac828b6e-1391-4a7f-b0df-2e672c33b869"
      unitRef="usd">87191000</us-gaap:NotesAndLoansReceivableNetNoncurrent>
    <us-gaap:PropertyPlantAndEquipmentNet
      contextRef="i225f85e38faa4bbdb4de1d8b9cf369bb_I20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzY2E5YmIwMTc5MjQ3NmZiYjIyNWU1ZDlkZWM4NjlmL3NlYzo5M2NhOWJiMDE3OTI0NzZmYmIyMjVlNWQ5ZGVjODY5Zl8xNi9mcmFnOmNhM2Q5OWRkMjk1ODQxYzQ4Yzk2ZDg0NGIzMGFkMjA5L3RhYmxlOmQ1Nzc2MTlkODM1ODRhZWNiNTE1YzZiODUwYjcwM2FmL3RhYmxlcmFuZ2U6ZDU3NzYxOWQ4MzU4NGFlY2I1MTVjNmI4NTBiNzAzYWZfMTUtMS0xLTEtMA_3916666d-d659-47f3-8eec-a2f69918769a"
      unitRef="usd">193920000</us-gaap:PropertyPlantAndEquipmentNet>
    <us-gaap:PropertyPlantAndEquipmentNet
      contextRef="ifbe16ec51ea244519b77d6036b4ef038_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzY2E5YmIwMTc5MjQ3NmZiYjIyNWU1ZDlkZWM4NjlmL3NlYzo5M2NhOWJiMDE3OTI0NzZmYmIyMjVlNWQ5ZGVjODY5Zl8xNi9mcmFnOmNhM2Q5OWRkMjk1ODQxYzQ4Yzk2ZDg0NGIzMGFkMjA5L3RhYmxlOmQ1Nzc2MTlkODM1ODRhZWNiNTE1YzZiODUwYjcwM2FmL3RhYmxlcmFuZ2U6ZDU3NzYxOWQ4MzU4NGFlY2I1MTVjNmI4NTBiNzAzYWZfMTUtMy0xLTEtMA_91755e3c-4f34-4f80-92a9-3a9c10cf4002"
      unitRef="usd">187599000</us-gaap:PropertyPlantAndEquipmentNet>
    <us-gaap:OperatingLeaseRightOfUseAsset
      contextRef="i225f85e38faa4bbdb4de1d8b9cf369bb_I20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzY2E5YmIwMTc5MjQ3NmZiYjIyNWU1ZDlkZWM4NjlmL3NlYzo5M2NhOWJiMDE3OTI0NzZmYmIyMjVlNWQ5ZGVjODY5Zl8xNi9mcmFnOmNhM2Q5OWRkMjk1ODQxYzQ4Yzk2ZDg0NGIzMGFkMjA5L3RhYmxlOmQ1Nzc2MTlkODM1ODRhZWNiNTE1YzZiODUwYjcwM2FmL3RhYmxlcmFuZ2U6ZDU3NzYxOWQ4MzU4NGFlY2I1MTVjNmI4NTBiNzAzYWZfMTYtMS0xLTEtMA_8ec75659-e40a-49e7-bb34-803f3a312721"
      unitRef="usd">6687000</us-gaap:OperatingLeaseRightOfUseAsset>
    <us-gaap:OperatingLeaseRightOfUseAsset
      contextRef="ifbe16ec51ea244519b77d6036b4ef038_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzY2E5YmIwMTc5MjQ3NmZiYjIyNWU1ZDlkZWM4NjlmL3NlYzo5M2NhOWJiMDE3OTI0NzZmYmIyMjVlNWQ5ZGVjODY5Zl8xNi9mcmFnOmNhM2Q5OWRkMjk1ODQxYzQ4Yzk2ZDg0NGIzMGFkMjA5L3RhYmxlOmQ1Nzc2MTlkODM1ODRhZWNiNTE1YzZiODUwYjcwM2FmL3RhYmxlcmFuZ2U6ZDU3NzYxOWQ4MzU4NGFlY2I1MTVjNmI4NTBiNzAzYWZfMTYtMy0xLTEtMA_95144322-cc96-4eae-9971-913340b1ee47"
      unitRef="usd">9776000</us-gaap:OperatingLeaseRightOfUseAsset>
    <us-gaap:IntangibleAssetsNetExcludingGoodwill
      contextRef="i225f85e38faa4bbdb4de1d8b9cf369bb_I20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzY2E5YmIwMTc5MjQ3NmZiYjIyNWU1ZDlkZWM4NjlmL3NlYzo5M2NhOWJiMDE3OTI0NzZmYmIyMjVlNWQ5ZGVjODY5Zl8xNi9mcmFnOmNhM2Q5OWRkMjk1ODQxYzQ4Yzk2ZDg0NGIzMGFkMjA5L3RhYmxlOmQ1Nzc2MTlkODM1ODRhZWNiNTE1YzZiODUwYjcwM2FmL3RhYmxlcmFuZ2U6ZDU3NzYxOWQ4MzU4NGFlY2I1MTVjNmI4NTBiNzAzYWZfMTctMS0xLTEtMA_f80f2e8b-640f-45ea-8cd1-5947e2d5ee62"
      unitRef="usd">70409000</us-gaap:IntangibleAssetsNetExcludingGoodwill>
    <us-gaap:IntangibleAssetsNetExcludingGoodwill
      contextRef="ifbe16ec51ea244519b77d6036b4ef038_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzY2E5YmIwMTc5MjQ3NmZiYjIyNWU1ZDlkZWM4NjlmL3NlYzo5M2NhOWJiMDE3OTI0NzZmYmIyMjVlNWQ5ZGVjODY5Zl8xNi9mcmFnOmNhM2Q5OWRkMjk1ODQxYzQ4Yzk2ZDg0NGIzMGFkMjA5L3RhYmxlOmQ1Nzc2MTlkODM1ODRhZWNiNTE1YzZiODUwYjcwM2FmL3RhYmxlcmFuZ2U6ZDU3NzYxOWQ4MzU4NGFlY2I1MTVjNmI4NTBiNzAzYWZfMTctMy0xLTEtMA_f0698614-3a54-49f3-b41a-d0ae143a8450"
      unitRef="usd">69720000</us-gaap:IntangibleAssetsNetExcludingGoodwill>
    <us-gaap:Goodwill
      contextRef="i225f85e38faa4bbdb4de1d8b9cf369bb_I20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzY2E5YmIwMTc5MjQ3NmZiYjIyNWU1ZDlkZWM4NjlmL3NlYzo5M2NhOWJiMDE3OTI0NzZmYmIyMjVlNWQ5ZGVjODY5Zl8xNi9mcmFnOmNhM2Q5OWRkMjk1ODQxYzQ4Yzk2ZDg0NGIzMGFkMjA5L3RhYmxlOmQ1Nzc2MTlkODM1ODRhZWNiNTE1YzZiODUwYjcwM2FmL3RhYmxlcmFuZ2U6ZDU3NzYxOWQ4MzU4NGFlY2I1MTVjNmI4NTBiNzAzYWZfMTgtMS0xLTEtMA_48965b81-7ff8-4ffd-817c-3aa8cf53c38d"
      unitRef="usd">179543000</us-gaap:Goodwill>
    <us-gaap:Goodwill
      contextRef="ifbe16ec51ea244519b77d6036b4ef038_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzY2E5YmIwMTc5MjQ3NmZiYjIyNWU1ZDlkZWM4NjlmL3NlYzo5M2NhOWJiMDE3OTI0NzZmYmIyMjVlNWQ5ZGVjODY5Zl8xNi9mcmFnOmNhM2Q5OWRkMjk1ODQxYzQ4Yzk2ZDg0NGIzMGFkMjA5L3RhYmxlOmQ1Nzc2MTlkODM1ODRhZWNiNTE1YzZiODUwYjcwM2FmL3RhYmxlcmFuZ2U6ZDU3NzYxOWQ4MzU4NGFlY2I1MTVjNmI4NTBiNzAzYWZfMTgtMy0xLTEtMA_94d76e50-8e6a-4b2a-864e-58164c97fa32"
      unitRef="usd">179522000</us-gaap:Goodwill>
    <us-gaap:Assets
      contextRef="i225f85e38faa4bbdb4de1d8b9cf369bb_I20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzY2E5YmIwMTc5MjQ3NmZiYjIyNWU1ZDlkZWM4NjlmL3NlYzo5M2NhOWJiMDE3OTI0NzZmYmIyMjVlNWQ5ZGVjODY5Zl8xNi9mcmFnOmNhM2Q5OWRkMjk1ODQxYzQ4Yzk2ZDg0NGIzMGFkMjA5L3RhYmxlOmQ1Nzc2MTlkODM1ODRhZWNiNTE1YzZiODUwYjcwM2FmL3RhYmxlcmFuZ2U6ZDU3NzYxOWQ4MzU4NGFlY2I1MTVjNmI4NTBiNzAzYWZfMTktMS0xLTEtMA_9132d3ae-43df-4d9f-9744-1eddf966f2e3"
      unitRef="usd">1838611000</us-gaap:Assets>
    <us-gaap:Assets
      contextRef="ifbe16ec51ea244519b77d6036b4ef038_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzY2E5YmIwMTc5MjQ3NmZiYjIyNWU1ZDlkZWM4NjlmL3NlYzo5M2NhOWJiMDE3OTI0NzZmYmIyMjVlNWQ5ZGVjODY5Zl8xNi9mcmFnOmNhM2Q5OWRkMjk1ODQxYzQ4Yzk2ZDg0NGIzMGFkMjA5L3RhYmxlOmQ1Nzc2MTlkODM1ODRhZWNiNTE1YzZiODUwYjcwM2FmL3RhYmxlcmFuZ2U6ZDU3NzYxOWQ4MzU4NGFlY2I1MTVjNmI4NTBiNzAzYWZfMTktMy0xLTEtMA_c68d410b-3ae2-4e83-a05b-6c650f9a524c"
      unitRef="usd">1925682000</us-gaap:Assets>
    <us-gaap:AccountsPayableAndOtherAccruedLiabilitiesCurrent
      contextRef="i225f85e38faa4bbdb4de1d8b9cf369bb_I20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzY2E5YmIwMTc5MjQ3NmZiYjIyNWU1ZDlkZWM4NjlmL3NlYzo5M2NhOWJiMDE3OTI0NzZmYmIyMjVlNWQ5ZGVjODY5Zl8xNi9mcmFnOmNhM2Q5OWRkMjk1ODQxYzQ4Yzk2ZDg0NGIzMGFkMjA5L3RhYmxlOmQ1Nzc2MTlkODM1ODRhZWNiNTE1YzZiODUwYjcwM2FmL3RhYmxlcmFuZ2U6ZDU3NzYxOWQ4MzU4NGFlY2I1MTVjNmI4NTBiNzAzYWZfMjMtMS0xLTEtMA_96cb2af7-6e34-4581-9703-d984670a00e3"
      unitRef="usd">29829000</us-gaap:AccountsPayableAndOtherAccruedLiabilitiesCurrent>
    <us-gaap:AccountsPayableAndOtherAccruedLiabilitiesCurrent
      contextRef="ifbe16ec51ea244519b77d6036b4ef038_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzY2E5YmIwMTc5MjQ3NmZiYjIyNWU1ZDlkZWM4NjlmL3NlYzo5M2NhOWJiMDE3OTI0NzZmYmIyMjVlNWQ5ZGVjODY5Zl8xNi9mcmFnOmNhM2Q5OWRkMjk1ODQxYzQ4Yzk2ZDg0NGIzMGFkMjA5L3RhYmxlOmQ1Nzc2MTlkODM1ODRhZWNiNTE1YzZiODUwYjcwM2FmL3RhYmxlcmFuZ2U6ZDU3NzYxOWQ4MzU4NGFlY2I1MTVjNmI4NTBiNzAzYWZfMjMtMy0xLTEtMA_d675fa7f-9871-459a-8b98-0277fdb69d93"
      unitRef="usd">42102000</us-gaap:AccountsPayableAndOtherAccruedLiabilitiesCurrent>
    <us-gaap:OperatingLeaseLiabilityCurrent
      contextRef="i225f85e38faa4bbdb4de1d8b9cf369bb_I20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzY2E5YmIwMTc5MjQ3NmZiYjIyNWU1ZDlkZWM4NjlmL3NlYzo5M2NhOWJiMDE3OTI0NzZmYmIyMjVlNWQ5ZGVjODY5Zl8xNi9mcmFnOmNhM2Q5OWRkMjk1ODQxYzQ4Yzk2ZDg0NGIzMGFkMjA5L3RhYmxlOmQ1Nzc2MTlkODM1ODRhZWNiNTE1YzZiODUwYjcwM2FmL3RhYmxlcmFuZ2U6ZDU3NzYxOWQ4MzU4NGFlY2I1MTVjNmI4NTBiNzAzYWZfMjQtMS0xLTEtMA_84cc63ce-ee13-4e31-9718-c8ff48c85b50"
      unitRef="usd">1206000</us-gaap:OperatingLeaseLiabilityCurrent>
    <us-gaap:OperatingLeaseLiabilityCurrent
      contextRef="ifbe16ec51ea244519b77d6036b4ef038_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzY2E5YmIwMTc5MjQ3NmZiYjIyNWU1ZDlkZWM4NjlmL3NlYzo5M2NhOWJiMDE3OTI0NzZmYmIyMjVlNWQ5ZGVjODY5Zl8xNi9mcmFnOmNhM2Q5OWRkMjk1ODQxYzQ4Yzk2ZDg0NGIzMGFkMjA5L3RhYmxlOmQ1Nzc2MTlkODM1ODRhZWNiNTE1YzZiODUwYjcwM2FmL3RhYmxlcmFuZ2U6ZDU3NzYxOWQ4MzU4NGFlY2I1MTVjNmI4NTBiNzAzYWZfMjQtMy0xLTEtMA_42c2263e-4b34-45b2-8adf-7878667f1609"
      unitRef="usd">1322000</us-gaap:OperatingLeaseLiabilityCurrent>
    <us-gaap:DerivativeLiabilitiesCurrent
      contextRef="i225f85e38faa4bbdb4de1d8b9cf369bb_I20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzY2E5YmIwMTc5MjQ3NmZiYjIyNWU1ZDlkZWM4NjlmL3NlYzo5M2NhOWJiMDE3OTI0NzZmYmIyMjVlNWQ5ZGVjODY5Zl8xNi9mcmFnOmNhM2Q5OWRkMjk1ODQxYzQ4Yzk2ZDg0NGIzMGFkMjA5L3RhYmxlOmQ1Nzc2MTlkODM1ODRhZWNiNTE1YzZiODUwYjcwM2FmL3RhYmxlcmFuZ2U6ZDU3NzYxOWQ4MzU4NGFlY2I1MTVjNmI4NTBiNzAzYWZfMjUtMS0xLTEtMA_3f14bba8-55ab-46a1-a17b-a170fb010546"
      unitRef="usd">169563000</us-gaap:DerivativeLiabilitiesCurrent>
    <us-gaap:DerivativeLiabilitiesCurrent
      contextRef="ifbe16ec51ea244519b77d6036b4ef038_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzY2E5YmIwMTc5MjQ3NmZiYjIyNWU1ZDlkZWM4NjlmL3NlYzo5M2NhOWJiMDE3OTI0NzZmYmIyMjVlNWQ5ZGVjODY5Zl8xNi9mcmFnOmNhM2Q5OWRkMjk1ODQxYzQ4Yzk2ZDg0NGIzMGFkMjA5L3RhYmxlOmQ1Nzc2MTlkODM1ODRhZWNiNTE1YzZiODUwYjcwM2FmL3RhYmxlcmFuZ2U6ZDU3NzYxOWQ4MzU4NGFlY2I1MTVjNmI4NTBiNzAzYWZfMjUtMy0xLTEtMA_8d437cf4-fef6-4532-a764-bc1b0249381d"
      unitRef="usd">163410000</us-gaap:DerivativeLiabilitiesCurrent>
    <us-gaap:LiabilitiesCurrent
      contextRef="i225f85e38faa4bbdb4de1d8b9cf369bb_I20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzY2E5YmIwMTc5MjQ3NmZiYjIyNWU1ZDlkZWM4NjlmL3NlYzo5M2NhOWJiMDE3OTI0NzZmYmIyMjVlNWQ5ZGVjODY5Zl8xNi9mcmFnOmNhM2Q5OWRkMjk1ODQxYzQ4Yzk2ZDg0NGIzMGFkMjA5L3RhYmxlOmQ1Nzc2MTlkODM1ODRhZWNiNTE1YzZiODUwYjcwM2FmL3RhYmxlcmFuZ2U6ZDU3NzYxOWQ4MzU4NGFlY2I1MTVjNmI4NTBiNzAzYWZfMjYtMS0xLTEtMA_8a4f97a1-9774-4a6e-86a8-98807fad9a55"
      unitRef="usd">200598000</us-gaap:LiabilitiesCurrent>
    <us-gaap:LiabilitiesCurrent
      contextRef="ifbe16ec51ea244519b77d6036b4ef038_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzY2E5YmIwMTc5MjQ3NmZiYjIyNWU1ZDlkZWM4NjlmL3NlYzo5M2NhOWJiMDE3OTI0NzZmYmIyMjVlNWQ5ZGVjODY5Zl8xNi9mcmFnOmNhM2Q5OWRkMjk1ODQxYzQ4Yzk2ZDg0NGIzMGFkMjA5L3RhYmxlOmQ1Nzc2MTlkODM1ODRhZWNiNTE1YzZiODUwYjcwM2FmL3RhYmxlcmFuZ2U6ZDU3NzYxOWQ4MzU4NGFlY2I1MTVjNmI4NTBiNzAzYWZfMjYtMy0xLTEtMA_703af9e7-ae80-4f05-9cc3-e28ad1336056"
      unitRef="usd">206834000</us-gaap:LiabilitiesCurrent>
    <us-gaap:DueToRelatedPartiesNoncurrent
      contextRef="i225f85e38faa4bbdb4de1d8b9cf369bb_I20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzY2E5YmIwMTc5MjQ3NmZiYjIyNWU1ZDlkZWM4NjlmL3NlYzo5M2NhOWJiMDE3OTI0NzZmYmIyMjVlNWQ5ZGVjODY5Zl8xNi9mcmFnOmNhM2Q5OWRkMjk1ODQxYzQ4Yzk2ZDg0NGIzMGFkMjA5L3RhYmxlOmQ1Nzc2MTlkODM1ODRhZWNiNTE1YzZiODUwYjcwM2FmL3RhYmxlcmFuZ2U6ZDU3NzYxOWQ4MzU4NGFlY2I1MTVjNmI4NTBiNzAzYWZfMjctMS0xLTEtMA_ed022f65-1de8-4ddd-8048-ced230f122e5"
      unitRef="usd">1768000</us-gaap:DueToRelatedPartiesNoncurrent>
    <us-gaap:DueToRelatedPartiesNoncurrent
      contextRef="ifbe16ec51ea244519b77d6036b4ef038_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzY2E5YmIwMTc5MjQ3NmZiYjIyNWU1ZDlkZWM4NjlmL3NlYzo5M2NhOWJiMDE3OTI0NzZmYmIyMjVlNWQ5ZGVjODY5Zl8xNi9mcmFnOmNhM2Q5OWRkMjk1ODQxYzQ4Yzk2ZDg0NGIzMGFkMjA5L3RhYmxlOmQ1Nzc2MTlkODM1ODRhZWNiNTE1YzZiODUwYjcwM2FmL3RhYmxlcmFuZ2U6ZDU3NzYxOWQ4MzU4NGFlY2I1MTVjNmI4NTBiNzAzYWZfMjctMy0xLTEtMA_e3435fd0-83f9-4d0a-8c33-72bb6c56e3a1"
      unitRef="usd">2188000</us-gaap:DueToRelatedPartiesNoncurrent>
    <us-gaap:OperatingLeaseLiabilityNoncurrent
      contextRef="i225f85e38faa4bbdb4de1d8b9cf369bb_I20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzY2E5YmIwMTc5MjQ3NmZiYjIyNWU1ZDlkZWM4NjlmL3NlYzo5M2NhOWJiMDE3OTI0NzZmYmIyMjVlNWQ5ZGVjODY5Zl8xNi9mcmFnOmNhM2Q5OWRkMjk1ODQxYzQ4Yzk2ZDg0NGIzMGFkMjA5L3RhYmxlOmQ1Nzc2MTlkODM1ODRhZWNiNTE1YzZiODUwYjcwM2FmL3RhYmxlcmFuZ2U6ZDU3NzYxOWQ4MzU4NGFlY2I1MTVjNmI4NTBiNzAzYWZfMjgtMS0xLTEtMA_d05b65e0-13af-49ea-82a0-b6490032f5ca"
      unitRef="usd">6333000</us-gaap:OperatingLeaseLiabilityNoncurrent>
    <us-gaap:OperatingLeaseLiabilityNoncurrent
      contextRef="ifbe16ec51ea244519b77d6036b4ef038_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzY2E5YmIwMTc5MjQ3NmZiYjIyNWU1ZDlkZWM4NjlmL3NlYzo5M2NhOWJiMDE3OTI0NzZmYmIyMjVlNWQ5ZGVjODY5Zl8xNi9mcmFnOmNhM2Q5OWRkMjk1ODQxYzQ4Yzk2ZDg0NGIzMGFkMjA5L3RhYmxlOmQ1Nzc2MTlkODM1ODRhZWNiNTE1YzZiODUwYjcwM2FmL3RhYmxlcmFuZ2U6ZDU3NzYxOWQ4MzU4NGFlY2I1MTVjNmI4NTBiNzAzYWZfMjgtMy0xLTEtMA_6dba7b1d-42ae-42d4-a471-4bf6ae3289c9"
      unitRef="usd">8492000</us-gaap:OperatingLeaseLiabilityNoncurrent>
    <us-gaap:Liabilities
      contextRef="i225f85e38faa4bbdb4de1d8b9cf369bb_I20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzY2E5YmIwMTc5MjQ3NmZiYjIyNWU1ZDlkZWM4NjlmL3NlYzo5M2NhOWJiMDE3OTI0NzZmYmIyMjVlNWQ5ZGVjODY5Zl8xNi9mcmFnOmNhM2Q5OWRkMjk1ODQxYzQ4Yzk2ZDg0NGIzMGFkMjA5L3RhYmxlOmQ1Nzc2MTlkODM1ODRhZWNiNTE1YzZiODUwYjcwM2FmL3RhYmxlcmFuZ2U6ZDU3NzYxOWQ4MzU4NGFlY2I1MTVjNmI4NTBiNzAzYWZfMzAtMS0xLTEtMA_e60262d7-1d26-4bcc-9d20-a239e8b1b834"
      unitRef="usd">208699000</us-gaap:Liabilities>
    <us-gaap:Liabilities
      contextRef="ifbe16ec51ea244519b77d6036b4ef038_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzY2E5YmIwMTc5MjQ3NmZiYjIyNWU1ZDlkZWM4NjlmL3NlYzo5M2NhOWJiMDE3OTI0NzZmYmIyMjVlNWQ5ZGVjODY5Zl8xNi9mcmFnOmNhM2Q5OWRkMjk1ODQxYzQ4Yzk2ZDg0NGIzMGFkMjA5L3RhYmxlOmQ1Nzc2MTlkODM1ODRhZWNiNTE1YzZiODUwYjcwM2FmL3RhYmxlcmFuZ2U6ZDU3NzYxOWQ4MzU4NGFlY2I1MTVjNmI4NTBiNzAzYWZfMzAtMy0xLTEtMA_6bc5e1c6-db82-41bc-8542-e660237959dd"
      unitRef="usd">217514000</us-gaap:Liabilities>
    <us-gaap:CommitmentsAndContingencies
      contextRef="i225f85e38faa4bbdb4de1d8b9cf369bb_I20210630"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzY2E5YmIwMTc5MjQ3NmZiYjIyNWU1ZDlkZWM4NjlmL3NlYzo5M2NhOWJiMDE3OTI0NzZmYmIyMjVlNWQ5ZGVjODY5Zl8xNi9mcmFnOmNhM2Q5OWRkMjk1ODQxYzQ4Yzk2ZDg0NGIzMGFkMjA5L3RhYmxlOmQ1Nzc2MTlkODM1ODRhZWNiNTE1YzZiODUwYjcwM2FmL3RhYmxlcmFuZ2U6ZDU3NzYxOWQ4MzU4NGFlY2I1MTVjNmI4NTBiNzAzYWZfMzEtMS0xLTEtMA_b201c5b5-5d7b-46f4-b52f-f4db029c9312"
      unitRef="usd"
      xsi:nil="true"/>
    <us-gaap:CommitmentsAndContingencies
      contextRef="ifbe16ec51ea244519b77d6036b4ef038_I20201231"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzY2E5YmIwMTc5MjQ3NmZiYjIyNWU1ZDlkZWM4NjlmL3NlYzo5M2NhOWJiMDE3OTI0NzZmYmIyMjVlNWQ5ZGVjODY5Zl8xNi9mcmFnOmNhM2Q5OWRkMjk1ODQxYzQ4Yzk2ZDg0NGIzMGFkMjA5L3RhYmxlOmQ1Nzc2MTlkODM1ODRhZWNiNTE1YzZiODUwYjcwM2FmL3RhYmxlcmFuZ2U6ZDU3NzYxOWQ4MzU4NGFlY2I1MTVjNmI4NTBiNzAzYWZfMzEtMy0xLTEtMA_bdaf9669-017d-429f-aa36-335aefc9fd2e"
      unitRef="usd"
      xsi:nil="true"/>
    <us-gaap:CommonStockValue
      contextRef="i225f85e38faa4bbdb4de1d8b9cf369bb_I20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzY2E5YmIwMTc5MjQ3NmZiYjIyNWU1ZDlkZWM4NjlmL3NlYzo5M2NhOWJiMDE3OTI0NzZmYmIyMjVlNWQ5ZGVjODY5Zl8xNi9mcmFnOmNhM2Q5OWRkMjk1ODQxYzQ4Yzk2ZDg0NGIzMGFkMjA5L3RhYmxlOmQ1Nzc2MTlkODM1ODRhZWNiNTE1YzZiODUwYjcwM2FmL3RhYmxlcmFuZ2U6ZDU3NzYxOWQ4MzU4NGFlY2I1MTVjNmI4NTBiNzAzYWZfMzQtMS0xLTEtMA_5e098358-4e52-4202-99a3-6577d5e81128"
      unitRef="usd">572858000</us-gaap:CommonStockValue>
    <us-gaap:CommonStockValue
      contextRef="ifbe16ec51ea244519b77d6036b4ef038_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzY2E5YmIwMTc5MjQ3NmZiYjIyNWU1ZDlkZWM4NjlmL3NlYzo5M2NhOWJiMDE3OTI0NzZmYmIyMjVlNWQ5ZGVjODY5Zl8xNi9mcmFnOmNhM2Q5OWRkMjk1ODQxYzQ4Yzk2ZDg0NGIzMGFkMjA5L3RhYmxlOmQ1Nzc2MTlkODM1ODRhZWNiNTE1YzZiODUwYjcwM2FmL3RhYmxlcmFuZ2U6ZDU3NzYxOWQ4MzU4NGFlY2I1MTVjNmI4NTBiNzAzYWZfMzQtMy0xLTEtMA_45fdf40b-dbc8-4445-906e-9521e4f1d45e"
      unitRef="usd">569260000</us-gaap:CommonStockValue>
    <us-gaap:AdditionalPaidInCapital
      contextRef="i225f85e38faa4bbdb4de1d8b9cf369bb_I20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzY2E5YmIwMTc5MjQ3NmZiYjIyNWU1ZDlkZWM4NjlmL3NlYzo5M2NhOWJiMDE3OTI0NzZmYmIyMjVlNWQ5ZGVjODY5Zl8xNi9mcmFnOmNhM2Q5OWRkMjk1ODQxYzQ4Yzk2ZDg0NGIzMGFkMjA5L3RhYmxlOmQ1Nzc2MTlkODM1ODRhZWNiNTE1YzZiODUwYjcwM2FmL3RhYmxlcmFuZ2U6ZDU3NzYxOWQ4MzU4NGFlY2I1MTVjNmI4NTBiNzAzYWZfMzUtMS0xLTEtMA_e46d937b-1e49-4eac-b6f5-560e8466ac09"
      unitRef="usd">32368000</us-gaap:AdditionalPaidInCapital>
    <us-gaap:AdditionalPaidInCapital
      contextRef="ifbe16ec51ea244519b77d6036b4ef038_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzY2E5YmIwMTc5MjQ3NmZiYjIyNWU1ZDlkZWM4NjlmL3NlYzo5M2NhOWJiMDE3OTI0NzZmYmIyMjVlNWQ5ZGVjODY5Zl8xNi9mcmFnOmNhM2Q5OWRkMjk1ODQxYzQ4Yzk2ZDg0NGIzMGFkMjA5L3RhYmxlOmQ1Nzc2MTlkODM1ODRhZWNiNTE1YzZiODUwYjcwM2FmL3RhYmxlcmFuZ2U6ZDU3NzYxOWQ4MzU4NGFlY2I1MTVjNmI4NTBiNzAzYWZfMzUtMy0xLTEtMA_78de5e64-ec48-4a8f-aaf0-36e09bc37fe4"
      unitRef="usd">34596000</us-gaap:AdditionalPaidInCapital>
    <us-gaap:RetainedEarningsAccumulatedDeficit
      contextRef="i225f85e38faa4bbdb4de1d8b9cf369bb_I20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzY2E5YmIwMTc5MjQ3NmZiYjIyNWU1ZDlkZWM4NjlmL3NlYzo5M2NhOWJiMDE3OTI0NzZmYmIyMjVlNWQ5ZGVjODY5Zl8xNi9mcmFnOmNhM2Q5OWRkMjk1ODQxYzQ4Yzk2ZDg0NGIzMGFkMjA5L3RhYmxlOmQ1Nzc2MTlkODM1ODRhZWNiNTE1YzZiODUwYjcwM2FmL3RhYmxlcmFuZ2U6ZDU3NzYxOWQ4MzU4NGFlY2I1MTVjNmI4NTBiNzAzYWZfMzYtMS0xLTEtMA_b270e9ba-9492-4254-b390-e0855cb57543"
      unitRef="usd">955721000</us-gaap:RetainedEarningsAccumulatedDeficit>
    <us-gaap:RetainedEarningsAccumulatedDeficit
      contextRef="ifbe16ec51ea244519b77d6036b4ef038_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzY2E5YmIwMTc5MjQ3NmZiYjIyNWU1ZDlkZWM4NjlmL3NlYzo5M2NhOWJiMDE3OTI0NzZmYmIyMjVlNWQ5ZGVjODY5Zl8xNi9mcmFnOmNhM2Q5OWRkMjk1ODQxYzQ4Yzk2ZDg0NGIzMGFkMjA5L3RhYmxlOmQ1Nzc2MTlkODM1ODRhZWNiNTE1YzZiODUwYjcwM2FmL3RhYmxlcmFuZ2U6ZDU3NzYxOWQ4MzU4NGFlY2I1MTVjNmI4NTBiNzAzYWZfMzYtMy0xLTEtMA_b6299a1d-3295-44d3-a7e3-baba37ef358e"
      unitRef="usd">1064509000</us-gaap:RetainedEarningsAccumulatedDeficit>
    <us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax
      contextRef="i225f85e38faa4bbdb4de1d8b9cf369bb_I20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzY2E5YmIwMTc5MjQ3NmZiYjIyNWU1ZDlkZWM4NjlmL3NlYzo5M2NhOWJiMDE3OTI0NzZmYmIyMjVlNWQ5ZGVjODY5Zl8xNi9mcmFnOmNhM2Q5OWRkMjk1ODQxYzQ4Yzk2ZDg0NGIzMGFkMjA5L3RhYmxlOmQ1Nzc2MTlkODM1ODRhZWNiNTE1YzZiODUwYjcwM2FmL3RhYmxlcmFuZ2U6ZDU3NzYxOWQ4MzU4NGFlY2I1MTVjNmI4NTBiNzAzYWZfMzctMS0xLTEtMA_71fa1acb-2160-4dce-bdfb-c3e92ee53b7b"
      unitRef="usd">71729000</us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax
      contextRef="ifbe16ec51ea244519b77d6036b4ef038_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzY2E5YmIwMTc5MjQ3NmZiYjIyNWU1ZDlkZWM4NjlmL3NlYzo5M2NhOWJiMDE3OTI0NzZmYmIyMjVlNWQ5ZGVjODY5Zl8xNi9mcmFnOmNhM2Q5OWRkMjk1ODQxYzQ4Yzk2ZDg0NGIzMGFkMjA5L3RhYmxlOmQ1Nzc2MTlkODM1ODRhZWNiNTE1YzZiODUwYjcwM2FmL3RhYmxlcmFuZ2U6ZDU3NzYxOWQ4MzU4NGFlY2I1MTVjNmI4NTBiNzAzYWZfMzctMy0xLTEtMA_823baac8-4124-49bc-9b49-93956bcaaf40"
      unitRef="usd">42999000</us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:StockholdersEquity
      contextRef="i225f85e38faa4bbdb4de1d8b9cf369bb_I20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzY2E5YmIwMTc5MjQ3NmZiYjIyNWU1ZDlkZWM4NjlmL3NlYzo5M2NhOWJiMDE3OTI0NzZmYmIyMjVlNWQ5ZGVjODY5Zl8xNi9mcmFnOmNhM2Q5OWRkMjk1ODQxYzQ4Yzk2ZDg0NGIzMGFkMjA5L3RhYmxlOmQ1Nzc2MTlkODM1ODRhZWNiNTE1YzZiODUwYjcwM2FmL3RhYmxlcmFuZ2U6ZDU3NzYxOWQ4MzU4NGFlY2I1MTVjNmI4NTBiNzAzYWZfMzgtMS0xLTEtMA_ffc64459-bdf4-4976-8c22-76c54e759a01"
      unitRef="usd">1632676000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="ifbe16ec51ea244519b77d6036b4ef038_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzY2E5YmIwMTc5MjQ3NmZiYjIyNWU1ZDlkZWM4NjlmL3NlYzo5M2NhOWJiMDE3OTI0NzZmYmIyMjVlNWQ5ZGVjODY5Zl8xNi9mcmFnOmNhM2Q5OWRkMjk1ODQxYzQ4Yzk2ZDg0NGIzMGFkMjA5L3RhYmxlOmQ1Nzc2MTlkODM1ODRhZWNiNTE1YzZiODUwYjcwM2FmL3RhYmxlcmFuZ2U6ZDU3NzYxOWQ4MzU4NGFlY2I1MTVjNmI4NTBiNzAzYWZfMzgtMy0xLTEtMA_0b9484df-492a-4086-8c80-d8cc572b0639"
      unitRef="usd">1711364000</us-gaap:StockholdersEquity>
    <us-gaap:MinorityInterest
      contextRef="i225f85e38faa4bbdb4de1d8b9cf369bb_I20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzY2E5YmIwMTc5MjQ3NmZiYjIyNWU1ZDlkZWM4NjlmL3NlYzo5M2NhOWJiMDE3OTI0NzZmYmIyMjVlNWQ5ZGVjODY5Zl8xNi9mcmFnOmNhM2Q5OWRkMjk1ODQxYzQ4Yzk2ZDg0NGIzMGFkMjA5L3RhYmxlOmQ1Nzc2MTlkODM1ODRhZWNiNTE1YzZiODUwYjcwM2FmL3RhYmxlcmFuZ2U6ZDU3NzYxOWQ4MzU4NGFlY2I1MTVjNmI4NTBiNzAzYWZfMzktMS0xLTEtMA_befe71e4-9541-4e7d-a407-9cbdf4ef6d9c"
      unitRef="usd">-2764000</us-gaap:MinorityInterest>
    <us-gaap:MinorityInterest
      contextRef="ifbe16ec51ea244519b77d6036b4ef038_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzY2E5YmIwMTc5MjQ3NmZiYjIyNWU1ZDlkZWM4NjlmL3NlYzo5M2NhOWJiMDE3OTI0NzZmYmIyMjVlNWQ5ZGVjODY5Zl8xNi9mcmFnOmNhM2Q5OWRkMjk1ODQxYzQ4Yzk2ZDg0NGIzMGFkMjA5L3RhYmxlOmQ1Nzc2MTlkODM1ODRhZWNiNTE1YzZiODUwYjcwM2FmL3RhYmxlcmFuZ2U6ZDU3NzYxOWQ4MzU4NGFlY2I1MTVjNmI4NTBiNzAzYWZfMzktMy0xLTEtMA_f7a01bb6-7013-4eab-919b-7f0d18fb8a7a"
      unitRef="usd">-3196000</us-gaap:MinorityInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i225f85e38faa4bbdb4de1d8b9cf369bb_I20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzY2E5YmIwMTc5MjQ3NmZiYjIyNWU1ZDlkZWM4NjlmL3NlYzo5M2NhOWJiMDE3OTI0NzZmYmIyMjVlNWQ5ZGVjODY5Zl8xNi9mcmFnOmNhM2Q5OWRkMjk1ODQxYzQ4Yzk2ZDg0NGIzMGFkMjA5L3RhYmxlOmQ1Nzc2MTlkODM1ODRhZWNiNTE1YzZiODUwYjcwM2FmL3RhYmxlcmFuZ2U6ZDU3NzYxOWQ4MzU4NGFlY2I1MTVjNmI4NTBiNzAzYWZfNDAtMS0xLTEtMA_3d292113-2267-40aa-a1f6-3e563d499256"
      unitRef="usd">1629912000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="ifbe16ec51ea244519b77d6036b4ef038_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzY2E5YmIwMTc5MjQ3NmZiYjIyNWU1ZDlkZWM4NjlmL3NlYzo5M2NhOWJiMDE3OTI0NzZmYmIyMjVlNWQ5ZGVjODY5Zl8xNi9mcmFnOmNhM2Q5OWRkMjk1ODQxYzQ4Yzk2ZDg0NGIzMGFkMjA5L3RhYmxlOmQ1Nzc2MTlkODM1ODRhZWNiNTE1YzZiODUwYjcwM2FmL3RhYmxlcmFuZ2U6ZDU3NzYxOWQ4MzU4NGFlY2I1MTVjNmI4NTBiNzAzYWZfNDAtMy0xLTEtMA_0e113c35-98c3-4bf3-a85c-8565a4abfbfd"
      unitRef="usd">1708168000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:LiabilitiesAndStockholdersEquity
      contextRef="i225f85e38faa4bbdb4de1d8b9cf369bb_I20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzY2E5YmIwMTc5MjQ3NmZiYjIyNWU1ZDlkZWM4NjlmL3NlYzo5M2NhOWJiMDE3OTI0NzZmYmIyMjVlNWQ5ZGVjODY5Zl8xNi9mcmFnOmNhM2Q5OWRkMjk1ODQxYzQ4Yzk2ZDg0NGIzMGFkMjA5L3RhYmxlOmQ1Nzc2MTlkODM1ODRhZWNiNTE1YzZiODUwYjcwM2FmL3RhYmxlcmFuZ2U6ZDU3NzYxOWQ4MzU4NGFlY2I1MTVjNmI4NTBiNzAzYWZfNDEtMS0xLTEtMA_65b8af39-e193-423b-84b5-49cf66daf11b"
      unitRef="usd">1838611000</us-gaap:LiabilitiesAndStockholdersEquity>
    <us-gaap:LiabilitiesAndStockholdersEquity
      contextRef="ifbe16ec51ea244519b77d6036b4ef038_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzY2E5YmIwMTc5MjQ3NmZiYjIyNWU1ZDlkZWM4NjlmL3NlYzo5M2NhOWJiMDE3OTI0NzZmYmIyMjVlNWQ5ZGVjODY5Zl8xNi9mcmFnOmNhM2Q5OWRkMjk1ODQxYzQ4Yzk2ZDg0NGIzMGFkMjA5L3RhYmxlOmQ1Nzc2MTlkODM1ODRhZWNiNTE1YzZiODUwYjcwM2FmL3RhYmxlcmFuZ2U6ZDU3NzYxOWQ4MzU4NGFlY2I1MTVjNmI4NTBiNzAzYWZfNDEtMy0xLTEtMA_3d9bc560-3aee-4c7d-95d3-894d04ab6615"
      unitRef="usd">1925682000</us-gaap:LiabilitiesAndStockholdersEquity>
    <us-gaap:CommonStockSharesIssued
      contextRef="i225f85e38faa4bbdb4de1d8b9cf369bb_I20210630"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzY2E5YmIwMTc5MjQ3NmZiYjIyNWU1ZDlkZWM4NjlmL3NlYzo5M2NhOWJiMDE3OTI0NzZmYmIyMjVlNWQ5ZGVjODY5Zl8xNi9mcmFnOmNhM2Q5OWRkMjk1ODQxYzQ4Yzk2ZDg0NGIzMGFkMjA5L3RleHRyZWdpb246Y2EzZDk5ZGQyOTU4NDFjNDhjOTZkODQ0YjMwYWQyMDlfMjc0ODc3OTA2OTk0NQ_0bca332b-e36e-44a0-b4e6-4af2da12ccb6"
      unitRef="shares">371805547</us-gaap:CommonStockSharesIssued>
    <us-gaap:CommonStockSharesIssued
      contextRef="ifbe16ec51ea244519b77d6036b4ef038_I20201231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzY2E5YmIwMTc5MjQ3NmZiYjIyNWU1ZDlkZWM4NjlmL3NlYzo5M2NhOWJiMDE3OTI0NzZmYmIyMjVlNWQ5ZGVjODY5Zl8xNi9mcmFnOmNhM2Q5OWRkMjk1ODQxYzQ4Yzk2ZDg0NGIzMGFkMjA5L3RleHRyZWdpb246Y2EzZDk5ZGQyOTU4NDFjNDhjOTZkODQ0YjMwYWQyMDlfNDA5_b8b6bb3b-21de-42fe-ab53-6da931387517"
      unitRef="shares">360253332</us-gaap:CommonStockSharesIssued>
    <us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax
      contextRef="i27f4e53b91ad4367b7f8d273eff27769_D20210401-20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzY2E5YmIwMTc5MjQ3NmZiYjIyNWU1ZDlkZWM4NjlmL3NlYzo5M2NhOWJiMDE3OTI0NzZmYmIyMjVlNWQ5ZGVjODY5Zl8xOS9mcmFnOmNhNDBhNzBkOTFkZDRiMGE4YTQxZjI0NmM2NDMxNTliL3RhYmxlOmZhYjNmZGNhNDc0YTQ1NDg5MWQ5MDg5NjU4NjM0M2RlL3RhYmxlcmFuZ2U6ZmFiM2ZkY2E0NzRhNDU0ODkxZDkwODk2NTg2MzQzZGVfMi0xLTEtMS0w_50888fbe-e363-413a-9c4d-6fa07d22528c"
      unitRef="usd">18848000</us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax
      contextRef="i39065c5daf934af885335c12f3cfa83f_D20200401-20200630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzY2E5YmIwMTc5MjQ3NmZiYjIyNWU1ZDlkZWM4NjlmL3NlYzo5M2NhOWJiMDE3OTI0NzZmYmIyMjVlNWQ5ZGVjODY5Zl8xOS9mcmFnOmNhNDBhNzBkOTFkZDRiMGE4YTQxZjI0NmM2NDMxNTliL3RhYmxlOmZhYjNmZGNhNDc0YTQ1NDg5MWQ5MDg5NjU4NjM0M2RlL3RhYmxlcmFuZ2U6ZmFiM2ZkY2E0NzRhNDU0ODkxZDkwODk2NTg2MzQzZGVfMi0zLTEtMS0w_e5a0d1c6-de8a-42fe-9f9c-9f1dd74eac8c"
      unitRef="usd">11432000</us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax
      contextRef="i69782326f71a44e3805518280ee22b6b_D20210101-20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzY2E5YmIwMTc5MjQ3NmZiYjIyNWU1ZDlkZWM4NjlmL3NlYzo5M2NhOWJiMDE3OTI0NzZmYmIyMjVlNWQ5ZGVjODY5Zl8xOS9mcmFnOmNhNDBhNzBkOTFkZDRiMGE4YTQxZjI0NmM2NDMxNTliL3RhYmxlOmZhYjNmZGNhNDc0YTQ1NDg5MWQ5MDg5NjU4NjM0M2RlL3RhYmxlcmFuZ2U6ZmFiM2ZkY2E0NzRhNDU0ODkxZDkwODk2NTg2MzQzZGVfMi01LTEtMS0w_51732b79-af08-43d1-8b57-f241034ec09e"
      unitRef="usd">33502000</us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax
      contextRef="i4a110e4972ef4113880ce582e3cda5c5_D20200101-20200630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzY2E5YmIwMTc5MjQ3NmZiYjIyNWU1ZDlkZWM4NjlmL3NlYzo5M2NhOWJiMDE3OTI0NzZmYmIyMjVlNWQ5ZGVjODY5Zl8xOS9mcmFnOmNhNDBhNzBkOTFkZDRiMGE4YTQxZjI0NmM2NDMxNTliL3RhYmxlOmZhYjNmZGNhNDc0YTQ1NDg5MWQ5MDg5NjU4NjM0M2RlL3RhYmxlcmFuZ2U6ZmFiM2ZkY2E0NzRhNDU0ODkxZDkwODk2NTg2MzQzZGVfMi03LTEtMS0w_6525ef23-b7df-4419-9995-4627eee1f413"
      unitRef="usd">20776000</us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax>
    <us-gaap:ExciseAndSalesTaxes
      contextRef="i27f4e53b91ad4367b7f8d273eff27769_D20210401-20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzY2E5YmIwMTc5MjQ3NmZiYjIyNWU1ZDlkZWM4NjlmL3NlYzo5M2NhOWJiMDE3OTI0NzZmYmIyMjVlNWQ5ZGVjODY5Zl8xOS9mcmFnOmNhNDBhNzBkOTFkZDRiMGE4YTQxZjI0NmM2NDMxNTliL3RhYmxlOmZhYjNmZGNhNDc0YTQ1NDg5MWQ5MDg5NjU4NjM0M2RlL3RhYmxlcmFuZ2U6ZmFiM2ZkY2E0NzRhNDU0ODkxZDkwODk2NTg2MzQzZGVfMy0xLTEtMS0w_2b7b4ead-bdf8-49e5-bd0a-ec7ed1202ecc"
      unitRef="usd">3226000</us-gaap:ExciseAndSalesTaxes>
    <us-gaap:ExciseAndSalesTaxes
      contextRef="i39065c5daf934af885335c12f3cfa83f_D20200401-20200630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzY2E5YmIwMTc5MjQ3NmZiYjIyNWU1ZDlkZWM4NjlmL3NlYzo5M2NhOWJiMDE3OTI0NzZmYmIyMjVlNWQ5ZGVjODY5Zl8xOS9mcmFnOmNhNDBhNzBkOTFkZDRiMGE4YTQxZjI0NmM2NDMxNTliL3RhYmxlOmZhYjNmZGNhNDc0YTQ1NDg5MWQ5MDg5NjU4NjM0M2RlL3RhYmxlcmFuZ2U6ZmFiM2ZkY2E0NzRhNDU0ODkxZDkwODk2NTg2MzQzZGVfMy0zLTEtMS0w_cb49ba58-f5e4-4ae0-aacf-cd515376dbe1"
      unitRef="usd">1549000</us-gaap:ExciseAndSalesTaxes>
    <us-gaap:ExciseAndSalesTaxes
      contextRef="i69782326f71a44e3805518280ee22b6b_D20210101-20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzY2E5YmIwMTc5MjQ3NmZiYjIyNWU1ZDlkZWM4NjlmL3NlYzo5M2NhOWJiMDE3OTI0NzZmYmIyMjVlNWQ5ZGVjODY5Zl8xOS9mcmFnOmNhNDBhNzBkOTFkZDRiMGE4YTQxZjI0NmM2NDMxNTliL3RhYmxlOmZhYjNmZGNhNDc0YTQ1NDg5MWQ5MDg5NjU4NjM0M2RlL3RhYmxlcmFuZ2U6ZmFiM2ZkY2E0NzRhNDU0ODkxZDkwODk2NTg2MzQzZGVfMy01LTEtMS0w_6317ecaa-247d-4a20-ba56-40fc72dfb46d"
      unitRef="usd">5269000</us-gaap:ExciseAndSalesTaxes>
    <us-gaap:ExciseAndSalesTaxes
      contextRef="i4a110e4972ef4113880ce582e3cda5c5_D20200101-20200630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzY2E5YmIwMTc5MjQ3NmZiYjIyNWU1ZDlkZWM4NjlmL3NlYzo5M2NhOWJiMDE3OTI0NzZmYmIyMjVlNWQ5ZGVjODY5Zl8xOS9mcmFnOmNhNDBhNzBkOTFkZDRiMGE4YTQxZjI0NmM2NDMxNTliL3RhYmxlOmZhYjNmZGNhNDc0YTQ1NDg5MWQ5MDg5NjU4NjM0M2RlL3RhYmxlcmFuZ2U6ZmFiM2ZkY2E0NzRhNDU0ODkxZDkwODk2NTg2MzQzZGVfMy03LTEtMS0w_59e4caee-aac5-4c15-88cc-9e1bda0dde33"
      unitRef="usd">2461000</us-gaap:ExciseAndSalesTaxes>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i27f4e53b91ad4367b7f8d273eff27769_D20210401-20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzY2E5YmIwMTc5MjQ3NmZiYjIyNWU1ZDlkZWM4NjlmL3NlYzo5M2NhOWJiMDE3OTI0NzZmYmIyMjVlNWQ5ZGVjODY5Zl8xOS9mcmFnOmNhNDBhNzBkOTFkZDRiMGE4YTQxZjI0NmM2NDMxNTliL3RhYmxlOmZhYjNmZGNhNDc0YTQ1NDg5MWQ5MDg5NjU4NjM0M2RlL3RhYmxlcmFuZ2U6ZmFiM2ZkY2E0NzRhNDU0ODkxZDkwODk2NTg2MzQzZGVfNC0xLTEtMS0w_3007c979-7e62-4502-a4ec-0e139822d1a5"
      unitRef="usd">15622000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i39065c5daf934af885335c12f3cfa83f_D20200401-20200630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzY2E5YmIwMTc5MjQ3NmZiYjIyNWU1ZDlkZWM4NjlmL3NlYzo5M2NhOWJiMDE3OTI0NzZmYmIyMjVlNWQ5ZGVjODY5Zl8xOS9mcmFnOmNhNDBhNzBkOTFkZDRiMGE4YTQxZjI0NmM2NDMxNTliL3RhYmxlOmZhYjNmZGNhNDc0YTQ1NDg5MWQ5MDg5NjU4NjM0M2RlL3RhYmxlcmFuZ2U6ZmFiM2ZkY2E0NzRhNDU0ODkxZDkwODk2NTg2MzQzZGVfNC0zLTEtMS0w_51ad3389-41e9-484c-894e-0921afdc9aef"
      unitRef="usd">9883000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i69782326f71a44e3805518280ee22b6b_D20210101-20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzY2E5YmIwMTc5MjQ3NmZiYjIyNWU1ZDlkZWM4NjlmL3NlYzo5M2NhOWJiMDE3OTI0NzZmYmIyMjVlNWQ5ZGVjODY5Zl8xOS9mcmFnOmNhNDBhNzBkOTFkZDRiMGE4YTQxZjI0NmM2NDMxNTliL3RhYmxlOmZhYjNmZGNhNDc0YTQ1NDg5MWQ5MDg5NjU4NjM0M2RlL3RhYmxlcmFuZ2U6ZmFiM2ZkY2E0NzRhNDU0ODkxZDkwODk2NTg2MzQzZGVfNC01LTEtMS0w_e899cd90-5ab4-439f-b21e-b458d3f71993"
      unitRef="usd">28233000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i4a110e4972ef4113880ce582e3cda5c5_D20200101-20200630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzY2E5YmIwMTc5MjQ3NmZiYjIyNWU1ZDlkZWM4NjlmL3NlYzo5M2NhOWJiMDE3OTI0NzZmYmIyMjVlNWQ5ZGVjODY5Zl8xOS9mcmFnOmNhNDBhNzBkOTFkZDRiMGE4YTQxZjI0NmM2NDMxNTliL3RhYmxlOmZhYjNmZGNhNDc0YTQ1NDg5MWQ5MDg5NjU4NjM0M2RlL3RhYmxlcmFuZ2U6ZmFiM2ZkY2E0NzRhNDU0ODkxZDkwODk2NTg2MzQzZGVfNC03LTEtMS0w_1d2f9ddc-a243-4bf8-8473-7670e85d1ac9"
      unitRef="usd">18315000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <cron:OtherCostOfGoodsAndServicesSold
      contextRef="i27f4e53b91ad4367b7f8d273eff27769_D20210401-20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzY2E5YmIwMTc5MjQ3NmZiYjIyNWU1ZDlkZWM4NjlmL3NlYzo5M2NhOWJiMDE3OTI0NzZmYmIyMjVlNWQ5ZGVjODY5Zl8xOS9mcmFnOmNhNDBhNzBkOTFkZDRiMGE4YTQxZjI0NmM2NDMxNTliL3RhYmxlOmZhYjNmZGNhNDc0YTQ1NDg5MWQ5MDg5NjU4NjM0M2RlL3RhYmxlcmFuZ2U6ZmFiM2ZkY2E0NzRhNDU0ODkxZDkwODk2NTg2MzQzZGVfNS0xLTEtMS0w_3ccba461-87a7-4bd0-8d4b-d7c35cb6cde5"
      unitRef="usd">19445000</cron:OtherCostOfGoodsAndServicesSold>
    <cron:OtherCostOfGoodsAndServicesSold
      contextRef="i39065c5daf934af885335c12f3cfa83f_D20200401-20200630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzY2E5YmIwMTc5MjQ3NmZiYjIyNWU1ZDlkZWM4NjlmL3NlYzo5M2NhOWJiMDE3OTI0NzZmYmIyMjVlNWQ5ZGVjODY5Zl8xOS9mcmFnOmNhNDBhNzBkOTFkZDRiMGE4YTQxZjI0NmM2NDMxNTliL3RhYmxlOmZhYjNmZGNhNDc0YTQ1NDg5MWQ5MDg5NjU4NjM0M2RlL3RhYmxlcmFuZ2U6ZmFiM2ZkY2E0NzRhNDU0ODkxZDkwODk2NTg2MzQzZGVfNS0zLTEtMS0w_fdce626a-7e83-4776-9eb5-0501c55324d9"
      unitRef="usd">9743000</cron:OtherCostOfGoodsAndServicesSold>
    <cron:OtherCostOfGoodsAndServicesSold
      contextRef="i69782326f71a44e3805518280ee22b6b_D20210101-20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzY2E5YmIwMTc5MjQ3NmZiYjIyNWU1ZDlkZWM4NjlmL3NlYzo5M2NhOWJiMDE3OTI0NzZmYmIyMjVlNWQ5ZGVjODY5Zl8xOS9mcmFnOmNhNDBhNzBkOTFkZDRiMGE4YTQxZjI0NmM2NDMxNTliL3RhYmxlOmZhYjNmZGNhNDc0YTQ1NDg5MWQ5MDg5NjU4NjM0M2RlL3RhYmxlcmFuZ2U6ZmFiM2ZkY2E0NzRhNDU0ODkxZDkwODk2NTg2MzQzZGVfNS01LTEtMS0w_84f3ea0f-3f7d-4add-b852-0fe82ff1c03d"
      unitRef="usd">35019000</cron:OtherCostOfGoodsAndServicesSold>
    <cron:OtherCostOfGoodsAndServicesSold
      contextRef="i4a110e4972ef4113880ce582e3cda5c5_D20200101-20200630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzY2E5YmIwMTc5MjQ3NmZiYjIyNWU1ZDlkZWM4NjlmL3NlYzo5M2NhOWJiMDE3OTI0NzZmYmIyMjVlNWQ5ZGVjODY5Zl8xOS9mcmFnOmNhNDBhNzBkOTFkZDRiMGE4YTQxZjI0NmM2NDMxNTliL3RhYmxlOmZhYjNmZGNhNDc0YTQ1NDg5MWQ5MDg5NjU4NjM0M2RlL3RhYmxlcmFuZ2U6ZmFiM2ZkY2E0NzRhNDU0ODkxZDkwODk2NTg2MzQzZGVfNS03LTEtMS0w_ec0b294f-7162-4f9e-832e-d7a721a286f6"
      unitRef="usd">16689000</cron:OtherCostOfGoodsAndServicesSold>
    <us-gaap:InventoryWriteDown
      contextRef="i27f4e53b91ad4367b7f8d273eff27769_D20210401-20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzY2E5YmIwMTc5MjQ3NmZiYjIyNWU1ZDlkZWM4NjlmL3NlYzo5M2NhOWJiMDE3OTI0NzZmYmIyMjVlNWQ5ZGVjODY5Zl8xOS9mcmFnOmNhNDBhNzBkOTFkZDRiMGE4YTQxZjI0NmM2NDMxNTliL3RhYmxlOmZhYjNmZGNhNDc0YTQ1NDg5MWQ5MDg5NjU4NjM0M2RlL3RhYmxlcmFuZ2U6ZmFiM2ZkY2E0NzRhNDU0ODkxZDkwODk2NTg2MzQzZGVfNi0xLTEtMS0w_2cc0e551-1484-49be-9e25-be9d29f1e286"
      unitRef="usd">11961000</us-gaap:InventoryWriteDown>
    <us-gaap:InventoryWriteDown
      contextRef="i39065c5daf934af885335c12f3cfa83f_D20200401-20200630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzY2E5YmIwMTc5MjQ3NmZiYjIyNWU1ZDlkZWM4NjlmL3NlYzo5M2NhOWJiMDE3OTI0NzZmYmIyMjVlNWQ5ZGVjODY5Zl8xOS9mcmFnOmNhNDBhNzBkOTFkZDRiMGE4YTQxZjI0NmM2NDMxNTliL3RhYmxlOmZhYjNmZGNhNDc0YTQ1NDg5MWQ5MDg5NjU4NjM0M2RlL3RhYmxlcmFuZ2U6ZmFiM2ZkY2E0NzRhNDU0ODkxZDkwODk2NTg2MzQzZGVfNi0zLTEtMS0w_1665176c-ff5f-4468-b9af-4a55504bf7cc"
      unitRef="usd">3062000</us-gaap:InventoryWriteDown>
    <us-gaap:InventoryWriteDown
      contextRef="i69782326f71a44e3805518280ee22b6b_D20210101-20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzY2E5YmIwMTc5MjQ3NmZiYjIyNWU1ZDlkZWM4NjlmL3NlYzo5M2NhOWJiMDE3OTI0NzZmYmIyMjVlNWQ5ZGVjODY5Zl8xOS9mcmFnOmNhNDBhNzBkOTFkZDRiMGE4YTQxZjI0NmM2NDMxNTliL3RhYmxlOmZhYjNmZGNhNDc0YTQ1NDg5MWQ5MDg5NjU4NjM0M2RlL3RhYmxlcmFuZ2U6ZmFiM2ZkY2E0NzRhNDU0ODkxZDkwODk2NTg2MzQzZGVfNi01LTEtMS0w_2a9dafe0-8a61-4eae-a96d-3660507151e9"
      unitRef="usd">11961000</us-gaap:InventoryWriteDown>
    <us-gaap:InventoryWriteDown
      contextRef="i4a110e4972ef4113880ce582e3cda5c5_D20200101-20200630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzY2E5YmIwMTc5MjQ3NmZiYjIyNWU1ZDlkZWM4NjlmL3NlYzo5M2NhOWJiMDE3OTI0NzZmYmIyMjVlNWQ5ZGVjODY5Zl8xOS9mcmFnOmNhNDBhNzBkOTFkZDRiMGE4YTQxZjI0NmM2NDMxNTliL3RhYmxlOmZhYjNmZGNhNDc0YTQ1NDg5MWQ5MDg5NjU4NjM0M2RlL3RhYmxlcmFuZ2U6ZmFiM2ZkY2E0NzRhNDU0ODkxZDkwODk2NTg2MzQzZGVfNi03LTEtMS0w_c3db7689-9d82-4eed-888e-71ee09f22527"
      unitRef="usd">11024000</us-gaap:InventoryWriteDown>
    <us-gaap:GrossProfit
      contextRef="i27f4e53b91ad4367b7f8d273eff27769_D20210401-20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzY2E5YmIwMTc5MjQ3NmZiYjIyNWU1ZDlkZWM4NjlmL3NlYzo5M2NhOWJiMDE3OTI0NzZmYmIyMjVlNWQ5ZGVjODY5Zl8xOS9mcmFnOmNhNDBhNzBkOTFkZDRiMGE4YTQxZjI0NmM2NDMxNTliL3RhYmxlOmZhYjNmZGNhNDc0YTQ1NDg5MWQ5MDg5NjU4NjM0M2RlL3RhYmxlcmFuZ2U6ZmFiM2ZkY2E0NzRhNDU0ODkxZDkwODk2NTg2MzQzZGVfNy0xLTEtMS0w_6a972024-7dd6-4b29-8e40-5d0b43be17ac"
      unitRef="usd">-15784000</us-gaap:GrossProfit>
    <us-gaap:GrossProfit
      contextRef="i39065c5daf934af885335c12f3cfa83f_D20200401-20200630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzY2E5YmIwMTc5MjQ3NmZiYjIyNWU1ZDlkZWM4NjlmL3NlYzo5M2NhOWJiMDE3OTI0NzZmYmIyMjVlNWQ5ZGVjODY5Zl8xOS9mcmFnOmNhNDBhNzBkOTFkZDRiMGE4YTQxZjI0NmM2NDMxNTliL3RhYmxlOmZhYjNmZGNhNDc0YTQ1NDg5MWQ5MDg5NjU4NjM0M2RlL3RhYmxlcmFuZ2U6ZmFiM2ZkY2E0NzRhNDU0ODkxZDkwODk2NTg2MzQzZGVfNy0zLTEtMS0w_0869b8a0-3b34-415b-86bf-8142d0f6609a"
      unitRef="usd">-2922000</us-gaap:GrossProfit>
    <us-gaap:GrossProfit
      contextRef="i69782326f71a44e3805518280ee22b6b_D20210101-20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzY2E5YmIwMTc5MjQ3NmZiYjIyNWU1ZDlkZWM4NjlmL3NlYzo5M2NhOWJiMDE3OTI0NzZmYmIyMjVlNWQ5ZGVjODY5Zl8xOS9mcmFnOmNhNDBhNzBkOTFkZDRiMGE4YTQxZjI0NmM2NDMxNTliL3RhYmxlOmZhYjNmZGNhNDc0YTQ1NDg5MWQ5MDg5NjU4NjM0M2RlL3RhYmxlcmFuZ2U6ZmFiM2ZkY2E0NzRhNDU0ODkxZDkwODk2NTg2MzQzZGVfNy01LTEtMS0w_9b6716ee-9243-4a31-b94d-e882f90a5140"
      unitRef="usd">-18747000</us-gaap:GrossProfit>
    <us-gaap:GrossProfit
      contextRef="i4a110e4972ef4113880ce582e3cda5c5_D20200101-20200630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzY2E5YmIwMTc5MjQ3NmZiYjIyNWU1ZDlkZWM4NjlmL3NlYzo5M2NhOWJiMDE3OTI0NzZmYmIyMjVlNWQ5ZGVjODY5Zl8xOS9mcmFnOmNhNDBhNzBkOTFkZDRiMGE4YTQxZjI0NmM2NDMxNTliL3RhYmxlOmZhYjNmZGNhNDc0YTQ1NDg5MWQ5MDg5NjU4NjM0M2RlL3RhYmxlcmFuZ2U6ZmFiM2ZkY2E0NzRhNDU0ODkxZDkwODk2NTg2MzQzZGVfNy03LTEtMS0w_c0138458-1c03-4078-a131-5aa07f9eeb8b"
      unitRef="usd">-9398000</us-gaap:GrossProfit>
    <us-gaap:SellingAndMarketingExpense
      contextRef="i27f4e53b91ad4367b7f8d273eff27769_D20210401-20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzY2E5YmIwMTc5MjQ3NmZiYjIyNWU1ZDlkZWM4NjlmL3NlYzo5M2NhOWJiMDE3OTI0NzZmYmIyMjVlNWQ5ZGVjODY5Zl8xOS9mcmFnOmNhNDBhNzBkOTFkZDRiMGE4YTQxZjI0NmM2NDMxNTliL3RhYmxlOmZhYjNmZGNhNDc0YTQ1NDg5MWQ5MDg5NjU4NjM0M2RlL3RhYmxlcmFuZ2U6ZmFiM2ZkY2E0NzRhNDU0ODkxZDkwODk2NTg2MzQzZGVfOS0xLTEtMS0w_025080e4-ad38-4b13-b966-204e56eff66b"
      unitRef="usd">13209000</us-gaap:SellingAndMarketingExpense>
    <us-gaap:SellingAndMarketingExpense
      contextRef="i39065c5daf934af885335c12f3cfa83f_D20200401-20200630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzY2E5YmIwMTc5MjQ3NmZiYjIyNWU1ZDlkZWM4NjlmL3NlYzo5M2NhOWJiMDE3OTI0NzZmYmIyMjVlNWQ5ZGVjODY5Zl8xOS9mcmFnOmNhNDBhNzBkOTFkZDRiMGE4YTQxZjI0NmM2NDMxNTliL3RhYmxlOmZhYjNmZGNhNDc0YTQ1NDg5MWQ5MDg5NjU4NjM0M2RlL3RhYmxlcmFuZ2U6ZmFiM2ZkY2E0NzRhNDU0ODkxZDkwODk2NTg2MzQzZGVfOS0zLTEtMS0w_077688b7-61ea-42ab-a6f2-c8e6a5769472"
      unitRef="usd">6501000</us-gaap:SellingAndMarketingExpense>
    <us-gaap:SellingAndMarketingExpense
      contextRef="i69782326f71a44e3805518280ee22b6b_D20210101-20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzY2E5YmIwMTc5MjQ3NmZiYjIyNWU1ZDlkZWM4NjlmL3NlYzo5M2NhOWJiMDE3OTI0NzZmYmIyMjVlNWQ5ZGVjODY5Zl8xOS9mcmFnOmNhNDBhNzBkOTFkZDRiMGE4YTQxZjI0NmM2NDMxNTliL3RhYmxlOmZhYjNmZGNhNDc0YTQ1NDg5MWQ5MDg5NjU4NjM0M2RlL3RhYmxlcmFuZ2U6ZmFiM2ZkY2E0NzRhNDU0ODkxZDkwODk2NTg2MzQzZGVfOS01LTEtMS0w_cbee0a11-7dc9-4f4f-9eba-8346c81d4288"
      unitRef="usd">23463000</us-gaap:SellingAndMarketingExpense>
    <us-gaap:SellingAndMarketingExpense
      contextRef="i4a110e4972ef4113880ce582e3cda5c5_D20200101-20200630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzY2E5YmIwMTc5MjQ3NmZiYjIyNWU1ZDlkZWM4NjlmL3NlYzo5M2NhOWJiMDE3OTI0NzZmYmIyMjVlNWQ5ZGVjODY5Zl8xOS9mcmFnOmNhNDBhNzBkOTFkZDRiMGE4YTQxZjI0NmM2NDMxNTliL3RhYmxlOmZhYjNmZGNhNDc0YTQ1NDg5MWQ5MDg5NjU4NjM0M2RlL3RhYmxlcmFuZ2U6ZmFiM2ZkY2E0NzRhNDU0ODkxZDkwODk2NTg2MzQzZGVfOS03LTEtMS0w_95da2167-c856-4226-b95f-bfdfd587ea93"
      unitRef="usd">13613000</us-gaap:SellingAndMarketingExpense>
    <us-gaap:ResearchAndDevelopmentExpense
      contextRef="i27f4e53b91ad4367b7f8d273eff27769_D20210401-20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzY2E5YmIwMTc5MjQ3NmZiYjIyNWU1ZDlkZWM4NjlmL3NlYzo5M2NhOWJiMDE3OTI0NzZmYmIyMjVlNWQ5ZGVjODY5Zl8xOS9mcmFnOmNhNDBhNzBkOTFkZDRiMGE4YTQxZjI0NmM2NDMxNTliL3RhYmxlOmZhYjNmZGNhNDc0YTQ1NDg5MWQ5MDg5NjU4NjM0M2RlL3RhYmxlcmFuZ2U6ZmFiM2ZkY2E0NzRhNDU0ODkxZDkwODk2NTg2MzQzZGVfMTAtMS0xLTEtMA_0d529f5f-2c8c-4e5b-a557-c68a0dd2f62a"
      unitRef="usd">5199000</us-gaap:ResearchAndDevelopmentExpense>
    <us-gaap:ResearchAndDevelopmentExpense
      contextRef="i39065c5daf934af885335c12f3cfa83f_D20200401-20200630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzY2E5YmIwMTc5MjQ3NmZiYjIyNWU1ZDlkZWM4NjlmL3NlYzo5M2NhOWJiMDE3OTI0NzZmYmIyMjVlNWQ5ZGVjODY5Zl8xOS9mcmFnOmNhNDBhNzBkOTFkZDRiMGE4YTQxZjI0NmM2NDMxNTliL3RhYmxlOmZhYjNmZGNhNDc0YTQ1NDg5MWQ5MDg5NjU4NjM0M2RlL3RhYmxlcmFuZ2U6ZmFiM2ZkY2E0NzRhNDU0ODkxZDkwODk2NTg2MzQzZGVfMTAtMy0xLTEtMA_02907507-af78-45bc-9e43-64e3f6467d67"
      unitRef="usd">3631000</us-gaap:ResearchAndDevelopmentExpense>
    <us-gaap:ResearchAndDevelopmentExpense
      contextRef="i69782326f71a44e3805518280ee22b6b_D20210101-20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzY2E5YmIwMTc5MjQ3NmZiYjIyNWU1ZDlkZWM4NjlmL3NlYzo5M2NhOWJiMDE3OTI0NzZmYmIyMjVlNWQ5ZGVjODY5Zl8xOS9mcmFnOmNhNDBhNzBkOTFkZDRiMGE4YTQxZjI0NmM2NDMxNTliL3RhYmxlOmZhYjNmZGNhNDc0YTQ1NDg5MWQ5MDg5NjU4NjM0M2RlL3RhYmxlcmFuZ2U6ZmFiM2ZkY2E0NzRhNDU0ODkxZDkwODk2NTg2MzQzZGVfMTAtNS0xLTEtMA_cac03843-55cc-4442-8d80-9a042c78f2dd"
      unitRef="usd">10301000</us-gaap:ResearchAndDevelopmentExpense>
    <us-gaap:ResearchAndDevelopmentExpense
      contextRef="i4a110e4972ef4113880ce582e3cda5c5_D20200101-20200630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzY2E5YmIwMTc5MjQ3NmZiYjIyNWU1ZDlkZWM4NjlmL3NlYzo5M2NhOWJiMDE3OTI0NzZmYmIyMjVlNWQ5ZGVjODY5Zl8xOS9mcmFnOmNhNDBhNzBkOTFkZDRiMGE4YTQxZjI0NmM2NDMxNTliL3RhYmxlOmZhYjNmZGNhNDc0YTQ1NDg5MWQ5MDg5NjU4NjM0M2RlL3RhYmxlcmFuZ2U6ZmFiM2ZkY2E0NzRhNDU0ODkxZDkwODk2NTg2MzQzZGVfMTAtNy0xLTEtMA_d7f9bea2-31cd-4966-922b-52864f25933d"
      unitRef="usd">8221000</us-gaap:ResearchAndDevelopmentExpense>
    <us-gaap:GeneralAndAdministrativeExpense
      contextRef="i27f4e53b91ad4367b7f8d273eff27769_D20210401-20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzY2E5YmIwMTc5MjQ3NmZiYjIyNWU1ZDlkZWM4NjlmL3NlYzo5M2NhOWJiMDE3OTI0NzZmYmIyMjVlNWQ5ZGVjODY5Zl8xOS9mcmFnOmNhNDBhNzBkOTFkZDRiMGE4YTQxZjI0NmM2NDMxNTliL3RhYmxlOmZhYjNmZGNhNDc0YTQ1NDg5MWQ5MDg5NjU4NjM0M2RlL3RhYmxlcmFuZ2U6ZmFiM2ZkY2E0NzRhNDU0ODkxZDkwODk2NTg2MzQzZGVfMTEtMS0xLTEtMA_505f630a-5fd9-4ef8-91df-d40ce0c5c8c1"
      unitRef="usd">22417000</us-gaap:GeneralAndAdministrativeExpense>
    <us-gaap:GeneralAndAdministrativeExpense
      contextRef="i39065c5daf934af885335c12f3cfa83f_D20200401-20200630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzY2E5YmIwMTc5MjQ3NmZiYjIyNWU1ZDlkZWM4NjlmL3NlYzo5M2NhOWJiMDE3OTI0NzZmYmIyMjVlNWQ5ZGVjODY5Zl8xOS9mcmFnOmNhNDBhNzBkOTFkZDRiMGE4YTQxZjI0NmM2NDMxNTliL3RhYmxlOmZhYjNmZGNhNDc0YTQ1NDg5MWQ5MDg5NjU4NjM0M2RlL3RhYmxlcmFuZ2U6ZmFiM2ZkY2E0NzRhNDU0ODkxZDkwODk2NTg2MzQzZGVfMTEtMy0xLTEtMA_ab7fb95f-6f86-4165-89ca-6b61c0b10ff9"
      unitRef="usd">18429000</us-gaap:GeneralAndAdministrativeExpense>
    <us-gaap:GeneralAndAdministrativeExpense
      contextRef="i69782326f71a44e3805518280ee22b6b_D20210101-20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzY2E5YmIwMTc5MjQ3NmZiYjIyNWU1ZDlkZWM4NjlmL3NlYzo5M2NhOWJiMDE3OTI0NzZmYmIyMjVlNWQ5ZGVjODY5Zl8xOS9mcmFnOmNhNDBhNzBkOTFkZDRiMGE4YTQxZjI0NmM2NDMxNTliL3RhYmxlOmZhYjNmZGNhNDc0YTQ1NDg5MWQ5MDg5NjU4NjM0M2RlL3RhYmxlcmFuZ2U6ZmFiM2ZkY2E0NzRhNDU0ODkxZDkwODk2NTg2MzQzZGVfMTEtNS0xLTEtMA_0546a3ab-11a0-4698-b117-835e3af02130"
      unitRef="usd">44323000</us-gaap:GeneralAndAdministrativeExpense>
    <us-gaap:GeneralAndAdministrativeExpense
      contextRef="i4a110e4972ef4113880ce582e3cda5c5_D20200101-20200630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzY2E5YmIwMTc5MjQ3NmZiYjIyNWU1ZDlkZWM4NjlmL3NlYzo5M2NhOWJiMDE3OTI0NzZmYmIyMjVlNWQ5ZGVjODY5Zl8xOS9mcmFnOmNhNDBhNzBkOTFkZDRiMGE4YTQxZjI0NmM2NDMxNTliL3RhYmxlOmZhYjNmZGNhNDc0YTQ1NDg5MWQ5MDg5NjU4NjM0M2RlL3RhYmxlcmFuZ2U6ZmFiM2ZkY2E0NzRhNDU0ODkxZDkwODk2NTg2MzQzZGVfMTEtNy0xLTEtMA_bfcb94ad-ce70-42d1-bc53-f4c0b612fb09"
      unitRef="usd">42188000</us-gaap:GeneralAndAdministrativeExpense>
    <us-gaap:AllocatedShareBasedCompensationExpense
      contextRef="i27f4e53b91ad4367b7f8d273eff27769_D20210401-20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzY2E5YmIwMTc5MjQ3NmZiYjIyNWU1ZDlkZWM4NjlmL3NlYzo5M2NhOWJiMDE3OTI0NzZmYmIyMjVlNWQ5ZGVjODY5Zl8xOS9mcmFnOmNhNDBhNzBkOTFkZDRiMGE4YTQxZjI0NmM2NDMxNTliL3RhYmxlOmZhYjNmZGNhNDc0YTQ1NDg5MWQ5MDg5NjU4NjM0M2RlL3RhYmxlcmFuZ2U6ZmFiM2ZkY2E0NzRhNDU0ODkxZDkwODk2NTg2MzQzZGVfMTItMS0xLTEtMA_06a34de7-b143-4c1d-bed5-3098ad47e395"
      unitRef="usd">2565000</us-gaap:AllocatedShareBasedCompensationExpense>
    <us-gaap:AllocatedShareBasedCompensationExpense
      contextRef="i39065c5daf934af885335c12f3cfa83f_D20200401-20200630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzY2E5YmIwMTc5MjQ3NmZiYjIyNWU1ZDlkZWM4NjlmL3NlYzo5M2NhOWJiMDE3OTI0NzZmYmIyMjVlNWQ5ZGVjODY5Zl8xOS9mcmFnOmNhNDBhNzBkOTFkZDRiMGE4YTQxZjI0NmM2NDMxNTliL3RhYmxlOmZhYjNmZGNhNDc0YTQ1NDg5MWQ5MDg5NjU4NjM0M2RlL3RhYmxlcmFuZ2U6ZmFiM2ZkY2E0NzRhNDU0ODkxZDkwODk2NTg2MzQzZGVfMTItMy0xLTEtMA_39d388f1-71a2-4cdf-a5c4-e8b3aeb4169e"
      unitRef="usd">2546000</us-gaap:AllocatedShareBasedCompensationExpense>
    <us-gaap:AllocatedShareBasedCompensationExpense
      contextRef="i69782326f71a44e3805518280ee22b6b_D20210101-20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzY2E5YmIwMTc5MjQ3NmZiYjIyNWU1ZDlkZWM4NjlmL3NlYzo5M2NhOWJiMDE3OTI0NzZmYmIyMjVlNWQ5ZGVjODY5Zl8xOS9mcmFnOmNhNDBhNzBkOTFkZDRiMGE4YTQxZjI0NmM2NDMxNTliL3RhYmxlOmZhYjNmZGNhNDc0YTQ1NDg5MWQ5MDg5NjU4NjM0M2RlL3RhYmxlcmFuZ2U6ZmFiM2ZkY2E0NzRhNDU0ODkxZDkwODk2NTg2MzQzZGVfMTItNS0xLTEtMA_98784325-1ce6-4b35-9d1f-4c7e418f2886"
      unitRef="usd">5064000</us-gaap:AllocatedShareBasedCompensationExpense>
    <us-gaap:AllocatedShareBasedCompensationExpense
      contextRef="i4a110e4972ef4113880ce582e3cda5c5_D20200101-20200630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzY2E5YmIwMTc5MjQ3NmZiYjIyNWU1ZDlkZWM4NjlmL3NlYzo5M2NhOWJiMDE3OTI0NzZmYmIyMjVlNWQ5ZGVjODY5Zl8xOS9mcmFnOmNhNDBhNzBkOTFkZDRiMGE4YTQxZjI0NmM2NDMxNTliL3RhYmxlOmZhYjNmZGNhNDc0YTQ1NDg5MWQ5MDg5NjU4NjM0M2RlL3RhYmxlcmFuZ2U6ZmFiM2ZkY2E0NzRhNDU0ODkxZDkwODk2NTg2MzQzZGVfMTItNy0xLTEtMA_486e8ae4-7906-4b21-81e9-fbaa762f344c"
      unitRef="usd">4982000</us-gaap:AllocatedShareBasedCompensationExpense>
    <us-gaap:DepreciationAndAmortization
      contextRef="i27f4e53b91ad4367b7f8d273eff27769_D20210401-20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzY2E5YmIwMTc5MjQ3NmZiYjIyNWU1ZDlkZWM4NjlmL3NlYzo5M2NhOWJiMDE3OTI0NzZmYmIyMjVlNWQ5ZGVjODY5Zl8xOS9mcmFnOmNhNDBhNzBkOTFkZDRiMGE4YTQxZjI0NmM2NDMxNTliL3RhYmxlOmZhYjNmZGNhNDc0YTQ1NDg5MWQ5MDg5NjU4NjM0M2RlL3RhYmxlcmFuZ2U6ZmFiM2ZkY2E0NzRhNDU0ODkxZDkwODk2NTg2MzQzZGVfMTMtMS0xLTEtMA_c947354a-813b-49ab-8d99-1cfe38dbd840"
      unitRef="usd">1043000</us-gaap:DepreciationAndAmortization>
    <us-gaap:DepreciationAndAmortization
      contextRef="i39065c5daf934af885335c12f3cfa83f_D20200401-20200630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzY2E5YmIwMTc5MjQ3NmZiYjIyNWU1ZDlkZWM4NjlmL3NlYzo5M2NhOWJiMDE3OTI0NzZmYmIyMjVlNWQ5ZGVjODY5Zl8xOS9mcmFnOmNhNDBhNzBkOTFkZDRiMGE4YTQxZjI0NmM2NDMxNTliL3RhYmxlOmZhYjNmZGNhNDc0YTQ1NDg5MWQ5MDg5NjU4NjM0M2RlL3RhYmxlcmFuZ2U6ZmFiM2ZkY2E0NzRhNDU0ODkxZDkwODk2NTg2MzQzZGVfMTMtMy0xLTEtMA_31e8adc7-f6e1-4047-861e-0d136aa1ac54"
      unitRef="usd">679000</us-gaap:DepreciationAndAmortization>
    <us-gaap:DepreciationAndAmortization
      contextRef="i69782326f71a44e3805518280ee22b6b_D20210101-20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzY2E5YmIwMTc5MjQ3NmZiYjIyNWU1ZDlkZWM4NjlmL3NlYzo5M2NhOWJiMDE3OTI0NzZmYmIyMjVlNWQ5ZGVjODY5Zl8xOS9mcmFnOmNhNDBhNzBkOTFkZDRiMGE4YTQxZjI0NmM2NDMxNTliL3RhYmxlOmZhYjNmZGNhNDc0YTQ1NDg5MWQ5MDg5NjU4NjM0M2RlL3RhYmxlcmFuZ2U6ZmFiM2ZkY2E0NzRhNDU0ODkxZDkwODk2NTg2MzQzZGVfMTMtNS0xLTEtMA_af54ccab-a75b-4531-84f2-f1c3bb02d345"
      unitRef="usd">1778000</us-gaap:DepreciationAndAmortization>
    <us-gaap:DepreciationAndAmortization
      contextRef="i4a110e4972ef4113880ce582e3cda5c5_D20200101-20200630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzY2E5YmIwMTc5MjQ3NmZiYjIyNWU1ZDlkZWM4NjlmL3NlYzo5M2NhOWJiMDE3OTI0NzZmYmIyMjVlNWQ5ZGVjODY5Zl8xOS9mcmFnOmNhNDBhNzBkOTFkZDRiMGE4YTQxZjI0NmM2NDMxNTliL3RhYmxlOmZhYjNmZGNhNDc0YTQ1NDg5MWQ5MDg5NjU4NjM0M2RlL3RhYmxlcmFuZ2U6ZmFiM2ZkY2E0NzRhNDU0ODkxZDkwODk2NTg2MzQzZGVfMTMtNy0xLTEtMA_e55401cc-9fdc-44aa-95c5-1a5ea6db22ab"
      unitRef="usd">1366000</us-gaap:DepreciationAndAmortization>
    <us-gaap:OperatingExpenses
      contextRef="i27f4e53b91ad4367b7f8d273eff27769_D20210401-20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzY2E5YmIwMTc5MjQ3NmZiYjIyNWU1ZDlkZWM4NjlmL3NlYzo5M2NhOWJiMDE3OTI0NzZmYmIyMjVlNWQ5ZGVjODY5Zl8xOS9mcmFnOmNhNDBhNzBkOTFkZDRiMGE4YTQxZjI0NmM2NDMxNTliL3RhYmxlOmZhYjNmZGNhNDc0YTQ1NDg5MWQ5MDg5NjU4NjM0M2RlL3RhYmxlcmFuZ2U6ZmFiM2ZkY2E0NzRhNDU0ODkxZDkwODk2NTg2MzQzZGVfMTQtMS0xLTEtMA_76ff862d-f1cd-461e-a41d-65bbe27d490e"
      unitRef="usd">44433000</us-gaap:OperatingExpenses>
    <us-gaap:OperatingExpenses
      contextRef="i39065c5daf934af885335c12f3cfa83f_D20200401-20200630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzY2E5YmIwMTc5MjQ3NmZiYjIyNWU1ZDlkZWM4NjlmL3NlYzo5M2NhOWJiMDE3OTI0NzZmYmIyMjVlNWQ5ZGVjODY5Zl8xOS9mcmFnOmNhNDBhNzBkOTFkZDRiMGE4YTQxZjI0NmM2NDMxNTliL3RhYmxlOmZhYjNmZGNhNDc0YTQ1NDg5MWQ5MDg5NjU4NjM0M2RlL3RhYmxlcmFuZ2U6ZmFiM2ZkY2E0NzRhNDU0ODkxZDkwODk2NTg2MzQzZGVfMTQtMy0xLTEtMA_d662f6d2-dcec-4573-9448-2afbdc6b6d7f"
      unitRef="usd">31786000</us-gaap:OperatingExpenses>
    <us-gaap:OperatingExpenses
      contextRef="i69782326f71a44e3805518280ee22b6b_D20210101-20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzY2E5YmIwMTc5MjQ3NmZiYjIyNWU1ZDlkZWM4NjlmL3NlYzo5M2NhOWJiMDE3OTI0NzZmYmIyMjVlNWQ5ZGVjODY5Zl8xOS9mcmFnOmNhNDBhNzBkOTFkZDRiMGE4YTQxZjI0NmM2NDMxNTliL3RhYmxlOmZhYjNmZGNhNDc0YTQ1NDg5MWQ5MDg5NjU4NjM0M2RlL3RhYmxlcmFuZ2U6ZmFiM2ZkY2E0NzRhNDU0ODkxZDkwODk2NTg2MzQzZGVfMTQtNS0xLTEtMA_25cb53b8-fb68-4c6f-bf6a-fc066d4b6870"
      unitRef="usd">84929000</us-gaap:OperatingExpenses>
    <us-gaap:OperatingExpenses
      contextRef="i4a110e4972ef4113880ce582e3cda5c5_D20200101-20200630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzY2E5YmIwMTc5MjQ3NmZiYjIyNWU1ZDlkZWM4NjlmL3NlYzo5M2NhOWJiMDE3OTI0NzZmYmIyMjVlNWQ5ZGVjODY5Zl8xOS9mcmFnOmNhNDBhNzBkOTFkZDRiMGE4YTQxZjI0NmM2NDMxNTliL3RhYmxlOmZhYjNmZGNhNDc0YTQ1NDg5MWQ5MDg5NjU4NjM0M2RlL3RhYmxlcmFuZ2U6ZmFiM2ZkY2E0NzRhNDU0ODkxZDkwODk2NTg2MzQzZGVfMTQtNy0xLTEtMA_49144751-1082-44fe-b914-c3a27dd73c72"
      unitRef="usd">70370000</us-gaap:OperatingExpenses>
    <us-gaap:OperatingIncomeLoss
      contextRef="i27f4e53b91ad4367b7f8d273eff27769_D20210401-20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzY2E5YmIwMTc5MjQ3NmZiYjIyNWU1ZDlkZWM4NjlmL3NlYzo5M2NhOWJiMDE3OTI0NzZmYmIyMjVlNWQ5ZGVjODY5Zl8xOS9mcmFnOmNhNDBhNzBkOTFkZDRiMGE4YTQxZjI0NmM2NDMxNTliL3RhYmxlOmZhYjNmZGNhNDc0YTQ1NDg5MWQ5MDg5NjU4NjM0M2RlL3RhYmxlcmFuZ2U6ZmFiM2ZkY2E0NzRhNDU0ODkxZDkwODk2NTg2MzQzZGVfMTUtMS0xLTEtMA_00dd98e1-7d95-4809-873f-5b36379f6e1a"
      unitRef="usd">-60217000</us-gaap:OperatingIncomeLoss>
    <us-gaap:OperatingIncomeLoss
      contextRef="i39065c5daf934af885335c12f3cfa83f_D20200401-20200630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzY2E5YmIwMTc5MjQ3NmZiYjIyNWU1ZDlkZWM4NjlmL3NlYzo5M2NhOWJiMDE3OTI0NzZmYmIyMjVlNWQ5ZGVjODY5Zl8xOS9mcmFnOmNhNDBhNzBkOTFkZDRiMGE4YTQxZjI0NmM2NDMxNTliL3RhYmxlOmZhYjNmZGNhNDc0YTQ1NDg5MWQ5MDg5NjU4NjM0M2RlL3RhYmxlcmFuZ2U6ZmFiM2ZkY2E0NzRhNDU0ODkxZDkwODk2NTg2MzQzZGVfMTUtMy0xLTEtMA_ad089d39-f8d7-45b1-aeb4-ab3ae455eb21"
      unitRef="usd">-34708000</us-gaap:OperatingIncomeLoss>
    <us-gaap:OperatingIncomeLoss
      contextRef="i69782326f71a44e3805518280ee22b6b_D20210101-20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzY2E5YmIwMTc5MjQ3NmZiYjIyNWU1ZDlkZWM4NjlmL3NlYzo5M2NhOWJiMDE3OTI0NzZmYmIyMjVlNWQ5ZGVjODY5Zl8xOS9mcmFnOmNhNDBhNzBkOTFkZDRiMGE4YTQxZjI0NmM2NDMxNTliL3RhYmxlOmZhYjNmZGNhNDc0YTQ1NDg5MWQ5MDg5NjU4NjM0M2RlL3RhYmxlcmFuZ2U6ZmFiM2ZkY2E0NzRhNDU0ODkxZDkwODk2NTg2MzQzZGVfMTUtNS0xLTEtMA_0323735d-2f02-4ad0-93ae-120252ff7dc9"
      unitRef="usd">-103676000</us-gaap:OperatingIncomeLoss>
    <us-gaap:OperatingIncomeLoss
      contextRef="i4a110e4972ef4113880ce582e3cda5c5_D20200101-20200630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzY2E5YmIwMTc5MjQ3NmZiYjIyNWU1ZDlkZWM4NjlmL3NlYzo5M2NhOWJiMDE3OTI0NzZmYmIyMjVlNWQ5ZGVjODY5Zl8xOS9mcmFnOmNhNDBhNzBkOTFkZDRiMGE4YTQxZjI0NmM2NDMxNTliL3RhYmxlOmZhYjNmZGNhNDc0YTQ1NDg5MWQ5MDg5NjU4NjM0M2RlL3RhYmxlcmFuZ2U6ZmFiM2ZkY2E0NzRhNDU0ODkxZDkwODk2NTg2MzQzZGVfMTUtNy0xLTEtMA_a95ae1c2-9d88-449d-ba33-14fad2f31d62"
      unitRef="usd">-79768000</us-gaap:OperatingIncomeLoss>
    <us-gaap:InterestIncomeExpenseNonoperatingNet
      contextRef="i27f4e53b91ad4367b7f8d273eff27769_D20210401-20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzY2E5YmIwMTc5MjQ3NmZiYjIyNWU1ZDlkZWM4NjlmL3NlYzo5M2NhOWJiMDE3OTI0NzZmYmIyMjVlNWQ5ZGVjODY5Zl8xOS9mcmFnOmNhNDBhNzBkOTFkZDRiMGE4YTQxZjI0NmM2NDMxNTliL3RhYmxlOmZhYjNmZGNhNDc0YTQ1NDg5MWQ5MDg5NjU4NjM0M2RlL3RhYmxlcmFuZ2U6ZmFiM2ZkY2E0NzRhNDU0ODkxZDkwODk2NTg2MzQzZGVfMTctMS0xLTEtMA_64e0fa86-15f4-4ccc-a153-6c6277a01829"
      unitRef="usd">2293000</us-gaap:InterestIncomeExpenseNonoperatingNet>
    <us-gaap:InterestIncomeExpenseNonoperatingNet
      contextRef="i39065c5daf934af885335c12f3cfa83f_D20200401-20200630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzY2E5YmIwMTc5MjQ3NmZiYjIyNWU1ZDlkZWM4NjlmL3NlYzo5M2NhOWJiMDE3OTI0NzZmYmIyMjVlNWQ5ZGVjODY5Zl8xOS9mcmFnOmNhNDBhNzBkOTFkZDRiMGE4YTQxZjI0NmM2NDMxNTliL3RhYmxlOmZhYjNmZGNhNDc0YTQ1NDg5MWQ5MDg5NjU4NjM0M2RlL3RhYmxlcmFuZ2U6ZmFiM2ZkY2E0NzRhNDU0ODkxZDkwODk2NTg2MzQzZGVfMTctMy0xLTEtMA_e3fe6635-8f81-41fd-ac77-ad3f918c36ec"
      unitRef="usd">3734000</us-gaap:InterestIncomeExpenseNonoperatingNet>
    <us-gaap:InterestIncomeExpenseNonoperatingNet
      contextRef="i69782326f71a44e3805518280ee22b6b_D20210101-20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzY2E5YmIwMTc5MjQ3NmZiYjIyNWU1ZDlkZWM4NjlmL3NlYzo5M2NhOWJiMDE3OTI0NzZmYmIyMjVlNWQ5ZGVjODY5Zl8xOS9mcmFnOmNhNDBhNzBkOTFkZDRiMGE4YTQxZjI0NmM2NDMxNTliL3RhYmxlOmZhYjNmZGNhNDc0YTQ1NDg5MWQ5MDg5NjU4NjM0M2RlL3RhYmxlcmFuZ2U6ZmFiM2ZkY2E0NzRhNDU0ODkxZDkwODk2NTg2MzQzZGVfMTctNS0xLTEtMA_740dc3f1-ce94-403b-a17d-2bf316a4ac3e"
      unitRef="usd">4622000</us-gaap:InterestIncomeExpenseNonoperatingNet>
    <us-gaap:InterestIncomeExpenseNonoperatingNet
      contextRef="i4a110e4972ef4113880ce582e3cda5c5_D20200101-20200630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzY2E5YmIwMTc5MjQ3NmZiYjIyNWU1ZDlkZWM4NjlmL3NlYzo5M2NhOWJiMDE3OTI0NzZmYmIyMjVlNWQ5ZGVjODY5Zl8xOS9mcmFnOmNhNDBhNzBkOTFkZDRiMGE4YTQxZjI0NmM2NDMxNTliL3RhYmxlOmZhYjNmZGNhNDc0YTQ1NDg5MWQ5MDg5NjU4NjM0M2RlL3RhYmxlcmFuZ2U6ZmFiM2ZkY2E0NzRhNDU0ODkxZDkwODk2NTg2MzQzZGVfMTctNy0xLTEtMA_6a1e1973-b886-4749-a9db-d7ea7af34f4f"
      unitRef="usd">11485000</us-gaap:InterestIncomeExpenseNonoperatingNet>
    <us-gaap:GainLossOnDerivativeInstrumentsNetPretax
      contextRef="i27f4e53b91ad4367b7f8d273eff27769_D20210401-20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzY2E5YmIwMTc5MjQ3NmZiYjIyNWU1ZDlkZWM4NjlmL3NlYzo5M2NhOWJiMDE3OTI0NzZmYmIyMjVlNWQ5ZGVjODY5Zl8xOS9mcmFnOmNhNDBhNzBkOTFkZDRiMGE4YTQxZjI0NmM2NDMxNTliL3RhYmxlOmZhYjNmZGNhNDc0YTQ1NDg5MWQ5MDg5NjU4NjM0M2RlL3RhYmxlcmFuZ2U6ZmFiM2ZkY2E0NzRhNDU0ODkxZDkwODk2NTg2MzQzZGVfMTktMS0xLTEtNjM3_d1d90884-b62b-4af4-b89b-aea8a28387b6"
      unitRef="usd">115248000</us-gaap:GainLossOnDerivativeInstrumentsNetPretax>
    <us-gaap:GainLossOnDerivativeInstrumentsNetPretax
      contextRef="i39065c5daf934af885335c12f3cfa83f_D20200401-20200630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzY2E5YmIwMTc5MjQ3NmZiYjIyNWU1ZDlkZWM4NjlmL3NlYzo5M2NhOWJiMDE3OTI0NzZmYmIyMjVlNWQ5ZGVjODY5Zl8xOS9mcmFnOmNhNDBhNzBkOTFkZDRiMGE4YTQxZjI0NmM2NDMxNTliL3RhYmxlOmZhYjNmZGNhNDc0YTQ1NDg5MWQ5MDg5NjU4NjM0M2RlL3RhYmxlcmFuZ2U6ZmFiM2ZkY2E0NzRhNDU0ODkxZDkwODk2NTg2MzQzZGVfMTktMy0xLTEtNjMz_1c96d2e2-ed01-445d-97a6-7fb5e94758bd"
      unitRef="usd">-35880000</us-gaap:GainLossOnDerivativeInstrumentsNetPretax>
    <us-gaap:GainLossOnDerivativeInstrumentsNetPretax
      contextRef="i69782326f71a44e3805518280ee22b6b_D20210101-20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzY2E5YmIwMTc5MjQ3NmZiYjIyNWU1ZDlkZWM4NjlmL3NlYzo5M2NhOWJiMDE3OTI0NzZmYmIyMjVlNWQ5ZGVjODY5Zl8xOS9mcmFnOmNhNDBhNzBkOTFkZDRiMGE4YTQxZjI0NmM2NDMxNTliL3RhYmxlOmZhYjNmZGNhNDc0YTQ1NDg5MWQ5MDg5NjU4NjM0M2RlL3RhYmxlcmFuZ2U6ZmFiM2ZkY2E0NzRhNDU0ODkxZDkwODk2NTg2MzQzZGVfMTgtNS0xLTEtMA_a2d8c34f-2e24-4a70-a1f6-50b7004af31a"
      unitRef="usd">-1626000</us-gaap:GainLossOnDerivativeInstrumentsNetPretax>
    <us-gaap:GainLossOnDerivativeInstrumentsNetPretax
      contextRef="i4a110e4972ef4113880ce582e3cda5c5_D20200101-20200630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzY2E5YmIwMTc5MjQ3NmZiYjIyNWU1ZDlkZWM4NjlmL3NlYzo5M2NhOWJiMDE3OTI0NzZmYmIyMjVlNWQ5ZGVjODY5Zl8xOS9mcmFnOmNhNDBhNzBkOTFkZDRiMGE4YTQxZjI0NmM2NDMxNTliL3RhYmxlOmZhYjNmZGNhNDc0YTQ1NDg5MWQ5MDg5NjU4NjM0M2RlL3RhYmxlcmFuZ2U6ZmFiM2ZkY2E0NzRhNDU0ODkxZDkwODk2NTg2MzQzZGVfMTgtNy0xLTEtMA_70c96aa2-acaa-4dc6-973e-c0298d288abb"
      unitRef="usd">77488000</us-gaap:GainLossOnDerivativeInstrumentsNetPretax>
    <us-gaap:AssetImpairmentCharges
      contextRef="i27f4e53b91ad4367b7f8d273eff27769_D20210401-20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzY2E5YmIwMTc5MjQ3NmZiYjIyNWU1ZDlkZWM4NjlmL3NlYzo5M2NhOWJiMDE3OTI0NzZmYmIyMjVlNWQ5ZGVjODY5Zl8xOS9mcmFnOmNhNDBhNzBkOTFkZDRiMGE4YTQxZjI0NmM2NDMxNTliL3RhYmxlOmZhYjNmZGNhNDc0YTQ1NDg5MWQ5MDg5NjU4NjM0M2RlL3RhYmxlcmFuZ2U6ZmFiM2ZkY2E0NzRhNDU0ODkxZDkwODk2NTg2MzQzZGVfMTktMS0xLTEtMTEz_82369ee7-aa1e-4dbe-b511-11b7d64e93cc"
      unitRef="usd">0</us-gaap:AssetImpairmentCharges>
    <us-gaap:AssetImpairmentCharges
      contextRef="i39065c5daf934af885335c12f3cfa83f_D20200401-20200630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzY2E5YmIwMTc5MjQ3NmZiYjIyNWU1ZDlkZWM4NjlmL3NlYzo5M2NhOWJiMDE3OTI0NzZmYmIyMjVlNWQ5ZGVjODY5Zl8xOS9mcmFnOmNhNDBhNzBkOTFkZDRiMGE4YTQxZjI0NmM2NDMxNTliL3RhYmxlOmZhYjNmZGNhNDc0YTQ1NDg5MWQ5MDg5NjU4NjM0M2RlL3RhYmxlcmFuZ2U6ZmFiM2ZkY2E0NzRhNDU0ODkxZDkwODk2NTg2MzQzZGVfMTktMy0xLTEtMTEz_ca1b8020-52de-44fc-ae8e-fa76071aaf2a"
      unitRef="usd">40000000</us-gaap:AssetImpairmentCharges>
    <us-gaap:AssetImpairmentCharges
      contextRef="i69782326f71a44e3805518280ee22b6b_D20210101-20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzY2E5YmIwMTc5MjQ3NmZiYjIyNWU1ZDlkZWM4NjlmL3NlYzo5M2NhOWJiMDE3OTI0NzZmYmIyMjVlNWQ5ZGVjODY5Zl8xOS9mcmFnOmNhNDBhNzBkOTFkZDRiMGE4YTQxZjI0NmM2NDMxNTliL3RhYmxlOmZhYjNmZGNhNDc0YTQ1NDg5MWQ5MDg5NjU4NjM0M2RlL3RhYmxlcmFuZ2U6ZmFiM2ZkY2E0NzRhNDU0ODkxZDkwODk2NTg2MzQzZGVfMTktNS0xLTEtMA_d1cda6f3-0d49-401d-a60b-a906330c4342"
      unitRef="usd">1741000</us-gaap:AssetImpairmentCharges>
    <us-gaap:AssetImpairmentCharges
      contextRef="i4a110e4972ef4113880ce582e3cda5c5_D20200101-20200630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzY2E5YmIwMTc5MjQ3NmZiYjIyNWU1ZDlkZWM4NjlmL3NlYzo5M2NhOWJiMDE3OTI0NzZmYmIyMjVlNWQ5ZGVjODY5Zl8xOS9mcmFnOmNhNDBhNzBkOTFkZDRiMGE4YTQxZjI0NmM2NDMxNTliL3RhYmxlOmZhYjNmZGNhNDc0YTQ1NDg5MWQ5MDg5NjU4NjM0M2RlL3RhYmxlcmFuZ2U6ZmFiM2ZkY2E0NzRhNDU0ODkxZDkwODk2NTg2MzQzZGVfMTktNy0xLTEtMA_95197b80-f5ea-4e46-98e5-28e1d1969869"
      unitRef="usd">40000000</us-gaap:AssetImpairmentCharges>
    <us-gaap:IncomeLossFromEquityMethodInvestments
      contextRef="i27f4e53b91ad4367b7f8d273eff27769_D20210401-20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzY2E5YmIwMTc5MjQ3NmZiYjIyNWU1ZDlkZWM4NjlmL3NlYzo5M2NhOWJiMDE3OTI0NzZmYmIyMjVlNWQ5ZGVjODY5Zl8xOS9mcmFnOmNhNDBhNzBkOTFkZDRiMGE4YTQxZjI0NmM2NDMxNTliL3RhYmxlOmZhYjNmZGNhNDc0YTQ1NDg5MWQ5MDg5NjU4NjM0M2RlL3RhYmxlcmFuZ2U6ZmFiM2ZkY2E0NzRhNDU0ODkxZDkwODk2NTg2MzQzZGVfMjEtMS0xLTEtMzkxNQ_bd4fc427-2453-4440-8064-33c9cbf6a6ad"
      unitRef="usd">-1115000</us-gaap:IncomeLossFromEquityMethodInvestments>
    <us-gaap:IncomeLossFromEquityMethodInvestments
      contextRef="i39065c5daf934af885335c12f3cfa83f_D20200401-20200630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzY2E5YmIwMTc5MjQ3NmZiYjIyNWU1ZDlkZWM4NjlmL3NlYzo5M2NhOWJiMDE3OTI0NzZmYmIyMjVlNWQ5ZGVjODY5Zl8xOS9mcmFnOmNhNDBhNzBkOTFkZDRiMGE4YTQxZjI0NmM2NDMxNTliL3RhYmxlOmZhYjNmZGNhNDc0YTQ1NDg5MWQ5MDg5NjU4NjM0M2RlL3RhYmxlcmFuZ2U6ZmFiM2ZkY2E0NzRhNDU0ODkxZDkwODk2NTg2MzQzZGVfMjEtMy0xLTEtMzkxNQ_1a89e11e-1298-4e16-ada5-359150eca857"
      unitRef="usd">-794000</us-gaap:IncomeLossFromEquityMethodInvestments>
    <us-gaap:IncomeLossFromEquityMethodInvestments
      contextRef="i69782326f71a44e3805518280ee22b6b_D20210101-20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzY2E5YmIwMTc5MjQ3NmZiYjIyNWU1ZDlkZWM4NjlmL3NlYzo5M2NhOWJiMDE3OTI0NzZmYmIyMjVlNWQ5ZGVjODY5Zl8xOS9mcmFnOmNhNDBhNzBkOTFkZDRiMGE4YTQxZjI0NmM2NDMxNTliL3RhYmxlOmZhYjNmZGNhNDc0YTQ1NDg5MWQ5MDg5NjU4NjM0M2RlL3RhYmxlcmFuZ2U6ZmFiM2ZkY2E0NzRhNDU0ODkxZDkwODk2NTg2MzQzZGVfMjEtNS0xLTEtMzkxNQ_67662331-2499-4ab6-9ea7-445b2be46cdf"
      unitRef="usd">-2758000</us-gaap:IncomeLossFromEquityMethodInvestments>
    <us-gaap:IncomeLossFromEquityMethodInvestments
      contextRef="i4a110e4972ef4113880ce582e3cda5c5_D20200101-20200630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzY2E5YmIwMTc5MjQ3NmZiYjIyNWU1ZDlkZWM4NjlmL3NlYzo5M2NhOWJiMDE3OTI0NzZmYmIyMjVlNWQ5ZGVjODY5Zl8xOS9mcmFnOmNhNDBhNzBkOTFkZDRiMGE4YTQxZjI0NmM2NDMxNTliL3RhYmxlOmZhYjNmZGNhNDc0YTQ1NDg5MWQ5MDg5NjU4NjM0M2RlL3RhYmxlcmFuZ2U6ZmFiM2ZkY2E0NzRhNDU0ODkxZDkwODk2NTg2MzQzZGVfMjEtNy0xLTEtMzkxNQ_5fce0e49-50d2-445c-80d3-cbdd33ed8f3d"
      unitRef="usd">-1966000</us-gaap:IncomeLossFromEquityMethodInvestments>
    <us-gaap:OtherNonoperatingIncomeExpense
      contextRef="i27f4e53b91ad4367b7f8d273eff27769_D20210401-20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzY2E5YmIwMTc5MjQ3NmZiYjIyNWU1ZDlkZWM4NjlmL3NlYzo5M2NhOWJiMDE3OTI0NzZmYmIyMjVlNWQ5ZGVjODY5Zl8xOS9mcmFnOmNhNDBhNzBkOTFkZDRiMGE4YTQxZjI0NmM2NDMxNTliL3RhYmxlOmZhYjNmZGNhNDc0YTQ1NDg5MWQ5MDg5NjU4NjM0M2RlL3RhYmxlcmFuZ2U6ZmFiM2ZkY2E0NzRhNDU0ODkxZDkwODk2NTg2MzQzZGVfMjAtMS0xLTEtMA_9b7348cc-e690-4778-b3b9-75cfd05e96b5"
      unitRef="usd">1127000</us-gaap:OtherNonoperatingIncomeExpense>
    <us-gaap:OtherNonoperatingIncomeExpense
      contextRef="i39065c5daf934af885335c12f3cfa83f_D20200401-20200630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzY2E5YmIwMTc5MjQ3NmZiYjIyNWU1ZDlkZWM4NjlmL3NlYzo5M2NhOWJiMDE3OTI0NzZmYmIyMjVlNWQ5ZGVjODY5Zl8xOS9mcmFnOmNhNDBhNzBkOTFkZDRiMGE4YTQxZjI0NmM2NDMxNTliL3RhYmxlOmZhYjNmZGNhNDc0YTQ1NDg5MWQ5MDg5NjU4NjM0M2RlL3RhYmxlcmFuZ2U6ZmFiM2ZkY2E0NzRhNDU0ODkxZDkwODk2NTg2MzQzZGVfMjAtMy0xLTEtMA_ef6b5b4d-ed26-4c04-9011-df28853f9fa2"
      unitRef="usd">-9000</us-gaap:OtherNonoperatingIncomeExpense>
    <us-gaap:OtherNonoperatingIncomeExpense
      contextRef="i69782326f71a44e3805518280ee22b6b_D20210101-20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzY2E5YmIwMTc5MjQ3NmZiYjIyNWU1ZDlkZWM4NjlmL3NlYzo5M2NhOWJiMDE3OTI0NzZmYmIyMjVlNWQ5ZGVjODY5Zl8xOS9mcmFnOmNhNDBhNzBkOTFkZDRiMGE4YTQxZjI0NmM2NDMxNTliL3RhYmxlOmZhYjNmZGNhNDc0YTQ1NDg5MWQ5MDg5NjU4NjM0M2RlL3RhYmxlcmFuZ2U6ZmFiM2ZkY2E0NzRhNDU0ODkxZDkwODk2NTg2MzQzZGVfMjAtNS0xLTEtMA_f2058b56-451c-4cf2-9ad6-3d356b687d28"
      unitRef="usd">911000</us-gaap:OtherNonoperatingIncomeExpense>
    <us-gaap:OtherNonoperatingIncomeExpense
      contextRef="i4a110e4972ef4113880ce582e3cda5c5_D20200101-20200630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzY2E5YmIwMTc5MjQ3NmZiYjIyNWU1ZDlkZWM4NjlmL3NlYzo5M2NhOWJiMDE3OTI0NzZmYmIyMjVlNWQ5ZGVjODY5Zl8xOS9mcmFnOmNhNDBhNzBkOTFkZDRiMGE4YTQxZjI0NmM2NDMxNTliL3RhYmxlOmZhYjNmZGNhNDc0YTQ1NDg5MWQ5MDg5NjU4NjM0M2RlL3RhYmxlcmFuZ2U6ZmFiM2ZkY2E0NzRhNDU0ODkxZDkwODk2NTg2MzQzZGVfMjAtNy0xLTEtMA_dca83f1f-2004-419d-9000-59fecd0dec29"
      unitRef="usd">785000</us-gaap:OtherNonoperatingIncomeExpense>
    <us-gaap:NonoperatingIncomeExpense
      contextRef="i27f4e53b91ad4367b7f8d273eff27769_D20210401-20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzY2E5YmIwMTc5MjQ3NmZiYjIyNWU1ZDlkZWM4NjlmL3NlYzo5M2NhOWJiMDE3OTI0NzZmYmIyMjVlNWQ5ZGVjODY5Zl8xOS9mcmFnOmNhNDBhNzBkOTFkZDRiMGE4YTQxZjI0NmM2NDMxNTliL3RhYmxlOmZhYjNmZGNhNDc0YTQ1NDg5MWQ5MDg5NjU4NjM0M2RlL3RhYmxlcmFuZ2U6ZmFiM2ZkY2E0NzRhNDU0ODkxZDkwODk2NTg2MzQzZGVfMjEtMS0xLTEtMA_507409b5-1de9-4f96-bb3a-06d7bbadc892"
      unitRef="usd">117553000</us-gaap:NonoperatingIncomeExpense>
    <us-gaap:NonoperatingIncomeExpense
      contextRef="i39065c5daf934af885335c12f3cfa83f_D20200401-20200630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzY2E5YmIwMTc5MjQ3NmZiYjIyNWU1ZDlkZWM4NjlmL3NlYzo5M2NhOWJiMDE3OTI0NzZmYmIyMjVlNWQ5ZGVjODY5Zl8xOS9mcmFnOmNhNDBhNzBkOTFkZDRiMGE4YTQxZjI0NmM2NDMxNTliL3RhYmxlOmZhYjNmZGNhNDc0YTQ1NDg5MWQ5MDg5NjU4NjM0M2RlL3RhYmxlcmFuZ2U6ZmFiM2ZkY2E0NzRhNDU0ODkxZDkwODk2NTg2MzQzZGVfMjEtMy0xLTEtMA_20f5d787-7300-42f9-8923-d842f10c0700"
      unitRef="usd">-72949000</us-gaap:NonoperatingIncomeExpense>
    <us-gaap:NonoperatingIncomeExpense
      contextRef="i69782326f71a44e3805518280ee22b6b_D20210101-20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzY2E5YmIwMTc5MjQ3NmZiYjIyNWU1ZDlkZWM4NjlmL3NlYzo5M2NhOWJiMDE3OTI0NzZmYmIyMjVlNWQ5ZGVjODY5Zl8xOS9mcmFnOmNhNDBhNzBkOTFkZDRiMGE4YTQxZjI0NmM2NDMxNTliL3RhYmxlOmZhYjNmZGNhNDc0YTQ1NDg5MWQ5MDg5NjU4NjM0M2RlL3RhYmxlcmFuZ2U6ZmFiM2ZkY2E0NzRhNDU0ODkxZDkwODk2NTg2MzQzZGVfMjEtNS0xLTEtMA_355e363d-c0fd-4896-82ab-2bce10c7fbd3"
      unitRef="usd">-592000</us-gaap:NonoperatingIncomeExpense>
    <us-gaap:NonoperatingIncomeExpense
      contextRef="i4a110e4972ef4113880ce582e3cda5c5_D20200101-20200630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzY2E5YmIwMTc5MjQ3NmZiYjIyNWU1ZDlkZWM4NjlmL3NlYzo5M2NhOWJiMDE3OTI0NzZmYmIyMjVlNWQ5ZGVjODY5Zl8xOS9mcmFnOmNhNDBhNzBkOTFkZDRiMGE4YTQxZjI0NmM2NDMxNTliL3RhYmxlOmZhYjNmZGNhNDc0YTQ1NDg5MWQ5MDg5NjU4NjM0M2RlL3RhYmxlcmFuZ2U6ZmFiM2ZkY2E0NzRhNDU0ODkxZDkwODk2NTg2MzQzZGVfMjEtNy0xLTEtMA_02e8aba5-2441-4aa6-9674-a8eea659a787"
      unitRef="usd">47792000</us-gaap:NonoperatingIncomeExpense>
    <us-gaap:IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i27f4e53b91ad4367b7f8d273eff27769_D20210401-20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzY2E5YmIwMTc5MjQ3NmZiYjIyNWU1ZDlkZWM4NjlmL3NlYzo5M2NhOWJiMDE3OTI0NzZmYmIyMjVlNWQ5ZGVjODY5Zl8xOS9mcmFnOmNhNDBhNzBkOTFkZDRiMGE4YTQxZjI0NmM2NDMxNTliL3RhYmxlOmZhYjNmZGNhNDc0YTQ1NDg5MWQ5MDg5NjU4NjM0M2RlL3RhYmxlcmFuZ2U6ZmFiM2ZkY2E0NzRhNDU0ODkxZDkwODk2NTg2MzQzZGVfMjQtMS0xLTEtMA_5fef9f9d-278d-44d1-a8d9-83e5348e8cad"
      unitRef="usd">57336000</us-gaap:IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i39065c5daf934af885335c12f3cfa83f_D20200401-20200630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzY2E5YmIwMTc5MjQ3NmZiYjIyNWU1ZDlkZWM4NjlmL3NlYzo5M2NhOWJiMDE3OTI0NzZmYmIyMjVlNWQ5ZGVjODY5Zl8xOS9mcmFnOmNhNDBhNzBkOTFkZDRiMGE4YTQxZjI0NmM2NDMxNTliL3RhYmxlOmZhYjNmZGNhNDc0YTQ1NDg5MWQ5MDg5NjU4NjM0M2RlL3RhYmxlcmFuZ2U6ZmFiM2ZkY2E0NzRhNDU0ODkxZDkwODk2NTg2MzQzZGVfMjQtMy0xLTEtMA_d8d64f51-9e89-4be4-836b-11f3a14d2d3d"
      unitRef="usd">-107657000</us-gaap:IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i69782326f71a44e3805518280ee22b6b_D20210101-20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzY2E5YmIwMTc5MjQ3NmZiYjIyNWU1ZDlkZWM4NjlmL3NlYzo5M2NhOWJiMDE3OTI0NzZmYmIyMjVlNWQ5ZGVjODY5Zl8xOS9mcmFnOmNhNDBhNzBkOTFkZDRiMGE4YTQxZjI0NmM2NDMxNTliL3RhYmxlOmZhYjNmZGNhNDc0YTQ1NDg5MWQ5MDg5NjU4NjM0M2RlL3RhYmxlcmFuZ2U6ZmFiM2ZkY2E0NzRhNDU0ODkxZDkwODk2NTg2MzQzZGVfMjQtNS0xLTEtMA_564ee7b6-8875-4c7d-88f8-d7cc5a295660"
      unitRef="usd">-104268000</us-gaap:IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i4a110e4972ef4113880ce582e3cda5c5_D20200101-20200630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzY2E5YmIwMTc5MjQ3NmZiYjIyNWU1ZDlkZWM4NjlmL3NlYzo5M2NhOWJiMDE3OTI0NzZmYmIyMjVlNWQ5ZGVjODY5Zl8xOS9mcmFnOmNhNDBhNzBkOTFkZDRiMGE4YTQxZjI0NmM2NDMxNTliL3RhYmxlOmZhYjNmZGNhNDc0YTQ1NDg5MWQ5MDg5NjU4NjM0M2RlL3RhYmxlcmFuZ2U6ZmFiM2ZkY2E0NzRhNDU0ODkxZDkwODk2NTg2MzQzZGVfMjQtNy0xLTEtMA_e4d1d80c-4773-4c1a-bf3f-6b8a34278d3a"
      unitRef="usd">-31976000</us-gaap:IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:IncomeLossFromDiscontinuedOperationsNetOfTax
      contextRef="i27f4e53b91ad4367b7f8d273eff27769_D20210401-20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzY2E5YmIwMTc5MjQ3NmZiYjIyNWU1ZDlkZWM4NjlmL3NlYzo5M2NhOWJiMDE3OTI0NzZmYmIyMjVlNWQ5ZGVjODY5Zl8xOS9mcmFnOmNhNDBhNzBkOTFkZDRiMGE4YTQxZjI0NmM2NDMxNTliL3RhYmxlOmZhYjNmZGNhNDc0YTQ1NDg5MWQ5MDg5NjU4NjM0M2RlL3RhYmxlcmFuZ2U6ZmFiM2ZkY2E0NzRhNDU0ODkxZDkwODk2NTg2MzQzZGVfMjUtMS0xLTEtMA_fda7a8cd-7e15-4d3d-8983-374f7ca0c393"
      unitRef="usd">-561000</us-gaap:IncomeLossFromDiscontinuedOperationsNetOfTax>
    <us-gaap:IncomeLossFromDiscontinuedOperationsNetOfTax
      contextRef="i39065c5daf934af885335c12f3cfa83f_D20200401-20200630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzY2E5YmIwMTc5MjQ3NmZiYjIyNWU1ZDlkZWM4NjlmL3NlYzo5M2NhOWJiMDE3OTI0NzZmYmIyMjVlNWQ5ZGVjODY5Zl8xOS9mcmFnOmNhNDBhNzBkOTFkZDRiMGE4YTQxZjI0NmM2NDMxNTliL3RhYmxlOmZhYjNmZGNhNDc0YTQ1NDg5MWQ5MDg5NjU4NjM0M2RlL3RhYmxlcmFuZ2U6ZmFiM2ZkY2E0NzRhNDU0ODkxZDkwODk2NTg2MzQzZGVfMjUtMy0xLTEtMA_19315a80-0a6b-45be-ab8b-47caea15a613"
      unitRef="usd">-46000</us-gaap:IncomeLossFromDiscontinuedOperationsNetOfTax>
    <us-gaap:IncomeLossFromDiscontinuedOperationsNetOfTax
      contextRef="i69782326f71a44e3805518280ee22b6b_D20210101-20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzY2E5YmIwMTc5MjQ3NmZiYjIyNWU1ZDlkZWM4NjlmL3NlYzo5M2NhOWJiMDE3OTI0NzZmYmIyMjVlNWQ5ZGVjODY5Zl8xOS9mcmFnOmNhNDBhNzBkOTFkZDRiMGE4YTQxZjI0NmM2NDMxNTliL3RhYmxlOmZhYjNmZGNhNDc0YTQ1NDg5MWQ5MDg5NjU4NjM0M2RlL3RhYmxlcmFuZ2U6ZmFiM2ZkY2E0NzRhNDU0ODkxZDkwODk2NTg2MzQzZGVfMjUtNS0xLTEtMA_f5238273-bbab-4751-807f-5217a5fd5eea"
      unitRef="usd">-582000</us-gaap:IncomeLossFromDiscontinuedOperationsNetOfTax>
    <us-gaap:IncomeLossFromDiscontinuedOperationsNetOfTax
      contextRef="i4a110e4972ef4113880ce582e3cda5c5_D20200101-20200630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzY2E5YmIwMTc5MjQ3NmZiYjIyNWU1ZDlkZWM4NjlmL3NlYzo5M2NhOWJiMDE3OTI0NzZmYmIyMjVlNWQ5ZGVjODY5Zl8xOS9mcmFnOmNhNDBhNzBkOTFkZDRiMGE4YTQxZjI0NmM2NDMxNTliL3RhYmxlOmZhYjNmZGNhNDc0YTQ1NDg5MWQ5MDg5NjU4NjM0M2RlL3RhYmxlcmFuZ2U6ZmFiM2ZkY2E0NzRhNDU0ODkxZDkwODk2NTg2MzQzZGVfMjUtNy0xLTEtMA_a9b4ab20-0e12-4791-ab2e-fbb012adbdbd"
      unitRef="usd">-46000</us-gaap:IncomeLossFromDiscontinuedOperationsNetOfTax>
    <us-gaap:ProfitLoss
      contextRef="i27f4e53b91ad4367b7f8d273eff27769_D20210401-20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzY2E5YmIwMTc5MjQ3NmZiYjIyNWU1ZDlkZWM4NjlmL3NlYzo5M2NhOWJiMDE3OTI0NzZmYmIyMjVlNWQ5ZGVjODY5Zl8xOS9mcmFnOmNhNDBhNzBkOTFkZDRiMGE4YTQxZjI0NmM2NDMxNTliL3RhYmxlOmZhYjNmZGNhNDc0YTQ1NDg5MWQ5MDg5NjU4NjM0M2RlL3RhYmxlcmFuZ2U6ZmFiM2ZkY2E0NzRhNDU0ODkxZDkwODk2NTg2MzQzZGVfMjYtMS0xLTEtMA_4d1447d8-1bb1-4b58-92f4-87c32408841e"
      unitRef="usd">56775000</us-gaap:ProfitLoss>
    <us-gaap:ProfitLoss
      contextRef="i39065c5daf934af885335c12f3cfa83f_D20200401-20200630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzY2E5YmIwMTc5MjQ3NmZiYjIyNWU1ZDlkZWM4NjlmL3NlYzo5M2NhOWJiMDE3OTI0NzZmYmIyMjVlNWQ5ZGVjODY5Zl8xOS9mcmFnOmNhNDBhNzBkOTFkZDRiMGE4YTQxZjI0NmM2NDMxNTliL3RhYmxlOmZhYjNmZGNhNDc0YTQ1NDg5MWQ5MDg5NjU4NjM0M2RlL3RhYmxlcmFuZ2U6ZmFiM2ZkY2E0NzRhNDU0ODkxZDkwODk2NTg2MzQzZGVfMjYtMy0xLTEtMA_6ae1f792-179e-4280-9347-1e7ebc6d588a"
      unitRef="usd">-107703000</us-gaap:ProfitLoss>
    <us-gaap:ProfitLoss
      contextRef="i69782326f71a44e3805518280ee22b6b_D20210101-20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzY2E5YmIwMTc5MjQ3NmZiYjIyNWU1ZDlkZWM4NjlmL3NlYzo5M2NhOWJiMDE3OTI0NzZmYmIyMjVlNWQ5ZGVjODY5Zl8xOS9mcmFnOmNhNDBhNzBkOTFkZDRiMGE4YTQxZjI0NmM2NDMxNTliL3RhYmxlOmZhYjNmZGNhNDc0YTQ1NDg5MWQ5MDg5NjU4NjM0M2RlL3RhYmxlcmFuZ2U6ZmFiM2ZkY2E0NzRhNDU0ODkxZDkwODk2NTg2MzQzZGVfMjYtNS0xLTEtMA_55bc3d61-01c1-4d88-b695-214eacc6cf9f"
      unitRef="usd">-104850000</us-gaap:ProfitLoss>
    <us-gaap:ProfitLoss
      contextRef="i4a110e4972ef4113880ce582e3cda5c5_D20200101-20200630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzY2E5YmIwMTc5MjQ3NmZiYjIyNWU1ZDlkZWM4NjlmL3NlYzo5M2NhOWJiMDE3OTI0NzZmYmIyMjVlNWQ5ZGVjODY5Zl8xOS9mcmFnOmNhNDBhNzBkOTFkZDRiMGE4YTQxZjI0NmM2NDMxNTliL3RhYmxlOmZhYjNmZGNhNDc0YTQ1NDg5MWQ5MDg5NjU4NjM0M2RlL3RhYmxlcmFuZ2U6ZmFiM2ZkY2E0NzRhNDU0ODkxZDkwODk2NTg2MzQzZGVfMjYtNy0xLTEtMA_d72007cb-595f-47f0-92e7-5e16e2262170"
      unitRef="usd">-32022000</us-gaap:ProfitLoss>
    <us-gaap:NetIncomeLossAttributableToNoncontrollingInterest
      contextRef="i27f4e53b91ad4367b7f8d273eff27769_D20210401-20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzY2E5YmIwMTc5MjQ3NmZiYjIyNWU1ZDlkZWM4NjlmL3NlYzo5M2NhOWJiMDE3OTI0NzZmYmIyMjVlNWQ5ZGVjODY5Zl8xOS9mcmFnOmNhNDBhNzBkOTFkZDRiMGE4YTQxZjI0NmM2NDMxNTliL3RhYmxlOmZhYjNmZGNhNDc0YTQ1NDg5MWQ5MDg5NjU4NjM0M2RlL3RhYmxlcmFuZ2U6ZmFiM2ZkY2E0NzRhNDU0ODkxZDkwODk2NTg2MzQzZGVfMjgtMS0xLTEtMTI5NDk_7eef6401-b823-4ff2-be3e-4cb830bfefaa"
      unitRef="usd">-279000</us-gaap:NetIncomeLossAttributableToNoncontrollingInterest>
    <us-gaap:NetIncomeLossAttributableToNoncontrollingInterest
      contextRef="i39065c5daf934af885335c12f3cfa83f_D20200401-20200630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzY2E5YmIwMTc5MjQ3NmZiYjIyNWU1ZDlkZWM4NjlmL3NlYzo5M2NhOWJiMDE3OTI0NzZmYmIyMjVlNWQ5ZGVjODY5Zl8xOS9mcmFnOmNhNDBhNzBkOTFkZDRiMGE4YTQxZjI0NmM2NDMxNTliL3RhYmxlOmZhYjNmZGNhNDc0YTQ1NDg5MWQ5MDg5NjU4NjM0M2RlL3RhYmxlcmFuZ2U6ZmFiM2ZkY2E0NzRhNDU0ODkxZDkwODk2NTg2MzQzZGVfMjgtMy0xLTEtMTI5NDk_4d8a426b-553a-467d-8790-6cc66dcb2a1b"
      unitRef="usd">-726000</us-gaap:NetIncomeLossAttributableToNoncontrollingInterest>
    <us-gaap:NetIncomeLossAttributableToNoncontrollingInterest
      contextRef="i69782326f71a44e3805518280ee22b6b_D20210101-20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzY2E5YmIwMTc5MjQ3NmZiYjIyNWU1ZDlkZWM4NjlmL3NlYzo5M2NhOWJiMDE3OTI0NzZmYmIyMjVlNWQ5ZGVjODY5Zl8xOS9mcmFnOmNhNDBhNzBkOTFkZDRiMGE4YTQxZjI0NmM2NDMxNTliL3RhYmxlOmZhYjNmZGNhNDc0YTQ1NDg5MWQ5MDg5NjU4NjM0M2RlL3RhYmxlcmFuZ2U6ZmFiM2ZkY2E0NzRhNDU0ODkxZDkwODk2NTg2MzQzZGVfMjgtNS0xLTEtMTI5NDk_1273a48c-b23a-42f8-a2a5-aef621ad5f95"
      unitRef="usd">-592000</us-gaap:NetIncomeLossAttributableToNoncontrollingInterest>
    <us-gaap:NetIncomeLossAttributableToNoncontrollingInterest
      contextRef="i4a110e4972ef4113880ce582e3cda5c5_D20200101-20200630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzY2E5YmIwMTc5MjQ3NmZiYjIyNWU1ZDlkZWM4NjlmL3NlYzo5M2NhOWJiMDE3OTI0NzZmYmIyMjVlNWQ5ZGVjODY5Zl8xOS9mcmFnOmNhNDBhNzBkOTFkZDRiMGE4YTQxZjI0NmM2NDMxNTliL3RhYmxlOmZhYjNmZGNhNDc0YTQ1NDg5MWQ5MDg5NjU4NjM0M2RlL3RhYmxlcmFuZ2U6ZmFiM2ZkY2E0NzRhNDU0ODkxZDkwODk2NTg2MzQzZGVfMjgtNy0xLTEtMTI5NDk_3c7f9c88-74af-4cbf-b062-54012a503268"
      unitRef="usd">-1085000</us-gaap:NetIncomeLossAttributableToNoncontrollingInterest>
    <us-gaap:NetIncomeLoss
      contextRef="i27f4e53b91ad4367b7f8d273eff27769_D20210401-20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzY2E5YmIwMTc5MjQ3NmZiYjIyNWU1ZDlkZWM4NjlmL3NlYzo5M2NhOWJiMDE3OTI0NzZmYmIyMjVlNWQ5ZGVjODY5Zl8xOS9mcmFnOmNhNDBhNzBkOTFkZDRiMGE4YTQxZjI0NmM2NDMxNTliL3RhYmxlOmZhYjNmZGNhNDc0YTQ1NDg5MWQ5MDg5NjU4NjM0M2RlL3RhYmxlcmFuZ2U6ZmFiM2ZkY2E0NzRhNDU0ODkxZDkwODk2NTg2MzQzZGVfMjktMS0xLTEtMTYwODc_fa67c358-ec48-4b00-bdf4-e7d09e1b72f1"
      unitRef="usd">57054000</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss
      contextRef="i39065c5daf934af885335c12f3cfa83f_D20200401-20200630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzY2E5YmIwMTc5MjQ3NmZiYjIyNWU1ZDlkZWM4NjlmL3NlYzo5M2NhOWJiMDE3OTI0NzZmYmIyMjVlNWQ5ZGVjODY5Zl8xOS9mcmFnOmNhNDBhNzBkOTFkZDRiMGE4YTQxZjI0NmM2NDMxNTliL3RhYmxlOmZhYjNmZGNhNDc0YTQ1NDg5MWQ5MDg5NjU4NjM0M2RlL3RhYmxlcmFuZ2U6ZmFiM2ZkY2E0NzRhNDU0ODkxZDkwODk2NTg2MzQzZGVfMjktMy0xLTEtMTYwODc_a2976b37-2b87-4a19-afa9-c434f6a97d48"
      unitRef="usd">-106977000</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss
      contextRef="i69782326f71a44e3805518280ee22b6b_D20210101-20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzY2E5YmIwMTc5MjQ3NmZiYjIyNWU1ZDlkZWM4NjlmL3NlYzo5M2NhOWJiMDE3OTI0NzZmYmIyMjVlNWQ5ZGVjODY5Zl8xOS9mcmFnOmNhNDBhNzBkOTFkZDRiMGE4YTQxZjI0NmM2NDMxNTliL3RhYmxlOmZhYjNmZGNhNDc0YTQ1NDg5MWQ5MDg5NjU4NjM0M2RlL3RhYmxlcmFuZ2U6ZmFiM2ZkY2E0NzRhNDU0ODkxZDkwODk2NTg2MzQzZGVfMjktNS0xLTEtMTYwODc_d1f7dcc8-1882-4ca7-835a-b576e0001c67"
      unitRef="usd">-104258000</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss
      contextRef="i4a110e4972ef4113880ce582e3cda5c5_D20200101-20200630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzY2E5YmIwMTc5MjQ3NmZiYjIyNWU1ZDlkZWM4NjlmL3NlYzo5M2NhOWJiMDE3OTI0NzZmYmIyMjVlNWQ5ZGVjODY5Zl8xOS9mcmFnOmNhNDBhNzBkOTFkZDRiMGE4YTQxZjI0NmM2NDMxNTliL3RhYmxlOmZhYjNmZGNhNDc0YTQ1NDg5MWQ5MDg5NjU4NjM0M2RlL3RhYmxlcmFuZ2U6ZmFiM2ZkY2E0NzRhNDU0ODkxZDkwODk2NTg2MzQzZGVfMjktNy0xLTEtMTYwODc_d12dd780-f9a6-4210-adff-27113f9f841b"
      unitRef="usd">-30937000</us-gaap:NetIncomeLoss>
    <us-gaap:ProfitLoss
      contextRef="i27f4e53b91ad4367b7f8d273eff27769_D20210401-20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzY2E5YmIwMTc5MjQ3NmZiYjIyNWU1ZDlkZWM4NjlmL3NlYzo5M2NhOWJiMDE3OTI0NzZmYmIyMjVlNWQ5ZGVjODY5Zl8xOS9mcmFnOmNhNDBhNzBkOTFkZDRiMGE4YTQxZjI0NmM2NDMxNTliL3RhYmxlOmZhYjNmZGNhNDc0YTQ1NDg5MWQ5MDg5NjU4NjM0M2RlL3RhYmxlcmFuZ2U6ZmFiM2ZkY2E0NzRhNDU0ODkxZDkwODk2NTg2MzQzZGVfMzUtMS0xLTEtMTYwODk_4afaf6da-0f87-4956-9d0e-5d0c6f05cd31"
      unitRef="usd">56775000</us-gaap:ProfitLoss>
    <us-gaap:ProfitLoss
      contextRef="i39065c5daf934af885335c12f3cfa83f_D20200401-20200630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzY2E5YmIwMTc5MjQ3NmZiYjIyNWU1ZDlkZWM4NjlmL3NlYzo5M2NhOWJiMDE3OTI0NzZmYmIyMjVlNWQ5ZGVjODY5Zl8xOS9mcmFnOmNhNDBhNzBkOTFkZDRiMGE4YTQxZjI0NmM2NDMxNTliL3RhYmxlOmZhYjNmZGNhNDc0YTQ1NDg5MWQ5MDg5NjU4NjM0M2RlL3RhYmxlcmFuZ2U6ZmFiM2ZkY2E0NzRhNDU0ODkxZDkwODk2NTg2MzQzZGVfMzUtMy0xLTEtMTYwODk_37150dc4-1f69-4874-83a2-48253f664c04"
      unitRef="usd">-107703000</us-gaap:ProfitLoss>
    <us-gaap:ProfitLoss
      contextRef="i69782326f71a44e3805518280ee22b6b_D20210101-20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzY2E5YmIwMTc5MjQ3NmZiYjIyNWU1ZDlkZWM4NjlmL3NlYzo5M2NhOWJiMDE3OTI0NzZmYmIyMjVlNWQ5ZGVjODY5Zl8xOS9mcmFnOmNhNDBhNzBkOTFkZDRiMGE4YTQxZjI0NmM2NDMxNTliL3RhYmxlOmZhYjNmZGNhNDc0YTQ1NDg5MWQ5MDg5NjU4NjM0M2RlL3RhYmxlcmFuZ2U6ZmFiM2ZkY2E0NzRhNDU0ODkxZDkwODk2NTg2MzQzZGVfMzUtNS0xLTEtMTYwODk_8b3c14f9-e6f7-41da-9d9e-cc7d41e2c4ba"
      unitRef="usd">-104850000</us-gaap:ProfitLoss>
    <us-gaap:ProfitLoss
      contextRef="i4a110e4972ef4113880ce582e3cda5c5_D20200101-20200630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzY2E5YmIwMTc5MjQ3NmZiYjIyNWU1ZDlkZWM4NjlmL3NlYzo5M2NhOWJiMDE3OTI0NzZmYmIyMjVlNWQ5ZGVjODY5Zl8xOS9mcmFnOmNhNDBhNzBkOTFkZDRiMGE4YTQxZjI0NmM2NDMxNTliL3RhYmxlOmZhYjNmZGNhNDc0YTQ1NDg5MWQ5MDg5NjU4NjM0M2RlL3RhYmxlcmFuZ2U6ZmFiM2ZkY2E0NzRhNDU0ODkxZDkwODk2NTg2MzQzZGVfMzUtNy0xLTEtMTYwODk_7fc50773-03cb-4f12-8943-d57c782f46c7"
      unitRef="usd">-32022000</us-gaap:ProfitLoss>
    <us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
      contextRef="i27f4e53b91ad4367b7f8d273eff27769_D20210401-20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzY2E5YmIwMTc5MjQ3NmZiYjIyNWU1ZDlkZWM4NjlmL3NlYzo5M2NhOWJiMDE3OTI0NzZmYmIyMjVlNWQ5ZGVjODY5Zl8xOS9mcmFnOmNhNDBhNzBkOTFkZDRiMGE4YTQxZjI0NmM2NDMxNTliL3RhYmxlOmZhYjNmZGNhNDc0YTQ1NDg5MWQ5MDg5NjU4NjM0M2RlL3RhYmxlcmFuZ2U6ZmFiM2ZkY2E0NzRhNDU0ODkxZDkwODk2NTg2MzQzZGVfMzItMS0xLTEtMA_90ff8133-880e-4e5b-900e-6ae263acb252"
      unitRef="usd">13470000</us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
      contextRef="i39065c5daf934af885335c12f3cfa83f_D20200401-20200630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzY2E5YmIwMTc5MjQ3NmZiYjIyNWU1ZDlkZWM4NjlmL3NlYzo5M2NhOWJiMDE3OTI0NzZmYmIyMjVlNWQ5ZGVjODY5Zl8xOS9mcmFnOmNhNDBhNzBkOTFkZDRiMGE4YTQxZjI0NmM2NDMxNTliL3RhYmxlOmZhYjNmZGNhNDc0YTQ1NDg5MWQ5MDg5NjU4NjM0M2RlL3RhYmxlcmFuZ2U6ZmFiM2ZkY2E0NzRhNDU0ODkxZDkwODk2NTg2MzQzZGVfMzItMy0xLTEtMA_32358be9-d812-4334-af9a-d534c93cbdba"
      unitRef="usd">51871000</us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
      contextRef="i69782326f71a44e3805518280ee22b6b_D20210101-20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzY2E5YmIwMTc5MjQ3NmZiYjIyNWU1ZDlkZWM4NjlmL3NlYzo5M2NhOWJiMDE3OTI0NzZmYmIyMjVlNWQ5ZGVjODY5Zl8xOS9mcmFnOmNhNDBhNzBkOTFkZDRiMGE4YTQxZjI0NmM2NDMxNTliL3RhYmxlOmZhYjNmZGNhNDc0YTQ1NDg5MWQ5MDg5NjU4NjM0M2RlL3RhYmxlcmFuZ2U6ZmFiM2ZkY2E0NzRhNDU0ODkxZDkwODk2NTg2MzQzZGVfMzItNS0xLTEtMA_85085618-f3ec-4b74-9704-06e206d07c24"
      unitRef="usd">29754000</us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
      contextRef="i4a110e4972ef4113880ce582e3cda5c5_D20200101-20200630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzY2E5YmIwMTc5MjQ3NmZiYjIyNWU1ZDlkZWM4NjlmL3NlYzo5M2NhOWJiMDE3OTI0NzZmYmIyMjVlNWQ5ZGVjODY5Zl8xOS9mcmFnOmNhNDBhNzBkOTFkZDRiMGE4YTQxZjI0NmM2NDMxNTliL3RhYmxlOmZhYjNmZGNhNDc0YTQ1NDg5MWQ5MDg5NjU4NjM0M2RlL3RhYmxlcmFuZ2U6ZmFiM2ZkY2E0NzRhNDU0ODkxZDkwODk2NTg2MzQzZGVfMzItNy0xLTEtMA_2e6ba7c8-3a43-48b7-bc33-1a6f1aa91458"
      unitRef="usd">-61821000</us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTax
      contextRef="i27f4e53b91ad4367b7f8d273eff27769_D20210401-20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzY2E5YmIwMTc5MjQ3NmZiYjIyNWU1ZDlkZWM4NjlmL3NlYzo5M2NhOWJiMDE3OTI0NzZmYmIyMjVlNWQ5ZGVjODY5Zl8xOS9mcmFnOmNhNDBhNzBkOTFkZDRiMGE4YTQxZjI0NmM2NDMxNTliL3RhYmxlOmZhYjNmZGNhNDc0YTQ1NDg5MWQ5MDg5NjU4NjM0M2RlL3RhYmxlcmFuZ2U6ZmFiM2ZkY2E0NzRhNDU0ODkxZDkwODk2NTg2MzQzZGVfMzQtMS0xLTEtMA_c4d49091-ddfb-4358-a836-ae05ea71afe4"
      unitRef="usd">13470000</us-gaap:OtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTax
      contextRef="i39065c5daf934af885335c12f3cfa83f_D20200401-20200630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzY2E5YmIwMTc5MjQ3NmZiYjIyNWU1ZDlkZWM4NjlmL3NlYzo5M2NhOWJiMDE3OTI0NzZmYmIyMjVlNWQ5ZGVjODY5Zl8xOS9mcmFnOmNhNDBhNzBkOTFkZDRiMGE4YTQxZjI0NmM2NDMxNTliL3RhYmxlOmZhYjNmZGNhNDc0YTQ1NDg5MWQ5MDg5NjU4NjM0M2RlL3RhYmxlcmFuZ2U6ZmFiM2ZkY2E0NzRhNDU0ODkxZDkwODk2NTg2MzQzZGVfMzQtMy0xLTEtMA_819160fd-603d-48f1-9d31-43741a55ce78"
      unitRef="usd">51871000</us-gaap:OtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTax
      contextRef="i69782326f71a44e3805518280ee22b6b_D20210101-20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzY2E5YmIwMTc5MjQ3NmZiYjIyNWU1ZDlkZWM4NjlmL3NlYzo5M2NhOWJiMDE3OTI0NzZmYmIyMjVlNWQ5ZGVjODY5Zl8xOS9mcmFnOmNhNDBhNzBkOTFkZDRiMGE4YTQxZjI0NmM2NDMxNTliL3RhYmxlOmZhYjNmZGNhNDc0YTQ1NDg5MWQ5MDg5NjU4NjM0M2RlL3RhYmxlcmFuZ2U6ZmFiM2ZkY2E0NzRhNDU0ODkxZDkwODk2NTg2MzQzZGVfMzQtNS0xLTEtMA_a5b4984d-593d-474b-b641-1877a0d6c1bd"
      unitRef="usd">29754000</us-gaap:OtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTax
      contextRef="i4a110e4972ef4113880ce582e3cda5c5_D20200101-20200630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzY2E5YmIwMTc5MjQ3NmZiYjIyNWU1ZDlkZWM4NjlmL3NlYzo5M2NhOWJiMDE3OTI0NzZmYmIyMjVlNWQ5ZGVjODY5Zl8xOS9mcmFnOmNhNDBhNzBkOTFkZDRiMGE4YTQxZjI0NmM2NDMxNTliL3RhYmxlOmZhYjNmZGNhNDc0YTQ1NDg5MWQ5MDg5NjU4NjM0M2RlL3RhYmxlcmFuZ2U6ZmFiM2ZkY2E0NzRhNDU0ODkxZDkwODk2NTg2MzQzZGVfMzQtNy0xLTEtMA_5db6db19-3d6b-4e27-b9b1-fb0945df9e8f"
      unitRef="usd">-61821000</us-gaap:OtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i27f4e53b91ad4367b7f8d273eff27769_D20210401-20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzY2E5YmIwMTc5MjQ3NmZiYjIyNWU1ZDlkZWM4NjlmL3NlYzo5M2NhOWJiMDE3OTI0NzZmYmIyMjVlNWQ5ZGVjODY5Zl8xOS9mcmFnOmNhNDBhNzBkOTFkZDRiMGE4YTQxZjI0NmM2NDMxNTliL3RhYmxlOmZhYjNmZGNhNDc0YTQ1NDg5MWQ5MDg5NjU4NjM0M2RlL3RhYmxlcmFuZ2U6ZmFiM2ZkY2E0NzRhNDU0ODkxZDkwODk2NTg2MzQzZGVfMzUtMS0xLTEtMA_fed700d6-543f-4635-8855-2ba4f42a7372"
      unitRef="usd">70245000</us-gaap:ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i39065c5daf934af885335c12f3cfa83f_D20200401-20200630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzY2E5YmIwMTc5MjQ3NmZiYjIyNWU1ZDlkZWM4NjlmL3NlYzo5M2NhOWJiMDE3OTI0NzZmYmIyMjVlNWQ5ZGVjODY5Zl8xOS9mcmFnOmNhNDBhNzBkOTFkZDRiMGE4YTQxZjI0NmM2NDMxNTliL3RhYmxlOmZhYjNmZGNhNDc0YTQ1NDg5MWQ5MDg5NjU4NjM0M2RlL3RhYmxlcmFuZ2U6ZmFiM2ZkY2E0NzRhNDU0ODkxZDkwODk2NTg2MzQzZGVfMzUtMy0xLTEtMA_5f1fc832-f63e-4ce5-acfb-88cdba4c7169"
      unitRef="usd">-55832000</us-gaap:ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i69782326f71a44e3805518280ee22b6b_D20210101-20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzY2E5YmIwMTc5MjQ3NmZiYjIyNWU1ZDlkZWM4NjlmL3NlYzo5M2NhOWJiMDE3OTI0NzZmYmIyMjVlNWQ5ZGVjODY5Zl8xOS9mcmFnOmNhNDBhNzBkOTFkZDRiMGE4YTQxZjI0NmM2NDMxNTliL3RhYmxlOmZhYjNmZGNhNDc0YTQ1NDg5MWQ5MDg5NjU4NjM0M2RlL3RhYmxlcmFuZ2U6ZmFiM2ZkY2E0NzRhNDU0ODkxZDkwODk2NTg2MzQzZGVfMzUtNS0xLTEtMA_a730a327-053d-4a2f-8693-9c8c5c6013ef"
      unitRef="usd">-75096000</us-gaap:ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i4a110e4972ef4113880ce582e3cda5c5_D20200101-20200630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzY2E5YmIwMTc5MjQ3NmZiYjIyNWU1ZDlkZWM4NjlmL3NlYzo5M2NhOWJiMDE3OTI0NzZmYmIyMjVlNWQ5ZGVjODY5Zl8xOS9mcmFnOmNhNDBhNzBkOTFkZDRiMGE4YTQxZjI0NmM2NDMxNTliL3RhYmxlOmZhYjNmZGNhNDc0YTQ1NDg5MWQ5MDg5NjU4NjM0M2RlL3RhYmxlcmFuZ2U6ZmFiM2ZkY2E0NzRhNDU0ODkxZDkwODk2NTg2MzQzZGVfMzUtNy0xLTEtMA_74f5c2f3-bf79-489f-a64b-1ba5ad24cf6f"
      unitRef="usd">-93843000</us-gaap:ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest
      contextRef="i27f4e53b91ad4367b7f8d273eff27769_D20210401-20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzY2E5YmIwMTc5MjQ3NmZiYjIyNWU1ZDlkZWM4NjlmL3NlYzo5M2NhOWJiMDE3OTI0NzZmYmIyMjVlNWQ5ZGVjODY5Zl8xOS9mcmFnOmNhNDBhNzBkOTFkZDRiMGE4YTQxZjI0NmM2NDMxNTliL3RhYmxlOmZhYjNmZGNhNDc0YTQ1NDg5MWQ5MDg5NjU4NjM0M2RlL3RhYmxlcmFuZ2U6ZmFiM2ZkY2E0NzRhNDU0ODkxZDkwODk2NTg2MzQzZGVfNDItMS0xLTEtMTI5ODE_35e46e90-ce73-44fa-9bed-a607c5dfacda"
      unitRef="usd">-394000</us-gaap:ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest>
    <us-gaap:ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest
      contextRef="i39065c5daf934af885335c12f3cfa83f_D20200401-20200630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzY2E5YmIwMTc5MjQ3NmZiYjIyNWU1ZDlkZWM4NjlmL3NlYzo5M2NhOWJiMDE3OTI0NzZmYmIyMjVlNWQ5ZGVjODY5Zl8xOS9mcmFnOmNhNDBhNzBkOTFkZDRiMGE4YTQxZjI0NmM2NDMxNTliL3RhYmxlOmZhYjNmZGNhNDc0YTQ1NDg5MWQ5MDg5NjU4NjM0M2RlL3RhYmxlcmFuZ2U6ZmFiM2ZkY2E0NzRhNDU0ODkxZDkwODk2NTg2MzQzZGVfNDItMy0xLTEtMTI5ODE_942ed9af-a3cb-40f9-b67a-a975cde18b20"
      unitRef="usd">-762000</us-gaap:ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest>
    <us-gaap:ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest
      contextRef="i69782326f71a44e3805518280ee22b6b_D20210101-20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzY2E5YmIwMTc5MjQ3NmZiYjIyNWU1ZDlkZWM4NjlmL3NlYzo5M2NhOWJiMDE3OTI0NzZmYmIyMjVlNWQ5ZGVjODY5Zl8xOS9mcmFnOmNhNDBhNzBkOTFkZDRiMGE4YTQxZjI0NmM2NDMxNTliL3RhYmxlOmZhYjNmZGNhNDc0YTQ1NDg5MWQ5MDg5NjU4NjM0M2RlL3RhYmxlcmFuZ2U6ZmFiM2ZkY2E0NzRhNDU0ODkxZDkwODk2NTg2MzQzZGVfNDItNS0xLTEtMTI5ODE_32aea538-1db1-44c8-99ea-4686010014c8"
      unitRef="usd">432000</us-gaap:ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest>
    <us-gaap:ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest
      contextRef="i4a110e4972ef4113880ce582e3cda5c5_D20200101-20200630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzY2E5YmIwMTc5MjQ3NmZiYjIyNWU1ZDlkZWM4NjlmL3NlYzo5M2NhOWJiMDE3OTI0NzZmYmIyMjVlNWQ5ZGVjODY5Zl8xOS9mcmFnOmNhNDBhNzBkOTFkZDRiMGE4YTQxZjI0NmM2NDMxNTliL3RhYmxlOmZhYjNmZGNhNDc0YTQ1NDg5MWQ5MDg5NjU4NjM0M2RlL3RhYmxlcmFuZ2U6ZmFiM2ZkY2E0NzRhNDU0ODkxZDkwODk2NTg2MzQzZGVfNDItNy0xLTEtMTI5ODE_770a0068-703a-423e-9c14-d9a4bce4ca5c"
      unitRef="usd">-1098000</us-gaap:ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest>
    <us-gaap:ComprehensiveIncomeNetOfTax
      contextRef="i27f4e53b91ad4367b7f8d273eff27769_D20210401-20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzY2E5YmIwMTc5MjQ3NmZiYjIyNWU1ZDlkZWM4NjlmL3NlYzo5M2NhOWJiMDE3OTI0NzZmYmIyMjVlNWQ5ZGVjODY5Zl8xOS9mcmFnOmNhNDBhNzBkOTFkZDRiMGE4YTQxZjI0NmM2NDMxNTliL3RhYmxlOmZhYjNmZGNhNDc0YTQ1NDg5MWQ5MDg5NjU4NjM0M2RlL3RhYmxlcmFuZ2U6ZmFiM2ZkY2E0NzRhNDU0ODkxZDkwODk2NTg2MzQzZGVfNDItMS0xLTEtMTYwOTY_5f1f75ce-8f04-4d2a-905e-ba6a51cddd16"
      unitRef="usd">70639000</us-gaap:ComprehensiveIncomeNetOfTax>
    <us-gaap:ComprehensiveIncomeNetOfTax
      contextRef="i39065c5daf934af885335c12f3cfa83f_D20200401-20200630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzY2E5YmIwMTc5MjQ3NmZiYjIyNWU1ZDlkZWM4NjlmL3NlYzo5M2NhOWJiMDE3OTI0NzZmYmIyMjVlNWQ5ZGVjODY5Zl8xOS9mcmFnOmNhNDBhNzBkOTFkZDRiMGE4YTQxZjI0NmM2NDMxNTliL3RhYmxlOmZhYjNmZGNhNDc0YTQ1NDg5MWQ5MDg5NjU4NjM0M2RlL3RhYmxlcmFuZ2U6ZmFiM2ZkY2E0NzRhNDU0ODkxZDkwODk2NTg2MzQzZGVfNDItMy0xLTEtMTYwOTY_5ca2a18c-5812-49c0-9d39-fbe731c740e7"
      unitRef="usd">-55070000</us-gaap:ComprehensiveIncomeNetOfTax>
    <us-gaap:ComprehensiveIncomeNetOfTax
      contextRef="i69782326f71a44e3805518280ee22b6b_D20210101-20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzY2E5YmIwMTc5MjQ3NmZiYjIyNWU1ZDlkZWM4NjlmL3NlYzo5M2NhOWJiMDE3OTI0NzZmYmIyMjVlNWQ5ZGVjODY5Zl8xOS9mcmFnOmNhNDBhNzBkOTFkZDRiMGE4YTQxZjI0NmM2NDMxNTliL3RhYmxlOmZhYjNmZGNhNDc0YTQ1NDg5MWQ5MDg5NjU4NjM0M2RlL3RhYmxlcmFuZ2U6ZmFiM2ZkY2E0NzRhNDU0ODkxZDkwODk2NTg2MzQzZGVfNDItNS0xLTEtMTYwOTY_13c44241-de54-4939-9024-7edf58c64108"
      unitRef="usd">-75528000</us-gaap:ComprehensiveIncomeNetOfTax>
    <us-gaap:ComprehensiveIncomeNetOfTax
      contextRef="i4a110e4972ef4113880ce582e3cda5c5_D20200101-20200630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzY2E5YmIwMTc5MjQ3NmZiYjIyNWU1ZDlkZWM4NjlmL3NlYzo5M2NhOWJiMDE3OTI0NzZmYmIyMjVlNWQ5ZGVjODY5Zl8xOS9mcmFnOmNhNDBhNzBkOTFkZDRiMGE4YTQxZjI0NmM2NDMxNTliL3RhYmxlOmZhYjNmZGNhNDc0YTQ1NDg5MWQ5MDg5NjU4NjM0M2RlL3RhYmxlcmFuZ2U6ZmFiM2ZkY2E0NzRhNDU0ODkxZDkwODk2NTg2MzQzZGVfNDItNy0xLTEtMTYwOTY_c15627d1-c45d-42eb-b3d1-4d24efd8de4b"
      unitRef="usd">-92745000</us-gaap:ComprehensiveIncomeNetOfTax>
    <us-gaap:IncomeLossFromContinuingOperationsPerDilutedShare
      contextRef="i27f4e53b91ad4367b7f8d273eff27769_D20210401-20210630"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzY2E5YmIwMTc5MjQ3NmZiYjIyNWU1ZDlkZWM4NjlmL3NlYzo5M2NhOWJiMDE3OTI0NzZmYmIyMjVlNWQ5ZGVjODY5Zl8xOS9mcmFnOmNhNDBhNzBkOTFkZDRiMGE4YTQxZjI0NmM2NDMxNTliL3RhYmxlOmZhYjNmZGNhNDc0YTQ1NDg5MWQ5MDg5NjU4NjM0M2RlL3RhYmxlcmFuZ2U6ZmFiM2ZkY2E0NzRhNDU0ODkxZDkwODk2NTg2MzQzZGVfNDEtMS0xLTEtMA_675bf772-1c5c-4a5a-bf15-07244d1c9908"
      unitRef="usdPerShare">0.15</us-gaap:IncomeLossFromContinuingOperationsPerDilutedShare>
    <us-gaap:IncomeLossFromContinuingOperationsPerBasicShare
      contextRef="i27f4e53b91ad4367b7f8d273eff27769_D20210401-20210630"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzY2E5YmIwMTc5MjQ3NmZiYjIyNWU1ZDlkZWM4NjlmL3NlYzo5M2NhOWJiMDE3OTI0NzZmYmIyMjVlNWQ5ZGVjODY5Zl8xOS9mcmFnOmNhNDBhNzBkOTFkZDRiMGE4YTQxZjI0NmM2NDMxNTliL3RhYmxlOmZhYjNmZGNhNDc0YTQ1NDg5MWQ5MDg5NjU4NjM0M2RlL3RhYmxlcmFuZ2U6ZmFiM2ZkY2E0NzRhNDU0ODkxZDkwODk2NTg2MzQzZGVfNDEtMS0xLTEtMA_d6281356-db5e-429e-982f-5e42c1d7107f"
      unitRef="usdPerShare">0.15</us-gaap:IncomeLossFromContinuingOperationsPerBasicShare>
    <us-gaap:IncomeLossFromContinuingOperationsPerDilutedShare
      contextRef="i39065c5daf934af885335c12f3cfa83f_D20200401-20200630"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzY2E5YmIwMTc5MjQ3NmZiYjIyNWU1ZDlkZWM4NjlmL3NlYzo5M2NhOWJiMDE3OTI0NzZmYmIyMjVlNWQ5ZGVjODY5Zl8xOS9mcmFnOmNhNDBhNzBkOTFkZDRiMGE4YTQxZjI0NmM2NDMxNTliL3RhYmxlOmZhYjNmZGNhNDc0YTQ1NDg5MWQ5MDg5NjU4NjM0M2RlL3RhYmxlcmFuZ2U6ZmFiM2ZkY2E0NzRhNDU0ODkxZDkwODk2NTg2MzQzZGVfNDEtMy0xLTEtMA_a5ebc63c-dc59-45c0-b4c2-fa5da5562a07"
      unitRef="usdPerShare">-0.31</us-gaap:IncomeLossFromContinuingOperationsPerDilutedShare>
    <us-gaap:IncomeLossFromContinuingOperationsPerBasicShare
      contextRef="i39065c5daf934af885335c12f3cfa83f_D20200401-20200630"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzY2E5YmIwMTc5MjQ3NmZiYjIyNWU1ZDlkZWM4NjlmL3NlYzo5M2NhOWJiMDE3OTI0NzZmYmIyMjVlNWQ5ZGVjODY5Zl8xOS9mcmFnOmNhNDBhNzBkOTFkZDRiMGE4YTQxZjI0NmM2NDMxNTliL3RhYmxlOmZhYjNmZGNhNDc0YTQ1NDg5MWQ5MDg5NjU4NjM0M2RlL3RhYmxlcmFuZ2U6ZmFiM2ZkY2E0NzRhNDU0ODkxZDkwODk2NTg2MzQzZGVfNDEtMy0xLTEtMA_d29c8b5a-9a81-41a0-8b71-7e9336e48fff"
      unitRef="usdPerShare">-0.31</us-gaap:IncomeLossFromContinuingOperationsPerBasicShare>
    <us-gaap:IncomeLossFromContinuingOperationsPerBasicShare
      contextRef="i69782326f71a44e3805518280ee22b6b_D20210101-20210630"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzY2E5YmIwMTc5MjQ3NmZiYjIyNWU1ZDlkZWM4NjlmL3NlYzo5M2NhOWJiMDE3OTI0NzZmYmIyMjVlNWQ5ZGVjODY5Zl8xOS9mcmFnOmNhNDBhNzBkOTFkZDRiMGE4YTQxZjI0NmM2NDMxNTliL3RhYmxlOmZhYjNmZGNhNDc0YTQ1NDg5MWQ5MDg5NjU4NjM0M2RlL3RhYmxlcmFuZ2U6ZmFiM2ZkY2E0NzRhNDU0ODkxZDkwODk2NTg2MzQzZGVfNDEtNS0xLTEtMA_4ab65d68-eeb4-44e6-b74a-b4e686f8182d"
      unitRef="usdPerShare">-0.28</us-gaap:IncomeLossFromContinuingOperationsPerBasicShare>
    <us-gaap:IncomeLossFromContinuingOperationsPerDilutedShare
      contextRef="i69782326f71a44e3805518280ee22b6b_D20210101-20210630"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzY2E5YmIwMTc5MjQ3NmZiYjIyNWU1ZDlkZWM4NjlmL3NlYzo5M2NhOWJiMDE3OTI0NzZmYmIyMjVlNWQ5ZGVjODY5Zl8xOS9mcmFnOmNhNDBhNzBkOTFkZDRiMGE4YTQxZjI0NmM2NDMxNTliL3RhYmxlOmZhYjNmZGNhNDc0YTQ1NDg5MWQ5MDg5NjU4NjM0M2RlL3RhYmxlcmFuZ2U6ZmFiM2ZkY2E0NzRhNDU0ODkxZDkwODk2NTg2MzQzZGVfNDEtNS0xLTEtMA_d2727dbe-cf96-4a0e-a46d-7025f6130db7"
      unitRef="usdPerShare">-0.28</us-gaap:IncomeLossFromContinuingOperationsPerDilutedShare>
    <us-gaap:IncomeLossFromContinuingOperationsPerDilutedShare
      contextRef="i4a110e4972ef4113880ce582e3cda5c5_D20200101-20200630"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzY2E5YmIwMTc5MjQ3NmZiYjIyNWU1ZDlkZWM4NjlmL3NlYzo5M2NhOWJiMDE3OTI0NzZmYmIyMjVlNWQ5ZGVjODY5Zl8xOS9mcmFnOmNhNDBhNzBkOTFkZDRiMGE4YTQxZjI0NmM2NDMxNTliL3RhYmxlOmZhYjNmZGNhNDc0YTQ1NDg5MWQ5MDg5NjU4NjM0M2RlL3RhYmxlcmFuZ2U6ZmFiM2ZkY2E0NzRhNDU0ODkxZDkwODk2NTg2MzQzZGVfNDEtNy0xLTEtMA_49a34991-6eba-40b5-ae1b-41913455d5f8"
      unitRef="usdPerShare">-0.09</us-gaap:IncomeLossFromContinuingOperationsPerDilutedShare>
    <us-gaap:IncomeLossFromContinuingOperationsPerBasicShare
      contextRef="i4a110e4972ef4113880ce582e3cda5c5_D20200101-20200630"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzY2E5YmIwMTc5MjQ3NmZiYjIyNWU1ZDlkZWM4NjlmL3NlYzo5M2NhOWJiMDE3OTI0NzZmYmIyMjVlNWQ5ZGVjODY5Zl8xOS9mcmFnOmNhNDBhNzBkOTFkZDRiMGE4YTQxZjI0NmM2NDMxNTliL3RhYmxlOmZhYjNmZGNhNDc0YTQ1NDg5MWQ5MDg5NjU4NjM0M2RlL3RhYmxlcmFuZ2U6ZmFiM2ZkY2E0NzRhNDU0ODkxZDkwODk2NTg2MzQzZGVfNDEtNy0xLTEtMA_a34079aa-af6e-499d-a1fc-da2d454db482"
      unitRef="usdPerShare">-0.09</us-gaap:IncomeLossFromContinuingOperationsPerBasicShare>
    <us-gaap:WeightedAverageNumberOfSharesOutstandingBasic
      contextRef="i27f4e53b91ad4367b7f8d273eff27769_D20210401-20210630"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzY2E5YmIwMTc5MjQ3NmZiYjIyNWU1ZDlkZWM4NjlmL3NlYzo5M2NhOWJiMDE3OTI0NzZmYmIyMjVlNWQ5ZGVjODY5Zl8xOS9mcmFnOmNhNDBhNzBkOTFkZDRiMGE4YTQxZjI0NmM2NDMxNTliL3RhYmxlOmZhYjNmZGNhNDc0YTQ1NDg5MWQ5MDg5NjU4NjM0M2RlL3RhYmxlcmFuZ2U6ZmFiM2ZkY2E0NzRhNDU0ODkxZDkwODk2NTg2MzQzZGVfNDQtMS0xLTEtMA_c1790266-cc19-4baa-9998-4690422a13fd"
      unitRef="shares">371721382</us-gaap:WeightedAverageNumberOfSharesOutstandingBasic>
    <us-gaap:WeightedAverageNumberOfSharesOutstandingBasic
      contextRef="i39065c5daf934af885335c12f3cfa83f_D20200401-20200630"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzY2E5YmIwMTc5MjQ3NmZiYjIyNWU1ZDlkZWM4NjlmL3NlYzo5M2NhOWJiMDE3OTI0NzZmYmIyMjVlNWQ5ZGVjODY5Zl8xOS9mcmFnOmNhNDBhNzBkOTFkZDRiMGE4YTQxZjI0NmM2NDMxNTliL3RhYmxlOmZhYjNmZGNhNDc0YTQ1NDg5MWQ5MDg5NjU4NjM0M2RlL3RhYmxlcmFuZ2U6ZmFiM2ZkY2E0NzRhNDU0ODkxZDkwODk2NTg2MzQzZGVfNDQtMy0xLTEtMA_efa4762c-cb7f-4d69-ad3a-ce6da858a38f"
      unitRef="shares">349075408</us-gaap:WeightedAverageNumberOfSharesOutstandingBasic>
    <us-gaap:WeightedAverageNumberOfSharesOutstandingBasic
      contextRef="i69782326f71a44e3805518280ee22b6b_D20210101-20210630"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzY2E5YmIwMTc5MjQ3NmZiYjIyNWU1ZDlkZWM4NjlmL3NlYzo5M2NhOWJiMDE3OTI0NzZmYmIyMjVlNWQ5ZGVjODY5Zl8xOS9mcmFnOmNhNDBhNzBkOTFkZDRiMGE4YTQxZjI0NmM2NDMxNTliL3RhYmxlOmZhYjNmZGNhNDc0YTQ1NDg5MWQ5MDg5NjU4NjM0M2RlL3RhYmxlcmFuZ2U6ZmFiM2ZkY2E0NzRhNDU0ODkxZDkwODk2NTg2MzQzZGVfNDQtNS0xLTEtMA_4ee3d5e2-9a1c-4fea-881a-89cd54bd624b"
      unitRef="shares">367391118</us-gaap:WeightedAverageNumberOfSharesOutstandingBasic>
    <us-gaap:WeightedAverageNumberOfSharesOutstandingBasic
      contextRef="i4a110e4972ef4113880ce582e3cda5c5_D20200101-20200630"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzY2E5YmIwMTc5MjQ3NmZiYjIyNWU1ZDlkZWM4NjlmL3NlYzo5M2NhOWJiMDE3OTI0NzZmYmIyMjVlNWQ5ZGVjODY5Zl8xOS9mcmFnOmNhNDBhNzBkOTFkZDRiMGE4YTQxZjI0NmM2NDMxNTliL3RhYmxlOmZhYjNmZGNhNDc0YTQ1NDg5MWQ5MDg5NjU4NjM0M2RlL3RhYmxlcmFuZ2U6ZmFiM2ZkY2E0NzRhNDU0ODkxZDkwODk2NTg2MzQzZGVfNDQtNy0xLTEtMA_807fb4c6-c25a-44d7-8ea1-16897ae0dba3"
      unitRef="shares">348946439</us-gaap:WeightedAverageNumberOfSharesOutstandingBasic>
    <us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding
      contextRef="i27f4e53b91ad4367b7f8d273eff27769_D20210401-20210630"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzY2E5YmIwMTc5MjQ3NmZiYjIyNWU1ZDlkZWM4NjlmL3NlYzo5M2NhOWJiMDE3OTI0NzZmYmIyMjVlNWQ5ZGVjODY5Zl8xOS9mcmFnOmNhNDBhNzBkOTFkZDRiMGE4YTQxZjI0NmM2NDMxNTliL3RhYmxlOmZhYjNmZGNhNDc0YTQ1NDg5MWQ5MDg5NjU4NjM0M2RlL3RhYmxlcmFuZ2U6ZmFiM2ZkY2E0NzRhNDU0ODkxZDkwODk2NTg2MzQzZGVfNDUtMS0xLTEtMA_5107fc9b-d889-4cc0-84d5-79d228a43b09"
      unitRef="shares">375349856</us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding>
    <us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding
      contextRef="i39065c5daf934af885335c12f3cfa83f_D20200401-20200630"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzY2E5YmIwMTc5MjQ3NmZiYjIyNWU1ZDlkZWM4NjlmL3NlYzo5M2NhOWJiMDE3OTI0NzZmYmIyMjVlNWQ5ZGVjODY5Zl8xOS9mcmFnOmNhNDBhNzBkOTFkZDRiMGE4YTQxZjI0NmM2NDMxNTliL3RhYmxlOmZhYjNmZGNhNDc0YTQ1NDg5MWQ5MDg5NjU4NjM0M2RlL3RhYmxlcmFuZ2U6ZmFiM2ZkY2E0NzRhNDU0ODkxZDkwODk2NTg2MzQzZGVfNDUtMy0xLTEtMA_9bc7d4f7-fbad-4a4e-b43b-851b78817057"
      unitRef="shares">349075408</us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding>
    <us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding
      contextRef="i69782326f71a44e3805518280ee22b6b_D20210101-20210630"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzY2E5YmIwMTc5MjQ3NmZiYjIyNWU1ZDlkZWM4NjlmL3NlYzo5M2NhOWJiMDE3OTI0NzZmYmIyMjVlNWQ5ZGVjODY5Zl8xOS9mcmFnOmNhNDBhNzBkOTFkZDRiMGE4YTQxZjI0NmM2NDMxNTliL3RhYmxlOmZhYjNmZGNhNDc0YTQ1NDg5MWQ5MDg5NjU4NjM0M2RlL3RhYmxlcmFuZ2U6ZmFiM2ZkY2E0NzRhNDU0ODkxZDkwODk2NTg2MzQzZGVfNDUtNS0xLTEtMA_6a918055-9de8-4285-a4f4-3356d0079bec"
      unitRef="shares">367391118</us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding>
    <us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding
      contextRef="i4a110e4972ef4113880ce582e3cda5c5_D20200101-20200630"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzY2E5YmIwMTc5MjQ3NmZiYjIyNWU1ZDlkZWM4NjlmL3NlYzo5M2NhOWJiMDE3OTI0NzZmYmIyMjVlNWQ5ZGVjODY5Zl8xOS9mcmFnOmNhNDBhNzBkOTFkZDRiMGE4YTQxZjI0NmM2NDMxNTliL3RhYmxlOmZhYjNmZGNhNDc0YTQ1NDg5MWQ5MDg5NjU4NjM0M2RlL3RhYmxlcmFuZ2U6ZmFiM2ZkY2E0NzRhNDU0ODkxZDkwODk2NTg2MzQzZGVfNDUtNy0xLTEtMA_046c472e-653d-4981-8c85-075f2e96b826"
      unitRef="shares">348946439</us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding>
    <us-gaap:CommonStockSharesOutstanding
      contextRef="i22dfc818a91c4bc99bcf6f1109597b56_I20210331"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzY2E5YmIwMTc5MjQ3NmZiYjIyNWU1ZDlkZWM4NjlmL3NlYzo5M2NhOWJiMDE3OTI0NzZmYmIyMjVlNWQ5ZGVjODY5Zl8yNS9mcmFnOjFhMTNiMjI5MDE5MTQ3NGNhMjc0YzQ2NGY4YWJmOTIwL3RhYmxlOjMwOTcxNjlmZGQ5MDQ3ZDg4ODBjZmRlNjVkYzdiYTZkL3RhYmxlcmFuZ2U6MzA5NzE2OWZkZDkwNDdkODg4MGNmZGU2NWRjN2JhNmRfMS0xLTEtMS0w_331620c2-bcee-42d8-8ac8-bf205420af2a"
      unitRef="shares">371656590</us-gaap:CommonStockSharesOutstanding>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i22dfc818a91c4bc99bcf6f1109597b56_I20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzY2E5YmIwMTc5MjQ3NmZiYjIyNWU1ZDlkZWM4NjlmL3NlYzo5M2NhOWJiMDE3OTI0NzZmYmIyMjVlNWQ5ZGVjODY5Zl8yNS9mcmFnOjFhMTNiMjI5MDE5MTQ3NGNhMjc0YzQ2NGY4YWJmOTIwL3RhYmxlOjMwOTcxNjlmZGQ5MDQ3ZDg4ODBjZmRlNjVkYzdiYTZkL3RhYmxlcmFuZ2U6MzA5NzE2OWZkZDkwNDdkODg4MGNmZGU2NWRjN2JhNmRfMS0zLTEtMS0w_efdb7a37-2ab9-46c7-82f8-f3eace2b9385"
      unitRef="usd">584912000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="iaba74aed20054433bd6c1d99389ea937_I20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzY2E5YmIwMTc5MjQ3NmZiYjIyNWU1ZDlkZWM4NjlmL3NlYzo5M2NhOWJiMDE3OTI0NzZmYmIyMjVlNWQ5ZGVjODY5Zl8yNS9mcmFnOjFhMTNiMjI5MDE5MTQ3NGNhMjc0YzQ2NGY4YWJmOTIwL3RhYmxlOjMwOTcxNjlmZGQ5MDQ3ZDg4ODBjZmRlNjVkYzdiYTZkL3RhYmxlcmFuZ2U6MzA5NzE2OWZkZDkwNDdkODg4MGNmZGU2NWRjN2JhNmRfMS03LTEtMS0w_ae6c7ab4-d3b1-4619-a783-d1c433fdf74f"
      unitRef="usd">32090000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="if6552787aa974a6b8ba4aa50cadb2110_I20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzY2E5YmIwMTc5MjQ3NmZiYjIyNWU1ZDlkZWM4NjlmL3NlYzo5M2NhOWJiMDE3OTI0NzZmYmIyMjVlNWQ5ZGVjODY5Zl8yNS9mcmFnOjFhMTNiMjI5MDE5MTQ3NGNhMjc0YzQ2NGY4YWJmOTIwL3RhYmxlOjMwOTcxNjlmZGQ5MDQ3ZDg4ODBjZmRlNjVkYzdiYTZkL3RhYmxlcmFuZ2U6MzA5NzE2OWZkZDkwNDdkODg4MGNmZGU2NWRjN2JhNmRfMS05LTEtMS0w_9f8acd7d-ae24-4ed9-aa42-1dddc541400d"
      unitRef="usd">895503000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i3243ae496b5b4b50976442544343adcf_I20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzY2E5YmIwMTc5MjQ3NmZiYjIyNWU1ZDlkZWM4NjlmL3NlYzo5M2NhOWJiMDE3OTI0NzZmYmIyMjVlNWQ5ZGVjODY5Zl8yNS9mcmFnOjFhMTNiMjI5MDE5MTQ3NGNhMjc0YzQ2NGY4YWJmOTIwL3RhYmxlOjMwOTcxNjlmZGQ5MDQ3ZDg4ODBjZmRlNjVkYzdiYTZkL3RhYmxlcmFuZ2U6MzA5NzE2OWZkZDkwNDdkODg4MGNmZGU2NWRjN2JhNmRfMS0xMS0xLTEtMA_b907a5aa-b0b5-46e7-be2a-962af4bdd19f"
      unitRef="usd">58144000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i578f5574593f4ae99f69ac675bbba2b7_I20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzY2E5YmIwMTc5MjQ3NmZiYjIyNWU1ZDlkZWM4NjlmL3NlYzo5M2NhOWJiMDE3OTI0NzZmYmIyMjVlNWQ5ZGVjODY5Zl8yNS9mcmFnOjFhMTNiMjI5MDE5MTQ3NGNhMjc0YzQ2NGY4YWJmOTIwL3RhYmxlOjMwOTcxNjlmZGQ5MDQ3ZDg4ODBjZmRlNjVkYzdiYTZkL3RhYmxlcmFuZ2U6MzA5NzE2OWZkZDkwNDdkODg4MGNmZGU2NWRjN2JhNmRfMS0xMy0xLTEtMA_98ea7ebc-adf6-4668-94a2-4ce7dd262eda"
      unitRef="usd">-2370000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i672ae438d5904d3aa27f245b59e5ba4c_I20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzY2E5YmIwMTc5MjQ3NmZiYjIyNWU1ZDlkZWM4NjlmL3NlYzo5M2NhOWJiMDE3OTI0NzZmYmIyMjVlNWQ5ZGVjODY5Zl8yNS9mcmFnOjFhMTNiMjI5MDE5MTQ3NGNhMjc0YzQ2NGY4YWJmOTIwL3RhYmxlOjMwOTcxNjlmZGQ5MDQ3ZDg4ODBjZmRlNjVkYzdiYTZkL3RhYmxlcmFuZ2U6MzA5NzE2OWZkZDkwNDdkODg4MGNmZGU2NWRjN2JhNmRfMS0xNS0xLTEtMA_a6dc8b79-675e-42dd-bf5e-fbe206650b66"
      unitRef="usd">1568279000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <cron:SharebasedCompensationArrangementBySharebasedPaymentAwardWarrantsExercisesInPeriod
      contextRef="i932ec7c01594418eb95662a351e601a2_D20210401-20210630"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzY2E5YmIwMTc5MjQ3NmZiYjIyNWU1ZDlkZWM4NjlmL3NlYzo5M2NhOWJiMDE3OTI0NzZmYmIyMjVlNWQ5ZGVjODY5Zl8yNS9mcmFnOjFhMTNiMjI5MDE5MTQ3NGNhMjc0YzQ2NGY4YWJmOTIwL3RhYmxlOjMwOTcxNjlmZGQ5MDQ3ZDg4ODBjZmRlNjVkYzdiYTZkL3RhYmxlcmFuZ2U6MzA5NzE2OWZkZDkwNDdkODg4MGNmZGU2NWRjN2JhNmRfNC0xLTEtMS0w_a4b3cf7f-92fa-4626-b488-a1bc4aad801d"
      unitRef="shares">10000</cron:SharebasedCompensationArrangementBySharebasedPaymentAwardWarrantsExercisesInPeriod>
    <cron:StockIssuedDuringPeriodValueWarrantsExercised
      contextRef="i932ec7c01594418eb95662a351e601a2_D20210401-20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzY2E5YmIwMTc5MjQ3NmZiYjIyNWU1ZDlkZWM4NjlmL3NlYzo5M2NhOWJiMDE3OTI0NzZmYmIyMjVlNWQ5ZGVjODY5Zl8yNS9mcmFnOjFhMTNiMjI5MDE5MTQ3NGNhMjc0YzQ2NGY4YWJmOTIwL3RhYmxlOjMwOTcxNjlmZGQ5MDQ3ZDg4ODBjZmRlNjVkYzdiYTZkL3RhYmxlcmFuZ2U6MzA5NzE2OWZkZDkwNDdkODg4MGNmZGU2NWRjN2JhNmRfNC0zLTEtMS0w_f5fc3b36-332d-47ca-b476-7f05d665c51d"
      unitRef="usd">4000</cron:StockIssuedDuringPeriodValueWarrantsExercised>
    <cron:StockIssuedDuringPeriodValueWarrantsExercised
      contextRef="ia4656c8d89cf4a84bdd02d8823c897bb_D20210401-20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzY2E5YmIwMTc5MjQ3NmZiYjIyNWU1ZDlkZWM4NjlmL3NlYzo5M2NhOWJiMDE3OTI0NzZmYmIyMjVlNWQ5ZGVjODY5Zl8yNS9mcmFnOjFhMTNiMjI5MDE5MTQ3NGNhMjc0YzQ2NGY4YWJmOTIwL3RhYmxlOjMwOTcxNjlmZGQ5MDQ3ZDg4ODBjZmRlNjVkYzdiYTZkL3RhYmxlcmFuZ2U6MzA5NzE2OWZkZDkwNDdkODg4MGNmZGU2NWRjN2JhNmRfNC03LTEtMS0w_e8b3c447-3cf8-4e7c-91a9-3e831ee8e78a"
      unitRef="usd">-2000</cron:StockIssuedDuringPeriodValueWarrantsExercised>
    <cron:StockIssuedDuringPeriodValueWarrantsExercised
      contextRef="i27f4e53b91ad4367b7f8d273eff27769_D20210401-20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzY2E5YmIwMTc5MjQ3NmZiYjIyNWU1ZDlkZWM4NjlmL3NlYzo5M2NhOWJiMDE3OTI0NzZmYmIyMjVlNWQ5ZGVjODY5Zl8yNS9mcmFnOjFhMTNiMjI5MDE5MTQ3NGNhMjc0YzQ2NGY4YWJmOTIwL3RhYmxlOjMwOTcxNjlmZGQ5MDQ3ZDg4ODBjZmRlNjVkYzdiYTZkL3RhYmxlcmFuZ2U6MzA5NzE2OWZkZDkwNDdkODg4MGNmZGU2NWRjN2JhNmRfNC0xNS0xLTEtMA_824391a5-fe5d-4c4b-97e4-e5e6fb276b09"
      unitRef="usd">2000</cron:StockIssuedDuringPeriodValueWarrantsExercised>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsRequisiteServicePeriodRecognition
      contextRef="ia4656c8d89cf4a84bdd02d8823c897bb_D20210401-20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzY2E5YmIwMTc5MjQ3NmZiYjIyNWU1ZDlkZWM4NjlmL3NlYzo5M2NhOWJiMDE3OTI0NzZmYmIyMjVlNWQ5ZGVjODY5Zl8yNS9mcmFnOjFhMTNiMjI5MDE5MTQ3NGNhMjc0YzQ2NGY4YWJmOTIwL3RhYmxlOjMwOTcxNjlmZGQ5MDQ3ZDg4ODBjZmRlNjVkYzdiYTZkL3RhYmxlcmFuZ2U6MzA5NzE2OWZkZDkwNDdkODg4MGNmZGU2NWRjN2JhNmRfNS03LTEtMS0w_5541c564-1550-4ea2-8560-080fa8dd255b"
      unitRef="usd">1864000</us-gaap:AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsRequisiteServicePeriodRecognition>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsRequisiteServicePeriodRecognition
      contextRef="i27f4e53b91ad4367b7f8d273eff27769_D20210401-20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzY2E5YmIwMTc5MjQ3NmZiYjIyNWU1ZDlkZWM4NjlmL3NlYzo5M2NhOWJiMDE3OTI0NzZmYmIyMjVlNWQ5ZGVjODY5Zl8yNS9mcmFnOjFhMTNiMjI5MDE5MTQ3NGNhMjc0YzQ2NGY4YWJmOTIwL3RhYmxlOjMwOTcxNjlmZGQ5MDQ3ZDg4ODBjZmRlNjVkYzdiYTZkL3RhYmxlcmFuZ2U6MzA5NzE2OWZkZDkwNDdkODg4MGNmZGU2NWRjN2JhNmRfNS0xNS0xLTEtMA_1c22b66d-30d5-4d73-a4bf-974c45c23b17"
      unitRef="usd">1864000</us-gaap:AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsRequisiteServicePeriodRecognition>
    <us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised
      contextRef="i932ec7c01594418eb95662a351e601a2_D20210401-20210630"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzY2E5YmIwMTc5MjQ3NmZiYjIyNWU1ZDlkZWM4NjlmL3NlYzo5M2NhOWJiMDE3OTI0NzZmYmIyMjVlNWQ5ZGVjODY5Zl8yNS9mcmFnOjFhMTNiMjI5MDE5MTQ3NGNhMjc0YzQ2NGY4YWJmOTIwL3RhYmxlOjMwOTcxNjlmZGQ5MDQ3ZDg4ODBjZmRlNjVkYzdiYTZkL3RhYmxlcmFuZ2U6MzA5NzE2OWZkZDkwNDdkODg4MGNmZGU2NWRjN2JhNmRfNi0xLTEtMS0w_6cb2bda6-38ad-4110-9331-1a8ab6746fad"
      unitRef="shares">80603</us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised>
    <us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised
      contextRef="i932ec7c01594418eb95662a351e601a2_D20210401-20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzY2E5YmIwMTc5MjQ3NmZiYjIyNWU1ZDlkZWM4NjlmL3NlYzo5M2NhOWJiMDE3OTI0NzZmYmIyMjVlNWQ5ZGVjODY5Zl8yNS9mcmFnOjFhMTNiMjI5MDE5MTQ3NGNhMjc0YzQ2NGY4YWJmOTIwL3RhYmxlOjMwOTcxNjlmZGQ5MDQ3ZDg4ODBjZmRlNjVkYzdiYTZkL3RhYmxlcmFuZ2U6MzA5NzE2OWZkZDkwNDdkODg4MGNmZGU2NWRjN2JhNmRfNi0zLTEtMS0w_acf75c72-2690-4763-ad8d-d5f593261362"
      unitRef="usd">102000</us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised>
    <us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised
      contextRef="ia4656c8d89cf4a84bdd02d8823c897bb_D20210401-20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzY2E5YmIwMTc5MjQ3NmZiYjIyNWU1ZDlkZWM4NjlmL3NlYzo5M2NhOWJiMDE3OTI0NzZmYmIyMjVlNWQ5ZGVjODY5Zl8yNS9mcmFnOjFhMTNiMjI5MDE5MTQ3NGNhMjc0YzQ2NGY4YWJmOTIwL3RhYmxlOjMwOTcxNjlmZGQ5MDQ3ZDg4ODBjZmRlNjVkYzdiYTZkL3RhYmxlcmFuZ2U6MzA5NzE2OWZkZDkwNDdkODg4MGNmZGU2NWRjN2JhNmRfNi03LTEtMS0w_21ee930e-297c-4b97-9b6d-ea80a16d7933"
      unitRef="usd">-102000</us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised>
    <us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised
      contextRef="i27f4e53b91ad4367b7f8d273eff27769_D20210401-20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzY2E5YmIwMTc5MjQ3NmZiYjIyNWU1ZDlkZWM4NjlmL3NlYzo5M2NhOWJiMDE3OTI0NzZmYmIyMjVlNWQ5ZGVjODY5Zl8yNS9mcmFnOjFhMTNiMjI5MDE5MTQ3NGNhMjc0YzQ2NGY4YWJmOTIwL3RhYmxlOjMwOTcxNjlmZGQ5MDQ3ZDg4ODBjZmRlNjVkYzdiYTZkL3RhYmxlcmFuZ2U6MzA5NzE2OWZkZDkwNDdkODg4MGNmZGU2NWRjN2JhNmRfNi0xNS0xLTEtMA_a9cd3230-57df-4b2d-8312-0a8d9ef505c7"
      unitRef="usd">0</us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised>
    <us-gaap:StockIssuedDuringPeriodSharesRestrictedStockAwardNetOfForfeitures
      contextRef="i932ec7c01594418eb95662a351e601a2_D20210401-20210630"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzY2E5YmIwMTc5MjQ3NmZiYjIyNWU1ZDlkZWM4NjlmL3NlYzo5M2NhOWJiMDE3OTI0NzZmYmIyMjVlNWQ5ZGVjODY5Zl8yNS9mcmFnOjFhMTNiMjI5MDE5MTQ3NGNhMjc0YzQ2NGY4YWJmOTIwL3RhYmxlOjMwOTcxNjlmZGQ5MDQ3ZDg4ODBjZmRlNjVkYzdiYTZkL3RhYmxlcmFuZ2U6MzA5NzE2OWZkZDkwNDdkODg4MGNmZGU2NWRjN2JhNmRfNy0xLTEtMS0w_b8427ac6-14a5-44ab-95a3-32756b43feb2"
      unitRef="shares">58354</us-gaap:StockIssuedDuringPeriodSharesRestrictedStockAwardNetOfForfeitures>
    <us-gaap:StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures
      contextRef="i932ec7c01594418eb95662a351e601a2_D20210401-20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzY2E5YmIwMTc5MjQ3NmZiYjIyNWU1ZDlkZWM4NjlmL3NlYzo5M2NhOWJiMDE3OTI0NzZmYmIyMjVlNWQ5ZGVjODY5Zl8yNS9mcmFnOjFhMTNiMjI5MDE5MTQ3NGNhMjc0YzQ2NGY4YWJmOTIwL3RhYmxlOjMwOTcxNjlmZGQ5MDQ3ZDg4ODBjZmRlNjVkYzdiYTZkL3RhYmxlcmFuZ2U6MzA5NzE2OWZkZDkwNDdkODg4MGNmZGU2NWRjN2JhNmRfNy0zLTEtMS0w_b72e8b67-b335-472e-b6fb-4ccf6117adf8"
      unitRef="usd">345000</us-gaap:StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures>
    <us-gaap:StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures
      contextRef="ia4656c8d89cf4a84bdd02d8823c897bb_D20210401-20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzY2E5YmIwMTc5MjQ3NmZiYjIyNWU1ZDlkZWM4NjlmL3NlYzo5M2NhOWJiMDE3OTI0NzZmYmIyMjVlNWQ5ZGVjODY5Zl8yNS9mcmFnOjFhMTNiMjI5MDE5MTQ3NGNhMjc0YzQ2NGY4YWJmOTIwL3RhYmxlOjMwOTcxNjlmZGQ5MDQ3ZDg4ODBjZmRlNjVkYzdiYTZkL3RhYmxlcmFuZ2U6MzA5NzE2OWZkZDkwNDdkODg4MGNmZGU2NWRjN2JhNmRfNy03LTEtMS0w_289ae77a-5963-4cf7-8709-329ddf6dd061"
      unitRef="usd">-345000</us-gaap:StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures>
    <us-gaap:StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures
      contextRef="i27f4e53b91ad4367b7f8d273eff27769_D20210401-20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzY2E5YmIwMTc5MjQ3NmZiYjIyNWU1ZDlkZWM4NjlmL3NlYzo5M2NhOWJiMDE3OTI0NzZmYmIyMjVlNWQ5ZGVjODY5Zl8yNS9mcmFnOjFhMTNiMjI5MDE5MTQ3NGNhMjc0YzQ2NGY4YWJmOTIwL3RhYmxlOjMwOTcxNjlmZGQ5MDQ3ZDg4ODBjZmRlNjVkYzdiYTZkL3RhYmxlcmFuZ2U6MzA5NzE2OWZkZDkwNDdkODg4MGNmZGU2NWRjN2JhNmRfNy0xNS0xLTEtMA_86e26c03-5c81-4609-814d-651728dc7be4"
      unitRef="usd">0</us-gaap:StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures>
    <us-gaap:AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation
      contextRef="ia4656c8d89cf4a84bdd02d8823c897bb_D20210401-20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzY2E5YmIwMTc5MjQ3NmZiYjIyNWU1ZDlkZWM4NjlmL3NlYzo5M2NhOWJiMDE3OTI0NzZmYmIyMjVlNWQ5ZGVjODY5Zl8yNS9mcmFnOjFhMTNiMjI5MDE5MTQ3NGNhMjc0YzQ2NGY4YWJmOTIwL3RhYmxlOjMwOTcxNjlmZGQ5MDQ3ZDg4ODBjZmRlNjVkYzdiYTZkL3RhYmxlcmFuZ2U6MzA5NzE2OWZkZDkwNDdkODg4MGNmZGU2NWRjN2JhNmRfOC03LTEtMS0xMjc3Ng_cfaf04da-0783-48ec-bfe8-2a3131fba781"
      unitRef="usd">183000</us-gaap:AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation>
    <us-gaap:AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation
      contextRef="i9a1c715fbcf44b979e7e0fcb5928d719_D20210401-20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzY2E5YmIwMTc5MjQ3NmZiYjIyNWU1ZDlkZWM4NjlmL3NlYzo5M2NhOWJiMDE3OTI0NzZmYmIyMjVlNWQ5ZGVjODY5Zl8yNS9mcmFnOjFhMTNiMjI5MDE5MTQ3NGNhMjc0YzQ2NGY4YWJmOTIwL3RhYmxlOjMwOTcxNjlmZGQ5MDQ3ZDg4ODBjZmRlNjVkYzdiYTZkL3RhYmxlcmFuZ2U6MzA5NzE2OWZkZDkwNDdkODg4MGNmZGU2NWRjN2JhNmRfOC05LTEtMS0xMjc3Ng_7d7174e7-a2ad-410b-a0d6-9b451b99f0d4"
      unitRef="usd">63000</us-gaap:AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation>
    <us-gaap:AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation
      contextRef="i27f4e53b91ad4367b7f8d273eff27769_D20210401-20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzY2E5YmIwMTc5MjQ3NmZiYjIyNWU1ZDlkZWM4NjlmL3NlYzo5M2NhOWJiMDE3OTI0NzZmYmIyMjVlNWQ5ZGVjODY5Zl8yNS9mcmFnOjFhMTNiMjI5MDE5MTQ3NGNhMjc0YzQ2NGY4YWJmOTIwL3RhYmxlOjMwOTcxNjlmZGQ5MDQ3ZDg4ODBjZmRlNjVkYzdiYTZkL3RhYmxlcmFuZ2U6MzA5NzE2OWZkZDkwNDdkODg4MGNmZGU2NWRjN2JhNmRfOC0xNS0xLTEtMTI3NzY_eef71bea-e54b-453f-8c42-9f8fb69676b6"
      unitRef="usd">246000</us-gaap:AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationRestrictedStockUnitsRequisiteServicePeriodRecognition
      contextRef="ia4656c8d89cf4a84bdd02d8823c897bb_D20210401-20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzY2E5YmIwMTc5MjQ3NmZiYjIyNWU1ZDlkZWM4NjlmL3NlYzo5M2NhOWJiMDE3OTI0NzZmYmIyMjVlNWQ5ZGVjODY5Zl8yNS9mcmFnOjFhMTNiMjI5MDE5MTQ3NGNhMjc0YzQ2NGY4YWJmOTIwL3RhYmxlOjMwOTcxNjlmZGQ5MDQ3ZDg4ODBjZmRlNjVkYzdiYTZkL3RhYmxlcmFuZ2U6MzA5NzE2OWZkZDkwNDdkODg4MGNmZGU2NWRjN2JhNmRfOC03LTEtMS0w_3a2a96c6-733d-4270-8ab6-868843f8245b"
      unitRef="usd">701000</us-gaap:AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationRestrictedStockUnitsRequisiteServicePeriodRecognition>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationRestrictedStockUnitsRequisiteServicePeriodRecognition
      contextRef="i27f4e53b91ad4367b7f8d273eff27769_D20210401-20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzY2E5YmIwMTc5MjQ3NmZiYjIyNWU1ZDlkZWM4NjlmL3NlYzo5M2NhOWJiMDE3OTI0NzZmYmIyMjVlNWQ5ZGVjODY5Zl8yNS9mcmFnOjFhMTNiMjI5MDE5MTQ3NGNhMjc0YzQ2NGY4YWJmOTIwL3RhYmxlOjMwOTcxNjlmZGQ5MDQ3ZDg4ODBjZmRlNjVkYzdiYTZkL3RhYmxlcmFuZ2U6MzA5NzE2OWZkZDkwNDdkODg4MGNmZGU2NWRjN2JhNmRfOC0xNS0xLTEtMA_3b6ed334-404e-432b-ba60-4d41085a1458"
      unitRef="usd">701000</us-gaap:AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationRestrictedStockUnitsRequisiteServicePeriodRecognition>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationOtherLongtermIncentivePlansRequisiteServicePeriodRecognition
      contextRef="i932ec7c01594418eb95662a351e601a2_D20210401-20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzY2E5YmIwMTc5MjQ3NmZiYjIyNWU1ZDlkZWM4NjlmL3NlYzo5M2NhOWJiMDE3OTI0NzZmYmIyMjVlNWQ5ZGVjODY5Zl8yNS9mcmFnOjFhMTNiMjI5MDE5MTQ3NGNhMjc0YzQ2NGY4YWJmOTIwL3RhYmxlOjMwOTcxNjlmZGQ5MDQ3ZDg4ODBjZmRlNjVkYzdiYTZkL3RhYmxlcmFuZ2U6MzA5NzE2OWZkZDkwNDdkODg4MGNmZGU2NWRjN2JhNmRfOS0zLTEtMS0w_9c064a72-6019-485e-91ca-5d4e4f683b56"
      unitRef="usd">2000000</us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationOtherLongtermIncentivePlansRequisiteServicePeriodRecognition>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationOtherLongtermIncentivePlansRequisiteServicePeriodRecognition
      contextRef="ia4656c8d89cf4a84bdd02d8823c897bb_D20210401-20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzY2E5YmIwMTc5MjQ3NmZiYjIyNWU1ZDlkZWM4NjlmL3NlYzo5M2NhOWJiMDE3OTI0NzZmYmIyMjVlNWQ5ZGVjODY5Zl8yNS9mcmFnOjFhMTNiMjI5MDE5MTQ3NGNhMjc0YzQ2NGY4YWJmOTIwL3RhYmxlOjMwOTcxNjlmZGQ5MDQ3ZDg4ODBjZmRlNjVkYzdiYTZkL3RhYmxlcmFuZ2U6MzA5NzE2OWZkZDkwNDdkODg4MGNmZGU2NWRjN2JhNmRfOS03LTEtMS0w_a7b6cca8-e0a5-44cf-8962-13a5132f7396"
      unitRef="usd">-1655000</us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationOtherLongtermIncentivePlansRequisiteServicePeriodRecognition>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationOtherLongtermIncentivePlansRequisiteServicePeriodRecognition
      contextRef="i27f4e53b91ad4367b7f8d273eff27769_D20210401-20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzY2E5YmIwMTc5MjQ3NmZiYjIyNWU1ZDlkZWM4NjlmL3NlYzo5M2NhOWJiMDE3OTI0NzZmYmIyMjVlNWQ5ZGVjODY5Zl8yNS9mcmFnOjFhMTNiMjI5MDE5MTQ3NGNhMjc0YzQ2NGY4YWJmOTIwL3RhYmxlOjMwOTcxNjlmZGQ5MDQ3ZDg4ODBjZmRlNjVkYzdiYTZkL3RhYmxlcmFuZ2U6MzA5NzE2OWZkZDkwNDdkODg4MGNmZGU2NWRjN2JhNmRfOS0xNS0xLTEtMA_fcc2aa2c-9574-422d-89cf-00daa4441111"
      unitRef="usd">345000</us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationOtherLongtermIncentivePlansRequisiteServicePeriodRecognition>
    <cron:StockholdersEquityOutOfPeriodAdjustment
      contextRef="i932ec7c01594418eb95662a351e601a2_D20210401-20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzY2E5YmIwMTc5MjQ3NmZiYjIyNWU1ZDlkZWM4NjlmL3NlYzo5M2NhOWJiMDE3OTI0NzZmYmIyMjVlNWQ5ZGVjODY5Zl8yNS9mcmFnOjFhMTNiMjI5MDE5MTQ3NGNhMjc0YzQ2NGY4YWJmOTIwL3RhYmxlOjMwOTcxNjlmZGQ5MDQ3ZDg4ODBjZmRlNjVkYzdiYTZkL3RhYmxlcmFuZ2U6MzA5NzE2OWZkZDkwNDdkODg4MGNmZGU2NWRjN2JhNmRfMTAtMy0xLTEtMA_51cbd9c5-c50e-4d28-ac8f-ccaa07c0cc5b"
      unitRef="usd">-14505000</cron:StockholdersEquityOutOfPeriodAdjustment>
    <cron:StockholdersEquityOutOfPeriodAdjustment
      contextRef="i9a1c715fbcf44b979e7e0fcb5928d719_D20210401-20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzY2E5YmIwMTc5MjQ3NmZiYjIyNWU1ZDlkZWM4NjlmL3NlYzo5M2NhOWJiMDE3OTI0NzZmYmIyMjVlNWQ5ZGVjODY5Zl8yNS9mcmFnOjFhMTNiMjI5MDE5MTQ3NGNhMjc0YzQ2NGY4YWJmOTIwL3RhYmxlOjMwOTcxNjlmZGQ5MDQ3ZDg4ODBjZmRlNjVkYzdiYTZkL3RhYmxlcmFuZ2U6MzA5NzE2OWZkZDkwNDdkODg4MGNmZGU2NWRjN2JhNmRfMTAtOS0xLTEtMA_459fd270-15a9-4318-a7ba-526ea33401ef"
      unitRef="usd">3227000</cron:StockholdersEquityOutOfPeriodAdjustment>
    <cron:StockholdersEquityOutOfPeriodAdjustment
      contextRef="i27f4e53b91ad4367b7f8d273eff27769_D20210401-20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzY2E5YmIwMTc5MjQ3NmZiYjIyNWU1ZDlkZWM4NjlmL3NlYzo5M2NhOWJiMDE3OTI0NzZmYmIyMjVlNWQ5ZGVjODY5Zl8yNS9mcmFnOjFhMTNiMjI5MDE5MTQ3NGNhMjc0YzQ2NGY4YWJmOTIwL3RhYmxlOjMwOTcxNjlmZGQ5MDQ3ZDg4ODBjZmRlNjVkYzdiYTZkL3RhYmxlcmFuZ2U6MzA5NzE2OWZkZDkwNDdkODg4MGNmZGU2NWRjN2JhNmRfMTAtMTUtMS0xLTA_0d5839c6-d741-4ed8-9936-7babad2644af"
      unitRef="usd">-11278000</cron:StockholdersEquityOutOfPeriodAdjustment>
    <us-gaap:ProfitLoss
      contextRef="i9a1c715fbcf44b979e7e0fcb5928d719_D20210401-20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzY2E5YmIwMTc5MjQ3NmZiYjIyNWU1ZDlkZWM4NjlmL3NlYzo5M2NhOWJiMDE3OTI0NzZmYmIyMjVlNWQ5ZGVjODY5Zl8yNS9mcmFnOjFhMTNiMjI5MDE5MTQ3NGNhMjc0YzQ2NGY4YWJmOTIwL3RhYmxlOjMwOTcxNjlmZGQ5MDQ3ZDg4ODBjZmRlNjVkYzdiYTZkL3RhYmxlcmFuZ2U6MzA5NzE2OWZkZDkwNDdkODg4MGNmZGU2NWRjN2JhNmRfMTEtOS0xLTEtMA_f46b1646-4be2-4dbe-8810-5f5c56ee6286"
      unitRef="usd">57054000</us-gaap:ProfitLoss>
    <us-gaap:ProfitLoss
      contextRef="i8e7f3ff52d71479293ec038396352775_D20210401-20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzY2E5YmIwMTc5MjQ3NmZiYjIyNWU1ZDlkZWM4NjlmL3NlYzo5M2NhOWJiMDE3OTI0NzZmYmIyMjVlNWQ5ZGVjODY5Zl8yNS9mcmFnOjFhMTNiMjI5MDE5MTQ3NGNhMjc0YzQ2NGY4YWJmOTIwL3RhYmxlOjMwOTcxNjlmZGQ5MDQ3ZDg4ODBjZmRlNjVkYzdiYTZkL3RhYmxlcmFuZ2U6MzA5NzE2OWZkZDkwNDdkODg4MGNmZGU2NWRjN2JhNmRfMTEtMTMtMS0xLTA_e32d488c-2541-4b4a-9503-0eaa7b8abf88"
      unitRef="usd">-279000</us-gaap:ProfitLoss>
    <us-gaap:ProfitLoss
      contextRef="i27f4e53b91ad4367b7f8d273eff27769_D20210401-20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzY2E5YmIwMTc5MjQ3NmZiYjIyNWU1ZDlkZWM4NjlmL3NlYzo5M2NhOWJiMDE3OTI0NzZmYmIyMjVlNWQ5ZGVjODY5Zl8yNS9mcmFnOjFhMTNiMjI5MDE5MTQ3NGNhMjc0YzQ2NGY4YWJmOTIwL3RhYmxlOjMwOTcxNjlmZGQ5MDQ3ZDg4ODBjZmRlNjVkYzdiYTZkL3RhYmxlcmFuZ2U6MzA5NzE2OWZkZDkwNDdkODg4MGNmZGU2NWRjN2JhNmRfMTEtMTUtMS0xLTA_d87e50d2-3984-4f9a-b78e-3fb6a3cee14e"
      unitRef="usd">56775000</us-gaap:ProfitLoss>
    <us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
      contextRef="i4e1c8fe7ad9241eaa0d77b74d41be015_D20210401-20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzY2E5YmIwMTc5MjQ3NmZiYjIyNWU1ZDlkZWM4NjlmL3NlYzo5M2NhOWJiMDE3OTI0NzZmYmIyMjVlNWQ5ZGVjODY5Zl8yNS9mcmFnOjFhMTNiMjI5MDE5MTQ3NGNhMjc0YzQ2NGY4YWJmOTIwL3RhYmxlOjMwOTcxNjlmZGQ5MDQ3ZDg4ODBjZmRlNjVkYzdiYTZkL3RhYmxlcmFuZ2U6MzA5NzE2OWZkZDkwNDdkODg4MGNmZGU2NWRjN2JhNmRfMTItMTEtMS0xLTA_76a2af55-f911-40f7-a175-a310f9cef71f"
      unitRef="usd">13585000</us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
      contextRef="i8e7f3ff52d71479293ec038396352775_D20210401-20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzY2E5YmIwMTc5MjQ3NmZiYjIyNWU1ZDlkZWM4NjlmL3NlYzo5M2NhOWJiMDE3OTI0NzZmYmIyMjVlNWQ5ZGVjODY5Zl8yNS9mcmFnOjFhMTNiMjI5MDE5MTQ3NGNhMjc0YzQ2NGY4YWJmOTIwL3RhYmxlOjMwOTcxNjlmZGQ5MDQ3ZDg4ODBjZmRlNjVkYzdiYTZkL3RhYmxlcmFuZ2U6MzA5NzE2OWZkZDkwNDdkODg4MGNmZGU2NWRjN2JhNmRfMTItMTMtMS0xLTA_7b2dafde-753f-40c4-ae03-a3e1b039e6fc"
      unitRef="usd">-115000</us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
      contextRef="i27f4e53b91ad4367b7f8d273eff27769_D20210401-20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzY2E5YmIwMTc5MjQ3NmZiYjIyNWU1ZDlkZWM4NjlmL3NlYzo5M2NhOWJiMDE3OTI0NzZmYmIyMjVlNWQ5ZGVjODY5Zl8yNS9mcmFnOjFhMTNiMjI5MDE5MTQ3NGNhMjc0YzQ2NGY4YWJmOTIwL3RhYmxlOjMwOTcxNjlmZGQ5MDQ3ZDg4ODBjZmRlNjVkYzdiYTZkL3RhYmxlcmFuZ2U6MzA5NzE2OWZkZDkwNDdkODg4MGNmZGU2NWRjN2JhNmRfMTItMTUtMS0xLTA_98e4f5be-1c6b-43b0-9581-7b0f8ce6c83b"
      unitRef="usd">13470000</us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax>
    <us-gaap:CommonStockSharesOutstanding
      contextRef="i1d565c32dabc40c08d36232dec1a7779_I20210630"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzY2E5YmIwMTc5MjQ3NmZiYjIyNWU1ZDlkZWM4NjlmL3NlYzo5M2NhOWJiMDE3OTI0NzZmYmIyMjVlNWQ5ZGVjODY5Zl8yNS9mcmFnOjFhMTNiMjI5MDE5MTQ3NGNhMjc0YzQ2NGY4YWJmOTIwL3RhYmxlOjMwOTcxNjlmZGQ5MDQ3ZDg4ODBjZmRlNjVkYzdiYTZkL3RhYmxlcmFuZ2U6MzA5NzE2OWZkZDkwNDdkODg4MGNmZGU2NWRjN2JhNmRfMTMtMS0xLTEtMA_2b83f408-c323-4a96-8c24-2b5333845643"
      unitRef="shares">371805547</us-gaap:CommonStockSharesOutstanding>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i1d565c32dabc40c08d36232dec1a7779_I20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzY2E5YmIwMTc5MjQ3NmZiYjIyNWU1ZDlkZWM4NjlmL3NlYzo5M2NhOWJiMDE3OTI0NzZmYmIyMjVlNWQ5ZGVjODY5Zl8yNS9mcmFnOjFhMTNiMjI5MDE5MTQ3NGNhMjc0YzQ2NGY4YWJmOTIwL3RhYmxlOjMwOTcxNjlmZGQ5MDQ3ZDg4ODBjZmRlNjVkYzdiYTZkL3RhYmxlcmFuZ2U6MzA5NzE2OWZkZDkwNDdkODg4MGNmZGU2NWRjN2JhNmRfMTMtMy0xLTEtMA_cd0a10ea-b8e9-47f6-82a3-54d89cf345cf"
      unitRef="usd">572858000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="ibbfd3d5a9feb460a8f0fe21cf2539d79_I20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzY2E5YmIwMTc5MjQ3NmZiYjIyNWU1ZDlkZWM4NjlmL3NlYzo5M2NhOWJiMDE3OTI0NzZmYmIyMjVlNWQ5ZGVjODY5Zl8yNS9mcmFnOjFhMTNiMjI5MDE5MTQ3NGNhMjc0YzQ2NGY4YWJmOTIwL3RhYmxlOjMwOTcxNjlmZGQ5MDQ3ZDg4ODBjZmRlNjVkYzdiYTZkL3RhYmxlcmFuZ2U6MzA5NzE2OWZkZDkwNDdkODg4MGNmZGU2NWRjN2JhNmRfMTMtNy0xLTEtMA_6b9c2460-760a-4d65-8fca-51f40a0592c0"
      unitRef="usd">32368000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i5b5acb4a63db4a419bb0b3e0c4a24492_I20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzY2E5YmIwMTc5MjQ3NmZiYjIyNWU1ZDlkZWM4NjlmL3NlYzo5M2NhOWJiMDE3OTI0NzZmYmIyMjVlNWQ5ZGVjODY5Zl8yNS9mcmFnOjFhMTNiMjI5MDE5MTQ3NGNhMjc0YzQ2NGY4YWJmOTIwL3RhYmxlOjMwOTcxNjlmZGQ5MDQ3ZDg4ODBjZmRlNjVkYzdiYTZkL3RhYmxlcmFuZ2U6MzA5NzE2OWZkZDkwNDdkODg4MGNmZGU2NWRjN2JhNmRfMTMtOS0xLTEtMA_445449a8-f745-41a2-9514-ea9141abb25f"
      unitRef="usd">955721000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i7d990708cda34586a3e37a53dd59fb03_I20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzY2E5YmIwMTc5MjQ3NmZiYjIyNWU1ZDlkZWM4NjlmL3NlYzo5M2NhOWJiMDE3OTI0NzZmYmIyMjVlNWQ5ZGVjODY5Zl8yNS9mcmFnOjFhMTNiMjI5MDE5MTQ3NGNhMjc0YzQ2NGY4YWJmOTIwL3RhYmxlOjMwOTcxNjlmZGQ5MDQ3ZDg4ODBjZmRlNjVkYzdiYTZkL3RhYmxlcmFuZ2U6MzA5NzE2OWZkZDkwNDdkODg4MGNmZGU2NWRjN2JhNmRfMTMtMTEtMS0xLTA_3f7236e0-fda0-4dc3-b81a-999b6b17db2e"
      unitRef="usd">71729000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i64458da0ec424fd8a6faf87d69636ecd_I20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzY2E5YmIwMTc5MjQ3NmZiYjIyNWU1ZDlkZWM4NjlmL3NlYzo5M2NhOWJiMDE3OTI0NzZmYmIyMjVlNWQ5ZGVjODY5Zl8yNS9mcmFnOjFhMTNiMjI5MDE5MTQ3NGNhMjc0YzQ2NGY4YWJmOTIwL3RhYmxlOjMwOTcxNjlmZGQ5MDQ3ZDg4ODBjZmRlNjVkYzdiYTZkL3RhYmxlcmFuZ2U6MzA5NzE2OWZkZDkwNDdkODg4MGNmZGU2NWRjN2JhNmRfMTMtMTMtMS0xLTA_251a93f1-b505-4980-8b3b-8cfe7cdb6a6c"
      unitRef="usd">-2764000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i225f85e38faa4bbdb4de1d8b9cf369bb_I20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzY2E5YmIwMTc5MjQ3NmZiYjIyNWU1ZDlkZWM4NjlmL3NlYzo5M2NhOWJiMDE3OTI0NzZmYmIyMjVlNWQ5ZGVjODY5Zl8yNS9mcmFnOjFhMTNiMjI5MDE5MTQ3NGNhMjc0YzQ2NGY4YWJmOTIwL3RhYmxlOjMwOTcxNjlmZGQ5MDQ3ZDg4ODBjZmRlNjVkYzdiYTZkL3RhYmxlcmFuZ2U6MzA5NzE2OWZkZDkwNDdkODg4MGNmZGU2NWRjN2JhNmRfMTMtMTUtMS0xLTA_692ae098-91c0-41d2-9bd5-d2c5628f596d"
      unitRef="usd">1629912000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:CommonStockSharesOutstanding
      contextRef="id078e2f741bd40b185fe15fe9cf71aa0_I20200331"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzY2E5YmIwMTc5MjQ3NmZiYjIyNWU1ZDlkZWM4NjlmL3NlYzo5M2NhOWJiMDE3OTI0NzZmYmIyMjVlNWQ5ZGVjODY5Zl8yNS9mcmFnOjFhMTNiMjI5MDE5MTQ3NGNhMjc0YzQ2NGY4YWJmOTIwL3RhYmxlOjI0YWJkMTlmMDhiYTRlM2E4NzJmMjVlOGU0MmQ1ODQyL3RhYmxlcmFuZ2U6MjRhYmQxOWYwOGJhNGUzYTg3MmYyNWU4ZTQyZDU4NDJfMTYtMS0xLTEtNzgzOA_f7268de6-9a82-4f30-8eb6-391bfa036f7f"
      unitRef="shares">348817472</us-gaap:CommonStockSharesOutstanding>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="id078e2f741bd40b185fe15fe9cf71aa0_I20200331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzY2E5YmIwMTc5MjQ3NmZiYjIyNWU1ZDlkZWM4NjlmL3NlYzo5M2NhOWJiMDE3OTI0NzZmYmIyMjVlNWQ5ZGVjODY5Zl8yNS9mcmFnOjFhMTNiMjI5MDE5MTQ3NGNhMjc0YzQ2NGY4YWJmOTIwL3RhYmxlOjI0YWJkMTlmMDhiYTRlM2E4NzJmMjVlOGU0MmQ1ODQyL3RhYmxlcmFuZ2U6MjRhYmQxOWYwOGJhNGUzYTg3MmYyNWU4ZTQyZDU4NDJfMTYtMy0xLTEtNzgzOA_22d73b20-3c3e-47f4-8e14-8885d24ba97b"
      unitRef="usd">563165000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i3168099a593240dc9af0efd91a744144_I20200331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzY2E5YmIwMTc5MjQ3NmZiYjIyNWU1ZDlkZWM4NjlmL3NlYzo5M2NhOWJiMDE3OTI0NzZmYmIyMjVlNWQ5ZGVjODY5Zl8yNS9mcmFnOjFhMTNiMjI5MDE5MTQ3NGNhMjc0YzQ2NGY4YWJmOTIwL3RhYmxlOjI0YWJkMTlmMDhiYTRlM2E4NzJmMjVlOGU0MmQ1ODQyL3RhYmxlcmFuZ2U6MjRhYmQxOWYwOGJhNGUzYTg3MmYyNWU4ZTQyZDU4NDJfMTYtNy0xLTEtNzgzOA_af4103c9-b34a-43ae-b1ed-20154798050f"
      unitRef="usd">25483000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i6c7b98afcbdf46659d197205a453981e_I20200331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzY2E5YmIwMTc5MjQ3NmZiYjIyNWU1ZDlkZWM4NjlmL3NlYzo5M2NhOWJiMDE3OTI0NzZmYmIyMjVlNWQ5ZGVjODY5Zl8yNS9mcmFnOjFhMTNiMjI5MDE5MTQ3NGNhMjc0YzQ2NGY4YWJmOTIwL3RhYmxlOjI0YWJkMTlmMDhiYTRlM2E4NzJmMjVlOGU0MmQ1ODQyL3RhYmxlcmFuZ2U6MjRhYmQxOWYwOGJhNGUzYTg3MmYyNWU4ZTQyZDU4NDJfMTYtOS0xLTEtNzgzOA_d8069d2d-1438-4db6-b2ed-8312224622a2"
      unitRef="usd">1213686000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i7f15d7e0c5e448758e421628b06b233f_I20200331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzY2E5YmIwMTc5MjQ3NmZiYjIyNWU1ZDlkZWM4NjlmL3NlYzo5M2NhOWJiMDE3OTI0NzZmYmIyMjVlNWQ5ZGVjODY5Zl8yNS9mcmFnOjFhMTNiMjI5MDE5MTQ3NGNhMjc0YzQ2NGY4YWJmOTIwL3RhYmxlOjI0YWJkMTlmMDhiYTRlM2E4NzJmMjVlOGU0MmQ1ODQyL3RhYmxlcmFuZ2U6MjRhYmQxOWYwOGJhNGUzYTg3MmYyNWU4ZTQyZDU4NDJfMTYtMTEtMS0xLTc4Mzg_b4a3cba2-6801-47f5-9d9c-663f50d6b634"
      unitRef="usd">-85877000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i03a4fd9ba8c844bea0cc0519e18e1383_I20200331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzY2E5YmIwMTc5MjQ3NmZiYjIyNWU1ZDlkZWM4NjlmL3NlYzo5M2NhOWJiMDE3OTI0NzZmYmIyMjVlNWQ5ZGVjODY5Zl8yNS9mcmFnOjFhMTNiMjI5MDE5MTQ3NGNhMjc0YzQ2NGY4YWJmOTIwL3RhYmxlOjI0YWJkMTlmMDhiYTRlM2E4NzJmMjVlOGU0MmQ1ODQyL3RhYmxlcmFuZ2U6MjRhYmQxOWYwOGJhNGUzYTg3MmYyNWU4ZTQyZDU4NDJfMTYtMTMtMS0xLTc4Mzg_bd66113e-3569-4676-a6b0-3497513b3721"
      unitRef="usd">-1189000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i3c0f68bcd0b6498c90c48a6506a0b9e3_I20200331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzY2E5YmIwMTc5MjQ3NmZiYjIyNWU1ZDlkZWM4NjlmL3NlYzo5M2NhOWJiMDE3OTI0NzZmYmIyMjVlNWQ5ZGVjODY5Zl8yNS9mcmFnOjFhMTNiMjI5MDE5MTQ3NGNhMjc0YzQ2NGY4YWJmOTIwL3RhYmxlOjI0YWJkMTlmMDhiYTRlM2E4NzJmMjVlOGU0MmQ1ODQyL3RhYmxlcmFuZ2U6MjRhYmQxOWYwOGJhNGUzYTg3MmYyNWU4ZTQyZDU4NDJfMTYtMTUtMS0xLTc4Mzg_f2fccfca-43fa-4b7e-88a7-f33f4922280c"
      unitRef="usd">1715268000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsRequisiteServicePeriodRecognition
      contextRef="i6d595f441a124fe6a1a07ecf8f23ee48_D20200401-20200630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzY2E5YmIwMTc5MjQ3NmZiYjIyNWU1ZDlkZWM4NjlmL3NlYzo5M2NhOWJiMDE3OTI0NzZmYmIyMjVlNWQ5ZGVjODY5Zl8yNS9mcmFnOjFhMTNiMjI5MDE5MTQ3NGNhMjc0YzQ2NGY4YWJmOTIwL3RhYmxlOjI0YWJkMTlmMDhiYTRlM2E4NzJmMjVlOGU0MmQ1ODQyL3RhYmxlcmFuZ2U6MjRhYmQxOWYwOGJhNGUzYTg3MmYyNWU4ZTQyZDU4NDJfMjAtNy0xLTEtNzgzOA_40289d5d-8168-4fec-a3c7-1331031bfaee"
      unitRef="usd">1770000</us-gaap:AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsRequisiteServicePeriodRecognition>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsRequisiteServicePeriodRecognition
      contextRef="i39065c5daf934af885335c12f3cfa83f_D20200401-20200630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzY2E5YmIwMTc5MjQ3NmZiYjIyNWU1ZDlkZWM4NjlmL3NlYzo5M2NhOWJiMDE3OTI0NzZmYmIyMjVlNWQ5ZGVjODY5Zl8yNS9mcmFnOjFhMTNiMjI5MDE5MTQ3NGNhMjc0YzQ2NGY4YWJmOTIwL3RhYmxlOjI0YWJkMTlmMDhiYTRlM2E4NzJmMjVlOGU0MmQ1ODQyL3RhYmxlcmFuZ2U6MjRhYmQxOWYwOGJhNGUzYTg3MmYyNWU4ZTQyZDU4NDJfMjAtMTUtMS0xLTc4Mzg_1b76f800-5269-4f6a-9ee2-3373bbb8ccf2"
      unitRef="usd">1770000</us-gaap:AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsRequisiteServicePeriodRecognition>
    <us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised
      contextRef="ic52bfb3ca2d34600a199a8873b1c09c0_D20200401-20200630"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzY2E5YmIwMTc5MjQ3NmZiYjIyNWU1ZDlkZWM4NjlmL3NlYzo5M2NhOWJiMDE3OTI0NzZmYmIyMjVlNWQ5ZGVjODY5Zl8yNS9mcmFnOjFhMTNiMjI5MDE5MTQ3NGNhMjc0YzQ2NGY4YWJmOTIwL3RhYmxlOjI0YWJkMTlmMDhiYTRlM2E4NzJmMjVlOGU0MmQ1ODQyL3RhYmxlcmFuZ2U6MjRhYmQxOWYwOGJhNGUzYTg3MmYyNWU4ZTQyZDU4NDJfMjEtMS0xLTEtNzgzOA_6b4c76dd-db4a-430b-8141-1abc58e4a101"
      unitRef="shares">1068930</us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised>
    <us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised
      contextRef="ic52bfb3ca2d34600a199a8873b1c09c0_D20200401-20200630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzY2E5YmIwMTc5MjQ3NmZiYjIyNWU1ZDlkZWM4NjlmL3NlYzo5M2NhOWJiMDE3OTI0NzZmYmIyMjVlNWQ5ZGVjODY5Zl8yNS9mcmFnOjFhMTNiMjI5MDE5MTQ3NGNhMjc0YzQ2NGY4YWJmOTIwL3RhYmxlOjI0YWJkMTlmMDhiYTRlM2E4NzJmMjVlOGU0MmQ1ODQyL3RhYmxlcmFuZ2U6MjRhYmQxOWYwOGJhNGUzYTg3MmYyNWU4ZTQyZDU4NDJfMjEtMy0xLTEtNzgzOA_3ee9aa89-59ff-493c-85df-59a044c1de79"
      unitRef="usd">1329000</us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised>
    <us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised
      contextRef="i6d595f441a124fe6a1a07ecf8f23ee48_D20200401-20200630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzY2E5YmIwMTc5MjQ3NmZiYjIyNWU1ZDlkZWM4NjlmL3NlYzo5M2NhOWJiMDE3OTI0NzZmYmIyMjVlNWQ5ZGVjODY5Zl8yNS9mcmFnOjFhMTNiMjI5MDE5MTQ3NGNhMjc0YzQ2NGY4YWJmOTIwL3RhYmxlOjI0YWJkMTlmMDhiYTRlM2E4NzJmMjVlOGU0MmQ1ODQyL3RhYmxlcmFuZ2U6MjRhYmQxOWYwOGJhNGUzYTg3MmYyNWU4ZTQyZDU4NDJfMjEtNy0xLTEtNzgzOA_152716bc-f713-4e91-bbf8-0462b5c63b1d"
      unitRef="usd">-1328000</us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised>
    <us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised
      contextRef="i39065c5daf934af885335c12f3cfa83f_D20200401-20200630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzY2E5YmIwMTc5MjQ3NmZiYjIyNWU1ZDlkZWM4NjlmL3NlYzo5M2NhOWJiMDE3OTI0NzZmYmIyMjVlNWQ5ZGVjODY5Zl8yNS9mcmFnOjFhMTNiMjI5MDE5MTQ3NGNhMjc0YzQ2NGY4YWJmOTIwL3RhYmxlOjI0YWJkMTlmMDhiYTRlM2E4NzJmMjVlOGU0MmQ1ODQyL3RhYmxlcmFuZ2U6MjRhYmQxOWYwOGJhNGUzYTg3MmYyNWU4ZTQyZDU4NDJfMjEtMTUtMS0xLTc4Mzg_4302da0c-7986-42d6-a82e-5e9f4062ef39"
      unitRef="usd">1000</us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationRestrictedStockUnitsRequisiteServicePeriodRecognition
      contextRef="i6d595f441a124fe6a1a07ecf8f23ee48_D20200401-20200630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzY2E5YmIwMTc5MjQ3NmZiYjIyNWU1ZDlkZWM4NjlmL3NlYzo5M2NhOWJiMDE3OTI0NzZmYmIyMjVlNWQ5ZGVjODY5Zl8yNS9mcmFnOjFhMTNiMjI5MDE5MTQ3NGNhMjc0YzQ2NGY4YWJmOTIwL3RhYmxlOjI0YWJkMTlmMDhiYTRlM2E4NzJmMjVlOGU0MmQ1ODQyL3RhYmxlcmFuZ2U6MjRhYmQxOWYwOGJhNGUzYTg3MmYyNWU4ZTQyZDU4NDJfMjItNy0xLTEtNzgzOA_4c963c6f-be8e-45f2-8333-1927b3865939"
      unitRef="usd">776000</us-gaap:AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationRestrictedStockUnitsRequisiteServicePeriodRecognition>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationRestrictedStockUnitsRequisiteServicePeriodRecognition
      contextRef="i39065c5daf934af885335c12f3cfa83f_D20200401-20200630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzY2E5YmIwMTc5MjQ3NmZiYjIyNWU1ZDlkZWM4NjlmL3NlYzo5M2NhOWJiMDE3OTI0NzZmYmIyMjVlNWQ5ZGVjODY5Zl8yNS9mcmFnOjFhMTNiMjI5MDE5MTQ3NGNhMjc0YzQ2NGY4YWJmOTIwL3RhYmxlOjI0YWJkMTlmMDhiYTRlM2E4NzJmMjVlOGU0MmQ1ODQyL3RhYmxlcmFuZ2U6MjRhYmQxOWYwOGJhNGUzYTg3MmYyNWU4ZTQyZDU4NDJfMjItMTUtMS0xLTc4Mzg_c54c8524-a65f-4af6-a9ef-c33b96b07fca"
      unitRef="usd">776000</us-gaap:AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationRestrictedStockUnitsRequisiteServicePeriodRecognition>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationOtherLongtermIncentivePlansRequisiteServicePeriodRecognition
      contextRef="i6d595f441a124fe6a1a07ecf8f23ee48_D20200401-20200630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzY2E5YmIwMTc5MjQ3NmZiYjIyNWU1ZDlkZWM4NjlmL3NlYzo5M2NhOWJiMDE3OTI0NzZmYmIyMjVlNWQ5ZGVjODY5Zl8yNS9mcmFnOjFhMTNiMjI5MDE5MTQ3NGNhMjc0YzQ2NGY4YWJmOTIwL3RhYmxlOjI0YWJkMTlmMDhiYTRlM2E4NzJmMjVlOGU0MmQ1ODQyL3RhYmxlcmFuZ2U6MjRhYmQxOWYwOGJhNGUzYTg3MmYyNWU4ZTQyZDU4NDJfMjMtNy0xLTEtNzgzOA_80543d5b-86cc-4223-b4b3-936be68054bb"
      unitRef="usd">345000</us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationOtherLongtermIncentivePlansRequisiteServicePeriodRecognition>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationOtherLongtermIncentivePlansRequisiteServicePeriodRecognition
      contextRef="i39065c5daf934af885335c12f3cfa83f_D20200401-20200630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzY2E5YmIwMTc5MjQ3NmZiYjIyNWU1ZDlkZWM4NjlmL3NlYzo5M2NhOWJiMDE3OTI0NzZmYmIyMjVlNWQ5ZGVjODY5Zl8yNS9mcmFnOjFhMTNiMjI5MDE5MTQ3NGNhMjc0YzQ2NGY4YWJmOTIwL3RhYmxlOjI0YWJkMTlmMDhiYTRlM2E4NzJmMjVlOGU0MmQ1ODQyL3RhYmxlcmFuZ2U6MjRhYmQxOWYwOGJhNGUzYTg3MmYyNWU4ZTQyZDU4NDJfMjMtMTUtMS0xLTc4Mzg_4a0cbbe8-3050-4869-8d73-d4e3193b2442"
      unitRef="usd">345000</us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationOtherLongtermIncentivePlansRequisiteServicePeriodRecognition>
    <cron:StockIssuedDuringPeriodValueTopupRightsExercised
      contextRef="ic52bfb3ca2d34600a199a8873b1c09c0_D20200401-20200630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzY2E5YmIwMTc5MjQ3NmZiYjIyNWU1ZDlkZWM4NjlmL3NlYzo5M2NhOWJiMDE3OTI0NzZmYmIyMjVlNWQ5ZGVjODY5Zl8yNS9mcmFnOjFhMTNiMjI5MDE5MTQ3NGNhMjc0YzQ2NGY4YWJmOTIwL3RhYmxlOjI0YWJkMTlmMDhiYTRlM2E4NzJmMjVlOGU0MmQ1ODQyL3RhYmxlcmFuZ2U6MjRhYmQxOWYwOGJhNGUzYTg3MmYyNWU4ZTQyZDU4NDJfMjQtMy0xLTEtNzgzOA_fa1b0b52-716a-49d4-9986-922e42a12021"
      unitRef="usd">717000</cron:StockIssuedDuringPeriodValueTopupRightsExercised>
    <cron:StockIssuedDuringPeriodValueTopupRightsExercised
      contextRef="i39065c5daf934af885335c12f3cfa83f_D20200401-20200630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzY2E5YmIwMTc5MjQ3NmZiYjIyNWU1ZDlkZWM4NjlmL3NlYzo5M2NhOWJiMDE3OTI0NzZmYmIyMjVlNWQ5ZGVjODY5Zl8yNS9mcmFnOjFhMTNiMjI5MDE5MTQ3NGNhMjc0YzQ2NGY4YWJmOTIwL3RhYmxlOjI0YWJkMTlmMDhiYTRlM2E4NzJmMjVlOGU0MmQ1ODQyL3RhYmxlcmFuZ2U6MjRhYmQxOWYwOGJhNGUzYTg3MmYyNWU4ZTQyZDU4NDJfMjQtMTUtMS0xLTc4Mzg_a6c8af97-7b3d-4525-aaeb-63977e0dd28a"
      unitRef="usd">717000</cron:StockIssuedDuringPeriodValueTopupRightsExercised>
    <us-gaap:ProfitLoss
      contextRef="ie91f1ea24b414f65af58207f3d177f44_D20200401-20200630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzY2E5YmIwMTc5MjQ3NmZiYjIyNWU1ZDlkZWM4NjlmL3NlYzo5M2NhOWJiMDE3OTI0NzZmYmIyMjVlNWQ5ZGVjODY5Zl8yNS9mcmFnOjFhMTNiMjI5MDE5MTQ3NGNhMjc0YzQ2NGY4YWJmOTIwL3RhYmxlOjI0YWJkMTlmMDhiYTRlM2E4NzJmMjVlOGU0MmQ1ODQyL3RhYmxlcmFuZ2U6MjRhYmQxOWYwOGJhNGUzYTg3MmYyNWU4ZTQyZDU4NDJfMjUtOS0xLTEtNzgzOA_5d2f20b6-fd1c-418c-8dc2-64906dc2a9a5"
      unitRef="usd">-106977000</us-gaap:ProfitLoss>
    <us-gaap:ProfitLoss
      contextRef="i3bd28b951b5141a3ac4946bb9c8d4486_D20200401-20200630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzY2E5YmIwMTc5MjQ3NmZiYjIyNWU1ZDlkZWM4NjlmL3NlYzo5M2NhOWJiMDE3OTI0NzZmYmIyMjVlNWQ5ZGVjODY5Zl8yNS9mcmFnOjFhMTNiMjI5MDE5MTQ3NGNhMjc0YzQ2NGY4YWJmOTIwL3RhYmxlOjI0YWJkMTlmMDhiYTRlM2E4NzJmMjVlOGU0MmQ1ODQyL3RhYmxlcmFuZ2U6MjRhYmQxOWYwOGJhNGUzYTg3MmYyNWU4ZTQyZDU4NDJfMjUtMTMtMS0xLTc4Mzg_179ae8d5-a1ae-4427-b56c-fd9caa9dc8b5"
      unitRef="usd">-726000</us-gaap:ProfitLoss>
    <us-gaap:ProfitLoss
      contextRef="i39065c5daf934af885335c12f3cfa83f_D20200401-20200630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzY2E5YmIwMTc5MjQ3NmZiYjIyNWU1ZDlkZWM4NjlmL3NlYzo5M2NhOWJiMDE3OTI0NzZmYmIyMjVlNWQ5ZGVjODY5Zl8yNS9mcmFnOjFhMTNiMjI5MDE5MTQ3NGNhMjc0YzQ2NGY4YWJmOTIwL3RhYmxlOjI0YWJkMTlmMDhiYTRlM2E4NzJmMjVlOGU0MmQ1ODQyL3RhYmxlcmFuZ2U6MjRhYmQxOWYwOGJhNGUzYTg3MmYyNWU4ZTQyZDU4NDJfMjUtMTUtMS0xLTc4Mzg_bd618def-5172-4a1c-a633-70ccc626dac0"
      unitRef="usd">-107703000</us-gaap:ProfitLoss>
    <us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
      contextRef="i7d089148856645de804437e1aae7cf7a_D20200401-20200630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzY2E5YmIwMTc5MjQ3NmZiYjIyNWU1ZDlkZWM4NjlmL3NlYzo5M2NhOWJiMDE3OTI0NzZmYmIyMjVlNWQ5ZGVjODY5Zl8yNS9mcmFnOjFhMTNiMjI5MDE5MTQ3NGNhMjc0YzQ2NGY4YWJmOTIwL3RhYmxlOjI0YWJkMTlmMDhiYTRlM2E4NzJmMjVlOGU0MmQ1ODQyL3RhYmxlcmFuZ2U6MjRhYmQxOWYwOGJhNGUzYTg3MmYyNWU4ZTQyZDU4NDJfMjYtMTEtMS0xLTc4Mzg_a98fa4a4-57dd-4afa-aebd-9c55bd47eca1"
      unitRef="usd">51907000</us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
      contextRef="i3bd28b951b5141a3ac4946bb9c8d4486_D20200401-20200630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzY2E5YmIwMTc5MjQ3NmZiYjIyNWU1ZDlkZWM4NjlmL3NlYzo5M2NhOWJiMDE3OTI0NzZmYmIyMjVlNWQ5ZGVjODY5Zl8yNS9mcmFnOjFhMTNiMjI5MDE5MTQ3NGNhMjc0YzQ2NGY4YWJmOTIwL3RhYmxlOjI0YWJkMTlmMDhiYTRlM2E4NzJmMjVlOGU0MmQ1ODQyL3RhYmxlcmFuZ2U6MjRhYmQxOWYwOGJhNGUzYTg3MmYyNWU4ZTQyZDU4NDJfMjYtMTMtMS0xLTc4Mzg_bfa31179-5e59-4ece-8f5a-69082b689eb4"
      unitRef="usd">-36000</us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
      contextRef="i39065c5daf934af885335c12f3cfa83f_D20200401-20200630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzY2E5YmIwMTc5MjQ3NmZiYjIyNWU1ZDlkZWM4NjlmL3NlYzo5M2NhOWJiMDE3OTI0NzZmYmIyMjVlNWQ5ZGVjODY5Zl8yNS9mcmFnOjFhMTNiMjI5MDE5MTQ3NGNhMjc0YzQ2NGY4YWJmOTIwL3RhYmxlOjI0YWJkMTlmMDhiYTRlM2E4NzJmMjVlOGU0MmQ1ODQyL3RhYmxlcmFuZ2U6MjRhYmQxOWYwOGJhNGUzYTg3MmYyNWU4ZTQyZDU4NDJfMjYtMTUtMS0xLTc4Mzg_7649df0c-ddc6-4733-877e-b173ee3bc2a6"
      unitRef="usd">51871000</us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax>
    <us-gaap:CommonStockSharesOutstanding
      contextRef="i7b64ecf012bd43b397dcea9317f0673b_I20200630"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzY2E5YmIwMTc5MjQ3NmZiYjIyNWU1ZDlkZWM4NjlmL3NlYzo5M2NhOWJiMDE3OTI0NzZmYmIyMjVlNWQ5ZGVjODY5Zl8yNS9mcmFnOjFhMTNiMjI5MDE5MTQ3NGNhMjc0YzQ2NGY4YWJmOTIwL3RhYmxlOjI0YWJkMTlmMDhiYTRlM2E4NzJmMjVlOGU0MmQ1ODQyL3RhYmxlcmFuZ2U6MjRhYmQxOWYwOGJhNGUzYTg3MmYyNWU4ZTQyZDU4NDJfMjctMS0xLTEtNzgzOA_03422c76-4712-4433-a281-c8185a8c7d32"
      unitRef="shares">349886402</us-gaap:CommonStockSharesOutstanding>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i7b64ecf012bd43b397dcea9317f0673b_I20200630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzY2E5YmIwMTc5MjQ3NmZiYjIyNWU1ZDlkZWM4NjlmL3NlYzo5M2NhOWJiMDE3OTI0NzZmYmIyMjVlNWQ5ZGVjODY5Zl8yNS9mcmFnOjFhMTNiMjI5MDE5MTQ3NGNhMjc0YzQ2NGY4YWJmOTIwL3RhYmxlOjI0YWJkMTlmMDhiYTRlM2E4NzJmMjVlOGU0MmQ1ODQyL3RhYmxlcmFuZ2U6MjRhYmQxOWYwOGJhNGUzYTg3MmYyNWU4ZTQyZDU4NDJfMjctMy0xLTEtNzgzOA_4fa52753-f06b-409f-bc9e-07b12ebc6782"
      unitRef="usd">565211000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="if06bdc9d2d5b40ca88594d8c716a000d_I20200630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzY2E5YmIwMTc5MjQ3NmZiYjIyNWU1ZDlkZWM4NjlmL3NlYzo5M2NhOWJiMDE3OTI0NzZmYmIyMjVlNWQ5ZGVjODY5Zl8yNS9mcmFnOjFhMTNiMjI5MDE5MTQ3NGNhMjc0YzQ2NGY4YWJmOTIwL3RhYmxlOjI0YWJkMTlmMDhiYTRlM2E4NzJmMjVlOGU0MmQ1ODQyL3RhYmxlcmFuZ2U6MjRhYmQxOWYwOGJhNGUzYTg3MmYyNWU4ZTQyZDU4NDJfMjctNy0xLTEtNzgzOA_1f8377cb-c4e7-4696-b8e2-602190dfb4cf"
      unitRef="usd">27046000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="ibd5f91f865b44c90b9aab2e68420d292_I20200630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzY2E5YmIwMTc5MjQ3NmZiYjIyNWU1ZDlkZWM4NjlmL3NlYzo5M2NhOWJiMDE3OTI0NzZmYmIyMjVlNWQ5ZGVjODY5Zl8yNS9mcmFnOjFhMTNiMjI5MDE5MTQ3NGNhMjc0YzQ2NGY4YWJmOTIwL3RhYmxlOjI0YWJkMTlmMDhiYTRlM2E4NzJmMjVlOGU0MmQ1ODQyL3RhYmxlcmFuZ2U6MjRhYmQxOWYwOGJhNGUzYTg3MmYyNWU4ZTQyZDU4NDJfMjctOS0xLTEtNzgzOA_8e7b57f2-6485-41e3-8ef0-4cb55b242d07"
      unitRef="usd">1106709000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="ib7db517c67504b3baeead491589a7ed6_I20200630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzY2E5YmIwMTc5MjQ3NmZiYjIyNWU1ZDlkZWM4NjlmL3NlYzo5M2NhOWJiMDE3OTI0NzZmYmIyMjVlNWQ5ZGVjODY5Zl8yNS9mcmFnOjFhMTNiMjI5MDE5MTQ3NGNhMjc0YzQ2NGY4YWJmOTIwL3RhYmxlOjI0YWJkMTlmMDhiYTRlM2E4NzJmMjVlOGU0MmQ1ODQyL3RhYmxlcmFuZ2U6MjRhYmQxOWYwOGJhNGUzYTg3MmYyNWU4ZTQyZDU4NDJfMjctMTEtMS0xLTc4Mzg_c5042bdb-6d85-4f16-82c0-744982a15378"
      unitRef="usd">-33970000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i87ce495c26b34c268c848a2934ad3f39_I20200630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzY2E5YmIwMTc5MjQ3NmZiYjIyNWU1ZDlkZWM4NjlmL3NlYzo5M2NhOWJiMDE3OTI0NzZmYmIyMjVlNWQ5ZGVjODY5Zl8yNS9mcmFnOjFhMTNiMjI5MDE5MTQ3NGNhMjc0YzQ2NGY4YWJmOTIwL3RhYmxlOjI0YWJkMTlmMDhiYTRlM2E4NzJmMjVlOGU0MmQ1ODQyL3RhYmxlcmFuZ2U6MjRhYmQxOWYwOGJhNGUzYTg3MmYyNWU4ZTQyZDU4NDJfMjctMTMtMS0xLTc4Mzg_d4eb1748-a51e-4d55-aa0c-be1e2e374f78"
      unitRef="usd">-1951000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="id670dc9b33e6430f9d7510009f7495a7_I20200630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzY2E5YmIwMTc5MjQ3NmZiYjIyNWU1ZDlkZWM4NjlmL3NlYzo5M2NhOWJiMDE3OTI0NzZmYmIyMjVlNWQ5ZGVjODY5Zl8yNS9mcmFnOjFhMTNiMjI5MDE5MTQ3NGNhMjc0YzQ2NGY4YWJmOTIwL3RhYmxlOjI0YWJkMTlmMDhiYTRlM2E4NzJmMjVlOGU0MmQ1ODQyL3RhYmxlcmFuZ2U6MjRhYmQxOWYwOGJhNGUzYTg3MmYyNWU4ZTQyZDU4NDJfMjctMTUtMS0xLTc4Mzg_755d23b8-001c-48f2-944a-e88f45636134"
      unitRef="usd">1663045000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:CommonStockSharesOutstanding
      contextRef="i89f360b9f95a44cea98ec721cc461ecf_I20201231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzY2E5YmIwMTc5MjQ3NmZiYjIyNWU1ZDlkZWM4NjlmL3NlYzo5M2NhOWJiMDE3OTI0NzZmYmIyMjVlNWQ5ZGVjODY5Zl8yMi9mcmFnOjQ0ZDZlZTY3ZmE5MDQwOWQ5NzA3MjkyYzUxNjlmNDExL3RhYmxlOmQzODY0MmU2YzkxYjQ0N2JhOWM0YTQ5NWNjZDlkYTVhL3RhYmxlcmFuZ2U6ZDM4NjQyZTZjOTFiNDQ3YmE5YzRhNDk1Y2NkOWRhNWFfMS0xLTEtMS0w_b716cde9-6cd8-4515-820a-20b6d8884a0b"
      unitRef="shares">360253332</us-gaap:CommonStockSharesOutstanding>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i89f360b9f95a44cea98ec721cc461ecf_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzY2E5YmIwMTc5MjQ3NmZiYjIyNWU1ZDlkZWM4NjlmL3NlYzo5M2NhOWJiMDE3OTI0NzZmYmIyMjVlNWQ5ZGVjODY5Zl8yMi9mcmFnOjQ0ZDZlZTY3ZmE5MDQwOWQ5NzA3MjkyYzUxNjlmNDExL3RhYmxlOmQzODY0MmU2YzkxYjQ0N2JhOWM0YTQ5NWNjZDlkYTVhL3RhYmxlcmFuZ2U6ZDM4NjQyZTZjOTFiNDQ3YmE5YzRhNDk1Y2NkOWRhNWFfMS0zLTEtMS0w_b7ccd0f4-c827-4a39-96bf-7346bf03e5bc"
      unitRef="usd">569260000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="idaa77962d21a4f8ca12568eede000e4f_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzY2E5YmIwMTc5MjQ3NmZiYjIyNWU1ZDlkZWM4NjlmL3NlYzo5M2NhOWJiMDE3OTI0NzZmYmIyMjVlNWQ5ZGVjODY5Zl8yMi9mcmFnOjQ0ZDZlZTY3ZmE5MDQwOWQ5NzA3MjkyYzUxNjlmNDExL3RhYmxlOmQzODY0MmU2YzkxYjQ0N2JhOWM0YTQ5NWNjZDlkYTVhL3RhYmxlcmFuZ2U6ZDM4NjQyZTZjOTFiNDQ3YmE5YzRhNDk1Y2NkOWRhNWFfMS03LTEtMS0w_9a3d2063-b698-4813-a1da-edd0bf7fd5fc"
      unitRef="usd">34596000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i6710ab378a79438f94aa90687467e6f3_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzY2E5YmIwMTc5MjQ3NmZiYjIyNWU1ZDlkZWM4NjlmL3NlYzo5M2NhOWJiMDE3OTI0NzZmYmIyMjVlNWQ5ZGVjODY5Zl8yMi9mcmFnOjQ0ZDZlZTY3ZmE5MDQwOWQ5NzA3MjkyYzUxNjlmNDExL3RhYmxlOmQzODY0MmU2YzkxYjQ0N2JhOWM0YTQ5NWNjZDlkYTVhL3RhYmxlcmFuZ2U6ZDM4NjQyZTZjOTFiNDQ3YmE5YzRhNDk1Y2NkOWRhNWFfMS05LTEtMS0w_c736e2fe-1cef-4123-a11e-d5082ce284a4"
      unitRef="usd">1064509000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="ib7805645a77f444aa3190c257d456437_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzY2E5YmIwMTc5MjQ3NmZiYjIyNWU1ZDlkZWM4NjlmL3NlYzo5M2NhOWJiMDE3OTI0NzZmYmIyMjVlNWQ5ZGVjODY5Zl8yMi9mcmFnOjQ0ZDZlZTY3ZmE5MDQwOWQ5NzA3MjkyYzUxNjlmNDExL3RhYmxlOmQzODY0MmU2YzkxYjQ0N2JhOWM0YTQ5NWNjZDlkYTVhL3RhYmxlcmFuZ2U6ZDM4NjQyZTZjOTFiNDQ3YmE5YzRhNDk1Y2NkOWRhNWFfMS0xMS0xLTEtMA_860fc2bf-ce4e-4b1d-807e-fce5caa326fb"
      unitRef="usd">42999000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="ie669a3c1e1ca4bd8acd069f0187ca14a_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzY2E5YmIwMTc5MjQ3NmZiYjIyNWU1ZDlkZWM4NjlmL3NlYzo5M2NhOWJiMDE3OTI0NzZmYmIyMjVlNWQ5ZGVjODY5Zl8yMi9mcmFnOjQ0ZDZlZTY3ZmE5MDQwOWQ5NzA3MjkyYzUxNjlmNDExL3RhYmxlOmQzODY0MmU2YzkxYjQ0N2JhOWM0YTQ5NWNjZDlkYTVhL3RhYmxlcmFuZ2U6ZDM4NjQyZTZjOTFiNDQ3YmE5YzRhNDk1Y2NkOWRhNWFfMS0xMy0xLTEtMA_1f331ada-84a1-4c97-af25-7934cf2c3e90"
      unitRef="usd">-3196000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="ifbe16ec51ea244519b77d6036b4ef038_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzY2E5YmIwMTc5MjQ3NmZiYjIyNWU1ZDlkZWM4NjlmL3NlYzo5M2NhOWJiMDE3OTI0NzZmYmIyMjVlNWQ5ZGVjODY5Zl8yMi9mcmFnOjQ0ZDZlZTY3ZmE5MDQwOWQ5NzA3MjkyYzUxNjlmNDExL3RhYmxlOmQzODY0MmU2YzkxYjQ0N2JhOWM0YTQ5NWNjZDlkYTVhL3RhYmxlcmFuZ2U6ZDM4NjQyZTZjOTFiNDQ3YmE5YzRhNDk1Y2NkOWRhNWFfMS0xNS0xLTEtMA_8dba1e05-3655-472b-a1d4-00b648761945"
      unitRef="usd">1708168000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <cron:SharebasedCompensationArrangementBySharebasedPaymentAwardWarrantsExercisesInPeriod
      contextRef="i52c9b3fb67014eb083670c6a1d51b149_D20210101-20210630"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzY2E5YmIwMTc5MjQ3NmZiYjIyNWU1ZDlkZWM4NjlmL3NlYzo5M2NhOWJiMDE3OTI0NzZmYmIyMjVlNWQ5ZGVjODY5Zl8yMi9mcmFnOjQ0ZDZlZTY3ZmE5MDQwOWQ5NzA3MjkyYzUxNjlmNDExL3RhYmxlOmQzODY0MmU2YzkxYjQ0N2JhOWM0YTQ5NWNjZDlkYTVhL3RhYmxlcmFuZ2U6ZDM4NjQyZTZjOTFiNDQ3YmE5YzRhNDk1Y2NkOWRhNWFfNC0xLTEtMS0w_ad18dadb-8673-4b55-bcf8-147a579c459d"
      unitRef="shares">7842859</cron:SharebasedCompensationArrangementBySharebasedPaymentAwardWarrantsExercisesInPeriod>
    <cron:StockIssuedDuringPeriodValueWarrantsExercised
      contextRef="i52c9b3fb67014eb083670c6a1d51b149_D20210101-20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzY2E5YmIwMTc5MjQ3NmZiYjIyNWU1ZDlkZWM4NjlmL3NlYzo5M2NhOWJiMDE3OTI0NzZmYmIyMjVlNWQ5ZGVjODY5Zl8yMi9mcmFnOjQ0ZDZlZTY3ZmE5MDQwOWQ5NzA3MjkyYzUxNjlmNDExL3RhYmxlOmQzODY0MmU2YzkxYjQ0N2JhOWM0YTQ5NWNjZDlkYTVhL3RhYmxlcmFuZ2U6ZDM4NjQyZTZjOTFiNDQ3YmE5YzRhNDk1Y2NkOWRhNWFfNC0zLTEtMS0w_958a3dbc-ee3c-4620-9196-43e42c1626c3"
      unitRef="usd">1165000</cron:StockIssuedDuringPeriodValueWarrantsExercised>
    <cron:StockIssuedDuringPeriodValueWarrantsExercised
      contextRef="i32ce7a4cf9fe4b5fb2ba774cbeb3025e_D20210101-20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzY2E5YmIwMTc5MjQ3NmZiYjIyNWU1ZDlkZWM4NjlmL3NlYzo5M2NhOWJiMDE3OTI0NzZmYmIyMjVlNWQ5ZGVjODY5Zl8yMi9mcmFnOjQ0ZDZlZTY3ZmE5MDQwOWQ5NzA3MjkyYzUxNjlmNDExL3RhYmxlOmQzODY0MmU2YzkxYjQ0N2JhOWM0YTQ5NWNjZDlkYTVhL3RhYmxlcmFuZ2U6ZDM4NjQyZTZjOTFiNDQ3YmE5YzRhNDk1Y2NkOWRhNWFfNC03LTEtMS0w_4d6375b7-be32-4ee2-8434-d7a7dfe79c6c"
      unitRef="usd">-1163000</cron:StockIssuedDuringPeriodValueWarrantsExercised>
    <cron:StockIssuedDuringPeriodValueWarrantsExercised
      contextRef="i69782326f71a44e3805518280ee22b6b_D20210101-20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzY2E5YmIwMTc5MjQ3NmZiYjIyNWU1ZDlkZWM4NjlmL3NlYzo5M2NhOWJiMDE3OTI0NzZmYmIyMjVlNWQ5ZGVjODY5Zl8yMi9mcmFnOjQ0ZDZlZTY3ZmE5MDQwOWQ5NzA3MjkyYzUxNjlmNDExL3RhYmxlOmQzODY0MmU2YzkxYjQ0N2JhOWM0YTQ5NWNjZDlkYTVhL3RhYmxlcmFuZ2U6ZDM4NjQyZTZjOTFiNDQ3YmE5YzRhNDk1Y2NkOWRhNWFfNC0xNS0xLTEtMA_78b1bd78-f57e-4cbe-aea4-358ea478c171"
      unitRef="usd">2000</cron:StockIssuedDuringPeriodValueWarrantsExercised>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsRequisiteServicePeriodRecognition
      contextRef="i32ce7a4cf9fe4b5fb2ba774cbeb3025e_D20210101-20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzY2E5YmIwMTc5MjQ3NmZiYjIyNWU1ZDlkZWM4NjlmL3NlYzo5M2NhOWJiMDE3OTI0NzZmYmIyMjVlNWQ5ZGVjODY5Zl8yMi9mcmFnOjQ0ZDZlZTY3ZmE5MDQwOWQ5NzA3MjkyYzUxNjlmNDExL3RhYmxlOmQzODY0MmU2YzkxYjQ0N2JhOWM0YTQ5NWNjZDlkYTVhL3RhYmxlcmFuZ2U6ZDM4NjQyZTZjOTFiNDQ3YmE5YzRhNDk1Y2NkOWRhNWFfNS03LTEtMS0w_a890d507-30a7-4b70-bb26-8066a8a7cd4d"
      unitRef="usd">3928000</us-gaap:AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsRequisiteServicePeriodRecognition>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsRequisiteServicePeriodRecognition
      contextRef="i69782326f71a44e3805518280ee22b6b_D20210101-20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzY2E5YmIwMTc5MjQ3NmZiYjIyNWU1ZDlkZWM4NjlmL3NlYzo5M2NhOWJiMDE3OTI0NzZmYmIyMjVlNWQ5ZGVjODY5Zl8yMi9mcmFnOjQ0ZDZlZTY3ZmE5MDQwOWQ5NzA3MjkyYzUxNjlmNDExL3RhYmxlOmQzODY0MmU2YzkxYjQ0N2JhOWM0YTQ5NWNjZDlkYTVhL3RhYmxlcmFuZ2U6ZDM4NjQyZTZjOTFiNDQ3YmE5YzRhNDk1Y2NkOWRhNWFfNS0xNS0xLTEtMA_1c43e519-dc28-416e-b4c0-5c318d2544e0"
      unitRef="usd">3928000</us-gaap:AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsRequisiteServicePeriodRecognition>
    <us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised
      contextRef="i52c9b3fb67014eb083670c6a1d51b149_D20210101-20210630"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzY2E5YmIwMTc5MjQ3NmZiYjIyNWU1ZDlkZWM4NjlmL3NlYzo5M2NhOWJiMDE3OTI0NzZmYmIyMjVlNWQ5ZGVjODY5Zl8yMi9mcmFnOjQ0ZDZlZTY3ZmE5MDQwOWQ5NzA3MjkyYzUxNjlmNDExL3RhYmxlOmQzODY0MmU2YzkxYjQ0N2JhOWM0YTQ5NWNjZDlkYTVhL3RhYmxlcmFuZ2U6ZDM4NjQyZTZjOTFiNDQ3YmE5YzRhNDk1Y2NkOWRhNWFfNi0xLTEtMS0w_cfa07c14-661d-4a2f-851d-e125b6ec66eb"
      unitRef="shares">3651002</us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised>
    <us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised
      contextRef="i52c9b3fb67014eb083670c6a1d51b149_D20210101-20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzY2E5YmIwMTc5MjQ3NmZiYjIyNWU1ZDlkZWM4NjlmL3NlYzo5M2NhOWJiMDE3OTI0NzZmYmIyMjVlNWQ5ZGVjODY5Zl8yMi9mcmFnOjQ0ZDZlZTY3ZmE5MDQwOWQ5NzA3MjkyYzUxNjlmNDExL3RhYmxlOmQzODY0MmU2YzkxYjQ0N2JhOWM0YTQ5NWNjZDlkYTVhL3RhYmxlcmFuZ2U6ZDM4NjQyZTZjOTFiNDQ3YmE5YzRhNDk1Y2NkOWRhNWFfNi0zLTEtMS0w_ab148d6f-3883-468b-b6a7-e2af6ac6efd1"
      unitRef="usd">3315000</us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised>
    <us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised
      contextRef="i32ce7a4cf9fe4b5fb2ba774cbeb3025e_D20210101-20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzY2E5YmIwMTc5MjQ3NmZiYjIyNWU1ZDlkZWM4NjlmL3NlYzo5M2NhOWJiMDE3OTI0NzZmYmIyMjVlNWQ5ZGVjODY5Zl8yMi9mcmFnOjQ0ZDZlZTY3ZmE5MDQwOWQ5NzA3MjkyYzUxNjlmNDExL3RhYmxlOmQzODY0MmU2YzkxYjQ0N2JhOWM0YTQ5NWNjZDlkYTVhL3RhYmxlcmFuZ2U6ZDM4NjQyZTZjOTFiNDQ3YmE5YzRhNDk1Y2NkOWRhNWFfNi03LTEtMS0w_6e8bc71b-8d2a-477e-a8c7-732c4d230e57"
      unitRef="usd">-3305000</us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised>
    <us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised
      contextRef="i69782326f71a44e3805518280ee22b6b_D20210101-20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzY2E5YmIwMTc5MjQ3NmZiYjIyNWU1ZDlkZWM4NjlmL3NlYzo5M2NhOWJiMDE3OTI0NzZmYmIyMjVlNWQ5ZGVjODY5Zl8yMi9mcmFnOjQ0ZDZlZTY3ZmE5MDQwOWQ5NzA3MjkyYzUxNjlmNDExL3RhYmxlOmQzODY0MmU2YzkxYjQ0N2JhOWM0YTQ5NWNjZDlkYTVhL3RhYmxlcmFuZ2U6ZDM4NjQyZTZjOTFiNDQ3YmE5YzRhNDk1Y2NkOWRhNWFfNi0xNS0xLTEtMA_713e068d-7b63-45ff-b690-9d89211ec947"
      unitRef="usd">10000</us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised>
    <us-gaap:StockIssuedDuringPeriodSharesRestrictedStockAwardNetOfForfeitures
      contextRef="i52c9b3fb67014eb083670c6a1d51b149_D20210101-20210630"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzY2E5YmIwMTc5MjQ3NmZiYjIyNWU1ZDlkZWM4NjlmL3NlYzo5M2NhOWJiMDE3OTI0NzZmYmIyMjVlNWQ5ZGVjODY5Zl8yMi9mcmFnOjQ0ZDZlZTY3ZmE5MDQwOWQ5NzA3MjkyYzUxNjlmNDExL3RhYmxlOmQzODY0MmU2YzkxYjQ0N2JhOWM0YTQ5NWNjZDlkYTVhL3RhYmxlcmFuZ2U6ZDM4NjQyZTZjOTFiNDQ3YmE5YzRhNDk1Y2NkOWRhNWFfNy0xLTEtMS0xMjgxNg_de65bca0-7468-47fd-a7d3-7c1ad42af0a2"
      unitRef="shares">58354</us-gaap:StockIssuedDuringPeriodSharesRestrictedStockAwardNetOfForfeitures>
    <us-gaap:StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures
      contextRef="i52c9b3fb67014eb083670c6a1d51b149_D20210101-20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzY2E5YmIwMTc5MjQ3NmZiYjIyNWU1ZDlkZWM4NjlmL3NlYzo5M2NhOWJiMDE3OTI0NzZmYmIyMjVlNWQ5ZGVjODY5Zl8yMi9mcmFnOjQ0ZDZlZTY3ZmE5MDQwOWQ5NzA3MjkyYzUxNjlmNDExL3RhYmxlOmQzODY0MmU2YzkxYjQ0N2JhOWM0YTQ5NWNjZDlkYTVhL3RhYmxlcmFuZ2U6ZDM4NjQyZTZjOTFiNDQ3YmE5YzRhNDk1Y2NkOWRhNWFfNy0zLTEtMS0xMjgxNg_e20c0910-4438-45cd-9c90-884f0c56af5a"
      unitRef="usd">345000</us-gaap:StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures>
    <us-gaap:StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures
      contextRef="i32ce7a4cf9fe4b5fb2ba774cbeb3025e_D20210101-20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzY2E5YmIwMTc5MjQ3NmZiYjIyNWU1ZDlkZWM4NjlmL3NlYzo5M2NhOWJiMDE3OTI0NzZmYmIyMjVlNWQ5ZGVjODY5Zl8yMi9mcmFnOjQ0ZDZlZTY3ZmE5MDQwOWQ5NzA3MjkyYzUxNjlmNDExL3RhYmxlOmQzODY0MmU2YzkxYjQ0N2JhOWM0YTQ5NWNjZDlkYTVhL3RhYmxlcmFuZ2U6ZDM4NjQyZTZjOTFiNDQ3YmE5YzRhNDk1Y2NkOWRhNWFfNy03LTEtMS0xMjgyMQ_f32e4f69-45fc-494a-a28b-16d1b38f9849"
      unitRef="usd">-345000</us-gaap:StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures>
    <us-gaap:StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures
      contextRef="i69782326f71a44e3805518280ee22b6b_D20210101-20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzY2E5YmIwMTc5MjQ3NmZiYjIyNWU1ZDlkZWM4NjlmL3NlYzo5M2NhOWJiMDE3OTI0NzZmYmIyMjVlNWQ5ZGVjODY5Zl8yMi9mcmFnOjQ0ZDZlZTY3ZmE5MDQwOWQ5NzA3MjkyYzUxNjlmNDExL3RhYmxlOmQzODY0MmU2YzkxYjQ0N2JhOWM0YTQ5NWNjZDlkYTVhL3RhYmxlcmFuZ2U6ZDM4NjQyZTZjOTFiNDQ3YmE5YzRhNDk1Y2NkOWRhNWFfNy0xNS0xLTEtMTI4MjE_2817271c-1d6b-4466-b3d1-7207e7f511af"
      unitRef="usd">0</us-gaap:StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures>
    <us-gaap:AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation
      contextRef="i32ce7a4cf9fe4b5fb2ba774cbeb3025e_D20210101-20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzY2E5YmIwMTc5MjQ3NmZiYjIyNWU1ZDlkZWM4NjlmL3NlYzo5M2NhOWJiMDE3OTI0NzZmYmIyMjVlNWQ5ZGVjODY5Zl8yMi9mcmFnOjQ0ZDZlZTY3ZmE5MDQwOWQ5NzA3MjkyYzUxNjlmNDExL3RhYmxlOmQzODY0MmU2YzkxYjQ0N2JhOWM0YTQ5NWNjZDlkYTVhL3RhYmxlcmFuZ2U6ZDM4NjQyZTZjOTFiNDQ3YmE5YzRhNDk1Y2NkOWRhNWFfNy03LTEtMS0w_44a339ab-5cad-41d5-9e81-6ccc27df282b"
      unitRef="usd">1162000</us-gaap:AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation>
    <us-gaap:AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation
      contextRef="i24b7b1f487f24a12927c251dc2cc0562_D20210101-20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzY2E5YmIwMTc5MjQ3NmZiYjIyNWU1ZDlkZWM4NjlmL3NlYzo5M2NhOWJiMDE3OTI0NzZmYmIyMjVlNWQ5ZGVjODY5Zl8yMi9mcmFnOjQ0ZDZlZTY3ZmE5MDQwOWQ5NzA3MjkyYzUxNjlmNDExL3RhYmxlOmQzODY0MmU2YzkxYjQ0N2JhOWM0YTQ5NWNjZDlkYTVhL3RhYmxlcmFuZ2U6ZDM4NjQyZTZjOTFiNDQ3YmE5YzRhNDk1Y2NkOWRhNWFfNy05LTEtMS0w_d4e5d6bc-5ebc-469d-bf24-358c17a25f36"
      unitRef="usd">7757000</us-gaap:AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation>
    <us-gaap:AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation
      contextRef="i69782326f71a44e3805518280ee22b6b_D20210101-20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzY2E5YmIwMTc5MjQ3NmZiYjIyNWU1ZDlkZWM4NjlmL3NlYzo5M2NhOWJiMDE3OTI0NzZmYmIyMjVlNWQ5ZGVjODY5Zl8yMi9mcmFnOjQ0ZDZlZTY3ZmE5MDQwOWQ5NzA3MjkyYzUxNjlmNDExL3RhYmxlOmQzODY0MmU2YzkxYjQ0N2JhOWM0YTQ5NWNjZDlkYTVhL3RhYmxlcmFuZ2U6ZDM4NjQyZTZjOTFiNDQ3YmE5YzRhNDk1Y2NkOWRhNWFfNy0xNS0xLTEtMA_c3962e72-2656-4abf-8b79-915cbf0d4473"
      unitRef="usd">8919000</us-gaap:AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationRestrictedStockUnitsRequisiteServicePeriodRecognition
      contextRef="i32ce7a4cf9fe4b5fb2ba774cbeb3025e_D20210101-20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzY2E5YmIwMTc5MjQ3NmZiYjIyNWU1ZDlkZWM4NjlmL3NlYzo5M2NhOWJiMDE3OTI0NzZmYmIyMjVlNWQ5ZGVjODY5Zl8yMi9mcmFnOjQ0ZDZlZTY3ZmE5MDQwOWQ5NzA3MjkyYzUxNjlmNDExL3RhYmxlOmQzODY0MmU2YzkxYjQ0N2JhOWM0YTQ5NWNjZDlkYTVhL3RhYmxlcmFuZ2U6ZDM4NjQyZTZjOTFiNDQ3YmE5YzRhNDk1Y2NkOWRhNWFfOC03LTEtMS0w_980f3868-7147-4e9d-bf9b-d45c1e42684a"
      unitRef="usd">1136000</us-gaap:AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationRestrictedStockUnitsRequisiteServicePeriodRecognition>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationRestrictedStockUnitsRequisiteServicePeriodRecognition
      contextRef="i69782326f71a44e3805518280ee22b6b_D20210101-20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzY2E5YmIwMTc5MjQ3NmZiYjIyNWU1ZDlkZWM4NjlmL3NlYzo5M2NhOWJiMDE3OTI0NzZmYmIyMjVlNWQ5ZGVjODY5Zl8yMi9mcmFnOjQ0ZDZlZTY3ZmE5MDQwOWQ5NzA3MjkyYzUxNjlmNDExL3RhYmxlOmQzODY0MmU2YzkxYjQ0N2JhOWM0YTQ5NWNjZDlkYTVhL3RhYmxlcmFuZ2U6ZDM4NjQyZTZjOTFiNDQ3YmE5YzRhNDk1Y2NkOWRhNWFfOC0xNS0xLTEtMA_9adbecde-9d0f-4d83-81da-8825c8ddf726"
      unitRef="usd">1136000</us-gaap:AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationRestrictedStockUnitsRequisiteServicePeriodRecognition>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationOtherLongtermIncentivePlansRequisiteServicePeriodRecognition
      contextRef="i52c9b3fb67014eb083670c6a1d51b149_D20210101-20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzY2E5YmIwMTc5MjQ3NmZiYjIyNWU1ZDlkZWM4NjlmL3NlYzo5M2NhOWJiMDE3OTI0NzZmYmIyMjVlNWQ5ZGVjODY5Zl8yMi9mcmFnOjQ0ZDZlZTY3ZmE5MDQwOWQ5NzA3MjkyYzUxNjlmNDExL3RhYmxlOmQzODY0MmU2YzkxYjQ0N2JhOWM0YTQ5NWNjZDlkYTVhL3RhYmxlcmFuZ2U6ZDM4NjQyZTZjOTFiNDQ3YmE5YzRhNDk1Y2NkOWRhNWFfOS0zLTEtMS0w_0c0bb96b-e919-41b9-9598-41110a29fa9c"
      unitRef="usd">2000000</us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationOtherLongtermIncentivePlansRequisiteServicePeriodRecognition>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationOtherLongtermIncentivePlansRequisiteServicePeriodRecognition
      contextRef="i32ce7a4cf9fe4b5fb2ba774cbeb3025e_D20210101-20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzY2E5YmIwMTc5MjQ3NmZiYjIyNWU1ZDlkZWM4NjlmL3NlYzo5M2NhOWJiMDE3OTI0NzZmYmIyMjVlNWQ5ZGVjODY5Zl8yMi9mcmFnOjQ0ZDZlZTY3ZmE5MDQwOWQ5NzA3MjkyYzUxNjlmNDExL3RhYmxlOmQzODY0MmU2YzkxYjQ0N2JhOWM0YTQ5NWNjZDlkYTVhL3RhYmxlcmFuZ2U6ZDM4NjQyZTZjOTFiNDQ3YmE5YzRhNDk1Y2NkOWRhNWFfOS03LTEtMS0w_4f030400-8151-4d4b-985a-f10bb6ef0e56"
      unitRef="usd">-1317000</us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationOtherLongtermIncentivePlansRequisiteServicePeriodRecognition>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationOtherLongtermIncentivePlansRequisiteServicePeriodRecognition
      contextRef="i69782326f71a44e3805518280ee22b6b_D20210101-20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzY2E5YmIwMTc5MjQ3NmZiYjIyNWU1ZDlkZWM4NjlmL3NlYzo5M2NhOWJiMDE3OTI0NzZmYmIyMjVlNWQ5ZGVjODY5Zl8yMi9mcmFnOjQ0ZDZlZTY3ZmE5MDQwOWQ5NzA3MjkyYzUxNjlmNDExL3RhYmxlOmQzODY0MmU2YzkxYjQ0N2JhOWM0YTQ5NWNjZDlkYTVhL3RhYmxlcmFuZ2U6ZDM4NjQyZTZjOTFiNDQ3YmE5YzRhNDk1Y2NkOWRhNWFfOS0xNS0xLTEtMA_3c44276a-7fdc-4b49-80a0-e02776941256"
      unitRef="usd">683000</us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationOtherLongtermIncentivePlansRequisiteServicePeriodRecognition>
    <cron:StockholdersEquityOutOfPeriodAdjustment
      contextRef="i52c9b3fb67014eb083670c6a1d51b149_D20210101-20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzY2E5YmIwMTc5MjQ3NmZiYjIyNWU1ZDlkZWM4NjlmL3NlYzo5M2NhOWJiMDE3OTI0NzZmYmIyMjVlNWQ5ZGVjODY5Zl8yMi9mcmFnOjQ0ZDZlZTY3ZmE5MDQwOWQ5NzA3MjkyYzUxNjlmNDExL3RhYmxlOmQzODY0MmU2YzkxYjQ0N2JhOWM0YTQ5NWNjZDlkYTVhL3RhYmxlcmFuZ2U6ZDM4NjQyZTZjOTFiNDQ3YmE5YzRhNDk1Y2NkOWRhNWFfMTAtMy0xLTEtMA_ecddda58-4cc1-47da-8239-e98f5a9ffc5c"
      unitRef="usd">-3227000</cron:StockholdersEquityOutOfPeriodAdjustment>
    <cron:StockholdersEquityOutOfPeriodAdjustment
      contextRef="i24b7b1f487f24a12927c251dc2cc0562_D20210101-20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzY2E5YmIwMTc5MjQ3NmZiYjIyNWU1ZDlkZWM4NjlmL3NlYzo5M2NhOWJiMDE3OTI0NzZmYmIyMjVlNWQ5ZGVjODY5Zl8yMi9mcmFnOjQ0ZDZlZTY3ZmE5MDQwOWQ5NzA3MjkyYzUxNjlmNDExL3RhYmxlOmQzODY0MmU2YzkxYjQ0N2JhOWM0YTQ5NWNjZDlkYTVhL3RhYmxlcmFuZ2U6ZDM4NjQyZTZjOTFiNDQ3YmE5YzRhNDk1Y2NkOWRhNWFfMTAtOS0xLTEtMA_658f3b8d-8b17-4f1e-b43d-611e4cf80965"
      unitRef="usd">3227000</cron:StockholdersEquityOutOfPeriodAdjustment>
    <cron:StockholdersEquityOutOfPeriodAdjustment
      contextRef="i69782326f71a44e3805518280ee22b6b_D20210101-20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzY2E5YmIwMTc5MjQ3NmZiYjIyNWU1ZDlkZWM4NjlmL3NlYzo5M2NhOWJiMDE3OTI0NzZmYmIyMjVlNWQ5ZGVjODY5Zl8yMi9mcmFnOjQ0ZDZlZTY3ZmE5MDQwOWQ5NzA3MjkyYzUxNjlmNDExL3RhYmxlOmQzODY0MmU2YzkxYjQ0N2JhOWM0YTQ5NWNjZDlkYTVhL3RhYmxlcmFuZ2U6ZDM4NjQyZTZjOTFiNDQ3YmE5YzRhNDk1Y2NkOWRhNWFfMTAtMTUtMS0xLTA_9edfd0f7-97cd-4b4d-a82e-47c0fed3a5ff"
      unitRef="usd">0</cron:StockholdersEquityOutOfPeriodAdjustment>
    <us-gaap:ProfitLoss
      contextRef="i24b7b1f487f24a12927c251dc2cc0562_D20210101-20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzY2E5YmIwMTc5MjQ3NmZiYjIyNWU1ZDlkZWM4NjlmL3NlYzo5M2NhOWJiMDE3OTI0NzZmYmIyMjVlNWQ5ZGVjODY5Zl8yMi9mcmFnOjQ0ZDZlZTY3ZmE5MDQwOWQ5NzA3MjkyYzUxNjlmNDExL3RhYmxlOmQzODY0MmU2YzkxYjQ0N2JhOWM0YTQ5NWNjZDlkYTVhL3RhYmxlcmFuZ2U6ZDM4NjQyZTZjOTFiNDQ3YmE5YzRhNDk1Y2NkOWRhNWFfMTEtOS0xLTEtMA_4e1cf775-e12c-41ed-b9dc-e4e95cf384ff"
      unitRef="usd">-104258000</us-gaap:ProfitLoss>
    <us-gaap:ProfitLoss
      contextRef="if8ae25ba0a1c4efd878426d129e53e7b_D20210101-20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzY2E5YmIwMTc5MjQ3NmZiYjIyNWU1ZDlkZWM4NjlmL3NlYzo5M2NhOWJiMDE3OTI0NzZmYmIyMjVlNWQ5ZGVjODY5Zl8yMi9mcmFnOjQ0ZDZlZTY3ZmE5MDQwOWQ5NzA3MjkyYzUxNjlmNDExL3RhYmxlOmQzODY0MmU2YzkxYjQ0N2JhOWM0YTQ5NWNjZDlkYTVhL3RhYmxlcmFuZ2U6ZDM4NjQyZTZjOTFiNDQ3YmE5YzRhNDk1Y2NkOWRhNWFfMTEtMTMtMS0xLTA_17bf8e53-5fa2-4f9b-a767-a0159d3d37f3"
      unitRef="usd">-592000</us-gaap:ProfitLoss>
    <us-gaap:ProfitLoss
      contextRef="i69782326f71a44e3805518280ee22b6b_D20210101-20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzY2E5YmIwMTc5MjQ3NmZiYjIyNWU1ZDlkZWM4NjlmL3NlYzo5M2NhOWJiMDE3OTI0NzZmYmIyMjVlNWQ5ZGVjODY5Zl8yMi9mcmFnOjQ0ZDZlZTY3ZmE5MDQwOWQ5NzA3MjkyYzUxNjlmNDExL3RhYmxlOmQzODY0MmU2YzkxYjQ0N2JhOWM0YTQ5NWNjZDlkYTVhL3RhYmxlcmFuZ2U6ZDM4NjQyZTZjOTFiNDQ3YmE5YzRhNDk1Y2NkOWRhNWFfMTEtMTUtMS0xLTA_7547982c-e3c7-404e-9cba-766af34cb1c3"
      unitRef="usd">-104850000</us-gaap:ProfitLoss>
    <us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
      contextRef="if19cdb6b9f6f463e8cdd761179f9db89_D20210101-20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzY2E5YmIwMTc5MjQ3NmZiYjIyNWU1ZDlkZWM4NjlmL3NlYzo5M2NhOWJiMDE3OTI0NzZmYmIyMjVlNWQ5ZGVjODY5Zl8yMi9mcmFnOjQ0ZDZlZTY3ZmE5MDQwOWQ5NzA3MjkyYzUxNjlmNDExL3RhYmxlOmQzODY0MmU2YzkxYjQ0N2JhOWM0YTQ5NWNjZDlkYTVhL3RhYmxlcmFuZ2U6ZDM4NjQyZTZjOTFiNDQ3YmE5YzRhNDk1Y2NkOWRhNWFfMTItMTEtMS0xLTA_659b3ff6-b471-487b-aac4-9f5ad5aac1b5"
      unitRef="usd">28730000</us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
      contextRef="if8ae25ba0a1c4efd878426d129e53e7b_D20210101-20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzY2E5YmIwMTc5MjQ3NmZiYjIyNWU1ZDlkZWM4NjlmL3NlYzo5M2NhOWJiMDE3OTI0NzZmYmIyMjVlNWQ5ZGVjODY5Zl8yMi9mcmFnOjQ0ZDZlZTY3ZmE5MDQwOWQ5NzA3MjkyYzUxNjlmNDExL3RhYmxlOmQzODY0MmU2YzkxYjQ0N2JhOWM0YTQ5NWNjZDlkYTVhL3RhYmxlcmFuZ2U6ZDM4NjQyZTZjOTFiNDQ3YmE5YzRhNDk1Y2NkOWRhNWFfMTItMTMtMS0xLTA_3c61aa62-a104-4eec-9a88-349949e0bea3"
      unitRef="usd">1024000</us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
      contextRef="i69782326f71a44e3805518280ee22b6b_D20210101-20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzY2E5YmIwMTc5MjQ3NmZiYjIyNWU1ZDlkZWM4NjlmL3NlYzo5M2NhOWJiMDE3OTI0NzZmYmIyMjVlNWQ5ZGVjODY5Zl8yMi9mcmFnOjQ0ZDZlZTY3ZmE5MDQwOWQ5NzA3MjkyYzUxNjlmNDExL3RhYmxlOmQzODY0MmU2YzkxYjQ0N2JhOWM0YTQ5NWNjZDlkYTVhL3RhYmxlcmFuZ2U6ZDM4NjQyZTZjOTFiNDQ3YmE5YzRhNDk1Y2NkOWRhNWFfMTItMTUtMS0xLTA_23ce77d2-afcd-42de-bf1f-da6d07b7dc32"
      unitRef="usd">29754000</us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax>
    <us-gaap:CommonStockSharesOutstanding
      contextRef="i1d565c32dabc40c08d36232dec1a7779_I20210630"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzY2E5YmIwMTc5MjQ3NmZiYjIyNWU1ZDlkZWM4NjlmL3NlYzo5M2NhOWJiMDE3OTI0NzZmYmIyMjVlNWQ5ZGVjODY5Zl8yMi9mcmFnOjQ0ZDZlZTY3ZmE5MDQwOWQ5NzA3MjkyYzUxNjlmNDExL3RhYmxlOmQzODY0MmU2YzkxYjQ0N2JhOWM0YTQ5NWNjZDlkYTVhL3RhYmxlcmFuZ2U6ZDM4NjQyZTZjOTFiNDQ3YmE5YzRhNDk1Y2NkOWRhNWFfMTMtMS0xLTEtMA_070308de-8209-4612-af62-a4ff4b468e95"
      unitRef="shares">371805547</us-gaap:CommonStockSharesOutstanding>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i1d565c32dabc40c08d36232dec1a7779_I20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzY2E5YmIwMTc5MjQ3NmZiYjIyNWU1ZDlkZWM4NjlmL3NlYzo5M2NhOWJiMDE3OTI0NzZmYmIyMjVlNWQ5ZGVjODY5Zl8yMi9mcmFnOjQ0ZDZlZTY3ZmE5MDQwOWQ5NzA3MjkyYzUxNjlmNDExL3RhYmxlOmQzODY0MmU2YzkxYjQ0N2JhOWM0YTQ5NWNjZDlkYTVhL3RhYmxlcmFuZ2U6ZDM4NjQyZTZjOTFiNDQ3YmE5YzRhNDk1Y2NkOWRhNWFfMTMtMy0xLTEtMA_78c1f098-c287-4046-bdf0-acb11c3347b7"
      unitRef="usd">572858000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="ibbfd3d5a9feb460a8f0fe21cf2539d79_I20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzY2E5YmIwMTc5MjQ3NmZiYjIyNWU1ZDlkZWM4NjlmL3NlYzo5M2NhOWJiMDE3OTI0NzZmYmIyMjVlNWQ5ZGVjODY5Zl8yMi9mcmFnOjQ0ZDZlZTY3ZmE5MDQwOWQ5NzA3MjkyYzUxNjlmNDExL3RhYmxlOmQzODY0MmU2YzkxYjQ0N2JhOWM0YTQ5NWNjZDlkYTVhL3RhYmxlcmFuZ2U6ZDM4NjQyZTZjOTFiNDQ3YmE5YzRhNDk1Y2NkOWRhNWFfMTMtNy0xLTEtMA_e2ce53ae-1a96-488f-9650-9b2f4c509069"
      unitRef="usd">32368000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i5b5acb4a63db4a419bb0b3e0c4a24492_I20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzY2E5YmIwMTc5MjQ3NmZiYjIyNWU1ZDlkZWM4NjlmL3NlYzo5M2NhOWJiMDE3OTI0NzZmYmIyMjVlNWQ5ZGVjODY5Zl8yMi9mcmFnOjQ0ZDZlZTY3ZmE5MDQwOWQ5NzA3MjkyYzUxNjlmNDExL3RhYmxlOmQzODY0MmU2YzkxYjQ0N2JhOWM0YTQ5NWNjZDlkYTVhL3RhYmxlcmFuZ2U6ZDM4NjQyZTZjOTFiNDQ3YmE5YzRhNDk1Y2NkOWRhNWFfMTMtOS0xLTEtMA_55c23544-32c2-4917-9332-19df7e95b76c"
      unitRef="usd">955721000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i7d990708cda34586a3e37a53dd59fb03_I20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzY2E5YmIwMTc5MjQ3NmZiYjIyNWU1ZDlkZWM4NjlmL3NlYzo5M2NhOWJiMDE3OTI0NzZmYmIyMjVlNWQ5ZGVjODY5Zl8yMi9mcmFnOjQ0ZDZlZTY3ZmE5MDQwOWQ5NzA3MjkyYzUxNjlmNDExL3RhYmxlOmQzODY0MmU2YzkxYjQ0N2JhOWM0YTQ5NWNjZDlkYTVhL3RhYmxlcmFuZ2U6ZDM4NjQyZTZjOTFiNDQ3YmE5YzRhNDk1Y2NkOWRhNWFfMTMtMTEtMS0xLTA_e56e7295-4892-46f7-ae6a-d230b1b2bee9"
      unitRef="usd">71729000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i64458da0ec424fd8a6faf87d69636ecd_I20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzY2E5YmIwMTc5MjQ3NmZiYjIyNWU1ZDlkZWM4NjlmL3NlYzo5M2NhOWJiMDE3OTI0NzZmYmIyMjVlNWQ5ZGVjODY5Zl8yMi9mcmFnOjQ0ZDZlZTY3ZmE5MDQwOWQ5NzA3MjkyYzUxNjlmNDExL3RhYmxlOmQzODY0MmU2YzkxYjQ0N2JhOWM0YTQ5NWNjZDlkYTVhL3RhYmxlcmFuZ2U6ZDM4NjQyZTZjOTFiNDQ3YmE5YzRhNDk1Y2NkOWRhNWFfMTMtMTMtMS0xLTA_f7ddb2a5-5fa5-4d2a-be63-a927ed845a62"
      unitRef="usd">-2764000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i225f85e38faa4bbdb4de1d8b9cf369bb_I20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzY2E5YmIwMTc5MjQ3NmZiYjIyNWU1ZDlkZWM4NjlmL3NlYzo5M2NhOWJiMDE3OTI0NzZmYmIyMjVlNWQ5ZGVjODY5Zl8yMi9mcmFnOjQ0ZDZlZTY3ZmE5MDQwOWQ5NzA3MjkyYzUxNjlmNDExL3RhYmxlOmQzODY0MmU2YzkxYjQ0N2JhOWM0YTQ5NWNjZDlkYTVhL3RhYmxlcmFuZ2U6ZDM4NjQyZTZjOTFiNDQ3YmE5YzRhNDk1Y2NkOWRhNWFfMTMtMTUtMS0xLTA_738a6310-ba9d-400d-bfc4-af741e905715"
      unitRef="usd">1629912000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:CommonStockSharesOutstanding
      contextRef="ibec8035afed7413580a92eb6c685b162_I20191231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzY2E5YmIwMTc5MjQ3NmZiYjIyNWU1ZDlkZWM4NjlmL3NlYzo5M2NhOWJiMDE3OTI0NzZmYmIyMjVlNWQ5ZGVjODY5Zl8yMi9mcmFnOjQ0ZDZlZTY3ZmE5MDQwOWQ5NzA3MjkyYzUxNjlmNDExL3RhYmxlOjdmNTJmY2Y3NzgwODQ3NWFiMTRkMWFhMTJlY2Y4OTVhL3RhYmxlcmFuZ2U6N2Y1MmZjZjc3ODA4NDc1YWIxNGQxYWExMmVjZjg5NWFfMS0xLTEtMS0w_20a3c7e0-6b52-444e-b60a-ebfbe7d5b171"
      unitRef="shares">348817472</us-gaap:CommonStockSharesOutstanding>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="ibec8035afed7413580a92eb6c685b162_I20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzY2E5YmIwMTc5MjQ3NmZiYjIyNWU1ZDlkZWM4NjlmL3NlYzo5M2NhOWJiMDE3OTI0NzZmYmIyMjVlNWQ5ZGVjODY5Zl8yMi9mcmFnOjQ0ZDZlZTY3ZmE5MDQwOWQ5NzA3MjkyYzUxNjlmNDExL3RhYmxlOjdmNTJmY2Y3NzgwODQ3NWFiMTRkMWFhMTJlY2Y4OTVhL3RhYmxlcmFuZ2U6N2Y1MmZjZjc3ODA4NDc1YWIxNGQxYWExMmVjZjg5NWFfMS0zLTEtMS0w_7130c729-ec5d-4a9e-836e-dd78232befd6"
      unitRef="usd">561165000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i22d6ccbfd09c4945825d9d9eccef7a82_I20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzY2E5YmIwMTc5MjQ3NmZiYjIyNWU1ZDlkZWM4NjlmL3NlYzo5M2NhOWJiMDE3OTI0NzZmYmIyMjVlNWQ5ZGVjODY5Zl8yMi9mcmFnOjQ0ZDZlZTY3ZmE5MDQwOWQ5NzA3MjkyYzUxNjlmNDExL3RhYmxlOjdmNTJmY2Y3NzgwODQ3NWFiMTRkMWFhMTJlY2Y4OTVhL3RhYmxlcmFuZ2U6N2Y1MmZjZjc3ODA4NDc1YWIxNGQxYWExMmVjZjg5NWFfMS03LTEtMS0w_f534d418-a70c-426a-bba3-f95571dc89cc"
      unitRef="usd">23234000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i5e450cfb71c44415b401ef2a8c9b958a_I20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzY2E5YmIwMTc5MjQ3NmZiYjIyNWU1ZDlkZWM4NjlmL3NlYzo5M2NhOWJiMDE3OTI0NzZmYmIyMjVlNWQ5ZGVjODY5Zl8yMi9mcmFnOjQ0ZDZlZTY3ZmE5MDQwOWQ5NzA3MjkyYzUxNjlmNDExL3RhYmxlOjdmNTJmY2Y3NzgwODQ3NWFiMTRkMWFhMTJlY2Y4OTVhL3RhYmxlcmFuZ2U6N2Y1MmZjZjc3ODA4NDc1YWIxNGQxYWExMmVjZjg5NWFfMS05LTEtMS0w_db358cfa-8e2a-4f16-afbb-49c157c4e74c"
      unitRef="usd">1137646000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i4dec53ede4f44421a40be0b4d3eb49a6_I20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzY2E5YmIwMTc5MjQ3NmZiYjIyNWU1ZDlkZWM4NjlmL3NlYzo5M2NhOWJiMDE3OTI0NzZmYmIyMjVlNWQ5ZGVjODY5Zl8yMi9mcmFnOjQ0ZDZlZTY3ZmE5MDQwOWQ5NzA3MjkyYzUxNjlmNDExL3RhYmxlOjdmNTJmY2Y3NzgwODQ3NWFiMTRkMWFhMTJlY2Y4OTVhL3RhYmxlcmFuZ2U6N2Y1MmZjZjc3ODA4NDc1YWIxNGQxYWExMmVjZjg5NWFfMS0xMS0xLTEtMA_32f08f3e-42da-4ad1-beba-2eccf1168eb5"
      unitRef="usd">27838000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="ic0274d7a972e4964b3d0fca8bddf9b4c_I20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzY2E5YmIwMTc5MjQ3NmZiYjIyNWU1ZDlkZWM4NjlmL3NlYzo5M2NhOWJiMDE3OTI0NzZmYmIyMjVlNWQ5ZGVjODY5Zl8yMi9mcmFnOjQ0ZDZlZTY3ZmE5MDQwOWQ5NzA3MjkyYzUxNjlmNDExL3RhYmxlOjdmNTJmY2Y3NzgwODQ3NWFiMTRkMWFhMTJlY2Y4OTVhL3RhYmxlcmFuZ2U6N2Y1MmZjZjc3ODA4NDc1YWIxNGQxYWExMmVjZjg5NWFfMS0xMy0xLTEtMA_7fdb1ce6-2849-448e-98c8-53841a71e84d"
      unitRef="usd">-853000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="ie4fc90ad6d7f4d39aea9cb65c8026e09_I20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzY2E5YmIwMTc5MjQ3NmZiYjIyNWU1ZDlkZWM4NjlmL3NlYzo5M2NhOWJiMDE3OTI0NzZmYmIyMjVlNWQ5ZGVjODY5Zl8yMi9mcmFnOjQ0ZDZlZTY3ZmE5MDQwOWQ5NzA3MjkyYzUxNjlmNDExL3RhYmxlOjdmNTJmY2Y3NzgwODQ3NWFiMTRkMWFhMTJlY2Y4OTVhL3RhYmxlcmFuZ2U6N2Y1MmZjZjc3ODA4NDc1YWIxNGQxYWExMmVjZjg5NWFfMS0xNS0xLTEtMA_4e513851-2d94-4195-b0c3-a78f04b3f3ef"
      unitRef="usd">1749030000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsRequisiteServicePeriodRecognition
      contextRef="ief0b929c9a76458b843a186c4b2a71f2_D20200101-20200630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzY2E5YmIwMTc5MjQ3NmZiYjIyNWU1ZDlkZWM4NjlmL3NlYzo5M2NhOWJiMDE3OTI0NzZmYmIyMjVlNWQ5ZGVjODY5Zl8yMi9mcmFnOjQ0ZDZlZTY3ZmE5MDQwOWQ5NzA3MjkyYzUxNjlmNDExL3RhYmxlOjdmNTJmY2Y3NzgwODQ3NWFiMTRkMWFhMTJlY2Y4OTVhL3RhYmxlcmFuZ2U6N2Y1MmZjZjc3ODA4NDc1YWIxNGQxYWExMmVjZjg5NWFfNS03LTEtMS0w_b90ca123-a230-407c-a5ab-354215024eef"
      unitRef="usd">3500000</us-gaap:AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsRequisiteServicePeriodRecognition>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsRequisiteServicePeriodRecognition
      contextRef="i4a110e4972ef4113880ce582e3cda5c5_D20200101-20200630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzY2E5YmIwMTc5MjQ3NmZiYjIyNWU1ZDlkZWM4NjlmL3NlYzo5M2NhOWJiMDE3OTI0NzZmYmIyMjVlNWQ5ZGVjODY5Zl8yMi9mcmFnOjQ0ZDZlZTY3ZmE5MDQwOWQ5NzA3MjkyYzUxNjlmNDExL3RhYmxlOjdmNTJmY2Y3NzgwODQ3NWFiMTRkMWFhMTJlY2Y4OTVhL3RhYmxlcmFuZ2U6N2Y1MmZjZjc3ODA4NDc1YWIxNGQxYWExMmVjZjg5NWFfNS0xNS0xLTEtMA_664e3dde-c161-4391-9d5e-53ab9a1ac888"
      unitRef="usd">3500000</us-gaap:AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsRequisiteServicePeriodRecognition>
    <us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised
      contextRef="ie28d03ed3f6c447e8db8badbe540043f_D20200101-20200630"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzY2E5YmIwMTc5MjQ3NmZiYjIyNWU1ZDlkZWM4NjlmL3NlYzo5M2NhOWJiMDE3OTI0NzZmYmIyMjVlNWQ5ZGVjODY5Zl8yMi9mcmFnOjQ0ZDZlZTY3ZmE5MDQwOWQ5NzA3MjkyYzUxNjlmNDExL3RhYmxlOjdmNTJmY2Y3NzgwODQ3NWFiMTRkMWFhMTJlY2Y4OTVhL3RhYmxlcmFuZ2U6N2Y1MmZjZjc3ODA4NDc1YWIxNGQxYWExMmVjZjg5NWFfNi0xLTEtMS0w_35b98818-ebb9-42b0-9a45-20b407bcca95"
      unitRef="shares">1068930</us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised>
    <us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised
      contextRef="ie28d03ed3f6c447e8db8badbe540043f_D20200101-20200630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzY2E5YmIwMTc5MjQ3NmZiYjIyNWU1ZDlkZWM4NjlmL3NlYzo5M2NhOWJiMDE3OTI0NzZmYmIyMjVlNWQ5ZGVjODY5Zl8yMi9mcmFnOjQ0ZDZlZTY3ZmE5MDQwOWQ5NzA3MjkyYzUxNjlmNDExL3RhYmxlOjdmNTJmY2Y3NzgwODQ3NWFiMTRkMWFhMTJlY2Y4OTVhL3RhYmxlcmFuZ2U6N2Y1MmZjZjc3ODA4NDc1YWIxNGQxYWExMmVjZjg5NWFfNi0zLTEtMS0w_96b6bb38-9226-4616-aa59-2781f3c7c194"
      unitRef="usd">1329000</us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised>
    <us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised
      contextRef="ief0b929c9a76458b843a186c4b2a71f2_D20200101-20200630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzY2E5YmIwMTc5MjQ3NmZiYjIyNWU1ZDlkZWM4NjlmL3NlYzo5M2NhOWJiMDE3OTI0NzZmYmIyMjVlNWQ5ZGVjODY5Zl8yMi9mcmFnOjQ0ZDZlZTY3ZmE5MDQwOWQ5NzA3MjkyYzUxNjlmNDExL3RhYmxlOjdmNTJmY2Y3NzgwODQ3NWFiMTRkMWFhMTJlY2Y4OTVhL3RhYmxlcmFuZ2U6N2Y1MmZjZjc3ODA4NDc1YWIxNGQxYWExMmVjZjg5NWFfNi03LTEtMS0w_b831fa31-a0ff-4532-abb4-6b57c2019ed6"
      unitRef="usd">-1328000</us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised>
    <us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised
      contextRef="i4a110e4972ef4113880ce582e3cda5c5_D20200101-20200630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzY2E5YmIwMTc5MjQ3NmZiYjIyNWU1ZDlkZWM4NjlmL3NlYzo5M2NhOWJiMDE3OTI0NzZmYmIyMjVlNWQ5ZGVjODY5Zl8yMi9mcmFnOjQ0ZDZlZTY3ZmE5MDQwOWQ5NzA3MjkyYzUxNjlmNDExL3RhYmxlOjdmNTJmY2Y3NzgwODQ3NWFiMTRkMWFhMTJlY2Y4OTVhL3RhYmxlcmFuZ2U6N2Y1MmZjZjc3ODA4NDc1YWIxNGQxYWExMmVjZjg5NWFfNi0xNS0xLTEtMA_a7002f7e-71bd-455d-9626-b917155b29a2"
      unitRef="usd">1000</us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationRestrictedStockUnitsRequisiteServicePeriodRecognition
      contextRef="ief0b929c9a76458b843a186c4b2a71f2_D20200101-20200630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzY2E5YmIwMTc5MjQ3NmZiYjIyNWU1ZDlkZWM4NjlmL3NlYzo5M2NhOWJiMDE3OTI0NzZmYmIyMjVlNWQ5ZGVjODY5Zl8yMi9mcmFnOjQ0ZDZlZTY3ZmE5MDQwOWQ5NzA3MjkyYzUxNjlmNDExL3RhYmxlOjdmNTJmY2Y3NzgwODQ3NWFiMTRkMWFhMTJlY2Y4OTVhL3RhYmxlcmFuZ2U6N2Y1MmZjZjc3ODA4NDc1YWIxNGQxYWExMmVjZjg5NWFfOS03LTEtMS0w_8bd71b11-ff2c-4389-b71f-36befd6a0c93"
      unitRef="usd">1482000</us-gaap:AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationRestrictedStockUnitsRequisiteServicePeriodRecognition>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationRestrictedStockUnitsRequisiteServicePeriodRecognition
      contextRef="i4a110e4972ef4113880ce582e3cda5c5_D20200101-20200630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzY2E5YmIwMTc5MjQ3NmZiYjIyNWU1ZDlkZWM4NjlmL3NlYzo5M2NhOWJiMDE3OTI0NzZmYmIyMjVlNWQ5ZGVjODY5Zl8yMi9mcmFnOjQ0ZDZlZTY3ZmE5MDQwOWQ5NzA3MjkyYzUxNjlmNDExL3RhYmxlOjdmNTJmY2Y3NzgwODQ3NWFiMTRkMWFhMTJlY2Y4OTVhL3RhYmxlcmFuZ2U6N2Y1MmZjZjc3ODA4NDc1YWIxNGQxYWExMmVjZjg5NWFfOS0xNS0xLTEtMA_2e9af5e6-db83-4c18-8e5b-493f20f173fa"
      unitRef="usd">1482000</us-gaap:AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationRestrictedStockUnitsRequisiteServicePeriodRecognition>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationOtherLongtermIncentivePlansRequisiteServicePeriodRecognition
      contextRef="ie28d03ed3f6c447e8db8badbe540043f_D20200101-20200630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzY2E5YmIwMTc5MjQ3NmZiYjIyNWU1ZDlkZWM4NjlmL3NlYzo5M2NhOWJiMDE3OTI0NzZmYmIyMjVlNWQ5ZGVjODY5Zl8yMi9mcmFnOjQ0ZDZlZTY3ZmE5MDQwOWQ5NzA3MjkyYzUxNjlmNDExL3RhYmxlOjdmNTJmY2Y3NzgwODQ3NWFiMTRkMWFhMTJlY2Y4OTVhL3RhYmxlcmFuZ2U6N2Y1MmZjZjc3ODA4NDc1YWIxNGQxYWExMmVjZjg5NWFfMTAtMy0xLTEtMA_3a94635d-b11e-4f44-bd67-6af609f649ad"
      unitRef="usd">2000000</us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationOtherLongtermIncentivePlansRequisiteServicePeriodRecognition>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationOtherLongtermIncentivePlansRequisiteServicePeriodRecognition
      contextRef="ief0b929c9a76458b843a186c4b2a71f2_D20200101-20200630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzY2E5YmIwMTc5MjQ3NmZiYjIyNWU1ZDlkZWM4NjlmL3NlYzo5M2NhOWJiMDE3OTI0NzZmYmIyMjVlNWQ5ZGVjODY5Zl8yMi9mcmFnOjQ0ZDZlZTY3ZmE5MDQwOWQ5NzA3MjkyYzUxNjlmNDExL3RhYmxlOjdmNTJmY2Y3NzgwODQ3NWFiMTRkMWFhMTJlY2Y4OTVhL3RhYmxlcmFuZ2U6N2Y1MmZjZjc3ODA4NDc1YWIxNGQxYWExMmVjZjg5NWFfMTAtNy0xLTEtMA_8736d65c-4b23-4e13-ab9d-2141159cba10"
      unitRef="usd">158000</us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationOtherLongtermIncentivePlansRequisiteServicePeriodRecognition>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationOtherLongtermIncentivePlansRequisiteServicePeriodRecognition
      contextRef="i4a110e4972ef4113880ce582e3cda5c5_D20200101-20200630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzY2E5YmIwMTc5MjQ3NmZiYjIyNWU1ZDlkZWM4NjlmL3NlYzo5M2NhOWJiMDE3OTI0NzZmYmIyMjVlNWQ5ZGVjODY5Zl8yMi9mcmFnOjQ0ZDZlZTY3ZmE5MDQwOWQ5NzA3MjkyYzUxNjlmNDExL3RhYmxlOjdmNTJmY2Y3NzgwODQ3NWFiMTRkMWFhMTJlY2Y4OTVhL3RhYmxlcmFuZ2U6N2Y1MmZjZjc3ODA4NDc1YWIxNGQxYWExMmVjZjg5NWFfMTAtMTUtMS0xLTA_f52503dc-25eb-476c-a8ea-2a76489e095e"
      unitRef="usd">2158000</us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationOtherLongtermIncentivePlansRequisiteServicePeriodRecognition>
    <cron:StockIssuedDuringPeriodValueTopupRightsExercised
      contextRef="ie28d03ed3f6c447e8db8badbe540043f_D20200101-20200630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzY2E5YmIwMTc5MjQ3NmZiYjIyNWU1ZDlkZWM4NjlmL3NlYzo5M2NhOWJiMDE3OTI0NzZmYmIyMjVlNWQ5ZGVjODY5Zl8yMi9mcmFnOjQ0ZDZlZTY3ZmE5MDQwOWQ5NzA3MjkyYzUxNjlmNDExL3RhYmxlOjdmNTJmY2Y3NzgwODQ3NWFiMTRkMWFhMTJlY2Y4OTVhL3RhYmxlcmFuZ2U6N2Y1MmZjZjc3ODA4NDc1YWIxNGQxYWExMmVjZjg5NWFfMTEtMy0xLTEtMA_51f17b13-9408-41d5-b42c-5a26d8e024f0"
      unitRef="usd">717000</cron:StockIssuedDuringPeriodValueTopupRightsExercised>
    <cron:StockIssuedDuringPeriodValueTopupRightsExercised
      contextRef="i4a110e4972ef4113880ce582e3cda5c5_D20200101-20200630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzY2E5YmIwMTc5MjQ3NmZiYjIyNWU1ZDlkZWM4NjlmL3NlYzo5M2NhOWJiMDE3OTI0NzZmYmIyMjVlNWQ5ZGVjODY5Zl8yMi9mcmFnOjQ0ZDZlZTY3ZmE5MDQwOWQ5NzA3MjkyYzUxNjlmNDExL3RhYmxlOjdmNTJmY2Y3NzgwODQ3NWFiMTRkMWFhMTJlY2Y4OTVhL3RhYmxlcmFuZ2U6N2Y1MmZjZjc3ODA4NDc1YWIxNGQxYWExMmVjZjg5NWFfMTEtMTUtMS0xLTA_8d81d756-3ab1-4c5e-9c89-ec73d6578778"
      unitRef="usd">717000</cron:StockIssuedDuringPeriodValueTopupRightsExercised>
    <us-gaap:ProfitLoss
      contextRef="i26b7daea50264418b7767fc75a7923c2_D20200101-20200630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzY2E5YmIwMTc5MjQ3NmZiYjIyNWU1ZDlkZWM4NjlmL3NlYzo5M2NhOWJiMDE3OTI0NzZmYmIyMjVlNWQ5ZGVjODY5Zl8yMi9mcmFnOjQ0ZDZlZTY3ZmE5MDQwOWQ5NzA3MjkyYzUxNjlmNDExL3RhYmxlOjdmNTJmY2Y3NzgwODQ3NWFiMTRkMWFhMTJlY2Y4OTVhL3RhYmxlcmFuZ2U6N2Y1MmZjZjc3ODA4NDc1YWIxNGQxYWExMmVjZjg5NWFfMTItOS0xLTEtMA_dd266eac-f551-478c-8937-fe896bf1c5b0"
      unitRef="usd">-30937000</us-gaap:ProfitLoss>
    <us-gaap:ProfitLoss
      contextRef="i7c11393ac61249f3805d21818892a170_D20200101-20200630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzY2E5YmIwMTc5MjQ3NmZiYjIyNWU1ZDlkZWM4NjlmL3NlYzo5M2NhOWJiMDE3OTI0NzZmYmIyMjVlNWQ5ZGVjODY5Zl8yMi9mcmFnOjQ0ZDZlZTY3ZmE5MDQwOWQ5NzA3MjkyYzUxNjlmNDExL3RhYmxlOjdmNTJmY2Y3NzgwODQ3NWFiMTRkMWFhMTJlY2Y4OTVhL3RhYmxlcmFuZ2U6N2Y1MmZjZjc3ODA4NDc1YWIxNGQxYWExMmVjZjg5NWFfMTItMTMtMS0xLTA_c96e9bcb-d2e0-40d7-9503-5b98fd918f3a"
      unitRef="usd">-1085000</us-gaap:ProfitLoss>
    <us-gaap:ProfitLoss
      contextRef="i4a110e4972ef4113880ce582e3cda5c5_D20200101-20200630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzY2E5YmIwMTc5MjQ3NmZiYjIyNWU1ZDlkZWM4NjlmL3NlYzo5M2NhOWJiMDE3OTI0NzZmYmIyMjVlNWQ5ZGVjODY5Zl8yMi9mcmFnOjQ0ZDZlZTY3ZmE5MDQwOWQ5NzA3MjkyYzUxNjlmNDExL3RhYmxlOjdmNTJmY2Y3NzgwODQ3NWFiMTRkMWFhMTJlY2Y4OTVhL3RhYmxlcmFuZ2U6N2Y1MmZjZjc3ODA4NDc1YWIxNGQxYWExMmVjZjg5NWFfMTItMTUtMS0xLTA_5cb5b7b2-73de-4b79-8669-0e8c407ec5b0"
      unitRef="usd">-32022000</us-gaap:ProfitLoss>
    <us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
      contextRef="ifa1d8c60d03c4b2d83a1d0b04dad4282_D20200101-20200630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzY2E5YmIwMTc5MjQ3NmZiYjIyNWU1ZDlkZWM4NjlmL3NlYzo5M2NhOWJiMDE3OTI0NzZmYmIyMjVlNWQ5ZGVjODY5Zl8yMi9mcmFnOjQ0ZDZlZTY3ZmE5MDQwOWQ5NzA3MjkyYzUxNjlmNDExL3RhYmxlOjdmNTJmY2Y3NzgwODQ3NWFiMTRkMWFhMTJlY2Y4OTVhL3RhYmxlcmFuZ2U6N2Y1MmZjZjc3ODA4NDc1YWIxNGQxYWExMmVjZjg5NWFfMTMtMTEtMS0xLTA_424673a9-809c-4ac2-a308-11384e8b0b9b"
      unitRef="usd">-61808000</us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
      contextRef="i7c11393ac61249f3805d21818892a170_D20200101-20200630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzY2E5YmIwMTc5MjQ3NmZiYjIyNWU1ZDlkZWM4NjlmL3NlYzo5M2NhOWJiMDE3OTI0NzZmYmIyMjVlNWQ5ZGVjODY5Zl8yMi9mcmFnOjQ0ZDZlZTY3ZmE5MDQwOWQ5NzA3MjkyYzUxNjlmNDExL3RhYmxlOjdmNTJmY2Y3NzgwODQ3NWFiMTRkMWFhMTJlY2Y4OTVhL3RhYmxlcmFuZ2U6N2Y1MmZjZjc3ODA4NDc1YWIxNGQxYWExMmVjZjg5NWFfMTMtMTMtMS0xLTA_b1d09f32-7057-4de8-b2fb-81324e31e287"
      unitRef="usd">-13000</us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
      contextRef="i4a110e4972ef4113880ce582e3cda5c5_D20200101-20200630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzY2E5YmIwMTc5MjQ3NmZiYjIyNWU1ZDlkZWM4NjlmL3NlYzo5M2NhOWJiMDE3OTI0NzZmYmIyMjVlNWQ5ZGVjODY5Zl8yMi9mcmFnOjQ0ZDZlZTY3ZmE5MDQwOWQ5NzA3MjkyYzUxNjlmNDExL3RhYmxlOjdmNTJmY2Y3NzgwODQ3NWFiMTRkMWFhMTJlY2Y4OTVhL3RhYmxlcmFuZ2U6N2Y1MmZjZjc3ODA4NDc1YWIxNGQxYWExMmVjZjg5NWFfMTMtMTUtMS0xLTA_57c82b48-e4f1-42f6-892a-db3d501db9ca"
      unitRef="usd">-61821000</us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax>
    <us-gaap:CommonStockSharesOutstanding
      contextRef="i7b64ecf012bd43b397dcea9317f0673b_I20200630"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzY2E5YmIwMTc5MjQ3NmZiYjIyNWU1ZDlkZWM4NjlmL3NlYzo5M2NhOWJiMDE3OTI0NzZmYmIyMjVlNWQ5ZGVjODY5Zl8yMi9mcmFnOjQ0ZDZlZTY3ZmE5MDQwOWQ5NzA3MjkyYzUxNjlmNDExL3RhYmxlOjdmNTJmY2Y3NzgwODQ3NWFiMTRkMWFhMTJlY2Y4OTVhL3RhYmxlcmFuZ2U6N2Y1MmZjZjc3ODA4NDc1YWIxNGQxYWExMmVjZjg5NWFfMTQtMS0xLTEtMA_6f6c073f-3b64-403f-a64c-1e249c6ade38"
      unitRef="shares">349886402</us-gaap:CommonStockSharesOutstanding>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i7b64ecf012bd43b397dcea9317f0673b_I20200630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzY2E5YmIwMTc5MjQ3NmZiYjIyNWU1ZDlkZWM4NjlmL3NlYzo5M2NhOWJiMDE3OTI0NzZmYmIyMjVlNWQ5ZGVjODY5Zl8yMi9mcmFnOjQ0ZDZlZTY3ZmE5MDQwOWQ5NzA3MjkyYzUxNjlmNDExL3RhYmxlOjdmNTJmY2Y3NzgwODQ3NWFiMTRkMWFhMTJlY2Y4OTVhL3RhYmxlcmFuZ2U6N2Y1MmZjZjc3ODA4NDc1YWIxNGQxYWExMmVjZjg5NWFfMTQtMy0xLTEtMA_3ab2ee4c-5879-497e-95d7-292d1dcc2dd6"
      unitRef="usd">565211000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="if06bdc9d2d5b40ca88594d8c716a000d_I20200630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzY2E5YmIwMTc5MjQ3NmZiYjIyNWU1ZDlkZWM4NjlmL3NlYzo5M2NhOWJiMDE3OTI0NzZmYmIyMjVlNWQ5ZGVjODY5Zl8yMi9mcmFnOjQ0ZDZlZTY3ZmE5MDQwOWQ5NzA3MjkyYzUxNjlmNDExL3RhYmxlOjdmNTJmY2Y3NzgwODQ3NWFiMTRkMWFhMTJlY2Y4OTVhL3RhYmxlcmFuZ2U6N2Y1MmZjZjc3ODA4NDc1YWIxNGQxYWExMmVjZjg5NWFfMTQtNy0xLTEtMA_3c037a84-7d73-4593-8408-6ad0e78dccab"
      unitRef="usd">27046000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="ibd5f91f865b44c90b9aab2e68420d292_I20200630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzY2E5YmIwMTc5MjQ3NmZiYjIyNWU1ZDlkZWM4NjlmL3NlYzo5M2NhOWJiMDE3OTI0NzZmYmIyMjVlNWQ5ZGVjODY5Zl8yMi9mcmFnOjQ0ZDZlZTY3ZmE5MDQwOWQ5NzA3MjkyYzUxNjlmNDExL3RhYmxlOjdmNTJmY2Y3NzgwODQ3NWFiMTRkMWFhMTJlY2Y4OTVhL3RhYmxlcmFuZ2U6N2Y1MmZjZjc3ODA4NDc1YWIxNGQxYWExMmVjZjg5NWFfMTQtOS0xLTEtMA_57fdcf06-62d1-48a0-b6ae-3f39596df2e6"
      unitRef="usd">1106709000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="ib7db517c67504b3baeead491589a7ed6_I20200630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzY2E5YmIwMTc5MjQ3NmZiYjIyNWU1ZDlkZWM4NjlmL3NlYzo5M2NhOWJiMDE3OTI0NzZmYmIyMjVlNWQ5ZGVjODY5Zl8yMi9mcmFnOjQ0ZDZlZTY3ZmE5MDQwOWQ5NzA3MjkyYzUxNjlmNDExL3RhYmxlOjdmNTJmY2Y3NzgwODQ3NWFiMTRkMWFhMTJlY2Y4OTVhL3RhYmxlcmFuZ2U6N2Y1MmZjZjc3ODA4NDc1YWIxNGQxYWExMmVjZjg5NWFfMTQtMTEtMS0xLTA_f5f53ba1-064a-4e27-adba-f3fe731ff7ea"
      unitRef="usd">-33970000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i87ce495c26b34c268c848a2934ad3f39_I20200630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzY2E5YmIwMTc5MjQ3NmZiYjIyNWU1ZDlkZWM4NjlmL3NlYzo5M2NhOWJiMDE3OTI0NzZmYmIyMjVlNWQ5ZGVjODY5Zl8yMi9mcmFnOjQ0ZDZlZTY3ZmE5MDQwOWQ5NzA3MjkyYzUxNjlmNDExL3RhYmxlOjdmNTJmY2Y3NzgwODQ3NWFiMTRkMWFhMTJlY2Y4OTVhL3RhYmxlcmFuZ2U6N2Y1MmZjZjc3ODA4NDc1YWIxNGQxYWExMmVjZjg5NWFfMTQtMTMtMS0xLTA_f4f65394-2bbf-4931-8922-0ad73fbe9ea6"
      unitRef="usd">-1951000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="id670dc9b33e6430f9d7510009f7495a7_I20200630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzY2E5YmIwMTc5MjQ3NmZiYjIyNWU1ZDlkZWM4NjlmL3NlYzo5M2NhOWJiMDE3OTI0NzZmYmIyMjVlNWQ5ZGVjODY5Zl8yMi9mcmFnOjQ0ZDZlZTY3ZmE5MDQwOWQ5NzA3MjkyYzUxNjlmNDExL3RhYmxlOjdmNTJmY2Y3NzgwODQ3NWFiMTRkMWFhMTJlY2Y4OTVhL3RhYmxlcmFuZ2U6N2Y1MmZjZjc3ODA4NDc1YWIxNGQxYWExMmVjZjg5NWFfMTQtMTUtMS0xLTA_6afc9cc0-c3c8-4d59-9aab-09ed61a07df1"
      unitRef="usd">1663045000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:ProfitLoss
      contextRef="i69782326f71a44e3805518280ee22b6b_D20210101-20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzY2E5YmIwMTc5MjQ3NmZiYjIyNWU1ZDlkZWM4NjlmL3NlYzo5M2NhOWJiMDE3OTI0NzZmYmIyMjVlNWQ5ZGVjODY5Zl8yOC9mcmFnOjBmMzU2YWJkNmM5MzQyY2JhM2ZlYzVkNWUzMzA4NzZkL3RhYmxlOmMwM2NjYzgzMmYwMDQxNTlhYjIzZDc4NDg5NThhMzI5L3RhYmxlcmFuZ2U6YzAzY2NjODMyZjAwNDE1OWFiMjNkNzg0ODk1OGEzMjlfMy0xLTEtMS0w_d51ad10f-10e1-4beb-b701-b4325712b6ed"
      unitRef="usd">-104850000</us-gaap:ProfitLoss>
    <us-gaap:ProfitLoss
      contextRef="i4a110e4972ef4113880ce582e3cda5c5_D20200101-20200630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzY2E5YmIwMTc5MjQ3NmZiYjIyNWU1ZDlkZWM4NjlmL3NlYzo5M2NhOWJiMDE3OTI0NzZmYmIyMjVlNWQ5ZGVjODY5Zl8yOC9mcmFnOjBmMzU2YWJkNmM5MzQyY2JhM2ZlYzVkNWUzMzA4NzZkL3RhYmxlOmMwM2NjYzgzMmYwMDQxNTlhYjIzZDc4NDg5NThhMzI5L3RhYmxlcmFuZ2U6YzAzY2NjODMyZjAwNDE1OWFiMjNkNzg0ODk1OGEzMjlfMy0zLTEtMS0w_3c0743eb-254f-42b5-a6c3-58082850153e"
      unitRef="usd">-32022000</us-gaap:ProfitLoss>
    <us-gaap:ShareBasedCompensation
      contextRef="i69782326f71a44e3805518280ee22b6b_D20210101-20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzY2E5YmIwMTc5MjQ3NmZiYjIyNWU1ZDlkZWM4NjlmL3NlYzo5M2NhOWJiMDE3OTI0NzZmYmIyMjVlNWQ5ZGVjODY5Zl8yOC9mcmFnOjBmMzU2YWJkNmM5MzQyY2JhM2ZlYzVkNWUzMzA4NzZkL3RhYmxlOmMwM2NjYzgzMmYwMDQxNTlhYjIzZDc4NDg5NThhMzI5L3RhYmxlcmFuZ2U6YzAzY2NjODMyZjAwNDE1OWFiMjNkNzg0ODk1OGEzMjlfNi0xLTEtMS0w_be0b1830-7b5f-4d18-a9f4-83d45608f2ec"
      unitRef="usd">5064000</us-gaap:ShareBasedCompensation>
    <us-gaap:ShareBasedCompensation
      contextRef="i4a110e4972ef4113880ce582e3cda5c5_D20200101-20200630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzY2E5YmIwMTc5MjQ3NmZiYjIyNWU1ZDlkZWM4NjlmL3NlYzo5M2NhOWJiMDE3OTI0NzZmYmIyMjVlNWQ5ZGVjODY5Zl8yOC9mcmFnOjBmMzU2YWJkNmM5MzQyY2JhM2ZlYzVkNWUzMzA4NzZkL3RhYmxlOmMwM2NjYzgzMmYwMDQxNTlhYjIzZDc4NDg5NThhMzI5L3RhYmxlcmFuZ2U6YzAzY2NjODMyZjAwNDE1OWFiMjNkNzg0ODk1OGEzMjlfNi0zLTEtMS0w_2001feb1-7696-4b1a-9b51-55d3c38ce467"
      unitRef="usd">4982000</us-gaap:ShareBasedCompensation>
    <us-gaap:DepreciationDepletionAndAmortization
      contextRef="i69782326f71a44e3805518280ee22b6b_D20210101-20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzY2E5YmIwMTc5MjQ3NmZiYjIyNWU1ZDlkZWM4NjlmL3NlYzo5M2NhOWJiMDE3OTI0NzZmYmIyMjVlNWQ5ZGVjODY5Zl8yOC9mcmFnOjBmMzU2YWJkNmM5MzQyY2JhM2ZlYzVkNWUzMzA4NzZkL3RhYmxlOmMwM2NjYzgzMmYwMDQxNTlhYjIzZDc4NDg5NThhMzI5L3RhYmxlcmFuZ2U6YzAzY2NjODMyZjAwNDE1OWFiMjNkNzg0ODk1OGEzMjlfNy0xLTEtMS0w_01546127-9ae4-4194-8158-e986a74a049e"
      unitRef="usd">5083000</us-gaap:DepreciationDepletionAndAmortization>
    <us-gaap:DepreciationDepletionAndAmortization
      contextRef="i4a110e4972ef4113880ce582e3cda5c5_D20200101-20200630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzY2E5YmIwMTc5MjQ3NmZiYjIyNWU1ZDlkZWM4NjlmL3NlYzo5M2NhOWJiMDE3OTI0NzZmYmIyMjVlNWQ5ZGVjODY5Zl8yOC9mcmFnOjBmMzU2YWJkNmM5MzQyY2JhM2ZlYzVkNWUzMzA4NzZkL3RhYmxlOmMwM2NjYzgzMmYwMDQxNTlhYjIzZDc4NDg5NThhMzI5L3RhYmxlcmFuZ2U6YzAzY2NjODMyZjAwNDE1OWFiMjNkNzg0ODk1OGEzMjlfNy0zLTEtMS0w_65889e10-7331-459a-9b81-25c304b127ff"
      unitRef="usd">2879000</us-gaap:DepreciationDepletionAndAmortization>
    <us-gaap:IncomeLossFromEquityMethodInvestments
      contextRef="i69782326f71a44e3805518280ee22b6b_D20210101-20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzY2E5YmIwMTc5MjQ3NmZiYjIyNWU1ZDlkZWM4NjlmL3NlYzo5M2NhOWJiMDE3OTI0NzZmYmIyMjVlNWQ5ZGVjODY5Zl8yOC9mcmFnOjBmMzU2YWJkNmM5MzQyY2JhM2ZlYzVkNWUzMzA4NzZkL3RhYmxlOmMwM2NjYzgzMmYwMDQxNTlhYjIzZDc4NDg5NThhMzI5L3RhYmxlcmFuZ2U6YzAzY2NjODMyZjAwNDE1OWFiMjNkNzg0ODk1OGEzMjlfOC0xLTEtMS00NDEw_67411db9-bad7-42cc-ba3d-8d5b1fd52132"
      unitRef="usd">-2758000</us-gaap:IncomeLossFromEquityMethodInvestments>
    <us-gaap:IncomeLossFromEquityMethodInvestments
      contextRef="i4a110e4972ef4113880ce582e3cda5c5_D20200101-20200630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzY2E5YmIwMTc5MjQ3NmZiYjIyNWU1ZDlkZWM4NjlmL3NlYzo5M2NhOWJiMDE3OTI0NzZmYmIyMjVlNWQ5ZGVjODY5Zl8yOC9mcmFnOjBmMzU2YWJkNmM5MzQyY2JhM2ZlYzVkNWUzMzA4NzZkL3RhYmxlOmMwM2NjYzgzMmYwMDQxNTlhYjIzZDc4NDg5NThhMzI5L3RhYmxlcmFuZ2U6YzAzY2NjODMyZjAwNDE1OWFiMjNkNzg0ODk1OGEzMjlfOC0zLTEtMS00NDEw_a00235f1-96d8-496d-a82b-14ee832a2e94"
      unitRef="usd">-1966000</us-gaap:IncomeLossFromEquityMethodInvestments>
    <us-gaap:GainLossOnDerivativeInstrumentsNetPretax
      contextRef="i69782326f71a44e3805518280ee22b6b_D20210101-20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzY2E5YmIwMTc5MjQ3NmZiYjIyNWU1ZDlkZWM4NjlmL3NlYzo5M2NhOWJiMDE3OTI0NzZmYmIyMjVlNWQ5ZGVjODY5Zl8yOC9mcmFnOjBmMzU2YWJkNmM5MzQyY2JhM2ZlYzVkNWUzMzA4NzZkL3RhYmxlOmMwM2NjYzgzMmYwMDQxNTlhYjIzZDc4NDg5NThhMzI5L3RhYmxlcmFuZ2U6YzAzY2NjODMyZjAwNDE1OWFiMjNkNzg0ODk1OGEzMjlfOC0xLTEtMS0w_d5ff912b-2fdb-40fc-84a9-8aa091b100de"
      unitRef="usd">-1626000</us-gaap:GainLossOnDerivativeInstrumentsNetPretax>
    <us-gaap:GainLossOnDerivativeInstrumentsNetPretax
      contextRef="i4a110e4972ef4113880ce582e3cda5c5_D20200101-20200630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzY2E5YmIwMTc5MjQ3NmZiYjIyNWU1ZDlkZWM4NjlmL3NlYzo5M2NhOWJiMDE3OTI0NzZmYmIyMjVlNWQ5ZGVjODY5Zl8yOC9mcmFnOjBmMzU2YWJkNmM5MzQyY2JhM2ZlYzVkNWUzMzA4NzZkL3RhYmxlOmMwM2NjYzgzMmYwMDQxNTlhYjIzZDc4NDg5NThhMzI5L3RhYmxlcmFuZ2U6YzAzY2NjODMyZjAwNDE1OWFiMjNkNzg0ODk1OGEzMjlfOC0zLTEtMS0w_87d8870d-5673-42c1-a560-02e81bc1743d"
      unitRef="usd">77488000</us-gaap:GainLossOnDerivativeInstrumentsNetPretax>
    <us-gaap:AssetImpairmentCharges
      contextRef="i69782326f71a44e3805518280ee22b6b_D20210101-20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzY2E5YmIwMTc5MjQ3NmZiYjIyNWU1ZDlkZWM4NjlmL3NlYzo5M2NhOWJiMDE3OTI0NzZmYmIyMjVlNWQ5ZGVjODY5Zl8yOC9mcmFnOjBmMzU2YWJkNmM5MzQyY2JhM2ZlYzVkNWUzMzA4NzZkL3RhYmxlOmMwM2NjYzgzMmYwMDQxNTlhYjIzZDc4NDg5NThhMzI5L3RhYmxlcmFuZ2U6YzAzY2NjODMyZjAwNDE1OWFiMjNkNzg0ODk1OGEzMjlfMTEtMS0xLTEtNzQ1_7279763f-ffe8-4c83-94e0-105df3345037"
      unitRef="usd">1741000</us-gaap:AssetImpairmentCharges>
    <us-gaap:AssetImpairmentCharges
      contextRef="i4a110e4972ef4113880ce582e3cda5c5_D20200101-20200630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzY2E5YmIwMTc5MjQ3NmZiYjIyNWU1ZDlkZWM4NjlmL3NlYzo5M2NhOWJiMDE3OTI0NzZmYmIyMjVlNWQ5ZGVjODY5Zl8yOC9mcmFnOjBmMzU2YWJkNmM5MzQyY2JhM2ZlYzVkNWUzMzA4NzZkL3RhYmxlOmMwM2NjYzgzMmYwMDQxNTlhYjIzZDc4NDg5NThhMzI5L3RhYmxlcmFuZ2U6YzAzY2NjODMyZjAwNDE1OWFiMjNkNzg0ODk1OGEzMjlfMTEtMy0xLTEtNzQ5_9fc3b0a9-7764-4bde-8a1f-10a1070bca39"
      unitRef="usd">40000000</us-gaap:AssetImpairmentCharges>
    <us-gaap:ProvisionForDoubtfulAccounts
      contextRef="i69782326f71a44e3805518280ee22b6b_D20210101-20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzY2E5YmIwMTc5MjQ3NmZiYjIyNWU1ZDlkZWM4NjlmL3NlYzo5M2NhOWJiMDE3OTI0NzZmYmIyMjVlNWQ5ZGVjODY5Zl8yOC9mcmFnOjBmMzU2YWJkNmM5MzQyY2JhM2ZlYzVkNWUzMzA4NzZkL3RhYmxlOmMwM2NjYzgzMmYwMDQxNTlhYjIzZDc4NDg5NThhMzI5L3RhYmxlcmFuZ2U6YzAzY2NjODMyZjAwNDE1OWFiMjNkNzg0ODk1OGEzMjlfMTAtMS0xLTEtMA_ee258a8f-f8a7-4776-8b81-d31a6dfa8def"
      unitRef="usd">0</us-gaap:ProvisionForDoubtfulAccounts>
    <us-gaap:ProvisionForDoubtfulAccounts
      contextRef="i4a110e4972ef4113880ce582e3cda5c5_D20200101-20200630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzY2E5YmIwMTc5MjQ3NmZiYjIyNWU1ZDlkZWM4NjlmL3NlYzo5M2NhOWJiMDE3OTI0NzZmYmIyMjVlNWQ5ZGVjODY5Zl8yOC9mcmFnOjBmMzU2YWJkNmM5MzQyY2JhM2ZlYzVkNWUzMzA4NzZkL3RhYmxlOmMwM2NjYzgzMmYwMDQxNTlhYjIzZDc4NDg5NThhMzI5L3RhYmxlcmFuZ2U6YzAzY2NjODMyZjAwNDE1OWFiMjNkNzg0ODk1OGEzMjlfMTAtMy0xLTEtMA_6757f255-6d80-4358-ae21-a9d5f9a0f89b"
      unitRef="usd">1357000</us-gaap:ProvisionForDoubtfulAccounts>
    <us-gaap:OtherNoncashIncomeExpense
      contextRef="i69782326f71a44e3805518280ee22b6b_D20210101-20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzY2E5YmIwMTc5MjQ3NmZiYjIyNWU1ZDlkZWM4NjlmL3NlYzo5M2NhOWJiMDE3OTI0NzZmYmIyMjVlNWQ5ZGVjODY5Zl8yOC9mcmFnOjBmMzU2YWJkNmM5MzQyY2JhM2ZlYzVkNWUzMzA4NzZkL3RhYmxlOmMwM2NjYzgzMmYwMDQxNTlhYjIzZDc4NDg5NThhMzI5L3RhYmxlcmFuZ2U6YzAzY2NjODMyZjAwNDE1OWFiMjNkNzg0ODk1OGEzMjlfMTEtMS0xLTEtMA_45a22630-4b05-45ec-a7e8-52745ef7666d"
      unitRef="usd">1192000</us-gaap:OtherNoncashIncomeExpense>
    <us-gaap:OtherNoncashIncomeExpense
      contextRef="i4a110e4972ef4113880ce582e3cda5c5_D20200101-20200630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzY2E5YmIwMTc5MjQ3NmZiYjIyNWU1ZDlkZWM4NjlmL3NlYzo5M2NhOWJiMDE3OTI0NzZmYmIyMjVlNWQ5ZGVjODY5Zl8yOC9mcmFnOjBmMzU2YWJkNmM5MzQyY2JhM2ZlYzVkNWUzMzA4NzZkL3RhYmxlOmMwM2NjYzgzMmYwMDQxNTlhYjIzZDc4NDg5NThhMzI5L3RhYmxlcmFuZ2U6YzAzY2NjODMyZjAwNDE1OWFiMjNkNzg0ODk1OGEzMjlfMTEtMy0xLTEtMA_365c3c27-15c9-482c-974d-2c4677ab7c1e"
      unitRef="usd">-599000</us-gaap:OtherNoncashIncomeExpense>
    <us-gaap:IncreaseDecreaseInAccountsReceivable
      contextRef="i69782326f71a44e3805518280ee22b6b_D20210101-20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzY2E5YmIwMTc5MjQ3NmZiYjIyNWU1ZDlkZWM4NjlmL3NlYzo5M2NhOWJiMDE3OTI0NzZmYmIyMjVlNWQ5ZGVjODY5Zl8yOC9mcmFnOjBmMzU2YWJkNmM5MzQyY2JhM2ZlYzVkNWUzMzA4NzZkL3RhYmxlOmMwM2NjYzgzMmYwMDQxNTlhYjIzZDc4NDg5NThhMzI5L3RhYmxlcmFuZ2U6YzAzY2NjODMyZjAwNDE1OWFiMjNkNzg0ODk1OGEzMjlfMTMtMS0xLTEtMA_0b21eec6-5aaa-410d-8c51-f044ce953e40"
      unitRef="usd">2194000</us-gaap:IncreaseDecreaseInAccountsReceivable>
    <us-gaap:IncreaseDecreaseInAccountsReceivable
      contextRef="i4a110e4972ef4113880ce582e3cda5c5_D20200101-20200630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzY2E5YmIwMTc5MjQ3NmZiYjIyNWU1ZDlkZWM4NjlmL3NlYzo5M2NhOWJiMDE3OTI0NzZmYmIyMjVlNWQ5ZGVjODY5Zl8yOC9mcmFnOjBmMzU2YWJkNmM5MzQyY2JhM2ZlYzVkNWUzMzA4NzZkL3RhYmxlOmMwM2NjYzgzMmYwMDQxNTlhYjIzZDc4NDg5NThhMzI5L3RhYmxlcmFuZ2U6YzAzY2NjODMyZjAwNDE1OWFiMjNkNzg0ODk1OGEzMjlfMTMtMy0xLTEtMA_f9bfa8f5-556d-453e-bf65-e26efc774e3d"
      unitRef="usd">-2895000</us-gaap:IncreaseDecreaseInAccountsReceivable>
    <us-gaap:IncreaseDecreaseInOtherReceivables
      contextRef="i69782326f71a44e3805518280ee22b6b_D20210101-20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzY2E5YmIwMTc5MjQ3NmZiYjIyNWU1ZDlkZWM4NjlmL3NlYzo5M2NhOWJiMDE3OTI0NzZmYmIyMjVlNWQ5ZGVjODY5Zl8yOC9mcmFnOjBmMzU2YWJkNmM5MzQyY2JhM2ZlYzVkNWUzMzA4NzZkL3RhYmxlOmMwM2NjYzgzMmYwMDQxNTlhYjIzZDc4NDg5NThhMzI5L3RhYmxlcmFuZ2U6YzAzY2NjODMyZjAwNDE1OWFiMjNkNzg0ODk1OGEzMjlfMTQtMS0xLTEtMA_c79e36bd-f0b2-43a6-a14c-31b5424aa9df"
      unitRef="usd">-6960000</us-gaap:IncreaseDecreaseInOtherReceivables>
    <us-gaap:IncreaseDecreaseInOtherReceivables
      contextRef="i4a110e4972ef4113880ce582e3cda5c5_D20200101-20200630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzY2E5YmIwMTc5MjQ3NmZiYjIyNWU1ZDlkZWM4NjlmL3NlYzo5M2NhOWJiMDE3OTI0NzZmYmIyMjVlNWQ5ZGVjODY5Zl8yOC9mcmFnOjBmMzU2YWJkNmM5MzQyY2JhM2ZlYzVkNWUzMzA4NzZkL3RhYmxlOmMwM2NjYzgzMmYwMDQxNTlhYjIzZDc4NDg5NThhMzI5L3RhYmxlcmFuZ2U6YzAzY2NjODMyZjAwNDE1OWFiMjNkNzg0ODk1OGEzMjlfMTQtMy0xLTEtMA_aaa720c7-7d6d-4c94-a0bc-81ef49d6446d"
      unitRef="usd">3047000</us-gaap:IncreaseDecreaseInOtherReceivables>
    <us-gaap:IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
      contextRef="i69782326f71a44e3805518280ee22b6b_D20210101-20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzY2E5YmIwMTc5MjQ3NmZiYjIyNWU1ZDlkZWM4NjlmL3NlYzo5M2NhOWJiMDE3OTI0NzZmYmIyMjVlNWQ5ZGVjODY5Zl8yOC9mcmFnOjBmMzU2YWJkNmM5MzQyY2JhM2ZlYzVkNWUzMzA4NzZkL3RhYmxlOmMwM2NjYzgzMmYwMDQxNTlhYjIzZDc4NDg5NThhMzI5L3RhYmxlcmFuZ2U6YzAzY2NjODMyZjAwNDE1OWFiMjNkNzg0ODk1OGEzMjlfMTUtMS0xLTEtMA_1ef39fd3-2e42-4b88-86c9-c9859812f401"
      unitRef="usd">-1268000</us-gaap:IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets>
    <us-gaap:IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
      contextRef="i4a110e4972ef4113880ce582e3cda5c5_D20200101-20200630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzY2E5YmIwMTc5MjQ3NmZiYjIyNWU1ZDlkZWM4NjlmL3NlYzo5M2NhOWJiMDE3OTI0NzZmYmIyMjVlNWQ5ZGVjODY5Zl8yOC9mcmFnOjBmMzU2YWJkNmM5MzQyY2JhM2ZlYzVkNWUzMzA4NzZkL3RhYmxlOmMwM2NjYzgzMmYwMDQxNTlhYjIzZDc4NDg5NThhMzI5L3RhYmxlcmFuZ2U6YzAzY2NjODMyZjAwNDE1OWFiMjNkNzg0ODk1OGEzMjlfMTUtMy0xLTEtMA_f2260a37-8a3c-4535-afbd-7cd1177afd33"
      unitRef="usd">-1187000</us-gaap:IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets>
    <us-gaap:IncreaseDecreaseInInventories
      contextRef="i69782326f71a44e3805518280ee22b6b_D20210101-20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzY2E5YmIwMTc5MjQ3NmZiYjIyNWU1ZDlkZWM4NjlmL3NlYzo5M2NhOWJiMDE3OTI0NzZmYmIyMjVlNWQ5ZGVjODY5Zl8yOC9mcmFnOjBmMzU2YWJkNmM5MzQyY2JhM2ZlYzVkNWUzMzA4NzZkL3RhYmxlOmMwM2NjYzgzMmYwMDQxNTlhYjIzZDc4NDg5NThhMzI5L3RhYmxlcmFuZ2U6YzAzY2NjODMyZjAwNDE1OWFiMjNkNzg0ODk1OGEzMjlfMTctMS0xLTEtMTkyOTg_75c7bbcb-1eb6-4e8d-8768-f8dde5e80ca3"
      unitRef="usd">1010000</us-gaap:IncreaseDecreaseInInventories>
    <us-gaap:IncreaseDecreaseInInventories
      contextRef="i4a110e4972ef4113880ce582e3cda5c5_D20200101-20200630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzY2E5YmIwMTc5MjQ3NmZiYjIyNWU1ZDlkZWM4NjlmL3NlYzo5M2NhOWJiMDE3OTI0NzZmYmIyMjVlNWQ5ZGVjODY5Zl8yOC9mcmFnOjBmMzU2YWJkNmM5MzQyY2JhM2ZlYzVkNWUzMzA4NzZkL3RhYmxlOmMwM2NjYzgzMmYwMDQxNTlhYjIzZDc4NDg5NThhMzI5L3RhYmxlcmFuZ2U6YzAzY2NjODMyZjAwNDE1OWFiMjNkNzg0ODk1OGEzMjlfMTctMy0xLTEtMTkyOTg_e925392c-2060-4b8c-a15b-5a847cc31d89"
      unitRef="usd">24292000</us-gaap:IncreaseDecreaseInInventories>
    <us-gaap:InventoryWriteDown
      contextRef="i69782326f71a44e3805518280ee22b6b_D20210101-20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzY2E5YmIwMTc5MjQ3NmZiYjIyNWU1ZDlkZWM4NjlmL3NlYzo5M2NhOWJiMDE3OTI0NzZmYmIyMjVlNWQ5ZGVjODY5Zl8yOC9mcmFnOjBmMzU2YWJkNmM5MzQyY2JhM2ZlYzVkNWUzMzA4NzZkL3RhYmxlOmMwM2NjYzgzMmYwMDQxNTlhYjIzZDc4NDg5NThhMzI5L3RhYmxlcmFuZ2U6YzAzY2NjODMyZjAwNDE1OWFiMjNkNzg0ODk1OGEzMjlfMTYtMS0xLTEtMA_4f7db48a-7e4d-460d-9094-fe8b741d1e2a"
      unitRef="usd">11961000</us-gaap:InventoryWriteDown>
    <us-gaap:InventoryWriteDown
      contextRef="i4a110e4972ef4113880ce582e3cda5c5_D20200101-20200630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzY2E5YmIwMTc5MjQ3NmZiYjIyNWU1ZDlkZWM4NjlmL3NlYzo5M2NhOWJiMDE3OTI0NzZmYmIyMjVlNWQ5ZGVjODY5Zl8yOC9mcmFnOjBmMzU2YWJkNmM5MzQyY2JhM2ZlYzVkNWUzMzA4NzZkL3RhYmxlOmMwM2NjYzgzMmYwMDQxNTlhYjIzZDc4NDg5NThhMzI5L3RhYmxlcmFuZ2U6YzAzY2NjODMyZjAwNDE1OWFiMjNkNzg0ODk1OGEzMjlfMTYtMy0xLTEtMA_06a8c857-dce8-4dd1-aad1-81a9486757a6"
      unitRef="usd">11024000</us-gaap:InventoryWriteDown>
    <us-gaap:IncreaseDecreaseInAccountsPayableAndOtherOperatingLiabilities
      contextRef="i69782326f71a44e3805518280ee22b6b_D20210101-20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzY2E5YmIwMTc5MjQ3NmZiYjIyNWU1ZDlkZWM4NjlmL3NlYzo5M2NhOWJiMDE3OTI0NzZmYmIyMjVlNWQ5ZGVjODY5Zl8yOC9mcmFnOjBmMzU2YWJkNmM5MzQyY2JhM2ZlYzVkNWUzMzA4NzZkL3RhYmxlOmMwM2NjYzgzMmYwMDQxNTlhYjIzZDc4NDg5NThhMzI5L3RhYmxlcmFuZ2U6YzAzY2NjODMyZjAwNDE1OWFiMjNkNzg0ODk1OGEzMjlfMTctMS0xLTEtMA_7fa2a5e3-57b0-4b18-845c-a8ddd339a10b"
      unitRef="usd">-13412000</us-gaap:IncreaseDecreaseInAccountsPayableAndOtherOperatingLiabilities>
    <us-gaap:IncreaseDecreaseInAccountsPayableAndOtherOperatingLiabilities
      contextRef="i4a110e4972ef4113880ce582e3cda5c5_D20200101-20200630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzY2E5YmIwMTc5MjQ3NmZiYjIyNWU1ZDlkZWM4NjlmL3NlYzo5M2NhOWJiMDE3OTI0NzZmYmIyMjVlNWQ5ZGVjODY5Zl8yOC9mcmFnOjBmMzU2YWJkNmM5MzQyY2JhM2ZlYzVkNWUzMzA4NzZkL3RhYmxlOmMwM2NjYzgzMmYwMDQxNTlhYjIzZDc4NDg5NThhMzI5L3RhYmxlcmFuZ2U6YzAzY2NjODMyZjAwNDE1OWFiMjNkNzg0ODk1OGEzMjlfMTctMy0xLTEtMA_f40ef65c-109d-4fc7-bc9f-e4fc39fe6122"
      unitRef="usd">-8417000</us-gaap:IncreaseDecreaseInAccountsPayableAndOtherOperatingLiabilities>
    <us-gaap:NetCashProvidedByUsedInOperatingActivities
      contextRef="i69782326f71a44e3805518280ee22b6b_D20210101-20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzY2E5YmIwMTc5MjQ3NmZiYjIyNWU1ZDlkZWM4NjlmL3NlYzo5M2NhOWJiMDE3OTI0NzZmYmIyMjVlNWQ5ZGVjODY5Zl8yOC9mcmFnOjBmMzU2YWJkNmM5MzQyY2JhM2ZlYzVkNWUzMzA4NzZkL3RhYmxlOmMwM2NjYzgzMmYwMDQxNTlhYjIzZDc4NDg5NThhMzI5L3RhYmxlcmFuZ2U6YzAzY2NjODMyZjAwNDE1OWFiMjNkNzg0ODk1OGEzMjlfMTgtMS0xLTEtMA_799348f1-6bbc-4051-b8a0-94c93e99c899"
      unitRef="usd">-86197000</us-gaap:NetCashProvidedByUsedInOperatingActivities>
    <us-gaap:NetCashProvidedByUsedInOperatingActivities
      contextRef="i4a110e4972ef4113880ce582e3cda5c5_D20200101-20200630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzY2E5YmIwMTc5MjQ3NmZiYjIyNWU1ZDlkZWM4NjlmL3NlYzo5M2NhOWJiMDE3OTI0NzZmYmIyMjVlNWQ5ZGVjODY5Zl8yOC9mcmFnOjBmMzU2YWJkNmM5MzQyY2JhM2ZlYzVkNWUzMzA4NzZkL3RhYmxlOmMwM2NjYzgzMmYwMDQxNTlhYjIzZDc4NDg5NThhMzI5L3RhYmxlcmFuZ2U6YzAzY2NjODMyZjAwNDE1OWFiMjNkNzg0ODk1OGEzMjlfMTgtMy0xLTEtMA_9a9770ad-6eb4-4337-959e-bf1d24bce191"
      unitRef="usd">-78377000</us-gaap:NetCashProvidedByUsedInOperatingActivities>
    <us-gaap:PaymentsToAcquireMarketableSecurities
      contextRef="i69782326f71a44e3805518280ee22b6b_D20210101-20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzY2E5YmIwMTc5MjQ3NmZiYjIyNWU1ZDlkZWM4NjlmL3NlYzo5M2NhOWJiMDE3OTI0NzZmYmIyMjVlNWQ5ZGVjODY5Zl8yOC9mcmFnOjBmMzU2YWJkNmM5MzQyY2JhM2ZlYzVkNWUzMzA4NzZkL3RhYmxlOmMwM2NjYzgzMmYwMDQxNTlhYjIzZDc4NDg5NThhMzI5L3RhYmxlcmFuZ2U6YzAzY2NjODMyZjAwNDE1OWFiMjNkNzg0ODk1OGEzMjlfMjAtMS0xLTEtMA_529156e6-ad27-46b9-be0e-77a2c8ec615f"
      unitRef="usd">120180000</us-gaap:PaymentsToAcquireMarketableSecurities>
    <us-gaap:PaymentsToAcquireMarketableSecurities
      contextRef="i4a110e4972ef4113880ce582e3cda5c5_D20200101-20200630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzY2E5YmIwMTc5MjQ3NmZiYjIyNWU1ZDlkZWM4NjlmL3NlYzo5M2NhOWJiMDE3OTI0NzZmYmIyMjVlNWQ5ZGVjODY5Zl8yOC9mcmFnOjBmMzU2YWJkNmM5MzQyY2JhM2ZlYzVkNWUzMzA4NzZkL3RhYmxlOmMwM2NjYzgzMmYwMDQxNTlhYjIzZDc4NDg5NThhMzI5L3RhYmxlcmFuZ2U6YzAzY2NjODMyZjAwNDE1OWFiMjNkNzg0ODk1OGEzMjlfMjAtMy0xLTEtMA_64554e89-ffe9-4867-8099-bb60ceb3e6c1"
      unitRef="usd">200173000</us-gaap:PaymentsToAcquireMarketableSecurities>
    <us-gaap:ProceedsFromSaleAndMaturityOfMarketableSecurities
      contextRef="i69782326f71a44e3805518280ee22b6b_D20210101-20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzY2E5YmIwMTc5MjQ3NmZiYjIyNWU1ZDlkZWM4NjlmL3NlYzo5M2NhOWJiMDE3OTI0NzZmYmIyMjVlNWQ5ZGVjODY5Zl8yOC9mcmFnOjBmMzU2YWJkNmM5MzQyY2JhM2ZlYzVkNWUzMzA4NzZkL3RhYmxlOmMwM2NjYzgzMmYwMDQxNTlhYjIzZDc4NDg5NThhMzI5L3RhYmxlcmFuZ2U6YzAzY2NjODMyZjAwNDE1OWFiMjNkNzg0ODk1OGEzMjlfMjItMS0xLTEtMTU4MDE_02074cca-13f6-4322-9bb6-e66ee25753d8"
      unitRef="usd">136204000</us-gaap:ProceedsFromSaleAndMaturityOfMarketableSecurities>
    <us-gaap:ProceedsFromSaleAndMaturityOfMarketableSecurities
      contextRef="i4a110e4972ef4113880ce582e3cda5c5_D20200101-20200630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzY2E5YmIwMTc5MjQ3NmZiYjIyNWU1ZDlkZWM4NjlmL3NlYzo5M2NhOWJiMDE3OTI0NzZmYmIyMjVlNWQ5ZGVjODY5Zl8yOC9mcmFnOjBmMzU2YWJkNmM5MzQyY2JhM2ZlYzVkNWUzMzA4NzZkL3RhYmxlOmMwM2NjYzgzMmYwMDQxNTlhYjIzZDc4NDg5NThhMzI5L3RhYmxlcmFuZ2U6YzAzY2NjODMyZjAwNDE1OWFiMjNkNzg0ODk1OGEzMjlfMjItMy0xLTEtMTU4MDE_903c357f-a0ad-4c4d-bd59-465033f29fc4"
      unitRef="usd">279275000</us-gaap:ProceedsFromSaleAndMaturityOfMarketableSecurities>
    <us-gaap:PaymentsToAcquireOtherInvestments
      contextRef="i69782326f71a44e3805518280ee22b6b_D20210101-20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzY2E5YmIwMTc5MjQ3NmZiYjIyNWU1ZDlkZWM4NjlmL3NlYzo5M2NhOWJiMDE3OTI0NzZmYmIyMjVlNWQ5ZGVjODY5Zl8yOC9mcmFnOjBmMzU2YWJkNmM5MzQyY2JhM2ZlYzVkNWUzMzA4NzZkL3RhYmxlOmMwM2NjYzgzMmYwMDQxNTlhYjIzZDc4NDg5NThhMzI5L3RhYmxlcmFuZ2U6YzAzY2NjODMyZjAwNDE1OWFiMjNkNzg0ODk1OGEzMjlfMjMtMS0xLTEtMTU4MDE_32b03a11-c09d-431a-8395-a4bca0ab0e85"
      unitRef="usd">110392000</us-gaap:PaymentsToAcquireOtherInvestments>
    <us-gaap:PaymentsToAcquireOtherInvestments
      contextRef="i4a110e4972ef4113880ce582e3cda5c5_D20200101-20200630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzY2E5YmIwMTc5MjQ3NmZiYjIyNWU1ZDlkZWM4NjlmL3NlYzo5M2NhOWJiMDE3OTI0NzZmYmIyMjVlNWQ5ZGVjODY5Zl8yOC9mcmFnOjBmMzU2YWJkNmM5MzQyY2JhM2ZlYzVkNWUzMzA4NzZkL3RhYmxlOmMwM2NjYzgzMmYwMDQxNTlhYjIzZDc4NDg5NThhMzI5L3RhYmxlcmFuZ2U6YzAzY2NjODMyZjAwNDE1OWFiMjNkNzg0ODk1OGEzMjlfMjMtMy0xLTEtMTU4MDE_73eabb7b-3aaf-477a-b948-be7edc66bc6e"
      unitRef="usd">0</us-gaap:PaymentsToAcquireOtherInvestments>
    <us-gaap:PaymentsToAcquirePropertyPlantAndEquipment
      contextRef="i69782326f71a44e3805518280ee22b6b_D20210101-20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzY2E5YmIwMTc5MjQ3NmZiYjIyNWU1ZDlkZWM4NjlmL3NlYzo5M2NhOWJiMDE3OTI0NzZmYmIyMjVlNWQ5ZGVjODY5Zl8yOC9mcmFnOjBmMzU2YWJkNmM5MzQyY2JhM2ZlYzVkNWUzMzA4NzZkL3RhYmxlOmMwM2NjYzgzMmYwMDQxNTlhYjIzZDc4NDg5NThhMzI5L3RhYmxlcmFuZ2U6YzAzY2NjODMyZjAwNDE1OWFiMjNkNzg0ODk1OGEzMjlfMjEtMS0xLTEtMA_8752a128-10a0-4b4a-b146-1f196f0e4dc5"
      unitRef="usd">8347000</us-gaap:PaymentsToAcquirePropertyPlantAndEquipment>
    <us-gaap:PaymentsToAcquirePropertyPlantAndEquipment
      contextRef="i4a110e4972ef4113880ce582e3cda5c5_D20200101-20200630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzY2E5YmIwMTc5MjQ3NmZiYjIyNWU1ZDlkZWM4NjlmL3NlYzo5M2NhOWJiMDE3OTI0NzZmYmIyMjVlNWQ5ZGVjODY5Zl8yOC9mcmFnOjBmMzU2YWJkNmM5MzQyY2JhM2ZlYzVkNWUzMzA4NzZkL3RhYmxlOmMwM2NjYzgzMmYwMDQxNTlhYjIzZDc4NDg5NThhMzI5L3RhYmxlcmFuZ2U6YzAzY2NjODMyZjAwNDE1OWFiMjNkNzg0ODk1OGEzMjlfMjEtMy0xLTEtMA_3fb45069-0d58-4f2d-b821-954139aa3d35"
      unitRef="usd">13344000</us-gaap:PaymentsToAcquirePropertyPlantAndEquipment>
    <us-gaap:PaymentsToAcquireIntangibleAssets
      contextRef="i69782326f71a44e3805518280ee22b6b_D20210101-20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzY2E5YmIwMTc5MjQ3NmZiYjIyNWU1ZDlkZWM4NjlmL3NlYzo5M2NhOWJiMDE3OTI0NzZmYmIyMjVlNWQ5ZGVjODY5Zl8yOC9mcmFnOjBmMzU2YWJkNmM5MzQyY2JhM2ZlYzVkNWUzMzA4NzZkL3RhYmxlOmMwM2NjYzgzMmYwMDQxNTlhYjIzZDc4NDg5NThhMzI5L3RhYmxlcmFuZ2U6YzAzY2NjODMyZjAwNDE1OWFiMjNkNzg0ODk1OGEzMjlfMjItMS0xLTEtMA_13717ba2-2abe-450f-9074-7fad46519f35"
      unitRef="usd">843000</us-gaap:PaymentsToAcquireIntangibleAssets>
    <us-gaap:PaymentsToAcquireIntangibleAssets
      contextRef="i4a110e4972ef4113880ce582e3cda5c5_D20200101-20200630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzY2E5YmIwMTc5MjQ3NmZiYjIyNWU1ZDlkZWM4NjlmL3NlYzo5M2NhOWJiMDE3OTI0NzZmYmIyMjVlNWQ5ZGVjODY5Zl8yOC9mcmFnOjBmMzU2YWJkNmM5MzQyY2JhM2ZlYzVkNWUzMzA4NzZkL3RhYmxlOmMwM2NjYzgzMmYwMDQxNTlhYjIzZDc4NDg5NThhMzI5L3RhYmxlcmFuZ2U6YzAzY2NjODMyZjAwNDE1OWFiMjNkNzg0ODk1OGEzMjlfMjItMy0xLTEtMA_a0256912-bb07-487a-98ab-740f90ad742f"
      unitRef="usd">2754000</us-gaap:PaymentsToAcquireIntangibleAssets>
    <us-gaap:ProceedsFromSaleOfPropertyHeldForSale
      contextRef="i69782326f71a44e3805518280ee22b6b_D20210101-20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzY2E5YmIwMTc5MjQ3NmZiYjIyNWU1ZDlkZWM4NjlmL3NlYzo5M2NhOWJiMDE3OTI0NzZmYmIyMjVlNWQ5ZGVjODY5Zl8yOC9mcmFnOjBmMzU2YWJkNmM5MzQyY2JhM2ZlYzVkNWUzMzA4NzZkL3RhYmxlOmMwM2NjYzgzMmYwMDQxNTlhYjIzZDc4NDg5NThhMzI5L3RhYmxlcmFuZ2U6YzAzY2NjODMyZjAwNDE1OWFiMjNkNzg0ODk1OGEzMjlfMjYtMS0xLTEtMTc2OTU_d0082df5-6a51-40e1-aac5-6fc6b1168543"
      unitRef="usd">2059000</us-gaap:ProceedsFromSaleOfPropertyHeldForSale>
    <us-gaap:ProceedsFromSaleOfPropertyHeldForSale
      contextRef="i4a110e4972ef4113880ce582e3cda5c5_D20200101-20200630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzY2E5YmIwMTc5MjQ3NmZiYjIyNWU1ZDlkZWM4NjlmL3NlYzo5M2NhOWJiMDE3OTI0NzZmYmIyMjVlNWQ5ZGVjODY5Zl8yOC9mcmFnOjBmMzU2YWJkNmM5MzQyY2JhM2ZlYzVkNWUzMzA4NzZkL3RhYmxlOmMwM2NjYzgzMmYwMDQxNTlhYjIzZDc4NDg5NThhMzI5L3RhYmxlcmFuZ2U6YzAzY2NjODMyZjAwNDE1OWFiMjNkNzg0ODk1OGEzMjlfMjYtMy0xLTEtMTc2OTU_d0cb9e6e-7230-4759-9b25-e3826b7fc609"
      unitRef="usd">0</us-gaap:ProceedsFromSaleOfPropertyHeldForSale>
    <us-gaap:PaymentsToAcquireLoansReceivable
      contextRef="i69782326f71a44e3805518280ee22b6b_D20210101-20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzY2E5YmIwMTc5MjQ3NmZiYjIyNWU1ZDlkZWM4NjlmL3NlYzo5M2NhOWJiMDE3OTI0NzZmYmIyMjVlNWQ5ZGVjODY5Zl8yOC9mcmFnOjBmMzU2YWJkNmM5MzQyY2JhM2ZlYzVkNWUzMzA4NzZkL3RhYmxlOmMwM2NjYzgzMmYwMDQxNTlhYjIzZDc4NDg5NThhMzI5L3RhYmxlcmFuZ2U6YzAzY2NjODMyZjAwNDE1OWFiMjNkNzg0ODk1OGEzMjlfMjMtMS0xLTEtMA_6bfad57f-c2db-407f-9a9c-516382361502"
      unitRef="usd">5064000</us-gaap:PaymentsToAcquireLoansReceivable>
    <us-gaap:PaymentsToAcquireLoansReceivable
      contextRef="i4a110e4972ef4113880ce582e3cda5c5_D20200101-20200630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzY2E5YmIwMTc5MjQ3NmZiYjIyNWU1ZDlkZWM4NjlmL3NlYzo5M2NhOWJiMDE3OTI0NzZmYmIyMjVlNWQ5ZGVjODY5Zl8yOC9mcmFnOjBmMzU2YWJkNmM5MzQyY2JhM2ZlYzVkNWUzMzA4NzZkL3RhYmxlOmMwM2NjYzgzMmYwMDQxNTlhYjIzZDc4NDg5NThhMzI5L3RhYmxlcmFuZ2U6YzAzY2NjODMyZjAwNDE1OWFiMjNkNzg0ODk1OGEzMjlfMjMtMy0xLTEtMA_fda055b1-0cd7-460d-9a67-663d9b2fa192"
      unitRef="usd">23974000</us-gaap:PaymentsToAcquireLoansReceivable>
    <us-gaap:ProceedsFromSaleAndMaturityOfOtherInvestments
      contextRef="i69782326f71a44e3805518280ee22b6b_D20210101-20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzY2E5YmIwMTc5MjQ3NmZiYjIyNWU1ZDlkZWM4NjlmL3NlYzo5M2NhOWJiMDE3OTI0NzZmYmIyMjVlNWQ5ZGVjODY5Zl8yOC9mcmFnOjBmMzU2YWJkNmM5MzQyY2JhM2ZlYzVkNWUzMzA4NzZkL3RhYmxlOmMwM2NjYzgzMmYwMDQxNTlhYjIzZDc4NDg5NThhMzI5L3RhYmxlcmFuZ2U6YzAzY2NjODMyZjAwNDE1OWFiMjNkNzg0ODk1OGEzMjlfMjQtMS0xLTEtMA_62a8d150-0802-4942-89de-79374345dc2f"
      unitRef="usd">0</us-gaap:ProceedsFromSaleAndMaturityOfOtherInvestments>
    <us-gaap:ProceedsFromSaleAndMaturityOfOtherInvestments
      contextRef="i4a110e4972ef4113880ce582e3cda5c5_D20200101-20200630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzY2E5YmIwMTc5MjQ3NmZiYjIyNWU1ZDlkZWM4NjlmL3NlYzo5M2NhOWJiMDE3OTI0NzZmYmIyMjVlNWQ5ZGVjODY5Zl8yOC9mcmFnOjBmMzU2YWJkNmM5MzQyY2JhM2ZlYzVkNWUzMzA4NzZkL3RhYmxlOmMwM2NjYzgzMmYwMDQxNTlhYjIzZDc4NDg5NThhMzI5L3RhYmxlcmFuZ2U6YzAzY2NjODMyZjAwNDE1OWFiMjNkNzg0ODk1OGEzMjlfMjQtMy0xLTEtMA_9403f672-8b1e-44fb-8ce5-d97af9a4af4c"
      unitRef="usd">769000</us-gaap:ProceedsFromSaleAndMaturityOfOtherInvestments>
    <us-gaap:NetCashProvidedByUsedInInvestingActivities
      contextRef="i69782326f71a44e3805518280ee22b6b_D20210101-20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzY2E5YmIwMTc5MjQ3NmZiYjIyNWU1ZDlkZWM4NjlmL3NlYzo5M2NhOWJiMDE3OTI0NzZmYmIyMjVlNWQ5ZGVjODY5Zl8yOC9mcmFnOjBmMzU2YWJkNmM5MzQyY2JhM2ZlYzVkNWUzMzA4NzZkL3RhYmxlOmMwM2NjYzgzMmYwMDQxNTlhYjIzZDc4NDg5NThhMzI5L3RhYmxlcmFuZ2U6YzAzY2NjODMyZjAwNDE1OWFiMjNkNzg0ODk1OGEzMjlfMjUtMS0xLTEtMA_25c9f289-8f14-4782-909e-e68c0222511e"
      unitRef="usd">-106563000</us-gaap:NetCashProvidedByUsedInInvestingActivities>
    <us-gaap:NetCashProvidedByUsedInInvestingActivities
      contextRef="i4a110e4972ef4113880ce582e3cda5c5_D20200101-20200630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzY2E5YmIwMTc5MjQ3NmZiYjIyNWU1ZDlkZWM4NjlmL3NlYzo5M2NhOWJiMDE3OTI0NzZmYmIyMjVlNWQ5ZGVjODY5Zl8yOC9mcmFnOjBmMzU2YWJkNmM5MzQyY2JhM2ZlYzVkNWUzMzA4NzZkL3RhYmxlOmMwM2NjYzgzMmYwMDQxNTlhYjIzZDc4NDg5NThhMzI5L3RhYmxlcmFuZ2U6YzAzY2NjODMyZjAwNDE1OWFiMjNkNzg0ODk1OGEzMjlfMjUtMy0xLTEtMA_c3988d7c-9b8e-4da1-a4a1-40cb8aff6053"
      unitRef="usd">39799000</us-gaap:NetCashProvidedByUsedInInvestingActivities>
    <us-gaap:PaymentsRelatedToTaxWithholdingForShareBasedCompensation
      contextRef="i69782326f71a44e3805518280ee22b6b_D20210101-20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzY2E5YmIwMTc5MjQ3NmZiYjIyNWU1ZDlkZWM4NjlmL3NlYzo5M2NhOWJiMDE3OTI0NzZmYmIyMjVlNWQ5ZGVjODY5Zl8yOC9mcmFnOjBmMzU2YWJkNmM5MzQyY2JhM2ZlYzVkNWUzMzA4NzZkL3RhYmxlOmMwM2NjYzgzMmYwMDQxNTlhYjIzZDc4NDg5NThhMzI5L3RhYmxlcmFuZ2U6YzAzY2NjODMyZjAwNDE1OWFiMjNkNzg0ODk1OGEzMjlfMjgtMS0xLTEtMA_e598a358-f866-4084-b4b1-d6f9d9c93119"
      unitRef="usd">8919000</us-gaap:PaymentsRelatedToTaxWithholdingForShareBasedCompensation>
    <us-gaap:PaymentsRelatedToTaxWithholdingForShareBasedCompensation
      contextRef="i4a110e4972ef4113880ce582e3cda5c5_D20200101-20200630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzY2E5YmIwMTc5MjQ3NmZiYjIyNWU1ZDlkZWM4NjlmL3NlYzo5M2NhOWJiMDE3OTI0NzZmYmIyMjVlNWQ5ZGVjODY5Zl8yOC9mcmFnOjBmMzU2YWJkNmM5MzQyY2JhM2ZlYzVkNWUzMzA4NzZkL3RhYmxlOmMwM2NjYzgzMmYwMDQxNTlhYjIzZDc4NDg5NThhMzI5L3RhYmxlcmFuZ2U6YzAzY2NjODMyZjAwNDE1OWFiMjNkNzg0ODk1OGEzMjlfMjgtMy0xLTEtMA_e237d637-99e9-46c2-a4bc-7c03c46196e8"
      unitRef="usd">0</us-gaap:PaymentsRelatedToTaxWithholdingForShareBasedCompensation>
    <us-gaap:ProceedsFromPaymentsForOtherFinancingActivities
      contextRef="i69782326f71a44e3805518280ee22b6b_D20210101-20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzY2E5YmIwMTc5MjQ3NmZiYjIyNWU1ZDlkZWM4NjlmL3NlYzo5M2NhOWJiMDE3OTI0NzZmYmIyMjVlNWQ5ZGVjODY5Zl8yOC9mcmFnOjBmMzU2YWJkNmM5MzQyY2JhM2ZlYzVkNWUzMzA4NzZkL3RhYmxlOmMwM2NjYzgzMmYwMDQxNTlhYjIzZDc4NDg5NThhMzI5L3RhYmxlcmFuZ2U6YzAzY2NjODMyZjAwNDE1OWFiMjNkNzg0ODk1OGEzMjlfMjktMS0xLTEtMA_ea493b0d-3a87-4c9d-8d69-345f70a0ca8b"
      unitRef="usd">12000</us-gaap:ProceedsFromPaymentsForOtherFinancingActivities>
    <us-gaap:ProceedsFromPaymentsForOtherFinancingActivities
      contextRef="i4a110e4972ef4113880ce582e3cda5c5_D20200101-20200630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzY2E5YmIwMTc5MjQ3NmZiYjIyNWU1ZDlkZWM4NjlmL3NlYzo5M2NhOWJiMDE3OTI0NzZmYmIyMjVlNWQ5ZGVjODY5Zl8yOC9mcmFnOjBmMzU2YWJkNmM5MzQyY2JhM2ZlYzVkNWUzMzA4NzZkL3RhYmxlOmMwM2NjYzgzMmYwMDQxNTlhYjIzZDc4NDg5NThhMzI5L3RhYmxlcmFuZ2U6YzAzY2NjODMyZjAwNDE1OWFiMjNkNzg0ODk1OGEzMjlfMjktMy0xLTEtMA_8c1d0a48-d6a4-458b-a7be-962ad6dc00a5"
      unitRef="usd">1000</us-gaap:ProceedsFromPaymentsForOtherFinancingActivities>
    <us-gaap:NetCashProvidedByUsedInFinancingActivities
      contextRef="i69782326f71a44e3805518280ee22b6b_D20210101-20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzY2E5YmIwMTc5MjQ3NmZiYjIyNWU1ZDlkZWM4NjlmL3NlYzo5M2NhOWJiMDE3OTI0NzZmYmIyMjVlNWQ5ZGVjODY5Zl8yOC9mcmFnOjBmMzU2YWJkNmM5MzQyY2JhM2ZlYzVkNWUzMzA4NzZkL3RhYmxlOmMwM2NjYzgzMmYwMDQxNTlhYjIzZDc4NDg5NThhMzI5L3RhYmxlcmFuZ2U6YzAzY2NjODMyZjAwNDE1OWFiMjNkNzg0ODk1OGEzMjlfMzAtMS0xLTEtMA_27a88025-6bb4-4caf-9aea-5520e1a8171d"
      unitRef="usd">-8907000</us-gaap:NetCashProvidedByUsedInFinancingActivities>
    <us-gaap:NetCashProvidedByUsedInFinancingActivities
      contextRef="i4a110e4972ef4113880ce582e3cda5c5_D20200101-20200630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzY2E5YmIwMTc5MjQ3NmZiYjIyNWU1ZDlkZWM4NjlmL3NlYzo5M2NhOWJiMDE3OTI0NzZmYmIyMjVlNWQ5ZGVjODY5Zl8yOC9mcmFnOjBmMzU2YWJkNmM5MzQyY2JhM2ZlYzVkNWUzMzA4NzZkL3RhYmxlOmMwM2NjYzgzMmYwMDQxNTlhYjIzZDc4NDg5NThhMzI5L3RhYmxlcmFuZ2U6YzAzY2NjODMyZjAwNDE1OWFiMjNkNzg0ODk1OGEzMjlfMzAtMy0xLTEtMA_262c3866-ad53-4316-8a3c-b7bd10bc8779"
      unitRef="usd">1000</us-gaap:NetCashProvidedByUsedInFinancingActivities>
    <us-gaap:EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
      contextRef="i69782326f71a44e3805518280ee22b6b_D20210101-20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzY2E5YmIwMTc5MjQ3NmZiYjIyNWU1ZDlkZWM4NjlmL3NlYzo5M2NhOWJiMDE3OTI0NzZmYmIyMjVlNWQ5ZGVjODY5Zl8yOC9mcmFnOjBmMzU2YWJkNmM5MzQyY2JhM2ZlYzVkNWUzMzA4NzZkL3RhYmxlOmMwM2NjYzgzMmYwMDQxNTlhYjIzZDc4NDg5NThhMzI5L3RhYmxlcmFuZ2U6YzAzY2NjODMyZjAwNDE1OWFiMjNkNzg0ODk1OGEzMjlfMzEtMS0xLTEtMA_3b97f07e-601f-4aed-9670-aeb1310a86fb"
      unitRef="usd">18825000</us-gaap:EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents>
    <us-gaap:EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
      contextRef="i4a110e4972ef4113880ce582e3cda5c5_D20200101-20200630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzY2E5YmIwMTc5MjQ3NmZiYjIyNWU1ZDlkZWM4NjlmL3NlYzo5M2NhOWJiMDE3OTI0NzZmYmIyMjVlNWQ5ZGVjODY5Zl8yOC9mcmFnOjBmMzU2YWJkNmM5MzQyY2JhM2ZlYzVkNWUzMzA4NzZkL3RhYmxlOmMwM2NjYzgzMmYwMDQxNTlhYjIzZDc4NDg5NThhMzI5L3RhYmxlcmFuZ2U6YzAzY2NjODMyZjAwNDE1OWFiMjNkNzg0ODk1OGEzMjlfMzEtMy0xLTEtMA_4184319d-fff3-4fc7-bcde-349ccb020813"
      unitRef="usd">-51416000</us-gaap:EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
      contextRef="i69782326f71a44e3805518280ee22b6b_D20210101-20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzY2E5YmIwMTc5MjQ3NmZiYjIyNWU1ZDlkZWM4NjlmL3NlYzo5M2NhOWJiMDE3OTI0NzZmYmIyMjVlNWQ5ZGVjODY5Zl8yOC9mcmFnOjBmMzU2YWJkNmM5MzQyY2JhM2ZlYzVkNWUzMzA4NzZkL3RhYmxlOmMwM2NjYzgzMmYwMDQxNTlhYjIzZDc4NDg5NThhMzI5L3RhYmxlcmFuZ2U6YzAzY2NjODMyZjAwNDE1OWFiMjNkNzg0ODk1OGEzMjlfMzItMS0xLTEtMA_8c67a7f9-3d5c-428d-a949-83a21cbcdfb8"
      unitRef="usd">-182842000</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
      contextRef="i4a110e4972ef4113880ce582e3cda5c5_D20200101-20200630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzY2E5YmIwMTc5MjQ3NmZiYjIyNWU1ZDlkZWM4NjlmL3NlYzo5M2NhOWJiMDE3OTI0NzZmYmIyMjVlNWQ5ZGVjODY5Zl8yOC9mcmFnOjBmMzU2YWJkNmM5MzQyY2JhM2ZlYzVkNWUzMzA4NzZkL3RhYmxlOmMwM2NjYzgzMmYwMDQxNTlhYjIzZDc4NDg5NThhMzI5L3RhYmxlcmFuZ2U6YzAzY2NjODMyZjAwNDE1OWFiMjNkNzg0ODk1OGEzMjlfMzItMy0xLTEtMA_c023987b-42a7-40f1-bc3c-6b5439a2e1c6"
      unitRef="usd">-89993000</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
      contextRef="ifbe16ec51ea244519b77d6036b4ef038_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzY2E5YmIwMTc5MjQ3NmZiYjIyNWU1ZDlkZWM4NjlmL3NlYzo5M2NhOWJiMDE3OTI0NzZmYmIyMjVlNWQ5ZGVjODY5Zl8yOC9mcmFnOjBmMzU2YWJkNmM5MzQyY2JhM2ZlYzVkNWUzMzA4NzZkL3RhYmxlOmMwM2NjYzgzMmYwMDQxNTlhYjIzZDc4NDg5NThhMzI5L3RhYmxlcmFuZ2U6YzAzY2NjODMyZjAwNDE1OWFiMjNkNzg0ODk1OGEzMjlfMzMtMS0xLTEtMA_0e987f16-671c-4fef-848d-ed08929553c8"
      unitRef="usd">1078023000</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
      contextRef="ie4fc90ad6d7f4d39aea9cb65c8026e09_I20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzY2E5YmIwMTc5MjQ3NmZiYjIyNWU1ZDlkZWM4NjlmL3NlYzo5M2NhOWJiMDE3OTI0NzZmYmIyMjVlNWQ5ZGVjODY5Zl8yOC9mcmFnOjBmMzU2YWJkNmM5MzQyY2JhM2ZlYzVkNWUzMzA4NzZkL3RhYmxlOmMwM2NjYzgzMmYwMDQxNTlhYjIzZDc4NDg5NThhMzI5L3RhYmxlcmFuZ2U6YzAzY2NjODMyZjAwNDE1OWFiMjNkNzg0ODk1OGEzMjlfMzMtMy0xLTEtMA_eb687195-0646-4e8f-b75a-fdbada7b1cb0"
      unitRef="usd">1199693000</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
      contextRef="i225f85e38faa4bbdb4de1d8b9cf369bb_I20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzY2E5YmIwMTc5MjQ3NmZiYjIyNWU1ZDlkZWM4NjlmL3NlYzo5M2NhOWJiMDE3OTI0NzZmYmIyMjVlNWQ5ZGVjODY5Zl8yOC9mcmFnOjBmMzU2YWJkNmM5MzQyY2JhM2ZlYzVkNWUzMzA4NzZkL3RhYmxlOmMwM2NjYzgzMmYwMDQxNTlhYjIzZDc4NDg5NThhMzI5L3RhYmxlcmFuZ2U6YzAzY2NjODMyZjAwNDE1OWFiMjNkNzg0ODk1OGEzMjlfMzQtMS0xLTEtMA_01e14023-2df9-418e-bd81-cb55601c6c9c"
      unitRef="usd">895181000</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
      contextRef="id670dc9b33e6430f9d7510009f7495a7_I20200630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzY2E5YmIwMTc5MjQ3NmZiYjIyNWU1ZDlkZWM4NjlmL3NlYzo5M2NhOWJiMDE3OTI0NzZmYmIyMjVlNWQ5ZGVjODY5Zl8yOC9mcmFnOjBmMzU2YWJkNmM5MzQyY2JhM2ZlYzVkNWUzMzA4NzZkL3RhYmxlOmMwM2NjYzgzMmYwMDQxNTlhYjIzZDc4NDg5NThhMzI5L3RhYmxlcmFuZ2U6YzAzY2NjODMyZjAwNDE1OWFiMjNkNzg0ODk1OGEzMjlfMzQtMy0xLTEtMA_1d89c288-ab4f-42c6-8b96-9159884b1c79"
      unitRef="usd">1109700000</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents>
    <us-gaap:InterestPaidNet
      contextRef="i69782326f71a44e3805518280ee22b6b_D20210101-20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzY2E5YmIwMTc5MjQ3NmZiYjIyNWU1ZDlkZWM4NjlmL3NlYzo5M2NhOWJiMDE3OTI0NzZmYmIyMjVlNWQ5ZGVjODY5Zl8yOC9mcmFnOjBmMzU2YWJkNmM5MzQyY2JhM2ZlYzVkNWUzMzA4NzZkL3RhYmxlOmMwM2NjYzgzMmYwMDQxNTlhYjIzZDc4NDg5NThhMzI5L3RhYmxlcmFuZ2U6YzAzY2NjODMyZjAwNDE1OWFiMjNkNzg0ODk1OGEzMjlfMzYtMS0xLTEtMA_edcab813-f8ff-4f9f-9203-88e3a158256d"
      unitRef="usd">0</us-gaap:InterestPaidNet>
    <us-gaap:InterestPaidNet
      contextRef="i4a110e4972ef4113880ce582e3cda5c5_D20200101-20200630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzY2E5YmIwMTc5MjQ3NmZiYjIyNWU1ZDlkZWM4NjlmL3NlYzo5M2NhOWJiMDE3OTI0NzZmYmIyMjVlNWQ5ZGVjODY5Zl8yOC9mcmFnOjBmMzU2YWJkNmM5MzQyY2JhM2ZlYzVkNWUzMzA4NzZkL3RhYmxlOmMwM2NjYzgzMmYwMDQxNTlhYjIzZDc4NDg5NThhMzI5L3RhYmxlcmFuZ2U6YzAzY2NjODMyZjAwNDE1OWFiMjNkNzg0ODk1OGEzMjlfMzYtMy0xLTEtMA_322a8395-c06c-4ce1-96d6-c73ed31d89f7"
      unitRef="usd">90000</us-gaap:InterestPaidNet>
    <cron:InterestReceivedNet
      contextRef="i69782326f71a44e3805518280ee22b6b_D20210101-20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzY2E5YmIwMTc5MjQ3NmZiYjIyNWU1ZDlkZWM4NjlmL3NlYzo5M2NhOWJiMDE3OTI0NzZmYmIyMjVlNWQ5ZGVjODY5Zl8yOC9mcmFnOjBmMzU2YWJkNmM5MzQyY2JhM2ZlYzVkNWUzMzA4NzZkL3RhYmxlOmMwM2NjYzgzMmYwMDQxNTlhYjIzZDc4NDg5NThhMzI5L3RhYmxlcmFuZ2U6YzAzY2NjODMyZjAwNDE1OWFiMjNkNzg0ODk1OGEzMjlfMzctMS0xLTEtMA_8a473d7a-8346-42f5-ae13-f5f4051fa229"
      unitRef="usd">2961000</cron:InterestReceivedNet>
    <cron:InterestReceivedNet
      contextRef="i4a110e4972ef4113880ce582e3cda5c5_D20200101-20200630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzY2E5YmIwMTc5MjQ3NmZiYjIyNWU1ZDlkZWM4NjlmL3NlYzo5M2NhOWJiMDE3OTI0NzZmYmIyMjVlNWQ5ZGVjODY5Zl8yOC9mcmFnOjBmMzU2YWJkNmM5MzQyY2JhM2ZlYzVkNWUzMzA4NzZkL3RhYmxlOmMwM2NjYzgzMmYwMDQxNTlhYjIzZDc4NDg5NThhMzI5L3RhYmxlcmFuZ2U6YzAzY2NjODMyZjAwNDE1OWFiMjNkNzg0ODk1OGEzMjlfMzctMy0xLTEtMA_21445440-fc42-4471-8ea7-4a17af1a766e"
      unitRef="usd">11575000</cron:InterestReceivedNet>
    <us-gaap:IncomeTaxesPaidNet
      contextRef="i69782326f71a44e3805518280ee22b6b_D20210101-20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzY2E5YmIwMTc5MjQ3NmZiYjIyNWU1ZDlkZWM4NjlmL3NlYzo5M2NhOWJiMDE3OTI0NzZmYmIyMjVlNWQ5ZGVjODY5Zl8yOC9mcmFnOjBmMzU2YWJkNmM5MzQyY2JhM2ZlYzVkNWUzMzA4NzZkL3RhYmxlOmMwM2NjYzgzMmYwMDQxNTlhYjIzZDc4NDg5NThhMzI5L3RhYmxlcmFuZ2U6YzAzY2NjODMyZjAwNDE1OWFiMjNkNzg0ODk1OGEzMjlfMzgtMS0xLTEtMA_c8716145-c744-47f9-b71b-febf97aa6d08"
      unitRef="usd">858000</us-gaap:IncomeTaxesPaidNet>
    <us-gaap:IncomeTaxesPaidNet
      contextRef="i4a110e4972ef4113880ce582e3cda5c5_D20200101-20200630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzY2E5YmIwMTc5MjQ3NmZiYjIyNWU1ZDlkZWM4NjlmL3NlYzo5M2NhOWJiMDE3OTI0NzZmYmIyMjVlNWQ5ZGVjODY5Zl8yOC9mcmFnOjBmMzU2YWJkNmM5MzQyY2JhM2ZlYzVkNWUzMzA4NzZkL3RhYmxlOmMwM2NjYzgzMmYwMDQxNTlhYjIzZDc4NDg5NThhMzI5L3RhYmxlcmFuZ2U6YzAzY2NjODMyZjAwNDE1OWFiMjNkNzg0ODk1OGEzMjlfMzgtMy0xLTEtMA_df43c7d1-ca8e-4771-bbc5-735a785e36eb"
      unitRef="usd">0</us-gaap:IncomeTaxesPaidNet>
    <us-gaap:BasisOfPresentationAndSignificantAccountingPoliciesTextBlock
      contextRef="i69782326f71a44e3805518280ee22b6b_D20210101-20210630"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzY2E5YmIwMTc5MjQ3NmZiYjIyNWU1ZDlkZWM4NjlmL3NlYzo5M2NhOWJiMDE3OTI0NzZmYmIyMjVlNWQ5ZGVjODY5Zl8zNC9mcmFnOjYwNzFjM2U1NDE4NTRjN2M5MDhmOWM2ZmI5ZGFhNGQ1L3RleHRyZWdpb246NjA3MWMzZTU0MTg1NGM3YzkwOGY5YzZmYjlkYWE0ZDVfNTU4MA_eaa9fe5c-010f-4703-aa4a-f3ae4e644955">Background, Basis of Presentation and Accounting Policies&lt;div style="margin-bottom:6pt;margin-top:6pt;padding-left:36pt;text-align:justify;text-indent:-36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;(a)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;padding-left:24.34pt"&gt;Background&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Cronos Group Inc. (&#x201c;Cronos Group&#x201d; or the &#x201c;Company&#x201d;) is incorporated in the Province of British Columbia and under the &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Business Corporations Act&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; (British Columbia) with principal executive offices at 111 Peter Street, Suite 300, Toronto, Ontario, M5V 2H1. The Company&#x2019;s common shares are currently listed on the Toronto Stock Exchange (&#x201c;TSX&#x201d;) and Nasdaq Global Market (&#x201c;Nasdaq&#x201d;) under the ticker symbol &#x201c;CRON.&#x201d;&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Cronos Group is an innovative global cannabinoid company, with international production and distribution across five continents. The Company is committed to building disruptive intellectual property by advancing cannabis research, technology and product development and is seeking to build an iconic brand portfolio. Cronos Group&#x2019;s brand portfolio includes PEACE NATURALS&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;&#x2122;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;, a global wellness platform; two adult-use brands, COVE&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;&#x2122;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; and Spinach&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;&#x2122;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;; and three U.S. hemp-derived consumer products brands, Lord Jones&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;&#x2122;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;, Happy Dance&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;&#x2122; &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;and PEACE+&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;&#x2122;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Cronos Group has established strategic joint ventures in Canada, Israel, and Colombia. &#x201c;Cronos Israel&#x201d; consists of a cultivation company (Cronos Israel G.S. Cultivation Ltd.), a manufacturing company (Cronos Israel G.S. Manufacturing Ltd.), a distribution company (Cronos Israel G.S. Store Ltd.) and a pharmacy company (Cronos Israel G.S. Pharmacy Ltd.) and is consolidated for financial reporting purposes. The Company also holds approximately 31% of the issued capital of Cronos Australia Limited (&#x201c;Cronos Australia&#x201d;) and accounts for its investment in Cronos Australia under the equity method of accounting. For additional discussion regarding the joint ventures and strategic investment, see Note 3. Investments.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt;padding-left:36pt;text-align:justify;text-indent:-36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;(b)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;padding-left:23.78pt"&gt;Out-of-period adjustments&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;During the three months ended March 31, 2021, the Company identified an error in the accounting related to the withholding taxes on the net exercise of stock options, which resulted in an understatement of accounts payable and other liabilities of $966 and overstatements of other receivables, retained earnings and share capital of $3,202, $3,838 and $330, respectively, as of December 31, 2020. The error was deemed immaterial, and thus the Company has recorded an out-of-period adjustment to the condensed consolidated balance sheet and the condensed consolidated statement of changes in equity during the first quarter of 2021 to correct the error. This error had no impact to the condensed consolidated statement of net income (loss) and comprehensive income (loss). The impact of the out-of-period adjustments are included within the changes in operating assets and liabilities and withholding taxes paid on share-based awards lines in the Company&#x2019;s condensed consolidated statements of cash flows.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;During the three months ended June 30, 2021, the Company identified an error in the accounting related to the exercise of Top-up Rights (as defined herein), which resulted in an overstatement of share capital and an understatement of gain on revaluation of derivative liabilities of $3,227 as of December 31, 2020, and overstatements of share capital and loss on revaluation of derivative liabilities and an understatement of retained earnings of $14,505, $11,278 and $3,227, respectively, as of March 31, 2021. The error was deemed immaterial, and thus the Company has recorded an out-of-period adjustment to the condensed consolidated balance sheet, the condensed consolidated statement of net income (loss) and comprehensive income (loss) and the condensed consolidated statement of changes in equity during the second quarter of 2021 to correct the error. The impact of the out-of-period adjustments are included within the adjustments to net loss in the Company&#x2019;s condensed consolidated statements of cash flows.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt;padding-left:36pt;text-align:justify;text-indent:-36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;(c)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;padding-left:24.91pt"&gt;Basis of presentation&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The interim condensed consolidated financial statements of Cronos Group are unaudited. They have been prepared in accordance with Generally Accepted Accounting Principles in the United States (&#x201c;U.S. GAAP&#x201d;) for interim financial information and with applicable rules and regulations of the U.S. Securities and Exchange Commission relating to interim financial statements. Accordingly, they do not include all of the information and footnotes required by U.S. GAAP for complete financial statements. In the opinion of management, all adjustments (consisting of normal recurring accruals) considered necessary for a fair presentation have been included. Operating results for the three and six months ended June&#160;30, 2021 are not necessarily indicative of the results that may be expected for any other reporting period.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;These condensed consolidated financial statements should be read in conjunction with the Company&#x2019;s audited consolidated financial statements and related notes included in its Annual Report on Form 10-K for the year ended December 31, 2020 (the &#x201c;Annual Financial Statements&#x201d;).&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Certain prior year amounts have been reclassified to conform to the current year presentation of our condensed consolidated financial statements. These reclassifications had no effect on the reported results of operations and ending shareholders&#x2019; equity.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt;padding-left:36pt;text-align:justify;text-indent:-36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;(d)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;padding-left:23.78pt"&gt;Adoption of new accounting pronouncements&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;On January 1, 2021, the Company adopted ASU No. 2020-01, Investments-Equity Securities (Topic 321), Investments-Equity Method and Joint Ventures (Topic 323), and Derivatives and Hedging (Topic 815) (&#x201c;ASU No. 2020-01&#x201d;). ASU No. 2020-01 clarifies the interaction of accounting for the transition into and out of the equity method as well as measuring certain purchased options and forward contracts to acquire investments. The adoption of ASU No. 2020-01 did not have an impact on the Company&#x2019;s interim condensed consolidated financial statements.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;On January 1, 2021, the Company adopted ASU 2019-12, Income Taxes (Topic 740): Simplifying the Accounting for Income Taxes (&#x201c;ASU No. 2019-12&#x201d;). ASU No. 2019-12 eliminates certain exceptions and simplifies the application of U.S. GAAP-related changes in enacted tax laws or rates and employee stock option plans. The adoption of ASU No. 2019-12 did not have an impact on the Company&#x2019;s interim condensed consolidated financial statements.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt;padding-left:36pt;text-align:justify;text-indent:-36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;(e)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;padding-left:24.91pt"&gt;New accounting pronouncements not yet adopted&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In August 2020, the FASB issued ASU 2020-06, Debt &#x2013;Debt with Conversion and Other Options (Subtopic 470-20) and Derivatives and Hedging&#x2014;Contracts in Entity&#x2019;s Own Equity (Subtopic 815&#x2013;40) (&#x201c;ASU No. 2020-06&#x201d;). ASU No. 2020-06 simplifies the accounting for certain financial instruments with characteristics of liabilities and equity, including convertible instruments and contracts on an entity&#x2019;s own equity. ASU No. 2020-06 is part of the FASB&#x2019;s simplification initiative, which aims to reduce unnecessary complexity in U.S. GAAP. ASU No. 2020-06 is effective for fiscal years beginning after December 15, 2021, and interim periods within those fiscal years. The Company is currently evaluating the impact ASU No. 2020-06 will have on its condensed consolidated financial statements.&lt;/span&gt;&lt;/div&gt;</us-gaap:BasisOfPresentationAndSignificantAccountingPoliciesTextBlock>
    <cron:NumberOfContinentsWithInternationalProductionAndDistribution
      contextRef="i225f85e38faa4bbdb4de1d8b9cf369bb_I20210630"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzY2E5YmIwMTc5MjQ3NmZiYjIyNWU1ZDlkZWM4NjlmL3NlYzo5M2NhOWJiMDE3OTI0NzZmYmIyMjVlNWQ5ZGVjODY5Zl8zNC9mcmFnOjYwNzFjM2U1NDE4NTRjN2M5MDhmOWM2ZmI5ZGFhNGQ1L3RleHRyZWdpb246NjA3MWMzZTU0MTg1NGM3YzkwOGY5YzZmYjlkYWE0ZDVfOTg5NTYwNDY2NDAxMg_0fdef51f-5445-468c-ac7d-67de81765b2c"
      unitRef="continent">5</cron:NumberOfContinentsWithInternationalProductionAndDistribution>
    <cron:NumberOfAdultuseBrands
      contextRef="i225f85e38faa4bbdb4de1d8b9cf369bb_I20210630"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzY2E5YmIwMTc5MjQ3NmZiYjIyNWU1ZDlkZWM4NjlmL3NlYzo5M2NhOWJiMDE3OTI0NzZmYmIyMjVlNWQ5ZGVjODY5Zl8zNC9mcmFnOjYwNzFjM2U1NDE4NTRjN2M5MDhmOWM2ZmI5ZGFhNGQ1L3RleHRyZWdpb246NjA3MWMzZTU0MTg1NGM3YzkwOGY5YzZmYjlkYWE0ZDVfOTg5NTYwNDY2NDAyMQ_15ba5786-2607-4d8c-ad12-35b009f880b0"
      unitRef="brand">2</cron:NumberOfAdultuseBrands>
    <cron:NumberOfHempDerivedPersonalCareBrands
      contextRef="i225f85e38faa4bbdb4de1d8b9cf369bb_I20210630"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzY2E5YmIwMTc5MjQ3NmZiYjIyNWU1ZDlkZWM4NjlmL3NlYzo5M2NhOWJiMDE3OTI0NzZmYmIyMjVlNWQ5ZGVjODY5Zl8zNC9mcmFnOjYwNzFjM2U1NDE4NTRjN2M5MDhmOWM2ZmI5ZGFhNGQ1L3RleHRyZWdpb246NjA3MWMzZTU0MTg1NGM3YzkwOGY5YzZmYjlkYWE0ZDVfOTg5NTYwNDY2NDAyOQ_018f7c97-786b-4b28-a774-65f0486ed419"
      unitRef="brand">3</cron:NumberOfHempDerivedPersonalCareBrands>
    <us-gaap:EquityMethodInvestmentOwnershipPercentage
      contextRef="i52d0636c66ed4ea58c20dfcc9a4132e8_I20210630"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzY2E5YmIwMTc5MjQ3NmZiYjIyNWU1ZDlkZWM4NjlmL3NlYzo5M2NhOWJiMDE3OTI0NzZmYmIyMjVlNWQ5ZGVjODY5Zl8zNC9mcmFnOjYwNzFjM2U1NDE4NTRjN2M5MDhmOWM2ZmI5ZGFhNGQ1L3RleHRyZWdpb246NjA3MWMzZTU0MTg1NGM3YzkwOGY5YzZmYjlkYWE0ZDVfMTE3OQ_4eae84ef-3203-4138-965a-5803a548d246"
      unitRef="number">0.31</us-gaap:EquityMethodInvestmentOwnershipPercentage>
    <us-gaap:AccountsPayableAndOtherAccruedLiabilitiesCurrent
      contextRef="i6506a062286b47c0b48f06151d87d9e6_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzY2E5YmIwMTc5MjQ3NmZiYjIyNWU1ZDlkZWM4NjlmL3NlYzo5M2NhOWJiMDE3OTI0NzZmYmIyMjVlNWQ5ZGVjODY5Zl8zNC9mcmFnOjYwNzFjM2U1NDE4NTRjN2M5MDhmOWM2ZmI5ZGFhNGQ1L3RleHRyZWdpb246NjA3MWMzZTU0MTg1NGM3YzkwOGY5YzZmYjlkYWE0ZDVfMTY2Ng_786086c7-f111-4b28-99ac-172beee1cf1a"
      unitRef="usd">966000</us-gaap:AccountsPayableAndOtherAccruedLiabilitiesCurrent>
    <us-gaap:OtherReceivablesNetCurrent
      contextRef="i6506a062286b47c0b48f06151d87d9e6_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzY2E5YmIwMTc5MjQ3NmZiYjIyNWU1ZDlkZWM4NjlmL3NlYzo5M2NhOWJiMDE3OTI0NzZmYmIyMjVlNWQ5ZGVjODY5Zl8zNC9mcmFnOjYwNzFjM2U1NDE4NTRjN2M5MDhmOWM2ZmI5ZGFhNGQ1L3RleHRyZWdpb246NjA3MWMzZTU0MTg1NGM3YzkwOGY5YzZmYjlkYWE0ZDVfMTc0OA_4469e0db-d9b7-456b-ad9b-70f76e9556f8"
      unitRef="usd">-3202000</us-gaap:OtherReceivablesNetCurrent>
    <us-gaap:RetainedEarningsAccumulatedDeficit
      contextRef="i6506a062286b47c0b48f06151d87d9e6_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzY2E5YmIwMTc5MjQ3NmZiYjIyNWU1ZDlkZWM4NjlmL3NlYzo5M2NhOWJiMDE3OTI0NzZmYmIyMjVlNWQ5ZGVjODY5Zl8zNC9mcmFnOjYwNzFjM2U1NDE4NTRjN2M5MDhmOWM2ZmI5ZGFhNGQ1L3RleHRyZWdpb246NjA3MWMzZTU0MTg1NGM3YzkwOGY5YzZmYjlkYWE0ZDVfMTc1Mg_d604dd8f-9c5b-418d-bc1f-82f2cb2f7b42"
      unitRef="usd">-3838000</us-gaap:RetainedEarningsAccumulatedDeficit>
    <us-gaap:CommonStockValue
      contextRef="i6506a062286b47c0b48f06151d87d9e6_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzY2E5YmIwMTc5MjQ3NmZiYjIyNWU1ZDlkZWM4NjlmL3NlYzo5M2NhOWJiMDE3OTI0NzZmYmIyMjVlNWQ5ZGVjODY5Zl8zNC9mcmFnOjYwNzFjM2U1NDE4NTRjN2M5MDhmOWM2ZmI5ZGFhNGQ1L3RleHRyZWdpb246NjA3MWMzZTU0MTg1NGM3YzkwOGY5YzZmYjlkYWE0ZDVfMTc1OQ_2471585c-f69e-4d63-a881-1e297c669aa6"
      unitRef="usd">-330000</us-gaap:CommonStockValue>
    <us-gaap:GainLossOnDerivativeInstrumentsNetPretax
      contextRef="ic583ba915ef943c8be4157a2a9ead807_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzY2E5YmIwMTc5MjQ3NmZiYjIyNWU1ZDlkZWM4NjlmL3NlYzo5M2NhOWJiMDE3OTI0NzZmYmIyMjVlNWQ5ZGVjODY5Zl8zNC9mcmFnOjYwNzFjM2U1NDE4NTRjN2M5MDhmOWM2ZmI5ZGFhNGQ1L3RleHRyZWdpb246NjA3MWMzZTU0MTg1NGM3YzkwOGY5YzZmYjlkYWE0ZDVfOTg5NTYwNDY3MjkzNQ_317c4b17-21ba-458b-8a8a-ecf11dcd8add"
      unitRef="usd">3227000</us-gaap:GainLossOnDerivativeInstrumentsNetPretax>
    <us-gaap:CommonStockValue
      contextRef="ice66d39b8cf24a6b82c9c3c91f87fece_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzY2E5YmIwMTc5MjQ3NmZiYjIyNWU1ZDlkZWM4NjlmL3NlYzo5M2NhOWJiMDE3OTI0NzZmYmIyMjVlNWQ5ZGVjODY5Zl8zNC9mcmFnOjYwNzFjM2U1NDE4NTRjN2M5MDhmOWM2ZmI5ZGFhNGQ1L3RleHRyZWdpb246NjA3MWMzZTU0MTg1NGM3YzkwOGY5YzZmYjlkYWE0ZDVfOTg5NTYwNDY3MjkzNQ_fc572c91-68c5-4f4d-8a5d-fd073f2de92b"
      unitRef="usd">-3227000</us-gaap:CommonStockValue>
    <us-gaap:CommonStockValue
      contextRef="i71f353c527264f29bc7b447983a0f96b_I20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzY2E5YmIwMTc5MjQ3NmZiYjIyNWU1ZDlkZWM4NjlmL3NlYzo5M2NhOWJiMDE3OTI0NzZmYmIyMjVlNWQ5ZGVjODY5Zl8zNC9mcmFnOjYwNzFjM2U1NDE4NTRjN2M5MDhmOWM2ZmI5ZGFhNGQ1L3RleHRyZWdpb246NjA3MWMzZTU0MTg1NGM3YzkwOGY5YzZmYjlkYWE0ZDVfNDk0NzgwMjM0NzU3Mg_f57dc7e5-6e61-4e6a-9333-723b66b6aa93"
      unitRef="usd">-14505000</us-gaap:CommonStockValue>
    <us-gaap:GainLossOnDerivativeInstrumentsNetPretax
      contextRef="ib02278c2b0d7400b81a88f77d9b1d053_D20210101-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzY2E5YmIwMTc5MjQ3NmZiYjIyNWU1ZDlkZWM4NjlmL3NlYzo5M2NhOWJiMDE3OTI0NzZmYmIyMjVlNWQ5ZGVjODY5Zl8zNC9mcmFnOjYwNzFjM2U1NDE4NTRjN2M5MDhmOWM2ZmI5ZGFhNGQ1L3RleHRyZWdpb246NjA3MWMzZTU0MTg1NGM3YzkwOGY5YzZmYjlkYWE0ZDVfNDk0NzgwMjM0NzU4MQ_138193b6-4b11-4313-be93-df56b0ff22c8"
      unitRef="usd">11278000</us-gaap:GainLossOnDerivativeInstrumentsNetPretax>
    <us-gaap:RetainedEarningsAccumulatedDeficit
      contextRef="i71f353c527264f29bc7b447983a0f96b_I20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzY2E5YmIwMTc5MjQ3NmZiYjIyNWU1ZDlkZWM4NjlmL3NlYzo5M2NhOWJiMDE3OTI0NzZmYmIyMjVlNWQ5ZGVjODY5Zl8zNC9mcmFnOjYwNzFjM2U1NDE4NTRjN2M5MDhmOWM2ZmI5ZGFhNGQ1L3RleHRyZWdpb246NjA3MWMzZTU0MTg1NGM3YzkwOGY5YzZmYjlkYWE0ZDVfNDk0NzgwMjM0NzU5MA_bdfbe9e8-7744-454c-941e-97ef7c7e957a"
      unitRef="usd">3227000</us-gaap:RetainedEarningsAccumulatedDeficit>
    <us-gaap:BasisOfAccountingPolicyPolicyTextBlock
      contextRef="i69782326f71a44e3805518280ee22b6b_D20210101-20210630"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzY2E5YmIwMTc5MjQ3NmZiYjIyNWU1ZDlkZWM4NjlmL3NlYzo5M2NhOWJiMDE3OTI0NzZmYmIyMjVlNWQ5ZGVjODY5Zl8zNC9mcmFnOjYwNzFjM2U1NDE4NTRjN2M5MDhmOWM2ZmI5ZGFhNGQ1L3RleHRyZWdpb246NjA3MWMzZTU0MTg1NGM3YzkwOGY5YzZmYjlkYWE0ZDVfNTU3OA_77d8fafc-14fa-477b-be06-0f10c598a92c">Basis of presentation&lt;div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The interim condensed consolidated financial statements of Cronos Group are unaudited. They have been prepared in accordance with Generally Accepted Accounting Principles in the United States (&#x201c;U.S. GAAP&#x201d;) for interim financial information and with applicable rules and regulations of the U.S. Securities and Exchange Commission relating to interim financial statements. Accordingly, they do not include all of the information and footnotes required by U.S. GAAP for complete financial statements. In the opinion of management, all adjustments (consisting of normal recurring accruals) considered necessary for a fair presentation have been included. Operating results for the three and six months ended June&#160;30, 2021 are not necessarily indicative of the results that may be expected for any other reporting period.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;These condensed consolidated financial statements should be read in conjunction with the Company&#x2019;s audited consolidated financial statements and related notes included in its Annual Report on Form 10-K for the year ended December 31, 2020 (the &#x201c;Annual Financial Statements&#x201d;).&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Certain prior year amounts have been reclassified to conform to the current year presentation of our condensed consolidated financial statements. These reclassifications had no effect on the reported results of operations and ending shareholders&#x2019; equity.&lt;/span&gt;&lt;/div&gt;</us-gaap:BasisOfAccountingPolicyPolicyTextBlock>
    <us-gaap:NewAccountingPronouncementsPolicyPolicyTextBlock
      contextRef="i69782326f71a44e3805518280ee22b6b_D20210101-20210630"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzY2E5YmIwMTc5MjQ3NmZiYjIyNWU1ZDlkZWM4NjlmL3NlYzo5M2NhOWJiMDE3OTI0NzZmYmIyMjVlNWQ5ZGVjODY5Zl8zNC9mcmFnOjYwNzFjM2U1NDE4NTRjN2M5MDhmOWM2ZmI5ZGFhNGQ1L3RleHRyZWdpb246NjA3MWMzZTU0MTg1NGM3YzkwOGY5YzZmYjlkYWE0ZDVfNTU3OQ_22755404-4080-40d3-848a-72c114e8f346">Adoption of new accounting pronouncements&lt;div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;On January 1, 2021, the Company adopted ASU No. 2020-01, Investments-Equity Securities (Topic 321), Investments-Equity Method and Joint Ventures (Topic 323), and Derivatives and Hedging (Topic 815) (&#x201c;ASU No. 2020-01&#x201d;). ASU No. 2020-01 clarifies the interaction of accounting for the transition into and out of the equity method as well as measuring certain purchased options and forward contracts to acquire investments. The adoption of ASU No. 2020-01 did not have an impact on the Company&#x2019;s interim condensed consolidated financial statements.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;On January 1, 2021, the Company adopted ASU 2019-12, Income Taxes (Topic 740): Simplifying the Accounting for Income Taxes (&#x201c;ASU No. 2019-12&#x201d;). ASU No. 2019-12 eliminates certain exceptions and simplifies the application of U.S. GAAP-related changes in enacted tax laws or rates and employee stock option plans. The adoption of ASU No. 2019-12 did not have an impact on the Company&#x2019;s interim condensed consolidated financial statements.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt;padding-left:36pt;text-align:justify;text-indent:-36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;(e)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;padding-left:24.91pt"&gt;New accounting pronouncements not yet adopted&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In August 2020, the FASB issued ASU 2020-06, Debt &#x2013;Debt with Conversion and Other Options (Subtopic 470-20) and Derivatives and Hedging&#x2014;Contracts in Entity&#x2019;s Own Equity (Subtopic 815&#x2013;40) (&#x201c;ASU No. 2020-06&#x201d;). ASU No. 2020-06 simplifies the accounting for certain financial instruments with characteristics of liabilities and equity, including convertible instruments and contracts on an entity&#x2019;s own equity. ASU No. 2020-06 is part of the FASB&#x2019;s simplification initiative, which aims to reduce unnecessary complexity in U.S. GAAP. ASU No. 2020-06 is effective for fiscal years beginning after December 15, 2021, and interim periods within those fiscal years. The Company is currently evaluating the impact ASU No. 2020-06 will have on its condensed consolidated financial statements.&lt;/span&gt;&lt;/div&gt;</us-gaap:NewAccountingPronouncementsPolicyPolicyTextBlock>
    <us-gaap:InventoryDisclosureTextBlock
      contextRef="i69782326f71a44e3805518280ee22b6b_D20210101-20210630"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzY2E5YmIwMTc5MjQ3NmZiYjIyNWU1ZDlkZWM4NjlmL3NlYzo5M2NhOWJiMDE3OTI0NzZmYmIyMjVlNWQ5ZGVjODY5Zl8zNy9mcmFnOjdhYTdjOTAyNzgxNDRiNTI5Njg1NmQ3OGRiNGFjMTc5L3RleHRyZWdpb246N2FhN2M5MDI3ODE0NGI1Mjk2ODU2ZDc4ZGI0YWMxNzlfMzMz_a1855cac-6d36-473c-bef2-e6da9691c29a">Inventory, net&lt;div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Inventory, net is comprised of the following items:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:59.733%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.605%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:16.816%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.327%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:16.819%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;As of June&#160;30, 2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;As of December 31, 2020&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Raw materials&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7,471&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;11,489&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Work-in-progress&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;17,291&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;26,278&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Finished goods&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;10,247&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5,905&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Supplies and consumables&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;596&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;330&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;35,605&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;44,002&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:12pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Inventory is written down for any obsolescence such as slow-moving or non-marketable products, or when the net realizable value of inventory is less than the carrying value. During the three months ended June&#160;30, 2021 and 2020, the Company recorded write-downs related to inventory of $11,961 and $3,062, respectively. During the six months ended June&#160;30, 2021 and 2020, the Company recorded write-downs related to inventory of $11,961 and $11,024, respectively.&lt;/span&gt;&lt;/div&gt;</us-gaap:InventoryDisclosureTextBlock>
    <us-gaap:ScheduleOfInventoryCurrentTableTextBlock
      contextRef="i69782326f71a44e3805518280ee22b6b_D20210101-20210630"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzY2E5YmIwMTc5MjQ3NmZiYjIyNWU1ZDlkZWM4NjlmL3NlYzo5M2NhOWJiMDE3OTI0NzZmYmIyMjVlNWQ5ZGVjODY5Zl8zNy9mcmFnOjdhYTdjOTAyNzgxNDRiNTI5Njg1NmQ3OGRiNGFjMTc5L3RleHRyZWdpb246N2FhN2M5MDI3ODE0NGI1Mjk2ODU2ZDc4ZGI0YWMxNzlfMzM0_250c8786-f063-49a9-b06d-60aa2a2e7b93">&lt;div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Inventory, net is comprised of the following items:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:59.733%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.605%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:16.816%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.327%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:16.819%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;As of June&#160;30, 2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;As of December 31, 2020&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Raw materials&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7,471&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;11,489&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Work-in-progress&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;17,291&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;26,278&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Finished goods&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;10,247&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5,905&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Supplies and consumables&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;596&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;330&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;35,605&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;44,002&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:ScheduleOfInventoryCurrentTableTextBlock>
    <us-gaap:InventoryRawMaterialsNetOfReserves
      contextRef="i225f85e38faa4bbdb4de1d8b9cf369bb_I20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzY2E5YmIwMTc5MjQ3NmZiYjIyNWU1ZDlkZWM4NjlmL3NlYzo5M2NhOWJiMDE3OTI0NzZmYmIyMjVlNWQ5ZGVjODY5Zl8zNy9mcmFnOjdhYTdjOTAyNzgxNDRiNTI5Njg1NmQ3OGRiNGFjMTc5L3RhYmxlOmNjY2U3ODc4ZWNiMjQ1NjhhNmRiZDczMWQ5MGYzODRjL3RhYmxlcmFuZ2U6Y2NjZTc4NzhlY2IyNDU2OGE2ZGJkNzMxZDkwZjM4NGNfMS0yLTEtMS0w_e1e96ccd-e9c9-481e-a2ea-f5f19f7972b9"
      unitRef="usd">7471000</us-gaap:InventoryRawMaterialsNetOfReserves>
    <us-gaap:InventoryRawMaterialsNetOfReserves
      contextRef="ifbe16ec51ea244519b77d6036b4ef038_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzY2E5YmIwMTc5MjQ3NmZiYjIyNWU1ZDlkZWM4NjlmL3NlYzo5M2NhOWJiMDE3OTI0NzZmYmIyMjVlNWQ5ZGVjODY5Zl8zNy9mcmFnOjdhYTdjOTAyNzgxNDRiNTI5Njg1NmQ3OGRiNGFjMTc5L3RhYmxlOmNjY2U3ODc4ZWNiMjQ1NjhhNmRiZDczMWQ5MGYzODRjL3RhYmxlcmFuZ2U6Y2NjZTc4NzhlY2IyNDU2OGE2ZGJkNzMxZDkwZjM4NGNfMS00LTEtMS0w_c43bf9c8-c275-4842-bcb1-c172a76f7e42"
      unitRef="usd">11489000</us-gaap:InventoryRawMaterialsNetOfReserves>
    <us-gaap:InventoryWorkInProcessNetOfReserves
      contextRef="i225f85e38faa4bbdb4de1d8b9cf369bb_I20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzY2E5YmIwMTc5MjQ3NmZiYjIyNWU1ZDlkZWM4NjlmL3NlYzo5M2NhOWJiMDE3OTI0NzZmYmIyMjVlNWQ5ZGVjODY5Zl8zNy9mcmFnOjdhYTdjOTAyNzgxNDRiNTI5Njg1NmQ3OGRiNGFjMTc5L3RhYmxlOmNjY2U3ODc4ZWNiMjQ1NjhhNmRiZDczMWQ5MGYzODRjL3RhYmxlcmFuZ2U6Y2NjZTc4NzhlY2IyNDU2OGE2ZGJkNzMxZDkwZjM4NGNfMi0yLTEtMS0w_f20d1a79-4cf1-4a5c-9a6c-ae982f5e72ce"
      unitRef="usd">17291000</us-gaap:InventoryWorkInProcessNetOfReserves>
    <us-gaap:InventoryWorkInProcessNetOfReserves
      contextRef="ifbe16ec51ea244519b77d6036b4ef038_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzY2E5YmIwMTc5MjQ3NmZiYjIyNWU1ZDlkZWM4NjlmL3NlYzo5M2NhOWJiMDE3OTI0NzZmYmIyMjVlNWQ5ZGVjODY5Zl8zNy9mcmFnOjdhYTdjOTAyNzgxNDRiNTI5Njg1NmQ3OGRiNGFjMTc5L3RhYmxlOmNjY2U3ODc4ZWNiMjQ1NjhhNmRiZDczMWQ5MGYzODRjL3RhYmxlcmFuZ2U6Y2NjZTc4NzhlY2IyNDU2OGE2ZGJkNzMxZDkwZjM4NGNfMi00LTEtMS0w_37de6886-f70a-4cbd-8f42-529b2ce9b409"
      unitRef="usd">26278000</us-gaap:InventoryWorkInProcessNetOfReserves>
    <us-gaap:InventoryFinishedGoodsNetOfReserves
      contextRef="i225f85e38faa4bbdb4de1d8b9cf369bb_I20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzY2E5YmIwMTc5MjQ3NmZiYjIyNWU1ZDlkZWM4NjlmL3NlYzo5M2NhOWJiMDE3OTI0NzZmYmIyMjVlNWQ5ZGVjODY5Zl8zNy9mcmFnOjdhYTdjOTAyNzgxNDRiNTI5Njg1NmQ3OGRiNGFjMTc5L3RhYmxlOmNjY2U3ODc4ZWNiMjQ1NjhhNmRiZDczMWQ5MGYzODRjL3RhYmxlcmFuZ2U6Y2NjZTc4NzhlY2IyNDU2OGE2ZGJkNzMxZDkwZjM4NGNfMy0yLTEtMS0w_9611d78a-9159-4cd5-83ed-7449d972779f"
      unitRef="usd">10247000</us-gaap:InventoryFinishedGoodsNetOfReserves>
    <us-gaap:InventoryFinishedGoodsNetOfReserves
      contextRef="ifbe16ec51ea244519b77d6036b4ef038_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzY2E5YmIwMTc5MjQ3NmZiYjIyNWU1ZDlkZWM4NjlmL3NlYzo5M2NhOWJiMDE3OTI0NzZmYmIyMjVlNWQ5ZGVjODY5Zl8zNy9mcmFnOjdhYTdjOTAyNzgxNDRiNTI5Njg1NmQ3OGRiNGFjMTc5L3RhYmxlOmNjY2U3ODc4ZWNiMjQ1NjhhNmRiZDczMWQ5MGYzODRjL3RhYmxlcmFuZ2U6Y2NjZTc4NzhlY2IyNDU2OGE2ZGJkNzMxZDkwZjM4NGNfMy00LTEtMS0w_0dfec015-e3ab-40e6-a71c-a49b249c4de5"
      unitRef="usd">5905000</us-gaap:InventoryFinishedGoodsNetOfReserves>
    <us-gaap:InventorySuppliesNetOfReserves
      contextRef="i225f85e38faa4bbdb4de1d8b9cf369bb_I20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzY2E5YmIwMTc5MjQ3NmZiYjIyNWU1ZDlkZWM4NjlmL3NlYzo5M2NhOWJiMDE3OTI0NzZmYmIyMjVlNWQ5ZGVjODY5Zl8zNy9mcmFnOjdhYTdjOTAyNzgxNDRiNTI5Njg1NmQ3OGRiNGFjMTc5L3RhYmxlOmNjY2U3ODc4ZWNiMjQ1NjhhNmRiZDczMWQ5MGYzODRjL3RhYmxlcmFuZ2U6Y2NjZTc4NzhlY2IyNDU2OGE2ZGJkNzMxZDkwZjM4NGNfNi0yLTEtMS0w_d7caeb90-4819-4600-a177-5fd3e62f17af"
      unitRef="usd">596000</us-gaap:InventorySuppliesNetOfReserves>
    <us-gaap:InventorySuppliesNetOfReserves
      contextRef="ifbe16ec51ea244519b77d6036b4ef038_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzY2E5YmIwMTc5MjQ3NmZiYjIyNWU1ZDlkZWM4NjlmL3NlYzo5M2NhOWJiMDE3OTI0NzZmYmIyMjVlNWQ5ZGVjODY5Zl8zNy9mcmFnOjdhYTdjOTAyNzgxNDRiNTI5Njg1NmQ3OGRiNGFjMTc5L3RhYmxlOmNjY2U3ODc4ZWNiMjQ1NjhhNmRiZDczMWQ5MGYzODRjL3RhYmxlcmFuZ2U6Y2NjZTc4NzhlY2IyNDU2OGE2ZGJkNzMxZDkwZjM4NGNfNi00LTEtMS0w_87a55435-c86d-43bc-82ac-b1c3160fb3aa"
      unitRef="usd">330000</us-gaap:InventorySuppliesNetOfReserves>
    <us-gaap:InventoryNet
      contextRef="i225f85e38faa4bbdb4de1d8b9cf369bb_I20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzY2E5YmIwMTc5MjQ3NmZiYjIyNWU1ZDlkZWM4NjlmL3NlYzo5M2NhOWJiMDE3OTI0NzZmYmIyMjVlNWQ5ZGVjODY5Zl8zNy9mcmFnOjdhYTdjOTAyNzgxNDRiNTI5Njg1NmQ3OGRiNGFjMTc5L3RhYmxlOmNjY2U3ODc4ZWNiMjQ1NjhhNmRiZDczMWQ5MGYzODRjL3RhYmxlcmFuZ2U6Y2NjZTc4NzhlY2IyNDU2OGE2ZGJkNzMxZDkwZjM4NGNfNy0yLTEtMS0w_b3594964-c55d-4c82-a39d-907f682455b2"
      unitRef="usd">35605000</us-gaap:InventoryNet>
    <us-gaap:InventoryNet
      contextRef="ifbe16ec51ea244519b77d6036b4ef038_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzY2E5YmIwMTc5MjQ3NmZiYjIyNWU1ZDlkZWM4NjlmL3NlYzo5M2NhOWJiMDE3OTI0NzZmYmIyMjVlNWQ5ZGVjODY5Zl8zNy9mcmFnOjdhYTdjOTAyNzgxNDRiNTI5Njg1NmQ3OGRiNGFjMTc5L3RhYmxlOmNjY2U3ODc4ZWNiMjQ1NjhhNmRiZDczMWQ5MGYzODRjL3RhYmxlcmFuZ2U6Y2NjZTc4NzhlY2IyNDU2OGE2ZGJkNzMxZDkwZjM4NGNfNy00LTEtMS0w_a9573f21-d9da-4578-bf4e-f59a45cc6f6b"
      unitRef="usd">44002000</us-gaap:InventoryNet>
    <us-gaap:InventoryWriteDown
      contextRef="i27f4e53b91ad4367b7f8d273eff27769_D20210401-20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzY2E5YmIwMTc5MjQ3NmZiYjIyNWU1ZDlkZWM4NjlmL3NlYzo5M2NhOWJiMDE3OTI0NzZmYmIyMjVlNWQ5ZGVjODY5Zl8zNy9mcmFnOjdhYTdjOTAyNzgxNDRiNTI5Njg1NmQ3OGRiNGFjMTc5L3RleHRyZWdpb246N2FhN2M5MDI3ODE0NGI1Mjk2ODU2ZDc4ZGI0YWMxNzlfNDk0NzgwMjMyNTcyNg_07458092-2095-4159-b4a6-34fbda5e72d5"
      unitRef="usd">11961000</us-gaap:InventoryWriteDown>
    <us-gaap:InventoryWriteDown
      contextRef="i39065c5daf934af885335c12f3cfa83f_D20200401-20200630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzY2E5YmIwMTc5MjQ3NmZiYjIyNWU1ZDlkZWM4NjlmL3NlYzo5M2NhOWJiMDE3OTI0NzZmYmIyMjVlNWQ5ZGVjODY5Zl8zNy9mcmFnOjdhYTdjOTAyNzgxNDRiNTI5Njg1NmQ3OGRiNGFjMTc5L3RleHRyZWdpb246N2FhN2M5MDI3ODE0NGI1Mjk2ODU2ZDc4ZGI0YWMxNzlfNDk0NzgwMjMyNTc1Mg_10cd58b4-15f4-4d29-aaa3-c5a277c7bac5"
      unitRef="usd">3062000</us-gaap:InventoryWriteDown>
    <us-gaap:InventoryWriteDown
      contextRef="i69782326f71a44e3805518280ee22b6b_D20210101-20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzY2E5YmIwMTc5MjQ3NmZiYjIyNWU1ZDlkZWM4NjlmL3NlYzo5M2NhOWJiMDE3OTI0NzZmYmIyMjVlNWQ5ZGVjODY5Zl8zNy9mcmFnOjdhYTdjOTAyNzgxNDRiNTI5Njg1NmQ3OGRiNGFjMTc5L3RleHRyZWdpb246N2FhN2M5MDI3ODE0NGI1Mjk2ODU2ZDc4ZGI0YWMxNzlfNDk0NzgwMjMyNTg1MQ_1728fb08-fd08-4b6e-9305-7ef94115d19d"
      unitRef="usd">11961000</us-gaap:InventoryWriteDown>
    <us-gaap:InventoryWriteDown
      contextRef="i4a110e4972ef4113880ce582e3cda5c5_D20200101-20200630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzY2E5YmIwMTc5MjQ3NmZiYjIyNWU1ZDlkZWM4NjlmL3NlYzo5M2NhOWJiMDE3OTI0NzZmYmIyMjVlNWQ5ZGVjODY5Zl8zNy9mcmFnOjdhYTdjOTAyNzgxNDRiNTI5Njg1NmQ3OGRiNGFjMTc5L3RleHRyZWdpb246N2FhN2M5MDI3ODE0NGI1Mjk2ODU2ZDc4ZGI0YWMxNzlfNDk0NzgwMjMyNTg1OQ_ef2a2995-09c4-4e1e-8fe6-a90472624070"
      unitRef="usd">11024000</us-gaap:InventoryWriteDown>
    <us-gaap:EquityMethodInvestmentsDisclosureTextBlock
      contextRef="i69782326f71a44e3805518280ee22b6b_D20210101-20210630"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzY2E5YmIwMTc5MjQ3NmZiYjIyNWU1ZDlkZWM4NjlmL3NlYzo5M2NhOWJiMDE3OTI0NzZmYmIyMjVlNWQ5ZGVjODY5Zl80MC9mcmFnOjQwNDNmMGZmZDk0ZjRjOWNiYzg4MjA0YTc0ODU5YjA1L3RleHRyZWdpb246NDA0M2YwZmZkOTRmNGM5Y2JjODgyMDRhNzQ4NTliMDVfNDMyMg_d5789681-d467-4101-9c43-b2ff66eb1057">Investments&lt;div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;(a)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;padding-left:24.34pt"&gt;Variable interest entities and investments in equity accounted investees, net&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company holds variable interests in Cronos Growing Company Inc. (&#x201c;Cronos GrowCo&#x201d;), Natuera S.&#xe0;.r.l (&#x201c;Natuera&#x201d;), MedMen Canada Inc. (&#x201c;MedMen Canada&#x201d;) and Cannasoul Lab Services Ltd. (&#x201c;CLS&#x201d;). The Company&#x2019;s investments in Cronos GrowCo, Natuera and MedMen Canada are exposed to economic variability from each entity&#x2019;s performance; however, the Company does not consolidate the entities as it does not have the power to direct the activities that most significantly impact each entity&#x2019;s economic performance. Thus, Cronos Group is not considered the primary beneficiary of each entity. These investments are accounted for as equity method investments classified as &#x201c;Investments in equity accounted investees, net&#x201d; in the consolidated balance sheets.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Cronos GrowCo is a joint venture incorporated under the Canada Business Corporations Act (&#x201c;CBCA&#x201d;) on June 14, 2018 with the objective of cultivating and commercializing cannabis and cannabis products. Cronos Group holds variable interests in Cronos GrowCo through its ownership of 50% of Cronos GrowCo&#x2019;s common shares and senior secured debt. Cronos GrowCo&#x2019;s economic performance is driven by the quantity and strains of cannabis grown. The joint venture partners mutually determine the quantity and strains of cannabis grown.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;MedMen Canada is a joint venture incorporated under the CBCA on March 13, 2018, with the objective of the retail sale and marketing of cannabis products in Canada. MedMen Canada holds the exclusive license to the MedMen brand in Canada for a minimum term of 20 years. The Company holds variable interests in MedMen Canada through its ownership of 50% of MedMen Canada&#x2019;s common shares and other subordinated debt. MedMen Canada&#x2019;s economic performance is driven by the quantity and strains of cannabis sold. Subject to applicable law, the joint venture partners mutually determine the quantity and strains of cannabis to be sold in MedMen Canada&#x2019;s retail stores, if and when stores are opened. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Natuera is a joint venture registered in Luxembourg with the objective of cultivating and commercializing hemp and cannabis products. The Company holds variable interests in Natuera through its ownership of 50% of Natuera&#x2019;s common shares. Natuera&#x2019;s economic performance is driven by the quantity and strains of cannabis grown, which is mutually determined by the joint venture partners.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;CLS is a wholly owned subsidiary of Cannasoul Analytics Ltd., incorporated with the purpose of establishing a commercial cannabis analytical testing laboratory located on the premises of Cronos Israel (the &#x201c;Cannasoul Collaboration&#x201d;). Cronos Israel agreed to advance up to ILS 8,297 ($2,511) by a non-recourse loan (the &#x201c;Cannasoul Collaboration Loan&#x201d;) to CLS over a period of two years from April 1, 2020 for the capital and operating expenditures of the laboratory. The loan bears interest at 3.5% annually. Cronos Israel will receive 70% of the profits of the laboratory until such time as it has recovered 150% of the amounts advanced to CLS, after which time it will receive 50% of the laboratory profits. As a result, the Company is exposed to economic variability from CLS&#x2019;s performance. The Company does not consolidate CLS as it does not have the power to direct the activities that most significantly impact the entity&#x2019;s economic performance; thus, the Company is not considered the primary beneficiary of the entity. The carrying amount of the non-recourse loan is recorded under loans receivable and the full loan amount, ILS 8,297, represents the Company&#x2019;s maximum potential exposure to losses through the Cannasoul Collaboration. See Note 4. Loans Receivable, net for further information regarding loans receivable.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;A reconciliation of the carrying amount of the investments in associates and joint ventures is as follows:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:45.844%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:15.566%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.327%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:15.566%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.327%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:15.570%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Ownership interest&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;As of June&#160;30, 2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;As of December 31, 2020&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Cronos Australia&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;31%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Cronos GrowCo&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;50%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;19,022&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;19,235&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Natuera&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(i)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;50%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,948&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;20,970&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;19,235&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:3pt;padding-left:27pt;text-align:justify;text-indent:-27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:700;line-height:120%;position:relative;top:-2.8pt;vertical-align:baseline"&gt;(i)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:22.1pt"&gt;On April 1, 2021, the Company and an affiliate of Agroidea (&#x201c;AGI&#x201d;), the other joint venture partner of Natuera, converted all advances made to Natuera under the master loan agreement entered into with Natuera on September 27, 2019 (the &#x201c;Natuera Series A Loan&#x201d;), plus accrued interest, into equity of Natuera. Total aggregate gross advances to Natuera under the Natuera Series A Loan were $15,500, of which the Company advanced 50% and AGI advanced the remaining 50%, or $7,750 each. As a result, the Company transferred the carrying value of the Natuera Series A Loan of approximately $2,013 plus accrued interest of $540, for a total investment value of $2,553, which approximates fair value, to investments in equity accounted investees in respect of Natuera. See Note 4. Loans Receivable, net.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:12pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company&#x2019;s share of net losses from equity investments accounted for under the equity method of accounting:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:41.677%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.788%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.355%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.788%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.355%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.788%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.355%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.794%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;For the three months ended June&#160;30,&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;For the six months ended June&#160;30,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Cronos Australia&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(235)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(235)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Cronos GrowCo&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(459)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(190)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(758)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(501)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Natuera&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(656)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(369)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(2,000)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1,230)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1,115)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(794)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(2,758)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1,966)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:12pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company determined that the maximum exposure of loss on investments in non-consolidated investments is limited to the Company&#x2019;s initial investment, advances and/or loans for each variable interest entity. The following is a summary of the maximum exposure to loss as of June&#160;30, 2021 and December&#160;31, 2020:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:47.788%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:15.566%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.355%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:15.566%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.355%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:15.570%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Ownership interest&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;As of June&#160;30, 2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;As of December 31, 2020&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Cronos Australia&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;31%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,573&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,530&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Cronos GrowCo&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;50%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;21,723&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;21,125&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;MedMen Canada&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;50%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;494&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;467&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Natuera&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;50%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;8,047&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;8,154&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;31,837&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;31,276&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;(b)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;padding-left:23.78pt"&gt;Other investments&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Other investments consist of investments in options of companies in the cannabis industry.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;On June 14, 2021, the Company purchased an option to acquire 473,787 shares of Class A Common Stock of PharmaCann, Inc. (&#x201c;PharmaCann&#x201d;), a vertically integrated cannabis company in the United States, at an exercise price of $0.0001 per share, representing approximately 10.5% of PharmaCann&#x2019;s issued and outstanding capital stock on a fully diluted basis, for an aggregate purchase price of approximately $110,392. The option exercise will be based upon various factors, including the status of U.S. federal cannabis legalization, as well as regulatory approvals, including in the states where PharmaCann operates that may be required upon exercise. This option is classified as an equity security without a readily determinable fair value. The Company has elected to measure the fair value of the option at cost less impairment, if any, and subsequently adjusted for observable price changes in orderly transactions for the identical or a similar investment of the same issuer. The option is reported as other investments on the condensed consolidated balance sheet for the period ended June 30, 2021. As of June 30, 2021 and December 31, 2020, the Company did not hold any additional other investments.&lt;/span&gt;&lt;/div&gt;</us-gaap:EquityMethodInvestmentsDisclosureTextBlock>
    <us-gaap:VariableInterestEntityOwnershipPercentage
      contextRef="i2c5e7037ffad4b3fb6a481d2db070fa0_D20180614-20180614"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzY2E5YmIwMTc5MjQ3NmZiYjIyNWU1ZDlkZWM4NjlmL3NlYzo5M2NhOWJiMDE3OTI0NzZmYmIyMjVlNWQ5ZGVjODY5Zl80MC9mcmFnOjQwNDNmMGZmZDk0ZjRjOWNiYzg4MjA0YTc0ODU5YjA1L3RleHRyZWdpb246NDA0M2YwZmZkOTRmNGM5Y2JjODgyMDRhNzQ4NTliMDVfMTA0NDUzNjA0NzcwNDA_9f53f937-691f-4be1-b490-6352142f2773"
      unitRef="number">0.50</us-gaap:VariableInterestEntityOwnershipPercentage>
    <cron:VariableInterestEntityQualitativeOrQuantitativeInformationLicenseTerm
      contextRef="i5fb990fe11674db5b7f9322fbc74ed16_D20180313-20180313"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzY2E5YmIwMTc5MjQ3NmZiYjIyNWU1ZDlkZWM4NjlmL3NlYzo5M2NhOWJiMDE3OTI0NzZmYmIyMjVlNWQ5ZGVjODY5Zl80MC9mcmFnOjQwNDNmMGZmZDk0ZjRjOWNiYzg4MjA0YTc0ODU5YjA1L3RleHRyZWdpb246NDA0M2YwZmZkOTRmNGM5Y2JjODgyMDRhNzQ4NTliMDVfOTky_4fb7ddbe-984b-4767-b2f4-507c4fe08821">P20Y</cron:VariableInterestEntityQualitativeOrQuantitativeInformationLicenseTerm>
    <us-gaap:VariableInterestEntityOwnershipPercentage
      contextRef="iee8bd06f99704a93846316c2ce890297_D20180313-20180313"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzY2E5YmIwMTc5MjQ3NmZiYjIyNWU1ZDlkZWM4NjlmL3NlYzo5M2NhOWJiMDE3OTI0NzZmYmIyMjVlNWQ5ZGVjODY5Zl80MC9mcmFnOjQwNDNmMGZmZDk0ZjRjOWNiYzg4MjA0YTc0ODU5YjA1L3RleHRyZWdpb246NDA0M2YwZmZkOTRmNGM5Y2JjODgyMDRhNzQ4NTliMDVfMTA3Ng_d9956711-0a82-4932-85a5-220740ddc022"
      unitRef="number">0.50</us-gaap:VariableInterestEntityOwnershipPercentage>
    <us-gaap:VariableInterestEntityOwnershipPercentage
      contextRef="i2dd929bbe65b485fba3ba327ce7e73d7_D20210101-20210630"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzY2E5YmIwMTc5MjQ3NmZiYjIyNWU1ZDlkZWM4NjlmL3NlYzo5M2NhOWJiMDE3OTI0NzZmYmIyMjVlNWQ5ZGVjODY5Zl80MC9mcmFnOjQwNDNmMGZmZDk0ZjRjOWNiYzg4MjA0YTc0ODU5YjA1L3RleHRyZWdpb246NDA0M2YwZmZkOTRmNGM5Y2JjODgyMDRhNzQ4NTliMDVfMTYyMw_99b12980-172a-4ad9-8fac-2189190ec59c"
      unitRef="number">0.50</us-gaap:VariableInterestEntityOwnershipPercentage>
    <cron:CollaborativeArrangementAmountOfAdvances
      contextRef="i00bf33a48aaa4cf2930896225af28659_I20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzY2E5YmIwMTc5MjQ3NmZiYjIyNWU1ZDlkZWM4NjlmL3NlYzo5M2NhOWJiMDE3OTI0NzZmYmIyMjVlNWQ5ZGVjODY5Zl80MC9mcmFnOjQwNDNmMGZmZDk0ZjRjOWNiYzg4MjA0YTc0ODU5YjA1L3RleHRyZWdpb246NDA0M2YwZmZkOTRmNGM5Y2JjODgyMDRhNzQ4NTliMDVfMjY0OQ_bd73200f-b5d6-4f2d-84d1-b97df58413df"
      unitRef="ils">8297000</cron:CollaborativeArrangementAmountOfAdvances>
    <cron:CollaborativeArrangementAmountOfAdvances
      contextRef="i00bf33a48aaa4cf2930896225af28659_I20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzY2E5YmIwMTc5MjQ3NmZiYjIyNWU1ZDlkZWM4NjlmL3NlYzo5M2NhOWJiMDE3OTI0NzZmYmIyMjVlNWQ5ZGVjODY5Zl80MC9mcmFnOjQwNDNmMGZmZDk0ZjRjOWNiYzg4MjA0YTc0ODU5YjA1L3RleHRyZWdpb246NDA0M2YwZmZkOTRmNGM5Y2JjODgyMDRhNzQ4NTliMDVfMjY1Mw_ec3aa220-4513-46c8-bd28-ea6567c30df6"
      unitRef="usd">2511000</cron:CollaborativeArrangementAmountOfAdvances>
    <cron:CollaborativeArrangementTermOfAgreement
      contextRef="ic24b8af14f4a4a25a1f88b1707e38fa7_D20210101-20210630"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzY2E5YmIwMTc5MjQ3NmZiYjIyNWU1ZDlkZWM4NjlmL3NlYzo5M2NhOWJiMDE3OTI0NzZmYmIyMjVlNWQ5ZGVjODY5Zl80MC9mcmFnOjQwNDNmMGZmZDk0ZjRjOWNiYzg4MjA0YTc0ODU5YjA1L3RleHRyZWdpb246NDA0M2YwZmZkOTRmNGM5Y2JjODgyMDRhNzQ4NTliMDVfMjcwNA_e283aa17-a8bc-4567-bc76-ad6e2021cef3">P2Y</cron:CollaborativeArrangementTermOfAgreement>
    <us-gaap:DebtInstrumentInterestRateStatedPercentage
      contextRef="i00bf33a48aaa4cf2930896225af28659_I20210630"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzY2E5YmIwMTc5MjQ3NmZiYjIyNWU1ZDlkZWM4NjlmL3NlYzo5M2NhOWJiMDE3OTI0NzZmYmIyMjVlNWQ5ZGVjODY5Zl80MC9mcmFnOjQwNDNmMGZmZDk0ZjRjOWNiYzg4MjA0YTc0ODU5YjA1L3RleHRyZWdpb246NDA0M2YwZmZkOTRmNGM5Y2JjODgyMDRhNzQ4NTliMDVfMjgxNQ_a5bf95ee-9d34-414e-816d-0c823ee31e8c"
      unitRef="number">0.035</us-gaap:DebtInstrumentInterestRateStatedPercentage>
    <cron:CollaborativeArrangementPercentageOfProfitsToBeReceived
      contextRef="i5822a176b17c44938c5acb5edec46594_I20210630"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzY2E5YmIwMTc5MjQ3NmZiYjIyNWU1ZDlkZWM4NjlmL3NlYzo5M2NhOWJiMDE3OTI0NzZmYmIyMjVlNWQ5ZGVjODY5Zl80MC9mcmFnOjQwNDNmMGZmZDk0ZjRjOWNiYzg4MjA0YTc0ODU5YjA1L3RleHRyZWdpb246NDA0M2YwZmZkOTRmNGM5Y2JjODgyMDRhNzQ4NTliMDVfMjg1NQ_35f177b0-8c0c-44cd-8d72-403ed2879147"
      unitRef="number">0.70</cron:CollaborativeArrangementPercentageOfProfitsToBeReceived>
    <cron:CollaborativeArrangementProfitsToBeReceivedMaximumPercentageOfAmountsAdvanced
      contextRef="i5822a176b17c44938c5acb5edec46594_I20210630"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzY2E5YmIwMTc5MjQ3NmZiYjIyNWU1ZDlkZWM4NjlmL3NlYzo5M2NhOWJiMDE3OTI0NzZmYmIyMjVlNWQ5ZGVjODY5Zl80MC9mcmFnOjQwNDNmMGZmZDk0ZjRjOWNiYzg4MjA0YTc0ODU5YjA1L3RleHRyZWdpb246NDA0M2YwZmZkOTRmNGM5Y2JjODgyMDRhNzQ4NTliMDVfMjkyNw_0d2dd3f1-7720-421a-a35e-f475a6716728"
      unitRef="number">1.50</cron:CollaborativeArrangementProfitsToBeReceivedMaximumPercentageOfAmountsAdvanced>
    <cron:CollaborativeArrangementPercentageOfProfitsToBeReceivedTriggeringEventSubsequentToMaximumPercentageOfAmountsAdvancedBeingMet
      contextRef="i5822a176b17c44938c5acb5edec46594_I20210630"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzY2E5YmIwMTc5MjQ3NmZiYjIyNWU1ZDlkZWM4NjlmL3NlYzo5M2NhOWJiMDE3OTI0NzZmYmIyMjVlNWQ5ZGVjODY5Zl80MC9mcmFnOjQwNDNmMGZmZDk0ZjRjOWNiYzg4MjA0YTc0ODU5YjA1L3RleHRyZWdpb246NDA0M2YwZmZkOTRmNGM5Y2JjODgyMDRhNzQ4NTliMDVfMjk5NQ_ec880521-01a0-4d82-8542-3592ae693595"
      unitRef="number">0.50</cron:CollaborativeArrangementPercentageOfProfitsToBeReceivedTriggeringEventSubsequentToMaximumPercentageOfAmountsAdvancedBeingMet>
    <cron:CollaborativeArrangementAmountOfAdvances
      contextRef="i00bf33a48aaa4cf2930896225af28659_I20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzY2E5YmIwMTc5MjQ3NmZiYjIyNWU1ZDlkZWM4NjlmL3NlYzo5M2NhOWJiMDE3OTI0NzZmYmIyMjVlNWQ5ZGVjODY5Zl80MC9mcmFnOjQwNDNmMGZmZDk0ZjRjOWNiYzg4MjA0YTc0ODU5YjA1L3RleHRyZWdpb246NDA0M2YwZmZkOTRmNGM5Y2JjODgyMDRhNzQ4NTliMDVfMzQ1Mg_259e1f5c-a09b-459c-96e6-9c3d0eb711c1"
      unitRef="ils">8297000</cron:CollaborativeArrangementAmountOfAdvances>
    <us-gaap:EquityMethodInvestmentsTextBlock
      contextRef="i69782326f71a44e3805518280ee22b6b_D20210101-20210630"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzY2E5YmIwMTc5MjQ3NmZiYjIyNWU1ZDlkZWM4NjlmL3NlYzo5M2NhOWJiMDE3OTI0NzZmYmIyMjVlNWQ5ZGVjODY5Zl80MC9mcmFnOjQwNDNmMGZmZDk0ZjRjOWNiYzg4MjA0YTc0ODU5YjA1L3RleHRyZWdpb246NDA0M2YwZmZkOTRmNGM5Y2JjODgyMDRhNzQ4NTliMDVfNDMyNQ_81b0fa31-7410-44d0-a307-c5275483cd9d">&lt;div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;A reconciliation of the carrying amount of the investments in associates and joint ventures is as follows:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:45.844%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:15.566%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.327%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:15.566%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.327%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:15.570%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Ownership interest&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;As of June&#160;30, 2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;As of December 31, 2020&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Cronos Australia&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;31%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Cronos GrowCo&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;50%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;19,022&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;19,235&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Natuera&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(i)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;50%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,948&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;20,970&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;19,235&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:3pt;padding-left:27pt;text-align:justify;text-indent:-27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:700;line-height:120%;position:relative;top:-2.8pt;vertical-align:baseline"&gt;(i)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:22.1pt"&gt;On April 1, 2021, the Company and an affiliate of Agroidea (&#x201c;AGI&#x201d;), the other joint venture partner of Natuera, converted all advances made to Natuera under the master loan agreement entered into with Natuera on September 27, 2019 (the &#x201c;Natuera Series A Loan&#x201d;), plus accrued interest, into equity of Natuera. Total aggregate gross advances to Natuera under the Natuera Series A Loan were $15,500, of which the Company advanced 50% and AGI advanced the remaining 50%, or $7,750 each. As a result, the Company transferred the carrying value of the Natuera Series A Loan of approximately $2,013 plus accrued interest of $540, for a total investment value of $2,553, which approximates fair value, to investments in equity accounted investees in respect of Natuera. See Note 4. Loans Receivable, net.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:12pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company&#x2019;s share of net losses from equity investments accounted for under the equity method of accounting:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:41.677%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.788%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.355%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.788%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.355%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.788%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.355%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.794%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;For the three months ended June&#160;30,&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;For the six months ended June&#160;30,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Cronos Australia&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(235)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(235)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Cronos GrowCo&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(459)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(190)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(758)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(501)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Natuera&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(656)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(369)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(2,000)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1,230)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1,115)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(794)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(2,758)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1,966)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:EquityMethodInvestmentsTextBlock>
    <us-gaap:EquityMethodInvestmentOwnershipPercentage
      contextRef="i52d0636c66ed4ea58c20dfcc9a4132e8_I20210630"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzY2E5YmIwMTc5MjQ3NmZiYjIyNWU1ZDlkZWM4NjlmL3NlYzo5M2NhOWJiMDE3OTI0NzZmYmIyMjVlNWQ5ZGVjODY5Zl80MC9mcmFnOjQwNDNmMGZmZDk0ZjRjOWNiYzg4MjA0YTc0ODU5YjA1L3RhYmxlOjk4NDBhYjI5YWQyMjQ2ZjdiYjYyOTY1NjRlMjFlZjdlL3RhYmxlcmFuZ2U6OTg0MGFiMjlhZDIyNDZmN2JiNjI5NjU2NGUyMWVmN2VfMS0xLTEtMS0w_ed4abdd2-03be-4511-afb3-af6dc2ba925f"
      unitRef="number">0.31</us-gaap:EquityMethodInvestmentOwnershipPercentage>
    <us-gaap:EquityMethodInvestments
      contextRef="i52d0636c66ed4ea58c20dfcc9a4132e8_I20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzY2E5YmIwMTc5MjQ3NmZiYjIyNWU1ZDlkZWM4NjlmL3NlYzo5M2NhOWJiMDE3OTI0NzZmYmIyMjVlNWQ5ZGVjODY5Zl80MC9mcmFnOjQwNDNmMGZmZDk0ZjRjOWNiYzg4MjA0YTc0ODU5YjA1L3RhYmxlOjk4NDBhYjI5YWQyMjQ2ZjdiYjYyOTY1NjRlMjFlZjdlL3RhYmxlcmFuZ2U6OTg0MGFiMjlhZDIyNDZmN2JiNjI5NjU2NGUyMWVmN2VfMS0zLTEtMS0w_6b3a564d-2112-448f-994f-5d69079379dc"
      unitRef="usd">0</us-gaap:EquityMethodInvestments>
    <us-gaap:EquityMethodInvestments
      contextRef="i78252faeeac94cf1b00fbbab110c7bb8_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzY2E5YmIwMTc5MjQ3NmZiYjIyNWU1ZDlkZWM4NjlmL3NlYzo5M2NhOWJiMDE3OTI0NzZmYmIyMjVlNWQ5ZGVjODY5Zl80MC9mcmFnOjQwNDNmMGZmZDk0ZjRjOWNiYzg4MjA0YTc0ODU5YjA1L3RhYmxlOjk4NDBhYjI5YWQyMjQ2ZjdiYjYyOTY1NjRlMjFlZjdlL3RhYmxlcmFuZ2U6OTg0MGFiMjlhZDIyNDZmN2JiNjI5NjU2NGUyMWVmN2VfMS01LTEtMS0w_6fd5324a-6d8f-4a73-9617-4a6872be3413"
      unitRef="usd">0</us-gaap:EquityMethodInvestments>
    <us-gaap:EquityMethodInvestmentOwnershipPercentage
      contextRef="i994476164a994f30beee53e661ac1a3f_I20210630"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzY2E5YmIwMTc5MjQ3NmZiYjIyNWU1ZDlkZWM4NjlmL3NlYzo5M2NhOWJiMDE3OTI0NzZmYmIyMjVlNWQ5ZGVjODY5Zl80MC9mcmFnOjQwNDNmMGZmZDk0ZjRjOWNiYzg4MjA0YTc0ODU5YjA1L3RhYmxlOjk4NDBhYjI5YWQyMjQ2ZjdiYjYyOTY1NjRlMjFlZjdlL3RhYmxlcmFuZ2U6OTg0MGFiMjlhZDIyNDZmN2JiNjI5NjU2NGUyMWVmN2VfMi0xLTEtMS0w_3620b6bd-565b-4363-99b5-9a1242144c2a"
      unitRef="number">0.50</us-gaap:EquityMethodInvestmentOwnershipPercentage>
    <us-gaap:EquityMethodInvestments
      contextRef="i994476164a994f30beee53e661ac1a3f_I20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzY2E5YmIwMTc5MjQ3NmZiYjIyNWU1ZDlkZWM4NjlmL3NlYzo5M2NhOWJiMDE3OTI0NzZmYmIyMjVlNWQ5ZGVjODY5Zl80MC9mcmFnOjQwNDNmMGZmZDk0ZjRjOWNiYzg4MjA0YTc0ODU5YjA1L3RhYmxlOjk4NDBhYjI5YWQyMjQ2ZjdiYjYyOTY1NjRlMjFlZjdlL3RhYmxlcmFuZ2U6OTg0MGFiMjlhZDIyNDZmN2JiNjI5NjU2NGUyMWVmN2VfMi0zLTEtMS0w_7a3d21a5-7d1a-4746-a0e7-f024a6078dd2"
      unitRef="usd">19022000</us-gaap:EquityMethodInvestments>
    <us-gaap:EquityMethodInvestments
      contextRef="i1b2c600c66ab4356a1aaf56482c504bd_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzY2E5YmIwMTc5MjQ3NmZiYjIyNWU1ZDlkZWM4NjlmL3NlYzo5M2NhOWJiMDE3OTI0NzZmYmIyMjVlNWQ5ZGVjODY5Zl80MC9mcmFnOjQwNDNmMGZmZDk0ZjRjOWNiYzg4MjA0YTc0ODU5YjA1L3RhYmxlOjk4NDBhYjI5YWQyMjQ2ZjdiYjYyOTY1NjRlMjFlZjdlL3RhYmxlcmFuZ2U6OTg0MGFiMjlhZDIyNDZmN2JiNjI5NjU2NGUyMWVmN2VfMi01LTEtMS0w_cd64375b-906d-4557-9837-9db4189a0ea6"
      unitRef="usd">19235000</us-gaap:EquityMethodInvestments>
    <us-gaap:EquityMethodInvestmentOwnershipPercentage
      contextRef="i21b51b5045c34ad2a57cb43054dca216_I20210630"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzY2E5YmIwMTc5MjQ3NmZiYjIyNWU1ZDlkZWM4NjlmL3NlYzo5M2NhOWJiMDE3OTI0NzZmYmIyMjVlNWQ5ZGVjODY5Zl80MC9mcmFnOjQwNDNmMGZmZDk0ZjRjOWNiYzg4MjA0YTc0ODU5YjA1L3RhYmxlOjk4NDBhYjI5YWQyMjQ2ZjdiYjYyOTY1NjRlMjFlZjdlL3RhYmxlcmFuZ2U6OTg0MGFiMjlhZDIyNDZmN2JiNjI5NjU2NGUyMWVmN2VfMy0xLTEtMS0w_d0287586-f1ae-4a8c-8b9f-0a05aca00eac"
      unitRef="number">0.50</us-gaap:EquityMethodInvestmentOwnershipPercentage>
    <us-gaap:EquityMethodInvestments
      contextRef="i21b51b5045c34ad2a57cb43054dca216_I20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzY2E5YmIwMTc5MjQ3NmZiYjIyNWU1ZDlkZWM4NjlmL3NlYzo5M2NhOWJiMDE3OTI0NzZmYmIyMjVlNWQ5ZGVjODY5Zl80MC9mcmFnOjQwNDNmMGZmZDk0ZjRjOWNiYzg4MjA0YTc0ODU5YjA1L3RhYmxlOjk4NDBhYjI5YWQyMjQ2ZjdiYjYyOTY1NjRlMjFlZjdlL3RhYmxlcmFuZ2U6OTg0MGFiMjlhZDIyNDZmN2JiNjI5NjU2NGUyMWVmN2VfMy0zLTEtMS0w_abcdeeae-855d-4c74-8d2a-b4999d09c0fb"
      unitRef="usd">1948000</us-gaap:EquityMethodInvestments>
    <us-gaap:EquityMethodInvestments
      contextRef="i223bb2102d6d47b4988c830f7fa1a159_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzY2E5YmIwMTc5MjQ3NmZiYjIyNWU1ZDlkZWM4NjlmL3NlYzo5M2NhOWJiMDE3OTI0NzZmYmIyMjVlNWQ5ZGVjODY5Zl80MC9mcmFnOjQwNDNmMGZmZDk0ZjRjOWNiYzg4MjA0YTc0ODU5YjA1L3RhYmxlOjk4NDBhYjI5YWQyMjQ2ZjdiYjYyOTY1NjRlMjFlZjdlL3RhYmxlcmFuZ2U6OTg0MGFiMjlhZDIyNDZmN2JiNjI5NjU2NGUyMWVmN2VfMy01LTEtMS0w_9e0f7ae7-0501-4c8c-a8f7-a47e8da51881"
      unitRef="usd">0</us-gaap:EquityMethodInvestments>
    <us-gaap:EquityMethodInvestments
      contextRef="i225f85e38faa4bbdb4de1d8b9cf369bb_I20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzY2E5YmIwMTc5MjQ3NmZiYjIyNWU1ZDlkZWM4NjlmL3NlYzo5M2NhOWJiMDE3OTI0NzZmYmIyMjVlNWQ5ZGVjODY5Zl80MC9mcmFnOjQwNDNmMGZmZDk0ZjRjOWNiYzg4MjA0YTc0ODU5YjA1L3RhYmxlOjk4NDBhYjI5YWQyMjQ2ZjdiYjYyOTY1NjRlMjFlZjdlL3RhYmxlcmFuZ2U6OTg0MGFiMjlhZDIyNDZmN2JiNjI5NjU2NGUyMWVmN2VfNC0zLTEtMS0w_6ac9805e-acfc-4db3-b0ce-19a84ba36c0b"
      unitRef="usd">20970000</us-gaap:EquityMethodInvestments>
    <us-gaap:EquityMethodInvestments
      contextRef="ifbe16ec51ea244519b77d6036b4ef038_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzY2E5YmIwMTc5MjQ3NmZiYjIyNWU1ZDlkZWM4NjlmL3NlYzo5M2NhOWJiMDE3OTI0NzZmYmIyMjVlNWQ5ZGVjODY5Zl80MC9mcmFnOjQwNDNmMGZmZDk0ZjRjOWNiYzg4MjA0YTc0ODU5YjA1L3RhYmxlOjk4NDBhYjI5YWQyMjQ2ZjdiYjYyOTY1NjRlMjFlZjdlL3RhYmxlcmFuZ2U6OTg0MGFiMjlhZDIyNDZmN2JiNjI5NjU2NGUyMWVmN2VfNC01LTEtMS0w_85694d07-4d8f-494a-aaca-3438ee16d333"
      unitRef="usd">19235000</us-gaap:EquityMethodInvestments>
    <cron:InvestmentsInAndAdvancesToAffiliatesAtFairValueAdvancesRepayments
      contextRef="i3851bec177234bbb9f9d96a1e3eab1d3_D20210401-20210401"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzY2E5YmIwMTc5MjQ3NmZiYjIyNWU1ZDlkZWM4NjlmL3NlYzo5M2NhOWJiMDE3OTI0NzZmYmIyMjVlNWQ5ZGVjODY5Zl80MC9mcmFnOjQwNDNmMGZmZDk0ZjRjOWNiYzg4MjA0YTc0ODU5YjA1L3RleHRyZWdpb246NDA0M2YwZmZkOTRmNGM5Y2JjODgyMDRhNzQ4NTliMDVfMTY0OTI2NzQ1MTQ2OA_e66e1c5d-6fc5-475f-8235-dc148c2066f0"
      unitRef="usd">15500000</cron:InvestmentsInAndAdvancesToAffiliatesAtFairValueAdvancesRepayments>
    <cron:InvestmentsInAndAdvancesToAffiliatesFundingCommitmentPercentage
      contextRef="i8b8f1fc37db0427b9d081e7b40a48cc0_I20210401"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzY2E5YmIwMTc5MjQ3NmZiYjIyNWU1ZDlkZWM4NjlmL3NlYzo5M2NhOWJiMDE3OTI0NzZmYmIyMjVlNWQ5ZGVjODY5Zl80MC9mcmFnOjQwNDNmMGZmZDk0ZjRjOWNiYzg4MjA0YTc0ODU5YjA1L3RleHRyZWdpb246NDA0M2YwZmZkOTRmNGM5Y2JjODgyMDRhNzQ4NTliMDVfMTY0OTI2NzQ1MTUwMw_e8b30708-26dd-44d4-b3de-61ded34a7e33"
      unitRef="number">0.50</cron:InvestmentsInAndAdvancesToAffiliatesFundingCommitmentPercentage>
    <cron:InvestmentsInAndAdvancesToAffiliatesFundingCommitmentPercentage
      contextRef="ia926bcff688b4febb81d8fa1a08955dc_I20210401"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzY2E5YmIwMTc5MjQ3NmZiYjIyNWU1ZDlkZWM4NjlmL3NlYzo5M2NhOWJiMDE3OTI0NzZmYmIyMjVlNWQ5ZGVjODY5Zl80MC9mcmFnOjQwNDNmMGZmZDk0ZjRjOWNiYzg4MjA0YTc0ODU5YjA1L3RleHRyZWdpb246NDA0M2YwZmZkOTRmNGM5Y2JjODgyMDRhNzQ4NTliMDVfMTY0OTI2NzQ1MTUzOA_b38b007b-0b80-448f-97a8-266907209040"
      unitRef="number">0.50</cron:InvestmentsInAndAdvancesToAffiliatesFundingCommitmentPercentage>
    <cron:InvestmentsInAndAdvancesToAffiliatesAtFairValueAdvancesRepayments
      contextRef="i3734fffa32be45c299b65b62d227d165_D20210401-20210401"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzY2E5YmIwMTc5MjQ3NmZiYjIyNWU1ZDlkZWM4NjlmL3NlYzo5M2NhOWJiMDE3OTI0NzZmYmIyMjVlNWQ5ZGVjODY5Zl80MC9mcmFnOjQwNDNmMGZmZDk0ZjRjOWNiYzg4MjA0YTc0ODU5YjA1L3RleHRyZWdpb246NDA0M2YwZmZkOTRmNGM5Y2JjODgyMDRhNzQ4NTliMDVfMTY0OTI2NzQ1MTU0Ng_570f0ddb-ed8f-417f-9aa7-b9588fa601bd"
      unitRef="usd">7750000</cron:InvestmentsInAndAdvancesToAffiliatesAtFairValueAdvancesRepayments>
    <cron:InvestmentsInAndAdvancesToAffiliatesAtFairValueAdvancesRepayments
      contextRef="ibb17976a662245c78f9ece050fbca040_D20210401-20210401"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzY2E5YmIwMTc5MjQ3NmZiYjIyNWU1ZDlkZWM4NjlmL3NlYzo5M2NhOWJiMDE3OTI0NzZmYmIyMjVlNWQ5ZGVjODY5Zl80MC9mcmFnOjQwNDNmMGZmZDk0ZjRjOWNiYzg4MjA0YTc0ODU5YjA1L3RleHRyZWdpb246NDA0M2YwZmZkOTRmNGM5Y2JjODgyMDRhNzQ4NTliMDVfMTY0OTI2NzQ1MTU0Ng_5e8e6ec9-499b-4911-950e-d1bcd4129b38"
      unitRef="usd">7750000</cron:InvestmentsInAndAdvancesToAffiliatesAtFairValueAdvancesRepayments>
    <us-gaap:NotesReceivableNet
      contextRef="i74feb9a5e3ba4f03b6af6468c854d7d3_I20210401"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzY2E5YmIwMTc5MjQ3NmZiYjIyNWU1ZDlkZWM4NjlmL3NlYzo5M2NhOWJiMDE3OTI0NzZmYmIyMjVlNWQ5ZGVjODY5Zl80MC9mcmFnOjQwNDNmMGZmZDk0ZjRjOWNiYzg4MjA0YTc0ODU5YjA1L3RleHRyZWdpb246NDA0M2YwZmZkOTRmNGM5Y2JjODgyMDRhNzQ4NTliMDVfMTY0OTI2NzQ1MTY0MQ_679c199f-fd55-482a-97f3-313aceb94b1e"
      unitRef="usd">2013000</us-gaap:NotesReceivableNet>
    <us-gaap:FinancingReceivableAccruedInterestBeforeAllowanceForCreditLoss
      contextRef="i74feb9a5e3ba4f03b6af6468c854d7d3_I20210401"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzY2E5YmIwMTc5MjQ3NmZiYjIyNWU1ZDlkZWM4NjlmL3NlYzo5M2NhOWJiMDE3OTI0NzZmYmIyMjVlNWQ5ZGVjODY5Zl80MC9mcmFnOjQwNDNmMGZmZDk0ZjRjOWNiYzg4MjA0YTc0ODU5YjA1L3RleHRyZWdpb246NDA0M2YwZmZkOTRmNGM5Y2JjODgyMDRhNzQ4NTliMDVfMTY0OTI2NzQ1MTY3MQ_aa069b47-12cd-4847-b730-e43a0ae6dccf"
      unitRef="usd">540000</us-gaap:FinancingReceivableAccruedInterestBeforeAllowanceForCreditLoss>
    <cron:InvestmentsInAndAdvancesToAffiliatesAtFairValueTransferToInvestmentsInEquityAccountedInvestees
      contextRef="i3851bec177234bbb9f9d96a1e3eab1d3_D20210401-20210401"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzY2E5YmIwMTc5MjQ3NmZiYjIyNWU1ZDlkZWM4NjlmL3NlYzo5M2NhOWJiMDE3OTI0NzZmYmIyMjVlNWQ5ZGVjODY5Zl80MC9mcmFnOjQwNDNmMGZmZDk0ZjRjOWNiYzg4MjA0YTc0ODU5YjA1L3RleHRyZWdpb246NDA0M2YwZmZkOTRmNGM5Y2JjODgyMDRhNzQ4NTliMDVfMjE5OTAyMzI3Njc2OA_445bb183-6dab-453b-bcac-16d2b68e28aa"
      unitRef="usd">2553000</cron:InvestmentsInAndAdvancesToAffiliatesAtFairValueTransferToInvestmentsInEquityAccountedInvestees>
    <us-gaap:IncomeLossFromEquityMethodInvestments
      contextRef="i30bada16350b499487452cc45133a766_D20210401-20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzY2E5YmIwMTc5MjQ3NmZiYjIyNWU1ZDlkZWM4NjlmL3NlYzo5M2NhOWJiMDE3OTI0NzZmYmIyMjVlNWQ5ZGVjODY5Zl80MC9mcmFnOjQwNDNmMGZmZDk0ZjRjOWNiYzg4MjA0YTc0ODU5YjA1L3RhYmxlOjg5ZDk2ZDhkYmNiYTQxYjRiY2JmOTE5NzI5ZjNmODI4L3RhYmxlcmFuZ2U6ODlkOTZkOGRiY2JhNDFiNGJjYmY5MTk3MjlmM2Y4MjhfNC0xLTEtMS0w_a4497b5c-9740-4f8e-a8a8-e28a6eb5cb83"
      unitRef="usd">0</us-gaap:IncomeLossFromEquityMethodInvestments>
    <us-gaap:IncomeLossFromEquityMethodInvestments
      contextRef="if1b554f135154a859f4b34c7f4f919c1_D20200401-20200630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzY2E5YmIwMTc5MjQ3NmZiYjIyNWU1ZDlkZWM4NjlmL3NlYzo5M2NhOWJiMDE3OTI0NzZmYmIyMjVlNWQ5ZGVjODY5Zl80MC9mcmFnOjQwNDNmMGZmZDk0ZjRjOWNiYzg4MjA0YTc0ODU5YjA1L3RhYmxlOjg5ZDk2ZDhkYmNiYTQxYjRiY2JmOTE5NzI5ZjNmODI4L3RhYmxlcmFuZ2U6ODlkOTZkOGRiY2JhNDFiNGJjYmY5MTk3MjlmM2Y4MjhfNC0zLTEtMS0w_e866611c-215e-4852-8a21-ff33870143a6"
      unitRef="usd">-235000</us-gaap:IncomeLossFromEquityMethodInvestments>
    <us-gaap:IncomeLossFromEquityMethodInvestments
      contextRef="id0c3e6d83e194fea9819a119d3744bb2_D20210101-20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzY2E5YmIwMTc5MjQ3NmZiYjIyNWU1ZDlkZWM4NjlmL3NlYzo5M2NhOWJiMDE3OTI0NzZmYmIyMjVlNWQ5ZGVjODY5Zl80MC9mcmFnOjQwNDNmMGZmZDk0ZjRjOWNiYzg4MjA0YTc0ODU5YjA1L3RhYmxlOjg5ZDk2ZDhkYmNiYTQxYjRiY2JmOTE5NzI5ZjNmODI4L3RhYmxlcmFuZ2U6ODlkOTZkOGRiY2JhNDFiNGJjYmY5MTk3MjlmM2Y4MjhfNC01LTEtMS0w_6dd6d2d1-20a5-44e6-8eb0-c598ea0f41fc"
      unitRef="usd">0</us-gaap:IncomeLossFromEquityMethodInvestments>
    <us-gaap:IncomeLossFromEquityMethodInvestments
      contextRef="ia01f832913b34cc9857827304dc28007_D20200101-20200630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzY2E5YmIwMTc5MjQ3NmZiYjIyNWU1ZDlkZWM4NjlmL3NlYzo5M2NhOWJiMDE3OTI0NzZmYmIyMjVlNWQ5ZGVjODY5Zl80MC9mcmFnOjQwNDNmMGZmZDk0ZjRjOWNiYzg4MjA0YTc0ODU5YjA1L3RhYmxlOjg5ZDk2ZDhkYmNiYTQxYjRiY2JmOTE5NzI5ZjNmODI4L3RhYmxlcmFuZ2U6ODlkOTZkOGRiY2JhNDFiNGJjYmY5MTk3MjlmM2Y4MjhfNC03LTEtMS0w_977f6cef-617b-44ac-85c1-0c113d1de8a3"
      unitRef="usd">-235000</us-gaap:IncomeLossFromEquityMethodInvestments>
    <us-gaap:IncomeLossFromEquityMethodInvestments
      contextRef="ia802a14b03cd4f04a97ecbdec57e7b1f_D20210401-20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzY2E5YmIwMTc5MjQ3NmZiYjIyNWU1ZDlkZWM4NjlmL3NlYzo5M2NhOWJiMDE3OTI0NzZmYmIyMjVlNWQ5ZGVjODY5Zl80MC9mcmFnOjQwNDNmMGZmZDk0ZjRjOWNiYzg4MjA0YTc0ODU5YjA1L3RhYmxlOjg5ZDk2ZDhkYmNiYTQxYjRiY2JmOTE5NzI5ZjNmODI4L3RhYmxlcmFuZ2U6ODlkOTZkOGRiY2JhNDFiNGJjYmY5MTk3MjlmM2Y4MjhfNS0xLTEtMS0w_848dff2c-febf-4ce5-b668-46cde27ae477"
      unitRef="usd">-459000</us-gaap:IncomeLossFromEquityMethodInvestments>
    <us-gaap:IncomeLossFromEquityMethodInvestments
      contextRef="iddbb1b3540664f4db9ee13a36913a70f_D20200401-20200630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzY2E5YmIwMTc5MjQ3NmZiYjIyNWU1ZDlkZWM4NjlmL3NlYzo5M2NhOWJiMDE3OTI0NzZmYmIyMjVlNWQ5ZGVjODY5Zl80MC9mcmFnOjQwNDNmMGZmZDk0ZjRjOWNiYzg4MjA0YTc0ODU5YjA1L3RhYmxlOjg5ZDk2ZDhkYmNiYTQxYjRiY2JmOTE5NzI5ZjNmODI4L3RhYmxlcmFuZ2U6ODlkOTZkOGRiY2JhNDFiNGJjYmY5MTk3MjlmM2Y4MjhfNS0zLTEtMS0w_6d299b13-68b1-4214-aacc-9ba4ff9a35b8"
      unitRef="usd">-190000</us-gaap:IncomeLossFromEquityMethodInvestments>
    <us-gaap:IncomeLossFromEquityMethodInvestments
      contextRef="i9f733a1140c84f8286365160805bda02_D20210101-20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzY2E5YmIwMTc5MjQ3NmZiYjIyNWU1ZDlkZWM4NjlmL3NlYzo5M2NhOWJiMDE3OTI0NzZmYmIyMjVlNWQ5ZGVjODY5Zl80MC9mcmFnOjQwNDNmMGZmZDk0ZjRjOWNiYzg4MjA0YTc0ODU5YjA1L3RhYmxlOjg5ZDk2ZDhkYmNiYTQxYjRiY2JmOTE5NzI5ZjNmODI4L3RhYmxlcmFuZ2U6ODlkOTZkOGRiY2JhNDFiNGJjYmY5MTk3MjlmM2Y4MjhfNS01LTEtMS0w_f6884a6c-b5d1-4bc2-af74-bd2687668b3d"
      unitRef="usd">-758000</us-gaap:IncomeLossFromEquityMethodInvestments>
    <us-gaap:IncomeLossFromEquityMethodInvestments
      contextRef="i747cf8446c5d4312bef9db8f92ed86e7_D20200101-20200630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzY2E5YmIwMTc5MjQ3NmZiYjIyNWU1ZDlkZWM4NjlmL3NlYzo5M2NhOWJiMDE3OTI0NzZmYmIyMjVlNWQ5ZGVjODY5Zl80MC9mcmFnOjQwNDNmMGZmZDk0ZjRjOWNiYzg4MjA0YTc0ODU5YjA1L3RhYmxlOjg5ZDk2ZDhkYmNiYTQxYjRiY2JmOTE5NzI5ZjNmODI4L3RhYmxlcmFuZ2U6ODlkOTZkOGRiY2JhNDFiNGJjYmY5MTk3MjlmM2Y4MjhfNS03LTEtMS0w_c5bab81f-61d5-4861-b1f8-d40f2d724639"
      unitRef="usd">-501000</us-gaap:IncomeLossFromEquityMethodInvestments>
    <us-gaap:IncomeLossFromEquityMethodInvestments
      contextRef="i09025c29bd8b4bf4aa6255cec7a052f9_D20210401-20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzY2E5YmIwMTc5MjQ3NmZiYjIyNWU1ZDlkZWM4NjlmL3NlYzo5M2NhOWJiMDE3OTI0NzZmYmIyMjVlNWQ5ZGVjODY5Zl80MC9mcmFnOjQwNDNmMGZmZDk0ZjRjOWNiYzg4MjA0YTc0ODU5YjA1L3RhYmxlOjg5ZDk2ZDhkYmNiYTQxYjRiY2JmOTE5NzI5ZjNmODI4L3RhYmxlcmFuZ2U6ODlkOTZkOGRiY2JhNDFiNGJjYmY5MTk3MjlmM2Y4MjhfNy0xLTEtMS0w_63199935-849c-4264-9644-03db850aeef4"
      unitRef="usd">-656000</us-gaap:IncomeLossFromEquityMethodInvestments>
    <us-gaap:IncomeLossFromEquityMethodInvestments
      contextRef="i9c2dea6ae084465eb492033eb5079812_D20200401-20200630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzY2E5YmIwMTc5MjQ3NmZiYjIyNWU1ZDlkZWM4NjlmL3NlYzo5M2NhOWJiMDE3OTI0NzZmYmIyMjVlNWQ5ZGVjODY5Zl80MC9mcmFnOjQwNDNmMGZmZDk0ZjRjOWNiYzg4MjA0YTc0ODU5YjA1L3RhYmxlOjg5ZDk2ZDhkYmNiYTQxYjRiY2JmOTE5NzI5ZjNmODI4L3RhYmxlcmFuZ2U6ODlkOTZkOGRiY2JhNDFiNGJjYmY5MTk3MjlmM2Y4MjhfNy0zLTEtMS0w_77cc1419-6652-496b-9b4b-3c3f162990b4"
      unitRef="usd">-369000</us-gaap:IncomeLossFromEquityMethodInvestments>
    <us-gaap:IncomeLossFromEquityMethodInvestments
      contextRef="i1d33f1b94b814dde969a15e41c194555_D20210101-20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzY2E5YmIwMTc5MjQ3NmZiYjIyNWU1ZDlkZWM4NjlmL3NlYzo5M2NhOWJiMDE3OTI0NzZmYmIyMjVlNWQ5ZGVjODY5Zl80MC9mcmFnOjQwNDNmMGZmZDk0ZjRjOWNiYzg4MjA0YTc0ODU5YjA1L3RhYmxlOjg5ZDk2ZDhkYmNiYTQxYjRiY2JmOTE5NzI5ZjNmODI4L3RhYmxlcmFuZ2U6ODlkOTZkOGRiY2JhNDFiNGJjYmY5MTk3MjlmM2Y4MjhfNy01LTEtMS0w_c3e91119-1bdc-4d68-8d65-f79e0d8954cd"
      unitRef="usd">-2000000</us-gaap:IncomeLossFromEquityMethodInvestments>
    <us-gaap:IncomeLossFromEquityMethodInvestments
      contextRef="ia3632b75442e4ecab5344b972f4835a5_D20200101-20200630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzY2E5YmIwMTc5MjQ3NmZiYjIyNWU1ZDlkZWM4NjlmL3NlYzo5M2NhOWJiMDE3OTI0NzZmYmIyMjVlNWQ5ZGVjODY5Zl80MC9mcmFnOjQwNDNmMGZmZDk0ZjRjOWNiYzg4MjA0YTc0ODU5YjA1L3RhYmxlOjg5ZDk2ZDhkYmNiYTQxYjRiY2JmOTE5NzI5ZjNmODI4L3RhYmxlcmFuZ2U6ODlkOTZkOGRiY2JhNDFiNGJjYmY5MTk3MjlmM2Y4MjhfNy03LTEtMS0w_9ed907d5-9b5c-43bd-aa32-aeef3fa789e3"
      unitRef="usd">-1230000</us-gaap:IncomeLossFromEquityMethodInvestments>
    <us-gaap:IncomeLossFromEquityMethodInvestments
      contextRef="i27f4e53b91ad4367b7f8d273eff27769_D20210401-20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzY2E5YmIwMTc5MjQ3NmZiYjIyNWU1ZDlkZWM4NjlmL3NlYzo5M2NhOWJiMDE3OTI0NzZmYmIyMjVlNWQ5ZGVjODY5Zl80MC9mcmFnOjQwNDNmMGZmZDk0ZjRjOWNiYzg4MjA0YTc0ODU5YjA1L3RhYmxlOjg5ZDk2ZDhkYmNiYTQxYjRiY2JmOTE5NzI5ZjNmODI4L3RhYmxlcmFuZ2U6ODlkOTZkOGRiY2JhNDFiNGJjYmY5MTk3MjlmM2Y4MjhfOS0xLTEtMS0w_d442f1e5-e5f2-4388-a208-2bb6e52a374b"
      unitRef="usd">-1115000</us-gaap:IncomeLossFromEquityMethodInvestments>
    <us-gaap:IncomeLossFromEquityMethodInvestments
      contextRef="i39065c5daf934af885335c12f3cfa83f_D20200401-20200630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzY2E5YmIwMTc5MjQ3NmZiYjIyNWU1ZDlkZWM4NjlmL3NlYzo5M2NhOWJiMDE3OTI0NzZmYmIyMjVlNWQ5ZGVjODY5Zl80MC9mcmFnOjQwNDNmMGZmZDk0ZjRjOWNiYzg4MjA0YTc0ODU5YjA1L3RhYmxlOjg5ZDk2ZDhkYmNiYTQxYjRiY2JmOTE5NzI5ZjNmODI4L3RhYmxlcmFuZ2U6ODlkOTZkOGRiY2JhNDFiNGJjYmY5MTk3MjlmM2Y4MjhfOS0zLTEtMS0w_692a3ad9-fad4-4ea8-a3c9-fe7e3dc67691"
      unitRef="usd">-794000</us-gaap:IncomeLossFromEquityMethodInvestments>
    <us-gaap:IncomeLossFromEquityMethodInvestments
      contextRef="i69782326f71a44e3805518280ee22b6b_D20210101-20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzY2E5YmIwMTc5MjQ3NmZiYjIyNWU1ZDlkZWM4NjlmL3NlYzo5M2NhOWJiMDE3OTI0NzZmYmIyMjVlNWQ5ZGVjODY5Zl80MC9mcmFnOjQwNDNmMGZmZDk0ZjRjOWNiYzg4MjA0YTc0ODU5YjA1L3RhYmxlOjg5ZDk2ZDhkYmNiYTQxYjRiY2JmOTE5NzI5ZjNmODI4L3RhYmxlcmFuZ2U6ODlkOTZkOGRiY2JhNDFiNGJjYmY5MTk3MjlmM2Y4MjhfOS01LTEtMS0w_282d8603-39b3-4192-a002-51df0db2f2ec"
      unitRef="usd">-2758000</us-gaap:IncomeLossFromEquityMethodInvestments>
    <us-gaap:IncomeLossFromEquityMethodInvestments
      contextRef="i4a110e4972ef4113880ce582e3cda5c5_D20200101-20200630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzY2E5YmIwMTc5MjQ3NmZiYjIyNWU1ZDlkZWM4NjlmL3NlYzo5M2NhOWJiMDE3OTI0NzZmYmIyMjVlNWQ5ZGVjODY5Zl80MC9mcmFnOjQwNDNmMGZmZDk0ZjRjOWNiYzg4MjA0YTc0ODU5YjA1L3RhYmxlOjg5ZDk2ZDhkYmNiYTQxYjRiY2JmOTE5NzI5ZjNmODI4L3RhYmxlcmFuZ2U6ODlkOTZkOGRiY2JhNDFiNGJjYmY5MTk3MjlmM2Y4MjhfOS03LTEtMS0w_15c7b66c-629d-4657-a7dd-4b4cc3422879"
      unitRef="usd">-1966000</us-gaap:IncomeLossFromEquityMethodInvestments>
    <us-gaap:ScheduleOfVariableInterestEntitiesTextBlock
      contextRef="i69782326f71a44e3805518280ee22b6b_D20210101-20210630"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzY2E5YmIwMTc5MjQ3NmZiYjIyNWU1ZDlkZWM4NjlmL3NlYzo5M2NhOWJiMDE3OTI0NzZmYmIyMjVlNWQ5ZGVjODY5Zl80MC9mcmFnOjQwNDNmMGZmZDk0ZjRjOWNiYzg4MjA0YTc0ODU5YjA1L3RleHRyZWdpb246NDA0M2YwZmZkOTRmNGM5Y2JjODgyMDRhNzQ4NTliMDVfNDMyNw_0b6300bd-6ea8-40a1-b999-0957fdba3bd2">The following is a summary of the maximum exposure to loss as of June&#160;30, 2021 and December&#160;31, 2020:&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:47.788%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:15.566%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.355%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:15.566%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.355%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:15.570%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Ownership interest&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;As of June&#160;30, 2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;As of December 31, 2020&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Cronos Australia&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;31%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,573&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,530&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Cronos GrowCo&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;50%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;21,723&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;21,125&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;MedMen Canada&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;50%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;494&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;467&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Natuera&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;50%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;8,047&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;8,154&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;31,837&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;31,276&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;/tr&gt;&lt;/table&gt;</us-gaap:ScheduleOfVariableInterestEntitiesTextBlock>
    <us-gaap:VariableInterestEntityOwnershipPercentage
      contextRef="i0a6f7aeaf7984695bd038544768f44ce_D20210101-20210630"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzY2E5YmIwMTc5MjQ3NmZiYjIyNWU1ZDlkZWM4NjlmL3NlYzo5M2NhOWJiMDE3OTI0NzZmYmIyMjVlNWQ5ZGVjODY5Zl80MC9mcmFnOjQwNDNmMGZmZDk0ZjRjOWNiYzg4MjA0YTc0ODU5YjA1L3RhYmxlOjY4M2YyY2JlZTczMDQzOGU5OTM3MTc2NzAzNzM4ZTVmL3RhYmxlcmFuZ2U6NjgzZjJjYmVlNzMwNDM4ZTk5MzcxNzY3MDM3MzhlNWZfMS0xLTEtMS0w_7e757b6a-7383-4768-a70a-9078c64a3fe0"
      unitRef="number">0.31</us-gaap:VariableInterestEntityOwnershipPercentage>
    <us-gaap:VariableInterestEntityEntityMaximumLossExposureAmount
      contextRef="i9b8aec0ea4404ec8b5d82299348089bf_I20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzY2E5YmIwMTc5MjQ3NmZiYjIyNWU1ZDlkZWM4NjlmL3NlYzo5M2NhOWJiMDE3OTI0NzZmYmIyMjVlNWQ5ZGVjODY5Zl80MC9mcmFnOjQwNDNmMGZmZDk0ZjRjOWNiYzg4MjA0YTc0ODU5YjA1L3RhYmxlOjY4M2YyY2JlZTczMDQzOGU5OTM3MTc2NzAzNzM4ZTVmL3RhYmxlcmFuZ2U6NjgzZjJjYmVlNzMwNDM4ZTk5MzcxNzY3MDM3MzhlNWZfMS01LTEtMS0w_02f2529c-88cd-4601-ba85-6ff8f0ddb267"
      unitRef="usd">1573000</us-gaap:VariableInterestEntityEntityMaximumLossExposureAmount>
    <us-gaap:VariableInterestEntityEntityMaximumLossExposureAmount
      contextRef="i66749f2799dd4940bef71ca978540e57_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzY2E5YmIwMTc5MjQ3NmZiYjIyNWU1ZDlkZWM4NjlmL3NlYzo5M2NhOWJiMDE3OTI0NzZmYmIyMjVlNWQ5ZGVjODY5Zl80MC9mcmFnOjQwNDNmMGZmZDk0ZjRjOWNiYzg4MjA0YTc0ODU5YjA1L3RhYmxlOjY4M2YyY2JlZTczMDQzOGU5OTM3MTc2NzAzNzM4ZTVmL3RhYmxlcmFuZ2U6NjgzZjJjYmVlNzMwNDM4ZTk5MzcxNzY3MDM3MzhlNWZfMS05LTEtMS0w_727847f4-f3ad-4664-bd83-f69ea1933085"
      unitRef="usd">1530000</us-gaap:VariableInterestEntityEntityMaximumLossExposureAmount>
    <us-gaap:VariableInterestEntityOwnershipPercentage
      contextRef="if3db2c911124490fab5cdb3084df56db_D20210101-20210630"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzY2E5YmIwMTc5MjQ3NmZiYjIyNWU1ZDlkZWM4NjlmL3NlYzo5M2NhOWJiMDE3OTI0NzZmYmIyMjVlNWQ5ZGVjODY5Zl80MC9mcmFnOjQwNDNmMGZmZDk0ZjRjOWNiYzg4MjA0YTc0ODU5YjA1L3RhYmxlOjY4M2YyY2JlZTczMDQzOGU5OTM3MTc2NzAzNzM4ZTVmL3RhYmxlcmFuZ2U6NjgzZjJjYmVlNzMwNDM4ZTk5MzcxNzY3MDM3MzhlNWZfMi0xLTEtMS0w_7361fa43-97bc-438c-9ee1-a0cb0f681613"
      unitRef="number">0.50</us-gaap:VariableInterestEntityOwnershipPercentage>
    <us-gaap:VariableInterestEntityEntityMaximumLossExposureAmount
      contextRef="i353124414ba44af49353f31dc922db70_I20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzY2E5YmIwMTc5MjQ3NmZiYjIyNWU1ZDlkZWM4NjlmL3NlYzo5M2NhOWJiMDE3OTI0NzZmYmIyMjVlNWQ5ZGVjODY5Zl80MC9mcmFnOjQwNDNmMGZmZDk0ZjRjOWNiYzg4MjA0YTc0ODU5YjA1L3RhYmxlOjY4M2YyY2JlZTczMDQzOGU5OTM3MTc2NzAzNzM4ZTVmL3RhYmxlcmFuZ2U6NjgzZjJjYmVlNzMwNDM4ZTk5MzcxNzY3MDM3MzhlNWZfMi01LTEtMS0w_82573f99-7d51-41c0-a242-6d7453821a1c"
      unitRef="usd">21723000</us-gaap:VariableInterestEntityEntityMaximumLossExposureAmount>
    <us-gaap:VariableInterestEntityEntityMaximumLossExposureAmount
      contextRef="i3afecd33173246f185a69d63285abf8c_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzY2E5YmIwMTc5MjQ3NmZiYjIyNWU1ZDlkZWM4NjlmL3NlYzo5M2NhOWJiMDE3OTI0NzZmYmIyMjVlNWQ5ZGVjODY5Zl80MC9mcmFnOjQwNDNmMGZmZDk0ZjRjOWNiYzg4MjA0YTc0ODU5YjA1L3RhYmxlOjY4M2YyY2JlZTczMDQzOGU5OTM3MTc2NzAzNzM4ZTVmL3RhYmxlcmFuZ2U6NjgzZjJjYmVlNzMwNDM4ZTk5MzcxNzY3MDM3MzhlNWZfMi05LTEtMS0w_f8c63ec1-046a-4ea2-bec0-b22c018d00f0"
      unitRef="usd">21125000</us-gaap:VariableInterestEntityEntityMaximumLossExposureAmount>
    <us-gaap:VariableInterestEntityOwnershipPercentage
      contextRef="ie2fdd9071c2c4923bce9ab671e6af04d_D20210101-20210630"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzY2E5YmIwMTc5MjQ3NmZiYjIyNWU1ZDlkZWM4NjlmL3NlYzo5M2NhOWJiMDE3OTI0NzZmYmIyMjVlNWQ5ZGVjODY5Zl80MC9mcmFnOjQwNDNmMGZmZDk0ZjRjOWNiYzg4MjA0YTc0ODU5YjA1L3RhYmxlOjY4M2YyY2JlZTczMDQzOGU5OTM3MTc2NzAzNzM4ZTVmL3RhYmxlcmFuZ2U6NjgzZjJjYmVlNzMwNDM4ZTk5MzcxNzY3MDM3MzhlNWZfMy0xLTEtMS0w_16441aa3-3bf6-49bf-8c06-663d046c6cc4"
      unitRef="number">0.50</us-gaap:VariableInterestEntityOwnershipPercentage>
    <us-gaap:VariableInterestEntityEntityMaximumLossExposureAmount
      contextRef="ib9811da8a9704222a0df27a3f63f596b_I20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzY2E5YmIwMTc5MjQ3NmZiYjIyNWU1ZDlkZWM4NjlmL3NlYzo5M2NhOWJiMDE3OTI0NzZmYmIyMjVlNWQ5ZGVjODY5Zl80MC9mcmFnOjQwNDNmMGZmZDk0ZjRjOWNiYzg4MjA0YTc0ODU5YjA1L3RhYmxlOjY4M2YyY2JlZTczMDQzOGU5OTM3MTc2NzAzNzM4ZTVmL3RhYmxlcmFuZ2U6NjgzZjJjYmVlNzMwNDM4ZTk5MzcxNzY3MDM3MzhlNWZfMy01LTEtMS0w_5fc34070-878a-40fc-81fa-c812f0f094df"
      unitRef="usd">494000</us-gaap:VariableInterestEntityEntityMaximumLossExposureAmount>
    <us-gaap:VariableInterestEntityEntityMaximumLossExposureAmount
      contextRef="iaaa05d4ed8b34a308235a68b7882864c_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzY2E5YmIwMTc5MjQ3NmZiYjIyNWU1ZDlkZWM4NjlmL3NlYzo5M2NhOWJiMDE3OTI0NzZmYmIyMjVlNWQ5ZGVjODY5Zl80MC9mcmFnOjQwNDNmMGZmZDk0ZjRjOWNiYzg4MjA0YTc0ODU5YjA1L3RhYmxlOjY4M2YyY2JlZTczMDQzOGU5OTM3MTc2NzAzNzM4ZTVmL3RhYmxlcmFuZ2U6NjgzZjJjYmVlNzMwNDM4ZTk5MzcxNzY3MDM3MzhlNWZfMy05LTEtMS0w_c475be6a-a3a4-4123-880a-87521cd3b4f6"
      unitRef="usd">467000</us-gaap:VariableInterestEntityEntityMaximumLossExposureAmount>
    <us-gaap:VariableInterestEntityOwnershipPercentage
      contextRef="i3b3152f5409c4a70870bd6f4cb775dd4_D20210101-20210630"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzY2E5YmIwMTc5MjQ3NmZiYjIyNWU1ZDlkZWM4NjlmL3NlYzo5M2NhOWJiMDE3OTI0NzZmYmIyMjVlNWQ5ZGVjODY5Zl80MC9mcmFnOjQwNDNmMGZmZDk0ZjRjOWNiYzg4MjA0YTc0ODU5YjA1L3RhYmxlOjY4M2YyY2JlZTczMDQzOGU5OTM3MTc2NzAzNzM4ZTVmL3RhYmxlcmFuZ2U6NjgzZjJjYmVlNzMwNDM4ZTk5MzcxNzY3MDM3MzhlNWZfNC0xLTEtMS0w_425b3805-7355-44b2-913d-58102569ca2f"
      unitRef="number">0.50</us-gaap:VariableInterestEntityOwnershipPercentage>
    <us-gaap:VariableInterestEntityEntityMaximumLossExposureAmount
      contextRef="ibda190acea7645e2a6859c2bdb2fc787_I20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzY2E5YmIwMTc5MjQ3NmZiYjIyNWU1ZDlkZWM4NjlmL3NlYzo5M2NhOWJiMDE3OTI0NzZmYmIyMjVlNWQ5ZGVjODY5Zl80MC9mcmFnOjQwNDNmMGZmZDk0ZjRjOWNiYzg4MjA0YTc0ODU5YjA1L3RhYmxlOjY4M2YyY2JlZTczMDQzOGU5OTM3MTc2NzAzNzM4ZTVmL3RhYmxlcmFuZ2U6NjgzZjJjYmVlNzMwNDM4ZTk5MzcxNzY3MDM3MzhlNWZfNC01LTEtMS0w_89a9c742-2995-4eb1-ab59-c9f356de370c"
      unitRef="usd">8047000</us-gaap:VariableInterestEntityEntityMaximumLossExposureAmount>
    <us-gaap:VariableInterestEntityEntityMaximumLossExposureAmount
      contextRef="i390d021c539343388dd3edb041b0e9aa_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzY2E5YmIwMTc5MjQ3NmZiYjIyNWU1ZDlkZWM4NjlmL3NlYzo5M2NhOWJiMDE3OTI0NzZmYmIyMjVlNWQ5ZGVjODY5Zl80MC9mcmFnOjQwNDNmMGZmZDk0ZjRjOWNiYzg4MjA0YTc0ODU5YjA1L3RhYmxlOjY4M2YyY2JlZTczMDQzOGU5OTM3MTc2NzAzNzM4ZTVmL3RhYmxlcmFuZ2U6NjgzZjJjYmVlNzMwNDM4ZTk5MzcxNzY3MDM3MzhlNWZfNC05LTEtMS0w_a3160e22-7f45-4781-944a-3c62069f008c"
      unitRef="usd">8154000</us-gaap:VariableInterestEntityEntityMaximumLossExposureAmount>
    <us-gaap:VariableInterestEntityEntityMaximumLossExposureAmount
      contextRef="i225f85e38faa4bbdb4de1d8b9cf369bb_I20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzY2E5YmIwMTc5MjQ3NmZiYjIyNWU1ZDlkZWM4NjlmL3NlYzo5M2NhOWJiMDE3OTI0NzZmYmIyMjVlNWQ5ZGVjODY5Zl80MC9mcmFnOjQwNDNmMGZmZDk0ZjRjOWNiYzg4MjA0YTc0ODU5YjA1L3RhYmxlOjY4M2YyY2JlZTczMDQzOGU5OTM3MTc2NzAzNzM4ZTVmL3RhYmxlcmFuZ2U6NjgzZjJjYmVlNzMwNDM4ZTk5MzcxNzY3MDM3MzhlNWZfNS01LTEtMS0w_3650ada3-d5fb-401d-a787-ba53dfba64d6"
      unitRef="usd">31837000</us-gaap:VariableInterestEntityEntityMaximumLossExposureAmount>
    <us-gaap:VariableInterestEntityEntityMaximumLossExposureAmount
      contextRef="ifbe16ec51ea244519b77d6036b4ef038_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzY2E5YmIwMTc5MjQ3NmZiYjIyNWU1ZDlkZWM4NjlmL3NlYzo5M2NhOWJiMDE3OTI0NzZmYmIyMjVlNWQ5ZGVjODY5Zl80MC9mcmFnOjQwNDNmMGZmZDk0ZjRjOWNiYzg4MjA0YTc0ODU5YjA1L3RhYmxlOjY4M2YyY2JlZTczMDQzOGU5OTM3MTc2NzAzNzM4ZTVmL3RhYmxlcmFuZ2U6NjgzZjJjYmVlNzMwNDM4ZTk5MzcxNzY3MDM3MzhlNWZfNS05LTEtMS0w_272174e1-b446-45be-83e8-f938df7bf6d5"
      unitRef="usd">31276000</us-gaap:VariableInterestEntityEntityMaximumLossExposureAmount>
    <us-gaap:SaleOfStockNumberOfSharesIssuedInTransaction
      contextRef="ic4e23b56bd44457695de2dfbd9a6ce67_D20210614-20210614"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzY2E5YmIwMTc5MjQ3NmZiYjIyNWU1ZDlkZWM4NjlmL3NlYzo5M2NhOWJiMDE3OTI0NzZmYmIyMjVlNWQ5ZGVjODY5Zl80MC9mcmFnOjQwNDNmMGZmZDk0ZjRjOWNiYzg4MjA0YTc0ODU5YjA1L3RleHRyZWdpb246NDA0M2YwZmZkOTRmNGM5Y2JjODgyMDRhNzQ4NTliMDVfMTA5OTUxMTY0Njg5Ng_65aef3bf-1a09-468b-87c3-8c3ce7fcf476"
      unitRef="shares">473787</us-gaap:SaleOfStockNumberOfSharesIssuedInTransaction>
    <us-gaap:SaleOfStockPricePerShare
      contextRef="iaa37e41bb48a45ae9333902e59ee2719_I20210614"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzY2E5YmIwMTc5MjQ3NmZiYjIyNWU1ZDlkZWM4NjlmL3NlYzo5M2NhOWJiMDE3OTI0NzZmYmIyMjVlNWQ5ZGVjODY5Zl80MC9mcmFnOjQwNDNmMGZmZDk0ZjRjOWNiYzg4MjA0YTc0ODU5YjA1L3RleHRyZWdpb246NDA0M2YwZmZkOTRmNGM5Y2JjODgyMDRhNzQ4NTliMDVfMTA5OTUxMTY0NzEyNA_347a5dd4-09a1-437b-a9b5-d1d657602606"
      unitRef="usdPerShare">0.0001</us-gaap:SaleOfStockPricePerShare>
    <us-gaap:SaleOfStockPercentageOfOwnershipAfterTransaction
      contextRef="ibd87bb26d08f46e4bfa11a80236a610a_D20210614-20210614"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzY2E5YmIwMTc5MjQ3NmZiYjIyNWU1ZDlkZWM4NjlmL3NlYzo5M2NhOWJiMDE3OTI0NzZmYmIyMjVlNWQ5ZGVjODY5Zl80MC9mcmFnOjQwNDNmMGZmZDk0ZjRjOWNiYzg4MjA0YTc0ODU5YjA1L3RleHRyZWdpb246NDA0M2YwZmZkOTRmNGM5Y2JjODgyMDRhNzQ4NTliMDVfMTA5OTUxMTY0Njg4OQ_d99b3213-88ef-46f7-a6e8-e64dac1f9db6"
      unitRef="number">0.105</us-gaap:SaleOfStockPercentageOfOwnershipAfterTransaction>
    <us-gaap:PaymentsToAcquireOtherInvestments
      contextRef="ibd87bb26d08f46e4bfa11a80236a610a_D20210614-20210614"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzY2E5YmIwMTc5MjQ3NmZiYjIyNWU1ZDlkZWM4NjlmL3NlYzo5M2NhOWJiMDE3OTI0NzZmYmIyMjVlNWQ5ZGVjODY5Zl80MC9mcmFnOjQwNDNmMGZmZDk0ZjRjOWNiYzg4MjA0YTc0ODU5YjA1L3RleHRyZWdpb246NDA0M2YwZmZkOTRmNGM5Y2JjODgyMDRhNzQ4NTliMDVfOTg5NTYwNDY3Mjc4Mw_cb536095-f5fe-4aaf-885f-7456c53a6187"
      unitRef="usd">110392000</us-gaap:PaymentsToAcquireOtherInvestments>
    <us-gaap:LoansNotesTradeAndOtherReceivablesExcludingAllowanceForCreditLossesTextBlock
      contextRef="i69782326f71a44e3805518280ee22b6b_D20210101-20210630"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzY2E5YmIwMTc5MjQ3NmZiYjIyNWU1ZDlkZWM4NjlmL3NlYzo5M2NhOWJiMDE3OTI0NzZmYmIyMjVlNWQ5ZGVjODY5Zl80My9mcmFnOjZlZDUwYmJmZmU2ZDRjMDJhOWRiZDFkNzYzNTUzOWFlL3RleHRyZWdpb246NmVkNTBiYmZmZTZkNGMwMmE5ZGJkMWQ3NjM1NTM5YWVfMTIzMw_bab253e1-6ec1-49b0-8f0a-1680d580afe4">Loans Receivable, net &lt;div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:21.955%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:39.177%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.466%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:15.566%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.466%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:15.570%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="6" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;As of June&#160;30, 2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;As of December 31, 2020&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="6" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;div style="padding-left:12pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Natuera Series A Loan&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(i)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,518&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="6" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;div style="padding-left:12pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;GrowCo Facility&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(ii)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,614&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,137&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="6" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Add: Accrued interest&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,414&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;428&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="6" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total current portion of loans receivable&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5,028&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7,083&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="6" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;div style="padding-left:12pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;GrowCo Facility&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(ii)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;77,474&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;69,939&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="6" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;div style="padding-left:12pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Mucci Promissory Note&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(iii)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;13,969&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;13,324&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="6" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;div style="padding-left:12pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Cannasoul Collaboration Loan&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(iv)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,870&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,261&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="6" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Add: Accrued interest&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;800&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,667&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="6" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total long-term portion of loans receivable&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;94,113&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;87,191&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="6" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total loans receivable, net&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;99,141&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;94,274&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt;margin-top:3pt;padding-left:27pt;text-align:justify;text-indent:-27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%"&gt;(i)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:19.46pt"&gt;On April 1, 2021, the Company and AGI converted all advances made to Natuera under the Series A Loan, plus accrued interest, into equity of Natuera. Total aggregate gross advances to Natuera under the Natuera Series A Loan were $15,500, of which the Company advanced 50% and AGI advanced the remaining 50%, or $7,750 each. As a result, the Company transferred the carrying value of the Natuera Series A Loan of approximately $2,013 plus accrued interest of $540, for a total investment value of $2,553, which approximates fair value, to investments in equity accounted investees in respect of Natuera. See Note 3. Investments.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt;margin-top:3pt;padding-left:27pt;text-align:justify;text-indent:-27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:400;line-height:120%;position:relative;top:-2.8pt;vertical-align:baseline"&gt;(ii)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:20.66pt"&gt;As of June&#160;30, 2021 and December&#160;31, 2020, Cronos GrowCo had drawn C$100,000 ($80,678) and C$95,150 ($74,626), respectively, from a credit agreement it entered into with the Company in August 2019 (the &#x201c;GrowCo Facility&#x201d;). As of June&#160;30, 2021 and December&#160;31, 2020, the Company had an allowance for credit losses of $1,590 and $1,470, respectively, recorded against the GrowCo Facility.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt;margin-top:3pt;padding-left:27pt;text-align:justify;text-indent:-27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:400;line-height:120%;position:relative;top:-2.8pt;vertical-align:baseline"&gt;(iii)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:19.22pt"&gt;As of June&#160;30, 2021 and December&#160;31, 2020, the Company had an allowance for credit losses of $278 and&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%"&gt;$259, respectively, recorded against the promissory note receivable agreement entered into with Mucci on June 28, 2019 (the &#x201c;Mucci Promissory Note&#x201d;).&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:3pt;padding-left:27pt;text-align:justify;text-indent:-27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:400;line-height:120%;position:relative;top:-2.8pt;vertical-align:baseline"&gt;(iv)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:19.5pt"&gt;As of June&#160;30, 2021 and December&#160;31, 2020 CLS has received ILS 6,223 and ILS 4,149 (approximately $1,909 and $1,287 respectively) from the Cannasoul Collaboration Loan. As of June&#160;30, 2021 and December&#160;31, 2020, the Company had an allowance for credit losses of $39 and $25, respectively, recorded against the Cannasoul Collaboration Loan.&lt;/span&gt;&lt;/div&gt;</us-gaap:LoansNotesTradeAndOtherReceivablesExcludingAllowanceForCreditLossesTextBlock>
    <us-gaap:ScheduleOfAccountsNotesLoansAndFinancingReceivableTextBlock
      contextRef="i69782326f71a44e3805518280ee22b6b_D20210101-20210630"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzY2E5YmIwMTc5MjQ3NmZiYjIyNWU1ZDlkZWM4NjlmL3NlYzo5M2NhOWJiMDE3OTI0NzZmYmIyMjVlNWQ5ZGVjODY5Zl80My9mcmFnOjZlZDUwYmJmZmU2ZDRjMDJhOWRiZDFkNzYzNTUzOWFlL3RleHRyZWdpb246NmVkNTBiYmZmZTZkNGMwMmE5ZGJkMWQ3NjM1NTM5YWVfMTIzNA_beb8f160-010c-45b0-b789-395cd7083708">&lt;div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:21.955%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:39.177%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.466%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:15.566%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.466%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:15.570%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="6" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;As of June&#160;30, 2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;As of December 31, 2020&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="6" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;div style="padding-left:12pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Natuera Series A Loan&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(i)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,518&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="6" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;div style="padding-left:12pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;GrowCo Facility&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(ii)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,614&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,137&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="6" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Add: Accrued interest&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,414&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;428&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="6" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total current portion of loans receivable&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5,028&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7,083&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="6" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;div style="padding-left:12pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;GrowCo Facility&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(ii)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;77,474&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;69,939&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="6" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;div style="padding-left:12pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Mucci Promissory Note&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(iii)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;13,969&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;13,324&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="6" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;div style="padding-left:12pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Cannasoul Collaboration Loan&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(iv)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,870&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,261&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="6" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Add: Accrued interest&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;800&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,667&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="6" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total long-term portion of loans receivable&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;94,113&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;87,191&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="6" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total loans receivable, net&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;99,141&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;94,274&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt;margin-top:3pt;padding-left:27pt;text-align:justify;text-indent:-27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%"&gt;(i)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:19.46pt"&gt;On April 1, 2021, the Company and AGI converted all advances made to Natuera under the Series A Loan, plus accrued interest, into equity of Natuera. Total aggregate gross advances to Natuera under the Natuera Series A Loan were $15,500, of which the Company advanced 50% and AGI advanced the remaining 50%, or $7,750 each. As a result, the Company transferred the carrying value of the Natuera Series A Loan of approximately $2,013 plus accrued interest of $540, for a total investment value of $2,553, which approximates fair value, to investments in equity accounted investees in respect of Natuera. See Note 3. Investments.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt;margin-top:3pt;padding-left:27pt;text-align:justify;text-indent:-27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:400;line-height:120%;position:relative;top:-2.8pt;vertical-align:baseline"&gt;(ii)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:20.66pt"&gt;As of June&#160;30, 2021 and December&#160;31, 2020, Cronos GrowCo had drawn C$100,000 ($80,678) and C$95,150 ($74,626), respectively, from a credit agreement it entered into with the Company in August 2019 (the &#x201c;GrowCo Facility&#x201d;). As of June&#160;30, 2021 and December&#160;31, 2020, the Company had an allowance for credit losses of $1,590 and $1,470, respectively, recorded against the GrowCo Facility.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt;margin-top:3pt;padding-left:27pt;text-align:justify;text-indent:-27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:400;line-height:120%;position:relative;top:-2.8pt;vertical-align:baseline"&gt;(iii)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:19.22pt"&gt;As of June&#160;30, 2021 and December&#160;31, 2020, the Company had an allowance for credit losses of $278 and&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%"&gt;$259, respectively, recorded against the promissory note receivable agreement entered into with Mucci on June 28, 2019 (the &#x201c;Mucci Promissory Note&#x201d;).&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:3pt;padding-left:27pt;text-align:justify;text-indent:-27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:400;line-height:120%;position:relative;top:-2.8pt;vertical-align:baseline"&gt;(iv)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:19.5pt"&gt;As of June&#160;30, 2021 and December&#160;31, 2020 CLS has received ILS 6,223 and ILS 4,149 (approximately $1,909 and $1,287 respectively) from the Cannasoul Collaboration Loan. As of June&#160;30, 2021 and December&#160;31, 2020, the Company had an allowance for credit losses of $39 and $25, respectively, recorded against the Cannasoul Collaboration Loan.&lt;/span&gt;&lt;/div&gt;</us-gaap:ScheduleOfAccountsNotesLoansAndFinancingReceivableTextBlock>
    <cron:FinancingReceivableBeforeAccruedInterestCurrent
      contextRef="i7e8821bb92b54aa5a40ec87007ddd06a_I20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzY2E5YmIwMTc5MjQ3NmZiYjIyNWU1ZDlkZWM4NjlmL3NlYzo5M2NhOWJiMDE3OTI0NzZmYmIyMjVlNWQ5ZGVjODY5Zl80My9mcmFnOjZlZDUwYmJmZmU2ZDRjMDJhOWRiZDFkNzYzNTUzOWFlL3RhYmxlOjc0N2M1NDc3NmU3NDRlZDc4ZjVmNDk5ODMxYTU5YTBkL3RhYmxlcmFuZ2U6NzQ3YzU0Nzc2ZTc0NGVkNzhmNWY0OTk4MzFhNTlhMGRfMS0zLTEtMS0w_11863580-29e9-4727-a1f4-df520bf866ef"
      unitRef="usd">0</cron:FinancingReceivableBeforeAccruedInterestCurrent>
    <cron:FinancingReceivableBeforeAccruedInterestCurrent
      contextRef="ic0f4e3758c364fee99c468147d904bdc_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzY2E5YmIwMTc5MjQ3NmZiYjIyNWU1ZDlkZWM4NjlmL3NlYzo5M2NhOWJiMDE3OTI0NzZmYmIyMjVlNWQ5ZGVjODY5Zl80My9mcmFnOjZlZDUwYmJmZmU2ZDRjMDJhOWRiZDFkNzYzNTUzOWFlL3RhYmxlOjc0N2M1NDc3NmU3NDRlZDc4ZjVmNDk5ODMxYTU5YTBkL3RhYmxlcmFuZ2U6NzQ3YzU0Nzc2ZTc0NGVkNzhmNWY0OTk4MzFhNTlhMGRfMS01LTEtMS0w_b44f87e1-015d-4735-8255-cec7656f377a"
      unitRef="usd">3518000</cron:FinancingReceivableBeforeAccruedInterestCurrent>
    <cron:FinancingReceivableBeforeAccruedInterestCurrent
      contextRef="i4d5e5ad8b8c04f0e81c4f56d20dd2667_I20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzY2E5YmIwMTc5MjQ3NmZiYjIyNWU1ZDlkZWM4NjlmL3NlYzo5M2NhOWJiMDE3OTI0NzZmYmIyMjVlNWQ5ZGVjODY5Zl80My9mcmFnOjZlZDUwYmJmZmU2ZDRjMDJhOWRiZDFkNzYzNTUzOWFlL3RhYmxlOjc0N2M1NDc3NmU3NDRlZDc4ZjVmNDk5ODMxYTU5YTBkL3RhYmxlcmFuZ2U6NzQ3YzU0Nzc2ZTc0NGVkNzhmNWY0OTk4MzFhNTlhMGRfMi0zLTEtMS0w_5c0b3bdc-cf09-469e-8b98-deebf142e516"
      unitRef="usd">1614000</cron:FinancingReceivableBeforeAccruedInterestCurrent>
    <cron:FinancingReceivableBeforeAccruedInterestCurrent
      contextRef="i389408e323054f34bb2d44166886cfa0_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzY2E5YmIwMTc5MjQ3NmZiYjIyNWU1ZDlkZWM4NjlmL3NlYzo5M2NhOWJiMDE3OTI0NzZmYmIyMjVlNWQ5ZGVjODY5Zl80My9mcmFnOjZlZDUwYmJmZmU2ZDRjMDJhOWRiZDFkNzYzNTUzOWFlL3RhYmxlOjc0N2M1NDc3NmU3NDRlZDc4ZjVmNDk5ODMxYTU5YTBkL3RhYmxlcmFuZ2U6NzQ3YzU0Nzc2ZTc0NGVkNzhmNWY0OTk4MzFhNTlhMGRfMi01LTEtMS0w_40ce824f-fa2d-46a5-9103-eb6595d61db8"
      unitRef="usd">3137000</cron:FinancingReceivableBeforeAccruedInterestCurrent>
    <cron:FinancingReceivableAccruedInterestCurrent
      contextRef="i0709927d1c004766b70bf1b85ffbd9b2_I20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzY2E5YmIwMTc5MjQ3NmZiYjIyNWU1ZDlkZWM4NjlmL3NlYzo5M2NhOWJiMDE3OTI0NzZmYmIyMjVlNWQ5ZGVjODY5Zl80My9mcmFnOjZlZDUwYmJmZmU2ZDRjMDJhOWRiZDFkNzYzNTUzOWFlL3RhYmxlOjc0N2M1NDc3NmU3NDRlZDc4ZjVmNDk5ODMxYTU5YTBkL3RhYmxlcmFuZ2U6NzQ3YzU0Nzc2ZTc0NGVkNzhmNWY0OTk4MzFhNTlhMGRfMy0zLTEtMS0w_967e97be-f0b1-4736-b027-a19d3342eca3"
      unitRef="usd">3414000</cron:FinancingReceivableAccruedInterestCurrent>
    <cron:FinancingReceivableAccruedInterestCurrent
      contextRef="i830d314bf026450e8e38d200944077bf_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzY2E5YmIwMTc5MjQ3NmZiYjIyNWU1ZDlkZWM4NjlmL3NlYzo5M2NhOWJiMDE3OTI0NzZmYmIyMjVlNWQ5ZGVjODY5Zl80My9mcmFnOjZlZDUwYmJmZmU2ZDRjMDJhOWRiZDFkNzYzNTUzOWFlL3RhYmxlOjc0N2M1NDc3NmU3NDRlZDc4ZjVmNDk5ODMxYTU5YTBkL3RhYmxlcmFuZ2U6NzQ3YzU0Nzc2ZTc0NGVkNzhmNWY0OTk4MzFhNTlhMGRfMy01LTEtMS0w_ff4b7fc0-cb91-4288-8706-5f364b99a030"
      unitRef="usd">428000</cron:FinancingReceivableAccruedInterestCurrent>
    <us-gaap:NotesAndLoansReceivableNetCurrent
      contextRef="i225f85e38faa4bbdb4de1d8b9cf369bb_I20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzY2E5YmIwMTc5MjQ3NmZiYjIyNWU1ZDlkZWM4NjlmL3NlYzo5M2NhOWJiMDE3OTI0NzZmYmIyMjVlNWQ5ZGVjODY5Zl80My9mcmFnOjZlZDUwYmJmZmU2ZDRjMDJhOWRiZDFkNzYzNTUzOWFlL3RhYmxlOjc0N2M1NDc3NmU3NDRlZDc4ZjVmNDk5ODMxYTU5YTBkL3RhYmxlcmFuZ2U6NzQ3YzU0Nzc2ZTc0NGVkNzhmNWY0OTk4MzFhNTlhMGRfNC0zLTEtMS0w_712ed0ae-8357-4c02-936b-d6c65d00c46b"
      unitRef="usd">5028000</us-gaap:NotesAndLoansReceivableNetCurrent>
    <us-gaap:NotesAndLoansReceivableNetCurrent
      contextRef="ifbe16ec51ea244519b77d6036b4ef038_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzY2E5YmIwMTc5MjQ3NmZiYjIyNWU1ZDlkZWM4NjlmL3NlYzo5M2NhOWJiMDE3OTI0NzZmYmIyMjVlNWQ5ZGVjODY5Zl80My9mcmFnOjZlZDUwYmJmZmU2ZDRjMDJhOWRiZDFkNzYzNTUzOWFlL3RhYmxlOjc0N2M1NDc3NmU3NDRlZDc4ZjVmNDk5ODMxYTU5YTBkL3RhYmxlcmFuZ2U6NzQ3YzU0Nzc2ZTc0NGVkNzhmNWY0OTk4MzFhNTlhMGRfNC01LTEtMS0w_bf59f9e7-7ab8-4d07-9ca4-4649d985408c"
      unitRef="usd">7083000</us-gaap:NotesAndLoansReceivableNetCurrent>
    <cron:FinancingReceivableBeforeAccruedInterestNoncurrent
      contextRef="i4d5e5ad8b8c04f0e81c4f56d20dd2667_I20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzY2E5YmIwMTc5MjQ3NmZiYjIyNWU1ZDlkZWM4NjlmL3NlYzo5M2NhOWJiMDE3OTI0NzZmYmIyMjVlNWQ5ZGVjODY5Zl80My9mcmFnOjZlZDUwYmJmZmU2ZDRjMDJhOWRiZDFkNzYzNTUzOWFlL3RhYmxlOjc0N2M1NDc3NmU3NDRlZDc4ZjVmNDk5ODMxYTU5YTBkL3RhYmxlcmFuZ2U6NzQ3YzU0Nzc2ZTc0NGVkNzhmNWY0OTk4MzFhNTlhMGRfNS0zLTEtMS0w_0e4ae4cb-3fec-427b-9848-4287c398eba5"
      unitRef="usd">77474000</cron:FinancingReceivableBeforeAccruedInterestNoncurrent>
    <cron:FinancingReceivableBeforeAccruedInterestNoncurrent
      contextRef="i389408e323054f34bb2d44166886cfa0_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzY2E5YmIwMTc5MjQ3NmZiYjIyNWU1ZDlkZWM4NjlmL3NlYzo5M2NhOWJiMDE3OTI0NzZmYmIyMjVlNWQ5ZGVjODY5Zl80My9mcmFnOjZlZDUwYmJmZmU2ZDRjMDJhOWRiZDFkNzYzNTUzOWFlL3RhYmxlOjc0N2M1NDc3NmU3NDRlZDc4ZjVmNDk5ODMxYTU5YTBkL3RhYmxlcmFuZ2U6NzQ3YzU0Nzc2ZTc0NGVkNzhmNWY0OTk4MzFhNTlhMGRfNS01LTEtMS0w_3fde5649-8a23-4da3-94ee-6e616a61e785"
      unitRef="usd">69939000</cron:FinancingReceivableBeforeAccruedInterestNoncurrent>
    <cron:FinancingReceivableBeforeAccruedInterestNoncurrent
      contextRef="i6c507204183f49389291963dff6d55c3_I20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzY2E5YmIwMTc5MjQ3NmZiYjIyNWU1ZDlkZWM4NjlmL3NlYzo5M2NhOWJiMDE3OTI0NzZmYmIyMjVlNWQ5ZGVjODY5Zl80My9mcmFnOjZlZDUwYmJmZmU2ZDRjMDJhOWRiZDFkNzYzNTUzOWFlL3RhYmxlOjc0N2M1NDc3NmU3NDRlZDc4ZjVmNDk5ODMxYTU5YTBkL3RhYmxlcmFuZ2U6NzQ3YzU0Nzc2ZTc0NGVkNzhmNWY0OTk4MzFhNTlhMGRfNi0zLTEtMS0w_5b2052be-8027-4f6d-8196-75ce197eb52b"
      unitRef="usd">13969000</cron:FinancingReceivableBeforeAccruedInterestNoncurrent>
    <cron:FinancingReceivableBeforeAccruedInterestNoncurrent
      contextRef="i09921e492ba24195a2e19b52c026c6f7_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzY2E5YmIwMTc5MjQ3NmZiYjIyNWU1ZDlkZWM4NjlmL3NlYzo5M2NhOWJiMDE3OTI0NzZmYmIyMjVlNWQ5ZGVjODY5Zl80My9mcmFnOjZlZDUwYmJmZmU2ZDRjMDJhOWRiZDFkNzYzNTUzOWFlL3RhYmxlOjc0N2M1NDc3NmU3NDRlZDc4ZjVmNDk5ODMxYTU5YTBkL3RhYmxlcmFuZ2U6NzQ3YzU0Nzc2ZTc0NGVkNzhmNWY0OTk4MzFhNTlhMGRfNi01LTEtMS0w_3672a39d-aaa0-4635-8d87-4911b995bb33"
      unitRef="usd">13324000</cron:FinancingReceivableBeforeAccruedInterestNoncurrent>
    <cron:FinancingReceivableBeforeAccruedInterestNoncurrent
      contextRef="i49f2e1595c1b41f4bcbef6f1031a9d69_I20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzY2E5YmIwMTc5MjQ3NmZiYjIyNWU1ZDlkZWM4NjlmL3NlYzo5M2NhOWJiMDE3OTI0NzZmYmIyMjVlNWQ5ZGVjODY5Zl80My9mcmFnOjZlZDUwYmJmZmU2ZDRjMDJhOWRiZDFkNzYzNTUzOWFlL3RhYmxlOjc0N2M1NDc3NmU3NDRlZDc4ZjVmNDk5ODMxYTU5YTBkL3RhYmxlcmFuZ2U6NzQ3YzU0Nzc2ZTc0NGVkNzhmNWY0OTk4MzFhNTlhMGRfNy0zLTEtMS0w_a8015395-2aeb-4820-9dae-6ef7421017fe"
      unitRef="usd">1870000</cron:FinancingReceivableBeforeAccruedInterestNoncurrent>
    <cron:FinancingReceivableBeforeAccruedInterestNoncurrent
      contextRef="i7c3fa2a3ef8f464583be7da8ce8425ee_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzY2E5YmIwMTc5MjQ3NmZiYjIyNWU1ZDlkZWM4NjlmL3NlYzo5M2NhOWJiMDE3OTI0NzZmYmIyMjVlNWQ5ZGVjODY5Zl80My9mcmFnOjZlZDUwYmJmZmU2ZDRjMDJhOWRiZDFkNzYzNTUzOWFlL3RhYmxlOjc0N2M1NDc3NmU3NDRlZDc4ZjVmNDk5ODMxYTU5YTBkL3RhYmxlcmFuZ2U6NzQ3YzU0Nzc2ZTc0NGVkNzhmNWY0OTk4MzFhNTlhMGRfNy01LTEtMS0w_b0d43e87-255a-4e63-8d2e-60256b24c858"
      unitRef="usd">1261000</cron:FinancingReceivableBeforeAccruedInterestNoncurrent>
    <cron:FinancingReceivableAccruedInterestNoncurrent
      contextRef="i0709927d1c004766b70bf1b85ffbd9b2_I20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzY2E5YmIwMTc5MjQ3NmZiYjIyNWU1ZDlkZWM4NjlmL3NlYzo5M2NhOWJiMDE3OTI0NzZmYmIyMjVlNWQ5ZGVjODY5Zl80My9mcmFnOjZlZDUwYmJmZmU2ZDRjMDJhOWRiZDFkNzYzNTUzOWFlL3RhYmxlOjc0N2M1NDc3NmU3NDRlZDc4ZjVmNDk5ODMxYTU5YTBkL3RhYmxlcmFuZ2U6NzQ3YzU0Nzc2ZTc0NGVkNzhmNWY0OTk4MzFhNTlhMGRfOC0zLTEtMS0w_b13bbbe8-5401-49aa-9ac1-01fe6f83039e"
      unitRef="usd">800000</cron:FinancingReceivableAccruedInterestNoncurrent>
    <cron:FinancingReceivableAccruedInterestNoncurrent
      contextRef="i830d314bf026450e8e38d200944077bf_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzY2E5YmIwMTc5MjQ3NmZiYjIyNWU1ZDlkZWM4NjlmL3NlYzo5M2NhOWJiMDE3OTI0NzZmYmIyMjVlNWQ5ZGVjODY5Zl80My9mcmFnOjZlZDUwYmJmZmU2ZDRjMDJhOWRiZDFkNzYzNTUzOWFlL3RhYmxlOjc0N2M1NDc3NmU3NDRlZDc4ZjVmNDk5ODMxYTU5YTBkL3RhYmxlcmFuZ2U6NzQ3YzU0Nzc2ZTc0NGVkNzhmNWY0OTk4MzFhNTlhMGRfOC01LTEtMS0w_9db8800d-1096-4dc3-80e2-bfaf0304a1c2"
      unitRef="usd">2667000</cron:FinancingReceivableAccruedInterestNoncurrent>
    <us-gaap:NotesAndLoansReceivableNetNoncurrent
      contextRef="i225f85e38faa4bbdb4de1d8b9cf369bb_I20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzY2E5YmIwMTc5MjQ3NmZiYjIyNWU1ZDlkZWM4NjlmL3NlYzo5M2NhOWJiMDE3OTI0NzZmYmIyMjVlNWQ5ZGVjODY5Zl80My9mcmFnOjZlZDUwYmJmZmU2ZDRjMDJhOWRiZDFkNzYzNTUzOWFlL3RhYmxlOjc0N2M1NDc3NmU3NDRlZDc4ZjVmNDk5ODMxYTU5YTBkL3RhYmxlcmFuZ2U6NzQ3YzU0Nzc2ZTc0NGVkNzhmNWY0OTk4MzFhNTlhMGRfOS0zLTEtMS0w_42b0af1c-0781-4b6f-a9dd-e22dcb174691"
      unitRef="usd">94113000</us-gaap:NotesAndLoansReceivableNetNoncurrent>
    <us-gaap:NotesAndLoansReceivableNetNoncurrent
      contextRef="ifbe16ec51ea244519b77d6036b4ef038_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzY2E5YmIwMTc5MjQ3NmZiYjIyNWU1ZDlkZWM4NjlmL3NlYzo5M2NhOWJiMDE3OTI0NzZmYmIyMjVlNWQ5ZGVjODY5Zl80My9mcmFnOjZlZDUwYmJmZmU2ZDRjMDJhOWRiZDFkNzYzNTUzOWFlL3RhYmxlOjc0N2M1NDc3NmU3NDRlZDc4ZjVmNDk5ODMxYTU5YTBkL3RhYmxlcmFuZ2U6NzQ3YzU0Nzc2ZTc0NGVkNzhmNWY0OTk4MzFhNTlhMGRfOS01LTEtMS0w_b287c20e-8d57-4943-b285-b43e8411e1d1"
      unitRef="usd">87191000</us-gaap:NotesAndLoansReceivableNetNoncurrent>
    <us-gaap:NotesReceivableNet
      contextRef="i225f85e38faa4bbdb4de1d8b9cf369bb_I20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzY2E5YmIwMTc5MjQ3NmZiYjIyNWU1ZDlkZWM4NjlmL3NlYzo5M2NhOWJiMDE3OTI0NzZmYmIyMjVlNWQ5ZGVjODY5Zl80My9mcmFnOjZlZDUwYmJmZmU2ZDRjMDJhOWRiZDFkNzYzNTUzOWFlL3RhYmxlOjc0N2M1NDc3NmU3NDRlZDc4ZjVmNDk5ODMxYTU5YTBkL3RhYmxlcmFuZ2U6NzQ3YzU0Nzc2ZTc0NGVkNzhmNWY0OTk4MzFhNTlhMGRfMTAtMy0xLTEtMA_d5d628af-b72d-4b23-8e95-da091c6c25fc"
      unitRef="usd">99141000</us-gaap:NotesReceivableNet>
    <us-gaap:NotesReceivableNet
      contextRef="ifbe16ec51ea244519b77d6036b4ef038_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzY2E5YmIwMTc5MjQ3NmZiYjIyNWU1ZDlkZWM4NjlmL3NlYzo5M2NhOWJiMDE3OTI0NzZmYmIyMjVlNWQ5ZGVjODY5Zl80My9mcmFnOjZlZDUwYmJmZmU2ZDRjMDJhOWRiZDFkNzYzNTUzOWFlL3RhYmxlOjc0N2M1NDc3NmU3NDRlZDc4ZjVmNDk5ODMxYTU5YTBkL3RhYmxlcmFuZ2U6NzQ3YzU0Nzc2ZTc0NGVkNzhmNWY0OTk4MzFhNTlhMGRfMTAtNS0xLTEtMA_da35c047-bc79-40c3-8bc9-496bf87ca80a"
      unitRef="usd">94274000</us-gaap:NotesReceivableNet>
    <cron:InvestmentsInAndAdvancesToAffiliatesAtFairValueAdvancesRepayments
      contextRef="i3851bec177234bbb9f9d96a1e3eab1d3_D20210401-20210401"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzY2E5YmIwMTc5MjQ3NmZiYjIyNWU1ZDlkZWM4NjlmL3NlYzo5M2NhOWJiMDE3OTI0NzZmYmIyMjVlNWQ5ZGVjODY5Zl80My9mcmFnOjZlZDUwYmJmZmU2ZDRjMDJhOWRiZDFkNzYzNTUzOWFlL3RleHRyZWdpb246NmVkNTBiYmZmZTZkNGMwMmE5ZGJkMWQ3NjM1NTM5YWVfMTA5OTUxMTYzMTg5MA_e66e1c5d-6fc5-475f-8235-dc148c2066f0"
      unitRef="usd">15500000</cron:InvestmentsInAndAdvancesToAffiliatesAtFairValueAdvancesRepayments>
    <cron:InvestmentsInAndAdvancesToAffiliatesFundingCommitmentPercentage
      contextRef="i8b8f1fc37db0427b9d081e7b40a48cc0_I20210401"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzY2E5YmIwMTc5MjQ3NmZiYjIyNWU1ZDlkZWM4NjlmL3NlYzo5M2NhOWJiMDE3OTI0NzZmYmIyMjVlNWQ5ZGVjODY5Zl80My9mcmFnOjZlZDUwYmJmZmU2ZDRjMDJhOWRiZDFkNzYzNTUzOWFlL3RleHRyZWdpb246NmVkNTBiYmZmZTZkNGMwMmE5ZGJkMWQ3NjM1NTM5YWVfMTY0OTI2NzQ0OTc4Ng_e8b30708-26dd-44d4-b3de-61ded34a7e33"
      unitRef="number">0.50</cron:InvestmentsInAndAdvancesToAffiliatesFundingCommitmentPercentage>
    <cron:InvestmentsInAndAdvancesToAffiliatesFundingCommitmentPercentage
      contextRef="ia926bcff688b4febb81d8fa1a08955dc_I20210401"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzY2E5YmIwMTc5MjQ3NmZiYjIyNWU1ZDlkZWM4NjlmL3NlYzo5M2NhOWJiMDE3OTI0NzZmYmIyMjVlNWQ5ZGVjODY5Zl80My9mcmFnOjZlZDUwYmJmZmU2ZDRjMDJhOWRiZDFkNzYzNTUzOWFlL3RleHRyZWdpb246NmVkNTBiYmZmZTZkNGMwMmE5ZGJkMWQ3NjM1NTM5YWVfMTY0OTI2NzQ0OTc5MA_b38b007b-0b80-448f-97a8-266907209040"
      unitRef="number">0.50</cron:InvestmentsInAndAdvancesToAffiliatesFundingCommitmentPercentage>
    <cron:InvestmentsInAndAdvancesToAffiliatesAtFairValueAdvancesRepayments
      contextRef="i3734fffa32be45c299b65b62d227d165_D20210401-20210401"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzY2E5YmIwMTc5MjQ3NmZiYjIyNWU1ZDlkZWM4NjlmL3NlYzo5M2NhOWJiMDE3OTI0NzZmYmIyMjVlNWQ5ZGVjODY5Zl80My9mcmFnOjZlZDUwYmJmZmU2ZDRjMDJhOWRiZDFkNzYzNTUzOWFlL3RleHRyZWdpb246NmVkNTBiYmZmZTZkNGMwMmE5ZGJkMWQ3NjM1NTM5YWVfMTA5OTUxMTYzMTk4Mg_570f0ddb-ed8f-417f-9aa7-b9588fa601bd"
      unitRef="usd">7750000</cron:InvestmentsInAndAdvancesToAffiliatesAtFairValueAdvancesRepayments>
    <cron:InvestmentsInAndAdvancesToAffiliatesAtFairValueAdvancesRepayments
      contextRef="ibb17976a662245c78f9ece050fbca040_D20210401-20210401"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzY2E5YmIwMTc5MjQ3NmZiYjIyNWU1ZDlkZWM4NjlmL3NlYzo5M2NhOWJiMDE3OTI0NzZmYmIyMjVlNWQ5ZGVjODY5Zl80My9mcmFnOjZlZDUwYmJmZmU2ZDRjMDJhOWRiZDFkNzYzNTUzOWFlL3RleHRyZWdpb246NmVkNTBiYmZmZTZkNGMwMmE5ZGJkMWQ3NjM1NTM5YWVfMTA5OTUxMTYzMTk4Mg_5e8e6ec9-499b-4911-950e-d1bcd4129b38"
      unitRef="usd">7750000</cron:InvestmentsInAndAdvancesToAffiliatesAtFairValueAdvancesRepayments>
    <us-gaap:NotesReceivableNet
      contextRef="i74feb9a5e3ba4f03b6af6468c854d7d3_I20210401"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzY2E5YmIwMTc5MjQ3NmZiYjIyNWU1ZDlkZWM4NjlmL3NlYzo5M2NhOWJiMDE3OTI0NzZmYmIyMjVlNWQ5ZGVjODY5Zl80My9mcmFnOjZlZDUwYmJmZmU2ZDRjMDJhOWRiZDFkNzYzNTUzOWFlL3RleHRyZWdpb246NmVkNTBiYmZmZTZkNGMwMmE5ZGJkMWQ3NjM1NTM5YWVfMTA5OTUxMTYzMjA2NA_679c199f-fd55-482a-97f3-313aceb94b1e"
      unitRef="usd">2013000</us-gaap:NotesReceivableNet>
    <us-gaap:FinancingReceivableAccruedInterestBeforeAllowanceForCreditLoss
      contextRef="i74feb9a5e3ba4f03b6af6468c854d7d3_I20210401"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzY2E5YmIwMTc5MjQ3NmZiYjIyNWU1ZDlkZWM4NjlmL3NlYzo5M2NhOWJiMDE3OTI0NzZmYmIyMjVlNWQ5ZGVjODY5Zl80My9mcmFnOjZlZDUwYmJmZmU2ZDRjMDJhOWRiZDFkNzYzNTUzOWFlL3RleHRyZWdpb246NmVkNTBiYmZmZTZkNGMwMmE5ZGJkMWQ3NjM1NTM5YWVfMzg0ODI5MDcwMzg5Ng_aa069b47-12cd-4847-b730-e43a0ae6dccf"
      unitRef="usd">540000</us-gaap:FinancingReceivableAccruedInterestBeforeAllowanceForCreditLoss>
    <cron:InvestmentsInAndAdvancesToAffiliatesAtFairValueTransferToInvestmentsInEquityAccountedInvestees
      contextRef="i3851bec177234bbb9f9d96a1e3eab1d3_D20210401-20210401"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzY2E5YmIwMTc5MjQ3NmZiYjIyNWU1ZDlkZWM4NjlmL3NlYzo5M2NhOWJiMDE3OTI0NzZmYmIyMjVlNWQ5ZGVjODY5Zl80My9mcmFnOjZlZDUwYmJmZmU2ZDRjMDJhOWRiZDFkNzYzNTUzOWFlL3RleHRyZWdpb246NmVkNTBiYmZmZTZkNGMwMmE5ZGJkMWQ3NjM1NTM5YWVfMjE5OTAyMzI2NTcwMQ_445bb183-6dab-453b-bcac-16d2b68e28aa"
      unitRef="usd">2553000</cron:InvestmentsInAndAdvancesToAffiliatesAtFairValueTransferToInvestmentsInEquityAccountedInvestees>
    <us-gaap:PaymentsToAcquireLoansReceivable
      contextRef="i41fdc77f9612409ab114fbdf3c20b8a8_D20210101-20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzY2E5YmIwMTc5MjQ3NmZiYjIyNWU1ZDlkZWM4NjlmL3NlYzo5M2NhOWJiMDE3OTI0NzZmYmIyMjVlNWQ5ZGVjODY5Zl80My9mcmFnOjZlZDUwYmJmZmU2ZDRjMDJhOWRiZDFkNzYzNTUzOWFlL3RleHRyZWdpb246NmVkNTBiYmZmZTZkNGMwMmE5ZGJkMWQ3NjM1NTM5YWVfNTQ5_707e9ef3-46b3-4d0c-b671-734fb32a8069"
      unitRef="cad">100000000</us-gaap:PaymentsToAcquireLoansReceivable>
    <us-gaap:PaymentsToAcquireLoansReceivable
      contextRef="i41fdc77f9612409ab114fbdf3c20b8a8_D20210101-20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzY2E5YmIwMTc5MjQ3NmZiYjIyNWU1ZDlkZWM4NjlmL3NlYzo5M2NhOWJiMDE3OTI0NzZmYmIyMjVlNWQ5ZGVjODY5Zl80My9mcmFnOjZlZDUwYmJmZmU2ZDRjMDJhOWRiZDFkNzYzNTUzOWFlL3RleHRyZWdpb246NmVkNTBiYmZmZTZkNGMwMmE5ZGJkMWQ3NjM1NTM5YWVfNTUz_c8193541-7313-427f-8513-eb231f924146"
      unitRef="usd">80678000</us-gaap:PaymentsToAcquireLoansReceivable>
    <us-gaap:PaymentsToAcquireLoansReceivable
      contextRef="i2873575c69e24565bb61cd0985446112_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzY2E5YmIwMTc5MjQ3NmZiYjIyNWU1ZDlkZWM4NjlmL3NlYzo5M2NhOWJiMDE3OTI0NzZmYmIyMjVlNWQ5ZGVjODY5Zl80My9mcmFnOjZlZDUwYmJmZmU2ZDRjMDJhOWRiZDFkNzYzNTUzOWFlL3RleHRyZWdpb246NmVkNTBiYmZmZTZkNGMwMmE5ZGJkMWQ3NjM1NTM5YWVfNTYy_0c6fb0df-5076-41f5-8c09-ddf02c0a3a16"
      unitRef="cad">95150000</us-gaap:PaymentsToAcquireLoansReceivable>
    <us-gaap:PaymentsToAcquireLoansReceivable
      contextRef="i2873575c69e24565bb61cd0985446112_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzY2E5YmIwMTc5MjQ3NmZiYjIyNWU1ZDlkZWM4NjlmL3NlYzo5M2NhOWJiMDE3OTI0NzZmYmIyMjVlNWQ5ZGVjODY5Zl80My9mcmFnOjZlZDUwYmJmZmU2ZDRjMDJhOWRiZDFkNzYzNTUzOWFlL3RleHRyZWdpb246NmVkNTBiYmZmZTZkNGMwMmE5ZGJkMWQ3NjM1NTM5YWVfNTY2_e58a442f-65d2-4871-b75a-7a81068718e8"
      unitRef="usd">74626000</us-gaap:PaymentsToAcquireLoansReceivable>
    <us-gaap:FinancingReceivableAllowanceForCreditLosses
      contextRef="i4d5e5ad8b8c04f0e81c4f56d20dd2667_I20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzY2E5YmIwMTc5MjQ3NmZiYjIyNWU1ZDlkZWM4NjlmL3NlYzo5M2NhOWJiMDE3OTI0NzZmYmIyMjVlNWQ5ZGVjODY5Zl80My9mcmFnOjZlZDUwYmJmZmU2ZDRjMDJhOWRiZDFkNzYzNTUzOWFlL3RleHRyZWdpb246NmVkNTBiYmZmZTZkNGMwMmE5ZGJkMWQ3NjM1NTM5YWVfNDk0NzgwMjMzNDMyMw_f023dde9-978b-4a19-80f9-963460f84d83"
      unitRef="usd">1590000</us-gaap:FinancingReceivableAllowanceForCreditLosses>
    <us-gaap:FinancingReceivableAllowanceForCreditLosses
      contextRef="i389408e323054f34bb2d44166886cfa0_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzY2E5YmIwMTc5MjQ3NmZiYjIyNWU1ZDlkZWM4NjlmL3NlYzo5M2NhOWJiMDE3OTI0NzZmYmIyMjVlNWQ5ZGVjODY5Zl80My9mcmFnOjZlZDUwYmJmZmU2ZDRjMDJhOWRiZDFkNzYzNTUzOWFlL3RleHRyZWdpb246NmVkNTBiYmZmZTZkNGMwMmE5ZGJkMWQ3NjM1NTM5YWVfNzY1_b91c0f31-76e7-4842-ba5a-6c80a0c1a980"
      unitRef="usd">1470000</us-gaap:FinancingReceivableAllowanceForCreditLosses>
    <us-gaap:FinancingReceivableAllowanceForCreditLosses
      contextRef="i6c507204183f49389291963dff6d55c3_I20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzY2E5YmIwMTc5MjQ3NmZiYjIyNWU1ZDlkZWM4NjlmL3NlYzo5M2NhOWJiMDE3OTI0NzZmYmIyMjVlNWQ5ZGVjODY5Zl80My9mcmFnOjZlZDUwYmJmZmU2ZDRjMDJhOWRiZDFkNzYzNTUzOWFlL3RleHRyZWdpb246NmVkNTBiYmZmZTZkNGMwMmE5ZGJkMWQ3NjM1NTM5YWVfNDk0NzgwMjMzNDMzMg_2470e089-428f-4a22-aff0-109e62fd86fa"
      unitRef="usd">278000</us-gaap:FinancingReceivableAllowanceForCreditLosses>
    <us-gaap:FinancingReceivableAllowanceForCreditLosses
      contextRef="i09921e492ba24195a2e19b52c026c6f7_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzY2E5YmIwMTc5MjQ3NmZiYjIyNWU1ZDlkZWM4NjlmL3NlYzo5M2NhOWJiMDE3OTI0NzZmYmIyMjVlNWQ5ZGVjODY5Zl80My9mcmFnOjZlZDUwYmJmZmU2ZDRjMDJhOWRiZDFkNzYzNTUzOWFlL3RleHRyZWdpb246NmVkNTBiYmZmZTZkNGMwMmE5ZGJkMWQ3NjM1NTM5YWVfOTA4_690464a4-d137-45ef-a5c6-2ffa1d3838a5"
      unitRef="usd">259000</us-gaap:FinancingReceivableAllowanceForCreditLosses>
    <cron:CollaborativeArrangementInstallmentsReceived
      contextRef="i00bf33a48aaa4cf2930896225af28659_I20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzY2E5YmIwMTc5MjQ3NmZiYjIyNWU1ZDlkZWM4NjlmL3NlYzo5M2NhOWJiMDE3OTI0NzZmYmIyMjVlNWQ5ZGVjODY5Zl80My9mcmFnOjZlZDUwYmJmZmU2ZDRjMDJhOWRiZDFkNzYzNTUzOWFlL3RleHRyZWdpb246NmVkNTBiYmZmZTZkNGMwMmE5ZGJkMWQ3NjM1NTM5YWVfMTAyNg_ce71c4a8-c236-4bf8-90e9-ea8f1a28de6f"
      unitRef="ils">6223000</cron:CollaborativeArrangementInstallmentsReceived>
    <cron:CollaborativeArrangementInstallmentsReceived
      contextRef="ifdf5fbc8e97845b297aa6f44576063c3_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzY2E5YmIwMTc5MjQ3NmZiYjIyNWU1ZDlkZWM4NjlmL3NlYzo5M2NhOWJiMDE3OTI0NzZmYmIyMjVlNWQ5ZGVjODY5Zl80My9mcmFnOjZlZDUwYmJmZmU2ZDRjMDJhOWRiZDFkNzYzNTUzOWFlL3RleHRyZWdpb246NmVkNTBiYmZmZTZkNGMwMmE5ZGJkMWQ3NjM1NTM5YWVfNDk0NzgwMjMzMzM5OA_e5c3256e-6ff9-4e14-b7dc-584129f868a0"
      unitRef="ils">4149000</cron:CollaborativeArrangementInstallmentsReceived>
    <cron:CollaborativeArrangementInstallmentsReceived
      contextRef="i00bf33a48aaa4cf2930896225af28659_I20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzY2E5YmIwMTc5MjQ3NmZiYjIyNWU1ZDlkZWM4NjlmL3NlYzo5M2NhOWJiMDE3OTI0NzZmYmIyMjVlNWQ5ZGVjODY5Zl80My9mcmFnOjZlZDUwYmJmZmU2ZDRjMDJhOWRiZDFkNzYzNTUzOWFlL3RleHRyZWdpb246NmVkNTBiYmZmZTZkNGMwMmE5ZGJkMWQ3NjM1NTM5YWVfMTA0NA_ede7b69e-4904-4403-9a29-cb17f7e3dffd"
      unitRef="usd">1909000</cron:CollaborativeArrangementInstallmentsReceived>
    <cron:CollaborativeArrangementInstallmentsReceived
      contextRef="ifdf5fbc8e97845b297aa6f44576063c3_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzY2E5YmIwMTc5MjQ3NmZiYjIyNWU1ZDlkZWM4NjlmL3NlYzo5M2NhOWJiMDE3OTI0NzZmYmIyMjVlNWQ5ZGVjODY5Zl80My9mcmFnOjZlZDUwYmJmZmU2ZDRjMDJhOWRiZDFkNzYzNTUzOWFlL3RleHRyZWdpb246NmVkNTBiYmZmZTZkNGMwMmE5ZGJkMWQ3NjM1NTM5YWVfNDk0NzgwMjMzMzQyOQ_bb849e87-ea11-4cfa-a8f4-319ec230a954"
      unitRef="usd">1287000</cron:CollaborativeArrangementInstallmentsReceived>
    <us-gaap:AllowanceForDoubtfulAccountsReceivableCurrent
      contextRef="i00bf33a48aaa4cf2930896225af28659_I20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzY2E5YmIwMTc5MjQ3NmZiYjIyNWU1ZDlkZWM4NjlmL3NlYzo5M2NhOWJiMDE3OTI0NzZmYmIyMjVlNWQ5ZGVjODY5Zl80My9mcmFnOjZlZDUwYmJmZmU2ZDRjMDJhOWRiZDFkNzYzNTUzOWFlL3RleHRyZWdpb246NmVkNTBiYmZmZTZkNGMwMmE5ZGJkMWQ3NjM1NTM5YWVfNDk0NzgwMjMzNDMzNg_af46af08-6270-415f-8b48-ca34c104d9b6"
      unitRef="usd">39000</us-gaap:AllowanceForDoubtfulAccountsReceivableCurrent>
    <us-gaap:AllowanceForDoubtfulAccountsReceivableCurrent
      contextRef="ifdf5fbc8e97845b297aa6f44576063c3_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzY2E5YmIwMTc5MjQ3NmZiYjIyNWU1ZDlkZWM4NjlmL3NlYzo5M2NhOWJiMDE3OTI0NzZmYmIyMjVlNWQ5ZGVjODY5Zl80My9mcmFnOjZlZDUwYmJmZmU2ZDRjMDJhOWRiZDFkNzYzNTUzOWFlL3RleHRyZWdpb246NmVkNTBiYmZmZTZkNGMwMmE5ZGJkMWQ3NjM1NTM5YWVfMTE1Ng_e6339b68-ae9e-4709-9e6d-fb3f413f3312"
      unitRef="usd">25000</us-gaap:AllowanceForDoubtfulAccountsReceivableCurrent>
    <us-gaap:DerivativeInstrumentsAndHedgingActivitiesDisclosureTextBlock
      contextRef="i69782326f71a44e3805518280ee22b6b_D20210101-20210630"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzY2E5YmIwMTc5MjQ3NmZiYjIyNWU1ZDlkZWM4NjlmL3NlYzo5M2NhOWJiMDE3OTI0NzZmYmIyMjVlNWQ5ZGVjODY5Zl80Ni9mcmFnOjE0YjkzMDBhMzZkNDQ1OTdhZGI5NzM0MDBlZTk5ZjYwL3RleHRyZWdpb246MTRiOTMwMGEzNmQ0NDU5N2FkYjk3MzQwMGVlOTlmNjBfNzQ2OA_cef53bc0-3a50-45ae-bd6c-26131cc3be3e">Derivative Liabilities &lt;div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;On March 8, 2019, the Company closed the previously announced investment in the Company (the &#x201c;Altria Investment&#x201d;) by Altria Group, Inc. (&#x201c;Altria&#x201d;), pursuant to a subscription agreement dated December 7, 2018. As of the closing date of the Altria Investment, the Altria Investment consisted of 149,831,154 common shares of the Company and one warrant of the Company (the &#x201c;Altria Warrant&#x201d;), all of which were issued to a wholly owned subsidiary of Altria. As of the closing date of the Altria Investment, Altria beneficially held an approximately 45% ownership interest in the Company (calculated on a non-diluted basis). As summarized in this note, if exercised in full on such date, the exercise of the Altria Warrant would have resulted in Altria holding a total ownership interest in the Company of approximately 55% (calculated on a non-diluted basis). As of June 30, 2021, Altria beneficially held an approximately 42% ownership interest in the Company (calculated on a non-diluted basis). As summarized in this note, if exercised in full on such date, the exercise of the Altria Warrant would have resulted in Altria holding a total ownership interest in the Company of approximately 53% (calculated on a non-diluted basis). Pursuant to the investor rights agreement between the Company and Altria, entered into in connection with the closing of the Altria Investment (the &#x201c;Investor Rights Agreement&#x201d;), the Company granted Altria certain rights, among others, summarized in this note.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The summaries below are qualified entirely by the terms and conditions fully set out in the Investor Rights Agreement and the Altria Warrant, as applicable.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt;padding-left:36pt;text-align:justify;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;a.&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:11.07pt"&gt;The Altria Warrant entitles the holder, subject to certain qualifications and limitations, to subscribe for and purchase up to an additional approximate 10% of the common shares of Cronos (approximately 83 million common shares at June&#160;30, 2021) at a per share exercise price of C$19.00, which expires on March 8, 2023.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt;padding-left:36pt;text-align:justify;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;b.&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:10.5pt"&gt;The Company granted to Altria, subject to certain qualifications and limitations, upon the occurrence of certain issuances of common shares of the Company executed by the Company (including issuances pursuant to the R&amp;amp;D partnership with Ginkgo Bioworks Inc. (&#x201c;Ginkgo&#x201d;) (the &#x201c;Ginkgo Strategic Partnership&#x201d;)), the right to purchase up to such number of common shares of the Company in order to maintain their ownership percentage of issued and outstanding common shares of the Company immediately preceding any issuance of shares by the Company (&#x201c;Pre-emptive Rights&#x201d;), at the same price per common share of the Company at which the common shares are sold in the relevant issuance. The price per common share of the Company to be paid by Altria pursuant to its exercise of its Pre-emptive Rights related to the Ginkgo Strategic Partnership will be C$16.25 per common share. These rights may not be exercised if Altria&#x2019;s ownership percentage of the issued and outstanding shares of the Company falls below 20%.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt;padding-left:36pt;text-align:justify;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;c.&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:11.07pt"&gt;In addition to (and without duplication of) the Pre-emptive Rights, the Company granted to Altria, subject to certain qualifications and limitations, the right to subscribe for common shares of the Company issuable in connection with the exercise, conversion or exchange of convertible securities of the Company issued prior to March 8, 2019 or thereafter (excluding any convertible securities of the Company owned by Altria or any of its subsidiaries), a share incentive plan of the Company, the exercise of any right granted by the Company pro rata to all shareholders of the Company to purchase additional common shares and/or securities of the Company, bona fide bank debt, equipment financing or non-equity interim financing transactions that contemplate an equity component or bona fide acquisitions (including acquisitions of assets or rights under a license or otherwise), mergers or similar business combination transactions or joint ventures involving the Company in order to maintain their ownership percentage of issued and outstanding common shares of the Company immediately preceding any such transactions (&#x201c;Top-up Rights&#x201d;).&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The price per common share to be paid by Altria pursuant to the exercise of its Top-up Rights will be, subject to certain limited exceptions, the 10-day volume-weighted average price of the common shares of the Company on the TSX for the ten full days preceding such exercise by Altria, provided that the price per common share of the Company to be paid by Altria pursuant to the exercise of its Top-up Rights in connection with the issuance of common shares of the Company pursuant to the exercise of options or warrants that were outstanding as of March 8, 2019 will be C$16.25 per common share without any set off, counterclaim, deduction, or withholding. These rights may not be exercised if Altria&#x2019;s ownership percentage of the issued and outstanding shares of the Company falls below 20%. The Altria Warrant, Pre-emptive Rights, and fixed price Top-up Rights have been classified as derivative liabilities.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;A reconciliation of the carrying amounts of the derivative liability for the three months ended June&#160;30, 2021 and 2020:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:18.483%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.761%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.911%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:14.316%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.911%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.761%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.911%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:14.872%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.911%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.763%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;As of April 1, 2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Revaluation gain&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Out-of-period adjustment&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Foreign exchange effect&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;As of June 30, 2021&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(a) Altria Warrant&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;234,656&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(85,778)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,205&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;150,083&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(b) Pre-emptive Rights&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;20,173&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(6,360)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;113&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;13,926&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(c) Top-up Rights&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;17,471&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(23,110)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;11,278&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(85)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5,554&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;272,300&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(115,248)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;11,278&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,233&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;169,563&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:18.483%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.761%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.911%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:14.316%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.911%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.761%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.911%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:14.872%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.911%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.763%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;As of April 1, 2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Revaluation loss&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Exercise of rights&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Foreign exchange effect&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;As of June&#160;30, 2020&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(a) Altria Warrant&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;132,366&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;30,052&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,540&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;165,958&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(b) Pre-emptive Rights&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;13,070&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,610&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;500&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;16,180&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(c) Top-up Rights&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;20,013&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,218&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(727)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,072&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;23,576&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;165,449&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;35,880&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(727)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5,112&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;205,714&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:12pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;A reconciliation of the carrying amounts of the derivative liability for the six months ended June&#160;30, 2021 and 2020:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:18.483%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.761%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.911%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:14.316%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.911%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.761%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.911%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:14.872%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.911%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.763%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;As of January 1, 2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Revaluation loss/(gain)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Exercise of rights&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Foreign exchange effect&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;As of June 30, 2021&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(a) Altria Warrant&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;138,858&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7,186&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4,039&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;150,083&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(b) Pre-emptive Rights&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;12,095&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,473&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;358&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;13,926&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(c) Top-up Rights&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;12,457&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(7,033)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;130&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5,554&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;163,410&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,626&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4,527&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;169,563&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:18.483%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.761%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.911%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:14.316%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.911%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.761%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.911%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:14.872%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.911%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.763%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;As of January 1, 2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Revaluation loss/(gain)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Exercise of rights&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Foreign exchange effect&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;As of June&#160;30, 2020&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(a) Altria Warrant&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;234,428&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(58,052)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(10,418)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;165,958&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(b) Pre-emptive Rights&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;12,787&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,925&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(532)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;16,180&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(c) Top-up Rights&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;49,945&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(23,361)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(727)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(2,281)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;23,576&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;297,160&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(77,488)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(727)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(13,231)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;205,714&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;margin-top:12pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Fluctuations in the Company&#x2019;s share price are a primary driver for the changes in the derivative valuations during each reporting period. As the share price decreases for each of the related derivative instruments, the liability of the instrument generally decreases. Share price is one of the significant observable inputs used in the fair value measurement of each of the Company&#x2019;s derivative instruments. During the three months ended June&#160;30, 2021, the Company&#x2019;s share price decreased from April 1, 2021 and we recorded an out-of-period adjustment of $11,278. See Note 1. Background, Basis of Presentation and Accounting Policies for more information on the out-of-period adjustment.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The fair values of the derivative liabilities were determined using the Black-Scholes pricing model as of June&#160;30, 2021 and December 31, 2020 applying the following inputs:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.583%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:31.257%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.639%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.357%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.639%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.357%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.639%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.776%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.639%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.357%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.639%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.357%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.644%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;As of June&#160;30, 2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;As of December 31, 2020&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Altria Warrant&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Pre-emptive Rights&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Top-up Rights&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Altria Warrant&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Pre-emptive Rights&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Top-up Rights&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Share price at valuation date &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(i)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$10.68&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$10.68&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$10.68&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$8.84&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$8.84&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$8.84&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Subscription price &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(i)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$19.00&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$16.25&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$16.25&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$19.00&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$16.25&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$16.25&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;div style="margin-top:1pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Weighted average risk-free interest rate &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(ii)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.38%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.28%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.31%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.21%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.17%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.13%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;div style="margin-top:1pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Weighted average expected life &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(iii)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1.68&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1.25&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1.31&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2.18&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1.50&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.98&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;div style="margin-top:1pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Expected annualized volatility&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline"&gt; (iv)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;75%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;75%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;75%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;81%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;81%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;81%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Expected dividend yield&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;padding-left:27pt;text-align:justify;text-indent:-27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:400;line-height:120%;position:relative;top:-2.8pt;vertical-align:baseline"&gt;(i)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:22.1pt"&gt;Per share in C$.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt;margin-top:3pt;padding-left:27pt;text-align:justify;text-indent:-27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:400;line-height:120%;position:relative;top:-2.8pt;vertical-align:baseline"&gt;(ii)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:20.66pt"&gt;The risk-free interest rate was based on Bank of Canada government treasury bills and bonds with a remaining term equal to the expected life of the derivative liabilities. As of June&#160;30, 2021 and December 31, 2020, the risk-free interest rate uses a range of approximately 0.15% to 0.85% and 0.10% to 0.39%, respectively, for the Pre-emptive Rights and Top-up Rights.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt;margin-top:3pt;padding-left:27pt;text-align:justify;text-indent:-27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:400;line-height:120%;position:relative;top:-2.8pt;vertical-align:baseline"&gt;(iii)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:19.22pt"&gt;The expected life represents the period of time, in years, that the derivative liabilities are expected to be outstanding. The expected life of the Pre-emptive Rights and Top-up Rights is determined based on the expected term of the underlying options, warrants, and shares, to which the Pre-emptive Rights and Top-up Rights are linked. As of June&#160;30, 2021 and December 31, 2020, the expected life uses a range of approximately 0.25 year to 4.25 years and 0.50 year to 5.00 years, respectively.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:3pt;padding-left:27pt;text-align:justify;text-indent:-27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:400;line-height:120%;position:relative;top:-2.8pt;vertical-align:baseline"&gt;(iv)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:19.5pt"&gt;Volatility was based on an equally weighted blended historical and implied volatility level of the underlying equity securities of the Company as of June&#160;30, 2021. As of December 31, 2020, volatility was based on the blended historical volatility levels of the Company and peer companies.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:12pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following table quantifies each of the significant inputs described above and provides a sensitivity analysis of the impact on the reported values of the derivative liabilities. The sensitivity analysis for each significant input is performed by assuming a 10% decrease in the input while other significant inputs remain constant at management&#x2019;s best estimate as of the respective dates. While a decrease in the inputs noted below would cause a decrease in the carrying value of the derivative liability, there would also be an equal but opposite impact on net income (loss).&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:28.761%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.466%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.038%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.327%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.038%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.327%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.038%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.327%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.038%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.327%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.038%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.327%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.048%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Decrease as of June&#160;30, 2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Decrease as of December 31, 2020&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Altria Warrant&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Pre-emptive Rights&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Top-up Rights&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Altria Warrant&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Pre-emptive Rights&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Top-up Rights&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Share price&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;31,375&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,146&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,302&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;25,819&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,527&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,989&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Weighted average expected life&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;14,220&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5,266&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;502&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;13,541&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,988&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,121&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Expected annualized volatility&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;27,375&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,348&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;968&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;26,183&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,269&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,602&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:12pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;These inputs are classified in Level 3 on the fair value hierarchy and are subject to volatility and several factors outside of the Company&#x2019;s control, which could significantly affect the fair value of these derivative liabilities in future periods.&lt;/span&gt;&lt;/div&gt;</us-gaap:DerivativeInstrumentsAndHedgingActivitiesDisclosureTextBlock>
    <us-gaap:StockIssuedDuringPeriodSharesNewIssues
      contextRef="i74b9dd5702d7406d891cf47a54534f5d_D20190308-20190308"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzY2E5YmIwMTc5MjQ3NmZiYjIyNWU1ZDlkZWM4NjlmL3NlYzo5M2NhOWJiMDE3OTI0NzZmYmIyMjVlNWQ5ZGVjODY5Zl80Ni9mcmFnOjE0YjkzMDBhMzZkNDQ1OTdhZGI5NzM0MDBlZTk5ZjYwL3RleHRyZWdpb246MTRiOTMwMGEzNmQ0NDU5N2FkYjk3MzQwMGVlOTlmNjBfMzA2_d27b0752-950f-46ef-95f9-4f88214a341f"
      unitRef="shares">149831154</us-gaap:StockIssuedDuringPeriodSharesNewIssues>
    <cron:ClassOfWarrantOrRightNumberOfWarrantsIssued
      contextRef="i0e42c55484f24f8ca353ad7f388b4066_D20190308-20190308"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzY2E5YmIwMTc5MjQ3NmZiYjIyNWU1ZDlkZWM4NjlmL3NlYzo5M2NhOWJiMDE3OTI0NzZmYmIyMjVlNWQ5ZGVjODY5Zl80Ni9mcmFnOjE0YjkzMDBhMzZkNDQ1OTdhZGI5NzM0MDBlZTk5ZjYwL3RleHRyZWdpb246MTRiOTMwMGEzNmQ0NDU5N2FkYjk3MzQwMGVlOTlmNjBfMzQy_46bdb129-abfa-413d-bde0-1f8fb8e15568"
      unitRef="warrant">1</cron:ClassOfWarrantOrRightNumberOfWarrantsIssued>
    <us-gaap:EquityMethodInvestmentOwnershipPercentage
      contextRef="idadea534a9454dde961a3571663d9316_I20190308"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzY2E5YmIwMTc5MjQ3NmZiYjIyNWU1ZDlkZWM4NjlmL3NlYzo5M2NhOWJiMDE3OTI0NzZmYmIyMjVlNWQ5ZGVjODY5Zl80Ni9mcmFnOjE0YjkzMDBhMzZkNDQ1OTdhZGI5NzM0MDBlZTk5ZjYwL3RleHRyZWdpb246MTRiOTMwMGEzNmQ0NDU5N2FkYjk3MzQwMGVlOTlmNjBfNTQ4_37250c61-39e1-46d6-85ed-3a8b513b4893"
      unitRef="number">0.45</us-gaap:EquityMethodInvestmentOwnershipPercentage>
    <cron:SubsidiaryOrEquityMethodInvesteeCumulativePercentageOwnershipAfterAllTransactionsIfWarrantsExercised
      contextRef="i12a4ebb046d84e5b9eb27c82479f837b_I20190308"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzY2E5YmIwMTc5MjQ3NmZiYjIyNWU1ZDlkZWM4NjlmL3NlYzo5M2NhOWJiMDE3OTI0NzZmYmIyMjVlNWQ5ZGVjODY5Zl80Ni9mcmFnOjE0YjkzMDBhMzZkNDQ1OTdhZGI5NzM0MDBlZTk5ZjYwL3RleHRyZWdpb246MTRiOTMwMGEzNmQ0NDU5N2FkYjk3MzQwMGVlOTlmNjBfODE3_298cb24c-9eda-4807-9de6-b1bff4c27b1d"
      unitRef="number">0.55</cron:SubsidiaryOrEquityMethodInvesteeCumulativePercentageOwnershipAfterAllTransactionsIfWarrantsExercised>
    <us-gaap:EquityMethodInvestmentOwnershipPercentage
      contextRef="i0a23fd4d2173473387281b095562f1e0_I20210630"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzY2E5YmIwMTc5MjQ3NmZiYjIyNWU1ZDlkZWM4NjlmL3NlYzo5M2NhOWJiMDE3OTI0NzZmYmIyMjVlNWQ5ZGVjODY5Zl80Ni9mcmFnOjE0YjkzMDBhMzZkNDQ1OTdhZGI5NzM0MDBlZTk5ZjYwL3RleHRyZWdpb246MTRiOTMwMGEzNmQ0NDU5N2FkYjk3MzQwMGVlOTlmNjBfMjE5OTAyMzI2ODk1OA_9e2c78ed-2702-4c6b-957b-e432cf94a181"
      unitRef="number">0.42</us-gaap:EquityMethodInvestmentOwnershipPercentage>
    <cron:SubsidiaryOrEquityMethodInvesteeCumulativePercentageOwnershipAfterAllTransactionsIfWarrantsExercised
      contextRef="iff243ffb3690436c962f2508a95b9bf9_I20210630"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzY2E5YmIwMTc5MjQ3NmZiYjIyNWU1ZDlkZWM4NjlmL3NlYzo5M2NhOWJiMDE3OTI0NzZmYmIyMjVlNWQ5ZGVjODY5Zl80Ni9mcmFnOjE0YjkzMDBhMzZkNDQ1OTdhZGI5NzM0MDBlZTk5ZjYwL3RleHRyZWdpb246MTRiOTMwMGEzNmQ0NDU5N2FkYjk3MzQwMGVlOTlmNjBfMjE5OTAyMzI2ODk2Mw_aacf34c7-4169-4a46-82f6-c7d7db82ee20"
      unitRef="number">0.53</cron:SubsidiaryOrEquityMethodInvesteeCumulativePercentageOwnershipAfterAllTransactionsIfWarrantsExercised>
    <cron:ClassOfWarrantOrRightMaximumAdditionalSubscriptionPercentage
      contextRef="iab341b8979a347a9b96abc3a20faff60_I20190308"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzY2E5YmIwMTc5MjQ3NmZiYjIyNWU1ZDlkZWM4NjlmL3NlYzo5M2NhOWJiMDE3OTI0NzZmYmIyMjVlNWQ5ZGVjODY5Zl80Ni9mcmFnOjE0YjkzMDBhMzZkNDQ1OTdhZGI5NzM0MDBlZTk5ZjYwL3RleHRyZWdpb246MTRiOTMwMGEzNmQ0NDU5N2FkYjk3MzQwMGVlOTlmNjBfMTQxNg_d08b9a1a-259a-40da-9305-99a0c3434a73"
      unitRef="number">0.10</cron:ClassOfWarrantOrRightMaximumAdditionalSubscriptionPercentage>
    <cron:ClassOfWarrantOrRightAdditionalSubscriptionNumberOfSecuritiesCalledByWarrantsOrRights
      contextRef="i5b5f21f6057c4e8e893d9e27815ea92a_I20210630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzY2E5YmIwMTc5MjQ3NmZiYjIyNWU1ZDlkZWM4NjlmL3NlYzo5M2NhOWJiMDE3OTI0NzZmYmIyMjVlNWQ5ZGVjODY5Zl80Ni9mcmFnOjE0YjkzMDBhMzZkNDQ1OTdhZGI5NzM0MDBlZTk5ZjYwL3RleHRyZWdpb246MTRiOTMwMGEzNmQ0NDU5N2FkYjk3MzQwMGVlOTlmNjBfMTQ2NQ_947cc10e-8d56-4a5a-a4cb-e543470fdbe4"
      unitRef="shares">83000000</cron:ClassOfWarrantOrRightAdditionalSubscriptionNumberOfSecuritiesCalledByWarrantsOrRights>
    <us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1
      contextRef="i1d456d0e4fcf43c6ad21f99b40cbf279_I20190308"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzY2E5YmIwMTc5MjQ3NmZiYjIyNWU1ZDlkZWM4NjlmL3NlYzo5M2NhOWJiMDE3OTI0NzZmYmIyMjVlNWQ5ZGVjODY5Zl80Ni9mcmFnOjE0YjkzMDBhMzZkNDQ1OTdhZGI5NzM0MDBlZTk5ZjYwL3RleHRyZWdpb246MTRiOTMwMGEzNmQ0NDU5N2FkYjk3MzQwMGVlOTlmNjBfMTUyMw_daa8aa02-7caa-4bcd-acb5-d2de65bd1899"
      unitRef="cadPerShare">19.00</us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1>
    <us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1
      contextRef="i379e3f598bfc45909cc782ee94752221_I20190308"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzY2E5YmIwMTc5MjQ3NmZiYjIyNWU1ZDlkZWM4NjlmL3NlYzo5M2NhOWJiMDE3OTI0NzZmYmIyMjVlNWQ5ZGVjODY5Zl80Ni9mcmFnOjE0YjkzMDBhMzZkNDQ1OTdhZGI5NzM0MDBlZTk5ZjYwL3RleHRyZWdpb246MTRiOTMwMGEzNmQ0NDU5N2FkYjk3MzQwMGVlOTlmNjBfMjQwNg_6d10f726-40df-4b18-a003-51253c0fcfc0"
      unitRef="cadPerShare">16.25</us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1>
    <cron:ClassOfWarrantOrRightMinimumOwnershipPercentageRequired
      contextRef="i379e3f598bfc45909cc782ee94752221_I20190308"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzY2E5YmIwMTc5MjQ3NmZiYjIyNWU1ZDlkZWM4NjlmL3NlYzo5M2NhOWJiMDE3OTI0NzZmYmIyMjVlNWQ5ZGVjODY5Zl80Ni9mcmFnOjE0YjkzMDBhMzZkNDQ1OTdhZGI5NzM0MDBlZTk5ZjYwL3RleHRyZWdpb246MTRiOTMwMGEzNmQ0NDU5N2FkYjk3MzQwMGVlOTlmNjBfMjU1OA_ee923d28-daa0-4183-a1f6-cf5793ad326a"
      unitRef="number">0.20</cron:ClassOfWarrantOrRightMinimumOwnershipPercentageRequired>
    <cron:ClassOfWarrantOrRightExercisePriceVolumeWeightedAveragePriceMeasurementPeriod
      contextRef="i92e07d954a1e4dc78f61eca5784be099_D20190308-20190308"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzY2E5YmIwMTc5MjQ3NmZiYjIyNWU1ZDlkZWM4NjlmL3NlYzo5M2NhOWJiMDE3OTI0NzZmYmIyMjVlNWQ5ZGVjODY5Zl80Ni9mcmFnOjE0YjkzMDBhMzZkNDQ1OTdhZGI5NzM0MDBlZTk5ZjYwL3RleHRyZWdpb246MTRiOTMwMGEzNmQ0NDU5N2FkYjk3MzQwMGVlOTlmNjBfMzg0OA_a6772cdc-6587-4eec-a5a3-aa1f8e7fc4d9">P10D</cron:ClassOfWarrantOrRightExercisePriceVolumeWeightedAveragePriceMeasurementPeriod>
    <cron:ClassOfWarrantOrRightExercisePriceVolumeWeightedAveragePriceMeasurementPeriodDaysPrecedingExercise
      contextRef="i92e07d954a1e4dc78f61eca5784be099_D20190308-20190308"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzY2E5YmIwMTc5MjQ3NmZiYjIyNWU1ZDlkZWM4NjlmL3NlYzo5M2NhOWJiMDE3OTI0NzZmYmIyMjVlNWQ5ZGVjODY5Zl80Ni9mcmFnOjE0YjkzMDBhMzZkNDQ1OTdhZGI5NzM0MDBlZTk5ZjYwL3RleHRyZWdpb246MTRiOTMwMGEzNmQ0NDU5N2FkYjk3MzQwMGVlOTlmNjBfMzk0MA_90b12341-c29f-4d69-a590-ea1b5c64260a"
      unitRef="day">10</cron:ClassOfWarrantOrRightExercisePriceVolumeWeightedAveragePriceMeasurementPeriodDaysPrecedingExercise>
    <us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1
      contextRef="i5c3db268f31b4ec899f7f0121d0b1bf8_I20190308"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzY2E5YmIwMTc5MjQ3NmZiYjIyNWU1ZDlkZWM4NjlmL3NlYzo5M2NhOWJiMDE3OTI0NzZmYmIyMjVlNWQ5ZGVjODY5Zl80Ni9mcmFnOjE0YjkzMDBhMzZkNDQ1OTdhZGI5NzM0MDBlZTk5ZjYwL3RleHRyZWdpb246MTRiOTMwMGEzNmQ0NDU5N2FkYjk3MzQwMGVlOTlmNjBfNDI3NA_4602a0c8-bc5c-4f87-b268-a5852dc167da"
      unitRef="cadPerShare">16.25</us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1>
    <cron:ClassOfWarrantOrRightMinimumOwnershipPercentageRequired
      contextRef="i5c3db268f31b4ec899f7f0121d0b1bf8_I20190308"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzY2E5YmIwMTc5MjQ3NmZiYjIyNWU1ZDlkZWM4NjlmL3NlYzo5M2NhOWJiMDE3OTI0NzZmYmIyMjVlNWQ5ZGVjODY5Zl80Ni9mcmFnOjE0YjkzMDBhMzZkNDQ1OTdhZGI5NzM0MDBlZTk5ZjYwL3RleHRyZWdpb246MTRiOTMwMGEzNmQ0NDU5N2FkYjk3MzQwMGVlOTlmNjBfNDQ4Nw_793dd295-6df3-4652-88cf-739a3ba2cb96"
      unitRef="number">0.20</cron:ClassOfWarrantOrRightMinimumOwnershipPercentageRequired>
    <us-gaap:FairValueNetDerivativeAssetLiabilityMeasuredOnRecurringBasisUnobservableInputReconciliationTableTextBlock
      contextRef="i69782326f71a44e3805518280ee22b6b_D20210101-20210630"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzY2E5YmIwMTc5MjQ3NmZiYjIyNWU1ZDlkZWM4NjlmL3NlYzo5M2NhOWJiMDE3OTI0NzZmYmIyMjVlNWQ5ZGVjODY5Zl80Ni9mcmFnOjE0YjkzMDBhMzZkNDQ1OTdhZGI5NzM0MDBlZTk5ZjYwL3RleHRyZWdpb246MTRiOTMwMGEzNmQ0NDU5N2FkYjk3MzQwMGVlOTlmNjBfNzQ2OQ_b87c5e18-6915-4bb5-98b1-0a0ffb925563">&lt;div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;A reconciliation of the carrying amounts of the derivative liability for the three months ended June&#160;30, 2021 and 2020:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:18.483%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.761%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.911%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:14.316%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.911%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.761%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.911%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:14.872%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.911%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.763%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;As of April 1, 2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Revaluation gain&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Out-of-period adjustment&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Foreign exchange effect&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;As of June 30, 2021&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(a) Altria Warrant&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;234,656&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(85,778)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,205&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;150,083&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(b) Pre-emptive Rights&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;20,173&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(6,360)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;113&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;13,926&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(c) Top-up Rights&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;17,471&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(23,110)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;11,278&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(85)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5,554&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;272,300&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(115,248)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;11,278&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,233&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;169,563&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:18.483%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.761%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.911%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:14.316%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.911%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.761%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.911%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:14.872%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.911%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.763%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;As of April 1, 2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Revaluation loss&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Exercise of rights&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Foreign exchange effect&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;As of June&#160;30, 2020&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(a) Altria Warrant&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;132,366&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;30,052&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,540&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;165,958&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(b) Pre-emptive Rights&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;13,070&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,610&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;500&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;16,180&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(c) Top-up Rights&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;20,013&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,218&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(727)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,072&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;23,576&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;165,449&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;35,880&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(727)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5,112&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;205,714&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:12pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;A reconciliation of the carrying amounts of the derivative liability for the six months ended June&#160;30, 2021 and 2020:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:18.483%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.761%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.911%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:14.316%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.911%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.761%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.911%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:14.872%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.911%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.763%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;As of January 1, 2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Revaluation loss/(gain)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Exercise of rights&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Foreign exchange effect&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;As of June 30, 2021&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(a) Altria Warrant&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;138,858&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7,186&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4,039&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;150,083&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(b) Pre-emptive Rights&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;12,095&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,473&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;358&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;13,926&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(c) Top-up Rights&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;12,457&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(7,033)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;130&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5,554&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;163,410&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,626&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4,527&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;169,563&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:18.483%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.761%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.911%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:14.316%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.911%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.761%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.911%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:14.872%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.911%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.763%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;As of January 1, 2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Revaluation loss/(gain)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Exercise of rights&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Foreign exchange effect&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;As of June&#160;30, 2020&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(a) Altria Warrant&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;234,428&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(58,052)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(10,418)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;165,958&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(b) Pre-emptive Rights&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;12,787&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,925&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(532)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;16,180&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(c) Top-up Rights&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;49,945&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(23,361)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(727)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(2,281)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;23,576&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;297,160&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(77,488)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(727)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(13,231)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;205,714&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:FairValueNetDerivativeAssetLiabilityMeasuredOnRecurringBasisUnobservableInputReconciliationTableTextBlock>
    <us-gaap:FairValueNetDerivativeAssetLiabilityMeasuredOnRecurringBasisWithUnobservableInputs
      contextRef="i7456fc9f9bac466e8f36318a7f2e0986_I20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzY2E5YmIwMTc5MjQ3NmZiYjIyNWU1ZDlkZWM4NjlmL3NlYzo5M2NhOWJiMDE3OTI0NzZmYmIyMjVlNWQ5ZGVjODY5Zl80Ni9mcmFnOjE0YjkzMDBhMzZkNDQ1OTdhZGI5NzM0MDBlZTk5ZjYwL3RhYmxlOjM4OGFhOWUwZjEyYjQ4NTlhMzQ1MjQ1NjU3M2VmOTAwL3RhYmxlcmFuZ2U6Mzg4YWE5ZTBmMTJiNDg1OWEzNDUyNDU2NTczZWY5MDBfMS0xLTEtMS0w_461fd02a-9913-482d-b1a2-9def5e3d73c1"
      unitRef="usd">-234656000</us-gaap:FairValueNetDerivativeAssetLiabilityMeasuredOnRecurringBasisWithUnobservableInputs>
    <us-gaap:FairValueNetDerivativeAssetLiabilityMeasuredOnRecurringBasisUnobservableInputsReconciliationGainLossIncludedInEarnings
      contextRef="iecf64aa815654085bee554811ab6f80e_D20210401-20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzY2E5YmIwMTc5MjQ3NmZiYjIyNWU1ZDlkZWM4NjlmL3NlYzo5M2NhOWJiMDE3OTI0NzZmYmIyMjVlNWQ5ZGVjODY5Zl80Ni9mcmFnOjE0YjkzMDBhMzZkNDQ1OTdhZGI5NzM0MDBlZTk5ZjYwL3RhYmxlOjM4OGFhOWUwZjEyYjQ4NTlhMzQ1MjQ1NjU3M2VmOTAwL3RhYmxlcmFuZ2U6Mzg4YWE5ZTBmMTJiNDg1OWEzNDUyNDU2NTczZWY5MDBfMS0zLTEtMS0w_c9437e57-40f8-466a-a8eb-264e63b19511"
      unitRef="usd">85778000</us-gaap:FairValueNetDerivativeAssetLiabilityMeasuredOnRecurringBasisUnobservableInputsReconciliationGainLossIncludedInEarnings>
    <cron:FairValueNetDerivativeAssetLiabilityMeasuredOnRecurringBasisUnobservableInputsReconciliationOutOfPeriodAdjustment
      contextRef="iecf64aa815654085bee554811ab6f80e_D20210401-20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzY2E5YmIwMTc5MjQ3NmZiYjIyNWU1ZDlkZWM4NjlmL3NlYzo5M2NhOWJiMDE3OTI0NzZmYmIyMjVlNWQ5ZGVjODY5Zl80Ni9mcmFnOjE0YjkzMDBhMzZkNDQ1OTdhZGI5NzM0MDBlZTk5ZjYwL3RhYmxlOjM4OGFhOWUwZjEyYjQ4NTlhMzQ1MjQ1NjU3M2VmOTAwL3RhYmxlcmFuZ2U6Mzg4YWE5ZTBmMTJiNDg1OWEzNDUyNDU2NTczZWY5MDBfMS01LTEtMS0w_477440f5-db1f-4b2e-aaba-772b9baf5164"
      unitRef="usd">0</cron:FairValueNetDerivativeAssetLiabilityMeasuredOnRecurringBasisUnobservableInputsReconciliationOutOfPeriodAdjustment>
    <us-gaap:FairValueNetDerivativeAssetLiabilityMeasuredOnRecurringBasisUnobservableInputsReconciliationGainLossIncludedInOtherComprehensiveIncomeLoss
      contextRef="iecf64aa815654085bee554811ab6f80e_D20210401-20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzY2E5YmIwMTc5MjQ3NmZiYjIyNWU1ZDlkZWM4NjlmL3NlYzo5M2NhOWJiMDE3OTI0NzZmYmIyMjVlNWQ5ZGVjODY5Zl80Ni9mcmFnOjE0YjkzMDBhMzZkNDQ1OTdhZGI5NzM0MDBlZTk5ZjYwL3RhYmxlOjM4OGFhOWUwZjEyYjQ4NTlhMzQ1MjQ1NjU3M2VmOTAwL3RhYmxlcmFuZ2U6Mzg4YWE5ZTBmMTJiNDg1OWEzNDUyNDU2NTczZWY5MDBfMS03LTEtMS0w_e552a374-7069-4b2f-80c9-0ca86c9dd9f0"
      unitRef="usd">-1205000</us-gaap:FairValueNetDerivativeAssetLiabilityMeasuredOnRecurringBasisUnobservableInputsReconciliationGainLossIncludedInOtherComprehensiveIncomeLoss>
    <us-gaap:FairValueNetDerivativeAssetLiabilityMeasuredOnRecurringBasisWithUnobservableInputs
      contextRef="i34995f47e8ba418fbd529b2ed52790dc_I20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzY2E5YmIwMTc5MjQ3NmZiYjIyNWU1ZDlkZWM4NjlmL3NlYzo5M2NhOWJiMDE3OTI0NzZmYmIyMjVlNWQ5ZGVjODY5Zl80Ni9mcmFnOjE0YjkzMDBhMzZkNDQ1OTdhZGI5NzM0MDBlZTk5ZjYwL3RhYmxlOjM4OGFhOWUwZjEyYjQ4NTlhMzQ1MjQ1NjU3M2VmOTAwL3RhYmxlcmFuZ2U6Mzg4YWE5ZTBmMTJiNDg1OWEzNDUyNDU2NTczZWY5MDBfMS05LTEtMS0w_edfa0266-b71f-414a-adc2-c55541aff7b1"
      unitRef="usd">-150083000</us-gaap:FairValueNetDerivativeAssetLiabilityMeasuredOnRecurringBasisWithUnobservableInputs>
    <us-gaap:FairValueNetDerivativeAssetLiabilityMeasuredOnRecurringBasisWithUnobservableInputs
      contextRef="i626147251ce249d59dd6e68a90196f38_I20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzY2E5YmIwMTc5MjQ3NmZiYjIyNWU1ZDlkZWM4NjlmL3NlYzo5M2NhOWJiMDE3OTI0NzZmYmIyMjVlNWQ5ZGVjODY5Zl80Ni9mcmFnOjE0YjkzMDBhMzZkNDQ1OTdhZGI5NzM0MDBlZTk5ZjYwL3RhYmxlOjM4OGFhOWUwZjEyYjQ4NTlhMzQ1MjQ1NjU3M2VmOTAwL3RhYmxlcmFuZ2U6Mzg4YWE5ZTBmMTJiNDg1OWEzNDUyNDU2NTczZWY5MDBfMi0xLTEtMS0w_16ff4cd1-25b7-4add-8cd5-d736672b5276"
      unitRef="usd">-20173000</us-gaap:FairValueNetDerivativeAssetLiabilityMeasuredOnRecurringBasisWithUnobservableInputs>
    <us-gaap:FairValueNetDerivativeAssetLiabilityMeasuredOnRecurringBasisUnobservableInputsReconciliationGainLossIncludedInEarnings
      contextRef="i8c832bd4137248cb9777e42d7526fc6e_D20210401-20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzY2E5YmIwMTc5MjQ3NmZiYjIyNWU1ZDlkZWM4NjlmL3NlYzo5M2NhOWJiMDE3OTI0NzZmYmIyMjVlNWQ5ZGVjODY5Zl80Ni9mcmFnOjE0YjkzMDBhMzZkNDQ1OTdhZGI5NzM0MDBlZTk5ZjYwL3RhYmxlOjM4OGFhOWUwZjEyYjQ4NTlhMzQ1MjQ1NjU3M2VmOTAwL3RhYmxlcmFuZ2U6Mzg4YWE5ZTBmMTJiNDg1OWEzNDUyNDU2NTczZWY5MDBfMi0zLTEtMS0w_6d70dda5-824e-4e4f-8401-c172147bbb53"
      unitRef="usd">6360000</us-gaap:FairValueNetDerivativeAssetLiabilityMeasuredOnRecurringBasisUnobservableInputsReconciliationGainLossIncludedInEarnings>
    <cron:FairValueNetDerivativeAssetLiabilityMeasuredOnRecurringBasisUnobservableInputsReconciliationOutOfPeriodAdjustment
      contextRef="i8c832bd4137248cb9777e42d7526fc6e_D20210401-20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzY2E5YmIwMTc5MjQ3NmZiYjIyNWU1ZDlkZWM4NjlmL3NlYzo5M2NhOWJiMDE3OTI0NzZmYmIyMjVlNWQ5ZGVjODY5Zl80Ni9mcmFnOjE0YjkzMDBhMzZkNDQ1OTdhZGI5NzM0MDBlZTk5ZjYwL3RhYmxlOjM4OGFhOWUwZjEyYjQ4NTlhMzQ1MjQ1NjU3M2VmOTAwL3RhYmxlcmFuZ2U6Mzg4YWE5ZTBmMTJiNDg1OWEzNDUyNDU2NTczZWY5MDBfMi01LTEtMS0w_02ccb2ca-4d60-455e-b8f9-4c3e9954bfde"
      unitRef="usd">0</cron:FairValueNetDerivativeAssetLiabilityMeasuredOnRecurringBasisUnobservableInputsReconciliationOutOfPeriodAdjustment>
    <us-gaap:FairValueNetDerivativeAssetLiabilityMeasuredOnRecurringBasisUnobservableInputsReconciliationGainLossIncludedInOtherComprehensiveIncomeLoss
      contextRef="i8c832bd4137248cb9777e42d7526fc6e_D20210401-20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzY2E5YmIwMTc5MjQ3NmZiYjIyNWU1ZDlkZWM4NjlmL3NlYzo5M2NhOWJiMDE3OTI0NzZmYmIyMjVlNWQ5ZGVjODY5Zl80Ni9mcmFnOjE0YjkzMDBhMzZkNDQ1OTdhZGI5NzM0MDBlZTk5ZjYwL3RhYmxlOjM4OGFhOWUwZjEyYjQ4NTlhMzQ1MjQ1NjU3M2VmOTAwL3RhYmxlcmFuZ2U6Mzg4YWE5ZTBmMTJiNDg1OWEzNDUyNDU2NTczZWY5MDBfMi03LTEtMS0w_47b61bee-54e2-42d5-a164-5eda8ff45d32"
      unitRef="usd">-113000</us-gaap:FairValueNetDerivativeAssetLiabilityMeasuredOnRecurringBasisUnobservableInputsReconciliationGainLossIncludedInOtherComprehensiveIncomeLoss>
    <us-gaap:FairValueNetDerivativeAssetLiabilityMeasuredOnRecurringBasisWithUnobservableInputs
      contextRef="ie4ec3b642b3b4457b78cb85e8d1838f0_I20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzY2E5YmIwMTc5MjQ3NmZiYjIyNWU1ZDlkZWM4NjlmL3NlYzo5M2NhOWJiMDE3OTI0NzZmYmIyMjVlNWQ5ZGVjODY5Zl80Ni9mcmFnOjE0YjkzMDBhMzZkNDQ1OTdhZGI5NzM0MDBlZTk5ZjYwL3RhYmxlOjM4OGFhOWUwZjEyYjQ4NTlhMzQ1MjQ1NjU3M2VmOTAwL3RhYmxlcmFuZ2U6Mzg4YWE5ZTBmMTJiNDg1OWEzNDUyNDU2NTczZWY5MDBfMi05LTEtMS0w_3a2b5ed5-9fd2-47c5-9bf0-74960021d956"
      unitRef="usd">-13926000</us-gaap:FairValueNetDerivativeAssetLiabilityMeasuredOnRecurringBasisWithUnobservableInputs>
    <us-gaap:FairValueNetDerivativeAssetLiabilityMeasuredOnRecurringBasisWithUnobservableInputs
      contextRef="i38d49776600045c1b8110dc70e805025_I20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzY2E5YmIwMTc5MjQ3NmZiYjIyNWU1ZDlkZWM4NjlmL3NlYzo5M2NhOWJiMDE3OTI0NzZmYmIyMjVlNWQ5ZGVjODY5Zl80Ni9mcmFnOjE0YjkzMDBhMzZkNDQ1OTdhZGI5NzM0MDBlZTk5ZjYwL3RhYmxlOjM4OGFhOWUwZjEyYjQ4NTlhMzQ1MjQ1NjU3M2VmOTAwL3RhYmxlcmFuZ2U6Mzg4YWE5ZTBmMTJiNDg1OWEzNDUyNDU2NTczZWY5MDBfMy0xLTEtMS0w_d80eb727-ecf1-4548-9e4a-e99107cff58d"
      unitRef="usd">-17471000</us-gaap:FairValueNetDerivativeAssetLiabilityMeasuredOnRecurringBasisWithUnobservableInputs>
    <us-gaap:FairValueNetDerivativeAssetLiabilityMeasuredOnRecurringBasisUnobservableInputsReconciliationGainLossIncludedInEarnings
      contextRef="i03741f2ae4674980813a9701e43f6a2b_D20210401-20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzY2E5YmIwMTc5MjQ3NmZiYjIyNWU1ZDlkZWM4NjlmL3NlYzo5M2NhOWJiMDE3OTI0NzZmYmIyMjVlNWQ5ZGVjODY5Zl80Ni9mcmFnOjE0YjkzMDBhMzZkNDQ1OTdhZGI5NzM0MDBlZTk5ZjYwL3RhYmxlOjM4OGFhOWUwZjEyYjQ4NTlhMzQ1MjQ1NjU3M2VmOTAwL3RhYmxlcmFuZ2U6Mzg4YWE5ZTBmMTJiNDg1OWEzNDUyNDU2NTczZWY5MDBfMy0zLTEtMS0w_008f0c4a-4acd-4382-9541-47a9b3718dc9"
      unitRef="usd">23110000</us-gaap:FairValueNetDerivativeAssetLiabilityMeasuredOnRecurringBasisUnobservableInputsReconciliationGainLossIncludedInEarnings>
    <cron:FairValueNetDerivativeAssetLiabilityMeasuredOnRecurringBasisUnobservableInputsReconciliationOutOfPeriodAdjustment
      contextRef="i03741f2ae4674980813a9701e43f6a2b_D20210401-20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzY2E5YmIwMTc5MjQ3NmZiYjIyNWU1ZDlkZWM4NjlmL3NlYzo5M2NhOWJiMDE3OTI0NzZmYmIyMjVlNWQ5ZGVjODY5Zl80Ni9mcmFnOjE0YjkzMDBhMzZkNDQ1OTdhZGI5NzM0MDBlZTk5ZjYwL3RhYmxlOjM4OGFhOWUwZjEyYjQ4NTlhMzQ1MjQ1NjU3M2VmOTAwL3RhYmxlcmFuZ2U6Mzg4YWE5ZTBmMTJiNDg1OWEzNDUyNDU2NTczZWY5MDBfMy01LTEtMS0w_91c86d35-7047-45a4-90eb-91c7d7f69132"
      unitRef="usd">-11278000</cron:FairValueNetDerivativeAssetLiabilityMeasuredOnRecurringBasisUnobservableInputsReconciliationOutOfPeriodAdjustment>
    <us-gaap:FairValueNetDerivativeAssetLiabilityMeasuredOnRecurringBasisUnobservableInputsReconciliationGainLossIncludedInOtherComprehensiveIncomeLoss
      contextRef="i03741f2ae4674980813a9701e43f6a2b_D20210401-20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzY2E5YmIwMTc5MjQ3NmZiYjIyNWU1ZDlkZWM4NjlmL3NlYzo5M2NhOWJiMDE3OTI0NzZmYmIyMjVlNWQ5ZGVjODY5Zl80Ni9mcmFnOjE0YjkzMDBhMzZkNDQ1OTdhZGI5NzM0MDBlZTk5ZjYwL3RhYmxlOjM4OGFhOWUwZjEyYjQ4NTlhMzQ1MjQ1NjU3M2VmOTAwL3RhYmxlcmFuZ2U6Mzg4YWE5ZTBmMTJiNDg1OWEzNDUyNDU2NTczZWY5MDBfMy03LTEtMS0w_d70bad0d-c4bd-4b33-be65-d4946b418743"
      unitRef="usd">85000</us-gaap:FairValueNetDerivativeAssetLiabilityMeasuredOnRecurringBasisUnobservableInputsReconciliationGainLossIncludedInOtherComprehensiveIncomeLoss>
    <us-gaap:FairValueNetDerivativeAssetLiabilityMeasuredOnRecurringBasisWithUnobservableInputs
      contextRef="ia2cd5cb93e97428dabd7e841eee51895_I20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzY2E5YmIwMTc5MjQ3NmZiYjIyNWU1ZDlkZWM4NjlmL3NlYzo5M2NhOWJiMDE3OTI0NzZmYmIyMjVlNWQ5ZGVjODY5Zl80Ni9mcmFnOjE0YjkzMDBhMzZkNDQ1OTdhZGI5NzM0MDBlZTk5ZjYwL3RhYmxlOjM4OGFhOWUwZjEyYjQ4NTlhMzQ1MjQ1NjU3M2VmOTAwL3RhYmxlcmFuZ2U6Mzg4YWE5ZTBmMTJiNDg1OWEzNDUyNDU2NTczZWY5MDBfMy05LTEtMS0w_fe4872dc-8e83-4eec-a2ce-b7bf421dd3d8"
      unitRef="usd">-5554000</us-gaap:FairValueNetDerivativeAssetLiabilityMeasuredOnRecurringBasisWithUnobservableInputs>
    <us-gaap:FairValueNetDerivativeAssetLiabilityMeasuredOnRecurringBasisWithUnobservableInputs
      contextRef="i672ae438d5904d3aa27f245b59e5ba4c_I20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzY2E5YmIwMTc5MjQ3NmZiYjIyNWU1ZDlkZWM4NjlmL3NlYzo5M2NhOWJiMDE3OTI0NzZmYmIyMjVlNWQ5ZGVjODY5Zl80Ni9mcmFnOjE0YjkzMDBhMzZkNDQ1OTdhZGI5NzM0MDBlZTk5ZjYwL3RhYmxlOjM4OGFhOWUwZjEyYjQ4NTlhMzQ1MjQ1NjU3M2VmOTAwL3RhYmxlcmFuZ2U6Mzg4YWE5ZTBmMTJiNDg1OWEzNDUyNDU2NTczZWY5MDBfNC0xLTEtMS0w_36ecf572-c3ba-4181-9f63-30802d986c02"
      unitRef="usd">-272300000</us-gaap:FairValueNetDerivativeAssetLiabilityMeasuredOnRecurringBasisWithUnobservableInputs>
    <us-gaap:FairValueNetDerivativeAssetLiabilityMeasuredOnRecurringBasisUnobservableInputsReconciliationGainLossIncludedInEarnings
      contextRef="i27f4e53b91ad4367b7f8d273eff27769_D20210401-20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzY2E5YmIwMTc5MjQ3NmZiYjIyNWU1ZDlkZWM4NjlmL3NlYzo5M2NhOWJiMDE3OTI0NzZmYmIyMjVlNWQ5ZGVjODY5Zl80Ni9mcmFnOjE0YjkzMDBhMzZkNDQ1OTdhZGI5NzM0MDBlZTk5ZjYwL3RhYmxlOjM4OGFhOWUwZjEyYjQ4NTlhMzQ1MjQ1NjU3M2VmOTAwL3RhYmxlcmFuZ2U6Mzg4YWE5ZTBmMTJiNDg1OWEzNDUyNDU2NTczZWY5MDBfNC0zLTEtMS0w_7184c9f0-f62d-4176-8c47-17749d1650f2"
      unitRef="usd">115248000</us-gaap:FairValueNetDerivativeAssetLiabilityMeasuredOnRecurringBasisUnobservableInputsReconciliationGainLossIncludedInEarnings>
    <cron:FairValueNetDerivativeAssetLiabilityMeasuredOnRecurringBasisUnobservableInputsReconciliationOutOfPeriodAdjustment
      contextRef="i27f4e53b91ad4367b7f8d273eff27769_D20210401-20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzY2E5YmIwMTc5MjQ3NmZiYjIyNWU1ZDlkZWM4NjlmL3NlYzo5M2NhOWJiMDE3OTI0NzZmYmIyMjVlNWQ5ZGVjODY5Zl80Ni9mcmFnOjE0YjkzMDBhMzZkNDQ1OTdhZGI5NzM0MDBlZTk5ZjYwL3RhYmxlOjM4OGFhOWUwZjEyYjQ4NTlhMzQ1MjQ1NjU3M2VmOTAwL3RhYmxlcmFuZ2U6Mzg4YWE5ZTBmMTJiNDg1OWEzNDUyNDU2NTczZWY5MDBfNC01LTEtMS0w_971ff4e9-6b97-4d20-a105-159e4de8f00d"
      unitRef="usd">-11278000</cron:FairValueNetDerivativeAssetLiabilityMeasuredOnRecurringBasisUnobservableInputsReconciliationOutOfPeriodAdjustment>
    <us-gaap:FairValueNetDerivativeAssetLiabilityMeasuredOnRecurringBasisUnobservableInputsReconciliationGainLossIncludedInOtherComprehensiveIncomeLoss
      contextRef="i27f4e53b91ad4367b7f8d273eff27769_D20210401-20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzY2E5YmIwMTc5MjQ3NmZiYjIyNWU1ZDlkZWM4NjlmL3NlYzo5M2NhOWJiMDE3OTI0NzZmYmIyMjVlNWQ5ZGVjODY5Zl80Ni9mcmFnOjE0YjkzMDBhMzZkNDQ1OTdhZGI5NzM0MDBlZTk5ZjYwL3RhYmxlOjM4OGFhOWUwZjEyYjQ4NTlhMzQ1MjQ1NjU3M2VmOTAwL3RhYmxlcmFuZ2U6Mzg4YWE5ZTBmMTJiNDg1OWEzNDUyNDU2NTczZWY5MDBfNC03LTEtMS0w_51adc08c-cda6-4de7-bbf0-aa1100e3226f"
      unitRef="usd">-1233000</us-gaap:FairValueNetDerivativeAssetLiabilityMeasuredOnRecurringBasisUnobservableInputsReconciliationGainLossIncludedInOtherComprehensiveIncomeLoss>
    <us-gaap:FairValueNetDerivativeAssetLiabilityMeasuredOnRecurringBasisWithUnobservableInputs
      contextRef="i225f85e38faa4bbdb4de1d8b9cf369bb_I20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzY2E5YmIwMTc5MjQ3NmZiYjIyNWU1ZDlkZWM4NjlmL3NlYzo5M2NhOWJiMDE3OTI0NzZmYmIyMjVlNWQ5ZGVjODY5Zl80Ni9mcmFnOjE0YjkzMDBhMzZkNDQ1OTdhZGI5NzM0MDBlZTk5ZjYwL3RhYmxlOjM4OGFhOWUwZjEyYjQ4NTlhMzQ1MjQ1NjU3M2VmOTAwL3RhYmxlcmFuZ2U6Mzg4YWE5ZTBmMTJiNDg1OWEzNDUyNDU2NTczZWY5MDBfNC05LTEtMS0w_4509e7bb-3ae8-4ae2-bf2e-eab993072adf"
      unitRef="usd">-169563000</us-gaap:FairValueNetDerivativeAssetLiabilityMeasuredOnRecurringBasisWithUnobservableInputs>
    <us-gaap:FairValueNetDerivativeAssetLiabilityMeasuredOnRecurringBasisWithUnobservableInputs
      contextRef="if715f02149d34306825baa5114765cba_I20200331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzY2E5YmIwMTc5MjQ3NmZiYjIyNWU1ZDlkZWM4NjlmL3NlYzo5M2NhOWJiMDE3OTI0NzZmYmIyMjVlNWQ5ZGVjODY5Zl80Ni9mcmFnOjE0YjkzMDBhMzZkNDQ1OTdhZGI5NzM0MDBlZTk5ZjYwL3RhYmxlOmVlZTEyYWNiZmVjNjQwYmI4MGRlN2ZjYzBiN2Y5NWRkL3RhYmxlcmFuZ2U6ZWVlMTJhY2JmZWM2NDBiYjgwZGU3ZmNjMGI3Zjk1ZGRfMS0xLTEtMS04NTQ_c4f84a9b-15e2-4912-bb5c-5d208d161bba"
      unitRef="usd">-132366000</us-gaap:FairValueNetDerivativeAssetLiabilityMeasuredOnRecurringBasisWithUnobservableInputs>
    <us-gaap:FairValueNetDerivativeAssetLiabilityMeasuredOnRecurringBasisUnobservableInputsReconciliationGainLossIncludedInEarnings
      contextRef="i1b9a300b5b514425a64d7bc17abb0931_D20200401-20200630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzY2E5YmIwMTc5MjQ3NmZiYjIyNWU1ZDlkZWM4NjlmL3NlYzo5M2NhOWJiMDE3OTI0NzZmYmIyMjVlNWQ5ZGVjODY5Zl80Ni9mcmFnOjE0YjkzMDBhMzZkNDQ1OTdhZGI5NzM0MDBlZTk5ZjYwL3RhYmxlOmVlZTEyYWNiZmVjNjQwYmI4MGRlN2ZjYzBiN2Y5NWRkL3RhYmxlcmFuZ2U6ZWVlMTJhY2JmZWM2NDBiYjgwZGU3ZmNjMGI3Zjk1ZGRfMS0zLTEtMS04NTg_da72d22d-b07a-4aee-b177-8ee5f6a2dc2b"
      unitRef="usd">-30052000</us-gaap:FairValueNetDerivativeAssetLiabilityMeasuredOnRecurringBasisUnobservableInputsReconciliationGainLossIncludedInEarnings>
    <us-gaap:FairValueNetDerivativeAssetLiabilityMeasuredOnRecurringBasisUnobservableInputsReconciliationSettlements
      contextRef="i1b9a300b5b514425a64d7bc17abb0931_D20200401-20200630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzY2E5YmIwMTc5MjQ3NmZiYjIyNWU1ZDlkZWM4NjlmL3NlYzo5M2NhOWJiMDE3OTI0NzZmYmIyMjVlNWQ5ZGVjODY5Zl80Ni9mcmFnOjE0YjkzMDBhMzZkNDQ1OTdhZGI5NzM0MDBlZTk5ZjYwL3RhYmxlOmVlZTEyYWNiZmVjNjQwYmI4MGRlN2ZjYzBiN2Y5NWRkL3RhYmxlcmFuZ2U6ZWVlMTJhY2JmZWM2NDBiYjgwZGU3ZmNjMGI3Zjk1ZGRfMS01LTEtMS04NjE_bc9d8b9f-3865-4dec-ad51-22a604eaa340"
      unitRef="usd">0</us-gaap:FairValueNetDerivativeAssetLiabilityMeasuredOnRecurringBasisUnobservableInputsReconciliationSettlements>
    <us-gaap:FairValueNetDerivativeAssetLiabilityMeasuredOnRecurringBasisUnobservableInputsReconciliationGainLossIncludedInOtherComprehensiveIncomeLoss
      contextRef="i1b9a300b5b514425a64d7bc17abb0931_D20200401-20200630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzY2E5YmIwMTc5MjQ3NmZiYjIyNWU1ZDlkZWM4NjlmL3NlYzo5M2NhOWJiMDE3OTI0NzZmYmIyMjVlNWQ5ZGVjODY5Zl80Ni9mcmFnOjE0YjkzMDBhMzZkNDQ1OTdhZGI5NzM0MDBlZTk5ZjYwL3RhYmxlOmVlZTEyYWNiZmVjNjQwYmI4MGRlN2ZjYzBiN2Y5NWRkL3RhYmxlcmFuZ2U6ZWVlMTJhY2JmZWM2NDBiYjgwZGU3ZmNjMGI3Zjk1ZGRfMS03LTEtMS04NjQ_f7c912ae-0a50-4a1c-b789-f7eba3d131ca"
      unitRef="usd">-3540000</us-gaap:FairValueNetDerivativeAssetLiabilityMeasuredOnRecurringBasisUnobservableInputsReconciliationGainLossIncludedInOtherComprehensiveIncomeLoss>
    <us-gaap:FairValueNetDerivativeAssetLiabilityMeasuredOnRecurringBasisWithUnobservableInputs
      contextRef="i69563d705edd465aabff3c895c85c313_I20200630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzY2E5YmIwMTc5MjQ3NmZiYjIyNWU1ZDlkZWM4NjlmL3NlYzo5M2NhOWJiMDE3OTI0NzZmYmIyMjVlNWQ5ZGVjODY5Zl80Ni9mcmFnOjE0YjkzMDBhMzZkNDQ1OTdhZGI5NzM0MDBlZTk5ZjYwL3RhYmxlOmVlZTEyYWNiZmVjNjQwYmI4MGRlN2ZjYzBiN2Y5NWRkL3RhYmxlcmFuZ2U6ZWVlMTJhY2JmZWM2NDBiYjgwZGU3ZmNjMGI3Zjk1ZGRfMS05LTEtMS04Njc_b70b154f-d467-4557-a47a-22a2aecfea93"
      unitRef="usd">-165958000</us-gaap:FairValueNetDerivativeAssetLiabilityMeasuredOnRecurringBasisWithUnobservableInputs>
    <us-gaap:FairValueNetDerivativeAssetLiabilityMeasuredOnRecurringBasisWithUnobservableInputs
      contextRef="id9dedf3ba4bb445d8d76440d2f0ce670_I20200331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzY2E5YmIwMTc5MjQ3NmZiYjIyNWU1ZDlkZWM4NjlmL3NlYzo5M2NhOWJiMDE3OTI0NzZmYmIyMjVlNWQ5ZGVjODY5Zl80Ni9mcmFnOjE0YjkzMDBhMzZkNDQ1OTdhZGI5NzM0MDBlZTk5ZjYwL3RhYmxlOmVlZTEyYWNiZmVjNjQwYmI4MGRlN2ZjYzBiN2Y5NWRkL3RhYmxlcmFuZ2U6ZWVlMTJhY2JmZWM2NDBiYjgwZGU3ZmNjMGI3Zjk1ZGRfMi0xLTEtMS04NTQ_c4dd45b8-c68c-4db4-a523-2e2bf941503e"
      unitRef="usd">-13070000</us-gaap:FairValueNetDerivativeAssetLiabilityMeasuredOnRecurringBasisWithUnobservableInputs>
    <us-gaap:FairValueNetDerivativeAssetLiabilityMeasuredOnRecurringBasisUnobservableInputsReconciliationGainLossIncludedInEarnings
      contextRef="ifc3c6e8680594375afc563066129c544_D20200401-20200630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzY2E5YmIwMTc5MjQ3NmZiYjIyNWU1ZDlkZWM4NjlmL3NlYzo5M2NhOWJiMDE3OTI0NzZmYmIyMjVlNWQ5ZGVjODY5Zl80Ni9mcmFnOjE0YjkzMDBhMzZkNDQ1OTdhZGI5NzM0MDBlZTk5ZjYwL3RhYmxlOmVlZTEyYWNiZmVjNjQwYmI4MGRlN2ZjYzBiN2Y5NWRkL3RhYmxlcmFuZ2U6ZWVlMTJhY2JmZWM2NDBiYjgwZGU3ZmNjMGI3Zjk1ZGRfMi0zLTEtMS04NTg_67062593-834a-4538-98c7-67e160c07c96"
      unitRef="usd">-2610000</us-gaap:FairValueNetDerivativeAssetLiabilityMeasuredOnRecurringBasisUnobservableInputsReconciliationGainLossIncludedInEarnings>
    <us-gaap:FairValueNetDerivativeAssetLiabilityMeasuredOnRecurringBasisUnobservableInputsReconciliationSettlements
      contextRef="ifc3c6e8680594375afc563066129c544_D20200401-20200630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzY2E5YmIwMTc5MjQ3NmZiYjIyNWU1ZDlkZWM4NjlmL3NlYzo5M2NhOWJiMDE3OTI0NzZmYmIyMjVlNWQ5ZGVjODY5Zl80Ni9mcmFnOjE0YjkzMDBhMzZkNDQ1OTdhZGI5NzM0MDBlZTk5ZjYwL3RhYmxlOmVlZTEyYWNiZmVjNjQwYmI4MGRlN2ZjYzBiN2Y5NWRkL3RhYmxlcmFuZ2U6ZWVlMTJhY2JmZWM2NDBiYjgwZGU3ZmNjMGI3Zjk1ZGRfMi01LTEtMS04NjE_22c5b8c9-b94b-4f38-9512-d9db681fe514"
      unitRef="usd">0</us-gaap:FairValueNetDerivativeAssetLiabilityMeasuredOnRecurringBasisUnobservableInputsReconciliationSettlements>
    <us-gaap:FairValueNetDerivativeAssetLiabilityMeasuredOnRecurringBasisUnobservableInputsReconciliationGainLossIncludedInOtherComprehensiveIncomeLoss
      contextRef="ifc3c6e8680594375afc563066129c544_D20200401-20200630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzY2E5YmIwMTc5MjQ3NmZiYjIyNWU1ZDlkZWM4NjlmL3NlYzo5M2NhOWJiMDE3OTI0NzZmYmIyMjVlNWQ5ZGVjODY5Zl80Ni9mcmFnOjE0YjkzMDBhMzZkNDQ1OTdhZGI5NzM0MDBlZTk5ZjYwL3RhYmxlOmVlZTEyYWNiZmVjNjQwYmI4MGRlN2ZjYzBiN2Y5NWRkL3RhYmxlcmFuZ2U6ZWVlMTJhY2JmZWM2NDBiYjgwZGU3ZmNjMGI3Zjk1ZGRfMi03LTEtMS04NjQ_8694efed-d80e-4177-81e9-3dba2aed326a"
      unitRef="usd">-500000</us-gaap:FairValueNetDerivativeAssetLiabilityMeasuredOnRecurringBasisUnobservableInputsReconciliationGainLossIncludedInOtherComprehensiveIncomeLoss>
    <us-gaap:FairValueNetDerivativeAssetLiabilityMeasuredOnRecurringBasisWithUnobservableInputs
      contextRef="i08475478dc1e46759179fb5a161607ba_I20200630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzY2E5YmIwMTc5MjQ3NmZiYjIyNWU1ZDlkZWM4NjlmL3NlYzo5M2NhOWJiMDE3OTI0NzZmYmIyMjVlNWQ5ZGVjODY5Zl80Ni9mcmFnOjE0YjkzMDBhMzZkNDQ1OTdhZGI5NzM0MDBlZTk5ZjYwL3RhYmxlOmVlZTEyYWNiZmVjNjQwYmI4MGRlN2ZjYzBiN2Y5NWRkL3RhYmxlcmFuZ2U6ZWVlMTJhY2JmZWM2NDBiYjgwZGU3ZmNjMGI3Zjk1ZGRfMi05LTEtMS04Njc_b81ca247-02e4-40f8-a1be-761eb4c7453a"
      unitRef="usd">-16180000</us-gaap:FairValueNetDerivativeAssetLiabilityMeasuredOnRecurringBasisWithUnobservableInputs>
    <us-gaap:FairValueNetDerivativeAssetLiabilityMeasuredOnRecurringBasisWithUnobservableInputs
      contextRef="i6e6227af7d3b47f5a13d2cf8fabe34f8_I20200331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzY2E5YmIwMTc5MjQ3NmZiYjIyNWU1ZDlkZWM4NjlmL3NlYzo5M2NhOWJiMDE3OTI0NzZmYmIyMjVlNWQ5ZGVjODY5Zl80Ni9mcmFnOjE0YjkzMDBhMzZkNDQ1OTdhZGI5NzM0MDBlZTk5ZjYwL3RhYmxlOmVlZTEyYWNiZmVjNjQwYmI4MGRlN2ZjYzBiN2Y5NWRkL3RhYmxlcmFuZ2U6ZWVlMTJhY2JmZWM2NDBiYjgwZGU3ZmNjMGI3Zjk1ZGRfMy0xLTEtMS04NTQ_f2be34d8-edfc-4083-a304-6b80d5a43b8f"
      unitRef="usd">-20013000</us-gaap:FairValueNetDerivativeAssetLiabilityMeasuredOnRecurringBasisWithUnobservableInputs>
    <us-gaap:FairValueNetDerivativeAssetLiabilityMeasuredOnRecurringBasisUnobservableInputsReconciliationGainLossIncludedInEarnings
      contextRef="iab54aa6542634043937616e303d80df7_D20200401-20200630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzY2E5YmIwMTc5MjQ3NmZiYjIyNWU1ZDlkZWM4NjlmL3NlYzo5M2NhOWJiMDE3OTI0NzZmYmIyMjVlNWQ5ZGVjODY5Zl80Ni9mcmFnOjE0YjkzMDBhMzZkNDQ1OTdhZGI5NzM0MDBlZTk5ZjYwL3RhYmxlOmVlZTEyYWNiZmVjNjQwYmI4MGRlN2ZjYzBiN2Y5NWRkL3RhYmxlcmFuZ2U6ZWVlMTJhY2JmZWM2NDBiYjgwZGU3ZmNjMGI3Zjk1ZGRfMy0zLTEtMS04NTg_bdd08cdb-f119-4a34-8581-343447465a7f"
      unitRef="usd">-3218000</us-gaap:FairValueNetDerivativeAssetLiabilityMeasuredOnRecurringBasisUnobservableInputsReconciliationGainLossIncludedInEarnings>
    <us-gaap:FairValueNetDerivativeAssetLiabilityMeasuredOnRecurringBasisUnobservableInputsReconciliationSettlements
      contextRef="iab54aa6542634043937616e303d80df7_D20200401-20200630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzY2E5YmIwMTc5MjQ3NmZiYjIyNWU1ZDlkZWM4NjlmL3NlYzo5M2NhOWJiMDE3OTI0NzZmYmIyMjVlNWQ5ZGVjODY5Zl80Ni9mcmFnOjE0YjkzMDBhMzZkNDQ1OTdhZGI5NzM0MDBlZTk5ZjYwL3RhYmxlOmVlZTEyYWNiZmVjNjQwYmI4MGRlN2ZjYzBiN2Y5NWRkL3RhYmxlcmFuZ2U6ZWVlMTJhY2JmZWM2NDBiYjgwZGU3ZmNjMGI3Zjk1ZGRfMy01LTEtMS04NjE_8529e58a-d636-4840-aa56-4675871d6eb1"
      unitRef="usd">727000</us-gaap:FairValueNetDerivativeAssetLiabilityMeasuredOnRecurringBasisUnobservableInputsReconciliationSettlements>
    <us-gaap:FairValueNetDerivativeAssetLiabilityMeasuredOnRecurringBasisUnobservableInputsReconciliationGainLossIncludedInOtherComprehensiveIncomeLoss
      contextRef="iab54aa6542634043937616e303d80df7_D20200401-20200630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzY2E5YmIwMTc5MjQ3NmZiYjIyNWU1ZDlkZWM4NjlmL3NlYzo5M2NhOWJiMDE3OTI0NzZmYmIyMjVlNWQ5ZGVjODY5Zl80Ni9mcmFnOjE0YjkzMDBhMzZkNDQ1OTdhZGI5NzM0MDBlZTk5ZjYwL3RhYmxlOmVlZTEyYWNiZmVjNjQwYmI4MGRlN2ZjYzBiN2Y5NWRkL3RhYmxlcmFuZ2U6ZWVlMTJhY2JmZWM2NDBiYjgwZGU3ZmNjMGI3Zjk1ZGRfMy03LTEtMS04NjQ_38070c6b-9f57-43dc-b7d7-a6c4925cf809"
      unitRef="usd">-1072000</us-gaap:FairValueNetDerivativeAssetLiabilityMeasuredOnRecurringBasisUnobservableInputsReconciliationGainLossIncludedInOtherComprehensiveIncomeLoss>
    <us-gaap:FairValueNetDerivativeAssetLiabilityMeasuredOnRecurringBasisWithUnobservableInputs
      contextRef="i1cd84431f8574b82a2e542790c822e83_I20200630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzY2E5YmIwMTc5MjQ3NmZiYjIyNWU1ZDlkZWM4NjlmL3NlYzo5M2NhOWJiMDE3OTI0NzZmYmIyMjVlNWQ5ZGVjODY5Zl80Ni9mcmFnOjE0YjkzMDBhMzZkNDQ1OTdhZGI5NzM0MDBlZTk5ZjYwL3RhYmxlOmVlZTEyYWNiZmVjNjQwYmI4MGRlN2ZjYzBiN2Y5NWRkL3RhYmxlcmFuZ2U6ZWVlMTJhY2JmZWM2NDBiYjgwZGU3ZmNjMGI3Zjk1ZGRfMy05LTEtMS04Njc_b639a704-2833-4e7e-8944-e7e34ca4ef3f"
      unitRef="usd">-23576000</us-gaap:FairValueNetDerivativeAssetLiabilityMeasuredOnRecurringBasisWithUnobservableInputs>
    <us-gaap:FairValueNetDerivativeAssetLiabilityMeasuredOnRecurringBasisWithUnobservableInputs
      contextRef="i3c0f68bcd0b6498c90c48a6506a0b9e3_I20200331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzY2E5YmIwMTc5MjQ3NmZiYjIyNWU1ZDlkZWM4NjlmL3NlYzo5M2NhOWJiMDE3OTI0NzZmYmIyMjVlNWQ5ZGVjODY5Zl80Ni9mcmFnOjE0YjkzMDBhMzZkNDQ1OTdhZGI5NzM0MDBlZTk5ZjYwL3RhYmxlOmVlZTEyYWNiZmVjNjQwYmI4MGRlN2ZjYzBiN2Y5NWRkL3RhYmxlcmFuZ2U6ZWVlMTJhY2JmZWM2NDBiYjgwZGU3ZmNjMGI3Zjk1ZGRfNC0xLTEtMS04NTQ_df56adb0-3518-42a0-9d7c-4bc2712db324"
      unitRef="usd">-165449000</us-gaap:FairValueNetDerivativeAssetLiabilityMeasuredOnRecurringBasisWithUnobservableInputs>
    <us-gaap:FairValueNetDerivativeAssetLiabilityMeasuredOnRecurringBasisUnobservableInputsReconciliationGainLossIncludedInEarnings
      contextRef="i39065c5daf934af885335c12f3cfa83f_D20200401-20200630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzY2E5YmIwMTc5MjQ3NmZiYjIyNWU1ZDlkZWM4NjlmL3NlYzo5M2NhOWJiMDE3OTI0NzZmYmIyMjVlNWQ5ZGVjODY5Zl80Ni9mcmFnOjE0YjkzMDBhMzZkNDQ1OTdhZGI5NzM0MDBlZTk5ZjYwL3RhYmxlOmVlZTEyYWNiZmVjNjQwYmI4MGRlN2ZjYzBiN2Y5NWRkL3RhYmxlcmFuZ2U6ZWVlMTJhY2JmZWM2NDBiYjgwZGU3ZmNjMGI3Zjk1ZGRfNC0zLTEtMS04NTg_f2dddc31-5e3b-43ce-b424-544f44576562"
      unitRef="usd">-35880000</us-gaap:FairValueNetDerivativeAssetLiabilityMeasuredOnRecurringBasisUnobservableInputsReconciliationGainLossIncludedInEarnings>
    <us-gaap:FairValueNetDerivativeAssetLiabilityMeasuredOnRecurringBasisUnobservableInputsReconciliationSettlements
      contextRef="i39065c5daf934af885335c12f3cfa83f_D20200401-20200630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzY2E5YmIwMTc5MjQ3NmZiYjIyNWU1ZDlkZWM4NjlmL3NlYzo5M2NhOWJiMDE3OTI0NzZmYmIyMjVlNWQ5ZGVjODY5Zl80Ni9mcmFnOjE0YjkzMDBhMzZkNDQ1OTdhZGI5NzM0MDBlZTk5ZjYwL3RhYmxlOmVlZTEyYWNiZmVjNjQwYmI4MGRlN2ZjYzBiN2Y5NWRkL3RhYmxlcmFuZ2U6ZWVlMTJhY2JmZWM2NDBiYjgwZGU3ZmNjMGI3Zjk1ZGRfNC01LTEtMS04NjE_eee83a8a-1c18-45c9-8a95-e7d7482aed77"
      unitRef="usd">727000</us-gaap:FairValueNetDerivativeAssetLiabilityMeasuredOnRecurringBasisUnobservableInputsReconciliationSettlements>
    <us-gaap:FairValueNetDerivativeAssetLiabilityMeasuredOnRecurringBasisUnobservableInputsReconciliationGainLossIncludedInOtherComprehensiveIncomeLoss
      contextRef="i39065c5daf934af885335c12f3cfa83f_D20200401-20200630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzY2E5YmIwMTc5MjQ3NmZiYjIyNWU1ZDlkZWM4NjlmL3NlYzo5M2NhOWJiMDE3OTI0NzZmYmIyMjVlNWQ5ZGVjODY5Zl80Ni9mcmFnOjE0YjkzMDBhMzZkNDQ1OTdhZGI5NzM0MDBlZTk5ZjYwL3RhYmxlOmVlZTEyYWNiZmVjNjQwYmI4MGRlN2ZjYzBiN2Y5NWRkL3RhYmxlcmFuZ2U6ZWVlMTJhY2JmZWM2NDBiYjgwZGU3ZmNjMGI3Zjk1ZGRfNC03LTEtMS04NjQ_d4b2bf50-5ee8-43e5-b1ab-78e11ace99dd"
      unitRef="usd">-5112000</us-gaap:FairValueNetDerivativeAssetLiabilityMeasuredOnRecurringBasisUnobservableInputsReconciliationGainLossIncludedInOtherComprehensiveIncomeLoss>
    <us-gaap:FairValueNetDerivativeAssetLiabilityMeasuredOnRecurringBasisWithUnobservableInputs
      contextRef="id670dc9b33e6430f9d7510009f7495a7_I20200630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzY2E5YmIwMTc5MjQ3NmZiYjIyNWU1ZDlkZWM4NjlmL3NlYzo5M2NhOWJiMDE3OTI0NzZmYmIyMjVlNWQ5ZGVjODY5Zl80Ni9mcmFnOjE0YjkzMDBhMzZkNDQ1OTdhZGI5NzM0MDBlZTk5ZjYwL3RhYmxlOmVlZTEyYWNiZmVjNjQwYmI4MGRlN2ZjYzBiN2Y5NWRkL3RhYmxlcmFuZ2U6ZWVlMTJhY2JmZWM2NDBiYjgwZGU3ZmNjMGI3Zjk1ZGRfNC05LTEtMS04Njc_245d6b9f-eb46-451d-9e9f-5ab6597d5abb"
      unitRef="usd">-205714000</us-gaap:FairValueNetDerivativeAssetLiabilityMeasuredOnRecurringBasisWithUnobservableInputs>
    <us-gaap:FairValueNetDerivativeAssetLiabilityMeasuredOnRecurringBasisWithUnobservableInputs
      contextRef="i386ef852060640f8a03a30f10d03a1cd_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzY2E5YmIwMTc5MjQ3NmZiYjIyNWU1ZDlkZWM4NjlmL3NlYzo5M2NhOWJiMDE3OTI0NzZmYmIyMjVlNWQ5ZGVjODY5Zl80Ni9mcmFnOjE0YjkzMDBhMzZkNDQ1OTdhZGI5NzM0MDBlZTk5ZjYwL3RhYmxlOjkyOGJiNDdkZjAzYzQyNjI4YWFkMjk1NDAwNTFhNjExL3RhYmxlcmFuZ2U6OTI4YmI0N2RmMDNjNDI2MjhhYWQyOTU0MDA1MWE2MTFfMS0xLTEtMS05MDc_638aec61-af97-483b-8f63-f22ed09094be"
      unitRef="usd">-138858000</us-gaap:FairValueNetDerivativeAssetLiabilityMeasuredOnRecurringBasisWithUnobservableInputs>
    <us-gaap:FairValueNetDerivativeAssetLiabilityMeasuredOnRecurringBasisUnobservableInputsReconciliationGainLossIncludedInEarnings
      contextRef="i45890500f835452a848efa1f84799c48_D20210101-20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzY2E5YmIwMTc5MjQ3NmZiYjIyNWU1ZDlkZWM4NjlmL3NlYzo5M2NhOWJiMDE3OTI0NzZmYmIyMjVlNWQ5ZGVjODY5Zl80Ni9mcmFnOjE0YjkzMDBhMzZkNDQ1OTdhZGI5NzM0MDBlZTk5ZjYwL3RhYmxlOjkyOGJiNDdkZjAzYzQyNjI4YWFkMjk1NDAwNTFhNjExL3RhYmxlcmFuZ2U6OTI4YmI0N2RmMDNjNDI2MjhhYWQyOTU0MDA1MWE2MTFfMS0zLTEtMS05MjM_11eca65c-e03d-47c6-a1e4-51e5fa1dd34c"
      unitRef="usd">-7186000</us-gaap:FairValueNetDerivativeAssetLiabilityMeasuredOnRecurringBasisUnobservableInputsReconciliationGainLossIncludedInEarnings>
    <us-gaap:FairValueNetDerivativeAssetLiabilityMeasuredOnRecurringBasisUnobservableInputsReconciliationSettlements
      contextRef="i45890500f835452a848efa1f84799c48_D20210101-20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzY2E5YmIwMTc5MjQ3NmZiYjIyNWU1ZDlkZWM4NjlmL3NlYzo5M2NhOWJiMDE3OTI0NzZmYmIyMjVlNWQ5ZGVjODY5Zl80Ni9mcmFnOjE0YjkzMDBhMzZkNDQ1OTdhZGI5NzM0MDBlZTk5ZjYwL3RhYmxlOjkyOGJiNDdkZjAzYzQyNjI4YWFkMjk1NDAwNTFhNjExL3RhYmxlcmFuZ2U6OTI4YmI0N2RmMDNjNDI2MjhhYWQyOTU0MDA1MWE2MTFfMS01LTEtMS05Mzg_72dd1203-71f1-44e0-9404-fdcc4385c479"
      unitRef="usd">0</us-gaap:FairValueNetDerivativeAssetLiabilityMeasuredOnRecurringBasisUnobservableInputsReconciliationSettlements>
    <us-gaap:FairValueNetDerivativeAssetLiabilityMeasuredOnRecurringBasisUnobservableInputsReconciliationGainLossIncludedInOtherComprehensiveIncomeLoss
      contextRef="i45890500f835452a848efa1f84799c48_D20210101-20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzY2E5YmIwMTc5MjQ3NmZiYjIyNWU1ZDlkZWM4NjlmL3NlYzo5M2NhOWJiMDE3OTI0NzZmYmIyMjVlNWQ5ZGVjODY5Zl80Ni9mcmFnOjE0YjkzMDBhMzZkNDQ1OTdhZGI5NzM0MDBlZTk5ZjYwL3RhYmxlOjkyOGJiNDdkZjAzYzQyNjI4YWFkMjk1NDAwNTFhNjExL3RhYmxlcmFuZ2U6OTI4YmI0N2RmMDNjNDI2MjhhYWQyOTU0MDA1MWE2MTFfMS03LTEtMS05NDI_8cb8271f-c15a-4a9a-b66b-865dcf78ba8b"
      unitRef="usd">-4039000</us-gaap:FairValueNetDerivativeAssetLiabilityMeasuredOnRecurringBasisUnobservableInputsReconciliationGainLossIncludedInOtherComprehensiveIncomeLoss>
    <us-gaap:FairValueNetDerivativeAssetLiabilityMeasuredOnRecurringBasisWithUnobservableInputs
      contextRef="i34995f47e8ba418fbd529b2ed52790dc_I20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzY2E5YmIwMTc5MjQ3NmZiYjIyNWU1ZDlkZWM4NjlmL3NlYzo5M2NhOWJiMDE3OTI0NzZmYmIyMjVlNWQ5ZGVjODY5Zl80Ni9mcmFnOjE0YjkzMDBhMzZkNDQ1OTdhZGI5NzM0MDBlZTk5ZjYwL3RhYmxlOjkyOGJiNDdkZjAzYzQyNjI4YWFkMjk1NDAwNTFhNjExL3RhYmxlcmFuZ2U6OTI4YmI0N2RmMDNjNDI2MjhhYWQyOTU0MDA1MWE2MTFfMS05LTEtMS05NDY_30381700-78a3-4f4e-9128-eb698829d686"
      unitRef="usd">-150083000</us-gaap:FairValueNetDerivativeAssetLiabilityMeasuredOnRecurringBasisWithUnobservableInputs>
    <us-gaap:FairValueNetDerivativeAssetLiabilityMeasuredOnRecurringBasisWithUnobservableInputs
      contextRef="i72ce1ade65834a50bf4468cde26bf617_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzY2E5YmIwMTc5MjQ3NmZiYjIyNWU1ZDlkZWM4NjlmL3NlYzo5M2NhOWJiMDE3OTI0NzZmYmIyMjVlNWQ5ZGVjODY5Zl80Ni9mcmFnOjE0YjkzMDBhMzZkNDQ1OTdhZGI5NzM0MDBlZTk5ZjYwL3RhYmxlOjkyOGJiNDdkZjAzYzQyNjI4YWFkMjk1NDAwNTFhNjExL3RhYmxlcmFuZ2U6OTI4YmI0N2RmMDNjNDI2MjhhYWQyOTU0MDA1MWE2MTFfMi0xLTEtMS05MDc_a3de5b4e-78e5-41c5-b7ef-ccd3151a0676"
      unitRef="usd">-12095000</us-gaap:FairValueNetDerivativeAssetLiabilityMeasuredOnRecurringBasisWithUnobservableInputs>
    <us-gaap:FairValueNetDerivativeAssetLiabilityMeasuredOnRecurringBasisUnobservableInputsReconciliationGainLossIncludedInEarnings
      contextRef="i94f8ae36db664c2bbb298d6c3f5792c3_D20210101-20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzY2E5YmIwMTc5MjQ3NmZiYjIyNWU1ZDlkZWM4NjlmL3NlYzo5M2NhOWJiMDE3OTI0NzZmYmIyMjVlNWQ5ZGVjODY5Zl80Ni9mcmFnOjE0YjkzMDBhMzZkNDQ1OTdhZGI5NzM0MDBlZTk5ZjYwL3RhYmxlOjkyOGJiNDdkZjAzYzQyNjI4YWFkMjk1NDAwNTFhNjExL3RhYmxlcmFuZ2U6OTI4YmI0N2RmMDNjNDI2MjhhYWQyOTU0MDA1MWE2MTFfMi0zLTEtMS05MjM_06eba498-3388-42ba-98ad-028a4e4bb64f"
      unitRef="usd">-1473000</us-gaap:FairValueNetDerivativeAssetLiabilityMeasuredOnRecurringBasisUnobservableInputsReconciliationGainLossIncludedInEarnings>
    <us-gaap:FairValueNetDerivativeAssetLiabilityMeasuredOnRecurringBasisUnobservableInputsReconciliationSettlements
      contextRef="i94f8ae36db664c2bbb298d6c3f5792c3_D20210101-20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzY2E5YmIwMTc5MjQ3NmZiYjIyNWU1ZDlkZWM4NjlmL3NlYzo5M2NhOWJiMDE3OTI0NzZmYmIyMjVlNWQ5ZGVjODY5Zl80Ni9mcmFnOjE0YjkzMDBhMzZkNDQ1OTdhZGI5NzM0MDBlZTk5ZjYwL3RhYmxlOjkyOGJiNDdkZjAzYzQyNjI4YWFkMjk1NDAwNTFhNjExL3RhYmxlcmFuZ2U6OTI4YmI0N2RmMDNjNDI2MjhhYWQyOTU0MDA1MWE2MTFfMi01LTEtMS05Mzg_12d4d415-9df0-465e-979b-f17201dee517"
      unitRef="usd">0</us-gaap:FairValueNetDerivativeAssetLiabilityMeasuredOnRecurringBasisUnobservableInputsReconciliationSettlements>
    <us-gaap:FairValueNetDerivativeAssetLiabilityMeasuredOnRecurringBasisUnobservableInputsReconciliationGainLossIncludedInOtherComprehensiveIncomeLoss
      contextRef="i94f8ae36db664c2bbb298d6c3f5792c3_D20210101-20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzY2E5YmIwMTc5MjQ3NmZiYjIyNWU1ZDlkZWM4NjlmL3NlYzo5M2NhOWJiMDE3OTI0NzZmYmIyMjVlNWQ5ZGVjODY5Zl80Ni9mcmFnOjE0YjkzMDBhMzZkNDQ1OTdhZGI5NzM0MDBlZTk5ZjYwL3RhYmxlOjkyOGJiNDdkZjAzYzQyNjI4YWFkMjk1NDAwNTFhNjExL3RhYmxlcmFuZ2U6OTI4YmI0N2RmMDNjNDI2MjhhYWQyOTU0MDA1MWE2MTFfMi03LTEtMS05NDI_7bea7996-7cc3-4206-b120-dfe029c4c555"
      unitRef="usd">-358000</us-gaap:FairValueNetDerivativeAssetLiabilityMeasuredOnRecurringBasisUnobservableInputsReconciliationGainLossIncludedInOtherComprehensiveIncomeLoss>
    <us-gaap:FairValueNetDerivativeAssetLiabilityMeasuredOnRecurringBasisWithUnobservableInputs
      contextRef="ie4ec3b642b3b4457b78cb85e8d1838f0_I20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzY2E5YmIwMTc5MjQ3NmZiYjIyNWU1ZDlkZWM4NjlmL3NlYzo5M2NhOWJiMDE3OTI0NzZmYmIyMjVlNWQ5ZGVjODY5Zl80Ni9mcmFnOjE0YjkzMDBhMzZkNDQ1OTdhZGI5NzM0MDBlZTk5ZjYwL3RhYmxlOjkyOGJiNDdkZjAzYzQyNjI4YWFkMjk1NDAwNTFhNjExL3RhYmxlcmFuZ2U6OTI4YmI0N2RmMDNjNDI2MjhhYWQyOTU0MDA1MWE2MTFfMi05LTEtMS05NDY_220643c5-a51f-46ad-84a5-a2d8463f5786"
      unitRef="usd">-13926000</us-gaap:FairValueNetDerivativeAssetLiabilityMeasuredOnRecurringBasisWithUnobservableInputs>
    <us-gaap:FairValueNetDerivativeAssetLiabilityMeasuredOnRecurringBasisWithUnobservableInputs
      contextRef="if0aa3f5449da461c85f0c0831bf3c984_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzY2E5YmIwMTc5MjQ3NmZiYjIyNWU1ZDlkZWM4NjlmL3NlYzo5M2NhOWJiMDE3OTI0NzZmYmIyMjVlNWQ5ZGVjODY5Zl80Ni9mcmFnOjE0YjkzMDBhMzZkNDQ1OTdhZGI5NzM0MDBlZTk5ZjYwL3RhYmxlOjkyOGJiNDdkZjAzYzQyNjI4YWFkMjk1NDAwNTFhNjExL3RhYmxlcmFuZ2U6OTI4YmI0N2RmMDNjNDI2MjhhYWQyOTU0MDA1MWE2MTFfMy0xLTEtMS05MDc_cdfc7d19-bb69-446b-9bf2-38265adf66cd"
      unitRef="usd">-12457000</us-gaap:FairValueNetDerivativeAssetLiabilityMeasuredOnRecurringBasisWithUnobservableInputs>
    <us-gaap:FairValueNetDerivativeAssetLiabilityMeasuredOnRecurringBasisUnobservableInputsReconciliationGainLossIncludedInEarnings
      contextRef="i10b0581e8a9b40e0a1e14e14bcc22d54_D20210101-20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzY2E5YmIwMTc5MjQ3NmZiYjIyNWU1ZDlkZWM4NjlmL3NlYzo5M2NhOWJiMDE3OTI0NzZmYmIyMjVlNWQ5ZGVjODY5Zl80Ni9mcmFnOjE0YjkzMDBhMzZkNDQ1OTdhZGI5NzM0MDBlZTk5ZjYwL3RhYmxlOjkyOGJiNDdkZjAzYzQyNjI4YWFkMjk1NDAwNTFhNjExL3RhYmxlcmFuZ2U6OTI4YmI0N2RmMDNjNDI2MjhhYWQyOTU0MDA1MWE2MTFfMy0zLTEtMS05MjM_29485a9b-c06c-4c4a-b666-626e5eba4767"
      unitRef="usd">7033000</us-gaap:FairValueNetDerivativeAssetLiabilityMeasuredOnRecurringBasisUnobservableInputsReconciliationGainLossIncludedInEarnings>
    <us-gaap:FairValueNetDerivativeAssetLiabilityMeasuredOnRecurringBasisUnobservableInputsReconciliationSettlements
      contextRef="i10b0581e8a9b40e0a1e14e14bcc22d54_D20210101-20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzY2E5YmIwMTc5MjQ3NmZiYjIyNWU1ZDlkZWM4NjlmL3NlYzo5M2NhOWJiMDE3OTI0NzZmYmIyMjVlNWQ5ZGVjODY5Zl80Ni9mcmFnOjE0YjkzMDBhMzZkNDQ1OTdhZGI5NzM0MDBlZTk5ZjYwL3RhYmxlOjkyOGJiNDdkZjAzYzQyNjI4YWFkMjk1NDAwNTFhNjExL3RhYmxlcmFuZ2U6OTI4YmI0N2RmMDNjNDI2MjhhYWQyOTU0MDA1MWE2MTFfMy01LTEtMS05Mzg_2e8f2730-8b39-4208-ae80-262fa76819a6"
      unitRef="usd">0</us-gaap:FairValueNetDerivativeAssetLiabilityMeasuredOnRecurringBasisUnobservableInputsReconciliationSettlements>
    <us-gaap:FairValueNetDerivativeAssetLiabilityMeasuredOnRecurringBasisUnobservableInputsReconciliationGainLossIncludedInOtherComprehensiveIncomeLoss
      contextRef="i10b0581e8a9b40e0a1e14e14bcc22d54_D20210101-20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzY2E5YmIwMTc5MjQ3NmZiYjIyNWU1ZDlkZWM4NjlmL3NlYzo5M2NhOWJiMDE3OTI0NzZmYmIyMjVlNWQ5ZGVjODY5Zl80Ni9mcmFnOjE0YjkzMDBhMzZkNDQ1OTdhZGI5NzM0MDBlZTk5ZjYwL3RhYmxlOjkyOGJiNDdkZjAzYzQyNjI4YWFkMjk1NDAwNTFhNjExL3RhYmxlcmFuZ2U6OTI4YmI0N2RmMDNjNDI2MjhhYWQyOTU0MDA1MWE2MTFfMy03LTEtMS05NDI_a09acc68-320a-4d4d-8db0-d54488a6329d"
      unitRef="usd">-130000</us-gaap:FairValueNetDerivativeAssetLiabilityMeasuredOnRecurringBasisUnobservableInputsReconciliationGainLossIncludedInOtherComprehensiveIncomeLoss>
    <us-gaap:FairValueNetDerivativeAssetLiabilityMeasuredOnRecurringBasisWithUnobservableInputs
      contextRef="ia2cd5cb93e97428dabd7e841eee51895_I20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzY2E5YmIwMTc5MjQ3NmZiYjIyNWU1ZDlkZWM4NjlmL3NlYzo5M2NhOWJiMDE3OTI0NzZmYmIyMjVlNWQ5ZGVjODY5Zl80Ni9mcmFnOjE0YjkzMDBhMzZkNDQ1OTdhZGI5NzM0MDBlZTk5ZjYwL3RhYmxlOjkyOGJiNDdkZjAzYzQyNjI4YWFkMjk1NDAwNTFhNjExL3RhYmxlcmFuZ2U6OTI4YmI0N2RmMDNjNDI2MjhhYWQyOTU0MDA1MWE2MTFfMy05LTEtMS05NDY_34f9d373-a301-49f9-a8ce-97624a701828"
      unitRef="usd">-5554000</us-gaap:FairValueNetDerivativeAssetLiabilityMeasuredOnRecurringBasisWithUnobservableInputs>
    <us-gaap:FairValueNetDerivativeAssetLiabilityMeasuredOnRecurringBasisWithUnobservableInputs
      contextRef="ifbe16ec51ea244519b77d6036b4ef038_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzY2E5YmIwMTc5MjQ3NmZiYjIyNWU1ZDlkZWM4NjlmL3NlYzo5M2NhOWJiMDE3OTI0NzZmYmIyMjVlNWQ5ZGVjODY5Zl80Ni9mcmFnOjE0YjkzMDBhMzZkNDQ1OTdhZGI5NzM0MDBlZTk5ZjYwL3RhYmxlOjkyOGJiNDdkZjAzYzQyNjI4YWFkMjk1NDAwNTFhNjExL3RhYmxlcmFuZ2U6OTI4YmI0N2RmMDNjNDI2MjhhYWQyOTU0MDA1MWE2MTFfNC0xLTEtMS05MDc_131fa8e0-7a7c-4141-ae59-e790e31c3b48"
      unitRef="usd">-163410000</us-gaap:FairValueNetDerivativeAssetLiabilityMeasuredOnRecurringBasisWithUnobservableInputs>
    <us-gaap:FairValueNetDerivativeAssetLiabilityMeasuredOnRecurringBasisUnobservableInputsReconciliationGainLossIncludedInEarnings
      contextRef="i69782326f71a44e3805518280ee22b6b_D20210101-20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzY2E5YmIwMTc5MjQ3NmZiYjIyNWU1ZDlkZWM4NjlmL3NlYzo5M2NhOWJiMDE3OTI0NzZmYmIyMjVlNWQ5ZGVjODY5Zl80Ni9mcmFnOjE0YjkzMDBhMzZkNDQ1OTdhZGI5NzM0MDBlZTk5ZjYwL3RhYmxlOjkyOGJiNDdkZjAzYzQyNjI4YWFkMjk1NDAwNTFhNjExL3RhYmxlcmFuZ2U6OTI4YmI0N2RmMDNjNDI2MjhhYWQyOTU0MDA1MWE2MTFfNC0zLTEtMS05MjM_3433f0dd-60c3-4a71-a90b-7aa4946a6bc8"
      unitRef="usd">-1626000</us-gaap:FairValueNetDerivativeAssetLiabilityMeasuredOnRecurringBasisUnobservableInputsReconciliationGainLossIncludedInEarnings>
    <us-gaap:FairValueNetDerivativeAssetLiabilityMeasuredOnRecurringBasisUnobservableInputsReconciliationSettlements
      contextRef="i69782326f71a44e3805518280ee22b6b_D20210101-20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzY2E5YmIwMTc5MjQ3NmZiYjIyNWU1ZDlkZWM4NjlmL3NlYzo5M2NhOWJiMDE3OTI0NzZmYmIyMjVlNWQ5ZGVjODY5Zl80Ni9mcmFnOjE0YjkzMDBhMzZkNDQ1OTdhZGI5NzM0MDBlZTk5ZjYwL3RhYmxlOjkyOGJiNDdkZjAzYzQyNjI4YWFkMjk1NDAwNTFhNjExL3RhYmxlcmFuZ2U6OTI4YmI0N2RmMDNjNDI2MjhhYWQyOTU0MDA1MWE2MTFfNC01LTEtMS05Mzg_cd3ba1fe-97cf-4e20-944c-8e6ef63a087e"
      unitRef="usd">0</us-gaap:FairValueNetDerivativeAssetLiabilityMeasuredOnRecurringBasisUnobservableInputsReconciliationSettlements>
    <us-gaap:FairValueNetDerivativeAssetLiabilityMeasuredOnRecurringBasisUnobservableInputsReconciliationGainLossIncludedInOtherComprehensiveIncomeLoss
      contextRef="i69782326f71a44e3805518280ee22b6b_D20210101-20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzY2E5YmIwMTc5MjQ3NmZiYjIyNWU1ZDlkZWM4NjlmL3NlYzo5M2NhOWJiMDE3OTI0NzZmYmIyMjVlNWQ5ZGVjODY5Zl80Ni9mcmFnOjE0YjkzMDBhMzZkNDQ1OTdhZGI5NzM0MDBlZTk5ZjYwL3RhYmxlOjkyOGJiNDdkZjAzYzQyNjI4YWFkMjk1NDAwNTFhNjExL3RhYmxlcmFuZ2U6OTI4YmI0N2RmMDNjNDI2MjhhYWQyOTU0MDA1MWE2MTFfNC03LTEtMS05NDI_7b60a4e3-6dbe-4f45-b67a-4112d9bd9d2e"
      unitRef="usd">-4527000</us-gaap:FairValueNetDerivativeAssetLiabilityMeasuredOnRecurringBasisUnobservableInputsReconciliationGainLossIncludedInOtherComprehensiveIncomeLoss>
    <us-gaap:FairValueNetDerivativeAssetLiabilityMeasuredOnRecurringBasisWithUnobservableInputs
      contextRef="i225f85e38faa4bbdb4de1d8b9cf369bb_I20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzY2E5YmIwMTc5MjQ3NmZiYjIyNWU1ZDlkZWM4NjlmL3NlYzo5M2NhOWJiMDE3OTI0NzZmYmIyMjVlNWQ5ZGVjODY5Zl80Ni9mcmFnOjE0YjkzMDBhMzZkNDQ1OTdhZGI5NzM0MDBlZTk5ZjYwL3RhYmxlOjkyOGJiNDdkZjAzYzQyNjI4YWFkMjk1NDAwNTFhNjExL3RhYmxlcmFuZ2U6OTI4YmI0N2RmMDNjNDI2MjhhYWQyOTU0MDA1MWE2MTFfNC05LTEtMS05NDY_6bb99e07-4903-45a4-8eba-d2c601c794c7"
      unitRef="usd">-169563000</us-gaap:FairValueNetDerivativeAssetLiabilityMeasuredOnRecurringBasisWithUnobservableInputs>
    <us-gaap:FairValueNetDerivativeAssetLiabilityMeasuredOnRecurringBasisWithUnobservableInputs
      contextRef="i006bb3bd444d41edb5d292ff7ec0668f_I20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzY2E5YmIwMTc5MjQ3NmZiYjIyNWU1ZDlkZWM4NjlmL3NlYzo5M2NhOWJiMDE3OTI0NzZmYmIyMjVlNWQ5ZGVjODY5Zl80Ni9mcmFnOjE0YjkzMDBhMzZkNDQ1OTdhZGI5NzM0MDBlZTk5ZjYwL3RhYmxlOjhkZTMyYzc2NmZiNTRiOTJiNzE2NzE0NGY0YTI4NTcwL3RhYmxlcmFuZ2U6OGRlMzJjNzY2ZmI1NGI5MmI3MTY3MTQ0ZjRhMjg1NzBfMS0xLTEtMS0w_8a496581-7473-4151-8227-c38334bf146c"
      unitRef="usd">-234428000</us-gaap:FairValueNetDerivativeAssetLiabilityMeasuredOnRecurringBasisWithUnobservableInputs>
    <us-gaap:FairValueNetDerivativeAssetLiabilityMeasuredOnRecurringBasisUnobservableInputsReconciliationGainLossIncludedInEarnings
      contextRef="i19c47df0e3634358808ebcc68facfcde_D20200101-20200630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzY2E5YmIwMTc5MjQ3NmZiYjIyNWU1ZDlkZWM4NjlmL3NlYzo5M2NhOWJiMDE3OTI0NzZmYmIyMjVlNWQ5ZGVjODY5Zl80Ni9mcmFnOjE0YjkzMDBhMzZkNDQ1OTdhZGI5NzM0MDBlZTk5ZjYwL3RhYmxlOjhkZTMyYzc2NmZiNTRiOTJiNzE2NzE0NGY0YTI4NTcwL3RhYmxlcmFuZ2U6OGRlMzJjNzY2ZmI1NGI5MmI3MTY3MTQ0ZjRhMjg1NzBfMS0zLTEtMS0w_cefbb5d7-c3ec-4310-9598-6b36a81f1552"
      unitRef="usd">58052000</us-gaap:FairValueNetDerivativeAssetLiabilityMeasuredOnRecurringBasisUnobservableInputsReconciliationGainLossIncludedInEarnings>
    <us-gaap:FairValueNetDerivativeAssetLiabilityMeasuredOnRecurringBasisUnobservableInputsReconciliationSettlements
      contextRef="i19c47df0e3634358808ebcc68facfcde_D20200101-20200630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzY2E5YmIwMTc5MjQ3NmZiYjIyNWU1ZDlkZWM4NjlmL3NlYzo5M2NhOWJiMDE3OTI0NzZmYmIyMjVlNWQ5ZGVjODY5Zl80Ni9mcmFnOjE0YjkzMDBhMzZkNDQ1OTdhZGI5NzM0MDBlZTk5ZjYwL3RhYmxlOjhkZTMyYzc2NmZiNTRiOTJiNzE2NzE0NGY0YTI4NTcwL3RhYmxlcmFuZ2U6OGRlMzJjNzY2ZmI1NGI5MmI3MTY3MTQ0ZjRhMjg1NzBfMS01LTEtMS0w_5b71d7d6-9305-4c07-9070-4ecd4007ad08"
      unitRef="usd">0</us-gaap:FairValueNetDerivativeAssetLiabilityMeasuredOnRecurringBasisUnobservableInputsReconciliationSettlements>
    <us-gaap:FairValueNetDerivativeAssetLiabilityMeasuredOnRecurringBasisUnobservableInputsReconciliationGainLossIncludedInOtherComprehensiveIncomeLoss
      contextRef="i19c47df0e3634358808ebcc68facfcde_D20200101-20200630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzY2E5YmIwMTc5MjQ3NmZiYjIyNWU1ZDlkZWM4NjlmL3NlYzo5M2NhOWJiMDE3OTI0NzZmYmIyMjVlNWQ5ZGVjODY5Zl80Ni9mcmFnOjE0YjkzMDBhMzZkNDQ1OTdhZGI5NzM0MDBlZTk5ZjYwL3RhYmxlOjhkZTMyYzc2NmZiNTRiOTJiNzE2NzE0NGY0YTI4NTcwL3RhYmxlcmFuZ2U6OGRlMzJjNzY2ZmI1NGI5MmI3MTY3MTQ0ZjRhMjg1NzBfMS03LTEtMS0w_5fb50549-34aa-4fcb-89aa-fa615c24f47a"
      unitRef="usd">10418000</us-gaap:FairValueNetDerivativeAssetLiabilityMeasuredOnRecurringBasisUnobservableInputsReconciliationGainLossIncludedInOtherComprehensiveIncomeLoss>
    <us-gaap:FairValueNetDerivativeAssetLiabilityMeasuredOnRecurringBasisWithUnobservableInputs
      contextRef="i69563d705edd465aabff3c895c85c313_I20200630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzY2E5YmIwMTc5MjQ3NmZiYjIyNWU1ZDlkZWM4NjlmL3NlYzo5M2NhOWJiMDE3OTI0NzZmYmIyMjVlNWQ5ZGVjODY5Zl80Ni9mcmFnOjE0YjkzMDBhMzZkNDQ1OTdhZGI5NzM0MDBlZTk5ZjYwL3RhYmxlOjhkZTMyYzc2NmZiNTRiOTJiNzE2NzE0NGY0YTI4NTcwL3RhYmxlcmFuZ2U6OGRlMzJjNzY2ZmI1NGI5MmI3MTY3MTQ0ZjRhMjg1NzBfMS05LTEtMS0w_9fd7247b-aa02-493e-9e81-d66134dd90e3"
      unitRef="usd">-165958000</us-gaap:FairValueNetDerivativeAssetLiabilityMeasuredOnRecurringBasisWithUnobservableInputs>
    <us-gaap:FairValueNetDerivativeAssetLiabilityMeasuredOnRecurringBasisWithUnobservableInputs
      contextRef="id3abf03099174cf38da9a24a053a4f90_I20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzY2E5YmIwMTc5MjQ3NmZiYjIyNWU1ZDlkZWM4NjlmL3NlYzo5M2NhOWJiMDE3OTI0NzZmYmIyMjVlNWQ5ZGVjODY5Zl80Ni9mcmFnOjE0YjkzMDBhMzZkNDQ1OTdhZGI5NzM0MDBlZTk5ZjYwL3RhYmxlOjhkZTMyYzc2NmZiNTRiOTJiNzE2NzE0NGY0YTI4NTcwL3RhYmxlcmFuZ2U6OGRlMzJjNzY2ZmI1NGI5MmI3MTY3MTQ0ZjRhMjg1NzBfMi0xLTEtMS0w_fd4af16f-f3be-4c8c-9d29-bf31d6d5d0d7"
      unitRef="usd">-12787000</us-gaap:FairValueNetDerivativeAssetLiabilityMeasuredOnRecurringBasisWithUnobservableInputs>
    <us-gaap:FairValueNetDerivativeAssetLiabilityMeasuredOnRecurringBasisUnobservableInputsReconciliationGainLossIncludedInEarnings
      contextRef="idc180b21ce4e4eefa7a1a4ccdb9ba7a9_D20200101-20200630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzY2E5YmIwMTc5MjQ3NmZiYjIyNWU1ZDlkZWM4NjlmL3NlYzo5M2NhOWJiMDE3OTI0NzZmYmIyMjVlNWQ5ZGVjODY5Zl80Ni9mcmFnOjE0YjkzMDBhMzZkNDQ1OTdhZGI5NzM0MDBlZTk5ZjYwL3RhYmxlOjhkZTMyYzc2NmZiNTRiOTJiNzE2NzE0NGY0YTI4NTcwL3RhYmxlcmFuZ2U6OGRlMzJjNzY2ZmI1NGI5MmI3MTY3MTQ0ZjRhMjg1NzBfMi0zLTEtMS0w_9b40bba1-a001-482d-ae4b-47b2d51a7df5"
      unitRef="usd">-3925000</us-gaap:FairValueNetDerivativeAssetLiabilityMeasuredOnRecurringBasisUnobservableInputsReconciliationGainLossIncludedInEarnings>
    <us-gaap:FairValueNetDerivativeAssetLiabilityMeasuredOnRecurringBasisUnobservableInputsReconciliationSettlements
      contextRef="idc180b21ce4e4eefa7a1a4ccdb9ba7a9_D20200101-20200630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzY2E5YmIwMTc5MjQ3NmZiYjIyNWU1ZDlkZWM4NjlmL3NlYzo5M2NhOWJiMDE3OTI0NzZmYmIyMjVlNWQ5ZGVjODY5Zl80Ni9mcmFnOjE0YjkzMDBhMzZkNDQ1OTdhZGI5NzM0MDBlZTk5ZjYwL3RhYmxlOjhkZTMyYzc2NmZiNTRiOTJiNzE2NzE0NGY0YTI4NTcwL3RhYmxlcmFuZ2U6OGRlMzJjNzY2ZmI1NGI5MmI3MTY3MTQ0ZjRhMjg1NzBfMi01LTEtMS0w_47aae470-94bc-488a-9926-7006ff130dd3"
      unitRef="usd">0</us-gaap:FairValueNetDerivativeAssetLiabilityMeasuredOnRecurringBasisUnobservableInputsReconciliationSettlements>
    <us-gaap:FairValueNetDerivativeAssetLiabilityMeasuredOnRecurringBasisUnobservableInputsReconciliationGainLossIncludedInOtherComprehensiveIncomeLoss
      contextRef="idc180b21ce4e4eefa7a1a4ccdb9ba7a9_D20200101-20200630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzY2E5YmIwMTc5MjQ3NmZiYjIyNWU1ZDlkZWM4NjlmL3NlYzo5M2NhOWJiMDE3OTI0NzZmYmIyMjVlNWQ5ZGVjODY5Zl80Ni9mcmFnOjE0YjkzMDBhMzZkNDQ1OTdhZGI5NzM0MDBlZTk5ZjYwL3RhYmxlOjhkZTMyYzc2NmZiNTRiOTJiNzE2NzE0NGY0YTI4NTcwL3RhYmxlcmFuZ2U6OGRlMzJjNzY2ZmI1NGI5MmI3MTY3MTQ0ZjRhMjg1NzBfMi03LTEtMS0w_95007e1e-030e-48f0-90b2-4ff8d383c01c"
      unitRef="usd">532000</us-gaap:FairValueNetDerivativeAssetLiabilityMeasuredOnRecurringBasisUnobservableInputsReconciliationGainLossIncludedInOtherComprehensiveIncomeLoss>
    <us-gaap:FairValueNetDerivativeAssetLiabilityMeasuredOnRecurringBasisWithUnobservableInputs
      contextRef="i08475478dc1e46759179fb5a161607ba_I20200630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzY2E5YmIwMTc5MjQ3NmZiYjIyNWU1ZDlkZWM4NjlmL3NlYzo5M2NhOWJiMDE3OTI0NzZmYmIyMjVlNWQ5ZGVjODY5Zl80Ni9mcmFnOjE0YjkzMDBhMzZkNDQ1OTdhZGI5NzM0MDBlZTk5ZjYwL3RhYmxlOjhkZTMyYzc2NmZiNTRiOTJiNzE2NzE0NGY0YTI4NTcwL3RhYmxlcmFuZ2U6OGRlMzJjNzY2ZmI1NGI5MmI3MTY3MTQ0ZjRhMjg1NzBfMi05LTEtMS0w_104e3f72-dc17-4feb-85a7-c5075bea9212"
      unitRef="usd">-16180000</us-gaap:FairValueNetDerivativeAssetLiabilityMeasuredOnRecurringBasisWithUnobservableInputs>
    <us-gaap:FairValueNetDerivativeAssetLiabilityMeasuredOnRecurringBasisWithUnobservableInputs
      contextRef="i4edcd0f0354740008d30a06bac0ea0bb_I20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzY2E5YmIwMTc5MjQ3NmZiYjIyNWU1ZDlkZWM4NjlmL3NlYzo5M2NhOWJiMDE3OTI0NzZmYmIyMjVlNWQ5ZGVjODY5Zl80Ni9mcmFnOjE0YjkzMDBhMzZkNDQ1OTdhZGI5NzM0MDBlZTk5ZjYwL3RhYmxlOjhkZTMyYzc2NmZiNTRiOTJiNzE2NzE0NGY0YTI4NTcwL3RhYmxlcmFuZ2U6OGRlMzJjNzY2ZmI1NGI5MmI3MTY3MTQ0ZjRhMjg1NzBfMy0xLTEtMS0w_03ef05c0-a14b-4299-b554-1e037adf2b8a"
      unitRef="usd">-49945000</us-gaap:FairValueNetDerivativeAssetLiabilityMeasuredOnRecurringBasisWithUnobservableInputs>
    <us-gaap:FairValueNetDerivativeAssetLiabilityMeasuredOnRecurringBasisUnobservableInputsReconciliationGainLossIncludedInEarnings
      contextRef="ia9cf8032e9f7433cb50aee032c5b988b_D20200101-20200630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzY2E5YmIwMTc5MjQ3NmZiYjIyNWU1ZDlkZWM4NjlmL3NlYzo5M2NhOWJiMDE3OTI0NzZmYmIyMjVlNWQ5ZGVjODY5Zl80Ni9mcmFnOjE0YjkzMDBhMzZkNDQ1OTdhZGI5NzM0MDBlZTk5ZjYwL3RhYmxlOjhkZTMyYzc2NmZiNTRiOTJiNzE2NzE0NGY0YTI4NTcwL3RhYmxlcmFuZ2U6OGRlMzJjNzY2ZmI1NGI5MmI3MTY3MTQ0ZjRhMjg1NzBfMy0zLTEtMS0w_8c79d1fb-2252-417b-a84b-c71345b4c816"
      unitRef="usd">23361000</us-gaap:FairValueNetDerivativeAssetLiabilityMeasuredOnRecurringBasisUnobservableInputsReconciliationGainLossIncludedInEarnings>
    <us-gaap:FairValueNetDerivativeAssetLiabilityMeasuredOnRecurringBasisUnobservableInputsReconciliationSettlements
      contextRef="ia9cf8032e9f7433cb50aee032c5b988b_D20200101-20200630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzY2E5YmIwMTc5MjQ3NmZiYjIyNWU1ZDlkZWM4NjlmL3NlYzo5M2NhOWJiMDE3OTI0NzZmYmIyMjVlNWQ5ZGVjODY5Zl80Ni9mcmFnOjE0YjkzMDBhMzZkNDQ1OTdhZGI5NzM0MDBlZTk5ZjYwL3RhYmxlOjhkZTMyYzc2NmZiNTRiOTJiNzE2NzE0NGY0YTI4NTcwL3RhYmxlcmFuZ2U6OGRlMzJjNzY2ZmI1NGI5MmI3MTY3MTQ0ZjRhMjg1NzBfMy01LTEtMS0w_a16af34e-f553-4129-87af-a7d95565c245"
      unitRef="usd">727000</us-gaap:FairValueNetDerivativeAssetLiabilityMeasuredOnRecurringBasisUnobservableInputsReconciliationSettlements>
    <us-gaap:FairValueNetDerivativeAssetLiabilityMeasuredOnRecurringBasisUnobservableInputsReconciliationGainLossIncludedInOtherComprehensiveIncomeLoss
      contextRef="ia9cf8032e9f7433cb50aee032c5b988b_D20200101-20200630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzY2E5YmIwMTc5MjQ3NmZiYjIyNWU1ZDlkZWM4NjlmL3NlYzo5M2NhOWJiMDE3OTI0NzZmYmIyMjVlNWQ5ZGVjODY5Zl80Ni9mcmFnOjE0YjkzMDBhMzZkNDQ1OTdhZGI5NzM0MDBlZTk5ZjYwL3RhYmxlOjhkZTMyYzc2NmZiNTRiOTJiNzE2NzE0NGY0YTI4NTcwL3RhYmxlcmFuZ2U6OGRlMzJjNzY2ZmI1NGI5MmI3MTY3MTQ0ZjRhMjg1NzBfMy03LTEtMS0w_c2ffae57-d160-4ae0-b19a-7eb7d7317f57"
      unitRef="usd">2281000</us-gaap:FairValueNetDerivativeAssetLiabilityMeasuredOnRecurringBasisUnobservableInputsReconciliationGainLossIncludedInOtherComprehensiveIncomeLoss>
    <us-gaap:FairValueNetDerivativeAssetLiabilityMeasuredOnRecurringBasisWithUnobservableInputs
      contextRef="i1cd84431f8574b82a2e542790c822e83_I20200630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzY2E5YmIwMTc5MjQ3NmZiYjIyNWU1ZDlkZWM4NjlmL3NlYzo5M2NhOWJiMDE3OTI0NzZmYmIyMjVlNWQ5ZGVjODY5Zl80Ni9mcmFnOjE0YjkzMDBhMzZkNDQ1OTdhZGI5NzM0MDBlZTk5ZjYwL3RhYmxlOjhkZTMyYzc2NmZiNTRiOTJiNzE2NzE0NGY0YTI4NTcwL3RhYmxlcmFuZ2U6OGRlMzJjNzY2ZmI1NGI5MmI3MTY3MTQ0ZjRhMjg1NzBfMy05LTEtMS0w_a2705e9f-a2eb-4502-b2be-2d5c3479bb69"
      unitRef="usd">-23576000</us-gaap:FairValueNetDerivativeAssetLiabilityMeasuredOnRecurringBasisWithUnobservableInputs>
    <us-gaap:FairValueNetDerivativeAssetLiabilityMeasuredOnRecurringBasisWithUnobservableInputs
      contextRef="ie4fc90ad6d7f4d39aea9cb65c8026e09_I20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzY2E5YmIwMTc5MjQ3NmZiYjIyNWU1ZDlkZWM4NjlmL3NlYzo5M2NhOWJiMDE3OTI0NzZmYmIyMjVlNWQ5ZGVjODY5Zl80Ni9mcmFnOjE0YjkzMDBhMzZkNDQ1OTdhZGI5NzM0MDBlZTk5ZjYwL3RhYmxlOjhkZTMyYzc2NmZiNTRiOTJiNzE2NzE0NGY0YTI4NTcwL3RhYmxlcmFuZ2U6OGRlMzJjNzY2ZmI1NGI5MmI3MTY3MTQ0ZjRhMjg1NzBfNC0xLTEtMS0w_5eb20162-5ace-47a6-9653-d9b03d99af66"
      unitRef="usd">-297160000</us-gaap:FairValueNetDerivativeAssetLiabilityMeasuredOnRecurringBasisWithUnobservableInputs>
    <us-gaap:FairValueNetDerivativeAssetLiabilityMeasuredOnRecurringBasisUnobservableInputsReconciliationGainLossIncludedInEarnings
      contextRef="i4a110e4972ef4113880ce582e3cda5c5_D20200101-20200630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzY2E5YmIwMTc5MjQ3NmZiYjIyNWU1ZDlkZWM4NjlmL3NlYzo5M2NhOWJiMDE3OTI0NzZmYmIyMjVlNWQ5ZGVjODY5Zl80Ni9mcmFnOjE0YjkzMDBhMzZkNDQ1OTdhZGI5NzM0MDBlZTk5ZjYwL3RhYmxlOjhkZTMyYzc2NmZiNTRiOTJiNzE2NzE0NGY0YTI4NTcwL3RhYmxlcmFuZ2U6OGRlMzJjNzY2ZmI1NGI5MmI3MTY3MTQ0ZjRhMjg1NzBfNC0zLTEtMS0w_9430cb60-c922-4e02-8d21-e4167a4c442a"
      unitRef="usd">77488000</us-gaap:FairValueNetDerivativeAssetLiabilityMeasuredOnRecurringBasisUnobservableInputsReconciliationGainLossIncludedInEarnings>
    <us-gaap:FairValueNetDerivativeAssetLiabilityMeasuredOnRecurringBasisUnobservableInputsReconciliationSettlements
      contextRef="i4a110e4972ef4113880ce582e3cda5c5_D20200101-20200630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzY2E5YmIwMTc5MjQ3NmZiYjIyNWU1ZDlkZWM4NjlmL3NlYzo5M2NhOWJiMDE3OTI0NzZmYmIyMjVlNWQ5ZGVjODY5Zl80Ni9mcmFnOjE0YjkzMDBhMzZkNDQ1OTdhZGI5NzM0MDBlZTk5ZjYwL3RhYmxlOjhkZTMyYzc2NmZiNTRiOTJiNzE2NzE0NGY0YTI4NTcwL3RhYmxlcmFuZ2U6OGRlMzJjNzY2ZmI1NGI5MmI3MTY3MTQ0ZjRhMjg1NzBfNC01LTEtMS0w_73a3fb63-6c6f-4baf-a945-3d82fc8b5add"
      unitRef="usd">727000</us-gaap:FairValueNetDerivativeAssetLiabilityMeasuredOnRecurringBasisUnobservableInputsReconciliationSettlements>
    <us-gaap:FairValueNetDerivativeAssetLiabilityMeasuredOnRecurringBasisUnobservableInputsReconciliationGainLossIncludedInOtherComprehensiveIncomeLoss
      contextRef="i4a110e4972ef4113880ce582e3cda5c5_D20200101-20200630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzY2E5YmIwMTc5MjQ3NmZiYjIyNWU1ZDlkZWM4NjlmL3NlYzo5M2NhOWJiMDE3OTI0NzZmYmIyMjVlNWQ5ZGVjODY5Zl80Ni9mcmFnOjE0YjkzMDBhMzZkNDQ1OTdhZGI5NzM0MDBlZTk5ZjYwL3RhYmxlOjhkZTMyYzc2NmZiNTRiOTJiNzE2NzE0NGY0YTI4NTcwL3RhYmxlcmFuZ2U6OGRlMzJjNzY2ZmI1NGI5MmI3MTY3MTQ0ZjRhMjg1NzBfNC03LTEtMS0w_660264a5-4817-460c-b5d8-59cc28a7004d"
      unitRef="usd">13231000</us-gaap:FairValueNetDerivativeAssetLiabilityMeasuredOnRecurringBasisUnobservableInputsReconciliationGainLossIncludedInOtherComprehensiveIncomeLoss>
    <us-gaap:FairValueNetDerivativeAssetLiabilityMeasuredOnRecurringBasisWithUnobservableInputs
      contextRef="id670dc9b33e6430f9d7510009f7495a7_I20200630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzY2E5YmIwMTc5MjQ3NmZiYjIyNWU1ZDlkZWM4NjlmL3NlYzo5M2NhOWJiMDE3OTI0NzZmYmIyMjVlNWQ5ZGVjODY5Zl80Ni9mcmFnOjE0YjkzMDBhMzZkNDQ1OTdhZGI5NzM0MDBlZTk5ZjYwL3RhYmxlOjhkZTMyYzc2NmZiNTRiOTJiNzE2NzE0NGY0YTI4NTcwL3RhYmxlcmFuZ2U6OGRlMzJjNzY2ZmI1NGI5MmI3MTY3MTQ0ZjRhMjg1NzBfNC05LTEtMS0w_f3eea383-10b5-4f64-8d44-07c64831f806"
      unitRef="usd">-205714000</us-gaap:FairValueNetDerivativeAssetLiabilityMeasuredOnRecurringBasisWithUnobservableInputs>
    <cron:FairValueNetDerivativeAssetLiabilityMeasuredOnRecurringBasisUnobservableInputsReconciliationOutOfPeriodAdjustment
      contextRef="i27f4e53b91ad4367b7f8d273eff27769_D20210401-20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzY2E5YmIwMTc5MjQ3NmZiYjIyNWU1ZDlkZWM4NjlmL3NlYzo5M2NhOWJiMDE3OTI0NzZmYmIyMjVlNWQ5ZGVjODY5Zl80Ni9mcmFnOjE0YjkzMDBhMzZkNDQ1OTdhZGI5NzM0MDBlZTk5ZjYwL3RleHRyZWdpb246MTRiOTMwMGEzNmQ0NDU5N2FkYjk3MzQwMGVlOTlmNjBfOTg5NTYwNDY2ODk2NA_8f941f88-90e8-4c77-84e3-90e44fcbb743"
      unitRef="usd">-11278000</cron:FairValueNetDerivativeAssetLiabilityMeasuredOnRecurringBasisUnobservableInputsReconciliationOutOfPeriodAdjustment>
    <us-gaap:FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTableTextBlock
      contextRef="i69782326f71a44e3805518280ee22b6b_D20210101-20210630"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzY2E5YmIwMTc5MjQ3NmZiYjIyNWU1ZDlkZWM4NjlmL3NlYzo5M2NhOWJiMDE3OTI0NzZmYmIyMjVlNWQ5ZGVjODY5Zl80Ni9mcmFnOjE0YjkzMDBhMzZkNDQ1OTdhZGI5NzM0MDBlZTk5ZjYwL3RleHRyZWdpb246MTRiOTMwMGEzNmQ0NDU5N2FkYjk3MzQwMGVlOTlmNjBfNzQ2NA_52065bd4-f3b9-47f6-8e6f-42cf9c4676cd">&lt;div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The fair values of the derivative liabilities were determined using the Black-Scholes pricing model as of June&#160;30, 2021 and December 31, 2020 applying the following inputs:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.583%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:31.257%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.639%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.357%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.639%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.357%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.639%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.776%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.639%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.357%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.639%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.357%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.644%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;As of June&#160;30, 2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;As of December 31, 2020&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Altria Warrant&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Pre-emptive Rights&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Top-up Rights&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Altria Warrant&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Pre-emptive Rights&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Top-up Rights&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Share price at valuation date &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(i)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$10.68&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$10.68&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$10.68&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$8.84&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$8.84&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$8.84&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Subscription price &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(i)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$19.00&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$16.25&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$16.25&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$19.00&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$16.25&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$16.25&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;div style="margin-top:1pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Weighted average risk-free interest rate &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(ii)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.38%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.28%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.31%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.21%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.17%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.13%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;div style="margin-top:1pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Weighted average expected life &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(iii)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1.68&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1.25&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1.31&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2.18&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1.50&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.98&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;div style="margin-top:1pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Expected annualized volatility&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline"&gt; (iv)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;75%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;75%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;75%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;81%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;81%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;81%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Expected dividend yield&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;padding-left:27pt;text-align:justify;text-indent:-27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:400;line-height:120%;position:relative;top:-2.8pt;vertical-align:baseline"&gt;(i)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:22.1pt"&gt;Per share in C$.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt;margin-top:3pt;padding-left:27pt;text-align:justify;text-indent:-27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:400;line-height:120%;position:relative;top:-2.8pt;vertical-align:baseline"&gt;(ii)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:20.66pt"&gt;The risk-free interest rate was based on Bank of Canada government treasury bills and bonds with a remaining term equal to the expected life of the derivative liabilities. As of June&#160;30, 2021 and December 31, 2020, the risk-free interest rate uses a range of approximately 0.15% to 0.85% and 0.10% to 0.39%, respectively, for the Pre-emptive Rights and Top-up Rights.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt;margin-top:3pt;padding-left:27pt;text-align:justify;text-indent:-27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:400;line-height:120%;position:relative;top:-2.8pt;vertical-align:baseline"&gt;(iii)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:19.22pt"&gt;The expected life represents the period of time, in years, that the derivative liabilities are expected to be outstanding. The expected life of the Pre-emptive Rights and Top-up Rights is determined based on the expected term of the underlying options, warrants, and shares, to which the Pre-emptive Rights and Top-up Rights are linked. As of June&#160;30, 2021 and December 31, 2020, the expected life uses a range of approximately 0.25 year to 4.25 years and 0.50 year to 5.00 years, respectively.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:3pt;padding-left:27pt;text-align:justify;text-indent:-27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:400;line-height:120%;position:relative;top:-2.8pt;vertical-align:baseline"&gt;(iv)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:19.5pt"&gt;Volatility was based on an equally weighted blended historical and implied volatility level of the underlying equity securities of the Company as of June&#160;30, 2021. As of December 31, 2020, volatility was based on the blended historical volatility levels of the Company and peer companies.&lt;/span&gt;&lt;/div&gt;</us-gaap:FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTableTextBlock>
    <us-gaap:DerivativeLiabilityMeasurementInput
      contextRef="i1257ed1c2bd045fbb8c920b7a673a2bc_I20210630"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzY2E5YmIwMTc5MjQ3NmZiYjIyNWU1ZDlkZWM4NjlmL3NlYzo5M2NhOWJiMDE3OTI0NzZmYmIyMjVlNWQ5ZGVjODY5Zl80Ni9mcmFnOjE0YjkzMDBhMzZkNDQ1OTdhZGI5NzM0MDBlZTk5ZjYwL3RhYmxlOjUwYzczMTgxNmExNTQxNDA4MzhhNmZlN2M0MzQxMjNlL3RhYmxlcmFuZ2U6NTBjNzMxODE2YTE1NDE0MDgzOGE2ZmU3YzQzNDEyM2VfMi0xLTEtMS0w_cb6ffe98-492a-422a-849b-29b9632576ba"
      unitRef="cadPerShare">10.68</us-gaap:DerivativeLiabilityMeasurementInput>
    <us-gaap:DerivativeLiabilityMeasurementInput
      contextRef="id354e82bb28e4e4f86ca8adb1f07698c_I20210630"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzY2E5YmIwMTc5MjQ3NmZiYjIyNWU1ZDlkZWM4NjlmL3NlYzo5M2NhOWJiMDE3OTI0NzZmYmIyMjVlNWQ5ZGVjODY5Zl80Ni9mcmFnOjE0YjkzMDBhMzZkNDQ1OTdhZGI5NzM0MDBlZTk5ZjYwL3RhYmxlOjUwYzczMTgxNmExNTQxNDA4MzhhNmZlN2M0MzQxMjNlL3RhYmxlcmFuZ2U6NTBjNzMxODE2YTE1NDE0MDgzOGE2ZmU3YzQzNDEyM2VfMi0zLTEtMS0w_1cc96a5b-0c62-4234-abe5-32c9f4ac5910"
      unitRef="cadPerShare">10.68</us-gaap:DerivativeLiabilityMeasurementInput>
    <us-gaap:DerivativeLiabilityMeasurementInput
      contextRef="i63dea78d92f24ac5a2eef5b4454a6dd3_I20210630"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzY2E5YmIwMTc5MjQ3NmZiYjIyNWU1ZDlkZWM4NjlmL3NlYzo5M2NhOWJiMDE3OTI0NzZmYmIyMjVlNWQ5ZGVjODY5Zl80Ni9mcmFnOjE0YjkzMDBhMzZkNDQ1OTdhZGI5NzM0MDBlZTk5ZjYwL3RhYmxlOjUwYzczMTgxNmExNTQxNDA4MzhhNmZlN2M0MzQxMjNlL3RhYmxlcmFuZ2U6NTBjNzMxODE2YTE1NDE0MDgzOGE2ZmU3YzQzNDEyM2VfMi01LTEtMS0w_cd04f056-9624-4a29-ae51-ae5d6d48f124"
      unitRef="cadPerShare">10.68</us-gaap:DerivativeLiabilityMeasurementInput>
    <us-gaap:DerivativeLiabilityMeasurementInput
      contextRef="i3353e98ec8c146078a9728dd2c05959d_I20201231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzY2E5YmIwMTc5MjQ3NmZiYjIyNWU1ZDlkZWM4NjlmL3NlYzo5M2NhOWJiMDE3OTI0NzZmYmIyMjVlNWQ5ZGVjODY5Zl80Ni9mcmFnOjE0YjkzMDBhMzZkNDQ1OTdhZGI5NzM0MDBlZTk5ZjYwL3RhYmxlOjUwYzczMTgxNmExNTQxNDA4MzhhNmZlN2M0MzQxMjNlL3RhYmxlcmFuZ2U6NTBjNzMxODE2YTE1NDE0MDgzOGE2ZmU3YzQzNDEyM2VfMi03LTEtMS0w_e2772dda-a78c-456f-8b05-6d20b9153eab"
      unitRef="cadPerShare">8.84</us-gaap:DerivativeLiabilityMeasurementInput>
    <us-gaap:DerivativeLiabilityMeasurementInput
      contextRef="i5b7f2fd4ed2c48b588a6b20efe0642c9_I20201231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzY2E5YmIwMTc5MjQ3NmZiYjIyNWU1ZDlkZWM4NjlmL3NlYzo5M2NhOWJiMDE3OTI0NzZmYmIyMjVlNWQ5ZGVjODY5Zl80Ni9mcmFnOjE0YjkzMDBhMzZkNDQ1OTdhZGI5NzM0MDBlZTk5ZjYwL3RhYmxlOjUwYzczMTgxNmExNTQxNDA4MzhhNmZlN2M0MzQxMjNlL3RhYmxlcmFuZ2U6NTBjNzMxODE2YTE1NDE0MDgzOGE2ZmU3YzQzNDEyM2VfMi05LTEtMS0w_38e57ad7-88be-4be6-bca9-8ff3de5a2522"
      unitRef="cadPerShare">8.84</us-gaap:DerivativeLiabilityMeasurementInput>
    <us-gaap:DerivativeLiabilityMeasurementInput
      contextRef="i4a625e9a51bd4f19acfab304939f7b6d_I20201231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzY2E5YmIwMTc5MjQ3NmZiYjIyNWU1ZDlkZWM4NjlmL3NlYzo5M2NhOWJiMDE3OTI0NzZmYmIyMjVlNWQ5ZGVjODY5Zl80Ni9mcmFnOjE0YjkzMDBhMzZkNDQ1OTdhZGI5NzM0MDBlZTk5ZjYwL3RhYmxlOjUwYzczMTgxNmExNTQxNDA4MzhhNmZlN2M0MzQxMjNlL3RhYmxlcmFuZ2U6NTBjNzMxODE2YTE1NDE0MDgzOGE2ZmU3YzQzNDEyM2VfMi0xMS0xLTEtMA_2d1ff392-685f-42cd-9601-4121a2695b0a"
      unitRef="cadPerShare">8.84</us-gaap:DerivativeLiabilityMeasurementInput>
    <us-gaap:DerivativeLiabilityMeasurementInput
      contextRef="i339cf0904cfb4c7199ff22f9b0f89460_I20210630"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzY2E5YmIwMTc5MjQ3NmZiYjIyNWU1ZDlkZWM4NjlmL3NlYzo5M2NhOWJiMDE3OTI0NzZmYmIyMjVlNWQ5ZGVjODY5Zl80Ni9mcmFnOjE0YjkzMDBhMzZkNDQ1OTdhZGI5NzM0MDBlZTk5ZjYwL3RhYmxlOjUwYzczMTgxNmExNTQxNDA4MzhhNmZlN2M0MzQxMjNlL3RhYmxlcmFuZ2U6NTBjNzMxODE2YTE1NDE0MDgzOGE2ZmU3YzQzNDEyM2VfMy0xLTEtMS0w_6ebc5005-9a99-4328-9143-b43881361924"
      unitRef="cadPerShare">19.00</us-gaap:DerivativeLiabilityMeasurementInput>
    <us-gaap:DerivativeLiabilityMeasurementInput
      contextRef="ic23329598e00476e92f1af90f155a47c_I20210630"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzY2E5YmIwMTc5MjQ3NmZiYjIyNWU1ZDlkZWM4NjlmL3NlYzo5M2NhOWJiMDE3OTI0NzZmYmIyMjVlNWQ5ZGVjODY5Zl80Ni9mcmFnOjE0YjkzMDBhMzZkNDQ1OTdhZGI5NzM0MDBlZTk5ZjYwL3RhYmxlOjUwYzczMTgxNmExNTQxNDA4MzhhNmZlN2M0MzQxMjNlL3RhYmxlcmFuZ2U6NTBjNzMxODE2YTE1NDE0MDgzOGE2ZmU3YzQzNDEyM2VfMy0zLTEtMS0w_a335cbea-e943-4eb4-93ac-f524c9241fa7"
      unitRef="cadPerShare">16.25</us-gaap:DerivativeLiabilityMeasurementInput>
    <us-gaap:DerivativeLiabilityMeasurementInput
      contextRef="i579c24557a25415ab76670fb8c125152_I20210630"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzY2E5YmIwMTc5MjQ3NmZiYjIyNWU1ZDlkZWM4NjlmL3NlYzo5M2NhOWJiMDE3OTI0NzZmYmIyMjVlNWQ5ZGVjODY5Zl80Ni9mcmFnOjE0YjkzMDBhMzZkNDQ1OTdhZGI5NzM0MDBlZTk5ZjYwL3RhYmxlOjUwYzczMTgxNmExNTQxNDA4MzhhNmZlN2M0MzQxMjNlL3RhYmxlcmFuZ2U6NTBjNzMxODE2YTE1NDE0MDgzOGE2ZmU3YzQzNDEyM2VfMy01LTEtMS0w_6b12a8c8-f390-4888-bf12-03b2e93c0466"
      unitRef="cadPerShare">16.25</us-gaap:DerivativeLiabilityMeasurementInput>
    <us-gaap:DerivativeLiabilityMeasurementInput
      contextRef="ib2597206a68d439e9d9fb442a0edbf09_I20201231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzY2E5YmIwMTc5MjQ3NmZiYjIyNWU1ZDlkZWM4NjlmL3NlYzo5M2NhOWJiMDE3OTI0NzZmYmIyMjVlNWQ5ZGVjODY5Zl80Ni9mcmFnOjE0YjkzMDBhMzZkNDQ1OTdhZGI5NzM0MDBlZTk5ZjYwL3RhYmxlOjUwYzczMTgxNmExNTQxNDA4MzhhNmZlN2M0MzQxMjNlL3RhYmxlcmFuZ2U6NTBjNzMxODE2YTE1NDE0MDgzOGE2ZmU3YzQzNDEyM2VfMy03LTEtMS0w_52216157-346c-47aa-9d8e-ae8ea7c772a2"
      unitRef="cadPerShare">19.00</us-gaap:DerivativeLiabilityMeasurementInput>
    <us-gaap:DerivativeLiabilityMeasurementInput
      contextRef="if7010204491b4497933eebbdfcad9d26_I20201231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzY2E5YmIwMTc5MjQ3NmZiYjIyNWU1ZDlkZWM4NjlmL3NlYzo5M2NhOWJiMDE3OTI0NzZmYmIyMjVlNWQ5ZGVjODY5Zl80Ni9mcmFnOjE0YjkzMDBhMzZkNDQ1OTdhZGI5NzM0MDBlZTk5ZjYwL3RhYmxlOjUwYzczMTgxNmExNTQxNDA4MzhhNmZlN2M0MzQxMjNlL3RhYmxlcmFuZ2U6NTBjNzMxODE2YTE1NDE0MDgzOGE2ZmU3YzQzNDEyM2VfMy05LTEtMS0w_d692a59d-1cbf-4db4-b646-d8064ea70133"
      unitRef="cadPerShare">16.25</us-gaap:DerivativeLiabilityMeasurementInput>
    <us-gaap:DerivativeLiabilityMeasurementInput
      contextRef="i26b4cc1b2d2c4abcb74127a35c819ef3_I20201231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzY2E5YmIwMTc5MjQ3NmZiYjIyNWU1ZDlkZWM4NjlmL3NlYzo5M2NhOWJiMDE3OTI0NzZmYmIyMjVlNWQ5ZGVjODY5Zl80Ni9mcmFnOjE0YjkzMDBhMzZkNDQ1OTdhZGI5NzM0MDBlZTk5ZjYwL3RhYmxlOjUwYzczMTgxNmExNTQxNDA4MzhhNmZlN2M0MzQxMjNlL3RhYmxlcmFuZ2U6NTBjNzMxODE2YTE1NDE0MDgzOGE2ZmU3YzQzNDEyM2VfMy0xMS0xLTEtMA_5ad425ee-ba11-4c12-b434-99f290536ab8"
      unitRef="cadPerShare">16.25</us-gaap:DerivativeLiabilityMeasurementInput>
    <us-gaap:DerivativeLiabilityMeasurementInput
      contextRef="i88181468f4494137aa775f1e418165d7_I20210630"
      decimals="4"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzY2E5YmIwMTc5MjQ3NmZiYjIyNWU1ZDlkZWM4NjlmL3NlYzo5M2NhOWJiMDE3OTI0NzZmYmIyMjVlNWQ5ZGVjODY5Zl80Ni9mcmFnOjE0YjkzMDBhMzZkNDQ1OTdhZGI5NzM0MDBlZTk5ZjYwL3RhYmxlOjUwYzczMTgxNmExNTQxNDA4MzhhNmZlN2M0MzQxMjNlL3RhYmxlcmFuZ2U6NTBjNzMxODE2YTE1NDE0MDgzOGE2ZmU3YzQzNDEyM2VfNC0xLTEtMS0w_d28d87a5-fcf3-4a23-beb0-d28a9a7976b2"
      unitRef="number">0.0038</us-gaap:DerivativeLiabilityMeasurementInput>
    <us-gaap:DerivativeLiabilityMeasurementInput
      contextRef="ic12d47490ce74a188ddc34240b7f1bea_I20210630"
      decimals="4"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzY2E5YmIwMTc5MjQ3NmZiYjIyNWU1ZDlkZWM4NjlmL3NlYzo5M2NhOWJiMDE3OTI0NzZmYmIyMjVlNWQ5ZGVjODY5Zl80Ni9mcmFnOjE0YjkzMDBhMzZkNDQ1OTdhZGI5NzM0MDBlZTk5ZjYwL3RhYmxlOjUwYzczMTgxNmExNTQxNDA4MzhhNmZlN2M0MzQxMjNlL3RhYmxlcmFuZ2U6NTBjNzMxODE2YTE1NDE0MDgzOGE2ZmU3YzQzNDEyM2VfNC0zLTEtMS0w_7cf1a343-a10a-4907-906c-6d34cec34347"
      unitRef="number">0.0028</us-gaap:DerivativeLiabilityMeasurementInput>
    <us-gaap:DerivativeLiabilityMeasurementInput
      contextRef="i6100f128578c4248a96b36db6968b813_I20210630"
      decimals="4"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzY2E5YmIwMTc5MjQ3NmZiYjIyNWU1ZDlkZWM4NjlmL3NlYzo5M2NhOWJiMDE3OTI0NzZmYmIyMjVlNWQ5ZGVjODY5Zl80Ni9mcmFnOjE0YjkzMDBhMzZkNDQ1OTdhZGI5NzM0MDBlZTk5ZjYwL3RhYmxlOjUwYzczMTgxNmExNTQxNDA4MzhhNmZlN2M0MzQxMjNlL3RhYmxlcmFuZ2U6NTBjNzMxODE2YTE1NDE0MDgzOGE2ZmU3YzQzNDEyM2VfNC01LTEtMS0w_87dcd147-383d-4840-ab69-ccafc13f3b6f"
      unitRef="number">0.0031</us-gaap:DerivativeLiabilityMeasurementInput>
    <us-gaap:DerivativeLiabilityMeasurementInput
      contextRef="i23edb2809b3b4515a9b05b50daa96971_I20201231"
      decimals="4"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzY2E5YmIwMTc5MjQ3NmZiYjIyNWU1ZDlkZWM4NjlmL3NlYzo5M2NhOWJiMDE3OTI0NzZmYmIyMjVlNWQ5ZGVjODY5Zl80Ni9mcmFnOjE0YjkzMDBhMzZkNDQ1OTdhZGI5NzM0MDBlZTk5ZjYwL3RhYmxlOjUwYzczMTgxNmExNTQxNDA4MzhhNmZlN2M0MzQxMjNlL3RhYmxlcmFuZ2U6NTBjNzMxODE2YTE1NDE0MDgzOGE2ZmU3YzQzNDEyM2VfNC03LTEtMS0w_cf800445-65ee-4252-ad05-5751b2b0890f"
      unitRef="number">0.0021</us-gaap:DerivativeLiabilityMeasurementInput>
    <us-gaap:DerivativeLiabilityMeasurementInput
      contextRef="ida0e51f36f7241508ea9f1cb51fab77b_I20201231"
      decimals="4"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzY2E5YmIwMTc5MjQ3NmZiYjIyNWU1ZDlkZWM4NjlmL3NlYzo5M2NhOWJiMDE3OTI0NzZmYmIyMjVlNWQ5ZGVjODY5Zl80Ni9mcmFnOjE0YjkzMDBhMzZkNDQ1OTdhZGI5NzM0MDBlZTk5ZjYwL3RhYmxlOjUwYzczMTgxNmExNTQxNDA4MzhhNmZlN2M0MzQxMjNlL3RhYmxlcmFuZ2U6NTBjNzMxODE2YTE1NDE0MDgzOGE2ZmU3YzQzNDEyM2VfNC05LTEtMS0w_59fdc892-1cc3-4d4d-8e9a-0d6979d9054d"
      unitRef="number">0.0017</us-gaap:DerivativeLiabilityMeasurementInput>
    <us-gaap:DerivativeLiabilityMeasurementInput
      contextRef="i1779eecf81de47219b6cdc404ab734e6_I20201231"
      decimals="4"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzY2E5YmIwMTc5MjQ3NmZiYjIyNWU1ZDlkZWM4NjlmL3NlYzo5M2NhOWJiMDE3OTI0NzZmYmIyMjVlNWQ5ZGVjODY5Zl80Ni9mcmFnOjE0YjkzMDBhMzZkNDQ1OTdhZGI5NzM0MDBlZTk5ZjYwL3RhYmxlOjUwYzczMTgxNmExNTQxNDA4MzhhNmZlN2M0MzQxMjNlL3RhYmxlcmFuZ2U6NTBjNzMxODE2YTE1NDE0MDgzOGE2ZmU3YzQzNDEyM2VfNC0xMS0xLTEtMA_47c317ac-f7ac-4c06-a7d8-16b14ff6b859"
      unitRef="number">0.0013</us-gaap:DerivativeLiabilityMeasurementInput>
    <cron:DerivativeLiabilityUsefulLifeTerm
      contextRef="ic02211497b5b474a8462f60dfc14b91f_D20210101-20210630"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzY2E5YmIwMTc5MjQ3NmZiYjIyNWU1ZDlkZWM4NjlmL3NlYzo5M2NhOWJiMDE3OTI0NzZmYmIyMjVlNWQ5ZGVjODY5Zl80Ni9mcmFnOjE0YjkzMDBhMzZkNDQ1OTdhZGI5NzM0MDBlZTk5ZjYwL3RhYmxlOjUwYzczMTgxNmExNTQxNDA4MzhhNmZlN2M0MzQxMjNlL3RhYmxlcmFuZ2U6NTBjNzMxODE2YTE1NDE0MDgzOGE2ZmU3YzQzNDEyM2VfNS0xLTEtMS0w_81a29758-18a3-487f-ad0d-b4bbce273433">P1Y8M4D</cron:DerivativeLiabilityUsefulLifeTerm>
    <cron:DerivativeLiabilityUsefulLifeTerm
      contextRef="ie494d1760a574e71a32cae2bcd0bc6f2_D20210101-20210630"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzY2E5YmIwMTc5MjQ3NmZiYjIyNWU1ZDlkZWM4NjlmL3NlYzo5M2NhOWJiMDE3OTI0NzZmYmIyMjVlNWQ5ZGVjODY5Zl80Ni9mcmFnOjE0YjkzMDBhMzZkNDQ1OTdhZGI5NzM0MDBlZTk5ZjYwL3RhYmxlOjUwYzczMTgxNmExNTQxNDA4MzhhNmZlN2M0MzQxMjNlL3RhYmxlcmFuZ2U6NTBjNzMxODE2YTE1NDE0MDgzOGE2ZmU3YzQzNDEyM2VfNS0zLTEtMS0w_27b38e0a-9589-4846-a0af-496e9b6cd2ba">P1Y3M</cron:DerivativeLiabilityUsefulLifeTerm>
    <cron:DerivativeLiabilityUsefulLifeTerm
      contextRef="id2d2173a25434cd79374e4a7cf5568c2_D20210101-20210630"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzY2E5YmIwMTc5MjQ3NmZiYjIyNWU1ZDlkZWM4NjlmL3NlYzo5M2NhOWJiMDE3OTI0NzZmYmIyMjVlNWQ5ZGVjODY5Zl80Ni9mcmFnOjE0YjkzMDBhMzZkNDQ1OTdhZGI5NzM0MDBlZTk5ZjYwL3RhYmxlOjUwYzczMTgxNmExNTQxNDA4MzhhNmZlN2M0MzQxMjNlL3RhYmxlcmFuZ2U6NTBjNzMxODE2YTE1NDE0MDgzOGE2ZmU3YzQzNDEyM2VfNS01LTEtMS0w_ca55db2d-fee9-4efa-ad66-34c08ec08069">P1Y3M21D</cron:DerivativeLiabilityUsefulLifeTerm>
    <cron:DerivativeLiabilityUsefulLifeTerm
      contextRef="i1da031054a504cf79b3d31bfcd7a323a_D20200101-20201231"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzY2E5YmIwMTc5MjQ3NmZiYjIyNWU1ZDlkZWM4NjlmL3NlYzo5M2NhOWJiMDE3OTI0NzZmYmIyMjVlNWQ5ZGVjODY5Zl80Ni9mcmFnOjE0YjkzMDBhMzZkNDQ1OTdhZGI5NzM0MDBlZTk5ZjYwL3RhYmxlOjUwYzczMTgxNmExNTQxNDA4MzhhNmZlN2M0MzQxMjNlL3RhYmxlcmFuZ2U6NTBjNzMxODE2YTE1NDE0MDgzOGE2ZmU3YzQzNDEyM2VfNS03LTEtMS0w_fff172ef-dc29-4edb-882c-2d9912e3c813">P2Y2M4D</cron:DerivativeLiabilityUsefulLifeTerm>
    <cron:DerivativeLiabilityUsefulLifeTerm
      contextRef="i1701f6b7d62b4512bfe98026f74288b7_D20200101-20201231"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzY2E5YmIwMTc5MjQ3NmZiYjIyNWU1ZDlkZWM4NjlmL3NlYzo5M2NhOWJiMDE3OTI0NzZmYmIyMjVlNWQ5ZGVjODY5Zl80Ni9mcmFnOjE0YjkzMDBhMzZkNDQ1OTdhZGI5NzM0MDBlZTk5ZjYwL3RhYmxlOjUwYzczMTgxNmExNTQxNDA4MzhhNmZlN2M0MzQxMjNlL3RhYmxlcmFuZ2U6NTBjNzMxODE2YTE1NDE0MDgzOGE2ZmU3YzQzNDEyM2VfNS05LTEtMS0w_2d8b6842-36d5-4c40-b9a9-3c3c810a89f0">P1Y6M</cron:DerivativeLiabilityUsefulLifeTerm>
    <cron:DerivativeLiabilityUsefulLifeTerm
      contextRef="i10d7bf0cfd8342e5b54a9ede98d85efa_D20200101-20201231"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzY2E5YmIwMTc5MjQ3NmZiYjIyNWU1ZDlkZWM4NjlmL3NlYzo5M2NhOWJiMDE3OTI0NzZmYmIyMjVlNWQ5ZGVjODY5Zl80Ni9mcmFnOjE0YjkzMDBhMzZkNDQ1OTdhZGI5NzM0MDBlZTk5ZjYwL3RhYmxlOjUwYzczMTgxNmExNTQxNDA4MzhhNmZlN2M0MzQxMjNlL3RhYmxlcmFuZ2U6NTBjNzMxODE2YTE1NDE0MDgzOGE2ZmU3YzQzNDEyM2VfNS0xMS0xLTEtMA_a9f2f136-2344-4318-954f-689e9d2ae8e0">P0Y11M23D</cron:DerivativeLiabilityUsefulLifeTerm>
    <us-gaap:DerivativeLiabilityMeasurementInput
      contextRef="if15b10fbb370412cb143458bfa546283_I20210630"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzY2E5YmIwMTc5MjQ3NmZiYjIyNWU1ZDlkZWM4NjlmL3NlYzo5M2NhOWJiMDE3OTI0NzZmYmIyMjVlNWQ5ZGVjODY5Zl80Ni9mcmFnOjE0YjkzMDBhMzZkNDQ1OTdhZGI5NzM0MDBlZTk5ZjYwL3RhYmxlOjUwYzczMTgxNmExNTQxNDA4MzhhNmZlN2M0MzQxMjNlL3RhYmxlcmFuZ2U6NTBjNzMxODE2YTE1NDE0MDgzOGE2ZmU3YzQzNDEyM2VfNi0xLTEtMS0w_cd445620-9cbb-4777-84e8-2dabede20742"
      unitRef="number">0.75</us-gaap:DerivativeLiabilityMeasurementInput>
    <us-gaap:DerivativeLiabilityMeasurementInput
      contextRef="i8c3dd53b7ced472bbe056909c36fa671_I20210630"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzY2E5YmIwMTc5MjQ3NmZiYjIyNWU1ZDlkZWM4NjlmL3NlYzo5M2NhOWJiMDE3OTI0NzZmYmIyMjVlNWQ5ZGVjODY5Zl80Ni9mcmFnOjE0YjkzMDBhMzZkNDQ1OTdhZGI5NzM0MDBlZTk5ZjYwL3RhYmxlOjUwYzczMTgxNmExNTQxNDA4MzhhNmZlN2M0MzQxMjNlL3RhYmxlcmFuZ2U6NTBjNzMxODE2YTE1NDE0MDgzOGE2ZmU3YzQzNDEyM2VfNi0zLTEtMS0w_b41fcbc2-220a-4309-8fe5-6d3628692131"
      unitRef="number">0.75</us-gaap:DerivativeLiabilityMeasurementInput>
    <us-gaap:DerivativeLiabilityMeasurementInput
      contextRef="ib976b88274494333b0625717658b451c_I20210630"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzY2E5YmIwMTc5MjQ3NmZiYjIyNWU1ZDlkZWM4NjlmL3NlYzo5M2NhOWJiMDE3OTI0NzZmYmIyMjVlNWQ5ZGVjODY5Zl80Ni9mcmFnOjE0YjkzMDBhMzZkNDQ1OTdhZGI5NzM0MDBlZTk5ZjYwL3RhYmxlOjUwYzczMTgxNmExNTQxNDA4MzhhNmZlN2M0MzQxMjNlL3RhYmxlcmFuZ2U6NTBjNzMxODE2YTE1NDE0MDgzOGE2ZmU3YzQzNDEyM2VfNi01LTEtMS0w_ac5c457e-8721-4603-9b9e-4251abf1388d"
      unitRef="number">0.75</us-gaap:DerivativeLiabilityMeasurementInput>
    <us-gaap:DerivativeLiabilityMeasurementInput
      contextRef="i3b4e489f4801442fbe965a24c9af5f86_I20201231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzY2E5YmIwMTc5MjQ3NmZiYjIyNWU1ZDlkZWM4NjlmL3NlYzo5M2NhOWJiMDE3OTI0NzZmYmIyMjVlNWQ5ZGVjODY5Zl80Ni9mcmFnOjE0YjkzMDBhMzZkNDQ1OTdhZGI5NzM0MDBlZTk5ZjYwL3RhYmxlOjUwYzczMTgxNmExNTQxNDA4MzhhNmZlN2M0MzQxMjNlL3RhYmxlcmFuZ2U6NTBjNzMxODE2YTE1NDE0MDgzOGE2ZmU3YzQzNDEyM2VfNi03LTEtMS0w_225f6a76-1a3b-4c7f-b5b1-b29face513a4"
      unitRef="number">0.81</us-gaap:DerivativeLiabilityMeasurementInput>
    <us-gaap:DerivativeLiabilityMeasurementInput
      contextRef="i57c58eedfb404984b87b46cbe12d3426_I20201231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzY2E5YmIwMTc5MjQ3NmZiYjIyNWU1ZDlkZWM4NjlmL3NlYzo5M2NhOWJiMDE3OTI0NzZmYmIyMjVlNWQ5ZGVjODY5Zl80Ni9mcmFnOjE0YjkzMDBhMzZkNDQ1OTdhZGI5NzM0MDBlZTk5ZjYwL3RhYmxlOjUwYzczMTgxNmExNTQxNDA4MzhhNmZlN2M0MzQxMjNlL3RhYmxlcmFuZ2U6NTBjNzMxODE2YTE1NDE0MDgzOGE2ZmU3YzQzNDEyM2VfNi05LTEtMS0w_e3228824-d44f-4546-9000-150df3094048"
      unitRef="number">0.81</us-gaap:DerivativeLiabilityMeasurementInput>
    <us-gaap:DerivativeLiabilityMeasurementInput
      contextRef="i9859907a6972416e881289ad4a8c7462_I20201231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzY2E5YmIwMTc5MjQ3NmZiYjIyNWU1ZDlkZWM4NjlmL3NlYzo5M2NhOWJiMDE3OTI0NzZmYmIyMjVlNWQ5ZGVjODY5Zl80Ni9mcmFnOjE0YjkzMDBhMzZkNDQ1OTdhZGI5NzM0MDBlZTk5ZjYwL3RhYmxlOjUwYzczMTgxNmExNTQxNDA4MzhhNmZlN2M0MzQxMjNlL3RhYmxlcmFuZ2U6NTBjNzMxODE2YTE1NDE0MDgzOGE2ZmU3YzQzNDEyM2VfNi0xMS0xLTEtMA_b67b4095-c420-4ff6-94d5-eb70d5365f69"
      unitRef="number">0.81</us-gaap:DerivativeLiabilityMeasurementInput>
    <us-gaap:DerivativeLiabilityMeasurementInput
      contextRef="id612af184d0d4ee8bae904a6cdcdba6f_I20210630"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzY2E5YmIwMTc5MjQ3NmZiYjIyNWU1ZDlkZWM4NjlmL3NlYzo5M2NhOWJiMDE3OTI0NzZmYmIyMjVlNWQ5ZGVjODY5Zl80Ni9mcmFnOjE0YjkzMDBhMzZkNDQ1OTdhZGI5NzM0MDBlZTk5ZjYwL3RhYmxlOjUwYzczMTgxNmExNTQxNDA4MzhhNmZlN2M0MzQxMjNlL3RhYmxlcmFuZ2U6NTBjNzMxODE2YTE1NDE0MDgzOGE2ZmU3YzQzNDEyM2VfNy0xLTEtMS0w_6828738a-2d21-4c99-9409-7eb631ee12b3"
      unitRef="number">0</us-gaap:DerivativeLiabilityMeasurementInput>
    <us-gaap:DerivativeLiabilityMeasurementInput
      contextRef="id5167c2418bc49d79a29b1d99ae027e1_I20210630"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzY2E5YmIwMTc5MjQ3NmZiYjIyNWU1ZDlkZWM4NjlmL3NlYzo5M2NhOWJiMDE3OTI0NzZmYmIyMjVlNWQ5ZGVjODY5Zl80Ni9mcmFnOjE0YjkzMDBhMzZkNDQ1OTdhZGI5NzM0MDBlZTk5ZjYwL3RhYmxlOjUwYzczMTgxNmExNTQxNDA4MzhhNmZlN2M0MzQxMjNlL3RhYmxlcmFuZ2U6NTBjNzMxODE2YTE1NDE0MDgzOGE2ZmU3YzQzNDEyM2VfNy0zLTEtMS0w_f19d9208-466b-4ff8-8fa2-f3adec706632"
      unitRef="number">0</us-gaap:DerivativeLiabilityMeasurementInput>
    <us-gaap:DerivativeLiabilityMeasurementInput
      contextRef="i79aea684554446b8864ca220d82ab826_I20210630"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzY2E5YmIwMTc5MjQ3NmZiYjIyNWU1ZDlkZWM4NjlmL3NlYzo5M2NhOWJiMDE3OTI0NzZmYmIyMjVlNWQ5ZGVjODY5Zl80Ni9mcmFnOjE0YjkzMDBhMzZkNDQ1OTdhZGI5NzM0MDBlZTk5ZjYwL3RhYmxlOjUwYzczMTgxNmExNTQxNDA4MzhhNmZlN2M0MzQxMjNlL3RhYmxlcmFuZ2U6NTBjNzMxODE2YTE1NDE0MDgzOGE2ZmU3YzQzNDEyM2VfNy01LTEtMS0w_a151e755-4300-4a02-bc2a-c1a7306f4db4"
      unitRef="number">0</us-gaap:DerivativeLiabilityMeasurementInput>
    <us-gaap:DerivativeLiabilityMeasurementInput
      contextRef="i50dc22d6133f49688c294c0961ff3e97_I20201231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzY2E5YmIwMTc5MjQ3NmZiYjIyNWU1ZDlkZWM4NjlmL3NlYzo5M2NhOWJiMDE3OTI0NzZmYmIyMjVlNWQ5ZGVjODY5Zl80Ni9mcmFnOjE0YjkzMDBhMzZkNDQ1OTdhZGI5NzM0MDBlZTk5ZjYwL3RhYmxlOjUwYzczMTgxNmExNTQxNDA4MzhhNmZlN2M0MzQxMjNlL3RhYmxlcmFuZ2U6NTBjNzMxODE2YTE1NDE0MDgzOGE2ZmU3YzQzNDEyM2VfNy03LTEtMS0w_d366995e-cbf9-4ccb-8199-ee858041b6ea"
      unitRef="number">0</us-gaap:DerivativeLiabilityMeasurementInput>
    <us-gaap:DerivativeLiabilityMeasurementInput
      contextRef="i6cc1c73280a94f4ab8a8e4826245a4a9_I20201231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzY2E5YmIwMTc5MjQ3NmZiYjIyNWU1ZDlkZWM4NjlmL3NlYzo5M2NhOWJiMDE3OTI0NzZmYmIyMjVlNWQ5ZGVjODY5Zl80Ni9mcmFnOjE0YjkzMDBhMzZkNDQ1OTdhZGI5NzM0MDBlZTk5ZjYwL3RhYmxlOjUwYzczMTgxNmExNTQxNDA4MzhhNmZlN2M0MzQxMjNlL3RhYmxlcmFuZ2U6NTBjNzMxODE2YTE1NDE0MDgzOGE2ZmU3YzQzNDEyM2VfNy05LTEtMS0w_78e0d713-d0ef-450a-a0d4-4e3872094307"
      unitRef="number">0</us-gaap:DerivativeLiabilityMeasurementInput>
    <us-gaap:DerivativeLiabilityMeasurementInput
      contextRef="ia1213fa5613b4ccc8ae504fe77e72358_I20201231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzY2E5YmIwMTc5MjQ3NmZiYjIyNWU1ZDlkZWM4NjlmL3NlYzo5M2NhOWJiMDE3OTI0NzZmYmIyMjVlNWQ5ZGVjODY5Zl80Ni9mcmFnOjE0YjkzMDBhMzZkNDQ1OTdhZGI5NzM0MDBlZTk5ZjYwL3RhYmxlOjUwYzczMTgxNmExNTQxNDA4MzhhNmZlN2M0MzQxMjNlL3RhYmxlcmFuZ2U6NTBjNzMxODE2YTE1NDE0MDgzOGE2ZmU3YzQzNDEyM2VfNy0xMS0xLTEtMA_1ab941c0-8200-4339-828e-43e1c52cb94b"
      unitRef="number">0</us-gaap:DerivativeLiabilityMeasurementInput>
    <us-gaap:DerivativeLiabilityMeasurementInput
      contextRef="i9ca6679fb2564fde8f5c255991b2b07b_I20210630"
      decimals="4"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzY2E5YmIwMTc5MjQ3NmZiYjIyNWU1ZDlkZWM4NjlmL3NlYzo5M2NhOWJiMDE3OTI0NzZmYmIyMjVlNWQ5ZGVjODY5Zl80Ni9mcmFnOjE0YjkzMDBhMzZkNDQ1OTdhZGI5NzM0MDBlZTk5ZjYwL3RleHRyZWdpb246MTRiOTMwMGEzNmQ0NDU5N2FkYjk3MzQwMGVlOTlmNjBfNTc4OQ_796bbadc-bece-44be-8ab3-35728628e152"
      unitRef="number">0.0015</us-gaap:DerivativeLiabilityMeasurementInput>
    <us-gaap:DerivativeLiabilityMeasurementInput
      contextRef="idce1c11532374f46a0debb9127ec0281_I20210630"
      decimals="4"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzY2E5YmIwMTc5MjQ3NmZiYjIyNWU1ZDlkZWM4NjlmL3NlYzo5M2NhOWJiMDE3OTI0NzZmYmIyMjVlNWQ5ZGVjODY5Zl80Ni9mcmFnOjE0YjkzMDBhMzZkNDQ1OTdhZGI5NzM0MDBlZTk5ZjYwL3RleHRyZWdpb246MTRiOTMwMGEzNmQ0NDU5N2FkYjk3MzQwMGVlOTlmNjBfNTc5NQ_16be9763-f195-4f0a-abd8-e3c5d5b09c07"
      unitRef="number">0.0085</us-gaap:DerivativeLiabilityMeasurementInput>
    <us-gaap:DerivativeLiabilityMeasurementInput
      contextRef="i91e2aab33be84cc8a26bac33aca37a7b_I20201231"
      decimals="4"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzY2E5YmIwMTc5MjQ3NmZiYjIyNWU1ZDlkZWM4NjlmL3NlYzo5M2NhOWJiMDE3OTI0NzZmYmIyMjVlNWQ5ZGVjODY5Zl80Ni9mcmFnOjE0YjkzMDBhMzZkNDQ1OTdhZGI5NzM0MDBlZTk5ZjYwL3RleHRyZWdpb246MTRiOTMwMGEzNmQ0NDU5N2FkYjk3MzQwMGVlOTlmNjBfNTgwMg_19e1e73d-23ac-4319-bdc1-6d4823d8c3a1"
      unitRef="number">0.0010</us-gaap:DerivativeLiabilityMeasurementInput>
    <us-gaap:DerivativeLiabilityMeasurementInput
      contextRef="ic5fe8049d90f4163b34bb2524a897f2d_I20201231"
      decimals="4"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzY2E5YmIwMTc5MjQ3NmZiYjIyNWU1ZDlkZWM4NjlmL3NlYzo5M2NhOWJiMDE3OTI0NzZmYmIyMjVlNWQ5ZGVjODY5Zl80Ni9mcmFnOjE0YjkzMDBhMzZkNDQ1OTdhZGI5NzM0MDBlZTk5ZjYwL3RleHRyZWdpb246MTRiOTMwMGEzNmQ0NDU5N2FkYjk3MzQwMGVlOTlmNjBfNTgwOA_f2e82eef-0fc6-4ba4-b9b6-4c7ab96fef45"
      unitRef="number">0.0039</us-gaap:DerivativeLiabilityMeasurementInput>
    <cron:DerivativeLiabilityUsefulLifeTerm
      contextRef="i5f97c3a427254d74b99f26c83a33f800_D20210101-20210630"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzY2E5YmIwMTc5MjQ3NmZiYjIyNWU1ZDlkZWM4NjlmL3NlYzo5M2NhOWJiMDE3OTI0NzZmYmIyMjVlNWQ5ZGVjODY5Zl80Ni9mcmFnOjE0YjkzMDBhMzZkNDQ1OTdhZGI5NzM0MDBlZTk5ZjYwL3RleHRyZWdpb246MTRiOTMwMGEzNmQ0NDU5N2FkYjk3MzQwMGVlOTlmNjBfNjI3NA_7b48e660-1f3e-4fe1-9a3d-50cda25fb354">P0Y3M</cron:DerivativeLiabilityUsefulLifeTerm>
    <cron:DerivativeLiabilityUsefulLifeTerm
      contextRef="i404e95ab180846458cdfa503e1b9d618_D20210101-20210630"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzY2E5YmIwMTc5MjQ3NmZiYjIyNWU1ZDlkZWM4NjlmL3NlYzo5M2NhOWJiMDE3OTI0NzZmYmIyMjVlNWQ5ZGVjODY5Zl80Ni9mcmFnOjE0YjkzMDBhMzZkNDQ1OTdhZGI5NzM0MDBlZTk5ZjYwL3RleHRyZWdpb246MTRiOTMwMGEzNmQ0NDU5N2FkYjk3MzQwMGVlOTlmNjBfNjI4NQ_63d25a5d-8672-4194-9889-e9e737b551d4">P4Y3M</cron:DerivativeLiabilityUsefulLifeTerm>
    <cron:DerivativeLiabilityUsefulLifeTerm
      contextRef="i1a39a101965648319dfe223e050e1870_D20200101-20201231"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzY2E5YmIwMTc5MjQ3NmZiYjIyNWU1ZDlkZWM4NjlmL3NlYzo5M2NhOWJiMDE3OTI0NzZmYmIyMjVlNWQ5ZGVjODY5Zl80Ni9mcmFnOjE0YjkzMDBhMzZkNDQ1OTdhZGI5NzM0MDBlZTk5ZjYwL3RleHRyZWdpb246MTRiOTMwMGEzNmQ0NDU5N2FkYjk3MzQwMGVlOTlmNjBfNjI5OA_5c0493d3-8a4e-4820-b470-e4118d65aecf">P0Y6M</cron:DerivativeLiabilityUsefulLifeTerm>
    <cron:DerivativeLiabilityUsefulLifeTerm
      contextRef="id736a2abed614a71a7524cefc38e23df_D20200101-20201231"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzY2E5YmIwMTc5MjQ3NmZiYjIyNWU1ZDlkZWM4NjlmL3NlYzo5M2NhOWJiMDE3OTI0NzZmYmIyMjVlNWQ5ZGVjODY5Zl80Ni9mcmFnOjE0YjkzMDBhMzZkNDQ1OTdhZGI5NzM0MDBlZTk5ZjYwL3RleHRyZWdpb246MTRiOTMwMGEzNmQ0NDU5N2FkYjk3MzQwMGVlOTlmNjBfNjMwOQ_fe112d48-c93c-4451-b389-f89a34cce0c8">P5Y</cron:DerivativeLiabilityUsefulLifeTerm>
    <cron:SensitivityAnalysisImpactOnNetIncomeLossTableTextBlock
      contextRef="i69782326f71a44e3805518280ee22b6b_D20210101-20210630"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzY2E5YmIwMTc5MjQ3NmZiYjIyNWU1ZDlkZWM4NjlmL3NlYzo5M2NhOWJiMDE3OTI0NzZmYmIyMjVlNWQ5ZGVjODY5Zl80Ni9mcmFnOjE0YjkzMDBhMzZkNDQ1OTdhZGI5NzM0MDBlZTk5ZjYwL3RleHRyZWdpb246MTRiOTMwMGEzNmQ0NDU5N2FkYjk3MzQwMGVlOTlmNjBfNzQ2Ng_c46ce939-fadb-4ffb-a63e-a0b42748c039">&lt;div style="margin-bottom:6pt;margin-top:12pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following table quantifies each of the significant inputs described above and provides a sensitivity analysis of the impact on the reported values of the derivative liabilities. The sensitivity analysis for each significant input is performed by assuming a 10% decrease in the input while other significant inputs remain constant at management&#x2019;s best estimate as of the respective dates. While a decrease in the inputs noted below would cause a decrease in the carrying value of the derivative liability, there would also be an equal but opposite impact on net income (loss).&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:28.761%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.466%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.038%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.327%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.038%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.327%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.038%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.327%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.038%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.327%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.038%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.327%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.048%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Decrease as of June&#160;30, 2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Decrease as of December 31, 2020&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Altria Warrant&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Pre-emptive Rights&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Top-up Rights&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Altria Warrant&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Pre-emptive Rights&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Top-up Rights&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Share price&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;31,375&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,146&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,302&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;25,819&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,527&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,989&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Weighted average expected life&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;14,220&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5,266&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;502&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;13,541&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,988&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,121&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Expected annualized volatility&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;27,375&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,348&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;968&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;26,183&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,269&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,602&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</cron:SensitivityAnalysisImpactOnNetIncomeLossTableTextBlock>
    <cron:SensitivityAnalysisImpactOf10PercentDecreaseIncreaseInSharePriceOnNetIncomeLoss
      contextRef="i34995f47e8ba418fbd529b2ed52790dc_I20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzY2E5YmIwMTc5MjQ3NmZiYjIyNWU1ZDlkZWM4NjlmL3NlYzo5M2NhOWJiMDE3OTI0NzZmYmIyMjVlNWQ5ZGVjODY5Zl80Ni9mcmFnOjE0YjkzMDBhMzZkNDQ1OTdhZGI5NzM0MDBlZTk5ZjYwL3RhYmxlOjU4YjhkMGUzODQyMzRjMzVhNWZjN2EyODMxMWFiZGMwL3RhYmxlcmFuZ2U6NThiOGQwZTM4NDIzNGMzNWE1ZmM3YTI4MzExYWJkYzBfMi0yLTEtMS0w_5123154e-7f95-46f5-ab57-11f538fe8200"
      unitRef="usd">31375000</cron:SensitivityAnalysisImpactOf10PercentDecreaseIncreaseInSharePriceOnNetIncomeLoss>
    <cron:SensitivityAnalysisImpactOf10PercentDecreaseIncreaseInSharePriceOnNetIncomeLoss
      contextRef="ie4ec3b642b3b4457b78cb85e8d1838f0_I20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzY2E5YmIwMTc5MjQ3NmZiYjIyNWU1ZDlkZWM4NjlmL3NlYzo5M2NhOWJiMDE3OTI0NzZmYmIyMjVlNWQ5ZGVjODY5Zl80Ni9mcmFnOjE0YjkzMDBhMzZkNDQ1OTdhZGI5NzM0MDBlZTk5ZjYwL3RhYmxlOjU4YjhkMGUzODQyMzRjMzVhNWZjN2EyODMxMWFiZGMwL3RhYmxlcmFuZ2U6NThiOGQwZTM4NDIzNGMzNWE1ZmM3YTI4MzExYWJkYzBfMi00LTEtMS0w_4a7485a2-7d1c-4b2a-a77d-e29f858fb9a4"
      unitRef="usd">3146000</cron:SensitivityAnalysisImpactOf10PercentDecreaseIncreaseInSharePriceOnNetIncomeLoss>
    <cron:SensitivityAnalysisImpactOf10PercentDecreaseIncreaseInSharePriceOnNetIncomeLoss
      contextRef="ia2cd5cb93e97428dabd7e841eee51895_I20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzY2E5YmIwMTc5MjQ3NmZiYjIyNWU1ZDlkZWM4NjlmL3NlYzo5M2NhOWJiMDE3OTI0NzZmYmIyMjVlNWQ5ZGVjODY5Zl80Ni9mcmFnOjE0YjkzMDBhMzZkNDQ1OTdhZGI5NzM0MDBlZTk5ZjYwL3RhYmxlOjU4YjhkMGUzODQyMzRjMzVhNWZjN2EyODMxMWFiZGMwL3RhYmxlcmFuZ2U6NThiOGQwZTM4NDIzNGMzNWE1ZmM3YTI4MzExYWJkYzBfMi02LTEtMS0w_d4ad0e4c-b2d0-4568-86f7-51d2025ce760"
      unitRef="usd">1302000</cron:SensitivityAnalysisImpactOf10PercentDecreaseIncreaseInSharePriceOnNetIncomeLoss>
    <cron:SensitivityAnalysisImpactOf10PercentDecreaseIncreaseInSharePriceOnNetIncomeLoss
      contextRef="i386ef852060640f8a03a30f10d03a1cd_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzY2E5YmIwMTc5MjQ3NmZiYjIyNWU1ZDlkZWM4NjlmL3NlYzo5M2NhOWJiMDE3OTI0NzZmYmIyMjVlNWQ5ZGVjODY5Zl80Ni9mcmFnOjE0YjkzMDBhMzZkNDQ1OTdhZGI5NzM0MDBlZTk5ZjYwL3RhYmxlOjU4YjhkMGUzODQyMzRjMzVhNWZjN2EyODMxMWFiZGMwL3RhYmxlcmFuZ2U6NThiOGQwZTM4NDIzNGMzNWE1ZmM3YTI4MzExYWJkYzBfMi04LTEtMS0xMDIx_c4c03914-7c81-4852-8c60-f6fe9a4f2391"
      unitRef="usd">25819000</cron:SensitivityAnalysisImpactOf10PercentDecreaseIncreaseInSharePriceOnNetIncomeLoss>
    <cron:SensitivityAnalysisImpactOf10PercentDecreaseIncreaseInSharePriceOnNetIncomeLoss
      contextRef="i72ce1ade65834a50bf4468cde26bf617_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzY2E5YmIwMTc5MjQ3NmZiYjIyNWU1ZDlkZWM4NjlmL3NlYzo5M2NhOWJiMDE3OTI0NzZmYmIyMjVlNWQ5ZGVjODY5Zl80Ni9mcmFnOjE0YjkzMDBhMzZkNDQ1OTdhZGI5NzM0MDBlZTk5ZjYwL3RhYmxlOjU4YjhkMGUzODQyMzRjMzVhNWZjN2EyODMxMWFiZGMwL3RhYmxlcmFuZ2U6NThiOGQwZTM4NDIzNGMzNWE1ZmM3YTI4MzExYWJkYzBfMi0xMC0xLTEtMTAyNQ_24e0c336-1145-4fa7-bad5-af15b3ddc2c5"
      unitRef="usd">2527000</cron:SensitivityAnalysisImpactOf10PercentDecreaseIncreaseInSharePriceOnNetIncomeLoss>
    <cron:SensitivityAnalysisImpactOf10PercentDecreaseIncreaseInSharePriceOnNetIncomeLoss
      contextRef="if0aa3f5449da461c85f0c0831bf3c984_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzY2E5YmIwMTc5MjQ3NmZiYjIyNWU1ZDlkZWM4NjlmL3NlYzo5M2NhOWJiMDE3OTI0NzZmYmIyMjVlNWQ5ZGVjODY5Zl80Ni9mcmFnOjE0YjkzMDBhMzZkNDQ1OTdhZGI5NzM0MDBlZTk5ZjYwL3RhYmxlOjU4YjhkMGUzODQyMzRjMzVhNWZjN2EyODMxMWFiZGMwL3RhYmxlcmFuZ2U6NThiOGQwZTM4NDIzNGMzNWE1ZmM3YTI4MzExYWJkYzBfMi0xMi0xLTEtMTAyOQ_1a135dcf-b1e9-441e-a7b0-4cb653137c5a"
      unitRef="usd">2989000</cron:SensitivityAnalysisImpactOf10PercentDecreaseIncreaseInSharePriceOnNetIncomeLoss>
    <cron:SensitivityAnalysisImpactOf10PercentDecreaseIncreaseInWeightedAverageExpectedLifeOnNetIncomeLoss
      contextRef="i34995f47e8ba418fbd529b2ed52790dc_I20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzY2E5YmIwMTc5MjQ3NmZiYjIyNWU1ZDlkZWM4NjlmL3NlYzo5M2NhOWJiMDE3OTI0NzZmYmIyMjVlNWQ5ZGVjODY5Zl80Ni9mcmFnOjE0YjkzMDBhMzZkNDQ1OTdhZGI5NzM0MDBlZTk5ZjYwL3RhYmxlOjU4YjhkMGUzODQyMzRjMzVhNWZjN2EyODMxMWFiZGMwL3RhYmxlcmFuZ2U6NThiOGQwZTM4NDIzNGMzNWE1ZmM3YTI4MzExYWJkYzBfMy0yLTEtMS0w_2ae1d6db-391d-4cbe-bd8d-b3ef432a52ab"
      unitRef="usd">14220000</cron:SensitivityAnalysisImpactOf10PercentDecreaseIncreaseInWeightedAverageExpectedLifeOnNetIncomeLoss>
    <cron:SensitivityAnalysisImpactOf10PercentDecreaseIncreaseInWeightedAverageExpectedLifeOnNetIncomeLoss
      contextRef="ie4ec3b642b3b4457b78cb85e8d1838f0_I20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzY2E5YmIwMTc5MjQ3NmZiYjIyNWU1ZDlkZWM4NjlmL3NlYzo5M2NhOWJiMDE3OTI0NzZmYmIyMjVlNWQ5ZGVjODY5Zl80Ni9mcmFnOjE0YjkzMDBhMzZkNDQ1OTdhZGI5NzM0MDBlZTk5ZjYwL3RhYmxlOjU4YjhkMGUzODQyMzRjMzVhNWZjN2EyODMxMWFiZGMwL3RhYmxlcmFuZ2U6NThiOGQwZTM4NDIzNGMzNWE1ZmM3YTI4MzExYWJkYzBfMy00LTEtMS0w_5a4bef55-3cbb-43b8-9682-4e3776f9a4ec"
      unitRef="usd">5266000</cron:SensitivityAnalysisImpactOf10PercentDecreaseIncreaseInWeightedAverageExpectedLifeOnNetIncomeLoss>
    <cron:SensitivityAnalysisImpactOf10PercentDecreaseIncreaseInWeightedAverageExpectedLifeOnNetIncomeLoss
      contextRef="ia2cd5cb93e97428dabd7e841eee51895_I20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzY2E5YmIwMTc5MjQ3NmZiYjIyNWU1ZDlkZWM4NjlmL3NlYzo5M2NhOWJiMDE3OTI0NzZmYmIyMjVlNWQ5ZGVjODY5Zl80Ni9mcmFnOjE0YjkzMDBhMzZkNDQ1OTdhZGI5NzM0MDBlZTk5ZjYwL3RhYmxlOjU4YjhkMGUzODQyMzRjMzVhNWZjN2EyODMxMWFiZGMwL3RhYmxlcmFuZ2U6NThiOGQwZTM4NDIzNGMzNWE1ZmM3YTI4MzExYWJkYzBfMy02LTEtMS0w_5dbe3b2b-dd33-4210-9d99-6333e793fc89"
      unitRef="usd">502000</cron:SensitivityAnalysisImpactOf10PercentDecreaseIncreaseInWeightedAverageExpectedLifeOnNetIncomeLoss>
    <cron:SensitivityAnalysisImpactOf10PercentDecreaseIncreaseInWeightedAverageExpectedLifeOnNetIncomeLoss
      contextRef="i386ef852060640f8a03a30f10d03a1cd_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzY2E5YmIwMTc5MjQ3NmZiYjIyNWU1ZDlkZWM4NjlmL3NlYzo5M2NhOWJiMDE3OTI0NzZmYmIyMjVlNWQ5ZGVjODY5Zl80Ni9mcmFnOjE0YjkzMDBhMzZkNDQ1OTdhZGI5NzM0MDBlZTk5ZjYwL3RhYmxlOjU4YjhkMGUzODQyMzRjMzVhNWZjN2EyODMxMWFiZGMwL3RhYmxlcmFuZ2U6NThiOGQwZTM4NDIzNGMzNWE1ZmM3YTI4MzExYWJkYzBfMy04LTEtMS0xMDIx_b977409d-fff1-443b-ad1a-3fa079b699c2"
      unitRef="usd">13541000</cron:SensitivityAnalysisImpactOf10PercentDecreaseIncreaseInWeightedAverageExpectedLifeOnNetIncomeLoss>
    <cron:SensitivityAnalysisImpactOf10PercentDecreaseIncreaseInWeightedAverageExpectedLifeOnNetIncomeLoss
      contextRef="i72ce1ade65834a50bf4468cde26bf617_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzY2E5YmIwMTc5MjQ3NmZiYjIyNWU1ZDlkZWM4NjlmL3NlYzo5M2NhOWJiMDE3OTI0NzZmYmIyMjVlNWQ5ZGVjODY5Zl80Ni9mcmFnOjE0YjkzMDBhMzZkNDQ1OTdhZGI5NzM0MDBlZTk5ZjYwL3RhYmxlOjU4YjhkMGUzODQyMzRjMzVhNWZjN2EyODMxMWFiZGMwL3RhYmxlcmFuZ2U6NThiOGQwZTM4NDIzNGMzNWE1ZmM3YTI4MzExYWJkYzBfMy0xMC0xLTEtMTAyNQ_9756bf2e-97ad-4137-a7d8-ca0f0b57cf21"
      unitRef="usd">1988000</cron:SensitivityAnalysisImpactOf10PercentDecreaseIncreaseInWeightedAverageExpectedLifeOnNetIncomeLoss>
    <cron:SensitivityAnalysisImpactOf10PercentDecreaseIncreaseInWeightedAverageExpectedLifeOnNetIncomeLoss
      contextRef="if0aa3f5449da461c85f0c0831bf3c984_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzY2E5YmIwMTc5MjQ3NmZiYjIyNWU1ZDlkZWM4NjlmL3NlYzo5M2NhOWJiMDE3OTI0NzZmYmIyMjVlNWQ5ZGVjODY5Zl80Ni9mcmFnOjE0YjkzMDBhMzZkNDQ1OTdhZGI5NzM0MDBlZTk5ZjYwL3RhYmxlOjU4YjhkMGUzODQyMzRjMzVhNWZjN2EyODMxMWFiZGMwL3RhYmxlcmFuZ2U6NThiOGQwZTM4NDIzNGMzNWE1ZmM3YTI4MzExYWJkYzBfMy0xMi0xLTEtMTAyOQ_5a4a6583-b2b0-42a9-998e-b27ac2569131"
      unitRef="usd">2121000</cron:SensitivityAnalysisImpactOf10PercentDecreaseIncreaseInWeightedAverageExpectedLifeOnNetIncomeLoss>
    <cron:SensitivityAnalysisImpactOf10PercentDecreaseIncreaseInExpectedAnnualizedVolatilityOnNetIncomeLoss
      contextRef="i34995f47e8ba418fbd529b2ed52790dc_I20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzY2E5YmIwMTc5MjQ3NmZiYjIyNWU1ZDlkZWM4NjlmL3NlYzo5M2NhOWJiMDE3OTI0NzZmYmIyMjVlNWQ5ZGVjODY5Zl80Ni9mcmFnOjE0YjkzMDBhMzZkNDQ1OTdhZGI5NzM0MDBlZTk5ZjYwL3RhYmxlOjU4YjhkMGUzODQyMzRjMzVhNWZjN2EyODMxMWFiZGMwL3RhYmxlcmFuZ2U6NThiOGQwZTM4NDIzNGMzNWE1ZmM3YTI4MzExYWJkYzBfNC0yLTEtMS0w_e5c7c4c9-c0ec-48f6-86d2-f0db4fdc2696"
      unitRef="usd">27375000</cron:SensitivityAnalysisImpactOf10PercentDecreaseIncreaseInExpectedAnnualizedVolatilityOnNetIncomeLoss>
    <cron:SensitivityAnalysisImpactOf10PercentDecreaseIncreaseInExpectedAnnualizedVolatilityOnNetIncomeLoss
      contextRef="ie4ec3b642b3b4457b78cb85e8d1838f0_I20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzY2E5YmIwMTc5MjQ3NmZiYjIyNWU1ZDlkZWM4NjlmL3NlYzo5M2NhOWJiMDE3OTI0NzZmYmIyMjVlNWQ5ZGVjODY5Zl80Ni9mcmFnOjE0YjkzMDBhMzZkNDQ1OTdhZGI5NzM0MDBlZTk5ZjYwL3RhYmxlOjU4YjhkMGUzODQyMzRjMzVhNWZjN2EyODMxMWFiZGMwL3RhYmxlcmFuZ2U6NThiOGQwZTM4NDIzNGMzNWE1ZmM3YTI4MzExYWJkYzBfNC00LTEtMS0w_a2ac04f8-7b20-4281-8455-3a8eadb647d8"
      unitRef="usd">2348000</cron:SensitivityAnalysisImpactOf10PercentDecreaseIncreaseInExpectedAnnualizedVolatilityOnNetIncomeLoss>
    <cron:SensitivityAnalysisImpactOf10PercentDecreaseIncreaseInExpectedAnnualizedVolatilityOnNetIncomeLoss
      contextRef="ia2cd5cb93e97428dabd7e841eee51895_I20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzY2E5YmIwMTc5MjQ3NmZiYjIyNWU1ZDlkZWM4NjlmL3NlYzo5M2NhOWJiMDE3OTI0NzZmYmIyMjVlNWQ5ZGVjODY5Zl80Ni9mcmFnOjE0YjkzMDBhMzZkNDQ1OTdhZGI5NzM0MDBlZTk5ZjYwL3RhYmxlOjU4YjhkMGUzODQyMzRjMzVhNWZjN2EyODMxMWFiZGMwL3RhYmxlcmFuZ2U6NThiOGQwZTM4NDIzNGMzNWE1ZmM3YTI4MzExYWJkYzBfNC02LTEtMS0w_bd186cbf-8049-4564-8906-36f18d560681"
      unitRef="usd">968000</cron:SensitivityAnalysisImpactOf10PercentDecreaseIncreaseInExpectedAnnualizedVolatilityOnNetIncomeLoss>
    <cron:SensitivityAnalysisImpactOf10PercentDecreaseIncreaseInExpectedAnnualizedVolatilityOnNetIncomeLoss
      contextRef="i386ef852060640f8a03a30f10d03a1cd_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzY2E5YmIwMTc5MjQ3NmZiYjIyNWU1ZDlkZWM4NjlmL3NlYzo5M2NhOWJiMDE3OTI0NzZmYmIyMjVlNWQ5ZGVjODY5Zl80Ni9mcmFnOjE0YjkzMDBhMzZkNDQ1OTdhZGI5NzM0MDBlZTk5ZjYwL3RhYmxlOjU4YjhkMGUzODQyMzRjMzVhNWZjN2EyODMxMWFiZGMwL3RhYmxlcmFuZ2U6NThiOGQwZTM4NDIzNGMzNWE1ZmM3YTI4MzExYWJkYzBfNC04LTEtMS0xMDIx_73104c36-a6bd-490f-aba3-9ee2fba17d27"
      unitRef="usd">26183000</cron:SensitivityAnalysisImpactOf10PercentDecreaseIncreaseInExpectedAnnualizedVolatilityOnNetIncomeLoss>
    <cron:SensitivityAnalysisImpactOf10PercentDecreaseIncreaseInExpectedAnnualizedVolatilityOnNetIncomeLoss
      contextRef="i72ce1ade65834a50bf4468cde26bf617_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzY2E5YmIwMTc5MjQ3NmZiYjIyNWU1ZDlkZWM4NjlmL3NlYzo5M2NhOWJiMDE3OTI0NzZmYmIyMjVlNWQ5ZGVjODY5Zl80Ni9mcmFnOjE0YjkzMDBhMzZkNDQ1OTdhZGI5NzM0MDBlZTk5ZjYwL3RhYmxlOjU4YjhkMGUzODQyMzRjMzVhNWZjN2EyODMxMWFiZGMwL3RhYmxlcmFuZ2U6NThiOGQwZTM4NDIzNGMzNWE1ZmM3YTI4MzExYWJkYzBfNC0xMC0xLTEtMTAyNQ_06685eef-53d7-40c3-9a06-74a9f452b3ff"
      unitRef="usd">2269000</cron:SensitivityAnalysisImpactOf10PercentDecreaseIncreaseInExpectedAnnualizedVolatilityOnNetIncomeLoss>
    <cron:SensitivityAnalysisImpactOf10PercentDecreaseIncreaseInExpectedAnnualizedVolatilityOnNetIncomeLoss
      contextRef="if0aa3f5449da461c85f0c0831bf3c984_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzY2E5YmIwMTc5MjQ3NmZiYjIyNWU1ZDlkZWM4NjlmL3NlYzo5M2NhOWJiMDE3OTI0NzZmYmIyMjVlNWQ5ZGVjODY5Zl80Ni9mcmFnOjE0YjkzMDBhMzZkNDQ1OTdhZGI5NzM0MDBlZTk5ZjYwL3RhYmxlOjU4YjhkMGUzODQyMzRjMzVhNWZjN2EyODMxMWFiZGMwL3RhYmxlcmFuZ2U6NThiOGQwZTM4NDIzNGMzNWE1ZmM3YTI4MzExYWJkYzBfNC0xMi0xLTEtMTAyOQ_030ea8b6-ef15-44c4-b33d-75a5e7cac3f3"
      unitRef="usd">2602000</cron:SensitivityAnalysisImpactOf10PercentDecreaseIncreaseInExpectedAnnualizedVolatilityOnNetIncomeLoss>
    <us-gaap:DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock
      contextRef="i69782326f71a44e3805518280ee22b6b_D20210101-20210630"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzY2E5YmIwMTc5MjQ3NmZiYjIyNWU1ZDlkZWM4NjlmL3NlYzo5M2NhOWJiMDE3OTI0NzZmYmIyMjVlNWQ5ZGVjODY5Zl80OS9mcmFnOjdkOTcyM2RkMjdkODRhNWFiYjJiMzcyOTJmYjZhMmUzL3RleHRyZWdpb246N2Q5NzIzZGQyN2Q4NGE1YWJiMmIzNzI5MmZiNmEyZTNfMjg0Ng_e91c1337-5cd8-448d-baba-6ee45cbbc70c">Share-based Payments&lt;div style="margin-bottom:6pt;margin-top:6pt;padding-left:36pt;text-align:justify;text-indent:-36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;(a)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;padding-left:24.34pt"&gt;Share-based award plans&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company has granted stock options, restricted share units (&#x201c;RSUs&#x201d;) and deferred share units (&#x201c;DSUs&#x201d;) to employees and non-employee directors under the Stock Option Plan dated May 26, 2015 (the &#x201c;2015 Stock Option Plan&#x201d;), the 2018 Stock Option Plan dated June 28, 2018 (the &#x201c;2018 Stock Option Plan&#x201d; and, together with the 2015 Stock Option Plan, the &#x201c;Prior Option Plans&#x201d;), the 2020 Omnibus Equity Incentive Plan dated March 29, 2020 (the &#x201c;2020 Omnibus Plan&#x201d;) and the DSU plan dated August 10, 2019 (the &#x201c;DSU Plan&#x201d;). The Company can no longer make grants under the Prior Option Plans.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following table summarizes the total share-based payments associated with the Company&#x2019;s stock options and RSUs for the three and six months ended June 30, 2021 and 2020:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:40.427%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.788%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.772%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.788%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.772%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.788%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.772%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.793%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;For the three months ended June&#160;30,&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;For the six months ended June&#160;30,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Stock options&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,864&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,770&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,928&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,500&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;RSUs&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;701&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;776&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,136&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,482&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total share-based payments&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,565&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,546&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5,064&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4,982&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:12pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;(b)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;padding-left:23.78pt"&gt;Stock options&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Vesting conditions for grants of options are determined by the Compensation Committee of the Company&#x2019;s Board of Directors. The typical vesting for stock option grants made under the 2020 Omnibus Plan is annual vesting over &lt;span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOjkzY2E5YmIwMTc5MjQ3NmZiYjIyNWU1ZDlkZWM4NjlmL3NlYzo5M2NhOWJiMDE3OTI0NzZmYmIyMjVlNWQ5ZGVjODY5Zl80OS9mcmFnOjdkOTcyM2RkMjdkODRhNWFiYjJiMzcyOTJmYjZhMmUzL3RleHRyZWdpb246N2Q5NzIzZGQyN2Q4NGE1YWJiMmIzNzI5MmZiNmEyZTNfMTAxNA_bcd0b46d-5e0a-4add-a684-db7137029aee"&gt;three&lt;/span&gt; to five years with a maximum term of ten years. The typical vesting for stock option grants made under the Prior Option Plans is quarterly vesting over &lt;span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOjkzY2E5YmIwMTc5MjQ3NmZiYjIyNWU1ZDlkZWM4NjlmL3NlYzo5M2NhOWJiMDE3OTI0NzZmYmIyMjVlNWQ5ZGVjODY5Zl80OS9mcmFnOjdkOTcyM2RkMjdkODRhNWFiYjJiMzcyOTJmYjZhMmUzL3RleHRyZWdpb246N2Q5NzIzZGQyN2Q4NGE1YWJiMmIzNzI5MmZiNmEyZTNfMTE1NA_462d9472-3856-448b-97f2-4ab4e5aeb10e"&gt;three&lt;/span&gt; to five years with a maximum term of seven years. The Prior Option Plans did not, and the 2020 Omnibus Plan does not, authorize grants of options with an exercise price below fair market value.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following is a summary of the changes in stock options during the six months ended June&#160;30, 2021 and 2020:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:51.261%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.761%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.327%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.761%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.327%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.763%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Weighted average exercise price (C$)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:700;line-height:100%;position:relative;top:-2.8pt;vertical-align:baseline"&gt; (i)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Number of options&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Weighted average remaining contractual term (years)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Balance as of January 1, 2021&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5.40&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;13,755,148&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2.30&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Exercise of options&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2.14&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(5,349,818)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Cancellation, forfeiture and expiry of options&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;14.86&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(33,699)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Balance as of June&#160;30, 2021&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7.45&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;8,371,631&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2.66&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Exercisable as of June&#160;30, 2021&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6.49&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4,679,240&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1.43&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;padding-left:18pt;text-align:justify;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:400;line-height:120%;position:relative;top:-2.8pt;vertical-align:baseline"&gt;(i)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:13.1pt"&gt;The weighted average exercise price reflects the conversion of foreign currency-denominated stock options translated into C$ using the average foreign exchange rate as of the date of issuance. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:51.538%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.483%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.327%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.483%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.327%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:14.042%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Weighted average exercise price (C$)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Number of options&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Weighted average remaining contractual term (years)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Balance as of January 1, 2020&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4.84&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;14,149,502&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2.56&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Exercise of options&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2.05&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1,807,909)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Cancellation, forfeiture and expiry of options&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;15.78&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(127,045)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Balance as of June&#160;30, 2020&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5.13&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;12,214,548&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2.05&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Exercisable as of June&#160;30, 2020&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:3pt double #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3.42&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;8,688,645&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1.78&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;No stock options were granted during the six months ended June&#160;30, 2021 and 2020.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following table summarizes stock options outstanding for the 2020 Omnibus Plan, the 2018 Stock Option Plan, and the 2015 Stock Option Plan:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.861%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:52.168%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:21.431%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.468%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:21.433%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Stock options outstanding as of&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;June 30, 2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;December 31, 2020&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2020 Omnibus Plan&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,000,000&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,000,000&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2018 Stock Option Plan &lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,586,725&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,627,715&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2015 Stock Option Plan &lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4,784,906&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;10,127,433&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total stock options outstanding&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;8,371,631&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;13,755,148&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:12pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%"&gt;(c)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;padding-left:27.13pt"&gt;Restricted share units&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following is a summary of the changes in RSUs for the six months ended June&#160;30, 2021 and 2020: &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:61.538%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:16.816%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.327%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:16.819%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Number of RSUs&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:700;line-height:100%;position:relative;top:-2.8pt;vertical-align:baseline"&gt; (i)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Weighted average grant date fair value (C$)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:700;line-height:100%;position:relative;top:-2.8pt;vertical-align:baseline"&gt;(ii)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Balance as of January 1, 2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;948,357&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7.66&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:12pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Granted&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(i)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;515,433&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;11.29&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Vested and issued&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(89,912)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7.52&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Balance as of June&#160;30, 2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,373,878&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;9.03&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:61.538%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:16.816%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.327%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:16.819%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Number of RSUs&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:700;line-height:100%;position:relative;top:-2.8pt;vertical-align:baseline"&gt; (i)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Weighted average grant date fair value (C$)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:700;line-height:100%;position:relative;top:-2.8pt;vertical-align:baseline"&gt;(ii)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Balance as of January 1, 2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;732,972&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;15.34&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:12pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Granted&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(i)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;279,277&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7.52&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Balance as of June&#160;30, 2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,012,249&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;13.18&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt;padding-left:18pt;text-align:justify;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:400;line-height:120%;position:relative;top:-2.8pt;vertical-align:baseline"&gt;(i)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:13.1pt"&gt;RSUs granted in the period vest annually in equal installments over a three-year period following the grant date, subject to such holder&#x2019;s continued employment through each vesting date. The vesting of such RSUs is not subject to the achievement of any performance criteria.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt;padding-left:18pt;text-align:justify;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:400;line-height:120%;position:relative;top:-2.8pt;vertical-align:baseline"&gt;(ii)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:11.66pt"&gt;The weighted average grant date fair value reflects the conversion of foreign currency-denominated RSUs translated into C$ using the foreign exchange rate as of the date of issuance. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:12pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%"&gt;(d)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;padding-left:26.24pt"&gt;Deferred share units&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following is a summary of the changes in DSUs during the six months ended June&#160;30, 2021 and 2020:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:61.538%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:16.816%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.327%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:16.819%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Number of DSUs&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Financial liability &lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Balance as of January 1, 2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;83,293&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;577&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Loss on revaluation&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;141&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Balance as of June&#160;30, 2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;83,293&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;718&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:61.538%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:16.816%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.327%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:16.819%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Number of DSUs&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Financial liability &lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Balance as of January 1, 2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;33,397&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;255&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;DSU liabilities settled&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(8,484)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(46)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Gain on revaluation&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(56)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Balance as of June&#160;30, 2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;24,913&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;153&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;(e)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;padding-left:24.91pt"&gt;Warrants&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following is a summary of the changes in warrants during the six months ended June&#160;30, 2021 and 2020:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:49.316%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:23.205%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.772%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:23.207%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Weighted average exercise price (C$)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Number of warrants&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Balance as of January 1, 2021&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.25&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7,987,349&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Exercise of warrants&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.25&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(7,987,349)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Balance as of June&#160;30, 2021&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:49.316%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:23.205%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.772%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:23.207%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Weighted average exercise price (C$)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Number of warrants&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Balance as of January 1, 2020 and June 30, 2020&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.26&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;18,066,662&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;As of June 30, 2021, there are no warrants outstanding other than the Altria Warrant. See Note 5. Derivative Liabilities for further description on the Altria Warrant.&lt;/span&gt;&lt;/div&gt;</us-gaap:DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock>
    <us-gaap:ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock
      contextRef="i69782326f71a44e3805518280ee22b6b_D20210101-20210630"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzY2E5YmIwMTc5MjQ3NmZiYjIyNWU1ZDlkZWM4NjlmL3NlYzo5M2NhOWJiMDE3OTI0NzZmYmIyMjVlNWQ5ZGVjODY5Zl80OS9mcmFnOjdkOTcyM2RkMjdkODRhNWFiYjJiMzcyOTJmYjZhMmUzL3RleHRyZWdpb246N2Q5NzIzZGQyN2Q4NGE1YWJiMmIzNzI5MmZiNmEyZTNfMjg0Nw_ef2174e4-e275-407d-93c0-6a5cea9949f5">&lt;div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following table summarizes the total share-based payments associated with the Company&#x2019;s stock options and RSUs for the three and six months ended June 30, 2021 and 2020:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:40.427%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.788%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.772%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.788%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.772%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.788%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.772%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.793%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;For the three months ended June&#160;30,&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;For the six months ended June&#160;30,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Stock options&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,864&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,770&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,928&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,500&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;RSUs&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;701&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;776&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,136&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,482&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total share-based payments&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,565&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,546&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5,064&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4,982&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock>
    <us-gaap:AllocatedShareBasedCompensationExpense
      contextRef="i1e4726863b724a379f5bd7d27ab5b3cc_D20210401-20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzY2E5YmIwMTc5MjQ3NmZiYjIyNWU1ZDlkZWM4NjlmL3NlYzo5M2NhOWJiMDE3OTI0NzZmYmIyMjVlNWQ5ZGVjODY5Zl80OS9mcmFnOjdkOTcyM2RkMjdkODRhNWFiYjJiMzcyOTJmYjZhMmUzL3RhYmxlOjNhYjFkOTRlOWViOTRiMDJhNjYyYjJlZDA0NTY0MDBkL3RhYmxlcmFuZ2U6M2FiMWQ5NGU5ZWI5NGIwMmE2NjJiMmVkMDQ1NjQwMGRfMi0xLTEtMS0xNDM2Mg_f5e036b7-8e71-4583-8b6a-e18fbaf2e444"
      unitRef="usd">1864000</us-gaap:AllocatedShareBasedCompensationExpense>
    <us-gaap:AllocatedShareBasedCompensationExpense
      contextRef="ie0f42dd5b3d34fe38a076491f8d4a0a5_D20200401-20200630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzY2E5YmIwMTc5MjQ3NmZiYjIyNWU1ZDlkZWM4NjlmL3NlYzo5M2NhOWJiMDE3OTI0NzZmYmIyMjVlNWQ5ZGVjODY5Zl80OS9mcmFnOjdkOTcyM2RkMjdkODRhNWFiYjJiMzcyOTJmYjZhMmUzL3RhYmxlOjNhYjFkOTRlOWViOTRiMDJhNjYyYjJlZDA0NTY0MDBkL3RhYmxlcmFuZ2U6M2FiMWQ5NGU5ZWI5NGIwMmE2NjJiMmVkMDQ1NjQwMGRfMi0zLTEtMS0xNDM2Mg_ab36b14b-9e78-4e88-a4d6-3d86f6c5d447"
      unitRef="usd">1770000</us-gaap:AllocatedShareBasedCompensationExpense>
    <us-gaap:AllocatedShareBasedCompensationExpense
      contextRef="idaf424f34df645f9a313b3cbd11846bb_D20210101-20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzY2E5YmIwMTc5MjQ3NmZiYjIyNWU1ZDlkZWM4NjlmL3NlYzo5M2NhOWJiMDE3OTI0NzZmYmIyMjVlNWQ5ZGVjODY5Zl80OS9mcmFnOjdkOTcyM2RkMjdkODRhNWFiYjJiMzcyOTJmYjZhMmUzL3RhYmxlOjNhYjFkOTRlOWViOTRiMDJhNjYyYjJlZDA0NTY0MDBkL3RhYmxlcmFuZ2U6M2FiMWQ5NGU5ZWI5NGIwMmE2NjJiMmVkMDQ1NjQwMGRfMi0yLTEtMS0w_0b61be96-45ec-4a04-8481-9ab2bd97e1d5"
      unitRef="usd">3928000</us-gaap:AllocatedShareBasedCompensationExpense>
    <us-gaap:AllocatedShareBasedCompensationExpense
      contextRef="ib8a293d71fca4827bbf9cac05f24fe68_D20200101-20200630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzY2E5YmIwMTc5MjQ3NmZiYjIyNWU1ZDlkZWM4NjlmL3NlYzo5M2NhOWJiMDE3OTI0NzZmYmIyMjVlNWQ5ZGVjODY5Zl80OS9mcmFnOjdkOTcyM2RkMjdkODRhNWFiYjJiMzcyOTJmYjZhMmUzL3RhYmxlOjNhYjFkOTRlOWViOTRiMDJhNjYyYjJlZDA0NTY0MDBkL3RhYmxlcmFuZ2U6M2FiMWQ5NGU5ZWI5NGIwMmE2NjJiMmVkMDQ1NjQwMGRfMi00LTEtMS0w_29a73df4-c130-49cd-bacb-04f802e42011"
      unitRef="usd">3500000</us-gaap:AllocatedShareBasedCompensationExpense>
    <us-gaap:AllocatedShareBasedCompensationExpense
      contextRef="ia9e804ad8293416391f6038663c9425b_D20210401-20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzY2E5YmIwMTc5MjQ3NmZiYjIyNWU1ZDlkZWM4NjlmL3NlYzo5M2NhOWJiMDE3OTI0NzZmYmIyMjVlNWQ5ZGVjODY5Zl80OS9mcmFnOjdkOTcyM2RkMjdkODRhNWFiYjJiMzcyOTJmYjZhMmUzL3RhYmxlOjNhYjFkOTRlOWViOTRiMDJhNjYyYjJlZDA0NTY0MDBkL3RhYmxlcmFuZ2U6M2FiMWQ5NGU5ZWI5NGIwMmE2NjJiMmVkMDQ1NjQwMGRfMy0xLTEtMS0xNDM2Mg_05a54901-0906-45e6-812c-782056c62ead"
      unitRef="usd">701000</us-gaap:AllocatedShareBasedCompensationExpense>
    <us-gaap:AllocatedShareBasedCompensationExpense
      contextRef="if0a238351a57425a8c0ba03f482ef4b9_D20200401-20200630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzY2E5YmIwMTc5MjQ3NmZiYjIyNWU1ZDlkZWM4NjlmL3NlYzo5M2NhOWJiMDE3OTI0NzZmYmIyMjVlNWQ5ZGVjODY5Zl80OS9mcmFnOjdkOTcyM2RkMjdkODRhNWFiYjJiMzcyOTJmYjZhMmUzL3RhYmxlOjNhYjFkOTRlOWViOTRiMDJhNjYyYjJlZDA0NTY0MDBkL3RhYmxlcmFuZ2U6M2FiMWQ5NGU5ZWI5NGIwMmE2NjJiMmVkMDQ1NjQwMGRfMy0zLTEtMS0xNDM2Mg_0b56367b-4e96-47d5-bb38-9fd8c653a521"
      unitRef="usd">776000</us-gaap:AllocatedShareBasedCompensationExpense>
    <us-gaap:AllocatedShareBasedCompensationExpense
      contextRef="ie5eb2f0b8440403abdac2db9e01adbb9_D20210101-20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzY2E5YmIwMTc5MjQ3NmZiYjIyNWU1ZDlkZWM4NjlmL3NlYzo5M2NhOWJiMDE3OTI0NzZmYmIyMjVlNWQ5ZGVjODY5Zl80OS9mcmFnOjdkOTcyM2RkMjdkODRhNWFiYjJiMzcyOTJmYjZhMmUzL3RhYmxlOjNhYjFkOTRlOWViOTRiMDJhNjYyYjJlZDA0NTY0MDBkL3RhYmxlcmFuZ2U6M2FiMWQ5NGU5ZWI5NGIwMmE2NjJiMmVkMDQ1NjQwMGRfMy0yLTEtMS0w_50766b7f-58e9-4bec-a4ca-0a27bbb8f1ae"
      unitRef="usd">1136000</us-gaap:AllocatedShareBasedCompensationExpense>
    <us-gaap:AllocatedShareBasedCompensationExpense
      contextRef="i10cd1c126464402b99bfac52e7ebdbb2_D20200101-20200630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzY2E5YmIwMTc5MjQ3NmZiYjIyNWU1ZDlkZWM4NjlmL3NlYzo5M2NhOWJiMDE3OTI0NzZmYmIyMjVlNWQ5ZGVjODY5Zl80OS9mcmFnOjdkOTcyM2RkMjdkODRhNWFiYjJiMzcyOTJmYjZhMmUzL3RhYmxlOjNhYjFkOTRlOWViOTRiMDJhNjYyYjJlZDA0NTY0MDBkL3RhYmxlcmFuZ2U6M2FiMWQ5NGU5ZWI5NGIwMmE2NjJiMmVkMDQ1NjQwMGRfMy00LTEtMS0w_d01f762b-15c6-44f8-ad1d-09147c5b40a2"
      unitRef="usd">1482000</us-gaap:AllocatedShareBasedCompensationExpense>
    <us-gaap:AllocatedShareBasedCompensationExpense
      contextRef="i27f4e53b91ad4367b7f8d273eff27769_D20210401-20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzY2E5YmIwMTc5MjQ3NmZiYjIyNWU1ZDlkZWM4NjlmL3NlYzo5M2NhOWJiMDE3OTI0NzZmYmIyMjVlNWQ5ZGVjODY5Zl80OS9mcmFnOjdkOTcyM2RkMjdkODRhNWFiYjJiMzcyOTJmYjZhMmUzL3RhYmxlOjNhYjFkOTRlOWViOTRiMDJhNjYyYjJlZDA0NTY0MDBkL3RhYmxlcmFuZ2U6M2FiMWQ5NGU5ZWI5NGIwMmE2NjJiMmVkMDQ1NjQwMGRfNC0xLTEtMS0xNDM2Mg_8ada6da0-0a22-4444-a222-17de39fc48a8"
      unitRef="usd">2565000</us-gaap:AllocatedShareBasedCompensationExpense>
    <us-gaap:AllocatedShareBasedCompensationExpense
      contextRef="i39065c5daf934af885335c12f3cfa83f_D20200401-20200630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzY2E5YmIwMTc5MjQ3NmZiYjIyNWU1ZDlkZWM4NjlmL3NlYzo5M2NhOWJiMDE3OTI0NzZmYmIyMjVlNWQ5ZGVjODY5Zl80OS9mcmFnOjdkOTcyM2RkMjdkODRhNWFiYjJiMzcyOTJmYjZhMmUzL3RhYmxlOjNhYjFkOTRlOWViOTRiMDJhNjYyYjJlZDA0NTY0MDBkL3RhYmxlcmFuZ2U6M2FiMWQ5NGU5ZWI5NGIwMmE2NjJiMmVkMDQ1NjQwMGRfNC0zLTEtMS0xNDM2Mg_5da5659d-dc2b-435d-bce1-10dfbf8942fb"
      unitRef="usd">2546000</us-gaap:AllocatedShareBasedCompensationExpense>
    <us-gaap:AllocatedShareBasedCompensationExpense
      contextRef="i69782326f71a44e3805518280ee22b6b_D20210101-20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzY2E5YmIwMTc5MjQ3NmZiYjIyNWU1ZDlkZWM4NjlmL3NlYzo5M2NhOWJiMDE3OTI0NzZmYmIyMjVlNWQ5ZGVjODY5Zl80OS9mcmFnOjdkOTcyM2RkMjdkODRhNWFiYjJiMzcyOTJmYjZhMmUzL3RhYmxlOjNhYjFkOTRlOWViOTRiMDJhNjYyYjJlZDA0NTY0MDBkL3RhYmxlcmFuZ2U6M2FiMWQ5NGU5ZWI5NGIwMmE2NjJiMmVkMDQ1NjQwMGRfNC0yLTEtMS0w_a4234147-60c5-4f1c-8cdf-2d0b6e51a319"
      unitRef="usd">5064000</us-gaap:AllocatedShareBasedCompensationExpense>
    <us-gaap:AllocatedShareBasedCompensationExpense
      contextRef="i4a110e4972ef4113880ce582e3cda5c5_D20200101-20200630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzY2E5YmIwMTc5MjQ3NmZiYjIyNWU1ZDlkZWM4NjlmL3NlYzo5M2NhOWJiMDE3OTI0NzZmYmIyMjVlNWQ5ZGVjODY5Zl80OS9mcmFnOjdkOTcyM2RkMjdkODRhNWFiYjJiMzcyOTJmYjZhMmUzL3RhYmxlOjNhYjFkOTRlOWViOTRiMDJhNjYyYjJlZDA0NTY0MDBkL3RhYmxlcmFuZ2U6M2FiMWQ5NGU5ZWI5NGIwMmE2NjJiMmVkMDQ1NjQwMGRfNC00LTEtMS0w_9ab62728-59d0-4f51-ba53-317fccd61468"
      unitRef="usd">4982000</us-gaap:AllocatedShareBasedCompensationExpense>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1
      contextRef="ic0313757b4a149aca72f641901924190_D20200329-20200329"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzY2E5YmIwMTc5MjQ3NmZiYjIyNWU1ZDlkZWM4NjlmL3NlYzo5M2NhOWJiMDE3OTI0NzZmYmIyMjVlNWQ5ZGVjODY5Zl80OS9mcmFnOjdkOTcyM2RkMjdkODRhNWFiYjJiMzcyOTJmYjZhMmUzL3RleHRyZWdpb246N2Q5NzIzZGQyN2Q4NGE1YWJiMmIzNzI5MmZiNmEyZTNfMTAyMA_9fd472b2-0b73-43fd-b64a-3040747336d6">P5Y</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod
      contextRef="i568a7b89865a4c0783608a8f7c7a5fbc_D20200329-20200329"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzY2E5YmIwMTc5MjQ3NmZiYjIyNWU1ZDlkZWM4NjlmL3NlYzo5M2NhOWJiMDE3OTI0NzZmYmIyMjVlNWQ5ZGVjODY5Zl80OS9mcmFnOjdkOTcyM2RkMjdkODRhNWFiYjJiMzcyOTJmYjZhMmUzL3RleHRyZWdpb246N2Q5NzIzZGQyN2Q4NGE1YWJiMmIzNzI5MmZiNmEyZTNfMTA0Ng_1e6d2e01-f0e4-44e8-839d-6889a52e44e7">P10Y</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1
      contextRef="i689be39a953e4627b86c363090d56882_D20200329-20200329"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzY2E5YmIwMTc5MjQ3NmZiYjIyNWU1ZDlkZWM4NjlmL3NlYzo5M2NhOWJiMDE3OTI0NzZmYmIyMjVlNWQ5ZGVjODY5Zl80OS9mcmFnOjdkOTcyM2RkMjdkODRhNWFiYjJiMzcyOTJmYjZhMmUzL3RleHRyZWdpb246N2Q5NzIzZGQyN2Q4NGE1YWJiMmIzNzI5MmZiNmEyZTNfMTE2MA_52bb3a29-d2c9-4c32-89ee-157091af1a23">P5Y</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod
      contextRef="i4146f88cdb16474694c2187038fecec2_D20200329-20200329"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzY2E5YmIwMTc5MjQ3NmZiYjIyNWU1ZDlkZWM4NjlmL3NlYzo5M2NhOWJiMDE3OTI0NzZmYmIyMjVlNWQ5ZGVjODY5Zl80OS9mcmFnOjdkOTcyM2RkMjdkODRhNWFiYjJiMzcyOTJmYjZhMmUzL3RleHRyZWdpb246N2Q5NzIzZGQyN2Q4NGE1YWJiMmIzNzI5MmZiNmEyZTNfMTE4Ng_84526134-c85d-42c1-9304-57a0b82583bb">P7Y</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod>
    <us-gaap:ScheduleOfStockOptionsRollForwardTableTextBlock
      contextRef="i69782326f71a44e3805518280ee22b6b_D20210101-20210630"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzY2E5YmIwMTc5MjQ3NmZiYjIyNWU1ZDlkZWM4NjlmL3NlYzo5M2NhOWJiMDE3OTI0NzZmYmIyMjVlNWQ5ZGVjODY5Zl80OS9mcmFnOjdkOTcyM2RkMjdkODRhNWFiYjJiMzcyOTJmYjZhMmUzL3RleHRyZWdpb246N2Q5NzIzZGQyN2Q4NGE1YWJiMmIzNzI5MmZiNmEyZTNfMjg0MA_1356cb73-8cd8-4e5d-8a1b-f81044080ffb">&lt;div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following is a summary of the changes in stock options during the six months ended June&#160;30, 2021 and 2020:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:51.261%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.761%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.327%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.761%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.327%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.763%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Weighted average exercise price (C$)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:700;line-height:100%;position:relative;top:-2.8pt;vertical-align:baseline"&gt; (i)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Number of options&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Weighted average remaining contractual term (years)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Balance as of January 1, 2021&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5.40&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;13,755,148&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2.30&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Exercise of options&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2.14&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(5,349,818)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Cancellation, forfeiture and expiry of options&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;14.86&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(33,699)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Balance as of June&#160;30, 2021&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7.45&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;8,371,631&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2.66&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Exercisable as of June&#160;30, 2021&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6.49&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4,679,240&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1.43&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;padding-left:18pt;text-align:justify;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:400;line-height:120%;position:relative;top:-2.8pt;vertical-align:baseline"&gt;(i)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:13.1pt"&gt;The weighted average exercise price reflects the conversion of foreign currency-denominated stock options translated into C$ using the average foreign exchange rate as of the date of issuance. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:51.538%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.483%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.327%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.483%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.327%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:14.042%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Weighted average exercise price (C$)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Number of options&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Weighted average remaining contractual term (years)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Balance as of January 1, 2020&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4.84&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;14,149,502&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2.56&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Exercise of options&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2.05&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1,807,909)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Cancellation, forfeiture and expiry of options&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;15.78&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(127,045)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Balance as of June&#160;30, 2020&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5.13&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;12,214,548&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2.05&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Exercisable as of June&#160;30, 2020&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:3pt double #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3.42&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;8,688,645&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1.78&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following table summarizes stock options outstanding for the 2020 Omnibus Plan, the 2018 Stock Option Plan, and the 2015 Stock Option Plan:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.861%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:52.168%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:21.431%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.468%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:21.433%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Stock options outstanding as of&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;June 30, 2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;December 31, 2020&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2020 Omnibus Plan&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,000,000&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,000,000&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2018 Stock Option Plan &lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,586,725&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,627,715&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2015 Stock Option Plan &lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4,784,906&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;10,127,433&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total stock options outstanding&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;8,371,631&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;13,755,148&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:ScheduleOfStockOptionsRollForwardTableTextBlock>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
      contextRef="ifbe16ec51ea244519b77d6036b4ef038_I20201231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzY2E5YmIwMTc5MjQ3NmZiYjIyNWU1ZDlkZWM4NjlmL3NlYzo5M2NhOWJiMDE3OTI0NzZmYmIyMjVlNWQ5ZGVjODY5Zl80OS9mcmFnOjdkOTcyM2RkMjdkODRhNWFiYjJiMzcyOTJmYjZhMmUzL3RhYmxlOmQ5YzFjYTA3OWJlYzQxMWE4MjBhMjdjODg1MGI0NDUzL3RhYmxlcmFuZ2U6ZDljMWNhMDc5YmVjNDExYTgyMGEyN2M4ODUwYjQ0NTNfMS0xLTEtMS0w_07aff689-1599-4233-89f2-1eb206816744"
      unitRef="cadPerShare">5.40</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
      contextRef="ifbe16ec51ea244519b77d6036b4ef038_I20201231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzY2E5YmIwMTc5MjQ3NmZiYjIyNWU1ZDlkZWM4NjlmL3NlYzo5M2NhOWJiMDE3OTI0NzZmYmIyMjVlNWQ5ZGVjODY5Zl80OS9mcmFnOjdkOTcyM2RkMjdkODRhNWFiYjJiMzcyOTJmYjZhMmUzL3RhYmxlOmQ5YzFjYTA3OWJlYzQxMWE4MjBhMjdjODg1MGI0NDUzL3RhYmxlcmFuZ2U6ZDljMWNhMDc5YmVjNDExYTgyMGEyN2M4ODUwYjQ0NTNfMS0zLTEtMS0w_6bab0956-0eb1-449c-b4c2-4e508f90c77b"
      unitRef="shares">13755148</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2
      contextRef="i539631cd7950486e81b39a054a00c7d0_D20200101-20201231"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzY2E5YmIwMTc5MjQ3NmZiYjIyNWU1ZDlkZWM4NjlmL3NlYzo5M2NhOWJiMDE3OTI0NzZmYmIyMjVlNWQ5ZGVjODY5Zl80OS9mcmFnOjdkOTcyM2RkMjdkODRhNWFiYjJiMzcyOTJmYjZhMmUzL3RhYmxlOmQ5YzFjYTA3OWJlYzQxMWE4MjBhMjdjODg1MGI0NDUzL3RhYmxlcmFuZ2U6ZDljMWNhMDc5YmVjNDExYTgyMGEyN2M4ODUwYjQ0NTNfMS01LTEtMS0w_45e59289-00f6-4194-9fcc-ad14d44dbcb8">P2Y3M18D</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2>
    <us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice
      contextRef="i69782326f71a44e3805518280ee22b6b_D20210101-20210630"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzY2E5YmIwMTc5MjQ3NmZiYjIyNWU1ZDlkZWM4NjlmL3NlYzo5M2NhOWJiMDE3OTI0NzZmYmIyMjVlNWQ5ZGVjODY5Zl80OS9mcmFnOjdkOTcyM2RkMjdkODRhNWFiYjJiMzcyOTJmYjZhMmUzL3RhYmxlOmQ5YzFjYTA3OWJlYzQxMWE4MjBhMjdjODg1MGI0NDUzL3RhYmxlcmFuZ2U6ZDljMWNhMDc5YmVjNDExYTgyMGEyN2M4ODUwYjQ0NTNfMy0xLTEtMS0w_5a561712-e136-454e-814e-e6ea8b1962eb"
      unitRef="cadPerShare">2.14</us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice>
    <us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised
      contextRef="i69782326f71a44e3805518280ee22b6b_D20210101-20210630"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzY2E5YmIwMTc5MjQ3NmZiYjIyNWU1ZDlkZWM4NjlmL3NlYzo5M2NhOWJiMDE3OTI0NzZmYmIyMjVlNWQ5ZGVjODY5Zl80OS9mcmFnOjdkOTcyM2RkMjdkODRhNWFiYjJiMzcyOTJmYjZhMmUzL3RhYmxlOmQ5YzFjYTA3OWJlYzQxMWE4MjBhMjdjODg1MGI0NDUzL3RhYmxlcmFuZ2U6ZDljMWNhMDc5YmVjNDExYTgyMGEyN2M4ODUwYjQ0NTNfMy0zLTEtMS0w_ebb9e5bf-46a6-4312-8952-81230dc8c36f"
      unitRef="shares">5349818</us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice
      contextRef="i69782326f71a44e3805518280ee22b6b_D20210101-20210630"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzY2E5YmIwMTc5MjQ3NmZiYjIyNWU1ZDlkZWM4NjlmL3NlYzo5M2NhOWJiMDE3OTI0NzZmYmIyMjVlNWQ5ZGVjODY5Zl80OS9mcmFnOjdkOTcyM2RkMjdkODRhNWFiYjJiMzcyOTJmYjZhMmUzL3RhYmxlOmQ5YzFjYTA3OWJlYzQxMWE4MjBhMjdjODg1MGI0NDUzL3RhYmxlcmFuZ2U6ZDljMWNhMDc5YmVjNDExYTgyMGEyN2M4ODUwYjQ0NTNfNC0xLTEtMS0w_b8f39da8-5774-486c-bc6c-24e5453c936f"
      unitRef="cadPerShare">14.86</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod
      contextRef="i69782326f71a44e3805518280ee22b6b_D20210101-20210630"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzY2E5YmIwMTc5MjQ3NmZiYjIyNWU1ZDlkZWM4NjlmL3NlYzo5M2NhOWJiMDE3OTI0NzZmYmIyMjVlNWQ5ZGVjODY5Zl80OS9mcmFnOjdkOTcyM2RkMjdkODRhNWFiYjJiMzcyOTJmYjZhMmUzL3RhYmxlOmQ5YzFjYTA3OWJlYzQxMWE4MjBhMjdjODg1MGI0NDUzL3RhYmxlcmFuZ2U6ZDljMWNhMDc5YmVjNDExYTgyMGEyN2M4ODUwYjQ0NTNfNC0zLTEtMS0w_0c0d2b75-1331-429e-b705-d652f274473e"
      unitRef="shares">33699</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
      contextRef="i225f85e38faa4bbdb4de1d8b9cf369bb_I20210630"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzY2E5YmIwMTc5MjQ3NmZiYjIyNWU1ZDlkZWM4NjlmL3NlYzo5M2NhOWJiMDE3OTI0NzZmYmIyMjVlNWQ5ZGVjODY5Zl80OS9mcmFnOjdkOTcyM2RkMjdkODRhNWFiYjJiMzcyOTJmYjZhMmUzL3RhYmxlOmQ5YzFjYTA3OWJlYzQxMWE4MjBhMjdjODg1MGI0NDUzL3RhYmxlcmFuZ2U6ZDljMWNhMDc5YmVjNDExYTgyMGEyN2M4ODUwYjQ0NTNfNS0xLTEtMS0w_dc0bca1a-88e9-480e-9c50-e31912492255"
      unitRef="cadPerShare">7.45</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
      contextRef="i225f85e38faa4bbdb4de1d8b9cf369bb_I20210630"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzY2E5YmIwMTc5MjQ3NmZiYjIyNWU1ZDlkZWM4NjlmL3NlYzo5M2NhOWJiMDE3OTI0NzZmYmIyMjVlNWQ5ZGVjODY5Zl80OS9mcmFnOjdkOTcyM2RkMjdkODRhNWFiYjJiMzcyOTJmYjZhMmUzL3RhYmxlOmQ5YzFjYTA3OWJlYzQxMWE4MjBhMjdjODg1MGI0NDUzL3RhYmxlcmFuZ2U6ZDljMWNhMDc5YmVjNDExYTgyMGEyN2M4ODUwYjQ0NTNfNS0zLTEtMS0w_b0c3501d-805d-4e8c-80ce-2f020a97c01e"
      unitRef="shares">8371631</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2
      contextRef="i69782326f71a44e3805518280ee22b6b_D20210101-20210630"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzY2E5YmIwMTc5MjQ3NmZiYjIyNWU1ZDlkZWM4NjlmL3NlYzo5M2NhOWJiMDE3OTI0NzZmYmIyMjVlNWQ5ZGVjODY5Zl80OS9mcmFnOjdkOTcyM2RkMjdkODRhNWFiYjJiMzcyOTJmYjZhMmUzL3RhYmxlOmQ5YzFjYTA3OWJlYzQxMWE4MjBhMjdjODg1MGI0NDUzL3RhYmxlcmFuZ2U6ZDljMWNhMDc5YmVjNDExYTgyMGEyN2M4ODUwYjQ0NTNfNS01LTEtMS0w_5d120e9c-8493-49f4-851b-747ad49ddb65">P2Y7M28D</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice
      contextRef="i225f85e38faa4bbdb4de1d8b9cf369bb_I20210630"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzY2E5YmIwMTc5MjQ3NmZiYjIyNWU1ZDlkZWM4NjlmL3NlYzo5M2NhOWJiMDE3OTI0NzZmYmIyMjVlNWQ5ZGVjODY5Zl80OS9mcmFnOjdkOTcyM2RkMjdkODRhNWFiYjJiMzcyOTJmYjZhMmUzL3RhYmxlOmQ5YzFjYTA3OWJlYzQxMWE4MjBhMjdjODg1MGI0NDUzL3RhYmxlcmFuZ2U6ZDljMWNhMDc5YmVjNDExYTgyMGEyN2M4ODUwYjQ0NTNfNi0xLTEtMS0w_ce965b30-36d8-4127-a2e7-c3df228577dc"
      unitRef="usdPerShare">6.49</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber
      contextRef="i225f85e38faa4bbdb4de1d8b9cf369bb_I20210630"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzY2E5YmIwMTc5MjQ3NmZiYjIyNWU1ZDlkZWM4NjlmL3NlYzo5M2NhOWJiMDE3OTI0NzZmYmIyMjVlNWQ5ZGVjODY5Zl80OS9mcmFnOjdkOTcyM2RkMjdkODRhNWFiYjJiMzcyOTJmYjZhMmUzL3RhYmxlOmQ5YzFjYTA3OWJlYzQxMWE4MjBhMjdjODg1MGI0NDUzL3RhYmxlcmFuZ2U6ZDljMWNhMDc5YmVjNDExYTgyMGEyN2M4ODUwYjQ0NTNfNi0zLTEtMS0w_25589765-0714-4b37-894a-6fcc3ed2f8e8"
      unitRef="shares">4679240</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageRemainingContractualTerm1
      contextRef="i69782326f71a44e3805518280ee22b6b_D20210101-20210630"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzY2E5YmIwMTc5MjQ3NmZiYjIyNWU1ZDlkZWM4NjlmL3NlYzo5M2NhOWJiMDE3OTI0NzZmYmIyMjVlNWQ5ZGVjODY5Zl80OS9mcmFnOjdkOTcyM2RkMjdkODRhNWFiYjJiMzcyOTJmYjZhMmUzL3RhYmxlOmQ5YzFjYTA3OWJlYzQxMWE4MjBhMjdjODg1MGI0NDUzL3RhYmxlcmFuZ2U6ZDljMWNhMDc5YmVjNDExYTgyMGEyN2M4ODUwYjQ0NTNfNi01LTEtMS0w_4e5cda04-bc6d-4ab4-a81c-209b25e5ada7">P1Y5M4D</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageRemainingContractualTerm1>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
      contextRef="ie4fc90ad6d7f4d39aea9cb65c8026e09_I20191231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzY2E5YmIwMTc5MjQ3NmZiYjIyNWU1ZDlkZWM4NjlmL3NlYzo5M2NhOWJiMDE3OTI0NzZmYmIyMjVlNWQ5ZGVjODY5Zl80OS9mcmFnOjdkOTcyM2RkMjdkODRhNWFiYjJiMzcyOTJmYjZhMmUzL3RhYmxlOjIwZTFlMjU5ZDFlOTQwMGI5ZjY5MTE2NTY1OWMzZDFmL3RhYmxlcmFuZ2U6MjBlMWUyNTlkMWU5NDAwYjlmNjkxMTY1NjU5YzNkMWZfMS0xLTEtMS0w_499e0fea-a085-4d4c-90b1-6213b6198b0f"
      unitRef="cadPerShare">4.84</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
      contextRef="ie4fc90ad6d7f4d39aea9cb65c8026e09_I20191231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzY2E5YmIwMTc5MjQ3NmZiYjIyNWU1ZDlkZWM4NjlmL3NlYzo5M2NhOWJiMDE3OTI0NzZmYmIyMjVlNWQ5ZGVjODY5Zl80OS9mcmFnOjdkOTcyM2RkMjdkODRhNWFiYjJiMzcyOTJmYjZhMmUzL3RhYmxlOjIwZTFlMjU5ZDFlOTQwMGI5ZjY5MTE2NTY1OWMzZDFmL3RhYmxlcmFuZ2U6MjBlMWUyNTlkMWU5NDAwYjlmNjkxMTY1NjU5YzNkMWZfMS0zLTEtMS0w_57e17fbe-b0cf-4003-81ca-8c32d8728305"
      unitRef="shares">14149502</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2
      contextRef="ic1ac4ebbf39f4d85959a2de4a782f891_D20190101-20191231"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzY2E5YmIwMTc5MjQ3NmZiYjIyNWU1ZDlkZWM4NjlmL3NlYzo5M2NhOWJiMDE3OTI0NzZmYmIyMjVlNWQ5ZGVjODY5Zl80OS9mcmFnOjdkOTcyM2RkMjdkODRhNWFiYjJiMzcyOTJmYjZhMmUzL3RhYmxlOjIwZTFlMjU5ZDFlOTQwMGI5ZjY5MTE2NTY1OWMzZDFmL3RhYmxlcmFuZ2U6MjBlMWUyNTlkMWU5NDAwYjlmNjkxMTY1NjU5YzNkMWZfMS01LTEtMS0w_e6da048f-5fc0-41a0-93be-182b6d605404">P2Y6M21D</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2>
    <us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice
      contextRef="i4a110e4972ef4113880ce582e3cda5c5_D20200101-20200630"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzY2E5YmIwMTc5MjQ3NmZiYjIyNWU1ZDlkZWM4NjlmL3NlYzo5M2NhOWJiMDE3OTI0NzZmYmIyMjVlNWQ5ZGVjODY5Zl80OS9mcmFnOjdkOTcyM2RkMjdkODRhNWFiYjJiMzcyOTJmYjZhMmUzL3RhYmxlOjIwZTFlMjU5ZDFlOTQwMGI5ZjY5MTE2NTY1OWMzZDFmL3RhYmxlcmFuZ2U6MjBlMWUyNTlkMWU5NDAwYjlmNjkxMTY1NjU5YzNkMWZfMy0xLTEtMS0w_9cedfc66-2a18-4b1d-b424-a47ed32a8fd8"
      unitRef="cadPerShare">2.05</us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice>
    <us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised
      contextRef="i4a110e4972ef4113880ce582e3cda5c5_D20200101-20200630"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzY2E5YmIwMTc5MjQ3NmZiYjIyNWU1ZDlkZWM4NjlmL3NlYzo5M2NhOWJiMDE3OTI0NzZmYmIyMjVlNWQ5ZGVjODY5Zl80OS9mcmFnOjdkOTcyM2RkMjdkODRhNWFiYjJiMzcyOTJmYjZhMmUzL3RhYmxlOjIwZTFlMjU5ZDFlOTQwMGI5ZjY5MTE2NTY1OWMzZDFmL3RhYmxlcmFuZ2U6MjBlMWUyNTlkMWU5NDAwYjlmNjkxMTY1NjU5YzNkMWZfMy0zLTEtMS0w_a07e8d92-d503-4d19-a462-0fa318ee23a5"
      unitRef="shares">1807909</us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice
      contextRef="i4a110e4972ef4113880ce582e3cda5c5_D20200101-20200630"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzY2E5YmIwMTc5MjQ3NmZiYjIyNWU1ZDlkZWM4NjlmL3NlYzo5M2NhOWJiMDE3OTI0NzZmYmIyMjVlNWQ5ZGVjODY5Zl80OS9mcmFnOjdkOTcyM2RkMjdkODRhNWFiYjJiMzcyOTJmYjZhMmUzL3RhYmxlOjIwZTFlMjU5ZDFlOTQwMGI5ZjY5MTE2NTY1OWMzZDFmL3RhYmxlcmFuZ2U6MjBlMWUyNTlkMWU5NDAwYjlmNjkxMTY1NjU5YzNkMWZfNC0xLTEtMS0w_416989f9-3f0e-4833-b9ab-948f8c85caf0"
      unitRef="cadPerShare">15.78</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod
      contextRef="i4a110e4972ef4113880ce582e3cda5c5_D20200101-20200630"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzY2E5YmIwMTc5MjQ3NmZiYjIyNWU1ZDlkZWM4NjlmL3NlYzo5M2NhOWJiMDE3OTI0NzZmYmIyMjVlNWQ5ZGVjODY5Zl80OS9mcmFnOjdkOTcyM2RkMjdkODRhNWFiYjJiMzcyOTJmYjZhMmUzL3RhYmxlOjIwZTFlMjU5ZDFlOTQwMGI5ZjY5MTE2NTY1OWMzZDFmL3RhYmxlcmFuZ2U6MjBlMWUyNTlkMWU5NDAwYjlmNjkxMTY1NjU5YzNkMWZfNC0zLTEtMS0w_ffd369f3-970e-458d-ace1-54a517c160f3"
      unitRef="shares">127045</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
      contextRef="id670dc9b33e6430f9d7510009f7495a7_I20200630"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzY2E5YmIwMTc5MjQ3NmZiYjIyNWU1ZDlkZWM4NjlmL3NlYzo5M2NhOWJiMDE3OTI0NzZmYmIyMjVlNWQ5ZGVjODY5Zl80OS9mcmFnOjdkOTcyM2RkMjdkODRhNWFiYjJiMzcyOTJmYjZhMmUzL3RhYmxlOjIwZTFlMjU5ZDFlOTQwMGI5ZjY5MTE2NTY1OWMzZDFmL3RhYmxlcmFuZ2U6MjBlMWUyNTlkMWU5NDAwYjlmNjkxMTY1NjU5YzNkMWZfNS0xLTEtMS0w_ce4ca463-450c-4b88-be99-a665c9cfa89a"
      unitRef="cadPerShare">5.13</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
      contextRef="id670dc9b33e6430f9d7510009f7495a7_I20200630"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzY2E5YmIwMTc5MjQ3NmZiYjIyNWU1ZDlkZWM4NjlmL3NlYzo5M2NhOWJiMDE3OTI0NzZmYmIyMjVlNWQ5ZGVjODY5Zl80OS9mcmFnOjdkOTcyM2RkMjdkODRhNWFiYjJiMzcyOTJmYjZhMmUzL3RhYmxlOjIwZTFlMjU5ZDFlOTQwMGI5ZjY5MTE2NTY1OWMzZDFmL3RhYmxlcmFuZ2U6MjBlMWUyNTlkMWU5NDAwYjlmNjkxMTY1NjU5YzNkMWZfNS0zLTEtMS0w_b61a8e30-d30e-433d-9b71-a5a6cd6ed1d1"
      unitRef="shares">12214548</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2
      contextRef="i4a110e4972ef4113880ce582e3cda5c5_D20200101-20200630"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzY2E5YmIwMTc5MjQ3NmZiYjIyNWU1ZDlkZWM4NjlmL3NlYzo5M2NhOWJiMDE3OTI0NzZmYmIyMjVlNWQ5ZGVjODY5Zl80OS9mcmFnOjdkOTcyM2RkMjdkODRhNWFiYjJiMzcyOTJmYjZhMmUzL3RhYmxlOjIwZTFlMjU5ZDFlOTQwMGI5ZjY5MTE2NTY1OWMzZDFmL3RhYmxlcmFuZ2U6MjBlMWUyNTlkMWU5NDAwYjlmNjkxMTY1NjU5YzNkMWZfNS01LTEtMS0w_ca3e882f-239f-416d-bac3-a5210a85f694">P2Y18D</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice
      contextRef="id670dc9b33e6430f9d7510009f7495a7_I20200630"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzY2E5YmIwMTc5MjQ3NmZiYjIyNWU1ZDlkZWM4NjlmL3NlYzo5M2NhOWJiMDE3OTI0NzZmYmIyMjVlNWQ5ZGVjODY5Zl80OS9mcmFnOjdkOTcyM2RkMjdkODRhNWFiYjJiMzcyOTJmYjZhMmUzL3RhYmxlOjIwZTFlMjU5ZDFlOTQwMGI5ZjY5MTE2NTY1OWMzZDFmL3RhYmxlcmFuZ2U6MjBlMWUyNTlkMWU5NDAwYjlmNjkxMTY1NjU5YzNkMWZfNi0xLTEtMS0w_0c31cf01-9a77-4769-a0ef-acb4d2d340eb"
      unitRef="usdPerShare">3.42</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber
      contextRef="id670dc9b33e6430f9d7510009f7495a7_I20200630"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzY2E5YmIwMTc5MjQ3NmZiYjIyNWU1ZDlkZWM4NjlmL3NlYzo5M2NhOWJiMDE3OTI0NzZmYmIyMjVlNWQ5ZGVjODY5Zl80OS9mcmFnOjdkOTcyM2RkMjdkODRhNWFiYjJiMzcyOTJmYjZhMmUzL3RhYmxlOjIwZTFlMjU5ZDFlOTQwMGI5ZjY5MTE2NTY1OWMzZDFmL3RhYmxlcmFuZ2U6MjBlMWUyNTlkMWU5NDAwYjlmNjkxMTY1NjU5YzNkMWZfNi0zLTEtMS0w_a5b54eca-0238-4de1-a19c-e689f7c1ccf7"
      unitRef="shares">8688645</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageRemainingContractualTerm1
      contextRef="i4a110e4972ef4113880ce582e3cda5c5_D20200101-20200630"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzY2E5YmIwMTc5MjQ3NmZiYjIyNWU1ZDlkZWM4NjlmL3NlYzo5M2NhOWJiMDE3OTI0NzZmYmIyMjVlNWQ5ZGVjODY5Zl80OS9mcmFnOjdkOTcyM2RkMjdkODRhNWFiYjJiMzcyOTJmYjZhMmUzL3RhYmxlOjIwZTFlMjU5ZDFlOTQwMGI5ZjY5MTE2NTY1OWMzZDFmL3RhYmxlcmFuZ2U6MjBlMWUyNTlkMWU5NDAwYjlmNjkxMTY1NjU5YzNkMWZfNi01LTEtMS0w_fec723da-3dc7-4f67-bbeb-318f70f07cc4">P1Y9M10D</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageRemainingContractualTerm1>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross
      contextRef="i4a110e4972ef4113880ce582e3cda5c5_D20200101-20200630"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzY2E5YmIwMTc5MjQ3NmZiYjIyNWU1ZDlkZWM4NjlmL3NlYzo5M2NhOWJiMDE3OTI0NzZmYmIyMjVlNWQ5ZGVjODY5Zl80OS9mcmFnOjdkOTcyM2RkMjdkODRhNWFiYjJiMzcyOTJmYjZhMmUzL3RleHRyZWdpb246N2Q5NzIzZGQyN2Q4NGE1YWJiMmIzNzI5MmZiNmEyZTNfOTg5NTYwNDY1NTAyMw_1c9f2158-f8c5-4387-870a-bb6978ced946"
      unitRef="shares">0</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross
      contextRef="i69782326f71a44e3805518280ee22b6b_D20210101-20210630"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzY2E5YmIwMTc5MjQ3NmZiYjIyNWU1ZDlkZWM4NjlmL3NlYzo5M2NhOWJiMDE3OTI0NzZmYmIyMjVlNWQ5ZGVjODY5Zl80OS9mcmFnOjdkOTcyM2RkMjdkODRhNWFiYjJiMzcyOTJmYjZhMmUzL3RleHRyZWdpb246N2Q5NzIzZGQyN2Q4NGE1YWJiMmIzNzI5MmZiNmEyZTNfOTg5NTYwNDY1NTAyMw_44f9f77c-5915-459e-bbdb-987a4cdcdae2"
      unitRef="shares">0</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
      contextRef="ib49e288fbb504210b764575656013515_I20210630"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzY2E5YmIwMTc5MjQ3NmZiYjIyNWU1ZDlkZWM4NjlmL3NlYzo5M2NhOWJiMDE3OTI0NzZmYmIyMjVlNWQ5ZGVjODY5Zl80OS9mcmFnOjdkOTcyM2RkMjdkODRhNWFiYjJiMzcyOTJmYjZhMmUzL3RhYmxlOjc0ZjZkOWViM2ZhNDQ5NDBhNmJiMTA3YjVmZjFhNzIwL3RhYmxlcmFuZ2U6NzRmNmQ5ZWIzZmE0NDk0MGE2YmIxMDdiNWZmMWE3MjBfMi0xLTEtMS0w_d4b5518f-942b-4451-91ad-544e2110b40d"
      unitRef="shares">2000000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
      contextRef="i940a5cbdd4164d3996cb15eddebf6022_I20201231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzY2E5YmIwMTc5MjQ3NmZiYjIyNWU1ZDlkZWM4NjlmL3NlYzo5M2NhOWJiMDE3OTI0NzZmYmIyMjVlNWQ5ZGVjODY5Zl80OS9mcmFnOjdkOTcyM2RkMjdkODRhNWFiYjJiMzcyOTJmYjZhMmUzL3RhYmxlOjc0ZjZkOWViM2ZhNDQ5NDBhNmJiMTA3YjVmZjFhNzIwL3RhYmxlcmFuZ2U6NzRmNmQ5ZWIzZmE0NDk0MGE2YmIxMDdiNWZmMWE3MjBfMi0zLTEtMS0w_d80c9ac7-4e5a-41a2-8d40-55d32cfb9467"
      unitRef="shares">2000000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
      contextRef="i71217ccb65f54a46844f4ef961eef8ed_I20210630"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzY2E5YmIwMTc5MjQ3NmZiYjIyNWU1ZDlkZWM4NjlmL3NlYzo5M2NhOWJiMDE3OTI0NzZmYmIyMjVlNWQ5ZGVjODY5Zl80OS9mcmFnOjdkOTcyM2RkMjdkODRhNWFiYjJiMzcyOTJmYjZhMmUzL3RhYmxlOjc0ZjZkOWViM2ZhNDQ5NDBhNmJiMTA3YjVmZjFhNzIwL3RhYmxlcmFuZ2U6NzRmNmQ5ZWIzZmE0NDk0MGE2YmIxMDdiNWZmMWE3MjBfMy0xLTEtMS0w_3c55cfa7-a411-4f48-93c9-7b2cbc73c17b"
      unitRef="shares">1586725</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
      contextRef="i9901793e0a0c46f483b159aad44d157c_I20201231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzY2E5YmIwMTc5MjQ3NmZiYjIyNWU1ZDlkZWM4NjlmL3NlYzo5M2NhOWJiMDE3OTI0NzZmYmIyMjVlNWQ5ZGVjODY5Zl80OS9mcmFnOjdkOTcyM2RkMjdkODRhNWFiYjJiMzcyOTJmYjZhMmUzL3RhYmxlOjc0ZjZkOWViM2ZhNDQ5NDBhNmJiMTA3YjVmZjFhNzIwL3RhYmxlcmFuZ2U6NzRmNmQ5ZWIzZmE0NDk0MGE2YmIxMDdiNWZmMWE3MjBfMy0zLTEtMS0w_2af36e37-09ea-4f9e-a481-fc7f859e8756"
      unitRef="shares">1627715</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
      contextRef="i67847aa2abfa472593c968c856dcd228_I20210630"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzY2E5YmIwMTc5MjQ3NmZiYjIyNWU1ZDlkZWM4NjlmL3NlYzo5M2NhOWJiMDE3OTI0NzZmYmIyMjVlNWQ5ZGVjODY5Zl80OS9mcmFnOjdkOTcyM2RkMjdkODRhNWFiYjJiMzcyOTJmYjZhMmUzL3RhYmxlOjc0ZjZkOWViM2ZhNDQ5NDBhNmJiMTA3YjVmZjFhNzIwL3RhYmxlcmFuZ2U6NzRmNmQ5ZWIzZmE0NDk0MGE2YmIxMDdiNWZmMWE3MjBfNC0xLTEtMS0w_3aa8f9c3-6732-45b4-99a9-3420f0924b92"
      unitRef="shares">4784906</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
      contextRef="ia6fe44bf977249a2919be8435dfaa9a2_I20201231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzY2E5YmIwMTc5MjQ3NmZiYjIyNWU1ZDlkZWM4NjlmL3NlYzo5M2NhOWJiMDE3OTI0NzZmYmIyMjVlNWQ5ZGVjODY5Zl80OS9mcmFnOjdkOTcyM2RkMjdkODRhNWFiYjJiMzcyOTJmYjZhMmUzL3RhYmxlOjc0ZjZkOWViM2ZhNDQ5NDBhNmJiMTA3YjVmZjFhNzIwL3RhYmxlcmFuZ2U6NzRmNmQ5ZWIzZmE0NDk0MGE2YmIxMDdiNWZmMWE3MjBfNC0zLTEtMS0w_6765a4f1-3637-4cb3-8aa4-ae7bb5770e38"
      unitRef="shares">10127433</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
      contextRef="i225f85e38faa4bbdb4de1d8b9cf369bb_I20210630"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzY2E5YmIwMTc5MjQ3NmZiYjIyNWU1ZDlkZWM4NjlmL3NlYzo5M2NhOWJiMDE3OTI0NzZmYmIyMjVlNWQ5ZGVjODY5Zl80OS9mcmFnOjdkOTcyM2RkMjdkODRhNWFiYjJiMzcyOTJmYjZhMmUzL3RhYmxlOjc0ZjZkOWViM2ZhNDQ5NDBhNmJiMTA3YjVmZjFhNzIwL3RhYmxlcmFuZ2U6NzRmNmQ5ZWIzZmE0NDk0MGE2YmIxMDdiNWZmMWE3MjBfNS0xLTEtMS0w_15a5f4ba-9758-4d4d-a9b5-a0371bf50205"
      unitRef="shares">8371631</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
      contextRef="ifbe16ec51ea244519b77d6036b4ef038_I20201231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzY2E5YmIwMTc5MjQ3NmZiYjIyNWU1ZDlkZWM4NjlmL3NlYzo5M2NhOWJiMDE3OTI0NzZmYmIyMjVlNWQ5ZGVjODY5Zl80OS9mcmFnOjdkOTcyM2RkMjdkODRhNWFiYjJiMzcyOTJmYjZhMmUzL3RhYmxlOjc0ZjZkOWViM2ZhNDQ5NDBhNmJiMTA3YjVmZjFhNzIwL3RhYmxlcmFuZ2U6NzRmNmQ5ZWIzZmE0NDk0MGE2YmIxMDdiNWZmMWE3MjBfNS0zLTEtMS0w_b282df74-adc3-430b-ad55-50a2a05a7483"
      unitRef="shares">13755148</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber>
    <us-gaap:ScheduleOfShareBasedCompensationRestrictedStockUnitsAwardActivityTableTextBlock
      contextRef="i69782326f71a44e3805518280ee22b6b_D20210101-20210630"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzY2E5YmIwMTc5MjQ3NmZiYjIyNWU1ZDlkZWM4NjlmL3NlYzo5M2NhOWJiMDE3OTI0NzZmYmIyMjVlNWQ5ZGVjODY5Zl80OS9mcmFnOjdkOTcyM2RkMjdkODRhNWFiYjJiMzcyOTJmYjZhMmUzL3RleHRyZWdpb246N2Q5NzIzZGQyN2Q4NGE1YWJiMmIzNzI5MmZiNmEyZTNfMjg0MQ_add9c867-0e51-4f73-9683-0ff59b835251">&lt;div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following is a summary of the changes in RSUs for the six months ended June&#160;30, 2021 and 2020: &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:61.538%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:16.816%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.327%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:16.819%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Number of RSUs&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:700;line-height:100%;position:relative;top:-2.8pt;vertical-align:baseline"&gt; (i)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Weighted average grant date fair value (C$)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:700;line-height:100%;position:relative;top:-2.8pt;vertical-align:baseline"&gt;(ii)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Balance as of January 1, 2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;948,357&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7.66&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:12pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Granted&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(i)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;515,433&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;11.29&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Vested and issued&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(89,912)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7.52&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Balance as of June&#160;30, 2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,373,878&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;9.03&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:61.538%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:16.816%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.327%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:16.819%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Number of RSUs&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:700;line-height:100%;position:relative;top:-2.8pt;vertical-align:baseline"&gt; (i)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Weighted average grant date fair value (C$)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:700;line-height:100%;position:relative;top:-2.8pt;vertical-align:baseline"&gt;(ii)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Balance as of January 1, 2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;732,972&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;15.34&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:12pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Granted&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(i)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;279,277&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7.52&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Balance as of June&#160;30, 2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,012,249&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;13.18&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt;padding-left:18pt;text-align:justify;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:400;line-height:120%;position:relative;top:-2.8pt;vertical-align:baseline"&gt;(i)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:13.1pt"&gt;RSUs granted in the period vest annually in equal installments over a three-year period following the grant date, subject to such holder&#x2019;s continued employment through each vesting date. The vesting of such RSUs is not subject to the achievement of any performance criteria.&lt;/span&gt;&lt;/div&gt;(ii)The weighted average grant date fair value reflects the conversion of foreign currency-denominated RSUs translated into C$ using the foreign exchange rate as of the date of issuance.</us-gaap:ScheduleOfShareBasedCompensationRestrictedStockUnitsAwardActivityTableTextBlock>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber
      contextRef="iff2854605c9948a0bd946fb90a42d547_I20201231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzY2E5YmIwMTc5MjQ3NmZiYjIyNWU1ZDlkZWM4NjlmL3NlYzo5M2NhOWJiMDE3OTI0NzZmYmIyMjVlNWQ5ZGVjODY5Zl80OS9mcmFnOjdkOTcyM2RkMjdkODRhNWFiYjJiMzcyOTJmYjZhMmUzL3RhYmxlOjFlNGUzYmI3ZWJmODRkYmQ5MmRiMzY5NjY5Y2RhYTg5L3RhYmxlcmFuZ2U6MWU0ZTNiYjdlYmY4NGRiZDkyZGIzNjk2NjljZGFhODlfMS0xLTEtMS0w_6bd9abb8-0329-47b7-83c5-6ec076acd590"
      unitRef="shares">948357</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue
      contextRef="iff2854605c9948a0bd946fb90a42d547_I20201231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzY2E5YmIwMTc5MjQ3NmZiYjIyNWU1ZDlkZWM4NjlmL3NlYzo5M2NhOWJiMDE3OTI0NzZmYmIyMjVlNWQ5ZGVjODY5Zl80OS9mcmFnOjdkOTcyM2RkMjdkODRhNWFiYjJiMzcyOTJmYjZhMmUzL3RhYmxlOjFlNGUzYmI3ZWJmODRkYmQ5MmRiMzY5NjY5Y2RhYTg5L3RhYmxlcmFuZ2U6MWU0ZTNiYjdlYmY4NGRiZDkyZGIzNjk2NjljZGFhODlfMS0zLTEtMS0w_45af9d43-61db-48df-867b-adb161eedbed"
      unitRef="usdPerShare">7.66</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod
      contextRef="ie5eb2f0b8440403abdac2db9e01adbb9_D20210101-20210630"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzY2E5YmIwMTc5MjQ3NmZiYjIyNWU1ZDlkZWM4NjlmL3NlYzo5M2NhOWJiMDE3OTI0NzZmYmIyMjVlNWQ5ZGVjODY5Zl80OS9mcmFnOjdkOTcyM2RkMjdkODRhNWFiYjJiMzcyOTJmYjZhMmUzL3RhYmxlOjFlNGUzYmI3ZWJmODRkYmQ5MmRiMzY5NjY5Y2RhYTg5L3RhYmxlcmFuZ2U6MWU0ZTNiYjdlYmY4NGRiZDkyZGIzNjk2NjljZGFhODlfMi0xLTEtMS0w_1e813088-e498-42f8-bb3d-833eca936248"
      unitRef="shares">515433</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue
      contextRef="ie5eb2f0b8440403abdac2db9e01adbb9_D20210101-20210630"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzY2E5YmIwMTc5MjQ3NmZiYjIyNWU1ZDlkZWM4NjlmL3NlYzo5M2NhOWJiMDE3OTI0NzZmYmIyMjVlNWQ5ZGVjODY5Zl80OS9mcmFnOjdkOTcyM2RkMjdkODRhNWFiYjJiMzcyOTJmYjZhMmUzL3RhYmxlOjFlNGUzYmI3ZWJmODRkYmQ5MmRiMzY5NjY5Y2RhYTg5L3RhYmxlcmFuZ2U6MWU0ZTNiYjdlYmY4NGRiZDkyZGIzNjk2NjljZGFhODlfMi0zLTEtMS0w_fa014f5d-1178-44c8-bd5e-b6aba2e326c0"
      unitRef="usdPerShare">11.29</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue>
    <cron:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedAndIssuedInPeriod
      contextRef="ie5eb2f0b8440403abdac2db9e01adbb9_D20210101-20210630"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzY2E5YmIwMTc5MjQ3NmZiYjIyNWU1ZDlkZWM4NjlmL3NlYzo5M2NhOWJiMDE3OTI0NzZmYmIyMjVlNWQ5ZGVjODY5Zl80OS9mcmFnOjdkOTcyM2RkMjdkODRhNWFiYjJiMzcyOTJmYjZhMmUzL3RhYmxlOjFlNGUzYmI3ZWJmODRkYmQ5MmRiMzY5NjY5Y2RhYTg5L3RhYmxlcmFuZ2U6MWU0ZTNiYjdlYmY4NGRiZDkyZGIzNjk2NjljZGFhODlfMy0xLTEtMS0w_445ab38e-dcb8-433e-a2ae-76776543141a"
      unitRef="shares">89912</cron:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedAndIssuedInPeriod>
    <cron:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedAndIssuedInPeriodWeightedAverageGrantDateFairValue
      contextRef="ie5eb2f0b8440403abdac2db9e01adbb9_D20210101-20210630"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzY2E5YmIwMTc5MjQ3NmZiYjIyNWU1ZDlkZWM4NjlmL3NlYzo5M2NhOWJiMDE3OTI0NzZmYmIyMjVlNWQ5ZGVjODY5Zl80OS9mcmFnOjdkOTcyM2RkMjdkODRhNWFiYjJiMzcyOTJmYjZhMmUzL3RhYmxlOjFlNGUzYmI3ZWJmODRkYmQ5MmRiMzY5NjY5Y2RhYTg5L3RhYmxlcmFuZ2U6MWU0ZTNiYjdlYmY4NGRiZDkyZGIzNjk2NjljZGFhODlfMy0zLTEtMS0w_29f4da68-d180-402e-9078-734d5cd3daa2"
      unitRef="usdPerShare">7.52</cron:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedAndIssuedInPeriodWeightedAverageGrantDateFairValue>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber
      contextRef="i38f48aaa7a5e481ebe8ebcada37e35a1_I20210630"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzY2E5YmIwMTc5MjQ3NmZiYjIyNWU1ZDlkZWM4NjlmL3NlYzo5M2NhOWJiMDE3OTI0NzZmYmIyMjVlNWQ5ZGVjODY5Zl80OS9mcmFnOjdkOTcyM2RkMjdkODRhNWFiYjJiMzcyOTJmYjZhMmUzL3RhYmxlOjFlNGUzYmI3ZWJmODRkYmQ5MmRiMzY5NjY5Y2RhYTg5L3RhYmxlcmFuZ2U6MWU0ZTNiYjdlYmY4NGRiZDkyZGIzNjk2NjljZGFhODlfNS0xLTEtMS0w_c621807d-96cf-46f8-bdb6-65b069e3eac3"
      unitRef="shares">1373878</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue
      contextRef="i38f48aaa7a5e481ebe8ebcada37e35a1_I20210630"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzY2E5YmIwMTc5MjQ3NmZiYjIyNWU1ZDlkZWM4NjlmL3NlYzo5M2NhOWJiMDE3OTI0NzZmYmIyMjVlNWQ5ZGVjODY5Zl80OS9mcmFnOjdkOTcyM2RkMjdkODRhNWFiYjJiMzcyOTJmYjZhMmUzL3RhYmxlOjFlNGUzYmI3ZWJmODRkYmQ5MmRiMzY5NjY5Y2RhYTg5L3RhYmxlcmFuZ2U6MWU0ZTNiYjdlYmY4NGRiZDkyZGIzNjk2NjljZGFhODlfNS0zLTEtMS0w_45bac9d2-df68-4979-956d-f95f936b42cc"
      unitRef="usdPerShare">9.03</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber
      contextRef="i9cd1e43e5a21454dbe1b88627687a079_I20191231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzY2E5YmIwMTc5MjQ3NmZiYjIyNWU1ZDlkZWM4NjlmL3NlYzo5M2NhOWJiMDE3OTI0NzZmYmIyMjVlNWQ5ZGVjODY5Zl80OS9mcmFnOjdkOTcyM2RkMjdkODRhNWFiYjJiMzcyOTJmYjZhMmUzL3RhYmxlOmJiMDVkOTg3NzdmODRmMDlhNDk3OWUyZDEwN2Y0ZTNkL3RhYmxlcmFuZ2U6YmIwNWQ5ODc3N2Y4NGYwOWE0OTc5ZTJkMTA3ZjRlM2RfMS0xLTEtMS01MjI1_273643ef-475f-4af2-ad97-b1dad6b1657a"
      unitRef="shares">732972</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue
      contextRef="i9cd1e43e5a21454dbe1b88627687a079_I20191231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzY2E5YmIwMTc5MjQ3NmZiYjIyNWU1ZDlkZWM4NjlmL3NlYzo5M2NhOWJiMDE3OTI0NzZmYmIyMjVlNWQ5ZGVjODY5Zl80OS9mcmFnOjdkOTcyM2RkMjdkODRhNWFiYjJiMzcyOTJmYjZhMmUzL3RhYmxlOmJiMDVkOTg3NzdmODRmMDlhNDk3OWUyZDEwN2Y0ZTNkL3RhYmxlcmFuZ2U6YmIwNWQ5ODc3N2Y4NGYwOWE0OTc5ZTJkMTA3ZjRlM2RfMS0zLTEtMS01MjI1_35ac3b4e-ab9b-4d3e-bf86-df430bf21bf7"
      unitRef="usdPerShare">15.34</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod
      contextRef="i10cd1c126464402b99bfac52e7ebdbb2_D20200101-20200630"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzY2E5YmIwMTc5MjQ3NmZiYjIyNWU1ZDlkZWM4NjlmL3NlYzo5M2NhOWJiMDE3OTI0NzZmYmIyMjVlNWQ5ZGVjODY5Zl80OS9mcmFnOjdkOTcyM2RkMjdkODRhNWFiYjJiMzcyOTJmYjZhMmUzL3RhYmxlOmJiMDVkOTg3NzdmODRmMDlhNDk3OWUyZDEwN2Y0ZTNkL3RhYmxlcmFuZ2U6YmIwNWQ5ODc3N2Y4NGYwOWE0OTc5ZTJkMTA3ZjRlM2RfMi0xLTEtMS01NTg0_8f105689-011a-48d6-b653-cf7186cf09b3"
      unitRef="shares">279277</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue
      contextRef="i10cd1c126464402b99bfac52e7ebdbb2_D20200101-20200630"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzY2E5YmIwMTc5MjQ3NmZiYjIyNWU1ZDlkZWM4NjlmL3NlYzo5M2NhOWJiMDE3OTI0NzZmYmIyMjVlNWQ5ZGVjODY5Zl80OS9mcmFnOjdkOTcyM2RkMjdkODRhNWFiYjJiMzcyOTJmYjZhMmUzL3RhYmxlOmJiMDVkOTg3NzdmODRmMDlhNDk3OWUyZDEwN2Y0ZTNkL3RhYmxlcmFuZ2U6YmIwNWQ5ODc3N2Y4NGYwOWE0OTc5ZTJkMTA3ZjRlM2RfMi0zLTEtMS01NTg3_21ccc7b0-0788-4237-a050-8e0693c37f64"
      unitRef="usdPerShare">7.52</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber
      contextRef="i80341dfa258d45e4926f94222e4d5cbc_I20200630"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzY2E5YmIwMTc5MjQ3NmZiYjIyNWU1ZDlkZWM4NjlmL3NlYzo5M2NhOWJiMDE3OTI0NzZmYmIyMjVlNWQ5ZGVjODY5Zl80OS9mcmFnOjdkOTcyM2RkMjdkODRhNWFiYjJiMzcyOTJmYjZhMmUzL3RhYmxlOmJiMDVkOTg3NzdmODRmMDlhNDk3OWUyZDEwN2Y0ZTNkL3RhYmxlcmFuZ2U6YmIwNWQ5ODc3N2Y4NGYwOWE0OTc5ZTJkMTA3ZjRlM2RfMy0xLTEtMS01MjI1_8aa5d1dc-5f2f-48b4-877c-e333262cdabf"
      unitRef="shares">1012249</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue
      contextRef="i80341dfa258d45e4926f94222e4d5cbc_I20200630"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzY2E5YmIwMTc5MjQ3NmZiYjIyNWU1ZDlkZWM4NjlmL3NlYzo5M2NhOWJiMDE3OTI0NzZmYmIyMjVlNWQ5ZGVjODY5Zl80OS9mcmFnOjdkOTcyM2RkMjdkODRhNWFiYjJiMzcyOTJmYjZhMmUzL3RhYmxlOmJiMDVkOTg3NzdmODRmMDlhNDk3OWUyZDEwN2Y0ZTNkL3RhYmxlcmFuZ2U6YmIwNWQ5ODc3N2Y4NGYwOWE0OTc5ZTJkMTA3ZjRlM2RfNS0zLTEtMS01NjEy_2d262693-5a28-4335-80a5-eb7fd4cda577"
      unitRef="usdPerShare">13.18</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1
      contextRef="ie5eb2f0b8440403abdac2db9e01adbb9_D20210101-20210630"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzY2E5YmIwMTc5MjQ3NmZiYjIyNWU1ZDlkZWM4NjlmL3NlYzo5M2NhOWJiMDE3OTI0NzZmYmIyMjVlNWQ5ZGVjODY5Zl80OS9mcmFnOjdkOTcyM2RkMjdkODRhNWFiYjJiMzcyOTJmYjZhMmUzL3RleHRyZWdpb246N2Q5NzIzZGQyN2Q4NGE1YWJiMmIzNzI5MmZiNmEyZTNfMjg0OA_72b50007-32a0-4807-86f2-3661661e4530">P3Y</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1
      contextRef="i10cd1c126464402b99bfac52e7ebdbb2_D20200101-20200630"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzY2E5YmIwMTc5MjQ3NmZiYjIyNWU1ZDlkZWM4NjlmL3NlYzo5M2NhOWJiMDE3OTI0NzZmYmIyMjVlNWQ5ZGVjODY5Zl80OS9mcmFnOjdkOTcyM2RkMjdkODRhNWFiYjJiMzcyOTJmYjZhMmUzL3RleHRyZWdpb246N2Q5NzIzZGQyN2Q4NGE1YWJiMmIzNzI5MmZiNmEyZTNfMjg0OA_9c0b6df3-6542-4281-a61b-250263daa164">P3Y</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1>
    <us-gaap:ScheduleOfOtherShareBasedCompensationActivityTableTextBlock
      contextRef="i69782326f71a44e3805518280ee22b6b_D20210101-20210630"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzY2E5YmIwMTc5MjQ3NmZiYjIyNWU1ZDlkZWM4NjlmL3NlYzo5M2NhOWJiMDE3OTI0NzZmYmIyMjVlNWQ5ZGVjODY5Zl80OS9mcmFnOjdkOTcyM2RkMjdkODRhNWFiYjJiMzcyOTJmYjZhMmUzL3RleHRyZWdpb246N2Q5NzIzZGQyN2Q4NGE1YWJiMmIzNzI5MmZiNmEyZTNfMjg1MA_968920cb-a02b-4e00-8d38-789dc681899d">&lt;div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following is a summary of the changes in DSUs during the six months ended June&#160;30, 2021 and 2020:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:61.538%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:16.816%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.327%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:16.819%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Number of DSUs&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Financial liability &lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Balance as of January 1, 2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;83,293&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;577&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Loss on revaluation&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;141&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Balance as of June&#160;30, 2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;83,293&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;718&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:61.538%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:16.816%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.327%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:16.819%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Number of DSUs&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Financial liability &lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Balance as of January 1, 2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;33,397&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;255&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;DSU liabilities settled&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(8,484)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(46)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Gain on revaluation&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(56)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Balance as of June&#160;30, 2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;24,913&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;153&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following is a summary of the changes in warrants during the six months ended June&#160;30, 2021 and 2020:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:49.316%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:23.205%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.772%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:23.207%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Weighted average exercise price (C$)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Number of warrants&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Balance as of January 1, 2021&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.25&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7,987,349&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Exercise of warrants&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.25&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(7,987,349)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Balance as of June&#160;30, 2021&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:49.316%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:23.205%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.772%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:23.207%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Weighted average exercise price (C$)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Number of warrants&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Balance as of January 1, 2020 and June 30, 2020&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.26&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;18,066,662&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:ScheduleOfOtherShareBasedCompensationActivityTableTextBlock>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber
      contextRef="iba2763eff8e446348674f7fa0f12395e_I20201231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzY2E5YmIwMTc5MjQ3NmZiYjIyNWU1ZDlkZWM4NjlmL3NlYzo5M2NhOWJiMDE3OTI0NzZmYmIyMjVlNWQ5ZGVjODY5Zl80OS9mcmFnOjdkOTcyM2RkMjdkODRhNWFiYjJiMzcyOTJmYjZhMmUzL3RhYmxlOjg2NDc3YzNmNzVjZTRmOWY4MWMwNTQ2NjIwMDM4MDI4L3RhYmxlcmFuZ2U6ODY0NzdjM2Y3NWNlNGY5ZjgxYzA1NDY2MjAwMzgwMjhfMS0xLTEtMS0w_e6b075cd-1041-449d-89ea-23397581044a"
      unitRef="shares">83293</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber>
    <us-gaap:DeferredCompensationSharebasedArrangementsLiabilityCurrentAndNoncurrent
      contextRef="iba2763eff8e446348674f7fa0f12395e_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzY2E5YmIwMTc5MjQ3NmZiYjIyNWU1ZDlkZWM4NjlmL3NlYzo5M2NhOWJiMDE3OTI0NzZmYmIyMjVlNWQ5ZGVjODY5Zl80OS9mcmFnOjdkOTcyM2RkMjdkODRhNWFiYjJiMzcyOTJmYjZhMmUzL3RhYmxlOjg2NDc3YzNmNzVjZTRmOWY4MWMwNTQ2NjIwMDM4MDI4L3RhYmxlcmFuZ2U6ODY0NzdjM2Y3NWNlNGY5ZjgxYzA1NDY2MjAwMzgwMjhfMS0zLTEtMS0w_4e61fd67-905d-4659-ba4f-9728d79a32f2"
      unitRef="usd">577000</us-gaap:DeferredCompensationSharebasedArrangementsLiabilityCurrentAndNoncurrent>
    <cron:ShareBasedPaymentArrangementGainLossOnRevaluation
      contextRef="i4d35a9dc2bff4f0fb74fef37bddc6703_D20210101-20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzY2E5YmIwMTc5MjQ3NmZiYjIyNWU1ZDlkZWM4NjlmL3NlYzo5M2NhOWJiMDE3OTI0NzZmYmIyMjVlNWQ5ZGVjODY5Zl80OS9mcmFnOjdkOTcyM2RkMjdkODRhNWFiYjJiMzcyOTJmYjZhMmUzL3RhYmxlOjg2NDc3YzNmNzVjZTRmOWY4MWMwNTQ2NjIwMDM4MDI4L3RhYmxlcmFuZ2U6ODY0NzdjM2Y3NWNlNGY5ZjgxYzA1NDY2MjAwMzgwMjhfNC0zLTEtMS0w_d7a177d4-f6b9-460a-b631-34ecc9d71c74"
      unitRef="usd">-141000</cron:ShareBasedPaymentArrangementGainLossOnRevaluation>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber
      contextRef="i8360952c01a040cc9bbd0c14cc59244b_I20210630"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzY2E5YmIwMTc5MjQ3NmZiYjIyNWU1ZDlkZWM4NjlmL3NlYzo5M2NhOWJiMDE3OTI0NzZmYmIyMjVlNWQ5ZGVjODY5Zl80OS9mcmFnOjdkOTcyM2RkMjdkODRhNWFiYjJiMzcyOTJmYjZhMmUzL3RhYmxlOjg2NDc3YzNmNzVjZTRmOWY4MWMwNTQ2NjIwMDM4MDI4L3RhYmxlcmFuZ2U6ODY0NzdjM2Y3NWNlNGY5ZjgxYzA1NDY2MjAwMzgwMjhfNS0xLTEtMS0w_7979c684-a1e5-4c6b-972b-e64082fe1d78"
      unitRef="shares">83293</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber>
    <us-gaap:DeferredCompensationSharebasedArrangementsLiabilityCurrentAndNoncurrent
      contextRef="i8360952c01a040cc9bbd0c14cc59244b_I20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzY2E5YmIwMTc5MjQ3NmZiYjIyNWU1ZDlkZWM4NjlmL3NlYzo5M2NhOWJiMDE3OTI0NzZmYmIyMjVlNWQ5ZGVjODY5Zl80OS9mcmFnOjdkOTcyM2RkMjdkODRhNWFiYjJiMzcyOTJmYjZhMmUzL3RhYmxlOjg2NDc3YzNmNzVjZTRmOWY4MWMwNTQ2NjIwMDM4MDI4L3RhYmxlcmFuZ2U6ODY0NzdjM2Y3NWNlNGY5ZjgxYzA1NDY2MjAwMzgwMjhfNS0zLTEtMS0w_7e50a1b4-43ce-44f7-a8c3-885562da3a91"
      unitRef="usd">718000</us-gaap:DeferredCompensationSharebasedArrangementsLiabilityCurrentAndNoncurrent>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber
      contextRef="ia6edd5e8ba094c259649f87d1ff2aa61_I20191231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzY2E5YmIwMTc5MjQ3NmZiYjIyNWU1ZDlkZWM4NjlmL3NlYzo5M2NhOWJiMDE3OTI0NzZmYmIyMjVlNWQ5ZGVjODY5Zl80OS9mcmFnOjdkOTcyM2RkMjdkODRhNWFiYjJiMzcyOTJmYjZhMmUzL3RhYmxlOjgzYWNiMzA0OTBlZDRjNmY4NjVjNDcyZjQ0NGRlN2RkL3RhYmxlcmFuZ2U6ODNhY2IzMDQ5MGVkNGM2Zjg2NWM0NzJmNDQ0ZGU3ZGRfMS0xLTEtMS0w_51e381f1-e0df-4f35-a242-fe0c4e04caa0"
      unitRef="shares">33397</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber>
    <us-gaap:DeferredCompensationSharebasedArrangementsLiabilityCurrentAndNoncurrent
      contextRef="ia6edd5e8ba094c259649f87d1ff2aa61_I20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzY2E5YmIwMTc5MjQ3NmZiYjIyNWU1ZDlkZWM4NjlmL3NlYzo5M2NhOWJiMDE3OTI0NzZmYmIyMjVlNWQ5ZGVjODY5Zl80OS9mcmFnOjdkOTcyM2RkMjdkODRhNWFiYjJiMzcyOTJmYjZhMmUzL3RhYmxlOjgzYWNiMzA0OTBlZDRjNmY4NjVjNDcyZjQ0NGRlN2RkL3RhYmxlcmFuZ2U6ODNhY2IzMDQ5MGVkNGM2Zjg2NWM0NzJmNDQ0ZGU3ZGRfMS0zLTEtMS0w_08bca8b1-c703-46f3-9456-441c8bd3882d"
      unitRef="usd">255000</us-gaap:DeferredCompensationSharebasedArrangementsLiabilityCurrentAndNoncurrent>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod
      contextRef="i64c0d8b09be647f1aa0d0ab87e24a14c_D20200101-20200630"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzY2E5YmIwMTc5MjQ3NmZiYjIyNWU1ZDlkZWM4NjlmL3NlYzo5M2NhOWJiMDE3OTI0NzZmYmIyMjVlNWQ5ZGVjODY5Zl80OS9mcmFnOjdkOTcyM2RkMjdkODRhNWFiYjJiMzcyOTJmYjZhMmUzL3RhYmxlOjgzYWNiMzA0OTBlZDRjNmY4NjVjNDcyZjQ0NGRlN2RkL3RhYmxlcmFuZ2U6ODNhY2IzMDQ5MGVkNGM2Zjg2NWM0NzJmNDQ0ZGU3ZGRfMy0xLTEtMS0w_ee35ddd4-8f9c-4183-8d5e-0877ce8420f4"
      unitRef="shares">8484</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod>
    <cron:ShareBasedPaymentArrangementLiabilitiesSettled
      contextRef="i64c0d8b09be647f1aa0d0ab87e24a14c_D20200101-20200630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzY2E5YmIwMTc5MjQ3NmZiYjIyNWU1ZDlkZWM4NjlmL3NlYzo5M2NhOWJiMDE3OTI0NzZmYmIyMjVlNWQ5ZGVjODY5Zl80OS9mcmFnOjdkOTcyM2RkMjdkODRhNWFiYjJiMzcyOTJmYjZhMmUzL3RhYmxlOjgzYWNiMzA0OTBlZDRjNmY4NjVjNDcyZjQ0NGRlN2RkL3RhYmxlcmFuZ2U6ODNhY2IzMDQ5MGVkNGM2Zjg2NWM0NzJmNDQ0ZGU3ZGRfMy0zLTEtMS0xMTE5_5aa710d3-71cd-4d7e-a1b2-3ab770c80d48"
      unitRef="usd">46000</cron:ShareBasedPaymentArrangementLiabilitiesSettled>
    <cron:ShareBasedPaymentArrangementGainLossOnRevaluation
      contextRef="i64c0d8b09be647f1aa0d0ab87e24a14c_D20200101-20200630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzY2E5YmIwMTc5MjQ3NmZiYjIyNWU1ZDlkZWM4NjlmL3NlYzo5M2NhOWJiMDE3OTI0NzZmYmIyMjVlNWQ5ZGVjODY5Zl80OS9mcmFnOjdkOTcyM2RkMjdkODRhNWFiYjJiMzcyOTJmYjZhMmUzL3RhYmxlOjgzYWNiMzA0OTBlZDRjNmY4NjVjNDcyZjQ0NGRlN2RkL3RhYmxlcmFuZ2U6ODNhY2IzMDQ5MGVkNGM2Zjg2NWM0NzJmNDQ0ZGU3ZGRfNC0zLTEtMS0w_5c8f875f-2198-4962-95f3-2e35f10ec6b8"
      unitRef="usd">56000</cron:ShareBasedPaymentArrangementGainLossOnRevaluation>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber
      contextRef="i80be6cf122864924818f07224f0ce952_I20200630"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzY2E5YmIwMTc5MjQ3NmZiYjIyNWU1ZDlkZWM4NjlmL3NlYzo5M2NhOWJiMDE3OTI0NzZmYmIyMjVlNWQ5ZGVjODY5Zl80OS9mcmFnOjdkOTcyM2RkMjdkODRhNWFiYjJiMzcyOTJmYjZhMmUzL3RhYmxlOjgzYWNiMzA0OTBlZDRjNmY4NjVjNDcyZjQ0NGRlN2RkL3RhYmxlcmFuZ2U6ODNhY2IzMDQ5MGVkNGM2Zjg2NWM0NzJmNDQ0ZGU3ZGRfNS0xLTEtMS0w_e0c101d7-9e94-4177-97f7-154b5ccf3dd8"
      unitRef="shares">24913</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber>
    <us-gaap:DeferredCompensationSharebasedArrangementsLiabilityCurrentAndNoncurrent
      contextRef="i80be6cf122864924818f07224f0ce952_I20200630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzY2E5YmIwMTc5MjQ3NmZiYjIyNWU1ZDlkZWM4NjlmL3NlYzo5M2NhOWJiMDE3OTI0NzZmYmIyMjVlNWQ5ZGVjODY5Zl80OS9mcmFnOjdkOTcyM2RkMjdkODRhNWFiYjJiMzcyOTJmYjZhMmUzL3RhYmxlOjgzYWNiMzA0OTBlZDRjNmY4NjVjNDcyZjQ0NGRlN2RkL3RhYmxlcmFuZ2U6ODNhY2IzMDQ5MGVkNGM2Zjg2NWM0NzJmNDQ0ZGU3ZGRfNS0zLTEtMS0w_e4cbf62d-2c10-4f60-b8b7-aad9c3b27397"
      unitRef="usd">153000</us-gaap:DeferredCompensationSharebasedArrangementsLiabilityCurrentAndNoncurrent>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue
      contextRef="ica96f8af8bfb4c02b4ff8f577beed8a9_I20201231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzY2E5YmIwMTc5MjQ3NmZiYjIyNWU1ZDlkZWM4NjlmL3NlYzo5M2NhOWJiMDE3OTI0NzZmYmIyMjVlNWQ5ZGVjODY5Zl80OS9mcmFnOjdkOTcyM2RkMjdkODRhNWFiYjJiMzcyOTJmYjZhMmUzL3RhYmxlOjA0OTgyOGY1YTAwYTQ3NGRiMTRmZGE5MzYxNTFmMjlhL3RhYmxlcmFuZ2U6MDQ5ODI4ZjVhMDBhNDc0ZGIxNGZkYTkzNjE1MWYyOWFfMS0xLTEtMS0w_8984b337-e609-4143-bdcb-681e6f26473c"
      unitRef="cadPerShare">0.25</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber
      contextRef="ica96f8af8bfb4c02b4ff8f577beed8a9_I20201231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzY2E5YmIwMTc5MjQ3NmZiYjIyNWU1ZDlkZWM4NjlmL3NlYzo5M2NhOWJiMDE3OTI0NzZmYmIyMjVlNWQ5ZGVjODY5Zl80OS9mcmFnOjdkOTcyM2RkMjdkODRhNWFiYjJiMzcyOTJmYjZhMmUzL3RhYmxlOjA0OTgyOGY1YTAwYTQ3NGRiMTRmZGE5MzYxNTFmMjlhL3RhYmxlcmFuZ2U6MDQ5ODI4ZjVhMDBhNDc0ZGIxNGZkYTkzNjE1MWYyOWFfMS0zLTEtMS0w_46bc9d2d-3965-4b33-9448-05f6c28f0dae"
      unitRef="shares">7987349</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue
      contextRef="ic97055dc0db04af88f485b12b96f84c2_D20210101-20210630"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzY2E5YmIwMTc5MjQ3NmZiYjIyNWU1ZDlkZWM4NjlmL3NlYzo5M2NhOWJiMDE3OTI0NzZmYmIyMjVlNWQ5ZGVjODY5Zl80OS9mcmFnOjdkOTcyM2RkMjdkODRhNWFiYjJiMzcyOTJmYjZhMmUzL3RhYmxlOjA0OTgyOGY1YTAwYTQ3NGRiMTRmZGE5MzYxNTFmMjlhL3RhYmxlcmFuZ2U6MDQ5ODI4ZjVhMDBhNDc0ZGIxNGZkYTkzNjE1MWYyOWFfMi0xLTEtMS0w_9336ed94-e294-4fae-bd51-275da6743183"
      unitRef="cadPerShare">0.25</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod
      contextRef="ic97055dc0db04af88f485b12b96f84c2_D20210101-20210630"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzY2E5YmIwMTc5MjQ3NmZiYjIyNWU1ZDlkZWM4NjlmL3NlYzo5M2NhOWJiMDE3OTI0NzZmYmIyMjVlNWQ5ZGVjODY5Zl80OS9mcmFnOjdkOTcyM2RkMjdkODRhNWFiYjJiMzcyOTJmYjZhMmUzL3RhYmxlOjA0OTgyOGY1YTAwYTQ3NGRiMTRmZGE5MzYxNTFmMjlhL3RhYmxlcmFuZ2U6MDQ5ODI4ZjVhMDBhNDc0ZGIxNGZkYTkzNjE1MWYyOWFfMi0zLTEtMS0w_9be40a79-306d-4b70-bf13-1d62d4720749"
      unitRef="shares">7987349</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue
      contextRef="iaa2e66f5a2c14062bebba1811782ccd6_I20210630"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzY2E5YmIwMTc5MjQ3NmZiYjIyNWU1ZDlkZWM4NjlmL3NlYzo5M2NhOWJiMDE3OTI0NzZmYmIyMjVlNWQ5ZGVjODY5Zl80OS9mcmFnOjdkOTcyM2RkMjdkODRhNWFiYjJiMzcyOTJmYjZhMmUzL3RhYmxlOjA0OTgyOGY1YTAwYTQ3NGRiMTRmZGE5MzYxNTFmMjlhL3RhYmxlcmFuZ2U6MDQ5ODI4ZjVhMDBhNDc0ZGIxNGZkYTkzNjE1MWYyOWFfNC0xLTEtMS0w_ab517be4-c18d-4675-8b30-cfc2b44a977f"
      unitRef="cadPerShare">0</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber
      contextRef="iaa2e66f5a2c14062bebba1811782ccd6_I20210630"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzY2E5YmIwMTc5MjQ3NmZiYjIyNWU1ZDlkZWM4NjlmL3NlYzo5M2NhOWJiMDE3OTI0NzZmYmIyMjVlNWQ5ZGVjODY5Zl80OS9mcmFnOjdkOTcyM2RkMjdkODRhNWFiYjJiMzcyOTJmYjZhMmUzL3RhYmxlOjA0OTgyOGY1YTAwYTQ3NGRiMTRmZGE5MzYxNTFmMjlhL3RhYmxlcmFuZ2U6MDQ5ODI4ZjVhMDBhNDc0ZGIxNGZkYTkzNjE1MWYyOWFfNC0zLTEtMS0w_9a725745-125f-416c-a57e-5f928020a4b8"
      unitRef="shares">0</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue
      contextRef="i5b77d92575e64e2d8a23bebd827ac114_I20191231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzY2E5YmIwMTc5MjQ3NmZiYjIyNWU1ZDlkZWM4NjlmL3NlYzo5M2NhOWJiMDE3OTI0NzZmYmIyMjVlNWQ5ZGVjODY5Zl80OS9mcmFnOjdkOTcyM2RkMjdkODRhNWFiYjJiMzcyOTJmYjZhMmUzL3RhYmxlOjg4ODQ3NzBiMDg1ODQ4MTE4MzgzYTZjODIzZDhjODMwL3RhYmxlcmFuZ2U6ODg4NDc3MGIwODU4NDgxMTgzODNhNmM4MjNkOGM4MzBfMS0xLTEtMS0w_819de121-1faf-454f-8b7e-284a4901021c"
      unitRef="cadPerShare">0.26</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue
      contextRef="ie7aae3f01257471596ea0269c60c3885_I20200630"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzY2E5YmIwMTc5MjQ3NmZiYjIyNWU1ZDlkZWM4NjlmL3NlYzo5M2NhOWJiMDE3OTI0NzZmYmIyMjVlNWQ5ZGVjODY5Zl80OS9mcmFnOjdkOTcyM2RkMjdkODRhNWFiYjJiMzcyOTJmYjZhMmUzL3RhYmxlOjg4ODQ3NzBiMDg1ODQ4MTE4MzgzYTZjODIzZDhjODMwL3RhYmxlcmFuZ2U6ODg4NDc3MGIwODU4NDgxMTgzODNhNmM4MjNkOGM4MzBfMS0xLTEtMS0w_c930209e-a000-4491-abc1-391e885025e7"
      unitRef="cadPerShare">0.26</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber
      contextRef="i5b77d92575e64e2d8a23bebd827ac114_I20191231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzY2E5YmIwMTc5MjQ3NmZiYjIyNWU1ZDlkZWM4NjlmL3NlYzo5M2NhOWJiMDE3OTI0NzZmYmIyMjVlNWQ5ZGVjODY5Zl80OS9mcmFnOjdkOTcyM2RkMjdkODRhNWFiYjJiMzcyOTJmYjZhMmUzL3RhYmxlOjg4ODQ3NzBiMDg1ODQ4MTE4MzgzYTZjODIzZDhjODMwL3RhYmxlcmFuZ2U6ODg4NDc3MGIwODU4NDgxMTgzODNhNmM4MjNkOGM4MzBfMS0zLTEtMS0w_46cdb59f-846d-46dd-a74e-0d9ea7b37e96"
      unitRef="shares">18066662</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber
      contextRef="ie7aae3f01257471596ea0269c60c3885_I20200630"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzY2E5YmIwMTc5MjQ3NmZiYjIyNWU1ZDlkZWM4NjlmL3NlYzo5M2NhOWJiMDE3OTI0NzZmYmIyMjVlNWQ5ZGVjODY5Zl80OS9mcmFnOjdkOTcyM2RkMjdkODRhNWFiYjJiMzcyOTJmYjZhMmUzL3RhYmxlOjg4ODQ3NzBiMDg1ODQ4MTE4MzgzYTZjODIzZDhjODMwL3RhYmxlcmFuZ2U6ODg4NDc3MGIwODU4NDgxMTgzODNhNmM4MjNkOGM4MzBfMS0zLTEtMS0w_a3825c8f-b647-4773-b6b8-d4c348c2724f"
      unitRef="shares">18066662</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber
      contextRef="iaa2e66f5a2c14062bebba1811782ccd6_I20210630"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzY2E5YmIwMTc5MjQ3NmZiYjIyNWU1ZDlkZWM4NjlmL3NlYzo5M2NhOWJiMDE3OTI0NzZmYmIyMjVlNWQ5ZGVjODY5Zl80OS9mcmFnOjdkOTcyM2RkMjdkODRhNWFiYjJiMzcyOTJmYjZhMmUzL3RleHRyZWdpb246N2Q5NzIzZGQyN2Q4NGE1YWJiMmIzNzI5MmZiNmEyZTNfOTg5NTYwNDY1NDIzMw_a01fecb0-ad10-423e-8841-199ed5424c71"
      unitRef="shares">0</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber>
    <us-gaap:EarningsPerShareTextBlock
      contextRef="i69782326f71a44e3805518280ee22b6b_D20210101-20210630"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzY2E5YmIwMTc5MjQ3NmZiYjIyNWU1ZDlkZWM4NjlmL3NlYzo5M2NhOWJiMDE3OTI0NzZmYmIyMjVlNWQ5ZGVjODY5Zl81Mi9mcmFnOjlkZDkxMTIyZjQxYzQzNzk5OGZlMGIyOGMwYjRhYjgwL3RleHRyZWdpb246OWRkOTExMjJmNDFjNDM3OTk4ZmUwYjI4YzBiNGFiODBfNzE3_83c919e8-4ffa-4ac5-b013-f119b79926a7">Earnings (Loss) per Share&lt;div style="margin-bottom:3pt;margin-top:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Basic and diluted earnings (loss) per share from continuing operations are calculated using the following numerators and denominators:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:50.705%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.566%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.772%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.566%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.772%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.872%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.772%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.875%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;For the three months ended June 30,&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;For the six months ended June 30,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 2.12pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 2.12pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Basic earnings (loss) per share computation&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Net income (loss) from continuing operations attributable to the shareholders of Cronos&#160;Group&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;57,615&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(106,931)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(103,676)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(30,891)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Weighted average number of common shares outstanding&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;371,721,382&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;349,075,408&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;367,391,118&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;348,946,439&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:11.25pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;Basic earnings (loss) from continuing operations per share&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(i)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.15&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(0.31)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(0.28)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(0.09)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:9pt"&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Loss from discontinued operations attributable to the shareholders of Cronos Group&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(561)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(46)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(582)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(46)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Weighted average number of common shares outstanding&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;371,721,382&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;349,075,408&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;367,391,118&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;348,946,439&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Basic earnings from discontinued operations per share&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.00&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.00&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.00&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.00&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:9pt"&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Diluted earnings (loss) per share computation&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Net income (loss) used in the computation of basic earnings (loss) from continuing operations per share&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;57,615&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(106,931)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(103,676)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(30,891)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Adjustment for gain (loss) on revaluation of derivative liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(729)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(729)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Net income (loss) used in the computation of diluted earnings (loss) from continuing operations per share&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;57,615&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(107,660)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(103,676)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(31,620)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:9pt"&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Weighted average number of common shares outstanding used in the computation of basic earnings (loss) per share&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;371,721,382&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;349,075,408&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;367,391,118&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;348,946,439&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Dilutive effect of warrants&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5,577&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Dilutive effect of stock options&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,027,518&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Dilutive effect of RSUs&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;595,379&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;div style="padding-left:11.25pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Weighted average number of common shares for computation of diluted earnings (loss) from continuing operations per share&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(i)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;375,349,856&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;349,075,408&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;367,391,118&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;348,946,439&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Diluted earnings (loss) from continuing operations per share&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.15&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(0.31)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(0.28)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(0.09)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:9pt"&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Loss from discontinued operations attributable to the shareholders of Cronos Group&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(561)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(46)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(582)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(46)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Weighted average number of common shares for computation of diluted loss from discontinued operations per share&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;375,349,856&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;349,075,408&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;367,391,118&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;348,946,439&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Diluted earnings from discontinued operations per share&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.00&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.00&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.00&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.00&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt;margin-top:3pt;padding-left:18pt;text-align:justify;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:400;line-height:120%;position:relative;top:-2.8pt;vertical-align:baseline"&gt;(i)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:13.1pt"&gt;In computing diluted earnings per share, incremental common shares are not considered in periods in which a net loss is reported as the inclusion of the common share equivalents would be anti-dilutive.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:12pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following securities were not included in the computation of diluted shares outstanding because the effect would be anti-dilutive or because conditions for contingently issuable shares were not satisfied at the end of the reporting periods.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:45.705%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.983%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.327%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.983%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.605%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.983%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.327%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.987%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Three months ended June&#160;30,&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Six months ended June&#160;30,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Ginkgo equity milestones&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;14,674,904&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;14,674,904&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;14,674,904&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;14,674,904&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Pre-emptive Rights&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;10,683,330&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;12,006,740&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;10,984,166&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;12,006,740&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Top-up Rights &#x2013; fixed price&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,698,611&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;26,686,413&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7,406,031&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;26,686,413&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Top-up Rights &#x2013; market price&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,504,561&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,941,349&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,063,822&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,941,349&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Altria Warrant&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;82,623,455&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;77,752,533&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;82,606,904&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;77,752,533&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Stock options&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,411,944&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;10,495,235&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6,136,113&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;10,547,256&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Warrants&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;17,521,903&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,784,377&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;17,536,558&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Restricted share units&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;265,904&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,012,249&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;717,127&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,012,249&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total anti-dilutive securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;116,862,709&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;162,091,326&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;128,373,444&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;162,158,002&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:EarningsPerShareTextBlock>
    <us-gaap:ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock
      contextRef="i69782326f71a44e3805518280ee22b6b_D20210101-20210630"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzY2E5YmIwMTc5MjQ3NmZiYjIyNWU1ZDlkZWM4NjlmL3NlYzo5M2NhOWJiMDE3OTI0NzZmYmIyMjVlNWQ5ZGVjODY5Zl81Mi9mcmFnOjlkZDkxMTIyZjQxYzQzNzk5OGZlMGIyOGMwYjRhYjgwL3RleHRyZWdpb246OWRkOTExMjJmNDFjNDM3OTk4ZmUwYjI4YzBiNGFiODBfNzE4_c7ece831-eee2-4664-8209-68b4c085ddec">&lt;div style="margin-bottom:3pt;margin-top:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Basic and diluted earnings (loss) per share from continuing operations are calculated using the following numerators and denominators:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:50.705%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.566%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.772%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.566%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.772%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.872%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.772%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.875%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;For the three months ended June 30,&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;For the six months ended June 30,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 2.12pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 2.12pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Basic earnings (loss) per share computation&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Net income (loss) from continuing operations attributable to the shareholders of Cronos&#160;Group&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;57,615&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(106,931)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(103,676)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(30,891)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Weighted average number of common shares outstanding&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;371,721,382&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;349,075,408&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;367,391,118&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;348,946,439&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:11.25pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;Basic earnings (loss) from continuing operations per share&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(i)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.15&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(0.31)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(0.28)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(0.09)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:9pt"&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Loss from discontinued operations attributable to the shareholders of Cronos Group&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(561)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(46)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(582)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(46)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Weighted average number of common shares outstanding&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;371,721,382&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;349,075,408&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;367,391,118&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;348,946,439&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Basic earnings from discontinued operations per share&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.00&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.00&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.00&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.00&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:9pt"&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Diluted earnings (loss) per share computation&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Net income (loss) used in the computation of basic earnings (loss) from continuing operations per share&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;57,615&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(106,931)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(103,676)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(30,891)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Adjustment for gain (loss) on revaluation of derivative liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(729)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(729)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Net income (loss) used in the computation of diluted earnings (loss) from continuing operations per share&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;57,615&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(107,660)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(103,676)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(31,620)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:9pt"&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Weighted average number of common shares outstanding used in the computation of basic earnings (loss) per share&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;371,721,382&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;349,075,408&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;367,391,118&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;348,946,439&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Dilutive effect of warrants&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5,577&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Dilutive effect of stock options&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,027,518&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Dilutive effect of RSUs&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;595,379&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;div style="padding-left:11.25pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Weighted average number of common shares for computation of diluted earnings (loss) from continuing operations per share&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(i)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;375,349,856&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;349,075,408&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;367,391,118&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;348,946,439&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Diluted earnings (loss) from continuing operations per share&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.15&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(0.31)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(0.28)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(0.09)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:9pt"&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Loss from discontinued operations attributable to the shareholders of Cronos Group&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(561)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(46)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(582)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(46)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Weighted average number of common shares for computation of diluted loss from discontinued operations per share&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;375,349,856&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;349,075,408&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;367,391,118&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;348,946,439&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Diluted earnings from discontinued operations per share&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.00&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.00&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.00&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.00&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt;margin-top:3pt;padding-left:18pt;text-align:justify;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:400;line-height:120%;position:relative;top:-2.8pt;vertical-align:baseline"&gt;(i)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:13.1pt"&gt;In computing diluted earnings per share, incremental common shares are not considered in periods in which a net loss is reported as the inclusion of the common share equivalents would be anti-dilutive.&lt;/span&gt;&lt;/div&gt;</us-gaap:ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock>
    <us-gaap:NetIncomeLossFromContinuingOperationsAvailableToCommonShareholdersBasic
      contextRef="i27f4e53b91ad4367b7f8d273eff27769_D20210401-20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzY2E5YmIwMTc5MjQ3NmZiYjIyNWU1ZDlkZWM4NjlmL3NlYzo5M2NhOWJiMDE3OTI0NzZmYmIyMjVlNWQ5ZGVjODY5Zl81Mi9mcmFnOjlkZDkxMTIyZjQxYzQzNzk5OGZlMGIyOGMwYjRhYjgwL3RhYmxlOmQ2NGI3MDhhZjNkNzQ1NWVhNmU0MGM2NTYyMjk5ZDZkL3RhYmxlcmFuZ2U6ZDY0YjcwOGFmM2Q3NDU1ZWE2ZTQwYzY1NjIyOTlkNmRfMy0xLTEtMS0w_29424dbb-e08f-456d-8419-eb4be6fdd600"
      unitRef="usd">57615000</us-gaap:NetIncomeLossFromContinuingOperationsAvailableToCommonShareholdersBasic>
    <us-gaap:NetIncomeLossFromContinuingOperationsAvailableToCommonShareholdersBasic
      contextRef="i39065c5daf934af885335c12f3cfa83f_D20200401-20200630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzY2E5YmIwMTc5MjQ3NmZiYjIyNWU1ZDlkZWM4NjlmL3NlYzo5M2NhOWJiMDE3OTI0NzZmYmIyMjVlNWQ5ZGVjODY5Zl81Mi9mcmFnOjlkZDkxMTIyZjQxYzQzNzk5OGZlMGIyOGMwYjRhYjgwL3RhYmxlOmQ2NGI3MDhhZjNkNzQ1NWVhNmU0MGM2NTYyMjk5ZDZkL3RhYmxlcmFuZ2U6ZDY0YjcwOGFmM2Q3NDU1ZWE2ZTQwYzY1NjIyOTlkNmRfMy0zLTEtMS0w_3c162154-5e6f-4ff5-a8e6-f5ed5403108d"
      unitRef="usd">-106931000</us-gaap:NetIncomeLossFromContinuingOperationsAvailableToCommonShareholdersBasic>
    <us-gaap:NetIncomeLossFromContinuingOperationsAvailableToCommonShareholdersBasic
      contextRef="i69782326f71a44e3805518280ee22b6b_D20210101-20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzY2E5YmIwMTc5MjQ3NmZiYjIyNWU1ZDlkZWM4NjlmL3NlYzo5M2NhOWJiMDE3OTI0NzZmYmIyMjVlNWQ5ZGVjODY5Zl81Mi9mcmFnOjlkZDkxMTIyZjQxYzQzNzk5OGZlMGIyOGMwYjRhYjgwL3RhYmxlOmQ2NGI3MDhhZjNkNzQ1NWVhNmU0MGM2NTYyMjk5ZDZkL3RhYmxlcmFuZ2U6ZDY0YjcwOGFmM2Q3NDU1ZWE2ZTQwYzY1NjIyOTlkNmRfMy01LTEtMS0w_f65919a5-108c-4adf-80f1-08bd06f98795"
      unitRef="usd">-103676000</us-gaap:NetIncomeLossFromContinuingOperationsAvailableToCommonShareholdersBasic>
    <us-gaap:NetIncomeLossFromContinuingOperationsAvailableToCommonShareholdersBasic
      contextRef="i4a110e4972ef4113880ce582e3cda5c5_D20200101-20200630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzY2E5YmIwMTc5MjQ3NmZiYjIyNWU1ZDlkZWM4NjlmL3NlYzo5M2NhOWJiMDE3OTI0NzZmYmIyMjVlNWQ5ZGVjODY5Zl81Mi9mcmFnOjlkZDkxMTIyZjQxYzQzNzk5OGZlMGIyOGMwYjRhYjgwL3RhYmxlOmQ2NGI3MDhhZjNkNzQ1NWVhNmU0MGM2NTYyMjk5ZDZkL3RhYmxlcmFuZ2U6ZDY0YjcwOGFmM2Q3NDU1ZWE2ZTQwYzY1NjIyOTlkNmRfMy03LTEtMS0w_eb805059-c0f8-4dec-befd-ff84869d9a9e"
      unitRef="usd">-30891000</us-gaap:NetIncomeLossFromContinuingOperationsAvailableToCommonShareholdersBasic>
    <us-gaap:WeightedAverageNumberOfSharesOutstandingBasic
      contextRef="i27f4e53b91ad4367b7f8d273eff27769_D20210401-20210630"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzY2E5YmIwMTc5MjQ3NmZiYjIyNWU1ZDlkZWM4NjlmL3NlYzo5M2NhOWJiMDE3OTI0NzZmYmIyMjVlNWQ5ZGVjODY5Zl81Mi9mcmFnOjlkZDkxMTIyZjQxYzQzNzk5OGZlMGIyOGMwYjRhYjgwL3RhYmxlOmQ2NGI3MDhhZjNkNzQ1NWVhNmU0MGM2NTYyMjk5ZDZkL3RhYmxlcmFuZ2U6ZDY0YjcwOGFmM2Q3NDU1ZWE2ZTQwYzY1NjIyOTlkNmRfNC0xLTEtMS0w_0508c3ce-7e69-44da-a446-a48c778029ef"
      unitRef="shares">371721382</us-gaap:WeightedAverageNumberOfSharesOutstandingBasic>
    <us-gaap:WeightedAverageNumberOfSharesOutstandingBasic
      contextRef="i39065c5daf934af885335c12f3cfa83f_D20200401-20200630"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzY2E5YmIwMTc5MjQ3NmZiYjIyNWU1ZDlkZWM4NjlmL3NlYzo5M2NhOWJiMDE3OTI0NzZmYmIyMjVlNWQ5ZGVjODY5Zl81Mi9mcmFnOjlkZDkxMTIyZjQxYzQzNzk5OGZlMGIyOGMwYjRhYjgwL3RhYmxlOmQ2NGI3MDhhZjNkNzQ1NWVhNmU0MGM2NTYyMjk5ZDZkL3RhYmxlcmFuZ2U6ZDY0YjcwOGFmM2Q3NDU1ZWE2ZTQwYzY1NjIyOTlkNmRfNC0zLTEtMS0w_3debb25a-6c20-4a88-b1f9-c9cddd22d655"
      unitRef="shares">349075408</us-gaap:WeightedAverageNumberOfSharesOutstandingBasic>
    <us-gaap:WeightedAverageNumberOfSharesOutstandingBasic
      contextRef="i69782326f71a44e3805518280ee22b6b_D20210101-20210630"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzY2E5YmIwMTc5MjQ3NmZiYjIyNWU1ZDlkZWM4NjlmL3NlYzo5M2NhOWJiMDE3OTI0NzZmYmIyMjVlNWQ5ZGVjODY5Zl81Mi9mcmFnOjlkZDkxMTIyZjQxYzQzNzk5OGZlMGIyOGMwYjRhYjgwL3RhYmxlOmQ2NGI3MDhhZjNkNzQ1NWVhNmU0MGM2NTYyMjk5ZDZkL3RhYmxlcmFuZ2U6ZDY0YjcwOGFmM2Q3NDU1ZWE2ZTQwYzY1NjIyOTlkNmRfNC01LTEtMS0w_2aeb164a-6f3c-4b8c-be2f-23c6655835ed"
      unitRef="shares">367391118</us-gaap:WeightedAverageNumberOfSharesOutstandingBasic>
    <us-gaap:WeightedAverageNumberOfSharesOutstandingBasic
      contextRef="i4a110e4972ef4113880ce582e3cda5c5_D20200101-20200630"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzY2E5YmIwMTc5MjQ3NmZiYjIyNWU1ZDlkZWM4NjlmL3NlYzo5M2NhOWJiMDE3OTI0NzZmYmIyMjVlNWQ5ZGVjODY5Zl81Mi9mcmFnOjlkZDkxMTIyZjQxYzQzNzk5OGZlMGIyOGMwYjRhYjgwL3RhYmxlOmQ2NGI3MDhhZjNkNzQ1NWVhNmU0MGM2NTYyMjk5ZDZkL3RhYmxlcmFuZ2U6ZDY0YjcwOGFmM2Q3NDU1ZWE2ZTQwYzY1NjIyOTlkNmRfNC03LTEtMS0w_898b5cab-217b-47cc-a8da-27cd1abb0e54"
      unitRef="shares">348946439</us-gaap:WeightedAverageNumberOfSharesOutstandingBasic>
    <us-gaap:IncomeLossFromContinuingOperationsPerBasicShare
      contextRef="i27f4e53b91ad4367b7f8d273eff27769_D20210401-20210630"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzY2E5YmIwMTc5MjQ3NmZiYjIyNWU1ZDlkZWM4NjlmL3NlYzo5M2NhOWJiMDE3OTI0NzZmYmIyMjVlNWQ5ZGVjODY5Zl81Mi9mcmFnOjlkZDkxMTIyZjQxYzQzNzk5OGZlMGIyOGMwYjRhYjgwL3RhYmxlOmQ2NGI3MDhhZjNkNzQ1NWVhNmU0MGM2NTYyMjk5ZDZkL3RhYmxlcmFuZ2U6ZDY0YjcwOGFmM2Q3NDU1ZWE2ZTQwYzY1NjIyOTlkNmRfNS0xLTEtMS0w_0da241c4-8f05-45dd-be8f-03513ed252c6"
      unitRef="usdPerShare">0.15</us-gaap:IncomeLossFromContinuingOperationsPerBasicShare>
    <us-gaap:IncomeLossFromContinuingOperationsPerBasicShare
      contextRef="i39065c5daf934af885335c12f3cfa83f_D20200401-20200630"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzY2E5YmIwMTc5MjQ3NmZiYjIyNWU1ZDlkZWM4NjlmL3NlYzo5M2NhOWJiMDE3OTI0NzZmYmIyMjVlNWQ5ZGVjODY5Zl81Mi9mcmFnOjlkZDkxMTIyZjQxYzQzNzk5OGZlMGIyOGMwYjRhYjgwL3RhYmxlOmQ2NGI3MDhhZjNkNzQ1NWVhNmU0MGM2NTYyMjk5ZDZkL3RhYmxlcmFuZ2U6ZDY0YjcwOGFmM2Q3NDU1ZWE2ZTQwYzY1NjIyOTlkNmRfNS0zLTEtMS0w_199befcd-4ecf-4326-a09a-b0797f7c45e2"
      unitRef="usdPerShare">-0.31</us-gaap:IncomeLossFromContinuingOperationsPerBasicShare>
    <us-gaap:IncomeLossFromContinuingOperationsPerBasicShare
      contextRef="i69782326f71a44e3805518280ee22b6b_D20210101-20210630"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzY2E5YmIwMTc5MjQ3NmZiYjIyNWU1ZDlkZWM4NjlmL3NlYzo5M2NhOWJiMDE3OTI0NzZmYmIyMjVlNWQ5ZGVjODY5Zl81Mi9mcmFnOjlkZDkxMTIyZjQxYzQzNzk5OGZlMGIyOGMwYjRhYjgwL3RhYmxlOmQ2NGI3MDhhZjNkNzQ1NWVhNmU0MGM2NTYyMjk5ZDZkL3RhYmxlcmFuZ2U6ZDY0YjcwOGFmM2Q3NDU1ZWE2ZTQwYzY1NjIyOTlkNmRfNS01LTEtMS0w_4ceb4e89-57e7-457a-aff8-e4284e9ce2b1"
      unitRef="usdPerShare">-0.28</us-gaap:IncomeLossFromContinuingOperationsPerBasicShare>
    <us-gaap:IncomeLossFromContinuingOperationsPerBasicShare
      contextRef="i4a110e4972ef4113880ce582e3cda5c5_D20200101-20200630"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzY2E5YmIwMTc5MjQ3NmZiYjIyNWU1ZDlkZWM4NjlmL3NlYzo5M2NhOWJiMDE3OTI0NzZmYmIyMjVlNWQ5ZGVjODY5Zl81Mi9mcmFnOjlkZDkxMTIyZjQxYzQzNzk5OGZlMGIyOGMwYjRhYjgwL3RhYmxlOmQ2NGI3MDhhZjNkNzQ1NWVhNmU0MGM2NTYyMjk5ZDZkL3RhYmxlcmFuZ2U6ZDY0YjcwOGFmM2Q3NDU1ZWE2ZTQwYzY1NjIyOTlkNmRfNS03LTEtMS0w_81c4ff3c-90a7-414b-84ba-a215015c6042"
      unitRef="usdPerShare">-0.09</us-gaap:IncomeLossFromContinuingOperationsPerBasicShare>
    <us-gaap:NetIncomeLossFromDiscontinuedOperationsAvailableToCommonShareholdersBasic
      contextRef="i27f4e53b91ad4367b7f8d273eff27769_D20210401-20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzY2E5YmIwMTc5MjQ3NmZiYjIyNWU1ZDlkZWM4NjlmL3NlYzo5M2NhOWJiMDE3OTI0NzZmYmIyMjVlNWQ5ZGVjODY5Zl81Mi9mcmFnOjlkZDkxMTIyZjQxYzQzNzk5OGZlMGIyOGMwYjRhYjgwL3RhYmxlOmQ2NGI3MDhhZjNkNzQ1NWVhNmU0MGM2NTYyMjk5ZDZkL3RhYmxlcmFuZ2U6ZDY0YjcwOGFmM2Q3NDU1ZWE2ZTQwYzY1NjIyOTlkNmRfNy0xLTEtMS0xOTE2OQ_8dda8444-4003-422e-891a-aa72f0f3617e"
      unitRef="usd">-561000</us-gaap:NetIncomeLossFromDiscontinuedOperationsAvailableToCommonShareholdersBasic>
    <us-gaap:NetIncomeLossFromDiscontinuedOperationsAvailableToCommonShareholdersBasic
      contextRef="i39065c5daf934af885335c12f3cfa83f_D20200401-20200630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzY2E5YmIwMTc5MjQ3NmZiYjIyNWU1ZDlkZWM4NjlmL3NlYzo5M2NhOWJiMDE3OTI0NzZmYmIyMjVlNWQ5ZGVjODY5Zl81Mi9mcmFnOjlkZDkxMTIyZjQxYzQzNzk5OGZlMGIyOGMwYjRhYjgwL3RhYmxlOmQ2NGI3MDhhZjNkNzQ1NWVhNmU0MGM2NTYyMjk5ZDZkL3RhYmxlcmFuZ2U6ZDY0YjcwOGFmM2Q3NDU1ZWE2ZTQwYzY1NjIyOTlkNmRfNy0zLTEtMS0xOTE2OQ_40610ab6-4c0d-4fc9-b72c-28372035648e"
      unitRef="usd">-46000</us-gaap:NetIncomeLossFromDiscontinuedOperationsAvailableToCommonShareholdersBasic>
    <us-gaap:NetIncomeLossFromDiscontinuedOperationsAvailableToCommonShareholdersBasic
      contextRef="i69782326f71a44e3805518280ee22b6b_D20210101-20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzY2E5YmIwMTc5MjQ3NmZiYjIyNWU1ZDlkZWM4NjlmL3NlYzo5M2NhOWJiMDE3OTI0NzZmYmIyMjVlNWQ5ZGVjODY5Zl81Mi9mcmFnOjlkZDkxMTIyZjQxYzQzNzk5OGZlMGIyOGMwYjRhYjgwL3RhYmxlOmQ2NGI3MDhhZjNkNzQ1NWVhNmU0MGM2NTYyMjk5ZDZkL3RhYmxlcmFuZ2U6ZDY0YjcwOGFmM2Q3NDU1ZWE2ZTQwYzY1NjIyOTlkNmRfNy01LTEtMS0xOTE2OQ_1fa02a03-d5b5-496f-a11e-504a64a6e10b"
      unitRef="usd">-582000</us-gaap:NetIncomeLossFromDiscontinuedOperationsAvailableToCommonShareholdersBasic>
    <us-gaap:NetIncomeLossFromDiscontinuedOperationsAvailableToCommonShareholdersBasic
      contextRef="i4a110e4972ef4113880ce582e3cda5c5_D20200101-20200630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzY2E5YmIwMTc5MjQ3NmZiYjIyNWU1ZDlkZWM4NjlmL3NlYzo5M2NhOWJiMDE3OTI0NzZmYmIyMjVlNWQ5ZGVjODY5Zl81Mi9mcmFnOjlkZDkxMTIyZjQxYzQzNzk5OGZlMGIyOGMwYjRhYjgwL3RhYmxlOmQ2NGI3MDhhZjNkNzQ1NWVhNmU0MGM2NTYyMjk5ZDZkL3RhYmxlcmFuZ2U6ZDY0YjcwOGFmM2Q3NDU1ZWE2ZTQwYzY1NjIyOTlkNmRfNy03LTEtMS0xOTE2OQ_26121a25-aeef-4f13-94ea-2f3c84d5690d"
      unitRef="usd">-46000</us-gaap:NetIncomeLossFromDiscontinuedOperationsAvailableToCommonShareholdersBasic>
    <us-gaap:WeightedAverageNumberOfSharesOutstandingBasic
      contextRef="i27f4e53b91ad4367b7f8d273eff27769_D20210401-20210630"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzY2E5YmIwMTc5MjQ3NmZiYjIyNWU1ZDlkZWM4NjlmL3NlYzo5M2NhOWJiMDE3OTI0NzZmYmIyMjVlNWQ5ZGVjODY5Zl81Mi9mcmFnOjlkZDkxMTIyZjQxYzQzNzk5OGZlMGIyOGMwYjRhYjgwL3RhYmxlOmQ2NGI3MDhhZjNkNzQ1NWVhNmU0MGM2NTYyMjk5ZDZkL3RhYmxlcmFuZ2U6ZDY0YjcwOGFmM2Q3NDU1ZWE2ZTQwYzY1NjIyOTlkNmRfOC0xLTEtMS0xOTE2OQ_8e62d8ca-0a68-42d8-8b92-23014c9f1189"
      unitRef="shares">371721382</us-gaap:WeightedAverageNumberOfSharesOutstandingBasic>
    <us-gaap:WeightedAverageNumberOfSharesOutstandingBasic
      contextRef="i39065c5daf934af885335c12f3cfa83f_D20200401-20200630"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzY2E5YmIwMTc5MjQ3NmZiYjIyNWU1ZDlkZWM4NjlmL3NlYzo5M2NhOWJiMDE3OTI0NzZmYmIyMjVlNWQ5ZGVjODY5Zl81Mi9mcmFnOjlkZDkxMTIyZjQxYzQzNzk5OGZlMGIyOGMwYjRhYjgwL3RhYmxlOmQ2NGI3MDhhZjNkNzQ1NWVhNmU0MGM2NTYyMjk5ZDZkL3RhYmxlcmFuZ2U6ZDY0YjcwOGFmM2Q3NDU1ZWE2ZTQwYzY1NjIyOTlkNmRfOC0zLTEtMS0xOTE2OQ_77b1d58d-2a4a-414f-ac33-f546e44ce51e"
      unitRef="shares">349075408</us-gaap:WeightedAverageNumberOfSharesOutstandingBasic>
    <us-gaap:WeightedAverageNumberOfSharesOutstandingBasic
      contextRef="i69782326f71a44e3805518280ee22b6b_D20210101-20210630"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzY2E5YmIwMTc5MjQ3NmZiYjIyNWU1ZDlkZWM4NjlmL3NlYzo5M2NhOWJiMDE3OTI0NzZmYmIyMjVlNWQ5ZGVjODY5Zl81Mi9mcmFnOjlkZDkxMTIyZjQxYzQzNzk5OGZlMGIyOGMwYjRhYjgwL3RhYmxlOmQ2NGI3MDhhZjNkNzQ1NWVhNmU0MGM2NTYyMjk5ZDZkL3RhYmxlcmFuZ2U6ZDY0YjcwOGFmM2Q3NDU1ZWE2ZTQwYzY1NjIyOTlkNmRfOC01LTEtMS0xOTE2OQ_66131be3-91c5-46c0-b6f1-b5bc54f2e3a7"
      unitRef="shares">367391118</us-gaap:WeightedAverageNumberOfSharesOutstandingBasic>
    <us-gaap:WeightedAverageNumberOfSharesOutstandingBasic
      contextRef="i4a110e4972ef4113880ce582e3cda5c5_D20200101-20200630"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzY2E5YmIwMTc5MjQ3NmZiYjIyNWU1ZDlkZWM4NjlmL3NlYzo5M2NhOWJiMDE3OTI0NzZmYmIyMjVlNWQ5ZGVjODY5Zl81Mi9mcmFnOjlkZDkxMTIyZjQxYzQzNzk5OGZlMGIyOGMwYjRhYjgwL3RhYmxlOmQ2NGI3MDhhZjNkNzQ1NWVhNmU0MGM2NTYyMjk5ZDZkL3RhYmxlcmFuZ2U6ZDY0YjcwOGFmM2Q3NDU1ZWE2ZTQwYzY1NjIyOTlkNmRfOC03LTEtMS0xOTE2OQ_1515293c-ff96-47d4-89ff-2631066cdd21"
      unitRef="shares">348946439</us-gaap:WeightedAverageNumberOfSharesOutstandingBasic>
    <us-gaap:IncomeLossFromDiscontinuedOperationsNetOfTaxPerBasicShare
      contextRef="i27f4e53b91ad4367b7f8d273eff27769_D20210401-20210630"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzY2E5YmIwMTc5MjQ3NmZiYjIyNWU1ZDlkZWM4NjlmL3NlYzo5M2NhOWJiMDE3OTI0NzZmYmIyMjVlNWQ5ZGVjODY5Zl81Mi9mcmFnOjlkZDkxMTIyZjQxYzQzNzk5OGZlMGIyOGMwYjRhYjgwL3RhYmxlOmQ2NGI3MDhhZjNkNzQ1NWVhNmU0MGM2NTYyMjk5ZDZkL3RhYmxlcmFuZ2U6ZDY0YjcwOGFmM2Q3NDU1ZWE2ZTQwYzY1NjIyOTlkNmRfOS0xLTEtMS0xOTE2OQ_0d22c099-3b80-4a92-a0b0-3927c80a8bdf"
      unitRef="usdPerShare">0.00</us-gaap:IncomeLossFromDiscontinuedOperationsNetOfTaxPerBasicShare>
    <us-gaap:IncomeLossFromDiscontinuedOperationsNetOfTaxPerBasicShare
      contextRef="i39065c5daf934af885335c12f3cfa83f_D20200401-20200630"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzY2E5YmIwMTc5MjQ3NmZiYjIyNWU1ZDlkZWM4NjlmL3NlYzo5M2NhOWJiMDE3OTI0NzZmYmIyMjVlNWQ5ZGVjODY5Zl81Mi9mcmFnOjlkZDkxMTIyZjQxYzQzNzk5OGZlMGIyOGMwYjRhYjgwL3RhYmxlOmQ2NGI3MDhhZjNkNzQ1NWVhNmU0MGM2NTYyMjk5ZDZkL3RhYmxlcmFuZ2U6ZDY0YjcwOGFmM2Q3NDU1ZWE2ZTQwYzY1NjIyOTlkNmRfOS0zLTEtMS0xOTE2OQ_637aaf9b-cf74-4b94-a559-a3544c6707eb"
      unitRef="usdPerShare">0.00</us-gaap:IncomeLossFromDiscontinuedOperationsNetOfTaxPerBasicShare>
    <us-gaap:IncomeLossFromDiscontinuedOperationsNetOfTaxPerBasicShare
      contextRef="i69782326f71a44e3805518280ee22b6b_D20210101-20210630"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzY2E5YmIwMTc5MjQ3NmZiYjIyNWU1ZDlkZWM4NjlmL3NlYzo5M2NhOWJiMDE3OTI0NzZmYmIyMjVlNWQ5ZGVjODY5Zl81Mi9mcmFnOjlkZDkxMTIyZjQxYzQzNzk5OGZlMGIyOGMwYjRhYjgwL3RhYmxlOmQ2NGI3MDhhZjNkNzQ1NWVhNmU0MGM2NTYyMjk5ZDZkL3RhYmxlcmFuZ2U6ZDY0YjcwOGFmM2Q3NDU1ZWE2ZTQwYzY1NjIyOTlkNmRfOS01LTEtMS0xOTE2OQ_216e8235-d95b-4aa5-a6dc-aeb473a1d6cf"
      unitRef="usdPerShare">0.00</us-gaap:IncomeLossFromDiscontinuedOperationsNetOfTaxPerBasicShare>
    <us-gaap:IncomeLossFromDiscontinuedOperationsNetOfTaxPerBasicShare
      contextRef="i4a110e4972ef4113880ce582e3cda5c5_D20200101-20200630"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzY2E5YmIwMTc5MjQ3NmZiYjIyNWU1ZDlkZWM4NjlmL3NlYzo5M2NhOWJiMDE3OTI0NzZmYmIyMjVlNWQ5ZGVjODY5Zl81Mi9mcmFnOjlkZDkxMTIyZjQxYzQzNzk5OGZlMGIyOGMwYjRhYjgwL3RhYmxlOmQ2NGI3MDhhZjNkNzQ1NWVhNmU0MGM2NTYyMjk5ZDZkL3RhYmxlcmFuZ2U6ZDY0YjcwOGFmM2Q3NDU1ZWE2ZTQwYzY1NjIyOTlkNmRfOS03LTEtMS0xOTE2OQ_5ab8315c-4db3-40b6-960b-1d6104d848f4"
      unitRef="usdPerShare">0.00</us-gaap:IncomeLossFromDiscontinuedOperationsNetOfTaxPerBasicShare>
    <us-gaap:NetIncomeLossFromContinuingOperationsAvailableToCommonShareholdersBasic
      contextRef="i27f4e53b91ad4367b7f8d273eff27769_D20210401-20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzY2E5YmIwMTc5MjQ3NmZiYjIyNWU1ZDlkZWM4NjlmL3NlYzo5M2NhOWJiMDE3OTI0NzZmYmIyMjVlNWQ5ZGVjODY5Zl81Mi9mcmFnOjlkZDkxMTIyZjQxYzQzNzk5OGZlMGIyOGMwYjRhYjgwL3RhYmxlOmQ2NGI3MDhhZjNkNzQ1NWVhNmU0MGM2NTYyMjk5ZDZkL3RhYmxlcmFuZ2U6ZDY0YjcwOGFmM2Q3NDU1ZWE2ZTQwYzY1NjIyOTlkNmRfNy0xLTEtMS0w_4c439f2a-99b9-4d63-8bf1-9773839b87c7"
      unitRef="usd">57615000</us-gaap:NetIncomeLossFromContinuingOperationsAvailableToCommonShareholdersBasic>
    <us-gaap:NetIncomeLossFromContinuingOperationsAvailableToCommonShareholdersBasic
      contextRef="i39065c5daf934af885335c12f3cfa83f_D20200401-20200630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzY2E5YmIwMTc5MjQ3NmZiYjIyNWU1ZDlkZWM4NjlmL3NlYzo5M2NhOWJiMDE3OTI0NzZmYmIyMjVlNWQ5ZGVjODY5Zl81Mi9mcmFnOjlkZDkxMTIyZjQxYzQzNzk5OGZlMGIyOGMwYjRhYjgwL3RhYmxlOmQ2NGI3MDhhZjNkNzQ1NWVhNmU0MGM2NTYyMjk5ZDZkL3RhYmxlcmFuZ2U6ZDY0YjcwOGFmM2Q3NDU1ZWE2ZTQwYzY1NjIyOTlkNmRfNy0zLTEtMS0w_adddecbf-195f-4609-8ee7-585f46546e43"
      unitRef="usd">-106931000</us-gaap:NetIncomeLossFromContinuingOperationsAvailableToCommonShareholdersBasic>
    <us-gaap:NetIncomeLossFromContinuingOperationsAvailableToCommonShareholdersBasic
      contextRef="i69782326f71a44e3805518280ee22b6b_D20210101-20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzY2E5YmIwMTc5MjQ3NmZiYjIyNWU1ZDlkZWM4NjlmL3NlYzo5M2NhOWJiMDE3OTI0NzZmYmIyMjVlNWQ5ZGVjODY5Zl81Mi9mcmFnOjlkZDkxMTIyZjQxYzQzNzk5OGZlMGIyOGMwYjRhYjgwL3RhYmxlOmQ2NGI3MDhhZjNkNzQ1NWVhNmU0MGM2NTYyMjk5ZDZkL3RhYmxlcmFuZ2U6ZDY0YjcwOGFmM2Q3NDU1ZWE2ZTQwYzY1NjIyOTlkNmRfNy01LTEtMS0w_13771483-fbce-43f7-84f0-b485717346de"
      unitRef="usd">-103676000</us-gaap:NetIncomeLossFromContinuingOperationsAvailableToCommonShareholdersBasic>
    <us-gaap:NetIncomeLossFromContinuingOperationsAvailableToCommonShareholdersBasic
      contextRef="i4a110e4972ef4113880ce582e3cda5c5_D20200101-20200630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzY2E5YmIwMTc5MjQ3NmZiYjIyNWU1ZDlkZWM4NjlmL3NlYzo5M2NhOWJiMDE3OTI0NzZmYmIyMjVlNWQ5ZGVjODY5Zl81Mi9mcmFnOjlkZDkxMTIyZjQxYzQzNzk5OGZlMGIyOGMwYjRhYjgwL3RhYmxlOmQ2NGI3MDhhZjNkNzQ1NWVhNmU0MGM2NTYyMjk5ZDZkL3RhYmxlcmFuZ2U6ZDY0YjcwOGFmM2Q3NDU1ZWE2ZTQwYzY1NjIyOTlkNmRfNy03LTEtMS0w_581f3439-c903-435e-9c9f-51b229141306"
      unitRef="usd">-30891000</us-gaap:NetIncomeLossFromContinuingOperationsAvailableToCommonShareholdersBasic>
    <us-gaap:DilutiveSecurities
      contextRef="i27f4e53b91ad4367b7f8d273eff27769_D20210401-20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzY2E5YmIwMTc5MjQ3NmZiYjIyNWU1ZDlkZWM4NjlmL3NlYzo5M2NhOWJiMDE3OTI0NzZmYmIyMjVlNWQ5ZGVjODY5Zl81Mi9mcmFnOjlkZDkxMTIyZjQxYzQzNzk5OGZlMGIyOGMwYjRhYjgwL3RhYmxlOmQ2NGI3MDhhZjNkNzQ1NWVhNmU0MGM2NTYyMjk5ZDZkL3RhYmxlcmFuZ2U6ZDY0YjcwOGFmM2Q3NDU1ZWE2ZTQwYzY1NjIyOTlkNmRfOC0xLTEtMS0w_68d52c15-c56b-428f-8aa3-546bf5150ab3"
      unitRef="usd">0</us-gaap:DilutiveSecurities>
    <us-gaap:DilutiveSecurities
      contextRef="i39065c5daf934af885335c12f3cfa83f_D20200401-20200630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzY2E5YmIwMTc5MjQ3NmZiYjIyNWU1ZDlkZWM4NjlmL3NlYzo5M2NhOWJiMDE3OTI0NzZmYmIyMjVlNWQ5ZGVjODY5Zl81Mi9mcmFnOjlkZDkxMTIyZjQxYzQzNzk5OGZlMGIyOGMwYjRhYjgwL3RhYmxlOmQ2NGI3MDhhZjNkNzQ1NWVhNmU0MGM2NTYyMjk5ZDZkL3RhYmxlcmFuZ2U6ZDY0YjcwOGFmM2Q3NDU1ZWE2ZTQwYzY1NjIyOTlkNmRfOC0zLTEtMS0w_3f186e2d-9318-43e1-a697-af5fd34a4a64"
      unitRef="usd">-729000</us-gaap:DilutiveSecurities>
    <us-gaap:DilutiveSecurities
      contextRef="i69782326f71a44e3805518280ee22b6b_D20210101-20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzY2E5YmIwMTc5MjQ3NmZiYjIyNWU1ZDlkZWM4NjlmL3NlYzo5M2NhOWJiMDE3OTI0NzZmYmIyMjVlNWQ5ZGVjODY5Zl81Mi9mcmFnOjlkZDkxMTIyZjQxYzQzNzk5OGZlMGIyOGMwYjRhYjgwL3RhYmxlOmQ2NGI3MDhhZjNkNzQ1NWVhNmU0MGM2NTYyMjk5ZDZkL3RhYmxlcmFuZ2U6ZDY0YjcwOGFmM2Q3NDU1ZWE2ZTQwYzY1NjIyOTlkNmRfOC01LTEtMS0w_5a71d3b7-1e72-4733-a054-3f817922de9c"
      unitRef="usd">0</us-gaap:DilutiveSecurities>
    <us-gaap:DilutiveSecurities
      contextRef="i4a110e4972ef4113880ce582e3cda5c5_D20200101-20200630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzY2E5YmIwMTc5MjQ3NmZiYjIyNWU1ZDlkZWM4NjlmL3NlYzo5M2NhOWJiMDE3OTI0NzZmYmIyMjVlNWQ5ZGVjODY5Zl81Mi9mcmFnOjlkZDkxMTIyZjQxYzQzNzk5OGZlMGIyOGMwYjRhYjgwL3RhYmxlOmQ2NGI3MDhhZjNkNzQ1NWVhNmU0MGM2NTYyMjk5ZDZkL3RhYmxlcmFuZ2U6ZDY0YjcwOGFmM2Q3NDU1ZWE2ZTQwYzY1NjIyOTlkNmRfOC03LTEtMS0w_ce14450a-6dd1-4b40-b430-1814abe5ca34"
      unitRef="usd">-729000</us-gaap:DilutiveSecurities>
    <us-gaap:NetIncomeLossFromContinuingOperationsAvailableToCommonShareholdersDiluted
      contextRef="i27f4e53b91ad4367b7f8d273eff27769_D20210401-20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzY2E5YmIwMTc5MjQ3NmZiYjIyNWU1ZDlkZWM4NjlmL3NlYzo5M2NhOWJiMDE3OTI0NzZmYmIyMjVlNWQ5ZGVjODY5Zl81Mi9mcmFnOjlkZDkxMTIyZjQxYzQzNzk5OGZlMGIyOGMwYjRhYjgwL3RhYmxlOmQ2NGI3MDhhZjNkNzQ1NWVhNmU0MGM2NTYyMjk5ZDZkL3RhYmxlcmFuZ2U6ZDY0YjcwOGFmM2Q3NDU1ZWE2ZTQwYzY1NjIyOTlkNmRfOS0xLTEtMS0w_9fe034cf-6265-4970-bcc7-db6fc6bdf720"
      unitRef="usd">57615000</us-gaap:NetIncomeLossFromContinuingOperationsAvailableToCommonShareholdersDiluted>
    <us-gaap:NetIncomeLossFromContinuingOperationsAvailableToCommonShareholdersDiluted
      contextRef="i39065c5daf934af885335c12f3cfa83f_D20200401-20200630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzY2E5YmIwMTc5MjQ3NmZiYjIyNWU1ZDlkZWM4NjlmL3NlYzo5M2NhOWJiMDE3OTI0NzZmYmIyMjVlNWQ5ZGVjODY5Zl81Mi9mcmFnOjlkZDkxMTIyZjQxYzQzNzk5OGZlMGIyOGMwYjRhYjgwL3RhYmxlOmQ2NGI3MDhhZjNkNzQ1NWVhNmU0MGM2NTYyMjk5ZDZkL3RhYmxlcmFuZ2U6ZDY0YjcwOGFmM2Q3NDU1ZWE2ZTQwYzY1NjIyOTlkNmRfOS0zLTEtMS0w_278b8152-b23f-46c5-b65a-4a94397fa4b4"
      unitRef="usd">-107660000</us-gaap:NetIncomeLossFromContinuingOperationsAvailableToCommonShareholdersDiluted>
    <us-gaap:NetIncomeLossFromContinuingOperationsAvailableToCommonShareholdersDiluted
      contextRef="i69782326f71a44e3805518280ee22b6b_D20210101-20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzY2E5YmIwMTc5MjQ3NmZiYjIyNWU1ZDlkZWM4NjlmL3NlYzo5M2NhOWJiMDE3OTI0NzZmYmIyMjVlNWQ5ZGVjODY5Zl81Mi9mcmFnOjlkZDkxMTIyZjQxYzQzNzk5OGZlMGIyOGMwYjRhYjgwL3RhYmxlOmQ2NGI3MDhhZjNkNzQ1NWVhNmU0MGM2NTYyMjk5ZDZkL3RhYmxlcmFuZ2U6ZDY0YjcwOGFmM2Q3NDU1ZWE2ZTQwYzY1NjIyOTlkNmRfOS01LTEtMS0w_ecad5897-c6be-49d5-9466-0971df4129bb"
      unitRef="usd">-103676000</us-gaap:NetIncomeLossFromContinuingOperationsAvailableToCommonShareholdersDiluted>
    <us-gaap:NetIncomeLossFromContinuingOperationsAvailableToCommonShareholdersDiluted
      contextRef="i4a110e4972ef4113880ce582e3cda5c5_D20200101-20200630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzY2E5YmIwMTc5MjQ3NmZiYjIyNWU1ZDlkZWM4NjlmL3NlYzo5M2NhOWJiMDE3OTI0NzZmYmIyMjVlNWQ5ZGVjODY5Zl81Mi9mcmFnOjlkZDkxMTIyZjQxYzQzNzk5OGZlMGIyOGMwYjRhYjgwL3RhYmxlOmQ2NGI3MDhhZjNkNzQ1NWVhNmU0MGM2NTYyMjk5ZDZkL3RhYmxlcmFuZ2U6ZDY0YjcwOGFmM2Q3NDU1ZWE2ZTQwYzY1NjIyOTlkNmRfOS03LTEtMS0w_207de005-1408-4e1f-951a-847510918bf2"
      unitRef="usd">-31620000</us-gaap:NetIncomeLossFromContinuingOperationsAvailableToCommonShareholdersDiluted>
    <us-gaap:WeightedAverageNumberOfSharesOutstandingBasic
      contextRef="i27f4e53b91ad4367b7f8d273eff27769_D20210401-20210630"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzY2E5YmIwMTc5MjQ3NmZiYjIyNWU1ZDlkZWM4NjlmL3NlYzo5M2NhOWJiMDE3OTI0NzZmYmIyMjVlNWQ5ZGVjODY5Zl81Mi9mcmFnOjlkZDkxMTIyZjQxYzQzNzk5OGZlMGIyOGMwYjRhYjgwL3RhYmxlOmQ2NGI3MDhhZjNkNzQ1NWVhNmU0MGM2NTYyMjk5ZDZkL3RhYmxlcmFuZ2U6ZDY0YjcwOGFmM2Q3NDU1ZWE2ZTQwYzY1NjIyOTlkNmRfMTEtMS0xLTEtMA_c5250765-7544-4221-9fb4-dcb6899dfe61"
      unitRef="shares">371721382</us-gaap:WeightedAverageNumberOfSharesOutstandingBasic>
    <us-gaap:WeightedAverageNumberOfSharesOutstandingBasic
      contextRef="i39065c5daf934af885335c12f3cfa83f_D20200401-20200630"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzY2E5YmIwMTc5MjQ3NmZiYjIyNWU1ZDlkZWM4NjlmL3NlYzo5M2NhOWJiMDE3OTI0NzZmYmIyMjVlNWQ5ZGVjODY5Zl81Mi9mcmFnOjlkZDkxMTIyZjQxYzQzNzk5OGZlMGIyOGMwYjRhYjgwL3RhYmxlOmQ2NGI3MDhhZjNkNzQ1NWVhNmU0MGM2NTYyMjk5ZDZkL3RhYmxlcmFuZ2U6ZDY0YjcwOGFmM2Q3NDU1ZWE2ZTQwYzY1NjIyOTlkNmRfMTEtMy0xLTEtMA_891ab39f-b0a8-402a-9552-714c361cce01"
      unitRef="shares">349075408</us-gaap:WeightedAverageNumberOfSharesOutstandingBasic>
    <us-gaap:WeightedAverageNumberOfSharesOutstandingBasic
      contextRef="i69782326f71a44e3805518280ee22b6b_D20210101-20210630"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzY2E5YmIwMTc5MjQ3NmZiYjIyNWU1ZDlkZWM4NjlmL3NlYzo5M2NhOWJiMDE3OTI0NzZmYmIyMjVlNWQ5ZGVjODY5Zl81Mi9mcmFnOjlkZDkxMTIyZjQxYzQzNzk5OGZlMGIyOGMwYjRhYjgwL3RhYmxlOmQ2NGI3MDhhZjNkNzQ1NWVhNmU0MGM2NTYyMjk5ZDZkL3RhYmxlcmFuZ2U6ZDY0YjcwOGFmM2Q3NDU1ZWE2ZTQwYzY1NjIyOTlkNmRfMTEtNS0xLTEtMA_f17f8b3d-b0bf-4cf2-b5a8-8001d7f1c188"
      unitRef="shares">367391118</us-gaap:WeightedAverageNumberOfSharesOutstandingBasic>
    <us-gaap:WeightedAverageNumberOfSharesOutstandingBasic
      contextRef="i4a110e4972ef4113880ce582e3cda5c5_D20200101-20200630"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzY2E5YmIwMTc5MjQ3NmZiYjIyNWU1ZDlkZWM4NjlmL3NlYzo5M2NhOWJiMDE3OTI0NzZmYmIyMjVlNWQ5ZGVjODY5Zl81Mi9mcmFnOjlkZDkxMTIyZjQxYzQzNzk5OGZlMGIyOGMwYjRhYjgwL3RhYmxlOmQ2NGI3MDhhZjNkNzQ1NWVhNmU0MGM2NTYyMjk5ZDZkL3RhYmxlcmFuZ2U6ZDY0YjcwOGFmM2Q3NDU1ZWE2ZTQwYzY1NjIyOTlkNmRfMTEtNy0xLTEtMA_754a2b28-b91c-46bb-83cd-cc4fd4a79c20"
      unitRef="shares">348946439</us-gaap:WeightedAverageNumberOfSharesOutstandingBasic>
    <us-gaap:IncrementalCommonSharesAttributableToShareBasedPaymentArrangements
      contextRef="ibfe5b711341a4fa5b15c489835848fe5_D20210401-20210630"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzY2E5YmIwMTc5MjQ3NmZiYjIyNWU1ZDlkZWM4NjlmL3NlYzo5M2NhOWJiMDE3OTI0NzZmYmIyMjVlNWQ5ZGVjODY5Zl81Mi9mcmFnOjlkZDkxMTIyZjQxYzQzNzk5OGZlMGIyOGMwYjRhYjgwL3RhYmxlOmQ2NGI3MDhhZjNkNzQ1NWVhNmU0MGM2NTYyMjk5ZDZkL3RhYmxlcmFuZ2U6ZDY0YjcwOGFmM2Q3NDU1ZWE2ZTQwYzY1NjIyOTlkNmRfMTItMS0xLTEtMA_3196ded5-16ad-4b47-b5ff-7f4f260f33b1"
      unitRef="shares">5577</us-gaap:IncrementalCommonSharesAttributableToShareBasedPaymentArrangements>
    <us-gaap:IncrementalCommonSharesAttributableToShareBasedPaymentArrangements
      contextRef="ife69fdb8512f485a8a3f1f66e868a24d_D20200401-20200630"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzY2E5YmIwMTc5MjQ3NmZiYjIyNWU1ZDlkZWM4NjlmL3NlYzo5M2NhOWJiMDE3OTI0NzZmYmIyMjVlNWQ5ZGVjODY5Zl81Mi9mcmFnOjlkZDkxMTIyZjQxYzQzNzk5OGZlMGIyOGMwYjRhYjgwL3RhYmxlOmQ2NGI3MDhhZjNkNzQ1NWVhNmU0MGM2NTYyMjk5ZDZkL3RhYmxlcmFuZ2U6ZDY0YjcwOGFmM2Q3NDU1ZWE2ZTQwYzY1NjIyOTlkNmRfMTItMy0xLTEtMA_e7d19ebe-bb12-4fd2-8193-b4302f60808c"
      unitRef="shares">0</us-gaap:IncrementalCommonSharesAttributableToShareBasedPaymentArrangements>
    <us-gaap:IncrementalCommonSharesAttributableToShareBasedPaymentArrangements
      contextRef="ic97055dc0db04af88f485b12b96f84c2_D20210101-20210630"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzY2E5YmIwMTc5MjQ3NmZiYjIyNWU1ZDlkZWM4NjlmL3NlYzo5M2NhOWJiMDE3OTI0NzZmYmIyMjVlNWQ5ZGVjODY5Zl81Mi9mcmFnOjlkZDkxMTIyZjQxYzQzNzk5OGZlMGIyOGMwYjRhYjgwL3RhYmxlOmQ2NGI3MDhhZjNkNzQ1NWVhNmU0MGM2NTYyMjk5ZDZkL3RhYmxlcmFuZ2U6ZDY0YjcwOGFmM2Q3NDU1ZWE2ZTQwYzY1NjIyOTlkNmRfMTItNS0xLTEtMA_20d63197-dfa3-431e-968a-12d8711ec4a4"
      unitRef="shares">0</us-gaap:IncrementalCommonSharesAttributableToShareBasedPaymentArrangements>
    <us-gaap:IncrementalCommonSharesAttributableToShareBasedPaymentArrangements
      contextRef="i4558c25f511848f29e1d0d9bd1c7f160_D20200101-20200630"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzY2E5YmIwMTc5MjQ3NmZiYjIyNWU1ZDlkZWM4NjlmL3NlYzo5M2NhOWJiMDE3OTI0NzZmYmIyMjVlNWQ5ZGVjODY5Zl81Mi9mcmFnOjlkZDkxMTIyZjQxYzQzNzk5OGZlMGIyOGMwYjRhYjgwL3RhYmxlOmQ2NGI3MDhhZjNkNzQ1NWVhNmU0MGM2NTYyMjk5ZDZkL3RhYmxlcmFuZ2U6ZDY0YjcwOGFmM2Q3NDU1ZWE2ZTQwYzY1NjIyOTlkNmRfMTItNy0xLTEtMA_6522e4d8-617c-49d3-b9e0-2e04a780e6d5"
      unitRef="shares">0</us-gaap:IncrementalCommonSharesAttributableToShareBasedPaymentArrangements>
    <us-gaap:IncrementalCommonSharesAttributableToShareBasedPaymentArrangements
      contextRef="i1e4726863b724a379f5bd7d27ab5b3cc_D20210401-20210630"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzY2E5YmIwMTc5MjQ3NmZiYjIyNWU1ZDlkZWM4NjlmL3NlYzo5M2NhOWJiMDE3OTI0NzZmYmIyMjVlNWQ5ZGVjODY5Zl81Mi9mcmFnOjlkZDkxMTIyZjQxYzQzNzk5OGZlMGIyOGMwYjRhYjgwL3RhYmxlOmQ2NGI3MDhhZjNkNzQ1NWVhNmU0MGM2NTYyMjk5ZDZkL3RhYmxlcmFuZ2U6ZDY0YjcwOGFmM2Q3NDU1ZWE2ZTQwYzY1NjIyOTlkNmRfMTMtMS0xLTEtMA_4318fba8-0c34-4d82-89b6-4d77ae85c464"
      unitRef="shares">3027518</us-gaap:IncrementalCommonSharesAttributableToShareBasedPaymentArrangements>
    <us-gaap:IncrementalCommonSharesAttributableToShareBasedPaymentArrangements
      contextRef="ie0f42dd5b3d34fe38a076491f8d4a0a5_D20200401-20200630"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzY2E5YmIwMTc5MjQ3NmZiYjIyNWU1ZDlkZWM4NjlmL3NlYzo5M2NhOWJiMDE3OTI0NzZmYmIyMjVlNWQ5ZGVjODY5Zl81Mi9mcmFnOjlkZDkxMTIyZjQxYzQzNzk5OGZlMGIyOGMwYjRhYjgwL3RhYmxlOmQ2NGI3MDhhZjNkNzQ1NWVhNmU0MGM2NTYyMjk5ZDZkL3RhYmxlcmFuZ2U6ZDY0YjcwOGFmM2Q3NDU1ZWE2ZTQwYzY1NjIyOTlkNmRfMTMtMy0xLTEtMA_f066c33b-4cf7-4dbd-abb6-8c9e69ae9f44"
      unitRef="shares">0</us-gaap:IncrementalCommonSharesAttributableToShareBasedPaymentArrangements>
    <us-gaap:IncrementalCommonSharesAttributableToShareBasedPaymentArrangements
      contextRef="idaf424f34df645f9a313b3cbd11846bb_D20210101-20210630"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzY2E5YmIwMTc5MjQ3NmZiYjIyNWU1ZDlkZWM4NjlmL3NlYzo5M2NhOWJiMDE3OTI0NzZmYmIyMjVlNWQ5ZGVjODY5Zl81Mi9mcmFnOjlkZDkxMTIyZjQxYzQzNzk5OGZlMGIyOGMwYjRhYjgwL3RhYmxlOmQ2NGI3MDhhZjNkNzQ1NWVhNmU0MGM2NTYyMjk5ZDZkL3RhYmxlcmFuZ2U6ZDY0YjcwOGFmM2Q3NDU1ZWE2ZTQwYzY1NjIyOTlkNmRfMTMtNS0xLTEtMA_cb22d87b-9c48-4770-afbb-fa8fd91dd0ff"
      unitRef="shares">0</us-gaap:IncrementalCommonSharesAttributableToShareBasedPaymentArrangements>
    <us-gaap:IncrementalCommonSharesAttributableToShareBasedPaymentArrangements
      contextRef="ib8a293d71fca4827bbf9cac05f24fe68_D20200101-20200630"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzY2E5YmIwMTc5MjQ3NmZiYjIyNWU1ZDlkZWM4NjlmL3NlYzo5M2NhOWJiMDE3OTI0NzZmYmIyMjVlNWQ5ZGVjODY5Zl81Mi9mcmFnOjlkZDkxMTIyZjQxYzQzNzk5OGZlMGIyOGMwYjRhYjgwL3RhYmxlOmQ2NGI3MDhhZjNkNzQ1NWVhNmU0MGM2NTYyMjk5ZDZkL3RhYmxlcmFuZ2U6ZDY0YjcwOGFmM2Q3NDU1ZWE2ZTQwYzY1NjIyOTlkNmRfMTMtNy0xLTEtMA_73a98ecb-6fd2-45fa-884d-cbd8bc3645a0"
      unitRef="shares">0</us-gaap:IncrementalCommonSharesAttributableToShareBasedPaymentArrangements>
    <us-gaap:IncrementalCommonSharesAttributableToShareBasedPaymentArrangements
      contextRef="ia9e804ad8293416391f6038663c9425b_D20210401-20210630"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzY2E5YmIwMTc5MjQ3NmZiYjIyNWU1ZDlkZWM4NjlmL3NlYzo5M2NhOWJiMDE3OTI0NzZmYmIyMjVlNWQ5ZGVjODY5Zl81Mi9mcmFnOjlkZDkxMTIyZjQxYzQzNzk5OGZlMGIyOGMwYjRhYjgwL3RhYmxlOmQ2NGI3MDhhZjNkNzQ1NWVhNmU0MGM2NTYyMjk5ZDZkL3RhYmxlcmFuZ2U6ZDY0YjcwOGFmM2Q3NDU1ZWE2ZTQwYzY1NjIyOTlkNmRfMTQtMS0xLTEtMA_1c9a87c5-0227-4976-8584-239734114cc3"
      unitRef="shares">595379</us-gaap:IncrementalCommonSharesAttributableToShareBasedPaymentArrangements>
    <us-gaap:IncrementalCommonSharesAttributableToShareBasedPaymentArrangements
      contextRef="if0a238351a57425a8c0ba03f482ef4b9_D20200401-20200630"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzY2E5YmIwMTc5MjQ3NmZiYjIyNWU1ZDlkZWM4NjlmL3NlYzo5M2NhOWJiMDE3OTI0NzZmYmIyMjVlNWQ5ZGVjODY5Zl81Mi9mcmFnOjlkZDkxMTIyZjQxYzQzNzk5OGZlMGIyOGMwYjRhYjgwL3RhYmxlOmQ2NGI3MDhhZjNkNzQ1NWVhNmU0MGM2NTYyMjk5ZDZkL3RhYmxlcmFuZ2U6ZDY0YjcwOGFmM2Q3NDU1ZWE2ZTQwYzY1NjIyOTlkNmRfMTQtMy0xLTEtMA_da134421-02b3-4a91-83e8-ba3100ed8766"
      unitRef="shares">0</us-gaap:IncrementalCommonSharesAttributableToShareBasedPaymentArrangements>
    <us-gaap:IncrementalCommonSharesAttributableToShareBasedPaymentArrangements
      contextRef="ie5eb2f0b8440403abdac2db9e01adbb9_D20210101-20210630"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzY2E5YmIwMTc5MjQ3NmZiYjIyNWU1ZDlkZWM4NjlmL3NlYzo5M2NhOWJiMDE3OTI0NzZmYmIyMjVlNWQ5ZGVjODY5Zl81Mi9mcmFnOjlkZDkxMTIyZjQxYzQzNzk5OGZlMGIyOGMwYjRhYjgwL3RhYmxlOmQ2NGI3MDhhZjNkNzQ1NWVhNmU0MGM2NTYyMjk5ZDZkL3RhYmxlcmFuZ2U6ZDY0YjcwOGFmM2Q3NDU1ZWE2ZTQwYzY1NjIyOTlkNmRfMTQtNS0xLTEtMA_69cdac88-daf5-4580-8f0b-8927ae4e24b4"
      unitRef="shares">0</us-gaap:IncrementalCommonSharesAttributableToShareBasedPaymentArrangements>
    <us-gaap:IncrementalCommonSharesAttributableToShareBasedPaymentArrangements
      contextRef="i10cd1c126464402b99bfac52e7ebdbb2_D20200101-20200630"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzY2E5YmIwMTc5MjQ3NmZiYjIyNWU1ZDlkZWM4NjlmL3NlYzo5M2NhOWJiMDE3OTI0NzZmYmIyMjVlNWQ5ZGVjODY5Zl81Mi9mcmFnOjlkZDkxMTIyZjQxYzQzNzk5OGZlMGIyOGMwYjRhYjgwL3RhYmxlOmQ2NGI3MDhhZjNkNzQ1NWVhNmU0MGM2NTYyMjk5ZDZkL3RhYmxlcmFuZ2U6ZDY0YjcwOGFmM2Q3NDU1ZWE2ZTQwYzY1NjIyOTlkNmRfMTQtNy0xLTEtMA_199b738c-9a17-42c1-a843-75da81d418a2"
      unitRef="shares">0</us-gaap:IncrementalCommonSharesAttributableToShareBasedPaymentArrangements>
    <us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding
      contextRef="i27f4e53b91ad4367b7f8d273eff27769_D20210401-20210630"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzY2E5YmIwMTc5MjQ3NmZiYjIyNWU1ZDlkZWM4NjlmL3NlYzo5M2NhOWJiMDE3OTI0NzZmYmIyMjVlNWQ5ZGVjODY5Zl81Mi9mcmFnOjlkZDkxMTIyZjQxYzQzNzk5OGZlMGIyOGMwYjRhYjgwL3RhYmxlOmQ2NGI3MDhhZjNkNzQ1NWVhNmU0MGM2NTYyMjk5ZDZkL3RhYmxlcmFuZ2U6ZDY0YjcwOGFmM2Q3NDU1ZWE2ZTQwYzY1NjIyOTlkNmRfMTctMS0xLTEtMA_286055b8-99e5-4121-8ee8-a2a7a07a2446"
      unitRef="shares">375349856</us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding>
    <us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding
      contextRef="i39065c5daf934af885335c12f3cfa83f_D20200401-20200630"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzY2E5YmIwMTc5MjQ3NmZiYjIyNWU1ZDlkZWM4NjlmL3NlYzo5M2NhOWJiMDE3OTI0NzZmYmIyMjVlNWQ5ZGVjODY5Zl81Mi9mcmFnOjlkZDkxMTIyZjQxYzQzNzk5OGZlMGIyOGMwYjRhYjgwL3RhYmxlOmQ2NGI3MDhhZjNkNzQ1NWVhNmU0MGM2NTYyMjk5ZDZkL3RhYmxlcmFuZ2U6ZDY0YjcwOGFmM2Q3NDU1ZWE2ZTQwYzY1NjIyOTlkNmRfMTctMy0xLTEtMA_52c4e66b-3922-4913-8ef0-99d403be3436"
      unitRef="shares">349075408</us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding>
    <us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding
      contextRef="i69782326f71a44e3805518280ee22b6b_D20210101-20210630"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzY2E5YmIwMTc5MjQ3NmZiYjIyNWU1ZDlkZWM4NjlmL3NlYzo5M2NhOWJiMDE3OTI0NzZmYmIyMjVlNWQ5ZGVjODY5Zl81Mi9mcmFnOjlkZDkxMTIyZjQxYzQzNzk5OGZlMGIyOGMwYjRhYjgwL3RhYmxlOmQ2NGI3MDhhZjNkNzQ1NWVhNmU0MGM2NTYyMjk5ZDZkL3RhYmxlcmFuZ2U6ZDY0YjcwOGFmM2Q3NDU1ZWE2ZTQwYzY1NjIyOTlkNmRfMTctNS0xLTEtMA_573aa8b7-bf4a-41e3-9d84-1d7057dffd3b"
      unitRef="shares">367391118</us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding>
    <us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding
      contextRef="i4a110e4972ef4113880ce582e3cda5c5_D20200101-20200630"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzY2E5YmIwMTc5MjQ3NmZiYjIyNWU1ZDlkZWM4NjlmL3NlYzo5M2NhOWJiMDE3OTI0NzZmYmIyMjVlNWQ5ZGVjODY5Zl81Mi9mcmFnOjlkZDkxMTIyZjQxYzQzNzk5OGZlMGIyOGMwYjRhYjgwL3RhYmxlOmQ2NGI3MDhhZjNkNzQ1NWVhNmU0MGM2NTYyMjk5ZDZkL3RhYmxlcmFuZ2U6ZDY0YjcwOGFmM2Q3NDU1ZWE2ZTQwYzY1NjIyOTlkNmRfMTctNy0xLTEtMA_eecd38c8-76db-42c3-a5f6-fc8fa86a360c"
      unitRef="shares">348946439</us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding>
    <us-gaap:IncomeLossFromContinuingOperationsPerDilutedShare
      contextRef="i27f4e53b91ad4367b7f8d273eff27769_D20210401-20210630"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzY2E5YmIwMTc5MjQ3NmZiYjIyNWU1ZDlkZWM4NjlmL3NlYzo5M2NhOWJiMDE3OTI0NzZmYmIyMjVlNWQ5ZGVjODY5Zl81Mi9mcmFnOjlkZDkxMTIyZjQxYzQzNzk5OGZlMGIyOGMwYjRhYjgwL3RhYmxlOmQ2NGI3MDhhZjNkNzQ1NWVhNmU0MGM2NTYyMjk5ZDZkL3RhYmxlcmFuZ2U6ZDY0YjcwOGFmM2Q3NDU1ZWE2ZTQwYzY1NjIyOTlkNmRfMTgtMS0xLTEtMA_14e82c38-bc6e-45dd-9c06-b706ac2489dc"
      unitRef="usdPerShare">0.15</us-gaap:IncomeLossFromContinuingOperationsPerDilutedShare>
    <us-gaap:IncomeLossFromContinuingOperationsPerDilutedShare
      contextRef="i39065c5daf934af885335c12f3cfa83f_D20200401-20200630"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzY2E5YmIwMTc5MjQ3NmZiYjIyNWU1ZDlkZWM4NjlmL3NlYzo5M2NhOWJiMDE3OTI0NzZmYmIyMjVlNWQ5ZGVjODY5Zl81Mi9mcmFnOjlkZDkxMTIyZjQxYzQzNzk5OGZlMGIyOGMwYjRhYjgwL3RhYmxlOmQ2NGI3MDhhZjNkNzQ1NWVhNmU0MGM2NTYyMjk5ZDZkL3RhYmxlcmFuZ2U6ZDY0YjcwOGFmM2Q3NDU1ZWE2ZTQwYzY1NjIyOTlkNmRfMTgtMy0xLTEtMA_c728f08e-2a53-46e7-a8b5-ec5c5d4e70d1"
      unitRef="usdPerShare">-0.31</us-gaap:IncomeLossFromContinuingOperationsPerDilutedShare>
    <us-gaap:IncomeLossFromContinuingOperationsPerDilutedShare
      contextRef="i69782326f71a44e3805518280ee22b6b_D20210101-20210630"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzY2E5YmIwMTc5MjQ3NmZiYjIyNWU1ZDlkZWM4NjlmL3NlYzo5M2NhOWJiMDE3OTI0NzZmYmIyMjVlNWQ5ZGVjODY5Zl81Mi9mcmFnOjlkZDkxMTIyZjQxYzQzNzk5OGZlMGIyOGMwYjRhYjgwL3RhYmxlOmQ2NGI3MDhhZjNkNzQ1NWVhNmU0MGM2NTYyMjk5ZDZkL3RhYmxlcmFuZ2U6ZDY0YjcwOGFmM2Q3NDU1ZWE2ZTQwYzY1NjIyOTlkNmRfMTgtNS0xLTEtMA_e0966c2a-9958-4223-a75e-8c2f6284c6f0"
      unitRef="usdPerShare">-0.28</us-gaap:IncomeLossFromContinuingOperationsPerDilutedShare>
    <us-gaap:IncomeLossFromContinuingOperationsPerDilutedShare
      contextRef="i4a110e4972ef4113880ce582e3cda5c5_D20200101-20200630"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzY2E5YmIwMTc5MjQ3NmZiYjIyNWU1ZDlkZWM4NjlmL3NlYzo5M2NhOWJiMDE3OTI0NzZmYmIyMjVlNWQ5ZGVjODY5Zl81Mi9mcmFnOjlkZDkxMTIyZjQxYzQzNzk5OGZlMGIyOGMwYjRhYjgwL3RhYmxlOmQ2NGI3MDhhZjNkNzQ1NWVhNmU0MGM2NTYyMjk5ZDZkL3RhYmxlcmFuZ2U6ZDY0YjcwOGFmM2Q3NDU1ZWE2ZTQwYzY1NjIyOTlkNmRfMTgtNy0xLTEtMA_dfd83635-60cc-43c1-96e6-297c7ae2f200"
      unitRef="usdPerShare">-0.09</us-gaap:IncomeLossFromContinuingOperationsPerDilutedShare>
    <us-gaap:NetIncomeLossFromDiscontinuedOperationsAvailableToCommonShareholdersDiluted
      contextRef="i27f4e53b91ad4367b7f8d273eff27769_D20210401-20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzY2E5YmIwMTc5MjQ3NmZiYjIyNWU1ZDlkZWM4NjlmL3NlYzo5M2NhOWJiMDE3OTI0NzZmYmIyMjVlNWQ5ZGVjODY5Zl81Mi9mcmFnOjlkZDkxMTIyZjQxYzQzNzk5OGZlMGIyOGMwYjRhYjgwL3RhYmxlOmQ2NGI3MDhhZjNkNzQ1NWVhNmU0MGM2NTYyMjk5ZDZkL3RhYmxlcmFuZ2U6ZDY0YjcwOGFmM2Q3NDU1ZWE2ZTQwYzY1NjIyOTlkNmRfMjUtMS0xLTEtMTkxODY_f7ca1a4b-b8df-4b76-b4b3-efceb4da1beb"
      unitRef="usd">-561000</us-gaap:NetIncomeLossFromDiscontinuedOperationsAvailableToCommonShareholdersDiluted>
    <us-gaap:NetIncomeLossFromDiscontinuedOperationsAvailableToCommonShareholdersDiluted
      contextRef="i39065c5daf934af885335c12f3cfa83f_D20200401-20200630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzY2E5YmIwMTc5MjQ3NmZiYjIyNWU1ZDlkZWM4NjlmL3NlYzo5M2NhOWJiMDE3OTI0NzZmYmIyMjVlNWQ5ZGVjODY5Zl81Mi9mcmFnOjlkZDkxMTIyZjQxYzQzNzk5OGZlMGIyOGMwYjRhYjgwL3RhYmxlOmQ2NGI3MDhhZjNkNzQ1NWVhNmU0MGM2NTYyMjk5ZDZkL3RhYmxlcmFuZ2U6ZDY0YjcwOGFmM2Q3NDU1ZWE2ZTQwYzY1NjIyOTlkNmRfMjUtMy0xLTEtMTkxODY_0e7a68ca-0814-439f-87d2-99fefdb73fc5"
      unitRef="usd">-46000</us-gaap:NetIncomeLossFromDiscontinuedOperationsAvailableToCommonShareholdersDiluted>
    <us-gaap:NetIncomeLossFromDiscontinuedOperationsAvailableToCommonShareholdersDiluted
      contextRef="i69782326f71a44e3805518280ee22b6b_D20210101-20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzY2E5YmIwMTc5MjQ3NmZiYjIyNWU1ZDlkZWM4NjlmL3NlYzo5M2NhOWJiMDE3OTI0NzZmYmIyMjVlNWQ5ZGVjODY5Zl81Mi9mcmFnOjlkZDkxMTIyZjQxYzQzNzk5OGZlMGIyOGMwYjRhYjgwL3RhYmxlOmQ2NGI3MDhhZjNkNzQ1NWVhNmU0MGM2NTYyMjk5ZDZkL3RhYmxlcmFuZ2U6ZDY0YjcwOGFmM2Q3NDU1ZWE2ZTQwYzY1NjIyOTlkNmRfMjUtNS0xLTEtMTkxODY_51901021-9fb1-424b-a029-6757f2293dd4"
      unitRef="usd">-582000</us-gaap:NetIncomeLossFromDiscontinuedOperationsAvailableToCommonShareholdersDiluted>
    <us-gaap:NetIncomeLossFromDiscontinuedOperationsAvailableToCommonShareholdersDiluted
      contextRef="i4a110e4972ef4113880ce582e3cda5c5_D20200101-20200630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzY2E5YmIwMTc5MjQ3NmZiYjIyNWU1ZDlkZWM4NjlmL3NlYzo5M2NhOWJiMDE3OTI0NzZmYmIyMjVlNWQ5ZGVjODY5Zl81Mi9mcmFnOjlkZDkxMTIyZjQxYzQzNzk5OGZlMGIyOGMwYjRhYjgwL3RhYmxlOmQ2NGI3MDhhZjNkNzQ1NWVhNmU0MGM2NTYyMjk5ZDZkL3RhYmxlcmFuZ2U6ZDY0YjcwOGFmM2Q3NDU1ZWE2ZTQwYzY1NjIyOTlkNmRfMjUtNy0xLTEtMTkxODY_37f8c43d-b730-494a-ae63-dac03dde4b57"
      unitRef="usd">-46000</us-gaap:NetIncomeLossFromDiscontinuedOperationsAvailableToCommonShareholdersDiluted>
    <us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding
      contextRef="i27f4e53b91ad4367b7f8d273eff27769_D20210401-20210630"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzY2E5YmIwMTc5MjQ3NmZiYjIyNWU1ZDlkZWM4NjlmL3NlYzo5M2NhOWJiMDE3OTI0NzZmYmIyMjVlNWQ5ZGVjODY5Zl81Mi9mcmFnOjlkZDkxMTIyZjQxYzQzNzk5OGZlMGIyOGMwYjRhYjgwL3RhYmxlOmQ2NGI3MDhhZjNkNzQ1NWVhNmU0MGM2NTYyMjk5ZDZkL3RhYmxlcmFuZ2U6ZDY0YjcwOGFmM2Q3NDU1ZWE2ZTQwYzY1NjIyOTlkNmRfMjYtMS0xLTEtMTkxODY_be568b3e-6ef5-4d9c-a0a1-41c52fe052e9"
      unitRef="shares">375349856</us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding>
    <us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding
      contextRef="i39065c5daf934af885335c12f3cfa83f_D20200401-20200630"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzY2E5YmIwMTc5MjQ3NmZiYjIyNWU1ZDlkZWM4NjlmL3NlYzo5M2NhOWJiMDE3OTI0NzZmYmIyMjVlNWQ5ZGVjODY5Zl81Mi9mcmFnOjlkZDkxMTIyZjQxYzQzNzk5OGZlMGIyOGMwYjRhYjgwL3RhYmxlOmQ2NGI3MDhhZjNkNzQ1NWVhNmU0MGM2NTYyMjk5ZDZkL3RhYmxlcmFuZ2U6ZDY0YjcwOGFmM2Q3NDU1ZWE2ZTQwYzY1NjIyOTlkNmRfMjYtMy0xLTEtMTkxODY_7f362494-05bc-40a8-8f69-83344762fca1"
      unitRef="shares">349075408</us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding>
    <us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding
      contextRef="i69782326f71a44e3805518280ee22b6b_D20210101-20210630"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzY2E5YmIwMTc5MjQ3NmZiYjIyNWU1ZDlkZWM4NjlmL3NlYzo5M2NhOWJiMDE3OTI0NzZmYmIyMjVlNWQ5ZGVjODY5Zl81Mi9mcmFnOjlkZDkxMTIyZjQxYzQzNzk5OGZlMGIyOGMwYjRhYjgwL3RhYmxlOmQ2NGI3MDhhZjNkNzQ1NWVhNmU0MGM2NTYyMjk5ZDZkL3RhYmxlcmFuZ2U6ZDY0YjcwOGFmM2Q3NDU1ZWE2ZTQwYzY1NjIyOTlkNmRfMjYtNS0xLTEtMTkxODY_4f27cf26-3e5f-4ae4-be38-a0cb7fcf294c"
      unitRef="shares">367391118</us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding>
    <us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding
      contextRef="i4a110e4972ef4113880ce582e3cda5c5_D20200101-20200630"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzY2E5YmIwMTc5MjQ3NmZiYjIyNWU1ZDlkZWM4NjlmL3NlYzo5M2NhOWJiMDE3OTI0NzZmYmIyMjVlNWQ5ZGVjODY5Zl81Mi9mcmFnOjlkZDkxMTIyZjQxYzQzNzk5OGZlMGIyOGMwYjRhYjgwL3RhYmxlOmQ2NGI3MDhhZjNkNzQ1NWVhNmU0MGM2NTYyMjk5ZDZkL3RhYmxlcmFuZ2U6ZDY0YjcwOGFmM2Q3NDU1ZWE2ZTQwYzY1NjIyOTlkNmRfMjYtNy0xLTEtMTkxODY_12fc0eb3-36ad-4aff-b6e5-4724dd2c63d4"
      unitRef="shares">348946439</us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding>
    <us-gaap:IncomeLossFromDiscontinuedOperationsNetOfTaxPerDilutedShare
      contextRef="i27f4e53b91ad4367b7f8d273eff27769_D20210401-20210630"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzY2E5YmIwMTc5MjQ3NmZiYjIyNWU1ZDlkZWM4NjlmL3NlYzo5M2NhOWJiMDE3OTI0NzZmYmIyMjVlNWQ5ZGVjODY5Zl81Mi9mcmFnOjlkZDkxMTIyZjQxYzQzNzk5OGZlMGIyOGMwYjRhYjgwL3RhYmxlOmQ2NGI3MDhhZjNkNzQ1NWVhNmU0MGM2NTYyMjk5ZDZkL3RhYmxlcmFuZ2U6ZDY0YjcwOGFmM2Q3NDU1ZWE2ZTQwYzY1NjIyOTlkNmRfMjctMS0xLTEtMTkxODY_474e3bee-1a30-4e86-b041-12ecd93f56b3"
      unitRef="usdPerShare">0.00</us-gaap:IncomeLossFromDiscontinuedOperationsNetOfTaxPerDilutedShare>
    <us-gaap:IncomeLossFromDiscontinuedOperationsNetOfTaxPerDilutedShare
      contextRef="i39065c5daf934af885335c12f3cfa83f_D20200401-20200630"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzY2E5YmIwMTc5MjQ3NmZiYjIyNWU1ZDlkZWM4NjlmL3NlYzo5M2NhOWJiMDE3OTI0NzZmYmIyMjVlNWQ5ZGVjODY5Zl81Mi9mcmFnOjlkZDkxMTIyZjQxYzQzNzk5OGZlMGIyOGMwYjRhYjgwL3RhYmxlOmQ2NGI3MDhhZjNkNzQ1NWVhNmU0MGM2NTYyMjk5ZDZkL3RhYmxlcmFuZ2U6ZDY0YjcwOGFmM2Q3NDU1ZWE2ZTQwYzY1NjIyOTlkNmRfMjctMy0xLTEtMTkxODY_8f9f871d-4828-4667-865c-0e51c0da9360"
      unitRef="usdPerShare">0.00</us-gaap:IncomeLossFromDiscontinuedOperationsNetOfTaxPerDilutedShare>
    <us-gaap:IncomeLossFromDiscontinuedOperationsNetOfTaxPerDilutedShare
      contextRef="i69782326f71a44e3805518280ee22b6b_D20210101-20210630"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzY2E5YmIwMTc5MjQ3NmZiYjIyNWU1ZDlkZWM4NjlmL3NlYzo5M2NhOWJiMDE3OTI0NzZmYmIyMjVlNWQ5ZGVjODY5Zl81Mi9mcmFnOjlkZDkxMTIyZjQxYzQzNzk5OGZlMGIyOGMwYjRhYjgwL3RhYmxlOmQ2NGI3MDhhZjNkNzQ1NWVhNmU0MGM2NTYyMjk5ZDZkL3RhYmxlcmFuZ2U6ZDY0YjcwOGFmM2Q3NDU1ZWE2ZTQwYzY1NjIyOTlkNmRfMjctNS0xLTEtMTkxODY_1d1177e2-fb6a-44d0-9567-c715c929c9c7"
      unitRef="usdPerShare">0.00</us-gaap:IncomeLossFromDiscontinuedOperationsNetOfTaxPerDilutedShare>
    <us-gaap:IncomeLossFromDiscontinuedOperationsNetOfTaxPerDilutedShare
      contextRef="i4a110e4972ef4113880ce582e3cda5c5_D20200101-20200630"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzY2E5YmIwMTc5MjQ3NmZiYjIyNWU1ZDlkZWM4NjlmL3NlYzo5M2NhOWJiMDE3OTI0NzZmYmIyMjVlNWQ5ZGVjODY5Zl81Mi9mcmFnOjlkZDkxMTIyZjQxYzQzNzk5OGZlMGIyOGMwYjRhYjgwL3RhYmxlOmQ2NGI3MDhhZjNkNzQ1NWVhNmU0MGM2NTYyMjk5ZDZkL3RhYmxlcmFuZ2U6ZDY0YjcwOGFmM2Q3NDU1ZWE2ZTQwYzY1NjIyOTlkNmRfMjctNy0xLTEtMTkxODY_8150edc2-08fe-48bd-93b4-7e6a66d47bbf"
      unitRef="usdPerShare">0.00</us-gaap:IncomeLossFromDiscontinuedOperationsNetOfTaxPerDilutedShare>
    <us-gaap:ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock
      contextRef="i69782326f71a44e3805518280ee22b6b_D20210101-20210630"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzY2E5YmIwMTc5MjQ3NmZiYjIyNWU1ZDlkZWM4NjlmL3NlYzo5M2NhOWJiMDE3OTI0NzZmYmIyMjVlNWQ5ZGVjODY5Zl81Mi9mcmFnOjlkZDkxMTIyZjQxYzQzNzk5OGZlMGIyOGMwYjRhYjgwL3RleHRyZWdpb246OWRkOTExMjJmNDFjNDM3OTk4ZmUwYjI4YzBiNGFiODBfNzIx_f2d80644-b529-4765-8294-a0d0a1ebbf3c">&lt;div style="margin-bottom:6pt;margin-top:12pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following securities were not included in the computation of diluted shares outstanding because the effect would be anti-dilutive or because conditions for contingently issuable shares were not satisfied at the end of the reporting periods.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:45.705%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.983%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.327%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.983%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.605%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.983%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.327%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.987%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Three months ended June&#160;30,&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Six months ended June&#160;30,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Ginkgo equity milestones&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;14,674,904&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;14,674,904&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;14,674,904&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;14,674,904&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Pre-emptive Rights&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;10,683,330&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;12,006,740&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;10,984,166&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;12,006,740&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Top-up Rights &#x2013; fixed price&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,698,611&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;26,686,413&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7,406,031&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;26,686,413&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Top-up Rights &#x2013; market price&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,504,561&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,941,349&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,063,822&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,941,349&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Altria Warrant&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;82,623,455&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;77,752,533&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;82,606,904&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;77,752,533&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Stock options&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,411,944&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;10,495,235&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6,136,113&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;10,547,256&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Warrants&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;17,521,903&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,784,377&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;17,536,558&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Restricted share units&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;265,904&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,012,249&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;717,127&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,012,249&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total anti-dilutive securities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;116,862,709&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;162,091,326&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;128,373,444&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;162,158,002&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock>
    <us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
      contextRef="i07a12b37b7f449bd8480c060ef9d4f22_D20210401-20210630"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzY2E5YmIwMTc5MjQ3NmZiYjIyNWU1ZDlkZWM4NjlmL3NlYzo5M2NhOWJiMDE3OTI0NzZmYmIyMjVlNWQ5ZGVjODY5Zl81Mi9mcmFnOjlkZDkxMTIyZjQxYzQzNzk5OGZlMGIyOGMwYjRhYjgwL3RhYmxlOjdjZGYyNzg5Njc4MDQ5MWQ4NWM1MDI2ZmNmNzU5YTg2L3RhYmxlcmFuZ2U6N2NkZjI3ODk2NzgwNDkxZDg1YzUwMjZmY2Y3NTlhODZfMi0xLTEtMS0w_a4d42dd8-37fd-4970-9199-2b619162f682"
      unitRef="shares">14674904</us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount>
    <us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
      contextRef="idb2773cdb0104962851c16f7f574a50e_D20200401-20200630"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzY2E5YmIwMTc5MjQ3NmZiYjIyNWU1ZDlkZWM4NjlmL3NlYzo5M2NhOWJiMDE3OTI0NzZmYmIyMjVlNWQ5ZGVjODY5Zl81Mi9mcmFnOjlkZDkxMTIyZjQxYzQzNzk5OGZlMGIyOGMwYjRhYjgwL3RhYmxlOjdjZGYyNzg5Njc4MDQ5MWQ4NWM1MDI2ZmNmNzU5YTg2L3RhYmxlcmFuZ2U6N2NkZjI3ODk2NzgwNDkxZDg1YzUwMjZmY2Y3NTlhODZfMi0zLTEtMS0w_6db87154-0841-4108-9fbc-a328abd94c0f"
      unitRef="shares">14674904</us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount>
    <us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
      contextRef="ibdb85022a38140dab47df2ef46523aed_D20210101-20210630"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzY2E5YmIwMTc5MjQ3NmZiYjIyNWU1ZDlkZWM4NjlmL3NlYzo5M2NhOWJiMDE3OTI0NzZmYmIyMjVlNWQ5ZGVjODY5Zl81Mi9mcmFnOjlkZDkxMTIyZjQxYzQzNzk5OGZlMGIyOGMwYjRhYjgwL3RhYmxlOjdjZGYyNzg5Njc4MDQ5MWQ4NWM1MDI2ZmNmNzU5YTg2L3RhYmxlcmFuZ2U6N2NkZjI3ODk2NzgwNDkxZDg1YzUwMjZmY2Y3NTlhODZfMi01LTEtMS0w_1d8985cb-65e4-4271-96cf-e6ab9ffe0455"
      unitRef="shares">14674904</us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount>
    <us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
      contextRef="i50bf03adb5b742b8bc014c0dff5918e9_D20200101-20200630"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzY2E5YmIwMTc5MjQ3NmZiYjIyNWU1ZDlkZWM4NjlmL3NlYzo5M2NhOWJiMDE3OTI0NzZmYmIyMjVlNWQ5ZGVjODY5Zl81Mi9mcmFnOjlkZDkxMTIyZjQxYzQzNzk5OGZlMGIyOGMwYjRhYjgwL3RhYmxlOjdjZGYyNzg5Njc4MDQ5MWQ4NWM1MDI2ZmNmNzU5YTg2L3RhYmxlcmFuZ2U6N2NkZjI3ODk2NzgwNDkxZDg1YzUwMjZmY2Y3NTlhODZfMi03LTEtMS0w_01cd8907-82bb-4216-8eb8-583f90cbc3c6"
      unitRef="shares">14674904</us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount>
    <us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
      contextRef="i8e9c7b0c611e46879a52eaa6a261c7ee_D20210401-20210630"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzY2E5YmIwMTc5MjQ3NmZiYjIyNWU1ZDlkZWM4NjlmL3NlYzo5M2NhOWJiMDE3OTI0NzZmYmIyMjVlNWQ5ZGVjODY5Zl81Mi9mcmFnOjlkZDkxMTIyZjQxYzQzNzk5OGZlMGIyOGMwYjRhYjgwL3RhYmxlOjdjZGYyNzg5Njc4MDQ5MWQ4NWM1MDI2ZmNmNzU5YTg2L3RhYmxlcmFuZ2U6N2NkZjI3ODk2NzgwNDkxZDg1YzUwMjZmY2Y3NTlhODZfMy0xLTEtMS0w_20ef9135-94b9-41e0-bc3d-e83f78320a92"
      unitRef="shares">10683330</us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount>
    <us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
      contextRef="i0c3ad44a3c0c42b5b2a0e88c68e8f3be_D20200401-20200630"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzY2E5YmIwMTc5MjQ3NmZiYjIyNWU1ZDlkZWM4NjlmL3NlYzo5M2NhOWJiMDE3OTI0NzZmYmIyMjVlNWQ5ZGVjODY5Zl81Mi9mcmFnOjlkZDkxMTIyZjQxYzQzNzk5OGZlMGIyOGMwYjRhYjgwL3RhYmxlOjdjZGYyNzg5Njc4MDQ5MWQ4NWM1MDI2ZmNmNzU5YTg2L3RhYmxlcmFuZ2U6N2NkZjI3ODk2NzgwNDkxZDg1YzUwMjZmY2Y3NTlhODZfMy0zLTEtMS0w_b543c295-051d-4135-a5a2-ce3cb44f4c6c"
      unitRef="shares">12006740</us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount>
    <us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
      contextRef="i02aad9012d39412c8efa06499f3fe95b_D20210101-20210630"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzY2E5YmIwMTc5MjQ3NmZiYjIyNWU1ZDlkZWM4NjlmL3NlYzo5M2NhOWJiMDE3OTI0NzZmYmIyMjVlNWQ5ZGVjODY5Zl81Mi9mcmFnOjlkZDkxMTIyZjQxYzQzNzk5OGZlMGIyOGMwYjRhYjgwL3RhYmxlOjdjZGYyNzg5Njc4MDQ5MWQ4NWM1MDI2ZmNmNzU5YTg2L3RhYmxlcmFuZ2U6N2NkZjI3ODk2NzgwNDkxZDg1YzUwMjZmY2Y3NTlhODZfMy01LTEtMS0w_d0d59383-da3d-44d1-88a0-8e23c6b3cbb2"
      unitRef="shares">10984166</us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount>
    <us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
      contextRef="id0d09d3774e94fa7b4f1f095f53f1374_D20200101-20200630"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzY2E5YmIwMTc5MjQ3NmZiYjIyNWU1ZDlkZWM4NjlmL3NlYzo5M2NhOWJiMDE3OTI0NzZmYmIyMjVlNWQ5ZGVjODY5Zl81Mi9mcmFnOjlkZDkxMTIyZjQxYzQzNzk5OGZlMGIyOGMwYjRhYjgwL3RhYmxlOjdjZGYyNzg5Njc4MDQ5MWQ4NWM1MDI2ZmNmNzU5YTg2L3RhYmxlcmFuZ2U6N2NkZjI3ODk2NzgwNDkxZDg1YzUwMjZmY2Y3NTlhODZfMy03LTEtMS0w_6da4a7ae-fb93-419d-9aa7-44868aa40de0"
      unitRef="shares">12006740</us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount>
    <us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
      contextRef="ia14076dba9894856b2d1229c872fe727_D20210401-20210630"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzY2E5YmIwMTc5MjQ3NmZiYjIyNWU1ZDlkZWM4NjlmL3NlYzo5M2NhOWJiMDE3OTI0NzZmYmIyMjVlNWQ5ZGVjODY5Zl81Mi9mcmFnOjlkZDkxMTIyZjQxYzQzNzk5OGZlMGIyOGMwYjRhYjgwL3RhYmxlOjdjZGYyNzg5Njc4MDQ5MWQ4NWM1MDI2ZmNmNzU5YTg2L3RhYmxlcmFuZ2U6N2NkZjI3ODk2NzgwNDkxZDg1YzUwMjZmY2Y3NTlhODZfNC0xLTEtMS0w_61ac0a39-1028-4a30-bdd5-601c484aeb13"
      unitRef="shares">3698611</us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount>
    <us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
      contextRef="i17878ee04a8b40efa8de800698c7563e_D20200401-20200630"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzY2E5YmIwMTc5MjQ3NmZiYjIyNWU1ZDlkZWM4NjlmL3NlYzo5M2NhOWJiMDE3OTI0NzZmYmIyMjVlNWQ5ZGVjODY5Zl81Mi9mcmFnOjlkZDkxMTIyZjQxYzQzNzk5OGZlMGIyOGMwYjRhYjgwL3RhYmxlOjdjZGYyNzg5Njc4MDQ5MWQ4NWM1MDI2ZmNmNzU5YTg2L3RhYmxlcmFuZ2U6N2NkZjI3ODk2NzgwNDkxZDg1YzUwMjZmY2Y3NTlhODZfNC0zLTEtMS0w_ac01b393-8f86-4ee0-9dbe-22d69444123d"
      unitRef="shares">26686413</us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount>
    <us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
      contextRef="i0edfc387d99e417686a470edbdd373bd_D20210101-20210630"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzY2E5YmIwMTc5MjQ3NmZiYjIyNWU1ZDlkZWM4NjlmL3NlYzo5M2NhOWJiMDE3OTI0NzZmYmIyMjVlNWQ5ZGVjODY5Zl81Mi9mcmFnOjlkZDkxMTIyZjQxYzQzNzk5OGZlMGIyOGMwYjRhYjgwL3RhYmxlOjdjZGYyNzg5Njc4MDQ5MWQ4NWM1MDI2ZmNmNzU5YTg2L3RhYmxlcmFuZ2U6N2NkZjI3ODk2NzgwNDkxZDg1YzUwMjZmY2Y3NTlhODZfNC01LTEtMS0w_c3dfd653-ad3e-49a2-8b9a-194533f325f9"
      unitRef="shares">7406031</us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount>
    <us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
      contextRef="i58fcf006ddda4fa090550e2cab1cbf48_D20200101-20200630"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzY2E5YmIwMTc5MjQ3NmZiYjIyNWU1ZDlkZWM4NjlmL3NlYzo5M2NhOWJiMDE3OTI0NzZmYmIyMjVlNWQ5ZGVjODY5Zl81Mi9mcmFnOjlkZDkxMTIyZjQxYzQzNzk5OGZlMGIyOGMwYjRhYjgwL3RhYmxlOjdjZGYyNzg5Njc4MDQ5MWQ4NWM1MDI2ZmNmNzU5YTg2L3RhYmxlcmFuZ2U6N2NkZjI3ODk2NzgwNDkxZDg1YzUwMjZmY2Y3NTlhODZfNC03LTEtMS0w_250458fc-f232-4021-b6a0-9fe049fb366e"
      unitRef="shares">26686413</us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount>
    <us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
      contextRef="if80975f641164c358482aa567573519b_D20210401-20210630"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzY2E5YmIwMTc5MjQ3NmZiYjIyNWU1ZDlkZWM4NjlmL3NlYzo5M2NhOWJiMDE3OTI0NzZmYmIyMjVlNWQ5ZGVjODY5Zl81Mi9mcmFnOjlkZDkxMTIyZjQxYzQzNzk5OGZlMGIyOGMwYjRhYjgwL3RhYmxlOjdjZGYyNzg5Njc4MDQ5MWQ4NWM1MDI2ZmNmNzU5YTg2L3RhYmxlcmFuZ2U6N2NkZjI3ODk2NzgwNDkxZDg1YzUwMjZmY2Y3NTlhODZfNS0xLTEtMS0w_352cff5f-fdb6-422d-b994-09933cbb7478"
      unitRef="shares">3504561</us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount>
    <us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
      contextRef="ie093f63ac9fb4d8581f1cefb3a20923d_D20200401-20200630"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzY2E5YmIwMTc5MjQ3NmZiYjIyNWU1ZDlkZWM4NjlmL3NlYzo5M2NhOWJiMDE3OTI0NzZmYmIyMjVlNWQ5ZGVjODY5Zl81Mi9mcmFnOjlkZDkxMTIyZjQxYzQzNzk5OGZlMGIyOGMwYjRhYjgwL3RhYmxlOjdjZGYyNzg5Njc4MDQ5MWQ4NWM1MDI2ZmNmNzU5YTg2L3RhYmxlcmFuZ2U6N2NkZjI3ODk2NzgwNDkxZDg1YzUwMjZmY2Y3NTlhODZfNS0zLTEtMS0w_97501ffd-0934-4a14-9b61-a218dce6a4cb"
      unitRef="shares">1941349</us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount>
    <us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
      contextRef="i346164b35069484faf6df727aae40e92_D20210101-20210630"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzY2E5YmIwMTc5MjQ3NmZiYjIyNWU1ZDlkZWM4NjlmL3NlYzo5M2NhOWJiMDE3OTI0NzZmYmIyMjVlNWQ5ZGVjODY5Zl81Mi9mcmFnOjlkZDkxMTIyZjQxYzQzNzk5OGZlMGIyOGMwYjRhYjgwL3RhYmxlOjdjZGYyNzg5Njc4MDQ5MWQ4NWM1MDI2ZmNmNzU5YTg2L3RhYmxlcmFuZ2U6N2NkZjI3ODk2NzgwNDkxZDg1YzUwMjZmY2Y3NTlhODZfNS01LTEtMS0w_14d5576e-794e-4bf2-b5bb-4ead3aba6737"
      unitRef="shares">3063822</us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount>
    <us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
      contextRef="if20736234eba41eeb39c9dfe0fe61633_D20200101-20200630"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzY2E5YmIwMTc5MjQ3NmZiYjIyNWU1ZDlkZWM4NjlmL3NlYzo5M2NhOWJiMDE3OTI0NzZmYmIyMjVlNWQ5ZGVjODY5Zl81Mi9mcmFnOjlkZDkxMTIyZjQxYzQzNzk5OGZlMGIyOGMwYjRhYjgwL3RhYmxlOjdjZGYyNzg5Njc4MDQ5MWQ4NWM1MDI2ZmNmNzU5YTg2L3RhYmxlcmFuZ2U6N2NkZjI3ODk2NzgwNDkxZDg1YzUwMjZmY2Y3NTlhODZfNS03LTEtMS0w_ecb94320-7cb7-47ca-b25d-4e005878e025"
      unitRef="shares">1941349</us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount>
    <us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
      contextRef="i1c433475eb1a48afaf0b953876eeacf2_D20210401-20210630"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzY2E5YmIwMTc5MjQ3NmZiYjIyNWU1ZDlkZWM4NjlmL3NlYzo5M2NhOWJiMDE3OTI0NzZmYmIyMjVlNWQ5ZGVjODY5Zl81Mi9mcmFnOjlkZDkxMTIyZjQxYzQzNzk5OGZlMGIyOGMwYjRhYjgwL3RhYmxlOjdjZGYyNzg5Njc4MDQ5MWQ4NWM1MDI2ZmNmNzU5YTg2L3RhYmxlcmFuZ2U6N2NkZjI3ODk2NzgwNDkxZDg1YzUwMjZmY2Y3NTlhODZfNi0xLTEtMS0w_fa318b8e-466d-4ee2-a0a0-55a2c92fd739"
      unitRef="shares">82623455</us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount>
    <us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
      contextRef="i0f06094e63234299ba9729e0c2d1605e_D20200401-20200630"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzY2E5YmIwMTc5MjQ3NmZiYjIyNWU1ZDlkZWM4NjlmL3NlYzo5M2NhOWJiMDE3OTI0NzZmYmIyMjVlNWQ5ZGVjODY5Zl81Mi9mcmFnOjlkZDkxMTIyZjQxYzQzNzk5OGZlMGIyOGMwYjRhYjgwL3RhYmxlOjdjZGYyNzg5Njc4MDQ5MWQ4NWM1MDI2ZmNmNzU5YTg2L3RhYmxlcmFuZ2U6N2NkZjI3ODk2NzgwNDkxZDg1YzUwMjZmY2Y3NTlhODZfNi0zLTEtMS0w_cdc807af-b7f5-40c1-ad45-683ef208d551"
      unitRef="shares">77752533</us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount>
    <us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
      contextRef="i1f706c52ea2f44629f37471cc5d6d92a_D20210101-20210630"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzY2E5YmIwMTc5MjQ3NmZiYjIyNWU1ZDlkZWM4NjlmL3NlYzo5M2NhOWJiMDE3OTI0NzZmYmIyMjVlNWQ5ZGVjODY5Zl81Mi9mcmFnOjlkZDkxMTIyZjQxYzQzNzk5OGZlMGIyOGMwYjRhYjgwL3RhYmxlOjdjZGYyNzg5Njc4MDQ5MWQ4NWM1MDI2ZmNmNzU5YTg2L3RhYmxlcmFuZ2U6N2NkZjI3ODk2NzgwNDkxZDg1YzUwMjZmY2Y3NTlhODZfNi01LTEtMS0w_b5ee4f27-e63f-41a4-b09b-fff0c127167b"
      unitRef="shares">82606904</us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount>
    <us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
      contextRef="i36bbfa161e6e4ec991260925b4204c65_D20200101-20200630"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzY2E5YmIwMTc5MjQ3NmZiYjIyNWU1ZDlkZWM4NjlmL3NlYzo5M2NhOWJiMDE3OTI0NzZmYmIyMjVlNWQ5ZGVjODY5Zl81Mi9mcmFnOjlkZDkxMTIyZjQxYzQzNzk5OGZlMGIyOGMwYjRhYjgwL3RhYmxlOjdjZGYyNzg5Njc4MDQ5MWQ4NWM1MDI2ZmNmNzU5YTg2L3RhYmxlcmFuZ2U6N2NkZjI3ODk2NzgwNDkxZDg1YzUwMjZmY2Y3NTlhODZfNi03LTEtMS0w_1b4f6de5-eae1-4f18-9f3d-cf89327b2be3"
      unitRef="shares">77752533</us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount>
    <us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
      contextRef="iaa7604cc407b458bade3731989eb0708_D20210401-20210630"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzY2E5YmIwMTc5MjQ3NmZiYjIyNWU1ZDlkZWM4NjlmL3NlYzo5M2NhOWJiMDE3OTI0NzZmYmIyMjVlNWQ5ZGVjODY5Zl81Mi9mcmFnOjlkZDkxMTIyZjQxYzQzNzk5OGZlMGIyOGMwYjRhYjgwL3RhYmxlOjdjZGYyNzg5Njc4MDQ5MWQ4NWM1MDI2ZmNmNzU5YTg2L3RhYmxlcmFuZ2U6N2NkZjI3ODk2NzgwNDkxZDg1YzUwMjZmY2Y3NTlhODZfNy0xLTEtMS0w_fd2b5a12-6c01-4417-8211-fec2567f182f"
      unitRef="shares">1411944</us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount>
    <us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
      contextRef="iea37729d5d364d418285846dc945175f_D20200401-20200630"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzY2E5YmIwMTc5MjQ3NmZiYjIyNWU1ZDlkZWM4NjlmL3NlYzo5M2NhOWJiMDE3OTI0NzZmYmIyMjVlNWQ5ZGVjODY5Zl81Mi9mcmFnOjlkZDkxMTIyZjQxYzQzNzk5OGZlMGIyOGMwYjRhYjgwL3RhYmxlOjdjZGYyNzg5Njc4MDQ5MWQ4NWM1MDI2ZmNmNzU5YTg2L3RhYmxlcmFuZ2U6N2NkZjI3ODk2NzgwNDkxZDg1YzUwMjZmY2Y3NTlhODZfNy0zLTEtMS0w_c9c027a5-2422-42af-b874-d68202e55959"
      unitRef="shares">10495235</us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount>
    <us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
      contextRef="i679dc97e17ab4806a7b6131c4dd48e32_D20210101-20210630"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzY2E5YmIwMTc5MjQ3NmZiYjIyNWU1ZDlkZWM4NjlmL3NlYzo5M2NhOWJiMDE3OTI0NzZmYmIyMjVlNWQ5ZGVjODY5Zl81Mi9mcmFnOjlkZDkxMTIyZjQxYzQzNzk5OGZlMGIyOGMwYjRhYjgwL3RhYmxlOjdjZGYyNzg5Njc4MDQ5MWQ4NWM1MDI2ZmNmNzU5YTg2L3RhYmxlcmFuZ2U6N2NkZjI3ODk2NzgwNDkxZDg1YzUwMjZmY2Y3NTlhODZfNy01LTEtMS0w_126b4b5f-e44a-411a-8d62-6bc1bc6baf32"
      unitRef="shares">6136113</us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount>
    <us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
      contextRef="i967a490799294ef8965b69b6ef9525d8_D20200101-20200630"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzY2E5YmIwMTc5MjQ3NmZiYjIyNWU1ZDlkZWM4NjlmL3NlYzo5M2NhOWJiMDE3OTI0NzZmYmIyMjVlNWQ5ZGVjODY5Zl81Mi9mcmFnOjlkZDkxMTIyZjQxYzQzNzk5OGZlMGIyOGMwYjRhYjgwL3RhYmxlOjdjZGYyNzg5Njc4MDQ5MWQ4NWM1MDI2ZmNmNzU5YTg2L3RhYmxlcmFuZ2U6N2NkZjI3ODk2NzgwNDkxZDg1YzUwMjZmY2Y3NTlhODZfNy03LTEtMS0w_65f6f8c6-a7af-4dd6-8fc0-4120f84638dd"
      unitRef="shares">10547256</us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount>
    <us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
      contextRef="ic12652ed09474f2eb1b373fa6ef881fd_D20210401-20210630"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzY2E5YmIwMTc5MjQ3NmZiYjIyNWU1ZDlkZWM4NjlmL3NlYzo5M2NhOWJiMDE3OTI0NzZmYmIyMjVlNWQ5ZGVjODY5Zl81Mi9mcmFnOjlkZDkxMTIyZjQxYzQzNzk5OGZlMGIyOGMwYjRhYjgwL3RhYmxlOjdjZGYyNzg5Njc4MDQ5MWQ4NWM1MDI2ZmNmNzU5YTg2L3RhYmxlcmFuZ2U6N2NkZjI3ODk2NzgwNDkxZDg1YzUwMjZmY2Y3NTlhODZfOC0xLTEtMS0w_869b30e1-dfeb-4151-9d57-a686d9ba350a"
      unitRef="shares">0</us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount>
    <us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
      contextRef="i8c63409f39764b86a65ebcee0efb5293_D20200401-20200630"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzY2E5YmIwMTc5MjQ3NmZiYjIyNWU1ZDlkZWM4NjlmL3NlYzo5M2NhOWJiMDE3OTI0NzZmYmIyMjVlNWQ5ZGVjODY5Zl81Mi9mcmFnOjlkZDkxMTIyZjQxYzQzNzk5OGZlMGIyOGMwYjRhYjgwL3RhYmxlOjdjZGYyNzg5Njc4MDQ5MWQ4NWM1MDI2ZmNmNzU5YTg2L3RhYmxlcmFuZ2U6N2NkZjI3ODk2NzgwNDkxZDg1YzUwMjZmY2Y3NTlhODZfOC0zLTEtMS0w_a537da30-bd94-4fd0-a3f3-5a7de2add4a2"
      unitRef="shares">17521903</us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount>
    <us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
      contextRef="iad823a91375044b38784f8b852ef2e86_D20210101-20210630"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzY2E5YmIwMTc5MjQ3NmZiYjIyNWU1ZDlkZWM4NjlmL3NlYzo5M2NhOWJiMDE3OTI0NzZmYmIyMjVlNWQ5ZGVjODY5Zl81Mi9mcmFnOjlkZDkxMTIyZjQxYzQzNzk5OGZlMGIyOGMwYjRhYjgwL3RhYmxlOjdjZGYyNzg5Njc4MDQ5MWQ4NWM1MDI2ZmNmNzU5YTg2L3RhYmxlcmFuZ2U6N2NkZjI3ODk2NzgwNDkxZDg1YzUwMjZmY2Y3NTlhODZfOC01LTEtMS0w_cf482d7a-ea6b-4bec-96cb-8654119d4ffc"
      unitRef="shares">2784377</us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount>
    <us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
      contextRef="i1cb9167df2d047b58be65b1aada6284d_D20200101-20200630"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzY2E5YmIwMTc5MjQ3NmZiYjIyNWU1ZDlkZWM4NjlmL3NlYzo5M2NhOWJiMDE3OTI0NzZmYmIyMjVlNWQ5ZGVjODY5Zl81Mi9mcmFnOjlkZDkxMTIyZjQxYzQzNzk5OGZlMGIyOGMwYjRhYjgwL3RhYmxlOjdjZGYyNzg5Njc4MDQ5MWQ4NWM1MDI2ZmNmNzU5YTg2L3RhYmxlcmFuZ2U6N2NkZjI3ODk2NzgwNDkxZDg1YzUwMjZmY2Y3NTlhODZfOC03LTEtMS0w_3b562304-3940-4838-bf4e-3376183bdf1c"
      unitRef="shares">17536558</us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount>
    <us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
      contextRef="i8b031f75a18e4c55ad561843012164a3_D20210401-20210630"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzY2E5YmIwMTc5MjQ3NmZiYjIyNWU1ZDlkZWM4NjlmL3NlYzo5M2NhOWJiMDE3OTI0NzZmYmIyMjVlNWQ5ZGVjODY5Zl81Mi9mcmFnOjlkZDkxMTIyZjQxYzQzNzk5OGZlMGIyOGMwYjRhYjgwL3RhYmxlOjdjZGYyNzg5Njc4MDQ5MWQ4NWM1MDI2ZmNmNzU5YTg2L3RhYmxlcmFuZ2U6N2NkZjI3ODk2NzgwNDkxZDg1YzUwMjZmY2Y3NTlhODZfOS0xLTEtMS0w_fc6d8ca3-dfbe-4ea4-95cd-2e09875cadab"
      unitRef="shares">265904</us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount>
    <us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
      contextRef="i4ae2733b6de04d388d8a96981e02f327_D20200401-20200630"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzY2E5YmIwMTc5MjQ3NmZiYjIyNWU1ZDlkZWM4NjlmL3NlYzo5M2NhOWJiMDE3OTI0NzZmYmIyMjVlNWQ5ZGVjODY5Zl81Mi9mcmFnOjlkZDkxMTIyZjQxYzQzNzk5OGZlMGIyOGMwYjRhYjgwL3RhYmxlOjdjZGYyNzg5Njc4MDQ5MWQ4NWM1MDI2ZmNmNzU5YTg2L3RhYmxlcmFuZ2U6N2NkZjI3ODk2NzgwNDkxZDg1YzUwMjZmY2Y3NTlhODZfOS0zLTEtMS0w_f73016ec-af2c-4ee0-ac4a-41e80481a47d"
      unitRef="shares">1012249</us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount>
    <us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
      contextRef="if4d517deea8b4c85b4949e8ed9c437c2_D20210101-20210630"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzY2E5YmIwMTc5MjQ3NmZiYjIyNWU1ZDlkZWM4NjlmL3NlYzo5M2NhOWJiMDE3OTI0NzZmYmIyMjVlNWQ5ZGVjODY5Zl81Mi9mcmFnOjlkZDkxMTIyZjQxYzQzNzk5OGZlMGIyOGMwYjRhYjgwL3RhYmxlOjdjZGYyNzg5Njc4MDQ5MWQ4NWM1MDI2ZmNmNzU5YTg2L3RhYmxlcmFuZ2U6N2NkZjI3ODk2NzgwNDkxZDg1YzUwMjZmY2Y3NTlhODZfOS01LTEtMS0w_c9847566-e2b3-4ecb-a095-692c8e6cabb0"
      unitRef="shares">717127</us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount>
    <us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
      contextRef="i120c7bf7be8a425aa4d5a03318d68bf0_D20200101-20200630"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzY2E5YmIwMTc5MjQ3NmZiYjIyNWU1ZDlkZWM4NjlmL3NlYzo5M2NhOWJiMDE3OTI0NzZmYmIyMjVlNWQ5ZGVjODY5Zl81Mi9mcmFnOjlkZDkxMTIyZjQxYzQzNzk5OGZlMGIyOGMwYjRhYjgwL3RhYmxlOjdjZGYyNzg5Njc4MDQ5MWQ4NWM1MDI2ZmNmNzU5YTg2L3RhYmxlcmFuZ2U6N2NkZjI3ODk2NzgwNDkxZDg1YzUwMjZmY2Y3NTlhODZfOS03LTEtMS0w_c5a7ef67-b223-445e-bbb4-560e86170c6c"
      unitRef="shares">1012249</us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount>
    <us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
      contextRef="i27f4e53b91ad4367b7f8d273eff27769_D20210401-20210630"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzY2E5YmIwMTc5MjQ3NmZiYjIyNWU1ZDlkZWM4NjlmL3NlYzo5M2NhOWJiMDE3OTI0NzZmYmIyMjVlNWQ5ZGVjODY5Zl81Mi9mcmFnOjlkZDkxMTIyZjQxYzQzNzk5OGZlMGIyOGMwYjRhYjgwL3RhYmxlOjdjZGYyNzg5Njc4MDQ5MWQ4NWM1MDI2ZmNmNzU5YTg2L3RhYmxlcmFuZ2U6N2NkZjI3ODk2NzgwNDkxZDg1YzUwMjZmY2Y3NTlhODZfMTAtMS0xLTEtMA_a3dbf2ac-e849-415f-beca-c7b7b937aaef"
      unitRef="shares">116862709</us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount>
    <us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
      contextRef="i39065c5daf934af885335c12f3cfa83f_D20200401-20200630"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzY2E5YmIwMTc5MjQ3NmZiYjIyNWU1ZDlkZWM4NjlmL3NlYzo5M2NhOWJiMDE3OTI0NzZmYmIyMjVlNWQ5ZGVjODY5Zl81Mi9mcmFnOjlkZDkxMTIyZjQxYzQzNzk5OGZlMGIyOGMwYjRhYjgwL3RhYmxlOjdjZGYyNzg5Njc4MDQ5MWQ4NWM1MDI2ZmNmNzU5YTg2L3RhYmxlcmFuZ2U6N2NkZjI3ODk2NzgwNDkxZDg1YzUwMjZmY2Y3NTlhODZfMTAtMy0xLTEtMA_bbac9698-5fb9-4e71-83a6-15492780e884"
      unitRef="shares">162091326</us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount>
    <us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
      contextRef="i69782326f71a44e3805518280ee22b6b_D20210101-20210630"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzY2E5YmIwMTc5MjQ3NmZiYjIyNWU1ZDlkZWM4NjlmL3NlYzo5M2NhOWJiMDE3OTI0NzZmYmIyMjVlNWQ5ZGVjODY5Zl81Mi9mcmFnOjlkZDkxMTIyZjQxYzQzNzk5OGZlMGIyOGMwYjRhYjgwL3RhYmxlOjdjZGYyNzg5Njc4MDQ5MWQ4NWM1MDI2ZmNmNzU5YTg2L3RhYmxlcmFuZ2U6N2NkZjI3ODk2NzgwNDkxZDg1YzUwMjZmY2Y3NTlhODZfMTAtNS0xLTEtMA_376096a0-b5ec-474e-9697-c83ca431b7a6"
      unitRef="shares">128373444</us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount>
    <us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
      contextRef="i4a110e4972ef4113880ce582e3cda5c5_D20200101-20200630"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzY2E5YmIwMTc5MjQ3NmZiYjIyNWU1ZDlkZWM4NjlmL3NlYzo5M2NhOWJiMDE3OTI0NzZmYmIyMjVlNWQ5ZGVjODY5Zl81Mi9mcmFnOjlkZDkxMTIyZjQxYzQzNzk5OGZlMGIyOGMwYjRhYjgwL3RhYmxlOjdjZGYyNzg5Njc4MDQ5MWQ4NWM1MDI2ZmNmNzU5YTg2L3RhYmxlcmFuZ2U6N2NkZjI3ODk2NzgwNDkxZDg1YzUwMjZmY2Y3NTlhODZfMTAtNy0xLTEtMA_f8fd5504-797a-401a-bbf4-5d50bf06f1cf"
      unitRef="shares">162158002</us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount>
    <us-gaap:SegmentReportingDisclosureTextBlock
      contextRef="i69782326f71a44e3805518280ee22b6b_D20210101-20210630"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzY2E5YmIwMTc5MjQ3NmZiYjIyNWU1ZDlkZWM4NjlmL3NlYzo5M2NhOWJiMDE3OTI0NzZmYmIyMjVlNWQ5ZGVjODY5Zl81NS9mcmFnOjk0NGQ2N2RjOTNmMjQ1MjliZTc4ZmNlMzRiOGMyZTBiL3RleHRyZWdpb246OTQ0ZDY3ZGM5M2YyNDUyOWJlNzhmY2UzNGI4YzJlMGJfMjk5Mg_05bfe000-43f3-4c58-882c-b87a25bd2a57">Segment Information&lt;div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Segment reporting is prepared on the same basis that the Company&#x2019;s chief operating decision makers (the &#x201c;CODMs&#x201d;) manage the business, make operating decisions and assess the Company&#x2019;s performance. The Company determined that it has the following two reportable segments: United States and Rest of World. &lt;/span&gt;&lt;span style="color:#212529;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The United States operating segment consists of the &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;manufacture and distribution of hemp-derived CBD infused products. &lt;/span&gt;&lt;span style="color:#212529;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Rest of World operating segment is involved in &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;the cultivation, manufacture, and marketing of cannabis and cannabis-derived products for the medical and adult-use markets&lt;/span&gt;&lt;span style="color:#212529;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;. &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;These two segments represent the geographic regions in which the Company operates and the different product offerings within each geographic region. The results of each segment are regularly reviewed by the CODMs to assess the performance of the segment and make decisions regarding the allocation of resources. The CODMs review adjusted earnings (loss) before interest, tax, depreciation and amortization (&#x201c;Adjusted EBITDA&#x201d;) as the measure of segment profit or loss to evaluate performance of and allocate resources for its reportable segments. Adjusted EBITDA is defined as earnings before interest, tax, depreciation, non-cash items and items that do not reflect management&#x2019;s assessment of on-going business performance.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The tables below set forth our condensed consolidated results of operations, expressed in thousands of U.S. dollars for the periods presented. Our condensed consolidated financial results for these periods are not necessarily indicative of the consolidated financial results that we will achieve in future periods&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Segment data was as follows for the three and six months ended June&#160;30, 2021 and 2020: &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;margin-top:6pt;text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:49.316%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.566%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.772%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.566%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.772%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.566%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.772%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.570%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="21" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Three months ended June&#160;30, 2021&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;United States&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Rest of World&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Corporate Expenses&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Cannabis flower&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;11,597&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;11,597&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Cannabis extracts&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,227&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,531&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,758&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;267&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;267&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Net revenue&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,227&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;13,395&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;15,622&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Share of loss from equity accounted investments&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,115&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,115&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Interest income&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;20&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,280&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,300&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Interest expense&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(7)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(7)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Interest income, net&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;20&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,273&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,293&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total assets&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;709,956&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;386,805&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;741,850&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,838,611&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Depreciation and amortization&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;68&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;975&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,043&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Adjusted EBITDA&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(10,711)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(32,605)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(6,443)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(49,759)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Purchase of property, plant and equipment, net&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;239&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,428&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,667&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:49.316%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.566%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.772%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.566%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.772%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.566%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.772%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.570%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="21" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Three months ended June 30, 2020&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;United States&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Rest of World&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Corporate Expenses&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Cannabis flower&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5,674&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5,674&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Cannabis extracts&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,174&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,917&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4,091&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;118&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;118&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Net revenue&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,174&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7,709&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;9,883&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Share of loss from equity accounted investments&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;794&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;794&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Interest income&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,808&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,817&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Interest expense&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(83)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(83)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Interest income, net&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,725&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,734&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total assets&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;250,470&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;348,569&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,311,248&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,910,287&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Depreciation and amortization&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;36&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;643&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;679&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Impairment loss on long-lived assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;40,000&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;40,000&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Adjusted EBITDA&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(4,785)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(18,618)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(3,583)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(26,986)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Purchase of property, plant and equipment, net&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;39&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6,894&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6,933&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;margin-top:6pt;text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:49.316%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.566%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.772%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.566%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.772%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.566%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.772%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.570%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="21" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Six months ended June&#160;30, 2021&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;United States&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Rest of World&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Corporate Expenses&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Cannabis flower&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;21,031&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;21,031&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Cannabis extracts&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4,668&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,234&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6,902&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;300&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;300&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Net revenue&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4,668&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;23,565&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;28,233&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;/tr&gt;&lt;tr style="height:14pt"&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Share of loss from equity accounted investments&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,758&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,758&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;/tr&gt;&lt;tr style="height:14pt"&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Interest income&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;23&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4,612&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4,635&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Interest expense&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(13)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(13)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Interest income, net&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;23&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4,599&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4,622&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;/tr&gt;&lt;tr style="height:14pt"&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total assets&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;709,956&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;386,805&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;741,850&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,838,611&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Depreciation and amortization&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;139&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,639&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,778&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Impairment loss on long-lived assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,741&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,741&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Adjusted EBITDA&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(20,221)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(54,789)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(11,323)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(86,333)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Purchase of property, plant and equipment, net&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;319&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;8,028&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;8,347&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:49.316%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.566%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.772%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.566%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.772%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.566%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.772%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.570%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="21" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Six months ended June 30, 2020&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;United States&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Rest of World&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Corporate Expenses&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Cannabis flower&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;8,415&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;8,415&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Cannabis extracts&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4,350&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5,317&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;9,667&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;233&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;233&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Net revenue&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4,350&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;13,965&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;18,315&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;/tr&gt;&lt;tr style="height:14pt"&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Share of loss from equity accounted investments&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,966&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,966&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;/tr&gt;&lt;tr style="height:14pt"&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Interest income&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;16&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;11,559&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;11,575&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Interest expense&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(90)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(90)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Interest income, net&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;16&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;11,469&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;11,485&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;/tr&gt;&lt;tr style="height:14pt"&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total assets&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;250,470&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;348,569&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,311,248&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,910,287&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Depreciation and amortization&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;69&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,297&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,366&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Impairment loss on long-lived assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;40,000&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;40,000&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Adjusted EBITDA&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(10,567)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(47,628)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(5,846)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(64,041)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Purchase of property, plant and equipment, net&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;219&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;13,125&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;13,344&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following tables set forth a reconciliation of net income (loss) as determined in accordance with U.S. GAAP to Adjusted EBITDA for the periods indicated:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:42.650%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.233%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.772%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.233%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.772%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.233%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.772%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.235%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="21" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Three months ended June&#160;30, 2021&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;United States&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Rest of World&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Corporate Expenses&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 6.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Net income (loss)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(11,719)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;79,627&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(11,133)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 7pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;56,775&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 18.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Interest income, net&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(20)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(2,273)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(2,293)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 18.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Share of loss from equity accounted investments&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,115&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,115&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:17.25pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Gain on revaluation of derivative liabilities&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(ii)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(115,248)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(115,248)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:17.25pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Transaction costs&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(iii)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,758&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,758&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:17.25pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other, net&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(iv)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1,127)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1,127)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:17.25pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Loss from discontinued operations&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(v)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;561&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;561&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:17.25pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Share-based payments&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(vi)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;822&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,743&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,565&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:17.25pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Review costs related to restatement of 2019 interim financial statements&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(vii)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,932&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,932&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Depreciation and amortization&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;206&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,997&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,203&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Adjusted EBITDA&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(10,711)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(32,605)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(6,443)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(49,759)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:42.650%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.233%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.772%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.233%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.772%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.233%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.772%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.235%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="21" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Three months ended June&#160;30, 2020&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;United States&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Rest of World&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Corporate&lt;br/&gt;Expenses&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Net loss&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(45,566)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(55,095)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(7,042)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 7pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(107,703)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 25pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Interest income, net&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(9)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(3,725)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(3,734)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 25pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Share of loss from equity accounted investments&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;794&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;794&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;div style="padding-left:24pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Impairment loss on long-lived assets&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(i)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;40,000&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;40,000&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;div style="padding-left:24pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Loss on revaluation of derivative liabilities&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(ii)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;35,880&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;35,880&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;div style="padding-left:24pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other, net&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(iv)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;9&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;div style="padding-left:24pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Loss from discontinued operations&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(v)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;46&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;46&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;div style="padding-left:24pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Share-based payments&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(vi)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;756&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,790&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,546&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;div style="padding-left:24pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Review costs related to restatement of 2019 interim financial statements&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(vii)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,459&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,459&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Depreciation and amortization&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;34&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,683&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,717&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Adjusted EBITDA&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(4,785)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(18,618)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(3,583)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(26,986)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:42.650%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.233%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.772%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.233%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.772%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.233%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.772%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.235%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="21" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Six months ended June&#160;30, 2021&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;United States&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Rest of World&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Corporate Expenses&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 6.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Net loss&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(23,811)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(62,520)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(18,519)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 7pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(104,850)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 18.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Interest income, net&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(23)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(4,599)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(4,622)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 18.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Share of loss from equity accounted investments&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,758&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,758&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;div style="padding-left:17.25pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Impairment loss on long-lived assets&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(i)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,741&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,741&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:17.25pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Loss on revaluation of derivative liabilities&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(ii)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,626&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,626&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:17.25pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Transaction costs&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(iii)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,259&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,259&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:17.25pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other, net&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(iv)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(911)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(911)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:17.25pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Loss from discontinued operations&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(v)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;582&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;582&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:17.25pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Share-based payments&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(vi)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,567&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,497&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5,064&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:17.25pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Review costs related to restatement of 2019 interim financial statements&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(vii)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,937&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,937&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Depreciation and amortization&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;305&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4,778&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5,083&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Adjusted EBITDA&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(20,221)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(54,789)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(11,323)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(86,333)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt;text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:42.650%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.233%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.772%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.233%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.772%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.233%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.772%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.235%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="21" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Six months ended June&#160;30, 2020&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;United States&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Rest of World&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Corporate Expenses&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Net income (loss)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(52,082)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;33,772&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(13,712)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 7pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(32,022)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Interest income, net&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(16)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(11,469)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(11,485)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Share of loss from equity accounted investments&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,966&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,966&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;div style="padding-left:17.25pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Impairment loss on long-lived assets&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(i)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;40,000&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;40,000&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:17.25pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Loss on revaluation of derivative liabilities&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(ii)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(77,488)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(77,488)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:17.25pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other, net&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(iv)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(785)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(785)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:17.25pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Loss from discontinued operations&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(v)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;46&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;46&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:17.25pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Share-based payments&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(vi)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,462&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,520&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4,982&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:17.25pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Review costs related to restatement of 2019 interim financial statements&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(vii)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7,866&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7,866&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Depreciation and amortization&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;69&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,810&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,879&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Adjusted EBITDA&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(10,567)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(47,628)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(5,846)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(64,041)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:3pt;padding-left:27pt;text-align:justify;text-indent:-27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:400;line-height:120%;position:relative;top:-2.8pt;vertical-align:baseline"&gt;(i)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:22.1pt"&gt;For the six months ended June 30, 2021, impairment loss on long-lived assets relates to impairment on a leased premise in the U.S. segment, and for the three and six months ended June 30, 2020, impairment loss on long-lived assets relates to impairment on goodwill and intangibles related to our U.S. segment in 2020. See Note 12. Impairment Loss on Long-Lived Assets.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt;margin-top:3pt;padding-left:27pt;text-align:justify;text-indent:-27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:400;line-height:120%;position:relative;top:-2.8pt;vertical-align:baseline"&gt;(ii)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:20.66pt"&gt;For the three and six months ended June 30, 2021 and 2020, gain/loss on revaluation of derivative liabilities represents the fair value changes on the derivative liabilities. See Note 5. Derivative Liabilities.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt;margin-top:3pt;padding-left:27pt;text-align:justify;text-indent:-27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:400;line-height:120%;position:relative;top:-2.8pt;vertical-align:baseline"&gt;(iii)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:19.22pt"&gt;For the three and six months ended June 30, 2021, transaction costs represents legal, financial and other advisory fees and expenses incurred in connection with various strategic investments. These costs are included in general and administrative expenses on the condensed consolidated statements of net income (loss) and comprehensive income (loss).&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt;margin-top:3pt;padding-left:27pt;text-align:justify;text-indent:-27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:400;line-height:120%;position:relative;top:-2.8pt;vertical-align:baseline"&gt;(iv)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:19.5pt"&gt;For the three and six months ended June 30, 2021, other, net is related to gain recorded on sale of the Company&#x2019;s Winnipeg facility previously designated as held-for-sale in the first quarter of 2021, For the three and six months ended June 30, 2020, other, net is primarily comprised of the gain recorded related to the sale of common shares of Aurora Cannabis, Inc. (&#x201c;Aurora&#x201d;), which were received in connection with the achievement of a milestone related to Aurora&#x2019;s acquisition of Whistler Medical Marijuana Corporation.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt;margin-top:3pt;padding-left:27pt;text-align:justify;text-indent:-27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:400;line-height:120%;position:relative;top:-2.8pt;vertical-align:baseline"&gt;(v)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:20.94pt"&gt;For the three and six months ended June 30, 2020, loss from discontinued operations relates to the discontinuance of Original B.C. Ltd. (&#x201c;OGBC&#x201d;). See Note 11. Held-For-Sale Assets and Discontinued Operations.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt;margin-top:3pt;padding-left:27pt;text-align:justify;text-indent:-27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:400;line-height:120%;position:relative;top:-2.8pt;vertical-align:baseline"&gt;(vi)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:19.5pt"&gt;For the three and six months ended June 30, 2021 and 2020, share-based payments relates to the vesting expenses of share-based compensation awarded to employees under the Company&#x2019;s share-based award plans as described in Note 6. Share-based Payments.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt;margin-top:3pt;padding-left:27pt;text-align:justify;text-indent:-27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:400;line-height:120%;position:relative;top:-2.8pt;vertical-align:baseline"&gt;(vii)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:18.06pt"&gt;For the three and six months ended June 30, 2021 and 2020, the financial statement review costs include costs related to the restatement of the Company&#x2019;s 2019 interim financial statements, costs related to the Company&#x2019;s responses to requests for information from various regulatory authorities relating to such restatement and legal costs defending shareholder class action complaints brought against the Company as a result of the restatement. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Net revenue attributed to a geographic region based on the location of the customer were as follows:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:42.372%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.816%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.327%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.816%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.605%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.816%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.327%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.821%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Three months ended June 30,&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Six months ended June 30,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Canada&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;10,664&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7,416&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;18,246&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;13,507&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Israel&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,310&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;293&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4,828&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;293&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;United States&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,227&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,174&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4,668&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4,350&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other countries&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;421&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;491&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;165&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Net revenue&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;15,622&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;9,883&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;28,233&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;18,315&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Property, plant and equipment assets were physically located in the following geographic regions:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:60.150%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:17.372%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.605%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:17.373%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;As of June&#160;30, 2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;As of December 31, 2020&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Canada&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;168,462&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;162,163&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Israel&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;23,936&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;23,143&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;United States&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,522&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,293&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total &lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;193,920&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;187,599&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company sells products through a limited number of major customers. Major customers are defined as customers that each individually accounted for greater than 10% of the Company&#x2019;s revenues.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;United States&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;During the three and six months ended June&#160;30, 2021 and 2020, the U.S. segment had no major customers.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;As of June&#160;30, 2021 and December 31, 2020, the Company had $106 and $65, respectively, in expected credit losses that have been recognized on receivables from contracts with customers.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;There was no loss from discontinued operations from the U.S. Segment for the three and six months ended June 30, 2021 and 2020.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Rest of World&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;During the three months ended June&#160;30, 2021, the Rest of World segment earned a total net revenue before excise taxes of $8,497 from three major customers, Ontario Cannabis Retail Corporation, Alberta Gaming, Liquor and Cannabis Commission and Soci&#xe9;t&#xe9; Qu&#xe9;b&#xe9;coise du Cannabis, accounting for 19%, 14% and 12%, respectively, of the Company&#x2019;s total net revenue before excise taxes. During the three months ended June&#160;30, 2020, the Rest of World segment earned a total net revenue before excise taxes of $7,040 from four major customers, together accounting for 71% of the Company&#x2019;s total net revenues before excise taxes.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;During the six months ended June 30, 2021, the Rest of World segment earned a total net revenue before excise taxes of $18,250 from four major customers, Ontario Cannabis Retail Corporation, Novolog Group, Soci&#xe9;t&#xe9; Qu&#xe9;b&#xe9;coise du Cannabis and Alberta Gaming, Liquor and Cannabis Commission, accounting for 15%, 14%, 13%, and 12% respectively, of the Company&#x2019;s total net revenue before excise taxes. During the six months ended June&#160;30, 2020, the Rest of World segment earned a total net revenue before excise taxes of $11,819 from four major customers, together accounting for 65% of the Company&#x2019;s total net revenues before excise taxes.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;As of June&#160;30, 2021 and December 31, 2020, the Company had $158 and $9, respectively, in expected credit losses that have been recognized on receivables from contracts with customers.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The loss from discontinued operations from the Rest of World segment for the three months ended June&#160;30, 2021 and 2020 was $561 and $46, respectively. The loss from discontinued operations from the Rest of World segment for the six months ended June&#160;30, 2021 and 2020 was $582 and $46, respectively.&lt;/span&gt;&lt;/div&gt;</us-gaap:SegmentReportingDisclosureTextBlock>
    <us-gaap:NumberOfReportableSegments
      contextRef="i69782326f71a44e3805518280ee22b6b_D20210101-20210630"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzY2E5YmIwMTc5MjQ3NmZiYjIyNWU1ZDlkZWM4NjlmL3NlYzo5M2NhOWJiMDE3OTI0NzZmYmIyMjVlNWQ5ZGVjODY5Zl81NS9mcmFnOjk0NGQ2N2RjOTNmMjQ1MjliZTc4ZmNlMzRiOGMyZTBiL3RleHRyZWdpb246OTQ0ZDY3ZGM5M2YyNDUyOWJlNzhmY2UzNGI4YzJlMGJfNDk0NzgwMjM1OTE1Ng_e8829cae-abeb-4c97-a237-0d9bc6cd122f"
      unitRef="segment">2</us-gaap:NumberOfReportableSegments>
    <us-gaap:NumberOfReportableSegments
      contextRef="i69782326f71a44e3805518280ee22b6b_D20210101-20210630"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzY2E5YmIwMTc5MjQ3NmZiYjIyNWU1ZDlkZWM4NjlmL3NlYzo5M2NhOWJiMDE3OTI0NzZmYmIyMjVlNWQ5ZGVjODY5Zl81NS9mcmFnOjk0NGQ2N2RjOTNmMjQ1MjliZTc4ZmNlMzRiOGMyZTBiL3RleHRyZWdpb246OTQ0ZDY3ZGM5M2YyNDUyOWJlNzhmY2UzNGI4YzJlMGJfNDk0NzgwMjM1OTE1MQ_b49c94c5-86fe-4869-b661-8acfbf3c093f"
      unitRef="segment">2</us-gaap:NumberOfReportableSegments>
    <us-gaap:ScheduleOfSegmentReportingInformationBySegmentTextBlock
      contextRef="i69782326f71a44e3805518280ee22b6b_D20210101-20210630"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzY2E5YmIwMTc5MjQ3NmZiYjIyNWU1ZDlkZWM4NjlmL3NlYzo5M2NhOWJiMDE3OTI0NzZmYmIyMjVlNWQ5ZGVjODY5Zl81NS9mcmFnOjk0NGQ2N2RjOTNmMjQ1MjliZTc4ZmNlMzRiOGMyZTBiL3RleHRyZWdpb246OTQ0ZDY3ZGM5M2YyNDUyOWJlNzhmY2UzNGI4YzJlMGJfMjk5Mw_517f7b72-239e-4893-aaa2-9809afbc3936">&lt;div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Segment data was as follows for the three and six months ended June&#160;30, 2021 and 2020: &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;margin-top:6pt;text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:49.316%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.566%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.772%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.566%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.772%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.566%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.772%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.570%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="21" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Three months ended June&#160;30, 2021&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;United States&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Rest of World&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Corporate Expenses&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Cannabis flower&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;11,597&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;11,597&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Cannabis extracts&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,227&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,531&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,758&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;267&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;267&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Net revenue&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,227&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;13,395&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;15,622&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Share of loss from equity accounted investments&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,115&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,115&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Interest income&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;20&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,280&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,300&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Interest expense&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(7)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(7)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Interest income, net&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;20&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,273&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,293&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total assets&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;709,956&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;386,805&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;741,850&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,838,611&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Depreciation and amortization&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;68&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;975&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,043&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Adjusted EBITDA&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(10,711)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(32,605)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(6,443)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(49,759)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Purchase of property, plant and equipment, net&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;239&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,428&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,667&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:49.316%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.566%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.772%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.566%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.772%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.566%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.772%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.570%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="21" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Three months ended June 30, 2020&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;United States&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Rest of World&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Corporate Expenses&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Cannabis flower&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5,674&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5,674&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Cannabis extracts&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,174&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,917&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4,091&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;118&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;118&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Net revenue&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,174&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7,709&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;9,883&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Share of loss from equity accounted investments&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;794&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;794&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Interest income&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,808&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,817&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Interest expense&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(83)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(83)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Interest income, net&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,725&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,734&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total assets&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;250,470&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;348,569&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,311,248&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,910,287&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Depreciation and amortization&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;36&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;643&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;679&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Impairment loss on long-lived assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;40,000&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;40,000&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Adjusted EBITDA&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(4,785)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(18,618)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(3,583)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(26,986)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Purchase of property, plant and equipment, net&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;39&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6,894&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6,933&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;margin-top:6pt;text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:49.316%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.566%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.772%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.566%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.772%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.566%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.772%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.570%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="21" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Six months ended June&#160;30, 2021&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;United States&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Rest of World&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Corporate Expenses&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Cannabis flower&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;21,031&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;21,031&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Cannabis extracts&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4,668&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,234&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6,902&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;300&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;300&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Net revenue&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4,668&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;23,565&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;28,233&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;/tr&gt;&lt;tr style="height:14pt"&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Share of loss from equity accounted investments&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,758&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,758&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;/tr&gt;&lt;tr style="height:14pt"&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Interest income&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;23&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4,612&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4,635&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Interest expense&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(13)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(13)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Interest income, net&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;23&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4,599&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4,622&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;/tr&gt;&lt;tr style="height:14pt"&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total assets&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;709,956&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;386,805&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;741,850&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,838,611&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Depreciation and amortization&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;139&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,639&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,778&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Impairment loss on long-lived assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,741&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,741&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Adjusted EBITDA&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(20,221)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(54,789)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(11,323)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(86,333)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Purchase of property, plant and equipment, net&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;319&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;8,028&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;8,347&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:49.316%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.566%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.772%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.566%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.772%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.566%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.772%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.570%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="21" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Six months ended June 30, 2020&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;United States&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Rest of World&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Corporate Expenses&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Cannabis flower&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;8,415&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;8,415&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Cannabis extracts&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4,350&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5,317&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;9,667&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;233&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;233&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Net revenue&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4,350&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;13,965&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;18,315&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;/tr&gt;&lt;tr style="height:14pt"&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Share of loss from equity accounted investments&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,966&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,966&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;/tr&gt;&lt;tr style="height:14pt"&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Interest income&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;16&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;11,559&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;11,575&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Interest expense&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(90)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(90)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Interest income, net&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;16&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;11,469&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;11,485&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;/tr&gt;&lt;tr style="height:14pt"&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total assets&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;250,470&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;348,569&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,311,248&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,910,287&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Depreciation and amortization&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;69&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,297&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,366&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Impairment loss on long-lived assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;40,000&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;40,000&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Adjusted EBITDA&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(10,567)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(47,628)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(5,846)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(64,041)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Purchase of property, plant and equipment, net&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;219&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;13,125&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;13,344&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following tables set forth a reconciliation of net income (loss) as determined in accordance with U.S. GAAP to Adjusted EBITDA for the periods indicated:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:42.650%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.233%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.772%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.233%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.772%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.233%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.772%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.235%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="21" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Three months ended June&#160;30, 2021&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;United States&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Rest of World&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Corporate Expenses&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 6.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Net income (loss)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(11,719)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;79,627&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(11,133)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 7pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;56,775&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 18.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Interest income, net&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(20)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(2,273)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(2,293)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 18.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Share of loss from equity accounted investments&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,115&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,115&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:17.25pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Gain on revaluation of derivative liabilities&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(ii)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(115,248)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(115,248)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:17.25pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Transaction costs&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(iii)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,758&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,758&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:17.25pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other, net&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(iv)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1,127)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1,127)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:17.25pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Loss from discontinued operations&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(v)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;561&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;561&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:17.25pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Share-based payments&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(vi)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;822&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,743&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,565&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:17.25pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Review costs related to restatement of 2019 interim financial statements&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(vii)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,932&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,932&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Depreciation and amortization&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;206&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,997&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,203&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Adjusted EBITDA&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(10,711)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(32,605)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(6,443)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(49,759)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:42.650%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.233%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.772%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.233%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.772%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.233%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.772%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.235%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="21" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Three months ended June&#160;30, 2020&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;United States&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Rest of World&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Corporate&lt;br/&gt;Expenses&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Net loss&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(45,566)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(55,095)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(7,042)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 7pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(107,703)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 25pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Interest income, net&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(9)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(3,725)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(3,734)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 25pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Share of loss from equity accounted investments&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;794&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;794&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;div style="padding-left:24pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Impairment loss on long-lived assets&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(i)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;40,000&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;40,000&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;div style="padding-left:24pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Loss on revaluation of derivative liabilities&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(ii)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;35,880&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;35,880&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;div style="padding-left:24pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other, net&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(iv)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;9&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;div style="padding-left:24pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Loss from discontinued operations&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(v)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;46&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;46&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;div style="padding-left:24pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Share-based payments&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(vi)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;756&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,790&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,546&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;div style="padding-left:24pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Review costs related to restatement of 2019 interim financial statements&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(vii)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,459&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,459&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Depreciation and amortization&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;34&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,683&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,717&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Adjusted EBITDA&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(4,785)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(18,618)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(3,583)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(26,986)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:42.650%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.233%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.772%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.233%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.772%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.233%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.772%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.235%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="21" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Six months ended June&#160;30, 2021&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;United States&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Rest of World&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Corporate Expenses&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 6.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Net loss&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(23,811)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(62,520)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(18,519)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 7pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(104,850)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 18.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Interest income, net&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(23)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(4,599)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(4,622)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 18.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Share of loss from equity accounted investments&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,758&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,758&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;div style="padding-left:17.25pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Impairment loss on long-lived assets&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(i)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,741&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,741&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:17.25pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Loss on revaluation of derivative liabilities&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(ii)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,626&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,626&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:17.25pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Transaction costs&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(iii)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,259&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,259&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:17.25pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other, net&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(iv)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(911)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(911)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:17.25pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Loss from discontinued operations&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(v)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;582&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;582&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:17.25pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Share-based payments&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(vi)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,567&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,497&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5,064&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:17.25pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Review costs related to restatement of 2019 interim financial statements&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(vii)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,937&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,937&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Depreciation and amortization&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;305&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4,778&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5,083&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Adjusted EBITDA&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(20,221)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(54,789)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(11,323)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(86,333)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt;text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:42.650%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.233%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.772%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.233%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.772%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.233%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.772%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.235%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="21" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Six months ended June&#160;30, 2020&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;United States&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Rest of World&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Corporate Expenses&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Net income (loss)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(52,082)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;33,772&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(13,712)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 7pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(32,022)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Interest income, net&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(16)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(11,469)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(11,485)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Share of loss from equity accounted investments&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,966&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,966&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;div style="padding-left:17.25pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Impairment loss on long-lived assets&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(i)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;40,000&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;40,000&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:17.25pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Loss on revaluation of derivative liabilities&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(ii)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(77,488)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(77,488)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:17.25pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other, net&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(iv)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(785)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(785)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:17.25pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Loss from discontinued operations&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(v)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;46&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;46&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:17.25pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Share-based payments&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(vi)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,462&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,520&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4,982&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:17.25pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Review costs related to restatement of 2019 interim financial statements&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(vii)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7,866&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7,866&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Depreciation and amortization&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;69&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,810&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,879&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Adjusted EBITDA&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(10,567)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(47,628)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(5,846)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(64,041)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:3pt;padding-left:27pt;text-align:justify;text-indent:-27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:400;line-height:120%;position:relative;top:-2.8pt;vertical-align:baseline"&gt;(i)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:22.1pt"&gt;For the six months ended June 30, 2021, impairment loss on long-lived assets relates to impairment on a leased premise in the U.S. segment, and for the three and six months ended June 30, 2020, impairment loss on long-lived assets relates to impairment on goodwill and intangibles related to our U.S. segment in 2020. See Note 12. Impairment Loss on Long-Lived Assets.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt;margin-top:3pt;padding-left:27pt;text-align:justify;text-indent:-27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:400;line-height:120%;position:relative;top:-2.8pt;vertical-align:baseline"&gt;(ii)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:20.66pt"&gt;For the three and six months ended June 30, 2021 and 2020, gain/loss on revaluation of derivative liabilities represents the fair value changes on the derivative liabilities. See Note 5. Derivative Liabilities.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt;margin-top:3pt;padding-left:27pt;text-align:justify;text-indent:-27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:400;line-height:120%;position:relative;top:-2.8pt;vertical-align:baseline"&gt;(iii)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:19.22pt"&gt;For the three and six months ended June 30, 2021, transaction costs represents legal, financial and other advisory fees and expenses incurred in connection with various strategic investments. These costs are included in general and administrative expenses on the condensed consolidated statements of net income (loss) and comprehensive income (loss).&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt;margin-top:3pt;padding-left:27pt;text-align:justify;text-indent:-27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:400;line-height:120%;position:relative;top:-2.8pt;vertical-align:baseline"&gt;(iv)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:19.5pt"&gt;For the three and six months ended June 30, 2021, other, net is related to gain recorded on sale of the Company&#x2019;s Winnipeg facility previously designated as held-for-sale in the first quarter of 2021, For the three and six months ended June 30, 2020, other, net is primarily comprised of the gain recorded related to the sale of common shares of Aurora Cannabis, Inc. (&#x201c;Aurora&#x201d;), which were received in connection with the achievement of a milestone related to Aurora&#x2019;s acquisition of Whistler Medical Marijuana Corporation.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt;margin-top:3pt;padding-left:27pt;text-align:justify;text-indent:-27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:400;line-height:120%;position:relative;top:-2.8pt;vertical-align:baseline"&gt;(v)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:20.94pt"&gt;For the three and six months ended June 30, 2020, loss from discontinued operations relates to the discontinuance of Original B.C. Ltd. (&#x201c;OGBC&#x201d;). See Note 11. Held-For-Sale Assets and Discontinued Operations.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt;margin-top:3pt;padding-left:27pt;text-align:justify;text-indent:-27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:400;line-height:120%;position:relative;top:-2.8pt;vertical-align:baseline"&gt;(vi)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:19.5pt"&gt;For the three and six months ended June 30, 2021 and 2020, share-based payments relates to the vesting expenses of share-based compensation awarded to employees under the Company&#x2019;s share-based award plans as described in Note 6. Share-based Payments.&lt;/span&gt;&lt;/div&gt;(vii)For the three and six months ended June 30, 2021 and 2020, the financial statement review costs include costs related to the restatement of the Company&#x2019;s 2019 interim financial statements, costs related to the Company&#x2019;s responses to requests for information from various regulatory authorities relating to such restatement and legal costs defending shareholder class action complaints brought against the Company as a result of the restatement.</us-gaap:ScheduleOfSegmentReportingInformationBySegmentTextBlock>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="ibc692233c14c49be87add169c0e2de75_D20210401-20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzY2E5YmIwMTc5MjQ3NmZiYjIyNWU1ZDlkZWM4NjlmL3NlYzo5M2NhOWJiMDE3OTI0NzZmYmIyMjVlNWQ5ZGVjODY5Zl81NS9mcmFnOjk0NGQ2N2RjOTNmMjQ1MjliZTc4ZmNlMzRiOGMyZTBiL3RhYmxlOjhlMGRhYjE1OGMzYTQyNTdhOWJkMTAzNzRmMDNiYzkxL3RhYmxlcmFuZ2U6OGUwZGFiMTU4YzNhNDI1N2E5YmQxMDM3NGYwM2JjOTFfMy0xLTEtMS0w_4c403b20-7b6c-4bd7-84f5-72b8b8552dfa"
      unitRef="usd">0</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i8f2910ecf1ae40e091d358fb8405c9bd_D20210401-20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzY2E5YmIwMTc5MjQ3NmZiYjIyNWU1ZDlkZWM4NjlmL3NlYzo5M2NhOWJiMDE3OTI0NzZmYmIyMjVlNWQ5ZGVjODY5Zl81NS9mcmFnOjk0NGQ2N2RjOTNmMjQ1MjliZTc4ZmNlMzRiOGMyZTBiL3RhYmxlOjhlMGRhYjE1OGMzYTQyNTdhOWJkMTAzNzRmMDNiYzkxL3RhYmxlcmFuZ2U6OGUwZGFiMTU4YzNhNDI1N2E5YmQxMDM3NGYwM2JjOTFfMy0zLTEtMS0w_830bdc55-1781-4c1b-81ed-e0a56f374274"
      unitRef="usd">11597000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="ia66d704cc8af4a879583109863080207_D20210401-20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzY2E5YmIwMTc5MjQ3NmZiYjIyNWU1ZDlkZWM4NjlmL3NlYzo5M2NhOWJiMDE3OTI0NzZmYmIyMjVlNWQ5ZGVjODY5Zl81NS9mcmFnOjk0NGQ2N2RjOTNmMjQ1MjliZTc4ZmNlMzRiOGMyZTBiL3RhYmxlOjhlMGRhYjE1OGMzYTQyNTdhOWJkMTAzNzRmMDNiYzkxL3RhYmxlcmFuZ2U6OGUwZGFiMTU4YzNhNDI1N2E5YmQxMDM3NGYwM2JjOTFfMy01LTEtMS0w_802fa7b8-86e9-4edc-86f1-0e738108b314"
      unitRef="usd">0</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i79727dab4c1240ceaa1f07e61bb81188_D20210401-20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzY2E5YmIwMTc5MjQ3NmZiYjIyNWU1ZDlkZWM4NjlmL3NlYzo5M2NhOWJiMDE3OTI0NzZmYmIyMjVlNWQ5ZGVjODY5Zl81NS9mcmFnOjk0NGQ2N2RjOTNmMjQ1MjliZTc4ZmNlMzRiOGMyZTBiL3RhYmxlOjhlMGRhYjE1OGMzYTQyNTdhOWJkMTAzNzRmMDNiYzkxL3RhYmxlcmFuZ2U6OGUwZGFiMTU4YzNhNDI1N2E5YmQxMDM3NGYwM2JjOTFfMy03LTEtMS0w_bbc57635-f6d3-4c0f-9f0a-5db6696bf9bc"
      unitRef="usd">11597000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="ibd153928ae104df6b058cc08f14f6f09_D20210401-20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzY2E5YmIwMTc5MjQ3NmZiYjIyNWU1ZDlkZWM4NjlmL3NlYzo5M2NhOWJiMDE3OTI0NzZmYmIyMjVlNWQ5ZGVjODY5Zl81NS9mcmFnOjk0NGQ2N2RjOTNmMjQ1MjliZTc4ZmNlMzRiOGMyZTBiL3RhYmxlOjhlMGRhYjE1OGMzYTQyNTdhOWJkMTAzNzRmMDNiYzkxL3RhYmxlcmFuZ2U6OGUwZGFiMTU4YzNhNDI1N2E5YmQxMDM3NGYwM2JjOTFfNC0xLTEtMS0w_9c17c1f3-64b1-4477-8ba6-988b0530d9fa"
      unitRef="usd">2227000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i032a3ff320db4a7383246d7d6de2326f_D20210401-20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzY2E5YmIwMTc5MjQ3NmZiYjIyNWU1ZDlkZWM4NjlmL3NlYzo5M2NhOWJiMDE3OTI0NzZmYmIyMjVlNWQ5ZGVjODY5Zl81NS9mcmFnOjk0NGQ2N2RjOTNmMjQ1MjliZTc4ZmNlMzRiOGMyZTBiL3RhYmxlOjhlMGRhYjE1OGMzYTQyNTdhOWJkMTAzNzRmMDNiYzkxL3RhYmxlcmFuZ2U6OGUwZGFiMTU4YzNhNDI1N2E5YmQxMDM3NGYwM2JjOTFfNC0zLTEtMS0w_ec78163b-4092-4f23-8199-d0c994690527"
      unitRef="usd">1531000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="ia76908c59acf4c64acd394bfc6223beb_D20210401-20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzY2E5YmIwMTc5MjQ3NmZiYjIyNWU1ZDlkZWM4NjlmL3NlYzo5M2NhOWJiMDE3OTI0NzZmYmIyMjVlNWQ5ZGVjODY5Zl81NS9mcmFnOjk0NGQ2N2RjOTNmMjQ1MjliZTc4ZmNlMzRiOGMyZTBiL3RhYmxlOjhlMGRhYjE1OGMzYTQyNTdhOWJkMTAzNzRmMDNiYzkxL3RhYmxlcmFuZ2U6OGUwZGFiMTU4YzNhNDI1N2E5YmQxMDM3NGYwM2JjOTFfNC01LTEtMS0w_a342db14-6fbb-43d4-a306-9b4a76e06d61"
      unitRef="usd">0</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="id339c655bfd341ce947f632c28a7cb54_D20210401-20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzY2E5YmIwMTc5MjQ3NmZiYjIyNWU1ZDlkZWM4NjlmL3NlYzo5M2NhOWJiMDE3OTI0NzZmYmIyMjVlNWQ5ZGVjODY5Zl81NS9mcmFnOjk0NGQ2N2RjOTNmMjQ1MjliZTc4ZmNlMzRiOGMyZTBiL3RhYmxlOjhlMGRhYjE1OGMzYTQyNTdhOWJkMTAzNzRmMDNiYzkxL3RhYmxlcmFuZ2U6OGUwZGFiMTU4YzNhNDI1N2E5YmQxMDM3NGYwM2JjOTFfNC03LTEtMS0w_5f801e1f-c534-4388-a96d-84324f9b7734"
      unitRef="usd">3758000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i32838a57ba6c4493badd924366696106_D20210401-20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzY2E5YmIwMTc5MjQ3NmZiYjIyNWU1ZDlkZWM4NjlmL3NlYzo5M2NhOWJiMDE3OTI0NzZmYmIyMjVlNWQ5ZGVjODY5Zl81NS9mcmFnOjk0NGQ2N2RjOTNmMjQ1MjliZTc4ZmNlMzRiOGMyZTBiL3RhYmxlOjhlMGRhYjE1OGMzYTQyNTdhOWJkMTAzNzRmMDNiYzkxL3RhYmxlcmFuZ2U6OGUwZGFiMTU4YzNhNDI1N2E5YmQxMDM3NGYwM2JjOTFfNS0xLTEtMS0w_cd420d1a-1bb7-44f7-9052-b7aa1d91a389"
      unitRef="usd">0</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i6f297f0a314745488d2a9a9e296b5375_D20210401-20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzY2E5YmIwMTc5MjQ3NmZiYjIyNWU1ZDlkZWM4NjlmL3NlYzo5M2NhOWJiMDE3OTI0NzZmYmIyMjVlNWQ5ZGVjODY5Zl81NS9mcmFnOjk0NGQ2N2RjOTNmMjQ1MjliZTc4ZmNlMzRiOGMyZTBiL3RhYmxlOjhlMGRhYjE1OGMzYTQyNTdhOWJkMTAzNzRmMDNiYzkxL3RhYmxlcmFuZ2U6OGUwZGFiMTU4YzNhNDI1N2E5YmQxMDM3NGYwM2JjOTFfNS0zLTEtMS0w_9c03d995-4751-4510-affb-23d833dfc1f3"
      unitRef="usd">267000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i07bd26499a384059b217b3a61ccfa0a7_D20210401-20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzY2E5YmIwMTc5MjQ3NmZiYjIyNWU1ZDlkZWM4NjlmL3NlYzo5M2NhOWJiMDE3OTI0NzZmYmIyMjVlNWQ5ZGVjODY5Zl81NS9mcmFnOjk0NGQ2N2RjOTNmMjQ1MjliZTc4ZmNlMzRiOGMyZTBiL3RhYmxlOjhlMGRhYjE1OGMzYTQyNTdhOWJkMTAzNzRmMDNiYzkxL3RhYmxlcmFuZ2U6OGUwZGFiMTU4YzNhNDI1N2E5YmQxMDM3NGYwM2JjOTFfNS01LTEtMS0w_f0762c96-b55c-4e12-80af-21984a261780"
      unitRef="usd">0</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="ib7b191b315bf4d3d9c5a469788ccac38_D20210401-20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzY2E5YmIwMTc5MjQ3NmZiYjIyNWU1ZDlkZWM4NjlmL3NlYzo5M2NhOWJiMDE3OTI0NzZmYmIyMjVlNWQ5ZGVjODY5Zl81NS9mcmFnOjk0NGQ2N2RjOTNmMjQ1MjliZTc4ZmNlMzRiOGMyZTBiL3RhYmxlOjhlMGRhYjE1OGMzYTQyNTdhOWJkMTAzNzRmMDNiYzkxL3RhYmxlcmFuZ2U6OGUwZGFiMTU4YzNhNDI1N2E5YmQxMDM3NGYwM2JjOTFfNS03LTEtMS0w_15bc19a9-73ec-4e1f-8c40-84cef371a9fb"
      unitRef="usd">267000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i2a563d1bc1a1451296d5f40e6cdf2912_D20210401-20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzY2E5YmIwMTc5MjQ3NmZiYjIyNWU1ZDlkZWM4NjlmL3NlYzo5M2NhOWJiMDE3OTI0NzZmYmIyMjVlNWQ5ZGVjODY5Zl81NS9mcmFnOjk0NGQ2N2RjOTNmMjQ1MjliZTc4ZmNlMzRiOGMyZTBiL3RhYmxlOjhlMGRhYjE1OGMzYTQyNTdhOWJkMTAzNzRmMDNiYzkxL3RhYmxlcmFuZ2U6OGUwZGFiMTU4YzNhNDI1N2E5YmQxMDM3NGYwM2JjOTFfNi0xLTEtMS0w_53fd6949-c66c-4cbe-a727-91ee75511ac6"
      unitRef="usd">2227000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i7b627a38d4bb4b2693a9598ca41f647d_D20210401-20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzY2E5YmIwMTc5MjQ3NmZiYjIyNWU1ZDlkZWM4NjlmL3NlYzo5M2NhOWJiMDE3OTI0NzZmYmIyMjVlNWQ5ZGVjODY5Zl81NS9mcmFnOjk0NGQ2N2RjOTNmMjQ1MjliZTc4ZmNlMzRiOGMyZTBiL3RhYmxlOjhlMGRhYjE1OGMzYTQyNTdhOWJkMTAzNzRmMDNiYzkxL3RhYmxlcmFuZ2U6OGUwZGFiMTU4YzNhNDI1N2E5YmQxMDM3NGYwM2JjOTFfNi0zLTEtMS0w_fa008124-4d81-4ebd-8498-5b396ad9fa9c"
      unitRef="usd">13395000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="ie916e4a685544ae3998d4e82e089944f_D20210401-20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzY2E5YmIwMTc5MjQ3NmZiYjIyNWU1ZDlkZWM4NjlmL3NlYzo5M2NhOWJiMDE3OTI0NzZmYmIyMjVlNWQ5ZGVjODY5Zl81NS9mcmFnOjk0NGQ2N2RjOTNmMjQ1MjliZTc4ZmNlMzRiOGMyZTBiL3RhYmxlOjhlMGRhYjE1OGMzYTQyNTdhOWJkMTAzNzRmMDNiYzkxL3RhYmxlcmFuZ2U6OGUwZGFiMTU4YzNhNDI1N2E5YmQxMDM3NGYwM2JjOTFfNi01LTEtMS0w_e37d6565-d73c-46f0-917d-fba75c7306aa"
      unitRef="usd">0</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i27f4e53b91ad4367b7f8d273eff27769_D20210401-20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzY2E5YmIwMTc5MjQ3NmZiYjIyNWU1ZDlkZWM4NjlmL3NlYzo5M2NhOWJiMDE3OTI0NzZmYmIyMjVlNWQ5ZGVjODY5Zl81NS9mcmFnOjk0NGQ2N2RjOTNmMjQ1MjliZTc4ZmNlMzRiOGMyZTBiL3RhYmxlOjhlMGRhYjE1OGMzYTQyNTdhOWJkMTAzNzRmMDNiYzkxL3RhYmxlcmFuZ2U6OGUwZGFiMTU4YzNhNDI1N2E5YmQxMDM3NGYwM2JjOTFfNi03LTEtMS0w_00ed97cd-fbb9-4cc8-943c-6e34548ed27c"
      unitRef="usd">15622000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:IncomeLossFromEquityMethodInvestments
      contextRef="i2a563d1bc1a1451296d5f40e6cdf2912_D20210401-20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzY2E5YmIwMTc5MjQ3NmZiYjIyNWU1ZDlkZWM4NjlmL3NlYzo5M2NhOWJiMDE3OTI0NzZmYmIyMjVlNWQ5ZGVjODY5Zl81NS9mcmFnOjk0NGQ2N2RjOTNmMjQ1MjliZTc4ZmNlMzRiOGMyZTBiL3RhYmxlOjhlMGRhYjE1OGMzYTQyNTdhOWJkMTAzNzRmMDNiYzkxL3RhYmxlcmFuZ2U6OGUwZGFiMTU4YzNhNDI1N2E5YmQxMDM3NGYwM2JjOTFfOC0xLTEtMS0w_5158990c-552e-4b9f-a0e7-27d06f93b558"
      unitRef="usd">0</us-gaap:IncomeLossFromEquityMethodInvestments>
    <us-gaap:IncomeLossFromEquityMethodInvestments
      contextRef="i7b627a38d4bb4b2693a9598ca41f647d_D20210401-20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzY2E5YmIwMTc5MjQ3NmZiYjIyNWU1ZDlkZWM4NjlmL3NlYzo5M2NhOWJiMDE3OTI0NzZmYmIyMjVlNWQ5ZGVjODY5Zl81NS9mcmFnOjk0NGQ2N2RjOTNmMjQ1MjliZTc4ZmNlMzRiOGMyZTBiL3RhYmxlOjhlMGRhYjE1OGMzYTQyNTdhOWJkMTAzNzRmMDNiYzkxL3RhYmxlcmFuZ2U6OGUwZGFiMTU4YzNhNDI1N2E5YmQxMDM3NGYwM2JjOTFfOC0zLTEtMS0w_5d926584-255c-43ec-bda4-7f74a9d8cf78"
      unitRef="usd">-1115000</us-gaap:IncomeLossFromEquityMethodInvestments>
    <us-gaap:IncomeLossFromEquityMethodInvestments
      contextRef="ie916e4a685544ae3998d4e82e089944f_D20210401-20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzY2E5YmIwMTc5MjQ3NmZiYjIyNWU1ZDlkZWM4NjlmL3NlYzo5M2NhOWJiMDE3OTI0NzZmYmIyMjVlNWQ5ZGVjODY5Zl81NS9mcmFnOjk0NGQ2N2RjOTNmMjQ1MjliZTc4ZmNlMzRiOGMyZTBiL3RhYmxlOjhlMGRhYjE1OGMzYTQyNTdhOWJkMTAzNzRmMDNiYzkxL3RhYmxlcmFuZ2U6OGUwZGFiMTU4YzNhNDI1N2E5YmQxMDM3NGYwM2JjOTFfOC01LTEtMS0w_4c09fe26-9d42-4b9b-8b53-6cd739545048"
      unitRef="usd">0</us-gaap:IncomeLossFromEquityMethodInvestments>
    <us-gaap:IncomeLossFromEquityMethodInvestments
      contextRef="i27f4e53b91ad4367b7f8d273eff27769_D20210401-20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzY2E5YmIwMTc5MjQ3NmZiYjIyNWU1ZDlkZWM4NjlmL3NlYzo5M2NhOWJiMDE3OTI0NzZmYmIyMjVlNWQ5ZGVjODY5Zl81NS9mcmFnOjk0NGQ2N2RjOTNmMjQ1MjliZTc4ZmNlMzRiOGMyZTBiL3RhYmxlOjhlMGRhYjE1OGMzYTQyNTdhOWJkMTAzNzRmMDNiYzkxL3RhYmxlcmFuZ2U6OGUwZGFiMTU4YzNhNDI1N2E5YmQxMDM3NGYwM2JjOTFfOC03LTEtMS0w_00457667-79e9-4660-a4ac-0a8f9a314736"
      unitRef="usd">-1115000</us-gaap:IncomeLossFromEquityMethodInvestments>
    <us-gaap:InvestmentIncomeInterest
      contextRef="i2a563d1bc1a1451296d5f40e6cdf2912_D20210401-20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzY2E5YmIwMTc5MjQ3NmZiYjIyNWU1ZDlkZWM4NjlmL3NlYzo5M2NhOWJiMDE3OTI0NzZmYmIyMjVlNWQ5ZGVjODY5Zl81NS9mcmFnOjk0NGQ2N2RjOTNmMjQ1MjliZTc4ZmNlMzRiOGMyZTBiL3RhYmxlOjhlMGRhYjE1OGMzYTQyNTdhOWJkMTAzNzRmMDNiYzkxL3RhYmxlcmFuZ2U6OGUwZGFiMTU4YzNhNDI1N2E5YmQxMDM3NGYwM2JjOTFfMTAtMS0xLTEtMA_7fa5688d-327b-4846-ba0c-af944cb9d6da"
      unitRef="usd">20000</us-gaap:InvestmentIncomeInterest>
    <us-gaap:InvestmentIncomeInterest
      contextRef="i7b627a38d4bb4b2693a9598ca41f647d_D20210401-20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzY2E5YmIwMTc5MjQ3NmZiYjIyNWU1ZDlkZWM4NjlmL3NlYzo5M2NhOWJiMDE3OTI0NzZmYmIyMjVlNWQ5ZGVjODY5Zl81NS9mcmFnOjk0NGQ2N2RjOTNmMjQ1MjliZTc4ZmNlMzRiOGMyZTBiL3RhYmxlOjhlMGRhYjE1OGMzYTQyNTdhOWJkMTAzNzRmMDNiYzkxL3RhYmxlcmFuZ2U6OGUwZGFiMTU4YzNhNDI1N2E5YmQxMDM3NGYwM2JjOTFfMTAtMy0xLTEtMA_a04a18d1-b2f1-4c85-8c55-56475e7cf6a1"
      unitRef="usd">2280000</us-gaap:InvestmentIncomeInterest>
    <us-gaap:InvestmentIncomeInterest
      contextRef="ie916e4a685544ae3998d4e82e089944f_D20210401-20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzY2E5YmIwMTc5MjQ3NmZiYjIyNWU1ZDlkZWM4NjlmL3NlYzo5M2NhOWJiMDE3OTI0NzZmYmIyMjVlNWQ5ZGVjODY5Zl81NS9mcmFnOjk0NGQ2N2RjOTNmMjQ1MjliZTc4ZmNlMzRiOGMyZTBiL3RhYmxlOjhlMGRhYjE1OGMzYTQyNTdhOWJkMTAzNzRmMDNiYzkxL3RhYmxlcmFuZ2U6OGUwZGFiMTU4YzNhNDI1N2E5YmQxMDM3NGYwM2JjOTFfMTAtNS0xLTEtMA_26bb86e4-f4bd-4ef9-9ee7-521ca62d9628"
      unitRef="usd">0</us-gaap:InvestmentIncomeInterest>
    <us-gaap:InvestmentIncomeInterest
      contextRef="i27f4e53b91ad4367b7f8d273eff27769_D20210401-20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzY2E5YmIwMTc5MjQ3NmZiYjIyNWU1ZDlkZWM4NjlmL3NlYzo5M2NhOWJiMDE3OTI0NzZmYmIyMjVlNWQ5ZGVjODY5Zl81NS9mcmFnOjk0NGQ2N2RjOTNmMjQ1MjliZTc4ZmNlMzRiOGMyZTBiL3RhYmxlOjhlMGRhYjE1OGMzYTQyNTdhOWJkMTAzNzRmMDNiYzkxL3RhYmxlcmFuZ2U6OGUwZGFiMTU4YzNhNDI1N2E5YmQxMDM3NGYwM2JjOTFfMTAtNy0xLTEtMA_ed221811-0036-4060-a3a2-48166c964fe8"
      unitRef="usd">2300000</us-gaap:InvestmentIncomeInterest>
    <us-gaap:InterestExpense
      contextRef="i2a563d1bc1a1451296d5f40e6cdf2912_D20210401-20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzY2E5YmIwMTc5MjQ3NmZiYjIyNWU1ZDlkZWM4NjlmL3NlYzo5M2NhOWJiMDE3OTI0NzZmYmIyMjVlNWQ5ZGVjODY5Zl81NS9mcmFnOjk0NGQ2N2RjOTNmMjQ1MjliZTc4ZmNlMzRiOGMyZTBiL3RhYmxlOjhlMGRhYjE1OGMzYTQyNTdhOWJkMTAzNzRmMDNiYzkxL3RhYmxlcmFuZ2U6OGUwZGFiMTU4YzNhNDI1N2E5YmQxMDM3NGYwM2JjOTFfMTEtMS0xLTEtMA_a65379d7-f92a-4061-bfc5-f0ad4cb7ea50"
      unitRef="usd">0</us-gaap:InterestExpense>
    <us-gaap:InterestExpense
      contextRef="i7b627a38d4bb4b2693a9598ca41f647d_D20210401-20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzY2E5YmIwMTc5MjQ3NmZiYjIyNWU1ZDlkZWM4NjlmL3NlYzo5M2NhOWJiMDE3OTI0NzZmYmIyMjVlNWQ5ZGVjODY5Zl81NS9mcmFnOjk0NGQ2N2RjOTNmMjQ1MjliZTc4ZmNlMzRiOGMyZTBiL3RhYmxlOjhlMGRhYjE1OGMzYTQyNTdhOWJkMTAzNzRmMDNiYzkxL3RhYmxlcmFuZ2U6OGUwZGFiMTU4YzNhNDI1N2E5YmQxMDM3NGYwM2JjOTFfMTEtMy0xLTEtMA_df7b010c-79f0-4d15-8b75-2129fea9b465"
      unitRef="usd">7000</us-gaap:InterestExpense>
    <us-gaap:InterestExpense
      contextRef="ie916e4a685544ae3998d4e82e089944f_D20210401-20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzY2E5YmIwMTc5MjQ3NmZiYjIyNWU1ZDlkZWM4NjlmL3NlYzo5M2NhOWJiMDE3OTI0NzZmYmIyMjVlNWQ5ZGVjODY5Zl81NS9mcmFnOjk0NGQ2N2RjOTNmMjQ1MjliZTc4ZmNlMzRiOGMyZTBiL3RhYmxlOjhlMGRhYjE1OGMzYTQyNTdhOWJkMTAzNzRmMDNiYzkxL3RhYmxlcmFuZ2U6OGUwZGFiMTU4YzNhNDI1N2E5YmQxMDM3NGYwM2JjOTFfMTEtNS0xLTEtMA_ed404494-4d7e-4d5a-b88e-049b4d74fcab"
      unitRef="usd">0</us-gaap:InterestExpense>
    <us-gaap:InterestExpense
      contextRef="i27f4e53b91ad4367b7f8d273eff27769_D20210401-20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzY2E5YmIwMTc5MjQ3NmZiYjIyNWU1ZDlkZWM4NjlmL3NlYzo5M2NhOWJiMDE3OTI0NzZmYmIyMjVlNWQ5ZGVjODY5Zl81NS9mcmFnOjk0NGQ2N2RjOTNmMjQ1MjliZTc4ZmNlMzRiOGMyZTBiL3RhYmxlOjhlMGRhYjE1OGMzYTQyNTdhOWJkMTAzNzRmMDNiYzkxL3RhYmxlcmFuZ2U6OGUwZGFiMTU4YzNhNDI1N2E5YmQxMDM3NGYwM2JjOTFfMTEtNy0xLTEtMA_9876d077-74c9-4d02-ace7-4edd2174d9cd"
      unitRef="usd">7000</us-gaap:InterestExpense>
    <us-gaap:InterestIncomeExpenseNonoperatingNet
      contextRef="i2a563d1bc1a1451296d5f40e6cdf2912_D20210401-20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzY2E5YmIwMTc5MjQ3NmZiYjIyNWU1ZDlkZWM4NjlmL3NlYzo5M2NhOWJiMDE3OTI0NzZmYmIyMjVlNWQ5ZGVjODY5Zl81NS9mcmFnOjk0NGQ2N2RjOTNmMjQ1MjliZTc4ZmNlMzRiOGMyZTBiL3RhYmxlOjhlMGRhYjE1OGMzYTQyNTdhOWJkMTAzNzRmMDNiYzkxL3RhYmxlcmFuZ2U6OGUwZGFiMTU4YzNhNDI1N2E5YmQxMDM3NGYwM2JjOTFfMTItMS0xLTEtMA_9a41ebc5-5aad-4c9b-9613-389d76b2102c"
      unitRef="usd">20000</us-gaap:InterestIncomeExpenseNonoperatingNet>
    <us-gaap:InterestIncomeExpenseNonoperatingNet
      contextRef="i7b627a38d4bb4b2693a9598ca41f647d_D20210401-20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzY2E5YmIwMTc5MjQ3NmZiYjIyNWU1ZDlkZWM4NjlmL3NlYzo5M2NhOWJiMDE3OTI0NzZmYmIyMjVlNWQ5ZGVjODY5Zl81NS9mcmFnOjk0NGQ2N2RjOTNmMjQ1MjliZTc4ZmNlMzRiOGMyZTBiL3RhYmxlOjhlMGRhYjE1OGMzYTQyNTdhOWJkMTAzNzRmMDNiYzkxL3RhYmxlcmFuZ2U6OGUwZGFiMTU4YzNhNDI1N2E5YmQxMDM3NGYwM2JjOTFfMTItMy0xLTEtMA_4f3599e8-71af-4ea0-8378-c8086ddb427c"
      unitRef="usd">2273000</us-gaap:InterestIncomeExpenseNonoperatingNet>
    <us-gaap:InterestIncomeExpenseNonoperatingNet
      contextRef="ie916e4a685544ae3998d4e82e089944f_D20210401-20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzY2E5YmIwMTc5MjQ3NmZiYjIyNWU1ZDlkZWM4NjlmL3NlYzo5M2NhOWJiMDE3OTI0NzZmYmIyMjVlNWQ5ZGVjODY5Zl81NS9mcmFnOjk0NGQ2N2RjOTNmMjQ1MjliZTc4ZmNlMzRiOGMyZTBiL3RhYmxlOjhlMGRhYjE1OGMzYTQyNTdhOWJkMTAzNzRmMDNiYzkxL3RhYmxlcmFuZ2U6OGUwZGFiMTU4YzNhNDI1N2E5YmQxMDM3NGYwM2JjOTFfMTItNS0xLTEtMA_e43a4fd3-a9c7-4beb-99e5-c3d531446ab1"
      unitRef="usd">0</us-gaap:InterestIncomeExpenseNonoperatingNet>
    <us-gaap:InterestIncomeExpenseNonoperatingNet
      contextRef="i27f4e53b91ad4367b7f8d273eff27769_D20210401-20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzY2E5YmIwMTc5MjQ3NmZiYjIyNWU1ZDlkZWM4NjlmL3NlYzo5M2NhOWJiMDE3OTI0NzZmYmIyMjVlNWQ5ZGVjODY5Zl81NS9mcmFnOjk0NGQ2N2RjOTNmMjQ1MjliZTc4ZmNlMzRiOGMyZTBiL3RhYmxlOjhlMGRhYjE1OGMzYTQyNTdhOWJkMTAzNzRmMDNiYzkxL3RhYmxlcmFuZ2U6OGUwZGFiMTU4YzNhNDI1N2E5YmQxMDM3NGYwM2JjOTFfMTItNy0xLTEtMA_552911d2-957e-4849-99e6-9d65e5fa0041"
      unitRef="usd">2293000</us-gaap:InterestIncomeExpenseNonoperatingNet>
    <us-gaap:Assets
      contextRef="i1afe4ab017a94c08b0390d1c04588202_I20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzY2E5YmIwMTc5MjQ3NmZiYjIyNWU1ZDlkZWM4NjlmL3NlYzo5M2NhOWJiMDE3OTI0NzZmYmIyMjVlNWQ5ZGVjODY5Zl81NS9mcmFnOjk0NGQ2N2RjOTNmMjQ1MjliZTc4ZmNlMzRiOGMyZTBiL3RhYmxlOjhlMGRhYjE1OGMzYTQyNTdhOWJkMTAzNzRmMDNiYzkxL3RhYmxlcmFuZ2U6OGUwZGFiMTU4YzNhNDI1N2E5YmQxMDM3NGYwM2JjOTFfMTMtMS0xLTEtMTg0MzM_ffce79d1-5da8-4f0f-b770-cc5a1cac2e8b"
      unitRef="usd">709956000</us-gaap:Assets>
    <us-gaap:Assets
      contextRef="i14c7d79dc30c40b9a6db30b130c667da_I20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzY2E5YmIwMTc5MjQ3NmZiYjIyNWU1ZDlkZWM4NjlmL3NlYzo5M2NhOWJiMDE3OTI0NzZmYmIyMjVlNWQ5ZGVjODY5Zl81NS9mcmFnOjk0NGQ2N2RjOTNmMjQ1MjliZTc4ZmNlMzRiOGMyZTBiL3RhYmxlOjhlMGRhYjE1OGMzYTQyNTdhOWJkMTAzNzRmMDNiYzkxL3RhYmxlcmFuZ2U6OGUwZGFiMTU4YzNhNDI1N2E5YmQxMDM3NGYwM2JjOTFfMTMtMy0xLTEtMTg0MzM_25a89660-c625-46d7-aa85-98303a629f26"
      unitRef="usd">386805000</us-gaap:Assets>
    <us-gaap:Assets
      contextRef="i64489be55285421f8e92af4479a619e6_I20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzY2E5YmIwMTc5MjQ3NmZiYjIyNWU1ZDlkZWM4NjlmL3NlYzo5M2NhOWJiMDE3OTI0NzZmYmIyMjVlNWQ5ZGVjODY5Zl81NS9mcmFnOjk0NGQ2N2RjOTNmMjQ1MjliZTc4ZmNlMzRiOGMyZTBiL3RhYmxlOjhlMGRhYjE1OGMzYTQyNTdhOWJkMTAzNzRmMDNiYzkxL3RhYmxlcmFuZ2U6OGUwZGFiMTU4YzNhNDI1N2E5YmQxMDM3NGYwM2JjOTFfMTMtNS0xLTEtMTg0MzM_3ec9931f-3f5f-4081-8806-84dddfb88904"
      unitRef="usd">741850000</us-gaap:Assets>
    <us-gaap:Assets
      contextRef="i225f85e38faa4bbdb4de1d8b9cf369bb_I20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzY2E5YmIwMTc5MjQ3NmZiYjIyNWU1ZDlkZWM4NjlmL3NlYzo5M2NhOWJiMDE3OTI0NzZmYmIyMjVlNWQ5ZGVjODY5Zl81NS9mcmFnOjk0NGQ2N2RjOTNmMjQ1MjliZTc4ZmNlMzRiOGMyZTBiL3RhYmxlOjhlMGRhYjE1OGMzYTQyNTdhOWJkMTAzNzRmMDNiYzkxL3RhYmxlcmFuZ2U6OGUwZGFiMTU4YzNhNDI1N2E5YmQxMDM3NGYwM2JjOTFfMTMtNy0xLTEtMTg0NTQ_e160f066-5076-4dea-ab85-57238fb63efc"
      unitRef="usd">1838611000</us-gaap:Assets>
    <us-gaap:DepreciationAndAmortization
      contextRef="i2a563d1bc1a1451296d5f40e6cdf2912_D20210401-20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzY2E5YmIwMTc5MjQ3NmZiYjIyNWU1ZDlkZWM4NjlmL3NlYzo5M2NhOWJiMDE3OTI0NzZmYmIyMjVlNWQ5ZGVjODY5Zl81NS9mcmFnOjk0NGQ2N2RjOTNmMjQ1MjliZTc4ZmNlMzRiOGMyZTBiL3RhYmxlOjhlMGRhYjE1OGMzYTQyNTdhOWJkMTAzNzRmMDNiYzkxL3RhYmxlcmFuZ2U6OGUwZGFiMTU4YzNhNDI1N2E5YmQxMDM3NGYwM2JjOTFfMTQtMS0xLTEtMA_3bd1dbb2-dafc-49e8-96cb-4bf826ce84d4"
      unitRef="usd">68000</us-gaap:DepreciationAndAmortization>
    <us-gaap:DepreciationAndAmortization
      contextRef="i7b627a38d4bb4b2693a9598ca41f647d_D20210401-20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzY2E5YmIwMTc5MjQ3NmZiYjIyNWU1ZDlkZWM4NjlmL3NlYzo5M2NhOWJiMDE3OTI0NzZmYmIyMjVlNWQ5ZGVjODY5Zl81NS9mcmFnOjk0NGQ2N2RjOTNmMjQ1MjliZTc4ZmNlMzRiOGMyZTBiL3RhYmxlOjhlMGRhYjE1OGMzYTQyNTdhOWJkMTAzNzRmMDNiYzkxL3RhYmxlcmFuZ2U6OGUwZGFiMTU4YzNhNDI1N2E5YmQxMDM3NGYwM2JjOTFfMTQtMy0xLTEtMA_1365003d-9946-4bd6-9db6-40fa846d6b2b"
      unitRef="usd">975000</us-gaap:DepreciationAndAmortization>
    <us-gaap:DepreciationAndAmortization
      contextRef="ie916e4a685544ae3998d4e82e089944f_D20210401-20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzY2E5YmIwMTc5MjQ3NmZiYjIyNWU1ZDlkZWM4NjlmL3NlYzo5M2NhOWJiMDE3OTI0NzZmYmIyMjVlNWQ5ZGVjODY5Zl81NS9mcmFnOjk0NGQ2N2RjOTNmMjQ1MjliZTc4ZmNlMzRiOGMyZTBiL3RhYmxlOjhlMGRhYjE1OGMzYTQyNTdhOWJkMTAzNzRmMDNiYzkxL3RhYmxlcmFuZ2U6OGUwZGFiMTU4YzNhNDI1N2E5YmQxMDM3NGYwM2JjOTFfMTQtNS0xLTEtMA_8fc11468-c8b7-454f-b9e9-478a24891283"
      unitRef="usd">0</us-gaap:DepreciationAndAmortization>
    <us-gaap:DepreciationAndAmortization
      contextRef="i27f4e53b91ad4367b7f8d273eff27769_D20210401-20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzY2E5YmIwMTc5MjQ3NmZiYjIyNWU1ZDlkZWM4NjlmL3NlYzo5M2NhOWJiMDE3OTI0NzZmYmIyMjVlNWQ5ZGVjODY5Zl81NS9mcmFnOjk0NGQ2N2RjOTNmMjQ1MjliZTc4ZmNlMzRiOGMyZTBiL3RhYmxlOjhlMGRhYjE1OGMzYTQyNTdhOWJkMTAzNzRmMDNiYzkxL3RhYmxlcmFuZ2U6OGUwZGFiMTU4YzNhNDI1N2E5YmQxMDM3NGYwM2JjOTFfMTQtNy0xLTEtMA_fc5947a4-61ff-450e-924a-a08565265f8e"
      unitRef="usd">1043000</us-gaap:DepreciationAndAmortization>
    <cron:AdjustedEarningsBeforeInterestTaxesDepreciationAndAmortization
      contextRef="i2a563d1bc1a1451296d5f40e6cdf2912_D20210401-20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzY2E5YmIwMTc5MjQ3NmZiYjIyNWU1ZDlkZWM4NjlmL3NlYzo5M2NhOWJiMDE3OTI0NzZmYmIyMjVlNWQ5ZGVjODY5Zl81NS9mcmFnOjk0NGQ2N2RjOTNmMjQ1MjliZTc4ZmNlMzRiOGMyZTBiL3RhYmxlOjhlMGRhYjE1OGMzYTQyNTdhOWJkMTAzNzRmMDNiYzkxL3RhYmxlcmFuZ2U6OGUwZGFiMTU4YzNhNDI1N2E5YmQxMDM3NGYwM2JjOTFfMTctMS0xLTEtMA_57e4b109-8def-4e42-8ff8-0e8e4bb172a8"
      unitRef="usd">-10711000</cron:AdjustedEarningsBeforeInterestTaxesDepreciationAndAmortization>
    <cron:AdjustedEarningsBeforeInterestTaxesDepreciationAndAmortization
      contextRef="i7b627a38d4bb4b2693a9598ca41f647d_D20210401-20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzY2E5YmIwMTc5MjQ3NmZiYjIyNWU1ZDlkZWM4NjlmL3NlYzo5M2NhOWJiMDE3OTI0NzZmYmIyMjVlNWQ5ZGVjODY5Zl81NS9mcmFnOjk0NGQ2N2RjOTNmMjQ1MjliZTc4ZmNlMzRiOGMyZTBiL3RhYmxlOjhlMGRhYjE1OGMzYTQyNTdhOWJkMTAzNzRmMDNiYzkxL3RhYmxlcmFuZ2U6OGUwZGFiMTU4YzNhNDI1N2E5YmQxMDM3NGYwM2JjOTFfMTctMy0xLTEtMA_569de834-eee9-40f4-9f61-31d686a54c8d"
      unitRef="usd">-32605000</cron:AdjustedEarningsBeforeInterestTaxesDepreciationAndAmortization>
    <cron:AdjustedEarningsBeforeInterestTaxesDepreciationAndAmortization
      contextRef="ie916e4a685544ae3998d4e82e089944f_D20210401-20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzY2E5YmIwMTc5MjQ3NmZiYjIyNWU1ZDlkZWM4NjlmL3NlYzo5M2NhOWJiMDE3OTI0NzZmYmIyMjVlNWQ5ZGVjODY5Zl81NS9mcmFnOjk0NGQ2N2RjOTNmMjQ1MjliZTc4ZmNlMzRiOGMyZTBiL3RhYmxlOjhlMGRhYjE1OGMzYTQyNTdhOWJkMTAzNzRmMDNiYzkxL3RhYmxlcmFuZ2U6OGUwZGFiMTU4YzNhNDI1N2E5YmQxMDM3NGYwM2JjOTFfMTctNS0xLTEtMA_6c1504cd-f4c3-4ba3-bc08-8f443b4ec895"
      unitRef="usd">-6443000</cron:AdjustedEarningsBeforeInterestTaxesDepreciationAndAmortization>
    <cron:AdjustedEarningsBeforeInterestTaxesDepreciationAndAmortization
      contextRef="i27f4e53b91ad4367b7f8d273eff27769_D20210401-20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzY2E5YmIwMTc5MjQ3NmZiYjIyNWU1ZDlkZWM4NjlmL3NlYzo5M2NhOWJiMDE3OTI0NzZmYmIyMjVlNWQ5ZGVjODY5Zl81NS9mcmFnOjk0NGQ2N2RjOTNmMjQ1MjliZTc4ZmNlMzRiOGMyZTBiL3RhYmxlOjhlMGRhYjE1OGMzYTQyNTdhOWJkMTAzNzRmMDNiYzkxL3RhYmxlcmFuZ2U6OGUwZGFiMTU4YzNhNDI1N2E5YmQxMDM3NGYwM2JjOTFfMTctNy0xLTEtMA_d69df234-602f-48dc-8603-b607556daba7"
      unitRef="usd">-49759000</cron:AdjustedEarningsBeforeInterestTaxesDepreciationAndAmortization>
    <us-gaap:PropertyPlantAndEquipmentAdditions
      contextRef="i2a563d1bc1a1451296d5f40e6cdf2912_D20210401-20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzY2E5YmIwMTc5MjQ3NmZiYjIyNWU1ZDlkZWM4NjlmL3NlYzo5M2NhOWJiMDE3OTI0NzZmYmIyMjVlNWQ5ZGVjODY5Zl81NS9mcmFnOjk0NGQ2N2RjOTNmMjQ1MjliZTc4ZmNlMzRiOGMyZTBiL3RhYmxlOjhlMGRhYjE1OGMzYTQyNTdhOWJkMTAzNzRmMDNiYzkxL3RhYmxlcmFuZ2U6OGUwZGFiMTU4YzNhNDI1N2E5YmQxMDM3NGYwM2JjOTFfMTctMS0xLTEtMTcyMzc_730c3d32-bb68-49bd-a85d-60a2126170ed"
      unitRef="usd">239000</us-gaap:PropertyPlantAndEquipmentAdditions>
    <us-gaap:PropertyPlantAndEquipmentAdditions
      contextRef="i7b627a38d4bb4b2693a9598ca41f647d_D20210401-20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzY2E5YmIwMTc5MjQ3NmZiYjIyNWU1ZDlkZWM4NjlmL3NlYzo5M2NhOWJiMDE3OTI0NzZmYmIyMjVlNWQ5ZGVjODY5Zl81NS9mcmFnOjk0NGQ2N2RjOTNmMjQ1MjliZTc4ZmNlMzRiOGMyZTBiL3RhYmxlOjhlMGRhYjE1OGMzYTQyNTdhOWJkMTAzNzRmMDNiYzkxL3RhYmxlcmFuZ2U6OGUwZGFiMTU4YzNhNDI1N2E5YmQxMDM3NGYwM2JjOTFfMTctMy0xLTEtMTcyNDY_8cf62ce6-0392-410e-915f-e56cc01355d9"
      unitRef="usd">1428000</us-gaap:PropertyPlantAndEquipmentAdditions>
    <us-gaap:PropertyPlantAndEquipmentAdditions
      contextRef="ie916e4a685544ae3998d4e82e089944f_D20210401-20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzY2E5YmIwMTc5MjQ3NmZiYjIyNWU1ZDlkZWM4NjlmL3NlYzo5M2NhOWJiMDE3OTI0NzZmYmIyMjVlNWQ5ZGVjODY5Zl81NS9mcmFnOjk0NGQ2N2RjOTNmMjQ1MjliZTc4ZmNlMzRiOGMyZTBiL3RhYmxlOjhlMGRhYjE1OGMzYTQyNTdhOWJkMTAzNzRmMDNiYzkxL3RhYmxlcmFuZ2U6OGUwZGFiMTU4YzNhNDI1N2E5YmQxMDM3NGYwM2JjOTFfMTctNS0xLTEtMTcyNDk_f526aa93-3c34-4f7b-a3da-4d4e5130f49c"
      unitRef="usd">0</us-gaap:PropertyPlantAndEquipmentAdditions>
    <us-gaap:PropertyPlantAndEquipmentAdditions
      contextRef="i27f4e53b91ad4367b7f8d273eff27769_D20210401-20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzY2E5YmIwMTc5MjQ3NmZiYjIyNWU1ZDlkZWM4NjlmL3NlYzo5M2NhOWJiMDE3OTI0NzZmYmIyMjVlNWQ5ZGVjODY5Zl81NS9mcmFnOjk0NGQ2N2RjOTNmMjQ1MjliZTc4ZmNlMzRiOGMyZTBiL3RhYmxlOjhlMGRhYjE1OGMzYTQyNTdhOWJkMTAzNzRmMDNiYzkxL3RhYmxlcmFuZ2U6OGUwZGFiMTU4YzNhNDI1N2E5YmQxMDM3NGYwM2JjOTFfMTctNy0xLTEtMTczNjk_1c7169c8-99b0-4309-9d0d-db244943d138"
      unitRef="usd">1667000</us-gaap:PropertyPlantAndEquipmentAdditions>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="if56e63da868340a8ab5d3b79c974e6b3_D20200401-20200630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzY2E5YmIwMTc5MjQ3NmZiYjIyNWU1ZDlkZWM4NjlmL3NlYzo5M2NhOWJiMDE3OTI0NzZmYmIyMjVlNWQ5ZGVjODY5Zl81NS9mcmFnOjk0NGQ2N2RjOTNmMjQ1MjliZTc4ZmNlMzRiOGMyZTBiL3RhYmxlOmVkMDExMzdmNzA1MjRmMGE5MzVlYzlhOTNmOGViMDc2L3RhYmxlcmFuZ2U6ZWQwMTEzN2Y3MDUyNGYwYTkzNWVjOWE5M2Y4ZWIwNzZfMy0xLTEtMS0xMzMz_2a5f3de2-f87c-43db-bfe6-7b14ac8a9b0f"
      unitRef="usd">0</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i15fc6f263af84b999d8cc92973692fbd_D20200401-20200630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzY2E5YmIwMTc5MjQ3NmZiYjIyNWU1ZDlkZWM4NjlmL3NlYzo5M2NhOWJiMDE3OTI0NzZmYmIyMjVlNWQ5ZGVjODY5Zl81NS9mcmFnOjk0NGQ2N2RjOTNmMjQ1MjliZTc4ZmNlMzRiOGMyZTBiL3RhYmxlOmVkMDExMzdmNzA1MjRmMGE5MzVlYzlhOTNmOGViMDc2L3RhYmxlcmFuZ2U6ZWQwMTEzN2Y3MDUyNGYwYTkzNWVjOWE5M2Y4ZWIwNzZfMy0zLTEtMS0xMzMz_e5e9d8b7-969b-47b4-9774-c22317d011c2"
      unitRef="usd">5674000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="ie5a13f5798a041098fb7986c993831fa_D20200401-20200630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzY2E5YmIwMTc5MjQ3NmZiYjIyNWU1ZDlkZWM4NjlmL3NlYzo5M2NhOWJiMDE3OTI0NzZmYmIyMjVlNWQ5ZGVjODY5Zl81NS9mcmFnOjk0NGQ2N2RjOTNmMjQ1MjliZTc4ZmNlMzRiOGMyZTBiL3RhYmxlOmVkMDExMzdmNzA1MjRmMGE5MzVlYzlhOTNmOGViMDc2L3RhYmxlcmFuZ2U6ZWQwMTEzN2Y3MDUyNGYwYTkzNWVjOWE5M2Y4ZWIwNzZfMy01LTEtMS0xMzMz_fc787ad6-f668-4ee5-914b-8031bc262907"
      unitRef="usd">0</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="ib1f0e90ff5d24c28ad9bc0faf46f5377_D20200401-20200630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzY2E5YmIwMTc5MjQ3NmZiYjIyNWU1ZDlkZWM4NjlmL3NlYzo5M2NhOWJiMDE3OTI0NzZmYmIyMjVlNWQ5ZGVjODY5Zl81NS9mcmFnOjk0NGQ2N2RjOTNmMjQ1MjliZTc4ZmNlMzRiOGMyZTBiL3RhYmxlOmVkMDExMzdmNzA1MjRmMGE5MzVlYzlhOTNmOGViMDc2L3RhYmxlcmFuZ2U6ZWQwMTEzN2Y3MDUyNGYwYTkzNWVjOWE5M2Y4ZWIwNzZfMi03LTEtMS0xNjIwMg_7a1531a4-6320-4d27-90ee-61b467466ca2"
      unitRef="usd">5674000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="ia93117ffad484ba8bac40f47a8a9f804_D20200401-20200630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzY2E5YmIwMTc5MjQ3NmZiYjIyNWU1ZDlkZWM4NjlmL3NlYzo5M2NhOWJiMDE3OTI0NzZmYmIyMjVlNWQ5ZGVjODY5Zl81NS9mcmFnOjk0NGQ2N2RjOTNmMjQ1MjliZTc4ZmNlMzRiOGMyZTBiL3RhYmxlOmVkMDExMzdmNzA1MjRmMGE5MzVlYzlhOTNmOGViMDc2L3RhYmxlcmFuZ2U6ZWQwMTEzN2Y3MDUyNGYwYTkzNWVjOWE5M2Y4ZWIwNzZfNC0xLTEtMS0xMzMz_97bea40d-5049-40ce-ba21-c46661cfb4ab"
      unitRef="usd">2174000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="ifab67f8b4459455295c2fdc641d9dc00_D20200401-20200630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzY2E5YmIwMTc5MjQ3NmZiYjIyNWU1ZDlkZWM4NjlmL3NlYzo5M2NhOWJiMDE3OTI0NzZmYmIyMjVlNWQ5ZGVjODY5Zl81NS9mcmFnOjk0NGQ2N2RjOTNmMjQ1MjliZTc4ZmNlMzRiOGMyZTBiL3RhYmxlOmVkMDExMzdmNzA1MjRmMGE5MzVlYzlhOTNmOGViMDc2L3RhYmxlcmFuZ2U6ZWQwMTEzN2Y3MDUyNGYwYTkzNWVjOWE5M2Y4ZWIwNzZfNC0zLTEtMS0xMzMz_27c26ff4-bfeb-4a6a-965e-e100e87dbfb4"
      unitRef="usd">1917000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i59d84c3c73bb412f8ab90480b3f1cacb_D20200401-20200630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzY2E5YmIwMTc5MjQ3NmZiYjIyNWU1ZDlkZWM4NjlmL3NlYzo5M2NhOWJiMDE3OTI0NzZmYmIyMjVlNWQ5ZGVjODY5Zl81NS9mcmFnOjk0NGQ2N2RjOTNmMjQ1MjliZTc4ZmNlMzRiOGMyZTBiL3RhYmxlOmVkMDExMzdmNzA1MjRmMGE5MzVlYzlhOTNmOGViMDc2L3RhYmxlcmFuZ2U6ZWQwMTEzN2Y3MDUyNGYwYTkzNWVjOWE5M2Y4ZWIwNzZfNC01LTEtMS0xMzMz_0d31fb89-1989-46fe-be2f-5c019f7ea009"
      unitRef="usd">0</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i2ca82879f2e54a14819f3d3b95640a8e_D20200401-20200630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzY2E5YmIwMTc5MjQ3NmZiYjIyNWU1ZDlkZWM4NjlmL3NlYzo5M2NhOWJiMDE3OTI0NzZmYmIyMjVlNWQ5ZGVjODY5Zl81NS9mcmFnOjk0NGQ2N2RjOTNmMjQ1MjliZTc4ZmNlMzRiOGMyZTBiL3RhYmxlOmVkMDExMzdmNzA1MjRmMGE5MzVlYzlhOTNmOGViMDc2L3RhYmxlcmFuZ2U6ZWQwMTEzN2Y3MDUyNGYwYTkzNWVjOWE5M2Y4ZWIwNzZfMy03LTEtMS0xNjIwMg_c7b193d3-e7ea-4fb1-9e5b-c67c8814e768"
      unitRef="usd">4091000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i91b1c7740b954489b1fe2f441dc90430_D20200401-20200630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzY2E5YmIwMTc5MjQ3NmZiYjIyNWU1ZDlkZWM4NjlmL3NlYzo5M2NhOWJiMDE3OTI0NzZmYmIyMjVlNWQ5ZGVjODY5Zl81NS9mcmFnOjk0NGQ2N2RjOTNmMjQ1MjliZTc4ZmNlMzRiOGMyZTBiL3RhYmxlOmVkMDExMzdmNzA1MjRmMGE5MzVlYzlhOTNmOGViMDc2L3RhYmxlcmFuZ2U6ZWQwMTEzN2Y3MDUyNGYwYTkzNWVjOWE5M2Y4ZWIwNzZfNS0xLTEtMS0xMzMz_5db23390-bf4a-4a8d-9c3e-76c4c8b6e679"
      unitRef="usd">0</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i37138226ae7b45ad97bc4468a768b4b1_D20200401-20200630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzY2E5YmIwMTc5MjQ3NmZiYjIyNWU1ZDlkZWM4NjlmL3NlYzo5M2NhOWJiMDE3OTI0NzZmYmIyMjVlNWQ5ZGVjODY5Zl81NS9mcmFnOjk0NGQ2N2RjOTNmMjQ1MjliZTc4ZmNlMzRiOGMyZTBiL3RhYmxlOmVkMDExMzdmNzA1MjRmMGE5MzVlYzlhOTNmOGViMDc2L3RhYmxlcmFuZ2U6ZWQwMTEzN2Y3MDUyNGYwYTkzNWVjOWE5M2Y4ZWIwNzZfNS0zLTEtMS0xMzMz_2e3e4394-376b-4fb6-af6f-ce2b3ab7ab73"
      unitRef="usd">118000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="id023d0b7d14c4eb9aba0197ea873d120_D20200401-20200630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzY2E5YmIwMTc5MjQ3NmZiYjIyNWU1ZDlkZWM4NjlmL3NlYzo5M2NhOWJiMDE3OTI0NzZmYmIyMjVlNWQ5ZGVjODY5Zl81NS9mcmFnOjk0NGQ2N2RjOTNmMjQ1MjliZTc4ZmNlMzRiOGMyZTBiL3RhYmxlOmVkMDExMzdmNzA1MjRmMGE5MzVlYzlhOTNmOGViMDc2L3RhYmxlcmFuZ2U6ZWQwMTEzN2Y3MDUyNGYwYTkzNWVjOWE5M2Y4ZWIwNzZfNS01LTEtMS0xMzMz_07945778-aabe-4ba5-9509-645b868622e0"
      unitRef="usd">0</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i8457d33e4cab43daac2e2e1046176545_D20200401-20200630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzY2E5YmIwMTc5MjQ3NmZiYjIyNWU1ZDlkZWM4NjlmL3NlYzo5M2NhOWJiMDE3OTI0NzZmYmIyMjVlNWQ5ZGVjODY5Zl81NS9mcmFnOjk0NGQ2N2RjOTNmMjQ1MjliZTc4ZmNlMzRiOGMyZTBiL3RhYmxlOmVkMDExMzdmNzA1MjRmMGE5MzVlYzlhOTNmOGViMDc2L3RhYmxlcmFuZ2U6ZWQwMTEzN2Y3MDUyNGYwYTkzNWVjOWE5M2Y4ZWIwNzZfNC03LTEtMS0xNjIwMg_105f7454-4d5c-450c-9f1f-49cb87c6e3b6"
      unitRef="usd">118000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="icb85df07ebfc4bfa99c08f8c9f0cb89c_D20200401-20200630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzY2E5YmIwMTc5MjQ3NmZiYjIyNWU1ZDlkZWM4NjlmL3NlYzo5M2NhOWJiMDE3OTI0NzZmYmIyMjVlNWQ5ZGVjODY5Zl81NS9mcmFnOjk0NGQ2N2RjOTNmMjQ1MjliZTc4ZmNlMzRiOGMyZTBiL3RhYmxlOmVkMDExMzdmNzA1MjRmMGE5MzVlYzlhOTNmOGViMDc2L3RhYmxlcmFuZ2U6ZWQwMTEzN2Y3MDUyNGYwYTkzNWVjOWE5M2Y4ZWIwNzZfNS0xLTEtMS0xNjIwMg_8f112d6b-2112-48c7-9166-c726a40c6290"
      unitRef="usd">2174000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="if83af42553ab4081bf67a6ecab2097fc_D20200401-20200630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzY2E5YmIwMTc5MjQ3NmZiYjIyNWU1ZDlkZWM4NjlmL3NlYzo5M2NhOWJiMDE3OTI0NzZmYmIyMjVlNWQ5ZGVjODY5Zl81NS9mcmFnOjk0NGQ2N2RjOTNmMjQ1MjliZTc4ZmNlMzRiOGMyZTBiL3RhYmxlOmVkMDExMzdmNzA1MjRmMGE5MzVlYzlhOTNmOGViMDc2L3RhYmxlcmFuZ2U6ZWQwMTEzN2Y3MDUyNGYwYTkzNWVjOWE5M2Y4ZWIwNzZfNS0zLTEtMS0xNjIwMg_420f596f-a4d3-4b9f-94c0-5fed8968adf6"
      unitRef="usd">7709000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i46e2093507a34f2fa6bcbc19a9aaaa63_D20200401-20200630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzY2E5YmIwMTc5MjQ3NmZiYjIyNWU1ZDlkZWM4NjlmL3NlYzo5M2NhOWJiMDE3OTI0NzZmYmIyMjVlNWQ5ZGVjODY5Zl81NS9mcmFnOjk0NGQ2N2RjOTNmMjQ1MjliZTc4ZmNlMzRiOGMyZTBiL3RhYmxlOmVkMDExMzdmNzA1MjRmMGE5MzVlYzlhOTNmOGViMDc2L3RhYmxlcmFuZ2U6ZWQwMTEzN2Y3MDUyNGYwYTkzNWVjOWE5M2Y4ZWIwNzZfNS01LTEtMS0xNjIwMg_d1a4f77c-a65b-4139-a549-6205e62a5066"
      unitRef="usd">0</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i39065c5daf934af885335c12f3cfa83f_D20200401-20200630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzY2E5YmIwMTc5MjQ3NmZiYjIyNWU1ZDlkZWM4NjlmL3NlYzo5M2NhOWJiMDE3OTI0NzZmYmIyMjVlNWQ5ZGVjODY5Zl81NS9mcmFnOjk0NGQ2N2RjOTNmMjQ1MjliZTc4ZmNlMzRiOGMyZTBiL3RhYmxlOmVkMDExMzdmNzA1MjRmMGE5MzVlYzlhOTNmOGViMDc2L3RhYmxlcmFuZ2U6ZWQwMTEzN2Y3MDUyNGYwYTkzNWVjOWE5M2Y4ZWIwNzZfNS03LTEtMS0xNjIwMg_08b5d34a-3c9d-410d-ac66-ce602d3d5bce"
      unitRef="usd">9883000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:IncomeLossFromEquityMethodInvestments
      contextRef="icb85df07ebfc4bfa99c08f8c9f0cb89c_D20200401-20200630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzY2E5YmIwMTc5MjQ3NmZiYjIyNWU1ZDlkZWM4NjlmL3NlYzo5M2NhOWJiMDE3OTI0NzZmYmIyMjVlNWQ5ZGVjODY5Zl81NS9mcmFnOjk0NGQ2N2RjOTNmMjQ1MjliZTc4ZmNlMzRiOGMyZTBiL3RhYmxlOmVkMDExMzdmNzA1MjRmMGE5MzVlYzlhOTNmOGViMDc2L3RhYmxlcmFuZ2U6ZWQwMTEzN2Y3MDUyNGYwYTkzNWVjOWE5M2Y4ZWIwNzZfOC0xLTEtMS0xMzQz_a3fe5f04-b34a-4d6d-8368-97458a31214d"
      unitRef="usd">0</us-gaap:IncomeLossFromEquityMethodInvestments>
    <us-gaap:IncomeLossFromEquityMethodInvestments
      contextRef="if83af42553ab4081bf67a6ecab2097fc_D20200401-20200630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzY2E5YmIwMTc5MjQ3NmZiYjIyNWU1ZDlkZWM4NjlmL3NlYzo5M2NhOWJiMDE3OTI0NzZmYmIyMjVlNWQ5ZGVjODY5Zl81NS9mcmFnOjk0NGQ2N2RjOTNmMjQ1MjliZTc4ZmNlMzRiOGMyZTBiL3RhYmxlOmVkMDExMzdmNzA1MjRmMGE5MzVlYzlhOTNmOGViMDc2L3RhYmxlcmFuZ2U6ZWQwMTEzN2Y3MDUyNGYwYTkzNWVjOWE5M2Y4ZWIwNzZfOC0zLTEtMS0xMzQz_d81ffa5b-68eb-40f0-9ef3-96f2ceb46532"
      unitRef="usd">-794000</us-gaap:IncomeLossFromEquityMethodInvestments>
    <us-gaap:IncomeLossFromEquityMethodInvestments
      contextRef="i46e2093507a34f2fa6bcbc19a9aaaa63_D20200401-20200630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzY2E5YmIwMTc5MjQ3NmZiYjIyNWU1ZDlkZWM4NjlmL3NlYzo5M2NhOWJiMDE3OTI0NzZmYmIyMjVlNWQ5ZGVjODY5Zl81NS9mcmFnOjk0NGQ2N2RjOTNmMjQ1MjliZTc4ZmNlMzRiOGMyZTBiL3RhYmxlOmVkMDExMzdmNzA1MjRmMGE5MzVlYzlhOTNmOGViMDc2L3RhYmxlcmFuZ2U6ZWQwMTEzN2Y3MDUyNGYwYTkzNWVjOWE5M2Y4ZWIwNzZfOC01LTEtMS0xMzQz_28ef78bf-eccd-4c96-af7a-85820fcf7e3d"
      unitRef="usd">0</us-gaap:IncomeLossFromEquityMethodInvestments>
    <us-gaap:IncomeLossFromEquityMethodInvestments
      contextRef="i39065c5daf934af885335c12f3cfa83f_D20200401-20200630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzY2E5YmIwMTc5MjQ3NmZiYjIyNWU1ZDlkZWM4NjlmL3NlYzo5M2NhOWJiMDE3OTI0NzZmYmIyMjVlNWQ5ZGVjODY5Zl81NS9mcmFnOjk0NGQ2N2RjOTNmMjQ1MjliZTc4ZmNlMzRiOGMyZTBiL3RhYmxlOmVkMDExMzdmNzA1MjRmMGE5MzVlYzlhOTNmOGViMDc2L3RhYmxlcmFuZ2U6ZWQwMTEzN2Y3MDUyNGYwYTkzNWVjOWE5M2Y4ZWIwNzZfNy03LTEtMS0xNjIwNA_17e728e3-f8e8-4c8d-9666-b88de6033d92"
      unitRef="usd">-794000</us-gaap:IncomeLossFromEquityMethodInvestments>
    <us-gaap:InvestmentIncomeInterest
      contextRef="icb85df07ebfc4bfa99c08f8c9f0cb89c_D20200401-20200630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzY2E5YmIwMTc5MjQ3NmZiYjIyNWU1ZDlkZWM4NjlmL3NlYzo5M2NhOWJiMDE3OTI0NzZmYmIyMjVlNWQ5ZGVjODY5Zl81NS9mcmFnOjk0NGQ2N2RjOTNmMjQ1MjliZTc4ZmNlMzRiOGMyZTBiL3RhYmxlOmVkMDExMzdmNzA1MjRmMGE5MzVlYzlhOTNmOGViMDc2L3RhYmxlcmFuZ2U6ZWQwMTEzN2Y3MDUyNGYwYTkzNWVjOWE5M2Y4ZWIwNzZfMTAtMS0xLTEtMTM0Nw_0f846088-2edf-4055-b068-89fe73c4d3e2"
      unitRef="usd">9000</us-gaap:InvestmentIncomeInterest>
    <us-gaap:InvestmentIncomeInterest
      contextRef="if83af42553ab4081bf67a6ecab2097fc_D20200401-20200630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzY2E5YmIwMTc5MjQ3NmZiYjIyNWU1ZDlkZWM4NjlmL3NlYzo5M2NhOWJiMDE3OTI0NzZmYmIyMjVlNWQ5ZGVjODY5Zl81NS9mcmFnOjk0NGQ2N2RjOTNmMjQ1MjliZTc4ZmNlMzRiOGMyZTBiL3RhYmxlOmVkMDExMzdmNzA1MjRmMGE5MzVlYzlhOTNmOGViMDc2L3RhYmxlcmFuZ2U6ZWQwMTEzN2Y3MDUyNGYwYTkzNWVjOWE5M2Y4ZWIwNzZfMTAtMy0xLTEtMTM0Nw_cd39280f-c889-4590-b8e6-a934d16839ca"
      unitRef="usd">3808000</us-gaap:InvestmentIncomeInterest>
    <us-gaap:InvestmentIncomeInterest
      contextRef="i46e2093507a34f2fa6bcbc19a9aaaa63_D20200401-20200630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzY2E5YmIwMTc5MjQ3NmZiYjIyNWU1ZDlkZWM4NjlmL3NlYzo5M2NhOWJiMDE3OTI0NzZmYmIyMjVlNWQ5ZGVjODY5Zl81NS9mcmFnOjk0NGQ2N2RjOTNmMjQ1MjliZTc4ZmNlMzRiOGMyZTBiL3RhYmxlOmVkMDExMzdmNzA1MjRmMGE5MzVlYzlhOTNmOGViMDc2L3RhYmxlcmFuZ2U6ZWQwMTEzN2Y3MDUyNGYwYTkzNWVjOWE5M2Y4ZWIwNzZfMTAtNS0xLTEtMTM0Nw_ab8afa46-6ae8-4280-ae20-1ddad99516bb"
      unitRef="usd">0</us-gaap:InvestmentIncomeInterest>
    <us-gaap:InvestmentIncomeInterest
      contextRef="i39065c5daf934af885335c12f3cfa83f_D20200401-20200630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzY2E5YmIwMTc5MjQ3NmZiYjIyNWU1ZDlkZWM4NjlmL3NlYzo5M2NhOWJiMDE3OTI0NzZmYmIyMjVlNWQ5ZGVjODY5Zl81NS9mcmFnOjk0NGQ2N2RjOTNmMjQ1MjliZTc4ZmNlMzRiOGMyZTBiL3RhYmxlOmVkMDExMzdmNzA1MjRmMGE5MzVlYzlhOTNmOGViMDc2L3RhYmxlcmFuZ2U6ZWQwMTEzN2Y3MDUyNGYwYTkzNWVjOWE5M2Y4ZWIwNzZfOS03LTEtMS0xNjIwNg_2abe7529-dc1e-4afc-b961-aeb6cf141aa1"
      unitRef="usd">3817000</us-gaap:InvestmentIncomeInterest>
    <us-gaap:InterestExpense
      contextRef="icb85df07ebfc4bfa99c08f8c9f0cb89c_D20200401-20200630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzY2E5YmIwMTc5MjQ3NmZiYjIyNWU1ZDlkZWM4NjlmL3NlYzo5M2NhOWJiMDE3OTI0NzZmYmIyMjVlNWQ5ZGVjODY5Zl81NS9mcmFnOjk0NGQ2N2RjOTNmMjQ1MjliZTc4ZmNlMzRiOGMyZTBiL3RhYmxlOmVkMDExMzdmNzA1MjRmMGE5MzVlYzlhOTNmOGViMDc2L3RhYmxlcmFuZ2U6ZWQwMTEzN2Y3MDUyNGYwYTkzNWVjOWE5M2Y4ZWIwNzZfMTEtMS0xLTEtMTM0Nw_84d42842-557b-484d-ac24-66672ae9a2d6"
      unitRef="usd">0</us-gaap:InterestExpense>
    <us-gaap:InterestExpense
      contextRef="if83af42553ab4081bf67a6ecab2097fc_D20200401-20200630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzY2E5YmIwMTc5MjQ3NmZiYjIyNWU1ZDlkZWM4NjlmL3NlYzo5M2NhOWJiMDE3OTI0NzZmYmIyMjVlNWQ5ZGVjODY5Zl81NS9mcmFnOjk0NGQ2N2RjOTNmMjQ1MjliZTc4ZmNlMzRiOGMyZTBiL3RhYmxlOmVkMDExMzdmNzA1MjRmMGE5MzVlYzlhOTNmOGViMDc2L3RhYmxlcmFuZ2U6ZWQwMTEzN2Y3MDUyNGYwYTkzNWVjOWE5M2Y4ZWIwNzZfMTEtMy0xLTEtMTM0Nw_3a5920c1-650d-407d-873d-f5ab17875aeb"
      unitRef="usd">83000</us-gaap:InterestExpense>
    <us-gaap:InterestExpense
      contextRef="i46e2093507a34f2fa6bcbc19a9aaaa63_D20200401-20200630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzY2E5YmIwMTc5MjQ3NmZiYjIyNWU1ZDlkZWM4NjlmL3NlYzo5M2NhOWJiMDE3OTI0NzZmYmIyMjVlNWQ5ZGVjODY5Zl81NS9mcmFnOjk0NGQ2N2RjOTNmMjQ1MjliZTc4ZmNlMzRiOGMyZTBiL3RhYmxlOmVkMDExMzdmNzA1MjRmMGE5MzVlYzlhOTNmOGViMDc2L3RhYmxlcmFuZ2U6ZWQwMTEzN2Y3MDUyNGYwYTkzNWVjOWE5M2Y4ZWIwNzZfMTEtNS0xLTEtMTM0Nw_f291d225-4d3b-47d9-8cf6-a4e4e8bcfe3a"
      unitRef="usd">0</us-gaap:InterestExpense>
    <us-gaap:InterestExpense
      contextRef="i39065c5daf934af885335c12f3cfa83f_D20200401-20200630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzY2E5YmIwMTc5MjQ3NmZiYjIyNWU1ZDlkZWM4NjlmL3NlYzo5M2NhOWJiMDE3OTI0NzZmYmIyMjVlNWQ5ZGVjODY5Zl81NS9mcmFnOjk0NGQ2N2RjOTNmMjQ1MjliZTc4ZmNlMzRiOGMyZTBiL3RhYmxlOmVkMDExMzdmNzA1MjRmMGE5MzVlYzlhOTNmOGViMDc2L3RhYmxlcmFuZ2U6ZWQwMTEzN2Y3MDUyNGYwYTkzNWVjOWE5M2Y4ZWIwNzZfMTAtNy0xLTEtMTYyMDY_2c70ed67-41c5-48e7-a095-881c123a677f"
      unitRef="usd">83000</us-gaap:InterestExpense>
    <us-gaap:InterestIncomeExpenseNonoperatingNet
      contextRef="icb85df07ebfc4bfa99c08f8c9f0cb89c_D20200401-20200630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzY2E5YmIwMTc5MjQ3NmZiYjIyNWU1ZDlkZWM4NjlmL3NlYzo5M2NhOWJiMDE3OTI0NzZmYmIyMjVlNWQ5ZGVjODY5Zl81NS9mcmFnOjk0NGQ2N2RjOTNmMjQ1MjliZTc4ZmNlMzRiOGMyZTBiL3RhYmxlOmVkMDExMzdmNzA1MjRmMGE5MzVlYzlhOTNmOGViMDc2L3RhYmxlcmFuZ2U6ZWQwMTEzN2Y3MDUyNGYwYTkzNWVjOWE5M2Y4ZWIwNzZfMTEtMS0xLTEtMTYyMDY_bd32567a-e24b-4e02-b4c8-247598d5c801"
      unitRef="usd">9000</us-gaap:InterestIncomeExpenseNonoperatingNet>
    <us-gaap:InterestIncomeExpenseNonoperatingNet
      contextRef="if83af42553ab4081bf67a6ecab2097fc_D20200401-20200630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzY2E5YmIwMTc5MjQ3NmZiYjIyNWU1ZDlkZWM4NjlmL3NlYzo5M2NhOWJiMDE3OTI0NzZmYmIyMjVlNWQ5ZGVjODY5Zl81NS9mcmFnOjk0NGQ2N2RjOTNmMjQ1MjliZTc4ZmNlMzRiOGMyZTBiL3RhYmxlOmVkMDExMzdmNzA1MjRmMGE5MzVlYzlhOTNmOGViMDc2L3RhYmxlcmFuZ2U6ZWQwMTEzN2Y3MDUyNGYwYTkzNWVjOWE5M2Y4ZWIwNzZfMTEtMy0xLTEtMTYyMDY_b77efbd3-980e-463e-85ae-57795c573252"
      unitRef="usd">3725000</us-gaap:InterestIncomeExpenseNonoperatingNet>
    <us-gaap:InterestIncomeExpenseNonoperatingNet
      contextRef="i46e2093507a34f2fa6bcbc19a9aaaa63_D20200401-20200630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzY2E5YmIwMTc5MjQ3NmZiYjIyNWU1ZDlkZWM4NjlmL3NlYzo5M2NhOWJiMDE3OTI0NzZmYmIyMjVlNWQ5ZGVjODY5Zl81NS9mcmFnOjk0NGQ2N2RjOTNmMjQ1MjliZTc4ZmNlMzRiOGMyZTBiL3RhYmxlOmVkMDExMzdmNzA1MjRmMGE5MzVlYzlhOTNmOGViMDc2L3RhYmxlcmFuZ2U6ZWQwMTEzN2Y3MDUyNGYwYTkzNWVjOWE5M2Y4ZWIwNzZfMTEtNS0xLTEtMTYyMDY_609cad11-bf31-45b7-9f36-c6e9a50f66ad"
      unitRef="usd">0</us-gaap:InterestIncomeExpenseNonoperatingNet>
    <us-gaap:InterestIncomeExpenseNonoperatingNet
      contextRef="i39065c5daf934af885335c12f3cfa83f_D20200401-20200630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzY2E5YmIwMTc5MjQ3NmZiYjIyNWU1ZDlkZWM4NjlmL3NlYzo5M2NhOWJiMDE3OTI0NzZmYmIyMjVlNWQ5ZGVjODY5Zl81NS9mcmFnOjk0NGQ2N2RjOTNmMjQ1MjliZTc4ZmNlMzRiOGMyZTBiL3RhYmxlOmVkMDExMzdmNzA1MjRmMGE5MzVlYzlhOTNmOGViMDc2L3RhYmxlcmFuZ2U6ZWQwMTEzN2Y3MDUyNGYwYTkzNWVjOWE5M2Y4ZWIwNzZfMTEtNy0xLTEtMTYyMDY_efc35f66-ba04-4838-83e4-fe162b200f78"
      unitRef="usd">3734000</us-gaap:InterestIncomeExpenseNonoperatingNet>
    <us-gaap:Assets
      contextRef="i702a586f0ecb4fc1b7bfe544770fb520_I20200630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzY2E5YmIwMTc5MjQ3NmZiYjIyNWU1ZDlkZWM4NjlmL3NlYzo5M2NhOWJiMDE3OTI0NzZmYmIyMjVlNWQ5ZGVjODY5Zl81NS9mcmFnOjk0NGQ2N2RjOTNmMjQ1MjliZTc4ZmNlMzRiOGMyZTBiL3RhYmxlOmVkMDExMzdmNzA1MjRmMGE5MzVlYzlhOTNmOGViMDc2L3RhYmxlcmFuZ2U6ZWQwMTEzN2Y3MDUyNGYwYTkzNWVjOWE5M2Y4ZWIwNzZfMTMtMS0xLTEtMTg0NDg_8e663f09-901c-40ed-baa1-8ffe06db5c1e"
      unitRef="usd">250470000</us-gaap:Assets>
    <us-gaap:Assets
      contextRef="if4396fb40fd54b7faa91c1e910136a74_I20200630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzY2E5YmIwMTc5MjQ3NmZiYjIyNWU1ZDlkZWM4NjlmL3NlYzo5M2NhOWJiMDE3OTI0NzZmYmIyMjVlNWQ5ZGVjODY5Zl81NS9mcmFnOjk0NGQ2N2RjOTNmMjQ1MjliZTc4ZmNlMzRiOGMyZTBiL3RhYmxlOmVkMDExMzdmNzA1MjRmMGE5MzVlYzlhOTNmOGViMDc2L3RhYmxlcmFuZ2U6ZWQwMTEzN2Y3MDUyNGYwYTkzNWVjOWE5M2Y4ZWIwNzZfMTMtMy0xLTEtMTg0NDg_8f416a52-504d-4659-b177-51a13822d4a2"
      unitRef="usd">348569000</us-gaap:Assets>
    <us-gaap:Assets
      contextRef="iad52c8a5170c4f5bbeca5c035dd90f4e_I20200630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzY2E5YmIwMTc5MjQ3NmZiYjIyNWU1ZDlkZWM4NjlmL3NlYzo5M2NhOWJiMDE3OTI0NzZmYmIyMjVlNWQ5ZGVjODY5Zl81NS9mcmFnOjk0NGQ2N2RjOTNmMjQ1MjliZTc4ZmNlMzRiOGMyZTBiL3RhYmxlOmVkMDExMzdmNzA1MjRmMGE5MzVlYzlhOTNmOGViMDc2L3RhYmxlcmFuZ2U6ZWQwMTEzN2Y3MDUyNGYwYTkzNWVjOWE5M2Y4ZWIwNzZfMTMtNS0xLTEtMTg0NDg_91101b96-2db3-48f2-8b70-41f23ed8c047"
      unitRef="usd">1311248000</us-gaap:Assets>
    <us-gaap:Assets
      contextRef="id670dc9b33e6430f9d7510009f7495a7_I20200630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzY2E5YmIwMTc5MjQ3NmZiYjIyNWU1ZDlkZWM4NjlmL3NlYzo5M2NhOWJiMDE3OTI0NzZmYmIyMjVlNWQ5ZGVjODY5Zl81NS9mcmFnOjk0NGQ2N2RjOTNmMjQ1MjliZTc4ZmNlMzRiOGMyZTBiL3RhYmxlOmVkMDExMzdmNzA1MjRmMGE5MzVlYzlhOTNmOGViMDc2L3RhYmxlcmFuZ2U6ZWQwMTEzN2Y3MDUyNGYwYTkzNWVjOWE5M2Y4ZWIwNzZfMTMtNy0xLTEtMjA3NzA_8b17fee5-34b1-419e-8c5f-a13cb137fce3"
      unitRef="usd">1910287000</us-gaap:Assets>
    <us-gaap:DepreciationAndAmortization
      contextRef="icb85df07ebfc4bfa99c08f8c9f0cb89c_D20200401-20200630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzY2E5YmIwMTc5MjQ3NmZiYjIyNWU1ZDlkZWM4NjlmL3NlYzo5M2NhOWJiMDE3OTI0NzZmYmIyMjVlNWQ5ZGVjODY5Zl81NS9mcmFnOjk0NGQ2N2RjOTNmMjQ1MjliZTc4ZmNlMzRiOGMyZTBiL3RhYmxlOmVkMDExMzdmNzA1MjRmMGE5MzVlYzlhOTNmOGViMDc2L3RhYmxlcmFuZ2U6ZWQwMTEzN2Y3MDUyNGYwYTkzNWVjOWE5M2Y4ZWIwNzZfMTUtMS0xLTEtMTM1Ng_682e495b-b8be-48aa-bfd4-0b28e5baa246"
      unitRef="usd">36000</us-gaap:DepreciationAndAmortization>
    <us-gaap:DepreciationAndAmortization
      contextRef="if83af42553ab4081bf67a6ecab2097fc_D20200401-20200630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzY2E5YmIwMTc5MjQ3NmZiYjIyNWU1ZDlkZWM4NjlmL3NlYzo5M2NhOWJiMDE3OTI0NzZmYmIyMjVlNWQ5ZGVjODY5Zl81NS9mcmFnOjk0NGQ2N2RjOTNmMjQ1MjliZTc4ZmNlMzRiOGMyZTBiL3RhYmxlOmVkMDExMzdmNzA1MjRmMGE5MzVlYzlhOTNmOGViMDc2L3RhYmxlcmFuZ2U6ZWQwMTEzN2Y3MDUyNGYwYTkzNWVjOWE5M2Y4ZWIwNzZfMTUtMy0xLTEtMTM1Ng_5ac469e1-4e74-4c7a-b126-bf01bfec0299"
      unitRef="usd">643000</us-gaap:DepreciationAndAmortization>
    <us-gaap:DepreciationAndAmortization
      contextRef="i46e2093507a34f2fa6bcbc19a9aaaa63_D20200401-20200630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzY2E5YmIwMTc5MjQ3NmZiYjIyNWU1ZDlkZWM4NjlmL3NlYzo5M2NhOWJiMDE3OTI0NzZmYmIyMjVlNWQ5ZGVjODY5Zl81NS9mcmFnOjk0NGQ2N2RjOTNmMjQ1MjliZTc4ZmNlMzRiOGMyZTBiL3RhYmxlOmVkMDExMzdmNzA1MjRmMGE5MzVlYzlhOTNmOGViMDc2L3RhYmxlcmFuZ2U6ZWQwMTEzN2Y3MDUyNGYwYTkzNWVjOWE5M2Y4ZWIwNzZfMTUtNS0xLTEtMTM1Ng_1a542e9b-7a6e-4567-b2cd-f04686ea33da"
      unitRef="usd">0</us-gaap:DepreciationAndAmortization>
    <us-gaap:DepreciationAndAmortization
      contextRef="i39065c5daf934af885335c12f3cfa83f_D20200401-20200630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzY2E5YmIwMTc5MjQ3NmZiYjIyNWU1ZDlkZWM4NjlmL3NlYzo5M2NhOWJiMDE3OTI0NzZmYmIyMjVlNWQ5ZGVjODY5Zl81NS9mcmFnOjk0NGQ2N2RjOTNmMjQ1MjliZTc4ZmNlMzRiOGMyZTBiL3RhYmxlOmVkMDExMzdmNzA1MjRmMGE5MzVlYzlhOTNmOGViMDc2L3RhYmxlcmFuZ2U6ZWQwMTEzN2Y3MDUyNGYwYTkzNWVjOWE5M2Y4ZWIwNzZfMTMtNy0xLTEtMTYyMDg_10624d13-4308-448d-83e8-3baf618fd51e"
      unitRef="usd">679000</us-gaap:DepreciationAndAmortization>
    <us-gaap:OperatingLeaseRightOfUseAssetAmortizationExpense
      contextRef="icb85df07ebfc4bfa99c08f8c9f0cb89c_D20200401-20200630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzY2E5YmIwMTc5MjQ3NmZiYjIyNWU1ZDlkZWM4NjlmL3NlYzo5M2NhOWJiMDE3OTI0NzZmYmIyMjVlNWQ5ZGVjODY5Zl81NS9mcmFnOjk0NGQ2N2RjOTNmMjQ1MjliZTc4ZmNlMzRiOGMyZTBiL3RhYmxlOmVkMDExMzdmNzA1MjRmMGE5MzVlYzlhOTNmOGViMDc2L3RhYmxlcmFuZ2U6ZWQwMTEzN2Y3MDUyNGYwYTkzNWVjOWE5M2Y4ZWIwNzZfMTUtMS0xLTEtNDg2Nw_7fde9b16-52b6-4127-a601-fa3e4d64a58e"
      unitRef="usd">40000000</us-gaap:OperatingLeaseRightOfUseAssetAmortizationExpense>
    <us-gaap:OperatingLeaseRightOfUseAssetAmortizationExpense
      contextRef="if83af42553ab4081bf67a6ecab2097fc_D20200401-20200630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzY2E5YmIwMTc5MjQ3NmZiYjIyNWU1ZDlkZWM4NjlmL3NlYzo5M2NhOWJiMDE3OTI0NzZmYmIyMjVlNWQ5ZGVjODY5Zl81NS9mcmFnOjk0NGQ2N2RjOTNmMjQ1MjliZTc4ZmNlMzRiOGMyZTBiL3RhYmxlOmVkMDExMzdmNzA1MjRmMGE5MzVlYzlhOTNmOGViMDc2L3RhYmxlcmFuZ2U6ZWQwMTEzN2Y3MDUyNGYwYTkzNWVjOWE5M2Y4ZWIwNzZfMTUtMy0xLTEtNDg2Nw_a526966b-225b-4a58-a897-c1e184576be9"
      unitRef="usd">0</us-gaap:OperatingLeaseRightOfUseAssetAmortizationExpense>
    <us-gaap:OperatingLeaseRightOfUseAssetAmortizationExpense
      contextRef="i46e2093507a34f2fa6bcbc19a9aaaa63_D20200401-20200630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzY2E5YmIwMTc5MjQ3NmZiYjIyNWU1ZDlkZWM4NjlmL3NlYzo5M2NhOWJiMDE3OTI0NzZmYmIyMjVlNWQ5ZGVjODY5Zl81NS9mcmFnOjk0NGQ2N2RjOTNmMjQ1MjliZTc4ZmNlMzRiOGMyZTBiL3RhYmxlOmVkMDExMzdmNzA1MjRmMGE5MzVlYzlhOTNmOGViMDc2L3RhYmxlcmFuZ2U6ZWQwMTEzN2Y3MDUyNGYwYTkzNWVjOWE5M2Y4ZWIwNzZfMTUtNS0xLTEtNDg2Nw_d744cfce-d143-4b03-be3f-3a21bcc1d416"
      unitRef="usd">0</us-gaap:OperatingLeaseRightOfUseAssetAmortizationExpense>
    <us-gaap:OperatingLeaseRightOfUseAssetAmortizationExpense
      contextRef="i39065c5daf934af885335c12f3cfa83f_D20200401-20200630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzY2E5YmIwMTc5MjQ3NmZiYjIyNWU1ZDlkZWM4NjlmL3NlYzo5M2NhOWJiMDE3OTI0NzZmYmIyMjVlNWQ5ZGVjODY5Zl81NS9mcmFnOjk0NGQ2N2RjOTNmMjQ1MjliZTc4ZmNlMzRiOGMyZTBiL3RhYmxlOmVkMDExMzdmNzA1MjRmMGE5MzVlYzlhOTNmOGViMDc2L3RhYmxlcmFuZ2U6ZWQwMTEzN2Y3MDUyNGYwYTkzNWVjOWE5M2Y4ZWIwNzZfMTUtNy0xLTEtNDg2Nw_be4bacd7-728e-4b3b-8252-586c18849d14"
      unitRef="usd">40000000</us-gaap:OperatingLeaseRightOfUseAssetAmortizationExpense>
    <cron:AdjustedEarningsBeforeInterestTaxesDepreciationAndAmortization
      contextRef="icb85df07ebfc4bfa99c08f8c9f0cb89c_D20200401-20200630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzY2E5YmIwMTc5MjQ3NmZiYjIyNWU1ZDlkZWM4NjlmL3NlYzo5M2NhOWJiMDE3OTI0NzZmYmIyMjVlNWQ5ZGVjODY5Zl81NS9mcmFnOjk0NGQ2N2RjOTNmMjQ1MjliZTc4ZmNlMzRiOGMyZTBiL3RhYmxlOmVkMDExMzdmNzA1MjRmMGE5MzVlYzlhOTNmOGViMDc2L3RhYmxlcmFuZ2U6ZWQwMTEzN2Y3MDUyNGYwYTkzNWVjOWE5M2Y4ZWIwNzZfMTctMS0xLTEtMTM2Mg_f39c239b-6e9f-4165-91de-66906c4f739b"
      unitRef="usd">-4785000</cron:AdjustedEarningsBeforeInterestTaxesDepreciationAndAmortization>
    <cron:AdjustedEarningsBeforeInterestTaxesDepreciationAndAmortization
      contextRef="if83af42553ab4081bf67a6ecab2097fc_D20200401-20200630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzY2E5YmIwMTc5MjQ3NmZiYjIyNWU1ZDlkZWM4NjlmL3NlYzo5M2NhOWJiMDE3OTI0NzZmYmIyMjVlNWQ5ZGVjODY5Zl81NS9mcmFnOjk0NGQ2N2RjOTNmMjQ1MjliZTc4ZmNlMzRiOGMyZTBiL3RhYmxlOmVkMDExMzdmNzA1MjRmMGE5MzVlYzlhOTNmOGViMDc2L3RhYmxlcmFuZ2U6ZWQwMTEzN2Y3MDUyNGYwYTkzNWVjOWE5M2Y4ZWIwNzZfMTctMy0xLTEtMTM2Mg_023c4e51-5cfc-42d9-95c0-0f1493e1c17b"
      unitRef="usd">-18618000</cron:AdjustedEarningsBeforeInterestTaxesDepreciationAndAmortization>
    <cron:AdjustedEarningsBeforeInterestTaxesDepreciationAndAmortization
      contextRef="i46e2093507a34f2fa6bcbc19a9aaaa63_D20200401-20200630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzY2E5YmIwMTc5MjQ3NmZiYjIyNWU1ZDlkZWM4NjlmL3NlYzo5M2NhOWJiMDE3OTI0NzZmYmIyMjVlNWQ5ZGVjODY5Zl81NS9mcmFnOjk0NGQ2N2RjOTNmMjQ1MjliZTc4ZmNlMzRiOGMyZTBiL3RhYmxlOmVkMDExMzdmNzA1MjRmMGE5MzVlYzlhOTNmOGViMDc2L3RhYmxlcmFuZ2U6ZWQwMTEzN2Y3MDUyNGYwYTkzNWVjOWE5M2Y4ZWIwNzZfMTctNS0xLTEtMTM2Mg_482e1c1e-9085-4940-9fb9-a0b304384c10"
      unitRef="usd">-3583000</cron:AdjustedEarningsBeforeInterestTaxesDepreciationAndAmortization>
    <cron:AdjustedEarningsBeforeInterestTaxesDepreciationAndAmortization
      contextRef="i39065c5daf934af885335c12f3cfa83f_D20200401-20200630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzY2E5YmIwMTc5MjQ3NmZiYjIyNWU1ZDlkZWM4NjlmL3NlYzo5M2NhOWJiMDE3OTI0NzZmYmIyMjVlNWQ5ZGVjODY5Zl81NS9mcmFnOjk0NGQ2N2RjOTNmMjQ1MjliZTc4ZmNlMzRiOGMyZTBiL3RhYmxlOmVkMDExMzdmNzA1MjRmMGE5MzVlYzlhOTNmOGViMDc2L3RhYmxlcmFuZ2U6ZWQwMTEzN2Y3MDUyNGYwYTkzNWVjOWE5M2Y4ZWIwNzZfMTYtNy0xLTEtMTYyMDg_857c2eef-6ea3-4079-8be6-c1a73409a36c"
      unitRef="usd">-26986000</cron:AdjustedEarningsBeforeInterestTaxesDepreciationAndAmortization>
    <us-gaap:PropertyPlantAndEquipmentAdditions
      contextRef="icb85df07ebfc4bfa99c08f8c9f0cb89c_D20200401-20200630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzY2E5YmIwMTc5MjQ3NmZiYjIyNWU1ZDlkZWM4NjlmL3NlYzo5M2NhOWJiMDE3OTI0NzZmYmIyMjVlNWQ5ZGVjODY5Zl81NS9mcmFnOjk0NGQ2N2RjOTNmMjQ1MjliZTc4ZmNlMzRiOGMyZTBiL3RhYmxlOmVkMDExMzdmNzA1MjRmMGE5MzVlYzlhOTNmOGViMDc2L3RhYmxlcmFuZ2U6ZWQwMTEzN2Y3MDUyNGYwYTkzNWVjOWE5M2Y4ZWIwNzZfMTctMS0xLTEtMTczMDY_fa82f900-fafa-436b-be8f-77efe39ffbd3"
      unitRef="usd">39000</us-gaap:PropertyPlantAndEquipmentAdditions>
    <us-gaap:PropertyPlantAndEquipmentAdditions
      contextRef="if83af42553ab4081bf67a6ecab2097fc_D20200401-20200630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzY2E5YmIwMTc5MjQ3NmZiYjIyNWU1ZDlkZWM4NjlmL3NlYzo5M2NhOWJiMDE3OTI0NzZmYmIyMjVlNWQ5ZGVjODY5Zl81NS9mcmFnOjk0NGQ2N2RjOTNmMjQ1MjliZTc4ZmNlMzRiOGMyZTBiL3RhYmxlOmVkMDExMzdmNzA1MjRmMGE5MzVlYzlhOTNmOGViMDc2L3RhYmxlcmFuZ2U6ZWQwMTEzN2Y3MDUyNGYwYTkzNWVjOWE5M2Y4ZWIwNzZfMTctMy0xLTEtMTczMDk_e3dcfd0d-a8b1-43de-a11f-81faab3eb0ca"
      unitRef="usd">6894000</us-gaap:PropertyPlantAndEquipmentAdditions>
    <us-gaap:PropertyPlantAndEquipmentAdditions
      contextRef="i46e2093507a34f2fa6bcbc19a9aaaa63_D20200401-20200630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzY2E5YmIwMTc5MjQ3NmZiYjIyNWU1ZDlkZWM4NjlmL3NlYzo5M2NhOWJiMDE3OTI0NzZmYmIyMjVlNWQ5ZGVjODY5Zl81NS9mcmFnOjk0NGQ2N2RjOTNmMjQ1MjliZTc4ZmNlMzRiOGMyZTBiL3RhYmxlOmVkMDExMzdmNzA1MjRmMGE5MzVlYzlhOTNmOGViMDc2L3RhYmxlcmFuZ2U6ZWQwMTEzN2Y3MDUyNGYwYTkzNWVjOWE5M2Y4ZWIwNzZfMTctNS0xLTEtMTczMTI_10cbea11-8c2e-4c49-81c4-97acedde1b90"
      unitRef="usd">0</us-gaap:PropertyPlantAndEquipmentAdditions>
    <us-gaap:PropertyPlantAndEquipmentAdditions
      contextRef="i39065c5daf934af885335c12f3cfa83f_D20200401-20200630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzY2E5YmIwMTc5MjQ3NmZiYjIyNWU1ZDlkZWM4NjlmL3NlYzo5M2NhOWJiMDE3OTI0NzZmYmIyMjVlNWQ5ZGVjODY5Zl81NS9mcmFnOjk0NGQ2N2RjOTNmMjQ1MjliZTc4ZmNlMzRiOGMyZTBiL3RhYmxlOmVkMDExMzdmNzA1MjRmMGE5MzVlYzlhOTNmOGViMDc2L3RhYmxlcmFuZ2U6ZWQwMTEzN2Y3MDUyNGYwYTkzNWVjOWE5M2Y4ZWIwNzZfMTctNy0xLTEtMTczNzI_ab991bab-95b0-474a-9f23-8796bca75c9e"
      unitRef="usd">6933000</us-gaap:PropertyPlantAndEquipmentAdditions>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="ia1fd0c77f444432fbb955ee120f3e358_D20210101-20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzY2E5YmIwMTc5MjQ3NmZiYjIyNWU1ZDlkZWM4NjlmL3NlYzo5M2NhOWJiMDE3OTI0NzZmYmIyMjVlNWQ5ZGVjODY5Zl81NS9mcmFnOjk0NGQ2N2RjOTNmMjQ1MjliZTc4ZmNlMzRiOGMyZTBiL3RhYmxlOjA0NzkyNmRhYWViMzQxYWY4MzY2OWVhN2M4NjhiY2I0L3RhYmxlcmFuZ2U6MDQ3OTI2ZGFhZWIzNDFhZjgzNjY5ZWE3Yzg2OGJjYjRfMy0xLTEtMS0xMjU5_3e78ff5f-a89b-43f6-b0d0-0b9e498ced63"
      unitRef="usd">0</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i1c1529d67f66409e980a87cdbacae6d9_D20210101-20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzY2E5YmIwMTc5MjQ3NmZiYjIyNWU1ZDlkZWM4NjlmL3NlYzo5M2NhOWJiMDE3OTI0NzZmYmIyMjVlNWQ5ZGVjODY5Zl81NS9mcmFnOjk0NGQ2N2RjOTNmMjQ1MjliZTc4ZmNlMzRiOGMyZTBiL3RhYmxlOjA0NzkyNmRhYWViMzQxYWY4MzY2OWVhN2M4NjhiY2I0L3RhYmxlcmFuZ2U6MDQ3OTI2ZGFhZWIzNDFhZjgzNjY5ZWE3Yzg2OGJjYjRfMy0zLTEtMS0xMjc1_e182321c-c052-4a74-8144-4492c7d74c88"
      unitRef="usd">21031000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="ifb7f0980f81c42e9b5667c26408eec94_D20210101-20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzY2E5YmIwMTc5MjQ3NmZiYjIyNWU1ZDlkZWM4NjlmL3NlYzo5M2NhOWJiMDE3OTI0NzZmYmIyMjVlNWQ5ZGVjODY5Zl81NS9mcmFnOjk0NGQ2N2RjOTNmMjQ1MjliZTc4ZmNlMzRiOGMyZTBiL3RhYmxlOjA0NzkyNmRhYWViMzQxYWY4MzY2OWVhN2M4NjhiY2I0L3RhYmxlcmFuZ2U6MDQ3OTI2ZGFhZWIzNDFhZjgzNjY5ZWE3Yzg2OGJjYjRfMy01LTEtMS0xMjc5_48d7172b-efb9-44d7-8345-7846ed1511d8"
      unitRef="usd">0</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i3f039d262efd4662b7daf3bd025bd767_D20210101-20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzY2E5YmIwMTc5MjQ3NmZiYjIyNWU1ZDlkZWM4NjlmL3NlYzo5M2NhOWJiMDE3OTI0NzZmYmIyMjVlNWQ5ZGVjODY5Zl81NS9mcmFnOjk0NGQ2N2RjOTNmMjQ1MjliZTc4ZmNlMzRiOGMyZTBiL3RhYmxlOjA0NzkyNmRhYWViMzQxYWY4MzY2OWVhN2M4NjhiY2I0L3RhYmxlcmFuZ2U6MDQ3OTI2ZGFhZWIzNDFhZjgzNjY5ZWE3Yzg2OGJjYjRfMi03LTEtMS0xNjIxMA_70212a95-03e0-499d-9fa9-e592e53a86f8"
      unitRef="usd">21031000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i4f7819da7513417abd35056f14170574_D20210101-20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzY2E5YmIwMTc5MjQ3NmZiYjIyNWU1ZDlkZWM4NjlmL3NlYzo5M2NhOWJiMDE3OTI0NzZmYmIyMjVlNWQ5ZGVjODY5Zl81NS9mcmFnOjk0NGQ2N2RjOTNmMjQ1MjliZTc4ZmNlMzRiOGMyZTBiL3RhYmxlOjA0NzkyNmRhYWViMzQxYWY4MzY2OWVhN2M4NjhiY2I0L3RhYmxlcmFuZ2U6MDQ3OTI2ZGFhZWIzNDFhZjgzNjY5ZWE3Yzg2OGJjYjRfNC0xLTEtMS0xMjU5_ef88475b-782b-45fc-9f47-8c57644eb927"
      unitRef="usd">4668000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i2a692272db324fad8fd9591624ebee99_D20210101-20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzY2E5YmIwMTc5MjQ3NmZiYjIyNWU1ZDlkZWM4NjlmL3NlYzo5M2NhOWJiMDE3OTI0NzZmYmIyMjVlNWQ5ZGVjODY5Zl81NS9mcmFnOjk0NGQ2N2RjOTNmMjQ1MjliZTc4ZmNlMzRiOGMyZTBiL3RhYmxlOjA0NzkyNmRhYWViMzQxYWY4MzY2OWVhN2M4NjhiY2I0L3RhYmxlcmFuZ2U6MDQ3OTI2ZGFhZWIzNDFhZjgzNjY5ZWE3Yzg2OGJjYjRfNC0zLTEtMS0xMjc1_a6bfb8ec-7103-4e5f-b767-5c570b2d6ff6"
      unitRef="usd">2234000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="ic645ffe32db24fe886c9079930540947_D20210101-20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzY2E5YmIwMTc5MjQ3NmZiYjIyNWU1ZDlkZWM4NjlmL3NlYzo5M2NhOWJiMDE3OTI0NzZmYmIyMjVlNWQ5ZGVjODY5Zl81NS9mcmFnOjk0NGQ2N2RjOTNmMjQ1MjliZTc4ZmNlMzRiOGMyZTBiL3RhYmxlOjA0NzkyNmRhYWViMzQxYWY4MzY2OWVhN2M4NjhiY2I0L3RhYmxlcmFuZ2U6MDQ3OTI2ZGFhZWIzNDFhZjgzNjY5ZWE3Yzg2OGJjYjRfNC01LTEtMS0xMjc5_145ba5fb-eaa0-4a22-b73e-714f72503d8e"
      unitRef="usd">0</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i28cc601c4515423c9fb7c740926652a1_D20210101-20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzY2E5YmIwMTc5MjQ3NmZiYjIyNWU1ZDlkZWM4NjlmL3NlYzo5M2NhOWJiMDE3OTI0NzZmYmIyMjVlNWQ5ZGVjODY5Zl81NS9mcmFnOjk0NGQ2N2RjOTNmMjQ1MjliZTc4ZmNlMzRiOGMyZTBiL3RhYmxlOjA0NzkyNmRhYWViMzQxYWY4MzY2OWVhN2M4NjhiY2I0L3RhYmxlcmFuZ2U6MDQ3OTI2ZGFhZWIzNDFhZjgzNjY5ZWE3Yzg2OGJjYjRfMy03LTEtMS0xNjIxMA_714e0cdb-4dc7-4a9b-9f89-19bfc04f59d9"
      unitRef="usd">6902000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="iaa3896f04f0b4ffa95465aa6125063d6_D20210101-20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzY2E5YmIwMTc5MjQ3NmZiYjIyNWU1ZDlkZWM4NjlmL3NlYzo5M2NhOWJiMDE3OTI0NzZmYmIyMjVlNWQ5ZGVjODY5Zl81NS9mcmFnOjk0NGQ2N2RjOTNmMjQ1MjliZTc4ZmNlMzRiOGMyZTBiL3RhYmxlOjA0NzkyNmRhYWViMzQxYWY4MzY2OWVhN2M4NjhiY2I0L3RhYmxlcmFuZ2U6MDQ3OTI2ZGFhZWIzNDFhZjgzNjY5ZWE3Yzg2OGJjYjRfNS0xLTEtMS0xMjU5_f87f1f3b-0405-470a-8f87-a8392c6f86fd"
      unitRef="usd">0</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="if969ee02513f48cdb95de50cc1bb0d51_D20210101-20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzY2E5YmIwMTc5MjQ3NmZiYjIyNWU1ZDlkZWM4NjlmL3NlYzo5M2NhOWJiMDE3OTI0NzZmYmIyMjVlNWQ5ZGVjODY5Zl81NS9mcmFnOjk0NGQ2N2RjOTNmMjQ1MjliZTc4ZmNlMzRiOGMyZTBiL3RhYmxlOjA0NzkyNmRhYWViMzQxYWY4MzY2OWVhN2M4NjhiY2I0L3RhYmxlcmFuZ2U6MDQ3OTI2ZGFhZWIzNDFhZjgzNjY5ZWE3Yzg2OGJjYjRfNS0zLTEtMS0xMjc1_42ebefcf-43eb-4fd6-8a08-6a645cb8b97a"
      unitRef="usd">300000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i2fd2e11500cb4edfaa54ab9e521c7c86_D20210101-20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzY2E5YmIwMTc5MjQ3NmZiYjIyNWU1ZDlkZWM4NjlmL3NlYzo5M2NhOWJiMDE3OTI0NzZmYmIyMjVlNWQ5ZGVjODY5Zl81NS9mcmFnOjk0NGQ2N2RjOTNmMjQ1MjliZTc4ZmNlMzRiOGMyZTBiL3RhYmxlOjA0NzkyNmRhYWViMzQxYWY4MzY2OWVhN2M4NjhiY2I0L3RhYmxlcmFuZ2U6MDQ3OTI2ZGFhZWIzNDFhZjgzNjY5ZWE3Yzg2OGJjYjRfNS01LTEtMS0xMjc5_ec85d8ce-e5a8-47a4-8377-b3ba76463761"
      unitRef="usd">0</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i1c31a39a4c79400497380f76939db7df_D20210101-20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzY2E5YmIwMTc5MjQ3NmZiYjIyNWU1ZDlkZWM4NjlmL3NlYzo5M2NhOWJiMDE3OTI0NzZmYmIyMjVlNWQ5ZGVjODY5Zl81NS9mcmFnOjk0NGQ2N2RjOTNmMjQ1MjliZTc4ZmNlMzRiOGMyZTBiL3RhYmxlOjA0NzkyNmRhYWViMzQxYWY4MzY2OWVhN2M4NjhiY2I0L3RhYmxlcmFuZ2U6MDQ3OTI2ZGFhZWIzNDFhZjgzNjY5ZWE3Yzg2OGJjYjRfNC03LTEtMS0xNjIxMA_dcc86184-c55f-451b-bf19-8fdb91e90e79"
      unitRef="usd">300000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i73f2057fe97d4f3a8524f987e78d1493_D20210101-20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzY2E5YmIwMTc5MjQ3NmZiYjIyNWU1ZDlkZWM4NjlmL3NlYzo5M2NhOWJiMDE3OTI0NzZmYmIyMjVlNWQ5ZGVjODY5Zl81NS9mcmFnOjk0NGQ2N2RjOTNmMjQ1MjliZTc4ZmNlMzRiOGMyZTBiL3RhYmxlOjA0NzkyNmRhYWViMzQxYWY4MzY2OWVhN2M4NjhiY2I0L3RhYmxlcmFuZ2U6MDQ3OTI2ZGFhZWIzNDFhZjgzNjY5ZWE3Yzg2OGJjYjRfNS0xLTEtMS0xNjIxMA_9aa172ba-838a-4ab2-8afe-8235b9ad6868"
      unitRef="usd">4668000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i9eea321560784f81a590aa8e3df3b187_D20210101-20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzY2E5YmIwMTc5MjQ3NmZiYjIyNWU1ZDlkZWM4NjlmL3NlYzo5M2NhOWJiMDE3OTI0NzZmYmIyMjVlNWQ5ZGVjODY5Zl81NS9mcmFnOjk0NGQ2N2RjOTNmMjQ1MjliZTc4ZmNlMzRiOGMyZTBiL3RhYmxlOjA0NzkyNmRhYWViMzQxYWY4MzY2OWVhN2M4NjhiY2I0L3RhYmxlcmFuZ2U6MDQ3OTI2ZGFhZWIzNDFhZjgzNjY5ZWE3Yzg2OGJjYjRfNS0zLTEtMS0xNjIxMA_8d58adde-509c-4d89-9e1d-385682764558"
      unitRef="usd">23565000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i5e244469383d46ddb452d43394f637d1_D20210101-20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzY2E5YmIwMTc5MjQ3NmZiYjIyNWU1ZDlkZWM4NjlmL3NlYzo5M2NhOWJiMDE3OTI0NzZmYmIyMjVlNWQ5ZGVjODY5Zl81NS9mcmFnOjk0NGQ2N2RjOTNmMjQ1MjliZTc4ZmNlMzRiOGMyZTBiL3RhYmxlOjA0NzkyNmRhYWViMzQxYWY4MzY2OWVhN2M4NjhiY2I0L3RhYmxlcmFuZ2U6MDQ3OTI2ZGFhZWIzNDFhZjgzNjY5ZWE3Yzg2OGJjYjRfNS01LTEtMS0xNjIxMA_21848447-a165-472b-b918-f410f669bcaf"
      unitRef="usd">0</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i69782326f71a44e3805518280ee22b6b_D20210101-20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzY2E5YmIwMTc5MjQ3NmZiYjIyNWU1ZDlkZWM4NjlmL3NlYzo5M2NhOWJiMDE3OTI0NzZmYmIyMjVlNWQ5ZGVjODY5Zl81NS9mcmFnOjk0NGQ2N2RjOTNmMjQ1MjliZTc4ZmNlMzRiOGMyZTBiL3RhYmxlOjA0NzkyNmRhYWViMzQxYWY4MzY2OWVhN2M4NjhiY2I0L3RhYmxlcmFuZ2U6MDQ3OTI2ZGFhZWIzNDFhZjgzNjY5ZWE3Yzg2OGJjYjRfNS03LTEtMS0xNTQzOA_b9582a15-802b-4586-88d5-26c1da2c9f42"
      unitRef="usd">28233000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:IncomeLossFromEquityMethodInvestments
      contextRef="i73f2057fe97d4f3a8524f987e78d1493_D20210101-20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzY2E5YmIwMTc5MjQ3NmZiYjIyNWU1ZDlkZWM4NjlmL3NlYzo5M2NhOWJiMDE3OTI0NzZmYmIyMjVlNWQ5ZGVjODY5Zl81NS9mcmFnOjk0NGQ2N2RjOTNmMjQ1MjliZTc4ZmNlMzRiOGMyZTBiL3RhYmxlOjA0NzkyNmRhYWViMzQxYWY4MzY2OWVhN2M4NjhiY2I0L3RhYmxlcmFuZ2U6MDQ3OTI2ZGFhZWIzNDFhZjgzNjY5ZWE3Yzg2OGJjYjRfOC0xLTEtMS0xMjgz_1b5c7490-33a3-476c-a840-982419084d81"
      unitRef="usd">0</us-gaap:IncomeLossFromEquityMethodInvestments>
    <us-gaap:IncomeLossFromEquityMethodInvestments
      contextRef="i9eea321560784f81a590aa8e3df3b187_D20210101-20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzY2E5YmIwMTc5MjQ3NmZiYjIyNWU1ZDlkZWM4NjlmL3NlYzo5M2NhOWJiMDE3OTI0NzZmYmIyMjVlNWQ5ZGVjODY5Zl81NS9mcmFnOjk0NGQ2N2RjOTNmMjQ1MjliZTc4ZmNlMzRiOGMyZTBiL3RhYmxlOjA0NzkyNmRhYWViMzQxYWY4MzY2OWVhN2M4NjhiY2I0L3RhYmxlcmFuZ2U6MDQ3OTI2ZGFhZWIzNDFhZjgzNjY5ZWE3Yzg2OGJjYjRfOC0zLTEtMS0xMjgz_b61ce4c5-3839-4c7f-9034-376cb7d9b7f6"
      unitRef="usd">-2758000</us-gaap:IncomeLossFromEquityMethodInvestments>
    <us-gaap:IncomeLossFromEquityMethodInvestments
      contextRef="i5e244469383d46ddb452d43394f637d1_D20210101-20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzY2E5YmIwMTc5MjQ3NmZiYjIyNWU1ZDlkZWM4NjlmL3NlYzo5M2NhOWJiMDE3OTI0NzZmYmIyMjVlNWQ5ZGVjODY5Zl81NS9mcmFnOjk0NGQ2N2RjOTNmMjQ1MjliZTc4ZmNlMzRiOGMyZTBiL3RhYmxlOjA0NzkyNmRhYWViMzQxYWY4MzY2OWVhN2M4NjhiY2I0L3RhYmxlcmFuZ2U6MDQ3OTI2ZGFhZWIzNDFhZjgzNjY5ZWE3Yzg2OGJjYjRfOC01LTEtMS0xMjgz_3a23b406-8593-46d6-9c28-3972379ec837"
      unitRef="usd">0</us-gaap:IncomeLossFromEquityMethodInvestments>
    <us-gaap:IncomeLossFromEquityMethodInvestments
      contextRef="i69782326f71a44e3805518280ee22b6b_D20210101-20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzY2E5YmIwMTc5MjQ3NmZiYjIyNWU1ZDlkZWM4NjlmL3NlYzo5M2NhOWJiMDE3OTI0NzZmYmIyMjVlNWQ5ZGVjODY5Zl81NS9mcmFnOjk0NGQ2N2RjOTNmMjQ1MjliZTc4ZmNlMzRiOGMyZTBiL3RhYmxlOjA0NzkyNmRhYWViMzQxYWY4MzY2OWVhN2M4NjhiY2I0L3RhYmxlcmFuZ2U6MDQ3OTI2ZGFhZWIzNDFhZjgzNjY5ZWE3Yzg2OGJjYjRfNy03LTEtMS0xNjIxMA_51077a31-2ec7-42cb-8069-b1322ca9923f"
      unitRef="usd">-2758000</us-gaap:IncomeLossFromEquityMethodInvestments>
    <us-gaap:InvestmentIncomeInterest
      contextRef="i73f2057fe97d4f3a8524f987e78d1493_D20210101-20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzY2E5YmIwMTc5MjQ3NmZiYjIyNWU1ZDlkZWM4NjlmL3NlYzo5M2NhOWJiMDE3OTI0NzZmYmIyMjVlNWQ5ZGVjODY5Zl81NS9mcmFnOjk0NGQ2N2RjOTNmMjQ1MjliZTc4ZmNlMzRiOGMyZTBiL3RhYmxlOjA0NzkyNmRhYWViMzQxYWY4MzY2OWVhN2M4NjhiY2I0L3RhYmxlcmFuZ2U6MDQ3OTI2ZGFhZWIzNDFhZjgzNjY5ZWE3Yzg2OGJjYjRfMTAtMS0xLTEtMTI4Nw_740918f2-4c47-4bc1-991b-6bb334711773"
      unitRef="usd">23000</us-gaap:InvestmentIncomeInterest>
    <us-gaap:InvestmentIncomeInterest
      contextRef="i9eea321560784f81a590aa8e3df3b187_D20210101-20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzY2E5YmIwMTc5MjQ3NmZiYjIyNWU1ZDlkZWM4NjlmL3NlYzo5M2NhOWJiMDE3OTI0NzZmYmIyMjVlNWQ5ZGVjODY5Zl81NS9mcmFnOjk0NGQ2N2RjOTNmMjQ1MjliZTc4ZmNlMzRiOGMyZTBiL3RhYmxlOjA0NzkyNmRhYWViMzQxYWY4MzY2OWVhN2M4NjhiY2I0L3RhYmxlcmFuZ2U6MDQ3OTI2ZGFhZWIzNDFhZjgzNjY5ZWE3Yzg2OGJjYjRfMTAtMy0xLTEtMTI4Nw_44abf7c3-2a58-486c-b0fa-7a2dbecb53cc"
      unitRef="usd">4612000</us-gaap:InvestmentIncomeInterest>
    <us-gaap:InvestmentIncomeInterest
      contextRef="i5e244469383d46ddb452d43394f637d1_D20210101-20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzY2E5YmIwMTc5MjQ3NmZiYjIyNWU1ZDlkZWM4NjlmL3NlYzo5M2NhOWJiMDE3OTI0NzZmYmIyMjVlNWQ5ZGVjODY5Zl81NS9mcmFnOjk0NGQ2N2RjOTNmMjQ1MjliZTc4ZmNlMzRiOGMyZTBiL3RhYmxlOjA0NzkyNmRhYWViMzQxYWY4MzY2OWVhN2M4NjhiY2I0L3RhYmxlcmFuZ2U6MDQ3OTI2ZGFhZWIzNDFhZjgzNjY5ZWE3Yzg2OGJjYjRfMTAtNS0xLTEtMTI4Nw_56164f1a-f704-4d3f-8c41-5b09804abcd5"
      unitRef="usd">0</us-gaap:InvestmentIncomeInterest>
    <us-gaap:InvestmentIncomeInterest
      contextRef="i69782326f71a44e3805518280ee22b6b_D20210101-20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzY2E5YmIwMTc5MjQ3NmZiYjIyNWU1ZDlkZWM4NjlmL3NlYzo5M2NhOWJiMDE3OTI0NzZmYmIyMjVlNWQ5ZGVjODY5Zl81NS9mcmFnOjk0NGQ2N2RjOTNmMjQ1MjliZTc4ZmNlMzRiOGMyZTBiL3RhYmxlOjA0NzkyNmRhYWViMzQxYWY4MzY2OWVhN2M4NjhiY2I0L3RhYmxlcmFuZ2U6MDQ3OTI2ZGFhZWIzNDFhZjgzNjY5ZWE3Yzg2OGJjYjRfOS03LTEtMS0xNjIxMA_825784b9-8b8a-4bc2-8d73-bfbb50704fe5"
      unitRef="usd">4635000</us-gaap:InvestmentIncomeInterest>
    <us-gaap:InterestExpense
      contextRef="i73f2057fe97d4f3a8524f987e78d1493_D20210101-20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzY2E5YmIwMTc5MjQ3NmZiYjIyNWU1ZDlkZWM4NjlmL3NlYzo5M2NhOWJiMDE3OTI0NzZmYmIyMjVlNWQ5ZGVjODY5Zl81NS9mcmFnOjk0NGQ2N2RjOTNmMjQ1MjliZTc4ZmNlMzRiOGMyZTBiL3RhYmxlOjA0NzkyNmRhYWViMzQxYWY4MzY2OWVhN2M4NjhiY2I0L3RhYmxlcmFuZ2U6MDQ3OTI2ZGFhZWIzNDFhZjgzNjY5ZWE3Yzg2OGJjYjRfMTEtMS0xLTEtMTI4Nw_bf4b388e-ce72-4ede-b56c-f1899270fe5a"
      unitRef="usd">0</us-gaap:InterestExpense>
    <us-gaap:InterestExpense
      contextRef="i9eea321560784f81a590aa8e3df3b187_D20210101-20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzY2E5YmIwMTc5MjQ3NmZiYjIyNWU1ZDlkZWM4NjlmL3NlYzo5M2NhOWJiMDE3OTI0NzZmYmIyMjVlNWQ5ZGVjODY5Zl81NS9mcmFnOjk0NGQ2N2RjOTNmMjQ1MjliZTc4ZmNlMzRiOGMyZTBiL3RhYmxlOjA0NzkyNmRhYWViMzQxYWY4MzY2OWVhN2M4NjhiY2I0L3RhYmxlcmFuZ2U6MDQ3OTI2ZGFhZWIzNDFhZjgzNjY5ZWE3Yzg2OGJjYjRfMTEtMy0xLTEtMTI4Nw_778ee972-20c8-42d1-86e9-a954e3b67f58"
      unitRef="usd">13000</us-gaap:InterestExpense>
    <us-gaap:InterestExpense
      contextRef="i5e244469383d46ddb452d43394f637d1_D20210101-20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzY2E5YmIwMTc5MjQ3NmZiYjIyNWU1ZDlkZWM4NjlmL3NlYzo5M2NhOWJiMDE3OTI0NzZmYmIyMjVlNWQ5ZGVjODY5Zl81NS9mcmFnOjk0NGQ2N2RjOTNmMjQ1MjliZTc4ZmNlMzRiOGMyZTBiL3RhYmxlOjA0NzkyNmRhYWViMzQxYWY4MzY2OWVhN2M4NjhiY2I0L3RhYmxlcmFuZ2U6MDQ3OTI2ZGFhZWIzNDFhZjgzNjY5ZWE3Yzg2OGJjYjRfMTEtNS0xLTEtMTI4Nw_116db466-5524-4849-b91c-e61dd2d887de"
      unitRef="usd">0</us-gaap:InterestExpense>
    <us-gaap:InterestExpense
      contextRef="i69782326f71a44e3805518280ee22b6b_D20210101-20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzY2E5YmIwMTc5MjQ3NmZiYjIyNWU1ZDlkZWM4NjlmL3NlYzo5M2NhOWJiMDE3OTI0NzZmYmIyMjVlNWQ5ZGVjODY5Zl81NS9mcmFnOjk0NGQ2N2RjOTNmMjQ1MjliZTc4ZmNlMzRiOGMyZTBiL3RhYmxlOjA0NzkyNmRhYWViMzQxYWY4MzY2OWVhN2M4NjhiY2I0L3RhYmxlcmFuZ2U6MDQ3OTI2ZGFhZWIzNDFhZjgzNjY5ZWE3Yzg2OGJjYjRfMTAtNy0xLTEtMTYyMTA_8c6bcb28-6911-4d53-bded-992140ffc65b"
      unitRef="usd">13000</us-gaap:InterestExpense>
    <us-gaap:InterestIncomeExpenseNonoperatingNet
      contextRef="i73f2057fe97d4f3a8524f987e78d1493_D20210101-20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzY2E5YmIwMTc5MjQ3NmZiYjIyNWU1ZDlkZWM4NjlmL3NlYzo5M2NhOWJiMDE3OTI0NzZmYmIyMjVlNWQ5ZGVjODY5Zl81NS9mcmFnOjk0NGQ2N2RjOTNmMjQ1MjliZTc4ZmNlMzRiOGMyZTBiL3RhYmxlOjA0NzkyNmRhYWViMzQxYWY4MzY2OWVhN2M4NjhiY2I0L3RhYmxlcmFuZ2U6MDQ3OTI2ZGFhZWIzNDFhZjgzNjY5ZWE3Yzg2OGJjYjRfMTEtMS0xLTEtMTYyMTA_25e7bd76-9379-47b0-b7c1-d66f217b4762"
      unitRef="usd">23000</us-gaap:InterestIncomeExpenseNonoperatingNet>
    <us-gaap:InterestIncomeExpenseNonoperatingNet
      contextRef="i9eea321560784f81a590aa8e3df3b187_D20210101-20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzY2E5YmIwMTc5MjQ3NmZiYjIyNWU1ZDlkZWM4NjlmL3NlYzo5M2NhOWJiMDE3OTI0NzZmYmIyMjVlNWQ5ZGVjODY5Zl81NS9mcmFnOjk0NGQ2N2RjOTNmMjQ1MjliZTc4ZmNlMzRiOGMyZTBiL3RhYmxlOjA0NzkyNmRhYWViMzQxYWY4MzY2OWVhN2M4NjhiY2I0L3RhYmxlcmFuZ2U6MDQ3OTI2ZGFhZWIzNDFhZjgzNjY5ZWE3Yzg2OGJjYjRfMTEtMy0xLTEtMTYyMTA_5261988c-fa8c-4bb6-a00a-13916f101ae6"
      unitRef="usd">4599000</us-gaap:InterestIncomeExpenseNonoperatingNet>
    <us-gaap:InterestIncomeExpenseNonoperatingNet
      contextRef="i5e244469383d46ddb452d43394f637d1_D20210101-20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzY2E5YmIwMTc5MjQ3NmZiYjIyNWU1ZDlkZWM4NjlmL3NlYzo5M2NhOWJiMDE3OTI0NzZmYmIyMjVlNWQ5ZGVjODY5Zl81NS9mcmFnOjk0NGQ2N2RjOTNmMjQ1MjliZTc4ZmNlMzRiOGMyZTBiL3RhYmxlOjA0NzkyNmRhYWViMzQxYWY4MzY2OWVhN2M4NjhiY2I0L3RhYmxlcmFuZ2U6MDQ3OTI2ZGFhZWIzNDFhZjgzNjY5ZWE3Yzg2OGJjYjRfMTEtNS0xLTEtMTYyMTA_4487f02f-99bc-435d-80e6-16a09ca2e01f"
      unitRef="usd">0</us-gaap:InterestIncomeExpenseNonoperatingNet>
    <us-gaap:InterestIncomeExpenseNonoperatingNet
      contextRef="i69782326f71a44e3805518280ee22b6b_D20210101-20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzY2E5YmIwMTc5MjQ3NmZiYjIyNWU1ZDlkZWM4NjlmL3NlYzo5M2NhOWJiMDE3OTI0NzZmYmIyMjVlNWQ5ZGVjODY5Zl81NS9mcmFnOjk0NGQ2N2RjOTNmMjQ1MjliZTc4ZmNlMzRiOGMyZTBiL3RhYmxlOjA0NzkyNmRhYWViMzQxYWY4MzY2OWVhN2M4NjhiY2I0L3RhYmxlcmFuZ2U6MDQ3OTI2ZGFhZWIzNDFhZjgzNjY5ZWE3Yzg2OGJjYjRfMTEtNy0xLTEtMTYyMTA_442372f7-f599-437d-b4e1-cc59a21344f5"
      unitRef="usd">4622000</us-gaap:InterestIncomeExpenseNonoperatingNet>
    <us-gaap:Assets
      contextRef="i1afe4ab017a94c08b0390d1c04588202_I20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzY2E5YmIwMTc5MjQ3NmZiYjIyNWU1ZDlkZWM4NjlmL3NlYzo5M2NhOWJiMDE3OTI0NzZmYmIyMjVlNWQ5ZGVjODY5Zl81NS9mcmFnOjk0NGQ2N2RjOTNmMjQ1MjliZTc4ZmNlMzRiOGMyZTBiL3RhYmxlOjA0NzkyNmRhYWViMzQxYWY4MzY2OWVhN2M4NjhiY2I0L3RhYmxlcmFuZ2U6MDQ3OTI2ZGFhZWIzNDFhZjgzNjY5ZWE3Yzg2OGJjYjRfMTMtMS0xLTEtMTg0NTY_ffce79d1-5da8-4f0f-b770-cc5a1cac2e8b"
      unitRef="usd">709956000</us-gaap:Assets>
    <us-gaap:Assets
      contextRef="i14c7d79dc30c40b9a6db30b130c667da_I20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzY2E5YmIwMTc5MjQ3NmZiYjIyNWU1ZDlkZWM4NjlmL3NlYzo5M2NhOWJiMDE3OTI0NzZmYmIyMjVlNWQ5ZGVjODY5Zl81NS9mcmFnOjk0NGQ2N2RjOTNmMjQ1MjliZTc4ZmNlMzRiOGMyZTBiL3RhYmxlOjA0NzkyNmRhYWViMzQxYWY4MzY2OWVhN2M4NjhiY2I0L3RhYmxlcmFuZ2U6MDQ3OTI2ZGFhZWIzNDFhZjgzNjY5ZWE3Yzg2OGJjYjRfMTMtMy0xLTEtMTg0NTY_25a89660-c625-46d7-aa85-98303a629f26"
      unitRef="usd">386805000</us-gaap:Assets>
    <us-gaap:Assets
      contextRef="i64489be55285421f8e92af4479a619e6_I20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzY2E5YmIwMTc5MjQ3NmZiYjIyNWU1ZDlkZWM4NjlmL3NlYzo5M2NhOWJiMDE3OTI0NzZmYmIyMjVlNWQ5ZGVjODY5Zl81NS9mcmFnOjk0NGQ2N2RjOTNmMjQ1MjliZTc4ZmNlMzRiOGMyZTBiL3RhYmxlOjA0NzkyNmRhYWViMzQxYWY4MzY2OWVhN2M4NjhiY2I0L3RhYmxlcmFuZ2U6MDQ3OTI2ZGFhZWIzNDFhZjgzNjY5ZWE3Yzg2OGJjYjRfMTMtNS0xLTEtMTg0NTY_3ec9931f-3f5f-4081-8806-84dddfb88904"
      unitRef="usd">741850000</us-gaap:Assets>
    <us-gaap:Assets
      contextRef="i225f85e38faa4bbdb4de1d8b9cf369bb_I20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzY2E5YmIwMTc5MjQ3NmZiYjIyNWU1ZDlkZWM4NjlmL3NlYzo5M2NhOWJiMDE3OTI0NzZmYmIyMjVlNWQ5ZGVjODY5Zl81NS9mcmFnOjk0NGQ2N2RjOTNmMjQ1MjliZTc4ZmNlMzRiOGMyZTBiL3RhYmxlOjA0NzkyNmRhYWViMzQxYWY4MzY2OWVhN2M4NjhiY2I0L3RhYmxlcmFuZ2U6MDQ3OTI2ZGFhZWIzNDFhZjgzNjY5ZWE3Yzg2OGJjYjRfMTMtNy0xLTEtMTg0NTY_dc23281b-91d7-4c8d-9741-2a5050f00e64"
      unitRef="usd">1838611000</us-gaap:Assets>
    <us-gaap:DepreciationAndAmortization
      contextRef="i73f2057fe97d4f3a8524f987e78d1493_D20210101-20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzY2E5YmIwMTc5MjQ3NmZiYjIyNWU1ZDlkZWM4NjlmL3NlYzo5M2NhOWJiMDE3OTI0NzZmYmIyMjVlNWQ5ZGVjODY5Zl81NS9mcmFnOjk0NGQ2N2RjOTNmMjQ1MjliZTc4ZmNlMzRiOGMyZTBiL3RhYmxlOjA0NzkyNmRhYWViMzQxYWY4MzY2OWVhN2M4NjhiY2I0L3RhYmxlcmFuZ2U6MDQ3OTI2ZGFhZWIzNDFhZjgzNjY5ZWE3Yzg2OGJjYjRfMTQtMS0xLTEtMTI5MQ_8d26312a-0efe-498f-8752-1f76b1c91ef2"
      unitRef="usd">139000</us-gaap:DepreciationAndAmortization>
    <us-gaap:DepreciationAndAmortization
      contextRef="i9eea321560784f81a590aa8e3df3b187_D20210101-20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzY2E5YmIwMTc5MjQ3NmZiYjIyNWU1ZDlkZWM4NjlmL3NlYzo5M2NhOWJiMDE3OTI0NzZmYmIyMjVlNWQ5ZGVjODY5Zl81NS9mcmFnOjk0NGQ2N2RjOTNmMjQ1MjliZTc4ZmNlMzRiOGMyZTBiL3RhYmxlOjA0NzkyNmRhYWViMzQxYWY4MzY2OWVhN2M4NjhiY2I0L3RhYmxlcmFuZ2U6MDQ3OTI2ZGFhZWIzNDFhZjgzNjY5ZWE3Yzg2OGJjYjRfMTQtMy0xLTEtMTI5MQ_b545d71c-55ca-4cb9-ac01-09f2325a9976"
      unitRef="usd">1639000</us-gaap:DepreciationAndAmortization>
    <us-gaap:DepreciationAndAmortization
      contextRef="i5e244469383d46ddb452d43394f637d1_D20210101-20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzY2E5YmIwMTc5MjQ3NmZiYjIyNWU1ZDlkZWM4NjlmL3NlYzo5M2NhOWJiMDE3OTI0NzZmYmIyMjVlNWQ5ZGVjODY5Zl81NS9mcmFnOjk0NGQ2N2RjOTNmMjQ1MjliZTc4ZmNlMzRiOGMyZTBiL3RhYmxlOjA0NzkyNmRhYWViMzQxYWY4MzY2OWVhN2M4NjhiY2I0L3RhYmxlcmFuZ2U6MDQ3OTI2ZGFhZWIzNDFhZjgzNjY5ZWE3Yzg2OGJjYjRfMTQtNS0xLTEtMTI5MQ_88d9511e-d31c-4508-bafb-a7701af8445a"
      unitRef="usd">0</us-gaap:DepreciationAndAmortization>
    <us-gaap:DepreciationAndAmortization
      contextRef="i69782326f71a44e3805518280ee22b6b_D20210101-20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzY2E5YmIwMTc5MjQ3NmZiYjIyNWU1ZDlkZWM4NjlmL3NlYzo5M2NhOWJiMDE3OTI0NzZmYmIyMjVlNWQ5ZGVjODY5Zl81NS9mcmFnOjk0NGQ2N2RjOTNmMjQ1MjliZTc4ZmNlMzRiOGMyZTBiL3RhYmxlOjA0NzkyNmRhYWViMzQxYWY4MzY2OWVhN2M4NjhiY2I0L3RhYmxlcmFuZ2U6MDQ3OTI2ZGFhZWIzNDFhZjgzNjY5ZWE3Yzg2OGJjYjRfMTMtNy0xLTEtMTU0NDA_438a74e0-7919-4016-a276-7dd3fc741e02"
      unitRef="usd">1778000</us-gaap:DepreciationAndAmortization>
    <us-gaap:OperatingLeaseRightOfUseAssetAmortizationExpense
      contextRef="i73f2057fe97d4f3a8524f987e78d1493_D20210101-20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzY2E5YmIwMTc5MjQ3NmZiYjIyNWU1ZDlkZWM4NjlmL3NlYzo5M2NhOWJiMDE3OTI0NzZmYmIyMjVlNWQ5ZGVjODY5Zl81NS9mcmFnOjk0NGQ2N2RjOTNmMjQ1MjliZTc4ZmNlMzRiOGMyZTBiL3RhYmxlOjA0NzkyNmRhYWViMzQxYWY4MzY2OWVhN2M4NjhiY2I0L3RhYmxlcmFuZ2U6MDQ3OTI2ZGFhZWIzNDFhZjgzNjY5ZWE3Yzg2OGJjYjRfMTUtMS0xLTEtMTI5NQ_a107479f-6e19-4929-a67c-2f047c4a6e5a"
      unitRef="usd">1741000</us-gaap:OperatingLeaseRightOfUseAssetAmortizationExpense>
    <us-gaap:OperatingLeaseRightOfUseAssetAmortizationExpense
      contextRef="i9eea321560784f81a590aa8e3df3b187_D20210101-20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzY2E5YmIwMTc5MjQ3NmZiYjIyNWU1ZDlkZWM4NjlmL3NlYzo5M2NhOWJiMDE3OTI0NzZmYmIyMjVlNWQ5ZGVjODY5Zl81NS9mcmFnOjk0NGQ2N2RjOTNmMjQ1MjliZTc4ZmNlMzRiOGMyZTBiL3RhYmxlOjA0NzkyNmRhYWViMzQxYWY4MzY2OWVhN2M4NjhiY2I0L3RhYmxlcmFuZ2U6MDQ3OTI2ZGFhZWIzNDFhZjgzNjY5ZWE3Yzg2OGJjYjRfMTUtMy0xLTEtMTI5NQ_88d753e4-60dc-4974-8e39-77f13b6009e0"
      unitRef="usd">0</us-gaap:OperatingLeaseRightOfUseAssetAmortizationExpense>
    <us-gaap:OperatingLeaseRightOfUseAssetAmortizationExpense
      contextRef="i5e244469383d46ddb452d43394f637d1_D20210101-20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzY2E5YmIwMTc5MjQ3NmZiYjIyNWU1ZDlkZWM4NjlmL3NlYzo5M2NhOWJiMDE3OTI0NzZmYmIyMjVlNWQ5ZGVjODY5Zl81NS9mcmFnOjk0NGQ2N2RjOTNmMjQ1MjliZTc4ZmNlMzRiOGMyZTBiL3RhYmxlOjA0NzkyNmRhYWViMzQxYWY4MzY2OWVhN2M4NjhiY2I0L3RhYmxlcmFuZ2U6MDQ3OTI2ZGFhZWIzNDFhZjgzNjY5ZWE3Yzg2OGJjYjRfMTUtNS0xLTEtMTI5NQ_11e4b365-9bcf-4f37-a943-43ae60518ad8"
      unitRef="usd">0</us-gaap:OperatingLeaseRightOfUseAssetAmortizationExpense>
    <us-gaap:OperatingLeaseRightOfUseAssetAmortizationExpense
      contextRef="i69782326f71a44e3805518280ee22b6b_D20210101-20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzY2E5YmIwMTc5MjQ3NmZiYjIyNWU1ZDlkZWM4NjlmL3NlYzo5M2NhOWJiMDE3OTI0NzZmYmIyMjVlNWQ5ZGVjODY5Zl81NS9mcmFnOjk0NGQ2N2RjOTNmMjQ1MjliZTc4ZmNlMzRiOGMyZTBiL3RhYmxlOjA0NzkyNmRhYWViMzQxYWY4MzY2OWVhN2M4NjhiY2I0L3RhYmxlcmFuZ2U6MDQ3OTI2ZGFhZWIzNDFhZjgzNjY5ZWE3Yzg2OGJjYjRfMTQtNy0xLTEtMTYyMTk_bd1f6e9c-393c-4a21-95ab-5dc6ab9b9fc1"
      unitRef="usd">1741000</us-gaap:OperatingLeaseRightOfUseAssetAmortizationExpense>
    <cron:AdjustedEarningsBeforeInterestTaxesDepreciationAndAmortization
      contextRef="i73f2057fe97d4f3a8524f987e78d1493_D20210101-20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzY2E5YmIwMTc5MjQ3NmZiYjIyNWU1ZDlkZWM4NjlmL3NlYzo5M2NhOWJiMDE3OTI0NzZmYmIyMjVlNWQ5ZGVjODY5Zl81NS9mcmFnOjk0NGQ2N2RjOTNmMjQ1MjliZTc4ZmNlMzRiOGMyZTBiL3RhYmxlOjA0NzkyNmRhYWViMzQxYWY4MzY2OWVhN2M4NjhiY2I0L3RhYmxlcmFuZ2U6MDQ3OTI2ZGFhZWIzNDFhZjgzNjY5ZWE3Yzg2OGJjYjRfMTctMS0xLTEtMTI5OQ_6a9b45d4-cc00-440d-9bbb-a20cff8cc73f"
      unitRef="usd">-20221000</cron:AdjustedEarningsBeforeInterestTaxesDepreciationAndAmortization>
    <cron:AdjustedEarningsBeforeInterestTaxesDepreciationAndAmortization
      contextRef="i9eea321560784f81a590aa8e3df3b187_D20210101-20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzY2E5YmIwMTc5MjQ3NmZiYjIyNWU1ZDlkZWM4NjlmL3NlYzo5M2NhOWJiMDE3OTI0NzZmYmIyMjVlNWQ5ZGVjODY5Zl81NS9mcmFnOjk0NGQ2N2RjOTNmMjQ1MjliZTc4ZmNlMzRiOGMyZTBiL3RhYmxlOjA0NzkyNmRhYWViMzQxYWY4MzY2OWVhN2M4NjhiY2I0L3RhYmxlcmFuZ2U6MDQ3OTI2ZGFhZWIzNDFhZjgzNjY5ZWE3Yzg2OGJjYjRfMTctMy0xLTEtMTI5OQ_746ee244-5d26-4b27-8a37-d5fcbeceb8b2"
      unitRef="usd">-54789000</cron:AdjustedEarningsBeforeInterestTaxesDepreciationAndAmortization>
    <cron:AdjustedEarningsBeforeInterestTaxesDepreciationAndAmortization
      contextRef="i5e244469383d46ddb452d43394f637d1_D20210101-20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzY2E5YmIwMTc5MjQ3NmZiYjIyNWU1ZDlkZWM4NjlmL3NlYzo5M2NhOWJiMDE3OTI0NzZmYmIyMjVlNWQ5ZGVjODY5Zl81NS9mcmFnOjk0NGQ2N2RjOTNmMjQ1MjliZTc4ZmNlMzRiOGMyZTBiL3RhYmxlOjA0NzkyNmRhYWViMzQxYWY4MzY2OWVhN2M4NjhiY2I0L3RhYmxlcmFuZ2U6MDQ3OTI2ZGFhZWIzNDFhZjgzNjY5ZWE3Yzg2OGJjYjRfMTctNS0xLTEtMTI5OQ_f4c4c635-51e0-45df-8ee6-eea33178ad48"
      unitRef="usd">-11323000</cron:AdjustedEarningsBeforeInterestTaxesDepreciationAndAmortization>
    <cron:AdjustedEarningsBeforeInterestTaxesDepreciationAndAmortization
      contextRef="i69782326f71a44e3805518280ee22b6b_D20210101-20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzY2E5YmIwMTc5MjQ3NmZiYjIyNWU1ZDlkZWM4NjlmL3NlYzo5M2NhOWJiMDE3OTI0NzZmYmIyMjVlNWQ5ZGVjODY5Zl81NS9mcmFnOjk0NGQ2N2RjOTNmMjQ1MjliZTc4ZmNlMzRiOGMyZTBiL3RhYmxlOjA0NzkyNmRhYWViMzQxYWY4MzY2OWVhN2M4NjhiY2I0L3RhYmxlcmFuZ2U6MDQ3OTI2ZGFhZWIzNDFhZjgzNjY5ZWE3Yzg2OGJjYjRfMTYtNy0xLTEtMTYyMjE_38592921-8220-4539-8f04-672997a4687b"
      unitRef="usd">-86333000</cron:AdjustedEarningsBeforeInterestTaxesDepreciationAndAmortization>
    <us-gaap:PropertyPlantAndEquipmentAdditions
      contextRef="i73f2057fe97d4f3a8524f987e78d1493_D20210101-20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzY2E5YmIwMTc5MjQ3NmZiYjIyNWU1ZDlkZWM4NjlmL3NlYzo5M2NhOWJiMDE3OTI0NzZmYmIyMjVlNWQ5ZGVjODY5Zl81NS9mcmFnOjk0NGQ2N2RjOTNmMjQ1MjliZTc4ZmNlMzRiOGMyZTBiL3RhYmxlOjA0NzkyNmRhYWViMzQxYWY4MzY2OWVhN2M4NjhiY2I0L3RhYmxlcmFuZ2U6MDQ3OTI2ZGFhZWIzNDFhZjgzNjY5ZWE3Yzg2OGJjYjRfMjItMS0xLTEtMTMxMQ_96db76de-a4b7-44e6-888e-07de528185f5"
      unitRef="usd">319000</us-gaap:PropertyPlantAndEquipmentAdditions>
    <us-gaap:PropertyPlantAndEquipmentAdditions
      contextRef="i9eea321560784f81a590aa8e3df3b187_D20210101-20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzY2E5YmIwMTc5MjQ3NmZiYjIyNWU1ZDlkZWM4NjlmL3NlYzo5M2NhOWJiMDE3OTI0NzZmYmIyMjVlNWQ5ZGVjODY5Zl81NS9mcmFnOjk0NGQ2N2RjOTNmMjQ1MjliZTc4ZmNlMzRiOGMyZTBiL3RhYmxlOjA0NzkyNmRhYWViMzQxYWY4MzY2OWVhN2M4NjhiY2I0L3RhYmxlcmFuZ2U6MDQ3OTI2ZGFhZWIzNDFhZjgzNjY5ZWE3Yzg2OGJjYjRfMjItMy0xLTEtMTMxMQ_d352ed4b-e578-49e9-86f3-98d3d660f07e"
      unitRef="usd">8028000</us-gaap:PropertyPlantAndEquipmentAdditions>
    <us-gaap:PropertyPlantAndEquipmentAdditions
      contextRef="i5e244469383d46ddb452d43394f637d1_D20210101-20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzY2E5YmIwMTc5MjQ3NmZiYjIyNWU1ZDlkZWM4NjlmL3NlYzo5M2NhOWJiMDE3OTI0NzZmYmIyMjVlNWQ5ZGVjODY5Zl81NS9mcmFnOjk0NGQ2N2RjOTNmMjQ1MjliZTc4ZmNlMzRiOGMyZTBiL3RhYmxlOjA0NzkyNmRhYWViMzQxYWY4MzY2OWVhN2M4NjhiY2I0L3RhYmxlcmFuZ2U6MDQ3OTI2ZGFhZWIzNDFhZjgzNjY5ZWE3Yzg2OGJjYjRfMjItNS0xLTEtMTMxMQ_e09f5751-c288-46a8-9b76-d0054cf090ff"
      unitRef="usd">0</us-gaap:PropertyPlantAndEquipmentAdditions>
    <us-gaap:PropertyPlantAndEquipmentAdditions
      contextRef="i69782326f71a44e3805518280ee22b6b_D20210101-20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzY2E5YmIwMTc5MjQ3NmZiYjIyNWU1ZDlkZWM4NjlmL3NlYzo5M2NhOWJiMDE3OTI0NzZmYmIyMjVlNWQ5ZGVjODY5Zl81NS9mcmFnOjk0NGQ2N2RjOTNmMjQ1MjliZTc4ZmNlMzRiOGMyZTBiL3RhYmxlOjA0NzkyNmRhYWViMzQxYWY4MzY2OWVhN2M4NjhiY2I0L3RhYmxlcmFuZ2U6MDQ3OTI2ZGFhZWIzNDFhZjgzNjY5ZWE3Yzg2OGJjYjRfMTctNy0xLTEtMTczNzU_2de3bd09-8d84-4b08-a1d9-95116abca677"
      unitRef="usd">8347000</us-gaap:PropertyPlantAndEquipmentAdditions>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="ib6c371f673124f889fe33d8feafa376a_D20200101-20200630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzY2E5YmIwMTc5MjQ3NmZiYjIyNWU1ZDlkZWM4NjlmL3NlYzo5M2NhOWJiMDE3OTI0NzZmYmIyMjVlNWQ5ZGVjODY5Zl81NS9mcmFnOjk0NGQ2N2RjOTNmMjQ1MjliZTc4ZmNlMzRiOGMyZTBiL3RhYmxlOjhjMmVjZjQ0MTM3MTQ4MzI4MDE3YTEwMzNhZjE3MjY4L3RhYmxlcmFuZ2U6OGMyZWNmNDQxMzcxNDgzMjgwMTdhMTAzM2FmMTcyNjhfMy0xLTEtMS0w_4aae2141-ae9e-40a4-91d5-2fdfa4cefe11"
      unitRef="usd">0</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i058566bd4b4941cfb44bfaea27053d23_D20200101-20200630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzY2E5YmIwMTc5MjQ3NmZiYjIyNWU1ZDlkZWM4NjlmL3NlYzo5M2NhOWJiMDE3OTI0NzZmYmIyMjVlNWQ5ZGVjODY5Zl81NS9mcmFnOjk0NGQ2N2RjOTNmMjQ1MjliZTc4ZmNlMzRiOGMyZTBiL3RhYmxlOjhjMmVjZjQ0MTM3MTQ4MzI4MDE3YTEwMzNhZjE3MjY4L3RhYmxlcmFuZ2U6OGMyZWNmNDQxMzcxNDgzMjgwMTdhMTAzM2FmMTcyNjhfMy0zLTEtMS0w_e4ac74cc-2f54-4c6b-b6ff-124c957bd8c6"
      unitRef="usd">8415000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="ib8262672cddb43529f39e6554b306595_D20200101-20200630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzY2E5YmIwMTc5MjQ3NmZiYjIyNWU1ZDlkZWM4NjlmL3NlYzo5M2NhOWJiMDE3OTI0NzZmYmIyMjVlNWQ5ZGVjODY5Zl81NS9mcmFnOjk0NGQ2N2RjOTNmMjQ1MjliZTc4ZmNlMzRiOGMyZTBiL3RhYmxlOjhjMmVjZjQ0MTM3MTQ4MzI4MDE3YTEwMzNhZjE3MjY4L3RhYmxlcmFuZ2U6OGMyZWNmNDQxMzcxNDgzMjgwMTdhMTAzM2FmMTcyNjhfMy01LTEtMS0w_d290110c-4571-479f-bdd3-d577a7359c13"
      unitRef="usd">0</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i4e842f8ace2f420eabc848a65486b991_D20200101-20200630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzY2E5YmIwMTc5MjQ3NmZiYjIyNWU1ZDlkZWM4NjlmL3NlYzo5M2NhOWJiMDE3OTI0NzZmYmIyMjVlNWQ5ZGVjODY5Zl81NS9mcmFnOjk0NGQ2N2RjOTNmMjQ1MjliZTc4ZmNlMzRiOGMyZTBiL3RhYmxlOjhjMmVjZjQ0MTM3MTQ4MzI4MDE3YTEwMzNhZjE3MjY4L3RhYmxlcmFuZ2U6OGMyZWNmNDQxMzcxNDgzMjgwMTdhMTAzM2FmMTcyNjhfMy03LTEtMS0w_5f5b7991-fa0f-46b8-8cbc-c071554fc4c4"
      unitRef="usd">8415000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i1508a4a4053d4dd08a6db69f6c1e840b_D20200101-20200630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzY2E5YmIwMTc5MjQ3NmZiYjIyNWU1ZDlkZWM4NjlmL3NlYzo5M2NhOWJiMDE3OTI0NzZmYmIyMjVlNWQ5ZGVjODY5Zl81NS9mcmFnOjk0NGQ2N2RjOTNmMjQ1MjliZTc4ZmNlMzRiOGMyZTBiL3RhYmxlOjhjMmVjZjQ0MTM3MTQ4MzI4MDE3YTEwMzNhZjE3MjY4L3RhYmxlcmFuZ2U6OGMyZWNmNDQxMzcxNDgzMjgwMTdhMTAzM2FmMTcyNjhfNC0xLTEtMS0w_92c485a7-0997-4286-b4e4-1877d02883c3"
      unitRef="usd">4350000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i08837b8da47246b3a38247a1afce6246_D20200101-20200630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzY2E5YmIwMTc5MjQ3NmZiYjIyNWU1ZDlkZWM4NjlmL3NlYzo5M2NhOWJiMDE3OTI0NzZmYmIyMjVlNWQ5ZGVjODY5Zl81NS9mcmFnOjk0NGQ2N2RjOTNmMjQ1MjliZTc4ZmNlMzRiOGMyZTBiL3RhYmxlOjhjMmVjZjQ0MTM3MTQ4MzI4MDE3YTEwMzNhZjE3MjY4L3RhYmxlcmFuZ2U6OGMyZWNmNDQxMzcxNDgzMjgwMTdhMTAzM2FmMTcyNjhfNC0zLTEtMS0w_3c6aafd8-3125-497a-b5e6-ee14b46e0c7e"
      unitRef="usd">5317000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i514785787edd460fb909104cd7dc4a04_D20200101-20200630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzY2E5YmIwMTc5MjQ3NmZiYjIyNWU1ZDlkZWM4NjlmL3NlYzo5M2NhOWJiMDE3OTI0NzZmYmIyMjVlNWQ5ZGVjODY5Zl81NS9mcmFnOjk0NGQ2N2RjOTNmMjQ1MjliZTc4ZmNlMzRiOGMyZTBiL3RhYmxlOjhjMmVjZjQ0MTM3MTQ4MzI4MDE3YTEwMzNhZjE3MjY4L3RhYmxlcmFuZ2U6OGMyZWNmNDQxMzcxNDgzMjgwMTdhMTAzM2FmMTcyNjhfNC01LTEtMS0w_cd704c4c-5eeb-4a50-9570-4d5ac9b26078"
      unitRef="usd">0</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="if253a5adac88412093cd3c8f27aa185f_D20200101-20200630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzY2E5YmIwMTc5MjQ3NmZiYjIyNWU1ZDlkZWM4NjlmL3NlYzo5M2NhOWJiMDE3OTI0NzZmYmIyMjVlNWQ5ZGVjODY5Zl81NS9mcmFnOjk0NGQ2N2RjOTNmMjQ1MjliZTc4ZmNlMzRiOGMyZTBiL3RhYmxlOjhjMmVjZjQ0MTM3MTQ4MzI4MDE3YTEwMzNhZjE3MjY4L3RhYmxlcmFuZ2U6OGMyZWNmNDQxMzcxNDgzMjgwMTdhMTAzM2FmMTcyNjhfNC03LTEtMS0w_3c4f2481-2e7c-40d6-a14e-aac182750ee7"
      unitRef="usd">9667000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i9f4c7e46c3d34f5aa34d2e09db3380cf_D20200101-20200630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzY2E5YmIwMTc5MjQ3NmZiYjIyNWU1ZDlkZWM4NjlmL3NlYzo5M2NhOWJiMDE3OTI0NzZmYmIyMjVlNWQ5ZGVjODY5Zl81NS9mcmFnOjk0NGQ2N2RjOTNmMjQ1MjliZTc4ZmNlMzRiOGMyZTBiL3RhYmxlOjhjMmVjZjQ0MTM3MTQ4MzI4MDE3YTEwMzNhZjE3MjY4L3RhYmxlcmFuZ2U6OGMyZWNmNDQxMzcxNDgzMjgwMTdhMTAzM2FmMTcyNjhfNS0xLTEtMS0w_4c9f5f61-87ed-49cd-aee4-956a6261a4ba"
      unitRef="usd">0</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i943cc5b8191b493f8aa9ee910e58ea43_D20200101-20200630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzY2E5YmIwMTc5MjQ3NmZiYjIyNWU1ZDlkZWM4NjlmL3NlYzo5M2NhOWJiMDE3OTI0NzZmYmIyMjVlNWQ5ZGVjODY5Zl81NS9mcmFnOjk0NGQ2N2RjOTNmMjQ1MjliZTc4ZmNlMzRiOGMyZTBiL3RhYmxlOjhjMmVjZjQ0MTM3MTQ4MzI4MDE3YTEwMzNhZjE3MjY4L3RhYmxlcmFuZ2U6OGMyZWNmNDQxMzcxNDgzMjgwMTdhMTAzM2FmMTcyNjhfNS0zLTEtMS0w_1ce7e4b1-f14b-421f-b697-4628d704b35c"
      unitRef="usd">233000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i42b8c121915c4f34996c473e36cccd8d_D20200101-20200630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzY2E5YmIwMTc5MjQ3NmZiYjIyNWU1ZDlkZWM4NjlmL3NlYzo5M2NhOWJiMDE3OTI0NzZmYmIyMjVlNWQ5ZGVjODY5Zl81NS9mcmFnOjk0NGQ2N2RjOTNmMjQ1MjliZTc4ZmNlMzRiOGMyZTBiL3RhYmxlOjhjMmVjZjQ0MTM3MTQ4MzI4MDE3YTEwMzNhZjE3MjY4L3RhYmxlcmFuZ2U6OGMyZWNmNDQxMzcxNDgzMjgwMTdhMTAzM2FmMTcyNjhfNS01LTEtMS0w_a1b9b441-5a87-42a7-94dc-fb417a3295f3"
      unitRef="usd">0</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i24f9699a302b4e86895a7c9098da3221_D20200101-20200630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzY2E5YmIwMTc5MjQ3NmZiYjIyNWU1ZDlkZWM4NjlmL3NlYzo5M2NhOWJiMDE3OTI0NzZmYmIyMjVlNWQ5ZGVjODY5Zl81NS9mcmFnOjk0NGQ2N2RjOTNmMjQ1MjliZTc4ZmNlMzRiOGMyZTBiL3RhYmxlOjhjMmVjZjQ0MTM3MTQ4MzI4MDE3YTEwMzNhZjE3MjY4L3RhYmxlcmFuZ2U6OGMyZWNmNDQxMzcxNDgzMjgwMTdhMTAzM2FmMTcyNjhfNS03LTEtMS0w_485c6f64-29f6-4090-b949-8909282b120a"
      unitRef="usd">233000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="iab9b56b2a03f4c6199d282bd8676a924_D20200101-20200630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzY2E5YmIwMTc5MjQ3NmZiYjIyNWU1ZDlkZWM4NjlmL3NlYzo5M2NhOWJiMDE3OTI0NzZmYmIyMjVlNWQ5ZGVjODY5Zl81NS9mcmFnOjk0NGQ2N2RjOTNmMjQ1MjliZTc4ZmNlMzRiOGMyZTBiL3RhYmxlOjhjMmVjZjQ0MTM3MTQ4MzI4MDE3YTEwMzNhZjE3MjY4L3RhYmxlcmFuZ2U6OGMyZWNmNDQxMzcxNDgzMjgwMTdhMTAzM2FmMTcyNjhfNi0xLTEtMS0w_0c854099-25cf-453a-9d34-29a8a65a8892"
      unitRef="usd">4350000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i13788f202c86441fa347b97f3162a453_D20200101-20200630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzY2E5YmIwMTc5MjQ3NmZiYjIyNWU1ZDlkZWM4NjlmL3NlYzo5M2NhOWJiMDE3OTI0NzZmYmIyMjVlNWQ5ZGVjODY5Zl81NS9mcmFnOjk0NGQ2N2RjOTNmMjQ1MjliZTc4ZmNlMzRiOGMyZTBiL3RhYmxlOjhjMmVjZjQ0MTM3MTQ4MzI4MDE3YTEwMzNhZjE3MjY4L3RhYmxlcmFuZ2U6OGMyZWNmNDQxMzcxNDgzMjgwMTdhMTAzM2FmMTcyNjhfNi0zLTEtMS0w_372e6528-17d4-4d9b-9baf-b9bb91b853f6"
      unitRef="usd">13965000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="iaf98f9473a3d428f9aab9f72e135866f_D20200101-20200630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzY2E5YmIwMTc5MjQ3NmZiYjIyNWU1ZDlkZWM4NjlmL3NlYzo5M2NhOWJiMDE3OTI0NzZmYmIyMjVlNWQ5ZGVjODY5Zl81NS9mcmFnOjk0NGQ2N2RjOTNmMjQ1MjliZTc4ZmNlMzRiOGMyZTBiL3RhYmxlOjhjMmVjZjQ0MTM3MTQ4MzI4MDE3YTEwMzNhZjE3MjY4L3RhYmxlcmFuZ2U6OGMyZWNmNDQxMzcxNDgzMjgwMTdhMTAzM2FmMTcyNjhfNi01LTEtMS0w_75afa57b-7b82-486f-8272-610d60c40a21"
      unitRef="usd">0</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i4a110e4972ef4113880ce582e3cda5c5_D20200101-20200630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzY2E5YmIwMTc5MjQ3NmZiYjIyNWU1ZDlkZWM4NjlmL3NlYzo5M2NhOWJiMDE3OTI0NzZmYmIyMjVlNWQ5ZGVjODY5Zl81NS9mcmFnOjk0NGQ2N2RjOTNmMjQ1MjliZTc4ZmNlMzRiOGMyZTBiL3RhYmxlOjhjMmVjZjQ0MTM3MTQ4MzI4MDE3YTEwMzNhZjE3MjY4L3RhYmxlcmFuZ2U6OGMyZWNmNDQxMzcxNDgzMjgwMTdhMTAzM2FmMTcyNjhfNi03LTEtMS0w_173187a3-4df6-40ff-8fd3-a07deb6a8904"
      unitRef="usd">18315000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:IncomeLossFromEquityMethodInvestments
      contextRef="iab9b56b2a03f4c6199d282bd8676a924_D20200101-20200630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzY2E5YmIwMTc5MjQ3NmZiYjIyNWU1ZDlkZWM4NjlmL3NlYzo5M2NhOWJiMDE3OTI0NzZmYmIyMjVlNWQ5ZGVjODY5Zl81NS9mcmFnOjk0NGQ2N2RjOTNmMjQ1MjliZTc4ZmNlMzRiOGMyZTBiL3RhYmxlOjhjMmVjZjQ0MTM3MTQ4MzI4MDE3YTEwMzNhZjE3MjY4L3RhYmxlcmFuZ2U6OGMyZWNmNDQxMzcxNDgzMjgwMTdhMTAzM2FmMTcyNjhfOC0xLTEtMS0w_1c99ea07-612c-42c8-9db8-d9725189b552"
      unitRef="usd">0</us-gaap:IncomeLossFromEquityMethodInvestments>
    <us-gaap:IncomeLossFromEquityMethodInvestments
      contextRef="i13788f202c86441fa347b97f3162a453_D20200101-20200630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzY2E5YmIwMTc5MjQ3NmZiYjIyNWU1ZDlkZWM4NjlmL3NlYzo5M2NhOWJiMDE3OTI0NzZmYmIyMjVlNWQ5ZGVjODY5Zl81NS9mcmFnOjk0NGQ2N2RjOTNmMjQ1MjliZTc4ZmNlMzRiOGMyZTBiL3RhYmxlOjhjMmVjZjQ0MTM3MTQ4MzI4MDE3YTEwMzNhZjE3MjY4L3RhYmxlcmFuZ2U6OGMyZWNmNDQxMzcxNDgzMjgwMTdhMTAzM2FmMTcyNjhfOC0zLTEtMS0w_18b82a3b-04c0-4156-a9d1-2043fb8d628b"
      unitRef="usd">-1966000</us-gaap:IncomeLossFromEquityMethodInvestments>
    <us-gaap:IncomeLossFromEquityMethodInvestments
      contextRef="iaf98f9473a3d428f9aab9f72e135866f_D20200101-20200630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzY2E5YmIwMTc5MjQ3NmZiYjIyNWU1ZDlkZWM4NjlmL3NlYzo5M2NhOWJiMDE3OTI0NzZmYmIyMjVlNWQ5ZGVjODY5Zl81NS9mcmFnOjk0NGQ2N2RjOTNmMjQ1MjliZTc4ZmNlMzRiOGMyZTBiL3RhYmxlOjhjMmVjZjQ0MTM3MTQ4MzI4MDE3YTEwMzNhZjE3MjY4L3RhYmxlcmFuZ2U6OGMyZWNmNDQxMzcxNDgzMjgwMTdhMTAzM2FmMTcyNjhfOC01LTEtMS0w_3326b8f4-8bc8-42f7-842e-9d24e3d9067a"
      unitRef="usd">0</us-gaap:IncomeLossFromEquityMethodInvestments>
    <us-gaap:IncomeLossFromEquityMethodInvestments
      contextRef="i4a110e4972ef4113880ce582e3cda5c5_D20200101-20200630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzY2E5YmIwMTc5MjQ3NmZiYjIyNWU1ZDlkZWM4NjlmL3NlYzo5M2NhOWJiMDE3OTI0NzZmYmIyMjVlNWQ5ZGVjODY5Zl81NS9mcmFnOjk0NGQ2N2RjOTNmMjQ1MjliZTc4ZmNlMzRiOGMyZTBiL3RhYmxlOjhjMmVjZjQ0MTM3MTQ4MzI4MDE3YTEwMzNhZjE3MjY4L3RhYmxlcmFuZ2U6OGMyZWNmNDQxMzcxNDgzMjgwMTdhMTAzM2FmMTcyNjhfOC03LTEtMS0w_f0a43b54-f378-4519-902a-d5cf4fea6e24"
      unitRef="usd">-1966000</us-gaap:IncomeLossFromEquityMethodInvestments>
    <us-gaap:InvestmentIncomeInterest
      contextRef="iab9b56b2a03f4c6199d282bd8676a924_D20200101-20200630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzY2E5YmIwMTc5MjQ3NmZiYjIyNWU1ZDlkZWM4NjlmL3NlYzo5M2NhOWJiMDE3OTI0NzZmYmIyMjVlNWQ5ZGVjODY5Zl81NS9mcmFnOjk0NGQ2N2RjOTNmMjQ1MjliZTc4ZmNlMzRiOGMyZTBiL3RhYmxlOjhjMmVjZjQ0MTM3MTQ4MzI4MDE3YTEwMzNhZjE3MjY4L3RhYmxlcmFuZ2U6OGMyZWNmNDQxMzcxNDgzMjgwMTdhMTAzM2FmMTcyNjhfMTAtMS0xLTEtMA_d002bc93-e4e9-445f-b77c-04d9e60821d8"
      unitRef="usd">16000</us-gaap:InvestmentIncomeInterest>
    <us-gaap:InvestmentIncomeInterest
      contextRef="i13788f202c86441fa347b97f3162a453_D20200101-20200630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzY2E5YmIwMTc5MjQ3NmZiYjIyNWU1ZDlkZWM4NjlmL3NlYzo5M2NhOWJiMDE3OTI0NzZmYmIyMjVlNWQ5ZGVjODY5Zl81NS9mcmFnOjk0NGQ2N2RjOTNmMjQ1MjliZTc4ZmNlMzRiOGMyZTBiL3RhYmxlOjhjMmVjZjQ0MTM3MTQ4MzI4MDE3YTEwMzNhZjE3MjY4L3RhYmxlcmFuZ2U6OGMyZWNmNDQxMzcxNDgzMjgwMTdhMTAzM2FmMTcyNjhfMTAtMy0xLTEtMA_96356487-dd06-490a-9f5e-1c979da06c2c"
      unitRef="usd">11559000</us-gaap:InvestmentIncomeInterest>
    <us-gaap:InvestmentIncomeInterest
      contextRef="iaf98f9473a3d428f9aab9f72e135866f_D20200101-20200630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzY2E5YmIwMTc5MjQ3NmZiYjIyNWU1ZDlkZWM4NjlmL3NlYzo5M2NhOWJiMDE3OTI0NzZmYmIyMjVlNWQ5ZGVjODY5Zl81NS9mcmFnOjk0NGQ2N2RjOTNmMjQ1MjliZTc4ZmNlMzRiOGMyZTBiL3RhYmxlOjhjMmVjZjQ0MTM3MTQ4MzI4MDE3YTEwMzNhZjE3MjY4L3RhYmxlcmFuZ2U6OGMyZWNmNDQxMzcxNDgzMjgwMTdhMTAzM2FmMTcyNjhfMTAtNS0xLTEtMA_bb114d4e-28cf-4668-8a4a-2a7747fd3321"
      unitRef="usd">0</us-gaap:InvestmentIncomeInterest>
    <us-gaap:InvestmentIncomeInterest
      contextRef="i4a110e4972ef4113880ce582e3cda5c5_D20200101-20200630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzY2E5YmIwMTc5MjQ3NmZiYjIyNWU1ZDlkZWM4NjlmL3NlYzo5M2NhOWJiMDE3OTI0NzZmYmIyMjVlNWQ5ZGVjODY5Zl81NS9mcmFnOjk0NGQ2N2RjOTNmMjQ1MjliZTc4ZmNlMzRiOGMyZTBiL3RhYmxlOjhjMmVjZjQ0MTM3MTQ4MzI4MDE3YTEwMzNhZjE3MjY4L3RhYmxlcmFuZ2U6OGMyZWNmNDQxMzcxNDgzMjgwMTdhMTAzM2FmMTcyNjhfMTAtNy0xLTEtMA_c4f40852-4587-4247-aaaa-cf5f0c2f4c7c"
      unitRef="usd">11575000</us-gaap:InvestmentIncomeInterest>
    <us-gaap:InterestExpense
      contextRef="iab9b56b2a03f4c6199d282bd8676a924_D20200101-20200630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzY2E5YmIwMTc5MjQ3NmZiYjIyNWU1ZDlkZWM4NjlmL3NlYzo5M2NhOWJiMDE3OTI0NzZmYmIyMjVlNWQ5ZGVjODY5Zl81NS9mcmFnOjk0NGQ2N2RjOTNmMjQ1MjliZTc4ZmNlMzRiOGMyZTBiL3RhYmxlOjhjMmVjZjQ0MTM3MTQ4MzI4MDE3YTEwMzNhZjE3MjY4L3RhYmxlcmFuZ2U6OGMyZWNmNDQxMzcxNDgzMjgwMTdhMTAzM2FmMTcyNjhfMTEtMS0xLTEtMA_6ec94f43-6bd4-442f-b06c-58b5a05fe3b7"
      unitRef="usd">0</us-gaap:InterestExpense>
    <us-gaap:InterestExpense
      contextRef="i13788f202c86441fa347b97f3162a453_D20200101-20200630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzY2E5YmIwMTc5MjQ3NmZiYjIyNWU1ZDlkZWM4NjlmL3NlYzo5M2NhOWJiMDE3OTI0NzZmYmIyMjVlNWQ5ZGVjODY5Zl81NS9mcmFnOjk0NGQ2N2RjOTNmMjQ1MjliZTc4ZmNlMzRiOGMyZTBiL3RhYmxlOjhjMmVjZjQ0MTM3MTQ4MzI4MDE3YTEwMzNhZjE3MjY4L3RhYmxlcmFuZ2U6OGMyZWNmNDQxMzcxNDgzMjgwMTdhMTAzM2FmMTcyNjhfMTEtMy0xLTEtMA_6074cf46-fd17-4344-891c-1b6cc31a3b5e"
      unitRef="usd">90000</us-gaap:InterestExpense>
    <us-gaap:InterestExpense
      contextRef="iaf98f9473a3d428f9aab9f72e135866f_D20200101-20200630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzY2E5YmIwMTc5MjQ3NmZiYjIyNWU1ZDlkZWM4NjlmL3NlYzo5M2NhOWJiMDE3OTI0NzZmYmIyMjVlNWQ5ZGVjODY5Zl81NS9mcmFnOjk0NGQ2N2RjOTNmMjQ1MjliZTc4ZmNlMzRiOGMyZTBiL3RhYmxlOjhjMmVjZjQ0MTM3MTQ4MzI4MDE3YTEwMzNhZjE3MjY4L3RhYmxlcmFuZ2U6OGMyZWNmNDQxMzcxNDgzMjgwMTdhMTAzM2FmMTcyNjhfMTEtNS0xLTEtMA_32b06b76-65e3-4d6d-8b03-5601f187f8e6"
      unitRef="usd">0</us-gaap:InterestExpense>
    <us-gaap:InterestExpense
      contextRef="i4a110e4972ef4113880ce582e3cda5c5_D20200101-20200630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzY2E5YmIwMTc5MjQ3NmZiYjIyNWU1ZDlkZWM4NjlmL3NlYzo5M2NhOWJiMDE3OTI0NzZmYmIyMjVlNWQ5ZGVjODY5Zl81NS9mcmFnOjk0NGQ2N2RjOTNmMjQ1MjliZTc4ZmNlMzRiOGMyZTBiL3RhYmxlOjhjMmVjZjQ0MTM3MTQ4MzI4MDE3YTEwMzNhZjE3MjY4L3RhYmxlcmFuZ2U6OGMyZWNmNDQxMzcxNDgzMjgwMTdhMTAzM2FmMTcyNjhfMTEtNy0xLTEtMA_757b439f-423a-419e-a167-e7b48dff7cbe"
      unitRef="usd">90000</us-gaap:InterestExpense>
    <us-gaap:InterestIncomeExpenseNonoperatingNet
      contextRef="iab9b56b2a03f4c6199d282bd8676a924_D20200101-20200630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzY2E5YmIwMTc5MjQ3NmZiYjIyNWU1ZDlkZWM4NjlmL3NlYzo5M2NhOWJiMDE3OTI0NzZmYmIyMjVlNWQ5ZGVjODY5Zl81NS9mcmFnOjk0NGQ2N2RjOTNmMjQ1MjliZTc4ZmNlMzRiOGMyZTBiL3RhYmxlOjhjMmVjZjQ0MTM3MTQ4MzI4MDE3YTEwMzNhZjE3MjY4L3RhYmxlcmFuZ2U6OGMyZWNmNDQxMzcxNDgzMjgwMTdhMTAzM2FmMTcyNjhfMTItMS0xLTEtMA_2f1bcff9-e2a9-415a-8d3f-b0d0f5a569a4"
      unitRef="usd">16000</us-gaap:InterestIncomeExpenseNonoperatingNet>
    <us-gaap:InterestIncomeExpenseNonoperatingNet
      contextRef="i13788f202c86441fa347b97f3162a453_D20200101-20200630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzY2E5YmIwMTc5MjQ3NmZiYjIyNWU1ZDlkZWM4NjlmL3NlYzo5M2NhOWJiMDE3OTI0NzZmYmIyMjVlNWQ5ZGVjODY5Zl81NS9mcmFnOjk0NGQ2N2RjOTNmMjQ1MjliZTc4ZmNlMzRiOGMyZTBiL3RhYmxlOjhjMmVjZjQ0MTM3MTQ4MzI4MDE3YTEwMzNhZjE3MjY4L3RhYmxlcmFuZ2U6OGMyZWNmNDQxMzcxNDgzMjgwMTdhMTAzM2FmMTcyNjhfMTItMy0xLTEtMA_b890db61-7acf-4368-9d1c-423378aea53b"
      unitRef="usd">11469000</us-gaap:InterestIncomeExpenseNonoperatingNet>
    <us-gaap:InterestIncomeExpenseNonoperatingNet
      contextRef="iaf98f9473a3d428f9aab9f72e135866f_D20200101-20200630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzY2E5YmIwMTc5MjQ3NmZiYjIyNWU1ZDlkZWM4NjlmL3NlYzo5M2NhOWJiMDE3OTI0NzZmYmIyMjVlNWQ5ZGVjODY5Zl81NS9mcmFnOjk0NGQ2N2RjOTNmMjQ1MjliZTc4ZmNlMzRiOGMyZTBiL3RhYmxlOjhjMmVjZjQ0MTM3MTQ4MzI4MDE3YTEwMzNhZjE3MjY4L3RhYmxlcmFuZ2U6OGMyZWNmNDQxMzcxNDgzMjgwMTdhMTAzM2FmMTcyNjhfMTItNS0xLTEtMA_c8019994-dccc-48ce-9d9a-fca7943a8846"
      unitRef="usd">0</us-gaap:InterestIncomeExpenseNonoperatingNet>
    <us-gaap:InterestIncomeExpenseNonoperatingNet
      contextRef="i4a110e4972ef4113880ce582e3cda5c5_D20200101-20200630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzY2E5YmIwMTc5MjQ3NmZiYjIyNWU1ZDlkZWM4NjlmL3NlYzo5M2NhOWJiMDE3OTI0NzZmYmIyMjVlNWQ5ZGVjODY5Zl81NS9mcmFnOjk0NGQ2N2RjOTNmMjQ1MjliZTc4ZmNlMzRiOGMyZTBiL3RhYmxlOjhjMmVjZjQ0MTM3MTQ4MzI4MDE3YTEwMzNhZjE3MjY4L3RhYmxlcmFuZ2U6OGMyZWNmNDQxMzcxNDgzMjgwMTdhMTAzM2FmMTcyNjhfMTItNy0xLTEtMA_018256d4-4d38-4750-b890-e54c8b7e1794"
      unitRef="usd">11485000</us-gaap:InterestIncomeExpenseNonoperatingNet>
    <us-gaap:Assets
      contextRef="i702a586f0ecb4fc1b7bfe544770fb520_I20200630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzY2E5YmIwMTc5MjQ3NmZiYjIyNWU1ZDlkZWM4NjlmL3NlYzo5M2NhOWJiMDE3OTI0NzZmYmIyMjVlNWQ5ZGVjODY5Zl81NS9mcmFnOjk0NGQ2N2RjOTNmMjQ1MjliZTc4ZmNlMzRiOGMyZTBiL3RhYmxlOjhjMmVjZjQ0MTM3MTQ4MzI4MDE3YTEwMzNhZjE3MjY4L3RhYmxlcmFuZ2U6OGMyZWNmNDQxMzcxNDgzMjgwMTdhMTAzM2FmMTcyNjhfMTMtMS0xLTEtMTg0Njk_8e663f09-901c-40ed-baa1-8ffe06db5c1e"
      unitRef="usd">250470000</us-gaap:Assets>
    <us-gaap:Assets
      contextRef="if4396fb40fd54b7faa91c1e910136a74_I20200630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzY2E5YmIwMTc5MjQ3NmZiYjIyNWU1ZDlkZWM4NjlmL3NlYzo5M2NhOWJiMDE3OTI0NzZmYmIyMjVlNWQ5ZGVjODY5Zl81NS9mcmFnOjk0NGQ2N2RjOTNmMjQ1MjliZTc4ZmNlMzRiOGMyZTBiL3RhYmxlOjhjMmVjZjQ0MTM3MTQ4MzI4MDE3YTEwMzNhZjE3MjY4L3RhYmxlcmFuZ2U6OGMyZWNmNDQxMzcxNDgzMjgwMTdhMTAzM2FmMTcyNjhfMTMtMy0xLTEtMTg0Njk_8f416a52-504d-4659-b177-51a13822d4a2"
      unitRef="usd">348569000</us-gaap:Assets>
    <us-gaap:Assets
      contextRef="iad52c8a5170c4f5bbeca5c035dd90f4e_I20200630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzY2E5YmIwMTc5MjQ3NmZiYjIyNWU1ZDlkZWM4NjlmL3NlYzo5M2NhOWJiMDE3OTI0NzZmYmIyMjVlNWQ5ZGVjODY5Zl81NS9mcmFnOjk0NGQ2N2RjOTNmMjQ1MjliZTc4ZmNlMzRiOGMyZTBiL3RhYmxlOjhjMmVjZjQ0MTM3MTQ4MzI4MDE3YTEwMzNhZjE3MjY4L3RhYmxlcmFuZ2U6OGMyZWNmNDQxMzcxNDgzMjgwMTdhMTAzM2FmMTcyNjhfMTMtNS0xLTEtMTg0Njk_91101b96-2db3-48f2-8b70-41f23ed8c047"
      unitRef="usd">1311248000</us-gaap:Assets>
    <us-gaap:Assets
      contextRef="id670dc9b33e6430f9d7510009f7495a7_I20200630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzY2E5YmIwMTc5MjQ3NmZiYjIyNWU1ZDlkZWM4NjlmL3NlYzo5M2NhOWJiMDE3OTI0NzZmYmIyMjVlNWQ5ZGVjODY5Zl81NS9mcmFnOjk0NGQ2N2RjOTNmMjQ1MjliZTc4ZmNlMzRiOGMyZTBiL3RhYmxlOjhjMmVjZjQ0MTM3MTQ4MzI4MDE3YTEwMzNhZjE3MjY4L3RhYmxlcmFuZ2U6OGMyZWNmNDQxMzcxNDgzMjgwMTdhMTAzM2FmMTcyNjhfMTMtNy0xLTEtMjA3NzQ_a1389a8d-ecd6-4889-9285-cd64dc330ed9"
      unitRef="usd">1910287000</us-gaap:Assets>
    <us-gaap:DepreciationAndAmortization
      contextRef="iab9b56b2a03f4c6199d282bd8676a924_D20200101-20200630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzY2E5YmIwMTc5MjQ3NmZiYjIyNWU1ZDlkZWM4NjlmL3NlYzo5M2NhOWJiMDE3OTI0NzZmYmIyMjVlNWQ5ZGVjODY5Zl81NS9mcmFnOjk0NGQ2N2RjOTNmMjQ1MjliZTc4ZmNlMzRiOGMyZTBiL3RhYmxlOjhjMmVjZjQ0MTM3MTQ4MzI4MDE3YTEwMzNhZjE3MjY4L3RhYmxlcmFuZ2U6OGMyZWNmNDQxMzcxNDgzMjgwMTdhMTAzM2FmMTcyNjhfMTQtMS0xLTEtMA_e23f4612-34eb-4114-8ae3-806ac80533fb"
      unitRef="usd">69000</us-gaap:DepreciationAndAmortization>
    <us-gaap:DepreciationAndAmortization
      contextRef="i13788f202c86441fa347b97f3162a453_D20200101-20200630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzY2E5YmIwMTc5MjQ3NmZiYjIyNWU1ZDlkZWM4NjlmL3NlYzo5M2NhOWJiMDE3OTI0NzZmYmIyMjVlNWQ5ZGVjODY5Zl81NS9mcmFnOjk0NGQ2N2RjOTNmMjQ1MjliZTc4ZmNlMzRiOGMyZTBiL3RhYmxlOjhjMmVjZjQ0MTM3MTQ4MzI4MDE3YTEwMzNhZjE3MjY4L3RhYmxlcmFuZ2U6OGMyZWNmNDQxMzcxNDgzMjgwMTdhMTAzM2FmMTcyNjhfMTQtMy0xLTEtMA_298878db-e2b2-4671-8c33-e223a71299a5"
      unitRef="usd">1297000</us-gaap:DepreciationAndAmortization>
    <us-gaap:DepreciationAndAmortization
      contextRef="iaf98f9473a3d428f9aab9f72e135866f_D20200101-20200630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzY2E5YmIwMTc5MjQ3NmZiYjIyNWU1ZDlkZWM4NjlmL3NlYzo5M2NhOWJiMDE3OTI0NzZmYmIyMjVlNWQ5ZGVjODY5Zl81NS9mcmFnOjk0NGQ2N2RjOTNmMjQ1MjliZTc4ZmNlMzRiOGMyZTBiL3RhYmxlOjhjMmVjZjQ0MTM3MTQ4MzI4MDE3YTEwMzNhZjE3MjY4L3RhYmxlcmFuZ2U6OGMyZWNmNDQxMzcxNDgzMjgwMTdhMTAzM2FmMTcyNjhfMTQtNS0xLTEtMA_9833871b-af05-440f-9b44-0143a1fca9de"
      unitRef="usd">0</us-gaap:DepreciationAndAmortization>
    <us-gaap:DepreciationAndAmortization
      contextRef="i4a110e4972ef4113880ce582e3cda5c5_D20200101-20200630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzY2E5YmIwMTc5MjQ3NmZiYjIyNWU1ZDlkZWM4NjlmL3NlYzo5M2NhOWJiMDE3OTI0NzZmYmIyMjVlNWQ5ZGVjODY5Zl81NS9mcmFnOjk0NGQ2N2RjOTNmMjQ1MjliZTc4ZmNlMzRiOGMyZTBiL3RhYmxlOjhjMmVjZjQ0MTM3MTQ4MzI4MDE3YTEwMzNhZjE3MjY4L3RhYmxlcmFuZ2U6OGMyZWNmNDQxMzcxNDgzMjgwMTdhMTAzM2FmMTcyNjhfMTQtNy0xLTEtMA_91fd1444-829a-497d-b20a-fbbf01c1078f"
      unitRef="usd">1366000</us-gaap:DepreciationAndAmortization>
    <us-gaap:OperatingLeaseRightOfUseAssetAmortizationExpense
      contextRef="iab9b56b2a03f4c6199d282bd8676a924_D20200101-20200630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzY2E5YmIwMTc5MjQ3NmZiYjIyNWU1ZDlkZWM4NjlmL3NlYzo5M2NhOWJiMDE3OTI0NzZmYmIyMjVlNWQ5ZGVjODY5Zl81NS9mcmFnOjk0NGQ2N2RjOTNmMjQ1MjliZTc4ZmNlMzRiOGMyZTBiL3RhYmxlOjhjMmVjZjQ0MTM3MTQ4MzI4MDE3YTEwMzNhZjE3MjY4L3RhYmxlcmFuZ2U6OGMyZWNmNDQxMzcxNDgzMjgwMTdhMTAzM2FmMTcyNjhfMTUtMS0xLTEtNDg3OQ_ad4589c1-f724-418a-89df-1f9f81bb8166"
      unitRef="usd">40000000</us-gaap:OperatingLeaseRightOfUseAssetAmortizationExpense>
    <us-gaap:OperatingLeaseRightOfUseAssetAmortizationExpense
      contextRef="i13788f202c86441fa347b97f3162a453_D20200101-20200630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzY2E5YmIwMTc5MjQ3NmZiYjIyNWU1ZDlkZWM4NjlmL3NlYzo5M2NhOWJiMDE3OTI0NzZmYmIyMjVlNWQ5ZGVjODY5Zl81NS9mcmFnOjk0NGQ2N2RjOTNmMjQ1MjliZTc4ZmNlMzRiOGMyZTBiL3RhYmxlOjhjMmVjZjQ0MTM3MTQ4MzI4MDE3YTEwMzNhZjE3MjY4L3RhYmxlcmFuZ2U6OGMyZWNmNDQxMzcxNDgzMjgwMTdhMTAzM2FmMTcyNjhfMTUtMy0xLTEtNDg3OQ_30a7b9a7-1095-46af-b7ae-edba715f082b"
      unitRef="usd">0</us-gaap:OperatingLeaseRightOfUseAssetAmortizationExpense>
    <us-gaap:OperatingLeaseRightOfUseAssetAmortizationExpense
      contextRef="iaf98f9473a3d428f9aab9f72e135866f_D20200101-20200630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzY2E5YmIwMTc5MjQ3NmZiYjIyNWU1ZDlkZWM4NjlmL3NlYzo5M2NhOWJiMDE3OTI0NzZmYmIyMjVlNWQ5ZGVjODY5Zl81NS9mcmFnOjk0NGQ2N2RjOTNmMjQ1MjliZTc4ZmNlMzRiOGMyZTBiL3RhYmxlOjhjMmVjZjQ0MTM3MTQ4MzI4MDE3YTEwMzNhZjE3MjY4L3RhYmxlcmFuZ2U6OGMyZWNmNDQxMzcxNDgzMjgwMTdhMTAzM2FmMTcyNjhfMTUtNS0xLTEtNDg3OQ_ec9e0662-c15a-46c3-85f8-7532d5b65751"
      unitRef="usd">0</us-gaap:OperatingLeaseRightOfUseAssetAmortizationExpense>
    <us-gaap:OperatingLeaseRightOfUseAssetAmortizationExpense
      contextRef="i4a110e4972ef4113880ce582e3cda5c5_D20200101-20200630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzY2E5YmIwMTc5MjQ3NmZiYjIyNWU1ZDlkZWM4NjlmL3NlYzo5M2NhOWJiMDE3OTI0NzZmYmIyMjVlNWQ5ZGVjODY5Zl81NS9mcmFnOjk0NGQ2N2RjOTNmMjQ1MjliZTc4ZmNlMzRiOGMyZTBiL3RhYmxlOjhjMmVjZjQ0MTM3MTQ4MzI4MDE3YTEwMzNhZjE3MjY4L3RhYmxlcmFuZ2U6OGMyZWNmNDQxMzcxNDgzMjgwMTdhMTAzM2FmMTcyNjhfMTUtNy0xLTEtNDg3OQ_26ed7780-8329-44d8-b476-2d95c83b835b"
      unitRef="usd">40000000</us-gaap:OperatingLeaseRightOfUseAssetAmortizationExpense>
    <cron:AdjustedEarningsBeforeInterestTaxesDepreciationAndAmortization
      contextRef="iab9b56b2a03f4c6199d282bd8676a924_D20200101-20200630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzY2E5YmIwMTc5MjQ3NmZiYjIyNWU1ZDlkZWM4NjlmL3NlYzo5M2NhOWJiMDE3OTI0NzZmYmIyMjVlNWQ5ZGVjODY5Zl81NS9mcmFnOjk0NGQ2N2RjOTNmMjQ1MjliZTc4ZmNlMzRiOGMyZTBiL3RhYmxlOjhjMmVjZjQ0MTM3MTQ4MzI4MDE3YTEwMzNhZjE3MjY4L3RhYmxlcmFuZ2U6OGMyZWNmNDQxMzcxNDgzMjgwMTdhMTAzM2FmMTcyNjhfMTYtMS0xLTEtMA_39a26a65-5881-4ce7-adec-148286212de3"
      unitRef="usd">-10567000</cron:AdjustedEarningsBeforeInterestTaxesDepreciationAndAmortization>
    <cron:AdjustedEarningsBeforeInterestTaxesDepreciationAndAmortization
      contextRef="i13788f202c86441fa347b97f3162a453_D20200101-20200630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzY2E5YmIwMTc5MjQ3NmZiYjIyNWU1ZDlkZWM4NjlmL3NlYzo5M2NhOWJiMDE3OTI0NzZmYmIyMjVlNWQ5ZGVjODY5Zl81NS9mcmFnOjk0NGQ2N2RjOTNmMjQ1MjliZTc4ZmNlMzRiOGMyZTBiL3RhYmxlOjhjMmVjZjQ0MTM3MTQ4MzI4MDE3YTEwMzNhZjE3MjY4L3RhYmxlcmFuZ2U6OGMyZWNmNDQxMzcxNDgzMjgwMTdhMTAzM2FmMTcyNjhfMTYtMy0xLTEtMA_d5093e20-883b-4b0c-a035-5f8a34231e73"
      unitRef="usd">-47628000</cron:AdjustedEarningsBeforeInterestTaxesDepreciationAndAmortization>
    <cron:AdjustedEarningsBeforeInterestTaxesDepreciationAndAmortization
      contextRef="iaf98f9473a3d428f9aab9f72e135866f_D20200101-20200630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzY2E5YmIwMTc5MjQ3NmZiYjIyNWU1ZDlkZWM4NjlmL3NlYzo5M2NhOWJiMDE3OTI0NzZmYmIyMjVlNWQ5ZGVjODY5Zl81NS9mcmFnOjk0NGQ2N2RjOTNmMjQ1MjliZTc4ZmNlMzRiOGMyZTBiL3RhYmxlOjhjMmVjZjQ0MTM3MTQ4MzI4MDE3YTEwMzNhZjE3MjY4L3RhYmxlcmFuZ2U6OGMyZWNmNDQxMzcxNDgzMjgwMTdhMTAzM2FmMTcyNjhfMTYtNS0xLTEtMA_9dd97150-fc31-427e-ba71-ce067dd92775"
      unitRef="usd">-5846000</cron:AdjustedEarningsBeforeInterestTaxesDepreciationAndAmortization>
    <cron:AdjustedEarningsBeforeInterestTaxesDepreciationAndAmortization
      contextRef="i4a110e4972ef4113880ce582e3cda5c5_D20200101-20200630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzY2E5YmIwMTc5MjQ3NmZiYjIyNWU1ZDlkZWM4NjlmL3NlYzo5M2NhOWJiMDE3OTI0NzZmYmIyMjVlNWQ5ZGVjODY5Zl81NS9mcmFnOjk0NGQ2N2RjOTNmMjQ1MjliZTc4ZmNlMzRiOGMyZTBiL3RhYmxlOjhjMmVjZjQ0MTM3MTQ4MzI4MDE3YTEwMzNhZjE3MjY4L3RhYmxlcmFuZ2U6OGMyZWNmNDQxMzcxNDgzMjgwMTdhMTAzM2FmMTcyNjhfMTYtNy0xLTEtMA_ec9e2bda-0c9a-4fa1-9250-9d4259532f6b"
      unitRef="usd">-64041000</cron:AdjustedEarningsBeforeInterestTaxesDepreciationAndAmortization>
    <us-gaap:PropertyPlantAndEquipmentAdditions
      contextRef="iab9b56b2a03f4c6199d282bd8676a924_D20200101-20200630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzY2E5YmIwMTc5MjQ3NmZiYjIyNWU1ZDlkZWM4NjlmL3NlYzo5M2NhOWJiMDE3OTI0NzZmYmIyMjVlNWQ5ZGVjODY5Zl81NS9mcmFnOjk0NGQ2N2RjOTNmMjQ1MjliZTc4ZmNlMzRiOGMyZTBiL3RhYmxlOjhjMmVjZjQ0MTM3MTQ4MzI4MDE3YTEwMzNhZjE3MjY4L3RhYmxlcmFuZ2U6OGMyZWNmNDQxMzcxNDgzMjgwMTdhMTAzM2FmMTcyNjhfMTctMS0xLTEtMTczMTc_5ba36614-38b3-481b-b4ee-15e92aaf74bc"
      unitRef="usd">219000</us-gaap:PropertyPlantAndEquipmentAdditions>
    <us-gaap:PropertyPlantAndEquipmentAdditions
      contextRef="i13788f202c86441fa347b97f3162a453_D20200101-20200630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzY2E5YmIwMTc5MjQ3NmZiYjIyNWU1ZDlkZWM4NjlmL3NlYzo5M2NhOWJiMDE3OTI0NzZmYmIyMjVlNWQ5ZGVjODY5Zl81NS9mcmFnOjk0NGQ2N2RjOTNmMjQ1MjliZTc4ZmNlMzRiOGMyZTBiL3RhYmxlOjhjMmVjZjQ0MTM3MTQ4MzI4MDE3YTEwMzNhZjE3MjY4L3RhYmxlcmFuZ2U6OGMyZWNmNDQxMzcxNDgzMjgwMTdhMTAzM2FmMTcyNjhfMTctMy0xLTEtMTczMjA_8f97333a-21dc-4a84-a267-35fd9ff4c7c5"
      unitRef="usd">13125000</us-gaap:PropertyPlantAndEquipmentAdditions>
    <us-gaap:PropertyPlantAndEquipmentAdditions
      contextRef="iaf98f9473a3d428f9aab9f72e135866f_D20200101-20200630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzY2E5YmIwMTc5MjQ3NmZiYjIyNWU1ZDlkZWM4NjlmL3NlYzo5M2NhOWJiMDE3OTI0NzZmYmIyMjVlNWQ5ZGVjODY5Zl81NS9mcmFnOjk0NGQ2N2RjOTNmMjQ1MjliZTc4ZmNlMzRiOGMyZTBiL3RhYmxlOjhjMmVjZjQ0MTM3MTQ4MzI4MDE3YTEwMzNhZjE3MjY4L3RhYmxlcmFuZ2U6OGMyZWNmNDQxMzcxNDgzMjgwMTdhMTAzM2FmMTcyNjhfMTctNS0xLTEtMTczMjM_a4424b99-a8fe-4451-ad11-1a57c3c94d55"
      unitRef="usd">0</us-gaap:PropertyPlantAndEquipmentAdditions>
    <us-gaap:PropertyPlantAndEquipmentAdditions
      contextRef="i4a110e4972ef4113880ce582e3cda5c5_D20200101-20200630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzY2E5YmIwMTc5MjQ3NmZiYjIyNWU1ZDlkZWM4NjlmL3NlYzo5M2NhOWJiMDE3OTI0NzZmYmIyMjVlNWQ5ZGVjODY5Zl81NS9mcmFnOjk0NGQ2N2RjOTNmMjQ1MjliZTc4ZmNlMzRiOGMyZTBiL3RhYmxlOjhjMmVjZjQ0MTM3MTQ4MzI4MDE3YTEwMzNhZjE3MjY4L3RhYmxlcmFuZ2U6OGMyZWNmNDQxMzcxNDgzMjgwMTdhMTAzM2FmMTcyNjhfMTctNy0xLTEtMTczNzc_b2992648-f21d-43d0-af40-012e35200cc9"
      unitRef="usd">13344000</us-gaap:PropertyPlantAndEquipmentAdditions>
    <us-gaap:ProfitLoss
      contextRef="i2a563d1bc1a1451296d5f40e6cdf2912_D20210401-20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzY2E5YmIwMTc5MjQ3NmZiYjIyNWU1ZDlkZWM4NjlmL3NlYzo5M2NhOWJiMDE3OTI0NzZmYmIyMjVlNWQ5ZGVjODY5Zl81NS9mcmFnOjk0NGQ2N2RjOTNmMjQ1MjliZTc4ZmNlMzRiOGMyZTBiL3RhYmxlOjM0OTY4NTgyMjZmNzQzZWE4Y2M4ZWM1ZTVkMmQzODY5L3RhYmxlcmFuZ2U6MzQ5Njg1ODIyNmY3NDNlYThjYzhlYzVlNWQyZDM4NjlfMi0xLTEtMS0w_f657e865-a751-48a0-a8de-b818378b5fba"
      unitRef="usd">-11719000</us-gaap:ProfitLoss>
    <us-gaap:ProfitLoss
      contextRef="i7b627a38d4bb4b2693a9598ca41f647d_D20210401-20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzY2E5YmIwMTc5MjQ3NmZiYjIyNWU1ZDlkZWM4NjlmL3NlYzo5M2NhOWJiMDE3OTI0NzZmYmIyMjVlNWQ5ZGVjODY5Zl81NS9mcmFnOjk0NGQ2N2RjOTNmMjQ1MjliZTc4ZmNlMzRiOGMyZTBiL3RhYmxlOjM0OTY4NTgyMjZmNzQzZWE4Y2M4ZWM1ZTVkMmQzODY5L3RhYmxlcmFuZ2U6MzQ5Njg1ODIyNmY3NDNlYThjYzhlYzVlNWQyZDM4NjlfMi0zLTEtMS0w_7a1e6278-aaa3-44a3-bf2f-cdc21e411303"
      unitRef="usd">79627000</us-gaap:ProfitLoss>
    <us-gaap:ProfitLoss
      contextRef="ie916e4a685544ae3998d4e82e089944f_D20210401-20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzY2E5YmIwMTc5MjQ3NmZiYjIyNWU1ZDlkZWM4NjlmL3NlYzo5M2NhOWJiMDE3OTI0NzZmYmIyMjVlNWQ5ZGVjODY5Zl81NS9mcmFnOjk0NGQ2N2RjOTNmMjQ1MjliZTc4ZmNlMzRiOGMyZTBiL3RhYmxlOjM0OTY4NTgyMjZmNzQzZWE4Y2M4ZWM1ZTVkMmQzODY5L3RhYmxlcmFuZ2U6MzQ5Njg1ODIyNmY3NDNlYThjYzhlYzVlNWQyZDM4NjlfMi01LTEtMS0w_a5538eb3-86cc-4829-9311-b85a56e98e16"
      unitRef="usd">-11133000</us-gaap:ProfitLoss>
    <us-gaap:ProfitLoss
      contextRef="i27f4e53b91ad4367b7f8d273eff27769_D20210401-20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzY2E5YmIwMTc5MjQ3NmZiYjIyNWU1ZDlkZWM4NjlmL3NlYzo5M2NhOWJiMDE3OTI0NzZmYmIyMjVlNWQ5ZGVjODY5Zl81NS9mcmFnOjk0NGQ2N2RjOTNmMjQ1MjliZTc4ZmNlMzRiOGMyZTBiL3RhYmxlOjM0OTY4NTgyMjZmNzQzZWE4Y2M4ZWM1ZTVkMmQzODY5L3RhYmxlcmFuZ2U6MzQ5Njg1ODIyNmY3NDNlYThjYzhlYzVlNWQyZDM4NjlfMi03LTEtMS0w_da32e140-d521-44b5-91bc-a7db57f6cd34"
      unitRef="usd">56775000</us-gaap:ProfitLoss>
    <us-gaap:InterestIncomeExpenseNonoperatingNet
      contextRef="i2a563d1bc1a1451296d5f40e6cdf2912_D20210401-20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzY2E5YmIwMTc5MjQ3NmZiYjIyNWU1ZDlkZWM4NjlmL3NlYzo5M2NhOWJiMDE3OTI0NzZmYmIyMjVlNWQ5ZGVjODY5Zl81NS9mcmFnOjk0NGQ2N2RjOTNmMjQ1MjliZTc4ZmNlMzRiOGMyZTBiL3RhYmxlOjM0OTY4NTgyMjZmNzQzZWE4Y2M4ZWM1ZTVkMmQzODY5L3RhYmxlcmFuZ2U6MzQ5Njg1ODIyNmY3NDNlYThjYzhlYzVlNWQyZDM4NjlfNC0xLTEtMS0w_586d6ce2-6f6c-4ff8-8c22-f8eca29da557"
      unitRef="usd">20000</us-gaap:InterestIncomeExpenseNonoperatingNet>
    <us-gaap:InterestIncomeExpenseNonoperatingNet
      contextRef="i7b627a38d4bb4b2693a9598ca41f647d_D20210401-20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzY2E5YmIwMTc5MjQ3NmZiYjIyNWU1ZDlkZWM4NjlmL3NlYzo5M2NhOWJiMDE3OTI0NzZmYmIyMjVlNWQ5ZGVjODY5Zl81NS9mcmFnOjk0NGQ2N2RjOTNmMjQ1MjliZTc4ZmNlMzRiOGMyZTBiL3RhYmxlOjM0OTY4NTgyMjZmNzQzZWE4Y2M4ZWM1ZTVkMmQzODY5L3RhYmxlcmFuZ2U6MzQ5Njg1ODIyNmY3NDNlYThjYzhlYzVlNWQyZDM4NjlfNC0zLTEtMS0w_5adee23b-78e8-432d-9c47-ed77d08c7ffd"
      unitRef="usd">2273000</us-gaap:InterestIncomeExpenseNonoperatingNet>
    <us-gaap:InterestIncomeExpenseNonoperatingNet
      contextRef="ie916e4a685544ae3998d4e82e089944f_D20210401-20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzY2E5YmIwMTc5MjQ3NmZiYjIyNWU1ZDlkZWM4NjlmL3NlYzo5M2NhOWJiMDE3OTI0NzZmYmIyMjVlNWQ5ZGVjODY5Zl81NS9mcmFnOjk0NGQ2N2RjOTNmMjQ1MjliZTc4ZmNlMzRiOGMyZTBiL3RhYmxlOjM0OTY4NTgyMjZmNzQzZWE4Y2M4ZWM1ZTVkMmQzODY5L3RhYmxlcmFuZ2U6MzQ5Njg1ODIyNmY3NDNlYThjYzhlYzVlNWQyZDM4NjlfNC01LTEtMS0w_0c0df99a-1374-423b-ac43-80d787abe862"
      unitRef="usd">0</us-gaap:InterestIncomeExpenseNonoperatingNet>
    <us-gaap:InterestIncomeExpenseNonoperatingNet
      contextRef="i27f4e53b91ad4367b7f8d273eff27769_D20210401-20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzY2E5YmIwMTc5MjQ3NmZiYjIyNWU1ZDlkZWM4NjlmL3NlYzo5M2NhOWJiMDE3OTI0NzZmYmIyMjVlNWQ5ZGVjODY5Zl81NS9mcmFnOjk0NGQ2N2RjOTNmMjQ1MjliZTc4ZmNlMzRiOGMyZTBiL3RhYmxlOjM0OTY4NTgyMjZmNzQzZWE4Y2M4ZWM1ZTVkMmQzODY5L3RhYmxlcmFuZ2U6MzQ5Njg1ODIyNmY3NDNlYThjYzhlYzVlNWQyZDM4NjlfNC03LTEtMS0w_20e1efe0-adea-41bd-bf6a-1ac2a887761f"
      unitRef="usd">2293000</us-gaap:InterestIncomeExpenseNonoperatingNet>
    <us-gaap:IncomeLossFromEquityMethodInvestments
      contextRef="i2a563d1bc1a1451296d5f40e6cdf2912_D20210401-20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzY2E5YmIwMTc5MjQ3NmZiYjIyNWU1ZDlkZWM4NjlmL3NlYzo5M2NhOWJiMDE3OTI0NzZmYmIyMjVlNWQ5ZGVjODY5Zl81NS9mcmFnOjk0NGQ2N2RjOTNmMjQ1MjliZTc4ZmNlMzRiOGMyZTBiL3RhYmxlOjM0OTY4NTgyMjZmNzQzZWE4Y2M4ZWM1ZTVkMmQzODY5L3RhYmxlcmFuZ2U6MzQ5Njg1ODIyNmY3NDNlYThjYzhlYzVlNWQyZDM4NjlfNi0xLTEtMS0w_b290ea8b-26fe-49f4-af18-73d9b3b52e8e"
      unitRef="usd">0</us-gaap:IncomeLossFromEquityMethodInvestments>
    <us-gaap:IncomeLossFromEquityMethodInvestments
      contextRef="i7b627a38d4bb4b2693a9598ca41f647d_D20210401-20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzY2E5YmIwMTc5MjQ3NmZiYjIyNWU1ZDlkZWM4NjlmL3NlYzo5M2NhOWJiMDE3OTI0NzZmYmIyMjVlNWQ5ZGVjODY5Zl81NS9mcmFnOjk0NGQ2N2RjOTNmMjQ1MjliZTc4ZmNlMzRiOGMyZTBiL3RhYmxlOjM0OTY4NTgyMjZmNzQzZWE4Y2M4ZWM1ZTVkMmQzODY5L3RhYmxlcmFuZ2U6MzQ5Njg1ODIyNmY3NDNlYThjYzhlYzVlNWQyZDM4NjlfNi0zLTEtMS0w_7a75b06b-775e-4640-a66a-52ee433b2d28"
      unitRef="usd">-1115000</us-gaap:IncomeLossFromEquityMethodInvestments>
    <us-gaap:IncomeLossFromEquityMethodInvestments
      contextRef="ie916e4a685544ae3998d4e82e089944f_D20210401-20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzY2E5YmIwMTc5MjQ3NmZiYjIyNWU1ZDlkZWM4NjlmL3NlYzo5M2NhOWJiMDE3OTI0NzZmYmIyMjVlNWQ5ZGVjODY5Zl81NS9mcmFnOjk0NGQ2N2RjOTNmMjQ1MjliZTc4ZmNlMzRiOGMyZTBiL3RhYmxlOjM0OTY4NTgyMjZmNzQzZWE4Y2M4ZWM1ZTVkMmQzODY5L3RhYmxlcmFuZ2U6MzQ5Njg1ODIyNmY3NDNlYThjYzhlYzVlNWQyZDM4NjlfNi01LTEtMS0w_b969682d-8085-406e-a32a-b5c90704cef6"
      unitRef="usd">0</us-gaap:IncomeLossFromEquityMethodInvestments>
    <us-gaap:IncomeLossFromEquityMethodInvestments
      contextRef="i27f4e53b91ad4367b7f8d273eff27769_D20210401-20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzY2E5YmIwMTc5MjQ3NmZiYjIyNWU1ZDlkZWM4NjlmL3NlYzo5M2NhOWJiMDE3OTI0NzZmYmIyMjVlNWQ5ZGVjODY5Zl81NS9mcmFnOjk0NGQ2N2RjOTNmMjQ1MjliZTc4ZmNlMzRiOGMyZTBiL3RhYmxlOjM0OTY4NTgyMjZmNzQzZWE4Y2M4ZWM1ZTVkMmQzODY5L3RhYmxlcmFuZ2U6MzQ5Njg1ODIyNmY3NDNlYThjYzhlYzVlNWQyZDM4NjlfNi03LTEtMS0w_d45cd22c-2f1d-4a40-b8e8-6cc65906a998"
      unitRef="usd">-1115000</us-gaap:IncomeLossFromEquityMethodInvestments>
    <us-gaap:GainLossOnDerivativeInstrumentsNetPretax
      contextRef="i2a563d1bc1a1451296d5f40e6cdf2912_D20210401-20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzY2E5YmIwMTc5MjQ3NmZiYjIyNWU1ZDlkZWM4NjlmL3NlYzo5M2NhOWJiMDE3OTI0NzZmYmIyMjVlNWQ5ZGVjODY5Zl81NS9mcmFnOjk0NGQ2N2RjOTNmMjQ1MjliZTc4ZmNlMzRiOGMyZTBiL3RhYmxlOjM0OTY4NTgyMjZmNzQzZWE4Y2M4ZWM1ZTVkMmQzODY5L3RhYmxlcmFuZ2U6MzQ5Njg1ODIyNmY3NDNlYThjYzhlYzVlNWQyZDM4NjlfOC0xLTEtMS0w_730051d0-88c6-4eda-814d-27458d0710fc"
      unitRef="usd">0</us-gaap:GainLossOnDerivativeInstrumentsNetPretax>
    <us-gaap:GainLossOnDerivativeInstrumentsNetPretax
      contextRef="i7b627a38d4bb4b2693a9598ca41f647d_D20210401-20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzY2E5YmIwMTc5MjQ3NmZiYjIyNWU1ZDlkZWM4NjlmL3NlYzo5M2NhOWJiMDE3OTI0NzZmYmIyMjVlNWQ5ZGVjODY5Zl81NS9mcmFnOjk0NGQ2N2RjOTNmMjQ1MjliZTc4ZmNlMzRiOGMyZTBiL3RhYmxlOjM0OTY4NTgyMjZmNzQzZWE4Y2M4ZWM1ZTVkMmQzODY5L3RhYmxlcmFuZ2U6MzQ5Njg1ODIyNmY3NDNlYThjYzhlYzVlNWQyZDM4NjlfOC0zLTEtMS0w_1f3fcfa9-ef68-415b-8dee-fc7e2edf8005"
      unitRef="usd">115248000</us-gaap:GainLossOnDerivativeInstrumentsNetPretax>
    <us-gaap:GainLossOnDerivativeInstrumentsNetPretax
      contextRef="ie916e4a685544ae3998d4e82e089944f_D20210401-20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzY2E5YmIwMTc5MjQ3NmZiYjIyNWU1ZDlkZWM4NjlmL3NlYzo5M2NhOWJiMDE3OTI0NzZmYmIyMjVlNWQ5ZGVjODY5Zl81NS9mcmFnOjk0NGQ2N2RjOTNmMjQ1MjliZTc4ZmNlMzRiOGMyZTBiL3RhYmxlOjM0OTY4NTgyMjZmNzQzZWE4Y2M4ZWM1ZTVkMmQzODY5L3RhYmxlcmFuZ2U6MzQ5Njg1ODIyNmY3NDNlYThjYzhlYzVlNWQyZDM4NjlfOC01LTEtMS0w_c828bc56-e22c-4c1d-a59b-d5812f8e49b7"
      unitRef="usd">0</us-gaap:GainLossOnDerivativeInstrumentsNetPretax>
    <us-gaap:GainLossOnDerivativeInstrumentsNetPretax
      contextRef="i27f4e53b91ad4367b7f8d273eff27769_D20210401-20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzY2E5YmIwMTc5MjQ3NmZiYjIyNWU1ZDlkZWM4NjlmL3NlYzo5M2NhOWJiMDE3OTI0NzZmYmIyMjVlNWQ5ZGVjODY5Zl81NS9mcmFnOjk0NGQ2N2RjOTNmMjQ1MjliZTc4ZmNlMzRiOGMyZTBiL3RhYmxlOjM0OTY4NTgyMjZmNzQzZWE4Y2M4ZWM1ZTVkMmQzODY5L3RhYmxlcmFuZ2U6MzQ5Njg1ODIyNmY3NDNlYThjYzhlYzVlNWQyZDM4NjlfOC03LTEtMS0w_cd28e2de-0da3-4a3d-af3a-56ff0353e822"
      unitRef="usd">115248000</us-gaap:GainLossOnDerivativeInstrumentsNetPretax>
    <us-gaap:RestructuringCharges
      contextRef="i2a563d1bc1a1451296d5f40e6cdf2912_D20210401-20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzY2E5YmIwMTc5MjQ3NmZiYjIyNWU1ZDlkZWM4NjlmL3NlYzo5M2NhOWJiMDE3OTI0NzZmYmIyMjVlNWQ5ZGVjODY5Zl81NS9mcmFnOjk0NGQ2N2RjOTNmMjQ1MjliZTc4ZmNlMzRiOGMyZTBiL3RhYmxlOjM0OTY4NTgyMjZmNzQzZWE4Y2M4ZWM1ZTVkMmQzODY5L3RhYmxlcmFuZ2U6MzQ5Njg1ODIyNmY3NDNlYThjYzhlYzVlNWQyZDM4NjlfOS0xLTEtMS0w_6192ed8c-2094-41de-807e-d23bf1f141fb"
      unitRef="usd">0</us-gaap:RestructuringCharges>
    <us-gaap:RestructuringCharges
      contextRef="i7b627a38d4bb4b2693a9598ca41f647d_D20210401-20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzY2E5YmIwMTc5MjQ3NmZiYjIyNWU1ZDlkZWM4NjlmL3NlYzo5M2NhOWJiMDE3OTI0NzZmYmIyMjVlNWQ5ZGVjODY5Zl81NS9mcmFnOjk0NGQ2N2RjOTNmMjQ1MjliZTc4ZmNlMzRiOGMyZTBiL3RhYmxlOjM0OTY4NTgyMjZmNzQzZWE4Y2M4ZWM1ZTVkMmQzODY5L3RhYmxlcmFuZ2U6MzQ5Njg1ODIyNmY3NDNlYThjYzhlYzVlNWQyZDM4NjlfOS0zLTEtMS0w_0697837e-b508-4d40-9dd1-24b0e7e26c82"
      unitRef="usd">0</us-gaap:RestructuringCharges>
    <us-gaap:RestructuringCharges
      contextRef="ie916e4a685544ae3998d4e82e089944f_D20210401-20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzY2E5YmIwMTc5MjQ3NmZiYjIyNWU1ZDlkZWM4NjlmL3NlYzo5M2NhOWJiMDE3OTI0NzZmYmIyMjVlNWQ5ZGVjODY5Zl81NS9mcmFnOjk0NGQ2N2RjOTNmMjQ1MjliZTc4ZmNlMzRiOGMyZTBiL3RhYmxlOjM0OTY4NTgyMjZmNzQzZWE4Y2M4ZWM1ZTVkMmQzODY5L3RhYmxlcmFuZ2U6MzQ5Njg1ODIyNmY3NDNlYThjYzhlYzVlNWQyZDM4NjlfOS01LTEtMS0w_ad54e217-211c-4b00-8500-8c0d75c7072b"
      unitRef="usd">2758000</us-gaap:RestructuringCharges>
    <us-gaap:RestructuringCharges
      contextRef="i27f4e53b91ad4367b7f8d273eff27769_D20210401-20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzY2E5YmIwMTc5MjQ3NmZiYjIyNWU1ZDlkZWM4NjlmL3NlYzo5M2NhOWJiMDE3OTI0NzZmYmIyMjVlNWQ5ZGVjODY5Zl81NS9mcmFnOjk0NGQ2N2RjOTNmMjQ1MjliZTc4ZmNlMzRiOGMyZTBiL3RhYmxlOjM0OTY4NTgyMjZmNzQzZWE4Y2M4ZWM1ZTVkMmQzODY5L3RhYmxlcmFuZ2U6MzQ5Njg1ODIyNmY3NDNlYThjYzhlYzVlNWQyZDM4NjlfOS03LTEtMS0w_0ad89a7f-172c-451d-a76e-9c73cc204946"
      unitRef="usd">2758000</us-gaap:RestructuringCharges>
    <us-gaap:OtherNonoperatingIncomeExpense
      contextRef="i2a563d1bc1a1451296d5f40e6cdf2912_D20210401-20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzY2E5YmIwMTc5MjQ3NmZiYjIyNWU1ZDlkZWM4NjlmL3NlYzo5M2NhOWJiMDE3OTI0NzZmYmIyMjVlNWQ5ZGVjODY5Zl81NS9mcmFnOjk0NGQ2N2RjOTNmMjQ1MjliZTc4ZmNlMzRiOGMyZTBiL3RhYmxlOjM0OTY4NTgyMjZmNzQzZWE4Y2M4ZWM1ZTVkMmQzODY5L3RhYmxlcmFuZ2U6MzQ5Njg1ODIyNmY3NDNlYThjYzhlYzVlNWQyZDM4NjlfMTAtMS0xLTEtMA_d2f48d18-2d19-4ffd-aa5c-fca673df4a46"
      unitRef="usd">0</us-gaap:OtherNonoperatingIncomeExpense>
    <us-gaap:OtherNonoperatingIncomeExpense
      contextRef="i7b627a38d4bb4b2693a9598ca41f647d_D20210401-20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzY2E5YmIwMTc5MjQ3NmZiYjIyNWU1ZDlkZWM4NjlmL3NlYzo5M2NhOWJiMDE3OTI0NzZmYmIyMjVlNWQ5ZGVjODY5Zl81NS9mcmFnOjk0NGQ2N2RjOTNmMjQ1MjliZTc4ZmNlMzRiOGMyZTBiL3RhYmxlOjM0OTY4NTgyMjZmNzQzZWE4Y2M4ZWM1ZTVkMmQzODY5L3RhYmxlcmFuZ2U6MzQ5Njg1ODIyNmY3NDNlYThjYzhlYzVlNWQyZDM4NjlfMTAtMy0xLTEtMA_1e3e52dd-ac8a-41b8-951c-72045a477c8f"
      unitRef="usd">1127000</us-gaap:OtherNonoperatingIncomeExpense>
    <us-gaap:OtherNonoperatingIncomeExpense
      contextRef="ie916e4a685544ae3998d4e82e089944f_D20210401-20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzY2E5YmIwMTc5MjQ3NmZiYjIyNWU1ZDlkZWM4NjlmL3NlYzo5M2NhOWJiMDE3OTI0NzZmYmIyMjVlNWQ5ZGVjODY5Zl81NS9mcmFnOjk0NGQ2N2RjOTNmMjQ1MjliZTc4ZmNlMzRiOGMyZTBiL3RhYmxlOjM0OTY4NTgyMjZmNzQzZWE4Y2M4ZWM1ZTVkMmQzODY5L3RhYmxlcmFuZ2U6MzQ5Njg1ODIyNmY3NDNlYThjYzhlYzVlNWQyZDM4NjlfMTAtNS0xLTEtMA_0ffe8f41-f3b8-4022-891e-336d94c198d9"
      unitRef="usd">0</us-gaap:OtherNonoperatingIncomeExpense>
    <us-gaap:OtherNonoperatingIncomeExpense
      contextRef="i27f4e53b91ad4367b7f8d273eff27769_D20210401-20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzY2E5YmIwMTc5MjQ3NmZiYjIyNWU1ZDlkZWM4NjlmL3NlYzo5M2NhOWJiMDE3OTI0NzZmYmIyMjVlNWQ5ZGVjODY5Zl81NS9mcmFnOjk0NGQ2N2RjOTNmMjQ1MjliZTc4ZmNlMzRiOGMyZTBiL3RhYmxlOjM0OTY4NTgyMjZmNzQzZWE4Y2M4ZWM1ZTVkMmQzODY5L3RhYmxlcmFuZ2U6MzQ5Njg1ODIyNmY3NDNlYThjYzhlYzVlNWQyZDM4NjlfMTAtNy0xLTEtMA_445d6dc7-897f-496d-aa3f-1cfe282b2181"
      unitRef="usd">1127000</us-gaap:OtherNonoperatingIncomeExpense>
    <us-gaap:IncomeLossFromDiscontinuedOperationsNetOfTax
      contextRef="i2a563d1bc1a1451296d5f40e6cdf2912_D20210401-20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzY2E5YmIwMTc5MjQ3NmZiYjIyNWU1ZDlkZWM4NjlmL3NlYzo5M2NhOWJiMDE3OTI0NzZmYmIyMjVlNWQ5ZGVjODY5Zl81NS9mcmFnOjk0NGQ2N2RjOTNmMjQ1MjliZTc4ZmNlMzRiOGMyZTBiL3RhYmxlOjM0OTY4NTgyMjZmNzQzZWE4Y2M4ZWM1ZTVkMmQzODY5L3RhYmxlcmFuZ2U6MzQ5Njg1ODIyNmY3NDNlYThjYzhlYzVlNWQyZDM4NjlfMTEtMS0xLTEtMA_1871a03f-72fb-4263-bccf-1f042356cee1"
      unitRef="usd">0</us-gaap:IncomeLossFromDiscontinuedOperationsNetOfTax>
    <us-gaap:IncomeLossFromDiscontinuedOperationsNetOfTax
      contextRef="i7b627a38d4bb4b2693a9598ca41f647d_D20210401-20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzY2E5YmIwMTc5MjQ3NmZiYjIyNWU1ZDlkZWM4NjlmL3NlYzo5M2NhOWJiMDE3OTI0NzZmYmIyMjVlNWQ5ZGVjODY5Zl81NS9mcmFnOjk0NGQ2N2RjOTNmMjQ1MjliZTc4ZmNlMzRiOGMyZTBiL3RhYmxlOjM0OTY4NTgyMjZmNzQzZWE4Y2M4ZWM1ZTVkMmQzODY5L3RhYmxlcmFuZ2U6MzQ5Njg1ODIyNmY3NDNlYThjYzhlYzVlNWQyZDM4NjlfMTEtMy0xLTEtMA_970ae643-c0c5-4063-8b0f-6105b74b7330"
      unitRef="usd">-561000</us-gaap:IncomeLossFromDiscontinuedOperationsNetOfTax>
    <us-gaap:IncomeLossFromDiscontinuedOperationsNetOfTax
      contextRef="ie916e4a685544ae3998d4e82e089944f_D20210401-20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzY2E5YmIwMTc5MjQ3NmZiYjIyNWU1ZDlkZWM4NjlmL3NlYzo5M2NhOWJiMDE3OTI0NzZmYmIyMjVlNWQ5ZGVjODY5Zl81NS9mcmFnOjk0NGQ2N2RjOTNmMjQ1MjliZTc4ZmNlMzRiOGMyZTBiL3RhYmxlOjM0OTY4NTgyMjZmNzQzZWE4Y2M4ZWM1ZTVkMmQzODY5L3RhYmxlcmFuZ2U6MzQ5Njg1ODIyNmY3NDNlYThjYzhlYzVlNWQyZDM4NjlfMTEtNS0xLTEtMA_c42646e2-50d4-4efe-96a2-bab50fc2313e"
      unitRef="usd">0</us-gaap:IncomeLossFromDiscontinuedOperationsNetOfTax>
    <us-gaap:IncomeLossFromDiscontinuedOperationsNetOfTax
      contextRef="i27f4e53b91ad4367b7f8d273eff27769_D20210401-20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzY2E5YmIwMTc5MjQ3NmZiYjIyNWU1ZDlkZWM4NjlmL3NlYzo5M2NhOWJiMDE3OTI0NzZmYmIyMjVlNWQ5ZGVjODY5Zl81NS9mcmFnOjk0NGQ2N2RjOTNmMjQ1MjliZTc4ZmNlMzRiOGMyZTBiL3RhYmxlOjM0OTY4NTgyMjZmNzQzZWE4Y2M4ZWM1ZTVkMmQzODY5L3RhYmxlcmFuZ2U6MzQ5Njg1ODIyNmY3NDNlYThjYzhlYzVlNWQyZDM4NjlfMTEtNy0xLTEtMA_33d6817a-73c0-4e22-8f92-7cb2465d467a"
      unitRef="usd">-561000</us-gaap:IncomeLossFromDiscontinuedOperationsNetOfTax>
    <us-gaap:AllocatedShareBasedCompensationExpense
      contextRef="i2a563d1bc1a1451296d5f40e6cdf2912_D20210401-20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzY2E5YmIwMTc5MjQ3NmZiYjIyNWU1ZDlkZWM4NjlmL3NlYzo5M2NhOWJiMDE3OTI0NzZmYmIyMjVlNWQ5ZGVjODY5Zl81NS9mcmFnOjk0NGQ2N2RjOTNmMjQ1MjliZTc4ZmNlMzRiOGMyZTBiL3RhYmxlOjM0OTY4NTgyMjZmNzQzZWE4Y2M4ZWM1ZTVkMmQzODY5L3RhYmxlcmFuZ2U6MzQ5Njg1ODIyNmY3NDNlYThjYzhlYzVlNWQyZDM4NjlfMTItMS0xLTEtMA_b171d295-ad2f-4149-89af-b07de08f1bec"
      unitRef="usd">822000</us-gaap:AllocatedShareBasedCompensationExpense>
    <us-gaap:AllocatedShareBasedCompensationExpense
      contextRef="i7b627a38d4bb4b2693a9598ca41f647d_D20210401-20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzY2E5YmIwMTc5MjQ3NmZiYjIyNWU1ZDlkZWM4NjlmL3NlYzo5M2NhOWJiMDE3OTI0NzZmYmIyMjVlNWQ5ZGVjODY5Zl81NS9mcmFnOjk0NGQ2N2RjOTNmMjQ1MjliZTc4ZmNlMzRiOGMyZTBiL3RhYmxlOjM0OTY4NTgyMjZmNzQzZWE4Y2M4ZWM1ZTVkMmQzODY5L3RhYmxlcmFuZ2U6MzQ5Njg1ODIyNmY3NDNlYThjYzhlYzVlNWQyZDM4NjlfMTItMy0xLTEtMA_ae289c09-f263-405d-8be6-73456b019fc9"
      unitRef="usd">1743000</us-gaap:AllocatedShareBasedCompensationExpense>
    <us-gaap:AllocatedShareBasedCompensationExpense
      contextRef="ie916e4a685544ae3998d4e82e089944f_D20210401-20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzY2E5YmIwMTc5MjQ3NmZiYjIyNWU1ZDlkZWM4NjlmL3NlYzo5M2NhOWJiMDE3OTI0NzZmYmIyMjVlNWQ5ZGVjODY5Zl81NS9mcmFnOjk0NGQ2N2RjOTNmMjQ1MjliZTc4ZmNlMzRiOGMyZTBiL3RhYmxlOjM0OTY4NTgyMjZmNzQzZWE4Y2M4ZWM1ZTVkMmQzODY5L3RhYmxlcmFuZ2U6MzQ5Njg1ODIyNmY3NDNlYThjYzhlYzVlNWQyZDM4NjlfMTItNS0xLTEtMA_6984f92d-c004-49df-b95d-ccd8ebde8377"
      unitRef="usd">0</us-gaap:AllocatedShareBasedCompensationExpense>
    <us-gaap:AllocatedShareBasedCompensationExpense
      contextRef="i27f4e53b91ad4367b7f8d273eff27769_D20210401-20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzY2E5YmIwMTc5MjQ3NmZiYjIyNWU1ZDlkZWM4NjlmL3NlYzo5M2NhOWJiMDE3OTI0NzZmYmIyMjVlNWQ5ZGVjODY5Zl81NS9mcmFnOjk0NGQ2N2RjOTNmMjQ1MjliZTc4ZmNlMzRiOGMyZTBiL3RhYmxlOjM0OTY4NTgyMjZmNzQzZWE4Y2M4ZWM1ZTVkMmQzODY5L3RhYmxlcmFuZ2U6MzQ5Njg1ODIyNmY3NDNlYThjYzhlYzVlNWQyZDM4NjlfMTItNy0xLTEtMA_a8a1c35a-ac56-46d9-9101-26f70318d23b"
      unitRef="usd">2565000</us-gaap:AllocatedShareBasedCompensationExpense>
    <cron:RestatementReviewExpense
      contextRef="i2a563d1bc1a1451296d5f40e6cdf2912_D20210401-20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzY2E5YmIwMTc5MjQ3NmZiYjIyNWU1ZDlkZWM4NjlmL3NlYzo5M2NhOWJiMDE3OTI0NzZmYmIyMjVlNWQ5ZGVjODY5Zl81NS9mcmFnOjk0NGQ2N2RjOTNmMjQ1MjliZTc4ZmNlMzRiOGMyZTBiL3RhYmxlOjM0OTY4NTgyMjZmNzQzZWE4Y2M4ZWM1ZTVkMmQzODY5L3RhYmxlcmFuZ2U6MzQ5Njg1ODIyNmY3NDNlYThjYzhlYzVlNWQyZDM4NjlfMTMtMS0xLTEtMA_77019d1f-bb2f-4112-8b2c-14eedd9ef86b"
      unitRef="usd">0</cron:RestatementReviewExpense>
    <cron:RestatementReviewExpense
      contextRef="i7b627a38d4bb4b2693a9598ca41f647d_D20210401-20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzY2E5YmIwMTc5MjQ3NmZiYjIyNWU1ZDlkZWM4NjlmL3NlYzo5M2NhOWJiMDE3OTI0NzZmYmIyMjVlNWQ5ZGVjODY5Zl81NS9mcmFnOjk0NGQ2N2RjOTNmMjQ1MjliZTc4ZmNlMzRiOGMyZTBiL3RhYmxlOjM0OTY4NTgyMjZmNzQzZWE4Y2M4ZWM1ZTVkMmQzODY5L3RhYmxlcmFuZ2U6MzQ5Njg1ODIyNmY3NDNlYThjYzhlYzVlNWQyZDM4NjlfMTMtMy0xLTEtMA_282c233e-9dea-47eb-b3fa-4521d72adb2f"
      unitRef="usd">0</cron:RestatementReviewExpense>
    <cron:RestatementReviewExpense
      contextRef="ie916e4a685544ae3998d4e82e089944f_D20210401-20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzY2E5YmIwMTc5MjQ3NmZiYjIyNWU1ZDlkZWM4NjlmL3NlYzo5M2NhOWJiMDE3OTI0NzZmYmIyMjVlNWQ5ZGVjODY5Zl81NS9mcmFnOjk0NGQ2N2RjOTNmMjQ1MjliZTc4ZmNlMzRiOGMyZTBiL3RhYmxlOjM0OTY4NTgyMjZmNzQzZWE4Y2M4ZWM1ZTVkMmQzODY5L3RhYmxlcmFuZ2U6MzQ5Njg1ODIyNmY3NDNlYThjYzhlYzVlNWQyZDM4NjlfMTMtNS0xLTEtMA_98276b24-2b36-4ff2-b09e-bf041e10b7b7"
      unitRef="usd">1932000</cron:RestatementReviewExpense>
    <cron:RestatementReviewExpense
      contextRef="i27f4e53b91ad4367b7f8d273eff27769_D20210401-20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzY2E5YmIwMTc5MjQ3NmZiYjIyNWU1ZDlkZWM4NjlmL3NlYzo5M2NhOWJiMDE3OTI0NzZmYmIyMjVlNWQ5ZGVjODY5Zl81NS9mcmFnOjk0NGQ2N2RjOTNmMjQ1MjliZTc4ZmNlMzRiOGMyZTBiL3RhYmxlOjM0OTY4NTgyMjZmNzQzZWE4Y2M4ZWM1ZTVkMmQzODY5L3RhYmxlcmFuZ2U6MzQ5Njg1ODIyNmY3NDNlYThjYzhlYzVlNWQyZDM4NjlfMTMtNy0xLTEtMA_3bdfe2d8-21ef-4d1a-8d10-bbb6cd8f242e"
      unitRef="usd">1932000</cron:RestatementReviewExpense>
    <us-gaap:DepreciationDepletionAndAmortization
      contextRef="i2a563d1bc1a1451296d5f40e6cdf2912_D20210401-20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzY2E5YmIwMTc5MjQ3NmZiYjIyNWU1ZDlkZWM4NjlmL3NlYzo5M2NhOWJiMDE3OTI0NzZmYmIyMjVlNWQ5ZGVjODY5Zl81NS9mcmFnOjk0NGQ2N2RjOTNmMjQ1MjliZTc4ZmNlMzRiOGMyZTBiL3RhYmxlOjM0OTY4NTgyMjZmNzQzZWE4Y2M4ZWM1ZTVkMmQzODY5L3RhYmxlcmFuZ2U6MzQ5Njg1ODIyNmY3NDNlYThjYzhlYzVlNWQyZDM4NjlfMTYtMS0xLTEtMA_219d519d-c1fd-4fbb-a776-c4bab35c2c16"
      unitRef="usd">206000</us-gaap:DepreciationDepletionAndAmortization>
    <us-gaap:DepreciationDepletionAndAmortization
      contextRef="i7b627a38d4bb4b2693a9598ca41f647d_D20210401-20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzY2E5YmIwMTc5MjQ3NmZiYjIyNWU1ZDlkZWM4NjlmL3NlYzo5M2NhOWJiMDE3OTI0NzZmYmIyMjVlNWQ5ZGVjODY5Zl81NS9mcmFnOjk0NGQ2N2RjOTNmMjQ1MjliZTc4ZmNlMzRiOGMyZTBiL3RhYmxlOjM0OTY4NTgyMjZmNzQzZWE4Y2M4ZWM1ZTVkMmQzODY5L3RhYmxlcmFuZ2U6MzQ5Njg1ODIyNmY3NDNlYThjYzhlYzVlNWQyZDM4NjlfMTYtMy0xLTEtMA_8114dcad-f6c0-412b-9f56-f07ce2e60167"
      unitRef="usd">2997000</us-gaap:DepreciationDepletionAndAmortization>
    <us-gaap:DepreciationDepletionAndAmortization
      contextRef="ie916e4a685544ae3998d4e82e089944f_D20210401-20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzY2E5YmIwMTc5MjQ3NmZiYjIyNWU1ZDlkZWM4NjlmL3NlYzo5M2NhOWJiMDE3OTI0NzZmYmIyMjVlNWQ5ZGVjODY5Zl81NS9mcmFnOjk0NGQ2N2RjOTNmMjQ1MjliZTc4ZmNlMzRiOGMyZTBiL3RhYmxlOjM0OTY4NTgyMjZmNzQzZWE4Y2M4ZWM1ZTVkMmQzODY5L3RhYmxlcmFuZ2U6MzQ5Njg1ODIyNmY3NDNlYThjYzhlYzVlNWQyZDM4NjlfMTYtNS0xLTEtMA_b92caf0a-9d8e-455e-a663-5a00890fb73a"
      unitRef="usd">0</us-gaap:DepreciationDepletionAndAmortization>
    <us-gaap:DepreciationDepletionAndAmortization
      contextRef="i27f4e53b91ad4367b7f8d273eff27769_D20210401-20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzY2E5YmIwMTc5MjQ3NmZiYjIyNWU1ZDlkZWM4NjlmL3NlYzo5M2NhOWJiMDE3OTI0NzZmYmIyMjVlNWQ5ZGVjODY5Zl81NS9mcmFnOjk0NGQ2N2RjOTNmMjQ1MjliZTc4ZmNlMzRiOGMyZTBiL3RhYmxlOjM0OTY4NTgyMjZmNzQzZWE4Y2M4ZWM1ZTVkMmQzODY5L3RhYmxlcmFuZ2U6MzQ5Njg1ODIyNmY3NDNlYThjYzhlYzVlNWQyZDM4NjlfMTYtNy0xLTEtMA_569720c7-696e-405d-aee5-e36505a34739"
      unitRef="usd">3203000</us-gaap:DepreciationDepletionAndAmortization>
    <cron:AdjustedEarningsBeforeInterestTaxesDepreciationAndAmortization
      contextRef="i2a563d1bc1a1451296d5f40e6cdf2912_D20210401-20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzY2E5YmIwMTc5MjQ3NmZiYjIyNWU1ZDlkZWM4NjlmL3NlYzo5M2NhOWJiMDE3OTI0NzZmYmIyMjVlNWQ5ZGVjODY5Zl81NS9mcmFnOjk0NGQ2N2RjOTNmMjQ1MjliZTc4ZmNlMzRiOGMyZTBiL3RhYmxlOjM0OTY4NTgyMjZmNzQzZWE4Y2M4ZWM1ZTVkMmQzODY5L3RhYmxlcmFuZ2U6MzQ5Njg1ODIyNmY3NDNlYThjYzhlYzVlNWQyZDM4NjlfMTctMS0xLTEtMA_7624d3cb-0115-427b-acb6-f7e93a008f82"
      unitRef="usd">-10711000</cron:AdjustedEarningsBeforeInterestTaxesDepreciationAndAmortization>
    <cron:AdjustedEarningsBeforeInterestTaxesDepreciationAndAmortization
      contextRef="i7b627a38d4bb4b2693a9598ca41f647d_D20210401-20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzY2E5YmIwMTc5MjQ3NmZiYjIyNWU1ZDlkZWM4NjlmL3NlYzo5M2NhOWJiMDE3OTI0NzZmYmIyMjVlNWQ5ZGVjODY5Zl81NS9mcmFnOjk0NGQ2N2RjOTNmMjQ1MjliZTc4ZmNlMzRiOGMyZTBiL3RhYmxlOjM0OTY4NTgyMjZmNzQzZWE4Y2M4ZWM1ZTVkMmQzODY5L3RhYmxlcmFuZ2U6MzQ5Njg1ODIyNmY3NDNlYThjYzhlYzVlNWQyZDM4NjlfMTctMy0xLTEtMA_0885fa9e-ffce-420e-bf80-0ab5f8eb01f2"
      unitRef="usd">-32605000</cron:AdjustedEarningsBeforeInterestTaxesDepreciationAndAmortization>
    <cron:AdjustedEarningsBeforeInterestTaxesDepreciationAndAmortization
      contextRef="ie916e4a685544ae3998d4e82e089944f_D20210401-20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzY2E5YmIwMTc5MjQ3NmZiYjIyNWU1ZDlkZWM4NjlmL3NlYzo5M2NhOWJiMDE3OTI0NzZmYmIyMjVlNWQ5ZGVjODY5Zl81NS9mcmFnOjk0NGQ2N2RjOTNmMjQ1MjliZTc4ZmNlMzRiOGMyZTBiL3RhYmxlOjM0OTY4NTgyMjZmNzQzZWE4Y2M4ZWM1ZTVkMmQzODY5L3RhYmxlcmFuZ2U6MzQ5Njg1ODIyNmY3NDNlYThjYzhlYzVlNWQyZDM4NjlfMTctNS0xLTEtMA_53cecb8c-6b6e-4329-9e17-abfe339ed31d"
      unitRef="usd">-6443000</cron:AdjustedEarningsBeforeInterestTaxesDepreciationAndAmortization>
    <cron:AdjustedEarningsBeforeInterestTaxesDepreciationAndAmortization
      contextRef="i27f4e53b91ad4367b7f8d273eff27769_D20210401-20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzY2E5YmIwMTc5MjQ3NmZiYjIyNWU1ZDlkZWM4NjlmL3NlYzo5M2NhOWJiMDE3OTI0NzZmYmIyMjVlNWQ5ZGVjODY5Zl81NS9mcmFnOjk0NGQ2N2RjOTNmMjQ1MjliZTc4ZmNlMzRiOGMyZTBiL3RhYmxlOjM0OTY4NTgyMjZmNzQzZWE4Y2M4ZWM1ZTVkMmQzODY5L3RhYmxlcmFuZ2U6MzQ5Njg1ODIyNmY3NDNlYThjYzhlYzVlNWQyZDM4NjlfMTctNy0xLTEtMA_d2cc0332-6b58-4812-a395-a09eb7997787"
      unitRef="usd">-49759000</cron:AdjustedEarningsBeforeInterestTaxesDepreciationAndAmortization>
    <us-gaap:ProfitLoss
      contextRef="icb85df07ebfc4bfa99c08f8c9f0cb89c_D20200401-20200630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzY2E5YmIwMTc5MjQ3NmZiYjIyNWU1ZDlkZWM4NjlmL3NlYzo5M2NhOWJiMDE3OTI0NzZmYmIyMjVlNWQ5ZGVjODY5Zl81NS9mcmFnOjk0NGQ2N2RjOTNmMjQ1MjliZTc4ZmNlMzRiOGMyZTBiL3RhYmxlOmMyMDc5OGU3NTU0NTRhYTc5N2Y1NGI2M2U3Njc3ZDY4L3RhYmxlcmFuZ2U6YzIwNzk4ZTc1NTQ1NGFhNzk3ZjU0YjYzZTc2NzdkNjhfMi0xLTEtMS0w_be69e42d-503d-4756-bb15-8bd79180e690"
      unitRef="usd">-45566000</us-gaap:ProfitLoss>
    <us-gaap:ProfitLoss
      contextRef="if83af42553ab4081bf67a6ecab2097fc_D20200401-20200630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzY2E5YmIwMTc5MjQ3NmZiYjIyNWU1ZDlkZWM4NjlmL3NlYzo5M2NhOWJiMDE3OTI0NzZmYmIyMjVlNWQ5ZGVjODY5Zl81NS9mcmFnOjk0NGQ2N2RjOTNmMjQ1MjliZTc4ZmNlMzRiOGMyZTBiL3RhYmxlOmMyMDc5OGU3NTU0NTRhYTc5N2Y1NGI2M2U3Njc3ZDY4L3RhYmxlcmFuZ2U6YzIwNzk4ZTc1NTQ1NGFhNzk3ZjU0YjYzZTc2NzdkNjhfMi0zLTEtMS0w_a6bd6b69-ba9c-4ba5-b1f2-687f6d216cda"
      unitRef="usd">-55095000</us-gaap:ProfitLoss>
    <us-gaap:ProfitLoss
      contextRef="i46e2093507a34f2fa6bcbc19a9aaaa63_D20200401-20200630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzY2E5YmIwMTc5MjQ3NmZiYjIyNWU1ZDlkZWM4NjlmL3NlYzo5M2NhOWJiMDE3OTI0NzZmYmIyMjVlNWQ5ZGVjODY5Zl81NS9mcmFnOjk0NGQ2N2RjOTNmMjQ1MjliZTc4ZmNlMzRiOGMyZTBiL3RhYmxlOmMyMDc5OGU3NTU0NTRhYTc5N2Y1NGI2M2U3Njc3ZDY4L3RhYmxlcmFuZ2U6YzIwNzk4ZTc1NTQ1NGFhNzk3ZjU0YjYzZTc2NzdkNjhfMi01LTEtMS0w_368acd1c-a5e5-4f9b-b41e-aad443a33581"
      unitRef="usd">-7042000</us-gaap:ProfitLoss>
    <us-gaap:ProfitLoss
      contextRef="i39065c5daf934af885335c12f3cfa83f_D20200401-20200630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzY2E5YmIwMTc5MjQ3NmZiYjIyNWU1ZDlkZWM4NjlmL3NlYzo5M2NhOWJiMDE3OTI0NzZmYmIyMjVlNWQ5ZGVjODY5Zl81NS9mcmFnOjk0NGQ2N2RjOTNmMjQ1MjliZTc4ZmNlMzRiOGMyZTBiL3RhYmxlOmMyMDc5OGU3NTU0NTRhYTc5N2Y1NGI2M2U3Njc3ZDY4L3RhYmxlcmFuZ2U6YzIwNzk4ZTc1NTQ1NGFhNzk3ZjU0YjYzZTc2NzdkNjhfMi03LTEtMS0w_b0d7cb03-83f9-4d7a-91bc-465ceae20d98"
      unitRef="usd">-107703000</us-gaap:ProfitLoss>
    <us-gaap:InterestIncomeExpenseNonoperatingNet
      contextRef="icb85df07ebfc4bfa99c08f8c9f0cb89c_D20200401-20200630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzY2E5YmIwMTc5MjQ3NmZiYjIyNWU1ZDlkZWM4NjlmL3NlYzo5M2NhOWJiMDE3OTI0NzZmYmIyMjVlNWQ5ZGVjODY5Zl81NS9mcmFnOjk0NGQ2N2RjOTNmMjQ1MjliZTc4ZmNlMzRiOGMyZTBiL3RhYmxlOmMyMDc5OGU3NTU0NTRhYTc5N2Y1NGI2M2U3Njc3ZDY4L3RhYmxlcmFuZ2U6YzIwNzk4ZTc1NTQ1NGFhNzk3ZjU0YjYzZTc2NzdkNjhfNC0xLTEtMS0w_d8e32372-de74-4046-b6f4-b2717854386f"
      unitRef="usd">9000</us-gaap:InterestIncomeExpenseNonoperatingNet>
    <us-gaap:InterestIncomeExpenseNonoperatingNet
      contextRef="if83af42553ab4081bf67a6ecab2097fc_D20200401-20200630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzY2E5YmIwMTc5MjQ3NmZiYjIyNWU1ZDlkZWM4NjlmL3NlYzo5M2NhOWJiMDE3OTI0NzZmYmIyMjVlNWQ5ZGVjODY5Zl81NS9mcmFnOjk0NGQ2N2RjOTNmMjQ1MjliZTc4ZmNlMzRiOGMyZTBiL3RhYmxlOmMyMDc5OGU3NTU0NTRhYTc5N2Y1NGI2M2U3Njc3ZDY4L3RhYmxlcmFuZ2U6YzIwNzk4ZTc1NTQ1NGFhNzk3ZjU0YjYzZTc2NzdkNjhfNC0zLTEtMS0w_d9316d33-79b8-4046-9a55-701eb344226c"
      unitRef="usd">3725000</us-gaap:InterestIncomeExpenseNonoperatingNet>
    <us-gaap:InterestIncomeExpenseNonoperatingNet
      contextRef="i46e2093507a34f2fa6bcbc19a9aaaa63_D20200401-20200630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzY2E5YmIwMTc5MjQ3NmZiYjIyNWU1ZDlkZWM4NjlmL3NlYzo5M2NhOWJiMDE3OTI0NzZmYmIyMjVlNWQ5ZGVjODY5Zl81NS9mcmFnOjk0NGQ2N2RjOTNmMjQ1MjliZTc4ZmNlMzRiOGMyZTBiL3RhYmxlOmMyMDc5OGU3NTU0NTRhYTc5N2Y1NGI2M2U3Njc3ZDY4L3RhYmxlcmFuZ2U6YzIwNzk4ZTc1NTQ1NGFhNzk3ZjU0YjYzZTc2NzdkNjhfNC01LTEtMS0w_c74897cf-f503-4a39-a846-2549dc82646f"
      unitRef="usd">0</us-gaap:InterestIncomeExpenseNonoperatingNet>
    <us-gaap:InterestIncomeExpenseNonoperatingNet
      contextRef="i39065c5daf934af885335c12f3cfa83f_D20200401-20200630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzY2E5YmIwMTc5MjQ3NmZiYjIyNWU1ZDlkZWM4NjlmL3NlYzo5M2NhOWJiMDE3OTI0NzZmYmIyMjVlNWQ5ZGVjODY5Zl81NS9mcmFnOjk0NGQ2N2RjOTNmMjQ1MjliZTc4ZmNlMzRiOGMyZTBiL3RhYmxlOmMyMDc5OGU3NTU0NTRhYTc5N2Y1NGI2M2U3Njc3ZDY4L3RhYmxlcmFuZ2U6YzIwNzk4ZTc1NTQ1NGFhNzk3ZjU0YjYzZTc2NzdkNjhfNC03LTEtMS0w_d1b61393-0635-4c7b-8a7e-729d81f12326"
      unitRef="usd">3734000</us-gaap:InterestIncomeExpenseNonoperatingNet>
    <us-gaap:IncomeLossFromEquityMethodInvestments
      contextRef="icb85df07ebfc4bfa99c08f8c9f0cb89c_D20200401-20200630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzY2E5YmIwMTc5MjQ3NmZiYjIyNWU1ZDlkZWM4NjlmL3NlYzo5M2NhOWJiMDE3OTI0NzZmYmIyMjVlNWQ5ZGVjODY5Zl81NS9mcmFnOjk0NGQ2N2RjOTNmMjQ1MjliZTc4ZmNlMzRiOGMyZTBiL3RhYmxlOmMyMDc5OGU3NTU0NTRhYTc5N2Y1NGI2M2U3Njc3ZDY4L3RhYmxlcmFuZ2U6YzIwNzk4ZTc1NTQ1NGFhNzk3ZjU0YjYzZTc2NzdkNjhfNi0xLTEtMS00NjQx_60e06f9b-c3b1-47fd-929f-c67e48327fa5"
      unitRef="usd">0</us-gaap:IncomeLossFromEquityMethodInvestments>
    <us-gaap:IncomeLossFromEquityMethodInvestments
      contextRef="if83af42553ab4081bf67a6ecab2097fc_D20200401-20200630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzY2E5YmIwMTc5MjQ3NmZiYjIyNWU1ZDlkZWM4NjlmL3NlYzo5M2NhOWJiMDE3OTI0NzZmYmIyMjVlNWQ5ZGVjODY5Zl81NS9mcmFnOjk0NGQ2N2RjOTNmMjQ1MjliZTc4ZmNlMzRiOGMyZTBiL3RhYmxlOmMyMDc5OGU3NTU0NTRhYTc5N2Y1NGI2M2U3Njc3ZDY4L3RhYmxlcmFuZ2U6YzIwNzk4ZTc1NTQ1NGFhNzk3ZjU0YjYzZTc2NzdkNjhfNi0zLTEtMS00NjQx_16c4a77a-5b18-4cd6-b271-6f5ebffd23d2"
      unitRef="usd">-794000</us-gaap:IncomeLossFromEquityMethodInvestments>
    <us-gaap:IncomeLossFromEquityMethodInvestments
      contextRef="i46e2093507a34f2fa6bcbc19a9aaaa63_D20200401-20200630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzY2E5YmIwMTc5MjQ3NmZiYjIyNWU1ZDlkZWM4NjlmL3NlYzo5M2NhOWJiMDE3OTI0NzZmYmIyMjVlNWQ5ZGVjODY5Zl81NS9mcmFnOjk0NGQ2N2RjOTNmMjQ1MjliZTc4ZmNlMzRiOGMyZTBiL3RhYmxlOmMyMDc5OGU3NTU0NTRhYTc5N2Y1NGI2M2U3Njc3ZDY4L3RhYmxlcmFuZ2U6YzIwNzk4ZTc1NTQ1NGFhNzk3ZjU0YjYzZTc2NzdkNjhfNi01LTEtMS00NjQx_adda06ea-fbd7-4351-92d4-aedb710ab592"
      unitRef="usd">0</us-gaap:IncomeLossFromEquityMethodInvestments>
    <us-gaap:IncomeLossFromEquityMethodInvestments
      contextRef="i39065c5daf934af885335c12f3cfa83f_D20200401-20200630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzY2E5YmIwMTc5MjQ3NmZiYjIyNWU1ZDlkZWM4NjlmL3NlYzo5M2NhOWJiMDE3OTI0NzZmYmIyMjVlNWQ5ZGVjODY5Zl81NS9mcmFnOjk0NGQ2N2RjOTNmMjQ1MjliZTc4ZmNlMzRiOGMyZTBiL3RhYmxlOmMyMDc5OGU3NTU0NTRhYTc5N2Y1NGI2M2U3Njc3ZDY4L3RhYmxlcmFuZ2U6YzIwNzk4ZTc1NTQ1NGFhNzk3ZjU0YjYzZTc2NzdkNjhfNi03LTEtMS00NjQx_c15f8c62-aef4-4ccb-82c4-0c3ca0404dc7"
      unitRef="usd">-794000</us-gaap:IncomeLossFromEquityMethodInvestments>
    <us-gaap:AssetImpairmentCharges
      contextRef="icb85df07ebfc4bfa99c08f8c9f0cb89c_D20200401-20200630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzY2E5YmIwMTc5MjQ3NmZiYjIyNWU1ZDlkZWM4NjlmL3NlYzo5M2NhOWJiMDE3OTI0NzZmYmIyMjVlNWQ5ZGVjODY5Zl81NS9mcmFnOjk0NGQ2N2RjOTNmMjQ1MjliZTc4ZmNlMzRiOGMyZTBiL3RhYmxlOmMyMDc5OGU3NTU0NTRhYTc5N2Y1NGI2M2U3Njc3ZDY4L3RhYmxlcmFuZ2U6YzIwNzk4ZTc1NTQ1NGFhNzk3ZjU0YjYzZTc2NzdkNjhfNi0xLTEtMS0w_3071a3e3-3926-4021-aeee-831a50dffbd2"
      unitRef="usd">40000000</us-gaap:AssetImpairmentCharges>
    <us-gaap:AssetImpairmentCharges
      contextRef="if83af42553ab4081bf67a6ecab2097fc_D20200401-20200630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzY2E5YmIwMTc5MjQ3NmZiYjIyNWU1ZDlkZWM4NjlmL3NlYzo5M2NhOWJiMDE3OTI0NzZmYmIyMjVlNWQ5ZGVjODY5Zl81NS9mcmFnOjk0NGQ2N2RjOTNmMjQ1MjliZTc4ZmNlMzRiOGMyZTBiL3RhYmxlOmMyMDc5OGU3NTU0NTRhYTc5N2Y1NGI2M2U3Njc3ZDY4L3RhYmxlcmFuZ2U6YzIwNzk4ZTc1NTQ1NGFhNzk3ZjU0YjYzZTc2NzdkNjhfNi0zLTEtMS0w_262e6dd4-72d6-419d-a63a-d18acb975993"
      unitRef="usd">0</us-gaap:AssetImpairmentCharges>
    <us-gaap:AssetImpairmentCharges
      contextRef="i46e2093507a34f2fa6bcbc19a9aaaa63_D20200401-20200630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzY2E5YmIwMTc5MjQ3NmZiYjIyNWU1ZDlkZWM4NjlmL3NlYzo5M2NhOWJiMDE3OTI0NzZmYmIyMjVlNWQ5ZGVjODY5Zl81NS9mcmFnOjk0NGQ2N2RjOTNmMjQ1MjliZTc4ZmNlMzRiOGMyZTBiL3RhYmxlOmMyMDc5OGU3NTU0NTRhYTc5N2Y1NGI2M2U3Njc3ZDY4L3RhYmxlcmFuZ2U6YzIwNzk4ZTc1NTQ1NGFhNzk3ZjU0YjYzZTc2NzdkNjhfNi01LTEtMS0w_4bfcdebb-884d-4960-93b9-ed713c868c73"
      unitRef="usd">0</us-gaap:AssetImpairmentCharges>
    <us-gaap:AssetImpairmentCharges
      contextRef="i39065c5daf934af885335c12f3cfa83f_D20200401-20200630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzY2E5YmIwMTc5MjQ3NmZiYjIyNWU1ZDlkZWM4NjlmL3NlYzo5M2NhOWJiMDE3OTI0NzZmYmIyMjVlNWQ5ZGVjODY5Zl81NS9mcmFnOjk0NGQ2N2RjOTNmMjQ1MjliZTc4ZmNlMzRiOGMyZTBiL3RhYmxlOmMyMDc5OGU3NTU0NTRhYTc5N2Y1NGI2M2U3Njc3ZDY4L3RhYmxlcmFuZ2U6YzIwNzk4ZTc1NTQ1NGFhNzk3ZjU0YjYzZTc2NzdkNjhfNi03LTEtMS0w_daa4e268-efa1-45d5-8df8-b92d04c65b49"
      unitRef="usd">40000000</us-gaap:AssetImpairmentCharges>
    <us-gaap:GainLossOnDerivativeInstrumentsNetPretax
      contextRef="icb85df07ebfc4bfa99c08f8c9f0cb89c_D20200401-20200630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzY2E5YmIwMTc5MjQ3NmZiYjIyNWU1ZDlkZWM4NjlmL3NlYzo5M2NhOWJiMDE3OTI0NzZmYmIyMjVlNWQ5ZGVjODY5Zl81NS9mcmFnOjk0NGQ2N2RjOTNmMjQ1MjliZTc4ZmNlMzRiOGMyZTBiL3RhYmxlOmMyMDc5OGU3NTU0NTRhYTc5N2Y1NGI2M2U3Njc3ZDY4L3RhYmxlcmFuZ2U6YzIwNzk4ZTc1NTQ1NGFhNzk3ZjU0YjYzZTc2NzdkNjhfNy0xLTEtMS0w_5ea2882c-3f61-48f1-8599-a9ee9d41eaa6"
      unitRef="usd">0</us-gaap:GainLossOnDerivativeInstrumentsNetPretax>
    <us-gaap:GainLossOnDerivativeInstrumentsNetPretax
      contextRef="if83af42553ab4081bf67a6ecab2097fc_D20200401-20200630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzY2E5YmIwMTc5MjQ3NmZiYjIyNWU1ZDlkZWM4NjlmL3NlYzo5M2NhOWJiMDE3OTI0NzZmYmIyMjVlNWQ5ZGVjODY5Zl81NS9mcmFnOjk0NGQ2N2RjOTNmMjQ1MjliZTc4ZmNlMzRiOGMyZTBiL3RhYmxlOmMyMDc5OGU3NTU0NTRhYTc5N2Y1NGI2M2U3Njc3ZDY4L3RhYmxlcmFuZ2U6YzIwNzk4ZTc1NTQ1NGFhNzk3ZjU0YjYzZTc2NzdkNjhfNy0zLTEtMS0w_18fdf2a2-4b47-43b2-999b-d69b02117056"
      unitRef="usd">-35880000</us-gaap:GainLossOnDerivativeInstrumentsNetPretax>
    <us-gaap:GainLossOnDerivativeInstrumentsNetPretax
      contextRef="i46e2093507a34f2fa6bcbc19a9aaaa63_D20200401-20200630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzY2E5YmIwMTc5MjQ3NmZiYjIyNWU1ZDlkZWM4NjlmL3NlYzo5M2NhOWJiMDE3OTI0NzZmYmIyMjVlNWQ5ZGVjODY5Zl81NS9mcmFnOjk0NGQ2N2RjOTNmMjQ1MjliZTc4ZmNlMzRiOGMyZTBiL3RhYmxlOmMyMDc5OGU3NTU0NTRhYTc5N2Y1NGI2M2U3Njc3ZDY4L3RhYmxlcmFuZ2U6YzIwNzk4ZTc1NTQ1NGFhNzk3ZjU0YjYzZTc2NzdkNjhfNy01LTEtMS0w_d0707f33-5fe4-460f-92b8-3d7850075f4a"
      unitRef="usd">0</us-gaap:GainLossOnDerivativeInstrumentsNetPretax>
    <us-gaap:GainLossOnDerivativeInstrumentsNetPretax
      contextRef="i39065c5daf934af885335c12f3cfa83f_D20200401-20200630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzY2E5YmIwMTc5MjQ3NmZiYjIyNWU1ZDlkZWM4NjlmL3NlYzo5M2NhOWJiMDE3OTI0NzZmYmIyMjVlNWQ5ZGVjODY5Zl81NS9mcmFnOjk0NGQ2N2RjOTNmMjQ1MjliZTc4ZmNlMzRiOGMyZTBiL3RhYmxlOmMyMDc5OGU3NTU0NTRhYTc5N2Y1NGI2M2U3Njc3ZDY4L3RhYmxlcmFuZ2U6YzIwNzk4ZTc1NTQ1NGFhNzk3ZjU0YjYzZTc2NzdkNjhfNy03LTEtMS0w_839287ff-625e-418e-a056-0e1e5fe5eba8"
      unitRef="usd">-35880000</us-gaap:GainLossOnDerivativeInstrumentsNetPretax>
    <us-gaap:OtherNonoperatingIncomeExpense
      contextRef="icb85df07ebfc4bfa99c08f8c9f0cb89c_D20200401-20200630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzY2E5YmIwMTc5MjQ3NmZiYjIyNWU1ZDlkZWM4NjlmL3NlYzo5M2NhOWJiMDE3OTI0NzZmYmIyMjVlNWQ5ZGVjODY5Zl81NS9mcmFnOjk0NGQ2N2RjOTNmMjQ1MjliZTc4ZmNlMzRiOGMyZTBiL3RhYmxlOmMyMDc5OGU3NTU0NTRhYTc5N2Y1NGI2M2U3Njc3ZDY4L3RhYmxlcmFuZ2U6YzIwNzk4ZTc1NTQ1NGFhNzk3ZjU0YjYzZTc2NzdkNjhfOC0xLTEtMS0w_0f46155e-9d49-4820-ab24-8d64141992e0"
      unitRef="usd">0</us-gaap:OtherNonoperatingIncomeExpense>
    <us-gaap:OtherNonoperatingIncomeExpense
      contextRef="if83af42553ab4081bf67a6ecab2097fc_D20200401-20200630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzY2E5YmIwMTc5MjQ3NmZiYjIyNWU1ZDlkZWM4NjlmL3NlYzo5M2NhOWJiMDE3OTI0NzZmYmIyMjVlNWQ5ZGVjODY5Zl81NS9mcmFnOjk0NGQ2N2RjOTNmMjQ1MjliZTc4ZmNlMzRiOGMyZTBiL3RhYmxlOmMyMDc5OGU3NTU0NTRhYTc5N2Y1NGI2M2U3Njc3ZDY4L3RhYmxlcmFuZ2U6YzIwNzk4ZTc1NTQ1NGFhNzk3ZjU0YjYzZTc2NzdkNjhfOC0zLTEtMS0w_599d5269-9c6a-4c6a-a182-a1e32113134b"
      unitRef="usd">-9000</us-gaap:OtherNonoperatingIncomeExpense>
    <us-gaap:OtherNonoperatingIncomeExpense
      contextRef="i46e2093507a34f2fa6bcbc19a9aaaa63_D20200401-20200630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzY2E5YmIwMTc5MjQ3NmZiYjIyNWU1ZDlkZWM4NjlmL3NlYzo5M2NhOWJiMDE3OTI0NzZmYmIyMjVlNWQ5ZGVjODY5Zl81NS9mcmFnOjk0NGQ2N2RjOTNmMjQ1MjliZTc4ZmNlMzRiOGMyZTBiL3RhYmxlOmMyMDc5OGU3NTU0NTRhYTc5N2Y1NGI2M2U3Njc3ZDY4L3RhYmxlcmFuZ2U6YzIwNzk4ZTc1NTQ1NGFhNzk3ZjU0YjYzZTc2NzdkNjhfOC01LTEtMS0w_a2b624f4-3733-4e9d-b48d-37b6f1572f52"
      unitRef="usd">0</us-gaap:OtherNonoperatingIncomeExpense>
    <us-gaap:OtherNonoperatingIncomeExpense
      contextRef="i39065c5daf934af885335c12f3cfa83f_D20200401-20200630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzY2E5YmIwMTc5MjQ3NmZiYjIyNWU1ZDlkZWM4NjlmL3NlYzo5M2NhOWJiMDE3OTI0NzZmYmIyMjVlNWQ5ZGVjODY5Zl81NS9mcmFnOjk0NGQ2N2RjOTNmMjQ1MjliZTc4ZmNlMzRiOGMyZTBiL3RhYmxlOmMyMDc5OGU3NTU0NTRhYTc5N2Y1NGI2M2U3Njc3ZDY4L3RhYmxlcmFuZ2U6YzIwNzk4ZTc1NTQ1NGFhNzk3ZjU0YjYzZTc2NzdkNjhfOC03LTEtMS0w_85c2d9c9-4244-4464-b3a6-6a00ce81f36c"
      unitRef="usd">-9000</us-gaap:OtherNonoperatingIncomeExpense>
    <us-gaap:IncomeLossFromDiscontinuedOperationsNetOfTax
      contextRef="icb85df07ebfc4bfa99c08f8c9f0cb89c_D20200401-20200630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzY2E5YmIwMTc5MjQ3NmZiYjIyNWU1ZDlkZWM4NjlmL3NlYzo5M2NhOWJiMDE3OTI0NzZmYmIyMjVlNWQ5ZGVjODY5Zl81NS9mcmFnOjk0NGQ2N2RjOTNmMjQ1MjliZTc4ZmNlMzRiOGMyZTBiL3RhYmxlOmMyMDc5OGU3NTU0NTRhYTc5N2Y1NGI2M2U3Njc3ZDY4L3RhYmxlcmFuZ2U6YzIwNzk4ZTc1NTQ1NGFhNzk3ZjU0YjYzZTc2NzdkNjhfOS0xLTEtMS0w_3f9e48a5-84fa-4875-af45-5916b89bf8fd"
      unitRef="usd">0</us-gaap:IncomeLossFromDiscontinuedOperationsNetOfTax>
    <us-gaap:IncomeLossFromDiscontinuedOperationsNetOfTax
      contextRef="if83af42553ab4081bf67a6ecab2097fc_D20200401-20200630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzY2E5YmIwMTc5MjQ3NmZiYjIyNWU1ZDlkZWM4NjlmL3NlYzo5M2NhOWJiMDE3OTI0NzZmYmIyMjVlNWQ5ZGVjODY5Zl81NS9mcmFnOjk0NGQ2N2RjOTNmMjQ1MjliZTc4ZmNlMzRiOGMyZTBiL3RhYmxlOmMyMDc5OGU3NTU0NTRhYTc5N2Y1NGI2M2U3Njc3ZDY4L3RhYmxlcmFuZ2U6YzIwNzk4ZTc1NTQ1NGFhNzk3ZjU0YjYzZTc2NzdkNjhfOS0zLTEtMS0w_454ef881-316f-40ea-8bb5-e4c0d46746dc"
      unitRef="usd">-46000</us-gaap:IncomeLossFromDiscontinuedOperationsNetOfTax>
    <us-gaap:IncomeLossFromDiscontinuedOperationsNetOfTax
      contextRef="i46e2093507a34f2fa6bcbc19a9aaaa63_D20200401-20200630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzY2E5YmIwMTc5MjQ3NmZiYjIyNWU1ZDlkZWM4NjlmL3NlYzo5M2NhOWJiMDE3OTI0NzZmYmIyMjVlNWQ5ZGVjODY5Zl81NS9mcmFnOjk0NGQ2N2RjOTNmMjQ1MjliZTc4ZmNlMzRiOGMyZTBiL3RhYmxlOmMyMDc5OGU3NTU0NTRhYTc5N2Y1NGI2M2U3Njc3ZDY4L3RhYmxlcmFuZ2U6YzIwNzk4ZTc1NTQ1NGFhNzk3ZjU0YjYzZTc2NzdkNjhfOS01LTEtMS0w_eb7dff5f-d0a9-4206-8fea-3f3d2c344391"
      unitRef="usd">0</us-gaap:IncomeLossFromDiscontinuedOperationsNetOfTax>
    <us-gaap:IncomeLossFromDiscontinuedOperationsNetOfTax
      contextRef="i39065c5daf934af885335c12f3cfa83f_D20200401-20200630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzY2E5YmIwMTc5MjQ3NmZiYjIyNWU1ZDlkZWM4NjlmL3NlYzo5M2NhOWJiMDE3OTI0NzZmYmIyMjVlNWQ5ZGVjODY5Zl81NS9mcmFnOjk0NGQ2N2RjOTNmMjQ1MjliZTc4ZmNlMzRiOGMyZTBiL3RhYmxlOmMyMDc5OGU3NTU0NTRhYTc5N2Y1NGI2M2U3Njc3ZDY4L3RhYmxlcmFuZ2U6YzIwNzk4ZTc1NTQ1NGFhNzk3ZjU0YjYzZTc2NzdkNjhfOS03LTEtMS0w_df3666d5-6b0a-4df9-8264-450d1dee8e7b"
      unitRef="usd">-46000</us-gaap:IncomeLossFromDiscontinuedOperationsNetOfTax>
    <us-gaap:AllocatedShareBasedCompensationExpense
      contextRef="icb85df07ebfc4bfa99c08f8c9f0cb89c_D20200401-20200630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzY2E5YmIwMTc5MjQ3NmZiYjIyNWU1ZDlkZWM4NjlmL3NlYzo5M2NhOWJiMDE3OTI0NzZmYmIyMjVlNWQ5ZGVjODY5Zl81NS9mcmFnOjk0NGQ2N2RjOTNmMjQ1MjliZTc4ZmNlMzRiOGMyZTBiL3RhYmxlOmMyMDc5OGU3NTU0NTRhYTc5N2Y1NGI2M2U3Njc3ZDY4L3RhYmxlcmFuZ2U6YzIwNzk4ZTc1NTQ1NGFhNzk3ZjU0YjYzZTc2NzdkNjhfMTAtMS0xLTEtMA_aab7c79e-9f0f-4ed2-8312-208f56540ff5"
      unitRef="usd">756000</us-gaap:AllocatedShareBasedCompensationExpense>
    <us-gaap:AllocatedShareBasedCompensationExpense
      contextRef="if83af42553ab4081bf67a6ecab2097fc_D20200401-20200630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzY2E5YmIwMTc5MjQ3NmZiYjIyNWU1ZDlkZWM4NjlmL3NlYzo5M2NhOWJiMDE3OTI0NzZmYmIyMjVlNWQ5ZGVjODY5Zl81NS9mcmFnOjk0NGQ2N2RjOTNmMjQ1MjliZTc4ZmNlMzRiOGMyZTBiL3RhYmxlOmMyMDc5OGU3NTU0NTRhYTc5N2Y1NGI2M2U3Njc3ZDY4L3RhYmxlcmFuZ2U6YzIwNzk4ZTc1NTQ1NGFhNzk3ZjU0YjYzZTc2NzdkNjhfMTAtMy0xLTEtMA_dfafe621-a75c-4725-8453-c1b6a12773f9"
      unitRef="usd">1790000</us-gaap:AllocatedShareBasedCompensationExpense>
    <us-gaap:AllocatedShareBasedCompensationExpense
      contextRef="i46e2093507a34f2fa6bcbc19a9aaaa63_D20200401-20200630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzY2E5YmIwMTc5MjQ3NmZiYjIyNWU1ZDlkZWM4NjlmL3NlYzo5M2NhOWJiMDE3OTI0NzZmYmIyMjVlNWQ5ZGVjODY5Zl81NS9mcmFnOjk0NGQ2N2RjOTNmMjQ1MjliZTc4ZmNlMzRiOGMyZTBiL3RhYmxlOmMyMDc5OGU3NTU0NTRhYTc5N2Y1NGI2M2U3Njc3ZDY4L3RhYmxlcmFuZ2U6YzIwNzk4ZTc1NTQ1NGFhNzk3ZjU0YjYzZTc2NzdkNjhfMTAtNS0xLTEtMA_311539ec-5480-4f70-8894-17db321cf96c"
      unitRef="usd">0</us-gaap:AllocatedShareBasedCompensationExpense>
    <us-gaap:AllocatedShareBasedCompensationExpense
      contextRef="i39065c5daf934af885335c12f3cfa83f_D20200401-20200630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzY2E5YmIwMTc5MjQ3NmZiYjIyNWU1ZDlkZWM4NjlmL3NlYzo5M2NhOWJiMDE3OTI0NzZmYmIyMjVlNWQ5ZGVjODY5Zl81NS9mcmFnOjk0NGQ2N2RjOTNmMjQ1MjliZTc4ZmNlMzRiOGMyZTBiL3RhYmxlOmMyMDc5OGU3NTU0NTRhYTc5N2Y1NGI2M2U3Njc3ZDY4L3RhYmxlcmFuZ2U6YzIwNzk4ZTc1NTQ1NGFhNzk3ZjU0YjYzZTc2NzdkNjhfMTAtNy0xLTEtMA_622fbd51-95cc-40df-9919-c63864527864"
      unitRef="usd">2546000</us-gaap:AllocatedShareBasedCompensationExpense>
    <cron:RestatementReviewExpense
      contextRef="icb85df07ebfc4bfa99c08f8c9f0cb89c_D20200401-20200630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzY2E5YmIwMTc5MjQ3NmZiYjIyNWU1ZDlkZWM4NjlmL3NlYzo5M2NhOWJiMDE3OTI0NzZmYmIyMjVlNWQ5ZGVjODY5Zl81NS9mcmFnOjk0NGQ2N2RjOTNmMjQ1MjliZTc4ZmNlMzRiOGMyZTBiL3RhYmxlOmMyMDc5OGU3NTU0NTRhYTc5N2Y1NGI2M2U3Njc3ZDY4L3RhYmxlcmFuZ2U6YzIwNzk4ZTc1NTQ1NGFhNzk3ZjU0YjYzZTc2NzdkNjhfMTEtMS0xLTEtMA_7d95c61c-2707-4a32-8c77-a4b7fbc1da1b"
      unitRef="usd">0</cron:RestatementReviewExpense>
    <cron:RestatementReviewExpense
      contextRef="if83af42553ab4081bf67a6ecab2097fc_D20200401-20200630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzY2E5YmIwMTc5MjQ3NmZiYjIyNWU1ZDlkZWM4NjlmL3NlYzo5M2NhOWJiMDE3OTI0NzZmYmIyMjVlNWQ5ZGVjODY5Zl81NS9mcmFnOjk0NGQ2N2RjOTNmMjQ1MjliZTc4ZmNlMzRiOGMyZTBiL3RhYmxlOmMyMDc5OGU3NTU0NTRhYTc5N2Y1NGI2M2U3Njc3ZDY4L3RhYmxlcmFuZ2U6YzIwNzk4ZTc1NTQ1NGFhNzk3ZjU0YjYzZTc2NzdkNjhfMTEtMy0xLTEtMA_1e3f15ff-4299-43cc-99d8-c7292d57c513"
      unitRef="usd">0</cron:RestatementReviewExpense>
    <cron:RestatementReviewExpense
      contextRef="i46e2093507a34f2fa6bcbc19a9aaaa63_D20200401-20200630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzY2E5YmIwMTc5MjQ3NmZiYjIyNWU1ZDlkZWM4NjlmL3NlYzo5M2NhOWJiMDE3OTI0NzZmYmIyMjVlNWQ5ZGVjODY5Zl81NS9mcmFnOjk0NGQ2N2RjOTNmMjQ1MjliZTc4ZmNlMzRiOGMyZTBiL3RhYmxlOmMyMDc5OGU3NTU0NTRhYTc5N2Y1NGI2M2U3Njc3ZDY4L3RhYmxlcmFuZ2U6YzIwNzk4ZTc1NTQ1NGFhNzk3ZjU0YjYzZTc2NzdkNjhfMTEtNS0xLTEtMA_255728d8-140e-4815-a661-4d0f6aa9b008"
      unitRef="usd">3459000</cron:RestatementReviewExpense>
    <cron:RestatementReviewExpense
      contextRef="i39065c5daf934af885335c12f3cfa83f_D20200401-20200630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzY2E5YmIwMTc5MjQ3NmZiYjIyNWU1ZDlkZWM4NjlmL3NlYzo5M2NhOWJiMDE3OTI0NzZmYmIyMjVlNWQ5ZGVjODY5Zl81NS9mcmFnOjk0NGQ2N2RjOTNmMjQ1MjliZTc4ZmNlMzRiOGMyZTBiL3RhYmxlOmMyMDc5OGU3NTU0NTRhYTc5N2Y1NGI2M2U3Njc3ZDY4L3RhYmxlcmFuZ2U6YzIwNzk4ZTc1NTQ1NGFhNzk3ZjU0YjYzZTc2NzdkNjhfMTEtNy0xLTEtMA_037620c4-dc13-46e7-af34-55779c34cd5d"
      unitRef="usd">3459000</cron:RestatementReviewExpense>
    <us-gaap:DepreciationDepletionAndAmortization
      contextRef="icb85df07ebfc4bfa99c08f8c9f0cb89c_D20200401-20200630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzY2E5YmIwMTc5MjQ3NmZiYjIyNWU1ZDlkZWM4NjlmL3NlYzo5M2NhOWJiMDE3OTI0NzZmYmIyMjVlNWQ5ZGVjODY5Zl81NS9mcmFnOjk0NGQ2N2RjOTNmMjQ1MjliZTc4ZmNlMzRiOGMyZTBiL3RhYmxlOmMyMDc5OGU3NTU0NTRhYTc5N2Y1NGI2M2U3Njc3ZDY4L3RhYmxlcmFuZ2U6YzIwNzk4ZTc1NTQ1NGFhNzk3ZjU0YjYzZTc2NzdkNjhfMTQtMS0xLTEtMA_0cf4efd0-aa3e-47a0-b6d3-067d92dba9d3"
      unitRef="usd">34000</us-gaap:DepreciationDepletionAndAmortization>
    <us-gaap:DepreciationDepletionAndAmortization
      contextRef="if83af42553ab4081bf67a6ecab2097fc_D20200401-20200630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzY2E5YmIwMTc5MjQ3NmZiYjIyNWU1ZDlkZWM4NjlmL3NlYzo5M2NhOWJiMDE3OTI0NzZmYmIyMjVlNWQ5ZGVjODY5Zl81NS9mcmFnOjk0NGQ2N2RjOTNmMjQ1MjliZTc4ZmNlMzRiOGMyZTBiL3RhYmxlOmMyMDc5OGU3NTU0NTRhYTc5N2Y1NGI2M2U3Njc3ZDY4L3RhYmxlcmFuZ2U6YzIwNzk4ZTc1NTQ1NGFhNzk3ZjU0YjYzZTc2NzdkNjhfMTQtMy0xLTEtMA_0af69bc0-a05b-4268-9898-f7793b77e37c"
      unitRef="usd">1683000</us-gaap:DepreciationDepletionAndAmortization>
    <us-gaap:DepreciationDepletionAndAmortization
      contextRef="i46e2093507a34f2fa6bcbc19a9aaaa63_D20200401-20200630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzY2E5YmIwMTc5MjQ3NmZiYjIyNWU1ZDlkZWM4NjlmL3NlYzo5M2NhOWJiMDE3OTI0NzZmYmIyMjVlNWQ5ZGVjODY5Zl81NS9mcmFnOjk0NGQ2N2RjOTNmMjQ1MjliZTc4ZmNlMzRiOGMyZTBiL3RhYmxlOmMyMDc5OGU3NTU0NTRhYTc5N2Y1NGI2M2U3Njc3ZDY4L3RhYmxlcmFuZ2U6YzIwNzk4ZTc1NTQ1NGFhNzk3ZjU0YjYzZTc2NzdkNjhfMTQtNS0xLTEtMA_ccc8a804-1486-499a-bf4f-5410e5179d59"
      unitRef="usd">0</us-gaap:DepreciationDepletionAndAmortization>
    <us-gaap:DepreciationDepletionAndAmortization
      contextRef="i39065c5daf934af885335c12f3cfa83f_D20200401-20200630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzY2E5YmIwMTc5MjQ3NmZiYjIyNWU1ZDlkZWM4NjlmL3NlYzo5M2NhOWJiMDE3OTI0NzZmYmIyMjVlNWQ5ZGVjODY5Zl81NS9mcmFnOjk0NGQ2N2RjOTNmMjQ1MjliZTc4ZmNlMzRiOGMyZTBiL3RhYmxlOmMyMDc5OGU3NTU0NTRhYTc5N2Y1NGI2M2U3Njc3ZDY4L3RhYmxlcmFuZ2U6YzIwNzk4ZTc1NTQ1NGFhNzk3ZjU0YjYzZTc2NzdkNjhfMTQtNy0xLTEtMA_6cc79ca8-46e1-40a0-aaa9-a218d6630b84"
      unitRef="usd">1717000</us-gaap:DepreciationDepletionAndAmortization>
    <cron:AdjustedEarningsBeforeInterestTaxesDepreciationAndAmortization
      contextRef="icb85df07ebfc4bfa99c08f8c9f0cb89c_D20200401-20200630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzY2E5YmIwMTc5MjQ3NmZiYjIyNWU1ZDlkZWM4NjlmL3NlYzo5M2NhOWJiMDE3OTI0NzZmYmIyMjVlNWQ5ZGVjODY5Zl81NS9mcmFnOjk0NGQ2N2RjOTNmMjQ1MjliZTc4ZmNlMzRiOGMyZTBiL3RhYmxlOmMyMDc5OGU3NTU0NTRhYTc5N2Y1NGI2M2U3Njc3ZDY4L3RhYmxlcmFuZ2U6YzIwNzk4ZTc1NTQ1NGFhNzk3ZjU0YjYzZTc2NzdkNjhfMTUtMS0xLTEtMA_3479ff87-385e-4e68-81b9-00ecaa15e0be"
      unitRef="usd">-4785000</cron:AdjustedEarningsBeforeInterestTaxesDepreciationAndAmortization>
    <cron:AdjustedEarningsBeforeInterestTaxesDepreciationAndAmortization
      contextRef="if83af42553ab4081bf67a6ecab2097fc_D20200401-20200630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzY2E5YmIwMTc5MjQ3NmZiYjIyNWU1ZDlkZWM4NjlmL3NlYzo5M2NhOWJiMDE3OTI0NzZmYmIyMjVlNWQ5ZGVjODY5Zl81NS9mcmFnOjk0NGQ2N2RjOTNmMjQ1MjliZTc4ZmNlMzRiOGMyZTBiL3RhYmxlOmMyMDc5OGU3NTU0NTRhYTc5N2Y1NGI2M2U3Njc3ZDY4L3RhYmxlcmFuZ2U6YzIwNzk4ZTc1NTQ1NGFhNzk3ZjU0YjYzZTc2NzdkNjhfMTUtMy0xLTEtMA_ec2ad022-4c16-43c0-b620-03d67c1d84c4"
      unitRef="usd">-18618000</cron:AdjustedEarningsBeforeInterestTaxesDepreciationAndAmortization>
    <cron:AdjustedEarningsBeforeInterestTaxesDepreciationAndAmortization
      contextRef="i46e2093507a34f2fa6bcbc19a9aaaa63_D20200401-20200630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzY2E5YmIwMTc5MjQ3NmZiYjIyNWU1ZDlkZWM4NjlmL3NlYzo5M2NhOWJiMDE3OTI0NzZmYmIyMjVlNWQ5ZGVjODY5Zl81NS9mcmFnOjk0NGQ2N2RjOTNmMjQ1MjliZTc4ZmNlMzRiOGMyZTBiL3RhYmxlOmMyMDc5OGU3NTU0NTRhYTc5N2Y1NGI2M2U3Njc3ZDY4L3RhYmxlcmFuZ2U6YzIwNzk4ZTc1NTQ1NGFhNzk3ZjU0YjYzZTc2NzdkNjhfMTUtNS0xLTEtMA_507fbc64-73e7-4a3c-aaaa-89f5a4e827b1"
      unitRef="usd">-3583000</cron:AdjustedEarningsBeforeInterestTaxesDepreciationAndAmortization>
    <cron:AdjustedEarningsBeforeInterestTaxesDepreciationAndAmortization
      contextRef="i39065c5daf934af885335c12f3cfa83f_D20200401-20200630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzY2E5YmIwMTc5MjQ3NmZiYjIyNWU1ZDlkZWM4NjlmL3NlYzo5M2NhOWJiMDE3OTI0NzZmYmIyMjVlNWQ5ZGVjODY5Zl81NS9mcmFnOjk0NGQ2N2RjOTNmMjQ1MjliZTc4ZmNlMzRiOGMyZTBiL3RhYmxlOmMyMDc5OGU3NTU0NTRhYTc5N2Y1NGI2M2U3Njc3ZDY4L3RhYmxlcmFuZ2U6YzIwNzk4ZTc1NTQ1NGFhNzk3ZjU0YjYzZTc2NzdkNjhfMTUtNy0xLTEtMA_a9b8f8f4-a370-490e-a4d8-9621694599ba"
      unitRef="usd">-26986000</cron:AdjustedEarningsBeforeInterestTaxesDepreciationAndAmortization>
    <us-gaap:ProfitLoss
      contextRef="i73f2057fe97d4f3a8524f987e78d1493_D20210101-20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzY2E5YmIwMTc5MjQ3NmZiYjIyNWU1ZDlkZWM4NjlmL3NlYzo5M2NhOWJiMDE3OTI0NzZmYmIyMjVlNWQ5ZGVjODY5Zl81NS9mcmFnOjk0NGQ2N2RjOTNmMjQ1MjliZTc4ZmNlMzRiOGMyZTBiL3RhYmxlOjEzZmNjYmI1NjhiMDRhNzk4OWQ0NDZkNWNkYjk4MWVjL3RhYmxlcmFuZ2U6MTNmY2NiYjU2OGIwNGE3OTg5ZDQ0NmQ1Y2RiOTgxZWNfMi0xLTEtMS0xNzAx_cf528f5d-8dab-4364-8090-48bbf2b8f18b"
      unitRef="usd">-23811000</us-gaap:ProfitLoss>
    <us-gaap:ProfitLoss
      contextRef="i9eea321560784f81a590aa8e3df3b187_D20210101-20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzY2E5YmIwMTc5MjQ3NmZiYjIyNWU1ZDlkZWM4NjlmL3NlYzo5M2NhOWJiMDE3OTI0NzZmYmIyMjVlNWQ5ZGVjODY5Zl81NS9mcmFnOjk0NGQ2N2RjOTNmMjQ1MjliZTc4ZmNlMzRiOGMyZTBiL3RhYmxlOjEzZmNjYmI1NjhiMDRhNzk4OWQ0NDZkNWNkYjk4MWVjL3RhYmxlcmFuZ2U6MTNmY2NiYjU2OGIwNGE3OTg5ZDQ0NmQ1Y2RiOTgxZWNfMi0zLTEtMS0xNzEy_c28a6a7a-4eba-485b-9ee0-049b50c00913"
      unitRef="usd">-62520000</us-gaap:ProfitLoss>
    <us-gaap:ProfitLoss
      contextRef="i5e244469383d46ddb452d43394f637d1_D20210101-20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzY2E5YmIwMTc5MjQ3NmZiYjIyNWU1ZDlkZWM4NjlmL3NlYzo5M2NhOWJiMDE3OTI0NzZmYmIyMjVlNWQ5ZGVjODY5Zl81NS9mcmFnOjk0NGQ2N2RjOTNmMjQ1MjliZTc4ZmNlMzRiOGMyZTBiL3RhYmxlOjEzZmNjYmI1NjhiMDRhNzk4OWQ0NDZkNWNkYjk4MWVjL3RhYmxlcmFuZ2U6MTNmY2NiYjU2OGIwNGE3OTg5ZDQ0NmQ1Y2RiOTgxZWNfMi01LTEtMS0xNzE4_71ce97af-69b0-4b37-876c-c4b0c8b1d91d"
      unitRef="usd">-18519000</us-gaap:ProfitLoss>
    <us-gaap:ProfitLoss
      contextRef="i69782326f71a44e3805518280ee22b6b_D20210101-20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzY2E5YmIwMTc5MjQ3NmZiYjIyNWU1ZDlkZWM4NjlmL3NlYzo5M2NhOWJiMDE3OTI0NzZmYmIyMjVlNWQ5ZGVjODY5Zl81NS9mcmFnOjk0NGQ2N2RjOTNmMjQ1MjliZTc4ZmNlMzRiOGMyZTBiL3RhYmxlOjEzZmNjYmI1NjhiMDRhNzk4OWQ0NDZkNWNkYjk4MWVjL3RhYmxlcmFuZ2U6MTNmY2NiYjU2OGIwNGE3OTg5ZDQ0NmQ1Y2RiOTgxZWNfMi03LTEtMS0xNjc1Mg_ae638d7d-512d-438d-b880-58219c2eafa2"
      unitRef="usd">-104850000</us-gaap:ProfitLoss>
    <us-gaap:InterestIncomeExpenseNonoperatingNet
      contextRef="i73f2057fe97d4f3a8524f987e78d1493_D20210101-20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzY2E5YmIwMTc5MjQ3NmZiYjIyNWU1ZDlkZWM4NjlmL3NlYzo5M2NhOWJiMDE3OTI0NzZmYmIyMjVlNWQ5ZGVjODY5Zl81NS9mcmFnOjk0NGQ2N2RjOTNmMjQ1MjliZTc4ZmNlMzRiOGMyZTBiL3RhYmxlOjEzZmNjYmI1NjhiMDRhNzk4OWQ0NDZkNWNkYjk4MWVjL3RhYmxlcmFuZ2U6MTNmY2NiYjU2OGIwNGE3OTg5ZDQ0NmQ1Y2RiOTgxZWNfNC0xLTEtMS0xNzAx_3ece2715-f39b-4a6d-8980-5de2f0025bbe"
      unitRef="usd">23000</us-gaap:InterestIncomeExpenseNonoperatingNet>
    <us-gaap:InterestIncomeExpenseNonoperatingNet
      contextRef="i9eea321560784f81a590aa8e3df3b187_D20210101-20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzY2E5YmIwMTc5MjQ3NmZiYjIyNWU1ZDlkZWM4NjlmL3NlYzo5M2NhOWJiMDE3OTI0NzZmYmIyMjVlNWQ5ZGVjODY5Zl81NS9mcmFnOjk0NGQ2N2RjOTNmMjQ1MjliZTc4ZmNlMzRiOGMyZTBiL3RhYmxlOjEzZmNjYmI1NjhiMDRhNzk4OWQ0NDZkNWNkYjk4MWVjL3RhYmxlcmFuZ2U6MTNmY2NiYjU2OGIwNGE3OTg5ZDQ0NmQ1Y2RiOTgxZWNfNC0zLTEtMS0xNzEy_e059f80e-578c-40aa-be1b-963eac434b19"
      unitRef="usd">4599000</us-gaap:InterestIncomeExpenseNonoperatingNet>
    <us-gaap:InterestIncomeExpenseNonoperatingNet
      contextRef="i5e244469383d46ddb452d43394f637d1_D20210101-20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzY2E5YmIwMTc5MjQ3NmZiYjIyNWU1ZDlkZWM4NjlmL3NlYzo5M2NhOWJiMDE3OTI0NzZmYmIyMjVlNWQ5ZGVjODY5Zl81NS9mcmFnOjk0NGQ2N2RjOTNmMjQ1MjliZTc4ZmNlMzRiOGMyZTBiL3RhYmxlOjEzZmNjYmI1NjhiMDRhNzk4OWQ0NDZkNWNkYjk4MWVjL3RhYmxlcmFuZ2U6MTNmY2NiYjU2OGIwNGE3OTg5ZDQ0NmQ1Y2RiOTgxZWNfNC01LTEtMS0xNzE4_83495ea8-d717-4b36-8fc4-e2d5c78ca1e2"
      unitRef="usd">0</us-gaap:InterestIncomeExpenseNonoperatingNet>
    <us-gaap:InterestIncomeExpenseNonoperatingNet
      contextRef="i69782326f71a44e3805518280ee22b6b_D20210101-20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzY2E5YmIwMTc5MjQ3NmZiYjIyNWU1ZDlkZWM4NjlmL3NlYzo5M2NhOWJiMDE3OTI0NzZmYmIyMjVlNWQ5ZGVjODY5Zl81NS9mcmFnOjk0NGQ2N2RjOTNmMjQ1MjliZTc4ZmNlMzRiOGMyZTBiL3RhYmxlOjEzZmNjYmI1NjhiMDRhNzk4OWQ0NDZkNWNkYjk4MWVjL3RhYmxlcmFuZ2U6MTNmY2NiYjU2OGIwNGE3OTg5ZDQ0NmQ1Y2RiOTgxZWNfMy03LTEtMS0xNjc1Mg_fa6ba203-7694-4fd7-8e0a-e4163e28d018"
      unitRef="usd">4622000</us-gaap:InterestIncomeExpenseNonoperatingNet>
    <us-gaap:IncomeLossFromEquityMethodInvestments
      contextRef="i73f2057fe97d4f3a8524f987e78d1493_D20210101-20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzY2E5YmIwMTc5MjQ3NmZiYjIyNWU1ZDlkZWM4NjlmL3NlYzo5M2NhOWJiMDE3OTI0NzZmYmIyMjVlNWQ5ZGVjODY5Zl81NS9mcmFnOjk0NGQ2N2RjOTNmMjQ1MjliZTc4ZmNlMzRiOGMyZTBiL3RhYmxlOjEzZmNjYmI1NjhiMDRhNzk4OWQ0NDZkNWNkYjk4MWVjL3RhYmxlcmFuZ2U6MTNmY2NiYjU2OGIwNGE3OTg5ZDQ0NmQ1Y2RiOTgxZWNfNi0xLTEtMS0xNzAx_7832ce39-0e22-48e0-b48f-6aaa37b10b84"
      unitRef="usd">0</us-gaap:IncomeLossFromEquityMethodInvestments>
    <us-gaap:IncomeLossFromEquityMethodInvestments
      contextRef="i9eea321560784f81a590aa8e3df3b187_D20210101-20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzY2E5YmIwMTc5MjQ3NmZiYjIyNWU1ZDlkZWM4NjlmL3NlYzo5M2NhOWJiMDE3OTI0NzZmYmIyMjVlNWQ5ZGVjODY5Zl81NS9mcmFnOjk0NGQ2N2RjOTNmMjQ1MjliZTc4ZmNlMzRiOGMyZTBiL3RhYmxlOjEzZmNjYmI1NjhiMDRhNzk4OWQ0NDZkNWNkYjk4MWVjL3RhYmxlcmFuZ2U6MTNmY2NiYjU2OGIwNGE3OTg5ZDQ0NmQ1Y2RiOTgxZWNfNi0zLTEtMS0xNzEy_76ac5fce-0a74-4882-aebb-2079ed2364e9"
      unitRef="usd">-2758000</us-gaap:IncomeLossFromEquityMethodInvestments>
    <us-gaap:IncomeLossFromEquityMethodInvestments
      contextRef="i5e244469383d46ddb452d43394f637d1_D20210101-20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzY2E5YmIwMTc5MjQ3NmZiYjIyNWU1ZDlkZWM4NjlmL3NlYzo5M2NhOWJiMDE3OTI0NzZmYmIyMjVlNWQ5ZGVjODY5Zl81NS9mcmFnOjk0NGQ2N2RjOTNmMjQ1MjliZTc4ZmNlMzRiOGMyZTBiL3RhYmxlOjEzZmNjYmI1NjhiMDRhNzk4OWQ0NDZkNWNkYjk4MWVjL3RhYmxlcmFuZ2U6MTNmY2NiYjU2OGIwNGE3OTg5ZDQ0NmQ1Y2RiOTgxZWNfNi01LTEtMS0xNzE4_f94e189a-364d-4741-afcf-801f7d8fbef9"
      unitRef="usd">0</us-gaap:IncomeLossFromEquityMethodInvestments>
    <us-gaap:IncomeLossFromEquityMethodInvestments
      contextRef="i69782326f71a44e3805518280ee22b6b_D20210101-20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzY2E5YmIwMTc5MjQ3NmZiYjIyNWU1ZDlkZWM4NjlmL3NlYzo5M2NhOWJiMDE3OTI0NzZmYmIyMjVlNWQ5ZGVjODY5Zl81NS9mcmFnOjk0NGQ2N2RjOTNmMjQ1MjliZTc4ZmNlMzRiOGMyZTBiL3RhYmxlOjEzZmNjYmI1NjhiMDRhNzk4OWQ0NDZkNWNkYjk4MWVjL3RhYmxlcmFuZ2U6MTNmY2NiYjU2OGIwNGE3OTg5ZDQ0NmQ1Y2RiOTgxZWNfNS03LTEtMS0xNjc1Mg_bd7f2044-8c92-4f4e-b69e-4cdc09035217"
      unitRef="usd">-2758000</us-gaap:IncomeLossFromEquityMethodInvestments>
    <us-gaap:AssetImpairmentCharges
      contextRef="i73f2057fe97d4f3a8524f987e78d1493_D20210101-20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzY2E5YmIwMTc5MjQ3NmZiYjIyNWU1ZDlkZWM4NjlmL3NlYzo5M2NhOWJiMDE3OTI0NzZmYmIyMjVlNWQ5ZGVjODY5Zl81NS9mcmFnOjk0NGQ2N2RjOTNmMjQ1MjliZTc4ZmNlMzRiOGMyZTBiL3RhYmxlOjEzZmNjYmI1NjhiMDRhNzk4OWQ0NDZkNWNkYjk4MWVjL3RhYmxlcmFuZ2U6MTNmY2NiYjU2OGIwNGE3OTg5ZDQ0NmQ1Y2RiOTgxZWNfNy0xLTEtMS0xNzAx_39dc4d7e-ef08-4760-ab5a-0f1ff2c09f95"
      unitRef="usd">1741000</us-gaap:AssetImpairmentCharges>
    <us-gaap:AssetImpairmentCharges
      contextRef="i9eea321560784f81a590aa8e3df3b187_D20210101-20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzY2E5YmIwMTc5MjQ3NmZiYjIyNWU1ZDlkZWM4NjlmL3NlYzo5M2NhOWJiMDE3OTI0NzZmYmIyMjVlNWQ5ZGVjODY5Zl81NS9mcmFnOjk0NGQ2N2RjOTNmMjQ1MjliZTc4ZmNlMzRiOGMyZTBiL3RhYmxlOjEzZmNjYmI1NjhiMDRhNzk4OWQ0NDZkNWNkYjk4MWVjL3RhYmxlcmFuZ2U6MTNmY2NiYjU2OGIwNGE3OTg5ZDQ0NmQ1Y2RiOTgxZWNfNy0zLTEtMS0xNzEy_31d50ebb-8d0d-4f2f-82d5-beb1d6bc4e03"
      unitRef="usd">0</us-gaap:AssetImpairmentCharges>
    <us-gaap:AssetImpairmentCharges
      contextRef="i5e244469383d46ddb452d43394f637d1_D20210101-20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzY2E5YmIwMTc5MjQ3NmZiYjIyNWU1ZDlkZWM4NjlmL3NlYzo5M2NhOWJiMDE3OTI0NzZmYmIyMjVlNWQ5ZGVjODY5Zl81NS9mcmFnOjk0NGQ2N2RjOTNmMjQ1MjliZTc4ZmNlMzRiOGMyZTBiL3RhYmxlOjEzZmNjYmI1NjhiMDRhNzk4OWQ0NDZkNWNkYjk4MWVjL3RhYmxlcmFuZ2U6MTNmY2NiYjU2OGIwNGE3OTg5ZDQ0NmQ1Y2RiOTgxZWNfNy01LTEtMS0xNzE4_ac238863-8216-4c38-9b68-675828676c43"
      unitRef="usd">0</us-gaap:AssetImpairmentCharges>
    <us-gaap:AssetImpairmentCharges
      contextRef="i69782326f71a44e3805518280ee22b6b_D20210101-20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzY2E5YmIwMTc5MjQ3NmZiYjIyNWU1ZDlkZWM4NjlmL3NlYzo5M2NhOWJiMDE3OTI0NzZmYmIyMjVlNWQ5ZGVjODY5Zl81NS9mcmFnOjk0NGQ2N2RjOTNmMjQ1MjliZTc4ZmNlMzRiOGMyZTBiL3RhYmxlOjEzZmNjYmI1NjhiMDRhNzk4OWQ0NDZkNWNkYjk4MWVjL3RhYmxlcmFuZ2U6MTNmY2NiYjU2OGIwNGE3OTg5ZDQ0NmQ1Y2RiOTgxZWNfNi03LTEtMS0xNjc1Mg_e8299219-36c4-45e6-8588-716d69077d55"
      unitRef="usd">1741000</us-gaap:AssetImpairmentCharges>
    <us-gaap:GainLossOnDerivativeInstrumentsNetPretax
      contextRef="i73f2057fe97d4f3a8524f987e78d1493_D20210101-20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzY2E5YmIwMTc5MjQ3NmZiYjIyNWU1ZDlkZWM4NjlmL3NlYzo5M2NhOWJiMDE3OTI0NzZmYmIyMjVlNWQ5ZGVjODY5Zl81NS9mcmFnOjk0NGQ2N2RjOTNmMjQ1MjliZTc4ZmNlMzRiOGMyZTBiL3RhYmxlOjEzZmNjYmI1NjhiMDRhNzk4OWQ0NDZkNWNkYjk4MWVjL3RhYmxlcmFuZ2U6MTNmY2NiYjU2OGIwNGE3OTg5ZDQ0NmQ1Y2RiOTgxZWNfOC0xLTEtMS0xNzAx_b1c484f4-bbd6-4232-8acf-105dca149120"
      unitRef="usd">0</us-gaap:GainLossOnDerivativeInstrumentsNetPretax>
    <us-gaap:GainLossOnDerivativeInstrumentsNetPretax
      contextRef="i9eea321560784f81a590aa8e3df3b187_D20210101-20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzY2E5YmIwMTc5MjQ3NmZiYjIyNWU1ZDlkZWM4NjlmL3NlYzo5M2NhOWJiMDE3OTI0NzZmYmIyMjVlNWQ5ZGVjODY5Zl81NS9mcmFnOjk0NGQ2N2RjOTNmMjQ1MjliZTc4ZmNlMzRiOGMyZTBiL3RhYmxlOjEzZmNjYmI1NjhiMDRhNzk4OWQ0NDZkNWNkYjk4MWVjL3RhYmxlcmFuZ2U6MTNmY2NiYjU2OGIwNGE3OTg5ZDQ0NmQ1Y2RiOTgxZWNfOC0zLTEtMS0xNzEy_bb1ca37e-6dad-4b35-8b37-869c38ceecae"
      unitRef="usd">-1626000</us-gaap:GainLossOnDerivativeInstrumentsNetPretax>
    <us-gaap:GainLossOnDerivativeInstrumentsNetPretax
      contextRef="i5e244469383d46ddb452d43394f637d1_D20210101-20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzY2E5YmIwMTc5MjQ3NmZiYjIyNWU1ZDlkZWM4NjlmL3NlYzo5M2NhOWJiMDE3OTI0NzZmYmIyMjVlNWQ5ZGVjODY5Zl81NS9mcmFnOjk0NGQ2N2RjOTNmMjQ1MjliZTc4ZmNlMzRiOGMyZTBiL3RhYmxlOjEzZmNjYmI1NjhiMDRhNzk4OWQ0NDZkNWNkYjk4MWVjL3RhYmxlcmFuZ2U6MTNmY2NiYjU2OGIwNGE3OTg5ZDQ0NmQ1Y2RiOTgxZWNfOC01LTEtMS0xNzE4_f7e612bd-b93f-4abd-9cdb-dca56cd5d68d"
      unitRef="usd">0</us-gaap:GainLossOnDerivativeInstrumentsNetPretax>
    <us-gaap:GainLossOnDerivativeInstrumentsNetPretax
      contextRef="i69782326f71a44e3805518280ee22b6b_D20210101-20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzY2E5YmIwMTc5MjQ3NmZiYjIyNWU1ZDlkZWM4NjlmL3NlYzo5M2NhOWJiMDE3OTI0NzZmYmIyMjVlNWQ5ZGVjODY5Zl81NS9mcmFnOjk0NGQ2N2RjOTNmMjQ1MjliZTc4ZmNlMzRiOGMyZTBiL3RhYmxlOjEzZmNjYmI1NjhiMDRhNzk4OWQ0NDZkNWNkYjk4MWVjL3RhYmxlcmFuZ2U6MTNmY2NiYjU2OGIwNGE3OTg5ZDQ0NmQ1Y2RiOTgxZWNfNy03LTEtMS0xNjc1Mg_2a6366a1-618b-48e5-ba8e-2783dfdd54b4"
      unitRef="usd">-1626000</us-gaap:GainLossOnDerivativeInstrumentsNetPretax>
    <us-gaap:RestructuringCharges
      contextRef="i73f2057fe97d4f3a8524f987e78d1493_D20210101-20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzY2E5YmIwMTc5MjQ3NmZiYjIyNWU1ZDlkZWM4NjlmL3NlYzo5M2NhOWJiMDE3OTI0NzZmYmIyMjVlNWQ5ZGVjODY5Zl81NS9mcmFnOjk0NGQ2N2RjOTNmMjQ1MjliZTc4ZmNlMzRiOGMyZTBiL3RhYmxlOjEzZmNjYmI1NjhiMDRhNzk4OWQ0NDZkNWNkYjk4MWVjL3RhYmxlcmFuZ2U6MTNmY2NiYjU2OGIwNGE3OTg5ZDQ0NmQ1Y2RiOTgxZWNfOS0xLTEtMS0xNzAx_2206768a-927b-4e70-9d41-6768ef50cbf2"
      unitRef="usd">0</us-gaap:RestructuringCharges>
    <us-gaap:RestructuringCharges
      contextRef="i9eea321560784f81a590aa8e3df3b187_D20210101-20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzY2E5YmIwMTc5MjQ3NmZiYjIyNWU1ZDlkZWM4NjlmL3NlYzo5M2NhOWJiMDE3OTI0NzZmYmIyMjVlNWQ5ZGVjODY5Zl81NS9mcmFnOjk0NGQ2N2RjOTNmMjQ1MjliZTc4ZmNlMzRiOGMyZTBiL3RhYmxlOjEzZmNjYmI1NjhiMDRhNzk4OWQ0NDZkNWNkYjk4MWVjL3RhYmxlcmFuZ2U6MTNmY2NiYjU2OGIwNGE3OTg5ZDQ0NmQ1Y2RiOTgxZWNfOS0zLTEtMS0xNzEy_e840017e-2b42-4da2-86e8-a6ab67e4192c"
      unitRef="usd">0</us-gaap:RestructuringCharges>
    <us-gaap:RestructuringCharges
      contextRef="i5e244469383d46ddb452d43394f637d1_D20210101-20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzY2E5YmIwMTc5MjQ3NmZiYjIyNWU1ZDlkZWM4NjlmL3NlYzo5M2NhOWJiMDE3OTI0NzZmYmIyMjVlNWQ5ZGVjODY5Zl81NS9mcmFnOjk0NGQ2N2RjOTNmMjQ1MjliZTc4ZmNlMzRiOGMyZTBiL3RhYmxlOjEzZmNjYmI1NjhiMDRhNzk4OWQ0NDZkNWNkYjk4MWVjL3RhYmxlcmFuZ2U6MTNmY2NiYjU2OGIwNGE3OTg5ZDQ0NmQ1Y2RiOTgxZWNfOS01LTEtMS0xNzE4_09d6ca30-e2a2-4bf7-9fc2-17fe87c1e163"
      unitRef="usd">3259000</us-gaap:RestructuringCharges>
    <us-gaap:RestructuringCharges
      contextRef="i69782326f71a44e3805518280ee22b6b_D20210101-20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzY2E5YmIwMTc5MjQ3NmZiYjIyNWU1ZDlkZWM4NjlmL3NlYzo5M2NhOWJiMDE3OTI0NzZmYmIyMjVlNWQ5ZGVjODY5Zl81NS9mcmFnOjk0NGQ2N2RjOTNmMjQ1MjliZTc4ZmNlMzRiOGMyZTBiL3RhYmxlOjEzZmNjYmI1NjhiMDRhNzk4OWQ0NDZkNWNkYjk4MWVjL3RhYmxlcmFuZ2U6MTNmY2NiYjU2OGIwNGE3OTg5ZDQ0NmQ1Y2RiOTgxZWNfOC03LTEtMS0xNjc1Mg_027f4f07-ee14-4bc5-8dbf-54b64fd838e9"
      unitRef="usd">3259000</us-gaap:RestructuringCharges>
    <us-gaap:OtherNonoperatingIncomeExpense
      contextRef="i73f2057fe97d4f3a8524f987e78d1493_D20210101-20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzY2E5YmIwMTc5MjQ3NmZiYjIyNWU1ZDlkZWM4NjlmL3NlYzo5M2NhOWJiMDE3OTI0NzZmYmIyMjVlNWQ5ZGVjODY5Zl81NS9mcmFnOjk0NGQ2N2RjOTNmMjQ1MjliZTc4ZmNlMzRiOGMyZTBiL3RhYmxlOjEzZmNjYmI1NjhiMDRhNzk4OWQ0NDZkNWNkYjk4MWVjL3RhYmxlcmFuZ2U6MTNmY2NiYjU2OGIwNGE3OTg5ZDQ0NmQ1Y2RiOTgxZWNfMTAtMS0xLTEtMTcwMQ_ce6c1bac-cdac-494d-bf5b-fea24eff7e26"
      unitRef="usd">0</us-gaap:OtherNonoperatingIncomeExpense>
    <us-gaap:OtherNonoperatingIncomeExpense
      contextRef="i9eea321560784f81a590aa8e3df3b187_D20210101-20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzY2E5YmIwMTc5MjQ3NmZiYjIyNWU1ZDlkZWM4NjlmL3NlYzo5M2NhOWJiMDE3OTI0NzZmYmIyMjVlNWQ5ZGVjODY5Zl81NS9mcmFnOjk0NGQ2N2RjOTNmMjQ1MjliZTc4ZmNlMzRiOGMyZTBiL3RhYmxlOjEzZmNjYmI1NjhiMDRhNzk4OWQ0NDZkNWNkYjk4MWVjL3RhYmxlcmFuZ2U6MTNmY2NiYjU2OGIwNGE3OTg5ZDQ0NmQ1Y2RiOTgxZWNfMTAtMy0xLTEtMTcxMg_01f6892f-f1d3-48b8-ad99-dc7f7447d861"
      unitRef="usd">911000</us-gaap:OtherNonoperatingIncomeExpense>
    <us-gaap:OtherNonoperatingIncomeExpense
      contextRef="i5e244469383d46ddb452d43394f637d1_D20210101-20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzY2E5YmIwMTc5MjQ3NmZiYjIyNWU1ZDlkZWM4NjlmL3NlYzo5M2NhOWJiMDE3OTI0NzZmYmIyMjVlNWQ5ZGVjODY5Zl81NS9mcmFnOjk0NGQ2N2RjOTNmMjQ1MjliZTc4ZmNlMzRiOGMyZTBiL3RhYmxlOjEzZmNjYmI1NjhiMDRhNzk4OWQ0NDZkNWNkYjk4MWVjL3RhYmxlcmFuZ2U6MTNmY2NiYjU2OGIwNGE3OTg5ZDQ0NmQ1Y2RiOTgxZWNfMTAtNS0xLTEtMTcxOA_f531328c-8e89-4ea4-9d96-a770a6257f3f"
      unitRef="usd">0</us-gaap:OtherNonoperatingIncomeExpense>
    <us-gaap:OtherNonoperatingIncomeExpense
      contextRef="i69782326f71a44e3805518280ee22b6b_D20210101-20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzY2E5YmIwMTc5MjQ3NmZiYjIyNWU1ZDlkZWM4NjlmL3NlYzo5M2NhOWJiMDE3OTI0NzZmYmIyMjVlNWQ5ZGVjODY5Zl81NS9mcmFnOjk0NGQ2N2RjOTNmMjQ1MjliZTc4ZmNlMzRiOGMyZTBiL3RhYmxlOjEzZmNjYmI1NjhiMDRhNzk4OWQ0NDZkNWNkYjk4MWVjL3RhYmxlcmFuZ2U6MTNmY2NiYjU2OGIwNGE3OTg5ZDQ0NmQ1Y2RiOTgxZWNfOS03LTEtMS0xNjc1Mg_18d1101c-8233-476f-954e-bd5e28e3ca54"
      unitRef="usd">911000</us-gaap:OtherNonoperatingIncomeExpense>
    <us-gaap:IncomeLossFromDiscontinuedOperationsNetOfTax
      contextRef="i73f2057fe97d4f3a8524f987e78d1493_D20210101-20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzY2E5YmIwMTc5MjQ3NmZiYjIyNWU1ZDlkZWM4NjlmL3NlYzo5M2NhOWJiMDE3OTI0NzZmYmIyMjVlNWQ5ZGVjODY5Zl81NS9mcmFnOjk0NGQ2N2RjOTNmMjQ1MjliZTc4ZmNlMzRiOGMyZTBiL3RhYmxlOjEzZmNjYmI1NjhiMDRhNzk4OWQ0NDZkNWNkYjk4MWVjL3RhYmxlcmFuZ2U6MTNmY2NiYjU2OGIwNGE3OTg5ZDQ0NmQ1Y2RiOTgxZWNfMTEtMS0xLTEtMTcwMQ_e6df5383-772c-4a33-9afc-27a6bb3e9605"
      unitRef="usd">0</us-gaap:IncomeLossFromDiscontinuedOperationsNetOfTax>
    <us-gaap:IncomeLossFromDiscontinuedOperationsNetOfTax
      contextRef="i9eea321560784f81a590aa8e3df3b187_D20210101-20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzY2E5YmIwMTc5MjQ3NmZiYjIyNWU1ZDlkZWM4NjlmL3NlYzo5M2NhOWJiMDE3OTI0NzZmYmIyMjVlNWQ5ZGVjODY5Zl81NS9mcmFnOjk0NGQ2N2RjOTNmMjQ1MjliZTc4ZmNlMzRiOGMyZTBiL3RhYmxlOjEzZmNjYmI1NjhiMDRhNzk4OWQ0NDZkNWNkYjk4MWVjL3RhYmxlcmFuZ2U6MTNmY2NiYjU2OGIwNGE3OTg5ZDQ0NmQ1Y2RiOTgxZWNfMTEtMy0xLTEtMTcxMg_b9fabc92-7aed-4388-8805-8d7275ff23d7"
      unitRef="usd">-582000</us-gaap:IncomeLossFromDiscontinuedOperationsNetOfTax>
    <us-gaap:IncomeLossFromDiscontinuedOperationsNetOfTax
      contextRef="i5e244469383d46ddb452d43394f637d1_D20210101-20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzY2E5YmIwMTc5MjQ3NmZiYjIyNWU1ZDlkZWM4NjlmL3NlYzo5M2NhOWJiMDE3OTI0NzZmYmIyMjVlNWQ5ZGVjODY5Zl81NS9mcmFnOjk0NGQ2N2RjOTNmMjQ1MjliZTc4ZmNlMzRiOGMyZTBiL3RhYmxlOjEzZmNjYmI1NjhiMDRhNzk4OWQ0NDZkNWNkYjk4MWVjL3RhYmxlcmFuZ2U6MTNmY2NiYjU2OGIwNGE3OTg5ZDQ0NmQ1Y2RiOTgxZWNfMTEtNS0xLTEtMTcxOA_3d668e13-5e7e-4692-ab30-af1a14e743e6"
      unitRef="usd">0</us-gaap:IncomeLossFromDiscontinuedOperationsNetOfTax>
    <us-gaap:IncomeLossFromDiscontinuedOperationsNetOfTax
      contextRef="i69782326f71a44e3805518280ee22b6b_D20210101-20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzY2E5YmIwMTc5MjQ3NmZiYjIyNWU1ZDlkZWM4NjlmL3NlYzo5M2NhOWJiMDE3OTI0NzZmYmIyMjVlNWQ5ZGVjODY5Zl81NS9mcmFnOjk0NGQ2N2RjOTNmMjQ1MjliZTc4ZmNlMzRiOGMyZTBiL3RhYmxlOjEzZmNjYmI1NjhiMDRhNzk4OWQ0NDZkNWNkYjk4MWVjL3RhYmxlcmFuZ2U6MTNmY2NiYjU2OGIwNGE3OTg5ZDQ0NmQ1Y2RiOTgxZWNfMTAtNy0xLTEtMTY3NTI_b8aa1b20-fd2e-48c5-a4b4-73a118d43241"
      unitRef="usd">-582000</us-gaap:IncomeLossFromDiscontinuedOperationsNetOfTax>
    <us-gaap:AllocatedShareBasedCompensationExpense
      contextRef="i73f2057fe97d4f3a8524f987e78d1493_D20210101-20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzY2E5YmIwMTc5MjQ3NmZiYjIyNWU1ZDlkZWM4NjlmL3NlYzo5M2NhOWJiMDE3OTI0NzZmYmIyMjVlNWQ5ZGVjODY5Zl81NS9mcmFnOjk0NGQ2N2RjOTNmMjQ1MjliZTc4ZmNlMzRiOGMyZTBiL3RhYmxlOjEzZmNjYmI1NjhiMDRhNzk4OWQ0NDZkNWNkYjk4MWVjL3RhYmxlcmFuZ2U6MTNmY2NiYjU2OGIwNGE3OTg5ZDQ0NmQ1Y2RiOTgxZWNfMTItMS0xLTEtMTcwMQ_9de835dc-3bce-49e4-bd4e-bd68f92294d4"
      unitRef="usd">1567000</us-gaap:AllocatedShareBasedCompensationExpense>
    <us-gaap:AllocatedShareBasedCompensationExpense
      contextRef="i9eea321560784f81a590aa8e3df3b187_D20210101-20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzY2E5YmIwMTc5MjQ3NmZiYjIyNWU1ZDlkZWM4NjlmL3NlYzo5M2NhOWJiMDE3OTI0NzZmYmIyMjVlNWQ5ZGVjODY5Zl81NS9mcmFnOjk0NGQ2N2RjOTNmMjQ1MjliZTc4ZmNlMzRiOGMyZTBiL3RhYmxlOjEzZmNjYmI1NjhiMDRhNzk4OWQ0NDZkNWNkYjk4MWVjL3RhYmxlcmFuZ2U6MTNmY2NiYjU2OGIwNGE3OTg5ZDQ0NmQ1Y2RiOTgxZWNfMTItMy0xLTEtMTcxMg_81250ff9-07a2-4bfd-9702-c4a76ecb0af3"
      unitRef="usd">3497000</us-gaap:AllocatedShareBasedCompensationExpense>
    <us-gaap:AllocatedShareBasedCompensationExpense
      contextRef="i5e244469383d46ddb452d43394f637d1_D20210101-20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzY2E5YmIwMTc5MjQ3NmZiYjIyNWU1ZDlkZWM4NjlmL3NlYzo5M2NhOWJiMDE3OTI0NzZmYmIyMjVlNWQ5ZGVjODY5Zl81NS9mcmFnOjk0NGQ2N2RjOTNmMjQ1MjliZTc4ZmNlMzRiOGMyZTBiL3RhYmxlOjEzZmNjYmI1NjhiMDRhNzk4OWQ0NDZkNWNkYjk4MWVjL3RhYmxlcmFuZ2U6MTNmY2NiYjU2OGIwNGE3OTg5ZDQ0NmQ1Y2RiOTgxZWNfMTItNS0xLTEtMTcxOA_67749959-1271-4389-b25b-b2eee3d17340"
      unitRef="usd">0</us-gaap:AllocatedShareBasedCompensationExpense>
    <us-gaap:AllocatedShareBasedCompensationExpense
      contextRef="i69782326f71a44e3805518280ee22b6b_D20210101-20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzY2E5YmIwMTc5MjQ3NmZiYjIyNWU1ZDlkZWM4NjlmL3NlYzo5M2NhOWJiMDE3OTI0NzZmYmIyMjVlNWQ5ZGVjODY5Zl81NS9mcmFnOjk0NGQ2N2RjOTNmMjQ1MjliZTc4ZmNlMzRiOGMyZTBiL3RhYmxlOjEzZmNjYmI1NjhiMDRhNzk4OWQ0NDZkNWNkYjk4MWVjL3RhYmxlcmFuZ2U6MTNmY2NiYjU2OGIwNGE3OTg5ZDQ0NmQ1Y2RiOTgxZWNfMTEtNy0xLTEtMTY3NTI_228de170-de64-4f9a-8d6f-448f027839b0"
      unitRef="usd">5064000</us-gaap:AllocatedShareBasedCompensationExpense>
    <cron:RestatementReviewExpense
      contextRef="i73f2057fe97d4f3a8524f987e78d1493_D20210101-20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzY2E5YmIwMTc5MjQ3NmZiYjIyNWU1ZDlkZWM4NjlmL3NlYzo5M2NhOWJiMDE3OTI0NzZmYmIyMjVlNWQ5ZGVjODY5Zl81NS9mcmFnOjk0NGQ2N2RjOTNmMjQ1MjliZTc4ZmNlMzRiOGMyZTBiL3RhYmxlOjEzZmNjYmI1NjhiMDRhNzk4OWQ0NDZkNWNkYjk4MWVjL3RhYmxlcmFuZ2U6MTNmY2NiYjU2OGIwNGE3OTg5ZDQ0NmQ1Y2RiOTgxZWNfMTMtMS0xLTEtMTcwMQ_19c6ae73-5a11-4d52-980f-ec48c0f11bda"
      unitRef="usd">0</cron:RestatementReviewExpense>
    <cron:RestatementReviewExpense
      contextRef="i9eea321560784f81a590aa8e3df3b187_D20210101-20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzY2E5YmIwMTc5MjQ3NmZiYjIyNWU1ZDlkZWM4NjlmL3NlYzo5M2NhOWJiMDE3OTI0NzZmYmIyMjVlNWQ5ZGVjODY5Zl81NS9mcmFnOjk0NGQ2N2RjOTNmMjQ1MjliZTc4ZmNlMzRiOGMyZTBiL3RhYmxlOjEzZmNjYmI1NjhiMDRhNzk4OWQ0NDZkNWNkYjk4MWVjL3RhYmxlcmFuZ2U6MTNmY2NiYjU2OGIwNGE3OTg5ZDQ0NmQ1Y2RiOTgxZWNfMTMtMy0xLTEtMTcxMg_87726422-c0dc-4c12-9f66-f43f9cd8d63a"
      unitRef="usd">0</cron:RestatementReviewExpense>
    <cron:RestatementReviewExpense
      contextRef="i5e244469383d46ddb452d43394f637d1_D20210101-20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzY2E5YmIwMTc5MjQ3NmZiYjIyNWU1ZDlkZWM4NjlmL3NlYzo5M2NhOWJiMDE3OTI0NzZmYmIyMjVlNWQ5ZGVjODY5Zl81NS9mcmFnOjk0NGQ2N2RjOTNmMjQ1MjliZTc4ZmNlMzRiOGMyZTBiL3RhYmxlOjEzZmNjYmI1NjhiMDRhNzk4OWQ0NDZkNWNkYjk4MWVjL3RhYmxlcmFuZ2U6MTNmY2NiYjU2OGIwNGE3OTg5ZDQ0NmQ1Y2RiOTgxZWNfMTMtNS0xLTEtMTcxOA_e0f9912a-2d42-4f13-861e-2eb57b1530be"
      unitRef="usd">3937000</cron:RestatementReviewExpense>
    <cron:RestatementReviewExpense
      contextRef="i69782326f71a44e3805518280ee22b6b_D20210101-20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzY2E5YmIwMTc5MjQ3NmZiYjIyNWU1ZDlkZWM4NjlmL3NlYzo5M2NhOWJiMDE3OTI0NzZmYmIyMjVlNWQ5ZGVjODY5Zl81NS9mcmFnOjk0NGQ2N2RjOTNmMjQ1MjliZTc4ZmNlMzRiOGMyZTBiL3RhYmxlOjEzZmNjYmI1NjhiMDRhNzk4OWQ0NDZkNWNkYjk4MWVjL3RhYmxlcmFuZ2U6MTNmY2NiYjU2OGIwNGE3OTg5ZDQ0NmQ1Y2RiOTgxZWNfMTItNy0xLTEtMTY3NTI_3e2cf275-9772-4284-815b-22cb8c6c0413"
      unitRef="usd">3937000</cron:RestatementReviewExpense>
    <us-gaap:DepreciationDepletionAndAmortization
      contextRef="i73f2057fe97d4f3a8524f987e78d1493_D20210101-20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzY2E5YmIwMTc5MjQ3NmZiYjIyNWU1ZDlkZWM4NjlmL3NlYzo5M2NhOWJiMDE3OTI0NzZmYmIyMjVlNWQ5ZGVjODY5Zl81NS9mcmFnOjk0NGQ2N2RjOTNmMjQ1MjliZTc4ZmNlMzRiOGMyZTBiL3RhYmxlOjEzZmNjYmI1NjhiMDRhNzk4OWQ0NDZkNWNkYjk4MWVjL3RhYmxlcmFuZ2U6MTNmY2NiYjU2OGIwNGE3OTg5ZDQ0NmQ1Y2RiOTgxZWNfMTYtMS0xLTEtMTcwOQ_07d215ad-8944-43e2-8677-68fc2653ab0f"
      unitRef="usd">305000</us-gaap:DepreciationDepletionAndAmortization>
    <us-gaap:DepreciationDepletionAndAmortization
      contextRef="i9eea321560784f81a590aa8e3df3b187_D20210101-20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzY2E5YmIwMTc5MjQ3NmZiYjIyNWU1ZDlkZWM4NjlmL3NlYzo5M2NhOWJiMDE3OTI0NzZmYmIyMjVlNWQ5ZGVjODY5Zl81NS9mcmFnOjk0NGQ2N2RjOTNmMjQ1MjliZTc4ZmNlMzRiOGMyZTBiL3RhYmxlOjEzZmNjYmI1NjhiMDRhNzk4OWQ0NDZkNWNkYjk4MWVjL3RhYmxlcmFuZ2U6MTNmY2NiYjU2OGIwNGE3OTg5ZDQ0NmQ1Y2RiOTgxZWNfMTYtMy0xLTEtMTcxNQ_95eaedf0-b6a9-4704-bc3d-c0d153952da0"
      unitRef="usd">4778000</us-gaap:DepreciationDepletionAndAmortization>
    <us-gaap:DepreciationDepletionAndAmortization
      contextRef="i5e244469383d46ddb452d43394f637d1_D20210101-20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzY2E5YmIwMTc5MjQ3NmZiYjIyNWU1ZDlkZWM4NjlmL3NlYzo5M2NhOWJiMDE3OTI0NzZmYmIyMjVlNWQ5ZGVjODY5Zl81NS9mcmFnOjk0NGQ2N2RjOTNmMjQ1MjliZTc4ZmNlMzRiOGMyZTBiL3RhYmxlOjEzZmNjYmI1NjhiMDRhNzk4OWQ0NDZkNWNkYjk4MWVjL3RhYmxlcmFuZ2U6MTNmY2NiYjU2OGIwNGE3OTg5ZDQ0NmQ1Y2RiOTgxZWNfMTYtNS0xLTEtMTcyMQ_402feeb8-1666-4436-b7ef-ff1f519b0cd8"
      unitRef="usd">0</us-gaap:DepreciationDepletionAndAmortization>
    <us-gaap:DepreciationDepletionAndAmortization
      contextRef="i69782326f71a44e3805518280ee22b6b_D20210101-20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzY2E5YmIwMTc5MjQ3NmZiYjIyNWU1ZDlkZWM4NjlmL3NlYzo5M2NhOWJiMDE3OTI0NzZmYmIyMjVlNWQ5ZGVjODY5Zl81NS9mcmFnOjk0NGQ2N2RjOTNmMjQ1MjliZTc4ZmNlMzRiOGMyZTBiL3RhYmxlOjEzZmNjYmI1NjhiMDRhNzk4OWQ0NDZkNWNkYjk4MWVjL3RhYmxlcmFuZ2U6MTNmY2NiYjU2OGIwNGE3OTg5ZDQ0NmQ1Y2RiOTgxZWNfMTMtNy0xLTEtMTY3NTI_816aa317-b47d-4779-b7ea-99c3e4941922"
      unitRef="usd">5083000</us-gaap:DepreciationDepletionAndAmortization>
    <cron:AdjustedEarningsBeforeInterestTaxesDepreciationAndAmortization
      contextRef="i73f2057fe97d4f3a8524f987e78d1493_D20210101-20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzY2E5YmIwMTc5MjQ3NmZiYjIyNWU1ZDlkZWM4NjlmL3NlYzo5M2NhOWJiMDE3OTI0NzZmYmIyMjVlNWQ5ZGVjODY5Zl81NS9mcmFnOjk0NGQ2N2RjOTNmMjQ1MjliZTc4ZmNlMzRiOGMyZTBiL3RhYmxlOjEzZmNjYmI1NjhiMDRhNzk4OWQ0NDZkNWNkYjk4MWVjL3RhYmxlcmFuZ2U6MTNmY2NiYjU2OGIwNGE3OTg5ZDQ0NmQ1Y2RiOTgxZWNfMTQtMS0xLTEtMTY3NTI_c17dd40a-29f7-4e35-8de1-797c870f5003"
      unitRef="usd">-20221000</cron:AdjustedEarningsBeforeInterestTaxesDepreciationAndAmortization>
    <cron:AdjustedEarningsBeforeInterestTaxesDepreciationAndAmortization
      contextRef="i9eea321560784f81a590aa8e3df3b187_D20210101-20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzY2E5YmIwMTc5MjQ3NmZiYjIyNWU1ZDlkZWM4NjlmL3NlYzo5M2NhOWJiMDE3OTI0NzZmYmIyMjVlNWQ5ZGVjODY5Zl81NS9mcmFnOjk0NGQ2N2RjOTNmMjQ1MjliZTc4ZmNlMzRiOGMyZTBiL3RhYmxlOjEzZmNjYmI1NjhiMDRhNzk4OWQ0NDZkNWNkYjk4MWVjL3RhYmxlcmFuZ2U6MTNmY2NiYjU2OGIwNGE3OTg5ZDQ0NmQ1Y2RiOTgxZWNfMTQtMy0xLTEtMTY3NTI_c05a2836-09db-47c3-acd9-19a14300e23f"
      unitRef="usd">-54789000</cron:AdjustedEarningsBeforeInterestTaxesDepreciationAndAmortization>
    <cron:AdjustedEarningsBeforeInterestTaxesDepreciationAndAmortization
      contextRef="i5e244469383d46ddb452d43394f637d1_D20210101-20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzY2E5YmIwMTc5MjQ3NmZiYjIyNWU1ZDlkZWM4NjlmL3NlYzo5M2NhOWJiMDE3OTI0NzZmYmIyMjVlNWQ5ZGVjODY5Zl81NS9mcmFnOjk0NGQ2N2RjOTNmMjQ1MjliZTc4ZmNlMzRiOGMyZTBiL3RhYmxlOjEzZmNjYmI1NjhiMDRhNzk4OWQ0NDZkNWNkYjk4MWVjL3RhYmxlcmFuZ2U6MTNmY2NiYjU2OGIwNGE3OTg5ZDQ0NmQ1Y2RiOTgxZWNfMTQtNS0xLTEtMTY3NTI_1ccbab0d-49cb-47f6-87f3-ccabe6394974"
      unitRef="usd">-11323000</cron:AdjustedEarningsBeforeInterestTaxesDepreciationAndAmortization>
    <cron:AdjustedEarningsBeforeInterestTaxesDepreciationAndAmortization
      contextRef="i69782326f71a44e3805518280ee22b6b_D20210101-20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzY2E5YmIwMTc5MjQ3NmZiYjIyNWU1ZDlkZWM4NjlmL3NlYzo5M2NhOWJiMDE3OTI0NzZmYmIyMjVlNWQ5ZGVjODY5Zl81NS9mcmFnOjk0NGQ2N2RjOTNmMjQ1MjliZTc4ZmNlMzRiOGMyZTBiL3RhYmxlOjEzZmNjYmI1NjhiMDRhNzk4OWQ0NDZkNWNkYjk4MWVjL3RhYmxlcmFuZ2U6MTNmY2NiYjU2OGIwNGE3OTg5ZDQ0NmQ1Y2RiOTgxZWNfMTQtNy0xLTEtMTY3NTI_be715c07-f65b-4fc2-a221-23cc456acc7b"
      unitRef="usd">-86333000</cron:AdjustedEarningsBeforeInterestTaxesDepreciationAndAmortization>
    <us-gaap:ProfitLoss
      contextRef="iab9b56b2a03f4c6199d282bd8676a924_D20200101-20200630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzY2E5YmIwMTc5MjQ3NmZiYjIyNWU1ZDlkZWM4NjlmL3NlYzo5M2NhOWJiMDE3OTI0NzZmYmIyMjVlNWQ5ZGVjODY5Zl81NS9mcmFnOjk0NGQ2N2RjOTNmMjQ1MjliZTc4ZmNlMzRiOGMyZTBiL3RhYmxlOmRjZTc4NDZiYzM0MjRlNzc4YTQxZjY1OTBkNjY4NTg5L3RhYmxlcmFuZ2U6ZGNlNzg0NmJjMzQyNGU3NzhhNDFmNjU5MGQ2Njg1ODlfMi0xLTEtMS0xNzMy_99e196a5-ae87-4d69-bba7-f76a4d2df75f"
      unitRef="usd">-52082000</us-gaap:ProfitLoss>
    <us-gaap:ProfitLoss
      contextRef="i13788f202c86441fa347b97f3162a453_D20200101-20200630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzY2E5YmIwMTc5MjQ3NmZiYjIyNWU1ZDlkZWM4NjlmL3NlYzo5M2NhOWJiMDE3OTI0NzZmYmIyMjVlNWQ5ZGVjODY5Zl81NS9mcmFnOjk0NGQ2N2RjOTNmMjQ1MjliZTc4ZmNlMzRiOGMyZTBiL3RhYmxlOmRjZTc4NDZiYzM0MjRlNzc4YTQxZjY1OTBkNjY4NTg5L3RhYmxlcmFuZ2U6ZGNlNzg0NmJjMzQyNGU3NzhhNDFmNjU5MGQ2Njg1ODlfMi0zLTEtMS0xNzM1_3ad3b8e6-2ebe-42c8-8f8b-af247d5e1580"
      unitRef="usd">33772000</us-gaap:ProfitLoss>
    <us-gaap:ProfitLoss
      contextRef="iaf98f9473a3d428f9aab9f72e135866f_D20200101-20200630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzY2E5YmIwMTc5MjQ3NmZiYjIyNWU1ZDlkZWM4NjlmL3NlYzo5M2NhOWJiMDE3OTI0NzZmYmIyMjVlNWQ5ZGVjODY5Zl81NS9mcmFnOjk0NGQ2N2RjOTNmMjQ1MjliZTc4ZmNlMzRiOGMyZTBiL3RhYmxlOmRjZTc4NDZiYzM0MjRlNzc4YTQxZjY1OTBkNjY4NTg5L3RhYmxlcmFuZ2U6ZGNlNzg0NmJjMzQyNGU3NzhhNDFmNjU5MGQ2Njg1ODlfMi01LTEtMS0xNzM4_1ad97707-aafe-4854-8247-47ccaaf8d1c2"
      unitRef="usd">-13712000</us-gaap:ProfitLoss>
    <us-gaap:ProfitLoss
      contextRef="i4a110e4972ef4113880ce582e3cda5c5_D20200101-20200630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzY2E5YmIwMTc5MjQ3NmZiYjIyNWU1ZDlkZWM4NjlmL3NlYzo5M2NhOWJiMDE3OTI0NzZmYmIyMjVlNWQ5ZGVjODY5Zl81NS9mcmFnOjk0NGQ2N2RjOTNmMjQ1MjliZTc4ZmNlMzRiOGMyZTBiL3RhYmxlOmRjZTc4NDZiYzM0MjRlNzc4YTQxZjY1OTBkNjY4NTg5L3RhYmxlcmFuZ2U6ZGNlNzg0NmJjMzQyNGU3NzhhNDFmNjU5MGQ2Njg1ODlfMi03LTEtMS0xNjc4MQ_e687316b-52fa-4d28-83bd-0305e8c81912"
      unitRef="usd">-32022000</us-gaap:ProfitLoss>
    <us-gaap:InterestIncomeExpenseNonoperatingNet
      contextRef="iab9b56b2a03f4c6199d282bd8676a924_D20200101-20200630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzY2E5YmIwMTc5MjQ3NmZiYjIyNWU1ZDlkZWM4NjlmL3NlYzo5M2NhOWJiMDE3OTI0NzZmYmIyMjVlNWQ5ZGVjODY5Zl81NS9mcmFnOjk0NGQ2N2RjOTNmMjQ1MjliZTc4ZmNlMzRiOGMyZTBiL3RhYmxlOmRjZTc4NDZiYzM0MjRlNzc4YTQxZjY1OTBkNjY4NTg5L3RhYmxlcmFuZ2U6ZGNlNzg0NmJjMzQyNGU3NzhhNDFmNjU5MGQ2Njg1ODlfNC0xLTEtMS0xNzMy_54969d62-f270-471e-a37c-e8dc40c4b007"
      unitRef="usd">16000</us-gaap:InterestIncomeExpenseNonoperatingNet>
    <us-gaap:InterestIncomeExpenseNonoperatingNet
      contextRef="i13788f202c86441fa347b97f3162a453_D20200101-20200630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzY2E5YmIwMTc5MjQ3NmZiYjIyNWU1ZDlkZWM4NjlmL3NlYzo5M2NhOWJiMDE3OTI0NzZmYmIyMjVlNWQ5ZGVjODY5Zl81NS9mcmFnOjk0NGQ2N2RjOTNmMjQ1MjliZTc4ZmNlMzRiOGMyZTBiL3RhYmxlOmRjZTc4NDZiYzM0MjRlNzc4YTQxZjY1OTBkNjY4NTg5L3RhYmxlcmFuZ2U6ZGNlNzg0NmJjMzQyNGU3NzhhNDFmNjU5MGQ2Njg1ODlfNC0zLTEtMS0xNzM1_3c4e55b9-a522-4cda-9281-8d138a0f525a"
      unitRef="usd">11469000</us-gaap:InterestIncomeExpenseNonoperatingNet>
    <us-gaap:InterestIncomeExpenseNonoperatingNet
      contextRef="iaf98f9473a3d428f9aab9f72e135866f_D20200101-20200630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzY2E5YmIwMTc5MjQ3NmZiYjIyNWU1ZDlkZWM4NjlmL3NlYzo5M2NhOWJiMDE3OTI0NzZmYmIyMjVlNWQ5ZGVjODY5Zl81NS9mcmFnOjk0NGQ2N2RjOTNmMjQ1MjliZTc4ZmNlMzRiOGMyZTBiL3RhYmxlOmRjZTc4NDZiYzM0MjRlNzc4YTQxZjY1OTBkNjY4NTg5L3RhYmxlcmFuZ2U6ZGNlNzg0NmJjMzQyNGU3NzhhNDFmNjU5MGQ2Njg1ODlfNC01LTEtMS0xNzM4_296a8671-f14f-4784-a412-b2a7af871959"
      unitRef="usd">0</us-gaap:InterestIncomeExpenseNonoperatingNet>
    <us-gaap:InterestIncomeExpenseNonoperatingNet
      contextRef="i4a110e4972ef4113880ce582e3cda5c5_D20200101-20200630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzY2E5YmIwMTc5MjQ3NmZiYjIyNWU1ZDlkZWM4NjlmL3NlYzo5M2NhOWJiMDE3OTI0NzZmYmIyMjVlNWQ5ZGVjODY5Zl81NS9mcmFnOjk0NGQ2N2RjOTNmMjQ1MjliZTc4ZmNlMzRiOGMyZTBiL3RhYmxlOmRjZTc4NDZiYzM0MjRlNzc4YTQxZjY1OTBkNjY4NTg5L3RhYmxlcmFuZ2U6ZGNlNzg0NmJjMzQyNGU3NzhhNDFmNjU5MGQ2Njg1ODlfMy03LTEtMS0xNjc4MQ_5a66ea62-0565-4b43-8c3a-6f30b994b477"
      unitRef="usd">11485000</us-gaap:InterestIncomeExpenseNonoperatingNet>
    <us-gaap:IncomeLossFromEquityMethodInvestments
      contextRef="iab9b56b2a03f4c6199d282bd8676a924_D20200101-20200630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzY2E5YmIwMTc5MjQ3NmZiYjIyNWU1ZDlkZWM4NjlmL3NlYzo5M2NhOWJiMDE3OTI0NzZmYmIyMjVlNWQ5ZGVjODY5Zl81NS9mcmFnOjk0NGQ2N2RjOTNmMjQ1MjliZTc4ZmNlMzRiOGMyZTBiL3RhYmxlOmRjZTc4NDZiYzM0MjRlNzc4YTQxZjY1OTBkNjY4NTg5L3RhYmxlcmFuZ2U6ZGNlNzg0NmJjMzQyNGU3NzhhNDFmNjU5MGQ2Njg1ODlfNi0xLTEtMS00NjYy_12927d66-3155-476d-8cb9-0e5719a61078"
      unitRef="usd">0</us-gaap:IncomeLossFromEquityMethodInvestments>
    <us-gaap:IncomeLossFromEquityMethodInvestments
      contextRef="i13788f202c86441fa347b97f3162a453_D20200101-20200630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzY2E5YmIwMTc5MjQ3NmZiYjIyNWU1ZDlkZWM4NjlmL3NlYzo5M2NhOWJiMDE3OTI0NzZmYmIyMjVlNWQ5ZGVjODY5Zl81NS9mcmFnOjk0NGQ2N2RjOTNmMjQ1MjliZTc4ZmNlMzRiOGMyZTBiL3RhYmxlOmRjZTc4NDZiYzM0MjRlNzc4YTQxZjY1OTBkNjY4NTg5L3RhYmxlcmFuZ2U6ZGNlNzg0NmJjMzQyNGU3NzhhNDFmNjU5MGQ2Njg1ODlfNi0zLTEtMS00NjYy_46459b55-b935-4958-9f41-1b00aaa3eac8"
      unitRef="usd">-1966000</us-gaap:IncomeLossFromEquityMethodInvestments>
    <us-gaap:IncomeLossFromEquityMethodInvestments
      contextRef="iaf98f9473a3d428f9aab9f72e135866f_D20200101-20200630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzY2E5YmIwMTc5MjQ3NmZiYjIyNWU1ZDlkZWM4NjlmL3NlYzo5M2NhOWJiMDE3OTI0NzZmYmIyMjVlNWQ5ZGVjODY5Zl81NS9mcmFnOjk0NGQ2N2RjOTNmMjQ1MjliZTc4ZmNlMzRiOGMyZTBiL3RhYmxlOmRjZTc4NDZiYzM0MjRlNzc4YTQxZjY1OTBkNjY4NTg5L3RhYmxlcmFuZ2U6ZGNlNzg0NmJjMzQyNGU3NzhhNDFmNjU5MGQ2Njg1ODlfNi01LTEtMS00NjYy_2b4fba51-2c6b-468e-b98e-8b85e6c267d3"
      unitRef="usd">0</us-gaap:IncomeLossFromEquityMethodInvestments>
    <us-gaap:IncomeLossFromEquityMethodInvestments
      contextRef="i4a110e4972ef4113880ce582e3cda5c5_D20200101-20200630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzY2E5YmIwMTc5MjQ3NmZiYjIyNWU1ZDlkZWM4NjlmL3NlYzo5M2NhOWJiMDE3OTI0NzZmYmIyMjVlNWQ5ZGVjODY5Zl81NS9mcmFnOjk0NGQ2N2RjOTNmMjQ1MjliZTc4ZmNlMzRiOGMyZTBiL3RhYmxlOmRjZTc4NDZiYzM0MjRlNzc4YTQxZjY1OTBkNjY4NTg5L3RhYmxlcmFuZ2U6ZGNlNzg0NmJjMzQyNGU3NzhhNDFmNjU5MGQ2Njg1ODlfNS03LTEtMS0xNjc4MQ_89ba48cc-7e0e-4213-a031-982223fd6daa"
      unitRef="usd">-1966000</us-gaap:IncomeLossFromEquityMethodInvestments>
    <us-gaap:AssetImpairmentCharges
      contextRef="iab9b56b2a03f4c6199d282bd8676a924_D20200101-20200630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzY2E5YmIwMTc5MjQ3NmZiYjIyNWU1ZDlkZWM4NjlmL3NlYzo5M2NhOWJiMDE3OTI0NzZmYmIyMjVlNWQ5ZGVjODY5Zl81NS9mcmFnOjk0NGQ2N2RjOTNmMjQ1MjliZTc4ZmNlMzRiOGMyZTBiL3RhYmxlOmRjZTc4NDZiYzM0MjRlNzc4YTQxZjY1OTBkNjY4NTg5L3RhYmxlcmFuZ2U6ZGNlNzg0NmJjMzQyNGU3NzhhNDFmNjU5MGQ2Njg1ODlfNi0xLTEtMS0xNzMy_e157e46c-db79-4e23-902b-4047f64ef882"
      unitRef="usd">40000000</us-gaap:AssetImpairmentCharges>
    <us-gaap:AssetImpairmentCharges
      contextRef="i13788f202c86441fa347b97f3162a453_D20200101-20200630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzY2E5YmIwMTc5MjQ3NmZiYjIyNWU1ZDlkZWM4NjlmL3NlYzo5M2NhOWJiMDE3OTI0NzZmYmIyMjVlNWQ5ZGVjODY5Zl81NS9mcmFnOjk0NGQ2N2RjOTNmMjQ1MjliZTc4ZmNlMzRiOGMyZTBiL3RhYmxlOmRjZTc4NDZiYzM0MjRlNzc4YTQxZjY1OTBkNjY4NTg5L3RhYmxlcmFuZ2U6ZGNlNzg0NmJjMzQyNGU3NzhhNDFmNjU5MGQ2Njg1ODlfNi0zLTEtMS0xNzM1_cd4ab666-b99f-4a60-9638-55989e1c4ecf"
      unitRef="usd">0</us-gaap:AssetImpairmentCharges>
    <us-gaap:AssetImpairmentCharges
      contextRef="iaf98f9473a3d428f9aab9f72e135866f_D20200101-20200630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzY2E5YmIwMTc5MjQ3NmZiYjIyNWU1ZDlkZWM4NjlmL3NlYzo5M2NhOWJiMDE3OTI0NzZmYmIyMjVlNWQ5ZGVjODY5Zl81NS9mcmFnOjk0NGQ2N2RjOTNmMjQ1MjliZTc4ZmNlMzRiOGMyZTBiL3RhYmxlOmRjZTc4NDZiYzM0MjRlNzc4YTQxZjY1OTBkNjY4NTg5L3RhYmxlcmFuZ2U6ZGNlNzg0NmJjMzQyNGU3NzhhNDFmNjU5MGQ2Njg1ODlfNi01LTEtMS0xNzM4_b15ddd88-19ec-4edd-a6a9-e18b9cdb6a64"
      unitRef="usd">0</us-gaap:AssetImpairmentCharges>
    <us-gaap:AssetImpairmentCharges
      contextRef="i4a110e4972ef4113880ce582e3cda5c5_D20200101-20200630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzY2E5YmIwMTc5MjQ3NmZiYjIyNWU1ZDlkZWM4NjlmL3NlYzo5M2NhOWJiMDE3OTI0NzZmYmIyMjVlNWQ5ZGVjODY5Zl81NS9mcmFnOjk0NGQ2N2RjOTNmMjQ1MjliZTc4ZmNlMzRiOGMyZTBiL3RhYmxlOmRjZTc4NDZiYzM0MjRlNzc4YTQxZjY1OTBkNjY4NTg5L3RhYmxlcmFuZ2U6ZGNlNzg0NmJjMzQyNGU3NzhhNDFmNjU5MGQ2Njg1ODlfNi03LTEtMS0xNjc4MQ_5cfd4a07-fcdc-4f22-9f37-8870d5c74d51"
      unitRef="usd">40000000</us-gaap:AssetImpairmentCharges>
    <us-gaap:GainLossOnDerivativeInstrumentsNetPretax
      contextRef="iab9b56b2a03f4c6199d282bd8676a924_D20200101-20200630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzY2E5YmIwMTc5MjQ3NmZiYjIyNWU1ZDlkZWM4NjlmL3NlYzo5M2NhOWJiMDE3OTI0NzZmYmIyMjVlNWQ5ZGVjODY5Zl81NS9mcmFnOjk0NGQ2N2RjOTNmMjQ1MjliZTc4ZmNlMzRiOGMyZTBiL3RhYmxlOmRjZTc4NDZiYzM0MjRlNzc4YTQxZjY1OTBkNjY4NTg5L3RhYmxlcmFuZ2U6ZGNlNzg0NmJjMzQyNGU3NzhhNDFmNjU5MGQ2Njg1ODlfNy0xLTEtMS0xNzMy_c7de39d2-7b44-4eed-83cc-5b718d96fbe9"
      unitRef="usd">0</us-gaap:GainLossOnDerivativeInstrumentsNetPretax>
    <us-gaap:GainLossOnDerivativeInstrumentsNetPretax
      contextRef="i13788f202c86441fa347b97f3162a453_D20200101-20200630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzY2E5YmIwMTc5MjQ3NmZiYjIyNWU1ZDlkZWM4NjlmL3NlYzo5M2NhOWJiMDE3OTI0NzZmYmIyMjVlNWQ5ZGVjODY5Zl81NS9mcmFnOjk0NGQ2N2RjOTNmMjQ1MjliZTc4ZmNlMzRiOGMyZTBiL3RhYmxlOmRjZTc4NDZiYzM0MjRlNzc4YTQxZjY1OTBkNjY4NTg5L3RhYmxlcmFuZ2U6ZGNlNzg0NmJjMzQyNGU3NzhhNDFmNjU5MGQ2Njg1ODlfNy0zLTEtMS0xNzM1_8303b1fe-b218-4361-ab04-bfac2c330e79"
      unitRef="usd">77488000</us-gaap:GainLossOnDerivativeInstrumentsNetPretax>
    <us-gaap:GainLossOnDerivativeInstrumentsNetPretax
      contextRef="iaf98f9473a3d428f9aab9f72e135866f_D20200101-20200630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzY2E5YmIwMTc5MjQ3NmZiYjIyNWU1ZDlkZWM4NjlmL3NlYzo5M2NhOWJiMDE3OTI0NzZmYmIyMjVlNWQ5ZGVjODY5Zl81NS9mcmFnOjk0NGQ2N2RjOTNmMjQ1MjliZTc4ZmNlMzRiOGMyZTBiL3RhYmxlOmRjZTc4NDZiYzM0MjRlNzc4YTQxZjY1OTBkNjY4NTg5L3RhYmxlcmFuZ2U6ZGNlNzg0NmJjMzQyNGU3NzhhNDFmNjU5MGQ2Njg1ODlfNy01LTEtMS0xNzM4_9575e333-1842-46a3-959e-098d6e8d0e11"
      unitRef="usd">0</us-gaap:GainLossOnDerivativeInstrumentsNetPretax>
    <us-gaap:GainLossOnDerivativeInstrumentsNetPretax
      contextRef="i4a110e4972ef4113880ce582e3cda5c5_D20200101-20200630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzY2E5YmIwMTc5MjQ3NmZiYjIyNWU1ZDlkZWM4NjlmL3NlYzo5M2NhOWJiMDE3OTI0NzZmYmIyMjVlNWQ5ZGVjODY5Zl81NS9mcmFnOjk0NGQ2N2RjOTNmMjQ1MjliZTc4ZmNlMzRiOGMyZTBiL3RhYmxlOmRjZTc4NDZiYzM0MjRlNzc4YTQxZjY1OTBkNjY4NTg5L3RhYmxlcmFuZ2U6ZGNlNzg0NmJjMzQyNGU3NzhhNDFmNjU5MGQ2Njg1ODlfNy03LTEtMS0xNjc4MQ_64f71760-ca12-4364-955d-236b7d868869"
      unitRef="usd">77488000</us-gaap:GainLossOnDerivativeInstrumentsNetPretax>
    <us-gaap:OtherNonoperatingIncomeExpense
      contextRef="iab9b56b2a03f4c6199d282bd8676a924_D20200101-20200630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzY2E5YmIwMTc5MjQ3NmZiYjIyNWU1ZDlkZWM4NjlmL3NlYzo5M2NhOWJiMDE3OTI0NzZmYmIyMjVlNWQ5ZGVjODY5Zl81NS9mcmFnOjk0NGQ2N2RjOTNmMjQ1MjliZTc4ZmNlMzRiOGMyZTBiL3RhYmxlOmRjZTc4NDZiYzM0MjRlNzc4YTQxZjY1OTBkNjY4NTg5L3RhYmxlcmFuZ2U6ZGNlNzg0NmJjMzQyNGU3NzhhNDFmNjU5MGQ2Njg1ODlfOC0xLTEtMS0xNzMy_39a9ff1d-951b-4146-a660-0bd8724ff39b"
      unitRef="usd">0</us-gaap:OtherNonoperatingIncomeExpense>
    <us-gaap:OtherNonoperatingIncomeExpense
      contextRef="i13788f202c86441fa347b97f3162a453_D20200101-20200630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzY2E5YmIwMTc5MjQ3NmZiYjIyNWU1ZDlkZWM4NjlmL3NlYzo5M2NhOWJiMDE3OTI0NzZmYmIyMjVlNWQ5ZGVjODY5Zl81NS9mcmFnOjk0NGQ2N2RjOTNmMjQ1MjliZTc4ZmNlMzRiOGMyZTBiL3RhYmxlOmRjZTc4NDZiYzM0MjRlNzc4YTQxZjY1OTBkNjY4NTg5L3RhYmxlcmFuZ2U6ZGNlNzg0NmJjMzQyNGU3NzhhNDFmNjU5MGQ2Njg1ODlfOC0zLTEtMS0xNzM1_5508d13d-945a-4822-9b50-d3c7c38b7d0b"
      unitRef="usd">785000</us-gaap:OtherNonoperatingIncomeExpense>
    <us-gaap:OtherNonoperatingIncomeExpense
      contextRef="iaf98f9473a3d428f9aab9f72e135866f_D20200101-20200630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzY2E5YmIwMTc5MjQ3NmZiYjIyNWU1ZDlkZWM4NjlmL3NlYzo5M2NhOWJiMDE3OTI0NzZmYmIyMjVlNWQ5ZGVjODY5Zl81NS9mcmFnOjk0NGQ2N2RjOTNmMjQ1MjliZTc4ZmNlMzRiOGMyZTBiL3RhYmxlOmRjZTc4NDZiYzM0MjRlNzc4YTQxZjY1OTBkNjY4NTg5L3RhYmxlcmFuZ2U6ZGNlNzg0NmJjMzQyNGU3NzhhNDFmNjU5MGQ2Njg1ODlfOC01LTEtMS0xNzM4_05f23833-594a-4c94-abde-14e1870ae9d8"
      unitRef="usd">0</us-gaap:OtherNonoperatingIncomeExpense>
    <us-gaap:OtherNonoperatingIncomeExpense
      contextRef="i4a110e4972ef4113880ce582e3cda5c5_D20200101-20200630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzY2E5YmIwMTc5MjQ3NmZiYjIyNWU1ZDlkZWM4NjlmL3NlYzo5M2NhOWJiMDE3OTI0NzZmYmIyMjVlNWQ5ZGVjODY5Zl81NS9mcmFnOjk0NGQ2N2RjOTNmMjQ1MjliZTc4ZmNlMzRiOGMyZTBiL3RhYmxlOmRjZTc4NDZiYzM0MjRlNzc4YTQxZjY1OTBkNjY4NTg5L3RhYmxlcmFuZ2U6ZGNlNzg0NmJjMzQyNGU3NzhhNDFmNjU5MGQ2Njg1ODlfOS03LTEtMS0xNjc4MQ_43f9f884-4d3f-40bf-8755-93258b87edcd"
      unitRef="usd">785000</us-gaap:OtherNonoperatingIncomeExpense>
    <us-gaap:IncomeLossFromDiscontinuedOperationsNetOfTax
      contextRef="iab9b56b2a03f4c6199d282bd8676a924_D20200101-20200630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzY2E5YmIwMTc5MjQ3NmZiYjIyNWU1ZDlkZWM4NjlmL3NlYzo5M2NhOWJiMDE3OTI0NzZmYmIyMjVlNWQ5ZGVjODY5Zl81NS9mcmFnOjk0NGQ2N2RjOTNmMjQ1MjliZTc4ZmNlMzRiOGMyZTBiL3RhYmxlOmRjZTc4NDZiYzM0MjRlNzc4YTQxZjY1OTBkNjY4NTg5L3RhYmxlcmFuZ2U6ZGNlNzg0NmJjMzQyNGU3NzhhNDFmNjU5MGQ2Njg1ODlfOS0xLTEtMS0xNzMy_bc701271-77e6-4e87-a381-6f48667003e4"
      unitRef="usd">0</us-gaap:IncomeLossFromDiscontinuedOperationsNetOfTax>
    <us-gaap:IncomeLossFromDiscontinuedOperationsNetOfTax
      contextRef="i13788f202c86441fa347b97f3162a453_D20200101-20200630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzY2E5YmIwMTc5MjQ3NmZiYjIyNWU1ZDlkZWM4NjlmL3NlYzo5M2NhOWJiMDE3OTI0NzZmYmIyMjVlNWQ5ZGVjODY5Zl81NS9mcmFnOjk0NGQ2N2RjOTNmMjQ1MjliZTc4ZmNlMzRiOGMyZTBiL3RhYmxlOmRjZTc4NDZiYzM0MjRlNzc4YTQxZjY1OTBkNjY4NTg5L3RhYmxlcmFuZ2U6ZGNlNzg0NmJjMzQyNGU3NzhhNDFmNjU5MGQ2Njg1ODlfOS0zLTEtMS0xNzM1_f9613262-888b-478c-b44b-ea2d06978ea5"
      unitRef="usd">-46000</us-gaap:IncomeLossFromDiscontinuedOperationsNetOfTax>
    <us-gaap:IncomeLossFromDiscontinuedOperationsNetOfTax
      contextRef="iaf98f9473a3d428f9aab9f72e135866f_D20200101-20200630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzY2E5YmIwMTc5MjQ3NmZiYjIyNWU1ZDlkZWM4NjlmL3NlYzo5M2NhOWJiMDE3OTI0NzZmYmIyMjVlNWQ5ZGVjODY5Zl81NS9mcmFnOjk0NGQ2N2RjOTNmMjQ1MjliZTc4ZmNlMzRiOGMyZTBiL3RhYmxlOmRjZTc4NDZiYzM0MjRlNzc4YTQxZjY1OTBkNjY4NTg5L3RhYmxlcmFuZ2U6ZGNlNzg0NmJjMzQyNGU3NzhhNDFmNjU5MGQ2Njg1ODlfOS01LTEtMS0xNzM4_a850fc10-9372-42db-b13b-0b96574010e6"
      unitRef="usd">0</us-gaap:IncomeLossFromDiscontinuedOperationsNetOfTax>
    <us-gaap:IncomeLossFromDiscontinuedOperationsNetOfTax
      contextRef="i4a110e4972ef4113880ce582e3cda5c5_D20200101-20200630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzY2E5YmIwMTc5MjQ3NmZiYjIyNWU1ZDlkZWM4NjlmL3NlYzo5M2NhOWJiMDE3OTI0NzZmYmIyMjVlNWQ5ZGVjODY5Zl81NS9mcmFnOjk0NGQ2N2RjOTNmMjQ1MjliZTc4ZmNlMzRiOGMyZTBiL3RhYmxlOmRjZTc4NDZiYzM0MjRlNzc4YTQxZjY1OTBkNjY4NTg5L3RhYmxlcmFuZ2U6ZGNlNzg0NmJjMzQyNGU3NzhhNDFmNjU5MGQ2Njg1ODlfMTAtNy0xLTEtMTY3ODE_414c05b9-82f9-4b8f-92c5-e5bb98a55111"
      unitRef="usd">-46000</us-gaap:IncomeLossFromDiscontinuedOperationsNetOfTax>
    <us-gaap:AllocatedShareBasedCompensationExpense
      contextRef="iab9b56b2a03f4c6199d282bd8676a924_D20200101-20200630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzY2E5YmIwMTc5MjQ3NmZiYjIyNWU1ZDlkZWM4NjlmL3NlYzo5M2NhOWJiMDE3OTI0NzZmYmIyMjVlNWQ5ZGVjODY5Zl81NS9mcmFnOjk0NGQ2N2RjOTNmMjQ1MjliZTc4ZmNlMzRiOGMyZTBiL3RhYmxlOmRjZTc4NDZiYzM0MjRlNzc4YTQxZjY1OTBkNjY4NTg5L3RhYmxlcmFuZ2U6ZGNlNzg0NmJjMzQyNGU3NzhhNDFmNjU5MGQ2Njg1ODlfMTAtMS0xLTEtMTczMg_5d0c8fbe-14f1-4787-82c8-f2d46600203a"
      unitRef="usd">1462000</us-gaap:AllocatedShareBasedCompensationExpense>
    <us-gaap:AllocatedShareBasedCompensationExpense
      contextRef="i13788f202c86441fa347b97f3162a453_D20200101-20200630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzY2E5YmIwMTc5MjQ3NmZiYjIyNWU1ZDlkZWM4NjlmL3NlYzo5M2NhOWJiMDE3OTI0NzZmYmIyMjVlNWQ5ZGVjODY5Zl81NS9mcmFnOjk0NGQ2N2RjOTNmMjQ1MjliZTc4ZmNlMzRiOGMyZTBiL3RhYmxlOmRjZTc4NDZiYzM0MjRlNzc4YTQxZjY1OTBkNjY4NTg5L3RhYmxlcmFuZ2U6ZGNlNzg0NmJjMzQyNGU3NzhhNDFmNjU5MGQ2Njg1ODlfMTAtMy0xLTEtMTczNQ_e2c1a4ae-35d7-4313-9ac6-2c87c87e7e20"
      unitRef="usd">3520000</us-gaap:AllocatedShareBasedCompensationExpense>
    <us-gaap:AllocatedShareBasedCompensationExpense
      contextRef="iaf98f9473a3d428f9aab9f72e135866f_D20200101-20200630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzY2E5YmIwMTc5MjQ3NmZiYjIyNWU1ZDlkZWM4NjlmL3NlYzo5M2NhOWJiMDE3OTI0NzZmYmIyMjVlNWQ5ZGVjODY5Zl81NS9mcmFnOjk0NGQ2N2RjOTNmMjQ1MjliZTc4ZmNlMzRiOGMyZTBiL3RhYmxlOmRjZTc4NDZiYzM0MjRlNzc4YTQxZjY1OTBkNjY4NTg5L3RhYmxlcmFuZ2U6ZGNlNzg0NmJjMzQyNGU3NzhhNDFmNjU5MGQ2Njg1ODlfMTAtNS0xLTEtMTczOA_885f781d-6b92-459a-a1cf-959f9f2167c2"
      unitRef="usd">0</us-gaap:AllocatedShareBasedCompensationExpense>
    <us-gaap:AllocatedShareBasedCompensationExpense
      contextRef="i4a110e4972ef4113880ce582e3cda5c5_D20200101-20200630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzY2E5YmIwMTc5MjQ3NmZiYjIyNWU1ZDlkZWM4NjlmL3NlYzo5M2NhOWJiMDE3OTI0NzZmYmIyMjVlNWQ5ZGVjODY5Zl81NS9mcmFnOjk0NGQ2N2RjOTNmMjQ1MjliZTc4ZmNlMzRiOGMyZTBiL3RhYmxlOmRjZTc4NDZiYzM0MjRlNzc4YTQxZjY1OTBkNjY4NTg5L3RhYmxlcmFuZ2U6ZGNlNzg0NmJjMzQyNGU3NzhhNDFmNjU5MGQ2Njg1ODlfMTEtNy0xLTEtMTY3ODE_8dd0c8a8-0a89-4642-9fac-8692ad406fd6"
      unitRef="usd">4982000</us-gaap:AllocatedShareBasedCompensationExpense>
    <cron:RestatementReviewExpense
      contextRef="iab9b56b2a03f4c6199d282bd8676a924_D20200101-20200630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzY2E5YmIwMTc5MjQ3NmZiYjIyNWU1ZDlkZWM4NjlmL3NlYzo5M2NhOWJiMDE3OTI0NzZmYmIyMjVlNWQ5ZGVjODY5Zl81NS9mcmFnOjk0NGQ2N2RjOTNmMjQ1MjliZTc4ZmNlMzRiOGMyZTBiL3RhYmxlOmRjZTc4NDZiYzM0MjRlNzc4YTQxZjY1OTBkNjY4NTg5L3RhYmxlcmFuZ2U6ZGNlNzg0NmJjMzQyNGU3NzhhNDFmNjU5MGQ2Njg1ODlfMTEtMS0xLTEtMTczMg_f7fbebf7-3470-4c68-97f9-f3748c7b58ca"
      unitRef="usd">0</cron:RestatementReviewExpense>
    <cron:RestatementReviewExpense
      contextRef="i13788f202c86441fa347b97f3162a453_D20200101-20200630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzY2E5YmIwMTc5MjQ3NmZiYjIyNWU1ZDlkZWM4NjlmL3NlYzo5M2NhOWJiMDE3OTI0NzZmYmIyMjVlNWQ5ZGVjODY5Zl81NS9mcmFnOjk0NGQ2N2RjOTNmMjQ1MjliZTc4ZmNlMzRiOGMyZTBiL3RhYmxlOmRjZTc4NDZiYzM0MjRlNzc4YTQxZjY1OTBkNjY4NTg5L3RhYmxlcmFuZ2U6ZGNlNzg0NmJjMzQyNGU3NzhhNDFmNjU5MGQ2Njg1ODlfMTEtMy0xLTEtMTczNQ_dfe62f94-b180-4e49-9c59-bca71b50f49c"
      unitRef="usd">0</cron:RestatementReviewExpense>
    <cron:RestatementReviewExpense
      contextRef="iaf98f9473a3d428f9aab9f72e135866f_D20200101-20200630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzY2E5YmIwMTc5MjQ3NmZiYjIyNWU1ZDlkZWM4NjlmL3NlYzo5M2NhOWJiMDE3OTI0NzZmYmIyMjVlNWQ5ZGVjODY5Zl81NS9mcmFnOjk0NGQ2N2RjOTNmMjQ1MjliZTc4ZmNlMzRiOGMyZTBiL3RhYmxlOmRjZTc4NDZiYzM0MjRlNzc4YTQxZjY1OTBkNjY4NTg5L3RhYmxlcmFuZ2U6ZGNlNzg0NmJjMzQyNGU3NzhhNDFmNjU5MGQ2Njg1ODlfMTEtNS0xLTEtMTczOA_0561ddec-5381-4d17-9e3f-9b2182d1797c"
      unitRef="usd">7866000</cron:RestatementReviewExpense>
    <cron:RestatementReviewExpense
      contextRef="i4a110e4972ef4113880ce582e3cda5c5_D20200101-20200630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzY2E5YmIwMTc5MjQ3NmZiYjIyNWU1ZDlkZWM4NjlmL3NlYzo5M2NhOWJiMDE3OTI0NzZmYmIyMjVlNWQ5ZGVjODY5Zl81NS9mcmFnOjk0NGQ2N2RjOTNmMjQ1MjliZTc4ZmNlMzRiOGMyZTBiL3RhYmxlOmRjZTc4NDZiYzM0MjRlNzc4YTQxZjY1OTBkNjY4NTg5L3RhYmxlcmFuZ2U6ZGNlNzg0NmJjMzQyNGU3NzhhNDFmNjU5MGQ2Njg1ODlfMTItNy0xLTEtMTY3ODE_c111221e-3431-4505-a3fc-baad5f6c2ad6"
      unitRef="usd">7866000</cron:RestatementReviewExpense>
    <us-gaap:DepreciationDepletionAndAmortization
      contextRef="iab9b56b2a03f4c6199d282bd8676a924_D20200101-20200630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzY2E5YmIwMTc5MjQ3NmZiYjIyNWU1ZDlkZWM4NjlmL3NlYzo5M2NhOWJiMDE3OTI0NzZmYmIyMjVlNWQ5ZGVjODY5Zl81NS9mcmFnOjk0NGQ2N2RjOTNmMjQ1MjliZTc4ZmNlMzRiOGMyZTBiL3RhYmxlOmRjZTc4NDZiYzM0MjRlNzc4YTQxZjY1OTBkNjY4NTg5L3RhYmxlcmFuZ2U6ZGNlNzg0NmJjMzQyNGU3NzhhNDFmNjU5MGQ2Njg1ODlfMTQtMS0xLTEtMTc0MQ_70d9815e-f761-44af-98db-75e724d46fba"
      unitRef="usd">69000</us-gaap:DepreciationDepletionAndAmortization>
    <us-gaap:DepreciationDepletionAndAmortization
      contextRef="i13788f202c86441fa347b97f3162a453_D20200101-20200630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzY2E5YmIwMTc5MjQ3NmZiYjIyNWU1ZDlkZWM4NjlmL3NlYzo5M2NhOWJiMDE3OTI0NzZmYmIyMjVlNWQ5ZGVjODY5Zl81NS9mcmFnOjk0NGQ2N2RjOTNmMjQ1MjliZTc4ZmNlMzRiOGMyZTBiL3RhYmxlOmRjZTc4NDZiYzM0MjRlNzc4YTQxZjY1OTBkNjY4NTg5L3RhYmxlcmFuZ2U6ZGNlNzg0NmJjMzQyNGU3NzhhNDFmNjU5MGQ2Njg1ODlfMTQtMy0xLTEtMTc0NA_d9ac38d9-5e6d-440e-aba5-b348abbab165"
      unitRef="usd">2810000</us-gaap:DepreciationDepletionAndAmortization>
    <us-gaap:DepreciationDepletionAndAmortization
      contextRef="iaf98f9473a3d428f9aab9f72e135866f_D20200101-20200630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzY2E5YmIwMTc5MjQ3NmZiYjIyNWU1ZDlkZWM4NjlmL3NlYzo5M2NhOWJiMDE3OTI0NzZmYmIyMjVlNWQ5ZGVjODY5Zl81NS9mcmFnOjk0NGQ2N2RjOTNmMjQ1MjliZTc4ZmNlMzRiOGMyZTBiL3RhYmxlOmRjZTc4NDZiYzM0MjRlNzc4YTQxZjY1OTBkNjY4NTg5L3RhYmxlcmFuZ2U6ZGNlNzg0NmJjMzQyNGU3NzhhNDFmNjU5MGQ2Njg1ODlfMTQtNS0xLTEtMTc0Nw_66fdc31b-3446-4d27-86cc-345e12b8136c"
      unitRef="usd">0</us-gaap:DepreciationDepletionAndAmortization>
    <us-gaap:DepreciationDepletionAndAmortization
      contextRef="i4a110e4972ef4113880ce582e3cda5c5_D20200101-20200630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzY2E5YmIwMTc5MjQ3NmZiYjIyNWU1ZDlkZWM4NjlmL3NlYzo5M2NhOWJiMDE3OTI0NzZmYmIyMjVlNWQ5ZGVjODY5Zl81NS9mcmFnOjk0NGQ2N2RjOTNmMjQ1MjliZTc4ZmNlMzRiOGMyZTBiL3RhYmxlOmRjZTc4NDZiYzM0MjRlNzc4YTQxZjY1OTBkNjY4NTg5L3RhYmxlcmFuZ2U6ZGNlNzg0NmJjMzQyNGU3NzhhNDFmNjU5MGQ2Njg1ODlfMTMtNy0xLTEtMTY3ODE_3a4432ef-7db3-4bae-9956-2ac224b2a8be"
      unitRef="usd">2879000</us-gaap:DepreciationDepletionAndAmortization>
    <cron:AdjustedEarningsBeforeInterestTaxesDepreciationAndAmortization
      contextRef="iab9b56b2a03f4c6199d282bd8676a924_D20200101-20200630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzY2E5YmIwMTc5MjQ3NmZiYjIyNWU1ZDlkZWM4NjlmL3NlYzo5M2NhOWJiMDE3OTI0NzZmYmIyMjVlNWQ5ZGVjODY5Zl81NS9mcmFnOjk0NGQ2N2RjOTNmMjQ1MjliZTc4ZmNlMzRiOGMyZTBiL3RhYmxlOmRjZTc4NDZiYzM0MjRlNzc4YTQxZjY1OTBkNjY4NTg5L3RhYmxlcmFuZ2U6ZGNlNzg0NmJjMzQyNGU3NzhhNDFmNjU5MGQ2Njg1ODlfMTQtMS0xLTEtMTY3ODE_ea5a00be-82a7-42ce-a800-0ae2ed7a6c8d"
      unitRef="usd">-10567000</cron:AdjustedEarningsBeforeInterestTaxesDepreciationAndAmortization>
    <cron:AdjustedEarningsBeforeInterestTaxesDepreciationAndAmortization
      contextRef="i13788f202c86441fa347b97f3162a453_D20200101-20200630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzY2E5YmIwMTc5MjQ3NmZiYjIyNWU1ZDlkZWM4NjlmL3NlYzo5M2NhOWJiMDE3OTI0NzZmYmIyMjVlNWQ5ZGVjODY5Zl81NS9mcmFnOjk0NGQ2N2RjOTNmMjQ1MjliZTc4ZmNlMzRiOGMyZTBiL3RhYmxlOmRjZTc4NDZiYzM0MjRlNzc4YTQxZjY1OTBkNjY4NTg5L3RhYmxlcmFuZ2U6ZGNlNzg0NmJjMzQyNGU3NzhhNDFmNjU5MGQ2Njg1ODlfMTQtMy0xLTEtMTY3ODE_891e1fe2-103a-47ab-845a-0f599bc03b75"
      unitRef="usd">-47628000</cron:AdjustedEarningsBeforeInterestTaxesDepreciationAndAmortization>
    <cron:AdjustedEarningsBeforeInterestTaxesDepreciationAndAmortization
      contextRef="iaf98f9473a3d428f9aab9f72e135866f_D20200101-20200630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzY2E5YmIwMTc5MjQ3NmZiYjIyNWU1ZDlkZWM4NjlmL3NlYzo5M2NhOWJiMDE3OTI0NzZmYmIyMjVlNWQ5ZGVjODY5Zl81NS9mcmFnOjk0NGQ2N2RjOTNmMjQ1MjliZTc4ZmNlMzRiOGMyZTBiL3RhYmxlOmRjZTc4NDZiYzM0MjRlNzc4YTQxZjY1OTBkNjY4NTg5L3RhYmxlcmFuZ2U6ZGNlNzg0NmJjMzQyNGU3NzhhNDFmNjU5MGQ2Njg1ODlfMTQtNS0xLTEtMTY3ODE_ad7c8e69-469c-429a-ae4f-97045dcc7f80"
      unitRef="usd">-5846000</cron:AdjustedEarningsBeforeInterestTaxesDepreciationAndAmortization>
    <cron:AdjustedEarningsBeforeInterestTaxesDepreciationAndAmortization
      contextRef="i4a110e4972ef4113880ce582e3cda5c5_D20200101-20200630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzY2E5YmIwMTc5MjQ3NmZiYjIyNWU1ZDlkZWM4NjlmL3NlYzo5M2NhOWJiMDE3OTI0NzZmYmIyMjVlNWQ5ZGVjODY5Zl81NS9mcmFnOjk0NGQ2N2RjOTNmMjQ1MjliZTc4ZmNlMzRiOGMyZTBiL3RhYmxlOmRjZTc4NDZiYzM0MjRlNzc4YTQxZjY1OTBkNjY4NTg5L3RhYmxlcmFuZ2U6ZGNlNzg0NmJjMzQyNGU3NzhhNDFmNjU5MGQ2Njg1ODlfMTQtNy0xLTEtMTY3ODE_211fd703-cd36-4f57-8291-82e739611b7d"
      unitRef="usd">-64041000</cron:AdjustedEarningsBeforeInterestTaxesDepreciationAndAmortization>
    <us-gaap:RevenueFromExternalCustomersByGeographicAreasTableTextBlock
      contextRef="i69782326f71a44e3805518280ee22b6b_D20210101-20210630"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzY2E5YmIwMTc5MjQ3NmZiYjIyNWU1ZDlkZWM4NjlmL3NlYzo5M2NhOWJiMDE3OTI0NzZmYmIyMjVlNWQ5ZGVjODY5Zl81NS9mcmFnOjk0NGQ2N2RjOTNmMjQ1MjliZTc4ZmNlMzRiOGMyZTBiL3RleHRyZWdpb246OTQ0ZDY3ZGM5M2YyNDUyOWJlNzhmY2UzNGI4YzJlMGJfMjk4Ng_2aed6107-15c2-46ce-a5e6-c370d5bf51e6">&lt;div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Net revenue attributed to a geographic region based on the location of the customer were as follows:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:42.372%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.816%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.327%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.816%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.605%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.816%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.327%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.821%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Three months ended June 30,&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Six months ended June 30,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Canada&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;10,664&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7,416&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;18,246&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;13,507&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Israel&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,310&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;293&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4,828&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;293&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;United States&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,227&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,174&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4,668&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4,350&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other countries&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;421&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;491&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;165&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Net revenue&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;15,622&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;9,883&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;28,233&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;18,315&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:RevenueFromExternalCustomersByGeographicAreasTableTextBlock>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i70c4790ac8ca40dd81fcf1ef3cef91b6_D20210401-20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzY2E5YmIwMTc5MjQ3NmZiYjIyNWU1ZDlkZWM4NjlmL3NlYzo5M2NhOWJiMDE3OTI0NzZmYmIyMjVlNWQ5ZGVjODY5Zl81NS9mcmFnOjk0NGQ2N2RjOTNmMjQ1MjliZTc4ZmNlMzRiOGMyZTBiL3RhYmxlOjRjZWFlMWI0OTIwOTQwOGY5NDZmNTU5MmUwNGU0MjFhL3RhYmxlcmFuZ2U6NGNlYWUxYjQ5MjA5NDA4Zjk0NmY1NTkyZTA0ZTQyMWFfMi0xLTEtMS0w_bfdf6f59-cda5-49b1-91d2-6e2f9d45a1da"
      unitRef="usd">10664000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="iad976d29836c4f2f84c635abe13f093d_D20200401-20200630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzY2E5YmIwMTc5MjQ3NmZiYjIyNWU1ZDlkZWM4NjlmL3NlYzo5M2NhOWJiMDE3OTI0NzZmYmIyMjVlNWQ5ZGVjODY5Zl81NS9mcmFnOjk0NGQ2N2RjOTNmMjQ1MjliZTc4ZmNlMzRiOGMyZTBiL3RhYmxlOjRjZWFlMWI0OTIwOTQwOGY5NDZmNTU5MmUwNGU0MjFhL3RhYmxlcmFuZ2U6NGNlYWUxYjQ5MjA5NDA4Zjk0NmY1NTkyZTA0ZTQyMWFfMi0zLTEtMS0w_3404d339-7f58-4850-a471-b2bd82f4156a"
      unitRef="usd">7416000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="ic93ed3f2e9634d2485631fcd4f0c2325_D20210101-20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzY2E5YmIwMTc5MjQ3NmZiYjIyNWU1ZDlkZWM4NjlmL3NlYzo5M2NhOWJiMDE3OTI0NzZmYmIyMjVlNWQ5ZGVjODY5Zl81NS9mcmFnOjk0NGQ2N2RjOTNmMjQ1MjliZTc4ZmNlMzRiOGMyZTBiL3RhYmxlOjRjZWFlMWI0OTIwOTQwOGY5NDZmNTU5MmUwNGU0MjFhL3RhYmxlcmFuZ2U6NGNlYWUxYjQ5MjA5NDA4Zjk0NmY1NTkyZTA0ZTQyMWFfMi01LTEtMS0w_6c71dee7-377a-4ac9-8f2c-be75d449c905"
      unitRef="usd">18246000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i9028e5a0bc1c44d493f8aa0ff5b63660_D20200101-20200630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzY2E5YmIwMTc5MjQ3NmZiYjIyNWU1ZDlkZWM4NjlmL3NlYzo5M2NhOWJiMDE3OTI0NzZmYmIyMjVlNWQ5ZGVjODY5Zl81NS9mcmFnOjk0NGQ2N2RjOTNmMjQ1MjliZTc4ZmNlMzRiOGMyZTBiL3RhYmxlOjRjZWFlMWI0OTIwOTQwOGY5NDZmNTU5MmUwNGU0MjFhL3RhYmxlcmFuZ2U6NGNlYWUxYjQ5MjA5NDA4Zjk0NmY1NTkyZTA0ZTQyMWFfMi03LTEtMS0w_8fc6277a-ef0c-44dc-a4dc-3dfcb14002d1"
      unitRef="usd">13507000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i8506d6aab4b24205822b2a1157fa9c1d_D20210401-20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzY2E5YmIwMTc5MjQ3NmZiYjIyNWU1ZDlkZWM4NjlmL3NlYzo5M2NhOWJiMDE3OTI0NzZmYmIyMjVlNWQ5ZGVjODY5Zl81NS9mcmFnOjk0NGQ2N2RjOTNmMjQ1MjliZTc4ZmNlMzRiOGMyZTBiL3RhYmxlOjRjZWFlMWI0OTIwOTQwOGY5NDZmNTU5MmUwNGU0MjFhL3RhYmxlcmFuZ2U6NGNlYWUxYjQ5MjA5NDA4Zjk0NmY1NTkyZTA0ZTQyMWFfMy0xLTEtMS0xNzc5_724c342b-39a7-4624-a093-95b124afe0a9"
      unitRef="usd">2310000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i0919d1ea594c4d4dabfdd26b1f697c1a_D20200401-20200630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzY2E5YmIwMTc5MjQ3NmZiYjIyNWU1ZDlkZWM4NjlmL3NlYzo5M2NhOWJiMDE3OTI0NzZmYmIyMjVlNWQ5ZGVjODY5Zl81NS9mcmFnOjk0NGQ2N2RjOTNmMjQ1MjliZTc4ZmNlMzRiOGMyZTBiL3RhYmxlOjRjZWFlMWI0OTIwOTQwOGY5NDZmNTU5MmUwNGU0MjFhL3RhYmxlcmFuZ2U6NGNlYWUxYjQ5MjA5NDA4Zjk0NmY1NTkyZTA0ZTQyMWFfMy0zLTEtMS0xNzgz_24df3290-2dfb-46c2-af26-ae44d5430624"
      unitRef="usd">293000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i741c56d990404b79b0cac9e98bf9ab73_D20210101-20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzY2E5YmIwMTc5MjQ3NmZiYjIyNWU1ZDlkZWM4NjlmL3NlYzo5M2NhOWJiMDE3OTI0NzZmYmIyMjVlNWQ5ZGVjODY5Zl81NS9mcmFnOjk0NGQ2N2RjOTNmMjQ1MjliZTc4ZmNlMzRiOGMyZTBiL3RhYmxlOjRjZWFlMWI0OTIwOTQwOGY5NDZmNTU5MmUwNGU0MjFhL3RhYmxlcmFuZ2U6NGNlYWUxYjQ5MjA5NDA4Zjk0NmY1NTkyZTA0ZTQyMWFfMy01LTEtMS0w_7170b08a-1d91-4943-89fa-e950edc27f7b"
      unitRef="usd">4828000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i5bc3d3cb5c994e7b8a8e525b6b1e17e4_D20200101-20200630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzY2E5YmIwMTc5MjQ3NmZiYjIyNWU1ZDlkZWM4NjlmL3NlYzo5M2NhOWJiMDE3OTI0NzZmYmIyMjVlNWQ5ZGVjODY5Zl81NS9mcmFnOjk0NGQ2N2RjOTNmMjQ1MjliZTc4ZmNlMzRiOGMyZTBiL3RhYmxlOjRjZWFlMWI0OTIwOTQwOGY5NDZmNTU5MmUwNGU0MjFhL3RhYmxlcmFuZ2U6NGNlYWUxYjQ5MjA5NDA4Zjk0NmY1NTkyZTA0ZTQyMWFfMy03LTEtMS0w_102d9b80-b0f2-40e3-80fe-c4c38a46c01b"
      unitRef="usd">293000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i44de340a6a1041189ce50fede1a5bebb_D20210401-20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzY2E5YmIwMTc5MjQ3NmZiYjIyNWU1ZDlkZWM4NjlmL3NlYzo5M2NhOWJiMDE3OTI0NzZmYmIyMjVlNWQ5ZGVjODY5Zl81NS9mcmFnOjk0NGQ2N2RjOTNmMjQ1MjliZTc4ZmNlMzRiOGMyZTBiL3RhYmxlOjRjZWFlMWI0OTIwOTQwOGY5NDZmNTU5MmUwNGU0MjFhL3RhYmxlcmFuZ2U6NGNlYWUxYjQ5MjA5NDA4Zjk0NmY1NTkyZTA0ZTQyMWFfNC0xLTEtMS0w_02e8ceb3-c157-45f7-9ea1-1630ee5abaa9"
      unitRef="usd">2227000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i64046da960714c4f90fcef13ebc59cac_D20200401-20200630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzY2E5YmIwMTc5MjQ3NmZiYjIyNWU1ZDlkZWM4NjlmL3NlYzo5M2NhOWJiMDE3OTI0NzZmYmIyMjVlNWQ5ZGVjODY5Zl81NS9mcmFnOjk0NGQ2N2RjOTNmMjQ1MjliZTc4ZmNlMzRiOGMyZTBiL3RhYmxlOjRjZWFlMWI0OTIwOTQwOGY5NDZmNTU5MmUwNGU0MjFhL3RhYmxlcmFuZ2U6NGNlYWUxYjQ5MjA5NDA4Zjk0NmY1NTkyZTA0ZTQyMWFfNC0zLTEtMS0w_3cc96490-cf20-4633-b2a3-90bebf4a15b2"
      unitRef="usd">2174000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i689f775c23d14a45b6271c2611e144cd_D20210101-20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzY2E5YmIwMTc5MjQ3NmZiYjIyNWU1ZDlkZWM4NjlmL3NlYzo5M2NhOWJiMDE3OTI0NzZmYmIyMjVlNWQ5ZGVjODY5Zl81NS9mcmFnOjk0NGQ2N2RjOTNmMjQ1MjliZTc4ZmNlMzRiOGMyZTBiL3RhYmxlOjRjZWFlMWI0OTIwOTQwOGY5NDZmNTU5MmUwNGU0MjFhL3RhYmxlcmFuZ2U6NGNlYWUxYjQ5MjA5NDA4Zjk0NmY1NTkyZTA0ZTQyMWFfNC01LTEtMS0w_f6131d53-496f-43b1-9734-48f3473cf1ce"
      unitRef="usd">4668000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="ia3f841640fcf416dbce4a93086b21e5a_D20200101-20200630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzY2E5YmIwMTc5MjQ3NmZiYjIyNWU1ZDlkZWM4NjlmL3NlYzo5M2NhOWJiMDE3OTI0NzZmYmIyMjVlNWQ5ZGVjODY5Zl81NS9mcmFnOjk0NGQ2N2RjOTNmMjQ1MjliZTc4ZmNlMzRiOGMyZTBiL3RhYmxlOjRjZWFlMWI0OTIwOTQwOGY5NDZmNTU5MmUwNGU0MjFhL3RhYmxlcmFuZ2U6NGNlYWUxYjQ5MjA5NDA4Zjk0NmY1NTkyZTA0ZTQyMWFfNC03LTEtMS0w_e369a9cd-e1dd-44cc-bc05-df05fb88d3fd"
      unitRef="usd">4350000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i12073826a3a04377a7cd14dedf89a23b_D20210401-20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzY2E5YmIwMTc5MjQ3NmZiYjIyNWU1ZDlkZWM4NjlmL3NlYzo5M2NhOWJiMDE3OTI0NzZmYmIyMjVlNWQ5ZGVjODY5Zl81NS9mcmFnOjk0NGQ2N2RjOTNmMjQ1MjliZTc4ZmNlMzRiOGMyZTBiL3RhYmxlOjRjZWFlMWI0OTIwOTQwOGY5NDZmNTU5MmUwNGU0MjFhL3RhYmxlcmFuZ2U6NGNlYWUxYjQ5MjA5NDA4Zjk0NmY1NTkyZTA0ZTQyMWFfNS0xLTEtMS0w_9a4e4085-b24f-478e-b191-c3a675bbeec8"
      unitRef="usd">421000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="if4be60de0dc04fcaab3cbb8c7454e2b3_D20200401-20200630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzY2E5YmIwMTc5MjQ3NmZiYjIyNWU1ZDlkZWM4NjlmL3NlYzo5M2NhOWJiMDE3OTI0NzZmYmIyMjVlNWQ5ZGVjODY5Zl81NS9mcmFnOjk0NGQ2N2RjOTNmMjQ1MjliZTc4ZmNlMzRiOGMyZTBiL3RhYmxlOjRjZWFlMWI0OTIwOTQwOGY5NDZmNTU5MmUwNGU0MjFhL3RhYmxlcmFuZ2U6NGNlYWUxYjQ5MjA5NDA4Zjk0NmY1NTkyZTA0ZTQyMWFfNS0zLTEtMS0w_a581b375-5917-4674-b4b2-73eb0ac0c843"
      unitRef="usd">0</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="id1c815493ddc46f2a6fa5ee4c4885b69_D20210101-20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzY2E5YmIwMTc5MjQ3NmZiYjIyNWU1ZDlkZWM4NjlmL3NlYzo5M2NhOWJiMDE3OTI0NzZmYmIyMjVlNWQ5ZGVjODY5Zl81NS9mcmFnOjk0NGQ2N2RjOTNmMjQ1MjliZTc4ZmNlMzRiOGMyZTBiL3RhYmxlOjRjZWFlMWI0OTIwOTQwOGY5NDZmNTU5MmUwNGU0MjFhL3RhYmxlcmFuZ2U6NGNlYWUxYjQ5MjA5NDA4Zjk0NmY1NTkyZTA0ZTQyMWFfNS01LTEtMS0w_b06b0a8c-ec85-4f02-979d-455bde1efa12"
      unitRef="usd">491000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i1dd5859753fc4494bc617d9e788b9a09_D20200101-20200630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzY2E5YmIwMTc5MjQ3NmZiYjIyNWU1ZDlkZWM4NjlmL3NlYzo5M2NhOWJiMDE3OTI0NzZmYmIyMjVlNWQ5ZGVjODY5Zl81NS9mcmFnOjk0NGQ2N2RjOTNmMjQ1MjliZTc4ZmNlMzRiOGMyZTBiL3RhYmxlOjRjZWFlMWI0OTIwOTQwOGY5NDZmNTU5MmUwNGU0MjFhL3RhYmxlcmFuZ2U6NGNlYWUxYjQ5MjA5NDA4Zjk0NmY1NTkyZTA0ZTQyMWFfNS03LTEtMS0w_f8f86a2b-f4d5-4425-aac0-ef4d9a032d82"
      unitRef="usd">165000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i27f4e53b91ad4367b7f8d273eff27769_D20210401-20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzY2E5YmIwMTc5MjQ3NmZiYjIyNWU1ZDlkZWM4NjlmL3NlYzo5M2NhOWJiMDE3OTI0NzZmYmIyMjVlNWQ5ZGVjODY5Zl81NS9mcmFnOjk0NGQ2N2RjOTNmMjQ1MjliZTc4ZmNlMzRiOGMyZTBiL3RhYmxlOjRjZWFlMWI0OTIwOTQwOGY5NDZmNTU5MmUwNGU0MjFhL3RhYmxlcmFuZ2U6NGNlYWUxYjQ5MjA5NDA4Zjk0NmY1NTkyZTA0ZTQyMWFfNi0xLTEtMS0w_0de542a5-c80d-4cfe-aae8-23ee4addbd07"
      unitRef="usd">15622000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i39065c5daf934af885335c12f3cfa83f_D20200401-20200630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzY2E5YmIwMTc5MjQ3NmZiYjIyNWU1ZDlkZWM4NjlmL3NlYzo5M2NhOWJiMDE3OTI0NzZmYmIyMjVlNWQ5ZGVjODY5Zl81NS9mcmFnOjk0NGQ2N2RjOTNmMjQ1MjliZTc4ZmNlMzRiOGMyZTBiL3RhYmxlOjRjZWFlMWI0OTIwOTQwOGY5NDZmNTU5MmUwNGU0MjFhL3RhYmxlcmFuZ2U6NGNlYWUxYjQ5MjA5NDA4Zjk0NmY1NTkyZTA0ZTQyMWFfNi0zLTEtMS0w_7c356f1f-9228-4026-b0e8-8b47866c07ba"
      unitRef="usd">9883000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i69782326f71a44e3805518280ee22b6b_D20210101-20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzY2E5YmIwMTc5MjQ3NmZiYjIyNWU1ZDlkZWM4NjlmL3NlYzo5M2NhOWJiMDE3OTI0NzZmYmIyMjVlNWQ5ZGVjODY5Zl81NS9mcmFnOjk0NGQ2N2RjOTNmMjQ1MjliZTc4ZmNlMzRiOGMyZTBiL3RhYmxlOjRjZWFlMWI0OTIwOTQwOGY5NDZmNTU5MmUwNGU0MjFhL3RhYmxlcmFuZ2U6NGNlYWUxYjQ5MjA5NDA4Zjk0NmY1NTkyZTA0ZTQyMWFfNi01LTEtMS0w_79c3b612-99ee-4210-b125-7a396f390868"
      unitRef="usd">28233000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i4a110e4972ef4113880ce582e3cda5c5_D20200101-20200630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzY2E5YmIwMTc5MjQ3NmZiYjIyNWU1ZDlkZWM4NjlmL3NlYzo5M2NhOWJiMDE3OTI0NzZmYmIyMjVlNWQ5ZGVjODY5Zl81NS9mcmFnOjk0NGQ2N2RjOTNmMjQ1MjliZTc4ZmNlMzRiOGMyZTBiL3RhYmxlOjRjZWFlMWI0OTIwOTQwOGY5NDZmNTU5MmUwNGU0MjFhL3RhYmxlcmFuZ2U6NGNlYWUxYjQ5MjA5NDA4Zjk0NmY1NTkyZTA0ZTQyMWFfNi03LTEtMS0w_39441bca-9e6e-44bc-8b83-38a21ff8b5c4"
      unitRef="usd">18315000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:LongLivedAssetsByGeographicAreasTableTextBlock
      contextRef="i69782326f71a44e3805518280ee22b6b_D20210101-20210630"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzY2E5YmIwMTc5MjQ3NmZiYjIyNWU1ZDlkZWM4NjlmL3NlYzo5M2NhOWJiMDE3OTI0NzZmYmIyMjVlNWQ5ZGVjODY5Zl81NS9mcmFnOjk0NGQ2N2RjOTNmMjQ1MjliZTc4ZmNlMzRiOGMyZTBiL3RleHRyZWdpb246OTQ0ZDY3ZGM5M2YyNDUyOWJlNzhmY2UzNGI4YzJlMGJfMjk5MA_6a0b13ee-d91c-4afd-a22b-0c87292316b7">&lt;div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Property, plant and equipment assets were physically located in the following geographic regions:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:60.150%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:17.372%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.605%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:17.373%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;As of June&#160;30, 2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;As of December 31, 2020&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Canada&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;168,462&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;162,163&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Israel&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;23,936&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;23,143&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;United States&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,522&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,293&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total &lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;193,920&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;187,599&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:LongLivedAssetsByGeographicAreasTableTextBlock>
    <us-gaap:NoncurrentAssets
      contextRef="ib400bcdb825949cb9d87ed7e77387db0_I20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzY2E5YmIwMTc5MjQ3NmZiYjIyNWU1ZDlkZWM4NjlmL3NlYzo5M2NhOWJiMDE3OTI0NzZmYmIyMjVlNWQ5ZGVjODY5Zl81NS9mcmFnOjk0NGQ2N2RjOTNmMjQ1MjliZTc4ZmNlMzRiOGMyZTBiL3RhYmxlOjM0OGU0MTA2ZTVkYTQwMTliNzBjYTIyOTlmOTZiYjUxL3RhYmxlcmFuZ2U6MzQ4ZTQxMDZlNWRhNDAxOWI3MGNhMjI5OWY5NmJiNTFfMS0xLTEtMS0w_a2a75155-9fad-4929-adf3-5eb782ffb94f"
      unitRef="usd">168462000</us-gaap:NoncurrentAssets>
    <us-gaap:NoncurrentAssets
      contextRef="i6d98056e96104c42af330a91259abb2c_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzY2E5YmIwMTc5MjQ3NmZiYjIyNWU1ZDlkZWM4NjlmL3NlYzo5M2NhOWJiMDE3OTI0NzZmYmIyMjVlNWQ5ZGVjODY5Zl81NS9mcmFnOjk0NGQ2N2RjOTNmMjQ1MjliZTc4ZmNlMzRiOGMyZTBiL3RhYmxlOjM0OGU0MTA2ZTVkYTQwMTliNzBjYTIyOTlmOTZiYjUxL3RhYmxlcmFuZ2U6MzQ4ZTQxMDZlNWRhNDAxOWI3MGNhMjI5OWY5NmJiNTFfMS0zLTEtMS0w_5e35ad5d-d43a-4985-897a-0b5b7d3ff1d0"
      unitRef="usd">162163000</us-gaap:NoncurrentAssets>
    <us-gaap:NoncurrentAssets
      contextRef="ic9b10d1ca8aa427693166bca2adb764d_I20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzY2E5YmIwMTc5MjQ3NmZiYjIyNWU1ZDlkZWM4NjlmL3NlYzo5M2NhOWJiMDE3OTI0NzZmYmIyMjVlNWQ5ZGVjODY5Zl81NS9mcmFnOjk0NGQ2N2RjOTNmMjQ1MjliZTc4ZmNlMzRiOGMyZTBiL3RhYmxlOjM0OGU0MTA2ZTVkYTQwMTliNzBjYTIyOTlmOTZiYjUxL3RhYmxlcmFuZ2U6MzQ4ZTQxMDZlNWRhNDAxOWI3MGNhMjI5OWY5NmJiNTFfMi0xLTEtMS0w_7aed5896-64a5-4497-bc1e-7e26152e1fe2"
      unitRef="usd">23936000</us-gaap:NoncurrentAssets>
    <us-gaap:NoncurrentAssets
      contextRef="i046692f7d6014223b3cb3cd2d79b04f9_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzY2E5YmIwMTc5MjQ3NmZiYjIyNWU1ZDlkZWM4NjlmL3NlYzo5M2NhOWJiMDE3OTI0NzZmYmIyMjVlNWQ5ZGVjODY5Zl81NS9mcmFnOjk0NGQ2N2RjOTNmMjQ1MjliZTc4ZmNlMzRiOGMyZTBiL3RhYmxlOjM0OGU0MTA2ZTVkYTQwMTliNzBjYTIyOTlmOTZiYjUxL3RhYmxlcmFuZ2U6MzQ4ZTQxMDZlNWRhNDAxOWI3MGNhMjI5OWY5NmJiNTFfMi0zLTEtMS0w_57177905-caeb-4dd1-8c2b-bd2b1e0912eb"
      unitRef="usd">23143000</us-gaap:NoncurrentAssets>
    <us-gaap:NoncurrentAssets
      contextRef="i18e4d04b45ca4c42a5f461314b4cf1a6_I20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzY2E5YmIwMTc5MjQ3NmZiYjIyNWU1ZDlkZWM4NjlmL3NlYzo5M2NhOWJiMDE3OTI0NzZmYmIyMjVlNWQ5ZGVjODY5Zl81NS9mcmFnOjk0NGQ2N2RjOTNmMjQ1MjliZTc4ZmNlMzRiOGMyZTBiL3RhYmxlOjM0OGU0MTA2ZTVkYTQwMTliNzBjYTIyOTlmOTZiYjUxL3RhYmxlcmFuZ2U6MzQ4ZTQxMDZlNWRhNDAxOWI3MGNhMjI5OWY5NmJiNTFfMy0xLTEtMS0w_0e1dbe63-43f4-431b-b9ce-9bd99fe08487"
      unitRef="usd">1522000</us-gaap:NoncurrentAssets>
    <us-gaap:NoncurrentAssets
      contextRef="i57ed1954cbd8415788c6fb0209f0f8f2_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzY2E5YmIwMTc5MjQ3NmZiYjIyNWU1ZDlkZWM4NjlmL3NlYzo5M2NhOWJiMDE3OTI0NzZmYmIyMjVlNWQ5ZGVjODY5Zl81NS9mcmFnOjk0NGQ2N2RjOTNmMjQ1MjliZTc4ZmNlMzRiOGMyZTBiL3RhYmxlOjM0OGU0MTA2ZTVkYTQwMTliNzBjYTIyOTlmOTZiYjUxL3RhYmxlcmFuZ2U6MzQ4ZTQxMDZlNWRhNDAxOWI3MGNhMjI5OWY5NmJiNTFfMy0zLTEtMS0w_bb8be446-6181-4870-a2dd-5ff1d2d1d2a4"
      unitRef="usd">2293000</us-gaap:NoncurrentAssets>
    <us-gaap:NoncurrentAssets
      contextRef="i225f85e38faa4bbdb4de1d8b9cf369bb_I20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzY2E5YmIwMTc5MjQ3NmZiYjIyNWU1ZDlkZWM4NjlmL3NlYzo5M2NhOWJiMDE3OTI0NzZmYmIyMjVlNWQ5ZGVjODY5Zl81NS9mcmFnOjk0NGQ2N2RjOTNmMjQ1MjliZTc4ZmNlMzRiOGMyZTBiL3RhYmxlOjM0OGU0MTA2ZTVkYTQwMTliNzBjYTIyOTlmOTZiYjUxL3RhYmxlcmFuZ2U6MzQ4ZTQxMDZlNWRhNDAxOWI3MGNhMjI5OWY5NmJiNTFfNS0xLTEtMS0w_0ddf8f6f-4c22-4eed-837f-7a802349be0d"
      unitRef="usd">193920000</us-gaap:NoncurrentAssets>
    <us-gaap:NoncurrentAssets
      contextRef="ifbe16ec51ea244519b77d6036b4ef038_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzY2E5YmIwMTc5MjQ3NmZiYjIyNWU1ZDlkZWM4NjlmL3NlYzo5M2NhOWJiMDE3OTI0NzZmYmIyMjVlNWQ5ZGVjODY5Zl81NS9mcmFnOjk0NGQ2N2RjOTNmMjQ1MjliZTc4ZmNlMzRiOGMyZTBiL3RhYmxlOjM0OGU0MTA2ZTVkYTQwMTliNzBjYTIyOTlmOTZiYjUxL3RhYmxlcmFuZ2U6MzQ4ZTQxMDZlNWRhNDAxOWI3MGNhMjI5OWY5NmJiNTFfNS0zLTEtMS0w_2dab9b11-2630-4d18-80cc-d720c426d5e4"
      unitRef="usd">187599000</us-gaap:NoncurrentAssets>
    <us-gaap:AllowanceForDoubtfulAccountsReceivableCurrent
      contextRef="i8c36c75ac6bc43f1a84b689b7e30c990_I20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzY2E5YmIwMTc5MjQ3NmZiYjIyNWU1ZDlkZWM4NjlmL3NlYzo5M2NhOWJiMDE3OTI0NzZmYmIyMjVlNWQ5ZGVjODY5Zl81NS9mcmFnOjk0NGQ2N2RjOTNmMjQ1MjliZTc4ZmNlMzRiOGMyZTBiL3RleHRyZWdpb246OTQ0ZDY3ZGM5M2YyNDUyOWJlNzhmY2UzNGI4YzJlMGJfMjEwOA_ad32467d-27c9-4541-9aa0-96fca14655d7"
      unitRef="usd">106000</us-gaap:AllowanceForDoubtfulAccountsReceivableCurrent>
    <us-gaap:AllowanceForDoubtfulAccountsReceivableCurrent
      contextRef="ideeca118de83445d869657437d768780_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzY2E5YmIwMTc5MjQ3NmZiYjIyNWU1ZDlkZWM4NjlmL3NlYzo5M2NhOWJiMDE3OTI0NzZmYmIyMjVlNWQ5ZGVjODY5Zl81NS9mcmFnOjk0NGQ2N2RjOTNmMjQ1MjliZTc4ZmNlMzRiOGMyZTBiL3RleHRyZWdpb246OTQ0ZDY3ZGM5M2YyNDUyOWJlNzhmY2UzNGI4YzJlMGJfMjExNQ_8fb0bb26-ac80-4e0d-b685-a77fc14e7f8f"
      unitRef="usd">65000</us-gaap:AllowanceForDoubtfulAccountsReceivableCurrent>
    <us-gaap:IncomeLossFromDiscontinuedOperationsNetOfTax
      contextRef="i094dc56c362c416aac0dd88497f3bd55_D20200401-20200630"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzY2E5YmIwMTc5MjQ3NmZiYjIyNWU1ZDlkZWM4NjlmL3NlYzo5M2NhOWJiMDE3OTI0NzZmYmIyMjVlNWQ5ZGVjODY5Zl81NS9mcmFnOjk0NGQ2N2RjOTNmMjQ1MjliZTc4ZmNlMzRiOGMyZTBiL3RleHRyZWdpb246OTQ0ZDY3ZGM5M2YyNDUyOWJlNzhmY2UzNGI4YzJlMGJfOTg5NTYwNDY5NzE2Mg_37534e0f-076a-462e-ab8e-bb643cb224ed"
      unitRef="usd">0</us-gaap:IncomeLossFromDiscontinuedOperationsNetOfTax>
    <us-gaap:IncomeLossFromDiscontinuedOperationsNetOfTax
      contextRef="i812abaaed027463984b850a5e2b42d2c_D20200101-20200630"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzY2E5YmIwMTc5MjQ3NmZiYjIyNWU1ZDlkZWM4NjlmL3NlYzo5M2NhOWJiMDE3OTI0NzZmYmIyMjVlNWQ5ZGVjODY5Zl81NS9mcmFnOjk0NGQ2N2RjOTNmMjQ1MjliZTc4ZmNlMzRiOGMyZTBiL3RleHRyZWdpb246OTQ0ZDY3ZGM5M2YyNDUyOWJlNzhmY2UzNGI4YzJlMGJfOTg5NTYwNDY5NzE2Mg_959e8722-2302-4fc8-ad39-fcee292819e8"
      unitRef="usd">0</us-gaap:IncomeLossFromDiscontinuedOperationsNetOfTax>
    <us-gaap:IncomeLossFromDiscontinuedOperationsNetOfTax
      contextRef="i3a27e92fff0846b5bad95097b919232f_D20210101-20210630"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzY2E5YmIwMTc5MjQ3NmZiYjIyNWU1ZDlkZWM4NjlmL3NlYzo5M2NhOWJiMDE3OTI0NzZmYmIyMjVlNWQ5ZGVjODY5Zl81NS9mcmFnOjk0NGQ2N2RjOTNmMjQ1MjliZTc4ZmNlMzRiOGMyZTBiL3RleHRyZWdpb246OTQ0ZDY3ZGM5M2YyNDUyOWJlNzhmY2UzNGI4YzJlMGJfOTg5NTYwNDY5NzE2Mg_e6adc93e-e496-4a67-b7a1-6b277e5b915e"
      unitRef="usd">0</us-gaap:IncomeLossFromDiscontinuedOperationsNetOfTax>
    <us-gaap:IncomeLossFromDiscontinuedOperationsNetOfTax
      contextRef="i34f72ee8566f4486917d56bc3b40f37f_D20210401-20210630"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzY2E5YmIwMTc5MjQ3NmZiYjIyNWU1ZDlkZWM4NjlmL3NlYzo5M2NhOWJiMDE3OTI0NzZmYmIyMjVlNWQ5ZGVjODY5Zl81NS9mcmFnOjk0NGQ2N2RjOTNmMjQ1MjliZTc4ZmNlMzRiOGMyZTBiL3RleHRyZWdpb246OTQ0ZDY3ZGM5M2YyNDUyOWJlNzhmY2UzNGI4YzJlMGJfOTg5NTYwNDY5NzE2Mg_f7140db0-4d63-4458-a295-abf41a559758"
      unitRef="usd">0</us-gaap:IncomeLossFromDiscontinuedOperationsNetOfTax>
    <us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax
      contextRef="i5c2d78ee6853443687a96daa15276fab_D20210401-20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzY2E5YmIwMTc5MjQ3NmZiYjIyNWU1ZDlkZWM4NjlmL3NlYzo5M2NhOWJiMDE3OTI0NzZmYmIyMjVlNWQ5ZGVjODY5Zl81NS9mcmFnOjk0NGQ2N2RjOTNmMjQ1MjliZTc4ZmNlMzRiOGMyZTBiL3RleHRyZWdpb246OTQ0ZDY3ZGM5M2YyNDUyOWJlNzhmY2UzNGI4YzJlMGJfMjM0Mg_4b45b5e7-318f-415d-aa42-6562b6139f24"
      unitRef="usd">8497000</us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax>
    <us-gaap:ConcentrationRiskPercentage1
      contextRef="i93bcd6f71ecb484fbb4d514bb054afb1_D20210401-20210630"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzY2E5YmIwMTc5MjQ3NmZiYjIyNWU1ZDlkZWM4NjlmL3NlYzo5M2NhOWJiMDE3OTI0NzZmYmIyMjVlNWQ5ZGVjODY5Zl81NS9mcmFnOjk0NGQ2N2RjOTNmMjQ1MjliZTc4ZmNlMzRiOGMyZTBiL3RleHRyZWdpb246OTQ0ZDY3ZGM5M2YyNDUyOWJlNzhmY2UzNGI4YzJlMGJfMjE5OTAyMzI2NTk2NA_ed53a79d-49d0-4f54-8f10-42c4d7e690ed"
      unitRef="number">0.19</us-gaap:ConcentrationRiskPercentage1>
    <us-gaap:ConcentrationRiskPercentage1
      contextRef="i211d75fcd6a546f899374d2d7176c1e2_D20210401-20210630"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzY2E5YmIwMTc5MjQ3NmZiYjIyNWU1ZDlkZWM4NjlmL3NlYzo5M2NhOWJiMDE3OTI0NzZmYmIyMjVlNWQ5ZGVjODY5Zl81NS9mcmFnOjk0NGQ2N2RjOTNmMjQ1MjliZTc4ZmNlMzRiOGMyZTBiL3RleHRyZWdpb246OTQ0ZDY3ZGM5M2YyNDUyOWJlNzhmY2UzNGI4YzJlMGJfMjE5OTAyMzI2NTk3MA_fccb9fea-caf9-4666-949c-bbaa204795ea"
      unitRef="number">0.14</us-gaap:ConcentrationRiskPercentage1>
    <us-gaap:ConcentrationRiskPercentage1
      contextRef="idd2a2576b3144d36986722b62b737a2d_D20210401-20210630"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzY2E5YmIwMTc5MjQ3NmZiYjIyNWU1ZDlkZWM4NjlmL3NlYzo5M2NhOWJiMDE3OTI0NzZmYmIyMjVlNWQ5ZGVjODY5Zl81NS9mcmFnOjk0NGQ2N2RjOTNmMjQ1MjliZTc4ZmNlMzRiOGMyZTBiL3RleHRyZWdpb246OTQ0ZDY3ZGM5M2YyNDUyOWJlNzhmY2UzNGI4YzJlMGJfMjQwNA_610cc8bf-ff01-4b6d-a989-2e0ffbc8045b"
      unitRef="number">0.12</us-gaap:ConcentrationRiskPercentage1>
    <us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax
      contextRef="i74697f2f39824e5d8fa61532bd9225b4_D20200401-20200630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzY2E5YmIwMTc5MjQ3NmZiYjIyNWU1ZDlkZWM4NjlmL3NlYzo5M2NhOWJiMDE3OTI0NzZmYmIyMjVlNWQ5ZGVjODY5Zl81NS9mcmFnOjk0NGQ2N2RjOTNmMjQ1MjliZTc4ZmNlMzRiOGMyZTBiL3RleHRyZWdpb246OTQ0ZDY3ZGM5M2YyNDUyOWJlNzhmY2UzNGI4YzJlMGJfMzI5ODUzNDg4NjgyOA_ff7f542c-a957-4352-98ca-add863ab70bf"
      unitRef="usd">7040000</us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax>
    <us-gaap:ConcentrationRiskPercentage1
      contextRef="i74697f2f39824e5d8fa61532bd9225b4_D20200401-20200630"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzY2E5YmIwMTc5MjQ3NmZiYjIyNWU1ZDlkZWM4NjlmL3NlYzo5M2NhOWJiMDE3OTI0NzZmYmIyMjVlNWQ5ZGVjODY5Zl81NS9mcmFnOjk0NGQ2N2RjOTNmMjQ1MjliZTc4ZmNlMzRiOGMyZTBiL3RleHRyZWdpb246OTQ0ZDY3ZGM5M2YyNDUyOWJlNzhmY2UzNGI4YzJlMGJfMzI5ODUzNDg4NzA2Ng_994dd834-924c-420e-87ee-f6a01628cae4"
      unitRef="number">0.71</us-gaap:ConcentrationRiskPercentage1>
    <us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax
      contextRef="ic588d92572e146368a7065a944f8c099_D20200101-20200630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzY2E5YmIwMTc5MjQ3NmZiYjIyNWU1ZDlkZWM4NjlmL3NlYzo5M2NhOWJiMDE3OTI0NzZmYmIyMjVlNWQ5ZGVjODY5Zl81NS9mcmFnOjk0NGQ2N2RjOTNmMjQ1MjliZTc4ZmNlMzRiOGMyZTBiL3RleHRyZWdpb246OTQ0ZDY3ZGM5M2YyNDUyOWJlNzhmY2UzNGI4YzJlMGJfMzI5ODUzNDg4NzA5NA_4543c1e3-a6af-42bc-98d2-6ab00da320c5"
      unitRef="usd">18250000</us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax>
    <us-gaap:ConcentrationRiskPercentage1
      contextRef="id59e6b6959b841bebcf3af4df3b502e6_D20200101-20200630"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzY2E5YmIwMTc5MjQ3NmZiYjIyNWU1ZDlkZWM4NjlmL3NlYzo5M2NhOWJiMDE3OTI0NzZmYmIyMjVlNWQ5ZGVjODY5Zl81NS9mcmFnOjk0NGQ2N2RjOTNmMjQ1MjliZTc4ZmNlMzRiOGMyZTBiL3RleHRyZWdpb246OTQ0ZDY3ZGM5M2YyNDUyOWJlNzhmY2UzNGI4YzJlMGJfMjE5OTAyMzI2NjAyNg_ad58b772-20ab-490b-a7b0-7a6a22996232"
      unitRef="number">0.15</us-gaap:ConcentrationRiskPercentage1>
    <us-gaap:ConcentrationRiskPercentage1
      contextRef="id58ad288eb10460ebcce6bf331a5886c_D20200101-20200630"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzY2E5YmIwMTc5MjQ3NmZiYjIyNWU1ZDlkZWM4NjlmL3NlYzo5M2NhOWJiMDE3OTI0NzZmYmIyMjVlNWQ5ZGVjODY5Zl81NS9mcmFnOjk0NGQ2N2RjOTNmMjQ1MjliZTc4ZmNlMzRiOGMyZTBiL3RleHRyZWdpb246OTQ0ZDY3ZGM5M2YyNDUyOWJlNzhmY2UzNGI4YzJlMGJfMjE5OTAyMzI2NjAzMg_c1e6154b-faa1-46bb-82b5-08760f0e75b5"
      unitRef="number">0.14</us-gaap:ConcentrationRiskPercentage1>
    <us-gaap:ConcentrationRiskPercentage1
      contextRef="i3d5f8123b8fe46de8a82ced9ca5ee737_D20200101-20200630"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzY2E5YmIwMTc5MjQ3NmZiYjIyNWU1ZDlkZWM4NjlmL3NlYzo5M2NhOWJiMDE3OTI0NzZmYmIyMjVlNWQ5ZGVjODY5Zl81NS9mcmFnOjk0NGQ2N2RjOTNmMjQ1MjliZTc4ZmNlMzRiOGMyZTBiL3RleHRyZWdpb246OTQ0ZDY3ZGM5M2YyNDUyOWJlNzhmY2UzNGI4YzJlMGJfMzI5ODUzNDg4NzExMA_5f817b96-3233-461c-ab99-6403cd9b906c"
      unitRef="number">0.13</us-gaap:ConcentrationRiskPercentage1>
    <us-gaap:ConcentrationRiskPercentage1
      contextRef="ie35646e7e6b447dc960fee8714bca44b_D20200101-20200630"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzY2E5YmIwMTc5MjQ3NmZiYjIyNWU1ZDlkZWM4NjlmL3NlYzo5M2NhOWJiMDE3OTI0NzZmYmIyMjVlNWQ5ZGVjODY5Zl81NS9mcmFnOjk0NGQ2N2RjOTNmMjQ1MjliZTc4ZmNlMzRiOGMyZTBiL3RleHRyZWdpb246OTQ0ZDY3ZGM5M2YyNDUyOWJlNzhmY2UzNGI4YzJlMGJfMzI5ODUzNDg4NzEyNQ_1b43fc50-a122-4d7d-903a-604c31790516"
      unitRef="number">0.12</us-gaap:ConcentrationRiskPercentage1>
    <us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax
      contextRef="ifefa84f4058a4db3af98ff73cf89d8f4_D20200101-20200630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzY2E5YmIwMTc5MjQ3NmZiYjIyNWU1ZDlkZWM4NjlmL3NlYzo5M2NhOWJiMDE3OTI0NzZmYmIyMjVlNWQ5ZGVjODY5Zl81NS9mcmFnOjk0NGQ2N2RjOTNmMjQ1MjliZTc4ZmNlMzRiOGMyZTBiL3RleHRyZWdpb246OTQ0ZDY3ZGM5M2YyNDUyOWJlNzhmY2UzNGI4YzJlMGJfMzI5ODUzNDg4NzA1Nw_a80c5e07-48d3-4847-8da8-2b82c495d1df"
      unitRef="usd">11819000</us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax>
    <us-gaap:ConcentrationRiskPercentage1
      contextRef="ifefa84f4058a4db3af98ff73cf89d8f4_D20200101-20200630"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzY2E5YmIwMTc5MjQ3NmZiYjIyNWU1ZDlkZWM4NjlmL3NlYzo5M2NhOWJiMDE3OTI0NzZmYmIyMjVlNWQ5ZGVjODY5Zl81NS9mcmFnOjk0NGQ2N2RjOTNmMjQ1MjliZTc4ZmNlMzRiOGMyZTBiL3RleHRyZWdpb246OTQ0ZDY3ZGM5M2YyNDUyOWJlNzhmY2UzNGI4YzJlMGJfMzI5ODUzNDg4Njk5Mg_f6ef6b33-ed02-4e7c-bd29-8d739a73795e"
      unitRef="number">0.65</us-gaap:ConcentrationRiskPercentage1>
    <us-gaap:AllowanceForDoubtfulAccountsReceivableCurrent
      contextRef="i72aea01958fa442a951467d9e067fb46_I20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzY2E5YmIwMTc5MjQ3NmZiYjIyNWU1ZDlkZWM4NjlmL3NlYzo5M2NhOWJiMDE3OTI0NzZmYmIyMjVlNWQ5ZGVjODY5Zl81NS9mcmFnOjk0NGQ2N2RjOTNmMjQ1MjliZTc4ZmNlMzRiOGMyZTBiL3RleHRyZWdpb246OTQ0ZDY3ZGM5M2YyNDUyOWJlNzhmY2UzNGI4YzJlMGJfMjc0MA_c269875d-d068-4819-95ac-6d4159058501"
      unitRef="usd">158000</us-gaap:AllowanceForDoubtfulAccountsReceivableCurrent>
    <us-gaap:AllowanceForDoubtfulAccountsReceivableCurrent
      contextRef="ib9d10d92b8c54f02a41178e1141532dd_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzY2E5YmIwMTc5MjQ3NmZiYjIyNWU1ZDlkZWM4NjlmL3NlYzo5M2NhOWJiMDE3OTI0NzZmYmIyMjVlNWQ5ZGVjODY5Zl81NS9mcmFnOjk0NGQ2N2RjOTNmMjQ1MjliZTc4ZmNlMzRiOGMyZTBiL3RleHRyZWdpb246OTQ0ZDY3ZGM5M2YyNDUyOWJlNzhmY2UzNGI4YzJlMGJfMjc0Nw_5428aaad-6b6a-4257-b063-39a8d7c12d31"
      unitRef="usd">9000</us-gaap:AllowanceForDoubtfulAccountsReceivableCurrent>
    <us-gaap:IncomeLossFromDiscontinuedOperationsNetOfTax
      contextRef="i27f4e53b91ad4367b7f8d273eff27769_D20210401-20210630"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzY2E5YmIwMTc5MjQ3NmZiYjIyNWU1ZDlkZWM4NjlmL3NlYzo5M2NhOWJiMDE3OTI0NzZmYmIyMjVlNWQ5ZGVjODY5Zl81NS9mcmFnOjk0NGQ2N2RjOTNmMjQ1MjliZTc4ZmNlMzRiOGMyZTBiL3RleHRyZWdpb246OTQ0ZDY3ZGM5M2YyNDUyOWJlNzhmY2UzNGI4YzJlMGJfNTQ5NzU1ODE0MzA2Ng_975b6be6-740c-4075-a747-c05a860e9e18"
      unitRef="usd">-561000</us-gaap:IncomeLossFromDiscontinuedOperationsNetOfTax>
    <us-gaap:IncomeLossFromDiscontinuedOperationsNetOfTax
      contextRef="i39065c5daf934af885335c12f3cfa83f_D20200401-20200630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzY2E5YmIwMTc5MjQ3NmZiYjIyNWU1ZDlkZWM4NjlmL3NlYzo5M2NhOWJiMDE3OTI0NzZmYmIyMjVlNWQ5ZGVjODY5Zl81NS9mcmFnOjk0NGQ2N2RjOTNmMjQ1MjliZTc4ZmNlMzRiOGMyZTBiL3RleHRyZWdpb246OTQ0ZDY3ZGM5M2YyNDUyOWJlNzhmY2UzNGI4YzJlMGJfNTQ5NzU1ODE0MzA4Mg_8c25c2e7-3f05-441c-9d24-5126991f4b23"
      unitRef="usd">-46000</us-gaap:IncomeLossFromDiscontinuedOperationsNetOfTax>
    <us-gaap:IncomeLossFromDiscontinuedOperationsNetOfTax
      contextRef="i69782326f71a44e3805518280ee22b6b_D20210101-20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzY2E5YmIwMTc5MjQ3NmZiYjIyNWU1ZDlkZWM4NjlmL3NlYzo5M2NhOWJiMDE3OTI0NzZmYmIyMjVlNWQ5ZGVjODY5Zl81NS9mcmFnOjk0NGQ2N2RjOTNmMjQ1MjliZTc4ZmNlMzRiOGMyZTBiL3RleHRyZWdpb246OTQ0ZDY3ZGM5M2YyNDUyOWJlNzhmY2UzNGI4YzJlMGJfNDk0NzgwMjMyOTM0Mw_baa9badb-5ffa-4186-a150-7b68d9089f70"
      unitRef="usd">-582000</us-gaap:IncomeLossFromDiscontinuedOperationsNetOfTax>
    <us-gaap:IncomeLossFromDiscontinuedOperationsNetOfTax
      contextRef="i4a110e4972ef4113880ce582e3cda5c5_D20200101-20200630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzY2E5YmIwMTc5MjQ3NmZiYjIyNWU1ZDlkZWM4NjlmL3NlYzo5M2NhOWJiMDE3OTI0NzZmYmIyMjVlNWQ5ZGVjODY5Zl81NS9mcmFnOjk0NGQ2N2RjOTNmMjQ1MjliZTc4ZmNlMzRiOGMyZTBiL3RleHRyZWdpb246OTQ0ZDY3ZGM5M2YyNDUyOWJlNzhmY2UzNGI4YzJlMGJfNDk0NzgwMjMyOTM1Mg_b72b2f6d-e92d-4c8b-91df-8b0cab54e583"
      unitRef="usd">-46000</us-gaap:IncomeLossFromDiscontinuedOperationsNetOfTax>
    <us-gaap:LossContingencyDisclosures
      contextRef="i69782326f71a44e3805518280ee22b6b_D20210101-20210630"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzY2E5YmIwMTc5MjQ3NmZiYjIyNWU1ZDlkZWM4NjlmL3NlYzo5M2NhOWJiMDE3OTI0NzZmYmIyMjVlNWQ5ZGVjODY5Zl81OC9mcmFnOjg2ZmM2YjFiZjYyMDRmNzViNjAyMjE0MWU1MWMyYjU2L3RleHRyZWdpb246ODZmYzZiMWJmNjIwNGY3NWI2MDIyMTQxZTUxYzJiNTZfNjM3Ng_be8aeebc-2359-4fbd-9a9c-e893fafe8a8b">Commitments and Contingencies&lt;div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;(a)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;padding-left:24.34pt"&gt;Commitments&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;There have been no material changes in the information regarding commitments as disclosed in the Company&#x2019;s Annual Financial Statements.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;(b)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;padding-left:23.78pt"&gt;Contingencies&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company is subject to various legal proceedings in the ordinary course of its business and in connection with its marketing, distribution and sale of its products. Many of these legal proceedings are in the early stages of litigation and seek damages that are unspecified or not quantified. Although the outcome of these matters cannot be predicted with certainty, the Company does not believe these legal proceedings, individually or in the aggregate, will have a material adverse effect on its financial condition but could be material to its results of operations for a quarterly period depending, in part, on its results for that quarter.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt;padding-left:18pt;text-align:justify;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;(i)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%;padding-left:8.57pt"&gt;Class action complaints relating to restatement&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;On March 11 and 12, 2020, two alleged shareholders of the Company separately filed two putative class action complaints in the U.S. District Court for the Eastern District of New York against the Company and its former Chief Executive Officer (now Executive Chairman) and Chief Financial Officer. The court has consolidated the cases, and the consolidated amended complaint alleges violations of Section 10(b) of the Securities Exchange Act of 1934 (the &#x201c;Exchange Act&#x201d;) and Rule 10b-5 promulgated thereunder against all defendants, and Section 20(a) of the Exchange Act against the individual defendants. The consolidated amended complaint generally alleges that certain of the Company&#x2019;s prior public statements about revenues and internal controls were incorrect based on the Company&#x2019;s disclosures relating to the Audit Committee of the Board of Directors&#x2019; review of the appropriateness of revenue recognized in connection with certain bulk resin purchases and sales of products through the wholesale channel. The consolidated amended complaint does not quantify a damage request. Defendants moved to dismiss on February 8, 2021. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;On June 3, 2020, an alleged shareholder filed a Statement of Claim, as amended on August 12, 2020, in the Ontario Superior Court of Justice in Toronto, Ontario, Canada, seeking, among other things, an order certifying the action as a class action on behalf of a putative class of shareholders and damages of an unspecified amount. The Amended Statement of Claim names the Company, its former Chief Executive Officer (now Executive Chairman), Chief Financial Officer, former Chief Financial Officer and Chief Commercial Officer, and current and former members of the Board of Directors as defendants and alleges breaches of the Ontario Securities Act, oppression under the Ontario Business Corporations Act and common law misrepresentation. The Amended Statement of Claim generally alleges that certain of the Company&#x2019;s prior public statements about revenues and internal controls were misrepresentations based on the Company&#x2019;s March 2, 2020 disclosure that the Audit Committee of the Board of Directors was conducting a review of the appropriateness of revenue recognized in connection with certain bulk resin purchases and sales of products through the wholesale channel, and the Company&#x2019;s subsequent restatement. The Amended Statement of Claim does not quantify a damage request. On June 28, 2021, the Ontario Court dismissed motions brought by the plaintiff for leave to commence a claim for misrepresentation under the Ontario Securities Act and for certification of the action as a class action. The plaintiff appealed the Court&#x2019;s dismissal of the motions, except with respect to the former Chief Financial Officer and Chief Commercial Officer, who agreed not to seek costs from plaintiff in connection with the dismissal of the motions&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt;padding-left:18pt;text-align:justify;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;(ii)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%;padding-left:5.8pt"&gt;Regulatory reviews relating to restatement&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company has been responding to requests for information from various regulatory authorities relating to its previously disclosed restatement of its financial statements for the first three quarters of 2019. The Company is responding to all such requests for information and cooperating with all regulatory authorities. The Company cannot predict the outcome of any such regulatory review or investigation and it is possible that additional investigations or one or more formal proceedings may be commenced against the Company and its current and former officers and directors in connection with these regulatory reviews and investigations. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt;padding-left:18pt;text-align:justify;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;(iii)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%;padding-left:3.03pt"&gt;Litigation relating to marketing, distribution and sale of products&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;On June 16, 2020, an alleged consumer filed a Statement of Claim on behalf of a class in the Court of Queen&#x2019;s Bench of Alberta in Alberta, Canada, against the Company and other Canadian cannabis manufacturers and/or distributors. On December 4, 2020, a Third Amended Statement of Claim was filed, which added a second alleged consumer. The Third Amended Statement of Claim alleges claims related to the defendants&#x2019; advertised content of cannabinoids in cannabis products for medicinal use on or after June 16, 2010 and cannabis products for adult use on or after October 17, 2018. The Third Amended Statement of Claim seeks a total of C$500 million for breach of contract, compensatory damages, and unjust enrichment or such other amount as may be proven in trial and C$5 million in punitive damages against each defendant, including the Company. The Third Amended Statement of Claim also seeks interest and costs associated with the action. The Company has not responded to the Third Amended Statement of Claim. &lt;/span&gt;&lt;/div&gt;A number of claims, including purported class actions, have been brought in the U.S. against companies engaged in the U.S. hemp business alleging, among other things, violations of state consumer protection, health and advertising laws. On April 8, 2020, a putative class action complaint was filed in the U.S. District Court for the Central District of California against Redwood Holding Group, LLC (&#x201c;Redwood&#x201d;), alleging violations of California&#x2019;s Unfair Competition Law, False Advertising Law, Consumers Legal Remedies Act, and breaches of the California Commercial Code for breach of express warranties and implied warranty of merchantability with respect to Redwood&#x2019;s marketing and sale of U.S. hemp products. The complaint did not quantify a damage request. On April 10, 2020, the class action complaint was dismissed for certain pleading deficiencies and the plaintiff was granted leave until April 24, 2020 to amend the complaint to establish federal subject matter jurisdiction. On April 28, 2020, the action was dismissed without prejudice for failure to prosecute and for failure to comply with a court order. As of the date of this Quarterly Report, the plaintiff has not refiled the complaint. The Company expects litigation and regulatory proceedings relating to the marketing, distribution and sale of its products to increase.</us-gaap:LossContingencyDisclosures>
    <us-gaap:LossContingencyNumberOfPlaintiffs
      contextRef="ia489f6e55d8f4b56a4c35ea7b7898ed6_D20200311-20200312"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzY2E5YmIwMTc5MjQ3NmZiYjIyNWU1ZDlkZWM4NjlmL3NlYzo5M2NhOWJiMDE3OTI0NzZmYmIyMjVlNWQ5ZGVjODY5Zl81OC9mcmFnOjg2ZmM2YjFiZjYyMDRmNzViNjAyMjE0MWU1MWMyYjU2L3RleHRyZWdpb246ODZmYzZiMWJmNjIwNGY3NWI2MDIyMTQxZTUxYzJiNTZfODk1_82770464-5c4b-4be2-b20a-14db15e04572"
      unitRef="shareholder">2</us-gaap:LossContingencyNumberOfPlaintiffs>
    <us-gaap:LossContingencyNewClaimsFiledNumber
      contextRef="ia489f6e55d8f4b56a4c35ea7b7898ed6_D20200311-20200312"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzY2E5YmIwMTc5MjQ3NmZiYjIyNWU1ZDlkZWM4NjlmL3NlYzo5M2NhOWJiMDE3OTI0NzZmYmIyMjVlNWQ5ZGVjODY5Zl81OC9mcmFnOjg2ZmM2YjFiZjYyMDRmNzViNjAyMjE0MWU1MWMyYjU2L3RleHRyZWdpb246ODZmYzZiMWJmNjIwNGY3NWI2MDIyMTQxZTUxYzJiNTZfOTUx_74044aaa-26bf-49d7-a853-95b680b37c67"
      unitRef="complaint">2</us-gaap:LossContingencyNewClaimsFiledNumber>
    <us-gaap:LossContingencyDamagesSoughtValue
      contextRef="i71fed0c557ee4fb3a307e51526e90c95_D20200616-20200616"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzY2E5YmIwMTc5MjQ3NmZiYjIyNWU1ZDlkZWM4NjlmL3NlYzo5M2NhOWJiMDE3OTI0NzZmYmIyMjVlNWQ5ZGVjODY5Zl81OC9mcmFnOjg2ZmM2YjFiZjYyMDRmNzViNjAyMjE0MWU1MWMyYjU2L3RleHRyZWdpb246ODZmYzZiMWJmNjIwNGY3NWI2MDIyMTQxZTUxYzJiNTZfNDY3NA_88401b7c-75c6-4e7a-af74-8ad9ef9c632b"
      unitRef="cad">500000000</us-gaap:LossContingencyDamagesSoughtValue>
    <cron:LossContingencyPunitiveDamagesSoughtValue
      contextRef="i71fed0c557ee4fb3a307e51526e90c95_D20200616-20200616"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzY2E5YmIwMTc5MjQ3NmZiYjIyNWU1ZDlkZWM4NjlmL3NlYzo5M2NhOWJiMDE3OTI0NzZmYmIyMjVlNWQ5ZGVjODY5Zl81OC9mcmFnOjg2ZmM2YjFiZjYyMDRmNzViNjAyMjE0MWU1MWMyYjU2L3RleHRyZWdpb246ODZmYzZiMWJmNjIwNGY3NWI2MDIyMTQxZTUxYzJiNTZfNDc5Nw_ef32fc2d-bc61-45c6-8dd8-e1112c7d4098"
      unitRef="cad">5000000</cron:LossContingencyPunitiveDamagesSoughtValue>
    <us-gaap:ConcentrationRiskDisclosureTextBlock
      contextRef="i69782326f71a44e3805518280ee22b6b_D20210101-20210630"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzY2E5YmIwMTc5MjQ3NmZiYjIyNWU1ZDlkZWM4NjlmL3NlYzo5M2NhOWJiMDE3OTI0NzZmYmIyMjVlNWQ5ZGVjODY5Zl82MS9mcmFnOjE3NDk5MWNiMmM0ZjRmM2I4NDJjMzkxZWM3ZGRiZGY1L3RleHRyZWdpb246MTc0OTkxY2IyYzRmNGYzYjg0MmMzOTFlYzdkZGJkZjVfNzczNA_e7401738-a008-4ed0-ae24-f7109fd2a4d2">Financial Instruments &lt;div style="margin-bottom:6pt;margin-top:6pt;padding-left:36pt;text-align:justify;text-indent:-36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;(a)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;padding-left:24.34pt"&gt;Fair value measurement &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company complies with ASC 820, Fair Value Measurements, for its financial assets and liabilities that are re-measured and reported at fair value at each reporting period, and non-financial assets and liabilities that are re-measured and reported at fair value at least annually. In general, fair values are determined by:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt;padding-left:36pt;text-align:justify;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x2022;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt"&gt;Level 1 inputs utilize quoted prices (unadjusted) in active markets for identical assets or liabilities. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt;padding-left:36pt;text-align:justify;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x2022;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt"&gt;Level 2 inputs utilize data points that are observable such as quoted prices, interest rates and yield curves. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt;padding-left:36pt;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x2022;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt"&gt;Level 3 inputs are unobservable data points for the asset or liability, and includes situations where there is little, if any, market activity for the asset or liability.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following tables present information about the Company&#x2019;s assets that are measured at fair value on a recurring basis as of June&#160;30, 2021 and December 31, 2020 and indicate the fair value hierarchy of the valuation techniques the Company utilized to determine such fair value.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:45.983%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.983%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.327%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.983%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.327%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.983%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.327%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.987%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="21" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;June&#160;30, 2021&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Level 1&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Level 2&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Level 3&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Cash and cash equivalents&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;895,181&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;895,181&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Short-term investments&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;201,699&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;201,699&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Derivative liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;169,563&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;169,563&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:45.983%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.983%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.327%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.983%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.327%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.983%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.327%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.987%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="21" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;December 31, 2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Level 1&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Level 2&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Level 3&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Cash and cash equivalents&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,078,023&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,078,023&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Short-term investments&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;211,766&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;211,766&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Derivative liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;163,410&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;163,410&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-top:12pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;There were no transfers between categories during the periods presented.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt;padding-left:36pt;text-align:justify;text-indent:-36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;(b)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;padding-left:23.78pt"&gt;Financial risks&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company&#x2019;s activities expose it to a variety of financial risks, including credit risk, market risk, interest rate risk, liquidity risk, and foreign currency rate risk.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;(i)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%;padding-left:26.57pt"&gt;Credit risk&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Credit risk is the risk of financial loss to the Company if a customer or counterparty to a financial instrument fails to meet its contractual obligations. The Company is exposed to credit risk from its operating activities, primarily accounts receivable and other receivables, and its investing activities, including cash held with banks and financial institutions, short-term investments, loans receivable, and advances to joint ventures. The Company&#x2019;s maximum exposure to this risk is equal to the carrying amount of these financial assets, which amounted to $1,210,287 and $1,403,491 as of June&#160;30, 2021 and December 31, 2020, respectively.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt;padding-left:36pt;text-align:justify;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;(a)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:120%;padding-left:6.34pt"&gt;C&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;ash and cash equivalents, short-term investments, and other receivables&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company held cash and cash equivalents and short-term investments and related interest receivable. Short-term investments and related interest receivable represents short-term investments with a maturity of less than a year and accrued interest as of period end. The cash and cash equivalents and short-term investments, including guaranteed investment certificates and bankers&#x2019; acceptances, are held with central banks and financial institutions that are highly rated. In addition to interest receivable, other receivables include sales taxes receivable from the government. As such, the Company has assessed an insignificant loss allowance on these financial instruments. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt;padding-left:36pt;text-align:justify;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;(b)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;padding-left:6.34pt"&gt;Accounts receivable&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;An impairment analysis is performed at each reporting date using a provision matrix to measure expected credit losses. The provision rates are based on the days past due for groupings of various customer segments with similar loss patterns. The calculation reflects the probability-weighted outcome, the time value of money and reasonable and supportable information that is available at the reporting date about past events, current conditions and forecasts of future economic conditions. Accounts receivable are written off when there is no reasonable expectation of recovery. Indicators that there is no reasonable expectation of recovery include, among others, the failure of a debtor to engage in a repayment plan and a failure to make contractual payments for a period of greater than 120 days past due. As of June&#160;30, 2021 and December 31, 2020, the Company had an allowance for credit losses of $264 and $74, respectively.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;As of June&#160;30, 2021, the Company has assessed that there is a concentration of credit risk, as 74% of the Company&#x2019;s accounts receivable were due from four customers with an established credit history with the Company. As of December 31, 2020, 78% of the Company&#x2019;s accounts receivable were due from four customers with an established credit history with the Company.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;(ii)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%;padding-left:23.8pt"&gt;Market risk&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Market risk is the risk that the fair value of, or future cash flows from, the Company&#x2019;s financial instruments will significantly fluctuate due to changes in market prices. The value of financial instruments can be affected by changes in interest rates, market and economic conditions, and equity and commodity prices. The Company is exposed to market risk in divesting its investments, such that unfavorable market conditions could result in dispositions of investments at less than their carrying values. Further, the revaluation of securities classified as fair value through net income could result in significant write-downs of the Company&#x2019;s investments, which would have an adverse impact on the Company&#x2019;s financial position, unless these would flow through other comprehensive income.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company manages market risk by having a portfolio of securities from multiple issuers so that the Company is not materially exposed to any one issuer.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;(iii)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%;padding-left:21.03pt"&gt;Interest rate risk&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Interest rate risk is the risk that the value or yield of fixed-income investments may decline if interest rates change. Fluctuations in interest rates may impact the level of income and expense recorded on the cash equivalents and short-term investments, and the market value of all interest-earning assets, other than those which possess a short-term to maturity. A 10% change in the interest rate in effect on June&#160;30, 2021 and December 31, 2020 would not have a material effect on (i) fair value of the cash equivalents and short-term investments as the majority of the portfolio has a maturity date of three months or less or (ii) interest income. Management continues to monitor external interest rates and revise the Company&#x2019;s investment strategy as a result. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;During the three months ended June&#160;30, 2021 and 2020, the Company recorded net interest income of $2,293 and $3,734, respectively. During the six months ended June&#160;30, 2021 and 2020, the Company recorded net interest income of $4,622 and $11,485, respectively.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;(iv)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%;padding-left:22.14pt"&gt;Liquidity risk&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Liquidity risk is the risk that the Company will not be able to meet its financial obligations as they become due and arises principally from the Company&#x2019;s accounts payable and other liabilities. The Company&#x2019;s policy is to review liquidity resources and ensure that sufficient funds are available to meet financial obligations as they become due. Further, the Company&#x2019;s management is responsible for ensuring funds exist and are readily accessible to support business opportunities as they arise. The Company&#x2019;s funding was primarily provided in the form of capital raised through the issuance of common shares and warrants. As of June&#160;30, 2021, the Company had assessed a concentration risk of vendors as 32% of accounts payables were due to one vendor. As of December 31, 2020, the Company had assessed a concentration risk of vendors as 64% due to four vendors.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;(v)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%;padding-left:24.91pt"&gt;Foreign currency risk&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Currency rate risk is the risk that the fair value of, or future cash flows from, the Company&#x2019;s financial instruments will significantly fluctuate due to changes in foreign exchange rates. The Company is exposed to this risk on investments in equity investees denominated in dollars, A$ and C$, and other assets and liabilities denominated in A$ and C$. The Company is further exposed to this risk through subsidiaries operating in Israel and the U.S. as the Company&#x2019;s functional currency is in Canadian dollars. The Company does not currently use foreign exchange contracts to hedge its exposure to currency rate risk. As such, the Company&#x2019;s financial position and financial results may be adversely affected by the unfavorable fluctuations in currency exchange rates. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;During the three months ended June&#160;30, 2021 and 2020, the Company had foreign currency gain on translation of $13,470 and $51,871, respectively. During the six months ended June&#160;30, 2021 and 2020, the Company had foreign currency gain (loss) on translation of $29,754 and $(61,821), respectively. A 10% change in the exchange rates for the U.S. dollar would affect the carrying value of net assets by approximately $162,991 and $170,817 as of June&#160;30, 2021 and December 31, 2020, respectively.&lt;/span&gt;&lt;/div&gt;</us-gaap:ConcentrationRiskDisclosureTextBlock>
    <us-gaap:ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock
      contextRef="i69782326f71a44e3805518280ee22b6b_D20210101-20210630"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzY2E5YmIwMTc5MjQ3NmZiYjIyNWU1ZDlkZWM4NjlmL3NlYzo5M2NhOWJiMDE3OTI0NzZmYmIyMjVlNWQ5ZGVjODY5Zl82MS9mcmFnOjE3NDk5MWNiMmM0ZjRmM2I4NDJjMzkxZWM3ZGRiZGY1L3RleHRyZWdpb246MTc0OTkxY2IyYzRmNGYzYjg0MmMzOTFlYzdkZGJkZjVfNzczNg_c97bc85a-5a92-4862-b2d0-7ae04f40228e">&lt;div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following tables present information about the Company&#x2019;s assets that are measured at fair value on a recurring basis as of June&#160;30, 2021 and December 31, 2020 and indicate the fair value hierarchy of the valuation techniques the Company utilized to determine such fair value.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:45.983%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.983%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.327%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.983%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.327%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.983%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.327%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.987%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="21" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;June&#160;30, 2021&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Level 1&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Level 2&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Level 3&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Cash and cash equivalents&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;895,181&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;895,181&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Short-term investments&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;201,699&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;201,699&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Derivative liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;169,563&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;169,563&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:45.983%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.983%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.327%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.983%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.327%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.983%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.327%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.987%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="21" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;December 31, 2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Level 1&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Level 2&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Level 3&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Cash and cash equivalents&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,078,023&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,078,023&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Short-term investments&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;211,766&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;211,766&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Derivative liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;163,410&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;163,410&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock>
    <us-gaap:CashAndCashEquivalentsFairValueDisclosure
      contextRef="icadc14e3a8f749f28ff691fa21d421ea_I20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzY2E5YmIwMTc5MjQ3NmZiYjIyNWU1ZDlkZWM4NjlmL3NlYzo5M2NhOWJiMDE3OTI0NzZmYmIyMjVlNWQ5ZGVjODY5Zl82MS9mcmFnOjE3NDk5MWNiMmM0ZjRmM2I4NDJjMzkxZWM3ZGRiZGY1L3RhYmxlOjc1NmQ2ODFiMGVkNzRlZWU5NzNjNzFhOGQyZGUxODZkL3RhYmxlcmFuZ2U6NzU2ZDY4MWIwZWQ3NGVlZTk3M2M3MWE4ZDJkZTE4NmRfMi0xLTEtMS0w_8b54b5dd-93c1-47c2-9676-7d6a21fe54e2"
      unitRef="usd">895181000</us-gaap:CashAndCashEquivalentsFairValueDisclosure>
    <us-gaap:CashAndCashEquivalentsFairValueDisclosure
      contextRef="i7b21c81f18bd4f52a9977bc7f8edb2bc_I20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzY2E5YmIwMTc5MjQ3NmZiYjIyNWU1ZDlkZWM4NjlmL3NlYzo5M2NhOWJiMDE3OTI0NzZmYmIyMjVlNWQ5ZGVjODY5Zl82MS9mcmFnOjE3NDk5MWNiMmM0ZjRmM2I4NDJjMzkxZWM3ZGRiZGY1L3RhYmxlOjc1NmQ2ODFiMGVkNzRlZWU5NzNjNzFhOGQyZGUxODZkL3RhYmxlcmFuZ2U6NzU2ZDY4MWIwZWQ3NGVlZTk3M2M3MWE4ZDJkZTE4NmRfMi0zLTEtMS0w_81b25ab3-caf2-4640-9275-c2674ef23a5c"
      unitRef="usd">0</us-gaap:CashAndCashEquivalentsFairValueDisclosure>
    <us-gaap:CashAndCashEquivalentsFairValueDisclosure
      contextRef="i11247526dfde4bb5bd7e7f7730ae47e9_I20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzY2E5YmIwMTc5MjQ3NmZiYjIyNWU1ZDlkZWM4NjlmL3NlYzo5M2NhOWJiMDE3OTI0NzZmYmIyMjVlNWQ5ZGVjODY5Zl82MS9mcmFnOjE3NDk5MWNiMmM0ZjRmM2I4NDJjMzkxZWM3ZGRiZGY1L3RhYmxlOjc1NmQ2ODFiMGVkNzRlZWU5NzNjNzFhOGQyZGUxODZkL3RhYmxlcmFuZ2U6NzU2ZDY4MWIwZWQ3NGVlZTk3M2M3MWE4ZDJkZTE4NmRfMi01LTEtMS0w_a5b02b63-6dee-41a9-a497-c8e98c10fd47"
      unitRef="usd">0</us-gaap:CashAndCashEquivalentsFairValueDisclosure>
    <us-gaap:CashAndCashEquivalentsFairValueDisclosure
      contextRef="i5fd10eeb00c74a3fa9afaced11fe7a7d_I20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzY2E5YmIwMTc5MjQ3NmZiYjIyNWU1ZDlkZWM4NjlmL3NlYzo5M2NhOWJiMDE3OTI0NzZmYmIyMjVlNWQ5ZGVjODY5Zl82MS9mcmFnOjE3NDk5MWNiMmM0ZjRmM2I4NDJjMzkxZWM3ZGRiZGY1L3RhYmxlOjc1NmQ2ODFiMGVkNzRlZWU5NzNjNzFhOGQyZGUxODZkL3RhYmxlcmFuZ2U6NzU2ZDY4MWIwZWQ3NGVlZTk3M2M3MWE4ZDJkZTE4NmRfMi03LTEtMS0w_89a572c6-5e4f-46ff-9d3e-4e302a7dd383"
      unitRef="usd">895181000</us-gaap:CashAndCashEquivalentsFairValueDisclosure>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities
      contextRef="icadc14e3a8f749f28ff691fa21d421ea_I20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzY2E5YmIwMTc5MjQ3NmZiYjIyNWU1ZDlkZWM4NjlmL3NlYzo5M2NhOWJiMDE3OTI0NzZmYmIyMjVlNWQ5ZGVjODY5Zl82MS9mcmFnOjE3NDk5MWNiMmM0ZjRmM2I4NDJjMzkxZWM3ZGRiZGY1L3RhYmxlOjc1NmQ2ODFiMGVkNzRlZWU5NzNjNzFhOGQyZGUxODZkL3RhYmxlcmFuZ2U6NzU2ZDY4MWIwZWQ3NGVlZTk3M2M3MWE4ZDJkZTE4NmRfMy0xLTEtMS0w_7b114ea7-304c-4764-bc9a-52aed8be7a2a"
      unitRef="usd">201699000</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities
      contextRef="i7b21c81f18bd4f52a9977bc7f8edb2bc_I20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzY2E5YmIwMTc5MjQ3NmZiYjIyNWU1ZDlkZWM4NjlmL3NlYzo5M2NhOWJiMDE3OTI0NzZmYmIyMjVlNWQ5ZGVjODY5Zl82MS9mcmFnOjE3NDk5MWNiMmM0ZjRmM2I4NDJjMzkxZWM3ZGRiZGY1L3RhYmxlOjc1NmQ2ODFiMGVkNzRlZWU5NzNjNzFhOGQyZGUxODZkL3RhYmxlcmFuZ2U6NzU2ZDY4MWIwZWQ3NGVlZTk3M2M3MWE4ZDJkZTE4NmRfMy0zLTEtMS0w_ea4f8f75-cb69-490a-8146-99b5e286fcd4"
      unitRef="usd">0</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities
      contextRef="i11247526dfde4bb5bd7e7f7730ae47e9_I20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzY2E5YmIwMTc5MjQ3NmZiYjIyNWU1ZDlkZWM4NjlmL3NlYzo5M2NhOWJiMDE3OTI0NzZmYmIyMjVlNWQ5ZGVjODY5Zl82MS9mcmFnOjE3NDk5MWNiMmM0ZjRmM2I4NDJjMzkxZWM3ZGRiZGY1L3RhYmxlOjc1NmQ2ODFiMGVkNzRlZWU5NzNjNzFhOGQyZGUxODZkL3RhYmxlcmFuZ2U6NzU2ZDY4MWIwZWQ3NGVlZTk3M2M3MWE4ZDJkZTE4NmRfMy01LTEtMS0w_26cdb429-d320-4e6c-a35b-a94b169027a3"
      unitRef="usd">0</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities
      contextRef="i5fd10eeb00c74a3fa9afaced11fe7a7d_I20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzY2E5YmIwMTc5MjQ3NmZiYjIyNWU1ZDlkZWM4NjlmL3NlYzo5M2NhOWJiMDE3OTI0NzZmYmIyMjVlNWQ5ZGVjODY5Zl82MS9mcmFnOjE3NDk5MWNiMmM0ZjRmM2I4NDJjMzkxZWM3ZGRiZGY1L3RhYmxlOjc1NmQ2ODFiMGVkNzRlZWU5NzNjNzFhOGQyZGUxODZkL3RhYmxlcmFuZ2U6NzU2ZDY4MWIwZWQ3NGVlZTk3M2M3MWE4ZDJkZTE4NmRfMy03LTEtMS0w_07cab8e2-2ce6-4d5a-810f-a7fd5e756705"
      unitRef="usd">201699000</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:DerivativeLiabilities
      contextRef="icadc14e3a8f749f28ff691fa21d421ea_I20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzY2E5YmIwMTc5MjQ3NmZiYjIyNWU1ZDlkZWM4NjlmL3NlYzo5M2NhOWJiMDE3OTI0NzZmYmIyMjVlNWQ5ZGVjODY5Zl82MS9mcmFnOjE3NDk5MWNiMmM0ZjRmM2I4NDJjMzkxZWM3ZGRiZGY1L3RhYmxlOjc1NmQ2ODFiMGVkNzRlZWU5NzNjNzFhOGQyZGUxODZkL3RhYmxlcmFuZ2U6NzU2ZDY4MWIwZWQ3NGVlZTk3M2M3MWE4ZDJkZTE4NmRfNC0xLTEtMS0w_0c398e06-daae-41f4-a8e2-6d7e254f6bba"
      unitRef="usd">0</us-gaap:DerivativeLiabilities>
    <us-gaap:DerivativeLiabilities
      contextRef="i7b21c81f18bd4f52a9977bc7f8edb2bc_I20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzY2E5YmIwMTc5MjQ3NmZiYjIyNWU1ZDlkZWM4NjlmL3NlYzo5M2NhOWJiMDE3OTI0NzZmYmIyMjVlNWQ5ZGVjODY5Zl82MS9mcmFnOjE3NDk5MWNiMmM0ZjRmM2I4NDJjMzkxZWM3ZGRiZGY1L3RhYmxlOjc1NmQ2ODFiMGVkNzRlZWU5NzNjNzFhOGQyZGUxODZkL3RhYmxlcmFuZ2U6NzU2ZDY4MWIwZWQ3NGVlZTk3M2M3MWE4ZDJkZTE4NmRfNC0zLTEtMS0w_b0d275b7-f6ed-4070-a74f-1402bc0bfa5f"
      unitRef="usd">0</us-gaap:DerivativeLiabilities>
    <us-gaap:DerivativeLiabilities
      contextRef="i11247526dfde4bb5bd7e7f7730ae47e9_I20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzY2E5YmIwMTc5MjQ3NmZiYjIyNWU1ZDlkZWM4NjlmL3NlYzo5M2NhOWJiMDE3OTI0NzZmYmIyMjVlNWQ5ZGVjODY5Zl82MS9mcmFnOjE3NDk5MWNiMmM0ZjRmM2I4NDJjMzkxZWM3ZGRiZGY1L3RhYmxlOjc1NmQ2ODFiMGVkNzRlZWU5NzNjNzFhOGQyZGUxODZkL3RhYmxlcmFuZ2U6NzU2ZDY4MWIwZWQ3NGVlZTk3M2M3MWE4ZDJkZTE4NmRfNC01LTEtMS0w_1503c0de-807a-45cb-8475-f0d70a5017dd"
      unitRef="usd">169563000</us-gaap:DerivativeLiabilities>
    <us-gaap:DerivativeLiabilities
      contextRef="i5fd10eeb00c74a3fa9afaced11fe7a7d_I20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzY2E5YmIwMTc5MjQ3NmZiYjIyNWU1ZDlkZWM4NjlmL3NlYzo5M2NhOWJiMDE3OTI0NzZmYmIyMjVlNWQ5ZGVjODY5Zl82MS9mcmFnOjE3NDk5MWNiMmM0ZjRmM2I4NDJjMzkxZWM3ZGRiZGY1L3RhYmxlOjc1NmQ2ODFiMGVkNzRlZWU5NzNjNzFhOGQyZGUxODZkL3RhYmxlcmFuZ2U6NzU2ZDY4MWIwZWQ3NGVlZTk3M2M3MWE4ZDJkZTE4NmRfNC03LTEtMS0w_4ebb0b29-c3bc-4460-97a2-e424545397cd"
      unitRef="usd">169563000</us-gaap:DerivativeLiabilities>
    <us-gaap:CashAndCashEquivalentsFairValueDisclosure
      contextRef="i03fa5c3c8b194478a5f52168419d56f6_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzY2E5YmIwMTc5MjQ3NmZiYjIyNWU1ZDlkZWM4NjlmL3NlYzo5M2NhOWJiMDE3OTI0NzZmYmIyMjVlNWQ5ZGVjODY5Zl82MS9mcmFnOjE3NDk5MWNiMmM0ZjRmM2I4NDJjMzkxZWM3ZGRiZGY1L3RhYmxlOjZmNjlhNGYxMDIwZTRlYmNiNmNmMzQyNTQ5M2UzNmQ0L3RhYmxlcmFuZ2U6NmY2OWE0ZjEwMjBlNGViY2I2Y2YzNDI1NDkzZTM2ZDRfMi0xLTEtMS0w_3b936414-e7dd-4805-b33f-c792b725e5b4"
      unitRef="usd">1078023000</us-gaap:CashAndCashEquivalentsFairValueDisclosure>
    <us-gaap:CashAndCashEquivalentsFairValueDisclosure
      contextRef="i79b10885dfdb4c659175e617a6ad2106_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzY2E5YmIwMTc5MjQ3NmZiYjIyNWU1ZDlkZWM4NjlmL3NlYzo5M2NhOWJiMDE3OTI0NzZmYmIyMjVlNWQ5ZGVjODY5Zl82MS9mcmFnOjE3NDk5MWNiMmM0ZjRmM2I4NDJjMzkxZWM3ZGRiZGY1L3RhYmxlOjZmNjlhNGYxMDIwZTRlYmNiNmNmMzQyNTQ5M2UzNmQ0L3RhYmxlcmFuZ2U6NmY2OWE0ZjEwMjBlNGViY2I2Y2YzNDI1NDkzZTM2ZDRfMi0zLTEtMS0w_7e3de884-ff67-4c47-bd69-daafbde56966"
      unitRef="usd">0</us-gaap:CashAndCashEquivalentsFairValueDisclosure>
    <us-gaap:CashAndCashEquivalentsFairValueDisclosure
      contextRef="if1d924d84462412da9f6d321275d484c_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzY2E5YmIwMTc5MjQ3NmZiYjIyNWU1ZDlkZWM4NjlmL3NlYzo5M2NhOWJiMDE3OTI0NzZmYmIyMjVlNWQ5ZGVjODY5Zl82MS9mcmFnOjE3NDk5MWNiMmM0ZjRmM2I4NDJjMzkxZWM3ZGRiZGY1L3RhYmxlOjZmNjlhNGYxMDIwZTRlYmNiNmNmMzQyNTQ5M2UzNmQ0L3RhYmxlcmFuZ2U6NmY2OWE0ZjEwMjBlNGViY2I2Y2YzNDI1NDkzZTM2ZDRfMi01LTEtMS0w_e51bb8be-4de4-479b-b781-c30f2f67b320"
      unitRef="usd">0</us-gaap:CashAndCashEquivalentsFairValueDisclosure>
    <us-gaap:CashAndCashEquivalentsFairValueDisclosure
      contextRef="i3a832b2da99a447594f2d6d56bcc8aa8_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzY2E5YmIwMTc5MjQ3NmZiYjIyNWU1ZDlkZWM4NjlmL3NlYzo5M2NhOWJiMDE3OTI0NzZmYmIyMjVlNWQ5ZGVjODY5Zl82MS9mcmFnOjE3NDk5MWNiMmM0ZjRmM2I4NDJjMzkxZWM3ZGRiZGY1L3RhYmxlOjZmNjlhNGYxMDIwZTRlYmNiNmNmMzQyNTQ5M2UzNmQ0L3RhYmxlcmFuZ2U6NmY2OWE0ZjEwMjBlNGViY2I2Y2YzNDI1NDkzZTM2ZDRfMi03LTEtMS0w_c4f3d644-de11-42d6-be4d-c3bcc310b2ab"
      unitRef="usd">1078023000</us-gaap:CashAndCashEquivalentsFairValueDisclosure>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities
      contextRef="i03fa5c3c8b194478a5f52168419d56f6_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzY2E5YmIwMTc5MjQ3NmZiYjIyNWU1ZDlkZWM4NjlmL3NlYzo5M2NhOWJiMDE3OTI0NzZmYmIyMjVlNWQ5ZGVjODY5Zl82MS9mcmFnOjE3NDk5MWNiMmM0ZjRmM2I4NDJjMzkxZWM3ZGRiZGY1L3RhYmxlOjZmNjlhNGYxMDIwZTRlYmNiNmNmMzQyNTQ5M2UzNmQ0L3RhYmxlcmFuZ2U6NmY2OWE0ZjEwMjBlNGViY2I2Y2YzNDI1NDkzZTM2ZDRfMy0xLTEtMS0w_4978c422-259a-4cfe-97dd-2b074143c52d"
      unitRef="usd">211766000</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities
      contextRef="i79b10885dfdb4c659175e617a6ad2106_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzY2E5YmIwMTc5MjQ3NmZiYjIyNWU1ZDlkZWM4NjlmL3NlYzo5M2NhOWJiMDE3OTI0NzZmYmIyMjVlNWQ5ZGVjODY5Zl82MS9mcmFnOjE3NDk5MWNiMmM0ZjRmM2I4NDJjMzkxZWM3ZGRiZGY1L3RhYmxlOjZmNjlhNGYxMDIwZTRlYmNiNmNmMzQyNTQ5M2UzNmQ0L3RhYmxlcmFuZ2U6NmY2OWE0ZjEwMjBlNGViY2I2Y2YzNDI1NDkzZTM2ZDRfMy0zLTEtMS0w_f40994d1-0da6-4ec2-911e-45123aab516e"
      unitRef="usd">0</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities
      contextRef="if1d924d84462412da9f6d321275d484c_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzY2E5YmIwMTc5MjQ3NmZiYjIyNWU1ZDlkZWM4NjlmL3NlYzo5M2NhOWJiMDE3OTI0NzZmYmIyMjVlNWQ5ZGVjODY5Zl82MS9mcmFnOjE3NDk5MWNiMmM0ZjRmM2I4NDJjMzkxZWM3ZGRiZGY1L3RhYmxlOjZmNjlhNGYxMDIwZTRlYmNiNmNmMzQyNTQ5M2UzNmQ0L3RhYmxlcmFuZ2U6NmY2OWE0ZjEwMjBlNGViY2I2Y2YzNDI1NDkzZTM2ZDRfMy01LTEtMS0w_14083911-c046-498e-a93e-8622a70400c7"
      unitRef="usd">0</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities
      contextRef="i3a832b2da99a447594f2d6d56bcc8aa8_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzY2E5YmIwMTc5MjQ3NmZiYjIyNWU1ZDlkZWM4NjlmL3NlYzo5M2NhOWJiMDE3OTI0NzZmYmIyMjVlNWQ5ZGVjODY5Zl82MS9mcmFnOjE3NDk5MWNiMmM0ZjRmM2I4NDJjMzkxZWM3ZGRiZGY1L3RhYmxlOjZmNjlhNGYxMDIwZTRlYmNiNmNmMzQyNTQ5M2UzNmQ0L3RhYmxlcmFuZ2U6NmY2OWE0ZjEwMjBlNGViY2I2Y2YzNDI1NDkzZTM2ZDRfMy03LTEtMS0w_6afd8bf7-dc6c-4765-b00d-b9321e42586f"
      unitRef="usd">211766000</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:DerivativeLiabilities
      contextRef="i03fa5c3c8b194478a5f52168419d56f6_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzY2E5YmIwMTc5MjQ3NmZiYjIyNWU1ZDlkZWM4NjlmL3NlYzo5M2NhOWJiMDE3OTI0NzZmYmIyMjVlNWQ5ZGVjODY5Zl82MS9mcmFnOjE3NDk5MWNiMmM0ZjRmM2I4NDJjMzkxZWM3ZGRiZGY1L3RhYmxlOjZmNjlhNGYxMDIwZTRlYmNiNmNmMzQyNTQ5M2UzNmQ0L3RhYmxlcmFuZ2U6NmY2OWE0ZjEwMjBlNGViY2I2Y2YzNDI1NDkzZTM2ZDRfNC0xLTEtMS0w_f4d95628-9a67-45aa-acb7-9b24b7a8d705"
      unitRef="usd">0</us-gaap:DerivativeLiabilities>
    <us-gaap:DerivativeLiabilities
      contextRef="i79b10885dfdb4c659175e617a6ad2106_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzY2E5YmIwMTc5MjQ3NmZiYjIyNWU1ZDlkZWM4NjlmL3NlYzo5M2NhOWJiMDE3OTI0NzZmYmIyMjVlNWQ5ZGVjODY5Zl82MS9mcmFnOjE3NDk5MWNiMmM0ZjRmM2I4NDJjMzkxZWM3ZGRiZGY1L3RhYmxlOjZmNjlhNGYxMDIwZTRlYmNiNmNmMzQyNTQ5M2UzNmQ0L3RhYmxlcmFuZ2U6NmY2OWE0ZjEwMjBlNGViY2I2Y2YzNDI1NDkzZTM2ZDRfNC0zLTEtMS0w_b44634ca-9432-45ec-85b5-02b50650812f"
      unitRef="usd">0</us-gaap:DerivativeLiabilities>
    <us-gaap:DerivativeLiabilities
      contextRef="if1d924d84462412da9f6d321275d484c_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzY2E5YmIwMTc5MjQ3NmZiYjIyNWU1ZDlkZWM4NjlmL3NlYzo5M2NhOWJiMDE3OTI0NzZmYmIyMjVlNWQ5ZGVjODY5Zl82MS9mcmFnOjE3NDk5MWNiMmM0ZjRmM2I4NDJjMzkxZWM3ZGRiZGY1L3RhYmxlOjZmNjlhNGYxMDIwZTRlYmNiNmNmMzQyNTQ5M2UzNmQ0L3RhYmxlcmFuZ2U6NmY2OWE0ZjEwMjBlNGViY2I2Y2YzNDI1NDkzZTM2ZDRfNC01LTEtMS0w_c113bb6e-3945-4e4a-9819-83234f9676ed"
      unitRef="usd">163410000</us-gaap:DerivativeLiabilities>
    <us-gaap:DerivativeLiabilities
      contextRef="i3a832b2da99a447594f2d6d56bcc8aa8_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzY2E5YmIwMTc5MjQ3NmZiYjIyNWU1ZDlkZWM4NjlmL3NlYzo5M2NhOWJiMDE3OTI0NzZmYmIyMjVlNWQ5ZGVjODY5Zl82MS9mcmFnOjE3NDk5MWNiMmM0ZjRmM2I4NDJjMzkxZWM3ZGRiZGY1L3RhYmxlOjZmNjlhNGYxMDIwZTRlYmNiNmNmMzQyNTQ5M2UzNmQ0L3RhYmxlcmFuZ2U6NmY2OWE0ZjEwMjBlNGViY2I2Y2YzNDI1NDkzZTM2ZDRfNC03LTEtMS0w_7950ef78-5082-48ca-9334-01d11f33cd40"
      unitRef="usd">163410000</us-gaap:DerivativeLiabilities>
    <us-gaap:ConcentrationRiskCreditRiskFinancialInstrumentMaximumExposure
      contextRef="i69782326f71a44e3805518280ee22b6b_D20210101-20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzY2E5YmIwMTc5MjQ3NmZiYjIyNWU1ZDlkZWM4NjlmL3NlYzo5M2NhOWJiMDE3OTI0NzZmYmIyMjVlNWQ5ZGVjODY5Zl82MS9mcmFnOjE3NDk5MWNiMmM0ZjRmM2I4NDJjMzkxZWM3ZGRiZGY1L3RleHRyZWdpb246MTc0OTkxY2IyYzRmNGYzYjg0MmMzOTFlYzdkZGJkZjVfMTg2NQ_9598ec73-6e98-41df-9836-2f5a9e83d14d"
      unitRef="usd">1210287000</us-gaap:ConcentrationRiskCreditRiskFinancialInstrumentMaximumExposure>
    <us-gaap:ConcentrationRiskCreditRiskFinancialInstrumentMaximumExposure
      contextRef="i539631cd7950486e81b39a054a00c7d0_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzY2E5YmIwMTc5MjQ3NmZiYjIyNWU1ZDlkZWM4NjlmL3NlYzo5M2NhOWJiMDE3OTI0NzZmYmIyMjVlNWQ5ZGVjODY5Zl82MS9mcmFnOjE3NDk5MWNiMmM0ZjRmM2I4NDJjMzkxZWM3ZGRiZGY1L3RleHRyZWdpb246MTc0OTkxY2IyYzRmNGYzYjg0MmMzOTFlYzdkZGJkZjVfMTg3Mg_2574ae69-d093-47cf-9895-8c62aa48e634"
      unitRef="usd">1403491000</us-gaap:ConcentrationRiskCreditRiskFinancialInstrumentMaximumExposure>
    <us-gaap:AccountsReceivableNoncurrentThresholdPeriodPastDueWriteoff
      contextRef="i225f85e38faa4bbdb4de1d8b9cf369bb_I20210630"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzY2E5YmIwMTc5MjQ3NmZiYjIyNWU1ZDlkZWM4NjlmL3NlYzo5M2NhOWJiMDE3OTI0NzZmYmIyMjVlNWQ5ZGVjODY5Zl82MS9mcmFnOjE3NDk5MWNiMmM0ZjRmM2I4NDJjMzkxZWM3ZGRiZGY1L3RleHRyZWdpb246MTc0OTkxY2IyYzRmNGYzYjg0MmMzOTFlYzdkZGJkZjVfMzUyMA_8b83ec1d-c82e-45b4-8a74-ad210fc2eaf8">P120D</us-gaap:AccountsReceivableNoncurrentThresholdPeriodPastDueWriteoff>
    <us-gaap:AllowanceForDoubtfulAccountsReceivableCurrent
      contextRef="i225f85e38faa4bbdb4de1d8b9cf369bb_I20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzY2E5YmIwMTc5MjQ3NmZiYjIyNWU1ZDlkZWM4NjlmL3NlYzo5M2NhOWJiMDE3OTI0NzZmYmIyMjVlNWQ5ZGVjODY5Zl82MS9mcmFnOjE3NDk5MWNiMmM0ZjRmM2I4NDJjMzkxZWM3ZGRiZGY1L3RleHRyZWdpb246MTc0OTkxY2IyYzRmNGYzYjg0MmMzOTFlYzdkZGJkZjVfNDk0NzgwMjMzNTc0Mg_8724b485-884d-4535-a0c8-c9f74a1c662a"
      unitRef="usd">264000</us-gaap:AllowanceForDoubtfulAccountsReceivableCurrent>
    <us-gaap:AllowanceForDoubtfulAccountsReceivableCurrent
      contextRef="ifbe16ec51ea244519b77d6036b4ef038_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzY2E5YmIwMTc5MjQ3NmZiYjIyNWU1ZDlkZWM4NjlmL3NlYzo5M2NhOWJiMDE3OTI0NzZmYmIyMjVlNWQ5ZGVjODY5Zl82MS9mcmFnOjE3NDk5MWNiMmM0ZjRmM2I4NDJjMzkxZWM3ZGRiZGY1L3RleHRyZWdpb246MTc0OTkxY2IyYzRmNGYzYjg0MmMzOTFlYzdkZGJkZjVfNDk0NzgwMjMzNTc0Ng_bcda2e9d-6d9b-4d5e-8167-0abab21f5ff3"
      unitRef="usd">74000</us-gaap:AllowanceForDoubtfulAccountsReceivableCurrent>
    <us-gaap:ConcentrationRiskPercentage1
      contextRef="i174d8021b6e348aeb60958d0fc273001_D20210101-20210630"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzY2E5YmIwMTc5MjQ3NmZiYjIyNWU1ZDlkZWM4NjlmL3NlYzo5M2NhOWJiMDE3OTI0NzZmYmIyMjVlNWQ5ZGVjODY5Zl82MS9mcmFnOjE3NDk5MWNiMmM0ZjRmM2I4NDJjMzkxZWM3ZGRiZGY1L3RleHRyZWdpb246MTc0OTkxY2IyYzRmNGYzYjg0MmMzOTFlYzdkZGJkZjVfMzczOA_f2a38f29-dc0e-4c59-b35d-d366dab79ee9"
      unitRef="number">0.74</us-gaap:ConcentrationRiskPercentage1>
    <us-gaap:ConcentrationRiskPercentage1
      contextRef="i22724e38ce2a43488a65f8a806950144_D20200101-20201231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzY2E5YmIwMTc5MjQ3NmZiYjIyNWU1ZDlkZWM4NjlmL3NlYzo5M2NhOWJiMDE3OTI0NzZmYmIyMjVlNWQ5ZGVjODY5Zl82MS9mcmFnOjE3NDk5MWNiMmM0ZjRmM2I4NDJjMzkxZWM3ZGRiZGY1L3RleHRyZWdpb246MTc0OTkxY2IyYzRmNGYzYjg0MmMzOTFlYzdkZGJkZjVfMzg3MQ_fb83ad79-ef2e-42f6-98fc-e2b50b66785a"
      unitRef="number">0.78</us-gaap:ConcentrationRiskPercentage1>
    <us-gaap:InterestIncomeExpenseNonoperatingNet
      contextRef="i27f4e53b91ad4367b7f8d273eff27769_D20210401-20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzY2E5YmIwMTc5MjQ3NmZiYjIyNWU1ZDlkZWM4NjlmL3NlYzo5M2NhOWJiMDE3OTI0NzZmYmIyMjVlNWQ5ZGVjODY5Zl82MS9mcmFnOjE3NDk5MWNiMmM0ZjRmM2I4NDJjMzkxZWM3ZGRiZGY1L3RleHRyZWdpb246MTc0OTkxY2IyYzRmNGYzYjg0MmMzOTFlYzdkZGJkZjVfNDk0NzgwMjMzMzI1MA_64e0fa86-15f4-4ccc-a153-6c6277a01829"
      unitRef="usd">2293000</us-gaap:InterestIncomeExpenseNonoperatingNet>
    <us-gaap:InterestIncomeExpenseNonoperatingNet
      contextRef="i39065c5daf934af885335c12f3cfa83f_D20200401-20200630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzY2E5YmIwMTc5MjQ3NmZiYjIyNWU1ZDlkZWM4NjlmL3NlYzo5M2NhOWJiMDE3OTI0NzZmYmIyMjVlNWQ5ZGVjODY5Zl82MS9mcmFnOjE3NDk5MWNiMmM0ZjRmM2I4NDJjMzkxZWM3ZGRiZGY1L3RleHRyZWdpb246MTc0OTkxY2IyYzRmNGYzYjg0MmMzOTFlYzdkZGJkZjVfNDk0NzgwMjMzMzI4OQ_e3fe6635-8f81-41fd-ac77-ad3f918c36ec"
      unitRef="usd">3734000</us-gaap:InterestIncomeExpenseNonoperatingNet>
    <us-gaap:InterestIncomeExpenseNonoperatingNet
      contextRef="i69782326f71a44e3805518280ee22b6b_D20210101-20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzY2E5YmIwMTc5MjQ3NmZiYjIyNWU1ZDlkZWM4NjlmL3NlYzo5M2NhOWJiMDE3OTI0NzZmYmIyMjVlNWQ5ZGVjODY5Zl82MS9mcmFnOjE3NDk5MWNiMmM0ZjRmM2I4NDJjMzkxZWM3ZGRiZGY1L3RleHRyZWdpb246MTc0OTkxY2IyYzRmNGYzYjg0MmMzOTFlYzdkZGJkZjVfNTc2NA_740dc3f1-ce94-403b-a17d-2bf316a4ac3e"
      unitRef="usd">4622000</us-gaap:InterestIncomeExpenseNonoperatingNet>
    <us-gaap:InterestIncomeExpenseNonoperatingNet
      contextRef="i4a110e4972ef4113880ce582e3cda5c5_D20200101-20200630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzY2E5YmIwMTc5MjQ3NmZiYjIyNWU1ZDlkZWM4NjlmL3NlYzo5M2NhOWJiMDE3OTI0NzZmYmIyMjVlNWQ5ZGVjODY5Zl82MS9mcmFnOjE3NDk5MWNiMmM0ZjRmM2I4NDJjMzkxZWM3ZGRiZGY1L3RleHRyZWdpb246MTc0OTkxY2IyYzRmNGYzYjg0MmMzOTFlYzdkZGJkZjVfNTc3MQ_6a1e1973-b886-4749-a9db-d7ea7af34f4f"
      unitRef="usd">11485000</us-gaap:InterestIncomeExpenseNonoperatingNet>
    <us-gaap:ConcentrationRiskPercentage1
      contextRef="ic32bc3c69d7c4dd0a165d3622a127739_D20210101-20210630"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzY2E5YmIwMTc5MjQ3NmZiYjIyNWU1ZDlkZWM4NjlmL3NlYzo5M2NhOWJiMDE3OTI0NzZmYmIyMjVlNWQ5ZGVjODY5Zl82MS9mcmFnOjE3NDk5MWNiMmM0ZjRmM2I4NDJjMzkxZWM3ZGRiZGY1L3RleHRyZWdpb246MTc0OTkxY2IyYzRmNGYzYjg0MmMzOTFlYzdkZGJkZjVfNjUwMg_160cdbf3-a318-47dc-a62f-d5727a5a8cef"
      unitRef="number">0.32</us-gaap:ConcentrationRiskPercentage1>
    <us-gaap:ConcentrationRiskPercentage1
      contextRef="ib0cf8aff30b04aaebfad1c5a5bfc4c6c_D20200101-20201231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzY2E5YmIwMTc5MjQ3NmZiYjIyNWU1ZDlkZWM4NjlmL3NlYzo5M2NhOWJiMDE3OTI0NzZmYmIyMjVlNWQ5ZGVjODY5Zl82MS9mcmFnOjE3NDk5MWNiMmM0ZjRmM2I4NDJjMzkxZWM3ZGRiZGY1L3RleHRyZWdpb246MTc0OTkxY2IyYzRmNGYzYjg0MmMzOTFlYzdkZGJkZjVfNjYyMw_3cc3293a-cd2d-4a7b-b3bf-fa927d57c705"
      unitRef="number">0.64</us-gaap:ConcentrationRiskPercentage1>
    <us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
      contextRef="i27f4e53b91ad4367b7f8d273eff27769_D20210401-20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzY2E5YmIwMTc5MjQ3NmZiYjIyNWU1ZDlkZWM4NjlmL3NlYzo5M2NhOWJiMDE3OTI0NzZmYmIyMjVlNWQ5ZGVjODY5Zl82MS9mcmFnOjE3NDk5MWNiMmM0ZjRmM2I4NDJjMzkxZWM3ZGRiZGY1L3RleHRyZWdpb246MTc0OTkxY2IyYzRmNGYzYjg0MmMzOTFlYzdkZGJkZjVfNDk0NzgwMjMzMjk0NQ_90ff8133-880e-4e5b-900e-6ae263acb252"
      unitRef="usd">13470000</us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
      contextRef="i39065c5daf934af885335c12f3cfa83f_D20200401-20200630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzY2E5YmIwMTc5MjQ3NmZiYjIyNWU1ZDlkZWM4NjlmL3NlYzo5M2NhOWJiMDE3OTI0NzZmYmIyMjVlNWQ5ZGVjODY5Zl82MS9mcmFnOjE3NDk5MWNiMmM0ZjRmM2I4NDJjMzkxZWM3ZGRiZGY1L3RleHRyZWdpb246MTc0OTkxY2IyYzRmNGYzYjg0MmMzOTFlYzdkZGJkZjVfNDk0NzgwMjMzMzEzNQ_32358be9-d812-4334-af9a-d534c93cbdba"
      unitRef="usd">51871000</us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
      contextRef="i69782326f71a44e3805518280ee22b6b_D20210101-20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzY2E5YmIwMTc5MjQ3NmZiYjIyNWU1ZDlkZWM4NjlmL3NlYzo5M2NhOWJiMDE3OTI0NzZmYmIyMjVlNWQ5ZGVjODY5Zl82MS9mcmFnOjE3NDk5MWNiMmM0ZjRmM2I4NDJjMzkxZWM3ZGRiZGY1L3RleHRyZWdpb246MTc0OTkxY2IyYzRmNGYzYjg0MmMzOTFlYzdkZGJkZjVfNDk0NzgwMjMzMzA5Nw_85085618-f3ec-4b74-9704-06e206d07c24"
      unitRef="usd">29754000</us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
      contextRef="i4a110e4972ef4113880ce582e3cda5c5_D20200101-20200630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzY2E5YmIwMTc5MjQ3NmZiYjIyNWU1ZDlkZWM4NjlmL3NlYzo5M2NhOWJiMDE3OTI0NzZmYmIyMjVlNWQ5ZGVjODY5Zl82MS9mcmFnOjE3NDk5MWNiMmM0ZjRmM2I4NDJjMzkxZWM3ZGRiZGY1L3RleHRyZWdpb246MTc0OTkxY2IyYzRmNGYzYjg0MmMzOTFlYzdkZGJkZjVfNDk0NzgwMjMzMzEyMw_2e6ba7c8-3a43-48b7-bc33-1a6f1aa91458"
      unitRef="usd">-61821000</us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax>
    <cron:SensitivityAnalysisOfCarryingValueNetAssetsImpactOf10PercentChangeInExchangeRate
      contextRef="i225f85e38faa4bbdb4de1d8b9cf369bb_I20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzY2E5YmIwMTc5MjQ3NmZiYjIyNWU1ZDlkZWM4NjlmL3NlYzo5M2NhOWJiMDE3OTI0NzZmYmIyMjVlNWQ5ZGVjODY5Zl82MS9mcmFnOjE3NDk5MWNiMmM0ZjRmM2I4NDJjMzkxZWM3ZGRiZGY1L3RleHRyZWdpb246MTc0OTkxY2IyYzRmNGYzYjg0MmMzOTFlYzdkZGJkZjVfNzY4OA_d56eb1bd-bd86-431e-bdee-6675515e2031"
      unitRef="usd">162991000</cron:SensitivityAnalysisOfCarryingValueNetAssetsImpactOf10PercentChangeInExchangeRate>
    <cron:SensitivityAnalysisOfCarryingValueNetAssetsImpactOf10PercentChangeInExchangeRate
      contextRef="ifbe16ec51ea244519b77d6036b4ef038_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzY2E5YmIwMTc5MjQ3NmZiYjIyNWU1ZDlkZWM4NjlmL3NlYzo5M2NhOWJiMDE3OTI0NzZmYmIyMjVlNWQ5ZGVjODY5Zl82MS9mcmFnOjE3NDk5MWNiMmM0ZjRmM2I4NDJjMzkxZWM3ZGRiZGY1L3RleHRyZWdpb246MTc0OTkxY2IyYzRmNGYzYjg0MmMzOTFlYzdkZGJkZjVfNzY5NQ_b4f58b00-43e2-4a77-99d3-23cff531f6c1"
      unitRef="usd">170817000</cron:SensitivityAnalysisOfCarryingValueNetAssetsImpactOf10PercentChangeInExchangeRate>
    <us-gaap:DisposalGroupsIncludingDiscontinuedOperationsDisclosureTextBlock
      contextRef="i69782326f71a44e3805518280ee22b6b_D20210101-20210630"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzY2E5YmIwMTc5MjQ3NmZiYjIyNWU1ZDlkZWM4NjlmL3NlYzo5M2NhOWJiMDE3OTI0NzZmYmIyMjVlNWQ5ZGVjODY5Zl82NC9mcmFnOjhlNjI5OTI1ODgxNTQ1M2E4NWZjOGM0NTY4Nzc5ZWFlL3RleHRyZWdpb246OGU2Mjk5MjU4ODE1NDUzYTg1ZmM4YzQ1Njg3NzllYWVfMTI5MQ_0af8d67e-a4d1-42cc-ba93-aae1742a3530">Held-For-Sale Assets and Discontinued OperationsDuring the year ended December 31, 2020, the Company advanced its plans for the sale and disposal of substantially all of the assets of OGBC and as a result, OGBC&#x2019;s results of operations were reclassified as discontinued operations in the accompanying condensed consolidated financial statements for all periods presented. During the quarter ended June 30, 2021, the Company determined that the fair value of OGBC was lower than the carrying value of the assets. As such, a write-down to these held-for-sale assets of $561 was recorded in the second quarter of 2021. As of June&#160;30, 2021, the assets and liabilities of OGBC continue to meet the definition of discontinued operations and are included as &#x201c;held-for-sale&#x201d; assets on the condensed consolidated balance sheet as of June&#160;30, 2021 and December 31, 2020, and loss from discontinued operations on the condensed consolidated statements of net income and comprehensive income for the three and six months ended June&#160;30, 2021 and 2020. &lt;div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;On June 10, 2021, the land and office building located in Winnipeg, Manitoba Canada, previously designated as held-for-sale in the first quarter of 2021, was sold for $2,059, net of costs to sell. As a result, the Company recorded a gain on the sale of $1,279 in other, net in its condensed consolidated income statement for the three and six months ended June 30, 2021.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following table summarizes the financial information for discontinued operations:&lt;/span&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:41.261%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.911%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.816%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.327%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.816%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.605%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.816%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.327%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.821%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="9" style="border-bottom:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Three months ended June 30,&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="border-bottom:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Six months ended June 30,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Loss from discontinued operations, net of income taxes&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(561)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(46)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(582)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(46)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:62.094%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.772%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.772%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:15.983%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.494%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:15.985%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;As of June&#160;30, 2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;As of December 31, 2020&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;OGBC assets classified as held-for-sale&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;645&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,176&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:DisposalGroupsIncludingDiscontinuedOperationsDisclosureTextBlock>
    <us-gaap:ImpairmentOfLongLivedAssetsToBeDisposedOf
      contextRef="i904d87a0584944d792e0d8b1355a0053_D20210401-20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzY2E5YmIwMTc5MjQ3NmZiYjIyNWU1ZDlkZWM4NjlmL3NlYzo5M2NhOWJiMDE3OTI0NzZmYmIyMjVlNWQ5ZGVjODY5Zl82NC9mcmFnOjhlNjI5OTI1ODgxNTQ1M2E4NWZjOGM0NTY4Nzc5ZWFlL3RleHRyZWdpb246OGU2Mjk5MjU4ODE1NDUzYTg1ZmM4YzQ1Njg3NzllYWVfMzI5ODUzNDg4OTQyOA_0ee52be7-f21c-4728-94cc-7be788ed5a5c"
      unitRef="usd">561000</us-gaap:ImpairmentOfLongLivedAssetsToBeDisposedOf>
    <us-gaap:ProceedsFromSaleOfPropertyHeldForSale
      contextRef="iecddccc2866d472bbb7974d5d612f613_D20210401-20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzY2E5YmIwMTc5MjQ3NmZiYjIyNWU1ZDlkZWM4NjlmL3NlYzo5M2NhOWJiMDE3OTI0NzZmYmIyMjVlNWQ5ZGVjODY5Zl82NC9mcmFnOjhlNjI5OTI1ODgxNTQ1M2E4NWZjOGM0NTY4Nzc5ZWFlL3RleHRyZWdpb246OGU2Mjk5MjU4ODE1NDUzYTg1ZmM4YzQ1Njg3NzllYWVfMjE5OTAyMzI1OTIzOA_25900e3a-737f-4d51-99f0-2d429805141e"
      unitRef="usd">2059000</us-gaap:ProceedsFromSaleOfPropertyHeldForSale>
    <us-gaap:DisposalGroupNotDiscontinuedOperationGainLossOnDisposal
      contextRef="iecddccc2866d472bbb7974d5d612f613_D20210401-20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzY2E5YmIwMTc5MjQ3NmZiYjIyNWU1ZDlkZWM4NjlmL3NlYzo5M2NhOWJiMDE3OTI0NzZmYmIyMjVlNWQ5ZGVjODY5Zl82NC9mcmFnOjhlNjI5OTI1ODgxNTQ1M2E4NWZjOGM0NTY4Nzc5ZWFlL3RleHRyZWdpb246OGU2Mjk5MjU4ODE1NDUzYTg1ZmM4YzQ1Njg3NzllYWVfMjE5OTAyMzI1OTI2Nw_63e8d548-5d39-4512-a9ea-9185524eb317"
      unitRef="usd">1279000</us-gaap:DisposalGroupNotDiscontinuedOperationGainLossOnDisposal>
    <us-gaap:ScheduleOfDisposalGroupsIncludingDiscontinuedOperationsIncomeStatementBalanceSheetAndAdditionalDisclosuresTextBlock
      contextRef="i69782326f71a44e3805518280ee22b6b_D20210101-20210630"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzY2E5YmIwMTc5MjQ3NmZiYjIyNWU1ZDlkZWM4NjlmL3NlYzo5M2NhOWJiMDE3OTI0NzZmYmIyMjVlNWQ5ZGVjODY5Zl82NC9mcmFnOjhlNjI5OTI1ODgxNTQ1M2E4NWZjOGM0NTY4Nzc5ZWFlL3RleHRyZWdpb246OGU2Mjk5MjU4ODE1NDUzYTg1ZmM4YzQ1Njg3NzllYWVfMTI5MA_6efd5daa-210a-41cb-b95d-734c9fd2340d">&lt;div style="margin-bottom:6pt;margin-top:6pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following table summarizes the financial information for discontinued operations:&lt;/span&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:41.261%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.911%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.816%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.327%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.816%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.605%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.816%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.327%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.821%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="9" style="border-bottom:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Three months ended June 30,&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="border-bottom:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Six months ended June 30,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Loss from discontinued operations, net of income taxes&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(561)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(46)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(582)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(46)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:62.094%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.772%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.772%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:15.983%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.494%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:15.985%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;As of June&#160;30, 2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;As of December 31, 2020&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;OGBC assets classified as held-for-sale&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;645&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,176&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:ScheduleOfDisposalGroupsIncludingDiscontinuedOperationsIncomeStatementBalanceSheetAndAdditionalDisclosuresTextBlock>
    <us-gaap:DiscontinuedOperationIncomeLossFromDiscontinuedOperationDuringPhaseOutPeriodNetOfTax
      contextRef="i904d87a0584944d792e0d8b1355a0053_D20210401-20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzY2E5YmIwMTc5MjQ3NmZiYjIyNWU1ZDlkZWM4NjlmL3NlYzo5M2NhOWJiMDE3OTI0NzZmYmIyMjVlNWQ5ZGVjODY5Zl82NC9mcmFnOjhlNjI5OTI1ODgxNTQ1M2E4NWZjOGM0NTY4Nzc5ZWFlL3RhYmxlOjBhODRmMDc3MDYzYjQwZTFiZjI5YjljOTM3NzkxZjA4L3RhYmxlcmFuZ2U6MGE4NGYwNzcwNjNiNDBlMWJmMjliOWM5Mzc3OTFmMDhfMi0xMC0xLTEtMA_056aaafb-0916-4abd-8351-11e1fa5b64fe"
      unitRef="usd">-561000</us-gaap:DiscontinuedOperationIncomeLossFromDiscontinuedOperationDuringPhaseOutPeriodNetOfTax>
    <us-gaap:DiscontinuedOperationIncomeLossFromDiscontinuedOperationDuringPhaseOutPeriodNetOfTax
      contextRef="i64c6418b6b224c7487942cebd8660eef_D20200401-20200630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzY2E5YmIwMTc5MjQ3NmZiYjIyNWU1ZDlkZWM4NjlmL3NlYzo5M2NhOWJiMDE3OTI0NzZmYmIyMjVlNWQ5ZGVjODY5Zl82NC9mcmFnOjhlNjI5OTI1ODgxNTQ1M2E4NWZjOGM0NTY4Nzc5ZWFlL3RhYmxlOjBhODRmMDc3MDYzYjQwZTFiZjI5YjljOTM3NzkxZjA4L3RhYmxlcmFuZ2U6MGE4NGYwNzcwNjNiNDBlMWJmMjliOWM5Mzc3OTFmMDhfMi0xMi0xLTEtMA_dd4ba73c-96b3-4f79-8bf4-7ec8bb7d1559"
      unitRef="usd">-46000</us-gaap:DiscontinuedOperationIncomeLossFromDiscontinuedOperationDuringPhaseOutPeriodNetOfTax>
    <us-gaap:DiscontinuedOperationIncomeLossFromDiscontinuedOperationDuringPhaseOutPeriodNetOfTax
      contextRef="i3a272e0b276a4cb1891236e443ba6b9f_D20210101-20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzY2E5YmIwMTc5MjQ3NmZiYjIyNWU1ZDlkZWM4NjlmL3NlYzo5M2NhOWJiMDE3OTI0NzZmYmIyMjVlNWQ5ZGVjODY5Zl82NC9mcmFnOjhlNjI5OTI1ODgxNTQ1M2E4NWZjOGM0NTY4Nzc5ZWFlL3RhYmxlOjBhODRmMDc3MDYzYjQwZTFiZjI5YjljOTM3NzkxZjA4L3RhYmxlcmFuZ2U6MGE4NGYwNzcwNjNiNDBlMWJmMjliOWM5Mzc3OTFmMDhfMi0xNC0xLTEtMA_ee5c582d-8328-41b6-8770-c603a6ee2770"
      unitRef="usd">-582000</us-gaap:DiscontinuedOperationIncomeLossFromDiscontinuedOperationDuringPhaseOutPeriodNetOfTax>
    <us-gaap:DiscontinuedOperationIncomeLossFromDiscontinuedOperationDuringPhaseOutPeriodNetOfTax
      contextRef="i199e66625a3f4900991433f926302578_D20200101-20200630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzY2E5YmIwMTc5MjQ3NmZiYjIyNWU1ZDlkZWM4NjlmL3NlYzo5M2NhOWJiMDE3OTI0NzZmYmIyMjVlNWQ5ZGVjODY5Zl82NC9mcmFnOjhlNjI5OTI1ODgxNTQ1M2E4NWZjOGM0NTY4Nzc5ZWFlL3RhYmxlOjBhODRmMDc3MDYzYjQwZTFiZjI5YjljOTM3NzkxZjA4L3RhYmxlcmFuZ2U6MGE4NGYwNzcwNjNiNDBlMWJmMjliOWM5Mzc3OTFmMDhfMi0xNi0xLTEtMA_f45113cd-24bc-4b95-86a5-c3932ba16981"
      unitRef="usd">-46000</us-gaap:DiscontinuedOperationIncomeLossFromDiscontinuedOperationDuringPhaseOutPeriodNetOfTax>
    <us-gaap:DisposalGroupIncludingDiscontinuedOperationAssetsNoncurrent
      contextRef="i3460e1558aee458a9a76219571d94bad_I20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzY2E5YmIwMTc5MjQ3NmZiYjIyNWU1ZDlkZWM4NjlmL3NlYzo5M2NhOWJiMDE3OTI0NzZmYmIyMjVlNWQ5ZGVjODY5Zl82NC9mcmFnOjhlNjI5OTI1ODgxNTQ1M2E4NWZjOGM0NTY4Nzc5ZWFlL3RhYmxlOjcyNjAxYzQxYWQ0ZTQ5YWZhNTgyMTBkYzFkNDI0ZWUxL3RhYmxlcmFuZ2U6NzI2MDFjNDFhZDRlNDlhZmE1ODIxMGRjMWQ0MjRlZTFfMS0xMS0xLTEtMA_c162f2f8-1827-41e9-9474-a07ee3751386"
      unitRef="usd">645000</us-gaap:DisposalGroupIncludingDiscontinuedOperationAssetsNoncurrent>
    <us-gaap:DisposalGroupIncludingDiscontinuedOperationAssetsNoncurrent
      contextRef="ibab7e231213f4709bd6c6600c444e9d5_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzY2E5YmIwMTc5MjQ3NmZiYjIyNWU1ZDlkZWM4NjlmL3NlYzo5M2NhOWJiMDE3OTI0NzZmYmIyMjVlNWQ5ZGVjODY5Zl82NC9mcmFnOjhlNjI5OTI1ODgxNTQ1M2E4NWZjOGM0NTY4Nzc5ZWFlL3RhYmxlOjcyNjAxYzQxYWQ0ZTQ5YWZhNTgyMTBkYzFkNDI0ZWUxL3RhYmxlcmFuZ2U6NzI2MDFjNDFhZDRlNDlhZmE1ODIxMGRjMWQ0MjRlZTFfMS0xMy0xLTEtMA_e4d2469d-6234-442b-b0c2-0789fa76b903"
      unitRef="usd">1176000</us-gaap:DisposalGroupIncludingDiscontinuedOperationAssetsNoncurrent>
    <us-gaap:AssetImpairmentChargesTextBlock
      contextRef="i69782326f71a44e3805518280ee22b6b_D20210101-20210630"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzY2E5YmIwMTc5MjQ3NmZiYjIyNWU1ZDlkZWM4NjlmL3NlYzo5M2NhOWJiMDE3OTI0NzZmYmIyMjVlNWQ5ZGVjODY5Zl83MC9mcmFnOjMxN2NmYTJiYTEwYzQ5NjdhNTM1YzEwZjJiYWUzZjVkL3RleHRyZWdpb246MzE3Y2ZhMmJhMTBjNDk2N2E1MzVjMTBmMmJhZTNmNWRfOTY4_1bde1912-55b8-485a-9654-578fee4a6e49">Impairment Loss on Long-Lived Assets&lt;div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;(a)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;padding-left:24.34pt"&gt;Property, plant, and equipment, net and right-of-use assets&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;During the six months ended June&#160;30, 2021, the Company recognized an impairment charge of $1,039 related to leasehold improvements located within leased premises, encompassing approximately 6,000 square feet, in Los Angeles, California, which the Company determined it no longer had plans to use. The significant change in the extent and manner in which the leasehold improvements are being used and the expectation that, more likely than not, the leasehold improvements will be disposed of before the end of their useful life triggered an impairment. The right-of-use lease asset associated with the leasehold improvements was also written down as a result of our decision to no longer use the leased premises. The Company recognized an impairment charge on the de-recognition of the right-of-use asset of $702 during the six months ended June&#160;30, 2021. Both of the impairment charges are recognized in the statement of net income (loss) as impairment loss on property, plant and equipment and right-of-use assets. No impairment charges were recorded during the three months ended June 30, 2021 and the three and six months ended June 30, 2020 on property, plant and equipment and right-of-use assets.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;(b)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;padding-left:23.78pt"&gt;Intangible assets, net and goodwill&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Goodwill and indefinite life intangible assets are reviewed for impairment annually or more frequently when events or changes in circumstances indicate that fair value of the reporting unit has been reduced to less than its carrying value. During the three months ended June&#160;30, 2020, the Company concluded that the projected impact of the COVID-19 pandemic on its sales and revenues in the near term, together with the volatility in the market conditions during the quarter, represented potential indicators of impairment for the Company&#x2019;s U.S. reporting unit as well as its Lord Jones brand acquired in September 2019. Accordingly, the Company performed an interim impairment analysis during the second quarter of 2020. As a result of this analysis, the Company recorded impairment charges of $35,000 on its U.S. reporting unit and $5,000 on its Lord Jones&#x2122; brand for the three and six months ended June 30, 2020, when the carrying value of these assets exceeded their fair value. No triggering events were identified or impairment charges recorded during the three and six months ended June 30, 2021 on intangible assets and goodwill.&lt;/span&gt;&lt;/div&gt;</us-gaap:AssetImpairmentChargesTextBlock>
    <us-gaap:ImpairmentOfLongLivedAssetsToBeDisposedOf
      contextRef="i69782326f71a44e3805518280ee22b6b_D20210101-20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzY2E5YmIwMTc5MjQ3NmZiYjIyNWU1ZDlkZWM4NjlmL3NlYzo5M2NhOWJiMDE3OTI0NzZmYmIyMjVlNWQ5ZGVjODY5Zl83MC9mcmFnOjMxN2NmYTJiYTEwYzQ5NjdhNTM1YzEwZjJiYWUzZjVkL3RleHRyZWdpb246MzE3Y2ZhMmJhMTBjNDk2N2E1MzVjMTBmMmJhZTNmNWRfNzc_255452c6-a0f3-4a03-81d6-a4a9d0c741e0"
      unitRef="usd">1039000</us-gaap:ImpairmentOfLongLivedAssetsToBeDisposedOf>
    <cron:LesseeOperatingLeaseAreaOfLandToBeDisposedOf
      contextRef="i69782326f71a44e3805518280ee22b6b_D20210101-20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzY2E5YmIwMTc5MjQ3NmZiYjIyNWU1ZDlkZWM4NjlmL3NlYzo5M2NhOWJiMDE3OTI0NzZmYmIyMjVlNWQ5ZGVjODY5Zl83MC9mcmFnOjMxN2NmYTJiYTEwYzQ5NjdhNTM1YzEwZjJiYWUzZjVkL3RleHRyZWdpb246MzE3Y2ZhMmJhMTBjNDk2N2E1MzVjMTBmMmJhZTNmNWRfMTcz_e139630c-8938-4ceb-abdd-0b74c253ea8d"
      unitRef="sqft">6000</cron:LesseeOperatingLeaseAreaOfLandToBeDisposedOf>
    <us-gaap:OperatingLeaseImpairmentLoss
      contextRef="i69782326f71a44e3805518280ee22b6b_D20210101-20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzY2E5YmIwMTc5MjQ3NmZiYjIyNWU1ZDlkZWM4NjlmL3NlYzo5M2NhOWJiMDE3OTI0NzZmYmIyMjVlNWQ5ZGVjODY5Zl83MC9mcmFnOjMxN2NmYTJiYTEwYzQ5NjdhNTM1YzEwZjJiYWUzZjVkL3RleHRyZWdpb246MzE3Y2ZhMmJhMTBjNDk2N2E1MzVjMTBmMmJhZTNmNWRfNzg3_42fbc03b-1c57-4168-90bc-e62d1f443ac4"
      unitRef="usd">702000</us-gaap:OperatingLeaseImpairmentLoss>
    <us-gaap:GoodwillImpairmentLoss
      contextRef="i037d0ab368aa4200bacafabacd180946_D20200401-20200630"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzY2E5YmIwMTc5MjQ3NmZiYjIyNWU1ZDlkZWM4NjlmL3NlYzo5M2NhOWJiMDE3OTI0NzZmYmIyMjVlNWQ5ZGVjODY5Zl83MC9mcmFnOjMxN2NmYTJiYTEwYzQ5NjdhNTM1YzEwZjJiYWUzZjVkL3RleHRyZWdpb246MzE3Y2ZhMmJhMTBjNDk2N2E1MzVjMTBmMmJhZTNmNWRfNDk0NzgwMjMyODI0Nw_93d8588d-124e-44df-ad35-3087cdfc138b"
      unitRef="usd">35000000</us-gaap:GoodwillImpairmentLoss>
    <us-gaap:GoodwillImpairmentLoss
      contextRef="iee9123f7b84a423aa2034824b667283b_D20200101-20200630"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzY2E5YmIwMTc5MjQ3NmZiYjIyNWU1ZDlkZWM4NjlmL3NlYzo5M2NhOWJiMDE3OTI0NzZmYmIyMjVlNWQ5ZGVjODY5Zl83MC9mcmFnOjMxN2NmYTJiYTEwYzQ5NjdhNTM1YzEwZjJiYWUzZjVkL3RleHRyZWdpb246MzE3Y2ZhMmJhMTBjNDk2N2E1MzVjMTBmMmJhZTNmNWRfNDk0NzgwMjMyODI0Nw_f4a9e6ae-25d2-4254-b78c-06fc5cd6e2b0"
      unitRef="usd">35000000</us-gaap:GoodwillImpairmentLoss>
    <us-gaap:ImpairmentOfIntangibleAssetsIndefinitelivedExcludingGoodwill
      contextRef="icaac8e35e79f4bc7b83a47868c7fbccf_D20200401-20200630"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzY2E5YmIwMTc5MjQ3NmZiYjIyNWU1ZDlkZWM4NjlmL3NlYzo5M2NhOWJiMDE3OTI0NzZmYmIyMjVlNWQ5ZGVjODY5Zl83MC9mcmFnOjMxN2NmYTJiYTEwYzQ5NjdhNTM1YzEwZjJiYWUzZjVkL3RleHRyZWdpb246MzE3Y2ZhMmJhMTBjNDk2N2E1MzVjMTBmMmJhZTNmNWRfNDk0NzgwMjMyODI2Mg_1519610b-6b3f-48ad-9e75-c70746d1af98"
      unitRef="usd">5000000</us-gaap:ImpairmentOfIntangibleAssetsIndefinitelivedExcludingGoodwill>
    <us-gaap:ImpairmentOfIntangibleAssetsIndefinitelivedExcludingGoodwill
      contextRef="i9d77515187ea4c40b907a43fd842a0f9_D20200101-20200630"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjkzY2E5YmIwMTc5MjQ3NmZiYjIyNWU1ZDlkZWM4NjlmL3NlYzo5M2NhOWJiMDE3OTI0NzZmYmIyMjVlNWQ5ZGVjODY5Zl83MC9mcmFnOjMxN2NmYTJiYTEwYzQ5NjdhNTM1YzEwZjJiYWUzZjVkL3RleHRyZWdpb246MzE3Y2ZhMmJhMTBjNDk2N2E1MzVjMTBmMmJhZTNmNWRfNDk0NzgwMjMyODI2Mg_2293c6d8-df17-4ba1-9ab2-7684f409caee"
      unitRef="usd">5000000</us-gaap:ImpairmentOfIntangibleAssetsIndefinitelivedExcludingGoodwill>
    <link:footnoteLink
      xlink:role="http://www.xbrl.org/2003/role/link"
      xlink:type="extended">
        <link:loc
          xlink:href="#id3VybDovL2RvY3MudjEvZG9jOjkzY2E5YmIwMTc5MjQ3NmZiYjIyNWU1ZDlkZWM4NjlmL3NlYzo5M2NhOWJiMDE3OTI0NzZmYmIyMjVlNWQ5ZGVjODY5Zl8xNi9mcmFnOmNhM2Q5OWRkMjk1ODQxYzQ4Yzk2ZDg0NGIzMGFkMjA5L3RhYmxlOmQ1Nzc2MTlkODM1ODRhZWNiNTE1YzZiODUwYjcwM2FmL3RhYmxlcmFuZ2U6ZDU3NzYxOWQ4MzU4NGFlY2I1MTVjNmI4NTBiNzAzYWZfMzQtMy0xLTEtMA_45fdf40b-dbc8-4445-906e-9521e4f1d45e"
          xlink:label="id3VybDovL2RvY3MudjEvZG9jOjkzY2E5YmIwMTc5MjQ3NmZiYjIyNWU1ZDlkZWM4NjlmL3NlYzo5M2NhOWJiMDE3OTI0NzZmYmIyMjVlNWQ5ZGVjODY5Zl8xNi9mcmFnOmNhM2Q5OWRkMjk1ODQxYzQ4Yzk2ZDg0NGIzMGFkMjA5L3RhYmxlOmQ1Nzc2MTlkODM1ODRhZWNiNTE1YzZiODUwYjcwM2FmL3RhYmxlcmFuZ2U6ZDU3NzYxOWQ4MzU4NGFlY2I1MTVjNmI4NTBiNzAzYWZfMzQtMy0xLTEtMA_45fdf40b-dbc8-4445-906e-9521e4f1d45e"
          xlink:type="locator"/>
        <link:footnote id="id3VybDovL2RvY3MudjEvZG9jOjkzY2E5YmIwMTc5MjQ3NmZiYjIyNWU1ZDlkZWM4NjlmL3NlYzo5M2NhOWJiMDE3OTI0NzZmYmIyMjVlNWQ5ZGVjODY5Zl8xNi9mcmFnOmNhM2Q5OWRkMjk1ODQxYzQ4Yzk2ZDg0NGIzMGFkMjA5L3RleHRyZWdpb246Y2EzZDk5ZGQyOTU4NDFjNDhjOTZkODQ0YjMwYWQyMDlfOTg5NTYwNDY1MTE0NQ_eb1add2a-1ec9-4add-ba58-e13e0f90c7fe" xlink:label="id3VybDovL2RvY3MudjEvZG9jOjkzY2E5YmIwMTc5MjQ3NmZiYjIyNWU1ZDlkZWM4NjlmL3NlYzo5M2NhOWJiMDE3OTI0NzZmYmIyMjVlNWQ5ZGVjODY5Zl8xNi9mcmFnOmNhM2Q5OWRkMjk1ODQxYzQ4Yzk2ZDg0NGIzMGFkMjA5L3RleHRyZWdpb246Y2EzZDk5ZGQyOTU4NDFjNDhjOTZkODQ0YjMwYWQyMDlfOTg5NTYwNDY1MTE0NQ_eb1add2a-1ec9-4add-ba58-e13e0f90c7fe" xlink:role="http://www.xbrl.org/2003/role/footnote" xlink:type="resource" xml:lang="en-US">Shares issued as of June&#160;30, 2021: 371,805,547 and December 31, 2020: 360,253,332.</link:footnote>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="id3VybDovL2RvY3MudjEvZG9jOjkzY2E5YmIwMTc5MjQ3NmZiYjIyNWU1ZDlkZWM4NjlmL3NlYzo5M2NhOWJiMDE3OTI0NzZmYmIyMjVlNWQ5ZGVjODY5Zl8xNi9mcmFnOmNhM2Q5OWRkMjk1ODQxYzQ4Yzk2ZDg0NGIzMGFkMjA5L3RhYmxlOmQ1Nzc2MTlkODM1ODRhZWNiNTE1YzZiODUwYjcwM2FmL3RhYmxlcmFuZ2U6ZDU3NzYxOWQ4MzU4NGFlY2I1MTVjNmI4NTBiNzAzYWZfMzQtMy0xLTEtMA_45fdf40b-dbc8-4445-906e-9521e4f1d45e"
          xlink:to="id3VybDovL2RvY3MudjEvZG9jOjkzY2E5YmIwMTc5MjQ3NmZiYjIyNWU1ZDlkZWM4NjlmL3NlYzo5M2NhOWJiMDE3OTI0NzZmYmIyMjVlNWQ5ZGVjODY5Zl8xNi9mcmFnOmNhM2Q5OWRkMjk1ODQxYzQ4Yzk2ZDg0NGIzMGFkMjA5L3RleHRyZWdpb246Y2EzZDk5ZGQyOTU4NDFjNDhjOTZkODQ0YjMwYWQyMDlfOTg5NTYwNDY1MTE0NQ_eb1add2a-1ec9-4add-ba58-e13e0f90c7fe"
          xlink:type="arc"/>
        <link:footnote id="id3VybDovL2RvY3MudjEvZG9jOjkzY2E5YmIwMTc5MjQ3NmZiYjIyNWU1ZDlkZWM4NjlmL3NlYzo5M2NhOWJiMDE3OTI0NzZmYmIyMjVlNWQ5ZGVjODY5Zl8xNi9mcmFnOmNhM2Q5OWRkMjk1ODQxYzQ4Yzk2ZDg0NGIzMGFkMjA5L3RleHRyZWdpb246Y2EzZDk5ZGQyOTU4NDFjNDhjOTZkODQ0YjMwYWQyMDlfOTg5NTYwNDY1MTE0NA_8348ab85-1f4e-4ef0-a58d-e175adf1fc29" xlink:label="id3VybDovL2RvY3MudjEvZG9jOjkzY2E5YmIwMTc5MjQ3NmZiYjIyNWU1ZDlkZWM4NjlmL3NlYzo5M2NhOWJiMDE3OTI0NzZmYmIyMjVlNWQ5ZGVjODY5Zl8xNi9mcmFnOmNhM2Q5OWRkMjk1ODQxYzQ4Yzk2ZDg0NGIzMGFkMjA5L3RleHRyZWdpb246Y2EzZDk5ZGQyOTU4NDFjNDhjOTZkODQ0YjMwYWQyMDlfOTg5NTYwNDY1MTE0NA_8348ab85-1f4e-4ef0-a58d-e175adf1fc29" xlink:role="http://www.xbrl.org/2003/role/footnote" xlink:type="resource" xml:lang="en-US">Authorized for issuance as of June&#160;30, 2021: unlimited and December 31, 2020: unlimited. </link:footnote>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="id3VybDovL2RvY3MudjEvZG9jOjkzY2E5YmIwMTc5MjQ3NmZiYjIyNWU1ZDlkZWM4NjlmL3NlYzo5M2NhOWJiMDE3OTI0NzZmYmIyMjVlNWQ5ZGVjODY5Zl8xNi9mcmFnOmNhM2Q5OWRkMjk1ODQxYzQ4Yzk2ZDg0NGIzMGFkMjA5L3RhYmxlOmQ1Nzc2MTlkODM1ODRhZWNiNTE1YzZiODUwYjcwM2FmL3RhYmxlcmFuZ2U6ZDU3NzYxOWQ4MzU4NGFlY2I1MTVjNmI4NTBiNzAzYWZfMzQtMy0xLTEtMA_45fdf40b-dbc8-4445-906e-9521e4f1d45e"
          xlink:to="id3VybDovL2RvY3MudjEvZG9jOjkzY2E5YmIwMTc5MjQ3NmZiYjIyNWU1ZDlkZWM4NjlmL3NlYzo5M2NhOWJiMDE3OTI0NzZmYmIyMjVlNWQ5ZGVjODY5Zl8xNi9mcmFnOmNhM2Q5OWRkMjk1ODQxYzQ4Yzk2ZDg0NGIzMGFkMjA5L3RleHRyZWdpb246Y2EzZDk5ZGQyOTU4NDFjNDhjOTZkODQ0YjMwYWQyMDlfOTg5NTYwNDY1MTE0NA_8348ab85-1f4e-4ef0-a58d-e175adf1fc29"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#id3VybDovL2RvY3MudjEvZG9jOjkzY2E5YmIwMTc5MjQ3NmZiYjIyNWU1ZDlkZWM4NjlmL3NlYzo5M2NhOWJiMDE3OTI0NzZmYmIyMjVlNWQ5ZGVjODY5Zl8xNi9mcmFnOmNhM2Q5OWRkMjk1ODQxYzQ4Yzk2ZDg0NGIzMGFkMjA5L3RhYmxlOmQ1Nzc2MTlkODM1ODRhZWNiNTE1YzZiODUwYjcwM2FmL3RhYmxlcmFuZ2U6ZDU3NzYxOWQ4MzU4NGFlY2I1MTVjNmI4NTBiNzAzYWZfMzQtMS0xLTEtMA_5e098358-4e52-4202-99a3-6577d5e81128"
          xlink:label="id3VybDovL2RvY3MudjEvZG9jOjkzY2E5YmIwMTc5MjQ3NmZiYjIyNWU1ZDlkZWM4NjlmL3NlYzo5M2NhOWJiMDE3OTI0NzZmYmIyMjVlNWQ5ZGVjODY5Zl8xNi9mcmFnOmNhM2Q5OWRkMjk1ODQxYzQ4Yzk2ZDg0NGIzMGFkMjA5L3RhYmxlOmQ1Nzc2MTlkODM1ODRhZWNiNTE1YzZiODUwYjcwM2FmL3RhYmxlcmFuZ2U6ZDU3NzYxOWQ4MzU4NGFlY2I1MTVjNmI4NTBiNzAzYWZfMzQtMS0xLTEtMA_5e098358-4e52-4202-99a3-6577d5e81128"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="id3VybDovL2RvY3MudjEvZG9jOjkzY2E5YmIwMTc5MjQ3NmZiYjIyNWU1ZDlkZWM4NjlmL3NlYzo5M2NhOWJiMDE3OTI0NzZmYmIyMjVlNWQ5ZGVjODY5Zl8xNi9mcmFnOmNhM2Q5OWRkMjk1ODQxYzQ4Yzk2ZDg0NGIzMGFkMjA5L3RhYmxlOmQ1Nzc2MTlkODM1ODRhZWNiNTE1YzZiODUwYjcwM2FmL3RhYmxlcmFuZ2U6ZDU3NzYxOWQ4MzU4NGFlY2I1MTVjNmI4NTBiNzAzYWZfMzQtMS0xLTEtMA_5e098358-4e52-4202-99a3-6577d5e81128"
          xlink:to="id3VybDovL2RvY3MudjEvZG9jOjkzY2E5YmIwMTc5MjQ3NmZiYjIyNWU1ZDlkZWM4NjlmL3NlYzo5M2NhOWJiMDE3OTI0NzZmYmIyMjVlNWQ5ZGVjODY5Zl8xNi9mcmFnOmNhM2Q5OWRkMjk1ODQxYzQ4Yzk2ZDg0NGIzMGFkMjA5L3RleHRyZWdpb246Y2EzZDk5ZGQyOTU4NDFjNDhjOTZkODQ0YjMwYWQyMDlfOTg5NTYwNDY1MTE0NA_8348ab85-1f4e-4ef0-a58d-e175adf1fc29"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="id3VybDovL2RvY3MudjEvZG9jOjkzY2E5YmIwMTc5MjQ3NmZiYjIyNWU1ZDlkZWM4NjlmL3NlYzo5M2NhOWJiMDE3OTI0NzZmYmIyMjVlNWQ5ZGVjODY5Zl8xNi9mcmFnOmNhM2Q5OWRkMjk1ODQxYzQ4Yzk2ZDg0NGIzMGFkMjA5L3RhYmxlOmQ1Nzc2MTlkODM1ODRhZWNiNTE1YzZiODUwYjcwM2FmL3RhYmxlcmFuZ2U6ZDU3NzYxOWQ4MzU4NGFlY2I1MTVjNmI4NTBiNzAzYWZfMzQtMS0xLTEtMA_5e098358-4e52-4202-99a3-6577d5e81128"
          xlink:to="id3VybDovL2RvY3MudjEvZG9jOjkzY2E5YmIwMTc5MjQ3NmZiYjIyNWU1ZDlkZWM4NjlmL3NlYzo5M2NhOWJiMDE3OTI0NzZmYmIyMjVlNWQ5ZGVjODY5Zl8xNi9mcmFnOmNhM2Q5OWRkMjk1ODQxYzQ4Yzk2ZDg0NGIzMGFkMjA5L3RleHRyZWdpb246Y2EzZDk5ZGQyOTU4NDFjNDhjOTZkODQ0YjMwYWQyMDlfOTg5NTYwNDY1MTE0NQ_eb1add2a-1ec9-4add-ba58-e13e0f90c7fe"
          xlink:type="arc"/>
    </link:footnoteLink>
</xbrl>
</XML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>15
<FILENAME>R1.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.2</span><table class="report" border="0" cellspacing="2" id="idm140382004644152">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Cover Page - shares<br></strong></div></th>
<th class="th" colspan="1">6 Months Ended</th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th"><div>Jun. 30, 2021</div></th>
<th class="th"><div>Aug. 05, 2021</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_CoverAbstract', window );"><strong>Cover [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_DocumentType', window );">Document Type</a></td>
<td class="text">10-Q<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_DocumentQuarterlyReport', window );">Document Quarterly Report</a></td>
<td class="text">true<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_DocumentPeriodEndDate', window );">Document Period End Date</a></td>
<td class="text">Jun. 30,  2021<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_DocumentTransitionReport', window );">Document Transition Report</a></td>
<td class="text">false<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityFileNumber', window );">Entity File Number</a></td>
<td class="text">001-38403<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityRegistrantName', window );">Entity Registrant Name</a></td>
<td class="text">CRONOS GROUP INC.<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityIncorporationStateCountryCode', window );">Entity Incorporation, State or Country Code</a></td>
<td class="text">Z4<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityAddressAddressLine1', window );">Entity Address, Address Line One</a></td>
<td class="text">111 Peter St. Suite 300<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityAddressCityOrTown', window );">Entity Address, City or Town</a></td>
<td class="text">Toronto<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityAddressStateOrProvince', window );">Entity Address, State or Province</a></td>
<td class="text">ON<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityAddressPostalZipCode', window );">Entity Address, Postal Zip Code</a></td>
<td class="text">M5V 2H1<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_CityAreaCode', window );">City Area Code</a></td>
<td class="text">416<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_LocalPhoneNumber', window );">Local Phone Number</a></td>
<td class="text">504-0004<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_Security12bTitle', window );">Title of 12(b) Security</a></td>
<td class="text">Common Shares, no par value<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_TradingSymbol', window );">Trading Symbol</a></td>
<td class="text">CRON<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_SecurityExchangeName', window );">Security Exchange Name</a></td>
<td class="text">NASDAQ<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityCurrentReportingStatus', window );">Entity Current Reporting Status</a></td>
<td class="text">Yes<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityInteractiveDataCurrent', window );">Entity Interactive Data Current</a></td>
<td class="text">Yes<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityFilerCategory', window );">Entity Filer Category</a></td>
<td class="text">Large Accelerated Filer<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntitySmallBusiness', window );">Entity Small Business</a></td>
<td class="text">false<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityEmergingGrowthCompany', window );">Entity Emerging Growth Company</a></td>
<td class="text">false<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityShellCompany', window );">Entity Shell Company</a></td>
<td class="text">false<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityCommonStockSharesOutstanding', window );">Entity Common Stock, Shares Outstanding (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">371,805,547<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_AmendmentFlag', window );">Amendment Flag</a></td>
<td class="text">false<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_DocumentFiscalYearFocus', window );">Document Fiscal Year Focus</a></td>
<td class="text">2021<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_DocumentFiscalPeriodFocus', window );">Document Fiscal Period Focus</a></td>
<td class="text">Q2<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityCentralIndexKey', window );">Entity Central Index Key</a></td>
<td class="text">0001656472<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_CurrentFiscalYearEndDate', window );">Current Fiscal Year End Date</a></td>
<td class="text">--12-31<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_AmendmentFlag">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the XBRL content amends previously-filed or accepted submission.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_AmendmentFlag</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_CityAreaCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Area code of city</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_CityAreaCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_CoverAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Cover page.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_CoverAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_CurrentFiscalYearEndDate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>End date of current fiscal year in the format --MM-DD.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_CurrentFiscalYearEndDate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:gMonthDayItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentFiscalPeriodFocus">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Fiscal period values are FY, Q1, Q2, and Q3.  1st, 2nd and 3rd quarter 10-Q or 10-QT statements have value Q1, Q2, and Q3 respectively, with 10-K, 10-KT or other fiscal year statements having FY.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentFiscalPeriodFocus</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:fiscalPeriodItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentFiscalYearFocus">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>This is focus fiscal year of the document report in YYYY format. For a 2006 annual report, which may also provide financial information from prior periods, fiscal 2006 should be given as the fiscal year focus. Example: 2006.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentFiscalYearFocus</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:gYearItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentPeriodEndDate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>For the EDGAR submission types of Form 8-K: the date of the report, the date of the earliest event reported; for the EDGAR submission types of Form N-1A: the filing date; for all other submission types: the end of the reporting or transition period.  The format of the date is YYYY-MM-DD.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentPeriodEndDate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:dateItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentQuarterlyReport">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true only for a form used as an quarterly report.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 10-Q<br> -Number 240<br> -Section 308<br> -Subsection a<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentQuarterlyReport</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentTransitionReport">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true only for a form used as a transition report.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Forms 10-K, 10-Q, 20-F<br> -Number 240<br> -Section 13<br> -Subsection a-1<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentTransitionReport</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentType">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentType</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:submissionTypeItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressAddressLine1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Address Line 1 such as Attn, Building Name, Street Name</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressAddressLine1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressCityOrTown">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Name of the City or Town</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressCityOrTown</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressPostalZipCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Code for the postal or zip code</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressPostalZipCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressStateOrProvince">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Name of the state or province.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressStateOrProvince</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:stateOrProvinceItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityCentralIndexKey">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation 12B<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityCentralIndexKey</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:centralIndexKeyItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityCommonStockSharesOutstanding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Indicate number of shares or other units outstanding of each of registrant's classes of capital or common stock or other ownership interests, if and as stated on cover of related periodic report. Where multiple classes or units exist define each class/interest by adding class of stock items such as Common Class A [Member], Common Class B [Member] or Partnership Interest [Member] onto the Instrument [Domain] of the Entity Listings, Instrument.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityCommonStockSharesOutstanding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityCurrentReportingStatus">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Indicate 'Yes' or 'No' whether registrants (1) have filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that registrants were required to file such reports), and (2) have been subject to such filing requirements for the past 90 days. This information should be based on the registrant's current or most recent filing containing the related disclosure.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityCurrentReportingStatus</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:yesNoItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityEmergingGrowthCompany">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Indicate if registrant meets the emerging growth company criteria.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation 12B<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityEmergingGrowthCompany</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityFileNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityFileNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:fileNumberItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityFilerCategory">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Indicate whether the registrant is one of the following: Large Accelerated Filer, Accelerated Filer, Non-accelerated Filer. Definitions of these categories are stated in Rule 12b-2 of the Exchange Act. This information should be based on the registrant's current or most recent filing containing the related disclosure.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation 12B<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityFilerCategory</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:filerCategoryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityIncorporationStateCountryCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Two-character EDGAR code representing the state or country of incorporation.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityIncorporationStateCountryCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:edgarStateCountryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityInteractiveDataCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T during the preceding 12 months (or for such shorter period that the registrant was required to submit such files).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation S-T<br> -Number 232<br> -Section 405<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityInteractiveDataCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:yesNoItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityRegistrantName">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation 12B<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityRegistrantName</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityShellCompany">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the registrant is a shell company as defined in Rule 12b-2 of the Exchange Act.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation 12B<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityShellCompany</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntitySmallBusiness">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Indicates that the company is a Smaller Reporting Company (SRC).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation 12B<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntitySmallBusiness</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_LocalPhoneNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Local phone number for entity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_LocalPhoneNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_Security12bTitle">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Title of a 12(b) registered security.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_Security12bTitle</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:securityTitleItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_SecurityExchangeName">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Name of the Exchange on which a security is registered.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection d1-1<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_SecurityExchangeName</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:edgarExchangeCodeItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_TradingSymbol">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Trading symbol of an instrument as listed on an exchange.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_TradingSymbol</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:tradingSymbolItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>16
<FILENAME>R2.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.2</span><table class="report" border="0" cellspacing="2" id="idm140382004508088">
<tr>
<th class="tl" colspan="2" rowspan="1"><div style="width: 200px;"><strong>Condensed Consolidated Balance Sheets - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th"><div>Jun. 30, 2021</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AssetsCurrentAbstract', window );"><strong>Current assets</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CashAndCashEquivalentsAtCarryingValue', window );">Cash and cash equivalents</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">$ 895,181<span></span>
</td>
<td class="nump">$ 1,078,023<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShortTermInvestments', window );">Short-term investments</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">201,699<span></span>
</td>
<td class="nump">211,766<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccountsReceivableNetCurrent', window );">Accounts receivable, net</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">11,299<span></span>
</td>
<td class="nump">8,928<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherReceivablesNetCurrent', window );">Other receivables</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">2,468<span></span>
</td>
<td class="nump">10,033<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NotesAndLoansReceivableNetCurrent', window );">Current portion of loans receivable, net</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">5,028<span></span>
</td>
<td class="nump">7,083<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PrepaidExpenseAndOtherAssetsCurrent', window );">Prepaids and other current assets</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">10,153<span></span>
</td>
<td class="nump">11,161<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InventoryNet', window );">Inventory, net</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">35,605<span></span>
</td>
<td class="nump">44,002<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AssetsHeldForSaleNotPartOfDisposalGroupCurrent', window );">Held-for-sale assets</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">645<span></span>
</td>
<td class="nump">1,176<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AssetsCurrent', window );">Total current assets</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">1,162,078<span></span>
</td>
<td class="nump">1,372,172<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AdvancesToAffiliate', window );">Advances to joint ventures</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">499<span></span>
</td>
<td class="nump">467<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EquityMethodInvestments', window );">Investments in equity accounted investees, net</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">20,970<span></span>
</td>
<td class="nump">19,235<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherLongTermInvestments', window );">Other investments</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">110,392<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NotesAndLoansReceivableNetNoncurrent', window );">Loan receivable, net</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">94,113<span></span>
</td>
<td class="nump">87,191<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentNet', window );">Property, plant and equipment, net</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">193,920<span></span>
</td>
<td class="nump">187,599<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingLeaseRightOfUseAsset', window );">Right-of-use assets</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">6,687<span></span>
</td>
<td class="nump">9,776<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IntangibleAssetsNetExcludingGoodwill', window );">Intangible assets, net</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">70,409<span></span>
</td>
<td class="nump">69,720<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Goodwill', window );">Goodwill</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">179,543<span></span>
</td>
<td class="nump">179,522<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Assets', window );">Total assets</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">1,838,611<span></span>
</td>
<td class="nump">1,925,682<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LiabilitiesCurrentAbstract', window );"><strong>Current liabilities</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccountsPayableAndOtherAccruedLiabilitiesCurrent', window );">Accounts payable and other liabilities</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">29,829<span></span>
</td>
<td class="nump">42,102<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingLeaseLiabilityCurrent', window );">Current portion of lease obligation</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">1,206<span></span>
</td>
<td class="nump">1,322<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeLiabilitiesCurrent', window );">Derivative liabilities</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">169,563<span></span>
</td>
<td class="nump">163,410<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LiabilitiesCurrent', window );">Total current liabilities</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">200,598<span></span>
</td>
<td class="nump">206,834<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DueToRelatedPartiesNoncurrent', window );">Due to non-controlling interests</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">1,768<span></span>
</td>
<td class="nump">2,188<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingLeaseLiabilityNoncurrent', window );">Lease obligation</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">6,333<span></span>
</td>
<td class="nump">8,492<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Liabilities', window );">Total liabilities</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">208,699<span></span>
</td>
<td class="nump">217,514<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommitmentsAndContingencies', window );">Commitments and contingencies</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterestAbstract', window );"><strong>Stockholders' Equity, Including Portion Attributable to Noncontrolling Interest [Abstract]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommonStockValue', window );">Share capital</a></td>
<td class="th" style="border-bottom: 0px;"><sup>[1],[2]</sup></td>
<td class="nump">572,858<span></span>
</td>
<td class="nump">569,260<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AdditionalPaidInCapital', window );">Additional paid-in capital</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">32,368<span></span>
</td>
<td class="nump">34,596<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RetainedEarningsAccumulatedDeficit', window );">Retained earnings</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">955,721<span></span>
</td>
<td class="nump">1,064,509<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax', window );">Accumulated other comprehensive income</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">71,729<span></span>
</td>
<td class="nump">42,999<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Total equity attributable to shareholders of Cronos Group</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">1,632,676<span></span>
</td>
<td class="nump">1,711,364<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_MinorityInterest', window );">Non-controlling interests</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="num">(2,764)<span></span>
</td>
<td class="num">(3,196)<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest', window );">Total shareholders&#8217; equity</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">1,629,912<span></span>
</td>
<td class="nump">1,708,168<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LiabilitiesAndStockholdersEquity', window );">Total liabilities and shareholders&#8217; equity</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">$ 1,838,611<span></span>
</td>
<td class="nump">$ 1,925,682<span></span>
</td>
</tr>
<tr><td colspan="3"></td></tr>
<tr><td colspan="3"><table class="outerFootnotes" width="100%">
<tr class="outerFootnote">
<td style="vertical-align: top; width: 12pt;" valign="top">[1]</td>
<td style="vertical-align: top;" valign="top">Authorized for issuance as of June&#160;30, 2021: unlimited and December 31, 2020: unlimited.</td>
</tr>
<tr class="outerFootnote">
<td style="vertical-align: top; width: 12pt;" valign="top">[2]</td>
<td style="vertical-align: top;" valign="top">Shares issued as of June&#160;30, 2021: 371,805,547 and December 31, 2020: 360,253,332.</td>
</tr>
</table></td></tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountsPayableAndOtherAccruedLiabilitiesCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of liabilities incurred to vendors for goods and services received, and accrued liabilities classified as other, payable within one year or the normal operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccountsPayableAndOtherAccruedLiabilitiesCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountsReceivableNetCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, after allowance for credit loss, of right to consideration from customer for product sold and service rendered in normal course of business, classified as current.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 310<br> -SubTopic 10<br> -Section 45<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=124259787&amp;loc=d3e4428-111522<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(3))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 3: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=124098289&amp;loc=d3e6676-107765<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 310<br> -SubTopic 10<br> -Section 45<br> -Paragraph 9<br> -URI http://asc.fasb.org/extlink&amp;oid=124259787&amp;loc=d3e4531-111522<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccountsReceivableNetCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Accumulated change in equity from transactions and other events and circumstances from non-owner sources, net of tax effect, at period end. Excludes Net Income (Loss), and accumulated changes in equity from transactions resulting from investments by owners and distributions to owners. Includes foreign currency translation items, certain pension adjustments, unrealized gains and losses on certain investments in debt and equity securities, other than temporary impairment (OTTI) losses related to factors other than credit losses on available-for-sale and held-to-maturity debt securities that an entity does not intend to sell and it is not more likely than not that the entity will be required to sell before recovery of the amortized cost basis, as well as changes in the fair value of derivatives related to the effective portion of a designated cash flow hedge.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(30)(a)(4))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 11<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=d3e637-108580<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(23)(a)(3))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400017&amp;loc=d3e572229-122910<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14A<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=SL7669686-108580<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (h)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=124501264&amp;loc=SL117420844-207641<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (g)(2)(ii)<br> -URI http://asc.fasb.org/extlink&amp;oid=124501264&amp;loc=SL117420844-207641<br><br>Reference 7: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=d3e681-108580<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AdditionalPaidInCapital">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of excess of issue price over par or stated value of stock and from other transaction involving stock or stockholder. Includes, but is not limited to, additional paid-in capital (APIC) for common and preferred stock.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 65<br> -Paragraph 15<br> -Subparagraph (g)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=121322162&amp;loc=SL121327923-165333<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(30)(a)(1))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AdditionalPaidInCapital</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AdvancesToAffiliate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Long-Term advances receivable from a party that is affiliated with the reporting entity by means of direct or indirect ownership. This does not include advances to clients.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 946<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-04.2)<br> -URI http://asc.fasb.org/extlink&amp;oid=120401414&amp;loc=d3e603758-122996<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 4<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=124098289&amp;loc=d3e6812-107765<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AdvancesToAffiliate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_Assets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Sum of the carrying amounts as of the balance sheet date of all assets that are recognized. Assets are probable future economic benefits obtained or controlled by an entity as a result of past transactions or events.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(11))<br> -URI http://asc.fasb.org/extlink&amp;oid=120398452&amp;loc=d3e534808-122878<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8736-108599<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(12))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400017&amp;loc=d3e572229-122910<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 8: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124433192&amp;loc=SL2890621-112765<br><br>Reference 9: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 14: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (bb)<br> -URI http://asc.fasb.org/extlink&amp;oid=123419778&amp;loc=d3e5710-111685<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 25<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=116870748&amp;loc=SL6758485-165988<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8933-108599<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8906-108599<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_Assets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AssetsCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Sum of the carrying amounts as of the balance sheet date of all assets that are expected to be realized in cash, sold, or consumed within one year (or the normal operating cycle, if longer). Assets are probable future economic benefits obtained or controlled by an entity as a result of past transactions or events.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=124098289&amp;loc=d3e6801-107765<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124433192&amp;loc=SL2890621-112765<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.9)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 8: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 25<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=116870748&amp;loc=SL6758485-165988<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 15: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (bb)<br> -URI http://asc.fasb.org/extlink&amp;oid=123419778&amp;loc=d3e5710-111685<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 20: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=124098289&amp;loc=d3e6676-107765<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AssetsCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AssetsCurrentAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AssetsCurrentAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AssetsHeldForSaleNotPartOfDisposalGroupCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of assets held-for-sale that are not part of a disposal group, expected to be sold within a year or the normal operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 15<br> -Paragraph 4<br> -Subparagraph (b)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=123398962&amp;loc=d3e400-110220<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AssetsHeldForSaleNotPartOfDisposalGroupCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashAndCashEquivalentsAtCarryingValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of currency on hand as well as demand deposits with banks or financial institutions. Includes other kinds of accounts that have the general characteristics of demand deposits. Also includes short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates. Excludes cash and cash equivalents within disposal group and discontinued operation.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3044-108585<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124098289&amp;loc=d3e6676-107765<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.1)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashAndCashEquivalentsAtCarryingValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommitmentsAndContingencies">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Represents the caption on the face of the balance sheet to indicate that the entity has entered into (1) purchase or supply arrangements that will require expending a portion of its resources to meet the terms thereof, and (2) is exposed to potential losses or, less frequently, gains, arising from (a) possible claims against a company's resources due to future performance under contract terms, and (b) possible losses or likely gains from uncertainties that will ultimately be resolved when one or more future events that are deemed likely to occur do occur or fail to occur.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.25)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03.(a),19)<br> -URI http://asc.fasb.org/extlink&amp;oid=120400017&amp;loc=d3e572229-122910<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03.17)<br> -URI http://asc.fasb.org/extlink&amp;oid=120398452&amp;loc=d3e534808-122878<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 450<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=121557415&amp;loc=d3e14326-108349<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommitmentsAndContingencies</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Aggregate par or stated value of issued nonredeemable common stock (or common stock redeemable solely at the option of the issuer). This item includes treasury stock repurchased by the entity. Note: elements for number of nonredeemable common shares, par value and other disclosure concepts are in another section within stockholders' equity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeLiabilitiesCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Fair value, after the effects of master netting arrangements, of a financial liability or contract with one or more underlyings, notional amount or payment provision or both, and the contract can be net settled by means outside the contract or delivery of an asset, expected to be settled within one year or normal operating cycle, if longer. Includes assets not subject to a master netting arrangement and not elected to be offset.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 20<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=51824906&amp;loc=SL20225862-175312<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeLiabilitiesCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DueToRelatedPartiesNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Portion of the carrying amount as of the balance sheet date of obligations due all related parties that is payable after one year or beyond the normal operating cycle if longer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(k)(1))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 850<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=6457730&amp;loc=d3e39549-107864<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.23)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(B))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(C))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DueToRelatedPartiesNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EquityMethodInvestments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>This item represents the carrying amount on the entity's balance sheet of its investment in common stock of an equity method investee. This is not an indicator of the fair value of the investment, rather it is the initial cost adjusted for the entity's share of earnings and losses of the investee, adjusted for any distributions (dividends) and other than temporary impairment (OTTI) losses recognized.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=109237563&amp;loc=d3e33749-111570<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 25<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8813-108599<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.12)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EquityMethodInvestments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_Goodwill">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount after accumulated impairment loss of an asset representing future economic benefits arising from other assets acquired in a business combination that are not individually identified and separately recognized.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(10)(1))<br> -URI http://asc.fasb.org/extlink&amp;oid=120398452&amp;loc=d3e534808-122878<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 45<br> -Paragraph 5<br> -URI http://asc.fasb.org/extlink&amp;oid=120320667&amp;loc=SL49117168-202975<br><br>Reference 3: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 45<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=99380562&amp;loc=d3e13770-109266<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_Goodwill</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IntangibleAssetsNetExcludingGoodwill">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Sum of the carrying amounts of all intangible assets, excluding goodwill, as of the balance sheet date, net of accumulated amortization and impairment charges.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 2<br> -Subparagraph ((a)(1),(b))<br> -URI http://asc.fasb.org/extlink&amp;oid=66006027&amp;loc=d3e16323-109275<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 45<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6388964&amp;loc=d3e16212-109274<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IntangibleAssetsNetExcludingGoodwill</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InventoryNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount after valuation and LIFO reserves of inventory expected to be sold, or consumed within one year or operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=124098289&amp;loc=d3e6676-107765<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.6(a))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InventoryNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_Liabilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Sum of the carrying amounts as of the balance sheet date of all liabilities that are recognized. Liabilities are probable future sacrifices of economic benefits arising from present obligations of an entity to transfer assets or provide services to other entities in the future.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.19-26)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124433192&amp;loc=SL2890621-112765<br><br>Reference 3: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8906-108599<br><br>Reference 4: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=124433192&amp;loc=SL2890621-112765<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 25<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=116870748&amp;loc=SL6758485-165988<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (bb)<br> -URI http://asc.fasb.org/extlink&amp;oid=123419778&amp;loc=d3e5710-111685<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=123419778&amp;loc=d3e5710-111685<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 20: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_Liabilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LiabilitiesAndStockholdersEquity">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of liabilities and equity items, including the portion of equity attributable to noncontrolling interests, if any.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(23))<br> -URI http://asc.fasb.org/extlink&amp;oid=120398452&amp;loc=d3e534808-122878<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(25))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400017&amp;loc=d3e572229-122910<br><br>Reference 5: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(32))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 7: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LiabilitiesAndStockholdersEquity</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LiabilitiesCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Total obligations incurred as part of normal operations that are expected to be paid during the following twelve months or within one business cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124433192&amp;loc=SL2890621-112765<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 4: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=124433192&amp;loc=SL2890621-112765<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 25<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=116870748&amp;loc=SL6758485-165988<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 7: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=123419778&amp;loc=d3e5710-111685<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (bb)<br> -URI http://asc.fasb.org/extlink&amp;oid=123419778&amp;loc=d3e5710-111685<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 20: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.21)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LiabilitiesCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LiabilitiesCurrentAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LiabilitiesCurrentAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_MinorityInterest">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Total of all stockholders' equity (deficit) items, net of receivables from officers, directors, owners, and affiliates of the entity which is directly or indirectly attributable to that ownership interest in subsidiary equity which is not attributable to the parent (that is, noncontrolling interest, previously referred to as minority interest).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(24))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400017&amp;loc=d3e572229-122910<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.31)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 10: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(22))<br> -URI http://asc.fasb.org/extlink&amp;oid=120398452&amp;loc=d3e534808-122878<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_MinorityInterest</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NotesAndLoansReceivableNetCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, after allowance for credit loss, of financing receivable, classified as current. Includes, but is not limited to, notes and loan receivable.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 310<br> -SubTopic 10<br> -Section 45<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=124259787&amp;loc=d3e4428-111522<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 310<br> -SubTopic 10<br> -Section 45<br> -Paragraph 9<br> -URI http://asc.fasb.org/extlink&amp;oid=124259787&amp;loc=d3e4531-111522<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (e)<br> -URI http://asc.fasb.org/extlink&amp;oid=124098289&amp;loc=d3e6676-107765<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(3)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(7))<br> -URI http://asc.fasb.org/extlink&amp;oid=120398452&amp;loc=d3e534808-122878<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=124098289&amp;loc=d3e6676-107765<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NotesAndLoansReceivableNetCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NotesAndLoansReceivableNetNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, after allowance for credit loss, of financing receivable, classified as noncurrent.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(3))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NotesAndLoansReceivableNetNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseLiabilityCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Present value of lessee's discounted obligation for lease payments from operating lease, classified as current.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123391704&amp;loc=SL77918627-209977<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeaseLiabilityCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseLiabilityNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Present value of lessee's discounted obligation for lease payments from operating lease, classified as noncurrent.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123391704&amp;loc=SL77918627-209977<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeaseLiabilityNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseRightOfUseAsset">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of lessee's right to use underlying asset under operating lease.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123391704&amp;loc=SL77918627-209977<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeaseRightOfUseAsset</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherLongTermInvestments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of long-term investments classified as other.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03.1(f))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400017&amp;loc=d3e572229-122910<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.12)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherLongTermInvestments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherReceivablesNetCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, after allowance, of receivables classified as other, due within one year or the operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherReceivablesNetCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PrepaidExpenseAndOtherAssetsCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of asset related to consideration paid in advance for costs that provide economic benefits in future periods, and amount of other assets that are expected to be realized or consumed within one year or the normal operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(7))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=124098289&amp;loc=d3e6676-107765<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(8))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PrepaidExpenseAndOtherAssetsCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount after accumulated depreciation, depletion and amortization of physical assets used in the normal conduct of business to produce goods and services and not intended for resale. Examples include, but are not limited to, land, buildings, machinery and equipment, office equipment, and furniture and fixtures.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(14))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6391035&amp;loc=d3e2868-110229<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(8))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400017&amp;loc=d3e572229-122910<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 360<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=124429447&amp;loc=SL124453093-239630<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(13))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 6: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RetainedEarningsAccumulatedDeficit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The cumulative amount of the reporting entity's undistributed earnings or deficit.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(30)(a)(3))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 65<br> -Paragraph 15<br> -Subparagraph (g)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=121322162&amp;loc=SL121327923-165333<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(23)(a)(4))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400017&amp;loc=d3e572229-122910<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (h)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=124501264&amp;loc=SL117420844-207641<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI http://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (g)(2)(i)<br> -URI http://asc.fasb.org/extlink&amp;oid=124501264&amp;loc=SL117420844-207641<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RetainedEarningsAccumulatedDeficit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShortTermInvestments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of investments including trading securities, available-for-sale securities, held-to-maturity securities, and short-term investments classified as other and current.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(4))<br> -URI http://asc.fasb.org/extlink&amp;oid=120398452&amp;loc=d3e534808-122878<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=120398452&amp;loc=d3e534808-122878<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(1)(g))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400017&amp;loc=d3e572229-122910<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(2))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShortTermInvestments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockholdersEquity">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Total of all stockholders' equity (deficit) items, net of receivables from officers, directors, owners, and affiliates of the entity which are attributable to the parent. The amount of the economic entity's stockholders' equity attributable to the parent excludes the amount of stockholders' equity which is allocable to that ownership interest in subsidiary equity which is not attributable to the parent (noncontrolling interest, minority interest). This excludes temporary equity and is sometimes called permanent equity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 310<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SAB Topic 4.E)<br> -URI http://asc.fasb.org/extlink&amp;oid=122038336&amp;loc=d3e74512-122707<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(31))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(30))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 7: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 8: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockholdersEquity</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of stockholders' equity (deficit), net of receivables from officers, directors, owners, and affiliates of the entity, attributable to both the parent and noncontrolling interests. Amount excludes temporary equity. Alternate caption for the concept is permanent equity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 45<br> -Paragraph 24<br> -URI http://asc.fasb.org/extlink&amp;oid=124436220&amp;loc=d3e21930-107793<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI http://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 45<br> -Paragraph 23<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=124436220&amp;loc=d3e21914-107793<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22644-107794<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 50<br> -Paragraph 5<br> -URI http://asc.fasb.org/extlink&amp;oid=124431353&amp;loc=SL124442411-227067<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 326<br> -SubTopic 10<br> -Section 65<br> -Paragraph 4<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=122640432&amp;loc=SL121648383-210437<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 105<br> -SubTopic 10<br> -Section 65<br> -Paragraph 6<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=124434974&amp;loc=SL124442142-165695<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 105<br> -SubTopic 10<br> -Section 65<br> -Paragraph 6<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=124434974&amp;loc=SL124442142-165695<br><br>Reference 9: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 16<br> -URI http://asc.fasb.org/extlink&amp;oid=123454820&amp;loc=SL4568740-111683<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (e)(3)<br> -URI http://asc.fasb.org/extlink&amp;oid=123482062&amp;loc=SL123482106-238011<br><br>Reference 11: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 45<br> -Paragraph 5<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=124436220&amp;loc=d3e21711-107793<br><br>Reference 13: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 14: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 30<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6450520&amp;loc=d3e32583-110901<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 65<br> -Paragraph 8<br> -Subparagraph (d)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=123459177&amp;loc=SL121830611-158277<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 30<br> -Section 45<br> -Paragraph 17<br> -URI http://asc.fasb.org/extlink&amp;oid=118261656&amp;loc=d3e32136-110900<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 65<br> -Paragraph 8<br> -Subparagraph (d)(3)<br> -URI http://asc.fasb.org/extlink&amp;oid=123459177&amp;loc=SL121830611-158277<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (f)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=124501264&amp;loc=SL117420844-207641<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 65<br> -Paragraph 15<br> -Subparagraph (f)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=121322162&amp;loc=SL121327923-165333<br><br>Reference 21: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 55<br> -Paragraph 4I<br> -URI http://asc.fasb.org/extlink&amp;oid=120409616&amp;loc=SL4590271-111686<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (f)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=124501264&amp;loc=SL117420844-207641<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 30<br> -Section 45<br> -Paragraph 20<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=118261656&amp;loc=d3e32211-110900<br><br>Reference 24: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 15<br> -URI http://asc.fasb.org/extlink&amp;oid=123454820&amp;loc=SL4568447-111683<br><br>Reference 25: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 65<br> -Paragraph 15<br> -Subparagraph (f)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=121322162&amp;loc=SL121327923-165333<br><br>Reference 26: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(3)<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22499-107794<br><br>Reference 27: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 65<br> -Paragraph 15<br> -Subparagraph (e)<br> -URI http://asc.fasb.org/extlink&amp;oid=121322162&amp;loc=SL121327923-165333<br><br>Reference 28: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 848<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 2<br> -Publisher FASB<br> -Subparagraph (a)(3)(iii)(03)<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterestAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterestAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>17
<FILENAME>R3.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.2</span><table class="report" border="0" cellspacing="2" id="idm140381999802872">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Condensed Consolidated Balance Sheet (Parenthetical) - shares<br></strong></div></th>
<th class="th"><div>Jun. 30, 2021</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementOfFinancialPositionAbstract', window );"><strong>Statement of Financial Position [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommonStockSharesIssued', window );">Common stock, shares issued (in shares)</a></td>
<td class="nump">371,805,547<span></span>
</td>
<td class="nump">360,253,332<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockSharesIssued">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Total number of common shares of an entity that have been sold or granted to shareholders (includes common shares that were issued, repurchased and remain in the treasury). These shares represent capital invested by the firm's shareholders and owners, and may be all or only a portion of the number of shares authorized. Shares issued include shares outstanding and shares held in the treasury.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockSharesIssued</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementOfFinancialPositionAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementOfFinancialPositionAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>18
<FILENAME>R4.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.2</span><table class="report" border="0" cellspacing="2" id="idm140382008304488">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Condensed Consolidated Statements of Net Income (Loss) and Comprehensive Income (Loss) - USD ($)<br></strong></div></th>
<th class="th" colspan="2">3 Months Ended</th>
<th class="th" colspan="2">6 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Jun. 30, 2021</div></th>
<th class="th"><div>Jun. 30, 2020</div></th>
<th class="th"><div>Jun. 30, 2021</div></th>
<th class="th"><div>Jun. 30, 2020</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeStatementAbstract', window );"><strong>Income Statement [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerIncludingAssessedTax', window );">Net revenue, before excise taxes</a></td>
<td class="nump">$ 18,848,000<span></span>
</td>
<td class="nump">$ 11,432,000<span></span>
</td>
<td class="nump">$ 33,502,000<span></span>
</td>
<td class="nump">$ 20,776,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ExciseAndSalesTaxes', window );">Excise taxes</a></td>
<td class="num">(3,226,000)<span></span>
</td>
<td class="num">(1,549,000)<span></span>
</td>
<td class="num">(5,269,000)<span></span>
</td>
<td class="num">(2,461,000)<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Net revenue</a></td>
<td class="nump">15,622,000<span></span>
</td>
<td class="nump">9,883,000<span></span>
</td>
<td class="nump">28,233,000<span></span>
</td>
<td class="nump">18,315,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cron_OtherCostOfGoodsAndServicesSold', window );">Cost of sales</a></td>
<td class="nump">19,445,000<span></span>
</td>
<td class="nump">9,743,000<span></span>
</td>
<td class="nump">35,019,000<span></span>
</td>
<td class="nump">16,689,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InventoryWriteDown', window );">Inventory write-down</a></td>
<td class="nump">11,961,000<span></span>
</td>
<td class="nump">3,062,000<span></span>
</td>
<td class="nump">11,961,000<span></span>
</td>
<td class="nump">11,024,000<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GrossProfit', window );">Gross loss</a></td>
<td class="num">(15,784,000)<span></span>
</td>
<td class="num">(2,922,000)<span></span>
</td>
<td class="num">(18,747,000)<span></span>
</td>
<td class="num">(9,398,000)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingExpensesAbstract', window );"><strong>Operating expenses</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SellingAndMarketingExpense', window );">Sales and marketing</a></td>
<td class="nump">13,209,000<span></span>
</td>
<td class="nump">6,501,000<span></span>
</td>
<td class="nump">23,463,000<span></span>
</td>
<td class="nump">13,613,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ResearchAndDevelopmentExpense', window );">Research and development (&#8220;R&amp;D&#8221;)</a></td>
<td class="nump">5,199,000<span></span>
</td>
<td class="nump">3,631,000<span></span>
</td>
<td class="nump">10,301,000<span></span>
</td>
<td class="nump">8,221,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GeneralAndAdministrativeExpense', window );">General and administrative</a></td>
<td class="nump">22,417,000<span></span>
</td>
<td class="nump">18,429,000<span></span>
</td>
<td class="nump">44,323,000<span></span>
</td>
<td class="nump">42,188,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AllocatedShareBasedCompensationExpense', window );">Share-based payments</a></td>
<td class="nump">2,565,000<span></span>
</td>
<td class="nump">2,546,000<span></span>
</td>
<td class="nump">5,064,000<span></span>
</td>
<td class="nump">4,982,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DepreciationAndAmortization', window );">Depreciation and amortization</a></td>
<td class="nump">1,043,000<span></span>
</td>
<td class="nump">679,000<span></span>
</td>
<td class="nump">1,778,000<span></span>
</td>
<td class="nump">1,366,000<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingExpenses', window );">Total operating expenses</a></td>
<td class="nump">44,433,000<span></span>
</td>
<td class="nump">31,786,000<span></span>
</td>
<td class="nump">84,929,000<span></span>
</td>
<td class="nump">70,370,000<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingIncomeLoss', window );">Operating loss</a></td>
<td class="num">(60,217,000)<span></span>
</td>
<td class="num">(34,708,000)<span></span>
</td>
<td class="num">(103,676,000)<span></span>
</td>
<td class="num">(79,768,000)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NonoperatingIncomeExpenseAbstract', window );"><strong>Other income (loss)</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InterestIncomeExpenseNonoperatingNet', window );">Interest income, net</a></td>
<td class="nump">2,293,000<span></span>
</td>
<td class="nump">3,734,000<span></span>
</td>
<td class="nump">4,622,000<span></span>
</td>
<td class="nump">11,485,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GainLossOnDerivativeInstrumentsNetPretax', window );">Gain (loss) on revaluation of derivative liabilities</a></td>
<td class="nump">115,248,000<span></span>
</td>
<td class="num">(35,880,000)<span></span>
</td>
<td class="num">(1,626,000)<span></span>
</td>
<td class="nump">77,488,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AssetImpairmentCharges', window );">Impairment loss on long-lived assets</a></td>
<td class="nump">0<span></span>
</td>
<td class="num">(40,000,000)<span></span>
</td>
<td class="num">(1,741,000)<span></span>
</td>
<td class="num">(40,000,000)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeLossFromEquityMethodInvestments', window );">Share of loss from equity accounted investments</a></td>
<td class="num">(1,115,000)<span></span>
</td>
<td class="num">(794,000)<span></span>
</td>
<td class="num">(2,758,000)<span></span>
</td>
<td class="num">(1,966,000)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherNonoperatingIncomeExpense', window );">Other, net</a></td>
<td class="nump">1,127,000<span></span>
</td>
<td class="num">(9,000)<span></span>
</td>
<td class="nump">911,000<span></span>
</td>
<td class="nump">785,000<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NonoperatingIncomeExpense', window );">Total other income (loss)</a></td>
<td class="nump">117,553,000<span></span>
</td>
<td class="num">(72,949,000)<span></span>
</td>
<td class="num">(592,000)<span></span>
</td>
<td class="nump">47,792,000<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest', window );">Income (loss) from continuing operations</a></td>
<td class="nump">57,336,000<span></span>
</td>
<td class="num">(107,657,000)<span></span>
</td>
<td class="num">(104,268,000)<span></span>
</td>
<td class="num">(31,976,000)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTax', window );">Loss from discontinued operations</a></td>
<td class="num">(561,000)<span></span>
</td>
<td class="num">(46,000)<span></span>
</td>
<td class="num">(582,000)<span></span>
</td>
<td class="num">(46,000)<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProfitLoss', window );">Net income (loss)</a></td>
<td class="nump">56,775,000<span></span>
</td>
<td class="num">(107,703,000)<span></span>
</td>
<td class="num">(104,850,000)<span></span>
</td>
<td class="num">(32,022,000)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetIncomeLossAttributableToNoncontrollingInterest', window );">Net loss attributable to non-controlling interest</a></td>
<td class="num">(279,000)<span></span>
</td>
<td class="num">(726,000)<span></span>
</td>
<td class="num">(592,000)<span></span>
</td>
<td class="num">(1,085,000)<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetIncomeLoss', window );">Net income (loss) attributable to Cronos Group</a></td>
<td class="nump">57,054,000<span></span>
</td>
<td class="num">(106,977,000)<span></span>
</td>
<td class="num">(104,258,000)<span></span>
</td>
<td class="num">(30,937,000)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract', window );"><strong>Statement of Comprehensive Income [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProfitLoss', window );">Net income (loss)</a></td>
<td class="nump">56,775,000<span></span>
</td>
<td class="num">(107,703,000)<span></span>
</td>
<td class="num">(104,850,000)<span></span>
</td>
<td class="num">(32,022,000)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract', window );"><strong>Other comprehensive income (loss)</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax', window );">Foreign exchange gain (loss) on translation</a></td>
<td class="nump">13,470,000<span></span>
</td>
<td class="nump">51,871,000<span></span>
</td>
<td class="nump">29,754,000<span></span>
</td>
<td class="num">(61,821,000)<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossNetOfTax', window );">Total other comprehensive income (loss)</a></td>
<td class="nump">13,470,000<span></span>
</td>
<td class="nump">51,871,000<span></span>
</td>
<td class="nump">29,754,000<span></span>
</td>
<td class="num">(61,821,000)<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest', window );">Comprehensive income (loss)</a></td>
<td class="nump">70,245,000<span></span>
</td>
<td class="num">(55,832,000)<span></span>
</td>
<td class="num">(75,096,000)<span></span>
</td>
<td class="num">(93,843,000)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest', window );">Less: comprehensive income (loss) attributable to non-controlling interests</a></td>
<td class="num">(394,000)<span></span>
</td>
<td class="num">(762,000)<span></span>
</td>
<td class="nump">432,000<span></span>
</td>
<td class="num">(1,098,000)<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ComprehensiveIncomeNetOfTax', window );">Cronos Group</a></td>
<td class="nump">$ 70,639,000<span></span>
</td>
<td class="num">$ (55,070,000)<span></span>
</td>
<td class="num">$ (75,528,000)<span></span>
</td>
<td class="num">$ (92,745,000)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EarningsPerShareBasicAndDilutedAbstract', window );"><strong>Net income (loss) per share</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeLossFromContinuingOperationsPerBasicShare', window );">Basic - continuing operations (in dollars per share)</a></td>
<td class="nump">$ 0.15<span></span>
</td>
<td class="num">$ (0.31)<span></span>
</td>
<td class="num">$ (0.28)<span></span>
</td>
<td class="num">$ (0.09)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeLossFromContinuingOperationsPerDilutedShare', window );">Diluted - continuing operations (in dollars per share)</a></td>
<td class="nump">$ 0.15<span></span>
</td>
<td class="num">$ (0.31)<span></span>
</td>
<td class="num">$ (0.28)<span></span>
</td>
<td class="num">$ (0.09)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EarningsPerShareBasicAndDilutedOtherDisclosuresAbstract', window );"><strong>Weighted average number of outstanding shares</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic', window );">Basic (in shares)</a></td>
<td class="nump">371,721,382<span></span>
</td>
<td class="nump">349,075,408<span></span>
</td>
<td class="nump">367,391,118<span></span>
</td>
<td class="nump">348,946,439<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding', window );">Diluted (in shares)</a></td>
<td class="nump">375,349,856<span></span>
</td>
<td class="nump">349,075,408<span></span>
</td>
<td class="nump">367,391,118<span></span>
</td>
<td class="nump">348,946,439<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cron_OtherCostOfGoodsAndServicesSold">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Other Cost Of Goods And Services Sold</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cron_OtherCostOfGoodsAndServicesSold</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cron_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AllocatedShareBasedCompensationExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of expense for award under share-based payment arrangement. Excludes amount capitalized.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5047-113901<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 14.F)<br> -URI http://asc.fasb.org/extlink&amp;oid=122041274&amp;loc=d3e301413-122809<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (h)(1)(i)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AllocatedShareBasedCompensationExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AssetImpairmentCharges">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of write-down of assets recognized in the income statement. Includes, but is not limited to, losses from tangible assets, intangible assets and goodwill.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3602-108585<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 45<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=123351718&amp;loc=d3e2420-110228<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AssetImpairmentCharges</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ComprehensiveIncomeNetOfTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount after tax of increase (decrease) in equity from transactions and other events and circumstances from net income and other comprehensive income, attributable to parent entity. Excludes changes in equity resulting from investments by owners and distributions to owners.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(22))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(24))<br> -URI http://asc.fasb.org/extlink&amp;oid=123367319&amp;loc=SL114868664-224227<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 5<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=d3e557-108580<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(26))<br> -URI http://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=SL7669625-108580<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=SL7669619-108580<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ComprehensiveIncomeNetOfTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount after tax of increase (decrease) in equity from transactions and other events and circumstances from net income (loss) and other comprehensive income (loss), attributable to noncontrolling interests. Excludes changes in equity resulting from investments by owners and distributions to owners.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=SL7669625-108580<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(21))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(25))<br> -URI http://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 55<br> -Paragraph 4K<br> -URI http://asc.fasb.org/extlink&amp;oid=120409616&amp;loc=SL4591552-111686<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=SL7669619-108580<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 21<br> -URI http://asc.fasb.org/extlink&amp;oid=123454820&amp;loc=SL4613674-111683<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(23))<br> -URI http://asc.fasb.org/extlink&amp;oid=123367319&amp;loc=SL114868664-224227<br><br>Reference 8: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 20<br> -URI http://asc.fasb.org/extlink&amp;oid=123454820&amp;loc=SL4569643-111683<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount after tax of increase (decrease) in equity from transactions and other events and circumstances from net income and other comprehensive income. Excludes changes in equity resulting from investments by owners and distributions to owners.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 55<br> -Paragraph 4K<br> -URI http://asc.fasb.org/extlink&amp;oid=120409616&amp;loc=SL4591552-111686<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=SL7669619-108580<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(20))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 19<br> -URI http://asc.fasb.org/extlink&amp;oid=123454820&amp;loc=SL4569616-111683<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=SL7669625-108580<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(22))<br> -URI http://asc.fasb.org/extlink&amp;oid=123367319&amp;loc=SL114868664-224227<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(24))<br> -URI http://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DepreciationAndAmortization">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The current period expense charged against earnings on long-lived, physical assets not used in production, and which are not intended for resale, to allocate or recognize the cost of such assets over their useful lives; or to record the reduction in book value of an intangible asset over the benefit period of such asset; or to reflect consumption during the period of an asset that is not used in production.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=6391035&amp;loc=d3e2868-110229<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DepreciationAndAmortization</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareBasicAndDilutedAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerShareBasicAndDilutedAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareBasicAndDilutedOtherDisclosuresAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerShareBasicAndDilutedOtherDisclosuresAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ExciseAndSalesTaxes">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of excise and sales taxes included in sales and revenues, which are then deducted as a cost of sales. Includes excise taxes, which are applied to specific types of transactions or items (such as gasoline or alcohol); and sales, use and value added taxes, which are applied to a broad class of revenue-producing transactions involving a wide range of goods and services.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(1))<br> -URI http://asc.fasb.org/extlink&amp;oid=123367319&amp;loc=SL114868664-224227<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ExciseAndSalesTaxes</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GainLossOnDerivativeInstrumentsNetPretax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Aggregate net gain (loss) on all derivative instruments recognized in earnings during the period, before tax effects.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4A<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=125515794&amp;loc=SL5618551-113959<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GainLossOnDerivativeInstrumentsNetPretax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GeneralAndAdministrativeExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The aggregate total of expenses of managing and administering the affairs of an entity, including affiliates of the reporting entity, which are not directly or indirectly associated with the manufacture, sale or creation of a product or product line.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03.4)<br> -URI http://asc.fasb.org/extlink&amp;oid=123367319&amp;loc=SL114868664-224227<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GeneralAndAdministrativeExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GrossProfit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Aggregate revenue less cost of goods and services sold or operating expenses directly attributable to the revenue generation activity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 31<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8924-108599<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8906-108599<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8736-108599<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8933-108599<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 9: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 18: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03.1,2)<br> -URI http://asc.fasb.org/extlink&amp;oid=123367319&amp;loc=SL114868664-224227<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8933-108599<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GrossProfit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount after tax of income (loss) from continuing operations including portion attributable to the noncontrolling interest.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8933-108599<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8933-108599<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8736-108599<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 13: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 19<br> -URI http://asc.fasb.org/extlink&amp;oid=123454820&amp;loc=SL4569616-111683<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123482062&amp;loc=SL123482106-238011<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 17: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 18: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 31<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8924-108599<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8906-108599<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22499-107794<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeLossFromContinuingOperationsPerBasicShare">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of net income (loss) from continuing operations per each share of common stock or unit outstanding during the reporting period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22583-107794<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(19))<br> -URI http://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123482062&amp;loc=SL123482106-238011<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(11))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=125511455&amp;loc=d3e1252-109256<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 7<br> -URI http://asc.fasb.org/extlink&amp;oid=125511455&amp;loc=d3e1337-109256<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22499-107794<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=125511455&amp;loc=SL5780133-109256<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(25))<br> -URI http://asc.fasb.org/extlink&amp;oid=123367319&amp;loc=SL114868664-224227<br><br>Reference 12: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(20))<br> -URI http://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(27))<br> -URI http://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br><br>Reference 14: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-03(13))<br> -URI http://asc.fasb.org/extlink&amp;oid=123367319&amp;loc=SL114868656-224227<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22595-107794<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeLossFromContinuingOperationsPerBasicShare</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeLossFromContinuingOperationsPerDilutedShare">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of net income (loss) derived from continuing operations during the period available to each share of common stock or common unit outstanding during the reporting period and to each share or unit that would have been outstanding assuming the issuance of common shares or units for all dilutive potential common shares or units outstanding during the reporting period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124432515&amp;loc=d3e3550-109257<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 7<br> -URI http://asc.fasb.org/extlink&amp;oid=125511455&amp;loc=d3e1337-109256<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123482062&amp;loc=SL123482106-238011<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(23))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(27))<br> -URI http://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22499-107794<br><br>Reference 8: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(11))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(25))<br> -URI http://asc.fasb.org/extlink&amp;oid=123367319&amp;loc=SL114868664-224227<br><br>Reference 10: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-03(13))<br> -URI http://asc.fasb.org/extlink&amp;oid=123367319&amp;loc=SL114868656-224227<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=125511455&amp;loc=SL5780133-109256<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=125511455&amp;loc=d3e1252-109256<br><br>Reference 13: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(19))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22583-107794<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22595-107794<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeLossFromContinuingOperationsPerDilutedShare</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount after tax of income (loss) from a discontinued operation including the portion attributable to the noncontrolling interest. Includes, but is not limited to, the income (loss) from operations during the phase-out period, gain (loss) on disposal, gain (loss) for reversal of write-down (write-down) to fair value, less cost to sell, and adjustments to a prior period gain (loss) on disposal.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(12))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 7<br> -URI http://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=SL51721683-107760<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 45<br> -Paragraph 3B<br> -URI http://asc.fasb.org/extlink&amp;oid=109222160&amp;loc=SL51721525-107759<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 5C<br> -Subparagraph (b)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=SL51721675-107760<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 45<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=109222160&amp;loc=d3e957-107759<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=d3e1361-107760<br><br>Reference 7: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 45<br> -Paragraph 3A<br> -URI http://asc.fasb.org/extlink&amp;oid=109222160&amp;loc=SL51721523-107759<br><br>Reference 8: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 45<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=109222160&amp;loc=d3e1012-107759<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 270<br> -Section 45<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=109227538&amp;loc=d3e44648-109337<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeLossFromEquityMethodInvestments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of income (loss) for proportionate share of equity method investee's income (loss).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(12))<br> -URI http://asc.fasb.org/extlink&amp;oid=123367319&amp;loc=SL114868664-224227<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(10))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3602-108585<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(13)(f))<br> -URI http://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (g)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8736-108599<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=109237563&amp;loc=d3e33749-111570<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeLossFromEquityMethodInvestments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeStatementAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeStatementAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InterestIncomeExpenseNonoperatingNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The net amount of nonoperating interest income (expense).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InterestIncomeExpenseNonoperatingNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InventoryWriteDown">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of loss from reductions in inventory due to subsequent measurement adjustments, including, but not limited to, physical deterioration, obsolescence, or changes in price levels.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 330<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=116847112&amp;loc=d3e4542-108314<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InventoryWriteDown</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetIncomeLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(22))<br> -URI http://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8933-108599<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22595-107794<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(18))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123482062&amp;loc=SL123482106-238011<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 50<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=124431353&amp;loc=SL124452729-227067<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 8: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(20))<br> -URI http://asc.fasb.org/extlink&amp;oid=123367319&amp;loc=SL114868664-224227<br><br>Reference 9: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3602-108585<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22499-107794<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22663-107794<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 17: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22583-107794<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=125511455&amp;loc=SL5780133-109256<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22658-107794<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=SL7669619-108580<br><br>Reference 25: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 31<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8924-108599<br><br>Reference 26: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 27: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 28: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 7<br> -URI http://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=SL51721683-107760<br><br>Reference 29: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=SL7669625-108580<br><br>Reference 30: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8736-108599<br><br>Reference 31: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 32: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 33: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 34: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8906-108599<br><br>Reference 35: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8933-108599<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetIncomeLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetIncomeLossAttributableToNoncontrollingInterest">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of Net Income (Loss) attributable to noncontrolling interest.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=SL7669625-108580<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1A<br> -Subparagraph (a)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=109239629&amp;loc=SL4573702-111684<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22658-107794<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=SL7669619-108580<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 55<br> -Paragraph 4J<br> -URI http://asc.fasb.org/extlink&amp;oid=120409616&amp;loc=SL4591551-111686<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22663-107794<br><br>Reference 7: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 50<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=124431353&amp;loc=SL124452729-227067<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetIncomeLossAttributableToNoncontrollingInterest</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NonoperatingIncomeExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The aggregate amount of income or expense from ancillary business-related activities (that is to say, excluding major activities considered part of the normal operations of the business).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03.7)<br> -URI http://asc.fasb.org/extlink&amp;oid=123367319&amp;loc=SL114868664-224227<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NonoperatingIncomeExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NonoperatingIncomeExpenseAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NonoperatingIncomeExpenseAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingExpenses">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Generally recurring costs associated with normal operations except for the portion of these expenses which can be clearly related to production and included in cost of sales or services. Includes selling, general and administrative expense.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingExpenses</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingExpensesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingExpensesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingIncomeLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The net result for the period of deducting operating expenses from operating revenues.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 31<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8924-108599<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8906-108599<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8933-108599<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8933-108599<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8736-108599<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingIncomeLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount after tax and reclassification adjustments of gain (loss) on foreign currency translation adjustments, foreign currency transactions designated and effective as economic hedges of a net investment in a foreign entity and intra-entity foreign currency transactions that are of a long-term-investment nature.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 10A<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=SL7669646-108580<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeLossNetOfTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount after tax and reclassification adjustments of other comprehensive income (loss).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=SL7669619-108580<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=124431353&amp;loc=SL124442407-227067<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=123467817&amp;loc=d3e21463-112644<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 30<br> -Section 45<br> -Paragraph 17<br> -URI http://asc.fasb.org/extlink&amp;oid=118261656&amp;loc=d3e32136-110900<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(21))<br> -URI http://asc.fasb.org/extlink&amp;oid=123367319&amp;loc=SL114868664-224227<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 55<br> -Paragraph 15<br> -URI http://asc.fasb.org/extlink&amp;oid=124507222&amp;loc=d3e1436-108581<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 30<br> -Section 45<br> -Paragraph 20<br> -URI http://asc.fasb.org/extlink&amp;oid=118261656&amp;loc=d3e32211-110900<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 30<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6450520&amp;loc=d3e32583-110901<br><br>Reference 9: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 50<br> -Paragraph 5<br> -URI http://asc.fasb.org/extlink&amp;oid=124431353&amp;loc=SL124442411-227067<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=SL7669625-108580<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(23))<br> -URI http://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(19))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherComprehensiveIncomeLossNetOfTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherNonoperatingIncomeExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of income (expense) related to nonoperating activities, classified as other.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03.9)<br> -URI http://asc.fasb.org/extlink&amp;oid=123367319&amp;loc=SL114868664-224227<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherNonoperatingIncomeExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProfitLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The consolidated profit or loss for the period, net of income taxes, including the portion attributable to the noncontrolling interest.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=SL7669619-108580<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1A<br> -Subparagraph (a)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=109239629&amp;loc=SL4573702-111684<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22663-107794<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8736-108599<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8933-108599<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123482062&amp;loc=SL123482106-238011<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 12: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 50<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=124431353&amp;loc=SL124452729-227067<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8906-108599<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3000-108585<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 19<br> -URI http://asc.fasb.org/extlink&amp;oid=123454820&amp;loc=SL4569616-111683<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8933-108599<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 7<br> -URI http://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=SL51721683-107760<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22499-107794<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 235<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-05(b)(2))<br> -URI http://asc.fasb.org/extlink&amp;oid=120399901&amp;loc=d3e537907-122884<br><br>Reference 23: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 31<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8924-108599<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=SL7669625-108580<br><br>Reference 25: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 26: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 27: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 28: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 29: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 30: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1A<br> -Subparagraph (c)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=109239629&amp;loc=SL4573702-111684<br><br>Reference 31: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 55<br> -Paragraph 4J<br> -URI http://asc.fasb.org/extlink&amp;oid=120409616&amp;loc=SL4591551-111686<br><br>Reference 32: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 55<br> -Paragraph 4K<br> -URI http://asc.fasb.org/extlink&amp;oid=120409616&amp;loc=SL4591552-111686<br><br>Reference 33: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22658-107794<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProfitLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ResearchAndDevelopmentExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The aggregate costs incurred (1) in a planned search or critical investigation aimed at discovery of new knowledge with the hope that such knowledge will be useful in developing a new product or service, a new process or technique, or in bringing about a significant improvement to an existing product or process; or (2) to translate research findings or other knowledge into a plan or design for a new product or process or for a significant improvement to an existing product or process whether intended for sale or the entity's use, during the reporting period charged to research and development projects, including the costs of developing computer software up to the point in time of achieving technological feasibility, and costs allocated in accounting for a business combination to in-process projects deemed to have no alternative future use.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 912<br> -SubTopic 730<br> -Section 25<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6472174&amp;loc=d3e58812-109433<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 985<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6501960&amp;loc=d3e128462-111756<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 730<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6420194&amp;loc=d3e21568-108373<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ResearchAndDevelopmentExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, excluding tax collected from customer, of revenue from satisfaction of performance obligation by transferring promised good or service to customer. Tax collected from customer is tax assessed by governmental authority that is both imposed on and concurrent with specific revenue-producing transaction, including, but not limited to, sales, use, value added and excise.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8906-108599<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 40<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e9031-108599<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 41<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e9038-108599<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8933-108599<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8933-108599<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123351226&amp;loc=SL49130543-203045<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8736-108599<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8736-108599<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 42<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e9054-108599<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 5<br> -URI http://asc.fasb.org/extlink&amp;oid=123351226&amp;loc=SL49130545-203045<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 924<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 11.L)<br> -URI http://asc.fasb.org/extlink&amp;oid=6472922&amp;loc=d3e499488-122856<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RevenueFromContractWithCustomerIncludingAssessedTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, including tax collected from customer, of revenue from satisfaction of performance obligation by transferring promised good or service to customer. Tax collected from customer is tax assessed by governmental authority that is both imposed on and concurrent with specific revenue-producing transaction, including, but not limited to, sales, use, value-added and excise.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 41<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e9038-108599<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 5<br> -URI http://asc.fasb.org/extlink&amp;oid=123351226&amp;loc=SL49130545-203045<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8933-108599<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8933-108599<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8906-108599<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8736-108599<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8736-108599<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123351226&amp;loc=SL49130543-203045<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 42<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e9054-108599<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 40<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e9031-108599<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 924<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 11.L)<br> -URI http://asc.fasb.org/extlink&amp;oid=6472922&amp;loc=d3e499488-122856<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RevenueFromContractWithCustomerIncludingAssessedTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SellingAndMarketingExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The aggregate total amount of expenses directly related to the marketing or selling of products or services.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SellingAndMarketingExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The average number of shares or units issued and outstanding that are used in calculating diluted EPS or earnings per unit (EPU), determined based on the timing of issuance of shares or units in the period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124432515&amp;loc=d3e3550-109257<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 16<br> -URI http://asc.fasb.org/extlink&amp;oid=125511455&amp;loc=d3e1505-109256<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of [basic] shares or units, after adjustment for contingently issuable shares or units and other shares or units not deemed outstanding, determined by relating the portion of time within a reporting period that common shares or units have been outstanding to the total time in that period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124432515&amp;loc=d3e3550-109257<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=125511455&amp;loc=d3e1448-109256<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_WeightedAverageNumberOfSharesOutstandingBasic</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>19
<FILENAME>R5.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.2</span><table class="report" border="0" cellspacing="2" id="idm140382008860696">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Condensed Consolidated Statements of Changes in Equity - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th"><div>Total</div></th>
<th class="th"><div>Share capital</div></th>
<th class="th"><div>Additional paid-in capital</div></th>
<th class="th"><div>Retained earnings</div></th>
<th class="th"><div>Accumulated other comprehensive income (loss)</div></th>
<th class="th"><div>Non-controlling interests</div></th>
</tr>
<tr class="rc">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommonStockSharesOutstanding', window );">Beginning balance (in shares) at Dec. 31, 2019</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">348,817,472<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest', window );">Beginning balance at Dec. 31, 2019</a></td>
<td class="nump">$ 1,749,030<span></span>
</td>
<td class="nump">$ 561,165<span></span>
</td>
<td class="nump">$ 23,234<span></span>
</td>
<td class="nump">$ 1,137,646<span></span>
</td>
<td class="nump">$ 27,838<span></span>
</td>
<td class="num">$ (853)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward', window );"><strong>Increase (Decrease) in Stockholders' Equity [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsRequisiteServicePeriodRecognition', window );">Vesting of options</a></td>
<td class="nump">$ 3,500<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">3,500<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised', window );">Options exercised (in shares)</a></td>
<td class="nump">1,807,909<span></span>
</td>
<td class="nump">1,068,930<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised', window );">Options exercised</a></td>
<td class="nump">$ 1<span></span>
</td>
<td class="nump">$ 1,329<span></span>
</td>
<td class="num">(1,328)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationRestrictedStockUnitsRequisiteServicePeriodRecognition', window );">Vesting of restricted share units</a></td>
<td class="nump">1,482<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,482<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationOtherLongtermIncentivePlansRequisiteServicePeriodRecognition', window );">Vesting of common shares issued in connection with the use of certain publicity rights in brand development</a></td>
<td class="nump">2,158<span></span>
</td>
<td class="nump">2,000<span></span>
</td>
<td class="nump">158<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cron_StockIssuedDuringPeriodValueTopupRightsExercised', window );">Top-up rights exercised</a></td>
<td class="nump">717<span></span>
</td>
<td class="nump">$ 717<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProfitLoss', window );">Net income (loss)</a></td>
<td class="num">(32,022)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(30,937)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(1,085)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax', window );">Foreign exchange gain (loss) on translation</a></td>
<td class="num">(61,821)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(61,808)<span></span>
</td>
<td class="num">(13)<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommonStockSharesOutstanding', window );">Ending balance (in shares) at Jun. 30, 2020</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">349,886,402<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest', window );">Ending balance at Jun. 30, 2020</a></td>
<td class="nump">1,663,045<span></span>
</td>
<td class="nump">$ 565,211<span></span>
</td>
<td class="nump">27,046<span></span>
</td>
<td class="nump">1,106,709<span></span>
</td>
<td class="num">(33,970)<span></span>
</td>
<td class="num">(1,951)<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommonStockSharesOutstanding', window );">Beginning balance (in shares) at Mar. 31, 2020</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">348,817,472<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest', window );">Beginning balance at Mar. 31, 2020</a></td>
<td class="nump">1,715,268<span></span>
</td>
<td class="nump">$ 563,165<span></span>
</td>
<td class="nump">25,483<span></span>
</td>
<td class="nump">1,213,686<span></span>
</td>
<td class="num">(85,877)<span></span>
</td>
<td class="num">(1,189)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward', window );"><strong>Increase (Decrease) in Stockholders' Equity [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsRequisiteServicePeriodRecognition', window );">Vesting of options</a></td>
<td class="nump">1,770<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,770<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised', window );">Options exercised (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,068,930<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised', window );">Options exercised</a></td>
<td class="nump">1<span></span>
</td>
<td class="nump">$ 1,329<span></span>
</td>
<td class="num">(1,328)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationRestrictedStockUnitsRequisiteServicePeriodRecognition', window );">Vesting of restricted share units</a></td>
<td class="nump">776<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">776<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationOtherLongtermIncentivePlansRequisiteServicePeriodRecognition', window );">Vesting of common shares issued in connection with the use of certain publicity rights in brand development</a></td>
<td class="nump">345<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">345<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cron_StockIssuedDuringPeriodValueTopupRightsExercised', window );">Top-up rights exercised</a></td>
<td class="nump">717<span></span>
</td>
<td class="nump">$ 717<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProfitLoss', window );">Net income (loss)</a></td>
<td class="num">(107,703)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(106,977)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(726)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax', window );">Foreign exchange gain (loss) on translation</a></td>
<td class="nump">51,871<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">51,907<span></span>
</td>
<td class="num">(36)<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommonStockSharesOutstanding', window );">Ending balance (in shares) at Jun. 30, 2020</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">349,886,402<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest', window );">Ending balance at Jun. 30, 2020</a></td>
<td class="nump">1,663,045<span></span>
</td>
<td class="nump">$ 565,211<span></span>
</td>
<td class="nump">27,046<span></span>
</td>
<td class="nump">1,106,709<span></span>
</td>
<td class="num">(33,970)<span></span>
</td>
<td class="num">(1,951)<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommonStockSharesOutstanding', window );">Beginning balance (in shares) at Dec. 31, 2020</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">360,253,332<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest', window );">Beginning balance at Dec. 31, 2020</a></td>
<td class="nump">1,708,168<span></span>
</td>
<td class="nump">$ 569,260<span></span>
</td>
<td class="nump">34,596<span></span>
</td>
<td class="nump">1,064,509<span></span>
</td>
<td class="nump">42,999<span></span>
</td>
<td class="num">(3,196)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward', window );"><strong>Increase (Decrease) in Stockholders' Equity [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cron_SharebasedCompensationArrangementBySharebasedPaymentAwardWarrantsExercisesInPeriod', window );">Warrants exercised (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">7,842,859<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cron_StockIssuedDuringPeriodValueWarrantsExercised', window );">Warrants exercised</a></td>
<td class="nump">2<span></span>
</td>
<td class="nump">$ 1,165<span></span>
</td>
<td class="num">(1,163)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsRequisiteServicePeriodRecognition', window );">Vesting of options</a></td>
<td class="nump">$ 3,928<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">3,928<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised', window );">Options exercised (in shares)</a></td>
<td class="nump">5,349,818<span></span>
</td>
<td class="nump">3,651,002<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised', window );">Options exercised</a></td>
<td class="nump">$ 10<span></span>
</td>
<td class="nump">$ 3,315<span></span>
</td>
<td class="num">(3,305)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesRestrictedStockAwardNetOfForfeitures', window );">Restricted share units settled (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">58,354<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures', window );">Restricted share units settled</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">$ 345<span></span>
</td>
<td class="num">(345)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation', window );">Withholding taxes paid on share-based awards</a></td>
<td class="num">(8,919)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(1,162)<span></span>
</td>
<td class="num">(7,757)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationRestrictedStockUnitsRequisiteServicePeriodRecognition', window );">Vesting of restricted share units</a></td>
<td class="nump">1,136<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,136<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationOtherLongtermIncentivePlansRequisiteServicePeriodRecognition', window );">Vesting of common shares issued in connection with the use of certain publicity rights in brand development</a></td>
<td class="nump">683<span></span>
</td>
<td class="nump">2,000<span></span>
</td>
<td class="num">(1,317)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cron_StockholdersEquityOutOfPeriodAdjustment', window );">Top-up rights out-of-period adjustment</a></td>
<td class="nump">0<span></span>
</td>
<td class="num">$ (3,227)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">3,227<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProfitLoss', window );">Net income (loss)</a></td>
<td class="num">(104,850)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(104,258)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(592)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax', window );">Foreign exchange gain (loss) on translation</a></td>
<td class="nump">29,754<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">28,730<span></span>
</td>
<td class="nump">1,024<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommonStockSharesOutstanding', window );">Ending balance (in shares) at Jun. 30, 2021</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">371,805,547<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest', window );">Ending balance at Jun. 30, 2021</a></td>
<td class="nump">1,629,912<span></span>
</td>
<td class="nump">$ 572,858<span></span>
</td>
<td class="nump">32,368<span></span>
</td>
<td class="nump">955,721<span></span>
</td>
<td class="nump">71,729<span></span>
</td>
<td class="num">(2,764)<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommonStockSharesOutstanding', window );">Beginning balance (in shares) at Mar. 31, 2021</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">371,656,590<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest', window );">Beginning balance at Mar. 31, 2021</a></td>
<td class="nump">1,568,279<span></span>
</td>
<td class="nump">$ 584,912<span></span>
</td>
<td class="nump">32,090<span></span>
</td>
<td class="nump">895,503<span></span>
</td>
<td class="nump">58,144<span></span>
</td>
<td class="num">(2,370)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward', window );"><strong>Increase (Decrease) in Stockholders' Equity [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cron_SharebasedCompensationArrangementBySharebasedPaymentAwardWarrantsExercisesInPeriod', window );">Warrants exercised (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">10,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cron_StockIssuedDuringPeriodValueWarrantsExercised', window );">Warrants exercised</a></td>
<td class="nump">2<span></span>
</td>
<td class="nump">$ 4<span></span>
</td>
<td class="num">(2)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsRequisiteServicePeriodRecognition', window );">Vesting of options</a></td>
<td class="nump">1,864<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,864<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised', window );">Options exercised (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">80,603<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised', window );">Options exercised</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">$ 102<span></span>
</td>
<td class="num">(102)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesRestrictedStockAwardNetOfForfeitures', window );">Restricted share units settled (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">58,354<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures', window );">Restricted share units settled</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">$ 345<span></span>
</td>
<td class="num">(345)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation', window );">Withholding taxes paid on share-based awards</a></td>
<td class="num">(246)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(183)<span></span>
</td>
<td class="num">(63)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationRestrictedStockUnitsRequisiteServicePeriodRecognition', window );">Vesting of restricted share units</a></td>
<td class="nump">701<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">701<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationOtherLongtermIncentivePlansRequisiteServicePeriodRecognition', window );">Vesting of common shares issued in connection with the use of certain publicity rights in brand development</a></td>
<td class="nump">345<span></span>
</td>
<td class="nump">2,000<span></span>
</td>
<td class="num">(1,655)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cron_StockholdersEquityOutOfPeriodAdjustment', window );">Top-up rights out-of-period adjustment</a></td>
<td class="num">(11,278)<span></span>
</td>
<td class="num">$ (14,505)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">3,227<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProfitLoss', window );">Net income (loss)</a></td>
<td class="nump">56,775<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">57,054<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(279)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax', window );">Foreign exchange gain (loss) on translation</a></td>
<td class="nump">13,470<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">13,585<span></span>
</td>
<td class="num">(115)<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommonStockSharesOutstanding', window );">Ending balance (in shares) at Jun. 30, 2021</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">371,805,547<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest', window );">Ending balance at Jun. 30, 2021</a></td>
<td class="nump">$ 1,629,912<span></span>
</td>
<td class="nump">$ 572,858<span></span>
</td>
<td class="nump">$ 32,368<span></span>
</td>
<td class="nump">$ 955,721<span></span>
</td>
<td class="nump">$ 71,729<span></span>
</td>
<td class="num">$ (2,764)<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cron_SharebasedCompensationArrangementBySharebasedPaymentAwardWarrantsExercisesInPeriod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Share-based Compensation Arrangement By Share-based Payment Award, Warrants, Exercises In Period</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cron_SharebasedCompensationArrangementBySharebasedPaymentAwardWarrantsExercisesInPeriod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cron_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cron_StockIssuedDuringPeriodValueTopupRightsExercised">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Stock Issued During Period, Value, Top-up Rights Exercised</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cron_StockIssuedDuringPeriodValueTopupRightsExercised</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cron_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cron_StockIssuedDuringPeriodValueWarrantsExercised">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Stock Issued During Period, Value, Warrants Exercised</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cron_StockIssuedDuringPeriodValueWarrantsExercised</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cron_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cron_StockholdersEquityOutOfPeriodAdjustment">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Stockholders' Equity, Out-Of-Period Adjustment</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cron_StockholdersEquityOutOfPeriodAdjustment</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cron_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of decrease to equity for grantee's tax withholding obligation for award under share-based payment arrangement.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationRestrictedStockUnitsRequisiteServicePeriodRecognition">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of increase to additional paid-in capital (APIC) for recognition of cost for restricted stock unit under share-based payment arrangement.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationRestrictedStockUnitsRequisiteServicePeriodRecognition</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsRequisiteServicePeriodRecognition">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of increase to additional paid-in capital (APIC) for recognition of cost for option under share-based payment arrangement.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsRequisiteServicePeriodRecognition</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationOtherLongtermIncentivePlansRequisiteServicePeriodRecognition">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of increase to additional paid-in capital (APIC) for recognition of cost for award under share-based payment arrangement, classified as other.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationOtherLongtermIncentivePlansRequisiteServicePeriodRecognition</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockSharesOutstanding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of shares of common stock outstanding. Common stock represent the ownership interest in a corporation.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=123467817&amp;loc=d3e21463-112644<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockSharesOutstanding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInStockholdersEquityRollForward</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount after tax and reclassification adjustments of gain (loss) on foreign currency translation adjustments, foreign currency transactions designated and effective as economic hedges of a net investment in a foreign entity and intra-entity foreign currency transactions that are of a long-term-investment nature.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 10A<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=SL7669646-108580<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProfitLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The consolidated profit or loss for the period, net of income taxes, including the portion attributable to the noncontrolling interest.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=SL7669619-108580<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1A<br> -Subparagraph (a)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=109239629&amp;loc=SL4573702-111684<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22663-107794<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8736-108599<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8933-108599<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123482062&amp;loc=SL123482106-238011<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 12: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 50<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=124431353&amp;loc=SL124452729-227067<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8906-108599<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3000-108585<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 19<br> -URI http://asc.fasb.org/extlink&amp;oid=123454820&amp;loc=SL4569616-111683<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8933-108599<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 7<br> -URI http://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=SL51721683-107760<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22499-107794<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 235<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-05(b)(2))<br> -URI http://asc.fasb.org/extlink&amp;oid=120399901&amp;loc=d3e537907-122884<br><br>Reference 23: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 31<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8924-108599<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=SL7669625-108580<br><br>Reference 25: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 26: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 27: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 28: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 29: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 30: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1A<br> -Subparagraph (c)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=109239629&amp;loc=SL4573702-111684<br><br>Reference 31: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 55<br> -Paragraph 4J<br> -URI http://asc.fasb.org/extlink&amp;oid=120409616&amp;loc=SL4591551-111686<br><br>Reference 32: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 55<br> -Paragraph 4K<br> -URI http://asc.fasb.org/extlink&amp;oid=120409616&amp;loc=SL4591552-111686<br><br>Reference 33: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22658-107794<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProfitLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodSharesRestrictedStockAwardNetOfForfeitures">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of shares issued during the period related to Restricted Stock Awards, net of any shares forfeited.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=123467817&amp;loc=d3e21463-112644<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI http://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodSharesRestrictedStockAwardNetOfForfeitures</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of share options (or share units) exercised during the current period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iv)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI http://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=123467817&amp;loc=d3e21463-112644<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Value of stock related to Restricted Stock Awards issued during the period, net of the stock value of such awards forfeited.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI http://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=123467817&amp;loc=d3e21463-112644<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Value of stock issued as a result of the exercise of stock options.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=123467817&amp;loc=d3e21463-112644<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI http://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.29-31)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of stockholders' equity (deficit), net of receivables from officers, directors, owners, and affiliates of the entity, attributable to both the parent and noncontrolling interests. Amount excludes temporary equity. Alternate caption for the concept is permanent equity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 45<br> -Paragraph 24<br> -URI http://asc.fasb.org/extlink&amp;oid=124436220&amp;loc=d3e21930-107793<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI http://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 45<br> -Paragraph 23<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=124436220&amp;loc=d3e21914-107793<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22644-107794<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 50<br> -Paragraph 5<br> -URI http://asc.fasb.org/extlink&amp;oid=124431353&amp;loc=SL124442411-227067<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 326<br> -SubTopic 10<br> -Section 65<br> -Paragraph 4<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=122640432&amp;loc=SL121648383-210437<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 105<br> -SubTopic 10<br> -Section 65<br> -Paragraph 6<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=124434974&amp;loc=SL124442142-165695<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 105<br> -SubTopic 10<br> -Section 65<br> -Paragraph 6<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=124434974&amp;loc=SL124442142-165695<br><br>Reference 9: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 16<br> -URI http://asc.fasb.org/extlink&amp;oid=123454820&amp;loc=SL4568740-111683<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (e)(3)<br> -URI http://asc.fasb.org/extlink&amp;oid=123482062&amp;loc=SL123482106-238011<br><br>Reference 11: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 45<br> -Paragraph 5<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=124436220&amp;loc=d3e21711-107793<br><br>Reference 13: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 14: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 30<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6450520&amp;loc=d3e32583-110901<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 65<br> -Paragraph 8<br> -Subparagraph (d)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=123459177&amp;loc=SL121830611-158277<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 30<br> -Section 45<br> -Paragraph 17<br> -URI http://asc.fasb.org/extlink&amp;oid=118261656&amp;loc=d3e32136-110900<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 65<br> -Paragraph 8<br> -Subparagraph (d)(3)<br> -URI http://asc.fasb.org/extlink&amp;oid=123459177&amp;loc=SL121830611-158277<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (f)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=124501264&amp;loc=SL117420844-207641<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 65<br> -Paragraph 15<br> -Subparagraph (f)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=121322162&amp;loc=SL121327923-165333<br><br>Reference 21: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 55<br> -Paragraph 4I<br> -URI http://asc.fasb.org/extlink&amp;oid=120409616&amp;loc=SL4590271-111686<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (f)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=124501264&amp;loc=SL117420844-207641<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 30<br> -Section 45<br> -Paragraph 20<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=118261656&amp;loc=d3e32211-110900<br><br>Reference 24: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 15<br> -URI http://asc.fasb.org/extlink&amp;oid=123454820&amp;loc=SL4568447-111683<br><br>Reference 25: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 65<br> -Paragraph 15<br> -Subparagraph (f)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=121322162&amp;loc=SL121327923-165333<br><br>Reference 26: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(3)<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22499-107794<br><br>Reference 27: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 65<br> -Paragraph 15<br> -Subparagraph (e)<br> -URI http://asc.fasb.org/extlink&amp;oid=121322162&amp;loc=SL121327923-165333<br><br>Reference 28: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 848<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 2<br> -Publisher FASB<br> -Subparagraph (a)(3)(iii)(03)<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>20
<FILENAME>R6.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.2</span><table class="report" border="0" cellspacing="2" id="idm140382007689512">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Condensed Consolidated Statements of Cash Flows - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="2">3 Months Ended</th>
<th class="th" colspan="2">6 Months Ended</th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Jun. 30, 2021</div></th>
<th class="th"><div>Jun. 30, 2020</div></th>
<th class="th"><div>Jun. 30, 2021</div></th>
<th class="th"><div>Jun. 30, 2020</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract', window );"><strong>Operating activities</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProfitLoss', window );">Net income (loss)</a></td>
<td class="nump">$ 56,775<span></span>
</td>
<td class="num">$ (107,703)<span></span>
</td>
<td class="num">$ (104,850)<span></span>
</td>
<td class="num">$ (32,022)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AdjustmentsNoncashItemsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract', window );"><strong>Adjustments to reconcile net loss to cash provided by operating activities:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensation', window );">Share-based payments</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">5,064<span></span>
</td>
<td class="nump">4,982<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DepreciationDepletionAndAmortization', window );">Depreciation and amortization</a></td>
<td class="nump">3,203<span></span>
</td>
<td class="nump">1,717<span></span>
</td>
<td class="nump">5,083<span></span>
</td>
<td class="nump">2,879<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeLossFromEquityMethodInvestments', window );">Share of loss from investments in equity accounted investees</a></td>
<td class="nump">1,115<span></span>
</td>
<td class="nump">794<span></span>
</td>
<td class="nump">2,758<span></span>
</td>
<td class="nump">1,966<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GainLossOnDerivativeInstrumentsNetPretax', window );">Gain (loss) on revaluation of derivative liabilities</a></td>
<td class="num">(115,248)<span></span>
</td>
<td class="nump">35,880<span></span>
</td>
<td class="nump">1,626<span></span>
</td>
<td class="num">(77,488)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AssetImpairmentCharges', window );">Impairment loss on long-lived assets</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">40,000<span></span>
</td>
<td class="nump">1,741<span></span>
</td>
<td class="nump">40,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProvisionForDoubtfulAccounts', window );">Expected credit losses on long-term financial assets</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">1,357<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherNoncashIncomeExpense', window );">Other non-cash operating activities, net</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(1,192)<span></span>
</td>
<td class="nump">599<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract', window );"><strong>Changes in operating assets and liabilities:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInAccountsReceivable', window );">Accounts receivable, net</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(2,194)<span></span>
</td>
<td class="nump">2,895<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInOtherReceivables', window );">Other receivables</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">6,960<span></span>
</td>
<td class="num">(3,047)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets', window );">Prepaids and other current assets</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,268<span></span>
</td>
<td class="nump">1,187<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInInventories', window );">Inventory, net</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(1,010)<span></span>
</td>
<td class="num">(24,292)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InventoryWriteDown', window );">Inventory write-down</a></td>
<td class="nump">11,961<span></span>
</td>
<td class="nump">3,062<span></span>
</td>
<td class="nump">11,961<span></span>
</td>
<td class="nump">11,024<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInAccountsPayableAndOtherOperatingLiabilities', window );">Accounts payable and other liabilities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(13,412)<span></span>
</td>
<td class="num">(8,417)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInOperatingActivities', window );">Cash flows used in operating activities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(86,197)<span></span>
</td>
<td class="num">(78,377)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract', window );"><strong>Investing activities</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PaymentsToAcquireMarketableSecurities', window );">Purchase of short-term investments</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(120,180)<span></span>
</td>
<td class="num">(200,173)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProceedsFromSaleAndMaturityOfMarketableSecurities', window );">Proceeds from short-term investments</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">136,204<span></span>
</td>
<td class="nump">279,275<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PaymentsToAcquireOtherInvestments', window );">Purchase of other investments</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(110,392)<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment', window );">Purchase of property, plant and equipment</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(8,347)<span></span>
</td>
<td class="num">(13,344)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PaymentsToAcquireIntangibleAssets', window );">Purchase of intangible assets</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(843)<span></span>
</td>
<td class="num">(2,754)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProceedsFromSaleOfPropertyHeldForSale', window );">Proceeds from sale of held-for-sale assets</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2,059<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PaymentsToAcquireLoansReceivable', window );">Advances on loans receivable</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(5,064)<span></span>
</td>
<td class="num">(23,974)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProceedsFromSaleAndMaturityOfOtherInvestments', window );">Proceeds from sale of other investments</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">769<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInInvestingActivities', window );">Cash flows provided by (used in) investing activities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(106,563)<span></span>
</td>
<td class="nump">39,799<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract', window );"><strong>Financing activities</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PaymentsRelatedToTaxWithholdingForShareBasedCompensation', window );">Withholding taxes paid on share-based awards</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(8,919)<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProceedsFromPaymentsForOtherFinancingActivities', window );">Proceeds from exercise of warrants and options</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">12<span></span>
</td>
<td class="nump">1<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInFinancingActivities', window );">Cash flows provided by (used in) financing activities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(8,907)<span></span>
</td>
<td class="nump">1<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents', window );">Effect of foreign currency translation on cash and cash equivalents</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">18,825<span></span>
</td>
<td class="num">(51,416)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect', window );">Net change in cash and cash equivalents</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(182,842)<span></span>
</td>
<td class="num">(89,993)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents', window );">Cash and cash equivalents, beginning of period</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,078,023<span></span>
</td>
<td class="nump">1,199,693<span></span>
</td>
<td class="nump">$ 1,199,693<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents', window );">Cash and cash equivalents, end of period</a></td>
<td class="nump">$ 895,181<span></span>
</td>
<td class="nump">$ 1,109,700<span></span>
</td>
<td class="nump">895,181<span></span>
</td>
<td class="nump">1,109,700<span></span>
</td>
<td class="nump">$ 1,078,023<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SupplementalCashFlowInformationAbstract', window );"><strong>Supplemental cash flow information</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InterestPaidNet', window );">Interest paid</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">90<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cron_InterestReceivedNet', window );">Interest received</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2,961<span></span>
</td>
<td class="nump">11,575<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeTaxesPaidNet', window );">Income taxes paid</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 858<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cron_InterestReceivedNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Interest Received, Net</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cron_InterestReceivedNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cron_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AdjustmentsNoncashItemsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AdjustmentsNoncashItemsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AssetImpairmentCharges">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of write-down of assets recognized in the income statement. Includes, but is not limited to, losses from tangible assets, intangible assets and goodwill.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3602-108585<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 45<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=123351718&amp;loc=d3e2420-110228<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AssetImpairmentCharges</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of cash and cash equivalents, and cash and cash equivalents restricted to withdrawal or usage. Excludes amount for disposal group and discontinued operations. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 24<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3521-108585<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3044-108585<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=123431023&amp;loc=SL98516268-108586<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of increase (decrease) in cash, cash equivalents, and cash and cash equivalents restricted to withdrawal or usage; including effect from exchange rate change. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 230<br> -Section 45<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=123444420&amp;loc=d3e33268-110906<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 24<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3521-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DepreciationDepletionAndAmortization">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The aggregate expense recognized in the current period that allocates the cost of tangible assets, intangible assets, or depleting assets to periods that benefit from use of the assets.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (e)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8736-108599<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DepreciationDepletionAndAmortization</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of increase (decrease) from effect of exchange rate changes on cash and cash equivalents, and cash and cash equivalents restricted to withdrawal or usage; held in foreign currencies. Excludes amounts for disposal group and discontinued operations. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 230<br> -Section 45<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=123444420&amp;loc=d3e33268-110906<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GainLossOnDerivativeInstrumentsNetPretax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Aggregate net gain (loss) on all derivative instruments recognized in earnings during the period, before tax effects.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4A<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=125515794&amp;loc=SL5618551-113959<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GainLossOnDerivativeInstrumentsNetPretax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeLossFromEquityMethodInvestments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of income (loss) for proportionate share of equity method investee's income (loss).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(12))<br> -URI http://asc.fasb.org/extlink&amp;oid=123367319&amp;loc=SL114868664-224227<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(10))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3602-108585<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(13)(f))<br> -URI http://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (g)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8736-108599<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=109237563&amp;loc=d3e33749-111570<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeLossFromEquityMethodInvestments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxesPaidNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of cash paid during the current period to foreign, federal, state, and local authorities as taxes on income, net of any cash received during the current period as refunds for the overpayment of taxes.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=123431023&amp;loc=d3e4297-108586<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxesPaidNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInAccountsPayableAndOtherOperatingLiabilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of increase (decrease) in obligations incurred but not paid, and operating obligations classified as other.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInAccountsPayableAndOtherOperatingLiabilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInAccountsReceivable">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The increase (decrease) during the reporting period in amount due within one year (or one business cycle) from customers for the credit sale of goods and services.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInAccountsReceivable</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInInventories">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The increase (decrease) during the reporting period in the aggregate value of all inventory held by the reporting entity, associated with underlying transactions that are classified as operating activities.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInInventories</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInOperatingCapitalAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInOtherReceivables">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of increase (decrease) in receivables classified as other.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInOtherReceivables</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of increase (decrease) in prepaid expenses, and assets classified as other.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InterestPaidNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of cash paid for interest, excluding capitalized interest, classified as operating activity. Includes, but is not limited to, payment to settle zero-coupon bond for accreted interest of debt discount and debt instrument with insignificant coupon interest rate in relation to effective interest rate of borrowing attributable to accreted interest of debt discount.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=123431023&amp;loc=d3e4297-108586<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 17<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3367-108585<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 25<br> -Subparagraph (e)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3536-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InterestPaidNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InventoryWriteDown">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of loss from reductions in inventory due to subsequent measurement adjustments, including, but not limited to, physical deterioration, obsolescence, or changes in price levels.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 330<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=116847112&amp;loc=d3e4542-108314<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InventoryWriteDown</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInFinancingActivities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of cash inflow (outflow) from financing activities, including discontinued operations. Financing activity cash flows include obtaining resources from owners and providing them with a return on, and a return of, their investment; borrowing money and repaying amounts borrowed, or settling the obligation; and obtaining and paying for other resources obtained from creditors on long-term credit.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 24<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3521-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetCashProvidedByUsedInFinancingActivities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInInvestingActivities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of cash inflow (outflow) from investing activities, including discontinued operations. Investing activity cash flows include making and collecting loans and acquiring and disposing of debt or equity instruments and property, plant, and equipment and other productive assets.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 24<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3521-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetCashProvidedByUsedInInvestingActivities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInOperatingActivities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of cash inflow (outflow) from operating activities, including discontinued operations. Operating activity cash flows include transactions, adjustments, and changes in value not defined as investing or financing activities.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 25<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3536-108585<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 24<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3521-108585<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetCashProvidedByUsedInOperatingActivities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherNoncashIncomeExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of income (expense) included in net income that results in no cash inflow (outflow), classified as other.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherNoncashIncomeExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentsRelatedToTaxWithholdingForShareBasedCompensation">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of cash outflow to satisfy grantee's tax withholding obligation for award under share-based payment arrangement.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 15<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3291-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PaymentsRelatedToTaxWithholdingForShareBasedCompensation</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentsToAcquireIntangibleAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The cash outflow to acquire asset without physical form usually arising from contractual or other legal rights, excluding goodwill.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 13<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3213-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PaymentsToAcquireIntangibleAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentsToAcquireLoansReceivable">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The cash outflow for the purchase of loan receivable arising from the financing of goods and services.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 13<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3213-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PaymentsToAcquireLoansReceivable</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentsToAcquireMarketableSecurities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of cash outflow for purchase of marketable security.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 320<br> -SubTopic 10<br> -Section 45<br> -Paragraph 11<br> -URI http://asc.fasb.org/extlink&amp;oid=124260329&amp;loc=d3e26853-111562<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PaymentsToAcquireMarketableSecurities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentsToAcquireOtherInvestments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of cash outflow to acquire investments classified as other.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 13<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3213-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PaymentsToAcquireOtherInvestments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The cash outflow associated with the acquisition of long-lived, physical assets that are used in the normal conduct of business to produce goods and services and not intended for resale; includes cash outflows to pay for construction of self-constructed assets.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 13<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3213-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PaymentsToAcquirePropertyPlantAndEquipment</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProceedsFromPaymentsForOtherFinancingActivities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of cash inflow (outflow) from financing activities classified as other.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3255-108585<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 15<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3291-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProceedsFromPaymentsForOtherFinancingActivities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProceedsFromSaleAndMaturityOfMarketableSecurities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The cash inflow associated with the aggregate amount received by the entity through sale or maturity of marketable securities  (held-to-maturity or available-for-sale) during the period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProceedsFromSaleAndMaturityOfMarketableSecurities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProceedsFromSaleAndMaturityOfOtherInvestments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The cash inflow associated with the sale and maturity (principal being due) of other investments, prepayment and call (request of early payment) of other investments not otherwise defined in the taxonomy.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 12<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3179-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProceedsFromSaleAndMaturityOfOtherInvestments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProceedsFromSaleOfPropertyHeldForSale">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The cash inflow from the sale of formerly productive land held for sale, anything permanently fixed to it, including buildings, structures on it, and so forth.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 12<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3179-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProceedsFromSaleOfPropertyHeldForSale</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProfitLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The consolidated profit or loss for the period, net of income taxes, including the portion attributable to the noncontrolling interest.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=SL7669619-108580<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1A<br> -Subparagraph (a)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=109239629&amp;loc=SL4573702-111684<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22663-107794<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8736-108599<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8933-108599<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123482062&amp;loc=SL123482106-238011<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 12: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 50<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=124431353&amp;loc=SL124452729-227067<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8906-108599<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3000-108585<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 19<br> -URI http://asc.fasb.org/extlink&amp;oid=123454820&amp;loc=SL4569616-111683<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8933-108599<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 7<br> -URI http://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=SL51721683-107760<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22499-107794<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 235<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-05(b)(2))<br> -URI http://asc.fasb.org/extlink&amp;oid=120399901&amp;loc=d3e537907-122884<br><br>Reference 23: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 31<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8924-108599<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=SL7669625-108580<br><br>Reference 25: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 26: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 27: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 28: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 29: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 30: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1A<br> -Subparagraph (c)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=109239629&amp;loc=SL4573702-111684<br><br>Reference 31: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 55<br> -Paragraph 4J<br> -URI http://asc.fasb.org/extlink&amp;oid=120409616&amp;loc=SL4591551-111686<br><br>Reference 32: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 55<br> -Paragraph 4K<br> -URI http://asc.fasb.org/extlink&amp;oid=120409616&amp;loc=SL4591552-111686<br><br>Reference 33: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22658-107794<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProfitLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProvisionForDoubtfulAccounts">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of expense (reversal of expense) for expected credit loss on accounts receivable.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 326<br> -SubTopic 20<br> -Section 50<br> -Paragraph 13<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=124255953&amp;loc=SL82919249-210447<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=123367319&amp;loc=SL114868664-224227<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProvisionForDoubtfulAccounts</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensation">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of noncash expense for share-based payment arrangement.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensation</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SupplementalCashFlowInformationAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SupplementalCashFlowInformationAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>21
<FILENAME>R7.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.2</span><table class="report" border="0" cellspacing="2" id="idm140381998129560">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Background, Basis of Presentation and Accounting Policies<br></strong></div></th>
<th class="th" colspan="1">6 Months Ended</th>
</tr>
<tr><th class="th"><div>Jun. 30, 2021</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract', window );"><strong>Organization, Consolidation and Presentation of Financial Statements [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BasisOfPresentationAndSignificantAccountingPoliciesTextBlock', window );">Background, Basis of Presentation and Accounting Policies</a></td>
<td class="text">Background, Basis of Presentation and Accounting Policies<div style="margin-bottom:6pt;margin-top:6pt;padding-left:36pt;text-align:justify;text-indent:-36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(a)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;padding-left:24.34pt">Background</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Cronos Group Inc. (&#8220;Cronos Group&#8221; or the &#8220;Company&#8221;) is incorporated in the Province of British Columbia and under the </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Business Corporations Act</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> (British Columbia) with principal executive offices at 111 Peter Street, Suite 300, Toronto, Ontario, M5V 2H1. The Company&#8217;s common shares are currently listed on the Toronto Stock Exchange (&#8220;TSX&#8221;) and Nasdaq Global Market (&#8220;Nasdaq&#8221;) under the ticker symbol &#8220;CRON.&#8221;</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Cronos Group is an innovative global cannabinoid company, with international production and distribution across five continents. The Company is committed to building disruptive intellectual property by advancing cannabis research, technology and product development and is seeking to build an iconic brand portfolio. Cronos Group&#8217;s brand portfolio includes PEACE NATURALS</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">&#8482;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, a global wellness platform; two adult-use brands, COVE</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">&#8482;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> and Spinach</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">&#8482;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">; and three U.S. hemp-derived consumer products brands, Lord Jones</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">&#8482;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, Happy Dance</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">&#8482; </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">and PEACE+</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">&#8482;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Cronos Group has established strategic joint ventures in Canada, Israel, and Colombia. &#8220;Cronos Israel&#8221; consists of a cultivation company (Cronos Israel G.S. Cultivation Ltd.), a manufacturing company (Cronos Israel G.S. Manufacturing Ltd.), a distribution company (Cronos Israel G.S. Store Ltd.) and a pharmacy company (Cronos Israel G.S. Pharmacy Ltd.) and is consolidated for financial reporting purposes. The Company also holds approximately 31% of the issued capital of Cronos Australia Limited (&#8220;Cronos Australia&#8221;) and accounts for its investment in Cronos Australia under the equity method of accounting. For additional discussion regarding the joint ventures and strategic investment, see Note 3. Investments.</span></div><div style="margin-bottom:6pt;margin-top:6pt;padding-left:36pt;text-align:justify;text-indent:-36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(b)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;padding-left:23.78pt">Out-of-period adjustments</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">During the three months ended March 31, 2021, the Company identified an error in the accounting related to the withholding taxes on the net exercise of stock options, which resulted in an understatement of accounts payable and other liabilities of $966 and overstatements of other receivables, retained earnings and share capital of $3,202, $3,838 and $330, respectively, as of December 31, 2020. The error was deemed immaterial, and thus the Company has recorded an out-of-period adjustment to the condensed consolidated balance sheet and the condensed consolidated statement of changes in equity during the first quarter of 2021 to correct the error. This error had no impact to the condensed consolidated statement of net income (loss) and comprehensive income (loss). The impact of the out-of-period adjustments are included within the changes in operating assets and liabilities and withholding taxes paid on share-based awards lines in the Company&#8217;s condensed consolidated statements of cash flows.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">During the three months ended June 30, 2021, the Company identified an error in the accounting related to the exercise of Top-up Rights (as defined herein), which resulted in an overstatement of share capital and an understatement of gain on revaluation of derivative liabilities of $3,227 as of December 31, 2020, and overstatements of share capital and loss on revaluation of derivative liabilities and an understatement of retained earnings of $14,505, $11,278 and $3,227, respectively, as of March 31, 2021. The error was deemed immaterial, and thus the Company has recorded an out-of-period adjustment to the condensed consolidated balance sheet, the condensed consolidated statement of net income (loss) and comprehensive income (loss) and the condensed consolidated statement of changes in equity during the second quarter of 2021 to correct the error. The impact of the out-of-period adjustments are included within the adjustments to net loss in the Company&#8217;s condensed consolidated statements of cash flows.</span></div><div style="margin-bottom:6pt;margin-top:6pt;padding-left:36pt;text-align:justify;text-indent:-36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(c)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;padding-left:24.91pt">Basis of presentation</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The interim condensed consolidated financial statements of Cronos Group are unaudited. They have been prepared in accordance with Generally Accepted Accounting Principles in the United States (&#8220;U.S. GAAP&#8221;) for interim financial information and with applicable rules and regulations of the U.S. Securities and Exchange Commission relating to interim financial statements. Accordingly, they do not include all of the information and footnotes required by U.S. GAAP for complete financial statements. In the opinion of management, all adjustments (consisting of normal recurring accruals) considered necessary for a fair presentation have been included. Operating results for the three and six months ended June&#160;30, 2021 are not necessarily indicative of the results that may be expected for any other reporting period.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">These condensed consolidated financial statements should be read in conjunction with the Company&#8217;s audited consolidated financial statements and related notes included in its Annual Report on Form 10-K for the year ended December 31, 2020 (the &#8220;Annual Financial Statements&#8221;).</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Certain prior year amounts have been reclassified to conform to the current year presentation of our condensed consolidated financial statements. These reclassifications had no effect on the reported results of operations and ending shareholders&#8217; equity.</span></div><div style="margin-bottom:6pt;margin-top:6pt;padding-left:36pt;text-align:justify;text-indent:-36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(d)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;padding-left:23.78pt">Adoption of new accounting pronouncements</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On January 1, 2021, the Company adopted ASU No. 2020-01, Investments-Equity Securities (Topic 321), Investments-Equity Method and Joint Ventures (Topic 323), and Derivatives and Hedging (Topic 815) (&#8220;ASU No. 2020-01&#8221;). ASU No. 2020-01 clarifies the interaction of accounting for the transition into and out of the equity method as well as measuring certain purchased options and forward contracts to acquire investments. The adoption of ASU No. 2020-01 did not have an impact on the Company&#8217;s interim condensed consolidated financial statements.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On January 1, 2021, the Company adopted ASU 2019-12, Income Taxes (Topic 740): Simplifying the Accounting for Income Taxes (&#8220;ASU No. 2019-12&#8221;). ASU No. 2019-12 eliminates certain exceptions and simplifies the application of U.S. GAAP-related changes in enacted tax laws or rates and employee stock option plans. The adoption of ASU No. 2019-12 did not have an impact on the Company&#8217;s interim condensed consolidated financial statements.</span></div><div style="margin-bottom:6pt;margin-top:6pt;padding-left:36pt;text-align:justify;text-indent:-36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(e)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;padding-left:24.91pt">New accounting pronouncements not yet adopted</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In August 2020, the FASB issued ASU 2020-06, Debt &#8211;Debt with Conversion and Other Options (Subtopic 470-20) and Derivatives and Hedging&#8212;Contracts in Entity&#8217;s Own Equity (Subtopic 815&#8211;40) (&#8220;ASU No. 2020-06&#8221;). ASU No. 2020-06 simplifies the accounting for certain financial instruments with characteristics of liabilities and equity, including convertible instruments and contracts on an entity&#8217;s own equity. ASU No. 2020-06 is part of the FASB&#8217;s simplification initiative, which aims to reduce unnecessary complexity in U.S. GAAP. ASU No. 2020-06 is effective for fiscal years beginning after December 15, 2021, and interim periods within those fiscal years. The Company is currently evaluating the impact ASU No. 2020-06 will have on its condensed consolidated financial statements.</span></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BasisOfPresentationAndSignificantAccountingPoliciesTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for the basis of presentation and significant accounting policies concepts. Basis of presentation describes the underlying basis used to prepare the financial statements (for example, US Generally Accepted Accounting Principles, Other Comprehensive Basis of Accounting, IFRS).  Accounting policies describe all significant accounting policies of the reporting entity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -URI http://asc.fasb.org/topic&amp;trid=2122369<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BasisOfPresentationAndSignificantAccountingPoliciesTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>22
<FILENAME>R8.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.2</span><table class="report" border="0" cellspacing="2" id="idm140381997899176">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Inventory, net<br></strong></div></th>
<th class="th" colspan="1">6 Months Ended</th>
</tr>
<tr><th class="th"><div>Jun. 30, 2021</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InventoryDisclosureAbstract', window );"><strong>Inventory Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InventoryDisclosureTextBlock', window );">Inventory, net</a></td>
<td class="text">Inventory, net<div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Inventory, net is comprised of the following items:</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:59.733%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:1.605%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:16.816%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:1.327%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:16.819%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">As of June&#160;30, 2021</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">As of December 31, 2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Raw materials</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7,471&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11,489&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Work-in-progress</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">17,291&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">26,278&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Finished goods</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10,247&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,905&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Supplies and consumables</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">596&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">330&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">35,605&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">44,002&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-bottom:6pt;margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Inventory is written down for any obsolescence such as slow-moving or non-marketable products, or when the net realizable value of inventory is less than the carrying value. During the three months ended June&#160;30, 2021 and 2020, the Company recorded write-downs related to inventory of $11,961 and $3,062, respectively. During the six months ended June&#160;30, 2021 and 2020, the Company recorded write-downs related to inventory of $11,961 and $11,024, respectively.</span></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InventoryDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InventoryDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InventoryDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for inventory. Includes, but is not limited to, the basis of stating inventory, the method of determining inventory cost, the classes of inventory, and the nature of the cost elements included in inventory.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 330<br> -URI http://asc.fasb.org/topic&amp;trid=2126998<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InventoryDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>23
<FILENAME>R9.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.2</span><table class="report" border="0" cellspacing="2" id="idm140381998193512">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Investments<br></strong></div></th>
<th class="th" colspan="1">6 Months Ended</th>
</tr>
<tr><th class="th"><div>Jun. 30, 2021</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EquityMethodInvestmentsAndJointVenturesAbstract', window );"><strong>Equity Method Investments and Joint Ventures [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EquityMethodInvestmentsDisclosureTextBlock', window );">Investments</a></td>
<td class="text">Investments<div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(a)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;padding-left:24.34pt">Variable interest entities and investments in equity accounted investees, net</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company holds variable interests in Cronos Growing Company Inc. (&#8220;Cronos GrowCo&#8221;), Natuera S.&#224;.r.l (&#8220;Natuera&#8221;), MedMen Canada Inc. (&#8220;MedMen Canada&#8221;) and Cannasoul Lab Services Ltd. (&#8220;CLS&#8221;). The Company&#8217;s investments in Cronos GrowCo, Natuera and MedMen Canada are exposed to economic variability from each entity&#8217;s performance; however, the Company does not consolidate the entities as it does not have the power to direct the activities that most significantly impact each entity&#8217;s economic performance. Thus, Cronos Group is not considered the primary beneficiary of each entity. These investments are accounted for as equity method investments classified as &#8220;Investments in equity accounted investees, net&#8221; in the consolidated balance sheets.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Cronos GrowCo is a joint venture incorporated under the Canada Business Corporations Act (&#8220;CBCA&#8221;) on June 14, 2018 with the objective of cultivating and commercializing cannabis and cannabis products. Cronos Group holds variable interests in Cronos GrowCo through its ownership of 50% of Cronos GrowCo&#8217;s common shares and senior secured debt. Cronos GrowCo&#8217;s economic performance is driven by the quantity and strains of cannabis grown. The joint venture partners mutually determine the quantity and strains of cannabis grown.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">MedMen Canada is a joint venture incorporated under the CBCA on March 13, 2018, with the objective of the retail sale and marketing of cannabis products in Canada. MedMen Canada holds the exclusive license to the MedMen brand in Canada for a minimum term of 20 years. The Company holds variable interests in MedMen Canada through its ownership of 50% of MedMen Canada&#8217;s common shares and other subordinated debt. MedMen Canada&#8217;s economic performance is driven by the quantity and strains of cannabis sold. Subject to applicable law, the joint venture partners mutually determine the quantity and strains of cannabis to be sold in MedMen Canada&#8217;s retail stores, if and when stores are opened. </span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Natuera is a joint venture registered in Luxembourg with the objective of cultivating and commercializing hemp and cannabis products. The Company holds variable interests in Natuera through its ownership of 50% of Natuera&#8217;s common shares. Natuera&#8217;s economic performance is driven by the quantity and strains of cannabis grown, which is mutually determined by the joint venture partners.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">CLS is a wholly owned subsidiary of Cannasoul Analytics Ltd., incorporated with the purpose of establishing a commercial cannabis analytical testing laboratory located on the premises of Cronos Israel (the &#8220;Cannasoul Collaboration&#8221;). Cronos Israel agreed to advance up to ILS 8,297 ($2,511) by a non-recourse loan (the &#8220;Cannasoul Collaboration Loan&#8221;) to CLS over a period of two years from April 1, 2020 for the capital and operating expenditures of the laboratory. The loan bears interest at 3.5% annually. Cronos Israel will receive 70% of the profits of the laboratory until such time as it has recovered 150% of the amounts advanced to CLS, after which time it will receive 50% of the laboratory profits. As a result, the Company is exposed to economic variability from CLS&#8217;s performance. The Company does not consolidate CLS as it does not have the power to direct the activities that most significantly impact the entity&#8217;s economic performance; thus, the Company is not considered the primary beneficiary of the entity. The carrying amount of the non-recourse loan is recorded under loans receivable and the full loan amount, ILS 8,297, represents the Company&#8217;s maximum potential exposure to losses through the Cannasoul Collaboration. See Note 4. Loans Receivable, net for further information regarding loans receivable.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">A reconciliation of the carrying amount of the investments in associates and joint ventures is as follows:</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:45.844%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:15.566%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:1.327%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:15.566%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:1.327%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:15.570%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Ownership interest</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">As of June&#160;30, 2021</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">As of December 31, 2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cronos Australia</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">31%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cronos GrowCo</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">50%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">19,022&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">19,235&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Natuera</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(i)</span></div></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">50%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,948&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">20,970&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">19,235&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-bottom:6pt;margin-top:3pt;padding-left:27pt;text-align:justify;text-indent:-27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:700;line-height:120%;position:relative;top:-2.8pt;vertical-align:baseline">(i)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:22.1pt">On April 1, 2021, the Company and an affiliate of Agroidea (&#8220;AGI&#8221;), the other joint venture partner of Natuera, converted all advances made to Natuera under the master loan agreement entered into with Natuera on September 27, 2019 (the &#8220;Natuera Series A Loan&#8221;), plus accrued interest, into equity of Natuera. Total aggregate gross advances to Natuera under the Natuera Series A Loan were $15,500, of which the Company advanced 50% and AGI advanced the remaining 50%, or $7,750 each. As a result, the Company transferred the carrying value of the Natuera Series A Loan of approximately $2,013 plus accrued interest of $540, for a total investment value of $2,553, which approximates fair value, to investments in equity accounted investees in respect of Natuera. See Note 4. Loans Receivable, net.</span></div><div style="margin-bottom:6pt;margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company&#8217;s share of net losses from equity investments accounted for under the equity method of accounting:</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:41.677%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.788%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.355%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.788%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.355%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.788%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.355%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.794%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">For the three months ended June&#160;30,</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">For the six months ended June&#160;30,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020</span></td></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cronos Australia</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(235)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(235)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cronos GrowCo</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(459)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(190)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(758)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(501)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Natuera</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(656)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(369)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2,000)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,230)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,115)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(794)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2,758)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,966)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-bottom:6pt;margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company determined that the maximum exposure of loss on investments in non-consolidated investments is limited to the Company&#8217;s initial investment, advances and/or loans for each variable interest entity. The following is a summary of the maximum exposure to loss as of June&#160;30, 2021 and December&#160;31, 2020:</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:47.788%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:15.566%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.355%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:15.566%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.355%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:15.570%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Ownership interest</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">As of June&#160;30, 2021</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">As of December 31, 2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cronos Australia</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">31%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,573&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,530&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cronos GrowCo</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">50%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">21,723&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">21,125&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">MedMen Canada</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">50%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">494&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">467&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Natuera</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">50%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8,047&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8,154&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">31,837&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">31,276&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr></table></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(b)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;padding-left:23.78pt">Other investments</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Other investments consist of investments in options of companies in the cannabis industry.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On June 14, 2021, the Company purchased an option to acquire 473,787 shares of Class A Common Stock of PharmaCann, Inc. (&#8220;PharmaCann&#8221;), a vertically integrated cannabis company in the United States, at an exercise price of $0.0001 per share, representing approximately 10.5% of PharmaCann&#8217;s issued and outstanding capital stock on a fully diluted basis, for an aggregate purchase price of approximately $110,392. The option exercise will be based upon various factors, including the status of U.S. federal cannabis legalization, as well as regulatory approvals, including in the states where PharmaCann operates that may be required upon exercise. This option is classified as an equity security without a readily determinable fair value. The Company has elected to measure the fair value of the option at cost less impairment, if any, and subsequently adjusted for observable price changes in orderly transactions for the identical or a similar investment of the same issuer. The option is reported as other investments on the condensed consolidated balance sheet for the period ended June 30, 2021. As of June 30, 2021 and December 31, 2020, the Company did not hold any additional other investments.</span></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EquityMethodInvestmentsAndJointVenturesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EquityMethodInvestmentsAndJointVenturesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EquityMethodInvestmentsDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for equity method investments and joint ventures. Equity method investments are investments that give the investor the ability to exercise significant influence over the operating and financial policies of an investee. Joint ventures are entities owned and operated by a small group of businesses as a separate and specific business or project for the mutual benefit of the members of the group.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -URI http://asc.fasb.org/topic&amp;trid=2196965<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EquityMethodInvestmentsDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>24
<FILENAME>R10.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.2</span><table class="report" border="0" cellspacing="2" id="idm140381999688168">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Loans Receivable, net<br></strong></div></th>
<th class="th" colspan="1">6 Months Ended</th>
</tr>
<tr><th class="th"><div>Jun. 30, 2021</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ReceivablesAbstract', window );"><strong>Receivables [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LoansNotesTradeAndOtherReceivablesExcludingAllowanceForCreditLossesTextBlock', window );">Loans Receivable, net</a></td>
<td class="text">Loans Receivable, net <div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:21.955%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:39.177%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:1.466%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:15.566%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:1.466%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:15.570%"/><td style="width:0.1%"/></tr><tr><td colspan="6" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">As of June&#160;30, 2021</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">As of December 31, 2020</span></td></tr><tr><td colspan="6" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><div style="padding-left:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Natuera Series A Loan</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(i)</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,518&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr><tr><td colspan="6" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><div style="padding-left:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">GrowCo Facility</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(ii)</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,614&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,137&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="6" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Add: Accrued interest</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,414&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">428&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr><tr><td colspan="6" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total current portion of loans receivable</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,028&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7,083&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr><tr><td colspan="6" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><div style="padding-left:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">GrowCo Facility</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(ii)</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">77,474&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">69,939&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr><tr><td colspan="6" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><div style="padding-left:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Mucci Promissory Note</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(iii)</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">13,969&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">13,324&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr><tr><td colspan="6" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><div style="padding-left:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cannasoul Collaboration Loan</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(iv)</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,870&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,261&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr><tr><td colspan="6" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Add: Accrued interest</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">800&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,667&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr><tr><td colspan="6" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total long-term portion of loans receivable</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">94,113&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">87,191&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr><tr><td colspan="6" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total loans receivable, net</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">99,141&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">94,274&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr></table></div><div style="margin-bottom:3pt;margin-top:3pt;padding-left:27pt;text-align:justify;text-indent:-27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(i)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:19.46pt">On April 1, 2021, the Company and AGI converted all advances made to Natuera under the Series A Loan, plus accrued interest, into equity of Natuera. Total aggregate gross advances to Natuera under the Natuera Series A Loan were $15,500, of which the Company advanced 50% and AGI advanced the remaining 50%, or $7,750 each. As a result, the Company transferred the carrying value of the Natuera Series A Loan of approximately $2,013 plus accrued interest of $540, for a total investment value of $2,553, which approximates fair value, to investments in equity accounted investees in respect of Natuera. See Note 3. Investments.</span></div><div style="margin-bottom:3pt;margin-top:3pt;padding-left:27pt;text-align:justify;text-indent:-27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:400;line-height:120%;position:relative;top:-2.8pt;vertical-align:baseline">(ii)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:20.66pt">As of June&#160;30, 2021 and December&#160;31, 2020, Cronos GrowCo had drawn C$100,000 ($80,678) and C$95,150 ($74,626), respectively, from a credit agreement it entered into with the Company in August 2019 (the &#8220;GrowCo Facility&#8221;). As of June&#160;30, 2021 and December&#160;31, 2020, the Company had an allowance for credit losses of $1,590 and $1,470, respectively, recorded against the GrowCo Facility.</span></div><div style="margin-bottom:3pt;margin-top:3pt;padding-left:27pt;text-align:justify;text-indent:-27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:400;line-height:120%;position:relative;top:-2.8pt;vertical-align:baseline">(iii)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:19.22pt">As of June&#160;30, 2021 and December&#160;31, 2020, the Company had an allowance for credit losses of $278 and</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">$259, respectively, recorded against the promissory note receivable agreement entered into with Mucci on June 28, 2019 (the &#8220;Mucci Promissory Note&#8221;).</span></div><div style="margin-bottom:6pt;margin-top:3pt;padding-left:27pt;text-align:justify;text-indent:-27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:400;line-height:120%;position:relative;top:-2.8pt;vertical-align:baseline">(iv)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:19.5pt">As of June&#160;30, 2021 and December&#160;31, 2020 CLS has received ILS 6,223 and ILS 4,149 (approximately $1,909 and $1,287 respectively) from the Cannasoul Collaboration Loan. As of June&#160;30, 2021 and December&#160;31, 2020, the Company had an allowance for credit losses of $39 and $25, respectively, recorded against the Cannasoul Collaboration Loan.</span></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LoansNotesTradeAndOtherReceivablesExcludingAllowanceForCreditLossesTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for claims held for amounts due a company, excluding disclosure for allowance for credit losses. Examples include, but are not limited to, trade accounts receivables, notes receivables, loans receivables. Also excludes disclosure for financing receivables.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 310<br> -SubTopic 10<br> -URI http://asc.fasb.org/subtopic&amp;trid=2196772<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LoansNotesTradeAndOtherReceivablesExcludingAllowanceForCreditLossesTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ReceivablesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ReceivablesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>25
<FILENAME>R11.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.2</span><table class="report" border="0" cellspacing="2" id="idm140381998188456">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Derivative Liabilities<br></strong></div></th>
<th class="th" colspan="1">6 Months Ended</th>
</tr>
<tr><th class="th"><div>Jun. 30, 2021</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract', window );"><strong>Derivative Instruments and Hedging Activities Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureTextBlock', window );">Derivative Liabilities</a></td>
<td class="text">Derivative Liabilities <div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On March 8, 2019, the Company closed the previously announced investment in the Company (the &#8220;Altria Investment&#8221;) by Altria Group, Inc. (&#8220;Altria&#8221;), pursuant to a subscription agreement dated December 7, 2018. As of the closing date of the Altria Investment, the Altria Investment consisted of 149,831,154 common shares of the Company and one warrant of the Company (the &#8220;Altria Warrant&#8221;), all of which were issued to a wholly owned subsidiary of Altria. As of the closing date of the Altria Investment, Altria beneficially held an approximately 45% ownership interest in the Company (calculated on a non-diluted basis). As summarized in this note, if exercised in full on such date, the exercise of the Altria Warrant would have resulted in Altria holding a total ownership interest in the Company of approximately 55% (calculated on a non-diluted basis). As of June 30, 2021, Altria beneficially held an approximately 42% ownership interest in the Company (calculated on a non-diluted basis). As summarized in this note, if exercised in full on such date, the exercise of the Altria Warrant would have resulted in Altria holding a total ownership interest in the Company of approximately 53% (calculated on a non-diluted basis). Pursuant to the investor rights agreement between the Company and Altria, entered into in connection with the closing of the Altria Investment (the &#8220;Investor Rights Agreement&#8221;), the Company granted Altria certain rights, among others, summarized in this note.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The summaries below are qualified entirely by the terms and conditions fully set out in the Investor Rights Agreement and the Altria Warrant, as applicable.</span></div><div style="margin-bottom:6pt;margin-top:6pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">a.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:11.07pt">The Altria Warrant entitles the holder, subject to certain qualifications and limitations, to subscribe for and purchase up to an additional approximate 10% of the common shares of Cronos (approximately 83 million common shares at June&#160;30, 2021) at a per share exercise price of C$19.00, which expires on March 8, 2023.</span></div><div style="margin-bottom:6pt;margin-top:6pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">b.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:10.5pt">The Company granted to Altria, subject to certain qualifications and limitations, upon the occurrence of certain issuances of common shares of the Company executed by the Company (including issuances pursuant to the R&amp;D partnership with Ginkgo Bioworks Inc. (&#8220;Ginkgo&#8221;) (the &#8220;Ginkgo Strategic Partnership&#8221;)), the right to purchase up to such number of common shares of the Company in order to maintain their ownership percentage of issued and outstanding common shares of the Company immediately preceding any issuance of shares by the Company (&#8220;Pre-emptive Rights&#8221;), at the same price per common share of the Company at which the common shares are sold in the relevant issuance. The price per common share of the Company to be paid by Altria pursuant to its exercise of its Pre-emptive Rights related to the Ginkgo Strategic Partnership will be C$16.25 per common share. These rights may not be exercised if Altria&#8217;s ownership percentage of the issued and outstanding shares of the Company falls below 20%.</span></div><div style="margin-bottom:6pt;margin-top:6pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">c.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:11.07pt">In addition to (and without duplication of) the Pre-emptive Rights, the Company granted to Altria, subject to certain qualifications and limitations, the right to subscribe for common shares of the Company issuable in connection with the exercise, conversion or exchange of convertible securities of the Company issued prior to March 8, 2019 or thereafter (excluding any convertible securities of the Company owned by Altria or any of its subsidiaries), a share incentive plan of the Company, the exercise of any right granted by the Company pro rata to all shareholders of the Company to purchase additional common shares and/or securities of the Company, bona fide bank debt, equipment financing or non-equity interim financing transactions that contemplate an equity component or bona fide acquisitions (including acquisitions of assets or rights under a license or otherwise), mergers or similar business combination transactions or joint ventures involving the Company in order to maintain their ownership percentage of issued and outstanding common shares of the Company immediately preceding any such transactions (&#8220;Top-up Rights&#8221;).</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The price per common share to be paid by Altria pursuant to the exercise of its Top-up Rights will be, subject to certain limited exceptions, the 10-day volume-weighted average price of the common shares of the Company on the TSX for the ten full days preceding such exercise by Altria, provided that the price per common share of the Company to be paid by Altria pursuant to the exercise of its Top-up Rights in connection with the issuance of common shares of the Company pursuant to the exercise of options or warrants that were outstanding as of March 8, 2019 will be C$16.25 per common share without any set off, counterclaim, deduction, or withholding. These rights may not be exercised if Altria&#8217;s ownership percentage of the issued and outstanding shares of the Company falls below 20%. The Altria Warrant, Pre-emptive Rights, and fixed price Top-up Rights have been classified as derivative liabilities.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">A reconciliation of the carrying amounts of the derivative liability for the three months ended June&#160;30, 2021 and 2020:</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:18.483%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.761%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.911%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:14.316%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.911%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.761%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.911%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:14.872%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.911%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.763%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">As of April 1, 2021</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Revaluation gain</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Out-of-period adjustment</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Foreign exchange effect</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">As of June 30, 2021</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(a) Altria Warrant</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">234,656&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(85,778)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,205&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">150,083&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(b) Pre-emptive Rights</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">20,173&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(6,360)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">113&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">13,926&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(c) Top-up Rights</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">17,471&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(23,110)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11,278&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(85)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,554&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">272,300&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(115,248)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11,278&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,233&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">169,563&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/></tr></table></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:18.483%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.761%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.911%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:14.316%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.911%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.761%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.911%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:14.872%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.911%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.763%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">As of April 1, 2020</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Revaluation loss</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Exercise of rights</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Foreign exchange effect</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">As of June&#160;30, 2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(a) Altria Warrant</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">132,366&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">30,052&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,540&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">165,958&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(b) Pre-emptive Rights</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">13,070&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,610&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">500&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">16,180&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(c) Top-up Rights</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">20,013&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,218&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(727)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,072&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">23,576&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">165,449&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">35,880&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(727)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,112&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">205,714&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/></tr></table></div><div style="margin-bottom:6pt;margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">A reconciliation of the carrying amounts of the derivative liability for the six months ended June&#160;30, 2021 and 2020:</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:18.483%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.761%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.911%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:14.316%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.911%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.761%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.911%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:14.872%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.911%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.763%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">As of January 1, 2021</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Revaluation loss/(gain)</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Exercise of rights</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Foreign exchange effect</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">As of June 30, 2021</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(a) Altria Warrant</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">138,858&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7,186&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,039&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">150,083&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(b) Pre-emptive Rights</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12,095&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,473&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">358&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">13,926&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(c) Top-up Rights</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12,457&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(7,033)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">130&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,554&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">163,410&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,626&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,527&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">169,563&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/></tr></table></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:18.483%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.761%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.911%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:14.316%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.911%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.761%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.911%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:14.872%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.911%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.763%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">As of January 1, 2020</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Revaluation loss/(gain)</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Exercise of rights</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Foreign exchange effect</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">As of June&#160;30, 2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(a) Altria Warrant</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">234,428&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(58,052)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(10,418)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">165,958&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(b) Pre-emptive Rights</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12,787&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,925&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(532)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">16,180&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(c) Top-up Rights</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">49,945&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(23,361)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(727)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2,281)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">23,576&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">297,160&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(77,488)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(727)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(13,231)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">205,714&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/></tr></table></div><div style="margin-bottom:12pt;margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Fluctuations in the Company&#8217;s share price are a primary driver for the changes in the derivative valuations during each reporting period. As the share price decreases for each of the related derivative instruments, the liability of the instrument generally decreases. Share price is one of the significant observable inputs used in the fair value measurement of each of the Company&#8217;s derivative instruments. During the three months ended June&#160;30, 2021, the Company&#8217;s share price decreased from April 1, 2021 and we recorded an out-of-period adjustment of $11,278. See Note 1. Background, Basis of Presentation and Accounting Policies for more information on the out-of-period adjustment.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The fair values of the derivative liabilities were determined using the Black-Scholes pricing model as of June&#160;30, 2021 and December 31, 2020 applying the following inputs:</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.583%"><tr><td style="width:1.0%"/><td style="width:31.257%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.639%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.357%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.639%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.357%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.639%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.776%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.639%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.357%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.639%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.357%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.644%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">As of June&#160;30, 2021</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">As of December 31, 2020</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Altria Warrant</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Pre-emptive Rights</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Top-up Rights</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Altria Warrant</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Pre-emptive Rights</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Top-up Rights</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Share price at valuation date </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(i)</span></div></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$10.68</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$10.68</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$10.68</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$8.84</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$8.84</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$8.84</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Subscription price </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(i)</span></div></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$19.00</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$16.25</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$16.25</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$19.00</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$16.25</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$16.25</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><div style="margin-top:1pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Weighted average risk-free interest rate </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">(ii)</span></div></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.38%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.28%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.31%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.21%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.17%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.13%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><div style="margin-top:1pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Weighted average expected life </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">(iii)</span></div></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.68</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.25</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.31</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.18</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.50</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.98</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><div style="margin-top:1pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Expected annualized volatility</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline"> (iv)</span></div></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">75%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">75%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">75%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">81%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">81%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">81%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Expected dividend yield</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;%</span></td></tr></table></div><div style="margin-top:6pt;padding-left:27pt;text-align:justify;text-indent:-27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:400;line-height:120%;position:relative;top:-2.8pt;vertical-align:baseline">(i)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:22.1pt">Per share in C$.</span></div><div style="margin-bottom:3pt;margin-top:3pt;padding-left:27pt;text-align:justify;text-indent:-27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:400;line-height:120%;position:relative;top:-2.8pt;vertical-align:baseline">(ii)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:20.66pt">The risk-free interest rate was based on Bank of Canada government treasury bills and bonds with a remaining term equal to the expected life of the derivative liabilities. As of June&#160;30, 2021 and December 31, 2020, the risk-free interest rate uses a range of approximately 0.15% to 0.85% and 0.10% to 0.39%, respectively, for the Pre-emptive Rights and Top-up Rights.</span></div><div style="margin-bottom:3pt;margin-top:3pt;padding-left:27pt;text-align:justify;text-indent:-27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:400;line-height:120%;position:relative;top:-2.8pt;vertical-align:baseline">(iii)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:19.22pt">The expected life represents the period of time, in years, that the derivative liabilities are expected to be outstanding. The expected life of the Pre-emptive Rights and Top-up Rights is determined based on the expected term of the underlying options, warrants, and shares, to which the Pre-emptive Rights and Top-up Rights are linked. As of June&#160;30, 2021 and December 31, 2020, the expected life uses a range of approximately 0.25 year to 4.25 years and 0.50 year to 5.00 years, respectively.</span></div><div style="margin-bottom:6pt;margin-top:3pt;padding-left:27pt;text-align:justify;text-indent:-27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:400;line-height:120%;position:relative;top:-2.8pt;vertical-align:baseline">(iv)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:19.5pt">Volatility was based on an equally weighted blended historical and implied volatility level of the underlying equity securities of the Company as of June&#160;30, 2021. As of December 31, 2020, volatility was based on the blended historical volatility levels of the Company and peer companies.</span></div><div style="margin-bottom:6pt;margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table quantifies each of the significant inputs described above and provides a sensitivity analysis of the impact on the reported values of the derivative liabilities. The sensitivity analysis for each significant input is performed by assuming a 10% decrease in the input while other significant inputs remain constant at management&#8217;s best estimate as of the respective dates. While a decrease in the inputs noted below would cause a decrease in the carrying value of the derivative liability, there would also be an equal but opposite impact on net income (loss).</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:28.761%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:1.466%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.038%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:1.327%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.038%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:1.327%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.038%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:1.327%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.038%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:1.327%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.038%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:1.327%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.048%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Decrease as of June&#160;30, 2021</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Decrease as of December 31, 2020</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Altria Warrant</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Pre-emptive Rights</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Top-up Rights</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Altria Warrant</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Pre-emptive Rights</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Top-up Rights</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Share price</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">31,375&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,146&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,302&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">25,819&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,527&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,989&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Weighted average expected life</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">14,220&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,266&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">502&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">13,541&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,988&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,121&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Expected annualized volatility</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">27,375&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,348&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">968&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">26,183&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,269&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,602&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr></table></div><div style="margin-bottom:6pt;margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">These inputs are classified in Level 3 on the fair value hierarchy and are subject to volatility and several factors outside of the Company&#8217;s control, which could significantly affect the fair value of these derivative liabilities in future periods.</span></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for derivative instruments and hedging activities including, but not limited to, risk management strategies, non-hedging derivative instruments, assets, liabilities, revenue and expenses, and methodologies and assumptions used in determining the amounts.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -URI http://asc.fasb.org/topic&amp;trid=2229140<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 50<br> -Paragraph 5<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123477628&amp;loc=d3e90205-114008<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>26
<FILENAME>R12.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.2</span><table class="report" border="0" cellspacing="2" id="idm140381998272472">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Share-based Payments<br></strong></div></th>
<th class="th" colspan="1">6 Months Ended</th>
</tr>
<tr><th class="th"><div>Jun. 30, 2021</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract', window );"><strong>Share-based Payment Arrangement [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock', window );">Share-based Payments</a></td>
<td class="text">Share-based Payments<div style="margin-bottom:6pt;margin-top:6pt;padding-left:36pt;text-align:justify;text-indent:-36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(a)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;padding-left:24.34pt">Share-based award plans</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company has granted stock options, restricted share units (&#8220;RSUs&#8221;) and deferred share units (&#8220;DSUs&#8221;) to employees and non-employee directors under the Stock Option Plan dated May 26, 2015 (the &#8220;2015 Stock Option Plan&#8221;), the 2018 Stock Option Plan dated June 28, 2018 (the &#8220;2018 Stock Option Plan&#8221; and, together with the 2015 Stock Option Plan, the &#8220;Prior Option Plans&#8221;), the 2020 Omnibus Equity Incentive Plan dated March 29, 2020 (the &#8220;2020 Omnibus Plan&#8221;) and the DSU plan dated August 10, 2019 (the &#8220;DSU Plan&#8221;). The Company can no longer make grants under the Prior Option Plans.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table summarizes the total share-based payments associated with the Company&#8217;s stock options and RSUs for the three and six months ended June 30, 2021 and 2020:</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:40.427%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.788%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.772%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.788%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.772%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.788%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.772%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.793%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">For the three months ended June&#160;30,</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">For the six months ended June&#160;30,</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Stock options</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,864&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,770&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,928&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,500&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">RSUs</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">701&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">776&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,136&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,482&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total share-based payments</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,565&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,546&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,064&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,982&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-bottom:6pt;margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(b)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;padding-left:23.78pt">Stock options</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Vesting conditions for grants of options are determined by the Compensation Committee of the Company&#8217;s Board of Directors. The typical vesting for stock option grants made under the 2020 Omnibus Plan is annual vesting over <span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOjkzY2E5YmIwMTc5MjQ3NmZiYjIyNWU1ZDlkZWM4NjlmL3NlYzo5M2NhOWJiMDE3OTI0NzZmYmIyMjVlNWQ5ZGVjODY5Zl80OS9mcmFnOjdkOTcyM2RkMjdkODRhNWFiYjJiMzcyOTJmYjZhMmUzL3RleHRyZWdpb246N2Q5NzIzZGQyN2Q4NGE1YWJiMmIzNzI5MmZiNmEyZTNfMTAxNA_bcd0b46d-5e0a-4add-a684-db7137029aee">three</span> to five years with a maximum term of ten years. The typical vesting for stock option grants made under the Prior Option Plans is quarterly vesting over <span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOjkzY2E5YmIwMTc5MjQ3NmZiYjIyNWU1ZDlkZWM4NjlmL3NlYzo5M2NhOWJiMDE3OTI0NzZmYmIyMjVlNWQ5ZGVjODY5Zl80OS9mcmFnOjdkOTcyM2RkMjdkODRhNWFiYjJiMzcyOTJmYjZhMmUzL3RleHRyZWdpb246N2Q5NzIzZGQyN2Q4NGE1YWJiMmIzNzI5MmZiNmEyZTNfMTE1NA_462d9472-3856-448b-97f2-4ab4e5aeb10e">three</span> to five years with a maximum term of seven years. The Prior Option Plans did not, and the 2020 Omnibus Plan does not, authorize grants of options with an exercise price below fair market value.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following is a summary of the changes in stock options during the six months ended June&#160;30, 2021 and 2020:</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:51.261%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.761%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:1.327%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.761%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:1.327%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.763%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Weighted average exercise price (C$)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:700;line-height:100%;position:relative;top:-2.8pt;vertical-align:baseline"> (i)</span></div></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Number of options</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Weighted average remaining contractual term (years)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance as of January 1, 2021</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5.40&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">13,755,148&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.30</span></td></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Exercise of options</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.14&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(5,349,818)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cancellation, forfeiture and expiry of options</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">14.86&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(33,699)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance as of June&#160;30, 2021</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7.45&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8,371,631&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.66</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Exercisable as of June&#160;30, 2021</span></td><td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6.49&#160;</span></td><td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,679,240&#160;</span></td><td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.43</span></td></tr></table></div><div style="margin-top:6pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:400;line-height:120%;position:relative;top:-2.8pt;vertical-align:baseline">(i)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:13.1pt">The weighted average exercise price reflects the conversion of foreign currency-denominated stock options translated into C$ using the average foreign exchange rate as of the date of issuance. </span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:51.538%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.483%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:1.327%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.483%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:1.327%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:14.042%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Weighted average exercise price (C$)</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Number of options</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Weighted average remaining contractual term (years)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance as of January 1, 2020</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.84&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">14,149,502&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.56</span></td></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Exercise of options</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.05&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,807,909)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cancellation, forfeiture and expiry of options</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">15.78&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(127,045)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance as of June&#160;30, 2020</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5.13&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12,214,548&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.05</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Exercisable as of June&#160;30, 2020</span></td><td style="background-color:#cceeff;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:3pt double #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.42&#160;</span></td><td style="background-color:#cceeff;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8,688,645&#160;</span></td><td style="background-color:#cceeff;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.78</span></td></tr></table></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">No stock options were granted during the six months ended June&#160;30, 2021 and 2020.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table summarizes stock options outstanding for the 2020 Omnibus Plan, the 2018 Stock Option Plan, and the 2015 Stock Option Plan:</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.861%"><tr><td style="width:1.0%"/><td style="width:52.168%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:21.431%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:1.468%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:21.433%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Stock options outstanding as of</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">June 30, 2021</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 31, 2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2020 Omnibus Plan</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,000,000&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,000,000&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2018 Stock Option Plan </span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,586,725</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,627,715&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2015 Stock Option Plan </span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,784,906&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10,127,433&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total stock options outstanding</span></td><td colspan="3" style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8,371,631</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">13,755,148&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr></table></div><div style="margin-bottom:6pt;margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">(c)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;padding-left:27.13pt">Restricted share units</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following is a summary of the changes in RSUs for the six months ended June&#160;30, 2021 and 2020: </span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:61.538%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:16.816%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:1.327%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:16.819%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Number of RSUs</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:700;line-height:100%;position:relative;top:-2.8pt;vertical-align:baseline"> (i)</span></div></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Weighted average grant date fair value (C$)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:700;line-height:100%;position:relative;top:-2.8pt;vertical-align:baseline">(ii)</span></div></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance as of January 1, 2021</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">948,357&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7.66&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Granted</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(i)</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">515,433&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11.29&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Vested and issued</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(89,912)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7.52&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance as of June&#160;30, 2021</span></td><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,373,878&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9.03&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:61.538%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:16.816%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:1.327%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:16.819%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Number of RSUs</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:700;line-height:100%;position:relative;top:-2.8pt;vertical-align:baseline"> (i)</span></div></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Weighted average grant date fair value (C$)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:700;line-height:100%;position:relative;top:-2.8pt;vertical-align:baseline">(ii)</span></div></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance as of January 1, 2020</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">732,972&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">15.34&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Granted</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(i)</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">279,277&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7.52&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance as of June&#160;30, 2020</span></td><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,012,249&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">13.18&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-bottom:6pt;margin-top:6pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:400;line-height:120%;position:relative;top:-2.8pt;vertical-align:baseline">(i)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:13.1pt">RSUs granted in the period vest annually in equal installments over a three-year period following the grant date, subject to such holder&#8217;s continued employment through each vesting date. The vesting of such RSUs is not subject to the achievement of any performance criteria.</span></div><div style="margin-bottom:6pt;margin-top:6pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:400;line-height:120%;position:relative;top:-2.8pt;vertical-align:baseline">(ii)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:11.66pt">The weighted average grant date fair value reflects the conversion of foreign currency-denominated RSUs translated into C$ using the foreign exchange rate as of the date of issuance. </span></div><div style="margin-bottom:6pt;margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">(d)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;padding-left:26.24pt">Deferred share units</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following is a summary of the changes in DSUs during the six months ended June&#160;30, 2021 and 2020:</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:61.538%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:16.816%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:1.327%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:16.819%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Number of DSUs</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Financial liability </span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance as of January 1, 2021</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">83,293&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">577&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Loss on revaluation</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">141&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance as of June&#160;30, 2021</span></td><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">83,293&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">718&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:61.538%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:16.816%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:1.327%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:16.819%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Number of DSUs</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Financial liability </span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance as of January 1, 2020</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">33,397&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">255&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">DSU liabilities settled</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(8,484)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(46)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Gain on revaluation</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(56)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance as of June&#160;30, 2020</span></td><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">24,913&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">153&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(e)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;padding-left:24.91pt">Warrants</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following is a summary of the changes in warrants during the six months ended June&#160;30, 2021 and 2020:</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:49.316%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:23.205%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.772%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:23.207%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Weighted average exercise price (C$)</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Number of warrants</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance as of January 1, 2021</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.25&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7,987,349&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Exercise of warrants</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.25&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(7,987,349)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance as of June&#160;30, 2021</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:49.316%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:23.205%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.772%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:23.207%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Weighted average exercise price (C$)</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Number of warrants</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance as of January 1, 2020 and June 30, 2020</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.26&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">18,066,662&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr></table></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span><br/></span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As of June 30, 2021, there are no warrants outstanding other than the Altria Warrant. See Note 5. Derivative Liabilities for further description on the Altria Warrant.</span></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for share-based payment arrangement.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -URI http://asc.fasb.org/topic&amp;trid=2228938<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>27
<FILENAME>R13.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.2</span><table class="report" border="0" cellspacing="2" id="idm140381999607400">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Earnings (Loss) Per Share<br></strong></div></th>
<th class="th" colspan="1">6 Months Ended</th>
</tr>
<tr><th class="th"><div>Jun. 30, 2021</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EarningsPerShareAbstract', window );"><strong>Earnings Per Share [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EarningsPerShareTextBlock', window );">Earnings (Loss) Per Share</a></td>
<td class="text">Earnings (Loss) per Share<div style="margin-bottom:3pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Basic and diluted earnings (loss) per share from continuing operations are calculated using the following numerators and denominators:</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:50.705%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.566%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.772%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.566%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.772%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.872%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.772%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.875%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">For the three months ended June 30,</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">For the six months ended June 30,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 2.12pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 2.12pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Basic earnings (loss) per share computation</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net income (loss) from continuing operations attributable to the shareholders of Cronos&#160;Group</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">57,615&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(106,931)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(103,676)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(30,891)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Weighted average number of common shares outstanding</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">371,721,382&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">349,075,408&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">367,391,118&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">348,946,439&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:11.25pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;Basic earnings (loss) from continuing operations per share</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(i)</span></div></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.15&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.31)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.28)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.09)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:9pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Loss from discontinued operations attributable to the shareholders of Cronos Group</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(561)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(46)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(582)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(46)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Weighted average number of common shares outstanding</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">371,721,382&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">349,075,408&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">367,391,118&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">348,946,439&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Basic earnings from discontinued operations per share</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.00&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.00&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.00&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.00&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:9pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Diluted earnings (loss) per share computation</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net income (loss) used in the computation of basic earnings (loss) from continuing operations per share</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">57,615&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(106,931)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(103,676)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(30,891)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Adjustment for gain (loss) on revaluation of derivative liabilities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(729)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(729)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net income (loss) used in the computation of diluted earnings (loss) from continuing operations per share</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">57,615&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(107,660)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(103,676)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(31,620)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:9pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Weighted average number of common shares outstanding used in the computation of basic earnings (loss) per share</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">371,721,382&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">349,075,408&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">367,391,118</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">348,946,439</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Dilutive effect of warrants</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,577&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Dilutive effect of stock options</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,027,518&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Dilutive effect of RSUs</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">595,379&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><div style="padding-left:11.25pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Weighted average number of common shares for computation of diluted earnings (loss) from continuing operations per share</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(i)</span></div></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">375,349,856&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">349,075,408&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">367,391,118</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">348,946,439</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Diluted earnings (loss) from continuing operations per share</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.15&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.31)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.28)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.09)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:9pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Loss from discontinued operations attributable to the shareholders of Cronos Group</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(561)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(46)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(582)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(46)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Weighted average number of common shares for computation of diluted loss from discontinued operations per share</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">375,349,856&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">349,075,408&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">367,391,118&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">348,946,439&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Diluted earnings from discontinued operations per share</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.00&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.00&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.00&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.00&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-bottom:3pt;margin-top:3pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:400;line-height:120%;position:relative;top:-2.8pt;vertical-align:baseline">(i)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:13.1pt">In computing diluted earnings per share, incremental common shares are not considered in periods in which a net loss is reported as the inclusion of the common share equivalents would be anti-dilutive.</span></div><div style="margin-bottom:6pt;margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following securities were not included in the computation of diluted shares outstanding because the effect would be anti-dilutive or because conditions for contingently issuable shares were not satisfied at the end of the reporting periods.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:45.705%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.983%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:1.327%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.983%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:1.605%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.983%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:1.327%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.987%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Three months ended June&#160;30,</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Six months ended June&#160;30,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Ginkgo equity milestones</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">14,674,904&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">14,674,904&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">14,674,904&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">14,674,904&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Pre-emptive Rights</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10,683,330&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12,006,740&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10,984,166&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12,006,740&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Top-up Rights &#8211; fixed price</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,698,611&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">26,686,413&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7,406,031&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">26,686,413&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Top-up Rights &#8211; market price</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,504,561&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,941,349&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,063,822&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,941,349&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Altria Warrant</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">82,623,455&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">77,752,533&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">82,606,904&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">77,752,533&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Stock options</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,411,944&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10,495,235&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,136,113&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10,547,256&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Warrants</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">17,521,903&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,784,377&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">17,536,558&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Restricted share units</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">265,904&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,012,249&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">717,127&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,012,249&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total anti-dilutive securities</span></td><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">116,862,709&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">162,091,326&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">128,373,444&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">162,158,002&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerShareAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for earnings per share.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=109243012&amp;loc=SL65017193-207537<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=124432515&amp;loc=d3e3550-109257<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -URI http://asc.fasb.org/topic&amp;trid=2144383<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=124432515&amp;loc=d3e3630-109257<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerShareTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>28
<FILENAME>R14.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.2</span><table class="report" border="0" cellspacing="2" id="idm140381998030232">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Segment Information<br></strong></div></th>
<th class="th" colspan="1">6 Months Ended</th>
</tr>
<tr><th class="th"><div>Jun. 30, 2021</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SegmentReportingAbstract', window );"><strong>Segment Reporting [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SegmentReportingDisclosureTextBlock', window );">Segment Information</a></td>
<td class="text">Segment Information<div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Segment reporting is prepared on the same basis that the Company&#8217;s chief operating decision makers (the &#8220;CODMs&#8221;) manage the business, make operating decisions and assess the Company&#8217;s performance. The Company determined that it has the following two reportable segments: United States and Rest of World. </span><span style="color:#212529;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The United States operating segment consists of the </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">manufacture and distribution of hemp-derived CBD infused products. </span><span style="color:#212529;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Rest of World operating segment is involved in </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">the cultivation, manufacture, and marketing of cannabis and cannabis-derived products for the medical and adult-use markets</span><span style="color:#212529;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">These two segments represent the geographic regions in which the Company operates and the different product offerings within each geographic region. The results of each segment are regularly reviewed by the CODMs to assess the performance of the segment and make decisions regarding the allocation of resources. The CODMs review adjusted earnings (loss) before interest, tax, depreciation and amortization (&#8220;Adjusted EBITDA&#8221;) as the measure of segment profit or loss to evaluate performance of and allocate resources for its reportable segments. Adjusted EBITDA is defined as earnings before interest, tax, depreciation, non-cash items and items that do not reflect management&#8217;s assessment of on-going business performance.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The tables below set forth our condensed consolidated results of operations, expressed in thousands of U.S. dollars for the periods presented. Our condensed consolidated financial results for these periods are not necessarily indicative of the consolidated financial results that we will achieve in future periods</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Segment data was as follows for the three and six months ended June&#160;30, 2021 and 2020: </span></div><div style="margin-bottom:12pt;margin-top:6pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:49.316%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.566%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.772%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.566%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.772%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.566%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.772%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.570%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="21" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Three months ended June&#160;30, 2021</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">United States</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Rest of World</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Corporate Expenses</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Total</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cannabis flower</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11,597&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11,597&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cannabis extracts</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,227&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,531&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,758&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">267&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">267&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net revenue</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,227&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">13,395&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">15,622&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr><tr style="height:15pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Share of loss from equity accounted investments</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,115&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,115&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr><tr style="height:15pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Interest income</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">20&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,280&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,300&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Interest expense</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(7)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(7)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Interest income, net</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">20&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,273&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,293&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr><tr style="height:15pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total assets</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">709,956&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">386,805&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">741,850&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,838,611&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Depreciation and amortization</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">68&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">975&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,043&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Adjusted EBITDA</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(10,711)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(32,605)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(6,443)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(49,759)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Purchase of property, plant and equipment, net</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">239&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,428&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,667&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr></table></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:49.316%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.566%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.772%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.566%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.772%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.566%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.772%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.570%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="21" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Three months ended June 30, 2020</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">United States</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Rest of World</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Corporate Expenses</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Total</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cannabis flower</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,674&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,674&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cannabis extracts</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,174&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,917&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,091&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">118&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">118&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net revenue</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,174&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7,709&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9,883&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr><tr style="height:15pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Share of loss from equity accounted investments</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">794&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">794&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr><tr style="height:15pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Interest income</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,808&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,817&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Interest expense</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(83)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(83)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Interest income, net</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,725&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,734&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr><tr style="height:15pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total assets</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">250,470&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">348,569&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,311,248&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,910,287&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Depreciation and amortization</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">36&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">643&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">679&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Impairment loss on long-lived assets</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">40,000&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">40,000&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Adjusted EBITDA</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(4,785)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(18,618)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(3,583)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(26,986)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Purchase of property, plant and equipment, net</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">39&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,894&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,933&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-bottom:12pt;margin-top:6pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:49.316%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.566%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.772%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.566%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.772%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.566%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.772%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.570%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="21" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Six months ended June&#160;30, 2021</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">United States</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Rest of World</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Corporate Expenses</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Total</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cannabis flower</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">21,031&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">21,031&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cannabis extracts</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,668&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,234&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,902&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">300&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">300&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net revenue</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,668&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">23,565&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">28,233&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr><tr style="height:14pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Share of loss from equity accounted investments</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,758&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,758&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr><tr style="height:14pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Interest income</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">23&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,612&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,635&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Interest expense</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(13)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(13)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Interest income, net</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">23&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,599&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,622&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr><tr style="height:14pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total assets</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">709,956&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">386,805&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">741,850&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,838,611&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Depreciation and amortization</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">139&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,639&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,778&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Impairment loss on long-lived assets</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,741&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,741&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Adjusted EBITDA</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(20,221)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(54,789)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(11,323)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(86,333)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Purchase of property, plant and equipment, net</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">319&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8,028&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8,347&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr></table></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:49.316%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.566%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.772%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.566%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.772%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.566%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.772%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.570%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="21" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Six months ended June 30, 2020</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">United States</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Rest of World</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Corporate Expenses</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Total</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cannabis flower</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8,415&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8,415&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cannabis extracts</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,350&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,317&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9,667&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">233&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">233&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net revenue</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,350&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">13,965&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">18,315&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr><tr style="height:14pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Share of loss from equity accounted investments</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,966&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,966&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr><tr style="height:14pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Interest income</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">16&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11,559&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11,575&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Interest expense</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(90)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(90)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Interest income, net</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">16&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11,469&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11,485&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr><tr style="height:14pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total assets</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">250,470&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">348,569&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,311,248&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,910,287&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Depreciation and amortization</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">69&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,297&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,366&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Impairment loss on long-lived assets</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">40,000&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">40,000&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Adjusted EBITDA</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(10,567)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(47,628)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(5,846)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(64,041)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Purchase of property, plant and equipment, net</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">219&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">13,125&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">13,344&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr></table></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following tables set forth a reconciliation of net income (loss) as determined in accordance with U.S. GAAP to Adjusted EBITDA for the periods indicated:</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:42.650%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.233%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.772%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.233%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.772%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.233%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.772%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.235%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="21" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Three months ended June&#160;30, 2021</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">United States</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Rest of World</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Corporate Expenses</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Total</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 6.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net income (loss)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(11,719)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">79,627&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(11,133)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 7pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">56,775</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 18.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Interest income, net</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(20)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2,273)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2,293)</span></td></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 18.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Share of loss from equity accounted investments</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,115&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,115</span></td></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:17.25pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Gain on revaluation of derivative liabilities</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(ii)</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(115,248)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(115,248)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:17.25pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Transaction costs</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(iii)</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,758&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,758</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:17.25pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other, net</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(iv)</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,127)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,127)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:17.25pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Loss from discontinued operations</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(v)</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">561&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">561</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:17.25pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Share-based payments</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(vi)</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">822&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,743&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,565</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:17.25pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Review costs related to restatement of 2019 interim financial statements</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(vii)</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,932&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,932</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Depreciation and amortization</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">206&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,997&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,203</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Adjusted EBITDA</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(10,711)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(32,605)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(6,443)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(49,759)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:42.650%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.233%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.772%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.233%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.772%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.233%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.772%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.235%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="21" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Three months ended June&#160;30, 2020</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">United States</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Rest of World</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Corporate<br/>Expenses</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Total</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net loss</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(45,566)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(55,095)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(7,042)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 7pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(107,703)</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 25pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Interest income, net</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(9)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(3,725)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(3,734)</span></td></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 25pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Share of loss from equity accounted investments</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">794&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">794</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:24pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Impairment loss on long-lived assets</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(i)</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">40,000&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">40,000</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:24pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Loss on revaluation of derivative liabilities</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(ii)</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">35,880&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">35,880</span></td></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:24pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other, net</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(iv)</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:24pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Loss from discontinued operations</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(v)</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">46&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">46</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:24pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Share-based payments</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(vi)</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">756&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,790&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,546</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:24pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Review costs related to restatement of 2019 interim financial statements</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(vii)</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,459&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,459</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Depreciation and amortization</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">34&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,683&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,717</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Adjusted EBITDA</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(4,785)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(18,618)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(3,583)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(26,986)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:42.650%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.233%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.772%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.233%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.772%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.233%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.772%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.235%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="21" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Six months ended June&#160;30, 2021</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">United States</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Rest of World</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Corporate Expenses</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Total</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 6.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net loss</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(23,811)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(62,520)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(18,519)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 7pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(104,850)</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 18.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Interest income, net</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(23)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(4,599)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(4,622)</span></td></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 18.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Share of loss from equity accounted investments</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,758&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,758</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><div style="padding-left:17.25pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Impairment loss on long-lived assets</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(i)</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,741&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,741</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:17.25pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Loss on revaluation of derivative liabilities</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(ii)</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,626&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,626</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:17.25pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Transaction costs</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(iii)</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,259&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,259</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:17.25pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other, net</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(iv)</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(911)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(911)</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:17.25pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Loss from discontinued operations</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(v)</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">582&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">582</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:17.25pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Share-based payments</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(vi)</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,567&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,497&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,064</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:17.25pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Review costs related to restatement of 2019 interim financial statements</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(vii)</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,937&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,937</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Depreciation and amortization</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">305&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,778&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,083</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Adjusted EBITDA</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(20,221)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(54,789)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(11,323)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(86,333)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:42.650%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.233%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.772%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.233%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.772%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.233%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.772%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.235%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="21" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Six months ended June&#160;30, 2020</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">United States</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Rest of World</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Corporate Expenses</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Total</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net income (loss)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(52,082)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">33,772&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(13,712)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 7pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(32,022)</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Interest income, net</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(16)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(11,469)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(11,485)</span></td></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Share of loss from equity accounted investments</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,966&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,966</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><div style="padding-left:17.25pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Impairment loss on long-lived assets</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(i)</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">40,000&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">40,000</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:17.25pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Loss on revaluation of derivative liabilities</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(ii)</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(77,488)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(77,488)</span></td></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:17.25pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other, net</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(iv)</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(785)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(785)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:17.25pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Loss from discontinued operations</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(v)</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">46&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">46</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:17.25pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Share-based payments</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(vi)</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,462&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,520&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,982</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:17.25pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Review costs related to restatement of 2019 interim financial statements</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(vii)</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7,866&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7,866</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Depreciation and amortization</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">69&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,810&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,879</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Adjusted EBITDA</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(10,567)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(47,628)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(5,846)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(64,041)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-bottom:6pt;margin-top:3pt;padding-left:27pt;text-align:justify;text-indent:-27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:400;line-height:120%;position:relative;top:-2.8pt;vertical-align:baseline">(i)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:22.1pt">For the six months ended June 30, 2021, impairment loss on long-lived assets relates to impairment on a leased premise in the U.S. segment, and for the three and six months ended June 30, 2020, impairment loss on long-lived assets relates to impairment on goodwill and intangibles related to our U.S. segment in 2020. See Note 12. Impairment Loss on Long-Lived Assets.</span></div><div style="margin-bottom:3pt;margin-top:3pt;padding-left:27pt;text-align:justify;text-indent:-27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:400;line-height:120%;position:relative;top:-2.8pt;vertical-align:baseline">(ii)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:20.66pt">For the three and six months ended June 30, 2021 and 2020, gain/loss on revaluation of derivative liabilities represents the fair value changes on the derivative liabilities. See Note 5. Derivative Liabilities.</span></div><div style="margin-bottom:3pt;margin-top:3pt;padding-left:27pt;text-align:justify;text-indent:-27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:400;line-height:120%;position:relative;top:-2.8pt;vertical-align:baseline">(iii)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:19.22pt">For the three and six months ended June 30, 2021, transaction costs represents legal, financial and other advisory fees and expenses incurred in connection with various strategic investments. These costs are included in general and administrative expenses on the condensed consolidated statements of net income (loss) and comprehensive income (loss).</span></div><div style="margin-bottom:3pt;margin-top:3pt;padding-left:27pt;text-align:justify;text-indent:-27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:400;line-height:120%;position:relative;top:-2.8pt;vertical-align:baseline">(iv)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:19.5pt">For the three and six months ended June 30, 2021, other, net is related to gain recorded on sale of the Company&#8217;s Winnipeg facility previously designated as held-for-sale in the first quarter of 2021, For the three and six months ended June 30, 2020, other, net is primarily comprised of the gain recorded related to the sale of common shares of Aurora Cannabis, Inc. (&#8220;Aurora&#8221;), which were received in connection with the achievement of a milestone related to Aurora&#8217;s acquisition of Whistler Medical Marijuana Corporation.</span></div><div style="margin-bottom:3pt;margin-top:3pt;padding-left:27pt;text-align:justify;text-indent:-27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:400;line-height:120%;position:relative;top:-2.8pt;vertical-align:baseline">(v)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:20.94pt">For the three and six months ended June 30, 2020, loss from discontinued operations relates to the discontinuance of Original B.C. Ltd. (&#8220;OGBC&#8221;). See Note 11. Held-For-Sale Assets and Discontinued Operations.</span></div><div style="margin-bottom:3pt;margin-top:3pt;padding-left:27pt;text-align:justify;text-indent:-27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:400;line-height:120%;position:relative;top:-2.8pt;vertical-align:baseline">(vi)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:19.5pt">For the three and six months ended June 30, 2021 and 2020, share-based payments relates to the vesting expenses of share-based compensation awarded to employees under the Company&#8217;s share-based award plans as described in Note 6. Share-based Payments.</span></div><div style="margin-bottom:3pt;margin-top:3pt;padding-left:27pt;text-align:justify;text-indent:-27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:400;line-height:120%;position:relative;top:-2.8pt;vertical-align:baseline">(vii)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:18.06pt">For the three and six months ended June 30, 2021 and 2020, the financial statement review costs include costs related to the restatement of the Company&#8217;s 2019 interim financial statements, costs related to the Company&#8217;s responses to requests for information from various regulatory authorities relating to such restatement and legal costs defending shareholder class action complaints brought against the Company as a result of the restatement. </span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Net revenue attributed to a geographic region based on the location of the customer were as follows:</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:42.372%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.816%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:1.327%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.816%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:1.605%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.816%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:1.327%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.821%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Three months ended June 30,</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Six months ended June 30,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Canada</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10,664&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7,416&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">18,246&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">13,507&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Israel</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,310&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">293&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,828&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">293&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">United States</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,227&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,174&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,668&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,350&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other countries</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">421&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">491&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">165&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net revenue</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">15,622&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9,883&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">28,233&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">18,315&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Property, plant and equipment assets were physically located in the following geographic regions:</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:60.150%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:17.372%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:1.605%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:17.373%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">As of June&#160;30, 2021</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">As of December 31, 2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Canada</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">168,462&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">162,163&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Israel</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">23,936&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">23,143&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">United States</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,522&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,293&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total </span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">193,920&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">187,599&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company sells products through a limited number of major customers. Major customers are defined as customers that each individually accounted for greater than 10% of the Company&#8217;s revenues.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">United States</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">During the three and six months ended June&#160;30, 2021 and 2020, the U.S. segment had no major customers.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As of June&#160;30, 2021 and December 31, 2020, the Company had $106 and $65, respectively, in expected credit losses that have been recognized on receivables from contracts with customers.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">There was no loss from discontinued operations from the U.S. Segment for the three and six months ended June 30, 2021 and 2020.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Rest of World</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">During the three months ended June&#160;30, 2021, the Rest of World segment earned a total net revenue before excise taxes of $8,497 from three major customers, Ontario Cannabis Retail Corporation, Alberta Gaming, Liquor and Cannabis Commission and Soci&#233;t&#233; Qu&#233;b&#233;coise du Cannabis, accounting for 19%, 14% and 12%, respectively, of the Company&#8217;s total net revenue before excise taxes. During the three months ended June&#160;30, 2020, the Rest of World segment earned a total net revenue before excise taxes of $7,040 from four major customers, together accounting for 71% of the Company&#8217;s total net revenues before excise taxes.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">During the six months ended June 30, 2021, the Rest of World segment earned a total net revenue before excise taxes of $18,250 from four major customers, Ontario Cannabis Retail Corporation, Novolog Group, Soci&#233;t&#233; Qu&#233;b&#233;coise du Cannabis and Alberta Gaming, Liquor and Cannabis Commission, accounting for 15%, 14%, 13%, and 12% respectively, of the Company&#8217;s total net revenue before excise taxes. During the six months ended June&#160;30, 2020, the Rest of World segment earned a total net revenue before excise taxes of $11,819 from four major customers, together accounting for 65% of the Company&#8217;s total net revenues before excise taxes.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As of June&#160;30, 2021 and December 31, 2020, the Company had $158 and $9, respectively, in expected credit losses that have been recognized on receivables from contracts with customers.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The loss from discontinued operations from the Rest of World segment for the three months ended June&#160;30, 2021 and 2020 was $561 and $46, respectively. The loss from discontinued operations from the Rest of World segment for the six months ended June&#160;30, 2021 and 2020 was $582 and $46, respectively.</span></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SegmentReportingAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SegmentReportingAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SegmentReportingDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for reporting segments including data and tables. Reportable segments include those that meet any of the following quantitative thresholds a) it's reported revenue, including sales to external customers and intersegment sales or transfers is 10 percent or more of the combined revenue, internal and external, of all operating segments b) the absolute amount of its reported profit or loss is 10 percent or more of the greater, in absolute amount of 1) the combined reported profit of all operating segments that did not report a loss or 2) the combined reported loss of all operating segments that did report a loss c) its assets are 10 percent or more of the combined assets of all operating segments.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 31<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8924-108599<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 34<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8981-108599<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 21<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8721-108599<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 40<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e9031-108599<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8933-108599<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (e)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8933-108599<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 26<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8844-108599<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 41<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e9038-108599<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8933-108599<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8736-108599<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 42<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e9054-108599<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 15<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8657-108599<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 21<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8721-108599<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -URI http://asc.fasb.org/topic&amp;trid=2134510<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SegmentReportingDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>29
<FILENAME>R15.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.2</span><table class="report" border="0" cellspacing="2" id="idm140381998210472">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Commitments and Contingencies<br></strong></div></th>
<th class="th" colspan="1">6 Months Ended</th>
</tr>
<tr><th class="th"><div>Jun. 30, 2021</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LossContingencyAbstract', window );"><strong>Loss Contingency [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LossContingencyDisclosures', window );">Commitments and Contingencies</a></td>
<td class="text">Commitments and Contingencies<div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(a)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;padding-left:24.34pt">Commitments</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">There have been no material changes in the information regarding commitments as disclosed in the Company&#8217;s Annual Financial Statements.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(b)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;padding-left:23.78pt">Contingencies</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company is subject to various legal proceedings in the ordinary course of its business and in connection with its marketing, distribution and sale of its products. Many of these legal proceedings are in the early stages of litigation and seek damages that are unspecified or not quantified. Although the outcome of these matters cannot be predicted with certainty, the Company does not believe these legal proceedings, individually or in the aggregate, will have a material adverse effect on its financial condition but could be material to its results of operations for a quarterly period depending, in part, on its results for that quarter.</span></div><div style="margin-bottom:6pt;margin-top:6pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">(i)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%;padding-left:8.57pt">Class action complaints relating to restatement</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On March 11 and 12, 2020, two alleged shareholders of the Company separately filed two putative class action complaints in the U.S. District Court for the Eastern District of New York against the Company and its former Chief Executive Officer (now Executive Chairman) and Chief Financial Officer. The court has consolidated the cases, and the consolidated amended complaint alleges violations of Section 10(b) of the Securities Exchange Act of 1934 (the &#8220;Exchange Act&#8221;) and Rule 10b-5 promulgated thereunder against all defendants, and Section 20(a) of the Exchange Act against the individual defendants. The consolidated amended complaint generally alleges that certain of the Company&#8217;s prior public statements about revenues and internal controls were incorrect based on the Company&#8217;s disclosures relating to the Audit Committee of the Board of Directors&#8217; review of the appropriateness of revenue recognized in connection with certain bulk resin purchases and sales of products through the wholesale channel. The consolidated amended complaint does not quantify a damage request. Defendants moved to dismiss on February 8, 2021. </span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On June 3, 2020, an alleged shareholder filed a Statement of Claim, as amended on August 12, 2020, in the Ontario Superior Court of Justice in Toronto, Ontario, Canada, seeking, among other things, an order certifying the action as a class action on behalf of a putative class of shareholders and damages of an unspecified amount. The Amended Statement of Claim names the Company, its former Chief Executive Officer (now Executive Chairman), Chief Financial Officer, former Chief Financial Officer and Chief Commercial Officer, and current and former members of the Board of Directors as defendants and alleges breaches of the Ontario Securities Act, oppression under the Ontario Business Corporations Act and common law misrepresentation. The Amended Statement of Claim generally alleges that certain of the Company&#8217;s prior public statements about revenues and internal controls were misrepresentations based on the Company&#8217;s March 2, 2020 disclosure that the Audit Committee of the Board of Directors was conducting a review of the appropriateness of revenue recognized in connection with certain bulk resin purchases and sales of products through the wholesale channel, and the Company&#8217;s subsequent restatement. The Amended Statement of Claim does not quantify a damage request. On June 28, 2021, the Ontario Court dismissed motions brought by the plaintiff for leave to commence a claim for misrepresentation under the Ontario Securities Act and for certification of the action as a class action. The plaintiff appealed the Court&#8217;s dismissal of the motions, except with respect to the former Chief Financial Officer and Chief Commercial Officer, who agreed not to seek costs from plaintiff in connection with the dismissal of the motions</span></div><div style="margin-bottom:6pt;margin-top:6pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">(ii)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%;padding-left:5.8pt">Regulatory reviews relating to restatement</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company has been responding to requests for information from various regulatory authorities relating to its previously disclosed restatement of its financial statements for the first three quarters of 2019. The Company is responding to all such requests for information and cooperating with all regulatory authorities. The Company cannot predict the outcome of any such regulatory review or investigation and it is possible that additional investigations or one or more formal proceedings may be commenced against the Company and its current and former officers and directors in connection with these regulatory reviews and investigations. </span></div><div style="margin-bottom:6pt;margin-top:6pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">(iii)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%;padding-left:3.03pt">Litigation relating to marketing, distribution and sale of products</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On June 16, 2020, an alleged consumer filed a Statement of Claim on behalf of a class in the Court of Queen&#8217;s Bench of Alberta in Alberta, Canada, against the Company and other Canadian cannabis manufacturers and/or distributors. On December 4, 2020, a Third Amended Statement of Claim was filed, which added a second alleged consumer. The Third Amended Statement of Claim alleges claims related to the defendants&#8217; advertised content of cannabinoids in cannabis products for medicinal use on or after June 16, 2010 and cannabis products for adult use on or after October 17, 2018. The Third Amended Statement of Claim seeks a total of C$500 million for breach of contract, compensatory damages, and unjust enrichment or such other amount as may be proven in trial and C$5 million in punitive damages against each defendant, including the Company. The Third Amended Statement of Claim also seeks interest and costs associated with the action. The Company has not responded to the Third Amended Statement of Claim. </span></div>A number of claims, including purported class actions, have been brought in the U.S. against companies engaged in the U.S. hemp business alleging, among other things, violations of state consumer protection, health and advertising laws. On April 8, 2020, a putative class action complaint was filed in the U.S. District Court for the Central District of California against Redwood Holding Group, LLC (&#8220;Redwood&#8221;), alleging violations of California&#8217;s Unfair Competition Law, False Advertising Law, Consumers Legal Remedies Act, and breaches of the California Commercial Code for breach of express warranties and implied warranty of merchantability with respect to Redwood&#8217;s marketing and sale of U.S. hemp products. The complaint did not quantify a damage request. On April 10, 2020, the class action complaint was dismissed for certain pleading deficiencies and the plaintiff was granted leave until April 24, 2020 to amend the complaint to establish federal subject matter jurisdiction. On April 28, 2020, the action was dismissed without prejudice for failure to prosecute and for failure to comply with a court order. As of the date of this Quarterly Report, the plaintiff has not refiled the complaint. The Company expects litigation and regulatory proceedings relating to the marketing, distribution and sale of its products to increase.<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LossContingencyAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LossContingencyAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LossContingencyDisclosures">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for loss and gain contingencies. Describes any existing condition, situation, or set of circumstances involving uncertainty as of the balance sheet date (or prior to issuance of the financial statements) as to a probable or reasonably possible loss incurred by an entity that will ultimately be resolved when one or more future events occur or fail to occur, and typically discloses the amount of loss recorded or a range of possible loss, or an assertion that no reasonable estimate can be made.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 450<br> -SubTopic 30<br> -URI http://asc.fasb.org/subtopic&amp;trid=2127197<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 450<br> -SubTopic 20<br> -URI http://asc.fasb.org/subtopic&amp;trid=2127163<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LossContingencyDisclosures</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>30
<FILENAME>R16.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.2</span><table class="report" border="0" cellspacing="2" id="idm140382005203480">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Financial Instruments<br></strong></div></th>
<th class="th" colspan="1">6 Months Ended</th>
</tr>
<tr><th class="th"><div>Jun. 30, 2021</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RisksAndUncertaintiesAbstract', window );"><strong>Risks and Uncertainties [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ConcentrationRiskDisclosureTextBlock', window );">Financial Instruments</a></td>
<td class="text">Financial Instruments <div style="margin-bottom:6pt;margin-top:6pt;padding-left:36pt;text-align:justify;text-indent:-36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(a)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;padding-left:24.34pt">Fair value measurement </span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company complies with ASC 820, Fair Value Measurements, for its financial assets and liabilities that are re-measured and reported at fair value at each reporting period, and non-financial assets and liabilities that are re-measured and reported at fair value at least annually. In general, fair values are determined by:</span></div><div style="margin-bottom:6pt;margin-top:6pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Level 1 inputs utilize quoted prices (unadjusted) in active markets for identical assets or liabilities. </span></div><div style="margin-bottom:6pt;margin-top:6pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Level 2 inputs utilize data points that are observable such as quoted prices, interest rates and yield curves. </span></div><div style="margin-bottom:6pt;margin-top:6pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Level 3 inputs are unobservable data points for the asset or liability, and includes situations where there is little, if any, market activity for the asset or liability.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following tables present information about the Company&#8217;s assets that are measured at fair value on a recurring basis as of June&#160;30, 2021 and December 31, 2020 and indicate the fair value hierarchy of the valuation techniques the Company utilized to determine such fair value.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:45.983%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.983%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:1.327%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.983%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:1.327%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.983%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:1.327%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.987%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="21" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">June&#160;30, 2021</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Level 1</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Level 2</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Level 3</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Total</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cash and cash equivalents</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">895,181&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">895,181&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Short-term investments</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">201,699&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">201,699&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Derivative liabilities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">169,563&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">169,563&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:45.983%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.983%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:1.327%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.983%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:1.327%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.983%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:1.327%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.987%"/><td style="width:0.1%"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="21" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 31, 2020</span></td><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Level 1</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Level 2</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Level 3</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Total</span></td><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cash and cash equivalents</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,078,023&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,078,023&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Short-term investments</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">211,766&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">211,766&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Derivative liabilities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">163,410&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">163,410&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/></tr></table></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">There were no transfers between categories during the periods presented.</span></div><div style="margin-bottom:6pt;margin-top:6pt;padding-left:36pt;text-align:justify;text-indent:-36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(b)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;padding-left:23.78pt">Financial risks</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company&#8217;s activities expose it to a variety of financial risks, including credit risk, market risk, interest rate risk, liquidity risk, and foreign currency rate risk.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">(i)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%;padding-left:26.57pt">Credit risk</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Credit risk is the risk of financial loss to the Company if a customer or counterparty to a financial instrument fails to meet its contractual obligations. The Company is exposed to credit risk from its operating activities, primarily accounts receivable and other receivables, and its investing activities, including cash held with banks and financial institutions, short-term investments, loans receivable, and advances to joint ventures. The Company&#8217;s maximum exposure to this risk is equal to the carrying amount of these financial assets, which amounted to $1,210,287 and $1,403,491 as of June&#160;30, 2021 and December 31, 2020, respectively.</span></div><div style="margin-bottom:6pt;margin-top:6pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">(a)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:120%;padding-left:6.34pt">C</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">ash and cash equivalents, short-term investments, and other receivables</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company held cash and cash equivalents and short-term investments and related interest receivable. Short-term investments and related interest receivable represents short-term investments with a maturity of less than a year and accrued interest as of period end. The cash and cash equivalents and short-term investments, including guaranteed investment certificates and bankers&#8217; acceptances, are held with central banks and financial institutions that are highly rated. In addition to interest receivable, other receivables include sales taxes receivable from the government. As such, the Company has assessed an insignificant loss allowance on these financial instruments. </span></div><div style="margin-bottom:6pt;margin-top:6pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">(b)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;padding-left:6.34pt">Accounts receivable</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">An impairment analysis is performed at each reporting date using a provision matrix to measure expected credit losses. The provision rates are based on the days past due for groupings of various customer segments with similar loss patterns. The calculation reflects the probability-weighted outcome, the time value of money and reasonable and supportable information that is available at the reporting date about past events, current conditions and forecasts of future economic conditions. Accounts receivable are written off when there is no reasonable expectation of recovery. Indicators that there is no reasonable expectation of recovery include, among others, the failure of a debtor to engage in a repayment plan and a failure to make contractual payments for a period of greater than 120 days past due. As of June&#160;30, 2021 and December 31, 2020, the Company had an allowance for credit losses of $264 and $74, respectively.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As of June&#160;30, 2021, the Company has assessed that there is a concentration of credit risk, as 74% of the Company&#8217;s accounts receivable were due from four customers with an established credit history with the Company. As of December 31, 2020, 78% of the Company&#8217;s accounts receivable were due from four customers with an established credit history with the Company.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">(ii)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%;padding-left:23.8pt">Market risk</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Market risk is the risk that the fair value of, or future cash flows from, the Company&#8217;s financial instruments will significantly fluctuate due to changes in market prices. The value of financial instruments can be affected by changes in interest rates, market and economic conditions, and equity and commodity prices. The Company is exposed to market risk in divesting its investments, such that unfavorable market conditions could result in dispositions of investments at less than their carrying values. Further, the revaluation of securities classified as fair value through net income could result in significant write-downs of the Company&#8217;s investments, which would have an adverse impact on the Company&#8217;s financial position, unless these would flow through other comprehensive income.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company manages market risk by having a portfolio of securities from multiple issuers so that the Company is not materially exposed to any one issuer.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">(iii)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%;padding-left:21.03pt">Interest rate risk</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Interest rate risk is the risk that the value or yield of fixed-income investments may decline if interest rates change. Fluctuations in interest rates may impact the level of income and expense recorded on the cash equivalents and short-term investments, and the market value of all interest-earning assets, other than those which possess a short-term to maturity. A 10% change in the interest rate in effect on June&#160;30, 2021 and December 31, 2020 would not have a material effect on (i) fair value of the cash equivalents and short-term investments as the majority of the portfolio has a maturity date of three months or less or (ii) interest income. Management continues to monitor external interest rates and revise the Company&#8217;s investment strategy as a result. </span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">During the three months ended June&#160;30, 2021 and 2020, the Company recorded net interest income of $2,293 and $3,734, respectively. During the six months ended June&#160;30, 2021 and 2020, the Company recorded net interest income of $4,622 and $11,485, respectively.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">(iv)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%;padding-left:22.14pt">Liquidity risk</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Liquidity risk is the risk that the Company will not be able to meet its financial obligations as they become due and arises principally from the Company&#8217;s accounts payable and other liabilities. The Company&#8217;s policy is to review liquidity resources and ensure that sufficient funds are available to meet financial obligations as they become due. Further, the Company&#8217;s management is responsible for ensuring funds exist and are readily accessible to support business opportunities as they arise. The Company&#8217;s funding was primarily provided in the form of capital raised through the issuance of common shares and warrants. As of June&#160;30, 2021, the Company had assessed a concentration risk of vendors as 32% of accounts payables were due to one vendor. As of December 31, 2020, the Company had assessed a concentration risk of vendors as 64% due to four vendors.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">(v)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%;padding-left:24.91pt">Foreign currency risk</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Currency rate risk is the risk that the fair value of, or future cash flows from, the Company&#8217;s financial instruments will significantly fluctuate due to changes in foreign exchange rates. The Company is exposed to this risk on investments in equity investees denominated in dollars, A$ and C$, and other assets and liabilities denominated in A$ and C$. The Company is further exposed to this risk through subsidiaries operating in Israel and the U.S. as the Company&#8217;s functional currency is in Canadian dollars. The Company does not currently use foreign exchange contracts to hedge its exposure to currency rate risk. As such, the Company&#8217;s financial position and financial results may be adversely affected by the unfavorable fluctuations in currency exchange rates. </span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">During the three months ended June&#160;30, 2021 and 2020, the Company had foreign currency gain on translation of $13,470 and $51,871, respectively. During the six months ended June&#160;30, 2021 and 2020, the Company had foreign currency gain (loss) on translation of $29,754 and $(61,821), respectively. A 10% change in the exchange rates for the U.S. dollar would affect the carrying value of net assets by approximately $162,991 and $170,817 as of June&#160;30, 2021 and December 31, 2020, respectively.</span></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ConcentrationRiskDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for any concentrations existing at the date of the financial statements that make an entity vulnerable to a reasonably possible, near-term, severe impact. This disclosure informs financial statement users about the general nature of the risk associated with the concentration, and may indicate the percentage of concentration risk as of the balance sheet date.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 275<br> -URI http://asc.fasb.org/topic&amp;trid=2134479<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ConcentrationRiskDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RisksAndUncertaintiesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RisksAndUncertaintiesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>31
<FILENAME>R17.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.2</span><table class="report" border="0" cellspacing="2" id="idm140382095581768">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Held-For-Sale Assets and Discontinued Operations<br></strong></div></th>
<th class="th" colspan="1">6 Months Ended</th>
</tr>
<tr><th class="th"><div>Jun. 30, 2021</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DiscontinuedOperationsAndDisposalGroupsAbstract', window );"><strong>Discontinued Operations and Disposal Groups [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsDisclosureTextBlock', window );">Held-For-Sale Assets and Discontinued Operations</a></td>
<td class="text">Held-For-Sale Assets and Discontinued OperationsDuring the year ended December 31, 2020, the Company advanced its plans for the sale and disposal of substantially all of the assets of OGBC and as a result, OGBC&#8217;s results of operations were reclassified as discontinued operations in the accompanying condensed consolidated financial statements for all periods presented. During the quarter ended June 30, 2021, the Company determined that the fair value of OGBC was lower than the carrying value of the assets. As such, a write-down to these held-for-sale assets of $561 was recorded in the second quarter of 2021. As of June&#160;30, 2021, the assets and liabilities of OGBC continue to meet the definition of discontinued operations and are included as &#8220;held-for-sale&#8221; assets on the condensed consolidated balance sheet as of June&#160;30, 2021 and December 31, 2020, and loss from discontinued operations on the condensed consolidated statements of net income and comprehensive income for the three and six months ended June&#160;30, 2021 and 2020. <div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On June 10, 2021, the land and office building located in Winnipeg, Manitoba Canada, previously designated as held-for-sale in the first quarter of 2021, was sold for $2,059, net of costs to sell. As a result, the Company recorded a gain on the sale of $1,279 in other, net in its condensed consolidated income statement for the three and six months ended June 30, 2021.</span></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table summarizes the financial information for discontinued operations:</span><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:41.261%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.911%"/><td style="width:0.1%"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td style="width:1.0%"/><td style="width:11.816%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:1.327%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.816%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:1.605%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.816%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:1.327%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.821%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="9" style="border-bottom:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Three months ended June 30,</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="border-bottom:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Six months ended June 30,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Loss from discontinued operations, net of income taxes</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(561)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(46)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(582)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(46)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr></table></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:62.094%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.772%"/><td style="width:0.1%"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td style="width:0.1%"/><td style="width:0.772%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:15.983%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.494%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:15.985%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">As of June&#160;30, 2021</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">As of December 31, 2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">OGBC assets classified as held-for-sale</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">645&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,176&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr></table></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DiscontinuedOperationsAndDisposalGroupsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DiscontinuedOperationsAndDisposalGroupsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DisposalGroupsIncludingDiscontinuedOperationsDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure related to a disposal group. Includes, but is not limited to, a discontinued operation, disposal classified as held-for-sale or disposed of by means other than sale or disposal of an individually significant component.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -URI http://asc.fasb.org/topic&amp;trid=2155823<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -URI http://asc.fasb.org/subtopic&amp;trid=2122178<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DisposalGroupsIncludingDiscontinuedOperationsDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>32
<FILENAME>R18.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.2</span><table class="report" border="0" cellspacing="2" id="idm140381999764840">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Impairment Loss on Long-Lived Assets<br></strong></div></th>
<th class="th" colspan="1">6 Months Ended</th>
</tr>
<tr><th class="th"><div>Jun. 30, 2021</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract', window );"><strong>Goodwill and Intangible Assets Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AssetImpairmentChargesTextBlock', window );">Impairment Loss on Long-Lived Assets</a></td>
<td class="text">Impairment Loss on Long-Lived Assets<div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(a)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;padding-left:24.34pt">Property, plant, and equipment, net and right-of-use assets</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">During the six months ended June&#160;30, 2021, the Company recognized an impairment charge of $1,039 related to leasehold improvements located within leased premises, encompassing approximately 6,000 square feet, in Los Angeles, California, which the Company determined it no longer had plans to use. The significant change in the extent and manner in which the leasehold improvements are being used and the expectation that, more likely than not, the leasehold improvements will be disposed of before the end of their useful life triggered an impairment. The right-of-use lease asset associated with the leasehold improvements was also written down as a result of our decision to no longer use the leased premises. The Company recognized an impairment charge on the de-recognition of the right-of-use asset of $702 during the six months ended June&#160;30, 2021. Both of the impairment charges are recognized in the statement of net income (loss) as impairment loss on property, plant and equipment and right-of-use assets. No impairment charges were recorded during the three months ended June 30, 2021 and the three and six months ended June 30, 2020 on property, plant and equipment and right-of-use assets.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(b)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;padding-left:23.78pt">Intangible assets, net and goodwill</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Goodwill and indefinite life intangible assets are reviewed for impairment annually or more frequently when events or changes in circumstances indicate that fair value of the reporting unit has been reduced to less than its carrying value. During the three months ended June&#160;30, 2020, the Company concluded that the projected impact of the COVID-19 pandemic on its sales and revenues in the near term, together with the volatility in the market conditions during the quarter, represented potential indicators of impairment for the Company&#8217;s U.S. reporting unit as well as its Lord Jones brand acquired in September 2019. Accordingly, the Company performed an interim impairment analysis during the second quarter of 2020. As a result of this analysis, the Company recorded impairment charges of $35,000 on its U.S. reporting unit and $5,000 on its Lord Jones&#8482; brand for the three and six months ended June 30, 2020, when the carrying value of these assets exceeded their fair value. No triggering events were identified or impairment charges recorded during the three and six months ended June 30, 2021 on intangible assets and goodwill.</span></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AssetImpairmentChargesTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for the details of the charge against earnings resulting from the aggregate write down of all assets from their carrying value to their fair value. Disclosure may also include a description of the impaired asset and facts and circumstances leading to the impairment, amount of the impairment loss and where the loss is located in the income statement, method(s) for determining fair value, and the segment in which the impaired asset is reported.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AssetImpairmentChargesTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>33
<FILENAME>R19.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.2</span><table class="report" border="0" cellspacing="2" id="idm140381999723912">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Background, Basis of Presentation and Accounting Policies (Policies)<br></strong></div></th>
<th class="th" colspan="1">6 Months Ended</th>
</tr>
<tr><th class="th"><div>Jun. 30, 2021</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract', window );"><strong>Organization, Consolidation and Presentation of Financial Statements [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BasisOfAccountingPolicyPolicyTextBlock', window );">Basis of presentation</a></td>
<td class="text">Basis of presentation<div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The interim condensed consolidated financial statements of Cronos Group are unaudited. They have been prepared in accordance with Generally Accepted Accounting Principles in the United States (&#8220;U.S. GAAP&#8221;) for interim financial information and with applicable rules and regulations of the U.S. Securities and Exchange Commission relating to interim financial statements. Accordingly, they do not include all of the information and footnotes required by U.S. GAAP for complete financial statements. In the opinion of management, all adjustments (consisting of normal recurring accruals) considered necessary for a fair presentation have been included. Operating results for the three and six months ended June&#160;30, 2021 are not necessarily indicative of the results that may be expected for any other reporting period.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">These condensed consolidated financial statements should be read in conjunction with the Company&#8217;s audited consolidated financial statements and related notes included in its Annual Report on Form 10-K for the year ended December 31, 2020 (the &#8220;Annual Financial Statements&#8221;).</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Certain prior year amounts have been reclassified to conform to the current year presentation of our condensed consolidated financial statements. These reclassifications had no effect on the reported results of operations and ending shareholders&#8217; equity.</span></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock', window );">Adoption of new accounting pronouncements and New accounting pronouncements not yet adopted</a></td>
<td class="text">Adoption of new accounting pronouncements<div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On January 1, 2021, the Company adopted ASU No. 2020-01, Investments-Equity Securities (Topic 321), Investments-Equity Method and Joint Ventures (Topic 323), and Derivatives and Hedging (Topic 815) (&#8220;ASU No. 2020-01&#8221;). ASU No. 2020-01 clarifies the interaction of accounting for the transition into and out of the equity method as well as measuring certain purchased options and forward contracts to acquire investments. The adoption of ASU No. 2020-01 did not have an impact on the Company&#8217;s interim condensed consolidated financial statements.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On January 1, 2021, the Company adopted ASU 2019-12, Income Taxes (Topic 740): Simplifying the Accounting for Income Taxes (&#8220;ASU No. 2019-12&#8221;). ASU No. 2019-12 eliminates certain exceptions and simplifies the application of U.S. GAAP-related changes in enacted tax laws or rates and employee stock option plans. The adoption of ASU No. 2019-12 did not have an impact on the Company&#8217;s interim condensed consolidated financial statements.</span></div><div style="margin-bottom:6pt;margin-top:6pt;padding-left:36pt;text-align:justify;text-indent:-36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(e)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;padding-left:24.91pt">New accounting pronouncements not yet adopted</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In August 2020, the FASB issued ASU 2020-06, Debt &#8211;Debt with Conversion and Other Options (Subtopic 470-20) and Derivatives and Hedging&#8212;Contracts in Entity&#8217;s Own Equity (Subtopic 815&#8211;40) (&#8220;ASU No. 2020-06&#8221;). ASU No. 2020-06 simplifies the accounting for certain financial instruments with characteristics of liabilities and equity, including convertible instruments and contracts on an entity&#8217;s own equity. ASU No. 2020-06 is part of the FASB&#8217;s simplification initiative, which aims to reduce unnecessary complexity in U.S. GAAP. ASU No. 2020-06 is effective for fiscal years beginning after December 15, 2021, and interim periods within those fiscal years. The Company is currently evaluating the impact ASU No. 2020-06 will have on its condensed consolidated financial statements.</span></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BasisOfAccountingPolicyPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for basis of accounting, or basis of presentation, used to prepare the financial statements (for example, US Generally Accepted Accounting Principles, Other Comprehensive Basis of Accounting, IFRS).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BasisOfAccountingPolicyPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy pertaining to new accounting pronouncements that may impact the entity's financial reporting. Includes, but is not limited to, quantification of the expected or actual impact.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>34
<FILENAME>R20.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.2</span><table class="report" border="0" cellspacing="2" id="idm140381997910328">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Inventory, net (Tables)<br></strong></div></th>
<th class="th" colspan="1">6 Months Ended</th>
</tr>
<tr><th class="th"><div>Jun. 30, 2021</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InventoryDisclosureAbstract', window );"><strong>Inventory Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfInventoryCurrentTableTextBlock', window );">Schedule of Inventory</a></td>
<td class="text"><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Inventory, net is comprised of the following items:</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:59.733%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:1.605%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:16.816%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:1.327%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:16.819%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">As of June&#160;30, 2021</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">As of December 31, 2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Raw materials</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7,471&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11,489&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Work-in-progress</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">17,291&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">26,278&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Finished goods</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10,247&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,905&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Supplies and consumables</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">596&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">330&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">35,605&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">44,002&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InventoryDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InventoryDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfInventoryCurrentTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the carrying amount as of the balance sheet date of merchandise, goods, commodities, or supplies held for future sale or to be used in manufacturing, servicing or production process.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(6)(c))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(6)(b))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(6)(a))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6361739&amp;loc=d3e7789-107766<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfInventoryCurrentTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>35
<FILENAME>R21.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.2</span><table class="report" border="0" cellspacing="2" id="idm140382000238872">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Investments (Tables)<br></strong></div></th>
<th class="th" colspan="1">6 Months Ended</th>
</tr>
<tr><th class="th"><div>Jun. 30, 2021</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EquityMethodInvestmentsAndJointVenturesAbstract', window );"><strong>Equity Method Investments and Joint Ventures [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EquityMethodInvestmentsTextBlock', window );">Schedule of Investments in Associates and Joint Ventures</a></td>
<td class="text"><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">A reconciliation of the carrying amount of the investments in associates and joint ventures is as follows:</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:45.844%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:15.566%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:1.327%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:15.566%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:1.327%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:15.570%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Ownership interest</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">As of June&#160;30, 2021</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">As of December 31, 2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cronos Australia</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">31%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cronos GrowCo</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">50%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">19,022&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">19,235&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Natuera</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(i)</span></div></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">50%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,948&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">20,970&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">19,235&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-bottom:6pt;margin-top:3pt;padding-left:27pt;text-align:justify;text-indent:-27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:700;line-height:120%;position:relative;top:-2.8pt;vertical-align:baseline">(i)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:22.1pt">On April 1, 2021, the Company and an affiliate of Agroidea (&#8220;AGI&#8221;), the other joint venture partner of Natuera, converted all advances made to Natuera under the master loan agreement entered into with Natuera on September 27, 2019 (the &#8220;Natuera Series A Loan&#8221;), plus accrued interest, into equity of Natuera. Total aggregate gross advances to Natuera under the Natuera Series A Loan were $15,500, of which the Company advanced 50% and AGI advanced the remaining 50%, or $7,750 each. As a result, the Company transferred the carrying value of the Natuera Series A Loan of approximately $2,013 plus accrued interest of $540, for a total investment value of $2,553, which approximates fair value, to investments in equity accounted investees in respect of Natuera. See Note 4. Loans Receivable, net.</span></div><div style="margin-bottom:6pt;margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company&#8217;s share of net losses from equity investments accounted for under the equity method of accounting:</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:41.677%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.788%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.355%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.788%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.355%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.788%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.355%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.794%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">For the three months ended June&#160;30,</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">For the six months ended June&#160;30,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020</span></td></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cronos Australia</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(235)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(235)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cronos GrowCo</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(459)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(190)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(758)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(501)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Natuera</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(656)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(369)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2,000)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,230)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,115)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(794)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2,758)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,966)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfVariableInterestEntitiesTextBlock', window );">Schedule of Variable Interest Entities</a></td>
<td class="text">The following is a summary of the maximum exposure to loss as of June&#160;30, 2021 and December&#160;31, 2020:<table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:47.788%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:15.566%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.355%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:15.566%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.355%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:15.570%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Ownership interest</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">As of June&#160;30, 2021</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">As of December 31, 2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cronos Australia</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">31%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,573&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,530&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cronos GrowCo</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">50%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">21,723&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">21,125&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">MedMen Canada</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">50%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">494&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">467&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Natuera</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">50%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8,047&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8,154&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">31,837&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">31,276&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr></table><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EquityMethodInvestmentsAndJointVenturesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EquityMethodInvestmentsAndJointVenturesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EquityMethodInvestmentsTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of equity method investments including, but not limited to, name of each investee or group of investments, percentage ownership, difference between recorded amount of an investment and the value of the underlying equity in the net assets, and summarized financial information.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EquityMethodInvestmentsTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfVariableInterestEntitiesTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the significant judgments and assumptions made in determining whether a variable interest (as defined) held by the entity requires the variable interest entity (VIE) (as defined) to be consolidated and (or) disclose information about its involvement with the VIE, individually or in aggregate (as applicable); the nature of restrictions, if any, on the consolidated VIE's assets and on the settlement of its liabilities reported by an entity in its statement of financial position, including the carrying amounts of such assets and liabilities; the nature of, and changes in, the risks associated with involvement in the VIE; how involvement with the VIE affects the entity's financial position, financial performance, and cash flows; the lack of recourse if creditors (or beneficial interest holders) of the consolidated VIE have no recourse to the general credit of the primary beneficiary (if applicable); the terms of arrangements, giving consideration to both explicit arrangements and implicit variable interests, if any, that could require the entity to provide financial support to the VIE, including events or circumstances that could expose the entity to a loss; the methodology used by the entity for determining whether or not it is the primary beneficiary of the variable interest entity; the significant factors considered and judgments made in determining that the power to direct the activities of a VIE that most significantly impact the VIE's economic performance are shared (as defined); the carrying amounts and classification of assets and liabilities of the VIE included in the statement of financial position; the entity's maximum exposure to loss, if any, as a result of its involvement with the VIE, including how the maximum exposure is determined and significant sources of the entity's exposure to the VIE; a comparison of the carrying amounts of the assets and liabilities and the entity's maximum exposure to loss; information about any liquidity arrangements, guarantees, and (or) other commitments by third parties that may affect the fair value or risk of the entity's variable interest in the VIE; whether or not the entity has provided financial support or other support (explicitly or implicitly) to the VIE that it was not previously contractually required to provide or whether the entity intends to provide that support, including the type and amount of the support and the primary reasons for providing the support; and supplemental information the entity determines necessary to provide.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 5A<br> -URI http://asc.fasb.org/extlink&amp;oid=123419778&amp;loc=SL6759159-111685<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=123419778&amp;loc=d3e5747-111685<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -URI http://asc.fasb.org/extlink&amp;oid=123419778&amp;loc=SL6228884-111685<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=123419778&amp;loc=d3e5710-111685<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=123419778&amp;loc=d3e5728-111685<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfVariableInterestEntitiesTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>36
<FILENAME>R22.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.2</span><table class="report" border="0" cellspacing="2" id="idm140381999764840">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Loans Receivable, net (Tables)<br></strong></div></th>
<th class="th" colspan="1">6 Months Ended</th>
</tr>
<tr><th class="th"><div>Jun. 30, 2021</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ReceivablesAbstract', window );"><strong>Receivables [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfAccountsNotesLoansAndFinancingReceivableTextBlock', window );">Schedule of Loan Receivable</a></td>
<td class="text"><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:21.955%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:39.177%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:1.466%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:15.566%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:1.466%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:15.570%"/><td style="width:0.1%"/></tr><tr><td colspan="6" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">As of June&#160;30, 2021</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">As of December 31, 2020</span></td></tr><tr><td colspan="6" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><div style="padding-left:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Natuera Series A Loan</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(i)</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,518&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr><tr><td colspan="6" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><div style="padding-left:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">GrowCo Facility</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(ii)</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,614&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,137&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="6" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Add: Accrued interest</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,414&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">428&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr><tr><td colspan="6" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total current portion of loans receivable</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,028&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7,083&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr><tr><td colspan="6" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><div style="padding-left:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">GrowCo Facility</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(ii)</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">77,474&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">69,939&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr><tr><td colspan="6" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><div style="padding-left:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Mucci Promissory Note</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(iii)</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">13,969&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">13,324&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr><tr><td colspan="6" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><div style="padding-left:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cannasoul Collaboration Loan</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(iv)</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,870&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,261&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr><tr><td colspan="6" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Add: Accrued interest</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">800&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,667&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr><tr><td colspan="6" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total long-term portion of loans receivable</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">94,113&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">87,191&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr><tr><td colspan="6" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total loans receivable, net</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">99,141&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">94,274&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr></table></div><div style="margin-bottom:3pt;margin-top:3pt;padding-left:27pt;text-align:justify;text-indent:-27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(i)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:19.46pt">On April 1, 2021, the Company and AGI converted all advances made to Natuera under the Series A Loan, plus accrued interest, into equity of Natuera. Total aggregate gross advances to Natuera under the Natuera Series A Loan were $15,500, of which the Company advanced 50% and AGI advanced the remaining 50%, or $7,750 each. As a result, the Company transferred the carrying value of the Natuera Series A Loan of approximately $2,013 plus accrued interest of $540, for a total investment value of $2,553, which approximates fair value, to investments in equity accounted investees in respect of Natuera. See Note 3. Investments.</span></div><div style="margin-bottom:3pt;margin-top:3pt;padding-left:27pt;text-align:justify;text-indent:-27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:400;line-height:120%;position:relative;top:-2.8pt;vertical-align:baseline">(ii)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:20.66pt">As of June&#160;30, 2021 and December&#160;31, 2020, Cronos GrowCo had drawn C$100,000 ($80,678) and C$95,150 ($74,626), respectively, from a credit agreement it entered into with the Company in August 2019 (the &#8220;GrowCo Facility&#8221;). As of June&#160;30, 2021 and December&#160;31, 2020, the Company had an allowance for credit losses of $1,590 and $1,470, respectively, recorded against the GrowCo Facility.</span></div><div style="margin-bottom:3pt;margin-top:3pt;padding-left:27pt;text-align:justify;text-indent:-27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:400;line-height:120%;position:relative;top:-2.8pt;vertical-align:baseline">(iii)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:19.22pt">As of June&#160;30, 2021 and December&#160;31, 2020, the Company had an allowance for credit losses of $278 and</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">$259, respectively, recorded against the promissory note receivable agreement entered into with Mucci on June 28, 2019 (the &#8220;Mucci Promissory Note&#8221;).</span></div><div style="margin-bottom:6pt;margin-top:3pt;padding-left:27pt;text-align:justify;text-indent:-27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:400;line-height:120%;position:relative;top:-2.8pt;vertical-align:baseline">(iv)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:19.5pt">As of June&#160;30, 2021 and December&#160;31, 2020 CLS has received ILS 6,223 and ILS 4,149 (approximately $1,909 and $1,287 respectively) from the Cannasoul Collaboration Loan. As of June&#160;30, 2021 and December&#160;31, 2020, the Company had an allowance for credit losses of $39 and $25, respectively, recorded against the Cannasoul Collaboration Loan.</span></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ReceivablesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ReceivablesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfAccountsNotesLoansAndFinancingReceivableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the various types of trade accounts and notes receivable and for each the gross carrying value, allowance, and net carrying value as of the balance sheet date. Presentation is categorized by current, noncurrent and unclassified receivables.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.3,4)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfAccountsNotesLoansAndFinancingReceivableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>37
<FILENAME>R23.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.2</span><table class="report" border="0" cellspacing="2" id="idm140381999666664">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Derivative Liabilities (Tables)<br></strong></div></th>
<th class="th" colspan="1">6 Months Ended</th>
</tr>
<tr><th class="th"><div>Jun. 30, 2021</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract', window );"><strong>Derivative Instruments and Hedging Activities Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueNetDerivativeAssetLiabilityMeasuredOnRecurringBasisUnobservableInputReconciliationTableTextBlock', window );">Schedule of Reconciliation of Carrying Amounts</a></td>
<td class="text"><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">A reconciliation of the carrying amounts of the derivative liability for the three months ended June&#160;30, 2021 and 2020:</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:18.483%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.761%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.911%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:14.316%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.911%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.761%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.911%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:14.872%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.911%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.763%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">As of April 1, 2021</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Revaluation gain</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Out-of-period adjustment</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Foreign exchange effect</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">As of June 30, 2021</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(a) Altria Warrant</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">234,656&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(85,778)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,205&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">150,083&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(b) Pre-emptive Rights</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">20,173&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(6,360)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">113&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">13,926&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(c) Top-up Rights</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">17,471&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(23,110)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11,278&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(85)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,554&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">272,300&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(115,248)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11,278&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,233&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">169,563&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/></tr></table></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:18.483%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.761%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.911%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:14.316%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.911%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.761%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.911%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:14.872%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.911%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.763%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">As of April 1, 2020</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Revaluation loss</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Exercise of rights</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Foreign exchange effect</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">As of June&#160;30, 2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(a) Altria Warrant</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">132,366&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">30,052&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,540&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">165,958&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(b) Pre-emptive Rights</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">13,070&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,610&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">500&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">16,180&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(c) Top-up Rights</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">20,013&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,218&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(727)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,072&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">23,576&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">165,449&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">35,880&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(727)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,112&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">205,714&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/></tr></table></div><div style="margin-bottom:6pt;margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">A reconciliation of the carrying amounts of the derivative liability for the six months ended June&#160;30, 2021 and 2020:</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:18.483%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.761%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.911%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:14.316%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.911%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.761%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.911%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:14.872%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.911%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.763%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">As of January 1, 2021</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Revaluation loss/(gain)</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Exercise of rights</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Foreign exchange effect</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">As of June 30, 2021</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(a) Altria Warrant</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">138,858&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7,186&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,039&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">150,083&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(b) Pre-emptive Rights</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12,095&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,473&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">358&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">13,926&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(c) Top-up Rights</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12,457&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(7,033)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">130&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,554&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">163,410&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,626&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,527&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">169,563&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/></tr></table></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:18.483%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.761%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.911%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:14.316%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.911%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.761%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.911%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:14.872%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.911%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.763%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">As of January 1, 2020</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Revaluation loss/(gain)</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Exercise of rights</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Foreign exchange effect</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">As of June&#160;30, 2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(a) Altria Warrant</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">234,428&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(58,052)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(10,418)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">165,958&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(b) Pre-emptive Rights</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12,787&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,925&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(532)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">16,180&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(c) Top-up Rights</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">49,945&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(23,361)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(727)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2,281)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">23,576&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">297,160&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(77,488)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(727)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(13,231)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">205,714&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/></tr></table></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTableTextBlock', window );">Schedule of Fair Values of Derivative Liabilities</a></td>
<td class="text"><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The fair values of the derivative liabilities were determined using the Black-Scholes pricing model as of June&#160;30, 2021 and December 31, 2020 applying the following inputs:</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.583%"><tr><td style="width:1.0%"/><td style="width:31.257%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.639%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.357%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.639%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.357%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.639%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.776%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.639%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.357%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.639%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.357%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.644%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">As of June&#160;30, 2021</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">As of December 31, 2020</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Altria Warrant</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Pre-emptive Rights</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Top-up Rights</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Altria Warrant</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Pre-emptive Rights</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Top-up Rights</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Share price at valuation date </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(i)</span></div></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$10.68</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$10.68</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$10.68</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$8.84</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$8.84</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$8.84</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Subscription price </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(i)</span></div></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$19.00</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$16.25</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$16.25</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$19.00</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$16.25</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$16.25</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><div style="margin-top:1pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Weighted average risk-free interest rate </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">(ii)</span></div></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.38%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.28%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.31%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.21%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.17%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.13%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><div style="margin-top:1pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Weighted average expected life </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">(iii)</span></div></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.68</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.25</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.31</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.18</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.50</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.98</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><div style="margin-top:1pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Expected annualized volatility</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline"> (iv)</span></div></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">75%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">75%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">75%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">81%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">81%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">81%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Expected dividend yield</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;%</span></td></tr></table></div><div style="margin-top:6pt;padding-left:27pt;text-align:justify;text-indent:-27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:400;line-height:120%;position:relative;top:-2.8pt;vertical-align:baseline">(i)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:22.1pt">Per share in C$.</span></div><div style="margin-bottom:3pt;margin-top:3pt;padding-left:27pt;text-align:justify;text-indent:-27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:400;line-height:120%;position:relative;top:-2.8pt;vertical-align:baseline">(ii)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:20.66pt">The risk-free interest rate was based on Bank of Canada government treasury bills and bonds with a remaining term equal to the expected life of the derivative liabilities. As of June&#160;30, 2021 and December 31, 2020, the risk-free interest rate uses a range of approximately 0.15% to 0.85% and 0.10% to 0.39%, respectively, for the Pre-emptive Rights and Top-up Rights.</span></div><div style="margin-bottom:3pt;margin-top:3pt;padding-left:27pt;text-align:justify;text-indent:-27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:400;line-height:120%;position:relative;top:-2.8pt;vertical-align:baseline">(iii)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:19.22pt">The expected life represents the period of time, in years, that the derivative liabilities are expected to be outstanding. The expected life of the Pre-emptive Rights and Top-up Rights is determined based on the expected term of the underlying options, warrants, and shares, to which the Pre-emptive Rights and Top-up Rights are linked. As of June&#160;30, 2021 and December 31, 2020, the expected life uses a range of approximately 0.25 year to 4.25 years and 0.50 year to 5.00 years, respectively.</span></div><div style="margin-bottom:6pt;margin-top:3pt;padding-left:27pt;text-align:justify;text-indent:-27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:400;line-height:120%;position:relative;top:-2.8pt;vertical-align:baseline">(iv)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:19.5pt">Volatility was based on an equally weighted blended historical and implied volatility level of the underlying equity securities of the Company as of June&#160;30, 2021. As of December 31, 2020, volatility was based on the blended historical volatility levels of the Company and peer companies.</span></div><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cron_SensitivityAnalysisImpactOnNetIncomeLossTableTextBlock', window );">Schedule of Sensitivity Analysis</a></td>
<td class="text"><div style="margin-bottom:6pt;margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table quantifies each of the significant inputs described above and provides a sensitivity analysis of the impact on the reported values of the derivative liabilities. The sensitivity analysis for each significant input is performed by assuming a 10% decrease in the input while other significant inputs remain constant at management&#8217;s best estimate as of the respective dates. While a decrease in the inputs noted below would cause a decrease in the carrying value of the derivative liability, there would also be an equal but opposite impact on net income (loss).</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:28.761%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:1.466%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.038%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:1.327%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.038%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:1.327%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.038%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:1.327%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.038%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:1.327%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.038%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:1.327%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.048%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Decrease as of June&#160;30, 2021</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Decrease as of December 31, 2020</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Altria Warrant</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Pre-emptive Rights</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Top-up Rights</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Altria Warrant</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Pre-emptive Rights</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Top-up Rights</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Share price</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">31,375&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,146&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,302&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">25,819&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,527&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,989&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Weighted average expected life</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">14,220&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,266&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">502&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">13,541&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,988&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,121&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Expected annualized volatility</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">27,375&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,348&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">968&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">26,183&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,269&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,602&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr></table></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cron_SensitivityAnalysisImpactOnNetIncomeLossTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Sensitivity Analysis, Impact On Net Income (Loss) [Table Text Block]</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cron_SensitivityAnalysisImpactOnNetIncomeLossTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cron_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of input and valuation technique used to measure fair value and change in valuation approach and technique for each separate class of asset and liability measured on recurring and nonrecurring basis.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 820<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (bbb)<br> -URI http://asc.fasb.org/extlink&amp;oid=123874694&amp;loc=d3e19207-110258<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueNetDerivativeAssetLiabilityMeasuredOnRecurringBasisUnobservableInputReconciliationTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of financial instrument classified as a derivative asset (liability) after deduction of derivative liability (asset) using recurring unobservable inputs that reflect the entity's own assumption about the assumptions market participants would use in pricing.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 820<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123874694&amp;loc=d3e19279-110258<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 820<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=123874694&amp;loc=d3e19207-110258<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueNetDerivativeAssetLiabilityMeasuredOnRecurringBasisUnobservableInputReconciliationTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>38
<FILENAME>R24.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.2</span><table class="report" border="0" cellspacing="2" id="idm140382008754056">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Share-based Payments (Tables)<br></strong></div></th>
<th class="th" colspan="1">6 Months Ended</th>
</tr>
<tr><th class="th"><div>Jun. 30, 2021</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract', window );"><strong>Share-based Payment Arrangement [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock', window );">Summary of Stock-based Compensation Expense</a></td>
<td class="text"><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table summarizes the total share-based payments associated with the Company&#8217;s stock options and RSUs for the three and six months ended June 30, 2021 and 2020:</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:40.427%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.788%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.772%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.788%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.772%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.788%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.772%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.793%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">For the three months ended June&#160;30,</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">For the six months ended June&#160;30,</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Stock options</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,864&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,770&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,928&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,500&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">RSUs</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">701&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">776&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,136&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,482&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total share-based payments</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,565&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,546&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,064&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,982&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfStockOptionsRollForwardTableTextBlock', window );">Summary of the Changes in Options and Options Outstanding</a></td>
<td class="text"><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following is a summary of the changes in stock options during the six months ended June&#160;30, 2021 and 2020:</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:51.261%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.761%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:1.327%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.761%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:1.327%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.763%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Weighted average exercise price (C$)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:700;line-height:100%;position:relative;top:-2.8pt;vertical-align:baseline"> (i)</span></div></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Number of options</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Weighted average remaining contractual term (years)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance as of January 1, 2021</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5.40&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">13,755,148&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.30</span></td></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Exercise of options</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.14&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(5,349,818)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cancellation, forfeiture and expiry of options</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">14.86&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(33,699)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance as of June&#160;30, 2021</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7.45&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8,371,631&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.66</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Exercisable as of June&#160;30, 2021</span></td><td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6.49&#160;</span></td><td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,679,240&#160;</span></td><td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.43</span></td></tr></table></div><div style="margin-top:6pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:400;line-height:120%;position:relative;top:-2.8pt;vertical-align:baseline">(i)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:13.1pt">The weighted average exercise price reflects the conversion of foreign currency-denominated stock options translated into C$ using the average foreign exchange rate as of the date of issuance. </span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:51.538%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.483%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:1.327%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.483%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:1.327%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:14.042%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Weighted average exercise price (C$)</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Number of options</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Weighted average remaining contractual term (years)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance as of January 1, 2020</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.84&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">14,149,502&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.56</span></td></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Exercise of options</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.05&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,807,909)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cancellation, forfeiture and expiry of options</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">15.78&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(127,045)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance as of June&#160;30, 2020</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5.13&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12,214,548&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.05</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Exercisable as of June&#160;30, 2020</span></td><td style="background-color:#cceeff;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:3pt double #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.42&#160;</span></td><td style="background-color:#cceeff;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8,688,645&#160;</span></td><td style="background-color:#cceeff;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.78</span></td></tr></table></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table summarizes stock options outstanding for the 2020 Omnibus Plan, the 2018 Stock Option Plan, and the 2015 Stock Option Plan:</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.861%"><tr><td style="width:1.0%"/><td style="width:52.168%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:21.431%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:1.468%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:21.433%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Stock options outstanding as of</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">June 30, 2021</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 31, 2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2020 Omnibus Plan</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,000,000&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,000,000&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2018 Stock Option Plan </span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,586,725</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,627,715&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2015 Stock Option Plan </span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,784,906&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10,127,433&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total stock options outstanding</span></td><td colspan="3" style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8,371,631</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">13,755,148&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr></table></div><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfShareBasedCompensationRestrictedStockUnitsAwardActivityTableTextBlock', window );">Summary of Changes in RSUs</a></td>
<td class="text"><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following is a summary of the changes in RSUs for the six months ended June&#160;30, 2021 and 2020: </span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:61.538%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:16.816%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:1.327%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:16.819%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Number of RSUs</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:700;line-height:100%;position:relative;top:-2.8pt;vertical-align:baseline"> (i)</span></div></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Weighted average grant date fair value (C$)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:700;line-height:100%;position:relative;top:-2.8pt;vertical-align:baseline">(ii)</span></div></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance as of January 1, 2021</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">948,357&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7.66&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Granted</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(i)</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">515,433&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11.29&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Vested and issued</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(89,912)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7.52&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance as of June&#160;30, 2021</span></td><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,373,878&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9.03&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:61.538%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:16.816%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:1.327%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:16.819%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Number of RSUs</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:700;line-height:100%;position:relative;top:-2.8pt;vertical-align:baseline"> (i)</span></div></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Weighted average grant date fair value (C$)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:700;line-height:100%;position:relative;top:-2.8pt;vertical-align:baseline">(ii)</span></div></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance as of January 1, 2020</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">732,972&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">15.34&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Granted</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(i)</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">279,277&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7.52&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance as of June&#160;30, 2020</span></td><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,012,249&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">13.18&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-bottom:6pt;margin-top:6pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:400;line-height:120%;position:relative;top:-2.8pt;vertical-align:baseline">(i)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:13.1pt">RSUs granted in the period vest annually in equal installments over a three-year period following the grant date, subject to such holder&#8217;s continued employment through each vesting date. The vesting of such RSUs is not subject to the achievement of any performance criteria.</span></div>(ii)The weighted average grant date fair value reflects the conversion of foreign currency-denominated RSUs translated into C$ using the foreign exchange rate as of the date of issuance.<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfOtherShareBasedCompensationActivityTableTextBlock', window );">Summary of Changes in DSUs and Warrants</a></td>
<td class="text"><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following is a summary of the changes in DSUs during the six months ended June&#160;30, 2021 and 2020:</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:61.538%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:16.816%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:1.327%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:16.819%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Number of DSUs</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Financial liability </span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance as of January 1, 2021</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">83,293&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">577&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Loss on revaluation</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">141&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance as of June&#160;30, 2021</span></td><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">83,293&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">718&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:61.538%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:16.816%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:1.327%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:16.819%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Number of DSUs</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Financial liability </span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance as of January 1, 2020</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">33,397&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">255&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">DSU liabilities settled</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(8,484)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(46)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Gain on revaluation</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(56)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance as of June&#160;30, 2020</span></td><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">24,913&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">153&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following is a summary of the changes in warrants during the six months ended June&#160;30, 2021 and 2020:</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:49.316%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:23.205%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.772%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:23.207%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Weighted average exercise price (C$)</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Number of warrants</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance as of January 1, 2021</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.25&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7,987,349&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Exercise of warrants</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.25&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(7,987,349)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance as of June&#160;30, 2021</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:49.316%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:23.205%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.772%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:23.207%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Weighted average exercise price (C$)</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Number of warrants</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance as of January 1, 2020 and June 30, 2020</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.26&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">18,066,662&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr></table></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of allocation of amount expensed and capitalized for award under share-based payment arrangement to statement of income or comprehensive income and statement of financial position. Includes, but is not limited to, corresponding line item in financial statement.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (h)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 14.F)<br> -URI http://asc.fasb.org/extlink&amp;oid=122041274&amp;loc=d3e301413-122809<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5047-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfOtherShareBasedCompensationActivityTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of activity for outstanding award under share-based payment arrangement excluding share and unit options and nonvested award.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfOtherShareBasedCompensationActivityTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfShareBasedCompensationRestrictedStockUnitsAwardActivityTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the number and weighted-average grant date fair value for restricted stock units that were outstanding at the beginning and end of the year, and the number of restricted stock units that were granted, vested, or forfeited during the year.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfShareBasedCompensationRestrictedStockUnitsAwardActivityTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfStockOptionsRollForwardTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the change in stock options.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfStockOptionsRollForwardTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>39
<FILENAME>R25.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.2</span><table class="report" border="0" cellspacing="2" id="idm140381999793832">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Earnings (Loss) Per Share (Tables)<br></strong></div></th>
<th class="th" colspan="1">6 Months Ended</th>
</tr>
<tr><th class="th"><div>Jun. 30, 2021</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EarningsPerShareAbstract', window );"><strong>Earnings Per Share [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock', window );">Schedule of Earnings (Loss) Per Share</a></td>
<td class="text"><div style="margin-bottom:3pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Basic and diluted earnings (loss) per share from continuing operations are calculated using the following numerators and denominators:</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:50.705%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.566%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.772%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.566%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.772%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.872%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.772%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.875%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">For the three months ended June 30,</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">For the six months ended June 30,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 2.12pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 2.12pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Basic earnings (loss) per share computation</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net income (loss) from continuing operations attributable to the shareholders of Cronos&#160;Group</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">57,615&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(106,931)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(103,676)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(30,891)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Weighted average number of common shares outstanding</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">371,721,382&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">349,075,408&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">367,391,118&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">348,946,439&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:11.25pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;Basic earnings (loss) from continuing operations per share</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(i)</span></div></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.15&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.31)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.28)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.09)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:9pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Loss from discontinued operations attributable to the shareholders of Cronos Group</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(561)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(46)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(582)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(46)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Weighted average number of common shares outstanding</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">371,721,382&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">349,075,408&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">367,391,118&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">348,946,439&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Basic earnings from discontinued operations per share</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.00&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.00&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.00&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.00&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:9pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Diluted earnings (loss) per share computation</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net income (loss) used in the computation of basic earnings (loss) from continuing operations per share</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">57,615&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(106,931)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(103,676)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(30,891)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Adjustment for gain (loss) on revaluation of derivative liabilities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(729)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(729)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net income (loss) used in the computation of diluted earnings (loss) from continuing operations per share</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">57,615&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(107,660)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(103,676)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(31,620)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:9pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Weighted average number of common shares outstanding used in the computation of basic earnings (loss) per share</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">371,721,382&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">349,075,408&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">367,391,118</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">348,946,439</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Dilutive effect of warrants</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,577&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Dilutive effect of stock options</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,027,518&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Dilutive effect of RSUs</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">595,379&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><div style="padding-left:11.25pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Weighted average number of common shares for computation of diluted earnings (loss) from continuing operations per share</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(i)</span></div></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">375,349,856&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">349,075,408&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">367,391,118</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">348,946,439</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Diluted earnings (loss) from continuing operations per share</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.15&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.31)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.28)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.09)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:9pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Loss from discontinued operations attributable to the shareholders of Cronos Group</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(561)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(46)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(582)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(46)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Weighted average number of common shares for computation of diluted loss from discontinued operations per share</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">375,349,856&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">349,075,408&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">367,391,118&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">348,946,439&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Diluted earnings from discontinued operations per share</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.00&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.00&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.00&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.00&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-bottom:3pt;margin-top:3pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:400;line-height:120%;position:relative;top:-2.8pt;vertical-align:baseline">(i)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:13.1pt">In computing diluted earnings per share, incremental common shares are not considered in periods in which a net loss is reported as the inclusion of the common share equivalents would be anti-dilutive.</span></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock', window );">Schedule of Antidilutive Securities Excluded from Computation of Diluted Shares Outstanding</a></td>
<td class="text"><div style="margin-bottom:6pt;margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following securities were not included in the computation of diluted shares outstanding because the effect would be anti-dilutive or because conditions for contingently issuable shares were not satisfied at the end of the reporting periods.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:45.705%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.983%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:1.327%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.983%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:1.605%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.983%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:1.327%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.987%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Three months ended June&#160;30,</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Six months ended June&#160;30,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Ginkgo equity milestones</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">14,674,904&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">14,674,904&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">14,674,904&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">14,674,904&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Pre-emptive Rights</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10,683,330&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12,006,740&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10,984,166&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12,006,740&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Top-up Rights &#8211; fixed price</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,698,611&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">26,686,413&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7,406,031&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">26,686,413&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Top-up Rights &#8211; market price</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,504,561&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,941,349&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,063,822&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,941,349&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Altria Warrant</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">82,623,455&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">77,752,533&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">82,606,904&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">77,752,533&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Stock options</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,411,944&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10,495,235&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,136,113&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10,547,256&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Warrants</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">17,521,903&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,784,377&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">17,536,558&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Restricted share units</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">265,904&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,012,249&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">717,127&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,012,249&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total anti-dilutive securities</span></td><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">116,862,709&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">162,091,326&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">128,373,444&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">162,158,002&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerShareAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of securities (including those issuable pursuant to contingent stock agreements) that could potentially dilute basic earnings per share (EPS) in the future that were not included in the computation of diluted EPS because to do so would increase EPS amounts or decrease loss per share amounts for the period presented, by antidilutive securities.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=124432515&amp;loc=d3e3550-109257<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of an entity's basic and diluted earnings per share calculations, including a reconciliation of numerators and denominators of the basic and diluted per-share computations for income from continuing operations.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124432515&amp;loc=d3e3550-109257<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>40
<FILENAME>R26.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.2</span><table class="report" border="0" cellspacing="2" id="idm140381997911176">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Segment Information (Tables)<br></strong></div></th>
<th class="th" colspan="1">6 Months Ended</th>
</tr>
<tr><th class="th"><div>Jun. 30, 2021</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SegmentReportingAbstract', window );"><strong>Segment Reporting [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock', window );">Schedule of Segment Data and Adjusted EBITDA</a></td>
<td class="text"><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Segment data was as follows for the three and six months ended June&#160;30, 2021 and 2020: </span></div><div style="margin-bottom:12pt;margin-top:6pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:49.316%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.566%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.772%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.566%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.772%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.566%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.772%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.570%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="21" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Three months ended June&#160;30, 2021</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">United States</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Rest of World</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Corporate Expenses</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Total</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cannabis flower</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11,597&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11,597&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cannabis extracts</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,227&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,531&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,758&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">267&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">267&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net revenue</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,227&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">13,395&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">15,622&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr><tr style="height:15pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Share of loss from equity accounted investments</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,115&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,115&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr><tr style="height:15pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Interest income</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">20&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,280&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,300&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Interest expense</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(7)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(7)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Interest income, net</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">20&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,273&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,293&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr><tr style="height:15pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total assets</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">709,956&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">386,805&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">741,850&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,838,611&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Depreciation and amortization</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">68&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">975&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,043&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Adjusted EBITDA</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(10,711)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(32,605)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(6,443)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(49,759)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Purchase of property, plant and equipment, net</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">239&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,428&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,667&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr></table></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:49.316%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.566%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.772%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.566%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.772%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.566%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.772%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.570%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="21" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Three months ended June 30, 2020</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">United States</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Rest of World</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Corporate Expenses</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Total</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cannabis flower</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,674&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,674&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cannabis extracts</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,174&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,917&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,091&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">118&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">118&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net revenue</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,174&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7,709&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9,883&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr><tr style="height:15pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Share of loss from equity accounted investments</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">794&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">794&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr><tr style="height:15pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Interest income</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,808&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,817&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Interest expense</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(83)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(83)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Interest income, net</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,725&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,734&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr><tr style="height:15pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total assets</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">250,470&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">348,569&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,311,248&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,910,287&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Depreciation and amortization</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">36&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">643&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">679&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Impairment loss on long-lived assets</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">40,000&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">40,000&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Adjusted EBITDA</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(4,785)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(18,618)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(3,583)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(26,986)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Purchase of property, plant and equipment, net</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">39&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,894&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,933&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-bottom:12pt;margin-top:6pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:49.316%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.566%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.772%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.566%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.772%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.566%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.772%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.570%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="21" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Six months ended June&#160;30, 2021</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">United States</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Rest of World</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Corporate Expenses</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Total</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cannabis flower</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">21,031&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">21,031&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cannabis extracts</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,668&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,234&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,902&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">300&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">300&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net revenue</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,668&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">23,565&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">28,233&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr><tr style="height:14pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Share of loss from equity accounted investments</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,758&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,758&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr><tr style="height:14pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Interest income</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">23&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,612&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,635&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Interest expense</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(13)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(13)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Interest income, net</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">23&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,599&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,622&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr><tr style="height:14pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total assets</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">709,956&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">386,805&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">741,850&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,838,611&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Depreciation and amortization</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">139&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,639&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,778&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Impairment loss on long-lived assets</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,741&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,741&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Adjusted EBITDA</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(20,221)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(54,789)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(11,323)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(86,333)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Purchase of property, plant and equipment, net</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">319&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8,028&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8,347&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr></table></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:49.316%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.566%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.772%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.566%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.772%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.566%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.772%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.570%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="21" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Six months ended June 30, 2020</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">United States</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Rest of World</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Corporate Expenses</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Total</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cannabis flower</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8,415&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8,415&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cannabis extracts</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,350&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,317&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9,667&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">233&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">233&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net revenue</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,350&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">13,965&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">18,315&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr><tr style="height:14pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Share of loss from equity accounted investments</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,966&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,966&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr><tr style="height:14pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Interest income</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">16&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11,559&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11,575&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Interest expense</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(90)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(90)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Interest income, net</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">16&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11,469&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11,485&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr><tr style="height:14pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total assets</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">250,470&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">348,569&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,311,248&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,910,287&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Depreciation and amortization</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">69&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,297&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,366&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Impairment loss on long-lived assets</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">40,000&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">40,000&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Adjusted EBITDA</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(10,567)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(47,628)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(5,846)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(64,041)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Purchase of property, plant and equipment, net</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">219&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">13,125&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">13,344&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr></table></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following tables set forth a reconciliation of net income (loss) as determined in accordance with U.S. GAAP to Adjusted EBITDA for the periods indicated:</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:42.650%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.233%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.772%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.233%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.772%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.233%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.772%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.235%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="21" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Three months ended June&#160;30, 2021</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">United States</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Rest of World</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Corporate Expenses</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Total</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 6.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net income (loss)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(11,719)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">79,627&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(11,133)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 7pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">56,775</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 18.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Interest income, net</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(20)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2,273)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2,293)</span></td></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 18.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Share of loss from equity accounted investments</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,115&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,115</span></td></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:17.25pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Gain on revaluation of derivative liabilities</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(ii)</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(115,248)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(115,248)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:17.25pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Transaction costs</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(iii)</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,758&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,758</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:17.25pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other, net</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(iv)</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,127)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,127)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:17.25pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Loss from discontinued operations</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(v)</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">561&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">561</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:17.25pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Share-based payments</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(vi)</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">822&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,743&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,565</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:17.25pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Review costs related to restatement of 2019 interim financial statements</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(vii)</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,932&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,932</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Depreciation and amortization</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">206&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,997&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,203</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Adjusted EBITDA</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(10,711)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(32,605)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(6,443)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(49,759)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:42.650%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.233%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.772%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.233%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.772%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.233%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.772%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.235%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="21" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Three months ended June&#160;30, 2020</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">United States</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Rest of World</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Corporate<br/>Expenses</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Total</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net loss</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(45,566)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(55,095)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(7,042)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 7pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(107,703)</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 25pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Interest income, net</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(9)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(3,725)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(3,734)</span></td></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 25pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Share of loss from equity accounted investments</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">794&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">794</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:24pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Impairment loss on long-lived assets</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(i)</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">40,000&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">40,000</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:24pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Loss on revaluation of derivative liabilities</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(ii)</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">35,880&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">35,880</span></td></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:24pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other, net</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(iv)</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:24pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Loss from discontinued operations</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(v)</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">46&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">46</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:24pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Share-based payments</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(vi)</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">756&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,790&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,546</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:24pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Review costs related to restatement of 2019 interim financial statements</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(vii)</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,459&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,459</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Depreciation and amortization</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">34&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,683&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,717</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Adjusted EBITDA</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(4,785)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(18,618)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(3,583)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(26,986)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:42.650%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.233%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.772%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.233%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.772%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.233%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.772%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.235%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="21" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Six months ended June&#160;30, 2021</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">United States</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Rest of World</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Corporate Expenses</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Total</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 6.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net loss</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(23,811)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(62,520)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(18,519)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 7pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(104,850)</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 18.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Interest income, net</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(23)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(4,599)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(4,622)</span></td></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 18.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Share of loss from equity accounted investments</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,758&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,758</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><div style="padding-left:17.25pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Impairment loss on long-lived assets</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(i)</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,741&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,741</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:17.25pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Loss on revaluation of derivative liabilities</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(ii)</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,626&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,626</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:17.25pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Transaction costs</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(iii)</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,259&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,259</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:17.25pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other, net</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(iv)</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(911)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(911)</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:17.25pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Loss from discontinued operations</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(v)</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">582&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">582</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:17.25pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Share-based payments</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(vi)</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,567&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,497&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,064</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:17.25pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Review costs related to restatement of 2019 interim financial statements</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(vii)</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,937&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,937</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Depreciation and amortization</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">305&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,778&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,083</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Adjusted EBITDA</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(20,221)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(54,789)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(11,323)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(86,333)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:42.650%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.233%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.772%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.233%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.772%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.233%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.772%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.235%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="21" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Six months ended June&#160;30, 2020</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">United States</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Rest of World</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Corporate Expenses</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Total</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net income (loss)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(52,082)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">33,772&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(13,712)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 7pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(32,022)</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Interest income, net</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(16)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(11,469)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(11,485)</span></td></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Share of loss from equity accounted investments</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,966&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,966</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><div style="padding-left:17.25pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Impairment loss on long-lived assets</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(i)</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">40,000&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">40,000</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:17.25pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Loss on revaluation of derivative liabilities</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(ii)</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(77,488)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(77,488)</span></td></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:17.25pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other, net</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(iv)</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(785)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(785)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:17.25pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Loss from discontinued operations</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(v)</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">46&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">46</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:17.25pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Share-based payments</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(vi)</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,462&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,520&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,982</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:17.25pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Review costs related to restatement of 2019 interim financial statements</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(vii)</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7,866&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7,866</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Depreciation and amortization</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">69&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,810&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 7pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,879</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Adjusted EBITDA</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(10,567)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(47,628)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(5,846)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(64,041)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-bottom:6pt;margin-top:3pt;padding-left:27pt;text-align:justify;text-indent:-27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:400;line-height:120%;position:relative;top:-2.8pt;vertical-align:baseline">(i)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:22.1pt">For the six months ended June 30, 2021, impairment loss on long-lived assets relates to impairment on a leased premise in the U.S. segment, and for the three and six months ended June 30, 2020, impairment loss on long-lived assets relates to impairment on goodwill and intangibles related to our U.S. segment in 2020. See Note 12. Impairment Loss on Long-Lived Assets.</span></div><div style="margin-bottom:3pt;margin-top:3pt;padding-left:27pt;text-align:justify;text-indent:-27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:400;line-height:120%;position:relative;top:-2.8pt;vertical-align:baseline">(ii)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:20.66pt">For the three and six months ended June 30, 2021 and 2020, gain/loss on revaluation of derivative liabilities represents the fair value changes on the derivative liabilities. See Note 5. Derivative Liabilities.</span></div><div style="margin-bottom:3pt;margin-top:3pt;padding-left:27pt;text-align:justify;text-indent:-27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:400;line-height:120%;position:relative;top:-2.8pt;vertical-align:baseline">(iii)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:19.22pt">For the three and six months ended June 30, 2021, transaction costs represents legal, financial and other advisory fees and expenses incurred in connection with various strategic investments. These costs are included in general and administrative expenses on the condensed consolidated statements of net income (loss) and comprehensive income (loss).</span></div><div style="margin-bottom:3pt;margin-top:3pt;padding-left:27pt;text-align:justify;text-indent:-27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:400;line-height:120%;position:relative;top:-2.8pt;vertical-align:baseline">(iv)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:19.5pt">For the three and six months ended June 30, 2021, other, net is related to gain recorded on sale of the Company&#8217;s Winnipeg facility previously designated as held-for-sale in the first quarter of 2021, For the three and six months ended June 30, 2020, other, net is primarily comprised of the gain recorded related to the sale of common shares of Aurora Cannabis, Inc. (&#8220;Aurora&#8221;), which were received in connection with the achievement of a milestone related to Aurora&#8217;s acquisition of Whistler Medical Marijuana Corporation.</span></div><div style="margin-bottom:3pt;margin-top:3pt;padding-left:27pt;text-align:justify;text-indent:-27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:400;line-height:120%;position:relative;top:-2.8pt;vertical-align:baseline">(v)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:20.94pt">For the three and six months ended June 30, 2020, loss from discontinued operations relates to the discontinuance of Original B.C. Ltd. (&#8220;OGBC&#8221;). See Note 11. Held-For-Sale Assets and Discontinued Operations.</span></div><div style="margin-bottom:3pt;margin-top:3pt;padding-left:27pt;text-align:justify;text-indent:-27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5.2pt;font-weight:400;line-height:120%;position:relative;top:-2.8pt;vertical-align:baseline">(vi)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:19.5pt">For the three and six months ended June 30, 2021 and 2020, share-based payments relates to the vesting expenses of share-based compensation awarded to employees under the Company&#8217;s share-based award plans as described in Note 6. Share-based Payments.</span></div>(vii)For the three and six months ended June 30, 2021 and 2020, the financial statement review costs include costs related to the restatement of the Company&#8217;s 2019 interim financial statements, costs related to the Company&#8217;s responses to requests for information from various regulatory authorities relating to such restatement and legal costs defending shareholder class action complaints brought against the Company as a result of the restatement.<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromExternalCustomersByGeographicAreasTableTextBlock', window );">Schedule of Revenue from External Customers by Geographic Areas</a></td>
<td class="text"><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Net revenue attributed to a geographic region based on the location of the customer were as follows:</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:42.372%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.816%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:1.327%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.816%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:1.605%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.816%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:1.327%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.821%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Three months ended June 30,</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Six months ended June 30,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Canada</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10,664&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7,416&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">18,246&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">13,507&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Israel</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,310&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">293&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,828&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">293&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">United States</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,227&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,174&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,668&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,350&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other countries</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">421&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">491&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">165&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net revenue</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">15,622&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9,883&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">28,233&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">18,315&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongLivedAssetsByGeographicAreasTableTextBlock', window );">Schedule of Long-lived Assets by Geographic Areas</a></td>
<td class="text"><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Property, plant and equipment assets were physically located in the following geographic regions:</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:60.150%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:17.372%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:1.605%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:17.373%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">As of June&#160;30, 2021</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">As of December 31, 2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Canada</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">168,462&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">162,163&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Israel</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">23,936&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">23,143&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">United States</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,522&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,293&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total </span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">193,920&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">187,599&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongLivedAssetsByGeographicAreasTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of long-lived assets, excluding financial instruments, long-term customer relationships of a financial institution, mortgage rights, deferred policy acquisition costs, and deferred tax assets, by geographic areas located in the entity's country of domicile and foreign countries in which the entity holds assets.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 41<br> -Subparagraph b<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e9038-108599<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongLivedAssetsByGeographicAreasTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RevenueFromExternalCustomersByGeographicAreasTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of revenue from external customers by geographic areas attributed to the entity's country of domicile and to foreign countries from which the entity derives revenue.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 41<br> -Subparagraph a<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e9038-108599<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RevenueFromExternalCustomersByGeographicAreasTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the profit or loss and total assets for each reportable segment. An entity discloses certain information on each reportable segment if the amounts (a) are included in the measure of segment profit or loss reviewed by the chief operating decision maker or (b) are otherwise regularly provided to the chief operating decision maker, even if not included in that measure of segment profit or loss.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8736-108599<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 25<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8813-108599<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=121556970&amp;loc=d3e13816-109267<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8906-108599<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SegmentReportingAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SegmentReportingAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>41
<FILENAME>R27.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.2</span><table class="report" border="0" cellspacing="2" id="idm140381999668936">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Financial Instruments (Tables)<br></strong></div></th>
<th class="th" colspan="1">6 Months Ended</th>
</tr>
<tr><th class="th"><div>Jun. 30, 2021</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RisksAndUncertaintiesAbstract', window );"><strong>Risks and Uncertainties [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock', window );">Schedule of Fair Value of Assets Measured on Recurring Basis</a></td>
<td class="text"><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following tables present information about the Company&#8217;s assets that are measured at fair value on a recurring basis as of June&#160;30, 2021 and December 31, 2020 and indicate the fair value hierarchy of the valuation techniques the Company utilized to determine such fair value.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:45.983%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.983%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:1.327%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.983%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:1.327%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.983%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:1.327%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.987%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="21" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">June&#160;30, 2021</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Level 1</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Level 2</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Level 3</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Total</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cash and cash equivalents</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">895,181&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">895,181&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Short-term investments</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">201,699&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">201,699&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Derivative liabilities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">169,563&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">169,563&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:45.983%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.983%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:1.327%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.983%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:1.327%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.983%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:1.327%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.987%"/><td style="width:0.1%"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="21" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 31, 2020</span></td><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Level 1</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Level 2</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Level 3</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Total</span></td><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cash and cash equivalents</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,078,023&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,078,023&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Short-term investments</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">211,766&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">211,766&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Derivative liabilities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">163,410&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">163,410&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/></tr></table></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RisksAndUncertaintiesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RisksAndUncertaintiesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of assets and liabilities, including [financial] instruments measured at fair value that are classified in stockholders' equity, if any, that are measured at fair value on a recurring basis. The disclosures contemplated herein include the fair value measurements at the reporting date by the level within the fair value hierarchy in which the fair value measurements in their entirety fall, segregating fair value measurements using quoted prices in active markets for identical assets (Level 1), significant other observable inputs (Level 2), and significant unobservable inputs (Level 3).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 820<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123874694&amp;loc=d3e19207-110258<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 820<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123874694&amp;loc=d3e19207-110258<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>42
<FILENAME>R28.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.2</span><table class="report" border="0" cellspacing="2" id="idm140381998030232">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Held-For-Sale Assets and Discontinued Operations (Tables)<br></strong></div></th>
<th class="th" colspan="1">6 Months Ended</th>
</tr>
<tr><th class="th"><div>Jun. 30, 2021</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DiscontinuedOperationsAndDisposalGroupsAbstract', window );"><strong>Discontinued Operations and Disposal Groups [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfDisposalGroupsIncludingDiscontinuedOperationsIncomeStatementBalanceSheetAndAdditionalDisclosuresTextBlock', window );">Summary of Financial Information for Discontinued Operations</a></td>
<td class="text"><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table summarizes the financial information for discontinued operations:</span><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:41.261%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.911%"/><td style="width:0.1%"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td style="width:1.0%"/><td style="width:11.816%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:1.327%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.816%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:1.605%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.816%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:1.327%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.821%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="9" style="border-bottom:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Three months ended June 30,</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="border-bottom:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Six months ended June 30,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Loss from discontinued operations, net of income taxes</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(561)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(46)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(582)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(46)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr></table></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:62.094%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.772%"/><td style="width:0.1%"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td style="width:0.1%"/><td style="width:0.772%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:15.983%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.494%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:15.985%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">As of June&#160;30, 2021</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">As of December 31, 2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">OGBC assets classified as held-for-sale</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">645&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,176&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr></table></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DiscontinuedOperationsAndDisposalGroupsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DiscontinuedOperationsAndDisposalGroupsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfDisposalGroupsIncludingDiscontinuedOperationsIncomeStatementBalanceSheetAndAdditionalDisclosuresTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of information related to a disposal group. Includes, but is not limited to, a discontinued operation, disposal classified as held-for-sale or disposed of by means other than sale or disposal of an individually significant component.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3A<br> -URI http://asc.fasb.org/extlink&amp;oid=109226691&amp;loc=SL51724579-110230<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=d3e1474-107760<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 5D<br> -URI http://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=SL51721677-107760<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 45<br> -Paragraph 11<br> -URI http://asc.fasb.org/extlink&amp;oid=109222160&amp;loc=SL51721533-107759<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 3A<br> -URI http://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=SL51721659-107760<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 4B<br> -URI http://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=SL51721665-107760<br><br>Reference 7: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=109226691&amp;loc=d3e2941-110230<br><br>Reference 8: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 5C<br> -URI http://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=SL51721675-107760<br><br>Reference 9: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 7<br> -URI http://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=SL51721683-107760<br><br>Reference 10: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=d3e1361-107760<br><br>Reference 11: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 5A<br> -URI http://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=SL51721671-107760<br><br>Reference 12: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 5B<br> -URI http://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=SL51721673-107760<br><br>Reference 13: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 4A<br> -URI http://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=SL51721663-107760<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfDisposalGroupsIncludingDiscontinuedOperationsIncomeStatementBalanceSheetAndAdditionalDisclosuresTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>43
<FILENAME>R29.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.2</span><table class="report" border="0" cellspacing="2" id="idm140382002621912">
<tr>
<th class="tl" colspan="2" rowspan="2"><div style="width: 200px;"><strong>Background, Basis of Presentation and Accounting Policies (Details)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="3">3 Months Ended</th>
<th class="th" colspan="2">6 Months Ended</th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr>
<th class="th">
<div>Jun. 30, 2021 </div>
<div>USD ($) </div>
<div>continent </div>
<div>brand</div>
</th>
<th class="th">
<div>Mar. 31, 2021 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Jun. 30, 2020 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Jun. 30, 2021 </div>
<div>USD ($) </div>
<div>continent </div>
<div>brand</div>
</th>
<th class="th">
<div>Jun. 30, 2020 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Dec. 31, 2020 </div>
<div>USD ($)</div>
</th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfEquityMethodInvestmentsLineItems', window );"><strong>Schedule of Equity Method Investments [Line Items]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cron_NumberOfContinentsWithInternationalProductionAndDistribution', window );">Number of continents with international production and distribution | continent</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">5<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">5<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cron_NumberOfAdultuseBrands', window );">Number of adult-use brands | brand</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">2<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cron_NumberOfHempDerivedPersonalCareBrands', window );">Number of hemp-derived cannabidiol personal care brands | brand</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">3<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">3<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccountsPayableAndOtherAccruedLiabilitiesCurrent', window );">Accounts payable and other liabilities</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">$ 29,829<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 29,829<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 42,102<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherReceivablesNetCurrent', window );">Other receivables</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">2,468<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2,468<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">10,033<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RetainedEarningsAccumulatedDeficit', window );">Retained earnings</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">955,721<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">955,721<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,064,509<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommonStockValue', window );">Share capital</a></td>
<td class="th" style="border-bottom: 0px;"><sup>[1],[2]</sup></td>
<td class="nump">572,858<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">572,858<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">569,260<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GainLossOnDerivativeInstrumentsNetPretax', window );">Gain (loss) on revaluation of derivative liabilities</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">$ 115,248<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">$ (35,880)<span></span>
</td>
<td class="num">$ (1,626)<span></span>
</td>
<td class="nump">$ 77,488<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_RestatementAxis=srt_RevisionOfPriorPeriodErrorCorrectionAdjustmentMember', window );">Error Correction, Adjustment | Error Related to Withholding Taxes on the Net Exercise of Stock Options</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfEquityMethodInvestmentsLineItems', window );"><strong>Schedule of Equity Method Investments [Line Items]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccountsPayableAndOtherAccruedLiabilitiesCurrent', window );">Accounts payable and other liabilities</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">966<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherReceivablesNetCurrent', window );">Other receivables</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(3,202)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RetainedEarningsAccumulatedDeficit', window );">Retained earnings</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(3,838)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommonStockValue', window );">Share capital</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(330)<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_RestatementAxis=srt_RevisionOfPriorPeriodErrorCorrectionAdjustmentMember', window );">Error Correction, Adjustment | Error Related to Exercise of Top-up Rights</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfEquityMethodInvestmentsLineItems', window );"><strong>Schedule of Equity Method Investments [Line Items]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RetainedEarningsAccumulatedDeficit', window );">Retained earnings</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 3,227<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommonStockValue', window );">Share capital</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(14,505)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(3,227)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GainLossOnDerivativeInstrumentsNetPretax', window );">Gain (loss) on revaluation of derivative liabilities</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 11,278<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 3,227<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis=cron_CronosAustraliaLimitedMember', window );">Cronos Australia</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfEquityMethodInvestmentsLineItems', window );"><strong>Schedule of Equity Method Investments [Line Items]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EquityMethodInvestmentOwnershipPercentage', window );">Ownership interest</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">31.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">31.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr><td colspan="7"></td></tr>
<tr><td colspan="7"><table class="outerFootnotes" width="100%">
<tr class="outerFootnote">
<td style="vertical-align: top; width: 12pt;" valign="top">[1]</td>
<td style="vertical-align: top;" valign="top">Authorized for issuance as of June&#160;30, 2021: unlimited and December 31, 2020: unlimited.</td>
</tr>
<tr class="outerFootnote">
<td style="vertical-align: top; width: 12pt;" valign="top">[2]</td>
<td style="vertical-align: top;" valign="top">Shares issued as of June&#160;30, 2021: 371,805,547 and December 31, 2020: 360,253,332.</td>
</tr>
</table></td></tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cron_NumberOfAdultuseBrands">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number Of Adult-use Brands</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cron_NumberOfAdultuseBrands</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cron_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:integerItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cron_NumberOfContinentsWithInternationalProductionAndDistribution">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number Of Continents With International Production And Distribution</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cron_NumberOfContinentsWithInternationalProductionAndDistribution</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cron_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:integerItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cron_NumberOfHempDerivedPersonalCareBrands">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number Of Hemp-derived Personal Care Brands</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cron_NumberOfHempDerivedPersonalCareBrands</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cron_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:integerItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountsPayableAndOtherAccruedLiabilitiesCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of liabilities incurred to vendors for goods and services received, and accrued liabilities classified as other, payable within one year or the normal operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccountsPayableAndOtherAccruedLiabilitiesCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Aggregate par or stated value of issued nonredeemable common stock (or common stock redeemable solely at the option of the issuer). This item includes treasury stock repurchased by the entity. Note: elements for number of nonredeemable common shares, par value and other disclosure concepts are in another section within stockholders' equity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EquityMethodInvestmentOwnershipPercentage">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The percentage of ownership of common stock or equity participation in the investee accounted for under the equity method of accounting.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (a)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EquityMethodInvestmentOwnershipPercentage</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GainLossOnDerivativeInstrumentsNetPretax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Aggregate net gain (loss) on all derivative instruments recognized in earnings during the period, before tax effects.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4A<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=125515794&amp;loc=SL5618551-113959<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GainLossOnDerivativeInstrumentsNetPretax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherReceivablesNetCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, after allowance, of receivables classified as other, due within one year or the operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherReceivablesNetCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RetainedEarningsAccumulatedDeficit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The cumulative amount of the reporting entity's undistributed earnings or deficit.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(30)(a)(3))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 65<br> -Paragraph 15<br> -Subparagraph (g)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=121322162&amp;loc=SL121327923-165333<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(23)(a)(4))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400017&amp;loc=d3e572229-122910<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (h)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=124501264&amp;loc=SL117420844-207641<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI http://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (g)(2)(i)<br> -URI http://asc.fasb.org/extlink&amp;oid=124501264&amp;loc=SL117420844-207641<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RetainedEarningsAccumulatedDeficit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfEquityMethodInvestmentsLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfEquityMethodInvestmentsLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_RestatementAxis=srt_RevisionOfPriorPeriodErrorCorrectionAdjustmentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_RestatementAxis=srt_RevisionOfPriorPeriodErrorCorrectionAdjustmentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ErrorCorrectionsAndPriorPeriodAdjustmentsRestatementByRestatementPeriodAndAmountAxis=cron_ErrorRelatedToWithholdingTaxesOnTheNetExerciseOfStockOptionsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ErrorCorrectionsAndPriorPeriodAdjustmentsRestatementByRestatementPeriodAndAmountAxis=cron_ErrorRelatedToWithholdingTaxesOnTheNetExerciseOfStockOptionsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ErrorCorrectionsAndPriorPeriodAdjustmentsRestatementByRestatementPeriodAndAmountAxis=cron_ErrorRelatedToExerciseOfTopUpRightsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ErrorCorrectionsAndPriorPeriodAdjustmentsRestatementByRestatementPeriodAndAmountAxis=cron_ErrorRelatedToExerciseOfTopUpRightsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis=cron_CronosAustraliaLimitedMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis=cron_CronosAustraliaLimitedMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>44
<FILENAME>R30.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.2</span><table class="report" border="0" cellspacing="2" id="idm140382000310632">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Inventory, net (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="2">3 Months Ended</th>
<th class="th" colspan="2">6 Months Ended</th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th"><div>Jun. 30, 2021</div></th>
<th class="th"><div>Jun. 30, 2020</div></th>
<th class="th"><div>Jun. 30, 2021</div></th>
<th class="th"><div>Jun. 30, 2020</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InventoryDisclosureAbstract', window );"><strong>Inventory Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InventoryRawMaterialsNetOfReserves', window );">Raw materials</a></td>
<td class="nump">$ 7,471<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 7,471<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 11,489<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InventoryWorkInProcessNetOfReserves', window );">Work-in-progress</a></td>
<td class="nump">17,291<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">17,291<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">26,278<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InventoryFinishedGoodsNetOfReserves', window );">Finished goods</a></td>
<td class="nump">10,247<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">10,247<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">5,905<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InventorySuppliesNetOfReserves', window );">Supplies and consumables</a></td>
<td class="nump">596<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">596<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">330<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InventoryNet', window );">Inventory, net</a></td>
<td class="nump">35,605<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">35,605<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 44,002<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InventoryWriteDown', window );">Inventory write-down</a></td>
<td class="nump">$ 11,961<span></span>
</td>
<td class="nump">$ 3,062<span></span>
</td>
<td class="nump">$ 11,961<span></span>
</td>
<td class="nump">$ 11,024<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InventoryDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InventoryDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InventoryFinishedGoodsNetOfReserves">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Carrying amount, net of valuation reserves and adjustments, as of the balance sheet date of merchandise or goods held by the company that are readily available for sale.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 330<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SAB Topic 5.BB)<br> -URI http://asc.fasb.org/extlink&amp;oid=27011343&amp;loc=d3e100047-122729<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(6)(a)(1))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InventoryFinishedGoodsNetOfReserves</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InventoryNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount after valuation and LIFO reserves of inventory expected to be sold, or consumed within one year or operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=124098289&amp;loc=d3e6676-107765<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.6(a))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InventoryNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InventoryRawMaterialsNetOfReserves">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Carrying amount, net of valuation reserves and adjustments, as of the balance sheet date of unprocessed items to be consumed in the manufacturing or production process.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 330<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SAB Topic 5.BB)<br> -URI http://asc.fasb.org/extlink&amp;oid=27011343&amp;loc=d3e100047-122729<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(6)(a)(4))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InventoryRawMaterialsNetOfReserves</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InventorySuppliesNetOfReserves">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Carrying amount, net of valuation reserves and adjustments, as of the balance sheet date of products used directly or indirectly in the manufacturing or production process, which may or may not become part of the final product. May also include items used in the storage, presentation or transportation of physical goods.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 330<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SAB TOPIC 5.BB)<br> -URI http://asc.fasb.org/extlink&amp;oid=27011343&amp;loc=d3e100047-122729<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.6(a)(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InventorySuppliesNetOfReserves</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InventoryWorkInProcessNetOfReserves">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Carrying amount, net of reserves and adjustments, as of the balance sheet date of merchandise or goods which are partially completed. This inventory is generally comprised of raw materials, labor and factory overhead costs, which require further materials, labor and overhead to be converted into finished goods, and which generally require the use of estimates to determine percentage complete and pricing.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 330<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SAB Topic 5.BB)<br> -URI http://asc.fasb.org/extlink&amp;oid=27011343&amp;loc=d3e100047-122729<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(6)(a)(3))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InventoryWorkInProcessNetOfReserves</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InventoryWriteDown">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of loss from reductions in inventory due to subsequent measurement adjustments, including, but not limited to, physical deterioration, obsolescence, or changes in price levels.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 330<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=116847112&amp;loc=d3e4542-108314<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InventoryWriteDown</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>45
<FILENAME>R31.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.2</span><table class="report" border="0" cellspacing="2" id="idm140382000350328">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Investments - Narrative (Details)<br> $ / shares in Units, &#8362; in Thousands, $ in Thousands</strong></div></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="2">6 Months Ended</th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th">
<div>Jun. 14, 2021 </div>
<div>USD ($) </div>
<div>$ / shares </div>
<div>shares</div>
</th>
<th class="th"><div>Jun. 14, 2018</div></th>
<th class="th"><div>Mar. 13, 2018</div></th>
<th class="th">
<div>Jun. 30, 2021 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Jun. 30, 2020 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Jun. 30, 2021 </div>
<div>ILS (&#8362;)</div>
</th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_VariableInterestEntityLineItems', window );"><strong>Variable Interest Entity [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SaleOfStockPricePerShare', window );">Sale of stock, price per share (in dollars per share) | $ / shares</a></td>
<td class="nump">$ 0.0001<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SaleOfStockPercentageOfOwnershipAfterTransaction', window );">Sale of stock, percentage of ownership after transaction</a></td>
<td class="nump">10.50%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PaymentsToAcquireOtherInvestments', window );">Purchase of other investments | $</a></td>
<td class="nump">$ 110,392<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 110,392<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_LegalEntityAxis=cron_PharmacannMember', window );">Pharmacann</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_VariableInterestEntityLineItems', window );"><strong>Variable Interest Entity [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SaleOfStockNumberOfSharesIssuedInTransaction', window );">Sale of stock, number of shares issued in transaction (in shares) | shares</a></td>
<td class="nump">473,787<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis=cron_CronosGrowingCompanyInc.Member', window );">Cronos GrowCo | Variable Interest Entity, Not Primary Beneficiary</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_VariableInterestEntityLineItems', window );"><strong>Variable Interest Entity [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_VariableInterestEntityOwnershipPercentage', window );">Ownership percentage</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">50.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">50.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis=cron_MedMenCanadaInc.Member', window );">MedMen Canada | Variable Interest Entity, Not Primary Beneficiary</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_VariableInterestEntityLineItems', window );"><strong>Variable Interest Entity [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_VariableInterestEntityOwnershipPercentage', window );">Ownership percentage</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">50.00%<span></span>
</td>
<td class="nump">50.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis=cron_NatueraMember', window );">Natuera | Variable Interest Entity, Not Primary Beneficiary</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_VariableInterestEntityLineItems', window );"><strong>Variable Interest Entity [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_VariableInterestEntityOwnershipPercentage', window );">Ownership percentage</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">50.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis=cron_CannasoulAnalyticsLtdMember', window );">Cannasoul | Establishment of a Commercial Cannabis Analytical Testing Laboratory | Variable Interest Entity, Not Primary Beneficiary</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_VariableInterestEntityLineItems', window );"><strong>Variable Interest Entity [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cron_CollaborativeArrangementPercentageOfProfitsToBeReceived', window );">Collaboration agreement, percentage of profits to be received</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">70.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">70.00%<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cron_CollaborativeArrangementProfitsToBeReceivedMaximumPercentageOfAmountsAdvanced', window );">Collaboration agreement, profits to be received, maximum percentage of amounts advanced</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">150.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">150.00%<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cron_CollaborativeArrangementPercentageOfProfitsToBeReceivedTriggeringEventSubsequentToMaximumPercentageOfAmountsAdvancedBeingMet', window );">Collaboration agreement, percentage of profits to be received, triggering event, subsequent to maximum percentage of amounts advanced being met</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">50.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">50.00%<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis=cron_CannasoulAnalyticsLtdMember', window );">Cannasoul | Establishment of a Commercial Cannabis Analytical Testing Laboratory | Variable Interest Entity, Not Primary Beneficiary | Cannasoul collaboration loan | Loans Receivable</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_VariableInterestEntityLineItems', window );"><strong>Variable Interest Entity [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cron_CollaborativeArrangementAmountOfAdvances', window );">Collaboration agreement, amount of advances</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 2,511<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">&#8362; 8,297<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cron_CollaborativeArrangementTermOfAgreement', window );">Collaboration agreement, term of agreement</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">2 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentInterestRateStatedPercentage', window );">Interest rate</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">3.50%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">3.50%<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_RangeAxis=srt_MinimumMember', window );">Minimum | MedMen Canada | Variable Interest Entity, Not Primary Beneficiary</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_VariableInterestEntityLineItems', window );"><strong>Variable Interest Entity [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cron_VariableInterestEntityQualitativeOrQuantitativeInformationLicenseTerm', window );">License term</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">20 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cron_CollaborativeArrangementAmountOfAdvances">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Collaborative Arrangement, Amount Of Advances</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cron_CollaborativeArrangementAmountOfAdvances</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cron_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cron_CollaborativeArrangementPercentageOfProfitsToBeReceived">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Collaborative Arrangement, Percentage Of Profits To Be Received</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cron_CollaborativeArrangementPercentageOfProfitsToBeReceived</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cron_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cron_CollaborativeArrangementPercentageOfProfitsToBeReceivedTriggeringEventSubsequentToMaximumPercentageOfAmountsAdvancedBeingMet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Collaborative Arrangement, Percentage Of Profits To Be Received, Triggering Event, Subsequent To Maximum Percentage Of Amounts Advanced Being Met</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cron_CollaborativeArrangementPercentageOfProfitsToBeReceivedTriggeringEventSubsequentToMaximumPercentageOfAmountsAdvancedBeingMet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cron_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cron_CollaborativeArrangementProfitsToBeReceivedMaximumPercentageOfAmountsAdvanced">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Collaborative Arrangement, Profits To Be Received, Maximum Percentage Of Amounts Advanced</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cron_CollaborativeArrangementProfitsToBeReceivedMaximumPercentageOfAmountsAdvanced</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cron_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cron_CollaborativeArrangementTermOfAgreement">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Collaborative Arrangement, Term Of Agreement</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cron_CollaborativeArrangementTermOfAgreement</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cron_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cron_VariableInterestEntityQualitativeOrQuantitativeInformationLicenseTerm">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Variable Interest Entity, Qualitative Or Quantitative Information, License Term</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cron_VariableInterestEntityQualitativeOrQuantitativeInformationLicenseTerm</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cron_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentInterestRateStatedPercentage">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Contractual interest rate for funds borrowed, under the debt agreement.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1B<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123466505&amp;loc=SL123495323-112611<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.22(a)(1))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentInterestRateStatedPercentage</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentsToAcquireOtherInvestments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of cash outflow to acquire investments classified as other.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 13<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3213-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PaymentsToAcquireOtherInvestments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SaleOfStockNumberOfSharesIssuedInTransaction">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The number of shares issued or sold by the subsidiary or equity method investee per stock transaction.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SaleOfStockNumberOfSharesIssuedInTransaction</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SaleOfStockPercentageOfOwnershipAfterTransaction">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Percentage of subsidiary's or equity investee's stock owned by parent company after stock transaction.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SaleOfStockPercentageOfOwnershipAfterTransaction</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SaleOfStockPricePerShare">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Per share amount received by subsidiary or equity investee for each share of common stock issued or sold in the stock transaction.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SaleOfStockPricePerShare</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_VariableInterestEntityLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_VariableInterestEntityLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_VariableInterestEntityOwnershipPercentage">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Percentage of the Variable Interest Entity's (VIE) voting interest owned by (or beneficial interest in) the reporting entity (directly or indirectly).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 5A<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=123419778&amp;loc=SL6759159-111685<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_VariableInterestEntityOwnershipPercentage</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_LegalEntityAxis=cron_PharmacannMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_LegalEntityAxis=cron_PharmacannMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis=cron_CronosGrowingCompanyInc.Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis=cron_CronosGrowingCompanyInc.Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ConsolidatedEntitiesAxis=us-gaap_VariableInterestEntityNotPrimaryBeneficiaryMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ConsolidatedEntitiesAxis=us-gaap_VariableInterestEntityNotPrimaryBeneficiaryMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis=cron_MedMenCanadaInc.Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis=cron_MedMenCanadaInc.Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis=cron_NatueraMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis=cron_NatueraMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis=cron_CannasoulAnalyticsLtdMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis=cron_CannasoulAnalyticsLtdMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TypeOfArrangementAxis=us-gaap_CollaborativeArrangementTransactionWithPartyToCollaborativeArrangementMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TypeOfArrangementAxis=us-gaap_CollaborativeArrangementTransactionWithPartyToCollaborativeArrangementMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cron_LoanReceivableNameAxis=cron_CannasoulCollaborationLoanMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cron_LoanReceivableNameAxis=cron_CannasoulCollaborationLoanMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis=us-gaap_LoansReceivableMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis=us-gaap_LoansReceivableMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_RangeAxis=srt_MinimumMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_RangeAxis=srt_MinimumMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>46
<FILENAME>R32.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.2</span><table class="report" border="0" cellspacing="2" id="idm140382113498824">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Investments - Schedule of Investments in Associates and Joint Ventures (Details)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="2">3 Months Ended</th>
<th class="th" colspan="2">6 Months Ended</th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th">
<div>Apr. 01, 2021 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Jun. 30, 2021 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Jun. 30, 2020 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Jun. 30, 2021 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Jun. 30, 2020 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Dec. 31, 2020 </div>
<div>USD ($)</div>
</th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfEquityMethodInvestmentsLineItems', window );"><strong>Schedule of Equity Method Investments [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EquityMethodInvestments', window );">Investments in equity accounted investees, net</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 20,970<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 20,970<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 19,235<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NotesReceivableNet', window );">Transfer to investments in equity accounted investees, excluding accrued interest</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">99,141<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">99,141<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">94,274<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeLossFromEquityMethodInvestments', window );">Share of loss from investments in equity accounted investees</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="num">$ (1,115)<span></span>
</td>
<td class="num">$ (794)<span></span>
</td>
<td class="num">$ (2,758)<span></span>
</td>
<td class="num">$ (1,966)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cron_LoanReceivableNameAxis=cron_NatuEraSeriesALoanMember', window );">NatuEra Series A Loan | Loans Receivable</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfEquityMethodInvestmentsLineItems', window );"><strong>Schedule of Equity Method Investments [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cron_InvestmentsInAndAdvancesToAffiliatesAtFairValueAdvancesRepayments', window );">Advances to affiliates</a></td>
<td class="nump">$ 15,500<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NotesReceivableNet', window );">Transfer to investments in equity accounted investees, excluding accrued interest</a></td>
<td class="nump">2,013<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FinancingReceivableAccruedInterestBeforeAllowanceForCreditLoss', window );">Accrued interest</a></td>
<td class="nump">540<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cron_InvestmentsInAndAdvancesToAffiliatesAtFairValueTransferToInvestmentsInEquityAccountedInvestees', window );">Transfer to investments in equity accounted investees</a></td>
<td class="nump">2,553<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cron_LoanReceivableNameAxis=cron_NatuEraSeriesALoanMember', window );">NatuEra Series A Loan | Loans Receivable | Cronos Group, Inc.</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfEquityMethodInvestmentsLineItems', window );"><strong>Schedule of Equity Method Investments [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cron_InvestmentsInAndAdvancesToAffiliatesAtFairValueAdvancesRepayments', window );">Advances to affiliates</a></td>
<td class="nump">$ 7,750<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cron_InvestmentsInAndAdvancesToAffiliatesFundingCommitmentPercentage', window );">Funding commitment percentage</a></td>
<td class="nump">0.50<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cron_LoanReceivableNameAxis=cron_NatuEraSeriesALoanMember', window );">NatuEra Series A Loan | Loans Receivable | AGI</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfEquityMethodInvestmentsLineItems', window );"><strong>Schedule of Equity Method Investments [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cron_InvestmentsInAndAdvancesToAffiliatesAtFairValueAdvancesRepayments', window );">Advances to affiliates</a></td>
<td class="nump">$ 7,750<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cron_InvestmentsInAndAdvancesToAffiliatesFundingCommitmentPercentage', window );">Funding commitment percentage</a></td>
<td class="nump">0.50<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis=cron_CronosAustraliaLimitedMember', window );">Cronos Australia</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfEquityMethodInvestmentsLineItems', window );"><strong>Schedule of Equity Method Investments [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EquityMethodInvestmentOwnershipPercentage', window );">Ownership interest</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">31.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">31.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EquityMethodInvestments', window );">Investments in equity accounted investees, net</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeLossFromEquityMethodInvestments', window );">Share of loss from investments in equity accounted investees</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="num">(235)<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="num">(235)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis=cron_CronosGrowingCompanyInc.Member', window );">Cronos GrowCo</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfEquityMethodInvestmentsLineItems', window );"><strong>Schedule of Equity Method Investments [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EquityMethodInvestmentOwnershipPercentage', window );">Ownership interest</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">50.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">50.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EquityMethodInvestments', window );">Investments in equity accounted investees, net</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 19,022<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 19,022<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">19,235<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeLossFromEquityMethodInvestments', window );">Share of loss from investments in equity accounted investees</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="num">$ (459)<span></span>
</td>
<td class="num">(190)<span></span>
</td>
<td class="num">$ (758)<span></span>
</td>
<td class="num">(501)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis=cron_NatueraMember', window );">Natuera</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfEquityMethodInvestmentsLineItems', window );"><strong>Schedule of Equity Method Investments [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EquityMethodInvestmentOwnershipPercentage', window );">Ownership interest</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">50.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">50.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EquityMethodInvestments', window );">Investments in equity accounted investees, net</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 1,948<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 1,948<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeLossFromEquityMethodInvestments', window );">Share of loss from investments in equity accounted investees</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="num">$ (656)<span></span>
</td>
<td class="num">$ (369)<span></span>
</td>
<td class="num">$ (2,000)<span></span>
</td>
<td class="num">$ (1,230)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cron_InvestmentsInAndAdvancesToAffiliatesAtFairValueAdvancesRepayments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Investments In And Advances To Affiliates, At Fair Value, Advances (Repayments)</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cron_InvestmentsInAndAdvancesToAffiliatesAtFairValueAdvancesRepayments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cron_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cron_InvestmentsInAndAdvancesToAffiliatesAtFairValueTransferToInvestmentsInEquityAccountedInvestees">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Investments In And Advances To Affiliates, At Fair Value, Transfer To Investments In Equity Accounted Investees</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cron_InvestmentsInAndAdvancesToAffiliatesAtFairValueTransferToInvestmentsInEquityAccountedInvestees</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cron_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cron_InvestmentsInAndAdvancesToAffiliatesFundingCommitmentPercentage">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Investments In And Advances To Affiliates, Funding Commitment Percentage</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cron_InvestmentsInAndAdvancesToAffiliatesFundingCommitmentPercentage</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cron_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:pureItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EquityMethodInvestmentOwnershipPercentage">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The percentage of ownership of common stock or equity participation in the investee accounted for under the equity method of accounting.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (a)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EquityMethodInvestmentOwnershipPercentage</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EquityMethodInvestments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>This item represents the carrying amount on the entity's balance sheet of its investment in common stock of an equity method investee. This is not an indicator of the fair value of the investment, rather it is the initial cost adjusted for the entity's share of earnings and losses of the investee, adjusted for any distributions (dividends) and other than temporary impairment (OTTI) losses recognized.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=109237563&amp;loc=d3e33749-111570<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 25<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8813-108599<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.12)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EquityMethodInvestments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinancingReceivableAccruedInterestBeforeAllowanceForCreditLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, before allowance for credit loss, of accrued interest on financing receivable.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 326<br> -SubTopic 20<br> -Section 50<br> -Paragraph 3B<br> -URI http://asc.fasb.org/extlink&amp;oid=124255953&amp;loc=SL120267963-210447<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinancingReceivableAccruedInterestBeforeAllowanceForCreditLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeLossFromEquityMethodInvestments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of income (loss) for proportionate share of equity method investee's income (loss).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(12))<br> -URI http://asc.fasb.org/extlink&amp;oid=123367319&amp;loc=SL114868664-224227<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(10))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3602-108585<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(13)(f))<br> -URI http://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (g)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8736-108599<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=109237563&amp;loc=d3e33749-111570<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeLossFromEquityMethodInvestments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NotesReceivableNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, after allowance for credit loss, of financing receivable. Excludes financing receivable covered under loss sharing agreement.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 326<br> -SubTopic 20<br> -Section 50<br> -Paragraph 5<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=124255953&amp;loc=SL82919230-210447<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(3))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 310<br> -SubTopic 10<br> -Section 45<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=124259787&amp;loc=d3e4428-111522<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NotesReceivableNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfEquityMethodInvestmentsLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfEquityMethodInvestmentsLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cron_LoanReceivableNameAxis=cron_NatuEraSeriesALoanMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cron_LoanReceivableNameAxis=cron_NatuEraSeriesALoanMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis=us-gaap_LoansReceivableMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis=us-gaap_LoansReceivableMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_LegalEntityAxis=cron_CronosGroupInc.Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_LegalEntityAxis=cron_CronosGroupInc.Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_LegalEntityAxis=cron_AgroideaMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_LegalEntityAxis=cron_AgroideaMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis=cron_CronosAustraliaLimitedMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis=cron_CronosAustraliaLimitedMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis=cron_CronosGrowingCompanyInc.Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis=cron_CronosGrowingCompanyInc.Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis=cron_NatueraMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis=cron_NatueraMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>47
<FILENAME>R33.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.2</span><table class="report" border="0" cellspacing="2" id="idm140382008320120">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Investments - Schedule of Variable Interest Entities (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1">6 Months Ended</th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th"><div>Jun. 14, 2018</div></th>
<th class="th"><div>Mar. 13, 2018</div></th>
<th class="th"><div>Jun. 30, 2021</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_VariableInterestEntityLineItems', window );"><strong>Variable Interest Entity [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_VariableInterestEntityEntityMaximumLossExposureAmount', window );">Maximum Exposure to Loss</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 31,837<span></span>
</td>
<td class="nump">$ 31,276<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis=cron_CronosAustraliaLimitedMember', window );">Cronos Australia | Variable Interest Entity, Not Primary Beneficiary</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_VariableInterestEntityLineItems', window );"><strong>Variable Interest Entity [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_VariableInterestEntityOwnershipPercentage', window );">Ownership interest</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">31.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_VariableInterestEntityEntityMaximumLossExposureAmount', window );">Maximum Exposure to Loss</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 1,573<span></span>
</td>
<td class="nump">1,530<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis=cron_CronosGrowingCompanyInc.Member', window );">Cronos GrowCo | Variable Interest Entity, Not Primary Beneficiary</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_VariableInterestEntityLineItems', window );"><strong>Variable Interest Entity [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_VariableInterestEntityOwnershipPercentage', window );">Ownership interest</a></td>
<td class="nump">50.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">50.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_VariableInterestEntityEntityMaximumLossExposureAmount', window );">Maximum Exposure to Loss</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 21,723<span></span>
</td>
<td class="nump">21,125<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis=cron_MedMenCanadaInc.Member', window );">MedMen Canada | Variable Interest Entity, Not Primary Beneficiary</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_VariableInterestEntityLineItems', window );"><strong>Variable Interest Entity [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_VariableInterestEntityOwnershipPercentage', window );">Ownership interest</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">50.00%<span></span>
</td>
<td class="nump">50.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_VariableInterestEntityEntityMaximumLossExposureAmount', window );">Maximum Exposure to Loss</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 494<span></span>
</td>
<td class="nump">467<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis=cron_NatuEraMember', window );">Natuera | Variable Interest Entity, Not Primary Beneficiary</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_VariableInterestEntityLineItems', window );"><strong>Variable Interest Entity [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_VariableInterestEntityOwnershipPercentage', window );">Ownership interest</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">50.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_VariableInterestEntityEntityMaximumLossExposureAmount', window );">Maximum Exposure to Loss</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 8,047<span></span>
</td>
<td class="nump">$ 8,154<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_VariableInterestEntityEntityMaximumLossExposureAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The reporting entity's maximum amount of exposure to loss as a result of its involvement with the Variable Interest Entity (VIE).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 6<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=123419778&amp;loc=d3e5747-111685<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -Subparagraph b<br> -URI http://asc.fasb.org/extlink&amp;oid=123419778&amp;loc=d3e5728-111685<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_VariableInterestEntityEntityMaximumLossExposureAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_VariableInterestEntityLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_VariableInterestEntityLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_VariableInterestEntityOwnershipPercentage">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Percentage of the Variable Interest Entity's (VIE) voting interest owned by (or beneficial interest in) the reporting entity (directly or indirectly).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 5A<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=123419778&amp;loc=SL6759159-111685<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_VariableInterestEntityOwnershipPercentage</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis=cron_CronosAustraliaLimitedMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis=cron_CronosAustraliaLimitedMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ConsolidatedEntitiesAxis=us-gaap_VariableInterestEntityNotPrimaryBeneficiaryMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ConsolidatedEntitiesAxis=us-gaap_VariableInterestEntityNotPrimaryBeneficiaryMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis=cron_CronosGrowingCompanyInc.Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis=cron_CronosGrowingCompanyInc.Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis=cron_MedMenCanadaInc.Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis=cron_MedMenCanadaInc.Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis=cron_NatuEraMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis=cron_NatuEraMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>48
<FILENAME>R34.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.2</span><table class="report" border="0" cellspacing="2" id="idm140382003109624">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Loans Receivable, net (Details)<br> &#8362; in Thousands, $ in Thousands, $ in Thousands</strong></div></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="3">6 Months Ended</th>
<th class="th" colspan="2">12 Months Ended</th>
<th class="th" colspan="1"></th>
<th class="th" colspan="2"></th>
</tr>
<tr>
<th class="th">
<div>Apr. 01, 2021 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Jun. 30, 2021 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Jun. 30, 2021 </div>
<div>CAD ($)</div>
</th>
<th class="th">
<div>Jun. 30, 2020 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Dec. 31, 2019 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Dec. 31, 2019 </div>
<div>CAD ($)</div>
</th>
<th class="th">
<div>Jun. 30, 2021 </div>
<div>ILS (&#8362;)</div>
</th>
<th class="th">
<div>Dec. 31, 2020 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Dec. 31, 2020 </div>
<div>ILS (&#8362;)</div>
</th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccountsNotesAndLoansReceivableLineItems', window );"><strong>Accounts, Notes, Loans and Financing Receivable [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NotesAndLoansReceivableNetCurrent', window );">Total current portion of loans receivable</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 5,028<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 7,083<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NotesAndLoansReceivableNetNoncurrent', window );">Total long-term portion of loans receivable</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">94,113<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">87,191<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NotesReceivableNet', window );">Total loans receivable, net</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">99,141<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">94,274<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PaymentsToAcquireLoansReceivable', window );">Draw downs</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">5,064<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 23,974<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AllowanceForDoubtfulAccountsReceivableCurrent', window );">Current expected credit loss allowance on accounts receivable</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">264<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">74<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis=us-gaap_LoansReceivableMember', window );">Loans Receivable</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccountsNotesAndLoansReceivableLineItems', window );"><strong>Accounts, Notes, Loans and Financing Receivable [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cron_FinancingReceivableAccruedInterestCurrent', window );">Add: Accrued interest</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">3,414<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">428<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cron_FinancingReceivableAccruedInterestNoncurrent', window );">Add: Accrued interest</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">800<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2,667<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cron_LoanReceivableNameAxis=cron_NatuEraSeriesALoanMember', window );">NatuEra Series A Loan | Loans Receivable</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccountsNotesAndLoansReceivableLineItems', window );"><strong>Accounts, Notes, Loans and Financing Receivable [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cron_FinancingReceivableBeforeAccruedInterestCurrent', window );">Current portion of loans receivable, before accrued interest</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">3,518<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NotesReceivableNet', window );">Total loans receivable, net</a></td>
<td class="nump">$ 2,013<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cron_InvestmentsInAndAdvancesToAffiliatesAtFairValueAdvancesRepayments', window );">Advances to affiliates</a></td>
<td class="nump">15,500<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FinancingReceivableAccruedInterestBeforeAllowanceForCreditLoss', window );">Accrued interest</a></td>
<td class="nump">540<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cron_InvestmentsInAndAdvancesToAffiliatesAtFairValueTransferToInvestmentsInEquityAccountedInvestees', window );">Transfer to investments in equity accounted investees</a></td>
<td class="nump">2,553<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cron_LoanReceivableNameAxis=cron_NatuEraSeriesALoanMember', window );">NatuEra Series A Loan | Loans Receivable | Cronos Group, Inc.</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccountsNotesAndLoansReceivableLineItems', window );"><strong>Accounts, Notes, Loans and Financing Receivable [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cron_InvestmentsInAndAdvancesToAffiliatesAtFairValueAdvancesRepayments', window );">Advances to affiliates</a></td>
<td class="nump">$ 7,750<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cron_InvestmentsInAndAdvancesToAffiliatesFundingCommitmentPercentage', window );">Funding commitment percentage</a></td>
<td class="nump">0.50<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cron_LoanReceivableNameAxis=cron_NatuEraSeriesALoanMember', window );">NatuEra Series A Loan | Loans Receivable | AGI</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccountsNotesAndLoansReceivableLineItems', window );"><strong>Accounts, Notes, Loans and Financing Receivable [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cron_InvestmentsInAndAdvancesToAffiliatesAtFairValueAdvancesRepayments', window );">Advances to affiliates</a></td>
<td class="nump">$ 7,750<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cron_InvestmentsInAndAdvancesToAffiliatesFundingCommitmentPercentage', window );">Funding commitment percentage</a></td>
<td class="nump">0.50<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cron_LoanReceivableNameAxis=cron_CronosGrowCoCreditFacilityMember', window );">GrowCo Facility | Loans Receivable</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccountsNotesAndLoansReceivableLineItems', window );"><strong>Accounts, Notes, Loans and Financing Receivable [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cron_FinancingReceivableBeforeAccruedInterestCurrent', window );">Current portion of loans receivable, before accrued interest</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,614<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">3,137<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cron_FinancingReceivableBeforeAccruedInterestNoncurrent', window );">Long term portion of loans receivable, before accrued interest</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">77,474<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">69,939<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PaymentsToAcquireLoansReceivable', window );">Draw downs</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">80,678<span></span>
</td>
<td class="nump">$ 100,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 74,626<span></span>
</td>
<td class="nump">$ 95,150<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FinancingReceivableAllowanceForCreditLosses', window );">Allowance for credit loss</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,590<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,470<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cron_LoanReceivableNameAxis=cron_A2645485OntarioInc.MucciPromissoryNoteMember', window );">Mucci promissory note | Loans Receivable</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccountsNotesAndLoansReceivableLineItems', window );"><strong>Accounts, Notes, Loans and Financing Receivable [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cron_FinancingReceivableBeforeAccruedInterestNoncurrent', window );">Long term portion of loans receivable, before accrued interest</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">13,969<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">13,324<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FinancingReceivableAllowanceForCreditLosses', window );">Allowance for credit loss</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">278<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">259<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cron_LoanReceivableNameAxis=cron_CannasoulCollaborationLoanMember', window );">Cannasoul collaboration loan | Loans Receivable</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccountsNotesAndLoansReceivableLineItems', window );"><strong>Accounts, Notes, Loans and Financing Receivable [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cron_FinancingReceivableBeforeAccruedInterestNoncurrent', window );">Long term portion of loans receivable, before accrued interest</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,870<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,261<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cron_LoanReceivableNameAxis=cron_CannasoulCollaborationLoanMember', window );">Cannasoul collaboration loan | Loans Receivable | Establishment of a Commercial Cannabis Analytical Testing Laboratory | Cannasoul | Variable Interest Entity, Not Primary Beneficiary</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccountsNotesAndLoansReceivableLineItems', window );"><strong>Accounts, Notes, Loans and Financing Receivable [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cron_CollaborativeArrangementInstallmentsReceived', window );">Collaborative arrangement, installment received</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,909<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">&#8362; 6,223<span></span>
</td>
<td class="nump">1,287<span></span>
</td>
<td class="nump">&#8362; 4,149<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AllowanceForDoubtfulAccountsReceivableCurrent', window );">Current expected credit loss allowance on accounts receivable</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 39<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 25<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cron_CollaborativeArrangementInstallmentsReceived">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Collaborative Arrangement, Installments Received</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cron_CollaborativeArrangementInstallmentsReceived</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cron_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cron_FinancingReceivableAccruedInterestCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Financing Receivable, Accrued Interest, Current</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cron_FinancingReceivableAccruedInterestCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cron_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cron_FinancingReceivableAccruedInterestNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Financing Receivable, Accrued Interest, Noncurrent</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cron_FinancingReceivableAccruedInterestNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cron_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cron_FinancingReceivableBeforeAccruedInterestCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Financing Receivable, Before Accrued Interest, Current</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cron_FinancingReceivableBeforeAccruedInterestCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cron_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cron_FinancingReceivableBeforeAccruedInterestNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Financing Receivable, Before Accrued Interest, Noncurrent</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cron_FinancingReceivableBeforeAccruedInterestNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cron_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cron_InvestmentsInAndAdvancesToAffiliatesAtFairValueAdvancesRepayments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Investments In And Advances To Affiliates, At Fair Value, Advances (Repayments)</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cron_InvestmentsInAndAdvancesToAffiliatesAtFairValueAdvancesRepayments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cron_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cron_InvestmentsInAndAdvancesToAffiliatesAtFairValueTransferToInvestmentsInEquityAccountedInvestees">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Investments In And Advances To Affiliates, At Fair Value, Transfer To Investments In Equity Accounted Investees</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cron_InvestmentsInAndAdvancesToAffiliatesAtFairValueTransferToInvestmentsInEquityAccountedInvestees</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cron_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cron_InvestmentsInAndAdvancesToAffiliatesFundingCommitmentPercentage">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Investments In And Advances To Affiliates, Funding Commitment Percentage</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cron_InvestmentsInAndAdvancesToAffiliatesFundingCommitmentPercentage</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cron_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:pureItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountsNotesAndLoansReceivableLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccountsNotesAndLoansReceivableLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AllowanceForDoubtfulAccountsReceivableCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of allowance for credit loss on accounts receivable, classified as current.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(4)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 310<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=123577603&amp;loc=d3e5074-111524<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 326<br> -SubTopic 20<br> -Section 45<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=124255206&amp;loc=SL82895884-210446<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AllowanceForDoubtfulAccountsReceivableCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinancingReceivableAccruedInterestBeforeAllowanceForCreditLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, before allowance for credit loss, of accrued interest on financing receivable.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 326<br> -SubTopic 20<br> -Section 50<br> -Paragraph 3B<br> -URI http://asc.fasb.org/extlink&amp;oid=124255953&amp;loc=SL120267963-210447<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinancingReceivableAccruedInterestBeforeAllowanceForCreditLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinancingReceivableAllowanceForCreditLosses">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of allowance for credit loss on financing receivable. Excludes allowance for financing receivable covered under loss sharing agreement.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 310<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11B<br> -Subparagraph (c)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=123577603&amp;loc=SL6953423-111524<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(7)(2))<br> -URI http://asc.fasb.org/extlink&amp;oid=120398452&amp;loc=d3e534808-122878<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 326<br> -SubTopic 20<br> -Section 45<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=124255206&amp;loc=SL82895884-210446<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 326<br> -SubTopic 20<br> -Section 50<br> -Paragraph 13<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124255953&amp;loc=SL82919249-210447<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 326<br> -SubTopic 20<br> -Section 50<br> -Paragraph 13<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=124255953&amp;loc=SL82919249-210447<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher SEC<br> -Name Regulation S-K (SK)<br> -Number 229<br> -Section 1405<br> -Paragraph (a)<br> -Subparagraph (3)<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher SEC<br> -Name Regulation S-K (SK)<br> -Number 229<br> -Section 1405<br> -Paragraph (c)<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher SEC<br> -Name Regulation S-K (SK)<br> -Number 229<br> -Section 1405<br> -Paragraph (a)<br> -Subparagraph (1)<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinancingReceivableAllowanceForCreditLosses</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NotesAndLoansReceivableNetCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, after allowance for credit loss, of financing receivable, classified as current. Includes, but is not limited to, notes and loan receivable.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 310<br> -SubTopic 10<br> -Section 45<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=124259787&amp;loc=d3e4428-111522<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 310<br> -SubTopic 10<br> -Section 45<br> -Paragraph 9<br> -URI http://asc.fasb.org/extlink&amp;oid=124259787&amp;loc=d3e4531-111522<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (e)<br> -URI http://asc.fasb.org/extlink&amp;oid=124098289&amp;loc=d3e6676-107765<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(3)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(7))<br> -URI http://asc.fasb.org/extlink&amp;oid=120398452&amp;loc=d3e534808-122878<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=124098289&amp;loc=d3e6676-107765<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NotesAndLoansReceivableNetCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NotesAndLoansReceivableNetNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, after allowance for credit loss, of financing receivable, classified as noncurrent.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(3))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NotesAndLoansReceivableNetNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NotesReceivableNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, after allowance for credit loss, of financing receivable. Excludes financing receivable covered under loss sharing agreement.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 326<br> -SubTopic 20<br> -Section 50<br> -Paragraph 5<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=124255953&amp;loc=SL82919230-210447<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(3))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 310<br> -SubTopic 10<br> -Section 45<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=124259787&amp;loc=d3e4428-111522<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NotesReceivableNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentsToAcquireLoansReceivable">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The cash outflow for the purchase of loan receivable arising from the financing of goods and services.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 13<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3213-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PaymentsToAcquireLoansReceivable</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis=us-gaap_LoansReceivableMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis=us-gaap_LoansReceivableMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cron_LoanReceivableNameAxis=cron_NatuEraSeriesALoanMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cron_LoanReceivableNameAxis=cron_NatuEraSeriesALoanMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_LegalEntityAxis=cron_CronosGroupInc.Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_LegalEntityAxis=cron_CronosGroupInc.Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_LegalEntityAxis=cron_AgroideaMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_LegalEntityAxis=cron_AgroideaMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cron_LoanReceivableNameAxis=cron_CronosGrowCoCreditFacilityMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cron_LoanReceivableNameAxis=cron_CronosGrowCoCreditFacilityMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cron_LoanReceivableNameAxis=cron_A2645485OntarioInc.MucciPromissoryNoteMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cron_LoanReceivableNameAxis=cron_A2645485OntarioInc.MucciPromissoryNoteMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cron_LoanReceivableNameAxis=cron_CannasoulCollaborationLoanMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cron_LoanReceivableNameAxis=cron_CannasoulCollaborationLoanMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TypeOfArrangementAxis=us-gaap_CollaborativeArrangementTransactionWithPartyToCollaborativeArrangementMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TypeOfArrangementAxis=us-gaap_CollaborativeArrangementTransactionWithPartyToCollaborativeArrangementMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis=cron_CannasoulAnalyticsLtdMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis=cron_CannasoulAnalyticsLtdMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ConsolidatedEntitiesAxis=us-gaap_VariableInterestEntityNotPrimaryBeneficiaryMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ConsolidatedEntitiesAxis=us-gaap_VariableInterestEntityNotPrimaryBeneficiaryMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>49
<FILENAME>R35.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.2</span><table class="report" border="0" cellspacing="2" id="idm140382003572264">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Derivative Liabilities - Narrative (Details)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1">3 Months Ended</th>
</tr>
<tr>
<th class="th">
<div>Mar. 08, 2019 </div>
<div>warrant </div>
<div>day </div>
<div>$ / shares </div>
<div>shares</div>
</th>
<th class="th">
<div>Jun. 30, 2021 </div>
<div>USD ($) </div>
<div>shares</div>
</th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeLineItems', window );"><strong>Derivative [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cron_FairValueNetDerivativeAssetLiabilityMeasuredOnRecurringBasisUnobservableInputsReconciliationOutOfPeriodAdjustment', window );">Derivative liability, out-of-period adjustment</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 11,278<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_LegalEntityAxis=cron_AltriaGroupInc.Member', window );">Altria Group, Inc. | Cronos Group, Inc.</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeLineItems', window );"><strong>Derivative [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EquityMethodInvestmentOwnershipPercentage', window );">Ownership interest</a></td>
<td class="nump">45.00%<span></span>
</td>
<td class="nump">42.00%<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SubsidiarySaleOfStockAxis=cron_AltriaInvestmentMember', window );">Altria Investment</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeLineItems', window );"><strong>Derivative [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesNewIssues', window );">Shares issued (in shares) | shares</a></td>
<td class="nump">149,831,154<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_ConsolidatedEntitiesAxis=srt_SubsidiariesMember', window );">Cronos Group, Inc. | Altria Group, Inc.</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeLineItems', window );"><strong>Derivative [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cron_SubsidiaryOrEquityMethodInvesteeCumulativePercentageOwnershipAfterAllTransactionsIfWarrantsExercised', window );">Ownership percentage, if warrant exercised</a></td>
<td class="nump">55.00%<span></span>
</td>
<td class="nump">53.00%<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightAxis=cron_AltriaInvestmentMember', window );">Altria Investment</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeLineItems', window );"><strong>Derivative [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cron_ClassOfWarrantOrRightMaximumAdditionalSubscriptionPercentage', window );">Maximum additional subscription percentage</a></td>
<td class="nump">10.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cron_ClassOfWarrantOrRightAdditionalSubscriptionNumberOfSecuritiesCalledByWarrantsOrRights', window );">Derivative liability, additional subscription (in shares) | shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">83,000,000<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightAxis=cron_AltriaWarrantMember', window );">Altria Warrant</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeLineItems', window );"><strong>Derivative [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cron_ClassOfWarrantOrRightNumberOfWarrantsIssued', window );">Number of warrants issued | warrant</a></td>
<td class="nump">1<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1', window );">Exercise price (in dollars per share) | $ / shares</a></td>
<td class="nump">$ 19.00<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cron_FairValueNetDerivativeAssetLiabilityMeasuredOnRecurringBasisUnobservableInputsReconciliationOutOfPeriodAdjustment', window );">Derivative liability, out-of-period adjustment</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightAxis=cron_PreemptiveRightsMember', window );">Pre-emptive Rights</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeLineItems', window );"><strong>Derivative [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1', window );">Exercise price (in dollars per share) | $ / shares</a></td>
<td class="nump">$ 16.25<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cron_ClassOfWarrantOrRightMinimumOwnershipPercentageRequired', window );">Exercise rights, minimum ownership percentage</a></td>
<td class="nump">20.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cron_FairValueNetDerivativeAssetLiabilityMeasuredOnRecurringBasisUnobservableInputsReconciliationOutOfPeriodAdjustment', window );">Derivative liability, out-of-period adjustment</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightAxis=cron_TopupRightsMember', window );">Top-up Rights</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeLineItems', window );"><strong>Derivative [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1', window );">Exercise price (in dollars per share) | $ / shares</a></td>
<td class="nump">$ 16.25<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cron_ClassOfWarrantOrRightMinimumOwnershipPercentageRequired', window );">Exercise rights, minimum ownership percentage</a></td>
<td class="nump">20.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cron_ClassOfWarrantOrRightExercisePriceVolumeWeightedAveragePriceMeasurementPeriod', window );">Exercise price, volume-weighted average price, measurement period</a></td>
<td class="text">10 days<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cron_ClassOfWarrantOrRightExercisePriceVolumeWeightedAveragePriceMeasurementPeriodDaysPrecedingExercise', window );">Exercise price, volume-weighted average price, measurement period, days preceding exercise | day</a></td>
<td class="nump">10<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cron_FairValueNetDerivativeAssetLiabilityMeasuredOnRecurringBasisUnobservableInputsReconciliationOutOfPeriodAdjustment', window );">Derivative liability, out-of-period adjustment</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 11,278<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cron_ClassOfWarrantOrRightAdditionalSubscriptionNumberOfSecuritiesCalledByWarrantsOrRights">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Class Of Warrant Or Right, Additional Subscription, Number Of Securities Called By Warrants Or Rights</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cron_ClassOfWarrantOrRightAdditionalSubscriptionNumberOfSecuritiesCalledByWarrantsOrRights</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cron_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cron_ClassOfWarrantOrRightExercisePriceVolumeWeightedAveragePriceMeasurementPeriod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Class Of Warrant Or Right, Exercise Price, Volume-Weighted Average Price, Measurement Period</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cron_ClassOfWarrantOrRightExercisePriceVolumeWeightedAveragePriceMeasurementPeriod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cron_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cron_ClassOfWarrantOrRightExercisePriceVolumeWeightedAveragePriceMeasurementPeriodDaysPrecedingExercise">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Class Of Warrant Or Right, Exercise Price, Volume-Weighted Average Price, Measurement Period, Days Preceding Exercise</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cron_ClassOfWarrantOrRightExercisePriceVolumeWeightedAveragePriceMeasurementPeriodDaysPrecedingExercise</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cron_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:integerItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cron_ClassOfWarrantOrRightMaximumAdditionalSubscriptionPercentage">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Class Of Warrant Or Right, Maximum Additional Subscription Percentage</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cron_ClassOfWarrantOrRightMaximumAdditionalSubscriptionPercentage</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cron_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cron_ClassOfWarrantOrRightMinimumOwnershipPercentageRequired">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Class Of Warrant Or Right, Minimum Ownership Percentage Required</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cron_ClassOfWarrantOrRightMinimumOwnershipPercentageRequired</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cron_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cron_ClassOfWarrantOrRightNumberOfWarrantsIssued">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Class Of Warrant Or Right, Number Of Warrants Issued</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cron_ClassOfWarrantOrRightNumberOfWarrantsIssued</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cron_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:integerItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cron_FairValueNetDerivativeAssetLiabilityMeasuredOnRecurringBasisUnobservableInputsReconciliationOutOfPeriodAdjustment">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Fair Value, Net Derivative Asset (Liability) Measured On Recurring Basis, Unobservable Inputs Reconciliation, Out-Of-Period Adjustment</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cron_FairValueNetDerivativeAssetLiabilityMeasuredOnRecurringBasisUnobservableInputsReconciliationOutOfPeriodAdjustment</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cron_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cron_SubsidiaryOrEquityMethodInvesteeCumulativePercentageOwnershipAfterAllTransactionsIfWarrantsExercised">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Subsidiary Or Equity Method Investee, Cumulative Percentage Ownership After All Transactions, If Warrants Exercised</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cron_SubsidiaryOrEquityMethodInvesteeCumulativePercentageOwnershipAfterAllTransactionsIfWarrantsExercised</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cron_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Exercise price per share or per unit of warrants or rights outstanding.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=123467817&amp;loc=d3e21475-112644<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EquityMethodInvestmentOwnershipPercentage">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The percentage of ownership of common stock or equity participation in the investee accounted for under the equity method of accounting.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (a)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EquityMethodInvestmentOwnershipPercentage</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodSharesNewIssues">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of new stock issued during the period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=123467817&amp;loc=d3e21463-112644<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI http://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodSharesNewIssues</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_LegalEntityAxis=cron_AltriaGroupInc.Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_LegalEntityAxis=cron_AltriaGroupInc.Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis=cron_CronosGroupInc.Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis=cron_CronosGroupInc.Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SubsidiarySaleOfStockAxis=cron_AltriaInvestmentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SubsidiarySaleOfStockAxis=cron_AltriaInvestmentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ConsolidatedEntitiesAxis=srt_SubsidiariesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ConsolidatedEntitiesAxis=srt_SubsidiariesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ClassOfWarrantOrRightAxis=cron_AltriaInvestmentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ClassOfWarrantOrRightAxis=cron_AltriaInvestmentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ClassOfWarrantOrRightAxis=cron_AltriaWarrantMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ClassOfWarrantOrRightAxis=cron_AltriaWarrantMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ClassOfWarrantOrRightAxis=cron_PreemptiveRightsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ClassOfWarrantOrRightAxis=cron_PreemptiveRightsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ClassOfWarrantOrRightAxis=cron_TopupRightsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ClassOfWarrantOrRightAxis=cron_TopupRightsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>50
<FILENAME>R36.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.2</span><table class="report" border="0" cellspacing="2" id="idm140382007964552">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Derivative Liabilities - Schedule of Reconciliation of Carrying Amounts (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="2">3 Months Ended</th>
<th class="th" colspan="2">6 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Jun. 30, 2021</div></th>
<th class="th"><div>Jun. 30, 2020</div></th>
<th class="th"><div>Jun. 30, 2021</div></th>
<th class="th"><div>Jun. 30, 2020</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cron_DerivativeInstrumentsRollForward', window );"><strong>Derivative Instruments [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueNetDerivativeAssetLiabilityMeasuredOnRecurringBasisWithUnobservableInputs', window );">Beginning balance</a></td>
<td class="nump">$ 272,300<span></span>
</td>
<td class="nump">$ 165,449<span></span>
</td>
<td class="nump">$ 163,410<span></span>
</td>
<td class="nump">$ 297,160<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueNetDerivativeAssetLiabilityMeasuredOnRecurringBasisUnobservableInputsReconciliationGainLossIncludedInEarnings', window );">Revaluation loss/(gain)</a></td>
<td class="num">(115,248)<span></span>
</td>
<td class="nump">35,880<span></span>
</td>
<td class="nump">1,626<span></span>
</td>
<td class="num">(77,488)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueNetDerivativeAssetLiabilityMeasuredOnRecurringBasisUnobservableInputsReconciliationSettlements', window );">Exercise of rights</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(727)<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="num">(727)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cron_FairValueNetDerivativeAssetLiabilityMeasuredOnRecurringBasisUnobservableInputsReconciliationOutOfPeriodAdjustment', window );">Out-of-period adjustment</a></td>
<td class="nump">11,278<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueNetDerivativeAssetLiabilityMeasuredOnRecurringBasisUnobservableInputsReconciliationGainLossIncludedInOtherComprehensiveIncomeLoss', window );">Foreign exchange effect</a></td>
<td class="nump">1,233<span></span>
</td>
<td class="nump">5,112<span></span>
</td>
<td class="nump">4,527<span></span>
</td>
<td class="num">(13,231)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueNetDerivativeAssetLiabilityMeasuredOnRecurringBasisWithUnobservableInputs', window );">Ending balance</a></td>
<td class="nump">169,563<span></span>
</td>
<td class="nump">205,714<span></span>
</td>
<td class="nump">169,563<span></span>
</td>
<td class="nump">205,714<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightAxis=cron_AltriaWarrantMember', window );">Altria Warrant</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cron_DerivativeInstrumentsRollForward', window );"><strong>Derivative Instruments [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueNetDerivativeAssetLiabilityMeasuredOnRecurringBasisWithUnobservableInputs', window );">Beginning balance</a></td>
<td class="nump">234,656<span></span>
</td>
<td class="nump">132,366<span></span>
</td>
<td class="nump">138,858<span></span>
</td>
<td class="nump">234,428<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueNetDerivativeAssetLiabilityMeasuredOnRecurringBasisUnobservableInputsReconciliationGainLossIncludedInEarnings', window );">Revaluation loss/(gain)</a></td>
<td class="num">(85,778)<span></span>
</td>
<td class="nump">30,052<span></span>
</td>
<td class="nump">7,186<span></span>
</td>
<td class="num">(58,052)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueNetDerivativeAssetLiabilityMeasuredOnRecurringBasisUnobservableInputsReconciliationSettlements', window );">Exercise of rights</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cron_FairValueNetDerivativeAssetLiabilityMeasuredOnRecurringBasisUnobservableInputsReconciliationOutOfPeriodAdjustment', window );">Out-of-period adjustment</a></td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueNetDerivativeAssetLiabilityMeasuredOnRecurringBasisUnobservableInputsReconciliationGainLossIncludedInOtherComprehensiveIncomeLoss', window );">Foreign exchange effect</a></td>
<td class="nump">1,205<span></span>
</td>
<td class="nump">3,540<span></span>
</td>
<td class="nump">4,039<span></span>
</td>
<td class="num">(10,418)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueNetDerivativeAssetLiabilityMeasuredOnRecurringBasisWithUnobservableInputs', window );">Ending balance</a></td>
<td class="nump">150,083<span></span>
</td>
<td class="nump">165,958<span></span>
</td>
<td class="nump">150,083<span></span>
</td>
<td class="nump">165,958<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightAxis=cron_PreemptiveRightsMember', window );">Pre-emptive Rights</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cron_DerivativeInstrumentsRollForward', window );"><strong>Derivative Instruments [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueNetDerivativeAssetLiabilityMeasuredOnRecurringBasisWithUnobservableInputs', window );">Beginning balance</a></td>
<td class="nump">20,173<span></span>
</td>
<td class="nump">13,070<span></span>
</td>
<td class="nump">12,095<span></span>
</td>
<td class="nump">12,787<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueNetDerivativeAssetLiabilityMeasuredOnRecurringBasisUnobservableInputsReconciliationGainLossIncludedInEarnings', window );">Revaluation loss/(gain)</a></td>
<td class="num">(6,360)<span></span>
</td>
<td class="nump">2,610<span></span>
</td>
<td class="nump">1,473<span></span>
</td>
<td class="nump">3,925<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueNetDerivativeAssetLiabilityMeasuredOnRecurringBasisUnobservableInputsReconciliationSettlements', window );">Exercise of rights</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cron_FairValueNetDerivativeAssetLiabilityMeasuredOnRecurringBasisUnobservableInputsReconciliationOutOfPeriodAdjustment', window );">Out-of-period adjustment</a></td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueNetDerivativeAssetLiabilityMeasuredOnRecurringBasisUnobservableInputsReconciliationGainLossIncludedInOtherComprehensiveIncomeLoss', window );">Foreign exchange effect</a></td>
<td class="nump">113<span></span>
</td>
<td class="nump">500<span></span>
</td>
<td class="nump">358<span></span>
</td>
<td class="num">(532)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueNetDerivativeAssetLiabilityMeasuredOnRecurringBasisWithUnobservableInputs', window );">Ending balance</a></td>
<td class="nump">13,926<span></span>
</td>
<td class="nump">16,180<span></span>
</td>
<td class="nump">13,926<span></span>
</td>
<td class="nump">16,180<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightAxis=cron_TopupRightsMember', window );">Top-up Rights</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cron_DerivativeInstrumentsRollForward', window );"><strong>Derivative Instruments [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueNetDerivativeAssetLiabilityMeasuredOnRecurringBasisWithUnobservableInputs', window );">Beginning balance</a></td>
<td class="nump">17,471<span></span>
</td>
<td class="nump">20,013<span></span>
</td>
<td class="nump">12,457<span></span>
</td>
<td class="nump">49,945<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueNetDerivativeAssetLiabilityMeasuredOnRecurringBasisUnobservableInputsReconciliationGainLossIncludedInEarnings', window );">Revaluation loss/(gain)</a></td>
<td class="num">(23,110)<span></span>
</td>
<td class="nump">3,218<span></span>
</td>
<td class="num">(7,033)<span></span>
</td>
<td class="num">(23,361)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueNetDerivativeAssetLiabilityMeasuredOnRecurringBasisUnobservableInputsReconciliationSettlements', window );">Exercise of rights</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(727)<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="num">(727)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cron_FairValueNetDerivativeAssetLiabilityMeasuredOnRecurringBasisUnobservableInputsReconciliationOutOfPeriodAdjustment', window );">Out-of-period adjustment</a></td>
<td class="nump">11,278<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueNetDerivativeAssetLiabilityMeasuredOnRecurringBasisUnobservableInputsReconciliationGainLossIncludedInOtherComprehensiveIncomeLoss', window );">Foreign exchange effect</a></td>
<td class="num">(85)<span></span>
</td>
<td class="nump">1,072<span></span>
</td>
<td class="nump">130<span></span>
</td>
<td class="num">(2,281)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueNetDerivativeAssetLiabilityMeasuredOnRecurringBasisWithUnobservableInputs', window );">Ending balance</a></td>
<td class="nump">$ 5,554<span></span>
</td>
<td class="nump">$ 23,576<span></span>
</td>
<td class="nump">$ 5,554<span></span>
</td>
<td class="nump">$ 23,576<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cron_DerivativeInstrumentsRollForward">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Derivative Instruments [Roll Forward]</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cron_DerivativeInstrumentsRollForward</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cron_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cron_FairValueNetDerivativeAssetLiabilityMeasuredOnRecurringBasisUnobservableInputsReconciliationOutOfPeriodAdjustment">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Fair Value, Net Derivative Asset (Liability) Measured On Recurring Basis, Unobservable Inputs Reconciliation, Out-Of-Period Adjustment</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cron_FairValueNetDerivativeAssetLiabilityMeasuredOnRecurringBasisUnobservableInputsReconciliationOutOfPeriodAdjustment</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cron_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueNetDerivativeAssetLiabilityMeasuredOnRecurringBasisUnobservableInputsReconciliationGainLossIncludedInEarnings">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of gain (loss) recognized in income from derivative asset (liability) after deduction of derivative liability (asset), measured at fair value on recurring basis using unobservable input (level 3).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 820<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=123874694&amp;loc=d3e19207-110258<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 820<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123874694&amp;loc=d3e19279-110258<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueNetDerivativeAssetLiabilityMeasuredOnRecurringBasisUnobservableInputsReconciliationGainLossIncludedInEarnings</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueNetDerivativeAssetLiabilityMeasuredOnRecurringBasisUnobservableInputsReconciliationGainLossIncludedInOtherComprehensiveIncomeLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of gain (loss) recognized in other comprehensive income from derivative asset (liability) after deduction of derivative liability (asset), measured at fair value on recurring basis using unobservable input (level 3).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 820<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123874694&amp;loc=d3e19279-110258<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 820<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123874694&amp;loc=d3e19207-110258<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueNetDerivativeAssetLiabilityMeasuredOnRecurringBasisUnobservableInputsReconciliationGainLossIncludedInOtherComprehensiveIncomeLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueNetDerivativeAssetLiabilityMeasuredOnRecurringBasisUnobservableInputsReconciliationSettlements">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of settlements of financial instrument classified as a derivative asset (liability) after deduction of derivative liability, measured using unobservable inputs that reflect the entity's own assumption about the assumptions market participants would use in pricing.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 820<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123874694&amp;loc=d3e19279-110258<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 820<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=123874694&amp;loc=d3e19207-110258<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueNetDerivativeAssetLiabilityMeasuredOnRecurringBasisUnobservableInputsReconciliationSettlements</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueNetDerivativeAssetLiabilityMeasuredOnRecurringBasisWithUnobservableInputs">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Fair value of financial instrument classified as derivative asset (liability) after deduction of derivative liability (asset), measured using unobservable inputs that reflect the entity's own assumption about the assumptions market participants would use in pricing.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 820<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123874694&amp;loc=d3e19207-110258<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 820<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123874694&amp;loc=d3e19279-110258<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueNetDerivativeAssetLiabilityMeasuredOnRecurringBasisWithUnobservableInputs</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ClassOfWarrantOrRightAxis=cron_AltriaWarrantMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ClassOfWarrantOrRightAxis=cron_AltriaWarrantMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ClassOfWarrantOrRightAxis=cron_PreemptiveRightsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ClassOfWarrantOrRightAxis=cron_PreemptiveRightsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ClassOfWarrantOrRightAxis=cron_TopupRightsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ClassOfWarrantOrRightAxis=cron_TopupRightsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>51
<FILENAME>R37.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.2</span><table class="report" border="0" cellspacing="2" id="idm140382003980392">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Derivative Liabilities - Schedule of Fair Values of Derivative Liabilities (Details)<br></strong></div></th>
<th class="th" colspan="1">6 Months Ended</th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr>
<th class="th">
<div>Jun. 30, 2021 </div>
<div>$ / shares</div>
</th>
<th class="th">
<div>Dec. 31, 2020 </div>
<div>$ / shares</div>
</th>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightAxis=cron_AltriaWarrantMember', window );">Altria Warrant | Share price at valuation date</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesLineItems', window );"><strong>Fair Value Measurement Inputs and Valuation Techniques [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeLiabilityMeasurementInput', window );">Derivative liability, measurement input</a></td>
<td class="nump">10.68<span></span>
</td>
<td class="nump">8.84<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightAxis=cron_AltriaWarrantMember', window );">Altria Warrant | Subscription price</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesLineItems', window );"><strong>Fair Value Measurement Inputs and Valuation Techniques [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeLiabilityMeasurementInput', window );">Derivative liability, measurement input</a></td>
<td class="nump">19.00<span></span>
</td>
<td class="nump">19.00<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightAxis=cron_AltriaWarrantMember', window );">Altria Warrant | Expected annualized volatility</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesLineItems', window );"><strong>Fair Value Measurement Inputs and Valuation Techniques [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeLiabilityMeasurementInput', window );">Derivative liability, measurement input</a></td>
<td class="nump">0.75<span></span>
</td>
<td class="nump">0.81<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightAxis=cron_AltriaWarrantMember', window );">Altria Warrant | Expected dividend yield</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesLineItems', window );"><strong>Fair Value Measurement Inputs and Valuation Techniques [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeLiabilityMeasurementInput', window );">Derivative liability, measurement input</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightAxis=cron_AltriaWarrantMember', window );">Altria Warrant | Weighted Average | Weighted average risk-free interest rate</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesLineItems', window );"><strong>Fair Value Measurement Inputs and Valuation Techniques [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeLiabilityMeasurementInput', window );">Derivative liability, measurement input</a></td>
<td class="nump">0.0038<span></span>
</td>
<td class="nump">0.0021<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightAxis=cron_AltriaWarrantMember', window );">Altria Warrant | Weighted Average | Weight average expected life</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesLineItems', window );"><strong>Fair Value Measurement Inputs and Valuation Techniques [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cron_DerivativeLiabilityUsefulLifeTerm', window );">Expected life</a></td>
<td class="text">1 year 8 months 4 days<span></span>
</td>
<td class="text">2 years 2 months 4 days<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightAxis=cron_PreemptiveRightsMember', window );">Pre-emptive Rights | Share price at valuation date</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesLineItems', window );"><strong>Fair Value Measurement Inputs and Valuation Techniques [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeLiabilityMeasurementInput', window );">Derivative liability, measurement input</a></td>
<td class="nump">10.68<span></span>
</td>
<td class="nump">8.84<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightAxis=cron_PreemptiveRightsMember', window );">Pre-emptive Rights | Subscription price</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesLineItems', window );"><strong>Fair Value Measurement Inputs and Valuation Techniques [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeLiabilityMeasurementInput', window );">Derivative liability, measurement input</a></td>
<td class="nump">16.25<span></span>
</td>
<td class="nump">16.25<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightAxis=cron_PreemptiveRightsMember', window );">Pre-emptive Rights | Expected annualized volatility</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesLineItems', window );"><strong>Fair Value Measurement Inputs and Valuation Techniques [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeLiabilityMeasurementInput', window );">Derivative liability, measurement input</a></td>
<td class="nump">0.75<span></span>
</td>
<td class="nump">0.81<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightAxis=cron_PreemptiveRightsMember', window );">Pre-emptive Rights | Expected dividend yield</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesLineItems', window );"><strong>Fair Value Measurement Inputs and Valuation Techniques [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeLiabilityMeasurementInput', window );">Derivative liability, measurement input</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightAxis=cron_PreemptiveRightsMember', window );">Pre-emptive Rights | Weighted Average | Weighted average risk-free interest rate</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesLineItems', window );"><strong>Fair Value Measurement Inputs and Valuation Techniques [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeLiabilityMeasurementInput', window );">Derivative liability, measurement input</a></td>
<td class="nump">0.0028<span></span>
</td>
<td class="nump">0.0017<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightAxis=cron_PreemptiveRightsMember', window );">Pre-emptive Rights | Weighted Average | Weight average expected life</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesLineItems', window );"><strong>Fair Value Measurement Inputs and Valuation Techniques [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cron_DerivativeLiabilityUsefulLifeTerm', window );">Expected life</a></td>
<td class="text">1 year 3 months<span></span>
</td>
<td class="text">1 year 6 months<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightAxis=cron_TopupRightsMember', window );">Top-up Rights | Share price at valuation date</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesLineItems', window );"><strong>Fair Value Measurement Inputs and Valuation Techniques [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeLiabilityMeasurementInput', window );">Derivative liability, measurement input</a></td>
<td class="nump">10.68<span></span>
</td>
<td class="nump">8.84<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightAxis=cron_TopupRightsMember', window );">Top-up Rights | Subscription price</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesLineItems', window );"><strong>Fair Value Measurement Inputs and Valuation Techniques [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeLiabilityMeasurementInput', window );">Derivative liability, measurement input</a></td>
<td class="nump">16.25<span></span>
</td>
<td class="nump">16.25<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightAxis=cron_TopupRightsMember', window );">Top-up Rights | Expected annualized volatility</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesLineItems', window );"><strong>Fair Value Measurement Inputs and Valuation Techniques [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeLiabilityMeasurementInput', window );">Derivative liability, measurement input</a></td>
<td class="nump">0.75<span></span>
</td>
<td class="nump">0.81<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightAxis=cron_TopupRightsMember', window );">Top-up Rights | Expected dividend yield</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesLineItems', window );"><strong>Fair Value Measurement Inputs and Valuation Techniques [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeLiabilityMeasurementInput', window );">Derivative liability, measurement input</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightAxis=cron_TopupRightsMember', window );">Top-up Rights | Weighted Average | Weighted average risk-free interest rate</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesLineItems', window );"><strong>Fair Value Measurement Inputs and Valuation Techniques [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeLiabilityMeasurementInput', window );">Derivative liability, measurement input</a></td>
<td class="nump">0.0031<span></span>
</td>
<td class="nump">0.0013<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightAxis=cron_TopupRightsMember', window );">Top-up Rights | Weighted Average | Weight average expected life</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesLineItems', window );"><strong>Fair Value Measurement Inputs and Valuation Techniques [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cron_DerivativeLiabilityUsefulLifeTerm', window );">Expected life</a></td>
<td class="text">1 year 3 months 21 days<span></span>
</td>
<td class="text">11 months 23 days<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightAxis=cron_PreEmptiveRightsAndTopUpRightsMember', window );">Pre-emptive Rights and Top-up Rights | Minimum | Weighted average risk-free interest rate</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesLineItems', window );"><strong>Fair Value Measurement Inputs and Valuation Techniques [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeLiabilityMeasurementInput', window );">Derivative liability, measurement input</a></td>
<td class="nump">0.0015<span></span>
</td>
<td class="nump">0.0010<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightAxis=cron_PreEmptiveRightsAndTopUpRightsMember', window );">Pre-emptive Rights and Top-up Rights | Minimum | Weight average expected life</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesLineItems', window );"><strong>Fair Value Measurement Inputs and Valuation Techniques [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cron_DerivativeLiabilityUsefulLifeTerm', window );">Expected life</a></td>
<td class="text">3 months<span></span>
</td>
<td class="text">6 months<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightAxis=cron_PreEmptiveRightsAndTopUpRightsMember', window );">Pre-emptive Rights and Top-up Rights | Maximum | Weighted average risk-free interest rate</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesLineItems', window );"><strong>Fair Value Measurement Inputs and Valuation Techniques [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeLiabilityMeasurementInput', window );">Derivative liability, measurement input</a></td>
<td class="nump">0.0085<span></span>
</td>
<td class="nump">0.0039<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightAxis=cron_PreEmptiveRightsAndTopUpRightsMember', window );">Pre-emptive Rights and Top-up Rights | Maximum | Weight average expected life</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesLineItems', window );"><strong>Fair Value Measurement Inputs and Valuation Techniques [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cron_DerivativeLiabilityUsefulLifeTerm', window );">Expected life</a></td>
<td class="text">4 years 3 months<span></span>
</td>
<td class="text">5 years<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cron_DerivativeLiabilityUsefulLifeTerm">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Derivative Liability, Useful Life, Term</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cron_DerivativeLiabilityUsefulLifeTerm</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cron_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeLiabilityMeasurementInput">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Value of input used to measure derivative liability.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 820<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (bbb)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=123874694&amp;loc=d3e19207-110258<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeLiabilityMeasurementInput</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:decimalItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ClassOfWarrantOrRightAxis=cron_AltriaWarrantMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ClassOfWarrantOrRightAxis=cron_AltriaWarrantMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_MeasurementInputTypeAxis=us-gaap_MeasurementInputSharePriceMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_MeasurementInputTypeAxis=us-gaap_MeasurementInputSharePriceMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_MeasurementInputTypeAxis=cron_MeasurementInputSubscriptionPriceMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_MeasurementInputTypeAxis=cron_MeasurementInputSubscriptionPriceMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_MeasurementInputTypeAxis=us-gaap_MeasurementInputPriceVolatilityMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_MeasurementInputTypeAxis=us-gaap_MeasurementInputPriceVolatilityMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_MeasurementInputTypeAxis=us-gaap_MeasurementInputExpectedDividendRateMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_MeasurementInputTypeAxis=us-gaap_MeasurementInputExpectedDividendRateMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_RangeAxis=srt_WeightedAverageMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_RangeAxis=srt_WeightedAverageMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_MeasurementInputTypeAxis=us-gaap_MeasurementInputRiskFreeInterestRateMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_MeasurementInputTypeAxis=us-gaap_MeasurementInputRiskFreeInterestRateMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_MeasurementInputTypeAxis=us-gaap_MeasurementInputExpectedTermMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_MeasurementInputTypeAxis=us-gaap_MeasurementInputExpectedTermMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ClassOfWarrantOrRightAxis=cron_PreemptiveRightsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ClassOfWarrantOrRightAxis=cron_PreemptiveRightsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ClassOfWarrantOrRightAxis=cron_TopupRightsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ClassOfWarrantOrRightAxis=cron_TopupRightsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ClassOfWarrantOrRightAxis=cron_PreEmptiveRightsAndTopUpRightsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ClassOfWarrantOrRightAxis=cron_PreEmptiveRightsAndTopUpRightsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_RangeAxis=srt_MinimumMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_RangeAxis=srt_MinimumMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_RangeAxis=srt_MaximumMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_RangeAxis=srt_MaximumMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>52
<FILENAME>R38.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.2</span><table class="report" border="0" cellspacing="2" id="idm140382098941432">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Derivative Liabilities - Schedule of Sensitivity Analysis (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th"><div>Jun. 30, 2021</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightAxis=cron_AltriaWarrantMember', window );">Altria Warrant</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cron_SensitivityAnalysisImpactOf10PercentDecreaseIncreaseOnNetIncomeLossAbstract', window );"><strong>Sensitivity Analysis, Impact of 10 Percent Decrease (Increase) on Net Income (Loss) [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cron_SensitivityAnalysisImpactOf10PercentDecreaseIncreaseInSharePriceOnNetIncomeLoss', window );">Share price</a></td>
<td class="nump">$ 31,375<span></span>
</td>
<td class="nump">$ 25,819<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cron_SensitivityAnalysisImpactOf10PercentDecreaseIncreaseInWeightedAverageExpectedLifeOnNetIncomeLoss', window );">Weighted average expected life</a></td>
<td class="nump">14,220<span></span>
</td>
<td class="nump">13,541<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cron_SensitivityAnalysisImpactOf10PercentDecreaseIncreaseInExpectedAnnualizedVolatilityOnNetIncomeLoss', window );">Expected annualized volatility</a></td>
<td class="nump">27,375<span></span>
</td>
<td class="nump">26,183<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightAxis=cron_PreemptiveRightsMember', window );">Pre-emptive Rights</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cron_SensitivityAnalysisImpactOf10PercentDecreaseIncreaseOnNetIncomeLossAbstract', window );"><strong>Sensitivity Analysis, Impact of 10 Percent Decrease (Increase) on Net Income (Loss) [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cron_SensitivityAnalysisImpactOf10PercentDecreaseIncreaseInSharePriceOnNetIncomeLoss', window );">Share price</a></td>
<td class="nump">3,146<span></span>
</td>
<td class="nump">2,527<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cron_SensitivityAnalysisImpactOf10PercentDecreaseIncreaseInWeightedAverageExpectedLifeOnNetIncomeLoss', window );">Weighted average expected life</a></td>
<td class="nump">5,266<span></span>
</td>
<td class="nump">1,988<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cron_SensitivityAnalysisImpactOf10PercentDecreaseIncreaseInExpectedAnnualizedVolatilityOnNetIncomeLoss', window );">Expected annualized volatility</a></td>
<td class="nump">2,348<span></span>
</td>
<td class="nump">2,269<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightAxis=cron_TopupRightsMember', window );">Top-up Rights</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cron_SensitivityAnalysisImpactOf10PercentDecreaseIncreaseOnNetIncomeLossAbstract', window );"><strong>Sensitivity Analysis, Impact of 10 Percent Decrease (Increase) on Net Income (Loss) [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cron_SensitivityAnalysisImpactOf10PercentDecreaseIncreaseInSharePriceOnNetIncomeLoss', window );">Share price</a></td>
<td class="nump">1,302<span></span>
</td>
<td class="nump">2,989<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cron_SensitivityAnalysisImpactOf10PercentDecreaseIncreaseInWeightedAverageExpectedLifeOnNetIncomeLoss', window );">Weighted average expected life</a></td>
<td class="nump">502<span></span>
</td>
<td class="nump">2,121<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cron_SensitivityAnalysisImpactOf10PercentDecreaseIncreaseInExpectedAnnualizedVolatilityOnNetIncomeLoss', window );">Expected annualized volatility</a></td>
<td class="nump">$ 968<span></span>
</td>
<td class="nump">$ 2,602<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cron_SensitivityAnalysisImpactOf10PercentDecreaseIncreaseInExpectedAnnualizedVolatilityOnNetIncomeLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Sensitivity Analysis, Impact Of 10 Percent Decrease (Increase) In Expected Annualized Volatility On Net Income (Loss)</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cron_SensitivityAnalysisImpactOf10PercentDecreaseIncreaseInExpectedAnnualizedVolatilityOnNetIncomeLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cron_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cron_SensitivityAnalysisImpactOf10PercentDecreaseIncreaseInSharePriceOnNetIncomeLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Sensitivity Analysis, Impact Of 10 Percent Decrease (Increase) In Share Price On Net Income (Loss)</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cron_SensitivityAnalysisImpactOf10PercentDecreaseIncreaseInSharePriceOnNetIncomeLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cron_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cron_SensitivityAnalysisImpactOf10PercentDecreaseIncreaseInWeightedAverageExpectedLifeOnNetIncomeLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Sensitivity Analysis, Impact Of 10 Percent Decrease (Increase) In Weighted Average Expected Life On Net Income (Loss)</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cron_SensitivityAnalysisImpactOf10PercentDecreaseIncreaseInWeightedAverageExpectedLifeOnNetIncomeLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cron_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cron_SensitivityAnalysisImpactOf10PercentDecreaseIncreaseOnNetIncomeLossAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Sensitivity Analysis, Impact Of 10 Percent Decrease (Increase) On Net Income (Loss) [Abstract]</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cron_SensitivityAnalysisImpactOf10PercentDecreaseIncreaseOnNetIncomeLossAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cron_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ClassOfWarrantOrRightAxis=cron_AltriaWarrantMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ClassOfWarrantOrRightAxis=cron_AltriaWarrantMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ClassOfWarrantOrRightAxis=cron_PreemptiveRightsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ClassOfWarrantOrRightAxis=cron_PreemptiveRightsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ClassOfWarrantOrRightAxis=cron_TopupRightsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ClassOfWarrantOrRightAxis=cron_TopupRightsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>53
<FILENAME>R39.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.2</span><table class="report" border="0" cellspacing="2" id="idm140382008444024">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Share-based Payments - Summary of Stock-based Compensation Expense (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="2">3 Months Ended</th>
<th class="th" colspan="2">6 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Jun. 30, 2021</div></th>
<th class="th"><div>Jun. 30, 2020</div></th>
<th class="th"><div>Jun. 30, 2021</div></th>
<th class="th"><div>Jun. 30, 2020</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems', window );"><strong>Share-based Payment Arrangement, Expensed and Capitalized, Amount [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AllocatedShareBasedCompensationExpense', window );">Share-based payments</a></td>
<td class="nump">$ 2,565<span></span>
</td>
<td class="nump">$ 2,546<span></span>
</td>
<td class="nump">$ 5,064<span></span>
</td>
<td class="nump">$ 4,982<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AwardTypeAxis=us-gaap_EmployeeStockOptionMember', window );">Stock options</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems', window );"><strong>Share-based Payment Arrangement, Expensed and Capitalized, Amount [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AllocatedShareBasedCompensationExpense', window );">Share-based payments</a></td>
<td class="nump">1,864<span></span>
</td>
<td class="nump">1,770<span></span>
</td>
<td class="nump">3,928<span></span>
</td>
<td class="nump">3,500<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AwardTypeAxis=us-gaap_RestrictedStockUnitsRSUMember', window );">Restricted share units</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems', window );"><strong>Share-based Payment Arrangement, Expensed and Capitalized, Amount [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AllocatedShareBasedCompensationExpense', window );">Share-based payments</a></td>
<td class="nump">$ 701<span></span>
</td>
<td class="nump">$ 776<span></span>
</td>
<td class="nump">$ 1,136<span></span>
</td>
<td class="nump">$ 1,482<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AllocatedShareBasedCompensationExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of expense for award under share-based payment arrangement. Excludes amount capitalized.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5047-113901<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 14.F)<br> -URI http://asc.fasb.org/extlink&amp;oid=122041274&amp;loc=d3e301413-122809<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (h)(1)(i)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AllocatedShareBasedCompensationExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AwardTypeAxis=us-gaap_EmployeeStockOptionMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AwardTypeAxis=us-gaap_EmployeeStockOptionMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AwardTypeAxis=us-gaap_RestrictedStockUnitsRSUMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AwardTypeAxis=us-gaap_RestrictedStockUnitsRSUMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>54
<FILENAME>R40.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.2</span><table class="report" border="0" cellspacing="2" id="idm140382007749704">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Share-based Payments - Stock Options Narrative (Details) - shares<br></strong></div></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="2">6 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Mar. 29, 2020</div></th>
<th class="th"><div>Jun. 30, 2021</div></th>
<th class="th"><div>Jun. 30, 2020</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross', window );">Issuance of options (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AwardTypeAxis=us-gaap_EmployeeStockOptionMember', window );">Stock options | 2020 Omnibus Plan</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod', window );">Expiration period</a></td>
<td class="text">10 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AwardTypeAxis=us-gaap_EmployeeStockOptionMember', window );">Stock options | Prior Option Plans</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod', window );">Expiration period</a></td>
<td class="text">7 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_RangeAxis=srt_MinimumMember', window );">Minimum | Stock options | 2020 Omnibus Plan</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1', window );">Vesting period</a></td>
<td class="text">3 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_RangeAxis=srt_MinimumMember', window );">Minimum | Stock options | Prior Option Plans</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1', window );">Vesting period</a></td>
<td class="text">3 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_RangeAxis=srt_MaximumMember', window );">Maximum | Stock options | 2020 Omnibus Plan</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1', window );">Vesting period</a></td>
<td class="text">5 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_RangeAxis=srt_MaximumMember', window );">Maximum | Stock options | Prior Option Plans</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1', window );">Vesting period</a></td>
<td class="text">5 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Period over which grantee's right to exercise award under share-based payment arrangement is no longer contingent on satisfaction of service or performance condition, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days. Includes, but is not limited to, combination of market, performance or service condition.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Gross number of share options (or share units) granted during the period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Period from grant date that an equity-based award expires, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AwardTypeAxis=us-gaap_EmployeeStockOptionMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AwardTypeAxis=us-gaap_EmployeeStockOptionMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PlanNameAxis=cron_A2020OmnibusPlanMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PlanNameAxis=cron_A2020OmnibusPlanMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PlanNameAxis=cron_PriorOptionPlansMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PlanNameAxis=cron_PriorOptionPlansMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_RangeAxis=srt_MinimumMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_RangeAxis=srt_MinimumMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_RangeAxis=srt_MaximumMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_RangeAxis=srt_MaximumMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>55
<FILENAME>R41.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.2</span><table class="report" border="0" cellspacing="2" id="idm140382008665096">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Share-based Payments - Summary of the Changes in Options (Details)<br></strong></div></th>
<th class="th" colspan="2">6 Months Ended</th>
<th class="th" colspan="2">12 Months Ended</th>
</tr>
<tr>
<th class="th">
<div>Jun. 30, 2021 </div>
<div>$ / shares </div>
<div>$ / shares </div>
<div>shares</div>
</th>
<th class="th">
<div>Jun. 30, 2020 </div>
<div>$ / shares </div>
<div>$ / shares </div>
<div>shares</div>
</th>
<th class="th">
<div>Dec. 31, 2020 </div>
<div>$ / shares </div>
<div>shares</div>
</th>
<th class="th">
<div>Dec. 31, 2019 </div>
<div>$ / shares </div>
<div>shares</div>
</th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward', window );"><strong>Weighted average exercise price (C$)</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice', window );">Balance at beginning of period (in dollars per share) | $ / shares</a></td>
<td class="nump">$ 5.40<span></span>
</td>
<td class="nump">$ 4.84<span></span>
</td>
<td class="nump">$ 4.84<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice', window );">Exercise of options (in dollars per share) | $ / shares</a></td>
<td class="nump">2.14<span></span>
</td>
<td class="nump">2.05<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice', window );">Cancellation, forfeiture and expiry of options (in dollars per share) | $ / shares</a></td>
<td class="nump">14.86<span></span>
</td>
<td class="nump">15.78<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice', window );">Balance at end of period (in dollars per share) | $ / shares</a></td>
<td class="nump">$ 7.45<span></span>
</td>
<td class="nump">$ 5.13<span></span>
</td>
<td class="nump">$ 5.40<span></span>
</td>
<td class="nump">$ 4.84<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice', window );">Weighted average exercise price of options exercisable (in dollars per share) | $ / shares</a></td>
<td class="nump">$ 6.49<span></span>
</td>
<td class="nump">$ 3.42<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward', window );"><strong>Number of options</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber', window );">Balance at beginning of period (in shares) | shares</a></td>
<td class="nump">13,755,148<span></span>
</td>
<td class="nump">14,149,502<span></span>
</td>
<td class="nump">14,149,502<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised', window );">Exercise of options (in shares) | shares</a></td>
<td class="num">(5,349,818)<span></span>
</td>
<td class="num">(1,807,909)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod', window );">Cancellation, forfeiture and expiry of options (in shares) | shares</a></td>
<td class="num">(33,699)<span></span>
</td>
<td class="num">(127,045)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber', window );">Balance at end of period (in shares) | shares</a></td>
<td class="nump">8,371,631<span></span>
</td>
<td class="nump">12,214,548<span></span>
</td>
<td class="nump">13,755,148<span></span>
</td>
<td class="nump">14,149,502<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber', window );">Exercisable (in shares) | shares</a></td>
<td class="nump">4,679,240<span></span>
</td>
<td class="nump">8,688,645<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedWeightedAverageGrantDateFairValueAbstract', window );"><strong>Weighted average remaining contractual term (years)</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2', window );">Outstanding</a></td>
<td class="text">2 years 7 months 28 days<span></span>
</td>
<td class="text">2 years 18 days<span></span>
</td>
<td class="text">2 years 3 months 18 days<span></span>
</td>
<td class="text">2 years 6 months 21 days<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageRemainingContractualTerm1', window );">Exercisable</a></td>
<td class="text">1 year 5 months 4 days<span></span>
</td>
<td class="text">1 year 9 months 10 days<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The number of shares into which fully or partially vested stock options outstanding as of the balance sheet date can be currently converted under the option plan.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iii)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The weighted-average price as of the balance sheet date at which grantees can acquire the shares reserved for issuance on vested portions of options outstanding and currently exercisable under the stock option plan.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iii)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>For presentations that combine terminations, the number of shares under options that were cancelled during the reporting period as a result of occurrence of a terminating event specified in contractual agreements pertaining to the stock option plan or that expired.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iv)(3)-(4)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Weighted average price of options that were either forfeited or expired.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iv)(3)-(4)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of options outstanding, including both vested and non-vested options.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(i)-(ii)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Weighted average price at which grantees can acquire the shares reserved for issuance under the stock option plan.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(i)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Weighted average price at which option holders acquired shares when converting their stock options into shares.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedWeightedAverageGrantDateFairValueAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedWeightedAverageGrantDateFairValueAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Weighted average remaining contractual term for option awards outstanding, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (e)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageRemainingContractualTerm1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Weighted average remaining contractual term for fully vested and expected to vest exercisable or convertible options, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days. Includes, but is not limited to, unvested options for which requisite service period has not been rendered but that are expected to vest based on achievement of performance condition, if forfeitures are recognized when they occur.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (e)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageRemainingContractualTerm1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of share options (or share units) exercised during the current period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iv)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI http://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=123467817&amp;loc=d3e21463-112644<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>56
<FILENAME>R42.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.2</span><table class="report" border="0" cellspacing="2" id="idm140382004082808">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Share-based Payments - Schedule of Stock Options Outstanding (Details) - shares<br></strong></div></th>
<th class="th"><div>Jun. 30, 2021</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
<th class="th"><div>Jun. 30, 2020</div></th>
<th class="th"><div>Dec. 31, 2019</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber', window );">Number of options outstanding (in shares)</a></td>
<td class="nump">8,371,631<span></span>
</td>
<td class="nump">13,755,148<span></span>
</td>
<td class="nump">12,214,548<span></span>
</td>
<td class="nump">14,149,502<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PlanNameAxis=cron_A2020OmnibusPlanMember', window );">2020 Omnibus Plan</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber', window );">Number of options outstanding (in shares)</a></td>
<td class="nump">2,000,000<span></span>
</td>
<td class="nump">2,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PlanNameAxis=cron_A2018StockOptionPlanMember', window );">2018 Stock Option Plan</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber', window );">Number of options outstanding (in shares)</a></td>
<td class="nump">1,586,725<span></span>
</td>
<td class="nump">1,627,715<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PlanNameAxis=cron_A2015StockOptionPlanMember', window );">2015 Stock Option Plan</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber', window );">Number of options outstanding (in shares)</a></td>
<td class="nump">4,784,906<span></span>
</td>
<td class="nump">10,127,433<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of options outstanding, including both vested and non-vested options.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(i)-(ii)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PlanNameAxis=cron_A2020OmnibusPlanMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PlanNameAxis=cron_A2020OmnibusPlanMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PlanNameAxis=cron_A2018StockOptionPlanMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PlanNameAxis=cron_A2018StockOptionPlanMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PlanNameAxis=cron_A2015StockOptionPlanMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PlanNameAxis=cron_A2015StockOptionPlanMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>57
<FILENAME>R43.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.2</span><table class="report" border="0" cellspacing="2" id="idm140382099825112">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Share-based Payments - Summary of Changes in RSUs (Details) - Restricted share units - $ / shares<br></strong></div></th>
<th class="th" colspan="2">6 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Jun. 30, 2021</div></th>
<th class="th"><div>Jun. 30, 2020</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward', window );"><strong>Number of awards</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber', window );">Balance at beginning of period (in shares)</a></td>
<td class="nump">948,357<span></span>
</td>
<td class="nump">732,972<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod', window );">Granted (in shares)</a></td>
<td class="nump">515,433<span></span>
</td>
<td class="nump">279,277<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cron_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedAndIssuedInPeriod', window );">Vested and issued/liabilities settled (in shares)</a></td>
<td class="num">(89,912)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber', window );">Balance at end of period (in shares)</a></td>
<td class="nump">1,373,878<span></span>
</td>
<td class="nump">1,012,249<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cron_DeferredCompensationSharebasedArrangementsLiabilityRollForward', window );"><strong>Deferred Compensation Share-based Arrangements, Liability [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue', window );">Balance at beginning of period (in dollars per share)</a></td>
<td class="nump">$ 7.66<span></span>
</td>
<td class="nump">$ 15.34<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue', window );">Granted (in dollars per share)</a></td>
<td class="nump">11.29<span></span>
</td>
<td class="nump">7.52<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cron_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedAndIssuedInPeriodWeightedAverageGrantDateFairValue', window );">Vested and issued (in dollars per share)</a></td>
<td class="nump">7.52<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue', window );">Balance at end of period (in dollars per share)</a></td>
<td class="nump">$ 9.03<span></span>
</td>
<td class="nump">$ 13.18<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1', window );">Vesting period</a></td>
<td class="text">3 years<span></span>
</td>
<td class="text">3 years<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cron_DeferredCompensationSharebasedArrangementsLiabilityRollForward">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Deferred Compensation Share-based Arrangements, Liability [Roll Forward]</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cron_DeferredCompensationSharebasedArrangementsLiabilityRollForward</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cron_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cron_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedAndIssuedInPeriod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Share-Based Compensation Arrangement By Share-Based Payment Award, Equity Instruments Other Than Options, Vested And Issued In Period</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cron_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedAndIssuedInPeriod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cron_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cron_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedAndIssuedInPeriodWeightedAverageGrantDateFairValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Share-Based Compensation Arrangement By Share-Based Payment Award, Equity Instruments Other Than Options, Vested And Issued In Period, Weighted Average Grant Date Fair Value</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cron_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedAndIssuedInPeriodWeightedAverageGrantDateFairValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cron_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Period over which grantee's right to exercise award under share-based payment arrangement is no longer contingent on satisfaction of service or performance condition, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days. Includes, but is not limited to, combination of market, performance or service condition.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The number of grants made during the period on other than stock (or unit) option plans (for example, phantom stock or unit plan, stock or unit appreciation rights plan, performance target plan).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(iii)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The weighted average fair value at grant date for nonvested equity-based awards issued during the period on other than stock (or unit) option plans (for example, phantom stock or unit plan, stock or unit appreciation rights plan, performance target plan).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(iii)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The number of non-vested equity-based payment instruments, excluding stock (or unit) options, that validly exist and are outstanding as of the balance sheet date.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(i)-(ii)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Per share or unit weighted-average fair value of nonvested award under share-based payment arrangement. Excludes share and unit options.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(i)-(ii)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AwardTypeAxis=us-gaap_RestrictedStockUnitsRSUMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AwardTypeAxis=us-gaap_RestrictedStockUnitsRSUMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>58
<FILENAME>R44.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.2</span><table class="report" border="0" cellspacing="2" id="idm140382004102648">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Share-based Payments - Summary of DSU Activity (Details) - Deferred Share Units (DSUs) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="2">6 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Jun. 30, 2021</div></th>
<th class="th"><div>Jun. 30, 2020</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward', window );"><strong>Number of awards</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber', window );">Balance at beginning of period (in shares)</a></td>
<td class="nump">83,293<span></span>
</td>
<td class="nump">33,397<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod', window );">Vested and issued/liabilities settled (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(8,484)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber', window );">Balance at end of period (in shares)</a></td>
<td class="nump">83,293<span></span>
</td>
<td class="nump">24,913<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cron_DeferredCompensationSharebasedArrangementsLiabilityRollForward', window );"><strong>Financial liability</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DeferredCompensationSharebasedArrangementsLiabilityCurrentAndNoncurrent', window );">Balance at beginning of period</a></td>
<td class="nump">$ 577<span></span>
</td>
<td class="nump">$ 255<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cron_ShareBasedPaymentArrangementLiabilitiesSettled', window );">DSU liabilities settled</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(46)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cron_ShareBasedPaymentArrangementGainLossOnRevaluation', window );">Loss on revaluation</a></td>
<td class="nump">141<span></span>
</td>
<td class="num">(56)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DeferredCompensationSharebasedArrangementsLiabilityCurrentAndNoncurrent', window );">Balance at end of period</a></td>
<td class="nump">$ 718<span></span>
</td>
<td class="nump">$ 153<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cron_DeferredCompensationSharebasedArrangementsLiabilityRollForward">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Deferred Compensation Share-based Arrangements, Liability [Roll Forward]</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cron_DeferredCompensationSharebasedArrangementsLiabilityRollForward</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cron_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cron_ShareBasedPaymentArrangementGainLossOnRevaluation">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Share-based Payment Arrangement, Gain (Loss) On Revaluation</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cron_ShareBasedPaymentArrangementGainLossOnRevaluation</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cron_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cron_ShareBasedPaymentArrangementLiabilitiesSettled">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Share-based Payment Arrangement, Liabilities Settled</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cron_ShareBasedPaymentArrangementLiabilitiesSettled</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cron_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredCompensationSharebasedArrangementsLiabilityCurrentAndNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Aggregate carrying value as of the balance sheet date of the liabilities for stock option plans and other equity-based compensation arrangements.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredCompensationSharebasedArrangementsLiabilityCurrentAndNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The number of non-vested equity-based payment instruments, excluding stock (or unit) options, that validly exist and are outstanding as of the balance sheet date.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(i)-(ii)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The number of equity-based payment instruments, excluding stock (or unit) options, that vested during the reporting period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(iii)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AwardTypeAxis=cron_DeferredShareUnitsDSUsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AwardTypeAxis=cron_DeferredShareUnitsDSUsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>59
<FILENAME>R45.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.2</span><table class="report" border="0" cellspacing="2" id="idm140382004874744">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Share-based Payments - Summary of Changes in Warrants (Details) - Warrants - $ / shares<br></strong></div></th>
<th class="th" colspan="2">6 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Jun. 30, 2021</div></th>
<th class="th"><div>Jun. 30, 2020</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward', window );"><strong>Weighted average exercise price (C$)</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue', window );">Balance at beginning of period (in dollars per share)</a></td>
<td class="nump">$ 0.25<span></span>
</td>
<td class="nump">$ 0.26<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue', window );">Exercise of warrants (in dollars per share)</a></td>
<td class="nump">0.25<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue', window );">Balance at end of period (in dollars per share)</a></td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">$ 0.26<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward', window );"><strong>Number of awards</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber', window );">Balance at beginning of period (in shares)</a></td>
<td class="nump">7,987,349<span></span>
</td>
<td class="nump">18,066,662<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod', window );">Exercise of warrants (in shares)</a></td>
<td class="num">(7,987,349)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber', window );">Balance at end of period (in shares)</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">18,066,662<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The number of non-vested equity-based payment instruments, excluding stock (or unit) options, that validly exist and are outstanding as of the balance sheet date.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(i)-(ii)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Per share or unit weighted-average fair value of nonvested award under share-based payment arrangement. Excludes share and unit options.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(i)-(ii)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The number of equity-based payment instruments, excluding stock (or unit) options, that vested during the reporting period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(iii)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The weighted average fair value as of grant date pertaining to an equity-based award plan other than a stock (or unit) option plan for which the grantee gained the right during the reporting period, by satisfying service and performance requirements, to receive or retain shares or units, other instruments, or cash in accordance with the terms of the arrangement.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(iii)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AwardTypeAxis=us-gaap_WarrantMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AwardTypeAxis=us-gaap_WarrantMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>60
<FILENAME>R46.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.2</span><table class="report" border="0" cellspacing="2" id="idm140382000309592">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Share-based Payments - Summary of Outstanding Warrants (Details) - shares<br></strong></div></th>
<th class="th"><div>Jun. 30, 2021</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
<th class="th"><div>Jun. 30, 2020</div></th>
<th class="th"><div>Dec. 31, 2019</div></th>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AwardTypeAxis=us-gaap_WarrantMember', window );">Warrants</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber', window );">Number of warrants (in shares)</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">7,987,349<span></span>
</td>
<td class="nump">18,066,662<span></span>
</td>
<td class="nump">18,066,662<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The number of non-vested equity-based payment instruments, excluding stock (or unit) options, that validly exist and are outstanding as of the balance sheet date.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(i)-(ii)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AwardTypeAxis=us-gaap_WarrantMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AwardTypeAxis=us-gaap_WarrantMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>61
<FILENAME>R47.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.2</span><table class="report" border="0" cellspacing="2" id="idm140382008159816">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Earnings (Loss) Per Share - Schedule of Earnings (Loss) Per Share (Details) - USD ($)<br> $ / shares in Units, $ in Thousands</strong></div></th>
<th class="th" colspan="2">3 Months Ended</th>
<th class="th" colspan="2">6 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Jun. 30, 2021</div></th>
<th class="th"><div>Jun. 30, 2020</div></th>
<th class="th"><div>Jun. 30, 2021</div></th>
<th class="th"><div>Jun. 30, 2020</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetIncomeLossAvailableToCommonStockholdersDilutedAbstract', window );"><strong>Basic earnings (loss) per share computation</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetIncomeLossFromContinuingOperationsAvailableToCommonShareholdersBasic', window );">Net income (loss) from continuing operations attributable to the shareholders of Cronos&#160;Group</a></td>
<td class="nump">$ 57,615<span></span>
</td>
<td class="num">$ (106,931)<span></span>
</td>
<td class="num">$ (103,676)<span></span>
</td>
<td class="num">$ (30,891)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic', window );">Weighted average number of common shares outstanding (in shares)</a></td>
<td class="nump">371,721,382<span></span>
</td>
<td class="nump">349,075,408<span></span>
</td>
<td class="nump">367,391,118<span></span>
</td>
<td class="nump">348,946,439<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeLossFromContinuingOperationsPerBasicShare', window );">Basic earnings (loss) from continuing operations per share (in dollars per share)</a></td>
<td class="nump">$ 0.15<span></span>
</td>
<td class="num">$ (0.31)<span></span>
</td>
<td class="num">$ (0.28)<span></span>
</td>
<td class="num">$ (0.09)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetIncomeLossFromDiscontinuedOperationsAvailableToCommonShareholdersBasic', window );">Loss from discontinued operations attributable to the shareholders of Cronos Group</a></td>
<td class="num">$ (561)<span></span>
</td>
<td class="num">$ (46)<span></span>
</td>
<td class="num">$ (582)<span></span>
</td>
<td class="num">$ (46)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTaxPerBasicShare', window );">Basic earnings from discontinued operations per share (in dollars per share)</a></td>
<td class="nump">$ 0.00<span></span>
</td>
<td class="nump">$ 0.00<span></span>
</td>
<td class="nump">$ 0.00<span></span>
</td>
<td class="nump">$ 0.00<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_WeightedAverageNumberOfSharesOutstandingDilutedDisclosureItemsAbstract', window );"><strong>Diluted earnings (loss) per share computation</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetIncomeLossFromContinuingOperationsAvailableToCommonShareholdersBasic', window );">Net income (loss) used in the computation of basic earnings (loss) from continuing operations per share</a></td>
<td class="nump">$ 57,615<span></span>
</td>
<td class="num">$ (106,931)<span></span>
</td>
<td class="num">$ (103,676)<span></span>
</td>
<td class="num">$ (30,891)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DilutiveSecurities', window );">Adjustment for gain (loss) on revaluation of derivative liabilities</a></td>
<td class="nump">0<span></span>
</td>
<td class="num">(729)<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="num">(729)<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetIncomeLossFromContinuingOperationsAvailableToCommonShareholdersDiluted', window );">Net income (loss) used in the computation of diluted earnings (loss) from continuing operations per share</a></td>
<td class="nump">$ 57,615<span></span>
</td>
<td class="num">$ (107,660)<span></span>
</td>
<td class="num">$ (103,676)<span></span>
</td>
<td class="num">$ (31,620)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic', window );">Weighted average number of common shares outstanding (in shares)</a></td>
<td class="nump">371,721,382<span></span>
</td>
<td class="nump">349,075,408<span></span>
</td>
<td class="nump">367,391,118<span></span>
</td>
<td class="nump">348,946,439<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding', window );">Weighted average number of common shares for computation of diluted earnings (loss) from continuing operations per share (in shares)</a></td>
<td class="nump">375,349,856<span></span>
</td>
<td class="nump">349,075,408<span></span>
</td>
<td class="nump">367,391,118<span></span>
</td>
<td class="nump">348,946,439<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeLossFromContinuingOperationsPerDilutedShare', window );">Diluted earnings (loss) from continuing operations per share (in dollars per share)</a></td>
<td class="nump">$ 0.15<span></span>
</td>
<td class="num">$ (0.31)<span></span>
</td>
<td class="num">$ (0.28)<span></span>
</td>
<td class="num">$ (0.09)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetIncomeLossFromDiscontinuedOperationsAvailableToCommonShareholdersDiluted', window );">Loss from discontinued operations attributable to the shareholders of Cronos Group</a></td>
<td class="num">$ (561)<span></span>
</td>
<td class="num">$ (46)<span></span>
</td>
<td class="num">$ (582)<span></span>
</td>
<td class="num">$ (46)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding', window );">Weighted average number of common shares for computation of diluted loss from discontinued operations per share (in shares)</a></td>
<td class="nump">375,349,856<span></span>
</td>
<td class="nump">349,075,408<span></span>
</td>
<td class="nump">367,391,118<span></span>
</td>
<td class="nump">348,946,439<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTaxPerDilutedShare', window );">Diluted earnings from discontinued operations per share (in dollars per share)</a></td>
<td class="nump">$ 0.00<span></span>
</td>
<td class="nump">$ 0.00<span></span>
</td>
<td class="nump">$ 0.00<span></span>
</td>
<td class="nump">$ 0.00<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AwardTypeAxis=us-gaap_WarrantMember', window );">Warrants</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_WeightedAverageNumberOfSharesOutstandingDilutedDisclosureItemsAbstract', window );"><strong>Diluted earnings (loss) per share computation</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncrementalCommonSharesAttributableToShareBasedPaymentArrangements', window );">Dilutive effect of awards (in shares)</a></td>
<td class="nump">5,577<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AwardTypeAxis=us-gaap_EmployeeStockOptionMember', window );">Stock options</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_WeightedAverageNumberOfSharesOutstandingDilutedDisclosureItemsAbstract', window );"><strong>Diluted earnings (loss) per share computation</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncrementalCommonSharesAttributableToShareBasedPaymentArrangements', window );">Dilutive effect of awards (in shares)</a></td>
<td class="nump">3,027,518<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AwardTypeAxis=us-gaap_RestrictedStockUnitsRSUMember', window );">Restricted share units</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_WeightedAverageNumberOfSharesOutstandingDilutedDisclosureItemsAbstract', window );"><strong>Diluted earnings (loss) per share computation</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncrementalCommonSharesAttributableToShareBasedPaymentArrangements', window );">Dilutive effect of awards (in shares)</a></td>
<td class="nump">595,379<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DilutiveSecurities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of increase (decrease) to net income used for calculating diluted earnings per share (EPS), resulting from the assumed exercise stock options, restrictive stock units (RSUs), convertible preferred stock of an employee stock ownership plan (ESOP), and other dilutive convertible securities.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=124432515&amp;loc=d3e3550-109257<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DilutiveSecurities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeLossFromContinuingOperationsPerBasicShare">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of net income (loss) from continuing operations per each share of common stock or unit outstanding during the reporting period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22583-107794<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(19))<br> -URI http://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123482062&amp;loc=SL123482106-238011<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(11))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=125511455&amp;loc=d3e1252-109256<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 7<br> -URI http://asc.fasb.org/extlink&amp;oid=125511455&amp;loc=d3e1337-109256<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22499-107794<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=125511455&amp;loc=SL5780133-109256<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(25))<br> -URI http://asc.fasb.org/extlink&amp;oid=123367319&amp;loc=SL114868664-224227<br><br>Reference 12: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(20))<br> -URI http://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(27))<br> -URI http://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br><br>Reference 14: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-03(13))<br> -URI http://asc.fasb.org/extlink&amp;oid=123367319&amp;loc=SL114868656-224227<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22595-107794<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeLossFromContinuingOperationsPerBasicShare</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeLossFromContinuingOperationsPerDilutedShare">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of net income (loss) derived from continuing operations during the period available to each share of common stock or common unit outstanding during the reporting period and to each share or unit that would have been outstanding assuming the issuance of common shares or units for all dilutive potential common shares or units outstanding during the reporting period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124432515&amp;loc=d3e3550-109257<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 7<br> -URI http://asc.fasb.org/extlink&amp;oid=125511455&amp;loc=d3e1337-109256<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123482062&amp;loc=SL123482106-238011<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(23))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(27))<br> -URI http://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22499-107794<br><br>Reference 8: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(11))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(25))<br> -URI http://asc.fasb.org/extlink&amp;oid=123367319&amp;loc=SL114868664-224227<br><br>Reference 10: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-03(13))<br> -URI http://asc.fasb.org/extlink&amp;oid=123367319&amp;loc=SL114868656-224227<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=125511455&amp;loc=SL5780133-109256<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=125511455&amp;loc=d3e1252-109256<br><br>Reference 13: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(19))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22583-107794<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22595-107794<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeLossFromContinuingOperationsPerDilutedShare</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTaxPerBasicShare">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Per basic share amount, after tax, of income (loss) from the day-to-day business activities of the discontinued operation and gain (loss) from the disposal of the discontinued operation.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=125511455&amp;loc=d3e1278-109256<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(25))<br> -URI http://asc.fasb.org/extlink&amp;oid=123367319&amp;loc=SL114868664-224227<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=125511455&amp;loc=SL5780133-109256<br><br>Reference 4: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(23))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(19))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(12))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 7<br> -URI http://asc.fasb.org/extlink&amp;oid=125511455&amp;loc=d3e1337-109256<br><br>Reference 8: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(27))<br> -URI http://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br><br>Reference 9: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(14))<br> -URI http://asc.fasb.org/extlink&amp;oid=123367319&amp;loc=SL114868664-224227<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTaxPerBasicShare</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTaxPerDilutedShare">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Per diluted share amount, after tax, of income (loss) from the day-to-day business activities of the discontinued operation and gain (loss) from the disposal of the discontinued operation.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 7<br> -URI http://asc.fasb.org/extlink&amp;oid=125511455&amp;loc=d3e1337-109256<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section S99<br> -Paragraph 5<br> -Subparagraph (SAB Topic 5.E)<br> -URI http://asc.fasb.org/extlink&amp;oid=120398118&amp;loc=d3e355146-122828<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=125511455&amp;loc=SL5780133-109256<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=125511455&amp;loc=d3e1278-109256<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTaxPerDilutedShare</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncrementalCommonSharesAttributableToShareBasedPaymentArrangements">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Additional shares included in the calculation of diluted EPS as a result of the potentially dilutive effect of share based payment arrangements using the treasury stock method.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 22<br> -URI http://asc.fasb.org/extlink&amp;oid=125511455&amp;loc=d3e1707-109256<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124432515&amp;loc=d3e3550-109257<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28A<br> -URI http://asc.fasb.org/extlink&amp;oid=125511455&amp;loc=d3e1500-109256<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 23<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=125511455&amp;loc=d3e1757-109256<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncrementalCommonSharesAttributableToShareBasedPaymentArrangements</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetIncomeLossAvailableToCommonStockholdersDilutedAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetIncomeLossAvailableToCommonStockholdersDilutedAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetIncomeLossFromContinuingOperationsAvailableToCommonShareholdersBasic">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, after deduction of tax, noncontrolling interests, dividends on preferred stock and participating securities; of income (loss) from continuing operations available to common shareholders.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 11<br> -URI http://asc.fasb.org/extlink&amp;oid=125511455&amp;loc=d3e1377-109256<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124432515&amp;loc=d3e3550-109257<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetIncomeLossFromContinuingOperationsAvailableToCommonShareholdersBasic</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetIncomeLossFromContinuingOperationsAvailableToCommonShareholdersDiluted">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, after deduction of tax, noncontrolling interests, dividends on preferred stock and participating securities, and addition from assumption of issuance of common shares for dilutive potential common shares; of income (loss) from continuing operations available to common shareholders.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 40<br> -Subparagraph (b)(3)<br> -URI http://asc.fasb.org/extlink&amp;oid=125511455&amp;loc=d3e1930-109256<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 40<br> -Subparagraph (b)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=125511455&amp;loc=d3e1930-109256<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 40<br> -Subparagraph (b)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=125511455&amp;loc=d3e1930-109256<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 16<br> -URI http://asc.fasb.org/extlink&amp;oid=125511455&amp;loc=d3e1505-109256<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124432515&amp;loc=d3e3550-109257<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetIncomeLossFromContinuingOperationsAvailableToCommonShareholdersDiluted</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetIncomeLossFromDiscontinuedOperationsAvailableToCommonShareholdersBasic">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, after deduction of tax, noncontrolling interests, dividends on preferred stock and participating securities; of income (loss) from discontinued operations available to common shareholders.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetIncomeLossFromDiscontinuedOperationsAvailableToCommonShareholdersBasic</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetIncomeLossFromDiscontinuedOperationsAvailableToCommonShareholdersDiluted">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, after deduction of tax, noncontrolling interests, dividends on preferred stock and participating securities, and addition from assumption of issuance of common shares for dilutive potential common shares; of income (loss) from discontinued operations available to common shareholders.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetIncomeLossFromDiscontinuedOperationsAvailableToCommonShareholdersDiluted</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The average number of shares or units issued and outstanding that are used in calculating diluted EPS or earnings per unit (EPU), determined based on the timing of issuance of shares or units in the period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124432515&amp;loc=d3e3550-109257<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 16<br> -URI http://asc.fasb.org/extlink&amp;oid=125511455&amp;loc=d3e1505-109256<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of [basic] shares or units, after adjustment for contingently issuable shares or units and other shares or units not deemed outstanding, determined by relating the portion of time within a reporting period that common shares or units have been outstanding to the total time in that period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124432515&amp;loc=d3e3550-109257<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=125511455&amp;loc=d3e1448-109256<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_WeightedAverageNumberOfSharesOutstandingBasic</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_WeightedAverageNumberOfSharesOutstandingDilutedDisclosureItemsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_WeightedAverageNumberOfSharesOutstandingDilutedDisclosureItemsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AwardTypeAxis=us-gaap_WarrantMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AwardTypeAxis=us-gaap_WarrantMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AwardTypeAxis=us-gaap_EmployeeStockOptionMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AwardTypeAxis=us-gaap_EmployeeStockOptionMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AwardTypeAxis=us-gaap_RestrictedStockUnitsRSUMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AwardTypeAxis=us-gaap_RestrictedStockUnitsRSUMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>62
<FILENAME>R48.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.2</span><table class="report" border="0" cellspacing="2" id="idm140382008274472">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Earnings (Loss) Per Share - Schedule of Antidilutive Securities Excluded from Computation of Diluted Shares Outstanding (Details) - shares<br></strong></div></th>
<th class="th" colspan="2">3 Months Ended</th>
<th class="th" colspan="2">6 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Jun. 30, 2021</div></th>
<th class="th"><div>Jun. 30, 2020</div></th>
<th class="th"><div>Jun. 30, 2021</div></th>
<th class="th"><div>Jun. 30, 2020</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems', window );"><strong>Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount', window );">Total anti-dilutive securities (in shares)</a></td>
<td class="nump">116,862,709<span></span>
</td>
<td class="nump">162,091,326<span></span>
</td>
<td class="nump">128,373,444<span></span>
</td>
<td class="nump">162,158,002<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis=cron_GinkgoEquityMilestonesMember', window );">Ginkgo equity milestones</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems', window );"><strong>Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount', window );">Total anti-dilutive securities (in shares)</a></td>
<td class="nump">14,674,904<span></span>
</td>
<td class="nump">14,674,904<span></span>
</td>
<td class="nump">14,674,904<span></span>
</td>
<td class="nump">14,674,904<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis=cron_PreemptiveRightsMember', window );">Pre-emptive Rights</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems', window );"><strong>Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount', window );">Total anti-dilutive securities (in shares)</a></td>
<td class="nump">10,683,330<span></span>
</td>
<td class="nump">12,006,740<span></span>
</td>
<td class="nump">10,984,166<span></span>
</td>
<td class="nump">12,006,740<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis=cron_TopUpRightsFixedPriceMember', window );">Top-up Rights &#8211; fixed price</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems', window );"><strong>Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount', window );">Total anti-dilutive securities (in shares)</a></td>
<td class="nump">3,698,611<span></span>
</td>
<td class="nump">26,686,413<span></span>
</td>
<td class="nump">7,406,031<span></span>
</td>
<td class="nump">26,686,413<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis=cron_TopUpRightsMarketPriceMember', window );">Top-up Rights &#8211; market price</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems', window );"><strong>Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount', window );">Total anti-dilutive securities (in shares)</a></td>
<td class="nump">3,504,561<span></span>
</td>
<td class="nump">1,941,349<span></span>
</td>
<td class="nump">3,063,822<span></span>
</td>
<td class="nump">1,941,349<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis=cron_AltriaWarrantMember', window );">Altria Warrant</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems', window );"><strong>Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount', window );">Total anti-dilutive securities (in shares)</a></td>
<td class="nump">82,623,455<span></span>
</td>
<td class="nump">77,752,533<span></span>
</td>
<td class="nump">82,606,904<span></span>
</td>
<td class="nump">77,752,533<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis=us-gaap_EmployeeStockOptionMember', window );">Stock options</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems', window );"><strong>Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount', window );">Total anti-dilutive securities (in shares)</a></td>
<td class="nump">1,411,944<span></span>
</td>
<td class="nump">10,495,235<span></span>
</td>
<td class="nump">6,136,113<span></span>
</td>
<td class="nump">10,547,256<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis=us-gaap_WarrantMember', window );">Warrants</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems', window );"><strong>Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount', window );">Total anti-dilutive securities (in shares)</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">17,521,903<span></span>
</td>
<td class="nump">2,784,377<span></span>
</td>
<td class="nump">17,536,558<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis=us-gaap_RestrictedStockUnitsRSUMember', window );">Restricted share units</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems', window );"><strong>Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount', window );">Total anti-dilutive securities (in shares)</a></td>
<td class="nump">265,904<span></span>
</td>
<td class="nump">1,012,249<span></span>
</td>
<td class="nump">717,127<span></span>
</td>
<td class="nump">1,012,249<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Securities (including those issuable pursuant to contingent stock agreements) that could potentially dilute basic earnings per share (EPS) or earnings per unit (EPU) in the future that were not included in the computation of diluted EPS or EPU because to do so would increase EPS or EPU amounts or decrease loss per share or unit amounts for the period presented.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=124432515&amp;loc=d3e3550-109257<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis=cron_GinkgoEquityMilestonesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis=cron_GinkgoEquityMilestonesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis=cron_PreemptiveRightsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis=cron_PreemptiveRightsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis=cron_TopUpRightsFixedPriceMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis=cron_TopUpRightsFixedPriceMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis=cron_TopUpRightsMarketPriceMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis=cron_TopUpRightsMarketPriceMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis=cron_AltriaWarrantMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis=cron_AltriaWarrantMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis=us-gaap_EmployeeStockOptionMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis=us-gaap_EmployeeStockOptionMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis=us-gaap_WarrantMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis=us-gaap_WarrantMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis=us-gaap_RestrictedStockUnitsRSUMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis=us-gaap_RestrictedStockUnitsRSUMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>63
<FILENAME>R49.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.2</span><table class="report" border="0" cellspacing="2" id="idm140382003423208">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Segment Information - Narrative (Details)<br></strong></div></th>
<th class="th" colspan="2">3 Months Ended</th>
<th class="th" colspan="2">6 Months Ended</th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th">
<div>Jun. 30, 2021 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Jun. 30, 2020 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Jun. 30, 2021 </div>
<div>USD ($) </div>
<div>segment</div>
</th>
<th class="th">
<div>Jun. 30, 2020 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Dec. 31, 2020 </div>
<div>USD ($)</div>
</th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SegmentReportingInformationLineItems', window );"><strong>Segment Reporting Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NumberOfReportableSegments', window );">Number of reportable segments | segment</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AllowanceForDoubtfulAccountsReceivableCurrent', window );">Current expected credit loss allowance on accounts receivable</a></td>
<td class="nump">$ 264,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 264,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 74,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTax', window );">Loss from discontinued operations</a></td>
<td class="num">(561,000)<span></span>
</td>
<td class="num">$ (46,000)<span></span>
</td>
<td class="num">(582,000)<span></span>
</td>
<td class="num">$ (46,000)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerIncludingAssessedTax', window );">Net revenue, before excise taxes</a></td>
<td class="nump">18,848,000<span></span>
</td>
<td class="nump">11,432,000<span></span>
</td>
<td class="nump">33,502,000<span></span>
</td>
<td class="nump">20,776,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementBusinessSegmentsAxis=cron_UnitedStatesSegmentMember', window );">United States</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SegmentReportingInformationLineItems', window );"><strong>Segment Reporting Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AllowanceForDoubtfulAccountsReceivableCurrent', window );">Current expected credit loss allowance on accounts receivable</a></td>
<td class="nump">106,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">106,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">65,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTax', window );">Loss from discontinued operations</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementBusinessSegmentsAxis=cron_RestOfWorldSegmentMember', window );">Rest of World</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SegmentReportingInformationLineItems', window );"><strong>Segment Reporting Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AllowanceForDoubtfulAccountsReceivableCurrent', window );">Current expected credit loss allowance on accounts receivable</a></td>
<td class="nump">158,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 158,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 9,000<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_MajorCustomersAxis=cron_FourMajorCustomersMember', window );">Four Major Customers | Rest of World</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SegmentReportingInformationLineItems', window );"><strong>Segment Reporting Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerIncludingAssessedTax', window );">Net revenue, before excise taxes</a></td>
<td class="nump">$ 8,497,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">18,250,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ConcentrationRiskByTypeAxis=us-gaap_CustomerConcentrationRiskMember', window );">Customer Concentration Risk | Revenue Benchmark | Four Major Customers | Rest of World</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SegmentReportingInformationLineItems', window );"><strong>Segment Reporting Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerIncludingAssessedTax', window );">Net revenue, before excise taxes</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 7,040,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 11,819,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ConcentrationRiskPercentage1', window );">Concentration risk, percentage</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">71.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">65.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ConcentrationRiskByTypeAxis=us-gaap_CustomerConcentrationRiskMember', window );">Customer Concentration Risk | Revenue Benchmark | Ontario Cannabis Retail Corporation | Rest of World</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SegmentReportingInformationLineItems', window );"><strong>Segment Reporting Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ConcentrationRiskPercentage1', window );">Concentration risk, percentage</a></td>
<td class="nump">19.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">15.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ConcentrationRiskByTypeAxis=us-gaap_CustomerConcentrationRiskMember', window );">Customer Concentration Risk | Revenue Benchmark | Novolog Group | Rest of World</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SegmentReportingInformationLineItems', window );"><strong>Segment Reporting Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ConcentrationRiskPercentage1', window );">Concentration risk, percentage</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">14.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ConcentrationRiskByTypeAxis=us-gaap_CustomerConcentrationRiskMember', window );">Customer Concentration Risk | Revenue Benchmark | Albert Gaming, Liquor and Cannabis Commission | Rest of World</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SegmentReportingInformationLineItems', window );"><strong>Segment Reporting Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ConcentrationRiskPercentage1', window );">Concentration risk, percentage</a></td>
<td class="nump">14.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">12.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ConcentrationRiskByTypeAxis=us-gaap_CustomerConcentrationRiskMember', window );">Customer Concentration Risk | Revenue Benchmark | Societe Quebecoise Du Cannabis | Rest of World</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SegmentReportingInformationLineItems', window );"><strong>Segment Reporting Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ConcentrationRiskPercentage1', window );">Concentration risk, percentage</a></td>
<td class="nump">12.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">13.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AllowanceForDoubtfulAccountsReceivableCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of allowance for credit loss on accounts receivable, classified as current.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(4)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 310<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=123577603&amp;loc=d3e5074-111524<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 326<br> -SubTopic 20<br> -Section 45<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=124255206&amp;loc=SL82895884-210446<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AllowanceForDoubtfulAccountsReceivableCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ConcentrationRiskPercentage1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>For an entity that discloses a concentration risk in relation to quantitative amount, which serves as the "benchmark" (or denominator) in the equation, this concept represents the concentration percentage derived from the division.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 42<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e9054-108599<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 275<br> -SubTopic 10<br> -Section 50<br> -Paragraph 18<br> -URI http://asc.fasb.org/extlink&amp;oid=99393423&amp;loc=d3e6351-108592<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 20<br> -URI http://asc.fasb.org/extlink&amp;oid=123594938&amp;loc=d3e13531-108611<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 21<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123594938&amp;loc=d3e13537-108611<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 275<br> -SubTopic 10<br> -Section 50<br> -Paragraph 20<br> -URI http://asc.fasb.org/extlink&amp;oid=99393423&amp;loc=d3e6404-108592<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ConcentrationRiskPercentage1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount after tax of income (loss) from a discontinued operation including the portion attributable to the noncontrolling interest. Includes, but is not limited to, the income (loss) from operations during the phase-out period, gain (loss) on disposal, gain (loss) for reversal of write-down (write-down) to fair value, less cost to sell, and adjustments to a prior period gain (loss) on disposal.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(12))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 7<br> -URI http://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=SL51721683-107760<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 45<br> -Paragraph 3B<br> -URI http://asc.fasb.org/extlink&amp;oid=109222160&amp;loc=SL51721525-107759<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 5C<br> -Subparagraph (b)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=SL51721675-107760<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 45<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=109222160&amp;loc=d3e957-107759<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=d3e1361-107760<br><br>Reference 7: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 45<br> -Paragraph 3A<br> -URI http://asc.fasb.org/extlink&amp;oid=109222160&amp;loc=SL51721523-107759<br><br>Reference 8: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 45<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=109222160&amp;loc=d3e1012-107759<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 270<br> -Section 45<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=109227538&amp;loc=d3e44648-109337<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NumberOfReportableSegments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of segments reported by the entity. A reportable segment is a component of an entity for which there is an accounting requirement to report separate financial information on that component in the entity's financial statements.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 18<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8672-108599<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NumberOfReportableSegments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:integerItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RevenueFromContractWithCustomerIncludingAssessedTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, including tax collected from customer, of revenue from satisfaction of performance obligation by transferring promised good or service to customer. Tax collected from customer is tax assessed by governmental authority that is both imposed on and concurrent with specific revenue-producing transaction, including, but not limited to, sales, use, value-added and excise.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 41<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e9038-108599<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 5<br> -URI http://asc.fasb.org/extlink&amp;oid=123351226&amp;loc=SL49130545-203045<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8933-108599<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8933-108599<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8906-108599<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8736-108599<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8736-108599<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123351226&amp;loc=SL49130543-203045<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 42<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e9054-108599<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 40<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e9031-108599<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 924<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 11.L)<br> -URI http://asc.fasb.org/extlink&amp;oid=6472922&amp;loc=d3e499488-122856<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RevenueFromContractWithCustomerIncludingAssessedTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SegmentReportingInformationLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SegmentReportingInformationLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementBusinessSegmentsAxis=cron_UnitedStatesSegmentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementBusinessSegmentsAxis=cron_UnitedStatesSegmentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementBusinessSegmentsAxis=cron_RestOfWorldSegmentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementBusinessSegmentsAxis=cron_RestOfWorldSegmentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_MajorCustomersAxis=cron_FourMajorCustomersMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_MajorCustomersAxis=cron_FourMajorCustomersMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ConcentrationRiskByTypeAxis=us-gaap_CustomerConcentrationRiskMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ConcentrationRiskByTypeAxis=us-gaap_CustomerConcentrationRiskMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ConcentrationRiskByBenchmarkAxis=us-gaap_RevenueFromContractWithCustomerMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ConcentrationRiskByBenchmarkAxis=us-gaap_RevenueFromContractWithCustomerMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_MajorCustomersAxis=cron_OntarioCannabisRetailCorporationMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_MajorCustomersAxis=cron_OntarioCannabisRetailCorporationMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_MajorCustomersAxis=cron_NovologGroupMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_MajorCustomersAxis=cron_NovologGroupMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_MajorCustomersAxis=cron_AlbertGamingLiquorAndCannabisCommissionMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_MajorCustomersAxis=cron_AlbertGamingLiquorAndCannabisCommissionMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_MajorCustomersAxis=cron_SocieteQuebecoiseDuCannabisMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_MajorCustomersAxis=cron_SocieteQuebecoiseDuCannabisMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>64
<FILENAME>R50.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.2</span><table class="report" border="0" cellspacing="2" id="idm140382086162824">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Segment Information - Schedule of Segment Data (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="2">3 Months Ended</th>
<th class="th" colspan="2">6 Months Ended</th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th"><div>Jun. 30, 2021</div></th>
<th class="th"><div>Jun. 30, 2020</div></th>
<th class="th"><div>Jun. 30, 2021</div></th>
<th class="th"><div>Jun. 30, 2020</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SegmentReportingInformationLineItems', window );"><strong>Segment Reporting Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Net revenue</a></td>
<td class="nump">$ 15,622<span></span>
</td>
<td class="nump">$ 9,883<span></span>
</td>
<td class="nump">$ 28,233<span></span>
</td>
<td class="nump">$ 18,315<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeLossFromEquityMethodInvestments', window );">Share of loss from equity accounted investments</a></td>
<td class="nump">1,115<span></span>
</td>
<td class="nump">794<span></span>
</td>
<td class="nump">2,758<span></span>
</td>
<td class="nump">1,966<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InvestmentIncomeInterest', window );">Interest income</a></td>
<td class="nump">2,300<span></span>
</td>
<td class="nump">3,817<span></span>
</td>
<td class="nump">4,635<span></span>
</td>
<td class="nump">11,575<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InterestExpense', window );">Interest expense</a></td>
<td class="num">(7)<span></span>
</td>
<td class="num">(83)<span></span>
</td>
<td class="num">(13)<span></span>
</td>
<td class="num">(90)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InterestIncomeExpenseNonoperatingNet', window );">Interest income, net</a></td>
<td class="nump">2,293<span></span>
</td>
<td class="nump">3,734<span></span>
</td>
<td class="nump">4,622<span></span>
</td>
<td class="nump">11,485<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Assets', window );">Total assets</a></td>
<td class="nump">1,838,611<span></span>
</td>
<td class="nump">1,910,287<span></span>
</td>
<td class="nump">1,838,611<span></span>
</td>
<td class="nump">1,910,287<span></span>
</td>
<td class="nump">$ 1,925,682<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DepreciationAndAmortization', window );">Depreciation and amortization</a></td>
<td class="nump">1,043<span></span>
</td>
<td class="nump">679<span></span>
</td>
<td class="nump">1,778<span></span>
</td>
<td class="nump">1,366<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingLeaseRightOfUseAssetAmortizationExpense', window );">Impairment loss on long-lived assets</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">40,000<span></span>
</td>
<td class="nump">1,741<span></span>
</td>
<td class="nump">40,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cron_AdjustedEarningsBeforeInterestTaxesDepreciationAndAmortization', window );">Adjusted EBITDA</a></td>
<td class="num">(49,759)<span></span>
</td>
<td class="num">(26,986)<span></span>
</td>
<td class="num">(86,333)<span></span>
</td>
<td class="num">(64,041)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentAdditions', window );">Purchase of property, plant and equipment, net</a></td>
<td class="nump">1,667<span></span>
</td>
<td class="nump">6,933<span></span>
</td>
<td class="nump">8,347<span></span>
</td>
<td class="nump">13,344<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_ConsolidationItemsAxis=us-gaap_OperatingSegmentsMember', window );">Operating Segments | United States</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SegmentReportingInformationLineItems', window );"><strong>Segment Reporting Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Net revenue</a></td>
<td class="nump">2,227<span></span>
</td>
<td class="nump">2,174<span></span>
</td>
<td class="nump">4,668<span></span>
</td>
<td class="nump">4,350<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeLossFromEquityMethodInvestments', window );">Share of loss from equity accounted investments</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InvestmentIncomeInterest', window );">Interest income</a></td>
<td class="nump">20<span></span>
</td>
<td class="nump">9<span></span>
</td>
<td class="nump">23<span></span>
</td>
<td class="nump">16<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InterestExpense', window );">Interest expense</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InterestIncomeExpenseNonoperatingNet', window );">Interest income, net</a></td>
<td class="nump">20<span></span>
</td>
<td class="nump">9<span></span>
</td>
<td class="nump">23<span></span>
</td>
<td class="nump">16<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Assets', window );">Total assets</a></td>
<td class="nump">709,956<span></span>
</td>
<td class="nump">250,470<span></span>
</td>
<td class="nump">709,956<span></span>
</td>
<td class="nump">250,470<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DepreciationAndAmortization', window );">Depreciation and amortization</a></td>
<td class="nump">68<span></span>
</td>
<td class="nump">36<span></span>
</td>
<td class="nump">139<span></span>
</td>
<td class="nump">69<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingLeaseRightOfUseAssetAmortizationExpense', window );">Impairment loss on long-lived assets</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">40,000<span></span>
</td>
<td class="nump">1,741<span></span>
</td>
<td class="nump">40,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cron_AdjustedEarningsBeforeInterestTaxesDepreciationAndAmortization', window );">Adjusted EBITDA</a></td>
<td class="num">(10,711)<span></span>
</td>
<td class="num">(4,785)<span></span>
</td>
<td class="num">(20,221)<span></span>
</td>
<td class="num">(10,567)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentAdditions', window );">Purchase of property, plant and equipment, net</a></td>
<td class="nump">239<span></span>
</td>
<td class="nump">39<span></span>
</td>
<td class="nump">319<span></span>
</td>
<td class="nump">219<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_ConsolidationItemsAxis=us-gaap_OperatingSegmentsMember', window );">Operating Segments | Rest of World</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SegmentReportingInformationLineItems', window );"><strong>Segment Reporting Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Net revenue</a></td>
<td class="nump">13,395<span></span>
</td>
<td class="nump">7,709<span></span>
</td>
<td class="nump">23,565<span></span>
</td>
<td class="nump">13,965<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeLossFromEquityMethodInvestments', window );">Share of loss from equity accounted investments</a></td>
<td class="nump">1,115<span></span>
</td>
<td class="nump">794<span></span>
</td>
<td class="nump">2,758<span></span>
</td>
<td class="nump">1,966<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InvestmentIncomeInterest', window );">Interest income</a></td>
<td class="nump">2,280<span></span>
</td>
<td class="nump">3,808<span></span>
</td>
<td class="nump">4,612<span></span>
</td>
<td class="nump">11,559<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InterestExpense', window );">Interest expense</a></td>
<td class="num">(7)<span></span>
</td>
<td class="num">(83)<span></span>
</td>
<td class="num">(13)<span></span>
</td>
<td class="num">(90)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InterestIncomeExpenseNonoperatingNet', window );">Interest income, net</a></td>
<td class="nump">2,273<span></span>
</td>
<td class="nump">3,725<span></span>
</td>
<td class="nump">4,599<span></span>
</td>
<td class="nump">11,469<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Assets', window );">Total assets</a></td>
<td class="nump">386,805<span></span>
</td>
<td class="nump">348,569<span></span>
</td>
<td class="nump">386,805<span></span>
</td>
<td class="nump">348,569<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DepreciationAndAmortization', window );">Depreciation and amortization</a></td>
<td class="nump">975<span></span>
</td>
<td class="nump">643<span></span>
</td>
<td class="nump">1,639<span></span>
</td>
<td class="nump">1,297<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingLeaseRightOfUseAssetAmortizationExpense', window );">Impairment loss on long-lived assets</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cron_AdjustedEarningsBeforeInterestTaxesDepreciationAndAmortization', window );">Adjusted EBITDA</a></td>
<td class="num">(32,605)<span></span>
</td>
<td class="num">(18,618)<span></span>
</td>
<td class="num">(54,789)<span></span>
</td>
<td class="num">(47,628)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentAdditions', window );">Purchase of property, plant and equipment, net</a></td>
<td class="nump">1,428<span></span>
</td>
<td class="nump">6,894<span></span>
</td>
<td class="nump">8,028<span></span>
</td>
<td class="nump">13,125<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_ConsolidationItemsAxis=us-gaap_CorporateNonSegmentMember', window );">Corporate Expenses</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SegmentReportingInformationLineItems', window );"><strong>Segment Reporting Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Net revenue</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeLossFromEquityMethodInvestments', window );">Share of loss from equity accounted investments</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InvestmentIncomeInterest', window );">Interest income</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InterestExpense', window );">Interest expense</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InterestIncomeExpenseNonoperatingNet', window );">Interest income, net</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Assets', window );">Total assets</a></td>
<td class="nump">741,850<span></span>
</td>
<td class="nump">1,311,248<span></span>
</td>
<td class="nump">741,850<span></span>
</td>
<td class="nump">1,311,248<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DepreciationAndAmortization', window );">Depreciation and amortization</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingLeaseRightOfUseAssetAmortizationExpense', window );">Impairment loss on long-lived assets</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cron_AdjustedEarningsBeforeInterestTaxesDepreciationAndAmortization', window );">Adjusted EBITDA</a></td>
<td class="num">(6,443)<span></span>
</td>
<td class="num">(3,583)<span></span>
</td>
<td class="num">(11,323)<span></span>
</td>
<td class="num">(5,846)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentAdditions', window );">Purchase of property, plant and equipment, net</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_ProductOrServiceAxis=cron_CannabisFlowerMember', window );">Cannabis flower</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SegmentReportingInformationLineItems', window );"><strong>Segment Reporting Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Net revenue</a></td>
<td class="nump">11,597<span></span>
</td>
<td class="nump">5,674<span></span>
</td>
<td class="nump">21,031<span></span>
</td>
<td class="nump">8,415<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_ProductOrServiceAxis=cron_CannabisFlowerMember', window );">Cannabis flower | Operating Segments | United States</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SegmentReportingInformationLineItems', window );"><strong>Segment Reporting Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Net revenue</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_ProductOrServiceAxis=cron_CannabisFlowerMember', window );">Cannabis flower | Operating Segments | Rest of World</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SegmentReportingInformationLineItems', window );"><strong>Segment Reporting Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Net revenue</a></td>
<td class="nump">11,597<span></span>
</td>
<td class="nump">5,674<span></span>
</td>
<td class="nump">21,031<span></span>
</td>
<td class="nump">8,415<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_ProductOrServiceAxis=cron_CannabisFlowerMember', window );">Cannabis flower | Corporate Expenses</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SegmentReportingInformationLineItems', window );"><strong>Segment Reporting Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Net revenue</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_ProductOrServiceAxis=cron_CannabisExtractsMember', window );">Cannabis extracts</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SegmentReportingInformationLineItems', window );"><strong>Segment Reporting Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Net revenue</a></td>
<td class="nump">3,758<span></span>
</td>
<td class="nump">4,091<span></span>
</td>
<td class="nump">6,902<span></span>
</td>
<td class="nump">9,667<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_ProductOrServiceAxis=cron_CannabisExtractsMember', window );">Cannabis extracts | Operating Segments | United States</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SegmentReportingInformationLineItems', window );"><strong>Segment Reporting Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Net revenue</a></td>
<td class="nump">2,227<span></span>
</td>
<td class="nump">2,174<span></span>
</td>
<td class="nump">4,668<span></span>
</td>
<td class="nump">4,350<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_ProductOrServiceAxis=cron_CannabisExtractsMember', window );">Cannabis extracts | Operating Segments | Rest of World</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SegmentReportingInformationLineItems', window );"><strong>Segment Reporting Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Net revenue</a></td>
<td class="nump">1,531<span></span>
</td>
<td class="nump">1,917<span></span>
</td>
<td class="nump">2,234<span></span>
</td>
<td class="nump">5,317<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_ProductOrServiceAxis=cron_CannabisExtractsMember', window );">Cannabis extracts | Corporate Expenses</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SegmentReportingInformationLineItems', window );"><strong>Segment Reporting Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Net revenue</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_ProductOrServiceAxis=us-gaap_ProductAndServiceOtherMember', window );">Other</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SegmentReportingInformationLineItems', window );"><strong>Segment Reporting Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Net revenue</a></td>
<td class="nump">267<span></span>
</td>
<td class="nump">118<span></span>
</td>
<td class="nump">300<span></span>
</td>
<td class="nump">233<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_ProductOrServiceAxis=us-gaap_ProductAndServiceOtherMember', window );">Other | Operating Segments | United States</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SegmentReportingInformationLineItems', window );"><strong>Segment Reporting Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Net revenue</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_ProductOrServiceAxis=us-gaap_ProductAndServiceOtherMember', window );">Other | Operating Segments | Rest of World</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SegmentReportingInformationLineItems', window );"><strong>Segment Reporting Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Net revenue</a></td>
<td class="nump">267<span></span>
</td>
<td class="nump">118<span></span>
</td>
<td class="nump">300<span></span>
</td>
<td class="nump">233<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_ProductOrServiceAxis=us-gaap_ProductAndServiceOtherMember', window );">Other | Corporate Expenses</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SegmentReportingInformationLineItems', window );"><strong>Segment Reporting Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Net revenue</a></td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cron_AdjustedEarningsBeforeInterestTaxesDepreciationAndAmortization">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Adjusted Earnings Before Interest, Taxes, Depreciation And Amortization</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cron_AdjustedEarningsBeforeInterestTaxesDepreciationAndAmortization</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cron_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_Assets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Sum of the carrying amounts as of the balance sheet date of all assets that are recognized. Assets are probable future economic benefits obtained or controlled by an entity as a result of past transactions or events.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(11))<br> -URI http://asc.fasb.org/extlink&amp;oid=120398452&amp;loc=d3e534808-122878<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8736-108599<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(12))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400017&amp;loc=d3e572229-122910<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 8: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124433192&amp;loc=SL2890621-112765<br><br>Reference 9: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 14: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (bb)<br> -URI http://asc.fasb.org/extlink&amp;oid=123419778&amp;loc=d3e5710-111685<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 25<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=116870748&amp;loc=SL6758485-165988<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8933-108599<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8906-108599<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_Assets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DepreciationAndAmortization">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The current period expense charged against earnings on long-lived, physical assets not used in production, and which are not intended for resale, to allocate or recognize the cost of such assets over their useful lives; or to record the reduction in book value of an intangible asset over the benefit period of such asset; or to reflect consumption during the period of an asset that is not used in production.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=6391035&amp;loc=d3e2868-110229<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DepreciationAndAmortization</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeLossFromEquityMethodInvestments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of income (loss) for proportionate share of equity method investee's income (loss).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(12))<br> -URI http://asc.fasb.org/extlink&amp;oid=123367319&amp;loc=SL114868664-224227<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(10))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3602-108585<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(13)(f))<br> -URI http://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (g)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8736-108599<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=109237563&amp;loc=d3e33749-111570<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeLossFromEquityMethodInvestments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InterestExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of the cost of borrowed funds accounted for as interest expense.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 835<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=6450988&amp;loc=d3e26243-108391<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 835<br> -SubTopic 30<br> -Section 45<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=124435984&amp;loc=d3e28555-108399<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8736-108599<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (210.5-03(11))<br> -URI http://asc.fasb.org/extlink&amp;oid=123367319&amp;loc=SL114868664-224227<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04.9)<br> -URI http://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InterestExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InterestIncomeExpenseNonoperatingNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The net amount of nonoperating interest income (expense).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InterestIncomeExpenseNonoperatingNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InvestmentIncomeInterest">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount before accretion (amortization) of purchase discount (premium) of interest income on nonoperating securities.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03.7(b))<br> -URI http://asc.fasb.org/extlink&amp;oid=123367319&amp;loc=SL114868664-224227<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8736-108599<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InvestmentIncomeInterest</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseRightOfUseAssetAmortizationExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of amortization expense for right-of-use asset from operating lease.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeaseRightOfUseAssetAmortizationExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentAdditions">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of acquisition of long-lived, physical assets used in the normal conduct of business and not intended for resale. Examples include, but are not limited to, land, buildings, machinery and equipment, office equipment, furniture and fixtures, and computer equipment.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentAdditions</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, excluding tax collected from customer, of revenue from satisfaction of performance obligation by transferring promised good or service to customer. Tax collected from customer is tax assessed by governmental authority that is both imposed on and concurrent with specific revenue-producing transaction, including, but not limited to, sales, use, value added and excise.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8906-108599<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 40<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e9031-108599<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 41<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e9038-108599<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8933-108599<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8933-108599<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123351226&amp;loc=SL49130543-203045<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8736-108599<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8736-108599<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 42<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e9054-108599<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 5<br> -URI http://asc.fasb.org/extlink&amp;oid=123351226&amp;loc=SL49130545-203045<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 924<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 11.L)<br> -URI http://asc.fasb.org/extlink&amp;oid=6472922&amp;loc=d3e499488-122856<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SegmentReportingInformationLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SegmentReportingInformationLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ConsolidationItemsAxis=us-gaap_OperatingSegmentsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ConsolidationItemsAxis=us-gaap_OperatingSegmentsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementBusinessSegmentsAxis=cron_UnitedStatesSegmentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementBusinessSegmentsAxis=cron_UnitedStatesSegmentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementBusinessSegmentsAxis=cron_RestOfWorldSegmentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementBusinessSegmentsAxis=cron_RestOfWorldSegmentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ConsolidationItemsAxis=us-gaap_CorporateNonSegmentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ConsolidationItemsAxis=us-gaap_CorporateNonSegmentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ProductOrServiceAxis=cron_CannabisFlowerMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ProductOrServiceAxis=cron_CannabisFlowerMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ProductOrServiceAxis=cron_CannabisExtractsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ProductOrServiceAxis=cron_CannabisExtractsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ProductOrServiceAxis=us-gaap_ProductAndServiceOtherMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ProductOrServiceAxis=us-gaap_ProductAndServiceOtherMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>65
<FILENAME>R51.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.2</span><table class="report" border="0" cellspacing="2" id="idm140382000966872">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Segment Information - Schedule of Adjusted EBITDA (Details) - USD ($)<br></strong></div></th>
<th class="th" colspan="2">3 Months Ended</th>
<th class="th" colspan="2">6 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Jun. 30, 2021</div></th>
<th class="th"><div>Jun. 30, 2020</div></th>
<th class="th"><div>Jun. 30, 2021</div></th>
<th class="th"><div>Jun. 30, 2020</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SegmentReportingInformationLineItems', window );"><strong>Segment Reporting Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProfitLoss', window );">Net income (loss)</a></td>
<td class="nump">$ 56,775,000<span></span>
</td>
<td class="num">$ (107,703,000)<span></span>
</td>
<td class="num">$ (104,850,000)<span></span>
</td>
<td class="num">$ (32,022,000)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InterestIncomeExpenseNonoperatingNet', window );">Interest income, net</a></td>
<td class="num">(2,293,000)<span></span>
</td>
<td class="num">(3,734,000)<span></span>
</td>
<td class="num">(4,622,000)<span></span>
</td>
<td class="num">(11,485,000)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeLossFromEquityMethodInvestments', window );">Share of loss from equity accounted investments</a></td>
<td class="nump">1,115,000<span></span>
</td>
<td class="nump">794,000<span></span>
</td>
<td class="nump">2,758,000<span></span>
</td>
<td class="nump">1,966,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AssetImpairmentCharges', window );">Impairment loss on long-lived assets</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">40,000,000<span></span>
</td>
<td class="nump">1,741,000<span></span>
</td>
<td class="nump">40,000,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GainLossOnDerivativeInstrumentsNetPretax', window );">Gain (loss) on revaluation of derivative liabilities</a></td>
<td class="num">(115,248,000)<span></span>
</td>
<td class="nump">35,880,000<span></span>
</td>
<td class="nump">1,626,000<span></span>
</td>
<td class="num">(77,488,000)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RestructuringCharges', window );">Transaction costs</a></td>
<td class="nump">2,758,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">3,259,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherNonoperatingIncomeExpense', window );">Other, net</a></td>
<td class="num">(1,127,000)<span></span>
</td>
<td class="nump">9,000<span></span>
</td>
<td class="num">(911,000)<span></span>
</td>
<td class="num">(785,000)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTax', window );">Loss from discontinued operations</a></td>
<td class="nump">561,000<span></span>
</td>
<td class="nump">46,000<span></span>
</td>
<td class="nump">582,000<span></span>
</td>
<td class="nump">46,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AllocatedShareBasedCompensationExpense', window );">Share-based payments</a></td>
<td class="nump">2,565,000<span></span>
</td>
<td class="nump">2,546,000<span></span>
</td>
<td class="nump">5,064,000<span></span>
</td>
<td class="nump">4,982,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cron_RestatementReviewExpense', window );">Review costs related to restatement of 2019 interim financial statements</a></td>
<td class="nump">1,932,000<span></span>
</td>
<td class="nump">3,459,000<span></span>
</td>
<td class="nump">3,937,000<span></span>
</td>
<td class="nump">7,866,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DepreciationDepletionAndAmortization', window );">Depreciation and amortization</a></td>
<td class="nump">3,203,000<span></span>
</td>
<td class="nump">1,717,000<span></span>
</td>
<td class="nump">5,083,000<span></span>
</td>
<td class="nump">2,879,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cron_AdjustedEarningsBeforeInterestTaxesDepreciationAndAmortization', window );">Adjusted EBITDA</a></td>
<td class="num">(49,759,000)<span></span>
</td>
<td class="num">(26,986,000)<span></span>
</td>
<td class="num">(86,333,000)<span></span>
</td>
<td class="num">(64,041,000)<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementBusinessSegmentsAxis=cron_UnitedStatesSegmentMember', window );">United States</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SegmentReportingInformationLineItems', window );"><strong>Segment Reporting Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTax', window );">Loss from discontinued operations</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_ConsolidationItemsAxis=us-gaap_OperatingSegmentsMember', window );">Operating Segments | United States</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SegmentReportingInformationLineItems', window );"><strong>Segment Reporting Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProfitLoss', window );">Net income (loss)</a></td>
<td class="num">(11,719,000)<span></span>
</td>
<td class="num">(45,566,000)<span></span>
</td>
<td class="num">(23,811,000)<span></span>
</td>
<td class="num">(52,082,000)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InterestIncomeExpenseNonoperatingNet', window );">Interest income, net</a></td>
<td class="num">(20,000)<span></span>
</td>
<td class="num">(9,000)<span></span>
</td>
<td class="num">(23,000)<span></span>
</td>
<td class="num">(16,000)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeLossFromEquityMethodInvestments', window );">Share of loss from equity accounted investments</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AssetImpairmentCharges', window );">Impairment loss on long-lived assets</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">40,000,000<span></span>
</td>
<td class="nump">1,741,000<span></span>
</td>
<td class="nump">40,000,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GainLossOnDerivativeInstrumentsNetPretax', window );">Gain (loss) on revaluation of derivative liabilities</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RestructuringCharges', window );">Transaction costs</a></td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherNonoperatingIncomeExpense', window );">Other, net</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTax', window );">Loss from discontinued operations</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AllocatedShareBasedCompensationExpense', window );">Share-based payments</a></td>
<td class="nump">822,000<span></span>
</td>
<td class="nump">756,000<span></span>
</td>
<td class="nump">1,567,000<span></span>
</td>
<td class="nump">1,462,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cron_RestatementReviewExpense', window );">Review costs related to restatement of 2019 interim financial statements</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DepreciationDepletionAndAmortization', window );">Depreciation and amortization</a></td>
<td class="nump">206,000<span></span>
</td>
<td class="nump">34,000<span></span>
</td>
<td class="nump">305,000<span></span>
</td>
<td class="nump">69,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cron_AdjustedEarningsBeforeInterestTaxesDepreciationAndAmortization', window );">Adjusted EBITDA</a></td>
<td class="num">(10,711,000)<span></span>
</td>
<td class="num">(4,785,000)<span></span>
</td>
<td class="num">(20,221,000)<span></span>
</td>
<td class="num">(10,567,000)<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_ConsolidationItemsAxis=us-gaap_OperatingSegmentsMember', window );">Operating Segments | Rest of World</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SegmentReportingInformationLineItems', window );"><strong>Segment Reporting Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProfitLoss', window );">Net income (loss)</a></td>
<td class="nump">79,627,000<span></span>
</td>
<td class="num">(55,095,000)<span></span>
</td>
<td class="num">(62,520,000)<span></span>
</td>
<td class="nump">33,772,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InterestIncomeExpenseNonoperatingNet', window );">Interest income, net</a></td>
<td class="num">(2,273,000)<span></span>
</td>
<td class="num">(3,725,000)<span></span>
</td>
<td class="num">(4,599,000)<span></span>
</td>
<td class="num">(11,469,000)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeLossFromEquityMethodInvestments', window );">Share of loss from equity accounted investments</a></td>
<td class="nump">1,115,000<span></span>
</td>
<td class="nump">794,000<span></span>
</td>
<td class="nump">2,758,000<span></span>
</td>
<td class="nump">1,966,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AssetImpairmentCharges', window );">Impairment loss on long-lived assets</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GainLossOnDerivativeInstrumentsNetPretax', window );">Gain (loss) on revaluation of derivative liabilities</a></td>
<td class="num">(115,248,000)<span></span>
</td>
<td class="nump">35,880,000<span></span>
</td>
<td class="nump">1,626,000<span></span>
</td>
<td class="num">(77,488,000)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RestructuringCharges', window );">Transaction costs</a></td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherNonoperatingIncomeExpense', window );">Other, net</a></td>
<td class="num">(1,127,000)<span></span>
</td>
<td class="nump">9,000<span></span>
</td>
<td class="num">(911,000)<span></span>
</td>
<td class="num">(785,000)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTax', window );">Loss from discontinued operations</a></td>
<td class="nump">561,000<span></span>
</td>
<td class="nump">46,000<span></span>
</td>
<td class="nump">582,000<span></span>
</td>
<td class="nump">46,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AllocatedShareBasedCompensationExpense', window );">Share-based payments</a></td>
<td class="nump">1,743,000<span></span>
</td>
<td class="nump">1,790,000<span></span>
</td>
<td class="nump">3,497,000<span></span>
</td>
<td class="nump">3,520,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cron_RestatementReviewExpense', window );">Review costs related to restatement of 2019 interim financial statements</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DepreciationDepletionAndAmortization', window );">Depreciation and amortization</a></td>
<td class="nump">2,997,000<span></span>
</td>
<td class="nump">1,683,000<span></span>
</td>
<td class="nump">4,778,000<span></span>
</td>
<td class="nump">2,810,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cron_AdjustedEarningsBeforeInterestTaxesDepreciationAndAmortization', window );">Adjusted EBITDA</a></td>
<td class="num">(32,605,000)<span></span>
</td>
<td class="num">(18,618,000)<span></span>
</td>
<td class="num">(54,789,000)<span></span>
</td>
<td class="num">(47,628,000)<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_ConsolidationItemsAxis=us-gaap_CorporateNonSegmentMember', window );">Corporate Expenses</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SegmentReportingInformationLineItems', window );"><strong>Segment Reporting Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProfitLoss', window );">Net income (loss)</a></td>
<td class="num">(11,133,000)<span></span>
</td>
<td class="num">(7,042,000)<span></span>
</td>
<td class="num">(18,519,000)<span></span>
</td>
<td class="num">(13,712,000)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InterestIncomeExpenseNonoperatingNet', window );">Interest income, net</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeLossFromEquityMethodInvestments', window );">Share of loss from equity accounted investments</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AssetImpairmentCharges', window );">Impairment loss on long-lived assets</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GainLossOnDerivativeInstrumentsNetPretax', window );">Gain (loss) on revaluation of derivative liabilities</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RestructuringCharges', window );">Transaction costs</a></td>
<td class="nump">2,758,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">3,259,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherNonoperatingIncomeExpense', window );">Other, net</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTax', window );">Loss from discontinued operations</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AllocatedShareBasedCompensationExpense', window );">Share-based payments</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cron_RestatementReviewExpense', window );">Review costs related to restatement of 2019 interim financial statements</a></td>
<td class="nump">1,932,000<span></span>
</td>
<td class="nump">3,459,000<span></span>
</td>
<td class="nump">3,937,000<span></span>
</td>
<td class="nump">7,866,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DepreciationDepletionAndAmortization', window );">Depreciation and amortization</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cron_AdjustedEarningsBeforeInterestTaxesDepreciationAndAmortization', window );">Adjusted EBITDA</a></td>
<td class="num">$ (6,443,000)<span></span>
</td>
<td class="num">$ (3,583,000)<span></span>
</td>
<td class="num">$ (11,323,000)<span></span>
</td>
<td class="num">$ (5,846,000)<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cron_AdjustedEarningsBeforeInterestTaxesDepreciationAndAmortization">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Adjusted Earnings Before Interest, Taxes, Depreciation And Amortization</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cron_AdjustedEarningsBeforeInterestTaxesDepreciationAndAmortization</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cron_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cron_RestatementReviewExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Restatement Review Expense</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cron_RestatementReviewExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cron_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AllocatedShareBasedCompensationExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of expense for award under share-based payment arrangement. Excludes amount capitalized.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5047-113901<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 14.F)<br> -URI http://asc.fasb.org/extlink&amp;oid=122041274&amp;loc=d3e301413-122809<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (h)(1)(i)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AllocatedShareBasedCompensationExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AssetImpairmentCharges">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of write-down of assets recognized in the income statement. Includes, but is not limited to, losses from tangible assets, intangible assets and goodwill.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3602-108585<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 45<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=123351718&amp;loc=d3e2420-110228<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AssetImpairmentCharges</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DepreciationDepletionAndAmortization">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The aggregate expense recognized in the current period that allocates the cost of tangible assets, intangible assets, or depleting assets to periods that benefit from use of the assets.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (e)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8736-108599<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DepreciationDepletionAndAmortization</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GainLossOnDerivativeInstrumentsNetPretax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Aggregate net gain (loss) on all derivative instruments recognized in earnings during the period, before tax effects.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4A<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=125515794&amp;loc=SL5618551-113959<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GainLossOnDerivativeInstrumentsNetPretax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount after tax of income (loss) from a discontinued operation including the portion attributable to the noncontrolling interest. Includes, but is not limited to, the income (loss) from operations during the phase-out period, gain (loss) on disposal, gain (loss) for reversal of write-down (write-down) to fair value, less cost to sell, and adjustments to a prior period gain (loss) on disposal.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(12))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 7<br> -URI http://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=SL51721683-107760<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 45<br> -Paragraph 3B<br> -URI http://asc.fasb.org/extlink&amp;oid=109222160&amp;loc=SL51721525-107759<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 5C<br> -Subparagraph (b)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=SL51721675-107760<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 45<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=109222160&amp;loc=d3e957-107759<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=d3e1361-107760<br><br>Reference 7: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 45<br> -Paragraph 3A<br> -URI http://asc.fasb.org/extlink&amp;oid=109222160&amp;loc=SL51721523-107759<br><br>Reference 8: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 45<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=109222160&amp;loc=d3e1012-107759<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 270<br> -Section 45<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=109227538&amp;loc=d3e44648-109337<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeLossFromEquityMethodInvestments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of income (loss) for proportionate share of equity method investee's income (loss).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(12))<br> -URI http://asc.fasb.org/extlink&amp;oid=123367319&amp;loc=SL114868664-224227<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(10))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3602-108585<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(13)(f))<br> -URI http://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (g)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8736-108599<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=109237563&amp;loc=d3e33749-111570<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeLossFromEquityMethodInvestments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InterestIncomeExpenseNonoperatingNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The net amount of nonoperating interest income (expense).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InterestIncomeExpenseNonoperatingNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherNonoperatingIncomeExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of income (expense) related to nonoperating activities, classified as other.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03.9)<br> -URI http://asc.fasb.org/extlink&amp;oid=123367319&amp;loc=SL114868664-224227<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherNonoperatingIncomeExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProfitLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The consolidated profit or loss for the period, net of income taxes, including the portion attributable to the noncontrolling interest.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=SL7669619-108580<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1A<br> -Subparagraph (a)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=109239629&amp;loc=SL4573702-111684<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22663-107794<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8736-108599<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8933-108599<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123482062&amp;loc=SL123482106-238011<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 12: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 50<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=124431353&amp;loc=SL124452729-227067<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8906-108599<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3000-108585<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 19<br> -URI http://asc.fasb.org/extlink&amp;oid=123454820&amp;loc=SL4569616-111683<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8933-108599<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 7<br> -URI http://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=SL51721683-107760<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22499-107794<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 235<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-05(b)(2))<br> -URI http://asc.fasb.org/extlink&amp;oid=120399901&amp;loc=d3e537907-122884<br><br>Reference 23: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 31<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8924-108599<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=SL7669625-108580<br><br>Reference 25: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 26: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 27: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 28: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 29: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 30: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1A<br> -Subparagraph (c)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=109239629&amp;loc=SL4573702-111684<br><br>Reference 31: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 55<br> -Paragraph 4J<br> -URI http://asc.fasb.org/extlink&amp;oid=120409616&amp;loc=SL4591551-111686<br><br>Reference 32: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 55<br> -Paragraph 4K<br> -URI http://asc.fasb.org/extlink&amp;oid=120409616&amp;loc=SL4591552-111686<br><br>Reference 33: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22658-107794<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProfitLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RestructuringCharges">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of expenses associated with exit or disposal activities pursuant to an authorized plan. Excludes expenses related to a discontinued operation or an asset retirement obligation.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 420<br> -SubTopic 10<br> -Section 45<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=109237686&amp;loc=d3e17752-110868<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 420<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 5.P.3)<br> -URI http://asc.fasb.org/extlink&amp;oid=115931487&amp;loc=d3e140864-122747<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3602-108585<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 420<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SAB Topic 5.P.4(b)(1))<br> -URI http://asc.fasb.org/extlink&amp;oid=115931487&amp;loc=d3e140904-122747<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RestructuringCharges</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SegmentReportingInformationLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SegmentReportingInformationLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementBusinessSegmentsAxis=cron_UnitedStatesSegmentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementBusinessSegmentsAxis=cron_UnitedStatesSegmentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ConsolidationItemsAxis=us-gaap_OperatingSegmentsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ConsolidationItemsAxis=us-gaap_OperatingSegmentsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementBusinessSegmentsAxis=cron_RestOfWorldSegmentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementBusinessSegmentsAxis=cron_RestOfWorldSegmentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ConsolidationItemsAxis=us-gaap_CorporateNonSegmentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ConsolidationItemsAxis=us-gaap_CorporateNonSegmentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>66
<FILENAME>R52.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.2</span><table class="report" border="0" cellspacing="2" id="idm140382000367416">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Segment Information - Schedule of Revenue from External Customers by Geographic Areas (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="2">3 Months Ended</th>
<th class="th" colspan="2">6 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Jun. 30, 2021</div></th>
<th class="th"><div>Jun. 30, 2020</div></th>
<th class="th"><div>Jun. 30, 2021</div></th>
<th class="th"><div>Jun. 30, 2020</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenuesFromExternalCustomersAndLongLivedAssetsLineItems', window );"><strong>Revenues from External Customers and Long-Lived Assets [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Net revenue</a></td>
<td class="nump">$ 15,622<span></span>
</td>
<td class="nump">$ 9,883<span></span>
</td>
<td class="nump">$ 28,233<span></span>
</td>
<td class="nump">$ 18,315<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_StatementGeographicalAxis=country_CA', window );">Canada</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenuesFromExternalCustomersAndLongLivedAssetsLineItems', window );"><strong>Revenues from External Customers and Long-Lived Assets [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Net revenue</a></td>
<td class="nump">10,664<span></span>
</td>
<td class="nump">7,416<span></span>
</td>
<td class="nump">18,246<span></span>
</td>
<td class="nump">13,507<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_StatementGeographicalAxis=country_US', window );">United States</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenuesFromExternalCustomersAndLongLivedAssetsLineItems', window );"><strong>Revenues from External Customers and Long-Lived Assets [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Net revenue</a></td>
<td class="nump">2,227<span></span>
</td>
<td class="nump">2,174<span></span>
</td>
<td class="nump">4,668<span></span>
</td>
<td class="nump">4,350<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_StatementGeographicalAxis=country_IL', window );">Israel</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenuesFromExternalCustomersAndLongLivedAssetsLineItems', window );"><strong>Revenues from External Customers and Long-Lived Assets [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Net revenue</a></td>
<td class="nump">2,310<span></span>
</td>
<td class="nump">293<span></span>
</td>
<td class="nump">4,828<span></span>
</td>
<td class="nump">293<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_StatementGeographicalAxis=cron_OtherCountriesMember', window );">Other countries</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenuesFromExternalCustomersAndLongLivedAssetsLineItems', window );"><strong>Revenues from External Customers and Long-Lived Assets [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Net revenue</a></td>
<td class="nump">$ 421<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">$ 491<span></span>
</td>
<td class="nump">$ 165<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, excluding tax collected from customer, of revenue from satisfaction of performance obligation by transferring promised good or service to customer. Tax collected from customer is tax assessed by governmental authority that is both imposed on and concurrent with specific revenue-producing transaction, including, but not limited to, sales, use, value added and excise.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8906-108599<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 40<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e9031-108599<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 41<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e9038-108599<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8933-108599<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8933-108599<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123351226&amp;loc=SL49130543-203045<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8736-108599<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8736-108599<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 42<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e9054-108599<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 5<br> -URI http://asc.fasb.org/extlink&amp;oid=123351226&amp;loc=SL49130545-203045<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 924<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 11.L)<br> -URI http://asc.fasb.org/extlink&amp;oid=6472922&amp;loc=d3e499488-122856<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RevenuesFromExternalCustomersAndLongLivedAssetsLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RevenuesFromExternalCustomersAndLongLivedAssetsLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_StatementGeographicalAxis=country_CA">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_StatementGeographicalAxis=country_CA</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_StatementGeographicalAxis=country_US">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_StatementGeographicalAxis=country_US</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_StatementGeographicalAxis=country_IL">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_StatementGeographicalAxis=country_IL</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_StatementGeographicalAxis=cron_OtherCountriesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_StatementGeographicalAxis=cron_OtherCountriesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>67
<FILENAME>R53.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.2</span><table class="report" border="0" cellspacing="2" id="idm140382005212632">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Segment Information - Schedule of Long-lived Assets by Geographic Areas (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th"><div>Jun. 30, 2021</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenuesFromExternalCustomersAndLongLivedAssetsLineItems', window );"><strong>Revenues from External Customers and Long-Lived Assets [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NoncurrentAssets', window );">Long-lived assets</a></td>
<td class="nump">$ 193,920<span></span>
</td>
<td class="nump">$ 187,599<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_StatementGeographicalAxis=country_CA', window );">Canada</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenuesFromExternalCustomersAndLongLivedAssetsLineItems', window );"><strong>Revenues from External Customers and Long-Lived Assets [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NoncurrentAssets', window );">Long-lived assets</a></td>
<td class="nump">168,462<span></span>
</td>
<td class="nump">162,163<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_StatementGeographicalAxis=country_IL', window );">Israel</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenuesFromExternalCustomersAndLongLivedAssetsLineItems', window );"><strong>Revenues from External Customers and Long-Lived Assets [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NoncurrentAssets', window );">Long-lived assets</a></td>
<td class="nump">23,936<span></span>
</td>
<td class="nump">23,143<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_StatementGeographicalAxis=country_US', window );">United States</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenuesFromExternalCustomersAndLongLivedAssetsLineItems', window );"><strong>Revenues from External Customers and Long-Lived Assets [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NoncurrentAssets', window );">Long-lived assets</a></td>
<td class="nump">$ 1,522<span></span>
</td>
<td class="nump">$ 2,293<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NoncurrentAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Long-lived assets other than financial instruments, long-term customer relationships of a financial institution, mortgage and other servicing rights, deferred policy acquisition costs, and deferred tax assets.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 41<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e9038-108599<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NoncurrentAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RevenuesFromExternalCustomersAndLongLivedAssetsLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RevenuesFromExternalCustomersAndLongLivedAssetsLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_StatementGeographicalAxis=country_CA">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_StatementGeographicalAxis=country_CA</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_StatementGeographicalAxis=country_IL">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_StatementGeographicalAxis=country_IL</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_StatementGeographicalAxis=country_US">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_StatementGeographicalAxis=country_US</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>68
<FILENAME>R54.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.2</span><table class="report" border="0" cellspacing="2" id="idm140382097884104">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Commitments and Contingencies (Details) - Pending Litigation<br> $ in Millions</strong></div></th>
<th class="th">
<div>Jun. 16, 2020 </div>
<div>CAD ($)</div>
</th>
<th class="th">
<div>Mar. 12, 2020 </div>
<div>shareholder </div>
<div>complaint</div>
</th>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LitigationStatusAxis=us-gaap_PendingLitigationMember', window );">Litigation Relating to Marketing, Distribution and Sale of Products</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LossContingenciesLineItems', window );"><strong>Loss Contingencies [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LossContingencyDamagesSoughtValue', window );">Damages sought</a></td>
<td class="nump">$ 500<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cron_LossContingencyPunitiveDamagesSoughtValue', window );">Punitive damages sought</a></td>
<td class="nump">$ 5<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_LitigationCaseAxis=cron_USDistrictCourtOfEasternDistrictOfNewYorkVsCronosMember', window );">U.S. District Court of Eastern District of New York Vs. Cronos</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LossContingenciesLineItems', window );"><strong>Loss Contingencies [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LossContingencyNumberOfPlaintiffs', window );">Number of alleged shareholders | shareholder</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LossContingencyNewClaimsFiledNumber', window );">Number of putative class action complaints | complaint</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cron_LossContingencyPunitiveDamagesSoughtValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Loss Contingency, Punitive Damages Sought, Value</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cron_LossContingencyPunitiveDamagesSoughtValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cron_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LossContingenciesLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LossContingenciesLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LossContingencyDamagesSoughtValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The value (monetary amount) of the award the plaintiff seeks in the legal matter.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 450<br> -SubTopic 20<br> -Section 50<br> -Paragraph 9<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121557415&amp;loc=d3e14557-108349<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 450<br> -SubTopic 20<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121557415&amp;loc=d3e14435-108349<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 450<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=121557415&amp;loc=d3e14326-108349<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LossContingencyDamagesSoughtValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LossContingencyNewClaimsFiledNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The total number of new claims filed pertaining to a loss contingency during the period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 450<br> -SubTopic 20<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121557415&amp;loc=d3e14435-108349<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LossContingencyNewClaimsFiledNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:integerItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LossContingencyNumberOfPlaintiffs">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of plaintiffs that have filed claims pertaining to a loss contingency.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LossContingencyNumberOfPlaintiffs</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:integerItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LitigationStatusAxis=us-gaap_PendingLitigationMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LitigationStatusAxis=us-gaap_PendingLitigationMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LossContingenciesByNatureOfContingencyAxis=us-gaap_UnfavorableRegulatoryActionMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LossContingenciesByNatureOfContingencyAxis=us-gaap_UnfavorableRegulatoryActionMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_LitigationCaseAxis=cron_USDistrictCourtOfEasternDistrictOfNewYorkVsCronosMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_LitigationCaseAxis=cron_USDistrictCourtOfEasternDistrictOfNewYorkVsCronosMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>69
<FILENAME>R55.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.2</span><table class="report" border="0" cellspacing="2" id="idm140382008283320">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Financial Instruments - Schedule of Fair Value of Assets Measured on Recurring Basis (Details) - Fair Value, Recurring - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th"><div>Jun. 30, 2021</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems', window );"><strong>Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CashAndCashEquivalentsFairValueDisclosure', window );">Cash and cash equivalents</a></td>
<td class="nump">$ 895,181<span></span>
</td>
<td class="nump">$ 1,078,023<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtSecurities', window );">Short-term investments</a></td>
<td class="nump">201,699<span></span>
</td>
<td class="nump">211,766<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeLiabilities', window );">Derivative liabilities</a></td>
<td class="nump">169,563<span></span>
</td>
<td class="nump">163,410<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueByMeasurementFrequencyAxis=us-gaap_FairValueMeasurementsRecurringMember', window );">Level 1</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems', window );"><strong>Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CashAndCashEquivalentsFairValueDisclosure', window );">Cash and cash equivalents</a></td>
<td class="nump">895,181<span></span>
</td>
<td class="nump">1,078,023<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtSecurities', window );">Short-term investments</a></td>
<td class="nump">201,699<span></span>
</td>
<td class="nump">211,766<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeLiabilities', window );">Derivative liabilities</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueByMeasurementFrequencyAxis=us-gaap_FairValueMeasurementsRecurringMember', window );">Level 2</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems', window );"><strong>Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CashAndCashEquivalentsFairValueDisclosure', window );">Cash and cash equivalents</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtSecurities', window );">Short-term investments</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeLiabilities', window );">Derivative liabilities</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueByMeasurementFrequencyAxis=us-gaap_FairValueMeasurementsRecurringMember', window );">Level 3</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems', window );"><strong>Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CashAndCashEquivalentsFairValueDisclosure', window );">Cash and cash equivalents</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtSecurities', window );">Short-term investments</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeLiabilities', window );">Derivative liabilities</a></td>
<td class="nump">$ 169,563<span></span>
</td>
<td class="nump">$ 163,410<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AvailableForSaleSecuritiesDebtSecurities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(6))<br> -URI http://asc.fasb.org/extlink&amp;oid=120398452&amp;loc=d3e534808-122878<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 326<br> -SubTopic 30<br> -Section 45<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=124258926&amp;loc=SL82898722-210454<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 320<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=124260329&amp;loc=d3e26610-111562<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 320<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (aa)<br> -URI http://asc.fasb.org/extlink&amp;oid=123581744&amp;loc=d3e27161-111563<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AvailableForSaleSecuritiesDebtSecurities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashAndCashEquivalentsFairValueDisclosure">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Fair value portion of currency on hand as well as demand deposits with banks or financial institutions. Includes other kinds of accounts that have the general characteristics of demand deposits. Also includes short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashAndCashEquivalentsFairValueDisclosure</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeLiabilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Fair value, after the effects of master netting arrangements, of a financial liability or contract with one or more underlyings, notional amount or payment provision or both, and the contract can be net settled by means outside the contract or delivery of an asset. Includes liabilities not subject to a master netting arrangement and not elected to be offset.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 20<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=51824906&amp;loc=SL20225862-175312<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 20<br> -Section 55<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=99393222&amp;loc=SL20226008-175313<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=123594938&amp;loc=d3e13433-108611<br><br>Reference 4: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 20<br> -Section 55<br> -Paragraph 22<br> -URI http://asc.fasb.org/extlink&amp;oid=99393222&amp;loc=SL20226052-175313<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeLiabilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueByMeasurementFrequencyAxis=us-gaap_FairValueMeasurementsRecurringMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueByMeasurementFrequencyAxis=us-gaap_FairValueMeasurementsRecurringMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel1Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel1Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel2Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel2Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel3Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel3Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>70
<FILENAME>R56.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.2</span><table class="report" border="0" cellspacing="2" id="idm140382008502424">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Financial Instruments - Credit Risk Narrative (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="1">6 Months Ended</th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Jun. 30, 2021</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ConcentrationRiskLineItems', window );"><strong>Concentration Risk [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ConcentrationRiskCreditRiskFinancialInstrumentMaximumExposure', window );">Maximum exposure to credit risk</a></td>
<td class="nump">$ 1,210,287<span></span>
</td>
<td class="nump">$ 1,403,491<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccountsReceivableNoncurrentThresholdPeriodPastDueWriteoff', window );">Accounts receivable, threshold period past due, writeoff</a></td>
<td class="text">120 days<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AllowanceForDoubtfulAccountsReceivableCurrent', window );">Current expected credit loss allowance on accounts receivable</a></td>
<td class="nump">$ 264<span></span>
</td>
<td class="nump">$ 74<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ConcentrationRiskByBenchmarkAxis=us-gaap_AccountsReceivableMember', window );">Accounts Receivable | Credit Concentration Risk | Four Customers</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ConcentrationRiskLineItems', window );"><strong>Concentration Risk [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ConcentrationRiskPercentage1', window );">Concentration risk, percentage</a></td>
<td class="nump">74.00%<span></span>
</td>
<td class="nump">78.00%<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountsReceivableNoncurrentThresholdPeriodPastDueWriteoff">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Threshold period for when accounts receivable, classified as noncurrent, is considered past due to write off as uncollectible, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 326<br> -SubTopic 20<br> -Section 50<br> -Paragraph 14<br> -URI http://asc.fasb.org/extlink&amp;oid=124255953&amp;loc=SL82919253-210447<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccountsReceivableNoncurrentThresholdPeriodPastDueWriteoff</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AllowanceForDoubtfulAccountsReceivableCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of allowance for credit loss on accounts receivable, classified as current.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(4)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 310<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=123577603&amp;loc=d3e5074-111524<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 326<br> -SubTopic 20<br> -Section 45<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=124255206&amp;loc=SL82895884-210446<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AllowanceForDoubtfulAccountsReceivableCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ConcentrationRiskCreditRiskFinancialInstrumentMaximumExposure">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Maximum amount of loss due to credit risk that, based on the gross fair value of the financial instrument, the entity would incur if parties to the financial instruments that make up the concentration failed completely to perform according to the terms of the contracts and the collateral or other security, if any, for the amount due proved to be of no value to the entity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 21<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123594938&amp;loc=d3e13537-108611<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ConcentrationRiskCreditRiskFinancialInstrumentMaximumExposure</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ConcentrationRiskLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ConcentrationRiskLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ConcentrationRiskPercentage1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>For an entity that discloses a concentration risk in relation to quantitative amount, which serves as the "benchmark" (or denominator) in the equation, this concept represents the concentration percentage derived from the division.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 42<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e9054-108599<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 275<br> -SubTopic 10<br> -Section 50<br> -Paragraph 18<br> -URI http://asc.fasb.org/extlink&amp;oid=99393423&amp;loc=d3e6351-108592<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 20<br> -URI http://asc.fasb.org/extlink&amp;oid=123594938&amp;loc=d3e13531-108611<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 21<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123594938&amp;loc=d3e13537-108611<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 275<br> -SubTopic 10<br> -Section 50<br> -Paragraph 20<br> -URI http://asc.fasb.org/extlink&amp;oid=99393423&amp;loc=d3e6404-108592<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ConcentrationRiskPercentage1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ConcentrationRiskByBenchmarkAxis=us-gaap_AccountsReceivableMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ConcentrationRiskByBenchmarkAxis=us-gaap_AccountsReceivableMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ConcentrationRiskByTypeAxis=us-gaap_CreditConcentrationRiskMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ConcentrationRiskByTypeAxis=us-gaap_CreditConcentrationRiskMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_MajorCustomersAxis=cron_FourCustomersMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_MajorCustomersAxis=cron_FourCustomersMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>71
<FILENAME>R57.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.2</span><table class="report" border="0" cellspacing="2" id="idm140381996852088">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Financial Instruments - Interest Rate Risk Narrative (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="2">3 Months Ended</th>
<th class="th" colspan="2">6 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Jun. 30, 2021</div></th>
<th class="th"><div>Jun. 30, 2020</div></th>
<th class="th"><div>Jun. 30, 2021</div></th>
<th class="th"><div>Jun. 30, 2020</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InvestmentsAllOtherInvestmentsAbstract', window );"><strong>Investments, All Other Investments [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InterestIncomeExpenseNonoperatingNet', window );">Interest income, net</a></td>
<td class="nump">$ 2,293<span></span>
</td>
<td class="nump">$ 3,734<span></span>
</td>
<td class="nump">$ 4,622<span></span>
</td>
<td class="nump">$ 11,485<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InterestIncomeExpenseNonoperatingNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The net amount of nonoperating interest income (expense).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InterestIncomeExpenseNonoperatingNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InvestmentsAllOtherInvestmentsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InvestmentsAllOtherInvestmentsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>72
<FILENAME>R58.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.2</span><table class="report" border="0" cellspacing="2" id="idm140381997992920">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Financial Instruments - Liquidity Risk Narrative (Details) - Accounts Payable - Supplier Concentration Risk<br></strong></div></th>
<th class="th" colspan="1">6 Months Ended</th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Jun. 30, 2021</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ConcentrationRiskByBenchmarkAxis=us-gaap_AccountsPayableMember', window );">One Vendor</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ConcentrationRiskLineItems', window );"><strong>Concentration Risk [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ConcentrationRiskPercentage1', window );">Concentration risk, percentage</a></td>
<td class="nump">32.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ConcentrationRiskByBenchmarkAxis=us-gaap_AccountsPayableMember', window );">Four Vendors</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ConcentrationRiskLineItems', window );"><strong>Concentration Risk [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ConcentrationRiskPercentage1', window );">Concentration risk, percentage</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">64.00%<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ConcentrationRiskLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ConcentrationRiskLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ConcentrationRiskPercentage1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>For an entity that discloses a concentration risk in relation to quantitative amount, which serves as the "benchmark" (or denominator) in the equation, this concept represents the concentration percentage derived from the division.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 42<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e9054-108599<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 275<br> -SubTopic 10<br> -Section 50<br> -Paragraph 18<br> -URI http://asc.fasb.org/extlink&amp;oid=99393423&amp;loc=d3e6351-108592<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 20<br> -URI http://asc.fasb.org/extlink&amp;oid=123594938&amp;loc=d3e13531-108611<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 21<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123594938&amp;loc=d3e13537-108611<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 275<br> -SubTopic 10<br> -Section 50<br> -Paragraph 20<br> -URI http://asc.fasb.org/extlink&amp;oid=99393423&amp;loc=d3e6404-108592<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ConcentrationRiskPercentage1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ConcentrationRiskByBenchmarkAxis=us-gaap_AccountsPayableMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ConcentrationRiskByBenchmarkAxis=us-gaap_AccountsPayableMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ConcentrationRiskByTypeAxis=us-gaap_SupplierConcentrationRiskMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ConcentrationRiskByTypeAxis=us-gaap_SupplierConcentrationRiskMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedGoodsAndNonemployeeServicesTransactionBySupplierAxis=cron_OneVendorMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedGoodsAndNonemployeeServicesTransactionBySupplierAxis=cron_OneVendorMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedGoodsAndNonemployeeServicesTransactionBySupplierAxis=cron_FourVendorsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedGoodsAndNonemployeeServicesTransactionBySupplierAxis=cron_FourVendorsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>73
<FILENAME>R59.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.2</span><table class="report" border="0" cellspacing="2" id="idm140382085741160">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Financial Instruments - Currency Rate Risk Narrative (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="2">3 Months Ended</th>
<th class="th" colspan="2">6 Months Ended</th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th"><div>Jun. 30, 2021</div></th>
<th class="th"><div>Jun. 30, 2020</div></th>
<th class="th"><div>Jun. 30, 2021</div></th>
<th class="th"><div>Jun. 30, 2020</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RisksAndUncertaintiesAbstract', window );"><strong>Risks and Uncertainties [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax', window );">Foreign exchange gain (loss) on translation</a></td>
<td class="nump">$ 13,470<span></span>
</td>
<td class="nump">$ 51,871<span></span>
</td>
<td class="nump">$ 29,754<span></span>
</td>
<td class="num">$ (61,821)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cron_SensitivityAnalysisOfCarryingValueNetAssetsImpactOf10PercentChangeInExchangeRate', window );">Impact of ten percent change in exchange rate</a></td>
<td class="nump">$ 162,991<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 162,991<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 170,817<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cron_SensitivityAnalysisOfCarryingValueNetAssetsImpactOf10PercentChangeInExchangeRate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Sensitivity Analysis Of Carrying Value, Net Assets, Impact Of 10 Percent Change In Exchange Rate</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cron_SensitivityAnalysisOfCarryingValueNetAssetsImpactOf10PercentChangeInExchangeRate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cron_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount after tax and reclassification adjustments of gain (loss) on foreign currency translation adjustments, foreign currency transactions designated and effective as economic hedges of a net investment in a foreign entity and intra-entity foreign currency transactions that are of a long-term-investment nature.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 10A<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=SL7669646-108580<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RisksAndUncertaintiesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RisksAndUncertaintiesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>74
<FILENAME>R60.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.2</span><table class="report" border="0" cellspacing="2" id="idm140382008947256">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Held-For-Sale Assets and Discontinued Operations (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="2">3 Months Ended</th>
<th class="th" colspan="2">6 Months Ended</th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th"><div>Jun. 30, 2021</div></th>
<th class="th"><div>Jun. 30, 2020</div></th>
<th class="th"><div>Jun. 30, 2021</div></th>
<th class="th"><div>Jun. 30, 2020</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems', window );"><strong>Income Statement, Balance Sheet and Additional Disclosures by Disposal Groups, Including Discontinued Operations [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ImpairmentOfLongLivedAssetsToBeDisposedOf', window );">Write-down to held-for-sale assets</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 1,039<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProceedsFromSaleOfPropertyHeldForSale', window );">Proceeds from sale of held-for-sale assets</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2,059<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisposalGroupClassificationAxis=us-gaap_DiscontinuedOperationsHeldforsaleMember', window );">Discontinued Operations, Held-for-sale | OGBC</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems', window );"><strong>Income Statement, Balance Sheet and Additional Disclosures by Disposal Groups, Including Discontinued Operations [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ImpairmentOfLongLivedAssetsToBeDisposedOf', window );">Write-down to held-for-sale assets</a></td>
<td class="nump">$ 561<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DiscontinuedOperationIncomeLossFromDiscontinuedOperationDuringPhaseOutPeriodNetOfTax', window );">Loss from discontinued operations, net of income taxes</a></td>
<td class="num">(561)<span></span>
</td>
<td class="num">$ (46)<span></span>
</td>
<td class="num">(582)<span></span>
</td>
<td class="num">$ (46)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisposalGroupIncludingDiscontinuedOperationAssetsNoncurrent', window );">OGBC assets classified as held-for-sale</a></td>
<td class="nump">645<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 645<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 1,176<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisposalGroupClassificationAxis=us-gaap_DisposalGroupHeldforsaleNotDiscontinuedOperationsMember', window );">Disposal Group, Held-for-sale, Not Discontinued Operations | OGBC</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems', window );"><strong>Income Statement, Balance Sheet and Additional Disclosures by Disposal Groups, Including Discontinued Operations [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProceedsFromSaleOfPropertyHeldForSale', window );">Proceeds from sale of held-for-sale assets</a></td>
<td class="nump">2,059<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisposalGroupNotDiscontinuedOperationGainLossOnDisposal', window );">Gain on sale of property held-for-sale</a></td>
<td class="nump">$ 1,279<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DiscontinuedOperationIncomeLossFromDiscontinuedOperationDuringPhaseOutPeriodNetOfTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount after tax of income (loss) from operations classified as a discontinued operation. Excludes gain (loss) on disposal and provision for gain (loss) until disposal.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 5C<br> -Subparagraph (b)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=SL51721675-107760<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 45<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=109222160&amp;loc=d3e957-107759<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 45<br> -Paragraph 3A<br> -URI http://asc.fasb.org/extlink&amp;oid=109222160&amp;loc=SL51721523-107759<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DiscontinuedOperationIncomeLossFromDiscontinuedOperationDuringPhaseOutPeriodNetOfTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DisposalGroupIncludingDiscontinuedOperationAssetsNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount classified as assets attributable to disposal group held for sale or disposed of, expected to be disposed of after one year or the normal operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 7<br> -URI http://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=SL51721683-107760<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (e)<br> -URI http://asc.fasb.org/extlink&amp;oid=109226691&amp;loc=d3e2941-110230<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 45<br> -Paragraph 11<br> -URI http://asc.fasb.org/extlink&amp;oid=123351718&amp;loc=d3e2510-110228<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 45<br> -Paragraph 11<br> -URI http://asc.fasb.org/extlink&amp;oid=109222160&amp;loc=SL51721533-107759<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 5B<br> -Subparagraph (e)<br> -URI http://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=SL51721673-107760<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 5C<br> -Subparagraph (a)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=SL51721675-107760<br><br>Reference 7: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 45<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=109222160&amp;loc=d3e1107-107759<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DisposalGroupIncludingDiscontinuedOperationAssetsNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DisposalGroupNotDiscontinuedOperationGainLossOnDisposal">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount before tax of gain (loss) recognized on the sale or disposal of a disposal group. Excludes discontinued operations.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 45<br> -Paragraph 5<br> -URI http://asc.fasb.org/extlink&amp;oid=123351718&amp;loc=d3e2443-110228<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3602-108585<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=109226691&amp;loc=d3e2941-110230<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DisposalGroupNotDiscontinuedOperationGainLossOnDisposal</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ImpairmentOfLongLivedAssetsToBeDisposedOf">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The aggregate amount of write-downs for impairments recognized during the period for long-lived assets held for abandonment, exchange or sale.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3602-108585<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 45<br> -Paragraph 15<br> -URI http://asc.fasb.org/extlink&amp;oid=123351718&amp;loc=d3e2611-110228<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ImpairmentOfLongLivedAssetsToBeDisposedOf</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProceedsFromSaleOfPropertyHeldForSale">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The cash inflow from the sale of formerly productive land held for sale, anything permanently fixed to it, including buildings, structures on it, and so forth.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 12<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3179-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProceedsFromSaleOfPropertyHeldForSale</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DisposalGroupClassificationAxis=us-gaap_DiscontinuedOperationsHeldforsaleMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DisposalGroupClassificationAxis=us-gaap_DiscontinuedOperationsHeldforsaleMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis=cron_OriginalBCMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis=cron_OriginalBCMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DisposalGroupClassificationAxis=us-gaap_DisposalGroupHeldforsaleNotDiscontinuedOperationsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DisposalGroupClassificationAxis=us-gaap_DisposalGroupHeldforsaleNotDiscontinuedOperationsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>75
<FILENAME>R61.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.2</span><table class="report" border="0" cellspacing="2" id="idm140382000299240">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Impairment Loss on Long-Lived Assets (Details)<br> ft&#178; in Thousands, $ in Thousands</strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
<th class="th" colspan="2">6 Months Ended</th>
</tr>
<tr>
<th class="th">
<div>Jun. 30, 2020 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Jun. 30, 2021 </div>
<div>USD ($) </div>
<div>ft&#178;</div>
</th>
<th class="th">
<div>Jun. 30, 2020 </div>
<div>USD ($)</div>
</th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassLineItems', window );"><strong>Indefinite-lived Intangible Assets [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ImpairmentOfLongLivedAssetsToBeDisposedOf', window );">Impairment of leasehold improvements to be disposed of</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 1,039<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cron_LesseeOperatingLeaseAreaOfLandToBeDisposedOf', window );">Lessee, operating lease, area of land to be disposed of (in sqft) | ft&#178;</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">6<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingLeaseImpairmentLoss', window );">Impairment charge on the de-recognition of the right-of-use asset</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 702<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ReportingUnitAxis=cron_UnitedStatesSegmentMember', window );">United States</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassLineItems', window );"><strong>Indefinite-lived Intangible Assets [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GoodwillImpairmentLoss', window );">Goodwill, impairment loss</a></td>
<td class="nump">$ 35,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 35,000<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_TradeNamesMember', window );">Lord Jones brand</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassLineItems', window );"><strong>Indefinite-lived Intangible Assets [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ImpairmentOfIntangibleAssetsIndefinitelivedExcludingGoodwill', window );">Impairment of intangible assets, indefinite-lived (excluding goodwill)</a></td>
<td class="nump">$ 5,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 5,000<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cron_LesseeOperatingLeaseAreaOfLandToBeDisposedOf">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Lessee, Operating Lease, Area Of Land To Be Disposed Of</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cron_LesseeOperatingLeaseAreaOfLandToBeDisposedOf</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cron_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:areaItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GoodwillImpairmentLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of loss from the write-down of an asset representing the future economic benefits arising from other assets acquired in a business combination that are not individually identified and separately recognized.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121556970&amp;loc=d3e13854-109267<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3602-108585<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (e)<br> -URI http://asc.fasb.org/extlink&amp;oid=121556970&amp;loc=d3e13816-109267<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 45<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=99380562&amp;loc=d3e13777-109266<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GoodwillImpairmentLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ImpairmentOfIntangibleAssetsIndefinitelivedExcludingGoodwill">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of impairment loss resulting from write-down of assets, excluding financial assets and goodwill, lacking physical substance and having a projected indefinite period of benefit to fair value.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=66006027&amp;loc=d3e16373-109275<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ImpairmentOfIntangibleAssetsIndefinitelivedExcludingGoodwill</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ImpairmentOfLongLivedAssetsToBeDisposedOf">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The aggregate amount of write-downs for impairments recognized during the period for long-lived assets held for abandonment, exchange or sale.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3602-108585<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 45<br> -Paragraph 15<br> -URI http://asc.fasb.org/extlink&amp;oid=123351718&amp;loc=d3e2611-110228<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ImpairmentOfLongLivedAssetsToBeDisposedOf</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseImpairmentLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of loss from impairment of right-of-use asset from operating lease.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 25<br> -Paragraph 6<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=123399704&amp;loc=SL77918431-209957<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeaseImpairmentLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ReportingUnitAxis=cron_UnitedStatesSegmentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ReportingUnitAxis=cron_UnitedStatesSegmentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_TradeNamesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_TradeNamesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EXCEL
<SEQUENCE>76
<FILENAME>Financial_Report.xlsx
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
begin 644 Financial_Report.xlsx
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M54YI-GA(FL>1-3_==M034NE(*!HFU"[Z^X>8.J"3L2PATQVSRS"G<9+Y)(Z
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MI:H; )A2FDGD3C: PQG'@3&U"@'')<)!'?KOO'T1?H$9!Z1!7(AB*Q!P7"&
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M5@^PN!Z(&U HG4OF<[K>J[,,NP*2^1*!2RUQ77D&!*2$NM;F&H!E7 =TSQH
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MA 'H_S\V3?_RQGRG:/<]N(O_ U!+ P04    " "E/ 93CM++J2D(  #@(@
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M($D#8A4Z (BS+,X,X-T C#W C]&."DK]"NJ)EJEU[XGS=C ]]2K-(IR:NTL
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MWQ5:#B#_UAC_8G""XP]P_3=02P,$%     @ I3P&4\U1IA"\"P  TR   !@
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M$VA&U': 6_5 [:#C(C0-0!M/$)P)E;*!XT$AR%73"-R3F%J7$>M]F#A7LTZ
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MP/S:H.9J7NB [O\8WOX?4$L#!!0    ( *4\!E-N=V?:]@0  )D,   9
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MNPAW+T8V[O)Y)PU=9=UP3?\=4%D#6E]*2H/^Q1XP_!NY_ =02P,$%     @
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M]ZQ0A 'T"$&9ZK>+&2FP96$JZSIX^?^;-;V@9:-ES/V/8,[-""_RN>,0>ZN
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M24*C;+)5[IM!=87V(S/O9EH$1!VR>9)^.\)/+[7_[P#= 7[UH-.;%?V=>/^
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M?(;G-I^W>PW7#H%2,G ;GN7:NP71I"^))GU1-.G*HDE?&/VDBJ:W!59-VB
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MR9&U'_0V'&RU+E@0G(!]WZBJ:5/1@T9&UM_6SYN&K9H"A=S4RZ)L0V)F6N,
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M.&78*=?!X:G"OG!^9>M:!5@Y>"%-*:ZL"<JLR12*_.DTX A>."VRN,LD;G%
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M&X*MX\^*)#H<7H#G*VM#>\$'=)^5SO\-4$L#!!0    ( *4\!E-"PFLO^PP
M +8F   9    >&PO=V]R:W-H965T<R]S:&5E=#$V+GAM;,U:;8_;-A+^*\3>
M]I  6J]?]K5- FPV#2Z'!BB:M/?A<!]HB;+92*)#4O;Z?OT],Z3>;.TV37NX
M Q9K2R:',\.99QZ.]&)G[">W5LJ+A[*HW,N3M?>;;\_/7;I6I703LU$5?LF-
M+:7'I5V=NXU5,N-)97$^GTZOSDNIJY-7+_C>C_;5"U/[0E?J1RM<79;2[E^K
MPNQ>GLQ.FAL_Z=7:TXWS5R\V<J4^*/_SYD>+J_-62J9+53EM*F%5_O+D;O;M
MZPL:SP-^T6KG>M\%6;(TYA-=O,M>GDQ)(56HU),$B8^MNE=%08*@QN<H\Z1=
MDB;VOS?2W[+ML&4IG;HWQ3]TYM<O3VY.1*9R61?^)[/[FXKV7)*\U!2._XM=
M&+NX/!%I[;PIXV1H4.HJ?,J'Z(?>A)OI(Q/F<<*<]0X+L99OI)>O7EBS$Y9&
M0QI]85-Y-I33%6W*!V_QJ\8\_^JMKF25:EF(=Y7SMH:_O7MQ[B&:!IRG4<SK
M(&;^B)@K\=Y4?NW$]U6FLN'\<ZC4ZC5O]'H]?U+@W^MJ(A;31,RG\]D3\A:M
MG0N6MWA$WD_:?7)"5IGXN4J5]0A7KY43_[Q;PFS$QK^>6.2B7>2"%[GXH\[\
M"C'BF7PNWDIMQ586M1*EDJZVBGX3']=*W)MR(ZN]2/%9D&4[[=?B[L.]N)G#
MC3SS%Y[YOIOI$H&\%AKB\W91Z9SRP5>%EDM=:/:47TLOI%5(Q;.X>,:#K-H8
MZ^G"B[Q3$%=*INOXLZY68J.L-EG"DRI3G?TWEBPP#'.JJI9%L9_ @V*E*F5E
MD?1&.I::*:\L<@IREOMOQ5__<C.?7WTG?E!;58B9T-6FAE*UASK_5N)S;6C%
MC=4IYC^K*YG]BOQ4V7.,C.B"S+2?R!+V:@8/Z[0S#_=ZUDT.%IP?+I@AG\7&
M:-K\UA-FZ93=RF6A@*/PKG1#Q1)(@54*3K#2J^#3O59%!C2QV^-E%\VR)+VN
M>O+[ZY,]'E'&EO0-V8?MU%5:U!F6<]K7DO 6 ;B&'C0+_[7##.\+!?URS,"T
MX*K@.,AY8HD)!WAN"E00BB-/ZCD8K!Q%OZY";6*07Z+PL)B8#V3L[/H[U^Q!
MZ\@NG@8A1#(07O"5I:4 ^)KF"I,+0))J(8FM?J-252Z5%8L9WYU&7V38=<^F
M]T6O-<+0INL]":/?Z'90VZMT7>G/-<=\E\LQ$C+A31>L8=\[N9,#Q9KP;:*J
MV>:/QB,4[Z5;LY8I?5&?:PTAC"^GXN;V,IG=S/"-O3;_;O"M^?7#&JEW1LK
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MBNZ5M"%&TM36_56"_P. "55E(52^QOI^I*]J">CTBE=J1@@B^SKG@AP$408
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MDR\)83_,YX1R24.^"[+'$!'(U-+3$<, <59RI?C41GZ3>X[=34&H17#5SJ-
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M73]HP:[Q+TE"E[>-R:PM\T(S:(H6"^2?H4D,8: H[ZG"%A,]^0P##JB8%J$
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MCN?:XR_.Q9S.>*([4PEG'L]?*J"X[PA!9S6!0W\ 09P.^1Q2YW$,$1P6>*&
M$I%%)!S/C]D<E9B@XXV'#A'.Z18 4H>RRNS@/G.C],K>VAI$) [G[=5FW]M?
M#-^T]Z'?AK>WRK]+O<H*@RRWQ%1W&N&DH=N;VO:E+BM[.[HHZ[K<V.9:2005
M#<#W98GX[%YH@?ZZ_/J_4$L#!!0    ( *4\!E,WN;C)LP8  !84   9
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MF\1QZ9*RM)IV.?G9V1V*](SB.ULR@3 W!JT!)E.XYB91TG)980J/)6KF;M'
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M$:QF6;PE%Q]:I.9E<B&T%BOS<\DH\%AN /UW0NB7CWR ZD7_]!]02P,$%
M  @ I3P&4]9\Z6(I P  RPH  !D   !X;"]W;W)K<VAE971S+W-H965T,S N
M>&ULI5;;;J,P$/T5"_6AE=IRAQ ED9H+VJY4J6JVVX?5/CC@)%;!9FT3VK]?
M<PF;$I=%ZDN"S3ESYIAAF$E!V2O?(R3 6YH0/M7V0F1C7>?1'J60W](,$7EG
M2UD*A5RRG<XSAF!<D=)$MPS#TU.(B3:;5'N/;#:AN4@P08\,\#Q-(7N?HX06
M4\W4CAM/>+<7Y88^FV1PA]9(/&>/3*[T-DJ,4T0XI@0PM)UJ=^8X#$I\!?B)
M4<%/KD'I9$/I:[FXCZ>:42:$$A2),@*4?P>T0$E2!I)I_&EB:JUD23R]/D8/
M*^_2RP9RM*#)"X[%?JJ--!"C+<P3\42+;ZCQXY;Q(IKPZA<4-=8U-!#E7-"T
M(<L,4DSJ?_C6G,,)0<91$ZR&8'4)SB<$NR'80Q6<AN ,57 ;@CN4X#4$KSK[
M^K"JDUY" 6<31@O 2K2,5EY4CZMBRP/&I"RLM6#R+I8\,;LG!T0$9>_7@,@R
MOEPB 7'"K\ ->%XOP>7%%;@ F( ?>YIS2&(^T864+<EZU$C,:PGK$PD;/% B
M]ARL2(QB!7_9S_=Z^+JTVWJVCI[G5F_ [SFY!;9Q#2S#,A7Y+(;3#96=KZFO
MOJ8>]M.7*))T4T7_<)9V6S]V%<_^7_V )>910GG.$/AUM^&"R:;QNT?!:16<
M2L'Y1.$)%K+@!6(8)LKJJ^E>12_[Z&'F.[X\V</I,QD""L]!INF,@A;U(7^W
MS=_MS?]%=M8;3&XR1G<,<:6%.H)[*NQ;0=?#(%1XCK(\RQ^I37BM":_71(@)
MEDTF!CM*U3W .T_.L!R_8V$0*CQ'N8'AJAWXK0._U\$ZS[($(PYD$P,1)?)+
M"C<)4GKQ%?I>Q\D 3'B.L6U#;6/4VACUVOC8KU7)C\Y%7>_D].KT!Z'"T=D+
MX3B&8:DM!*V%8)@%4# LT$U,"Z(R$BC>QL#KE/OB'&4;GM5Q.RC42H62U=EQ
MJY]\;%/$=M58Q&5)Y434?;/=;2>ONVK@Z.S/S?'"5.POS?&J'JS^A:_'O ?(
M=IAPD*"ME#)N??G\6#TZU0M!L^I3OZ%"#@[5Y5Y.FXB5 'E_2ZDX+DJ!=GZ=
M_0502P,$%     @ I3P&4XRH@<5(!0  _A<  !D   !X;"]W;W)K<VAE971S
M+W-H965T,S$N>&ULS5A;;]LV%/XKA-<.*9!%(N5;.L= ZUR:(>F"INT>ACW0
M$FT3E4B7I.(&Z(_?(:5(=BHQ=A<#>[%%BM^Y?.?P'%*CE51?]((Q@[YEJ= G
MG84QR]=!H.,%RZ@^DDLFX,U,JHP:&*IYH)>*T<2!LC0@8=@/,LI%9SQR<S=J
M/)*Y2;E@-PKI/,NHNG_+4KDZZ>#.P\0'/E\8.Q&,1TLZ9[?,?%K>*!@%E92$
M9TQH+@52;';2>8-?7T2A!;@5GSE;Z;5G9%V92OG%#BZ3DTYH+6(IBXT50>'O
MCDU8FEI)8,?74FBGTFF!Z\\/TL^=\^#,E&HVD>E?/#&+D\ZP@Q(VHWEJ/LC5
M.U8ZU+/R8IEJ]XM6Y=JP@^)<&YF58+ @XZ+XI]]*(M8 T: %0$H >03 W19
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M*?O&5X0(\)3$*;\8K(18OS<,'JQ(@OF0KDDJ9Y:4)5C(3_9H\#4C."R8DMA
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M_BM6U$FMM#5Q+@0J0&JAVYC:KFK7[F':@R&'8C6QF>U *^W'SPYIPC50#5[
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MCX8@C(&^/^1<O6W,T: X;+;_ 5!+ P04    " "E/ 93(D;_!)4&  !O(
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M1:,9N3YJE #=$V],N(#EB5U]'P.7WP"7?TKV94ZWW6[N4!F(O3(TXO7#"I4
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M-S#WETFB7T[R!U2[<^?_ U!+ P04    " "E/ 93W\<A<&T#  !)#   &0
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MORUFZ.+-)7J#N$1?MZHT5*[-.+2@T/U.N*K4O#^H(6?4?"KE-8JCMXA$!'?
M;_OA,[8"./;PZ!0>0EWJXI"Z.,3S#<[PW0BK.47W5&LJ;0]A7!/&GC ^0]A5
MR+?H+B^@FUVA<83F3*^8M AR@6-I&+JXDX?1)8*V_P-.-BRH'!Y\5@:J_]?-
MTE@-!'_W"!S4 @>]&2^V5#-4:+YB7;MW *<>[ QB-XUQ/$S&X:ZY2>THDF1X
M5$>=*$MJ94FOLGM_(-D:T1W38#"(/19@!; @^*93[($O:<C  ^+ZXD1L1U2<
M#'"WV+06F_:*_?"LC4I94L%_P'"G!)PS.%]/76+3E@PR;%>V(RK%6=PM=EB+
M'?:*G6MVQ?+">X"W<=/32%E-FOV:G3ZJ!8Y^IM-'K4K'>)"^V(YV$$G(L'LW
M<'1TY.B5.[TB; I)2/I2;4<4'F79&;F-%PA^Y5ZO"$_J%@^REW([HDAZQD7P
MT=)QOZ=_5<556?QWH^.CI^-?U-3QT=7Q3]EZA3XUP8B\W)!V%!EEYS;DZ.OX
MM8T=MST[::MM!Q%,SO@Z/AH[?FUGKPB;K\-1VFKV=A!)&SD=U(:->YZ[9/].
M]0.7!@FV 5AT/81L]>'>>IA85?BKWU)9N$CZX1;N^DR[ 'B^4<H^3]QMLO[W
M,/T74$L#!!0    ( *4\!E/3GE,:$P,  ) *   9    >&PO=V]R:W-H965T
M<R]S:&5E=#,Y+GAM;,U66V_:,!C]*U;4AU9J&^<*5(#$;5JG54)EW1ZF/;B)
M(583.[,=:/?K9SLAA9 BM/6A+V [YYSOZN3K;QA_$@G&$CQG*14#*Y$RO[%M
M$24X0^*:Y9BJ)TO&,R35EJ]LD7.,8D/*4MN%,+0S1*@U[)NS.1_V62%30O&<
M U%D&>(O8YRRS<!RK.W!/5DE4A_8PWZ.5GB!Y4,^YVIGURHQR3 5A%' \7)@
MC9R;F0,UP2"^$[P1.VN@0WED[$EO;N.!!;5'.,61U!)(_:WQ!*>I5E)^_*Y$
MK=JF)NZNM^J?3/ JF$<D\(2E/T@LDX'5M4",EZA(Y3W;?,950('6BU@JS"_8
M5%AH@:@0DF4567F0$5K^H^<J$3L$I=-.<"N"VR3X;Q"\BN"=:L&O"/ZI%H**
M8$*WR]A-XJ9(HF&?LPW@&JW4],)DW[!5O@C5C;*07#TEBB>'BP1Q?*53'8,Y
M>E$M( 6X HNR;P!;@H5DT5.%F+!,=:A IL:S9[W&X'R*)2*IN%"\A\44G)]=
M@#- */B6L$(@&HN^+96KVJ =56Z-2[?<-]SRP!VC,A%@1F,<M_"GQ_GA$;ZM
M4E3GR=WF:>P>%?Q2T&O@P4O@0M=I\6=R.AVVA?-_UF?_;'TO&5[=-)[1\TYO
M&C#B'-$5UNO+;6O$0%4?3%!.)$K)'QQ?@E'&"H7^^55)@EN),_'KB$-^[9!O
M'/)/<"BONKBMZ4J5T*CH5^AZZ 9AT+?7NY5L _GA/FAZ" I@Z.^#9H<@O]=U
M:]!>J$$=:G \5'T= <OU%11'4A?6>N''J&6G=JCS+K4L58*=Y#K=9@4F+:!.
M!S9J>0CR>FZW4<L64 !A>RV[=:C=HZ'>8R$YB:2*5.BH04%),]@]X5XMW/L8
M177@ZW<&ODM9*YG=2].!3J.L;:!.\XJV@!S':Z!F;2C_X)+:.U_8#/.5&6T$
MB'2NRO=F?5J/3R,S-#3.Q\[-Q&DYG^IQRWS17^7+6>T.\16A J1XJ4S!ZX[J
M05Z./^5&LMQ\WQ^95-."629J9,1< ]3S)6-RN]$&ZB%T^!=02P,$%     @
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M-C/!B@Q$\IW&>M$+V@&(R0QGB7X6R\^DV%#3\DU%HMPO6.9S6YT 3#.E!2O
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M_H.ZB?4<L*RDXD4#U@H*RC9/_- DH@. P2L U #0L0"_ ?C' H(&$!P+"!N
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M2955$',83Q[AQ@:;ZC6<CU$3RM2%L1GC'*4T.,<!CYP:Z+DQ=[N/DS&<GUW
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M0"BM@=F?"Z&W$WM _:@:_ %02P,$%     @ I3P&4^U(D3#L @  \@@  !D
M  !X;"]W;W)K<VAE971S+W-H965T-#4N>&ULI591;]HP$/XK5M2'5AHD! A0
M 5*AG;9)G5#1UF>3',1J8F>V@?;?[^P$%RA$K.,![,O==]]]/GP9;H5\42F
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MFI:I]0Q9T"376]+WGB+0;=2/^XWG2"Y4 HIH79='T719+B_>!XQBQSWK-#'
MS,>)&6@X3TQ RX$"CZ0DM)+Y/OY'"5;U%"&!>H(!&_68<B"I>*IXQDE>DZEZ
MG3YC_90 $HJ7-*&2$K,JA)V-O5W-!LAUB*9MA@8=14..3IE!#3/HY<HL[NF"
MBPL-G5=H79BJGS (VAN#&6@J- /0@P'JV25@(S6A]^K:I0IYCG@Q07O4BPG:
M(U^,7JWZ!39J&=KE\MF$Z;Y]P7(<)'UL(-U79$[\H$VZ =I'N@':1[K)JYWT
M1F!#N\+N.\U>6#A660PH1P/*)!W-L(YV-,/ZQ"-LA#:T*^W7D8]5$@/ZT83J
M"$BCJXZ"''!U2E8CM:%=:[]$4R>#A)_?R^'YO6R ]O6R =K7RR:O]EYN]#JT
M"_9.+[^X9(?#FGT8LAB&1%;(*3V-;H=3>REBSG$FA>VE6J/)D?LJ3P&H$:[(
M+ER+B%J)DO6:K*1N$+S'/!9#-8^Z<M'WP["U;@94>]V&(9$5<CKQ1I<BNRY]
MDFSU155N4;8V*AMIANRO 5]L\1IM@^S:YO+%,YS]+@K]]L;R8 !VUF\0$EDA
MIW-O) :R2XR/1*CC<*4)+\G-]:MV&ZW-48R"UUG(YCQ#]O/L\H7L;OS^U/?"
M:7L=N[C..@Y"(BNDG+IS]#TF)7Q3? @3BK \D^4;]7JT_MCVOOC$U!J_A[</
MT#"^@+=1^2FM<5]^V?N ^8:J(R@A:Q7*O0E5GKS\6%;>2+8KO@8MF90L+2ZW
M!"OII 'J]S5C\G"C ]2?+.?_ U!+ P04    " "E/ 93X!O45,X$  !J%P
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MYD9(QW:Q0P_PWU@E'K;*ZMD?I+ZQ&&R?%?6-*>'A[Z)W4N_TVM]='QI"D'Y
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M<3!2>(V\O"GJ?F.NJZ:)KNIJ$^D_MZOVJXG2BVI;MGII-N2=;MINXM']N!M
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M4M>=P/S]JJK:AS?= (>?M;CX/U!+ P04    " "E/ 93X +)T2@)   G.
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MUK,7MSYRAMA-"C'4)SR3XE+?UTU75+>CZ?'/GPP>7'1ZU?Z+:$SN&I-#8_)
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M<FMS:&5E=',O<VAE970U-"YX;6RU5=]/VS 0_E>LB >06).FM%#45H)TTY@
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M /-^*X1^FMA;3G&K7?P'4$L#!!0    ( *4\!E-3,(L6% ,  ) (   9
M>&PO=V]R:W-H965T<R]S:&5E=#4V+GAM;+56WV_:,!#^5TY1)[52UX1 @5:
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M1E54,T;#5YA62J%(GF'!#,*"ZP?XP91BM@[@<(:&\5P?D>'=[0P.#X[@ +B
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M[&>U^X!50 -G;Z6$\;^PJ_9& :RVQJJB A.#@LORG]U50AP DO@90%(!DL>
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MRD @'=M<B11XL='J%MV" :M@B9!RLU&&2*FL2?[2S]#[<1WN=AI'O;-Q>-O
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M<Y;3\E(53%HD4SJGQD[U+"P+S6A:@E,NPDZK%8<YY9(,^W*1W^2F#*9J(<V
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M:%0*CMQC)8QQ8K3^-8+)#^Q^ %!+ P04    " "E/ 93W7=639X$  "Y*
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MORR_=LYNP@7G!+\3/?X%4$L#!!0    ( *4\!E/63,"2X $  .,C   3
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M[;EZ!U!+ 0(4 Q0    ( *4\!E,'04UB@0   +$    0              "
M 0    !D;V-0<F]P<R]A<' N>&UL4$L! A0#%     @ I3P&4Q![ZWGN
M*P(  !$              ( !KP   &1O8U!R;W!S+V-O<F4N>&UL4$L! A0#
M%     @ I3P&4YE<G",0!@  G"<  !,              ( !S $  'AL+W1H
M96UE+W1H96UE,2YX;6Q02P$"% ,4    " "E/ 93QQ<RWA@%  #$%   &
M            @($-"   >&PO=V]R:W-H965T<R]S:&5E=#$N>&UL4$L! A0#
M%     @ I3P&4\\U?K2#!P  G1X  !@              ("!6PT  'AL+W=O
M<FMS:&5E=',O<VAE970R+GAM;%!+ 0(4 Q0    ( *4\!E,@PNKV(P(  )4$
M   8              " @105  !X;"]W;W)K<VAE971S+W-H965T,RYX;6Q0
M2P$"% ,4    " "E/ 93MM3_H18)  !,*P  &               @(%M%P
M>&PO=V]R:W-H965T<R]S:&5E=#0N>&UL4$L! A0#%     @ I3P&4QX@;UD(
M"@  $S<  !@              ("!N2   'AL+W=O<FMS:&5E=',O<VAE970U
M+GAM;%!+ 0(4 Q0    ( *4\!E..TLNI*0@  . B   8              "
M@?<J  !X;"]W;W)K<VAE971S+W-H965T-BYX;6Q02P$"% ,4    " "E/ 93
MHQN(GO +  !%(0  &               @(%6,P  >&PO=V]R:W-H965T<R]S
M:&5E=#<N>&UL4$L! A0#%     @ I3P&4TCB5C8K P  # <  !@
M     ("!?#\  'AL+W=O<FMS:&5E=',O<VAE970X+GAM;%!+ 0(4 Q0    (
M *4\!E/-4:80O L  -,@   8              " @=U"  !X;"]W;W)K<VAE
M971S+W-H965T.2YX;6Q02P$"% ,4    " "E/ 93;G=GVO8$  "9#   &0
M            @('/3@  >&PO=V]R:W-H965T<R]S:&5E=#$P+GAM;%!+ 0(4
M Q0    ( *4\!E.79>,0R0X  *DM   9              " @?Q3  !X;"]W
M;W)K<VAE971S+W-H965T,3$N>&UL4$L! A0#%     @ I3P&4X)GW2+Y!P
MIQ<  !D              ("!_&(  'AL+W=O<FMS:&5E=',O<VAE970Q,BYX
M;6Q02P$"% ,4    " "E/ 932/@?6M<%  #8$0  &0              @($L
M:P  >&PO=V]R:W-H965T<R]S:&5E=#$S+GAM;%!+ 0(4 Q0    ( *4\!E,U
MPOE:-Q   ,@Y   9              " @3IQ  !X;"]W;W)K<VAE971S+W-H
M965T,30N>&UL4$L! A0#%     @ I3P&4TZW);=Q"0  8AH  !D
M     ("!J($  'AL+W=O<FMS:&5E=',O<VAE970Q-2YX;6Q02P$"% ,4
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M+GAM;%!+ 0(4 Q0    ( *4\!E,O6/G2EP(  %0%   9              "
M@8:J  !X;"]W;W)K<VAE971S+W-H965T,C N>&UL4$L! A0#%     @ I3P&
M4ZS?:2DO!0  -PP  !D              ("!5*T  'AL+W=O<FMS:&5E=',O
M<VAE970R,2YX;6Q02P$"% ,4    " "E/ 93#NI$T <%  "2#   &0
M        @(&ZL@  >&PO=V]R:W-H965T<R]S:&5E=#(R+GAM;%!+ 0(4 Q0
M   ( *4\!E/$*$^I6P@  #H7   9              " @?BW  !X;"]W;W)K
M<VAE971S+W-H965T,C,N>&UL4$L! A0#%     @ I3P&4S>YN,FS!@  %A0
M !D              ("!BL   'AL+W=O<FMS:&5E=',O<VAE970R-"YX;6Q0
M2P$"% ,4    " "E/ 93].Z2]!4&  "B$@  &0              @(%TQP
M>&PO=V]R:W-H965T<R]S:&5E=#(U+GAM;%!+ 0(4 Q0    ( *4\!E.HY8G;
MY@L  &HI   9              " @<#-  !X;"]W;W)K<VAE971S+W-H965T
M,C8N>&UL4$L! A0#%     @ I3P&4[YP=H1  P  < <  !D
M ("!W=D  'AL+W=O<FMS:&5E=',O<VAE970R-RYX;6Q02P$"% ,4    " "E
M/ 93N([4)KX"   8!@  &0              @(%4W0  >&PO=V]R:W-H965T
M<R]S:&5E=#(X+GAM;%!+ 0(4 Q0    ( *4\!E-JVBV[[ 4  -T7   9
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M970S,RYX;6Q02P$"% ,4    " "E/ 93(D;_!)4&  !O(   &0
M    @(%'^   >&PO=V]R:W-H965T<R]S:&5E=#,T+GAM;%!+ 0(4 Q0    (
M *4\!E.%@ V6BP0  !(4   9              " @1/_  !X;"]W;W)K<VAE
M971S+W-H965T,S4N>&UL4$L! A0#%     @ I3P&4Q5R(1/=!0  31P  !D
M             ("!U0,! 'AL+W=O<FMS:&5E=',O<VAE970S-BYX;6Q02P$"
M% ,4    " "E/ 93?Y?Z1SD&  "I*P  &0              @('I"0$ >&PO
M=V]R:W-H965T<R]S:&5E=#,W+GAM;%!+ 0(4 Q0    ( *4\!E/?QR%P;0,
M $D,   9              " @5D0 0!X;"]W;W)K<VAE971S+W-H965T,S@N
M>&UL4$L! A0#%     @ I3P&4].>4QH3 P  D H  !D              ("!
M_1,! 'AL+W=O<FMS:&5E=',O<VAE970S.2YX;6Q02P$"% ,4    " "E/ 93
MK!C#$!@#  !>#@  &0              @(%'%P$ >&PO=V]R:W-H965T<R]S
M:&5E=#0P+GAM;%!+ 0(4 Q0    ( *4\!E-IA-+?<00  !\2   9
M      " @98: 0!X;"]W;W)K<VAE971S+W-H965T-#$N>&UL4$L! A0#%
M  @ I3P&4UA_[X_U @  \PH  !D              ("!/A\! 'AL+W=O<FMS
M:&5E=',O<VAE970T,BYX;6Q02P$"% ,4    " "E/ 93[=&6L8(#  !@"P
M&0              @(%J(@$ >&PO=V]R:W-H965T<R]S:&5E=#0S+GAM;%!+
M 0(4 Q0    ( *4\!E/Z@WT,(P,  & )   9              " @2,F 0!X
M;"]W;W)K<VAE971S+W-H965T-#0N>&UL4$L! A0#%     @ I3P&4^U(D3#L
M @  \@@  !D              ("!?2D! 'AL+W=O<FMS:&5E=',O<VAE970T
M-2YX;6Q02P$"% ,4    " "E/ 93\?&JOE<"   O!@  &0
M@(&@+ $ >&PO=V]R:W-H965T<R]S:&5E=#0V+GAM;%!+ 0(4 Q0    ( *4\
M!E->3JF7M 4  +X<   9              " @2XO 0!X;"]W;W)K<VAE971S
M+W-H965T-#<N>&UL4$L! A0#%     @ I3P&4^ ;U%3.!   :A<  !D
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M=#4R+GAM;%!+ 0(4 Q0    ( *4\!E-[RO;+R0(  !P)   9
M  " @2=7 0!X;"]W;W)K<VAE971S+W-H965T-3,N>&UL4$L! A0#%     @
MI3P&4X\<GG[6 @  >@<  !D              ("!)UH! 'AL+W=O<FMS:&5E
M=',O<VAE970U-"YX;6Q02P$"% ,4    " "E/ 93;N!0B&\#  #A#@  &0
M            @($T70$ >&PO=V]R:W-H965T<R]S:&5E=#4U+GAM;%!+ 0(4
M Q0    ( *4\!E-3,(L6% ,  ) (   9              " @=I@ 0!X;"]W
M;W)K<VAE971S+W-H965T-38N>&UL4$L! A0#%     @ I3P&4Z_;CP** @
MO 8  !D              ("!)60! 'AL+W=O<FMS:&5E=',O<VAE970U-RYX
M;6Q02P$"% ,4    " "E/ 93M?MI07D"  #W!@  &0              @('F
M9@$ >&PO=V]R:W-H965T<R]S:&5E=#4X+GAM;%!+ 0(4 Q0    ( *4\!E/C
M;#HWXP(  "$(   9              " @99I 0!X;"]W;W)K<VAE971S+W-H
M965T-3DN>&UL4$L! A0#%     @ I3P&4QKHP*O# P  V0T  !D
M     ("!L&P! 'AL+W=O<FMS:&5E=',O<VAE970V,"YX;6Q02P$"% ,4
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M+W=O<FMB;V]K+GAM;%!+ 0(4 Q0    ( *4\!E/U29+, 0(  %XD   :
M          "  61] 0!X;"]?<F5L<R]W;W)K8F]O:RYX;6PN<F5L<U!+ 0(4
M Q0    ( *4\!E/63,"2X $  .,C   3              "  9U_ 0!;0V]N
E=&5N=%]4>7!E<UTN>&UL4$L%!@    !% $4 VA(  *Z! 0    $!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>77
<FILENAME>Show.js
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
// Edgar(tm) Renderer was created by staff of the U.S. Securities and Exchange Commission.  Data and content created by government employees within the scope of their employment are not subject to domestic copyright protection. 17 U.S.C. 105.
var Show={};Show.LastAR=null,Show.showAR=function(a,r,w){if(Show.LastAR)Show.hideAR();var e=a;while(e&&e.nodeName!='TABLE')e=e.nextSibling;if(!e||e.nodeName!='TABLE'){var ref=((window)?w.document:document).getElementById(r);if(ref){e=ref.cloneNode(!0);
e.removeAttribute('id');a.parentNode.appendChild(e)}}
if(e)e.style.display='block';Show.LastAR=e};Show.hideAR=function(){Show.LastAR.style.display='none'};Show.toggleNext=function(a){var e=a;while(e.nodeName!='DIV')e=e.nextSibling;if(!e.style){}else if(!e.style.display){}else{var d,p_;if(e.style.display=='none'){d='block';p='-'}else{d='none';p='+'}
e.style.display=d;if(a.textContent){a.textContent=p+a.textContent.substring(1)}else{a.innerText=p+a.innerText.substring(1)}}}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>78
<FILENAME>report.css
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
/* Updated 2009-11-04 */
/* v2.2.0.24 */

/* DefRef Styles */
..report table.authRefData{
	background-color: #def;
	border: 2px solid #2F4497;
	font-size: 1em;
	position: absolute;
}

..report table.authRefData a {
	display: block;
	font-weight: bold;
}

..report table.authRefData p {
	margin-top: 0px;
}

..report table.authRefData .hide {
	background-color: #2F4497;
	padding: 1px 3px 0px 0px;
	text-align: right;
}

..report table.authRefData .hide a:hover {
	background-color: #2F4497;
}

..report table.authRefData .body {
	height: 150px;
	overflow: auto;
	width: 400px;
}

..report table.authRefData table{
	font-size: 1em;
}

/* Report Styles */
..pl a, .pl a:visited {
	color: black;
	text-decoration: none;
}

/* table */
..report {
	background-color: white;
	border: 2px solid #acf;
	clear: both;
	color: black;
	font: normal 8pt Helvetica, Arial, san-serif;
	margin-bottom: 2em;
}

..report hr {
	border: 1px solid #acf;
}

/* Top labels */
..report th {
	background-color: #acf;
	color: black;
	font-weight: bold;
	text-align: center;
}

..report th.void	{
	background-color: transparent;
	color: #000000;
	font: bold 10pt Helvetica, Arial, san-serif;
	text-align: left;
}

..report .pl {
	text-align: left;
	vertical-align: top;
	white-space: normal;
	width: 200px;
	white-space: normal; /* word-wrap: break-word; */
}

..report td.pl a.a {
	cursor: pointer;
	display: block;
	width: 200px;
	overflow: hidden;
}

..report td.pl div.a {
	width: 200px;
}

..report td.pl a:hover {
	background-color: #ffc;
}

/* Header rows... */
..report tr.rh {
	background-color: #acf;
	color: black;
	font-weight: bold;
}

/* Calendars... */
..report .rc {
	background-color: #f0f0f0;
}

/* Even rows... */
..report .re, .report .reu {
	background-color: #def;
}

..report .reu td {
	border-bottom: 1px solid black;
}

/* Odd rows... */
..report .ro, .report .rou {
	background-color: white;
}

..report .rou td {
	border-bottom: 1px solid black;
}

..report .rou table td, .report .reu table td {
	border-bottom: 0px solid black;
}

/* styles for footnote marker */
..report .fn {
	white-space: nowrap;
}

/* styles for numeric types */
..report .num, .report .nump {
	text-align: right;
	white-space: nowrap;
}

..report .nump {
	padding-left: 2em;
}

..report .nump {
	padding: 0px 0.4em 0px 2em;
}

/* styles for text types */
..report .text {
	text-align: left;
	white-space: normal;
}

..report .text .big {
	margin-bottom: 1em;
	width: 17em;
}

..report .text .more {
	display: none;
}

..report .text .note {
	font-style: italic;
	font-weight: bold;
}

..report .text .small {
	width: 10em;
}

..report sup {
	font-style: italic;
}

..report .outerFootnotes {
	font-size: 1em;
}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>79
<FILENAME>FilingSummary.xml
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<XML>
<?xml version='1.0' encoding='utf-8'?>
<FilingSummary>
  <Version>3.21.2</Version>
  <ProcessingTime/>
  <ReportFormat>html</ReportFormat>
  <ContextCount>415</ContextCount>
  <ElementCount>348</ElementCount>
  <EntityCount>1</EntityCount>
  <FootnotesReported>true</FootnotesReported>
  <SegmentCount>95</SegmentCount>
  <ScenarioCount>0</ScenarioCount>
  <TuplesReported>false</TuplesReported>
  <UnitCount>15</UnitCount>
  <MyReports>
    <Report instance="cron-20210630.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R1.htm</HtmlFileName>
      <LongName>0001001 - Document - Cover Page</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://thecronosgroup.com/role/CoverPage</Role>
      <ShortName>Cover Page</ShortName>
      <MenuCategory>Cover</MenuCategory>
      <Position>1</Position>
    </Report>
    <Report instance="cron-20210630.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R2.htm</HtmlFileName>
      <LongName>1001002 - Statement - Condensed Consolidated Balance Sheets</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://thecronosgroup.com/role/CondensedConsolidatedBalanceSheets</Role>
      <ShortName>Condensed Consolidated Balance Sheets</ShortName>
      <MenuCategory>Statements</MenuCategory>
      <Position>2</Position>
    </Report>
    <Report instance="cron-20210630.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R3.htm</HtmlFileName>
      <LongName>1002003 - Statement - Condensed Consolidated Balance Sheet (Parenthetical)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://thecronosgroup.com/role/CondensedConsolidatedBalanceSheetParenthetical</Role>
      <ShortName>Condensed Consolidated Balance Sheet (Parenthetical)</ShortName>
      <MenuCategory>Statements</MenuCategory>
      <Position>3</Position>
    </Report>
    <Report instance="cron-20210630.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R4.htm</HtmlFileName>
      <LongName>1003004 - Statement - Condensed Consolidated Statements of Net Income (Loss) and Comprehensive Income (Loss)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://thecronosgroup.com/role/CondensedConsolidatedStatementsofNetIncomeLossandComprehensiveIncomeLoss</Role>
      <ShortName>Condensed Consolidated Statements of Net Income (Loss) and Comprehensive Income (Loss)</ShortName>
      <MenuCategory>Statements</MenuCategory>
      <Position>4</Position>
    </Report>
    <Report instance="cron-20210630.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R5.htm</HtmlFileName>
      <LongName>1004005 - Statement - Condensed Consolidated Statements of Changes in Equity</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://thecronosgroup.com/role/CondensedConsolidatedStatementsofChangesinEquity</Role>
      <ShortName>Condensed Consolidated Statements of Changes in Equity</ShortName>
      <MenuCategory>Statements</MenuCategory>
      <Position>5</Position>
    </Report>
    <Report instance="cron-20210630.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R6.htm</HtmlFileName>
      <LongName>1005006 - Statement - Condensed Consolidated Statements of Cash Flows</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://thecronosgroup.com/role/CondensedConsolidatedStatementsofCashFlows</Role>
      <ShortName>Condensed Consolidated Statements of Cash Flows</ShortName>
      <MenuCategory>Statements</MenuCategory>
      <Position>6</Position>
    </Report>
    <Report instance="cron-20210630.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R7.htm</HtmlFileName>
      <LongName>2101101 - Disclosure - Background, Basis of Presentation and Accounting Policies</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://thecronosgroup.com/role/BackgroundBasisofPresentationandAccountingPolicies</Role>
      <ShortName>Background, Basis of Presentation and Accounting Policies</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>7</Position>
    </Report>
    <Report instance="cron-20210630.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R8.htm</HtmlFileName>
      <LongName>2104102 - Disclosure - Inventory, net</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://thecronosgroup.com/role/Inventorynet</Role>
      <ShortName>Inventory, net</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>8</Position>
    </Report>
    <Report instance="cron-20210630.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R9.htm</HtmlFileName>
      <LongName>2107103 - Disclosure - Investments</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://thecronosgroup.com/role/Investments</Role>
      <ShortName>Investments</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>9</Position>
    </Report>
    <Report instance="cron-20210630.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R10.htm</HtmlFileName>
      <LongName>2112104 - Disclosure - Loans Receivable, net</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://thecronosgroup.com/role/LoansReceivablenet</Role>
      <ShortName>Loans Receivable, net</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>10</Position>
    </Report>
    <Report instance="cron-20210630.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R11.htm</HtmlFileName>
      <LongName>2115105 - Disclosure - Derivative Liabilities</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://thecronosgroup.com/role/DerivativeLiabilities</Role>
      <ShortName>Derivative Liabilities</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>11</Position>
    </Report>
    <Report instance="cron-20210630.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R12.htm</HtmlFileName>
      <LongName>2121106 - Disclosure - Share-based Payments</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://thecronosgroup.com/role/SharebasedPayments</Role>
      <ShortName>Share-based Payments</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>12</Position>
    </Report>
    <Report instance="cron-20210630.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R13.htm</HtmlFileName>
      <LongName>2131107 - Disclosure - Earnings (Loss) Per Share</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://thecronosgroup.com/role/EarningsLossPerShare</Role>
      <ShortName>Earnings (Loss) Per Share</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>13</Position>
    </Report>
    <Report instance="cron-20210630.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R14.htm</HtmlFileName>
      <LongName>2135108 - Disclosure - Segment Information</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://thecronosgroup.com/role/SegmentInformation</Role>
      <ShortName>Segment Information</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>14</Position>
    </Report>
    <Report instance="cron-20210630.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R15.htm</HtmlFileName>
      <LongName>2142109 - Disclosure - Commitments and Contingencies</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://thecronosgroup.com/role/CommitmentsandContingencies</Role>
      <ShortName>Commitments and Contingencies</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>15</Position>
    </Report>
    <Report instance="cron-20210630.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R16.htm</HtmlFileName>
      <LongName>2144110 - Disclosure - Financial Instruments</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://thecronosgroup.com/role/FinancialInstruments</Role>
      <ShortName>Financial Instruments</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>16</Position>
    </Report>
    <Report instance="cron-20210630.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R17.htm</HtmlFileName>
      <LongName>2151111 - Disclosure - Held-For-Sale Assets and Discontinued Operations</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://thecronosgroup.com/role/HeldForSaleAssetsandDiscontinuedOperations</Role>
      <ShortName>Held-For-Sale Assets and Discontinued Operations</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>17</Position>
    </Report>
    <Report instance="cron-20210630.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R18.htm</HtmlFileName>
      <LongName>2154112 - Disclosure - Impairment Loss on Long-Lived Assets</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://thecronosgroup.com/role/ImpairmentLossonLongLivedAssets</Role>
      <ShortName>Impairment Loss on Long-Lived Assets</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>18</Position>
    </Report>
    <Report instance="cron-20210630.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R19.htm</HtmlFileName>
      <LongName>2202201 - Disclosure - Background, Basis of Presentation and Accounting Policies (Policies)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://thecronosgroup.com/role/BackgroundBasisofPresentationandAccountingPoliciesPolicies</Role>
      <ShortName>Background, Basis of Presentation and Accounting Policies (Policies)</ShortName>
      <MenuCategory>Policies</MenuCategory>
      <ParentRole>http://thecronosgroup.com/role/BackgroundBasisofPresentationandAccountingPolicies</ParentRole>
      <Position>19</Position>
    </Report>
    <Report instance="cron-20210630.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R20.htm</HtmlFileName>
      <LongName>2305301 - Disclosure - Inventory, net (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://thecronosgroup.com/role/InventorynetTables</Role>
      <ShortName>Inventory, net (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://thecronosgroup.com/role/Inventorynet</ParentRole>
      <Position>20</Position>
    </Report>
    <Report instance="cron-20210630.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R21.htm</HtmlFileName>
      <LongName>2308302 - Disclosure - Investments (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://thecronosgroup.com/role/InvestmentsTables</Role>
      <ShortName>Investments (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://thecronosgroup.com/role/Investments</ParentRole>
      <Position>21</Position>
    </Report>
    <Report instance="cron-20210630.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R22.htm</HtmlFileName>
      <LongName>2313303 - Disclosure - Loans Receivable, net (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://thecronosgroup.com/role/LoansReceivablenetTables</Role>
      <ShortName>Loans Receivable, net (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://thecronosgroup.com/role/LoansReceivablenet</ParentRole>
      <Position>22</Position>
    </Report>
    <Report instance="cron-20210630.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R23.htm</HtmlFileName>
      <LongName>2316304 - Disclosure - Derivative Liabilities (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://thecronosgroup.com/role/DerivativeLiabilitiesTables</Role>
      <ShortName>Derivative Liabilities (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://thecronosgroup.com/role/DerivativeLiabilities</ParentRole>
      <Position>23</Position>
    </Report>
    <Report instance="cron-20210630.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R24.htm</HtmlFileName>
      <LongName>2322305 - Disclosure - Share-based Payments (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://thecronosgroup.com/role/SharebasedPaymentsTables</Role>
      <ShortName>Share-based Payments (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://thecronosgroup.com/role/SharebasedPayments</ParentRole>
      <Position>24</Position>
    </Report>
    <Report instance="cron-20210630.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R25.htm</HtmlFileName>
      <LongName>2332306 - Disclosure - Earnings (Loss) Per Share (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://thecronosgroup.com/role/EarningsLossPerShareTables</Role>
      <ShortName>Earnings (Loss) Per Share (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://thecronosgroup.com/role/EarningsLossPerShare</ParentRole>
      <Position>25</Position>
    </Report>
    <Report instance="cron-20210630.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R26.htm</HtmlFileName>
      <LongName>2336307 - Disclosure - Segment Information (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://thecronosgroup.com/role/SegmentInformationTables</Role>
      <ShortName>Segment Information (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://thecronosgroup.com/role/SegmentInformation</ParentRole>
      <Position>26</Position>
    </Report>
    <Report instance="cron-20210630.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R27.htm</HtmlFileName>
      <LongName>2345308 - Disclosure - Financial Instruments (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://thecronosgroup.com/role/FinancialInstrumentsTables</Role>
      <ShortName>Financial Instruments (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://thecronosgroup.com/role/FinancialInstruments</ParentRole>
      <Position>27</Position>
    </Report>
    <Report instance="cron-20210630.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R28.htm</HtmlFileName>
      <LongName>2352309 - Disclosure - Held-For-Sale Assets and Discontinued Operations (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://thecronosgroup.com/role/HeldForSaleAssetsandDiscontinuedOperationsTables</Role>
      <ShortName>Held-For-Sale Assets and Discontinued Operations (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://thecronosgroup.com/role/HeldForSaleAssetsandDiscontinuedOperations</ParentRole>
      <Position>28</Position>
    </Report>
    <Report instance="cron-20210630.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R29.htm</HtmlFileName>
      <LongName>2403401 - Disclosure - Background, Basis of Presentation and Accounting Policies (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://thecronosgroup.com/role/BackgroundBasisofPresentationandAccountingPoliciesDetails</Role>
      <ShortName>Background, Basis of Presentation and Accounting Policies (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://thecronosgroup.com/role/BackgroundBasisofPresentationandAccountingPoliciesPolicies</ParentRole>
      <Position>29</Position>
    </Report>
    <Report instance="cron-20210630.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R30.htm</HtmlFileName>
      <LongName>2406402 - Disclosure - Inventory, net (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://thecronosgroup.com/role/InventorynetDetails</Role>
      <ShortName>Inventory, net (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://thecronosgroup.com/role/InventorynetTables</ParentRole>
      <Position>30</Position>
    </Report>
    <Report instance="cron-20210630.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R31.htm</HtmlFileName>
      <LongName>2409403 - Disclosure - Investments - Narrative (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://thecronosgroup.com/role/InvestmentsNarrativeDetails</Role>
      <ShortName>Investments - Narrative (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>31</Position>
    </Report>
    <Report instance="cron-20210630.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R32.htm</HtmlFileName>
      <LongName>2410404 - Disclosure - Investments - Schedule of Investments in Associates and Joint Ventures (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://thecronosgroup.com/role/InvestmentsScheduleofInvestmentsinAssociatesandJointVenturesDetails</Role>
      <ShortName>Investments - Schedule of Investments in Associates and Joint Ventures (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>32</Position>
    </Report>
    <Report instance="cron-20210630.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R33.htm</HtmlFileName>
      <LongName>2411405 - Disclosure - Investments - Schedule of Variable Interest Entities (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://thecronosgroup.com/role/InvestmentsScheduleofVariableInterestEntitiesDetails</Role>
      <ShortName>Investments - Schedule of Variable Interest Entities (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>33</Position>
    </Report>
    <Report instance="cron-20210630.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R34.htm</HtmlFileName>
      <LongName>2414406 - Disclosure - Loans Receivable, net (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://thecronosgroup.com/role/LoansReceivablenetDetails</Role>
      <ShortName>Loans Receivable, net (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://thecronosgroup.com/role/LoansReceivablenetTables</ParentRole>
      <Position>34</Position>
    </Report>
    <Report instance="cron-20210630.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R35.htm</HtmlFileName>
      <LongName>2417407 - Disclosure - Derivative Liabilities - Narrative (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://thecronosgroup.com/role/DerivativeLiabilitiesNarrativeDetails</Role>
      <ShortName>Derivative Liabilities - Narrative (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>35</Position>
    </Report>
    <Report instance="cron-20210630.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R36.htm</HtmlFileName>
      <LongName>2418408 - Disclosure - Derivative Liabilities - Schedule of Reconciliation of Carrying Amounts (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://thecronosgroup.com/role/DerivativeLiabilitiesScheduleofReconciliationofCarryingAmountsDetails</Role>
      <ShortName>Derivative Liabilities - Schedule of Reconciliation of Carrying Amounts (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>36</Position>
    </Report>
    <Report instance="cron-20210630.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R37.htm</HtmlFileName>
      <LongName>2419409 - Disclosure - Derivative Liabilities - Schedule of Fair Values of Derivative Liabilities (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://thecronosgroup.com/role/DerivativeLiabilitiesScheduleofFairValuesofDerivativeLiabilitiesDetails</Role>
      <ShortName>Derivative Liabilities - Schedule of Fair Values of Derivative Liabilities (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>37</Position>
    </Report>
    <Report instance="cron-20210630.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R38.htm</HtmlFileName>
      <LongName>2420410 - Disclosure - Derivative Liabilities - Schedule of Sensitivity Analysis (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://thecronosgroup.com/role/DerivativeLiabilitiesScheduleofSensitivityAnalysisDetails</Role>
      <ShortName>Derivative Liabilities - Schedule of Sensitivity Analysis (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>38</Position>
    </Report>
    <Report instance="cron-20210630.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R39.htm</HtmlFileName>
      <LongName>2423411 - Disclosure - Share-based Payments - Summary of Stock-based Compensation Expense (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://thecronosgroup.com/role/SharebasedPaymentsSummaryofStockbasedCompensationExpenseDetails</Role>
      <ShortName>Share-based Payments - Summary of Stock-based Compensation Expense (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>39</Position>
    </Report>
    <Report instance="cron-20210630.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R40.htm</HtmlFileName>
      <LongName>2424412 - Disclosure - Share-based Payments - Stock Options Narrative (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://thecronosgroup.com/role/SharebasedPaymentsStockOptionsNarrativeDetails</Role>
      <ShortName>Share-based Payments - Stock Options Narrative (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>40</Position>
    </Report>
    <Report instance="cron-20210630.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R41.htm</HtmlFileName>
      <LongName>2425413 - Disclosure - Share-based Payments - Summary of the Changes in Options (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://thecronosgroup.com/role/SharebasedPaymentsSummaryoftheChangesinOptionsDetails</Role>
      <ShortName>Share-based Payments - Summary of the Changes in Options (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>41</Position>
    </Report>
    <Report instance="cron-20210630.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R42.htm</HtmlFileName>
      <LongName>2426414 - Disclosure - Share-based Payments - Schedule of Stock Options Outstanding (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://thecronosgroup.com/role/SharebasedPaymentsScheduleofStockOptionsOutstandingDetails</Role>
      <ShortName>Share-based Payments - Schedule of Stock Options Outstanding (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>42</Position>
    </Report>
    <Report instance="cron-20210630.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R43.htm</HtmlFileName>
      <LongName>2427415 - Disclosure - Share-based Payments - Summary of Changes in RSUs (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://thecronosgroup.com/role/SharebasedPaymentsSummaryofChangesinRSUsDetails</Role>
      <ShortName>Share-based Payments - Summary of Changes in RSUs (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>43</Position>
    </Report>
    <Report instance="cron-20210630.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R44.htm</HtmlFileName>
      <LongName>2428416 - Disclosure - Share-based Payments - Summary of DSU Activity (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://thecronosgroup.com/role/SharebasedPaymentsSummaryofDSUActivityDetails</Role>
      <ShortName>Share-based Payments - Summary of DSU Activity (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>44</Position>
    </Report>
    <Report instance="cron-20210630.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R45.htm</HtmlFileName>
      <LongName>2429417 - Disclosure - Share-based Payments - Summary of Changes in Warrants (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://thecronosgroup.com/role/SharebasedPaymentsSummaryofChangesinWarrantsDetails</Role>
      <ShortName>Share-based Payments - Summary of Changes in Warrants (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>45</Position>
    </Report>
    <Report instance="cron-20210630.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R46.htm</HtmlFileName>
      <LongName>2430418 - Disclosure - Share-based Payments - Summary of Outstanding Warrants (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://thecronosgroup.com/role/SharebasedPaymentsSummaryofOutstandingWarrantsDetails</Role>
      <ShortName>Share-based Payments - Summary of Outstanding Warrants (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>46</Position>
    </Report>
    <Report instance="cron-20210630.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R47.htm</HtmlFileName>
      <LongName>2433419 - Disclosure - Earnings (Loss) Per Share - Schedule of Earnings (Loss) Per Share (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://thecronosgroup.com/role/EarningsLossPerShareScheduleofEarningsLossPerShareDetails</Role>
      <ShortName>Earnings (Loss) Per Share - Schedule of Earnings (Loss) Per Share (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://thecronosgroup.com/role/EarningsLossPerShareTables</ParentRole>
      <Position>47</Position>
    </Report>
    <Report instance="cron-20210630.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R48.htm</HtmlFileName>
      <LongName>2434420 - Disclosure - Earnings (Loss) Per Share - Schedule of Antidilutive Securities Excluded from Computation of Diluted Shares Outstanding (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://thecronosgroup.com/role/EarningsLossPerShareScheduleofAntidilutiveSecuritiesExcludedfromComputationofDilutedSharesOutstandingDetails</Role>
      <ShortName>Earnings (Loss) Per Share - Schedule of Antidilutive Securities Excluded from Computation of Diluted Shares Outstanding (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://thecronosgroup.com/role/EarningsLossPerShareTables</ParentRole>
      <Position>48</Position>
    </Report>
    <Report instance="cron-20210630.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R49.htm</HtmlFileName>
      <LongName>2437421 - Disclosure - Segment Information - Narrative (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://thecronosgroup.com/role/SegmentInformationNarrativeDetails</Role>
      <ShortName>Segment Information - Narrative (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>49</Position>
    </Report>
    <Report instance="cron-20210630.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R50.htm</HtmlFileName>
      <LongName>2438422 - Disclosure - Segment Information - Schedule of Segment Data (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://thecronosgroup.com/role/SegmentInformationScheduleofSegmentDataDetails</Role>
      <ShortName>Segment Information - Schedule of Segment Data (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>50</Position>
    </Report>
    <Report instance="cron-20210630.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R51.htm</HtmlFileName>
      <LongName>2439423 - Disclosure - Segment Information - Schedule of Adjusted EBITDA (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://thecronosgroup.com/role/SegmentInformationScheduleofAdjustedEBITDADetails</Role>
      <ShortName>Segment Information - Schedule of Adjusted EBITDA (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>51</Position>
    </Report>
    <Report instance="cron-20210630.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R52.htm</HtmlFileName>
      <LongName>2440424 - Disclosure - Segment Information - Schedule of Revenue from External Customers by Geographic Areas (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://thecronosgroup.com/role/SegmentInformationScheduleofRevenuefromExternalCustomersbyGeographicAreasDetails</Role>
      <ShortName>Segment Information - Schedule of Revenue from External Customers by Geographic Areas (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>52</Position>
    </Report>
    <Report instance="cron-20210630.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R53.htm</HtmlFileName>
      <LongName>2441425 - Disclosure - Segment Information - Schedule of Long-lived Assets by Geographic Areas (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://thecronosgroup.com/role/SegmentInformationScheduleofLonglivedAssetsbyGeographicAreasDetails</Role>
      <ShortName>Segment Information - Schedule of Long-lived Assets by Geographic Areas (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>53</Position>
    </Report>
    <Report instance="cron-20210630.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R54.htm</HtmlFileName>
      <LongName>2443426 - Disclosure - Commitments and Contingencies (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://thecronosgroup.com/role/CommitmentsandContingenciesDetails</Role>
      <ShortName>Commitments and Contingencies (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://thecronosgroup.com/role/CommitmentsandContingencies</ParentRole>
      <Position>54</Position>
    </Report>
    <Report instance="cron-20210630.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R55.htm</HtmlFileName>
      <LongName>2446427 - Disclosure - Financial Instruments - Schedule of Fair Value of Assets Measured on Recurring Basis (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://thecronosgroup.com/role/FinancialInstrumentsScheduleofFairValueofAssetsMeasuredonRecurringBasisDetails</Role>
      <ShortName>Financial Instruments - Schedule of Fair Value of Assets Measured on Recurring Basis (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>55</Position>
    </Report>
    <Report instance="cron-20210630.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R56.htm</HtmlFileName>
      <LongName>2447428 - Disclosure - Financial Instruments - Credit Risk Narrative (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://thecronosgroup.com/role/FinancialInstrumentsCreditRiskNarrativeDetails</Role>
      <ShortName>Financial Instruments - Credit Risk Narrative (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>56</Position>
    </Report>
    <Report instance="cron-20210630.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R57.htm</HtmlFileName>
      <LongName>2448429 - Disclosure - Financial Instruments - Interest Rate Risk Narrative (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://thecronosgroup.com/role/FinancialInstrumentsInterestRateRiskNarrativeDetails</Role>
      <ShortName>Financial Instruments - Interest Rate Risk Narrative (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>57</Position>
    </Report>
    <Report instance="cron-20210630.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R58.htm</HtmlFileName>
      <LongName>2449430 - Disclosure - Financial Instruments - Liquidity Risk Narrative (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://thecronosgroup.com/role/FinancialInstrumentsLiquidityRiskNarrativeDetails</Role>
      <ShortName>Financial Instruments - Liquidity Risk Narrative (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>58</Position>
    </Report>
    <Report instance="cron-20210630.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R59.htm</HtmlFileName>
      <LongName>2450431 - Disclosure - Financial Instruments - Currency Rate Risk Narrative (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://thecronosgroup.com/role/FinancialInstrumentsCurrencyRateRiskNarrativeDetails</Role>
      <ShortName>Financial Instruments - Currency Rate Risk Narrative (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>59</Position>
    </Report>
    <Report instance="cron-20210630.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R60.htm</HtmlFileName>
      <LongName>2453432 - Disclosure - Held-For-Sale Assets and Discontinued Operations (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://thecronosgroup.com/role/HeldForSaleAssetsandDiscontinuedOperationsDetails</Role>
      <ShortName>Held-For-Sale Assets and Discontinued Operations (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://thecronosgroup.com/role/HeldForSaleAssetsandDiscontinuedOperationsTables</ParentRole>
      <Position>60</Position>
    </Report>
    <Report instance="cron-20210630.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R61.htm</HtmlFileName>
      <LongName>2455433 - Disclosure - Impairment Loss on Long-Lived Assets (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://thecronosgroup.com/role/ImpairmentLossonLongLivedAssetsDetails</Role>
      <ShortName>Impairment Loss on Long-Lived Assets (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://thecronosgroup.com/role/ImpairmentLossonLongLivedAssets</ParentRole>
      <Position>61</Position>
    </Report>
    <Report>
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <LongName>All Reports</LongName>
      <ReportType>Book</ReportType>
      <ShortName>All Reports</ShortName>
    </Report>
  </MyReports>
  <InputFiles>
    <File doctype="10-Q" original="cron-20210630.htm">cron-20210630.htm</File>
    <File>a10-qq22021102.htm</File>
    <File>a10-qq22021311.htm</File>
    <File>a10-qq22021312.htm</File>
    <File>a10-qq22021321.htm</File>
    <File>a10-qq22021322.htm</File>
    <File>cron-20210630.xsd</File>
    <File>cron-20210630_cal.xml</File>
    <File>cron-20210630_def.xml</File>
    <File>cron-20210630_lab.xml</File>
    <File>cron-20210630_pre.xml</File>
    <File>ex103robertmadoreemploymen.htm</File>
    <File>ex104jerrybarbato.htm</File>
  </InputFiles>
  <SupplementalFiles/>
  <BaseTaxonomies>
    <BaseTaxonomy>http://fasb.org/us-gaap/2021-01-31</BaseTaxonomy>
    <BaseTaxonomy>http://xbrl.sec.gov/country/2021</BaseTaxonomy>
    <BaseTaxonomy>http://xbrl.sec.gov/dei/2021</BaseTaxonomy>
    <BaseTaxonomy>http://fasb.org/srt/2021-01-31</BaseTaxonomy>
  </BaseTaxonomies>
  <HasPresentationLinkbase>true</HasPresentationLinkbase>
  <HasCalculationLinkbase>true</HasCalculationLinkbase>
</FilingSummary>
</XML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>JSON
<SEQUENCE>82
<FILENAME>MetaLinks.json
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
{
 "instance": {
  "cron-20210630.htm": {
   "axisCustom": 1,
   "axisStandard": 32,
   "contextCount": 415,
   "dts": {
    "calculationLink": {
     "local": [
      "cron-20210630_cal.xml"
     ]
    },
    "definitionLink": {
     "local": [
      "cron-20210630_def.xml"
     ]
    },
    "inline": {
     "local": [
      "cron-20210630.htm"
     ]
    },
    "labelLink": {
     "local": [
      "cron-20210630_lab.xml"
     ],
     "remote": [
      "https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-doc-2021-01-31.xml"
     ]
    },
    "presentationLink": {
     "local": [
      "cron-20210630_pre.xml"
     ]
    },
    "referenceLink": {
     "remote": [
      "https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-ref-2021-01-31.xml"
     ]
    },
    "schema": {
     "local": [
      "cron-20210630.xsd"
     ],
     "remote": [
      "https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd",
      "http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xl-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xlink-2003-12-31.xsd",
      "https://www.xbrl.org/dtr/type/2020-01-21/types.xsd",
      "https://www.xbrl.org/2020/extensible-enumerations-2.0.xsd",
      "http://www.xbrl.org/2005/xbrldt-2005.xsd",
      "http://www.xbrl.org/2006/ref-2006-02-27.xsd",
      "https://xbrl.fasb.org/srt/2021/elts/srt-types-2021-01-31.xsd",
      "https://xbrl.sec.gov/country/2021/country-2021.xsd",
      "https://xbrl.fasb.org/srt/2021/elts/srt-roles-2021-01-31.xsd",
      "https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd",
      "https://xbrl.fasb.org/us-gaap/2021/elts/us-types-2021-01-31.xsd",
      "https://xbrl.fasb.org/us-gaap/2021/elts/us-roles-2021-01-31.xsd",
      "https://xbrl.sec.gov/dei/2021/dei-2021.xsd",
      "http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd",
      "http://www.xbrl.org/lrr/role/net-2009-12-16.xsd",
      "https://xbrl.sec.gov/dei/2021/dei-2021_doc.xsd",
      "http://www.xbrl.org/lrr/role/reference-2009-12-16.xsd",
      "https://xbrl.fasb.org/us-gaap/2021/elts/us-parts-codification-2021-01-31.xsd",
      "https://xbrl.sec.gov/dei/2021/dei-2021_ref.xsd"
     ]
    }
   },
   "elementCount": 516,
   "entityCount": 1,
   "hidden": {
    "http://fasb.org/us-gaap/2021-01-31": 2,
    "http://xbrl.sec.gov/dei/2021": 5,
    "total": 7
   },
   "keyCustom": 45,
   "keyStandard": 303,
   "memberCustom": 45,
   "memberStandard": 42,
   "nsprefix": "cron",
   "nsuri": "http://thecronosgroup.com/20210630",
   "report": {
    "R1": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "cron-20210630.htm",
      "contextRef": "i69782326f71a44e3805518280ee22b6b_D20210101-20210630",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "dei:DocumentType",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "document",
     "isDefault": "true",
     "longName": "0001001 - Document - Cover Page",
     "role": "http://thecronosgroup.com/role/CoverPage",
     "shortName": "Cover Page",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "cron-20210630.htm",
      "contextRef": "i69782326f71a44e3805518280ee22b6b_D20210101-20210630",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "dei:DocumentType",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R10": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "cron-20210630.htm",
      "contextRef": "i69782326f71a44e3805518280ee22b6b_D20210101-20210630",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:LoansNotesTradeAndOtherReceivablesExcludingAllowanceForCreditLossesTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2112104 - Disclosure - Loans Receivable, net",
     "role": "http://thecronosgroup.com/role/LoansReceivablenet",
     "shortName": "Loans Receivable, net",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "cron-20210630.htm",
      "contextRef": "i69782326f71a44e3805518280ee22b6b_D20210101-20210630",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:LoansNotesTradeAndOtherReceivablesExcludingAllowanceForCreditLossesTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R11": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "cron-20210630.htm",
      "contextRef": "i69782326f71a44e3805518280ee22b6b_D20210101-20210630",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:DerivativeInstrumentsAndHedgingActivitiesDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2115105 - Disclosure - Derivative Liabilities",
     "role": "http://thecronosgroup.com/role/DerivativeLiabilities",
     "shortName": "Derivative Liabilities",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "cron-20210630.htm",
      "contextRef": "i69782326f71a44e3805518280ee22b6b_D20210101-20210630",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:DerivativeInstrumentsAndHedgingActivitiesDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R12": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "cron-20210630.htm",
      "contextRef": "i69782326f71a44e3805518280ee22b6b_D20210101-20210630",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2121106 - Disclosure - Share-based Payments",
     "role": "http://thecronosgroup.com/role/SharebasedPayments",
     "shortName": "Share-based Payments",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "cron-20210630.htm",
      "contextRef": "i69782326f71a44e3805518280ee22b6b_D20210101-20210630",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R13": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "cron-20210630.htm",
      "contextRef": "i69782326f71a44e3805518280ee22b6b_D20210101-20210630",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:EarningsPerShareTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2131107 - Disclosure - Earnings (Loss) Per Share",
     "role": "http://thecronosgroup.com/role/EarningsLossPerShare",
     "shortName": "Earnings (Loss) Per Share",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "cron-20210630.htm",
      "contextRef": "i69782326f71a44e3805518280ee22b6b_D20210101-20210630",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:EarningsPerShareTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R14": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "cron-20210630.htm",
      "contextRef": "i69782326f71a44e3805518280ee22b6b_D20210101-20210630",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:SegmentReportingDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2135108 - Disclosure - Segment Information",
     "role": "http://thecronosgroup.com/role/SegmentInformation",
     "shortName": "Segment Information",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "cron-20210630.htm",
      "contextRef": "i69782326f71a44e3805518280ee22b6b_D20210101-20210630",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:SegmentReportingDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R15": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "cron-20210630.htm",
      "contextRef": "i69782326f71a44e3805518280ee22b6b_D20210101-20210630",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:LossContingencyDisclosures",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2142109 - Disclosure - Commitments and Contingencies",
     "role": "http://thecronosgroup.com/role/CommitmentsandContingencies",
     "shortName": "Commitments and Contingencies",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "cron-20210630.htm",
      "contextRef": "i69782326f71a44e3805518280ee22b6b_D20210101-20210630",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:LossContingencyDisclosures",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R16": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "cron-20210630.htm",
      "contextRef": "i69782326f71a44e3805518280ee22b6b_D20210101-20210630",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ConcentrationRiskDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2144110 - Disclosure - Financial Instruments",
     "role": "http://thecronosgroup.com/role/FinancialInstruments",
     "shortName": "Financial Instruments",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "cron-20210630.htm",
      "contextRef": "i69782326f71a44e3805518280ee22b6b_D20210101-20210630",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ConcentrationRiskDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R17": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "cron-20210630.htm",
      "contextRef": "i69782326f71a44e3805518280ee22b6b_D20210101-20210630",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:DisposalGroupsIncludingDiscontinuedOperationsDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2151111 - Disclosure - Held-For-Sale Assets and Discontinued Operations",
     "role": "http://thecronosgroup.com/role/HeldForSaleAssetsandDiscontinuedOperations",
     "shortName": "Held-For-Sale Assets and Discontinued Operations",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "cron-20210630.htm",
      "contextRef": "i69782326f71a44e3805518280ee22b6b_D20210101-20210630",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:DisposalGroupsIncludingDiscontinuedOperationsDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R18": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "cron-20210630.htm",
      "contextRef": "i69782326f71a44e3805518280ee22b6b_D20210101-20210630",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:AssetImpairmentChargesTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2154112 - Disclosure - Impairment Loss on Long-Lived Assets",
     "role": "http://thecronosgroup.com/role/ImpairmentLossonLongLivedAssets",
     "shortName": "Impairment Loss on Long-Lived Assets",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "cron-20210630.htm",
      "contextRef": "i69782326f71a44e3805518280ee22b6b_D20210101-20210630",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:AssetImpairmentChargesTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R19": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "cron-20210630.htm",
      "contextRef": "i69782326f71a44e3805518280ee22b6b_D20210101-20210630",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:BasisOfAccountingPolicyPolicyTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2202201 - Disclosure - Background, Basis of Presentation and Accounting Policies (Policies)",
     "role": "http://thecronosgroup.com/role/BackgroundBasisofPresentationandAccountingPoliciesPolicies",
     "shortName": "Background, Basis of Presentation and Accounting Policies (Policies)",
     "subGroupType": "policies",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "cron-20210630.htm",
      "contextRef": "i69782326f71a44e3805518280ee22b6b_D20210101-20210630",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:BasisOfAccountingPolicyPolicyTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R2": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "cron-20210630.htm",
      "contextRef": "i225f85e38faa4bbdb4de1d8b9cf369bb_I20210630",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:CashAndCashEquivalentsAtCarryingValue",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "statement",
     "isDefault": "false",
     "longName": "1001002 - Statement - Condensed Consolidated Balance Sheets",
     "role": "http://thecronosgroup.com/role/CondensedConsolidatedBalanceSheets",
     "shortName": "Condensed Consolidated Balance Sheets",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "cron-20210630.htm",
      "contextRef": "i225f85e38faa4bbdb4de1d8b9cf369bb_I20210630",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:CashAndCashEquivalentsAtCarryingValue",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R20": {
     "firstAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "cron-20210630.htm",
      "contextRef": "i69782326f71a44e3805518280ee22b6b_D20210101-20210630",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfInventoryCurrentTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2305301 - Disclosure - Inventory, net (Tables)",
     "role": "http://thecronosgroup.com/role/InventorynetTables",
     "shortName": "Inventory, net (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "cron-20210630.htm",
      "contextRef": "i69782326f71a44e3805518280ee22b6b_D20210101-20210630",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfInventoryCurrentTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R21": {
     "firstAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "cron-20210630.htm",
      "contextRef": "i69782326f71a44e3805518280ee22b6b_D20210101-20210630",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:EquityMethodInvestmentsTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2308302 - Disclosure - Investments (Tables)",
     "role": "http://thecronosgroup.com/role/InvestmentsTables",
     "shortName": "Investments (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "cron-20210630.htm",
      "contextRef": "i69782326f71a44e3805518280ee22b6b_D20210101-20210630",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:EquityMethodInvestmentsTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R22": {
     "firstAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "cron-20210630.htm",
      "contextRef": "i69782326f71a44e3805518280ee22b6b_D20210101-20210630",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfAccountsNotesLoansAndFinancingReceivableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2313303 - Disclosure - Loans Receivable, net (Tables)",
     "role": "http://thecronosgroup.com/role/LoansReceivablenetTables",
     "shortName": "Loans Receivable, net (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "cron-20210630.htm",
      "contextRef": "i69782326f71a44e3805518280ee22b6b_D20210101-20210630",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfAccountsNotesLoansAndFinancingReceivableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R23": {
     "firstAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "cron-20210630.htm",
      "contextRef": "i69782326f71a44e3805518280ee22b6b_D20210101-20210630",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:FairValueNetDerivativeAssetLiabilityMeasuredOnRecurringBasisUnobservableInputReconciliationTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2316304 - Disclosure - Derivative Liabilities (Tables)",
     "role": "http://thecronosgroup.com/role/DerivativeLiabilitiesTables",
     "shortName": "Derivative Liabilities (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "cron-20210630.htm",
      "contextRef": "i69782326f71a44e3805518280ee22b6b_D20210101-20210630",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:FairValueNetDerivativeAssetLiabilityMeasuredOnRecurringBasisUnobservableInputReconciliationTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R24": {
     "firstAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "cron-20210630.htm",
      "contextRef": "i69782326f71a44e3805518280ee22b6b_D20210101-20210630",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2322305 - Disclosure - Share-based Payments (Tables)",
     "role": "http://thecronosgroup.com/role/SharebasedPaymentsTables",
     "shortName": "Share-based Payments (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "cron-20210630.htm",
      "contextRef": "i69782326f71a44e3805518280ee22b6b_D20210101-20210630",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R25": {
     "firstAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "cron-20210630.htm",
      "contextRef": "i69782326f71a44e3805518280ee22b6b_D20210101-20210630",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2332306 - Disclosure - Earnings (Loss) Per Share (Tables)",
     "role": "http://thecronosgroup.com/role/EarningsLossPerShareTables",
     "shortName": "Earnings (Loss) Per Share (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "cron-20210630.htm",
      "contextRef": "i69782326f71a44e3805518280ee22b6b_D20210101-20210630",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R26": {
     "firstAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "cron-20210630.htm",
      "contextRef": "i69782326f71a44e3805518280ee22b6b_D20210101-20210630",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfSegmentReportingInformationBySegmentTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2336307 - Disclosure - Segment Information (Tables)",
     "role": "http://thecronosgroup.com/role/SegmentInformationTables",
     "shortName": "Segment Information (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "cron-20210630.htm",
      "contextRef": "i69782326f71a44e3805518280ee22b6b_D20210101-20210630",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfSegmentReportingInformationBySegmentTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R27": {
     "firstAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "cron-20210630.htm",
      "contextRef": "i69782326f71a44e3805518280ee22b6b_D20210101-20210630",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2345308 - Disclosure - Financial Instruments (Tables)",
     "role": "http://thecronosgroup.com/role/FinancialInstrumentsTables",
     "shortName": "Financial Instruments (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "cron-20210630.htm",
      "contextRef": "i69782326f71a44e3805518280ee22b6b_D20210101-20210630",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R28": {
     "firstAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "cron-20210630.htm",
      "contextRef": "i69782326f71a44e3805518280ee22b6b_D20210101-20210630",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfDisposalGroupsIncludingDiscontinuedOperationsIncomeStatementBalanceSheetAndAdditionalDisclosuresTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2352309 - Disclosure - Held-For-Sale Assets and Discontinued Operations (Tables)",
     "role": "http://thecronosgroup.com/role/HeldForSaleAssetsandDiscontinuedOperationsTables",
     "shortName": "Held-For-Sale Assets and Discontinued Operations (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "cron-20210630.htm",
      "contextRef": "i69782326f71a44e3805518280ee22b6b_D20210101-20210630",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfDisposalGroupsIncludingDiscontinuedOperationsIncomeStatementBalanceSheetAndAdditionalDisclosuresTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R29": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "cron-20210630.htm",
      "contextRef": "i225f85e38faa4bbdb4de1d8b9cf369bb_I20210630",
      "decimals": "INF",
      "first": true,
      "lang": "en-US",
      "name": "cron:NumberOfContinentsWithInternationalProductionAndDistribution",
      "reportCount": 1,
      "unitRef": "continent",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2403401 - Disclosure - Background, Basis of Presentation and Accounting Policies (Details)",
     "role": "http://thecronosgroup.com/role/BackgroundBasisofPresentationandAccountingPoliciesDetails",
     "shortName": "Background, Basis of Presentation and Accounting Policies (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "cron-20210630.htm",
      "contextRef": "i6506a062286b47c0b48f06151d87d9e6_I20201231",
      "decimals": "-3",
      "lang": "en-US",
      "name": "us-gaap:AccountsPayableAndOtherAccruedLiabilitiesCurrent",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R3": {
     "firstAnchor": {
      "ancestors": [
       "link:footnote",
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "cron-20210630.htm",
      "contextRef": "i225f85e38faa4bbdb4de1d8b9cf369bb_I20210630",
      "decimals": "INF",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:CommonStockSharesIssued",
      "reportCount": 1,
      "unique": true,
      "unitRef": "shares",
      "xsiNil": "false"
     },
     "groupType": "statement",
     "isDefault": "false",
     "longName": "1002003 - Statement - Condensed Consolidated Balance Sheet (Parenthetical)",
     "role": "http://thecronosgroup.com/role/CondensedConsolidatedBalanceSheetParenthetical",
     "shortName": "Condensed Consolidated Balance Sheet (Parenthetical)",
     "subGroupType": "parenthetical",
     "uniqueAnchor": {
      "ancestors": [
       "link:footnote",
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "cron-20210630.htm",
      "contextRef": "i225f85e38faa4bbdb4de1d8b9cf369bb_I20210630",
      "decimals": "INF",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:CommonStockSharesIssued",
      "reportCount": 1,
      "unique": true,
      "unitRef": "shares",
      "xsiNil": "false"
     }
    },
    "R30": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfInventoryCurrentTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "cron-20210630.htm",
      "contextRef": "i225f85e38faa4bbdb4de1d8b9cf369bb_I20210630",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:InventoryRawMaterialsNetOfReserves",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2406402 - Disclosure - Inventory, net (Details)",
     "role": "http://thecronosgroup.com/role/InventorynetDetails",
     "shortName": "Inventory, net (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfInventoryCurrentTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "cron-20210630.htm",
      "contextRef": "ifbe16ec51ea244519b77d6036b4ef038_I20201231",
      "decimals": "-3",
      "lang": "en-US",
      "name": "us-gaap:InventoryRawMaterialsNetOfReserves",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R31": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "cron-20210630.htm",
      "contextRef": "iaa37e41bb48a45ae9333902e59ee2719_I20210614",
      "decimals": "INF",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:SaleOfStockPricePerShare",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usdPerShare",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2409403 - Disclosure - Investments - Narrative (Details)",
     "role": "http://thecronosgroup.com/role/InvestmentsNarrativeDetails",
     "shortName": "Investments - Narrative (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "cron-20210630.htm",
      "contextRef": "iaa37e41bb48a45ae9333902e59ee2719_I20210614",
      "decimals": "INF",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:SaleOfStockPricePerShare",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usdPerShare",
      "xsiNil": "false"
     }
    },
    "R32": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:EquityMethodInvestmentsTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "cron-20210630.htm",
      "contextRef": "i225f85e38faa4bbdb4de1d8b9cf369bb_I20210630",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:EquityMethodInvestments",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2410404 - Disclosure - Investments - Schedule of Investments in Associates and Joint Ventures (Details)",
     "role": "http://thecronosgroup.com/role/InvestmentsScheduleofInvestmentsinAssociatesandJointVenturesDetails",
     "shortName": "Investments - Schedule of Investments in Associates and Joint Ventures (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:EquityMethodInvestmentsTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "cron-20210630.htm",
      "contextRef": "i78252faeeac94cf1b00fbbab110c7bb8_I20201231",
      "decimals": "-3",
      "lang": "en-US",
      "name": "us-gaap:EquityMethodInvestments",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R33": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "ix:continuation",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "cron-20210630.htm",
      "contextRef": "i225f85e38faa4bbdb4de1d8b9cf369bb_I20210630",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:VariableInterestEntityEntityMaximumLossExposureAmount",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2411405 - Disclosure - Investments - Schedule of Variable Interest Entities (Details)",
     "role": "http://thecronosgroup.com/role/InvestmentsScheduleofVariableInterestEntitiesDetails",
     "shortName": "Investments - Schedule of Variable Interest Entities (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "ix:continuation",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "cron-20210630.htm",
      "contextRef": "i225f85e38faa4bbdb4de1d8b9cf369bb_I20210630",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:VariableInterestEntityEntityMaximumLossExposureAmount",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R34": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfAccountsNotesLoansAndFinancingReceivableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "cron-20210630.htm",
      "contextRef": "i225f85e38faa4bbdb4de1d8b9cf369bb_I20210630",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:NotesAndLoansReceivableNetCurrent",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2414406 - Disclosure - Loans Receivable, net (Details)",
     "role": "http://thecronosgroup.com/role/LoansReceivablenetDetails",
     "shortName": "Loans Receivable, net (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfAccountsNotesLoansAndFinancingReceivableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "cron-20210630.htm",
      "contextRef": "i0709927d1c004766b70bf1b85ffbd9b2_I20210630",
      "decimals": "-3",
      "lang": "en-US",
      "name": "cron:FinancingReceivableAccruedInterestCurrent",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R35": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "cron-20210630.htm",
      "contextRef": "i27f4e53b91ad4367b7f8d273eff27769_D20210401-20210630",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "cron:FairValueNetDerivativeAssetLiabilityMeasuredOnRecurringBasisUnobservableInputsReconciliationOutOfPeriodAdjustment",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2417407 - Disclosure - Derivative Liabilities - Narrative (Details)",
     "role": "http://thecronosgroup.com/role/DerivativeLiabilitiesNarrativeDetails",
     "shortName": "Derivative Liabilities - Narrative (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "cron-20210630.htm",
      "contextRef": "idadea534a9454dde961a3571663d9316_I20190308",
      "decimals": "2",
      "lang": "en-US",
      "name": "us-gaap:EquityMethodInvestmentOwnershipPercentage",
      "reportCount": 1,
      "unique": true,
      "unitRef": "number",
      "xsiNil": "false"
     }
    },
    "R36": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:FairValueNetDerivativeAssetLiabilityMeasuredOnRecurringBasisUnobservableInputReconciliationTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "cron-20210630.htm",
      "contextRef": "i672ae438d5904d3aa27f245b59e5ba4c_I20210331",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:FairValueNetDerivativeAssetLiabilityMeasuredOnRecurringBasisWithUnobservableInputs",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2418408 - Disclosure - Derivative Liabilities - Schedule of Reconciliation of Carrying Amounts (Details)",
     "role": "http://thecronosgroup.com/role/DerivativeLiabilitiesScheduleofReconciliationofCarryingAmountsDetails",
     "shortName": "Derivative Liabilities - Schedule of Reconciliation of Carrying Amounts (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:FairValueNetDerivativeAssetLiabilityMeasuredOnRecurringBasisUnobservableInputReconciliationTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "cron-20210630.htm",
      "contextRef": "i672ae438d5904d3aa27f245b59e5ba4c_I20210331",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:FairValueNetDerivativeAssetLiabilityMeasuredOnRecurringBasisWithUnobservableInputs",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R37": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "cron-20210630.htm",
      "contextRef": "i1257ed1c2bd045fbb8c920b7a673a2bc_I20210630",
      "decimals": "2",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:DerivativeLiabilityMeasurementInput",
      "reportCount": 1,
      "unique": true,
      "unitRef": "cadPerShare",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2419409 - Disclosure - Derivative Liabilities - Schedule of Fair Values of Derivative Liabilities (Details)",
     "role": "http://thecronosgroup.com/role/DerivativeLiabilitiesScheduleofFairValuesofDerivativeLiabilitiesDetails",
     "shortName": "Derivative Liabilities - Schedule of Fair Values of Derivative Liabilities (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "cron-20210630.htm",
      "contextRef": "i1257ed1c2bd045fbb8c920b7a673a2bc_I20210630",
      "decimals": "2",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:DerivativeLiabilityMeasurementInput",
      "reportCount": 1,
      "unique": true,
      "unitRef": "cadPerShare",
      "xsiNil": "false"
     }
    },
    "R38": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "cron:SensitivityAnalysisImpactOnNetIncomeLossTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "cron-20210630.htm",
      "contextRef": "i34995f47e8ba418fbd529b2ed52790dc_I20210630",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "cron:SensitivityAnalysisImpactOf10PercentDecreaseIncreaseInSharePriceOnNetIncomeLoss",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2420410 - Disclosure - Derivative Liabilities - Schedule of Sensitivity Analysis (Details)",
     "role": "http://thecronosgroup.com/role/DerivativeLiabilitiesScheduleofSensitivityAnalysisDetails",
     "shortName": "Derivative Liabilities - Schedule of Sensitivity Analysis (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "cron:SensitivityAnalysisImpactOnNetIncomeLossTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "cron-20210630.htm",
      "contextRef": "i34995f47e8ba418fbd529b2ed52790dc_I20210630",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "cron:SensitivityAnalysisImpactOf10PercentDecreaseIncreaseInSharePriceOnNetIncomeLoss",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R39": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "ix:continuation",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "cron-20210630.htm",
      "contextRef": "i27f4e53b91ad4367b7f8d273eff27769_D20210401-20210630",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:AllocatedShareBasedCompensationExpense",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2423411 - Disclosure - Share-based Payments - Summary of Stock-based Compensation Expense (Details)",
     "role": "http://thecronosgroup.com/role/SharebasedPaymentsSummaryofStockbasedCompensationExpenseDetails",
     "shortName": "Share-based Payments - Summary of Stock-based Compensation Expense (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "cron-20210630.htm",
      "contextRef": "i1e4726863b724a379f5bd7d27ab5b3cc_D20210401-20210630",
      "decimals": "-3",
      "lang": "en-US",
      "name": "us-gaap:AllocatedShareBasedCompensationExpense",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R4": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "cron-20210630.htm",
      "contextRef": "i27f4e53b91ad4367b7f8d273eff27769_D20210401-20210630",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "statement",
     "isDefault": "false",
     "longName": "1003004 - Statement - Condensed Consolidated Statements of Net Income (Loss) and Comprehensive Income (Loss)",
     "role": "http://thecronosgroup.com/role/CondensedConsolidatedStatementsofNetIncomeLossandComprehensiveIncomeLoss",
     "shortName": "Condensed Consolidated Statements of Net Income (Loss) and Comprehensive Income (Loss)",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "cron-20210630.htm",
      "contextRef": "i27f4e53b91ad4367b7f8d273eff27769_D20210401-20210630",
      "decimals": "-3",
      "lang": "en-US",
      "name": "us-gaap:ExciseAndSalesTaxes",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R40": {
     "firstAnchor": {
      "ancestors": [
       "us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross",
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "cron-20210630.htm",
      "contextRef": "i69782326f71a44e3805518280ee22b6b_D20210101-20210630",
      "decimals": "INF",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross",
      "reportCount": 1,
      "unique": true,
      "unitRef": "shares",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2424412 - Disclosure - Share-based Payments - Stock Options Narrative (Details)",
     "role": "http://thecronosgroup.com/role/SharebasedPaymentsStockOptionsNarrativeDetails",
     "shortName": "Share-based Payments - Stock Options Narrative (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross",
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "cron-20210630.htm",
      "contextRef": "i69782326f71a44e3805518280ee22b6b_D20210101-20210630",
      "decimals": "INF",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross",
      "reportCount": 1,
      "unique": true,
      "unitRef": "shares",
      "xsiNil": "false"
     }
    },
    "R41": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfStockOptionsRollForwardTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "cron-20210630.htm",
      "contextRef": "ifbe16ec51ea244519b77d6036b4ef038_I20201231",
      "decimals": "2",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice",
      "reportCount": 1,
      "unitRef": "cadPerShare",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2425413 - Disclosure - Share-based Payments - Summary of the Changes in Options (Details)",
     "role": "http://thecronosgroup.com/role/SharebasedPaymentsSummaryoftheChangesinOptionsDetails",
     "shortName": "Share-based Payments - Summary of the Changes in Options (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfStockOptionsRollForwardTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "cron-20210630.htm",
      "contextRef": "i69782326f71a44e3805518280ee22b6b_D20210101-20210630",
      "decimals": "2",
      "lang": "en-US",
      "name": "us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice",
      "reportCount": 1,
      "unique": true,
      "unitRef": "cadPerShare",
      "xsiNil": "false"
     }
    },
    "R42": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "ix:continuation",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "cron-20210630.htm",
      "contextRef": "i225f85e38faa4bbdb4de1d8b9cf369bb_I20210630",
      "decimals": "INF",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber",
      "reportCount": 1,
      "unitRef": "shares",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2426414 - Disclosure - Share-based Payments - Schedule of Stock Options Outstanding (Details)",
     "role": "http://thecronosgroup.com/role/SharebasedPaymentsScheduleofStockOptionsOutstandingDetails",
     "shortName": "Share-based Payments - Schedule of Stock Options Outstanding (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "ix:continuation",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "cron-20210630.htm",
      "contextRef": "ib49e288fbb504210b764575656013515_I20210630",
      "decimals": "INF",
      "lang": "en-US",
      "name": "us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber",
      "reportCount": 1,
      "unique": true,
      "unitRef": "shares",
      "xsiNil": "false"
     }
    },
    "R43": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfShareBasedCompensationRestrictedStockUnitsAwardActivityTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "cron-20210630.htm",
      "contextRef": "iff2854605c9948a0bd946fb90a42d547_I20201231",
      "decimals": "INF",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber",
      "reportCount": 1,
      "unique": true,
      "unitRef": "shares",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2427415 - Disclosure - Share-based Payments - Summary of Changes in RSUs (Details)",
     "role": "http://thecronosgroup.com/role/SharebasedPaymentsSummaryofChangesinRSUsDetails",
     "shortName": "Share-based Payments - Summary of Changes in RSUs (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfShareBasedCompensationRestrictedStockUnitsAwardActivityTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "cron-20210630.htm",
      "contextRef": "iff2854605c9948a0bd946fb90a42d547_I20201231",
      "decimals": "INF",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber",
      "reportCount": 1,
      "unique": true,
      "unitRef": "shares",
      "xsiNil": "false"
     }
    },
    "R44": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfOtherShareBasedCompensationActivityTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "cron-20210630.htm",
      "contextRef": "iba2763eff8e446348674f7fa0f12395e_I20201231",
      "decimals": "INF",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber",
      "reportCount": 1,
      "unique": true,
      "unitRef": "shares",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2428416 - Disclosure - Share-based Payments - Summary of DSU Activity (Details)",
     "role": "http://thecronosgroup.com/role/SharebasedPaymentsSummaryofDSUActivityDetails",
     "shortName": "Share-based Payments - Summary of DSU Activity (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfOtherShareBasedCompensationActivityTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "cron-20210630.htm",
      "contextRef": "iba2763eff8e446348674f7fa0f12395e_I20201231",
      "decimals": "INF",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber",
      "reportCount": 1,
      "unique": true,
      "unitRef": "shares",
      "xsiNil": "false"
     }
    },
    "R45": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "ix:continuation",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "cron-20210630.htm",
      "contextRef": "ica96f8af8bfb4c02b4ff8f577beed8a9_I20201231",
      "decimals": "2",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue",
      "reportCount": 1,
      "unique": true,
      "unitRef": "cadPerShare",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2429417 - Disclosure - Share-based Payments - Summary of Changes in Warrants (Details)",
     "role": "http://thecronosgroup.com/role/SharebasedPaymentsSummaryofChangesinWarrantsDetails",
     "shortName": "Share-based Payments - Summary of Changes in Warrants (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "ix:continuation",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "cron-20210630.htm",
      "contextRef": "ica96f8af8bfb4c02b4ff8f577beed8a9_I20201231",
      "decimals": "2",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue",
      "reportCount": 1,
      "unique": true,
      "unitRef": "cadPerShare",
      "xsiNil": "false"
     }
    },
    "R46": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "ix:continuation",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "cron-20210630.htm",
      "contextRef": "iaa2e66f5a2c14062bebba1811782ccd6_I20210630",
      "decimals": "INF",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber",
      "reportCount": 1,
      "unitRef": "shares",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2430418 - Disclosure - Share-based Payments - Summary of Outstanding Warrants (Details)",
     "role": "http://thecronosgroup.com/role/SharebasedPaymentsSummaryofOutstandingWarrantsDetails",
     "shortName": "Share-based Payments - Summary of Outstanding Warrants (Details)",
     "subGroupType": "details",
     "uniqueAnchor": null
    },
    "R47": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "cron-20210630.htm",
      "contextRef": "i27f4e53b91ad4367b7f8d273eff27769_D20210401-20210630",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:NetIncomeLossFromContinuingOperationsAvailableToCommonShareholdersBasic",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2433419 - Disclosure - Earnings (Loss) Per Share - Schedule of Earnings (Loss) Per Share (Details)",
     "role": "http://thecronosgroup.com/role/EarningsLossPerShareScheduleofEarningsLossPerShareDetails",
     "shortName": "Earnings (Loss) Per Share - Schedule of Earnings (Loss) Per Share (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "cron-20210630.htm",
      "contextRef": "i27f4e53b91ad4367b7f8d273eff27769_D20210401-20210630",
      "decimals": "-3",
      "lang": "en-US",
      "name": "us-gaap:NetIncomeLossFromDiscontinuedOperationsAvailableToCommonShareholdersBasic",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R48": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "cron-20210630.htm",
      "contextRef": "i27f4e53b91ad4367b7f8d273eff27769_D20210401-20210630",
      "decimals": "0",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount",
      "reportCount": 1,
      "unique": true,
      "unitRef": "shares",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2434420 - Disclosure - Earnings (Loss) Per Share - Schedule of Antidilutive Securities Excluded from Computation of Diluted Shares Outstanding (Details)",
     "role": "http://thecronosgroup.com/role/EarningsLossPerShareScheduleofAntidilutiveSecuritiesExcludedfromComputationofDilutedSharesOutstandingDetails",
     "shortName": "Earnings (Loss) Per Share - Schedule of Antidilutive Securities Excluded from Computation of Diluted Shares Outstanding (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "cron-20210630.htm",
      "contextRef": "i27f4e53b91ad4367b7f8d273eff27769_D20210401-20210630",
      "decimals": "0",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount",
      "reportCount": 1,
      "unique": true,
      "unitRef": "shares",
      "xsiNil": "false"
     }
    },
    "R49": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "cron-20210630.htm",
      "contextRef": "i69782326f71a44e3805518280ee22b6b_D20210101-20210630",
      "decimals": "INF",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:NumberOfReportableSegments",
      "reportCount": 1,
      "unique": true,
      "unitRef": "segment",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2437421 - Disclosure - Segment Information - Narrative (Details)",
     "role": "http://thecronosgroup.com/role/SegmentInformationNarrativeDetails",
     "shortName": "Segment Information - Narrative (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "cron-20210630.htm",
      "contextRef": "i69782326f71a44e3805518280ee22b6b_D20210101-20210630",
      "decimals": "INF",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:NumberOfReportableSegments",
      "reportCount": 1,
      "unique": true,
      "unitRef": "segment",
      "xsiNil": "false"
     }
    },
    "R5": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "cron-20210630.htm",
      "contextRef": "ibec8035afed7413580a92eb6c685b162_I20191231",
      "decimals": "INF",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:CommonStockSharesOutstanding",
      "reportCount": 1,
      "unique": true,
      "unitRef": "shares",
      "xsiNil": "false"
     },
     "groupType": "statement",
     "isDefault": "false",
     "longName": "1004005 - Statement - Condensed Consolidated Statements of Changes in Equity",
     "role": "http://thecronosgroup.com/role/CondensedConsolidatedStatementsofChangesinEquity",
     "shortName": "Condensed Consolidated Statements of Changes in Equity",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "cron-20210630.htm",
      "contextRef": "ibec8035afed7413580a92eb6c685b162_I20191231",
      "decimals": "INF",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:CommonStockSharesOutstanding",
      "reportCount": 1,
      "unique": true,
      "unitRef": "shares",
      "xsiNil": "false"
     }
    },
    "R50": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:RevenueFromExternalCustomersByGeographicAreasTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "cron-20210630.htm",
      "contextRef": "i27f4e53b91ad4367b7f8d273eff27769_D20210401-20210630",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2438422 - Disclosure - Segment Information - Schedule of Segment Data (Details)",
     "role": "http://thecronosgroup.com/role/SegmentInformationScheduleofSegmentDataDetails",
     "shortName": "Segment Information - Schedule of Segment Data (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfSegmentReportingInformationBySegmentTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "cron-20210630.htm",
      "contextRef": "i27f4e53b91ad4367b7f8d273eff27769_D20210401-20210630",
      "decimals": "-3",
      "lang": "en-US",
      "name": "us-gaap:InvestmentIncomeInterest",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R51": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "cron-20210630.htm",
      "contextRef": "i27f4e53b91ad4367b7f8d273eff27769_D20210401-20210630",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ProfitLoss",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2439423 - Disclosure - Segment Information - Schedule of Adjusted EBITDA (Details)",
     "role": "http://thecronosgroup.com/role/SegmentInformationScheduleofAdjustedEBITDADetails",
     "shortName": "Segment Information - Schedule of Adjusted EBITDA (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "ix:continuation",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "cron-20210630.htm",
      "contextRef": "i27f4e53b91ad4367b7f8d273eff27769_D20210401-20210630",
      "decimals": "-3",
      "lang": "en-US",
      "name": "us-gaap:RestructuringCharges",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R52": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:RevenueFromExternalCustomersByGeographicAreasTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "cron-20210630.htm",
      "contextRef": "i27f4e53b91ad4367b7f8d273eff27769_D20210401-20210630",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2440424 - Disclosure - Segment Information - Schedule of Revenue from External Customers by Geographic Areas (Details)",
     "role": "http://thecronosgroup.com/role/SegmentInformationScheduleofRevenuefromExternalCustomersbyGeographicAreasDetails",
     "shortName": "Segment Information - Schedule of Revenue from External Customers by Geographic Areas (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:RevenueFromExternalCustomersByGeographicAreasTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "cron-20210630.htm",
      "contextRef": "i70c4790ac8ca40dd81fcf1ef3cef91b6_D20210401-20210630",
      "decimals": "-3",
      "lang": "en-US",
      "name": "us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R53": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:LongLivedAssetsByGeographicAreasTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "cron-20210630.htm",
      "contextRef": "i225f85e38faa4bbdb4de1d8b9cf369bb_I20210630",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:NoncurrentAssets",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2441425 - Disclosure - Segment Information - Schedule of Long-lived Assets by Geographic Areas (Details)",
     "role": "http://thecronosgroup.com/role/SegmentInformationScheduleofLonglivedAssetsbyGeographicAreasDetails",
     "shortName": "Segment Information - Schedule of Long-lived Assets by Geographic Areas (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:LongLivedAssetsByGeographicAreasTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "cron-20210630.htm",
      "contextRef": "i225f85e38faa4bbdb4de1d8b9cf369bb_I20210630",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:NoncurrentAssets",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R54": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "cron-20210630.htm",
      "contextRef": "i71fed0c557ee4fb3a307e51526e90c95_D20200616-20200616",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:LossContingencyDamagesSoughtValue",
      "reportCount": 1,
      "unique": true,
      "unitRef": "cad",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2443426 - Disclosure - Commitments and Contingencies (Details)",
     "role": "http://thecronosgroup.com/role/CommitmentsandContingenciesDetails",
     "shortName": "Commitments and Contingencies (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "cron-20210630.htm",
      "contextRef": "i71fed0c557ee4fb3a307e51526e90c95_D20200616-20200616",
      "decimals": "-6",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:LossContingencyDamagesSoughtValue",
      "reportCount": 1,
      "unique": true,
      "unitRef": "cad",
      "xsiNil": "false"
     }
    },
    "R55": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "cron-20210630.htm",
      "contextRef": "i5fd10eeb00c74a3fa9afaced11fe7a7d_I20210630",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:CashAndCashEquivalentsFairValueDisclosure",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2446427 - Disclosure - Financial Instruments - Schedule of Fair Value of Assets Measured on Recurring Basis (Details)",
     "role": "http://thecronosgroup.com/role/FinancialInstrumentsScheduleofFairValueofAssetsMeasuredonRecurringBasisDetails",
     "shortName": "Financial Instruments - Schedule of Fair Value of Assets Measured on Recurring Basis (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "cron-20210630.htm",
      "contextRef": "i5fd10eeb00c74a3fa9afaced11fe7a7d_I20210630",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:CashAndCashEquivalentsFairValueDisclosure",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R56": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "cron-20210630.htm",
      "contextRef": "i69782326f71a44e3805518280ee22b6b_D20210101-20210630",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ConcentrationRiskCreditRiskFinancialInstrumentMaximumExposure",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2447428 - Disclosure - Financial Instruments - Credit Risk Narrative (Details)",
     "role": "http://thecronosgroup.com/role/FinancialInstrumentsCreditRiskNarrativeDetails",
     "shortName": "Financial Instruments - Credit Risk Narrative (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "cron-20210630.htm",
      "contextRef": "i69782326f71a44e3805518280ee22b6b_D20210101-20210630",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ConcentrationRiskCreditRiskFinancialInstrumentMaximumExposure",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R57": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "cron-20210630.htm",
      "contextRef": "i27f4e53b91ad4367b7f8d273eff27769_D20210401-20210630",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:InterestIncomeExpenseNonoperatingNet",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2448429 - Disclosure - Financial Instruments - Interest Rate Risk Narrative (Details)",
     "role": "http://thecronosgroup.com/role/FinancialInstrumentsInterestRateRiskNarrativeDetails",
     "shortName": "Financial Instruments - Interest Rate Risk Narrative (Details)",
     "subGroupType": "details",
     "uniqueAnchor": null
    },
    "R58": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "cron-20210630.htm",
      "contextRef": "ic32bc3c69d7c4dd0a165d3622a127739_D20210101-20210630",
      "decimals": "2",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ConcentrationRiskPercentage1",
      "reportCount": 1,
      "unique": true,
      "unitRef": "number",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2449430 - Disclosure - Financial Instruments - Liquidity Risk Narrative (Details)",
     "role": "http://thecronosgroup.com/role/FinancialInstrumentsLiquidityRiskNarrativeDetails",
     "shortName": "Financial Instruments - Liquidity Risk Narrative (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "cron-20210630.htm",
      "contextRef": "ic32bc3c69d7c4dd0a165d3622a127739_D20210101-20210630",
      "decimals": "2",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ConcentrationRiskPercentage1",
      "reportCount": 1,
      "unique": true,
      "unitRef": "number",
      "xsiNil": "false"
     }
    },
    "R59": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "cron-20210630.htm",
      "contextRef": "i27f4e53b91ad4367b7f8d273eff27769_D20210401-20210630",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2450431 - Disclosure - Financial Instruments - Currency Rate Risk Narrative (Details)",
     "role": "http://thecronosgroup.com/role/FinancialInstrumentsCurrencyRateRiskNarrativeDetails",
     "shortName": "Financial Instruments - Currency Rate Risk Narrative (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "cron-20210630.htm",
      "contextRef": "ifbe16ec51ea244519b77d6036b4ef038_I20201231",
      "decimals": "-3",
      "lang": "en-US",
      "name": "cron:SensitivityAnalysisOfCarryingValueNetAssetsImpactOf10PercentChangeInExchangeRate",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R6": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "cron-20210630.htm",
      "contextRef": "i27f4e53b91ad4367b7f8d273eff27769_D20210401-20210630",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ProfitLoss",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "statement",
     "isDefault": "false",
     "longName": "1005006 - Statement - Condensed Consolidated Statements of Cash Flows",
     "role": "http://thecronosgroup.com/role/CondensedConsolidatedStatementsofCashFlows",
     "shortName": "Condensed Consolidated Statements of Cash Flows",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "cron-20210630.htm",
      "contextRef": "i69782326f71a44e3805518280ee22b6b_D20210101-20210630",
      "decimals": "-3",
      "lang": "en-US",
      "name": "us-gaap:ShareBasedCompensation",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R60": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "cron-20210630.htm",
      "contextRef": "i69782326f71a44e3805518280ee22b6b_D20210101-20210630",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ImpairmentOfLongLivedAssetsToBeDisposedOf",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2453432 - Disclosure - Held-For-Sale Assets and Discontinued Operations (Details)",
     "role": "http://thecronosgroup.com/role/HeldForSaleAssetsandDiscontinuedOperationsDetails",
     "shortName": "Held-For-Sale Assets and Discontinued Operations (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "ix:continuation",
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "cron-20210630.htm",
      "contextRef": "i904d87a0584944d792e0d8b1355a0053_D20210401-20210630",
      "decimals": "-3",
      "lang": "en-US",
      "name": "us-gaap:ImpairmentOfLongLivedAssetsToBeDisposedOf",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R61": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "cron-20210630.htm",
      "contextRef": "i69782326f71a44e3805518280ee22b6b_D20210101-20210630",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ImpairmentOfLongLivedAssetsToBeDisposedOf",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2455433 - Disclosure - Impairment Loss on Long-Lived Assets (Details)",
     "role": "http://thecronosgroup.com/role/ImpairmentLossonLongLivedAssetsDetails",
     "shortName": "Impairment Loss on Long-Lived Assets (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "cron-20210630.htm",
      "contextRef": "i69782326f71a44e3805518280ee22b6b_D20210101-20210630",
      "decimals": "-3",
      "lang": "en-US",
      "name": "cron:LesseeOperatingLeaseAreaOfLandToBeDisposedOf",
      "reportCount": 1,
      "unique": true,
      "unitRef": "sqft",
      "xsiNil": "false"
     }
    },
    "R7": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "cron-20210630.htm",
      "contextRef": "i69782326f71a44e3805518280ee22b6b_D20210101-20210630",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:BasisOfPresentationAndSignificantAccountingPoliciesTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2101101 - Disclosure - Background, Basis of Presentation and Accounting Policies",
     "role": "http://thecronosgroup.com/role/BackgroundBasisofPresentationandAccountingPolicies",
     "shortName": "Background, Basis of Presentation and Accounting Policies",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "cron-20210630.htm",
      "contextRef": "i69782326f71a44e3805518280ee22b6b_D20210101-20210630",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:BasisOfPresentationAndSignificantAccountingPoliciesTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R8": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "cron-20210630.htm",
      "contextRef": "i69782326f71a44e3805518280ee22b6b_D20210101-20210630",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:InventoryDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2104102 - Disclosure - Inventory, net",
     "role": "http://thecronosgroup.com/role/Inventorynet",
     "shortName": "Inventory, net",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "cron-20210630.htm",
      "contextRef": "i69782326f71a44e3805518280ee22b6b_D20210101-20210630",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:InventoryDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R9": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "cron-20210630.htm",
      "contextRef": "i69782326f71a44e3805518280ee22b6b_D20210101-20210630",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:EquityMethodInvestmentsDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2107103 - Disclosure - Investments",
     "role": "http://thecronosgroup.com/role/Investments",
     "shortName": "Investments",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "cron-20210630.htm",
      "contextRef": "i69782326f71a44e3805518280ee22b6b_D20210101-20210630",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:EquityMethodInvestmentsDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    }
   },
   "segmentCount": 95,
   "tag": {
    "country_CA": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "CANADA",
        "terseLabel": "Canada"
       }
      }
     },
     "localname": "CA",
     "nsuri": "http://xbrl.sec.gov/country/2021",
     "presentation": [
      "http://thecronosgroup.com/role/SegmentInformationScheduleofLonglivedAssetsbyGeographicAreasDetails",
      "http://thecronosgroup.com/role/SegmentInformationScheduleofRevenuefromExternalCustomersbyGeographicAreasDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "country_IL": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "ISRAEL",
        "terseLabel": "Israel"
       }
      }
     },
     "localname": "IL",
     "nsuri": "http://xbrl.sec.gov/country/2021",
     "presentation": [
      "http://thecronosgroup.com/role/SegmentInformationScheduleofLonglivedAssetsbyGeographicAreasDetails",
      "http://thecronosgroup.com/role/SegmentInformationScheduleofRevenuefromExternalCustomersbyGeographicAreasDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "country_US": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "UNITED STATES",
        "terseLabel": "United States"
       }
      }
     },
     "localname": "US",
     "nsuri": "http://xbrl.sec.gov/country/2021",
     "presentation": [
      "http://thecronosgroup.com/role/SegmentInformationScheduleofLonglivedAssetsbyGeographicAreasDetails",
      "http://thecronosgroup.com/role/SegmentInformationScheduleofRevenuefromExternalCustomersbyGeographicAreasDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "cron_A2015StockOptionPlanMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "2015 Stock Option Plan [Member]",
        "label": "2015 Stock Option Plan [Member]",
        "terseLabel": "2015 Stock Option Plan"
       }
      }
     },
     "localname": "A2015StockOptionPlanMember",
     "nsuri": "http://thecronosgroup.com/20210630",
     "presentation": [
      "http://thecronosgroup.com/role/SharebasedPaymentsScheduleofStockOptionsOutstandingDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "cron_A2018StockOptionPlanMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "2018 Stock Option Plan [Member]",
        "label": "2018 Stock Option Plan [Member]",
        "terseLabel": "2018 Stock Option Plan"
       }
      }
     },
     "localname": "A2018StockOptionPlanMember",
     "nsuri": "http://thecronosgroup.com/20210630",
     "presentation": [
      "http://thecronosgroup.com/role/SharebasedPaymentsScheduleofStockOptionsOutstandingDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "cron_A2020OmnibusPlanMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "2020 Omnibus Plan",
        "label": "2020 Omnibus Plan [Member]",
        "terseLabel": "2020 Omnibus Plan"
       }
      }
     },
     "localname": "A2020OmnibusPlanMember",
     "nsuri": "http://thecronosgroup.com/20210630",
     "presentation": [
      "http://thecronosgroup.com/role/SharebasedPaymentsScheduleofStockOptionsOutstandingDetails",
      "http://thecronosgroup.com/role/SharebasedPaymentsStockOptionsNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "cron_A2645485OntarioInc.MucciPromissoryNoteMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "2645485 Ontario Inc. Mucci Promissory Note [Member]",
        "label": "2645485 Ontario Inc. Mucci Promissory Note [Member]",
        "terseLabel": "Mucci promissory note"
       }
      }
     },
     "localname": "A2645485OntarioInc.MucciPromissoryNoteMember",
     "nsuri": "http://thecronosgroup.com/20210630",
     "presentation": [
      "http://thecronosgroup.com/role/LoansReceivablenetDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "cron_AdjustedEarningsBeforeInterestTaxesDepreciationAndAmortization": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Adjusted Earnings Before Interest, Taxes, Depreciation And Amortization",
        "label": "Adjusted Earnings Before Interest, Taxes, Depreciation And Amortization",
        "terseLabel": "Adjusted EBITDA"
       }
      }
     },
     "localname": "AdjustedEarningsBeforeInterestTaxesDepreciationAndAmortization",
     "nsuri": "http://thecronosgroup.com/20210630",
     "presentation": [
      "http://thecronosgroup.com/role/SegmentInformationScheduleofAdjustedEBITDADetails",
      "http://thecronosgroup.com/role/SegmentInformationScheduleofSegmentDataDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "cron_AgroideaMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Agroidea",
        "label": "Agroidea [Member]",
        "terseLabel": "AGI"
       }
      }
     },
     "localname": "AgroideaMember",
     "nsuri": "http://thecronosgroup.com/20210630",
     "presentation": [
      "http://thecronosgroup.com/role/InvestmentsScheduleofInvestmentsinAssociatesandJointVenturesDetails",
      "http://thecronosgroup.com/role/LoansReceivablenetDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "cron_AlbertGamingLiquorAndCannabisCommissionMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Albert Gaming, Liquor And Cannabis Commission",
        "label": "Albert Gaming, Liquor And Cannabis Commission [Member]",
        "terseLabel": "Albert Gaming, Liquor and Cannabis Commission"
       }
      }
     },
     "localname": "AlbertGamingLiquorAndCannabisCommissionMember",
     "nsuri": "http://thecronosgroup.com/20210630",
     "presentation": [
      "http://thecronosgroup.com/role/SegmentInformationNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "cron_AltriaGroupInc.Member": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Altria Group, Inc. [Member]",
        "label": "Altria Group, Inc. [Member]",
        "terseLabel": "Altria Group, Inc."
       }
      }
     },
     "localname": "AltriaGroupInc.Member",
     "nsuri": "http://thecronosgroup.com/20210630",
     "presentation": [
      "http://thecronosgroup.com/role/DerivativeLiabilitiesNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "cron_AltriaInvestmentMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Altria Investment [Member]",
        "label": "Altria Investment [Member]",
        "terseLabel": "Altria Investment"
       }
      }
     },
     "localname": "AltriaInvestmentMember",
     "nsuri": "http://thecronosgroup.com/20210630",
     "presentation": [
      "http://thecronosgroup.com/role/DerivativeLiabilitiesNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "cron_AltriaWarrantMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Altria Warrant [Member]",
        "label": "Altria Warrant [Member]",
        "terseLabel": "Altria Warrant",
        "verboseLabel": "Altria Warrant"
       }
      }
     },
     "localname": "AltriaWarrantMember",
     "nsuri": "http://thecronosgroup.com/20210630",
     "presentation": [
      "http://thecronosgroup.com/role/DerivativeLiabilitiesNarrativeDetails",
      "http://thecronosgroup.com/role/DerivativeLiabilitiesScheduleofFairValuesofDerivativeLiabilitiesDetails",
      "http://thecronosgroup.com/role/DerivativeLiabilitiesScheduleofReconciliationofCarryingAmountsDetails",
      "http://thecronosgroup.com/role/DerivativeLiabilitiesScheduleofSensitivityAnalysisDetails",
      "http://thecronosgroup.com/role/EarningsLossPerShareScheduleofAntidilutiveSecuritiesExcludedfromComputationofDilutedSharesOutstandingDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "cron_CannabisExtractsMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Cannabis Extracts [Member]",
        "label": "Cannabis Extracts [Member]",
        "terseLabel": "Cannabis extracts"
       }
      }
     },
     "localname": "CannabisExtractsMember",
     "nsuri": "http://thecronosgroup.com/20210630",
     "presentation": [
      "http://thecronosgroup.com/role/SegmentInformationScheduleofSegmentDataDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "cron_CannabisFlowerMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Cannabis Flower [Member]",
        "label": "Cannabis Flower [Member]",
        "terseLabel": "Cannabis flower"
       }
      }
     },
     "localname": "CannabisFlowerMember",
     "nsuri": "http://thecronosgroup.com/20210630",
     "presentation": [
      "http://thecronosgroup.com/role/SegmentInformationScheduleofSegmentDataDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "cron_CannasoulAnalyticsLtdMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Cannasoul Analytics Ltd.",
        "label": "Cannasoul Analytics Ltd. [Member]",
        "terseLabel": "Cannasoul"
       }
      }
     },
     "localname": "CannasoulAnalyticsLtdMember",
     "nsuri": "http://thecronosgroup.com/20210630",
     "presentation": [
      "http://thecronosgroup.com/role/InvestmentsNarrativeDetails",
      "http://thecronosgroup.com/role/LoansReceivablenetDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "cron_CannasoulCollaborationLoanMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Cannasoul Collaboration Loan",
        "label": "Cannasoul Collaboration Loan [Member]",
        "terseLabel": "Cannasoul collaboration loan"
       }
      }
     },
     "localname": "CannasoulCollaborationLoanMember",
     "nsuri": "http://thecronosgroup.com/20210630",
     "presentation": [
      "http://thecronosgroup.com/role/InvestmentsNarrativeDetails",
      "http://thecronosgroup.com/role/LoansReceivablenetDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "cron_ClassOfWarrantOrRightAdditionalSubscriptionNumberOfSecuritiesCalledByWarrantsOrRights": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Class Of Warrant Or Right, Additional Subscription, Number Of Securities Called By Warrants Or Rights",
        "label": "Class Of Warrant Or Right, Additional Subscription, Number Of Securities Called By Warrants Or Rights",
        "terseLabel": "Derivative liability, additional subscription (in shares)"
       }
      }
     },
     "localname": "ClassOfWarrantOrRightAdditionalSubscriptionNumberOfSecuritiesCalledByWarrantsOrRights",
     "nsuri": "http://thecronosgroup.com/20210630",
     "presentation": [
      "http://thecronosgroup.com/role/DerivativeLiabilitiesNarrativeDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "cron_ClassOfWarrantOrRightExercisePriceVolumeWeightedAveragePriceMeasurementPeriod": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Class Of Warrant Or Right, Exercise Price, Volume-Weighted Average Price, Measurement Period",
        "label": "Class Of Warrant Or Right, Exercise Price, Volume-Weighted Average Price, Measurement Period",
        "terseLabel": "Exercise price, volume-weighted average price, measurement period"
       }
      }
     },
     "localname": "ClassOfWarrantOrRightExercisePriceVolumeWeightedAveragePriceMeasurementPeriod",
     "nsuri": "http://thecronosgroup.com/20210630",
     "presentation": [
      "http://thecronosgroup.com/role/DerivativeLiabilitiesNarrativeDetails"
     ],
     "xbrltype": "durationItemType"
    },
    "cron_ClassOfWarrantOrRightExercisePriceVolumeWeightedAveragePriceMeasurementPeriodDaysPrecedingExercise": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Class Of Warrant Or Right, Exercise Price, Volume-Weighted Average Price, Measurement Period, Days Preceding Exercise",
        "label": "Class Of Warrant Or Right, Exercise Price, Volume-Weighted Average Price, Measurement Period, Days Preceding Exercise",
        "terseLabel": "Exercise price, volume-weighted average price, measurement period, days preceding exercise"
       }
      }
     },
     "localname": "ClassOfWarrantOrRightExercisePriceVolumeWeightedAveragePriceMeasurementPeriodDaysPrecedingExercise",
     "nsuri": "http://thecronosgroup.com/20210630",
     "presentation": [
      "http://thecronosgroup.com/role/DerivativeLiabilitiesNarrativeDetails"
     ],
     "xbrltype": "integerItemType"
    },
    "cron_ClassOfWarrantOrRightMaximumAdditionalSubscriptionPercentage": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Class Of Warrant Or Right, Maximum Additional Subscription Percentage",
        "label": "Class Of Warrant Or Right, Maximum Additional Subscription Percentage",
        "terseLabel": "Maximum additional subscription percentage"
       }
      }
     },
     "localname": "ClassOfWarrantOrRightMaximumAdditionalSubscriptionPercentage",
     "nsuri": "http://thecronosgroup.com/20210630",
     "presentation": [
      "http://thecronosgroup.com/role/DerivativeLiabilitiesNarrativeDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "cron_ClassOfWarrantOrRightMinimumOwnershipPercentageRequired": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Class Of Warrant Or Right, Minimum Ownership Percentage Required",
        "label": "Class Of Warrant Or Right, Minimum Ownership Percentage Required",
        "terseLabel": "Exercise rights, minimum ownership percentage"
       }
      }
     },
     "localname": "ClassOfWarrantOrRightMinimumOwnershipPercentageRequired",
     "nsuri": "http://thecronosgroup.com/20210630",
     "presentation": [
      "http://thecronosgroup.com/role/DerivativeLiabilitiesNarrativeDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "cron_ClassOfWarrantOrRightNumberOfWarrantsIssued": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Class Of Warrant Or Right, Number Of Warrants Issued",
        "label": "Class Of Warrant Or Right, Number Of Warrants Issued",
        "terseLabel": "Number of warrants issued"
       }
      }
     },
     "localname": "ClassOfWarrantOrRightNumberOfWarrantsIssued",
     "nsuri": "http://thecronosgroup.com/20210630",
     "presentation": [
      "http://thecronosgroup.com/role/DerivativeLiabilitiesNarrativeDetails"
     ],
     "xbrltype": "integerItemType"
    },
    "cron_CollaborativeArrangementAmountOfAdvances": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Collaborative Arrangement, Amount Of Advances",
        "label": "Collaborative Arrangement, Amount Of Advances",
        "terseLabel": "Collaboration agreement, amount of advances"
       }
      }
     },
     "localname": "CollaborativeArrangementAmountOfAdvances",
     "nsuri": "http://thecronosgroup.com/20210630",
     "presentation": [
      "http://thecronosgroup.com/role/InvestmentsNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "cron_CollaborativeArrangementInstallmentsReceived": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Collaborative Arrangement, Installments Received",
        "label": "Collaborative Arrangement, Installments Received",
        "terseLabel": "Collaborative arrangement, installment received"
       }
      }
     },
     "localname": "CollaborativeArrangementInstallmentsReceived",
     "nsuri": "http://thecronosgroup.com/20210630",
     "presentation": [
      "http://thecronosgroup.com/role/LoansReceivablenetDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "cron_CollaborativeArrangementPercentageOfProfitsToBeReceived": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Collaborative Arrangement, Percentage Of Profits To Be Received",
        "label": "Collaborative Arrangement, Percentage Of Profits To Be Received",
        "terseLabel": "Collaboration agreement, percentage of profits to be received"
       }
      }
     },
     "localname": "CollaborativeArrangementPercentageOfProfitsToBeReceived",
     "nsuri": "http://thecronosgroup.com/20210630",
     "presentation": [
      "http://thecronosgroup.com/role/InvestmentsNarrativeDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "cron_CollaborativeArrangementPercentageOfProfitsToBeReceivedTriggeringEventSubsequentToMaximumPercentageOfAmountsAdvancedBeingMet": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Collaborative Arrangement, Percentage Of Profits To Be Received, Triggering Event, Subsequent To Maximum Percentage Of Amounts Advanced Being Met",
        "label": "Collaborative Arrangement, Percentage Of Profits To Be Received, Triggering Event, Subsequent To Maximum Percentage Of Amounts Advanced Being Met",
        "terseLabel": "Collaboration agreement, percentage of profits to be received, triggering event, subsequent to maximum percentage of amounts advanced being met"
       }
      }
     },
     "localname": "CollaborativeArrangementPercentageOfProfitsToBeReceivedTriggeringEventSubsequentToMaximumPercentageOfAmountsAdvancedBeingMet",
     "nsuri": "http://thecronosgroup.com/20210630",
     "presentation": [
      "http://thecronosgroup.com/role/InvestmentsNarrativeDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "cron_CollaborativeArrangementProfitsToBeReceivedMaximumPercentageOfAmountsAdvanced": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Collaborative Arrangement, Profits To Be Received, Maximum Percentage Of Amounts Advanced",
        "label": "Collaborative Arrangement, Profits To Be Received, Maximum Percentage Of Amounts Advanced",
        "terseLabel": "Collaboration agreement, profits to be received, maximum percentage of amounts advanced"
       }
      }
     },
     "localname": "CollaborativeArrangementProfitsToBeReceivedMaximumPercentageOfAmountsAdvanced",
     "nsuri": "http://thecronosgroup.com/20210630",
     "presentation": [
      "http://thecronosgroup.com/role/InvestmentsNarrativeDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "cron_CollaborativeArrangementTermOfAgreement": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Collaborative Arrangement, Term Of Agreement",
        "label": "Collaborative Arrangement, Term Of Agreement",
        "terseLabel": "Collaboration agreement, term of agreement"
       }
      }
     },
     "localname": "CollaborativeArrangementTermOfAgreement",
     "nsuri": "http://thecronosgroup.com/20210630",
     "presentation": [
      "http://thecronosgroup.com/role/InvestmentsNarrativeDetails"
     ],
     "xbrltype": "durationItemType"
    },
    "cron_CronosAustraliaLimitedMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Cronos Australia Limited [Member]",
        "label": "Cronos Australia Limited [Member]",
        "terseLabel": "Cronos Australia"
       }
      }
     },
     "localname": "CronosAustraliaLimitedMember",
     "nsuri": "http://thecronosgroup.com/20210630",
     "presentation": [
      "http://thecronosgroup.com/role/BackgroundBasisofPresentationandAccountingPoliciesDetails",
      "http://thecronosgroup.com/role/InvestmentsScheduleofInvestmentsinAssociatesandJointVenturesDetails",
      "http://thecronosgroup.com/role/InvestmentsScheduleofVariableInterestEntitiesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "cron_CronosGroupInc.Member": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Cronos Group, Inc. [Member]",
        "label": "Cronos Group, Inc. [Member]",
        "terseLabel": "Cronos Group, Inc."
       }
      }
     },
     "localname": "CronosGroupInc.Member",
     "nsuri": "http://thecronosgroup.com/20210630",
     "presentation": [
      "http://thecronosgroup.com/role/DerivativeLiabilitiesNarrativeDetails",
      "http://thecronosgroup.com/role/InvestmentsScheduleofInvestmentsinAssociatesandJointVenturesDetails",
      "http://thecronosgroup.com/role/LoansReceivablenetDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "cron_CronosGrowCoCreditFacilityMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Cronos GrowCo Credit Facility [Member]",
        "label": "Cronos GrowCo Credit Facility [Member]",
        "terseLabel": "GrowCo Facility"
       }
      }
     },
     "localname": "CronosGrowCoCreditFacilityMember",
     "nsuri": "http://thecronosgroup.com/20210630",
     "presentation": [
      "http://thecronosgroup.com/role/LoansReceivablenetDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "cron_CronosGrowingCompanyInc.Member": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Cronos Growing Company Inc. [Member]",
        "label": "Cronos Growing Company Inc. [Member]",
        "terseLabel": "Cronos GrowCo"
       }
      }
     },
     "localname": "CronosGrowingCompanyInc.Member",
     "nsuri": "http://thecronosgroup.com/20210630",
     "presentation": [
      "http://thecronosgroup.com/role/InvestmentsNarrativeDetails",
      "http://thecronosgroup.com/role/InvestmentsScheduleofInvestmentsinAssociatesandJointVenturesDetails",
      "http://thecronosgroup.com/role/InvestmentsScheduleofVariableInterestEntitiesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "cron_DeferredCompensationSharebasedArrangementsLiabilityRollForward": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Deferred Compensation Share-based Arrangements, Liability [Roll Forward]",
        "label": "Deferred Compensation Share-based Arrangements, Liability [Roll Forward]",
        "terseLabel": "Deferred Compensation Share-based Arrangements, Liability [Roll Forward]",
        "verboseLabel": "Financial liability"
       }
      }
     },
     "localname": "DeferredCompensationSharebasedArrangementsLiabilityRollForward",
     "nsuri": "http://thecronosgroup.com/20210630",
     "presentation": [
      "http://thecronosgroup.com/role/SharebasedPaymentsSummaryofChangesinRSUsDetails",
      "http://thecronosgroup.com/role/SharebasedPaymentsSummaryofDSUActivityDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "cron_DeferredShareUnitsDSUsMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Deferred Share Units (DSUs) [Member]",
        "label": "Deferred Share Units (DSUs) [Member]",
        "terseLabel": "Deferred Share Units (DSUs)"
       }
      }
     },
     "localname": "DeferredShareUnitsDSUsMember",
     "nsuri": "http://thecronosgroup.com/20210630",
     "presentation": [
      "http://thecronosgroup.com/role/SharebasedPaymentsSummaryofDSUActivityDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "cron_DerivativeInstrumentsRollForward": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Derivative Instruments [Roll Forward]",
        "label": "Derivative Instruments [Roll Forward]",
        "terseLabel": "Derivative Instruments [Roll Forward]"
       }
      }
     },
     "localname": "DerivativeInstrumentsRollForward",
     "nsuri": "http://thecronosgroup.com/20210630",
     "presentation": [
      "http://thecronosgroup.com/role/DerivativeLiabilitiesScheduleofReconciliationofCarryingAmountsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "cron_DerivativeLiabilityUsefulLifeTerm": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Derivative Liability, Useful Life, Term",
        "label": "Derivative Liability, Useful Life, Term",
        "terseLabel": "Expected life"
       }
      }
     },
     "localname": "DerivativeLiabilityUsefulLifeTerm",
     "nsuri": "http://thecronosgroup.com/20210630",
     "presentation": [
      "http://thecronosgroup.com/role/DerivativeLiabilitiesScheduleofFairValuesofDerivativeLiabilitiesDetails"
     ],
     "xbrltype": "durationItemType"
    },
    "cron_ErrorRelatedToExerciseOfTopUpRightsMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Error Related To Exercise Of Top-Up Rights",
        "label": "Error Related To Exercise Of Top-Up Rights [Member]",
        "terseLabel": "Error Related to Exercise of Top-up Rights"
       }
      }
     },
     "localname": "ErrorRelatedToExerciseOfTopUpRightsMember",
     "nsuri": "http://thecronosgroup.com/20210630",
     "presentation": [
      "http://thecronosgroup.com/role/BackgroundBasisofPresentationandAccountingPoliciesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "cron_ErrorRelatedToWithholdingTaxesOnTheNetExerciseOfStockOptionsMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Error Related To Withholding Taxes On The Net Exercise Of Stock Options",
        "label": "Error Related To Withholding Taxes On The Net Exercise Of Stock Options [Member]",
        "terseLabel": "Error Related to Withholding Taxes on the Net Exercise of Stock Options"
       }
      }
     },
     "localname": "ErrorRelatedToWithholdingTaxesOnTheNetExerciseOfStockOptionsMember",
     "nsuri": "http://thecronosgroup.com/20210630",
     "presentation": [
      "http://thecronosgroup.com/role/BackgroundBasisofPresentationandAccountingPoliciesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "cron_FairValueNetDerivativeAssetLiabilityMeasuredOnRecurringBasisUnobservableInputsReconciliationOutOfPeriodAdjustment": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Fair Value, Net Derivative Asset (Liability) Measured On Recurring Basis, Unobservable Inputs Reconciliation, Out-Of-Period Adjustment",
        "label": "Fair Value, Net Derivative Asset (Liability) Measured On Recurring Basis, Unobservable Inputs Reconciliation, Out-Of-Period Adjustment",
        "negatedLabel": "Derivative liability, out-of-period adjustment",
        "negatedTerseLabel": "Out-of-period adjustment"
       }
      }
     },
     "localname": "FairValueNetDerivativeAssetLiabilityMeasuredOnRecurringBasisUnobservableInputsReconciliationOutOfPeriodAdjustment",
     "nsuri": "http://thecronosgroup.com/20210630",
     "presentation": [
      "http://thecronosgroup.com/role/DerivativeLiabilitiesNarrativeDetails",
      "http://thecronosgroup.com/role/DerivativeLiabilitiesScheduleofReconciliationofCarryingAmountsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "cron_FinancingReceivableAccruedInterestCurrent": {
     "auth_ref": [],
     "calculation": {
      "http://thecronosgroup.com/role/LoansReceivablenetDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_NotesAndLoansReceivableNetCurrent",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Financing Receivable, Accrued Interest, Current",
        "label": "Financing Receivable, Accrued Interest, Current",
        "terseLabel": "Add: Accrued interest"
       }
      }
     },
     "localname": "FinancingReceivableAccruedInterestCurrent",
     "nsuri": "http://thecronosgroup.com/20210630",
     "presentation": [
      "http://thecronosgroup.com/role/LoansReceivablenetDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "cron_FinancingReceivableAccruedInterestNoncurrent": {
     "auth_ref": [],
     "calculation": {
      "http://thecronosgroup.com/role/LoansReceivablenetDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_NotesAndLoansReceivableNetNoncurrent",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Financing Receivable, Accrued Interest, Noncurrent",
        "label": "Financing Receivable, Accrued Interest, Noncurrent",
        "terseLabel": "Add: Accrued interest"
       }
      }
     },
     "localname": "FinancingReceivableAccruedInterestNoncurrent",
     "nsuri": "http://thecronosgroup.com/20210630",
     "presentation": [
      "http://thecronosgroup.com/role/LoansReceivablenetDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "cron_FinancingReceivableBeforeAccruedInterestCurrent": {
     "auth_ref": [],
     "calculation": {
      "http://thecronosgroup.com/role/LoansReceivablenetDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_NotesAndLoansReceivableNetCurrent",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Financing Receivable, Before Accrued Interest, Current",
        "label": "Financing Receivable, Before Accrued Interest, Current",
        "terseLabel": "Current portion of loans receivable, before accrued interest"
       }
      }
     },
     "localname": "FinancingReceivableBeforeAccruedInterestCurrent",
     "nsuri": "http://thecronosgroup.com/20210630",
     "presentation": [
      "http://thecronosgroup.com/role/LoansReceivablenetDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "cron_FinancingReceivableBeforeAccruedInterestNoncurrent": {
     "auth_ref": [],
     "calculation": {
      "http://thecronosgroup.com/role/LoansReceivablenetDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_NotesAndLoansReceivableNetNoncurrent",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Financing Receivable, Before Accrued Interest, Noncurrent",
        "label": "Financing Receivable, Before Accrued Interest, Noncurrent",
        "terseLabel": "Long term portion of loans receivable, before accrued interest"
       }
      }
     },
     "localname": "FinancingReceivableBeforeAccruedInterestNoncurrent",
     "nsuri": "http://thecronosgroup.com/20210630",
     "presentation": [
      "http://thecronosgroup.com/role/LoansReceivablenetDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "cron_FourCustomersMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Four Customers",
        "label": "Four Customers [Member]",
        "terseLabel": "Four Customers"
       }
      }
     },
     "localname": "FourCustomersMember",
     "nsuri": "http://thecronosgroup.com/20210630",
     "presentation": [
      "http://thecronosgroup.com/role/FinancialInstrumentsCreditRiskNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "cron_FourMajorCustomersMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Four Major Customers",
        "label": "Four Major Customers [Member]",
        "terseLabel": "Four Major Customers"
       }
      }
     },
     "localname": "FourMajorCustomersMember",
     "nsuri": "http://thecronosgroup.com/20210630",
     "presentation": [
      "http://thecronosgroup.com/role/SegmentInformationNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "cron_FourVendorsMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Four Vendors",
        "label": "Four Vendors [Member]",
        "terseLabel": "Four Vendors"
       }
      }
     },
     "localname": "FourVendorsMember",
     "nsuri": "http://thecronosgroup.com/20210630",
     "presentation": [
      "http://thecronosgroup.com/role/FinancialInstrumentsLiquidityRiskNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "cron_GinkgoEquityMilestonesMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Ginkgo Equity Milestones [Member]",
        "label": "Ginkgo Equity Milestones [Member]",
        "terseLabel": "Ginkgo equity milestones"
       }
      }
     },
     "localname": "GinkgoEquityMilestonesMember",
     "nsuri": "http://thecronosgroup.com/20210630",
     "presentation": [
      "http://thecronosgroup.com/role/EarningsLossPerShareScheduleofAntidilutiveSecuritiesExcludedfromComputationofDilutedSharesOutstandingDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "cron_InterestReceivedNet": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Interest Received, Net",
        "label": "Interest Received, Net",
        "terseLabel": "Interest received"
       }
      }
     },
     "localname": "InterestReceivedNet",
     "nsuri": "http://thecronosgroup.com/20210630",
     "presentation": [
      "http://thecronosgroup.com/role/CondensedConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "cron_InvestmentsInAndAdvancesToAffiliatesAtFairValueAdvancesRepayments": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Investments In And Advances To Affiliates, At Fair Value, Advances (Repayments)",
        "label": "Investments In And Advances To Affiliates, At Fair Value, Advances (Repayments)",
        "verboseLabel": "Advances to affiliates"
       }
      }
     },
     "localname": "InvestmentsInAndAdvancesToAffiliatesAtFairValueAdvancesRepayments",
     "nsuri": "http://thecronosgroup.com/20210630",
     "presentation": [
      "http://thecronosgroup.com/role/InvestmentsScheduleofInvestmentsinAssociatesandJointVenturesDetails",
      "http://thecronosgroup.com/role/LoansReceivablenetDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "cron_InvestmentsInAndAdvancesToAffiliatesAtFairValueTransferToInvestmentsInEquityAccountedInvestees": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Investments In And Advances To Affiliates, At Fair Value, Transfer To Investments In Equity Accounted Investees",
        "label": "Investments In And Advances To Affiliates, At Fair Value, Transfer To Investments In Equity Accounted Investees",
        "terseLabel": "Transfer to investments in equity accounted investees"
       }
      }
     },
     "localname": "InvestmentsInAndAdvancesToAffiliatesAtFairValueTransferToInvestmentsInEquityAccountedInvestees",
     "nsuri": "http://thecronosgroup.com/20210630",
     "presentation": [
      "http://thecronosgroup.com/role/InvestmentsScheduleofInvestmentsinAssociatesandJointVenturesDetails",
      "http://thecronosgroup.com/role/LoansReceivablenetDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "cron_InvestmentsInAndAdvancesToAffiliatesFundingCommitmentPercentage": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Investments In And Advances To Affiliates, Funding Commitment Percentage",
        "label": "Investments In And Advances To Affiliates, Funding Commitment Percentage",
        "terseLabel": "Funding commitment percentage"
       }
      }
     },
     "localname": "InvestmentsInAndAdvancesToAffiliatesFundingCommitmentPercentage",
     "nsuri": "http://thecronosgroup.com/20210630",
     "presentation": [
      "http://thecronosgroup.com/role/InvestmentsScheduleofInvestmentsinAssociatesandJointVenturesDetails",
      "http://thecronosgroup.com/role/LoansReceivablenetDetails"
     ],
     "xbrltype": "pureItemType"
    },
    "cron_LesseeOperatingLeaseAreaOfLandToBeDisposedOf": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Lessee, Operating Lease, Area Of Land To Be Disposed Of",
        "label": "Lessee, Operating Lease, Area Of Land To Be Disposed Of",
        "terseLabel": "Lessee, operating lease, area of land to be disposed of (in sqft)"
       }
      }
     },
     "localname": "LesseeOperatingLeaseAreaOfLandToBeDisposedOf",
     "nsuri": "http://thecronosgroup.com/20210630",
     "presentation": [
      "http://thecronosgroup.com/role/ImpairmentLossonLongLivedAssetsDetails"
     ],
     "xbrltype": "areaItemType"
    },
    "cron_LoanReceivableNameAxis": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Loan Receivable, Name [Axis]",
        "label": "Loan Receivable, Name [Axis]",
        "terseLabel": "Loan Receivable, Name [Axis]"
       }
      }
     },
     "localname": "LoanReceivableNameAxis",
     "nsuri": "http://thecronosgroup.com/20210630",
     "presentation": [
      "http://thecronosgroup.com/role/InvestmentsNarrativeDetails",
      "http://thecronosgroup.com/role/InvestmentsScheduleofInvestmentsinAssociatesandJointVenturesDetails",
      "http://thecronosgroup.com/role/LoansReceivablenetDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "cron_LoanReceivableNameDomain": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "[Domain] for Loan Receivable, Name [Axis]",
        "label": "Loan Receivable, Name [Domain]",
        "terseLabel": "Loan Receivable, Name [Domain]"
       }
      }
     },
     "localname": "LoanReceivableNameDomain",
     "nsuri": "http://thecronosgroup.com/20210630",
     "presentation": [
      "http://thecronosgroup.com/role/InvestmentsNarrativeDetails",
      "http://thecronosgroup.com/role/InvestmentsScheduleofInvestmentsinAssociatesandJointVenturesDetails",
      "http://thecronosgroup.com/role/LoansReceivablenetDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "cron_LossContingencyPunitiveDamagesSoughtValue": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Loss Contingency, Punitive Damages Sought, Value",
        "label": "Loss Contingency, Punitive Damages Sought, Value",
        "terseLabel": "Punitive damages sought"
       }
      }
     },
     "localname": "LossContingencyPunitiveDamagesSoughtValue",
     "nsuri": "http://thecronosgroup.com/20210630",
     "presentation": [
      "http://thecronosgroup.com/role/CommitmentsandContingenciesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "cron_MeasurementInputSubscriptionPriceMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Measurement Input, Subscription Price [Member]",
        "label": "Measurement Input, Subscription Price [Member]",
        "terseLabel": "Subscription price"
       }
      }
     },
     "localname": "MeasurementInputSubscriptionPriceMember",
     "nsuri": "http://thecronosgroup.com/20210630",
     "presentation": [
      "http://thecronosgroup.com/role/DerivativeLiabilitiesScheduleofFairValuesofDerivativeLiabilitiesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "cron_MedMenCanadaInc.Member": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "MedMen Canada Inc. [Member]",
        "label": "MedMen Canada Inc. [Member]",
        "terseLabel": "MedMen Canada"
       }
      }
     },
     "localname": "MedMenCanadaInc.Member",
     "nsuri": "http://thecronosgroup.com/20210630",
     "presentation": [
      "http://thecronosgroup.com/role/InvestmentsNarrativeDetails",
      "http://thecronosgroup.com/role/InvestmentsScheduleofVariableInterestEntitiesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "cron_NatuEraMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "NatuEra [Member]",
        "label": "NatuEra [Member]",
        "terseLabel": "Natuera"
       }
      }
     },
     "localname": "NatuEraMember",
     "nsuri": "http://thecronosgroup.com/20210630",
     "presentation": [
      "http://thecronosgroup.com/role/InvestmentsScheduleofVariableInterestEntitiesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "cron_NatuEraSeriesALoanMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "NatuEra Series A Loan [Member]",
        "label": "NatuEra Series A Loan [Member]",
        "terseLabel": "NatuEra Series A Loan"
       }
      }
     },
     "localname": "NatuEraSeriesALoanMember",
     "nsuri": "http://thecronosgroup.com/20210630",
     "presentation": [
      "http://thecronosgroup.com/role/InvestmentsScheduleofInvestmentsinAssociatesandJointVenturesDetails",
      "http://thecronosgroup.com/role/LoansReceivablenetDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "cron_NatueraMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Natuera [Member]",
        "label": "Natuera [Member]",
        "terseLabel": "Natuera"
       }
      }
     },
     "localname": "NatueraMember",
     "nsuri": "http://thecronosgroup.com/20210630",
     "presentation": [
      "http://thecronosgroup.com/role/InvestmentsNarrativeDetails",
      "http://thecronosgroup.com/role/InvestmentsScheduleofInvestmentsinAssociatesandJointVenturesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "cron_NovologGroupMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Novolog Group",
        "label": "Novolog Group [Member]",
        "terseLabel": "Novolog Group"
       }
      }
     },
     "localname": "NovologGroupMember",
     "nsuri": "http://thecronosgroup.com/20210630",
     "presentation": [
      "http://thecronosgroup.com/role/SegmentInformationNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "cron_NumberOfAdultuseBrands": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number Of Adult-use Brands",
        "label": "Number Of Adult-use Brands",
        "terseLabel": "Number of adult-use brands"
       }
      }
     },
     "localname": "NumberOfAdultuseBrands",
     "nsuri": "http://thecronosgroup.com/20210630",
     "presentation": [
      "http://thecronosgroup.com/role/BackgroundBasisofPresentationandAccountingPoliciesDetails"
     ],
     "xbrltype": "integerItemType"
    },
    "cron_NumberOfContinentsWithInternationalProductionAndDistribution": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number Of Continents With International Production And Distribution",
        "label": "Number Of Continents With International Production And Distribution",
        "terseLabel": "Number of continents with international production and distribution"
       }
      }
     },
     "localname": "NumberOfContinentsWithInternationalProductionAndDistribution",
     "nsuri": "http://thecronosgroup.com/20210630",
     "presentation": [
      "http://thecronosgroup.com/role/BackgroundBasisofPresentationandAccountingPoliciesDetails"
     ],
     "xbrltype": "integerItemType"
    },
    "cron_NumberOfHempDerivedPersonalCareBrands": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number Of Hemp-derived Personal Care Brands",
        "label": "Number Of Hemp-derived Personal Care Brands",
        "terseLabel": "Number of hemp-derived cannabidiol personal care brands"
       }
      }
     },
     "localname": "NumberOfHempDerivedPersonalCareBrands",
     "nsuri": "http://thecronosgroup.com/20210630",
     "presentation": [
      "http://thecronosgroup.com/role/BackgroundBasisofPresentationandAccountingPoliciesDetails"
     ],
     "xbrltype": "integerItemType"
    },
    "cron_OneVendorMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "One Vendor",
        "label": "One Vendor [Member]",
        "terseLabel": "One Vendor"
       }
      }
     },
     "localname": "OneVendorMember",
     "nsuri": "http://thecronosgroup.com/20210630",
     "presentation": [
      "http://thecronosgroup.com/role/FinancialInstrumentsLiquidityRiskNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "cron_OntarioCannabisRetailCorporationMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Ontario Cannabis Retail Corporation",
        "label": "Ontario Cannabis Retail Corporation [Member]",
        "terseLabel": "Ontario Cannabis Retail Corporation"
       }
      }
     },
     "localname": "OntarioCannabisRetailCorporationMember",
     "nsuri": "http://thecronosgroup.com/20210630",
     "presentation": [
      "http://thecronosgroup.com/role/SegmentInformationNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "cron_OriginalBCMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Original BC",
        "label": "Original BC [Member]",
        "terseLabel": "OGBC"
       }
      }
     },
     "localname": "OriginalBCMember",
     "nsuri": "http://thecronosgroup.com/20210630",
     "presentation": [
      "http://thecronosgroup.com/role/HeldForSaleAssetsandDiscontinuedOperationsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "cron_OtherCostOfGoodsAndServicesSold": {
     "auth_ref": [],
     "calculation": {
      "http://thecronosgroup.com/role/CondensedConsolidatedStatementsofNetIncomeLossandComprehensiveIncomeLoss": {
       "order": 2.0,
       "parentTag": "us-gaap_GrossProfit",
       "weight": -1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Other Cost Of Goods And Services Sold",
        "label": "Other Cost Of Goods And Services Sold",
        "terseLabel": "Cost of sales"
       }
      }
     },
     "localname": "OtherCostOfGoodsAndServicesSold",
     "nsuri": "http://thecronosgroup.com/20210630",
     "presentation": [
      "http://thecronosgroup.com/role/CondensedConsolidatedStatementsofNetIncomeLossandComprehensiveIncomeLoss"
     ],
     "xbrltype": "monetaryItemType"
    },
    "cron_OtherCountriesMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Other Countries [Member]",
        "label": "Other Countries [Member]",
        "terseLabel": "Other countries"
       }
      }
     },
     "localname": "OtherCountriesMember",
     "nsuri": "http://thecronosgroup.com/20210630",
     "presentation": [
      "http://thecronosgroup.com/role/SegmentInformationScheduleofRevenuefromExternalCustomersbyGeographicAreasDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "cron_PharmacannMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Pharmacann",
        "label": "Pharmacann [Member]",
        "terseLabel": "Pharmacann"
       }
      }
     },
     "localname": "PharmacannMember",
     "nsuri": "http://thecronosgroup.com/20210630",
     "presentation": [
      "http://thecronosgroup.com/role/InvestmentsNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "cron_PreEmptiveRightsAndTopUpRightsMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Pre-Emptive Rights And Top-Up Rights",
        "label": "Pre-Emptive Rights And Top-Up Rights [Member]",
        "terseLabel": "Pre-emptive Rights and Top-up Rights"
       }
      }
     },
     "localname": "PreEmptiveRightsAndTopUpRightsMember",
     "nsuri": "http://thecronosgroup.com/20210630",
     "presentation": [
      "http://thecronosgroup.com/role/DerivativeLiabilitiesScheduleofFairValuesofDerivativeLiabilitiesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "cron_PreemptiveRightsMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Pre-emptive Rights [Member]",
        "label": "Pre-emptive Rights [Member]",
        "terseLabel": "Pre-emptive Rights",
        "verboseLabel": "Pre-emptive Rights"
       }
      }
     },
     "localname": "PreemptiveRightsMember",
     "nsuri": "http://thecronosgroup.com/20210630",
     "presentation": [
      "http://thecronosgroup.com/role/DerivativeLiabilitiesNarrativeDetails",
      "http://thecronosgroup.com/role/DerivativeLiabilitiesScheduleofFairValuesofDerivativeLiabilitiesDetails",
      "http://thecronosgroup.com/role/DerivativeLiabilitiesScheduleofReconciliationofCarryingAmountsDetails",
      "http://thecronosgroup.com/role/DerivativeLiabilitiesScheduleofSensitivityAnalysisDetails",
      "http://thecronosgroup.com/role/EarningsLossPerShareScheduleofAntidilutiveSecuritiesExcludedfromComputationofDilutedSharesOutstandingDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "cron_PriorOptionPlansMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Prior Option Plans",
        "label": "Prior Option Plans [Member]",
        "terseLabel": "Prior Option Plans"
       }
      }
     },
     "localname": "PriorOptionPlansMember",
     "nsuri": "http://thecronosgroup.com/20210630",
     "presentation": [
      "http://thecronosgroup.com/role/SharebasedPaymentsStockOptionsNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "cron_RestOfWorldSegmentMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Rest Of World Segment [Member]",
        "label": "Rest Of World Segment [Member]",
        "terseLabel": "Rest of World"
       }
      }
     },
     "localname": "RestOfWorldSegmentMember",
     "nsuri": "http://thecronosgroup.com/20210630",
     "presentation": [
      "http://thecronosgroup.com/role/SegmentInformationNarrativeDetails",
      "http://thecronosgroup.com/role/SegmentInformationScheduleofAdjustedEBITDADetails",
      "http://thecronosgroup.com/role/SegmentInformationScheduleofSegmentDataDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "cron_RestatementReviewExpense": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Restatement Review Expense",
        "label": "Restatement Review Expense",
        "verboseLabel": "Review costs related to restatement of 2019 interim financial statements"
       }
      }
     },
     "localname": "RestatementReviewExpense",
     "nsuri": "http://thecronosgroup.com/20210630",
     "presentation": [
      "http://thecronosgroup.com/role/SegmentInformationScheduleofAdjustedEBITDADetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "cron_SensitivityAnalysisImpactOf10PercentDecreaseIncreaseInExpectedAnnualizedVolatilityOnNetIncomeLoss": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Sensitivity Analysis, Impact Of 10 Percent Decrease (Increase) In Expected Annualized Volatility On Net Income (Loss)",
        "label": "Sensitivity Analysis, Impact Of 10 Percent Decrease (Increase) In Expected Annualized Volatility On Net Income (Loss)",
        "terseLabel": "Expected annualized volatility"
       }
      }
     },
     "localname": "SensitivityAnalysisImpactOf10PercentDecreaseIncreaseInExpectedAnnualizedVolatilityOnNetIncomeLoss",
     "nsuri": "http://thecronosgroup.com/20210630",
     "presentation": [
      "http://thecronosgroup.com/role/DerivativeLiabilitiesScheduleofSensitivityAnalysisDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "cron_SensitivityAnalysisImpactOf10PercentDecreaseIncreaseInSharePriceOnNetIncomeLoss": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Sensitivity Analysis, Impact Of 10 Percent Decrease (Increase) In Share Price On Net Income (Loss)",
        "label": "Sensitivity Analysis, Impact Of 10 Percent Decrease (Increase) In Share Price On Net Income (Loss)",
        "terseLabel": "Share price"
       }
      }
     },
     "localname": "SensitivityAnalysisImpactOf10PercentDecreaseIncreaseInSharePriceOnNetIncomeLoss",
     "nsuri": "http://thecronosgroup.com/20210630",
     "presentation": [
      "http://thecronosgroup.com/role/DerivativeLiabilitiesScheduleofSensitivityAnalysisDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "cron_SensitivityAnalysisImpactOf10PercentDecreaseIncreaseInWeightedAverageExpectedLifeOnNetIncomeLoss": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Sensitivity Analysis, Impact Of 10 Percent Decrease (Increase) In Weighted Average Expected Life On Net Income (Loss)",
        "label": "Sensitivity Analysis, Impact Of 10 Percent Decrease (Increase) In Weighted Average Expected Life On Net Income (Loss)",
        "terseLabel": "Weighted average expected life"
       }
      }
     },
     "localname": "SensitivityAnalysisImpactOf10PercentDecreaseIncreaseInWeightedAverageExpectedLifeOnNetIncomeLoss",
     "nsuri": "http://thecronosgroup.com/20210630",
     "presentation": [
      "http://thecronosgroup.com/role/DerivativeLiabilitiesScheduleofSensitivityAnalysisDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "cron_SensitivityAnalysisImpactOf10PercentDecreaseIncreaseOnNetIncomeLossAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Sensitivity Analysis, Impact Of 10 Percent Decrease (Increase) On Net Income (Loss) [Abstract]",
        "label": "Sensitivity Analysis, Impact Of 10 Percent Decrease (Increase) On Net Income (Loss) [Abstract]",
        "terseLabel": "Sensitivity Analysis, Impact of 10 Percent Decrease (Increase) on Net Income (Loss) [Abstract]"
       }
      }
     },
     "localname": "SensitivityAnalysisImpactOf10PercentDecreaseIncreaseOnNetIncomeLossAbstract",
     "nsuri": "http://thecronosgroup.com/20210630",
     "presentation": [
      "http://thecronosgroup.com/role/DerivativeLiabilitiesScheduleofSensitivityAnalysisDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "cron_SensitivityAnalysisImpactOnNetIncomeLossTableTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Sensitivity Analysis, Impact On Net Income (Loss) [Table Text Block]",
        "label": "Sensitivity Analysis, Impact On Net Income (Loss) [Table Text Block]",
        "terseLabel": "Schedule of Sensitivity Analysis"
       }
      }
     },
     "localname": "SensitivityAnalysisImpactOnNetIncomeLossTableTextBlock",
     "nsuri": "http://thecronosgroup.com/20210630",
     "presentation": [
      "http://thecronosgroup.com/role/DerivativeLiabilitiesTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "cron_SensitivityAnalysisOfCarryingValueNetAssetsImpactOf10PercentChangeInExchangeRate": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Sensitivity Analysis Of Carrying Value, Net Assets, Impact Of 10 Percent Change In Exchange Rate",
        "label": "Sensitivity Analysis Of Carrying Value, Net Assets, Impact Of 10 Percent Change In Exchange Rate",
        "terseLabel": "Impact of ten percent change in exchange rate"
       }
      }
     },
     "localname": "SensitivityAnalysisOfCarryingValueNetAssetsImpactOf10PercentChangeInExchangeRate",
     "nsuri": "http://thecronosgroup.com/20210630",
     "presentation": [
      "http://thecronosgroup.com/role/FinancialInstrumentsCurrencyRateRiskNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "cron_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedAndIssuedInPeriod": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Share-Based Compensation Arrangement By Share-Based Payment Award, Equity Instruments Other Than Options, Vested And Issued In Period",
        "label": "Share-Based Compensation Arrangement By Share-Based Payment Award, Equity Instruments Other Than Options, Vested And Issued In Period",
        "negatedTerseLabel": "Vested and issued/liabilities settled (in shares)"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedAndIssuedInPeriod",
     "nsuri": "http://thecronosgroup.com/20210630",
     "presentation": [
      "http://thecronosgroup.com/role/SharebasedPaymentsSummaryofChangesinRSUsDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "cron_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedAndIssuedInPeriodWeightedAverageGrantDateFairValue": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Share-Based Compensation Arrangement By Share-Based Payment Award, Equity Instruments Other Than Options, Vested And Issued In Period, Weighted Average Grant Date Fair Value",
        "label": "Share-Based Compensation Arrangement By Share-Based Payment Award, Equity Instruments Other Than Options, Vested And Issued In Period, Weighted Average Grant Date Fair Value",
        "terseLabel": "Vested and issued (in dollars per share)"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedAndIssuedInPeriodWeightedAverageGrantDateFairValue",
     "nsuri": "http://thecronosgroup.com/20210630",
     "presentation": [
      "http://thecronosgroup.com/role/SharebasedPaymentsSummaryofChangesinRSUsDetails"
     ],
     "xbrltype": "perShareItemType"
    },
    "cron_ShareBasedPaymentArrangementGainLossOnRevaluation": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Share-based Payment Arrangement, Gain (Loss) On Revaluation",
        "label": "Share-based Payment Arrangement, Gain (Loss) On Revaluation",
        "negatedTerseLabel": "Loss on revaluation"
       }
      }
     },
     "localname": "ShareBasedPaymentArrangementGainLossOnRevaluation",
     "nsuri": "http://thecronosgroup.com/20210630",
     "presentation": [
      "http://thecronosgroup.com/role/SharebasedPaymentsSummaryofDSUActivityDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "cron_ShareBasedPaymentArrangementLiabilitiesSettled": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Share-based Payment Arrangement, Liabilities Settled",
        "label": "Share-based Payment Arrangement, Liabilities Settled",
        "negatedTerseLabel": "DSU liabilities settled"
       }
      }
     },
     "localname": "ShareBasedPaymentArrangementLiabilitiesSettled",
     "nsuri": "http://thecronosgroup.com/20210630",
     "presentation": [
      "http://thecronosgroup.com/role/SharebasedPaymentsSummaryofDSUActivityDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "cron_SharebasedCompensationArrangementBySharebasedPaymentAwardWarrantsExercisesInPeriod": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Share-based Compensation Arrangement By Share-based Payment Award, Warrants, Exercises In Period",
        "label": "Share-based Compensation Arrangement By Share-based Payment Award, Warrants, Exercises In Period",
        "terseLabel": "Warrants exercised (in shares)"
       }
      }
     },
     "localname": "SharebasedCompensationArrangementBySharebasedPaymentAwardWarrantsExercisesInPeriod",
     "nsuri": "http://thecronosgroup.com/20210630",
     "presentation": [
      "http://thecronosgroup.com/role/CondensedConsolidatedStatementsofChangesinEquity"
     ],
     "xbrltype": "sharesItemType"
    },
    "cron_SocieteQuebecoiseDuCannabisMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Societe Quebecoise du Cannabis",
        "label": "Societe Quebecoise du Cannabis [Member]",
        "terseLabel": "Societe Quebecoise Du Cannabis"
       }
      }
     },
     "localname": "SocieteQuebecoiseDuCannabisMember",
     "nsuri": "http://thecronosgroup.com/20210630",
     "presentation": [
      "http://thecronosgroup.com/role/SegmentInformationNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "cron_StockIssuedDuringPeriodValueTopupRightsExercised": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Stock Issued During Period, Value, Top-up Rights Exercised",
        "label": "Stock Issued During Period, Value, Top-up Rights Exercised",
        "terseLabel": "Top-up rights exercised"
       }
      }
     },
     "localname": "StockIssuedDuringPeriodValueTopupRightsExercised",
     "nsuri": "http://thecronosgroup.com/20210630",
     "presentation": [
      "http://thecronosgroup.com/role/CondensedConsolidatedStatementsofChangesinEquity"
     ],
     "xbrltype": "monetaryItemType"
    },
    "cron_StockIssuedDuringPeriodValueWarrantsExercised": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Stock Issued During Period, Value, Warrants Exercised",
        "label": "Stock Issued During Period, Value, Warrants Exercised",
        "terseLabel": "Warrants exercised"
       }
      }
     },
     "localname": "StockIssuedDuringPeriodValueWarrantsExercised",
     "nsuri": "http://thecronosgroup.com/20210630",
     "presentation": [
      "http://thecronosgroup.com/role/CondensedConsolidatedStatementsofChangesinEquity"
     ],
     "xbrltype": "monetaryItemType"
    },
    "cron_StockholdersEquityOutOfPeriodAdjustment": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Stockholders' Equity, Out-Of-Period Adjustment",
        "label": "Stockholders' Equity, Out-Of-Period Adjustment",
        "terseLabel": "Top-up rights out-of-period adjustment"
       }
      }
     },
     "localname": "StockholdersEquityOutOfPeriodAdjustment",
     "nsuri": "http://thecronosgroup.com/20210630",
     "presentation": [
      "http://thecronosgroup.com/role/CondensedConsolidatedStatementsofChangesinEquity"
     ],
     "xbrltype": "monetaryItemType"
    },
    "cron_SubsidiaryOrEquityMethodInvesteeCumulativePercentageOwnershipAfterAllTransactionsIfWarrantsExercised": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Subsidiary Or Equity Method Investee, Cumulative Percentage Ownership After All Transactions, If Warrants Exercised",
        "label": "Subsidiary Or Equity Method Investee, Cumulative Percentage Ownership After All Transactions, If Warrants Exercised",
        "terseLabel": "Ownership percentage, if warrant exercised"
       }
      }
     },
     "localname": "SubsidiaryOrEquityMethodInvesteeCumulativePercentageOwnershipAfterAllTransactionsIfWarrantsExercised",
     "nsuri": "http://thecronosgroup.com/20210630",
     "presentation": [
      "http://thecronosgroup.com/role/DerivativeLiabilitiesNarrativeDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "cron_TopUpRightsFixedPriceMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Top-Up Rights - Fixed Price [Member]",
        "label": "Top-Up Rights - Fixed Price [Member]",
        "terseLabel": "Top-up Rights \u2013 fixed price"
       }
      }
     },
     "localname": "TopUpRightsFixedPriceMember",
     "nsuri": "http://thecronosgroup.com/20210630",
     "presentation": [
      "http://thecronosgroup.com/role/EarningsLossPerShareScheduleofAntidilutiveSecuritiesExcludedfromComputationofDilutedSharesOutstandingDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "cron_TopUpRightsMarketPriceMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Top-Up Rights - Market Price [Member]",
        "label": "Top-Up Rights - Market Price [Member]",
        "terseLabel": "Top-up Rights \u2013 market price"
       }
      }
     },
     "localname": "TopUpRightsMarketPriceMember",
     "nsuri": "http://thecronosgroup.com/20210630",
     "presentation": [
      "http://thecronosgroup.com/role/EarningsLossPerShareScheduleofAntidilutiveSecuritiesExcludedfromComputationofDilutedSharesOutstandingDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "cron_TopupRightsMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Top-up Rights [Member]",
        "label": "Top-up Rights [Member]",
        "verboseLabel": "Top-up Rights"
       }
      }
     },
     "localname": "TopupRightsMember",
     "nsuri": "http://thecronosgroup.com/20210630",
     "presentation": [
      "http://thecronosgroup.com/role/DerivativeLiabilitiesNarrativeDetails",
      "http://thecronosgroup.com/role/DerivativeLiabilitiesScheduleofFairValuesofDerivativeLiabilitiesDetails",
      "http://thecronosgroup.com/role/DerivativeLiabilitiesScheduleofReconciliationofCarryingAmountsDetails",
      "http://thecronosgroup.com/role/DerivativeLiabilitiesScheduleofSensitivityAnalysisDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "cron_USDistrictCourtOfEasternDistrictOfNewYorkVsCronosMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "U.S. District Court of Eastern District of New York Vs. Cronos",
        "label": "U.S. District Court of Eastern District of New York Vs. Cronos [Member]",
        "terseLabel": "U.S. District Court of Eastern District of New York Vs. Cronos"
       }
      }
     },
     "localname": "USDistrictCourtOfEasternDistrictOfNewYorkVsCronosMember",
     "nsuri": "http://thecronosgroup.com/20210630",
     "presentation": [
      "http://thecronosgroup.com/role/CommitmentsandContingenciesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "cron_UnitedStatesSegmentMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "United States Segment [Member]",
        "label": "United States Segment [Member]",
        "terseLabel": "United States"
       }
      }
     },
     "localname": "UnitedStatesSegmentMember",
     "nsuri": "http://thecronosgroup.com/20210630",
     "presentation": [
      "http://thecronosgroup.com/role/ImpairmentLossonLongLivedAssetsDetails",
      "http://thecronosgroup.com/role/SegmentInformationNarrativeDetails",
      "http://thecronosgroup.com/role/SegmentInformationScheduleofAdjustedEBITDADetails",
      "http://thecronosgroup.com/role/SegmentInformationScheduleofSegmentDataDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "cron_VariableInterestEntityQualitativeOrQuantitativeInformationLicenseTerm": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Variable Interest Entity, Qualitative Or Quantitative Information, License Term",
        "label": "Variable Interest Entity, Qualitative Or Quantitative Information, License Term",
        "terseLabel": "License term"
       }
      }
     },
     "localname": "VariableInterestEntityQualitativeOrQuantitativeInformationLicenseTerm",
     "nsuri": "http://thecronosgroup.com/20210630",
     "presentation": [
      "http://thecronosgroup.com/role/InvestmentsNarrativeDetails"
     ],
     "xbrltype": "durationItemType"
    },
    "dei_AmendmentFlag": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true when the XBRL content amends previously-filed or accepted submission.",
        "label": "Amendment Flag",
        "terseLabel": "Amendment Flag"
       }
      }
     },
     "localname": "AmendmentFlag",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://thecronosgroup.com/role/CoverPage"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_CityAreaCode": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Area code of city",
        "label": "City Area Code",
        "terseLabel": "City Area Code"
       }
      }
     },
     "localname": "CityAreaCode",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://thecronosgroup.com/role/CoverPage"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_CoverAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Cover page.",
        "label": "Cover [Abstract]",
        "terseLabel": "Cover page."
       }
      }
     },
     "localname": "CoverAbstract",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "xbrltype": "stringItemType"
    },
    "dei_CurrentFiscalYearEndDate": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "End date of current fiscal year in the format --MM-DD.",
        "label": "Current Fiscal Year End Date",
        "terseLabel": "Current Fiscal Year End Date"
       }
      }
     },
     "localname": "CurrentFiscalYearEndDate",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://thecronosgroup.com/role/CoverPage"
     ],
     "xbrltype": "gMonthDayItemType"
    },
    "dei_DocumentFiscalPeriodFocus": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Fiscal period values are FY, Q1, Q2, and Q3.  1st, 2nd and 3rd quarter 10-Q or 10-QT statements have value Q1, Q2, and Q3 respectively, with 10-K, 10-KT or other fiscal year statements having FY.",
        "label": "Document Fiscal Period Focus",
        "terseLabel": "Document Fiscal Period Focus"
       }
      }
     },
     "localname": "DocumentFiscalPeriodFocus",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://thecronosgroup.com/role/CoverPage"
     ],
     "xbrltype": "fiscalPeriodItemType"
    },
    "dei_DocumentFiscalYearFocus": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "This is focus fiscal year of the document report in YYYY format. For a 2006 annual report, which may also provide financial information from prior periods, fiscal 2006 should be given as the fiscal year focus. Example: 2006.",
        "label": "Document Fiscal Year Focus",
        "terseLabel": "Document Fiscal Year Focus"
       }
      }
     },
     "localname": "DocumentFiscalYearFocus",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://thecronosgroup.com/role/CoverPage"
     ],
     "xbrltype": "gYearItemType"
    },
    "dei_DocumentPeriodEndDate": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "For the EDGAR submission types of Form 8-K: the date of the report, the date of the earliest event reported; for the EDGAR submission types of Form N-1A: the filing date; for all other submission types: the end of the reporting or transition period.  The format of the date is YYYY-MM-DD.",
        "label": "Document Period End Date",
        "terseLabel": "Document Period End Date"
       }
      }
     },
     "localname": "DocumentPeriodEndDate",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://thecronosgroup.com/role/CoverPage"
     ],
     "xbrltype": "dateItemType"
    },
    "dei_DocumentQuarterlyReport": {
     "auth_ref": [
      "r538"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true only for a form used as an quarterly report.",
        "label": "Document Quarterly Report",
        "terseLabel": "Document Quarterly Report"
       }
      }
     },
     "localname": "DocumentQuarterlyReport",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://thecronosgroup.com/role/CoverPage"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_DocumentTransitionReport": {
     "auth_ref": [
      "r539"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true only for a form used as a transition report.",
        "label": "Document Transition Report",
        "terseLabel": "Document Transition Report"
       }
      }
     },
     "localname": "DocumentTransitionReport",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://thecronosgroup.com/role/CoverPage"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_DocumentType": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'.",
        "label": "Document Type",
        "terseLabel": "Document Type"
       }
      }
     },
     "localname": "DocumentType",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://thecronosgroup.com/role/CoverPage"
     ],
     "xbrltype": "submissionTypeItemType"
    },
    "dei_EntityAddressAddressLine1": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Address Line 1 such as Attn, Building Name, Street Name",
        "label": "Entity Address, Address Line One",
        "terseLabel": "Entity Address, Address Line One"
       }
      }
     },
     "localname": "EntityAddressAddressLine1",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://thecronosgroup.com/role/CoverPage"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityAddressCityOrTown": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Name of the City or Town",
        "label": "Entity Address, City or Town",
        "terseLabel": "Entity Address, City or Town"
       }
      }
     },
     "localname": "EntityAddressCityOrTown",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://thecronosgroup.com/role/CoverPage"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityAddressPostalZipCode": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Code for the postal or zip code",
        "label": "Entity Address, Postal Zip Code",
        "terseLabel": "Entity Address, Postal Zip Code"
       }
      }
     },
     "localname": "EntityAddressPostalZipCode",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://thecronosgroup.com/role/CoverPage"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityAddressStateOrProvince": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Name of the state or province.",
        "label": "Entity Address, State or Province",
        "terseLabel": "Entity Address, State or Province"
       }
      }
     },
     "localname": "EntityAddressStateOrProvince",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://thecronosgroup.com/role/CoverPage"
     ],
     "xbrltype": "stateOrProvinceItemType"
    },
    "dei_EntityCentralIndexKey": {
     "auth_ref": [
      "r540"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK.",
        "label": "Entity Central Index Key",
        "terseLabel": "Entity Central Index Key"
       }
      }
     },
     "localname": "EntityCentralIndexKey",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://thecronosgroup.com/role/CoverPage"
     ],
     "xbrltype": "centralIndexKeyItemType"
    },
    "dei_EntityCommonStockSharesOutstanding": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicate number of shares or other units outstanding of each of registrant's classes of capital or common stock or other ownership interests, if and as stated on cover of related periodic report. Where multiple classes or units exist define each class/interest by adding class of stock items such as Common Class A [Member], Common Class B [Member] or Partnership Interest [Member] onto the Instrument [Domain] of the Entity Listings, Instrument.",
        "label": "Entity Common Stock, Shares Outstanding",
        "terseLabel": "Entity Common Stock, Shares Outstanding (in shares)"
       }
      }
     },
     "localname": "EntityCommonStockSharesOutstanding",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://thecronosgroup.com/role/CoverPage"
     ],
     "xbrltype": "sharesItemType"
    },
    "dei_EntityCurrentReportingStatus": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicate 'Yes' or 'No' whether registrants (1) have filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that registrants were required to file such reports), and (2) have been subject to such filing requirements for the past 90 days. This information should be based on the registrant's current or most recent filing containing the related disclosure.",
        "label": "Entity Current Reporting Status",
        "terseLabel": "Entity Current Reporting Status"
       }
      }
     },
     "localname": "EntityCurrentReportingStatus",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://thecronosgroup.com/role/CoverPage"
     ],
     "xbrltype": "yesNoItemType"
    },
    "dei_EntityDomain": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "All the names of the entities being reported upon in a document. Any legal structure used to conduct activities or to hold assets. Some examples of such structures are corporations, partnerships, limited liability companies, grantor trusts, and other trusts. This item does not include business and geographical segments which are included in the geographical or business segments domains.",
        "label": "Entity [Domain]",
        "terseLabel": "Entity [Domain]"
       }
      }
     },
     "localname": "EntityDomain",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://thecronosgroup.com/role/DerivativeLiabilitiesNarrativeDetails",
      "http://thecronosgroup.com/role/InvestmentsNarrativeDetails",
      "http://thecronosgroup.com/role/InvestmentsScheduleofInvestmentsinAssociatesandJointVenturesDetails",
      "http://thecronosgroup.com/role/LoansReceivablenetDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "dei_EntityEmergingGrowthCompany": {
     "auth_ref": [
      "r540"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicate if registrant meets the emerging growth company criteria.",
        "label": "Entity Emerging Growth Company",
        "terseLabel": "Entity Emerging Growth Company"
       }
      }
     },
     "localname": "EntityEmergingGrowthCompany",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://thecronosgroup.com/role/CoverPage"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_EntityFileNumber": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen.",
        "label": "Entity File Number",
        "terseLabel": "Entity File Number"
       }
      }
     },
     "localname": "EntityFileNumber",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://thecronosgroup.com/role/CoverPage"
     ],
     "xbrltype": "fileNumberItemType"
    },
    "dei_EntityFilerCategory": {
     "auth_ref": [
      "r540"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicate whether the registrant is one of the following: Large Accelerated Filer, Accelerated Filer, Non-accelerated Filer. Definitions of these categories are stated in Rule 12b-2 of the Exchange Act. This information should be based on the registrant's current or most recent filing containing the related disclosure.",
        "label": "Entity Filer Category",
        "terseLabel": "Entity Filer Category"
       }
      }
     },
     "localname": "EntityFilerCategory",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://thecronosgroup.com/role/CoverPage"
     ],
     "xbrltype": "filerCategoryItemType"
    },
    "dei_EntityIncorporationStateCountryCode": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Two-character EDGAR code representing the state or country of incorporation.",
        "label": "Entity Incorporation, State or Country Code",
        "terseLabel": "Entity Incorporation, State or Country Code"
       }
      }
     },
     "localname": "EntityIncorporationStateCountryCode",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://thecronosgroup.com/role/CoverPage"
     ],
     "xbrltype": "edgarStateCountryItemType"
    },
    "dei_EntityInteractiveDataCurrent": {
     "auth_ref": [
      "r544"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true when the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T during the preceding 12 months (or for such shorter period that the registrant was required to submit such files).",
        "label": "Entity Interactive Data Current",
        "terseLabel": "Entity Interactive Data Current"
       }
      }
     },
     "localname": "EntityInteractiveDataCurrent",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://thecronosgroup.com/role/CoverPage"
     ],
     "xbrltype": "yesNoItemType"
    },
    "dei_EntityRegistrantName": {
     "auth_ref": [
      "r540"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC.",
        "label": "Entity Registrant Name",
        "terseLabel": "Entity Registrant Name"
       }
      }
     },
     "localname": "EntityRegistrantName",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://thecronosgroup.com/role/CoverPage"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityShellCompany": {
     "auth_ref": [
      "r540"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true when the registrant is a shell company as defined in Rule 12b-2 of the Exchange Act.",
        "label": "Entity Shell Company",
        "terseLabel": "Entity Shell Company"
       }
      }
     },
     "localname": "EntityShellCompany",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://thecronosgroup.com/role/CoverPage"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_EntitySmallBusiness": {
     "auth_ref": [
      "r540"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicates that the company is a Smaller Reporting Company (SRC).",
        "label": "Entity Small Business",
        "terseLabel": "Entity Small Business"
       }
      }
     },
     "localname": "EntitySmallBusiness",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://thecronosgroup.com/role/CoverPage"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_LegalEntityAxis": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The set of legal entities associated with a report.",
        "label": "Legal Entity [Axis]",
        "terseLabel": "Legal Entity [Axis]"
       }
      }
     },
     "localname": "LegalEntityAxis",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://thecronosgroup.com/role/DerivativeLiabilitiesNarrativeDetails",
      "http://thecronosgroup.com/role/InvestmentsNarrativeDetails",
      "http://thecronosgroup.com/role/InvestmentsScheduleofInvestmentsinAssociatesandJointVenturesDetails",
      "http://thecronosgroup.com/role/LoansReceivablenetDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "dei_LocalPhoneNumber": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Local phone number for entity.",
        "label": "Local Phone Number",
        "terseLabel": "Local Phone Number"
       }
      }
     },
     "localname": "LocalPhoneNumber",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://thecronosgroup.com/role/CoverPage"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_Security12bTitle": {
     "auth_ref": [
      "r536"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Title of a 12(b) registered security.",
        "label": "Title of 12(b) Security",
        "terseLabel": "Title of 12(b) Security"
       }
      }
     },
     "localname": "Security12bTitle",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://thecronosgroup.com/role/CoverPage"
     ],
     "xbrltype": "securityTitleItemType"
    },
    "dei_SecurityExchangeName": {
     "auth_ref": [
      "r537"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Name of the Exchange on which a security is registered.",
        "label": "Security Exchange Name",
        "terseLabel": "Security Exchange Name"
       }
      }
     },
     "localname": "SecurityExchangeName",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://thecronosgroup.com/role/CoverPage"
     ],
     "xbrltype": "edgarExchangeCodeItemType"
    },
    "dei_TradingSymbol": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Trading symbol of an instrument as listed on an exchange.",
        "label": "Trading Symbol",
        "terseLabel": "Trading Symbol"
       }
      }
     },
     "localname": "TradingSymbol",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://thecronosgroup.com/role/CoverPage"
     ],
     "xbrltype": "tradingSymbolItemType"
    },
    "srt_ConsolidatedEntitiesAxis": {
     "auth_ref": [
      "r126",
      "r288",
      "r293",
      "r301",
      "r371",
      "r372",
      "r377",
      "r378",
      "r447",
      "r532"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Consolidated Entities [Axis]",
        "terseLabel": "Consolidated Entities [Axis]"
       }
      }
     },
     "localname": "ConsolidatedEntitiesAxis",
     "nsuri": "http://fasb.org/srt/2021-01-31",
     "presentation": [
      "http://thecronosgroup.com/role/DerivativeLiabilitiesNarrativeDetails",
      "http://thecronosgroup.com/role/InvestmentsNarrativeDetails",
      "http://thecronosgroup.com/role/InvestmentsScheduleofVariableInterestEntitiesDetails",
      "http://thecronosgroup.com/role/LoansReceivablenetDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "srt_ConsolidatedEntitiesDomain": {
     "auth_ref": [
      "r126",
      "r288",
      "r293",
      "r301",
      "r371",
      "r372",
      "r377",
      "r378",
      "r447",
      "r532"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Consolidated Entities [Domain]",
        "terseLabel": "Consolidated Entities [Domain]"
       }
      }
     },
     "localname": "ConsolidatedEntitiesDomain",
     "nsuri": "http://fasb.org/srt/2021-01-31",
     "presentation": [
      "http://thecronosgroup.com/role/DerivativeLiabilitiesNarrativeDetails",
      "http://thecronosgroup.com/role/InvestmentsNarrativeDetails",
      "http://thecronosgroup.com/role/InvestmentsScheduleofVariableInterestEntitiesDetails",
      "http://thecronosgroup.com/role/LoansReceivablenetDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "srt_ConsolidationItemsAxis": {
     "auth_ref": [
      "r126",
      "r178",
      "r191",
      "r192",
      "r193",
      "r194",
      "r196",
      "r198",
      "r202",
      "r288",
      "r289",
      "r290",
      "r291",
      "r292",
      "r293",
      "r295",
      "r296",
      "r298",
      "r300",
      "r301"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Consolidation Items [Axis]",
        "terseLabel": "Consolidation Items [Axis]"
       }
      }
     },
     "localname": "ConsolidationItemsAxis",
     "nsuri": "http://fasb.org/srt/2021-01-31",
     "presentation": [
      "http://thecronosgroup.com/role/SegmentInformationScheduleofAdjustedEBITDADetails",
      "http://thecronosgroup.com/role/SegmentInformationScheduleofSegmentDataDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "srt_ConsolidationItemsDomain": {
     "auth_ref": [
      "r126",
      "r178",
      "r191",
      "r192",
      "r193",
      "r194",
      "r196",
      "r198",
      "r202",
      "r288",
      "r289",
      "r290",
      "r291",
      "r292",
      "r293",
      "r295",
      "r296",
      "r298",
      "r300",
      "r301"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Consolidation Items [Domain]",
        "terseLabel": "Consolidation Items [Domain]"
       }
      }
     },
     "localname": "ConsolidationItemsDomain",
     "nsuri": "http://fasb.org/srt/2021-01-31",
     "presentation": [
      "http://thecronosgroup.com/role/SegmentInformationScheduleofAdjustedEBITDADetails",
      "http://thecronosgroup.com/role/SegmentInformationScheduleofSegmentDataDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "srt_EquityMethodInvesteeNameDomain": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Investment, Name [Domain]",
        "terseLabel": "Investment, Name [Domain]"
       }
      }
     },
     "localname": "EquityMethodInvesteeNameDomain",
     "nsuri": "http://fasb.org/srt/2021-01-31",
     "presentation": [
      "http://thecronosgroup.com/role/BackgroundBasisofPresentationandAccountingPoliciesDetails",
      "http://thecronosgroup.com/role/DerivativeLiabilitiesNarrativeDetails",
      "http://thecronosgroup.com/role/InvestmentsNarrativeDetails",
      "http://thecronosgroup.com/role/InvestmentsScheduleofInvestmentsinAssociatesandJointVenturesDetails",
      "http://thecronosgroup.com/role/InvestmentsScheduleofVariableInterestEntitiesDetails",
      "http://thecronosgroup.com/role/LoansReceivablenetDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "srt_LitigationCaseAxis": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Litigation Case [Axis]",
        "terseLabel": "Litigation Case [Axis]"
       }
      }
     },
     "localname": "LitigationCaseAxis",
     "nsuri": "http://fasb.org/srt/2021-01-31",
     "presentation": [
      "http://thecronosgroup.com/role/CommitmentsandContingenciesDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "srt_LitigationCaseTypeDomain": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Litigation Case [Domain]",
        "terseLabel": "Litigation Case [Domain]"
       }
      }
     },
     "localname": "LitigationCaseTypeDomain",
     "nsuri": "http://fasb.org/srt/2021-01-31",
     "presentation": [
      "http://thecronosgroup.com/role/CommitmentsandContingenciesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "srt_MajorCustomersAxis": {
     "auth_ref": [
      "r211",
      "r314",
      "r317",
      "r507"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Customer [Axis]",
        "terseLabel": "Customer [Axis]"
       }
      }
     },
     "localname": "MajorCustomersAxis",
     "nsuri": "http://fasb.org/srt/2021-01-31",
     "presentation": [
      "http://thecronosgroup.com/role/FinancialInstrumentsCreditRiskNarrativeDetails",
      "http://thecronosgroup.com/role/SegmentInformationNarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "srt_MaximumMember": {
     "auth_ref": [
      "r304",
      "r308",
      "r329",
      "r331",
      "r454",
      "r455",
      "r456",
      "r457",
      "r458",
      "r459",
      "r460",
      "r504",
      "r508",
      "r533",
      "r534"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Maximum [Member]",
        "terseLabel": "Maximum"
       }
      }
     },
     "localname": "MaximumMember",
     "nsuri": "http://fasb.org/srt/2021-01-31",
     "presentation": [
      "http://thecronosgroup.com/role/DerivativeLiabilitiesScheduleofFairValuesofDerivativeLiabilitiesDetails",
      "http://thecronosgroup.com/role/SharebasedPaymentsStockOptionsNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "srt_MinimumMember": {
     "auth_ref": [
      "r304",
      "r308",
      "r329",
      "r331",
      "r454",
      "r455",
      "r456",
      "r457",
      "r458",
      "r459",
      "r460",
      "r504",
      "r508",
      "r533",
      "r534"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Minimum [Member]",
        "terseLabel": "Minimum"
       }
      }
     },
     "localname": "MinimumMember",
     "nsuri": "http://fasb.org/srt/2021-01-31",
     "presentation": [
      "http://thecronosgroup.com/role/DerivativeLiabilitiesScheduleofFairValuesofDerivativeLiabilitiesDetails",
      "http://thecronosgroup.com/role/InvestmentsNarrativeDetails",
      "http://thecronosgroup.com/role/SharebasedPaymentsStockOptionsNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "srt_NameOfMajorCustomerDomain": {
     "auth_ref": [
      "r211",
      "r314",
      "r317",
      "r507"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Customer [Domain]",
        "terseLabel": "Customer [Domain]"
       }
      }
     },
     "localname": "NameOfMajorCustomerDomain",
     "nsuri": "http://fasb.org/srt/2021-01-31",
     "presentation": [
      "http://thecronosgroup.com/role/FinancialInstrumentsCreditRiskNarrativeDetails",
      "http://thecronosgroup.com/role/SegmentInformationNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "srt_ProductOrServiceAxis": {
     "auth_ref": [
      "r205",
      "r314",
      "r315",
      "r462",
      "r503",
      "r505"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Product and Service [Axis]",
        "terseLabel": "Product and Service [Axis]"
       }
      }
     },
     "localname": "ProductOrServiceAxis",
     "nsuri": "http://fasb.org/srt/2021-01-31",
     "presentation": [
      "http://thecronosgroup.com/role/SegmentInformationScheduleofSegmentDataDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "srt_ProductsAndServicesDomain": {
     "auth_ref": [
      "r205",
      "r314",
      "r315",
      "r462",
      "r503",
      "r505"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Product and Service [Domain]",
        "terseLabel": "Product and Service [Domain]"
       }
      }
     },
     "localname": "ProductsAndServicesDomain",
     "nsuri": "http://fasb.org/srt/2021-01-31",
     "presentation": [
      "http://thecronosgroup.com/role/SegmentInformationScheduleofSegmentDataDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "srt_RangeAxis": {
     "auth_ref": [
      "r304",
      "r308",
      "r318",
      "r329",
      "r331",
      "r454",
      "r455",
      "r456",
      "r457",
      "r458",
      "r459",
      "r460",
      "r504",
      "r508",
      "r533",
      "r534"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Statistical Measurement [Axis]",
        "terseLabel": "Statistical Measurement [Axis]"
       }
      }
     },
     "localname": "RangeAxis",
     "nsuri": "http://fasb.org/srt/2021-01-31",
     "presentation": [
      "http://thecronosgroup.com/role/DerivativeLiabilitiesScheduleofFairValuesofDerivativeLiabilitiesDetails",
      "http://thecronosgroup.com/role/InvestmentsNarrativeDetails",
      "http://thecronosgroup.com/role/SharebasedPaymentsStockOptionsNarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "srt_RangeMember": {
     "auth_ref": [
      "r304",
      "r308",
      "r318",
      "r329",
      "r331",
      "r454",
      "r455",
      "r456",
      "r457",
      "r458",
      "r459",
      "r460",
      "r504",
      "r508",
      "r533",
      "r534"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Statistical Measurement [Domain]",
        "terseLabel": "Statistical Measurement [Domain]"
       }
      }
     },
     "localname": "RangeMember",
     "nsuri": "http://fasb.org/srt/2021-01-31",
     "presentation": [
      "http://thecronosgroup.com/role/DerivativeLiabilitiesScheduleofFairValuesofDerivativeLiabilitiesDetails",
      "http://thecronosgroup.com/role/InvestmentsNarrativeDetails",
      "http://thecronosgroup.com/role/SharebasedPaymentsStockOptionsNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "srt_RestatementAxis": {
     "auth_ref": [
      "r1",
      "r128",
      "r129",
      "r130",
      "r131",
      "r132",
      "r133",
      "r134",
      "r135",
      "r136",
      "r138",
      "r139",
      "r140",
      "r141",
      "r142",
      "r143",
      "r163",
      "r229",
      "r230",
      "r357",
      "r362",
      "r406",
      "r407",
      "r408",
      "r409",
      "r509",
      "r510",
      "r511",
      "r512",
      "r513",
      "r514",
      "r515",
      "r516",
      "r517",
      "r518",
      "r545",
      "r546"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Revision of Prior Period [Axis]",
        "terseLabel": "Restatement [Axis]"
       }
      }
     },
     "localname": "RestatementAxis",
     "nsuri": "http://fasb.org/srt/2021-01-31",
     "presentation": [
      "http://thecronosgroup.com/role/BackgroundBasisofPresentationandAccountingPoliciesDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "srt_RestatementDomain": {
     "auth_ref": [
      "r1",
      "r128",
      "r129",
      "r130",
      "r131",
      "r132",
      "r133",
      "r134",
      "r135",
      "r136",
      "r138",
      "r139",
      "r140",
      "r141",
      "r142",
      "r143",
      "r163",
      "r229",
      "r230",
      "r357",
      "r362",
      "r406",
      "r407",
      "r408",
      "r409",
      "r509",
      "r510",
      "r511",
      "r512",
      "r513",
      "r514",
      "r515",
      "r516",
      "r517",
      "r518",
      "r545",
      "r546"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Revision of Prior Period [Domain]",
        "terseLabel": "Restatement [Domain]"
       }
      }
     },
     "localname": "RestatementDomain",
     "nsuri": "http://fasb.org/srt/2021-01-31",
     "presentation": [
      "http://thecronosgroup.com/role/BackgroundBasisofPresentationandAccountingPoliciesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "srt_RevisionOfPriorPeriodErrorCorrectionAdjustmentMember": {
     "auth_ref": [
      "r133",
      "r134",
      "r135",
      "r138",
      "r139",
      "r141",
      "r142"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Revision of Prior Period, Error Correction, Adjustment [Member]",
        "terseLabel": "Error Correction, Adjustment"
       }
      }
     },
     "localname": "RevisionOfPriorPeriodErrorCorrectionAdjustmentMember",
     "nsuri": "http://fasb.org/srt/2021-01-31",
     "presentation": [
      "http://thecronosgroup.com/role/BackgroundBasisofPresentationandAccountingPoliciesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis": {
     "auth_ref": [
      "r223"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Investment, Name [Axis]",
        "terseLabel": "Investment, Name [Axis]"
       }
      }
     },
     "localname": "ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis",
     "nsuri": "http://fasb.org/srt/2021-01-31",
     "presentation": [
      "http://thecronosgroup.com/role/BackgroundBasisofPresentationandAccountingPoliciesDetails",
      "http://thecronosgroup.com/role/DerivativeLiabilitiesNarrativeDetails",
      "http://thecronosgroup.com/role/InvestmentsNarrativeDetails",
      "http://thecronosgroup.com/role/InvestmentsScheduleofInvestmentsinAssociatesandJointVenturesDetails",
      "http://thecronosgroup.com/role/InvestmentsScheduleofVariableInterestEntitiesDetails",
      "http://thecronosgroup.com/role/LoansReceivablenetDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "srt_SegmentGeographicalDomain": {
     "auth_ref": [
      "r206",
      "r207",
      "r314",
      "r316",
      "r506",
      "r523",
      "r524",
      "r525",
      "r526",
      "r527",
      "r528",
      "r529",
      "r530",
      "r531"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Geographical [Domain]",
        "terseLabel": "Geographical [Domain]"
       }
      }
     },
     "localname": "SegmentGeographicalDomain",
     "nsuri": "http://fasb.org/srt/2021-01-31",
     "presentation": [
      "http://thecronosgroup.com/role/SegmentInformationScheduleofLonglivedAssetsbyGeographicAreasDetails",
      "http://thecronosgroup.com/role/SegmentInformationScheduleofRevenuefromExternalCustomersbyGeographicAreasDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "srt_StatementGeographicalAxis": {
     "auth_ref": [
      "r206",
      "r207",
      "r314",
      "r316",
      "r506",
      "r521",
      "r523",
      "r524",
      "r525",
      "r526",
      "r527",
      "r528",
      "r529",
      "r530",
      "r531"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Geographical [Axis]",
        "terseLabel": "Geographical [Axis]"
       }
      }
     },
     "localname": "StatementGeographicalAxis",
     "nsuri": "http://fasb.org/srt/2021-01-31",
     "presentation": [
      "http://thecronosgroup.com/role/SegmentInformationScheduleofLonglivedAssetsbyGeographicAreasDetails",
      "http://thecronosgroup.com/role/SegmentInformationScheduleofRevenuefromExternalCustomersbyGeographicAreasDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "srt_SubsidiariesMember": {
     "auth_ref": [
      "r326",
      "r444",
      "r445",
      "r446"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Subsidiaries [Member]",
        "terseLabel": "Cronos Group, Inc."
       }
      }
     },
     "localname": "SubsidiariesMember",
     "nsuri": "http://fasb.org/srt/2021-01-31",
     "presentation": [
      "http://thecronosgroup.com/role/DerivativeLiabilitiesNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "srt_WeightedAverageMember": {
     "auth_ref": [
      "r454",
      "r456",
      "r459",
      "r533",
      "r534"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Weighted Average [Member]",
        "terseLabel": "Weighted Average"
       }
      }
     },
     "localname": "WeightedAverageMember",
     "nsuri": "http://fasb.org/srt/2021-01-31",
     "presentation": [
      "http://thecronosgroup.com/role/DerivativeLiabilitiesScheduleofFairValuesofDerivativeLiabilitiesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_AccountsNotesAndLoansReceivableLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Accounts, Notes, Loans and Financing Receivable [Line Items]",
        "terseLabel": "Accounts, Notes, Loans and Financing Receivable [Line Items]"
       }
      }
     },
     "localname": "AccountsNotesAndLoansReceivableLineItems",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://thecronosgroup.com/role/LoansReceivablenetDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis": {
     "auth_ref": [
      "r65"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by type of receivable.",
        "label": "Receivable Type [Axis]",
        "terseLabel": "Receivable Type [Axis]"
       }
      }
     },
     "localname": "AccountsNotesLoansAndFinancingReceivableByReceivableTypeAxis",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://thecronosgroup.com/role/InvestmentsNarrativeDetails",
      "http://thecronosgroup.com/role/InvestmentsScheduleofInvestmentsinAssociatesandJointVenturesDetails",
      "http://thecronosgroup.com/role/LoansReceivablenetDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_AccountsPayableAndOtherAccruedLiabilitiesCurrent": {
     "auth_ref": [],
     "calculation": {
      "http://thecronosgroup.com/role/CondensedConsolidatedBalanceSheets": {
       "order": 1.0,
       "parentTag": "us-gaap_LiabilitiesCurrent",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of liabilities incurred to vendors for goods and services received, and accrued liabilities classified as other, payable within one year or the normal operating cycle, if longer.",
        "label": "Accounts Payable and Other Accrued Liabilities, Current",
        "terseLabel": "Accounts payable and other liabilities"
       }
      }
     },
     "localname": "AccountsPayableAndOtherAccruedLiabilitiesCurrent",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://thecronosgroup.com/role/BackgroundBasisofPresentationandAccountingPoliciesDetails",
      "http://thecronosgroup.com/role/CondensedConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AccountsPayableMember": {
     "auth_ref": [
      "r34"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Obligations incurred and payable to vendors for goods and services received.",
        "label": "Accounts Payable [Member]",
        "terseLabel": "Accounts Payable"
       }
      }
     },
     "localname": "AccountsPayableMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://thecronosgroup.com/role/FinancialInstrumentsLiquidityRiskNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_AccountsReceivableMember": {
     "auth_ref": [
      "r522"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Due from customers or clients for goods or services that have been delivered or sold.",
        "label": "Accounts Receivable [Member]",
        "terseLabel": "Accounts Receivable"
       }
      }
     },
     "localname": "AccountsReceivableMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://thecronosgroup.com/role/FinancialInstrumentsCreditRiskNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_AccountsReceivableNetCurrent": {
     "auth_ref": [
      "r28",
      "r41",
      "r213",
      "r214"
     ],
     "calculation": {
      "http://thecronosgroup.com/role/CondensedConsolidatedBalanceSheets": {
       "order": 3.0,
       "parentTag": "us-gaap_AssetsCurrent",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, after allowance for credit loss, of right to consideration from customer for product sold and service rendered in normal course of business, classified as current.",
        "label": "Accounts Receivable, after Allowance for Credit Loss, Current",
        "verboseLabel": "Accounts receivable, net"
       }
      }
     },
     "localname": "AccountsReceivableNetCurrent",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://thecronosgroup.com/role/CondensedConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AccountsReceivableNoncurrentThresholdPeriodPastDueWriteoff": {
     "auth_ref": [
      "r235"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Threshold period for when accounts receivable, classified as noncurrent, is considered past due to write off as uncollectible, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.",
        "label": "Accounts Receivable, Noncurrent, Threshold Period Past Due, Writeoff",
        "terseLabel": "Accounts receivable, threshold period past due, writeoff"
       }
      }
     },
     "localname": "AccountsReceivableNoncurrentThresholdPeriodPastDueWriteoff",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://thecronosgroup.com/role/FinancialInstrumentsCreditRiskNarrativeDetails"
     ],
     "xbrltype": "durationItemType"
    },
    "us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax": {
     "auth_ref": [
      "r44",
      "r75",
      "r76",
      "r77",
      "r487",
      "r514",
      "r518"
     ],
     "calculation": {
      "http://thecronosgroup.com/role/CondensedConsolidatedBalanceSheets": {
       "order": 4.0,
       "parentTag": "us-gaap_StockholdersEquity",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Accumulated change in equity from transactions and other events and circumstances from non-owner sources, net of tax effect, at period end. Excludes Net Income (Loss), and accumulated changes in equity from transactions resulting from investments by owners and distributions to owners. Includes foreign currency translation items, certain pension adjustments, unrealized gains and losses on certain investments in debt and equity securities, other than temporary impairment (OTTI) losses related to factors other than credit losses on available-for-sale and held-to-maturity debt securities that an entity does not intend to sell and it is not more likely than not that the entity will be required to sell before recovery of the amortized cost basis, as well as changes in the fair value of derivatives related to the effective portion of a designated cash flow hedge.",
        "label": "Accumulated Other Comprehensive Income (Loss), Net of Tax",
        "terseLabel": "Accumulated other comprehensive income"
       }
      }
     },
     "localname": "AccumulatedOtherComprehensiveIncomeLossNetOfTax",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://thecronosgroup.com/role/CondensedConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AccumulatedOtherComprehensiveIncomeMember": {
     "auth_ref": [
      "r74",
      "r77",
      "r84",
      "r85",
      "r86",
      "r128",
      "r129",
      "r130",
      "r376",
      "r509",
      "r510",
      "r546"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Accumulated increase (decrease) in equity from transactions and other events and circumstances from non-owner sources, attributable to the parent. Excludes net income (loss), and accumulated changes in equity from transactions resulting from investments by owners and distributions to owners.",
        "label": "AOCI Attributable to Parent [Member]",
        "terseLabel": "Accumulated other comprehensive income (loss)"
       }
      }
     },
     "localname": "AccumulatedOtherComprehensiveIncomeMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://thecronosgroup.com/role/CondensedConsolidatedStatementsofChangesinEquity"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_AdditionalPaidInCapital": {
     "auth_ref": [
      "r42",
      "r357",
      "r450"
     ],
     "calculation": {
      "http://thecronosgroup.com/role/CondensedConsolidatedBalanceSheets": {
       "order": 2.0,
       "parentTag": "us-gaap_StockholdersEquity",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of excess of issue price over par or stated value of stock and from other transaction involving stock or stockholder. Includes, but is not limited to, additional paid-in capital (APIC) for common and preferred stock.",
        "label": "Additional Paid in Capital",
        "terseLabel": "Additional paid-in capital"
       }
      }
     },
     "localname": "AdditionalPaidInCapital",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://thecronosgroup.com/role/CondensedConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AdditionalPaidInCapitalMember": {
     "auth_ref": [
      "r128",
      "r129",
      "r130",
      "r354",
      "r355",
      "r356",
      "r407"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Excess of issue price over par or stated value of the entity's capital stock and amounts received from other transactions involving the entity's stock or stockholders.",
        "label": "Additional Paid-in Capital [Member]",
        "terseLabel": "Additional paid-in capital"
       }
      }
     },
     "localname": "AdditionalPaidInCapitalMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://thecronosgroup.com/role/CondensedConsolidatedStatementsofChangesinEquity"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_AdjustmentsForErrorCorrectionDomain": {
     "auth_ref": [
      "r133",
      "r134",
      "r135",
      "r138",
      "r139",
      "r141",
      "r142"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Type of error correction.",
        "label": "Error Correction, Type [Domain]",
        "terseLabel": "Error Correction, Type [Domain]"
       }
      }
     },
     "localname": "AdjustmentsForErrorCorrectionDomain",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://thecronosgroup.com/role/BackgroundBasisofPresentationandAccountingPoliciesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_AdjustmentsNoncashItemsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Adjustments, Noncash Items, to Reconcile Net Income (Loss) to Cash Provided by (Used in) Operating Activities [Abstract]",
        "terseLabel": "Adjustments to reconcile net loss to cash provided by operating activities:"
       }
      }
     },
     "localname": "AdjustmentsNoncashItemsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://thecronosgroup.com/role/CondensedConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of decrease to equity for grantee's tax withholding obligation for award under share-based payment arrangement.",
        "label": "Share-based Payment Arrangement, Decrease for Tax Withholding Obligation",
        "negatedTerseLabel": "Withholding taxes paid on share-based awards"
       }
      }
     },
     "localname": "AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://thecronosgroup.com/role/CondensedConsolidatedStatementsofChangesinEquity"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationRestrictedStockUnitsRequisiteServicePeriodRecognition": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of increase to additional paid-in capital (APIC) for recognition of cost for restricted stock unit under share-based payment arrangement.",
        "label": "APIC, Share-based Payment Arrangement, Restricted Stock Unit, Increase for Cost Recognition",
        "terseLabel": "Vesting of restricted share units"
       }
      }
     },
     "localname": "AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationRestrictedStockUnitsRequisiteServicePeriodRecognition",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://thecronosgroup.com/role/CondensedConsolidatedStatementsofChangesinEquity"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsRequisiteServicePeriodRecognition": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of increase to additional paid-in capital (APIC) for recognition of cost for option under share-based payment arrangement.",
        "label": "APIC, Share-based Payment Arrangement, Option, Increase for Cost Recognition",
        "terseLabel": "Vesting of options"
       }
      }
     },
     "localname": "AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsRequisiteServicePeriodRecognition",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://thecronosgroup.com/role/CondensedConsolidatedStatementsofChangesinEquity"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationOtherLongtermIncentivePlansRequisiteServicePeriodRecognition": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of increase to additional paid-in capital (APIC) for recognition of cost for award under share-based payment arrangement, classified as other.",
        "label": "APIC, Share-based Payment Arrangement, Other, Increase for Cost Recognition",
        "terseLabel": "Vesting of common shares issued in connection with the use of certain publicity rights in brand development"
       }
      }
     },
     "localname": "AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationOtherLongtermIncentivePlansRequisiteServicePeriodRecognition",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://thecronosgroup.com/role/CondensedConsolidatedStatementsofChangesinEquity"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AdvancesToAffiliate": {
     "auth_ref": [
      "r32",
      "r520"
     ],
     "calculation": {
      "http://thecronosgroup.com/role/CondensedConsolidatedBalanceSheets": {
       "order": 2.0,
       "parentTag": "us-gaap_Assets",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Long-Term advances receivable from a party that is affiliated with the reporting entity by means of direct or indirect ownership. This does not include advances to clients.",
        "label": "Advances to Affiliate",
        "terseLabel": "Advances to joint ventures"
       }
      }
     },
     "localname": "AdvancesToAffiliate",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://thecronosgroup.com/role/CondensedConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AllocatedShareBasedCompensationExpense": {
     "auth_ref": [
      "r333",
      "r352",
      "r358"
     ],
     "calculation": {
      "http://thecronosgroup.com/role/CondensedConsolidatedStatementsofNetIncomeLossandComprehensiveIncomeLoss": {
       "order": 4.0,
       "parentTag": "us-gaap_OperatingExpenses",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of expense for award under share-based payment arrangement. Excludes amount capitalized.",
        "label": "Share-based Payment Arrangement, Expense",
        "terseLabel": "Share-based payments"
       }
      }
     },
     "localname": "AllocatedShareBasedCompensationExpense",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://thecronosgroup.com/role/CondensedConsolidatedStatementsofNetIncomeLossandComprehensiveIncomeLoss",
      "http://thecronosgroup.com/role/SegmentInformationScheduleofAdjustedEBITDADetails",
      "http://thecronosgroup.com/role/SharebasedPaymentsSummaryofStockbasedCompensationExpenseDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AllowanceForDoubtfulAccountsReceivableCurrent": {
     "auth_ref": [
      "r48",
      "r216",
      "r231"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of allowance for credit loss on accounts receivable, classified as current.",
        "label": "Accounts Receivable, Allowance for Credit Loss, Current",
        "verboseLabel": "Current expected credit loss allowance on accounts receivable"
       }
      }
     },
     "localname": "AllowanceForDoubtfulAccountsReceivableCurrent",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://thecronosgroup.com/role/FinancialInstrumentsCreditRiskNarrativeDetails",
      "http://thecronosgroup.com/role/LoansReceivablenetDetails",
      "http://thecronosgroup.com/role/SegmentInformationNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount": {
     "auth_ref": [
      "r159"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Securities (including those issuable pursuant to contingent stock agreements) that could potentially dilute basic earnings per share (EPS) or earnings per unit (EPU) in the future that were not included in the computation of diluted EPS or EPU because to do so would increase EPS or EPU amounts or decrease loss per share or unit amounts for the period presented.",
        "label": "Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount",
        "terseLabel": "Total anti-dilutive securities (in shares)"
       }
      }
     },
     "localname": "AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://thecronosgroup.com/role/EarningsLossPerShareScheduleofAntidilutiveSecuritiesExcludedfromComputationofDilutedSharesOutstandingDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis": {
     "auth_ref": [
      "r159"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by type of antidilutive security.",
        "label": "Antidilutive Securities [Axis]",
        "terseLabel": "Antidilutive Securities [Axis]"
       }
      }
     },
     "localname": "AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://thecronosgroup.com/role/EarningsLossPerShareScheduleofAntidilutiveSecuritiesExcludedfromComputationofDilutedSharesOutstandingDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]",
        "terseLabel": "Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]"
       }
      }
     },
     "localname": "AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://thecronosgroup.com/role/EarningsLossPerShareScheduleofAntidilutiveSecuritiesExcludedfromComputationofDilutedSharesOutstandingDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_AntidilutiveSecuritiesNameDomain": {
     "auth_ref": [
      "r159"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Incremental common shares attributable to securities that were not included in diluted earnings per share (EPS) because to do so would increase EPS amounts or decrease loss per share amounts for the period presented.",
        "label": "Antidilutive Securities, Name [Domain]",
        "terseLabel": "Antidilutive Securities, Name [Domain]"
       }
      }
     },
     "localname": "AntidilutiveSecuritiesNameDomain",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://thecronosgroup.com/role/EarningsLossPerShareScheduleofAntidilutiveSecuritiesExcludedfromComputationofDilutedSharesOutstandingDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_ArrangementsAndNonarrangementTransactionsMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Collaborative arrangement and arrangement other than collaborative applicable to revenue-generating activity or operations.",
        "label": "Collaborative Arrangement and Arrangement Other than Collaborative [Domain]",
        "terseLabel": "Collaborative Arrangement and Arrangement Other than Collaborative [Domain]"
       }
      }
     },
     "localname": "ArrangementsAndNonarrangementTransactionsMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://thecronosgroup.com/role/InvestmentsNarrativeDetails",
      "http://thecronosgroup.com/role/LoansReceivablenetDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_AssetImpairmentCharges": {
     "auth_ref": [
      "r119",
      "r260"
     ],
     "calculation": {
      "http://thecronosgroup.com/role/CondensedConsolidatedStatementsofCashFlows": {
       "order": 14.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0
      },
      "http://thecronosgroup.com/role/CondensedConsolidatedStatementsofNetIncomeLossandComprehensiveIncomeLoss": {
       "order": 1.0,
       "parentTag": "us-gaap_NonoperatingIncomeExpense",
       "weight": -1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of write-down of assets recognized in the income statement. Includes, but is not limited to, losses from tangible assets, intangible assets and goodwill.",
        "label": "Asset Impairment Charges",
        "negatedTerseLabel": "Impairment loss on long-lived assets",
        "terseLabel": "Impairment loss on long-lived assets"
       }
      }
     },
     "localname": "AssetImpairmentCharges",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://thecronosgroup.com/role/CondensedConsolidatedStatementsofCashFlows",
      "http://thecronosgroup.com/role/CondensedConsolidatedStatementsofNetIncomeLossandComprehensiveIncomeLoss",
      "http://thecronosgroup.com/role/SegmentInformationScheduleofAdjustedEBITDADetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AssetImpairmentChargesTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for the details of the charge against earnings resulting from the aggregate write down of all assets from their carrying value to their fair value. Disclosure may also include a description of the impaired asset and facts and circumstances leading to the impairment, amount of the impairment loss and where the loss is located in the income statement, method(s) for determining fair value, and the segment in which the impaired asset is reported.",
        "label": "Asset Impairment Charges [Text Block]",
        "terseLabel": "Impairment Loss on Long-Lived Assets"
       }
      }
     },
     "localname": "AssetImpairmentChargesTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://thecronosgroup.com/role/ImpairmentLossonLongLivedAssets"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_Assets": {
     "auth_ref": [
      "r124",
      "r186",
      "r193",
      "r200",
      "r225",
      "r288",
      "r289",
      "r290",
      "r292",
      "r293",
      "r294",
      "r295",
      "r297",
      "r299",
      "r301",
      "r302",
      "r371",
      "r377",
      "r430",
      "r448",
      "r450",
      "r464",
      "r486"
     ],
     "calculation": {
      "http://thecronosgroup.com/role/CondensedConsolidatedBalanceSheets": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Sum of the carrying amounts as of the balance sheet date of all assets that are recognized. Assets are probable future economic benefits obtained or controlled by an entity as a result of past transactions or events.",
        "label": "Assets",
        "terseLabel": "Total assets",
        "totalLabel": "Total assets"
       }
      }
     },
     "localname": "Assets",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://thecronosgroup.com/role/CondensedConsolidatedBalanceSheets",
      "http://thecronosgroup.com/role/SegmentInformationScheduleofSegmentDataDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AssetsAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Assets [Abstract]",
        "terseLabel": "Assets"
       }
      }
     },
     "localname": "AssetsAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://thecronosgroup.com/role/CondensedConsolidatedBalanceSheets"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_AssetsCurrent": {
     "auth_ref": [
      "r30",
      "r31",
      "r69",
      "r124",
      "r225",
      "r288",
      "r289",
      "r290",
      "r292",
      "r293",
      "r294",
      "r295",
      "r297",
      "r299",
      "r301",
      "r302",
      "r371",
      "r377",
      "r430",
      "r448",
      "r450"
     ],
     "calculation": {
      "http://thecronosgroup.com/role/CondensedConsolidatedBalanceSheets": {
       "order": 5.0,
       "parentTag": "us-gaap_Assets",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Sum of the carrying amounts as of the balance sheet date of all assets that are expected to be realized in cash, sold, or consumed within one year (or the normal operating cycle, if longer). Assets are probable future economic benefits obtained or controlled by an entity as a result of past transactions or events.",
        "label": "Assets, Current",
        "totalLabel": "Total current assets"
       }
      }
     },
     "localname": "AssetsCurrent",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://thecronosgroup.com/role/CondensedConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AssetsCurrentAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Assets, Current [Abstract]",
        "terseLabel": "Current assets"
       }
      }
     },
     "localname": "AssetsCurrentAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://thecronosgroup.com/role/CondensedConsolidatedBalanceSheets"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_AssetsHeldForSaleNotPartOfDisposalGroupCurrent": {
     "auth_ref": [
      "r256",
      "r450"
     ],
     "calculation": {
      "http://thecronosgroup.com/role/CondensedConsolidatedBalanceSheets": {
       "order": 8.0,
       "parentTag": "us-gaap_AssetsCurrent",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of assets held-for-sale that are not part of a disposal group, expected to be sold within a year or the normal operating cycle, if longer.",
        "label": "Assets Held-for-sale, Not Part of Disposal Group, Current",
        "terseLabel": "Held-for-sale assets"
       }
      }
     },
     "localname": "AssetsHeldForSaleNotPartOfDisposalGroupCurrent",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://thecronosgroup.com/role/CondensedConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AvailableForSaleSecuritiesDebtSecurities": {
     "auth_ref": [
      "r219",
      "r221",
      "r238",
      "r469"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale).",
        "label": "Debt Securities, Available-for-sale",
        "terseLabel": "Short-term investments"
       }
      }
     },
     "localname": "AvailableForSaleSecuritiesDebtSecurities",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://thecronosgroup.com/role/FinancialInstrumentsScheduleofFairValueofAssetsMeasuredonRecurringBasisDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AwardTypeAxis": {
     "auth_ref": [
      "r334",
      "r353"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by type of award under share-based payment arrangement.",
        "label": "Award Type [Axis]",
        "terseLabel": "Award Type [Axis]"
       }
      }
     },
     "localname": "AwardTypeAxis",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://thecronosgroup.com/role/EarningsLossPerShareScheduleofEarningsLossPerShareDetails",
      "http://thecronosgroup.com/role/SharebasedPaymentsStockOptionsNarrativeDetails",
      "http://thecronosgroup.com/role/SharebasedPaymentsSummaryofChangesinRSUsDetails",
      "http://thecronosgroup.com/role/SharebasedPaymentsSummaryofChangesinWarrantsDetails",
      "http://thecronosgroup.com/role/SharebasedPaymentsSummaryofDSUActivityDetails",
      "http://thecronosgroup.com/role/SharebasedPaymentsSummaryofOutstandingWarrantsDetails",
      "http://thecronosgroup.com/role/SharebasedPaymentsSummaryofStockbasedCompensationExpenseDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_BasisOfAccountingPolicyPolicyTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy for basis of accounting, or basis of presentation, used to prepare the financial statements (for example, US Generally Accepted Accounting Principles, Other Comprehensive Basis of Accounting, IFRS).",
        "label": "Basis of Accounting, Policy [Policy Text Block]",
        "terseLabel": "Basis of presentation"
       }
      }
     },
     "localname": "BasisOfAccountingPolicyPolicyTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://thecronosgroup.com/role/BackgroundBasisofPresentationandAccountingPoliciesPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_BasisOfPresentationAndSignificantAccountingPoliciesTextBlock": {
     "auth_ref": [
      "r127"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for the basis of presentation and significant accounting policies concepts. Basis of presentation describes the underlying basis used to prepare the financial statements (for example, US Generally Accepted Accounting Principles, Other Comprehensive Basis of Accounting, IFRS).  Accounting policies describe all significant accounting policies of the reporting entity.",
        "label": "Basis of Presentation and Significant Accounting Policies [Text Block]",
        "terseLabel": "Background, Basis of Presentation and Accounting Policies"
       }
      }
     },
     "localname": "BasisOfPresentationAndSignificantAccountingPoliciesTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://thecronosgroup.com/role/BackgroundBasisofPresentationandAccountingPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_CashAndCashEquivalentsAtCarryingValue": {
     "auth_ref": [
      "r26",
      "r57",
      "r121"
     ],
     "calculation": {
      "http://thecronosgroup.com/role/CondensedConsolidatedBalanceSheets": {
       "order": 1.0,
       "parentTag": "us-gaap_AssetsCurrent",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of currency on hand as well as demand deposits with banks or financial institutions. Includes other kinds of accounts that have the general characteristics of demand deposits. Also includes short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates. Excludes cash and cash equivalents within disposal group and discontinued operation.",
        "label": "Cash and Cash Equivalents, at Carrying Value",
        "terseLabel": "Cash and cash equivalents"
       }
      }
     },
     "localname": "CashAndCashEquivalentsAtCarryingValue",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://thecronosgroup.com/role/CondensedConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_CashAndCashEquivalentsFairValueDisclosure": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Fair value portion of currency on hand as well as demand deposits with banks or financial institutions. Includes other kinds of accounts that have the general characteristics of demand deposits. Also includes short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.",
        "label": "Cash and Cash Equivalents, Fair Value Disclosure",
        "terseLabel": "Cash and cash equivalents"
       }
      }
     },
     "localname": "CashAndCashEquivalentsFairValueDisclosure",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://thecronosgroup.com/role/FinancialInstrumentsScheduleofFairValueofAssetsMeasuredonRecurringBasisDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents": {
     "auth_ref": [
      "r115",
      "r121",
      "r123"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cash and cash equivalents, and cash and cash equivalents restricted to withdrawal or usage. Excludes amount for disposal group and discontinued operations. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.",
        "label": "Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents",
        "periodEndLabel": "Cash and cash equivalents, end of period",
        "periodStartLabel": "Cash and cash equivalents, beginning of period"
       }
      }
     },
     "localname": "CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://thecronosgroup.com/role/CondensedConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect": {
     "auth_ref": [
      "r115",
      "r431"
     ],
     "calculation": {
      "http://thecronosgroup.com/role/CondensedConsolidatedStatementsofCashFlows": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of increase (decrease) in cash, cash equivalents, and cash and cash equivalents restricted to withdrawal or usage; including effect from exchange rate change. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.",
        "label": "Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect",
        "totalLabel": "Net change in cash and cash equivalents"
       }
      }
     },
     "localname": "CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://thecronosgroup.com/role/CondensedConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ClassOfWarrantOrRightAxis": {
     "auth_ref": [
      "r312",
      "r332"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by type of warrant or right issued.",
        "label": "Class of Warrant or Right [Axis]",
        "terseLabel": "Class of Warrant or Right [Axis]"
       }
      }
     },
     "localname": "ClassOfWarrantOrRightAxis",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://thecronosgroup.com/role/DerivativeLiabilitiesNarrativeDetails",
      "http://thecronosgroup.com/role/DerivativeLiabilitiesScheduleofFairValuesofDerivativeLiabilitiesDetails",
      "http://thecronosgroup.com/role/DerivativeLiabilitiesScheduleofReconciliationofCarryingAmountsDetails",
      "http://thecronosgroup.com/role/DerivativeLiabilitiesScheduleofSensitivityAnalysisDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ClassOfWarrantOrRightDomain": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Name of the class or type of warrant or right outstanding. Warrants and rights represent derivative securities that give the holder the right to purchase securities (usually equity) from the issuer at a specific price within a certain time frame. Warrants are often included in a new debt issue to entice investors by a higher return potential. The main difference between warrants and call options is that warrants are issued and guaranteed by the company, whereas options are exchange instruments and are not issued by the company. Also, the lifetime of a warrant is often measured in years, while the lifetime of a typical option is measured in months.",
        "label": "Class of Warrant or Right [Domain]",
        "terseLabel": "Class of Warrant or Right [Domain]"
       }
      }
     },
     "localname": "ClassOfWarrantOrRightDomain",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://thecronosgroup.com/role/DerivativeLiabilitiesNarrativeDetails",
      "http://thecronosgroup.com/role/DerivativeLiabilitiesScheduleofFairValuesofDerivativeLiabilitiesDetails",
      "http://thecronosgroup.com/role/DerivativeLiabilitiesScheduleofReconciliationofCarryingAmountsDetails",
      "http://thecronosgroup.com/role/DerivativeLiabilitiesScheduleofSensitivityAnalysisDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1": {
     "auth_ref": [
      "r310"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Exercise price per share or per unit of warrants or rights outstanding.",
        "label": "Class of Warrant or Right, Exercise Price of Warrants or Rights",
        "terseLabel": "Exercise price (in dollars per share)"
       }
      }
     },
     "localname": "ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://thecronosgroup.com/role/DerivativeLiabilitiesNarrativeDetails"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_CollaborativeArrangementTransactionWithPartyToCollaborativeArrangementMember": {
     "auth_ref": [
      "r365"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Collaborative arrangement transaction between parties to collaborative arrangement.",
        "label": "Collaborative Arrangement, Transaction with Party to Collaborative Arrangement [Member]",
        "terseLabel": "Establishment of a Commercial Cannabis Analytical Testing Laboratory"
       }
      }
     },
     "localname": "CollaborativeArrangementTransactionWithPartyToCollaborativeArrangementMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://thecronosgroup.com/role/InvestmentsNarrativeDetails",
      "http://thecronosgroup.com/role/LoansReceivablenetDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_CommitmentsAndContingencies": {
     "auth_ref": [
      "r63",
      "r275",
      "r472",
      "r492"
     ],
     "calculation": {
      "http://thecronosgroup.com/role/CondensedConsolidatedBalanceSheets": {
       "order": 3.0,
       "parentTag": "us-gaap_LiabilitiesAndStockholdersEquity",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Represents the caption on the face of the balance sheet to indicate that the entity has entered into (1) purchase or supply arrangements that will require expending a portion of its resources to meet the terms thereof, and (2) is exposed to potential losses or, less frequently, gains, arising from (a) possible claims against a company's resources due to future performance under contract terms, and (b) possible losses or likely gains from uncertainties that will ultimately be resolved when one or more future events that are deemed likely to occur do occur or fail to occur.",
        "label": "Commitments and Contingencies",
        "terseLabel": "Commitments and contingencies"
       }
      }
     },
     "localname": "CommitmentsAndContingencies",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://thecronosgroup.com/role/CondensedConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_CommonStockMember": {
     "auth_ref": [
      "r128",
      "r129",
      "r407"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Stock that is subordinate to all other stock of the issuer.",
        "label": "Common Stock [Member]",
        "verboseLabel": "Share capital"
       }
      }
     },
     "localname": "CommonStockMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://thecronosgroup.com/role/CondensedConsolidatedStatementsofChangesinEquity"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_CommonStockSharesIssued": {
     "auth_ref": [
      "r39"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Total number of common shares of an entity that have been sold or granted to shareholders (includes common shares that were issued, repurchased and remain in the treasury). These shares represent capital invested by the firm's shareholders and owners, and may be all or only a portion of the number of shares authorized. Shares issued include shares outstanding and shares held in the treasury.",
        "label": "Common Stock, Shares, Issued",
        "terseLabel": "Common stock, shares issued (in shares)"
       }
      }
     },
     "localname": "CommonStockSharesIssued",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://thecronosgroup.com/role/CondensedConsolidatedBalanceSheetParenthetical"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_CommonStockSharesOutstanding": {
     "auth_ref": [
      "r39",
      "r309"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of shares of common stock outstanding. Common stock represent the ownership interest in a corporation.",
        "label": "Common Stock, Shares, Outstanding",
        "periodEndLabel": "Ending balance (in shares)",
        "periodStartLabel": "Beginning balance (in shares)"
       }
      }
     },
     "localname": "CommonStockSharesOutstanding",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://thecronosgroup.com/role/CondensedConsolidatedStatementsofChangesinEquity"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_CommonStockValue": {
     "auth_ref": [
      "r39",
      "r450"
     ],
     "calculation": {
      "http://thecronosgroup.com/role/CondensedConsolidatedBalanceSheets": {
       "order": 1.0,
       "parentTag": "us-gaap_StockholdersEquity",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Aggregate par or stated value of issued nonredeemable common stock (or common stock redeemable solely at the option of the issuer). This item includes treasury stock repurchased by the entity. Note: elements for number of nonredeemable common shares, par value and other disclosure concepts are in another section within stockholders' equity.",
        "label": "Common Stock, Value, Issued",
        "terseLabel": "Share capital"
       }
      }
     },
     "localname": "CommonStockValue",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://thecronosgroup.com/role/BackgroundBasisofPresentationandAccountingPoliciesDetails",
      "http://thecronosgroup.com/role/CondensedConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ComprehensiveIncomeNetOfTax": {
     "auth_ref": [
      "r80",
      "r82",
      "r83",
      "r97",
      "r480",
      "r501"
     ],
     "calculation": {
      "http://thecronosgroup.com/role/CondensedConsolidatedStatementsofNetIncomeLossandComprehensiveIncomeLoss": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount after tax of increase (decrease) in equity from transactions and other events and circumstances from net income and other comprehensive income, attributable to parent entity. Excludes changes in equity resulting from investments by owners and distributions to owners.",
        "label": "Comprehensive Income (Loss), Net of Tax, Attributable to Parent",
        "totalLabel": "Cronos Group"
       }
      }
     },
     "localname": "ComprehensiveIncomeNetOfTax",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://thecronosgroup.com/role/CondensedConsolidatedStatementsofNetIncomeLossandComprehensiveIncomeLoss"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest": {
     "auth_ref": [
      "r80",
      "r82",
      "r96",
      "r369",
      "r370",
      "r389",
      "r479",
      "r500"
     ],
     "calculation": {
      "http://thecronosgroup.com/role/CondensedConsolidatedStatementsofNetIncomeLossandComprehensiveIncomeLoss": {
       "order": 1.0,
       "parentTag": "us-gaap_ComprehensiveIncomeNetOfTax",
       "weight": -1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount after tax of increase (decrease) in equity from transactions and other events and circumstances from net income (loss) and other comprehensive income (loss), attributable to noncontrolling interests. Excludes changes in equity resulting from investments by owners and distributions to owners.",
        "label": "Comprehensive Income (Loss), Net of Tax, Attributable to Noncontrolling Interest",
        "terseLabel": "Less: comprehensive income (loss) attributable to non-controlling interests"
       }
      }
     },
     "localname": "ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://thecronosgroup.com/role/CondensedConsolidatedStatementsofNetIncomeLossandComprehensiveIncomeLoss"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest": {
     "auth_ref": [
      "r80",
      "r82",
      "r95",
      "r368",
      "r389",
      "r478",
      "r499"
     ],
     "calculation": {
      "http://thecronosgroup.com/role/CondensedConsolidatedStatementsofNetIncomeLossandComprehensiveIncomeLoss": {
       "order": 2.0,
       "parentTag": "us-gaap_ComprehensiveIncomeNetOfTax",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount after tax of increase (decrease) in equity from transactions and other events and circumstances from net income and other comprehensive income. Excludes changes in equity resulting from investments by owners and distributions to owners.",
        "label": "Comprehensive Income (Loss), Net of Tax, Including Portion Attributable to Noncontrolling Interest",
        "totalLabel": "Comprehensive income (loss)"
       }
      }
     },
     "localname": "ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://thecronosgroup.com/role/CondensedConsolidatedStatementsofNetIncomeLossandComprehensiveIncomeLoss"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ConcentrationRiskBenchmarkDomain": {
     "auth_ref": [
      "r169",
      "r170",
      "r211",
      "r426",
      "r427",
      "r522"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The denominator in a calculation of a disclosed concentration risk percentage.",
        "label": "Concentration Risk Benchmark [Domain]",
        "terseLabel": "Concentration Risk Benchmark [Domain]"
       }
      }
     },
     "localname": "ConcentrationRiskBenchmarkDomain",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://thecronosgroup.com/role/FinancialInstrumentsCreditRiskNarrativeDetails",
      "http://thecronosgroup.com/role/FinancialInstrumentsLiquidityRiskNarrativeDetails",
      "http://thecronosgroup.com/role/SegmentInformationNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_ConcentrationRiskByBenchmarkAxis": {
     "auth_ref": [
      "r169",
      "r170",
      "r211",
      "r426",
      "r427",
      "r519",
      "r522"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by benchmark of concentration risk.",
        "label": "Concentration Risk Benchmark [Axis]",
        "terseLabel": "Concentration Risk Benchmark [Axis]"
       }
      }
     },
     "localname": "ConcentrationRiskByBenchmarkAxis",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://thecronosgroup.com/role/FinancialInstrumentsCreditRiskNarrativeDetails",
      "http://thecronosgroup.com/role/FinancialInstrumentsLiquidityRiskNarrativeDetails",
      "http://thecronosgroup.com/role/SegmentInformationNarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ConcentrationRiskByTypeAxis": {
     "auth_ref": [
      "r169",
      "r170",
      "r211",
      "r426",
      "r427",
      "r519",
      "r522"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by type of concentration risk, for example, but not limited to, asset, liability, net assets, geographic, customer, employees, supplier, lender.",
        "label": "Concentration Risk Type [Axis]",
        "terseLabel": "Concentration Risk Type [Axis]"
       }
      }
     },
     "localname": "ConcentrationRiskByTypeAxis",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://thecronosgroup.com/role/FinancialInstrumentsCreditRiskNarrativeDetails",
      "http://thecronosgroup.com/role/FinancialInstrumentsLiquidityRiskNarrativeDetails",
      "http://thecronosgroup.com/role/SegmentInformationNarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ConcentrationRiskCreditRiskFinancialInstrumentMaximumExposure": {
     "auth_ref": [
      "r428"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Maximum amount of loss due to credit risk that, based on the gross fair value of the financial instrument, the entity would incur if parties to the financial instruments that make up the concentration failed completely to perform according to the terms of the contracts and the collateral or other security, if any, for the amount due proved to be of no value to the entity.",
        "label": "Concentration Risk, Credit Risk, Financial Instrument, Maximum Exposure",
        "terseLabel": "Maximum exposure to credit risk"
       }
      }
     },
     "localname": "ConcentrationRiskCreditRiskFinancialInstrumentMaximumExposure",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://thecronosgroup.com/role/FinancialInstrumentsCreditRiskNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ConcentrationRiskDisclosureTextBlock": {
     "auth_ref": [
      "r172"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for any concentrations existing at the date of the financial statements that make an entity vulnerable to a reasonably possible, near-term, severe impact. This disclosure informs financial statement users about the general nature of the risk associated with the concentration, and may indicate the percentage of concentration risk as of the balance sheet date.",
        "label": "Concentration Risk Disclosure [Text Block]",
        "terseLabel": "Financial Instruments"
       }
      }
     },
     "localname": "ConcentrationRiskDisclosureTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://thecronosgroup.com/role/FinancialInstruments"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ConcentrationRiskLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Concentration Risk [Line Items]",
        "terseLabel": "Concentration Risk [Line Items]"
       }
      }
     },
     "localname": "ConcentrationRiskLineItems",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://thecronosgroup.com/role/FinancialInstrumentsCreditRiskNarrativeDetails",
      "http://thecronosgroup.com/role/FinancialInstrumentsLiquidityRiskNarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ConcentrationRiskPercentage1": {
     "auth_ref": [
      "r169",
      "r170",
      "r211",
      "r426",
      "r427"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "For an entity that discloses a concentration risk in relation to quantitative amount, which serves as the \"benchmark\" (or denominator) in the equation, this concept represents the concentration percentage derived from the division.",
        "label": "Concentration Risk, Percentage",
        "terseLabel": "Concentration risk, percentage"
       }
      }
     },
     "localname": "ConcentrationRiskPercentage1",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://thecronosgroup.com/role/FinancialInstrumentsCreditRiskNarrativeDetails",
      "http://thecronosgroup.com/role/FinancialInstrumentsLiquidityRiskNarrativeDetails",
      "http://thecronosgroup.com/role/SegmentInformationNarrativeDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "us-gaap_ConcentrationRiskTable": {
     "auth_ref": [
      "r167",
      "r169",
      "r170",
      "r171",
      "r426",
      "r429",
      "r522"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Describes the nature of a concentration, a benchmark to which it is compared, and the percentage that the risk is to the benchmark.",
        "label": "Concentration Risk [Table]",
        "terseLabel": "Concentration Risk [Table]"
       }
      }
     },
     "localname": "ConcentrationRiskTable",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://thecronosgroup.com/role/FinancialInstrumentsCreditRiskNarrativeDetails",
      "http://thecronosgroup.com/role/FinancialInstrumentsLiquidityRiskNarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ConcentrationRiskTypeDomain": {
     "auth_ref": [
      "r169",
      "r170",
      "r211",
      "r426",
      "r427",
      "r522"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "For an entity that discloses a concentration risk as a percentage of some financial balance or benchmark, identifies the type (for example, asset, liability, net assets, geographic, customer, employees, supplier, lender) of the concentration.",
        "label": "Concentration Risk Type [Domain]",
        "terseLabel": "Concentration Risk Type [Domain]"
       }
      }
     },
     "localname": "ConcentrationRiskTypeDomain",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://thecronosgroup.com/role/FinancialInstrumentsCreditRiskNarrativeDetails",
      "http://thecronosgroup.com/role/FinancialInstrumentsLiquidityRiskNarrativeDetails",
      "http://thecronosgroup.com/role/SegmentInformationNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_CorporateNonSegmentMember": {
     "auth_ref": [
      "r191",
      "r192",
      "r193",
      "r194",
      "r196",
      "r202",
      "r204"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Corporate headquarters or functional department that may not earn revenues or may earn revenues that are only incidental to the activities of the entity and is not considered an operating segment.",
        "label": "Corporate, Non-Segment [Member]",
        "terseLabel": "Corporate Expenses"
       }
      }
     },
     "localname": "CorporateNonSegmentMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://thecronosgroup.com/role/SegmentInformationScheduleofAdjustedEBITDADetails",
      "http://thecronosgroup.com/role/SegmentInformationScheduleofSegmentDataDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_CreditConcentrationRiskMember": {
     "auth_ref": [
      "r429"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Reflects the percentage that a specified receivable or amount at risk from a counterparty under a contractual arrangement is to a specified benchmark, such as total receivables, net revenues, pretax results. Risk is the materially adverse effects of loss attributable to (a) the failure to collect a significant receivable from a major customer or group of homogeneous accounts, or (b) a failure by a counterparty to perform under terms of a contractual arrangement.",
        "label": "Credit Concentration Risk [Member]",
        "terseLabel": "Credit Concentration Risk"
       }
      }
     },
     "localname": "CreditConcentrationRiskMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://thecronosgroup.com/role/FinancialInstrumentsCreditRiskNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_CustomerConcentrationRiskMember": {
     "auth_ref": [
      "r168",
      "r211"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Reflects the percentage that revenues in the period from one or more significant customers is to net revenues, as defined by the entity, such as total net revenues, product line revenues, segment revenues. The risk is the materially adverse effects of loss of a significant customer.",
        "label": "Customer Concentration Risk [Member]",
        "terseLabel": "Customer Concentration Risk"
       }
      }
     },
     "localname": "CustomerConcentrationRiskMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://thecronosgroup.com/role/SegmentInformationNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_DebtInstrumentInterestRateStatedPercentage": {
     "auth_ref": [
      "r61",
      "r303"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Contractual interest rate for funds borrowed, under the debt agreement.",
        "label": "Debt Instrument, Interest Rate, Stated Percentage",
        "terseLabel": "Interest rate"
       }
      }
     },
     "localname": "DebtInstrumentInterestRateStatedPercentage",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://thecronosgroup.com/role/InvestmentsNarrativeDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "us-gaap_DeferredCompensationSharebasedArrangementsLiabilityCurrentAndNoncurrent": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Aggregate carrying value as of the balance sheet date of the liabilities for stock option plans and other equity-based compensation arrangements.",
        "label": "Deferred Compensation Share-based Arrangements, Liability, Current and Noncurrent",
        "periodEndLabel": "Balance at end of period",
        "periodStartLabel": "Balance at beginning of period"
       }
      }
     },
     "localname": "DeferredCompensationSharebasedArrangementsLiabilityCurrentAndNoncurrent",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://thecronosgroup.com/role/SharebasedPaymentsSummaryofDSUActivityDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DepreciationAndAmortization": {
     "auth_ref": [
      "r119",
      "r262"
     ],
     "calculation": {
      "http://thecronosgroup.com/role/CondensedConsolidatedStatementsofNetIncomeLossandComprehensiveIncomeLoss": {
       "order": 5.0,
       "parentTag": "us-gaap_OperatingExpenses",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The current period expense charged against earnings on long-lived, physical assets not used in production, and which are not intended for resale, to allocate or recognize the cost of such assets over their useful lives; or to record the reduction in book value of an intangible asset over the benefit period of such asset; or to reflect consumption during the period of an asset that is not used in production.",
        "label": "Depreciation, Depletion and Amortization, Nonproduction",
        "terseLabel": "Depreciation and amortization",
        "verboseLabel": "Depreciation and amortization"
       }
      }
     },
     "localname": "DepreciationAndAmortization",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://thecronosgroup.com/role/CondensedConsolidatedStatementsofNetIncomeLossandComprehensiveIncomeLoss",
      "http://thecronosgroup.com/role/SegmentInformationScheduleofSegmentDataDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DepreciationDepletionAndAmortization": {
     "auth_ref": [
      "r119",
      "r181"
     ],
     "calculation": {
      "http://thecronosgroup.com/role/CondensedConsolidatedStatementsofCashFlows": {
       "order": 13.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The aggregate expense recognized in the current period that allocates the cost of tangible assets, intangible assets, or depleting assets to periods that benefit from use of the assets.",
        "label": "Depreciation, Depletion and Amortization",
        "terseLabel": "Depreciation and amortization",
        "verboseLabel": "Depreciation and amortization"
       }
      }
     },
     "localname": "DepreciationDepletionAndAmortization",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://thecronosgroup.com/role/CondensedConsolidatedStatementsofCashFlows",
      "http://thecronosgroup.com/role/SegmentInformationScheduleofAdjustedEBITDADetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Derivative Instruments and Hedging Activities Disclosure [Abstract]",
        "terseLabel": "Derivative Instruments and Hedging Activities Disclosure [Abstract]"
       }
      }
     },
     "localname": "DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureTextBlock": {
     "auth_ref": [
      "r405",
      "r410"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for derivative instruments and hedging activities including, but not limited to, risk management strategies, non-hedging derivative instruments, assets, liabilities, revenue and expenses, and methodologies and assumptions used in determining the amounts.",
        "label": "Derivative Instruments and Hedging Activities Disclosure [Text Block]",
        "terseLabel": "Derivative Liabilities"
       }
      }
     },
     "localname": "DerivativeInstrumentsAndHedgingActivitiesDisclosureTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://thecronosgroup.com/role/DerivativeLiabilities"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipByIncomeStatementLocationByDerivativeInstrumentRiskTable": {
     "auth_ref": [
      "r394",
      "r396",
      "r398",
      "r399",
      "r400",
      "r403",
      "r404"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of information about the location and amount of derivative instruments and nonderivative instruments designated as hedging instruments reported before netting adjustments, and the amount of gain (loss) on derivative instruments and nonderivative instruments designated and qualified as hedging instruments.",
        "label": "Derivative Instruments, Gain (Loss) [Table]",
        "terseLabel": "Derivative Instruments, Gain (Loss) [Table]"
       }
      }
     },
     "localname": "DerivativeInstrumentsGainLossByHedgingRelationshipByIncomeStatementLocationByDerivativeInstrumentRiskTable",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://thecronosgroup.com/role/DerivativeLiabilitiesScheduleofReconciliationofCarryingAmountsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_DerivativeInstrumentsGainLossLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Derivative Instruments, Gain (Loss) [Line Items]",
        "terseLabel": "Derivative Instruments, Gain (Loss) [Line Items]"
       }
      }
     },
     "localname": "DerivativeInstrumentsGainLossLineItems",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://thecronosgroup.com/role/DerivativeLiabilitiesScheduleofReconciliationofCarryingAmountsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_DerivativeLiabilities": {
     "auth_ref": [
      "r70",
      "r71",
      "r72",
      "r425"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Fair value, after the effects of master netting arrangements, of a financial liability or contract with one or more underlyings, notional amount or payment provision or both, and the contract can be net settled by means outside the contract or delivery of an asset. Includes liabilities not subject to a master netting arrangement and not elected to be offset.",
        "label": "Derivative Liability",
        "terseLabel": "Derivative liabilities"
       }
      }
     },
     "localname": "DerivativeLiabilities",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://thecronosgroup.com/role/FinancialInstrumentsScheduleofFairValueofAssetsMeasuredonRecurringBasisDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DerivativeLiabilitiesCurrent": {
     "auth_ref": [
      "r70"
     ],
     "calculation": {
      "http://thecronosgroup.com/role/CondensedConsolidatedBalanceSheets": {
       "order": 2.0,
       "parentTag": "us-gaap_LiabilitiesCurrent",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Fair value, after the effects of master netting arrangements, of a financial liability or contract with one or more underlyings, notional amount or payment provision or both, and the contract can be net settled by means outside the contract or delivery of an asset, expected to be settled within one year or normal operating cycle, if longer. Includes assets not subject to a master netting arrangement and not elected to be offset.",
        "label": "Derivative Liability, Current",
        "terseLabel": "Derivative liabilities"
       }
      }
     },
     "localname": "DerivativeLiabilitiesCurrent",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://thecronosgroup.com/role/CondensedConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DerivativeLiabilityMeasurementInput": {
     "auth_ref": [
      "r416"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Value of input used to measure derivative liability.",
        "label": "Derivative Liability, Measurement Input",
        "terseLabel": "Derivative liability, measurement input"
       }
      }
     },
     "localname": "DerivativeLiabilityMeasurementInput",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://thecronosgroup.com/role/DerivativeLiabilitiesScheduleofFairValuesofDerivativeLiabilitiesDetails"
     ],
     "xbrltype": "decimalItemType"
    },
    "us-gaap_DerivativeLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Derivative [Line Items]",
        "terseLabel": "Derivative [Line Items]"
       }
      }
     },
     "localname": "DerivativeLineItems",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://thecronosgroup.com/role/DerivativeLiabilitiesNarrativeDetails",
      "http://thecronosgroup.com/role/DerivativeLiabilitiesScheduleofSensitivityAnalysisDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_DerivativeTable": {
     "auth_ref": [
      "r391",
      "r392",
      "r393",
      "r394",
      "r395",
      "r397",
      "r398",
      "r401",
      "r402",
      "r404",
      "r405"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Schedule that describes and identifies a derivative or group of derivatives on a disaggregated basis, such as for individual instruments, or small groups of similar instruments. May include a combination of the type of instrument, risks being hedged, notional amount, hedge designation, related hedged item, inception date, maturity date, or other relevant item.",
        "label": "Derivative [Table]",
        "terseLabel": "Derivative [Table]"
       }
      }
     },
     "localname": "DerivativeTable",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://thecronosgroup.com/role/DerivativeLiabilitiesNarrativeDetails",
      "http://thecronosgroup.com/role/DerivativeLiabilitiesScheduleofSensitivityAnalysisDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_DilutiveSecurities": {
     "auth_ref": [
      "r160"
     ],
     "calculation": {
      "http://thecronosgroup.com/role/EarningsLossPerShareScheduleofEarningsLossPerShareDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_NetIncomeLossFromContinuingOperationsAvailableToCommonShareholdersDiluted",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of increase (decrease) to net income used for calculating diluted earnings per share (EPS), resulting from the assumed exercise stock options, restrictive stock units (RSUs), convertible preferred stock of an employee stock ownership plan (ESOP), and other dilutive convertible securities.",
        "label": "Dilutive Securities, Effect on Basic Earnings Per Share",
        "terseLabel": "Adjustment for gain (loss) on revaluation of derivative liabilities"
       }
      }
     },
     "localname": "DilutiveSecurities",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://thecronosgroup.com/role/EarningsLossPerShareScheduleofEarningsLossPerShareDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock": {
     "auth_ref": [
      "r359"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for share-based payment arrangement.",
        "label": "Share-based Payment Arrangement [Text Block]",
        "terseLabel": "Share-based Payments"
       }
      }
     },
     "localname": "DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://thecronosgroup.com/role/SharebasedPayments"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Share-based Payment Arrangement [Abstract]",
        "terseLabel": "Share-based Payment Arrangement [Abstract]"
       }
      }
     },
     "localname": "DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_DiscontinuedOperationIncomeLossFromDiscontinuedOperationDuringPhaseOutPeriodNetOfTax": {
     "auth_ref": [
      "r6",
      "r7",
      "r21"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount after tax of income (loss) from operations classified as a discontinued operation. Excludes gain (loss) on disposal and provision for gain (loss) until disposal.",
        "label": "Discontinued Operation, Income (Loss) from Discontinued Operation During Phase-out Period, Net of Tax",
        "terseLabel": "Loss from discontinued operations, net of income taxes"
       }
      }
     },
     "localname": "DiscontinuedOperationIncomeLossFromDiscontinuedOperationDuringPhaseOutPeriodNetOfTax",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://thecronosgroup.com/role/HeldForSaleAssetsandDiscontinuedOperationsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DiscontinuedOperationsAndDisposalGroupsAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Discontinued Operations and Disposal Groups [Abstract]"
       }
      }
     },
     "localname": "DiscontinuedOperationsAndDisposalGroupsAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_DiscontinuedOperationsHeldforsaleMember": {
     "auth_ref": [
      "r4",
      "r5",
      "r20"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Component or group of components classified as held-for-sale and representing a strategic shift that has or will have a major effect on operations and financial results. Includes a business or nonprofit activity on acquisition classified as held-for-sale.",
        "label": "Discontinued Operations, Held-for-sale [Member]",
        "terseLabel": "Discontinued Operations, Held-for-sale"
       }
      }
     },
     "localname": "DiscontinuedOperationsHeldforsaleMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://thecronosgroup.com/role/HeldForSaleAssetsandDiscontinuedOperationsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_DisposalGroupClassificationAxis": {
     "auth_ref": [
      "r20"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by disposal group classification.",
        "label": "Disposal Group Classification [Axis]",
        "terseLabel": "Disposal Group Classification [Axis]"
       }
      }
     },
     "localname": "DisposalGroupClassificationAxis",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://thecronosgroup.com/role/HeldForSaleAssetsandDiscontinuedOperationsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_DisposalGroupClassificationDomain": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Component or group of components disposed of, including but not limited to, disposal group held-for-sale or disposed of by sale, disposed of by means other than sale, and discontinued operations.",
        "label": "Disposal Group Classification [Domain]",
        "terseLabel": "Disposal Group Classification [Domain]"
       }
      }
     },
     "localname": "DisposalGroupClassificationDomain",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://thecronosgroup.com/role/HeldForSaleAssetsandDiscontinuedOperationsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_DisposalGroupHeldforsaleNotDiscontinuedOperationsMember": {
     "auth_ref": [
      "r20",
      "r258",
      "r267"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disposal group that is classified as held-for-sale. Excludes disposals classified as discontinued operations.",
        "label": "Disposal Group, Held-for-sale, Not Discontinued Operations [Member]",
        "terseLabel": "Disposal Group, Held-for-sale, Not Discontinued Operations"
       }
      }
     },
     "localname": "DisposalGroupHeldforsaleNotDiscontinuedOperationsMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://thecronosgroup.com/role/HeldForSaleAssetsandDiscontinuedOperationsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_DisposalGroupIncludingDiscontinuedOperationAssetsNoncurrent": {
     "auth_ref": [
      "r2",
      "r3",
      "r18",
      "r20",
      "r24",
      "r257",
      "r265"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount classified as assets attributable to disposal group held for sale or disposed of, expected to be disposed of after one year or the normal operating cycle, if longer.",
        "label": "Disposal Group, Including Discontinued Operation, Assets, Noncurrent",
        "terseLabel": "OGBC assets classified as held-for-sale"
       }
      }
     },
     "localname": "DisposalGroupIncludingDiscontinuedOperationAssetsNoncurrent",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://thecronosgroup.com/role/HeldForSaleAssetsandDiscontinuedOperationsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DisposalGroupNotDiscontinuedOperationGainLossOnDisposal": {
     "auth_ref": [
      "r119",
      "r261",
      "r264"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount before tax of gain (loss) recognized on the sale or disposal of a disposal group. Excludes discontinued operations.",
        "label": "Disposal Group, Not Discontinued Operation, Gain (Loss) on Disposal",
        "terseLabel": "Gain on sale of property held-for-sale"
       }
      }
     },
     "localname": "DisposalGroupNotDiscontinuedOperationGainLossOnDisposal",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://thecronosgroup.com/role/HeldForSaleAssetsandDiscontinuedOperationsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DisposalGroupsIncludingDiscontinuedOperationsDisclosureTextBlock": {
     "auth_ref": [
      "r25",
      "r269"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure related to a disposal group. Includes, but is not limited to, a discontinued operation, disposal classified as held-for-sale or disposed of by means other than sale or disposal of an individually significant component.",
        "label": "Disposal Groups, Including Discontinued Operations, Disclosure [Text Block]",
        "terseLabel": "Held-For-Sale Assets and Discontinued Operations"
       }
      }
     },
     "localname": "DisposalGroupsIncludingDiscontinuedOperationsDisclosureTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://thecronosgroup.com/role/HeldForSaleAssetsandDiscontinuedOperations"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain": {
     "auth_ref": [
      "r328",
      "r330"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Name of disposal group.",
        "label": "Disposal Group Name [Domain]",
        "terseLabel": "Disposal Group Name [Domain]"
       }
      }
     },
     "localname": "DisposalGroupsIncludingDiscontinuedOperationsNameDomain",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://thecronosgroup.com/role/HeldForSaleAssetsandDiscontinuedOperationsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_DueToRelatedPartiesNoncurrent": {
     "auth_ref": [
      "r62",
      "r125",
      "r291",
      "r293",
      "r294",
      "r300",
      "r301",
      "r302",
      "r445"
     ],
     "calculation": {
      "http://thecronosgroup.com/role/CondensedConsolidatedBalanceSheets": {
       "order": 2.0,
       "parentTag": "us-gaap_Liabilities",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Portion of the carrying amount as of the balance sheet date of obligations due all related parties that is payable after one year or beyond the normal operating cycle if longer.",
        "label": "Due to Related Parties, Noncurrent",
        "terseLabel": "Due to non-controlling interests"
       }
      }
     },
     "localname": "DueToRelatedPartiesNoncurrent",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://thecronosgroup.com/role/CondensedConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_EarningsPerShareAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Earnings Per Share [Abstract]",
        "terseLabel": "Earnings Per Share [Abstract]"
       }
      }
     },
     "localname": "EarningsPerShareAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_EarningsPerShareBasicAndDilutedAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Earnings Per Share, Basic and Diluted [Abstract]",
        "terseLabel": "Net income (loss) per share"
       }
      }
     },
     "localname": "EarningsPerShareBasicAndDilutedAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://thecronosgroup.com/role/CondensedConsolidatedStatementsofNetIncomeLossandComprehensiveIncomeLoss"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_EarningsPerShareBasicAndDilutedOtherDisclosuresAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Earnings Per Share, Basic and Diluted, Other Disclosures [Abstract]",
        "terseLabel": "Weighted average number of outstanding shares"
       }
      }
     },
     "localname": "EarningsPerShareBasicAndDilutedOtherDisclosuresAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://thecronosgroup.com/role/CondensedConsolidatedStatementsofNetIncomeLossandComprehensiveIncomeLoss"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_EarningsPerShareDilutedLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Earnings Per Share, Diluted, by Common Class, Including Two Class Method [Line Items]",
        "terseLabel": "Earnings Per Share, Diluted, by Common Class, Including Two Class Method [Line Items]"
       }
      }
     },
     "localname": "EarningsPerShareDilutedLineItems",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://thecronosgroup.com/role/EarningsLossPerShareScheduleofEarningsLossPerShareDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_EarningsPerShareTextBlock": {
     "auth_ref": [
      "r159",
      "r161",
      "r162",
      "r165"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for earnings per share.",
        "label": "Earnings Per Share [Text Block]",
        "terseLabel": "Earnings (Loss) Per Share"
       }
      }
     },
     "localname": "EarningsPerShareTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://thecronosgroup.com/role/EarningsLossPerShare"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents": {
     "auth_ref": [
      "r431"
     ],
     "calculation": {
      "http://thecronosgroup.com/role/CondensedConsolidatedStatementsofCashFlows": {
       "order": 1.0,
       "parentTag": "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of increase (decrease) from effect of exchange rate changes on cash and cash equivalents, and cash and cash equivalents restricted to withdrawal or usage; held in foreign currencies. Excludes amounts for disposal group and discontinued operations. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.",
        "label": "Effect of Exchange Rate on Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents",
        "terseLabel": "Effect of foreign currency translation on cash and cash equivalents"
       }
      }
     },
     "localname": "EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://thecronosgroup.com/role/CondensedConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Share-based Payment Arrangement, Expensed and Capitalized, Amount [Line Items]",
        "terseLabel": "Share-based Payment Arrangement, Expensed and Capitalized, Amount [Line Items]"
       }
      }
     },
     "localname": "EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://thecronosgroup.com/role/SharebasedPaymentsSummaryofStockbasedCompensationExpenseDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_EmployeeStockOptionMember": {
     "auth_ref": [
      "r350"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Share-based payment arrangement granting right, subject to vesting and other restrictions, to purchase or sell certain number of shares at predetermined price for specified period of time.",
        "label": "Share-based Payment Arrangement, Option [Member]",
        "terseLabel": "Stock options"
       }
      }
     },
     "localname": "EmployeeStockOptionMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://thecronosgroup.com/role/EarningsLossPerShareScheduleofAntidilutiveSecuritiesExcludedfromComputationofDilutedSharesOutstandingDetails",
      "http://thecronosgroup.com/role/EarningsLossPerShareScheduleofEarningsLossPerShareDetails",
      "http://thecronosgroup.com/role/SharebasedPaymentsStockOptionsNarrativeDetails",
      "http://thecronosgroup.com/role/SharebasedPaymentsSummaryofStockbasedCompensationExpenseDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_EquityComponentDomain": {
     "auth_ref": [
      "r0",
      "r84",
      "r85",
      "r86",
      "r128",
      "r129",
      "r130",
      "r132",
      "r139",
      "r142",
      "r166",
      "r228",
      "r309",
      "r311",
      "r354",
      "r355",
      "r356",
      "r361",
      "r362",
      "r407",
      "r432",
      "r433",
      "r434",
      "r435",
      "r436",
      "r438",
      "r509",
      "r510",
      "r511",
      "r546"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Components of equity are the parts of the total Equity balance including that which is allocated to common, preferred, treasury stock, retained earnings, etc.",
        "label": "Equity Component [Domain]",
        "terseLabel": "Equity Component [Domain]"
       }
      }
     },
     "localname": "EquityComponentDomain",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://thecronosgroup.com/role/CondensedConsolidatedStatementsofChangesinEquity"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_EquityMethodInvestmentOwnershipPercentage": {
     "auth_ref": [
      "r223"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The percentage of ownership of common stock or equity participation in the investee accounted for under the equity method of accounting.",
        "label": "Equity Method Investment, Ownership Percentage",
        "verboseLabel": "Ownership interest"
       }
      }
     },
     "localname": "EquityMethodInvestmentOwnershipPercentage",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://thecronosgroup.com/role/BackgroundBasisofPresentationandAccountingPoliciesDetails",
      "http://thecronosgroup.com/role/DerivativeLiabilitiesNarrativeDetails",
      "http://thecronosgroup.com/role/InvestmentsScheduleofInvestmentsinAssociatesandJointVenturesDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "us-gaap_EquityMethodInvestments": {
     "auth_ref": [
      "r58",
      "r187",
      "r222"
     ],
     "calculation": {
      "http://thecronosgroup.com/role/CondensedConsolidatedBalanceSheets": {
       "order": 8.0,
       "parentTag": "us-gaap_Assets",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "This item represents the carrying amount on the entity's balance sheet of its investment in common stock of an equity method investee. This is not an indicator of the fair value of the investment, rather it is the initial cost adjusted for the entity's share of earnings and losses of the investee, adjusted for any distributions (dividends) and other than temporary impairment (OTTI) losses recognized.",
        "label": "Equity Method Investments",
        "verboseLabel": "Investments in equity accounted investees, net"
       }
      }
     },
     "localname": "EquityMethodInvestments",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://thecronosgroup.com/role/CondensedConsolidatedBalanceSheets",
      "http://thecronosgroup.com/role/InvestmentsScheduleofInvestmentsinAssociatesandJointVenturesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_EquityMethodInvestmentsAndJointVenturesAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Equity Method Investments and Joint Ventures [Abstract]",
        "terseLabel": "Equity Method Investments and Joint Ventures [Abstract]"
       }
      }
     },
     "localname": "EquityMethodInvestmentsAndJointVenturesAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_EquityMethodInvestmentsDisclosureTextBlock": {
     "auth_ref": [
      "r227"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for equity method investments and joint ventures. Equity method investments are investments that give the investor the ability to exercise significant influence over the operating and financial policies of an investee. Joint ventures are entities owned and operated by a small group of businesses as a separate and specific business or project for the mutual benefit of the members of the group.",
        "label": "Equity Method Investments and Joint Ventures Disclosure [Text Block]",
        "terseLabel": "Investments"
       }
      }
     },
     "localname": "EquityMethodInvestmentsDisclosureTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://thecronosgroup.com/role/Investments"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_EquityMethodInvestmentsTextBlock": {
     "auth_ref": [
      "r226"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of equity method investments including, but not limited to, name of each investee or group of investments, percentage ownership, difference between recorded amount of an investment and the value of the underlying equity in the net assets, and summarized financial information.",
        "label": "Equity Method Investments [Table Text Block]",
        "terseLabel": "Schedule of Investments in Associates and Joint Ventures"
       }
      }
     },
     "localname": "EquityMethodInvestmentsTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://thecronosgroup.com/role/InvestmentsTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ErrorCorrectionsAndPriorPeriodAdjustmentsRestatementByRestatementPeriodAndAmountAxis": {
     "auth_ref": [
      "r133",
      "r134",
      "r135",
      "r138",
      "r139",
      "r141",
      "r142"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by type of error correction.",
        "label": "Error Correction, Type [Axis]",
        "terseLabel": "Error Correction, Type [Axis]"
       }
      }
     },
     "localname": "ErrorCorrectionsAndPriorPeriodAdjustmentsRestatementByRestatementPeriodAndAmountAxis",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://thecronosgroup.com/role/BackgroundBasisofPresentationandAccountingPoliciesDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ExciseAndSalesTaxes": {
     "auth_ref": [
      "r90"
     ],
     "calculation": {
      "http://thecronosgroup.com/role/CondensedConsolidatedStatementsofNetIncomeLossandComprehensiveIncomeLoss": {
       "order": 2.0,
       "parentTag": "us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax",
       "weight": -1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The amount of excise and sales taxes included in sales and revenues, which are then deducted as a cost of sales. Includes excise taxes, which are applied to specific types of transactions or items (such as gasoline or alcohol); and sales, use and value added taxes, which are applied to a broad class of revenue-producing transactions involving a wide range of goods and services.",
        "label": "Excise and Sales Taxes",
        "negatedTerseLabel": "Excise taxes"
       }
      }
     },
     "localname": "ExciseAndSalesTaxes",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://thecronosgroup.com/role/CondensedConsolidatedStatementsofNetIncomeLossandComprehensiveIncomeLoss"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]",
        "terseLabel": "Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]"
       }
      }
     },
     "localname": "FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://thecronosgroup.com/role/FinancialInstrumentsScheduleofFairValueofAssetsMeasuredonRecurringBasisDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable": {
     "auth_ref": [
      "r411",
      "r412",
      "r413",
      "r423"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of information about asset and liability measured at fair value on recurring and nonrecurring basis.",
        "label": "Fair Value, Recurring and Nonrecurring [Table]",
        "terseLabel": "Fair Value, Recurring and Nonrecurring [Table]"
       }
      }
     },
     "localname": "FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://thecronosgroup.com/role/FinancialInstrumentsScheduleofFairValueofAssetsMeasuredonRecurringBasisDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Fair Value Measurement Inputs and Valuation Techniques [Line Items]",
        "terseLabel": "Fair Value Measurement Inputs and Valuation Techniques [Line Items]"
       }
      }
     },
     "localname": "FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesLineItems",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://thecronosgroup.com/role/DerivativeLiabilitiesScheduleofFairValuesofDerivativeLiabilitiesDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTable": {
     "auth_ref": [
      "r414"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of information about input and valuation technique used to measure fair value and change in valuation approach and technique for each separate class of asset and liability measured on recurring and nonrecurring basis.",
        "label": "Fair Value Measurement Inputs and Valuation Techniques [Table]",
        "terseLabel": "Fair Value Measurement Inputs and Valuation Techniques [Table]"
       }
      }
     },
     "localname": "FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTable",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://thecronosgroup.com/role/DerivativeLiabilitiesScheduleofFairValuesofDerivativeLiabilitiesDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTableTextBlock": {
     "auth_ref": [
      "r414"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of input and valuation technique used to measure fair value and change in valuation approach and technique for each separate class of asset and liability measured on recurring and nonrecurring basis.",
        "label": "Fair Value Measurement Inputs and Valuation Techniques [Table Text Block]",
        "terseLabel": "Schedule of Fair Values of Derivative Liabilities"
       }
      }
     },
     "localname": "FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://thecronosgroup.com/role/DerivativeLiabilitiesTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_FairValueByFairValueHierarchyLevelAxis": {
     "auth_ref": [
      "r305",
      "r306",
      "r307",
      "r319",
      "r320",
      "r321",
      "r322",
      "r323",
      "r324",
      "r325",
      "r327",
      "r412",
      "r451",
      "r452",
      "r453"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by level within fair value hierarchy and fair value measured at net asset value per share as practical expedient.",
        "label": "Fair Value Hierarchy and NAV [Axis]",
        "terseLabel": "Fair Value Hierarchy and NAV [Axis]"
       }
      }
     },
     "localname": "FairValueByFairValueHierarchyLevelAxis",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://thecronosgroup.com/role/FinancialInstrumentsScheduleofFairValueofAssetsMeasuredonRecurringBasisDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_FairValueByMeasurementFrequencyAxis": {
     "auth_ref": [
      "r411",
      "r412",
      "r415",
      "r416",
      "r424"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by measurement frequency.",
        "label": "Measurement Frequency [Axis]",
        "terseLabel": "Measurement Frequency [Axis]"
       }
      }
     },
     "localname": "FairValueByMeasurementFrequencyAxis",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://thecronosgroup.com/role/FinancialInstrumentsScheduleofFairValueofAssetsMeasuredonRecurringBasisDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_FairValueDisclosuresAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Fair Value Disclosures [Abstract]",
        "terseLabel": "Fair Value Disclosures [Abstract]"
       }
      }
     },
     "localname": "FairValueDisclosuresAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_FairValueInputsLevel1Member": {
     "auth_ref": [
      "r305",
      "r319",
      "r320",
      "r325",
      "r327",
      "r412",
      "r451"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Quoted prices in active markets for identical assets or liabilities that the reporting entity can access at the measurement date.",
        "label": "Fair Value, Inputs, Level 1 [Member]",
        "terseLabel": "Level 1"
       }
      }
     },
     "localname": "FairValueInputsLevel1Member",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://thecronosgroup.com/role/FinancialInstrumentsScheduleofFairValueofAssetsMeasuredonRecurringBasisDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_FairValueInputsLevel2Member": {
     "auth_ref": [
      "r305",
      "r306",
      "r307",
      "r319",
      "r320",
      "r325",
      "r327",
      "r412",
      "r452"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Inputs other than quoted prices included within level 1 that are observable for an asset or liability, either directly or indirectly, including, but not limited to, quoted prices for similar assets or liabilities in active markets, or quoted prices for identical or similar assets or liabilities in inactive markets.",
        "label": "Fair Value, Inputs, Level 2 [Member]",
        "terseLabel": "Level 2"
       }
      }
     },
     "localname": "FairValueInputsLevel2Member",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://thecronosgroup.com/role/FinancialInstrumentsScheduleofFairValueofAssetsMeasuredonRecurringBasisDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_FairValueInputsLevel3Member": {
     "auth_ref": [
      "r305",
      "r306",
      "r307",
      "r319",
      "r320",
      "r321",
      "r322",
      "r323",
      "r324",
      "r325",
      "r327",
      "r412",
      "r453"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Unobservable inputs that reflect the entity's own assumption about the assumptions market participants would use in pricing.",
        "label": "Fair Value, Inputs, Level 3 [Member]",
        "terseLabel": "Level 3"
       }
      }
     },
     "localname": "FairValueInputsLevel3Member",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://thecronosgroup.com/role/FinancialInstrumentsScheduleofFairValueofAssetsMeasuredonRecurringBasisDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_FairValueMeasurementFrequencyDomain": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Measurement frequency.",
        "label": "Measurement Frequency [Domain]",
        "terseLabel": "Measurement Frequency [Domain]"
       }
      }
     },
     "localname": "FairValueMeasurementFrequencyDomain",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://thecronosgroup.com/role/FinancialInstrumentsScheduleofFairValueofAssetsMeasuredonRecurringBasisDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_FairValueMeasurementsFairValueHierarchyDomain": {
     "auth_ref": [
      "r305",
      "r306",
      "r307",
      "r319",
      "r320",
      "r321",
      "r322",
      "r323",
      "r324",
      "r325",
      "r327",
      "r451",
      "r452",
      "r453"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Categories used to prioritize the inputs to valuation techniques to measure fair value.",
        "label": "Fair Value Hierarchy and NAV [Domain]",
        "terseLabel": "Fair Value Hierarchy and NAV [Domain]"
       }
      }
     },
     "localname": "FairValueMeasurementsFairValueHierarchyDomain",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://thecronosgroup.com/role/FinancialInstrumentsScheduleofFairValueofAssetsMeasuredonRecurringBasisDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_FairValueMeasurementsRecurringMember": {
     "auth_ref": [
      "r421",
      "r424"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Frequent fair value measurement. Includes, but is not limited to, fair value adjustment for impairment of asset, liability or equity, frequently measured at fair value.",
        "label": "Fair Value, Recurring [Member]",
        "terseLabel": "Fair Value, Recurring"
       }
      }
     },
     "localname": "FairValueMeasurementsRecurringMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://thecronosgroup.com/role/FinancialInstrumentsScheduleofFairValueofAssetsMeasuredonRecurringBasisDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_FairValueNetDerivativeAssetLiabilityMeasuredOnRecurringBasisUnobservableInputReconciliationTableTextBlock": {
     "auth_ref": [
      "r417",
      "r422"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of financial instrument classified as a derivative asset (liability) after deduction of derivative liability (asset) using recurring unobservable inputs that reflect the entity's own assumption about the assumptions market participants would use in pricing.",
        "label": "Fair Value, Net Derivative Asset (Liability) Measured on Recurring Basis, Unobservable Input Reconciliation [Table Text Block]",
        "terseLabel": "Schedule of Reconciliation of Carrying Amounts"
       }
      }
     },
     "localname": "FairValueNetDerivativeAssetLiabilityMeasuredOnRecurringBasisUnobservableInputReconciliationTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://thecronosgroup.com/role/DerivativeLiabilitiesTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_FairValueNetDerivativeAssetLiabilityMeasuredOnRecurringBasisUnobservableInputsReconciliationGainLossIncludedInEarnings": {
     "auth_ref": [
      "r418",
      "r422"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of gain (loss) recognized in income from derivative asset (liability) after deduction of derivative liability (asset), measured at fair value on recurring basis using unobservable input (level 3).",
        "label": "Fair Value, Net Derivative Asset (Liability) Measured on Recurring Basis, Unobservable Inputs Reconciliation, Gain (Loss) Included in Earnings",
        "negatedTerseLabel": "Revaluation loss/(gain)"
       }
      }
     },
     "localname": "FairValueNetDerivativeAssetLiabilityMeasuredOnRecurringBasisUnobservableInputsReconciliationGainLossIncludedInEarnings",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://thecronosgroup.com/role/DerivativeLiabilitiesScheduleofReconciliationofCarryingAmountsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_FairValueNetDerivativeAssetLiabilityMeasuredOnRecurringBasisUnobservableInputsReconciliationGainLossIncludedInOtherComprehensiveIncomeLoss": {
     "auth_ref": [
      "r419",
      "r422"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of gain (loss) recognized in other comprehensive income from derivative asset (liability) after deduction of derivative liability (asset), measured at fair value on recurring basis using unobservable input (level 3).",
        "label": "Fair Value, Net Derivative Asset (Liability) Measured on Recurring Basis, Unobservable Inputs Reconciliation, Gain (Loss) Included in Other Comprehensive Income (Loss)",
        "negatedTerseLabel": "Foreign exchange effect"
       }
      }
     },
     "localname": "FairValueNetDerivativeAssetLiabilityMeasuredOnRecurringBasisUnobservableInputsReconciliationGainLossIncludedInOtherComprehensiveIncomeLoss",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://thecronosgroup.com/role/DerivativeLiabilitiesScheduleofReconciliationofCarryingAmountsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_FairValueNetDerivativeAssetLiabilityMeasuredOnRecurringBasisUnobservableInputsReconciliationSettlements": {
     "auth_ref": [
      "r420",
      "r422"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of settlements of financial instrument classified as a derivative asset (liability) after deduction of derivative liability, measured using unobservable inputs that reflect the entity's own assumption about the assumptions market participants would use in pricing.",
        "label": "Fair Value, Net Derivative Asset (Liability) Measured on Recurring Basis, Unobservable Inputs Reconciliation, Settlements",
        "negatedTerseLabel": "Exercise of rights"
       }
      }
     },
     "localname": "FairValueNetDerivativeAssetLiabilityMeasuredOnRecurringBasisUnobservableInputsReconciliationSettlements",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://thecronosgroup.com/role/DerivativeLiabilitiesScheduleofReconciliationofCarryingAmountsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_FairValueNetDerivativeAssetLiabilityMeasuredOnRecurringBasisWithUnobservableInputs": {
     "auth_ref": [
      "r411",
      "r422"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Fair value of financial instrument classified as derivative asset (liability) after deduction of derivative liability (asset), measured using unobservable inputs that reflect the entity's own assumption about the assumptions market participants would use in pricing.",
        "label": "Fair Value, Net Derivative Asset (Liability) Measured on Recurring Basis with Unobservable Inputs",
        "negatedPeriodEndLabel": "Ending balance",
        "negatedPeriodStartLabel": "Beginning balance"
       }
      }
     },
     "localname": "FairValueNetDerivativeAssetLiabilityMeasuredOnRecurringBasisWithUnobservableInputs",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://thecronosgroup.com/role/DerivativeLiabilitiesScheduleofReconciliationofCarryingAmountsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_FinancingReceivableAccruedInterestBeforeAllowanceForCreditLoss": {
     "auth_ref": [
      "r236"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, before allowance for credit loss, of accrued interest on financing receivable.",
        "label": "Financing Receivable, Accrued Interest, before Allowance for Credit Loss",
        "terseLabel": "Accrued interest"
       }
      }
     },
     "localname": "FinancingReceivableAccruedInterestBeforeAllowanceForCreditLoss",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://thecronosgroup.com/role/InvestmentsScheduleofInvestmentsinAssociatesandJointVenturesDetails",
      "http://thecronosgroup.com/role/LoansReceivablenetDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_FinancingReceivableAllowanceForCreditLosses": {
     "auth_ref": [
      "r215",
      "r231",
      "r232",
      "r234",
      "r470",
      "r541",
      "r542",
      "r543"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of allowance for credit loss on financing receivable. Excludes allowance for financing receivable covered under loss sharing agreement.",
        "label": "Financing Receivable, Allowance for Credit Loss",
        "terseLabel": "Allowance for credit loss"
       }
      }
     },
     "localname": "FinancingReceivableAllowanceForCreditLosses",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://thecronosgroup.com/role/LoansReceivablenetDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_GainLossOnDerivativeInstrumentsNetPretax": {
     "auth_ref": [
      "r396"
     ],
     "calculation": {
      "http://thecronosgroup.com/role/CondensedConsolidatedStatementsofCashFlows": {
       "order": 11.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": -1.0
      },
      "http://thecronosgroup.com/role/CondensedConsolidatedStatementsofNetIncomeLossandComprehensiveIncomeLoss": {
       "order": 3.0,
       "parentTag": "us-gaap_NonoperatingIncomeExpense",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Aggregate net gain (loss) on all derivative instruments recognized in earnings during the period, before tax effects.",
        "label": "Gain (Loss) on Derivative Instruments, Net, Pretax",
        "negatedTerseLabel": "Gain (loss) on revaluation of derivative liabilities",
        "terseLabel": "Gain (loss) on revaluation of derivative liabilities"
       }
      }
     },
     "localname": "GainLossOnDerivativeInstrumentsNetPretax",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://thecronosgroup.com/role/BackgroundBasisofPresentationandAccountingPoliciesDetails",
      "http://thecronosgroup.com/role/CondensedConsolidatedStatementsofCashFlows",
      "http://thecronosgroup.com/role/CondensedConsolidatedStatementsofNetIncomeLossandComprehensiveIncomeLoss",
      "http://thecronosgroup.com/role/SegmentInformationScheduleofAdjustedEBITDADetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_GeneralAndAdministrativeExpense": {
     "auth_ref": [
      "r101"
     ],
     "calculation": {
      "http://thecronosgroup.com/role/CondensedConsolidatedStatementsofNetIncomeLossandComprehensiveIncomeLoss": {
       "order": 3.0,
       "parentTag": "us-gaap_OperatingExpenses",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The aggregate total of expenses of managing and administering the affairs of an entity, including affiliates of the reporting entity, which are not directly or indirectly associated with the manufacture, sale or creation of a product or product line.",
        "label": "General and Administrative Expense",
        "terseLabel": "General and administrative"
       }
      }
     },
     "localname": "GeneralAndAdministrativeExpense",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://thecronosgroup.com/role/CondensedConsolidatedStatementsofNetIncomeLossandComprehensiveIncomeLoss"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_Goodwill": {
     "auth_ref": [
      "r243",
      "r245",
      "r450",
      "r463"
     ],
     "calculation": {
      "http://thecronosgroup.com/role/CondensedConsolidatedBalanceSheets": {
       "order": 6.0,
       "parentTag": "us-gaap_Assets",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount after accumulated impairment loss of an asset representing future economic benefits arising from other assets acquired in a business combination that are not individually identified and separately recognized.",
        "label": "Goodwill",
        "verboseLabel": "Goodwill"
       }
      }
     },
     "localname": "Goodwill",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://thecronosgroup.com/role/CondensedConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Goodwill and Intangible Assets Disclosure [Abstract]",
        "terseLabel": "Goodwill and Intangible Assets Disclosure [Abstract]"
       }
      }
     },
     "localname": "GoodwillAndIntangibleAssetsDisclosureAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_GoodwillImpairmentLoss": {
     "auth_ref": [
      "r119",
      "r244",
      "r246",
      "r249"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of loss from the write-down of an asset representing the future economic benefits arising from other assets acquired in a business combination that are not individually identified and separately recognized.",
        "label": "Goodwill, Impairment Loss",
        "verboseLabel": "Goodwill, impairment loss"
       }
      }
     },
     "localname": "GoodwillImpairmentLoss",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://thecronosgroup.com/role/ImpairmentLossonLongLivedAssetsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_GrossProfit": {
     "auth_ref": [
      "r100",
      "r124",
      "r186",
      "r192",
      "r196",
      "r199",
      "r202",
      "r225",
      "r288",
      "r289",
      "r290",
      "r293",
      "r294",
      "r295",
      "r297",
      "r299",
      "r301",
      "r302",
      "r430"
     ],
     "calculation": {
      "http://thecronosgroup.com/role/CondensedConsolidatedStatementsofNetIncomeLossandComprehensiveIncomeLoss": {
       "order": 2.0,
       "parentTag": "us-gaap_OperatingIncomeLoss",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Aggregate revenue less cost of goods and services sold or operating expenses directly attributable to the revenue generation activity.",
        "label": "Gross Profit",
        "totalLabel": "Gross loss"
       }
      }
     },
     "localname": "GrossProfit",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://thecronosgroup.com/role/CondensedConsolidatedStatementsofNetIncomeLossandComprehensiveIncomeLoss"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ImpairmentOfIntangibleAssetsIndefinitelivedExcludingGoodwill": {
     "auth_ref": [
      "r119",
      "r254"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of impairment loss resulting from write-down of assets, excluding financial assets and goodwill, lacking physical substance and having a projected indefinite period of benefit to fair value.",
        "label": "Impairment of Intangible Assets, Indefinite-lived (Excluding Goodwill)",
        "terseLabel": "Impairment of intangible assets, indefinite-lived (excluding goodwill)"
       }
      }
     },
     "localname": "ImpairmentOfIntangibleAssetsIndefinitelivedExcludingGoodwill",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://thecronosgroup.com/role/ImpairmentLossonLongLivedAssetsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ImpairmentOfLongLivedAssetsToBeDisposedOf": {
     "auth_ref": [
      "r119",
      "r259"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The aggregate amount of write-downs for impairments recognized during the period for long-lived assets held for abandonment, exchange or sale.",
        "label": "Impairment of Long-Lived Assets to be Disposed of",
        "terseLabel": "Impairment of leasehold improvements to be disposed of",
        "verboseLabel": "Write-down to held-for-sale assets"
       }
      }
     },
     "localname": "ImpairmentOfLongLivedAssetsToBeDisposedOf",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://thecronosgroup.com/role/HeldForSaleAssetsandDiscontinuedOperationsDetails",
      "http://thecronosgroup.com/role/ImpairmentLossonLongLivedAssetsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest": {
     "auth_ref": [
      "r124",
      "r131",
      "r186",
      "r192",
      "r196",
      "r199",
      "r202",
      "r225",
      "r288",
      "r289",
      "r290",
      "r293",
      "r294",
      "r295",
      "r297",
      "r299",
      "r301",
      "r302",
      "r368",
      "r409",
      "r430"
     ],
     "calculation": {
      "http://thecronosgroup.com/role/CondensedConsolidatedStatementsofNetIncomeLossandComprehensiveIncomeLoss": {
       "order": 2.0,
       "parentTag": "us-gaap_ProfitLoss",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount after tax of income (loss) from continuing operations including portion attributable to the noncontrolling interest.",
        "label": "Income (Loss) from Continuing Operations, Net of Tax, Including Portion Attributable to Noncontrolling Interest",
        "totalLabel": "Income (loss) from continuing operations"
       }
      }
     },
     "localname": "IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://thecronosgroup.com/role/CondensedConsolidatedStatementsofNetIncomeLossandComprehensiveIncomeLoss"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncomeLossFromContinuingOperationsPerBasicShare": {
     "auth_ref": [
      "r88",
      "r98",
      "r131",
      "r133",
      "r134",
      "r136",
      "r137",
      "r147",
      "r156",
      "r157",
      "r409",
      "r473",
      "r475",
      "r481",
      "r495"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The amount of net income (loss) from continuing operations per each share of common stock or unit outstanding during the reporting period.",
        "label": "Income (Loss) from Continuing Operations, Per Basic Share",
        "terseLabel": "Basic - continuing operations (in dollars per share)",
        "verboseLabel": "Basic earnings (loss) from continuing operations per share (in dollars per share)"
       }
      }
     },
     "localname": "IncomeLossFromContinuingOperationsPerBasicShare",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://thecronosgroup.com/role/CondensedConsolidatedStatementsofNetIncomeLossandComprehensiveIncomeLoss",
      "http://thecronosgroup.com/role/EarningsLossPerShareScheduleofEarningsLossPerShareDetails"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_IncomeLossFromContinuingOperationsPerDilutedShare": {
     "auth_ref": [
      "r88",
      "r98",
      "r131",
      "r133",
      "r134",
      "r136",
      "r137",
      "r147",
      "r156",
      "r157",
      "r158",
      "r409",
      "r481",
      "r495",
      "r498",
      "r502"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The amount of net income (loss) derived from continuing operations during the period available to each share of common stock or common unit outstanding during the reporting period and to each share or unit that would have been outstanding assuming the issuance of common shares or units for all dilutive potential common shares or units outstanding during the reporting period.",
        "label": "Income (Loss) from Continuing Operations, Per Diluted Share",
        "terseLabel": "Diluted - continuing operations (in dollars per share)",
        "verboseLabel": "Diluted earnings (loss) from continuing operations per share (in dollars per share)"
       }
      }
     },
     "localname": "IncomeLossFromContinuingOperationsPerDilutedShare",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://thecronosgroup.com/role/CondensedConsolidatedStatementsofNetIncomeLossandComprehensiveIncomeLoss",
      "http://thecronosgroup.com/role/EarningsLossPerShareScheduleofEarningsLossPerShareDetails"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTax": {
     "auth_ref": [
      "r6",
      "r7",
      "r8",
      "r9",
      "r10",
      "r21",
      "r24",
      "r363",
      "r496"
     ],
     "calculation": {
      "http://thecronosgroup.com/role/CondensedConsolidatedStatementsofNetIncomeLossandComprehensiveIncomeLoss": {
       "order": 1.0,
       "parentTag": "us-gaap_ProfitLoss",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount after tax of income (loss) from a discontinued operation including the portion attributable to the noncontrolling interest. Includes, but is not limited to, the income (loss) from operations during the phase-out period, gain (loss) on disposal, gain (loss) for reversal of write-down (write-down) to fair value, less cost to sell, and adjustments to a prior period gain (loss) on disposal.",
        "label": "Income (Loss) from Discontinued Operations, Net of Tax, Including Portion Attributable to Noncontrolling Interest",
        "negatedTerseLabel": "Loss from discontinued operations",
        "terseLabel": "Loss from discontinued operations"
       }
      }
     },
     "localname": "IncomeLossFromDiscontinuedOperationsNetOfTax",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://thecronosgroup.com/role/CondensedConsolidatedStatementsofNetIncomeLossandComprehensiveIncomeLoss",
      "http://thecronosgroup.com/role/SegmentInformationNarrativeDetails",
      "http://thecronosgroup.com/role/SegmentInformationScheduleofAdjustedEBITDADetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTaxPerBasicShare": {
     "auth_ref": [
      "r92",
      "r98",
      "r151",
      "r156",
      "r157",
      "r481",
      "r496",
      "r498",
      "r502"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Per basic share amount, after tax, of income (loss) from the day-to-day business activities of the discontinued operation and gain (loss) from the disposal of the discontinued operation.",
        "label": "Income (Loss) from Discontinued Operations and Disposal of Discontinued Operations, Net of Tax, Per Basic Share",
        "terseLabel": "Basic earnings from discontinued operations per share (in dollars per share)"
       }
      }
     },
     "localname": "IncomeLossFromDiscontinuedOperationsNetOfTaxPerBasicShare",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://thecronosgroup.com/role/EarningsLossPerShareScheduleofEarningsLossPerShareDetails"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTaxPerDilutedShare": {
     "auth_ref": [
      "r151",
      "r156",
      "r157",
      "r390"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Per diluted share amount, after tax, of income (loss) from the day-to-day business activities of the discontinued operation and gain (loss) from the disposal of the discontinued operation.",
        "label": "Income (Loss) from Discontinued Operations and Disposal of Discontinued Operations, Net of Tax, Per Diluted Share",
        "terseLabel": "Diluted earnings from discontinued operations per share (in dollars per share)"
       }
      }
     },
     "localname": "IncomeLossFromDiscontinuedOperationsNetOfTaxPerDilutedShare",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://thecronosgroup.com/role/EarningsLossPerShareScheduleofEarningsLossPerShareDetails"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_IncomeLossFromEquityMethodInvestments": {
     "auth_ref": [
      "r91",
      "r119",
      "r183",
      "r222",
      "r474",
      "r494"
     ],
     "calculation": {
      "http://thecronosgroup.com/role/CondensedConsolidatedStatementsofCashFlows": {
       "order": 12.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": -1.0
      },
      "http://thecronosgroup.com/role/CondensedConsolidatedStatementsofNetIncomeLossandComprehensiveIncomeLoss": {
       "order": 2.0,
       "parentTag": "us-gaap_NonoperatingIncomeExpense",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of income (loss) for proportionate share of equity method investee's income (loss).",
        "label": "Income (Loss) from Equity Method Investments",
        "negatedLabel": "Share of loss from equity accounted investments",
        "negatedTerseLabel": "Share of loss from investments in equity accounted investees",
        "terseLabel": "Share of loss from equity accounted investments",
        "verboseLabel": "Share of loss from investments in equity accounted investees"
       }
      }
     },
     "localname": "IncomeLossFromEquityMethodInvestments",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://thecronosgroup.com/role/CondensedConsolidatedStatementsofCashFlows",
      "http://thecronosgroup.com/role/CondensedConsolidatedStatementsofNetIncomeLossandComprehensiveIncomeLoss",
      "http://thecronosgroup.com/role/InvestmentsScheduleofInvestmentsinAssociatesandJointVenturesDetails",
      "http://thecronosgroup.com/role/SegmentInformationScheduleofAdjustedEBITDADetails",
      "http://thecronosgroup.com/role/SegmentInformationScheduleofSegmentDataDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncomeStatementAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Income Statement [Abstract]",
        "terseLabel": "Income Statement [Abstract]"
       }
      }
     },
     "localname": "IncomeStatementAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis": {
     "auth_ref": [
      "r328",
      "r330"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by name of disposal group.",
        "label": "Disposal Group Name [Axis]",
        "terseLabel": "Disposal Group Name [Axis]"
       }
      }
     },
     "localname": "IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://thecronosgroup.com/role/HeldForSaleAssetsandDiscontinuedOperationsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Income Statement, Balance Sheet and Additional Disclosures by Disposal Groups, Including Discontinued Operations [Line Items]",
        "terseLabel": "Income Statement, Balance Sheet and Additional Disclosures by Disposal Groups, Including Discontinued Operations [Line Items]"
       }
      }
     },
     "localname": "IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://thecronosgroup.com/role/HeldForSaleAssetsandDiscontinuedOperationsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsTable": {
     "auth_ref": [
      "r3",
      "r12",
      "r13",
      "r14",
      "r15",
      "r16",
      "r17",
      "r19",
      "r22",
      "r23",
      "r24",
      "r267",
      "r268"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of information about a disposal group. Includes, but is not limited to, a discontinued operation, disposal classified as held-for-sale or disposed of by means other than sale or disposal of an individually significant component.",
        "label": "Disposal Groups, Including Discontinued Operations [Table]",
        "terseLabel": "Disposal Groups, Including Discontinued Operations [Table]"
       }
      }
     },
     "localname": "IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsTable",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://thecronosgroup.com/role/HeldForSaleAssetsandDiscontinuedOperationsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_IncomeTaxesPaidNet": {
     "auth_ref": [
      "r122"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The amount of cash paid during the current period to foreign, federal, state, and local authorities as taxes on income, net of any cash received during the current period as refunds for the overpayment of taxes.",
        "label": "Income Taxes Paid, Net",
        "terseLabel": "Income taxes paid"
       }
      }
     },
     "localname": "IncomeTaxesPaidNet",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://thecronosgroup.com/role/CondensedConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncreaseDecreaseInAccountsPayableAndOtherOperatingLiabilities": {
     "auth_ref": [
      "r118"
     ],
     "calculation": {
      "http://thecronosgroup.com/role/CondensedConsolidatedStatementsofCashFlows": {
       "order": 10.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of increase (decrease) in obligations incurred but not paid, and operating obligations classified as other.",
        "label": "Increase (Decrease) in Accounts Payable and Other Operating Liabilities",
        "terseLabel": "Accounts payable and other liabilities"
       }
      }
     },
     "localname": "IncreaseDecreaseInAccountsPayableAndOtherOperatingLiabilities",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://thecronosgroup.com/role/CondensedConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncreaseDecreaseInAccountsReceivable": {
     "auth_ref": [
      "r118"
     ],
     "calculation": {
      "http://thecronosgroup.com/role/CondensedConsolidatedStatementsofCashFlows": {
       "order": 6.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The increase (decrease) during the reporting period in amount due within one year (or one business cycle) from customers for the credit sale of goods and services.",
        "label": "Increase (Decrease) in Accounts Receivable",
        "negatedTerseLabel": "Accounts receivable, net"
       }
      }
     },
     "localname": "IncreaseDecreaseInAccountsReceivable",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://thecronosgroup.com/role/CondensedConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncreaseDecreaseInInventories": {
     "auth_ref": [
      "r118"
     ],
     "calculation": {
      "http://thecronosgroup.com/role/CondensedConsolidatedStatementsofCashFlows": {
       "order": 9.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The increase (decrease) during the reporting period in the aggregate value of all inventory held by the reporting entity, associated with underlying transactions that are classified as operating activities.",
        "label": "Increase (Decrease) in Inventories",
        "negatedTerseLabel": "Inventory, net"
       }
      }
     },
     "localname": "IncreaseDecreaseInInventories",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://thecronosgroup.com/role/CondensedConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncreaseDecreaseInOperatingCapitalAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Increase (Decrease) in Operating Capital [Abstract]",
        "terseLabel": "Changes in operating assets and liabilities:"
       }
      }
     },
     "localname": "IncreaseDecreaseInOperatingCapitalAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://thecronosgroup.com/role/CondensedConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_IncreaseDecreaseInOtherReceivables": {
     "auth_ref": [
      "r118"
     ],
     "calculation": {
      "http://thecronosgroup.com/role/CondensedConsolidatedStatementsofCashFlows": {
       "order": 3.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of increase (decrease) in receivables classified as other.",
        "label": "Increase (Decrease) in Other Receivables",
        "negatedTerseLabel": "Other receivables"
       }
      }
     },
     "localname": "IncreaseDecreaseInOtherReceivables",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://thecronosgroup.com/role/CondensedConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets": {
     "auth_ref": [
      "r118"
     ],
     "calculation": {
      "http://thecronosgroup.com/role/CondensedConsolidatedStatementsofCashFlows": {
       "order": 5.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of increase (decrease) in prepaid expenses, and assets classified as other.",
        "label": "Increase (Decrease) in Prepaid Expense and Other Assets",
        "negatedTerseLabel": "Prepaids and other current assets"
       }
      }
     },
     "localname": "IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://thecronosgroup.com/role/CondensedConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncreaseDecreaseInStockholdersEquityRollForward": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.",
        "label": "Increase (Decrease) in Stockholders' Equity [Roll Forward]",
        "terseLabel": "Increase (Decrease) in Stockholders' Equity [Roll Forward]"
       }
      }
     },
     "localname": "IncreaseDecreaseInStockholdersEquityRollForward",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://thecronosgroup.com/role/CondensedConsolidatedStatementsofChangesinEquity"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_IncrementalCommonSharesAttributableToShareBasedPaymentArrangements": {
     "auth_ref": [
      "r148",
      "r149",
      "r150",
      "r158"
     ],
     "calculation": {
      "http://thecronosgroup.com/role/EarningsLossPerShareScheduleofEarningsLossPerShareDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding",
       "weight": 1.0
      }
     },
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Additional shares included in the calculation of diluted EPS as a result of the potentially dilutive effect of share based payment arrangements using the treasury stock method.",
        "label": "Incremental Common Shares Attributable to Dilutive Effect of Share-based Payment Arrangements",
        "terseLabel": "Dilutive effect of awards (in shares)"
       }
      }
     },
     "localname": "IncrementalCommonSharesAttributableToShareBasedPaymentArrangements",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://thecronosgroup.com/role/EarningsLossPerShareScheduleofEarningsLossPerShareDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis": {
     "auth_ref": [
      "r251",
      "r253"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by type or class of assets, excluding financial assets and goodwill, lacking physical substance and having a projected indefinite period of benefit.",
        "label": "Indefinite-lived Intangible Assets [Axis]",
        "terseLabel": "Indefinite-lived Intangible Assets [Axis]"
       }
      }
     },
     "localname": "IndefiniteLivedIntangibleAssetsByMajorClassAxis",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://thecronosgroup.com/role/ImpairmentLossonLongLivedAssetsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Indefinite-lived Intangible Assets [Line Items]",
        "terseLabel": "Indefinite-lived Intangible Assets [Line Items]"
       }
      }
     },
     "localname": "IndefiniteLivedIntangibleAssetsByMajorClassLineItems",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://thecronosgroup.com/role/ImpairmentLossonLongLivedAssetsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_IndefiniteLivedIntangibleAssetsMajorClassNameDomain": {
     "auth_ref": [
      "r251",
      "r253"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The major class of indefinite-lived intangible asset (for example, trade names, etc. but not all-inclusive), excluding goodwill. A major class is composed of intangible assets that can be grouped together because they are similar, either by their nature or by their use in the operations of the company.",
        "label": "Indefinite-lived Intangible Assets, Major Class Name [Domain]",
        "terseLabel": "Indefinite-lived Intangible Assets, Major Class Name [Domain]"
       }
      }
     },
     "localname": "IndefiniteLivedIntangibleAssetsMajorClassNameDomain",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://thecronosgroup.com/role/ImpairmentLossonLongLivedAssetsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_IntangibleAssetsNetExcludingGoodwill": {
     "auth_ref": [
      "r250",
      "r252"
     ],
     "calculation": {
      "http://thecronosgroup.com/role/CondensedConsolidatedBalanceSheets": {
       "order": 7.0,
       "parentTag": "us-gaap_Assets",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Sum of the carrying amounts of all intangible assets, excluding goodwill, as of the balance sheet date, net of accumulated amortization and impairment charges.",
        "label": "Intangible Assets, Net (Excluding Goodwill)",
        "terseLabel": "Intangible assets, net"
       }
      }
     },
     "localname": "IntangibleAssetsNetExcludingGoodwill",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://thecronosgroup.com/role/CondensedConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_InterestExpense": {
     "auth_ref": [
      "r89",
      "r180",
      "r439",
      "r440",
      "r482"
     ],
     "calculation": {
      "http://thecronosgroup.com/role/SegmentInformationScheduleofSegmentDataDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_InterestIncomeExpenseNonoperatingNet",
       "weight": -1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of the cost of borrowed funds accounted for as interest expense.",
        "label": "Interest Expense",
        "negatedLabel": "Interest expense"
       }
      }
     },
     "localname": "InterestExpense",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://thecronosgroup.com/role/SegmentInformationScheduleofSegmentDataDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_InterestIncomeExpenseNonoperatingNet": {
     "auth_ref": [],
     "calculation": {
      "http://thecronosgroup.com/role/CondensedConsolidatedStatementsofNetIncomeLossandComprehensiveIncomeLoss": {
       "order": 4.0,
       "parentTag": "us-gaap_NonoperatingIncomeExpense",
       "weight": 1.0
      },
      "http://thecronosgroup.com/role/SegmentInformationScheduleofSegmentDataDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The net amount of nonoperating interest income (expense).",
        "label": "Interest Income (Expense), Nonoperating, Net",
        "negatedLabel": "Interest income, net",
        "terseLabel": "Interest income, net",
        "totalLabel": "Interest income, net"
       }
      }
     },
     "localname": "InterestIncomeExpenseNonoperatingNet",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://thecronosgroup.com/role/CondensedConsolidatedStatementsofNetIncomeLossandComprehensiveIncomeLoss",
      "http://thecronosgroup.com/role/FinancialInstrumentsInterestRateRiskNarrativeDetails",
      "http://thecronosgroup.com/role/SegmentInformationScheduleofAdjustedEBITDADetails",
      "http://thecronosgroup.com/role/SegmentInformationScheduleofSegmentDataDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_InterestPaidNet": {
     "auth_ref": [
      "r113",
      "r116",
      "r122"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cash paid for interest, excluding capitalized interest, classified as operating activity. Includes, but is not limited to, payment to settle zero-coupon bond for accreted interest of debt discount and debt instrument with insignificant coupon interest rate in relation to effective interest rate of borrowing attributable to accreted interest of debt discount.",
        "label": "Interest Paid, Excluding Capitalized Interest, Operating Activities",
        "terseLabel": "Interest paid"
       }
      }
     },
     "localname": "InterestPaidNet",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://thecronosgroup.com/role/CondensedConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_InventoryDisclosureAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Inventory Disclosure [Abstract]",
        "terseLabel": "Inventory Disclosure [Abstract]"
       }
      }
     },
     "localname": "InventoryDisclosureAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_InventoryDisclosureTextBlock": {
     "auth_ref": [
      "r242"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for inventory. Includes, but is not limited to, the basis of stating inventory, the method of determining inventory cost, the classes of inventory, and the nature of the cost elements included in inventory.",
        "label": "Inventory Disclosure [Text Block]",
        "terseLabel": "Inventory, net"
       }
      }
     },
     "localname": "InventoryDisclosureTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://thecronosgroup.com/role/Inventorynet"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_InventoryFinishedGoodsNetOfReserves": {
     "auth_ref": [
      "r49",
      "r241"
     ],
     "calculation": {
      "http://thecronosgroup.com/role/InventorynetDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_InventoryNet",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Carrying amount, net of valuation reserves and adjustments, as of the balance sheet date of merchandise or goods held by the company that are readily available for sale.",
        "label": "Inventory, Finished Goods, Net of Reserves",
        "terseLabel": "Finished goods"
       }
      }
     },
     "localname": "InventoryFinishedGoodsNetOfReserves",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://thecronosgroup.com/role/InventorynetDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_InventoryNet": {
     "auth_ref": [
      "r27",
      "r68",
      "r450"
     ],
     "calculation": {
      "http://thecronosgroup.com/role/CondensedConsolidatedBalanceSheets": {
       "order": 7.0,
       "parentTag": "us-gaap_AssetsCurrent",
       "weight": 1.0
      },
      "http://thecronosgroup.com/role/InventorynetDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount after valuation and LIFO reserves of inventory expected to be sold, or consumed within one year or operating cycle, if longer.",
        "label": "Inventory, Net",
        "terseLabel": "Inventory, net",
        "totalLabel": "Inventory, net"
       }
      }
     },
     "localname": "InventoryNet",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://thecronosgroup.com/role/CondensedConsolidatedBalanceSheets",
      "http://thecronosgroup.com/role/InventorynetDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_InventoryRawMaterialsNetOfReserves": {
     "auth_ref": [
      "r51",
      "r241"
     ],
     "calculation": {
      "http://thecronosgroup.com/role/InventorynetDetails": {
       "order": 4.0,
       "parentTag": "us-gaap_InventoryNet",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Carrying amount, net of valuation reserves and adjustments, as of the balance sheet date of unprocessed items to be consumed in the manufacturing or production process.",
        "label": "Inventory, Raw Materials, Net of Reserves",
        "terseLabel": "Raw materials"
       }
      }
     },
     "localname": "InventoryRawMaterialsNetOfReserves",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://thecronosgroup.com/role/InventorynetDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_InventorySuppliesNetOfReserves": {
     "auth_ref": [
      "r67",
      "r240"
     ],
     "calculation": {
      "http://thecronosgroup.com/role/InventorynetDetails": {
       "order": 3.0,
       "parentTag": "us-gaap_InventoryNet",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Carrying amount, net of valuation reserves and adjustments, as of the balance sheet date of products used directly or indirectly in the manufacturing or production process, which may or may not become part of the final product. May also include items used in the storage, presentation or transportation of physical goods.",
        "label": "Inventory, Supplies, Net of Reserves",
        "terseLabel": "Supplies and consumables"
       }
      }
     },
     "localname": "InventorySuppliesNetOfReserves",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://thecronosgroup.com/role/InventorynetDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_InventoryWorkInProcessNetOfReserves": {
     "auth_ref": [
      "r50",
      "r241"
     ],
     "calculation": {
      "http://thecronosgroup.com/role/InventorynetDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_InventoryNet",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Carrying amount, net of reserves and adjustments, as of the balance sheet date of merchandise or goods which are partially completed. This inventory is generally comprised of raw materials, labor and factory overhead costs, which require further materials, labor and overhead to be converted into finished goods, and which generally require the use of estimates to determine percentage complete and pricing.",
        "label": "Inventory, Work in Process, Net of Reserves",
        "terseLabel": "Work-in-progress"
       }
      }
     },
     "localname": "InventoryWorkInProcessNetOfReserves",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://thecronosgroup.com/role/InventorynetDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_InventoryWriteDown": {
     "auth_ref": [
      "r239"
     ],
     "calculation": {
      "http://thecronosgroup.com/role/CondensedConsolidatedStatementsofCashFlows": {
       "order": 2.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0
      },
      "http://thecronosgroup.com/role/CondensedConsolidatedStatementsofNetIncomeLossandComprehensiveIncomeLoss": {
       "order": 3.0,
       "parentTag": "us-gaap_GrossProfit",
       "weight": -1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of loss from reductions in inventory due to subsequent measurement adjustments, including, but not limited to, physical deterioration, obsolescence, or changes in price levels.",
        "label": "Inventory Write-down",
        "terseLabel": "Inventory write-down"
       }
      }
     },
     "localname": "InventoryWriteDown",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://thecronosgroup.com/role/CondensedConsolidatedStatementsofCashFlows",
      "http://thecronosgroup.com/role/CondensedConsolidatedStatementsofNetIncomeLossandComprehensiveIncomeLoss",
      "http://thecronosgroup.com/role/InventorynetDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_InvestmentIncomeInterest": {
     "auth_ref": [
      "r102",
      "r179"
     ],
     "calculation": {
      "http://thecronosgroup.com/role/SegmentInformationScheduleofSegmentDataDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_InterestIncomeExpenseNonoperatingNet",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount before accretion (amortization) of purchase discount (premium) of interest income on nonoperating securities.",
        "label": "Investment Income, Interest",
        "terseLabel": "Interest income"
       }
      }
     },
     "localname": "InvestmentIncomeInterest",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://thecronosgroup.com/role/SegmentInformationScheduleofSegmentDataDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_InvestmentsAllOtherInvestmentsAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Investments, All Other Investments [Abstract]"
       }
      }
     },
     "localname": "InvestmentsAllOtherInvestmentsAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_Liabilities": {
     "auth_ref": [
      "r59",
      "r124",
      "r194",
      "r225",
      "r288",
      "r289",
      "r290",
      "r293",
      "r294",
      "r295",
      "r297",
      "r299",
      "r301",
      "r302",
      "r372",
      "r377",
      "r378",
      "r430",
      "r448",
      "r449"
     ],
     "calculation": {
      "http://thecronosgroup.com/role/CondensedConsolidatedBalanceSheets": {
       "order": 2.0,
       "parentTag": "us-gaap_LiabilitiesAndStockholdersEquity",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Sum of the carrying amounts as of the balance sheet date of all liabilities that are recognized. Liabilities are probable future sacrifices of economic benefits arising from present obligations of an entity to transfer assets or provide services to other entities in the future.",
        "label": "Liabilities",
        "totalLabel": "Total liabilities"
       }
      }
     },
     "localname": "Liabilities",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://thecronosgroup.com/role/CondensedConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LiabilitiesAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Liabilities [Abstract]",
        "terseLabel": "Liabilities"
       }
      }
     },
     "localname": "LiabilitiesAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://thecronosgroup.com/role/CondensedConsolidatedBalanceSheets"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_LiabilitiesAndStockholdersEquity": {
     "auth_ref": [
      "r47",
      "r124",
      "r225",
      "r430",
      "r450",
      "r466",
      "r490"
     ],
     "calculation": {
      "http://thecronosgroup.com/role/CondensedConsolidatedBalanceSheets": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of liabilities and equity items, including the portion of equity attributable to noncontrolling interests, if any.",
        "label": "Liabilities and Equity",
        "totalLabel": "Total liabilities and shareholders\u2019 equity"
       }
      }
     },
     "localname": "LiabilitiesAndStockholdersEquity",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://thecronosgroup.com/role/CondensedConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LiabilitiesCurrent": {
     "auth_ref": [
      "r60",
      "r124",
      "r225",
      "r288",
      "r289",
      "r290",
      "r293",
      "r294",
      "r295",
      "r297",
      "r299",
      "r301",
      "r302",
      "r372",
      "r377",
      "r378",
      "r430",
      "r448",
      "r449",
      "r450"
     ],
     "calculation": {
      "http://thecronosgroup.com/role/CondensedConsolidatedBalanceSheets": {
       "order": 1.0,
       "parentTag": "us-gaap_Liabilities",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Total obligations incurred as part of normal operations that are expected to be paid during the following twelve months or within one business cycle, if longer.",
        "label": "Liabilities, Current",
        "totalLabel": "Total current liabilities"
       }
      }
     },
     "localname": "LiabilitiesCurrent",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://thecronosgroup.com/role/CondensedConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LiabilitiesCurrentAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Liabilities, Current [Abstract]",
        "terseLabel": "Current liabilities"
       }
      }
     },
     "localname": "LiabilitiesCurrentAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://thecronosgroup.com/role/CondensedConsolidatedBalanceSheets"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_LitigationStatusAxis": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by status of pending, threatened, or settled litigation.",
        "label": "Litigation Status [Axis]",
        "terseLabel": "Litigation Status [Axis]"
       }
      }
     },
     "localname": "LitigationStatusAxis",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://thecronosgroup.com/role/CommitmentsandContingenciesDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_LitigationStatusDomain": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Status of pending, threatened, or settled litigation.",
        "label": "Litigation Status [Domain]",
        "terseLabel": "Litigation Status [Domain]"
       }
      }
     },
     "localname": "LitigationStatusDomain",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://thecronosgroup.com/role/CommitmentsandContingenciesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_LoansNotesTradeAndOtherReceivablesExcludingAllowanceForCreditLossesTextBlock": {
     "auth_ref": [
      "r218"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for claims held for amounts due a company, excluding disclosure for allowance for credit losses. Examples include, but are not limited to, trade accounts receivables, notes receivables, loans receivables. Also excludes disclosure for financing receivables.",
        "label": "Loans, Notes, Trade and Other Receivables, Excluding Allowance for Credit Losses [Text Block]",
        "terseLabel": "Loans Receivable, net"
       }
      }
     },
     "localname": "LoansNotesTradeAndOtherReceivablesExcludingAllowanceForCreditLossesTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://thecronosgroup.com/role/LoansReceivablenet"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_LoansReceivableMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "An amount of money or property, or a portion thereof, leant to a borrower (debtor) in exchange for a promise to repay the amount borrowed plus interest at a date certain in the future.",
        "label": "Loans Receivable [Member]",
        "terseLabel": "Loans Receivable"
       }
      }
     },
     "localname": "LoansReceivableMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://thecronosgroup.com/role/InvestmentsNarrativeDetails",
      "http://thecronosgroup.com/role/InvestmentsScheduleofInvestmentsinAssociatesandJointVenturesDetails",
      "http://thecronosgroup.com/role/LoansReceivablenetDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_LongLivedAssetsByGeographicAreasTableTextBlock": {
     "auth_ref": [
      "r209"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of long-lived assets, excluding financial instruments, long-term customer relationships of a financial institution, mortgage rights, deferred policy acquisition costs, and deferred tax assets, by geographic areas located in the entity's country of domicile and foreign countries in which the entity holds assets.",
        "label": "Long-lived Assets by Geographic Areas [Table Text Block]",
        "terseLabel": "Schedule of Long-lived Assets by Geographic Areas"
       }
      }
     },
     "localname": "LongLivedAssetsByGeographicAreasTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://thecronosgroup.com/role/SegmentInformationTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_LossContingenciesByNatureOfContingencyAxis": {
     "auth_ref": [
      "r275",
      "r276",
      "r277",
      "r279",
      "r280",
      "r281",
      "r283",
      "r286",
      "r287"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by type of existing condition, situation, or set of circumstances involving uncertainty as to possible loss to an enterprise that will ultimately be resolved when one or more future events occur or fail to occur.",
        "label": "Loss Contingency Nature [Axis]",
        "terseLabel": "Loss Contingency Nature [Axis]"
       }
      }
     },
     "localname": "LossContingenciesByNatureOfContingencyAxis",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://thecronosgroup.com/role/CommitmentsandContingenciesDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_LossContingenciesLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Loss Contingencies [Line Items]",
        "terseLabel": "Loss Contingencies [Line Items]"
       }
      }
     },
     "localname": "LossContingenciesLineItems",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://thecronosgroup.com/role/CommitmentsandContingenciesDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_LossContingenciesTable": {
     "auth_ref": [
      "r275",
      "r276",
      "r277",
      "r279",
      "r280",
      "r281",
      "r283",
      "r286",
      "r287"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Discloses the specific components (such as the nature, name, and date) of the loss contingency and gives an estimate of the possible loss or range of loss, or states that a reasonable estimate cannot be made. Excludes environmental contingencies, warranties and unconditional purchase obligations.",
        "label": "Loss Contingencies [Table]",
        "terseLabel": "Loss Contingencies [Table]"
       }
      }
     },
     "localname": "LossContingenciesTable",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://thecronosgroup.com/role/CommitmentsandContingenciesDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_LossContingencyAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Loss Contingency [Abstract]",
        "terseLabel": "Loss Contingency [Abstract]"
       }
      }
     },
     "localname": "LossContingencyAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_LossContingencyDamagesSoughtValue": {
     "auth_ref": [
      "r275",
      "r278",
      "r282"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The value (monetary amount) of the award the plaintiff seeks in the legal matter.",
        "label": "Loss Contingency, Damages Sought, Value",
        "terseLabel": "Damages sought"
       }
      }
     },
     "localname": "LossContingencyDamagesSoughtValue",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://thecronosgroup.com/role/CommitmentsandContingenciesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LossContingencyDisclosures": {
     "auth_ref": [
      "r284",
      "r285"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for loss and gain contingencies. Describes any existing condition, situation, or set of circumstances involving uncertainty as of the balance sheet date (or prior to issuance of the financial statements) as to a probable or reasonably possible loss incurred by an entity that will ultimately be resolved when one or more future events occur or fail to occur, and typically discloses the amount of loss recorded or a range of possible loss, or an assertion that no reasonable estimate can be made.",
        "label": "Contingencies Disclosure [Text Block]",
        "terseLabel": "Commitments and Contingencies"
       }
      }
     },
     "localname": "LossContingencyDisclosures",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://thecronosgroup.com/role/CommitmentsandContingencies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_LossContingencyNatureDomain": {
     "auth_ref": [
      "r275",
      "r276",
      "r277",
      "r279",
      "r280",
      "r281",
      "r283",
      "r286",
      "r287"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "An existing condition, situation, or set of circumstances involving uncertainty as to possible loss to an enterprise that will ultimately be resolved when one or more future events occur or fail to occur. Resolution of the uncertainty may confirm the incurrence of a loss or impairment of an asset or the incurrence of a liability.",
        "label": "Loss Contingency, Nature [Domain]",
        "terseLabel": "Loss Contingency, Nature [Domain]"
       }
      }
     },
     "localname": "LossContingencyNatureDomain",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://thecronosgroup.com/role/CommitmentsandContingenciesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_LossContingencyNewClaimsFiledNumber": {
     "auth_ref": [
      "r278"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The total number of new claims filed pertaining to a loss contingency during the period.",
        "label": "Loss Contingency, New Claims Filed, Number",
        "terseLabel": "Number of putative class action complaints"
       }
      }
     },
     "localname": "LossContingencyNewClaimsFiledNumber",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://thecronosgroup.com/role/CommitmentsandContingenciesDetails"
     ],
     "xbrltype": "integerItemType"
    },
    "us-gaap_LossContingencyNumberOfPlaintiffs": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of plaintiffs that have filed claims pertaining to a loss contingency.",
        "label": "Loss Contingency, Number of Plaintiffs",
        "terseLabel": "Number of alleged shareholders"
       }
      }
     },
     "localname": "LossContingencyNumberOfPlaintiffs",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://thecronosgroup.com/role/CommitmentsandContingenciesDetails"
     ],
     "xbrltype": "integerItemType"
    },
    "us-gaap_MeasurementInputExpectedDividendRateMember": {
     "auth_ref": [
      "r414"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Measurement input using expected dividend rate to be paid to holder of share per year.",
        "label": "Measurement Input, Expected Dividend Rate [Member]",
        "terseLabel": "Expected dividend yield"
       }
      }
     },
     "localname": "MeasurementInputExpectedDividendRateMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://thecronosgroup.com/role/DerivativeLiabilitiesScheduleofFairValuesofDerivativeLiabilitiesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_MeasurementInputExpectedTermMember": {
     "auth_ref": [
      "r414"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Measurement input using period financial instrument is expected to be outstanding. Excludes maturity date.",
        "label": "Measurement Input, Expected Term [Member]",
        "terseLabel": "Weight average expected life"
       }
      }
     },
     "localname": "MeasurementInputExpectedTermMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://thecronosgroup.com/role/DerivativeLiabilitiesScheduleofFairValuesofDerivativeLiabilitiesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_MeasurementInputPriceVolatilityMember": {
     "auth_ref": [
      "r414"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Measurement input using rate at which price of security will increase (decrease) for given set of returns.",
        "label": "Measurement Input, Price Volatility [Member]",
        "terseLabel": "Expected annualized volatility"
       }
      }
     },
     "localname": "MeasurementInputPriceVolatilityMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://thecronosgroup.com/role/DerivativeLiabilitiesScheduleofFairValuesofDerivativeLiabilitiesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_MeasurementInputRiskFreeInterestRateMember": {
     "auth_ref": [
      "r414"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Measurement input using interest rate on instrument with zero risk of financial loss.",
        "label": "Measurement Input, Risk Free Interest Rate [Member]",
        "terseLabel": "Weighted average risk-free interest rate"
       }
      }
     },
     "localname": "MeasurementInputRiskFreeInterestRateMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://thecronosgroup.com/role/DerivativeLiabilitiesScheduleofFairValuesofDerivativeLiabilitiesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_MeasurementInputSharePriceMember": {
     "auth_ref": [
      "r414"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Measurement input using share price of saleable stock.",
        "label": "Measurement Input, Share Price [Member]",
        "terseLabel": "Share price at valuation date"
       }
      }
     },
     "localname": "MeasurementInputSharePriceMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://thecronosgroup.com/role/DerivativeLiabilitiesScheduleofFairValuesofDerivativeLiabilitiesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_MeasurementInputTypeAxis": {
     "auth_ref": [
      "r414"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by type of measurement input used to determine value of asset and liability.",
        "label": "Measurement Input Type [Axis]",
        "terseLabel": "Measurement Input Type [Axis]"
       }
      }
     },
     "localname": "MeasurementInputTypeAxis",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://thecronosgroup.com/role/DerivativeLiabilitiesScheduleofFairValuesofDerivativeLiabilitiesDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_MeasurementInputTypeDomain": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Measurement input used to determine value of asset and liability.",
        "label": "Measurement Input Type [Domain]",
        "terseLabel": "Measurement Input Type [Domain]"
       }
      }
     },
     "localname": "MeasurementInputTypeDomain",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://thecronosgroup.com/role/DerivativeLiabilitiesScheduleofFairValuesofDerivativeLiabilitiesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_MinorityInterest": {
     "auth_ref": [
      "r66",
      "r124",
      "r225",
      "r288",
      "r293",
      "r294",
      "r295",
      "r301",
      "r302",
      "r430",
      "r465",
      "r489"
     ],
     "calculation": {
      "http://thecronosgroup.com/role/CondensedConsolidatedBalanceSheets": {
       "order": 2.0,
       "parentTag": "us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Total of all stockholders' equity (deficit) items, net of receivables from officers, directors, owners, and affiliates of the entity which is directly or indirectly attributable to that ownership interest in subsidiary equity which is not attributable to the parent (that is, noncontrolling interest, previously referred to as minority interest).",
        "label": "Stockholders' Equity Attributable to Noncontrolling Interest",
        "terseLabel": "Non-controlling interests"
       }
      }
     },
     "localname": "MinorityInterest",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://thecronosgroup.com/role/CondensedConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_NetCashProvidedByUsedInFinancingActivities": {
     "auth_ref": [
      "r115"
     ],
     "calculation": {
      "http://thecronosgroup.com/role/CondensedConsolidatedStatementsofCashFlows": {
       "order": 2.0,
       "parentTag": "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cash inflow (outflow) from financing activities, including discontinued operations. Financing activity cash flows include obtaining resources from owners and providing them with a return on, and a return of, their investment; borrowing money and repaying amounts borrowed, or settling the obligation; and obtaining and paying for other resources obtained from creditors on long-term credit.",
        "label": "Net Cash Provided by (Used in) Financing Activities",
        "totalLabel": "Cash flows provided by (used in) financing activities"
       }
      }
     },
     "localname": "NetCashProvidedByUsedInFinancingActivities",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://thecronosgroup.com/role/CondensedConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Net Cash Provided by (Used in) Financing Activities [Abstract]",
        "terseLabel": "Financing activities"
       }
      }
     },
     "localname": "NetCashProvidedByUsedInFinancingActivitiesAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://thecronosgroup.com/role/CondensedConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_NetCashProvidedByUsedInInvestingActivities": {
     "auth_ref": [
      "r115"
     ],
     "calculation": {
      "http://thecronosgroup.com/role/CondensedConsolidatedStatementsofCashFlows": {
       "order": 3.0,
       "parentTag": "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cash inflow (outflow) from investing activities, including discontinued operations. Investing activity cash flows include making and collecting loans and acquiring and disposing of debt or equity instruments and property, plant, and equipment and other productive assets.",
        "label": "Net Cash Provided by (Used in) Investing Activities",
        "totalLabel": "Cash flows provided by (used in) investing activities"
       }
      }
     },
     "localname": "NetCashProvidedByUsedInInvestingActivities",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://thecronosgroup.com/role/CondensedConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Net Cash Provided by (Used in) Investing Activities [Abstract]",
        "terseLabel": "Investing activities"
       }
      }
     },
     "localname": "NetCashProvidedByUsedInInvestingActivitiesAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://thecronosgroup.com/role/CondensedConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_NetCashProvidedByUsedInOperatingActivities": {
     "auth_ref": [
      "r115",
      "r117",
      "r120"
     ],
     "calculation": {
      "http://thecronosgroup.com/role/CondensedConsolidatedStatementsofCashFlows": {
       "order": 4.0,
       "parentTag": "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect",
       "weight": 1.0
      }
     },
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cash inflow (outflow) from operating activities, including discontinued operations. Operating activity cash flows include transactions, adjustments, and changes in value not defined as investing or financing activities.",
        "label": "Net Cash Provided by (Used in) Operating Activities",
        "totalLabel": "Cash flows used in operating activities"
       }
      }
     },
     "localname": "NetCashProvidedByUsedInOperatingActivities",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://thecronosgroup.com/role/CondensedConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Net Cash Provided by (Used in) Operating Activities [Abstract]",
        "terseLabel": "Operating activities"
       }
      }
     },
     "localname": "NetCashProvidedByUsedInOperatingActivitiesAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://thecronosgroup.com/role/CondensedConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_NetIncomeLoss": {
     "auth_ref": [
      "r24",
      "r78",
      "r81",
      "r86",
      "r93",
      "r120",
      "r124",
      "r131",
      "r133",
      "r134",
      "r136",
      "r137",
      "r141",
      "r142",
      "r155",
      "r186",
      "r192",
      "r196",
      "r199",
      "r202",
      "r225",
      "r288",
      "r289",
      "r290",
      "r293",
      "r294",
      "r295",
      "r297",
      "r299",
      "r301",
      "r302",
      "r409",
      "r430",
      "r476",
      "r497"
     ],
     "calculation": {
      "http://thecronosgroup.com/role/CondensedConsolidatedStatementsofNetIncomeLossandComprehensiveIncomeLoss": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.",
        "label": "Net Income (Loss) Attributable to Parent",
        "totalLabel": "Net income (loss) attributable to Cronos Group"
       }
      }
     },
     "localname": "NetIncomeLoss",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://thecronosgroup.com/role/CondensedConsolidatedStatementsofNetIncomeLossandComprehensiveIncomeLoss"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_NetIncomeLossAttributableToNoncontrollingInterest": {
     "auth_ref": [
      "r78",
      "r81",
      "r86",
      "r141",
      "r142",
      "r374",
      "r388"
     ],
     "calculation": {
      "http://thecronosgroup.com/role/CondensedConsolidatedStatementsofNetIncomeLossandComprehensiveIncomeLoss": {
       "order": 1.0,
       "parentTag": "us-gaap_NetIncomeLoss",
       "weight": -1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of Net Income (Loss) attributable to noncontrolling interest.",
        "label": "Net Income (Loss) Attributable to Noncontrolling Interest",
        "terseLabel": "Net loss attributable to non-controlling interest"
       }
      }
     },
     "localname": "NetIncomeLossAttributableToNoncontrollingInterest",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://thecronosgroup.com/role/CondensedConsolidatedStatementsofNetIncomeLossandComprehensiveIncomeLoss"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_NetIncomeLossAvailableToCommonStockholdersDilutedAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Net Income (Loss) Available to Common Stockholders, Diluted [Abstract]",
        "terseLabel": "Basic earnings (loss) per share computation"
       }
      }
     },
     "localname": "NetIncomeLossAvailableToCommonStockholdersDilutedAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://thecronosgroup.com/role/EarningsLossPerShareScheduleofEarningsLossPerShareDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_NetIncomeLossFromContinuingOperationsAvailableToCommonShareholdersBasic": {
     "auth_ref": [
      "r145",
      "r158"
     ],
     "calculation": {
      "http://thecronosgroup.com/role/EarningsLossPerShareScheduleofEarningsLossPerShareDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_NetIncomeLossFromContinuingOperationsAvailableToCommonShareholdersDiluted",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, after deduction of tax, noncontrolling interests, dividends on preferred stock and participating securities; of income (loss) from continuing operations available to common shareholders.",
        "label": "Net Income (Loss) from Continuing Operations Available to Common Shareholders, Basic",
        "terseLabel": "Net income (loss) from continuing operations attributable to the shareholders of Cronos\u00a0Group",
        "verboseLabel": "Net income (loss) used in the computation of basic earnings (loss) from continuing operations per share"
       }
      }
     },
     "localname": "NetIncomeLossFromContinuingOperationsAvailableToCommonShareholdersBasic",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://thecronosgroup.com/role/EarningsLossPerShareScheduleofEarningsLossPerShareDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_NetIncomeLossFromContinuingOperationsAvailableToCommonShareholdersDiluted": {
     "auth_ref": [
      "r146",
      "r152",
      "r153",
      "r154",
      "r158"
     ],
     "calculation": {
      "http://thecronosgroup.com/role/EarningsLossPerShareScheduleofEarningsLossPerShareDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, after deduction of tax, noncontrolling interests, dividends on preferred stock and participating securities, and addition from assumption of issuance of common shares for dilutive potential common shares; of income (loss) from continuing operations available to common shareholders.",
        "label": "Net Income (Loss) from Continuing Operations Available to Common Shareholders, Diluted",
        "totalLabel": "Net income (loss) used in the computation of diluted earnings (loss) from continuing operations per share"
       }
      }
     },
     "localname": "NetIncomeLossFromContinuingOperationsAvailableToCommonShareholdersDiluted",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://thecronosgroup.com/role/EarningsLossPerShareScheduleofEarningsLossPerShareDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_NetIncomeLossFromDiscontinuedOperationsAvailableToCommonShareholdersBasic": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, after deduction of tax, noncontrolling interests, dividends on preferred stock and participating securities; of income (loss) from discontinued operations available to common shareholders.",
        "label": "Net Income (Loss) from Discontinued Operations Available to Common Shareholders, Basic",
        "terseLabel": "Loss from discontinued operations attributable to the shareholders of Cronos Group"
       }
      }
     },
     "localname": "NetIncomeLossFromDiscontinuedOperationsAvailableToCommonShareholdersBasic",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://thecronosgroup.com/role/EarningsLossPerShareScheduleofEarningsLossPerShareDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_NetIncomeLossFromDiscontinuedOperationsAvailableToCommonShareholdersDiluted": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, after deduction of tax, noncontrolling interests, dividends on preferred stock and participating securities, and addition from assumption of issuance of common shares for dilutive potential common shares; of income (loss) from discontinued operations available to common shareholders.",
        "label": "Net Income (Loss) from Discontinued Operations Available to Common Shareholders, Diluted",
        "terseLabel": "Loss from discontinued operations attributable to the shareholders of Cronos Group"
       }
      }
     },
     "localname": "NetIncomeLossFromDiscontinuedOperationsAvailableToCommonShareholdersDiluted",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://thecronosgroup.com/role/EarningsLossPerShareScheduleofEarningsLossPerShareDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy pertaining to new accounting pronouncements that may impact the entity's financial reporting. Includes, but is not limited to, quantification of the expected or actual impact.",
        "label": "New Accounting Pronouncements, Policy [Policy Text Block]",
        "terseLabel": "Adoption of new accounting pronouncements and New accounting pronouncements not yet adopted"
       }
      }
     },
     "localname": "NewAccountingPronouncementsPolicyPolicyTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://thecronosgroup.com/role/BackgroundBasisofPresentationandAccountingPoliciesPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_NoncontrollingInterestMember": {
     "auth_ref": [
      "r128",
      "r129",
      "r130",
      "r311",
      "r366"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "This element represents that portion of equity (net assets) in a subsidiary not attributable, directly or indirectly, to the parent. A noncontrolling interest is sometimes called a minority interest.",
        "label": "Noncontrolling Interest [Member]",
        "terseLabel": "Non-controlling interests"
       }
      }
     },
     "localname": "NoncontrollingInterestMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://thecronosgroup.com/role/CondensedConsolidatedStatementsofChangesinEquity"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_NoncurrentAssets": {
     "auth_ref": [
      "r207"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Long-lived assets other than financial instruments, long-term customer relationships of a financial institution, mortgage and other servicing rights, deferred policy acquisition costs, and deferred tax assets.",
        "label": "Long-Lived Assets",
        "terseLabel": "Long-lived assets"
       }
      }
     },
     "localname": "NoncurrentAssets",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://thecronosgroup.com/role/SegmentInformationScheduleofLonglivedAssetsbyGeographicAreasDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_NonoperatingIncomeExpense": {
     "auth_ref": [
      "r103"
     ],
     "calculation": {
      "http://thecronosgroup.com/role/CondensedConsolidatedStatementsofNetIncomeLossandComprehensiveIncomeLoss": {
       "order": 1.0,
       "parentTag": "us-gaap_IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The aggregate amount of income or expense from ancillary business-related activities (that is to say, excluding major activities considered part of the normal operations of the business).",
        "label": "Nonoperating Income (Expense)",
        "totalLabel": "Total other income (loss)"
       }
      }
     },
     "localname": "NonoperatingIncomeExpense",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://thecronosgroup.com/role/CondensedConsolidatedStatementsofNetIncomeLossandComprehensiveIncomeLoss"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_NonoperatingIncomeExpenseAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Nonoperating Income (Expense) [Abstract]",
        "terseLabel": "Other income (loss)"
       }
      }
     },
     "localname": "NonoperatingIncomeExpenseAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://thecronosgroup.com/role/CondensedConsolidatedStatementsofNetIncomeLossandComprehensiveIncomeLoss"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_NotesAndLoansReceivableNetCurrent": {
     "auth_ref": [
      "r28",
      "r29",
      "r40",
      "r213",
      "r214",
      "r471"
     ],
     "calculation": {
      "http://thecronosgroup.com/role/CondensedConsolidatedBalanceSheets": {
       "order": 5.0,
       "parentTag": "us-gaap_AssetsCurrent",
       "weight": 1.0
      },
      "http://thecronosgroup.com/role/LoansReceivablenetDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_NotesReceivableNet",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, after allowance for credit loss, of financing receivable, classified as current. Includes, but is not limited to, notes and loan receivable.",
        "label": "Financing Receivable, after Allowance for Credit Loss, Current",
        "terseLabel": "Current portion of loans receivable, net",
        "totalLabel": "Total current portion of loans receivable"
       }
      }
     },
     "localname": "NotesAndLoansReceivableNetCurrent",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://thecronosgroup.com/role/CondensedConsolidatedBalanceSheets",
      "http://thecronosgroup.com/role/LoansReceivablenetDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_NotesAndLoansReceivableNetNoncurrent": {
     "auth_ref": [
      "r41"
     ],
     "calculation": {
      "http://thecronosgroup.com/role/CondensedConsolidatedBalanceSheets": {
       "order": 9.0,
       "parentTag": "us-gaap_Assets",
       "weight": 1.0
      },
      "http://thecronosgroup.com/role/LoansReceivablenetDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_NotesReceivableNet",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, after allowance for credit loss, of financing receivable, classified as noncurrent.",
        "label": "Financing Receivable, after Allowance for Credit Loss, Noncurrent",
        "terseLabel": "Loan receivable, net",
        "totalLabel": "Total long-term portion of loans receivable"
       }
      }
     },
     "localname": "NotesAndLoansReceivableNetNoncurrent",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://thecronosgroup.com/role/CondensedConsolidatedBalanceSheets",
      "http://thecronosgroup.com/role/LoansReceivablenetDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_NotesReceivableNet": {
     "auth_ref": [
      "r41",
      "r213",
      "r237"
     ],
     "calculation": {
      "http://thecronosgroup.com/role/LoansReceivablenetDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, after allowance for credit loss, of financing receivable. Excludes financing receivable covered under loss sharing agreement.",
        "label": "Financing Receivable, after Allowance for Credit Loss",
        "terseLabel": "Transfer to investments in equity accounted investees, excluding accrued interest",
        "totalLabel": "Total loans receivable, net"
       }
      }
     },
     "localname": "NotesReceivableNet",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://thecronosgroup.com/role/InvestmentsScheduleofInvestmentsinAssociatesandJointVenturesDetails",
      "http://thecronosgroup.com/role/LoansReceivablenetDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_NumberOfReportableSegments": {
     "auth_ref": [
      "r174"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of segments reported by the entity. A reportable segment is a component of an entity for which there is an accounting requirement to report separate financial information on that component in the entity's financial statements.",
        "label": "Number of Reportable Segments",
        "terseLabel": "Number of reportable segments"
       }
      }
     },
     "localname": "NumberOfReportableSegments",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://thecronosgroup.com/role/SegmentInformationNarrativeDetails"
     ],
     "xbrltype": "integerItemType"
    },
    "us-gaap_OperatingExpenses": {
     "auth_ref": [],
     "calculation": {
      "http://thecronosgroup.com/role/CondensedConsolidatedStatementsofNetIncomeLossandComprehensiveIncomeLoss": {
       "order": 1.0,
       "parentTag": "us-gaap_OperatingIncomeLoss",
       "weight": -1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Generally recurring costs associated with normal operations except for the portion of these expenses which can be clearly related to production and included in cost of sales or services. Includes selling, general and administrative expense.",
        "label": "Operating Expenses",
        "totalLabel": "Total operating expenses"
       }
      }
     },
     "localname": "OperatingExpenses",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://thecronosgroup.com/role/CondensedConsolidatedStatementsofNetIncomeLossandComprehensiveIncomeLoss"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OperatingExpensesAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Operating Expenses [Abstract]",
        "terseLabel": "Operating expenses"
       }
      }
     },
     "localname": "OperatingExpensesAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://thecronosgroup.com/role/CondensedConsolidatedStatementsofNetIncomeLossandComprehensiveIncomeLoss"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_OperatingIncomeLoss": {
     "auth_ref": [
      "r186",
      "r192",
      "r196",
      "r199",
      "r202"
     ],
     "calculation": {
      "http://thecronosgroup.com/role/CondensedConsolidatedStatementsofNetIncomeLossandComprehensiveIncomeLoss": {
       "order": 2.0,
       "parentTag": "us-gaap_IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The net result for the period of deducting operating expenses from operating revenues.",
        "label": "Operating Income (Loss)",
        "totalLabel": "Operating loss"
       }
      }
     },
     "localname": "OperatingIncomeLoss",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://thecronosgroup.com/role/CondensedConsolidatedStatementsofNetIncomeLossandComprehensiveIncomeLoss"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OperatingLeaseImpairmentLoss": {
     "auth_ref": [
      "r441"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of loss from impairment of right-of-use asset from operating lease.",
        "label": "Operating Lease, Impairment Loss",
        "terseLabel": "Impairment charge on the de-recognition of the right-of-use asset"
       }
      }
     },
     "localname": "OperatingLeaseImpairmentLoss",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://thecronosgroup.com/role/ImpairmentLossonLongLivedAssetsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OperatingLeaseLiabilityCurrent": {
     "auth_ref": [
      "r443"
     ],
     "calculation": {
      "http://thecronosgroup.com/role/CondensedConsolidatedBalanceSheets": {
       "order": 3.0,
       "parentTag": "us-gaap_LiabilitiesCurrent",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Present value of lessee's discounted obligation for lease payments from operating lease, classified as current.",
        "label": "Operating Lease, Liability, Current",
        "verboseLabel": "Current portion of lease obligation"
       }
      }
     },
     "localname": "OperatingLeaseLiabilityCurrent",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://thecronosgroup.com/role/CondensedConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OperatingLeaseLiabilityNoncurrent": {
     "auth_ref": [
      "r443"
     ],
     "calculation": {
      "http://thecronosgroup.com/role/CondensedConsolidatedBalanceSheets": {
       "order": 3.0,
       "parentTag": "us-gaap_Liabilities",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Present value of lessee's discounted obligation for lease payments from operating lease, classified as noncurrent.",
        "label": "Operating Lease, Liability, Noncurrent",
        "verboseLabel": "Lease obligation"
       }
      }
     },
     "localname": "OperatingLeaseLiabilityNoncurrent",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://thecronosgroup.com/role/CondensedConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OperatingLeaseRightOfUseAsset": {
     "auth_ref": [
      "r442"
     ],
     "calculation": {
      "http://thecronosgroup.com/role/CondensedConsolidatedBalanceSheets": {
       "order": 1.0,
       "parentTag": "us-gaap_Assets",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of lessee's right to use underlying asset under operating lease.",
        "label": "Operating Lease, Right-of-Use Asset",
        "verboseLabel": "Right-of-use assets"
       }
      }
     },
     "localname": "OperatingLeaseRightOfUseAsset",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://thecronosgroup.com/role/CondensedConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OperatingLeaseRightOfUseAssetAmortizationExpense": {
     "auth_ref": [
      "r119"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of amortization expense for right-of-use asset from operating lease.",
        "label": "Operating Lease, Right-of-Use Asset, Amortization Expense",
        "terseLabel": "Impairment loss on long-lived assets"
       }
      }
     },
     "localname": "OperatingLeaseRightOfUseAssetAmortizationExpense",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://thecronosgroup.com/role/SegmentInformationScheduleofSegmentDataDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OperatingSegmentsMember": {
     "auth_ref": [
      "r191",
      "r192",
      "r193",
      "r194",
      "r196",
      "r202"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Identifies components of an entity that engage in business activities from which they may earn revenue and incur expenses, including transactions with other components of the same entity.",
        "label": "Operating Segments [Member]",
        "terseLabel": "Operating Segments"
       }
      }
     },
     "localname": "OperatingSegmentsMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://thecronosgroup.com/role/SegmentInformationScheduleofAdjustedEBITDADetails",
      "http://thecronosgroup.com/role/SegmentInformationScheduleofSegmentDataDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Organization, Consolidation and Presentation of Financial Statements [Abstract]",
        "terseLabel": "Organization, Consolidation and Presentation of Financial Statements [Abstract]"
       }
      }
     },
     "localname": "OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax": {
     "auth_ref": [
      "r73"
     ],
     "calculation": {
      "http://thecronosgroup.com/role/CondensedConsolidatedStatementsofNetIncomeLossandComprehensiveIncomeLoss": {
       "order": 1.0,
       "parentTag": "us-gaap_OtherComprehensiveIncomeLossNetOfTax",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount after tax and reclassification adjustments of gain (loss) on foreign currency translation adjustments, foreign currency transactions designated and effective as economic hedges of a net investment in a foreign entity and intra-entity foreign currency transactions that are of a long-term-investment nature.",
        "label": "Other Comprehensive Income (Loss), Foreign Currency Transaction and Translation Adjustment, Net of Tax",
        "terseLabel": "Foreign exchange gain (loss) on translation",
        "verboseLabel": "Foreign exchange gain (loss) on translation"
       }
      }
     },
     "localname": "OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://thecronosgroup.com/role/CondensedConsolidatedStatementsofChangesinEquity",
      "http://thecronosgroup.com/role/CondensedConsolidatedStatementsofNetIncomeLossandComprehensiveIncomeLoss",
      "http://thecronosgroup.com/role/FinancialInstrumentsCurrencyRateRiskNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherComprehensiveIncomeLossNetOfTax": {
     "auth_ref": [
      "r79",
      "r82",
      "r84",
      "r85",
      "r87",
      "r94",
      "r309",
      "r432",
      "r437",
      "r438",
      "r477",
      "r498"
     ],
     "calculation": {
      "http://thecronosgroup.com/role/CondensedConsolidatedStatementsofNetIncomeLossandComprehensiveIncomeLoss": {
       "order": 1.0,
       "parentTag": "us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount after tax and reclassification adjustments of other comprehensive income (loss).",
        "label": "Other Comprehensive Income (Loss), Net of Tax",
        "totalLabel": "Total other comprehensive income (loss)"
       }
      }
     },
     "localname": "OtherComprehensiveIncomeLossNetOfTax",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://thecronosgroup.com/role/CondensedConsolidatedStatementsofNetIncomeLossandComprehensiveIncomeLoss"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Other Comprehensive Income (Loss), Net of Tax [Abstract]",
        "terseLabel": "Other comprehensive income (loss)"
       }
      }
     },
     "localname": "OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://thecronosgroup.com/role/CondensedConsolidatedStatementsofNetIncomeLossandComprehensiveIncomeLoss"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_OtherLongTermInvestments": {
     "auth_ref": [
      "r58",
      "r493"
     ],
     "calculation": {
      "http://thecronosgroup.com/role/CondensedConsolidatedBalanceSheets": {
       "order": 3.0,
       "parentTag": "us-gaap_Assets",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of long-term investments classified as other.",
        "label": "Other Long-term Investments",
        "terseLabel": "Other investments"
       }
      }
     },
     "localname": "OtherLongTermInvestments",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://thecronosgroup.com/role/CondensedConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherNoncashIncomeExpense": {
     "auth_ref": [
      "r120"
     ],
     "calculation": {
      "http://thecronosgroup.com/role/CondensedConsolidatedStatementsofCashFlows": {
       "order": 1.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of income (expense) included in net income that results in no cash inflow (outflow), classified as other.",
        "label": "Other Noncash Income (Expense)",
        "negatedLabel": "Other non-cash operating activities, net"
       }
      }
     },
     "localname": "OtherNoncashIncomeExpense",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://thecronosgroup.com/role/CondensedConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherNonoperatingIncomeExpense": {
     "auth_ref": [
      "r104"
     ],
     "calculation": {
      "http://thecronosgroup.com/role/CondensedConsolidatedStatementsofNetIncomeLossandComprehensiveIncomeLoss": {
       "order": 5.0,
       "parentTag": "us-gaap_NonoperatingIncomeExpense",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of income (expense) related to nonoperating activities, classified as other.",
        "label": "Other Nonoperating Income (Expense)",
        "negatedTerseLabel": "Other, net",
        "terseLabel": "Other, net"
       }
      }
     },
     "localname": "OtherNonoperatingIncomeExpense",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://thecronosgroup.com/role/CondensedConsolidatedStatementsofNetIncomeLossandComprehensiveIncomeLoss",
      "http://thecronosgroup.com/role/SegmentInformationScheduleofAdjustedEBITDADetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherReceivablesNetCurrent": {
     "auth_ref": [],
     "calculation": {
      "http://thecronosgroup.com/role/CondensedConsolidatedBalanceSheets": {
       "order": 4.0,
       "parentTag": "us-gaap_AssetsCurrent",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, after allowance, of receivables classified as other, due within one year or the operating cycle, if longer.",
        "label": "Other Receivables, Net, Current",
        "terseLabel": "Other receivables"
       }
      }
     },
     "localname": "OtherReceivablesNetCurrent",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://thecronosgroup.com/role/BackgroundBasisofPresentationandAccountingPoliciesDetails",
      "http://thecronosgroup.com/role/CondensedConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PaymentsRelatedToTaxWithholdingForShareBasedCompensation": {
     "auth_ref": [
      "r111"
     ],
     "calculation": {
      "http://thecronosgroup.com/role/CondensedConsolidatedStatementsofCashFlows": {
       "order": 2.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cash outflow to satisfy grantee's tax withholding obligation for award under share-based payment arrangement.",
        "label": "Payment, Tax Withholding, Share-based Payment Arrangement",
        "negatedTerseLabel": "Withholding taxes paid on share-based awards"
       }
      }
     },
     "localname": "PaymentsRelatedToTaxWithholdingForShareBasedCompensation",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://thecronosgroup.com/role/CondensedConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PaymentsToAcquireIntangibleAssets": {
     "auth_ref": [
      "r108"
     ],
     "calculation": {
      "http://thecronosgroup.com/role/CondensedConsolidatedStatementsofCashFlows": {
       "order": 3.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInInvestingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The cash outflow to acquire asset without physical form usually arising from contractual or other legal rights, excluding goodwill.",
        "label": "Payments to Acquire Intangible Assets",
        "negatedTerseLabel": "Purchase of intangible assets"
       }
      }
     },
     "localname": "PaymentsToAcquireIntangibleAssets",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://thecronosgroup.com/role/CondensedConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PaymentsToAcquireLoansReceivable": {
     "auth_ref": [
      "r107"
     ],
     "calculation": {
      "http://thecronosgroup.com/role/CondensedConsolidatedStatementsofCashFlows": {
       "order": 5.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInInvestingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The cash outflow for the purchase of loan receivable arising from the financing of goods and services.",
        "label": "Payments to Acquire Loans Receivable",
        "negatedTerseLabel": "Advances on loans receivable",
        "terseLabel": "Draw downs"
       }
      }
     },
     "localname": "PaymentsToAcquireLoansReceivable",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://thecronosgroup.com/role/CondensedConsolidatedStatementsofCashFlows",
      "http://thecronosgroup.com/role/LoansReceivablenetDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PaymentsToAcquireMarketableSecurities": {
     "auth_ref": [
      "r220"
     ],
     "calculation": {
      "http://thecronosgroup.com/role/CondensedConsolidatedStatementsofCashFlows": {
       "order": 2.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInInvestingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cash outflow for purchase of marketable security.",
        "label": "Payments to Acquire Marketable Securities",
        "negatedTerseLabel": "Purchase of short-term investments"
       }
      }
     },
     "localname": "PaymentsToAcquireMarketableSecurities",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://thecronosgroup.com/role/CondensedConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PaymentsToAcquireOtherInvestments": {
     "auth_ref": [
      "r109"
     ],
     "calculation": {
      "http://thecronosgroup.com/role/CondensedConsolidatedStatementsofCashFlows": {
       "order": 7.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInInvestingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cash outflow to acquire investments classified as other.",
        "label": "Payments to Acquire Other Investments",
        "negatedLabel": "Purchase of other investments",
        "terseLabel": "Purchase of other investments"
       }
      }
     },
     "localname": "PaymentsToAcquireOtherInvestments",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://thecronosgroup.com/role/CondensedConsolidatedStatementsofCashFlows",
      "http://thecronosgroup.com/role/InvestmentsNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PaymentsToAcquirePropertyPlantAndEquipment": {
     "auth_ref": [
      "r108"
     ],
     "calculation": {
      "http://thecronosgroup.com/role/CondensedConsolidatedStatementsofCashFlows": {
       "order": 4.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInInvestingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The cash outflow associated with the acquisition of long-lived, physical assets that are used in the normal conduct of business to produce goods and services and not intended for resale; includes cash outflows to pay for construction of self-constructed assets.",
        "label": "Payments to Acquire Property, Plant, and Equipment",
        "negatedTerseLabel": "Purchase of property, plant and equipment"
       }
      }
     },
     "localname": "PaymentsToAcquirePropertyPlantAndEquipment",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://thecronosgroup.com/role/CondensedConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PendingLitigationMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Risk of loss associated with the outcome of pending litigation against the entity, for example, but not limited to, litigation in arbitration or within the trial process.",
        "label": "Pending Litigation [Member]",
        "terseLabel": "Pending Litigation"
       }
      }
     },
     "localname": "PendingLitigationMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://thecronosgroup.com/role/CommitmentsandContingenciesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_PlanNameAxis": {
     "auth_ref": [
      "r334",
      "r353"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by plan name for share-based payment arrangement.",
        "label": "Plan Name [Axis]",
        "terseLabel": "Plan Name [Axis]"
       }
      }
     },
     "localname": "PlanNameAxis",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://thecronosgroup.com/role/SharebasedPaymentsScheduleofStockOptionsOutstandingDetails",
      "http://thecronosgroup.com/role/SharebasedPaymentsStockOptionsNarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_PlanNameDomain": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Plan name for share-based payment arrangement.",
        "label": "Plan Name [Domain]",
        "terseLabel": "Plan Name [Domain]"
       }
      }
     },
     "localname": "PlanNameDomain",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://thecronosgroup.com/role/SharebasedPaymentsScheduleofStockOptionsOutstandingDetails",
      "http://thecronosgroup.com/role/SharebasedPaymentsStockOptionsNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_PrepaidExpenseAndOtherAssetsCurrent": {
     "auth_ref": [
      "r30",
      "r55",
      "r56"
     ],
     "calculation": {
      "http://thecronosgroup.com/role/CondensedConsolidatedBalanceSheets": {
       "order": 6.0,
       "parentTag": "us-gaap_AssetsCurrent",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of asset related to consideration paid in advance for costs that provide economic benefits in future periods, and amount of other assets that are expected to be realized or consumed within one year or the normal operating cycle, if longer.",
        "label": "Prepaid Expense and Other Assets, Current",
        "terseLabel": "Prepaids and other current assets"
       }
      }
     },
     "localname": "PrepaidExpenseAndOtherAssetsCurrent",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://thecronosgroup.com/role/CondensedConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ProceedsFromPaymentsForOtherFinancingActivities": {
     "auth_ref": [
      "r110",
      "r112"
     ],
     "calculation": {
      "http://thecronosgroup.com/role/CondensedConsolidatedStatementsofCashFlows": {
       "order": 1.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cash inflow (outflow) from financing activities classified as other.",
        "label": "Proceeds from (Payments for) Other Financing Activities",
        "terseLabel": "Proceeds from exercise of warrants and options"
       }
      }
     },
     "localname": "ProceedsFromPaymentsForOtherFinancingActivities",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://thecronosgroup.com/role/CondensedConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ProceedsFromSaleAndMaturityOfMarketableSecurities": {
     "auth_ref": [],
     "calculation": {
      "http://thecronosgroup.com/role/CondensedConsolidatedStatementsofCashFlows": {
       "order": 6.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInInvestingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The cash inflow associated with the aggregate amount received by the entity through sale or maturity of marketable securities  (held-to-maturity or available-for-sale) during the period.",
        "label": "Proceeds from Sale and Maturity of Marketable Securities",
        "terseLabel": "Proceeds from short-term investments"
       }
      }
     },
     "localname": "ProceedsFromSaleAndMaturityOfMarketableSecurities",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://thecronosgroup.com/role/CondensedConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ProceedsFromSaleAndMaturityOfOtherInvestments": {
     "auth_ref": [
      "r106"
     ],
     "calculation": {
      "http://thecronosgroup.com/role/CondensedConsolidatedStatementsofCashFlows": {
       "order": 1.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInInvestingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The cash inflow associated with the sale and maturity (principal being due) of other investments, prepayment and call (request of early payment) of other investments not otherwise defined in the taxonomy.",
        "label": "Proceeds from Sale and Maturity of Other Investments",
        "terseLabel": "Proceeds from sale of other investments"
       }
      }
     },
     "localname": "ProceedsFromSaleAndMaturityOfOtherInvestments",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://thecronosgroup.com/role/CondensedConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ProceedsFromSaleOfPropertyHeldForSale": {
     "auth_ref": [
      "r105"
     ],
     "calculation": {
      "http://thecronosgroup.com/role/CondensedConsolidatedStatementsofCashFlows": {
       "order": 8.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInInvestingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The cash inflow from the sale of formerly productive land held for sale, anything permanently fixed to it, including buildings, structures on it, and so forth.",
        "label": "Proceeds from Sale of Property Held-for-sale",
        "terseLabel": "Proceeds from sale of held-for-sale assets"
       }
      }
     },
     "localname": "ProceedsFromSaleOfPropertyHeldForSale",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://thecronosgroup.com/role/CondensedConsolidatedStatementsofCashFlows",
      "http://thecronosgroup.com/role/HeldForSaleAssetsandDiscontinuedOperationsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ProductAndServiceOtherMember": {
     "auth_ref": [
      "r315"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Article or substance produced by nature, labor or machinery and act of providing assistance, classified as other.",
        "label": "Product and Service, Other [Member]",
        "terseLabel": "Other"
       }
      }
     },
     "localname": "ProductAndServiceOtherMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://thecronosgroup.com/role/SegmentInformationScheduleofSegmentDataDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_ProfitLoss": {
     "auth_ref": [
      "r24",
      "r78",
      "r81",
      "r86",
      "r114",
      "r124",
      "r131",
      "r141",
      "r142",
      "r186",
      "r192",
      "r196",
      "r199",
      "r202",
      "r225",
      "r288",
      "r289",
      "r290",
      "r293",
      "r294",
      "r295",
      "r297",
      "r299",
      "r301",
      "r302",
      "r368",
      "r373",
      "r375",
      "r388",
      "r389",
      "r409",
      "r430",
      "r483"
     ],
     "calculation": {
      "http://thecronosgroup.com/role/CondensedConsolidatedStatementsofCashFlows": {
       "order": 7.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0
      },
      "http://thecronosgroup.com/role/CondensedConsolidatedStatementsofNetIncomeLossandComprehensiveIncomeLoss": {
       "order": 2.0,
       "parentTag": "us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The consolidated profit or loss for the period, net of income taxes, including the portion attributable to the noncontrolling interest.",
        "label": "Net Income (Loss), Including Portion Attributable to Noncontrolling Interest",
        "totalLabel": "Net income (loss)",
        "verboseLabel": "Net income (loss)"
       }
      }
     },
     "localname": "ProfitLoss",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://thecronosgroup.com/role/CondensedConsolidatedStatementsofCashFlows",
      "http://thecronosgroup.com/role/CondensedConsolidatedStatementsofChangesinEquity",
      "http://thecronosgroup.com/role/CondensedConsolidatedStatementsofNetIncomeLossandComprehensiveIncomeLoss",
      "http://thecronosgroup.com/role/SegmentInformationScheduleofAdjustedEBITDADetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PropertyPlantAndEquipmentAdditions": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of acquisition of long-lived, physical assets used in the normal conduct of business and not intended for resale. Examples include, but are not limited to, land, buildings, machinery and equipment, office equipment, furniture and fixtures, and computer equipment.",
        "label": "Property, Plant and Equipment, Additions",
        "terseLabel": "Purchase of property, plant and equipment, net"
       }
      }
     },
     "localname": "PropertyPlantAndEquipmentAdditions",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://thecronosgroup.com/role/SegmentInformationScheduleofSegmentDataDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PropertyPlantAndEquipmentNet": {
     "auth_ref": [
      "r35",
      "r36",
      "r263",
      "r450",
      "r484",
      "r491"
     ],
     "calculation": {
      "http://thecronosgroup.com/role/CondensedConsolidatedBalanceSheets": {
       "order": 4.0,
       "parentTag": "us-gaap_Assets",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount after accumulated depreciation, depletion and amortization of physical assets used in the normal conduct of business to produce goods and services and not intended for resale. Examples include, but are not limited to, land, buildings, machinery and equipment, office equipment, and furniture and fixtures.",
        "label": "Property, Plant and Equipment, Net",
        "verboseLabel": "Property, plant and equipment, net"
       }
      }
     },
     "localname": "PropertyPlantAndEquipmentNet",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://thecronosgroup.com/role/CondensedConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ProvisionForDoubtfulAccounts": {
     "auth_ref": [
      "r99",
      "r233"
     ],
     "calculation": {
      "http://thecronosgroup.com/role/CondensedConsolidatedStatementsofCashFlows": {
       "order": 4.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of expense (reversal of expense) for expected credit loss on accounts receivable.",
        "label": "Accounts Receivable, Credit Loss Expense (Reversal)",
        "terseLabel": "Expected credit losses on long-term financial assets"
       }
      }
     },
     "localname": "ProvisionForDoubtfulAccounts",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://thecronosgroup.com/role/CondensedConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ReceivableTypeDomain": {
     "auth_ref": [
      "r65"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Financing arrangement representing a contractual right to receive money either on demand or on fixed and determinable dates.",
        "label": "Receivable [Domain]",
        "terseLabel": "Receivable [Domain]"
       }
      }
     },
     "localname": "ReceivableTypeDomain",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://thecronosgroup.com/role/InvestmentsNarrativeDetails",
      "http://thecronosgroup.com/role/InvestmentsScheduleofInvestmentsinAssociatesandJointVenturesDetails",
      "http://thecronosgroup.com/role/LoansReceivablenetDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_ReceivablesAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Receivables [Abstract]",
        "terseLabel": "Receivables [Abstract]"
       }
      }
     },
     "localname": "ReceivablesAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_ReportingUnitAxis": {
     "auth_ref": [
      "r248",
      "r249"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by reporting unit.",
        "label": "Reporting Unit [Axis]",
        "terseLabel": "Reporting Unit [Axis]"
       }
      }
     },
     "localname": "ReportingUnitAxis",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://thecronosgroup.com/role/ImpairmentLossonLongLivedAssetsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ReportingUnitDomain": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Level of reporting at which goodwill is tested for impairment.",
        "label": "Reporting Unit [Domain]",
        "terseLabel": "Reporting Unit [Domain]"
       }
      }
     },
     "localname": "ReportingUnitDomain",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://thecronosgroup.com/role/ImpairmentLossonLongLivedAssetsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_ResearchAndDevelopmentExpense": {
     "auth_ref": [
      "r360",
      "r461",
      "r535"
     ],
     "calculation": {
      "http://thecronosgroup.com/role/CondensedConsolidatedStatementsofNetIncomeLossandComprehensiveIncomeLoss": {
       "order": 2.0,
       "parentTag": "us-gaap_OperatingExpenses",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The aggregate costs incurred (1) in a planned search or critical investigation aimed at discovery of new knowledge with the hope that such knowledge will be useful in developing a new product or service, a new process or technique, or in bringing about a significant improvement to an existing product or process; or (2) to translate research findings or other knowledge into a plan or design for a new product or process or for a significant improvement to an existing product or process whether intended for sale or the entity's use, during the reporting period charged to research and development projects, including the costs of developing computer software up to the point in time of achieving technological feasibility, and costs allocated in accounting for a business combination to in-process projects deemed to have no alternative future use.",
        "label": "Research and Development Expense",
        "terseLabel": "Research and development (\u201cR&amp;D\u201d)"
       }
      }
     },
     "localname": "ResearchAndDevelopmentExpense",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://thecronosgroup.com/role/CondensedConsolidatedStatementsofNetIncomeLossandComprehensiveIncomeLoss"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_RestrictedStockUnitsRSUMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Share instrument which is convertible to stock or an equivalent amount of cash, after a specified period of time or when specified performance conditions are met.",
        "label": "Restricted Stock Units (RSUs) [Member]",
        "terseLabel": "Restricted share units"
       }
      }
     },
     "localname": "RestrictedStockUnitsRSUMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://thecronosgroup.com/role/EarningsLossPerShareScheduleofAntidilutiveSecuritiesExcludedfromComputationofDilutedSharesOutstandingDetails",
      "http://thecronosgroup.com/role/EarningsLossPerShareScheduleofEarningsLossPerShareDetails",
      "http://thecronosgroup.com/role/SharebasedPaymentsSummaryofChangesinRSUsDetails",
      "http://thecronosgroup.com/role/SharebasedPaymentsSummaryofStockbasedCompensationExpenseDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_RestructuringCharges": {
     "auth_ref": [
      "r119",
      "r270",
      "r272",
      "r273"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of expenses associated with exit or disposal activities pursuant to an authorized plan. Excludes expenses related to a discontinued operation or an asset retirement obligation.",
        "label": "Restructuring Charges",
        "terseLabel": "Transaction costs"
       }
      }
     },
     "localname": "RestructuringCharges",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://thecronosgroup.com/role/SegmentInformationScheduleofAdjustedEBITDADetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_RetainedEarningsAccumulatedDeficit": {
     "auth_ref": [
      "r43",
      "r311",
      "r357",
      "r450",
      "r488",
      "r513",
      "r518"
     ],
     "calculation": {
      "http://thecronosgroup.com/role/CondensedConsolidatedBalanceSheets": {
       "order": 3.0,
       "parentTag": "us-gaap_StockholdersEquity",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The cumulative amount of the reporting entity's undistributed earnings or deficit.",
        "label": "Retained Earnings (Accumulated Deficit)",
        "terseLabel": "Retained earnings"
       }
      }
     },
     "localname": "RetainedEarningsAccumulatedDeficit",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://thecronosgroup.com/role/BackgroundBasisofPresentationandAccountingPoliciesDetails",
      "http://thecronosgroup.com/role/CondensedConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_RetainedEarningsMember": {
     "auth_ref": [
      "r0",
      "r128",
      "r129",
      "r130",
      "r132",
      "r139",
      "r142",
      "r228",
      "r354",
      "r355",
      "r356",
      "r361",
      "r362",
      "r407",
      "r509",
      "r511"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The cumulative amount of the reporting entity's undistributed earnings or deficit.",
        "label": "Retained Earnings [Member]",
        "terseLabel": "Retained earnings"
       }
      }
     },
     "localname": "RetainedEarningsMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://thecronosgroup.com/role/CondensedConsolidatedStatementsofChangesinEquity"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax": {
     "auth_ref": [
      "r177",
      "r178",
      "r191",
      "r197",
      "r198",
      "r205",
      "r206",
      "r211",
      "r313",
      "r314",
      "r462"
     ],
     "calculation": {
      "http://thecronosgroup.com/role/CondensedConsolidatedStatementsofNetIncomeLossandComprehensiveIncomeLoss": {
       "order": 1.0,
       "parentTag": "us-gaap_GrossProfit",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, excluding tax collected from customer, of revenue from satisfaction of performance obligation by transferring promised good or service to customer. Tax collected from customer is tax assessed by governmental authority that is both imposed on and concurrent with specific revenue-producing transaction, including, but not limited to, sales, use, value added and excise.",
        "label": "Revenue from Contract with Customer, Excluding Assessed Tax",
        "totalLabel": "Net revenue",
        "verboseLabel": "Net revenue"
       }
      }
     },
     "localname": "RevenueFromContractWithCustomerExcludingAssessedTax",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://thecronosgroup.com/role/CondensedConsolidatedStatementsofNetIncomeLossandComprehensiveIncomeLoss",
      "http://thecronosgroup.com/role/SegmentInformationScheduleofRevenuefromExternalCustomersbyGeographicAreasDetails",
      "http://thecronosgroup.com/role/SegmentInformationScheduleofSegmentDataDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_RevenueFromContractWithCustomerIncludingAssessedTax": {
     "auth_ref": [
      "r177",
      "r178",
      "r191",
      "r197",
      "r198",
      "r205",
      "r206",
      "r211",
      "r313",
      "r314",
      "r462"
     ],
     "calculation": {
      "http://thecronosgroup.com/role/CondensedConsolidatedStatementsofNetIncomeLossandComprehensiveIncomeLoss": {
       "order": 1.0,
       "parentTag": "us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, including tax collected from customer, of revenue from satisfaction of performance obligation by transferring promised good or service to customer. Tax collected from customer is tax assessed by governmental authority that is both imposed on and concurrent with specific revenue-producing transaction, including, but not limited to, sales, use, value-added and excise.",
        "label": "Revenue from Contract with Customer, Including Assessed Tax",
        "terseLabel": "Net revenue, before excise taxes"
       }
      }
     },
     "localname": "RevenueFromContractWithCustomerIncludingAssessedTax",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://thecronosgroup.com/role/CondensedConsolidatedStatementsofNetIncomeLossandComprehensiveIncomeLoss",
      "http://thecronosgroup.com/role/SegmentInformationNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_RevenueFromContractWithCustomerMember": {
     "auth_ref": [
      "r169",
      "r211"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Revenue from satisfaction of performance obligation by transferring promised product and service to customer, when it serves as benchmark in concentration of risk calculation.",
        "label": "Revenue from Contract with Customer Benchmark [Member]",
        "terseLabel": "Revenue Benchmark"
       }
      }
     },
     "localname": "RevenueFromContractWithCustomerMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://thecronosgroup.com/role/SegmentInformationNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_RevenueFromExternalCustomersByGeographicAreasTableTextBlock": {
     "auth_ref": [
      "r208"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of revenue from external customers by geographic areas attributed to the entity's country of domicile and to foreign countries from which the entity derives revenue.",
        "label": "Revenue from External Customers by Geographic Areas [Table Text Block]",
        "terseLabel": "Schedule of Revenue from External Customers by Geographic Areas"
       }
      }
     },
     "localname": "RevenueFromExternalCustomersByGeographicAreasTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://thecronosgroup.com/role/SegmentInformationTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_RevenuesFromExternalCustomersAndLongLivedAssetsLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Revenues from External Customers and Long-Lived Assets [Line Items]",
        "terseLabel": "Revenues from External Customers and Long-Lived Assets [Line Items]"
       }
      }
     },
     "localname": "RevenuesFromExternalCustomersAndLongLivedAssetsLineItems",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://thecronosgroup.com/role/SegmentInformationScheduleofLonglivedAssetsbyGeographicAreasDetails",
      "http://thecronosgroup.com/role/SegmentInformationScheduleofRevenuefromExternalCustomersbyGeographicAreasDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_RisksAndUncertaintiesAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Risks and Uncertainties [Abstract]",
        "terseLabel": "Risks and Uncertainties [Abstract]"
       }
      }
     },
     "localname": "RisksAndUncertaintiesAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_SaleOfStockNameOfTransactionDomain": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Sale of the entity's stock, including, but not limited to, initial public offering (IPO) and private placement.",
        "label": "Sale of Stock [Domain]",
        "terseLabel": "Sale of Stock [Domain]"
       }
      }
     },
     "localname": "SaleOfStockNameOfTransactionDomain",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://thecronosgroup.com/role/DerivativeLiabilitiesNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_SaleOfStockNumberOfSharesIssuedInTransaction": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The number of shares issued or sold by the subsidiary or equity method investee per stock transaction.",
        "label": "Sale of Stock, Number of Shares Issued in Transaction",
        "terseLabel": "Sale of stock, number of shares issued in transaction (in shares)"
       }
      }
     },
     "localname": "SaleOfStockNumberOfSharesIssuedInTransaction",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://thecronosgroup.com/role/InvestmentsNarrativeDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_SaleOfStockPercentageOfOwnershipAfterTransaction": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Percentage of subsidiary's or equity investee's stock owned by parent company after stock transaction.",
        "label": "Sale of Stock, Percentage of Ownership after Transaction",
        "terseLabel": "Sale of stock, percentage of ownership after transaction"
       }
      }
     },
     "localname": "SaleOfStockPercentageOfOwnershipAfterTransaction",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://thecronosgroup.com/role/InvestmentsNarrativeDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "us-gaap_SaleOfStockPricePerShare": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Per share amount received by subsidiary or equity investee for each share of common stock issued or sold in the stock transaction.",
        "label": "Sale of Stock, Price Per Share",
        "terseLabel": "Sale of stock, price per share (in dollars per share)"
       }
      }
     },
     "localname": "SaleOfStockPricePerShare",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://thecronosgroup.com/role/InvestmentsNarrativeDetails"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_ScheduleOfAccountsNotesLoansAndFinancingReceivableTable": {
     "auth_ref": [
      "r65"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Schedule itemizing specific types of trade accounts and notes receivable, and for each the gross carrying value, allowance, and net carrying value as of the balance sheet date. Presentation is categorized by current, noncurrent and unclassified receivables.",
        "label": "Schedule of Accounts, Notes, Loans and Financing Receivable [Table]",
        "terseLabel": "Schedule of Accounts, Notes, Loans and Financing Receivable [Table]"
       }
      }
     },
     "localname": "ScheduleOfAccountsNotesLoansAndFinancingReceivableTable",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://thecronosgroup.com/role/LoansReceivablenetDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ScheduleOfAccountsNotesLoansAndFinancingReceivableTextBlock": {
     "auth_ref": [
      "r65"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of the various types of trade accounts and notes receivable and for each the gross carrying value, allowance, and net carrying value as of the balance sheet date. Presentation is categorized by current, noncurrent and unclassified receivables.",
        "label": "Schedule of Accounts, Notes, Loans and Financing Receivable [Table Text Block]",
        "terseLabel": "Schedule of Loan Receivable"
       }
      }
     },
     "localname": "ScheduleOfAccountsNotesLoansAndFinancingReceivableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://thecronosgroup.com/role/LoansReceivablenetTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable": {
     "auth_ref": [
      "r159"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Schedule for securities (including those issuable pursuant to contingent stock agreements) that could potentially dilute basic earnings per share (EPS) in the future that were not included in the computation of diluted EPS because to do so would increase EPS amounts or decrease loss per share amounts for the period presented, by Antidilutive Securities.",
        "label": "Schedule of Antidilutive Securities Excluded from Computation of Earnings Per Share [Table]",
        "terseLabel": "Schedule of Antidilutive Securities Excluded from Computation of Earnings Per Share [Table]"
       }
      }
     },
     "localname": "ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://thecronosgroup.com/role/EarningsLossPerShareScheduleofAntidilutiveSecuritiesExcludedfromComputationofDilutedSharesOutstandingDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock": {
     "auth_ref": [
      "r159"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of securities (including those issuable pursuant to contingent stock agreements) that could potentially dilute basic earnings per share (EPS) in the future that were not included in the computation of diluted EPS because to do so would increase EPS amounts or decrease loss per share amounts for the period presented, by antidilutive securities.",
        "label": "Schedule of Antidilutive Securities Excluded from Computation of Earnings Per Share [Table Text Block]",
        "terseLabel": "Schedule of Antidilutive Securities Excluded from Computation of Diluted Shares Outstanding"
       }
      }
     },
     "localname": "ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://thecronosgroup.com/role/EarningsLossPerShareTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfDisposalGroupsIncludingDiscontinuedOperationsIncomeStatementBalanceSheetAndAdditionalDisclosuresTextBlock": {
     "auth_ref": [
      "r3",
      "r12",
      "r13",
      "r14",
      "r15",
      "r16",
      "r17",
      "r19",
      "r22",
      "r23",
      "r24",
      "r267",
      "r268"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of information related to a disposal group. Includes, but is not limited to, a discontinued operation, disposal classified as held-for-sale or disposed of by means other than sale or disposal of an individually significant component.",
        "label": "Disposal Groups, Including Discontinued Operations [Table Text Block]",
        "terseLabel": "Summary of Financial Information for Discontinued Operations"
       }
      }
     },
     "localname": "ScheduleOfDisposalGroupsIncludingDiscontinuedOperationsIncomeStatementBalanceSheetAndAdditionalDisclosuresTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://thecronosgroup.com/role/HeldForSaleAssetsandDiscontinuedOperationsTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock": {
     "auth_ref": [
      "r158"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of an entity's basic and diluted earnings per share calculations, including a reconciliation of numerators and denominators of the basic and diluted per-share computations for income from continuing operations.",
        "label": "Schedule of Earnings Per Share, Basic and Diluted [Table Text Block]",
        "terseLabel": "Schedule of Earnings (Loss) Per Share"
       }
      }
     },
     "localname": "ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://thecronosgroup.com/role/EarningsLossPerShareTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfEarningsPerShareDilutedByCommonClassTable": {
     "auth_ref": [
      "r147",
      "r151",
      "r156",
      "r158",
      "r164"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Complete disclosure pertaining to an entity's diluted earnings per share.",
        "label": "Schedule of Earnings Per Share, Diluted, by Common Class, Including Two Class Method [Table]",
        "terseLabel": "Schedule of Earnings Per Share, Diluted, by Common Class, Including Two Class Method [Table]"
       }
      }
     },
     "localname": "ScheduleOfEarningsPerShareDilutedByCommonClassTable",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://thecronosgroup.com/role/EarningsLossPerShareScheduleofEarningsLossPerShareDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTable": {
     "auth_ref": [
      "r333",
      "r351",
      "r358"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of information about amount recognized for award under share-based payment arrangement. Includes, but is not limited to, amount expensed in statement of income or comprehensive income, amount capitalized in statement of financial position, and corresponding reporting line item in financial statements.",
        "label": "Share-based Payment Arrangement, Expensed and Capitalized, Amount [Table]",
        "terseLabel": "Share-based Payment Arrangement, Expensed and Capitalized, Amount [Table]"
       }
      }
     },
     "localname": "ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTable",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://thecronosgroup.com/role/SharebasedPaymentsSummaryofStockbasedCompensationExpenseDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock": {
     "auth_ref": [
      "r333",
      "r351",
      "r358"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of allocation of amount expensed and capitalized for award under share-based payment arrangement to statement of income or comprehensive income and statement of financial position. Includes, but is not limited to, corresponding line item in financial statement.",
        "label": "Share-based Payment Arrangement, Expensed and Capitalized, Amount [Table Text Block]",
        "terseLabel": "Summary of Stock-based Compensation Expense"
       }
      }
     },
     "localname": "ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://thecronosgroup.com/role/SharebasedPaymentsTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfEquityMethodInvestmentsLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Schedule of Equity Method Investments [Line Items]",
        "terseLabel": "Schedule of Equity Method Investments [Line Items]"
       }
      }
     },
     "localname": "ScheduleOfEquityMethodInvestmentsLineItems",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://thecronosgroup.com/role/BackgroundBasisofPresentationandAccountingPoliciesDetails",
      "http://thecronosgroup.com/role/InvestmentsScheduleofInvestmentsinAssociatesandJointVenturesDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ScheduleOfEquityMethodInvestmentsTable": {
     "auth_ref": [
      "r24",
      "r124",
      "r224",
      "r225",
      "r430"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Summarization of information required and determined to be disclosed concerning equity method investments in common stock. The summarized information includes: (a) the name of each investee or group of investees for which combined disclosure is appropriate, (2) the percentage ownership of common stock, (3) the difference, if any, between the carrying amount of an investment and the value of the underlying equity in the net assets and the accounting treatment of difference, if any, and (4) the aggregate value of each identified investment based on its quoted market price, if available.",
        "label": "Schedule of Equity Method Investments [Table]",
        "terseLabel": "Schedule of Equity Method Investments [Table]"
       }
      }
     },
     "localname": "ScheduleOfEquityMethodInvestmentsTable",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://thecronosgroup.com/role/BackgroundBasisofPresentationandAccountingPoliciesDetails",
      "http://thecronosgroup.com/role/InvestmentsScheduleofInvestmentsinAssociatesandJointVenturesDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock": {
     "auth_ref": [
      "r411",
      "r412"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of assets and liabilities, including [financial] instruments measured at fair value that are classified in stockholders' equity, if any, that are measured at fair value on a recurring basis. The disclosures contemplated herein include the fair value measurements at the reporting date by the level within the fair value hierarchy in which the fair value measurements in their entirety fall, segregating fair value measurements using quoted prices in active markets for identical assets (Level 1), significant other observable inputs (Level 2), and significant unobservable inputs (Level 3).",
        "label": "Schedule of Fair Value, Assets and Liabilities Measured on Recurring Basis [Table Text Block]",
        "terseLabel": "Schedule of Fair Value of Assets Measured on Recurring Basis"
       }
      }
     },
     "localname": "ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://thecronosgroup.com/role/FinancialInstrumentsTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfIndefiniteLivedIntangibleAssetsTable": {
     "auth_ref": [
      "r253",
      "r255"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Schedule of assets, excluding financial assets and goodwill, lacking physical substance and exist in perpetuity.",
        "label": "Schedule of Indefinite-Lived Intangible Assets [Table]",
        "terseLabel": "Schedule of Indefinite-Lived Intangible Assets [Table]"
       }
      }
     },
     "localname": "ScheduleOfIndefiniteLivedIntangibleAssetsTable",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://thecronosgroup.com/role/ImpairmentLossonLongLivedAssetsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ScheduleOfInventoryCurrentTableTextBlock": {
     "auth_ref": [
      "r33",
      "r52",
      "r53",
      "r54"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of the carrying amount as of the balance sheet date of merchandise, goods, commodities, or supplies held for future sale or to be used in manufacturing, servicing or production process.",
        "label": "Schedule of Inventory, Current [Table Text Block]",
        "terseLabel": "Schedule of Inventory"
       }
      }
     },
     "localname": "ScheduleOfInventoryCurrentTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://thecronosgroup.com/role/InventorynetTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfOtherShareBasedCompensationActivityTableTextBlock": {
     "auth_ref": [
      "r344"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of activity for outstanding award under share-based payment arrangement excluding share and unit options and nonvested award.",
        "label": "Share-based Payment Arrangement, Outstanding Award, Activity, Excluding Option [Table Text Block]",
        "terseLabel": "Summary of Changes in DSUs and Warrants"
       }
      }
     },
     "localname": "ScheduleOfOtherShareBasedCompensationActivityTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://thecronosgroup.com/role/SharebasedPaymentsTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfRevenuesFromExternalCustomersAndLongLivedAssetsTable": {
     "auth_ref": [
      "r90",
      "r210"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Schedule of material long-lived assets (excluding financial instruments, customer relationships with financial institutions, mortgage and other servicing rights, deferred policy acquisition costs, and deferred taxes assets) located in identified geographic areas and/or the amount of revenue from external customers attributed to that country from which revenue is material.  An entity may also provide subtotals of geographic information about groups of countries.",
        "label": "Schedule of Revenues from External Customers and Long-Lived Assets [Table]",
        "terseLabel": "Schedule of Revenues from External Customers and Long-Lived Assets [Table]"
       }
      }
     },
     "localname": "ScheduleOfRevenuesFromExternalCustomersAndLongLivedAssetsTable",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://thecronosgroup.com/role/SegmentInformationScheduleofLonglivedAssetsbyGeographicAreasDetails",
      "http://thecronosgroup.com/role/SegmentInformationScheduleofRevenuefromExternalCustomersbyGeographicAreasDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable": {
     "auth_ref": [
      "r186",
      "r189",
      "r195",
      "r247"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "A table disclosing the profit or loss and total assets for each reportable segment of the entity. An entity discloses certain information on each reportable segment if the amounts (a) are included in the measure of segment profit or loss reviewed by the chief operating decision maker or (b) are otherwise regularly provided to the chief operating decision maker, even if not included in that measure of segment profit or loss.",
        "label": "Schedule of Segment Reporting Information, by Segment [Table]",
        "terseLabel": "Schedule of Segment Reporting Information, by Segment [Table]"
       }
      }
     },
     "localname": "ScheduleOfSegmentReportingInformationBySegmentTable",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://thecronosgroup.com/role/SegmentInformationNarrativeDetails",
      "http://thecronosgroup.com/role/SegmentInformationScheduleofAdjustedEBITDADetails",
      "http://thecronosgroup.com/role/SegmentInformationScheduleofSegmentDataDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock": {
     "auth_ref": [
      "r186",
      "r189",
      "r195",
      "r247"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of the profit or loss and total assets for each reportable segment. An entity discloses certain information on each reportable segment if the amounts (a) are included in the measure of segment profit or loss reviewed by the chief operating decision maker or (b) are otherwise regularly provided to the chief operating decision maker, even if not included in that measure of segment profit or loss.",
        "label": "Schedule of Segment Reporting Information, by Segment [Table Text Block]",
        "terseLabel": "Schedule of Segment Data and Adjusted EBITDA"
       }
      }
     },
     "localname": "ScheduleOfSegmentReportingInformationBySegmentTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://thecronosgroup.com/role/SegmentInformationTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable": {
     "auth_ref": [
      "r334",
      "r353"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of information about share-based payment arrangement.",
        "label": "Schedule of Share-based Compensation Arrangements by Share-based Payment Award [Table]",
        "terseLabel": "Schedule of Share-based Compensation Arrangements by Share-based Payment Award [Table]"
       }
      }
     },
     "localname": "ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://thecronosgroup.com/role/SharebasedPaymentsScheduleofStockOptionsOutstandingDetails",
      "http://thecronosgroup.com/role/SharebasedPaymentsStockOptionsNarrativeDetails",
      "http://thecronosgroup.com/role/SharebasedPaymentsSummaryofChangesinRSUsDetails",
      "http://thecronosgroup.com/role/SharebasedPaymentsSummaryofChangesinWarrantsDetails",
      "http://thecronosgroup.com/role/SharebasedPaymentsSummaryofDSUActivityDetails",
      "http://thecronosgroup.com/role/SharebasedPaymentsSummaryofOutstandingWarrantsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ScheduleOfShareBasedCompensationRestrictedStockUnitsAwardActivityTableTextBlock": {
     "auth_ref": [
      "r338"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of the number and weighted-average grant date fair value for restricted stock units that were outstanding at the beginning and end of the year, and the number of restricted stock units that were granted, vested, or forfeited during the year.",
        "label": "Share-based Payment Arrangement, Restricted Stock Unit, Activity [Table Text Block]",
        "terseLabel": "Summary of Changes in RSUs"
       }
      }
     },
     "localname": "ScheduleOfShareBasedCompensationRestrictedStockUnitsAwardActivityTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://thecronosgroup.com/role/SharebasedPaymentsTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfStockOptionsRollForwardTableTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of the change in stock options.",
        "label": "Schedule of Stock Options Roll Forward [Table Text Block]",
        "terseLabel": "Summary of the Changes in Options and Options Outstanding"
       }
      }
     },
     "localname": "ScheduleOfStockOptionsRollForwardTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://thecronosgroup.com/role/SharebasedPaymentsTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfVariableInterestEntitiesTable": {
     "auth_ref": [
      "r371",
      "r372",
      "r377",
      "r378",
      "r379",
      "r381",
      "r383",
      "r385",
      "r386"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of qualitative and quantitative information related to variable interests the entity holds, whether or not such variable interest entity (VIE) is included in the reporting entity's consolidated financial statements. Includes, but is not limited to, description of the significant judgments and assumptions made in determining whether a variable interest (as defined) held by the entity requires the variable interest entity (VIE) (as defined) to be consolidated and (or) disclose information about its involvement with the VIE, individually or in aggregate (as applicable); the nature of restrictions, if any, on the consolidated VIE's assets and on the settlement of its liabilities reported by an entity in its statement of financial position, including the carrying amounts of such assets and liabilities; the nature of, and changes in, the risks associated with involvement in the VIE; how involvement with the VIE affects the entity's financial position, financial performance, and cash flows; the lack of recourse if creditors (or beneficial interest holders) of the consolidated VIE have no recourse to the general credit of the primary beneficiary (if applicable); the terms of arrangements, giving consideration to both explicit arrangements and implicit variable interests, if any, that could require the entity to provide financial support to the VIE, including events or circumstances that could expose the entity to a loss; the methodology used by the entity for determining whether or not it is the primary beneficiary of the variable interest entity; the significant factors considered and judgments made in determining that the power to direct the activities of a VIE that most significantly impact the VIE's economic performance are shared (as defined); the carrying amounts and classification of assets and liabilities of the VIE included in the statement of financial position; the entity's maximum exposure to loss, if any, as a result of its involvement with the VIE, including how the maximum exposure is determined and significant sources of the entity's exposure to the VIE; a tabular comparison of the carrying amounts of the assets and liabilities and the entity's maximum exposure to loss; information about any liquidity arrangements, guarantees, and (or) other commitments by third parties that may affect the fair value or risk of the entity's variable interest in the VIE; whether or not the entity has provided financial support or other support (explicitly or implicitly) to the VIE that it was not previously contractually required to provide or whether the entity intends to provide that support, including the type and amount of the support and the primary reasons for providing the support; and supplemental information the entity determines necessary to provide.",
        "label": "Schedule of Variable Interest Entities [Table]",
        "terseLabel": "Schedule of Variable Interest Entities [Table]"
       }
      }
     },
     "localname": "ScheduleOfVariableInterestEntitiesTable",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://thecronosgroup.com/role/InvestmentsNarrativeDetails",
      "http://thecronosgroup.com/role/InvestmentsScheduleofVariableInterestEntitiesDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ScheduleOfVariableInterestEntitiesTextBlock": {
     "auth_ref": [
      "r379",
      "r381",
      "r383",
      "r385",
      "r386"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of the significant judgments and assumptions made in determining whether a variable interest (as defined) held by the entity requires the variable interest entity (VIE) (as defined) to be consolidated and (or) disclose information about its involvement with the VIE, individually or in aggregate (as applicable); the nature of restrictions, if any, on the consolidated VIE's assets and on the settlement of its liabilities reported by an entity in its statement of financial position, including the carrying amounts of such assets and liabilities; the nature of, and changes in, the risks associated with involvement in the VIE; how involvement with the VIE affects the entity's financial position, financial performance, and cash flows; the lack of recourse if creditors (or beneficial interest holders) of the consolidated VIE have no recourse to the general credit of the primary beneficiary (if applicable); the terms of arrangements, giving consideration to both explicit arrangements and implicit variable interests, if any, that could require the entity to provide financial support to the VIE, including events or circumstances that could expose the entity to a loss; the methodology used by the entity for determining whether or not it is the primary beneficiary of the variable interest entity; the significant factors considered and judgments made in determining that the power to direct the activities of a VIE that most significantly impact the VIE's economic performance are shared (as defined); the carrying amounts and classification of assets and liabilities of the VIE included in the statement of financial position; the entity's maximum exposure to loss, if any, as a result of its involvement with the VIE, including how the maximum exposure is determined and significant sources of the entity's exposure to the VIE; a comparison of the carrying amounts of the assets and liabilities and the entity's maximum exposure to loss; information about any liquidity arrangements, guarantees, and (or) other commitments by third parties that may affect the fair value or risk of the entity's variable interest in the VIE; whether or not the entity has provided financial support or other support (explicitly or implicitly) to the VIE that it was not previously contractually required to provide or whether the entity intends to provide that support, including the type and amount of the support and the primary reasons for providing the support; and supplemental information the entity determines necessary to provide.",
        "label": "Schedule of Variable Interest Entities [Table Text Block]",
        "terseLabel": "Schedule of Variable Interest Entities"
       }
      }
     },
     "localname": "ScheduleOfVariableInterestEntitiesTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://thecronosgroup.com/role/InvestmentsTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_SegmentDomain": {
     "auth_ref": [
      "r173",
      "r177",
      "r178",
      "r179",
      "r180",
      "r181",
      "r182",
      "r183",
      "r184",
      "r185",
      "r186",
      "r187",
      "r188",
      "r191",
      "r192",
      "r193",
      "r194",
      "r196",
      "r197",
      "r198",
      "r199",
      "r200",
      "r202",
      "r211",
      "r271",
      "r274",
      "r503"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Components of an entity that engage in business activities from which they may earn revenue and incur expenses, including transactions with other components of the same entity.",
        "label": "Segments [Domain]",
        "terseLabel": "Segments [Domain]"
       }
      }
     },
     "localname": "SegmentDomain",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://thecronosgroup.com/role/SegmentInformationNarrativeDetails",
      "http://thecronosgroup.com/role/SegmentInformationScheduleofAdjustedEBITDADetails",
      "http://thecronosgroup.com/role/SegmentInformationScheduleofSegmentDataDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_SegmentReportingAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Segment Reporting [Abstract]",
        "terseLabel": "Segment Reporting [Abstract]"
       }
      }
     },
     "localname": "SegmentReportingAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_SegmentReportingDisclosureTextBlock": {
     "auth_ref": [
      "r173",
      "r175",
      "r176",
      "r186",
      "r190",
      "r196",
      "r200",
      "r201",
      "r202",
      "r203",
      "r205",
      "r210",
      "r211",
      "r212"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for reporting segments including data and tables. Reportable segments include those that meet any of the following quantitative thresholds a) it's reported revenue, including sales to external customers and intersegment sales or transfers is 10 percent or more of the combined revenue, internal and external, of all operating segments b) the absolute amount of its reported profit or loss is 10 percent or more of the greater, in absolute amount of 1) the combined reported profit of all operating segments that did not report a loss or 2) the combined reported loss of all operating segments that did report a loss c) its assets are 10 percent or more of the combined assets of all operating segments.",
        "label": "Segment Reporting Disclosure [Text Block]",
        "terseLabel": "Segment Information"
       }
      }
     },
     "localname": "SegmentReportingDisclosureTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://thecronosgroup.com/role/SegmentInformation"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_SegmentReportingInformationLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Segment Reporting Information [Line Items]",
        "terseLabel": "Segment Reporting Information [Line Items]"
       }
      }
     },
     "localname": "SegmentReportingInformationLineItems",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://thecronosgroup.com/role/SegmentInformationNarrativeDetails",
      "http://thecronosgroup.com/role/SegmentInformationScheduleofAdjustedEBITDADetails",
      "http://thecronosgroup.com/role/SegmentInformationScheduleofSegmentDataDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_SellingAndMarketingExpense": {
     "auth_ref": [],
     "calculation": {
      "http://thecronosgroup.com/role/CondensedConsolidatedStatementsofNetIncomeLossandComprehensiveIncomeLoss": {
       "order": 1.0,
       "parentTag": "us-gaap_OperatingExpenses",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The aggregate total amount of expenses directly related to the marketing or selling of products or services.",
        "label": "Selling and Marketing Expense",
        "terseLabel": "Sales and marketing"
       }
      }
     },
     "localname": "SellingAndMarketingExpense",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://thecronosgroup.com/role/CondensedConsolidatedStatementsofNetIncomeLossandComprehensiveIncomeLoss"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ShareBasedCompensation": {
     "auth_ref": [
      "r118"
     ],
     "calculation": {
      "http://thecronosgroup.com/role/CondensedConsolidatedStatementsofCashFlows": {
       "order": 8.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of noncash expense for share-based payment arrangement.",
        "label": "Share-based Payment Arrangement, Noncash Expense",
        "terseLabel": "Share-based payments"
       }
      }
     },
     "localname": "ShareBasedCompensation",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://thecronosgroup.com/role/CondensedConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1": {
     "auth_ref": [
      "r335"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Period over which grantee's right to exercise award under share-based payment arrangement is no longer contingent on satisfaction of service or performance condition, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days. Includes, but is not limited to, combination of market, performance or service condition.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Award Vesting Period",
        "terseLabel": "Vesting period"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://thecronosgroup.com/role/SharebasedPaymentsStockOptionsNarrativeDetails",
      "http://thecronosgroup.com/role/SharebasedPaymentsSummaryofChangesinRSUsDetails"
     ],
     "xbrltype": "durationItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod": {
     "auth_ref": [
      "r346"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The number of grants made during the period on other than stock (or unit) option plans (for example, phantom stock or unit plan, stock or unit appreciation rights plan, performance target plan).",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Grants in Period",
        "terseLabel": "Granted (in shares)"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://thecronosgroup.com/role/SharebasedPaymentsSummaryofChangesinRSUsDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue": {
     "auth_ref": [
      "r346"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The weighted average fair value at grant date for nonvested equity-based awards issued during the period on other than stock (or unit) option plans (for example, phantom stock or unit plan, stock or unit appreciation rights plan, performance target plan).",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Grants in Period, Weighted Average Grant Date Fair Value",
        "terseLabel": "Granted (in dollars per share)"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://thecronosgroup.com/role/SharebasedPaymentsSummaryofChangesinRSUsDetails"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber": {
     "auth_ref": [
      "r345"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The number of non-vested equity-based payment instruments, excluding stock (or unit) options, that validly exist and are outstanding as of the balance sheet date.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Number",
        "periodEndLabel": "Balance at end of period (in shares)",
        "periodStartLabel": "Balance at beginning of period (in shares)",
        "verboseLabel": "Number of warrants (in shares)"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://thecronosgroup.com/role/SharebasedPaymentsSummaryofChangesinRSUsDetails",
      "http://thecronosgroup.com/role/SharebasedPaymentsSummaryofChangesinWarrantsDetails",
      "http://thecronosgroup.com/role/SharebasedPaymentsSummaryofDSUActivityDetails",
      "http://thecronosgroup.com/role/SharebasedPaymentsSummaryofOutstandingWarrantsDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Number of Shares [Roll Forward]",
        "terseLabel": "Number of awards"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://thecronosgroup.com/role/SharebasedPaymentsSummaryofChangesinRSUsDetails",
      "http://thecronosgroup.com/role/SharebasedPaymentsSummaryofChangesinWarrantsDetails",
      "http://thecronosgroup.com/role/SharebasedPaymentsSummaryofDSUActivityDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue": {
     "auth_ref": [
      "r345"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Per share or unit weighted-average fair value of nonvested award under share-based payment arrangement. Excludes share and unit options.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Weighted Average Grant Date Fair Value",
        "periodEndLabel": "Balance at end of period (in dollars per share)",
        "periodStartLabel": "Balance at beginning of period (in dollars per share)"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://thecronosgroup.com/role/SharebasedPaymentsSummaryofChangesinRSUsDetails",
      "http://thecronosgroup.com/role/SharebasedPaymentsSummaryofChangesinWarrantsDetails"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Weighted Average Grant Date Fair Value [Abstract]",
        "terseLabel": "Weighted average exercise price (C$)"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://thecronosgroup.com/role/SharebasedPaymentsSummaryofChangesinWarrantsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod": {
     "auth_ref": [
      "r347"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The number of equity-based payment instruments, excluding stock (or unit) options, that vested during the reporting period.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Vested in Period",
        "negatedLabel": "Exercise of warrants (in shares)",
        "negatedTerseLabel": "Vested and issued/liabilities settled (in shares)"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://thecronosgroup.com/role/SharebasedPaymentsSummaryofChangesinWarrantsDetails",
      "http://thecronosgroup.com/role/SharebasedPaymentsSummaryofDSUActivityDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue": {
     "auth_ref": [
      "r347"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The weighted average fair value as of grant date pertaining to an equity-based award plan other than a stock (or unit) option plan for which the grantee gained the right during the reporting period, by satisfying service and performance requirements, to receive or retain shares or units, other instruments, or cash in accordance with the terms of the arrangement.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Vested in Period, Weighted Average Grant Date Fair Value",
        "terseLabel": "Exercise of warrants (in dollars per share)"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://thecronosgroup.com/role/SharebasedPaymentsSummaryofChangesinWarrantsDetails"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award [Line Items]",
        "terseLabel": "Share-based Compensation Arrangement by Share-based Payment Award [Line Items]"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://thecronosgroup.com/role/SharebasedPaymentsScheduleofStockOptionsOutstandingDetails",
      "http://thecronosgroup.com/role/SharebasedPaymentsStockOptionsNarrativeDetails",
      "http://thecronosgroup.com/role/SharebasedPaymentsSummaryofChangesinRSUsDetails",
      "http://thecronosgroup.com/role/SharebasedPaymentsSummaryofChangesinWarrantsDetails",
      "http://thecronosgroup.com/role/SharebasedPaymentsSummaryofDSUActivityDetails",
      "http://thecronosgroup.com/role/SharebasedPaymentsSummaryofOutstandingWarrantsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber": {
     "auth_ref": [
      "r341"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The number of shares into which fully or partially vested stock options outstanding as of the balance sheet date can be currently converted under the option plan.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Number",
        "verboseLabel": "Exercisable (in shares)"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://thecronosgroup.com/role/SharebasedPaymentsSummaryoftheChangesinOptionsDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice": {
     "auth_ref": [
      "r341"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The weighted-average price as of the balance sheet date at which grantees can acquire the shares reserved for issuance on vested portions of options outstanding and currently exercisable under the stock option plan.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Weighted Average Exercise Price",
        "terseLabel": "Weighted average exercise price of options exercisable (in dollars per share)"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://thecronosgroup.com/role/SharebasedPaymentsSummaryoftheChangesinOptionsDetails"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod": {
     "auth_ref": [
      "r343"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "For presentations that combine terminations, the number of shares under options that were cancelled during the reporting period as a result of occurrence of a terminating event specified in contractual agreements pertaining to the stock option plan or that expired.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Options, Forfeitures and Expirations in Period",
        "negatedTerseLabel": "Cancellation, forfeiture and expiry of options (in shares)"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://thecronosgroup.com/role/SharebasedPaymentsSummaryoftheChangesinOptionsDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice": {
     "auth_ref": [
      "r343"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Weighted average price of options that were either forfeited or expired.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Options, Forfeitures and Expirations in Period, Weighted Average Exercise Price",
        "terseLabel": "Cancellation, forfeiture and expiry of options (in dollars per share)"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://thecronosgroup.com/role/SharebasedPaymentsSummaryoftheChangesinOptionsDetails"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Gross number of share options (or share units) granted during the period.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Gross",
        "terseLabel": "Issuance of options (in shares)"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://thecronosgroup.com/role/SharebasedPaymentsStockOptionsNarrativeDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber": {
     "auth_ref": [
      "r340",
      "r353"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of options outstanding, including both vested and non-vested options.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Number",
        "periodEndLabel": "Balance at end of period (in shares)",
        "periodStartLabel": "Balance at beginning of period (in shares)",
        "terseLabel": "Number of options outstanding (in shares)"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://thecronosgroup.com/role/SharebasedPaymentsScheduleofStockOptionsOutstandingDetails",
      "http://thecronosgroup.com/role/SharebasedPaymentsSummaryoftheChangesinOptionsDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding [Roll Forward]",
        "terseLabel": "Number of options"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://thecronosgroup.com/role/SharebasedPaymentsSummaryoftheChangesinOptionsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice": {
     "auth_ref": [
      "r339"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Weighted average price at which grantees can acquire the shares reserved for issuance under the stock option plan.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Weighted Average Exercise Price",
        "periodEndLabel": "Balance at end of period (in dollars per share)",
        "periodStartLabel": "Balance at beginning of period (in dollars per share)"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://thecronosgroup.com/role/SharebasedPaymentsSummaryoftheChangesinOptionsDetails"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Weighted Average Exercise Price [Abstract]",
        "terseLabel": "Weighted average exercise price (C$)"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://thecronosgroup.com/role/SharebasedPaymentsSummaryoftheChangesinOptionsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain": {
     "auth_ref": [
      "r332",
      "r337"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Award under share-based payment arrangement.",
        "label": "Award Type [Domain]",
        "terseLabel": "Award Type [Domain]"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://thecronosgroup.com/role/EarningsLossPerShareScheduleofEarningsLossPerShareDetails",
      "http://thecronosgroup.com/role/SharebasedPaymentsStockOptionsNarrativeDetails",
      "http://thecronosgroup.com/role/SharebasedPaymentsSummaryofChangesinRSUsDetails",
      "http://thecronosgroup.com/role/SharebasedPaymentsSummaryofChangesinWarrantsDetails",
      "http://thecronosgroup.com/role/SharebasedPaymentsSummaryofDSUActivityDetails",
      "http://thecronosgroup.com/role/SharebasedPaymentsSummaryofOutstandingWarrantsDetails",
      "http://thecronosgroup.com/role/SharebasedPaymentsSummaryofStockbasedCompensationExpenseDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Weighted average price at which option holders acquired shares when converting their stock options into shares.",
        "label": "Share-based Compensation Arrangements by Share-based Payment Award, Options, Exercises in Period, Weighted Average Exercise Price",
        "terseLabel": "Exercise of options (in dollars per share)"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://thecronosgroup.com/role/SharebasedPaymentsSummaryoftheChangesinOptionsDetails"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_ShareBasedGoodsAndNonemployeeServicesTransactionBySupplierAxis": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by supplier.",
        "label": "Supplier [Axis]",
        "terseLabel": "Supplier [Axis]"
       }
      }
     },
     "localname": "ShareBasedGoodsAndNonemployeeServicesTransactionBySupplierAxis",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://thecronosgroup.com/role/FinancialInstrumentsLiquidityRiskNarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ShareBasedGoodsAndNonemployeeServicesTransactionSupplierDomain": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Specific identification or general nature of (for example, a construction contractor, a consulting firm) the party from whom the goods or services were or are to be received.",
        "label": "Supplier [Domain]",
        "terseLabel": "Supplier [Domain]"
       }
      }
     },
     "localname": "ShareBasedGoodsAndNonemployeeServicesTransactionSupplierDomain",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://thecronosgroup.com/role/FinancialInstrumentsLiquidityRiskNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod": {
     "auth_ref": [
      "r336"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Period from grant date that an equity-based award expires, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Expiration Period",
        "terseLabel": "Expiration period"
       }
      }
     },
     "localname": "SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://thecronosgroup.com/role/SharebasedPaymentsStockOptionsNarrativeDetails"
     ],
     "xbrltype": "durationItemType"
    },
    "us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedWeightedAverageGrantDateFairValueAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Options, Nonvested, Weighted Average Grant Date Fair Value [Abstract]",
        "terseLabel": "Weighted average remaining contractual term (years)"
       }
      }
     },
     "localname": "SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedWeightedAverageGrantDateFairValueAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://thecronosgroup.com/role/SharebasedPaymentsSummaryoftheChangesinOptionsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2": {
     "auth_ref": [
      "r348"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Weighted average remaining contractual term for option awards outstanding, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Weighted Average Remaining Contractual Term",
        "verboseLabel": "Outstanding"
       }
      }
     },
     "localname": "SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://thecronosgroup.com/role/SharebasedPaymentsSummaryoftheChangesinOptionsDetails"
     ],
     "xbrltype": "durationItemType"
    },
    "us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageRemainingContractualTerm1": {
     "auth_ref": [
      "r349"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Weighted average remaining contractual term for fully vested and expected to vest exercisable or convertible options, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days. Includes, but is not limited to, unvested options for which requisite service period has not been rendered but that are expected to vest based on achievement of performance condition, if forfeitures are recognized when they occur.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested and Expected to Vest, Exercisable, Weighted Average Remaining Contractual Term",
        "terseLabel": "Exercisable"
       }
      }
     },
     "localname": "SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageRemainingContractualTerm1",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://thecronosgroup.com/role/SharebasedPaymentsSummaryoftheChangesinOptionsDetails"
     ],
     "xbrltype": "durationItemType"
    },
    "us-gaap_ShortTermInvestments": {
     "auth_ref": [
      "r37",
      "r467",
      "r468",
      "r485"
     ],
     "calculation": {
      "http://thecronosgroup.com/role/CondensedConsolidatedBalanceSheets": {
       "order": 2.0,
       "parentTag": "us-gaap_AssetsCurrent",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of investments including trading securities, available-for-sale securities, held-to-maturity securities, and short-term investments classified as other and current.",
        "label": "Short-term Investments",
        "terseLabel": "Short-term investments"
       }
      }
     },
     "localname": "ShortTermInvestments",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://thecronosgroup.com/role/CondensedConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_StatementBusinessSegmentsAxis": {
     "auth_ref": [
      "r11",
      "r173",
      "r177",
      "r178",
      "r179",
      "r180",
      "r181",
      "r182",
      "r183",
      "r184",
      "r185",
      "r186",
      "r187",
      "r188",
      "r191",
      "r192",
      "r193",
      "r194",
      "r196",
      "r197",
      "r198",
      "r199",
      "r200",
      "r202",
      "r211",
      "r247",
      "r266",
      "r271",
      "r274",
      "r503"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by business segments.",
        "label": "Segments [Axis]",
        "terseLabel": "Segments [Axis]"
       }
      }
     },
     "localname": "StatementBusinessSegmentsAxis",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://thecronosgroup.com/role/SegmentInformationNarrativeDetails",
      "http://thecronosgroup.com/role/SegmentInformationScheduleofAdjustedEBITDADetails",
      "http://thecronosgroup.com/role/SegmentInformationScheduleofSegmentDataDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_StatementEquityComponentsAxis": {
     "auth_ref": [
      "r0",
      "r64",
      "r84",
      "r85",
      "r86",
      "r128",
      "r129",
      "r130",
      "r132",
      "r139",
      "r142",
      "r166",
      "r228",
      "r309",
      "r311",
      "r354",
      "r355",
      "r356",
      "r361",
      "r362",
      "r407",
      "r432",
      "r433",
      "r434",
      "r435",
      "r436",
      "r438",
      "r509",
      "r510",
      "r511",
      "r546"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by component of equity.",
        "label": "Equity Components [Axis]",
        "terseLabel": "Equity Components [Axis]"
       }
      }
     },
     "localname": "StatementEquityComponentsAxis",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://thecronosgroup.com/role/CondensedConsolidatedStatementsofChangesinEquity"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_StatementLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Statement [Line Items]",
        "terseLabel": "Statement [Line Items]"
       }
      }
     },
     "localname": "StatementLineItems",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://thecronosgroup.com/role/CondensedConsolidatedStatementsofChangesinEquity"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_StatementOfCashFlowsAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Statement of Cash Flows [Abstract]",
        "terseLabel": "Statement of Cash Flows [Abstract]"
       }
      }
     },
     "localname": "StatementOfCashFlowsAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_StatementOfFinancialPositionAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Statement of Financial Position [Abstract]",
        "terseLabel": "Statement of Financial Position [Abstract]"
       }
      }
     },
     "localname": "StatementOfFinancialPositionAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Statement of Comprehensive Income [Abstract]",
        "terseLabel": "Statement of Comprehensive Income [Abstract]"
       }
      }
     },
     "localname": "StatementOfIncomeAndComprehensiveIncomeAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://thecronosgroup.com/role/CondensedConsolidatedStatementsofNetIncomeLossandComprehensiveIncomeLoss"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_StatementOfStockholdersEquityAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Statement of Stockholders' Equity [Abstract]",
        "terseLabel": "Statement of Stockholders' Equity [Abstract]"
       }
      }
     },
     "localname": "StatementOfStockholdersEquityAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_StatementTable": {
     "auth_ref": [
      "r128",
      "r129",
      "r130",
      "r166",
      "r462"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Schedule reflecting a Statement of Income, Statement of Cash Flows, Statement of Financial Position, Statement of Shareholders' Equity and Other Comprehensive Income, or other statement as needed.",
        "label": "Statement [Table]",
        "terseLabel": "Statement [Table]"
       }
      }
     },
     "localname": "StatementTable",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://thecronosgroup.com/role/CondensedConsolidatedStatementsofChangesinEquity"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_StockIssuedDuringPeriodSharesNewIssues": {
     "auth_ref": [
      "r38",
      "r39",
      "r309",
      "r311"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of new stock issued during the period.",
        "label": "Stock Issued During Period, Shares, New Issues",
        "terseLabel": "Shares issued (in shares)"
       }
      }
     },
     "localname": "StockIssuedDuringPeriodSharesNewIssues",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://thecronosgroup.com/role/DerivativeLiabilitiesNarrativeDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_StockIssuedDuringPeriodSharesRestrictedStockAwardNetOfForfeitures": {
     "auth_ref": [
      "r38",
      "r39",
      "r309",
      "r311"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of shares issued during the period related to Restricted Stock Awards, net of any shares forfeited.",
        "label": "Stock Issued During Period, Shares, Restricted Stock Award, Net of Forfeitures",
        "terseLabel": "Restricted share units settled (in shares)"
       }
      }
     },
     "localname": "StockIssuedDuringPeriodSharesRestrictedStockAwardNetOfForfeitures",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://thecronosgroup.com/role/CondensedConsolidatedStatementsofChangesinEquity"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised": {
     "auth_ref": [
      "r38",
      "r39",
      "r309",
      "r311",
      "r342"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of share options (or share units) exercised during the current period.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercises in Period",
        "negatedTerseLabel": "Exercise of options (in shares)",
        "terseLabel": "Options exercised (in shares)"
       }
      }
     },
     "localname": "StockIssuedDuringPeriodSharesStockOptionsExercised",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://thecronosgroup.com/role/CondensedConsolidatedStatementsofChangesinEquity",
      "http://thecronosgroup.com/role/SharebasedPaymentsSummaryoftheChangesinOptionsDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures": {
     "auth_ref": [
      "r309",
      "r311"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Value of stock related to Restricted Stock Awards issued during the period, net of the stock value of such awards forfeited.",
        "label": "Stock Issued During Period, Value, Restricted Stock Award, Net of Forfeitures",
        "terseLabel": "Restricted share units settled"
       }
      }
     },
     "localname": "StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://thecronosgroup.com/role/CondensedConsolidatedStatementsofChangesinEquity"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised": {
     "auth_ref": [
      "r64",
      "r309",
      "r311"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Value of stock issued as a result of the exercise of stock options.",
        "label": "Stock Issued During Period, Value, Stock Options Exercised",
        "terseLabel": "Options exercised"
       }
      }
     },
     "localname": "StockIssuedDuringPeriodValueStockOptionsExercised",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://thecronosgroup.com/role/CondensedConsolidatedStatementsofChangesinEquity"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_StockholdersEquity": {
     "auth_ref": [
      "r39",
      "r45",
      "r46",
      "r124",
      "r217",
      "r225",
      "r430",
      "r450"
     ],
     "calculation": {
      "http://thecronosgroup.com/role/CondensedConsolidatedBalanceSheets": {
       "order": 1.0,
       "parentTag": "us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Total of all stockholders' equity (deficit) items, net of receivables from officers, directors, owners, and affiliates of the entity which are attributable to the parent. The amount of the economic entity's stockholders' equity attributable to the parent excludes the amount of stockholders' equity which is allocable to that ownership interest in subsidiary equity which is not attributable to the parent (noncontrolling interest, minority interest). This excludes temporary equity and is sometimes called permanent equity.",
        "label": "Stockholders' Equity Attributable to Parent",
        "totalLabel": "Total equity attributable to shareholders of Cronos Group"
       }
      }
     },
     "localname": "StockholdersEquity",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://thecronosgroup.com/role/CondensedConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest": {
     "auth_ref": [
      "r0",
      "r1",
      "r85",
      "r124",
      "r128",
      "r129",
      "r130",
      "r132",
      "r139",
      "r225",
      "r228",
      "r311",
      "r354",
      "r355",
      "r356",
      "r361",
      "r362",
      "r366",
      "r367",
      "r387",
      "r407",
      "r430",
      "r432",
      "r433",
      "r438",
      "r510",
      "r511",
      "r546"
     ],
     "calculation": {
      "http://thecronosgroup.com/role/CondensedConsolidatedBalanceSheets": {
       "order": 1.0,
       "parentTag": "us-gaap_LiabilitiesAndStockholdersEquity",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of stockholders' equity (deficit), net of receivables from officers, directors, owners, and affiliates of the entity, attributable to both the parent and noncontrolling interests. Amount excludes temporary equity. Alternate caption for the concept is permanent equity.",
        "label": "Stockholders' Equity, Including Portion Attributable to Noncontrolling Interest",
        "periodEndLabel": "Ending balance",
        "periodStartLabel": "Beginning balance",
        "totalLabel": "Total shareholders\u2019 equity"
       }
      }
     },
     "localname": "StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://thecronosgroup.com/role/CondensedConsolidatedBalanceSheets",
      "http://thecronosgroup.com/role/CondensedConsolidatedStatementsofChangesinEquity"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterestAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Stockholders' Equity, Including Portion Attributable to Noncontrolling Interest [Abstract]",
        "terseLabel": "Stockholders' Equity, Including Portion Attributable to Noncontrolling Interest [Abstract]"
       }
      }
     },
     "localname": "StockholdersEquityIncludingPortionAttributableToNoncontrollingInterestAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://thecronosgroup.com/role/CondensedConsolidatedBalanceSheets"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_SubsidiarySaleOfStockAxis": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by type of sale of the entity's stock.",
        "label": "Sale of Stock [Axis]",
        "terseLabel": "Sale of Stock [Axis]"
       }
      }
     },
     "localname": "SubsidiarySaleOfStockAxis",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://thecronosgroup.com/role/DerivativeLiabilitiesNarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_SupplementalCashFlowInformationAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Supplemental Cash Flow Information [Abstract]",
        "terseLabel": "Supplemental cash flow information"
       }
      }
     },
     "localname": "SupplementalCashFlowInformationAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://thecronosgroup.com/role/CondensedConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_SupplierConcentrationRiskMember": {
     "auth_ref": [
      "r168"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Reflects the percentage that purchases in the period from one or more significant suppliers is to cost of goods or services, as defined by the entity, such as total cost of sales or services, product line cost of sales or services, segment cost of sales or services. Risk is the materially adverse effects of loss of a material supplier or a supplier of critically needed goods or services.",
        "label": "Supplier Concentration Risk [Member]",
        "terseLabel": "Supplier Concentration Risk"
       }
      }
     },
     "localname": "SupplierConcentrationRiskMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://thecronosgroup.com/role/FinancialInstrumentsLiquidityRiskNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_TradeNamesMember": {
     "auth_ref": [
      "r364"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Rights acquired through registration of a business name to gain or protect exclusive use thereof.",
        "label": "Trade Names [Member]",
        "terseLabel": "Lord Jones brand"
       }
      }
     },
     "localname": "TradeNamesMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://thecronosgroup.com/role/ImpairmentLossonLongLivedAssetsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_TypeOfArrangementAxis": {
     "auth_ref": [
      "r365"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by collaborative arrangement and arrangement other than collaborative applicable to revenue-generating activity or operations.",
        "label": "Collaborative Arrangement and Arrangement Other than Collaborative [Axis]",
        "terseLabel": "Collaborative Arrangement and Arrangement Other than Collaborative [Axis]"
       }
      }
     },
     "localname": "TypeOfArrangementAxis",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://thecronosgroup.com/role/InvestmentsNarrativeDetails",
      "http://thecronosgroup.com/role/LoansReceivablenetDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_UnfavorableRegulatoryActionMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "A enacted or proposed action, ruling or regulation that is likely to or possibly will have an adverse effect on the entity's financial position or results of operations, excluding tax matters.",
        "label": "Unfavorable Regulatory Action [Member]",
        "terseLabel": "Litigation Relating to Marketing, Distribution and Sale of Products"
       }
      }
     },
     "localname": "UnfavorableRegulatoryActionMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://thecronosgroup.com/role/CommitmentsandContingenciesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_VariableInterestEntityEntityMaximumLossExposureAmount": {
     "auth_ref": [
      "r380",
      "r384"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The reporting entity's maximum amount of exposure to loss as a result of its involvement with the Variable Interest Entity (VIE).",
        "label": "Variable Interest Entity, Reporting Entity Involvement, Maximum Loss Exposure, Amount",
        "terseLabel": "Maximum Exposure to Loss"
       }
      }
     },
     "localname": "VariableInterestEntityEntityMaximumLossExposureAmount",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://thecronosgroup.com/role/InvestmentsScheduleofVariableInterestEntitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_VariableInterestEntityLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Variable Interest Entity [Line Items]",
        "terseLabel": "Variable Interest Entity [Line Items]"
       }
      }
     },
     "localname": "VariableInterestEntityLineItems",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://thecronosgroup.com/role/InvestmentsNarrativeDetails",
      "http://thecronosgroup.com/role/InvestmentsScheduleofVariableInterestEntitiesDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_VariableInterestEntityNotPrimaryBeneficiaryMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Variable Interest Entities (VIE) in which the entity does not have a controlling financial interest (as defined) and of which it is therefore not the primary beneficiary. VIEs of which the entity is not the primary beneficiary because it does not have the power to direct the activities of the VIE that most significantly impact the VIE's economic performance and for which it does not have the obligation to absorb losses of the VIE that could potentially be significant to the VIE or the right to receive benefits from the VIE that could potentially be significant to the VIE are not included in the consolidated financial statements of the entity.",
        "label": "Variable Interest Entity, Not Primary Beneficiary [Member]",
        "terseLabel": "Variable Interest Entity, Not Primary Beneficiary"
       }
      }
     },
     "localname": "VariableInterestEntityNotPrimaryBeneficiaryMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://thecronosgroup.com/role/InvestmentsNarrativeDetails",
      "http://thecronosgroup.com/role/InvestmentsScheduleofVariableInterestEntitiesDetails",
      "http://thecronosgroup.com/role/LoansReceivablenetDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_VariableInterestEntityOwnershipPercentage": {
     "auth_ref": [
      "r382"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Percentage of the Variable Interest Entity's (VIE) voting interest owned by (or beneficial interest in) the reporting entity (directly or indirectly).",
        "label": "Variable Interest Entity, Qualitative or Quantitative Information, Ownership Percentage",
        "terseLabel": "Ownership percentage",
        "verboseLabel": "Ownership interest"
       }
      }
     },
     "localname": "VariableInterestEntityOwnershipPercentage",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://thecronosgroup.com/role/InvestmentsNarrativeDetails",
      "http://thecronosgroup.com/role/InvestmentsScheduleofVariableInterestEntitiesDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "us-gaap_WarrantMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Security that gives the holder the right to purchase shares of stock in accordance with the terms of the instrument, usually upon payment of a specified amount.",
        "label": "Warrant [Member]",
        "terseLabel": "Warrants"
       }
      }
     },
     "localname": "WarrantMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://thecronosgroup.com/role/EarningsLossPerShareScheduleofAntidilutiveSecuritiesExcludedfromComputationofDilutedSharesOutstandingDetails",
      "http://thecronosgroup.com/role/EarningsLossPerShareScheduleofEarningsLossPerShareDetails",
      "http://thecronosgroup.com/role/SharebasedPaymentsSummaryofChangesinWarrantsDetails",
      "http://thecronosgroup.com/role/SharebasedPaymentsSummaryofOutstandingWarrantsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding": {
     "auth_ref": [
      "r146",
      "r158"
     ],
     "calculation": {
      "http://thecronosgroup.com/role/EarningsLossPerShareScheduleofEarningsLossPerShareDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The average number of shares or units issued and outstanding that are used in calculating diluted EPS or earnings per unit (EPU), determined based on the timing of issuance of shares or units in the period.",
        "label": "Weighted Average Number of Shares Outstanding, Diluted",
        "terseLabel": "Diluted (in shares)",
        "totalLabel": "Weighted average number of common shares for computation of diluted earnings (loss) from continuing operations per share (in shares)",
        "verboseLabel": "Weighted average number of common shares for computation of diluted loss from discontinued operations per share (in shares)"
       }
      }
     },
     "localname": "WeightedAverageNumberOfDilutedSharesOutstanding",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://thecronosgroup.com/role/CondensedConsolidatedStatementsofNetIncomeLossandComprehensiveIncomeLoss",
      "http://thecronosgroup.com/role/EarningsLossPerShareScheduleofEarningsLossPerShareDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_WeightedAverageNumberOfSharesOutstandingBasic": {
     "auth_ref": [
      "r144",
      "r158"
     ],
     "calculation": {
      "http://thecronosgroup.com/role/EarningsLossPerShareScheduleofEarningsLossPerShareDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding",
       "weight": 1.0
      }
     },
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of [basic] shares or units, after adjustment for contingently issuable shares or units and other shares or units not deemed outstanding, determined by relating the portion of time within a reporting period that common shares or units have been outstanding to the total time in that period.",
        "label": "Weighted Average Number of Shares Outstanding, Basic",
        "terseLabel": "Weighted average number of common shares outstanding (in shares)",
        "verboseLabel": "Basic (in shares)"
       }
      }
     },
     "localname": "WeightedAverageNumberOfSharesOutstandingBasic",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://thecronosgroup.com/role/CondensedConsolidatedStatementsofNetIncomeLossandComprehensiveIncomeLoss",
      "http://thecronosgroup.com/role/EarningsLossPerShareScheduleofEarningsLossPerShareDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_WeightedAverageNumberOfSharesOutstandingDilutedDisclosureItemsAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Weighted Average Number of Shares Outstanding Reconciliation [Abstract]",
        "terseLabel": "Diluted earnings (loss) per share computation"
       }
      }
     },
     "localname": "WeightedAverageNumberOfSharesOutstandingDilutedDisclosureItemsAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://thecronosgroup.com/role/EarningsLossPerShareScheduleofEarningsLossPerShareDetails"
     ],
     "xbrltype": "stringItemType"
    }
   },
   "unitCount": 15
  }
 },
 "std_ref": {
  "r0": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "105",
   "URI": "http://asc.fasb.org/extlink&oid=124434974&loc=SL124442142-165695"
  },
  "r1": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "105",
   "URI": "http://asc.fasb.org/extlink&oid=124434974&loc=SL124442142-165695"
  },
  "r10": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "205",
   "URI": "http://asc.fasb.org/extlink&oid=109222650&loc=d3e1361-107760"
  },
  "r100": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03.1,2)",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=123367319&loc=SL114868664-224227"
  },
  "r101": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03.4)",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=123367319&loc=SL114868664-224227"
  },
  "r102": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03.7(b))",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=123367319&loc=SL114868664-224227"
  },
  "r103": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03.7)",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=123367319&loc=SL114868664-224227"
  },
  "r104": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03.9)",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=123367319&loc=SL114868664-224227"
  },
  "r105": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "12",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=123570139&loc=d3e3179-108585"
  },
  "r106": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "12",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=123570139&loc=d3e3179-108585"
  },
  "r107": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=123570139&loc=d3e3213-108585"
  },
  "r108": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=123570139&loc=d3e3213-108585"
  },
  "r109": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=123570139&loc=d3e3213-108585"
  },
  "r11": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)",
   "Topic": "205",
   "URI": "http://asc.fasb.org/extlink&oid=109222650&loc=d3e1361-107760"
  },
  "r110": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "14",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=123570139&loc=d3e3255-108585"
  },
  "r111": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=123570139&loc=d3e3291-108585"
  },
  "r112": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=123570139&loc=d3e3291-108585"
  },
  "r113": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "17",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=123570139&loc=d3e3367-108585"
  },
  "r114": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=123570139&loc=d3e3000-108585"
  },
  "r115": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "24",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=123570139&loc=d3e3521-108585"
  },
  "r116": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "25",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(e)",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=123570139&loc=d3e3536-108585"
  },
  "r117": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "25",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=123570139&loc=d3e3536-108585"
  },
  "r118": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "28",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=123570139&loc=d3e3602-108585"
  },
  "r119": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "28",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=123570139&loc=d3e3602-108585"
  },
  "r12": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "205",
   "URI": "http://asc.fasb.org/extlink&oid=109222650&loc=d3e1361-107760"
  },
  "r120": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "28",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=123570139&loc=d3e3602-108585"
  },
  "r121": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=123570139&loc=d3e3044-108585"
  },
  "r122": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=123431023&loc=d3e4297-108586"
  },
  "r123": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=123431023&loc=SL98516268-108586"
  },
  "r124": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.4-08(g)(1)(ii))",
   "Topic": "235",
   "URI": "http://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690"
  },
  "r125": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.4-08(k)(1))",
   "Topic": "235",
   "URI": "http://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690"
  },
  "r126": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.12-04(a))",
   "Topic": "235",
   "URI": "http://asc.fasb.org/extlink&oid=120395691&loc=d3e24072-122690"
  },
  "r127": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "235",
   "URI": "http://asc.fasb.org/topic&trid=2122369"
  },
  "r128": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "23",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "250",
   "URI": "http://asc.fasb.org/extlink&oid=124436220&loc=d3e21914-107793"
  },
  "r129": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "24",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "250",
   "URI": "http://asc.fasb.org/extlink&oid=124436220&loc=d3e21930-107793"
  },
  "r13": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "205",
   "URI": "http://asc.fasb.org/extlink&oid=109222650&loc=d3e1474-107760"
  },
  "r130": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "250",
   "URI": "http://asc.fasb.org/extlink&oid=124436220&loc=d3e21711-107793"
  },
  "r131": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)(2)",
   "Topic": "250",
   "URI": "http://asc.fasb.org/extlink&oid=124431687&loc=d3e22499-107794"
  },
  "r132": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)(3)",
   "Topic": "250",
   "URI": "http://asc.fasb.org/extlink&oid=124431687&loc=d3e22499-107794"
  },
  "r133": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "11",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "250",
   "URI": "http://asc.fasb.org/extlink&oid=124431687&loc=d3e22694-107794"
  },
  "r134": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "11",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "250",
   "URI": "http://asc.fasb.org/extlink&oid=124431687&loc=d3e22694-107794"
  },
  "r135": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "12",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "250",
   "URI": "http://asc.fasb.org/extlink&oid=124431687&loc=SL124452830-107794"
  },
  "r136": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "250",
   "URI": "http://asc.fasb.org/extlink&oid=124431687&loc=d3e22583-107794"
  },
  "r137": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "250",
   "URI": "http://asc.fasb.org/extlink&oid=124431687&loc=d3e22595-107794"
  },
  "r138": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "250",
   "URI": "http://asc.fasb.org/extlink&oid=124431687&loc=d3e22644-107794"
  },
  "r139": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "250",
   "URI": "http://asc.fasb.org/extlink&oid=124431687&loc=d3e22644-107794"
  },
  "r14": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "205",
   "URI": "http://asc.fasb.org/extlink&oid=109222650&loc=SL51721659-107760"
  },
  "r140": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "250",
   "URI": "http://asc.fasb.org/extlink&oid=124431687&loc=d3e22644-107794"
  },
  "r141": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "250",
   "URI": "http://asc.fasb.org/extlink&oid=124431687&loc=d3e22658-107794"
  },
  "r142": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "9",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "250",
   "URI": "http://asc.fasb.org/extlink&oid=124431687&loc=d3e22663-107794"
  },
  "r143": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB Topic 11.M.Q2)",
   "Topic": "250",
   "URI": "http://asc.fasb.org/extlink&oid=122038215&loc=d3e31137-122693"
  },
  "r144": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "260",
   "URI": "http://asc.fasb.org/extlink&oid=125511455&loc=d3e1448-109256"
  },
  "r145": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "11",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "260",
   "URI": "http://asc.fasb.org/extlink&oid=125511455&loc=d3e1377-109256"
  },
  "r146": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "16",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "260",
   "URI": "http://asc.fasb.org/extlink&oid=125511455&loc=d3e1505-109256"
  },
  "r147": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "260",
   "URI": "http://asc.fasb.org/extlink&oid=125511455&loc=d3e1252-109256"
  },
  "r148": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "22",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "260",
   "URI": "http://asc.fasb.org/extlink&oid=125511455&loc=d3e1707-109256"
  },
  "r149": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "23",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "260",
   "URI": "http://asc.fasb.org/extlink&oid=125511455&loc=d3e1757-109256"
  },
  "r15": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "205",
   "URI": "http://asc.fasb.org/extlink&oid=109222650&loc=SL51721663-107760"
  },
  "r150": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "28A",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "260",
   "URI": "http://asc.fasb.org/extlink&oid=125511455&loc=d3e1500-109256"
  },
  "r151": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "260",
   "URI": "http://asc.fasb.org/extlink&oid=125511455&loc=d3e1278-109256"
  },
  "r152": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "40",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)(1)",
   "Topic": "260",
   "URI": "http://asc.fasb.org/extlink&oid=125511455&loc=d3e1930-109256"
  },
  "r153": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "40",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)(2)",
   "Topic": "260",
   "URI": "http://asc.fasb.org/extlink&oid=125511455&loc=d3e1930-109256"
  },
  "r154": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "40",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)(3)",
   "Topic": "260",
   "URI": "http://asc.fasb.org/extlink&oid=125511455&loc=d3e1930-109256"
  },
  "r155": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "60B",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "260",
   "URI": "http://asc.fasb.org/extlink&oid=125511455&loc=SL5780133-109256"
  },
  "r156": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "60B",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "260",
   "URI": "http://asc.fasb.org/extlink&oid=125511455&loc=SL5780133-109256"
  },
  "r157": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "260",
   "URI": "http://asc.fasb.org/extlink&oid=125511455&loc=d3e1337-109256"
  },
  "r158": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "260",
   "URI": "http://asc.fasb.org/extlink&oid=124432515&loc=d3e3550-109257"
  },
  "r159": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "260",
   "URI": "http://asc.fasb.org/extlink&oid=124432515&loc=d3e3550-109257"
  },
  "r16": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "205",
   "URI": "http://asc.fasb.org/extlink&oid=109222650&loc=SL51721665-107760"
  },
  "r160": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "260",
   "URI": "http://asc.fasb.org/extlink&oid=124432515&loc=d3e3550-109257"
  },
  "r161": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "260",
   "URI": "http://asc.fasb.org/extlink&oid=124432515&loc=d3e3630-109257"
  },
  "r162": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "260",
   "URI": "http://asc.fasb.org/extlink&oid=109243012&loc=SL65017193-207537"
  },
  "r163": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Topic": "260",
   "URI": "http://asc.fasb.org/extlink&oid=125512782&loc=d3e3842-109258"
  },
  "r164": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "52",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Topic": "260",
   "URI": "http://asc.fasb.org/extlink&oid=125512782&loc=d3e4984-109258"
  },
  "r165": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "260",
   "URI": "http://asc.fasb.org/topic&trid=2144383"
  },
  "r166": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "272",
   "URI": "http://asc.fasb.org/extlink&oid=125520817&loc=d3e70191-108054"
  },
  "r167": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "16",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "275",
   "URI": "http://asc.fasb.org/extlink&oid=99393423&loc=d3e6327-108592"
  },
  "r168": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "18",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "275",
   "URI": "http://asc.fasb.org/extlink&oid=99393423&loc=d3e6351-108592"
  },
  "r169": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "18",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "275",
   "URI": "http://asc.fasb.org/extlink&oid=99393423&loc=d3e6351-108592"
  },
  "r17": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "205",
   "URI": "http://asc.fasb.org/extlink&oid=109222650&loc=SL51721671-107760"
  },
  "r170": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "20",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "275",
   "URI": "http://asc.fasb.org/extlink&oid=99393423&loc=d3e6404-108592"
  },
  "r171": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "21",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "275",
   "URI": "http://asc.fasb.org/extlink&oid=99393423&loc=d3e6442-108592"
  },
  "r172": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "275",
   "URI": "http://asc.fasb.org/topic&trid=2134479"
  },
  "r173": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8657-108599"
  },
  "r174": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "18",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8672-108599"
  },
  "r175": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "21",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8721-108599"
  },
  "r176": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "21",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8721-108599"
  },
  "r177": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "22",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8736-108599"
  },
  "r178": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "22",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8736-108599"
  },
  "r179": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "22",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8736-108599"
  },
  "r18": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(e)",
   "Topic": "205",
   "URI": "http://asc.fasb.org/extlink&oid=109222650&loc=SL51721673-107760"
  },
  "r180": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "22",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8736-108599"
  },
  "r181": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "22",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(e)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8736-108599"
  },
  "r182": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "22",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(f)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8736-108599"
  },
  "r183": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "22",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(g)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8736-108599"
  },
  "r184": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "22",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(h)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8736-108599"
  },
  "r185": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "22",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(j)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8736-108599"
  },
  "r186": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "22",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8736-108599"
  },
  "r187": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "25",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8813-108599"
  },
  "r188": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "25",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8813-108599"
  },
  "r189": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "25",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8813-108599"
  },
  "r19": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "205",
   "URI": "http://asc.fasb.org/extlink&oid=109222650&loc=SL51721673-107760"
  },
  "r190": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "26",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8844-108599"
  },
  "r191": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "30",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8906-108599"
  },
  "r192": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "30",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8906-108599"
  },
  "r193": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "30",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8906-108599"
  },
  "r194": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "30",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8906-108599"
  },
  "r195": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "30",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8906-108599"
  },
  "r196": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "31",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8924-108599"
  },
  "r197": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "32",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8933-108599"
  },
  "r198": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "32",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8933-108599"
  },
  "r199": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "32",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8933-108599"
  },
  "r2": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "20",
   "Topic": "205",
   "URI": "http://asc.fasb.org/extlink&oid=109222160&loc=d3e1107-107759"
  },
  "r20": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5C",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)(2)",
   "Topic": "205",
   "URI": "http://asc.fasb.org/extlink&oid=109222650&loc=SL51721675-107760"
  },
  "r200": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "32",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8933-108599"
  },
  "r201": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "32",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(e)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8933-108599"
  },
  "r202": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "32",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(f)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8933-108599"
  },
  "r203": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "34",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8981-108599"
  },
  "r204": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8475-108599"
  },
  "r205": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "40",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e9031-108599"
  },
  "r206": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "41",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e9038-108599"
  },
  "r207": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "41",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e9038-108599"
  },
  "r208": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "41",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "a",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e9038-108599"
  },
  "r209": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "41",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "b",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e9038-108599"
  },
  "r21": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5C",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)(2)",
   "Topic": "205",
   "URI": "http://asc.fasb.org/extlink&oid=109222650&loc=SL51721675-107760"
  },
  "r210": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "41",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e9038-108599"
  },
  "r211": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "42",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e9054-108599"
  },
  "r212": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "280",
   "URI": "http://asc.fasb.org/topic&trid=2134510"
  },
  "r213": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "310",
   "URI": "http://asc.fasb.org/extlink&oid=124259787&loc=d3e4428-111522"
  },
  "r214": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "9",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "310",
   "URI": "http://asc.fasb.org/extlink&oid=124259787&loc=d3e4531-111522"
  },
  "r215": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "11B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(1)",
   "Topic": "310",
   "URI": "http://asc.fasb.org/extlink&oid=123577603&loc=SL6953423-111524"
  },
  "r216": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "310",
   "URI": "http://asc.fasb.org/extlink&oid=123577603&loc=d3e5074-111524"
  },
  "r217": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB Topic 4.E)",
   "Topic": "310",
   "URI": "http://asc.fasb.org/extlink&oid=122038336&loc=d3e74512-122707"
  },
  "r218": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "SubTopic": "10",
   "Topic": "310",
   "URI": "http://asc.fasb.org/subtopic&trid=2196772"
  },
  "r219": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "320",
   "URI": "http://asc.fasb.org/extlink&oid=124260329&loc=d3e26610-111562"
  },
  "r22": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5C",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "205",
   "URI": "http://asc.fasb.org/extlink&oid=109222650&loc=SL51721675-107760"
  },
  "r220": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "11",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "320",
   "URI": "http://asc.fasb.org/extlink&oid=124260329&loc=d3e26853-111562"
  },
  "r221": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(aa)",
   "Topic": "320",
   "URI": "http://asc.fasb.org/extlink&oid=123581744&loc=d3e27161-111563"
  },
  "r222": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "323",
   "URI": "http://asc.fasb.org/extlink&oid=109237563&loc=d3e33749-111570"
  },
  "r223": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)(1)",
   "Topic": "323",
   "URI": "http://asc.fasb.org/extlink&oid=114001798&loc=d3e33918-111571"
  },
  "r224": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)(b)",
   "Topic": "323",
   "URI": "http://asc.fasb.org/extlink&oid=114001798&loc=d3e33918-111571"
  },
  "r225": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "323",
   "URI": "http://asc.fasb.org/extlink&oid=114001798&loc=d3e33918-111571"
  },
  "r226": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "323",
   "URI": "http://asc.fasb.org/extlink&oid=114001798&loc=d3e33918-111571"
  },
  "r227": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "323",
   "URI": "http://asc.fasb.org/topic&trid=2196965"
  },
  "r228": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "326",
   "URI": "http://asc.fasb.org/extlink&oid=122640432&loc=SL121648383-210437"
  },
  "r229": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(e)(3)",
   "Topic": "326",
   "URI": "http://asc.fasb.org/extlink&oid=122640432&loc=SL121648383-210437"
  },
  "r23": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5D",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "205",
   "URI": "http://asc.fasb.org/extlink&oid=109222650&loc=SL51721677-107760"
  },
  "r230": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(e)(4)",
   "Topic": "326",
   "URI": "http://asc.fasb.org/extlink&oid=122640432&loc=SL121648383-210437"
  },
  "r231": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "20",
   "Topic": "326",
   "URI": "http://asc.fasb.org/extlink&oid=124255206&loc=SL82895884-210446"
  },
  "r232": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "326",
   "URI": "http://asc.fasb.org/extlink&oid=124255953&loc=SL82919249-210447"
  },
  "r233": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "326",
   "URI": "http://asc.fasb.org/extlink&oid=124255953&loc=SL82919249-210447"
  },
  "r234": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(f)",
   "Topic": "326",
   "URI": "http://asc.fasb.org/extlink&oid=124255953&loc=SL82919249-210447"
  },
  "r235": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "14",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "326",
   "URI": "http://asc.fasb.org/extlink&oid=124255953&loc=SL82919253-210447"
  },
  "r236": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "326",
   "URI": "http://asc.fasb.org/extlink&oid=124255953&loc=SL120267963-210447"
  },
  "r237": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "326",
   "URI": "http://asc.fasb.org/extlink&oid=124255953&loc=SL82919230-210447"
  },
  "r238": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Topic": "326",
   "URI": "http://asc.fasb.org/extlink&oid=124258926&loc=SL82898722-210454"
  },
  "r239": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "330",
   "URI": "http://asc.fasb.org/extlink&oid=116847112&loc=d3e4542-108314"
  },
  "r24": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "205",
   "URI": "http://asc.fasb.org/extlink&oid=109222650&loc=SL51721683-107760"
  },
  "r240": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB TOPIC 5.BB)",
   "Topic": "330",
   "URI": "http://asc.fasb.org/extlink&oid=27011343&loc=d3e100047-122729"
  },
  "r241": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB Topic 5.BB)",
   "Topic": "330",
   "URI": "http://asc.fasb.org/extlink&oid=27011343&loc=d3e100047-122729"
  },
  "r242": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "330",
   "URI": "http://asc.fasb.org/topic&trid=2126998"
  },
  "r243": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "20",
   "Topic": "350",
   "URI": "http://asc.fasb.org/extlink&oid=99380562&loc=d3e13770-109266"
  },
  "r244": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "20",
   "Topic": "350",
   "URI": "http://asc.fasb.org/extlink&oid=99380562&loc=d3e13777-109266"
  },
  "r245": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "20",
   "Topic": "350",
   "URI": "http://asc.fasb.org/extlink&oid=120320667&loc=SL49117168-202975"
  },
  "r246": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(e)",
   "Topic": "350",
   "URI": "http://asc.fasb.org/extlink&oid=121556970&loc=d3e13816-109267"
  },
  "r247": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "350",
   "URI": "http://asc.fasb.org/extlink&oid=121556970&loc=d3e13816-109267"
  },
  "r248": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "350",
   "URI": "http://asc.fasb.org/extlink&oid=121556970&loc=SL108378252-109267"
  },
  "r249": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "350",
   "URI": "http://asc.fasb.org/extlink&oid=121556970&loc=d3e13854-109267"
  },
  "r25": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "SubTopic": "20",
   "Topic": "205",
   "URI": "http://asc.fasb.org/subtopic&trid=2122178"
  },
  "r250": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Topic": "350",
   "URI": "http://asc.fasb.org/extlink&oid=6388964&loc=d3e16212-109274"
  },
  "r251": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(b)",
   "Topic": "350",
   "URI": "http://asc.fasb.org/extlink&oid=66006027&loc=d3e16265-109275"
  },
  "r252": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "((a)(1),(b))",
   "Topic": "350",
   "URI": "http://asc.fasb.org/extlink&oid=66006027&loc=d3e16323-109275"
  },
  "r253": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(b)",
   "Topic": "350",
   "URI": "http://asc.fasb.org/extlink&oid=66006027&loc=d3e16323-109275"
  },
  "r254": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(b)",
   "Topic": "350",
   "URI": "http://asc.fasb.org/extlink&oid=66006027&loc=d3e16373-109275"
  },
  "r255": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(b),(d)",
   "Topic": "350",
   "URI": "http://asc.fasb.org/extlink&oid=66006027&loc=d3e16373-109275"
  },
  "r256": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "15",
   "SubTopic": "10",
   "Subparagraph": "(b)(2)",
   "Topic": "360",
   "URI": "http://asc.fasb.org/extlink&oid=123398962&loc=d3e400-110220"
  },
  "r257": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "11",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "360",
   "URI": "http://asc.fasb.org/extlink&oid=123351718&loc=d3e2510-110228"
  },
  "r258": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "14",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "360",
   "URI": "http://asc.fasb.org/extlink&oid=123351718&loc=d3e2599-110228"
  },
  "r259": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "360",
   "URI": "http://asc.fasb.org/extlink&oid=123351718&loc=d3e2611-110228"
  },
  "r26": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=124098289&loc=d3e6676-107765"
  },
  "r260": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "360",
   "URI": "http://asc.fasb.org/extlink&oid=123351718&loc=d3e2420-110228"
  },
  "r261": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "360",
   "URI": "http://asc.fasb.org/extlink&oid=123351718&loc=d3e2443-110228"
  },
  "r262": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "360",
   "URI": "http://asc.fasb.org/extlink&oid=6391035&loc=d3e2868-110229"
  },
  "r263": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "360",
   "URI": "http://asc.fasb.org/extlink&oid=6391035&loc=d3e2868-110229"
  },
  "r264": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "360",
   "URI": "http://asc.fasb.org/extlink&oid=109226691&loc=d3e2941-110230"
  },
  "r265": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(e)",
   "Topic": "360",
   "URI": "http://asc.fasb.org/extlink&oid=109226691&loc=d3e2941-110230"
  },
  "r266": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(f)",
   "Topic": "360",
   "URI": "http://asc.fasb.org/extlink&oid=109226691&loc=d3e2941-110230"
  },
  "r267": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "360",
   "URI": "http://asc.fasb.org/extlink&oid=109226691&loc=d3e2941-110230"
  },
  "r268": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "360",
   "URI": "http://asc.fasb.org/extlink&oid=109226691&loc=SL51724579-110230"
  },
  "r269": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "360",
   "URI": "http://asc.fasb.org/topic&trid=2155823"
  },
  "r27": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=124098289&loc=d3e6676-107765"
  },
  "r270": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "420",
   "URI": "http://asc.fasb.org/extlink&oid=109237686&loc=d3e17752-110868"
  },
  "r271": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "420",
   "URI": "http://asc.fasb.org/extlink&oid=6394359&loc=d3e17939-110869"
  },
  "r272": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB Topic 5.P.3)",
   "Topic": "420",
   "URI": "http://asc.fasb.org/extlink&oid=115931487&loc=d3e140864-122747"
  },
  "r273": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB Topic 5.P.4(b)(1))",
   "Topic": "420",
   "URI": "http://asc.fasb.org/extlink&oid=115931487&loc=d3e140904-122747"
  },
  "r274": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB Topic 5.P.4(d))",
   "Topic": "420",
   "URI": "http://asc.fasb.org/extlink&oid=115931487&loc=d3e140904-122747"
  },
  "r275": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "450",
   "URI": "http://asc.fasb.org/extlink&oid=121557415&loc=d3e14326-108349"
  },
  "r276": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "450",
   "URI": "http://asc.fasb.org/extlink&oid=121557415&loc=d3e14615-108349"
  },
  "r277": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "450",
   "URI": "http://asc.fasb.org/extlink&oid=121557415&loc=d3e14394-108349"
  },
  "r278": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "450",
   "URI": "http://asc.fasb.org/extlink&oid=121557415&loc=d3e14435-108349"
  },
  "r279": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "450",
   "URI": "http://asc.fasb.org/extlink&oid=121557415&loc=d3e14435-108349"
  },
  "r28": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=124098289&loc=d3e6676-107765"
  },
  "r280": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "450",
   "URI": "http://asc.fasb.org/extlink&oid=121557415&loc=d3e14453-108349"
  },
  "r281": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "450",
   "URI": "http://asc.fasb.org/extlink&oid=121557415&loc=d3e14472-108349"
  },
  "r282": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "9",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "450",
   "URI": "http://asc.fasb.org/extlink&oid=121557415&loc=d3e14557-108349"
  },
  "r283": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "9",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "450",
   "URI": "http://asc.fasb.org/extlink&oid=121557415&loc=d3e14557-108349"
  },
  "r284": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "SubTopic": "20",
   "Topic": "450",
   "URI": "http://asc.fasb.org/subtopic&trid=2127163"
  },
  "r285": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "SubTopic": "30",
   "Topic": "450",
   "URI": "http://asc.fasb.org/subtopic&trid=2127197"
  },
  "r286": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "460",
   "URI": "http://asc.fasb.org/extlink&oid=124440162&loc=d3e12021-110248"
  },
  "r287": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "460",
   "URI": "http://asc.fasb.org/extlink&oid=124440162&loc=d3e12053-110248"
  },
  "r288": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-01(a)(4)(i))",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=124359900&loc=SL124442526-122756"
  },
  "r289": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-01(a)(4)(ii))",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=124359900&loc=SL124442526-122756"
  },
  "r29": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(e)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=124098289&loc=d3e6676-107765"
  },
  "r290": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-01(a)(4)(iii)(A))",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=124359900&loc=SL124442526-122756"
  },
  "r291": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-01(a)(4)(iii)(B))",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=124359900&loc=SL124442526-122756"
  },
  "r292": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-01(a)(4)(iii))",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=124359900&loc=SL124442526-122756"
  },
  "r293": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-01(a)(4)(iv))",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=124359900&loc=SL124442526-122756"
  },
  "r294": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-01(a)(5))",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=124359900&loc=SL124442526-122756"
  },
  "r295": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-02(a)(4)(i))",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=124359900&loc=SL124442552-122756"
  },
  "r296": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-02(a)(4)(iii)(A)",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=124359900&loc=SL124442552-122756"
  },
  "r297": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-02(a)(4)(iii)(A))",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=124359900&loc=SL124442552-122756"
  },
  "r298": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-02(a)(4)(iii)(B)",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=124359900&loc=SL124442552-122756"
  },
  "r299": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-02(a)(4)(iii)(B))",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=124359900&loc=SL124442552-122756"
  },
  "r3": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "11",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "20",
   "Topic": "205",
   "URI": "http://asc.fasb.org/extlink&oid=109222160&loc=SL51721533-107759"
  },
  "r30": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=124098289&loc=d3e6676-107765"
  },
  "r300": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-02(a)(4)(iii)(C))",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=124359900&loc=SL124442552-122756"
  },
  "r301": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-02(a)(4)(iv))",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=124359900&loc=SL124442552-122756"
  },
  "r302": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-02(a)(5))",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=124359900&loc=SL124442552-122756"
  },
  "r303": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=123466505&loc=SL123495323-112611"
  },
  "r304": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=123466505&loc=SL123495323-112611"
  },
  "r305": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1D",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(c)",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=123466505&loc=SL123495340-112611"
  },
  "r306": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "69B",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "20",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=123466577&loc=SL123495735-112612"
  },
  "r307": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "69C",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "20",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=123466577&loc=SL123495737-112612"
  },
  "r308": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "505",
   "URI": "http://asc.fasb.org/extlink&oid=123467817&loc=SL123496158-112644"
  },
  "r309": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "505",
   "URI": "http://asc.fasb.org/extlink&oid=123467817&loc=d3e21463-112644"
  },
  "r31": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=124098289&loc=d3e6801-107765"
  },
  "r310": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "505",
   "URI": "http://asc.fasb.org/extlink&oid=123467817&loc=d3e21475-112644"
  },
  "r311": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.3-04)",
   "Topic": "505",
   "URI": "http://asc.fasb.org/extlink&oid=120397183&loc=d3e187085-122770"
  },
  "r312": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "50",
   "Topic": "505",
   "URI": "http://asc.fasb.org/extlink&oid=6784392&loc=d3e188667-122775"
  },
  "r313": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "606",
   "URI": "http://asc.fasb.org/extlink&oid=123351226&loc=SL49130543-203045"
  },
  "r314": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "606",
   "URI": "http://asc.fasb.org/extlink&oid=123351226&loc=SL49130545-203045"
  },
  "r315": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "91",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "606",
   "URI": "http://asc.fasb.org/extlink&oid=123410239&loc=SL49130690-203046-203046"
  },
  "r316": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "91",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "606",
   "URI": "http://asc.fasb.org/extlink&oid=123410239&loc=SL49130690-203046-203046"
  },
  "r317": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "91",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "606",
   "URI": "http://asc.fasb.org/extlink&oid=123410239&loc=SL49130690-203046-203046"
  },
  "r318": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)(i)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920"
  },
  "r319": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)(ii)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920"
  },
  "r32": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=124098289&loc=d3e6812-107765"
  },
  "r320": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)(iv)(01)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920"
  },
  "r321": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)(iv)(02)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920"
  },
  "r322": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)(iv)(02)(A)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920"
  },
  "r323": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)(iv)(02)(B)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920"
  },
  "r324": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)(iv)(02)(C)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920"
  },
  "r325": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)(iv)(03)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920"
  },
  "r326": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(n)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920"
  },
  "r327": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "17",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "20",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=123450688&loc=d3e4179-114921"
  },
  "r328": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "11",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "80",
   "Subparagraph": "(a)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=65877416&loc=SL14450702-114947"
  },
  "r329": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "80",
   "Subparagraph": "(d)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=65877416&loc=SL14450657-114947"
  },
  "r33": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=6361739&loc=d3e7789-107766"
  },
  "r330": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "80",
   "Subparagraph": "(a)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=65877416&loc=SL14450673-114947"
  },
  "r331": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "80",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=35742348&loc=SL14450788-114948"
  },
  "r332": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5047-113901"
  },
  "r333": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5047-113901"
  },
  "r334": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5047-113901"
  },
  "r335": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)(1)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
  },
  "r336": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)(2)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
  },
  "r337": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a),(g)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
  },
  "r338": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(1)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
  },
  "r339": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(1)(i)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
  },
  "r34": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(19)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r340": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(1)(i)-(ii)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
  },
  "r341": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(1)(iii)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
  },
  "r342": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(1)(iv)(2)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
  },
  "r343": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(1)(iv)(3)-(4)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
  },
  "r344": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(2)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
  },
  "r345": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(2)(i)-(ii)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
  },
  "r346": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(2)(iii)(1)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
  },
  "r347": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(2)(iii)(2)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
  },
  "r348": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(e)(1)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
  },
  "r349": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(e)(2)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
  },
  "r35": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(13))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r350": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(g)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
  },
  "r351": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(h)(1)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
  },
  "r352": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(h)(1)(i)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
  },
  "r353": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
  },
  "r354": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(e)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=121322162&loc=SL121327923-165333"
  },
  "r355": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(f)(1)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=121322162&loc=SL121327923-165333"
  },
  "r356": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(f)(2)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=121322162&loc=SL121327923-165333"
  },
  "r357": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(g)(2)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=121322162&loc=SL121327923-165333"
  },
  "r358": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB Topic 14.F)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=122041274&loc=d3e301413-122809"
  },
  "r359": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "718",
   "URI": "http://asc.fasb.org/topic&trid=2228938"
  },
  "r36": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(14))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r360": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "730",
   "URI": "http://asc.fasb.org/extlink&oid=6420194&loc=d3e21568-108373"
  },
  "r361": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(d)(2)",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=123459177&loc=SL121830611-158277"
  },
  "r362": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(d)(3)",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=123459177&loc=SL121830611-158277"
  },
  "r363": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "270",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=109227538&loc=d3e44648-109337"
  },
  "r364": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "14",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "805",
   "URI": "http://asc.fasb.org/extlink&oid=123410050&loc=d3e5263-128473"
  },
  "r365": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "808",
   "URI": "http://asc.fasb.org/extlink&oid=6931272&loc=SL5834143-161434"
  },
  "r366": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "810",
   "URI": "http://asc.fasb.org/extlink&oid=123454820&loc=SL4568447-111683"
  },
  "r367": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "16",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "810",
   "URI": "http://asc.fasb.org/extlink&oid=123454820&loc=SL4568740-111683"
  },
  "r368": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "19",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "810",
   "URI": "http://asc.fasb.org/extlink&oid=123454820&loc=SL4569616-111683"
  },
  "r369": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "20",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "810",
   "URI": "http://asc.fasb.org/extlink&oid=123454820&loc=SL4569643-111683"
  },
  "r37": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(2))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r370": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "21",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "810",
   "URI": "http://asc.fasb.org/extlink&oid=123454820&loc=SL4613674-111683"
  },
  "r371": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "25",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "810",
   "URI": "http://asc.fasb.org/extlink&oid=116870748&loc=SL6758485-165988"
  },
  "r372": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "25",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "810",
   "URI": "http://asc.fasb.org/extlink&oid=116870748&loc=SL6758485-165988"
  },
  "r373": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)(1)",
   "Topic": "810",
   "URI": "http://asc.fasb.org/extlink&oid=109239629&loc=SL4573702-111684"
  },
  "r374": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)(2)",
   "Topic": "810",
   "URI": "http://asc.fasb.org/extlink&oid=109239629&loc=SL4573702-111684"
  },
  "r375": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(1)",
   "Topic": "810",
   "URI": "http://asc.fasb.org/extlink&oid=109239629&loc=SL4573702-111684"
  },
  "r376": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c),(3)",
   "Topic": "810",
   "URI": "http://asc.fasb.org/extlink&oid=109239629&loc=SL4573702-111684"
  },
  "r377": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(bb)",
   "Topic": "810",
   "URI": "http://asc.fasb.org/extlink&oid=123419778&loc=d3e5710-111685"
  },
  "r378": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "810",
   "URI": "http://asc.fasb.org/extlink&oid=123419778&loc=d3e5710-111685"
  },
  "r379": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "810",
   "URI": "http://asc.fasb.org/extlink&oid=123419778&loc=d3e5710-111685"
  },
  "r38": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(28))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r380": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "b",
   "Topic": "810",
   "URI": "http://asc.fasb.org/extlink&oid=123419778&loc=d3e5728-111685"
  },
  "r381": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "810",
   "URI": "http://asc.fasb.org/extlink&oid=123419778&loc=d3e5728-111685"
  },
  "r382": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "810",
   "URI": "http://asc.fasb.org/extlink&oid=123419778&loc=SL6759159-111685"
  },
  "r383": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "810",
   "URI": "http://asc.fasb.org/extlink&oid=123419778&loc=SL6759159-111685"
  },
  "r384": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "810",
   "URI": "http://asc.fasb.org/extlink&oid=123419778&loc=d3e5747-111685"
  },
  "r385": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "810",
   "URI": "http://asc.fasb.org/extlink&oid=123419778&loc=d3e5747-111685"
  },
  "r386": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "9",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "810",
   "URI": "http://asc.fasb.org/extlink&oid=123419778&loc=SL6228884-111685"
  },
  "r387": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4I",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Topic": "810",
   "URI": "http://asc.fasb.org/extlink&oid=120409616&loc=SL4590271-111686"
  },
  "r388": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4J",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Topic": "810",
   "URI": "http://asc.fasb.org/extlink&oid=120409616&loc=SL4591551-111686"
  },
  "r389": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4K",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Topic": "810",
   "URI": "http://asc.fasb.org/extlink&oid=120409616&loc=SL4591552-111686"
  },
  "r39": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(29))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r390": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB Topic 5.E)",
   "Topic": "810",
   "URI": "http://asc.fasb.org/extlink&oid=120398118&loc=d3e355146-122828"
  },
  "r391": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=125515794&loc=SL5579240-113959"
  },
  "r392": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=125515794&loc=SL5579245-113959"
  },
  "r393": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=125515794&loc=SL5580258-113959"
  },
  "r394": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=125515794&loc=d3e41620-113959"
  },
  "r395": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=125515794&loc=d3e41638-113959"
  },
  "r396": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=125515794&loc=SL5618551-113959"
  },
  "r397": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=125515794&loc=SL5624163-113959"
  },
  "r398": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4C",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=125515794&loc=SL5624171-113959"
  },
  "r399": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4D",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=125515794&loc=SL5624177-113959"
  },
  "r4": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "205",
   "URI": "http://asc.fasb.org/extlink&oid=109222160&loc=SL51721494-107759"
  },
  "r40": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(3)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r400": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4E",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=125515794&loc=SL5624181-113959"
  },
  "r401": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=125515794&loc=d3e41641-113959"
  },
  "r402": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=125515794&loc=d3e41678-113959"
  },
  "r403": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "182",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=123421605&loc=SL5629052-113961"
  },
  "r404": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "25",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=121577467&loc=d3e76258-113986"
  },
  "r405": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "40",
   "Subparagraph": "(f)",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=123477628&loc=d3e90205-114008"
  },
  "r406": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(b)(2)",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=123482062&loc=SL123482106-238011"
  },
  "r407": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(e)(3)",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=123482062&loc=SL123482106-238011"
  },
  "r408": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(e)(4)",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=123482062&loc=SL123482106-238011"
  },
  "r409": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(f)",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=123482062&loc=SL123482106-238011"
  },
  "r41": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(3))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r410": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "815",
   "URI": "http://asc.fasb.org/topic&trid=2229140"
  },
  "r411": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "820",
   "URI": "http://asc.fasb.org/extlink&oid=123874694&loc=d3e19207-110258"
  },
  "r412": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "820",
   "URI": "http://asc.fasb.org/extlink&oid=123874694&loc=d3e19207-110258"
  },
  "r413": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(bb)",
   "Topic": "820",
   "URI": "http://asc.fasb.org/extlink&oid=123874694&loc=d3e19207-110258"
  },
  "r414": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(bbb)",
   "Topic": "820",
   "URI": "http://asc.fasb.org/extlink&oid=123874694&loc=d3e19207-110258"
  },
  "r415": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(bbb)(1)",
   "Topic": "820",
   "URI": "http://asc.fasb.org/extlink&oid=123874694&loc=d3e19207-110258"
  },
  "r416": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(bbb)(2)",
   "Topic": "820",
   "URI": "http://asc.fasb.org/extlink&oid=123874694&loc=d3e19207-110258"
  },
  "r417": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "820",
   "URI": "http://asc.fasb.org/extlink&oid=123874694&loc=d3e19207-110258"
  },
  "r418": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(1)",
   "Topic": "820",
   "URI": "http://asc.fasb.org/extlink&oid=123874694&loc=d3e19207-110258"
  },
  "r419": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(1a)",
   "Topic": "820",
   "URI": "http://asc.fasb.org/extlink&oid=123874694&loc=d3e19207-110258"
  },
  "r42": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(30)(a)(1))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r420": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(2)",
   "Topic": "820",
   "URI": "http://asc.fasb.org/extlink&oid=123874694&loc=d3e19207-110258"
  },
  "r421": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "820",
   "URI": "http://asc.fasb.org/extlink&oid=123874694&loc=d3e19207-110258"
  },
  "r422": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "820",
   "URI": "http://asc.fasb.org/extlink&oid=123874694&loc=d3e19279-110258"
  },
  "r423": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "820",
   "URI": "http://asc.fasb.org/extlink&oid=123874694&loc=d3e19279-110258"
  },
  "r424": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "820",
   "URI": "http://asc.fasb.org/extlink&oid=123874694&loc=SL6742756-110258"
  },
  "r425": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "825",
   "URI": "http://asc.fasb.org/extlink&oid=123594938&loc=d3e13433-108611"
  },
  "r426": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "20",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "825",
   "URI": "http://asc.fasb.org/extlink&oid=123594938&loc=d3e13531-108611"
  },
  "r427": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "21",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "825",
   "URI": "http://asc.fasb.org/extlink&oid=123594938&loc=d3e13537-108611"
  },
  "r428": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "21",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "825",
   "URI": "http://asc.fasb.org/extlink&oid=123594938&loc=d3e13537-108611"
  },
  "r429": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "21",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "825",
   "URI": "http://asc.fasb.org/extlink&oid=123594938&loc=d3e13537-108611"
  },
  "r43": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(30)(a)(3))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r430": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "28",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(f)",
   "Topic": "825",
   "URI": "http://asc.fasb.org/extlink&oid=123596393&loc=d3e14064-108612"
  },
  "r431": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "230",
   "Topic": "830",
   "URI": "http://asc.fasb.org/extlink&oid=123444420&loc=d3e33268-110906"
  },
  "r432": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "17",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Topic": "830",
   "URI": "http://asc.fasb.org/extlink&oid=118261656&loc=d3e32136-110900"
  },
  "r433": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "20",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Subparagraph": "(a)",
   "Topic": "830",
   "URI": "http://asc.fasb.org/extlink&oid=118261656&loc=d3e32211-110900"
  },
  "r434": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "20",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Subparagraph": "(b)",
   "Topic": "830",
   "URI": "http://asc.fasb.org/extlink&oid=118261656&loc=d3e32211-110900"
  },
  "r435": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "20",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Subparagraph": "(c)",
   "Topic": "830",
   "URI": "http://asc.fasb.org/extlink&oid=118261656&loc=d3e32211-110900"
  },
  "r436": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "20",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Subparagraph": "(d)",
   "Topic": "830",
   "URI": "http://asc.fasb.org/extlink&oid=118261656&loc=d3e32211-110900"
  },
  "r437": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "20",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Topic": "830",
   "URI": "http://asc.fasb.org/extlink&oid=118261656&loc=d3e32211-110900"
  },
  "r438": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Topic": "830",
   "URI": "http://asc.fasb.org/extlink&oid=6450520&loc=d3e32583-110901"
  },
  "r439": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "835",
   "URI": "http://asc.fasb.org/extlink&oid=6450988&loc=d3e26243-108391"
  },
  "r44": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(30)(a)(4))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r440": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Topic": "835",
   "URI": "http://asc.fasb.org/extlink&oid=124435984&loc=d3e28555-108399"
  },
  "r441": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "25",
   "SubTopic": "20",
   "Subparagraph": "(c)",
   "Topic": "842",
   "URI": "http://asc.fasb.org/extlink&oid=123399704&loc=SL77918431-209957"
  },
  "r442": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "842",
   "URI": "http://asc.fasb.org/extlink&oid=123391704&loc=SL77918627-209977"
  },
  "r443": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "842",
   "URI": "http://asc.fasb.org/extlink&oid=123391704&loc=SL77918627-209977"
  },
  "r444": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "850",
   "URI": "http://asc.fasb.org/extlink&oid=6457730&loc=d3e39549-107864"
  },
  "r445": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "850",
   "URI": "http://asc.fasb.org/extlink&oid=6457730&loc=d3e39549-107864"
  },
  "r446": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "850",
   "URI": "http://asc.fasb.org/extlink&oid=6457730&loc=d3e39603-107864"
  },
  "r447": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "14",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "852",
   "URI": "http://asc.fasb.org/extlink&oid=124437977&loc=d3e55792-112764"
  },
  "r448": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "852",
   "URI": "http://asc.fasb.org/extlink&oid=124433192&loc=SL2890621-112765"
  },
  "r449": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "852",
   "URI": "http://asc.fasb.org/extlink&oid=124433192&loc=SL2890621-112765"
  },
  "r45": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(30))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r450": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Topic": "852",
   "URI": "http://asc.fasb.org/extlink&oid=84165509&loc=d3e56426-112766"
  },
  "r451": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(bb)(1)",
   "Topic": "860",
   "URI": "http://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719"
  },
  "r452": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(bb)(2)",
   "Topic": "860",
   "URI": "http://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719"
  },
  "r453": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(bb)(3)",
   "Topic": "860",
   "URI": "http://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719"
  },
  "r454": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(c)(1)",
   "Topic": "860",
   "URI": "http://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719"
  },
  "r455": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(c)(2)",
   "Topic": "860",
   "URI": "http://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719"
  },
  "r456": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(c)(3)",
   "Topic": "860",
   "URI": "http://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719"
  },
  "r457": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)(1)",
   "Topic": "860",
   "URI": "http://asc.fasb.org/extlink&oid=121570589&loc=d3e107314-111719"
  },
  "r458": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)(2)",
   "Topic": "860",
   "URI": "http://asc.fasb.org/extlink&oid=121570589&loc=d3e107314-111719"
  },
  "r459": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)(3)",
   "Topic": "860",
   "URI": "http://asc.fasb.org/extlink&oid=121570589&loc=d3e107314-111719"
  },
  "r46": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(31))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r460": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "910",
   "URI": "http://asc.fasb.org/extlink&oid=123353855&loc=SL119991595-234733"
  },
  "r461": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "25",
   "SubTopic": "730",
   "Topic": "912",
   "URI": "http://asc.fasb.org/extlink&oid=6472174&loc=d3e58812-109433"
  },
  "r462": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB Topic 11.L)",
   "Topic": "924",
   "URI": "http://asc.fasb.org/extlink&oid=6472922&loc=d3e499488-122856"
  },
  "r463": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.9-03(10)(1))",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=120398452&loc=d3e534808-122878"
  },
  "r464": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.9-03(11))",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=120398452&loc=d3e534808-122878"
  },
  "r465": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.9-03(22))",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=120398452&loc=d3e534808-122878"
  },
  "r466": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.9-03(23))",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=120398452&loc=d3e534808-122878"
  },
  "r467": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.9-03(4))",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=120398452&loc=d3e534808-122878"
  },
  "r468": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.9-03(5))",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=120398452&loc=d3e534808-122878"
  },
  "r469": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.9-03(6))",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=120398452&loc=d3e534808-122878"
  },
  "r47": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(32))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r470": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.9-03(7)(2))",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=120398452&loc=d3e534808-122878"
  },
  "r471": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.9-03(7))",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=120398452&loc=d3e534808-122878"
  },
  "r472": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.9-03.17)",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=120398452&loc=d3e534808-122878"
  },
  "r473": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.7-04(19))",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=120399700&loc=SL114874048-224260"
  },
  "r474": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.9-04(13)(f))",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=120399700&loc=SL114874048-224260"
  },
  "r475": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.9-04(20))",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=120399700&loc=SL114874048-224260"
  },
  "r476": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.9-04(22))",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=120399700&loc=SL114874048-224260"
  },
  "r477": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.9-04(23))",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=120399700&loc=SL114874048-224260"
  },
  "r478": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.9-04(24))",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=120399700&loc=SL114874048-224260"
  },
  "r479": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.9-04(25))",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=120399700&loc=SL114874048-224260"
  },
  "r48": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(4)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r480": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.9-04(26))",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=120399700&loc=SL114874048-224260"
  },
  "r481": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.9-04(27))",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=120399700&loc=SL114874048-224260"
  },
  "r482": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.9-04.9)",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=120399700&loc=SL114874048-224260"
  },
  "r483": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "235",
   "Subparagraph": "(SX 210.9-05(b)(2))",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=120399901&loc=d3e537907-122884"
  },
  "r484": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "360",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=124429447&loc=SL124453093-239630"
  },
  "r485": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03(a)(1)(g))",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=120400017&loc=d3e572229-122910"
  },
  "r486": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03(a)(12))",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=120400017&loc=d3e572229-122910"
  },
  "r487": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03(a)(23)(a)(3))",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=120400017&loc=d3e572229-122910"
  },
  "r488": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03(a)(23)(a)(4))",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=120400017&loc=d3e572229-122910"
  },
  "r489": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03(a)(24))",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=120400017&loc=d3e572229-122910"
  },
  "r49": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(6)(a)(1))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r490": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03(a)(25))",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=120400017&loc=d3e572229-122910"
  },
  "r491": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03(a)(8))",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=120400017&loc=d3e572229-122910"
  },
  "r492": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03.(a),19)",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=120400017&loc=d3e572229-122910"
  },
  "r493": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03.1(f))",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=120400017&loc=d3e572229-122910"
  },
  "r494": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.7-04(10))",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=120400993&loc=SL114874131-224263"
  },
  "r495": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.7-04(11))",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=120400993&loc=SL114874131-224263"
  },
  "r496": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.7-04(12))",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=120400993&loc=SL114874131-224263"
  },
  "r497": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.7-04(18))",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=120400993&loc=SL114874131-224263"
  },
  "r498": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.7-04(19))",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=120400993&loc=SL114874131-224263"
  },
  "r499": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.7-04(20))",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=120400993&loc=SL114874131-224263"
  },
  "r5": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1D",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "20",
   "Topic": "205",
   "URI": "http://asc.fasb.org/extlink&oid=109222160&loc=SL51721503-107759"
  },
  "r50": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(6)(a)(3))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r500": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.7-04(21))",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=120400993&loc=SL114874131-224263"
  },
  "r501": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.7-04(22))",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=120400993&loc=SL114874131-224263"
  },
  "r502": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.7-04(23))",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=120400993&loc=SL114874131-224263"
  },
  "r503": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4H",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "40",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=116884468&loc=SL65671331-158438"
  },
  "r504": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "40",
   "Subparagraph": "(d)",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=124506351&loc=SL117782755-158439"
  },
  "r505": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13H",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "40",
   "Subparagraph": "(a)",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=124504033&loc=SL117783719-158441"
  },
  "r506": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13H",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "40",
   "Subparagraph": "(b)",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=124504033&loc=SL117783719-158441"
  },
  "r507": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13H",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "40",
   "Subparagraph": "(c)",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=124504033&loc=SL117783719-158441"
  },
  "r508": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "29F",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "40",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=124504033&loc=SL117819544-158441"
  },
  "r509": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(e)",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=124501264&loc=SL117420844-207641"
  },
  "r51": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(6)(a)(4))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r510": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(f)(1)",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=124501264&loc=SL117420844-207641"
  },
  "r511": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(f)(2)",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=124501264&loc=SL117420844-207641"
  },
  "r512": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(g)(1)",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=124501264&loc=SL117420844-207641"
  },
  "r513": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(g)(2)(i)",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=124501264&loc=SL117420844-207641"
  },
  "r514": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(g)(2)(ii)",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=124501264&loc=SL117420844-207641"
  },
  "r515": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(g)(2)(iii)",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=124501264&loc=SL117420844-207641"
  },
  "r516": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(g)(2)(iv)",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=124501264&loc=SL117420844-207641"
  },
  "r517": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(h)(1)",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=124501264&loc=SL117420844-207641"
  },
  "r518": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(h)(2)",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=124501264&loc=SL117420844-207641"
  },
  "r519": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "825",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=123600520&loc=SL75241803-196195"
  },
  "r52": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(6)(a))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r520": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.6-04.2)",
   "Topic": "946",
   "URI": "http://asc.fasb.org/extlink&oid=120401414&loc=d3e603758-122996"
  },
  "r521": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "310",
   "Subparagraph": "(SX 210.12-29(Footnote 4))",
   "Topic": "948",
   "URI": "http://asc.fasb.org/extlink&oid=120402547&loc=d3e617274-123014"
  },
  "r522": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "310",
   "Topic": "954",
   "URI": "http://asc.fasb.org/extlink&oid=123364037&loc=d3e3115-115594"
  },
  "r523": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "360",
   "Subparagraph": "(SX 210.12-28(Column B))",
   "Topic": "970",
   "URI": "http://asc.fasb.org/extlink&oid=120402810&loc=d3e638233-123024"
  },
  "r524": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "360",
   "Subparagraph": "(SX 210.12-28(Column C))",
   "Topic": "970",
   "URI": "http://asc.fasb.org/extlink&oid=120402810&loc=d3e638233-123024"
  },
  "r525": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "360",
   "Subparagraph": "(SX 210.12-28(Column D))",
   "Topic": "970",
   "URI": "http://asc.fasb.org/extlink&oid=120402810&loc=d3e638233-123024"
  },
  "r526": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "360",
   "Subparagraph": "(SX 210.12-28(Column E))",
   "Topic": "970",
   "URI": "http://asc.fasb.org/extlink&oid=120402810&loc=d3e638233-123024"
  },
  "r527": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "360",
   "Subparagraph": "(SX 210.12-28(Column F))",
   "Topic": "970",
   "URI": "http://asc.fasb.org/extlink&oid=120402810&loc=d3e638233-123024"
  },
  "r528": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "360",
   "Subparagraph": "(SX 210.12-28(Column G))",
   "Topic": "970",
   "URI": "http://asc.fasb.org/extlink&oid=120402810&loc=d3e638233-123024"
  },
  "r529": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "360",
   "Subparagraph": "(SX 210.12-28(Column H))",
   "Topic": "970",
   "URI": "http://asc.fasb.org/extlink&oid=120402810&loc=d3e638233-123024"
  },
  "r53": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(6)(b))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r530": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "360",
   "Subparagraph": "(SX 210.12-28(Column I))",
   "Topic": "970",
   "URI": "http://asc.fasb.org/extlink&oid=120402810&loc=d3e638233-123024"
  },
  "r531": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "360",
   "Subparagraph": "(SX 210.12-28(Footnote 2))",
   "Topic": "970",
   "URI": "http://asc.fasb.org/extlink&oid=120402810&loc=d3e638233-123024"
  },
  "r532": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "360",
   "Subparagraph": "(SX 210.12-28(Footnote 4))",
   "Topic": "970",
   "URI": "http://asc.fasb.org/extlink&oid=120402810&loc=d3e638233-123024"
  },
  "r533": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "310",
   "Subparagraph": "(c)",
   "Topic": "976",
   "URI": "http://asc.fasb.org/extlink&oid=6497875&loc=d3e22274-108663"
  },
  "r534": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "310",
   "Subparagraph": "(b)",
   "Topic": "978",
   "URI": "http://asc.fasb.org/extlink&oid=123360121&loc=d3e27327-108691"
  },
  "r535": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "985",
   "URI": "http://asc.fasb.org/extlink&oid=6501960&loc=d3e128462-111756"
  },
  "r536": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "12",
   "Subsection": "b"
  },
  "r537": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "12",
   "Subsection": "d1-1"
  },
  "r538": {
   "Name": "Form 10-Q",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "308",
   "Subsection": "a"
  },
  "r539": {
   "Name": "Forms 10-K, 10-Q, 20-F",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "13",
   "Subsection": "a-1"
  },
  "r54": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(6)(c))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r540": {
   "Name": "Regulation 12B",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "12",
   "Subsection": "b-2"
  },
  "r541": {
   "Name": "Regulation S-K (SK)",
   "Number": "229",
   "Paragraph": "(a)",
   "Publisher": "SEC",
   "Section": "1405",
   "Subparagraph": "(1)"
  },
  "r542": {
   "Name": "Regulation S-K (SK)",
   "Number": "229",
   "Paragraph": "(a)",
   "Publisher": "SEC",
   "Section": "1405",
   "Subparagraph": "(3)"
  },
  "r543": {
   "Name": "Regulation S-K (SK)",
   "Number": "229",
   "Paragraph": "(c)",
   "Publisher": "SEC",
   "Section": "1405"
  },
  "r544": {
   "Name": "Regulation S-T",
   "Number": "232",
   "Publisher": "SEC",
   "Section": "405"
  },
  "r545": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(a)(3)(iii)(01)",
   "Topic": "848"
  },
  "r546": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(a)(3)(iii)(03)",
   "Topic": "848"
  },
  "r55": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(7))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r56": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(8))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r57": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.1)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r58": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.12)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r59": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.19-26)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r6": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "20",
   "Topic": "205",
   "URI": "http://asc.fasb.org/extlink&oid=109222160&loc=d3e957-107759"
  },
  "r60": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.21)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r61": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.22(a)(1))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r62": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.23)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r63": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.25)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r64": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.29-31)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r65": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.3,4)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r66": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.31)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r67": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.6(a)(5))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r68": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.6(a))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r69": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.9)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r7": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3A",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "20",
   "Topic": "205",
   "URI": "http://asc.fasb.org/extlink&oid=109222160&loc=SL51721523-107759"
  },
  "r70": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(c)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=51824906&loc=SL20225862-175312"
  },
  "r71": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "20",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=99393222&loc=SL20226008-175313"
  },
  "r72": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "22",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "20",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=99393222&loc=SL20226052-175313"
  },
  "r73": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10A",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=124509347&loc=SL7669646-108580"
  },
  "r74": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10A",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=124509347&loc=SL7669646-108580"
  },
  "r75": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "11",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=124509347&loc=d3e637-108580"
  },
  "r76": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "14",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=124509347&loc=d3e681-108580"
  },
  "r77": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "14A",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=124509347&loc=SL7669686-108580"
  },
  "r78": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=124509347&loc=SL7669619-108580"
  },
  "r79": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=124509347&loc=SL7669619-108580"
  },
  "r8": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3B",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "20",
   "Topic": "205",
   "URI": "http://asc.fasb.org/extlink&oid=109222160&loc=SL51721525-107759"
  },
  "r80": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=124509347&loc=SL7669619-108580"
  },
  "r81": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=124509347&loc=SL7669625-108580"
  },
  "r82": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=124509347&loc=SL7669625-108580"
  },
  "r83": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=124509347&loc=d3e557-108580"
  },
  "r84": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=124431353&loc=SL124442407-227067"
  },
  "r85": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=124431353&loc=SL124442411-227067"
  },
  "r86": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=124431353&loc=SL124452729-227067"
  },
  "r87": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=124507222&loc=d3e1436-108581"
  },
  "r88": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03(13))",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=123367319&loc=SL114868656-224227"
  },
  "r89": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(210.5-03(11))",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=123367319&loc=SL114868664-224227"
  },
  "r9": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "20",
   "Topic": "205",
   "URI": "http://asc.fasb.org/extlink&oid=109222160&loc=d3e1012-107759"
  },
  "r90": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03(1))",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=123367319&loc=SL114868664-224227"
  },
  "r91": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03(12))",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=123367319&loc=SL114868664-224227"
  },
  "r92": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03(14))",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=123367319&loc=SL114868664-224227"
  },
  "r93": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03(20))",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=123367319&loc=SL114868664-224227"
  },
  "r94": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03(21))",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=123367319&loc=SL114868664-224227"
  },
  "r95": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03(22))",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=123367319&loc=SL114868664-224227"
  },
  "r96": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03(23))",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=123367319&loc=SL114868664-224227"
  },
  "r97": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03(24))",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=123367319&loc=SL114868664-224227"
  },
  "r98": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03(25))",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=123367319&loc=SL114868664-224227"
  },
  "r99": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03(5))",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=123367319&loc=SL114868664-224227"
  }
 },
 "version": "2.1"
}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>ZIP
<SEQUENCE>83
<FILENAME>0001656472-21-000091-xbrl.zip
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
begin 644 0001656472-21-000091-xbrl.zip
M4$L#!!0    ( *4\!E,#26CR=4L  "GY 0 2    83$P+7%Q,C(P,C$Q,#(N
M:'1M[7UI<]Q&ENWW]RLP]GL>,@*DN&BWQQ$4Q;;93RTI1+D]\^E%%I!5E18*
MJ,9"JOK7O[OE@J5(2I948)D3$VVQJ@ D,F_>O,NYY_[T'R_?G+[_G[=GT;Q>
M9-';WUZ\.C^-OMM[\.#WX],'#UZ^?QG]^OX?KZ*'^P>'T?M2Y96I39&K[,&#
ML]??1=_-ZWKY_,&#JZNK_:OC_:*</7C_[@'>ZN&#K"@JO9_6Z7<__X2?P/]J
ME?[\OW[ZC[V]Z&61- N=UU%2:E7K-&HJD\^BWU-=?8CV]N17I\5R59K9O(Z.
M#HX.H]^+\H.Y5/Q];>I,_VSO\],#_ONG!_20GR9%NOKYI]1<1B;]K^_,Y.GD
MR40?/CF:/)H^G#QY^G3ZY*E2#Y\^FR3J\.'QD_]W? RC? "_YXNJ>I7I__IN
M8?*]N<8!/']RM*Q_O#)I/7]^>'#P?[YK_:[6'^L]E9E9_IR&"]]."W@Y^3HI
MLJ)\_OT!_=^/^,W>5"U,MGK^G^_-0E?1:WT5O2L6*O_/N((IWJMT::;\P\K\
M6\,3X>'TYY6,!NZ3F5S;T1T^>0A#.OLX-Q-31X<'^T<_/<#?VW?JO5DPX@2F
M3Y=??,B'MQKRR3_.7K\\>QF=O'X9O3N[>'_R'OYHCSU<#U7.8$DF15T7B^>'
MN"3R45TL^>\1O-@1BL?9?Y^=_O;^_)]GT=D_WKYZ\S_PGN^CDU_>G9WAO[[H
M&_(G)D_AK^>'SQ[M'S]:?GD1[+[VP\'7WJGGIHI^^/[IT='!C_8M-S'_)[-2
M:]8,WV(0P[-!\W#XX^Z?7FY9W$?[SS:WM"_.WO]^=O;ZA^\?/?WQ2[W0X>'Q
MMWFE82$Y???F]9N+Z+>+D^CTU3GNT(NS=_\\/SV[B%Z].KUS+[EV2^HQ[,C3
M8K%4^6J;]N.&Q7<OVN1DJCR-]K9D)M^_>0DVR(MW)[^>_./.O=*XM_W91YTT
MM;G4]QO_B[W.7H2;#U_J\/#NG<7#[U05F<Y6T;0H(Y3<95,NP7^LHFJI$S,U
MX"+.=:E-'M^Y][W6]OCEW9O?WD;GKT_W[]Q[K=$[(] YIV61%U7T2UDTRS&H
M'=RN6[*\?[5M^NN;=^_/3T]>WV_1+SRO15F;1.5CV)Y?S#U_MDE)_?W7LW=G
M)Q<;]0E0)8B?%YDJ4M'5O,BRU5YQE8-FJ)I)95*CRE543*-02?_P_:-G7\R0
MN5\&7 9G=T?+4E^:HJE ;5.\$%;"Y'4!AU*D%\NL6%$@7MF 671EZGED]V<,
M/RO@?J4L97334L9P\^CO#?SRZ.#P60R7F63.9X6"6\)+)D4.U](X8!03'15+
M72I.*T1C<5O>E 8$# 8TJD#B]NV33<XJBZK*&Q3CHX.C@]B)?:2JRLQ0TEM[
MB5RN)S]6X<8!&0[5'EA$5:/X\PN=H%A'3_>?X3;!G_7E:OO6=$2Z#PZAI"E+
MF!K4?K1HL*:356O)0 I(/Q6<W"2--C=Z&IWG>7%)FBEZ,YV:1)?;MUB;W8!Z
M.L4] BOU]R;7T6',F=ZQG )G;G@O53V*"%;<DEP, [4%_LI4<U0]"E1+2M^7
MNJIA\&NT#RBZJ-(U.G1PZK/OMGU"/B*-=&6R#$V@VN2-QI6:*_@4)DR#503_
M4DFBJ\J>*DE3P2SKLHJC2UC0 O]1-<ME9NBSU%1U:28-J:AE6>"E,'!<=C;:
MFMS\"QZ#'URJK%&33./#IP;7QH @F!Q6?L$ZCJ2I5*D&B4A*75=K94#>[_$Q
M3(!5F\]+G2E\Q;4P"1&9 W^)FE1%UM3]2WBE?OYI4OX\A&3@_YV7]LY+-=-[
MDU*K#WMJ"B;N<Y5=J57UW9=$<ZP=S"?MC0VY_&)]B-Z(.Q:[J!%3HK)8BL93
M<.)E!C1'%>WHCTG6I(C0.<E X)2]\#Q/]NEJ4U?>)P C?U=43T;@'I0U,OUW
MZF*F43!9C8U PX\F1KA%2A?!/.-3O"KYD!=7F4YG\(1ZKL!"1ZR*.PG1&Q I
MC\D'+IHZRLS"U*0=66)!QRY!OFOT&$@Y@!(.]:FI87/E1;X'>LTD<BGM!?PP
M@>VG:V.U]:6IX%\R&%3#Y"*SIQ".+%(EG!"@V5EEP]$ %]>P36E(F9[!'1=X
MQ$\018>GAR$_OX)-*1M_VZ(LK]_\'KU'$?O;FW=G&Q4R<!YL0$-9[P%G7$V*
M2\U"LVCJ1N&A#T<X>(9\/KMX2VA_D2?2%DI_EL^*(NV=Y/[!@?P.B"\-!'X
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M F8J#"#1[6Q?""S.*Z8UL:EPIFRQ-$&\#+,'N[[E,J4[JSD#%IO<_=G:*S!
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MZ8;BUECJ:[39#-ME5/W5\)HV1DVYU#7U+D-^H-4>]N>,H[)8J:Q>[4UAF>-
M+:*GC+%OV(O:7F$ED[^FS[#>@4N7::9W8-H62"FP),8?T/#5KBUMQN$U6,A"
M?3)6Y%"#,[^*+9N ];W)NL43AB.&_#$L9VDN%1O_!85\S0)!.TAVP/]UI;#:
MGXAT%L$/LL)<<\1U2F:ZYBR= O&08X25[ .U,WRXYX637@2=A8U4F7*"+/J
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MV\-CB0T7TW4'!AN4(Q"6]F2.0618.[AQ.>YY#$Y;U2WXB7N EP-X';7G8OL
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MH\[9T8[9[?PH=/XI-!;D($LMKA!-%9H W>UHIX\M OL7\>$O:]U-<I9^]N/
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M9+W\[Z1(5_"?>;W(?O[_4$L#!!0    ( *4\!E-)6>ID<0@  #0I   2
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M$ZSCS#T_XB+>VJ>_3^AN-I[^#E!+ P04    " "E/ 93S;"@ZG8(   >*@
M$@   &$Q,"UQ<3(R,#(Q,S$R+FAT;>U:;6_;MAK]?G\%Y^)V"> 7^2U)G32
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MV%29K,\S,O26)RR$VLU'!@Z5W'M^\A25K(/ZY4"6QS1/FFH[&[$MK?W_L7M
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M#T/$;S[?7[PCT]G)9/I[I_W<0/[1*6Y\?/5_'J%J*]EF0EM LW[DTF)3!F'
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M("M/^FCV>+)\_GRF%S5]]HC>R.+^]-%S.9+EW3<R+Y.%,GFE>N^_6EW&2-9
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M.!!PO%1:OW<85^_B_8')G^?B/SKT/^S%_2MU/['\C21>_?B+-_^R)C8"KH0
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MI'6F!I03ANRMP:STS!HGQK _[W-H>WLV?S53XLK1;+JGSGJHDS"YU&O(%.O
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ME<I6, FB*&5\,(D\--<H<N%BD9#TGSB&)1%[Q?!^Y;)Q%')L1@I#*Y83-PD
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MMX>S,I&E_'0J+&4V6<B=TTMKV]O8NFTL0<347/.8'4BHN5&TP3NNZ%Q@&,'
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M5]N+GJ*W6CK6?_G4[YUT QIW0*K_W6SB/.(]FB9T<_.Y^I?;NYN[S[<W_ZK
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M5<<=F[,NNZ'>ZCC.MO3#K8O5=VX6(A<Q&IN_\\@ 0;TX'Y=RF.R^A/1NTJH
M&I(R2T\%*0SB*C&D8_3(TB2-(5I)8W-TE+4,G7ISHX0FFHC>A4A%%/3.#KT3
MF91$">!=GU.8./S0&!EJ#?@$QA/L$\R-O+<!]H1H3B[3DXE/O,F_HUY")X.I
MCH*NOF>SB+T-(" [A/[[*]I!K(=F+[T;Q#JKNW#0O3CHX,JAT.B5R,9#Y-@B
M;J)"S@$;:<P2LXQ01<G:AFQ)/77>5@E+-!&\B]#$+N"=)7@G# A!.&>4(N_S
M48QH(S)&$60(8QP[$F-.N30M-?TIT!*.N'?2Y=!V/[7=A8Y$"4$\LM34^7B,
M3H*![_+BN^^<Y"Y]U>N%;^U.IW#1O;C(7TFSU#C1J!V2'"?$1;1(^T"0,%Q%
M&D2,$IP9A5L<-\:7*9&();,D"HCG >()60DLC9:$(V8%!V\@,>0XL2A@&PEG
M5G.!P1L BZ(YX<0G$Y XG^ E"O%8-D2AF =1S*=).X%K(X73!*F4\N'-%) F
MR@/C6.V38)[5XM;*M 0OF1 KB=0%& H%J0]%ZD1T@0<EH\!(1VD1=Q0L>LDC
M$II([HU*EM$Q4NFJB54VP0I0/Y&6NGD_XE</.9V,5+.LH?^:W\.O!LLN3#NK
M<.R]./;+%2D+PFA@-I]L"PGQ8!(RBG-$8@C)2)EHK'7\--,M2695*Z 9HEF_
MB*H4,BMDMGB!L$)F]R6S2X/12QTXP0Y\N4@1CYHAFXL722\%3L8*RGTF,T-%
M2^I9'96;+YF-[<GS5IS/7UY3U:S=PCO<8^)I&3Q/Z)WD':8?'W>:;WBD5JZ\
MX?Y7V[IVISUL_T1N;1:;$(]YCQG%8IL[B.?5CCM3#N8,L3:W>SRE4I.;(S&D
M075L3VV]9W]1<O(G0SWU9E^S.N'>5N@*&IJ+\)K'<^WOT52[*+WG??\DAHEE
MHHC5/L D_7Q%_,E([ZA-"LF84ZR%)N!?8X:"T5PJ;#'._C4U+4U7+2NAD-/*
MD=,BO.!"3G,FIPEM*ZE$RH=(C58$R,E8! N-1I@JE8*3)A@@)TY;9/IB8(W,
MMFBX47AN[!_W^C4R>ZGJY SFJN>@93:_5G(QFG$BY)R83@LM/826KDA5:.Z]
M9#ZB& E#/+)L,Q&-O$Z):Z^%RTE@I$5Q8[+*2W[&DID9!;VS1>^E4<&IIU3F
MHF"N]G@<1=J&A)166DJ5 )^F+L^Q<CD;2V%3;,''OL+,_QKO%$-\VAGE"S C
M+L>C^#93TM!598I$8,2L1D)8A[BT!%FB7/Z!D\,$"RZ!AJ1I"3EUFF?#(B\%
MO8LR(PIZ9XG>2R-"!\Z43QREF"08$8PBJR1'SA.'*3=,DYRD+5F+DY4\"+)<
M!4:GM22><NG!!=@8A9NFY*:KBA66)Z-L#DHH<'"LC$A+,#2,UE@E&XP5(M?S
MP"UAYEYE="E#%T\2YPNP1@K.I\?YI0VB,+,IZ]'8J#'B"0MDO&<H4FT#84QB
M(3/.94LSWGR</QGABZV3F N,PF"@#,!^KP/7?*K:@,5^')0"(8\8ZSB)^[TW
ML6.',?QM^YFGBB[P ZGJBO9%#)C2) 4B(6K$0PA(8ZZ1CX$RG BE4>28JY)3
M&R0EU-%$\"XBU%' .TOP7MH9D7$F4L!(LV0 O#@+US"&%'5.>B$CLP3LC!;1
MC0'ODY&\^*ND6S3$=KAEP[90T ,IZ(HF1L#"21$Q(N#R9!%.H"!J,7*2&XP9
M3<+;+,+)6%'$6$D /U[&10'PPP%\:4/(X*QR)"!.\UEN&CBR/.=TNB1M9%0;
MGPN#M/CT!0(7E'01VH/CCCW-+8T_Q_RBKIQE (4T)DOD9R(?,TH0>9+AWL5N
MZQ3NO ]WGFU>"9Y(3"4-"I% )3"F]\@$BI&ES$3MB-.,YSBO;LF954%HP'[.
M# ,K3Q+@B]W/*0"_+\ GC"/G121>HN T19PXC[3@%$69BQXJ(TP( '"B6H),
MO9$S?X _F>#+\][147M4B;@^#IWA!P\0NQX 4?TVB+'*!0<K\_LLC\#/9XG_
M/F@_Z[8[_[LV[)_$'W$^\:";W?!\\C$+VN^ ]A>3R[D#TO7""22"RHF?B2,G
M:$*)!X<I^$&,T RE'V#>&.F#^:Q 9?[-=_Y=KC8NV"R<9A F*OOC)B%KF42,
M"1N3-RG0>.O\>ZI.<1,6H9L]X;>'MA\/>QU8S0=UI7;U9UW5<WA:1'1F(:(3
MVE_/;SS^/,H7/Y-UA.21+(]ZT"MOC]LY#'(^T#-MB:SS>W_5E#^/>X-VYH=G
M_;SSVOX:_\PF)6+UIW_H4&<',=]@;>.W=JMJMR_-(NCD$O)>?( FKZN][MMA
MSW_YC^WD=;<X<?=85J\<"A81&\V$1CP*<.)@;) QEB$IP.@141-"]=J&4+2E
MQ:RR;LLF5:,0NX"(2T'LM(B=. @L4D@<.Q2<!]C"B"&#941&4!)Y(H$+6*J$
M-"TJIS[#4XX"/T!S#IJ<^QI,G&/;#JC=/3=Y2HKLHVFS78S)WS DV]WGHP$I
M/'0O'KIR$CAR&0Q3#@'KF%RDTB,GDT!"XJBYE-9G00)&6ZQDQZXF;A<A6U9P
M.QO<3IR_T2&**#F*GH/]8'4.I"6,F 17P'FF4N2 6]X29FH=H$8FQC;<?'@3
MAQ9>#%6T_2XT_A&JT[O><-@[:CX!+<!P.!^-%^/!V/3^Y.BDSM;?BJGMVR6_
M[GY<='!U4TGA:)Q%AIL<?1 <.68PBE@+X9U0@K.U#2-$2]&IBZ1,Y<M<0&*Y
M A#+@N0%F!(%R;-'\L3VG*3&6!(0HT8@S@-#5D6&G'66J9B8T#$?E<,2#(OI
M*T7/$,M/*C1Q.>?'*OB^=W3<CX>Q.\C29>TN_!T7'Z98%II:C(K\^1#5"LW/
M)P=HNQZ?OWJ#7"%[+^W;[X6S[L595X[W*I(LL=XA"MR#>/ 1N9 <\BP:&J-@
M3KFU#47 ^'A<$?F'&1^/'L18%E0O1GZ]H'J>J)[0.*/,69NW1@C-M>Z=1\9Q
M@PPS0CIO;>*X5E\W,TL[?Q0S9.E5SD;I/I4=#OMM=S*LR_,,>]5@(C,H2[,_
M[_>ZO4'U"A[^>"XJ: ]/J%\6@EN V5+O[8Y'[44]L(7#[L5A5PX.I^0EK$0F
MVR.9PY1$VE.*E/2"1R6,Q21[4Y+1EE2SDFN?0\7%1P^;/&'4+\"L*:B?'O67
ME@MVAFN>ZT4;:A''.J->8Q2T]T)1!P1=2[PK0EI,SET;;5:HGV6 13?;L-EM
MCCC:H[+4;PLQ3@;PG/#;/?AJI]WM]8&EML?C4MCJ7FQUI<2]BRDJ$CDR@A,$
M5DE EF.%C,]&2TPR&)_UE=0-3'7M9%F)FRPC=!]N813H+AZZEX9&4N _.">1
MPG4E*.N0@<%#*N% ='+:*KNVP5KDA@R01X'N3(,CC=FC^9E&R.#^YZ,>02%Z
M65RA1PF ;'=]YR1WZM^C.H.;$X&N_5X6:+JT% NK/8#5=K>N"(ZP0 TE0&B4
M2@7ND[7(DB01BT*RP(VA65B:M"0U+4-F)=@T:T6"58R8E&S6PA&/R1$3(98(
M!.&90$9[EF7<&+):9.$2*2RW+KD4ZA +UBTR?=[Z_$(L<SI;LQS&T82 6JU@
M<G=CZ8[Z,B,2?L:@5T+O)&],G3_:%!94LT)5]ZZ[/JNN68W58K$Z=)O=4$+M
M4ZX#5]1LI  G-S&#(C&P#E#FD.9.( [C)V6PB1"7UP'-=$N2J5./9PNAQSSZ
M5 BT$.BRF-N%0&=-H*<3SK9Q7DB,F(T1<:\",B(PI T/& QI*4E=&@6<[I;4
M4SO;#2#0VLS^H_;,SJ5?)D1VCFS_4[M;?[$$J%S1W*$_R %^/AD,V^ET]%*[
M&V)W^ SEBV:-6K%.?P5;>KL8#EW7/Q?#^7TN"C[Z3DV^TK]T_4+C+?5ZPVY6
M+UQ&0'?BO]Z<?G@?CAWE$MIW]F'K"]SW]>G>/H!SZ^7GW:W#SWO['P#HK_'!
MYYUO!^]?G^YL==+>_B>QNW_P;7?K ,#[ N]N?M2,:^NT0"1Q "AP*K)"!S!X
ME+ AD>2IR5PZZJXWO3QVA\/A\;,__OCV[=OZ=]?OK/?ZG_Z@&+,_^O#V'^?7
MKFULG@P/>WT8K)#)N&H/!B>VZV-EZX2]?Y]TXPC>#+>J; 8_@X6@TSYJYV,'
MV5_;BCX>N=BO&*DOP!,7K%<U5YQ_V<95L:7;9*U6%6+-P1A>E[* [ K(7G^,
MCD G48M(] 9Q^!TY0!F C$6<#/8JQ8>"K!9+&]3@RK"Y%5JWVEQU5&0P$[]U
M>_?EP]1^1@^Q73_#A;F%E]/<>O#$V?GL\=Z6AW9MTKW]+WGB8.<M8]2AR"2P
M,\]%87B4,(42#990[YU<VV */% L6H*K:P;4;41ZO^GP,"N\3(=IIL/NUJ;X
MZ+23SK%\]BCDRB(I(NL$0S)8PPC32A %$T#B%A6L!5/EV@187\0ZN?$_KO]'
MT]?@7SNGM%:?C+'*737(IPP !="@0:SEKVLWH3X4F=I=L&3:>0-^""_4VKWK
MMS[^^/:4K-<V_[4U_EL[# _/7>.)SXW]%WSY$>N@#2?#VS\RT:\^YHV@1^I$
M_H/XY<3/W-H:R(9Y"TL))LI0KF1R#E:=*((!@M#2I(_$K)U_Z+!_.9<^1>3Z
MT7Y!-L$#/K.=;_9TL/;'53\+G*QQ@U2VO&[KKPE_#*^+D>3IZ(C)Q1C4GB+T
M6\<>#^*S\U_^/)?C;7?KIZ\_].?X=N.!NT$DM!Z?T=N7;5K'HW:--V?&WSQ^
M>[U^ZP?/=_2>PNN<JEO?QNODUO=^=ENJUIEB=[KMK_:4;G2S7];_[JM7>]0.
MH1,?:3]I\G!1M=WUZ[=FUUP^_&S$?1\FV#R?SC)WZZL+RGP^29EO+X@R6ZB[
M<5B-SC-6O^43C;_7=LJ5XXY7WY^YW/,#M+X7/7B_X*DY :&^X[,LG]7V=TD$
MW>Y6X.:?P%U#/;3OUM]6(;-D?]"JXG<?,_)K1><\Q,=@A8[_.H*N&L(U)UU[
M$K)/_RO%Y.O8NF./7B3+W+Q2UB&]VSLTI;F%PD<-A_6NUZ\+G#Z#R1/[(Z_^
M?VQCVE(=]K,;\(]?+]E@C.[7RV<^D9D]B&X^U& W;AC9,9I^,)+(> V^.Z7>
MGWV?PE>>1Z 7:\QHL<Z)?(@M(_"ZDN9!MLS/WJ/KE#WLKC^UD("#J5RFQM[-
M2GR$R?KHEY9G?D+/?)=]N2OVU4V!C6L?OA[,6"8ODE-P]^C,:8>0=4UFSY%D
MG<W!Y9U;8R46R]/8>?4LO5N#?N%>_9( S%W<@U%4; &I,#_NG=V2J J6=:R.
MX+K#017!X [UYDW%<.NA(889=<E\SNS<K5?>MK_?H4^FG2^_BE/=D [2[&[+
M6W)WB9/\\FF?5)?A60#M#AVSC'TSU70J,VJ6AU*;D.%Z\Q/G6&X_?HW=D]BJ
M7$R]?LQQO_8@5D/[_7KQ^E\]^(Q3?Q>T<3!M]N_]'OZ7&8F/^M3W.2"A$L\2
MFH;8P)E43B4=J&+0%U0I:3YNU8DF'!,T Y'V>I*^[/>.<FPRM^Y]>WCX''RV
MWE'L7QRRVQP,(OQ_:)+"XM[;R^R#W:U_'NZ>_?/+WO[++Q^VWK1W7KW@!_NO
MOW_X#/<X@KMN[7S?W>^T+W-_/QP>?(;6O,J?]1BN);M;G\0.?,<._'?W\SMH
MUP[>H6\ZUW)_CUZV=^B'+_!LT+XW\/EW>&_KR_</6U^^P7_I[OXGNG/V^@S:
MFG;:X[S?M_C;1X&UULG%G+K"$"?,(N-Y0#)9K *E@FJ_MD%T2_.YGY][8%;O
M!89F><:VL%]AOPOV8P9+X46N6<RX35H+QH0G-#&?K&:I9C]\SGZXL%^SV>_L
M@OVBL#@0+U&(VH[RMDPR'GZ0$%2N@E6S'VGQ&U*V"OL]4%5@A0EP=3E0&J4I
MHS(I8CF/3&,AB*8:QTBIDVYL 9)B 2X%!Y)+"Y H1ITRR":L$6>!(.V$0HER
M@AF/'AN8GHRU!)X[!ZX*#3YI#EQ1 N26$!RY430F3@C3&OLH-(W,!PO6X=@(
M),4(7 H"9!<$* 45,5&&G,IJO9P89$PN>R2IBC$2&&V6 X8M-7]M[IFPWU.J
M@?3B)Q',.^ED3:7M^:C<=2]9W@7&[T9#DL_H Q\-]O/(%'*Z#SF=3L3GP#)S
MX(>&7#L K#,3!?R&+8I>Q4!@K*+W6=R3TD<3]WR8Z?7HNKQ+@]U%1I\*=J?&
M[F5TR3MNZ@/$242.N(T86>L3\D$0P90,+M9U/P2_7KJH8'<EL+O(J$G![M38
MO8R*2$94]-8BRE4 [%*<M0 DXCAY14-R7(:U#=&BLF!W1;&[2(>_8'=J[%XZ
M],)$[K.0%:RVX,9[(I#6WB,3B0L6AQ!9=NA;7%Z7 GP4[#ZEW*,F"=XO2^BQ
M0=DW0%0E]#@-4^T^G_#N&<;*&V60BI(B+C!%ED>/<"3,:$H#L5EW3[0D?5+[
MSX44FA46**0P=U(XF]B0M8$Q;1 G$7YH[K,.9T384&)3\,;&M+9A6EJSP@F%
M$QJ:I%$X87I.N Q'1&V,#P8C81U'G)F$'"41.2YT8##<QF271K<H*Z102*&I
MB0N%%*8GA<LX!PDTF1 \LI37Y6\TTEPQI*3"40MP'KRI<_<9$4M!"D\I<>%Y
M;S#,\CN#'/![8ID+#0M]^'ZO^VQO>!C[>5#VTJM>+]0U!F+_:]O'P=M>)Q26
MN@]+O9V,<7CO+)<$:645L%3 2 ?N4% >_%4G?8@YQF%:G$_-4F4_I;E(7D2\
MHB!Y]DB^#$RDX*.DTB(5-=@;0+_(1"<0%IAX(1CEP>3 A.)3^R %R,T%\B*"
M# 7(LP?R931!\\2BQ0FQ5"<WY$('6E"$4]0T)>(Q"VL;3+0PN9[=4)"\,DA>
M1&2@('GV2+X, 42/'34\(47R!F(R$6E&(QC75E%BJ98I5\F6+:F;A.09)3PL
MA:._W?T:N\->_[3ZUF\/86AZW[K3)$&L-B4M,M7A8F3>YX'9@G$I1'0?(IK4
M$:'>XPAV(")<<\2-B^ ;4(%<-(&:1")047V2WMR0=/6P6.22;D.L-GX7F950
M\#LM?B]]>R*E($IZE)+(AR"E1LY8^,T*(3!W28W.&6$YJT2D M\&PG>1"00%
MOM/"]]*CI]8 Y4:,M)4$\6@CLD8&Q*3$ BLB2#1E^5U]_"YRK[_@=UK\7OKQ
MG@6GP$=')FCPXV,,2&L=P:V/$9N4=?A4C5],>8/PNZ!22X_GO+_J]P:#J@,_
MIMFB7ZG,HP7+#@S@@>&W>_!2/69_]WNI/2R$=!]"FM0=D!;6$" ;I$*0B#MJ
MD(X<(Q&PX\Q%HJRO3R8H?9V0[GV(JAFYAC/<-WBRB)^!_U\0OT#$7T8 L);&
M:8L1<XPC3H1#6KJ$-.$TX 2.A+'YU*2YX2A2 ?R3!?P,(@8%\ L$_&7,P#BI
MB(P1F3I]V#*"G.$!1:UI,M@*PG&=/JQN*%A?$/]D$3^#&$-!_ (1/Q%EP#!:
M7&B4,WP0QTHC2P#VPEJLDHG1:9<3^)BYKO7?,,"OO&3"WG',!7Z[GZKX_3@7
MZKX] C&+R&FY1W/N\92.P=1Z-W7)\2/;_Q+SA"^'89J0'/,V=CKYH%XW[)P/
MS(L1$97U]Q[K[][D41A,!0;'B",;F$;<$086MY0P6#"L$D912EA_"6M1W*1L
MO9)WN\1),@7'L\+Q1*@,R%9KIY D,9>-L0Y9F2CR.DHK@(BYHFL;LB7PU)OM
M!<;-A?$BDV4*C&<%8S*ASQLCMH0@%;Q!//&4S[-9I!F77I/ J=9K&Y2UN"P'
MVE88QXM,FBDXGA6.+\-:!BPI2J2"]3<K]%(JP:P6";D44A!:19O%<<"LEJ1)
M.'Y*AV#>Q$&T?7]8>_HA?HV=WO%1[ ZKW_[['YI2_.>;_[9'QW]NU7^1/Z\%
M&TN&W^-H@8Y&#=AJZW+,"E\]0)]X?S-SU2@4L/D1!T%-3K2G7GL$XPD.A!!
M8%)G?6*:)+5979R8J>, )5NWN5A>K(1GP?(,L7QZB65JL!)8(9N41ERX+#3.
M&9+@$2;)I0I2Y9,SDI7,^Q7&\F*E-PN69X?EW<MUV5N/F0;P"N%A7>:<(ATT
M1L9B3KW2B88 G@1NL>DC>P7,S07S8B4S"YAG".;+A3FH9%RT%#'B ^)YH\T
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M%!D;)&*!"9E+@02J :CD^AY_66)7!J\S<.4+7N>)UXF*73Z;/"2A;/$@3DR
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MP7+DF24)7(E!H#1#/BVGC$4?%<])V[2-"\DL.+BF.!BE$%1I!6 2'DJK+7
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MRHS^@:J"G+D>OH?*=0;!KUFG]=DB$07--8RBE0H3'BS6+/WF9"(/@EC"3=V
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M2N<QIQNLUR5>L$#Z2HFI8=F5!<@?$,CW)]:!%#HRJSW2EBC$(\D-"YE'DI#
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MQYQ1":N()"8)<1L#Q'0*(QL=801;+5-.S.B6INO$2-XD9];P.-CE YL&#-8
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MX5('IGV4,C#CM$^46^DT]<8S;TC2*H$YNDGWL'$?SE_8Y(6"J2=(:B\03SS
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ME%9XO[GOYNMIN\B)#_P6S''9@@B-^YNE:?_;SIM/5KAD1(S(!,81)SPB361
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M$RI4;P+.6R]4OU1Y:P-@5P*PW?GZ+D>8<RYJ)#C.5'W6(F-]/A"=HDR:869
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M.4U(BD A6@%\=TI8I*P&E(5?=<R)$MZ25"ZK>VOB!8*OTSF!^*7?.X0 QI?
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M!>P; #;G,AN)0)U1,?4^>HB)1>-MR$)9[ZL+[BGA[8P+3GEO;:*:@*6"@'2
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M$!54)N"+0\&")"(:GH/Q$F?Y;;T*%6 KP%: ?>)TMWIR%@?/$T^.4I0K<)*
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M7]ZP >?.WD&W,Y.(H=5-.!GFD$2\93F,(GK4'_+9T3F_]_:P/TY:[A*B-Z:
M<[C>WY>\0;GMG!:?;^7%)N K'21\1&B^**;8<QD:SB7H^ &8*:M1Z2\)C)B#
MXFREN-X9;FC")<HK/Y=L3&'6^[1?YMG?V-J-?=<]&70&;[!1X7!KOYU0+\<F
MIO_M#0;;Q6>TC8_]K=L+WYX;D)V^Y>TO.P%42%8@<KG8Q#IZXA0R2$<]<G<P
M@0J[TDJ#X ZP>P_[1_,3G,P'*,;GXM$#I4$I2E[N=;N]X\;-4 :_A<*ZCTTJ
M,I4<ZEFC63W UN*W 0^BEGF JB)J>(/0[_B21<7W4 -K)GR_5S89%!5I,)ES
M>&@XZ<9WZS23;RQ=J-3V^@48_G;=HXDL7^;/**V>>_-B#6G:?*&Q12%%7;DL
M[P5_"CX,CO;*2[L6H_]93%K%&].XXYKV-1>AHHD=TL,O^O/>?^B@*8):U.;#
M%BK<."+N2V/K:CRU^E?$D>([P;^-BCC"I>%+CU>[5L0C^%X?F\>Y^8T9M/9[
M#78F'*W6<>^H&UO!H38ZYX* FG,#DTU__J [3QH-%_7CX?U<=] 8 L:8W?+8
M";V#9HV:'K/]5/J@8$;KERZBQC]ON%JKRV1A.!/'T1R]/C:]1')TW<$@O1A_
M^#5V!@===_*BL]_,[.:B7V<?."=I3O/ X>%?CSOQ<+=$6R K:2(N1EN!1D\>
M'5YK#HWC36:.<;.F%;OT,%V[V3&V!DK=\,K+&VO7J#!WT%;!=6UK;>MS;RM<
MK:T_V7)XC3"WGY[*Y(5SKQSY-D3(1?.2\_J%GAOX]G*\GEW&XJ\01_A<.N>"
M(G.=_:V+G&Q3X9?#!7N4X:\UZ'4[L57ZY?KQEP_9T1O=PW['M3X.W1!7"5V]
M[+VG7_TV_??HNO"B?Z9VXPVZ<<:?M0CLJ[+Z\_=^/IVW6"E]AAUXN7S>=Y[=
MA]BF\+Z)8S[H=T*ZB\0T/[ONRC!/6X^A-_]QO@\7]_[3[]TOCURJ%[\T7NUH
M$,]GA@-K909=DG, ,]E'R:WG"7]H2^,E216)F-WILG^T%WN'H^-7M)9G1O],
M_8) 8QK^9G_\LY&#/XL8G#.JGT6\B<=I4!]OBX%/7W>_;;[^<+KU\NW)YNF[
MKYNG?^VV/W[^VN:O3K9>;G[?_/A'Y_/KS>.+VV)V.UNOWQY_WL:VOWQSVGZ]
M>=K^^(I]WML4G[;?P.;IJ^^?/O[[VZ?3W_)FAYY,*IT6KZR$1'0NT:TJ2^*\
MU(2Q+(7)J>R565E'S4?,2<XX5!GO3)S*T6N*587%"HMW"(L)4A!> 2^5ST%J
MKTWP1B83F4%IH146'S4LTC-8!*?!2,>)CBP0\-P1IW4DB=ML)*Z'MB3=%*L,
M5$7%BHK/&Q4=#U$&;TO.#N F.A^1. )+*4EFK*RH^*A1D4]R?H"+-$$@GD=*
M0"I#C,J:2!9QA&5(6I524JN"\HJ*%16?-RH*HQ)R!4X554"S<50X01&Q(GY@
MX9+]7A45'PDJP@@5OV^^?/-])T")66- =#",('7DQ 1%258Y(57,' ^NK'.Y
M:MC%/6<5&BLT/BMHU#PDYF)2THA2;M=G &5"3%SYK-@EB=\J-#X2:/R^^?LH
MZ<[VQDG[[0Z'1(,0BC &90>]T\2[*(DK!>-$C($'B>"X*KFNV'BU]WC6P/A$
M43%3YT26 #8Z4"P8F6F@IM0@%\$:J*CXR%&Q,T'%K;<[S#$A8\C$LV0) $O$
M:8]J=?!*"B9TD*Z@HC5WSA@7 HE7#(1[#%#U<;R-RF&KW)=S&]07$1[$Y_;+
M7"!_U)BVG'[D\?AN#(=W7+ZC["ZM('<+D#N9<BQSEUA4T1/4?&,!M41\-)%X
MD3(([B1W?F6=P2KG%]/K_!#?[HZ_5;%=:C]G%=N[$MN)XU,Z\"E+2413'EIX
M0ZPRO*0?UEIEZW!FK*S+5:ZNZ?BL4KO$?K@JFDLKFA/OFXP^"<\]B5$( CB2
MQ$9KB1)")&U%#L:B:%[7]U8%\YFZ@JK,WI7,SOJ&O-4:J(TDY\Q0T1>>N,@<
M$=E1;;VR-G!DPF)5PL5BBE5TJZNBBN[]B>YYWX75$@>:)V*U0S66"4V<CH8$
M1S/U4H?,60EYL<94V5TRV5U.@WJ5W;N3W5D+>REV5'";E&3W2)B=)=::A+]J
M%[A4EHD2E+'*^ .LN\]AW]I9762WOW^$[3F=23UVIS76^?5Z\NF!WW):WL<S
M8N-L0DRRVE7TNSGZM7^?,KTG&72 8$F@*1 P61&C(B>91@\Y!JZL0MS3"]S3
MM40Q%14"EMN*7R'@SB!@8L9WW 4*V1#M>:$^AI%2OY@(9Y*+."=0ARG41\ U
MU9:* (\) 1[0(U#%_,[$?.(2\(CD*OA,2F&9LB$'B+%4$:$R,U$JJ@QJ.%95
M(7_"0KZ<WH4J_W<F_[/N!2T8A2 4<<I' I9FXKP3Q*;$LW=,1ZYQJ5>K2/HJ
M##Q=&%A.3T6%@3N#@?.N"JH4*G<I$RFB)D #8H!#,J#!V0P2M<"<"^='];_B
MP-/%@>7T>E0<N$,<F'5[4$&3,UZ1E)DD  &(%R(2+9U,.K@@LB@XH!:V2W]A
M_I#9BNKGJW<\V@H0@[,* R6/7^BZP:"4?XBEFL#_-O57Q+A00W:=_JBHP&XG
M]5T_[ [KG)0K!T?^*TI1J<LT51NEJ=V7BC>QBY>'PUY_T!0:[,1TKF#*6<6$
M AC]7G=U5.@O-+4)INHO=/&N.3>/FFW3\'Z#2VL>X@OEH\.C_KANXKR"+.7A
M'42!9L+=OI+!\/:^_Z_U2TLDC,9#E'M<+ =T5J*@X.S45:-VT,DES@]ZW:/#
MRR^YD$/S@>9<*3(]T^U3_Y;F-K!J17#6>\JTY:!5]IYSF62TB/I&V;P#=F5\
MT6Y_XOO\DHA'5/]&7,8W?.&ZQ^YDL/*OV:'$41NU2!=IO*S#I@:8KLFFS-$]
MEZ:P\J:5*91<TXPO/,^]X&O4+"31_?S]7G\T?Z[K1\:;W/E<GI_Z]7<D';U!
MZS4N/ <M9 EK-]U_M=@-:@_7(>W>(=X,UX#?>Z6Z6JFAA9^:T77%V?Y'9]_M
MAPZN!N\/\8N]II3M+Q_VW5'LX/%_WE'_C0425^R?D/MY9RYV<.XF5?%D?)H[
MON@<XM/"%=C[+V_*XMX[PKO&IJ3 /U9;Z7M(12B;U+YN#UG5X> Z0W/=GIB_
M2C7$[/)^ROG.=)IAPW&IZ?4;)O!B6'NN*;[WWVYIVM+:[1>MZC]^OEIJI'K-
MRH7C^WM1R/9+IFIWCI5<RG5_7-:IH;1794.7\_7<_/GU]I)POO+B!:1J:(A:
M:]U)#<4K/OZ.ROT=#<@7YPY>O.P,0K<W0+*[E0O!1BAN9L^[0BQ3_+TW.!PT
MN^=_*W4._W0G#1(O2^F_K?=CY39^V]H.)YO\W;?-\OGE.U12_\#GX'U.P\G6
M]K_W/GW]O+NY]^'T?.F_-G^+"O";T\^OWY[@9VB_?L4^E>?OH=)Z^D9N8GO;
M>Z]./F^W\^;7+[3]92=9%I@0FL@0#2JG94>H\XZHE$ &[X.F86C00!4AQ8UB
MCG )-,,AD"YI%#UI66(F:$:S,S9X?;Y48-/I9%A=<MSM%Y3)&:D\IY4,1^;G
MCYUM)FK;8*P"&GR$[%3QPR0AM8O9))/C7.9[N;(S4P-4S!?XV2*KY:3[YR2-
MJ/WB[J9:ZI4>?ZX>+:P)*!TQ/0W<L>O'%K*._<&E6N+-U<\',"F<U4#==8/6
MEU*2(Q5% 7&EU3LH<WA8[?<0YWISI*$9Q6J(5+"8 3C]]=W[#X/F(_OUGXT1
M(::<^OU+SGXY?3:2S[1WT.V=I#2L^HV21<;?M&*GGX9FB&8=;6P([YNF;35-
M:_V)X] :DM5-=]+BJM158K+U2SES]+SFBPM7C5O05%4L%YE+[UQJ6K6X61V>
M=>[6<RX;W;J\#MZ]]R4U12F/.X>[XV?-:<^P':/[_MGO]/K31P?GF\MI:VMO
MO^./!JU7P_JZJ-"@[!8SRDRG],-NB]MAN:ES;9^ZQW2/-,-03L2!:B;ZZ%X;
M1U]PKK984]>+V9F;E5.G[S$L_#F>60'OL=]K=7O[7[ C]MRW-)QHT\-Z\977
M+B#K'2[![\-NBD==7(!?C2;?^]3_NQ/29-V=7IDWNKCP-I^V\CMD>U_VBR'Z
MS\92U2S7SWIQ/MY)F3,-"4CB6A*@.A*DO90H)T-RUH+-\L9U>9<.0<^7Y1T<
M[6%S\2:#9FH?]E"]&T+A:!$Y&'&)4MJVAPIV$:\S?#AO8IW!XD8X"]XV!72;
MNZ->,:SG.^A\;^UA@W<'K6$%[ :XQG7XFE.*T+]XK@5@@:[!'9239'Q-7]',
M=KUC6B_>)E@;>Y>-M6(1UM:?>J;MXZR&^<<,8EU JK.RH8M(B_7(NV@NE,_O
MH&MO_QJ9;JY3^NVR>SR1FG!7+%-[BVZHG;Q^H=YMG:]UOBYW)U^K/O.B]MG>
MM<?IQ_4AIW6-.TJS>]4<PP_:$0^68_A!W_H:P8$L@>;**.$U!R<T*O0^E@AQ
MYZ47(8QL+C!C<[EFE.#8.#.RMJ0XWQA3(@+W!VEIHOUN:',91?NU=S]]_0.O
M>]?=^OA7!W_B,_^]V_[ZZ02OZWY^N4';VY]*I."W\]%^F_R/SB:VI?WZ@_S\
M\0W^Q/?;>\7;Y7E[?WW;?/F6M;^^/=Y\_2Z?1?J]I]_;+S?YYI>=+!,5RFMB
MDF8$2KH#XY4CJ>SY=IDG "@)2HR")4TC?"8[CSBS>D6]94:]1#/P&$NQ 0$Y
M">.H5F!9-A$<=;)!/3I&/5I1;^E0[_0<ZCF/F,? $YNT(9",(0ZB(B(:E560
M$4 7U-/ZFLF%*^I5U'LBJ!<=HAYD 3$KD-DZP01R/!\9,Z#\?/]:1;TE0KU)
M2A?J%?/)*B1X):6+HT ,&$:L\]Q'JQ.+LM2CM7Q16[TKWE6\6X*WO@;>>>.X
M%5&S'!P8KKW/-KA 94843,J,6!ZK+&]9\6Z2OX9;IT7,0 (3E( -)4PP>%)R
MVE#4:3EEK."=I(^#W]W6W?,8 *K$-UQJW_[1MMPY[WKU;;F/!9V<38:"BP8Q
M"I@2J'TJ*HQ2(EC@TE_!\E8AZ*XAZ.2">8U*)\'BH-"25P?9ER*&\4"TX52J
MH'AR<65=TVMF$+VJP-\IN;JJB^[9RVZFC@LC)'-2HZPZ$ZAW5&1D&2F#MU>P
M'U79O7O9/6\DHEXJH;0GT&A..DKBO3#$YFB"DL+)DKM;ZVM6LJFR^YAD-\GD
M>:;> *" "N>C"SQZFRAST8]DMUI!EEBL)U802;527F<B32F9Z5,@#H(C",^H
M[7F3F4O%ZLM$%>DG+-*,AL@"XPH4"C7WUOKL@N1))X\BS:NBO^PB/5'T(V59
M*^X)DP'7Z)*RUD46D6XST$%Z0-DN(HU4:XE$>D%!1<VS]9*K]=N7[H.XH8EE
MM&] X/O'WE'9A="86:JM]K9=\V0 GNL,20IOD:)!8? ZF\BUP)[B2-=MC5):
M:H!O_W[!C&)<="HZ6J@:1Y@'(/B!$Z9C$C8',*[)1R[5HBH2+$*B'H=WJ^)I
MQ=.?9(BV5,D@H\M6@,O&2"$D$N@L0G9&Y!K_M.QX>MZTA6.)4&DCB8&7,LTR
M$A\2(XS&[+.QP+-O\!1NK0E7/*UX6O'T]ID+*IXN$9Y.;(H.N  &FB@:)/G_
M[+UY4QO)LC[\513<\_YB3H2*4TO6YCE!A&UL7Y^XB&L;CP/^<=1JA$'RE<1@
M^/1O5HM%;#9( EJB)V8\LI;NZJK*)Y?*?!(R"\2$F F/U*LDF1.L=-5NTWGG
MSS=(VB#ILT=2<(S1!%:7@U3&A#$T)&EX$@$MG"";4&[=D?0BE&N=5UQS0] N
MI8BDDA'OI"""Z1Q"5 P4^OC0MK.'<FN I$O 5WX+E9NO#Y6;6-6FHG*[L<!U
M<0G<_DIX]]ZW@H6Q.V8(*L1 I_1:_7S!&S0H5.NC-#C :\26/S[G&CJ#K?*7
M@^YHE&XE>W_5+]QW^.'Z&2_;F.=K=/RC[.[6WZ>#*2.89"TZ&\Z!BVF"\NL:
M UFK.SQM\'M^J3Z*3NO2S.),!=+]27:[,:;>BT5#U>F9M;9>_NR\_.H#FI.@
M(I&).@*XR8E3!DCTF@E-N74IK:Q5%"NGV[MP[/V*/2U0@;^4VJ,*!>N"TSPK
M8)8RR\O_3C6GX):<O;BD*\N"O(B'@R-$R6'J76-6NYE ;8!;XEM%*?WJ^!JW
MZ<M"LEC]<;J_Q\QJ;#$5Z2Q+?KSQ\JO-$33WG%"O!0&1(_$*'!$4J 8MA(IJ
M92T7ZK_CY ;7&$K'U&(.Q>]G]^#PH%5 H$CQKS:%5,9I;ZQ1TD&@V@A%C3-9
M!^UD]F$>F\+_?E/XJYL";:ONF%IYO"6>WXXHW+<LJ<@3FK(935X"D PQPD:B
MC+%.EDKMI!$$4N_F#3$3:E\G:BRP_7^';H#[:O^X0>X;%NT-0^0&Q:-%02;"
MR)*@8#RQ.G/$< ])NN31?[D?<BMC?1+662D27AWE506!CHVE$>77\ :YGW#)
M.2*WY-X+A],?>; $@N#$V)0(DYI:YC)S7,P;N0&]HVQ,B)XIT* L!,Z,IL+D
M%%*8RZ9HD'N:'0&(W 8D5TP "49& CPP8E&/$ZD=]89+([Q?62M-F'Z)W3>
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M.$Y,!$JDC(*'["WZ^8L&&,^AD/7FD$)K%LO\OIDZ"P1JFG&F0V&_S1(<.NP
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M%AZ=]3\Z9V)//],@=(>I]0,]X]3ZX_4_IC;GEF!Z+NJRCJ[B=E.,= ,11U-
M\,P+"(*[K2<<&K<J&Y>-SQX"Y1YR-EEJ[5.*QMF;J0Z;GG /%WTN4>=OQYOO
MMMGVULNC[2T<V[N/W8VMCP<[[][(C9/MGYVMMP<;>_N[5Z//)>J\N?X>=O;^
MVMU8?[7;60]TY]W[GYUW.]^WM[Z?=/;>L(TOV\>;7]Y>KKTRUH 70I.DJ"7
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M.N?,H7H4,\UX?M5@XJ)CXC/(0VK0<:82]Z.O7!MOF.3$<U$RD8(D7DE7J#U
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M#26/Y%=M;"X)W.,7[SVI0W^6Y=I"R4]A5'SR(S<8N-ZH*<K[%9+XG*37""&
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M>8>'_O-'?]@MPWDQ2/M5<[0_"P$-$=6OKZ(<ZKAR@96U/[H7I$VXEM.=F\Q
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M2A2<\4#1:3$Q&51@U@0ME6@"%@LN]Q<!"Y1ZY@5:+B8;10#7G-CH$^$\*@N
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MM*=%!SH5W!>)=9E;G:D3##1(,"9R9YU-W"HOQ9V"^BJ,5PSCLSF''Q716DE
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M6P$N&R.%D('Q+$)V1N2J FX4"5[W5E)3JL" (R+86 IB1^)"L8*3HCR**'W
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MQ5J\L7TF_ETLA@KO%7D#9O!VDBNKE"><E_;VB&;BC-4DL,0,2*U\LK4XZQ/
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M4M$U":]T+AG<[*:O]Q\5GVW%9QN]#Q6T]P'M-:<#8PI72BDB41LB8,"6=.-
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M_>_DQNF/,N#7^>TX-5[\>;:JI1U^A+3>7G%#]=X<.$8U:)N)2H6S+$=;3^E
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MU,E*>J? 57;)2>&;LQY0RXJ[J,Q7F:]-+]Y>[U<EO262WIQ++!B*^K@%$D-
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MXQ%W5B!'$D52JR0#)=*'G&!:-+!9WE)XH;C-0GJAN%M07*ZI@ T36%G&$TV
M'.\\,=98^$>R0G$;17'D@N*8U-8'XI$542">C$..DXBL#9PSRYC(1?Q4 _/Y
MK>:%X9XHPRV2#.?6?:$6']--9SUFL!1>!)L,XS9I+0 OGM#$?+*:I<)Z&\5Z
M;&*[XJ"\PPS!(!G$@[+($ <J'@QGM#"5!:-S*+EJJ"NV\]RS>.E/]NSEO)PW
M404@;4W0. ]8J%IU@9M&U8F#+<NKL6+/UN6Z0J/^GZE@/%W:N!D'A1,6X(3F
MRRE_5M"14:8H"E%QQ#&7R,G$D:.**"TXTS(]>W&?*)$-WJQ;T+H$)\VMI_ "
MY.4#>>*U"881&1A#RC@] K*Q0B"%272,<TJESSMU%;V/TZ: >7/WW2_!&W&[
MHIT%QLN&\<0SX1771OF$D@!%G5MFD-6 92JX"5[G.I[+2TB[P6A^JGDT5FQH
ME\EYC:B>6-Z!.$F880C&2"#NE4/:JH@4-4&31"BCLIZ<&;^?W7T>E0PWB#^'
M53ES]LPE12@] H=&73,G1P'F8*4J];HG5?Q[V!J<5=9[>,,<7=GJ? 4RF"DY
M4G*&/X"K8_$JZ:_KH=J+@^-N>#L9I<+-BW#S)*('-[^\^WXH<<0RKP)YY@CB
M*@5DJ$G(2Q6Y9E0E*TH9@"V ]#*#5@J*'QS%/V903*3G5BF+A",:M*P@:S<F
MDDD 1:= 6:#/7B@SKV,5!#\9!*_,"U+@O'0XDQDX@YA:+*-%R06%.!,$)N7
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M6X91I(!@[I)")GF*""A56GD2B62Y5"05\VEGG@Z(2PC$2D,@"HSO[R>\[$'
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MCXM=I7]>["JM?OG0L</0@N-S-+ZD_CL')$P9\><:[U5G+G=P'EH#J^_XO#6
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M*S+4;CVDE^ ?67S5HP#\ 0#^8P;@7'(!9"V0,PP ;H1&!E1K1!S&UEH6K0>
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M[ YB1>A.-:DZ7YW7]_Y/;LA_ZH;4A>G[.[,[]JZ%!]M2>&P./O".E-, N:5
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M..^Q"][3R4N:*2_"#(9@:#TH??#!0O*.@-S00(#W6$/@^:1"FZ'U39'>DI+
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MC+AD##EJ&3(8:#MQ2X2C&=]$+2OD;JOP_2AL!@DFHE+"4Q8(MQR,!:J(IY*
MR<"Y#\4;\*C /?$&)$D8"8(A;F1"G.6 6L4XXCHQKIA/Q,?L#9#RWMZ >X%[
M^7$3!=FC8%&6-"<P>2>?X/_!^<BM85A+1PEH;R5NX%$A>^(HB$P::WQ D81<
MP=5[Y#P6*"0LDM,ZL!0RLIFX]UK<LI#]Y(,#]NNTB1Y>8=!KW=%9L!4KB(1B
MQ325EEG,<\"?\J!XA!B2-I:RVS@+"O6LE'K^G/((&,LCQUJ G<!!J5 Z(D<,
M09Y9J81S,7H-U$/G,YB7U<,G ^'$790X1!P\YLE;ZYAW3GO%!8_4L07] =>5
MCB[ ?G!@3UP!5FCBF!)(&)+C>Q1'.8X+*18=MAY[S=DVU)#>[@7$0+PF@AL6
M@N<R42N3%3%RS[463II;. ,*AE>,X8G%[[ $K&J/8!(6B"=,P>(W8"$(X4(D
M,5E"87(VZYV<R^K_0VG6(0@MC!(L><X-=UX2%4Q46CMCL2FK_YL'WHE1GW32
MTE*'$@\ 7DX%LC#OH@A_P^@Q&C2 ETBQ*>!=TNK_"(-TAXI--N^G<@:6JO*E
M)-R#\#=5B<><"9?8P)E43B4=*"C@*5&E+I2O$D;Q&*A].K4)F,J"4RN0UQBT
M,9\B4'O4B#)0K4&47< *J%TT)*7+W>=52FT67MUZ7F4&2^%%L,DP;A-8LHP)
M3VAB/EG-4@E?>52\.O%9*<^$3"0A0ZE&'%.)' 9>U8XK+:7'RMEG+TQ#ZWN'
MS!9:+;1::/7^2?H+K6XJK4YM(S*>.4DH,B9&Q&'HD"-4(&69D0EF4RWULQ=4
M-R@KO%IXM?#JDG=3W+\P?.'5S>'5B8>7&<Z)\Q:9*(%7N?.@J6J&F+:4I*2=
M\+Q.<\7(O9V\&\"K5U2!_W6FYL]#EP#*1;?KFMNCVGREZL^EJC]B;_=06NP(
M@VD^&.(16,<!6>A?A+U6U%!&I%-/H^K/?WNY).3@K%&7PAL5QHI_#UNGHS)9
MH_*-=1F?T^.S?I;J]MFHWL^H5%Y=7*RN[I.+9\W5"=K>DC\2[Q!Q_>$[UWI1
M=ZXDM(8J.KFQ;"6%:>9/?13%#';K^I:Y[LIH)CLOW[?<8AF/L$M>11]/7.Q5
MC(Q*VI:2#R7O[Y)>_FG$M3BX@_/!:2H,-]Z9H%4,*BK%M H.'[Z]MW^IV>WX
M8:\'%#'2%9^(D;.'][,1<[!+/Q_\WU^?P,C9.VBWFC]^__+IX.W9_D'[9/\@
MM_7#]\M&SMZ/=QR,F.][KSY#F]X?@Y'S??_C6[;WIGF\]^6MV/\(QM+)OUO-
M@S_2WG2 N*56"2($,LD&Q TUR(;$D(@.%/J4G.$IA['H!I=+7NQ\HLE\"Z4]
M/4J3P8!!*Z.1!'//J4V,86L(,)QUCOJ:TC !^ZM0VIHH;;+,*"(3-HB  F<6
M*$T+I(VR"#OA5& ID8 SI=$&D4MVB#\0I3WYW7CK2M7[*,C'&T=P(-YJ:SE5
MTC BI?,P<P>G) ]%GUHS^4S'CBD;@]!&(LES62QN%'*>1*0BE4302%+,*3I8
MP[![UT8H8?V;"%?,I30TJ2 QX92RO-F.^4!#SMS)DRFZPMKA.J4K***4P0)Y
M&QWB(1"D/77(!>I(Q*#A15?#E?"2QF]+TO@]"I8A.O* N>/"V]HB$8GG!#+P
MBT_$RJ(4K)EESJ8#RB,)+DJ&.$L</@@0C/$1&1>,21%KKG- >4,L+9Y\4[PH
M!:VC1+\J!F($]RYH3H32VLOD0 TP"2>=:-$)UH[6B4[@G':1<U#AB28(H(F1
MI2$@D3T'-,!_EM=9-.^?V7=%Z7K.5YVAI?'G %_5F4OR:#R.S8@'W8%M5XOJ
MB3^-!=K>&,0E]\Z3"4.D5"0M(M/)6NY<<#R UJ%!STA,&N>*0KC>*68F+1,.
M :;]G.;14XIXC %IIA)25F/*N'$1!U (#6L8NJSZ3$M"S)H3OQ36+*RYS-18
M+A(9O2#14LX%,4YEQQV3CL>$F2Z*^=I9<Z*8TV"=<80@"K,8XH%HI+'W*"B*
M/:<RB%@'9*N&,.9IL.8M@K(?973OP7&L7G9/X,EG53^VV_WJM-<-0S_H5X-C
M&(>CX\I6[=9)[0@$>.6 NVZJ3NR7;J_RX^T._9UJ;_:'RO8BX#3!\T)E^U,'
M!L=V4$7KCZM6!WJL%89UP+#U=0I0.!OP7!WUHAW D^#D3D7P_^9'#B8MK;.I
MJ=_ZYYE%^CNS,<1Y9#*[M#I#6XO<]-B,7Y_E83CM]EOYA.>]V(8SO\9)5.__
MSL9KCX<23RZQ#D1L.+C^DKD8RC4-,>67>F?J\[@WB0 ]BLA!O_^%;(+&/K?M
M;_:L_^S76<$&&1[?7%%X^G7O/B7N>$>(6G-8;6"V$7>.RQ8[BMPM@/IGMV5T
M!VN]C%#GJYGNC_J?35Q<N#J*]V6OV^GVJS= ,J?5VX[?N6M$\RT#PS>^0YK=
M =QLT 66ZX38Z0,7PK=Z=.N]%'^T.K;C6[8]6I#)VR_ZU2\?.G88,CO_\X'Z
M[T']2PL.SD-KL_4=G[<&\#1_"_WVE[=Y>TMW"'<-=4SZ/QI5_.YC!N5QG@'M
M29[4^HL,S:(]<?6$4VLTU_=32@^F]8\:#BIXMU?/O<]!E8N]?!8TQVY,6ZKC
M7K8[_J=EF+?&.4R4H5S)Y!RE(HI@X#(M33I4H"35,Q>,;][KF6'WKU_MBTN3
MZG5*8OUY21\9F1O66X4E\Y$8Q25)6G@&CY8Z4)V\DQN\8>Q:G,PQ&[U^'7DY
MV[W6H5&]&O;R7K:LD8*2'&.])Z[?^EZ=P*7'_2J"F(4K]NS4YV4[ME%?^V'G
MSQU0NH_JC73'%O3K[IQB_01ZZ[H=3'5OS.WB:4PK^G6O_&,!-X+V3'HEK)?.
M<Y:(U=Q);9R*#'MC?K+E8=97L)OW*\)L&__H]EZ!G3E(P_;NR$3IOX<FM[YF
MD+\<N1,>NR/A'GMA7W_;WSVT@<&%*B"JO$%<<(*,M1@9F;PE7 H1\JHZGH^S
MJT5@D?$-,<(MB0Y1,\Y% (:60G&F@I)::7R]FZB,[YW&]WOSW:%.#L.T*)'U
M&B,><4  *H&L4LD3'E72Z=F+*Q*L-L! [Y]&GRWK]EDC[P:.W_/?P(Z^%T%M
MK=K=G"%AY!4XME]CY6+LP&6^>]0!C@E5M_YK/"#]*O6Z)[5(Y&?TJV^MP?'3
M8LN#X[R5^IOM5XN$.AH>O)! ?M1S(G/^VQ"TYD8EYH(0-V1J>]O\8\:/"FWW
MV9?Z#0S-?NQ<!@\8:]#=_X&1R_DO7K7Z8]TFAOW3.-*T^LTXV$_362_PEF%G
M_^!(- \^?6O"\YL_7M.]HT.F! /T)(25M(A+&I%UN1"(DYQYT#MY# LYS36A
MN91H#)B"!LD,3'9:8"LB=9P&ZF_(>%*&?27#;H2)6E&**,,4\>0U@AG3H.1C
MI(9J H<7R\MHJ8J&II2PYM()9X,1V"AGB*&,IAL2B)5A7\FP1VF#-RRBR(U$
MW$J%G+($24>5B@(&2\3%AITG16/40LK$.6@^1 4!>BYS'">FT@UICLNPKV38
MDR(<!Y>7Q7*<*1> =FI 67*)$RMRF0% >Z<[IRS=X8=:>QJI1&%J@*KNQ0B-
M#EX8FW^.C<V\QG(+Z[6:,UP?B8:UH'_B?>P/LHWZL=MKA\?QAHOY)V[P2XQL
M[IE>N/!+1-NKU_"J01T\UYGD\P=5'>0H9H]GJP]/LM_CR FZ2#RNIT'I&,&<
M 'N.@0UGC0S6$D&53/8V1>V6E;,-"._)Y6R[A^6WAX',\K8&)Z)"C.B$.!$!
MY:V/2 I)G23,),J?O= -,#3FR6E,/;7\S7JU&M5^9V![K6[UTG8ZUK7Z('P#
MVVI7+[N]T[&SME'MMEWL#6SU!C#2.6I4_VG]/83;9"ZZN.YE]^2DU>]G,<N_
M_]GUK?_O?RACOPU&_ZO>#4=?W.A_OIME-0PO[M X7WK.B,F\>*WTCE:_+PFP
M8<Z'G&PM>L<U3\[Q( AW#@MNDR,W"#"]+*0@F7FQ>-0%[UO]O_X;>_D'>Q3)
MA30BNG7B^%KL'^R>[?UX2YL'?]'F[F$,@MFZ2),),-DFP9%.!+Z!!1Q4E ;'
M.G)O3B[_M['@$%-"@A()AMD*+I,VABF>MQ$2)3V)M SQ PPQV]L]3-X[DZ)%
MWB8#]K*4*.>Q 7O96HJY,B):&&(^/\0U%RPVRB%02X62CA'. Y-&2Y43)E*G
MF+(TE%%>SBB_^P;@E01[KUU"8,(2Q)V$><5H@VC$*3FO,4P[,++SF[#^][)+
M\9K H%LI*SO5@HH27I^BI+@T*M'$C*8\BJ"3E40PZH*A5#B^PEH,15&:%N@?
M;\7^*_CMU1&T^>AL'V@K*9B-J >1%@IQ)B@RVEMD0]"26:>P2\]>J 8,UC5*
M4^H.>_,ZTZ![%.MBV?=26.XI2(7G%A>+'[NT>71H# <!8!P9RCVH*3@BK6)$
M25I,) 4)R4&S:K[&Y+71CW-$T[^2Y9Z60?MS1\7Z"-H+K0%"0M%(N 1+-@=W
M"&LX3]IC<YLBDH6@'QZ) K0/+C@#Q9TA*RU8M=1Y(.@ 5JUU& ?+*/:BSB=.
MQ6(,?2NKMMG]"J@Y&@4^-NY@L=;*[6*V\3V-W"!,E$X:89SFQ$7G$[.)A\2<
MP#3*&V2[S!F+6T!?=L]@SK!!:*<4A6ZU#BQ=[)!5#B,%DDNI,9*R7-MT?N5]
M82,7'F0#U3HZL'$DAB'V,.2),6*!V.1-2XEEB.\RQ#_VC@Z!B$#_X@XF3@NF
MD'0.:>H$PEI)G'!4PHFKC=Q%AY@%D32AS.D4N0Q16TU]#,;G2N5@Y)8A7OY\
M\_K[WNYA[G;EC$0,^!R&F(!IX(Q!DF/F@W$&2P]#/)_$ (9X<4=&9$)R&17
MEW,5O $QBE$KPIVWG+LRS \PS&?-=X?$<9:\P,B2O)<XJ( ,9A9)S#TC.;D5
MD5<[-1[*IW%S2.H:/1HI)JMYXAAF'AX<*!1&@^G,?-(&K%)>%.9-D.Q=TOQV
M:#5HQ!$KQ'4  M-<(1VL1M3!#,*-""3DW-2DH:_PMS^\2^.>DE08[PZ>KK]$
MCG60,4D'<UJ.0$,\*I_S]1D0#L6,!97"Y!"7*P)#BTMCI5'QBMIH,3%")]
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MT*[:33AR\.7XKU9G<#:[-A"ZT(31%>U6_!JO>[O&;/Y-:-_X5>W146:/06S
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MCFDE+$R]Q(8KX;N)$SAQS^8VDLTU 4[NFE$41%QW$N[H#H@M/?(#4X]M([6
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MX5 ?  IP'TG&@D:V!,B#1;J6!^):Q?!?4W;..PHQ:=.H'1X7I[P<XQEWM%W
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M :KW9OPK((T#QIZ:(?;KR\7^[H\@"FP>FXD>!Q96CT2.'C#?T2D1*(TMSM(
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M[<L&,.-.N=IH9RVU2P)U%VZ[ ^U35IUH[T"E+$H L70P=GZ/TT&WZ!XL9Q<
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M#)H-F67+R+M(>P)X4 ) O4%Z;L2XYS8*D10ZNK-XE%?3C@6/B;242=F^XEC
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M99J;L?TG7*:YR?;:ZPLY1U1,@KETH,N<P:M,[<NM9&P-!<Q9:=K8"!>8..A
ML6SX@FKSL6A4)1KBBIXB594IT8K+=$>!= : \*0VH%K30.0T$VD12G&!VF1;
M9+ 8I!*UV!06?4NHX;[Q\4:P2.L*GBL(!E@LT%:^CPO5LQ7$J^S1W+R6WC9$
M29SL:+OD'>!3:EU0.P@:/04=,6,)4?$WP1A=(V/Z36ND$+\HI%T@W;ZHH^)
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M#7I)*$@%>CKN/"(9JOZ>']HC%)@F**<.7;5I5*GDE\"VI;^VG:"IG*\B&;R
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MF>:>7#\I,]].);V.L)]^97,TMYN.D-CSQ!S9BBE&K@DCFL#( P]X3@)2\VV
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M2&T^4HUI7Q_VZYYR%&:;CUESM&<B8W>K&ISA)JY>P9RFT]35L.2J28'T67D
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M4]RM6"#Z3JY@#M\.=7HYA:'C;47"*G!@X[!JS8YA>!_P8,=SJD8K7X:183,
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M*P)N+0%/]5&_WV'ZO523=-2T<_+93=(#M3UI<C7+&S^DNCF8P[9?-\N2/;>
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M"3(4X6ZXR)K;ZN>WI0%=9QLCMG&0X^0.BMO+[9NL:[E5^.H.=XXQ]L23;^/
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M^S]3X&7%C5]-1KHQW3NC9??^VQ&)K.BX[70\GNC6N(%T?- R FW1-*O OW?
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MJC)_VR<%-">!;G//AR,C+1M]A$64T=6-6#@2\@VH!-L!@"=%"W"H=V' N.O
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M79@2V,\W\O;#AX,/P>V9FZ7/J^Y8QVNF_)%/ME"ZBSTXF<@8Q3QW9\X@8O$
M?@<.QP#*A*/]'$=GSS,"\A..1J\_'H3A)9A)IRA+K+1)@*2V.',GE.TX;EE
MDZ9@R.BL)<Z'F@KPMX1?_\SQZ[N$-U/]\@&9,Y.6GQ+F; =,=CAD2F162/&T
MHA#M_%%'^@9JG:$#,^W])Y\Z/+O0S,FS<*M DX?VA/T"+J;+"22\671FHG^3
M< YF:[QSPHVJ_DS$=?G!DZ7\A6<-!>*,4ULH/-C:^)7-(Q"00DFPA"UF+'2$
M@R/?0BJ5!UO$>B'$#,?[!42+9O2O_RMU:SUR%LC+B0V?4D'1%<;*M7.2'B$'
M[4DA^Z)"^=P-?-8I<_ML^]:8G,#,+R=E@M'H37,M6F,@NLI@IHM'K1_^!Z=!
M%8"GM",O_$G8:3E[$^_-7:&34&_018EHGB:O!E '%4I5Y\P.^.@>ER 2.\0N
M_Q*Q-:*YI]#8Y,1,_.79FQ1;*6V7S!1-;BO]. "C5[9GT^F*G_C_]A955\0S
M1["X$N#?I$&7)EK0^/AWSFW).)M&MF ?(7U@2Q@S+8P'NL%?QG=H&@<!R9MT
M1-++:%7:+&+"K9GXVZ0I@_8E"#79S =DY2-(&.E;%)L$J04V D5&B/0TT>ZQ
M UJ&0M@SC0*"5,1OR)8CC@1H:E8!^O_*!60! 29HP?MLS/Y=<HRKD-9P-C!>
M7E-XQ%X*11KUNV\9]]$E>Z.Q,=;2)]B]+0GXH\L$86,#I[BK<><;)VZT:D+\
M*),I;\%0C_!+L/\CGH8:_>ACSRUR6 #O@W0#8L5CIN.!4!"' $HL$I<F K!)
M;X(U!:X_:8.LA;77BT I!IX A=-QJR1=2A[2B*Y=-UVQ2,R2)E_.)$%I1BE8
MV6NT670.K&] U+ZGTVVOH(=L'[!+1]AO>-&F+>*UF3$0WTTM*G'@;R";[22[
M5<), .5;C$) HJ!X,B=<=P"D9D)K6@;LWS'@Z0+]ECD^>&G_P:0WV+-CP.D7
M:P!*C/T6I!:[>['#JL.6E.%)V,[SZ?*M3H>#5E3:WW"<5.A44*,?0:M@(=U$
M>N(OTG[VENA/%3Z*0/N-HBB\Z()!]*YH3*S9C)<'CUS4]Q=9_>#B89(_750&
MQA-R=CUJAEPOZ\,$_L-&!;5"Z:JU^E0';)1RY]BVR\]4UZO<!758ZML+5F55
MX5)(Y:SY+9[)\[HA^Z=S0SZQA'*GHU1*TF%5]-C)*['</1'Y0. \%[#4@S7'
MLR](+7G =0+X,J+$E(249LS%*=:B1,Y'2XWD.PQ4H#-> YBM@0#ZW1<JD=L*
M/MO@DVC*2C!ZKH94<K_=<C\UO;7YX]SER16+3 :T8\]F,O<0CR[4=GR5?)&[
M75TM'T,J@$'?*Q&_G0[0>^ER)<"4@.^X@#_@"4E)_R-)_X\RWB\*F$,YLR#@
M,X,]XNR.KG0V#@5H\&?OW163U%%1B"L9D0IS1&W0]5/X<4\#W8;>D35)]X%W
M&#6S7Z7UP_94;VI,P4W@>WZH_1KX\4H$C11S)>\=_J!K_BIR[F!4$67$I:,&
M[\_+ L*W!'Q3K&+^,K]03D3&O8N<Y0<_^$J*X [#P<5,E0/2BQ$#LG*-/"\D
M6?(85\-9F+B7X,_B4KLLN(&"2X$QF)-F&>2O^--QLFMP-L-%X\PSGD"+@F_N
M?)NB#T04P>9,^:B=Q+_%[2SZPI8!!73L@4,0\"I>L>>>9]&ME =*B;&89)H+
MA1/9Z;@31Z:(;\LS0$@"8=PNM04&MF'<N+@+T-/HV# ?WQ_P7 IZ&M7O/EYP
M_M*L#?E+-UD:\WIHN>"R;D:6?UBO&[65E7='0'$1Z0<<(--:\KGAS\NON7HB
M7VE1R%>"W\K3.[Z3#.O/*3_=SE>KD-&J3P9@,5G(*MDV9J83>Z.,0 $3Y!)V
M'C77^8I1A9&_^8'^/& <)7-.);6O);4/#Y+4/C954GM;$ZN_D%WQG.3J4=D!
MXTSIU1_??OJBO7M';/[ARS]^_J2]^_V7#Y]^>_OEW8??]ZOW7=C/,\M]CX>[
MRWV?.3?=>*V]Y[<@B3^*UA!83*@S6<SY_$KL8@&_14NI2>$4RK4IF'$B> KV
MG93#DJ'X)07 ;"Q,93^S%)C,L<HLK\_I=S+5:GNU,(>&]H,52@$8'NT2A[J1
M@ C@6)_F*-F2SV6#224V:%AE7D-[^YJJ[&J_, JBWP[9QA#]VZ0[3]*"AC*'
M[WWWGA)3O)AR_H"\DB)*F#4B4JYDX7J99.G'@2A,NQ![QT,IQ\IJ&P3]ME<
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M:4065#,O/=K16O0U@E@%/M54@Q]+*6 [P5!EWP5 0/X*?^=_Q6*E,H=>%&G
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MM@4>$72^0<]IG9U0MM;S^%PB5I:22KE)<L<F[I"R(_:5BM,"6?D>EB!=N_+
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M.6Z3<$GB72C2YCJ0;:/$5"3Z"@UED#BS#RDF!:&"PJ]P1[&N<87,)P#, =Y
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M$2PR7VS=MTG[S0*\* 9TK7VHC%"1(?F,3OB/(C+I,9_Q$FHNWO\12,7U07^
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MQ]J?^\N?B Q_+WU&$C\B&7TN5^&+(/WS)I@^43$<_8U.9^K*!^K<4@'H$'=
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MXCQF4SV^^CI-@+C?:7?:PZG'G@)YZY8YRD6EF] 3=6GAA+L.V+;SGP',3\,
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M;OEA\;P4BF_H39PD6[0)B5'@*RGZY=X".7P! E/%ZB!*%'W"B6O C,G9:L"
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MQY.;NBU3,))3K2:7H5 <QL@3TKRICSI63=J,+%MYI]N(8U^NZ1DV)ZR+CFO
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M4<K,21,<%!<MF6O<0'"B0%$F^1A+4+J37T^"W&$??;7.O%TEW5O:9@/2S/8
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M?5GI?'VT8,'B35&@=8W"U&L!%V*!)"WRZ%R63 P(?'\)QSW>=P1T-B(:#<I
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M_^8 F94[WYQ,GRT6LS0)9%&&:?Y_9J3.?] /+NE@&:9C_M:/';JS_C#K7^O
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MF"\_O9L]]-LW:TG)<JXC'?6V@.)6@K.*T=*"(I5Y'QO=XP^YBCUDDK2DS.Q
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M'>95:F]@9;FW3,C4*=3=VUG9(,S.%?#+6?K7B\7B$O-/EW.R)E_3,V;Y[8=
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MY\]G%Q_G^*$&%RN :7:!];?.K%:ZB, @AR1JLQH"C6<.16@4I1@KUC-9CN
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M+=*3I.9:CHF1ARB;O 0'%XH_'-)T#[[W &_LX'L'T;X%W[> L4_P?0L,QIX
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MQW?#846Q:+("GY0!6IF'X#4'(P1W=>R=-K$KC \\XZBA'$)O#=Y(KC>+955
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M7EGG/$\]\_ZZ//?T.=4:C'8YJ?=%_3LI^.5LL7@U?8-_A//+E?[.DHG<I"B
M[,@ BD<)SAH-'*7W-LF@9;<BG]Z/_L:> 2!ID' YU/ZI=;21UYE)@C$R@*V!
MB(EL?F'(#,Y>AMCF^JG)B;G//#$>BD!G(G"G0QW'+L!+)"KJR+TU27&=VC@5
M7V&>V$YAW[U ?IAY8D5GYGT6P/2J/(I5\XE<_I"84+1C>B;:Y#Z<6)Y8+R8\
MFB?6!Y%CR;#ILJ9O>6);Y(GU(LL8J3;;('TL+(XJ>U%B /3D+2CA&01/_F:2
M+ E6NYSD/5T#'PQ[>^6)'1QY^P \="SAQAQ>";W*-?KI[>\WTXBD"+IH5LC-
MJ+X&4Z$ZJQQ,(!<$F46_'J]^(J*ZZ2D'&"]M#N*F".K."!Q NM?GOJ/_#/-5
ML6[C!J[KCQFMB>NCZ[N7 )92<L%R([0BOS9HX4,*@MN@6<Z\4R/7]0?N/0TL
M9)>EL0)X#.3 ,_+BG2>.8D0=R#'RCIG]G$JGD ;V9-GE%Y>\3!6AA !;9!T:
MYRWXHCF@C(E;AS+H X.BC2(.\"09]CTZQ"8GVQ+Q.#/-GBX&S\(:)I@&8TL=
MG"T"1,D")"NDYK(P;X\V">V ^C <TJJW?@4.\'7NQ=\CSFU[6A&T+=O:B0,B
MJZUZ)6?@373 A?4VQ131'5L/]9XJ^/8V'^;;W)+)QYE?][0.O(@Z(&UF681:
MX)]=W=8TB*R85Q(EYC:CNPYA]4> X-VWSKC((JH$SH3:%2E'B+6C;N+:^^"8
MM.QHL?KFKAPDC8[*DEE/*\[1\(+$:(_2@G+*@V?<@O4\T\9OG/#Y6-^7KZ3N
MI1=7]U;WTH=H1_5&K14D!++Z(@H)9I6AY',F-'1M:B<X.D.VH&B44O.M[N64
MWZ<=:':<=OGUOF$D-R9+#;*V0";;NX#+L;8OB"KEG +Z VO+-U;=R_ 902SH
M%+PR(+VE/=H76SN9)9#26HN>&><:&0-?83K@3M;P7B _S'1 (8H-HG! S1UM
M"Y:1B6$=)%,8V122R?51O=_2 7=FPJ/I@'T0.99$JBYK^I8.N$4Z8"^RC)%1
MM0W2Q\+BH(215B=(J;8Y,Y'<L6(T&&]#+9B65NWI@O%@V-LK'?#@R-L'X :D
MO<XTNDY ,YD9A59!#";7=LH"0B'9C,&L/)J@0YO<DB_$.$!_M3FRLZ%@.8"\
MP%>7R\4R3/-D^KYM9N C#VJ=&]AUC6O9@2A"R*C(-BM2Q90C1BY"S,6*R+@V
MCV4'/O+(O><'6IE+PAQ!FD)<SSP3UX,'Q7WQ-EE6T!V6SW],^8$W(PZE18NN
M9K&K&I#EJPDW#))UQA<IC%BOS]VWDD\X\K\=]_<7S>]#GA;9>H-YO8%I9QD=
M@2PR60N*(S@G+7BNA?'.N*B_A;P.@MM[@?PP0UY12B.*#E!<*J"2CN!UG4Z;
M"_=6"&5#&S?NQ$)>O9CP:,BK#R+'$BSHLJ9O(:\M0EZ]R#)*$>$62!\+B^D5
MER$XA&@"O>/&>XBK>6LB*:883S+OJ0_EP;"W5\CKX,C;!^#F(2^K0B*?/(&A
MWP3%HH-09 ;4=+IXE,YC&Z?J%$->O9!]-.35!Y:Q0EX_A_ET,GV_J&V:7N-\
MI9T;TV96-OUTA[#7]@\;)/0UT%K7PE_%9$PJI6)+45+E('1@2DFA=>#$C;/M
M'[O;GG#SR9\_=7)^2;[SK2.D?"F)A(5BZ^Q6%0UX8QSD0GLIT9N(WV:;>$JR
M77?#WW#Y8DJP8U7JLS](E]70?C>C7>%B-ET-)?DP.Z>W:G']Y&=QL9R'M#R3
M246?' =N"ITK-M'+KFR$A %1IN13;),WM[7(X^^R@_)J?<<<![H&P: O!/^%
ME/:<?/#)])(T]8K<RM5)M&%!58'7"Z)#:9+.0F:R!.W 8N2@M$4(DM1HLY3<
M&2,=MADT/] "QN?C2)1YC*@CX=W"</RR\N8JL'H=TUC<N9VY$C8%EX.7#N@E
MKAT]@B"+VRI +#:DG+,N;;;'7F)^+11LAUV#7-VG7Q8Z3U:2KN0_RZI(5[($
M9AP=(C$@.$W$\"KS&*TS-K?IK]=3T*^%;"WQ:]#E]=[V_--DD:Z$QMQK@S9>
MNVA#@"+1D37#+01,$CQ3O"3+7"QM\D<&6\+70M']8'Z?O&K<0]DY$PW/%F02
M 13*3.:V5"!T,EQGF07R0SN4=ST_-B-+!'A5WH4_O]R)#/.)!V5 )T)412[(
MPC*%L"7;2GNA/&\3>]U:Y*_EA1T'T_LOJ!GK!;U65EW9^6QQ.;]RD#_KSFO/
MA"@"F*A)#+K0#L-=@92*+EQ&TEZ;&]1AY#^QT,,>0&W@T WEEXK$Z;WVY!\P
MC:1)&<ETLQ)L2E8D5;SG>#QQB/YZ7*$\^0/?8KJ<KP9@G"5RE5)MD&ER37[U
M!<F#(N4(SX)E7BK7J$_]?5G&?_7V\7:L3[[9#9(&3NWN7+U6UYG.:.B]*D"Z
MH8U+!@,Q) M6<*U-S,Z(-KV:!EO"5TG)_1"@@;_<S^6P*CE3(TA)U1'Q=9Q$
MT$Z0?R1+$8YD9FV"U&.['//5M7$XOX/;XMER.9_$R^45HO?OD^]<-Y]Y;Z5F
MBHY-4Z<;,$V^F?4:1'(>C4.59#/?8T?9O\KW>63([[_(NM&+?*VS>[H\BUDQ
MGAF#0.]R36]0Y$DI!(9!Y*!2UJG-X+^>@GZ5=&P)9@.WN%.,^*[P9T(*AX5K
MT-PR$MC5>;*&@:'3SAE:0(EM8E>]1?TJ^=<6T/L,M(<0]K^QR&0TG*O,:>?&
M0DLQ&GQ2BGQAYKFQAJG0Y@9JP$5\E:S=%PGN\]F-?9H7%TJ*:$"6.I];UDM>
M54=JT0$0F"N6FS:3=G8ZS9O?!GRQ1057G(S%0A$\@Q(J@?=:@92!Q2R9RK%-
MU'4'H;_*]W@LD#=$80>L#7P@9OWCIZM-Y_EY6"RN>]_0VRE+G<6H:\NWE 60
MV>8 F423D%O'&XW)ZB_L6/5^32/^K4$ZS+H]=,P'S3GD7.@@J[.; YT;X&LY
M;8E1&&SC\1U8W5XCS!^MT.NC^V.I;>JRIF\5>EM4Z/4BRQA%3ML@?2PLULA"
MP,2 L1+(8+"JGB.,%NBM+MI+W<C;.Q[V]JK0.SCR]@&X>85>,M;R$"RIHPZT
M"*0=M[I=)__,F"B4+&WZR9YBA5XO9!^MT.L#2X,:DI\O/I[//B&N\JVN>IY<
M"T;^2C'<6P@FUWMN$R%8[R!IH1EGIIC49G=Z4*1OW!D(K@9[S1LD[WN2JC-<
M15N-9'WS]O=KX4)4Y!NI#"RC !63 7*4,Q3E@XO9)A7:]+5Z5*QO?!H0M@=3
M74:M'GXV74[RO9R=G_],YY<9<UG=*%Q\O%RN]#Y[,%;8K.!X8/E&J%%NJ='U
MF;^(AFN=K;:&F&4\JW/#$A%816^8>:*L>6!)=XQ_/"K,+U\*<S\P<!ML,H*8
M90KMZYDCV0>U6,\J#D+9*&TFJU:TJ9@>:@4[1Y)VD^/9Q>QRNB0U\B2\\*"Y
MH:W,9C*SZK]XU$I[YP/#-NW.!A%__)-J+_R]%\@:'?JF+?MV7,Y58%#7&?81
M"[!83WL6:#6&EL19U$Q%J5 TZF0]Z#K&"N8?!(_W2(&#N0_8;>$_?MK\ :NX
M3XFL),7)[+6)7)]2/!G 9*L*5K@7R)AKU,JRX:+V?U<Q/E6'W?T'HTP#;WFS
M9'=\NB[R-;W@>$K"/5U6' HE.E%U1SSWP3L6#$:1+2"K)?1"!?"B:!"N9*T-
M0QW:U(3LAV]/72\<*]WZP#@@S6IXX>SO],WWLZO&VK].SG&QG$UQ<1U14B'J
MZ$(&6TNF%*I81S#4*@ZO$D,34LI/15B>?,JA>$O; C)KH<T!/9N58*_GB!<?
MZX+?U*RM&Y%D<%Q&'Z!>:X"25D'0/D&*D6,,P8?UT2</ +SY\T\)V@$T./2[
M^V[V\?>/5]+\,OD3\^OY).&U7/1T*0(WH.W_W]Z7-K=Q)&U^W_^2NW4?7S9"
MDH]7$1I):]DSL9\8=61)&%.$7H#46/OK-PN'2(($V UT-4#((8?&E#7=3^63
M7959>=4TZR0=K5.7VOD^U/;F@;DG+T>?>LDYT3N4+ >L(=W$]8\P^Q.O[P++
M109?4WA5JOU"A2W@,/HZXP"9#V2NY]B7Y =O.5.6#Y/F@ 66"V O+J]GDW _
MUAS0B<(<G1=%.=I:8@;O<P3$X%$RK;%T8_>1AY\3J8?*KD%_GAV!7Z.EU*1?
M@>Q&,@*T@<"LI$-#!U.KLUKUXCFA.'T351A6]"WJ+N]/-ZN53R4)R%+6L;J!
M8)'*@G68C58,<SK+H7--N=]?Q UJ'7<'ZZ-.(F>?(6DR)U1F!$ZP! 4=%UJS
M:-,/D6/15!^&HV!K)>+0 P:7]_>OK\IT]GEQ4?&VZG25SB'3!)]^ZC"C WNB
MW\@HD(Y[3TZP5\PHST2@7W1\<Y9B%D:JBP[//S#ZMWS!;_AE.KN>7'V\\Z;;
MV)*UT<I@R-LSR8**D5P^0=^:E)FKDF60OM&HC@[H#JZ/795Q+5]2HP*KM\XO
M=,(2=-9@(DK:3V6$&*6";&V1Y.R2R=5F@OEV3$?("1M:0Q[4I@Y#0(/0^(O+
MR^E_PE7"7Z:SGZ8W\;K<7+Y(J4;MY[]APLG7BO;5S6Q&:"]R\"(49\!)VK(5
M6=_@-/V8F-""F622;M,!IA?,,U2@=C0U"''TJ> D ]X+SE6"4#BO!ET$%XL$
M@9A<<(8^CN/7Y9ZA1C4CJ4'#M=_P*Q*R=3>*6F+\K\GUIU<W\VM:PXR6<GE3
M\P9?S.=(_^0*V=$&:KU%R"'1-Q"\ W((%1C!33!6>LW;M.W; ^P9JE=KRAHT
M0R.<"2O4*H7?)O,_W^.L_D'XB/Q"E.1B$AKH;#8DBU(@.H/TH^,EB%P0VU1I
M[T)UAGHS& D-+@#O#/_<+H:7WU;_<9E]8WV4:+0$S7FM+8J$EB</*#%QKGV6
MJDU#U3W CC;-M[42M2;J5#+Z'GPL+[]]K\2D33-XR2/MGEJ#TC'3>H0!ZY4O
M0F:A4IM:PQV@CI]1UT@?GMK$]N2E@6W^ %H%MKJ5ZP*M:<;;#G#'278;C,BG
M%.1 %D96%&^9975ZE926]N;:\RTX1TZFS=9)HS U:HD]NH(\D9UV#/WH(_P6
M>K&RX!] 7%W .\E=1N?!:E>-^&C!<87@?:@I%V3CFT:ZL1O8^+;R8"1N*L>
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M5I'<+4-;DTL2 EH")U6.K@@C7:>>7:?(_!9;8C3B^\AVZ+J<7Z8WL_N+7%>
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M5^%-/]Y>OSD'WGI*;< PW.)><E'U]6J!98+KQ *78\Q%E#H>SA @1CZJHPU
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M)F6V(\#Q'9Z!J>WBA!_(2X,[^GM"N(-NVTW9.I*LL@W62X2$A<Q5;C+$7)L
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MN9 ;%X];PF!;7S'^N7^P]*>#BZYO(LCJC^MO,<SQ?_^/_P]02P,$%     @
MI3P&4X[88^=!^@  D7L* !4   !C<F]N+3(P,C$P-C,P7VQA8BYX;6S<O7MS
MW#:3-_K_?@J<;-6>I$I(> %)\-G+6[+L9'W*L?S:RI/WE.O4%*X2GXQ(+<FQ
MK?WT!^!E[L,!."1%[Q]Q;(D$NG]--!J-OOS;__KVN 1?1%XD6?KO/[@_.S\
MD;*,)^G]O__PQ]VO$/_PO_[CG_[IW_XO"/_/JX_OP.N,K1Y%6H*;7)!2</ U
M*1_ GUP4?P&99X_@SRS_*_E"(/R/ZJ6;[.DY3^X?2N YGKO_V_QO;HPY\L,(
M<@=CB#R7PYAS!W*.(\Q0[,8LN+K_FPBXRSQ/0C\,)$0A#V <4@81"IP XX#[
MHAYTF:1__4W_04DA@&(N+:I__OL/#V7Y]+=??OGZ]>O/WVB^_#G+[W_Q',?_
MI7WZA^;Q;P?/?_6KI]TXCG^I?KM^M$B./:B&=7_Y/[^_^\0>Q".!25J4)&5Z
M@B+Y6U']\%W&2%EA?I8N</()_2_8/@;UCZ#K0=_]^5O!?_B/?P*@AB//EN*C
MD$#__X^/;T].&?^BG_@E%?=:LA]$GF3\4TGR\AVA8JFHKT8KGY_$O_]0)(]/
M2]'^["$7\OBPRSS?&553&6LJW5!3^<^G)OOE O('HK<\I'4 XBIVWP]%8Q>F
M[P<C]T[I!S$^P5O37$QR_4&]2?E4W^YZJHM)'Y_BH3Z+K"3+"3Z+S31;)"_U
M#]ZIOS73Z($ZE&DU3Z.ZMT@5WTJ1<E%KRYVA0<+__0?UM\6J@/>$/"T^K9X4
M5WKO(\L;4CS\NLR^ODUEEC]6BOR:%F5.6+E ,8](S$,H.8XA<J0#XX#X,!*N
M1T+*71[$BW+]J2]$"O_XU%)53=UKWA\L<"A/K.=<%-DJ9YN=\'%Y;'M3.YO>
M"_$O*7D4Q1-I7E#$:Z.AYN<_MLD&3-$-I"(<)!O*_^V7#<O#P;]\*5"7$^*I
M20::9K!%-/C<DOW_G80V8SL$+K45DN7[0&6L+U";Q5XH'BN4)"EHQ68SY"_:
M$/Q%+,NB_0G4/X&.VU@N_VP[]R\'7\]UWO))<G9&>,T3O[!,F6A/)=R1HS9I
M+P*DS"[Z\&HQ*1)_ %G.1:Y,]"/L'BR6]UDIBFNU(V4D+3X*)I3-39="603O
M%9>K/%?S+QSDRQA["/HLB""* P8QD0%T, IEY+J$^IZ-HC*9=&Y:2M,*\C6M
M5T#9>'9ZR0CJ@$8^INJ4XSB.@MJE(21$'76BF$88.1%%4BS*]3XW/=0G=O(A
MH:ZV<;#,TGNH)/L(GK*\TEJ95#]4;&R)800)F&T+0^,Z\I[P:Y*J<Z4ZJH./
M6Y\PD0I?<+U4FD6?.H%2+OJTSI,2O,N*X@IL>!ENG[!!;M!-PFCB27<(&RCV
MMP>K=^WVAB(O%^_5QW0K?R?_R/*;55%FCR)_G3V2)%UX+& $(0RY\$.(2(1A
M[ 8N9&%$?"^D-$+"9#/HG&5NVK^E#GRNZ3MM-UD@V:UI!L-G9-5B#HVQJC!B
MO4LWJ &V](+ZU[Y.Z)YA$B5@Q&2[ZLT>[F<"?GH@N7A%"L%OLL<GD1:U?9GG
M2LJ5_?GJ>?/(!_*L?W3]E>3\S7^MDO+Y;:H,T<K36]R6#R*_>R#I[9,>HOB[
M*-2I_&U:^ST6TN?(%0&!/!8,(@\Q2!!VH$L<'$>>2P+*%@<>GO,GM(GH-UIS
M9NZP(==?320@*0=)4:P$5\N/T&29E(DH0"'*<JE^_6.2@D*C4/QD>9J>ZNOP
MD<N$VD0@C:( (AX1B 6-H4"^.EZP.'+8^NOX[C^,D;^)-]]$SI)":)-9,:08
M+HOOX!,P],C,2:P3N70T/U#?W7"PS338XAK09[#]7,,YJ%B_ C7S8(M[4+$/
M2L4_: "X HTV49]*#<* _J&)Q3:L@VDJXJ?U4$TLD@,7U]3S]S.0?B5)_G>R
M7(G?!2E6>459L?[A?R8B5T,^/#=6O908819Z$ ?2A2@0(<28<LB8'_A^@&(O
M<FR<95:SS^W<I.D$%:%@36EEJKR__KOE6:J?-,RVE-$P'MNM<Q&\UBJ\%TR#
MZF$["B95IKW V=>(_0;IZ?H7Y=N4J6.D]O4MI,<E"0B#;H25^>TQ FDL NBP
M2$81QFX8N%:.Y^W1Y^9A5L0I$T=3!WY<*OI^ J0L\X2N2NU# V4&;O(LS0KP
M6YZMGBR=S#NP&GJ3^X(ULG[1.+UM<'I7X72]A],',K!W^!@2P[J!=V:8UM][
MC+D#Q^[1A^R6N*(J77Q4-M"M_#/+E_R3N->:Y'?Q2$6^0($3AY0ZD,3<A\A5
M9VZ"L ]C5\J8,\85;R862N<L<[-$-)WZ.%Q1:K:BNU'L7MF#83/R"J]@N6U@
M 0V5X'--IZ%EUHT3;^) *]M^?+QVIIL=;L;ZT B/6B_J1RMEYX2^4ZFZ[I<G
M47E&]+>JS^SA'BJPWL6K35SIU)^;+U+P6/*8"!@(?<<N(U>9.@A!+\2Q9 P3
M$B!C_7=TBKDIOVUKYDKOZ#];K.SC(!JHOXNA&?OFZ@"5/HKO.#P66N]BF"92
M>7W@LM-WG4AT*KOC;TZGZ3HIWU%SW4_:7]3?9&F1+1.N;Q7>I&5UZW/]+2D6
M6&DWB3"&+O5CB#@*(.:(0]_G$I-(L! 9!6UU33([/;=%)V@)!9\UJ18W]B<A
M/7]A/P108VN]/AA97=V? ^'BF_N3$TQV<7^.Q>U[^[//VBUZ+I)%-<SSFT>1
MWR?IO5(F7\L'[4(GZ?-",!K@2 ;*NA$!1#&AD+H"09T5Q;#+W#@*3=;]F7GF
MMO1K4D%+*ZB)!0VU9HO_'+3=ZW] P$96 3VQ,E8"AD@<T0.%8#_?9U]^42/4
M:D#]I=( U=H_-^XDR]^0N58#F#[>SX=[^R1R9?:E]^\$*<1'G3YY*_\HQ'51
MB')!O="G+$"089TRR84'8^:'4/@HH($G")7AXHO(:69Z&=4YG\T7OCWKB*=T
M32#,)%P5 A!-8V'GS.W&U\RY.QAF(VN%-9V@(O0*K-%3Q(**VN'\O$:@#.KW
M[9YQ4C^P$?/[?F&SE_JID8])\9<.)OY#D9^7)$DK&Z5-E&)(RCB*!(P)]I5%
MX0M(:>Q#5WB,.U)B!P<V-]J=L\W-KJB(K>Y4=\@U2:'J ;691AD,P+&=R_VQ
MLU8H1I@,JE"Z9YQ4H1@QOZ]0S%[JIU"N&<M6:5E460I5BH*::)V$LDE7>/6\
M^?N=FJHZ9GO$=R(_"&"$(@Z1X+$R6Q"&L0@CC"D*A!O9Z)M+B)F=.EI3"#2)
M5KZ-081CIJ&F@GSTVS$KM*V5UA P#:K3+B)H4I4W!'3[&G&0,>U=N!]UN&-S
M;\"DSZE''(@\G5T5.R$DB&$8^C&*2,20^L_4:[LU[MS4V"=]65&4"2-+L!7J
MU".]:AN\\_[9GI",K&9ZHV'EECW"^\6>V.TQ)W.^'F%DV]]Z[-=]7:S7G"M!
M%\W_WB6I<!>.ZZ,@# 3T$5/'H0"[:HF2"/(HQ'&(&**QT7&H<Y:Y+=C&9=B0
M>-7^!6ABP6UJF(C=#:RI>_5"N*9QKMHCU<.]VH'$!<[58Z-.[%KM8.S0L=KU
M<+_CRVN1J]V]3+Z(=YM<N@6/<:0>5PJ0!@@B788NIKH8$2>!XP6$A[Y1YG/G
M+'-;^!LBP59>H=V!XSB<9B>)BT$:>;EOX=,2., -BA'W@UK^QV>:U*3O9';?
M5N]^N-^R?_--)TTJF_\368KBCGQ37ZD3"9?P0,)($JJL<NK!V.<>5'N_0(C0
M4'*W1]+RD:F,/NKI\XMK2D&I2;1;]L?@-%OT?=&9:(>O$=%^S8H^<->)C?6B
M[^!^T"5_;)Y)%WP'H_O+O>O1/H&A2U(4M_+/.C?Z-J^N4WXGWY+'U:.R(Q(=
M24>6GU:T8'E2I11^$.KK24MR+Q9"N)*0((0A=75DE2LA]4,*9>!*WT$L()Y1
M9-7%E,S-5FC(!F1--RBV" =/:\IMXBLO$56WNIE4 ",KI8J-*B*]9@3<YO4%
M[A5HQ;+A!FRS SY,+A:;Z-B)Q#-5$.VH8K(,MQT VNZHW$LFF#!X=P <=F-\
MAQBPK\OJUV0I\AME'=YG^?-"X( +KNL)$A>K,VO$U)G5=2 .'!0'- AYB.V<
M53OCSVT':IPO%8V@)=+6-[6+H*E7JC<NT_BC#"'IX80ZRO@%[J?=\29V/!UE
MYM#E=/RQ'H;H>U*NWN2DS4P2//)"-X)1C-5A4^H*62'V8(@%=9B#'8\:K=;#
MH>>V4#5Q(B<6!L<N4@:&76_^1UZ0#5U]<HUV,;"PHGIC,9%99(R)G85SE.U.
MDV7WC>ELD*.4[A@5QY_HH7+^2)-2Z X:I2AV4W7=**"$!3X,8A+HTIX!Q-(/
M(8X]Y',:QMQSC=7/R6GFIHIJ0D%-J<5B/(VC@7(:!)V1%=4.,)?DAI]&RD*%
M#8+81.JL)W)VRNTL()V*[O3;TRF]LQSL*,#S3P]= O^F*0E.PDA2CC&D5$J(
MF*00"T_ ."*^X)YDCN\/4__^9I[%[QNRNBJQ#UH0OP4^QJ&,*/<A9]2#R/4H
M)#YA4'B22,(<SW?Q,-7P^P _62E\=A[^H9$WNZ<9%,^1=[.>)?!OIJM_?_,B
MQ>]OYE7Y_J9OV?O]%WL6PV8/@J^6XE:>+4Y9G*I.>:<I6M 8>9*B  9>S" *
MU!\8QP'T8^Z*./2X$]EU=QJ*LKEM+BUC6JV9%+HM.BO=@L\5DY8A\<.)W4QQ
MOH@P1U:P$\O1O@#QT)@/6V%X,.JF+2$\-*@'-8('G\ ^0']#0UUX^'=1/F3\
M;?I%%*6>Y/"G0NAN#57"#*$2!Y$2N$>$LF%]JH\1*(24\RAT0^[ZB)I&]%]"
MR-S4_H;J*Z!IM"[3<I%4NM7TE%B/K)5M8;9**1@"HXMS$"XB8K*DA2&@VLYR
M&&2\GC:R=L%4Y=E719**HO7&U$626"00<6-'2<G'$ DF8<R5OF.!;AQ("!;,
MJOYYYVQS4VHM;;WR,KMQ-30LAT)K;&/1$"A[*\\$@&$MM\X9I[7&3)@_L+",
M7NIQT?1)V6A)F7S1*1HI63X72?'V47T/Y:UTG2;BY;5@N:YG\39M_U^9<!_R
MA(G;=+>6-N&>3Q%S(*,$081D!*D;*'.**"/*(2Y7BL?X>FI@XF:GB#2AX$E3
M:G%1,[3$#"["7E .HZNX-6>@9>T*U,SI"$#7:4/Z0,L@^+%E\2?P-JT/QZ!B
M$]RFX* :^PM*UN+B[@4E/-%UWPM*VN[*<"11=%XT#CWG=->3(Z&U<ZDYUAR7
M%,O^FJ3W37FZK8K&B 2Q(*X/0X=3B!QEX<>^]"!2!CW%U T]S\B?;3#7W#;3
M3>7CKS=9G]+0QQ$UV!V'PVGDS6X+(GW%UI!Z>5'MX\CUJ:Y],8*3E]GN@63/
M>MN=V)@5WCX^Q M4X.[DY7@I[NY7+FP:I_3S)E>U*M:WSA-N:GWPV_2CT'?\
MBHQ71.T ?Z09+41>W6R^39]6I?JU@D"]4WU[E3O[3GPK7RGN_UI0YB#D\QA2
MW_<ADBZ%F# )*2+8HXZ/&#&*VIN<\KFI^>T+K%VZ]4]N2)X_ZQ5Y_5@5">K9
MM6[TS\',3S1+(8\= ;+NEG=56=A;J?L5X\K6;EG_J:W#PX&2_II]4/%_!;81
M !4$^Q],?7L)- R@PF&,-GQ3R6Z<%GZC4_\R[?^F$LK)UH&3$=!O8[PAQ8/^
M3U]0?"%+[6C4K7_48:847/_B.N6[/]AZLN[GVAZ$M@Y&RQ57S+SYQA[T;?!'
M4HHW4@I6+H2'I1?Q"#(B=4P[BV$<$NTT##R!M4-1)VN;AQ!.2_[<XA&UVJQI
MU"VBF>*N*H-0_45L^+3;&R?^(LPVR/G*>>R3G&+E"N@_P19'5V##;/U++??]
MG^V\4(, 6A3 CRT./U7=@VHH0(L%T&" &HWAMLJ7D>*@^^7$+$RZ:;Z,>/9W
MSA>B8J(;M3T/X;K4N/!%Z+DNAD0B=6STU!89.SZ# 9)<^)0B/^*CWJ:=(&QV
MI\(NYWYVUKF?'?'F6Q>/'USX(UW,#2#2>5_*';N;>7EICGP9-X!4OX^+N+[2
M'?\2[HP(!K^ .S7?O"_?SJ!T\<7;N?'[U']8:5_SK;SFJV6Y*L2K7-G5Q2+&
M"&.',B@"774PE!3&A,?0\V)$A8N"(+8H!'%TCKGMLS65>D<EFLZJ91.M*+4I
MD' <3H/M[G*01MZY&GR4%KM>X_-J('QL*DE<C--4)27L\;(L+M&)1'>5B>.O
M3EANHI/VW;H3W8\.57SQ>%VL=O)/VEU9E7B](<NEX*^>F[>+YO5B(7!$"-6]
M8B@)=7E6!^(((Z5!)9<2>;$KC3HGC$?BW#3ND=+.SU<GBS?^F*2@T'$G5G%G
MX\C:)'+BI24XMION="'!$P4$K\!&)6Y8!36OX-5S.U*Q'LIF9QE'T)<6BIQ2
MX"]?07("P0]087(HF=B7GKQXYA>N23D4<N>+50XV4[\[P@]YQH3@Q:\*%%WP
M^3KEOY-2S_E\*V_+!Y%O$IV*!7,(%VY(H._&'"(L74C4]P 9BVD<,3>4OE&&
M9:_9Y[:IM\0#_4&!@M3A+)FF&B0;LNUNZ.SD87;!-AK*(V^\NP!KRJNKL)9V
MC79%/7AK@+;UA58OU :]C[*C8-+KI%[@[-\&]1ND9R;EN93V4QGMMY4^+G[-
M<BD215Q5$^7-MZ<DKT8HWJ;UO=1"<N)[;N"H8U 8ZV95(228$"A9)+$4W(L<
MOT?[BM$)-UKPTS?#N-%%@I9+4IM5<LU%I0*$9J-2 %G-I?V9:;H/PTQ)ST/.
M$UT-&=0LZ2Q9<@4:KJ_ %M_5I['%N0Z<J7D?,.EU*C$-FS@[.M73)M].)82#
M!-[))IY!*'RQ&YKX293ELJ[^LN">'TJ'!-#AH82(^A1B7SK0<_4>& 5.C%"/
MO6XB\F>ZX[WY)O*JW9':UG(+I]#4PC?;S^8DR^\_Z+W8BWJ_ EL8S#3>_;S0
MYAOMWD'[]QOK?EX@HT:Z&TS?LX=H4CQE!5G^EF>KIV(=$*A^K.8KDW2EB'L2
MS4ZK?[K,-,6;1!XD.,$A5CN9'S+MUE)'-]V#,/28" D/!6>A5;O1"PF:FZ?K
M/\620V6[P,H'4XF_-K:W.0(;EBQ[EEXJ/K,-:4JAC+S3M*R FI?M(.\3$KD"
M&X[ YU%RI8;"=]A>JY<2-6U;UH$@/.C@.M2X]IVR7C=7=;^J4<GR_Q4D_U7]
MI%CX*(@Y(CX,0L>#2@%',)8Q@@PYH>>R$(<H,NV6=6*.N6G1EDQ0TPDTH:"B
MU+QMUBDXNU7@0""-K=7L\;'JH74&@5Y]M$Z-.5DOK3-,;??3.O=HSR3#JH3[
MC:8T+6L5\C$I_FI+F>#(]Q@BT'495<L\]"'U!8*4. YW94!9C&PLJ\[9YK;@
MF^KV.]0"3:YETEXGPF;&SV"XC1UK<PJR 0MR6&$R;()9YXS3YH.9,'^0OF7T
M4C\]<IO?DS3Y[VI0-4.1+1->>U=3_D%]8FVXSZULVDN0Y;J<XB8_(]#E"25A
MT/.518%<3YWD(C>$@2,I\['OB=#J)#<(57/32]M,78$=MJI3W39CVAFY9@UL
M>+-.Q1E6SF9:;W+IC:P=IQ*<M2H=%.A!5>XPE$VJF@<%<U^%#SMX/U6OLW^2
M7(]X*]]EZ?V[Y(O@M5?I+GLEZM.J.I+*A1L&'O5#I<29&T.$L =CSY,0NP%"
MA :1CZ/%%Y'3S%2A&\]ML^RW*1AO]?^9)Z6 //N:@C(##]HG)[,<5H%GI.+
M3A.;BT'0."*,^="5:H6AR&.0^($ZK+. "M=!/C'K5CFJ$";II+ FO.H,IC/5
M'K(E!\GC4YY]:12L$@X5@#=,J ?'$HO9)C@*V"-O=+LX:ZIA17;K>ZXA?FT
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M% ]K/?/<=I@UB;WK7)F#'M' IX)1Z/N1[I*)(T@0=J$7,AGR" L9$[O61Z/
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MWSUX5<>QZO"_=>97IZTZSOZYR<FHRWZT?6E][GFAC"7T0GVYYZLS#\:! ]T
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M>Q7>V1EHLD([Q\C?+JQS]/>6D3(ZIBM_7MQ<+V+LT)A(!#UU.E0G1B8@%OH
MB9$@+'81%T85 C=#SFUYW9"4<&(8CK !YDQ82"]VQP[GN'Y__?IZ@(OY ^8Z
MED_S<+V$FG]LEM'64-/<E!^0OK[A/OQ-/V_.NLKG'VE2-O>8-) AQHA!GTM=
MARX((7%"#U+L,-=WO8!@JYOG(W/,;5EMBMQJ&GO>&1_#TNQP<B%"(Z]$6W"L
M3?P.]@<UQH_-,ZG9W,'HOH';]>AL';<?L^7RURS7+RT\%OD>Q2&,7!(J+2+4
M7NQ2%W*]"4<N"UC?_B]3D#\W!;5QS1!-GF51D(E%/QN/3$^!_L]URU2%W2MW
M'OBLP0$-.J-TQ9E2K-^;TV:;A?]IGILCXGD!]\TQ*OH6;&ZN4==[\J>2E*MB
M$3NQ( [V8!#A "(1"AC+.((1\YW((T3M?(%=P>;C$\UM,ZII7<<G;.S#FES;
M@LTGT#WO!1H*LY'U?5^X>A1L[L;B@H+-)P:>N&!S-WN'!9O//-^G&$G&$E&*
M_[T25+ L*<3KU0U)4T*3HFF-X+F>IT[)',;,UW';H83$E1@2Q,*84!HZ3)I7
M$CDWW=Q40T,PV% ,7J] 2[--E8>S0)_Q:0T.W]A6X2%R?(/<^<X2?2"TJ7(Q
M))13E:CHA'2H:A*FP'27@C@[RH1U'$PYVBW"8/S6!>X+>MYDI/LFX[YAN)?P
M\YL.='A-2O$K2?*J6-4U5=8E8>7"$9'#'$JA%W@.1+X,("&8PDA0)@+B4#<R
M*@KU<BS,;7OX<S^#-A?:LZ6-H:J!L2)Y199 D?((?GP6).\5=C+M5V+A[9BM
M[.?O\3CFTSC([ZS T-U0!-!PU+4 P><6D:&]'"\BSN$]'=.R,;VWXT7$=-3C
M\3*4]-MO-UVOBH]B6548S^[(MS^3\N$A6^I6]+]F^7$_SH(3UT>>+R&+B=HX
M"?$@9<R' 9$,82EDX+(>5=,O(,E(&4Y?4'V+=%"2;Z( 3R3ANKQZL:4*^[C\
M+Q&?V8XVMC1F4DWHM6"Y4+\&,LN!X@]LR^R6+I/[BJ7AMI8!<!UTC[B$GDF5
M_0# [6OM(8;LIWXKO[9.VB'%P]N498^B*6NU<)7RE%*I5.9R!)$D%,:,"1A@
METH4.=QSO5:YFNG5DW/UT)HC*\SZEBM59VA-+,B>U"98^5*KMFQ5HZTKD K#
M0N;GP393A9<!.(VBJY%KB 0UE>#'AL[3IRQK]746BT&5T^G9)E4]9YG>5RSG
M7^BG-O8J<M>WOK?RPU*=LLM$RF+A^"$.!%9[GD=BB"*A_=,!@=05CB_5<I;(
M*!#9>,:Y^2"V0BF62W&O]OW*UM+Z7,UNISC.PVVF0 8%<61%<EB+?X/HAN#A
M%(HQ-H,JEO.S3JI@C$'85S3F+_:X#:L+[%;FT=OT.N5M?ZB[[%K*9)DH@Z"X
M+M<GTZK$KA3Y7;;S8GVG?\VJH%:QKMI;+#P1\D@&$8PE"R$*: #C$.MN4(X3
M$I]0;M8#:@):YZ;D6O)U4Z1DPX#Z.Q!U[!!I>6A^KYBPN%L:6?(&=WOSD>?(
M^G:+7MVG47=M7/=AN\O AMLK<%UN^3VOP/HC4(_MC=($D*T97Y=LG]%'8'$[
M.9^/8:*KS;E\%'9WI=.(J?.B=602IKNEG0;+G2O>B:;LV<HSS[XDA5ITOV;Y
MZVQ%2[E:-I,4B\"EGA,S'W+$I*X9X<-85P +/4%CZ824V97+[YIL;J: /E@R
MO9I9+GA2@J6R"-L6GND]K.Y:99(J229D"4A5S,VRYV07]&8'H*$ '7DO;DG:
M:BUY!6YJ7*MS47.*!S]^%%^4;,ER0,^*"4;#MIWLFG#:EI,&K!^TFS1YIT]1
M=O5'5ERO]"V;TGGODL=$K:XFHLKQ91#2D&K-XD/$F0<)9Q1Z"$6>$[D1H^;1
M?UTSS4W+U+2"-;$V%;.[ #4X"0P%T\BZ8Q\AT!#:)[2O$S*;FN$#03=5"?#>
M$%K6\3: I;LL=]< $U;9-N!CMVBVR0M]:V!K+[>.P*[#'>JB4Y\>A"@K4U)M
MH>K;(<O72<&4B;)2W\VK9_6/ITSMHK_EV>I)V8YLN=*7;OJ9RJ>U$ORVO@+*
MTN*NZF_M.['ONU$ 4>QBB 1Q8.QY/A1N& 61SXF,C)(R)J9[;OJ\Y0#4+%R!
M-1-@FPNP80-\KABQ+K0]S6=A9H;.4-@C[THCR+E'->])41^X O@TM$]<-7Q2
M@1Q6&I]V^@%*9UQ_2XH%(9Y'9"B@AWD,D=J 8!PZ/N2"R0 3QEQ$>A?.T#/,
M;9/8KPRA:;RD:$:%HIFFO@B;D76J'2R7E<O89GV\8AG5+"]7*F.;R<Y"&3L/
M7F*G:F?.KXJH^NITI8;?*(\/(G^=+%?*,*XBOQ:(!U@*AT#FQAPBB;G.^&,0
MN5X<ARST0[MZ.=84S$TM-+0!"-B:^#942QL0NJ@HSY9+DA>ZU&P=?V&9Z&$O
M)M>-.):.A#[3%?@"WX7$<R,8>!*36 %$0VI7*G9404U3\K45E2"YSL)1LM'N
MX9^ 7I GI+>6V O)T<:2'TDVH]_XUL%Y[S:BV#"P98E?Z>YEH!5AQ<701GD/
M $<PKVVH> %#N0=(QTW>/@/UO"U3'YSNTU-97(ASWV->!#W/01 QZD""0@I]
MA#'Q'19XKE5(X/;@<]N;-&U-5ZH>UNH.;(8W6SW!&%G'&.-@?TUUA.%AKZ6V
M)YCV&NH(:P?73L>>Z;=(US?I;].G55F\$U_$TFV<_-(1F(8XA )+"I&GD*(2
M865T4B?@Q$'"]VS6;,=<<UO"%6W M5NY75B:+>2!$!IY76^'^M2$7H$&L %O
M22PP&73I=\TWJ28P8'Q?,9B\TD]/O!?E#2D>J@MO+OBKYS\*'5=31]8H(^)Z
MG1NS3EKWG8C$+B-0!+$/$0TXQ,Q5?W@A<=1_B(G(1GW8DS WK;(F=2N5R$[%
M]!"#F>89%]R1%9(B'FCJ04N^3O3_47, DO0GL(%]P\4H&?O]01Q4@_4@8U+%
MUA^F?7UWP4C]U.!O6<:_)LOEV\<GI6KUS8$^3RV4,80#PBAT"!$Z&3V 5" !
M6:CLI @Q-PJ1G=_G^$3S<^ZT=%Z!9$UI%?YGI]=.X&JFNR[':F3]M %I0V(5
MRS><ZNG&8%#U<F*J255(-[O[:N+,TQ>T7='AQ]5-87U%L/ (9:['0RBU[Q<)
M'$/B$A=&L?Y(0HR=V+X%R]XD<[-J-AU)UH0V!2A[]&;9![1; PP%T\CKOP="
M_1JXG(#@LF8N^X-.W]CE!%M'F[R<>K9/(<XR8W\U.;MU1L'MJKR5'ZK.A9NR
M#0M!0L>ATH&$ZQIN3DP@07$,I<<]3U <<(^9E^,TFW1N2N N>X*K)Y#KPD$%
MR%8ES"1L>CR2-=4VE24-P>]6$&-!.K+"V*;X_VYRIJZ HAK>2EC3#:['1-6F
M:N?PZ$Y5NW,8E"UK>=K!U5W1TW"L">MZVG&W6]W3\MU^)[@WS2VT&K8MJI.P
MZY0W%U]5T8RMH*^U&\5U$')YS& 4J7,>DJ$/21@'T&$!#GW7951:76#UI&-N
M>O^@VF:Z+M2@-H&B)&D5YUGW=[4[$_:5E-FA<0+\1]XD6@ZJ&_J*ARM0<0$4
MZ.V5_573M&.+E5%<7Q?".>@!M2\MDYY@+P1L_XA[Z7 ]2P$EA";+VL&6\D,%
MOB"$>HC$NDB]LHH1P2$D0:@D1A&)XB!6)V1E&F<E69IIS7,36JG'];1CFL5J
M#K#<4%VMS>UB0/_RS]ASHW]M2F98E@8Z![^9*AP2U)%UWKL])-]THV9?",@0
MBF'K )V;=-HR0(80'%0!,GVOQTG\^C[/$BY(<YF./=\)N$MA[(H((L$C2'R"
M(8JI\&+!7"2,;+$C8\_-OKK^[:W%\6X/)X.S<7_N1U[I+6%]4E?W8+ XS/:'
M8Z(S:TO@0*?1X_QV'CKW7IGN;'F<UITCY(E'>L8OBNKL\DZIM+K^;O,Y^5Y(
MB:?434C"$"(J0DA][L((>8Z,B!N&S*@#])EYYJ:)&C+!AD[+N,83<)K9* .
M-++".L1GA&"H,S ,&P-Y8JYIPR&[&3Z(C#SS>#]-\'HE[K*F./,'DFL31]=5
MK3M_+5SAB#"(0^A(X>AZ' @22AADV"%AQ&FHQK31!YVSS4TK*&)U_;^J6K+N
MKI(MEWH1)*F:7!2V57ZZ@3;3%(/!-_:E8(U<0REH2*V:CS3$#J<VC# 95'ET
MSSBI"C%B?E^1F+TT1/K?\>SA]Z*\E7?DVWYF4HPDQLK"@*ZOE8T4 20A<J'
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M+Q&FH;-W(A&-[>W=D<Z&$7#=2.?M@736[(#?SDK'WH4[ *S#^G O(6A:)^X
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MGNL>"(WIK?9!*L!3?0&%Z][IES>.[)&^(/>I%_K2A8'>@,U&;=\_/++YVKX
MQKY:&_O*6*@R%Q@QD*9Y":# $)"",* EHY!F18IR$N#4/#_:1%V8>SFKTA!)
M=;:WO <+6UXX85853P/T M@%4[B@>0&R@F@ &9: %DB#4I893[4L5>FTA$1
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M@\H?EI?V5< 3PMCK;K5^7*W-TSZNEE_5O1VPM;QXAFA><H!3C #D$)G]&%=
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M?2:<V[!L\W::;;\$"&*5$R1YRKQ.K"X--+7%LY(SO!S>13S=%K08* V\O-0
M61GKRH'O':#R)O9K.$2EV8N#C4IZUU1^24%7KP\CA/=+,ZOF69_9W'8*G!5"
M:I1E$&C)(( R-V9[1C7 JF"YSFB&[0&%.P^\>/[4/O]6O.31R.?WZ;]$SNV+
M[X''X!Z]!@HKFK7VQ.))5O;<_J V:2^R-J-9J*J,YUNQG?^(7/?R DQ1>>#E
M&*-^_A<4?/G57[K,W^W?)$C_HE;W:_;X?2[8HO%0(<JTSDKSR=,L!3#C)2 I
M9 !"76*M)2G=HD8[1YG:AW\H88"C_S*:UWW\43 :F S\X/%R[5]5O[=7__((
MHSGTKRIYZ,N_?G&<JFW5%N7S>B[:BF$D%T6NH "9RA6 *2H!(VD*:*HQ4HPC
M0KR,_FL#3HT$*OF21RM@PK;)#[9XJETGDFT]?6E7L78S#V(B.#!%G*G)5N-9
MB3M"(;9+V Q:?NUDT%<MNG8)@FNEUB[>YV]7?%ZOY)/8;FZ7LHFTVC0KH4Y+
M2:E !E)LMA(8:T!8(8$62$%=0/-WX6I77!QE:I32"%JY4!M) \R+RZ!>-R^B
M0#7TJ6((2EY6QE44>EL9ET<8S<JXJN2AE7']XC KXZ.1TSHI5PMST7V[8=E9
M& 6#1.:@(-:MF*6V(P?. 9,*DK3,D;$_?"R,KL&F1@6V:."!L,F\D=;3Q=B)
MKYM5$0NU@5GA6,R=KV$ 4\(%D*AF1.> HYH0+JJ_-!^<[@ECCR]JH\Q-WVU]
M!5M@?_5HC90F46#&6)XBKCC .+=QP+:U3\HYR,M44"61*EGI0Q^=HTV-/UIA
MJU52[L5-?OKW?R-YGO[GEW]G#X__^;;Z*?M/SRH%W<"[\4HT. <FEB,D#R2]
MFDKD32Q.B$1EENX11Z46)^5?<HO;38%)%T+8M*+-%R74_(<]9K5,]K1>FQ&^
MF5G8?%\MFF2/SVRS??ND_KZ>;]5*ZUFFJ#+_KX$B6  (\Q1P3CE :4FER)4F
MBGME( 2+,C5::C5)UCM5;I)MJT+R6.F0/!HE$FF;VOS1Z.&9X1 ^=6[<-<Z$
M#$QLN[GX<C 7>SUNDITF39V3Q.J2O+7S\O=K\^*?A]$;TKBY&^'BC)OOT1NV
MDQR1_D\,(]RWZM&PPKR.CEG*VP=;C/?_U)UHI"!IH4D!;/EL (6-(J>2 ZE3
MS7B)H,R\G,T=8TV-,@]%K6P0=B"L'R]V(4P9S+*\5.:#8 A +!B@2)2@JI2*
M4 %+ MWZ2$7&>)RF4B.A[+:\1$)NX/7C4,H;8QD_+M0.O4.1JT7EL78@=8'I
MO60XP!1U3>@:;U32=U#\):N[W-*W$$:[<GQ<;=7FPXHMK;OPY_F2+879^>_7
MDWWY \AUJ6VK)P()!U!C#!A+)>"B3*DF0@GAU=>RARQ3H_W# J-6_@,K+;1X
MA?_\N-'52*@/3&>'@+=Z6.HRFMQ4,["IF&VGS<&$C%1Z(AC=@8I+^,OS2N4C
M@H&[7" B_)&AQC'?OE]NMNNG^ARV]J+:+E=?M[8=N#'(A?D'=J]F6&F2\A("
MQ%0)(.721F.70.;(E@CC4&1.(5G^0T^-0W>' &OOD P/O%UMNB%0'-S$XS8^
MHY7Z9G^L\J5J;56+GNQECVG<^>(5V=9S'GYDT\\7EE-+T/L)@6>[RCQ=K!Z4
M+41_N]VNY_RI:IG^;77^3&C&TASK3#+ I=V#BIP"EJ7&)I0:ZU3DK)29UX&O
MKP13(S"C0+(PLB?L0'B;5+>\<#SL>3KL/4..1\9#XC[T.;*RC&>%;SLHW+[
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MF,9(_8=$,!.Q2(G1 6'/&%/CFU;,8"-G4 MJQCM]:/:SC">,!N84>WB,:<,
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M-5B]@;'F3QLO6M9:PYT06ON[W6S8WP31';WT*W:[>'Y9ZT9?ORS%IK7T9R5
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MRT.:)VDL0)9DB@Y$5?(M8R"%*94X3F)HU\O;<ORI$<5NE)OHU$CZJ^UYIC=
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MA,J&YP(("1,H&<UR:E1BR5V$J?%8(]\FE)1?D!=H/Q\4DRACF(,4T@S ,$(
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MRC>H)UOP-YYK,]-GP/D;V.XY:%)V4+VB(_=5VWO3GSGCB)Q76\96AE$-&4>
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M7V*9INEJ8K*S+*K:<M>1?Z*=@\A\IJ#;FJ19#LSK)A#\/FUC>XW=H'%@-78
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MS]U68QT$VS]_2=-U-]#:>F])#.!RHK@LQ18./M?KE]9E\%%%T#)J5$$FQ=N
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M=?K$E5^_]JIT\%HH3%#JQ7]5BJ>(,VI@B9";BDS%;Y7/V,HO?8R*7FJ-VD1
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M(P3F%-C")>?)^""VNN&\\UH^@.A#K=T>K[Z9*E$24ZIV6\I2&E#.5\ON#:3
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MG>MP1,^2(P;B=G<<'GCXN!F'ABC87X3C7SUXNT \_U1WW+5 EM=]<1)MNRJ
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MH'M2[6';80>+[U:KWS*,X_:([?JU=HUB>]';1[>83S(82[$9LUF#LFB /-H
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M W/,5%N5("!F<)S);)D)$COK0GN BA-]69BX>.50.)QD[]D/'W]_E2YF7\F
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MNMXAU/T4@;EG0_?G/C)M)5D[:(S%UX[P\8^P_ ]>W"8D%QE\3>FJ5.=I"EO
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M%35;'97>ANP$@XB!@N4ZL\,K)@@M=& 7%3>VS2O=<R?KS*P=A(-G07: 4#H
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MQA)'%^'>]2/V.PPK_##[],?%^_+["M>:<INTJ]M<9<5-J//#L;9/I< A%F;
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M/=43A^KD^IT$8OO(I5.(R2TIEDY?=,E@&=;I$)98I$P!GKQGL9!?ZX]GQ>0
MB#4KHYH68OO(I2>('> 6O[NN-THI1:V)G]XE3X%;KAUPR4$(*04E7/;8.*L_
M!AF=P+B/0.7HN.A *=Z$U1]$4/U_/_[W<O8UG']G2F[>%,ZD1F:=E5#4NH*2
M&?">.]!*2ENO%B?:;+79^8B=>);'A]'=,J(F,NT K*^^AMEYU?>?%LN/1-7'
MRKPU?W_ >''S)_*OT:+E@4CB%I0WE:Y(X)+9.6]<EN:IS:+[8W77$W;BH4X.
MU282[0"I/^"2]*[6$=_B[!EG7(=BR1/'RBF3&(1:J&PL)E>=J<3:F- 'CW/Z
M=_\X&#Q<5J=54_2&3C>[J+5=OX3E<DWXR#5#3WRA84W0KG0=I42S4&!DK?.@
M!9+1LII#M$I BB9[R[0+H4U5RW%+QS?>=\X6O<R9(DHG:^^%A\A% I<$1NYM
M$+I-@/[P>7HNFAR"BV?+PX=SOX.K\1X5K[^]QGGZXW-8_F>=Z7?)E!1]@J)3
M;094N1:X9\B%!7)+,;/<IH;AN9--BZLQI/\<H X119?0NJ)FFPG3/-9!6@B&
MUS1!3@C1VP+,.V:L0<8:.6#/G:PS:!V$@V=!=H!0.@#9J[1>+E,++9#\1M+!
MJT>=HIFE&!J8\=4'101?ASZ4HHHKP18CV]R"CYVH-U =(O>[<>,80N@ 3 ]H
M7AU$NE8Z:T317@>RYZX^$M8FLDPACM4.F8M":M[F9>V)0TV;MSC.%;B7 'K$
MTJV1MH4.GJ.+4%Q]JLDU/H[!@=02HY<B.W$D+$T].WITP3_KI.\GA1X M0ZH
M[Q&TM;3",..TI=/S2.9;%PY><U6;XSG3W,LH&@5]3QVK,U#M*_R[H!I-$A-/
ML_]'^/=B>;/KJBI;D,K;G -X#.1;*B$@%L-K08RPZ)B7:2?3M-,<^_O?GS8+
M.N*--@)[)P;'+^$SOB_?T;#5'6&]X"8F"(&E2H2F\\L(4J44DU-&Q9W><W;"
MR*/'F&Y4_:%R78S-Y*E'Y/RTN+SAQ]8,.N.B1N\HBJB#$;BF\R=&0:IE+B27
M2BR[;3)XX,>G$_U(\EJ,R+P>7).[=O/F*8CNO*AST)"4975*CX%HN05&OEOM
MA4C$I..XNN_Z&$IYC*AI/_;W"*2;5Z0'WIC^$?Z<?;[\_..?7S;U$T(BBQ8S
M&"7(I[,J0M2> 2\*2U))&=EF$,=!Q^[,1]X3.\]!LID@.T#M_?37S7K7WPAH
MJS\6Y_E77,X6^=>PNOCA$O^UG%W@HI2SA+K.# J@G%PO+B:-5T2IX*5P#-HC
M;].OM_^9.TLZC8/7(XFP![">GR_^1PI8:WQ^6%S&BW)Y?I_Z-QO2SW@6.@EA
M(4B/H"*Y-I'G""*ID"-W=&.UF;DVZ)B=18TC0;*9H/9&X5=<QD6KJYZTJ_Z-
M\ GYF2^^I.0T>$4T* P&7%&&+@ ;4Q31%-=F]/13I^K,;VQT4>\KAM.JNGH[
MI\_BZN)#N,"6M5?/?J=A!=8P&D>JPWH[_TJ?7'^?#-A[.N_R]M^ZGH0C#+,E
M*I"LY/K::" 8YNF/009IG;>QC8+O=KY#C=L5Z]_.24)(?BW.5]6C6'S!*H+Y
MIU^0>, Y][H$L"9[4-HQB(@(CH<2N"M1^#:5-;N<;MJHI &*[AJ^T45T6@;P
MW>R_ES.*R+ZUM'Y/?Z2AZ1M W5'J3Y4HRI;$H?@Z$C&Z D%'"FV=]=)R%>@&
M?S'UI\J7&*J^1,?K[.\4P2?GP5G&HA'!ZF-5#'9??SH$%SO6GP[A?@?AZ+/%
M;DG(S)W*8&)TQ*)<P!<D.QR#*LQ$IAI--#K)^M-!TA]:?SI$%%U"ZT[)FRDQ
MRV(M6&X4*%%K %C.$"C<D<HQPQHMGSGQ^M-!.!A:?SI$*!V ["HC\VOX=JON
M4>DB;'02N/?5FI-"AJ3(3RU.J\RUYHU<^P>/TQN<#I'X(WG;_=G? 8:>*GY3
MB4G,Q4,6/((*2D"(=<!W<HQ3_%,$^[OLM,'-MY< >L32K9HW1)N<I'#96R1%
MLZR 2T[5C3DR*Z:UB,=J##N!LM-!@A]0=CI$"AT ZN/EER_G,UP^5NXH6?1!
MA A9LSJTH% (XWFH?71.R*089VT>W9\Y6&? VA< =S<UC"B-'L#U!W'S=5AA
M_GFQR*M-5SE^_G*^^(;X$9=?9PE7ORW#?!76.WM??[MBP%I%N6!HF#/ K*M[
M[S$03VNCB4#-M,@JIC99Y,/.W=ESY>'WYQ'%>(*@O:)UJ_X\9(;K(B]7J8U,
M0L20(!BI<^;!F1BZ .WWYY[6GAX380>"^P!Q3UW'^WZ._\1Y7BROVO>"L#(P
M#<G;6M]B,OC,*([R(:$SO(B[U4F/U/#>^>'3PM(A EV,Q-VID5&+E#>'ORI1
M-BF&H.O@GR*(#4XP.KWR8+(MW@FZ+H+9"1OW?GK:\'(J=!S&X0ZNQ2<*5'1B
MS&=30'!%H92,DBCQCBCAF:.QW&&;]2PG5@0^:@YC/_;W"*3;)4F)T"\,!4\E
MEMIH$Q0X700((921'KD(^CA0&EH9-D4)]R#)#ZD,&R*&TRJ,V!14IF^M*\.>
M_4[+V5R#:#Q*A826WADA)=C,!*CL$GAR@D"84)?]6,X;%80UK9!85RZ]67PF
M ?Z!\Q5Q>%-N5+><_[18XNS3_$H6MUP*.LWZ3^<;$Y+_?;DI?/H%+]Z7W\*?
M9R4*QY0E==.:@6)UNSII),@2##-61\G:5&6WH:?G"HTAN+QK03N0_J2EWFN_
M]F.EG&S+[.+;JWDX_[::K=Z7-V1POLWFG]8C)XFPS=3)MY^_$ O>%\ZV5\V;
M/\+\$S'MQS_3^J^JO:*KA[.@R"W6UB1RB^OT(UXB_/_M75EO&S<0?N]_(<#[
M>"D0IVT:P*B")GTV> P= :H4R$[;_/L.)2NR)=G62LM=V@@""(@M[\[Q<3A#
MS@'@:<#]CE/UK$&N0MFX<4O_,!Y??>UZ#K_#+-TUR5TS[^>I=')>H-CG7R%-
MUEFDB_E)_D*'I_?D)9S*3T^^P>%7O5G1\&5QXV?O"KE;.!LEHO.FS)0N=W/,
M,N*LIZ5DUOBLG,P.JFR '0D]NW'Q@Z?B[C'[FG#=':9BVTE\.XL[9(9[!4TD
M\RR(!%<$!9(XS9-S)@B?*O4X/I/R<7V"FGC<:W@\I(Y?@T5=G954MJMW[QC<
MNA[B;20;:Z/(1F=)$F6R5)5)$H3%#Y5 "G1!/:US:#>PC=T,KY_D3BMQ[<I_
M1$"LYOU<^%FIU?SX&= =FJ<W*4W+U_SLWASP[9)-$E@TZ(D!KM$R/D^A$\0,
M02O"75)1)5,GJ7D$9E^6)>^"^KV;PL:1]!J,_QFG<-U?,KCYKWG^UG4EN B9
M>QE(EI82Z<K9L0$@&#'F[%.0NE*3RH'M_PG+[^);IP5^-Q1+IA2#+PUV?5ZG
M9MG *;%):R$D%XG6&5$V$(,OR\YW0?=^Z6A[B&G@WNX!AV]G_N9FFJ=QC8!5
M']<H&% #Q#@5<:O*FOA,<:>U3J1($;W;J7#U8M%]PL8N=6X03$^%J&=JMFV@
MWF5Q&&&-"!:(*RU5T#HX9,@(XKE2 *Q<Q@]P;'*(M-&M;'] .!YD)VBE#9@=
M6(W%&<R+)3*ZJ5:RB0E50@X,+0#9DIQ8%Q/1&?<F$#%'6Z<LXT@"FX7<*;#8
M!UWO.FH#>ENAW>/FC\7M88XWA7/)>.,$$/2.')%,)Q)2:4K)7"G#"]2;.KG)
M)Q(\[I5;=6A6UV$#4*WO_ZP;-*O(0Q"&,%EJEHV-)"C0*!4I41,0F*S5<&@(
M_L9=""_!AVT09PVLODX,EN;7F_$)7&5C4T!SYA*1O!R31MP46;!). U*I0%B
MN>,)?NTQ7G?LG7,+>2(0QBYBF"RGUU,4\\7;3;6DME$Q+PDDYPOQ'#=JKTBV
M)@@6/75T9U-XK+YEY\D-N<RU=+GH2[ -6,'ZZ_-R.QL9HA?."2*]*A6Z'(B7
MGI&H-.- %>.V3KWT@$R.6^#ZPQLY'7$M+,:_O_CILDAEDB\7\^O+Z3^0UO=F
MGQ87L!8"<IJO8H88,DH<>,"@7"<,R@WN?"):*54*4=@Z3LC1)+YVM^-$D.TN
MABH:;Z++]8?E(@*DF]]0.>7^=Y+Q)RB^VV_W+H6O0!EC>*!$0*FF20I*R9<D
MPAI'G8W&JSK'S4>1]]ICRWY W+^F&[#%#^3XV,'3._0=2TG#9+[Y^I6)(*0&
M2Y11I<6)QT@DH4B9U,Q ""K: >Y/CB?XM3LL_4!\"#2T ?I]MNY5[J#^#G[E
MEZ]+5,"'S_X&)E]OU\-"OA?M:&.4\$F2F!,E4D6,LKP6&*!3*7@R,59JDU2#
MFW&+IU_0<AD71VVLI:W8GY;ZVN';CMVYTDY*9D,B%%Q$5@TC(4M'J M6&6ZD
M#W5&QYU!]%$K0_U8&<.@HMV$UVW(4TP!/NUAV'-*>NMSC^PIF;43Y3VEKI9.
M+/].9S,$\7LD>WX]#9M4VBV4OZ?VX=\+9TN7 X'QH602D6F9)(&#*P.Y6((Z
MU=&=R#R[\7!Y[E89;S_[Y?7]Q' IC-#9*1*%6C6B8<0G97&Y<B?!9I9,'>OY
M#&'C'HG40])>9^(>]?-B[=@9V?I'/GD8JU8S+[\;))EV/C-1=ES!2N,52CP'
M3Y035H,JD5:=RJ%!C=NVDN8]2CA/Y]-;6*EC]]7KDWCJ= Y" &&TG*HP!\19
M:HC&M9M4LD[SVN54Q]#YDDQ?%YP]7@?5N_8:"&F>X>GBVWHZ>$D'6_>>9%EG
MI3WQ,6/$9I(B'A(0L-;B?QSCE>HH.Q(Z<E/&BIC9NWNKI\#V\;EE[M[-OW7&
M9,HIR>C:$)E!(HM1$2NR]=0$ [3235IW8L>^4ZL(GFY /5N3#8#UT](G*.1_
M;WJIM )'-7%Z=:EN.+K%F9'LO=4^!)MR'23N4M(TS,Y7_:)'/32 HS_ARV)9
MIC;^A3);+;R00&1G%'HL4 ZIC"@9^Y18983@.4<6Z\2_>Z2,W,]VN(WU/"6T
MAJ)-4EQ0F5/+B)6LQ.D!!<+P@WDO$X:KN,3JE$0<(&;D1GGGJ?<IL)P@Z[&3
M20O9D%9G[3<?X;H<'=R9SJS0$/,RB[8,M9)\=<<O-5$"@K!.,"YV"KT?R2I]
M]!4-X> 4S2UZ%V,#MJ.#8[B]1.%<B ":$HC T3L$2X+3I6^4$QAG&V'3Z+'A
M91M9G6T&B*>IL@6X'IUS9SED+T4J_1$2D4Y1XDWIWQAT"I)[(7V=7GLO)LNR
M-EI.3I?LHKJQ]]-+0 Y@LIF^?@G^!MXLP2./?IYV\T"UHL+A9J!5CF6*"\;7
MQEG"-5,Z4\6U/F[X1)>WCIT'.1#,ZFJC =/WD*N'-S]7@C*C0">B#$;2TI9.
MCHHF I9%QZUBJ=)TIJ>H&CL]<6 #UYN"&@#;YM9EAPO#<N"">4*C"2@>4ZY7
MLD2GV4O%(*3$ZXRQ.$S/V E] P.L!Z4T45UPWQ/8E=I6J+,BU%__N\NRVO!^
ME0S^RV52$0;N1":9B=4!W01!O<B!"3"5^I&=0?78^74CNGI5%5P_P^3N%^4C
MH%7_^:?_ 5!+ P04    " "E/ 93]F\&*)QT  #=@ , '@   &5X,3 S<F]B
M97)T;6%D;W)E96UP;&]Y;65N+FAT;>R]:7/;R)(N_/W]%;A]9LY($9!:BR5O
M9SI"EN5NW7%;#DG=OO-I @2*(MH@P,8BF?/KW]QJP491W@C1G)@X;9$$4*C*
MRLKER2?_]7]>7YQ>__?[,V]23A/O_1^OWIZ?>C_M_/SSA\/3GW]^??W:^^WZ
M][?>D]V]?>\Z#](B+N,L#9*??SY[]Y/WTZ0L9R]^_OGN[F[W[G WRV]^OK[\
M&6_UY.<DRPJU&Y713[_\"S^!_U5!],O_]Z__L[/CO<[":JK2T@MS%90J\JHB
M3F^\#Y$J/GH[._*KTVPVS^.;2>D=[!WL>Q^R_&-\&_#W95PFZA=]GW_]S'__
MZV=ZR+]&633_Y5]1?.O%T7_^%$=/GJO#\/G1T5CM/SE\%CX;/S^.]I^%X_WP
M(#Q6A_^S#X/\&7[.UQ3E/%'_^=,T3G<F"I__XNG!K'QY%T?EY,7^WMZ__U3_
M79#?P$]'65EFTQ>'\,M2?2IW@B2^25_0^.'WXPS>5BX(LR3+7_QCC_[O)7ZS
M,PZF<3)_\1_7\505WCMUYUUFTR#]#[^ .=\I5!Z/^8=%_+\*Q@ /H3_O9'QP
MGR1.E1[O_@$.\NS3)![%I;>_MWOXKY_Q]UUO61O]WN[^P?=X@?W&"SSI?H'_
M=W;ZQ_7YQ3OOS[/+*_AO_2WN>9?FFX0@*"K_ZJ]RL-Q:\*O\>>:=_?[^[<5_
M_W[V[MH[^?7R[ S_M>3J?*<W6FYQMLI)7'C__,>S@X.]E_H%ONU NJ?VY"97
MBK7 ]QA$]VS0/.R_W'[ 2JYHW5Z=77\X.WOWSW\</7O9.]I9$$6@D7<2-8;K
M]IY]A]%V+^[IY<6[BROOCZL3[_3M.6Z:J[/+/\]/SZZ\MV]/'SY^.!OR7X;T
MVKV;2PUA;YUFTUF0S@>]L[[:6K-JC=,(=,F+G54N_S__L7^\][+]OSM>D$;>
MSAJ(?;>X75Z\.KN\]GX_>7UQ>;8&;SGLS7WV2855&=^J(6QOK[5NCVI->6?B
MR^SO?\:Q^DC>LL@2E<R]<99[*,.S*I^!EU=XQ4R%\3@&1VZB<A6G?GLU']\4
M+#1(?KV\^..]=_[N='<-WK1'30U 19WF69H5WJ]Y5LV&H*7N,^_+;/9];/ON
MZ>JS&S[\=G9Y=G*URADDA2'FI >.8^#=3;(DF>]D=RGHC:(:%7$4!_G<R\:>
MN^S@J#Q_V:]/-A/_D(F_BXL)W+K,/)7>!#>*OH0;W\8A? PSCW\;N\"+4];S
M&<?]:&DFL1I[;^(T2,,X2+R+\1BNS3M7;3"+]C K>Y4*;R@"8V7@+DX2;Q+
MO\ [4FF!GP4AB N)$?XVK(HRFZJ\\+U;E489_J.H9K,DIL^BN"CS>%21!,WR
M#"^%T:*]E,'EN5>E\=^5H@]N@Z0*1@G<,TO',3IB*&-Q"A;'-* ;X*_*/(A0
M;,-<E49J1<3]FACRS^'U<B]7:*70*P4@LTD<E#"*+?4I3"H\<+V3!(89\'6^
M=YZ&NW1U#(\PVBE6Q39]FJN$ M<XPC+&&Y79C<+7\;V!F/>#.30?I MJ3OCA
M\4:CWZ/11<"=#1NI(LX5Z_@2ME><PC_AN,WC$O:OIZ:S))M3]B70D=.'G;'?
M?XD>C_X^>??:&XJ(6)$(PH]I=I>HZ 8/_TE0>A2\-Y%S'X1$U* /"K^<9%7I
M)?$T+DGILDH#U3T#!5BBC499(=#MKIJ.2U"^:9;N@)<8AW(IR2=^&(*\JC+6
MA\!M7,"_9#"HW;U9D)>LR]V1>0&(,AX8?!* ),/%)>AQ&E*B;N".<#(H;X0I
M1#R48A1Z5=B#X3.LR*$KH7<7'[QKE+(W3IQL)7(&%B+( !R.*@^TB8B3#DNJ
M;C*2)_QS6I45+%^8@8$0I"6?_D;]%'B/,HC1$2"3LRZ;UE*XR;*H92?8A_.S
M<A6J>%;2[XH*S=-8I2'Y%7>3.)R02&&<8C1W-T;D+]:K/([E(R U,V1XUL%[
MV&Y@MPS!/O!9$KR@@'E-DNRNX.34HBA)1V*T%CC!35N/YZ]P&^_OKFZEZ]-R
M\'3WZ9&>F4B%&6^<%Q5,4HZ7@F"(L_?8IKY;QO9W]U<GXHVY/]@].,*)N*Z=
MS<4D  =KI,0PTRIP*:\;#^ I*,D0_1?XY4EU [Z8]]PGQ(SO@98J*M!XK#TC
M/"=AD]%NB^"1Y9U2:=-4$+UG0C4I68ZDR7M%PH7)Z&&_(!<);MD+G-&8$WM)
M, +]6I7]E_1FT;MCJKW?N?\[R6WH]4;MC'(5?-P)QF!%O B2NV!>-(;P6;"@
M1;":WO$]<-.M:(NI:1"C *,,FO.V]"C+%81T[I/D@7SR^5L7.)%@&(_CF: -
M6O?J!W)LGHW'$D1X#>\TA-.S/P$Q4$7=/;$'C^F,?)N%P?J<D0>/YXP<!06<
M7."&P@3':(?GV;2N3R@%^_1EX4VR*>@<.B=WO==5CNH)?PEZ?=J*=)NK[M5!
M[4M@-'  ST#-S9(@Q&=BK!&]XE"//$<=F>J#_8\TQM#A58D1R%VOYU6#6U"K
MY..@LV'<VS(/;E6"QSB<4T66PB_ '5=_5W$.]T3_6.7D3W</-JHH6HE."LGS
MFFB/P\>D/1#(#*9:.<GR^'_IV^*QK4*W(CD<H"(Y+SG;&&9I%-L(13W&U/3U
MN]2!A,T6J*7N[?U;=J=NT52/:20D!T6I QEBB[=O;M6+=@.F@=GH78.Y0ZD*
M1GD61*(686XI10/_]5%AI/ DM/OG-BS6T#[+J$%\"70G%(9XO" I,CNWH .K
M699*5C%DI0OSC=.4*DS\8/#P-BZ"PN<!@[::QJ6;#0IJ&X/?%%]]I/HT'H>Y
MX0[__,>3IR\Q,I/QS6,,/\ZUL@^S*BTQ@T,^38<E*D\)B@(L=+XUW0;NB.'*
M$I1GZQ2Q$\53J2>)18,"G9$S<+Y[409X-L P)"F%=XJGT_A&@FC3H(0'@/"\
MAN]!FMB+LY?60U5AD*99Z=U401[ 5( H3,"M@U'#?VE*NP4KP P=VS%TQ 3N
MBOBT2C[]%:0H!\Z9!I)=%?@ 7C%WY/:[2&HS"LX@XL3.<#Y4M.N=E+0P+)G%
M)*N2R)&/+@G@4346#!8H43<PT7-9J*K$,;9W(8Y'"P,-^2]8R2**0QISCSCH
M8;NB5I<'G'7X03:2V"5\H3[-<'_J&+KX\44\BC$^SK9!JNZ"I,^:<'8>RU"8
M\38.4A!T5AI&[Y12/B-;VL0N4>&AA,8IKXH>SO_%Z,!I4!7*VX(?16I,XQZI
M)+OC-)T668J&PKS'8Y$]=TWD+8LE7A/VC(P>@ZVL?W$MY-\R<&=)Z:$%32TM
MU5U<6,EIO.AWGT-G M?$<'KRF RG,[NNKRLW>OU8UJ#;;'HR0+.IRRG1G@4I
M!'$D<"NI3RH/<9O2%S.P=_*"]@\HPA2!&ZB@X?#*PIAV&NTDT@(AY0Y!2Y I
M!'\F"1X @BM98 O1[XNN$[NN3EJ&T*YW#J==E8SA4?HL[_62Y';=VL9JD#@M
MRKP*18E8Y9*KFPK>AZR569:7YGX4S+4WZH%0^=Y0@.*G9Q>#B'3U&*N\6CYX
M_%5.65\\I7TOD2!-W4P3] ZN!ZX_!ZG!S)C$LZ+#S@RBOT#EJPZ3NGE@P,=3
MI4HOG 3I#=[:N.QDV\XD1QDD9(>#;??!S;-K66SD31O2MKAHZSZE][29V5ZE
MTML*M@>C] YW"64=J=NL5#TJ 71&0H)%*X7K3SH((34D9.(;L+ZS:\\RR:EH
MDX@IZ4V"+GESC4T<2$V(@O$XB/,ZL,'1-V S^763+(_1"Q#@#Z;*<0-HO-S9
MA<_>:!E\5(YM;!ZY94 A]*W-1X'^]499D$?DVZ6<#@<+;8Q^PZP:@5L!KY6"
M=5FBGD^SE+]DM-Q\FUR',*QF@38(Y2(.URV%%WLD4CX:DI3ODYC; &$&9[8^
MZAPWN_\XC<"\OX$Y3>:H;4%(Z%\H@2"8Y03WB#F]1_!M?YPU$$^!$):IO4"C
M=]K@G2$F'P=3C'WP Z<^A[7APR%M>-KOL-4BLE;PC*BADF8$U$/3*2C(BHW+
M"FT=.FO 6(JZ[)ZEL(*UQ^QX[+@IY?T&MQYEV4=OJQ:?V5X.GO=(1" :D@BP
MSL>(#^E7-0;=7Q8"I)QJ>\>")G'M$69'T:^6H8%A&43,P1- TT<904QT;"[#
MPR."8P&/A'DY89O6GBNS7/T%<A,*D--1[W(HF%%0L)P1!<O&RSG*/XZC*NRJ
M(F(C_ ZFV?D)V!PW.LB8U7].#V 'ML3"!QA*A;4S%.0C:=<A(S>3P&(,CUH3
M259#DF029 8;C\5PF$Y5A#&%MHO]O3S6;H?96Z6[C ;Y39Z! 3^-"Y@6V%$8
M9&$YI]AUENB_V'QO'PKSAVMYJ7V^7]?C&"3W@ F1)+C#C52[%P:'2G2/4C!+
M.+GRV$)]W8)Q])C"K1C94&EA<?ROV*=;D[#KT?<*NRZQ&#KL^BJ @_HJP"CH
M=Y*4'EQ_1RXS:.9J I2*%/%]F/_V"AHVZI0_KO[MR=&>#T/TO82"%W:[@TU9
MA:Q]4*10M4RR!*>B\(90<>ZLP'!BGLZ@;-AY%L1D@D1QCBGD2)$G*]&9&&ZO
M/L*Y"$L3HSV58M%FED>4>6[F]&V /9CG&26N,4&'H,PM)\S>YQ(T0Z$(=<*J
MR0S7.RZP3!,6'-[E!+/5&!_EX'KG:XEAU[BX4>6Y8%J*:O07U0=E>(1A: T=
MG%'%Z=I(R4>/+G_7I\0.!J?$3E@IO.<X$PG<JRRMBM5J-+ ^..0OX::#O8,#
M< :*$(8Z5T'>F]Y1X"7$J+K09\)[(-BO-,7Q=1=&%&(8%!-OA"^-H,#4B?7"
M58HPQ)T@G92";E3!5%>P>"O?E6T-0F$U:A X$AQ&Q(0\-U*<Q69_I>X3E5W[
MM"_-(D.!:;Q1I;Q<-D.KNTHQE,<3%L._8\KXP<ON'QS].P[(V:B^01A8)TY0
MXGS+8(HX'1^1!Y1T,^O@O,BLRHLJ2!L3(2K".6RTZV?GD*9EUWLC]5O!;1:S
M2H2+HZP:E4TQ(#]8@!Y&$@@NDW8L=AW2(V*V[XI9'2:$MGE^2_%7Q465!%-
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M"-ZPV%UI/6]]-U".1>B 6EV=+#H>Z:_@M9FF5$?&,,[A:T #"J>;K'7 >[G
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MW S2=JYTDGNH:1'108<Z?4CQRP;:UC3>/#V[<*"WMI-)S6]G?*\XZ^,8;JC
M>]X_$@QC*P*,0P_Q;<2/3G><%*69$Y@4F$D"?<";U,R<,4RF3L?!I643@:+O
M<;OMD:6#+>K";)(EA%S.JQLZ= Q3:NOJ5N)/SD@QF[B+%2K2L=)]LGK6P#5>
M6 *:W$J"HJ;D"2^%5R#_,J+#<@*N;362!RUNGM8SZE(F]-M;MRQEX-'$82F)
MRIS9^',<QJUMF(8-%:N<SF,D<(6U,7@^.D!TXS\X,55 97=5G'#6*87=2R^%
M(7N,:V08URZJZ91P>KD\GP8' L6Y8C8EPIPSV+=9<HM/F&8YRCF<L;#U(H3E
MYT$5$>R>VQ-H)/NX_+))FE0@>HQU+[#G7%RP8)B9 UE4Z4UP(Q0=6D5PHIFH
MJ6O"Q%&C.U]Z!.G*W$XB7A0F8KC@.V!KMCC]BS+,M"S8/,^I[\2XRB>TE32$
M'G\J09A9I>E[39,/M[=LO1E.JP,#ON9GO&?'2_&&T#8=C+)0GS"',0GRH"A8
M\JB\/';KEG49,:DXF@FS 7E\\ 4.450T,K>!S\ 2)6U:D#+$#O=[SZ)4G;X:
MQ!$[##^[=L2BNIC,"ZQ>Q1F=<F\P.*."61#&5HDWV@5BFG.6D^NL&AXGGU-R
M>!@N:Y>1+:@UYPRQ&WT6.1S7<C*&<)9GTG1Z0;LQN/'^LST+I\3CS3=].-GC
MYT8\.E6.8Y"-(L!=YVL=M&:/@\X4=AUG<=H^EGPBW+/%RE(A/<:SVYS9 ;P1
MO(/-JB.%.DXXUX7CBU.S6E!S\4?%[5Q,'0_%:/4VC!2>48\NM=@70AL>T]>"
M$%I'0T\0KLM^L/Q:Q-(ZBPC26AXH1EMOZ]"ICFGP#[;@#PW@ W=9QGE<U%R^
M$33K*P/A>-SGCM& D,_'-HSUN4FDG@(,#$O5=9AFH?RLMZ<3C@LS @P9!52X
MTM3:_ "NFTRH0H/_R+CT X9PFV%+,CQ*B<02HW_!;9;73M,F[$5T(_D[IL3\
M<=26GZZ^MIPFLTWJ:HZ6KQ*'71/BEW@XQ"]'N\>'U-1MJ>AV!Y[5]02M7R.!
M6(E](WEZE3:J1H+Y.O7IBP>TI@>[1T3F4T\7=*CA_J3!%V0KUF9!A[.B^\]W
MC[IW*0+Z=!6R+D"V<+[[]C.Q<-'6[2D.WI*03 JKXD#PC:N*5,]R.N.E,;@I
M>/5C9#<J)ZME-Z*I9/,EJ$WP=H.'JB.7VJ9I6ZN=>#N8C7BPM[M/&]%ZM)TK
M<D/V92Q$)Y:OHQ1*>\/&@>1DR@9NT5Y*BRR)(XI.:1JE2S#^L+FYQ*A/.(^Y
M__S9$7-K,'B9247 _?:V]H7([#,D!XWZAO:G@N1VP4LV0IK[@HD[R!G3/7LU
M08?/UR&E'_7KS0LNK'X0X8B^*5%]N._;V9R]GCB(<6H#-YDL)?AN4 )7AJH(
M$.#N&I^U)Q,;GBHIWJ)I13:YV$41D1\X%[M"QE_'_XHU.J:[]1:1:=:MA69.
MPW03;^T/RE;5-PB5E,#SQNTPJRD&U^R?L>69Y#X(&-=)(Z0@F!/O6QS-;:W0
MB)(=S4B+E)ATM_)T^Z!C5&3<B']-5'JO.D,R)M_$-RU-4TO/K57WV0&=MIJ5
M] &GQ5+=E&SICTL#X"^D_3&=.MQBU[ZF/0ZQ/L'$VZ=GEQ-EPW$LZO4^-:U^
M1@@EL!PC+BM^FR/$0:_3^[H#%,AYUQ&/4.MV$QX;.C/V0^>K->"#]DTECX6)
M-NV X(.L*T/;TWU]==\L8W68KF5C+$&+&Z+%S8 \W4$!]RXT<5.7#NQ'(>*#
M=\ILAV;!$0L&)+C(+=T_P-"_L.[5.+*FE'8LMNBXYN!:1-K]C:D\Z;^\=#6E
M!$.YC]-RO8R<@+*E!B8^MS$U5W;:36!,R"E,<-BSG!9-]^TUDN7^]A59*IG8
M&J1PN;M:=IW:L-OM?!KW-ANRX\:$1X7##<XFBGW;&V_I%N;KT_OY=CCQ$^.V
MF3X>?:+\,-1H3WG_HRQ&6)&8M*C43!*'4FA.CJ>9KF$LQ:+\3J00 3+"]1IE
MMYRO:N62.%=4U+6=OG%'&10KE0660KO0>LN4L],"-^'B]T3)_=HY2A_42/+I
M'ITT$86#U^X050>DO4TW,7$*T[S>]H,P]K0+\ZZCP/2I]649_57)8=I*7PT
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M&;C[-WXM1][;L!Q#+?R=Y<KJ;&%IT.6;A-$"N7GZ@R>,AK.!E1K.!M8*VMG
MN,28?6KT@A\[P9=6[^JU@9D/KZN+BQJ'_W=0YZL'C7=G"XFIQP5 MS(4;>Z@
M)H"@(]P<3]'Y!"G%J@<J3JO3SU/Y!!I]HJT;-T'D.+:"H%Q(:FLA<]-CN*LN
MDKBM\>E%J6:%ERIJFYG/V=:<9K?-()49!L6>X,)(QDCE4$5<JV"KMW!,@KO"
M(6<TOGT"MG3IU+Q\XW6G.[Z )\*XEI"$TR!-@Q$J@[!<I41Z6S"2( JV33#7
M%N\5''*@6>]D*^S%O/BZMI&SYK'40 8@/8@74LV.L(U>JQW9<ZP$+A@A _MA
MKK="[ *T;4!%DRQU!C'^HVA"BYP-T<S9X 2 3H]S#,F&5$4G+M7_PB+4J@ Y
M]IC%6-^A?:BF,0?/3G$"B06Y_9U %1#*@(%FDRE4-)FZJU'A^G)11ON%$F;N
M3J/7 B</]@XMRPTAO#C!K*$2SGNOS5$TO*9"J!A!ZDV(^RTHK UQWRK>O'[X
MDEZCI+-0PC:@.[6\FUO%CF!=.'B..;^O8Z]]121+)/4$#A0V88^]#8DIX>OF
M6VQROKO<GMAG-+S314AY%#+*<N::FP:@O8+8H9K1);ZU\]9-'G&"?CJ%E\6B
M>T.;<!<7CZ^,LEMFGSXFAM9+88]&"3\%0RO%'MN/;1UZ?/$!LK.^R]*=UW$1
M)AG"J@?E6[@,UPW]ME99FL&$!0X.=RFL]QFLV$VS4PQL--HH1XYE%P@BR^4;
MT+BXPG]7J+ 5=^S#+-PXQ@6)!1G*'#*J9.P4P8O<4XG-5K;[L0,XM115]""+
MN[.$[Y/@ENU0MR22#J5T)S);0%A5S$ H,['(.^,BRC(/(FQ7@9@Q(;Y \=V9
M9$(7= [OF21@O2($Z[TFP&G7)?.OS4SNO$9J<?AUY)V_[_BY[\D/R,'&F@;$
MT'3]3GV*N6NZ8&A*7#UR4.^R_"/.-49PT:;&MFI("81>D4/K@<Q%>8:8T4*C
MO5R&5_O1:*Y[53G@47PKTT[4Z2WJ3>&YB28+H48=A>7H2VXP^3.9RM_L5>/H
M,;$M'Q9S\-*G\IV]CXY'1T$9\(<EDN;8/[%C:I"'NE>LG45'U/B7KNR!>QGD
MQG) $8XU'SX\M&3X!\PV7A):RD6P/E1:" &/*]=,7Z,'&$Z0B.=&@MM_D3.&
M+B52HO!GNHK))^@)%I4@CE"EH/$4,_S@XV#IP;2*B:C#CIU>U+P_J,F/RDB$
M.P&V >Q4@;A'M$T8RNU6JO%M$-\3!H5^AW'%K1?,+> X!_&Y<?IXU20B#ND%
MP@PK6$9QDIA7 $LOR,%"O%'&:6Q0R_Q=931^V]Y%)&*FZ-WUZ$7<7,E*8#/4
M_%#>[Z4,DYE%P+S&JAJT'>F?L!)1EAL46HGD'/"W+!ZJR_D,K-N_$<JCNPO3
M6,9Q:/6-R*;,CLIOJ4W.K )11!R<3R39]%^2&=YC3>"#T7TF)\K16DZ#=0T>
M?B/CUT)-D/Q$7/U4>AMU2DY=]-S'\L5-.1L1B0O&3Q@O#%[*> S+@0CJNACH
M0 O22X$?0DU20(?-Q#)T+75P'G;@&3LP?V#]@T:[ 3\@9U8:4L>*CP#IP.";
M#\%Y%5K64!?.UW86QH:*+(S%9Z'O=KBOB;E 40\C..;R"@4URV^"-/Y?N8+Y
M+849QV:L#0.;8G$04,_'F'LQ@X^$.V5K )"H][2* T!#;;,ET#R^*8.&8':M
M3$(,&G%,0LL^S;2L/^D01W>P_++X"^<J[XNVD.-#X6U2E3L*D%'_*1TIHOGK
M-1%UE8C?BSZ9.RM-%.>6ADK+ T]^8810FT,8/4-6+V9-1U 7',SH#?G$'530
MKH:OZ1/33 ;U$^ZX(*'F*0@U1+EDL/Y0V@^?NI;>N5V"04@@P8L<>]! \40J
M.88+)R?/=4.9"1!IDY1>,-7/?O"D](JF79^7LPH<H-!00PK7)B5&6MA,S?%H
M)+[!G7='''U@_D_@00C54R720=))*%N!# V%YE;+_EL3%WXXJ#Q3W5=W:&6)
M^]2N[V+E>OJS=9]W)!^%-7(3-[_4#,(B]^-B47$MS!ZY$>.;F2'Q1*0>=5@!
M6Q4>O#']NG:?*)B"NB#"R'+7.R' /E*USEOU3;6WD&A3)NEC&'K?]-$(N.5=
M49K@@8YS-VJ$>^MK30&47X-WM]AMJ4>!AD<;J+>LM\)_W5;)C7 .WRJ>7&MG
M^%H>#!,\E]2Y(J!==_4);.^"<=,<<F]Q&R*5:*]4494F&#18:$(,8.@T47C>
M>.D.[KM>+&+KP3!V/V>^3SOE6X)M'R_V07A<XY@B_];'*+9M&!%+/IEM"PLS
M,6B3:G%D12E33O)3N)9!!YV6\$+S_3C,56@_!5ZBZ^Y.[1I\L>#V[@J-#&:B
M-S@G@)Y60U?#TUP?9' ;Q DWNFT1:#)%99&!BTJSJ&:*M&Z'0X_L=?&MW+M^
MF[BA)]QJ<BV^^&*-7 UZ=^J&N##)@V^4"_AZO' 8$/83?YL0")AHP$>):NYS
MN;YH51#@-U,0*DVKW2A"D+>MQ<Z<]6+%A($]JM5L@5U(3ZF/Y)N86!$=L1$C
M4DR1FE!G*R>B9$H5'!E?N^K&X4"8=2B\2T5WE\[Y-:02@:'Z@5!;#> 34[QC
M8#%1?()I=MJ6-5:KUJLQ=MK[4Q;3Y>BL%=QEM/,41^Q<_5?#+VFLAN^-$61-
M/6/Q/U.%_-YI%/@8N54)^IY!&6 )9^&3G5AA]0]=Y :*I-FM_MZ$@G,UQJBX
MKN/K/6/Q("DR9KUQ4K3B4=MBZT5^N57-'/XSP[+(%!O>O2^*UO+\$A4PO3V\
MDLI!X1<2,J=R5SI%#0,5',MN&QJKCK6Q39.$"G+&Z94))DP8O>9^#+96-LU&
M<:+LRYBGF-]1#B"]<6;)UGNV[) I\YJDB%LKQ,2CU(GE4^HL.2OS+/G\A/FP
M%-%PL/;&H._G(*"M.1'N]T:W)PJ!%K[IR5Q(6RL;,;O#8E>"537;!R$JHDHI
M<BV)+[JL/]@I 2_*SG /!-B[%+C#RM_;P-9[W7>/5BZXT7^*K&@6WC1KINN<
MSA<66M?0HW>JJ"D,W*;$^MJ<!+)]N+R(,@T9FQ264+_0W19HXYN^ 6)SWSM9
MG9#0.UC$,E&C!,:9NT8 62Z%IO&W%Q &,L9B]S]VKW:]-RK2@7'Z^ZHDYIW6
M()W@NJY;/MA_HQ4;?%3EG!$Y^Q1.,)AJ6=(.G^"]]%7/]H[-54$^"D#][%Q\
M2M1<7W"PMW>P;3!]>:M553>AD&%W(*P?KD%3,$#8!>%(E\>N+Q&3^)9S.VM$
M+J#'O/_L\) &C3@F^$N_P!\I)0UHS@H82J2<PG0Z5!U'P@N#5#@K)@K<1&F.
M@ 8HYI'A5_C/A/T/N]9CNT"45ZBECW7O#L9,U@.1]1\R^SR62D;,7,.^N[B?
M.*GR(%\>@Z=4AO085B[Y4(&= UI"Q7P:$C(Z,6T_^"]?HIO(FP!*/$_5G!W<
MF!E3DKGQ&XU+.7:V#MWL%O00;4DR@HNJD&X.K:8N5/I.9#8\:X4B_XY:G*#M
MC>F;UO%-5@>7Y1.LNHJ='Y'[H"+*-I*70OU[^@@]]2MVA4/LS;EA&V*F+;^[
M?>/>%R0(FM9IM17%PW<3.EYP-#_?A(Y7,>TC"A-'&@_.;8;LCBHL&9ULC6T,
M"Z+1R847%ORM8T &8>2*?US(%G8V?><^$5)7'3:(--6!2Z0AO9#0NWYT0,X^
M .'P6LIVXIH& 0]_Y#Y(@ V)T"5L_Z_F5=&F#,B%;^%Z \CO_@KC@$.ZF X@
MH:N[&&%SK_A6+!%*B^>$IXD1<$5DE&5<%)5BD*)417+*5]",I $[;!S$.I48
M;U5"1V31,; ?@AL3#1=CV^^L\:*[8 BE*M%Z(&H$%>$'"79-@__"/H/_\"@+
MN< ,E7,=&&HNX]#Y=.N>QZ95F"C$4X0Q/@QO4!"4;9J5%/& HY([!.;!5!6F
M.1IQBE+<.L1/=2@JPTO""5Y>4%Q9![(0F\F&ID%$B'*_I3*\8GM=-NYHNV_?
M]O:?'19!TN!4>GLGZS!E[ [5M)64EH!-"+%\;("P$@?Y"[S<(I(NBB6(;G5C
MLF]W69Y$+OZ7@K9\GSAECXBCJ,P<&I0<,^5_:!>=X@3F0[[<)V\HE:] ;BN,
MT 2Z<K3KL\;MVM^;.T<J8$P0D>GJ)J+F@8Y7"0JBT0B-1XD.Z[;M_(S^;D&M
M^@K3^U*/H_8G[, =!&&AGM"**@>=<D=7@I1_"G1,O!"2M1*!L1)(J9%>22K0
M;;>*-B#B5DD[$G+2DS_9/$Q91_$?44XX65#O&<U^^)%;))H9+N KXC]G#Y%:
M7,;4&)-S73ZAML$-!$LSP]HBOC^-^X_+MX6O _<QX=+,.[GK)#ZA_4G?:YJY
MUM/%U:O9&#-<-[Q$3A NBRB=7LRGHRRA9'O)D1"W$VN8S>8D%!Q6RF"FW*!/
MJ^%C-BZ)%XM36=-9[,2X,,J_;=OF4?:RF# ZM4K-G[7- @,T0R!)D7_?,V>V
M$:SD$5UPO:_AMS9/("=M1ZD )R>HW%N2%&:3:'B^S[#K^&^252,;!B^,4AO&
M,UEVO#,<?WJ(M]N>L77TB7P;X$!B)2.M"4-;7BB!7;_.HXVC<?28:R74-?.Z
MXNK_ZD853W14T9UY&ZM_3_?^D^X]1VVN8XD8F=NJ!;NV=7Z)KWF%!HU"N##%
M1+Q+5GMTG11=.RD,;+9*S>AC%*499G=F$YJ$QLPS_E(D;5W._+#WS&\$L@VJ
MA%/-R=RFOANIF?L,-_WSLXMMVFB=IW:S=,79[<P6W'5G1Z*9![!V/G3KKEP9
MN::,>Q?Q-9K1' /WX=\?E<^I NJX*>4']M#B8'%4<1R3^V"B1N90HZ"T=8Q2
M5W R;I8QUU(MB@)HZYGN[<;7A+=H&D0N@FGCE#"Q9ZH&;#IA"*#N[AJB =AQ
MV[L]U5#"S6AH$$#GPY%A@!<6=%9G[*#PMTLI8%ZW!6>$Q20@D),P;V&:VHUA
MI?2"'$.T*UB>V!'*Z5C%OV$?26U(XPZ+83!Q"INFTCV-<5]X]AUX$@)DI#"L
MY=H#[<9D>99,>\1M:V-LZ$TWIS3N"-N\TWNXP;)&WK!VDP@_C/IJTNQ/70"$
ME/A9!%E/S_<O(%@>U@D0+7D"C*N<_6&WO)432S"%/7,,:R,*A6KU:/50#"9Q
MKK1SM*5SJ^"P$Q!1 %$$A"*ZXA:V:MNXFW1')[A;-$CX]$.(]^,NY8 KKRPN
M]KPE@1W  NP(3<*W27 L$*3]O4V&8Q7S;LC%)<9'R8R>[=@\5FSG"&$W1',$
MP8?:Y!=@CE"!(\E%PDWI*92F(@?/9-KRU%"-BT8CN9#[%,2#]WH-9H5/X(U/
MD*.@U##I=+$J*)@>MN3.*935)7#1O<J*/9B6REJ&WZBPK8S!'$V+,5=*F7.*
M?U#[WF^A^7JL17 X<_%D?($.N%AUCBE%&OZAPU3=*[<('YXYS$F];/WU2!B:
M$0QBJ[$HH4>;:V OU@PCFT\Q:0<?:@VD:$*$FPFF?5PE:.L6]8#X@N? %!<U
M #N5_U,),<L,UT<W$*[=\T0=Z&16G3W1> %+*FTQ&<P7Q05T#3EL!3]PC'WK
MU"ESX.$*^4U]3>Q^\%&>9ZJDJE8DUYGO8"<"W\NS>9 @DRTLMN\(+SI.&'$$
M;:ST%5I$^6OZ##'C7!Q,\[T%DS?%HOT9]0N&@8,K+\7#.#QJ*S[-HG@\)_\*
M?+NYK^OUM2M&MB&J!@[3\,>PJ'E\&[#IG%&<+9XBO 'I!/B_IO!064U'&@-^
MD&3Q8M75J$%8&V-0+6D,$JW]1Z5FOJ$NXJI3XA]L(O*UB)G^4_C3:F:Z)>7"
M_N!"8A=)M2%5L?:G0*WX/H&T$:)^2/1CL:OZC7G,<+!.S[T0?H$OA7XTW-JF
MI!Q"B3Z>B_N25HQ%-@.E@&#._.%2>J-],(WA1\@=.IQYEL;AMK<%LI HZ<(U
MB*Q+!X_'$'QU(P4]:]X=ZI$6B1HW5Y=? L<+!GVWD[^DU@R*"3>%I5'?8P:?
MQH6JM\+HK(UJR6A?1,[NP*))1=.WATCRNEY ##S:H-3WE8PN6P@DM3]U:XEW
M)$4,)!#@Q(X[\P@V$]5HB-4S7!E63  :<=!D(=C.(*R? \/3D[8F>GF\I%XF
M^?.[9@AY2CJJX-AG2#-C/R$TU&U7Q*Q"%(MQB&MK=T'[Q==FGYR_M"B95<T1
M0P*<ZHQ ,XD(@V90-,R1B,O6JGIE)O,&D"''-2AD.@LZU\EH2D,BPG;ZK@%W
M*]8N/HPH09MAJ(2:)HO$U5"]QD1@<0-CA>6:PE16I!<=7?6$K$F[=J51X:0D
M##K_R*\EI!SDAI/HT-_V9AN=8BU8Z.P&2T\=0U;&3NP\R!G<D5+68<(4RW%X
M5CG B-/*1R.E 25A5)2ZI1_& IO%+!@?!V..MC^<<K<"_T5WC9A06J3>.8L$
MS9!2)O%ZG[<2IUS%B?@^T_^9SV!3!]M"4/L,3@],>E/G6KL2]U+@ C^[0R-;
MWY"FS,UKHF^BQDK?<6;(GUU(HKP5<O*XU4,=;0GK>?7@GMMB2J[4#>CR>GZO
MYYD\4;=.(XP%5K&U7;B[K_-L/(M')$VFSV-@<(Z\AA%VQ.0S H.]632WV=3:
MO%GFH *$N^PHGJIOQ>Z0?7"#_7VEU,RPL,W=Q."V.(3Z(6VO&BO*DB]Y7/-0
MUT'6NX!H3\C\;#TC6FP?F^U $96Z><,43EC^:5-+-I2"?VUBG(MBG/N;&.<J
MYGUA]K/9[M'6M<*&D6B"HF)(HG/4/&@2;?-KX32EVK3E'5DC:O0&NVM-K,N;
M7NOR?.RW(ZX2@"%$$G<SZT_(-4-0U+R9H" V5]_E@5%?361[,+^K-8!O6;'=
MP<B)U!+3@MU[)W38J.F[B1WTN(XV4=2X\3=U_]9$V"9+NC*& DQ2TT2+5G8R
MD)@NL;KRM_\<AGFVRZ6-'GL>WPMVYC6D5N*,T\C90^IA&6J+ID,/$I+/XEHT
M*/"?->XOVZ1.BH%D-]?^R<)'PE)G+;E>FX*5P\$5K"#C]:D(VL#:Z3A"[9 W
M?"Y\R80EJ)M'S"R&Y)3O;U-_=*>OK"X><>@J'OZ\.JF%*2>UU;(&KN70=.(G
M32Q7^E>5NO66AKP(HQNF6:"0'_H.-:)O8%^^?H9O&OWX'DYPKI#/"8:UY=#I
M4$TONMY2$>M)T *YD,C>5WGHG"5T&W;V-$,H!PNH*4K@AC.81E3I^FF$[O /
M1=,0U$U4#EKDPLK;Z4KCU0*\]%MU_&$P"T*L=K9N)X=QUN2\&QY-.I-S4G=E
MNRFXLI\#'!F)!],$2SJ5?$DG_\'A1>&AQDM\EX@9BX&2DA)PPB\MI-9"28)!
M0^+YS+3<",%TJ+LSX:&J_TVY/!49_F%#V(2#<.F?&4[M$ T0D:_P%-\+2R4P
M=6@9W(E5'(=+Z4*)@])V#;E(7GA6S".V6Y#+I5YG,.2FKP2F.(3LC5[C-5$"
M R1:-%T%+'&VB0X;5(A3<P&^$E*N8/*&00#VY[6$@4M?O"VU1O7091,2ZQR3
MO(%"N <AD_DLT7*ISPVYU?U]5!^7C R/1(S9FC$3@:G]#%DEN!?&316@,Z:4
MJ."1<%+5^U-\T;I^_JJN< U-_%^0X#:#H#V\#MMH[)W *0(GSQ>X^"M\9T1.
MM.I""]U.8@#'FCYX!W"L22'H%G5]G$L6#S&;"NO/=/8D$<:\2 7PJ>G02>![
MMIF0>E/_-<;L?%4,M,WF*B?=S;8.<W:H9]UML-I)&NC44%'K2J>&'(&!SDY>
M$3_6JC<8G$OQ7Q6<<EB-C4?\1& <J.@8W1KF\8A]1@J6$].'$(HU -+UWH:G
M&3$S(JG.%:@[=+L4%7%N"W#9("8FX,8^[/F&FL>A'<&[:#6]S/B&)1CG=CI^
MP^FXM,V$A]'E6$J#;7VOVXA9\&;ZJY,;,(? TR:FC=]-?,!P^#TYWC9@!Z[9
M[SXZQ=>H';/X"1>GUZ$X(&#)1]\;86?/"0*=D<\\40'\<$QTADPC!P-#1E.!
M)HSX'#>L*QH0@V@HBIY067F14=B$;@"6$K/]&1A5?72:: />JJ@3-H/_%28!
M9@C0?-"&%C5+BQL\+1Q=B[$C$4]RFB%XNT1,=ZK\%MF*TRQAI .I,DWRHB&_
M*'</*J:F;1=OK%&<%?,4KM#%%0(SX)VH']+W-J/[WF8#25@$23CX@2$)JW7U
MO&D<YME.UZ8PA5CB&<DVBG@;6>HFH=N$LT?^XGU4$-3Q%GQG)Z?Q>1O)X*L(
M\->G_72XD]"^HWE]L_<]+^QZG@.@4MM.F+_K0&X>P=I3>[S'L&.TO,ZK&TY=
MU\V7E5NT YPUQQ1XG Q\ TM>/QED\OJ*>F"6)E%[JHGJ!YG*7IY^0Z>K*2WJ
MIJDE>^W2"WQ9YKJ9J#8<=819SQBO>V\RVKFNH+*_1:GG15GK97*Y?@\K,P*L
M4!JXXP.>+\+DQ)]22P6=8(.?O'>Z$9C/.R@-;;/7KBS#O7?,N"E/%5B_ $_Q
M>Z_#7!\V/Y5LJ7FN[H>H"6%@3,$4$^:U9D_POMR.S%88-"J0"$[$56J-%QX@
M#9^>E>$$7%N9"*PB\L(JSZGLUEE=P_40.!^[!#F?T6.\#3A! B/-Y7+KX#.H
M*GEI;;!9ZMI2"Y<+68>* :3E!'=)<YT;E$?2N%7<<9?V0]>5,?4S5ZG8GO"]
M'5_ 1+Z-\[)2_:N84V5J3?NV,*;=2*KR3B6W>,8<;&-*#GL_\2DSPT[+QBRF
MNMK/D2JVWP<@6O6I'X* L2XQXS)-1C#=J15]DV'#GK6('F,5Y/)3^,RCY^3/
M&$U",)5"45=QOP&3 0E3(.OC%N =U0K)?2QU.HU!8A7.E NR0/#*/+[E=MG2
MYU>Z(D@16% ("Q)G_ZOD(P^C*)RQ-![ <R.$4+JPWVP[XQH.XI3J.L>'(V7.
MB66/)*GZUGM"<36>F$P2=<"B!V-84+>]>B?E.C[YJQQ$?K_JU2VB[8C-61BG
MMQEH,F-!&U:IUB-=7K5>]><:V5])%7YA/GY _N#1H_ 'SS3SX;KX@W<9%S9L
M';!#6&S<OT[WCSEW-'-B0RKP]DT;B0TW.&02A2@V.NO6<=\>#V[?OC8$W*O=
MI*\_FQJUJQRGE]/V51;D$7$7U7KT.IWB FJ0RG!)+>RNJ/OMXVS+V7]4Z^Z[
M^'YG&R+NSNVPRE#_K+9!N?(\=PL(ZCO4F)K;.A4P5=.1=6O;TV>.4H\7S]>[
MW(8UM!/M4##46@37&J2!=1M.T)RL$;,))8/!9S-XFQ'1F!S5;;O0"*Y?J6,C
MG9?6FN-EN2Z5YI>-<PTRI+77W3&I/D%;J;NK-$K71G,]'9SFNJ M=&94PSKI
M+S)/I),4,<;5K?YF:"'+[7WKM:?4P_D6$0%RQ=F%PYP?Q)HTG\C@1JKO<.<*
MD\C7BI*!#1V(\SK]X-Q:$#6[0NL=83:A@I*Q*KBO ^F&,*QFTAI20J2%HFXT
M'FJ!<4U[==RE?H\%#5TVB(.??MD__,$1!P-2L\\&IV8O55GE9+C_KGGS5JMI
M3T _2B=P-. *Q'AEX01;R, _LPQ)D@S%G^]4X;NT?&XA#)($)!(J*\C*FF)4
MX485V[4NXP[7%;Q&)1UHI$,V&)K$SJ0;EQC[!>_+3;Z=1UJ%:4EY77O47H0U
M=)W]OVL/ *5/]6HS9CIL=B%WR%*)#)U* KN/*JFXMTQA"'_09Q!:H3@B3%$M
M2H<(NRTS.9:T_$S%("=4G82!AXB/,,"07>^/CK[U#_:GZT>K)=AS8TM]C+::
MZ,R,-DZ7FK*>$W29GN7=A( .#9]O,J0=HZ!8 !^?QJZOV$@GB@7=[8>/?HD<
MH%VA:SFYJC&;Q9:(JSX#QF_I7,&U 5L\'YP.QN :..K@1P9<B+=:#7Q5C?X2
MKF+;^'$?P7 =^>LN\S97XQRT :IKT!P2AB, ,%H/GY$Y;5O5!,>%/4/I%B:Y
MY#TY(QYAXEH5F'"I=+$QTC57<#I,F=4YH&Q54<9E51++S<!@5D'D3;!1B5II
M=TM$>P3A1P_5B=$UQK>/M-A22ZLQ=T4KD@#5(9,X5S>L>>K1AR3^B-H9X1?!
M%*O;2RI0A\/6PHVL]^-D0.0(Z(H/Z"!+X4O(!$D9L6*<W1DA136<$."!_5VA
M[\)QG,+$9@K?;>K#!)9NE 8_Q$K++'<(&AMY&]A%\.0DR%$0O]TV:)_*$M'"
MM!(X@_0X#HH1TR/M2W?S,)J426+M[MELF\>R;3J@"F836?Q1<)O%44!<G6.P
M<ZM12=36$TX)I\(*BE!CC/"Q=1<AG!D?%HPUXR<,*XAY_[UG\D67P)%Z"0C;
MOMVB1"J:Q[Q#L>%62JQ0UM;(BG+'Y;5P:I+MT.*T=?!H1<"164.-!(-@:YAL
MF_=,MH3FK9 @N8')$8AU].CLFNY(Y+,5QD$;9LW3W:='>F8B9&VEY7Q!)C)>
MBFV;214_MIGOWNG/=O<',_76JQ>5H32<\E)O0]TJYE3OQ2%E;Z7C!;&B@^_O
MF<X!#H^<52*:L]B\UT*%<1^?#&//W#N<Y"68E8J3PD]]:3ZH9Y8>?PN'4I,R
MKK/S5M>;V+YRZ(J!FLVI10>>#"/J'O=7E<];> ^*C<(P0+VUVLZ)SG65J!1E
M:&]/SQZC7,W<[7HG(?(KP_0DK:"UK,K"]^'SJ!!@[$@QU540@8W%+2/ )2>0
M'+9$X81WJAKY;AJ@O%JMMU?=Q*&:&.(DQLXK*37'J3>5,5DD-LWH=*+WI4%(
M-JRD>><@=ZE+5;1-6,=\8?! 83\2;$%# 1F5@^PSFRGG[8D!,8G5&$:$-&/:
MUJ,Y=B#.CI@8H@#[VH_N,.I3B0>#4XE757X+QFVR4G4WB%SE*MY<5*GW5#8V
MJ&8=6P!A@2V BZ.Z438MZLL'!@H=>,NZ0$V>#9#O\HQ;EIFE6K5=41.;K7H5
MHOHTB4?H(^-14F;;F'ZD%MGB8$O[->M6C%1YAYA._!*="H<6J9!P&7?]*O 0
MPG[PQJ$B&P=OEF-WNUJ@@-H "%.N4,5@NR#,;F#N0#^]Z.PRA#SSX 95)3;[
M,#M%_\"\>FLJ7#(%W=(HC72? ;=!7X=O6&%D67$;7'R5)!!OC_/2<C<Y+%.%
M#2O( ,'$BVEK@*B=2KH6=DULKFZ"/%HFW[Y@/V]2OS_]LO]DD_H=BL(>7HWG
M!["[,?:)&^TZ^#0$'*_K$46*2MP%_((#M28S%^61,M'-3KU9,">W2:?B:DH/
MU#]F1DM\3;;@@SD6?LLGS#R?*]V8B&DR&,D^4?!DEXR;!E K<F?G0C.XK(T1
M/SP8NK89G^P]/R%A26(,:ZY8<&O=0JUD^"TA+ A E48L7]1><6ZC^B)[W%H5
M#N+:RXIG7^<B1.[Y')/"EQ@=J'#_L"FP__S9L4\Y]RD_;JO,;L2"T(]S1-C*
M;L'>->VA093]N),P@'*?[>9RFYX5ELFX%7NB /1T%-]4: \%C%$@OB MP+PJ
M]04WF 4M6/<\A'I\CA0W8(W;(E:[^WWLRM?H.F'TR1)3>?N[>.G.X5:XO>T;
M[(",AT,SU$8C8.HD\XD9T):1O6E%[1(:K3/$_M.='O6WM2X=5>JD0[1ZWO9U
M.SHJ@^.NP13.X;9;".A)D?DY\TP'4C@ >*=%5<^9P<_MFT+.KKB5@.ZWOD=1
M+'D(\[0L> B\6$G=3*6#<$%!0&R &HB=>YZB\\!!0'R_1M5B-RS%E]YK1&]-
MLX,0]2!GN@/L.J%O_RXK\0VUF=X0MK8;+J+)K./8B3P>.UV:.Y6;B37BNKAS
MM15L;QUL;[W:=G'Z9GG@7J*&B$*3!,FD9W41WE8@G#8<N'7O+M2=LA (O@I#
M7='?[5[(Y)OFB;HE'XE.L_ ?0;45ATAY?:7XK8@_>5O'4O162,J7I-&YO9;L
M%%4SM0+ VX&/,E>ZGR<.<1SGN+4UZB<*3'*M((&8>%O?!K_]='?_:"DVXI9_
M568S,%YVG^'EMRHGHC&Q\T>P13D-5$Y6J=%U06*]QJLM#J8>T8E+:1^:5X95
MH4A8O;:2-DDUK7A:'#()1R@+5[(H'DWEHP3?9K=:DR'24'"G9:6EK*I%\3OV
M<4^:M[6#>X#J*)*ZHR@?*C1$/1MF-_:WZFBQ#5LU(ET[)\KF#3J>!9.)E "@
M&XTJZ-ZB6ATT>YZZ%:F:V*JAL-<G,CB\(K03-$))TC?!]U6\>2, B.8#U7QC
MED[\ ^P6H&M*S ^E1;#INR;VV:[W6W;'Q:+<;:9HE9&YX%GAA^2N5KYW&X1B
M8QK/G:.&MB>!+]UJXJGIS)HB=CK1_;*P$,^<P)1,K!O2-KS9@5B,,NY\Q+ 6
M_"DE<27K)PB68!0GL47 VFCJNFB)X15\_8J+3JKY;7"WZE!4MXU^0T/D#2&A
M;CA[*S8Z TJ@UX4P">X,A0/Y[/C':S"2J(A 6Q'NK^H.ON.CRT9HW65]#J[A
M%<=<H9835;!:B3P?+Q-DB!2;929^&:<,4*$J0*/:,#35Y[ZC1Y%;ON.ZZM0"
MR]4>Y*;I.Q3&70:W!4-1B#/%.FP-" 0[D30NO4LC02M=S'.RC+DY([[17U4>
M%Y$XC7Q[</&B^DQTFY4.3 <&$E5B+!(,.+O)@]DD#KTBS&:J"?5P\E!T$EH4
M2MZ$4,$8*(W8P![5<)0(4:'WEN)J\AI@7K"(4@=VT/\P7-N-R+*.8;ASL3:'
MT/!*,4ZHR_ 0TM?U9 AW/^Z(PF!3P?$8-!0="]QJ!(P9\NBHY@US'U@\IX5/
MK*[.[LM.RV7A^;A)UZ5%Z+/=_;VAB-O^,4%DJ0V FBF:'.^MN@$+]R1"1W;U
MPN?4J;FPOXYNOH;O2J6HP[&0G-I.,5]$[+QA0F\8T!LVDOSL:G3&&AE^64<"
M6BC )_0:%->?Z_"*E-1A@3V,Y8\K[]^>^3!G^OSJ? /I(:H[ DC@F(<*>^$V
M2^#.01XCG1<B15/]E A)4/G6@I.\"XBYBP"(! W1Q7<;K,(BK,+1#XY56-&\
MATD03XO&CL C!RM2I2B8:IIU[GT<Q D<*!K^U.'S@_GD: !G)ZW/43(8R+\Y
M2CZ@UEDI(^*/&V![E['2STT5]EB7PO<[*1W^ <)9XI2SLA(:I\PA["*,SFE,
M.9IE-BK'A4T49,]+H0:XT6#:(I@JS I\R?@B_""R*5U;_><%S?OJ^G&YK04N
MPM5X8!9<%8GE9_IVI!_D-K5;BRN)K\1?FTF!4Q\AEHG4]SKYN/6)ANP/!D)O
M5,RIP8FNVCY=$A*N@Q&U')5-U<:%A;XBLT+::6)B3+H8!QR%V')"+''/[Y$K
M&B&NN2)VHCZ+<ZKX4[:*:^ ?)&%3.?*%]+P8\E'?6]%D!I[E<SG(:9__IH*D
MG.AFI_4Z2AM\*."9.8; PT1A]UBP@\.)"C]*N#Z/,?V'X\:HI_N5KH<>PSP[
M5[6*>>0-BX7^1K/,B#+K-U)-TPY.,=6<;4EGLW^<13 (!4WV$NAR(7>^9<0&
M"]C/RL&\X*G0Y)IW+IK95!BI'9K&M30H280,6&@[[9 **=QR)C]C>G,.2NEG
M-AXIK'M1XS$_[B'M?:>GKS53()Q+@ZD\,>?2>P))N!6NJSV?7LV-DAJI)+MK
M:@-3 M(93XF9$XB*T[6-9Y*9A#TV)U^#*5AP<SI.;1IUWS7Q8D9_3>)<>L6[
MFD@?J** -'% 3S'&IQESR/^5C23)R\3Q];<*DB)KOOCR%,U+TRI:1E@BOP</
MMN*^*YQB<#I N'Q<'=Q)!2>#P1C%3 !,Y&V<)?5?:PH2Y]"<$1DR5_+8\AW/
M:2A>#^^OCT,\F/(&QUJM,)Q%K3EWAX:_&"F+K@#A$CYP:O80.N,6&"F(&F]M
M\*92>V'30^.<7X!IKOB&K#/L%X"_,3<H84N@O2-@\)9#AP/1VQ]]1RO%NYAQ
M1B]LSAO #L,9,'WE,>048T0SHO;)FJXEZ!N5@-;(LS0.D=XS+:8Q%82Y[0*Q
M P>XM+17M+WF\:;UMG9GT7C;;TT!1G*-.TV@T-J8S<3T#;X^T =MS^\82'T@
M(\X___%\_^65693WN"AO"/4(JOKYX<L'O&5_S/.!DU/378[J6GSG3:#\IU_V
MCW^L0'F/H'QO _[\G??A_/K=V=65]^&WL\NSBS<K=68:&M4FX;HQ>P29$_7V
M;0"B:XT5UYC[D^JFPKX!!WL'^\L>#BRR?(P9A91'*M^A6N]9H5[H?[Q$7K D
MF+^(4QH#7?2R?KN.6:(=PE_;;;J[QUNUA#U71OK)\O4N??5S&;6_.]X].CKN
M_79O=[_WNT5W/7RZ^^3YX5>_[?'ND[W^;X=U5YB"XZ/^2]W;_DR+Q@L'LE&
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MZB;+G0&1]AF[^J3>NZ"(@K^U>U#F 1UDI-F=+0D7JE#15Z[BI]QMOSN[*8^
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M0L^0&X;.H4E<8TS)4W6L8G2VGH3KL0S(FZW73\I/J012&26Y.78 4$L#!!0
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M=D[^[%Z*\P_BZ+1S\KGW0Q"ZPW&V_Q1BK7[G'[MGW<L[MKS$#F$K[U;)[]:
M3M<-&O?MV?0^=ET"6JDG&N]P1PN3)2%((SJA,W[$21,0A)KORYN8NC(N$RB?
ML/NL+R-J$+!,R'A+!<-<$\^G6DX],$RT6B<V(Y)[;)9Z,ZS"4D+^(9PV9MB
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MEZ0P#^V+@UM (EPPC,Y-T*EI[[0#MQ"6S-B17(4IS7*;6TI?@=$T$*LVP@6
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M*Y_8()_<S[H*[^-&_)=+7=GYL=25#4R^@O\,LU'X[O\ 4$L! A0#%     @
MI3P&4P-):/)U2P  *?D! !(              ( !     &$Q,"UQ<3(R,#(Q
M,3 R+FAT;5!+ 0(4 Q0    ( *4\!E-)6>ID<0@  #0I   2
M  "  :5+  !A,3 M<7$R,C R,3,Q,2YH=&U02P$"% ,4    " "E/ 93S;"@
MZG8(   >*@  $@              @ %&5   83$P+7%Q,C(P,C$S,3(N:'1M
M4$L! A0#%     @ I3P&4\#*"&IL!@  ]!P  !(              ( ![%P
M &$Q,"UQ<3(R,#(Q,S(Q+FAT;5!+ 0(4 Q0    ( *4\!E/'/>A:6P8  ' <
M   2              "  8AC  !A,3 M<7$R,C R,3,R,BYH=&U02P$"% ,4
M    " "E/ 93DG">I!$? P"3?BD $0              @ $3:@  8W)O;BTR
M,#(Q,#8S,"YH=&U02P$"% ,4    " "E/ 93DQ#1-WD4  #CU@  $0
M        @ %3B0, 8W)O;BTR,#(Q,#8S,"YX<V102P$"% ,4    " "E/ 93
M\[(+0E(<  "C$@$ %0              @ '[G0, 8W)O;BTR,#(Q,#8S,%]C
M86PN>&UL4$L! A0#%     @ I3P&4S43M[5:=0  "%8% !4
M ( !@+H# &-R;VXM,C R,3 V,S!?9&5F+GAM;%!+ 0(4 Q0    ( *4\!E..
MV&/G0?H  )%["@ 5              "  0TP! !C<F]N+3(P,C$P-C,P7VQA
M8BYX;6Q02P$"% ,4    " "E/ 93M?)RZ*JE   =R0< %0
M@ &!*@4 8W)O;BTR,#(Q,#8S,%]P<F4N>&UL4$L! A0#%     @ I3P&4_9O
M!BB<=   W8 # !X              ( !7M % &5X,3 S<F]B97)T;6%D;W)E
M96UP;&]Y;65N+FAT;5!+ 0(4 Q0    ( *4\!E/&Z=4LC"L  #DD 0 5
M          "  39%!@!E>#$P-&IE<G)Y8F%R8F%T;RYH=&U02P4&      T
,#0!9 P  ]7 &

end
</TEXT>
</DOCUMENT>
</SEC-DOCUMENT>
